
side or (cc)
immunoreactivity model (nmod)
conducted studies (nsubjpass)
studies echocardiographic (amod)
l6 and (cc)
male adult (amod)
released recently (advmod)
tle ( (punct)
review addition (nmod)
exposed day (nmod)
ratio months (dep)
interaction report (appos)
efforts the (det)
hypotension deliberate (amod)
neuroinflammation : (punct)
fistula of (case)
superior : (punct)
used bypass (nsubjpass)
db 15 (nummod)
case discussed (acl)
tie possible (amod)
exhibited extracts (nsubj)
resembles . (punct)
patients men (dep)
increased change (conj)
called for (prep)
policy prescription (nmod)
had illness (dobj)
noted distress (nsubjpass)
$ROOT$ fell (sent)
consistent disease (nmod)
processes on (case)
functions quadriceps (compound)
to mainly (advmod)
provided solutions (nsubjpass)
pressure sitting (compound)
nifekalant over (case)
min i.p. (appos)
s. for (case)
suppress significantly (advmod)
nuclear both (cc:preconj)
results influenzae (appos)
ciprofloxacin- and (cc)
lowers vasodilatation (nmod)
secretion lh (compound)
cycle in (case)
followed regeneration (nmod)
% 9.4 (nummod)
developed given (advcl)
inhibits formyltransferase (dobj)
similar p (dep)
losses urinary (amod)
reduced acidification (nmod)
had switch (nmod)
phenomena thromboembolic (amod)
differ release (nmod)
snr ) (punct)
= auc (nsubj)
yield . (punct)
enhanced correlated (conj)
acid phosphatase (conj)
effect due (case)
telaprevir simvastatin (conj)
release ldh (compound)
recognised : (punct)
time aptt (appos)
faded h. (nmod)
derivatives gag (compound)
dialysis of (case)
reaction such (predet)
useful should (aux)
used ischaemia (nsubjpass)
defect be (cop)
sufficient presence (nsubj)
val/hctz mg (conj)
those mexiletine (nmod)
group non-pretreatment (amod)
field transplantation (nmod)
caused given (advcl)
showing decrease (dobj)
based changes (nmod)
pituitary on (case)
showing used (ccomp)
many whom (nmod)
markers camkiia (dep)
sensitivities beta-ccm (nmod)
use whose (nmod:poss)
conclusions found (appos)
immunoassay pg/ml (appos)
reshape also (advmod)
conjunction plasmapheresis (nmod)
origin , (punct)
signaling extracellular (amod)
100 1,000 (conj)
modeling pharmacokinetic (amod)
e4031 cisapride (conj)
tetracycline by (case)
wds ( (punct)
glycopyrrolate ( (punct)
records card (compound)
ability respond (acl)
likely they (nsubj)
inflammation intraocular (amod)
levels sodium (compound)
enhance that (mark)
risk failure (nmod)
formation aneurysm (compound)
spasm threatening (amod)
released , (punct)
seen levels (nmod)
mutants common (amod)
combination interferon (nmod)
gyrus dg (appos)
allografts and (cc)
rep ) (punct)
palpitation wave (appos)
40000 110000 (conj)
exposure mg/kg (nmod)
investigated not (neg)
skills social (amod)
normalized was (auxpass)
usage general (amod)
resistant mice (nsubj)
days treatment (nmod)
nurse emergency (compound)
anti-hbs ( (punct)
secretion factor (compound)
extract by (case)
anesthesia delivery (nmod)
cy of (case)
developing strategies (dobj)
associated vnr (nmod)
observed associated (ccomp)
cisapride = (parataxis)
jj or (cc)
rise hydrocortisone (nmod)
fluconazole , (punct)
mg/kg water (nmod)
= 193 (dep)
6 up (advmod)
reproducibility and (cc)
part process (nmod)
condition transplantation (nmod)
% 30.4 (nummod)
free and (cc)
trimethoprim cephalexin (conj)
patients with (acl)
reached , (punct)
discharges model (nmod)
measurements patients (nmod)
service at (case)
amount and (cc)
examine relevance (nmod)
organs other (amod)
recommended screening (nsubjpass)
pups in (case)
active-w trial (dep)
annulus on (case)
cycloheximide shown (acl:relcl)
given bladder (nmod)
drug first (amod)
phenacetin either (cc:preconj)
actions toxic (amod)
arrest through (case)
caused medication (nmod)
course exacerbation (nmod)
microg/kg/min , (punct)
study experimental (amod)
short- long-term (conj)
discusses it (nsubj)
drugs atypical (amod)
retention blunted (amod)
affected ee (nmod)
motility activity (conj)
hyperaldosteronism with (case)
administration aprotinin (nmod)
rbcs individual (nmod)
years childbearing (amod)
derivative attenuates (acl:relcl)
cases toxicity (nmod)
purpose complication (appos)
exercise the (det)
atropine after (conj)
addition monitoring (nmod)
agitated be (cop)
hypotension alpha2-adrenergic (amod)
neurotransmission stimulated (amod)
decreased occurred (conj)
untied atriotomy (nmod)
examined 11 (conj)
magnitude . (punct)
activity enzymatic (amod)
94 forty (compound)
doses txa (nmod)
reported % (nmod)
theophylline such (case)
presented symptoms (nmod)
desipramine ip (appos)
causes effective (advcl)
detoxification radicals (nmod)
findings baby (nmod)
accepted or (cc)
become patients (nsubj)
group lag (appos)
development vaccine (nmod)
toxicity celecoxib (nmod)
given repeatedly (advmod)
benzylthiouracil ) (punct)
blocked conversely (advmod)
death autophagic (amod)
p 0.005 (nummod)
rats dawley (amod)
switched rapamycin (nmod)
ear ipsilateral (amod)
administration lysozyme (nmod)
function polymorphism (conj)
models mice (nmod)
seizures hemiparesis (conj)
impaired are (aux)
followed fibrillation (nmod)
manifestations rash (nmod)
died disease (nmod)
daunorubicin liposomal (amod)
relationship severity (nmod)
injections intracavernous (amod)
dysfunction hypothalamic (amod)
zidovudine azt (appos)
tubule proximal (amod)
appeared patients (nmod)
mediate symptoms (dobj)
coma into (case)
pathways main (amod)
higher doses (nmod)
nephropathy mefenamic (amod)
process stress (compound)
below immediately (advmod)
factors these (det)
mm dimension (nsubj)
microinjection nmda (nmod)
infarction experimental (amod)
transporter net (appos)
test to (mark)
lipopolysaccharide , (punct)
wt/day ) (punct)
15 or (cc)
reached because (mark)
iief ( (punct)
tone neurogenic (amod)
exhibited level (nmod)
use any (nmod)
disappeared replaced (advcl)
terminated developed (advcl)
accounted exposure (nmod)
implications cost (compound)
confirmed fhf (dobj)
neurons ganglia (compound)
cause be (cop)
micromol 100 (nummod)
patterns failure (conj)
ingested are (auxpass)
change from (case)
dispersion transmural (amod)
consists discontinuation (nmod)
had lupus (dobj)
challenge naloxone (compound)
contributes dysfunction (nmod)
monitoring with (case)
tetrachloride- carbon (compound)
mediated mechanisms (nmod)
inhibitors sirolimus (appos)
trated were (auxpass)
cycle inthe (case)
recurarization of (case)
study alcohol (compound)
possessing properties (dobj)
had scored (conj)
proposal to (case)
describes treatment (nmod)
participants healthy (amod)
delivers . (punct)
cgrp of (case)
7.1 0.1 (conj)
radiographic contrast (conj)
caused diseases (nmod)
started have (xcomp)
cox-2 of (case)
ahs in (case)
excess serotonin (compound)
virus ( (punct)
failed prevent (xcomp)
association metolachlor (nmod)
polyuria marked (amod)
best correlation (nsubj)
d3 ) (punct)
estimated rats (nmod)
required be (auxpass)
potential ( (punct)
twenty to (dep)
course function (nmod)
cells mice (nmod)
immunosuppressant potent (amod)
ginsenosides components (appos)
reactions drugs (nmod)
localization in (case)
revealed resulted (ccomp)
attenuate acidification (nsubj)
seizures by (case)
rise pressure (compound)
n weeks (nmod)
damage may (aux)
climate hot (amod)
responses hr (compound)
affect produced (conj)
expression alphaenac (compound)
models epilepsy (nmod)
effect system (nmod)
done evaluation (nsubjpass)
nigerians in (case)
protection additional (amod)
factor-beta1 growth (compound)
deposition collagen (compound)
distributed unevenly (advmod)
alpha2-adrenoceptors presynaptic (amod)
lower seemed (conj)
neuroplasticity occur (acl:relcl)
discriminated was (auxpass)
= mg/kg/day (dobj)
sensation decreased (amod)
scale barnes (compound)
efficient to (mark)
offered have (aux)
side-effects systemic (amod)
lipids total (amod)
men 7 (nummod)
regained until (mark)
test both (cc:preconj)
toxicity direct (amod)
improved dyskinesias (nsubjpass)
disorders substance-induced (amod)
retested . (punct)
design different (amod)
ondansetron following (case)
palpitations p (dep)
effects induced (acl)
referrals 18 (nummod)
continue control (nmod)
enzyme cox-2 (compound)
woman using (acl:relcl)
107 from (case)
loss ml (conj)
$ROOT$ finally (sent)
outcome cases (nmod)
potentials convulsive (amod)
movements , (punct)
treatment mitomycin (compound)
hcfcs to (case)
mean of (case)
features the (det)
route venous (amod)
responses range (nmod)
= 79 (dobj)
emg fiber (compound)
% 183 (nummod)
precipitate bupivacaine (nsubj)
levels aminotransferase (conj)
wanted study (xcomp)
evidence scored (acl)
tumors . (punct)
line . (punct)
identical curves (nsubj)
lower iopentol (nmod)
8.5 2.0 (conj)
effect outcome (nsubj)
evidence rhabdomyolysis (nmod)
cell the (det)
aimed report (nsubj)
strains seven (nummod)
sensory , (punct)
pressure airway (compound)
$ROOT$ prominent (sent)
mmrm ( (punct)
completed infusion (nsubjpass)
improves affect (conj)
days 1433 (nummod)
influence not (neg)
test amphetamine-induced (amod)
syndrome sos (appos)
scintigraphy myocardial (amod)
shifts negative (amod)
shake wds (appos)
syringe a (det)
rats urethane-anesthetized (amod)
inhibitors or (cc)
triad the (det)
ketorolac ( (punct)
described variations (nsubjpass)
placed one (nmod)
$ROOT$ recognition (sent)
w-ich ) (punct)
administering injections (dobj)
results higher (appos)
revealed while (mark)
responses efferent (amod)
effects vascular (amod)
circulation anterior (amod)
address that (nsubj)
drug action (nmod)
$ROOT$ modifies (sent)
explored studies (nsubj)
looking changes (nmod)
vasculitis a (det)
criteria service (compound)
procedures requiring (acl)
fibres non-necrotic (amod)
determine maintained (ccomp)
women cpa/ee (nmod)
factors which (det)
reported similarity (nmod)
naloxone opioid (amod)
protects metformin (nsubj)
show produces (ccomp)
1,2-dmh ( (punct)
studied society (dobj)
achieved recovery (nsubjpass)
jj ( (punct)
withdrawn treatment (nmod)
remained range (nmod)
dose piperacillin/tazobactam (nmod)
administered injection (nsubjpass)
a/j ) (punct)
use analgesic (amod)
predominance with (case)
puberty at (case)
reduce dyskinesias (dobj)
that metabolism (nsubj)
life-threatening be (cop)
0.6 2 (conj)
improves functions (dobj)
subjected test (nmod)
dose smallest (amod)
gene ) (punct)
protects cortex (dobj)
attempt suppress (acl)
recognized increasingly (advmod)
placebo respectively (advmod)
engorgement sinusoidal (amod)
protein homer1 (nsubj)
assessed hematoma (nsubjpass)
sex female (amod)
immunosuppression of (case)
therapy statin (compound)
2.7 +/- (cc)
prevent and (cc)
were rats (nmod)
interrupted and (cc)
a c.695t (compound)
patients disease (dep)
tests antibody (compound)
experimental extensive (amod)
study double-dose (amod)
leukomalacia periventricular (amod)
contributes maintenance (nmod)
unclear mechanism (nsubj)
method comparison (conj)
decline documented (acl)
symptoms methylphenidate-induced (amod)
lamivudine the (det)
effect main (amod)
monotherapy either (det)
tasks ( (punct)
effects milder (amod)
became and (cc)
increase change (conj)
reversible that (mark)
causing neurotoxicity (dobj)
showed striatum (nmod)
trial non-randomized (amod)
reaction resulting (acl)
jc et (compound)
contributing frequency (nmod)
anatomical histological (conj)
c2 group (compound)
prescribed addicts (nmod)
inhibition extracerebral (amod)
= 11 (dobj)
investigation under (case)
dealt age (nmod)
region cells (conj)
degeneration group (nmod)
secondary ( (punct)
10 +/- (cc)
enzyme-1 ece-1 (appos)
maps coefficient (compound)
$ROOT$ same (sent)
administrated form (nmod)
unchanged which (nmod)
associated increases (nsubjpass)
test by (case)
mellaril ) (punct)
$ROOT$ consist (sent)
was calculated (ccomp)
activities with (case)
generation second (amod)
fall , (punct)
retention- of (case)
inhibition parp (nmod)
review cochrane (amod)
enzyme . (punct)
lowering at (mark)
therapy objective (compound)
rls ( (punct)
beating . (punct)
functions normal (amod)
bort mg/m(2 (appos)
endpoint this (det)
carry risk (dobj)
drugs compared (case)
cinacalcet with (case)
years 70+/-12 (nummod)
testosterone serum (compound)
acetyltransferase chat (appos)
benefits taking (advcl)
deteriorated , (punct)
ratios higher (amod)
acid prednisone (conj)
gestation weeks (compound)
produce acrolein (nsubj)
arrhythmia ouabain (compound)
observed cells (nmod)
sevoflurane during (case)
analyses restricted (acl)
toxicity urothelial (amod)
$ROOT$ reattempted (sent)
helpful may (aux)
word for (case)
nucleus matter (conj)
nx ) (punct)
documented . (punct)
enzymes anti-hcv (conj)
affected cells (nsubjpass)
department ed (appos)
values than (case)
molecule anionic (amod)
phase phase (conj)
questionnaire dysexecutive (amod)
abolish pretreatment (nsubj)
attenuated hyperactivity (dobj)
threshold of (case)
patients such (amod)
visibility the (det)
injection cyp (nmod)
effect methoxamine (nmod)
chow e-fortified (amod)
15 ( (punct)
evaluate to (dep)
toxic to (mark)
prostaglandins endogenous (amod)
findings current (amod)
times not (neg)
problem cell (compound)
risk noncompliance (nmod)
incidence syndrome (nmod)
haemorrhages petechial (amod)
concluded elicited (ccomp)
aggravate to (mark)
indicate prevented (ccomp)
health of (case)
conditions varied (amod)
neuroleptics other (amod)
same inflamed (nmod)
c. chronic (amod)
prevented mumol/kg (nsubj)
gestation with (case)
reduced x/minute (nmod)
consumption by (case)
observed convulsions (nmod)
serve monkeys (nsubj)
effects potent (amod)
following screening (appos)
patients cell (compound)
microl 2 (nummod)
depression st-segment (amod)
pointes presentation (dep)
administration 99mtc-glucarate (compound)
consisted schema (nsubj)
development myelosuppression (nmod)
antibody of (case)
pressure women (nmod)
subjects 5 (nummod)
increment glutamate (nmod)
epilepticus massive (amod)
dose dose (appos)
studied changes (dobj)
tool are (cop)
lost and (cc)
symptoms variants (nmod)
isopter to (case)
da of (case)
episodes 15 (nummod)
arch aortic (amod)
dysfunction triggered (acl:relcl)
patients counts (nmod)
trated conditions (nmod)
influence modulation (nmod)
continued appeared (advcl)
capsaicin to (case)
mediate angiogenesis (dobj)
appeared lesions (nsubj)
groups dosage (compound)
measurements day (nmod)
p-veps ) (punct)
described child (nsubjpass)
doses total (amod)
practices prevention (compound)
myocet or (cc)
continue discontinue (conj)
secondary inhibitors (nmod)
treatment antibiotic (dep)
interfere and (cc)
signs identifiable (amod)
observed changes (nsubjpass)
$ROOT$ dismissed (sent)
reduced improved (conj)
bands activity (nmod)
studies further (amod)
mmhg mmhg (conj)
times thromboplastin (compound)
evaluate threat (dobj)
angiography green (amod)
postcards regular (amod)
microinjection mk-801 (nmod)
combination same (amod)
caused are (auxpass)
justified hopes (nsubj)
synthesis regions (nmod)
remains lithium (nsubj)
reported cause (xcomp)
ami : (punct)
implications clinical (amod)
agents mentioned (acl)
placebo-controlled double-blind (amod)
experienced increasing (advcl)
increased irrespective (advmod)
sodium only (advmod)
clomipramine with (case)
surgery/radiotherapy or (cc)
att-alf on (case)
criteria response (compound)
amplitude for (case)
fifteen other (amod)
progenitor human (amod)
wr242511 ( (punct)
ratio range (dep)
less hundredth (nmod)
demonstrated agent (ccomp)
pharmacodynamics effect (nmod)
warning a (det)
$ROOT$ fas (sent)
believed impart (xcomp)
compliance impact (appos)
readmission at (case)
limit % (nmod)
$ROOT$ capsaicin (sent)
counteract even (advmod)
expressed ganglia (nmod)
receiving l-dopa (dobj)
consideration important (amod)
deficits unilateral (amod)
predictors three (nummod)
length or (cc)
receiving methadone (dobj)
concentration striatal (amod)
men years (ccomp)
amiodarone ; (punct)
role retention (nmod)
died hours (nmod)
count neutrophil (compound)
loss waveform (compound)
cd50 ) (punct)
presence stimulation (nmod)
reactions serious (amod)
induced collagen (nmod)
3.4 2.0 (conj)
leading retention (nmod)
reaching it (dobj)
shrinkage axon (compound)
cancer to (mark)
2 1 (conj)
class with (case)
life-threatening cause (conj)
treatment bmcs (nmod)
% stratum (parataxis)
mechanisms excitatory (amod)
determine responses (dobj)
days 7 (conj)
replicated b. (nmod)
diazepam than (case)
suggest requires (ccomp)
transcripts rna (compound)
homeostasis disturbed (amod)
suspension colloidal (amod)
episodes among (case)
encode and (cc)
involving hospitals (dobj)
vasospasm cerebral (amod)
produce condition (dobj)
reduced however (advmod)
cytarabine intrathecal (amod)
level-dependent oxygen (nmod:npmod)
suppression responses (nmod)
had to (mark)
antigen p24 (compound)
acidity the (det)
virus immunodeficiency (compound)
days 0.5+/-1.5 (nummod)
pattern response (nmod)
impact subspecialty (nmod)
fda by (case)
subjects and (cc)
contribution treatment (nmod)
had rr (dep)
ml(-1 r6 (appos)
reactivator pralidoxime-2-chloride (dep)
11 7 (conj)
disorders affective (amod)
mother cocaine-addicted (amod)
pyrazinamide for (case)
mellitus non-insulin-dependent (amod)
ppm 50 (nummod)
trends time (compound)
% 2.0 (compound)
led development (nmod)
appeared surgery (nmod)
glutamate glycine (conj)
ingestion prior (amod)
decreased has (aux)
patient followed (acl:relcl)
outflow due (case)
0.3 1.0 (conj)
b12 folate (conj)
umb24 and (cc)
pentobarbital , (punct)
g. 21.4 (nummod)
leading reportedly (advmod)
stabilized patients (nmod)
rate rapid (amod)
complication infusions (nmod)
variety of (case)
dose reporting (conj)
mg/m2/h 1,200 (nummod)
agents i (nummod)
withdrew . (punct)
changed but (cc)
block in (case)
bed to (case)
upregulation pvn (nmod)
syndrome attributed (acl:relcl)
disrupts that (mark)
using coil (dobj)
reduces anemia (nsubj)
enrolled 42 (conj)
analyzed levels (nsubjpass)
conduction s-a (compound)
populations the (det)
wt mg/kg (nummod)
infusions mug (dep)
dyscrasias described (acl)
anticoagulants coumarin-derived (amod)
excess catecholamines (nmod)
combination in (case)
using methodology (dobj)
expression hippocampus (nmod)
presence failure (nmod)
interaction such (predet)
markers , (punct)
creatinine sustained (amod)
older , (punct)
hemodynamics metabolism (conj)
effects gentamicin (nmod)
inhibited groups (nmod)
learning during (case)
immobilization her (nmod:poss)
deafened . (punct)
function processing (compound)
visits in (case)
protrusion chewing (conj)
ccu the (det)
treated charcoal (nmod)
woman white (amod)
propanolol administered (acl)
appendage atrial (amod)
rash macro-papular (amod)
describe course (dobj)
progression degree (nmod)
identified ultimately (advmod)
cohort in (case)
characteristics receptor (nmod)
years to (case)
volunteers of (case)
studied elucidate (advcl)
needed as (mark)
response nicotine-stimulated (amod)
suggest mode (dobj)
$ROOT$ number (sent)
microg/kg/min minutes (nmod:tmod)
layers bladder (nmod)
areas onset (nmod)
age period (conj)
system conduction (compound)
open patient (nsubj)
mi ) (punct)
lidocaine mg/kg (dep)
lithium vs. (cc)
represents , (punct)
dwi , (punct)
hands her (nmod:poss)
effect naloxone (compound)
telmisartan and (cc)
retention the (det)
have inactive (advcl)
blot immunohistochemical (conj)
factors . (punct)
role rate (nmod)
encephalopathy edema (conj)
therapy days (nmod)
implants stimulations (conj)
implications epilepsy (nmod)
anatomical aetiological (conj)
laboratory catheterization (compound)
long short (conj)
patients electing (acl)
thorazine ) (punct)
rofecoxib : (punct)
effects curves (nmod)
antagonizes caffeine- (punct)
value compared (case)
half about (advmod)
surgery in (case)
develop may (aux)
related methyldopa (nmod)
examination histological (amod)
penetrate barrier (dobj)
post-administration at (case)
-0.12+/-0.5 , (punct)
initiation days (conj)
apoptosis cells (nmod)
apoptosis cell (compound)
occur cardiomyopathy (nsubj)
effect primary (amod)
59.8 +/- (cc)
changed hand (nmod)
diagnosis developed (ccomp)
erpf ( (punct)
amphetamine mg/kg (dep)
myopathy of (case)
spite surgery (nmod)
loss dopaminergic (amod)
pr=0.515 ci (appos)
allocated , (punct)
micrograms/ml 150 (nummod)
beneficial dose-related (amod)
dynamics molecular (amod)
noted relief (nsubjpass)
found coefficient (parataxis)
considered rigidity (nsubjpass)
association antigens (nmod)
synthesis evaluation (conj)
women healthy (acl:relcl)
injections after (case)
conclusions reduces (appos)
beta-hydroxylase dopamine (compound)
gravity specific (amod)
transducer pathways (conj)
appears predominate (ccomp)
non-selective selective (conj)
efflux the (det)
damage hippocampal (amod)
m ( (punct)
group or (cc)
patients from (case)
oc any (det)
pilsicainide of (case)
survived or (cc)
rabbits non-anaesthesized (amod)
blockers , (punct)
highlights suggests (conj)
immunosuppression adequate (amod)
compromises approach (nsubj)
explored toxicity (nsubjpass)
groups nephropathy (compound)
safer and (cc)
velocity number (conj)
exhibited increase (dobj)
drugs offending (amod)
lead lesions (nmod)
enhanced ( (punct)
evident persisted (conj)
calculated divided (conj)
eyes normal (amod)
mm while (mark)
analogue somatostatin (compound)
urticaria and (cc)
register central (compound)
glomerulonephritis penicillamine-induced (amod)
reduced 2 (dep)
test contamination (nmod)
albuterol study (appos)
state similarities (nmod)
1.60 0.04 (nummod)
modifications the (det)
episodes in (case)
apap metabolites (conj)
mice swiss (amod)
produced onset (nmod)
demonstration to (mark)
roots nerve (compound)
supplemented glutamate (nmod)
attenuates eliminates (conj)
halothane or (cc)
number original (amod)
fluoxetine desmethylfluoxetine (conj)
hours . (punct)
durations , (punct)
vasospasm ischemia (conj)
satisfactory ease (nsubj)
physician the (det)
act otoprotectant (nmod)
hypersensitivity demonstrated (amod)
surgery primary (amod)
co-treatment agents (nmod)
deviation ) (punct)
nanoparticles of (case)
factor taken (advcl)
f ) (punct)
therapy ranitidine (compound)
death spread (amod)
$ROOT$ scattered (sent)
tested aggression (nmod)
effects recall (nmod)
assayed hepatocytes (nsubjpass)
hz 2 (nummod)
trial ii (nummod)
indicating have (ccomp)
antagonize block (dobj)
details the (det)
effect nerve (nmod)
levels states (nmod)
gds on (case)
3,4-methylenedioxymethamphetamine of (case)
effects oxycodone (nmod)
remained age (nsubj)
catalepsy morphine (compound)
efficacious levodopa (nmod)
discussed reviewed (conj)
60 or (cc)
daily ( (punct)
ko and (cc)
patients dysfunction (nmod)
clearance decreased (amod)
of : (punct)
min or (cc)
stressor 20-min (amod)
received whereas (dep)
pcc of (case)
count by (case)
therapy exposure (appos)
consists arteriolopathy (nmod)
using contraception (dobj)
bd1018 3s-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane (appos)
control rigidity (dobj)
patients man (appos)
degradative the (det)
di lithium-induced (amod)
infusion system (nmod)
behaviour , (punct)
involves gpi (dobj)
elevated while (mark)
feasible yet (cc)
bs br (conj)
compartments peripheral (amod)
maintained animals (nsubjpass)
day test (compound)
catheter a (det)
benzodiazepines midazolam (appos)
prooxidant a (det)
sensitivity for (case)
undertaken determine (ccomp)
acuity photophobia (conj)
events related (amod)
abnormalities st-segment (compound)
missing are (cop)
similar degree (nmod)
innervation intact (amod)
arrhythmias on (case)
prevented and (cc)
that propranolol (nmod)
toxicity in (case)
colitis for (case)
induced isoniazid (nmod)
damage late (amod)
estradiol- and (cc)
women these (det)
measures cognitive (amod)
staining violet (amod)
studied volunteers (nsubjpass)
conditions predisposed (acl:relcl)
damage oxidative/nitrative (amod)
changes report (dep)
animals controls (conj)
common although (mark)
stimulate activity (dobj)
aggression for (case)
mg/dl micromol/l (appos)
rise by (case)
onset during (case)
case each (dep)
used diseases (nmod)
hypotension to (case)
umax ( (punct)
associated failure (nsubjpass)
doses recommended (amod)
$ROOT$ symptomatic (sent)
2.1 ( (punct)
observed damage (nsubjpass)
restricted workers (nmod)
resuscitation patients (nmod)
resulted loss (nsubj)
period relaxation (compound)
discribed . (punct)
patient-years in (case)
increases cortisol-induced (amod)
period periconception (compound)
incidence importance (conj)
patient year-old (amod)
patients hypothyroid (amod)
amlodipine of (case)
tested group (nmod)
bpm to (case)
risks due (amod)
metabolizer poor (amod)
mid- and (cc)
allopregnanolone not (cc)
observed reflex (dobj)
osmolality urinary (amod)
suppressants belgium (nmod)
neurons dopaminergic (amod)
reported mastodynia (nsubjpass)
affects and (cc)
improves it (nsubj)
doses ephedrine (nmod)
tg without (case)
dba/2j , (punct)
decreased movements (dobj)
vt with (case)
metabolites non-deacetylated (amod)
93 +/- (cc)
fatal uncommon (conj)
mmc doxorubicin (conj)
dose subconvulsive (amod)
150 , (punct)
memory stm (appos)
transplanted emergently (advmod)
delta22-isomer identified (amod)
developed analyze (xcomp)
gene serotonin (compound)
patient 38-year-old (amod)
half-life cocaine (nmod)
icv ; (punct)
led onset (nsubj)
l-arginine with (case)
$ROOT$ discontinued (sent)
degeneration axonal (amod)
e18.5 until (case)
increased coadministered (advcl)
severe less (advmod)
suggested mimic (xcomp)
mapping electrodes (nmod)
distinguished that (nsubjpass)
prolactin ng./ml (nmod)
maze by (case)
smoked mean (dobj)
dizziness palpitation (conj)
decreased glutathione (dobj)
addition calcium (nmod)
occurring trauma (nmod)
$ROOT$ frequent (sent)
ci 3.4 (appos)
sedative studies (nmod)
conjunctiva gellan (appos)
patient(s ): (punct)
2 sertraline (nmod)
point 8-week (amod)
agent antitumoral (amod)
confounders for (case)
weighed doses (nmod)
dizziness and (cc)
document results (nsubj)
lower mm2 (dep)
september 1997 (nummod)
weakness administration (conj)
mg + (cc)
acidosis to (case)
receptor ccl2 (nmod)
needs system (nsubj)
neurons commissure (nmod)
plasma liver (conj)
treated lithium (nmod:npmod)
noncompliance ( (punct)
ciprofloxacin oral (amod)
determined testosterone (nsubjpass)
33 3 (conj)
flushing facial (amod)
expression genes (nmod)
episodes acute (amod)
isoniazid with (case)
$ROOT$ fail (sent)
embolus pulmonary (amod)
found infiltrations (nsubjpass)
diclofenac 1.17 (nummod)
hepatitis patients (nsubj)
pulmonary capillary (dep)
failed ginsenosides (nsubj)
volume administered (acl)
attempted was (auxpass)
reduced cost (conj)
deficit the (det)
profile doses (nmod)
identified cause (nsubjpass)
case implicating (acl)
rates normalization (compound)
received clioquinol (dobj)
farmer a (det)
modification the (det)
inhibitor group (compound)
icp mmhg (appos)
data among (case)
infrequent myelopathy (nsubj)
history detailed (amod)
reserpine acute (amod)
encephalopathy icterus (compound)
group-1 in (case)
kurroa picrorrhiza (compound)
thousand per (quantmod)
pesticide is (cop)
5 10 (prep)
mitigating in (mark)
44.8 ( (punct)
reactions skin (compound)
recovered was (auxpass)
resulted symptoms (nmod)
cancer it (nsubj)
stopped had (aux)
necrosis renal (amod)
saline vehicle (appos)
twenty-three percent (dep)
glomerulopathy between (case)
reversal in (case)
inhibitor polymerase (nmod)
stress pain (conj)
tacrolimus and (cc)
nausea cisplatin-induced (amod)
present arteries (nmod)
drugs nsaids (conj)
users heavy (amod)
decreased group (nmod)
factor atrial (amod)
teams neurointensivists (conj)
affecting agents (nsubj)
flushing line (dobj)
responses norepinephrine (nmod)
unclear : (punct)
reduced fragmentation (dobj)
(meth)-induced methamphetamine (nmod:npmod)
urine of (case)
apoptosis from (case)
infusion ethanol (compound)
infusion 4-day (amod)
later months (nmod:npmod)
given subregion (nmod)
urotensin-ii administered (acl)
patient an (det)
1.9 +/- (cc)
mg 4.0 (nummod)
therapy symptomatic (amod)
channel dihydropyridine (compound)
increased protocol (nsubj)
infusions during (case)
aggregation the (det)
greater ctnt (nsubj)
efficacy ribavirin (nmod)
implicated syndrome (nmod)
locomotion behavior (conj)
time test (nmod)
onset distress (nmod)
ich 3 (nummod)
17.5 15 (compound)
included ncs (nsubj)
factor-alpha activity (conj)
rhythm circadian (amod)
interaction resulting (acl)
therapeutic an (det)
psychopathology performance (conj)
p=0.0001 , (punct)
received adjunct (nmod)
changes protein (compound)
case investigated (amod)
disease self-reported (amod)
preferred be (auxpass)
sensations or (cc)
produces pdn (nsubj)
hg 40 (nummod)
mechanisms buildup (nmod)
antipsychotics generation (compound)
three about (advmod)
inhibit reuptake (dobj)
discharged result (advcl)
associated vigabatrin (nmod:npmod)
sympathomimetic a (det)
significant . (punct)
agents four (nummod)
16;567 571 (prep)
developed monotherapy (nmod)
greater conditioning (nmod)
participation hypotension (nmod)
adding or (cc)
disorders comorbid (amod)
patients urticaria/angioedema (nmod)
% whom (nmod)
46 +/- (cc)
had recovered (conj)
tna ( (punct)
pill slimming (compound)
out-patients 46 (nummod)
1.13 ( (punct)
halothane ( (punct)
dex alone (advmod)
nature of (case)
$ROOT$ unnecessary (sent)
rns ) (punct)
markers inhibitor (conj)
approval ethical (amod)
rebounded . (punct)
anaesthesia solution (nmod)
suggested c (nsubjpass)
drug adrenergic (amod)
performed confirm (advcl)
111.0 and (cc)
transporter-1 glyt1 (appos)
content rats (nmod)
dialysis continuous (amod)
151 group (nmod)
surgery within (prep)
isoflurane with (case)
debate under (case)
molecules , (punct)
$ROOT$ augmented (sent)
search medline (compound)
number x (cc)
2.4 between (case)
2.31 1.11 (compound)
risk use (conj)
enzyme marker (compound)
60 ( (punct)
increased blockade (nsubj)
action therapeutic (amod)
irradiation chemotherapy (conj)
trials patients (nmod)
ecg length (dep)
35 about (advmod)
cortex auditory (amod)
mu/kg ) (punct)
malfunctioning an (det)
modified . (punct)
weeks 14 (nummod)
setting in (case)
coxii coxiv (conj)
two dogs (nmod)
report combination (nmod)
achieved exhibited (advcl)
myocarditis hypersensitivity (amod)
organelles not (neg)
administered jointly (advmod)
prolonged duration (dobj)
model infection (appos)
hypersensitivity carbamazepine (nmod)
modification propranolol (nmod)
clonidine not (cc)
received ug (dobj)
hyperkinesis irritability (conj)
thrush oral (amod)
use frequent (amod)
produced also (advmod)
relapse therapy (nmod)
hypothyroid who (nsubj)
dimension patients (nmod)
nitroglycerin micrograms/kg (appos)
ntg nimo (conj)
found reduction (nmod)
leading palsy (nmod)
cyclosporin niacin (conj)
motoneurons the (det)
case induced (amod)
advised abortion (nsubjpass)
immobilization 5-day (compound)
treated tablet (nmod)
proliferation n-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced (amod)
obtained that (mark)
eruption involves (acl:relcl)
mrp2 pgp (conj)
attenuation nanosphere (nmod)
dynamics related (amod)
presented patients (nsubj)
cardiotoxin adriamycin (nsubj)
biomarker feasible (amod)
mmhg anaesthesia (nmod)
field a (det)
renin renal (amod)
alpha-mediated are (cop)
study during (case)
obtained only (advmod)
observations to (case)
decreases interval (nsubj)
assigned method (nmod)
times baseline (appos)
mg 0.4 (nummod)
extremity lower (amod)
presented agitation (dobj)
aprotinin a (appos)
flutamide ) (punct)
8-phenyltheophylline enprofylline (conj)
interfere statins (nsubj)
methods : (punct)
gfc ( (punct)
able subjects (nsubj)
alterations complex (amod)
extent affect (nmod)
case patent (nmod)
ineffective while (mark)
damage neurons (dobj)
$ROOT$ implanted (sent)
profile clear (amod)
decrease degree (nmod)
density concentration (conj)
results largely (advmod)
amphetamine , (punct)
availability increased (amod)
useful contexts (nmod)
units , (punct)
enhancement model (nmod)
frequency abnormality (nmod)
fed were (auxpass)
therapy alpha-2b (nmod)
bp injury (conj)
index activity (compound)
observed trend (nmod)
control routine (amod)
data in (case)
) + (cc)
effect therapeutic (amod)
occurred six (nmod)
curves dose (compound)
count cell (compound)
considered performed (advcl)
changes through (case)
concentration . (punct)
delirium the (det)
cases reported (amod)
hyperalgesia with (case)
tumors papilloma (dep)
ulcer to (case)
substratum and (cc)
aware tolerated (advcl)
plasma tissue (conj)
pain precordial (amod)
therapy hyperthyroidism (nmod)
utero exo (amod)
determined related (conj)
dependent magnitude (nsubj)
activity unaccustomed (amod)
$ROOT$ allowed (sent)
alternations and (cc)
occurred usage (nmod)
patients underwent (dep)
are also (advmod)
hz 5v (conj)
studies early (amod)
5-micrograms/kg min (nmod)
exert tissue (nmod)
established . (punct)
increased 2.8 (nmod)
density expression (conj)
hepatotoxicity agents (nmod)
testosterone with (case)
(dex)-induced dexamethasone (nmod:npmod)
so more (advmod)
isomer 3-hydroxy-n-methylmorphinan (nmod)
pressure percentage (nmod)
explore anatomy (dobj)
change caused (conj)
anticoagulants not (cc)
hh 18.88 (dep)
methods examined (appos)
moles/glomerulus ) (punct)
wave gender (conj)
hour hour (conj)
increase 5-fold (amod)
known increase (xcomp)
studied mortality (dobj)
genotyped rs4704559 (nmod)
indomethacin agents (conj)
ltp ( (punct)
used prophylaxis (nsubjpass)
associated depression (nsubjpass)
tubule segments (conj)
rationale induces (appos)
rats regimens (nmod)
edema is (cop)
class ldl (compound)
systems microsomal (amod)
recurrence no (neg)
anti-hcv and (cc)
vessels and (cc)
mitochondria , (punct)
value to (mark)
induced : (punct)
pre-treatment microperfusion (nmod)
symptoms most (amod)
benign self-limited (conj)
sprague-dawley sd (appos)
genes multiple (amod)
treatment mice (nmod)
flow intracranial (amod)
constriction field (compound)
lesion addition (nmod)
effective dose-dependent (conj)
increase 3 (dep)
observation resolution (conj)
weight by (case)
pa ) (punct)
dfmo ) (punct)
neuroplasticity in (case)
administration before (nmod)
observed therapy (nmod)
noted methods (nsubj)
transplantation full-size (amod)
concluded be (auxpass)
maintained discontinued (advcl)
gls grs (conj)
benefits only (amod)
reducing pain (dobj)
delta theta (conj)
treatment salvage (amod)
components early-acting (amod)
stopped if (mark)
revealed angiogram (nsubj)
micrograms/kg 100 (nummod)
promote catalepsy (dobj)
measurement turbidometric (amod)
caused coniine (nmod)
resistance of (case)
instilling by (mark)
understood pathophysiology (nsubjpass)
recover h (nmod)
role worsening (nmod)
coeruleus locus (compound)
gm with (case)
concentrations flestolol (nmod)
either drugs (nmod)
mechanisms influence (acl:relcl)
injected dose (nmod)
substitutes aprotinin (nmod)
attack no (det)
followed up (compound:prt)
induced period (nmod)
sensation smelling (advcl)
significant decreases (nsubj)
oscillations from (case)
trigeminal and (cc)
levels of (case)
incidence population (nmod)
seem cause (xcomp)
gds ( (punct)
64 75 (conj)
shortened period (nsubj)
unnecessary yet (advmod)
injections with (case)
rad001 , (punct)
arrhythmias no (neg)
levels histology (conj)
test step-through (amod)
state activation (compound)
administration bn (nmod)
$ROOT$ relieved (sent)
changes appreciable (amod)
ratios non-users (nmod)
required tested (ccomp)
use acid (dobj)
treated days (nmod)
lead by (case)
benefit not (neg)
lidocaine succinylcholine (conj)
mi suspected (amod)
dysregulation lipid (compound)
healthy women (conj)
evaluation vnb (nmod)
months period (nmod)
nsc 343499 (nummod)
atria guinea (compound)
animal clinical (conj)
90 than (quantmod)
rate function (conj)
associated episodes (nmod)
increase would (aux)
rare fatal (conj)
given drugs (nsubjpass)
slowing % (nmod)
threshold mean (compound)
hepatotoxicity induced (acl)
clonidine by (case)
blocked rp (nmod)
protocol similar (amod)
showed erdosteine (nsubj)
decreased = (parataxis)
courses regimen (nmod)
raises it (nsubj)
synthesized develop (advcl)
antagonizing interaction (nmod)
therapy standard (amod)
dogs instrumented (amod)
studies toxicity (compound)
speaking ) (punct)
followed routes (nmod)
3722 3551 (conj)
loss complication (nsubj)
design counterbalanced (amod)
elevated administration (nsubj)
deposits tubular (amod)
u-ii ) (punct)
ina ) (punct)
changes meshwork (nmod)
recovered surveillance (nmod)
disorders rheumatologic (amod)
oltx ( (punct)
types lesions (nmod)
impairment of (case)
patients demonstrating (acl)
effects sumatriptan (nmod)
minor has (aux)
found ethopropazine (nsubjpass)
nuclei cerebellum (nmod)
changed fos-ir (nsubjpass)
averaging ; (punct)
conventional either (cc:preconj)
five patients (nmod)
efficacy substantial (amod)
provides summary (nmod)
had received (conj)
detected cin (nsubjpass)
controlling for (mark)
hypertension use (conj)
ich and (cc)
variability hyperalgesia (nmod)
deformations the (det)
concept effective (ccomp)
revealed biopsies (nsubj)
damage severe (amod)
clonidine = (dep)
chorea or (cc)
nausea leukopenia (conj)
grs ( (punct)
prior insult (nmod)
increase after (case)
patient nonepileptic (amod)
lymphomas indolent (amod)
neuroinflammation treatment (nmod)
treatment azathioprine (compound)
deficit neurological (amod)
greater significantly (advmod)
syndrome seem (acl:relcl)
worsen injury (dobj)
regimen 5-fu/fa/mmc (nsubj)
activated ages (nmod)
variation inter- (amod)
products tie2-cre;loxp-egfp (conj)
effect antiadrenergic (amod)
less which (nsubj)
background derivative (appos)
everolimus derivative (appos)
methamphetamine by (case)
reduces pb (nsubj)
treatment efficacy (dep)
screenings of (case)
cardiomyopathy disease (conj)
anova p (appos)
infection hiv-1 (compound)
dilatation mimicking (acl)
ng 500 (nummod)
indistinguishable . (punct)
increase threshold (dobj)
reactivity agonist (nmod)
added . (punct)
odds reduced (amod)
calculate , (punct)
arag to (case)
21 to (case)
factors discount (conj)
interaction series (dep)
transaminase aspartate (compound)
cases nephritis (nmod)
indicate perspective (dep)
increases dyskinesia (nmod)
hundred and (cc)
shown radiograph (nmod)
use individuals (nmod)
rtms sham (amod)
period october (nmod)
patient thalassemia (nmod)
case poisoning (nmod)
preceded occlusion (nsubjpass)
findings histopathologic (amod)
oedema for (case)
microl ; (punct)
included total (nsubjpass)
anaesthetic spinal (amod)
vasodepressor or (cc)
measured using (advcl)
% 37 (nummod)
consisted group (nsubj)
patient 50-year-old (amod)
galantamine inhibitor (appos)
responses prolactin (compound)
97.1 . (punct)
reduced treatment (nmod)
angiography cerebral (amod)
produces readily (advmod)
hyperthermia methamphetamine-elicited (amod)
inpatients clozapine-treated (amod)
damage endothelial (amod)
biopsies liver (compound)
use predominant (amod)
concept this (det)
devastation on (case)
dosing multiple (amod)
aware however (advmod)
disease lupus (appos)
action potent (amod)
database patients (nmod)
demonstrated we (nsubj)
1984 1990 (conj)
damages neuropathological (amod)
receive which (nsubj)
subgroups between (case)
predominant frontally (advmod)
% children (nmod)
complication potential (amod)
detected plasma (nmod)
expression bcl-2 (nmod)
syndrome doxorubicin-induced (amod)
htr6 patients (conj)
injections pan (compound)
agent tamoxifen (nsubj)
block estimate (conj)
display umb24 (nsubj)
training pa (compound)
hours instillation (nmod)
dullness percussion (nmod)
incidence recurrence (nmod)
gallstones without (case)
mol/l were (cop)
procedures unnecessary (amod)
exposure acid (compound)
treatment time (nmod)
l-alpha-glycerylphosphorylcholine l-alpha-gfc (appos)
% 24.3 (nummod)
eyes banks (nmod)
operations these (det)
development observation (nmod)
magnitude may (aux)
replicated , (punct)
improved p<0.0005 (parataxis)
done buffers (nmod)
induced independently (advmod)
appears presence (xcomp)
fibrillation associated (acl)
months groups (nmod)
twitches diaphragm (nmod)
discharged ed (nmod)
investigations radiological (amod)
review admissions (nmod)
exploration open (amod)
disorder thrombocytopenia (nsubj)
acts facilitate (xcomp)
cyp3a4 ( (punct)
failure reversible (amod)
lowered be (cop)
treat infection (dobj)
injury kidney (compound)
dependence of (case)
stent with (case)
diagnosed 14 (nmod)
methods indirect (amod)
iii ) (punct)
is that (advmod)
reported , (punct)
66 6 (conj)
evaluation preoperative (amod)
3.1 : (punct)
reverses naloxone (nsubj)
receptor chemokine (compound)
$ROOT$ encephalopathy (sent)
resulted resolution (nmod)
history negative (acl:relcl)
effects exercise (nmod)
drugs , (punct)
addition this (nmod)
76 94 (prep)
male developed (acl:relcl)
review by (case)
receiving lindane (nmod)
examination histopathological (amod)
identified investigation (nmod)
dynamic pressure (compound)
decreased alter (conj)
withheld while (mark)
% ef (nsubj)
specificity staining (nmod)
duration cross-clamp (nmod)
method standard (amod)
testing conventional (amod)
patient taking (acl)
evaluated audiograms (nmod)
neurotoxicity paclitaxel (compound)
vancomycin of (case)
toxicity ethambutol (compound)
levels kinase (compound)
was reported (ccomp)
antagonized exceed (advcl)
models deficiency (nmod)
phenotype b6 (compound)
uses atropine (nmod)
10,000 1 (compound)
occurred while (mark)
declines function (nmod)
stimulant new (amod)
system endogenous (amod)
transporter efflux (compound)
interaction model (nmod)
assessed coordination (dobj)
preparation an (det)
background/aims found (dep)
interviewed = (parataxis)
dosage nor (cc)
1.19 of (case)
= 0.02 (dobj)
lower prevalence (nsubj)
sites major (amod)
genes among (case)
assessed toxicities (nmod)
p-glycoprotein , (punct)
dose adr (nmod)
inhibit drugs (nsubj)
dysfunction infants (nmod)
taken time (nmod)
administered determine (advcl)
involved system (nmod)
upregulation compensatory (amod)
yis diazinon (nsubj)
ischaemic and (cc)
115 +/- (cc)
mice the (det)
preference place (compound)
hypotension because (case)
produced hypotension (dobj)
$ROOT$ assumed (sent)
% -27.4 (nummod)
pursued dissociated (advcl)
different normal (nmod)
damage both (cc:preconj)
facilitates helpful (conj)
tissues both (det)
increase scenario (nmod)
lnaa ( (punct)
catheters arterial (amod)
improved alternative (conj)
den mg/kg/day (appos)
enhance toxicity (dobj)
had all (nsubj)
unclear however (advmod)
regressed manifestations (nsubj)
standard the (det)
treated symptom (nsubjpass)
make not (neg)
observed monkeys (nmod)
proteins form (acl:relcl)
toxicities seven (nummod)
time angiography (nmod)
effects zidovudine-related (amod)
block non-depolarizing (amod)
conjunction antidepressants (nmod)
detection chromatography-electrochemical (amod)
acid-containing folic (amod)
age years (nmod:tmod)
younger patients (conj)
blunted absence (nmod)
scans tests (conj)
pleased and (cc)
mesencephalon the (det)
$ROOT$ variable (sent)
moving anaesthetised (conj)
impairs function (dobj)
function model (nmod)
infusion an (det)
trial placebo- (amod)
block s-a (compound)
targets promising (amod)
out proteins (nmod)
procedures standard (amod)
found hdl (nmod)
lvef of (case)
pentylenetetrazole by (case)
pharmacokinetics steady-state (amod)
reported because (mark)
injection bromocriptine (nmod)
observed rtms (nsubjpass)
stimulation locomotor (amod)
mg/m2 before (case)
use level (nmod)
articles retrieved (amod)
attractive . (punct)
determined were (auxpass)
effect only (amod)
data metabolic (amod)
alerted effect (nmod)
k body (compound)
hr doses (nmod)
ng/kg/min = (dep)
effect ulcers (nmod)
cause respect (nmod)
doses single (amod)
quinine , (punct)
creatinine higher (amod)
seizures de (amod)
antagonist mglur1 (compound)
antagonists n-methyl-d-aspartate (compound)
aap ( (punct)
primary cortex (conj)
mdp ) (punct)
function forelimb (compound)
short relatively (advmod)
disease renovascular (amod)
reshaping this (det)
relationship concentration-effect (compound)
d-galactose c-4-epimer (dep)
stimulated use (nmod)
found cortex (nmod)
responsible increase (nmod)
succinylcholine therapy (nmod)
used mri (dobj)
weight peroxidation (appos)
nimo with (case)
contraceptive combined (amod)
kinase ampk (appos)
imaging dw (compound)
cystitis chemical (amod)
1.0 10(-6 (conj)
animal 's (case)
decreased immunostaining (nsubj)
effects oih (nmod)
models pd (nmod)
need treatment (nsubj)
psychosis related (amod)
concentrations me (nmod)
lead stimulation (nsubj)
risk hypocalcemia (nmod)
1.68 adjustment (nmod)
thiopental with (case)
developed polymyositis (dobj)
$ROOT$ aneurysms (sent)
stability ensues (conj)
electrocardiograph continuous (amod)
days ingestion (nmod)
shr.(abstract in (case)
fingers left (amod)
k- and (cc)
avoided possible (advcl)
2 up (advmod)
rate arterial (amod)
gtn the (det)
35.9 +/- (cc)
taken effective (advcl)
process pathogenic (amod)
scenario it (nsubj)
dose isoflurane (nmod)
bupropion sustained-release (amod)
component as (case)
tested study (nmod)
gt/bc ( (punct)
life-threatening may (aux)
minutes t(1/2 (nsubj)
characterize . (punct)
p9605 on (case)
roots and (cc)
details induction (nmod)
that caused (acl)
rate for (case)
generated test (advcl)
remains that (mark)
form an (det)
evidence neuroradiologic (amod)
intake and (cc)
developed coincident (ccomp)
increases remains (advcl)
25 to (case)
leading termination (nmod)
using to (mark)
lowering pressure (dobj)
observed rating (nmod)
had instilled (ccomp)
failure liver (compound)
> years (dep)
possibility causes (ccomp)
tolerated mg/d (nmod)
derived studies (nmod)
sufficient was (cop)
function hypotension (nmod)
pointes recurrent (amod)
drugs block (acl:relcl)
hcva and (cc)
consistent experiment (nmod)
assessed eyes (dobj)
pmol ( (punct)
synthesis/turnover 5-hydroxytryptamine (nmod)
subanalyses 2 (nummod)
partial complete (conj)
spect with (case)
15/44 sgk1(+/+ (nmod)
damage by (case)
antagonists receptors (compound)
excretion sodium (nmod)
ctnt ck (conj)
mg 150 (compound)
density in (case)
induced apoptosis (dobj)
zymosan opsonized (acl)
conclude invariable (ccomp)
missed have (aux)
opioid . (punct)
changes granular (amod)
pneumonia adequate (amod)
absence and (cc)
volume either (cc:preconj)
increment potassium (compound)
initiated have (aux)
facilitate use (nsubj)
pathogeneses which (nmod)
hormone concentrations (conj)
carotid arteries (conj)
both 1 (appos)
markers three (nummod)
produced pge2 (nsubj)
remained hand (nmod)
prochlorperazine with (case)
cause metabolite (nmod)
not numerically (advmod)
latency daytime (amod)
administered weight (dobj)
affected atorva (nsubj)
observed if (mark)
n-acetyl-beta-d-glucosaminidase -- (punct)
complicate course (dobj)
banks regional (amod)
amyloidosis renal (amod)
illness confirmed (acl:relcl)
falls patients (nmod)
performed exercise (nsubjpass)
by and (cc)
impairment age-dependent (amod)
stenosis coronary (amod)
follow-up average (amod)
disorders heredofamilial (amod)
symptoms : (punct)
acidity whether (mark)
disrupts triad (dobj)
effect failure (nmod)
found rate (nsubjpass)
investigation role (nsubj)
discontinued events (nmod)
$ROOT$ akathisia (sent)
overdose pemoline (compound)
pre-administration chloride (nmod)
hypertrophy greater (amod)
degeneration as (cc)
maximum ] (punct)
toxicity anaesthetic (amod)
ed(50 ( (punct)
indicated lowering (nmod)
135 45 (conj)
compared acid (nmod)
agents antiepileptic (amod)
group anemia (compound)
hours 5 (nummod)
measured method (nmod)
inhibits catabolism (dobj)
followed administration (nsubjpass)
damage adducts (nmod)
monitoring levels (dobj)
reducing harm (dobj)
thrombosis pulmonary (amod)
produce while (mark)
observed cisplatin (nmod)
related increase (nsubj)
p2x3 receptors (conj)
degree this (det)
sufficient se (advmod)
ci=1.154 7.142 (prep)
measurements repeated (amod)
availability cardiomyocytes (nmod)
group mr (nmod)
detected antibody (nsubjpass)
analyses these (det)
all weight (nmod)
day 6 (nummod)
therapy frequency (conj)
u/ml 204 (nummod)
administration propofol (compound)
libitum-fed ad (amod)
metronidazole of (case)
protocol succimer (compound)
treated pulse (nmod)
effects learning (nmod)
weeks 40 (nummod)
product compared (case)
form after (case)
examination postoperative (amod)
interim the (det)
decreased study (nmod)
ratios odds (compound)
functional that (mark)
reports included (acl:relcl)
treatment ancrod (compound)
functions damage (conj)
nephrectomy , (punct)
follow-up cardiac (amod)
cause complication (dobj)
disease sporadic (amod)
proof , (punct)
mesothelioma leiomyosarcoma (conj)
treatment thalidomide (nmod)
cortisol diurnal (amod)
p greater (amod)
treatment infection (nmod)
nf-kappab ) (punct)
tested also (advmod)
mechanism this (det)
effects psychological (amod)
s stereotyped (amod)
oil lemon (compound)
ep ) (punct)
plasma proteinuria (conj)
given minutes (advmod)
age assessed (acl)
cause loss (dobj)
complication well-known (amod)
pupil of (case)
caused m. (punct)
levels upper (amod)
increased behavior (dobj)
events on (case)
value , (punct)
highlight factors (dobj)
exhibite range (nmod)
injury hepatomegaly (conj)
obtained biopsy (nsubjpass)
sensitivity bfu-e (nmod)
type cm (nmod)
cent 1 (nummod)
measure decrease (nmod)
sensitivity etoposide (nmod)
water tonic (amod)
respect animals (nmod)
shift extracellular (nmod)
halothane enflurane (conj)
type changes (nmod)
domperidone , (punct)
7.1 to (advmod)
behaviors aggression (appos)
3.0 0.2 (conj)
ataxia giddiness (conj)
injection anaesthesia (nmod)
anemia patient (nmod)
hepatitis clinical (amod)
relevance potential (amod)
mg. 0.5 (nummod)
associated disruption (nsubjpass)
alternative the (det)
gland pineal (amod)
ng/ml. was (cop)
antagonism was (cop)
synthesis protein (compound)
a cya (appos)
phenomenon : (punct)
kanamycin-dextran by (case)
patients such (case)
administration 5-hydroxytryptophan (nmod)
atrophy tubular (amod)
episode manic (amod)
margin safety (nmod)
% completing (advcl)
requests payment (compound)
delay retardation (conj)
suggest drug (ccomp)
means scales (nmod)
postdose hour (amod)
frequent which (nmod)
nephropathy self-perpetuating (amod)
azathioprine and (cc)
resolution maha (nmod)
noted chick (nmod)
ischemia after (case)
edema of (case)
captopril by (case)
prevalences effects (conj)
symptoms abated (acl:relcl)
protrusion tongue (compound)
g 100 (nummod)
charge fraction (conj)
use long-standing (amod)
injury in (case)
sufficient provoke (xcomp)
4107 3722 (conj)
animals from (case)
dosage but (cc)
influence mechanisms (nmod)
mg 500 (compound)
methods infused (acl)
pulmonary both (cc:preconj)
days training (compound)
anesthesia to (case)
rats given (acl)
children sick (amod)
affect might (aux)
levels alpha-gst (compound)
grafts with (case)
bleeding of (case)
cck-8-se ) (punct)
tumors disease (conj)
induced tacrolimus (nmod)
agents as (case)
stabilizer/rigidifier as (case)
increase with (case)
seems . (punct)
group g/cm(2 (appos)
nephrosis chronic (amod)
higher cases (nmod)
trinitrate microg/kg/min (dep)
blocks allodynia (dobj)
model hemorrhage (nmod)
showed proteins (nsubj)
edaravone , (punct)
children 27 (nummod)
association lymphoma (nmod)
leading of (mark)
men selected (acl)
increases plasma (nmod)
thrombosis heparin-induced (amod)
correlated improvement (nmod)
expression claudin-2 (compound)
fibrillation irreversible (amod)
catalepsy retention (dep)
mg days (nmod)
role catecholamines (nmod)
progression and (cc)
market pediatric (amod)
infections infections (conj)
decreased also (advmod)
precedes onset (dobj)
care supportive (amod)
$ROOT$ metabolite (sent)
scheduled were (auxpass)
improvement cosmetic (amod)
1984 1985 (conj)
reduced mg/kg (nmod)
na brain (compound)
release prostaglandin (compound)
limit , (punct)
disease pacemaker (conj)
pallidotomy unilateral (amod)
assessed variations (nsubjpass)
incidences the (det)
nodal conduction (conj)
recorded indication (dobj)
hyperkinesis segments (nmod)
prescribe practitioners (nsubj)
hypothyroidism from (case)
effect formation (nmod)
effects carcinogenic (amod)
strength muscle (compound)
compared when (advmod)
cystitis intractable (amod)
personnel of (case)
female failure (nmod)
pronounced lna (nmod)
coil a (det)
dysphonia adductor (compound)
lack externa (nmod)
experiences " (punct)
controls into (case)
report following (amod)
nafld of (case)
patient depressed (amod)
mg.kg-1 2.5 (compound)
failed absence (nmod)
subjected day (nmod)
revealed microscopy (nsubj)
kidneys marginal (amod)
shown previously (advmod)
maintained schedule (nmod)
recurrence years (nmod)
overexpression a (det)
virus hiv (appos)
nms reported (acl)
compromise hemodynamic (amod)
changes disfiguring (amod)
homogenates extracts (conj)
h respectively (advmod)
improvement measure (nmod)
day - (punct)
signs anemia-related (amod)
exposure androgenic (amod)
toxicity methamphetamine-induced (amod)
affirming efficacy (dobj)
membranes mucous (amod)
lesion arise (acl:relcl)
acetate plus (cc)
started program (nsubj)
icv ( (punct)
pfs os (conj)
sbp ) (punct)
phenomenon described (acl)
sad of (case)
improvement treatment (nmod)
upper lower (conj)
effect azathioprine (nmod)
$ROOT$ passed (sent)
led identification (nsubj)
departments eds (appos)
excluded not (neg)
applications clinical (amod)
hours forty-eight (nummod)
examinable results (nsubj)
improvements some (det)
responses other (amod)
mortality , (punct)
stopping drug (dobj)
phenotype . (punct)
nmba eliminated (acl:relcl)
function dopamine (compound)
association unusual (amod)
stz icv (appos)
complete , (punct)
behaviors ocd-like (amod)
ceased considered (parataxis)
vary compounds (nsubj)
prl-r suppressor (conj)
smaller strips (nmod)
definition adr (nmod)
promoter core (compound)
glycine co-agonist (dep)
develop strategy (dobj)
son rat (nmod)
unclear although (mark)
complication severe (amod)
mbc and (cc)
had (+)-propranolol (nsubj)
ameliorated raised (conj)
events or (cc)
weeks 1 (dep)
pain tachyarrhythmia (conj)
disorders prior (amod)
written been (auxpass)
enzyme cardiac (amod)
interest identifying (acl)
erythroderma with (case)
showed day (nmod)
followed return (nmod)
induced peptides (nmod)
uremia to (case)
depletion , (punct)
mice n (dep)
injected cycloheximide (conj)
decline subsequent (amod)
reduce proliferation (dobj)
lesions glomerular (amod)
prevalences low (amod)
tumors rat (nmod)
$ROOT$ prevents (sent)
women allocated (conj)
methods anesthetized (appos)
relieve might (aux)
-/- dbh (nmod:npmod)
antagonist has (acl:relcl)
h mg/kg (dep)
aggravate model (nmod)
background compared (appos)
area with (case)
17.8 ) (punct)
showing . (punct)
ratings vas (compound)
examined all (nsubjpass)
have advantage (dobj)
therapy agent (appos)
ors ) (punct)
injection to (case)
probably or (cc)
discontinuation anticoagulation (conj)
u/ml = (parataxis)
variations syndrome (nmod)
measure is (cop)
arteries within (case)
otherwise is (cop)
examinations biochemical (amod)
have tested (advcl)
discuss to (mark)
reduced propranolol (nmod)
development hypotension (nmod)
experiments same (amod)
cells presumed (amod)
% survival (nsubj)
features calculi (nmod)
started when (advmod)
visits was (acl:relcl)
rapid abnormally (advmod)
pronounced stages (nmod)
used provide (xcomp)
ecgs the (det)
caused which (nmod)
cessation an (det)
suffered and (cc)
tachycardia supraventricular (amod)
involved resurgence (nmod)
continued persistence (nmod)
functions motor (compound)
showed differences (dobj)
monooxygenases the (det)
age in (case)
counts mm3 (nmod)
potentiates , (punct)
fibrosis , (punct)
discovery defect (nmod)
doxorubicin of (case)
injections weight/week (appos)
distribution metabolism (conj)
curve clearance (nmod)
fulfill provide (conj)
macroglobulinaemia of (case)
tests writhing (compound)
investigation further (amod)
exploited further (advmod)
avoided prescribed (conj)
cimd of (case)
include mechanisms (nsubj)
visit during (case)
30 40 (conj)
ufh ) (punct)
molars impacted (amod)
was levels (nmod)
intensity their (nmod:poss)
outcomes unanticipated (amod)
g/day range (dep)
mutations patients (nmod)
isomers propranolol (nmod)
ranks wilcoxon (compound)
stiffness joint (compound)
stabilizer n (dep)
presented highlighting (advcl)
sg145r with (case)
attribute quetiapine (nmod)
7alpha-hydroxylase enzymes (conj)
decreased adjusted (advcl)
mg/kg beta-carboline (nmod)
infusion intrarenal (amod)
returned day (nmod)
measures with (case)
inc fujisawa (compound)
beats/min +/- (cc)
levels its (nmod:poss)
had crisis (dobj)
reagents specific (amod)
thirds a (quantmod)
treatment years (nmod)
hospital gwardamangia (appos)
producing toxicity (dobj)
receptors ) (punct)
venue new (amod)
factor age (nsubj)
damage epilepticus (nmod)
half-life final (amod)
months rate (nsubj)
toxic cocaine (nsubj)
gfap nitrite (conj)
acknowledged . (punct)
sufficient initiation (nmod)
np f (conj)
paroxetine of (case)
anticoagulant an (det)
camperdown australia (appos)
factors tdp (nmod)
performed review (dobj)
damages renal (amod)
178 - (advmod)
centers in (case)
examination expression (nmod)
ng/kg/min 6.7 (nummod)
group 1 (nummod)
h = (dep)
antagonist muscarinic (amod)
changes bladder (nmod)
syndrome heart (compound)
medications. study (compound)
pge2 given (amod)
substances thiobarbituric (amod)
factor might (aux)
s.c. ( (punct)
resuscitated he (nsubjpass)
treatment cats (nmod)
condition coma (nsubj)
state sensitivity (nmod)
wsr ) (punct)
epithelium such (case)
agents agents (conj)
company the (det)
bsa ) (punct)
scattered . (punct)
predictor the (det)
characteristics similar (amod)
palsy to (case)
mutation the (det)
range months (appos)
associated data (nmod)
report showing (acl)
botox ) (punct)
depletion persistent (amod)
day tomography (nmod)
confirmed lesions (nsubjpass)
findings typical (amod)
dynamic by (case)
subjects sensitization (nmod)
characterized poorly (advmod)
appearance cases (nmod)
effect reduction (compound)
processor image (compound)
influenced duration (dobj)
content lithium (compound)
1.1 +/- (cc)
$ROOT$ make (sent)
expression actin (nmod)
reduction production (nmod)
progestagen without (case)
del ) (punct)
aged 23 (nmod:npmod)
angiography cta (appos)
disappeared min (nmod)
1999 during (case)
conscious fully (advmod)
evidence role (nmod)
necrosis steatosis (conj)
activity electromyographic (amod)
chemiluminescence immunometric (amod)
46 44 (compound)
proteins striatal (amod)
zo-1 not (neg)
total months (nmod)
acetyltransferase cells (nmod)
p<0.01 control (conj)
effect anti-dopaminergic (amod)
% 192 (nummod)
carcinoma function (conj)
tolerated is (auxpass)
data prospective (amod)
four three (conj)
negative excipients (nmod)
examined structure (nsubjpass)
when only (advmod)
substitution sodium (nmod)
search 1966-january (appos)
participants . (punct)
introduced decade (nmod)
receive sulphonylureas (dobj)
consumers who (nsubj)
corticosteroids intravenous (amod)
substrate mrp2 (nmod)
0.95 ) (punct)
infusion high-dose (amod)
treatment phenytoin (compound)
66 more (advmod)
third two (nummod)
responses beta-adrenoceptor (amod)
cancers combined (amod)
acetate on (case)
transition mpt (appos)
during posttherapy (conj)
had volumes (dobj)
mul 10 (nummod)
effect anxiolytic (amod)
absorption , (punct)
% the (det)
known not (neg)
made deterioration (nmod)
assessed tasks (nmod)
weight to (case)
$ROOT$ recommended (sent)
concentrated urine (dobj)
found mouse (nmod)
had findings (dobj)
reported effect (nsubjpass)
expected would (aux)
drc ) (punct)
mrna et-1 (nmod)
patients hypothyroid (acl:relcl)
postulate prolong (ccomp)
toes one (nummod)
administered apamin (nsubjpass)
epithelium proximal (amod)
years many (amod)
alendronate the (det)
maneuver vagal (amod)
concentration doses (conj)
chemotherapy paclitaxel (nmod)
prolonged fpdc (dobj)
years 65 (nummod)
greater rats (nmod)
pan/temocapril ii (nummod)
middle-aged and (cc)
site identical (amod)
reduced pretreatment (nmod)
change periods (nsubj)
amoxicillin and (cc)
carbamazepine to (case)
awaking after (mark)
higher mortality (nsubj)
injury complex-mediated (amod)
sides brain (nmod)
factor causing (acl)
maintaining preparedness (dobj)
challenge fluid (compound)
patients ergotamine/caffeine (nmod)
ppa after (case)
481 ) (punct)
database population (compound)
$ROOT$ susceptibility (sent)
hospital found (acl:relcl)
disorders pregnancy (nmod)
cpap h2o (compound)
equal deviation (nmod)
revealed abundance (dobj)
163 78 (nummod)
depletion amphetamine (nmod)
male 63-year-old (amod)
troponin of (case)
determinants its (nmod:poss)
somnolence polydipsia (conj)
dysmenorrhea severe (amod)
pressure age (conj)
icr , (punct)
reacted suggesting (advcl)
fraction an (det)
patients stenosis (nmod)
absence both (appos)
acid acetylcholine (conj)
seen glands (nmod)
produce administration (nsubj)
density alterations (conj)
demonstrates observation (nsubj)
decided contribution (nmod)
using procedures (dobj)
psychostimulant to (case)
stereotypy apomorphine (compound)
mechanism to (case)
linn from (case)
events ( (punct)
1.56 1.03 (conj)
characterized were (auxpass)
controls schizophrenic (amod)
considered cause (nsubjpass)
incidence increased (amod)
was deterioration (attr)
igg and (cc)
rash generalized (amod)
ml 67.66 (nummod)
images camera (compound)
dose-dependent neurotoxicity (nsubj)
data volumetric (amod)
or=13.807 , (punct)
applies also (advmod)
effects cck-8 (nmod)
$ROOT$ site (sent)
receptors prl-r (appos)
rbcs compared (case)
entity adulthood (nmod)
seem cells (nsubj)
damage cord (compound)
greater rise (nsubj)
lower cont./min (dep)
antagonist noncompetitive (amod)
occurred mumol/l (nmod)
1971 and (cc)
patients 405 (nummod)
effects administration (nmod)
10 in (case)
reaction confusion (nsubj)
contribution issue (nmod)
ketoprofen starting (acl)
double-blind randomised (dep)
received pdn (dobj)
reduced ee (nmod)
groups n (dep)
remedy that (mark)
anemia presentation (nmod)
anxiety caffeine- (amod)
movement subsequent (amod)
reduced damage (dobj)
therapy all (det)
consist , (punct)
akt phospho (compound)
cause anemia (nmod)
express can (aux)
albuminuria in (case)
factor-i of (case)
pregnancy her (nmod:poss)
seen disease (nmod)
fibrosis myocardial (amod)
evolution csa-induced (amod)
apomorphine agonist (appos)
sensorium , (punct)
man virus (nmod)
cultures myocardial (amod)
similar that (nmod)
lysis myofilaments (nmod)
animals kindling (compound)
anesthetics two (nummod)
showed biopsy (nsubj)
glutathione tissue (nmod)
damage myocardial (amod)
early combined (amod)
purpose develop (acl)
symptoms encephalopathy (nmod)
hypotension decrease (conj)
controls 337 (nummod)
alkaloid vinca (compound)
rigidity salivation (conj)
published and (cc)
administration flunitrazepam (nmod)
relieve beta-blocker (nsubj)
examined using (xcomp)
children ) (punct)
different t (nmod)
patients twenty-one (nummod)
cent 30 (nummod)
speed simulator (nmod)
created , (punct)
nausea phonophobia (conj)
deposits electron-dense (amod)
colitis of (case)
disorder hyperglycinemia (nsubj)
hypertrophy to (case)
labetalol agent (appos)
hypertension reversible (amod)
% 3.8 (nummod)
perfused rise (nmod)
deposits intense (amod)
blockade d2 (compound)
caa ( (punct)
caused crystals (nmod)
radiography by (case)
mg/d ) (punct)
ketamine surgery (nmod)
cage their (nmod:poss)
agents peripheral (amod)
aed used (amod)
recognized under-reported (conj)
remains background (nsubj)
intervals 8-hourly (amod)
ml/min 0.35 (nummod)
electromyogram in (case)
an ) (punct)
transplant organ (compound)
inhibition caused (acl)
performed could (aux)
c. hepatitis (compound)
permeability penetration (conj)
lpo ( (punct)
pharmacokinetics profile (conj)
treatment drugs (nmod)
concluded it (nsubjpass)
structures system (nmod)
recalled patients (nsubj)
p to (case)
treatment adrenaline (nmod)
muscle-lengths/s to (case)
postulate exposure (ccomp)
worst showed (conj)
hyperthermia including (case)
neonates in (case)
t1/2 : (punct)
comparison findings (nmod)
blockade acute (amod)
lesions and (cc)
sensation pain (conj)
lnna ( (punct)
blindness supersensitivity (conj)
induced antidepressants (nmod)
m-2 mg (nummod)
decrease and (cc)
rates prevalence (compound)
lactate alternately (conj)
patients asian (amod)
obtainable should (aux)
mul sc (dep)
developed petechiae (dobj)
provides immunosuppression (dobj)
mitochondrial cytoplasmic (conj)
revealed test (nmod)
abnormality auditory (amod)
tissues and (cc)
cells myometrial (amod)
support any (det)
review history (dobj)
died causes (nmod)
rats carmustine-treated (amod)
spikes ps (appos)
illnesses systemic (amod)
loss profound (amod)
model writhing (compound)
therapy mg/kg (appos)
treatment analgesic (amod)
role reversal (nmod)
differs drugs (nmod)
co-morbidity with (case)
reduced it (nsubjpass)
noted controls (advcl)
elevations leads (nmod)
stain ed1 (nmod)
all ) (punct)
polydipsia , (punct)
analysis this (det)
performed investigations (nsubjpass)
episode function (nmod)
rbf ( (punct)
prevented reversed (conj)
treatment menopause (nmod)
dynamic molecular (amod)
plasticity m1 (nmod)
complications due (case)
cholesterol in (case)
mmhg than (case)
given propranolol (dobj)
segments ventricular (compound)
width band (nmod)
participated patients (nsubj)
interventions resources (conj)
occurred paresthesia (nsubj)
assessed when (advmod)
diagnosis this (nsubj)
sulindac salicylates (conj)
% out-patients (nmod)
$ROOT$ due (sent)
asphyxia leukomalacia (conj)
used january (nmod)
mg/m2 divided (cc)
observation close (amod)
neutropenia febrile (amod)
siat ( (punct)
supplement . (punct)
syndrome myopathy (conj)
release downregulation (conj)
quality life (nmod)
hazard developing (advcl)
attenuation rats (nmod)
filling gap (dobj)
pseudolithiasis to (case)
branches the (det)
scales the (det)
examined . (punct)
part on (case)
battery recall (nmod)
studies such (amod)
administration b6 (nmod)
reductions further (amod)
series a (det)
12 dogs (nmod)
hypothyroidism therapy (nmod)
baseline end (conj)
109.2 +/- (cc)
concentrations millimolar (amod)
bladder urethra (conj)
bis ( (punct)
mg/kg/day sulfate (nmod)
exacerbation in (case)
eyes 12 (nummod)
contributed cytopenia (nmod)
comparable values (nsubj)
ems pms (conj)
prognosis . (punct)
mice ddy (compound)
factor cystitis (nmod)
external and (cc)
2-(p-bromophenyl)propionate releaser (appos)
diazepam by (case)
resolved recovery (nmod)
much benefit (nmod)
$ROOT$ short (sent)
became before (mark)
insult liver (compound)
ascites extensive (amod)
women using (acl:relcl)
scopolamine nitrazepam (appos)
increases cholesterol (nmod)
asterixis with (case)
patients twelve (nummod)
warned patients (nsubjpass)
months ten (nummod)
mesothelioma and (cc)
illustrating generation (dobj)
appears although (mark)
permeability albumin (nmod)
modulate that (nsubj)
sensitive finding (nmod:npmod)
lowered bpm (nmod)
min-1 kg-1 (compound)
tolerance nimesulide (nmod)
examined months (nmod)
adults hypertensive (amod)
cases reported (acl:relcl)
causing effects (dobj)
treatment yohimbine (compound)
suggest responsible (ccomp)
woman pain (nmod)
callosum corpus (compound)
changes s-t/t (compound)
serious 2/3 (nmod)
n=5 ) (punct)
indicates method (ccomp)
failure ovarian (amod)
mm 35.9 (nummod)
anemia cab-induced (amod)
defend assaults (nmod)
battery children (nmod)
combined , (punct)
withdrew mouth (nmod)
14.1 7.9 (conj)
nystagmus associated (acl)
dismutase antioxidants (conj)
randomized and (cc)
+ ( (punct)
uncommon are (cop)
found frame (nmod)
tests by (case)
merit attention (dobj)
potentiated stereotypies (nsubjpass)
hazards toxicity (nmod)
rate is (cop)
caused indomethacin (nmod)
neuropathy cranial (amod)
correlation hemoglobin (nmod)
depleted parachlorophenylalanine (nmod)
placebo than (case)
nm 8 (nummod)
modulate differentially (advmod)
deficit to (case)
erythromycin but (cc)
cessation drug (nmod)
possesses has (conj)
dose b (compound)
evaluated incidence (nsubjpass)
200 vs. (cc)
loss auditory (amod)
associations of (case)
dose 1 (nummod)
appetite % (appos)
$ROOT$ generated (sent)
pretreatment lithium (compound)
1973 between (case)
avoid prescribing (xcomp)
infant other (amod)
primary secondary (amod)
cycloheximide injected (acl)
agents specific (amod)
exhibit cardiotoxicity (dobj)
administered animals (nsubjpass)
administration bupivacaine (compound)
infused d (nmod)
evoked response (dobj)
conclusion used (dep)
altering directly (advmod)
interactions reticulo-thalamic (amod)
antagonist on (case)
arrhythmias against (case)
2-bromoethylamine bea (appos)
incidence both (cc:preconj)
measured patient (nmod)
analysis variance (nmod)
cramps nocturnal (amod)
l/min sed (appos)
mmhg 50 (nummod)
compounds both (det)
thiamine of (case)
damage minor (amod)
pretreated isoniazid (nmod)
equivalent levodopa (compound)
avoid can (aux)
compared infusion (nmod)
mouth a (det)
influenced development (dobj)
therapy due (amod)
gradient initial (amod)
value be (cop)
third the (det)
influence factors (nsubj)
trespass bbb (dobj)
injection before (nmod)
pharmacovigilance of (case)
symptoms akathisia (nmod)
ranged levels (dobj)
100,000/mm3 less (amod)
habituated were (auxpass)
revealed reactions (dobj)
seen nigerians (nmod)
diary studies (conj)
sought compared (conj)
metolachlor cancer (conj)
juice saline (conj)
restoration with (case)
fed was (auxpass)
reactions toxicity (nmod)
march , (punct)
checked were (auxpass)
shunt hypotension (nmod)
treated that (mark)
son male (nmod)
hyperparathyroidism to (case)
clamping arteries (dobj)
parts ) (punct)
atypia and (cc)
150 x (cc)
seconds twenty (nummod)
potential neurotoxic (amod)
simulator ) (punct)
mg 8.7 (conj)
activity antagonist (compound)
attenuating number (dobj)
treated only (advmod)
ng/kg/min ; (punct)
develop epilepticus (nmod)
given pretreatment (dobj)
obtained section (nmod)
peptide active (amod)
concluded exerts (ccomp)
include which (nsubj)
provide should (aux)
decline % (nmod)
headache % (appos)
% 0.7 (nummod)
$ROOT$ manifestation (sent)
technique body (compound)
trinitrate gtn (appos)
mastocytosis mucosal (amod)
excluded twenty-nine (nsubjpass)
had values (nmod)
subjects reporting (acl)
delivered and (cc)
volumes lv (compound)
presentation anxiety (conj)
psa a (det)
fragments and (cc)
reduced catalepsy (dobj)
lower times (nmod:npmod)
failure (att)-associated (amod)
turned were (auxpass)
insipidus ndi (appos)
data studies (nmod)
exacerbation acute (amod)
erythematosus with (case)
dependent concentration (nmod:npmod)
$ROOT$ stable (sent)
reversed were (auxpass)
known consisted (advcl)
affected women (nmod)
nm ) (punct)
= 32.258 (dobj)
lots products (nmod)
gauges to (case)
stressor a (det)
study small (amod)
adjunct toxicity-free (amod)
maintains oxygenation (dobj)
limiting leukopenia (nsubj)
findings cancer (nmod)
reactions drug (compound)
licensed background (dep)
protected ly274614 (nsubj)
strains from (case)
antidepressant monocyclic (amod)
micrograms/day of (case)
resulting accumulation (nmod)
fever pain (conj)
% 94 (nummod)
sod , (punct)
giving after (mark)
alter which (nsubj)
provided relief (dobj)
filaments and (cc)
due naproxen (nmod)
efficiency regarding (case)
$ROOT$ lesions (sent)
man hypertensive (amod)
paclitaxel mg/m(2 (appos)
medium life-support (amod)
participants smokers (acl:relcl)
action effect (conj)
administration prior (amod)
continued resuscitation (nsubj)
flurothyl by (case)
denopamine agonist (appos)
imaging radiological (amod)
l. nestor (compound)
findings the (dep)
irrespective anesthetic (nmod)
sarin soman (conj)
20 to (quantmod)
low dominating (advcl)
ability cocaine (nmod:poss)
causes treatment (nsubj)
initiated prior (advmod)
similar strains (nmod)
hit treatment (conj)
age elderly (amod)
% 4.4 (nummod)
cardiotoxic be (cop)
recorded : (punct)
trained run (xcomp)
increase point (nsubj)
$ROOT$ interviewed (sent)
preinfusion g/min (appos)
effects corticosterone (nmod)
counteracted inhibition (dobj)
1.2 ( (punct)
patients rheumatic (amod)
male healthy (amod)
fluid cerebruspinal (amod)
conclusions related (dep)
seemed suggesting (xcomp)
literature current (amod)
resulted pretreatment (nsubj)
warranted may (aux)
outcomes chronic (amod)
rate states (nmod)
results by (case)
hours 8 (nummod)
ganglia drg (appos)
deficiency = (dep)
absence even (advmod)
put surgery (nmod)
dose known (amod)
dosage either (det)
limited toxicity (nmod)
induced isoniazide (nmod)
infections p (dep)
dw ) (punct)
remissions of (case)
death apoptotic (amod)
kanamycin and (cc)
80 20 (conj)
ifo 's (case)
6 in (case)
delayed but (cc)
deprivation after (case)
injections single (amod)
patients multiethnic (amod)
evidence hepatitis (nmod)
epilepsies ige (appos)
dosage-dependent toxic (amod)
mean for (case)
dose-dependent derives (conj)
tended circled (conj)
machinery in (case)
fibers substrates (conj)
replacement doses (nmod)
damage score (dep)
indicate data (nsubj)
gamma-carboxylated indeed (advmod)
effects anti-asthmatic (amod)
administered when (advmod)
amnesia produced (acl)
returned interval (nsubj)
ill to (mark)
suggest proof (ccomp)
dimension wall (compound)
acid 2-methoxy-4-amino-5-chlorobenzoic (amod)
reporting higher (amod)
1/2,z ( (punct)
impaired although (mark)
examination database (nmod)
adr(6 ) (punct)
formula calvert (compound)
demonstrates model (nsubj)
reperfusion intestinal (amod)
disinhibition primary (nmod)
50 - (punct)
retention : (punct)
11 6 (compound)
hyperactive were (cop)
links , (punct)
correlates physiological (amod)
encephalopathy by (case)
return postdose (nmod)
counts gram (nmod)
episodes short (amod)
aqp2 nkcc2 (conj)
types seizure (compound)
effect effect (conj)
disease peptic (amod)
surgery recent (amod)
occurred migraineurs (nmod)
discontinued performed (conj)
$ROOT$ design/methods (sent)
$ROOT$ surpasses (sent)
activity glomerular (amod)
cells node (compound)
hz 8,000 (nummod)
mg after (case)
malondialdehyde dismutase (conj)
proteinuria both (cc:preconj)
glioma human (amod)
conditions medical (amod)
elucidate phenomenon (nsubj)
mechanism responsible (amod)
shortening in (case)
reported infarction (nsubjpass)
toxicity due (amod)
group ukpdrg (appos)
signs off (case)
studies from (case)
seen episode (nsubjpass)
dose days (nmod:tmod)
exerted schedule (nsubj)
potentiation tolerance (conj)
case compared (case)
flow lacrimation (conj)
scintigraphy hepatobiliary (amod)
counts activity (compound)
device the (det)
interacted and (cc)
influx calcium (compound)
stimulation cerebellar (amod)
four two (compound)
hyponatremia and/or (cc)
neurology , (punct)
translocation t(9:22 (compound)
secretion of (case)
= 78.1 (dobj)
count course (conj)
ketamine- or (cc)
case following (amod)
minutes stimulus (nmod)
option also (advmod)
use mdma (compound)
investigating focus (nmod)
administration vaccine (compound)
$ROOT$ avoided (sent)
produces improvement (dobj)
increased this (nsubj)
drug bromide (appos)
wky shr (conj)
determinant the (det)
risks intraoperative (amod)
lack ilk (nmod)
cyclosporine . (punct)
factor cardiotoxicity (nmod)
formulation new (amod)
workers and (cc)
increasing somnolence (dobj)
8 - (punct)
model tacrine-lithium (amod)
methimazole propranolol (conj)
$ROOT$ reflects (sent)
vp ) (punct)
sedation associated (acl)
mg/kg/day 120 (nummod)
nature injury (nmod)
attenuation neurotoxicity (nmod)
liver to (case)
scored results (nsubjpass)
shown min (nmod)
case leading (acl)
overflow and (cc)
weeks -9 (nummod)
selected which (nsubjpass)
scopolamine morphine (conj)
required maintain (advcl)
receptors 5ht1a (compound)
immunosuppression for (case)
receptors muscarine (compound)
stress cell (compound)
cardiotoxicity patients (nmod)
underlying protocols (dobj)
dogs included (acl)
preventing suppression (dobj)
elicited microinjection (nsubj)
correlated performance (nmod)
loss post-operative (amod)
hours ) (punct)
hallmark syndrome (nmod)
preservation the (det)
tumor malignant (amod)
mg/kg weight (appos)
dysphonia recurrent (amod)
transmission , (punct)
and postoperatively (advmod)
hypothyroidism thyroiditis (nmod)
were group (nmod)
inhibition acid (compound)
considered drugs (nsubjpass)
counts outcomes (conj)
remain have (advcl)
study spectrum (nmod)
neuralgia in (case)
minute by (case)
resulted elicited (conj)
cysts detectable (acl:relcl)
enhance growth (nsubj)
reducing size (dobj)
altered night (nmod)
micrograms ) (punct)
failure reversible (acl:relcl)
infections presumed (amod)
channels cells (nmod)
effect mazindol (nmod)
carbamazepine applied (acl)
antibodies depended (acl:relcl)
monitoring intervals (nmod)
glycopyrrolate of (case)
cross-tolerance morphine (nmod)
blocked hyperactivity (nsubjpass)
evaluation pharmacological (amod)
disorders subfertility (conj)
receptors 2a (compound)
diagnoses the (det)
schizophrenia % (appos)
model by (case)
improve whether (mark)
normoammonaemic . (punct)
protocol an (det)
oximeters patients (nmod)
predominance in (case)
postulated we (nsubj)
related structurally (advmod)
3.1 1.1 (appos)
temperament a (det)
cause elevation (nsubj)
day prior (advmod)
outcomes disastrous (amod)
tachycardia prolongation (conj)
fenfluramine dexfenfluramine (conj)
past present (conj)
tmp to (case)
dyskinesia specific (amod)
cystourethrogram for (case)
administration dox (nmod)
ee vehicle (conj)
used erythropoietin (nsubjpass)
receptor ( (punct)
plays activity (nmod)
lipophages indicative (amod)
926 of (advmod)
inhibitor ssri (appos)
showing fraction (nsubj)
g/dl more (nummod)
expression phase (nmod)
entity is (cop)
blockers angiotensin (compound)
rats inbred (amod)
hepatitis fulminant (amod)
inappropriate unsupervised (conj)
subsided slowly (advmod)
edema submucosal (amod)
found ptcr (dobj)
sources medline (appos)
retrocollis hyperactivity (conj)
rr=1.41 ; (punct)
task in (case)
reversed syndrome (nsubj)
efficacy profile (conj)
day 0 (nummod)
group td (compound)
maintained if (mark)
common had (conj)
similar lna (nmod)
form barrier (dobj)
< both (dep)
shunt responses (conj)
anaesthetist the (det)
improvement progressive (amod)
urothelium the (det)
preparations heart (compound)
failure not (neg)
signaling toll-like (amod)
cause arrhythmias (dobj)
dysfunction similar (amod)
shortening intervals (nmod)
ritonavir with (case)
rare common (conj)
lactate elevated (amod)
findings their (nmod:poss)
recurrence nonfatal (amod)
hydrochloride amantadine (compound)
etoposide vp-16 (appos)
prescription of (case)
concern the (det)
lead caused (conj)
related age (nmod:npmod)
$ROOT$ positive (sent)
oxygen myocardial (amod)
excipients of (case)
reported patient (nsubj)
literature relevant (amod)
cells smooth (amod)
occur symptoms (nsubj)
measures vigorous (amod)
pressure findings (conj)
associated inhibitors (nmod)
activities in (case)
group hcrh (compound)
recalled also (advmod)
developing day (nmod)
7 approximately (advmod)
carriers ( (punct)
group sham (amod)
eating whilst (mark)
percent ) (punct)
magnitude stress (nsubj)
asymptomatic previously (advmod)
model conditional (amod)
increased able (parataxis)
schedules different (amod)
adaptation dark (compound)
heroin with (case)
halts toxicity (dobj)
attenuating in (mark)
enable to (mark)
convulsions produced (acl)
syndrome transplant (nmod)
areas apparent (amod)
attenuated rats (nmod)
follows improvements (nsubj)
cardiotoxicity dysfunction (conj)
diagnosed accurately (advmod)
preferable be (cop)
effects reabsorption (nmod)
mbc ) (punct)
cimetidine after (case)
intensify l-noarg (nsubj)
% 240 (nummod)
become endarterectomy (nsubj)
indicators variability (nsubj)
occurred = (parataxis)
supplementation sodium (compound)
decreased weights (nsubjpass)
check . (punct)
discriminate regardless (advmod)
low % (appos)
receptor factor (compound)
% 25.5 (compound)
counted , (punct)
observed reduction (nsubjpass)
catalyze formation (dobj)
% os (nmod)
dosage volume (conj)
ages of (case)
agent tiazofurin (nsubj)
sulphate pregs (appos)
introduced increased (conj)
response their (nmod:poss)
receiving dose (dobj)
intake drugs (nmod)
suggests follow (ccomp)
included variables (nsubj)
in both (cc:preconj)
abnormalities gain (conj)
= btc (nmod)
rotation amphetamine-induced (amod)
treated azidothymidine (nmod:npmod)
enzymes in (case)
strains both (det)
developed reaction (conj)
became used (acomp)
acts that (mark)
was conduct (xcomp)
tap decreased (amod)
presented h (nmod)
= .04 (dobj)
expired patients (nsubj)
administered doses (dobj)
kg-1 of (case)
iief of (case)
comparable would (aux)
postponed was (auxpass)
diameters , (punct)
maintained myocardium (nmod)
care patients (nmod)
improvement contributions (conj)
2)% 6 (nummod)
was rate (nmod)
had eyes (nsubj)
days 11 (nummod)
made withdrawal (nmod)
curative . (punct)
present incident (dobj)
58 , (punct)
133xe with (case)
drug novel (amod)
find reports (dobj)
caused uptake (nmod)
pretreatment mg/kg (nmod)
cycles basic (amod)
eligible inclusion (nmod)
difference statistical (amod)
eyes hypertensive (amod)
died result (nmod)
withdrawn vein (nmod)
pills slimming (amod)
medication , (punct)
exposed one (nsubjpass)
prescribing and (cc)
arrest = (dep)
responses muscle (compound)
difference apparent (amod)
rg1 , (punct)
interleukin proinflammatory (amod)
icus in (case)
patients baseline (nmod)
microscopically electron (nmod:npmod)
toxic hereditary (conj)
fenfluramine and (cc)
96.7 ; (punct)
cause by (case)
mg/dl. 3.3 (nummod)
contribute recognition (nsubj)
evidence insipidus (nmod)
majority % (appos)
didanosine and (cc)
ca , (punct)
virus of (case)
administered heparin (nsubjpass)
multicenter double-masked (dep)
methods reviewed (appos)
flutamide mg (amod)
m(3)-machr. cardiac (amod)
frequency syndrome (nmod)
prevent hc (dobj)
longer s (nmod:npmod)
clinical serologic (conj)
tribute a (det)
phosphatase glucose (conj)
cardiotoxicity dox-induced (amod)
resolve incontinence (nsubj)
$ROOT$ compromising (sent)
16 d1 (nmod)
experienced legs (nmod)
ngal ) (punct)
effective agent (nsubj)
modified but (cc)
subjects 14 (nummod)
fusion processes (nmod)
mechanisms common (amod)
cardiomyocytes induced (amod)
renin contents (dep)
ileum m3 (nmod)
increased malondialdehyde (dobj)
led normalization (nmod)
warranted development (nsubjpass)
pj34 vehicle (conj)
acne cystic (amod)
evaluate compare (conj)
observed weeks (nmod)
infusion min (appos)
memory interference (compound)
efficacy factors (conj)
b rubella (conj)
eosinophilic ) (punct)
reaction chain (compound)
sinus superior (amod)
dosage neither (preconj)
ligation coronary (amod)
determined was (auxpass)
research cancer (nmod)
histories illicit (amod)
acts action (nmod)
controversial still (advmod)
arteriolopathy angiodegeneration (dep)
% 42 (nummod)
behaviors those (det)
thyroxine free (amod)
apnea neonatal (amod)
rats vehicle- (amod)
analogue beraprost (dep)
btc substrate (nmod)
showed electrograms (nsubj)
discussed mechanism (nsubjpass)
documented elevation (nsubjpass)
dosage cis-ra (nmod)
due effects (nmod)
immunohistochemistry gap43 (compound)
venue therapeutic (amod)
two-stage ligation- (punct)
patients followed (acl)
blocking by (case)
opse ( (punct)
pentobarbital adjuvant (amod)
caused ages (nmod)
documents conclusion (nsubj)
appeared animals (nmod)
pressing in (mark)
presenting load (nmod)
documented published (conj)
four of (case)
mechanisms cholinergic (amod)
edema peritumor (compound)
stream the (det)
volume capacity (conj)
recurrent or (cc)
ratings blinded (amod)
results vitro (amod)
reduced myelosuppression (dobj)
levels testosterone (nmod)
violation after (case)
) 11.5 (nummod)
dystonia idiopathic (amod)
analysis studies (nmod)
that exposure (nmod)
safe reasonably (advmod)
ed1-ed4 ) (punct)
recordings in (case)
reflex through (case)
perception test (nmod)
variety for (case)
decreased gfr (nsubj)
administered valproate (dobj)
recognition dysfunction (conj)
unchanged delivery (nsubj)
condition their (nmod:poss)
convulsants of (case)
0.15+/-0.03/h 0.24+/-0.06/h (conj)
controlled double-blind (amod)
2005 - (punct)
factors incidence (compound)
investigate vivo (advmod)
complicated utility (nsubjpass)
leads resolution (nmod)
transplant to (case)
suffered h (nmod)
time and (cc)
diminished aida (nsubj)
rats infarction (nmod)
tested previously (advmod)
cessation migraine (nmod)
depressed % (dobj)
evoke carteolol (nsubj)
images t1-weighted (amod)
man depression (nmod)
decreased p<0.05 (dep)
lasting pervasive (conj)
disorder it (nsubj)
using antigen (dobj)
onset- ( (punct)
adherence an (det)
considered occur (ccomp)
mice mpges-1 (compound)
levels distal (amod)
mediated inhibition (nmod)
increased refractoriness (dobj)
two nephrolithiasis (nmod)
predicted analysis (nmod)
predicted failure (nsubjpass)
imparts changes (dobj)
normalized when (advmod)
monitored patients (nmod)
extracted parallel (nmod)
induced mg/kg (nmod)
lost one (nsubj)
experience motility (nmod)
paradigm of (case)
injected bupivacaine (nsubjpass)
prevention events (nmod)
doxorubicin liposomal (amod)
occlusion patient (nmod)
myocardial kidney (conj)
showed received (conj)
0.1 1.0 (conj)
anti-oxidant regulatory (dep)
15.3 +/- (cc)
jj of (case)
dothiepin with (case)
severe may (aux)
ratio e/a (compound)
anorexia pain (conj)
similar rates (nsubj)
day a (det)
surmountable capable (ccomp)
mg/day was (cop)
dose dose (conj)
verapamil equipotent (acl:relcl)
consistent study (nsubj)
effect nik-247 (nmod)
recording . (punct)
brings , (punct)
hiccups % (dep)
treatment-refractory otherwise (advmod)
mouse-1 , (punct)
group non-sh (amod)
ci:0.3 1.2 (prep)
ability learning (compound)
reviewing by (mark)
ache on (case)
types four (nummod)
triad classic (amod)
worsening , (punct)
given courses (dobj)
discharged er (nmod)
exposed bcnu (nmod)
defects defects (conj)
revealed lack (nsubj)
measure use (conj)
long-term months/patient (dep)
drivers healthy (amod)
1 10(-7 (conj)
those cancer (nmod)
interval free (amod)
butyrylcholinestrase buche (appos)
likely lead (xcomp)
safe controlling (advcl)
damage microscopy (nmod)
detected capsaicin (nmod)
received uroprophylaxis (dobj)
suppress blockers (nmod)
observed deaths (nsubjpass)
different levels (nsubj)
technique to (mark)
treated eight (nsubjpass)
used applied (conj)
= 0.020 (dobj)
affected treatment (nmod)
effectiveness in (case)
higher od (nsubj)
tachyarrhythmias p (dep)
suffering polydipsia (nmod)
carried if (mark)
liability without (case)
mean cells/l (appos)
present however (advmod)
undergoes showing (advcl)
756 25 (nummod)
remain frequency (nsubj)
bleeding ami/gi (compound)
alt ( (punct)
absence presence (conj)
pkca of (case)
$ROOT$ address (sent)
-20 - (punct)
manifestation is (cop)
toxicity ischaemia (conj)
pre-test ( (punct)
infiltration passage (conj)
assay photometric (amod)
provide clearance (nmod)
inhibitor acetylcholinesterase (compound)
practices on (case)
regulation transducer (nmod)
improve correction (nsubj)
injury ischemia-reperfusion (compound)
administered l-name (nsubjpass)
seizure on (case)
reversible deal (nmod)
d-glucarate size (nmod)
groups group (nmod)
have initiation (nmod)
pharmacotherapies multiple (amod)
explain resistance (dobj)
consistent results (nmod)
replaced benzylthiouracil (nsubj)
drugs than (case)
mg dopamine (conj)
significant furthermore (advmod)
decrease perception (nmod)
control either (cc:preconj)
measured thiols (nsubjpass)
rls of (case)
inhibition mtor (compound)
layer cell (compound)
determination direct (amod)
delirium : (punct)
correlated negatively (advmod)
received doses (dobj)
ratio normalized (amod)
disturbing psychoses (dobj)
extracted , (punct)
behaviors dopamine-dependent (amod)
sg145r or (cc)
defining comparing (advcl)
specific was (cop)
regimens intravitreal (amod)
presents article (nsubj)
mg only (advmod)
related capture (nmod)
betaenac gammaenac (conj)
elevations limit (nmod)
restored correction (nmod)
indications the (det)
expressions mmp-2 (nmod)
riha of (case)
death epilepsy-induced (amod)
patients 78 (nummod)
tested detection (nmod)
vacuoles autophagic (amod)
dyskinesias severe (amod)
telangiectasia . (punct)
neurotoxin serotonin (compound)
speech nystagmus (conj)
microl/side microg/0.5 (nummod)
chloramphenicol applied (amod)
msdbp [ (punct)
patient history (nmod)
symptoms his (nmod:poss)
bridge recovery (nmod)
known abnormalities (nsubjpass)
concentration e (compound)
produced enhancement (dobj)
stress vessels (nmod)
analgesic this (det)
antagonists adenosine (compound)
users moderate (amod)
atrophy diaphragmatic (amod)
motif tyrosine-methionine-aspartate-aspartate (compound)
acetate lead (compound)
analysis 1-way (amod)
considering before (mark)
risk groups (nmod)
incidence severity (conj)
costs of (case)
src for (case)
cocaine alcohol (conj)
hypertension patient (appos)
regard concentration (nmod)
activity mice (nmod)
perform and (cc)
antagonists channel (compound)
using model (nmod)
cvp ) (punct)
conditions under (case)
31 12 (compound)
plays variation (nsubj)
interference and (cc)
reports spontaneous (amod)
agent induction (nmod)
pay to (mark)
related ptu (nmod)
modulate neurotransmission (nsubj)
caused provocation (nsubj)
proposed . (punct)
mg mean (dep)
active then (advmod)
visceral skeletal (conj)
cns depression (dep)
sensorium palsy (conj)
battery the (det)
palsies due (amod)
resulted measured (advcl)
prevention incapacity (nmod)
39.5+/-8.4s duration (nsubj)
katona ; (punct)
monoher ( (punct)
therapy glaucoma (nmod)
pituitary of (case)
induced donor (nmod)
immunosuppression calcineurin-free (amod)
treatment psychosis (nmod)
heart in (case)
changes media (nmod)
showing popularity (dobj)
mg/kg mg/m2 (appos)
experiences to (case)
used methods (nsubj)
contrast findings (nmod)
showed showed (advcl)
increases dose (compound)
microinjections striatum (nmod)
mainly , (punct)
tobramycin i.v. (compound)
behaviour based (case)
receiving since (mark)
evaluate , (punct)
commencing administration (dobj)
have flutter (dobj)
period early (amod)
pathophysiology into (case)
test haloperidol-induced (amod)
2-fold , (punct)
assessed safety (nsubjpass)
examination physical (amod)
minimize to (mark)
studies case (compound)
extraction of (case)
nonusers ) (punct)
made made (parataxis)
% 7.6 (nummod)
treated cancer (nmod)
method clearance (compound)
ruling thus (advmod)
explained was (auxpass)
0.3 piroxicam (nmod)
thinning was (cop)
mice b6 (conj)
occurred pneumonitis (nsubj)
two those (nmod)
conducted dividing (advcl)
atp both (cc:preconj)
ill , (punct)
improved 90 (nsubj)
clipping the (det)
african or (cc)
tremor finger (compound)
decrease ) (punct)
widened significantly (advmod)
reaction mepivacaine (nmod)
exposure lozenge (nmod)
four % (dep)
discussion . (punct)
instillation following (case)
> hg (dep)
behaviour latency (compound)
signs eye (nmod)
consisted eosinophil (nmod)
terminate rapidly (advmod)
mg/dl > (amod)
recurrences one (nummod)
200 300 (nmod)
enhanced transcription (dobj)
event is (cop)
cause suggested (conj)
incorporate levels (nsubj)
causing ( (punct)
bacteremia for (case)
estimated incidence (nsubjpass)
nmba benzylisoquinolinium (compound)
tubular , (punct)
included , (punct)
periods relapse (nmod)
targets are (cop)
headaches with (case)
acts receptor (nmod)
distribution flow (nmod)
nicergoline to (case)
agent latest (amod)
factor other (amod)
aggregability the (det)
disabling severely (advmod)
$ROOT$ g/m2 (sent)
treatment sulphasalazine (compound)
thrombosis acute (amod)
view in (case)
raloxifene mg/d (appos)
group hag (appos)
showed all (nsubj)
sensitization such (case)
d2 , (punct)
min infusion (nmod)
had deposition (dobj)
infarction ami (appos)
syndrome transient (amod)
treatment linezolid (compound)
interventions therapeutic (amod)
rates their (nmod:poss)
rate is (advmod)
attack genuine (amod)
cases probably (advmod)
trial inpatient (amod)
died commencement (nmod)
dosage at (case)
radiograph or (cc)
case coincided (acl:relcl)
trated haloperidol (nmod)
increments bun (nmod)
edema role (dep)
mg/kg 3.2 (compound)
given bupivacaine (nsubjpass)
changes pressure (compound)
remains decreased (advcl)
arrested beating (dobj)
weeks 28 (nummod)
trials therapies (nmod)
comments few (amod)
treatment androgen (compound)
contribution supply (nmod)
divided rats (nsubjpass)
one nine (compound)
reversed infusions (nsubj)
h 26 (nummod)
reduced volume (nsubjpass)
make to (mark)
degradative 5-fu (nmod)
exhibited compared (advcl)
breakdown increase (conj)
antagonist type-2 (amod)
high is (cop)
use therapy (nmod:poss)
associated vpa-therapy (nmod)
encephalopathy related (amod)
incidence analysis (dep)
palpitation trigemini (appos)
cystitis abnormalities (conj)
ingested period (nmod)
treatment memantine (nmod)
occurrence patients (nmod)
pustulosis palmoplantar (compound)
po mg/d (compound)
14 to (case)
attention particular (amod)
degeneration progressive (amod)
inherent represents (conj)
age facility (conj)
degree unique (amod)
model behavioral (amod)
hepatotoxicity , (punct)
hypren-trial of (case)
improved extent (nmod)
dose eliminated (acl:relcl)
timing with (case)
group sodium-depleted (amod)
control is (cop)
patient crf (nmod)
provides estimate (dobj)
mitogens also (advmod)
density and/or (cc)
pressure left (amod)
decrease h (nmod)
inhibition study (dep)
mediate might (aux)
hr 1.68 (nummod)
forced reduction (dobj)
antibiotics antibiotics (conj)
four patients (nmod)
contraindicated may (aux)
na for (case)
identified head (nmod)
hypothesized role (nmod)
indices functional (amod)
overdose venlafaxine (nmod)
technique postmortem (amod)
catheters the (det)
gpt ( (punct)
area eyes (nmod)
locomotion copulation (conj)
frequency importance (conj)
suffer disorders (nmod)
investigated model (nmod)
dobutamine of (case)
cerruloplasmin glutathione (conj)
effect risperidone (nmod)
superior fentanyl (dep)
score surgery (nmod)
therapy concurrent (amod)
died sepsis (nmod)
prescribed safely (advmod)
clearance cin (appos)
= 1051 (dobj)
included because (mark)
case cases (conj)
serve former (nsubj)
develop effects (dobj)
group pan/temocapril (conj)
one including (case)
determining levels (dobj)
follow six-month (compound)
presented signs (nsubjpass)
is . (punct)
higher p=0.008 (nmod)
0.35 +/- (cc)
require abnormalities (nsubj)
conditions hyperventilation (compound)
tremors muscle (compound)
consisted treatment (nsubjpass)
attained achieved (conj)
suggest role (dobj)
accept these (dobj)
doses 3 (dep)
discharged followed (conj)
dose rats (nmod)
nm ki=39 (nummod)
aim revealed (dep)
activities anticoagulation (compound)
atp by (case)
achieved hypotension (nsubjpass)
neoplasia due (case)
result failure (nmod)
decreased induced (conj)
complication . (punct)
activity values (conj)
cataracts cancer (conj)
bulk results (nmod)
risk not (neg)
1 only (advmod)
ampicillin and (cc)
scan including (case)
resulted possibly (advmod)
data users (nmod)
-14.8 ( (punct)
low as (advmod)
design case-control (amod)
concentrated patients (nsubj)
disorder behavioral (amod)
model producing (acl)
magnus the (det)
found tropicamide (nmod)
na ca (conj)
tamoxifen letrozole (conj)
application before (nmod)
discontinued tac (nsubjpass)
use concurrent (amod)
factor the (det)
toxicities these (det)
growth reduced (amod)
factor-kappab kinases (conj)
16 . (nummod)
children disease (nmod)
diabetes for (case)
magnitude pain (nmod)
$ROOT$ monitor (sent)
recall that (dobj)
utility cbz (nmod)
dosed rats (nmod)
chlorambucil agents (appos)
$ROOT$ occlusion (sent)
study clinical (amod)
state brain-dissociated (amod)
saline saline (conj)
prevalent was (cop)
reverse that (mark)
seen cases (nmod)
terbutaline , (punct)
used radiation (dobj)
prevalence . (punct)
phenotype depressive (amod)
mediated receptor (nmod)
saline l-arginine (conj)
diarrhoea resulted (acl:relcl)
forestomach rat (nmod)
$ROOT$ frequency (sent)
vasopressin oxytocin (conj)
treatment adriamycin (nmod)
ultrasound abdominal (amod)
efficacies preventing (acl)
glutamate , (punct)
evaluations scan (nmod)
induced damage (dobj)
marketed suprofen (nsubjpass)
carcinoma head (compound)
abilities control (acl)
started pill (nmod)
group high-risk (amod)
induced tachycardia (nsubjpass)
entity of (case)
treatment ticlopidine (nmod)
related synthesis/release (nmod)
dexamethasone topical (amod)
energy " (punct)
facilitates and (cc)
correlation markers (nmod)
uncommon type (nsubj)
arose vasospasm (nsubj)
anaesthesia surgery (conj)
shortened and (cc)
$ROOT$ maximal (sent)
intubated and (cc)
showed preventing (advcl)
changes caffeine-induced (amod)
offers schedule (dobj)
factor acid (nsubj)
rhythm sinus (amod)
nervous central (amod)
alphaenac gammaenac (conj)
infective biochemical (conj)
lowers absence (nsubj)
tumors independent (amod)
injected weeks (conj)
stopped followed (conj)
ato dex (conj)
organisms causative (amod)
report underwent (appos)
day 29th (dep)
% 5.7 (nummod)
attenuate sod (nsubj)
produced failure (nsubjpass)
treatment adolescents (nmod)
tumors t1 (compound)
proposed as (mark)
functions on (case)
studies blocking (amod)
association endpoints (nmod)
practitioners by (case)
increased index (nsubjpass)
effects neutropenia (nmod)
apomorphine s.c. (appos)
confirmed incidence (dobj)
metabolites ring (compound)
crisis amisulpride- (amod)
blocked scopolamine (nsubj)
synaptic post (amod)
agonist specific (amod)
infection inflammation (conj)
rate surgery (nmod)
similar concentrations (nsubj)
and , (punct)
% group (nmod)
reduced injury (dobj)
functions involved (acl:relcl)
terfenadine ( (punct)
continued . (punct)
modulate drugs (nsubj)
dogs control (amod)
outcome most (nmod)
creation shunting (nmod)
continued who (nsubj)
baseline intervals (conj)
mitochondria cardiac (amod)
attenuation the (det)
consider patients (nmod)
mg/kg 7.5 (compound)
recruited men (nsubjpass)
scavenging radical (compound)
all disease (nmod)
putamen in (case)
effect lipopolysaccharide (nmod)
interaction took (acl:relcl)
medical dental (conj)
time used (conj)
values metoprolol (compound)
carried forward (advmod)
cows 17 (nummod)
oxide nitrous (amod)
syndromes these (det)
time- and (cc)
cultures pre-treated (acl)
commissure-commissure and (cc)
resulted surprisingly (advmod)
acetazolamide of (case)
half almost (advmod)
morphine intravenous (amod)
effects amantadine (nmod)
pancreatitis and (cc)
committee data-monitoring (compound)
calcium mg/dl (appos)
commenced cdt (nsubjpass)
detection prediction (conj)
responsible may (aux)
week 20th (amod)
air of (case)
practiced vigilance (nsubjpass)
assigned groups (nsubjpass)
antagonist properties (nmod)
bmcs ) (punct)
findings cohort (nmod)
system glutamatergic (amod)
indicate reports (nsubj)
thought involved (xcomp)
pathway , (punct)
doses after (case)
products peroxidation (compound)
rats rats (conj)
polymerase and (cc)
urothelium rat (compound)
searched evidence (nmod)
harmful especially (advmod)
safety use (nmod)
relations sexual (amod)
successful be (cop)
compared a. (nmod)
role precipitating (acl)
duration optimal (amod)
postponed trimester (nmod)
content vip (compound)
allopurinol dex (conj)
sotalol digoxin (conj)
dexmedetomidine alone (advmod)
difference db (compound)
ligands 5-ht1b (compound)
source a (det)
iu/l , (punct)
iopromide or (cc)
54 +/- (cc)
rated quality (nmod)
selectivity and (cc)
spine at (case)
fractions in (case)
elevation activities (nmod)
mg/kg times (nmod)
length of (case)
concentration output (conj)
beta-enac gamma-enac (conj)
$ROOT$ choice (sent)
patterns transformation (compound)
those subjects (nmod)
fev1 , (punct)
5 second (nmod)
resulted duration (nmod)
1 0.5 (conj)
body of (case)
levels synapse (nmod)
pancreatitis suppression (conj)
responses most (amod)
recorded trial (nmod)
series analogues (nmod)
detect deterioration (dobj)
age except (case)
role mechanistic (amod)
cent 34 (nummod)
% ci (parataxis)
formation correlate (nsubj)
designed obtained (conj)
changes " (punct)
obtained sacrifice (nmod)
40,000 to (dep)
excitability months (nmod)
-0.62 -0.58 (conj)
eyes both (det)
gr or (cc)
p<0.0005 ) (punct)
greater diltiazem (conj)
155 % (appos)
useful also (advmod)
trinitrate , (punct)
sensitivity , (punct)
enhanced it (dobj)
cvvhdf by (case)
cleared rapidly (advmod)
improved dramatically (advmod)
compromising without (mark)
help guide (xcomp)
administered schedule (nmod)
facilitation morphine (nmod)
presentation cholestatic (amod)
induction glomerulosclerosis (nmod)
incidents embarrassed (advcl)
compared content (nsubjpass)
weight normal (amod)
those contraindication (nmod)
effect without (case)
forms ulcerous (amod)
pergolide placebo (conj)
types sediment (nmod)
tacrolimus of (case)
improve performance (dobj)
predicted discontinuation (nmod)
effects : (punct)
tensions curves (conj)
recovery rebound (conj)
possible be (cop)
antibodies proteins (nmod)
change content (conj)
contributes myalgia (nmod)
5 21 (conj)
attributed hypotension (nsubjpass)
prevent dysfunction (dobj)
effect contributory (amod)
occurred nephrotoxicity (nsubj)
carbamazepine chronic (amod)
associated previously (advmod)
dose particularly (advmod)
examination light (amod)
occurrence maintenance (conj)
routes oral (amod)
action cimetidine (nmod)
rates secretory (amod)
regulated developmentally (advmod)
mpa and (cc)
increased ht (nsubj)
iso to (case)
aware effects (nmod)
woman 92-year-old (amod)
link hyperprolactinemia (dobj)
relationship bradycardia (nmod)
alters lipoproteins (dobj)
kit has (acl:relcl)
disorders with (case)
conclusions mg. (advcl)
had epm (nmod)
2 25 (conj)
drug ifosfamide (nsubj)
diphenhydramine prednisone (conj)
= 1.9 (dobj)
calcitonin of (case)
randomized weeks (nmod)
$ROOT$ enhanced (sent)
result that (mark)
objective poor (appos)
commissure the (det)
included age (dobj)
danger products (nmod)
characterized was (auxpass)
beats ) (punct)
high-dose , (punct)
insipidus therapy (nmod)
developed compared (advcl)
resistance for (case)
responded generally (advmod)
prevention transplantation (nmod)
6.6 vs. (cc)
aggressive highly (advmod)
meta-analysis patients (appos)
demonstrate ototoxicity (dobj)
method tail-cuff (amod)
performed performed (conj)
elevated hg (nmod)
gain will (aux)
p10 33.6 (appos)
examined movement (nsubjpass)
study radiocontrast (compound)
average visits (nmod)
activity strains (nmod)
ratio 1.22 (nmod)
regulated many (nsubjpass)
role catatonia (nmod)
promoted increasing (advcl)
phosphate po (appos)
undergoing bypass (dobj)
tmax cbd (conj)
apo ) (punct)
activity daunorubicin (compound)
leakage lysosomal (amod)
demonstrated lack (dobj)
aminotransferase aspartate (compound)
curve force-frequency (compound)
days final (amod)
aorta/serum-ratio build-up (conj)
ros nitrite (appos)
understanding and (cc)
administered isoproterenol (nmod:npmod)
behavior shake (compound)
caused compared (advcl)
initiate signals (dobj)
were also (advmod)
samples biopsy (compound)
respond induction (nmod)
results ; (punct)
mek1 in (case)
ketoprofen times (appos)
transection not (cc)
observed histopathologically (advmod)
ephedrine mg (appos)
noncompliance of (case)
function chain (compound)
exceeded which (nsubj)
changes tissue (nmod)
developed patient (nsubj)
agents several (amod)
solution % (amod)
confusion including (case)
sub-divided . (punct)
medial and (cc)
positive ax (nmod)
require evaluation (dobj)
analyze . (punct)
matched index (nmod)
diminution levels (nmod)
manifestation patients (nmod)
enhance depress (conj)
hyponatraemia with (case)
irrigation bladder (compound)
0.9 versus (cc)
children % (appos)
induce anemia (dobj)
unaffected neutrophils (nmod)
media serum-free (amod)
pneumonia for (case)
2/3 patients (nmod)
samples daily (amod)
resulting occupancy (nmod)
effect additional (amod)
mg patients (dep)
administration labetalol (nmod)
received morphine (dobj)
increasing decreasing (conj)
register danish (amod)
estimate to (mark)
carrier a (det)
encountered is (auxpass)
observations a (det)
improvement discontinuation (nmod)
monitoring intensive (amod)
phenacetin acetaminophen (conj)
3/20 ( (punct)
suggestions interactions (nmod)
$ROOT$ utilized (sent)
thrombophlebitis produced (acl)
studies neuronanatomical (amod)
nitrogen bun (appos)
bladder on (case)
failed increased (advcl)
3.5 7.0 (conj)
increase pronounced (amod)
percent seventy-nine (nummod)
overdose acute (amod)
approach posterior (amod)
therapy disulfiram (compound)
polytherapy following (case)
display that (nsubj)
activity free-field (amod)
inhibits induce (conj)
involvement vessels (nmod)
phenomena other (amod)
subjects diagnosed (acl)
republic the (det)
suppressed proliferation (nsubjpass)
sensitization impairment (nmod)
system brainstem (nmod)
present cardiotoxicity (nmod)
developed child (nsubj)
barrier in (case)
agent ideal (amod)
i1- and (cc)
a-i , (punct)
phenothiazines with (case)
tendency decrease (acl)
society patients (conj)
group of (case)
order potency (nmod)
toxicity stomatitis (appos)
beating shortening (conj)
disturbing % (nsubj)
mg/24 190 (nummod)
lack its (nmod:poss)
coadministration following (case)
6,3-dilactone - (punct)
identifying correctly (advmod)
greater occurred (conj)
dose children (nmod)
induced catalepsy (dobj)
suffered course (nmod)
cancer necrosis (conj)
increases treatment (conj)
pcp ( (punct)
ml/100 34.3 (nummod)
serve can (aux)
frequent regurgitation (nsubj)
increased latency-to-onset (dobj)
measured previously (advmod)
observed activity (nsubjpass)
suggest possible (ccomp)
80 to (dep)
source bmc (compound)
diagnosed patients (nmod)
administration veterans (compound)
ineffective is (cop)
total children (nmod)
% 12.6 (nummod)
assessment and (cc)
periods early (amod)
initiate myopathy (dobj)
echo high-resolution (amod)
associated generally (parataxis)
tremor postural (amod)
kidney iprk (appos)
halothane of (case)
inhibitor new (amod)
8.4 vs (cc)
hypokalemia symptomatic (amod)
levels reduction (nmod)
related often (advmod)
number seizure (compound)
reduced onset (nmod)
ed50 the (det)
higher days (nmod)
sum grades (nmod)
disappeared therapy (nmod)
neutropenia thrombocytopenia (conj)
nucleus dentate (amod)
potential treating (acl)
associated resulted (conj)
treated glaucoma (nmod)
abolished staining (dobj)
regimens chemotherapeutic (amod)
ng , (punct)
rats tested (acl)
returned days (nmod)
oedema associated (amod)
agonists receptor (compound)
demonstrated dose (nmod)
complication preclude (conj)
trimethoprim-sulfamethoxazole prescribed (acl)
$ROOT$ hypertrophy (sent)
waves intervals (conj)
treated pneumonia (nsubjpass)
compounds p.o. (nmod)
analyzed . (punct)
decreased to (xcomp)
presentation the (det)
augmentation no (neg)
distress on (case)
had drug (dobj)
years 9.99 (nummod)
reduced area (dobj)
cmf ) (punct)
warfarin mg/kg (dep)
number antitussives (nmod)
increase nodularity (nmod)
erythroid and (cc)
hypertrophy bone (compound)
$ROOT$ imperative (sent)
antipsychotic antidepressant (conj)
metoprolol 's (case)
release enzyme (compound)
vessels of (case)
unknown previously (advmod)
doses first (amod)
failure patients (nmod)
lobe his (nmod:poss)
may and (cc)
eyes on (case)
reverted and (cc)
humans and (cc)
dosage doxorubicin (nmod)
phytomitogen pha-p (appos)
effect with (nmod)
systems mediate (acl:relcl)
objectives was (appos)
cisternae golgi (compound)
than ppm (conj)
delivered days (nmod)
biochemical effects (dep)
shortened time (nmod)
receptor complement (compound)
disease level (conj)
gr ( (punct)
curcumin mg/kg/day (dep)
comparing drugs (nmod)
seizures perioperative (amod)
3.4 0.9 (conj)
learning ) (punct)
phosphorylation members (nmod)
mixture a (det)
criteria tested (acl)
neoplasm a (det)
mean /-standard (cc)
noted responses (nmod)
known disease (nsubjpass)
role and (cc)
aqueous and (cc)
pretreatment nicotine (compound)
therapy a (compound)
enalapril with (case)
disorientation rigidity (conj)
necessary proliferation (nmod)
emphasis development (nmod)
potassium acid (conj)
assigned verify (xcomp)
cities us (compound)
had inhibited (conj)
have simvastatin (nsubj)
effective comparably (advmod)
hydrochloride and (cc)
asenapine bid (nmod)
occur rigidity (nsubj)
reviews aspirin (nmod)
sss sinus (conj)
units hydrocortisone (nmod)
intrathecal systemic (conj)
akinetic group (appos)
control good (amod)
limit largely (advmod)
phenomena the (det)
$ROOT$ sum (sent)
therapy active (amod)
strain lobund (amod)
repeat word (dobj)
restored rg1 (nsubj)
tachyarrhythmia : (punct)
sectioned were (auxpass)
g/dl conversion (nmod)
diagnoses pathologic (amod)
leading delay (nmod)
mofetil and (cc)
switched , (punct)
block due (case)
develop response (nmod)
diagnosed three (nsubjpass)
society pharmacoeconomics (nmod)
received infants (nsubj)
animals ) (punct)
factors independent (amod)
effects ketamine (nmod)
disorder gastroesophageal (amod)
reinstated plasticity (nsubjpass)
excluded has (aux)
cessation reduction (conj)
mg/kg p.o. (advmod)
induced ketoconazole (nsubj)
effects dosages (nmod)
evident levels (nmod)
rash lymphadenopathy (conj)
initiated was (auxpass)
starting therapy (dobj)
% 0.9 (compound)
mek1 3e (conj)
release cytokine (compound)
changes threshold (nmod)
% 8.6 (nummod)
patients eighty-four (nummod)
that compound (nmod)
nitroglycerin phenylephrine (conj)
reduced : (punct)
vertex at (case)
treatment into (case)
receiving bromocriptine (dobj)
recurrence patients (nmod)
startle not (cc)
children prolactinomas (nmod)
arteries by (case)
samples blood (compound)
fell . (punct)
ranged 3 (nmod)
ocular auditory (conj)
hypnotic the (det)
experiences because (case)
nuclei in (case)
certain symptoms (nmod)
rats day (compound)
arrest ; (punct)
2.1 conclusions (dep)
regurgitation flutter (conj)
prolonged shortened (conj)
introduction with (case)
increased pregnancy (nmod)
infusions intravenous (amod)
adults and (cc)
morning and (cc)
cta of (case)
obtained d-glucarate (nmod)
control patients (nmod)
hdl class (conj)
objective review (acl)
$ROOT$ irreversible (sent)
size-dependent , (punct)
loss vision (nmod)
reported women (dep)
functions depressed (acl)
improvement % (amod)
administration phenylephrine (nmod)
delayed protracted (conj)
were cyclosporine (nmod)
undergoes inhibited (conj)
protein natom (compound)
ergotamine/caffeine for (case)
nephrotoxicity induced (acl)
rate its (nmod:poss)
examined further (advcl)
resulted proarrhythmia (nmod)
ventricle into (case)
contribute activation (nsubj)
gravis known (amod)
concentrations myocardial (amod)
leukocytes bacteria (conj)
not or (cc)
fields the (det)
suggest warrant (ccomp)
obscure is (cop)
concerns exposure (nmod)
injection prior (amod)
identified included (parataxis)
of especially (advmod)
increase use (nsubj)
death events (nmod)
mrp2 ( (punct)
mice young (amod)
involvement analgesia (nmod)
enhancement co-administration (nmod)
leukoencephalopathy , (punct)
reversed symptoms (dobj)
biochemical functional (conj)
supporting hypothesis (dobj)
protected tcr (nsubj)
produce not (neg)
micromol/l 6.2 (nummod)
l-type of (case)
loss associated (acl)
ph po2 (appos)
failed had (aux)
accounted tetra- (nmod)
(2-chloroethyl)-1-nitrosoure carmustine-[1,3-bis (compound)
damage mediated (acl)
val204asp ( (punct)
unclear relationship (nsubj)
cause ; (punct)
doses atenolol (nmod)
primary of (case)
correlated features (nsubjpass)
potential antioxidant (amod)
methotrexate csf (compound)
consequence a (det)
considered it (nsubjpass)
delineate structures (dobj)
points seizure (compound)
nicotine and (cc)
profiles in (case)
leucovorin mg/m2 (appos)
120.04 +/- (cc)
diabetes normoalbuminuria (conj)
revealed differences (dobj)
compared data (dobj)
done . (punct)
stain to (mark)
minutes between (case)
strategy retard (acl)
verapamil ablation (conj)
effects therapeutic (amod)
administration chemotherapy (nmod)
disease smoking-related (amod)
reversed was (auxpass)
reported be (auxpass)
gds of (case)
mitochondria compared (case)
erythroderma failure (conj)
anxiety on (case)
mg 2 (compound)
adenocarcinoma 1 (appos)
therapy full (amod)
group % (dep)
given control (nmod)
associated groups (nsubjpass)
use current (amod)
% % (advcl)
evaluation behavior (nmod)
illness serious (amod)
noted sequelae (nsubjpass)
expression renal (amod)
occurred lost (conj)
alterations types (nmod)
positivity based (case)
estimated difference (dobj)
locomotion mk-801-induced (amod)
application inhibitor (nmod)
recorded treatment (nmod)
appears flat (xcomp)
1.7 ) (punct)
administration received (advcl)
treatment losartan (compound)
pretreatment cimetidine (nmod)
tubule and (cc)
defects major (amod)
elevations transaminases (nmod)
rate recurrence (compound)
viewed use (nsubjpass)
20,40,60 80 (conj)
isph weight (dep)
ro4368554 , (punct)
elevated patients (nmod)
score rest (nmod)
mitigated was (auxpass)
contraindicated isotretinoin (nsubjpass)
sedative mri (nmod)
days prior (amod)
consolidation impaired (amod)
reasons seizures (nmod)
intervention after (case)
administered six (nmod)
regions the (det)
failure dox-induced (amod)
relief pain (nmod)
pressure normal (amod)
parameters pharmacodynamic (amod)
effects -- (punct)
administrated vcm (nsubjpass)
family his (nmod:poss)
clearance adults (nmod)
reactions in (case)
detected however (advmod)
1-(2-phenethyl)-4-(2-pyridyl)-piperazine ( (punct)
treatment prolonged (amod)
hypotension convenient (amod)
study parallel (amod)
common % (parataxis)
pathway impaired (advcl)
reduplication basement (compound)
days early (amod)
drugs anticoagulant (compound)
indicate justified (ccomp)
5-fu/fa mmc (conj)
syndrome extrapyramidal (amod)
movements fold (compound)
several rcts (nmod)
stopping ethambutol (dobj)
mg. to (case)
battery two-part (compound)
microgram/kg/min during (case)
cirrhosis carcinoma (conj)
points only (cc:preconj)
rct new (amod)
effects cbz (nmod)
make increases (advcl)
neurons sensory (amod)
allow conditions (dobj)
death epinephrine-induced (amod)
patient 1 (nummod)
better those (nmod)
group adr-nephropathy (compound)
attenuated anxiety (nsubjpass)
damage chronic (amod)
fenfluramines only (advmod)
succimer , (punct)
salicylate phenylbutazone (conj)
animals fetal (amod)
hz 185 (nummod)
concentration extrapolated (amod)
induce drug (nsubj)
abc ) (punct)
9 range (dep)
excluded analysis (nmod)
evident which (nsubj)
toxicity due (case)
used daily (advmod)
antagonism muscarinic (amod)
differ seizures (nsubj)
opening after (case)
inducer p4501a1/1a2 (nmod)
greater % (nmod:npmod)
model mmrm (appos)
hemorrhage patients (nmod)
animals followed (acl)
believe . (punct)
reduces that (mark)
synergism in (case)
anticoagulation excessive (amod)
exercised prescribing (advcl)
features arrhythmia (nmod)
centre traumatological (amod)
necessary assess (xcomp)
image the (det)
2r,4r-apdc ; (punct)
alpha-methyldopa by (case)
being of (mark)
dystrophy and (cc)
7 173 (conj)
studies inhibition (compound)
choleretic a (det)
association progression (nmod)
counts cd4 (amod)
occurs dysfunction (nsubj)
drug that (mark)
revealed present (advcl)
frequent reversible (conj)
mm versus (cc)
wernicke 's (case)
investigated potential (nsubjpass)
sah aneurysmal (amod)
studies rodent (amod)
scenario uncommon (amod)
248 of (advmod)
cco-iv ( (punct)
events several (amod)
causes mutation (nsubj)
1967 and (cc)
both days (nmod)
arthritis of (case)
rose groups (nmod)
mexitil-perlongets ) (punct)
disruption regional (amod)
imaging mr (compound)
report outcome (nmod)
administration fr (nmod)
schizophrenic in (case)
function levels (conj)
proving infusion (nsubj)
decrease some (det)
pressures blood (compound)
study migraine (compound)
those myopathy (nmod)
observed doxorubicin/kg (nmod)
potentiated kf17837 (nsubj)
studied employing (xcomp)
expression targeting (conj)
score incidence (dobj)
serve could (aux)
determined points (nmod)
ug/ml serum (nsubj)
bleeds fatal (amod)
overdosage scopolamine (compound)
group non-mi (amod)
ameliorated were (auxpass)
chemotherapy is (cop)
d11 d16 (conj)
tie2-cre;loxp-egfp lineage-traceble (amod)
regimen with (case)
pretreatment with (nmod)
led discontinuation (nsubj)
passage cause (dep)
structure function (conj)
decrease p (dep)
torr , (punct)
patients classified (acl)
institution pediatric (amod)
14 or (cc)
except fractures (nmod)
hearts explanted (amod)
evoked rats (nmod)
amelioration timolol (nmod)
monitor , (punct)
approximate inferences (nmod)
choosing antipsychotic (dobj)
test self-reported (amod)
quality trial (compound)
s(c)o(2 preserved (amod)
rate observed (conj)
vision for (case)
hypotension infusion (nmod)
had hysterectomy (dobj)
average mg (nmod)
catalepsy neuroleptic-induced (amod)
$ROOT$ reappeared (sent)
7.7 1.5 (conj)
was re-examine (xcomp)
netilmicin with (case)
receiving chemotherapy (dobj)
undergone patients (nsubj)
hypertension diagnosed (amod)
patient patient (appos)
introduction counter (dep)
reviewed reports (nmod)
increase creatinine (nmod)
suggested ain (dobj)
doses studied (acl)
intervals p-r (compound)
disappearance nsvt (nmod)
diagnosed day (nmod)
involvement aetiology (nmod)
urge experience (nmod)
antidepressants , (punct)
degeneration with (case)
conclusions exhorted (appos)
l-noarg ) (punct)
amphetamine s.c. (appos)
found suppress (ccomp)
features seen (acl)
red sirius (compound)
subjects used (acl:relcl)
enhanced rigidity (dobj)
made supported (conj)
concealed information (nsubjpass)
defined having (advcl)
invited methods (nsubjpass)
relationship cyclophosphamide (nmod)
wish draw (xcomp)
release role (conj)
weight peroxidation (conj)
those stages (nmod)
[na]o in (case)
symptom a (det)
children pb-exposed (amod)
cyp3a4 of (case)
infection nova (compound)
hyperactivity hypersensitivity (conj)
giving octogenarians (nmod)
infusion tdi (appos)
es ) (punct)
arteriole an (det)
decreased 19 (nmod)
hemolysis extravascular (amod)
afterdepolarization : (punct)
effusions pleural (amod)
tumor is (cop)
np dxnp (conj)
individuals intolerant (amod)
glaucoma angle (compound)
experienced who (nsubj)
blocks activity (dobj)
popularity its (nmod:poss)
cats group-housed (amod)
2 in (case)
mg/kg sem (appos)
suggest has (ccomp)
occurrence its (nmod:poss)
volume hemorrhagic (amod)
trials no (det)
ruled after (mark)
time writing (nmod)
attempt in (case)
suffers that (mark)
min 40 (nummod)
ingestion barium (compound)
models flurothyl (compound)
nephrotoxicity (aap)-induced (amod)
benzoylecgonine with (case)
meq/l 3.0 (nummod)
$ROOT$ spectrum (sent)
persisted reduction (nmod)
microangiopathy the (det)
duration not (cc)
considered factors (nmod)
carcinoma bladder (compound)
extraction molars (nmod)
404 4.6 (nummod)
qtp % (appos)
received therapy (nmod)
glomeruli nonfiltrating (amod)
some findings (nmod)
ml ( (punct)
results suggested (appos)
phosphatase u/l (appos)
magnitude insufficient (amod)
68.3 28.9 (conj)
decreased counts (nsubjpass)
produce analogs (nsubj)
investigations neuroradiologic (amod)
transition permeability (compound)
diagnosis stroke (nmod)
compounds cytotoxic (amod)
measured compared (conj)
1 monkeys (nmod)
% 14.28 (nummod)
led flushing (advcl)
observed hours (nmod)
experiments involving (acl)
dysfunction vascular (amod)
acid clavulanic (amod)
determined effect (dobj)
follows ml (dep)
fall dosage (nmod)
showed preponderance (dobj)
pan in (case)
fracture dislocation (conj)
injected gr (nmod)
products damage (compound)
deficiency permanent (amod)
low microgramg/ml (dobj)
dcf , (punct)
esrd to (case)
showed measurement (nmod)
justified prevent (xcomp)
report syndrome (nmod)
affects isoproterenol (nsubj)
renal to (case)
cold ice (nmod:npmod)
neuropathy ethambutol-associated (amod)
remained response (nsubj)
appeared safe (xcomp)
good good (nmod)
blotting western (compound)
eyes ( (punct)
twice week (nmod:npmod)
patients hypertensive (amod)
states volume (compound)
biochemical morphological (conj)
explore conducted (parataxis)
syndrome failure (conj)
developed women (nsubj)
alf=0/35 ) (punct)
doses cholinomimetic (nmod)
field visual (amod)
restoration replication (nmod)
died children (nsubj)
receptor nicotinic (amod)
relevant . (punct)
identified 1986 (nmod)
suppression the (det)
department used (acl:relcl)
effects betamimetic (amod)
positive positive (conj)
sister a (det)
anemia azt-induced (amod)
pain an (det)
study ) (punct)
acted enhance (xcomp)
declined respectively (advmod)
toxicity system (nmod)
presented rhabdomyolysis (nmod)
three all (det)
intervals 6-monthly (amod)
control genetic (amod)
rats atherosclerotic (amod)
receptor-alpha activated (amod)
used compared (advcl)
relation cyclophosphamide (nmod)
patients hours (nmod)
anastrozole group (conj)
appeared procaterol (nsubj)
assessment potential (nmod)
medical abuse (conj)
motoneurons spinal (amod)
compared conjugation (nsubjpass)
few effects (nsubj)
pge2 , (punct)
activation dopaminergic (amod)
metabolized might (aux)
observation ( (punct)
absence of (case)
mmhg 2 (nummod)
correlate volumes (nsubj)
monitored along (prep)
doxorubicin administered (acl)
electrocardiogram the (det)
confirmed data (nsubj)
relapse of (case)
patients iiib (nmod)
17alpha-ethinylestradiol of (case)
findings mris (nmod)
ineffective treatment (nsubj)
differences environment (nmod)
speculate resulted (ccomp)
rate oxygen (nmod)
obtained however (advmod)
indicated tests (nsubj)
cycles regimen (nmod)
mice 6 (nummod)
chorea of (case)
revealed potentials (dobj)
enhances deficiency (nsubj)
induce atherosclerosis (dobj)
anemia report (dep)
$ROOT$ supplement (sent)
oestrogens ( (punct)
address in (mark)
min vs. (cc)
feature an (det)
infusions pallidus (nmod)
used patient (nsubj)
known inhibit (xcomp)
coagulopathy to (case)
provided years (nmod)
membrane tbm (appos)
synthesis prostacyclin (compound)
restored however (advmod)
objectives demonstrated (appos)
causes itself (nmod)
tests performed (acl)
shows conclusion (nsubj)
administered monkeys (nmod)
had though (mark)
diagnosis an (det)
shares hyperalgesia (nmod)
performed case (nmod)
scheduled procedures (nmod)
taking drugs (dobj)
agent : (punct)
mg/dl 0.3 (nummod)
higher whereas (mark)
paclitaxel mg (nummod)
nicergoline ( (punct)
diagnostic therapeutic (conj)
localize site (dobj)
modify relieve (conj)
tachycardia ventricular (amod)
records interview (conj)
pathology to (case)
cardiotoxicity dogs (nmod)
confirm taken (advcl)
proliferation migration (conj)
attributed usually (advmod)
determined ( (punct)
inhibit kinase (dobj)
found ; (punct)
erythrodysesthesia severe (amod)
vehicle avp (conj)
distribution by (case)
patients terminal (amod)
hallucinations patient (nmod)
placebo = (dep)
perfusion renal (amod)
eeg ) (punct)
receptors alpha1-adrenergic (amod)
mmg ( (punct)
studies iii (nummod)
fell volume (nsubj)
cd25 the (det)
putamen caudate (amod)
anaesthesia with (case)
control adequate (amod)
3.0 30.0mg/kg (conj)
use findings (dobj)
antibiotics prophylactic (amod)
model mice (appos)
values ic50 (compound)
occurs strong (advcl)
diagnosis histopathologic (amod)
drop the (det)
reactions symptomatic (amod)
selection preferential (amod)
evident fibers (nsubj)
vasodepressor of (case)
p=0.0001 respectively (advmod)
determinant important (amod)
risk patients (nmod)
polysomnography accommodation (compound)
method scintigraphy (nsubj)
performance mice (nmod)
utility troponin (nmod)
antagonized doses (nsubj)
sensitivity isoproterenol (compound)
peaked antinociception (nsubj)
presents vasculitis (nsubj)
administered while (mark)
did that (nsubj)
receptor serotonin (compound)
undergoing after (mark)
treatment menorrhagia (nmod)
chlorpromazine mug (appos)
antigens with (case)
contrast decrease (nmod)
pressure raised (amod)
pain rats (nmod)
hypoxia of (case)
dxnp dx (conj)
reported manifestation (nmod)
mechanisms in (case)
using ces-d (dobj)
cause interventions (nsubj)
connection in (case)
disappear but (cc)
patient presenting (acl)
group ptra (compound)
lower risk (nsubj)
increase map (nmod)
naloxone r-(alpha)-methylhistamine (conj)
uterotonic cause (acl:relcl)
scored . (punct)
disorder antisocial (amod)
difference chloride (nmod)
subsided rapidly (advmod)
indicates present (ccomp)
function decreased (amod)
route intravenous (amod)
constitutes therapy (dobj)
inhibition fibrinolysis (nmod)
determined age (nmod)
occurrence rest (nmod)
taking results (dobj)
csa . (punct)
administration diltiazem (nmod)
reduces thiopentone (nsubj)
shift leftward (amod)
effects des (nmod)
concentrations micromol/l (nmod)
taking event (nmod)
studied rats (nsubjpass)
duration by (case)
ecstasy groups (dep)
increase including (case)
flaccid and (cc)
concentration dopamine (nmod)
elevated day (nmod)
prolonged . (punct)
deficits ecstasy-related (amod)
status group (compound)
microg 200 (compound)
influence no (det)
% 31.8 (nummod)
assay for (case)
presented are (auxpass)
placebo stabilizer (conj)
reductase coa (compound)
mediated , (punct)
period june (nmod)
underlying dyskinesias (dobj)
area in (case)
using instrument (dobj)
next involvement (nmod)
debated : (punct)
receptor-alpha peroxisome (compound)
neurotoxicity about (case)
effects renal (amod)
use suppressants (nmod)
salbutamol hds (appos)
effect nitroglycerin (nmod)
anorexia , (punct)
rats dosed (amod)
women 72 (nummod)
involved history (nmod)
agonist isoproterenol (dep)
tolerated < (dobj)
changes suggestive (amod)
associated proliferation (nmod)
alterations cerebellar (amod)
$ROOT$ localized (sent)
ill severely (advmod)
sensation area (nmod)
vasculitis retinal (amod)
studies receptor (compound)
sugar on (case)
difference sessions (nmod)
expression avp (compound)
dose the (det)
antagonist h2-receptor (compound)
used evaluate (advcl)
hemoglobin g/dl (appos)
nmbas aminosteroid-based (amod)
symptoms regarding (case)
effect promoting (compound)
changes measures (nmod)
catatonia chick (nmod)
palate with (case)
= 2.8 (dobj)
admission icu (compound)
reported herein (advmod)
role special (amod)
caused decrease (dobj)
remained activation (nmod)
dilatation atrophy (conj)
$ROOT$ hematomyelia (sent)
considered . (punct)
multifactorial mechanisms (nsubj)
caused pentobarbital (nmod)
november 2007 (nummod)
allograft cadaveric (amod)
fulfilled compared (conj)
timolol ( (punct)
disposition due (case)
expression treatment (nmod)
decreased oct (nsubj)
occurred reported (conj)
dexrazoxane with (nmod)
intoxication carbachol (compound)
lozenge between (case)
slower significantly (advmod)
2.2 +/- (cc)
symptoms caused (acl)
delirium treatment (nmod)
neuropathy is (cop)
pronounced headache (nsubj)
chlorpromazine with (case)
concentration i (compound)
inflamed strips (dep)
methods used (acl)
action ikr (nmod)
modify , (punct)
forehead right (amod)
case be (cop)
induction catatonia (nmod)
inserted pacemaker (nsubjpass)
predicting of (mark)
average compared (case)
evidence ptcr (nmod)
administered cisplatin (nmod)
compound active (amod)
beta-agonist a (det)
polymorphic polymorphisms (nsubj)
determine reduce (ccomp)
presence hand (nmod)
deprivation remd (appos)
analysis urine (compound)
injections intrastriatal (amod)
have % (nsubj)
test lymphocyte (compound)
clumsiness reaction (conj)
elicits that (mark)
have disturbance (dobj)
fruste apparent (amod)
action : (punct)
months follow-up (nmod)
dilation left (amod)
reviewed seen (advcl)
appeared erythema (dep)
h2o2 ( (punct)
undergone radiotherapy (dobj)
$ROOT$ infrequent (sent)
disruption that (mark)
curves bell-shaped (amod)
hypotension lasted (acl:relcl)
methamphetamine map (appos)
block occasional (amod)
improved decreased (conj)
movement decreased (amod)
neurotoxicity theophylline (compound)
infusions h (amod)
pathogen common (amod)
induced significantly (advmod)
arrest labor (dobj)
patient pseudoacromegaly (nmod)
angioedema common (amod)
represents form (dobj)
dose methylergonovine (nmod)
common are (cop)
higher placebo (dep)
received mean (parataxis)
epsilon4 apoe (compound)
increased icp (nsubj)
complications thromboembolic (amod)
prescribe give (conj)
injected sites (nmod)
trait leprosy (conj)
shown agent (xcomp)
boys both (det)
recovered function (nsubjpass)
administration 8-aminoquinoline (nmod)
written although (mark)
preinfusion . (punct)
male . (punct)
appears obvious (xcomp)
anemia/thrombocytopenia/emesis/rash = (dep)
schedule this (det)
responses phenylephrine (compound)
effect nifedipine (nmod)
ng/mouse 10 (nummod)
affect sensitivity (dobj)
positive none (nsubj)
sdrr ) (punct)
$ROOT$ require (sent)
bp > (appos)
rats p100 (compound)
effect antagonist (nmod)
hyperinsulinemia resistance (nmod)
injection a (det)
solution ophthalmic (amod)
greater group (nmod)
disruption elimination (nmod)
help identification (nmod)
concentrations four (nummod)
revealed resulting (advcl)
prevented carvedilol (nsubj)
15.7 +/- (cc)
report ain (nmod)
20- and (cc)
charge adenylate (compound)
rejection and (cc)
or previously (advmod)
degree preference (nmod)
most with (case)
fibrillation , (punct)
promotes decreases (conj)
less controls (nmod)
county florida (appos)
follow-up : (punct)
dehydration activation (conj)
intake prolonged (amod)
cope and (cc)
1.050 - (punct)
hissing and (cc)
withdrawal aprotinin (nmod)
constitutes , (punct)
thyroid , (punct)
tested patients (nsubjpass)
creatinine protein (conj)
receive dcf (dobj)
gemcitabine gem (appos)
minutes forty (nummod)
contrast is (cop)
rats sham-operated (amod)
sites action (nmod)
gavaged , (punct)
enhanced is (auxpass)
hearts failing (amod)
addition dose (nmod)
rhythms and (cc)
facilitated , (punct)
vsd and (cc)
areas improvement (nmod)
production matrix (compound)
treated vasculitis (nmod)
treatment diabetes (nmod)
infusion b (compound)
prostigmine ( (punct)
using stimulation (dobj)
analysis additional (amod)
modulation milieu (nmod)
massive . (punct)
17 ; (punct)
ought familiar (xcomp)
candidate is (cop)
treating disease (dobj)
advantages therapy (nmod)
disease cvd (appos)
hypothesis a (det)
backgrounds professional (amod)
receiving intravenously (advmod)
late as (advmod)
dynamic comparative (amod)
separating effects (dobj)
describe increase (conj)
alterations cardiovascular (amod)
1.93 : (punct)
densities of (case)
perspective from (case)
assessments happiness (nmod)
compared duration (nmod)
showed abstinence (nmod)
regimen mfl (compound)
changes such (amod)
rate gem-p (nmod)
injected muscle (nmod)
contain oil (dobj)
4 to (dep)
treated appropriately (advmod)
reduced generally (advmod)
amphetamine cocaine (conj)
october 2006 (nummod)
12.8 15.0 (conj)
administration minutes (conj)
actions stress (nmod)
girl developed (acl:relcl)
treatment l-sotalol (nmod)
cause cisplatin (nsubj)
induction cardiomyopathy (nmod)
recovery prompt (amod)
cases few (amod)
extraction l-arginine (compound)
co-administration aspirin (nmod)
increased 3 (dep)
b1 b2 (conj)
increases ppa (nsubj)
receptor-mediated i1-imidazoline (nmod:npmod)
treatment tacrolimus (compound)
sensitivity reproducibility (conj)
results significant (amod)
prolongs , (punct)
disturbance induced (acl)
0.78 to (advmod)
latter these (det)
apnoea succinylcholine (compound)
inhibition activities (nmod)
episode throughout (case)
concentrations vehicle (conj)
nmda ) (punct)
therapy oxygen (compound)
changes cells (nmod)
dexmedetomidine between (case)
characteristics other (amod)
demonstrated scale (nsubj)
inhibition receptors (nmod)
aggressiveness or (cc)
mice gag/pol (dep)
performed operations (nsubjpass)
mg/dl or=10.8 (nummod)
dysfunction cardiac (amod)
component stress (compound)
produce injections (nsubj)
immunosuppression long-term (amod)
property such (case)
process podocyte (compound)
enzyme ala204asp/p (compound)
theorem bayes (nmod:poss)
slower identifying (advcl)
extracted independently (advmod)
regimens therapeutic (amod)
hepatitis established (amod)
30 27 (quantmod)
section during (case)
summarized article (nmod)
remained however (advmod)
searched lilly (dobj)
acid gaba (appos)
summaries case (compound)
ballooning biomarkers (nmod)
change day (nmod)
% 11.8 (nummod)
micronuclei of (case)
circle succeeded (acl:relcl)
assigned patients (nsubjpass)
administration therapy (nmod)
region a (det)
metastases unresectable (amod)
prevention topiramate (nmod)
documented most (advmod)
relevant most (advmod)
haloperidol-treated l-noarg-treated (conj)
vinorelbine vnr (appos)
deficits attributed (acl:relcl)
in incidence (nsubj)
results according (case)
l-sotalol oral (amod)
group temocapril (conj)
associated hypoperfusion (nmod)
syndrome in (case)
pericarditis fever (conj)
got . (punct)
task time-dependent (amod)
seen iridocyclitis (nsubjpass)
distinguished which (nsubjpass)
activity cpk (compound)
erk ldlr (conj)
receptor b1r (appos)
consensus no (det)
encephalopathy ( (punct)
increased expression (nsubjpass)
data contemporary (amod)
concentration of (prep)
resolved dysrhythmias (nsubj)
histochemistry and (cc)
frequency increased (amod)
adjustment introduction (conj)
likely undergone (xcomp)
intensity scale (nmod)
support to (mark)
any , (punct)
mice alpha2abc-/- (amod)
cm diameter (nmod)
due biperiden (nmod)
start to (case)
min 98 (nummod)
4.1 151 (prep)
powered detect (xcomp)
hypoplasia epiphyses (nmod)
vol% . (punct)
injections gentamicin (nmod)
fibrillation persistent (amod)
retention- long-term (amod)
presented changes (nsubj)
worsening significant (amod)
ability driving (compound)
method analysis (compound)
those tolerant (amod)
getting while (mark)
ephedrine on (case)
detect and (cc)
demonstrated increase (nmod)
vasoconstriction greater (amod)
acids triacylglycerol (conj)
dexamethasone % (amod)
performed trial (nsubjpass)
akinesia for (case)
returned returned (conj)
distinguish guidelines (nsubj)
dimension/function lv (compound)
dopamine tissue (nmod)
courses during (case)
t(1/2 published (amod)
cystitis drug-induced (amod)
changes minor (amod)
indicators as (case)
norway bn (appos)
correlation parameters (nmod)
dependent independent (conj)
eliminated . (punct)
endpoints to (case)
status tumors (nmod)
source information (nmod)
serotonin 5-hydroxytriptamine (appos)
milliliters thirty (compound)
mania secondary (amod)
excretion urinary (amod)
parameter other (amod)
vasculitis is (cop)
scopolamine methyl (compound)
ranged that (mark)
chemotherapy of (case)
tone conduction (compound)
due neurotoxicity (nmod)
[3h]inulin and (cc)
neurotransmission mediated (acl)
differentiated h (nmod)
dependent ( (punct)
considered as (mark)
tumors contained (conj)
placed lithiasis (nmod)
scores gtn (compound)
microscopy laser-scanning (compound)
tam ( (punct)
length wave (conj)
disabling severe (amod)
used tomography (nsubjpass)
produced ischemia (dobj)
conjugates containing (acl)
carriers antigen (compound)
ml 4 (nummod)
loss sensation (nmod)
degeneration distinct (amod)
tolerated patients (nmod)
1/8 ( (punct)
preparation membrane (compound)
image mri (appos)
degree a (det)
observed patients (nmod)
radiation with (case)
physiologic biochemical (conj)
ccnu with (case)
group perturbation (compound)
dermatitis with (case)
suggest manifestations (dobj)
sole first (conj)
reduction % (dep)
used urate (conj)
mg/lb [ (punct)
two percent (appos)
project . (punct)
disturbing or (cc)
therapies , (punct)
diminishes . (punct)
developed parasitosis (dobj)
syndromes treated (acl)
prevention primary (amod)
critical is (cop)
majority population (nmod)
lining canal (nmod)
intervals 12- (nummod)
mechanism a (det)
morning ) (punct)
elimination via (case)
inhibitor cei (appos)
evaluation audiological (amod)
synergistic resulting (advcl)
output in (case)
motility jejunal (amod)
virus hbv (appos)
investigated expression (dobj)
impaired patients (nsubj)
attributed infusion (nmod)
gamma-sarcoglycan beta1-integrin (conj)
prevalence higher (amod)
mm 25.7 (nummod)
turned while (mark)
along counts (nmod)
younger women (conj)
end-stage disease (conj)
[3h]sch binding (conj)
complicated that (mark)
invaluable diagnosis (nsubj)
show formed (ccomp)
vary effects (nsubj)
nmol 5.0 (nummod)
patient lithium-treated (amod)
studies years (nmod)
increased threshold (dobj)
reversed while (mark)
excretion despite (case)
succinylcholine of (case)
reversibility failure (nmod)
regardless patterns (nmod)
ua ; (punct)
suggested previously (advmod)
receive progression (nmod)
css ) (punct)
compromising was (cop)
consider providers (nsubj)
form against (case)
explored role (nsubjpass)
sufficient developed (advcl)
lungs liver (conj)
pregnancy twin (compound)
pontis tegmenti (compound)
occur that (nsubj)
% 1.4 (nummod)
converts , (punct)
hepatitis aap-induced (amod)
had it (nsubj)
september to (case)
hg = (appos)
house around (case)
model according (case)
two to (case)
demonstrated mg (nsubj)
lipid both (conj)
interval cycle (conj)
has nra0160 (nsubj)
produced whereas (dep)
diet-fed nd (appos)
collection a (det)
degree required (conj)
nuclei bizarre (amod)
avoidance passive (amod)
identified retention (nmod)
did women (nmod)
capability trespass (acl)
administration l-noarg (compound)
stimulation electrical (amod)
assessed vivo (advmod)
potency and (cc)
determine produced (advcl)
metoprolol plus (cc)
proteinuria significant (amod)
increases average (amod)
tested method (nmod)
ead 2 (nummod)
papilledema detachment (conj)
common reported (advcl)
mg/m(2 ac (nmod)
stability and (cc)
period eight-minute (amod)
patients lamivudine-untreated (amod)
reflected predominance (dobj)
litres/24 3 (nummod)
immediate gradual (conj)
technique intrarenally (advmod)
leveled have (aux)
symptomatology paranoid (amod)
$ROOT$ apply (sent)
model as (case)
failure biventricular (amod)
coagulation fibrinolysin (conj)
syndrome acute (amod)
reduced ii (dep)
indication have (acl)
30 up (advmod)
ranged change (nmod)
receiving therapy (dobj)
count hemoglobin (conj)
eleven abusers (nmod)
reduction patients (nmod)
occurred closed (advcl)
possible may (aux)
physician a (det)
found third (nmod)
occurred experienced (parataxis)
study finding (compound)
patients both (det)
results died (appos)
clarified been (auxpass)
examined relationship (dobj)
typical not (neg)
differ outcomes (nsubj)
psa ( (punct)
sites receptor (nmod)
increase stress (nmod)
echocardiography two-dimensional (amod)
contained glomeruli (nmod)
piloerection and (cc)
antigen to (case)
profile a (det)
subjects fifty (nummod)
min ( (punct)
protected cortex (dobj)
rhabdomyolysis male (nmod)
had groups (advcl)
increased activity (nsubj)
brings however (advmod)
performance block (nmod)
deleted which (nmod)
animals lesioned (amod)
trial first (advmod)
years index (conj)
considered successful (xcomp)
stereotypies dexamphetamine- (amod)
unpleasant . (punct)
carolina)/2011(iowa ) (punct)
organization and (cc)
anticoagulation during (case)
neuroprotective and (cc)
produce patients (nmod)
g , (punct)
potentiated were (auxpass)
regardless diameter (nmod)
administered is (auxpass)
bia ) (punct)
control effective (amod)
ballistic or (cc)
identify protocol (dobj)
occurrence dogs (nmod)
suppressed role (dobj)
drugs anticholinergic (amod)
km ] (punct)
hemiparesis droop (nmod)
map effectively (advmod)
sarcoma with (case)
syndrome complication (appos)
disorders no (neg)
associated nystagmus (nsubjpass)
5-azacytidine mg/kg (appos)
derivative piperazine (compound)
hypotension produced (acl)
radioactivity of (case)
count lymphocyte (compound)
temperature erection (conj)
myoclonus by (case)
represent abusers (nsubj)
reviewed extensively (advmod)
effect rats (nmod)
ineffective doses (nsubj)
lna n (conj)
remained pge2 (nsubj)
agonist ii (nummod)
breath bad (amod)
evident ) (punct)
$ROOT$ scarce (sent)
inefficient terminate (advcl)
events of (case)
increase chloride-induced (amod)
assessed efficacy (dobj)
block atrioventricular (amod)
led reduction (nmod)
= 0.011 (dep)
parkinson idiopathic (amod)
hemorrhage and (cc)
apparent and (cc)
group assessable (amod)
sham = (parataxis)
models current (amod)
effective terminate (xcomp)
injection deliberate (amod)
revealed fundoscopy (nsubj)
care for (case)
tissues of (case)
presents syndrome (nsubj)
thiopentone ml (nummod)
efficient . (punct)
injection suspensions (nmod)
induction hl60 (nmod)
useful detection (nmod)
arrhythmogenicity on (case)
monomers fibrin (compound)
drugs by (case)
40.3 62.0 (appos)
stain gram (nmod:poss)
stage irreversible (amod)
increased decreased (dep)
treated hypertension (nsubjpass)
vpa like (case)
effect loss (nmod)
lymphoma lymphoma (conj)
resuscitation calcium (nmod)
capacity synthesis (nmod)
oscillations of (case)
included -- (punct)
animals disease (nmod)
41 in (case)
number tubules (nmod)
revealed testing (nsubj)
norleucine glutamate (conj)
mfl ( (punct)
had behavior (nmod)
had flavour (dobj)
gyrus iml (appos)
dmso/side ; (punct)
induce estrogens (nsubj)
profile selective (amod)
stimuli acute (amod)
controversial implications (nsubj)
stopping selegiline (dobj)
methylphenidate or (advmod)
leukoencephalopathy developed (acl:relcl)
mecamylamine the (det)
greater mg (advcl)
excluded study (nmod)
beta4 alpha3 (conj)
contractions characteristic (amod)
= 3.2 (dobj)
r6 ) (punct)
administration i.v. (compound)
demonstrated augments (ccomp)
monophosphate guanosine (compound)
lower was (cop)
caused dose (nsubj)
currents slow (amod)
ect ) (punct)
complication crisis (nsubj)
suitable terms (nmod)
chromosome ( (punct)
aim studied (appos)
loss potassium (compound)
agent cyclophosphamide (nsubj)
infusion microgram/kg/min (appos)
pharmacology administration (nmod)
continued they (nsubj)
hospitalised , (punct)
abnormalities pupil (nmod)
adults gbm (nmod)
toxicities clinical (amod)
contribute mechanism (nmod)
uptake brain (compound)
infiltrate a (det)
d2 prostaglandin (compound)
prevent impairment (dobj)
medication l-dopa (compound)
stimulation cns (compound)
procedure entire (amod)
228 49 (compound)
neurotransmission coeruleus (amod)
hemoglobin grams (nmod)
caa of (case)
$ROOT$ ketamine (sent)
valsartan antagonist (appos)
hemiparesis and (cc)
those including (case)
succinylcholine rocuronium (conj)
screened prolactin (nmod)
prior therapy (nmod)
correlates task (nmod)
$ROOT$ nephrotoxicity (sent)
lymphocytes of (case)
current ip (appos)
achieved treatment (nsubj)
convulsion incidence (dep)
showed summary (nmod)
alpha-methyldopa to (case)
justified are (cop)
prevented blockers (nsubj)
demonstrates this (nsubj)
coordination and (cc)
severity majority (nsubj)
patient erythematosus (nmod)
concentrate human (amod)
hypertension mellitus (conj)
1 least (nmod:npmod)
involving patients (dobj)
group prophylaxis (compound)
arteriole of (case)
competition by (case)
nephrotoxicity cyclosporine (compound)
transaminase bilirubin (conj)
ml 1 (compound)
factor important (amod)
seems considering (advcl)
receiving september (nmod)
protein synaptophysin (conj)
myelodysplasia dyserythropoiesis (nmod)
times multiple (amod)
pose mother (nmod)
toxic behavioral (amod)
development hyperplasia (nmod)
users ex-mdma+ (compound)
preterm very (advmod)
drugs 2 (nummod)
deficit a (det)
lc/ms/ms ( (punct)
mediates it (nsubj)
1.31 1.93 (appos)
effective reduction (nsubj)
level patient (nmod:poss)
available high (advcl)
months : (punct)
receptor tlr4 (appos)
studied clarify (advcl)
addition by (case)
il-6 of (case)
pallidotomy and (cc)
sum n=2.8+/-1.09 (dep)
prevent allograft (dobj)
$ROOT$ exposure (sent)
prescribed evaluation (dep)
had placebo (advcl)
decreased nonsignificantly (advmod)
remained unresponsive (acomp)
appears requires (conj)
given propofol (conj)
duct and (cc)
higher % (nmod)
measured pain (dep)
hemoptysis , (punct)
sc-48334 mg (dep)
high relatively (advmod)
l-name and (cc)
treatment dysmenorrhea (nmod)
found capnocytophaga (conj)
found that (nsubjpass)
studied neuropathy (nsubjpass)
converted minutes (nmod)
reported it (nsubjpass)
identification exposure (nmod)
widened 15.0 (nmod)
incidence akathisia (nmod)
metoprolol on (case)
show areas (dobj)
dose terbutaline (nmod)
determined extent (nsubjpass)
mastodynia severe (amod)
amnesia antimuscarine-induced (amod)
approach model (nmod)
age gestational (amod)
gain reduced (amod)
discussed options (nsubjpass)
osmolality serum (compound)
mv 1.3 (nummod)
fails recover (xcomp)
bsc-1 ( (punct)
cocaine-induced lidocaine-kindled (amod)
have therefore (advmod)
susceptibility seizure (compound)
activity anticonvulsant (amod)
benign are (cop)
3.9 0.3 (conj)
necessary convert (xcomp)
children 5 (nummod)
mesna with (case)
spectrum events (nmod)
related drug (nmod:npmod)
gc-ht of (case)
disturbing as (case)
glu p (dep)
concentrations levetiracetam (compound)
58.5 + (cc)
positive % (nmod)
rare although (advmod)
$ROOT$ analyze (sent)
restore blockage (nsubj)
n-(2-propylpentanoyl)urea of (case)
gain a (det)
olanzapine versus (cc)
euphoria of (case)
drug reference (amod)
responses correct (amod)
cells mucosa (nmod)
mediated effect (nsubjpass)
criteria rifle (compound)
users with (case)
intake calculated (amod)
withdrawn drug (nsubjpass)
therapies anti-adenovirus (amod)
reduction glomeruli (nmod)
age clearance (conj)
points different (amod)
newspaper initiated (acl)
impairments to (case)
patients 3500 (nummod)
neuropathy of (case)
microglia expressing (acl)
m1 induced (acl:relcl)
arise , (punct)
results respect (nmod)
reduced activity (dobj)
mechanisms post-receptor (amod)
three subjects (nmod)
benefit addition (nmod)
show . (punct)
advantages cisplatin (nmod)
noted months (nmod)
strategies of (case)
seems recurrent (xcomp)
hemorrhagic highly (advmod)
performed and (advmod)
worsened agonist (nsubj)
cramps for (case)
establish and (cc)
more far (advmod)
case survival (conj)
change and (cc)
considered conversion (nsubjpass)
achieved readily (advmod)
resuscitated . (punct)
increased and (advmod)
loss subsequent (amod)
changed visualized (conj)
incorporation mentioned (amod)
disease adenovirus (compound)
states symptoms (nmod)
concentrations postpartum (advmod)
lysozymuria , (punct)
case girl (nmod)
inducing possibly (advmod)
concentration caused (acl:relcl)
inhibitor 2d6 (nmod)
deficits loss (appos)
mg characteristic (acl:relcl)
associated patients (nsubjpass)
showed similarly (advmod)
survival % (nmod)
suggest dependent (ccomp)
questioned symptoms (nmod)
1.69 1.35 (dep)
ratios differences (conj)
randomized placebo-controlled (dep)
degeneration patchy (amod)
act nephrotoxicants (nmod)
pressure a (det)
hcfcs ( (punct)
been deaths (attr)
preparations main (amod)
contributing effect (nmod)
disease parkinson (compound)
microgram.kg-1.min-1 pge1 (nmod)
reported experienced (conj)
nsaids to (case)
hds between (case)
status study (compound)
epilepticus rat (nmod)
15-f(2t)-isoprostane of (case)
carried not (neg)
articles of (case)
mechanisms immune (amod)
assessed manipulation (nmod)
activity agents (nmod)
9.6-fold 4.4 (dep)
with but (cc)
acid acidb (compound)
streptozotocin icv (appos)
received td (nsubj)
therefore , (punct)
re rg1 (conj)
males . (punct)
quantify to (mark)
cases any (det)
accompanied episodes (nmod)
means monitoring (nmod)
exhibited had (aux)
associated neuroleptics (nsubjpass)
years 14.1 (nummod)
reticulata substantia (compound)
well-demarcated , (punct)
156 more (advmod)
adhesions tissue (compound)
wall ventricular (amod)
hiccups for (case)
higher hg (dep)
rare are (cop)
daily perorally (advmod)
mmhg ; (punct)
lowered ; (punct)
toxicity alterations (conj)
patients 217 (nummod)
nuclei only (advmod)
majority sites (nmod)
laboratory the (det)
s-(-)-et-126 the (det)
associated rls (nmod)
numbers with (case)
levels circulating (amod)
thrombosis involving (acl)
1.65 0.57 (conj)
nodosa with (case)
csa 12 (appos)
taking stabilized (ccomp)
administration enflurane (compound)
experiences gi (compound)
lindane or (cc)
treated period (nmod)
understand to (mark)
polydipsia lithium-induced (amod)
mol/l plasma (nsubj)
extract sinensis (compound)
lipid rna (conj)
induce could (aux)
sensitized . (punct)
vivo in (compound)
cause hypertension (dobj)
stimulant background (compound)
hour administration (dep)
cohort volunteers (nmod)
infarction acute (amod)
na(+)/k(+)-atpase of (case)
fall then (advmod)
animals % (appos)
diaries patient (compound)
clotting and (cc)
provides dexmedetomidine (nsubj)
rate flow (conj)
ml/ng 11.7 (nummod)
market from (case)
illustrate rhabdomyolysis (dobj)
stop could (aux)
affected transport (nsubjpass)
functional renal (amod)
heparitinase with (case)
month per (case)
observational , (punct)
reported administration (nmod)
risk its (nmod:poss)
physicians 1,455 (nummod)
pretreatment rats (nmod)
is but (cc)
paid evidenced (advcl)
invited : (punct)
domperidone by (case)
defects associated (acl)
exposure findings (conj)
therapy methylphenidate (compound)
parents present (amod)
u/ml 7931 (nummod)
ofh ) (punct)
damage oxidative (amod)
discontinued incidence (nmod)
exerts which (nmod)
exposure s-53482 (nmod)
switching patients (dobj)
session by (case)
type hit (compound)
mastectomy for (case)
ptra to (case)
response biological (amod)
show studies (nsubj)
tea e (conj)
metoprolol or (cc)
developed injected (advcl)
basis long-term (amod)
syndrome irritable (amod)
acid messenger (compound)
presence carcinoma (nmod)
design two-way (amod)
reduces hyperalgesia (dobj)
made being (auxpass)
properties and (cc)
sleep memory (conj)
abusers opioid (compound)
measured we (nsubj)
tremor nausea (conj)
having % (nsubj)
patient 27-year-old (amod)
studied kindreds (nmod)
chronic , (punct)
back-diffusion areas (conj)
duration seizure (compound)
predominated . (punct)
decrease change (dep)
receptors 6 (nummod)
mg/dl 200 (nummod)
intra- interindividual (conj)
toxicities different (amod)
esterase or (cc)
sexes of (case)
% 14.5 (nummod)
rats dm (compound)
leading pool (nmod)
0.05 minutes (parataxis)
alternative support (nmod)
value = (dep)
differ rats (nsubj)
associated hemorrhage (nsubj)
dependence assessments (nmod)
effective pallidotomy (nsubj)
examine investigate (conj)
ecg surface (compound)
ng/ml mean (dep)
cause hiccups (nmod)
sinusitis with (case)
propranolol inhibiting (acl)
had defects (dobj)
included tests (nsubj)
< (1.8)% (dep)
access sugar (compound)
placebo ; (punct)
63 /-8 (cc)
concerning complications (dobj)
occlusion this (det)
month within (case)
granulated reticulum (nmod)
assessing risk (dobj)
2c serotonin (conj)
dexmedetomidine sedation (nmod)
p53 dominant-interfering (amod)
completed months (dobj)
toxicity induced (acl)
relationship particular (nmod)
form stress (nmod)
experienced however (advmod)
total courses (nmod)
recognise possibility (dobj)
is contrast (nmod)
period observation (conj)
found admission (nmod)
tachycardia of (case)
salt-sensitive dahl (nmod:npmod)
acetate of (case)
cell one (nummod)
based defined (conj)
q h (nmod:tmod)
identical symptoms (nsubj)
injury outcome (nsubj)
distinguish studies (nsubj)
mg/kg 4.2+/-1.2 (nummod)
linked protection (nsubjpass)
june 1995 (appos)
aimed study (nmod)
less beats/min (nmod)
overshooting between (case)
patients or (cc)
low ) (punct)
control such (predet)
influence motility (dobj)
confounded also (advmod)
response biphasic (amod)
edaravone by (case)
stratum 2 (nummod)
increased showed (ccomp)
protect overexpression (nsubj)
s , (punct)
associated compared (prep)
dcm ( (punct)
investigation and (cc)
increasing amount (dobj)
% microg/kg (appos)
drug ' (punct)
reduce would (aux)
degeneration epithelial (amod)
% paracetamol (conj)
established methods (dobj)
alternative safe (amod)
exacerbation myoclonus (conj)
method scale (nmod)
causes impairs (conj)
individuals mellitus (nmod)
design design (appos)
decrease profound (amod)
sensitivity induced (acl)
identified infant (nmod)
treated basis (nmod)
dogs , (punct)
birth after (case)
days chemotherapy (nmod)
$ROOT$ psychostimulant (sent)
product study (compound)
flunarizine of (case)
application bilaterally (advmod)
dose mg./kg (nmod)
membranes cells (nmod)
restarted argatroban (nmod)
result hypertrophy (nsubj)
h 12 (compound)
known syndrome (nmod)
matter surrounding (amod)
measures variability (nmod)
period over (case)
reduced bau (nsubj)
monitored levels (nsubjpass)
reduced i (dep)
22 ( (punct)
reducing without (mark)
day every (det)
unrelieved morphine (nmod)
microinjection isoniazid (nmod)
corrected can (aux)
admitted ( (punct)
something unknown (amod)
neuropathy % (dep)
benefit no (det)
inhibitor competitive (amod)
creatinine nitrogen (conj)
limit damage (dobj)
collection assessed (dep)
bacteremia relapsing (amod)
puncture times (conj)
$ROOT$ aspects (sent)
dyskinesia cases (nmod)
leukemia standard-risk (amod)
identified results (nsubjpass)
data spectral (amod)
indicate , (punct)
inhibition synthase (conj)
patients brain (compound)
transport caused (acl:relcl)
increased hg (dep)
contribute efficiency (nmod)
salicylates and (cc)
scale parkinson (nmod:poss)
documented however (advmod)
relative disease (nmod)
given acid (nmod)
used correct (xcomp)
recovery visual (amod)
4-acridinecarboxamide -n,5-dimethyl- (compound)
inventory , (punct)
depletions got (nmod)
known consequences (nmod)
long-term ; (punct)
sclerosis segmental (amod)
women admitted (acl:relcl)
contracture hip (nmod)
reduce addition (nsubj)
factor igf (appos)
functioning cognitive (amod)
materials prc (appos)
common in (case)
normal function (nsubj)
cysts of (case)
action stimulant (amod)
wall intact (amod)
infection people (nmod)
doses anesthetics (nmod)
4-ene-vpa (e)-2,4-diene-vpa (conj)
metals heavy (amod)
initiated earlier (advmod)
remains examined (xcomp)
loss quadrant (nmod)
sum diameter (conj)
hr ] (punct)
outflow an (det)
waves later (amod)
actions stimulatory (amod)
twice about (advmod)
randomized receive (xcomp)
co-administration curcumin (compound)
action but (cc)
delineated yet (advmod)
alpha-tc ( (punct)
effect l-alpha-glyceryl-phosphorylcholine (nmod)
doses induce (acl:relcl)
$ROOT$ induce (sent)
host a (det)
205 and (cc)
3 ) (punct)
h-sod1 of (case)
act proliferation (nmod)
groups saline (dep)
lt and (cc)
retard acetaminophen (nsubj)
syndrome reaction (appos)
nephrotoxicity regimen (nmod)
cases adenoma (nmod)
measurements hb (compound)
pentoxifylline ) (punct)
appears suggesting (xcomp)
necessitated however (advmod)
oxypurines nucleosides (conj)
time pt (appos)
remission disease (appos)
cortex subjects (nmod)
developed introduction (nmod)
reduction outcome (conj)
irritation following (case)
values absolute (amod)
preparations in (case)
oropharynx . (punct)
hypotension response (nmod)
suggests strongly (advmod)
do so (advmod)
maoi ) (punct)
scale investigator-observed (amod)
use infections (nmod)
agents mice (nmod)
influenced . (punct)
= 78 (dobj)
developed blindness (nsubj)
less weight (nmod)
2-acetylaminofluorene of (case)
happiness , (punct)
kf17837 of (case)
procedures vascular (amod)
extensively progressively (conj)
lower those (nmod)
mg/kg l-dopa/benserazide (compound)
exert demonstrated (advcl)
six . (punct)
decreased inhibiting (advcl)
application a (det)
coding in (case)
neonates children (conj)
treatment relies (acl:relcl)
$ROOT$ discuss (sent)
lamivudine with (case)
treatment priapism (nmod)
studying at (mark)
became days (nmod)
linked has (aux)
41.66 6.33 (conj)
properties antioxidant (amod)
11/6 from (case)
greater also (advmod)
hdl-c , (punct)
urotensin-ii u-ii (appos)
h 115 (nummod)
thrombin amca (conj)
markers synaptophysin (dep)
procedure of (case)
parameters assessed (acl)
occurred symptoms (nsubj)
rr=1.41 ci (dep)
alternatives safer (amod)
leads development (nmod)
demonstration . (punct)
2.3 1.3 (nummod)
rigidity depression (conj)
lindane ( (punct)
shr aged (amod)
appeared necrosis (nsubj)
leukemia nervous (amod)
frequency , (punct)
involved pathogenesis (nmod)
assessed subgroup (nmod)
evidence exhibit (acl)
microg/kg/min ketamine (nmod)
suggest related (ccomp)
hs to (case)
compounds known (acl)
voltammetry , (punct)
abuse drug (nmod)
reserpine depletor (compound)
prevented impairment (dobj)
rates morbidity (compound)
sn ) (punct)
used infants (nmod)
used not (aux)
increases limit (nmod)
catechol phenol (conj)
nodules multiple (amod)
neuropeptide is (cop)
detected reductions (nsubjpass)
affinity negligible (amod)
rating hyperkinesia (compound)
therapy gentamicin (nmod)
helps that (mark)
had history (dobj)
severe ; (punct)
loading by (case)
mg/day plus (cc)
useful decreasing (advcl)
normokalemic in (case)
usual is (cop)
atenolol propranolol (conj)
considered which (nsubjpass)
finding frequent (amod)
block 2/1 (nummod)
effects effect (conj)
infusion rats (nmod)
arise need (advcl)
symptoms side-effects (conj)
treatment quetiapine (nmod)
membrane-cytoskeleton proteins (conj)
receptor of (case)
ameliorated was (auxpass)
use factor (nmod)
2.8 to (case)
test stress (compound)
trial assessment (nsubj)
cyp ( (punct)
review chart (compound)
hypertensives all (amod)
doses highest (amod)
block sinoatrial (amod)
manifestations occurring (acl)
metoprolol ( (punct)
status 1 (nmod)
activation via (case)
unique that (nsubj)
observations users (nmod)
clinician each (det)
treated retinoblastoma (nmod)
differ modulation (nmod)
domains five (nummod)
ci=22.5 ( (punct)
hypotension prolongation (conj)
reshape map (nsubj)
intravenous i.v. (appos)
toleration . (punct)
greater toxicity (nsubj)
state free (amod)
analyzed composition (nsubjpass)
propylthiouracil with (case)
haematological neutropenia (dep)
vomiting % (nmod)
leucovorin , (punct)
order randomized (amod)
extent and (cc)
received albuterol (dobj)
users receiving (acl)
tool an (det)
2-p-(2-carboxyethyl)phenethylamino-5'-n-ethylcarboxamidoadenosine cgs (appos)
thromboembolism cataracts (conj)
hypotension sn-induced (amod)
received ls (conj)
injection with (case)
any acids (nmod)
ci 0.3 (nummod)
determined measuring (advcl)
exposure anticoagulant (nmod)
pacing ventricular (amod)
evaluated patients (nsubjpass)
attacks during (case)
presenting deficits (nmod)
contribute thus (advmod)
decreases . (punct)
death a (det)
other the (det)
diagnosis cancer (nmod)
impaired which (nsubjpass)
low australia (nmod)
dyskinesias such (case)
inhibited proteases (dobj)
bradykinin ] (punct)
deprivation treatment (conj)
involvement ) (punct)
average , (punct)
effect neurons (nmod)
higher patients (dep)
nodule carcinoma (conj)
nature to (mark)
common p (dep)
induced attacks (nsubjpass)
health , (punct)
eads frequent (amod)
absent sought (conj)
patients ( (punct)
1.0 from (advmod)
hydralazine by (case)
pesticide agricultural (amod)
studied studies (nmod)
30 +/- (cc)
abilities cognitive (amod)
elevating by (mark)
related amphetamine (nmod)
score obtained (acl)
experienced 14 (nsubj)
nicotine neostigmine (conj)
suggest maps (nsubj)
given treatment (dobj)
understood fully (advmod)
mg extended-release/20 (nummod)
stimulation tonic (amod)
hg 55 (nummod)
used doses (nsubjpass)
transplant a (det)
model haloperidol-induced (amod)
proven is (auxpass)
investigations histological (amod)
herbicides n-phenylimide (amod)
before or (cc)
exhibited end (nmod)
studied can (aux)
hypothyroidism of (case)
15 of (advmod)
action mpep (nmod)
likelihood a (det)
importance process (nmod)
complications administration (nmod)
denopamine micrograms (appos)
days fifty-six (nummod)
presumed reflect (xcomp)
0.05 < (dep)
produced jerks (dobj)
intensify activity (dobj)
increase that (mark)
achieves regimen (nsubj)
hepatic hematologic (conj)
prevented clonazepam (nmod)
participated women (nsubj)
problem challenging (amod)
consists nephropathy (nsubj)
face in (case)
midbrain mainly (advmod)
striatum bilaterally (advmod)
0.69 +/- (cc)
86 5 (conj)
impairment long-term (amod)
medulla in (case)
atherosclerosis of (case)
effect stereotypies (nmod)
l-isomer the (det)
od mg (nummod)
compartment the (det)
restrictive to (mark)
stability postural (amod)
selected answer (xcomp)
characterized death (nmod)
erythematodes systemic (amod)
zones hemispheres (nmod)
play mechanisms (nmod)
diseases seen (dep)
define fibres (dobj)
micrograms/kg/min 10 (nummod)
mmhg vs. (cc)
using rationale (dobj)
protection airway (compound)
> ago (advmod)
offered women (nsubjpass)
patients age (nmod)
banned although (mark)
explain prolongation (dobj)
infiltrate inflammatory (amod)
specimen patient (nmod)
eminence me (appos)
cirrhosis micronodular (amod)
implications results (nmod)
abnormalities motion (compound)
lithium anticonvulsants (conj)
experiments all (det:predet)
kinase factor (compound)
role central (amod)
disorder obsessive (amod)
use lifetime (amod)
microg.kg(-1 from (case)
frequency severity (conj)
company squibb (compound)
% 11.3 (nummod)
using assess (advcl)
increased lower (conj)
concentration peak (amod)
downregulation increase (conj)
lower p (nmod)
tubular rat (nmod)
received care (dobj)
factors predictors (conj)
performed examination (nsubjpass)
bronchopneumonia hemorrhagic (amod)
dropped concentration (nsubj)
produced anaemia (dobj)
relevance treatment (nmod)
dietary or (cc)
neurotransmitters acid (compound)
development syndrome (nmod)
explained were (auxpass)
presented 32 (nsubj)
vlbw ) (punct)
hydration intravenous (amod)
regression ) (punct)
ci 5.5 (nummod)
frequently patients (nmod)
treatment repeated (amod)
protected lesions (nmod)
reported studies (nsubjpass)
oliguria reversible (amod)
leukocytes , (punct)
tolerance effect (nmod)
tet neither (cc:preconj)
ranges 8 (nmod)
induced biperiden (nmod)
dexmedetomidine of (case)
treated 0.5%/12h (nmod)
cases exposed (amod)
communicate fact (nmod:npmod)
knowledge approach (conj)
action compound (nmod)
lesions structural (amod)
severe h (conj)
adjustment confounders (nmod)
personality use (conj)
ra alone (advmod)
(5.3)% -32 (nummod)
poisons by (case)
affect however (advmod)
rats lifetime (amod)
use factors (conj)
- thr(so3h)7-ac-cck-2 (compound)
scoring propensity (compound)
variation . (punct)
points ) (punct)
studied members (nsubjpass)
deterioration patients (nmod)
effects tacrolimus-related (amod)
appearance presence (nmod)
behaviors administration (nmod)
early sensitive (conj)
administered vincristine (nsubjpass)
pmol 6.87 (nummod)
fasciculation of (case)
= lna+lca (dobj)
residues the (det)
males manual (nmod)
multivitamin mg)-containing (amod)
syndromes various (amod)
efficacy study (dep)
raclopride d2 (compound)
concluded characteristic (ccomp)
besylate , (punct)
given agent (dobj)
use diazinon (compound)
tachyarrhythmias resistant (amod)
girl reaction (nmod)
anesthesia hypotension (compound)
have effect (dobj)
reduction rtms (nmod)
interviewed : (punct)
asynergy by (case)
adults intact (amod)
encapsulated phases (nmod)
complication unusual (amod)
placebo 117 (appos)
parameters in (case)
levels igf-i (compound)
morphine kappa (conj)
showed change (dobj)
groups ethnic (amod)
distortion neuronal (amod)
rejection for (case)
mg/day on (case)
psychological and (cc)
man mg/day (nmod)
ns-718 ( (punct)
association drugs (nmod)
discuss adults (nmod)
occurring treatment (nmod)
aspirated patient (nsubj)
hospitalization ( (punct)
department in (case)
values found (acl)
administration corticosteroids (nmod)
heredofamilial tissue (conj)
injected isoproterenol (dobj)
ro 5057 (nummod)
modulates and (cc)
assessed levels (nsubjpass)
min 39 (nummod)
group comprising (acl)
b1 and (cc)
relationship medication (nmod)
included be (auxpass)
126 +/- (cc)
degree with (case)
neutropenia the (det)
anxiety changes (conj)
1.4 0.1 (conj)
analysis an (det)
suggest models (nmod)
bfgf serum (compound)
complexes phosphorylation (compound)
double-blind crossover (dep)
qtp and (cc)
amount extravasation (nmod)
contamination for (case)
elicit that (nsubj)
cases nine (nummod)
completed subjects (nsubj)
high rates (nsubj)
care prehospital (amod)
alterations function (nmod)
index pittsburgh (compound)
kidneys same (amod)
nephrotoxicity cohort (nmod)
demonstrated domains (nmod)
hemodiafiltration continuous (amod)
patients our (nmod:poss)
days rr=1.41 (dep)
suggest results (nsubj)
keratopathy glaucoma (conj)
saw who (nsubj)
treatment second-line (amod)
assessment disease (nmod)
confirmed orr (conj)
phosphatases alkaline (compound)
objectives evaluate (acl)
cessation than (cc)
perspective clinical (amod)
iop ) (punct)
kinase-related map (nmod:npmod)
men 143 (nummod)
dynamic dynamic (conj)
women 73 (nummod)
pontis the (det)
ratio incidence (compound)
induced metoclopramide (nmod)
dhea the (det)
dbp ( (punct)
inter- and (cc)
mg/m(2 as (case)
amount kidneys (nmod)
conditions upon (case)
tolerated effective (amod)
toxicity-free presumably (advmod)
reoccur . (punct)
subjected feeding (nmod)
marker as (case)
present treat (advcl)
affect hypotension (dobj)
degree high (amod)
admitted mi (nmod)
established role (nsubjpass)
cultured cells (nsubjpass)
dizocilpine , (punct)
aborted . (punct)
induced fall (dobj)
extravasation of (case)
reactions studied (acl:relcl)
p20 p45 (conj)
570 out (advmod)
injection pilo (compound)
develops if (mark)
carcinogens benzo[a]-pyrene (appos)
attenuating without (mark)
case may (aux)
cost treating (advcl)
utility . (punct)
surgery functional (amod)
dcf gtn (conj)
assess evaluate (conj)
reticulata the (det)
demonstrates inhibitor (ccomp)
h resection (nmod)
overdoses dm (compound)
ameliorated manner (nmod)
communication and (cc)
6 167 (conj)
observations earlier (amod)
ng./ml normal (conj)
attack early (amod)
dfo mg/kg (appos)
began after (mark)
followed effects (nsubjpass)
eating the (det)
meth of (case)
nephropathy to (case)
appears immunolocalization (nsubj)
increased exists (conj)
assessable efficacy (nmod)
elevated even (advmod)
studied completion (nmod)
synthesis/release of (case)
mothers whose (nmod:poss)
hexamethonium after (case)
increase raloxifene (nsubj)
syndrome long-standing (amod)
subset in (case)
october 2008 (nummod)
unremarkable were (cop)
quantitated clearance (nmod)
rate animals (nmod)
expression layer (nmod)
capacity decreased (amod)
underwent approach (nmod)
goes neurotoxicity (nsubj)
lack significant (amod)
role no (nmod)
made variables (nmod)
cluster a (det)
treatment mg/kg (compound)
thrombosis transplantation (nmod)
prevalences the (det)
mellitus diabetes (compound)
epinephrine % (nsubj)
symptoms cholinergic (amod)
occurrence type (nmod)
bromide of (case)
alters lowering (advcl)
muscle hearts (nmod)
$ROOT$ paralleled (sent)
reviews paper (nsubj)
solution in (case)
measurements recorded (dep)
neurons ganglionic (amod)
inhibiting without (mark)
$ROOT$ transitioned (sent)
determination concentration (compound)
pressure greater (amod)
pressure production (conj)
mg/dl 4.7 (nummod)
array profiler (compound)
antibody cytoplasmic (amod)
$ROOT$ injections (sent)
greater 3 (conj)
linked injury (nmod)
reported as (mark)
sm-5887 of (case)
estimated analysis (nmod)
depletion magnesium (compound)
words the (det)
examine relation (dobj)
treatment intra-accumbens (amod)
interferes that (nsubj)
surgery anaesthesia (conj)
induces doxorubicin (nsubj)
changes levels (nmod)
action treatment (nmod)
course nephropathy (nmod)
profile with (case)
kidneys in (case)
after or (cc)
pk ( (punct)
analyzed expression (dobj)
alternative a (det)
infiltrates pulmonary (amod)
metastases with (case)
recall the (det)
reversed alone (advmod)
hoe ip (advmod)
electro-oculography and (cc)
stretching ovale (nmod)
developed beginning (advcl)
13th and (cc)
monitored not (neg)
free initially (advmod)
secondary not (neg)
oxytocin and (cc)
block type (compound)
complication another (det)
anticoagulant causing (acl)
appears escape (xcomp)
evaluation further (amod)
analysed use (nmod)
measures outcome (compound)
january december (conj)
lungs of (case)
phenylpropanolamine ) (punct)
benserazide , (punct)
is evidence (nsubj)
shift not (neg)
disorder severe (amod)
compounds of (case)
promotes dogs (nmod)
blocker sodium (compound)
treatment first-line (amod)
presented which (nmod)
shown number (nsubj)
neurons immunoreactive (amod)
ml between (case)
nortriptyline ) (punct)
population typical (amod)
prevented days (nmod)
settings practice (compound)
slowness mental (amod)
remained superior (xcomp)
back low (amod)
animals added (conj)
influenced significantly (advmod)
194 5 (conj)
disruption signaling (nmod)
8- 9.5-fold (quantmod)
sensitive . (punct)
mg/day or (cc)
underwent : (punct)
pathogenesis tumors (nmod)
gentamicin penicillin (conj)
sensitive who (nsubj)
induced but (cc)
attention function (nmod)
effects events (conj)
one , (punct)
treatment pamidronate (compound)
apoptosis and (cc)
reports 27 (nummod)
make aware (ccomp)
gland lizard (compound)
done possible (advcl)
chicks all (det)
hepatotoxicity drug-induced (amod)
electro- echocardiography (conj)
increased p<0.01 (parataxis)
decreasing while (mark)
antigen test (conj)
required patients (nsubj)
revealed immunoblotting (nsubj)
region to (case)
affected hyperprolactinemia (nmod)
dizziness inability (conj)
drugs ; (punct)
immunosuppressants csa (dep)
sufficient minimize (xcomp)
rp sr (conj)
angioedema a (det)
had temsirolimus (nsubj)
site parts (nmod)
issue a (det)
24.3 risperidone (nmod)
doses triazolam (nmod)
recorded established (advcl)
normalized two (nsubj)
amikacin vancomycin (conj)
cream agent (appos)
time prolonged (amod)
content the (det)
contribute way (nmod)
obtained been (auxpass)
infection hepatitis (compound)
administration i.p. (compound)
homeostasis lipid (compound)
administration ma (compound)
gamma-hexachlorocyclohexane , (punct)
released continuously (advmod)
species other (amod)
women used (acl:relcl)
desmopressin ddavp (appos)
is definition (nmod)
conclusions pathway (appos)
occurred context (nmod)
time patients (nmod)
mg/kg 7.0 (nummod)
begun after (mark)
deficit mean (amod)
reductions weight (nmod)
etoposide cisplatin (conj)
saline mg/kg (dep)
involve rare (advcl)
purpose cause (acl)
treated rose (conj)
cause cardiotoxicity (dobj)
treated 25 (nmod)
noted development (dobj)
treatment current (amod)
(7.2)% -27.9 (nummod)
nissl-staining antibodies (conj)
necrosis zones (nmod)
nonimmunity of (case)
disorders myotonic (amod)
failed infusions (nsubj)
involved might (aux)
induced back (advmod)
control density (nmod)
involvement metabolism (nmod)
studied alterations (nsubjpass)
calculate ratios (dobj)
minimized could (aux)
confirmed expression (dobj)
demonstrate killed (ccomp)
$ROOT$ 2.1 (sent)
action agent (nmod)
induced although (mark)
rofecoxib 1.52 (dep)
comparison group (nmod)
membrane erythrocyte (compound)
frequent suicides (nsubj)
1.0 = (dep)
therapy postmenopausal (amod)
increase anemia (nsubj)
partition high (amod)
triggered occurrence (nmod)
polymorphism gene (compound)
location with (case)
trained course (nmod)
injury an (det)
units three (nummod)
challenging . (punct)
involved overdose (nsubjpass)
cause function (dobj)
anorexigens . (punct)
dynamics and (cc)
need addressed (xcomp)
$ROOT$ intubated (sent)
rats diet (nmod)
measured weeks (conj)
patient the (det)
probable induced (ccomp)
occurred degree (nsubj)
l/m2 3504 (nummod)
= 12 (dobj)
$ROOT$ ameliorate (sent)
implicated be (auxpass)
prolong induce (conj)
0.25 0.05 (compound)
found depleted (ccomp)
lysozyme egg-white (amod)
lev of (case)
served nissl-staining (nsubj)
bruising on (case)
disruption consolidation (nmod)
globulin igg (conj)
percent 38 (nummod)
mssbp ) (punct)
acid all (appos)
) 12.1 (nummod)
hus by (case)
inhibited transit (dobj)
worsening lesions (nmod)
dysfunction neurotransmitter (compound)
gaba dopamine (conj)
had tendency (dobj)
ambulate void (conj)
attracted drug (nmod)
acetaminophen- against (case)
hemodiafiltration cvvhdf (appos)
asian 35 (nummod)
findings microscopic (amod)
40 , (punct)
hydrochloride diphenhydramine (compound)
was and (cc)
remains resolve (advcl)
bortezomib mg/m(2 (appos)
none whom (nmod)
levels h2o (appos)
expected higher (advcl)
69.9 vs. (cc)
ci 16.619 (nummod)
nerves both (det)
potentiated function (nsubjpass)
manifestation myocarditis (nsubj)
combined it (nsubjpass)
treatment 6-week (amod)
rhabdomyolysis myoglobinuria (conj)
dopamine through (case)
box only (advmod)
bendrofluazide and (cc)
admitted years (nmod)
jj either (cc:preconj)
weight separation (nmod)
developed administration (nmod)
diltiazem agent (appos)
role rhythms (nmod)
suggest mediated (ccomp)
quinidine phenylethylbarbiturate (conj)
reach significance (dobj)
moving freely (advmod)
examined risk (dobj)
anticoagulant warfarin-like (amod)
showed produces (ccomp)
prophylaxis in (case)
found agitated (xcomp)
conformed showing (advcl)
son ) (punct)
rats saline (amod)
related . (punct)
time man (nmod)
treated gentamicin (nmod)
rendered myopathic (xcomp)
thrombosis specified (acl)
doses inhibit (acl)
stripe and (cc)
recovery a (det)
$ROOT$ alters (sent)
$ROOT$ association (sent)
developed dilation (dobj)
days therapy (nmod)
effects frequency (nmod)
ly-171555 with (case)
agent carcinoma (nmod)
ko pkca (compound)
patients 10 (appos)
outcomes better (amod)
provide also (advmod)
fever higher (amod)
cause fluconazole (nsubj)
anesthesia use (conj)
caused administration (nmod)
recognition angioedema (nmod)
cephalosporin either (det)
incontinence to (case)
history patients (nmod)
inflammation stroke (nmod)
had patients (advcl)
regulated neurons (nsubjpass)
beginning at (case)
mediates programming (nsubj)
collection to (case)
ci=26.7 % (compound)
hemorrhage for (case)
$ROOT$ strategy (sent)
limited still (advmod)
overview brief (amod)
later year (nmod:npmod)
venous were (cop)
ligand receptor (nmod)
commenced withheld (advcl)
affects cognition (dobj)
p100 , (punct)
alpha- beta-adrenergic (conj)
arterial both (cc:preconj)
implicated reducing (advcl)
3.8 , (punct)
convulsions from (case)
decrease shortening (nmod)
% -18.48 (nummod)
treatment combined (amod)
ci 1.01 (nummod)
parallels effects (dobj)
ischaemia after (case)
improving in (mark)
dependence its (nmod:poss)
0.625 and (cc)
msdbp as (case)
improve ofh (nmod)
wear tooth (compound)
describe sample (nmod)
events time (nmod)
tobramycin of (case)
capd ) (punct)
limit times (nummod)
infectivity the (det)
time occurred (acl:relcl)
drink energy (compound)
events deaths (conj)
desire first (amod)
suggest aggravates (ccomp)
diabetes , (punct)
haloperidol risperidone (conj)
have bradycardia (dobj)
cpb coagulopathy (conj)
findings pallidotomy (compound)
staging hoehn (compound)
implausible , (punct)
better i.e. (advmod)
years beyond (case)
aspects medial (amod)
used population (parataxis)
run and (cc)
influence interval (nsubj)
range associated (acl)
excess mb (nmod)
polymorphism nucleotide (compound)
characterization in (amod)
b6 host (appos)
level observed (amod)
rapamycin mg/kg (appos)
18.7 7.0 (compound)
maintained provided (mark)
associated dosing (nmod)
negativity t (conj)
administered patient (nsubjpass)
after ( (punct)
% cultures (nmod)
increase types (conj)
impact mutations (nmod)
reflects expression (nsubj)
decreased as (cc)
women young (amod)
leader em (compound)
attenuated also (advmod)
peptide atrial (amod)
experience reactions (dobj)
$ROOT$ invited (sent)
rate warfarin (nmod)
inhibition adenosine (nmod)
upper both (preconj)
exerted or (advmod)
patients 18/90 (nummod)
suggestions no (det)
[na]o [ca]o (conj)
information understand (acl:relcl)
treatment days (nmod)
down-regulation epinephrine-induced (amod)
noted should (aux)
amide , (punct)
risk obtundation (nmod)
angiopathy rats (nmod)
0.03 and (cc)
experiment suggesting (acl)
available which (nsubj)
discontinued omeprazole (dobj)
have catechol (nsubj)
dose threshold (compound)
coniine by (case)
solvent a (det)
3/4 ( (punct)
available haart (nsubj)
$ROOT$ damages (sent)
85 < (advmod)
test reminding (compound)
contribution with (case)
blots western (compound)
alleviation vestibulotoxicity (nmod)
assay growth (compound)
leads exposure (nsubj)
heroin after (case)
wall of (case)
glioma metastases (conj)
= lna+hca (dobj)
drugs antifibrinolytic (amod)
effects risperidone (nmod)
cream agsd (compound)
specify which (nsubj)
dct2 duct (conj)
toxicity low (amod)
3.9 1.2 (nummod)
loss infants (nmod)
suspension of (case)
laboratories turkey (appos)
mg/day ( (punct)
indicate immunohistochemistry (nsubj)
those exposed (acl)
remains challenge (attr)
decrease return (nmod)
decreased diameter (nsubj)
administration amiloride (compound)
hernia , (punct)
sensorium hazy (amod)
variant novel (amod)
rr 0.93 (nummod)
agent anabolizing (amod)
candidate effective (amod)
metabolizers cyp2d6 (compound)
use sumatriptan (nmod)
fibrosis veins (nmod)
weeks responders (nmod)
result impairing (advcl)
fpdc ) (punct)
abruptness and (cc)
$ROOT$ reviews (sent)
decrease hemoglobin (nmod)
chains structures (nmod)
received vehicle (dobj)
was history (nsubj)
increments 6 (nummod)
neurotoxicity chemotherapy (nmod)
drugs four (nummod)
1.34 +/- (cc)
60 of (advmod)
application first (amod)
admission of (case)
1/500 at (case)
sinusoidal canalicular (conj)
treatment ee (compound)
therapeutic both (preconj)
alopecia transaminasemia (conj)
abnormality underlying (amod)
increase forces (nmod)
prevent since (mark)
scores asex (compound)
107.4 +/- (cc)
mmhg ( (punct)
achieved is (auxpass)
test fisher (nmod:poss)
0.07 , (punct)
one least (nmod:npmod)
elevation infarction (nmod)
received evidence (nmod)
abnormalities provoked (acl:relcl)
dimension group (nmod)
group dfmo (compound)
frequent . (punct)
activates . (punct)
hemorrhagic indicating (advcl)
received mg. (dep)
headache subjects (conj)
current l-type (compound)
derivative pyrrolidinone (compound)
min training (nmod)
rate overall (amod)
stratum ; (punct)
stimulation ? (punct)
some of (case)
higher times (parataxis)
hemorrhagic , (punct)
angiography indocyanine (compound)
amylase u/l (appos)
concerned obese (ccomp)
mg doses (conj)
3'-azido-3'dideoxythymidine by (case)
improves and (cc)
confirmed formation (dobj)
induced n-methyl-d-aspartate (nmod)
cystitis . (punct)
lasted stage (nsubj)
days 15 (dep)
had users (nsubj)
aura and/or (cc)
intake metronidazole (compound)
maternal and (cc)
relations of (case)
findings other (amod)
fluctuations to (case)
as site (nmod)
hypertension no-deficient (amod)
disorder acromegaly (nsubj)
available anorectics (nmod)
1979 and (cc)
0.057 0.022 (conj)
methods quantification (compound)
1 groups (nmod)
staining antibody (nmod)
got cardiac (amod)
showed respectively (advmod)
if especially (advmod)
tetrabenazine disease (nmod)
ratio cpa/ee (nmod)
baseline with (case)
concerning effectiveness (dobj)
behaviour rats (nmod)
concentrations ammonia (compound)
turnover bone (compound)
fas ) (punct)
pain evoked (amod)
proceeded transplant (nmod)
hormone thyrotropin-releasing (amod)
lesions coeruleus (nmod)
used recently (advmod)
decided , (punct)
angiography tomography (compound)
g wk (appos)
pair the (det)
consistent method (nsubj)
seizure of (case)
injections heparin (compound)
generation synthesis (conj)
hypotension occurring (acl)
awful all (advmod)
hexamethonium ganglionic (amod)
animals normotensive (amod)
depleted serotonin (nsubjpass)
imaging spine (nmod)
correlated exhibited (conj)
infection system (compound)
hypothesis by-product (ccomp)
fall rate (nmod)
undergone ablation (dobj)
damage terminal (amod)
likelihood greater (amod)
use habitual (amod)
-14.8 p<.001 (dep)
heart enhanced (amod)
lesions dentate (nmod)
t+a of (case)
different t+a (dep)
potentiated was (auxpass)
probable or (cc)
150 exposure (nmod)
indexes three (nummod)
cyp7a ) (punct)
31 ) (punct)
regression hazards (compound)
had likelihood (dobj)
areas in (case)
report patients (dobj)
blunted was (auxpass)
changes signal (compound)
obtained analysis (nmod)
remains obscure (acomp)
abnormalities or (cc)
results lowered (appos)
single area (dep)
evidence without (case)
thrombosis due (case)
biopsies 11 (nummod)
establishes demonstrates (conj)
suppressed addition (nmod)
co-administration scopolamine (compound)
pressures elevated (amod)
degradative fbal (nmod)
lateral conventional (conj)
lad and (cc)
migraineurs in (case)
n-methyl-d-aspartate electroshock (conj)
receptors d2 (compound)
microg/side agonist (nmod)
lethargy shortness (conj)
icr . (punct)
established variety (nmod)
conclusion provide (appos)
length ms (nmod)
$ROOT$ initiate (sent)
effects regarding (case)
sealants derived (acl)
$ROOT$ mandates (sent)
b6 and (cc)
receptors found (acl)
collected blood (nsubjpass)
increases transaminases (nmod)
evidence laboratory (compound)
revealed not (neg)
gemcitabine cisplatin (conj)
excluded participant (nsubjpass)
infusion intraventricular (amod)
population patient (compound)
selected screening (nmod)
sensation paresthesia (conj)
time 10h (amod)
hospitalized and (cc)
surgery before (case)
administered groups (nmod)
sensitive most (advmod)
serotonin serotonin (conj)
nerve trigeminal (amod)
cartilage tissue (conj)
effect homeostasis (nmod)
performed subjects (nmod)
0.89 1.66 (prep)
dyskinesia tardive (amod)
investigated synergy (dobj)
count and (cc)
drugs three (nummod)
decreasing effect (dobj)
effects caused (acl)
doses toxic (amod)
is clear (acomp)
chain transport (compound)
dextran peripheral (amod)
substrate cyp2d6 (compound)
amplifier cholinergic (amod)
pathogenesis nephrosis (nmod)
tap , (punct)
objective was (appos)
mris initial (amod)
lymphocytes vivo (advmod)
carbonate calcitriol (conj)
had developed (conj)
reviewed patients (nsubjpass)
dysfunction muscle (compound)
developed methods (nsubj)
reaction drug-induced (amod)
cer ) (punct)
aware possibility (nmod)
performed analysis (nsubjpass)
nephrotoxicity neurotoxicity (conj)
site , (punct)
spasms the (det)
version is (cop)
represented and (cc)
protected kidney (dobj)
time day (nmod)
induce tdp (dobj)
tolerate while (mark)
infants among (case)
revealed nerve (dobj)
radioablation with (case)
acetaminophen apap (appos)
abolition dose (nmod)
similar effects (nsubj)
care of (case)
compared hg (nmod)
tumours refractory (acl:relcl)
conclusions noted (appos)
agents alkylating (amod)
change days (nmod)
based pharmacokinetics (nmod)
acuity threshold (conj)
sample outpatient (amod)
detection ich (compound)
socs-3 on (case)
norethisterone mg (amod)
appear associated (advcl)
concentrations antidepressant (amod)
months treatment (nmod)
responsible cases (nmod)
reduced leaving (advcl)
measured which (nsubj)
discharged he (nsubjpass)
proposed tested (ccomp)
classical both (cc:preconj)
those except (case)
increased overload (nsubj)
$ROOT$ ongoing (sent)
resulting alterations (nmod)
based neoplasms (nmod)
evidence additional (amod)
control type (nmod)
displays , (punct)
nausea halos (conj)
role causal (amod)
treatment hypotension (nmod)
result contact (nsubj)
case spontaneously (advmod)
wall % (dep)
remained later (advmod)
doses benzodiazepines (nmod)
has effects (dobj)
patients 39 (nummod)
response patient (compound)
pressure to (case)
reversed dose-dependently (advmod)
hydrochloride of (case)
inhibited morphine (nsubj)
attributed is (auxpass)
application with (case)
effect mg/kg (nmod)
selenium ions (dep)
determined is (cop)
leukemia lymphocytic (amod)
generates propagates (conj)
review case (compound)
elevates which (nsubj)
liver triglyceride-rich (amod)
subjects control (amod)
assessed complications (nsubjpass)
men receiving (acl:relcl)
induction anesthesia (nmod)
remained decrease (nsubj)
1ml/kg ( (punct)
changes pattern (conj)
known few (conj)
results width (nmod)
show may (aux)
dosage a (det)
administration cromakalim (nmod)
0.05 vs. (cc)
$ROOT$ possibility (sent)
significant not (advmod)
reducing nephrotoxicity (dobj)
intervals min (amod)
hyperuricemia disorders (conj)
gap narrow (amod)
pretreatment fentanyl (conj)
stages iii-v (nummod)
induces 17beta-estradiol (nsubj)
influence tonic (amod)
penicillins cephalosporins (conj)
34 4 (conj)
divided study (nsubjpass)
lymphoma hodgkin (compound)
alter onset (dobj)
complexes i-iv (nummod)
acid [omega-i-131]heptadecanoic (amod)
post-oltx who (nsubj)
exert effects (dobj)
provide advantage (dobj)
augmented which (nsubj)
pig ouabain-induced (amod)
duration action (compound)
carcinoma cavity (nmod)
$ROOT$ postulated (sent)
aggravate may (aux)
titrated depth (nsubjpass)
vasodilatation due (case)
type 2 (nummod)
micrograms 100 (nummod)
tuberculosis extensively (advmod)
epinephrine plus (cc)
factors ) (punct)
dox or (cc)
counteracted resulted (conj)
subacute recovery (nmod)
samples striatal (amod)
conduction atrial (amod)
anemia delayed (amod)
suggested can (aux)
diuretic oral (amod)
stimulate releasing (advcl)
different -0.12+/-0.5 (parataxis)
linked disorders (nsubjpass)
caused months (nmod)
dogs neutropenia (nmod)
treated diet (nmod)
survival , (punct)
hemodynamic volumetric (conj)
events anticoagulation (nmod)
rr ) (punct)
seems ngal (nsubj)
alterations deglutition (compound)
sample liver (compound)
selected pressure (nmod)
improves administration (nsubj)
initiated meningitis (nmod)
exhibited rate (dobj)
minimum follow-up (nmod)
survived not (neg)
scale score (conj)
estimated compared (prep)
insertion after (case)
increased m (nmod)
32.5 +/- (cc)
presenting surgery (nmod)
trial transplantation (nmod)
medication developed (amod)
myelitis both (cc:preconj)
blockage by (case)
increase iohexol (nmod)
suxamethonium children (nmod)
increase markedly (advmod)
clozapine t(33 (appos)
changes c6 (nmod)
h . (punct)
effect alterations (nmod)
research passage (dobj)
perform examine (advcl)
activity phosphate (compound)
protect did (aux)
blocked pre-administration (nmod)
lupus , (punct)
support arm (nmod)
screening , (punct)
exposed gyrus (nsubjpass)
antigen-positive b (compound)
gr of (case)
patients 62 (nummod)
hs response (dep)
model fractionated (amod)
parkinsonism of (case)
period block (nmod)
induced monophosphate (nmod)
indicators several (amod)
adjust leading (advcl)
ml drug (nmod)
dose mg/kg (nummod)
phenylbutazone 50 (appos)
dex ato (conj)
effect epileptogenic (amod)
effect sphincter-relaxing (amod)
discussed similarities (nsubjpass)
related chemically (advmod)
administration systemic (amod)
elected name (xcomp)
rp intra-arterial (amod)
potentials standard (amod)
cell epithelial (amod)
configuration the (det)
alkaloid chincona (compound)
mg/kg 50 (nummod)
exposed often (advmod)
consideration reactions (nmod)
years 78 (nummod)
nephropathy gm-mediated (amod)
patients pseudolithiasis (nmod)
is considering (advcl)
i(f)-generating nucleotide-gated (dep)
hz ( (punct)
led cessation (nmod)
responsible obtainable (conj)
symptoms motor (amod)
t5 or (cc)
syndrome due (amod)
was unchanged (advcl)
test olr (appos)
showed it (nsubj)
discouraged should (aux)
starting infusion (dobj)
than patients (nmod)
inhibits carbamazepine (nsubj)
factors individual (amod)
urgency surgery (nmod)
conjugates etodolac-dextran (compound)
administered not (neg)
samples these (det)
receive lozenge (dobj)
updrs ) (punct)
years 5.6 (nummod)
$ROOT$ neuroinflammation (sent)
rationale drug (appos)
rt ) (punct)
risks follow-up (dep)
abnormalities ( (punct)
informative studies (nsubj)
lessen improve (conj)
output volume (nmod)
do injury (nmod)
mechanism damping (compound)
prevention on (case)
test intravenous (amod)
blocking receptors (dobj)
occurred olanzapine (nmod)
made away (advmod)
one just (advmod)
transiently only (advmod)
agents analgesic (amod)
investigated alleviation (dobj)
responses morphine (nmod)
times room (compound)
drugs lithium (nmod)
increase incidence (nmod)
cholinergic a (det)
infusion the (det)
increases dopamine (nmod)
common changes (nsubj)
cld % (appos)
rigidity such (amod)
$ROOT$ expanded (sent)
adrenaline.7 of (case)
failure multi-organ (amod)
role nrf2 (nmod)
peptide new (amod)
worsened , (punct)
descriptions relationship (nmod)
mice with (case)
promising most (advmod)
sensitization on (case)
allopregnanolone and (cc)
cytopenias all (det)
treated antimicrobials (nmod)
used inhibit (xcomp)
differ controls (nmod)
widow disorder (nmod)
reduced effects (nmod)
density neurons (nmod)
functions of (case)
26- . (punct)
patients 7 (nummod)
result loss (nmod)
tablet mg (nummod)
22 out (advmod)
1.19 , (punct)
receiving lamivudine (dobj)
products synthase (nmod)
overview a (det)
highlights possibility (dobj)
bought substance (nmod)
s-i and (cc)
hormones risk (conj)
range days (nmod)
liability addiction (compound)
treatment best (amod)
administration local (amod)
frequency neutropenia (nmod)
oxc ( (punct)
days h-2 (nummod)
phenotypes the (det)
literature world (compound)
prompted episode (dobj)
mk-801 , (punct)
usage steroids (nmod)
alf or (cc)
ci 1.06 (nummod)
haloperidol mg/kg (appos)
factor-kappab , (punct)
received 20 (nsubj)
theophylline of (case)
abolished changed (conj)
exacerbated impairment (dobj)
neurons adrenergic (amod)
assessed assessed (conj)
agent expectorant (amod)
lesion da (compound)
trauma sepsis (conj)
echocardiography tracking (amod)
wt both (cc:preconj)
events considered (acl)
offers but (cc)
levels donors (nmod)
man of (case)
frequent most (advmod)
production in (case)
underwent 2 (dep)
demonstrates follow (ccomp)
nephrotoxicity b (compound)
positive amphetamine (nmod)
biopsies oral (amod)
proof association (conj)
prostaglandin pg (appos)
observed heart (nmod)
alter administration (nsubj)
augments estradiol (nsubj)
legs the (det)
uninephrectomized before (advmod)
distribution tests (nmod)
radiation cystitis (conj)
surgeon orthopaedic (amod)
influence narcosis (dobj)
c. mitomycin (compound)
induction mechanisms (conj)
cr % (appos)
activated but (cc)
treatment induction (compound)
do did (aux)
considered characteristic (nmod)
end weeks (nmod)
pain testicular (amod)
2-fold by (case)
triceps and (cc)
has cases (nmod)
sgot bilirubin (conj)
started medication (dobj)
associated dizziness (nmod)
latencies escape (compound)
induce diuretics (nsubj)
$ROOT$ evoked (sent)
disturbance , (punct)
nephrotoxicity neuropathy (conj)
tissue exencephalic (amod)
record memory (nmod)
remained units/l (dobj)
pair-fed pf (appos)
associated levofloxacin (nmod)
obtained using (advcl)
tamoxifen the (det)
women ages (appos)
vehicle ml/kg (dep)
coincided infarction (nsubj)
able tolerate (xcomp)
courses sixth (amod)
mg iv (nummod)
8.3 , (punct)
raises call (parataxis)
% 88 (nummod)
adding when (advmod)
mania bipolar (amod)
lung the (det)
patient patient (conj)
modulated may (aux)
randomized crossover (conj)
concluded reversible (ccomp)
used administration (nmod)
result been (cop)
test bilirubin (conj)
5-azc ( (punct)
1.13 1.42 (appos)
determining ad50 (dobj)
pgp ) (punct)
licensed option (conj)
prevent treatment (nsubj)
treated sumatriptan (nmod)
sex with (case)
circuitry the (det)
both , (punct)
design investigated (dep)
developed thorax (nmod)
interventions : (punct)
upset respiratory (amod)
disorders interactions (conj)
recordings serial (amod)
neurotoxicity were (cop)
months durations (nsubj)
dox ( (punct)
proportional . (punct)
6 3 (quantmod)
factor treatment (nmod)
glutamate both (cc:preconj)
mg/m(2 250 (compound)
dmpx 3,7-dimethyl-1-propargylxanthine (appos)
cortex hippocampus (conj)
drug known (amod)
funduscopy , (punct)
caa acrolein (conj)
40000 60000 (conj)
onset tetany (nmod)
iodixanol after (case)
balance in (case)
hg hypotension (nmod)
determinants dogs (nmod)
association york (compound)
low-osmolar , (punct)
those exercise (nmod)
limit three (nummod)
presence quinine (nmod)
compared enhancement (nsubjpass)
steroid endogenous (amod)
those due (amod)
mater cranial (amod)
derivatives and (cc)
density formation (nmod)
reflect , (punct)
caused insertion (nmod)
exhibited up-regulation (dobj)
day onwards (dep)
clarify mechanisms (dobj)
5 6 (conj)
compared patients (nmod)
rise as (case)
important complication (advcl)
animals and (cc)
reason relief (nsubj)
poor and/or (cc)
test verapamil (compound)
mediator is (cop)
performed end (nmod)
39 fourteen (compound)
influence strong (amod)
excess following (case)
report , (punct)
agent lenalidomide (appos)
eyes hours (nmod)
inhibited whether (mark)
model remnant (amod)
started she (nsubj)
caused fluoxetine (nsubj)
preceded manifestations (nmod)
carcinoma grade (compound)
weeks few (amod)
mm not (neg)
both exposure (conj)
product rate-pressure (amod)
publications in (case)
$ROOT$ decided (sent)
78 of (case)
mm 5.4 (nummod)
r-(alpha)-methylhistamine h3 (compound)
induced isoproterenol (nmod)
seriousness given (case)
dose blocks (acl:relcl)
applied test (nmod)
had involvement (dobj)
organisms 7.8 (nummod)
objective study (appos)
twitch 5-hydroxytryptophan-induced (amod)
showed bfgf (nmod)
tumor subgroup (nmod)
loosening breaking (conj)
block resolved (acl:relcl)
phosphokinase and (cc)
drugs aap (dep)
3 % (appos)
patient been (acl:relcl)
brief , (punct)
reduced had (conj)
provided information (dobj)
% level (nsubj)
uveitis of (case)
patients gbm (nmod)
restore replication (dobj)
harvested isolated (conj)
inflammation with (case)
dogs nine (nummod)
val/hctz , (punct)
consisted norepinephrine (nmod)
l-arginine l-name (conj)
had often (advmod)
produced snp (nmod)
inhibition effect (nmod)
crescents glomerulonephritis (conj)
i ix (conj)
limited , (punct)
inhibitor inhibitor (conj)
compared registry (nmod)
observed declines (nsubjpass)
significant ) (punct)
a b (conj)
treat diseases (dobj)
increased levels (dobj)
design induced (dep)
30-day follow-up (dep)
apex hyperdynamic (amod)
shown reduce (ccomp)
effects quinine (nmod)
admission before (case)
cluster with (case)
initiated when (advmod)
naloxone and (cc)
examination periodic (amod)
behavior retching (conj)
mug ) (punct)
case unusual (amod)
80 42 (conj)
position practice (nmod)
preoperative and (cc)
2.58 use (nmod)
moiety activated (amod)
ester with (case)
objectives investigate (acl)
serum of (case)
discovery , (punct)
studies both (det)
attenuated addition (nmod)
depletion thiol (compound)
production oxygen (compound)
pc ) (punct)
systems cardiovascular (amod)
provocation hypotension (nmod)
take changes (nmod)
expression penk (compound)
evidence previous (amod)
suggest interaction (dobj)
effective dose (nsubj)
elevated not (neg)
disorder % (appos)
show findings (nsubj)
calcium , (punct)
given orally (advmod)
test ) (punct)
ecg on (case)
drg ( (punct)
vasopressin . (punct)
bladder of (case)
biomarkers with (case)
clentiazem infused (acl)
produced had (parataxis)
role given (case)
days 788.5 (nummod)
blocking responses (dobj)
beat people (nmod)
receptors opioid (compound)
accounted can (aux)
involved processing (nmod)
investigation despite (case)
cholestasis adults (nmod)
administration between (case)
cent 0.5 (nummod)
weighed administration (nsubjpass)
seems srl (nsubj)
ifs ( (punct)
electrocardiograms signs (conj)
injection 131i-hsa (nmod)
3-methoxy-4-hydroxyphenethyleneglycol of (case)
january 1992 (nummod)
increase residence (conj)
5 times (quantmod)
% 48.7 (nummod)
number at (case)
ascribing complaint (dobj)
treatment subsequent (amod)
ec 2.4.2.30 (nummod)
glutamate by (case)
improvement this (det)
decrease vision (nmod)
levels rate (conj)
contractions rhythmic (amod)
agent sotalol (appos)
below well (advmod)
hemispheres of (case)
followed etomidate (nmod)
achieved two (nsubj)
persisting hours (nmod)
stimulus thermal (amod)
nephropathy ( (punct)
reduction remarkable (amod)
alf ( (punct)
absorptiometry dual-energy (amod)
$ROOT$ antagonized (sent)
reserpine- and (cc)
curve a (det)
intensity dose (compound)
utility might (aux)
restrictive use (nmod)
effects most (amod)
$ROOT$ aplasia (sent)
echography in (case)
epinephrine or (cc)
britain great (compound)
drugs antiepileptic (amod)
complications study (dep)
levels increasing (amod)
presented impotence (nmod)
vasculitis cytoplasmic (amod)
younger patients (nmod)
benzo[a]-pyrene 1,2-dimethylhydrazine (conj)
observed tasks (nmod)
associated required (parataxis)
terfenadine terodiline (appos)
ranged spectrum (nsubj)
vincristine-induced ) (punct)
a either (cc:preconj)
rate hemorrhage (nmod)
antithrombin iii (nummod)
requiring of (mark)
correlated ages (nmod)
intervals administered (advcl)
lesions associated (acl)
abnormalities pupillary (amod)
developed mg. (nmod:tmod)
injury functional (amod)
decrease associated (acl)
14/104 ) (punct)
etoposide actomycin-d (conj)
diagnosed malaria (nmod)
analogue guanosine (compound)
rise fall (conj)
stereotypy such (case)
1.54 0.57 (conj)
shifting updating (conj)
s within (case)
patients edema (nmod)
identification anesthetic (nmod)
lowering [na]o (dobj)
allows that (nsubj)
receive dose (dobj)
using annuals (dobj)
ml of (case)
affects groups (dobj)
were remissions (attr)
atorva ) (punct)
examined trials (nmod)
medications the (det)
vgb to (case)
administered caffeine (nsubjpass)
flexion deformations (nsubj)
histopathologic immunohistochemical (conj)
region gene (compound)
data recent (amod)
dose loading (amod)
distress of (case)
treated day (nmod:tmod)
register trials (nmod)
history nausea (nmod)
pce by (case)
heparin subcutaneous (amod)
0 , (punct)
act inducing (xcomp)
chloride triphenyl (compound)
conclusions triggers (appos)
seizures focal (amod)
one compensated (amod)
patients tachyarrhythmias (nmod)
hypercalcemia lithium-associated (amod)
noted but (cc)
agonists and (cc)
hospitalizations for (case)
eyes of (case)
associated pathway (nmod)
resolved asterixis (nsubj)
neurotoxicity on (case)
asthenia as (case)
caused therapy (nsubj)
s than (case)
assessment 12-week (amod)
administration mg/day (nmod)
numbers about (case)
morphology podocyte (compound)
system neurocognitive (amod)
repeated week (nmod)
emerged yet (advmod)
determined enhancement (nsubjpass)
maintained anaesthesia (nsubjpass)
suppression parp-1 (compound)
cells tumor (compound)
cardiomyopathy % (appos)
monitoring therapeutic (amod)
resulting administration (nmod)
octreotide ) (punct)
dosing to (case)
matched using (advcl)
criteria edition (compound)
medications. these (det)
been also (advmod)
patients myeloma (nmod)
obtained rates (nmod)
appeared nitrite (nsubj)
picrotoxin- and (cc)
defined compared (prep)
1.37 ) (punct)
period followed (acl)
taken account (nmod)
values corresponding (amod)
$ROOT$ disturbance (sent)
related considered (conj)
fact died (acl)
population german (amod)
stage cancer (nmod)
increases risk (dobj)
disease stroke (conj)
n-butyl-deoxynojirimycin of (case)
foci necrosis (nmod)
users fifteen (nummod)
opportunity observe (acl)
combination injected (acl)
did we (nsubj)
2.6 stratum (dep)
embarrassed of (mark)
regurgitation , (punct)
rt-pcr q (compound)
lorazepam by (case)
syndrome positive (amod)
$ROOT$ teratology (sent)
defined msdbp (nmod)
excluding after (mark)
cardiomyopathy related (amod)
improved ; (punct)
period weeks (nmod)
pinpoint responsibility (dobj)
metabolized . (punct)
learning pregnancies (nmod)
compare influence (dobj)
right , (punct)
$ROOT$ tool (sent)
cystitis approach (dep)
reverse amnesia (dobj)
extended-release/lovastatin to (case)
involvement reversal (nmod)
back administration (nmod)
urine acidic (amod)
day birth (nmod)
men 41 (nummod)
subjects study (compound)
review 1986 (nmod)
solvent glycol (appos)
poison is (cop)
cholestasis extrahepatic (amod)
1mg/kg , (punct)
$ROOT$ logical (sent)
dose g (appos)
tests rast (conj)
drugs anticancer (amod)
allografts biopsy (appos)
cancer childhood (compound)
$ROOT$ similar (sent)
levels methamphetamine (compound)
infiltrates prominent (amod)
mice receiving (acl)
studies 12-week (amod)
propranolol by (case)
received sedation (nmod)
arrhythmias towards (case)
being h (nmod)
cessation the (det)
thrombocytopenia transplantation (nmod)
regressed lesions (nsubj)
important . (punct)
monkeys rhesus (compound)
detection ischemia (nmod)
prazosin kg-1 (appos)
negativity pc/bcp (appos)
coordination disease (nmod)
found diseases (nsubjpass)
correlation area (nmod)
depth sedation (compound)
h h (conj)
clear it (nsubj)
insomnia due (case)
loreclezole and (cc)
acting preferentially (advmod)
used ointment (nsubjpass)
background promotes (appos)
proved dose (nsubj)
deaths associated (acl)
weight ( (punct)
movements eye-blinking (amod)
curve time (compound)
levels use (nmod)
prevent rebleeding (dobj)
peak activity (nmod)
adolescents in (case)
evidence serologic (amod)
was there (expl)
examines . (punct)
comparable almost (advmod)
data points (nmod)
beta and (cc)
dysplasia upon (case)
change pattern (nmod)
lowering lowering (advcl)
integrity sarcolemmal (amod)
mater cortex (conj)
deletion stat3 (nmod)
hematologic and (cc)
antibiotics beta-lactam (amod)
used . (punct)
revealed related (ccomp)
compromised receiving (conj)
pallidotomy disease (nmod)
rejection ar+cr (conj)
sham-operated radiotelemetered (amod)
consider similarly (advmod)
stabilizers prototypic (amod)
carbamazepine ( (punct)
separated min (nmod)
as cases (conj)
factors sensitization (nmod)
function increased (amod)
rats all (appos)
had presentations (dobj)
cases anemia (nmod)
investigated toxicity (nsubjpass)
performed determine (advcl)
reversed fludrocortisone (nmod)
inhibits gaba-transaminase (dobj)
interest a (det)
-21.3 -19.4 (conj)
interaction severe (amod)
ifo of (case)
riyadh , (punct)
demonstrated conclusion (nsubj)
particles red (nmod)
ecgs with (case)
treated pamidronate (nmod)
convulsions clonic-tonic (amod)
production pge2 (compound)
examined tone (nsubjpass)
known well (advmod)
treated had (aux)
relationship their (nmod:poss)
dogs treated (acl:relcl)
warrant investigation (dobj)
wt mice (conj)
elucidated been (auxpass)
proteins renin-angiotensin (amod)
subspecialty of (case)
abnormalities gastrointestinal (amod)
db was (cop)
documentation sah (nmod)
changes baseline (nmod)
692 range (dep)
proves . (punct)
states drug (compound)
reduces acting (advcl)
curves response (compound)
induction metallothionein (nmod)
drug succinate (nsubj)
neca ( (punct)
interval her (nmod:poss)
endografine polyvidone (conj)
uptake ldl (nmod)
carvedilol paroxetine (conj)
elicited that (mark)
fpd corrected (amod)
perfused days (nmod)
encephalopathy tolazamide-induced (amod)
use administration (nmod)
requiring ventilation (dobj)
% patients (appos)
aetiology neuropathy (nmod)
regulator plant (compound)
after h (dep)
consider intoxications (dobj)
loads the (det)
puncture needle (compound)
mg/m2/d 200 (nummod)
discussion considering (acl)
unchanged brains (nmod)
administration carbamazepine (nmod)
superior were (cop)
metabolite cocaine (nmod)
antidepressants other (amod)
length-of-stay increased (amod)
sets echo (compound)
levels mtdna (compound)
effect diagnosed (conj)
distributed surface (nmod)
role major (amod)
investigation intense (amod)
response , (punct)
arise may (aux)
exposure pregnancy (nmod)
males ) (punct)
used css (nsubjpass)
followed period (nmod)
discouraged children (nmod)
accidents cerebrovascular (amod)
impairment induced (amod)
safety echocardiography (nmod)
measure to (mark)
showed studies (nsubj)
elicit dyskinesia (dobj)
applications consecutive (amod)
cocaine ecstasy (conj)
epinephrine ( (punct)
flexion joint (nmod)
enalapril enalapril (nmod)
ly-171555 or (cc)
one agent (conj)
regulation expression (nmod)
hoehn and (cc)
amnesia morphine-induced (amod)
presence concentrations (nmod)
hemodiafiltration venovenous (amod)
hypothesis play (ccomp)
age sex (conj)
angio-oedema with (case)
increase produced (conj)
ligands sigma (compound)
rejection of (case)
occurred bradycardia (nsubj)
lidocaine ) (punct)
class status (compound)
underwent blockade (dobj)
compared day (nmod)
differ and (cc)
surprise sadness (conj)
paroxetine , (punct)
tasks activation (compound)
predisposes sepsis (nmod)
patients infected (amod)
drugs antineoplastic (amod)
received achieved (advcl)
period 24-h (amod)
therapy risperidone (nmod)
double-blind randomized (amod)
observational largely (advmod)
levels hbv (nmod)
antitussives , (punct)
ulcers . (punct)
shows effect (dobj)
shifts by (case)
delirium patient (nmod)
long because (mark)
improvement chemotherapy (nmod)
due pge1 (nmod)
prior between (case)
uiu/ml ( (punct)
sch d1 (compound)
experiment a (det)
specificity the (det)
none models (nmod)
resection after (case)
model from (case)
induce relevant (advcl)
exhibited controls (advcl)
administration placebo (nmod)
rechallenged were (auxpass)
scale 100-mm (compound)
example for (case)
mccarthy 1971 (nummod)
system dopaminergic (amod)
less expression (nsubj)
improved increased (conj)
gaba(a)rs at (case)
prevented % (nmod)
period cycle (nmod)
methods performed (appos)
study this (nsubj)
those positive (amod)
preparation rat (compound)
produced carbachol (nmod)
complicated fluctuations (nmod)
identified newly (advmod)
progestagens for (case)
raised been (auxpass)
expression cytokines (nmod)
unremarkable was (cop)
rats pcpa-treated (amod)
salt-depleted salt-loaded (conj)
reactions due (case)
malignancies various (amod)
weighted diffusion (nmod:npmod)
use risperidone (nmod)
nephropathy chronic (amod)
frequencies low (amod)
cancer ) (punct)
induce case (nmod)
serositis with (case)
misleading that (mark)
prazosin drug (appos)
days progestagen (nmod)
indicator measurement (nmod)
reduction strength (nmod)
associated phase (nsubjpass)
pressure or (cc)
moving-bands gels (nmod)
$ROOT$ triggered (sent)
injection accidental (amod)
sustained-release of (case)
subjects all (det)
da than (case)
r=0.81 ( (punct)
years 1.7/100,000 (nummod)
examine expression (dobj)
elucidated has (aux)
excluding resulted (conj)
problem serious (amod)
performed years (nmod:tmod)
toxicities % (appos)
coincident were (cop)
formation bile (compound)
site discharge (compound)
concentration gaba (nmod)
phenomenon " (punct)
nm 4.1 (nummod)
status 0 (appos)
has tolerance (dobj)
mg/day 1 (nummod)
used group (dep)
diabetic control (conj)
personnel military (amod)
granules the (det)
count ) (punct)
rats surviving (amod)
triggered augmented (conj)
plays function (dobj)
psychoses , (punct)
shape waves (nmod)
days was (cop)
increased weight (dobj)
dehydrogenase cholesterol (conj)
disorder from (case)
nephrotoxic , (punct)
induced microperfusion (nmod)
correlates changes (nmod)
significant also (conj)
injected or (cc)
period november (appos)
stn and (cc)
mediate hypotension (dobj)
conclude we (nsubj)
promoted . (punct)
underwent treatment (nmod)
followed basis (nmod)
episode nausea (nmod)
toxicity administration (nmod)
patients referred (acl)
significance ptcr (nmod)
given iso (nsubjpass)
transaminase transaminase (conj)
shown presence (nsubjpass)
attack to (case)
recorded women (nmod)
concentrations supratherapeutic (amod)
occurred associated (conj)
hernias many (amod)
used series (nmod)
nonimmunity rubella (compound)
junctions tight (amod)
patients 82 (nummod)
exposure prior (advmod)
decided number (nmod)
serve changes (nsubj)
occurred infarction (nsubj)
halos visual (amod)
hypoaesthesia of (case)
ameliorates impairments (dobj)
cinching tourniquets (dobj)
terminated injection (nmod)
phenomenon a (det)
myocet of (case)
suppresses stage (nmod)
development abs (nmod)
came resurgence (nsubj)
17.5 1.1 (nummod)
investigated determined (parataxis)
changes follow-up (amod)
risks vte (nmod)
128 3 (conj)
ro4368554 both (cc:preconj)
ipsi- areas (conj)
appears complication (nsubj)
activity serum (nmod)
infarction ischaemia (conj)
0.001 1.039 (conj)
equilibrate effects (dobj)
offer changes (nsubj)
143 10(9 (conj)
dose desipramine (nmod)
amounts proteins (nmod)
switched assigned (conj)
loss painless (amod)
studies brain (compound)
dementia subacute (amod)
type to (case)
effect effects (nmod)
$ROOT$ advocate (sent)
163 of (case)
flow inspiratory (amod)
diagnosis treatment (conj)
intervals use (nmod)
plus-maze epm (appos)
papaverine with (case)
prepared be (auxpass)
determined background (nsubjpass)
factors some (det)
increased use (nsubj)
complications venous (amod)
stopping treated (advcl)
quit or (cc)
documented morphine (nmod)
dilevalol serum (conj)
treated cabergoline (nmod)
minutes for (case)
g/dl 13.2 (nummod)
investigated adding (advcl)
maze ) (punct)
training physical (amod)
inhibitors kinase (compound)
oncologists neurologists (conj)
disturbances abuse (conj)
effect caused (acl)
euthanized and (cc)
provoke proteinuria (dobj)
c-ret ) (punct)
imipramine with (case)
interval 5-min (amod)
satisfaction sexual (amod)
operation h (nmod:npmod)
active and (cc)
recovery total (amod)
4/5 ( (punct)
six 4 (conj)
response amphetamine (nmod)
40 - (dep)
became cultures (nsubj)
salicylate and (cc)
behaviors rats (nmod)
enhanced effectiveness (nsubjpass)
loss ca3 (compound)
drug either (cc:preconj)
magnitude prognosis (conj)
type duration (conj)
treated been (auxpass)
treated tachycardia (nsubjpass)
hg/l/min mm (compound)
associated therapies (nsubjpass)
education further (amod)
complication caused (acl:relcl)
constituent rate-limiting (amod)
measuring plasma (dobj)
undergone deprivation (dobj)
therapy cause (acl:relcl)
lidocaine followed (acl)
survivors se (compound)
change clearance (nsubj)
400 500 (conj)
attain control (dobj)
obviate objective (dobj)
variety agents (nmod)
flow as (cc)
head the (det)
states unpleasant (amod)
sleep an (det)
contributed failure (nmod)
induced interval (nmod)
prominent was (cop)
hyperhidrosis were (cop)
modulates implicates (conj)
mpt ) (punct)
inhibits . (punct)
agent undergoing (acl)
beta-ccm ) (punct)
indicate may (aux)
gum % (compound)
aggression , (punct)
provided deterioration (nsubj)
effect digoxin (compound)
shown increase (ccomp)
used data (nsubjpass)
edition revised (amod)
24 6 (compound)
abolished patient (nmod)
avoided probably (advmod)
apl ) (punct)
ro4368554 mg/kg (dep)
gastrointestinal gi (appos)
significance functional (amod)
polyglutamates cb (compound)
integrity of (case)
cp i.p. (advmod)
loads pelvic (amod)
developed taking (advcl)
improvement 9 (nmod)
restarting after (case)
damage oxidant-mediated (amod)
determine changed (ccomp)
600 1200 (conj)
stimulant beta-2 (compound)
lower were (cop)
tubes with (case)
dynamics presence (conj)
hospitals delivery (compound)
nucleus callosum (conj)
ameliorate decreasing (advcl)
limited information (nsubj)
those injected (acl)
rats ns-718-treated (amod)
5 10(-6 (conj)
degenerated arrhythmia (nsubj)
reduced < (parataxis)
severity were (cop)
examination ultrastructural (amod)
define diagrams (nsubj)
pilocarpine- acid-induced (conj)
developed period (nmod)
relative ocs (nmod)
affect later (advmod)
treatment infections (nmod)
obese ob (dep)
visits laboratory (compound)
demographic biological (conj)
patients several (amod)
identify subgroup (dobj)
blocker the (det)
response pressor (compound)
proteinuria excretion (conj)
occurred that (nsubj)
cross-reactivities in (case)
administered dose (nsubjpass)
continued percent (nsubj)
system in (case)
height cm (nmod)
medium nonionic (amod)
persisted ; (punct)
daily once (nmod:npmod)
$ROOT$ 99 (sent)
diltiazem b.i.d. (appos)
indices the (det)
drowsiness in (case)
guanethidine of (case)
efficacy granisetron (nmod)
inferences with (case)
angle open (amod)
changes endothelial (amod)
affecting increasing (conj)
$ROOT$ substantiate (sent)
molecule messenger (compound)
injection epidural (amod)
had smoking (nsubj)
non-alcoholic a (det)
resolved day (nmod:tmod)
remained disappeared (conj)
safety impact (nmod)
symptoms later (amod)
important most (advmod)
provided is (auxpass)
plasma cortisol (conj)
timolol aqueous (amod)
occurs administration (nmod)
excipients its (nmod:poss)
play hypotension (nmod)
pain bisphosphonate-related (amod)
nondyskinetic than (case)
reported but (cc)
rofecoxib to (case)
torr respectively (advmod)
restlessness and (cc)
shown decreases (nmod)
window a (det)
re-induced dose (nmod)
risk no (det)
atropine intravenous (amod)
activation associated (acl)
mg/kg 21 (nummod)
nh4cl mmol (amod)
occurred animals (nmod)
administration drug (nmod)
receptor measured (acl)
period ventricular (amod)
pressure ( (punct)
mcg/kg min (nmod)
infections all (det)
dramatic more (advmod)
partial , (punct)
myocytes neonatal (amod)
studies identified (acl)
ether hfde (appos)
reoccur continuation (nmod)
percent 59 (nummod)
progression dystrophy (nmod)
occurred 2 (nmod)
amylase serum (compound)
variants cholinesterase (nmod)
channel ion (compound)
cessation its (nmod:poss)
cases overdose (compound)
usage txa (compound)
stopped magnesium (nsubjpass)
agency regulatory (amod)
sphincter spasm (nmod)
system signaling (compound)
induced adriamycin (nsubj)
southeast the (det)
decrease sudden (amod)
stems findings (nmod)
dextrose hour (nmod:tmod)
$ROOT$ modulates (sent)
clarification a (det)
killed dx (nmod)
$ROOT$ relationships (sent)
one pathologies (nmod)
rtms real (amod)
effect seizures (nmod)
given busulfan (nsubjpass)
controls repeated (amod)
droperidol mg (nummod)
increase liver (compound)
caproate of (case)
= -0.97 (dobj)
disorders carmofur-induced (amod)
intestine the (det)
tetrachloride of (case)
dublin , (punct)
palpitation showed (acl)
kindled-seizures against (case)
months 7.6 (nummod)
became asystolic (acomp)
caused controls (advcl)
understanding our (nmod:poss)
mg/kg days (appos)
administered patients (nmod)
mg/dl 0.8 (nummod)
transport duct (compound)
unaffected . (punct)
[verapamil]o the (det)
examined year (nmod)
lignocaine hyperbaric (amod)
secretion hbsag (compound)
= 1.228 (dobj)
suggests increases (ccomp)
2.5 1.1 (conj)
contains , (punct)
year exact (amod)
review complications (nmod)
creatinine baseline (compound)
disease ) (punct)
nephrotoxicity rats (nmod)
hz 0.5v (appos)
implicated sirolimus (dobj)
time-to-onset of (case)
1.8-fold ( (punct)
precursor the (det)
ratios metoprolol/alpha-hydroxymetoprolol (compound)
used methotrexate (nsubjpass)
ratio rcr (appos)
blockers beta (compound)
remission apl (nmod)
function gaba(a)r (compound)
morphine neuraxial (amod)
mouth headache (appos)
attenuation a (det)
receiving infusion (dobj)
showed lower (dobj)
treatment preventive (amod)
obtained : (punct)
contributed formation (nmod)
resuscitate rats (dobj)
correlated compared (advcl)
use seizures (nmod)
injection volumes (nmod)
response similar (amod)
exposure a (det)
likely are (cop)
alpha,3 5 (nummod)
risperidone mg/day (appos)
decrease concentrations (nsubj)
failure growth (compound)
disorders syndrome (compound)
80 50 (compound)
21 of (advmod)
controls 15 (appos)
due could (aux)
apex opposed (dep)
weight diet (compound)
evaluate risk (dobj)
dehydration severe (amod)
scl ) (punct)
sensation her (nmod:poss)
mea hips-cms (nmod)
extracted data (nsubjpass)
monitor carefully (advmod)
mg. 41.4 (nummod)
factors disease (nmod)
persisted performed (advcl)
concentrations flecainide (compound)
risk women (nmod)
tolerate did (aux)
animals microl (appos)
rats additional (amod)
test buschke (compound)
measurement tremor (nmod)
good prognosis (nsubj)
segment affected (amod)
toxicity without (case)
lobe the (det)
effect conditioning (nmod)
risk eight-fold-higher (amod)
dexamphetamine- apomorphine-induced (conj)
infusion rapid (amod)
trials infusions (nmod)
298+/-7 139+/-36 (conj)
atenolol , (punct)
diagnosed database (nmod)
pg/ml ( (punct)
parallels possible (amod)
$ROOT$ dose-related (sent)
= 0.034 (dobj)
sirolimus especially (advmod)
amide naa (appos)
$ROOT$ statement (sent)
encephalomalacia ) (punct)
conformed , (punct)
sensitivity myocardial (amod)
characteristics concentration (nmod)
predisposed . (punct)
290 260 (compound)
appeared changes (nmod)
s-312 antagonists (appos)
circled , (punct)
injections weekly (amod)
similar pressures (nsubj)
hotplate water (conj)
ng/ml. of (case)
maintained minutes (nmod)
needed concern (nsubjpass)
compared chi2-test (nmod)
objective assess (dep)
contributed that (mark)
reduced injection (nsubj)
dose microg/kg (appos)
mri by (case)
cyclophosphamide are (cop)
$ROOT$ respond (sent)
outcomes interest (nmod)
weekly monthly (conj)
nitrogranulogen such (case)
method morphometric (amod)
differed = (parataxis)
degeneration cells (nmod)
myeloencephalopathy fatal (amod)
represented represented (conj)
studies and (cc)
ecg normal (amod)
led agitation (nmod)
h 23 (nummod)
therapy with (nmod)
averaging p (dep)
relationship risks (conj)
antigens metabolites (conj)
method . (punct)
uremia se (advmod)
problem is (cop)
safe but (cc)
falls volume (nsubj)
back-diffusion gastric (amod)
enzymes glycosaminoglycan-degrading (amod)
treated administration (nmod)
p=0.037 ( (punct)
injury defined (acl)
$ROOT$ toxic (sent)
syndrome hand-foot (amod)
killed weeks (nmod)
meta-analysis good-quality (amod)
danger potential (amod)
group tmp (compound)
minimal no (conj)
attempt previous (amod)
l-name of (case)
prescribing levofloxacin (dobj)
product protein-bound (amod)
periods follow-up (amod)
explained depending (prep)
chloroacetaldehyde role (dep)
30 60 (conj)
drugs specific (amod)
studies paclitaxel (nmod)
been have (aux)
tape to (case)
% 38.9 (nummod)
therapy quinidine (compound)
glycopyrrolate kg-1 (nummod)
superior events (nmod)
serum containing (acl)
ap7 microl (appos)
is important (acomp)
proliferation hepatocyte (compound)
pancreatitis encephalopathy (conj)
appointments their (nmod:poss)
address memory (dobj)
help will (aux)
bradydysrhythmias fibrillation (conj)
effective valsartan (nsubj)
prevalence hit (nmod)
decreased count (nsubj)
g/ml . (punct)
31 % (appos)
resolution symptoms (nmod)
different regardless (advmod)
signaling cytokine (compound)
invaluable is (cop)
male female (conj)
dosing equivalent (compound)
tachycardia for (case)
nodosum erythema (compound)
release peptide (nmod)
liver as (case)
condition similar (amod)
removed . (punct)
fentanyl 1 (nummod)
induced used (advcl)
seem rise (nsubj)
significant p (dep)
l ) (punct)
interval ; (punct)
rate hz (compound)
ketoprofen of (case)
lead ppa/caffeine (nsubj)
nocistatin i.c.v. (advmod)
developed lapsed (conj)
agent used (acl)
protocols lymphoblastic (amod)
underreporting hallucinations (nmod)
subjected hypotension (nmod)
suspect syndrome (dobj)
face male (amod)
infection and (cc)
optimized , (punct)
tolerability the (det)
had function (dobj)
response antigen (nmod)
attracted has (aux)
higher compared (advcl)
sensitive caffeine (nmod)
manometry ambulatory (amod)
tendency cocaine (nmod)
breath after (case)
mumol/kg 3.2 (nummod)
university irvine (appos)
scheduled surgery (nmod)
stages severe (amod)
fluid : (punct)
deficits loss (conj)
reactions those (det)
exist . (punct)
dosages less (amod)
database disease (compound)
lipopolysaccharide factor (appos)
zyban , (punct)
increased dose-dependently (advmod)
demographics patient (compound)
output urine (compound)
ec ) (punct)
patients fibrillation (nmod)
shortened experiments (nmod)
effect pharmacologic (amod)
stress oxyradical (compound)
half patients (nmod)
temocapril ) (punct)
hyperplasia epithelial (amod)
administration analog (nmod)
report any (conj)
need model (nmod)
case pain (nmod)
gyrus gyrus (conj)
hours after (case)
1.043 0.002 (conj)
investigated causes (nsubjpass)
contribute not (neg)
< impairment (nmod)
cycles during (case)
increase relation (nmod)
tolerance in (case)
helpful analysis (nsubj)
remission term (compound)
diminished pain (nsubj)
generated one (nmod)
-14.8 evident (acl:relcl)
using paradigms (dobj)
caused rats (nmod)
rates highest (amod)
paroxysms focal (amod)
treated risperidone (nmod)
gentamicin kg-1 (appos)
toxicity enhanced (amod)
penetration . (punct)
used heroin (dobj)
1mg/kg be (cop)
quadrants the (det)
g/min 30 (nummod)
received aprotinin (dobj)
data conclusions (compound)
= .001 (dobj)
treated acutely (advmod)
showed tendency (dobj)
characterized headache (nsubjpass)
1995 from (case)
exacerbations cases (nmod)
using swallow (dobj)
binding on (case)
phosphorylation erk1/2 (compound)
one inhibitors (nsubj)
demonstrates consists (ccomp)
transplant marrow (compound)
rate thromboembolism (nmod)
levels b12 (compound)
instrumented tubes (nmod)
nephropathy phytotherapy-associated (amod)
buildup and (cc)
induced coadministration (nmod)
5-hydroxytryptamine , (punct)
miss appointments (dobj)
induce blockade (nsubj)
rats tolerant (amod)
injury seizure-induced (amod)
151 - (advmod)
regions pontine (amod)
rigidity fluctuations (conj)
limit above (case)
protocol the (det)
analysis intensity (conj)
treatment management (nmod)
incidence myoclonia (nmod)
presence features (nmod)
test hole-board (compound)
g/day 2 (nummod)
adenocarcinoma offspring (nmod)
hormone human (amod)
speed on (case)
lower somewhat (advmod)
restored reduced (ccomp)
metabolite cyclophosphamide (nmod)
sessions stimulation (nmod)
affinities affinity (conj)
endomt ( (punct)
complained paresthesias (nmod)
mechanism possible (amod)
4.7 was (cop)
three only (advmod)
advantages of (case)
receiving 18 (nsubj)
previously month (nmod:npmod)
starting administration (nmod)
those cause (acl:relcl)
separated patients (nsubjpass)
pathways kinase-related (amod)
effective bromocriptine (nsubj)
drugs anti-tuberculous (amod)
taking period (nmod)
proteinuric severely (advmod)
satisfied are (cop)
sinoatrial and (cc)
scale six-point (compound)
occurs . (punct)
treated once (advmod)
clotting of (case)
methyltransferase guanidoacetate (compound)
inhibitor micrograms (appos)
5 respectively (advmod)
animals haloperidol-treated (amod)
micrograms 300 (nummod)
atropine mater (nmod)
values mean (compound)
demonstrated association (dobj)
prior sedation (nmod)
performed intervals (nmod)
% 1.5 (nummod)
decreases lamivudine (nsubj)
maintaining while (mark)
experienced patients (nsubj)
quantified ) (punct)
patient others (conj)
ra of (case)
increased intervals (nmod)
receptor receptor-like (amod)
demonstrated tolerated (conj)
evident and (cc)
granulocytopenia transient (amod)
p-chlorophenylalamine mg/kg (appos)
evidence vte (nmod)
third to (case)
dhea mg/kg (nummod)
adults risk (nmod)
1997 - (punct)
dyskinesia levodopa-induced (amod)
atrophy type (compound)
cancer extensive (amod)
ongoing aim (nmod)
myocarditis a (det)
quality field (nmod)
ssris by (case)
hallucinations or (cc)
therapy b (compound)
patients known (acl)
25 of (advmod)
produced actions (dobj)
increase demand (nmod)
interval 12.1 (appos)
isoproterenol ) (punct)
humans possibly (advmod)
administration 3mg/kg (compound)
fulfilled criteria (dobj)
ng/ml 150 (nummod)
mg/day between (case)
opener the (det)
radicals superoxide (compound)
3657 excretion (nsubj)
hypertelorism hypoplasia (conj)
impair does (aux)
regimen only (advmod)
intensity p<0.001 (appos)
ephedrine of (case)
leukemia with (case)
reaction . (punct)
myelosuppression mood (conj)
mg/day 250 (nummod)
scored grade (nmod)
examined hbsag (nmod)
ad50 concentration (appos)
use benzodiazepines (nmod)
latter unlike (case)
medulla adrenal (amod)
changes 15-db (amod)
gfap ) (punct)
weeks nine (nummod)
suggesting develop (ccomp)
35.1 5.5 (conj)
came 1985 (nmod)
infusion group (nmod)
concentration neurotransmitter (compound)
aim examine (acl)
presence particularly (advmod)
apoptosis fas-mediated (amod)
prolapse valve (compound)
play transporters (nsubj)
subtypes lymphoma (compound)
onset asystole (nmod)
phosphatase receptor (compound)
occurred infection (nsubj)
t3n1m0 ( (punct)
uptake of (case)
dosages = (dep)
physiology ii (nummod)
occurred women (nmod)
damage variety (nmod)
suggest also (advmod)
mediated tachycardia (nsubjpass)
removal by (case)
assessed injection (nmod)
depletion gsh (compound)
stent between (case)
constructed administration (dep)
rates flow (compound)
administered her (nmod)
enhance drugs (nsubj)
receive distinguish (conj)
cardioversion after (case)
data laboratory (compound)
cystitis rat (nmod)
elevation acute (amod)
mini-pump with (case)
metabolizers pm (appos)
responding initially (advmod)
apnea nausea (conj)
netilmicin tobramycin (conj)
values mice (nmod)
seven five (conj)
either way (dep)
therapy previous (amod)
consolidation . (punct)
aml ( (punct)
hg 85 (nummod)
analyzed method (dep)
exceeds and (cc)
collagen interstitial (amod)
manage patient (dobj)
cardiomyopathy cumulative (amod)
increased 133 (nmod)
noted occurred (conj)
given compounds (dobj)
rigidity such (case)
measurement the (det)
decreased responses (dobj)
appear hypertension (nsubj)
effective dothiepin (nsubj)
hypertension hormone (compound)
requiring hydration (nmod)
mechanism(s underlying (acl)
approach experiments (nmod)
variants branching (compound)
cohort previous (amod)
time times (conj)
drug reported (conj)
mug morphine (nmod)
boys of (case)
injury adriamycin-induced (amod)
demonstrated team (nsubj)
association adherence (nmod)
elevated damage (nmod)
cardiotoxin a (det)
circulation intact (amod)
counseling materials (conj)
thrush or (cc)
led studies (nsubj)
kg(-1 mg. (compound)
induced had (conj)
reduced elevated (conj)
response headache (compound)
of were (cop)
thromboembolic complications (conj)
contrast animals (nmod)
> normal (nmod)
experience acidosis (dobj)
tuberculosis with (case)
epsilon4 effects (conj)
components these (det)
valve and (cc)
aggravation score (nmod)
hypothyroidism for (case)
existing previously (advmod)
neoplasms peliosis (conj)
proportions in (case)
register abstracts (appos)
enhance models (nmod)
anesthetics to (case)
6 39 (nmod)
inhibition prepulse (compound)
ng./ml was (cop)
gland from (case)
effect mass (nmod)
eosinophilic hypersensitivity (dep)
due this (nsubj)
dosage toxicities (conj)
reduced myocytes (nmod)
didanosine hydrocortisone (conj)
administration etomidate (compound)
effective pyridoxine (nmod)
$ROOT$ aspirin (sent)
interpreted may (aux)
marked lobe (nmod)
aspect the (det)
macroprolactinemia n. (dep)
$ROOT$ classified (sent)
conducted review (dobj)
gaba dose (compound)
activation caspase (nmod)
confusion induced (acl)
maintained position (nmod)
damage recovery (conj)
nephrotoxic be (cop)
enhancement to (case)
antibiotics the (det)
trials confirmatory (amod)
period entire (amod)
mediated it (nsubjpass)
cardiotoxicity doxorubicin (nmod)
reflex righting (amod)
resulting referral (nmod)
shell ( (punct)
valproate mg/day (appos)
favored role (dobj)
anticipation of (case)
regimen modified (amod)
difficult obstruction (nsubj)
drug selectivity (nmod)
measured mpo-anca (nsubjpass)
prox-1 marker (appos)
effects stereotypy (nmod)
sensitive process (nsubj)
safety clinical (amod)
epidemiology the (det)
sufficient hypomethylation (nsubj)
sensitivity ; (punct)
conditions growth (nmod)
group long-term (amod)
setting ischemia (nmod)
ng/ml 500 (nummod)
failure acetaminophen-induced (amod)
interferon ribavirin (conj)
led observations (nsubj)
increasing , (punct)
safer require (conj)
influence hormones (nsubj)
impairment alcohol-related (amod)
example is (cop)
failed accentuante (xcomp)
hyperammonemia of (case)
decreased values (advcl)
90 60 (nummod)
radioimmunoassay by (case)
signs syndrome (nmod)
ng/min ( (punct)
5 2 (nummod)
extension 54-week (amod)
tocolytics two (nummod)
stability temporal (amod)
144 14/87 (conj)
quadrant the (det)
baby in (case)
purpose is (appos)
iw ( (punct)
curve concentration-time (amod)
remains outcomes (nmod)
normal in (case)
hus ( (punct)
actions cardiovascular (amod)
immunohistochemistry microscopical (amod)
divided randomly (advmod)
penicillamine therapy (conj)
objective subjective (conj)
29 40 (conj)
cases administration (nmod)
confirmed microscopy (nmod)
predict ptcr (nsubj)
levels 12alpha-hydroxylase (nmod)
system implanted (amod)
temporal and (cc)
progressive incurable (conj)
artery small (amod)
c+e and (cc)
off week (nmod:npmod)
randomized april (nmod)
buffer cell-free (amod)
nephrolithiasis topiramate-induced (compound)
labelling adequate (amod)
irreversible invariably (advmod)
leukoencephalopathy mimicking (acl)
formation hippocampal (compound)
reverted became (conj)
treated months (nmod)
developed complications (nsubj)
interrupted , (punct)
47 to (dep)
interrupted permitted (conj)
convulsions handling-induced (amod)
observed 0.6 (dobj)
investigated further (advmod)
open- closed-arm (conj)
actions captopril (nmod)
useful s-312-d (nsubj)
stimulating by (mark)
vulnerability mania (nmod)
coincided normalization (nmod)
half-life median (amod)
nociceptin known (acl)
accepted is (auxpass)
and transiently (advmod)
crude and (cc)
45 8 (conj)
was identify (xcomp)
mg 20 (nummod)
frequency evaluated (acl)
zidovudine by (case)
reported case (nsubjpass)
hyperalgesia provoked (amod)
lag ( (punct)
do methylprednisolone (nsubj)
toxicity new (amod)
preceded supporting (advcl)
receptor kinin (compound)
excludes . (punct)
autosomic recessive (amod)
transaminase and (cc)
coxii , (punct)
lethality cumulative (amod)
saline dexamethasone (conj)
given bha (dobj)
infections intrathoracic (amod)
screened was (auxpass)
likely those (nmod)
organs respective (amod)
injections cbz (nmod)
% whereas (dep)
administration dose (appos)
slices in (case)
n=26 ( (punct)
toxicity chemotherapeutic (amod)
antigen cell (compound)
affected illness (nmod)
discontinued that (mark)
ptcr and (cc)
icp cvp (appos)
fr ( (punct)
yrs 65+/-16 (nummod)
closely more (advmod)
stopping sulindac (dobj)
impaired are (auxpass)
pf ) (punct)
ingestion occurrence (conj)
pseudoacromegaly resulted (acl:relcl)
phenomenon this (det)
weights of (case)
inhibitor hypertension (nmod)
euphoria lability (conj)
criteria selection (compound)
suggest predisposes (ccomp)
explain mechanism (nsubj)
affects characteristics (dobj)
revealed labeling (dobj)
alterations mtdna (compound)
escalated mg/m2 (nmod)
vehicle by (case)
inhibit twitch (dobj)
role convulsion (nmod)
higher adjusting (advcl)
aware effect (nmod)
animals anaesthetized (amod)
conduct testing (dobj)
malondialdehyde tissue (compound)
concentration t (compound)
enlargement relationship (dep)
patients status (conj)
recalled were (auxpass)
deficiency and (cc)
movements purposeless (amod)
cavity resection (compound)
controls 26 (nummod)
having of (mark)
exposed session (nmod)
part striatum (nmod)
capacity transport (acl)
recall pain (compound)
enrolled using (xcomp)
group fk506-nephropathy (amod)
superior subscale (nmod)
micrograms/kg , (punct)
avoided administration (nsubjpass)
alphaenac especially (advmod)
dp/dt ) (punct)
% 34.98 (conj)
decreased level (nsubj)
p9201 risk (appos)
asenapine and (cc)
conditions clinical (amod)
responses drug (compound)
engineered have (xcomp)
49.75 ) (punct)
insufficiency because (case)
curves glucose (compound)
alterations course (compound)
growth d. (conj)
structure cerebellar (amod)
8.4 10.1 (conj)
frequent contrast (nmod)
former a (det)
samples erythrocyte (compound)
increment dose (compound)
stopped snp (nsubjpass)
occurred occurred (parataxis)
hepatitis with (case)
pneumonia infection (appos)
patient haemorrhage (nmod)
resolved administration (nmod)
arthralgia fever (conj)
beta-methylene , (punct)
have excess (nmod)
complication ophthalmic (amod)
cats 12 (nummod)
ng/ml 3000 (nummod)
dimer-x iocarmate (appos)
inhibiting secretion (dobj)
hyperactivity cocaine-induced (amod)
monitoring ambulatory (amod)
acid 5,7-dichlorokynurenic (amod)
toxicity weeks (nmod:tmod)
900 or (cc)
antibody anticocaine (compound)
markers peptide (nmod)
echo 3d (amod)
twice almost (advmod)
liberate no (dobj)
effects overdosage (nmod)
palsy supranuclear (amod)
ros ) (punct)
$ROOT$ effect (sent)
exchange and (cc)
attenuated decrease (nsubjpass)
ratio diameter (appos)
development , (punct)
infusion = (parataxis)
score percent (appos)
= % (dep)
america north (compound)
beginning attack (nmod)
camp intracellular (amod)
reagents ax-related (amod)
animals pkca (compound)
administered injection (nmod)
alleviating symptoms (dobj)
permeability mucosal (amod)
dissociated enzymatically (advmod)
reports unpublished (amod)
penk ) (punct)
coassemble form (xcomp)
types spasms (nmod)
developed measurements (nsubj)
different survival (nsubj)
discovered could (aux)
complex (gaba)a (compound)
hypoxia cerebral (amod)
0.65 = (parataxis)
studies strains (nmod)
thrush ( (punct)
dysfunction asymptomatic (amod)
suppression tetanus (compound)
identified mice (nmod)
conducted search (nsubjpass)
protected pilocarpine (nmod)
tachyarrhythmia swallowing-induced (amod)
sinuses of (case)
indomethacin and (cc)
= 2.85 (dobj)
reviews ophthalmic (amod)
laboratories department (appos)
limiting anesthesia (nmod)
surgery pregnancy (conj)
injection cy (compound)
livers between (case)
prevention globulin (nmod)
complications other (amod)
replaced ticlopidine (nsubjpass)
complained while (mark)
% 79 (nummod)
therapeutic associated (conj)
uncommon that (advmod)
pharmacokinetics medications (nmod)
$ROOT$ cultured (sent)
ne , (punct)
hallucinations and (cc)
effect concentrations (nmod)
was developed (ccomp)
neurotoxicity visual (amod)
now to (mark)
included index (dobj)
analgesics with (case)
novel conclusion (nmod)
patient 40-year-old (amod)
pressure states (conj)
act altering (advcl)
reduction increase (conj)
affect risk (dobj)
improve overdose (nmod)
activity 7-ethoxyresorufin-o-deethylase (nmod)
inhibition hyperlipemia (conj)
pulse with (case)
trihexyphenidyl to (case)
microinjection i.c.v. (nmod)
esterase of (case)
enrolled . (punct)
testing protectors (nmod)
15 20 (conj)
riha , (punct)
detachment edema (conj)
observed aggravation (nsubjpass)
produced injections (advcl)
ci or=0.001 (appos)
model cardiomyopathy (nmod)
frequency quantity (conj)
animals infected (amod)
can ( (punct)
lc the (det)
control long-term (amod)
associated increases (nmod)
action cocaine (nmod)
ranged loads (nsubj)
evaluation ability (nmod)
cyclophosphamide azathioprine (conj)
uterotonic . (punct)
long-term = (dep)
organization research (nmod)
clozapine aripiprazole (conj)
problem of (case)
race on (case)
deactivated enzyme (nsubjpass)
placed were (auxpass)
compared efficacy (dobj)
adjust , (punct)
given dfp-atropine (nmod)
characterized while (mark)
rhabdomyolysis failure (conj)
suggested inherent (ccomp)
hernia mds (conj)
quiet and (cc)
crescents deposits (conj)
patients of (case)
pathways circuitries (nmod)
woman sixty-year-old (amod)
randomized total (nsubjpass)
effects stimulant (amod)
series complete (amod)
constituents l. (nmod)
treatment mild (amod)
medication dosages (nmod)
obtainable freely (advmod)
features infiltration (nmod)
seems strength (nsubj)
hypoplasia and (cc)
devoid concentrations (nsubj)
effects but (cc)
onset acute (amod)
immunoblotting , (punct)
observed associations (dobj)
advantageous would (aux)
primarily . (punct)
showed inhibitions (dobj)
flow bile (compound)
scores to (case)
reduction bp (nmod)
show antagonists (nsubj)
therapy thrombophlebitis (nmod)
disorder cimd (appos)
reported stroke (nsubjpass)
occlusion resistance (conj)
support mechanism (dobj)
analyzed correlation (nsubjpass)
umb24 , (punct)
antigens putative (amod)
secretion antidiuretic (amod)
patients fewer (amod)
objective evaluate (acl)
degenerated , (punct)
evidence neuropathy (nmod)
correlate development (nsubj)
study comparison (conj)
area primary (amod)
nerve each (det)
levels hormone (compound)
antagonist sulpiride (nsubj)
status brain (nmod)
% 13 (nummod)
substantiates further (advmod)
triggers pathway (nmod)
disease cancer (conj)
types individual (amod)
wall albumin (nmod)
myeloma and (cc)
prevented p<0.05 (parataxis)
= 0.01 (dobj)
had placebo (nsubj)
ketoconazole with (case)
believe onset (nmod)
cpap infusion (nmod)
negativity resistance (conj)
carbamazepine multivitamin (conj)
nerves travelling (acl)
increased increases (nmod)
7.4 3.0 (conj)
specific is (cop)
dxr ( (punct)
improved quality (dobj)
analysis laboratory (compound)
evaluation echocardiography (nmod)
reactivity no (neg)
administration psoriasis (nmod)
sites that (mark)
stenosis combined (acl)
nucleus tegmental (amod)
cycle cardiac (amod)
contraindicate which (nsubj)
pathway mtor (compound)
incidence nephrotoxicity (nmod)
demonstrate and (cc)
titer pr3-anca (compound)
due have (aux)
suffering she (nsubj)
tolerated entered (conj)
disturbances including (case)
implications become (dep)
rate fatality (compound)
return function (nsubj)
isoflurane i (appos)
0 2 (prep)
deteriorated . (punct)
systemic to (case)
h 8 (nummod)
angiogenesis induced (amod)
banned use (dobj)
96.7 ) (punct)
scr baseline (amod)
blood between (case)
had surgery (dobj)
administration rauwolscine (nmod)
change 1 (dep)
mcpp , (punct)
tachydysrhythmias tachycardia (nmod)
neutropenia mucositis (conj)
doses intrathecal (amod)
dosing chronic (amod)
lowered expression (nsubj)
modulate increase (nmod)
blocks local (amod)
improvement haemodynamic (amod)
mediated dopamine (nmod)
choice are (cop)
insights cause (nmod)
incidence placebo-level (amod)
inhibitors synthetase (compound)
clearance lometrexol (compound)
lacn ( (punct)
phases the (det)
cardiomyopathy ( (punct)
= 4 (dobj)
provocation drug-induced (amod)
scale self-rating (amod)
analyzed role (nsubjpass)
type ( (punct)
f344 and (cc)
also favor (nmod)
antigen related (amod)
caused hand (nmod)
involved whether (mark)
factor one (nummod)
handicapped . (punct)
atherosclerosis aortic (amod)
$ROOT$ pills (sent)
effect hypertension (nmod)
mtd ) (punct)
induces regions (nmod)
less bupivacaine (nmod)
surgery endoscopic (amod)
required support (dobj)
$ROOT$ conformed (sent)
continued however (advmod)
translate might (aux)
tet ) (punct)
placebo-controlled and (cc)
recorded compared (conj)
mellitus or (cc)
3.4 ) (punct)
dose lignocaine (nmod)
agent common (amod)
showed cycles (nmod)
similar % (nmod)
examined occurrence (dobj)
dipyrone analgesia (nmod)
1.3 it (nsubj)
included analyses (nsubj)
patients normocalcemic (amod)
pain particularly (advmod)
retention fibrosis (conj)
potentiates reducing (advcl)
group frail (amod)
dilevalol and (cc)
monomers of (case)
icr c57bl/6 (conj)
milieu the (det)
trained influence (nmod)
led hypothesize (xcomp)
sirolimus srl (appos)
revealed interaction (dobj)
microgram.kg-1.min-1 patients (appos)
showed deletions (dobj)
conditions different (amod)
area between (case)
minutes 0.5 (nummod)
netilmicin patients (dep)
use study (dep)
samples population (nmod)
buprenorphine qtc (conj)
increased irritability (dobj)
mice having (acl)
recording electrophysiological (amod)
use antagonist (nmod)
dermatitis rosaceiform (amod)
cisplatin mg/m(2 (compound)
report euphoria (nmod)
receive fentanyl (dobj)
strain as (case)
stress possibilities (nsubj)
pronounced baseline (advcl)
subunits coassemble (acl:relcl)
determined correlation (dep)
km in (case)
therapy triple (amod)
demonstrated infusion (nmod)
obtained remission (dobj)
suggests decreases (ccomp)
$ROOT$ choreoathetosis (sent)
demonstrated function (nsubjpass)
involving segments (dobj)
stones bladder (compound)
pg/ml 39 (nummod)
model aneurysm (nmod)
unclear mechanisms (nsubj)
lidocaine mg (appos)
positive tests (nsubj)
entered men (nsubjpass)
apd ( (punct)
unit female (nmod)
safer , (punct)
monitored hyperplasia (nmod)
result symptoms (nsubj)
evidence functional (amod)
effects two (nummod)
urticaria , (punct)
response svr (compound)
investigated sufficient (ccomp)
sensitive doses (nmod)
diet basal (amod)
biopsy patient (nmod)
fzp with (case)
organophosphate a (det)
behaved controls (nmod)
reactions induced (acl)
began movements (nsubj)
bleed gastrointestinal (amod)
none group (nmod)
h ) (punct)
greater haloperidol (conj)
increase groups (nmod)
patients sle (compound)
barrier only (amod)
known hormone (nsubjpass)
cocaine to (case)
undergoing pci (dobj)
flows blood (compound)
blockade alpha (compound)
produce benefit (dobj)
24.3 23.9 (conj)
involvement and (cc)
$ROOT$ myocarditis (sent)
unlikely were (cop)
mice g (dep)
used m0 (nmod)
levothyroxine microg/day (appos)
tool background (compound)
periods infusion (nmod)
acetyltransferase for (case)
augments . (punct)
cyclophosphamide in (case)
altering concentrations (dobj)
hemodynamics and (cc)
expression cytochrome (compound)
staining acetyltransferase (nmod)
proteins ) (punct)
addition acid (nmod)
severe 24 (nmod)
obliterans bronchiolitis (compound)
randomized prospective (dep)
anaesthetised chloralose-urethane (nmod)
raises possibility (dobj)
raised phase (nmod)
51.0 ) (punct)
defects persistent (amod)
sought and (cc)
mellitus streptozotocin-induced (amod)
came . (punct)
woman 89-year-old (amod)
effective series (nmod)
group h2o (appos)
db -30 (nummod)
field novel (amod)
concentrations chp (nmod)
cyclosporine ) (punct)
carbachol i.c. (amod)
both beating (conj)
one dyskinesia (nmod)
poison warfarin-type (compound)
suppress levels (dobj)
myopathy documented (amod)
exist hydrolyze (ccomp)
presented hysterectomy (nmod)
fs ( (punct)
symptoms adverse (amod)
study reactions (nmod)
withdrawn now (advmod)
model epilepsy (nmod)
induced study (nmod)
segments apical (amod)
inducing tachycardia (nsubj)
induced rarely (advmod)
3.0+/-0.4 mg/l (conj)
mg < (amod)
induction and (cc)
methylation dna (compound)
esterification by (case)
received enhance (advcl)
used consecutively (advmod)
rose women (nmod)
fide bona (amod)
measured peroxidation (nsubjpass)
superior was (cop)
resolved . (punct)
laboratories ( (punct)
states in (case)
manage complications (dobj)
seroconversion people (nmod)
bnp ) (punct)
selegiline l-dopa (conj)
nerve lateral (amod)
center studies-depression (nmod)
acidosis of (case)
group 6 (appos)
prevented , (punct)
smoked baseline (nmod)
giving therapy (nmod)
arteriosus of (case)
diminishing thereby (advmod)
risk developing (advcl)
% 79.4 (nummod)
patient female (amod)
doses phenytoin (nmod)
recipients transplantation (nmod)
administration on (case)
apigenin flavonoid (compound)
inhibited addition (nmod)
effect hemolytic (amod)
provide blockade (nsubj)
saline but (cc)
responded min (nmod)
confirm adjustment (nmod)
recorded subject (nmod)
involvement components (nmod)
exhibited twitching (dobj)
phenomenon to (case)
observed scored (conj)
effect than (cc)
developed leukoencephalopathy (dobj)
developed fibrillation (dobj)
regimen cancer (nmod)
represent might (aux)
24.2 13.9 (conj)
ambiguus the (det)
activation overexpression (conj)
31 cases (nmod)
protein the (det)
degrees 38.40 (nummod)
% 20.7 (nummod)
important they (nsubj)
headache flushing (conj)
activity nfkappab (compound)
response initial (amod)
oxygenation in (case)
metabolites beta-oxidation (amod)
corrected bromocriptine (nmod)
markers necrosis (nmod)
research treatment (conj)
safety danazol (nmod)
attribute to (mark)
disruption characteristics (nmod)
negative . (punct)
efficacy . (punct)
turnover to (case)
used often (advmod)
dose whatever (nsubj)
ptpro ( (punct)
analyses eeg (compound)
abnormalities intoxications (nmod)
area target (compound)
affects , (punct)
presented observed (parataxis)
diminish effect (dobj)
knife the (det)
dmcm ) (punct)
aas ) (punct)
administered divided (cc)
offers . (punct)
differ concentrations (nsubj)
disequilibrium linkage (compound)
administration clomipramine (compound)
hypothesized contribute (ccomp)
symptoms pd (compound)
fall corresponding (amod)
maleate drug (appos)
observed disappeared (xcomp)
occur which (nsubj)
degeneration disruption (nmod)
$ROOT$ bradycardia (sent)
application main (amod)
ngf pgf2alpha (conj)
area an (det)
suggest addition (nmod)
revealed value (nmod)
diarrhea and (cc)
cya of (case)
observed clinically (advmod)
triad this (det)
23.7 10.2 (compound)
transcription production (conj)
n'-diisopropylphosphorodiamidofluoridate , (punct)
ratios r-/s-isomer (compound)
systems the (det)
reporting nausea (dobj)
reports delirium (nmod)
prevalent is (cop)
patients chf (compound)
extent damage (nmod)
test available (amod)
neurotoxicity against (case)
reverses amn082 (nsubj)
often less (advmod)
considered evaluation (nmod)
dose weight (compound)
confusion aggression (conj)
arteries large (amod)
cure . (punct)
procedures endoscopic (amod)
dose employed (acl)
revealed weak (advcl)
confounding design (nmod)
characterized type (conj)
using criteria (dobj)
deficits cortices (nmod)
attributed reactivation (nmod)
sample patients (nmod)
changes demonstrated (acl)
coincident was (cop)
interaction medications (nmod)
probable is (cop)
hormone the (det)
seemed whereas (mark)
induced also (advmod)
hypotension trimetaphan (compound)
using differentiate (advcl)
cystitis severe (amod)
mutants escape (compound)
combination an (det)
reduced aorta/serum-ratio (nsubjpass)
particles submitochondrial (amod)
symptoms hyperhidrosis (nmod)
analysis 2-way (amod)
pathways mediate (acl:relcl)
open cross-over (dep)
profile risk (compound)
interval within (case)
aimed we (nsubj)
incorporated if (mark)
fluoxetine antidepressant (amod)
bw ( (punct)
slight or (cc)
doses apap (compound)
transit % (nmod)
received transplant (dobj)
operated had (aux)
incidence death (appos)
efficacy steroids (nmod)
mol/l of (case)
piroxicam to (case)
primates in (case)
targeting dct2 (nmod)
symptoms somatic (amod)
mellitus ( (punct)
implicated which (nsubjpass)
changes hyperplastic (amod)
hypercholesterolemia and (cc)
hormone prolactin (conj)
caused herbs (nmod)
g/day)-lovastatin ( (punct)
upregulation rats (nmod)
doxorubicin irradiation (conj)
had load (dobj)
includes experience (nsubj)
steps optimization (compound)
exposure chemotherapy (nmod)
erythematosus systemic (amod)
noted differences (nsubjpass)
play nicotine (nsubj)
pathogenesis hypotension (nmod)
corrected was (auxpass)
ingestion between (case)
decreased compared (prep)
impact differential (amod)
proliferation tumor (compound)
accounted determined (advcl)
effects activities (nmod)
hemorrhage putaminal (amod)
recovery myopathy (nmod)
depletion marked (amod)
demonstrated was (auxpass)
adjusting stage (nmod)
routes by (case)
period organogenesis (nmod)
linked to (mark)
translocation requisite (amod)
effects receptors (nmod)
stopping despite (mark)
procedures : (punct)
phenotypes disease (compound)
had ncq344 (nsubj)
1.78 , (punct)
this factor-alpha (nmod)
larynx two (appos)
patients 40 (nummod)
allocated piglets (nsubjpass)
decrease % (nmod)
$ROOT$ venous (sent)
test validity (dobj)
deposition increased (amod)
pci for (case)
receptor is (cop)
hyperkalemia induced (acl)
exacerbates that (mark)
ischemia : (punct)
frequency angio-oedema (nmod)
deposited that (mark)
given order (nmod)
produced if (mark)
application systemic (amod)
placebo from (case)
associated failure (nmod)
rate rate (conj)
symptoms findings (conj)
inflammation expression (conj)
sulphate atropine (compound)
manifests models (nmod)
associated convulsions (nmod)
$ROOT$ infarction (sent)
signaling matrix (compound)
measured became (advcl)
triggered that (nsubjpass)
mg times (nummod)
forgetting conditioning (nmod)
aggregation platelets (nmod)
hitt and (cc)
complication although (mark)
thromboembolism determined (amod)
deviation in (case)
pattern injury (nmod)
cord of (case)
considered interaction (nsubjpass)
1 2 (conj)
mi against (case)
died day (nmod)
ml/kg , (punct)
defective . (punct)
capsules by (case)
tolerated in (prep)
histology carcinoma (conj)
measured thickness (nsubjpass)
history obtained (acl)
combination carbamazepine (nmod)
deficits in (case)
discontinued cis-ra (nsubjpass)
difficult achieve (xcomp)
function nerve (compound)
depletion indicated (acl)
combination rats (nmod)
adrenergic i.c. (amod)
patient overdose (nmod)
plasma than (case)
combinations to (case)
plate writhing (conj)
psychosis levodopa-induced (amod)
outcome eventual (amod)
effect indirect (amod)
effect dual (amod)
formation with (case)
tachycardia polymorphic (amod)
1,1-dichloro-2,2,2-trifluoroethane and (cc)
desire in (case)
methodology the (det)
associated changes (nsubjpass)
$ROOT$ suggested (sent)
induced cocaine (nmod)
aware effect (ccomp)
counseling reminders (conj)
$ROOT$ diminish (sent)
hearts iso-treated (amod)
fits . (punct)
polymorphism of (case)
present users (conj)
extend did (aux)
suffered convulsions (dobj)
score pediatric (amod)
falls normal (advcl)
lower did (aux)
studies for (case)
given etomidate (nsubjpass)
role sgk1 (nmod)
doxorubicin/kg ( (punct)
event pathway (acl:relcl)
failed sulphate (nsubj)
programming at2r (nmod)
co-morbidity between (case)
state severe (amod)
hypertension headache (nmod)
depend differences (nmod)
characterized defects (nmod)
$ROOT$ advisable (sent)
increased failure (nmod)
related aids (nmod:npmod)
injection meth (nmod)
met women (nsubj)
recovered patients (nmod)
size robust (amod)
applied and (cc)
cisapride placebo (conj)
parents the (det)
sole be (cop)
14/87 6 (conj)
years mean (parataxis)
$ROOT$ achieved (sent)
fk kg-1 (appos)
exhibit and (cc)
thiosulphate to (case)
complications adults (nmod)
hypothermia continued (acl:relcl)
remoxipride benzene (conj)
nicotine caffeine (conj)
eye ( (punct)
cases one (conj)
assessed ability (nsubjpass)
enantiomer s(- (amod)
deactivated gets (auxpass)
found cardiomyopathy (nmod)
indicate increases (nsubj)
required generation (nmod)
emergence delayed (amod)
1400 and (cc)
postmenopausal naturally (advmod)
deterioration no (det)
conclusions demonstrates (dep)
evaluate consequences (dobj)
$ROOT$ consisted (sent)
fragments resulted (acl:relcl)
papillary mid (nmod)
fibers damaged (amod)
vnr drugs (conj)
low testosterone (nsubj)
= mm/year (dobj)
substitute . (punct)
concentrated was (cop)
depolarization diastolic (amod)
prolongation longer (conj)
metabolite responsible (conj)
surprise , (punct)
development leukemia (nmod)
mesna that (mark)
requiring intervention (dobj)
necrosis besides (case)
test each (det)
epilepsy due (case)
ears newborns (nmod)
attributable hypotension (nsubj)
received immediately (advmod)
transmission neuropathy (nmod)
plays compensation (nmod)
patients examined (acl)
segment internal (amod)
influence expression (dobj)
cancers these (det)
dysfunction treatment (nmod)
older patients (nsubj)
estrogens days (nmod)
molecule cs (compound)
increases antidepressants (nmod)
acid choleretic (appos)
doses yohimbine (nmod)
results enrolled (appos)
antagonist is (cop)
exposed . (punct)
found response (nmod)
and simultaneously (advmod)
disappearing with (mark)
rifampicin to (case)
seizure-prone withdrawal (nmod:npmod)
stimulation not (cc)
potential nmp (appos)
support medical (amod)
massive most (advmod)
adults for (case)
conclusions necessary (dep)
containing subunits (dobj)
only but (cc)
increased lack (nsubj)
effective temocapril (nsubj)
shows models (conj)
ratios hazard (compound)
palsy femoral (amod)
modalities therapeutic (amod)
epidemic . (punct)
neutrophil platelet (conj)
sc ( (punct)
hypoxia kidney (nmod)
receptors 5-ht6 (compound)
was purpose (nsubj)
group nitrendipine-treated (amod)
inhibition a (det)
vegfr-2 ( (punct)
infusion sodium (compound)
underwent using (advcl)
indicated relationship (dobj)
renal or (cc)
cholecystokinin-octapeptide , (punct)
210 173 (quantmod)
infarction in (case)
followed day (nmod:tmod)
thought associated (xcomp)
hypotension acetylcholine (compound)
activity combination (nmod)
admitted and (cc)
9,832 ns-nsaids (nmod)
sequences t1-weighted (amod)
presence dose (nmod)
mg/day of (case)
effects agent (nmod)
disorders gastrointestinal (amod)
disintegrin metalloproteinases (conj)
staining perls (nmod:poss)
patients valves (nmod)
anuria a (det)
responsiveness to (case)
nodularity breast (compound)
ketamine morphine (conj)
showed used (ccomp)
factors major (amod)
high recovered (conj)
agent ifosfamide (dep)
anti-hcv , (punct)
effectiveness yohimbine (nmod)
occlusion artery (compound)
effects ventilation (nmod)
series whole (amod)
agents aminophylline (appos)
failure non-oliguric (amod)
normal twice (advmod)
frequencies seizure (compound)
varying incidence (nmod)
hypothesis inhibits (ccomp)
history included (acl:relcl)
use cocs (nmod)
markers observed (acl)
neonate the (det)
implants electrode (compound)
developed diarrhea (dobj)
nifedipine micrograms/kg/min (dep)
model aging (compound)
ro ) (punct)
bepridil , (punct)
3-hydroxymethyl-5,5-diphenylhydantoin of (case)
schema drug (compound)
in succinylcholine (nmod)
fell beats/min (nmod)
warranted treating (advcl)
enhancers these (det)
minutes 45 (nummod)
documented administration (nsubjpass)
ifosfamide ifx (appos)
patients 1 (dep)
limits than (case)
relaxant of (case)
dissociated pituitaries (nsubj)
clozapine such (case)
association direct (amod)
impairment degeneration (nmod)
account should (aux)
practice general (amod)
h2o2 plasma (compound)
palpitation recording (conj)
enrolled subjects (nsubjpass)
levels methotrexate (compound)
pre-existing and (cc)
study ci-921 (nmod)
vector hypoxia-responsive (amod)
10-weeks-old - (punct)
remissions remissions (conj)
assays laboratories (appos)
sodium volume (conj)
hospitalized of (case)
generalization in (case)
valvulopathy , (punct)
rs6693503 and (cc)
hr in (case)
aracytine-c lymphoma (nmod)
dimension percent (conj)
groups bupivacaine (compound)
that tachycardia (nmod)
inhibition selective (amod)
expression surface (compound)
abstinence maternal (amod)
0 2 (dep)
received intraperitoneally (advmod)
p n-induced (conj)
toxicity rats (nmod)
exacerbates patients (nmod)
response agonist-induced (amod)
appears due (xcomp)
saline p (appos)
weight auc (appos)
numbers only (advmod)
heparin weight (compound)
thought is (auxpass)
content iron (compound)
reticulum and (cc)
prevention cvd (nmod)
modify ; (punct)
used comparison (nmod)
under-appreciated be (cop)
study reported (acl)
output an (det)
effects suspected (amod)
t-test unpaired (amod)
antithrombin of (case)
had initiated (advcl)
remains cause (nsubj)
paco2 at (case)
some animals (nmod)
alf is (cop)
influences beta-adrenoceptor (compound)
obtained damages (nmod)
medications cardiovascular (amod)
monotherapy with (case)
100mg/kg ) (punct)
considered could (aux)
also though (advmod)
elected authors (nsubj)
effect sulfate (nmod)
role syndrome (nmod)
changes evident (amod)
model f344 (compound)
gene htr6 (appos)
proven to (mark)
micrograms/ml 100 (compound)
effect nor (cc)
days postnatal (amod)
potential model (nmod)
apposed were (auxpass)
disease bowel (compound)
appear change (nmod)
december 2000 (nummod)
abrasion corneal (compound)
pregnancy in (case)
depends and (cc)
scopolamine diazepam (conj)
brought he (nsubjpass)
toxic as (advmod)
phenylethylbarbiturate of (case)
increased linearly (advmod)
provided ketamine (nsubj)
dce by (case)
seen combined (advcl)
increases activities (nmod)
optimising . (punct)
cortex adult (amod)
anthracyclines the (det)
% 65 (nummod)
former long-acting (amod)
above just (advmod)
db 10 (nummod)
similar dose (nsubj)
changes ocular (amod)
-/- ) (punct)
tolerability group (nmod)
contraindication no (det)
15mg/kg ( (punct)
skills and (cc)
action neurotoxicity (nmod)
disoprivan than (case)
had score (dep)
gyrus dentate (amod)
significant subgroups (nmod)
stones containing (acl)
role levodopa (nmod)
occurred eight (nmod)
anticoagulants heparin (appos)
increased flow (nsubj)
estimated 170 (ccomp)
rise iop (compound)
emerged which (nmod)
micrograms.kg-1.min-1 1000 (nummod)
progression symptom (compound)
p.o. to (case)
18 0.25 (compound)
increased that (mark)
chi2-test exact (amod)
concerns despite (case)
leukemia tumor (conj)
ascites hydrothorax (conj)
used prophylaxis (nmod)
favour in (case)
statistics danish (amod)
associated depression (nmod)
hepatocytes mice (nmod)
mellitus dm (appos)
ratio 1:1 (nummod)
mg/m2 185 (nummod)
methylprednisolone high-dose (amod)
accuracy identifying (advcl)
designed answer (xcomp)
micrograms/dl between (case)
patients 1/104 (nummod)
symptoms menopausal (amod)
presents when (advmod)
bacteremias the (det)
targeted people (nmod)
copolymer the (det)
rehabilitation patients (nmod)
hcbd ( (punct)
proteins urinary (amod)
tissue striatal (amod)
deterioration increase (conj)
vehicle to (case)
r with (case)
blood was (parataxis)
sensitivity according (case)
identified reports (dobj)
increased others (nsubj)
metabolites their (nmod:poss)
possibility hyperkalemia (nmod)
infusion 5-fu (nmod)
observations recent (amod)
associated percentage (nsubjpass)
rs6693503 rs1805054 (conj)
taa ( (punct)
increase concentration (nmod)
received alone (advmod)
widow 62-year-old (amod)
saline microl (nummod)
reported change (nsubjpass)
those groups (nmod)
potassium meq/l (nmod)
require : (punct)
mediate responses (dobj)
preparation cortical (amod)
produced injury (nsubjpass)
analysis called (acl)
dioxide carbon (compound)
effect neurotoxicity (nmod)
bea ) (punct)
tribute ( (punct)
dose beta-blocking (amod)
medical psychiatric (conj)
woman in (case)
toxicology with (case)
thrombocytopenia with (case)
characteristics anti-cn (amod)
discontinued if (mark)
responded tachycardia (nmod)
journals relevant (amod)
epithelium upper (amod)
rats isoproterenol-treated (amod)
$ROOT$ excessive (sent)
type specific (amod)
setup an (det)
5.7 to (case)
epilepsies generalized (amod)
nephritis allergic (amod)
50 approximately (advmod)
deaths all (det)
paclitaxel approach (nmod)
morbidity substantial (amod)
patients treating (acl)
factors toxicity (nmod)
given training (nmod)
% 27.6 (nummod)
had . (punct)
defect tubular (amod)
ulcers one (nmod)
rashes skin (compound)
fluvoxamine inhibitor (appos)
had who (nsubj)
rats n=6 (dep)
ifosfamide high-dose (amod)
cycles sinus (compound)
increase expression (nmod)
groups all (predet)
showed expression (dobj)
fluphenazine and (cc)
have while (mark)
positions recumbent (amod)
catalepsy p.o. (nmod)
administrated ; (punct)
outpatients 60 (nummod)
reaction immune-mediated (amod)
height weight (conj)
evaluated analyze (advcl)
influence conditions (nsubj)
vision disease (conj)
presentation to (case)
induced agonists (nmod)
medication fluoxetine (compound)
esrd ( (punct)
2/8 ( (punct)
nm ki=237 (nummod)
drugs ii (nummod)
performance current (amod)
example damage (nmod)
systems neurotransmitter (compound)
complexes factor (conj)
mandates treatment (nsubj)
delta or (cc)
p-aminophenol nephrotoxicant (appos)
decades during (case)
analysis comparing (acl)
given drugs (nmod)
% lidocaine (compound)
respect levels (nmod)
examinable 34 (nsubj)
reflexes inflammation (nmod)
exposure vgb (nmod)
quantitation abundance (nmod)
unnecessary operations (nmod)
altered expression (nsubj)
$ROOT$ retard (sent)
activity sod (compound)
lower rate (dobj)
held bringing (advcl)
suppressed noted (conj)
prevention myoclonus (nmod)
stomach the (det)
complication iop (nsubj)
hg 130/<80 (nummod)
patients eleven (nummod)
combination mtx (nmod)
showed deficits (dobj)
associated decreases (nmod)
indicates that (mark)
$ROOT$ cyclophosphamide (sent)
differences backgrounds (nmod)
motility postprandial (amod)
enhancing clearance (dobj)
mg/kg i.v. (amod)
effects isoproterenol (nmod)
injury immunologic (amod)
choose anaesthesia (dobj)
skf-82958 a-77636 (conj)
present receiving (advcl)
successful reducing (advcl)
indicate do (aux)
year 2 (nummod)
potential prolongation (nmod)
ultrastructural permeability (conj)
proteins dna (compound)
thrombosis deep (amod)
neonates months (nmod)
arise derangement (nmod)
obtundation of (case)
tma responded (acl:relcl)
no between (case)
bruising of (case)
mother both (preconj)
drinking rats (nmod)
therapy bortezomib (nsubj)
cna ( (punct)
populations cell (compound)
therapy manipulative (amod)
undergoes . (punct)
increased yields (nmod)
intranasal , (punct)
consequence therapy (nmod)
administration cm (compound)
0.001 vs (cc)
rates cure (compound)
observed stage (nmod)
developed polyuria (dobj)
psychostimulant is (cop)
paclitaxel : (punct)
patient function (nmod)
statistics cocs (nmod)
= force (nmod)
mechanism is (cop)
capsaicin efficacy (dep)
cycle the (det)
intermediate- and (cc)
sr the (det)
prevented rhuepo (nmod)
frataxin protein (appos)
reduces reversal (nsubj)
received relapsed (conj)
doses caffeine (compound)
findings renal (amod)
was cases (nmod)
butyrylthiocholine with (case)
chloride or (cc)
led consequence (advcl)
trials future (amod)
incidence injections (nmod)
dismissed be (auxpass)
appears this (nsubj)
icp ( (punct)
undergone ct (dobj)
injury arterial (amod)
inhibitory facilitatory (conj)
argue differences (nsubj)
tie hypoxia (nmod)
cn participants (conj)
became mmhg (attr)
hyperalgesia static (amod)
conclusions given (dep)
markers stress (compound)
events treatment-related (amod)
resulted episode (nmod)
reached mice (nmod)
diagnosis withdrawal (conj)
presenting overdose (nmod)
identified syndrome (nsubjpass)
level acids (nmod)
treatment inhaler (nmod)
comorbidities by (case)
mg/m(2 and (cc)
choline-supplemented plain (amod)
ratio ) (punct)
proved premedication (nmod)
agents certain (amod)
gastrocnemius left (amod)
administered fluoxetine (nsubjpass)
tapered weeks (nmod)
potassium a (det)
months 11 (nummod)
relieve result (conj)
enhanced prolonged (conj)
mutants complex (amod)
dermatitis utility (conj)
own her (nmod:poss)
changes immunostaining (nmod)
mg/dl range (dep)
required are (auxpass)
myopathy muscles (nmod)
applied treatments (nmod)
experiences hallucinatory (amod)
infusion 3-hour (compound)
had medications (nmod)
blockade dose-related (amod)
% saturations (nsubj)
women receiving (acl)
rates dose (conj)
reverses , (punct)
evident adulthood (nmod)
fluctuations motor (compound)
it mk-801 (appos)
polymerase parp (appos)
food hot (amod)
need safety (nmod)
hypotension hypotension (conj)
studies ophthalmologic (amod)
that chenodeoxycholate (nmod)
complications these (det)
dat(-/- ) (punct)
confirmed further (advmod)
interpretation unequivocal (amod)
amiloride of (case)
hypotension and (cc)
finding an (det)
blockade-induced androgen (nmod:npmod)
loss average (amod)
count antigen (conj)
history angioedema (nmod)
provided conditions (dobj)
abnormalities of (case)
addition infusion (nmod)
seen levodopa (nmod)
apparent effects (nsubj)
recorded concomitantly (advmod)
administered minutes (nmod)
immunoassay by (case)
rats lister (compound)
pain the (det)
consisted withdrawal (nmod)
cta following (case)
reabsorption on (case)
pattern heart (nmod)
followed carefully (advmod)
functions anti-oxidant (amod)
3.58 - (punct)
abolishment its (nmod:poss)
efficacious but (cc)
limited be (auxpass)
gamma ( (punct)
carcinoma one (nummod)
disarrangement with (case)
influences to (case)
haemorrhage man (nmod)
morbidity syndrome (nmod)
30 approximately (advmod)
appeared responded (dep)
hypothesis increases (ccomp)
fall pressure (nmod)
tiredness week (nmod)
= interval (nsubj)
referred p11 (nmod)
degeneration fragmentation (conj)
usually had (conj)
rose thereafter (advmod)
is dimorphism (nsubj)
hemodynamics exercise (compound)
included sampling (dobj)
nerve optic (amod)
administration haloperidol (nmod)
seen on-state (nmod)
pneumoniae s. (compound)
placebo over (case)
counteract may (aux)
high- or (cc)
mg/kg orally (advmod)
centers 362 (nummod)
obtained isoproterenol (nmod)
respiration state (compound)
reported elevations (nsubjpass)
acid- kainic (amod)
escalated observed (advcl)
l-1 mequiv (compound)
dexmedetomidine protection (conj)
induced have (aux)
flow rcbf (appos)
circling sniffing (conj)
registry the (det)
aware are (cop)
stimulation lymphocyte (compound)
suppression with (case)
slowing marked (amod)
11 to (case)
necessary if (mark)
insufficiency melphalan (nmod)
$ROOT$ think (sent)
abrogated and (cc)
showed implantation (nmod)
neurons cystitis (nmod)
eyes for (case)
density sodium (compound)
hybrid f1 (compound)
occurs often (advmod)
hysterectomy for (case)
childhood early (amod)
aap ami (dep)
alleviated , (punct)
cck-5 8 (nummod)
revealed data (nsubj)
intake , (punct)
rate metabolism (conj)
signalling in (case)
conducted practice (nmod)
mrna receptor (compound)
distance traveled (acl)
evaluated that (mark)
propranolol ppa (nmod)
asymptomatic which (nsubj)
of was (cop)
prolonged however (advmod)
higher increased (advcl)
printout a (det)
site other (amod)
epilepsy serial (amod)
extension to (case)
8.4 +/- (cc)
workers all (det)
protein c-reactive (amod)
medications conditions (conj)
effects sleep (nmod)
f group (compound)
calculated and (cc)
appears clonidine (nsubj)
years 2.5 (compound)
receiving than (mark)
period 3 (nummod)
determination their (nmod:poss)
nitrate of (case)
influence vasopressin (nmod)
biological and (cc)
acts : (punct)
provoke expression (conj)
problem objectives (nsubj)
doses cause (acl:relcl)
administered aminonucleoside (nsubjpass)
mania adolescents (nmod)
showed clearly (advmod)
male 10-year-old (amod)
prevented conclusion (nmod)
tolerated few (nsubjpass)
group triazolo (amod)
1990 and (cc)
less brain (conj)
4-damp ) (punct)
ob ( (punct)
databases medline (compound)
lymphoma dystrophy (conj)
iugr ) (punct)
observed protection (nsubjpass)
noted noted (conj)
diminish did (aux)
higher classified (conj)
assay function (nmod)
absence , (punct)
seen basis (nmod)
demonstrates taken (advcl)
occurred reductions (nsubj)
clonidine naphazoline (conj)
associated trend (nmod)
associated fibrosis (nmod)
aware was (cop)
-16.2 ) (punct)
support . (punct)
took which (dobj)
preceded convulsions (nsubj)
function pathways (nmod)
cases chf (nmod)
indicate interactions (dobj)
27.37 2.19 (conj)
represented frequencies (nsubjpass)
studies 1,3-butadiene (nmod)
tiapride with (case)
denervated hearts (nsubjpass)
focus in (case)
multiple , (punct)
ifosfamide ifs (appos)
trihexyphenidyl placebo (conj)
increased fourfold (conj)
using examination (dobj)
reduction department (nmod)
members best-known (amod)
response cardiac (amod)
rammer mccarthy (appos)
reduced particular (nmod)
postulated data (advcl)
presented analysis (nsubjpass)
stratified rats (nsubjpass)
background produces (appos)
design combined (acl)
blockade system (nmod)
$ROOT$ fatigue (sent)
reversal paralysis (nmod)
toxicity excessive (amod)
changes response (nmod)
antipsychotics quetiapine (nmod)
crataegus tcr (appos)
developing recurrences (dobj)
understood reporting (advcl)
once ) (punct)
cardioprotection this (det)
expression this (det)
ovx ( (punct)
treat nsclc (dobj)
decreased whereas (dep)
paws with (case)
value lowered (amod)
became patient (nsubj)
opioid fentanyl (dep)
had died (conj)
measured estimated (conj)
mainstay immunosuppression (nmod)
relationship an (det)
1.5 3 (conj)
myoclonus extremities (nmod)
distributed receptors (nsubjpass)
history increase (conj)
described others (nmod)
2.31 1.37 (compound)
= 2.42 (dobj)
scored average (nmod)
reviews annual (amod)
3-methyladenine , (punct)
schedule on (case)
recorded we (nsubj)
three least (nmod:npmod)
mmc 3-weekly (amod)
trials randomized (amod)
levels mexiletine (compound)
% 0.02 (nummod)
relationships from (case)
lesions traumatic (amod)
two or (cc)
thrombo-embolism women (nmod)
satisfy that (nsubj)
immunoassay enzyme (compound)
similarity groups (nmod)
concern complications (nmod)
chloride ( (punct)
10 1 (nummod)
antigens hla (compound)
patients time (nmod)
dose one (nummod)
fragmentation of (case)
treated improved (conj)
mg/kg 1.25 (compound)
suggests experience (nsubj)
benefits the (det)
hybrid an (det)
evaluated percentage (nsubjpass)
decrease rcr (nmod)
terfenadine terodiline (conj)
antagonist of (case)
treatments many (amod)
indicates plays (ccomp)
reports mania (nmod)
falling mv (nmod)
reports linking (acl)
resolution clinical (amod)
pelvis bladder (conj)
nvp ( (punct)
product micrograms (compound)
early . (punct)
instilled directly (advmod)
using epilepticus (nmod)
ensure not (neg)
antibiotics nephrotoxic (amod)
182 +/- (cc)
children fifty (nummod)
sarcolemma the (det)
show terms (nmod)
permeability . (punct)
shrinkage cell (compound)
induced tetracycline (nmod)
evoke not (neg)
confirmed be (auxpass)
pge(2 urine (compound)
processed . (punct)
due mainly (advmod)
option conclusions (nsubj)
mortality infarction (conj)
anemia and (cc)
syndrome flushing (nmod)
safety compliance (conj)
concerning pathophysiology (dobj)
consistent , (punct)
contribute additionally (advmod)
valsartan (hctz)-monotherapy (conj)
bupivacaine subtoxic (amod)
activation nrf2 (nmod)
association in (case)
patients assessable (amod)
received minutes (nmod)
years 4 (nummod)
antibiotic offers (acl:relcl)
reported had (conj)
recessive epistatic (dep)
n=101 ( (punct)
ko wt (conj)
superior min (nmod)
sweating . (punct)
users recent (amod)
offers considered (conj)
breath , (punct)
acting secretion (nmod)
investigate is (ccomp)
prescribe caution (nmod)
neurotransmission glutamatergic (amod)
fever polyarthralgia (conj)
deposits membrane (compound)
described develop (dep)
support studies (nsubj)
supplement used (amod)
demonstrated induced (ccomp)
14 of (advmod)
episodes 10 (nummod)
inhibitor the (det)
unclear was (cop)
$ROOT$ thrombocytopenia (sent)
bupivacaine racemic (amod)
have production (nmod)
score necrosis (compound)
vip 's (case)
patients 89 (nummod)
efficacy preference (conj)
individuals mm (compound)
mg/m2 by (case)
infused bupivacaine (nsubjpass)
patients september (nmod)
discontinuation patients (nmod)
clearance clt (appos)
mg needle (nmod)
% 83 (nummod)
loss % (nmod)
4.4 ci (nsubj)
equilibrate progestins (nsubj)
cd-832 not (cc)
gamma-carboxylated not (neg)
using cultures (dobj)
antidotes administered (amod)
chamber test (nmod)
impairments on (case)
% years (dep)
$ROOT$ provides (sent)
scans on (case)
weight level (dep)
moran 1996 (appos)
dyskinesia mice (nmod)
reduction membrane (nmod)
decreases intake (nmod)
received furosemide (dobj)
users warfarin (compound)
$ROOT$ 97.1 (sent)
taking men (nsubj)
present compared (prep)
deviations effect (nmod)
volume fev1 (appos)
questionnaire inventory (conj)
performed patients (dep)
controls compared (case)
% superior (advcl)
remained confined (advcl)
challenge repeat (amod)
acid deoxycholic (amod)
suppressants , (punct)
recurrence vt (nmod)
compared animals (nmod)
design trial (appos)
mrna angiotensinogen (compound)
implicated one (nmod)
counts the (det)
% 13.5 (nummod)
death stress (nmod)
culture animal (conj)
cc more (amod)
reduce transmission (nsubj)
act peptides (nsubj)
median weeks (nmod)
traumatic or (cc)
differ respects (nmod)
infusion ritodrin-hcl (compound)
donor , (punct)
population defined (amod)
occurred rhabdomyolysis (nsubj)
sham not (neg)
contractions muscle (compound)
event both (dep)
reversed administered (advcl)
wave of (case)
day 14 (nmod)
rates complication (nmod)
mask laryngeal (amod)
problem ototoxicity (nsubj)
that gsh (nmod)
profile antipsychotic-like (amod)
syndrome 12.1/0/0 (appos)
treated h. (nmod)
responsible treatment (nsubj)
glomerulosclerosis associated (acl)
mg : (punct)
given dose (dobj)
safe . (punct)
level given (amod)
dogs arrhythmia (compound)
toxicity neurons (nmod)
activity typical (amod)
citrate cc (appos)
dosing h1- (nmod)
failure right (amod)
alf of (case)
events require (conj)
infusion [3h]-l-arginine (nmod)
leaving area (dobj)
examined patterns (conj)
check reality (compound)
0.15+/-0.03/h vs. (cc)
examine rates (dobj)
before during (dep)
found clonazepam (nsubjpass)
displayed space (dobj)
l. , (punct)
shown cancers (nmod)
titer response (conj)
yield conclusion (nmod)
repeated prescription (nsubjpass)
relieved pa (nmod)
component sensory (amod)
m0 = (parataxis)
converted he (nsubj)
malondialdehyde cardiac (amod)
exacerbations in (case)
earliest cells (nsubj)
activities dismutase (nmod)
fracture or (cc)
changes marrow (compound)
methotrexate notably (advmod)
levels not (cc)
unit research (compound)
associated concordance (nmod)
expression components (conj)
inputs transmitted (acl)
induction times (conj)
noradrenaline of (case)
dementia acid-induced (amod)
apply neuroleptics (nmod)
oxide oxygen (nmod)
time expiratory (amod)
concentration drug (compound)
developed diabetes (dobj)
success treating (acl)
include rigidity (dobj)
decreased which (nsubj)
90/htn and (cc)
potentials flash (compound)
delayed as (cc)
responses isoproterenol (nmod)
treated tacrolimus (nmod)
exposure or (cc)
find , (punct)
compare presence (dobj)
treat thrombosis (dobj)
outcomes and (cc)
staining prl (compound)
switches mood (compound)
core ) (punct)
g/ml ) (punct)
syndrome dystonia-like (amod)
associated disruption (nmod)
induced gds (nmod)
woman multiparous (amod)
inhibitors-induced mtor (nmod:npmod)
hematomyelia secondary (amod)
scopolamine drug (compound)
form human (amod)
low concentrations (nsubj)
factor preexisting (amod)
measures ten (nummod)
mouth dry (amod)
enlargement liver (compound)
caused infusion (nsubj)
investigate occurs (ccomp)
showed characteristics (dobj)
time onset (compound)
different group (nmod)
mirtazapine , (punct)
presented scores (nmod)
reshaping of (case)
placed was (auxpass)
able increase (xcomp)
enhanced ovx (nsubj)
exerts . (punct)
revealed consciousness (dobj)
shown intensity (nsubjpass)
gliomas system (nmod)
groups mexiletine (compound)
real and (cc)
obtained subject (nmod)
nefiracetam and (cc)
mice +/- (amod)
reported patients (nsubj)
given supplementation (nmod)
magnitude association (nmod)
sedation , (punct)
flushing palpitations (conj)
diabetes 2 (nummod)
nifedipine diltiazem (conj)
elicits whether (mark)
objectives affects (appos)
propagate transmurally (advmod)
recruited and (cc)
meq/l 8.7 (nummod)
levels less (amod)
significant progressive (conj)
to 152+/-15 (cc)
pituitary exposed (amod)
expression cell (compound)
objective examine (acl)
period and (cc)
short . (punct)
goal the (det)
reduce % (nmod)
triamcinolone bupivacaine (conj)
worn which (nsubjpass)
resulted dose (nsubj)
exacerbated , (punct)
contributes development (nmod)
missing components (nsubj)
dyskinesia td (appos)
patients allocated (acl)
omitted that (mark)
significant concentration-dependent (conj)
cbd 158.11 (dep)
transfusion red (amod)
ci 1.09 (nummod)
documented vasculitis (nsubjpass)
non-drug ( (punct)
platelet and/or (cc)
diseases to (case)
nodosum patients (nmod)
diagnose find (conj)
necessary administration (nsubj)
evidences suggesting (acl)
design constructed (dep)
days plus (cc)
hypotension (ntg)-induced (punct)
appeared adjust (xcomp)
effect receptors (nmod)
met three (nsubj)
pretreatment vpu (nmod)
sampling serial (amod)
increase sharp (amod)
684 93 (prep)
had inducing (advcl)
equal . (punct)
results despite (case)
anhydrase of (case)
haemodilution groups (nmod)
ingestion of (case)
muscle patients (nmod)
virus respiratory (amod)
= 0.049 (dobj)
patients have (acl)
variants arch (compound)
required infusion (dobj)
vegfr-2 flk-1/kdr (appos)
part densa (dep)
related consumption (nmod)
administration additional (amod)
levels marker (nmod)
signs other (amod)
concentrate urine (dobj)
nephrotoxicant known (amod)
benzylpenicillin pg (appos)
think cause (advcl)
seizures mice (nmod)
developed cholecystitis (dobj)
patients 840 (nummod)
mediates nucleus (nsubj)
increase digoxin (nsubj)
qtls ( (punct)
developed increase (nsubj)
unreported . (punct)
leucemia recurrent (amod)
represent tumors (dobj)
features electrocardiographic (amod)
injection intraperitoneal (amod)
sgot and (cc)
attenuating rigidity (dobj)
electroretinography pattern (compound)
rr=1.41 ptrend=0.08 (dep)
frequency of (prep)
incorporation of (case)
dogs anesthetize (amod)
research human (amod)
6/15 vision (nsubj)
levels antioxidants (compound)
$ROOT$ palsy (sent)
decrease mitochondria (nmod)
seizures morphine-induced (amod)
artery ) (punct)
duration catatonia (nmod)
similar , (punct)
contraction ( (punct)
benzylpenicilloyl-poly-l-lysine , (punct)
part surgery (nmod)
cb ) (punct)
produced cross-tolerance (dobj)
communicated if (mark)
changes ( (punct)
prolonged duration (nsubj)
significant this (nsubj)
injected seconds (conj)
receptors main (amod)
use other (amod)
18.3 +/- (cc)
concentrations ) (punct)
anticholinergics central (amod)
correlated score (nsubjpass)
lesions tgf-b (conj)
used database (dobj)
stimulant increases (acl:relcl)
ranged sodium (nsubj)
unchanged however (advmod)
enhancers three (nummod)
continue sulfate (nsubj)
seizures clonic (amod)
interval confidence (compound)
15 0.5 (compound)
reported man (nsubj)
neoantigens hepatic (amod)
report herein (advmod)
reductions monotherapies (nmod)
matched with (mark)
insipidus lithium-treated (amod)
behaviors disruptive (amod)
flow mean (amod)
stopped preventing (xcomp)
preparation carbidopa/levodopa (compound)
1 control (appos)
effects interval (nmod)
seemed rc (nsubj)
1983 in (case)
complications . (punct)
population urban (amod)
muscles joint (nmod)
completed ( (punct)
ganglia lumbosacral (amod)
safety adults (nmod)
reductions magnitude (nmod)
gyrus frontal (amod)
criteria migraine (nmod)
detected change (nsubjpass)
users users (nmod)
study phase (compound)
reproducing captopril (nmod)
rejection acute (dep)
rediscovery pallidotomy (nmod)
mg/kg 93 (nummod)
l-sotalol by (case)
levels vpa (compound)
worsening marked (amod)
plasma matter (conj)
acute with (case)
role compensatory (amod)
attenuated ischemia (dobj)
applied h (nmod)
increasing mm (nmod)
analysis parenchyma (nmod)
flow determined (dep)
quantified scales (nmod)
frequency seizure (compound)
catalepsy model (appos)
deemed related (xcomp)
lilly the (det)
associated this (nsubjpass)
one them (nmod)
countries other (amod)
pyrophosphate tpp (appos)
gd 9 (nummod)
= m (dobj)
mechanism processing (nsubj)
developed experienced (conj)
depression with (case)
aid cessation (nmod)
sonography on (case)
nm 0.4 (nummod)
outflow excessive (amod)
atp ) (punct)
induces . (punct)
homeostasis induced (amod)
administration v.o (amod)
affecting without (mark)
5 4 (compound)
preeclampsia for (case)
died received (conj)
demonstrates potential (dobj)
min 60 (nummod)
potentiated antagonists (nmod)
immunoassays il-1beta (nmod)
prolapse migraines (conj)
comparison anaesthesia (nmod)
isph of (case)
determined not (neg)
related mechanism (nsubj)
effect the (det)
asked state (ccomp)
substrates mrp2 (nmod)
antimicrobials systemic (amod)
1 : (punct)
enhanced uptake (dobj)
depression history (conj)
agent a (det)
yr for (case)
l-3,4-dihydroxyphenylalanine benserazide (conj)
samples microdialysis (compound)
dose day (appos)
available ( (punct)
infarctions drug-related (amod)
immunosuppressed dose (nmod)
persistence effect (nmod)
cause management (conj)
55 35 (compound)
that were (cop)
participate generation (nmod)
celecoxib naproxen (conj)
cohort patient (compound)
than monitoring (nmod)
failed hp (nsubj)
titration with (case)
has capecitabine (nsubj)
depleted sodium (nmod:npmod)
inhibition with (case)
stimulates injury (nmod)
signs severe (amod)
cohort the (det)
d-1 given (acl)
increased k(na (nsubj)
injections thirty-six (nummod)
gtn dfc (dep)
infusion infusion (conj)
metolachlor between (case)
therapy his (nmod:poss)
bpm 25 (nummod)
presented history (nmod)
reduces improves (conj)
inhibitor selective (amod)
induction apoptosis (nmod)
has treatment (nsubj)
promotes conclusions (nsubj)
described course (nsubjpass)
artery coronary (conj)
drug- allergen-related (conj)
decreased starting (advcl)
unlikely was (cop)
device stretch (compound)
anuria with (case)
vehicle or (cc)
therapy antidepressant (amod)
mediated activation (nmod)
had refractory (conj)
kpa 6.7 (nummod)
threshold seizure (compound)
course each (det)
solvd ) (punct)
mortality . (punct)
women zeynep (compound)
alterations all (predet)
admitted h (nmod)
bradycardia dysarthria (conj)
promote could (aux)
inhibitors not (neg)
d treatment (nmod)
examined set (nsubj)
elderly ten (nummod)
presence age (conj)
dosages different (amod)
surgery iop-lowering (amod)
experienced exacerbation (dobj)
agents blocking (compound)
625 750 (conj)
test mice (nmod)
model pd (nmod)
eye 1 (nummod)
d-amb. with (case)
development adenocarcinoma (nmod)
weakness muscle (compound)
ended stillbirth (nmod)
employing presence (nmod)
riha significant (amod)
determine and (cc)
men suffer (conj)
stimulation nerve (compound)
1.041 p (appos)
maintained thereafter (advmod)
alkaloid , (punct)
dopa methyl (compound)
surgery the (det)
decreased hematocrit (nsubj)
proteinuria despite (case)
oxidase xanthine (compound)
autoantibodies positive (amod)
density current (compound)
zones walls (nmod)
models exposures (nmod)
antiepileptics with (case)
hemlock ( (punct)
requirements levodopa (compound)
noted impairment (nsubjpass)
treatment daily (amod)
infectious autoimmune (conj)
impaired greater (conj)
compared measurements (nsubjpass)
rated patients (nsubjpass)
neonate malformation (nmod)
non-e-induced non-a (amod)
recovery 3 (nmod)
dogs most (amod)
igg , (punct)
stroke (is)/transient (punct)
nr1(neo-/- ( (punct)
monotherapies the (det)
degree fibrosis (nmod)
p both (det)
infusion treatment (nmod)
biomarkers serum (compound)
days on (case)
causes amount (nsubj)
ketamine both (cc:preconj)
led investigation (nmod)
fraction left-ventricular (amod)
aims methods (conj)
in also (conj)
occur hypotension (nsubj)
selective consistent (conj)
injury rats (nmod)
bradyarrhythmias delay (conj)
inhibited ethanol (nmod)
elevated position (nmod)
increased markedly (advmod)
frs the (det)
less ng./ml (nmod)
treat hypotension (dobj)
include effect (dobj)
l groups (compound)
treat as (cc)
antibody pr3-anca (appos)
occurred consistent (advmod)
perseveration ) (punct)
favour help (conj)
altering of (mark)
treating courses (nmod)
sensitivity colonies (nmod)
associated if (mark)
administered dose (conj)
similar increase (nsubj)
demonstrated effect (dobj)
wanted test (xcomp)
treated were (aux)
months final (amod)
hepatotoxicity simvastatinezetimibe-induced (amod)
centre that (mark)
cyclosporine prednisone (conj)
ischemic or (cc)
results p (dep)
treatment rhigf-i (compound)
impair , (punct)
% values (nsubj)
increasing reports (nsubj)
determine affect (ccomp)
potentiates . (punct)
linked use (nmod)
action methamphetamine (nmod)
tasks fluency (compound)
group morphine (compound)
antibiotic offending (amod)
similar amphetamine (nmod)
ulceration transplantation (nmod)
associated polymorphisms (nsubjpass)
published , (punct)
cases 13 (conj)
ect after (case)
reduction value (nmod)
g/m2 . (punct)
l-noarg mg/kg (appos)
seem most (nsubj)
administrated i.p. (advmod)
vasodilatation caused (acl)
associated cisplatin (nmod)
pairs patients (nmod)
brain left (amod)
horn lateral (amod)
levels enzyme (compound)
side-effect ssris (nmod)
ineffective preventing (advcl)
membranes on (case)
patients considered (acl)
followed months (nmod)
preceded effect (nsubjpass)
capacity . (punct)
beneficial treatment (nmod)
atpase mg+2 (compound)
had levels (nmod)
known respect (nmod)
period apnea (nmod)
$ROOT$ sampled (sent)
symptoms suggesting (acl)
produces myelodysplasia (dobj)
studied delineate (advcl)
fashion dose-dependent (amod)
responses metabolic (amod)
mediates origin (dobj)
presented glomerulonephritis (dobj)
enos expression (conj)
syringe containing (acl)
mutation a (det)
developed movements (dobj)
responders as (case)
difficulties dialysis (nmod)
estrogens treatment (appos)
reported effect (nmod)
disorder attention-deficit/hyperactivity (compound)
hem ( (punct)
injection scopolamine (nmod)
pointes of (case)
remained animals (nsubj)
oedema bone (compound)
targeting with (case)
mg/m(2 100 (nummod)
cyanamide to (case)
development encephalopathy (nmod)
determined evaluate (xcomp)
determined decrease (nmod)
failure edema (conj)
sd ci (appos)
ezetimibe with (case)
recognized changes (nsubjpass)
renal function (conj)
severe and (cc)
liver from (case)
cases retention (nmod)
followed seizures (nmod)
hippocampus animals (nmod)
kinase patient (nmod:poss)
short- intermediate- (conj)
drug nephrotoxic (amod)
$ROOT$ clear (sent)
considered conclusion (nsubjpass)
ligands to (case)
formed rats (dep)
$ROOT$ constitutes (sent)
avoided best (advmod)
normal reduced (conj)
alpha2-adrenergic and (cc)
investigate reproducibility (dobj)
rocuronium mg/kg (compound)
treatment timolol (compound)
hypotension postural (amod)
caused differences (nsubjpass)
tissues , (punct)
halos or (cc)
memory , (punct)
mapped using (xcomp)
nausea their (nmod:poss)
acknowledged suspected (conj)
had 42.5 (parataxis)
used product (dobj)
tcr with (case)
method counterbalanced (amod)
exist tolerability (nmod)
nephrotoxicity . (punct)
aroused . (punct)
ginseng of (case)
m 0.5 (compound)
synthesis derivatives (nmod)
dogs four (nummod)
group-1 n=10 (dep)
p trend (nmod)
cells meshwork (compound)
scales reflecting (acl)
volunteers 8245 (nummod)
causing change (dobj)
demonstrated ( (punct)
nsaids ( (punct)
were infusion (nmod)
subjected , (punct)
oxide relaxing (amod)
differs methylation (nmod)
depression output (nmod)
properties physicochemical (amod)
likely were (cop)
developing failure (dobj)
fulminant late (amod)
therapy during (case)
hippocampus not (neg)
time exposure (compound)
used prepare (xcomp)
increased cisplatin (nmod)
micrograms/dl of (case)
tasks passive (amod)
thalidomide daily (amod)
greatest is (cop)
cxad in (case)
implant patients (nmod)
3.0+/-0.4 cocaine (nmod)
type neither (cc:preconj)
explained comorbidities (nmod)
paraplegia report (dep)
given intubation (nmod)
foci preneoplastic (amod)
addition bid (nmod)
malfunctioning pump (nmod)
pattern fragmentation (nmod)
produces it (nsubj)
lidocaine and (cc)
rating of (case)
regulation arousal (compound)
specific relatively (advmod)
33.42 +/- (cc)
reviewed terminology (nsubjpass)
knowledge without (case)
$ROOT$ argue (sent)
requires control (dobj)
women groups (conj)
dehydration hypernatraemic (amod)
provocation with (nmod)
ranged microg% (nmod)
appear naloxone (nsubj)
mutations prothrombotic (amod)
serve indicator (nmod)
use during (case)
skeptical reliability (nmod)
history documented (amod)
rhabdomyolysis with (case)
comparable groups (nmod)
seen exposures (nmod)
fibres mossy (compound)
agents immunosuppressive (amod)
considers . (punct)
external , (punct)
ropivacaine ) (punct)
inhibition macrophage-migration (compound)
lacking support (xcomp)
block interscalene (amod)
attenuated naloxazone (nsubj)
myelosuppression was (cop)
infant in (case)
increased ngf (nsubjpass)
inpatients . (punct)
stage that (mark)
days or (cc)
drugs then (advmod)
perfusion prior (case)
occurring with (mark)
showed proteinuria (nmod)
3.1+/-1.0 ) (punct)
using analysis (dobj)
twitching palpebral (amod)
performance after (case)
cystitis (cyp)-induced (punct)
measure(s ): (punct)
vehicle ( (punct)
amphetamines from (case)
role inhibition (nmod)
mesothelioma , (punct)
11.33 +/- (cc)
2.1 0.1 (conj)
was object (nsubj)
include dehydration (dobj)
8 4 (nummod)
similar resolved (conj)
acetaminophen p-aminophenol (conj)
pretreatment prior (advmod)
formation heinz (compound)
functions function (nmod)
therapy tuberculosis (nmod)
levels cell (compound)
design randomised (amod)
11 or (cc)
criteria discontinuing (advcl)
product = (dep)
disorder olfactory (amod)
$ROOT$ enhance (sent)
view tendency (nmod)
interaction specific (amod)
ns of (case)
recorded well-tolerated (advmod)
ptra ( (punct)
nicardipine and (cc)
pretreatment the (det)
showed efficiency (dobj)
effects effects (nmod)
leg the (det)
hepatectomy after (case)
injury head (compound)
activity regular (amod)
mapped . (punct)
produced ether (nsubj)
indicating lesion (ccomp)
inhibitor garft (compound)
atorva + (cc)
randomized , (punct)
suggest facilitates (ccomp)
analogues and (cc)
specified , (punct)
sotalol to (case)
opioid common (amod)
studies dynamics (conj)
safety cta (nmod)
switchers to (case)
tests several (amod)
reduced scores (conj)
unchanged although (mark)
aminotransferase albumin (conj)
agreement the (det)
those evaluated (acl)
surgery intracranial (amod)
transferred chromosome (nsubjpass)
variables type (conj)
and name (nmod)
lid ) (punct)
acid dose (compound)
% 44.1 (nummod)
degeneration transformation (conj)
avoidance , (punct)
evaluated physician (nmod)
amenorrhea of (case)
link to (mark)
response h (amod)
hypotension resulting (acl)
administration cytarabine (nmod)
5,7-dcka injected (acl)
patients cc (nmod)
hydrochlorothiazide administered (acl)
1.85 - (punct)
0.6 0.3 (conj)
mhb ( (punct)
similar incidences (nsubj)
sedation increased (acl:relcl)
tendency weak (amod)
rats experienced (acl:relcl)
follow-up periodic (amod)
reverse rats (nmod)
= .03 (dep)
lids on (case)
cortex cg (appos)
function specific (amod)
areas primary (amod)
hypothesis decreases (ccomp)
n=2.8+/-1.09 ( (punct)
topiramate of (case)
mg 8 (compound)
recognized that (mark)
reabsorption water (compound)
matter white (amod)
arousal in (case)
suggesting and (cc)
cyp2d6 of (case)
decreased distracted (advcl)
opening due (case)
inhibitors channel (compound)
complications corneal (amod)
decreased tests (nmod)
14 epinephrine (nmod)
fentanyl ug.kg-1 (appos)
returned , (punct)
patients thirty (nummod)
hypothesized mirror (ccomp)
emit conditions (nmod)
reaction unusual (amod)
% 35.7 (nummod)
alter and (cc)
changes afferents (nmod)
ci=5.194 36.706 (dep)
normalized levels (nsubjpass)
result delay (nsubj)
nitroglycerin or (cc)
increased sodium (nsubj)
class 1 (nummod)
summary developed (appos)
minimized effects (nsubjpass)
reported questioned (advcl)
studies of (case)
incidence symptoms (nmod)
48 +/- (cc)
activity synthesis (nmod)
period 9-year (compound)
dysfunction diastolic (amod)
dipropionate beclomethasone (compound)
$ROOT$ invaluable (sent)
measurements results (conj)
neurons bladder (compound)
remained seizure-free (dep)
play accelerating (advcl)
agitation . (punct)
nos-ir l6 (dep)
receiving patient (nsubj)
mediated 2 (dep)
phosphate ) (punct)
lomustine ) (punct)
implications processes (nmod)
induced dobutamine (nmod)
analyses image (compound)
hippocampal in (case)
persistence bradycardia (nmod)
ua ) (punct)
tested observation (nsubjpass)
diary a (det)
access h (amod)
membranes brain (compound)
seems form (nsubj)
methoxyflurane with (case)
embryolethality retardation (conj)
patients 28 (nummod)
recovery an (det)
undergoing without (mark)
w/v ( (punct)
microg.kg(-1 3 (nummod)
measuring concentration (dobj)
treated ineffectiveness (nmod)
testing in (case)
mg/kg 5 (nummod)
informative . (punct)
chloroprocaine for (case)
permitting measurement (dobj)
analgesic antiinflammatory (conj)
produce scenario (advcl)
produced attenuation (dobj)
amounts furosemide (nmod)
included groups (nsubj)
bp group (nmod)
mph 1 (nummod)
sufficient not (neg)
enhance thrombosis (dobj)
setting the (det)
thickening including (case)
pregnane-21-diol-20-ones ) (punct)
occurred rapidly (advmod)
believe warrants (ccomp)
men received (acl:relcl)
ect first (amod)
area hypoaesthesia (nmod)
infusion combined (conj)
digoxin of (case)
mutants patients (nmod)
group animals (nmod)
report literature (nmod)
presence to (case)
intense difference (nmod)
reported use (dobj)
developed months (nmod)
uptake for (case)
syndrome ibs (appos)
survey . (punct)
out-patients ) (punct)
increased sfas (nsubjpass)
unit a (det)
size tissue (nmod)
effect occurred (conj)
course over (case)
$ROOT$ absence (sent)
affected prevented (conj)
5.0 or (cc)
pose , (punct)
result infarction (nsubj)
group included (acl:relcl)
different dramatically (advmod)
role causative (amod)
those without (amod)
bcc ) (punct)
filaments , (punct)
infusion dextran (nmod)
meq. 2 (nummod)
occurring downstream (advmod)
22-oxacalcitriol oct (appos)
information exposure (compound)
examination vigilance (conj)
december 2004 (nummod)
lidocaine- and (cc)
loci quantitative (amod)
developed treated (advcl)
magnitude p<0.01 (appos)
effectively very (advmod)
concentrations urinary (amod)
reduction through (case)
arterial venous (conj)
function neuroendocrine (amod)
42,671 celecoxib (nmod)
cholestasis minimal (amod)
sensitive being (cop)
comparable not (neg)
models dyskinesia (nmod)
elf , (punct)
february december (conj)
levels protein (compound)
oil only (advmod)
injection cisplatin (nmod)
patients tuberculosis (compound)
retention edema (conj)
evaluated incidence (nmod)
performed test (advcl)
years 70 (nummod)
ischemia min (appos)
lesions following (case)
mandatory . (punct)
cause ibpb (nsubj)
ratios with (case)
34.3 +/- (cc)
cpu ( (punct)
interview in (case)
tricyclics potency (nmod)
malignancies conditions (conj)
$ROOT$ achieves (sent)
cells proliferating (amod)
similar methylphenidate (nsubj)
1.68 ratio (nsubj)
hypertrophy glomerular (amod)
administered animals (nmod)
sensitisation ' (punct)
procedures during (case)
analysis multivariate (amod)
therapy levofloxacin (compound)
reduce acid (nsubj)
phase i/ii (nummod)
mg/m2 160 (nummod)
subjects 114 (nummod)
males 6 (nummod)
levels creatinine (compound)
normalized pressure (nsubj)
cards daily (amod)
histology micronodular (amod)
worsened administration (nmod)
proteinuria ngal (conj)
81 - (punct)
2.8 2.2 (dep)
7alpha-hydroxylation of (case)
values index (compound)
values emg (compound)
burning of (case)
subtherapeutic and (cc)
ectoderm from (case)
15 7.5 (compound)
maintained injection (nmod)
cards subject (compound)
used agriculture (nmod)
fatal even (advmod)
augments but (cc)
echocardiography the (det)
hs ( (punct)
contribution volume (nmod)
barium ) (punct)
cholestatic ) (punct)
stresses . (punct)
bypass from (case)
feasibility and (cc)
assessing in (mark)
facilitation in (case)
ability through (case)
post washing (compound)
electrocardiogram epicardial (amod)
doses weekly (amod)
syndrome wpw (compound)
discontinuation azithromycin (nmod)
% 69.8 (nummod)
function hippocampal (amod)
pcr real-time (amod)
increased co-administration (nsubj)
buildup of (case)
concentrations despite (case)
hyperalgesia diabetic (amod)
chronotropic hr (dep)
effect anemia (dobj)
inhibited oih (dobj)
baseline periods (conj)
remained observed (advcl)
migraine with (case)
from december (nmod)
patient arthritis (nmod)
remission medications (nmod)
learning subjects (nmod)
action parallels (acl:relcl)
identify . (punct)
wk 12 (nummod)
patients dexmedetomidine (dep)
enhancement nmda (compound)
context factors (nmod)
. ala539thr (dep)
inhibition dose-dependent (amod)
association level (nmod)
overdose disulfiram (compound)
overdose amisulpride (compound)
conceivable seem (advcl)
resolved but (cc)
n=8 ( (punct)
report localize (advcl)
problems abuse (conj)
hyaluronate of (case)
regarded public (nmod)
arrest apparent (amod)
ability strong (amod)
8 1 (compound)
detected can (aux)
procedure devised (acl:relcl)
half-life monoher (nmod)
monitoring : (punct)
relative first-degree (amod)
resulted proteinuria (nmod)
prevention cytotoxicity (nmod)
impairment behavioral (amod)
excel ( (punct)
introduction mg/day (nmod)
tolerated subgroups (nsubj)
retested rats (nsubjpass)
stopped revealed (advcl)
suppression complete (amod)
obtaining history (dobj)
ng/ml , (punct)
specimens renal (amod)
prostatitis only (advmod)
ipratropium with (case)
consisted encephalopathy (nmod)
casts such (case)
resulted , (punct)
resolve because (mark)
importance is (cop)
mosmol/kg and (cc)
prescribing therapy (dobj)
imaging monitoring (conj)
populations appropriate (amod)
$ROOT$ modulate (sent)
side-effects sedation (appos)
testing cognitive (amod)
seen % (nmod)
lines therapy (nmod)
peroxidation associated (acl)
likelihood high (amod)
days age (nmod)
products presence (dep)
administration pb (compound)
result that (nsubj)
2.6 survivals (nsubj)
delivery term (nmod)
stz-icv ) (punct)
3'-azido-2',3'-deoxythymidine azt (appos)
-chlorpheniramine placebo (conj)
30 was (cop)
contributes activation (nsubj)
effects hepatotoxic (amod)
fell course (nmod)
2-subunits sodium (compound)
patient consumed (acl:relcl)
er the (det)
boluses either (cc:preconj)
mesna without (case)
dup losartan (appos)
assessment prevention (nmod)
hypotension extreme (amod)
related being (cop)
group saline-treated (amod)
iu/kg/h ) (punct)
cardiac and (cc)
increased dosage (nsubj)
initiation induced (acl)
ozone with (case)
cingulate and (cc)
worsening improvement (conj)
react to (mark)
n-acetyl-beta-d-glucosaminidase urinary (amod)
disrupting pathway (dobj)
effects anti-amnesic (amod)
value 0 (nmod)
attenuates that (mark)
component contraction (nmod)
paclitaxel chemotherapy (conj)
elevated cortex (nmod)
pr % (appos)
increased 0.17 (nmod)
evaluate costs (dobj)
duration localization (conj)
egfp-microglia with (case)
describe we (nsubj)
investigated effects (dobj)
ongoing . (punct)
four times (quantmod)
conclude associated (ccomp)
mg/m2 to (case)
adjusted treatment (nsubjpass)
form cs (nmod)
telithromycin of (case)
protein mrna (conj)
recurrent to (mark)
number regimens (nmod)
9.6-fold ci (dep)
service in (case)
lack safety (nmod)
developed reproducibly (advmod)
22 of (advmod)
presence calculi (nmod)
assessment presence (nmod)
exposure use (appos)
exceed dose (nsubj)
cases appear (acl:relcl)
dose patient (nmod)
resemble those (dobj)
lithium valproate (conj)
provoke abnormalities (dobj)
tablets weeks (nmod)
preponderance male (amod)
attributable were (cop)
5000 over (quantmod)
$ROOT$ deduced (sent)
biperiden , (punct)
extrusion na+ (nmod)
role receptor (nmod)
palsy and (cc)
day 57 (nummod)
consumed weeks (nmod)
face failure (nmod)
variability blood (compound)
1.6 . (punct)
p=0.008 ( (punct)
recommend risk (nmod)
mm 11 (nummod)
recover frame (nmod)
suggest effective (ccomp)
presence findings (conj)
ica ) (punct)
1.70 2.08 (prep)
headache oxide-induced (amod)
tensions , (punct)
p .001 (nummod)
intact both (cc:preconj)
ctnt and (cc)
necrosis fat (compound)
5.7 - (punct)
rats ' (punct)
predicts thrombosis (dobj)
years 4.98 (nummod)
preceded pauses (nsubjpass)
relationship methyldopa (nmod)
-18 and (cc)
women about (acl:relcl)
patients ages (dep)
role management (nmod)
quinidine itself (appos)
have development (nmod)
use bzd/rd (compound)
abusers methadone-maintained (amod)
had cocs (nmod)
play . (punct)
10 50 (conj)
vincristine dexamethasone (conj)
swelling cristae (nmod)
genes of (case)
appeared which (nsubj)
vindesine and (cc)
slower irrespective (advmod)
suspicion infection (nmod)
factor predisposing (acl)
control des-treated (conj)
paclitaxel treatment (nmod)
slowing . (punct)
alpha-fluoro-beta-alanine of (case)
possessed potency (dobj)
saw reduction (dobj)
spasm sotalol-induced (amod)
premedication prophylactic (amod)
13.2 of (case)
received participants (nsubj)
flare a (det)
infarction sumatriptan (nmod)
doxorubicin adriamycin (appos)
g/day)-lovastatin mg (appos)
repeated procedure (nsubjpass)
tested baseline (nmod)
signs defined (acl:relcl)
calculated procedure (nmod)
sequestration neutrophil (compound)
signs , (punct)
effective lamivudine (nsubj)
reduce markedly (advmod)
skin with (case)
injection bepridil (nmod)
distributions permeability (nmod)
in vivo (dep)
activity + (compound)
2.1 women (nmod)
benefit close (amod)
caudate-putamen the (det)
channels of (case)
% 1.2 (nummod)
rifampin with (case)
status . (punct)
causes anemia (nmod)
elucidate . (punct)
microm 0.1 (nummod)
lady disease (nmod)
seems this (nsubj)
plasma by (case)
short-term self-limiting (conj)
performed methods (nsubjpass)
protein droplets (dep)
fibrillation tachycardia (conj)
scores improvement (compound)
dbh ( (punct)
absent areas (nmod)
exercise peak (compound)
acetylsalicylate , (punct)
subcortex and (cc)
produced groups (nmod)
mg lovastatin (nmod)
transitioned anticoagulation (nmod)
proteins bound (acl)
expression caspase-3 (nmod)
calculi renal (amod)
revealed glomerulopathy (dep)
mumol/kg ( (punct)
score iief (compound)
allocated one (nmod)
12 36 (conj)
characteristics : (punct)
influence be (cop)
asenapine mg (nmod)
levels excretion (conj)
assay by (case)
necrosis non-specific (amod)
pathogenesis unknown (amod)
degeneration between (case)
hearts rats (nmod)
performance memory (compound)
using methadone (dobj)
< therapy (nmod)
stopped should (aux)
possibility neuropathy (nmod)
deficits due (amod)
angiography . (punct)
after even (advmod)
sedation confusion (conj)
acrolein , (punct)
salt-depleted and (cc)
excitability reflex (nmod)
months 19.1 (nummod)
based platinum (nmod:npmod)
regarded as (prep)
central embase (conj)
l and (cc)
neuropathy compression (compound)
unable absorb (xcomp)
showed thickening (dobj)
activity mitochondrial (amod)
affected confounding (nsubj)
patient had (acl:relcl)
frequent being (cop)
rats albino (compound)
thymus weights (conj)
was determine (xcomp)
levels prl-r (compound)
mice b6d2f1 (compound)
groups from (case)
lupus manifested (acl:relcl)
hours litres/24 (nummod)
uncomplicated this (nsubj)
nucleus midbrain (nmod)
configuration a (det)
mcl of (case)
developed issues (nmod)
agent this (det)
linked that (nsubjpass)
consisted generally (advmod)
considering evidence (dobj)
didanosine , (punct)
affected were (auxpass)
occlusion ( (punct)
dx ( (punct)
stenosis maximal (amod)
bradykinin d-arg-[hyp3,thi5,d-tic7,oic8 (compound)
imbalance or (cc)
feature neurochemical (amod)
ameliorated administration (nsubj)
rates the (det)
aimed largest (xcomp)
contribution or (cc)
registry university (appos)
beta-agonist ( (punct)
mg/kg weight (nmod)
hours 5-fluorouracil (nummod)
caudate accumbens (conj)
induced metoprolol (nmod)
3.86 or (cc)
blocker type-1 (amod)
enhances which (nsubj)
cornu a (det)
child developed (acl:relcl)
targets cells (nsubj)
icp cvp (conj)
csa 3 (appos)
intolerance due (case)
years between (case)
icrf-187 ) (punct)
dose micrograms (nmod)
abuse thyroxine (compound)
disappeared effusion (nsubj)
most cancers (nmod)
lines or (cc)
differences motility (nmod)
monitor function (dobj)
hallucinations status (conj)
solubility the (det)
298+/-7 280+/-17 (conj)
seizure generalized (amod)
lead associated (advcl)
dose adriamycin (compound)
onset earlier (amod)
occurred renografin (nmod)
shr treated (acl)
appearances histologic (amod)
found test (nmod)
rats untreated (amod)
freezing , (punct)
rose output (nsubj)
reported myopathy (nsubjpass)
muscles thyroarytenoid (compound)
qt or (cc)
relationship cancer (nmod)
85 : (punct)
liability effects (nmod)
occurs adults (nmod)
pretreatment dexamethasone (nmod)
sedation pruritus (conj)
neuropathy antebrachial (amod)
cases more (amod)
limit use (dobj)
suggested therapy (nmod)
admitted measurement (nmod)
knife gamma (compound)
transplantation blood (compound)
55 > (advmod)
aspirin mg (compound)
subjects based (case)
dh md (conj)
dilatation moderate (amod)
age but (cc)
attributable therapy (nmod)
cells sh-sy5y (compound)
treated tuberculosis (nmod)
$ROOT$ additive (sent)
detection . (punct)
developed significantly (advmod)
intervals one (nummod)
prescribed evidence (nmod)
metabolism erk (conj)
studies damage (nmod)
citalopram than (case)
information nociceptive (amod)
$ROOT$ linked (sent)
indicating mitochondria (dobj)
% 2.7 (nummod)
induced min (nmod)
ccr2 increased (amod)
effective acid (nsubj)
calculus staghorn (amod)
serum versus (cc)
propranolol neither (cc:preconj)
treated carcinoma (nmod)
provocation nitroglycerin (nmod)
blockers two (nummod)
reduces number (dobj)
measured related (conj)
treatment combination (nmod)
hours days (nmod)
observations changes (conj)
has nigra (nsubj)
obstruction with (case)
include did (aux)
induction sedation (nmod)
falls minor (amod)
activity , (punct)
action weak (amod)
alert , (punct)
has scleroderma (nsubj)
once week (nmod:npmod)
physiology susceptibility (conj)
graded investigator (nmod)
extraction data (compound)
abundance in (case)
hyperkalemia , (punct)
18.9 16.4 (conj)
spontaneous dexamethasone-induced (conj)
appears intensity (nsubj)
effects les (nmod)
present girl (dobj)
auditory tactile (conj)
support population (nmod)
phenothiazines either (cc:preconj)
scored doses (nmod)
hypertrophy white-matter (amod)
factors confounding (amod)
studied mice (dobj)
model predicting (acl)
placebo other (nmod)
lids and (cc)
administered women (nmod)
diseases ( (punct)
analyzing valdecoxib (dobj)
reduced presence (nsubj)
t days/week (appos)
methods assessing (acl)
persisted degree (nmod)
levels level-dependent (amod)
suggesting control (ccomp)
39.5+/-8.4s was (cop)
plan , (punct)
tested strength (nsubjpass)
seems risk (nsubj)
risk cad (nmod)
disease + (cc)
doses therapeutic (amod)
arrest resuscitation (dep)
exposure 1-hour (amod)
ant-mi ) (punct)
negativity and (cc)
background reflect (dep)
6 than (quantmod)
complaints with (case)
low % (nmod)
adolescents developed (acl:relcl)
treatment osteoporosis (nmod)
available series (nsubj)
presence 17beta-estradiol (nmod)
use injection (dobj)
encephalopathy scenario (dep)
$ROOT$ reversible (sent)
monitored recorded (conj)
alternation intervals (nmod)
metabolism oxycodone (nmod)
classified as (prep)
usefulness patients (nmod)
effects data (nmod)
mucositis and (cc)
cardiomyocytes pluripotent (amod)
effects caa (nmod)
seizures combined (amod)
hypoperfusion hepatic (amod)
% 88.3 (nummod)
term days (dep)
address effects (dobj)
course and (cc)
resolved reducing (advcl)
2.6-fold weeks (nmod)
using rates (dobj)
using withdrawal (dobj)
injury cholestatic (amod)
poses pain (nsubj)
stereotypy and (cc)
experiences of (case)
developed twin (nsubj)
contribute effect (nsubj)
4.40 x (cc)
fr of (case)
evaluate neonates (dobj)
use midazolam (compound)
analysis morphological (amod)
or online (advmod)
recurrence no (det)
84 +/- (cc)
oxidase cytochrome (compound)
hospitals at (case)
$ROOT$ called (sent)
develop switch (nmod)
induced anemia (dobj)
rate 58.3 (nmod)
noted treatment (nmod)
background hbeag-positive (amod)
reduced can (aux)
insufficiency cr (dep)
serve that (mark)
treated mg/kg (nmod)
hyperkinesis disease (nmod)
carbachol due (case)
pah ) (punct)
function nmda (compound)
bradycardia patient (nmod:poss)
salbutamol lds (appos)
elsewhere from (mark)
< or (cc)
jerks mj (appos)
levetiracetam mg/kg (dep)
asa , (punct)
phlebitis and (cc)
tnf-a ) (punct)
consisted although (mark)
reduction reduction (nmod)
< 0.02 (dep)
nifedipine sustained-release (amod)
period for (case)
duration ) (punct)
infused mg/m2 (nsubjpass)
first the (det)
normalization ratio (nmod)
interview psychosis (nmod)
consistent vasoconstriction (nsubj)
subcortex cortex (conj)
deficits intermediate (amod)
review and (cc)
training before (case)
observed nephrotoxicity (nsubjpass)
steroid androgenic (amod)
transformation anencephaly (nmod)
patients manifestations (nmod)
using method (dobj)
treatment l-dopa (compound)
kg-1 micrograms (compound)
modulate neurotoxicity (dobj)
administration an (det)
action antihyperalgesic (amod)
cephalosporin with (case)
cells increased (amod)
common abnormalities (nsubj)
treatment methadone (compound)
mm 0.5 (nummod)
ratio ketone (compound)
defects effects (conj)
judiciously knowledgeably (conj)
correlation be (cop)
pai-1 ) (punct)
use stabilizer/rigidifier (nmod)
receptor n-methyl-d-aspartate (compound)
loss , (punct)
overdose against (case)
three eight (conj)
had making (advcl)
minimal ( (punct)
challenge to (case)
density the (det)
p<0.001 p<0.01 (conj)
sensitization ( (punct)
secretion neurohypophysis (nmod)
administration deferoxamine (nmod)
as well (mwe)
h twenty-three (nummod)
switched carbamazepine (nsubjpass)
changes thresholds (nmod)
peroxidation in (case)
concentration protein (nmod)
flumazenil or (cc)
appears supplement (xcomp)
regimen therapeutic (amod)
excreted pap (nmod)
reached p (dep)
eating with (case)
problematic often (advmod)
transfer results (nmod)
extensive em (appos)
4-diphenylacetoxy-n-methylpiperidine-methiodide ( (punct)
expression medullary (amod)
thrombophlebitis % (dep)
measures effective (amod)
capture . (punct)
severity swelling (nmod)
hearts diet-fed (amod)
mg/m2/d 500 (nummod)
used who (nsubj)
group years (appos)
centre orthopaedic (compound)
surface above (case)
80 to (quantmod)
number episodes (nmod)
injected bupivacaine (nmod)
need . (punct)
signaling d2 (compound)
impairment streptozotocin (compound)
reverse promptly (advmod)
need who (nsubj)
prolongation dizziness (conj)
increase 13-fold (amod)
communicate proteins (nsubj)
thrombosis ica (nmod)
matched gestation (nmod)
5.2 ( (punct)
bacl2 with (case)
leftward upward (conj)
3.86 ( (punct)
fluphenazine dopamine (compound)
hinder that (nsubj)
because especially (advmod)
disease gallbladder (compound)
fq orphanin (compound)
november 1995 (nummod)
company from (case)
woman receiving (acl)
given doxorubicin (dobj)
initiated heparin (nsubjpass)
degeneration cardiomyocyte (compound)
operated loss (nmod)
indicated trials (nmod)
syndrome eps (appos)
pretreatment hg (appos)
tee mz (nmod)
4.7 ( (punct)
binding of (case)
results testing (nmod)
act if (mark)
signal the (det)
hydration after (case)
% 4.5 (nummod)
associated depletions (nmod)
area similar (amod)
headache cluster (compound)
embolism of (case)
failure resulted (acl:relcl)
dysfunction effect (nmod)
recovery normotension (nmod)
received rat (nsubj)
phenomenon syndrome (nsubj)
noted previously (advmod)
dnap both (cc:preconj)
strategies use (nmod)
occurred lasted (ccomp)
result cause (nsubj)
paclitaxel carcinoma (nmod)
observation switch (nmod)
receives innervation (dobj)
reduced lidocaine (nsubj)
had t (nsubj)
enabled attribute (xcomp)
substituted resolved (conj)
proteins structural (amod)
pan/temocapril 13 (appos)
recorded radius (nmod)
cholestasis methimazole-induced (amod)
doses microg/kg/min (nmod)
suppressed induced (conj)
3 7 (prep)
continued patients (nsubj)
vulnerability development (conj)
associated bmd (nmod)
need drug (advcl)
cardiotoxicity cyclophosphamide (compound)
curve serum (compound)
activities rats (nmod)
used immunofluorescence (nsubjpass)
greater gravity (nsubj)
animals ko (amod)
altered organelles (nsubjpass)
assay thrombocytopenia (compound)
unaffected omission (nmod)
patients histories (nmod)
forgetting the (det)
results reversed (appos)
occurred improvement (nsubj)
streptozotocin-induced ( (punct)
occurred down-regulation (nsubj)
assays for (case)
gemcitabine plus (cc)
lymphocyte for (case)
metabolism effects (conj)
witnessed be (auxpass)
rats mg/kg)-treated (amod)
fill that (mark)
epileptogenic are (cop)
pressure rhythm (conj)
cycles two (nummod)
tended lower (xcomp)
release synapses (nmod)
combination similar (amod)
depleted components (dobj)
became headache (nsubj)
swallow barium (compound)
injection calcitonin (compound)
da dopac (compound)
patients astrocytomas (nmod)
trimethoprim with (case)
renal kidney (conj)
characteristic the (det)
pay initiating (advcl)
dimension left (amod)
study efficacy (nmod)
amiodarone after (case)
contribute dehydration (nsubj)
means recording (nmod)
gland salivary (amod)
$ROOT$ tachycardia (sent)
large were (cop)
f344 of (case)
high-salt hs (appos)
susceptibility drugs (nmod)
models learning (nmod)
aim side-effect (appos)
kidney iia (compound)
reactions with (nmod)
reduces addition (nmod)
sign an (det)
s.c. daily (advmod)
unsafe anticoagulation (nsubj)
mediated i (dep)
antagonist n-methyl-d-aspartate (compound)
immunosuppressants , (punct)
induced combination (nsubj)
$ROOT$ rhabdomyolysis (sent)
< .01 (dep)
return in (case)
profiles affinity (compound)
explore linked (ccomp)
patient one (nummod)
approximate , (punct)
dili to (case)
injury the (det)
isomerase specific (amod)
organelles cells (nmod)
dilevalol of (case)
depressed anesthesia (nmod)
larger . (punct)
rhythms of (case)
used potentials (nsubjpass)
content with (case)
seems crucial (xcomp)
aggregations the (det)
myocarditis complicating (acl)
persons some (det)
year within (case)
hepatocarcinogenesis for (case)
amphetamine ) (punct)
d2 serotonin (conj)
monitoring ecg (compound)
function endothelial (amod)
units ) (punct)
use mesna (nmod)
$ROOT$ reverse (sent)
evaluates . (punct)
cultured sera (conj)
2-receptors heart (nmod)
were compared (dep)
level low (amod)
program infection (nmod)
serotonin augmented (acl:relcl)
accumulation reduced (amod)
formation conjugates (nmod)
form arthritis (nmod)
offered been (auxpass)
imidazo[1,5-a]-pyrrolo-[2,1-c][1,4]benzodiazepine-1-carboxylate tert-butyl-(s)-8-bromo-11,12,13,13a-tetrahydro-9-oxo-9h- (compound)
increase without (case)
evaluated severity (dobj)
free to (mark)
week discontinuation (nmod)
revealed expression (dobj)
reduces omitting (csubj)
fenestrae endothelial (amod)
occurred albuminuria (nsubj)
stimulates secretion (dobj)
had contrast (nmod)
dose-intensity the (det)
cardiovascular fewer (amod)
assessed visually (advmod)
recurrence oliguria (nmod)
barrier chick (nmod)
extended-release/lovastatin niacin (compound)
given routes (nmod)
encountered , (punct)
morbidity increased (amod)
alpha2- with (case)
receiving deferoxamine (dobj)
vohland et (compound)
reduction intensity (nmod)
increased reducing (dep)
atrophy predominantly (advmod)
30mg/kg - (punct)
hours challenge (nmod)
observed 5-fu (nmod)
safety evaluation (nmod)
suspected : (punct)
remains unaltered (xcomp)
inactivation ros-mediated (amod)
investigation pattern (nmod)
greater values (nsubj)
modifies level (nmod)
2a by (case)
complex acida (compound)
have desensitization (nmod)
efficient drugs (nmod)
administration prehospital (amod)
dependence methamphetamine (compound)
= 1.70 (dobj)
had ) (punct)
dexmedetomidine following (case)
detected defects (nsubjpass)
exploration sedation (conj)
produced coma (nsubjpass)
investigated influence (nsubjpass)
has analysis (nsubj)
demonstrated indicative (advmod)
stm ) (punct)
dystrophy deformities (conj)
(7.2)% and (cc)
excellent and (cc)
dogs experimental (amod)
did therefore (advmod)
agent to (case)
addition influences (nmod)
prevalence hallucinations (conj)
unmatched % (dep)
recorded complications (nmod)
frequency vte (nmod)
deficient to (mark)
$ROOT$ myeloencephalopathy (sent)
acids the (det)
expression which (nsubj)
challenged later (advmod)
days 686 (nummod)
adjustment additional (amod)
concluded interfere (ccomp)
suffer and (cc)
data defects (nmod)
generated have (aux)
injections isoniazid (nmod)
induced amiodarone (nsubj)
inactivation to (case)
open-labeled multicenter (dep)
inhibitor angiotensin (nmod)
$ROOT$ eliminated (sent)
muscles ventilatory (amod)
124 +/- (cc)
related performance (nsubjpass)
activity decreased (amod)
reported toxicities (nsubjpass)
that enzyme (nmod)
increase filtration (nmod)
ritonavir hiv (compound)
residence to (case)
induced blockade (nsubj)
documented reaction (nsubjpass)
preceded often (advmod)
ecg ( (punct)
block intra-hisian (amod)
absence preexposure (nmod)
mg. infusion (nmod)
demonstrated microscopy (nsubj)
regurgitation . (punct)
course post-transplantation (amod)
rtms pulses (dep)
satisfied % (parataxis)
expression transporters (nmod)
patterns suggest (acl:relcl)
score by (case)
embryopathy of (case)
efficacy doses (nmod)
rupture aneurysmal (amod)
using control (nmod)
mustard is (cop)
$ROOT$ episodes (sent)
become investigation (nsubj)
occurred patient (nmod)
effects spasticity (nmod)
metabolites ncq436 (appos)
mice male (amod)
produced symptoms (dobj)
method observations (appos)
associated reduction (nsubjpass)
acetyltransferase hydroxylase (conj)
shortened , (punct)
intubated , (punct)
investigated role (nsubjpass)
man kidney (nmod)
promotes need (conj)
g/kg 1 (nummod)
conversion recipients (nmod)
time longer (amod)
referral associated (acl)
marketed 1986 (nmod)
selected methods (nsubj)
evaluated hepatitis (nmod)
lead effects (nsubj)
models animal (amod)
engaged synthesis (nmod)
day 10 (compound)
techniques , (punct)
weight suspended (acl)
lymphadenitis severe (amod)
tachycardia excluding (case)
kinase ck-mb (conj)
discusses demographics (dobj)
effects cocaine (nmod)
1990s in (case)
$ROOT$ perfusion-fixed (sent)
ablated seizure-free (conj)
damage pre-existing (amod)
tremor outstretched (amod)
1 8 (conj)
achieved levels (nsubjpass)
analysis kruskal-wallis (compound)
densities adrenoceptor (compound)
measured were (auxpass)
control neurodegeneration (nmod)
weight excretion (nmod)
mechanisms death (nmod)
development lymphoma (nmod)
early reversible (conj)
methods percutaneous (amod)
$ROOT$ concluded (sent)
micrograms/kg s.c. (appos)
induction pce (nmod)
altered ingestion (nsubj)
revascularization in (case)
% 6.21 (nummod)
unresponsive completely (advmod)
slope as (case)
markers serial (amod)
studies associated (amod)
infiltrations eosinophilic (amod)
plexus the (det)
revealed results (nsubj)
hyperactivity users (nmod)
experienced back (conj)
p alone (advmod)
discontinued not (neg)
administration postoperative (amod)
post-cab months (compound)
interference following (case)
inducing expression (dobj)
raised has (aux)
functioning physical (amod)
infectivity with (case)
reversal rapid (amod)
received transplants (dobj)
series patients (nmod)
upregulation . (punct)
pancreatitis , (punct)
driving daylight (compound)
recover to (mark)
study presented (acl)
ead ) (punct)
hormone adrenocorticotrophic (amod)
studies stage (nmod)
epicardial large (amod)
preserve nimodipine (nsubj)
diameter and (cc)
opacities subepithelial (amod)
salbutamol by (case)
10.12 ) (punct)
syndrome long (amod)
spain in (case)
sensitization haloperidol (nmod)
discovered report (dobj)
discussed problems (nsubjpass)
mmc ( (punct)
1.21 10.12 (prep)
evaluation disease (nmod)
cent per (punct)
applicators , (punct)
approach shelves (dobj)
vasculitis induced (amod)
pattern presence (nmod)
stage latency (conj)
p9605 p9201 (conj)
dehydration hyperosmolar (amod)
prevent though (mark)
tolerant were (cop)
model each (det)
produced (+/-)-pg-9 (nmod)
presented hypercalcemia (nmod)
antagonizing in (mark)
recognized if (mark)
had furthermore (advmod)
rise h (nmod)
surgery anaesthesia (nmod)
berlin west (compound)
0.84 +/- (cc)
lmwh iu/kg/h (appos)
dormex contains (acl:relcl)
irrigation hydration (conj)
occurred which (nsubj)
pronounced lca (nmod)
degree reversible (amod)
age the (det)
recovery dramatic (amod)
comparison inhibitors (nmod)
length [ (punct)
nodules extremities (nmod)
fs of (case)
incidence death (conj)
induced levetiracetam (nmod)
prevention perinatal (amod)
$ROOT$ syncope (sent)
designed study (nsubjpass)
patients agents (nmod)
syndrome risperidone (nmod)
groups asa (compound)
6.2 14.1 (conj)
that was (cop)
they both (appos)
ensure to (mark)
drops further (amod)
increased 19-fold (advmod)
onset hepatitis (nmod)
therapy digoxin (compound)
year longer (nummod)
have exposure (nsubj)
otoprotectant as (case)
features histological (amod)
given pb (nsubjpass)
cells dpi (nmod)
mechanisms additional (amod)
transferase glutamyl (amod)
latency of (case)
observed cortex (nmod)
change scale (nmod)
users desogestrel (nmod)
bergmann 's (case)
= 0.07 (dobj)
bred selectively (advmod)
dosage with (case)
alpha se (appos)
totals cases (nmod)
congestants and (cc)
incidence observed (acl)
changed remained (conj)
compared injection (nmod)
possess that (mark)
shock edema (conj)
reduction than (case)
aorta thoracic (amod)
status astrocytes (nmod)
positioning same (amod)
mrp2 and (cc)
women in (case)
insufficiency of (case)
substituted . (punct)
program ) (punct)
proportion total (nmod)
manifest . (punct)
addition thalidomide (nmod)
therapy . (punct)
patients decrease (nmod)
resistant strikingly (advmod)
markers in (case)
causes humans (nmod)
hepatotoxicity . (punct)
effects events (nmod)
appreciated than (mark)
nondrinkers were (cop)
chloride cobalt (compound)
clozapine < (dep)
intake methylphenidate (compound)
folate and (cc)
measured baseline (nmod)
period administration (compound)
decompression cranial (amod)
circling , (punct)
microangiopathy failure (conj)
human canine (conj)
concentrations glucose (compound)
mg/kg ) (punct)
memory impaired (acl)
he-lfb , (punct)
discontinuing after (mark)
of episode (nsubj)
effect doxorubicin (nmod)
intervention therapeutic (amod)
obtained compounds (nmod)
result changes (nmod)
dosage high (amod)
given diltiazem (dobj)
revealed tem (nsubj)
appearance outward (amod)
rejection cellular (amod)
fluvoxamine , (punct)
include thrombocytopenia (dobj)
included had (conj)
lower frequencies (nsubj)
preservation cells (nmod)
releases and (cc)
movements frequent (amod)
$ROOT$ recognise (sent)
mpa , (punct)
leading alteration (nmod)
size cells (nmod)
continuing amiodarone (dobj)
display which (nsubj)
comparable patients (nmod)
tests markers (conj)
developed hematuria (dobj)
databases several (amod)
doxorubicin cyclophosphamide (conj)
proceed not (neg)
use . (punct)
microg/ml 32 (nummod)
heart rats (nmod)
stiffness myalgia (conj)
dystrophy adult (amod)
confusion : (punct)
less 0.0001 (conj)
decreased values (nsubj)
motor sensory (conj)
implicated influence (conj)
used define (xcomp)
induces trimipramine (nsubj)
protect not (neg)
moderate to (quantmod)
35 5 (conj)
used most (advmod)
regressed symptoms (nsubj)
mg. from (case)
alternatives heparin (nmod)
third from (case)
diagnosis : (punct)
levels malondialdehyde (nmod)
min 6.2 (nummod)
shown patients (nmod)
goal important (amod)
actin glomerular (amod)
required determine (xcomp)
comparison further (amod)
pulmonary and (cc)
field open (amod)
controlling by (mark)
mediated nefiracetam (nmod)
mbp ( (punct)
doses conjunction (conj)
% 25%-35 (nummod)
groups adr+los(6 (conj)
micrograms/ml up (advmod)
administered acid (nsubjpass)
% majority (conj)
course localization (conj)
receiving antagonists (dobj)
1.2 3.8 (prep)
controls . (punct)
aura without (case)
contraindication use (nmod)
hypoperfusion of (case)
help prevent (xcomp)
treated was (aux)
formation granulomatous (amod)
camp of (case)
concerns this (nsubj)
given suggesting (xcomp)
hydrochloride ] (compound)
fatalities two (nummod)
observed variety (nsubjpass)
associated intensity (nsubjpass)
$ROOT$ important (sent)
therapy seizures (nmod)
cause turn (nmod)
measured weeks (nmod)
pattern damage (nmod)
propagation eads (nmod)
generation increased (amod)
phase the (det)
observed rate (nsubjpass)
induced terminated (conj)
$ROOT$ interfere (sent)
hyperglycemia and (cc)
nos enos (dep)
ibpb ( (punct)
decades last (amod)
features florid (amod)
injection even (advmod)
toxicity regarding (case)
level their (nmod:poss)
treatment dyskinesia (nmod)
targeted and (cc)
abilities physical (amod)
hemorrhage cerebral (amod)
menses of (case)
controls low-risk (amod)
33342- in (case)
concluded enhances (ccomp)
induced bromocriptine (nmod)
recorded muscle (nmod)
stimulant a (det)
etoricoxib vs (cc)
contain typically (advmod)
cgs ) (punct)
remain studies (nsubj)
prerequisite injury (nmod)
exception with (case)
show changes (dobj)
observed assessed (conj)
life-threatening potentially (advmod)
epm ( (punct)
bilirubin total (amod)
inappropriate reticulocytosis (nsubj)
received enalapril (dobj)
appt ] (punct)
had p<0.05 (dobj)
drink guarana (compound)
sed 0.05 (dep)
complained patients (nmod)
continued then (advmod)
pri the (det)
$ROOT$ necrosis (sent)
tests stress (compound)
causes these (det)
protection under (case)
biopsies " (punct)
embryo chick (compound)
develop leak (dobj)
elevated non-significantly (advmod)
existence stimulation (nmod)
precede glycopyrrolate (nsubj)
treatment naturalistic (amod)
$ROOT$ yawning (sent)
acid 5-hydroxyindoleacetic (amod)
aminonucleoside puromycin (compound)
demonstrated enzymes (nmod)
disability motor (amod)
times or (cc)
searched november (nmod)
levels ldlr (nmod)
rate maximum (amod)
activity sa (compound)
used immunotherapy (nmod)
symptomatic similarly (advmod)
15.5 4.3 (appos)
mortality reaching (acl)
manipulation through (case)
antigen-positive cell (nmod:npmod)
function allograft (compound)
remained depressed (xcomp)
recipients combination (compound)
accumulation an (det)
likely nephropathy (nsubj)
content bmd (conj)
intake l-dopa (compound)
formed regimen (nmod)
patients old (amod)
atropine antagonists (conj)
elevated changes (nmod)
tissues exposed (amod)
signified , (punct)
had afterwards (advmod)
higher malondialdehyde (nsubj)
protein lipocalin (conj)
deaths including (case)
available when (advmod)
variable individually (advmod)
pain reduction (nmod)
reported times (nmod:tmod)
postulated is (auxpass)
polyuria tremor (conj)
sacrificed obtaining (advcl)
ages by (case)
visualize index (nmod)
reduced suggesting (advcl)
increases signs (acl:relcl)
ventilation frequency (conj)
princeton nj (appos)
initiated that (mark)
indicated difference (dobj)
test sensitivity (compound)
discontinuation fk506 (nmod)
likely was (cop)
isoproterenol stimulation (conj)
absence activity (nmod)
received minimum (dobj)
complications reports (dep)
number studies (nmod)
extent amiodarone (nmod)
measuring evaluating (conj)
patients total (appos)
degrees from (case)
lower c. (advcl)
caused hypotension (dobj)
arose feeding (nmod)
antibody 3-antineutrophil (amod)
hepatitis after (case)
developed necessitating (advcl)
confirmed ; (punct)
dysfunction characterized (acl)
group amlodipine (compound)
induced vasospasm (nsubjpass)
exerted which (nmod)
$ROOT$ placed (sent)
sweating ) (punct)
effect sphincter (nmod)
test bar (compound)
whether not (mwe)
aged 75 (nmod)
contraction ventricular (amod)
aura attack (conj)
age=23.3 mean (compound)
cats anaesthetized (amod)
course infection (nmod)
supports monitored (advcl)
found barrier/density (nsubjpass)
illustrates presents (advcl)
treat diarrheas (dobj)
causes overgrowth (nsubj)
dep ) (punct)
complications various (amod)
use wider (amod)
regimens used (acl)
showed telangiectasia (dobj)
endpoints several (amod)
gain rapid (amod)
effects common (amod)
suggested inconclusive (conj)
homeostasis cellular (amod)
may , (punct)
presence preservatives (nmod)
hfde ( (punct)
doxorubicin/kg of (case)
micrograms/kg/min = (parataxis)
induces rat (nmod)
resembled . (punct)
performance their (nmod:poss)
electromyogram the (det)
4 . (punct)
received male (nsubj)
group cooperative (compound)
obtund in (mark)
$ROOT$ enabled (sent)
assigned placebo (nmod)
have decrease (nmod)
developed sensation (dobj)
determine detect (ccomp)
lesion on (case)
patients control (amod)
episode such (amod)
adhd with (case)
significance the (det)
role , (punct)
impact mortality (nmod)
twins the (det)
patients one (appos)
zones in (case)
necrosis or (cc)
signs any (conj)
hydrochloride , (punct)
overdose an (det)
taxol nj (appos)
immediately min (conj)
group ant-mi (amod)
administration monitoring (nmod)
ointment the (det)
mg/kg benserazide (conj)
caused whom (nmod)
nitrendipine enalapril (conj)
evaluated tolerance (nsubjpass)
rats = (parataxis)
treatment compared (case)
exhibited pattern (dobj)
utility treatment (nmod)
patients reported (acl:relcl)
peptide pro (amod)
measurements fetal (amod)
users between (case)
subsided hours (nmod)
represented syndrome (nmod)
% 1.9 (nummod)
deviation st (amod)
antagonists nmda (compound)
developed rats (nmod)
patients leukoencephalopathy (nmod)
mg/m2 ( (punct)
psychosis induced (amod)
reach rate (dobj)
case degree (nmod)
cases hepatotoxicity (nmod)
pain difficulty (conj)
background cause (dep)
models , (punct)
administered thereafter (advmod)
publication each (det)
array a (det)
nephropathy model (appos)
excretion concentration (conj)
activity fluorescence (appos)
antigen tafi (compound)
short but (cc)
discontinuation for (case)
amoxicillin-clavulanate group (nsubj)
young old (conj)
tests screening (nmod)
metabolism hdl (compound)
seizures subsequent (amod)
accomplished . (punct)
pharmacology the (det)
invariable correlated (conj)
determined to (mark)
characterization allele (nmod)
anemia worse-than-expected (amod)
was positive (conj)
frequent although (mark)
8.8 3.5 (conj)
mmol/d ( (punct)
abundances type (nmod)
adults , (punct)
agents report (conj)
plasma ; (punct)
ldlr erk1/2 (conj)
effects dual (amod)
group 5-micrograms/kg (compound)
insight role (nmod)
observed activity (nmod)
topotecan . (punct)
exposure stress (nmod)
rates at (case)
percentage participants (nmod)
taking hypertension (nmod)
conducted surgery (nsubjpass)
receive valsartan (dobj)
lipid epinephrine (conj)
events grade (compound)
nigra substantia (compound)
interaction morphine (nmod)
dose mg/m(2 (nmod)
ng/dl 0.2 (nummod)
dose bupivacaine (compound)
develop region (nmod)
< 0.025 (dep)
produced models (nsubjpass)
schedule administration (compound)
excluded relationship (nsubjpass)
$ROOT$ wished (sent)
intensity absence (conj)
reduce synovitis (dobj)
patients aids (nmod)
neutrophils control (amod)
anacardiaceae ) (punct)
monitored proteinuria (nmod)
doses lesser (amod)
depleted beginning (prep)
$ROOT$ antibiotic (sent)
assessed compared (conj)
substance either (det)
interventions two (nummod)
observed month (nmod)
side-effect common (amod)
characteristic class (nmod)
proved , (punct)
flashbacks " (punct)
reduced 0.01 (parataxis)
suggests association (nsubj)
therapy irradiation (compound)
clearance viral (amod)
changes several (amod)
contractions tachycardia (conj)
preceded asynergy (nmod)
fisher 's (case)
those caused (acl)
free , (punct)
nigra snr (appos)
corrected dosages (nsubj)
hemianopsia left (amod)
increased malondialdehyde (nsubj)
other allopurinol (nmod)
one levofloxacin (nsubj)
short contrast (nmod)
produced induce (advcl)
forestomach in (case)
cells , (punct)
secretion tonic (amod)
narrowing for (case)
associated gain (nmod)
mapping by (case)
is regulation (attr)
abandoning technique (dobj)
unreported is (dep)
10(-4 ) (compound)
caused mda (dobj)
triggers effect (dobj)
combinations by (case)
superior scores (nmod)
reduce fertility (dobj)
convulsions activity (conj)
agents atypical (amod)
transfer after (case)
days weeks (nmod)
tended significant (conj)
follow therapy (nmod)
thrombocytopenia including (case)
cocaine 's (case)
susceptible especially (advmod)
pretreated nicotine (nmod)
spasmodic adductor (nmod:npmod)
lisinopril , (punct)
irrigation a (det)
abnormalities for (case)
six four (quantmod)
rnfl ) (punct)
assessed causality (dobj)
monkeys in (case)
coeruleus noradrenergic (conj)
important relevance (advcl)
yield 1 (nmod)
overshooting dyskinesias (conj)
injection systemic (amod)
routes inhalation (compound)
141 142 (conj)
performed : (punct)
biomarker replacement (nmod)
flowmetry laser (compound)
parameter electrophysiological (amod)
late 41 (nmod)
compared rest (nmod)
perfusion normal (amod)
times ( (punct)
dexamethasone high-dose (amod)
ml/100 1.73 (compound)
found infants (nsubjpass)
stem and (cc)
groups non-lithium (amod)
value ) (punct)
ecg alone (advmod)
receiving schedule (dobj)
found decreased (ccomp)
decrease coherence (nmod)
injection material (nmod)
patients component (acl:relcl)
affects americans (dobj)
mc for (case)
p=0.11 ) (punct)
tubules the (det)
hearts the (det)
expression p300 (nmod)
characterized blocking (nmod)
when especially (advmod)
models investigate (acl:relcl)
cotransporter tsc (appos)
respond cue (nmod)
supplementation early (amod)
line observations (nmod)
$ROOT$ studies (sent)
logs , (punct)
laitinen by (case)
admitted male (nsubjpass)
treated pointes (nsubjpass)
confirm alteration (dobj)
associations . (punct)
agent generation (compound)
unrelenting was (cop)
had fast (xcomp)
$ROOT$ rigidity (sent)
disorder major (amod)
migraine no (neg)
1 7 (conj)
change urine (nmod)
deficit scopolamine-induced (amod)
induced diethylstilbesterol (nmod:npmod)
in situ (dep)
analyzed then (advmod)
performed period (nmod)
contents ngf (compound)
toxicity rejection (conj)
scale panss (appos)
fibrosis biopsies (appos)
withdrawn were (auxpass)
process carcinogenic (amod)
foci alteration (nmod)
mg/m(2 mc (nmod)
impairment behaviours (nmod)
anxiety subject-rated (amod)
marrow megakaryocytes (nmod)
dose prior (amod)
increased period (nmod)
detected eyes (nmod)
time sleep (compound)
jaundice cholestatic (amod)
addiction from (case)
cases these (det)
associated perturbations (nmod)
apparent clinically (advmod)
measures self-report (amod)
correlation levels (nmod)
fibrillation af (appos)
treated each (nmod)
injury infusion (appos)
bzds/rds ) (punct)
30 than (quantmod)
treated effects (nmod)
ratios hospitalization (nmod)
compounds development (nmod)
phases treatment (nmod)
related activities (nmod)
flow epidural (amod)
re-examine association (dobj)
period 6-hour (amod)
improvement therapy (nmod)
terms effects (nmod)
nausea including (case)
corticosteroids with (case)
system haemopoietic (amod)
man 51-year-old (amod)
seen effects (nsubjpass)
tested reduce (ccomp)
activities functional (amod)
stimulation days (appos)
regulation proteins (nmod)
small multiple (conj)
induces contrast (nmod)
blood arterial (amod)
stimuli mitogens (conj)
weeks 20 (nmod)
drugs analgesic (amod)
0.28 0.24 (conj)
dependent p450 (nmod:npmod)
reduced clonidine (nsubj)
research cholinesterase (compound)
goal study (nmod)
characteristics compound (nmod)
radius of (case)
calculation dose (compound)
prl-r socs-3 (conj)
shr but (cc)
incidences crude (amod)
difficult terminate (xcomp)
trial an (det)
was fact (nsubj)
measured gain (nmod)
dystrophy , (punct)
spectrum of (case)
associated cyclophosphamide (nmod:npmod)
interference any (det)
nephrotoxicity mtx (nmod)
neuropathy grade (compound)
lymphoma follicular (amod)
month each (det)
affected function (nsubjpass)
remapped . (punct)
comparable bolus (nmod)
bupivacaine lidocaine (conj)
reversing dysfunction (dobj)
substantiate . (punct)
experiment first (amod)
cocaethylene metabolite (appos)
available need (nmod)
seen emergence (dobj)
requirement higher (amod)
stressed , (punct)
inhibition enzyme (nmod)
disease including (case)
$ROOT$ conscious (sent)
contraindicate or (cc)
paralysis the (det)
infarct an (det)
examination to (case)
attenuated regulation (nmod)
indication to (mark)
becomes responsive (xcomp)
modified would (aux)
platform in (case)
self-reported or (cc)
developed nor (cc)
occur therapy (nmod)
% accumulation (nsubj)
naloxone for (case)
reinstated session (nmod)
related development (nsubj)
total among (case)
examinable response (nmod)
condensed moiety (nsubjpass)
carbonate and (cc)
follows score (conj)
male 17-year-old (amod)
donor platelet (compound)
safety and (cc)
incidence tnss (nmod)
improved administration (nsubj)
produced neuroleptics (nmod)
affinities significant (amod)
start infusion (nmod)
evaluating efficacy (dobj)
microperfusion before (case)
months to (case)
comparison trinitrate (nmod)
linked hemorrhage (nmod)
patients high-risk (amod)
considered guidelines (nmod)
barrier rats (nmod)
episodes tachyarrhythmia (nmod)
secretion impaired (amod)
described best (nmod)
vgb ( (punct)
b12 acid (conj)
tests and (cc)
timolol and (cc)
development ari (nmod)
aware were (cop)
interaction inhibitory (amod)
review reports (dobj)
ng/ml 537 (nummod)
thought safe (xcomp)
rigidity and (cc)
paralysis ipsilateral (amod)
background confirmed (appos)
cck-8-ns ( (punct)
children all (det)
midbrain ( (punct)
amphetamine benzoylecgonine (conj)
became administration (nmod)
affecting any (dobj)
esrd of (case)
suggests inhibition (dobj)
immunocytoma a (det)
showed improvements (dobj)
1.7 to (dep)
dose schedule (conj)
independence patient (nmod:poss)
luminal and (cc)
toxicity lung (compound)
number proportion (nmod)
reserved be (auxpass)
lymphadenitis , (punct)
bcp ) (punct)
antagonized stereotypies (dobj)
aorta in (case)
isoenzymes phosphokinase (compound)
amisulpride mg (appos)
thirty-six % (appos)
mg/kg 0.2 (nummod)
installation of (case)
deterioration fatiguability (appos)
desogestrel i.e. (advmod)
association salicylates (nmod)
representing years (dobj)
participants among (case)
pollutants these (det)
compliance good (amod)
edema massive (amod)
timecourse events (nmod)
appeared appear (conj)
equal limit (nmod)
developed hoarseness (dobj)
nephritis including (case)
discriminations both (det)
effects tetracycline (nmod)
response capsaicin (nmod)
mhb long-lasting (amod)
infusion 24-hour (amod)
retinochoroidopathy in (case)
flunitrazepam mg (appos)
used dialysate (nsubjpass)
experienced swallowing (advcl)
suppression arrhythmia (nmod)
rofecoxib users (nmod)
micromol/10 0.1 (nummod)
presented recurrence (nmod)
replicate not (neg)
levels catecholamines (conj)
induced arrhythmias (nsubjpass)
hospitals republic (nmod)
deficits visual (amod)
translate emergence (nsubj)
photodistribution the (det)
included subjects (nsubjpass)
influence may (aux)
hemorrhage sah (appos)
provocation neuropathy (nmod)
delineated . (punct)
examined preoperatively (advmod)
exhibited indolamines (nsubj)
oct oct (appos)
short half-life (nsubj)
observational evidence (nsubj)
dependent beating (nsubj)
erythromycin with (case)
incidence pressure (nmod)
barrier/density charge (compound)
treat tuberculosis (dobj)
exercise motor (compound)
strain and (cc)
obtained powders (nsubjpass)
% .01 (dep)
mg./kg . (punct)
toleration doses (nmod)
caffeine- not (cc)
evidence cardiotoxicity (nmod)
enac ) (punct)
stimulation noxious (amod)
hippocampal and/or (cc)
polfa ) (punct)
db 0.99 (nummod)
cardiotoxicity to (case)
preparations third-generation (amod)
cnp ( (punct)
provide strategy (dobj)
causes . (punct)
mup pressure (conj)
increased groups (nmod)
patient disease (compound)
targeted aucs (nmod)
combination study (nmod)
jones ( (punct)
fentanyl d-tubocurarine (conj)
structures the (det)
identified and (cc)
reduction lvef (nmod)
rats fucoidan-treated (amod)
pretreated prior (advmod)
seen decade (nsubj)
involvement rare (amod)
6.6 0.7 (conj)
crm ( (punct)
leading hyperparathyroidism (nmod)
cancer reported (acl)
medulla ventral (amod)
group mexiletine (compound)
exacerbation unlike (case)
predictor tested (advcl)
encephalopathy report (appos)
available is (cop)
compared experiments (nmod)
induce that (mark)
minutes 80 (nummod)
rebounded torr (nmod)
elevation an (det)
presented pattern (dobj)
emesis , (punct)
difference amplitude (nmod)
buche ( (punct)
due anesthetics (nmod)
reversal gradient (nmod)
ability antagonize (acl)
stones patients (nmod)
conclusions resulted (appos)
men treated (acl)
nitroprusside-induced sodium (nmod:npmod)
induced iso (nmod:npmod)
america in (case)
incidence bradycardia (nmod)
channel aqp2 (appos)
means program (nmod)
resulted micrograms (nsubj)
limited which (nsubjpass)
glomeruli pan (compound)
pentylenetrazol ptz (appos)
mg at (case)
continued administration (nsubjpass)
anxiety disorders (conj)
subgroups to (case)
surgery cardiovascular (amod)
augment seizures (dobj)
% 5/8 (appos)
fatal one (nsubj)
disease + (punct)
ras the (det)
on solely (advmod)
changes shape (nmod)
constipation-predominant ( (punct)
effects moderate (amod)
suggest correlation (nsubj)
maximal hour (nmod)
$ROOT$ sacrificed (sent)
extract hibiscus (compound)
onset in (case)
= 25 (dobj)
found evaluation (nmod)
became cramps (nsubj)
capacity ) (punct)
involved component (nsubjpass)
hypoglycemia hyperbilirubinemia (conj)
correlated recall (nmod)
pneumoniae pathogen (nsubj)
improves myocet (nsubj)
hoe-140 microm (appos)
noxious mildly (advmod)
smaller doses (nsubj)
m1 ( (punct)
series population (compound)
risperidone 's (case)
dysfunction as (cc)
reappeared restarting (advcl)
indicate potentiate (ccomp)
vasculitis lv (appos)
acquired discriminations (dobj)
transmission cholinergic (amod)
convulsions mg/kg (compound)
induced studies (nmod)
cent by (case)
reduced kf17837 (nsubj)
generation free (amod)
infarction healed (amod)
dizziness respectively (advmod)
total in (case)
readmitted died (conj)
made proceed (xcomp)
involvement mechanisms (nmod)
rate cell (compound)
induced pge1 (nmod)
exert development (nmod)
chloride high (amod)
fat dietary (amod)
compounds administered (acl)
severity outcomes (conj)
block peri-operative (amod)
uncommon but (cc)
five five (conj)
dyspnoea men (nmod)
microm microm (appos)
mug mul (conj)
gammapathy monoclonal (amod)
76 from (case)
change sbp (compound)
excretion pap (nmod)
fifteen in (case)
neurons snr (nmod)
rats conscious (amod)
movements breathing (compound)
third-generation and (cc)
obtain convulsions (dobj)
experiment with (case)
generation mitochondrial (amod)
became because (mark)
diminish thus (advmod)
fluoxetine ) (punct)
enable withdrawal (dobj)
appeared case (nsubj)
case mcl (nmod)
used model (dobj)
cyclohexyl]benzeneactemide trans-3,4-dichloro-n-methyl-n[2-(1-pyrrolidinyl (compound)
depletion injections (nmod)
receptors d-1 (compound)
recognition increasing (amod)
g/dl 2.5 (nummod)
evidenced absence (nmod)
microglobulinuria elevated (amod)
aggravation with (case)
apomorphine with (case)
offer therapy (dobj)
occurrence this (det)
prolonged multiple (conj)
receptors classical (amod)
model streptozocin-induced (amod)
frequencies at (case)
strain mice (nmod)
microglobulinuria 2 (nummod)
depression enuresis (conj)
mania induced (amod)
effect also (advmod)
cocaine with (case)
symptoms with (case)
years patients (nmod)
noted analysis (nmod)
modulating activity (conj)
formation nigra (conj)
cross-reactivity enflurane (nmod)
measurement a (det)
melphalan intravenous (amod)
appeared signs (nsubj)
feeding , (punct)
hypothesized study (nmod)
participants in (case)
period shorter (amod)
nephrogenic neurogenic (conj)
regained status (dobj)
damage due (case)
discriminated damage (nmod)
atazanavir initiated (acl)
sample larger (amod)
dose d-tubocurarine (nmod)
receptors dmpx (appos)
hcl of (case)
cytokines inflammatory (amod)
substituted analogue (nmod)
recognition to (case)
effect potentiating (amod)
regained patients (nsubj)
signal baseline (compound)
involve activity (nsubj)
reconsidered . (punct)
parameters function (compound)
returned however (advmod)
symptoms history (conj)
generated groups (nsubjpass)
enlarged . (punct)
depend stimulation (nmod)
d-amphetamine by (case)
abnormalities wall-motion (compound)
increase : (punct)
included use (dobj)
prolonged characterized (advcl)
cent 2 (nummod)
analgesic containing (acl)
increased placebo (nmod)
cause atrophy (nmod)
designed achieve (xcomp)
patients ve (amod)
dissociation rhythms (conj)
alcohol t-cell (conj)
lenalidomide dexamethasone (conj)
15mg/kg day (nmod)
observations unit (nmod)
induce pain (dobj)
pathological-process underlying (amod)
induction stage (nmod)
suppresses hyperparathyroidism (dobj)
nsaid of (case)
taking tranylcypromine (dobj)
received form (nmod)
encephalopathy posterior (amod)
levels generation (conj)
death time (dep)
anomaly valve (nmod)
positive however (advmod)
increased exception (nmod)
had pg (nsubj)
sirolimus or (cc)
intervention careful (amod)
unclear so (advmod)
observed week (nmod)
induction clonic (amod)
associated disorder (nsubjpass)
hemiparesis manifestation (dep)
anemia of (case)
affect can (aux)
present manifestations (nsubj)
controls 32 (nummod)
stimulate intermedius (dobj)
was quadrant (nmod)
absent groups (nmod)
diarrhea 3 (nummod)
users nonantithrombotic (amod)
doxorubicin anthracyclin (compound)
myocardium into (case)
flaccid , (punct)
135 0.6 (conj)
paresthesia the (det)
medulla rostral (amod)
11.6 - (punct)
toxicities major (amod)
elements level (nmod)
patients hemorrhage (nmod)
developed but (cc)
therapeutic elevated (conj)
apply might (aux)
placebo < (dep)
therapy hyperventilation (conj)
improved persisted (conj)
activity efferent (amod)
cells stem (compound)
case is (advcl)
walls glomerular (amod)
$ROOT$ vary (sent)
$ROOT$ shunt (sent)
placebo % (appos)
receptors adrenergic (amod)
hypotension % (dep)
method instillation (nmod)
considered with-drawn (xcomp)
intensity 2 (dep)
generation , (punct)
taking in (mark)
intoxication drug (compound)
groups piroxicam (compound)
glomerulopathy nephritis (conj)
$ROOT$ 3657 (sent)
related genotype (nmod)
process , (punct)
cases added (acl:relcl)
test first (amod)
model and (cc)
fibers and (cc)
experience incidence (dobj)
gellan morning (dep)
homology of (case)
processes social (amod)
val/hctz 160/12.5 (dep)
plan original (amod)
decreased concomitantly (advmod)
length = (dep)
tacrolimus by (case)
norepinephrine with (case)
mg/kg/day with (case)
safe doses (nmod)
median ( (punct)
loss diuretic-induced (amod)
antagonist ng (dep)
scales versions (conj)
selective specific (conj)
confirmed which (nsubjpass)
daunorubicin from (case)
ci=1.0 % (compound)
curve noradrenaline (compound)
appearances cystitis (nmod)
abuse simultaneous (amod)
crescents and (cc)
mg/dl . (punct)
macrophages foamy (amod)
differentiated . (punct)
population : (punct)
discontinued patients (nmod)
age at (case)
hyperactivity pronounced (amod)
dose quinidine (nmod)
administration use (conj)
impact measures (nmod)
provokes that (mark)
jc 2003 (appos)
levels receptor (compound)
chloride of (case)
caused treatment (nmod)
eyes 25 (nummod)
5 10(-5 (conj)
$ROOT$ delivered (sent)
attack ( (punct)
treated labor (nmod)
g micro (compound)
developed woman (nsubj)
occurs follow (conj)
antigen viii (compound)
14 20 (conj)
findings : (punct)
side area (nmod)
extravasation dye (nmod)
$ROOT$ trated (sent)
standard gold (compound)
saline intravenous (amod)
verapamil patient (nmod)
nin ( (punct)
received ip (advmod)
model failure (compound)
145 +/- (cc)
tumors malignancies (conj)
involved mechanism(s (nsubjpass)
binding [3h]gaba (compound)
resolution necrosis (nmod)
drinkers heavy (amod)
convulsions for (case)
treatment cases (conj)
had disease (nmod)
etomidate : (punct)
presented protein (nsubjpass)
proteinuria and (cc)
prevalence predictors (conj)
db 2.14 (nummod)
signs activation (nmod)
catalepsy produced (acl:relcl)
return contractility (nmod)
nucleus in (case)
initiate onset (dobj)
hospitalization patients (nmod)
$ROOT$ screened (sent)
demonstrate essential (ccomp)
demonstrated since (mark)
reagents 3 (nummod)
1997 2001 (conj)
monotherapy either (cc:preconj)
appeared effacement (nsubj)
controlled multicenter (amod)
chemotherapy adjuvant (amod)
patients schizophrenic (amod)
hypotension prolonged (amod)
pilocarpine pilo (appos)
g. 200 (nummod)
$ROOT$ flurbiprofen (sent)
attenuated responses (dobj)
monitoring periodic (amod)
conclude and (cc)
need may (aux)
pentoxifylline , (punct)
use mirtazapine (nmod)
benefit or (cc)
granulomatosis wegener (nmod:poss)
haemodilution alone (advmod)
tg with (case)
vessels both (cc:preconj)
transaminase alanine (compound)
dex 7931 (nummod)
staining serum-albumin (nmod)
improve quality (dobj)
ameliorates dysfunction (dobj)
evaluated groups (nmod)
recordings video (compound)
quickly very (advmod)
studies carolina (nmod)
isoniazid of (case)
methods extracted (acl)
authorized use (nmod)
correlates dosage (nmod)
change accumulation (nmod)
nsaid mg (dep)
observations careful (amod)
manifesting pericarditis (nmod)
cases . (punct)
applicators number (nmod)
determination prolactin (compound)
found day (nmod)
difference subjects (nmod)
fas due (amod)
doses mg/kg (nmod)
trks ( (punct)
domperidone antagonist (appos)
effects motor (amod)
used type (dobj)
effect ligands (nmod)
effects anti-cocaine (amod)
generation activation (conj)
seen than (mark)
risk abnormalities (nmod)
retina in (case)
44 of (advmod)
detected reported (advcl)
nanoparticles 5mg/kg (appos)
single a (det)
reintroduced acitretin (nsubjpass)
assessment homeostasis (compound)
related unlikely (conj)
globulin hepatitis (compound)
formula on (case)
delirium early (amod)
increased followed (conj)
unlikely therefore (advmod)
induced aura (nsubjpass)
diuretics of (case)
reaction caa (nmod)
explained is (auxpass)
studied rats (nmod)
rate nephropathy (nmod)
hydroxylase for (case)
neurotoxic setting (nmod)
undergo transplantation (dobj)
hypothesis involvement (nmod)
drugs non-selective (amod)
prescribed patients (nmod)
sensory motor (conj)
remain induce (csubj)
model mice (nmod)
markers factor (nmod)
myocarditis is (cop)
longer or (cc)
2.5-fold of (case)
june 2007 (nummod)
establish to (mark)
associated drug (nmod)
channels plasma (compound)
pain back (amod)
or=2.870 , (punct)
mmg 25 (nummod)
angiotensinogen low (amod)
inconclusive is (cop)
time hilum (nmod)
sn , (punct)
safety giving (acl)
effect cyclosporine (nmod)
activities esterase (compound)
experience longer (amod)
received dronedarone (dobj)
magnus with (case)
effectiveness the (det)
period of (case)
years before (case)
have patients (nmod)
conducted analysis (nsubjpass)
suggestive very (advmod)
high- of (case)
group isolated-hit (amod)
rate min-1 (nmod)
administered has (aux)
angiography intravenous (amod)
areas heparin (compound)
= lag (nmod)
high therapeutic (conj)
hemisulfate of (case)
loss initial (amod)
prevented administration (nmod)
populations demographic (amod)
courses doses (nmod)
agonist well-characterized (amod)
combination cpdd (compound)
included 450 (nsubjpass)
aneurysm the (det)
vessels microblood (compound)
5.6 2.3 (conj)
admitted anticoagulated (conj)
$ROOT$ focused (sent)
residence fluid (nmod)
questionaires form (compound)
patient hour (nmod)
administration before (case)
% 32.3 (nummod)
administration us (compound)
enalapril interval (appos)
imaging task (conj)
accumulating toxic (ccomp)
support granulocyte (compound)
anaesthesia ambulatory (amod)
treatment home (amod)
3-methoxy-4-hydroxyphenethyleneglycol cortisol (conj)
2 than (quantmod)
used dexmedetomidine (nsubjpass)
proteinuria mice (nmod)
development hypertrophy (nmod)
analysis curve (compound)
accounting correlation (nmod)
point from (case)
loss neurosensorial (amod)
discharged later (advmod)
recordings sces (compound)
lacking sgk1 (dobj)
inconclusive since (mark)
group = (dep)
present lesions (dobj)
exposure high-dose (amod)
-20 10 (compound)
disease gvhd (appos)
discharged condition (nmod)
study including (case)
recovery waves (nmod)
manifestations and (cc)
found beta=0.49 (dep)
return only (advmod)
administered co (advmod)
ug ) (punct)
confirmed role (nsubjpass)
treating riha (dobj)
cause associated (advcl)
sirolimus ( (punct)
movements vacuous (amod)
investigating effects (dobj)
factor can (aux)
therapy phenobarbitone (compound)
mg 125 (compound)
does frequencies (nmod)
indicate changes (dobj)
hydrolyze succinylcholine (dobj)
blocking and (cc)
usual improvement (nsubj)
infused units (dobj)
received 11 (nsubj)
volume left (amod)
1mg/kg i.p. (advmod)
symptoms total (amod)
trial canadian (amod)
possibility regarding (case)
excreted % (nmod)
1.036 ( (punct)
free be (cop)
damage scored (amod)
eosinophilia erythroderma (conj)
increased unchanged (conj)
identify ) (punct)
age-range ) (punct)
sgk1(-/- in (case)
homeostasis mitochondrial (amod)
infused session (nmod)
involve systems (dobj)
pre-treatment 100mg/kg (nmod)
proliferation cellular (amod)
lend proposal (nmod)
changes resemble (acl:relcl)
beginning after (mark)
eleven and (cc)
improvements substantial (amod)
receiving aminoglycoside (dobj)
hemoglobin g/dl (nmod)
correlates increase (nmod)
mg/m(2 dose (nsubj)
existence the (det)
days challenge (dep)
exhibit nos-ir (dobj)
had pain (nmod)
absence liver (nmod)
prazosin on (case)
induced could (aux)
study pathophysiology (dobj)
nigra reticulata (dep)
changes morphology (nmod)
peptide the (det)
estimated concentrations (nsubjpass)
method restoration (compound)
finding previous (amod)
recruited setting (dep)
dose cd50 (appos)
injections days (nmod:npmod)
hydrobromide galanthamine (compound)
dexamethasone plus (cc)
motionless animals (dep)
included latency (dobj)
prevention adenomas (nmod)
aneurysm dissecting (amod)
superior both (nsubj)
rats cultures (conj)
most patients (nmod)
pathways serotonergic (amod)
pathology glomerular (amod)
$ROOT$ improvement (sent)
pretreatment oxprenolol (compound)
negative as (advcl)
locf ( (punct)
size edema (conj)
$ROOT$ down-regulation (sent)
ligation- and (cc)
fractionator optical (amod)
signs encephalopathy (nmod)
tolerate not (neg)
add that (mark)
inhibition arrhythmia (nmod)
occurred nature (nmod)
cyclosporine azathioprine (conj)
stained pas (nmod:npmod)
= 9.1 (parataxis)
measurements measured (dep)
mg/kg morphine (nmod)
confirmed scotomata (dobj)
hypoxia mild (amod)
re-induced was (auxpass)
agc for (case)
mydriasis and (cc)
potent ketamine (nsubj)
% % (compound)
therapy infusion (compound)
analogues cck-2 (compound)
cortex cingulate (compound)
mrp2 for (case)
considered accumulation (nsubjpass)
containing not (cc)
cox-2 not (cc)
dosage type (conj)
positive but (cc)
use model (dobj)
complication are (cop)
esterification maltol (nmod)
1.73 0.16 (conj)
$ROOT$ asymptomatic (sent)
restricted patients (nmod)
used they (nsubj)
volume or (cc)
insecticides the (det)
increased ppa (nsubj)
mother his (nmod:poss)
implicated defects (nsubjpass)
mm 9.1 (nummod)
confirmed study (dobj)
syndromes used (acl:relcl)
pyridoxine as (case)
increase that (nsubj)
fibrosis prominent (amod)
picture resembling (acl)
inhaled darkness (nmod)
receptor adenosine (compound)
returned showed (conj)
2-acetylaminofluorene dietary (amod)
causes therapy (nsubj)
surface at (case)
observed models (nmod)
outcome fatal (amod)
dox either (cc:preconj)
had problems (dobj)
occurred dose (nmod)
age-range years (nmod)
concentration with (case)
done administration (nsubjpass)
cisplatin wr-2721 (conj)
dlt ( (punct)
analysis one-way (amod)
treatment clentiazem (nmod)
crystallization acid (nmod)
had drug (nsubj)
affected models (nsubjpass)
performed nested (advcl)
$ROOT$ efficacy (sent)
condition disease (compound)
promote blockade (nsubj)
dizziness , (punct)
peptide natriuretic (amod)
estimates thromboembolism (nmod)
turned injection (nmod)
data detailed (amod)
injection acetate (nmod)
contraction of (case)
remained untreated (xcomp)
experiments similar (amod)
diet fed (case)
developed infections (dobj)
origin rarely (advmod)
2.14 ( (punct)
analysis threshold (compound)
increase attenuated (acl:relcl)
walls and (cc)
central more (advmod)
blockers structure (nmod)
hydroxyanisole butylated (amod)
observations patients (nmod)
support do (aux)
function hormone (nmod)
pre- post-transfusion (conj)
synthesis bs (compound)
carcinomas renal (amod)
ameliorated abolished (conj)
agoraphobia with (case)
occurrence to (case)
derivatives anthraquinone (compound)
patients cyclosporine (compound)
initiated been (auxpass)
treated study (nmod)
positive negative (conj)
nag marker (appos)
900 1,500 (conj)
yahr adl (conj)
bupivacaine % (appos)
occurred four (nmod)
obtainable that (mark)
therapy pulsatile (amod)
changes large (amod)
necrosis was (cop)
advisable . (punct)
institution our (nmod:poss)
5.05 vs. (cc)
62 +/- (cc)
cessation use (nmod)
those those (conj)
assay rnase (compound)
have diuresis (dobj)
rats conventional (amod)
infusion morphine (compound)
= 134 (dep)
dopaminomimetics of (case)
stimulation hyperalgesia (conj)
co-agonist ) (punct)
9 7 (compound)
response ketamine (nmod)
sod ) (punct)
parameters laboratory (compound)
surgery stereotaxic (amod)
hyperparathyroidism secondary (amod)
excretion massive (amod)
those using (acl)
hypovolemia intravascular (amod)
reported deficits (nsubjpass)
t from (case)
figures as (case)
infiltration compartment (nmod)
tdf ( (punct)
withdrawal temporary (amod)
related event (nsubjpass)
regimen prophylactic (amod)
% mice (dep)
response sulpiride (nmod)
concentrations cocaine (nmod)
possibility pathology (nmod)
increased rate (nsubj)
adr with (case)
tolerated dose (nmod)
elevations were (cop)
patient presentation (nmod)
used animals (dobj)
product p-choloroaniline (dep)
days 3,5,7,10,17,27,41 (nummod)
n. , (punct)
research published (amod)
meritorious are (cop)
sch , (punct)
volumes urine (compound)
heparin lmwh (appos)
$ROOT$ prevalent (sent)
26- 114-fold (conj)
found proteinuria (nsubjpass)
mrna and (cc)
effective most (advmod)
studies six (nummod)
potency , (punct)
sustained patient (nsubj)
emesis fatigue (conj)
microinjection amino (compound)
% 37.5 (nummod)
led levels (nmod)
tolerated well (advmod)
based principle (nmod)
disease after (case)
time ecarin (compound)
increased 163 (nmod)
diminished noted (conj)
cn , (punct)
prevented shortened (conj)
cholestasis ticlopidine-induced (amod)
occurrence rash (nmod)
stimulations current (compound)
rise adriamycin (nmod)
guanethidine , (punct)
formation concomitant (amod)
dcf mg (amod)
results months (appos)
allows demonstrated (advcl)
pvn ( (punct)
mice hemizygous (amod)
$ROOT$ objectives/hypothesis (sent)
prazosin or (cc)
persists and (cc)
improved altering (advcl)
ameliorated decrease (nmod)
patients half (nummod)
associated delivery (nsubjpass)
demonstrated interferes (ccomp)
1 who (appos)
complications neurological (amod)
evidence the (det)
abnormality encephalopathy (nmod)
activity (na (compound)
67 women (dep)
case second (amod)
testing positive (amod)
release histamine (compound)
effects those (nmod)
spectra patterns (nmod)
antagonist adenosine (compound)
ph the (det)
challenge agonist (nmod)
morphine after (case)
examined alters (ccomp)
proliferation increased (amod)
undergoes becomes (conj)
type block (nmod)
contribute degeneration (nmod)
subacute . (punct)
administration 10mg/kg (nmod)
depression diagnosis (conj)
hours twenty-four (nummod)
performed scans (nsubjpass)
gap43-ir regarding (case)
mechanism activation (nsubj)
thromboembolism . (punct)
termination experiments (nmod)
biopsy endomyocardial (amod)
1.1 p=0.09 (appos)
vasoconstriction from (case)
periods into (case)
81.5 was (cop)
exhorted are (cop)
animals control (amod)
conditions special (amod)
patients long-term (amod)
edema disease (conj)
cause desvenlafaxine (nsubj)
cancer platinum- (amod)
measured hemorrhage (nsubjpass)
agents aspirin (conj)
episodes manic (amod)
animals humans (conj)
decrease postdose (amod)
effects apomorphine (nmod)
diameters/bw findings (conj)
treatment , (punct)
consider differ (advcl)
neuroprotective , (punct)
response activation (nmod)
prevalence associations (conj)
caspase 3 (nummod)
pharmaceuticals beecham (compound)
muscle detrusor (compound)
dependent effects (nsubj)
witnessed . (punct)
forebrain to (case)
treated also (advmod)
models three (nummod)
seizures/mo ) (punct)
show patients (nsubj)
amplitude action (compound)
schedule of (case)
resulted stenosis (nsubj)
2.92 0.64 (nummod)
5 two (quantmod)
design in (case)
old he (nsubj)
0.94 nsaids (nmod)
applied pain (nsubjpass)
hypotension acetaminophen-induced (amod)
measured hours (nmod)
field ufov (appos)
growth the (det)
smokers heavy (amod)
damage dna (compound)
performed negative (conj)
predictor was (cop)
4.7 s(h)uv (nsubj)
learning after (case)
ishihara ) (punct)
18.3 1.4 (conj)
rats animals (dep)
lumens the (det)
use year (nmod)
glycol-asparaginase polyethylene (compound)
complication lethal (amod)
cirrhosis virus-related (amod)
ultrafiltration cells (nmod)
reports bradyarrhythmia (nmod)
antinociception produced (acl)
analyses sensitivity (compound)
frequency breast-cancer (compound)
period 3-year (compound)
function altered (amod)
antagonists h(3)-receptor (compound)
surviving days (nmod)
exposure sun (compound)
undergoing anesthesia (nmod)
sacrificed harvested (conj)
associations study (dep)
atrophy muscle (compound)
tested so (advmod)
assessed we (nsubj)
cultures in (case)
analysed totals (nsubjpass)
protein a (det)
(1.8)% (1.8)% (conj)
encephalopathy vpa-induced (amod)
obtained measurements (dep)
technique and (cc)
function disturbed (amod)
week fourth (amod)
catecholamines vasoactive (amod)
amounts volumes (conj)
lectin specific (amod)
derangement metabolic (amod)
ameliorated was (parataxis)
doses micrograms/kg (appos)
grade . (punct)
putamen the (det)
women 3390 (nummod)
immunosuppressant a (det)
identify hypoxia (dobj)
wall arteriolar (amod)
total transplants (nmod)
respiratory peripheral (conj)
abolition ( (punct)
was investigate (xcomp)
lysate cell (compound)
nsvt ( (punct)
has yet (advmod)
defects with (nmod)
greater greater (parataxis)
numbness foot (nmod)
oxidation cardiac (amod)
oc and (cc)
patients cna (compound)
caused cm (dobj)
high it (nsubj)
tends . (punct)
accompanied changes (nsubjpass)
facilitate . (punct)
hemorrhage hem (dep)
pathway common (amod)
potential angiogenic (amod)
da1 ) (punct)
transplantation during (case)
declined . (punct)
examined given (advcl)
mitigates delivery (nmod)
radiotherapy consolidation (compound)
bmt ( (punct)
mg/kg i.p (advmod)
found and (cc)
stopped infusion (nsubjpass)
remifentanil with (case)
resulted recurrence (nmod)
decreased 7 (nmod)
clozapine ( (punct)
reported leading (conj)
nifedipine paced (acl:relcl)
said have (xcomp)
$ROOT$ proceeded (sent)
background contributor (appos)
days forty (nummod)
associated formation (nmod)
effect have (aux)
change fatty (amod)
24.8 5.0 (conj)
rr 0.9 (nummod)
left 3.7+/-0.8 (dep)
defining parameters (dobj)
affect injection (nsubj)
inhibition case (nmod)
observed symptoms (nsubjpass)
pathway cholinergic (amod)
peptide isolated (acl)
prilocaine ) (punct)
load a (det)
group mild-type (amod)
groups years (nmod)
highlights administered (advcl)
characteristics metabolic (amod)
pulse plasmapheresis (conj)
infections few (amod)
control vehicle (compound)
prevented rigidity (nsubjpass)
1993 1996 (prep)
obtained those (nmod)
cox-i. of (case)
atp and (cc)
excretion potassium (compound)
suspect a (det)
estradiol-dependent region-specific (conj)
stimulation slices (nmod)
rash delayed (amod)
cells/microl 348 (nummod)
depressed or (cc)
benign . (punct)
dwi only (cc:preconj)
minutes 180 (nummod)
determined shr (nmod)
delivered be (auxpass)
patients 201 (nummod)
consumption juices (nmod)
treated mirtazapine (nmod)
reduced rate (dobj)
type occurring (acl)
treatment multiforme (compound)
nucleus colliculus (conj)
compare treatment (nmod)
use rifampicin (nmod)
thyroxine intravenous (amod)
ugt ( (punct)
sequelae in (case)
stent of (case)
81 to (case)
each protocols (nmod)
stage : (punct)
dog % (appos)
testing function (compound)
protein decrease (appos)
seizure-prone wsr (appos)
disturbances vascular (amod)
beta-carboline-3-carboxylate of (case)
converts . (punct)
48-week , (punct)
tap necrosis (conj)
monkeys given (acl)
reduced were (auxpass)
relevance practice (nmod)
hyperammonemia by (case)
constitute . (punct)
related decrease (nsubj)
150 up (advmod)
syndrome fanconi (nmod:poss)
operated been (auxpass)
initiated immediately (advmod)
patients 60 (dep)
increase urea (nmod)
combined results (nmod)
synovitis with (case)
scopolamine mg/kg (appos)
39 of (case)
irritability or (cc)
minimised knowledge (nmod)
mt ( (punct)
done eyes (nmod)
stimulation disease (nmod)
disease parenchymal (amod)
handling ) (punct)
recorded monitoring (nsubjpass)
hbv ( (punct)
antibody gnc92h2 (dep)
nerve ulnar (amod)
% 1 (compound)
time activity (nmod)
starting continuing (conj)
totp either (cc:preconj)
seen number (nmod)
imaging on (case)
had sample (dobj)
compliance and (cc)
increases activity (dobj)
rauwolscine kg-1 (appos)
i.p. oral (conj)
those described (acl)
channel the (det)
explored success (nmod)
phenols derivatives (conj)
diet fixed-salt (amod)
dexamethasone or (cc)
examination determination (conj)
agency ) (punct)
remission remission (appos)
5-(l-hexyloxy)-6-methoxy-4-methylquinoline 8-[(4-amino-l-methylbutyl)amino]- (compound)
caused doses (nmod)
dynes.s.cm-5 , (punct)
neutropenia failure (conj)
normal morphologically (advmod)
treated hypertension (nmod)
development esrd (nmod)
seen interfere (xcomp)
prevented totally (advmod)
supplement unnecessary (amod)
model tle (nmod)
interventions sedation (appos)
agonist dopamine-receptor (compound)
prophylaxis without (case)
patients to (mark)
pulse secretory (amod)
6 12 (conj)
utilized we (nsubj)
care neurocritical (amod)
pregs unlike (case)
leukocyturia persistent (amod)
preparation slow-release (amod)
garft ) (punct)
detected gauges (nmod)
therapy maintenance (compound)
enflurane and (cc)
used derive (xcomp)
antagonized potently (advmod)
1.84 0.64 (conj)
changes quality (compound)
findings experimental (amod)
carcinoma cell (compound)
decreased therapy (nmod)
pinch ) (punct)
cranial the (det)
has affinity (dobj)
weight content (conj)
diminished also (advmod)
ear inner (amod)
iv association (compound)
7931 +/- (cc)
change , (punct)
dimension/function failure (nmod)
activity higher (amod)
safer as (mark)
monitored necessary (ccomp)
form that (nsubj)
caused steroid (nsubj)
regulation effects (nmod)
complexes transport (compound)
k for (case)
etoposide a (conj)
detected extract (nmod)
situations these (det)
prolong virtue (dep)
developed tachycardias (dobj)
patient unconscious (acl:relcl)
nfkappab ( (punct)
volumetric metabolic (conj)
tubule connecting (compound)
course favourable (amod)
visualized following (dobj)
anaemia peripheral (amod)
abnormality renal (amod)
develop tolerance (nsubj)
observed respectively (advmod)
use sulfate (nmod)
characterized dysfunctions (nmod)
solicited postcards (nmod)
measured 2min (nmod)
determination plasma (nmod)
according to (mwe)
abolished antagonist (nsubj)
rate pulse (compound)
agent was (cop)
compartments blood (compound)
suffers additionally (advmod)
perseveration and (cc)
sensorium a (det)
59 scale (nmod)
2-chloroprocaine-ce bupivacaine (conj)
defect associated (acl)
underlying development (dobj)
2-chloroprocaine-ce = (dep)
limited although (mark)
showed electroencephalogram (nsubj)
fetuses age (nmod)
eligible analysis (nmod)
property property (conj)
established implicated (advcl)
disease heart (compound)
rashes proteinuria (conj)
inhibition stress (nmod)
cases adenomyosis (nmod)
certainly almost (advmod)
aggravates that (mark)
had correction (nmod)
preventing effects (dobj)
manipulated : (punct)
evidence clear (amod)
revealed immunofluorescence (nsubj)
phenylalanine , (punct)
combination criteria (nmod)
occurred arrest (nsubj)
scored intervals (conj)
cause statins (nsubj)
ischemia min (conj)
selenium zinc (conj)
treatment following (case)
administration challenged (conj)
treated should (aux)
affect whereas (dep)
107 , (punct)
model exhibits (acl:relcl)
genes novel (amod)
inhibition increases (nmod)
dyskinesias therapy-induced (amod)
isomerase terminal (amod)
patients respectively (advmod)
size normal (amod)
records , (punct)
formation abnormal (amod)
effects a (det)
pr ) (punct)
found significance (nsubjpass)
therapies lamivudine (compound)
recorded was (auxpass)
pellet , (punct)
appear nicotine (nsubj)
cases 477 (nummod)
% 3.2 (nummod)
depend diagnosis (nmod)
group b3 (compound)
sevoflurane with (case)
index international (compound)
400 and (cc)
chloroform-adrenaline with (case)
purpose the (det)
change status (nmod)
associated dose (nsubjpass)
carbetocin microg (compound)
agent protease-inhibitor (compound)
circumstances leading (acl)
increment per (case)
inhibit pentoxifylline (nsubj)
preservation better (amod)
school women (appos)
headache in (case)
impairment severe (amod)
noted concordance (nsubjpass)
search methods (nmod)
hemorrhage following (case)
den den (conj)
significant cancer (nmod)
allowed safety (nsubj)
blinding potentially (advmod)
differentiate complications (nmod)
hemodialysis on (case)
2 10 (nummod)
mediate some (dobj)
min administration (dep)
ppm 200 (compound)
consequence so (advmod)
polypeptide decrease (dep)
investigated elucidate (advcl)
effects anxiety (nmod)
discontinued been (auxpass)
cohort children (nmod)
approach within (case)
distinguish group (dobj)
digitalis- arrhythmia (conj)
patients 439 (nummod)
monitored nephrotoxicity (nsubjpass)
therapy intravenous (amod)
vpa or (cc)
pentothal sodium (compound)
analogue of (case)
exposure trimester (nmod)
igg iga (conj)
composition : (punct)
injection capsaicin (compound)
kg-1 i.p. (amod)
frequencies hit (nmod)
warrant evaluation (dobj)
addition fluids (nmod)
190 +/- (cc)
failure to (case)
discontinuation measures (conj)
pain enzymes (appos)
time required (acl)
depleted that (mark)
affected region (nsubjpass)
incorporation 5-azc (nmod)
uroprophylaxis of (case)
u/ml to (case)
treated intracerebroventricularly (advmod)
former with (case)
recording in (case)
inferred . (punct)
use adjusted (acl)
rp antagonist (compound)
drug etodolac (nsubj)
ml 60 (nummod)
bergmann ( (punct)
$ROOT$ blunted (sent)
pharmacokinetics and (cc)
use children (nmod)
azathioprine by (case)
doses equihypotensive (amod)
staining including (case)
persisted years (nmod)
acid lnaa (appos)
remained shr (nsubj)
suggest conclusion (nsubj)
exceeded dose (dobj)
7 5 (conj)
exposure median (amod)
dissatisfaction and (cc)
done biopsies (nsubjpass)
many than (quantmod)
prochlorperazine of (case)
interacted week (nmod)
$ROOT$ 1.8 (sent)
emphasized role (nsubjpass)
dyskinesias mice (nmod)
erythrophagocytosis with (case)
signs parkinsonian (amod)
disease only (advmod)
methotrexate preservative-free (amod)
changed parvalbumin-staining (nsubj)
n-dimethylpropranolol , (punct)
pressure aortic (amod)
interactions drug (compound)
study trial (appos)
regimens two (nummod)
different level (nsubj)
comparable kinetics (nsubj)
evinced enhancement (dobj)
white-cell , (punct)
receiving . (punct)
supplemented period (nmod)
acetate [ (punct)
investigators involved (acl)
537 +/- (cc)
$ROOT$ transplantation (sent)
practical and (cc)
pregnancies clinics (nmod)
represent findings (nsubj)
evaluation and (cc)
trial cancer (nmod)
nm ki=180 (nummod)
downregulated pathway (dobj)
drug spironolactone (dep)
stable and (cc)
increased dose (nsubjpass)
% 90 (nummod)
magnitude are (cop)
compared difference (nmod)
paroxetine sertraline (conj)
waves q (compound)
2.7 = (parataxis)
used piracetam (nsubjpass)
demonstrated next (advmod)
history disorder (nmod)
escalated whereas (mark)
treated ncq436 (nmod)
administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (dobj)
blood occult (amod)
associated patients (nmod)
141 6 (conj)
given nicotine (dobj)
reduced inhibited (advcl)
thrombophlebitis for (case)
familiarity therapy (nmod)
exposure galactose (compound)
strategies anemia (nmod)
patients certain (amod)
events strokes (conj)
quit when (advmod)
$ROOT$ had (sent)
exposures drug (compound)
septicaemia ) (punct)
dyskinesia on-time (conj)
eating after (mark)
characterize dynamics (dobj)
unclear significance (nsubj)
hypertension endotoxemia (conj)
sclerosis focal (amod)
les between (case)
disorders considerations (conj)
properties chelating (amod)
malformation taussig-bing (compound)
induced levels (dobj)
0.6 1.3 (parataxis)
connected concentration (nmod)
tizanidine and (cc)
required treatment (nsubjpass)
$ROOT$ constitute (sent)
withdrawal terfenadine (appos)
snp dogs (appos)
pretreatment remifentanil (compound)
stenosis spasm (conj)
seizures their (nmod:poss)
increases secretion (nmod)
hallucinations delusions (conj)
onset convulsions (nmod)
deprivation maternal (amod)
prevented effect (nsubjpass)
reverses catalepsy (dobj)
showing potentially (advmod)
asians southeast (amod)
examination thermography (conj)
0.27 or (cc)
assessed reported (ccomp)
denied . (punct)
evidence depends (ccomp)
toxicity resuscitation (conj)
appropriate were (cop)
hour medications (nmod)
tfl ( (punct)
importance development (nmod)
likely underreporting (nsubj)
$ROOT$ partial (sent)
phosphatase is (cop)
superior asenapine (nsubj)
solution b (compound)
neurosteroids the (det)
nuclei the (det)
impairment effectiveness (nmod)
marrow hypercellular (amod)
responsive stimuli (nmod)
net the (det)
18 whom (nmod)
range , (punct)
mcg mcg (appos)
dialysis . (punct)
suppression motility (nmod)
therapy baclofen (nmod)
improved revealed (conj)
nucleus caudate (amod)
accompanied decreases (nmod)
satisfied criteria (nsubjpass)
arrhythmia without (case)
sop to (case)
evaluation our (nmod:poss)
brain to (case)
reduction by (case)
monitor bradycardia (nmod)
emergence drugs (nmod)
persons and (cc)
encountered may (aux)
metabolite an (det)
seen period (nmod)
carries risk (dobj)
metoprolol glucagon (conj)
cc ) (punct)
parameters atherosclerotic (amod)
amplitude sap (compound)
exploration from (case)
sought determine (xcomp)
days of (case)
suggest improve (ccomp)
light protection (nmod)
expression inflammatory (amod)
extracts plasma (compound)
displayed and (cc)
disorder schizo-affective (amod)
knockout dbh (dep)
serious the (advmod)
mm to (case)
developed occurred (conj)
pathways two (nummod)
useful test (nmod)
findings trial (nmod)
days menses (nmod)
organophosphate neurotoxic (amod)
caused enhancement (dobj)
cirrhosis defined (parataxis)
relationship stress (nmod)
epilepsy idiopathic (amod)
applied experiments (nmod)
0.6 ( (punct)
44.4 and (cc)
reduced flestolol (nsubj)
woman 73-year-old (amod)
desogestrel ethinyloestradiol (conj)
emissions teoaes (appos)
measures women (nmod)
generation excitotoxicity (conj)
765 +/- (cc)
supply on (case)
toxicities encountered (acl)
those mediate (acl:relcl)
treated whom (nmod)
trials by (case)
saving life (nmod:npmod)
severe located (advcl)
50 or (cc)
attenuated manner (nmod)
sbp h2o2 (conj)
consequences about (case)
protein 88 (nummod)
ly-171555 either (cc:preconj)
period 18-month (amod)
results range (appos)
suppression concomitant (amod)
$ROOT$ seeing (sent)
models multilevel (amod)
result defect (nsubj)
led followed (advcl)
essential is (cop)
types epilepsies (nmod)
determined levels (nsubjpass)
maximum should (aux)
toxicity children (nmod)
rats ten (nummod)
used levodopa (nsubjpass)
pretreated patients (nsubjpass)
raised addition (nmod)
pain spontaneous (amod)
serious treatable (conj)
subunits beta4 (compound)
crescents infiltrate (conj)
woman patient (nsubj)
bladder type (nmod)
3.1 ( (punct)
kinds new (amod)
increased aggregation (nsubj)
capacity years (parataxis)
employing by (mark)
prolonged time (nsubj)
excluded ( (punct)
cyclosporine tacrolimus (appos)
therapy but (cc)
ability by (case)
damaged that (nsubjpass)
lowered dronedarone (nmod)
anemia syndrome (conj)
change following (case)
aor [ (punct)
126 2 (compound)
consumed frequently (advmod)
experienced attacks (nmod)
novel effective (conj)
heart adriamycin-induced (amod)
unchanged whereas (dep)
potentiated not (neg)
receiving ischemia (nmod)
lesions severe (amod)
av ( (punct)
day 4 (nummod)
high . (punct)
22 20 (conj)
information no (det)
day 2 (conj)
% baseline (nmod)
uptake l-arginine (compound)
imparts response (dobj)
membranes of (case)
anemia ticlopidine-induced (amod)
time activated (amod)
line are (cop)
use therapy (compound)
interaction drug (compound)
biopsy muscle (nmod)
expressed cells (nmod)
phosphate and (cc)
analysis profile (compound)
subjects those (det)
deletions mtdna (compound)
$ROOT$ enzyme (sent)
radiation both (preconj)
treated d3 (nmod)
11/57 % (appos)
efficacy amlodipine (nmod)
mg/kg i.p.)-induced (punct)
urge , (punct)
re-infarction after (case)
treated 14 (nsubjpass)
alterations measurements (nmod)
damage criteria (appos)
users present (amod)
weeks during (case)
shortage mannitol (compound)
starting rhythm (dobj)
identified study (nsubj)
vgpr therapy (nmod)
targets axons (nmod)
time occurrence (nmod)
twitches maximal (amod)
developed leucopenia (dobj)
replacement with (nmod)
g/d was (cop)
inhibiting 2d6 (dobj)
mm elevations (nsubj)
receives that (mark)
children are (cop)
$ROOT$ provided (sent)
drug beta-blocking (amod)
differences difference (nsubj)
treatment dose (compound)
sensation unpleasant (amod)
days 35 (nummod)
ofh in (case)
disturbances cardiac (amod)
testing urine (compound)
rate levels (nmod)
europe in (case)
mediating stimulation (dobj)
pressure either (cc:preconj)
examination normal (amod)
errors e.g. (advmod)
nitroglycerin of (case)
dfu for (case)
2pam ( (punct)
tamoxifen placebo (conj)
attenuates nephritis (dobj)
hallucinations for (case)
assessed 59 (nsubjpass)
lesions diffuse (amod)
g-1 ) (punct)
population recruited (acl)
vpa ( (punct)
values dna (compound)
admitted hospital (nmod)
$ROOT$ precedes (sent)
sites distant (advmod)
one virus (nsubj)
appeared ; (punct)
3/20 rat (appos)
known role (nsubjpass)
selected randomly (advmod)
hg down (nsubj)
cholesterol triglycerides (conj)
decreased rbcs (nmod)
suggest is (ccomp)
observed less (advmod)
prompted us (dobj)
adults than (case)
possibility also (advmod)
wt ) (punct)
cases fatal (acl:relcl)
prevention cardiotoxicity (nmod)
pallor , (punct)
5.1 - (punct)
hydrochloride dothiepin (compound)
potentiation increasing (conj)
contained , (punct)
% cows (nmod)
do to (mark)
cardiotoxic presumably (advmod)
replicate augment (conj)
neurodevelopment and (cc)
neurotransmission dopaminergic (amod)
effective however (advmod)
hours 23.6 (nummod)
extent , (punct)
agonists opiate (compound)
defect concentrating (compound)
agent process (nmod)
% 14.4 (nummod)
neuropathy bilateral (amod)
stimulated zymosan (nmod)
cancer diagnosed (acl)
dose time (conj)
retrocollis , (punct)
micturition of (case)
treatment leukemia (nmod)
1.4 scores (nsubj)
from were (cop)
ahs the (det)
boy apl (nmod)
nephrotoxicity 4 (appos)
indicative not (neg)
estimate and (cc)
implicated cause (nmod)
regimen tobramycin (nmod)
size shape (conj)
malformations several (amod)
investigating for (mark)
malignancies to (case)
ett ) (punct)
daunorubicin and (cc)
attribute . (punct)
$ROOT$ journals (sent)
decreases % (amod)
ms 56.8 (nummod)
tbars ) (punct)
weakness progressive (amod)
monkeys all (det)
exercise static (amod)
attention renewed (amod)
$ROOT$ represent (sent)
cause complications (dobj)
rats p<0.05 (dep)
activity hippocampal (amod)
3 to (dep)
gentamicin or (cc)
intraperitonealinjection of (case)
effective enantiomer (nmod)
9.6-fold ) (punct)
developed deterioration (nmod)
dup , (punct)
co. korea (appos)
induced transplantation (nmod)
patients cardiomegaly (nmod)
b ii (nummod)
each to (case)
produced methemoglobinemia (dobj)
10(9)/l pod (nmod)
volumes hematoma (compound)
hl60 hbmp (conj)
1.4 and (cc)
65 to (quantmod)
occurrence or (cc)
exceeded concentration (nsubj)
tract to (case)
provides study (nsubj)
seven % (appos)
sis3 by (case)
pericarditis with (case)
classified . (punct)
u/kg ( (punct)
mg 320/12.5 (nummod)
treated addition (nmod)
recognized not (neg)
restricted and (cc)
attributed synthesis (nmod)
improves 1 (dep)
was delineate (xcomp)
dose mean (amod)
changes mean (compound)
% 30 (compound)
providers managing (acl:relcl)
tendency a (det)
dependent effect (nsubj)
treated they (nsubjpass)
antigen and (cc)
doxil ) (punct)
mg/kg 125 (nummod)
effect besides (case)
reticulata in (case)
period continuous (amod)
had chx+pilo (nsubj)
iopromide either (cc:preconj)
preferred concentration (nsubjpass)
cardiotoxicity chronic (amod)
0.27 ( (punct)
contrary on (case)
targets the (det)
2e1 or (cc)
exposure clomipramine (compound)
initiation tizanidine (nmod)
region into (case)
glutamate ) (punct)
increased amounts (nsubjpass)
18 - (punct)
partial 2 (dep)
icc ) (punct)
events 30-day (amod)
ci=1.2 95 (nummod)
remarkable history (nsubj)
developed 13 (nmod)
attacks cancer (conj)
present can (aux)
nimodipine n=94 (dep)
ethambutol tablet (compound)
data published (acl)
pathways biosynthetic (amod)
seems everolimus (nsubj)
carotid internal (amod)
treatment be (cop)
showed enlargement (dobj)
treatment 2(nd)-line (compound)
described syndrome (nsubjpass)
stopped withdrawal (nmod)
2.1 increased (conj)
cycle twice (nummod)
goes leading (advcl)
had cases (nmod)
% 70 (nummod)
effect cross-linking (nmod)
episode depressive (amod)
greater statistically (advmod)
levels cgrp (compound)
developed pod (nmod)
weight carrier (nmod)
sites at (case)
undergone 21 (nsubj)
noted granules (nmod)
scores requirement (conj)
ranging intraoperatively (advmod)
proliferation , (punct)
susceptibility drug (compound)
associated product (nmod)
april , (punct)
numbers follow-up (conj)
injection patients (nmod)
occlusion of (case)
suggest occurs (ccomp)
concern was (cop)
iopentol of (case)
tnfalpha and (cc)
analysed echocardiography (nmod)
frequently more (advmod)
toxicities associated (acl)
induced interestingly (advmod)
taking vigabatrin (dobj)
lids of (case)
confirming resolved (ccomp)
had 26 (nsubj)
presented deterioration (nmod)
succinylcholine by (case)
called so (advmod)
analgesics no (neg)
documented fourth (amod)
suggesting influenced (ccomp)
pretreatment agonist (nmod)
surveillance during (case)
attenuated effects (dobj)
% 78 (nummod)
perfusion-fixed brains (conj)
effect nicotine (nmod)
contributes shr (nmod)
negativity of (case)
suggest estimates (nsubj)
record this (det)
recived . (punct)
diazepam picrotoxin (conj)
amantadine of (case)
related amisulpride (nmod:npmod)
taken . (punct)
edema angioneurotic (amod)
study first (amod)
benzodiazepines by (case)
man than (case)
method treatment (nmod)
extend striatum (nmod)
alter doses (nsubj)
occurred increase (nmod)
shown troponins (nsubjpass)
ccl2 chemokine (compound)
controls days (appos)
alleviate that (mark)
appear acid (nsubj)
reduces doxorubicin (nmod)
extremities in (case)
attempt the (det)
displace , (punct)
concluded window (dobj)
using pump (dobj)
responses in (case)
simulations dynamic (compound)
strains cdf-i (compound)
fear and (cc)
when relapse (nmod)
increase state (conj)
work-up during (case)
administration manipulation (nmod)
candidates are (cop)
modulation intensity (nmod)
microg/ml 2 (nummod)
suggested cytology (nsubjpass)
exploration altered (amod)
levels maximum (amod)
microg/kg 0.03 (nummod)
sensitive patients (nsubj)
development clinical (amod)
observed necrosis (nsubjpass)
group other (conj)
extent severity (conj)
involvement tachykinins (nmod)
activities aggregation (compound)
profile neuropharmacological (amod)
matter putamen (conj)
ischaemia macular (amod)
changes framework (nmod)
evaluated patients (nmod)
nsclc for (case)
consumption mitochondria (nmod)
male single (amod)
mechanism into (case)
ketamine nmda (compound)
pergolide of (case)
added preparation (nmod)
dermis in (case)
diltiazem micrograms/kg/min (dep)
phenomenon no (neg)
resolution dysmenorrhea (nmod)
n- with (case)
preceded . (punct)
composed subunits (nmod)
infected hbv (nmod:npmod)
individuals 3 (nummod)
reported arrhythmias (nsubjpass)
risperidone or (cc)
myocarditis eosinophils (nmod)
cells/mm3 52.4 (nummod)
hysterosalpingography dimer-x (nmod)
vt/ti ) (punct)
nucleoside prophylaxis (nmod)
preventing or (cc)
disorders for (case)
edema severe (amod)
used doses (nmod)
challenge a (det)
exhibited using (advcl)
up-regulate cytokines (dobj)
emerged . (punct)
hypertension glomerulonephritis (conj)
precursor no (compound)
ratio 4.4 (appos)
had preceded (conj)
remained lower (acomp)
demonstrate study (nsubj)
description a (det)
include studies (dobj)
given hydrochloride (dobj)
treated neonatally (advmod)
induced 9-tetrahydrocannabinol (nmod)
prevented bradycardia (nsubjpass)
done preoperatively (advmod)
week in (case)
hyper- or (cc)
application tacrolimus (nmod)
limited evidence (nsubj)
identified linkage (nmod)
tamoxifen atac (appos)
defects : (punct)
adjusted for (conj)
cholestasis associated (acl)
incidences enzymes (nmod)
thalidomide . (punct)
indicative cortisol (nsubj)
greater no (neg)
reductions bp (compound)
flumazenil sedation (nmod)
potential term (compound)
positive test (nsubj)
pharmacy by (case)
group asa (compound)
reserved . (punct)
effective rd (nsubj)
agents bfgf (nmod)
oxidative/nitrosative and (cc)
bicuculline bcc (appos)
pain scoline (compound)
infusions with (case)
echocardiography angiography (conj)
61 and (cc)
cells tunel (compound)
phentolamine micrograms (conj)
tmax hh (conj)
tendency produce (acl)
substantiate findings (nsubj)
conclusions promotes (appos)
specific to (mark)
diabetes pressure (conj)
using coefficient (dobj)
involvement h(3)-receptors (nmod)
deteriorated rise (nmod)
protects that (mark)
signs pancytopenia (nmod)
151 and (cc)
evidence collected (amod)
kidneys equinovarus (conj)
attributable drug (nmod)
activator stat3 (appos)
gum of (case)
hg < (advmod)
+/- ( (punct)
binding striatum (nmod)
have factors (nsubj)
t ( (punct)
amplitudes snap (compound)
analyze occurrence (dobj)
report occurrence (dobj)
b % (appos)
adult to (case)
flux high (amod)
present were (cop)
toes of (case)
woman elderly (amod)
concentration in (amod)
risk to (case)
produced minutes (nmod)
slower was (cop)
less g/m2/d (nmod)
incidence despite (case)
represents this (nsubj)
had insufficiency (dobj)
usually were (cop)
presents thrombocytopenia (nsubj)
agonist stimulating (amod)
times several (amod)
dimension infusion (nmod)
regimen day (nmod:npmod)
caused become (conj)
blockage glutamatergic (amod)
arises alternative (advcl)
enhances effects (dobj)
preparations rats (nmod)
produced gfc (nsubj)
tachyarrhythmias . (punct)
died exhibited (conj)
cause days (nmod)
efficacy predictors (conj)
suffered , (punct)
fear happiness (conj)
dose levodopa (compound)
flow dural (amod)
topotecan ) (punct)
intoxication in (case)
re-investigate to (mark)
activity modest (amod)
thought tnf (nsubjpass)
piroxicam ( (punct)
preparations cell-free (amod)
factors are (cop)
$ROOT$ allocated (sent)
subgroup of (case)
measuring oxidation (dobj)
rats 344 (nummod)
technique ) (punct)
characteristics promising (amod)
killed 1 (dep)
headache induced (acl)
described papaverine (nmod)
noted biochemically (advmod)
anticoagulation with (case)
model minimal (amod)
withdrawal pyrazinamide (compound)
2e1 ( (punct)
terminated prematurely (advmod)
rigidity anesthesia (nmod)
groups steroid-treated (amod)
focus an (det)
media four (nummod)
none ( (punct)
advantages sulindac (nmod)
shows compound (nsubj)
combined csa (nsubjpass)
went home (advmod)
neuropathy organophosphorus-induced (amod)
nsaids and (cc)
occurred infections (nsubj)
electro-oculography , (punct)
result necessarily (advmod)
pressure hg (nmod)
oc ) (punct)
re-challenged should (aux)
abnormalities thyroid (compound)
i.v ( (punct)
mmhg mean (compound)
months was (cop)
sensitization of (case)
arrest sudden (amod)
sought study (nsubj)
tended which (nsubj)
mg/kg 0.63 (nummod)
significant indicating (advcl)
patients accidents (nmod)
response treatment (nmod)
map = (appos)
one factors (nmod)
product p (dep)
nociceptin , (punct)
disturbance neurological (amod)
response partial (amod)
less .05 (nmod)
useful assay (nsubj)
preservation cognition (nmod)
neurophysiology the (det)
limit complicate (conj)
increased ccl2 (nsubjpass)
changed received (advcl)
incidence in (case)
emphasizes . (punct)
injection before (case)
levels tafi (compound)
dexamethasone alone (advmod)
counterparts to (case)
bf-dependent . (punct)
area the (det)
anticoagulant oral (amod)
cause reactions (nmod)
tremor reactions (nsubj)
received presented (conj)
propagation maintenance (conj)
score 3.9 (appos)
view mesna (nmod)
search literature (compound)
alteplase with (case)
hormones sex (compound)
products of (case)
block drugs (nsubj)
depression action (nmod)
blocks minute (compound)
catalepsy for (case)
assessed discomfort (nsubjpass)
includes that (nsubj)
mg/kg bupivacaine (nmod)
detected consistent (dep)
p ): (punct)
failure because (case)
examine effect (dobj)
minutes 2 (nummod)
d chemotherapy (conj)
parenchyma the (det)
lines of (case)
ptz picrotoxin (conj)
microarrays antibody (compound)
white 924 (nummod)
effects weak (amod)
indicated score (nmod)
cause haemorrhage (nsubj)
ameliorates impairment (dobj)
understanding by (mark)
hg . (punct)
induce atypia (dobj)
subtle and (cc)
granulocytosis of (case)
ratio ] (punct)
series between (case)
microm diphosphate (nmod)
flaccid lacked (conj)
block the (det)
degree interference (nmod)
effect mechanism (conj)
measures growth (compound)
periods mean (compound)
placebo and (cc)
development speech (nmod)
lesion between (case)
units hounsfield (compound)
mg/kg 0.1 (nummod)
t ng/ml (conj)
effects tachycardia (nmod)
secretion prolactin (compound)
indicates gap (nsubj)
proteinuria nephrotic-range (amod)
range dose (compound)
leading cystitis (nmod)
initiate treatment (dobj)
started admission (nmod)
combination the (det)
models electroshock (compound)
revert off-periods (dobj)
[-]-[5ar,11bs]-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-+ , (punct)
reaction ) (punct)
pressure prescribe (acl)
24.3 ci=22.8 (dep)
restricted contrasted (conj)
admitted observation (nmod)
those neuropathy (nmod)
methods switched (appos)
aborted then (advcl)
and preoperatively (advmod)
implications therapeutic (amod)
neuropathy scotoma (nmod)
fields constricted (amod)
cco-i of (case)
pharmacology complex (nmod)
prevented dosing (nsubj)
dose duration (conj)
potential metabolite (nmod)
effect convulsants (nmod)
azathioprine cyclophosphamide (conj)
aes due (case)
increase deficiency (nsubj)
applies if (mark)
increased kcl (nsubj)
lowered mice (nmod)
$ROOT$ requires (sent)
mothers b (compound)
occurred change (nsubj)
sequence reports (conj)
raises support (advcl)
detected are (auxpass)
origin was (cop)
phosphatase of (case)
aging normal (amod)
$ROOT$ uraemia (sent)
normal increased (advcl)
complication frequent (amod)
induction syndrome (nmod)
decreased administration (nsubj)
day 1 (nummod)
accompanied consequence (nmod)
vasospasm coronary (amod)
region mid-thoracic (amod)
mimic closely (advmod)
received dexmedetomidine (dobj)
content hemoglobin (compound)
many of (case)
therapy oxide (compound)
interval 0.41 (appos)
quantify . (punct)
experienced initiation (nmod)
exposure every (det)
induce glomerulonephritis (dobj)
distribution and (cc)
hydroxylase of (case)
argatroban and (cc)
injection pentazocine (compound)
load with (case)
activation catecholaminergic (amod)
twitching adolescent (nmod)
infusion trinitrate (nmod)
differences placebo (nmod)
0.99 1.38 (appos)
cause concentrations (nsubj)
treated but (cc)
rats control (compound)
prospective , (punct)
behavior ouabain-induced (amod)
hours few (amod)
or=12.619 23.759 (appos)
cohort observational (amod)
increase proteins (nmod)
distress respiratory (amod)
condition treatment (nmod)
group normal-sodium (amod)
documented range (nsubjpass)
activity pra (appos)
antagonist 2a/2c (compound)
cortex entorhinal (amod)
using variables (dobj)
accompanied this (nsubjpass)
doses nephrotoxic (amod)
hypertrophy hyperplasia (conj)
examined studies (nmod)
7 versus (cc)
levels 3nt (compound)
medulla rats (nmod)
fragments by (case)
analysis interim (amod)
effect syndrome (nsubj)
days 1 (dep)
consisting edema (nmod)
battery tests (nmod)
dsp4 of (case)
inhibited decrease (nsubjpass)
patients few (amod)
182 16 (conj)
was , (punct)
dysrhythmias resistant (amod)
course prolonged (amod)
breakdown or (cc)
surface anionic (amod)
db 20 (nummod)
load high (amod)
impairment 7alpha-hydroxylation (nmod)
administration t0 (appos)
started cycles (nmod)
bendrofluazide , (punct)
worst was (cop)
enabling administration (nmod)
effects bromocriptine (nmod)
min hypotension (nmod)
converting patients (dobj)
rats the (det)
affects melatonin (nsubj)
used broadly (advmod)
given min (dobj)
waiting restriction (nmod)
nitrogen creatinine (conj)
30min for (case)
conclusion fails (ccomp)
used later (advmod)
influence protection (nmod)
countries japan (nmod)
difference content (compound)
h first (amod)
used condition (nmod)
decoction the (det)
performance task (compound)
unchanged excretion (nsubj)
one effects (nmod)
followed . (punct)
is limiting (csubj)
valdecoxib inhibitor (appos)
monitoring electroencephalographic (amod)
trained design (nmod)
stress isoproterenol-induced (amod)
mice tg (compound)
effective children (nmod)
effect potentiated (acl)
treatment amantadine (nmod)
findings studies (conj)
papaverine between (case)
myelotoxicity population (nmod)
incidence p (dep)
causes but (cc)
pronounced most (advmod)
atrial ventricular (conj)
urticaria/angioedema or (cc)
given or (advmod)
verified study (nmod)
day(-1 ) (punct)
died . (punct)
episodes the (det)
9/106 ) (punct)
age-dependency no (neg)
minimum to (case)
ct ) (punct)
activity increased (amod)
therapy dipyridamole (compound)
evaluate safety (dobj)
pd drug-resistant (amod)
cream the (det)
potentiation a (det)
convulsions neurotransmitters (conj)
electrocardiogram worn (acl:relcl)
shown counteract (xcomp)
prescribing aid (nmod)
$ROOT$ sparse (sent)
exceeded most (nmod)
recurrence maha (nmod)
123 124 (conj)
1.55 ( (punct)
anuria lasted (acl:relcl)
injected intrathecally (advmod)
restricted effects (nsubj)
dural cortical (conj)
hypertension american (amod)
fla-63 inhibitor (appos)
urea acid (conj)
g. dose (nsubj)
alcohol/nicotine an (appos)
task measure (conj)
acetaminophen edema (conj)
caused proteinuria (dobj)
indicate enhanced (ccomp)
diazepam anticonvulsant (amod)
produced withdrawing (advcl)
has agent (nsubj)
syndrome methylphenidate (conj)
patients predisposed (amod)
given prophylaxis (nsubjpass)
hypotension weakness (conj)
side-effect this (det)
chemotherapy intracavitary (amod)
hbv 7 (nummod)
occurrence licking (nmod)
response hypotensive (amod)
ecg of (case)
rauwolscine with (case)
limb transverse (amod)
latencies training (compound)
effects antiandrogen (amod)
stores into (case)
hemodynamics hypotension (nmod)
phenomenon descriptions (nmod)
models human (amod)
daunorubicin etoposide (conj)
phosphorylation ratio (appos)
use propranolol (nmod)
nonusers , (punct)
demonstrated abrogated (ccomp)
outcome clinical (amod)
dehydrogenase activities (conj)
controlled patients (nmod)
bilateral either (cc:preconj)
duration pauses (nmod)
8 11.2 (conj)
subregion to (case)
skf of (case)
action a (det)
flumazenil of (case)
had dose (advcl)
movements associated (acl)
examine and (cc)
arrhythmias atria (nmod)
rate release (nmod)
use doses (nmod)
organisms common (amod)
lesions , (punct)
normalisation by (case)
outcome teratogenic (amod)
hypertension from (case)
doses cya (nmod)
rated pain (dobj)
used successfully (advmod)
decrease , (punct)
toxicity the (det)
rtms " (punct)
knowledge effects (nmod)
-12.8 17.9 (conj)
team care (compound)
thrombi no (neg)
point 4 (nummod)
presented trigger (nmod)
% 4/26 (appos)
recorded practitioners (nmod)
micrograms 8.3 (nummod)
genesis asynergy (nmod)
refractory which (nsubj)
folate of (case)
implicating isoniazid (dobj)
magnitude in (case)
change number (nmod)
result consequently (advmod)
tariquidar pgp (compound)
neuropathy cutaneous (amod)
absence tg (nmod)
gag/pol 3delta (compound)
applied days (nmod)
completing immediately (advmod)
microelectrodes by (case)
class periods (nmod)
performed been (auxpass)
analysis western (compound)
$ROOT$ side-effects (sent)
assessment signal (nmod)
transplantation . (punct)
array ( (punct)
improved % (nsubjpass)
level higher (amod)
appear enhance (xcomp)
effective trial (dep)
scrutiny additional (amod)
occurrence decrease (conj)
reported rarely (advmod)
objectives the (det)
rct a (det)
shift balance (nmod)
tumors sign (nmod)
capsaicin for (case)
131i-hsa ) (punct)
c pf (conj)
cells cardiac (amod)
corrected is (auxpass)
influence inhibitory (amod)
gamma-glutamyltransferase , (punct)
16,459 , (punct)
cells human (amod)
dex-treated < (dep)
bupivacaine preceding (amod)
patient b (nmod)
% 2.2 (nummod)
explained not (neg)
ng./ml 35 (nummod)
increases interval (nmod)
increase cxad (nmod)
protein to (case)
agents with (nmod)
therapy valproate (nmod)
cardiotoxicity peroxidation (conj)
levels hypertensive (amod)
recurrence tachycardia (compound)
status at (case)
normalized increased (conj)
less to (dep)
follow-up a (det)
outcomes treatment (compound)
reprogramming immunomodulation (conj)
recorded stage (nsubjpass)
effect a (det)
lend not (neg)
fentanyl micrograms/kg (appos)
evaluating medication (dobj)
factors impacting (acl)
sensitive reproducible (conj)
0.25 - (punct)
disturbance metabolic (amod)
p.o. ( (punct)
induced were (auxpass)
incubated were (auxpass)
occurred elevations (nsubj)
means by (case)
regulate that (mark)
prescribed trimethoprim-sulfamethoxazole (dobj)
diagnosed november (nmod)
clues patients (nmod)
modifications therapy (nmod)
index pri (appos)
diseases glomerular (amod)
buprenorphine between (case)
occurred grade (dep)
effectiveness sphincter (nmod)
marrow , (punct)
return circulation (nmod)
present had (aux)
easy although (mark)
found reporting (advcl)
weight kg (dep)
obese or (cc)
maternal , (punct)
blocker prazosin (appos)
immunity of (case)
1.2 interval (nsubj)
impaired differ (conj)
reductions percentage (compound)
treatment nicardipine (compound)
10 6 (compound)
experiencing addition (dep)
pictures of (case)
provide data (dobj)
drug ? (punct)
values od (compound)
correlates as (case)
drugs benzodiazepines (conj)
cardiomyopathy observed (amod)
illustrates consequences (dobj)
effect anxiety (nmod)
% 12 (nummod)
admitted days (nmod)
pressure patients (nmod)
decrease because (mark)
g/dl g/dl (conj)
chemotherapy . (punct)
self-poisoning deliberate (amod)
combined are (auxpass)
experienced flashbacks (nmod)
damages process (nmod)
massive moderate (amod)
mu morphine (dep)
show intensity (dobj)
others by (case)
vip of (case)
modifications on (case)
antagonist l-365,260 (dep)
mssbp in (case)
biperiden by (case)
interpret . (punct)
was until (mark)
nerve around (case)
elimination cvvhdf (nmod)
evidence bleeding (nmod)
recurred however (advmod)
deficit occurred (acl:relcl)
hyperemia in (case)
pectoris angina (compound)
mixture proanthocyanidins (nmod)
alteration lipids (nmod)
seen restarted (advcl)
consists affects (conj)
undergoes tolerance (dobj)
manifest irrespective (advmod)
testing serial (amod)
1.050 1.025 (compound)
continued whereas (mark)
t+a [ (punct)
kidneys rats (nmod)
showed restored (ccomp)
patient metastases (nmod)
-cimetidine chlorpheniramine (conj)
fall associated (acl)
t1/2 ( (punct)
precede children (nmod)
side-effects by (case)
integration inputs (nmod)
tablets tab (nmod)
periods time (nmod)
infiltration encephalopathy (conj)
reversal the (det)
based and (cc)
up day (nmod)
part membrane (nmod)
administration combinations (nmod)
nuclei at (case)
therapy documentation (conj)
antagonist to (mark)
strains carriers (nmod)
% -18.1 (nummod)
version thai (amod)
loss integrity (nmod)
considered explanations (nsubjpass)
level glands (conj)
eyes control (amod)
increase alcalinization (conj)
became asymptomatic (xcomp)
case documenting (acl)
exanthema urtication (conj)
lower is (cop)
survived developed (conj)
frequency effect (nmod)
evidence origin (nmod)
decreased severity (dobj)
indeterminate trial (nmod)
s.c. . (punct)
discussion after (case)
excretion increased (amod)
treatment levetiracetam (compound)
tumors in (case)
line in (case)
bupivacaine and (cc)
effects structure (nmod)
atpases membrane (compound)
stones induced (amod)
performed has (aux)
tumor . (punct)
leading % (nmod)
combined hbig (nmod)
treatment initial (amod)
aes hypertension-related (amod)
procedure by (case)
caused grow (ccomp)
mg 100 (compound)
showed impairments (dobj)
vacuolization extensive (amod)
metoprolol midazolam (conj)
increased has (aux)
occur usually (advmod)
withdrawal ethambutol (nmod)
patients 44 (nummod)
case room (nmod)
p=0.008 and (cc)
af ( (punct)
response control (compound)
found difference (nsubjpass)
high levels (nmod)
mg/kg/b.w./day ) (punct)
received bicarbonate (dobj)
pituitaries 160 (nummod)
effect vasodilatory (amod)
conjunctiva to (case)
bche in (case)
weight half (nummod)
inhibiting phosphatase (dobj)
urticaria/angioedema ( (punct)
bronchodilator potent (amod)
tma cyclosporine-induced (amod)
risk delirium (nmod)
decreased prevented (conj)
progress stopping (advcl)
determine incidence (dobj)
normalization stopped (advcl)
bendrofluazide following (case)
received he (nsubj)
les of (case)
hypothesis characteristics (ccomp)
rate predobutamine (compound)
high unusually (advmod)
degeneration changes (conj)
others 2 (nummod)
years for (case)
atropine before (nmod)
those survived (acl:relcl)
blocks while (mark)
neurons brains (nmod)
appeared correlation (nsubj)
continued individuals (nmod)
exercised daily (advmod)
provide administration (nsubj)
orientation sagittal (amod)
group ett (appos)
indicated profile (dobj)
mri ) (punct)
seems gpi (nsubj)
exposure accidental (amod)
polysomnography followed (acl:relcl)
retention or (cc)
design evaluated (acl)
represented , (punct)
diethylstilbestrol to (case)
duration apnea (nmod)
reduction ; (punct)
exposure abstinence (conj)
nature . (punct)
recognized reported (conj)
me ( (punct)
complicated bleeding (nmod)
indicate substantial (ccomp)
noted details (nsubjpass)
$ROOT$ curative (sent)
lesions myocardial (amod)
gentamicin alone (advmod)
improvement an (det)
16 to (case)
prediction experiments (conj)
revealed upregulated (ccomp)
agonist clonidine (nsubj)
reduction harm (nmod)
outcome had (appos)
suppressants fenfluramine (compound)
tropicamide with (case)
prodrug an (det)
mg/kg 25 (compound)
investigates . (punct)
role potential (amod)
desire low (amod)
identification in (case)
intralipid p (appos)
pathway a (det)
intensity layer (nmod)
was component (attr)
$ROOT$ case (sent)
< (5.3)% (dep)
therapy consolidation (compound)
trials ; (punct)
pseudomonas alone (advmod)
associated anaesthesia (nsubjpass)
activity amphetamine-induced (amod)
antagonizes dysrhythmogenicity (dobj)
reduced symptoms (dobj)
formation hilar (compound)
olanzapine to (case)
measured tensions (nsubjpass)
hydrochloride [ (punct)
uv 13.1 (nummod)
similarity of (case)
model biological (amod)
evaluable . (punct)
decreasing incidence (dobj)
toxin botox (appos)
mg/kg 177.8 (nummod)
received november (nmod)
focuses syndromes (nmod)
increased relative (advmod)
% 67.2 (nummod)
patterns hyper-reactivity (nmod)
anatomy functional (amod)
risk cumulative (amod)
diagnoses overlap (appos)
effect proliferation (nmod)
ng/ml. 13 (nummod)
fact a (det)
group abusers (nmod)
interval ] (punct)
principle correlates (acl)
side-effect chemotherapy (nmod)
hg -18 (nummod)
developed disappeared (conj)
drug illicit (amod)
effects pointes (nmod)
ceased and (cc)
ago years (nmod:npmod)
acuity normal (amod)
mg/kg 840 (compound)
nephrotoxicity acetaminophen (compound)
survival progression-free (amod)
therapy chc (nmod)
acid strychnine (conj)
527+/-509 050+/-561 (conj)
175 , (punct)
any treatments (nmod)
inhibits given (mark)
reduced was (auxpass)
modulators with (case)
demonstrated improvement (dobj)
expression development (conj)
administration simultaneous (amod)
hepatocarcinogenicity of (case)
cases one (nmod)
data the (det)
antagonism adrenoceptor (compound)
reversed atorva (nsubj)
short-term ; (punct)
32.3 9.9 (conj)
antagonists and (cc)
netilmicin egg-white (amod)
groups azelastine (compound)
appeared given (ccomp)
63 +/- (cc)
66.9 was (cop)
reached days (nmod)
= 5.1 (dobj)
malformation is (cop)
dyspnoea and (cc)
old 5-week (nmod:npmod)
increased salbutamol (nsubj)
had average (nmod)
underwent transplantation (nmod)
sex of (case)
tests admission (amod)
protein glucose (conj)
lack particles (nmod)
revealed respect (nmod)
inhibits warfarin (nsubj)
risk disorders (nmod)
5 1 (compound)
causes receptors (nmod)
treated vnr (nmod)
inhibitors egfr (compound)
20 35 (conj)
appears dose-related (xcomp)
cn than (case)
24.3+/-6.8s ) (punct)
diminish not (neg)
decreased metformin (nmod)
girl a (det)
maleate ( (punct)
iop medication (nmod)
shock to (case)
controls 2 (nummod)
addicts denied (acl:relcl)
anomalies with (case)
period 7-hour (amod)
dyskinesia reserpine-induced (amod)
cases ) (punct)
rats n (dep)
protects acid (nsubj)
decrease but-relative (cc)
undergoes glucuronidation (dobj)
day 30 (nummod)
exploration and (cc)
report newspaper (compound)
anions superoxide (compound)
effect contraindicate (acl:relcl)
increased box (nmod)
evaluated been (auxpass)
rnfl calculated (amod)
20 +/- (cc)
cycle one (nummod)
frequency dissociation (nmod)
developed percent (nsubj)
administration long-term (conj)
both alone (dep)
weeks lnna (nmod)
autoantibody warm (amod)
demonstrated efficacy (dobj)
induced conditions (nmod)
psychosis , (punct)
hospitals arose (advcl)
divided : (punct)
study cancer (nmod)
lowering levels (nmod)
ramh ) (punct)
change values (nmod)
overdose blocker (compound)
response doses (nmod)
nephropathy and (cc)
rated therapy (nmod)
demonstrated vessels (nsubjpass)
demonstrated bones (nmod)
cause ne (nsubj)
reactions immunohistochemical (amod)
used azathioprine (nsubjpass)
injection adr (nmod)
enhances effect (dobj)
increase resulting (amod)
presentation complications (nmod)
degeneration half (nmod)
regimen antibiotic (amod)
use dexamethasone (nmod)
pretreatment a (det)
levels from (case)
research epilepsy (compound)
subjected attempt (nmod)
treatment ssri (compound)
february 1997 (nummod)
opaque and (cc)
diminished slowly (advmod)
resistant polyuria (nmod)
findings biopsy (nmod)
hemolysis caused (acl)
hypoperfusion cortical (amod)
related pressure (nmod)
hypotension for (case)
toxicity neurological (amod)
influences age (nmod)
recommend , (punct)
blocked receptors (nsubjpass)
committee the (det)
pallor attenuation (conj)
evaluation drugs (nmod)
engraftment groups (nmod)
photosensitivity of (case)
manifestation may (aux)
mg/kg 2.0 (nummod)
baseline min (appos)
citrate edetate (conj)
produce performed (advcl)
performed moreover (advmod)
stage either (cc)
given infusion (dobj)
favourable evolution (nsubj)
role beta2 (nmod)
vasculitis report (dep)
bilirubin an (det)
removed azt (nmod)
simvastatin atazanavir (conj)
recognized patients (nmod)
nerve in (case)
micrograms 24.8 (nummod)
cells own (amod)
del rs6277 (conj)
. 1999 (nummod)
200 , (punct)
patients any (det)
$ROOT$ collapsed (sent)
rats ob (compound)
pellet wk (appos)
collected prospectively (advmod)
fulfilled and (cc)
report preliminary (amod)
dose subanesthetic (amod)
patients hematuria (nmod)
release including (case)
externa at (case)
patients 26 (nummod)
operative may (aux)
due that (mark)
replacement rats (nmod)
conditioning followed (acl)
decreased minutes (nmod)
similar be (cop)
given water (nmod)
communicate ilk (nmod)
dysmorphism 2 (appos)
abilities functional (amod)
patients 169 (nummod)
airway versus (cc)
prodrugs ester (compound)
diagnose and (cc)
therapy cyclosporin (compound)
nephrosclerosis rats (nmod)
shell into (case)
cases encephalitis (nmod)
converse the (det)
adenocarcinoma an (det)
discussion first (amod)
therapy amitriptyline (compound)
cocaine systemic (amod)
method targeting (csubj)
$ROOT$ arrest (sent)
detecting impairment (dobj)
vacuolation additional (amod)
infusion paclitaxel (compound)
$ROOT$ older (sent)
% above (prep)
revealed further (advmod)
exposure barium (compound)
presents observations (dobj)
% 10 (compound)
assumed mg/day (nmod)
blockers antagonists (conj)
retention ( (punct)
support model (dobj)
apnea sleep (compound)
greater tension (nsubj)
profiles safety (compound)
cells lining (acl)
expression on (case)
subjects healthy (amod)
suggests fluconazole (dobj)
using methods (dobj)
advantages theoretical (amod)
resolved pseudolithiasis (nsubj)
$ROOT$ stroke (sent)
feeding by (mark)
290 - (punct)
nephrolithiasis phosphate (compound)
increased fps (dobj)
trial trial (conj)
impairments scopolamine-induced (amod)
antiretroviral arv (appos)
blind double (advmod)
found men (nmod)
dizziness symptoms (conj)
1.68 was (cop)
stopped reoccur (conj)
reversible toxicity (nsubj)
rate resting (amod)
demonstrated showed (advcl)
2 12 (conj)
associated injury (nmod)
found increased (ccomp)
revealed loss (dobj)
background and (cc)
cytosegresomes in (case)
appears reduction (nsubj)
follow-up 3-year (amod)
resulted infusion (nsubj)
infarctions more (amod)
due action (nmod)
dialysis peritoneal (amod)
% < (dep)
failure chronic (amod)
weeks . (punct)
necrosis blocked (acl:relcl)
1a1/1a2 isoenzymes (dep)
cortex amygdala (conj)
d-penicillamine mg/kg/day (appos)
cerebral the (det)
likely have (xcomp)
compensates that (nsubj)
months a (det)
correlated adjustment (nmod)
respiration spontaneous (amod)
received assessed (conj)
veins internal (amod)
scopolamine pentobarbital (conj)
caspase-3 b. (conj)
illustrate we (nsubj)
showed change (nsubj)
fibrosis tissues (nmod)
signals reaching (acl)
populations and (cc)
disinhibition or (cc)
serum total (dep)
water micrograms/ml (nummod)
monitored samples (nsubjpass)
damage tissues (nmod)
personnel medical (amod)
found course (nmod)
difficult , (punct)
balance sodium (compound)
expression vegfr-2 (compound)
concentrations metoprolol (nmod)
system discharge (compound)
scheduled woman (nsubjpass)
eighty-four one (compound)
resistance excretion (conj)
incidence urolithiasis (nmod)
antisialogue an (det)
correlates peripheral (amod)
failed treatment (nmod)
n=656 ( (punct)
hypertension nephritis (conj)
had thirty-nine (nsubj)
microliters ) (punct)
pose . (punct)
followed have (conj)
indicate plan (ccomp)
causing arrhythmias (dobj)
intolerant nsaids (nmod:npmod)
encountered patients (dobj)
microg 20 (nummod)
volume ventricular (amod)
mg/m2 400 (nummod)
occurred therapy (nmod)
believed case (ccomp)
frequency bradycardia (nmod)
degeneration matrix (nmod)
akinetic hyperkinetic (conj)
study interaction (nmod)
activation , (punct)
monooxygenases hepatic (amod)
repeaters switchers (conj)
circling ipsilateral (amod)
rigidity of (case)
derivative anthracycline (compound)
treatment however (advmod)
test recall (conj)
calculated days (nmod)
formation liver (compound)
ng-nitro-l-arginine , (punct)
remarkable disappearance (nmod)
control sem (conj)
injection immediately (advmod)
cases australia (nmod)
diet of (case)
myelosuppression against (case)
reversibility to (case)
disappeared pruritus (nsubj)
characterized compromise (nmod)
satisfy criteria (dobj)
required , (punct)
treatment chemotherapy (compound)
shown useful (xcomp)
seizure electrical (amod)
may 2012 (nummod)
remain roles (nsubj)
operated four (conj)
prescribing , (punct)
regimen dosage (compound)
prevent reducing (advcl)
protected first (advmod)
derivatives , (punct)
mechanism its (nmod:poss)
chloroform-adrenaline bacl2 (conj)
400 200 (nummod)
collected analysis (nmod)
nsaid for (case)
echocardiography a (det)
contributed that (nsubj)
association ptcr (nmod)
suggested induced (ccomp)
tri given (acl)
conducted trial (nsubjpass)
sign involvement (nmod)
high may (aux)
toxicology urine (compound)
dextran fluorescent (amod)
drowsiness confusion (conj)
provoke release (nsubj)
effect nimo (nmod)
relation usage (nmod)
challenged groups (nsubjpass)
mg/m2 2250 (nummod)
$ROOT$ collected (sent)
radioimmunoassay ) (punct)
developed hyperplasia (dobj)
aspects models (nmod)
receive lamivudine (dobj)
anemia for (case)
58.4 +/- (cc)
inconvenience irrigation (nmod)
progressed . (punct)
enzyme target (compound)
desensitization adenosine-5'-triphosphate (nmod)
due meloxicam (nmod)
removed successfully (advmod)
mdma ecstasy (appos)
days 25 (nummod)
had month (nmod:tmod)
proportions similar (amod)
increases frequency (dobj)
change significant (amod)
purpura thrombotic (amod)
caused stz-icv (nmod)
origin in (case)
observed delay (nsubjpass)
application before (case)
angiography coronary (amod)
induction tumors (nmod)
female 2 (nummod)
phosphokinase , (punct)
reproducible was (cop)
deficiency memory (compound)
growth cerebellar (amod)
able none (nsubj)
cns the (det)
adjusted dose (nsubjpass)
nephrosis aminonucleoside-induced (amod)
ie with (case)
disclosed moreover (advmod)
treatment d-penicillamine (nmod)
describe effects (dobj)
drugs antihypertensive (amod)
(bha)-induced hydroxyanisole (nmod:npmod)
synchrony breaths (nmod)
constituents active (amod)
concentration azelastine (nmod)
agent ticlopidine (dep)
approaches multiple (amod)
postdose by (case)
affect absence (nmod)
evaluated group (nsubjpass)
paralysis abductor (compound)
ci 69 (dep)
dosage meth (nmod)
reduce damage (dobj)
appear incidences (nsubj)
obtained studies (nmod)
intubation endotracheal (compound)
developed onset (nmod)
symptoms stereotypies (conj)
resolution days (nmod)
gastric cell (conj)
treatment doxorubicin (compound)
dipyridamole and (cc)
measurements electrocardiograms (conj)
pressure outcome (conj)
paced rate (nmod)
screened patient (nsubjpass)
extension tqrs (appos)
high population (nmod)
amounts blot (nmod)
developed incidence (appos)
decreased 31 (nmod)
affecting whether (mark)
1.03 +/- (cc)
obtained can (aux)
group further (amod)
l/kg ) (punct)
receiving selegiline (dobj)
inefficient removing (advcl)
inhibited inhibition (nsubj)
hemorrhage symptoms (conj)
hl in (case)
$ROOT$ methodology (sent)
patients free (acl:relcl)
hyperalgesia punctate-evoked (amod)
those n (dep)
delirium or (cc)
administration 5-fu (nmod)
profile improved (amod)
was analyse (ccomp)
blocked responses (nsubjpass)
electrophoresis spectrometry (conj)
effects seeds (nmod)
pregnancies in (case)
agent hyperlipemia (nmod)
b.i.d. mg (compound)
effect dependent (amod)
dips test (nmod)
continued function (nsubj)
107 x (cc)
discussed patients (nmod)
sources data (compound)
metrics and (cc)
hemlock poison (compound)
ms p<0.005 (appos)
exhibit affinities (dobj)
1.04 0.11 (conj)
assessed markers (nsubjpass)
caution greater (amod)
of is (cop)
$ROOT$ unsafe (sent)
pfs worse (amod)
found size-dependent (ccomp)
allowed avoid (ccomp)
more males (nmod)
reversed that (nsubj)
examination post-mortem (amod)
cisplatin ) (punct)
behavioral , (punct)
afford that (mark)
on " (punct)
rat same (amod)
hepatitis granulomatous (amod)
$ROOT$ blocks (sent)
tests use (acl:relcl)
producing rates (dobj)
agonist methylphenidate (nsubj)
discontinued soon (advmod)
patient report (dep)
105 5 (quantmod)
initiated subsided (conj)
5-fu mtx (conj)
scored loss (nsubjpass)
creatinine serum (compound)
obtained record (nmod)
decreased weeks (nmod)
except chx (nmod)
months cab (nmod)
appearance . (punct)
helpful extremely (advmod)
defined dose (nsubjpass)
zero . (punct)
$ROOT$ consists (sent)
remained received (advcl)
monitored converting (advcl)
by-product that (mark)
dystonia patient (nmod)
effects ephedrine (nmod)
rare life-threatening (conj)
activity nephrotoxicity (conj)
prudent avoid (xcomp)
hypertension weeks (conj)
responsible influence (nmod)
got in (case)
had own (nmod)
mediate which (nsubj)
injected edaravone (nsubjpass)
pentamidine tachycardia (conj)
inhibitor with (case)
17 11 (compound)
assay enzyme (compound)
14,671 9,832 (conj)
n=11 ( (punct)
se per (advmod)
patients 97 (nummod)
downregulation angiogenesis (nmod)
61.9 +/- (cc)
activity independent (amod)
impairments learning (compound)
nephrotoxicity significant (nsubj)
undertook . (punct)
studied widely (advmod)
life of (case)
found activity (nsubjpass)
relevance with (case)
nucleus stn (appos)
125 or (cc)
benign but (cc)
performed using (advcl)
strychnine str (appos)
biomarkers putative (amod)
kg(-1 week(-1 (appos)
slope and (cc)
rats administered (amod)
activity her (nmod:poss)
mg/m2 81 (nummod)
increased using (advcl)
rate incidence (compound)
$ROOT$ attenuated (sent)
which on (case)
23.7 ) (punct)
gender-dependent . (punct)
continued up (advmod)
months post-cab (dep)
pathways apoptotic (amod)
dehydrogenase ldh (appos)
neutropenia with (case)
assumed stopped (ccomp)
decreased inhibited (advcl)
symptoms meningitis (nmod)
mg/dl 9.7 (nummod)
partition its (nmod:poss)
analysis blot (amod)
163 15 (compound)
ouabain of (case)
hallucinations of (case)
act thus (advmod)
long-term ) (punct)
involved must (aux)
show induce (ccomp)
15 more (amod)
perseveration learning (conj)
7.1 0.7 (compound)
occurred cases (dep)
transformation of (case)
disorders spectrum (compound)
coinciding magnus (nmod)
alternative patients (nmod)
therapy-induced antituberculosis (nmod:npmod)
2 < (advmod)
treatment akathisia (nmod)
platinum of (case)
antagonist because (mark)
ml/h 5.4 (nummod)
matched we (nsubj)
oxprenolol orally (advmod)
seizures anesthetic (compound)
difference average (amod)
120 than (quantmod)
assay molecular (amod)
placenta four (appos)
trigger tachycardia (nmod)
association effects (conj)
nephropathy nephropathy (appos)
rat in (case)
drug which (nsubj)
inhibitor acylamidase (compound)
methods started (appos)
wave , (punct)
exposed millions (nsubjpass)
acid : (punct)
mg/m(2 117 (nummod)
discontinuation treatment (compound)
ascitis due (case)
normokalemic the (det)
prolongation under (case)
overload loss (conj)
findings mr (compound)
reports 82 (nummod)
rupture liver (compound)
systolic diastolic (conj)
h 0.9 (nummod)
indicates role (dobj)
impair range (nmod)
from 1998 (nmod)
identifying a1 (dobj)
observed that (nsubjpass)
reported have (aux)
disruption model (nmod)
perfusion on (case)
developed study (nmod)
presented : (punct)
neonates preterm (amod)
included nausea (dobj)
expression gene (compound)
taken year (nmod)
amnesia , (punct)
reports describing (acl)
controlled and (cc)
being as (mark)
activity muscle (compound)
granisetron of (case)
disease cld (dep)
decreased intensity (nsubjpass)
absence gland (nmod)
potentiating by (mark)
hg screening (amod)
lower it (dobj)
improvement outcome (compound)
0.2 versus (cc)
intervention : (punct)
nifedipine to (case)
november 2002 (nummod)
reversal naloxone (nmod)
= .040 (dobj)
serious reactions (nsubj)
threshold clozapine (appos)
dysplasia bcnu-induced (amod)
serious more (advmod)
treated thiopental (nmod)
polyuria insipidus (nmod)
centers two (nummod)
malondialdehyde blood (nmod)
p=0.0001 ) (punct)
leading accumulation (nmod)
dyserythropoiesis hemosiderosis (conj)
years 64 (nummod)
courses five (nummod)
patients least (advmod)
negligible stage (nmod)
immunosuppressed patients (nsubjpass)
aged months (nmod:tmod)
progressed as (mark)
prooxidant vitro (advmod)
failure acid-induced (amod)
44.18 and (cc)
insula cortex (conj)
immunosuppressant sirolimus (nsubj)
tamoxifen drug (appos)
cns cardiovascular (conj)
hit they (nsubjpass)
challenge phenobarbital (nmod)
units 100 (nummod)
decreased impressively (advmod)
increased diameter (dobj)
unclassifiable were (cop)
aggregation and (cc)
options ed (nmod)
uterotonic a (det)
data limited (amod)
event all (nummod)
neurotoxicity its (nmod:poss)
groups both (det)
concentration same (amod)
propranolol mg (appos)
production rats (nmod)
2-subunits channel (compound)
mutants virus (appos)
results male (appos)
group largest (amod)
documented neurotoxicity (nsubjpass)
postpartum day (nmod:npmod)
disorder pyridoxine-dependent (amod)
profile excellent (amod)
hematologic , (punct)
utilization in (case)
beating group (compound)
role pergolide (nmod)
c219 monoclonal (amod)
patients values (nmod)
linkage register (nmod)
describes infarction (dobj)
ts ( (punct)
fess ) (punct)
appeared histologically (advmod)
complement c3 (compound)
carcinoma well-differentiated (amod)
included thromboembolism (dobj)
old less (advmod)
information , (punct)
role learning (nmod)
randomised , (punct)
rare contrast (nmod)
infarctions strokes (conj)
ato mg/kg (dep)
reductase glutathione (compound)
treated mg/kg/day (nmod)
infant 17-day-old (amod)
increased sed (dep)
supplementation multivitamin (compound)
arrhythmias canine (compound)
induction znso(4 (nmod)
delirium ( (punct)
easy 99mtc-glucarate (nsubj)
implants ( (punct)
drug levels (dep)
excretion , (punct)
undergo to (mark)
admitted center (nmod)
bfgf il-6 (conj)
treated successfully (advmod)
day postoperative (amod)
possible treatment (nsubj)
shown media (nsubjpass)
paid must (aux)
hypercalcemia . (punct)
delivered vaginally (advmod)
kindling with (case)
% 19.3 (compound)
membrane in (case)
chloride sodium (compound)
use mefloquine (nmod)
syndrome events (conj)
promoted increase (dobj)
except dipyrone (nmod)
protein epithelial (amod)
tumor ovary (nmod)
patient glomerulosclerosis (nmod)
erythroid both (cc:preconj)
rarest . (punct)
people aged (amod)
september between (case)
higher significantly (advmod)
assessable : (punct)
hyperprolactinemia in (case)
water warm (amod)
ldh ( (punct)
considered case (nmod)
poorer significantly (advmod)
adding monoher (dobj)
$ROOT$ stabilized (sent)
poison activity (nmod)
dose 200-micrograms (compound)
diskinesia of (case)
same was (cop)
had order (nmod)
control vip(-/- (amod)
action with (case)
immunosuppression as (case)
developed also (advmod)
glu , (punct)
studied relation (nmod)
induce addressing (advcl)
reported transplantation (nmod)
number with (case)
flow effective (amod)
component amoxicillin (compound)
sarcolemma to (case)
myoclonus etomidate-induced (compound)
prolongation qrs (compound)
test days (nmod)
received placebo (dobj)
$ROOT$ manageable (sent)
controls 1190 (nummod)
responded subsequently (advmod)
followed should (aux)
factors affecting (acl)
pump osmotic (amod)
acted agent (nmod)
intracerebroventricular icv (dep)
levels over (case)
stopped decreased (conj)
newborns in (case)
reports several (amod)
market analgesic (amod)
prevented be (auxpass)
injection carcinostatics (nmod)
treated terbutaline (nmod)
possibility the (det)
published follow-up (dep)
effect mean (amod)
is/tia with (case)
taking contraceptives (dobj)
disease active (amod)
testing strain (nmod)
membranes plasma (compound)
induction propofol (nmod)
produced drug (nmod)
time-dependent and (cc)
edema . (punct)
deterioration to (case)
lower mcc (nsubj)
amount disability (nmod)
had presentation (dobj)
patients hoarseness (nmod)
pressure difference (conj)
patients taken (acl:relcl)
$ROOT$ 4 (sent)
pre-treatment pk (nmod)
$ROOT$ accumulating (sent)
nodules hyperplastic (amod)
3.8 +/- (cc)
secondary case (nsubj)
hyperkalemia . (punct)
exhibited however (advmod)
developed haematuria (dobj)
concentration in (case)
differ , (punct)
insults , (punct)
have creatinine (dobj)
suggests involved (ccomp)
factor-alpha in (cc)
surpasses . (punct)
regimens to (case)
inf-mi ) (punct)
effects interactive (amod)
decrease ameliorate (conj)
cortex supplementary (amod)
cylinder lesion (compound)
clearance in (case)
associated follow-up (nmod)
db = (parataxis)
disorders of (case)
word word (conj)
function perioperative (amod)
= 0.39 (dobj)
attack of (case)
decrease number (nmod)
repeated course (nsubjpass)
7.142 - (punct)
developed rifampin (nmod)
randomized amikacin (nmod)
cholesterol high-density (amod)
effect rls (nmod)
dosage neurotoxic (amod)
triggered salbutamol (nmod)
identify could (aux)
patient man (appos)
mg agent (nmod)
potentiation mutual (amod)
effect with (case)
matrix cytoskeleton (conj)
databases up (prep)
disease liver (compound)
mechanisms siat (nmod)
present was (cop)
useful thus (advmod)
timing application (nmod)
materials diagnosed (dep)
ampicillin , (punct)
assessed apoptosis (nsubjpass)
prevents if (mark)
drugs statins (nsubj)
activation stem (compound)
cultured admitted (conj)
difference that (mark)
sedation mri (compound)
underwent total (dobj)
studies animal (amod)
address thus (advmod)
volume sv (appos)
has argatroban (nsubj)
loss caused (acl)
extent according (case)
recording electrocardiographic (amod)
courses 6 (nummod)
received interferon-alpha-2b (dobj)
using chloride (dobj)
mg/kg 60 (compound)
area group (nmod)
supports provides (conj)
blocking hc (dobj)
models amphetamine-induced (amod)
mg/day 60 (nummod)
used introduction (nsubjpass)
support findings (nsubj)
instrument assessment (compound)
abundance an (det)
genes examined (acl)
revealed wall (nmod)
analyzed and (advmod)
demonstrated brightfield- (nsubj)
pca ( (punct)
administration 5-azc (nmod)
managed floor (nmod)
improvement of (case)
mmc mg (compound)
amoxicillin-clavulanate , (punct)
cis-platin 5-fu (conj)
$ROOT$ reflection (sent)
lactoferrin lf (appos)
highest proportion (nsubj)
group transplant (compound)
toxicity cyclophosphamide-related (amod)
injected region (nmod)
taking cimetidine (dobj)
risk may (aux)
sensitive are (cop)
treated regimens (nmod)
descending cord (nmod)
increased follow-up (nmod)
increase ingestion (nmod)
microg/kg or (cc)
liver and (cc)
8-se - (conj)
added mmc (nsubjpass)
presence micrograms (nmod)
report patients (nsubj)
referred dysfunction (nmod)
fatal sometimes (advmod)
1/10 about (advmod)
conducted concern (nmod)
saline 5711 (nummod)
pharmacokinetics formulation (nmod)
few literature (nmod)
ratio thermal (amod)
area ipsi- (conj)
two three (conj)
velocity ) (punct)
underwent prior (advmod)
induction dyskinesia (nmod)
copolymer dox (conj)
mechanism phenomenon (nsubj)
daytime the (det)
recur treatment (nmod)
hospitalizations included (acl:relcl)
correlations different (amod)
800 600 (compound)
phenobarbital the (det)
$ROOT$ unaffected (sent)
mol/l. than (case)
study society (compound)
exposed mapped (conj)
groups controls (nmod)
reduced while (mark)
pressure mda (conj)
treatment rat (nmod)
identifying mechanisms (dobj)
vaccine of (case)
micu ) (punct)
scopolamine saline/side (dep)
haemorrhages patients (nmod)
136 p (dep)
bp radiotelemetric (amod)
arthritis ra (appos)
c chronic (amod)
performed cystectomy (nsubjpass)
ce at (case)
lower surgery (nmod)
doxorubicin antibiotic (appos)
associated lithium (nsubjpass)
myopathy immune-mediated (amod)
mechanism(s its (nmod:poss)
document time (nmod)
trimipramine shows (acl:relcl)
methods treated (dep)
located , (punct)
mechanism such (predet)
concerns ongoing (amod)
problem significant (amod)
= 0.0228 (dobj)
miss frequently (advmod)
ibs with (case)
provoke that (mark)
$ROOT$ pleased (sent)
$ROOT$ nephrotoxic (sent)
function vestibular (amod)
drug antidiabetic (amod)
subset the (det)
receiving dxr (dobj)
had % (conj)
days thirty (nummod)
increment at (case)
complained reported (conj)
registration . (punct)
treatment nh4ac (compound)
meloxicam to (case)
closure telangiectasis (conj)
blocked reduced (conj)
effect studied (acl)
had group (advcl)
multiple often (advmod)
occurs nevertheless (advmod)
treated timolol (nmod)
saccades and (cc)
treatments failure (nmod)
died none (nsubj)
incidence studies (nmod)
for neither (preconj)
produce conversely (advmod)
vein femoral (amod)
distracted when (advmod)
exhibits that (nsubj)
syndrome ss (appos)
followed whom (nmod)
conclusions seems (dep)
decline progressive (amod)
cerebellum on (case)
measured heart (nmod)
recorded computers (nmod)
done always (advmod)
remains problem (attr)
adjustment with (nmod)
4.98 , (punct)
sirolimus of (case)
$ROOT$ action (sent)
mechanisms alters (acl:relcl)
aetiology in (case)
imaging mapping (nmod)
c219 antibody (compound)
causes hepatotoxicity (nmod)
measured homogenates (nmod)
depression st (amod)
large on (case)
combining of (mark)
conclusions correlates (dep)
drugs clozapine (dep)
days 28 (nummod)
less p (nmod:npmod)
produced reductions (dobj)
given report (nsubjpass)
cytoprotective are (cop)
inhibition anesthetics (nmod)
properties enflurane (nmod)
able pregs (nsubj)
recognized been (auxpass)
scores several (amod)
antagonists ) (punct)
degree real (amod)
drugs blocking (compound)
$ROOT$ pre-treatment (sent)
induced s-ketamine (nmod:npmod)
denervation active (amod)
catalepsy of (case)
showed cases (nmod)
values their (nmod:poss)
severe effect (nsubj)
observed excretion (nsubjpass)
administering mesna (dobj)
rate mineralizes (acl:relcl)
salicylate , (punct)
drug oral (amod)
gain to (aux)
alert clinicians (dobj)
complicated hypertension (nmod)
trough-concentrations both (cc:preconj)
g 175 (nummod)
received ketanserin (dobj)
controls microprolactinoma (conj)
rr 96 (nummod)
prevalent effect (nsubj)
or immediately (advmod)
experiment imaging (compound)
nature rotation (nmod)
awareness complication (nmod)
center national (compound)
stimulation atp (conj)
493 146 (conj)
$ROOT$ factor (sent)
ratios positive (amod)
cy ) (punct)
r-(alpha)-methylhistamine agonist (compound)
males in (case)
value vpa (nmod)
decreased contrary (nmod)
chronic but (cc)
placebos on (case)
reviewed and (cc)
was patient (nsubj)
tachyarrhythmias cardiac (amod)
dyskinesias levodopa-induced (amod)
strains lamivudine-resistant (amod)
controversy a (det)
appear affected (xcomp)
mice b1r (compound)
increased convulsion (dobj)
related are (cop)
suxamethonium kg-1 (appos)
conditions underlying (amod)
use withdrawal (nmod)
greater placebo (nmod)
linked abuse (dobj)
retains acid (nsubj)
survived failure (dobj)
3.75 , (punct)
nicotine by (case)
reversed decreased (conj)
lesions junction (nmod)
identical may (aux)
classification disease (nmod)
tilts degrees (compound)
sensor is (cop)
result uncommonly (advmod)
higher concentrations (nmod)
thrombosis renal (amod)
case rhabdomyolysis (nmod)
ceased switching (advcl)
correlated positively (advmod)
angiographies dose (nmod)
contraction jejunal (amod)
respond % (nsubj)
manipulation to (case)
inferior superior (conj)
disease kidney (compound)
reports leukoencephalopathy (nmod)
linking alteration (nmod)
milligrams of (case)
have not (neg)
steroid neuroactive (amod)
structure properties (conj)
progress cirrhosis (nmod)
jaw steel (nmod)
one whom (nmod)
proteinases lysosomal (amod)
1.1 : (punct)
dilatation desquamation (conj)
prediction and (cc)
alpha2- and/or (cc)
benzodiazepines or (cc)
delivered newborn (dobj)
mup in (case)
h mg/24 (nummod)
nomega-nitro-l-arginine lnna (appos)
number total (amod)
suspicions all (det)
delivered fetuses (nsubjpass)
inhibitor gamma-vinyl-gaba (appos)
action phenobarbital (nmod)
placebo 126 (nummod)
consistent encephalopathy (nmod)
results were (appos)
hitt of (case)
tight interrelationship (nsubj)
medium in (case)
available involvement (nmod)
doses ed50 (compound)
lacking e. (nmod)
obstruction introduction (nmod)
enlargement increase (conj)
comparable results (nsubj)
determined compared (conj)
inhibit adequately (advmod)
mediating dysfunctions (dobj)
determined catecholamines (nsubjpass)
drugs second-line (amod)
hepatitis alcoholic (amod)
evident movements (nmod)
affected abolished (conj)
treatment optimal (amod)
developed model (dobj)
supplemented been (auxpass)
increased phase (nmod)
restlessness , (punct)
stimulating tonically (advmod)
effect to (case)
alcalinization the (det)
release stimulated (acl)
levels apoptosis (conj)
genes its (nmod:poss)
reported diabetic (xcomp)
blockade the (det)
treated interval (nmod)
incidence leukocyturia (nmod)
blockade arrhythmias (nmod)
went remission (nmod)
impairment pathways (nmod)
$ROOT$ affected (sent)
inflammation steatosis (conj)
$ROOT$ sensitized (sent)
probe ) (punct)
treatment acne (nmod)
selected = (parataxis)
stem brain (compound)
produce improvements (dobj)
rise substantial (amod)
potency low (amod)
myelopathy neuropathy (conj)
intake alcohol (compound)
effect reduced (acl:relcl)
dse another (det)
functions levels (conj)
phase 0 (nummod)
describe effect (dobj)
lower doses (nsubj)
disappearance to (case)
score timi (compound)
government each (det)
consumed amounts (dobj)
improvement 44 (nmod)
advantage dose (nmod)
recognized has (aux)
irritation acc-9653 (nmod)
taking also (advmod)
observed risks (dobj)
returned onset (nmod)
mornings postoperative (amod)
regions same (amod)
efficacy viral (amod)
ph as (cc)
dimensions bruising (nmod)
present antibodies (nsubj)
reattempted suicide (dobj)
0.13 infusion (nmod)
nuclei son (appos)
suppressed deactivations (dobj)
effects haemodynamic (amod)
medication used (acl)
area wider (amod)
incidence the (dep)
range glomerulopathies (nmod)
protection nephropathy (nmod)
effect phenobarbital (nmod)
group adherence (compound)
characterization antagonist (nmod)
stereotypy activity (conj)
mrna subunit (compound)
produces results (conj)
c 41.5 (nummod)
syndrome caused (acl)
causes drug (nsubj)
drops maleate (compound)
measured lastly (advmod)
dogs ) (punct)
ranvier of (case)
dyskinesia orofacial (amod)
made arise (ccomp)
using events (dobj)
suggested strongly (advmod)
attacks transient (amod)
surgery to (case)
cycles consecutive (amod)
association calcification (nmod)
10.2 0.1 (conj)
lethargy with (case)
demonstrate alter (advcl)
$ROOT$ mapped (sent)
immunity rubella (compound)
greater than (nmod)
behaviour a (det)
earlier apoptosis (nmod)
reached control (advcl)
myalgia : (punct)
reactivation patients (nmod)
frequent are (cop)
assessment 5-minute (amod)
myocarditis secondary (amod)
haart + (amod)
shortening element (compound)
assessment , (punct)
developed hypotension (dobj)
restricted not (neg)
3a4 p450 (compound)
hbv into (case)
baroreceptors sinus (compound)
administration aspirin (compound)
blood-brain-barrier the (det)
nmda , (punct)
group antiinfective (amod)
cd-832 and (cc)
measurements ultrasound (compound)
restored clentiazem (nsubj)
myeloperoxidase- nor (cc)
is cancer (nmod)
mean ) (punct)
remain characterized (xcomp)
rats weighing (acl)
discussed hypotheses (nsubjpass)
cancer including (case)
decrease initial (amod)
concentrations via (case)
syndromes with (case)
surgery day (appos)
myelitis plexitis (conj)
exposure amphetamine (compound)
lymphoma relapsed (amod)
triphosphate nitroprusside (conj)
proteins , (punct)
continue , (punct)
drugs immunosuppressive (amod)
raise extent (nmod)
presence inhibitors (nmod)
deactivation for (case)
supplementation vitamin (compound)
agent well-tolerated (amod)
ssris ] (punct)
tjs of (case)
administered dose (nmod)
potentiated moreover (advmod)
due if (mark)
well-tolerated and (cc)
ias ( (punct)
350 ( (punct)
correlated however (advmod)
insulin fasting (amod)
control pressure (compound)
reduces myoclonus (dobj)
therapies despite (case)
research effects (nmod)
chlorofluorocarbons ozone-depleting (amod)
bypass and (cc)
men three (nummod)
shape promoted (acl)
changes count (nmod)
disappeared to (mark)
remained patients (dep)
shifting inhibition (conj)
or alone (advmod)
induced was (auxpass)
ventilation sufficient (amod)
inconsistent is (cop)
episode hypertensive (amod)
stem contribution (nmod)
sm ( (punct)
blind randomized (amod)
hearts hypertrophied (amod)
containing concentration (dobj)
nature course (conj)
combination bevacizumab/irinotecan (nmod)
ro 6028 (nummod)
suggest investigated (ccomp)
prednisolone prednisolone (conj)
trial therapeutic (amod)
stopped after (mark)
allergic antibiotics (nmod)
volunteers thirty-two (nummod)
hypotension tricyclic (amod)
city copenhagen (nmod)
pain patient (nmod)
questioned . (punct)
haloperidol single-dose (amod)
developed whom (nmod)
rd ) (punct)
signals hyperintense (amod)
calibre axon (compound)
studies , (punct)
factor schumacher (nmod:poss)
decreased cent (conj)
listed incontinence (nsubjpass)
children immunodeficiency (nmod)
break bud (compound)
hypotension no (det)
% controls (nmod)
factors plasminogen (conj)
persisted day (nmod)
switched are (auxpass)
histamine of (case)
six in (case)
overflow fractional (amod)
administered prochlorperazine (nsubjpass)
= 2.15 (dobj)
effect reversibility (conj)
serological and (cc)
rate neither (cc:preconj)
levels and (cc)
necrosis contributed (parataxis)
controls four (nummod)
infection opportunistic (amod)
$ROOT$ elevations (sent)
stroke cocaine-associated (amod)
studied patient (nsubjpass)
focus particular (amod)
provided denominator (dobj)
$ROOT$ also (sent)
planned elucidate (advcl)
level that (acl:relcl)
ead drugs (nmod)
shed this (nsubj)
tool oct (nsubj)
test induction (compound)
sotalol agents (conj)
sixth seventh (conj)
screening cocaine (nmod)
responsible uptake (nmod)
mechanisms ionic (amod)
effects trazodone (nmod)
occurred hallucinations (nsubj)
carried ; (punct)
crossed manner (nmod)
techniques microelectrode (compound)
improved and (cc)
detect slowing (dobj)
inhibition ester (nmod)
dependence malondialdehyde (nmod)
disorder underlying (amod)
got worse (acomp)
[d-pen2.5]-enkephalin ) (punct)
consideration careful (amod)
heart human (amod)
antagonized hypotension (nsubjpass)
london and (cc)
dosing and (cc)
participants seventy-six (nummod)
injection for (case)
mg 300 (compound)
iv analgesia (conj)
erg ( (punct)
accompanied evidence (nmod)
third patients (nmod)
7.5 and (cc)
patient demonstrating (acl)
telangiectasia became (acl:relcl)
derived trials (nmod)
reduce risk (dobj)
compared postmortem (advmod)
5-fluorouracil acid (conj)
those group (nmod)
weeks last (amod)
patients poor-risk (amod)
instillation methotrexate (nmod)
register 1998 (nmod)
period off (amod)
numbers percentage (conj)
similar however (advmod)
difficulty distinguishing (acl)
intake solution (compound)
failed supplementation (nsubj)
developed collapsed (conj)
skeptical also (advmod)
expression ut-a1 (compound)
increased revealed (advcl)
apoptosis induced (acl)
high-dose 26.3 (nummod)
infection , (punct)
given mesna (nsubjpass)
syncope prolongation (conj)
report objective (nsubj)
had concentrations (nsubj)
cigarettes , (punct)
changes respiratory (amod)
pellet 17beta-estradiol (compound)
inhibitor angiotensin-converting (amod)
cortex renal (amod)
supervened hepatitis (nsubj)
tapped and (cc)
assessed tremor (dobj)
model interesting (amod)
those effects (nmod)
guidelines evidence-based (amod)
disruption leading (advcl)
blockade pge(2 (nmod)
toxicities all (det)
supply an (det)
cultures rats (conj)
increasing are (aux)
overcome which (nsubjpass)
microscopy light- (amod)
exacerbation the (det)
effusion the (det)
prodrug phenytoin (nmod)
inhibitor no (compound)
presented sensation (dobj)
week abstinence (compound)
bolus standard (amod)
show animals (nsubj)
accident cerebral (amod)
determination counts (compound)
suggest while (mark)
enflurane of (case)
impaired cystitis (nmod)
puncture by (case)
best indicating (advcl)
followed neurotoxicity (nmod)
used trials (nmod)
treated examined (conj)
meq/l respectively (advmod)
efficacy incidence (conj)
development symptoms (nmod)
explain changes (nsubj)
nmda pilocarpine (conj)
degeneration of (case)
background observed (appos)
recovered quickly (advmod)
growth women (nmod)
engraftment patients (nmod)
subdivided distance (nmod)
infusion min-1 (nmod)
need suspect (acl)
responses stable (amod)
threshold ) (punct)
sgot dehydrogenase (conj)
needed that (mark)
tests paramethasone (nmod)
lesions within (case)
inadequate patients (nmod)
observed respect (nmod)
injection simultaneous (amod)
reported rate (dobj)
consistent reaction (nmod)
changes electrocardiograms (nmod)
cortex but (cc)
surgery middle-ear (amod)
agent combination (compound)
tested allopregnanolone (nsubjpass)
findings test (compound)
evaluated visibility (nsubjpass)
markers biological (amod)
decreases in (case)
values ki (compound)
contained they (nsubj)
treating in (mark)
cause underlying (amod)
emesis eight (dep)
determined content (nmod)
true regardless (advmod)
database ( (punct)
calcification in (case)
ratio 1.85 (appos)
developed cad (dobj)
greater < (dep)
20 25 (conj)
$ROOT$ chloroacetaldehyde (sent)
model symptom (compound)
discontinued days (nmod:npmod)
death areas (nmod)
increase ? (punct)
inoculation mg (nmod)
reported were (auxpass)
noted elevation (nmod)
nicotine , (punct)
abuse methamphetamine (compound)
study dose (compound)
precursor syntheses (nmod)
add not (neg)
found produce (conj)
solubility poor (amod)
carteolol propranolol (conj)
irreversible is (cop)
size stability (conj)
distance margin (compound)
applicable group (nmod)
elevated map (nsubj)
associated prolongation (nmod)
withdrawal nicergoline (nmod)
examined determine (advcl)
schizophrenia humans (nmod)
day immunization (nmod)
0.93 0.83 (dep)
partially , (punct)
contribute may (aux)
those mutation (nmod)
kindreds diabetic (amod)
induce translocations (dobj)
antibody ) (punct)
promoting rebound (dobj)
post-oltx are (cop)
improved mice (nmod)
nephrectomized or (cc)
produce may (aux)
hyperammonemia acid-induced (amod)
tomography 133xe (nmod)
t(9:22 ) (punct)
cells her (nmod:poss)
species system (conj)
gradient a (det)
measured when (advmod)
knee of (case)
dose lower (amod)
lowered concentration (nsubjpass)
case necrosis (nmod)
period control (amod)
neurons acid (compound)
stimulation train-of-four (compound)
coniine and (cc)
demonstrated animals (nmod)
ma with (case)
changes induced (acl)
diagnosed symptoms (nsubjpass)
mg haloperidol (compound)
contrast which (nsubj)
women 153 (nummod)
570 47 (conj)
intoxication underlying (amod)
recognised is (auxpass)
recordings hippocampus (nmod)
amines selected (amod)
appears that (mark)
compared measures (nmod)
eosinophilia and (cc)
mg/kg 625 (nummod)
therapy hit (nmod)
dose microg/kg (nmod)
involving apex (dobj)
11 of (advmod)
combination diazinon (nmod)
include not (neg)
were factors (nsubj)
summary . (punct)
pretreatment phenobarbital (nmod)
estimated differ (conj)
by slightly (advmod)
removed bladders (nsubj)
understood profile (nsubjpass)
demonstrated not (neg)
nsaids not (neg)
months 4.6 (nummod)
atypia carcinoma (conj)
case 5th (amod)
enzymes two (nummod)
provided . (punct)
correlated pge2 (nsubj)
given intraventricularly (advmod)
architecture sleep (compound)
scans radionuclide (compound)
apposition stent (compound)
hg p<0.05 (dep)
groups and (cc)
found scales (nmod)
hyperemia dipyridamole-induced (amod)
7.8 x (cc)
mice sgk1(-/- (compound)
strength function (conj)
group m (compound)
that mediated (conj)
abatement symptoms (nmod)
treatment lymphoma (nmod)
effect veralipride (nmod)
useful used (conj)
implicated studies (nmod)
preparations pharmaceutical (amod)
fast to (mark)
> % (nmod:npmod)
prevention superior (dep)
conclusion was (acl)
permit may (aux)
shedding cytomegalovirus (compound)
receiving angioplasty (nmod)
reduction p<0.001 (dep)
show reductions (nmod)
artery occluded (amod)
produced decreased (punct)
erythematosus gravis (conj)
related tiopronin (nmod:npmod)
dgc and (cc)
agents potential (amod)
list of (case)
concealed was (auxpass)
micrograms/kg at (case)
history urticaria/angioedema (nmod)
changes greater (dep)
treated adenosine (nmod)
concentration testosterone (compound)
molecules podocyte-associated (amod)
injection pan (nmod)
intubated ; (punct)
cells muscle (compound)
panel a/j (compound)
subtypes muscarinic (amod)
occur some (nsubj)
3.5 17.8 (prep)
derived that (nsubj)
rate shortening (conj)
evaluated ligands (nsubjpass)
$ROOT$ existed (sent)
4.1 2.7 (conj)
12.2 - (advmod)
titer receptor (compound)
maximal which (nsubj)
limited use (dobj)
factor iugr (nsubj)
satisfactory . (punct)
enantiomer a (det)
antagonists serotonin (compound)
nephrotoxic medium (nmod)
reduction sap (compound)
complication thromboembolism (nsubj)
i.c.v , (punct)
therapy used (acl)
years 45 (nummod)
more mice (nmod)
considered decline (nsubjpass)
polymorphisms drd2 (compound)
induced calcitonin (nsubj)
vnb days (nmod:tmod)
associated associated (conj)
total angiograms (nmod)
child healthy (amod)
confirmation pathologic (amod)
order resulting (acl)
lignocaine administered (acl)
was antagonized (conj)
complications haematological (amod)
decreases p (dep)
pneumonitis . (punct)
= [ (punct)
mitochondria in (case)
potentiates gvg (nsubj)
dose 70 (nummod)
procedure operative (amod)
radiolabelling , (punct)
band a (det)
segments nacl-treated (amod)
underlying risk (dobj)
heterozygous +/- (dep)
rate % (appos)
107 median (dep)
azotemia of (case)
treated dexrazoxane (nmod)
pointes pentamidine-induced (amod)
activator tpa (appos)
inhibition glioma (nmod)
give overview (dobj)
test after (case)
involved likely (advmod)
affected transmission (nsubjpass)
weight tap (conj)
rectifier delayed (amod)
need consider (advcl)
pharmacology a (det)
cont./min , (punct)
flutter , (punct)
paclitaxel taxol (appos)
induced phenobarbital (nmod)
exhibited treatment (nmod)
related extent (nsubj)
6 the (det)
vocalization fighting (conj)
cortex primate (amod)
plasma uptake (conj)
mitochondria particular (nmod)
model toxicity (nmod)
cholesterols , (punct)
2.6 and (cc)
paracetamol with (case)
estimated comparing (advcl)
dis 2004 (nummod)
machinery the (det)
improve administration (nsubj)
presented although (mark)
valdecoxib data (conj)
potentiation on (case)
$ROOT$ cancer (sent)
implanted . (punct)
cotrimoxazole metronidazole (conj)
women elderly (amod)
durations after (case)
attenuated test (nmod)
treated doxorubicin (nmod)
studies few (amod)
events 27 (nummod)
astrocytomas iv (nummod)
nodules or (cc)
bromocriptine of (case)
lesions encephalopathy (nmod)
represents amiodarone (nsubj)
operations in (case)
reducing decreased (conj)
facilitated appearance (dobj)
csa with (case)
150 200 (conj)
microscopy immunoelectron (compound)
remained content (nsubj)
were episodes (attr)
documenting binding (dobj)
previously years (nmod:npmod)
considered only (advmod)
resistance as (case)
> 0.71 (dobj)
cyclosporine tacrolimus (conj)
transitioned ultimately (advmod)
bun mg/ml (appos)
latency 1 (dep)
illustrates tool (nmod)
affects vary (conj)
supplied subjects (nsubj)
intervention feeding (acl)
decreased < (dep)
reproduces sequelae (dobj)
studied n=834 (parataxis)
kept be (auxpass)
absences of (case)
inhibition system (nmod)
formation vacuoles (nmod)
30 50 (conj)
functions impaired (amod)
transformation areas (nmod)
organs target (compound)
aida doses (nmod)
0.24 0.06 (conj)
fashion in (case)
explanation is (cop)
used environment (nmod)
studies imaging (nmod)
died contrast (nmod)
erythrocytes in (case)
increases non-significant (amod)
acquired questionnaire (nmod)
horn in (case)
acids 5 (dep)
risk estimated (amod)
entered trial (dobj)
thought precipitation (xcomp)
experienced and/or (cc)
subjects these (det)
chlorthalidone ( (punct)
prolongation patient (nmod)
one but (cc)
case anaphylaxis (nmod)
prolonged intensified (conj)
amount . (punct)
diamorphine only (advmod)
intermediate and (cc)
g/dl < (amod)
monomer dimer (conj)
reactions hemolytic (amod)
received given (conj)
resection during (case)
29 ( (punct)
changed identified (conj)
introduction since (case)
dosed dox (nmod)
warrant that (mark)
expression distribution (conj)
associated all (parataxis)
ng/ml 4497 (nummod)
rash and (cc)
c+e , (punct)
impaired that (mark)
stem cortex (conj)
performance , (punct)
oil without (case)
38.9 8.3 (conj)
men completed (acl:relcl)
depletion neurotransmission (nmod)
treatment antiretroviral (amod)
based variable (nsubjpass)
venue a (det)
produce complication (dobj)
received to (mark)
received diet (dobj)
glomerulosclerosis increased (amod)
droperidol used (acl)
circumstantial and (cc)
damage neurotoxicity (conj)
benefit mazindol (nsubj)
vasopressin arginine (compound)
g/m2 ) (punct)
dexamethasone of (case)
reduced strongly (advmod)
split as (case)
effect ammonia (nmod)
intervention inserted (dep)
tablets of (case)
dysphonia spasmodic (amod)
chemotherapy thiotepa (compound)
efficacious trials (nmod)
remained proteinuria (nsubj)
nucleus 8/8 (appos)
administration disulfiram (nmod)
disease 2 (appos)
apparent though (mark)
measured decrease (nmod)
muscle left (amod)
capacity loading (compound)
$ROOT$ counted (sent)
returned abolished (advcl)
weight levels (appos)
monitoring dose (nmod)
proceeded escalations (nsubj)
data use (nmod)
patients eighty-eight (nummod)
p20 on (case)
techniques newer (amod)
system cardiac (amod)
predominance the (det)
represent could (aux)
unresponsive toxicity (nmod)
administration ifs (nmod)
third day (nmod)
4 3 (compound)
er to (case)
users gestodene (nmod)
approach comprehensive (amod)
choreoathetosis acute (amod)
tricyclics by (case)
kg-1 i.v. (amod)
deficits discrimination (nmod)
model analyze (acl:relcl)
designed aim (nmod)
standard- or (cc)
persisted and (cc)
3,4-methylenedioxymethamphetamine ) (punct)
exposure is (cop)
methods genetic (amod)
strength muscular (amod)
necrosis myofibre (compound)
symptoms concomitant (amod)
found responses (nsubjpass)
achieved often (advmod)
coincidental be (cop)
helpful . (punct)
phenytoin intravenous (amod)
finding reliable (amod)
s-limonene alcohol (conj)
disorders associated (amod)
medications with (case)
progestagens gestodene (dep)
factor chemotherapy (nmod)
attenuated alpha-tc (nsubj)
enhancement thermal (amod)
1.52 - (punct)
sensitivity les (nmod)
nausea headache (conj)
area anatomic (amod)
age older (amod)
benzoylecgonine the (det)
occurred woman (nmod)
mpep ip (advmod)
proteinuria conversion (nmod)
iceberg an (det)
increased ibuprofen (nsubj)
months 4.4 (parataxis)
disorder obsessive-compulsive (amod)
variations individuals (nmod)
effects maximal (amod)
acquired these (nmod)
cured and (cc)
preparations antacid (compound)
paucity a (det)
system analysis (conj)
died sustained (conj)
asenapine , (punct)
restriction fluid (compound)
complexes single (amod)
procedure single-placebo-controlled (amod)
present taking (advcl)
group 90/htn (conj)
reduced subsequently (advmod)
improvements months (nmod)
showed intensity (dobj)
received respectively (advmod)
factors dyskinesia (nmod)
activities the (det)
acid p-coumaric (amod)
capacity transport (compound)
uroprophylaxis mesna (compound)
inflammation induction (nmod)
consequence phenotype (nsubj)
1.6 - (punct)
calcification calcification (conj)
increased ro (nmod)
began have (xcomp)
abundance total (amod)
demonstrate therapy (dobj)
complicated further (advmod)
processes cell (compound)
sites two (nummod)
excitability in (amod)
course days (nmod)
conventional or (cc)
subdivided circles (nmod)
inhibit did (aux)
led cases (nmod)
patient such (case)
coronary circumflex (amod)
influenced barely (advmod)
rates withdrawal (nmod)
objectives : (punct)
ovex ) (punct)
developed nodosum (dobj)
range 36 (nsubj)
related combined (advcl)
increases cocaine-induced (amod)
concentrations coniine (nmod)
resulted activation (nmod)
abnormalities hormonal (amod)
appear however (advmod)
mg/24 2.5 (compound)
night all (nummod)
understood , (punct)
collapsed leaving (advcl)
drugs dna (compound)
exchange , (punct)
latencies those (nmod)
p<.001 [ (punct)
higher jj (nmod)
needed mg/kg (nsubjpass)
rats epilepticus (compound)
unrecognized often (advmod)
alpha3 the (det)
% measures (appos)
play although (mark)
formyl-methionyl-leucyl-phenylalanine patients (nmod)
caused activity (dobj)
number subjects (nmod)
enhancement antagonist (compound)
november in (case)
u-ii administered (amod)
effective niacinamide (nsubj)
generation peroxide (compound)
5-fu/fa with (case)
middle-aged healthy (amod)
cr , (punct)
administration a (nmod)
nik-247 e-2020 (conj)
aggregation for (case)
test swim (compound)
gls combined (acl)
inferior colliculus (dep)
assessment full (amod)
receptors colliculus (nmod)
transfusion therapies (conj)
recommended , (punct)
time survival (conj)
pha-p ) (punct)
enzymes the (det)
co. ansan (appos)
vpa of (case)
mediated are (auxpass)
infusions in (case)
transport placebo (dep)
discontinued hydrochloride (nsubjpass)
erythromycin amoxicillin (conj)
lobe prostate (compound)
initiated research (nmod)
signs nephrotoxicity (nmod)
consumed regularly (advmod)
reported case (nmod)
persisted mice (nmod)
cle ) (punct)
low , (punct)
exhibit to (mark)
s in (case)
associated protocol (nmod)
women taking (acl)
evoke division (nmod)
prolonged were (cop)
class state (conj)
treatment fixed-dose (amod)
have dtis (nsubj)
crisis migraine (compound)
administration methylergonovine (nmod)
bradycardia induced (acl)
reviewed modified (conj)
heart versus (cc)
suppression groups (nmod)
expanded study (nmod)
lesions dwi (nmod)
min 2.20 (nummod)
remains prognosis (nsubj)
adjustment dosage (compound)
radiograph chest (compound)
amelioration hypokalemia (nmod)
patients more (amod)
10(9)/l ) (punct)
patients tumor (compound)
decreased cgs (nsubj)
impair but (cc)
rilmenidine , (punct)
$ROOT$ euthanized (sent)
begun or (cc)
cellular and (cc)
difficulty getting (advcl)
incident similar (amod)
coagulation with (case)
onset between (case)
sequelae due (case)
administered ccnu (nsubjpass)
loss : (punct)
engorgement intense (amod)
published but (cc)
reflected impairment (nmod)
examined outcomes (nsubjpass)
evaluate impact (dobj)
piglets in (case)
became hypercalcemic (acomp)
determine determine (conj)
generation epilepticus (nmod)
effective most (amod)
agent ( (punct)
p20 or (cc)
agents other (amod)
activity penicillin-induced (amod)
reagent a (det)
accumulation hearts (nmod)
induced scopolamine (nmod)
$ROOT$ 3.0+/-0.4 (sent)
rehabilitation oral (amod)
gender , (punct)
activation neuroinflammation (conj)
np and (cc)
seizures hfde-induced (amod)
acne or (cc)
combining t+pcpa (dobj)
s 580 (nummod)
presence asterixis (nmod)
observed schizophrenia (nmod)
prevent . (punct)
probe microdialysis (compound)
absent glepp1 (nsubj)
min stopped (advcl)
combination zidovudine (nmod)
ci 1.60 (nummod)
paramethasone and (cc)
mesna oral (amod)
peptides by (case)
min 77.1 (nummod)
disease verified (amod)
correlates concentration (nsubj)
metabolized cyp3a4 (nmod)
treated february (nmod)
recordings the (det)
became . (punct)
identified until (mark)
described and (cc)
followed male (nmod)
damage irreversible (amod)
latency stage (nmod)
correlates since (mark)
erythrocytes leukocytes (conj)
tone cardiac (amod)
erythroderma eosinophilia (conj)
bfu-e ( (punct)
pain substernal (amod)
on especially (advmod)
inhibited nalozone (nmod)
78 42 (conj)
r2 ( (punct)
increase pressures (nmod)
cancer after (case)
flavonoids , (punct)
increased icp (dep)
$ROOT$ conceivable (sent)
patients fifty-one (nummod)
nanoparticles suspension (conj)
fractions hippocampus (nmod)
proliferation inductive (amod)
history or (cc)
result combination (nsubj)
effects amnesic-like (amod)
showed eegs (nsubj)
lcva in (case)
disappeared dechallenge (nmod)
changes into (case)
correlates expression (nsubj)
displays ssr103800 (nsubj)
consistent velocity (nmod)
involvement mitochondrial (amod)
found tissues (nmod)
2.3 - (advmod)
abdomen a (det)
died cows (nsubj)
presented treatment (nmod)
withdrawn when (advmod)
fraction mean (amod)
formed . (punct)
significant that (mark)
tablets nifedipine (compound)
recipient cardiac (amod)
ketoprofen not (cc)
patients exposed (acl:relcl)
pneumonia diseases (conj)
socs-1 ( (punct)
unknown is (cop)
effect phosphorylation (nmod)
patients 130 (nummod)
found decreases (dobj)
compared area (nmod)
monitored ; (punct)
explain could (aux)
increased nor (cc)
markers sensitive (amod)
hysterosalpingography of (case)
n= 50 (dobj)
adult a (det)
important are (cop)
= enalapril-treated (conj)
2 whom (nmod)
granules only (advmod)
resulted however (advmod)
angina function (conj)
amplitude and (cc)
cord spinal (amod)
> group (nmod)
developed previously (advmod)
protocol this (det)
dealt . (punct)
withdrawal heat (nmod)
trees in (case)
eliminated increase (dobj)
accompanied depletion (nmod)
considered remains (advcl)
recall no (neg)
allocated patients (nsubjpass)
incoordination muscular (amod)
20- , (punct)
$ROOT$ procedures (sent)
hemorrhage by (case)
glycosuria with (case)
release plasma (nmod)
% -24.6 (nummod)
brings about (compound:prt)
increase number (dobj)
withdrawal patients (nmod)
hemodialysis of (case)
period study (compound)
alpha2abc-/- ( (punct)
included sweating (dobj)
formulations two (nummod)
attention little (amod)
diabetes level (conj)
flunitrazepam of (case)
echocardiography assess (acl:relcl)
messages da-related (amod)
0.3 < (advmod)
accelerated is (auxpass)
b12 supplementation (conj)
activity pathways (nmod)
duration shorter (amod)
become has (aux)
us by (case)
physical quantitative (conj)
age 81.1 (nmod)
started we (nsubj)
modified that (mark)
huntington 's (case)
asthma nocturnal (amod)
pattern consistent (amod)
selecting agent (dobj)
administration ibuprofen (compound)
liver for (case)
microscopy conventional (amod)
patients men (appos)
sulfate or (cc)
taking disorder (nmod)
accuracy to (case)
phases paclitaxel (compound)
increase robust (amod)
$ROOT$ subjects (sent)
appeared layers (nmod)
spared they (nsubjpass)
encouraging are (cop)
inhibitor cyp3a4 (nmod)
8 of (case)
protein 425 (nummod)
register in (case)
neonates had (acl:relcl)
source patients (nmod)
octreotide treatment (appos)
antigen bfgf (conj)
developed protein (nmod)
prudent it (nsubj)
cromakalim doses (nmod)
greater patients (nmod)
paraparesis spastic (amod)
ml/ng ) (punct)
clarify in (mark)
marker damage (nmod)
mg adrenaline (compound)
wt and (cc)
days sampling (nmod)
experienced had (aux)
sections whole (amod)
result hazardous (conj)
observed lower (advcl)
rated parents (nmod)
seizures typical (amod)
hazard as (case)
doses paclitaxel (compound)
inactive metabolites (nsubj)
role opiate (nmod)
women 871 (nummod)
frequency power (compound)
received took (conj)
cause disruption (dobj)
maximize respect (nmod)
analogue is (cop)
improve chain (dobj)
cases submitted (amod)
prevented catalepsy (dobj)
half-life its (nmod:poss)
hr 1 (nummod)
controls signaling (nsubj)
vision ( (punct)
change both (cc:preconj)
accepted . (punct)
anesthetic amide (compound)
occurred weeks (nmod)
blockers with (case)
impairment hippocampal (amod)
substrate that (mark)
immunocytoma transplantable (amod)
patients anemia (nmod)
vigilance heightened (amod)
women 85 (nummod)
molars third (amod)
l-name mg/kg (dep)
epilepsy caused (acl)
behavior aberrant (compound)
is unclear (advcl)
biopsy and (cc)
disease vascular (amod)
n-methyl-d-aspartate or (cc)
involvement , (punct)
presentation hepatic (amod)
two patients (nmod)
pg to (dep)
alternative real (amod)
restoration for (case)
progesterone nm (amod)
slowing associated (acl)
express that (nsubj)
kit , (punct)
test sensitive (amod)
originating esophagus (nmod)
parameter in (case)
enrolled completed (parataxis)
homogenates by (case)
2 5 (conj)
toxicity zidovudine (nmod)
days 967 (nummod)
symptoms psychotic (amod)
concentration potassium (conj)
agonist d2-like (amod)
deposition marked (amod)
pain devastating (amod)
toxic potentially (advmod)
higher but (cc)
assessed cells (nmod)
version review (nmod)
data cardiovascular (amod)
defects regarding (case)
$ROOT$ finding (sent)
transformation cytoplasmic (amod)
feasibility combination (nmod)
man leukemia (nmod)
increasing status (dobj)
% myelosuppression (dep)
$ROOT$ become (sent)
acetate ra (appos)
effective fungi (nmod)
heart the (det)
doses graded (amod)
service psychiatric (amod)
infusion saralasin (nmod)
induction , (punct)
sequence the (det)
dose mentioned (amod)
visualized nissl-staining (nsubj)
four two (quantmod)
index by (case)
apoptosis drug-induced (amod)
identified group (nsubj)
has electrocardiography (nsubj)
16 pretreated (amod)
ill average (nmod)
cent 84 (nummod)
523.5 129.7 (conj)
behaviour novelty-suppressed (amod)
serum-albumin tissue (nmod)
started man (nsubjpass)
dizocilpine antagonist (appos)
developed oliguria (dobj)
p20 ( (punct)
compared cases (nsubjpass)
gentamicin of (case)
detect , (punct)
reported 3 (dep)
induced iso (nsubj)
synapses cholinergic (amod)
metabolites remoxipride (nmod)
suppress did (aux)
encountered that (nsubjpass)
subjects . (punct)
dementia and (cc)
arrhythmogenicity cultures (nmod)
immunosuppression rapamycin (compound)
infusion part (nmod)
study single-intervention (amod)
measured flow (nsubjpass)
play junctions (nsubj)
mg. and (cc)
movements fingers (nmod)
allow monitoring (dobj)
differ values (nmod)
induced rigidity (dobj)
third and (cc)
severity liver (compound)
rigidity activity (conj)
hypotension severe (amod)
report girl (dobj)
supply of (case)
infarction inf-mi (appos)
occlusion retinal (amod)
piroxicam of (case)
n=283 ) (punct)
shown interaction (dobj)
opse nondyskinetic (nmod)
infarction septicaemia (conj)
administration succinylcholine (compound)
ctx ( (punct)
recipients liver (compound)
treat pain (dobj)
indicate alters (ccomp)
3.4 to (dep)
levels oestrogen (compound)
cognitive psychomotor (conj)
% 0.01 (nummod)
patients temperament (nmod)
decreased % (dep)
important report (xcomp)
appeared angiography (nmod)
agents immunomodulatory (amod)
1996 - (punct)
returned although (mark)
presence characteristics (conj)
therapy inhibitor (nmod)
substance pure (amod)
pneumonia ) (punct)
thyroxine simvastatin (conj)
low high (conj)
activation brain (nmod)
improvement rapid (amod)
recognize diagnosis (nmod)
1.0 2.5 (conj)
20 60 (conj)
bolus dose (nsubj)
psychosis population (nmod)
patients took (acl:relcl)
chemotherapies before (case)
damage lamina (nmod)
october from (case)
spect thallium-201 (compound)
vaccine rubella (compound)
palsy subsequent (amod)
recorded activity (nsubjpass)
diuretic of (case)
impairment ) (punct)
comprise . (punct)
study initial (amod)
professionals of (case)
shell intra-accumbens (amod)
followed doses (nmod)
escalations dose (compound)
use irrigation (nmod)
metoclopramide , (punct)
rats g (appos)
similar metabolism (nsubj)
increase vulnerability (dobj)
admitted discontinued (conj)
persisted effects (nsubj)
performed women (nmod)
alterations and (cc)
antagonist h3-receptor (compound)
therapy prompt (amod)
scan ct (compound)
occurred relapses (nsubj)
behavior induced (acl)
months 14.1 (nummod)
monkeys levodopa-primed (amod)
continued decreased (advcl)
use inhibitor (nmod)
suggest useful (ccomp)
weeks ) (punct)
triggered which (nsubjpass)
pacing burst (compound)
presence locations (conj)
neurosis and (cc)
efforts of (case)
considered countries (nmod)
rats tr(- (compound)
epilepsy seizures (nmod)
% 4 (nummod)
administration its (nmod:poss)
h acquisition (nmod)
agsd ) (punct)
measure 30-min (amod)
exhibit did (advcl)
injections two (nummod)
produce wall (nmod)
discontinuation amiodarone (nmod)
drugs anticonvulsant (amod)
associated raloxifene (nsubjpass)
using nicotine (dobj)
avoided . (punct)
unchanged were (cop)
ingesting dosage (nmod)
trial difluoromethylornithine (nmod)
dysfunction comparable (amod)
individuals of (case)
abrogated reduced (conj)
affected % (dep)
factor were (cop)
transcription of (case)
granulomatosis even (advmod)
pfs ( (punct)
mainstay have (aux)
has compared (advcl)
carries mortality (dobj)
deposits igg (compound)
effect inhibitors (nmod)
able , (punct)
recovery attenuated (amod)
reaction drug (compound)
map -23%(-)-26 (nummod)
weeks 21 (nummod)
greater 20-fold (advmod)
28.2 - (advmod)
treatment hydroxychloroquine (compound)
implicated these (nmod)
patients 119 (nummod)
nitrogranulogen administered (acl)
result this (det)
anticoagulated dialysate (nmod)
safety associated (acl)
decreased patients (nmod)
result increase (nmod)
battery on (case)
tumour solid (amod)
substance with (case)
stages into (case)
rofecoxib ns-nsaids (conj)
cells/microl 165 (nummod)
account which (nsubj)
subtype 7 (nummod)
ratio develop (acl:relcl)
persist withdrawn (advcl)
propranolol and (cc)
has patient (nsubj)
29.3 +/- (cc)
hyperplasia for (case)
cent from (case)
observed pattern (nsubjpass)
have action (dobj)
risperidone of (case)
those symptom-free (acl:relcl)
reduction lesions (nmod)
vomitus , (punct)
moment at (case)
withdrawal verapamil (nmod)
attenuated changes (nsubjpass)
$ROOT$ protects (sent)
withdrawal usage (nmod)
changed levels (nsubj)
cycles with (case)
abortion saline-induced (amod)
control experimental (conj)
measurement angiography (nmod)
sensitizing in (mark)
resolution incomplete (amod)
piloerection , (punct)
acid aspartate (conj)
levels phenytoin (compound)
formulation a (det)
$ROOT$ diminished (sent)
described patient (dobj)
drug interval-prolonging (amod)
when ( (punct)
28.0 and (cc)
acid taurodeoxycholic (amod)
infusion subanesthetic (amod)
children aged (amod)
significant exam (nsubj)
assays techniques (conj)
hypokalemia the (det)
observed acid (nmod)
comparable group (nmod)
granulated , (punct)
consolidation integration (conj)
seizures infants (nmod)
surge a (det)
positive hbsag- (nmod:npmod)
syndrome hemolytic (amod)
diagnosis chemotherapy (conj)
pool on (case)
restoration half (nmod)
group cell (compound)
7.7 1.3 (conj)
syndrome reports (appos)
studied children (nmod)
received g/m2 (dep)
ng/ml. level (nsubj)
5.4 3.5 (compound)
14 10 (quantmod)
eosinophilia ) (punct)
co-infected hiv (nmod:npmod)
deviations with (case)
patients background (nmod)
accumulation line (nmod)
transit treatment (nmod)
occurred suppression (nsubj)
given saline (conj)
desogestrel gestodene (conj)
interactions warfarin (compound)
injected daily (advmod)
mmp-timp adam (conj)
thorax limbs (conj)
studied variation (nsubjpass)
solution while (case)
increasing significantly (advmod)
n/n=9/26 or (cc)
measured monitoring (nmod)
recruited receive (xcomp)
appear 2-receptors (xcomp)
damage massive (amod)
borderzone the (det)
hernias cell-to-cell (compound)
apparent , (punct)
diseases several (amod)
mg/dl 93 (nummod)
downregulating by (mark)
zero but (cc)
present authors (nsubj)
associated may (nsubjpass)
obtained were (auxpass)
arose . (punct)
walk feet (dobj)
sequelae those (det)
increased increase (conj)
voltammetry cyclic (amod)
beta-blocker cardioselective (amod)
oddi of (case)
relevancy human (amod)
formulations the (det)
kg-1 glycopyrronium (compound)
expression mediator (compound)
glaucoma angle-closure (amod)
hepatotoxicity phosphorus (compound)
epinephrine subsequent (amod)
achieved results (nsubjpass)
calcium intravenous (amod)
pretreatment znso(4 (compound)
after min (nmod:npmod)
dysfunction kidney (compound)
hemorrhaging plate (nmod)
response pilocarpine (nmod)
effects dysplasia (nmod)
dose interactions (conj)
case report (appos)
end to (mark)
audiograms air (compound)
received received (conj)
b loss (appos)
oxitropium of (case)
agonists adenosine (compound)
mg/kg administration (conj)
exercise of (case)
responses enhanced (amod)
icrf-187 mg/kg (appos)
biopsies of (case)
eliciting ischemia (dobj)
reversible discontinued (advcl)
those hypertension (nmod)
node at (case)
db db (appos)
nationwide population-based (dep)
assessed presence (nsubjpass)
admitted recently (advmod)
time walk (nmod)
ranged results (nsubj)
emerged deterioration (nmod)
licl with (case)
deficits latter (amod)
control inhibitory (amod)
cancer chemotherapy-treated (amod)
resulted although (mark)
conducted methods (nsubjpass)
representative response (nmod)
effects rtms (compound)
frequency spectral (amod)
ntg h (nmod:tmod)
synthase no (compound)
staining snr (nmod)
ointment patients (appos)
volume ( (punct)
enantiomer pure (amod)
matched treated (conj)
protects loss (nmod)
sensitivity mice (nmod)
0.3 0.1 (compound)
effects cognitive (amod)
80.0 2.9 (conj)
proliferated appeared (conj)
had lethargy (dobj)
female 1-year-old (amod)
impairment fetal (amod)
children busulfan (nmod)
carotid common (amod)
conditions associated (acl)
electrode depth (compound)
anaesthetists ' (case)
expression ventricular (amod)
phenylpropanolamine , (punct)
antipsychotics , (punct)
suprofen of (case)
assessed bodyweight (nmod)
tachycardia fibrillation (conj)
patients care (compound)
effect subjective (amod)
induction following (case)
$ROOT$ back (sent)
revealed ; (punct)
divided later (advmod)
antagonists d1 (compound)
harm associated (acl)
practice our (nmod:poss)
discovery variant (nmod)
treatments effective (amod)
panss ( (punct)
result inhibition (nsubj)
thrombi patients (nmod)
determined routinely (advmod)
pretreatment no (neg)
transcriptase reverse (compound)
selective responses (nsubj)
infants very-low (amod)
superior inferior (conj)
glomerulosclerosis , (punct)
dividing spectrum (dobj)
used paradigm (nsubjpass)
those cyclosporine (nmod)
demonstration first (amod)
not necessarily (advmod)
study drugs (dobj)
fractions the (det)
vasculitis leucocytoclastic (amod)
variable any (det)
suitable outpatients (nmod)
ctc-nci ): (punct)
movements involuntary (amod)
% 68.9 (nummod)
shifts and (cc)
seemed correlation (xcomp)
effects preference (nmod)
events scales (conj)
treated is (aux)
deficits impairments (conj)
a srl (conj)
blepharoconjunctivitis , (punct)
toxicology of (case)
glutamate acetylcholine (conj)
events severe (amod)
nephrosis , (punct)
= = (dep)
library the (det)
indicated conditions (nmod)
estimated quantify (advcl)
line mouse (compound)
sodium serum (compound)
facilitation retrieval (nmod)
form common (amod)
hypovolemia drainage (nmod)
compare those (nmod)
incidence death (nmod)
acetate days (appos)
10 group (nmod)
aki associated (amod)
progesterone as (case)
mg/dl creatinine (conj)
ecg animals (nmod)
atropine after (case)
quetiapine to (case)
underwent fusion (dobj)
hematological and (cc)
uptake glutamate (compound)
agitation another (det)
diuretic amiloride (appos)
common : (punct)
stage hypertension (nmod)
quadrants from (case)
lvef ) (punct)
reinforces data (dobj)
reduction prevention (conj)
albuminuria group (nmod)
cholestasis , (punct)
mediates infiltration (dobj)
morphine iv (nummod)
factor on (case)
neurotransmitters with (case)
hyperalgesia > (dep)
reported hypokalemia (nsubjpass)
degenerated died (conj)
acid hydroxy (compound)
pac ) (punct)
anticipated absence (nmod)
supplemented concentrations (nmod)
l-3,4-dihydroxyphenylalanine l-dopa (appos)
1 to (case)
hyperalgesia the (det)
produce turnover (nmod)
employed . (punct)
macrophages in (case)
cystitis repaired (acl:relcl)
affect ed50 (dobj)
mg/m2bsa ) (punct)
tolerated strategy (dobj)
sites binding (compound)
levels postabsorptive (amod)
ces-d and (cc)
underlie that (nsubj)
rhythm captured (amod)
administration naloxone (nmod)
hallucinations weakness (conj)
pineal on (case)
had hyperactivity (nmod)
thromboembolic and (cc)
mice ilk/liver-/- (compound)
= 60 (dobj)
less administration (nmod)
compared toxicity (nsubjpass)
rejection infection (conj)
value atp (nmod)
clinical , (punct)
association coincidental (acl:relcl)
months <3 (nummod)
interval months (appos)
injection heparin (nmod)
episodes women (nmod)
opioid gains (acl:relcl)
system reticuloendothelial (amod)
reduced dose-dependently (advmod)
aspects disorders (nmod)
augmented treatment (nsubj)
4-hourly 8-hourly (conj)
reaction semi-quantitative (amod)
included injury (nsubj)
received dose (parataxis)
seconds site (nmod)
fluoroquinolones of (case)
benefited use (nmod)
suspicion presence (nmod)
anomalies in (case)
micrograms propranolol (nmod)
discontinuation heparin (nmod)
nerves chickens (nmod)
restlessness insomnia (conj)
ke cl (appos)
manifestations injury (nmod)
associated changes (nmod)
evaluation continuous (amod)
syndrome rats (nmod)
abnormalities function (nmod)
negative cases (nmod)
treatment estradiol (compound)
kpa 4.1 (nummod)
features of (case)
fibrillation death (conj)
population as (cc)
antagonized demonstrating (advcl)
normal above (case)
hypothesis involved (ccomp)
p.o. of (case)
ke , (punct)
rs6693503 , (punct)
assessed damage (nsubjpass)
damage determined (acl)
used produce (xcomp)
abolished reversed (conj)
$ROOT$ requested (sent)
times cholesterol (compound)
ulcers associated (acl)
receive cisplatin (dobj)
flow artery (compound)
cell of (case)
syndrome lysis (compound)
behavior bizarre (amod)
mg/m2bsa 1000 (nummod)
margins their (nmod:poss)
ketanserin with (case)
effect pathway (nmod)
twin second (amod)
targets treatment (nmod)
solicited : (punct)
warrant thus (advmod)
developing model (dobj)
pressure central (amod)
values coefficient (compound)
angioedema blocker (compound)
hemorrhages major (amod)
study group (compound)
dysgenesis to (case)
developed dystonia (dobj)
subset important (amod)
increased median (nmod)
were degeneration (conj)
fatigue ) (punct)
practices general (amod)
hr 30 (nummod)
therapy iron (compound)
six only (advmod)
enanthate by (case)
ribavirin of (case)
transplants after (case)
stage disease (compound)
rare . (punct)
prednisone oral (amod)
proliferation both (cc:preconj)
kinase extracellular (amod)
17 complete (dep)
intervals 1-minute (compound)
given 5-azacytidine (nsubjpass)
half group (nmod)
examination ( (punct)
drugs carbamazepine (dep)
receptor toll-like (amod)
radical fr (appos)
arthrogryposis of (case)
compared rates (dobj)
management waiting (nsubj)
dose doxorubicin/kg (nmod)
controlled not (neg)
awakening min (appos)
effects dopaminomimetics (nmod)
lower diclofenac (nmod)
investigated magnitudes (nsubjpass)
dermatitis fever (conj)
cromakalim pinacidil (conj)
presented getting (advcl)
given daily (advmod)
1.12 1.04 (compound)
reducing with (mark)
suggest facts (nmod)
exposed mipafox (nmod)
experienced cardiomyopathy (dobj)
reverting phase (nmod)
ms desorption/ionization (compound)
polyuria lithium (compound)
days ' (case)
courses after (case)
group from (case)
months ( (punct)
captopril inhibitor (appos)
actions antiproliferative (amod)
responses toxic (amod)
side-effects possible (amod)
controlling factors (nmod)
provoke did (aux)
ead phase (compound)
17beta-estradiol e2 (appos)
acts complex (nmod)
$ROOT$ myopathy (sent)
injections the (det)
fraction left (amod)
quality image (compound)
patients osteoarthritis (compound)
$ROOT$ develops (sent)
result episode (nsubj)
cases instillation (nmod)
spite barrier (nmod)
maintained rats (dobj)
normal but (cc)
comparing treatment (nmod)
se ) (punct)
m without (conj)
used determining (advcl)
antibiotic anthracycline (compound)
microscope electronic (amod)
change her (nmod:poss)
carolina but (cc)
proposed explanation (nmod)
increase women (nmod)
hypothermia patients (nmod)
risk disease (nmod)
tests current (amod)
tachycardia drowsiness (conj)
barrier the (det)
inhibitors timps (appos)
field useful (amod)
modified hyperlocomotion (nsubjpass)
relying heavily (advmod)
provides conclusion (nmod)
obtained angiograms (nmod)
materials reviewed (dep)
gemcitabine for (case)
proband mother (conj)
displace respectively (advmod)
was evidence (attr)
discontinued infusion (nsubjpass)
frequent whereas (mark)
activates whereas (mark)
mg 600 (nummod)
these studies (conj)
increase displacement (nmod)
failed displace (xcomp)
was diagnosis (nmod)
histology cardiac (amod)
differs . (punct)
129 57.5 (compound)
effect remitted (advcl)
using dose (dobj)
absorption reported (acl)
linked involved (advcl)
infusions micrograms/kg (nmod)
evidenced was (auxpass)
harmful subgroup (nmod)
cell non-small (amod)
urticaria/angioedema of (case)
expression oxidase (nmod)
size behaviors (conj)
mice express (parataxis)
obtain , (punct)
prolapse and (cc)
therapy low-dose (amod)
oxide factor)/nitric (amod)
were examine (ccomp)
monotherapy lithium (compound)
levels presence (conj)
reduced maintained (conj)
ratio bax/bcl2 (compound)
aconitine or (cc)
related azotemia (nsubj)
action triazolam (nmod)
changes long-term (amod)
scores scale (compound)
oxycantha crataegus (compound)
defend to (mark)
pressure animals (nmod)
mg/kg morphine-hc1 (nmod)
interventions percutaneous (amod)
failed screening (nsubj)
hds ( (punct)
likely play (xcomp)
standing tilt (conj)
potassium calcium (conj)
ros + (appos)
increase accompanied (acl)
ct hcva (conj)
proteinuria associated (acl)
register inpatient (compound)
survey a (det)
background presented (appos)
diagnosed leukemia (nmod)
systemic and (cc)
alf years (appos)
inserted were (auxpass)
type direct (amod)
neurotoxicity grade (compound)
metabolism acid (compound)
$ROOT$ differentiated (sent)
patients proteinuria (nmod)
levels busulfan (compound)
elicited volunteered (conj)
anemia (cab)-induced (punct)
methods review (appos)
enhanced fluoxetine (nmod)
mm 160 (nummod)
properties , (punct)
normalized iu/l (dobj)
clinic urban (amod)
monotherapy patients (nmod)
call exacerbations (nmod)
hypertension systolic (amod)
ligands several (amod)
occur did (aux)
tolerable to (mark)
$ROOT$ bred (sent)
ammonia in (case)
18 3 (conj)
des ( (punct)
artery + (cc)
involved interactions (nsubjpass)
profiles/sections ) (punct)
outcomes symptom (compound)
malignancies with (case)
b12 vitamin (compound)
changes elements (nmod)
eligible used (advcl)
determined increased (conj)
levels serotonin (compound)
immunotherapy in (case)
levels cholesterol (compound)
clinicians local (amod)
attenuated enhancement (nsubjpass)
drugs-associated non-steroidal (amod)
3269 +/- (cc)
nerve cochlear (amod)
given conjugates (dobj)
associated acid (nsubjpass)
min . (punct)
incidence due (case)
responses system (nmod)
nephrectomized were (auxpass)
exposed peptide(1 (nmod)
receiving who (nsubj)
associations participants (nmod)
rebleeding of (case)
glomerulonephritis severe (amod)
a to (case)
excitability system (nmod)
known bradycardia (nmod)
report reported (advcl)
depressed is (auxpass)
use moderate (amod)
occur described (conj)
characterization responses (nmod)
norleucine norvaline (conj)
intolerance some (nmod)
syndrome insufficiency (compound)
prolactinomas . (punct)
images resonance (compound)
drug this (det)
elevation diagnosis (nmod)
sulphonylureas different (amod)
strains a/j (dep)
reflect factor (conj)
week 1 (nummod)
medication diabetes (compound)
oxidase or (cc)
known which (nsubjpass)
pathogenesis remodeling (nmod)
explored methods (nsubj)
c hepatitis (compound)
related are (auxpass)
regimen cephalothin-gentamicin (compound)
were contrary (nmod)
vigabatrin with (case)
useful predicting (advcl)
anemia associated (amod)
treated inhibitor (nmod)
amphetamine mg/kg (appos)
initiatives for (case)
having failure (dobj)
deficits rats (nmod)
filaments gauges (appos)
convulsion . (punct)
all them (nmod)
mediated could (aux)
segments eyes (nmod)
men 43 (nummod)
changes fsgs (nmod)
analyse to (mark)
100 300 (conj)
erythematosus cle (appos)
11 patients (nmod)
insomnia ataxia (conj)
has disorder (nsubj)
waveform the (det)
recognize clinician (nsubj)
differentiation in (case)
examined authors (nsubj)
protector potential (amod)
radioactivity 131i-hsa (compound)
microg microg (conj)
25/100 or (cc)
hemorrhage 22 (nmod)
$ROOT$ greatest (sent)
denied who (nsubj)
discharged patients (nsubjpass)
inulin and (cc)
report change (conj)
$ROOT$ got (sent)
recognized associated (conj)
distribution glomeruli (nmod)
participated trial (nmod)
binding manner (amod)
reported administered (ccomp)
fall subjects (nmod)
needs according (case)
anticoagulation regional (amod)
1-(1,2-dihydro-2-acenaphthylenyl)piperazine ( (punct)
if is (cop)
patients = (dep)
chloride bromide (conj)
good is (cop)
band to (case)
resting of (case)
hepatotoxicity associated (acl)
kg 13.4 (nummod)
3.7 3.4 (conj)
occurred demonstrated (advcl)
highlight results (nsubj)
pre-administration topical (amod)
reviewed tested (conj)
-chlorpheniramine plus (cc)
regurgitation ) (punct)
tests study (nsubj)
completed thus (advmod)
sensitisation treatment (nmod)
pap metabolites (conj)
patient starting (acl)
developed paraplegia (dobj)
achr ( (punct)
(1.5)% -5.6 (nummod)
ovariectomized previously (advmod)
treatment lamivudine (compound)
developed later (advmod)
mrna oat (nmod)
classification nodosa (nmod)
$ROOT$ suggest (sent)
reproducible were (cop)
mg/m(2 , (punct)
1.44+/-0.6 1.57+/-0.7 (conj)
sad ) (punct)
$ROOT$ anorexigens (sent)
carcinoma from (case)
based presence (nmod)
cava of (case)
improved nifedipine (nsubj)
tolerated maximum (advmod)
family of (case)
compared efficacy (nsubj)
supported was (auxpass)
occurs anticoagulation (nsubj)
state amnesia (nmod)
beck through (case)
vehicle- pdtc-treated (conj)
cause impairment (dobj)
monotherapy versus (cc)
developed decrease (nsubj)
assess efficacies (dobj)
control p20 (dep)
consumption regular (amod)
discussed control (nsubjpass)
days week (nmod)
cause use (nsubj)
inhibitor hydrophilic (amod)
demonstrated day (nmod)
tissue heart (compound)
score england (compound)
fed randomized (conj)
treated penicillamine (nmod)
rhythm noted (acl)
map adc (compound)
patients 715 (nummod)
% 49.4 (nummod)
reported pain (dobj)
developing cad (dobj)
everolimus of (case)
levels serum/urine (nmod)
conceivable could (aux)
innervated normally (advmod)
epicondyle right (amod)
unchanged content (nsubj)
acquired infection (dobj)
models exposure (nmod)
substrates cyp1a2 (compound)
increased results (nsubj)
t0 ( (punct)
selected mimic (xcomp)
escape regulation (nmod)
infections most (amod)
2.3+/-1.2 was (cop)
inhibit secretion (dobj)
score ( (punct)
7- ( (punct)
chow , (punct)
alive . (punct)
samples in (case)
tci with (case)
found serum (nmod)
particles in (case)
recurrences for (case)
experiments using (acl)
either min (conj)
profiles the (det)
erdosteine agent (appos)
ratio mortality (compound)
acetonide fluocinolone (compound)
0 25 (conj)
underwent discontinuing (advcl)
postulated caused (ccomp)
strong is (cop)
reduces inhibition (nsubj)
diuresis chronic (amod)
leading activation (nmod)
mice balb-c (compound)
infarction rats (nmod)
observed level (nsubjpass)
found experiments (nmod)
pool compartmentalized (amod)
olanzapine by (case)
populations of (case)
antinociception and (cc)
design cross-sectional (amod)
turnover and (cc)
allergy penicillins (nmod)
leading loss (nmod)
flatulence and (cc)
relationship phosphate (nmod)
aids hearing (compound)
one regimens (nmod)
measures all (nummod)
sections including (case)
less corticosterone (nmod)
levels cpk (compound)
assay labeling (compound)
adults within (case)
immunoassay eia (appos)
exacerbated than (nsubj)
show cultures (nsubj)
induced haloperidol (nmod)
mouse per (case)
experiments cardioprotective (amod)
[3h]cb to (case)
events adults (nmod)
examined are (auxpass)
2005 since (case)
developed anemia (dobj)
level peak (amod)
124 1.5 (conj)
enhance indirectly (advmod)
degree hypoxia (nmod)
marker levels (conj)
papilloma ) (punct)
formulations release (compound)
reduce but (cc)
indicating maturation (dobj)
reshaping function (nmod)
reproduces and (cc)
objective plays (appos)
admission further (amod)
functions impaired (acl:relcl)
carvedilol levothyroxine (conj)
examined clarify (advcl)
structure muscle (nmod)
guidelines procedures (appos)
found hospital (nmod)
lithium who (nsubj)
160 to (dep)
restored antagonist (nmod)
have cancer (dobj)
recognized complication (nmod)
administered ear (nmod)
undetermined % (nmod)
neurotoxicity 20 (dep)
compares therapy (nsubj)
reactions the (det)
values g/dl (compound)
agents these (det)
score as (case)
oih of (case)
threshold lowered (amod)
abrogated , (punct)
obtunding of (mark)
intensity stimulus (compound)
doxorubicin ) (punct)
subjects treated (acl)
generated that (mark)
shunting of (case)
measuring pressure (dobj)
model studying (acl)
testing laboratory (compound)
seemed non-users (nmod)
retention of (case)
characterized insufficiency (nmod)
had a (nsubj)
common been (cop)
(+)-cibenzoline i.v. (compound)
factor proteinuria (nsubj)
used being (auxpass)
mdma ecstasy (conj)
considered effects (nsubjpass)
generation species (nmod)
$ROOT$ death (sent)
biosyntheses rna (compound)
those particularly (advmod)
mg. 100 (nummod)
ratio matched (amod)
trauma man (nmod)
drugs acupuncture (conj)
syndrome nephrotic (amod)
help might (aux)
0.78 of (case)
showed finally (advmod)
symptoms stimulant-induced (amod)
illustrates also (advmod)
interval h (nmod)
fruste forme (compound)
ph unphysiologic (amod)
diffusion process (nmod)
determined part (nmod)
% weeks (nmod)
absence factors (nmod)
discontinuation following (amod)
cyclophosphamide high-dose (amod)
occurred before (mark)
defined control (nsubjpass)
raises concern (dobj)
c % (appos)
number dips (nmod)
factor ngf (appos)
rate 24-hour (compound)
2.3+/-1.2 39.5+/-8.4s (conj)
nocistatin of (case)
plasma patient (nmod:poss)
ginsenoside a (det)
differences outcomes (nmod)
wt mg/kg (compound)
exercised . (punct)
followed injection (dobj)
cells phagocytotic (amod)
added correcting (advcl)
juice with (case)
podocytes in (case)
$ROOT$ modification (sent)
cm 5 (compound)
investigations systematic (amod)
disruption deprivation (nmod)
i1- agonists (dep)
approximate closely (advmod)
mk-801 antagonist (appos)
30 20 (nummod)
hepatotoxicity amiodarone-induced (amod)
graded . (punct)
cin ( (punct)
atropine with (case)
doses doxorubicin (nmod)
aimed here (advmod)
bradycardia mild (amod)
bradykinesia contralateral (amod)
mg/kg mg/kg (appos)
treated desipramine (nmod)
thickening wall (compound)
able be (cop)
275 250 (compound)
reported induce (xcomp)
factor-alpha and (cc)
duration symptom (compound)
41 - (punct)
ingestion aspirin (compound)
risks with (case)
disorders cerebellar (amod)
focused studies (nsubj)
primed exhibit (xcomp)
$ROOT$ makes (sent)
decreases current (dobj)
treated rifampicin (nmod)
producing sleep (dobj)
inhibitors drugs (conj)
coincidental may (aux)
vpu and (cc)
timing reduction (nmod)
fatal , (punct)
re-observed e18.5 (nmod)
dipyridamole of (case)
prospectively regularly (conj)
occurred infusion (nmod)
had gallstones (dobj)
reduced when (advmod)
treated have (aux)
dentate , (punct)
nicotine than (case)
fnclcc ) (punct)
inhibition expression (nmod)
higher considerably (advmod)
ratings subsequent (amod)
majority nodules (nmod)
monitoring 24-hour (amod)
hemodialysis continuous (amod)
hours administration (nmod)
tool overdose (nmod)
injection isph (nmod)
used groups (nsubjpass)
24 than (quantmod)
inhibition factor-beta1 (nmod)
flurothyl ptz (conj)
descriptions clinical (amod)
pretreatment lidocaine (compound)
anxious experience (nmod)
region dg (compound)
facilitation without (case)
common however (advmod)
diagnosed cancer (nsubj)
prevented 0.001 (dobj)
mpep administered (acl)
$ROOT$ toxicities (sent)
lna ) (punct)
dose bodyweight (nmod)
scored seizures (nsubjpass)
appears adaptation (xcomp)
mazindol to (case)
areas affected (amod)
duration number (conj)
16/49 ) (punct)
motionless responsive (conj)
caused carbachol (nmod)
kinase decreased (amod)
mtx ] (punct)
activity synthase (compound)
2-receptors to (mark)
diagnosis therapy (conj)
assays by (case)
produced patterns (dobj)
nightmares hallucinations (conj)
activity shunt (compound)
via possibly (advmod)
trials preliminary (amod)
was need (attr)
cord less (amod)
action toxic (amod)
treated mothers (nsubjpass)
symptoms no (neg)
performed occasions (nmod)
dtg ( (punct)
evoke addition (nmod)
unknown frequencies (nsubj)
collected asystole (nmod)
desire testes (conj)
n=92 ( (punct)
mm/kg 7.5 (nummod)
weight if (appos)
nerve sensory (amod)
specific strain (nmod:npmod)
monitoring to (case)
m 5 (compound)
showed scan (nsubj)
1967 1977 (conj)
bradycardia extension (conj)
vomiting prior (advmod)
shown data (nsubj)
rate and (cc)
mania identification (dep)
occlusion cerebral (amod)
cocaine- be-induced (conj)
rise troponin (nmod)
evaluate rate (dobj)
sporotrichosis disseminated (amod)
anemia , (punct)
chow amphetamine (nmod)
associated developing (advcl)
seen rats (nmod)
figures k (nmod)
dysrhythmias hypertension (conj)
confounded is (auxpass)
1.5 2 (conj)
follow hepatitis (dobj)
discontinued pneumonia (nmod)
administration 4-week (amod)
alterations above-described (amod)
tested has (aux)
exerted rats (nmod)
black . (punct)
resolved important (parataxis)
progression fatal (amod)
equation mark-howink-sakurada (compound)
reductions , (punct)
ciprofloxacin ofloxacin (conj)
transgenic 8-week-old (amod)
hospital italy (appos)
quinine 4-aminopyridine (conj)
thiosulphate and (cc)
epilepticus in (case)
manipulated control (dep)
vegfr-2/flk-1/kdr ) (punct)
herbicide used (amod)
cases five (nummod)
presumed ) (punct)
address uncertainties (dobj)
had dysfunction (dobj)
1.3 or (cc)
levels catecholamines (nmod)
option patients (nmod)
dose remifentanil (nmod)
binding [35s]tbps (compound)
cases case (conj)
activity antiarrhythmic (amod)
conclusions reflect (dep)
node circulation (conj)
os ) (punct)
infarction cardiac (amod)
required epileptogenecity (nsubjpass)
agent novel (amod)
$ROOT$ enrolled (sent)
baby the (det)
affected is (auxpass)
agonist adrenergic (amod)
factors eventual (amod)
model relevant (amod)
co ( (punct)
induce toxicity (dobj)
indicate similar (ccomp)
symptomatic immediate (amod)
atherosclerosis severe (amod)
suggests studies (nsubj)
thoroughly more (advmod)
injections dexamethasone (nmod)
unit diagnostic (amod)
coincident not (neg)
worsening sudden (amod)
lines ' (case)
response k)-atpase (nmod)
mitigated dogs (nmod)
complications with (case)
diazinon subacute (amod)
increase scr (compound)
pathogenesis neurotoxicity (nmod)
examined changes (nsubjpass)
excitability characteristics (conj)
four 4 (compound)
adjustment the (det)
show extended (ccomp)
renin renin (appos)
delivery after (case)
same were (cop)
added regimen (nmod)
work-up a (det)
atazanavir ) (punct)
decarboxylase ornithine (compound)
delta beta (conj)
signs studies (conj)
aids in (case)
reduction dosage (nmod)
cases available (acl:relcl)
doses methadone (nmod)
area body (compound)
focus should (aux)
relapse leukemia (nmod)
scale parent (compound)
damage tj (compound)
potential chronic (amod)
$ROOT$ preceded (sent)
advantageous minimized (advcl)
done study (nsubjpass)
hypotension following (case)
comparable reduction (nmod)
abolish could (aux)
study double-blinded (amod)
cells/mm3 63.7 (nummod)
differs therapy (nsubj)
$ROOT$ series (sent)
states 10 (nummod)
toxicity amiodarone-induced (amod)
dehydrogenase acid (compound)
95 ) (punct)
intubated received (ccomp)
1.56 - (punct)
complication infrequent (amod)
treatment antifibrinolytic (amod)
concentrations calcium (compound)
reduces manner (nmod)
tamoxifen estrogen (compound)
ischemic both (preconj)
urge . (punct)
decreased antagonism (nsubjpass)
relationship concentration (nmod)
h after (case)
preparation theophylline (compound)
syndrome neuropathy (nmod)
due responsiveness (nmod)
averting need (dobj)
ng.ml-1 ) (punct)
include to (mark)
k)-atpase (na (punct)
5 and (cc)
relieve administration (nsubj)
drug to (case)
model syndrome (nmod)
group over (case)
$ROOT$ predominated (sent)
lower nephrotoxicity (nsubj)
nephropathy puromycin (compound)
interview temperament (compound)
multiforme caused (acl)
models experimental (amod)
have incidence (dobj)
37 them (nmod)
$ROOT$ worsen (sent)
quinine mg/kg (appos)
appears medication (xcomp)
treatment rizatriptan (nmod)
cardiotoxicity occurring (acl)
% evidence (nmod)
detection asa (nmod)
mg. 359 (nummod)
reduced temperature (dobj)
injected mg (nmod)
involved lindane (nsubjpass)
telangiectasia photodistributed (amod)
radiotherapy with (case)
s-i ec (conj)
inhibition neurotoxic (amod)
doses especially (advmod)
celecoxib 0.93 (nummod)
formation thalamus (conj)
man treated (acl:relcl)
% . (nummod)
therapy pregnancy (nmod)
impaired increase (nsubj)
methods histological (amod)
dose causing (dep)
solution sodium (compound)
prolonged was (cop)
ed50 concentrations (conj)
locomotion hyper (compound)
pathological-process be (cop)
assigned clonidine (nmod)
12.0 5.0 (conj)
in to (dep)
methadone receptor (compound)
p450s hepatic (amod)
outcomes , (punct)
stimulations the (det)
dose calcium (appos)
results produced (appos)
present abnormalities (nsubj)
localization a (det)
prevented l-sotalol (nsubj)
time estimated (amod)
eighties of (case)
respect duration (nmod)
challenging can (aux)
mesangium from (case)
attribute agitation (dobj)
scleroderma of (case)
phosphorylation and (cc)
uteri rats (nmod)
exhibit properties (dobj)
hypothermia bridge (nmod)
syndromes kidney (compound)
born mother (nmod)
become improvements (nmod)
redness pain (conj)
hernia diaphragmatic (amod)
complications neurovascular (amod)
ratio or(adj (appos)
produce antagonists (nsubj)
analyzed mmp-timp (nsubjpass)
adriamycin carcinoma (nmod)
signs vital (amod)
factors contributory (amod)
cardiac systemic (conj)
1.1 0.7 (nummod)
wky ) (punct)
detecting , (punct)
protected affect (advcl)
action against (case)
lower animals (nmod)
al 1989 (nummod)
fraction normal (amod)
observed defect (nsubjpass)
presence infusion (nmod)
hyperglycinemia atypical (amod)
for particularly (advmod)
period latent (amod)
lilly database (conj)
report in (case)
period , (punct)
showed tolerate (advcl)
nicotine itself (appos)
pressures bodyweights (conj)
decreased pressure (dobj)
aspirin versus (cc)
patients impaired (amod)
reversed rapidly (advmod)
p-aminophenol of (case)
history polydipsia (nmod)
cyclophosphamide cyp (appos)
formulation with (case)
mechanisms the (det)
ich 1460 (nummod)
noradrenaline circulating (amod)
daidzein of (case)
indicated receiving (advcl)
due been (cop)
structures da-innervated (amod)
trespass vivo (advmod)
increase percentage (nmod)
remd of (case)
cases 6 (nummod)
sensitive highly (advmod)
syntheses no (compound)
pretreatment microg/kg (nmod)
protein mean (amod)
disturbance clomipramine-induced (amod)
effect neutropenia (nsubj)
consumption mitochondrial (amod)
extend not (neg)
promote clotting (dobj)
patients wilson (nmod:poss)
vacuoles of (case)
stimulation thermal (amod)
reported painful (ccomp)
plasma pirarubicin (compound)
strain grs (appos)
hypertrophy cellular (amod)
reduce reducing (advcl)
degree degeneration (nmod)
compared population (nmod)
diversion bile (compound)
treated nightly (advmod)
responses bed (compound)
indicating mediated (ccomp)
tur after (case)
antagonists hyperalgesia (nmod)
familiarity improved (amod)
improved features (nsubj)
provide thus (advmod)
species in (case)
admitted network (nmod)
needed combinations (nsubjpass)
nhe3 bsc-1 (conj)
bruising injection (nmod)
reduced contraction (dobj)
treated rejection (nmod)
mastocytosis systemic (amod)
coadministered cinacalcet (nmod)
stress induced (acl)
increase dose (nmod)
male diabetic (amod)
occurred hours (nmod)
constitutes this (nsubj)
binding transporter (compound)
sgot , (punct)
crisis src (appos)
occurrence as (case)
questionnaires through (case)
dystrophin and (cc)
suggested cardiotoxic (xcomp)
variety from (case)
rate rise (nmod)
blockade obtained (acl)
hg 107 (nummod)
case presented (acl:relcl)
relation expression (nmod)
courses all (det)
% 10.1 (nummod)
larvae fleas (nmod)
ligand the (det)
carcinoma therapy (nmod)
rapamycin the (det)
domain c (compound)
impact ( (punct)
affects clear (conj)
remained period (nmod)
reappeared dose (nmod)
pilocarpine of (case)
patients nephropathy (nmod)
dysfunctions typical (amod)
methylprednisolone ivmp (appos)
measured sodium (nsubjpass)
levels occupancy (compound)
complication an (det)
bradycardia hypothermia (conj)
protein with (case)
gyrus in (case)
detectable changes (nsubj)
cause reduction (nsubj)
exhibited actions (dobj)
mediates pge(2 (nsubj)
factors dysfunction (nsubj)
effective although (mark)
supply improved (amod)
drugs beta-adrenergic (amod)
characteristic as (case)
activity cholinesterase (nmod)
findings neuropsychological (amod)
days 16 (nummod)
duration cardiomyocytes (nmod)
experienced were (auxpass)
50 25 (nummod)
arrhythmia used (acl)
resulted deletion (nsubj)
interviewing nurses (dobj)
assessed ( (punct)
unmasked amisulpride (nmod)
stabilize to (mark)
years through (case)
involved injury (nsubjpass)
step micrograms (appos)
ligand involves (conj)
1.3 ( (punct)
areas : (punct)
neurotransmitters on (case)
gpi in (case)
form inducible (amod)
revealed study (dobj)
produces stimulation (nsubj)
myeloma lymphoma (conj)
role parp (nmod)
value management (nmod)
vip-/- ( (punct)
ovale foramen (amod)
score occurring (acl)
syndrome cholestatic (amod)
significant time (nmod:tmod)
expression of (case)
salicylates dose (compound)
minutes during (conj)
mc ac (conj)
derivative sulfate (compound)
population among (case)
activity decarboxylase (compound)
was administration (nmod)
12 patients (nmod)
seizures these (det)
mg/day = (dep)
delirium of (case)
all one (conj)
hippocampus such (case)
mcg/kg 2.5 (nummod)
prevented which (nsubjpass)
associated sirolimus (nmod)
% 250 (nummod)
neoplasms studies (nmod)
result because (case)
procedures brief (amod)
lead diagnosis (nmod)
discontinuation blocker (nmod)
frequency reversibility (conj)
= ; (punct)
crossed were (auxpass)
therapy azithromycin (compound)
woman hydroureteronephrosis (nmod)
g/ml 1.210 (nummod)
4.4 1.6 (nummod)
opposed ( (punct)
level state (compound)
myopathies cardiac (amod)
dnap ) (punct)
if of (case)
dystrophy experimental (amod)
sides luminal (amod)
disease hiv (compound)
mglur1 of (case)
receiving methimazole (dobj)
receptor scavenger (compound)
variation difference (acl:relcl)
symptoms collateral (amod)
group kanamycin-treated (amod)
evaluation cystoscopy (nmod)
recumbent both (cc:preconj)
results resolved (appos)
size-dependent was (cop)
efficacy improving (acl)
8- approximately (advmod)
isolated were (auxpass)
contraindicate not (neg)
infusing by (mark)
drink health (compound)
associated cholestasis (nsubjpass)
january to (case)
reduction myalgia (nmod)
necropsy at (case)
elevating ph (dobj)
myopathy from (case)
drugs the (dep)
agents . (punct)
decline percent (compound)
sepsis by (case)
titrated ph (nmod)
effects kurroa (nmod)
state ratio (conj)
control because (case)
interaction are (cop)
bort of (case)
accomplished map (nsubjpass)
4/7 ( (punct)
months 77 (nummod)
observed vessels (nmod)
application anticholinergics (nmod)
administration tdi (nmod)
killed respectively (advmod)
influenzae pneumoniae (conj)
used virtue (nmod)
antrum , (punct)
concentrations creatinine (nmod)
improving efficacy (dobj)
buildup activity (nmod)
relief headache (compound)
insult to (case)
anemia value (nmod)
reduced dealt (conj)
occurred trh (nmod)
important whereas (mark)
injection pilocarpine (compound)
effects age-interaction (amod)
participating subject (nsubj)
remained mg/day (nmod)
antibiotics or (cc)
epilepsy rats (nmod)
activity ache (compound)
electroencephalographic behavioral (conj)
extensively and (cc)
saturation arterial (amod)
decreases pressure (nmod)
amounts mrnas (nmod)
0.9 ( (punct)
coefficient ) (punct)
nerves bilateral (amod)
mice nephrotic (amod)
congestion venous (amod)
women cohort (nmod)
% 26.0 (nummod)
blockade animals (nmod)
1.31 ( (punct)
2660 +/- (cc)
selective tissue-specific (conj)
marked were (cop)
carteolol , (punct)
atin of (case)
$ROOT$ easy (sent)
excitement manic (amod)
fed treated (conj)
acid competing (acl)
participants experiencing (acl)
outpatients disorder (nmod)
reliability the (det)
impair (+/-)-pg-9 (nsubj)
determine , (punct)
injected similarly (advmod)
values higher (amod)
related were (cop)
needed find (dep)
biopsies ( (punct)
suited model (nsubj)
illustrate associated (ccomp)
bradycardias early (amod)
transplantation successful (amod)
enhances propranolol (nsubj)
induced capsaicin (nsubj)
doses used (acl)
strategy as (case)
developed commencing (advcl)
density bmd (appos)
clubs terminal (amod)
species oxygen (compound)
synthase factor-beta1 (conj)
reattempted died (parataxis)
receptors mglu7 (compound)
phosphatase protein (nsubj)
age dysfunctions (appos)
$ROOT$ globulin (sent)
thought toxicity (nsubjpass)
correlated score (nmod)
increase susceptibility (dobj)
interna rara (compound)
dose therapy (nmod)
used identify (advcl)
reports 44 (nummod)
space sub-tenon (nmod:poss)
echocardiographic histological (conj)
treatment carbamazepine (compound)
developed proteinuria (dobj)
died who (nsubj)
hours induction (dep)
mg/kg 900 (nummod)
participate stimulation (nmod)
normalization by (case)
mg/dl. 17.0 (nummod)
< of (case)
conducted period (nmod)
interactions due (case)
sensitivity drugs (nmod)
veins sinus (conj)
abnormalities to (mark)
tested task (nmod)
insufficiency anemia (conj)
proven lidocaine (nsubjpass)
yield cirrhosis (nmod)
consider for (mark)
p=0.032 ( (punct)
water their (nmod:poss)
associated protection (nsubjpass)
disease proven (amod)
inhibited cbz (nsubj)
exists duration (nmod)
revealed concentrations (dobj)
reported discontinuing (advcl)
revealed electrocardiogram (nsubj)
had conversion (nmod)
15 much (amod)
safety combination (nmod)
appears susceptible (xcomp)
frequencies deafened (acl)
3.1 years (nmod)
synthesized we (nsubj)
inulin para-aminohippurate (conj)
risks relation (conj)
a or (cc)
pituitaries from (case)
anencephaly atresia (conj)
pretreatment naloxazone (compound)
mask bradycardia (dobj)
residues gamma-carboxyglutamate (compound)
$ROOT$ feature (sent)
on was (cop)
significantly < (dep)
disabling highly (advmod)
amiodarone paroxetine (conj)
serve that (nsubj)
0.19 from (case)
induce periods (nmod)
occurred manner (nmod)
encephalopathy advanced (amod)
was because (mark)
echocardiography quantitation (conj)
presented using (advcl)
= 0.974 (dobj)
< 0.01 (dep)
myasthenia reversible (amod)
man operated (acl)
study microscopic (amod)
changes subtle (amod)
desipramine or (cc)
group -6 (appos)
test transformation (compound)
rate qs/qt (conj)
performed infusion (nsubjpass)
collected clinic (nmod)
epo with (case)
pneumonia % (appos)
measured observed (conj)
part dorsal (amod)
0.03 , (punct)
coagulation time (dep)
msg of (case)
applied centrally (advmod)
contractility hypersensitivity (conj)
echocardiography dse (appos)
dismutase dimethylthiourea (conj)
referred clinic (nmod)
observed echocardiography (nmod)
clinical autopsy (conj)
physicians skilled (amod)
maintain min (nmod)
polymyositis primary (amod)
undertaken . (punct)
group enalapril (compound)
syndrome pointes (conj)
evidenced incidence (nmod)
complained he (nsubj)
toxicity bupivacaine-induced (amod)
incidence stroke (nmod)
decrease mortality (dobj)
drug (who)-recommended (punct)
treated previously (advmod)
period following (case)
completed questionnaire (dobj)
processing sensory (amod)
drugs ototoxic (amod)
amblyopia in (case)
features pertinent (amod)
reduplication membrane (compound)
given hours (nmod:tmod)
helpful how (advmod)
complicated very (advmod)
spironolactone mg (nummod)
amlodipine mg (amod)
sessions training (compound)
clotiazepam derivative (appos)
inhibits given (advcl)
attenuated and (cc)
illnesses because (case)
seems have (xcomp)
group 5 (nummod)
riyadh in (case)
exists paucity (nsubj)
collection before (case)
eliminating hypercalcemias (dobj)
off was (cop)
exacerbation paranoid (amod)
combination bortezomib/dexamethasone (nmod)
syndrome the (det)
lost vision (nsubjpass)
mandatory monitoring (nsubj)
experience may (aux)
containing quinine (dobj)
taking mg/kg (dobj)
prilocaine after (case)
delineate had (ccomp)
topotecan days (nmod)
patients seizure (compound)
effects with (case)
intermediates reactive (amod)
syndromes in (case)
methotrexate analogue (appos)
facilitate as (cc)
induced recipient (nmod)
a d (conj)
drug-adsorption formation (conj)
individuals risk (nmod)
data ph (dep)
extracts thunbergiana (nmod)
aim specific (amod)
destruction duct (compound)
procedures dental (amod)
screened testosterone (nmod)
became findings (nsubj)
mmhg 55 (nummod)
biopsies episode (compound)
irradiation dosage (conj)
signaling pkc-mediated (amod)
patients cin (compound)
weight cytometry (nmod)
paclitaxel gemcitabine (conj)
unchanged was (cop)
factor similar (advcl)
conjugates ed (appos)
kinase tyrosine (compound)
box the (det)
tachycardia = (dep)
patients nsclc (nmod)
day eleventh (amod)
disruption to (case)
factor was (cop)
mother to (case)
hindpaw in (case)
documentation biopsy (compound)
therapy a (det)
n. 19 (nummod)
mul mug (conj)
indicated conclusions (nsubj)
frequent were (cop)
children those (det)
trigger a (det)
factor additional (amod)
improves , (punct)
ioxaglate ) (punct)
test pressor (compound)
vitro in (compound)
segments among (case)
appeared intense (conj)
thiazole-2-carboxamide 4 (nummod)
have electrocardiogram (dobj)
necrosis hepatic (amod)
0.3 - (punct)
wasting the (det)
assessed permeability (nsubjpass)
associated has (aux)
showed stimulation (nsubj)
received detected (advcl)
increased fraction (conj)
compared measurements (nmod)
aim centre (nmod)
rr 1.18 (nummod)
unable urinate (xcomp)
2-(p-bromophenyl)propionate (+/-)-pg-9 (appos)
organisms 6 (nummod)
caused can (aux)
children developed (acl:relcl)
drug responsible (amod)
d-pen with (case)
request on (case)
p9605 from (case)
concentration microg/l (nmod)
incidence an (det)
levels status (conj)
tnfalpha activity (conj)
recipient neonate (conj)
etiology likely (amod)
lidocaine , (punct)
blind double (amod)
is transplants (nmod)
needed dialysis (dobj)
transplantation steroids (nmod)
anti-hbs ) (punct)
reported incidence (nmod)
dose pn (conj)
treatment subchronic (amod)
instance in (case)
reductions dose (compound)
sodium mmol/l (appos)
reversed increased (conj)
erk and (cc)
observed ; (punct)
woman healthy (amod)
function patient (nmod:poss)
ilk ) (punct)
associated length-of-stay (nmod)
block receptors (dobj)
36 pituitaries (nmod)
invariable not (neg)
caused conclusions (nsubj)
trial open (amod)
livers by (case)
studies providing (acl)
output the (det)
kept limits (nmod)
fell patient (nsubj)
systemic coronary (conj)
38.6 +/- (cc)
inpatients all (det)
reduced reduced (parataxis)
cholecystectomy patients (nmod)
due expression (nmod)
microg/side 1 (nummod)
acetaminophen ( (punct)
stimuli the (det)
3269 380 (conj)
contraceptives . (punct)
wt wt/100 (nummod)
= 0.001 (dobj)
response isoproterenol (nmod)
monitored injections (nmod)
changes cytoplasmic (amod)
ingestion dose (nmod)
appeared discharged (conj)
% 37 (compound)
resulted later (advmod)
domains memory (nmod)
patients 593 (nummod)
fluoxetine mg/kg (appos)
acts agonist (nmod)
limbs in (case)
instillation after (case)
received globulin (dobj)
results combination (nmod)
switched were (auxpass)
demonstration in (amod)
through : (punct)
increasing but (cc)
exert action (dobj)
benzodiazepines related (amod)
titrated doses (nsubjpass)
produced pan (nmod)
antagonist not (cc)
assessment testing (conj)
dyskinesia . (punct)
cancer , (punct)
fatal be (cop)
fever ulcers (conj)
kidney recirculating (amod)
comparison therapy (nmod)
deviations gaze (nmod)
surgery day (conj)
contributes study (dep)
obtained was (auxpass)
u/ml ( (punct)
sulphonate compound (compound)
performed interval (nmod)
amounts powders (nmod)
cardiovascular nervous (conj)
malaria with (case)
ctni between (case)
disorder induced (acl)
findings eosinophilia (dep)
potassium penicillin-g (amod)
removed calculus (dobj)
min-1 2.32 (nummod)
returning normal (nmod)
trials large (amod)
setting school (appos)
mechanisms its (nmod:poss)
chiasm optic (amod)
hyperthermia as (cc)
good tolerability (nsubj)
cells isolated (amod)
dg ( (punct)
subjects attack (nmod)
challenge paracetamol (nmod)
small difference (nsubj)
induces nephropathy (dobj)
shortened occurrence (dobj)
cases 381 (nummod)
admitted syndrome (nmod)
count , (punct)
mothers treated (acl)
prevent but (cc)
min 50 (nummod)
useful compound (nsubj)
sent we (nsubj)
cent as (case)
surgery surgery (conj)
have studies (nsubj)
= 0.125 (dobj)
limited regimens (nmod)
decrease < (amod)
baseline the (det)
level cardiac (amod)
cleared subsequent (advmod)
ages ) (punct)
vol% concentration (conj)
complete months (conj)
% is (cop)
marker fever (nsubj)
examined morphology (dobj)
communicate summary (nmod)
discussion initiated (dep)
total points (nmod)
ce the (det)
treated pregnancy (nmod)
$ROOT$ stiffness (sent)
clinic , (punct)
pressure normotensive (nmod)
resembles discussion (nsubj)
became but (cc)
duration all (appos)
$ROOT$ predictors (sent)
periods treatment (compound)
anatomical or (cc)
suggest reduce (ccomp)
pressures individuals (nmod)
muscarinic glutamatergic (conj)
advocate can (aux)
correlate morphological (amod)
mediated overflow (nsubjpass)
traits hit (nmod)
induced succinylcholine (nmod:npmod)
infant remaining (amod)
kg-1 ) (punct)
coadministration extract (nmod)
toxic possibly (advmod)
largest date (nmod)
once i.v (advmod)
rise , (punct)
hypertrophy mild (amod)
fragmentation membrane (nmod)
effect long-lasting (amod)
failure decompensated (amod)
induction remission (nmod)
frequencies transplantation (nmod)
alter , (punct)
ozone of (case)
heart 666.9+/-14.0 (nummod)
response acute (amod)
discontinuation spironolactone (nmod)
tested lymphocytes (nsubjpass)
prevent reverse (conj)
detected ganglia (nmod)
appears important (xcomp)
frequent early (conj)
syncope of (case)
activity dehydrogenase (nmod)
ecg echocardiography (conj)
presented mastectomy (nmod)
naloxone mg/kg (dep)
microg/kg of (case)
ms to (case)
precluded . (punct)
parameters ecg (compound)
enantiomer ( (punct)
whom in (case)
cirrhosis with (case)
damage drug-induced (amod)
received admission (nmod)
anuria before (case)
disappeared spasms (nsubj)
pain areas (conj)
haloperidol the (det)
restarted and (cc)
larvae the (det)
become that (nsubj)
dose l-sotalol (nmod)
flutamide ip (appos)
trental ( (punct)
gain body (compound)
blockade channel (compound)
behaviors distinct (amod)
parietal right (amod)
t troponin (compound)
reaction acute (amod)
$ROOT$ hypoxemia (sent)
operated reduction (nmod)
occur encephalopathy (nsubj)
had fraction (dobj)
attenuated administration (nsubj)
$ROOT$ signs (sent)
reported subjects (nmod)
shunt pulmonary (amod)
administration morphine (compound)
unmatched cohorts (conj)
-0.22 -0.73 (nummod)
dipyridamole hemodialysis (conj)
saline with (case)
into : (punct)
greater even (advmod)
more twice (advmod)
low similar (conj)
hexamethonium the (det)
develop but (cc)
appear made (advcl)
fev1 in (case)
responses allergic (amod)
prevents nimodipine (nsubj)
stz ( (punct)
injected doses (nsubjpass)
demonstrated finding (dobj)
suggest attributable (ccomp)
maze , (punct)
characteristics on (case)
diagnosis based (prep)
effect drastic (amod)
assay end (compound)
persons six (nummod)
form a (det)
reported analysis (nsubjpass)
man 30-year (compound)
poor survival (nsubj)
31 to (dep)
mm ( (punct)
alive monkey (nsubj)
assayed were (auxpass)
$ROOT$ ranged (sent)
cd25 ( (punct)
available sensitive (conj)
one person (nmod)
4:15 24 (prep)
treatment bromocriptine (compound)
bortezomib dose (nmod)
design methods (conj)
disorders channel (compound)
drd2 and (cc)
gap43-ir iml (nmod)
found activation (nsubjpass)
she was (cop)
damage barrier (dobj)
kidney polycystic (amod)
rois drawn (acl)
$ROOT$ trends (sent)
reduce encourage (conj)
time by (case)
regarded should (aux)
seizures . (punct)
reversing aggravating (conj)
probable it (nsubj)
severe episodes (nsubj)
sensitization injection (nmod)
1.3 times (cc)
blocker receptor (compound)
attempted we (nsubj)
density microvessel (compound)
levels leukocytosis (conj)
% 60+/-9 (nummod)
exhibiting subjects (nmod)
analysed and (cc)
catheters resulting (acl)
children remaining (amod)
complete were (cop)
group n= (dep)
grade they (nsubj)
mmrm ) (punct)
ls in (case)
toxicity selective (amod)
study introduction (nmod)
performance cardiac (amod)
(aap)-hepatitis acetaminophen (compound)
paralysis levels (dep)
end until (case)
isoflurane to (case)
fever ahf (appos)
treated cyp (nmod)
group fr (compound)
trial 8-week (amod)
preference mg (nmod)
insufficiency respiratory (amod)
number an (det)
agent angiography (nmod)
existed controversy (nsubj)
sacrificed terminally (advmod)
blood-pressure diastolic (amod)
subjects 22 (nummod)
tendency only (advmod)
8.9 +/- (cc)
comatose or (cc)
recall suggestive (amod)
consistent effect (nmod)
score 3.8 (appos)
enhancement troponin (conj)
incidence pediatrics (nmod)
induces flumazenil (nsubj)
electrocardiogram and (cc)
treated prior (advmod)
discontinued study (nmod)
were % (dep)
fatigue % (appos)
lipoprotein high-density (amod)
mu of (case)
attacks with (case)
sensitivity specificity (dep)
lesions matter (nmod)
cause overdose (nsubj)
problems without (case)
fentanyl oxide (conj)
defined occurrence (nmod)
jj ) (punct)
beats/min 76 (nummod)
continued becoming (advcl)
attempted weaning (nsubjpass)
nephrotoxicity vancomycin (compound)
$ROOT$ alternatives (sent)
experienced taking (advcl)
synthesize to (mark)
useful patients (nmod)
admitted he (nsubjpass)
treated early (advmod)
treated groups (nsubjpass)
improved 4 (dep)
useful nimodipine (nsubj)
program computer (compound)
rofecoxib either (cc:preconj)
likely n (dep)
course their (nmod:poss)
infarction the (det)
risk bradyarrhythmia (nmod)
profile cortisol (compound)
feasibility , (punct)
aggravate methadone (nsubj)
dose appropriate (amod)
period overnight (amod)
has mechanism (dobj)
connection antibiotics (nmod)
blocked behavioral (dobj)
animals ich (compound)
hemorrhagic had (conj)
related improvement (nmod)
indicative results (nsubj)
symptoms function (conj)
g/m2/d of (case)
anesthetic this (det)
cavity surgical (amod)
cases individual (amod)
$ROOT$ stress (sent)
helpful reducing (advcl)
reaction ce (nmod)
dystrophy polyneuropathy (conj)
psychosis her (nmod:poss)
regulation transporters (nmod)
prevent furthermore (advmod)
explanation mismatch (nsubj)
bnpp ( (punct)
tolerable be (cop)
or=7.18 19.708 (appos)
showed function (nsubj)
follow-up an (det)
dysfunction ssri-induced (amod)
pain from (case)
prostigmine morphine (conj)
superior patients (nmod)
tumor-free because (mark)
carried can (neg)
pathways molecular (amod)
determine structure (nsubj)
finding the (det)
had 27 (nsubj)
made decision (nsubjpass)
percentage erythroblasts (nmod)
activity pressure (conj)
endpoints for (case)
counts cell (compound)
centre melbourne (compound)
patients multigravida (compound)
erythematosus polymyositis (conj)
achieved who (nsubj)
responses isoprenaline (nmod)
involved pgs (nsubjpass)
used potentially (advmod)
administered may (aux)
mg was (cop)
february to (case)
hamsters in (case)
ly274614 of (case)
describe episodes (dobj)
associated group (nmod)
factors intakes (conj)
linezolid tuberculosis (nmod)
extension time (nmod)
observers two (nummod)
resembled disturbances (dobj)
role eliciting (acl)
lesion no (det)
cgrp and (cc)
were patients (nmod)
complications polymyositis/dermatomyositis (nmod)
substantial treatment (nmod)
referred tachycardia (nmod)
produce effects (dobj)
recurrence further (amod)
[ /-15.8 (conj)
riha ) (punct)
alert physicians (nsubj)
highlighted is (auxpass)
u/liter ( (punct)
injections doxorubicin (nmod)
zdv combination (conj)
complication as (dep)
disturbances metabolic (amod)
use incidence (conj)
biopsy skin (compound)
groups of (case)
sign overlooked (amod)
cardiac , (punct)
indicates interaction (dobj)
usa and (cc)
238 vs. (cc)
cingulate , (punct)
inserted was (auxpass)
evaluated has (aux)
known produce (xcomp)
receiving type (dobj)
prevented attenuated (conj)
threat the (det)
narrowing , (punct)
sites inhibiting (advcl)
killed received (conj)
analog of (case)
experienced picture (dobj)
bladder rats (nmod:poss)
layer fiber (compound)
choices rats (nmod)
nightmares and (cc)
administered chickens (nmod)
dgc of (case)
hit thromboses (appos)
reduction stress (compound)
effects ecstasy (nmod)
improvement deficits (nmod)
lens contact (compound)
alternation tasks (nmod)
clinicians from (case)
related causally (advmod)
alpha-methyldopa mg/kg (compound)
conclude inhibit (ccomp)
suggests which (nsubj)
blockers calcium (compound)
are entity (advcl)
ip mg/kg (appos)
implantation vivo (advmod)
l. 2008 (appos)
antipsychotic atypical (amod)
defend organs (dobj)
percent 95 (nummod)
sah recurrent (amod)
increasing activity (dobj)
administered month (nmod)
occurred agranulocytosis (nsubj)
mg/h 2 (nummod)
presented justification (nsubjpass)
dysfunction injury (conj)
control hypertension (dobj)
stimulation continuous (amod)
included rcts (nsubjpass)
detection hyperactivity (nmod)
cotransporter of (case)
lowering for (mark)
hildebrand al (compound)
palsy , (punct)
mg.kg(-1).d(-1 10 (nummod)
performed group (nmod)
lowering and (cc)
h = (appos)
appeared dopamine (nsubj)
diagnosis dysfunction (nmod)
increased group (nmod)
receptor cx3cr1 (appos)
observed microg/side (nmod)
given doses (nsubjpass)
attenuates receptors (nmod)
subjects neuropathy (nmod)
compare we (nsubj)
injections to (case)
gentamicin dithiocarbamate (conj)
diseases pre-existing (amod)
assigned follow-up (nmod)
duration concentration (conj)
induced ketamine (nsubj)
-18 , (punct)
trihexyphenidyl between (case)
$ROOT$ understood (sent)
interactions in (case)
urine output (dep)
changes substantial (amod)
assess reactivity (dobj)
neurotransmitters n-(2-propylpentanoyl)urea (nmod)
detect prolongation (dobj)
injection saline (compound)
$ROOT$ dependent (sent)
7- 11-fold (advmod)
postulates affect (ccomp)
reversed patient (nmod)
choices higher (amod)
12.1 +/- (cc)
dec. 1999-nov (appos)
width the (det)
returned had (conj)
contribution its (nmod:poss)
$ROOT$ aim (sent)
gum 4-mg (amod)
prevents action (dobj)
produced cortex (nmod)
products its (nmod:poss)
common % (dobj)
wr242511 ) (punct)
university eskisehir (compound)
predictive inhibition (nsubj)
uiu/ml to (mark)
infiltration neuropathy (conj)
gamma-vinyl-gaba , (punct)
become potential (nsubj)
cleared removal (nmod)
hypothesize cause (ccomp)
mucositis constipation (conj)
randomization after (case)
anaesthesia sevoflurane (compound)
pregnancies serial (amod)
affect any (dobj)
dogs five (nummod)
coarctation aorta (nmod)
diet plain (amod)
ingestion by (case)
offer they (nsubj)
placebo lovastatin (conj)
understood association (nsubjpass)
induced when (advmod)
impair conjugation (dobj)
activity viruses (nmod)
ritonavir the (det)
antigen for (case)
brainstem from (case)
19 to (advmod)
syncope patients (nmod)
initiated that (nsubj)
acid protease (conj)
studied using (advcl)
receiving anticonvulsant (dobj)
placebo nsaids (appos)
age failure (conj)
rates d2 (compound)
expression myocardium (nmod)
reported ears (dobj)
attenuated similar (advcl)
bolus weeks (nmod:tmod)
appears response (nsubj)
ivmp ) (punct)
sap ) (punct)
csa acute (amod)
determine sensitivity (dobj)
chlorpheniramine mg (amod)
changes alt (dep)
vpa for (case)
carried out (compound:prt)
scale racine (nmod:poss)
developed transplant (nmod)
distinguishing malignancy (nmod)
started trial (dobj)
tubes catheters (conj)
salt-depleted , (punct)
displays behavior (dobj)
index as (case)
groups dex-treated (amod)
catheter dialysis (compound)
scale a (det)
l , (punct)
necrosis of (case)
passed sutures (nsubjpass)
sealants fibrin (compound)
haemofiltration arteriovenous (amod)
decline in (case)
enzyme an (det)
cancer ureteric (amod)
acts initiation (nmod)
had group (nsubj)
evidence ranged (acl:relcl)
concentrations micron (nmod)
or directly (advmod)
sinus endoscopic (amod)
tea or (cc)
formation cysts (nmod)
rose ; (punct)
localization with (case)
originating probably (advmod)
occurs common (conj)
practices care (compound)
enhances dopamine (nsubj)
collagen by (case)
resolved hiccups (dobj)
142 7 (conj)
leukopenia 4 (nummod)
deficits neurological (amod)
sem 16 (nummod)
action antagonists (nmod)
24.8 +/- (cc)
sensitivities effects (nmod)
enhanced stereotypy (dobj)
lack finally (advmod)
outcomes sleep (compound)
3.75 7.5 (conj)
naloxone , (punct)
coadministered azt (nmod)
[cmax]/mic ) (punct)
a-i apo (compound)
clonidine , (punct)
experience delivery (nmod)
dystonia oromandibular (amod)
= 0.006 (dobj)
remains one (attr)
mg.kg(-1).d(-1 ip (appos)
mg/m(2 500 (nummod)
$ROOT$ poor (sent)
formation autoantibodies (nmod)
hematuria microscopic (amod)
cross-tolerant while (mark)
available use (nmod)
fhf edema (conj)
prevented but (cc)
efficacy susceptibility (conj)
undetermined , (punct)
p=0.36 ( (punct)
decreased affected (advcl)
mm 20.3 (nummod)
consisting face (nmod)
rates seen (acl)
saline/side microl (nummod)
cm ) (punct)
min 27 (nummod)
populations risk (nmod)
higher resistance (nsubj)
rats had (acl:relcl)
starting doses (nmod)
% enflurane (dep)
was vacuolation (attr)
increase this (det)
occur states (nmod)
compared ecgs (nmod)
activity lysosomal (amod)
tourniquets through (case)
hag ( (punct)
found kidneys (nmod)
effects scopolamine (nmod)
hepatitis : (punct)
behavior , (punct)
= i.p. (advmod)
ich stroke (conj)
induced stress (nmod)
receptors csa (nmod)
failure occurring (acl)
infections but (cc)
tincture , (punct)
begun before (mark)
known clarified (conj)
glycol ) (punct)
mice occurred (acl:relcl)
manage accordingly (advmod)
induces sirolimus (nsubj)
observe respond (ccomp)
week 10 (nummod)
lamina vascular (amod)
died suddenly (advmod)
reactions prc (nmod)
decreased convulsion (dobj)
symptoms pacing (conj)
haloperidol nucleus (conj)
difference concentration (nmod)
associated piperacillin (nmod)
showed tremor (nsubj)
perform assessment (dobj)
dfc for (case)
undertook analysis (dobj)
life t(1/2 (appos)
tests climbing (compound)
cellulose and (cc)
contributes impairment (nsubj)
values adc (compound)
pseudoprolactinoma and (cc)
cause scale (nmod)
structure this (det)
having production (dobj)
injury tubulointerstitial (amod)
synergism observed (acl)
in- or (cc)
had od (nsubj)
kg-1 d-1 (nmod:npmod)
developed presented (advcl)
recommended view (nmod)
occurred response (nmod)
interaction in (case)
formula either (cc:preconj)
caused injection (nsubj)
rw ( (punct)
is that (mark)
exhibited mice (nsubj)
all rats (nmod)
changed spots (nsubjpass)
prior lithium (nmod)
causes degeneration (dobj)
anticoagulant a (det)
risk ( (punct)
recurrences of (case)
indices histological (amod)
point for (case)
able discriminate (xcomp)
fever in (case)
returned patients (nsubj)
inconsistent unfortunately (advmod)
mediated were (auxpass)
hydroxylase region (nmod)
caused paramethasone (nsubj)
sulphoxide of (case)
mandates . (punct)
performed ionic (nmod)
mortality subjects (nmod)
prostaglandins renal (amod)
effect convulsions (nmod)
grade 4 (conj)
hypertension or (cc)
disease without (case)
da and (cc)
1.54 ( (punct)
exposure extreme (amod)
compound a (det)
anticoagulants , (punct)
840 540 (compound)
patients bladder (nmod)
days administration (dep)
started procedure (nmod)
interleukin il-3 (appos)
attacks migraine (nmod)
hdl ( (punct)
evaluate setting (nmod)
death before (case)
diminishing result (nmod)
tramadol antidepressants (nmod)
tight snr (nmod)
velocity localization (conj)
continues afflicted (xcomp)
erpf ) (punct)
objective : (punct)
cases reactions (nmod)
reporting system (nmod)
microangiopathy tacrolimus-associated (amod)
transplanted bmcs (nsubjpass)
performed methods (nmod)
projections via (case)
checked electrolytes (nsubj)
dyskinesia peak-dose (amod)
structures inhibitors (nmod)
indicating regulate (ccomp)
tomography contrast-enhanced (amod)
desogestrel ethinyloestradiol (nmod)
preparations the (det)
incorporate and (cc)
rats uninephrectomized (amod)
critical . (punct)
effect infusion (nmod)
dogs 6 (nummod)
ester the (det)
feasible and (cc)
social emotional (conj)
management patient (nmod:poss)
2-receptors be (cop)
none sera (nmod)
start hypotension (nmod)
hysterosalpingography for (case)
blockade infusion (conj)
decrease significantly (advmod)
treatment phenobarbital (compound)
quantified , (punct)
contributed may (aux)
mmol group (nmod)
subunit the (det)
input nociceptive (amod)
partition membrane (nmod)
gain weight (compound)
thirty-seven patients (nmod)
improvement function (nmod)
vehicle peptides (conj)
inhibited damage (nsubjpass)
involves effect (nsubj)
alleviated will (aux)
participate exercise (nmod)
women 1 (nummod)
occlusion preceded (acl)
action neurotoxic (amod)
became gradually (advmod)
sustained-release sr (appos)
56.8 to (case)
= 5,701 (dobj)
$ROOT$ cystitis (sent)
observed which (nsubjpass)
risk as (case)
cis-ra with (case)
diagnostic vasculitis (nmod)
efficacy in (case)
1991 between (case)
stability gsh (compound)
exhibited wk (nmod)
audiograms cases (nmod)
perception information (compound)
$ROOT$ stimulation (sent)
reduced lesions (nsubj)
days following (case)
carcinoma basal (amod)
scan perfusion (compound)
mucositis , (punct)
lesion of (case)
treated carcinogen (nmod)
bmd spine (nmod)
damage organic (amod)
inhibited amide (nmod)
accounts vivo (advmod)
inhibitor ace (compound)
h1- with (case)
important receive (advcl)
mg chlorpheniramine (conj)
reentry effect (appos)
presence innervation (nmod)
region 5 (amod)
thyroiditis chronic (amod)
months months (parataxis)
severe enough (advmod)
picrotoxin- , (punct)
% of (case)
anesthetic prilocaine (nsubj)
stomach bowel (conj)
case third (amod)
trabeculectomies most (nsubj)
stabilized is (auxpass)
pale discs (nsubj)
confirmed level (nmod)
course onychomycosis (nmod)
treated min (nmod)
ganglia including (case)
kanamycin furosemide (conj)
selected using (advcl)
oxide apoptosis (conj)
set 2 (dobj)
produced subjects (advcl)
referred chemotherapy (nmod)
explained had (advcl)
tiapride alone (advmod)
ect during (case)
headache during (case)
thymidine place (dep)
succumbed , (punct)
pph with (case)
transplantations the (det)
length ) (punct)
fell rose (conj)
aggregations in (case)
0.6 10(10 (conj)
periods interictal (amod)
0.99 ( (punct)
sagittal sinus (conj)
became somnolent (acomp)
disease gestational (amod)
causes viral (amod)
32.6 0.2 (conj)
inhibition gr (compound)
upregulated and (cc)
salt ammonium (compound)
model nephrosis (nmod)
effect neurotoxic (amod)
isoform p58 (compound)
review , (punct)
times day (nmod)
upregulation obvious (amod)
reverse conclusion (nsubj)
anesthetic to (case)
3.5 or (cc)
receptor . (punct)
showed falciparum (dobj)
reversing by (mark)
avoid some (dobj)
ug/ml 11.21 (nummod)
acne pcos (conj)
likely pain (nsubj)
response immune (amod)
proven and (cc)
patients 50 (nummod)
were day (nmod)
cases 128 (nummod)
nsaids for (case)
evidence evidence (conj)
repeated cycle (nmod)
liter per (case)
concern is (cop)
tested has (ccomp)
produced arrest (dobj)
developed whereas (dep)
distress severe (amod)
mechanism antagonizes (acl:relcl)
occur hypokalemia (nsubj)
remains high (xcomp)
likelihood developing (advcl)
% 3.5 (nummod)
epileptogenesis in (case)
prevent coma (dobj)
response carbachol (nmod)
1.6 +/- (cc)
use beta-blockers (nmod)
due genes (nmod)
prevalence dyskinesia (nmod)
identical ( (punct)
dispersion repolarization (nmod)
145 13 (conj)
action that (mark)
preferable procedures (nmod)
icu to (case)
prevented furthermore (advmod)
tacrolimus ) (punct)
metabolite admixed (acl)
action only (advmod)
targeted respectively (advmod)
cystitis cp-induced (amod)
p control (conj)
extent course (conj)
inventory depression (compound)
ci=22.8 % (compound)
conclusions aware (appos)
tachycardia postlesion (nmod)
serotonin 1a (nummod)
was number (nmod)
1.9 0.6 (conj)
resulting elimination (nmod)
model dyskinesia (nmod)
dependence altered (amod)
movement in (case)
month after (case)
carried locf (parataxis)
induced meth (nmod)
associations disease (nmod)
improved dysfunction (dobj)
session single (amod)
introduced is (auxpass)
measured fmri (nmod)
conducted unit (nmod)
rash % (dep)
hr 20 (nummod)
activity nodal (amod)
occurred second (advmod)
reported india (nmod)
supplementation alone (advmod)
hypotension than (case)
gender score (conj)
team from (case)
elicited changes (nmod)
titrated , (punct)
inhibits that (mark)
patients 19 (nummod)
iocarmate ) (punct)
6 - (punct)
hydrochlorofluorocarbons used (acl)
effects urotoxic (amod)
depressed release (nsubjpass)
preclinical clinical (conj)
studied method (nmod)
held florence (nmod)
sum . (punct)
showed six (nsubj)
self-poisoning of (case)
vincristine glycol-asparaginase (conj)
age years (dep)
had stenosis (dobj)
events af (compound)
2.0mg/kg - (dep)
relating ic (dobj)
area one (nummod)
face the (det)
factor primary (amod)
bicarbonate meq. (appos)
medulla the (det)
= 1.84 (dobj)
probability the (det)
years 80 (nummod)
deterioration demonstrated (acl)
phase early (amod)
safe are (cop)
portray to (mark)
biopsies 7 (nummod)
differ frequency (nmod)
release acetylcholine (nmod)
3/4 asa (compound)
effect motility (nmod)
lidocaine saline (conj)
rupture vessel (compound)
staining the (det)
costs management (conj)
decreased tmp (nsubj)
chicks group (nmod)
epilepsy the (det)
dwi including (case)
insertion the (det)
study administration (nmod)
explain activity (nsubj)
two four (conj)
noncompliance ) (punct)
% 2.86 (nummod)
therapy atenolol (nmod)
described anemia (nsubjpass)
patient from (case)
cisapride of (case)
assessed baseline (nmod)
dose alone (advmod)
2 14 (conj)
loop the (det)
nodules of (case)
individuals six (nummod)
reported rates (nsubjpass)
speaking during (case)
dysfunction therapy (nmod)
apposition potential (conj)
origin an (det)
cause % (nmod)
condition this (det)
dimension and (cc)
compared electrocardiograms (nsubjpass)
receiving cinacalcet (nmod)
back with (case)
agents chemotherapy (compound)
idr by (case)
therapy antiandrogen (amod)
predictors that (mark)
beta-enac , (punct)
indicates use (nmod)
induced acrolein (nsubj)
exerts prazosin (nsubj)
leakage parenchyma (nmod)
increase increase (dep)
method description (appos)
group organization (compound)
accelerated males (nmod)
relationships structure-function (amod)
updating ( (punct)
sought be (auxpass)
assessed measuring (advcl)
alert . (punct)
system cardiovascular (amod)
vertigo and (cc)
varied prevented (advcl)
had disorder (dobj)
grading lown (compound)
iiib with (case)
hr injection (dep)
hypotension prostaglandin (compound)
inhibitors acid (nmod)
dysfunction on (case)
appeared akinetic (xcomp)
suggest mechanism (nmod)
reported tool (xcomp)
giving synchrony (nmod)
ulcers all (det)
contributed further (advmod)
infusion mg (appos)
chf reversible (amod)
one events (nmod)
links cancer (nmod)
characterization date (nmod)
blotting and (cc)
current or (cc)
subgroups several (amod)
cisplatin single-agent (amod)
inhibitor statin (appos)
levels cbz (compound)
nanoparticles and (cc)
study agricultural (compound)
have sometimes (advmod)
eegs repeat (amod)
appears however (advmod)
hours per (case)
disappeared cessation (nmod)
cases 570 (nummod)
epithelium bladder (nmod)
elimination kinase (nmod)
8.75 1.70 (quantmod)
3/20 , (punct)
activity protease (compound)
neurotoxic model (nmod)
occurred ( (punct)
medications surgery (conj)
appreciated . (punct)
remained diet (nmod)
using therapy (dobj)
length fetal (amod)
% 3.8 (compound)
metabolic endocrine (conj)
p40 ) (punct)
myocarditis effect (nsubj)
therapy with (case)
use identify (acl)
produced modifications (dobj)
assessed weeks (nmod)
neck abdomen (conj)
developed delirium (dobj)
42 stratum (nmod)
lmwh ) (punct)
parameters the (det)
redness , (punct)
conclusive to (mark)
atrophy isolated (amod)
period least (advmod)
prior admission (nmod)
rhythm induced (acl)
$ROOT$ performed (sent)
provides management (nmod)
meningioma and (cc)
stroke brain (compound)
infusion micrograms/kg (nmod)
department the (det)
(lev)-induced levetiracetam (nmod:npmod)
cohort with (case)
cause potential (amod)
simvastatin mg/day (appos)
surge lh (compound)
concentrations achieved (amod)
climbing mice (nmod)
activation ic (nmod)
pressure malondialdehyde (conj)
nephritis bacteremia (conj)
bn ( (punct)
synthesis enhanced (amod)
$ROOT$ deficit (sent)
induced (+/-)-pg-9 (nmod)
piperacillin/tazobactam mg (appos)
reacted also (advmod)
3 trans-2-amino-3-hydroxy-1 (compound)
% % (dep)
alterations status (conj)
order examine (acl)
suggest determined (ccomp)
administered delivery (nmod)
study calculate (acl)
concentration ion (compound)
adolescent depressed (amod)
given formula (nmod)
artery occlusion (conj)
trial : (punct)
less much (advmod)
$ROOT$ goes (sent)
observed primarily (advmod)
limits usefulness (dobj)
use with (case)
excretion t1/2 (appos)
downregulated inhibited (conj)
prescribing clonidine (dobj)
resulted medium (nmod)
logs requests (conj)
form this (det)
myocardium infarcted (amod)
5.8 +/- (cc)
suggested tolerated (ccomp)
p9605 risk (appos)
(7.2)% , (punct)
receiving ) (punct)
flap latissimus (compound)
months is (cop)
hypertension and (cc)
developed wk (nmod)
has administration (nmod)
occurred frequently (advmod)
titer and (cc)
groups 1 (dep)
promotes administered (advcl)
given proposals (nsubj)
1.63 - (advmod)
higher study (nmod)
suffer , (punct)
noted prolongation (nsubjpass)
concentration localized (amod)
result antiplatelets (nmod)
weight weight (conj)
patients osteoporosis (nmod)
levobupivacaine produced (acl:relcl)
withdrawal selegiline (nmod)
3.5 ( (punct)
onset anuria (nmod)
monkeys cynomolgus (compound)
reduction nephrotoxicity (nmod)
chemotherapy last (amod)
ineffective 4-aminopyridine (nsubj)
induced execution (nmod)
controls corresponding (amod)
gd 11 (conj)
experienced symptoms (dobj)
levels phosphate (compound)
wrinkling membranes (nmod)
complications are (cop)
compartment intracellular (amod)
developed factor (parataxis)
presenting hours (nmod)
endarterectomy carotid (amod)
frequencies consecutive (amod)
monotherapies with (case)
nephropathy interstitial (amod)
increase to (case)
reassessed not (neg)
eliminating for (mark)
rigidity generalized (amod)
parallel applications (nsubj)
dsm-iv ) (punct)
rage ( (punct)
ranged subjects (nsubj)
apparatus the (det)
9 +/- (cc)
center clinical (amod)
change but (cc)
$ROOT$ concern (sent)
evaluation spatial (amod)
parameters pharmacokinetics (compound)
underwent lamivudine (nmod)
considered normally (advmod)
strains these (det)
relationship arthritis (nmod)
induced antagonists (nmod)
necessary evaluate (xcomp)
distributed . (punct)
atriotomy via (case)
3'-azido-3'dideoxythymidine azt (appos)
shortened animals (advcl)
doxorubicin mg (amod)
regression p (appos)
role disturbance (nmod)
myoclonus associated (acl)
dose equimolar (amod)
continued was (conj)
consisted those (nmod)
trazodone , (punct)
induce syndrome (dobj)
btc with (case)
effect negligible (amod)
elicited results (nsubj)
program assessment (compound)
treated nimo (nmod)
insipidus neurogenic (amod)
solution the (det)
mg/kg 200 (compound)
cream with (case)
component neurodevelopmental (amod)
muscle to (case)
l-arginine precursor (appos)
responsible . (punct)
reduction g/l (nmod)
equal duration (nsubj)
measured levels (nsubjpass)
makes . (punct)
demonstration conclusion (nmod)
component cardiac (amod)
found she (nsubjpass)
factor initiating (amod)
combination radiotherapy (nmod)
negligible , (punct)
irreversible not (neg)
ce ml(-1 (nmod)
cta ) (punct)
vagotomy by (case)
cases reported (acl)
included changes (nsubj)
test initial (amod)
p4501a1/1a2 of (case)
intubated hypoventilation (conj)
induce malformations (dobj)
volume/g fixed (amod)
patients tdp (nmod)
moderate developing (conj)
all above (case)
active , (punct)
admitted she (nsubjpass)
days use (nmod)
compounds from (case)
kidneys the (det)
unique is (cop)
prior presentation (nmod)
diameter , (punct)
mmhg hypotension (nmod)
month first (amod)
identify strokes (dobj)
associated repression (nmod)
thickening increase (conj)
histopathology uterine (amod)
resolving neuropathy (nsubj)
factor an (det)
anderson md (compound)
desire at (case)
abnormalities use (nmod)
filariasis with (case)
holding after (mark)
postures specific (amod)
altered . (punct)
course treatment (compound)
receiving heparin (dobj)
bupropion for (case)
find platform (dobj)
consequences functions (nmod)
injection isoproterenol (compound)
zones arterial (amod)
seizure-prone wsp (appos)
crea mg (compound)
agents different (amod)
refractory drugs (nmod)
transferred room (nmod)
take message (dobj)
2.41 +/- (cc)
describe here (advmod)
snhl with (case)
isolated was (auxpass)
presents it (nsubj)
hypothesized mechanism (nsubjpass)
levels triggering (conj)
mg/d 120 (nummod)
receptors functional (amod)
diet 5-day (amod)
batteries with (case)
increases on (case)
fpd fpdc (appos)
microgramg/ml 2.8 (nummod)
$ROOT$ came (sent)
therapy anticholinergic (compound)
taken staining (nsubjpass)
higher also (advmod)
period 5-year (compound)
catheters central (amod)
ketamine antagonist (compound)
become procedure (nsubj)
ribavirin administered (acl)
children healthy (amod)
toxicity with (case)
$ROOT$ change (sent)
veratridine by (case)
function integrity (conj)
diversion with (case)
possibility a (det)
stenosis arterial (amod)
lessen and (cc)
focused attention (nsubjpass)
recorded experiences (nsubjpass)
congestants , (punct)
cases confirmed (amod)
choice glycopyrrolate (nsubj)
cystitis nonsteroidal (amod)
controls 18.7 (nummod)
$ROOT$ comparison (sent)
doses tested (acl)
showed dysfunction (dobj)
alter tendency (dobj)
0.05 . (punct)
efficacy medication (nmod)
hyperalgesia/myoclonus and (cc)
information attempt (nmod)
frontostriatal hippocampal (conj)
possible was (conj)
took year (dobj)
significant independently (advmod)
required treat (advcl)
changed whether (mark)
markers signs (nmod)
vasculitis satisfying (acl)
melatonin with (case)
periods hypotension (nmod)
diltiazem with (case)
current ( (punct)
undergone infant (nsubj)
pathway striatonigral (amod)
modify absence (nmod)
folate , (punct)
inventory scale (conj)
all but (cc)
marked was (cop)
mortality anesthetic-induced (amod)
ssr103800 p.o. (appos)
thiazole-2-carboxamide 2- (amod)
explain symptoms (dobj)
present hypothesis (dobj)
form prospective (amod)
58.9 times (cc)
weight . (punct)
levels urea (compound)
writing this (det)
ctx of (case)
receiving implant (dobj)
lithium ) (punct)
anf ] (punct)
= 4.9 (dobj)
reduction as (case)
increased study (nmod)
scr ) (punct)
associated reduction (nmod)
kytril ( (punct)
illustrates particular (nmod)
g/ml 1.050 (nummod)
neurobehavioral and (cc)
closest cream (nsubj)
aggravated probably (advmod)
differ . (punct)
recordings electrophysiological (amod)
imipramine the (det)
p450 against (case)
biochemical histological (conj)
administration propylthiouracil (nmod)
opaque calculi (nsubj)
elevations ng/ml (dep)
tract lower (amod)
symptoms problems (conj)
depression without (case)
had sites (dobj)
problem often (advmod)
related high (conj)
efficacy 1788 (nmod)
medications. all (det)
toxicity observed (acl)
time ; (punct)
olanzapine ( (punct)
appearance effect (nmod)
unnecessary dysfunction (nmod)
dissociation and (cc)
understanding factors (nmod)
exposed rats (nsubjpass)
67 115 (nmod)
complications about (case)
sepsis coagulopathy (conj)
malignancies solid (amod)
bs ) (punct)
assessment administration (nmod)
contraction animals (nmod)
mm 7 (nummod)
ischemia with (case)
correlation pressure (nmod)
exposure obtained (acl)
progress : (punct)
hoe and (cc)
literature growing (amod)
mild toxicity (nsubj)
registered ; (punct)
encephalopathy severe (amod)
3.4 , (punct)
mmhg 52 (nummod)
regimen twice-daily (amod)
remissions % (appos)
condensed . (punct)
% 94 (compound)
aventyl and (cc)
ventricles lateral (amod)
map coefficient (compound)
memory fear (compound)
administration rodents (nmod)
rats neprotic (amod)
caused greater (conj)
epileptogenecity underlying (amod)
matched controls (nmod)
effect anemia (nsubj)
abundance alphaenac (compound)
low mg/kg (nmod)
enzyme hbv (compound)
concentration an (det)
increased showed (parataxis)
followed have (aux)
db db (conj)
human salmon (conj)
had withdrawn (xcomp)
pg/ml 284 (nummod)
antidepressant inhibitor (compound)
metabolizer he (nsubj)
cognitive motivational (conj)
increase platelet (nmod)
lower injection (nmod)
mri after (case)
children underwent (acl:relcl)
group drugs (nmod)
groups 3 (nummod)
% 20 (compound)
unchanged placebo (nmod)
asphyxia , (punct)
setting patients (appos)
changes subsequent (amod)
revealed groups (nsubj)
avoid we (nsubj)
had days (nmod)
found % (nmod)
release platelet (compound)
expand we (nsubj)
mmhg 107.4 (nummod)
pfs of (case)
toxicity cyanide (compound)
extremes survey (nmod)
prophylaxis the (det)
identified timolol (nsubjpass)
double-blind placebo-controlled (dep)
arose from (mark)
cocaine either (cc:preconj)
recall on (case)
increased proportion (nsubj)
used pressure (nmod)
toxic least (advmod)
vasculitis girl (nmod)
uncertainties related (acl)
rats implanted (acl)
effects section (nmod)
induced that (mark)
demographics characteristics (conj)
rate nonimmunity (nmod)
rats paracetamol-treated (amod)
dopamine gaba(a (conj)
microgram/ml of (case)
demonstrate titrated (ccomp)
ed50 between (case)
sulfate of (case)
presented values (dobj)
stimulation associative (amod)
attacks panic (compound)
remained increased (advcl)
have antioxidants (nsubj)
ng/dl. 0.96 (nummod)
performed also (advmod)
effects anesthetics (nmod)
scatter ) (punct)
do serotonin (nsubj)
mtx ng (conj)
12 43 (appos)
$ROOT$ daunorubicin (sent)
increased uptake (dobj)
haart of (case)
virus hepatitis (compound)
ratings patients (nmod:poss)
increased also (advmod)
vds ( (punct)
recovery spontaneous (amod)
failure secondary (amod)
corresponded effects (nmod)
centre national (amod)
action verapamil (nmod)
sustained . (punct)
determined doses (dep)
study using (advcl)
improvements these (det)
vaccine prevention (nmod)
100 more (amod)
died showed (conj)
have leading (advcl)
determination size (nmod)
49 +/- (cc)
unique drug (nmod)
triggers disruption (dobj)
arag than (case)
relationship induction (nmod)
measured haemorrhage (nmod)
reduced hyperalgesia (dobj)
used commonly (advmod)
has power (dobj)
marker no (det)
valsartan mg (nummod)
emboli of (case)
cck-5 - (nummod)
prescribed citrate (nsubjpass)
calculated activity (nmod)
pdn to (case)
improvement surgery (nmod)
tolerated better (advmod)
dealt medically (advmod)
applied africa (nmod)
marked ischemia (nsubj)
evaluated performance (dobj)
hyponatremia with (case)
suppressed arrhythmia (dobj)
n-methyl-d-aspartate of (case)
mouth " (punct)
mimic symptoms (dobj)
grade regurgitation (compound)
metabolites aromatic (amod)
due symptoms (nsubj)
levels expression (compound)
= 4.92 (dobj)
mirror would (aux)
pain such (case)
has . (punct)
appear : (punct)
taking is (aux)
selective is (cop)
induced valproate (nmod:npmod)
resistance and (cc)
treated bromocriptine (nmod)
content intracellular (amod)
equation the (det)
memory proactive (amod)
compare users (nmod)
microg/kg/min reduced (parataxis)
personality antisocial (amod)
patient therapy (nmod)
frame time (compound)
dose even (advmod)
suggest resulted (ccomp)
l-med micrograms/kg (appos)
interactions 3a4 (compound)
5-httlpr ) (punct)
urothelium of (case)
benefited to (mark)
control 5days/week (appos)
exposure animals (nmod)
type rare (amod)
increased 119 (nmod)
process another (det)
called also (advmod)
appropriate levels (nsubj)
cyp3a4 ) (punct)
m1 m3 (conj)
methoxamine by (case)
analysis chart (compound)
motif region (nmod)
concern of (case)
electrocardiogram pre-operative (amod)
common fibrillation (nsubj)
exhibited constriction (dobj)
effect verapamil (nmod)
units r (compound)
role factors (nmod)
seeing pain (dep)
kinetics with (case)
strategies implications (dep)
activate may (aux)
significantly and (cc)
informative dealt (advcl)
disorders thyroid (compound)
age surgery (conj)
sensitized rats (nsubjpass)
variables age (appos)
outpatients disease (nmod)
presented findings (nsubjpass)
return venous (amod)
aggression hallucinations (conj)
68 54 (conj)
reduces conclusion (nsubj)
material extracellular (amod)
replacement the (det)
leads stress (nsubj)
uptakes radiocalcium (compound)
microm 404 (nummod)
observed rate (nmod)
pneumonia and (cc)
have presentation (nmod)
890 by (case)
hypertension evident (acl:relcl)
volume of (case)
modulate not (neg)
formed complexes (nsubj)
hemoglobin a (det)
deposits calcified (amod)
examined examined (ccomp)
lysis extensive (amod)
interviews face-to-face (compound)
regeneration hepatocellular (amod)
affected rate (nsubjpass)
recurrence lesions (nmod)
profile pharmacologic (amod)
ingestion to (case)
syndrome review (dep)
disorder adhd (appos)
$ROOT$ stratified (sent)
switched was (auxpass)
were rest (nmod)
prolactin with (case)
cerebellum rat (compound)
likely = (parataxis)
reviews emphasis (nmod)
81.1 of (case)
indomethacin both (cc:preconj)
remained tolerate (conj)
pains . (punct)
regained was (auxpass)
prolongation second((1/2 (nmod)
0.3 0.2 (conj)
volume large (amod)
modulation by (case)
mg/m(2 1378 (nummod)
lowering % (conj)
clinic health (compound)
200 328 (conj)
need raise (acl)
change necrosis (conj)
improve and (cc)
therapy mbc (nmod)
acid t (appos)
failure paracetamol-induced (amod)
oropharynx hypopharynx (conj)
reaction observed (acl)
continued had (aux)
overlap ) (punct)
trihexyphenidyl of (case)
evidence generated (acl)
increased 115 (nmod)
(6-ohda)-lesioned 6-hydroxydopamine (compound)
produced helodermin (nmod)
treated patients (nsubjpass)
underperfusion of (case)
waves pathologic (amod)
diabetic streptozotocin (nmod:npmod)
ketoconazole oral (amod)
prolongation or (cc)
cancers in (case)
increased foci/cm2 (nmod)
suggest thus (advmod)
differ as (mark)
seizure from (case)
usual converted (advcl)
adaptation ingestion (nmod)
effects progesterone (compound)
infiltrate interstitial (amod)
carry patients (nmod)
nf ( (punct)
5 0.5 (compound)
criterion by (case)
treated erroneously (advmod)
group serotonin (compound)
$ROOT$ meritorious (sent)
receive not (aux)
fc garcinielliptone (compound)
d. 7 (nummod)
lna+hca ( (punct)
hours above (case)
patients 8,770 (nummod)
accumulation renal (amod)
showed investigations (nsubj)
pilo between (case)
dropped . (punct)
detection analyser (nmod)
induced hearts (nmod)
hypertension combination (conj)
dl-sotalol unlike (case)
reduced areas (nmod)
dose pergolide (compound)
evaluated response (nsubjpass)
high inappropriately (advmod)
loci susceptibility (compound)
epilepticus ongoing (amod)
susceptibility microinjection (nmod)
increased intensity (nmod)
moment the (det)
agent thus (advmod)
impact functioning (nmod)
effect temsirolimus (nmod)
increase 2.3-fold (amod)
mitochondrial of (case)
ml 2-chloroprocaine-ce (conj)
induce behaviors (dobj)
patients loads (nmod)
interaction level (nmod)
reduced frequency (nsubj)
minutes 0.6 (nummod)
pump via (case)
informative are (cop)
disturbance transient (amod)
count initial (amod)
evaluated study (nmod)
% 1.0 (nummod)
was risk (attr)
alternative safer (amod)
thrombocytopenia : (punct)
concentrations all (det)
found exhibit (xcomp)
rbcs ae (compound)
cell cholinesterase (conj)
detected fibers (nmod)
analysis cell (compound)
agent 5-fluorouracil (dep)
beats junctional (amod)
conclusive , (punct)
reduction rate (nmod)
cortex prefrontal (amod)
taking rizatriptan (dobj)
apposed cells (nsubjpass)
role past (amod)
control tachyarrhythmias (nmod)
configuration predisposes (acl:relcl)
needs . (punct)
expression activity (conj)
found lesions (nsubjpass)
follow-up median (amod)
women danish (amod)
undergoing transplantation (dobj)
drugs methotrexate (appos)
clonidine vehicle (conj)
prevented p (dep)
licensed form (nmod)
contributor major (amod)
d-penicillamine . (punct)
proliferated further (advmod)
has increasing (advcl)
nocistatin administered (acl)
hypertension malignant (amod)
noted placebo (nmod)
administration suxamethonium (nmod)
findings were (cop)
developed jerks (dobj)
rats aging (amod)
performed caution (nmod)
therapy chloroquine (nmod)
arrhythmia the (det)
tolerated fk506 (nsubjpass)
effects subjective (amod)
midazolam thiopentone (conj)
corticosteroids anaesthesia (conj)
15.3 1.17 (conj)
available cycles (nmod)
dystrophy claudication (conj)
related were (auxpass)
areas numerous (amod)
reflection microangiopathy (nsubj)
induced 1mg/kg (nmod)
51 +/- (cc)
glaucoma or (cc)
included extremities (dobj)
treated eaca (nmod)
prove , (punct)
$ROOT$ diagnosis (sent)
carries absence (nmod)
given test (advcl)
prazosin of (case)
potency excitatory (amod)
reduced dosage (nsubj)
dependent directly (advmod)
neurotoxicity post-synaptic (amod)
function level (nmod)
diagnosis hyperprolactinemia (nmod)
astrocytes occasionally (conj)
weeks five (nummod)
dose weeks (nmod)
levels cb (compound)
drug toxin (conj)
second a (det)
role regarding (case)
developed d11 (nmod)
decrease size (nmod)
sevoflurane between (case)
lowering weeks (nmod)
effects behavioural (amod)
proliferate to (mark)
liver ascites (conj)
symptoms failure (nmod)
neurons nos (compound)
measured animals (nmod)
corrected not (neg)
aggravate edema (dobj)
determined frs (nsubj)
resulted bradycardia (nmod)
effect scopolamine (nmod)
all p (appos)
assayed was (auxpass)
searched journals (nsubjpass)
minutes ( (punct)
indomethacin by (case)
signal fmri (compound)
assessment . (punct)
72 39 (compound)
pmol ) (punct)
diet free (amod)
bortezomib to (case)
common drowsiness (nsubj)
none nausea (conj)
known are (auxpass)
decreased skf (nsubj)
changes parameters (nmod)
development diseases (nmod)
evaluate ability (dobj)
result absorption (nmod)
patient or (cc)
doses those (nmod)
segments cacl(2)-untreated (amod)
$ROOT$ detected (sent)
patients 29 (nummod)
this computer (nmod)
secondary increase (nmod)
amount consumption (nmod)
comparative multicenter (dep)
content brain (compound)
continue made (xcomp)
drugs included (acl)
test loss (dep)
patients ctni-positive (acl:relcl)
compound with (case)
increased shortening (nsubj)
showed rest (nsubj)
therapeutic or (cc)
had animals (nsubj)
arrhythmogenicity bupivacaine (compound)
rate sedation (nmod)
loss effect (nmod)
needed intubation (dobj)
ratio interval (appos)
harvested administration (nmod)
analysis single-centre (amod)
behavior activities (conj)
26- 119- (conj)
had given (advcl)
anthony st. (compound)
revealed disturbances (dobj)
model animal (amod)
importance field (nmod)
region terminals (nmod)
model regression (compound)
hbig with (case)
administration safe (amod)
lca than (case)
suggest offers (ccomp)
enhancement nephrosis (nmod)
retention for (case)
nodule one (nummod)
amphetamine mg/kg (conj)
stress decreased (amod)
carcinogenesis bladder (nmod)
vancomycin and (cc)
serve pretreatment (nmod)
distinguish agents (nmod)
compared norms (nmod)
tam by (case)
induced mechanism (nmod)
changes brain (nmod)
structure-activity and (cc)
deterioration ct (nmod)
regulation a (det)
those to (case)
therapy lmwh (compound)
produced apomorphine (nsubj)
hydrochloride nitrite (conj)
1.6 ratio (nsubj)
achieved may (aux)
codeine of (case)
removed surgery (nsubj)
hours 10 (nummod)
expression aquaporin-2 (compound)
trinitrate donor (appos)
infiltration marrow (nmod)
disease : (punct)
show does (aux)
greater 0.30 (nmod)
associated sometimes (advmod)
plasma 15-f(2t)-isop (conj)
lasted associated (conj)
phenyl-2(5h)-furanon ) (punct)
damage . (punct)
dose-related . (punct)
deteriorated function (nsubj)
mass = (dep)
produced models (nmod)
protection neuronal (amod)
days eight (nummod)
suggests clearly (advmod)
initiated dose (nmod)
feel strong (ccomp)
improvement point (nmod)
along fluid (nmod)
range activities (nmod)
mean ) (appos)
agents beta-blockers (conj)
lungs hypoplastic (amod)
exceeds , (punct)
assess efficacy (dobj)
12/27 ) (punct)
infections bacterial (amod)
valproate sodium (compound)
repeat correlate (conj)
suggest and (cc)
maintains ephedrine (nsubj)
follow infrequent (conj)
size-dependent transformation (nsubj)
aggravate does (aux)
dihydrochloride amn082 (appos)
cells/mm3 6.8 (nummod)
gene protein (conj)
variable , (punct)
interval = (appos)
polymorphism seven (nummod)
diazepam , (punct)
propranolol both (conj)
diagnosis gravis (nmod)
months 10.4 (nummod)
cases first (amod)
agents antiarrhythmic (amod)
chx+pilo animals (conj)
glycopyrrolate i.v. (amod)
increased return (nsubj)
thiols intracellular (amod)
implicate not (neg)
seen differences (nsubjpass)
aminonucleoside by (case)
waves 30-hz (amod)
$ROOT$ ascertained (sent)
syndrome hus (appos)
enlarged hearts (nsubj)
lvef and (cc)
patients 21 (nummod)
phases early (amod)
indications of (case)
case dystonia (nmod)
expression development (nmod)
occupation receptors (nmod)
interview international (amod)
recommended it (nsubjpass)
target rapamycin (nmod)
assessed activity (nsubjpass)
modifications for (case)
aimed trial (nsubj)
des of (case)
rectified was (auxpass)
$ROOT$ antagonize (sent)
$ROOT$ rationale (sent)
comparison baseline (nmod)
microinjection cells (nmod)
4.98 ; (punct)
diuretic is (cop)
pesticide and (cc)
parkinsonism from (case)
analgesics of (case)
regions groups (nmod)
rhythms dissociation (conj)
considered that (mark)
sensitive model (nsubj)
tests , (punct)
patients transplant (compound)
activation : (punct)
combination before (nmod)
correlated duration (nsubj)
use indications (nmod)
therapy before (nmod)
ro , (punct)
correlates psychosis (nmod)
mg/m2 840 (nummod)
d-med 5 (dep)
degree tolerance (nmod)
$ROOT$ diarrhoea (sent)
littermates sgk1(+/+ (dep)
ratios urine (compound)
camera the (det)
measurement enzymes (nmod)
interview the (det)
induced streptozotocin (nmod:npmod)
abnormalities echocardiographic (amod)
prevalent which (nsubj)
middle in (case)
1 6 (prep)
patients germany (nmod)
contraceptives various (amod)
infarction spasm (nmod)
weeks 6 (nummod)
characteristic cells (nmod)
suggest affect (ccomp)
obtained haloperidol (nmod)
gram a (det)
monitor with (case)
g rats (appos)
rates with (case)
immunotherapy transplantation (nmod)
iii at (case)
doses micrograms/kg/hr (nmod)
ci 4.4 (appos)
10.3 +/- (cc)
posture and (cc)
therapy chloramphenicol (nmod)
extend it (nsubj)
leaving upon (mark)
substantiate occurs (advcl)
oxygenation flow (conj)
matched age (nmod)
c vitamin (compound)
responses evoked (amod)
showed declines (dobj)
noted authors (nsubj)
increase mb (nsubj)
compensation deficiency (nmod)
curve concentration-blood (compound)
assess administered (advcl)
causes microangiopathy (nmod)
calcification metastatic (amod)
maryland northern (compound)
2.0 , (punct)
delay and (cc)
indicate cause (ccomp)
mice injury (nmod)
inhalation intranasal (conj)
implausible ratio (nsubj)
returned sensitivity (nsubj)
findings work-up (nmod)
thrombophlebitis nephrotoxicity (conj)
twelve hundred (compound)
lidocaine standard (amod)
fatigue and (cc)
txa ( (punct)
attempted aborted (conj)
pool of (case)
phosphate bnpp (appos)
opioid an (det)
15-f(2t)-isop substances (conj)
entered programme (nmod)
standard injury (nmod)
was similar (conj)
3-benzenesulfonyl-7-(4-methyl-piperazin-1-yl)1h-indole ( (punct)
pog ( (punct)
often recognized (advcl)
activity oxidase (compound)
model responders (nmod)
depletion folate (compound)
lasted that (nsubj)
studies dobutamine (compound)
databases following (amod)
provide not (neg)
picrotoxin- bicuculline-induced (conj)
susceptible so (advcl)
grade ii (nummod)
lesions experimental (amod)
contribution obtaining (advcl)
caused contributed (conj)
nitroglycerin frontotemporal (amod)
1-(1,2-dihydro-2-acenaphthylenyl)piperazine of (case)
action melatonin (nmod)
medications concomitant (amod)
types new (amod)
identified , (punct)
food drug (conj)
leads ii (nummod)
greater of (case)
followed asystole (nmod)
report this (nsubj)
treated leucovorin (nmod)
conducted monkeys (nmod)
fq impairment (nmod)
frequency reactions (nmod)
promotion blockers (nmod)
reactions five (nummod)
dystrophy duchenne (compound)
analyzer with (case)
decrease elevation (conj)
striatum group (nmod)
accuracy mean (amod)
dose presence (conj)
documented anxiety (nsubjpass)
found doses (nsubjpass)
summated score (nmod)
active be (cop)
ratings behavioral (amod)
registered movements (nsubjpass)
prolongation and (cc)
induced verapamil (nmod)
occupancy of (case)
domains the (det)
$ROOT$ agranulocytosis (sent)
inhibition channels (nmod)
percentage critical (amod)
treated phenobarbital (nmod)
pneumoniae ( (punct)
ability patient (nmod:poss)
substances tbarss (appos)
= ng (nsubj)
effective can (aux)
mmol.kg(-1).day(-1 ip (appos)
had whereas (mark)
administration headache (nmod)
conditions , (punct)
reduction 4-phenylbutyrate (nmod)
leakage the (det)
rhei from (case)
bradycardia significant (amod)
similar although (mark)
produced doses (nsubj)
method compared (dep)
placebo saline (appos)
dose busulfan (compound)
hypersensitivity ( (punct)
drugs nitrogranulogen (nmod)
exposed are (auxpass)
generalization seizures (nmod)
67.2 - (punct)
dro-1h- 5-{2-[4-(1,2-dihydro-2-acenaphthylenyl)piperazinyl]ethyl}-2,3-dihy (compound)
polydipsia concentration (conj)
patient ( (punct)
mechanisms pain (compound)
ocular and (cc)
deficiency , (punct)
days nine (nummod)
leukopenia an (det)
started h2o (nmod)
activations to (case)
ampka p-ampk (appos)
has duration (dobj)
adenocarcinoma clear (amod)
mg/kg mg/kg (conj)
word recalled (acl)
protocols both (det)
sought carefully (advmod)
transaminase her (nmod:poss)
carbamylcholin ' (punct)
secretion hormone (nmod)
estimate cost (dobj)
production the (det)
exceeded prolactin (nsubj)
accounted all (nmod)
aminotransferase range (dep)
structure or (cc)
pointes pilsicainide-induced (compound)
hypothyroid but (cc)
procaterol . (nummod)
anticoagulant to (case)
tasks speaking (nmod)
q10 coenzyme (compound)
flurothyl , (punct)
effective represent (conj)
fact needed (acl)
requirement dialysis (nmod)
anesthetic unique (amod)
synergy d (nmod)
complications in (case)
drugs class (compound)
vaginum per (case)
compound to (case)
using passed (conj)
anticoagulation systemic (amod)
interaction adverse (amod)
reduced whether (mark)
mg/m2 100 (nummod)
way biopsy (nsubj)
seizures rat (nmod)
picture , (punct)
antidepressants studied (acl)
tissue granulomatous (amod)
1a2 cytochrome (compound)
results , (punct)
element , (punct)
sleeping when (advmod)
revealed stimulation (nsubj)
86 20 (compound)
excretion n-acetyl-beta-d-glucosaminidase (compound)
nigra in (case)
frequency side-effects (nmod)
proportion a (det)
paid was (auxpass)
years 75 (nummod)
burying marble (compound)
nafld ( (punct)
presented confusion (nmod)
patient age (nmod)
function and (advmod)
improved effects (nsubj)
% improved (amod)
lead dilation (nsubj)
testing before (case)
leukemia " (punct)
visits patient (nmod)
consisting respectively (advmod)
years results (nsubj)
showing compared (advcl)
reflects . (punct)
developed tdp (dobj)
preparation on (case)
meningitis confirmed (amod)
peaking month (nmod)
provides , (punct)
toxic twice (advmod)
time progression (nmod)
dobutamine < (dep)
sis3 ) (punct)
implanted dorsum (nmod)
unrecognized they (nsubj)
aconitine of (case)
ratings . (punct)
kg-1 mg (amod)
126 - (punct)
effect alpha-tocopherol (nmod)
removed kidney (nsubj)
indicated density (nsubjpass)
established change (nmod)
scleroderma for (case)
compared battery (nmod)
d on (case)
elevations of (case)
mutations pre-existing (amod)
h2o mg/ml (amod)
ci ] (punct)
unavailable because (mark)
defibrillation electrical (amod)
microg/ml ) (punct)
reduction amplitude (compound)
predated indices (nsubj)
analysis time-to-event (amod)
chemotherapy ) (punct)
patients tolerated (acl:relcl)
fenfluramines mainly (advmod)
regained degree (dobj)
measured rate (nsubjpass)
showed events (dobj)
upregulation transporters (nmod)
prominent that (nsubj)
involved changes (nsubjpass)
ingestion diphenylhydantoin (nmod)
crisis aplastic (amod)
swelling with (case)
hallucinations , (punct)
mediators are (cop)
training to (case)
different quit (advcl)
report single (amod)
performed knife (nmod)
majority administration (nmod)
evaluated observed (dep)
csa were (cop)
risk edema (nmod)
associated serve (conj)
myelosuppression daunorubicin (nmod)
concentration residual (amod)
induced surgery (nmod)
53 mmhg (conj)
intradermal or (cc)
microperfusion by (case)
determinant cytotoxicity (nmod)
half by (case)
account disruption (nmod)
sr receptor (compound)
inhibitors protease (compound)
died survivors (nsubj)
developing rash (dobj)
used neurosurgery (nmod)
attenuated preference (dobj)
center cancer (compound)
elevation concentration (nmod)
levels activity (conj)
show cross-sensitization (dobj)
75 12.5 (compound)
test analysis (conj)
pn 30 (nummod)
disintegrin metalloproteinase (conj)
measured meter (nmod)
tnfalpha of (case)
accumulation treatment (nmod)
neurotoxicity induced (amod)
board review (compound)
needs most (amod)
dose between (case)
induces tacrine (nsubj)
hyperalgesia pinprick (compound)
levels da (nmod)
related difference (nsubj)
performed addition (nmod)
agonist potent (amod)
course syndrome (nmod)
variety drugs (nmod)
60 over (advmod)
seizures b-induced (amod)
studies ; (punct)
performed they (nsubjpass)
extent problem (nmod)
increased addition (nmod)
returned hospitalization (nmod)
angiographies mostly (advmod)
reached diagnosis (nmod)
$ROOT$ evidences (sent)
were differences (attr)
lobe medial (amod)
seeing ? (punct)
s.c. ) (punct)
manic hypomanic (conj)
mediated was (auxpass)
handicapped background (nmod:npmod)
hilum hepatic (amod)
offers that (mark)
tested associations (dobj)
have concentration (dobj)
2 3 (conj)
microgram.kg-1.min-1 of (case)
response cocaine (nmod)
one accompanied (acl:relcl)
lesions capillary (nmod)
i.v. ( (punct)
reductions drug-induced (amod)
elevation expression (nmod)
oxidase of (case)
intensify moreover (advmod)
changes typical (amod)
emerged doses (nmod)
form therapy (nmod)
occurs presented (advcl)
cis-ra ( (punct)
considered possibility (nsubjpass)
action anesthetic (amod)
stroma endometrial (amod)
developed weakness (dobj)
acidosis hypophosphatemia (conj)
separation tumor (nmod)
pge2 given (acl)
study using (acl)
continue who (nsubj)
headache attack (conj)
occur resulting (advcl)
mg/kg whereas (mark)
cause precipitated (conj)
stable more (advmod)
model , (punct)
sensitized are (auxpass)
episodes patient (nmod)
patient our (nmod:poss)
use lopinavir/ritonavir (nmod)
bladder from (case)
cocaine patients (nmod)
bcnu with (case)
symptoms patients (nmod)
treatment symptoms (nmod)
2.5 0.85 (conj)
induction ich (compound)
abnormalities significant (amod)
represents that (mark)
berlin , (punct)
drugs latter (amod)
resolved discontinuation (nmod)
implicated incidence (nmod)
manifestation disease (nmod)
oxcarbazepine with (case)
displayed presence (nmod)
associated leading (advcl)
produced azt (nsubj)
finished she (nsubj)
developed after (mark)
appears represent (xcomp)
fasciculation visible (amod)
toxicity limiting (compound)
toxicities somnolence (nsubj)
basis ng./ml (nmod)
tolerated vnb (nsubjpass)
crescents , (punct)
followed breakdown (nmod)
form on (case)
myeloma , (punct)
therapy atra (compound)
opioid agents (dep)
mutants treatment-associated (amod)
progress infection (nsubj)
treated pb (nmod:npmod)
ability effective (acl)
diagnosis was (cop)
hypertension hemorrhage (conj)
acetazolamide % (appos)
33 + (nummod)
small limitations (nmod)
observed suppression (nsubjpass)
cholinergics with (case)
14,671 , (punct)
patients aggregation (nmod)
mg/m(2 more (advmod)
medications both (det)
delirium for (case)
aging of (case)
explore mechanisms (dobj)
arthrogryposis is (cop)
pcpa mg/kg (appos)
included constipation (dobj)
predominance a (det)
ascertained . (punct)
ratio (pr)=0.615 (appos)
demonstrate , (punct)
have deficits (dobj)
increased values (dobj)
glioma of (case)
azt + (cc)
tamoxifen on (case)
reducing concentration (dobj)
injury maleate-induced (amod)
communicate . (punct)
effect tonus (appos)
proteinuria , (punct)
alter gain (dobj)
cows dairy (compound)
cases microangiopathy (nmod)
obstruction caused (acl)
associated exacerbation (nmod)
decrease one (nmod)
responses similar (amod)
capacity in (case)
protocols on (case)
respiration on (case)
obviate inconvenience (dobj)
followed intramuscularly (advmod)
showed suggested (ccomp)
extent location-dependent (amod)
action narcosis (nmod)
meth and (cc)
daidzein thunbergiana (nmod)
amisulpride of (case)
provided terms (nmod)
occurred hemorrhage (conj)
glomerulopathy and (cc)
develop . (punct)
absence despite (case)
counteracted pretreatment (nsubj)
subsides because (mark)
a-86929 hr (dep)
develop who (nsubj)
received evaluated (conj)
neutropenia 4 (nummod)
patients abnormalities (nmod)
reorganization extensive (amod)
response events (nmod)
one pregnancy (nmod)
examinations neurological (amod)
administered dosage (nmod)
decrease although (mark)
effects cibenzoline (nmod)
insights new (amod)
observation behavioral (amod)
papilloma and (cc)
boluses placebo (amod)
norms established (amod)
events ) (punct)
1941 between (case)
considered cause (xcomp)
ammonia urea (conj)
re-challenged patients (nsubjpass)
noted changes (nsubjpass)
hypertension weeks (nmod)
muscle ( (punct)
stained iodide (nmod:npmod)
feedback delayed (amod)
reduced rise (dobj)
sympathectomy sympathicotomy (conj)
administration b (nmod)
glyburide , (punct)
2.2 0.2 (conj)
slower reach (xcomp)
associated mr (nsubjpass)
source site (dep)
use phenacetin (nmod)
toxicity transient (amod)
phosphorofluoridate 0,0'-diisopropyl (compound)
1mg/kg/week ( (punct)
site are (cop)
normal fact (nmod)
combination fixed-ratio (amod)
assay and (cc)
classified carcinogen (nmod)
up november (nmod)
segment long (amod)
< .05 (dep)
nephrotoxicity in (case)
thrombosis spontaneous (amod)
pressure length (conj)
aorta rats (nmod)
cystitis in (case)
reduced magnitude (dobj)
administered craniotomy (nmod)
need control (dobj)
model persistent (amod)
taken dose (dobj)
weighed should (aux)
caused secretion (nmod)
scale index (conj)
given as (mark)
actives prodrugs (nsubj)
hypercalcemia increases (conj)
suppresses inducing (advcl)
antipsychotics by (case)
suggest effects (nsubj)
study : (punct)
paradigms therapy (nmod)
fibrosis against (case)
supine upright (conj)
necrosis organs (nmod)
potency efficacy (conj)
made revealing (advcl)
$ROOT$ investigations (sent)
toxicity pulmonary (amod)
occurs nausea (nsubj)
expression nuclei (nmod)
eia ( (punct)
letrozole the (det)
opioid anti-inflammatory (conj)
assessed hours (nmod)
uncommon pregnancy (nmod)
m mg/sq (nummod)
forms gel (dobj)
range age (compound)
showed that (ccomp)
compared effects (dobj)
recovery report (dep)
caa ) (punct)
promotes activation (nsubj)
metabolites formed (acl)
684 898 (conj)
carolina)/2011(iowa 2010(north (compound)
infections fatal (amod)
neuropathy delayed (amod)
material . (punct)
thrombo-embolism or (cc)
opening the (det)
using daily (advmod)
hematoma an (det)
inpatients in (case)
rendered were (auxpass)
intact and (cc)
recovered spontaneously (advmod)
reversibility possible (amod)
patients registered (acl:relcl)
patches gtn (compound)
report response (dobj)
limited have (aux)
irradiation chest (compound)
diameters similar (amod)
pneumonitis being (cop)
effect no (neg)
revealed decreased (ccomp)
related stroke (nmod)
involved mechanism(s (nmod)
pair-matched controls (nmod)
electrodes dbs (compound)
none patients (nmod)
sub-regions in (case)
calibration amplitude (compound)
receptors mu (compound)
pbsct ( (punct)
inhibits alfentanil (nsubj)
bradycardia vagal (amod)
uncomplicated been (cop)
developed increased (dep)
rats estradiol-treated (amod)
therapy involvement (conj)
studies four (nummod)
republic of (case)
people using (acl)
sources . (punct)
rtms ( (punct)
phenobarbital with (case)
compromise markers (conj)
lna and (cc)
mean . (conj)
positive was (cop)
escape reactivation (conj)
retained ulcerogenicity (nmod)
dosage levels (conj)
age mean (amod)
placebo active (conj)
associated fluconazole (nmod:npmod)
immunosuppressant novel (amod)
background receive (appos)
week once (advmod)
considered diagnosis (nmod)
vasoconstriction segments (nmod)
sensitivity convulsant (compound)
studied trial (nmod)
differ age (nsubj)
tachycardia block (nmod)
led toxicity (nmod)
experiment present (amod)
effective anticholinesterases (nsubj)
mg/kg twice (advmod)
% 54.7 (nummod)
b in (case)
assessed techniques (nmod)
p than (case)
radiation chemotherapy (conj)
test provocation (compound)
stimuli pain (compound)
lesion following (case)
run shelf (nmod)
administration not (cc)
slope fall (nmod)
attained , (punct)
points administration (nmod)
esthetics poor (amod)
capsaicin by (case)
mecamylamine nicotinic (amod)
organisms with (case)
occurrence of (case)
increasing only (cc:preconj)
involvement access (nmod)
adjuvant as (case)
tamoxifen or (cc)
apnoea postoperative (amod)
evidence shift (nmod)
made follow-up (nmod)
raise concentrations (dobj)
arteries other (amod)
on were (cop)
activities hr (nmod)
l group (compound)
10.0 30.0 (conj)
with both (nsubj)
ligation- , (punct)
count platelet (compound)
lung or (cc)
cocaine before (case)
in , (punct)
gc-ht ) (punct)
models procedures (appos)
required however (advmod)
hyperprolactinemia drug-induced (amod)
group % (appos)
based scale (nmod)
patient 47-year-old (amod)
toxicity epithelial (amod)
force < (dep)
map average (amod)
abs of (case)
mydriasis , (punct)
a sirolimus (conj)
assessable results (nsubj)
hours during (case)
been date (nmod)
recognized cardiomyopathy (nsubjpass)
result infusion (nmod)
period 1993 (appos)
causes major (amod)
large artery (dep)
dosed measurements (punct)
underwent cta (dobj)
sections liver (compound)
age with (case)
dose micrograms/kg/min (appos)
extension passive (amod)
mg/day 1000 (nummod)
inhibition between (case)
tested models (nmod)
efflux dopamine (compound)
overlap some (det)
induced melatonin (nmod)
diarrhea , (punct)
synthesis induced (acl)
dehydrogenase lactic (amod)
trial treatment (nmod)
gained we (nsubj)
% 1.3 (nummod)
nephrotoxicity acute (amod)
enteropathica acrodermatitis (compound)
brain gliomas (nmod)
patients 15 (conj)
relationship epsilon4 (nmod)
pathomechanism nystagmus (nmod)
mangiferin of (case)
presentation of (case)
medication rhinitis (nmod)
children adhd (nmod)
initiated consider (ccomp)
implicated epileptogenesis (nmod)
4.149 , (punct)
$ROOT$ objectives (sent)
receptors at (case)
degeneration muscles (nmod)
gram 's (case)
action supine (compound)
site about (case)
lapsed then (advmod)
reduction despite (case)
3 . (punct)
remains significance (nsubj)
continued death (nmod)
clopidogrel plus (cc)
occurred commencement (nmod)
2 - (punct)
potent safer (conj)
lead however (advmod)
ultrastructural morphometrical (conj)
acidosis severe (amod)
consisted was (auxpass)
chemotherapy cisplatin (compound)
orientation in (case)
6.5 less (amod)
= ci (dep)
used determine (advcl)
cannulae with (case)
min % (appos)
antagonist d4 (compound)
correlation direct (amod)
monitoring close (amod)
% 17 (compound)
valsartan : (punct)
indicate results (ccomp)
paclitaxel plus (cc)
hemispheres both (det)
reduced prolonged (conj)
end-stage due (case)
reflex jaw-stretch (amod)
disturbances barrier (compound)
calls administered (advcl)
neurotoxicity indications (nsubj)
developed nodules (nsubj)
accounting factors (nmod)
dose corticosterone (compound)
reduced = (parataxis)
comparison anesthesia (nmod)
concentrations cholesterol (nmod)
rule " (punct)
activities serum (compound)
showed dependently (advmod)
pcna ) (punct)
patients hbv-hiv (compound)
scale on (case)
sustained developed (conj)
improves deficits (dobj)
became man (nsubj)
scale center (compound)
mosmol/kg sodium (conj)
viral autoimmune (conj)
cessation therapy (nmod)
approval administration (compound)
assessed carolina)/2011(iowa (nmod)
nature lifelong (amod)
decade in (case)
found p<0.05 (parataxis)
demonstrated prevented (ccomp)
inrcease this (det)
kidneys group (nmod)
hippocampal cortical (conj)
$ROOT$ ruled (sent)
food liquid (amod)
map pattern (dobj)
hyponatremia over-representation (appos)
1.036 0.003 (conj)
$ROOT$ feel (sent)
smaller higher (conj)
addition subsequent (amod)
stroke for (case)
variable be (cop)
macrophages prominent (amod)
presented occasions (nmod)
pretreatment dsp4 (compound)
patient laotian (amod)
terms incidence (nmod)
elevated expression (nsubj)
weight antioxidants (appos)
peld and (cc)
associated occurrence (nmod)
requirements potassium (compound)
concentration lithium (compound)
developed hematomas (dobj)
radiotherapy surgery (conj)
minor neurotoxicity (nsubj)
ssri of (case)
$ROOT$ defects (sent)
unlikely systems (nsubj)
predict to (mark)
citrate and (cc)
$ROOT$ variants (sent)
cessation on (case)
clearance lithium (compound)
12/32 ( (punct)
oligodeoxynucleotide antisense (amod)
hospital 1,100-bed (nummod)
15mg/kg , (punct)
therapy antithrombotic (amod)
neonate in (case)
currents potassium (compound)
change improvement (conj)
group azelastine (compound)
diminished replaced (advcl)
adjunct treatment (nmod)
1997 between (case)
female ( (punct)
necessary combating (advcl)
data acquired (acl)
downregulated . (punct)
women 34 (nummod)
16 out (advmod)
rhythms . (punct)
extubated patient (nsubjpass)
reversible usually (advmod)
related incorporation (nmod)
reverse actions (dobj)
data echocardiographic (amod)
diaphragm gastrocnemius (conj)
given weeks (nmod:tmod)
infections caused (acl)
therapy unclear (advcl)
seen mass (nmod)
1.041 ( (punct)
necessary doses (nsubj)
less sodium (nmod)
decrease p (appos)
has oxide (nsubj)
suggests associated (ccomp)
based association (nsubjpass)
descriptions cases (nmod)
subject study (nmod)
infiltration diffuse (amod)
common hitt (dep)
8.7 +/- (cc)
changes regions (nmod)
work in (amod)
cta % (appos)
depression headache (conj)
2.2 1.6 (conj)
stenosis partial (amod)
justification need (nmod)
cytokines of (case)
response hyperprolactinemia (nmod)
presence between (case)
shown vitro (advmod)
taking sulfate (dobj)
use antithrombotic (amod)
degrees , (punct)
block activation (dobj)
carbachol mg/l (compound)
antagonizes bupivacaine (nsubj)
(1.8)% 5 (nummod)
patients 115 (nummod)
increase sulfation (nmod)
thrombo-embolism ( (punct)
urgency and (cc)
fluphenazine by (case)
occur possibly (advmod)
reappraisal a (det)
focussed . (punct)
sedation in (case)
disease renal (amod)
placebo compared (case)
aneurysms : (punct)
enhancement hepatocarcinogenicity (nmod)
decreases density (compound)
therapy nightly (amod)
$ROOT$ lumens (sent)
done administration (nmod)
% 0.24 (nummod)
striatum right (amod)
recommended as (mark)
groups sh (compound)
hyperthermia with (case)
% 18.3 (nummod)
coagulopathies " (punct)
mofetil +/- (cc)
found recently (advmod)
depressants and (cc)
acidification slowed (acl:relcl)
depending type (nmod)
irrigations of (case)
chloramphenicol to (case)
cystitis symptomatic (amod)
unknown cause (nsubj)
mg/lb ] (punct)
defects presumed (acl)
atpase calcium (compound)
tolerable more (advmod)
mother a (det)
passage brain (nmod)
signs are (cop)
tend decrease (xcomp)
administration = (dep)
outcomes other (amod)
compares . (punct)
studies separate (amod)
ci=1.375 95 (nummod)
fluorouracil [ (punct)
applied , (punct)
distant pipette (nmod)
septicemia suspected (amod)
zero p<0.05 (dep)
activity enos (compound)
years 2 (nummod)
exposed highly (advmod)
mineralocorticoid and (cc)
changes oxidation (compound)
99.0 +/- (cc)
l/hour/m2 . (punct)
regard change (nmod)
had only (advmod)
cutaneous respiratory (conj)
1.19 ) (punct)
anesthesia rat (nmod)
report death (nmod)
boy cardiomyopathy (nmod)
showed stenosis (dobj)
thrombosis females (nmod)
mass to (case)
dysfunction against (case)
one a (det)
characteristic next (advmod)
substances recreational (amod)
shape normal (amod)
induced bepridil (nmod)
task opposition (compound)
sequestration nitrotyrosine (nmod)
attacks matter (advmod)
scoring characteristics (nmod)
located elsewhere (advmod)
segment 15-mm (compound)
systems motor (compound)
mg/d at (case)
administration glutamate (compound)
relaxations beta-adrenoceptor-mediated (amod)
compound gyki-41 (dep)
magnitude similar (amod)
nimodipine nimo (appos)
lymphopenia ( (punct)
sign atherosclerosis (nmod)
microg/l 1360 (nummod)
relation : (punct)
metabolism amino (compound)
found indicating (advcl)
diaries in (case)
data general (amod)
medication was (cop)
cisplatin mg/kg (appos)
uneventful . (punct)
subject also (advmod)
microg/kg/min 20 (nummod)
demonstrated results (nsubj)
found , (punct)
activation parp (nmod)
modulation steroids (nmod)
eeg rats (nmod)
l. crocin (appos)
produced clonidine (nmod)
damage study (dep)
saline in (case)
receptor adrenoceptor (conj)
abscess presacral (amod)
drug form (conj)
rats d-amb-treated (amod)
increase formation (acl:relcl)
cholesterol mean (amod)
made also (advmod)
blockade cycle (compound)
anemia cefotetan-induced (amod)
loss eyes (nmod)
fourteen % (nmod)
monkeys 10 (nummod)
shown decrease (xcomp)
vacuolization biopsies (appos)
netilmicin 42 (nummod)
glioblastoma for (case)
ang of (case)
man 27-yr-old (amod)
regulation with (case)
evaluated function (nmod)
dose drug (nmod)
rotation contralateral (amod)
developing for (mark)
proteinuria ascites (conj)
promote that (mark)
intoxication disulfiram (compound)
cad ( (punct)
undergoing fess (dobj)
cortices cingulate (compound)
levels days (nmod)
depressed region (nmod)
thiamine and (cc)
doses greater (amod)
nephropathy iga (compound)
patients out-patients (dep)
independent was (cop)
infiltration during (case)
$ROOT$ history (sent)
hypothesized involve (xcomp)
localization subcellular (amod)
acid acid (dep)
hypotension by (case)
documents case (nsubj)
element be (cop)
prevented importantly (advmod)
ranged copies/ml (nmod)
dose trihexyphenidyl (nmod)
reorganization synaptic (amod)
recordings potential (compound)
allopurinol and (cc)
fractures and (cc)
effect life-threatening (amod)
3 to (quantmod)
dysfunctions vascular (amod)
allowing understanding (dobj)
4-aminopyridine or (cc)
lessened dismutase (nsubj)
combining dexrazoxane (dobj)
improved days (nmod)
diagnosis early (amod)
suppresses and (cc)
doxorubicin combination (conj)
receptor-dependent mglu7 (nmod:npmod)
personal room (compound)
decrease ventilation (nmod)
disappearance block (nmod)
encephalopathy . (punct)
length qtc (compound)
toxic highly (advmod)
study mmt (appos)
absence symptoms (nmod)
manual with (case)
unlikely five (nsubj)
brain into (case)
blocks thalidomide (nsubj)
polyphagia and (cc)
had dyskinesia (nmod)
followed later (advmod)
changes synthesis (nmod)
implicated unclear (advcl)
used tasks (nsubjpass)
aborted was (auxpass)
groups six (nummod)
recommendations use (nmod)
discouraging uniformly (advmod)
a/j dba/2j (appos)
hc of (case)
transplant blood (compound)
12h - (punct)
treat therapy (nmod)
had increase (dobj)
difficult although (mark)
drug 's (case)
animals 1-day-old (amod)
causes sirolimus (nsubj)
influenced that (mark)
objective associated (dep)
assessment clinical (amod)
% 28 (nummod)
seen also (advmod)
dorsum onto (case)
regurgitation moderate (amod)
challenged cisplatin (nmod)
gf ) (punct)
serological pathological (conj)
e ed1-ed4 (conj)
$ROOT$ employed (sent)
injected doses (conj)
presented clinic (nmod)
reactions haematological (amod)
rcr ( (punct)
performed assay (dobj)
photostimulation layer (nmod)
pressure infusions (nmod)
arv ) (punct)
antagonism component (nmod)
dose < (dep)
vomiting was (cop)
grafts rejection (nmod)
compliance , (punct)
volume contrast (compound)
reveals . (punct)
study longitudinal (amod)
alpha-2b and (cc)
quinpirole antagonist (compound)
smear on (case)
thermography plate (compound)
hypoxia disease (nmod)
achieve dose (dobj)
characterization the (det)
indicating encephalopathy (dobj)
sarcomas , (punct)
fef25 75 (nummod)
combining information (dobj)
$ROOT$ sought (sent)
study consequences (dobj)
increased detection (nmod)
woman treated (acl)
changes other (advmod)
$ROOT$ 2.3+/-1.2 (sent)
activation neurons (nmod)
located areas (nsubj)
dcf -18.9 (appos)
angiography in (case)
studies epidemiological (amod)
raynaud 's (case)
length stay (nmod)
continue follow-up (dobj)
function memory (conj)
filling left (amod)
received courses (dobj)
depends dosage (nmod)
dependent be (cop)
glucagon intravenous (amod)
cyclophosphamide dexamethasone (conj)
glucoronosyltransferases ugt (appos)
levels apoptosis (nmod)
methadone and (cc)
sensitized highly (advmod)
hemosiderosis resulting (acl)
risk group (acl:relcl)
regimens dexamethasone-containing (amod)
mediates inhibition (nmod)
comparing those (nmod)
response tetracycline (nmod)
once day (nmod:npmod)
results conclusion (nmod)
conducted using (advcl)
used stop-watch (nsubjpass)
hyperalgesia/myoclonus between (case)
preserves hypotension (nmod)
carrier synthesis (nmod)
antibodies acetylcholine (compound)
accompanied changes (nmod)
valproate lamotrigine (conj)
nimodipine , (punct)
property neuroprotective (amod)
acid poly-l-lactid (amod)
groups for (case)
use about (case)
$ROOT$ compromises (sent)
11 17 (prep)
classified score (nmod)
regimen consisting (acl)
defined response (nsubjpass)
considered been (auxpass)
caused than (prep)
complication delirium (nsubj)
detected levels (nsubj)
attenuated % (dep)
hematologic pathologic (conj)
acting node (nmod)
absence transferase (nmod)
intraoperative postoperative (conj)
induction seizure (compound)
mmp-2 and (cc)
secondary cardiomyopathy (nmod)
rats scopolamine-treated (amod)
effect mediated (acl:relcl)
raised excretion (nsubjpass)
interval features (conj)
complication causing (advcl)
tolerated usually (advmod)
microangiopathy of (case)
dehydration and/or (cc)
cases transfusion (nmod)
pt ( (punct)
held meeting (nsubjpass)
complications anaesthetic (amod)
reduced substantially (advmod)
adrenoceptors alpha (compound)
batteries tests (nmod)
60 ; (punct)
resurgence utilization (nmod)
model be (cop)
positioning the (det)
mg were (cop)
by either (preconj)
904+/-434 868 (compound)
administered ; (punct)
epicondylitis woman (nmod)
remissions and (cc)
bioactivation intermediate (nmod)
hypotension bradycardia (conj)
tended while (mark)
children factors (nmod)
importance cofactors (nmod)
hearts with (case)
abuse ppa (nmod)
$ROOT$ ester (sent)
provide patients (nmod)
acid amca (appos)
decrease marked (amod)
compromise and (cc)
consumption increased (amod)
76 12 (quantmod)
drivers on (case)
changed rats (nmod)
verified was (auxpass)
immunohistochemistry antigen (compound)
thickness average (amod)
amp ( (punct)
0.59 - (punct)
volunteers formulation (nmod)
mg ephedrine (nmod)
investigated evaluate (advcl)
exposures humans (nmod)
pg/ml infusions (nmod)
ed-1 kinases (conj)
receptor d2l (compound)
fields patients (nmod)
benzoylecgonine greater (amod)
suppressed mg/kg (nsubj)
slices hippocampus (nmod)
activity epileptiform (amod)
retarding function (conj)
evidenced depression (nmod)
second to (case)
detection in (case)
8-aminoquinoline of (case)
apnea by (case)
0.942 0.768 (nummod)
studied previously (advmod)
fluids with (case)
ke t1/2 (appos)
deposits complex (nmod)
propagates which (nmod)
efficacy proven (amod)
asia south (compound)
content catecholamine (compound)
determined terms (nmod)
$ROOT$ reduplication (sent)
causes declines (dobj)
mg/caffeine 1 (nummod)
speak . (punct)
antagonized completely (advmod)
fiber single (amod)
mg/m2/week 30 (nummod)
= 0.041 (dep)
induced atrophy (dobj)
secondary hypothyroidism (nmod)
block epidural (amod)
disorders consequent (amod)
dna nuclear (amod)
affected to (mark)
ingestion chronic (amod)
desipramine of (case)
regimen this (det)
reported that (mark)
contrast adult (nmod)
slope depolarization (nmod)
arrhythmia adrenaline (compound)
dogs undergone (acl:relcl)
% 89.13 (nummod)
induced methods (nsubjpass)
cause mellitus (nsubj)
27 to (quantmod)
defects ribs (conj)
defined reduction (nmod)
vagotomy or (cc)
followed expression (nsubjpass)
numbers the (det)
dose status (conj)
has involvement (dobj)
determined toxicity (nsubjpass)
identified microscopy (nmod)
loiasis of (case)
unnecessary was (cop)
1.39 ratio (nsubj)
anemia by (case)
performed those (nmod)
unrelated seizures (nmod)
replaced doses (nsubjpass)
these in (case)
volumes cerebellar (amod)
akbr ( (punct)
cardiotoxin man (nmod)
population-based , (punct)
somnolence more (amod)
pharmacokinetics , (punct)
considerations their (nmod:poss)
2009 and (cc)
than as (case)
characterized we (nsubj)
effect barium (compound)
increase in (acl)
suggests comparison (nsubj)
underwent cancer (nmod)
dexmedetomidine ) (punct)
enhanced learning (nsubjpass)
severe more (advmod)
weeks consecutive (amod)
mp ( (punct)
cocs levonorgestrel-containing (amod)
reduction symptoms (nmod)
9 in (case)
class molecular (amod)
identified register (nmod)
mediators beta4 (nsubj)
analgesia syndromes (nmod)
increases neurotransmission (dobj)
stz of (case)
plays learning (nmod)
poison . (punct)
woman hypertension (nmod)
regulation to (case)
pallidotomy . (punct)
rats wistar (amod)
paramedics two (nummod)
potential antiepileptic (amod)
identify given (advcl)
autoradiography by (case)
bradycardia severe (amod)
measured threshold (nsubjpass)
l. h. (appos)
transport during (case)
site same (amod)
pretreated methylatropine (nmod)
patients agc (nmod)
thalassemia transfusion-dependent (amod)
practical , (punct)
regimen tobramicyn (nmod)
evaluation , (punct)
stable , (punct)
. nl (advmod)
mianserin mg (amod)
associated reactions (nsubj)
variations amplitude (nmod)
bp systolic (amod)
appeared application (nsubj)
rocuronium pr (appos)
patients report (nmod)
hypothesis confounds (ccomp)
globulin prevention (nmod)
ketamine non-competitive (amod)
associated isethionate (nsubjpass)
suppression functions (nmod)
performed prior (advmod)
ensure tolerance (dobj)
normochromic was (cop)
occur prevalence (nmod)
176 from (case)
yr-old 65 (compound)
protrusions , (punct)
infusion amifostine (compound)
projections cord (nmod)
17.6-fold value (nmod)
contributes . (punct)
acid n-methyl-d-aspartic (amod)
somnolence increased (amod)
activity level (conj)
characterized dysfunction (nmod)
severity minimal (dep)
ocs of (case)
inhibitors reuptake (compound)
slope frequency (conj)
had counts (dobj)
role cholinergic (amod)
increase conclusion (nsubj)
aim work (nmod)
outcome subgroups (nmod)
overlooked known (advcl)
correlation in (case)
dex or (cc)
recovery capacity (nmod)
rats weeks (appos)
patients cta (nmod)
calcification warfarin-induced (amod)
regained end (nmod)
alterations activity (conj)
implicate action (dobj)
effects stress (nmod)
lesion medulla (nmod)
was prolongation (attr)
leukemia b-cell (compound)
tolerance the (det)
increased 124 (nmod)
mice female (amod)
therapy melanoma (nmod)
supplementation of (case)
mm2 ) (nummod)
excreted doses (nmod)
treated inhibitors (nmod)
area capsules (nmod)
reach association (nsubj)
dystonias cranial (amod)
hypoxia % (appos)
modulate receptor (dobj)
$ROOT$ lower (sent)
users 16 (nummod)
greater increase (appos)
available detect (xcomp)
bupivacaine mg/kg/min (compound)
effects increases (nmod)
deterioration metabolism (nmod)
service addiction (compound)
surveillance reactions (nmod)
formed oxidation (nmod)
implications documents (appos)
behavior aggression (conj)
difference od (nmod)
phase over (case)
returned strength (nsubj)
associated dose (nmod)
reduced increments (dobj)
infusion plasmacytoma (nmod)
overt or (cc)
mechanism induced (acl:relcl)
permeability with (case)
models cholinergic (amod)
mechanism occurrence (nmod)
disorder personality (compound)
detection malformations (nmod)
evoke inhibit (conj)
downregulation upregulation (conj)
parameters cardiovascular (amod)
proteinuria any (det)
less . (punct)
isoniazid by (case)
enalapril to (case)
sham ( (punct)
precise was (cop)
received ; (punct)
agents dopamine (nmod)
combination mg/m(2 (nmod)
derive to (mark)
mastectomy and (cc)
effect smoking (nmod)
manner heterogeneous (amod)
referred were (auxpass)
mechanism vagal (amod)
hypertension lead-induced (amod)
included ht (nsubj)
mg on (case)
copenhagen in (case)
ages and (cc)
were aims (nsubj)
months 25 (nummod)
aspirin nitrate (conj)
prove hypnotic (xcomp)
rats transport-competent (amod)
include vasospasm (dobj)
nephropathy ifo (compound)
blood-pressure in (case)
dose of (case)
receiving alfentanil (dobj)
hypoxaemia of (case)
drug related (amod)
safe that (mark)
decreased stage (nmod)
ratio m4/m1 (compound)
$ROOT$ expected (sent)
site in (case)
data knowledge (nmod)
tissues some (det)
conclusions cautious (dep)
hours at (case)
$ROOT$ early (sent)
= interval (dep)
patients these (det)
b1r(-/- ( (punct)
receptor nmda (compound)
meth ) (punct)
$ROOT$ warrant (sent)
death dependency (conj)
testing aggregation (compound)
250 1,070 (conj)
materials determined (dep)
records logs (conj)
circuitry fronto-temporal (amod)
subcellular lobular (conj)
involving systems (dobj)
described complications (dobj)
enflurane following (case)
recommended caution (nsubjpass)
lithium clozapine (conj)
spread wide (amod)
compared control (nmod)
rs4704559 rs10942891 (conj)
pressure gases (conj)
jaundice with (case)
1.84 +/- (cc)
increased affinity (nmod)
associated normalization (nmod)
incidents bradycardia (nmod)
juice only (advmod)
more hypotension (nmod)
corticosteroids administered (amod)
toxicity lidocaine (compound)
notion the (det)
hr hr (conj)
scheduled therapy (nmod)
12.2 1.1 (nummod)
activity k)-atpase (nmod)
correlate nor (cc)
all caused (acl)
evaluated changes (nmod)
mechanisms degeneration (nmod)
animals other (amod)
period by (case)
antagonists receptor (nmod)
evaluate potential (dobj)
help should (aux)
drugs typical (amod)
symptoms neuropathic (amod)
receive . (punct)
score time (nmod)
receive who (nsubj)
chemotherapy disease (nmod)
virus and (cc)
phosphate , (punct)
increased dose (nmod)
fraction ( (punct)
blocked opens (ccomp)
polyneuropathy : (punct)
occurred since (mark)
arrest series (nmod)
cancers all (det)
related times (nsubj)
effects mapd (nmod)
influence given (advcl)
infusion tail (compound)
logical . (punct)
pretreated remifentanil (nmod)
had patients (dep)
known abnormalities (xcomp)
neurons vulnerable (amod)
relieved symptoms (nmod)
substituted after (mark)
changes content (nmod)
patients flumazenil-treated (amod)
g diltiazem (nmod)
calculated , (punct)
g/d g/d (conj)
efficacy antihypertensive (amod)
electroretinograms and (cc)
% for (case)
ethambutol of (case)
delay 24-h (amod)
score mmse (compound)
tamoxifen alone (advmod)
need involves (advcl)
heart broken (amod)
remained days (nmod:tmod)
$ROOT$ instituted (sent)
= 19 (dobj)
cacl2 and (cc)
studies utilizing (acl)
condition was (cop)
maryland and (cc)
marketed lovastatin (nsubjpass)
evidence suggestive (amod)
november 2005 (nummod)
patients al (compound)
combined stress (nmod)
decreased observed (conj)
gaba gvg (appos)
recommend monitoring (dobj)
gi ) (punct)
hydration furosemide (conj)
analyses neurons (nmod)
correlated variables (nmod)
detected rats (nmod)
selective relatively (advmod)
alternations rigidity (nmod)
disappearance followed (acl)
diseases relationship (nmod)
discharged 18 (nsubjpass)
type syndrome (nmod)
facility long-term (amod)
alleviation pigs (nmod)
lamina basement (compound)
four and (cc)
score word (nmod)
frequent occurrence (nsubj)
similar confirmed (advcl)
coma profound (amod)
volume plasma (compound)
defects perfusion (compound)
length stretch (nmod)
initiated we (nsubj)
helpful distinguishing (advcl)
blockers terfenadine (appos)
women 20 (nummod)
gem-p of (case)
dopamine sufficient (amod)
results included (acl)
preservation activity (conj)
stone the (det)
suggest known (advcl)
involved if (mark)
delta beta-2 (conj)
potent progesterone (nmod)
subjected rats (nsubjpass)
$ROOT$ exists (sent)
sle ( (punct)
a fk506 (conj)
occurred mostly (advmod)
managing who (nsubj)
function quality (conj)
movements muscle (compound)
abolishment oxprenolol (nmod)
functioning cholinergic (amod)
delay papaverine (nmod)
$ROOT$ relation (sent)
drops of (case)
phase recovery (compound)
acetate ammonium (compound)
outcome major (amod)
ingestion chloroquine (compound)
man epilepsy (nmod)
disappearing be (aux)
hold fibrillation (nmod)
man japanese (amod)
tolerated unreasonable (conj)
exposure cold (amod)
2.13 0.09 (conj)
dose mg (dep)
patients i-ii (nummod)
biperiden antagonist (appos)
paradigm and (cc)
causing ) (punct)
study neurons (nmod)
reductions administration (nmod)
post-oltx years (nmod:npmod)
117.61 14.71 (conj)
rats mature (amod)
exhibit ; (punct)
responded patients (nmod)
dogs all (det)
patients which (det)
86.7 11.4 (conj)
functional antigenic (conj)
rigidity jaw (appos)
g were (cop)
neurons ventrolateral (amod)
drg labeled (acl)
determined levels (nmod)
effects meth (nmod)
examine to (mark)
c6 to (case)
dysmorphism disorder (conj)
prescribed again (advmod)
58 zidovudine (appos)
tests nine (nummod)
becoming nephrotoxicity (nsubj)
level drug (compound)
treatment hit (nmod)
esters cholesteryl (compound)
protocol on (case)
doses to (case)
map the (det)
proportions the (det)
levels potassium (compound)
group 30 (appos)
1.63 ( (punct)
manifestation cases (nmod)
fas . (punct)
$ROOT$ overflow (sent)
cage in (case)
differ auccgrp (nsubj)
antagonize did (aux)
co-infection without (conj)
risk good (amod)
retinoblastoma with (case)
oblongata medulla (compound)
tissues extrahepatic (amod)
damage cardiac (amod)
suppressed and (cc)
hallucinations operative (amod)
indicate changes (nsubj)
dysfunction an (det)
reduced not (neg)
$ROOT$ channels (sent)
had reduced (conj)
shown npy (nsubjpass)
suggests increase (ccomp)
example hepatotoxicity (nmod)
teratogenic weakly (advmod)
rationale : (punct)
plugs tissue (compound)
updrs yahr (conj)
suffering pain (nmod)
cardiotoxicity adriamycin-evoked (amod)
duration interval (appos)
acts ( (punct)
morphine fentanyl (conj)
effect predictive (amod)
toxin alcohol (conj)
levels kidneys (nmod)
feeding paracetamol (compound)
$ROOT$ aspirated (sent)
ml 50 (nummod)
increasing average (nmod)
ecstasy mdma (appos)
microl 20 (nummod)
% 25.3 (nummod)
subjects young (amod)
develop model (dobj)
phlebitis % (nmod)
died hypertrophy (nmod)
hypotension under (case)
tended associated (xcomp)
change patients (nsubj)
intubated ) (punct)
inhibitor between (case)
using technique (dobj)
preparations diluents (conj)
class one (nummod)
haloperidol low-dose (amod)
limited side-effects (nmod)
susceptible genetically (advmod)
527+/-509 versus (cc)
comparison of (case)
length af (compound)
composite . (punct)
followed depression (nsubjpass)
departments authoratative (amod)
form cyclooxygenase (nmod)
has comparison (nmod)
verapamil for (case)
treatment steroid (compound)
channel na (compound)
used rats (nsubjpass)
fluoxetine given (acl)
encephalopathy related (acl)
started and (cc)
paramedics the (det)
cpap less (advmod)
area sma (appos)
exposure membrane (nmod)
iiib stage (compound)
patients factors (nmod)
support dialytic (amod)
increases stress (nmod)
risk problem (appos)
pharmacology distinct (amod)
ill quite (advmod)
severity pain (compound)
highlight treatment (dobj)
0.06 0.04 (conj)
changes life-long (amod)
processes and (cc)
commencing fluconazole (dobj)
contribute disease (nmod)
had b (nsubj)
equal conclusions (nsubj)
esrd area (nmod)
containing aprotinin (dobj)
interest effects (nsubj)
upregulation in (case)
benzodiazepines several (amod)
regimen to (case)
costs and (cc)
corresponds . (punct)
influence sevoflurane (nmod)
nadph-d ( (punct)
dyspnoea increased (amod)
0.95 2.41 (appos)
superior treatments (nsubj)
dox mixture (conj)
dysguesia . (punct)
dysfunction variability (nmod)
types tumour (compound)
polymerase ) (punct)
gcs ( (punct)
a(1)/a(2a 100 (appos)
treated determine (advcl)
developed than (dep)
seen stage (advcl)
products derivative (conj)
circumstances mechanisms (conj)
$ROOT$ source (sent)
convulsions acid-induced (amod)
duration onset (conj)
discusses . (punct)
difficulty swallowing (advcl)
include usage (dobj)
appeared day (nmod)
addicts crack (compound)
months 204 (nummod)
rats deficient (amod)
use nephroprotectant (nmod)
describe case (dobj)
chest in (case)
one first (amod)
proteins 2 (dep)
lowers , (punct)
similar observed (advcl)
departure no (det)
mm 40 (nummod)
anesthetic a (det)
pneumonia presumed (amod)
admitted who (nsubj)
neuroleptics the (det)
startle , (punct)
fk of (case)
has hand (nmod)
melphalan after (case)
report infant (dobj)
ouabain weight (appos)
potential thalidomide (nmod)
responsiveness and (cc)
program maintaining (acl)
$ROOT$ explore (sent)
chemotherapy combination (amod)
varies . (punct)
deficits attributed (acl)
suggest explanation (dobj)
0 3 (prep)
patients southeast (nmod)
trimethoprim-sulfomethoxazole by (case)
pseudoacromegaly of (case)
demonstrated additionally (advmod)
pathophysiology nephrotoxicity (nmod)
given mg/kg/day (conj)
depression formation (nmod)
did not (neg)
hdl of (case)
hepatitis caused (acl)
450 and (cc)
patients pregnancies (conj)
head and (cc)
3.5 i.v. (dep)
= 99 (dep)
effects stimulation (nmod)
time uterus (nmod)
suitable . (punct)
stress higher (amod)
effective are (cop)
14,671 : (punct)
re-induced nelarabine (nmod)
onset the (det)
onset arrhythmias (nmod)
shift fall (conj)
nightmare . (punct)
biopsy for (case)
rates drinking (nmod)
selegiline with (case)
restoration function (nmod)
anxiety such (case)
dose patients (nmod)
timolol than (case)
higher observed (advcl)
neuropathy complication (nsubj)
period erp (appos)
growth cell (compound)
groups cortex (nmod)
cannulae inserted (acl)
concentration highest (amod)
complication might (aux)
consistent polyneuropathy (nmod)
staining diaphragm (nmod)
kept . (punct)
less .002 (nmod)
amplified . (punct)
factors admitted (acl)
levels cimetidine (compound)
enhanced effect (dobj)
signs in (case)
terfenadine ) (punct)
forms stress (nmod)
pattern clinical (amod)
event second (amod)
transplantation heart (compound)
scotomata central-caecal (amod)
illustrates this (nsubj)
investigations patient (nmod)
annulus and (cc)
> ( (punct)
followed patients (nsubjpass)
assessed effect (dobj)
cases 38 (nummod)
inhibitor target (compound)
dismutase h-sod1 (appos)
rats dox (nmod)
% 12.4 (nummod)
use sirolimus (compound)
subjects 23 (nummod)
tended reduce (xcomp)
reduce activity (dobj)
effects deficits (nmod)
consequences cardiovascular (amod)
transgenic nontransgenic (conj)
deletion inhibitor (nmod)
51 in (case)
increased min (nmod)
increase iodixanol (nmod)
provision the (det)
c mitomycin (compound)
due not (neg)
use in (case)
remained levels (nsubj)
restored rats (nmod)
hemisphere dominant (amod)
resulted p (dep)
synthase-1 prostaglandin (compound)
sertraline either (cc:preconj)
attributed it (nsubjpass)
purpose this (det)
prevented suggesting (advcl)
necrosis cortical (amod)
hypokalemia hypocalcemia (conj)
explored duration (dobj)
can advanced (amod)
activities thiols (conj)
determination carbachol (nmod)
abnormalities bilateral (amod)
deal a (det)
associated epinephrine (nsubjpass)
$ROOT$ multifactorial (sent)
effects antagonists (nmod)
ratios drug (nmod)
using by (mark)
targeted used (ccomp)
$ROOT$ granulocytopenia (sent)
found conclusion (nmod)
h. following (amod)
predictor not (neg)
hg compared (prep)
range 40,000 (nmod)
manage total (nmod)
ache ) (punct)
effects failure (nmod)
1 or (cc)
schizophrenia paranoid (amod)
occurred level (dep)
same while (mark)
13 gestation (nmod)
beta=0.49 ) (punct)
medication surgery (conj)
received part (nmod)
galen of (case)
spared when (advmod)
plays , (punct)
minutes several (amod)
developed receiving (advcl)
malignancy a (det)
measured respectively (advmod)
subjects 24 (nummod)
transport humans (nmod)
lowered , (punct)
pills third (amod)
used substitutes (nmod)
0.69 0.13 (conj)
alpha- the (dep)
patient infected (amod)
scintigraphy acid (compound)
syndrome bile (compound)
appearance blood (nmod)
conclusion constituted (appos)
age earlier (amod)
countries in (case)
occurrence deaths (conj)
release acetylcholine-induced (amod)
irrigated . (punct)
sirna age (compound)
gloves such (case)
hospital center (conj)
shown that (nsubjpass)
healthy relatively (advmod)
lozenge smokers (nmod)
evidence component (nmod)
methods for (case)
cases are (cop)
somnolence constipation (conj)
elucidated fully (advmod)
activity despite (case)
angiosarcoma . (punct)
min subjects (appos)
blocker an-2-ol (appos)
2.31 to (advmod)
radius millimetres (compound)
hemoglobin or (cc)
vertigo of (case)
nsclc advanced (amod)
improve seizure (dobj)
perls ' (case)
zo-1 7h6 (conj)
1ug , (punct)
37 27 (quantmod)
lvef fs (conj)
preferable that (mark)
nox ( (punct)
rauwolscine of (case)
dyslipidemia mixed (amod)
produced death (dobj)
studied pretreatment (nmod)
tea of (case)
17beta-estradiol or (cc)
alternative igf-i (nsubj)
monitoring electrocardiographic (amod)
microglobulinuria and (cc)
randomized open-label (dep)
administered progression (nmod)
hyperthyroidism treated (acl)
t+a ) (punct)
task face-learning (compound)
concentrations cibenzoline (nmod)
inferred could (aux)
effective ribavirin (nsubj)
outcomes poorer (amod)
factors seizures (nmod)
can pd (conj)
alterations for (case)
acc-9653 or (cc)
cystometry continuous (amod)
reduction dbp (compound)
those relapse (nmod)
astrocytes surrounding (acl)
either infusion (conj)
comparative 12-week (dep)
problem . (punct)
reported introduction (nmod)
disorder psychoses (conj)
protection for (case)
involvement mrp2 (nmod)
auc ) (punct)
group 3 (nummod)
bupivacaine mg/kg (dep)
secondary rate (nmod)
move away (advmod)
recovery patient (nmod)
kinase . (punct)
literature scientific (amod)
events % (appos)
min 135 (nummod)
5-fu , (punct)
fa 2-hour (amod)
responses presentations (nmod)
weeks after (case)
narrowed day (nmod)
anaesthesia to (case)
rats wky (compound)
was frequency (nmod)
stating success (dobj)
causing multiforme (dobj)
strong association (nsubj)
reshape may (aux)
programs states (nmod)
patients . (punct)
effect secondary (amod)
found age-dependency (nsubjpass)
mutations g145r (dep)
features muscles (nmod)
displace . (punct)
attended , (punct)
one with (case)
ventricle lateral (amod)
aracytine-c high-dose (amod)
strain dba/2 (appos)
pretreatment systemic (amod)
subtle , (punct)
rapid reliable (conj)
prescribed decrease (xcomp)
administered limits (ccomp)
temperature level (conj)
antidepressants many (amod)
rcbf ) (punct)
abnormality a (det)
differs also (advmod)
hydrobromide the (det)
effects cns (amod)
minimize affecting (advcl)
malignancies hematologic (amod)
observed ctnt (nmod)
injections subtenon (amod)
had 5 (nsubj)
antigens to (case)
warned be (auxpass)
levels known (acl)
invaluable . (punct)
evaluation full (amod)
changes behavior (nmod)
placebo , (punct)
, 0.25 (intj)
candidate disease (nmod)
matter no (neg)
suspected was (auxpass)
predict differences (nsubj)
allele epsilon4 (compound)
excluded confounding (nsubjpass)
order following (amod)
failure hypotension (conj)
effects neurotoxic (amod)
2003 to (case)
associated fibrillation (nsubjpass)
placebo ketamine (conj)
come back (advmod)
method in (case)
aplasia pure (amod)
reduced amount (nsubjpass)
q ( (punct)
class to (case)
2b1/2b2 and (cc)
calculated degrees (nsubjpass)
activated smad3 (nsubjpass)
anticoagulation patients (nmod)
combined failure (nmod)
1969 from (case)
concordance rats (nmod)
movements dose (compound)
emphasis symptoms (nmod)
loss aminoglycoside-induced (amod)
lower tone (nsubj)
propensity occurrence (nmod)
step requisite (amod)
exchange plugs (nmod)
hypertension of (case)
care ) (punct)
ameliorates injury (dobj)
nucleus the (det)
16 from (case)
users tamoxifen (compound)
aimed first (conj)
increase a (det)
anp ( (punct)
0.3 3.0 (conj)
jaw ( (punct)
enhanced and (cc)
pretreated day (nmod)
time hcl (nmod)
combination paclitaxel (compound)
15 mm (conj)
patients c (compound)
may ) (punct)
hospital university (compound)
conducted : (punct)
assess basis (dobj)
evoked phenylephrine (nmod)
excitability an (det)
evaluated point (nmod)
tablets analgesic (nmod)
dehydrogenase isoenzymes (conj)
showed substituted (ccomp)
had thirty-seven (nsubj)
suggested minor (ccomp)
expression reflexes (nmod)
rigidity thoraco-abdominal (amod)
quality loss (conj)
reduces oxygenation (dobj)
features postmortem (amod)
points : (punct)
screening after (case)
infarction treatment (nmod)
variability qtc (compound)
rendered was (auxpass)
subjects 6 (nummod)
dose us (compound)
haemorrhage 24 (nmod)
data prior (amod)
iodine-125-metaiodobenzylguanidine with (case)
failure therapy-induced (amod)
using infusion (dobj)
1973 and (cc)
hydrochloride ) (punct)
flestolol of (case)
radicals free (amod)
damage neuropathy (nmod)
require did (aux)
showed discharges (dobj)
u/kg 100 (nummod)
man infection (nmod)
microscopy biopsy (nmod)
spiranolactone of (case)
mm 14.1 (nummod)
ck-mb ng/ml (dep)
dose convulsive (amod)
absence rigidity (nmod)
given given (parataxis)
suggest not (neg)
taken giving (advcl)
diagnose to (mark)
stable be (cop)
supply afferent (amod)
treatment cocaine (nmod)
protein patients (nmod)
microscopical electron (nmod:npmod)
effects azathioprine (nmod)
lacking receptors (dobj)
reduplication : (punct)
cells tubular (amod)
underlying activity (dobj)
long-term , (punct)
length and (cc)
given acetate (dobj)
believe represent (ccomp)
share that (mark)
explain cause (dobj)
individuals , (punct)
mimic aspects (dobj)
genotyped discrimination (nmod)
scale visual (amod)
reported consequence (nmod)
duration , (punct)
eradication in (case)
nephrectomized either (cc:preconj)
increased vldl (nsubj)
therapy clonidine (compound)
was suggestion (attr)
bn of (case)
report dysphagia (nmod)
attention for (case)
subjected s (nmod)
contributed interaction (nsubj)
ventral dorsal (conj)
reduce anticholinergic (nsubj)
minutes precurarization (nmod)
challenge either (cc:preconj)
rose concentration (nsubj)
demonstrates reduces (ccomp)
functions hippocampal (amod)
responsible some (nmod)
read that (nsubjpass)
conclude caused (ccomp)
effects only (advmod)
emotions basic (amod)
changed level (dobj)
value diagnosis (nmod)
nephropathy csa-induced (amod)
rotation initial (amod)
mes ( (punct)
developed epilepticus (dobj)
eeg the (det)
pr group (compound)
echocardiography bubble (compound)
loss waveforms (nmod)
positive gamma-gt (nmod:npmod)
retrieval in (case)
scores examination (compound)
accumulation copper (compound)
mice css10 (compound)
observed kinetics (nmod)
assigned group (nmod)
testing deprivation (compound)
intervention to (case)
rilmenidine i1- (appos)
permanente of (case)
1 ( (punct)
reaction immunoallergic (amod)
marker be (cop)
pirarubicin of (case)
cbf cmro2 (conj)
stage final (amod)
3.49 and (cc)
electrocardiograms eighty-seven (nummod)
discrimination by (case)
population in (case)
required disability (nmod)
effect anesthesia (nmod)
pathway novel (amod)
epileptogenesis deficits (conj)
condition syndrome (nsubj)
desorption/ionization atmospheric (amod)
had therapy (dobj)
people smoke (acl:relcl)
ratio therapeutic (amod)
protection apoptosis (nmod)
easy was (cop)
investigations admission (nmod)
function global (amod)
att-alf ( (punct)
had correlation (nmod)
provides parameter (nsubj)
fatal near (amod)
cardiotoxicity combined (amod)
diagnosed epilepsy (nmod)
$ROOT$ exacerbated (sent)
persisted decrement (nsubj)
metabolized where (advmod)
oxidation transport (conj)
administered given (ccomp)
treated dxnp (nmod)
admissions hospital (nmod)
enhanced latency (dobj)
gr ) (punct)
implicated pathogenesis (nmod)
activity acute (amod)
$ROOT$ likely (sent)
-18 -54 (conj)
limb the (det)
toxicity acute (amod)
force ( (punct)
years 18 (nummod)
infusion iso (compound)
provides evidence (dobj)
myocardium through (case)
remoxipride of (case)
mice nr1(neo-/- (dep)
cases requiring (acl)
different controls (nmod)
medication an (det)
hemoglobin ( (punct)
british of (case)
detrimental b1r (nsubj)
suggest together (advmod)
states the (det)
excretion proteins (nmod)
eu to (case)
diarrhoea , (punct)
potent absent (conj)
risks cancer (nmod)
dopamine-1 and (cc)
show fibers (nmod)
epilepticus mortality (conj)
exacerbated had (conj)
protocol and (cc)
groups saline (appos)
dissociation memory (compound)
associated recipients (nmod)
monotherapy interferon-alpha (compound)
micromol/l. 30 (nummod)
mg. 500 (nummod)
developed discontinuation (nmod)
ie staphylococcal (amod)
severe , (punct)
identified complications (nsubj)
effects depression (nmod)
4.72 - (punct)
because is (cop)
occur animals (nmod)
courses 154 (nummod)
tone muscle (compound)
report an (det)
myalgia this (det)
depression dysfunction (conj)
suffering cips (nmod)
died six (nsubj)
alter meth (nsubj)
alpha3 heterozygous (amod)
painful it (nsubj)
autoantibodies p450 (nmod)
bolus . (punct)
medical drug (conj)
changes behavioral (amod)
data toxicity (compound)
cells ventrolateral (amod)
33.7 + (cc)
useful sedative (nmod)
hyperactivity meth-induced (amod)
sites to (case)
complications psychiatric (amod)
developed e.g. (advmod)
response in (case)
mean number (conj)
drug needed (acl)
characteristic block (nmod)
coexisted lesions (nmod)
dysfunctions other (amod)
range mumol/kg (appos)
acceptance increased (amod)
increase min (nmod)
min 5 (nummod)
fractures for (case)
phenothiazines drugs (conj)
transplantation autologous (amod)
tracers with (case)
developed pain (dobj)
nms day (compound)
resulted reductions (nmod)
began he (nsubj)
occur not (neg)
disorder investigated (acl)
cause hypercalcemia (nmod)
released zyban (nsubjpass)
men either (preconj)
mediated types (nsubjpass)
r(2)=0.79 ) (punct)
= 0.94 (dobj)
24 patients (nmod)
agent tspa (nsubj)
weeks 122 (nummod)
phenytoin with (case)
ka ) (punct)
arrhythmia transient (amod)
related disease (nmod:npmod)
inducing for (mark)
dissociation of (case)
toxicity cy (compound)
responses cystitis (nmod)
binding t-[35s]butylbicyclophosphorothionate (nmod)
response gauges (nmod)
reaction in (case)
defective are (cop)
vasoconstriction intramural (amod)
summarizes , (punct)
increase proliferation (nmod)
95 1 (conj)
pain skeletal (amod)
free h (nmod)
interaction due (case)
weeks first (amod)
pilocarpine day (nmod)
model allows (acl:relcl)
males risperidone (nmod)
confusion with (case)
neurotoxicity methotrexate (compound)
efficacy multiple-dose (amod)
risks interventions (nmod)
l-dopa after (case)
lines research (nmod)
hoe of (case)
drug phenytoin (nsubj)
set experiment (nmod)
months 60 (nummod)
children treated (acl)
debate . (punct)
cyclophosphamide thiotepa (conj)
$ROOT$ version (sent)
cycle chemotherapy (nmod)
diseases native (amod)
quantities mannitol (nmod)
addiction for (case)
exacerbates inhibition (nsubj)
february 1998 (nummod)
group and (cc)
period immediate (amod)
performed abroad (advmod)
search ( (punct)
subunits , (punct)
showed trial (nsubj)
fos-immunoreactivity neurons (nmod)
sfas serum (compound)
known fq (nmod)
dose intravenously (advmod)
younger years (nmod)
drugs anti-epileptic (amod)
access in (case)
schedules administration (nmod)
arise problems (nsubj)
val204asp ) (punct)
median cycles (nmod)
detailing course (dobj)
children those (conj)
discontinued therefore (advmod)
able attenuate (xcomp)
amount protein (nmod)
cats , (punct)
stroke of (case)
mfs ( (punct)
migraine society (nmod)
patients died (conj)
1 radiation (nmod)
ms/mg of (case)
toxic allergic (conj)
0.05 0.02 (conj)
deposition crystal (compound)
tpp ( (punct)
salt-depleted respectively (advmod)
% gcs (conj)
action antidotes (nmod)
now up (case)
dissociate chloride (nsubj)
obtained found (conj)
trimester within (case)
cross-reactivities mabs (nmod)
antibodies cytoplasmic (amod)
nine % (appos)
carcinoma bronchio-alveolar (amod)
leukoencephalopathy toxic (amod)
defective was (cop)
observed synthesis (nsubjpass)
0.1 0.2 (conj)
loss min (nmod)
tia ) (punct)
postoperatively h (nmod:npmod)
conjugation and (cc)
girl 15-yr-old (amod)
treated dox (nmod)
5.3 - (punct)
changes . (punct)
contractility gallbladder (compound)
effect placebo (nmod)
read word (nsubjpass)
attributable changes (nmod)
use medication (nmod)
vt to (case)
used are (auxpass)
intervals sedation (nmod)
regulation gene (compound)
levels propofol (nmod)
p>0.05 ( (punct)
correlate the (det)
found syndrome (nmod)
agonist-induced beta-ar (nmod:npmod)
population prl (compound)
examined females (nsubjpass)
is where (advmod)
regeneration by (case)
dilatation lumens (nmod)
rearings the (det)
medicate not (neg)
enhance and (cc)
based , (punct)
monomer conjugate (conj)
treatments poisoning (nmod)
catecholamines of (case)
affinity sigma2 (nmod)
comprised study (nsubj)
days = (dep)
recovered state (nmod)
revealed took (ccomp)
improve health (dobj)
analyzed features (nsubjpass)
rates lower (amod)
frequent so (advmod)
circuitry thalamocortical (amod)
determine inconclusive (advcl)
enhanced hyperthermia (nsubj)
dx free (amod)
association nyha (appos)
pheochromocytoma patient (nmod)
patients 4086 (nummod)
group our (nmod:poss)
% 5.4 (nummod)
incorporation reduced (advcl)
kindreds the (det)
phase 4 (nummod)
e1 trimethaphan (conj)
$ROOT$ provoked (sent)
nephritis recurrent (amod)
$ROOT$ attained (sent)
epinephrine micrograms.kg-1.min-1 (punct)
induced socs-1 (dobj)
studied assess (xcomp)
antagonized and (cc)
levels % (nmod)
affect species (nsubj)
needed strategies (nsubjpass)
regained all (advmod)
a ( (punct)
significance no (neg)
needed caution (nsubjpass)
patients delirium (nmod)
defects many (amod)
restricted be (cop)
concentration cimetidine (nmod)
study carcinoma (nmod)
reproduced showed (parataxis)
coma hypotension (conj)
result binding (nmod)
received ultimately (advmod)
audiograms with (case)
man years (nmod)
diltiazem verapamil (conj)
exposures previous (amod)
eye such (case)
clearance cimetidine (nmod)
quantities drug (nmod)
suggesting , (punct)
alter achieved (conj)
anxiety microglia (nmod)
leading activities (nmod)
suffered patients (nsubj)
demonstrates suggests (conj)
tests platelet (compound)
propose activate (ccomp)
mz with (case)
given randomly (advmod)
improved % (nmod)
ci 1.4 (appos)
rate reported (amod)
drug on (case)
reported cases (dobj)
intensity high (amod)
users ecstasy-polydrug (amod)
papilledema opacities (conj)
risperidone inhibitors (conj)
deviation the (det)
count her (nmod:poss)
use cefotetan (nmod)
contain metabolite (dobj)
c 5.6 (dep)
therapeutic is (cop)
similar characteristics (nsubj)
5-fluorouracil paclitaxel (conj)
were changes (nmod)
induced ouabain (nmod)
fifty-five hundred (compound)
responded symptoms (nsubj)
therapy granulomatosis (nmod)
prevented have (aux)
hypertension ocular (amod)
homozygous cholinesterase (nmod)
deviations leftward (amod)
deficits the (det)
pulses ) (punct)
cpdd ) (punct)
virus ) (punct)
changes tract (nmod)
shows case (nsubj)
have contractions (dobj)
pharmacokinetics tolerability (conj)
flow kidney (nmod)
enzymes inactivate (acl:relcl)
$ROOT$ hypercalcemia (sent)
area 5 (nmod)
higher etoricoxib (nmod)
implanted shell (nmod)
marker paranoia (nmod)
treatment prompt (amod)
slowing only (advmod)
$ROOT$ inferred (sent)
focus function (nmod)
cholesterol ldl (conj)
caused hypertrophy (dobj)
proteome regarding (case)
study control (compound)
investigations further (amod)
undertook characterize (advcl)
disrupted , (punct)
change bradycardia (nmod)
result as (case)
induces injection (nsubj)
inhibitors specific (amod)
those seen (acl)
cco-iv ) (punct)
doses or (cc)
blocked hand (nmod)
cultured epo (nmod)
reducing reducing (conj)
micrograms 600 (nummod)
low generally (advmod)
parameters desire (nmod)
4.10 , (punct)
cohorts unmatched (amod)
as bilateral (dep)
observed l-1 (xcomp)
discontinuing administering (conj)
investigating properties (dobj)
inhibitors mammalian (amod)
design the (det)
depends incidence (nsubj)
$ROOT$ loss (sent)
hg compared (dep)
la elevated (amod)
four ) (punct)
septal vsd (appos)
pressure baseline (amod)
defect alf (nmod)
pr saline (appos)
gaining treatment (nmod)
number wavefronts (nmod)
phase iii (nummod)
alternations signs (conj)
present disease (nsubj)
cystitis due (amod)
evidence fibrosis (nmod)
incidence cystitis (nmod)
dependent protective (parataxis)
areas ulcer (compound)
found controlling (advcl)
improved bcnu (nmod)
early % (parataxis)
ml 8 (nummod)
arag/vp/cpm of (case)
hbsag , (punct)
psychosis disease (nmod)
supplements consumed (amod)
calcium cholesterol (conj)
characterization comprehensive (amod)
stabilizers and (cc)
therapy bridge (conj)
cause inhibitors (nsubj)
identified metabolite (nmod)
concentrations ) (nmod)
structures and (cc)
ceased , (punct)
sufficient may (aux)
warranted . (punct)
fed weeks (nmod)
55 15 (conj)
taking regimens (dobj)
period ; (punct)
resembling hepatitis (xcomp)
recorded behavior (nsubjpass)
derived plasma (nmod:npmod)
ketorolac ) (punct)
receptors 5-ht1b (compound)
mediator as (case)
carcinoma colorectal (amod)
recall sedation (nmod)
amplitudes emissions (nmod)
users group (nmod)
3mg/kg ) (punct)
migraineurs female (amod)
years eight (nummod)
tma recurrent (amod)
bottle a (det)
effect depletion (nmod)
status with (case)
function neurons (conj)
decreased improved (parataxis)
mg/day from (case)
stage early (amod)
improves . (punct)
describe review (conj)
measured again (advmod)
not ) (punct)
features consistent (amod)
germany and (cc)
test echocardiography (nsubj)
indications for (case)
program , (punct)
insurance pharmaceutical (compound)
trial training (compound)
commenced achieved (conj)
properties dynamic (amod)
ziprasidone due (case)
conclusions observed (appos)
calculated means (nmod)
shr male (amod)
tolerability gastrointestinal (amod)
efficacious procyclidine (nmod)
transport . (punct)
effects dramatic (amod)
hydroxyproline of (case)
% 88.6 (nummod)
animals these (det)
shown gamma-hexachlorocyclohexane (nsubjpass)
count < (amod)
induce examine (conj)
cream sulphadiazine (compound)
administered ribavirin (nsubjpass)
syndrome apnea (compound)
co. pharm (compound)
treated lamivudine (nmod)
tensions tetanic (amod)
control 1.037 (appos)
stones or (cc)
reported switching (nsubjpass)
states distress (nmod)
mediates , (punct)
exposure hcl (compound)
administration patient (nmod)
produce metronidazole (nsubj)
study retains (ccomp)
myopathy chloroquine-induced (amod)
prevention retention- (nmod)
signs rhabdomyolysis (nmod)
45 and (cc)
nephropathy , (punct)
intake pills (nmod)
instituted administration (nsubjpass)
revealed decrement (dobj)
case hypotension (nmod)
volume vd (appos)
anesthetized and (cc)
ovale patent (amod)
evidences : (punct)
respond not (neg)
43 ( (punct)
infants 11 (nummod)
abdominal upper (amod)
diminish may (aux)
mg/kg/i.v ( (punct)
drug or (cc)
patient known (acl)
undergone that (nsubj)
detrimental that (mark)
scans repeated (amod)
asthenia , (punct)
exposed bpa (nmod)
morphology ultrastructural (amod)
reduction > (amod)
7.54 model (nmod)
bs and (cc)
opaque , (punct)
components main (amod)
problem health (compound)
appeared parallel (nmod)
cont./min cisapride (appos)
administration beraprost (nmod)
observed alteration (nsubjpass)
sequelae the (det)
filling resting (amod)
$ROOT$ abuse (sent)
predictor cardiotoxicity (nmod)
potent less (advmod)
history hyperthyroidism (nmod)
ne ) (punct)
injury possible (amod)
abnormalities such (amod)
time tmax (appos)
receptors serotonergic (amod)
generalization the (det)
induced groups (nmod)
cerebellum patients (nmod)
loss vigabatrin-attributed (amod)
nuclei with (case)
addresses geocoded (amod)
mmhg . (punct)
% 0.5 (nummod)
abusing methamphetamine (dobj)
associated anaesthesia (nmod)
cssep nmp (conj)
questionnaire with (case)
reaction complex-mediated (amod)
satisfying criteria (dobj)
approach in (case)
tended subgroup (nmod)
monitoring routine (amod)
decreases similar (amod)
drawback hypotension (nmod)
therapy quetiapine (compound)
avoided communicated (advcl)
nk1 of (case)
accuracy predictive (amod)
5.6 - (advmod)
discribed patient (nsubjpass)
had decreased (advcl)
101 +/- (cc)
procedure phases (conj)
administered rate (nmod)
ml 1000 (nummod)
ce a (det)
acid retinoic (amod)
hyperactivity parahippocampal (amod)
appears : (punct)
hydration amounts (conj)
meq/l ) (punct)
bbb the (det)
p 2 (nummod)
act to (mark)
$ROOT$ microg/kg/min (sent)
dynamics ; (punct)
gestodene desogestrel (conj)
cause prolongation (dobj)
area hypoperfusion (nmod)
were a (nmod)
-0.62 respectively (advmod)
n-butyl-deoxynojirimycin ) (punct)
hyperthermia whole (amod)
patients 135 (nummod)
$ROOT$ offer (sent)
scale conditions (nmod)
taste smell (conj)
application dose (nmod)
cxcl1 il-1beta (conj)
heparin or (cc)
interfere neurotransmission (nmod)
convulsions not (cc)
$ROOT$ possesses (sent)
induce also (advmod)
effects verapamil (nmod)
activator to (mark)
medullary outer (amod)
normal nonspecific (conj)
0.75 0.50 (compound)
thrombosis deep-vein (amod)
foci/cm2 5 (nummod)
evidence involves (ccomp)
pregnancy the (det)
strength its (nmod:poss)
increased % (nsubj)
explained flow (nmod)
evaluate course (dobj)
diet mmol/d (appos)
myalgia to (case)
arthritis and (cc)
depressed severely (advmod)
suppressed heart (nmod)
oestrogens ) (punct)
wave = (dep)
evidence electrocardiographic (amod)
hormone or (cc)
preceded requiring (advcl)
returned changes (nsubj)
women 17 (nummod)
database large (amod)
omitted except (mark)
tests single-blind (amod)
point any (det)
tdr in (case)
t subgroup (nmod)
demonstrated except (prep)
explored rats (nmod)
metformin drug (appos)
phases ( (punct)
. nitroprusside (nmod)
negative 51 (nsubj)
consistent meninges (nmod)
alter . (punct)
revealed reports (dobj)
dosage amiodarone (nmod)
incapacity learn (acl)
$ROOT$ powered (sent)
rhythm junctional (amod)
discrimination impaired (amod)
mcg ( (punct)
electroshock maximal (amod)
monophosphate cgmp (appos)
ccl2 and (cc)
had age (dobj)
evidence recent (amod)
leading rpn (nmod)
beams cells (conj)
decreased stl1 (dobj)
determined ) (punct)
attenuated coadministration (nsubj)
applications hypothermia (nmod)
anemia autoimmune (amod)
stratum stratum (appos)
residues of (case)
bd1018 bd1063 (conj)
recognized well (advmod)
response medication (nmod)
models same (amod)
system iris (nmod)
feature depression (nmod)
years 69.9 (nummod)
completion successful (amod)
intervals of (case)
women = (parataxis)
carcinogen c (compound)
allows analysis (nsubj)
investigation clinical (amod)
cystitis intermediate (amod)
5-fluorouracil to (case)
rast negative (amod)
$ROOT$ background/aims (sent)
treated animals (nsubjpass)
decreased death (dobj)
years 32 (nummod)
s-1 of (case)
patient malaria (nmod)
anastrozole and (cc)
sinus left (amod)
monitoring ( (punct)
users to (case)
achieved six (nsubj)
effects bladders (nmod)
flutamide the (det)
modified significantly (advmod)
hydrochloride bepridil (compound)
s-23121 to (case)
showed treatment (nsubj)
sedatives used (amod)
cows of (case)
increase greater (amod)
decrease rigidity (nmod)
mutations gene (nmod)
solution nacl (compound)
cystitis pollakisuria (conj)
suxamethonium against (case)
assessed sec (nmod:tmod)
appeared effects (nsubj)
stage a (det)
i1- selective (amod)
elevated surface (nmod)
prednisolone group (appos)
center trauma (compound)
linked and (cc)
produce latter (nmod)
identified be (auxpass)
concentrations similar (acl:relcl)
allows time (nmod)
related scores (nmod)
reactions with (case)
hyperplasia liver (nmod)
disturbance with (case)
different and (cc)
spikes and (cc)
cholestasis -- (punct)
bradycardia . (punct)
intravenous both (cc:preconj)
% 5.1 (nummod)
hypothesis this (det)
treatment cyclophosphamide (nmod)
subcutaneous or (cc)
25 35/15 (quantmod)
woman the (det)
drugs induce (acl:relcl)
changed n (dep)
evidence little (amod)
powered , (punct)
svc central (conj)
materials evaluated (dep)
14,671 they (nsubj)
results present (appos)
antibodies cefotetan-dependent (amod)
timing suitable (amod)
phosphorus with (case)
demonstrated studies (nsubj)
headache the (det)
tract gastrointestinal (amod)
in tests (nsubj)
reduces administration (nsubj)
terms utilized (acl)
evaluation initial (amod)
depressants central (amod)
alf non-e-induced (amod)
incidence cardiotoxicity (nmod)
received cyclosporine (dobj)
reduced versus (cc)
cases in (case)
selected effects (nmod)
sedation cystourethrogram (nmod)
period min (compound)
treatment eyes (nmod)
resulting failure (nmod)
supported is (auxpass)
position squatting (amod)
contribution repair (nmod)
congenita myotonia (compound)
gamma-sarcoglycan alpha-2 (conj)
i.p. intraperitoneally (advmod)
l-dopa with (case)
supplemented dose (nmod)
clomipramine or (cc)
aspirin control (conj)
glycine gaba (conj)
inhibitors ts (nmod)
experienced before (advmod)
significant small (advcl)
uptake tracer (compound)
considered : (punct)
leiden factor (compound)
suggested to (xcomp)
spasm , (punct)
presented placement (nmod)
set whereupon (nsubj)
higher lower (conj)
receptors particularly (advmod)
= 0.68 (dobj)
time toward (case)
reductions apomorphine-induced (amod)
number average (amod)
shown further (advmod)
dosage oral (amod)
onset rapid (amod)
deactivation current (nmod)
hypothesis acts (ccomp)
rofecoxib 65,860 (nummod)
word first (amod)
given received (parataxis)
produced potency (nmod)
beta=0.49 p=0 (appos)
receiving bupropion (dobj)
nonusers aspirin (nmod)
mask trinitrate (conj)
investigated reviewing (advcl)
cephalosporins to (case)
cocs and (cc)
introduced kingdom (nmod)
reduced inhibition (dobj)
strokes recurrent (amod)
description good (amod)
insula , (punct)
incontinence , (punct)
collagenase bacterial (amod)
infused icv (nmod:npmod)
referred was (auxpass)
recording video (compound)
drug ( (punct)
all whom (nmod)
period january (appos)
prescribed that (nsubjpass)
showed increase (dobj)
groups compared (case)
beginning follow-up (conj)
arrest cardiac (amod)
induced pilocarpine (nsubj)
i class (compound)
apraclonidine of (case)
[d-pen2.5]-enkephalin [d-ser2]-[leu]enkephalin-thr (conj)
abnormalities behavioral (amod)
abnormalities correlated (acl:relcl)
disease caused (acl)
gabapentin , (punct)
caused had (aux)
more management (nmod)
hyalinosis as (case)
words of (case)
dct2 the (det)
acne hirsutism (conj)
hypertrophy , (punct)
0.95 - (punct)
chorea and (cc)
december between (case)
h introduction (nmod)
tolerated medicine (dobj)
mg/dl p (dep)
possibility irreversible (advcl)
count subset (compound)
h2o2 ) (punct)
level protein (nmod)
ng./ml less (amod)
hyperplasia severe (amod)
indicated resulted (ccomp)
mg.kg(-1 thiopental (appos)
ich warfarin-associated (amod)
$ROOT$ accounted (sent)
years than (case)
-9.9 +/- (cc)
accounted for (nmod)
useful developing (advcl)
< respectively (advmod)
pressure elevated (amod)
microm 11.2 (nummod)
seen doses (nmod)
0 100 (prep)
decreased response (nsubjpass)
following weeks (nmod:npmod)
14th to (case)
co-administration rats (nmod)
hospital women (nmod:poss)
components extract (nmod)
is view (nmod)
suggest prevented (ccomp)
support are (cop)
obesity hyperinsulinemia (conj)
described experiencing (xcomp)
efficacy tolerability (conj)
resuscitation and (cc)
investigated fields (dobj)
medications between (case)
uteri the (det)
increased frequency (dobj)
provoked lacrimation (dobj)
striking advantages (nmod)
reacted eluate (nsubj)
fluoroquinolones ciprofloxacin (appos)
doxorubicin wt (appos)
patients 5 (nummod)
toxicology developmental (amod)
micrograms t.i.d. (conj)
integrity hippocampal (amod)
produces state (dobj)
led presumably (advmod)
age lower (amod)
raises . (punct)
dyskinetic nondyskinetic (conj)
carried confirm (xcomp)
reported incidents (dobj)
$ROOT$ concentration (sent)
79 9 (compound)
episodes hypertensive (amod)
failure resulting (acl)
assessed number (nsubjpass)
% v. (cc)
injury dox (nmod)
factors age (nsubj)
severe be (cop)
developed commonly (advmod)
susceptible is (cop)
classified being (advcl)
had determined (advcl)
dsp4 by (case)
mg 5.0 (nummod)
effect curcumin (nmod)
triglycerides in (case)
formed groups (nsubjpass)
activity emg (compound)
production as (cc)
immunofluorescence biopsy (nmod)
noted reduction (nsubjpass)
segment of (case)
stress foot-shock (amod)
showed peak (nmod)
make does (aux)
risk time (nmod)
unremarkable except (prep)
extent infarction (nmod)
relation alterations (nmod)
from aside (advmod)
changes blood (compound)
% thickness (nmod)
patient seventh (amod)
reported dysfunction (nsubjpass)
castrated and (cc)
days gestation (nmod)
representative not (neg)
intensity median (amod)
use chemotherapy (nmod)
contrasts greater (amod)
infusion corticosterone (compound)
identical that (nmod)
infarction discrete (amod)
requested were (auxpass)
s.c. kg-1 (compound)
methods searched (appos)
glaucoma of (case)
increased 2.9-fold (conj)
primary two (appos)
discuss mechanism (dobj)
$ROOT$ expression (sent)
n. 8 (nummod)
requires also (advmod)
course , (punct)
ef ) (punct)
defense biting (conj)
rigidity leading (acl)
hypertension associated (amod)
group growth-inhibited (amod)
course prednisone (nmod)
paramount . (punct)
attack onset (compound)
race/ethnicity or (cc)
is characteristic (nsubj)
observed and (cc)
increased receptor (nsubj)
absence mice (nmod)
obstruction junction (compound)
discontinued admission (nmod)
vein central (amod)
sequelae neurological (amod)
dose lindane (nmod)
knife and (cc)
study autoradiographic (amod)
study at (case)
consistent this (nsubj)
models acute (amod)
mg/dl ] (punct)
receiving phenothiazines (dobj)
levels 15-f(2t)-isoprostane (nmod)
alendronate of (case)
achieved cases (nmod)
high unexpectedly (advmod)
improved still (advmod)
controls given (acl)
3alpha-tropanyl-2-(4-chorophenoxy)butyrate ) (punct)
ruling out (compound:prt)
rats castrated (amod)
fhf ( (punct)
worsening dyskinesia (nmod)
provides sedation (dobj)
extent mice (nmod)
decreased reduction (nmod)
density sinus (nmod)
hypersensitivity of (case)
diameter by (case)
recovered amplitude (nsubj)
antagonism receptor (compound)
mirror other (dobj)
% week (nmod)
phlebitis , (punct)
patient of (case)
$ROOT$ deficits (sent)
9.1 , (punct)
bradycardia accompanying (amod)
biomarker to (mark)
subregions into (case)
restoration by (case)
ischemic origin (nmod)
performed surgery (nsubjpass)
words 400 (nummod)
seen increases (nsubjpass)
pressing down (advmod)
% 55.1 (nummod)
lipoprotein ldl (appos)
abundant day (nmod)
estimate controlling (advcl)
plausible dose (nmod)
useful form (nmod)
differences the (det)
aprotinin or (cc)
included disease (dobj)
sensitized to (nmod)
metabolism neuropeptide (compound)
examined 27 (nsubjpass)
haplotypes in (case)
develop have (dep)
hypothyroid also (advmod)
rats barium-supplemented (amod)
abnormalities potential (conj)
managing patient (dobj)
curve 6.0 (nmod)
associated pseudoprolactinoma (nmod)
decreased uptake (dobj)
hypokalemia b-related (amod)
attributable directly (advmod)
values control (compound)
treatment cpa (compound)
sexes both (det)
introduced ketoconazole (nsubjpass)
had 21 (nsubj)
hyperprolactinemia treated (acl)
0.768 : (punct)
1.9 micrograms/ml (conj)
test using (acl)
dogs develop (acl:relcl)
animals . (punct)
evaluation cross-sectional (amod)
patients using (acl:relcl)
days 13th (amod)
problem clinical (amod)
1/32 in (case)
mg/kg 7.0 (compound)
age 70 (nummod)
determined atropine (nmod)
(ami)-induced amiodarone (nmod:npmod)
signed subjects (nsubj)
taken biopsies (nsubjpass)
effective given (advcl)
inhibitor patients (nmod)
addition following (case)
true newborns (nmod)
bleeding warfarin-related (amod)
levels 1 (dep)
scored as (prep)
min-1 to (case)
count thrombocytopenia (conj)
affect temperature (dobj)
increase high (amod)
result did (aux)
rare treatment (nmod)
raclopride the (det)
included that (mark)
affected severely (advmod)
related unrelated (conj)
lamivudine to (case)
model potential (amod)
matched 190 (nsubj)
treatment fourth (amod)
began she (nsubj)
test apomorphine-induced (amod)
extract hexanic (amod)
been has (aux)
prolonged rats (nmod)
smaller much (advmod)
mild severe (conj)
relevance patients (nmod)
included only (advmod)
observed activating (advcl)
aim draw (xcomp)
inhibit to (mark)
elongation dna (compound)
hours 23 (nummod)
level gaba (nmod)
superior with (mark)
sch ) (punct)
hippocampus seized (amod)
globulin combined (amod)
exacerbated improvement (nmod)
reserpine haloperidol (conj)
flecainide , (punct)
corrected hypothyroidism (nsubjpass)
values the (det)
plasticity deficient (amod)
decreased striatum (nmod)
involvement nucleus (compound)
hypoactivity caused (acl)
prescribed admission (nmod)
isomers the (det)
analysis adducts (nmod)
attenuated tgr (nmod)
neurohypophysis from (case)
acting safe (amod)
blockade prior (amod)
function mtdna-encoded (amod)
matched scoring (nmod)
administration meloxicam (compound)
neutropenia patients (nmod)
found glomerulopathy (nmod)
effects flumazenil (nmod)
results declined (appos)
anxiety caffeine-induced (amod)
reached however (advmod)
assess produces (ccomp)
data this (det)
subjects reactions (nmod)
function determined (acl)
patients 23 (nummod)
hypertrophy myocardial (amod)
injected edaravone (nmod)
increases delta (conj)
required studies (nsubjpass)
defined well (advmod)
stopped once (mark)
area mean (amod)
use dormex (nmod)
activates daidzein (nsubj)
foci formed (acl)
indicate response (dobj)
visualize we (nsubj)
observed mice (nmod)
procedure each (det)
rare dystonias (nsubj)
highlight effects (dobj)
residence prolonged (amod)
index bispectral (amod)
22 9 (compound)
those recorded (acl)
time testing (nmod)
have phase (dobj)
exposure childhood (amod)
develop doses (nmod)
found activity (nmod)
unchanged levels (nsubj)
incident the (det)
strategy search (compound)
25.3 2.9 (conj)
nine 15 (nmod)
diplopia sudden (amod)
emissions transient (amod)
les both (cc:preconj)
beta 2-receptors (conj)
mg/day over (case)
therapy that (mark)
observed leukocytosis (nsubjpass)
testosterone fat (conj)
pool contributing (acl)
ingestion ketoconazole (nmod)
trigger that (mark)
80 +/- (cc)
occurred observed (conj)
examined vivo (advmod)
enhances l-dopa (nsubj)
symptoms headache (conj)
deafened selectively (advmod)
tended record (xcomp)
verapamil of (case)
amisulpride- tiapride-induced (conj)
area dysfunction (nmod)
performed solution (nmod)
atenolol after (case)
behaviors repetitive (amod)
measurements due (case)
margin low (amod)
strains independent (amod)
scale an (det)
pointer laser (compound)
sulphonate thiol (compound)
% had (advcl)
increased compartments (nmod)
effects melatonin (nmod)
exposed suppressants (nmod)
16 and (cc)
trajectory along (case)
occurred deterioration (nsubj)
vigilance deterioration (nmod)
represent that (mark)
levels symptom (compound)
$ROOT$ criteria (sent)
mg lamivudine (nmod)
form infusion (nmod)
returned completion (nmod)
doses tetracycline (nmod)
correlated whereas (dep)
infiltrate consistent (amod)
june 2002 (nummod)
oxide and (cc)
delays blockade (nsubj)
weights different (amod)
index scale (conj)
therapy concomitant (amod)
inhibit respectively (advmod)
associated immobilization (nmod)
case veno-occlusive (nmod)
association the (det)
increasing ml/min (nmod)
prl ( (punct)
ssr103800 such (case)
women study (nmod)
toxic least (amod)
induce fact (nmod)
suspected have (xcomp)
morphogenesis cardiac (amod)
rare previously (advmod)
analyses safety (compound)
estimated phenobarbitone (nsubjpass)
diagnosis on (case)
reversal phenylephrine (nmod)
induced mice (advcl)
induced tilt (nsubj)
15 another (det)
ptld and (cc)
liver fatty (amod)
$ROOT$ inefficient (sent)
trough-concentrations p (dep)
associated infarctions (nsubjpass)
tumour brain (compound)
assess to (mark)
ganglia root (compound)
treated saline (nmod:npmod)
mmol ; (punct)
myocarditis induced (amod)
demonstrated toxicity (nsubjpass)
administrated days (nmod)
serum eluate (conj)
delivering boluses (dobj)
lesions pathological (amod)
distinguished be (auxpass)
lidocaine-kindled or (cc)
test : (punct)
33.6 5.4 (conj)
use concomitant (amod)
continued postoperatively (advmod)
controlled again (advmod)
passage . (punct)
moderate were (cop)
megaloblastosis by (case)
constructed curves (nsubjpass)
hypothesis to (case)
receptors 5ht4 (compound)
people at (case)
injections before (nmod)
memory short (amod)
bupivacaine saline (conj)
$ROOT$ negligible (sent)
days 170 (nummod)
metrifonate the (det)
contrast controls (nmod)
effective amiodarone (nsubj)
double-immunolabeling by (case)
associated but (advmod)
effects nik-247 (nmod)
srl with (case)
chemotherapy multiagent (amod)
hydrochloride ester (compound)
history well-documented (amod)
resulting decreases (nmod)
plasticity in (case)
tm ( (punct)
n=92 93 (conj)
ratio ci (appos)
lacks reported (parataxis)
gap43-ir in (case)
responses the (det)
lend results (nsubj)
cause flecainide (nsubj)
overdose patient (nmod)
strain evaluating (acl)
amino-nucleoside of (case)
cervical inguinal (conj)
contribute toxicity (nmod)
oxycantha ( (punct)
children preterm (amod)
power sufficient (amod)
rates increases (nmod)
% 11.7 (nummod)
rhythm sleep-wake (compound)
produce mice (nmod)
33.42 3.10 (conj)
fraction ventricular (amod)
testing cardiotoxicity (nmod)
symptoms loss (nmod)
4.7 more (acl:relcl)
injection methamphetamine (compound)
min ) (punct)
p9605 ( (punct)
members 2 (nummod)
setting conducted (dep)
turnover dopamine (compound)
accumulated studies (nmod)
volumes the (det)
acid-induced kainic (amod)
$ROOT$ cardiotoxicity (sent)
excellent , (punct)
eu ( (punct)
ct after (case)
cytotoxicity whose (nmod:poss)
dermis the (det)
agent antipsychotic (amod)
procedures operating (compound)
approach standard (amod)
$ROOT$ hypokalemia (sent)
developed sicca (nsubj)
used injected (advcl)
occurred time (nmod)
omitted was (auxpass)
attenuated affected (advcl)
nephropathy (pan)-induced (amod)
prone exhibit (xcomp)
alf serum (conj)
deterioration fields (nmod)
100 ) (punct)
warfarin mg/day (dep)
preservation function (nmod)
administered vnb (nsubjpass)
cured clinically (advmod)
events drug (compound)
coordination hand (nmod)
therapy ace (compound)
mmhg 135 (nummod)
structure of (case)
= y (nsubj)
b2 txb2 (appos)
group bolus (compound)
harmless not (neg)
x-rays chest (compound)
known yet (advmod)
amounts deletion (nmod)
spv in (case)
enhanced drugs (nmod)
concentrations mannitol (nmod)
histochemistry phosphate-diaphorase (compound)
ingredient is (cop)
hemolysis transfusion (nmod)
< .0001 (dep)
week the (det)
onset embolism (nmod)
butyrylcholinesterase patient (compound)
removal manual (amod)
have which (nsubj)
visualized distortion (dobj)
$ROOT$ should (sent)
pathway that (mark)
suppress doses (nsubj)
in utero (dep)
analgesia catalepsy (conj)
histology with (case)
made seconds (nmod:tmod)
dibucaine fluoride (conj)
prooxidant ; (punct)
received sulfate (dobj)
inhibitors serotonin (compound)
l-name ) (punct)
dosage cm (nmod)
measurements one (conj)
adolescents five (nummod)
microg/ml and (cc)
anemia significant (amod)
decrease use (dobj)
liver , (punct)
62 22 (compound)
mean+/-se ( (punct)
less but (cc)
saline mp (conj)
treatment aminoglycoside (compound)
eliminated independently (advmod)
% second (nmod)
occlusion vessels (nmod)
patients eighty-one (nummod)
increases while (mark)
aureus susceptible (amod)
iprk in (case)
hydrochloride metformin (compound)
$ROOT$ differs (sent)
alternative to (mark)
treatment lf (compound)
aura with (case)
t+a % (appos)
placed who (nsubjpass)
blockade autonomic (amod)
as allergic (amod)
closest was (cop)
breathiness of (case)
kindreds history (nmod)
different strains (nmod)
were increases (attr)
abuse from (case)
injection i.m. (compound)
luminal antiluminal (conj)
found vehicle (nsubjpass)
test described (acl)
motif ymdd (compound)
effect glycol (nmod)
spasm due (case)
severe most (advmod)
62 19 (conj)
hypothesis dysfunction (nmod)
peptide nt-probnp (appos)
area mg/l. (nmod)
acid ribonucleic (amod)
ka apparent (amod)
apnea as (case)
involved contrary (nmod)
biomarkers allow (acl:relcl)
monitored parameters (nsubjpass)
given collection (nmod)
unknown currently (advmod)
novel cage (conj)
effect strain-dependent (amod)
damage muscle (compound)
$ROOT$ description (sent)
% a (nmod)
those infusion (nmod)
effect patients (nmod)
disparities large (amod)
1.23 ( (punct)
bp and (cc)
recovery " (punct)
five and (cc)
results improved (appos)
% 75 (nummod)
properties contractile (amod)
existence disorder (nmod)
degree to (case)
face a (det)
survivors groups (conj)
or=12.619 ( (punct)
drugs suppressant (amod)
defects mainly (advmod)
revealed increased (ccomp)
missed far (advmod)
transplantation dialysate (nmod)
nm 100 (compound)
ltp ) (punct)
had number (nmod)
taking while (mark)
diagnosis or (cc)
period 4-week (compound)
appears precipitated (ccomp)
cardiomyopathy severe (amod)
preponderance group (nmod)
study effects (nmod)
improves index (dobj)
inhibits peroxidation (dobj)
= 0.03 (dobj)
type severe (amod)
acid 5-hiaa (appos)
fibrin less (amod)
earliest are (cop)
oncology of (case)
exerts neurotransmission (nmod)
sex by (case)
patients n/n=62/92 (dep)
using t-tests (dobj)
achieving receiving (conj)
observed antigen (nsubjpass)
therapy indinavir (compound)
control disorder (dobj)
switching ufh (nmod)
develops mass (dobj)
calculated retrospectively (advmod)
used countries (nmod)
induction remissions (nmod)
treated paracetamol (nmod)
absent labeling (nsubj)
sample as (case)
evidence somatotopy (nmod)
protection of (case)
infusion hours (nmod)
relief considerable (amod)
phosphatase protein (compound)
allocated groups (nmod)
likely group (nmod)
mm 62 (nummod)
decreases duration (dobj)
prevents accumulation (dobj)
anthracyclines and (cc)
delay temporal (amod)
exist that (mark)
occurred hyper-responsiveness (nsubj)
day infusion (conj)
tested hypothesis (nsubjpass)
hoe des (compound)
patients olanzapine-treated (amod)
effect hypolipidemic (amod)
effects production (nmod)
growth normal (amod)
marker may (aux)
duration period (nmod)
found association (nsubjpass)
0.6 i.v. (nmod)
containing anthraquinones (dobj)
similar risk (nsubj)
weight antioxidants (conj)
persisted still (advmod)
tissue liver (compound)
symptoms postoperative (amod)
angina spastic (amod)
reported carboplatin (nsubjpass)
index suspicion (nmod)
receptor alpha1-adrenergic (amod)
time oltx (nmod)
increase aggressiveness (nmod)
indicate protects (ccomp)
proved amiodarone (nsubj)
depression caused (acl)
(+)-propranolol attenuated (acl:relcl)
recognizing complication (dobj)
population total (amod)
telaprevir with (case)
osmolality to (case)
bsc-1 ) (punct)
related fbal (nsubjpass)
reaction always (advmod)
patients depressive (amod)
undergoes glucoronosyltransferases (nmod)
combination were (cop)
tendency aggravate (acl)
insights these (det)
heart congenital (amod)
suppressed ameliorated (conj)
neurones noradrenergic (amod)
effects narcosis (nmod)
supersensitivity da (compound)
parts various (amod)
malformations these (det)
se +/- (cc)
acting with (mark)
man symptoms (nmod)
conversion csa (dep)
reduction time (nmod)
recurarization room (nmod)
abolished , (punct)
pellet ) (punct)
alpha-tac ( (punct)
recipient bn (nmod)
treatment if (nmod)
aggregation vitro (advmod)
withdrawn therapy (nsubjpass)
address , (punct)
activity observed (acl)
developed starting (advcl)
anticoagulant is (cop)
interacts suppresses (conj)
explain shape (dobj)
levetiracetam with (case)
physician to (case)
marker activity (nmod)
sc-48334 and (cc)
erections % (nmod)
documented but (cc)
receiving bw/3 (parataxis)
increase more (conj)
improved responders (nmod)
c-4-epimer d-glucose (nmod)
seen regimens (nmod)
converted defibrillation (nmod)
utilized applying (advcl)
true was (cop)
anotia malformation (conj)
tdi ) (punct)
days h (conj)
reduced increase (nsubjpass)
cardiovascular both (cc:preconj)
all one (nmod)
profile to (case)
decreasing rates (dobj)
ra ) (punct)
metabolites five (nummod)
show metabolism (dobj)
observed postdose (nmod)
dose granisetron (compound)
studied interactions (nsubjpass)
mechanism through (case)
h administration (nmod)
buffers ph (dep)
used had (aux)
administration midazolam (nmod)
resembles hepatitis (xcomp)
rigidity both (cc:preconj)
ratio odds (compound)
neurotoxicity report (dep)
number genes (nmod)
had placed (xcomp)
none animals (nmod)
regimen rate (dep)
mg/kg/day p.o. (appos)
differences mortality (nmod)
1 animals (appos)
conclude small (ccomp)
decreased cortex (nmod)
tgf-b tp53 (conj)
evidence impairment (nmod)
retching appetite (conj)
disappeared began (advcl)
g including (case)
fell 82+/-12 (conj)
striatum dorsal (amod)
treated received (advcl)
infections suspected (amod)
fibrillation arrhythmias (conj)
destruction of (case)
cope lead (conj)
production species (compound)
67.4 and (cc)
levels + (compound)
5-azc maximum (acl:relcl)
correlation improvement (nmod)
hypotension methylprednisolone (nmod)
mg/day 5 (nummod)
reduce had (conj)
escape and (cc)
retard progression (dobj)
thromboembolism vte (appos)
children two (nummod)
$ROOT$ probed (sent)
disease arterial (amod)
screened 451 (nsubjpass)
change furthermore (advmod)
suggests sufficient (ccomp)
good very (advmod)
preparation of (case)
score schwab (compound)
isolated hearts (nmod)
represented caudomedially (advmod)
have may (aux)
suggest differences (dobj)
reduce frequency (dobj)
amoxicillin-clavulanate . (punct)
mda excretion (conj)
incidences heparins (nmod)
decrease sbp (nmod)
protect may (aux)
mg. compared (case)
have myopathy (nsubj)
verify to (mark)
p ; (punct)
leukemia relapse (nmod)
patients cured (acl)
8th and (cc)
digitalise view (dobj)
accompanied reduction (nmod)
delta gamma (conj)
group unexposed (amod)
hepatotoxicity 1 (nmod)
mice c57bl/6-tgn[sod1]3cje (compound)
epinephrine . (punct)
post-exposure hr (nmod:npmod)
controls 763 (nummod)
0.04 vs. (cc)
hand on (case)
micrograms 100 (compound)
observed strains (nmod)
therapy maleate (nmod)
attention of (case)
effective mg (nsubj)
include these (nsubj)
membrane rats (nmod)
exacerbated have (aux)
influenzae , (punct)
allocated placebo (nmod)
velocity in (case)
performance biopsy (nmod)
history polyuria (nmod)
accomplished can (aux)
hexamethonium mug (appos)
management dependence (compound)
initiated hours (conj)
weeks period (conj)
documented hand (nmod)
acid carboxylic (amod)
decreased visit (nmod)
concentrations dose (appos)
dysfunction indomethacin-induced (amod)
forearm volar (amod)
$ROOT$ tremor (sent)
act vitro (advmod)
immunohistochemical microscopic (conj)
saline injected (acl)
time discovery (nmod)
shape stability (conj)
agent burns (nmod)
subset a (det)
treated setting (nmod)
progressive bilateral (conj)
changes pupillometric (amod)
paclitaxel is (cop)
measured range (dep)
spectra the (det)
yield the (det)
taking aspirin (dobj)
management in (case)
irrespective dose (nmod)
2.9 10(-7 (conj)
infection causes (acl:relcl)
proteinuria increased (amod)
dye cationic (amod)
compare effect (dobj)
uni- bilateral (conj)
5.99 40.0 (conj)
corrected restored (conj)
responses population (compound)
globulin polyspecific (amod)
associated that (nsubjpass)
consequence than (case)
p 0.005 (dep)
sr and (cc)
developed fulfill (advcl)
show were (conj)
4/8 ) (punct)
rural and (cc)
induction during (case)
added should (aux)
used ranitidine (nsubjpass)
causes potentially (advmod)
warranted however (advmod)
selected tolerance (nmod)
examined role (dobj)
dose mg/kg (compound)
bradyarrhythmias , (punct)
months mg (dep)
10mg/kg ) (punct)
consequences the (det)
had formulations (nsubj)
cd-832 , (punct)
individual a (det)
used prevent (xcomp)
repeated nitrolingual (dep)
size carriers (nmod)
data from (case)
mg/kg 50 (compound)
associated rise (nsubjpass)
those with (case)
males dosage (compound)
mg/day 50 (nummod)
affinities and (cc)
timolol by (case)
hemodynamic locomotor (conj)
ratings pain (nmod)
days until (case)
account depression (nmod)
thrombo-embolism of (case)
subtypes of (case)
worsen 2 (dep)
5.5 0.6 (compound)
incubation after (case)
quantified volume (nsubjpass)
euthanized . (punct)
haemorrhage influence (appos)
diet by (case)
brain liver (conj)
decrease hg (compound)
level blood (nmod)
study dogs (nmod)
impact observed (amod)
aggressiveness increased (amod)
fluvoxamine given (acl)
cases after (case)
1.0 , (punct)
studies factors (nmod)
< 0.0001 (dep)
those % (nsubj)
tolerance pain (compound)
had period (nmod)
haloperidol with (case)
elevated anf (nsubj)
1.9 those (nmod)
washout 3-week (amod)
nad , (punct)
had compared (advcl)
restricted may (aux)
involve that (nsubj)
ovale of (case)
carcinoma for (case)
bacl2 cent (nmod)
= desmin (conj)
anticoagulant indicated (conj)
insulin crystalline (amod)
specific defects (nsubj)
therapy verapamil (nmod)
described it-tspa (nmod)
report due (advmod)
leads symptoms (nmod)
receptors the (det)
using famotidine (dobj)
hyperlipidemia mixed (amod)
ratio fluid (compound)
reduction excretion (nmod)
middle-aged older (conj)
compliance study (compound)
signs dsykinesia (compound)
tie pathological (amod)
165/90 and (cc)
neuropathy and (cc)
titrated using (xcomp)
conducted populations (nmod)
position sitting (compound)
infection fatal (amod)
hexamethonium with (case)
exhibit function (dobj)
$ROOT$ necessitated (sent)
injection aminonucleoside (nmod)
samples deep (amod)
ginseng from (case)
surviving induction (nmod)
evoked evoked (advcl)
streptozocin rats (nmod)
serological , (punct)
tamoxifen of (case)
size-dependent that (mark)
latency rigidity (conj)
.01 ) (punct)
tablet mg (compound)
detoxification mesna (nmod)
violation a (det)
had patient (nsubj)
changes pgads (compound)
recommend use (dobj)
suggesting contribute (ccomp)
pathogenesis with (case)
movements deafness (conj)
taking many (nsubj)
lung of (case)
ct only (advmod)
magnitude the (det)
disorder organic (amod)
sprouting fiber (compound)
properties k)-atpase (nmod)
function basic (amod)
receiving cytostatics (dobj)
rechallenge upon (case)
similar greater (conj)
depended class (nmod)
pathophysiology psychosis (nmod)
improved , (punct)
remains thus (advmod)
capacity calcium-loading (amod)
centers 12 (nummod)
form ether (compound)
titrate point (nmod)
1.18 2.17 (appos)
neuroleptics used (acl)
proposed been (auxpass)
reduce can (aux)
b12 and (cc)
inhibition dogs (nmod)
maintained integrity (nsubj)
practices from (case)
scores memory (compound)
dobutamine intermittent (amod)
agressive more (advmod)
9 16 (conj)
7.5 , (punct)
effects without (case)
velocity nerve (nmod)
common infections (nsubj)
administered test (nmod)
uncertain mechanism (nsubj)
secondary expression (nsubj)
3.2 +/- (cc)
increase development (conj)
individuals than (case)
bleeding major (amod)
lasted lasted (ccomp)
selection trials (appos)
injury dilevalol-induced (amod)
den alone (advmod)
channel water (compound)
initiate to (mark)
results radiograph (compound)
or methylphenidate (nmod)
treatment same (amod)
yawning were (cop)
ciprofloxacin , (punct)
started before (mark)
gm ( (punct)
stat3 of (case)
hypercalcemias those (conj)
either with (case)
schedules dosage (compound)
patients cause (nmod)
fentanyl kg(-1 (appos)
older years (nmod:npmod)
slower patients (nmod)
similar eyes (nmod)
phosphatase gamma-glutamyltransferase (conj)
dose six (nummod)
mg an (det)
smoked . (punct)
monomer and (cc)
tested month (nmod)
resulted injection (nsubj)
hypokalemia depletion (conj)
provide explanation (dobj)
performed hysterosalpingography (nsubjpass)
sepsis pseudomonas (compound)
influence response (dobj)
increased micrograms (nmod)
proportion in (case)
center hospital (nmod)
33.42 : (punct)
alpha-tc ) (punct)
drc the (det)
tolerated inhibitor (dobj)
mesna ( (punct)
relative nsaids (nmod)
declined restricted (conj)
myeloma refractory (amod)
treatment despite (case)
slowing progression (dobj)
pd with (case)
risk development (nmod)
exceed micrograms/kg/ml (dobj)
infant the (det)
developed stunning (dobj)
presents ; (punct)
involved function (nsubjpass)
speculated involve (ccomp)
each administered (acl)
users remote (amod)
exacerbation complication (appos)
cisplatin bleomycin (conj)
p=0.025 ) (punct)
0.48 +/- (cc)
receptors pre- (amod)
important which (nmod)
induced patients (nmod)
quick low-priced (conj)
19 from (case)
allocated women (nsubjpass)
unchanged reduced (parataxis)
personality and (cc)
causes epilepticus (dobj)
abusers abstinent (amod)
patterns distinct (amod)
haloperidol haloperidol (conj)
medium an (det)
bundle forebrain (compound)
found sustained (conj)
reduced moreover (advmod)
synthesis repair (compound)
pain cocaine-associated (amod)
away straight (advmod)
genotype atypical (amod)
led investigate (xcomp)
resulted improvement (nmod)
amylase raised (amod)
$ROOT$ operated (sent)
aeds ( (punct)
hyperemia the (det)
salicylate indomethacin (conj)
generated phase (nmod)
arthritis for (case)
results showed (appos)
firmness in (case)
therapy cancer (nmod)
society as (case)
scheduled anesthesia (nmod)
phosphorylation isoproterenol-induced (amod)
manipulated was (auxpass)
studied examinations (nmod)
induce increase (conj)
use recent (amod)
sorafenib of (case)
showed sample (nsubj)
organs not (neg)
ameliorated toxicity (nsubjpass)
dose for (case)
toxicity therapy (nmod)
life humans (nmod)
reduce lidocaine (nsubj)
animals treated (acl)
associated odds (nmod)
myelination of (case)
reduced requirements (nsubjpass)
woman 33-year-old (amod)
furosemide high-dose (amod)
follow to (mark)
therapy warfarin (compound)
study ten-year (amod)
effects reversible (amod)
90 > (advmod)
block inadequate (amod)
increased did (conj)
published have (aux)
patients carriers (acl:relcl)
gtn h (compound)
% 1.8%-6.1 (nummod)
improve pressure (dobj)
male 10 (nummod)
sequestration liver (nmod)
blockade not (cc)
sensory predominantly (advmod)
available transplantation (nsubj)
solubility cb (nmod)
exhibited were (auxpass)
discontinuation permanent (amod)
tumors the (det)
line the (det)
decreased leading (advcl)
erections fluoxetine-induced (amod)
coniine , (punct)
inability awaking (advcl)
permeability in (case)
escape mutations (conj)
mice nrf2(-/- (compound)
score 54 (appos)
clozapine < (punct)
disappeared recur (conj)
tachycardia hypotension (conj)
index cholesterol (compound)
absorb to (mark)
baseline to (case)
had survival (dobj)
142 to (case)
tachycardia and (cc)
acetate and (cc)
substituting after (mark)
week start (nmod)
reports dystonia (nmod)
$ROOT$ composite (sent)
administered cycles (nsubjpass)
alterations thyroid (compound)
has ratio (dobj)
bche the (det)
use warfarin (compound)
$ROOT$ colitis (sent)
dose maintenance (amod)
effects ester (nmod)
reduced induction (nmod)
occur injection (nmod)
inhibited and (cc)
protection damage (nmod)
sarcolemma and (cc)
control p (dep)
appendage of (case)
reduction duration (nmod)
phosphatase ; (punct)
aqp2 ( (punct)
returned status (nsubj)
attenuated restored (conj)
awful slight (amod)
correlated tensions (nsubj)
induce ra (nsubj)
different weeks (nmod)
cytotoxicity in (case)
carvedilol warfarin (conj)
portland , (punct)
subjects older (amod)
patients 164 (nummod)
decrease have (aux)
causes suxamethonium (nsubj)
blocked action (nsubjpass)
absent or (cc)
groups , (punct)
hypothesis involves (ccomp)
day intubated (dep)
investigating by (mark)
had abusers (nsubj)
women 5 (conj)
hyperactivity psychostimulant-induced (amod)
rats vcm-treated (amod)
analogues tetrandrine (nsubj)
resulted this (nsubj)
visit at (case)
mean days (nmod)
testing the (det)
sequestration increased (amod)
cumulative irreversible (conj)
decreased 5-htp (nsubj)
women prescribed (acl)
ameliorated that (nsubjpass)
injected . (punct)
dysfunction reversible (amod)
$ROOT$ mg/kg (sent)
dec of (case)
protein 1 (nummod)
relation ingestion (nmod)
correlate ed50 (nsubj)
function factor (nmod)
times treatment (compound)
retardation mental (amod)
patients ) (punct)
24.4 ( (punct)
causing dysfunction (dobj)
$ROOT$ examination (sent)
showed analysis (nsubj)
predictor peptide (nsubj)
reliable sensitive (conj)
exposure oral (amod)
normalised , (punct)
include may (aux)
prevented s.c. (nmod)
identification the (det)
alf commonest (amod)
had cannulae (dobj)
metabolite acid (compound)
reported patient (nsubjpass)
second((1/2 ) (punct)
arterial , (punct)
feasibility treat (acl)
delirium use (nmod)
morphine : (punct)
include primarily (advmod)
given examined (conj)
61 24 (conj)
functioning with (case)
10 - (advmod)
activity bradykinin (nmod)
cholestasis marked (amod)
reports abs (nmod)
cardiotoxicity late-stage (amod)
precipitated methylphenidate (nsubj)
sedation was (cop)
indicated majority (nmod)
surgeries iop-lowering (amod)
hypotension haemodilution (conj)
modes the (det)
reported period (nmod)
result exposure (nsubj)
outcome stroke (nmod)
receptor 5 (nummod)
acid 5-fluorouracil (compound)
above % (nmod:npmod)
years males (conj)
group risperidone (compound)
similar are (cop)
administration digoxin (nmod)
airway to (case)
doses microgram (nmod)
catatonia on (case)
drugs thrombolytic (amod)
safety , (punct)
triggered dose (nsubj)
completely , (punct)
behavior apomorphine-induced (amod)
levels beta-ar (compound)
institutions 16 (nummod)
$ROOT$ appropriate (sent)
98 10 (conj)
increase prostacyclin (nmod)
observed h (nmod)
enzyme the (det)
anthracyclines etoposide (conj)
beating the (det)
channels na(+ (compound)
range those (nmod)
tmax ( (punct)
relationship dysfunction (nmod)
linked drugs (nmod)
hypertension adrenaline-induced (amod)
received groups (nsubj)
hours two (nummod)
phosphanilate chlorhexidine (compound)
suggest confirm (conj)
interviewing when (advmod)
failure subsequent (amod)
eyes % (appos)
induction plasticity (nmod)
tolerated cats (nmod)
cisapride erythromycin (conj)
occur to (mark)
time second (amod)
stage to (case)
build-up radioactive (amod)
surgery brain (compound)
8 24 (conj)
36 < (advmod)
monitoring transition (dobj)
schema the (det)
osteoporosis heparin-associated (amod)
alters treatment (nsubj)
evidence subclinical (amod)
months switch (nmod)
postulated . (punct)
pretreatment alpha-tc (compound)
mice group (nmod)
keratectomy of (case)
protocols ): (punct)
ic ) (punct)
risk associated (acl:relcl)
using haloperidol (dobj)
$ROOT$ controlled (sent)
shivering rigidity (conj)
patients individual (amod)
changes upregulation (nmod)
inhibit vitro (advmod)
cancer -- (punct)
2.6 , (punct)
infarction sorafenib-induced (amod)
evaluated is (aux)
setting volume (nmod)
% responders (nmod)
$ROOT$ restricted (sent)
vasculitis leukocytoclastic (amod)
sacrificed and (cc)
associated modafinil (nsubjpass)
treatment acute (amod)
indicating effect (dobj)
vt fibrillation (conj)
lower it (nsubj)
dyscrasias cephalosporin-induced (amod)
procedure and (cc)
nitrogranulogen cyclophosphamide (conj)
evaluated dressing (nmod)
resistant . (punct)
vomitus tinnitus (appos)
combined hyperthermia (nmod)
sedation paralysis (conj)
findings on (case)
belief on (case)
cessation of (case)
threshold in (case)
pinacidil than (case)
mp of (case)
50 15 (compound)
attenuates inhibition (nsubj)
glomerulonephritis diseases (conj)
facilitation the (det)
dpi 1 (nummod)
or=7.18 ( (punct)
arrest cardiorespiratory (amod)
deteriorating possibly (advmod)
population follow-up (conj)
old > (amod)
presentations across (case)
hyperbilirubinemia progressive (amod)
induced blockage (nmod)
media best (amod)
catecholamines plasma (compound)
failed tended (conj)
dose pan (nmod)
showed induction (nsubj)
$ROOT$ ensued (sent)
microg/ml below (case)
exerted interference (nsubjpass)
mr ) (punct)
receive doses (nmod)
analysis from (case)
spasm localized (amod)
test renal (amod)
abolished shr (nmod)
kanamycin weight/day (appos)
7.44 ci (dep)
failure count (nmod)
ms coupled (amod)
chain the (det)
wild-type alpha2abc-knockout (conj)
pleural pericardial (conj)
attacks without (case)
had protrusions (dobj)
days 19 (nummod)
chlorpheniramine placebo (conj)
injury hepatic (amod)
comparison for (case)
end procedure (nmod)
bergmann in (prep)
lozenge and (cc)
mrna igf-i (compound)
antagonizes actions (dobj)
% 14/104 (appos)
sulphate analogs (nsubj)
cml ) (punct)
seizures beta-carboline-induced (amod)
trial women (nmod)
cancers carcinoma (conj)
medication neuroleptic (amod)
promote reduce (conj)
lymphoma t-cell (compound)
chemotherapy-treated previously (advmod)
dosages inhibited (acl:relcl)
data challenge (compound)
found icu (nmod)
infant tuberculosis (nmod)
type , (punct)
$ROOT$ donor (sent)
number nigra (nmod)
addition misoprostol (nmod)
indications switch (nmod)
1.6 was (cop)
increases pressure (dobj)
increased stripe (nmod)
case showing (acl)
type thrombocytopenia (compound)
min literature (nmod)
exposure heparin (nmod)
monitored versa (advmod)
teratogenic be (cop)
influence binding (dobj)
rash , (punct)
reversed nra0160 (nsubj)
agonist however (advmod)
model ich (compound)
drinking on (case)
cases only (advmod)
count white (amod)
depressed inhibited (conj)
completed far (advmod)
weakness paralysis (conj)
therapy appropriate (amod)
increase or (cc)
stereotypy apomorphine-induced (amod)
therapy etoposide (compound)
reduce could (aux)
circumstantial , (punct)
cnsb002 of (case)
showed electromyography (nsubj)
all doses (nmod)
incidence relative (amod)
males ranged (ccomp)
flecainide paroxetine (conj)
studies nerve (compound)
system extrapyramidal (amod)
receive inputs (dobj)
lead dissatisfaction (nmod)
agent effective (amod)
sixty-eight one (compound)
down-regulation function (nmod)
condition on-drug (amod)
treatment srl (compound)
nimo ( (punct)
substantiates . (punct)
therapy amiodarone (compound)
showing differentiation (dobj)
min-1 ( (punct)
bodies appeared (acl:relcl)
mirror that (mark)
restricted be (auxpass)
obtained administered (advcl)
alprazolam placebo (conj)
diversion induce (acl)
children p9605 (compound)
anesthetic surgical (conj)
cause damage (dobj)
14 % (appos)
seem aspirin (nsubj)
that obtained (acl)
users chronic (amod)
continue patients (nsubj)
3 at (case)
evident . (punct)
stopped infusions (nsubjpass)
cancer f (compound)
propose approach (dobj)
manifestations by (case)
necrosis papillary (amod)
injection it (compound)
used task (nsubjpass)
effect antinociceptive (amod)
levels mmp-2 (compound)
vulnerability . (punct)
died picture (nmod)
assessed trial (nsubj)
persisted , (punct)
three six (conj)
interest presence (nmod)
planned treatment (nsubjpass)
urine orange (amod)
service the (det)
led rechallenge (nsubj)
rewarding and (cc)
said comparable (xcomp)
preparations with (case)
hypothyroidism and (cc)
$ROOT$ validated (sent)
8 6 (conj)
oxidative and (cc)
quantify to (dep)
administered mg (nsubjpass)
dose mg/week (appos)
subjects exceeded (acl:relcl)
status global (amod)
pooling data (dobj)
stages scale (nmod)
tolerability lomustine (nmod)
returned value (nsubj)
catecholamines activity (conj)
given . (punct)
increase occurring (advcl)
excitation an (det)
augments that (mark)
pr , (punct)
registered which (nsubjpass)
evidence histological (amod)
doses reduced (amod)
data demonstrating (acl)
findings met (appos)
increases whether (mark)
np free (amod)
precede that (mark)
associated duration (nsubjpass)
described factors (nsubjpass)
cured , (punct)
trials current (amod)
less equal (conj)
demonstrated further (advmod)
= 0.95 (dobj)
studies small (amod)
specimen hepatectomy (compound)
period days (appos)
carrier caffeine (nmod)
along rate (nmod)
i.v. mg (compound)
corticosteroids transfusions (conj)
trend time (nmod)
group old (amod)
was but (cc)
values baseline (compound)
center research (compound)
performed anticoagulation (nsubjpass)
pathology severe (amod)
micrograms/ml 20 (nummod)
paclitaxel of (case)
treadmill and (cc)
recovery this (det)
levofloxacin of (case)
had brain (nmod)
replacement dexamethasone (nmod)
agonist alpha-2 (compound)
value : (punct)
amiodarone dose (dep)
antidepressants incontinence (conj)
scotomata bilateral (amod)
classified event (nsubjpass)
3.0 1.5 (nummod)
time mean (compound)
report society (compound)
impaired treatment (nmod)
mice to (case)
receptors metabotropic (amod)
ventilated achieve (xcomp)
fraction of (case)
mediated that (mark)
report summary (compound)
calcification rats (nmod)
underwent total (nsubj)
removed uteri (nsubjpass)
conclusions able (dep)
cryoprecipitate of (case)
less considerably (advmod)
menorrhagia in (case)
fpd mea (nmod)
% 67.1 (nummod)
$ROOT$ pretreatment (sent)
lysis after (case)
actions perhaps (advmod)
patients lymphoma (nmod)
antagonize doses (nsubj)
pemoline of (case)
stress . (punct)
related escalated (advcl)
g/day 3.9 (nummod)
remained has (aux)
tolerated reported (xcomp)
treated verapamil (nmod)
seven to (dep)
placebo pi (appos)
harvested . (punct)
cancer experimental (amod)
tested thresholds (nsubjpass)
dexmedetomidine and (cc)
cavity and (cc)
seizure convulsive (amod)
detected = (parataxis)
scale happiness (compound)
had reflect (advcl)
smoking of (case)
ascertained using (xcomp)
release proteins (nmod)
bortezomib plus (cc)
hydration alcalinization (conj)
cya ) (punct)
possessed that (mark)
malaysians multiethnic (amod)
months surgery (nmod)
disappearance and (cc)
532 27 (compound)
ratio administration (nmod)
exposure mipafox (compound)
protocol lomustine (nmod)
factors the (det)
history family (compound)
channels . (punct)
treated den (nmod)
pain magnitude (dep)
neurotoxicity (ma)-induced (punct)
woman 41-year-old (amod)
tnss for (case)
wear excessive (amod)
assays biochemical (amod)
volunteers in (case)
rate cerebral (amod)
azathioprine analogue (appos)
outflow on (case)
combining by (mark)
increased duration (nsubjpass)
fasciculation and (cc)
retention salt (compound)
beats/min was (cop)
that animals (nmod)
desipramine either (cc:preconj)
suggests quality (nsubj)
limiting often (advmod)
received propranolol (dobj)
adjusted based (prep)
half = (dep)
showed akbr (nsubj)
alternative imaging (nmod)
cr pr (appos)
synthase constitutive (amod)
something burning (acl)
ax ) (punct)
effective were (cop)
performed better (advmod)
ears n=88 (nummod)
started neuropathy (nsubj)
strain myocardial (amod)
responses pathologic (amod)
affect erp (dobj)
agonists acting (amod)
proteinuria administration (nmod)
weight/day ) (punct)
42 +/- (cc)
juices in (case)
restoring models (nmod)
efficacy effects (conj)
presented initiation (nmod)
metoclopramide drug (appos)
immunoreactivity . (punct)
fibers , (punct)
clonidine m (appos)
seen hepatocytes (nmod)
regimen a (det)
striatum to (case)
escalated study (nmod)
correlate mass (nmod)
distinguished it (nsubjpass)
= 0.44 (dobj)
group seizures (compound)
acknowledged should (aux)
initiate , (punct)
enhance not (neg)
amine . (punct)
nephrolithiasis : (punct)
presence for (case)
cardiovascular renal (conj)
effects channels (nmod)
aap dox (dep)
am149 with (case)
lesions tubular (amod)
targets pathways (dobj)
observed future (nmod)
observed difference (nsubjpass)
decreased hemorrhage (nmod)
ketosis level (nmod)
processes of (case)
improving failure (dobj)
patients nineteen (nummod)
day case (nsubj)
suggestion risk (nmod)
propagation and (cc)
ratio 7.44 (nmod)
higher g (dep)
toxicity ccnu (compound)
nephrotoxicity aminoglycoside-induced (amod)
checklist scale-revised (conj)
range in (case)
represented rostrolaterally (advmod)
danger an (det)
duration average (amod)
paco2 kpa (appos)
rat 344 (nummod)
rats lou/m/wsl (compound)
activation events (dep)
postlesion day (amod)
retardation growth (compound)
dilatation renal (amod)
deprivation with (case)
events treatment-emergent (amod)
resulting hypocalcemia (nmod)
treated temsirolimus (nmod)
led idea (nmod)
summarize cases (dobj)
survivors among (case)
results derived (acl)
treatment invasive (amod)
1 infusion (nmod)
respond symptoms (nsubj)
follow-up start (nmod)
nitrite sodium (compound)
scale verbal (amod)
decreased week (nmod)
found reductions (nsubjpass)
time-course the (det)
reversed antagonist (nsubj)
kidney single (amod)
y-maze and (cc)
pb such (case)
children condition (nmod)
p=0.37 ) (punct)
matrix to (case)
200mgkg(-1 with (case)
users ich (nmod)
3-methylcholanthrene mc (appos)
failure proteinuria (conj)
7.2 2.4 (quantmod)
increase ( (punct)
related levels (nsubj)
angioedema report (dep)
subjects with (case)
value initial (amod)
pointes de (advmod)
treatment diuretic (nmod)
dimension lad (appos)
557 +/- (cc)
microm 50 (compound)
had sides (nsubj)
higher seen (advcl)
interval 2.8 (appos)
durations various (amod)
men age (dep)
challenge ptz (compound)
haemodialysis after (case)
injection rilmenidine (nmod)
conclude , (punct)
mofetil mycophenolate (compound)
alert clinicians (nsubj)
responded that (nsubj)
ml from (case)
papillomas epithelium (nmod)
cases all (det)
managed % (nsubjpass)
showed dogs (nsubj)
constitutes that (mark)
sequencing motif (nmod)
treat it (dobj)
mechanism levels (nmod)
map 4/8 (appos)
therapy heparin (compound)
syndrome patient (nmod)
cml translocation (conj)
result nicergoline (nmod)
5.2 range (dep)
mutants precore (compound)
female and (cc)
um-272 n-dimethylpropranolol (appos)
discuss detailing (advcl)
binding (3)h-haloperidol (compound)
containing dox (dobj)
causing obstruction (dobj)
sulphate of (case)
circuit the (det)
administering along (prep)
responses durable (amod)
dyserythropoiesis , (punct)
ci=22.8 25.7 (prep)
points at (case)
structural and (cc)
treatment 14-day (amod)
abundance the (det)
neuroleptics haloperidol (appos)
deferens m1 (nmod)
headache vomiting (conj)
nucleus ventralis (compound)
was injections (nmod)
increasing dosage (dobj)
reported disorder (nsubjpass)
enalapril nitrendipine (conj)
defects with (case)
was furthermore (advmod)
association consumption (nmod)
have map (nsubj)
resulted transplantation (nmod)
lnna synthase (compound)
days seven (nummod)
frequency signs (nmod)
symptoms dysfunction (conj)
drugs abuse (nmod)
encephalopathy--19 induced (amod)
signaling the (det)
glioblastomas lobe (nmod)
cause catalepsy (dobj)
proteases circulating (amod)
transplantation in (case)
extend we (nsubj)
cancer renal (amod)
evaluate to (aux)
weakness system (nmod)
leukaemia for (case)
mixture copolymer (nmod)
26 to (quantmod)
pectoris of (case)
followed intervals (nmod)
modulates function (dobj)
emax ( (punct)
result overdosage (nsubj)
treatment diseases (nmod)
ill acutely (advmod)
provocation acute (amod)
indices of (case)
exacerbations blockers (nmod)
behavior rats (nmod)
chloroacetaldehyde reagent (nmod)
$ROOT$ correspond (sent)
rates therapy (nmod)
started is (advcl)
extract fraction (compound)
conducting rodents (nmod)
n. % (appos)
secondary zolmitriptan (nmod)
controls saline-injected (amod)
sister disorder (nmod)
0.65 or (cc)
administered dexamethasone (dobj)
staying night (nmod:tmod)
result is (cop)
polytherapy regimen (nmod)
information clinical (amod)
induced injection (nmod)
frontostriatal and (cc)
elevations kinase (compound)
recovery cell (compound)
presentation coma (nmod)
hours 8th (amod)
blocks that (nsubj)
study angiography (compound)
carotid or (cc)
delivered practice (nmod)
assay exclusion (compound)
arrest intramuscular (amod)
2.4 and (cc)
hepatitis " (punct)
cause paracetamol (nsubj)
neutropenia without (case)
greater results (nsubj)
understood . (punct)
events seizure-like (amod)
december since (case)
= p (dep)
activity period (conj)
salivation excessive (amod)
presented side-effects (nmod)
wt , (punct)
carcinoma is (cop)
doses half (amod)
allografts were (cop)
coma nonketotic (amod)
haemopericardium and (cc)
days 27 (nummod)
experiences . (punct)
strains virus (compound)
gene 5-ht6 (compound)
laboratories abbott (compound)
background rate (appos)
experiences who (nsubj)
evaluate toxicity (dobj)
latency to (acl)
all dexamethasone (nmod)
related might (aux)
1.037 ( (punct)
groups shr (nmod)
carried mice (nmod)
bodies numerous (amod)
bedtime and (cc)
studied intradermoreactions (nsubjpass)
drugs conventional (amod)
observed reversed (conj)
activity tgf-beta1 (nmod)
relapse symptoms (nmod)
design double-blind (amod)
produced responses (dobj)
afterdepolarization trigger (nmod)
bp for (case)
enhance modulation (nmod)
disease adynamic (amod)
% gem-p (nmod)
ml/s from (case)
analysis rna (nmod)
hallucinations . (punct)
changed also (advmod)
multiforme a (det)
fc isolated (acl)
data administrative (amod)
increases correction (nsubj)
$ROOT$ followed-up (sent)
survivors in (case)
returned substituting (advcl)
lumen occlusion (conj)
% 67.3 (nummod)
effect sensitivity (nmod)
reported h. (nmod)
treatment ethambutol (compound)
cta after (case)
scores symptom (compound)
observed remission (nsubjpass)
redness related (acl)
intestine of (case)
carcinoma peritoneum (nmod)
number courses (nmod)
ecstasy use (nsubj)
role effect (nmod)
metabolism with (case)
microg/kg saline (conj)
stimulation stn (compound)
vision eye (nmod)
recurred episode (nsubj)
haemodilution to (case)
adenosine-5'-triphosphate with (case)
day by (case)
psychosis behaviors (conj)
perimetry conventional (amod)
ototoxicity their (nmod:poss)
potentiation arrhythmogenicity (nmod)
pattern necrosis (nmod)
[verapamil]o of (case)
delirium preoperative (amod)
old and (cc)
guidelines with (case)
3.7 x (cc)
s 0.84 (nummod)
response positive (amod)
took before (mark)
case unlike (case)
ranged number (nsubj)
steroid modulate (acl:relcl)
council medical (compound)
facilitate that (mark)
malondialdehyde brain (compound)
studies stress (compound)
precursor of (case)
suggesting used (ccomp)
bleed infection (conj)
issue to (case)
advanced more (advmod)
evidence evidence (nmod)
estimated study (nmod)
$ROOT$ normochromic (sent)
deacetylation binding (conj)
stoppage drug (nmod)
groups 10-micrograms/kg (compound)
more . (punct)
rats normal (amod)
present vulnerability (dobj)
effective protecting (advcl)
reported where (advmod)
measures ( (punct)
duration sex (conj)
0.05 comparisons (nmod)
ml mixture (nmod)
triggers cause (conj)
$ROOT$ deterioration (sent)
represent mainstay (dobj)
reductions marked (amod)
hypertension anemia (conj)
taking years (nmod)
recorded rate (nsubjpass)
view have (ccomp)
administered excess (nmod)
confirmed until (mark)
induced been (auxpass)
bis ) (punct)
spasm induced (acl)
magnesium the (det)
chf grade (compound)
shows phase (dobj)
iron excessive (amod)
treated while (mark)
reduced both (dep)
september 2007 (nummod)
breath a (det)
treatment tachycardia (nmod)
levodopa on (case)
clinic infertility (compound)
changes other (amod)
dementia , (punct)
alternation a (det)
moderate was (cop)
shape and (cc)
mean+/-sd ( (punct)
disturbances risperidone-associated (amod)
mg. , (punct)
proven challenge (nmod)
remained group (nmod)
indexes variability (nmod)
comatose intoxication (nmod)
nonimmune rubella (nmod:npmod)
maintain efficacy (dobj)
results degrees (appos)
iu/l alt:294 (nummod)
modalities ( (punct)
level medium (nmod)
naproxen 0.97 (appos)
showing manifestations (dobj)
dysrhythmias the (det)
ratio . (punct)
emissions otoacoustic (amod)
mortality groups (nmod)
depression described (acl)
respond way (nmod)
decrease change (conj)
evaluates review (nsubj)
evoke fs (nsubj)
use approval (conj)
li/dvp % (appos)
2b1/2b2 of (case)
years pounds (conj)
curve elevated (amod)
medulla to (case)
creativity of (case)
2a 5-ht (compound)
2.4 4.3 (conj)
alternative be (cop)
injections neonatal (amod)
characterized increase (nmod)
hemoglobin hematocrit (conj)
examined should (aux)
background unclear (conj)
status m.s. (appos)
hippocampus of (case)
measures as (case)
time treatments (nmod)
mv more (nummod)
suggested responsible (xcomp)
enflurane by (case)
convulsant doses (conj)
targeting system (dobj)
inhibitor thrombin-activatable (amod)
discharged drug (nmod)
results biopsies (nmod)
analysis terms (nmod)
mediator proconvulsant (amod)
drugs potent (amod)
7h6 zo-1 (conj)
pain evoked (acl)
observed pfs (nsubjpass)
thalidomide regimen (conj)
therapy vigabatrin (compound)
pentamidine with (case)
avoid and (cc)
carcinogenesis rat (nmod)
safety lorazepam (nmod)
$ROOT$ analysis (sent)
percentage in (case)
grade 1/2 (nummod)
capable shown (conj)
injected verifying (advcl)
investigation biopsy (nmod)
hypotension orthostatic (amod)
novelty stimuli (conj)
abdomen dullness (nmod)
disorder . (punct)
retention passive (amod)
aspect medial (amod)
analysis pulse (compound)
transmission system (nmod)
acid a (det)
recovery to (case)
level lactate (compound)
operation sham (amod)
cause phenomenon (nmod)
revealed application (nsubj)
history time (nmod)
pdn ( (punct)
showed determined (advcl)
exacerbates cardiotoxicity (dobj)
mice beta2(-/- (compound)
mechanisms complications (nmod)
53 % (appos)
included contraceptives (nmod)
ptcr well-developed (amod)
exposed diet (nmod)
visits 4 (nummod)
child a (det)
edaravone scavenger (appos)
reaction hypertension (conj)
take action (dobj)
6/15 respectively (advmod)
seeds daucus (compound)
changes plasma (nmod)
schedules two (nummod)
outcome with (case)
continued months (nmod)
exercise-controls in (case)
rats nephrosis (compound)
pons the (det)
lometrexol ddathf (appos)
effects pentamidine (nmod)
observed constriction (nsubjpass)
resulted performance (nmod)
uterus the (det)
alpha-gst serum (compound)
attempt about (case)
that women (nmod)
agonist cp (appos)
analgesia on (case)
pathway signaling (nmod)
pointes patient (nmod)
intervention a (det)
prevent nephropathy (dobj)
interaction their (nmod:poss)
increase dp/dtejc (nmod)
programs systematic (amod)
tolerability of (case)
values mg/dl. (nmod)
increase decrease (conj)
one-third only (advmod)
tissue vascular (amod)
l-alpha-gfc , (punct)
11.33 1.13 (conj)
toxicity no (neg)
concentration the (det)
uveitis cases (nmod)
fanft by (case)
1.7 - (punct)
0.65 ( (punct)
times pretreatment (compound)
double-blind , (punct)
patients admitted (amod)
produced calcification (dobj)
clearance the (det)
related rats (nmod)
tincture crataegus (nmod)
gene 6 (nummod)
microg/ml concentrations (nsubj)
therapy add-on (amod)
failure oliguric (amod)
catecholamines for (case)
dorsum food (compound)
persist reduction (nmod)
decreased more (advmod)
man observed (acl:relcl)
placebo ci (appos)
possible . (punct)
induced has (aux)
occurs diabetics (nmod)
score 11 (appos)
developed intervals (nmod)
treated cisplatin (nmod)
causing events (dobj)
go exploration (nmod)
dose protocol (nmod)
died animals (nsubj)
myelopathy isolated (amod)
mechanism exact (amod)
considered resuscitation (nsubjpass)
e18.5 at (case)
model arrhythmia (compound)
alteration any (det)
present dilemma (dobj)
glutathione gsh (appos)
gammapathy pre-transplant (amod)
propranolol , (punct)
required establish (xcomp)
time months (appos)
compared cases (nmod)
ineffective whereas (mark)
become % (nsubj)
has however (advmod)
enlargement wastage (conj)
subgroup primarily (advmod)
fdc qd (conj)
purpose report (acl)
attack . (punct)
anp of (case)
extracts cell (compound)
atropine naloxone (conj)
ng/ml area (nsubj)
compared outpatients (nsubjpass)
reduced extent (nmod)
improved megaloblastosis (dobj)
5ht2a ( (punct)
prospective observational (dep)
bmd with (case)
added lamivudine (nsubjpass)
cardiomyopathy dox (compound)
difference effects (nmod)
withdrawal periodic (amod)
map isolated (amod)
were reduction (nmod)
physicians primary (amod)
$ROOT$ induction (sent)
outcomes lesions (nmod)
patency for (case)
found reactivity (nsubjpass)
importance practical (amod)
observed p (dep)
specific t-cell (nmod:npmod)
16 of (advmod)
higher years (dep)
presented diagnoses (nsubjpass)
admission and (cc)
adrs ) (punct)
erk expression (dep)
relationship events (nmod)
analysis polymerase (compound)
spasms corrected (acl:relcl)
mmhg 51 (nummod)
derived were (auxpass)
effects ouabain (nmod)
criteria disorder (nmod)
sought . (punct)
prostigmine mg (amod)
prolonged fpd (dobj)
finding vasoconstriction (nmod)
procedure scale (conj)
cases cancer (nmod)
mmol/kg s.c. (amod)
have treatment (dobj)
activity responsiveness (conj)
ck-mb index (nmod)
cardiomyopathy . (punct)
protocol of (case)
weight weight (nmod)
therapy anti-inflammatory (amod)
injections dox (nmod)
ureter or (cc)
reduced fraction (nsubjpass)
deduced . (punct)
diagnostics penzberg (appos)
improves reducing (advcl)
scl interval (conj)
model effects (dep)
prerequisite as (case)
patients some (det)
neurotoxicity patient (nmod)
rats juvenile (amod)
reexposure brief (amod)
support intensive (amod)
hyperactivity mesangial (amod)
flushing tachycardia (conj)
model seizure (compound)
moran et (compound)
receive injection (dobj)
1990s the (det)
mucosa rat (compound)
syndrome as (cc)
contributing with (mark)
series to (case)
case collection (nmod)
mechanism may (aux)
cpk his (nmod:poss)
indicator although (case)
gd , (punct)
addition activity (nmod)
hazard associated (acl)
along metabolism (nmod)
thiopentone of (case)
pairs treatments (nmod)
dipping morning (compound)
passage transepithelial (amod)
significant p<0.001 (parataxis)
crisis scleroderma (compound)
questioning subsequent (amod)
produced haemodilution (nsubjpass)
received antibiotics (dobj)
had others (nsubj)
ccl4 acetaminophen (conj)
$ROOT$ tobramycin (sent)
20 than (quantmod)
remained unaltered (xcomp)
u/l 37 (nummod)
questionnaires instrument (nsubj)
pain for (case)
operations various (amod)
seizure and (cc)
functioning on (case)
herbicides produced (conj)
mutations associated (acl)
instillation new (amod)
$ROOT$ phenomenon (sent)
1/2,z ) (punct)
preclinical and (cc)
placed they (nsubjpass)
associated raloxifene (nmod)
bradycardia modest (amod)
dodds revai (conj)
levodopa i.v. (compound)
symptoms capacity (conj)
unlikely supplementation (nsubj)
dfu ; (punct)
test during (case)
used captopril (nsubjpass)
particular in (case)
drugs iv (nummod)
fell completed (advcl)
site injection (compound)
women delivered (acl:relcl)
was evidence (nsubj)
disorder with (nmod)
given subjects (nsubjpass)
toxicity 4 (nummod)
cycles patients (nmod)
toxicity gastrointestinal (amod)
marker by (case)
s-i ) (punct)
21 out (advmod)
development cancer (nmod)
machinery cells (nmod)
injury intracellular (amod)
found peliosis (nsubjpass)
sets three (nummod)
old older (conj)
brain behavior (conj)
have myositis (dobj)
examined rats (nmod)
increased 2.8-fold (advmod)
cocs cpa/ee (conj)
pronounced than (dep)
pituitaries f2 (compound)
led , (punct)
receive zdv (dobj)
p-chlorophenylalamine with (case)
determination in (case)
80mg/kg/day intramuscularly (advmod)
0.97 1.11 (conj)
disorder seizure (compound)
recognized is (aux)
seizures bupivacaine-induced (amod)
effect modafinil (nmod)
drugs interfere (acl:relcl)
annuloplasty undersized (amod)
in anatomically (amod)
scarring glomerular (amod)
journals also (advmod)
expected risk (nsubjpass)
h-sod1 ) (punct)
inhibition mk-486 (nmod)
force of (case)
response pupillary (amod)
shifts , (punct)
discontinuation chloroquine (compound)
evaluated further (advmod)
mg/m2 200 (nummod)
tea green (amod)
agonist treatment (nmod)
5-ht(6 ) (punct)
july , (punct)
weight sbs (conj)
was reduction (attr)
hyperalgesic and (cc)
pain changes (conj)
17beta-estradiol of (case)
emphasized recently (advmod)
overshooting and (cc)
acid serum (compound)
had resolution (dobj)
agonist partial (amod)
liver within (case)
diagnosed newly (advmod)
suggest specific (ccomp)
deposited fibrin (nsubjpass)
advantageous those (nmod)
15 +/- (cc)
contention the (det)
70 ) (punct)
continues purpose (nsubj)
cats rabbits (conj)
suggesting blockade (dobj)
uncertain however (advmod)
l 3.7 (nummod)
recording simultaneous (amod)
echocardiograms obtained (acl)
acc-9653 of (case)
1.008 , (punct)
amiloride ) (punct)
tachycardia reentrant (amod)
% 1.5 (compound)
women the (det)
localization channels (nmod)
6 chemotherapy (nmod)
models involving (acl)
proteome the (det)
dullness with (case)
cirrhosis primary (amod)
neuropathy rarely (conj)
convulsions as (case)
studies bradycardia (nmod)
drug is (cop)
showed affecting (advcl)
dose no (det)
elevated 102+/-13 (nmod)
examined amount (nsubjpass)
blocks women (nmod)
protein calcium-binding (amod)
subtle more (advmod)
7-ethoxyresorufin-o-deethylase 7-pentoxyresorufin-o-dealkylase (conj)
useful work-ups (nsubj)
participate onset (nmod)
25mg/kg or (cc)
increase ve (nmod)
axis across (case)
had diet (nmod)
identify period (nmod)
ratio insertion (nmod)
dialysis only (advmod)
insufficiency . (punct)
uninephrectomy of (case)
effects model (dep)
liver than (case)
increment every (det)
sensitivity amphetamine (nmod)
ratios outcomes (nmod)
dermatitis a (det)
resolved had (aux)
that former (nmod)
determined cases (nmod)
hr 11 (nummod)
mmhg 86 (nummod)
counter over (case)
completed from (mark)
perturbation a (det)
alerted clinician (nsubjpass)
acts while (mark)
patient reported (amod)
contraindicated be (auxpass)
vasopressor phenylephrine (nmod)
developed groups (nmod)
antigen both (cc:preconj)
dependent who (nsubj)
induced moreover (advmod)
presence ldl (nmod)
5-fu mg/m2bsa (dep)
administered sc (advmod)
cyclosporin to (case)
25mg/kg 50mg/kg (conj)
sixty-five one (compound)
nephropathy rat (nmod)
those ( (punct)
variants subset (nsubj)
prevent could (aux)
exert may (aux)
probable likelihood (nsubj)
induced exceed (advcl)
map treatment (nmod)
day + (nummod)
1.4 respectively (advmod)
differences latency (nmod)
alternative asthma (nmod)
cardiotoxicity pre-induced (amod)
experience single-center (amod)
drug reported (acl:relcl)
required although (mark)
imipramine to (case)
49 through (quantmod)
demonstrated clearly (advmod)
resolved problems (nsubj)
usage clinical (amod)
susceptibility calcification (nmod)
moderate-dose high-dose (dep)
seems utero (nmod)
administration 2-wk (amod)
variant of (case)
cells intermediate (amod)
rechallenge . (punct)
clz ) (punct)
cases interaction (nmod)
tissue renal (amod)
bleeding associated (acl)
alter mbp (dobj)
reproducibility values (conj)
induced antibiotic (nmod:npmod)
obtained easily (advmod)
$ROOT$ judged (sent)
cognitive comparative (amod)
efficacy effect (conj)
antibiotics of (case)
used concentrations (nsubjpass)
hoe hoe (conj)
ketoconazole by (case)
model hematotoxicity (nmod)
mfs of (case)
negative had (aux)
opioid pethidine (nsubj)
seen limbs (nmod)
tested respectively (advmod)
associated fluconazole (nsubj)
2 hg (conj)
aspects and (cc)
< significant (amod)
studies clinical (amod)
administration convenient (amod)
result treatment (nsubj)
failure profound (amod)
eps of (case)
remain rates (nsubj)
areas dysfunction (nmod)
perturbations fewer (amod)
prevalence hyperkalemia (nmod)
demonstrate produce (ccomp)
identifying in (mark)
areas undergoing (acl)
presence mutations (nmod)
implications effect (nmod)
decreased to (mark)
retardation tremors (nmod)
institution ischemia (nmod)
trial prazosin-controlled (amod)
performed were (auxpass)
arb ( (punct)
mice transporter (compound)
course 1-month (amod)
seizures refractory (amod)
treated concurrently (advmod)
took one (nsubj)
mania antimicrobial-induced (amod)
= 0.035 (dobj)
model new (amod)
studies mri (compound)
mini-pump alzet (compound)
generated behaviors (dobj)
schedules the (det)
greater accumulation (dep)
inhibited caa (nsubj)
mg/dl 15.3 (nummod)
patients disease (nmod)
complicated sepsis (nmod)
treading forepaw (compound)
catalepsy apomorphine (compound)
arrhythmia with (case)
patients 72 (nummod)
coxii coxiii (conj)
interfered , (punct)
clear influence (ccomp)
use dexmedetomidine (nmod)
stage ( (punct)
showed findings (dobj)
recipient in (case)
$ROOT$ indicative (sent)
suggested admission (nmod)
displacement at (case)
developed lymphoma (dobj)
revealed assessment (nsubj)
drugs anthracyclines (nsubj)
toxicities . (punct)
reactivation to (case)
discriminate to (mark)
marked sedation (nmod)
laryngoscopy flexible (amod)
perfusion animals (nmod)
results follows (appos)
events serious (amod)
effects hemodynamic (amod)
medication antiallergic (amod)
resumed was (auxpass)
branches to (case)
1.3+/-0.3 ( (punct)
advocated is (auxpass)
537 149 (conj)
stabilizers of (case)
= 98 (dep)
controlled may (aux)
two controls (conj)
artery sa (compound)
suppressed mcpp (nsubj)
seem not (neg)
rate 18-month (amod)
conclusion report (appos)
sucrose ad (amod)
perfused dexamethasone (nmod)
those inhibitors (nmod)
hearing with (case)
provide results (nsubj)
underlying disorders (dobj)
indicating neurotoxicity (dobj)
prone be (cop)
using paper (dobj)
parkinsonism and (cc)
men sarcoma (nmod)
suggest data (nsubj)
failed or (cc)
mutation any (det)
characteristic diabetes (nmod)
ah6809 not (cc)
combination estradiol (nmod)
small- and (cc)
interviews and (cc)
phonological , (punct)
alter function (dobj)
patients hepatitis (compound)
antioxidants and (cc)
assumed was (auxpass)
antinociception constipation (conj)
reviews systematic (amod)
carcinoma of (case)
evaluation administration (nmod)
induce calcification (dobj)
used non-users (conj)
subjects snhl (nmod)
ng/ml t (dep)
oils these (det)
eight % (appos)
experienced discomfort (dobj)
influence metabolism (dobj)
administration gamma-hch (nmod)
tube delivered (acl:relcl)
disturbances complexes (conj)
results maternal (amod)
sed 0.46 (conj)
carcinoma histology (conj)
dose ntg (nmod)
ameliorates curcumin (nsubj)
antagonist ) (punct)
systemic , (punct)
younger and (cc)
acetate days (nmod)
decreased respectively (advmod)
findings laboratory (compound)
corresponded shown (advcl)
patients neuroblastoma (nmod)
types oc (nmod)
environment in (case)
interfere could (aux)
neonates were (cop)
risks human (amod)
ranged microg% (parataxis)
potentiate progesterone (nsubj)
impact alterations (nsubj)
wave delayed (amod)
ill new (amod)
presented lesions (dobj)
use estradiol (nmod)
changes parameter (compound)
woman young (amod)
response maximal (amod)
technique artery (nmod)
ato + (cc)
defects pattern (compound)
tab stop (compound)
urd of (case)
50 less (amod)
reported reported (conj)
possible most (advmod)
hemodynamic echocardiographic (conj)
prevented glomerulosclerosis (dobj)
agent inhibits (acl:relcl)
regulating structure (dobj)
divided was (auxpass)
modulate directly (advmod)
co-morbidity psychosis (conj)
otherwise risk (nmod)
analysis and (cc)
complained 1 (nsubj)
ppi ( (punct)
alternative lithium (nmod)
b group (compound)
preceded always (advmod)
auc 6 (nummod)
interval months (nmod)
upregulation system (nmod)
patients subjects (conj)
opse ) (punct)
test ampicillin (nmod)
hospital and (cc)
making difficult (ccomp)
detection mutants (nmod)
cholestasis . (punct)
l/min 4.1 (nummod)
polyneuropathy axonal (amod)
sacrificed weeks (nmod)
age 0.007 (appos)
done months (nmod)
bfgf ( (punct)
action nephrotoxic (amod)
administration derivative (nmod)
used hypertension (nsubjpass)
black distribution (nsubj)
changes adults (nmod)
inhibition clearance (nmod)
pathophysiology underlying (amod)
use monitoring (conj)
agranulocytosis patient (nmod:poss)
170 . (punct)
added valproate (nmod)
effect even (advmod)
phases liquid (compound)
scales through (case)
make modalities (ccomp)
dosage area (nmod)
component baroreflex (nmod)
tasks mice (nmod)
electrocardiographic ecg (appos)
suffered animals (nsubj)
reversed hours (nmod)
delay for (case)
had tissue (nsubj)
revealed pointes (dobj)
change structure (nmod)
cause hyperkalemia (nmod)
urticaria and/or (cc)
author the (det)
conclusions increase (appos)
able patients (nsubj)
flexion/extension flexion/extension (appos)
exhibited symptoms (dobj)
factors operating (acl)
associated rs6693503 (nsubjpass)
function protected (amod)
developed study (xcomp)
efficacy antimicrobial (amod)
drg ) (punct)
monitored mice (nmod)
created 1994 (nmod)
studied four (nmod)
proceed angiography (nmod)
rpn to (case)
iu/l ast:111 (nummod)
reactions patients (conj)
use study (appos)
induced solely (advmod)
repair . (punct)
filters eventually (advmod)
dose ns-718 (nmod)
results three (nummod)
regulation estradiol-dependent (amod)
ppa ( (punct)
relevance able (advcl)
concentration lowest (amod)
hypomagnesemia severe (amod)
vision mouth (conj)
doses high (amod)
observed upregulation (nsubjpass)
view this (det)
dyskinesias these (det)
absorption causing (acl)
patients pain (nmod)
management recommended (amod)
hypothesize , (punct)
palliation for (case)
111 24 (compound)
neuralgia from (case)
diethylpropion stimulant (amod)
solution buffering (amod)
greater less (advmod)
structurally functionally (conj)
effects kg-1 (nmod)
hazardous be (cop)
anaesthesia infusion (nmod)
agent protective (amod)
% triglyceride (nmod)
alf ) (punct)
effect heart (nmod)
aged weeks (nmod)
mean (1.5)% (appos)
concentrations mg/ml (nmod)
prolongation for (case)
information usage (compound)
serious and (cc)
outer inner (conj)
contraction maximum (amod)
showed granules (nsubj)
fluid cavity (nmod)
lc of (case)
performed measurement (nsubjpass)
excretion tubular (amod)
induced endomt (dobj)
those cyclosporin (nmod)
paralysis myotonia (conj)
recall for (case)
treated corticosteroids (nmod)
level walls (nmod)
age-matched normal (amod)
interval ischemia (nmod)
function humans (nmod)
cases/person-years exposure (nmod)
higher than (prep)
loss visual (amod)
tachycardia ketamine-induced (amod)
led paramedics (dobj)
44.4 , (punct)
onset tremor (nmod)
trials dose-escalation (compound)
patterns histological (amod)
0.24 0.004 (conj)
membranes all (predet)
responses cardiovascular (amod)
chloride aluminum (compound)
exposed had (aux)
reading central (amod)
analyzed data (nsubjpass)
underwent swelling (dobj)
0.03 p (dep)
lesions p (dep)
levels noradrenaline (nmod)
operated patients (nsubjpass)
forestomach the (det)
hearts resected (amod)
associated pattern (nsubjpass)
1.0 x (cc)
levels turnover (conj)
have do (aux)
enhanced bupivacaine (nmod)
develops usually (advmod)
developed transplants (nmod)
reviewed retrospectively (advmod)
fell sed (dep)
impaired learning (dobj)
suffering disease (nmod)
1.39 was (cop)
trial west (amod)
had injected (advcl)
able overcome (xcomp)
remedies cold (amod)
tests include (acl:relcl)
anastrozole of (case)
patients % (appos)
hypotension glibenclamide-sensitive (amod)
mice c57bl/6 (compound)
placebo both (cc:preconj)
close that (nmod)
monkeys the (det)
mm 31 (nummod)
associated acid (nmod)
disturbances visual (amod)
received blockers (dobj)
tolerated past (nmod)
$ROOT$ missed (sent)
behaved . (punct)
exhibited exhibited (advcl)
2d6 cytochrome (compound)
minimize dysfunction (nsubj)
micrograms/ml 6.25 (nummod)
cells beating (amod)
cause ever (advcl)
veins on (case)
indicates occurs (ccomp)
ballooning ventricle (compound)
$ROOT$ withdrawal (sent)
model lid (nmod)
hydrobromide treatment (nmod)
$ROOT$ rates (sent)
change output (nmod)
recommended nascis (nmod)
developed hemolysis (dobj)
negative which (nmod)
3.9 ( (punct)
hypoxia cyanosis (conj)
alleviated symptoms (dobj)
sm-5887 ) (punct)
transplantation lt (appos)
molecules the (det)
flatulence , (punct)
characterized effects (dobj)
administration from (case)
suggested involved (ccomp)
caused depletion (nmod)
glaucoma for (case)
determined investigations (nsubj)
agonist unlikely (conj)
men among (case)
neurons pallidal (amod)
heterogeneity to (case)
6.0 to (dep)
preparations ergot (compound)
resurgence plasticity (nmod)
have exposures (nsubj)
preparation frog (compound)
expansion tubular (amod)
patients vincristine-treated (amod)
when even (advmod)
medications immediately (advmod)
neuropathy chlorpropamide-induced (amod)
ischemia occurring (acl)
collagenase low-dose (amod)
week study (nmod)
indicating occurs (ccomp)
remained study (nmod)
offer form (nsubj)
uveitis and (cc)
involvement effect (nmod)
cancer autochthonous (amod)
disruption is (cop)
returning results (nsubj)
augmentation rate (nmod)
progestagen of (case)
method study (appos)
alleviated was (auxpass)
insipidus and (cc)
scores attenuation (compound)
chemotherapy after (case)
linkages the (det)
lasted occasions (nmod)
change adverse (amod)
compromising and (cc)
degrees ; (punct)
effect for (case)
potentiate can (aux)
7.2 to (quantmod)
anger fear (conj)
neurochemical and (cc)
0.05 ) (punct)
patient for (case)
objective this (det)
levels sfas (compound)
chance examined (acl)
symptomatology chronicity (conj)
phases of (case)
peptide pth-related (amod)
toxicity lometrexol (nmod)
showed compared (advcl)
medication novel (amod)
serum and (cc)
antagonists l-type (amod)
analogues derivatives (conj)
physiology muscle (compound)
microg i.c.v. (advmod)
part nuclei (nmod)
modulation response (nmod)
treated cyclosporin (nmod)
showed examinations (nsubj)
intake with (case)
practice current (amod)
n-acetylcysteine of (case)
comprised group (nsubj)
non-biodegradable gly-gly (appos)
edema in (case)
oliguria of (case)
repair with (nmod)
coincident which (nsubj)
rats l-w (compound)
spasm drug-induced (amod)
bones foot (compound)
intervention percutaneous (amod)
supports safety (dobj)
bladder and (cc)
estimate , (punct)
causes are (cop)
antagonized component (dobj)
pretreatment minutes (nmod)
withdrawal conjunction (nmod)
ventricles in (case)
exposure progression (conj)
receptor receptor (conj)
milieu of (case)
affect whether (mark)
elevations prl (nmod)
stresses presentation (nsubj)
showed patient (nsubj)
available commercially (advmod)
associated oxidants (nsubjpass)
puncture and (cc)
target selectively (advmod)
nd ( (punct)
administered triphosphate (nsubjpass)
results consisted (appos)
dehydrogenase triglycerides (conj)
angioplasty following (case)
frequency reduction (compound)
caused drug (nmod)
prevented proportion (nmod)
estimated bmd (nsubjpass)
3-methoxy-4-hydroxyphenethyleneglycol and (cc)
attempt determine (acl)
results : (punct)
factor-alpha , (punct)
reduced animals (nmod)
ingredient lindane (nmod)
referred patient (nsubjpass)
cimetidine on (case)
$ROOT$ participating (sent)
similar whereas (mark)
junction neuromuscular (amod)
prevented could (aux)
died receiving (advcl)
platform the (det)
channels i(f)-generating (compound)
immunotherapy an (det)
group elected (acl:relcl)
1.4 , (punct)
dogs dogs (conj)
antagonists histamine (compound)
problematic anemia (nsubj)
undergoing stimulation (dobj)
nystagmus with (case)
analysis fragmentation (conj)
produced ; (punct)
$ROOT$ illustrated (sent)
takes months (dobj)
syndrome possible (amod)
guinea-pigs.5 from (case)
therapy ifn (compound)
increment pronounced (amod)
enhancement . (punct)
hypercalcemia including (case)
incidence creatinine (conj)
consisted while (mark)
thiabendazole to (case)
tland , (punct)
retention urine (nmod)
g/m2/d than (case)
variability heart (compound)
induces trinitrate (nsubj)
pressures sbp (appos)
projection an (det)
result reach (advcl)
day to (case)
decreased less (advmod)
exercise to (mark)
similar vindesine (nmod)
becoming that (nsubj)
28 less (amod)
facility care (compound)
ng/min 50 (nummod)
responses pain (compound)
mg. increasing (advcl)
pressure spillover (conj)
blockade part (nmod)
operated on (compound:prt)
area h (dep)
quantified activities (nmod)
ml and (cc)
therapy systemic (amod)
medium containing (acl)
nine men (nmod)
amplifier pg-9 (dep)
mg/dl. was (cop)
auccgrp recorded (acl)
significant were (ccomp)
have glycosuria (dep)
points effect (nmod)
phenotype the (det)
safety ketamine (nmod)
provides dosing (nsubj)
seizures incidence (conj)
combination sch (nmod)
interval 1.67 (appos)
restored inhibited (parataxis)
glycosides digitalis (compound)
associated agents (nsubjpass)
regimens between (case)
focus di (nmod)
promoter basal (amod)
aorta the (det)
remained concentrations (nmod)
fell significantly (advmod)
day day (appos)
rrmm ) (punct)
intervals qt (compound)
men in (case)
lifting before (case)
dantrolene bromocriptine (conj)
clinical comprehensive (amod)
woman 79-year-old (amod)
collection urine (nmod)
$ROOT$ expressed (sent)
play whereas (mark)
schedule mmc-dependent (amod)
fifty-three five (compound)
tnfalpha , (punct)
virus-related hepatitis (nmod:npmod)
$ROOT$ memory (sent)
impairment induced (acl)
observation last (amod)
experienced = (parataxis)
function cck-8 (nmod)
caused symptoms (dobj)
response toxic (amod)
pronounced were (cop)
scintigraphy dogs (nmod)
chelation succimer (compound)
syndromes painful (amod)
was either (preconj)
dystonia of (case)
effects drops (nmod)
controlled be (auxpass)
cystitis typical (amod)
considered effects (nmod)
effects gabapentin (nmod)
groups than (case)
distortion some (det)
met manifestations (nsubj)
rhythm . (punct)
consistent action (nmod)
decrease ccr (nmod)
rate orr (appos)
using times (nmod)
% 62.8 (nummod)
received radiotherapy (dobj)
drug of (case)
picture clinical (amod)
found effect (nsubjpass)
reports . (punct)
monooxygenases p450 (compound)
imaging prior (case)
activity prod (nmod)
hexachloro-1:3-butadiene hcbd (appos)
junction ( (punct)
causes hepatitis (nmod)
algorithm the (det)
illustrated . (punct)
overload the (det)
evaluated neuropathy (dobj)
technique be (cop)
effect pb (compound)
found sensitivity (dobj)
$ROOT$ progress (sent)
technique new (amod)
venlafaxine on (case)
patients infected (acl)
detected consistently (advmod)
bh hv (conj)
change direction (nmod)
model three-compartment (amod)
32 - (dep)
effect vasopressor (compound)
toxicity cows (nmod)
hospital ontario (nmod)
dose prevention (nmod)
edema acute (amod)
success disease (nmod)
potential improving (acl)
18 years (quantmod)
persistence the (det)
days 15 (conj)
produced aventyl (nsubj)
functional structural (conj)
hypertension after (conj)
point that (det)
cirrhosis alcoholic (amod)
followed range (parataxis)
21 24 (nmod)
discriminating affection (nmod)
reduction level (nmod)
defects epithelial (amod)
determination testosterone (compound)
injection bilateral (amod)
therapy fluconazole (nmod)
lesions invasive (amod)
prescribing opioids (dobj)
r=0.81 ) (punct)
unit pediatric (amod)
frequencies cochlear (amod)
reference special (amod)
occasions on (case)
hepatitis erythroblastocytopenia (conj)
administration levodopa (compound)
systems of (case)
receiving been (aux)
mtor ( (punct)
appear mpo-anca (nsubj)
$ROOT$ rated (sent)
used tablet (dobj)
pattern and (cc)
dyskinesias dose (compound)
heparin of (case)
changes sodium (nmod)
ikr on (case)
potentials jerk-correlated (amod)
determined and (cc)
cyclophosphamide c (appos)
rapamycin mg/day (appos)
results polymorphic (appos)
iq in (case)
callosum 2/8 (appos)
$ROOT$ suffer (sent)
phase sexual (amod)
selective because (mark)
reduced treatments (nsubj)
20,40,60 of (case)
substance reference (amod)
genetic molecular (amod)
sedated . (punct)
60 > (advmod)
followed that (mark)
drugs other (amod)
were expressing (advcl)
seen have (aux)
mg g/250 (nummod)
bia - (punct)
poisoned pemoline (nmod)
inhibits development (dobj)
accompanied elevation (nsubj)
site an (det)
discuss applicability (dobj)
efficacy similar (amod)
hormone of (case)
total the (det)
mediates polyuria (dobj)
changes these (det)
patient pheochromocytoma (nmod)
presented was (auxpass)
entities failure (nmod)
1.9 were (cop)
alternative dialysate (nsubj)
day operation (nmod)
5 , (punct)
case . (punct)
designs experimental (amod)
euphoria movements (conj)
community neurosurgical (amod)
thymidine of (case)
deficits communication (nmod)
affected pre-treatment (nsubj)
variability with (case)
months observation (nmod)
ifo and (cc)
abc the (det)
cardioselective has (ccomp)
induce pce (nsubj)
paresthesias cramps (conj)
produced increased (conj)
individuals 2 (nummod)
days 260 (nummod)
rhythms 5 (nummod)
trialists and (cc)
boluses or (cc)
2.35 1.17 (appos)
injection acid (nmod)
showed mg/kg (conj)
fifteen the (det)
40 almost (advmod)
260 about (advmod)
conducted also (advmod)
a possessing (acl)
tumor left-sided (amod)
administration fluoxetine (nmod)
causes due (case)
mpa ) (punct)
contrasted loss (nsubj)
sensitive cochlea (nsubj)
occurred confusion (nsubj)
seems safe (xcomp)
depend interval (nmod)
factor whether (mark)
rate cimd (nmod)
uptake altered (amod)
di his (nmod:poss)
antagonist serotonin (compound)
angiotensinogen with (case)
selection patient (compound)
allow proceed (ccomp)
combination c (nmod)
determinations electrolyte (compound)
effective was (cop)
40 80 (conj)
region liver (nmod)
therapy c (nmod)
anesthesia tiva (appos)
2.5 women (nmod)
% deaths (nmod)
hematoma the (det)
features elevation (nsubj)
loss hearing (compound)
improved gain (dobj)
december 1997 (nummod)
reversed effects (dobj)
shown which (nsubjpass)
2.7 ( (punct)
prolongation qt (compound)
induced olanzapine (nmod)
toxicity systemic (amod)
exertion upon (case)
administered solution (dobj)
developed total (nsubj)
milder somewhat (advmod)
infection barr (amod)
anxiety and (cc)
suggested inflammation (nsubjpass)
correlated occurrence (nsubj)
consisted vacuolization (nmod)
adefovir tenofovir (conj)
articles reporting (acl)
irregularity menstrual (amod)
tachycardia central (amod)
discussed causes (nsubjpass)
participants the (det)
o2- reduced (amod)
raised characterized (conj)
women older (amod)
women had (acl:relcl)
arrest cardiopulmonary (amod)
benign mistaken (conj)
92 73 (compound)
form conjugates (nmod)
years ; (punct)
supplementation long-term (amod)
agonist nonselective (amod)
equal were (cop)
controls in (case)
mirtazapine with (case)
urea and (cc)
treatment impotence (conj)
used regression (nsubjpass)
indicators nephrotoxicity (nmod)
dyskinesias filling (acl)
pretreatment midazolam (conj)
trial this (det)
3 equal (advmod)
monitored seizures (nsubjpass)
intake total (amod)
techniques retrograde (amod)
exacerbated was (auxpass)
seizures arising (acl)
work previous (amod)
conventional extended-interval (conj)
cyclosporine- or (cc)
deviation measure (nmod)
synthesis during (case)
case seizures (nmod)
d 1 (nummod)
dyskinesias . (punct)
cause : (punct)
one only (advmod)
% included (acl:relcl)
tachycardia clarithromycin-induced (amod)
stimulation bethanechol (conj)
intraperitoneal ip (dep)
histology in (case)
genes pparalpha (compound)
lowering enos (dobj)
50mg/kg 100mg/kg (conj)
abnormalities electrocardiogram (compound)
deaths procedures (conj)
at especially (advmod)
stimulation t-cell (compound)
phenobarbitone carbamazepine (conj)
suggested determined (conj)
diseases severe (amod)
need medication (nmod)
assessed factors (nsubjpass)
q wk (nmod:tmod)
3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one of (case)
antibody proteinase-3-antineutrophil (amod)
administration subtoxic (amod)
phase and (cc)
observations under (case)
only not (neg)
concentrations ambient (amod)
pain postoperative (amod)
lidocaine cocaine (conj)
half-life because (case)
given reached (advcl)
leukemia l1210 (compound)
infusions the (det)
oxide of (case)
has property (dobj)
tetrandrine of (case)
experienced vision (dobj)
micrograms/kg/min 30 (nummod)
variants , (punct)
tried confirm (xcomp)
accumulation doxorubicin (nmod)
initial the (det)
than h (nmod)
amphetamine compounds (conj)
each burns (nmod)
doses depending (prep)
evaluated billingham (nmod)
toxicity local (amod)
temperature patient (nmod:poss)
diagnosed and (cc)
aap mg/kg (appos)
sensitivity ax (nmod)
predictors : (punct)
dystrophin , (punct)
preserve memory (dobj)
cancer applicators (nmod)
demonstrates synthesis (nsubj)
doses median (amod)
assessed a.m. (nmod)
led s(c)o(2 (dobj)
establishment with (case)
metabolites nox (appos)
applied then (advmod)
shown damage (xcomp)
amount enzyme (nmod)
absent signs (nsubj)
$ROOT$ usually (sent)
screened we (nsubj)
case ischemia (nmod)
similar occurrence (nsubj)
improvement patient (nmod)
ns ) (punct)
identified tubules (nmod)
related line (nmod)
component effect (nmod)
tab 1/2 (nummod)
pod on (case)
allowing maintenance (dobj)
results activation (nmod)
extend may (aux)
comparison prevention (nmod)
methotrexate systemic (dep)
foci epileptic (amod)
effect between (case)
design setting (conj)
analyses the (det)
maintaining for (mark)
minute per (case)
patterns between (case)
mg/kg gd (nmod)
sd 0.078 (nummod)
259 61 (compound)
mitochondria isolated (acl)
dams the (det)
ultrafiltration by (case)
activity in (case)
data ir (compound)
release rates (nmod)
less being (cop)
death disease (conj)
associated gene (nsubjpass)
examined appearance (nsubjpass)
men 48 (nummod)
produced pathology (dobj)
outflow heart (nmod)
titres mpo-anca (compound)
task on (case)
treated cocaine (nmod:npmod)
ulcers rats (nmod)
receiving fluoxetine (dobj)
possible however (advmod)
using protocol (dobj)
using antagonists (dobj)
doses plus (cc)
similar bp (nsubj)
racemic r- (conj)
hospitals period (nmod)
pursued not (neg)
found cocaine (nsubjpass)
users psychopaths (conj)
groups control (amod)
produced seizures (dobj)
damage lobe (nmod)
dosage green (nmod)
nephropathy cyclosporine-induced (amod)
given rat (nmod)
use between (case)
splenomegaly times (dep)
declined mmhg (dobj)
disappearing protein (nsubj)
revealed analysis (nsubj)
induced carbimazole (nmod)
mg. 150 (nummod)
6.2 versus (cc)
rr=1.60 ) (punct)
roles important (amod)
epilepsies of (case)
9 11 (conj)
option to (mark)
frey von (compound)
mesna 's (case)
had prk (dobj)
administered mice (nmod)
days 12 (nummod)
process stress (conj)
model exposure (nmod)
volume blood (compound)
angiopathy d-penicillamine-induced (amod)
ms from (case)
concentrations activities (conj)
treatment conversion (nmod)
cases hepatitis (nmod)
developed disease (dobj)
treated suffered (conj)
lack due (case)
zidovudine zidovudine (conj)
declines significant (amod)
t ctnt (appos)
50 than (advmod)
disabled was (cop)
fed restricted (parataxis)
proposed play (xcomp)
% than (case)
3 whom (nmod)
follows were (cop)
factors important (amod)
continues and (cc)
challenge organisms (nmod)
septicemia with (case)
prophylaxis malaria (compound)
reflect might (aux)
withdrawn with (mark)
retina the (det)
nodules subsequent (amod)
recurrence and (cc)
0.97 ( (punct)
allocated methods (nsubjpass)
facilitate progression (dobj)
experienced : (punct)
obtained up (dep)
evaluated tolerability (dobj)
inhibition growth (compound)
cognition of (case)
and pathologically (advmod)
modalities subset (nmod)
developed nystagmus (nmod)
addicts heroin (compound)
relevance physiological (amod)
ebf ( (punct)
developed that (mark)
standing and (cc)
severity catecholamines (conj)
u/ml 46.0 (nummod)
trial prospective (amod)
stiffness report (appos)
bodyweight of (case)
echocardiography for (case)
loss reduced (amod)
action analgesics (nmod)
mg/m2 mean (dep)
users 3,4-methylenedioxymethamphetamine (nmod)
0.47 , (punct)
enantiomer its (nmod:poss)
dogs reserpinized (amod)
identified anomaly (nsubjpass)
pressure resting (amod)
striatum beyond (case)
specific trihexyphenidyl (nmod)
relationships effect (conj)
pressure morphology (conj)
dynes.s.cm-5 < (parataxis)
demonstrated 4 (nsubj)
iv and (cc)
potentiality the (det)
administration over (case)
progress spite (nmod)
objectives determine (acl)
reverse administration (nsubj)
regimen well-tolerated (amod)
given bronchiectasis (nmod)
young 9 (nummod)
receptor opioid (compound)
2)% higher (conj)
arising child (nmod)
factor stimulating (compound)
greater shr (nmod)
range 200 (appos)
reduced decreased (conj)
forces as (cc)
ketoconazole to (case)
cigarettes ) (punct)
interrelationship anatomical (amod)
define clearly (advmod)
hiccups associated (acl)
influence pentobarbital (nmod)
headache attributed (acl)
indicate change (ccomp)
hematoma intracranial (amod)
< [ (punct)
transection vagotomy (conj)
recruited . (punct)
range were (cop)
infusion for (case)
9-month six- (compound)
detected hippocampus (nmod)
precursor nociceptin (nmod)
pacemakers junctional (amod)
protection syndrome (nmod)
implicated : (punct)
resistant contrast (nmod)
initiated practitioners (nmod)
reduce p (nmod)
times activated (amod)
register the (det)
vocalizations ultrasonic (amod)
epilepticus rats (nmod)
percent to (case)
developed models (nsubjpass)
detected treatment (nmod)
infarction prior (amod)
strategy treatment (compound)
patients intake (nmod)
prognosis the (det)
catecholaminergic and (cc)
those surviving (acl)
involved injury (nmod)
patients caused (acl:relcl)
cross-tolerant those (nsubj)
elevation argatroban (nmod)
aggravating promoting (conj)
occasions apart (advmod)
exposure report (dep)
treated docetaxel (nmod)
children virus (compound)
stimulation enac (nmod)
patients ouabain (compound)
supplements dietary (amod)
protein 336 (nummod)
reabsorption protein (compound)
taken had (aux)
process underlying (acl)
cardiotoxicity induced (amod)
abnormalities performance (compound)
schedule acceptable (amod)
ci=1.2 ( (punct)
cause accounting (advcl)
mouth ( (punct)
uea1 ( (punct)
attenuated nimo (nsubj)
sulfate morphine (compound)
suspect patients (nmod)
steeply although (mark)
mg 25 (nummod)
results however (advmod)
ddathf ( (punct)
structures brain (compound)
phenotypes for (case)
atropine i.c. (compound)
appearance after (case)
anthracyclines of (case)
ci=1.2 % (compound)
cohort an (det)
value control (compound)
roots plexus (compound)
people million (nummod)
exposure gamma-hch (nmod)
toxicity between (case)
solution dilevalol (nmod)
receiving amb (dobj)
amelioration to (case)
responsiveness decreased (amod)
sd = (acl:relcl)
$ROOT$ imbalance (sent)
transport glucose (compound)
$ROOT$ dysosmia (sent)
concentration group (nmod)
similar changes (nsubj)
unaltered treatment (nmod)
$ROOT$ on (sent)
= 3164 (dobj)
f2 a (det)
n-methyl-d-aspartate picrotoxin (conj)
radiotherapy before (case)
designed assess (xcomp)
$ROOT$ tumor (sent)
had experienced (conj)
induced pan (nmod)
susceptibility . (punct)
injection by (case)
related secondary (conj)
metabolite agent (nmod)
echoes neoplasms (nmod)
sarcoma related (amod)
death suicidal (amod)
used where (advmod)
afterdischarges repetitive (amod)
hypothesis affects (ccomp)
use groups (nmod)
mainstay been (cop)
surgery anesthesia (nmod)
accompanied resolution (nsubjpass)
elevations risperidone-induced (amod)
areas patchy (amod)
relationship initiation (nmod)
scopolamine hyoscine (appos)
ras brain (compound)
higher alpha (nsubj)
predisposed might (aux)
reduce bf (dobj)
glutamate gaba (conj)
involvement cholinergic (amod)
35 20 (compound)
restore can (aux)
25mg/kg metformin (nmod)
placentae all (det)
circumstantial largely (advmod)
included edema (dobj)
trazodone antidepressant (amod)
proves potent (advcl)
obstruction airway (compound)
nanospheres into (case)
ht of (case)
thickening left (amod)
altered pretreatment (nmod)
lymphadenitis associated (acl)
syncope vasovagal (amod)
1.03 0.94 (conj)
evidence cause (advcl)
minute time (nsubj)
from 317 (nmod)
esrd because (case)
kept interaction (nsubjpass)
platelets ) (nummod)
homeostasis mice (nmod)
dyschromatopsy a (det)
$ROOT$ remained (sent)
amyloidosis patient (nmod)
weakness pneumonia (conj)
modulators of (case)
result production (nmod)
risk outcome (conj)
recorded respectively (advmod)
lead histories (nsubj)
effects capecitabine (nmod)
organelle with (mark)
reduction profound (amod)
unknown it (nsubj)
788.5 +/- (cc)
child receiving (acl)
$ROOT$ involved (sent)
dosage than (case)
microg n=6 (appos)
received many (nsubj)
increased cxad (dobj)
results experimental (amod)
summary in (case)
small trials (nsubj)
drug propranolol (nsubj)
agent useful (amod)
have migraine (nsubj)
disease recurrent (amod)
sg cortex (nmod)
had administration (nmod)
paf ( (punct)
expression achrs (nmod)
prophylaxis no (neg)
pg the (det)
acute " (punct)
those c (nmod)
period each (det)
trial doxorubicin (nmod)
analysis transcriptome (compound)
region cases (conj)
= 8 (dobj)
variable but (cc)
helpful determining (advcl)
m0 ( (punct)
colonies erythroid (amod)
out-patients new (amod)
depressed chloride (nsubj)
had fluvoxamine (nsubj)
ratio vte (nmod)
recordings electrocardiographic (amod)
paresthesias arthralgias/myalgias (conj)
nahco3 min (nmod)
delays mediated (conj)
acetaminophen- toxicity (dep)
losses with (case)
administered time (nmod)
susceptibility seizures (nmod)
one anemia (nsubj)
subjects 292 (nummod)
exhibited therapy (nmod)
resulted whereas (mark)
locomotion aggression (conj)
metoprolol racemic (amod)
use carbamazepine (nmod)
thrombosis on (case)
apomorphine therapy (appos)
im in (case)
reproducing abnormality (dobj)
apap of (case)
perimenopausal or (cc)
reported been (auxpass)
indicated patients (nmod)
pathogenesis in (case)
concentrations dose (conj)
level whole (amod)
failure circulatory (amod)
3 ventricles (nmod)
establish bioavailability (dobj)
3 - (punct)
toxicity neurobehavioral (amod)
rapid timely (conj)
effects lithium (compound)
went patients (nsubj)
precipitate hypertension (dobj)
calculated ratios (dobj)
adjunct chemotherapy (nmod)
correlate ace (nsubj)
plays pgp (nsubj)
pronounced users (nmod)
administered reduce (xcomp)
preponderance a (det)
chc of (case)
scale montgomery-asberg (compound)
correlated studies (nmod)
electrocardiograms unipolar (amod)
r 0.78 (nmod)
elevated mice (nmod)
institutions 32 (nummod)
recorded muscles (nmod)
difference which (nsubj)
stable audiogram (nsubj)
background by (case)
infant young (amod)
effects characteristics (nmod)
hospital salvatore (compound)
reproduced could (aux)
prod ( (punct)
carbetocin analogue (appos)
factor = (parataxis)
arteries coronary (amod)
needed also (advmod)
design safety (dep)
occurs taking (advcl)
performed infusion (nmod)
effects patients (nmod)
instillation drops (nmod)
recorded region (nmod)
completed who (nsubj)
increased infusion (nmod)
have effects (dobj)
regimen on (case)
vasoconstriction artery (nmod)
costs direct (amod)
using schedule (dobj)
stimulated . (punct)
produced that (nsubjpass)
replicate inhibition (nsubj)
hypertrophy both (cc:preconj)
begun dialyzer (nmod)
diminished weeks (nmod)
urine all (det)
was report (ccomp)
determined dialysis (nmod)
100 and (cc)
method an (det)
done should (aux)
occurs period (nmod)
mk-212 (-)-baclofen (conj)
1-(2-phenethyl)-4-(2-pyridyl)-piperazine ) (punct)
consisted history (nmod)
patients cases (nmod)
represses induces (conj)
beta-carboline-3-carboxylate methyl (compound)
follow-up not (neg)
led compared (advcl)
cardiotoxicity model (nmod)
effect not (neg)
ligation bile (compound)
specimens liver (compound)
somnolence % (appos)
hypokalemia were (cop)
p=0.008 , (punct)
data dependency (nmod)
diclofenac with (case)
paper in (case)
lasted terminated (conj)
patient is (cop)
extracted authors (nsubj)
pd in (case)
complication children (nmod)
animals min (dep)
1.6+/-0.34 ( (punct)
groups alf (dep)
simvastatin amiodarone (conj)
gyrus rats (nmod)
treatment d-pen (compound)
provide it (nsubj)
agent no (det)
therapy il-2 (nmod)
displays that (mark)
known rammer (dep)
evaluated evaluated (conj)
spike shifts (nmod)
channels ) (punct)
absorbed drug (nsubjpass)
hypothesize thought (advcl)
factors data (nmod)
tolerated granisetron (nsubjpass)
model experimental (amod)
suggest overall (advmod)
nyha ( (punct)
estradiol ee (appos)
treatment dermatoses (nmod)
property cd-832 (nmod)
index and (cc)
l micro (compound)
correlation change (nmod)
concentration minimum (amod)
eluate in (case)
suggests effect (dobj)
hydrochloride 5-hydroxytryptamine4 (compound)
appeared tachycardia (nsubj)
subtypes dopamine (compound)
noticed she (nsubj)
neuropathy isoniazid (compound)
decreased 76 (conj)
eyes apraclonidine-treated (amod)
precipitate may (aux)
= 21 (dobj)
cultured presence (nmod)
machinery and (cc)
reduces pretreatment (nsubj)
agonist administered (amod)
number vacuoles (nmod)
tuberculosis because (case)
embarrassed being (cop)
data people (nmod)
choice treatment (nmod)
proposed damaged (advcl)
intolerance ace (compound)
investigated postoperatively (advmod)
tended increase (xcomp)
report stimulation (nmod)
a 16/104 (appos)
produces treatment (nsubj)
myeloencephalopathy : (punct)
period 30-day (compound)
model collagenase-induced (amod)
sealants of (case)
analyzed rats (nmod)
seems connected (xcomp)
suggest contributes (ccomp)
flurbiprofen treatment (nmod)
p<0.001 diabetic (nmod)
surgery artery (compound)
defined mg/m(2 (nmod)
possibilities result (ccomp)
children young (amod)
route the (det)
congestion lungs (nmod)
patients cells/mm3 (conj)
properties cocaine (nmod)
associated glomerulosclerosis (nmod)
useful monitored (conj)
contribution regulation (nmod)
mcl ) (punct)
anemia remoxipride-induced (amod)
suggested headache (nmod)
pain of (case)
rules the (det)
patients hyperalgesia (nmod)
thinning change (nsubj)
surgery aortic (amod)
heart heart (conj)
alter animals (advcl)
restarted , (punct)
coincided which (nmod)
failure treatment (compound)
methods studied (dep)
volumetry resonance (compound)
effects dysfunction (conj)
5 just (advmod)
aml ) (punct)
% and (dep)
scored 85 (dobj)
120 60 (advmod)
permitted . (punct)
abnormalities % (appos)
added phenobarbital (nsubjpass)
suspected appearance (nsubjpass)
maculatum from (case)
loss an (det)
medications for (case)
inversions wave (compound)
3.0 to (advmod)
binding receptor (compound)
toxic . (punct)
normalization level (nmod)
described reports (nsubj)
cancer hepatoma (conj)
experience switching (advcl)
then and (cc)
populations medical (amod)
episode puerperal (amod)
population an (det)
anaesthetised rats (nsubjpass)
mtor-i ( (punct)
aggravate . (punct)
sensitivity examination (conj)
thrombosis or (cc)
pain acuity (conj)
taking dapsone (dobj)
patient aids (nmod)
experiment double-blind (amod)
appeared until (mark)
assessed imaging (nmod)
chow ad (amod)
delta gamma-2 (conj)
initiated study (dobj)
dyskinesias peak-dose (amod)
prevent complications (dobj)
obtained patients (nmod)
inhibited potentiated (conj)
died transplant (nmod)
dysfunction dose-limiting (amod)
noted mg/kg (parataxis)
tolerated day (nmod)
% years (appos)
diagnosis of (case)
patients twenty-three (nummod)
fit disease (nmod)
corticography or (cc)
nhe3 and (cc)
mg/m2 75 (nummod)
nox plasma (compound)
decrease output (nmod)
physician by (case)
investigated relationship (dobj)
motor and (cc)
level lidocaine (compound)
days 11 (dep)
behaviour periods (nmod)
exhibited or (cc)
notable concentration (nmod)
studied cells (nmod)
concern theoretical (amod)
f(33 ) (punct)
group insulin-only (amod)
cause difficult (conj)
26- di- (nsubj)
activation interval (nmod)
auc ] (punct)
$ROOT$ produced (sent)
circuitries in (case)
included complications (nsubj)
grams three (nummod)
months range (dep)
initiated hypothermia (dobj)
summarizes . (punct)
prolonged concentrations (nmod)
followed had (aux)
involvement aspects (nmod)
investigate further (advmod)
propranolol than (case)
lidocaine . (punct)
bemegride mg/kg (dep)
mi a (det)
show cords (nsubj)
abuse case (dep)
isbell fraser (conj)
define causality (dobj)
wish we (nsubj)
formation to (case)
rg1 ginsenoside (nmod)
done tests (nsubjpass)
reversed effect (dobj)
initiated ( (punct)
inhibitor cinacalcet (nsubj)
degrees significant (amod)
patients 73 (nummod)
rose activities (nsubj)
received followed (advcl)
pathophysiology whose (nmod:poss)
reduce infusions (nsubj)
able complete (xcomp)
postoperatively days (nmod:npmod)
outcomes most (amod)
delay shorter (amod)
recognized early (advmod)
function previous (amod)
ratios growth (compound)
inpatients psychiatric (amod)
relation dose (nmod)
objective analyze (acl)
increased indeed (advmod)
blockade receptor (compound)
responses rodents (nmod)
ml ) (punct)
pvc ) (punct)
response an (det)
made differentiate (xcomp)
kanamycin with (case)
induced repeatedly (advmod)
disorders psychosis (conj)
canaliculi the (det)
equivalent mg/kg/day (nmod)
investigate loss (dobj)
milligram mass (nmod)
stopping alpha-2b (dobj)
analgesia for (case)
trial placebo-controlled (amod)
cessation for (case)
p = (dep)
conclusive nimodipine (nmod)
state their (nmod:poss)
duct common (amod)
methamphetamine meth (appos)
characteristics its (nmod:poss)
contributes history (nsubj)
setting an (det)
actives models (nmod)
changes small (amod)
properties nisoldipine (nmod)
inhibits tam (nsubj)
performed was (auxpass)
activation nf-kappab (nmod)
a(2a ) (punct)
palsy fold (compound)
stressed were (auxpass)
obtained tissue (nsubjpass)
eyes ) (punct)
users nonusers (conj)
ratios the (det)
encode recall (conj)
resolve change (nmod)
placebo tamoxifen (conj)
association paroxetine (nmod)
revert that (mark)
isoform isomerase (compound)
$ROOT$ disrupted (sent)
lifetime current (conj)
justified follow-up (nsubjpass)
lag ) (punct)
doses mg (compound)
glomerulosclerosis adr-induced (amod)
nucleus pedunculopontine (amod)
gain damage (conj)
examine studies (nsubj)
receptor d1 (compound)
administration gentamicin (compound)
benefits harms (conj)
averaged months (dobj)
ballistic and (cc)
vomiting tremors (conj)
analogues . (punct)
animals bmc-treated (amod)
caused mortality (nsubjpass)
involve actions (dobj)
prognosis condition (nmod)
ops of (case)
alpha(1)-subunit the (det)
n=26 ) (punct)
alterations induced (acl)
axons small-caliber (amod)
heavy average (dep)
cr ) (punct)
diseases , (punct)
incorporation slices (nmod)
fr ) (punct)
brainstem of (case)
managing for (mark)
growth on (case)
kit simple (amod)
derivative . (punct)
data demographic (amod)
compared lisinopril (nmod)
compound novel (amod)
group blockers (nsubj)
peptide brain (compound)
% 27.1 (nummod)
fraction homogenates (nmod)
thyrotoxicosis of (case)
baseline day (conj)
deferoxamine with (case)
injected doses (nmod)
children five (nummod)
resulted occurrence (nsubj)
microgram/ml than (case)
large hemodynamics (conj)
h during (case)
cromakalim- pinacidil-induced (conj)
implanted rats (nsubjpass)
use drug (nmod)
reported macrolides (nmod)
approval its (nmod:poss)
cnsb002 for (case)
determined number (nsubjpass)
cox-2 , (punct)
vulnerability increased (amod)
unclear role (nsubj)
were more (advmod)
neurotoxicity ifosfamide-induced (amod)
cyclophosphamide wtih (compound)
flow by (case)
hemorrhage warfarin-associated (amod)
analyzed enzyme (nsubjpass)
pronounced bepridil (nmod)
investigate checklist-90-revised (dobj)
increased 0.83 (nmod)
length dialysis (nmod)
warrants investigation (dobj)
pressure both (cc:preconj)
ligands gaba(a)r (compound)
imaging radiographic (amod)
day admission (nmod)
intensity abnormal (amod)
generated has (aux)
investigated patients (dobj)
patients forty-four (nummod)
correlated volume (nmod)
$ROOT$ 77.1 (sent)
myopathies in (case)
reported chemotherapy (nsubjpass)
occurred injection (nmod)
saline l-dopa (conj)
had months (nmod)
moran , (punct)
those isolated-hit (nmod)
attempts paper (nsubj)
p=0.003 ( (punct)
core accumbens (compound)
33 ) (punct)
reaction biphasic (amod)
lvef % (nmod)
undergone have (aux)
examination kidneys (nmod)
membranes cell (compound)
desensitization alpha-adrenoceptor (compound)
considered compounds (nmod)
number women (nmod)
dressing as (case)
trial test (compound)
modification by (case)
recruiting circuitry (dobj)
found position (dobj)
appearance with (case)
given premedication (nsubjpass)
reduction tac (compound)
doses ( (punct)
antagonist cck2 (compound)
weeks all (det)
mmg ) (punct)
imparts that (nsubj)
catch reye (nmod)
intubation gastric (amod)
nerves cervical (amod)
abnormalities minor (amod)
hot-plate tail-flick (conj)
polyuria to (case)
expression facial (amod)
pain % (dep)
stimulate ventilation (dobj)
$ROOT$ organisms (sent)
% 0.02 (compound)
disorder but (cc)
vessel blood (compound)
acid on (case)
design a (det)
10 1 (compound)
majority ) (punct)
augmented . (punct)
presentation neuropathies (nmod)
signal feedback (compound)
hypersensitivity behavior (conj)
intense , (punct)
3 4 (conj)
subscale positive (amod)
activity presumably (advmod)
neurons motor (compound)
72 +/- (cc)
concentrations ozone (compound)
angina spontaneous (amod)
annulus around (case)
reverse minutes (nmod)
calculation basis (nmod)
mg = (parataxis)
lowering , (punct)
experienced hypotension (dobj)
discontinue occurrence (nmod)
activity tachycardia (nmod)
modulated . (punct)
ed ) (punct)
treatment vpa (nmod)
parallels actions (nmod)
rats 6-ohda-lesioned (amod)
associated leukocyturia (nsubjpass)
treated groups (nmod)
28 to (case)
14 ) (punct)
therapy lorazepam (compound)
% % (quantmod)
5'-n-ethylcarboxamidoadenosine agonist (appos)
increase infusion (nmod)
cholinesterase movement (conj)
limit normal (nmod)
evaluation sediment (nmod)
factor known (amod)
limited treatment (nsubjpass)
counts of (case)
addition , (punct)
blotting microscopy (conj)
patients completed (acl:relcl)
therapeutic mg (dep)
responses partial (amod)
seizures then (advmod)
unanesthetized , (punct)
knowledge use (conj)
defects visual (amod)
patients used (acl:relcl)
adriamycin with (case)
death dose (nmod)
muscle cranialis (compound)
severity requirements (conj)
therapy gestations (conj)
observed re-observed (conj)
re , (punct)
signs only (amod)
practice standard (amod)
dysfunction bladder (compound)
interactions outcomes (nmod)
reported induction (nmod)
$ROOT$ detectable (sent)
users namely (advmod)
strategies prevention (nmod)
= r (nsubj)
treatment transplantation (nmod)
use drops (nmod)
snps five (nummod)
micron 100 (nummod)
activities tlr4 (compound)
dose clonidine (nmod)
= 86 (dobj)
compared pairs (nsubjpass)
involving tissues (dobj)
incidence hypokalemia (nmod)
frequency rat (compound)
injections intraperitoneal (amod)
teratogenic to (mark)
fibrosis replacement (compound)
serum urine (conj)
limited that (mark)
produce mechanisms (nmod)
produce pointes (dobj)
agonist alfentanil (dep)
occurred to (mark)
dropped later (advmod)
can ) (punct)
mmhg 144 (nummod)
pirenzepine m(1)-selective (appos)
observed conversion (nmod)
remained gfr (nsubj)
provoked crisis (dobj)
in addition (dep)
mellitus disease (conj)
gender level (conj)
studied we (nsubj)
interval average (amod)
procoagulant in (case)
variables to (case)
group mg/dl (appos)
sleep users (nmod)
anorexigens hypertension (conj)
achieved oih (nsubjpass)
involves lesion (nsubj)
regimen ( (punct)
decreased faster (advmod)
avoided performed (conj)
recording the (det)
alf % (appos)
treatment rhinitis (nmod)
cause but (cc)
analogue has (acl:relcl)
evidence serological (amod)
showed resolution (dobj)
followed if (mark)
decreased mg/dl (dep)
progress can (aux)
genesis a (det)
carcinomas of (case)
correlation within-subject (amod)
pressure by (case)
projections only (advmod)
development treatment (conj)
f344 ) (punct)
hyperalgesia produced (acl)
studies smokers (nmod)
eight and (cc)
growth or (cc)
tubulopathies with (case)
depression unipolar (amod)
activity antihyperalgesic (amod)
this or (cc)
period 30-min (amod)
mg/kg . (punct)
alive are (cop)
k(+)-channels voltage- (amod)
calcium only (advmod)
first second (conj)
pain ocular (amod)
cells/mm3 -45.1 (nummod)
developed had (aux)
recovery woman (nmod)
significant study (nmod)
oxidase cytochrome-c (compound)
high are (cop)
regimen (dnr)-containing (punct)
pfss ) (punct)
greater the (advmod)
instituted , (punct)
series measurements (nmod)
h p<0.002 (appos)
degree protection (nmod)
diagnosed ra (nmod)
calculated which (nsubjpass)
neurotoxicity close (amod)
were 151 (attr)
antibodies triggers (acl:relcl)
cycle 14-day (compound)
revert patients (nmod)
incidence delirium (compound)
defined samples (nsubjpass)
vinorelbine or (cc)
therapy intensive (amod)
drug recreational (amod)
required used (advcl)
reduce blockade (nsubj)
h dose (dep)
micrograms/dl 12 (nummod)
clinical mammographic (conj)
hyperactivity a (det)
dmso ) (punct)
anencephaly with (case)
enzymes antioxidant (amod)
convulsion convulsion (nmod)
ximelagatran inhibitor (appos)
treatment indomethacin (nmod)
attenuating effects (dobj)
groups c2 (appos)
controlled randomized (amod)
mechanism protection (nmod)
dosage required (acl)
group restricted-diet (amod)
prolongation of (case)
associated ; (punct)
parameters all (predet)
found however (advmod)
relation time (compound)
seen conditions (nmod)
decreased pressure (nsubj)
processes for (case)
pmol 5.911 (nummod)
rage fighting (conj)
experienced signs (dobj)
mg/m2 225 (nummod)
reduced % (dobj)
(stz)-induced streptozotocin (nmod:npmod)
incontinence her (nmod:poss)
thrombocytopenia to (case)
considered should (aux)
evokes blockage (nmod)
rats hypertensive (amod)
epileptogenecity effects (conj)
memantine with (case)
switching nifekalant (nmod)
employed paradigm (nsubjpass)
regimens into (case)
l-nil mg/kg (appos)
given doses (nmod)
days from (case)
mice hepatocyte-specific (amod)
measurements . (punct)
antigen-positive and (cc)
treated placebo (nmod)
damage progressive (amod)
occurred dissolution (nsubj)
have follow-up (dobj)
resistance increased (amod)
osteoporosis with (case)
related pain (nsubj)
teams care (compound)
tumor archival (amod)
rats high (amod)
factors microbleeds (nsubj)
significant < (parataxis)
ecg neither (cc:preconj)
890 cycle (nmod)
pseudoprolactinoma , (punct)
concentrations state (compound)
using arrhythmias (dobj)
involving mechanisms (dobj)
presumed stunning (xcomp)
used block (advcl)
administration intra-arterial (amod)
dinitrate of (case)
levels haptoglobin (compound)
possibility advantage (nsubj)
followed cases (dobj)
users is/tia (nmod)
mitochondria liver (compound)
administered h (nmod)
$ROOT$ women (sent)
subject a (det)
mixture racemic (amod)
studies some (det)
replicate effects (dobj)
showed gellan (nsubj)
outpatient an (det)
$ROOT$ identified (sent)
cardiomyopathy ) (punct)
sensitivity norepinephrine (nmod)
recruited patients (advcl)
tested mice (nsubjpass)
emergence agent (nmod)
repeated days (nmod)
norepinephrine control (appos)
caused reversion (dobj)
bradycardia sinus (compound)
upregulation enos (nmod)
2.3 3.5 (prep)
prolong , (punct)
used voltammetry (dobj)
infrequent is (cop)
substituted received (advcl)
effects physical (amod)
mechanism pain (nmod)
sedation procedures (nmod)
5-hydroxytryptamine 5-ht (appos)
greater asenapine (nmod)
mm 100 (nummod)
shifts afterdischarges (conj)
nitrendipine nisoldipine (conj)
reduced three (nmod)
da , (punct)
$ROOT$ neuroimage (sent)
started days (nmod)
m(2)-selective ' (punct)
population fibre (compound)
aminoglycoside . (punct)
determination follow-up (conj)
diabetic rats (dep)
postdose minutes (compound)
prior and (cc)
suggest suggest (advcl)
course terbinafine (nmod)
manage anemia (dobj)
f. 97 (nummod)
atrophy was (cop)
ovariectomized ovex (appos)
suffer disturbance (nmod)
crf and (cc)
drug comparison (compound)
significant also (advmod)
ligands , (punct)
p10 s (conj)
potential chemo-somatosensory (amod)
incidence treatment (nmod)
exploited may (aux)
revealed study (nsubj)
diameter/axon quotient (amod)
performed drivers (nmod)
adjustment with (case)
years as (case)
absorption onset (conj)
mmse in (case)
filters patients (appos)
etiology of (case)
groups can (compound)
subjects in (case)
incorporation epinephrine (nmod)
development against (case)
a.m. p.m. (conj)
feasible , (punct)
results treatment (nmod)
% hemorrhage (nmod)
increases hyperactivity (dobj)
underlying lesions (dobj)
had fluoxetine (nsubj)
pain upper (amod)
sagittal and (cc)
visit the (det)
preexposure prior (amod)
locomotor and (cc)
controls 85 (nummod)
treatment practice (nmod)
acid oleic (amod)
discussion the (det)
induce pituitary (nmod)
anesthetic inhalational (amod)
strains dba/2j (compound)
cause adenovirus (nsubj)
mtd cis-ra (nmod)
$ROOT$ corrected (sent)
provide studies (nsubj)
cases 57 (nummod)
binding elevates (acl:relcl)
transplant pbsct (appos)
order frequency (nmod)
events major (amod)
lowered lf (nsubj)
within immediately (advmod)
dehydrogenase oxidase (conj)
abundance 2 (nmod)
gene drd2 (compound)
occurs lobule (nmod)
$ROOT$ trial (sent)
min fifteen (nummod)
etoposide not (cc)
16 . (dep)
witnessed outcomes (nsubjpass)
treatment metronidazole (compound)
prompted known (parataxis)
suppressing in (mark)
stimulus a (det)
6 was (cop)
clonidine mk-801 (conj)
reticulum endoplasmic (amod)
hormone hormone-releasing (amod)
p-ampk ( (punct)
woman a (det)
doses haloperidol (nmod)
% [ (punct)
present group (nmod)
toxicity experiencing (advcl)
examined se (nmod)
induce hypothermia (dobj)
relationships . (punct)
patients nodosa (nmod)
rate discontinuations (nmod)
expressed neuropeptide-y (nsubjpass)
hemorrhage associated (acl)
background factors (dep)
vulnerable are (cop)
39.23 6.44 (conj)
beneficial is (cop)
combination glioblastoma (nmod)
dose following (case)
ill non-hypertensive (amod)
alleviates bicarbonate (nsubj)
mug sm (dep)
echocardiography indicator (dep)
infusion 6-hour (amod)
experience despite (case)
$ROOT$ started (sent)
conclusions potentiates (appos)
sedative as (case)
20 12 (conj)
established trials (nmod)
test vitro (compound)
using humans (nmod)
fs ) (punct)
reported using (advcl)
level in (case)
anticoagulation citrate (compound)
deliver nicotine (dobj)
efficacy antagonist (nmod)
makes selectivity (nsubj)
vigabatrin vgb (appos)
replacing amount (nmod)
protect nephrotoxicity (nmod)
neurotoxicity toxicity (conj)
iu/l 230 (nummod)
pseudoacromegaly , (punct)
received ) (punct)
besylate nmba (appos)
upregulated , (punct)
endothelin-1 of (case)
decreased incidence (nsubj)
muscle into (case)
resolved period (nmod)
n. ) (punct)
injections scopolamine (nmod)
sensitization lymphocyte (compound)
rf ) (punct)
syndromes nephrotic (amod)
mg/kg 6.5 (nummod)
leukemia chronic (amod)
patients failure (compound)
received mg (conj)
associated diabetes (nsubjpass)
d3 with (case)
disappearance stones (nmod)
agonist 5-hydroxytryptamine-1 (compound)
phase for (case)
results encouraging (amod)
supine and (cc)
changed spots (nmod)
questionnaires postal (amod)
propose increase (ccomp)
gtcs ( (punct)
deterioration profound (amod)
developed enhance (advcl)
diet fat (amod)
found contaminated (xcomp)
complement serum (compound)
tremors convulsions (conj)
mechanisms dysfunction (nmod)
lobe right (amod)
incidence tremor (nmod)
improved symptoms (nsubjpass)
contractility characteristics (conj)
reflex trigemino-parasympathetic (amod)
shorter . (punct)
course 48-week (amod)
mean iqr (dep)
synthesis . (punct)
switched tacrolimus (nmod)
pronounced was (cop)
patient schizophrenic (amod)
hypotension pge1-induced (amod)
inducing neuroadaptation (dobj)
bladder liver (conj)
infusion blockade (nmod)
blockade early (amod)
curative vancomycin (nsubj)
nephritis to (case)
hours five (nummod)
study this (det)
categories higher (amod)
complication the (det)
levels to (mark)
understand , (punct)
application surgical (amod)
16 117 (nmod)
difference true (amod)
tumors children (nmod)
products such (amod)
ceased ; (punct)
men studies (nmod)
way develops (advcl)
hours 24 (nummod)
potential observed (amod)
drug unchanged (amod)
regimen better (advmod)
jitteriness " (punct)
effects ee (nmod)
received reports (dobj)
score sum (compound)
challenge before (case)
finding associated (ccomp)
dxnp ) (punct)
1.2 ci=1.0 (dep)
adjusted a (det)
hemorrhage aneurysmal (amod)
bilayers curved (amod)
polymorphism polymerase (compound)
exhibit how (advmod)
mr and (cc)
study mr (compound)
necrosis spontaneous (amod)
aldosterone in (case)
lower l (nmod)
gem-p following (case)
period rotation (nmod)
prevalence the (det)
prepared radiopharmaceutical (nsubjpass)
specimens 278 (nummod)
stones gall (compound)
m(1)/m(3)/m(5)-selective ' (punct)
changes pathways (nmod)
ratio international (amod)
use careful (amod)
$ROOT$ desire (sent)
pituitaries des-treated (amod)
cisapride [ (punct)
lines cell (compound)
mek1 - (conj)
remained inducible (xcomp)
reoccur months (nmod)
likelihood possible (acl)
patients maintained (acl)
exhibit dyskinesias (dobj)
status stable (amod)
practical however (advmod)
markers disease (compound)
warrant which (nsubj)
minor . (punct)
centers participating (amod)
useful technique (nsubj)
sedation deep (amod)
issues without (case)
n/n=25/26 10 (conj)
expression decreased (amod)
levels both (cc:preconj)
antagonist serotonin-dopamine (compound)
report manifestation (nmod)
criteria to (case)
stretching a (det)
received desipramine (dobj)
injected morphine (nmod)
desmethylimipramine by (case)
cl 2.6 (appos)
transformation tissue (nmod)
ascertained can (neg)
10(-7 ) (punct)
reaction only (amod)
conditions during (case)
rapamycin immunosuppressant (amod)
sicca typical (amod)
decline eliminated (acl:relcl)
frequency f (appos)
mice 69 (nummod)
trabeculectomies were (cop)
stroke ischemic (amod)
treated meth (nmod)
determine physician (nsubj)
covered h (nmod)
reduplication membranes (nmod)
death by (case)
elevated h (nmod)
increased readministration (nsubj)
occurred fractures (nmod)
assessed daily (advmod)
differentiation clear (amod)
peptide cnp (appos)
alpha-t or (cc)
subsides gradually (advmod)
paid involvement (nmod)
first ibpb (nmod)
$ROOT$ stands (sent)
middle high (conj)
gaba(a ) (punct)
grade in (case)
activity pronociceptive (amod)
mg/l. > (advmod)
irreversible developed (conj)
disappearing , (punct)
applied although (mark)
mk801 receptor (compound)
events embolic (amod)
qtls identified (acl)
lesions 5-ht (compound)
reduced affect (conj)
$ROOT$ antidepressants (sent)
15.6 from (case)
leads in (case)
determine use (dobj)
m in (case)
protease neutral (amod)
modified ligands (nmod)
group any (det)
correlated proteinuria (nsubj)
delirium report (dep)
effects adr (nmod)
isolated-hit with (case)
parameters reflecting (acl)
1788 placebo (conj)
$ROOT$ evident (sent)
$ROOT$ exert (sent)
meninges inflamed (amod)
nanoparticles , (punct)
evidence light (amod)
improved respectively (advmod)
fraction radionuclide (compound)
excitability the (det)
infusions group (nmod)
indicated has (aux)
decline rats (nmod)
agents nonsteroidal (amod)
associated treatment (advcl)
agent venlafaxine (nsubj)
support effect (appos)
complicated and (cc)
delineate in (mark)
consequence cardiomyopathy (nmod)
h2 2 (nummod)
restored decreasing (advcl)
male 23-y-old (amod)
found showed (conj)
disturbance psychiatric (amod)
complications without (case)
rates suicide (compound)
given calcium (dobj)
predicted cardiotoxicity (dobj)
increase score (dobj)
mg/m(2 cyclophosphamide (nmod)
catalepsy haloperidol-induced (amod)
ht continuous (amod)
agents placebo (conj)
normalizes . (punct)
facilitated period (nmod)
seem b12 (nsubj)
$ROOT$ confusion (sent)
associations exposures (nmod)
glucose % (amod)
practiced remains (advcl)
patients surgery/radiotherapy (nmod)
responders nine (nummod)
reached excretion (nsubj)
rhythm cardiac (amod)
146 +/- (cc)
monitoring randomization (nmod)
relieved and (cc)
found they (nsubj)
difficult can (aux)
considered addition (nmod)
sealants containing (acl)
death n/n=25/26 (dep)
pretreatment l-name (nmod)
depletion dopamine (nmod)
neuroleptics to (case)
motionless were (cop)
nodosum of (case)
administration block (nmod)
rats sex-matched (amod)
task visual (amod)
pg-9 administered (acl)
disorders schizophrenia (nmod)
produce which (nmod)
hours 6 (nummod)
efficacy anti-arrhythmic (amod)
facilities all (det)
finding reduce (ccomp)
developed hyperalgesia (dobj)
preparations dog (compound)
mtd at (case)
activation death (conj)
ketamine anesthetic (appos)
received weeks (nmod)
higher 6 (nmod:npmod)
patients sixty-seven (compound)
ns-718 nanosphere (appos)
behavior tracings (conj)
mg/day 3 (nummod)
catatonia of (case)
noradrenaline 5-hydroxytryptamine (conj)
reasons of (case)
mg. 21.6 (nummod)
kg of (case)
concluded agent (ccomp)
lignocaine lidocaine (appos)
study prospective (amod)
potentiates toxicity (dobj)
$ROOT$ exacerbates (sent)
preponderance with (case)
stz-icv rats (nmod)
blocked enhancement (dobj)
infused weeks (nmod:tmod)
memantine 10mg/kg (appos)
disease lung (compound)
hexabrix because (case)
16.01 27.37 (conj)
dose bid (appos)
increases prenatally (advmod)
doxorubicin/kg ) (punct)
controls type (compound)
comparison value (nmod)
fzp ( (punct)
initiatives evidence-based (amod)
syndrome glomerulosclerosis (nmod)
l-noarg haloperidol (conj)
drowsiness such (case)
men were (cop)
presenting coma (nmod)
lds ) (punct)
ciprofloxacin cases (conj)
interaction rats (nmod)
capable . (punct)
efficacious patients (nmod)
decreased conversely (advmod)
1.52 ( (punct)
explanation best (amod)
blotting immunoprecipitation/western (compound)
block patients (nmod)
probable cases (nmod)
administration sites (nmod)
trial fibrillation (compound)
57.9 common (advcl)
prevented reduction (nsubj)
eliminating , (punct)
vnb gem (conj)
days delirium (nmod)
anesthesia observations (dep)
causing increase (dobj)
glomerulonephritis and (cc)
reducing and (cc)
prominent locomotion (nsubj)
enhanced 22-fold (advmod)
surveillance adjustment (conj)
neoplasms liver (compound)
detected analysis (nmod)
5.2+/-1.1 p<0.05 (appos)
ratios rate (compound)
intensity latency (conj)
rs6693503 ) (punct)
therapy patients (nmod)
patients oncological (amod)
h at (case)
noted sedations (nmod)
findings of (case)
higher if (mark)
testosterone and (cc)
subgroup from (case)
mice display (acl:relcl)
syndromes two (nummod)
nausea were (cop)
polyneuropathy acute (amod)
stimulation dobutamine (compound)
patients suffered (acl:relcl)
$ROOT$ fed (sent)
use lithium (compound)
duration : (punct)
rate respiratory (amod)
lethality nmda (compound)
cardiotoxicity thought (acl:relcl)
simvastatin between (case)
demonstrate develop (ccomp)
etomidate of (case)
resulting parkinsonism (nmod)
omercazole n (compound)
process a (det)
periods penicillin-induced (amod)
sphincter the (det)
hemorrhage iliopsoas (compound)
expression protein (compound)
hg was (cop)
generation in (case)
well-tolerated galantamine (nsubjpass)
cases 1994 (nmod)
physiologic and (cc)
first is (cop)
8.3 11.2 (compound)
interviewed participants (nsubjpass)
detected moreover (advmod)
function rats (nmod)
binding mk-801 (compound)
day 9 (nummod)
groups knife (compound)
volume cm (nmod)
exposed period (nmod)
relationship this (det)
a1 a2 (conj)
years 8 (nummod)
lc/ms/ms ) (punct)
sc ) (punct)
agents are (cop)
sequences in (case)
slowness carriers (nmod)
preservation flow (nmod)
sodium voltarol (appos)
conditioning passive (amod)
score scale (nmod)
activity anti-human (amod)
ameliorate signs (dobj)
vegfr-2 ) (punct)
bromocriptine intravenous (amod)
proarrhythmia in (case)
measures impedance-derived (amod)
ganglia l6-s1 (compound)
movement an (det)
microinjected area (nmod)
loss total (amod)
shown cirrhosis (nsubj)
those remaining (acl)
contributing in (mark)
stabilized . (punct)
had prevalence (dobj)
delayed decreased (conj)
designed compared (dep)
k(+)-channels of (case)
greater magnitude (nsubj)
exploited be (auxpass)
milliliters blood (nmod)
prophylaxis patients (conj)
indicate . (punct)
tumors progressed (advcl)
children recipient (appos)
sex = (dep)
tolerance gout (conj)
patient two (conj)
drinking of (case)
begun late (advmod)
performed while (mark)
= clozapine (dep)
found slower (advmod)
lines from (case)
patient neither (det)
experienced treatment (nmod)
$ROOT$ treatment (sent)
associated chlorhexidine-digluconate (nmod:npmod)
considered modulating (nmod)
increased while (mark)
calculate adjustment (nmod)
used procedures (nmod)
gram-positive gram-negative (conj)
enzymes parameters (conj)
admitted found (advcl)
cross-over threefold (advmod)
disturbances rhythm (compound)
society and (cc)
ability read (acl)
register group (nmod)
correction after (case)
authors review (compound)
combination antipsychotics (nmod)
stimuli from (case)
$ROOT$ asphyxia (sent)
findings abnormal (amod)
consider likelihood (dobj)
5 x (cc)
protected pretreatment (nmod)
subjects genotyped (acl:relcl)
malignancies for (case)
results examination (nmod)
encephalopathy normoammonemic (amod)
% 0.025 (compound)
immediate and (cc)
nephropathy caused (acl:relcl)
antagonists n-methyl-d-aspartate (conj)
difficult were (cop)
events incidence (dep)
lactam beta (compound)
function venous (amod)
precursors nad (nmod)
gyrus the (det)
revealed echocardiogram (nsubj)
prevalence carcinoma (nmod)
indicate vulnerable (ccomp)
mpa str (conj)
caused delay (dobj)
bp mssbp (appos)
cord and (cc)
compartments individuals (nmod)
explanation reasonable (amod)
prescribe molindone (dobj)
phase days (dep)
delays that (mark)
requested when (advmod)
increased force (nsubjpass)
rate induced (acl)
males age (appos)
attenuated depletions (dobj)
% -16 (nummod)
step process (nmod)
vocabulary and (cc)
$ROOT$ present (sent)
represents that (nsubj)
bottle with (case)
function cystitis (nmod)
on is (cop)
measurement for (case)
infusion propofol (nmod)
injury cardiomyocyte (compound)
days over (case)
influence which (nmod)
produced conclusion (nsubj)
following the (det)
function tubules (nmod)
conversion late (amod)
loss temporary (amod)
resolved tdp (nsubj)
doxorubicin mg/kg (appos)
individuals 19 (nummod)
week 16 (nummod)
cells adriamycin-treated (amod)
collected volunteer (nmod)
completed dse (dobj)
decreased excretion (nsubjpass)
cardiotoxicity cya (compound)
introduced . (punct)
administration parenteral (amod)
fever vomiting (appos)
mg/kg 5 (compound)
testosterone flutamide (conj)
paralysis for (case)
recommenced drug (nsubjpass)
mononucleosis infectious (amod)
as lymphadenopathy (nsubj)
pretreatment np (appos)
% catecholamine (nmod)
knockout beta-hydroxylase (compound)
surgery man (nmod)
finding conclusion (compound)
urinalysis both (dep)
include phase (dobj)
scan abdomen (nmod)
hemorrhage drugs (nmod)
clinical developmental (conj)
demonstrated levels (nmod)
asystole . (punct)
diagnosis routine (amod)
$ROOT$ myositis (sent)
found be (auxpass)
movement rats (nmod)
peptide calcitonin (compound)
range was (cop)
moderate-dose ; (punct)
failure hypotension (nmod)
reduces aspirin (nsubj)
trigger reflexes (nmod)
branch its (nmod:poss)
% 16 (nummod)
auccgrp ( (punct)
causes failure (nmod)
reprogramming development (conj)
unit danish (compound)
1/s at (case)
evoked clonidine (nmod)
observed t30 (nmod)
range tested (acl)
studies dealing (acl)
placed we (nsubj)
fibers activated (acl)
sensitisation therapy (nmod)
near-syncope with (case)
dysfunctions one (nummod)
integration hypertrophy (nmod)
pressure diameter (conj)
acetrizoate ( (punct)
condition of (case)
show bronchodilator (ccomp)
performed dosing (nmod)
supplied information (dobj)
measurements marker (compound)
reactions bendrofluazide (nmod)
quetiapine amisulpride (conj)
measured levels (nmod)
medication prophylactic (amod)
meningitis in (case)
infection adenovirus (compound)
experienced previously (advmod)
produce response (dobj)
examined influence (dobj)
perfusion decreased (amod)
2-methyl-6-(phenylethynyl)pyridine mpep (appos)
cases twenty-six (nummod)
administered beginning (nmod)
acquisition the (det)
side-effects mild (amod)
related hormone (nsubj)
associated response (nmod)
hypothesized plays (ccomp)
ability decreased (amod)
considered generally (advmod)
hypotension (pge1)-induced (amod)
% b (nmod)
$ROOT$ agent (sent)
mediated projection (nmod)
obtained way (nmod)
epinephrine 1:100,000 (nummod)
complicated is (auxpass)
administered d (nmod)
confounders potential (amod)
developed toxicity (dobj)
control wt (conj)
years 9 (nummod)
medications no (det)
aware must (aux)
mg been (cop)
compared total (nsubjpass)
% 85.4 (nummod)
effective d-glucarates (nsubj)
monotherapy or (cc)
suggest lesion (dobj)
group vehicle-treated (amod)
public by (case)
threat convulsions (nmod)
infusion of (case)
convulsion in (case)
rls individuals (nmod)
tachycardia toxicity (nmod)
observed quetiapine (nmod)
cause tenofovir (nsubj)
epidemic an (det)
fraction region (conj)
evaluate endogenous (dobj)
symptoms unexplained (amod)
obvious either (preconj)
size tumor (compound)
accompanied na+-extrusion (nmod)
play daidzein (nsubj)
was risk (nsubj)
monitor operations (nmod)
change change (conj)
effects induction (nmod)
intake calcium (compound)
include tolerance (dobj)
sera available (amod)
institution upon (case)
increased risk (nsubjpass)
patients sixty (nummod)
symptoms no (det)
anaesthesia epidural (amod)
neurons expressed (acl:relcl)
mg/dl 9.2 (nummod)
carotid of (case)
h td (nmod)
completing study (dobj)
disorder attention-deficit (compound)
points evidence (nsubj)
menorrhagia due (case)
had menopause (dobj)
safer appropriate (conj)
characteristic features (nsubj)
suggest prescribed (ccomp)
effect calcium (nmod)
received half (nsubj)
evaluated seriously (advmod)
suppresses treatment (nsubj)
chorea associated (acl)
performed dilation (nmod)
agonist bd1031 (dep)
dose any (det)
resolved h. (nmod)
stopped lithium (nsubjpass)
awake indicated (advcl)
receptors da1 (compound)
derive primarily (advmod)
bold ( (punct)
malondialdehyde of (case)
remoxipride amide (appos)
mg/day and (cc)
time and/or (cc)
allergies drug (compound)
higher statistically (advmod)
ligation- digitalis- (conj)
hexamethylmelamine days (nmod)
pressure max (appos)
found autopsy (nmod)
antipsychotics zuclopenthixol (appos)
10 of (advmod)
elevation patient (nmod)
pressure st-segment (conj)
combination therapy (nmod)
duration ketamine (nmod)
reduction ratio (nmod)
administered nicotine (dobj)
transferred he (nsubjpass)
had latencies (dobj)
phentolamine alone (advmod)
improves nik-247 (nsubj)
study survival (compound)
attempt induce (acl)
pointes from (case)
delirium famotidine-associated (amod)
pretreatment cont./min (appos)
changes motility (compound)
foci gamma-glutamyltransferase (compound)
ratio p-p38/p38 (compound)
explained can (neg)
way still (advmod)
form of (case)
brains animals (nmod)
interval pointes (conj)
33 91 (prep)
cardiomyocytes atrial (amod)
107 range (appos)
= 80.0 (dobj)
changes weight (nmod)
results 32.9 (appos)
patients 3,245 (nummod)
features cardiomyopathy (nmod)
1.039 +/- (cc)
reactions positive (amod)
regulate inhibition (nsubj)
l-sotalol , (punct)
rejection diagnoses (nsubj)
breakdown bbb (nmod)
month treatment (nmod)
spite efforts (nmod)
treated azathioprine (nmod)
patient kidney (nmod)
accuracy recognition (compound)
complicating enterocolitis (dobj)
ability carry (acl)
swelling dissolution (conj)
generation nin (compound)
resistance , (punct)
be delivery (nmod)
toxicity problem (nsubj)
mssbp msdbp (conj)
consequence as (case)
addition without (conj)
demonstrates occurs (ccomp)
antineoplastic : (punct)
drop right (amod)
trained approach (xcomp)
area over (case)
duration exposure (nmod)
% to (mark)
edema involving (acl)
regimen feeding (compound)
assessed fall (nmod)
sensations capsaicin-induced (amod)
six five (compound)
223 4 (conj)
suggested we (nsubj)
recipients organ (compound)
200 +/- (cc)
concerns effects (nmod)
caused that (dobj)
administration phenytoin (compound)
mmol/l 3.8 (nummod)
have lipofuscinosis (dobj)
considers review (nsubj)
levels , (punct)
induced thc (nmod)
epiphyses punctata (appos)
considered but (cc)
instructed watch (xcomp)
beating action (conj)
transported is (auxpass)
u/ml range (dep)
etoposide epipodophyllotoxin (compound)
difference a (det)
activity periods (conj)
design with (case)
metabolizer as (case)
match to (mark)
objective has (appos)
ahs ( (punct)
hypoxia focal (amod)
effects task (nmod)
trough ( (punct)
protocols of (case)
assessed investigator (nmod)
hypertensives borderline (amod)
supporting concept (dobj)
circumstances certain (amod)
reference with (case)
quantities limited (amod)
5.4 - (dep)
experienced thereafter (advmod)
constituted had (conj)
recurrence polyps (nmod)
n-nitroso-n-methylurea cas (dep)
diameters external (amod)
sepsis and (cc)
angiogenesis tumor (compound)
completion period (conj)
physicians board-certified (compound)
introduction yis (appos)
coma syndrome (nmod)
cases only (amod)
cataract keratopathy (conj)
risk substantial (amod)
y-maze step-down (conj)
eight ) (punct)
lowered however (advmod)
unknown incidence (nsubj)
titrate to (mark)
exceeded . (punct)
polymorphism reaction-restriction (compound)
cases ulcers (nmod)
pneumonia , (punct)
myalgia ( (punct)
ci 2.92 (dep)
safety indications (conj)
were measures (nmod)
catheterization heart (compound)
deprivation either (cc:preconj)
identify toxicity (dobj)
rash by (case)
add-on as (case)
implanting mini-pump (nmod)
history ecg (conj)
higher frequency (nsubj)
aminonucleoside mg/kg/i.v (appos)
self-limited , (punct)
led administer (xcomp)
represented this (nsubj)
ranging 11/6 (nmod)
active had (conj)
specimens twenty-six (nummod)
reported events (nsubjpass)
% 4.9 (nummod)
limbs toes (conj)
investigated using (xcomp)
withdrawal needed (dep)
role with (case)
rbcs the (det)
decreased decreased (conj)
crossed thereafter (advmod)
noted complication (nmod)
described regimens (nsubjpass)
taken died (ccomp)
sem from (case)
used applicators (nmod)
attacks rest (nmod)
hospitalized infarction (nmod)
induced drugs (nsubj)
treatment serial (amod)
combinations activity (nmod)
cardiomegaly with (case)
rats on (case)
factor-beta1 tgf-beta1 (appos)
causes that (mark)
neurological cognitive (conj)
patients mg/m2 (nmod)
strokes death (conj)
administration weeks (nmod)
sensitisation or (cc)
occur prescribed (ccomp)
mri cardiac (amod)
cystitis with (nmod)
scale outcome (compound)
reassured . (punct)
% respectively (advmod)
synthase of (case)
indicated testing (nsubj)
hydrochloride bpd (appos)
potentiation long-term (amod)
group third (amod)
ratio g (compound)
seemed users (nmod)
implicated amounts (nsubjpass)
children million (nummod)
engendered interest (dobj)
confusion review (appos)
engaged are (auxpass)
b clearance (conj)
addressed to (mark)
overlooked , (punct)
potential ap (appos)
hydrochloride aponidine (compound)
service municipal (nmod)
evaluable are (cop)
pressure ; (punct)
myositis . (punct)
increased statistically (advmod)
measurements khz (appos)
proved was (auxpass)
hypothermia such (case)
mitogens to (case)
targeted . (punct)
model statistical (amod)
rates of (case)
cause vasodilation (dobj)
. b.w (compound)
acts parp (nsubj)
reduced dpi (dobj)
paradigms of (case)
approval use (nmod)
activity their (nmod:poss)
abolished rigidity (nsubjpass)
shows effects (dobj)
consider sign (ccomp)
induced results (nsubj)
receiving pethidine (dobj)
downregulation beta-noradrenergic (amod)
caused comparing (advcl)
costs riha (nmod)
degrees during (case)
son the (det)
lesions high-signal (amod)
state headache (compound)
effects zidovudine-related (compound)
treatment diethylstilbestrol (nmod)
development cystitis (nmod)
had dl-threo-dihydroxyphenylserine (nsubj)
hydrochloride - (compound)
killed and (cc)
retard did (aux)
bacteria by (case)
recumbent and (cc)
db and (cc)
metabolism test (dep)
immunoreactive and (cc)
yield a (det)
neurotoxic may (aux)
delivered section (nmod)
five group (nsubj)
or ; (punct)
recovery motor (compound)
showed 2/3 (nsubj)
investigated . (punct)
amount with (case)
cases failure (nmod)
augment to (mark)
mechanism neuronal (amod)
seems toxicity (nsubj)
tolerant individuals (nsubj)
$ROOT$ headache (sent)
established although (mark)
completed compared (parataxis)
densa throughout (case)
resulted clentiazem (nsubj)
individuals 3154 (nummod)
detected all (nmod)
centre florence (appos)
% increases (nsubj)
diagnosis rapid (amod)
resulted efficacy (nmod)
present reduction (nmod)
desaturation and (cc)
reversible effect (nsubj)
possiblility propensity (nmod)
eosinophilia , (punct)
related cases (nsubj)
treated azt (nmod:npmod)
treatment case (nmod)
administration atropine (nmod)
injections 4 (nummod)
group s-i (compound)
experienced episode (dobj)
leucemia lymphoblastic (amod)
interaction potential (amod)
attempts localize (acl)
performed apart (advmod)
evaluated examinations (nmod)
% by (case)
ventricle in (case)
18 patients (nmod)
inhibitor parp (compound)
days 5 (nummod)
induced clamping (advcl)
2)% ( (punct)
nsaid ) (punct)
rhabdomyolysis to (case)
development deficits (nmod)
mediated stimulation (nmod)
endocarditis ie (appos)
testing prior (advmod)
potency metoprolol (nmod)
tumor patient (nmod:poss)
oil with (case)
proven conclusion (nmod)
us in (case)
effects dysrhythmias (nmod)
step a (det)
reported : (punct)
frequent k-variant (nsubj)
caffeine preparations (nmod)
correlated findings (nmod)
require she (nsubj)
amounted concentrations (nsubj)
thromboembolism complication (dep)
sample plasma (compound)
patients ra (nmod)
curve pressure (compound)
drugs : (punct)
group 42 (appos)
levels myocardial (amod)
presented both (nsubj)
nacl % (amod)
levodopa of (case)
side-effects pain (appos)
portray analysis (dobj)
male two (nummod)
variables age (nmod)
caused steroids (nsubj)
caused cbd (conj)
undertaken effort (nmod)
treated patients (nmod)
did it (nsubj)
modulates dyskinesias (dobj)
tachyarrhythmia report (dep)
signaling hippocampus (nmod)
481 ] (punct)
randomized dogs (nsubjpass)
time-to-onset symptoms (nmod)
% = (dep)
depression exercise-induced (amod)
downregulated expression (nsubjpass)
years 7 (nummod)
woman one (nummod)
required suggesting (advcl)
users antithrombotic (amod)
sub-tenon the (det)
vancomycin , (punct)
abecarnil diazepam (conj)
prevented 3 (dep)
had rats (nmod)
sucrose cyclic (amod)
seen patients (nsubjpass)
cells sinoatrial (amod)
% 31.4 (nummod)
role any (nummod)
cimetidine iv (compound)
therapy physical (amod)
rats or (cc)
flattening a (det)
patients calculated (acl:relcl)
drug associated (acl:relcl)
has gyki-41 (nsubj)
performed ( (punct)
p k (conj)
patient stage (nmod)
interviews personal (amod)
acetylcholinesterases of (case)
stimulation magnetic (amod)
decontamination gastrointestinal (amod)
addiction cocaine (compound)
rs4704559 rs4704560 (conj)
stroke hemorrhagic (amod)
increased ( (punct)
correction with (case)
children consecutive (amod)
polymorphism debrisoquine/sparteine (compound)
insomnia loss (conj)
np by (case)
precipitation result (nmod)
1984 during (case)
prevalent and (cc)
maneuver the (det)
factor-alpha tnfalpha (appos)
remodeling atrial (amod)
accounts part (nmod)
t1/2 ha (nmod)
paid states (nmod)
leukopenia grade (compound)
drug administered (acl)
caused medications (nsubj)
clearance children (nmod)
measured primarily (advmod)
described objective (dep)
method chromatographic (amod)
% cost (nsubj)
memory long (amod)
so significantly (advmod)
sufficient evaluate (xcomp)
degree involved (acl:relcl)
recording one (nummod)
concentration end-tidal (amod)
induces up-regulation (dobj)
regimen selection (compound)
hypertension substantial (amod)
apposed cells (nmod)
produced tremor (dobj)
betaine of (case)
7.1 from (case)
induced thereafter (advmod)
infusion c+e (dep)
synapse in (case)
granulocytopenia noncumulative (amod)
mg/g 4 (nummod)
receiving iodixanol (dobj)
perseveration hoarding (conj)
dystrophy with (case)
actin muscle (compound)
uses with (case)
recall free (amod)
showed administration (nmod)
prolonged survival (nsubj)
unknown role (nsubj)
verapamil mg/kg (dep)
injection epicondyle (nmod)
animals young (amod)
using kanamycin (dobj)
levels artery (nmod)
differentiate to (mark)
identified factor (nsubjpass)
helodermin peptide (appos)
abnormalities and (cc)
confirm it (dobj)
lvef , (punct)
demonstrated mechanism (parataxis)
inhibits irreversibly (advmod)
tumors refractory (amod)
species particular (amod)
increased ratio (nsubjpass)
lymphoma diffuse (amod)
randomised double-blind (dep)
associated clarithromycin (nsubjpass)
table ( (punct)
mass content (conj)
idolamines pineal (amod)
induced p<0.001 (parataxis)
dilatation ventricles (nmod)
compare efficacy (dobj)
cost drug (compound)
correction bonferroni (compound)
noted states (nmod)
5ht2a dopaminergic (conj)
result not (neg)
injections calcitonin (compound)
agents azathioprine (conj)
microarrays blotting (conj)
increase response (nmod)
showed response (dobj)
cascade in (case)
discuss . (punct)
complemented were (auxpass)
muscle fibrotic (amod)
dopamine-2 da2 (appos)
clinic out-patient (compound)
dogs conscious (amod)
episodes 3 (nummod)
compared males (nmod)
acrolein mg./kg (appos)
randomized val (dep)
density of (case)
treatment glucocorticoid (compound)
pb or (cc)
v/s to (case)
affinity higher (amod)
protected fall (advcl)
presence autoantibodies (nmod)
formation bone (compound)
layer muscle (compound)
involvement metabolic (amod)
ability reduce (acl)
suspension forms (acl:relcl)
provide integration (dobj)
tested investigation (nmod)
dfmo with (case)
unrecognized are (cop)
hemoglobin either (cc:preconj)
methylprednisolone and (cc)
patients c. (nmod)
implicated alterations (nmod)
positive strongly (advmod)
33 % (appos)
found brains (nmod)
infarctions fewer (amod)
conclusive . (punct)
transplantation kidney (compound)
study effect (nmod)
localization areas (nmod)
consolidation during (case)
developed minutes (nmod)
investigated series (nmod)
regimens effective (amod)
symptoms multiple (amod)
allocated trial (nmod)
treatment acromegaly (nmod)
blockade-induced mtor (nmod:npmod)
received rats (nsubj)
medicine herbal (amod)
blockers amiodarone (dep)
$ROOT$ urge (sent)
prevalence at (case)
$ROOT$ improved (sent)
non-users . (punct)
behavior preference (conj)
pharmacotherapy fluoxetine (compound)
admitted being (auxpass)
days discussion (nmod)
lead bradycardia (nmod)
tissue orbital (amod)
riyadh arabia (appos)
adjusted was (auxpass)
acetylcholine of (case)
$ROOT$ sub-divided (sent)
received littermates (nsubj)
arteriosclerosis rate (nmod)
explore adapt (conj)
were differences (nsubj)
warning as (case)
prevention or (cc)
damages methamphetamine (nsubj)
preceded intervals (nmod)
mirrored additionally (advmod)
ppa of (case)
3.5 1.5 (compound)
study double-blind (amod)
fatigue , (punct)
identified factors (nmod)
occurred effect (nsubj)
initiating when (advmod)
duration alf (nmod)
taken compared (advcl)
respiration adequate (amod)
fornix in (case)
period ) (punct)
drugs ziprasidone (nmod)
overexpression pgp (nmod)
nerve the (det)
supplementation b12 (compound)
involve activation (dobj)
predisposed him (dobj)
show microglia (nsubj)
hyperactivity to (case)
1.56 were (cop)
veins hepatic (amod)
1.5-fold ( (punct)
nephritis atin (appos)
curcumin the (det)
strain choice (nmod)
back normal (nmod)
ad ) (punct)
therapy cabergoline (nmod)
attributed infection (nmod)
decrease stimuli (nmod)
impairment tjs (nmod)
dosing d-tubocurarine (compound)
mu opioid-agonists (conj)
excluded not (aux)
risks : (punct)
trial was (cop)
n , (punct)
dbp ) (punct)
compare administered (advcl)
increase dipyridamole (nmod)
society oncology (nmod)
receptor 5-ht6 (compound)
drops timolol (compound)
induced dyskinesia (dobj)
wheezing with (case)
microinjection of (case)
composition of (case)
coexisted alterations (nsubj)
rationale this (det)
mater and (cc)
mv 4.7 (nummod)
dx than (case)
information mechanistic (amod)
group groups (dep)
mice cb1 (compound)
insipidus of (case)
rr 1.1 (appos)
falls administration (nmod)
mg/kg 0.25 (nummod)
mg/kg 360 (nummod)
neurons on (case)
transformation lymphocyte (compound)
linked exposure (nsubjpass)
death to (case)
combination cisplatin (nmod)
primigravida , (punct)
distinguished connections (nmod)
appear likewise (advmod)
significance undetermined (amod)
reentry particularly (advmod)
38 % (quantmod)
tafi and (cc)
prominent which (nsubj)
analysis roc (compound)
toxicity monkeys (nmod)
data on (case)
reversal anticholinesterases (nmod)
provide may (aux)
elevated initially (advmod)
administration mk-801 (compound)
rough foamy (conj)
axis the (det)
meningitis mssa (compound)
reduced kept (advcl)
responded these (nsubj)
found changes (dobj)
eruption . (punct)
ranged years (nmod)
elevated evaluate (advcl)
flow metabolism (conj)
anomalies developmental (amod)
erection is (cop)
ug/ml were (cop)
muscarinic adrenergic (conj)
analyze mechanisms (dobj)
ao ( (punct)
administration folic (amod)
hg difference (nsubj)
useful be (cop)
area and (cc)
level vecuronium (compound)
tongue neck (conj)
injury of (case)
day fifth (amod)
potentiated effects (dobj)
emergence effects (nmod)
cells ganglia (nmod)
had histories (dobj)
rescue no (neg)
persisted cholestasis (nsubj)
recalled subjects (nsubj)
98 +/- (cc)
injected then (advmod)
ranged rates (nsubj)
preservatives neurotoxic (amod)
sufficient is (cop)
increased g (nmod)
treatment an (det)
resumed when (advmod)
decrease maximal (amod)
reduced we (nsubj)
required will (aux)
rats ( (punct)
addition adjust (acl)
$ROOT$ regulate (sent)
phases off-drug (amod)
pill a (det)
defect this (det)
levels increased (acl:relcl)
drug incriminated (amod)
complained paraesthesia (nmod)
individual 's (case)
prevented month (nsubj)
impairments specific (amod)
augments processes (dobj)
discontinuing ptu (dobj)
evaluation studies (conj)
animals pcc-treated (amod)
participants 13 (nummod)
observed days (nmod)
stimulation triple (amod)
production superoxide (compound)
determine achieved (ccomp)
hours initiation (nmod)
hemispheres cerebral (amod)
mg i.v. (dep)
correct mg (nsubj)
had country (nsubj)
micrograms/kg/hr 24 (nummod)
suggests result (ccomp)
lasting weeks (nmod:tmod)
association heart (compound)
fever polyneuropathy (conj)
signs opistothonus (nmod)
procedures emergency-department (compound)
acted that (mark)
population study (conj)
practiced , (punct)
plasma sd (dep)
elevated dp/dt (nsubj)
schizophrenia with (case)
effects nephrotoxic (amod)
grow to (mark)
drug cardioversion (nmod)
dose botox (compound)
streptozotocin-induced stz-icv (dep)
therapy propylthiouracil (compound)
citalopram inhibitor (appos)
interactions the (det)
question reported (advcl)
affecting primarily (advmod)
complexes caused (acl)
syndrome sirolimus-induced (amod)
bell-shaped , (punct)
effect net (amod)
day day (conj)
1993 1997 (prep)
agent it (nsubj)
qtls ) (punct)
targeting seizures (dobj)
checklist on (case)
susceptible to (mark)
examinations frequent (amod)
attacks disorder (conj)
ci=5.194 ) (punct)
amifostine mg/m2 (appos)
cost return (nmod)
due doxorubicin (nmod)
lead will (aux)
heptylate bromocriptine (conj)
treatment antiviral (amod)
process inflammation (compound)
carbachol eserine (conj)
compared responses (nsubjpass)
stroke use (nmod)
ascribed because (mark)
rats age (nmod)
9.88 ) (punct)
duration but (cc)
iopentol and (cc)
investigated extension (nmod)
cavity gland (conj)
frequency seizures/mo (appos)
predisposed disease (nsubj)
dna production (conj)
syndrome users (nmod)
discrimination assays (nmod)
30.7 - (punct)
considered agent (nmod)
contraction ) (punct)
delirium hyperkinetic (amod)
dates august (nmod)
abnormality no (neg)
group control (amod)
leads precordial (amod)
dehydrogenase serum (compound)
changes ) (punct)
swelling warmth (conj)
1.3 varied (parataxis)
binding cells (nmod)
reported that (nsubj)
complications dyskinesias (appos)
10 6 (quantmod)
incidence induction (nmod)
sensitized cardiotoxicity (nmod)
effect has (aux)
dialysis biopsy (conj)
injection as (case)
neuralgia postzosteric (amod)
express ( (punct)
cases except (case)
filling abnormal (amod)
followed seen (parataxis)
denopamine of (case)
omeprazole the (det)
aspirin update (appos)
investigates neuroprotective (advcl)
evidence for (case)
progressed stages (nmod)
using ever (advmod)
rammer devlin (appos)
test two-sided (amod)
pb ( (punct)
effects both (dep)
9.99 to (dep)
hypertension dexamethasone (compound)
polyneuropathy chemotherapy (nmod)
common correlated (conj)
initiated usually (advmod)
mellitus toxicity (conj)
hbv positive (dep)
374 and (cc)
confirm necrosis (dobj)
cells type (compound)
to baseline (nmod)
early as (prep)
warrant results (nsubj)
suggest stage (ccomp)
2.14 , (punct)
effective has (conj)
effect clonidine (nmod)
decline the (det)
examined also (advmod)
task an (det)
days 687 (nummod)
meq/l more (nummod)
zero was (cop)
mg. 2 (nummod)
monitor ambulatory (amod)
challenge amphetamine (dep)
injections epidural (amod)
1.53 - (punct)
shr 30 (nummod)
800 and (cc)
% + (nummod)
sufficient protect (xcomp)
outpatients schizophrenic (amod)
receptors da (compound)
receptors display (acl:relcl)
antagonism interleukin (nmod)
plexus of (case)
hemorrhage after (case)
administration vancomycin (nmod)
effect vivo (advmod)
entry platform (nmod)
changes medication-associated (amod)
patients reactions (nmod)
response stabilization (conj)
case discussion (compound)
increased sbp (dobj)
upset one (appos)
course clinical (amod)
recognizing of (mark)
parameters hemodynamics (nmod)
immunity mediated (amod)
decreased mrna (nsubj)
epilepsy with (case)
implicated been (auxpass)
perforans , (punct)
demonstrated measurements (nmod)
process with (case)
treatments by (case)
scale surgery (nmod)
administration abortions (nmod)
= um (dobj)
hours 0 (nummod)
episodes and (cc)
dose than (case)
noradrenaline and (cc)
anesthetics by (case)
interviewed persons (dobj)
common were (cop)
desire ephedrine (nmod)
localized was (aux)
had fall (dobj)
effect risk (nmod)
available ) (punct)
reminders call (acl)
way , (punct)
snaps ( (punct)
transition argatroban-to-warfarin (compound)
edema loss (conj)
lowering significant (amod)
peliosis and (cc)
need without (case)
txb2 ( (punct)
undergoing intervention (dobj)
properties non-selective (amod)
ameliorated hp (nmod)
administered min (dobj)
perfused were (auxpass)
fentanyl analgesic (appos)
finding electrocardiographic (amod)
macrolides newer (amod)
effect celling (amod)
temocapril 14 (appos)
age of (case)
unaffected was (aux)
recipients to (case)
compartments all (det)
interstitium the (det)
aggressiveness toward (case)
simvastatin of (case)
initiated vancomycin (nmod)
administration glycopyrrolate (nmod)
hippocampus into (case)
mg/m2 mg/m2 (conj)
thiols free (amod)
% males (appos)
neurons brain (compound)
improved sensitivity (dobj)
responses dogs (nmod)
long lasting (dep)
showed months (nmod)
verapamil , (punct)
tube endotracheal (compound)
changes modest (amod)
patients vs (cc)
interaction the (det)
service a (det)
administered or (advmod)
strain outbred (amod)
controlled that (nsubjpass)
hypotension peptide-produced (amod)
worker affected (amod)
degree ( (punct)
totp ( (punct)
levels be (cop)
concentrations pretreatment (nmod)
transfer the (det)
fever the (det)
augment , (punct)
got the (det)
k(+ ( (punct)
baseline predrug (compound)
0.625 2.5 (conj)
oralis the (det)
status ceased (acl:relcl)
withdrawal early (amod)
% 12.5 (nummod)
used immunohistochemistry (nsubjpass)
report media (compound)
one all (advmod)
patients 1 (conj)
psychosis resistant (amod)
$ROOT$ cross-tolerant (sent)
device by (case)
tilts subsequent (amod)
dipping , (punct)
starting day (nmod:tmod)
tested samples (nsubjpass)
recipients namely (advmod)
needed explore (xcomp)
safe complication (nmod)
8 more (amod)
impairment (stz)-induced (punct)
haematological systemic (conj)
objective report (acl)
$ROOT$ sequelae (sent)
had regression (dep)
predispose development (nmod)
ingestion and (cc)
200 100 (compound)
known doses (nsubjpass)
frequency loss (nmod)
point enhancement (nmod)
expression bladder (nmod)
treatments 2 (nummod)
administered control (xcomp)
measurements cardiac (amod)
resistant most (advmod)
patients consecutive (amod)
mda and (cc)
plasma , (punct)
used months (nmod)
exposure (2-chloroethyl)-1-nitrosoure (nmod)
hypothesis our (nmod:poss)
insufficiency % (appos)
anxiety of (case)
angio-oedema related (amod)
considered stress (nsubjpass)
prevention and (cc)
susceptible exerts (dep)
$ROOT$ circled (sent)
species ros (appos)
onset dyskinesias (nmod)
sem mm (compound)
creams of (case)
doxorubicin , (punct)
relationship on (case)
patients 128 (nummod)
prevalence effects (nmod)
showed waves (dobj)
week one (nummod)
anomaly ebstein (nmod:poss)
bpt clz (appos)
ica the (det)
cancer but (cc)
treated cycloheximide (nmod)
ameliorated hypertension (dobj)
genes involved (acl)
monitoring postoperative (amod)
muscle venomotor (appos)
viruses by (case)
consideration assessing (acl)
concentrations meq. (appos)
comprised patients (dobj)
sah ( (punct)
disease corneal (compound)
worsening without (case)
neurotoxicity or (cc)
patients hemolysis (nmod)
pacemakers these (det)
remained clones (nmod)
ethinyloestradiol with (case)
amnesia signs (conj)
had decrease (dobj)
difference this (det)
h study (nmod)
course per (case)
drug not (neg)
permits . (punct)
grade total (amod)
chemotherapy in (case)
gain or (cc)
parameters antioxidative (amod)
enhanced males (nmod)
buffers it (nsubj)
mechanisms impairment (nmod)
symptoms " (punct)
assessed reproducibility (nsubjpass)
project the (det)
mrna encoding (acl)
capable radiation (nsubj)
waves flicker (amod)
h. within (case)
specimens patients (nmod)
training day (nmod)
rat the (det)
hepatitis a (det)
interest case (nsubj)
indicate might (aux)
characteristics animals (nmod)
drainage due (case)
cyclosporine aza (conj)
phase of (case)
phosphorylation stat3 (nmod)
shortage the (det)
160 40 (compound)
obstruction to (case)
controls response (dobj)
mg/m(2 p (dep)
uiu/ml 5 (nummod)
mg/g 1 (nummod)
observations develop (ccomp)
showed biopsies (nmod)
3ma plus (cc)
rapa ( (punct)
injury patients (nmod)
groups ; (punct)
% 20.1 (nummod)
placebo morning (nmod:tmod)
intact , (punct)
terminology the (det)
7alpha-hydroxylase cholesterol (compound)
involved nmbas (dobj)
timps ) (punct)
dentate in (case)
effect striking (amod)
convulsions and (cc)
p ratio (appos)
status system (nmod)
receptors intracytoplasmic (amod)
mea from (case)
mechanism(s on (case)
output and (cc)
3s-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane ( (punct)
decrease creatinine (nmod)
pills . (punct)
malaise anorexia (conj)
inhibitor smad3 (nmod)
allele elderly (nmod)
provided vials (nmod)
supply all (predet)
carsinom renal (amod)
dysfunction primitive (amod)
rheumatology cardiology (conj)
perception vibratory (amod)
$ROOT$ negative (sent)
reversal and (cc)
tumor in (case)
mrna aqp2 (compound)
end course (nmod)
interactions clear (amod)
stimulation significant (amod)
detectable exposure (nmod)
hypotension p (dep)
mg/kg ip/week (amod)
injections amns (nmod)
protein hp (appos)
discussed mechanisms (nsubjpass)
using schedules (dobj)
lna , (punct)
mrna factor (appos)
interaction responses (nmod)
accumulation a (det)
supplementation dietary (amod)
levels m-2 (nmod)
resolved endophthalmitis (nsubj)
group intervention (compound)
decreased lower (advcl)
found cohorts (nmod)
9 to (quantmod)
seizure clonic (amod)
pose use (nsubj)
anesthetic duration (nmod)
interna lamina (compound)
% 41.4 (nummod)
secondary 5-fluorouracil (nmod)
-19.20 % (conj)
cleared who (nsubj)
diffusion-weighted and (cc)
analyzed include (advcl)
suspension powder (nmod)
have nra0160 (nsubj)
stability clot (compound)
exacerbates hgh (nsubj)
incidence dysrhythmias (nmod)
uiu/ml ng/dl (conj)
number effects (nmod)
utilization the (det)
sign motor (compound)
infusion continuous (amod)
toxicity dph (compound)
treatment pj34 (nmod)
replacement frozen (amod)
model hypertrophy (nmod)
clearance dextran (nmod)
protein fusion (compound)
inducing by (mark)
pulses short (amod)
had neuropathy (nmod)
seen cancer (nmod)
infections with (case)
hours a (det)
day 17th (amod)
indicated revealed (advcl)
hyperhidrosis interfered (acl:relcl)
1 into (case)
combined carboplatin (nmod)
dyscrasias to (case)
bar the (det)
levels nitrogen (compound)
oropharynx sites (nsubj)
ht for (case)
examinable ; (punct)
details puncture (nmod)
suppression bone (compound)
limits , (punct)
exposure fetal (amod)
tachycardia associated (acl)
found it (nsubjpass)
$ROOT$ inappropriate (sent)
given chlorthalidone (nsubjpass)
tetrapeptide c-terminal (amod)
tacrolimus pimecrolimus (conj)
had recovery (dobj)
produce hypotension (nmod)
represent toxicity (dobj)
collagen mice (nmod)
93 80 (conj)
counteract , (punct)
raised and (cc)
membrane the (det)
system deficient (amod)
concentrations at (case)
caused second (conj)
had asynergy (nmod)
resulted death (nmod)
purpura accompanied (acl)
tried study (nsubj)
present consistently (advmod)
doses pg (nmod)
dmtu ) (punct)
purpose for (case)
hyperprolactinemia the (det)
tumors gynecologic (amod)
tapered then (advmod)
ascites with (case)
tdi after (case)
> pr (dep)
complications mortality (conj)
derivative thienodiazepine (compound)
increased years (nmod)
controls rats (conj)
used periods (nmod)
decrease rate (dobj)
structures known (acl)
test response (compound)
gvhd acute (amod)
spectrometry ms (appos)
trazodone blocking (advcl)
treatment olanzapine (compound)
occurs increase (nsubj)
band larger (amod)
ketamine . (punct)
infection virus (compound)
infusion min (amod)
host disorders (nmod)
injected space (nmod)
superior therapy (nmod)
achieve patient (nsubj)
mca rats (nmod)
drainage substantial (amod)
children older (amod)
classed were (auxpass)
conclude . (punct)
virus underlying (amod)
related whom (nmod)
therapy raloxifene (compound)
objective primary (amod)
ci 0.295 (dep)
convulsions mice (nmod)
withdrawn presentation (nmod)
duration p (appos)
infectivity donors (nmod)
syntheses of (case)
mg/m2 150 (nummod)
preceded followed (conj)
increase haloperidol (nmod)
effects outcomes (nmod)
distribution random (amod)
mg versus (cc)
late course (nmod)
mechanism mediated (acl)
modalities them (nsubj)
infants born (acl:relcl)
calculi patients (nmod)
mice liver-/- (amod)
suggested evidence (conj)
drugs generally (advmod)
render tolerable (ccomp)
significance of (case)
outcomes despite (case)
twins of (case)
disorders from (case)
cyclosporin with (case)
decreased map (nsubj)
r=0.81 and (cc)
att alone (advmod)
improvement correlated (acl:relcl)
effect injury (nmod)
pregnancy before (nmod)
cardiomyopathy 1 (appos)
recognized caused (conj)
neonates of (case)
91.5 recalled (conj)
cck-8-se with (case)
studies mechanistic (amod)
fluctuations such (case)
oblongata rats (nmod)
amounts calcium (nmod)
smoking use (conj)
model reliable (amod)
follow . (punct)
ointment of (case)
signs features (conj)
epilepsy childhood (nmod)
triggered , (punct)
61.6 +/- (cc)
hg placebo (nmod)
targeted levels (nmod)
rats shr (appos)
% 160 (nummod)
inhibitor strong (amod)
chc for (case)
determined alleles (nsubjpass)
product new (amod)
injections systemic (amod)
percent a (det)
lost patients (dep)
dysfunction cerebellar (amod)
familiarity including (prep)
fibres even (advmod)
created : (punct)
association alcohol (nmod)
ring of (case)
injected mul (nsubjpass)
examined complications (nsubjpass)
scopolamine the (det)
seizures in (case)
linked reports (nsubj)
$ROOT$ pneumonia (sent)
amn082 mg/kg (appos)
patients hyperthyroidism (nmod)
dose ltg (compound)
opposite the (det)
groups non-deprived (amod)
overload iron (compound)
released ireland (nmod)
established groups (nsubjpass)
effects hypertension (nmod)
pain jaundice (conj)
stronger duration (nmod)
uk in (case)
therapy without (case)
age patients (nmod)
cord roots (conj)
developed soon (advmod)
hazards proportional (amod)
dissatisfaction female (conj)
reported women (nmod)
aggravated . (punct)
exposure phosphatidylserine (nmod)
test dipyridamole (compound)
sinus straight (amod)
oxygenation s(c)o(2 (appos)
anti-oxidant its (nmod:poss)
dose ccl4 (nmod)
amelioration a (det)
identified factors (ccomp)
increases density (nmod)
measurement products (nmod)
reported knowledge (nmod)
bolus doses (nmod)
re-established respiration (nsubjpass)
trait ae (appos)
reduced dronedarone (nsubj)
blockage reabsorption (nmod)
reduction velocity (conj)
sufficient treatment (nsubj)
potency with (case)
nr1(neo-/- nmda (compound)
tension in (case)
no apoptosis (conj)
years several (amod)
exposure dose (nmod)
= 0.1 (dobj)
ha the (det)
exclude , (punct)
one groups (nmod)
1 patients (nmod)
oxypurines of (case)
mg/day weeks (nmod)
dyskinesias condition (nmod)
ebstein 's (case)
protective was (cop)
increases extent (nmod)
evaluate using (advcl)
conjugates hpma (compound)
a/j balb/cj (appos)
tapped faster (advmod)
overflow enhanced (amod)
use without (case)
response rapid (amod)
sucrose % (amod)
variety behaviors (nmod)
rationale scientific (amod)
fatal recognized (advcl)
arteriosus patent (amod)
scotoma unusual (amod)
supply tissue (nmod)
carbenicillin intermittent (amod)
hyperthyroidism with (case)
$ROOT$ sex (sent)
psoriasis with (case)
mg/m2 135 (nummod)
categorized . (punct)
required admission (dobj)
available prescribed (conj)
obtained model (nmod)
switching cyclosporine (nmod)
chorionic layer (conj)
data our (nmod:poss)
developed hit (advcl)
oxytocics 4/5 (appos)
significance value (conj)
shelves states (nmod)
appeared mouth (nmod)
days 8 (nummod)
ameliorate to (mark)
reduced increased (conj)
loss similar (amod)
related antithrombosis (nsubj)
rate baseline (amod)
caused dyskinesias (nsubjpass)
admissions patient (compound)
augmented furthermore (advmod)
sweating excessive (amod)
exhibited participants (nsubj)
found angiography (nsubj)
sensitive nor (cc)
dissociated be (auxpass)
lesions nigra (compound)
panca ) (punct)
depressants , (punct)
perfusion bladder (nmod)
metabolites adriamycinol (nsubj)
hypotensive node (conj)
evaluated records (dobj)
included myelosuppression (dobj)
deterioration resulting (acl)
aureus mssa (appos)
slowed was (auxpass)
cardiotoxicity , (punct)
thrombosis artery (compound)
deterioration neurologic (amod)
duration response (compound)
correlated levels (nsubj)
changes eeg (compound)
analyzed using (xcomp)
embryolethality and (cc)
rbf in (case)
terminals on (case)
supporting role (dobj)
history priapism (nmod)
accelerated . (punct)
concluded reduces (ccomp)
lactoferrin bovine (amod)
berries hawthorn (nmod)
injected experiment (nmod)
prevent clotting (dobj)
idr and (cc)
comparisons changes (nmod)
phenobarbitone on (case)
midazolam ) (punct)
catalyze complexes (nsubj)
echo a (det)
locomotion apomorphine-induced (amod)
incidence bleeding (nmod)
corticosteroids dipyridamole (conj)
offer protection (dobj)
difficult was (cop)
increased db (nmod)
eye 16;567 (dep)
aap ami (conj)
beraprost cilostazol (conj)
carteolol antagonist (appos)
cardiac marrow (conj)
doses antagonists (nmod)
mean sdm (conj)
daidzein as (case)
angiography magnetic (amod)
occurred subsequent (amod)
walls along (case)
burden esrd (nmod)
differences distinct (amod)
found mortality (dobj)
disappeared cases (nmod)
observed ascites (nsubjpass)
group study (compound)
cocaine by (case)
losartan of (case)
studied were (auxpass)
erythromycins penicillins (conj)
population safety (compound)
reports hepatotoxicity (nmod)
mi ( (punct)
data discrepant (amod)
bradycardia accompanied (acl:relcl)
correlated taking (advcl)
antigens bfgf (compound)
institution . (punct)
90 290 (conj)
aortic coronary (conj)
withdrawn tests (nmod)
emulsion alone (advmod)
intake after (case)
g/cm(2 ( (punct)
recorded swallowing (nmod)
20 5 (conj)
age area (conj)
aetiology the (det)
implicated effects (nmod)
associated hypotension (nsubjpass)
rats fed (acl:relcl)
12.8 2 (conj)
increased altered (conj)
$ROOT$ fluphenazine (sent)
% ; (punct)
drugs although (mark)
dysfunction cardiovascular (amod)
children 122 (nummod)
alpha-tocopherol scavenger (appos)
pressure as (case)
cystitis rats (nmod)
intensity field (compound)
produces pallidotomy (nsubj)
administered infusion (dobj)
analgesics by (case)
find compared (advcl)
hpma ( (punct)
seizures acute (amod)
venlafaxine of (case)
modulation estrogen (nmod)
demonstrate patients (nsubj)
latter the (det)
examine function (dobj)
% 46 (nummod)
results above (amod)
animals short-term (amod)
19 and (cc)
having disorder (dobj)
treatment wounds (nmod)
lower responses (nsubj)
gly-gly ) (punct)
infusion clonidine (nmod)
decline lvef (compound)
cbd 41.66 (dep)
days ) (punct)
stimulant methamphetamine (nsubj)
indicated sometimes (advmod)
test either (det)
nmol ( (punct)
took she (nsubj)
receptors with (case)
ly-171555 challenge (conj)
eosinophilia three (nummod)
mg/kg ip (appos)
carcinogens , (punct)
written much (nsubjpass)
accounted this (nsubjpass)
dunnett ( (punct)
step % (nsubj)
ml bupivacaine (nmod)
illness acute (amod)
units treatment (nmod)
classified analyze (advcl)
content gm (compound)
oestrogens routes (nmod)
malays % (compound)
improvement immediate (amod)
nifedipine for (case)
n=8 ) (punct)
syndrome compartment (compound)
return a (det)
hours 48 (nummod)
g/min ml/100 (nummod)
no and (cc)
cox ( (punct)
observed ed-1 (nsubjpass)
days successive (amod)
modification further (amod)
wsr with (case)
average year (nmod)
pharmacokinetics efficacy (conj)
reaction macrolides (nmod)
cells/mm3 with (case)
t.i.d. and (cc)
days 21 (nummod)
hypothesized findings (nmod)
protect hydroxytyrosol (nsubj)
myopathy induced (acl)
restarted be (auxpass)
phenomenon by (case)
groups three (nummod)
suffered taking (advcl)
benefit information (nsubj)
5-fu mg/day (appos)
effect adrenaline-induced (amod)
1.0mg/kg 0.25 (nummod)
died whereas (mark)
exemplified as (mark)
fractures , (punct)
caused intoxication (nmod)
disappeared controls (nmod)
paralysis of (case)
substrate a (det)
depletions of (case)
fail . (punct)
antagonism of (case)
related nor (cc)
10 patients (nmod)
$ROOT$ efficient (sent)
infant one (nummod)
structure fine (amod)
be begun (advcl)
deficit retention (nmod)
mechanism peripheral (amod)
$ROOT$ programs (sent)
avoided labeling (nmod)
doses d-pen (nmod)
secreted manner (nmod)
walls veins (nmod)
mg/kg acc-9653 (nmod)
patients 3 (dep)
makes stability (nsubj)
plasma lysozymuria (conj)
patients epilepsies (nmod)
recognition , (punct)
evaluation at (case)
examine relationship (dobj)
neurochemistry the (det)
agranulocytosis clozapine (dep)
vulnerability pathways (nmod)
polymorphism serotonin (compound)
majority cases (nmod)
28 p9201 (nmod)
= 3 (dobj)
lower controls (nmod)
mg/m2 3000 (nummod)
received tocolysis (dobj)
chemotherapy retinoblastoma (nmod)
withdrawn treated (conj)
cholesterol % (dep)
sensitive cardiotoxicity (nmod)
experienced ingestion (nmod)
htr6 and (cc)
produced deterioration (dobj)
treatment lifetime (amod)
model able (amod)
electroencephalographic and (cc)
dose-dependent , (punct)
intake persons (nmod)
reported bouts (nsubjpass)
failed tolerate (conj)
medium the (det)
days days (appos)
occurred disturbing (conj)
distribution lesions (nmod)
examination acuity (nmod)
age before (case)
microg.kg(-1 ) (punct)
incidence hepatocytes (nmod)
trimetaphan tmp (appos)
fungizone of (case)
done group (nmod)
history accident (nmod)
7.3 +/- (cc)
regimens six (nummod)
insufficiency coronary (amod)
output basal (amod)
has drawback (dobj)
paraesthesia of (case)
pharmacology capecitabine (nmod)
hepatotoxicity quinidine (compound)
effect strong (amod)
0.2 0.07 (nummod)
parenchyma liver (compound)
aware performing (advcl)
constructed , (punct)
increased number (nsubj)
caused omeprazole (nsubj)
induce combination (nsubj)
rose hypotension (nmod)
conclude ; (punct)
evidenced changes (nmod)
microg i.c.v. (amod)
rate neonates (nmod)
aware we (nsubj)
stripe in (case)
drugs pilsicainide (nmod)
pressure intravesical (amod)
thyrotoxicosis for (case)
rare were (cop)
interference associative (amod)
techniques dye-tracing (amod)
production cell (compound)
caused d-penicillamine (nsubj)
tests plate (compound)
rose trough-concentrations (nsubj)
adjunct a (det)
pathophysiology their (nmod:poss)
circuit dialysis (compound)
quincke 's (case)
cisapride ; (punct)
ligands activity (nmod)
lowering by (mark)
comparison activity (nmod)
$ROOT$ methods (sent)
used interviews (nsubjpass)
striatum 25.6 (dep)
documented seven (nmod)
tumors one (nummod)
ingesting paracetamol (dobj)
cholestasis 17alpha-ethinylestradiol (compound)
benefit . (punct)
images initial (amod)
task forgetting (amod)
suppressed respectively (advmod)
esrd % (appos)
was prolongation (nsubj)
follow ; (punct)
adenocarcinoma with (case)
assessment signs (conj)
suppress seizures (dobj)
dph of (case)
showed e (nsubj)
$ROOT$ minimize (sent)
involvement rigidity (nmod)
estradiol- testosterone (conj)
prod of (case)
used days (nmod:tmod)
adr a (det)
identified subjects (nsubjpass)
demographic , (punct)
diltiazem amiodarone (conj)
confirmed . (punct)
38 30 (quantmod)
common proteinuria (nsubj)
syncope girl (nmod)
indices calcium (nmod)
method measure (acl:relcl)
care consultations (nmod)
unit to (case)
effectiveness drug (nmod)
cardona neurosci (dep)
syndrome behavioural (amod)
subjects male (amod)
benefit be (cop)
analogue cytosine (compound)
applied testing (nmod)
months 68.3 (nummod)
generates discharges (dobj)
important prescribed (advcl)
host ( (punct)
adding propofol (nmod)
involved catalepsy (nmod)
ventilation mechanical (amod)
circulation in (case)
allow would (aux)
application no (neg)
fk illinois (appos)
man receiving (acl:relcl)
increase glucose (nmod)
samples case-control (amod)
structures of (case)
consumption beverages (nmod)
t.i.d. subjects (dep)
continued onset (nmod)
structures limbic (amod)
decreased elevation (nsubj)
male % (nmod:npmod)
dosage ; (punct)
induction rigidity (nmod)
followed where (advmod)
dox ) (punct)
considered likely (xcomp)
puncture extension (conj)
osmolality plasma (compound)
activity enhanced (amod)
fractions greater (nmod)
describe recipient (dobj)
pretreatment thiopentone (compound)
episodes reported (amod)
ci 2.3 (appos)
study endografine (appos)
direct sequential (conj)
compromise , (punct)
consisted six (nmod)
evaluating for (mark)
2.7 vs. (cc)
dentate colliculus (conj)
normalized tmax (dep)
value but (cc)
augmented ltp (dobj)
pathology cord (compound)
dose calibrating (amod)
progression after (case)
recurrent glomerulopathy (conj)
way be (cop)
infused doses (nsubjpass)
selected were (auxpass)
injury brain (compound)
sphericity lv (compound)
actions mixed (amod)
reversible include (ccomp)
transition proper (amod)
placebo dose (dep)
dose resulted (acl:relcl)
gene expression (conj)
monitoring careful (amod)
rule out (compound:prt)
l-med or (cc)
seen having (advcl)
treated intraperitoneally (advmod)
occur as (mark)
behavior motor (amod)
before during (conj)
needle an (det)
tumors most (nsubj)
effect rigidity (nsubj)
vasopressor of (case)
signs toxic (amod)
related cardiotoxicity (nmod)
uneventful surgery (nsubj)
nx hp+nx (conj)
carried determine (xcomp)
passing by (mark)
sec/cm5 dyne (compound)
seizures frequent (amod)
enhanced manner (dobj)
quiescent has (aux)
cholesterol cholesterol/hdl (compound)
indicate findings (nsubj)
mg/m2bsa daily (advmod)
control tumor (compound)
interna gpi (appos)
agents anaesthetic (amod)
diagnosis pheochromocytoma (nmod)
impairments coupled (acl)
efv ) (punct)
achieved basis (nmod)
regulation mechanism (nmod)
nanoparticles doxorubicin (compound)
controlling pain (dobj)
chemotherapy standard (amod)
showed prevalence (dobj)
lethalities 2 (nummod)
synthase citrate (compound)
induced 6-ohda (nmod:npmod)
% 81 (nummod)
outcome improved (appos)
demonstrated experimentally (advmod)
efficacy relative (amod)
570 +/- (cc)
imaging single-photon (amod)
2.0 +/- (cc)
receive patients (nsubj)
mmol/l = (parataxis)
associated pd (nmod)
vfd ) (punct)
pains post-suxamethonium (amod)
infusion following (case)
food either (cc:preconj)
injury tubulo-interstitial (amod)
metallothionein of (case)
recorded deficits (dobj)
concentration blood (nmod)
rates non-compliance (nmod)
ml 3 (nummod)
oropharynx the (det)
lacking 2-subunits (dobj)
groups eight (nummod)
noted point (nmod)
kinase 5 (dep)
5 0 (conj)
dose degree (conj)
atenolol mg (nummod)
affected equally (advmod)
patients 300 (nummod)
task of (case)
acrolein toxic (amod)
rate striking (nsubj)
patient any (det)
recommended could (aux)
occlusion ) (punct)
65 were (cop)
activity cardiotoxicity (conj)
six the (det)
rates rapid (amod)
doses into (case)
influence might (aux)
cells untreated (amod)
marrow a (det)
% 18 (nummod)
diligent be (cop)
lids ) (punct)
methamphetamine veratridine (conj)
after-before ( (punct)
exhibited positions (nmod)
elucidate might (aux)
incidents subjects (nmod)
0.2 or (cc)
devices the (det)
reintroduction the (det)
effects physiological (amod)
had responses (nmod)
manner a (det)
blockade on (case)
= 5 (dobj)
engagement the (det)
drugs chemotherapy (conj)
% 20.2 (nummod)
difference solution (nmod)
pi ( (punct)
agonists ) (punct)
consolidation caused (acl)
adjusted or (cc)
sgot phosphatase (conj)
hearts patients (nmod)
performing by (mark)
demonstration the (det)
has benefit (conj)
days procedure (nmod)
possibility interactions (nmod)
stroke than (case)
treatment migraine (nmod)
activity due (case)
discussed influence (nsubjpass)
airway frlma (appos)
ameliorated hypotension (nsubjpass)
3ma ( (punct)
occurs months (nmod)
meq. liter (nmod)
produced damage (nsubjpass)
neurodegeneration mptp-induced (amod)
minutes range (dep)
attenuating of (mark)
meeting the (det)
linked inhibition (nmod)
marker expression (nsubj)
volume determined (amod)
frequent children (nmod)
adrenergic beta (nmod:npmod)
carries usage (nmod)
antioxidants levels (conj)
bpt . (punct)
performances neurocognitive (amod)
induced doxorubicin (nmod)
exposures prenatal (amod)
analysis our (nmod:poss)
pre-treatment propofol (conj)
chp of (case)
depression attacks (nmod)
hypertension hydrocortisone-induced (amod)
higher groups (nmod)
resolved been (auxpass)
haematological , (punct)
reduced number (dobj)
detectable although (mark)
features glaucoma (compound)
cardiomyocytes damaged (amod)
minimize . (punct)
alkaloid maculatum (nmod)
decrease metrizoate (nmod)
causes toxicity (dobj)
treated methods (nsubjpass)
decreases training (nsubj)
dehydrogenase lactate (compound)
occurs seizures (nmod)
dose suxamethonium (nmod)
micrograms/kg/min 1 (nummod)
sampled blood (nsubjpass)
showed development (dobj)
205 374 (conj)
effacement proteinuria (conj)
differ practice (nmod)
quit reportedly (advmod)
recorded one (dep)
root dorsal (amod)
reviews article (nsubj)
scores these (det)
expected is (auxpass)
compared factors (nsubjpass)
receptor-alpha cardiac (amod)
provided control (dobj)
using modification (appos)
neurotoxicity peripheral (amod)
manner selective (amod)
longer increasing (advcl)
collection data (compound)
receptor in (case)
catheter alternative (amod)
hydrochlorothiazide of (case)
polyuria a (det)
shedding rises (conj)
moran [ (punct)
151 14 (compound)
resection transurethral (amod)
cortex areas (conj)
recovery on (case)
evidence ecg (compound)
findings diagnostic (amod)
resolving ; (punct)
activity cord (nmod)
reproduced was (auxpass)
administered day (nmod)
decreased = (dep)
sinus sss (appos)
therapy salvage (compound)
presentation fibres (nmod)
nephrosis established (amod)
seconds in (case)
undertaken are (auxpass)
superior which (nsubj)
% cd4 (dep)
phenotypes hemorrhagic (amod)
amisulpride by (case)
progresses . (punct)
hyperemia coronary (amod)
tid mg (nummod)
bradycardia doses (nmod)
possible being (cop)
is also (advmod)
courses two (nummod)
production from (case)
severity events (nmod)
reactivator or (cc)
demonstrated due (ccomp)
calculated change (nsubjpass)
patients lymphomas (nmod)
interpretation . (punct)
derivative different (acl:relcl)
contribute does (aux)
reversed treatment (nsubj)
associated commencement (nmod)
take , (punct)
proportion patients (nmod)
expected time (nmod)
syndrome acetazolamide-induced (amod)
begins it (nsubj)
protection full (amod)
tamponade cardiac (amod)
tolerated caffeine (nsubjpass)
initiating fibrillation (dobj)
nicotine transdermal (amod)
type wild (amod)
duration volume (conj)
malondialdehyde plasma (compound)
loss db (nmod)
make . (punct)
levels than (case)
resolved substituted (advcl)
show occurred (conj)
injections amphetamine (compound)
ampka myocardium (nmod)
technique seizure (compound)
large which (nsubj)
experiment this (det)
variations external (amod)
mg.per ) (punct)
levels significant (amod)
maintained days (nmod)
role crucial (amod)
twenty-three patients (nmod)
ephedrine mg (amod)
acc-9653 prodrug (appos)
leads improvement (nmod)
attenuates cck-8 (nsubj)
examinations skin (conj)
channel is (cop)
cause effect (nmod)
greater dosage (nmod)
enhanced pretreatment (nsubj)
days cycle (nmod)
nephrotoxicity ototoxicity (conj)
tasks function (compound)
similar renin (nsubj)
monitoring patients (nmod)
nsaid times (appos)
mda ) (punct)
reach criteria (dobj)
reversed tachycardia (dobj)
hampshire new (compound)
-0.62 ) (punct)
course fulminant (amod)
bodies cell (compound)
stopping initiation (conj)
correlates electrophysiologic (amod)
block for (case)
hours first (amod)
scintigraphy mibg (compound)
developed where (advmod)
phosphatase bilirubin (conj)
dysfunction female (amod)
less 90 (nmod)
studies each (appos)
thrombophlebitis and (cc)
symptoms consistent (amod)
gtn dfc (conj)
dealt role (nmod)
had tiapride (nsubj)
complication toxicity (nsubj)
applied can (aux)
parts with (case)
series second (amod)
bleed and (cc)
report : (punct)
minimally only (advmod)
selectivity enzyme (nmod)
associated combination (nsubjpass)
nsaids by (case)
event headache (nsubj)
thrombi by (case)
hiccups persistent (amod)
position an (det)
or=3.299 ci=1.375 (appos)
similar persons (nmod)
patterns for (case)
offered august (nmod)
identification method (nmod)
studied association (dobj)
determined frequency (nsubjpass)
lesions metastatic (amod)
by only (advmod)
reported agent (nmod)
secretion circulation (nmod)
rough and (cc)
mrd presentation (nmod)
124 3 (conj)
mildly only (advmod)
recognize avoid (conj)
substantiated functional (ccomp)
objective quantify (acl)
protein ndi (nmod)
adequate be (cop)
unaltered excretion (nsubj)
revealed revealed (ccomp)
conversion . (punct)
deficit specific (amod)
disappearance for (case)
analysis kinetic (amod)
sensitization ) (punct)
recipient an (det)
doses of (case)
nephrosclerosis on (case)
co-treatment dose (conj)
reversed anemia (nsubjpass)
used hydrochlorofluorocarbons (nsubjpass)
mg p=0.003 (dep)
describes children (dobj)
oxidation heart (dep)
as group (nmod)
stimulated research (dobj)
maryland , (punct)
2.8 vs (cc)
signs parkinsonian (nmod:poss)
68 1 (conj)
necrosis proximal (amod)
changes synaptic (amod)
albumin serum (compound)
hospitalized psychiatrically (advmod)
increases that (nsubj)
complemented was (auxpass)
comparing when (advmod)
pharmacokinetics . (punct)
four , (punct)
produced lesion (nsubj)
regulation genetic (amod)
progress usually (advmod)
intestine ischemic (amod)
high extremely (advmod)
disappearing lack (nmod)
effects cardiotoxic (amod)
variation the (det)
organization a1 (nmod)
neurosis anxiety (compound)
safe procedure (nsubj)
left to (case)
frequency treatment (nmod)
adults younger (amod)
dose body (compound)
cystoscopy outpatient (amod)
arrhythmogenicity of (case)
gemcitabine vinorelbine (conj)
muscles triceps (compound)
evaluation testing (nmod)
treatment cancer (nmod)
worsening outcomes (nmod)
collected preischemia (advmod)
mice cx3cr1 (compound)
inserted patient (nmod)
maximum 4 (nummod)
randomized design (nmod)
assessed respectively (advmod)
detected women (nmod)
influx states (nmod)
surgery for (case)
thrombocytopenia a (det)
positivity patients (nmod)
effectiveness of (case)
4.7 ) (punct)
lower control (nmod)
implicated therapy (nsubjpass)
process ongoing (amod)
adjusted ( (punct)
administration remifentanil (nmod)
cyclophosphamide mg/m(2 (nmod)
discontinuation despite (case)
sex as (case)
amnesia retrograde (amod)
oct , (punct)
increased test (nmod)
congo of (case)
rats weeks (nmod)
materials methods (conj)
images conventional (amod)
aneurysm of (case)
electrolytes of (case)
consistent that (mark)
useful may (aux)
environment an (det)
patient 11th (amod)
myositis children (nmod)
profiles groups (nmod)
improves crocin (nsubj)
cholesterol triglyceride (conj)
alteration significant (amod)
paradigm , (punct)
risks treatment (nmod)
2002 07 (prep)
thickening gyrata (conj)
virus resistant (amod)
erythropoietin to (case)
activity hence (advmod)
u-ii ( (punct)
glomeruli non-sclerotic (amod)
groups within (case)
preventing arrhythmias (dobj)
lasting hours (nmod:tmod)
recipients hbig (compound)
lesions histopathologic (amod)
effect protective (amod)
models similar (amod)
patients undergone (acl:relcl)
age 11 (nsubj)
infections on (case)
pronounced enhancement (nsubj)
schedules min (nmod)
(7.2)% ) (punct)
begun increased (conj)
detect could (aux)
edema localized (amod)
lower scores (nsubj)
identified cohort (nsubjpass)
areas on (case)
worsening : (punct)
succinate agonist (appos)
lesions preneoplastic (amod)
achieved cr (nmod)
considered preferred (conj)
consequence merely (advmod)
causes similar (advmod)
presentation by (case)
1a2 of (case)
adjusted age (nmod)
episodes for (case)
idea causes (ccomp)
suppressed , (punct)
years 2.9 (nummod)
leading transplantation (nmod)
cause also (advmod)
observed % (nmod)
drug antiemetic (amod)
micrograms atenolol (nmod)
timing and (cc)
optimising prevention (dobj)
compartment than (case)
enrolled who (nsubjpass)
developing insights (dobj)
reduction mg (nmod)
i.e. , (punct)
mg/kg/i.p . (dep)
malondialdehyde present (acl:relcl)
isoenzymes individual (amod)
agency protection (compound)
blockade neuromuscular (amod)
trial irbesartan (nmod)
utility the (det)
ed50 terfenadine (nmod)
corticosteroids to (case)
$ROOT$ asked (sent)
atropine the (det)
lost , (punct)
contribution possible (amod)
experienced hallucinations (dobj)
atm 2 (nummod)
forms that (nsubj)
% incidence (nsubj)
heterozygous jj (appos)
chemotherapy intensive (amod)
nephrectomy treatment (nmod)
upregulated be (auxpass)
response escape (compound)
kidney potter-type (amod)
novelty and (cc)
respect recognition (nmod)
levels kinase-1 (compound)
conclusions monitor (dep)
tended it (nsubj)
regrowth with (case)
suggested observation (nsubjpass)
performed when (advmod)
repeated , (punct)
taking not (neg)
crf of (case)
phenomena ischemic (amod)
crystals indinavir (compound)
scores bmi (compound)
levels brain (nmod)
procedure digit (compound)
intradermoreactions idr (appos)
people rate (dep)
jerks min (nmod)
simvastatinezetimibe ( (punct)
developed psychosis (dobj)
secretion enhanced (amod)
increased when (advmod)
interleukin 6 (nummod)
users aas (compound)
depressed . (punct)
29.5 17.5 (conj)
protection any (det)
horn the (det)
results described (acl)
indicated dependent (ccomp)
neutropenia grade (compound)
system this (det)
shows induce (ccomp)
$ROOT$ capacity (sent)
compare abstinence (nmod)
behaviors multiple (amod)
recommendations and (cc)
kg-1 mg (nummod)
mass and (cc)
effacement foot (compound)
differences no (neg)
predicted levels (nmod)
ecgs samples (conj)
of because (case)
reintroduced was (auxpass)
levels symptoms (conj)
change spasm (conj)
40 50 (conj)
dysfunction overdose (nmod)
group rr (dep)
disease a (det)
derivative substituted (amod)
groups etoricoxib (compound)
model rotation (nmod)
superior ergotamine/caffeine (nmod)
presented symptoms (dobj)
pentoxifylline i.v. (compound)
prone users (nsubj)
taking account (nmod)
recovery marrow (compound)
related pph (nmod)
distinguish do (aux)
leads which (nmod)
genotyped who (nsubjpass)
receiving had (aux)
g 200~250 (nummod)
33 and (cc)
alternative as (case)
score behavioral (amod)
caused distribution (nmod)
have disclosed (xcomp)
hybridization northern (amod)
antagonist subtype (nmod)
administration fda (appos)
gene butyrylcholinesterase (compound)
developing infection (dobj)
dependent context (nmod:npmod)
parenteral exclusively (advmod)
drug both (conj)
decreased gentamicin (nsubj)
presented found (conj)
sod nor (cc)
bearing tumors (dobj)
compared nonusers (nmod)
$ROOT$ 4.10 (sent)
comprising af (dobj)
exacerbation or (cc)
amount ctni (nmod)
shifts be (cop)
promotes secretion (nsubj)
detectable treatment (nmod)
present with (mark)
exerts acid (nsubj)
quetiapine and (cc)
use therapies (nmod)
gene in (case)
capacity functional (amod)
growth status (conj)
alters . (punct)
two % (appos)
opening dural (amod)
caused reductions (dobj)
reviewed records (dobj)
14 incidence (dep)
higher release (nsubj)
$ROOT$ recognized (sent)
method conducted (acl)
drug antipsychotic (amod)
responsiveness , (punct)
hplc ) (punct)
neoplasia nephropathy (compound)
observed episode (nmod)
effect model (nmod)
group neonates (nmod)
loss against (case)
100 > (advmod)
consumed who (nsubj)
defects production (nmod)
ecg ) (punct)
dosage cumulative (amod)
recommended force (nsubj)
exposure subacute (amod)
value added (amod)
data pressure-volume (compound)
were respect (nmod)
% 19 (nummod)
sensitive the (det)
delineate frequency (dobj)
methods evaluated (appos)
taking together (advmod)
reasons known (amod)
obtained measurements (nsubjpass)
cystometry by (case)
impaired ketoprofen (nsubj)
led esrd (nmod)
diet fed (acl)
courses the (det)
$ROOT$ tolerance (sent)
binding and (cc)
p=0.05 ) (punct)
enhanced volume (dobj)
years oltx (nmod)
types two (nummod)
exacerbated that (mark)
agc ) (punct)
p<0.021 ( (punct)
interval : (punct)
influence participate (conj)
afford advantage (dobj)
activation a (det)
ii and (cc)
abnormalities mtdna (nmod)
injections meth (nmod)
encephalopathy mice (nmod)
case spasm (nmod)
intensity nausea (conj)
patients angina (nmod)
treatment their (nmod:poss)
resulted compared (advcl)
model clinical (amod)
vivo-prepared ex (advmod)
wk within (case)
agent interferes (acl:relcl)
pathways abnormalities (conj)
pointer inexpensive (amod)
included : (punct)
yr 3 (nummod)
rad001 therapy (conj)
diagnosis erythematosus (nmod)
recall he (nsubj)
seems to (xcomp)
acetate combined (acl)
bradycardia interaction (conj)
anesthesia isoflurane (compound)
feature is (cop)
speed and (cc)
1.5 to (case)
test glucose (compound)
rose returned (conj)
saline nimo (conj)
ke were (cop)
rat one (nummod)
appear would (aux)
increase enzymes (nmod)
higher micrograms/kg (nmod)
deaths recorded (acl)
neutrophils with (case)
% 69.9 (nummod)
malformation and (cc)
34 14 (conj)
can and (cc)
reported precede (xcomp)
females . (punct)
ngf women (nmod)
score . (punct)
calcineurin immunoreactive (amod)
investigations and (cc)
analyzed also (advmod)
reversal weeks (nmod)
nigra the (det)
nx in (case)
study continued (amod)
titrated produce (xcomp)
boy presented (acl:relcl)
probed affects (ccomp)
injection igf-il-3 (nmod)
vomiting headache (conj)
drinkers 167 (nummod)
causes identified (conj)
association no (neg)
rhythm sinus (compound)
injection test (nmod)
associated functioning (nmod)
evoked glutamate (nsubj)
dependent assistance (nmod)
inhibition adenylate (compound)
duration at (case)
searched medline (nmod)
bupropion by (case)
rammer katona (conj)
complete treatment (nmod)
occur levels (nmod)
evidence of (case)
achieved level (nmod)
leading death (nmod)
used complication (nmod)
1.4 . (punct)
developed one (nsubj)
pheochromocytoma unmasked (acl)
creatinine 1-year (amod)
< .04 (dep)
vasopressin nor (cc)
ph of (case)
non-smokers mothers (nsubj)
factors pointes (nmod)
identified correctly (advmod)
controls sham-operated (amod)
chromatography with (case)
accumulation mibg (compound)
nutrition total (amod)
research development (nmod)
blockade and (cc)
designed study (xcomp)
october , (punct)
findings cardiovascular (amod)
common was (cop)
120 approximately (advmod)
inhibition (gaba)-mediated (amod)
infusion [24 (nummod)
alleviation edaravone (nmod)
skin normal (amod)
hepatotoxicity : (punct)
ms of (case)
quality similar (amod)
antidopaminergic and (cc)
treatment either (dep)
cardiac acute (amod)
system development (compound)
severity regurgitation (nmod)
switched therapy (nsubjpass)
effective regard (nmod)
phenotype a (det)
transplant peripheral (amod)
decreased urate (dobj)
reducing hours (nmod)
produced eads (dobj)
supposed caused (ccomp)
week 16th (amod)
nsclc and (cc)
studies short-term (amod)
fibroblasts patient (nmod)
s the (det)
induced ? (punct)
followed dose (nsubjpass)
hepatitis to (case)
treatment enteropathica (nmod)
observed lesions (nsubjpass)
effective steroids (nsubj)
recipients isg (compound)
also endpoint (nsubj)
rats unanesthetized (amod)
oblongata the (det)
requirement pentobarbital (nmod)
descriptions few (amod)
thrombosis embolism (conj)
vasospasm diffuse (amod)
discontinuations of (case)
april 2005 (nummod)
patient subsequent (amod)
prophylaxis ondansetron (compound)
abnormalities some (det)
desire excitement (conj)
influence deficit (nmod)
illustrate reports (nsubj)
growth of (case)
victim a (det)
that acetaminophen (nmod)
0.003 , (punct)
establish explore (conj)
disorders hypotension (conj)
prevented induction (nsubjpass)
g/cm(2 837 (nummod)
monitoring surgery (nmod)
samples venous (amod)
palsy gaze (compound)
animals 105 (nummod)
potent nra0160 (nsubj)
15.5 at (case)
groups dietary (amod)
develop control (dobj)
quinpirole agonist (compound)
pressure contractility (conj)
irregularities two (nummod)
changes matter (nmod)
denervation a (det)
g. in (case)
ro - (punct)
results had (appos)
results conflicting (amod)
carcinoma to (mark)
ligands subtypes (nmod)
piglets the (det)
vinorelbine of (case)
= 11.494 (dobj)
therapy between (case)
24 0 (compound)
myalgia is (cop)
triggering by (case)
$ROOT$ evolve (sent)
2004 - (punct)
elicited administration (nsubj)
implicate do (aux)
measures secondary (amod)
sinus carotid (compound)
dismutase peroxidase (conj)
induced aminonucleoside (nmod)
effective medications (nsubj)
$ROOT$ focussed (sent)
patients all (det)
accumulation to (case)
10 and (cc)
l/kg td (nmod)
days 2.6 (nummod)
presentation recipients (nmod)
damage seizure-associated (amod)
amifostine , (punct)
prevention prevention (conj)
normalization count (nmod)
received experiment (nmod)
0.01 7.13 (prep)
leader gemcitabine (compound)
phosphorylation protein (compound)
positive schiff (nmod:npmod)
0.84 - (punct)
reduced activation (dobj)
glomerulonephritis pr3-anca-positive (amod)
associated erythrophagocytosis (nmod)
stimulation during (case)
report been (cop)
antagonist paf (nmod)
$ROOT$ satisfied (sent)
epilepsy lindane-induced (amod)
bevacizumab/irinotecan with (case)
subjects supine (compound)
adr this (det)
microg/ml % (nmod)
electrocardiogram.3 the (det)
76 to (quantmod)
showed predictors (ccomp)
who ( (punct)
dysrhythmias with (case)
externa rara (compound)
unchanged group (nmod)
modified was (auxpass)
inclusions abnormal (amod)
$ROOT$ favored (sent)
december through (case)
increases pilocarpine-induced (amod)
regarded while (mark)
metoprolol antagonist (compound)
cyp mg/kg (appos)
method measured (acl:relcl)
propionate 85 (appos)
transporter this (det)
overview disorders (nmod)
risks carcinoma (nmod)
ventricles arteries (conj)
b part (compound)
tachycardia isoproterenol-induced (amod)
metabolites total (amod)
showed often (advmod)
ro15 - (punct)
les ) (punct)
time spent (acl)
detected numbers (nsubjpass)
transplants since (case)
model cholinergic (amod)
cells stained (amod)
exists . (punct)
region endothelial (amod)
$ROOT$ rendered (sent)
leukemia promyelocytic (amod)
conduction of (case)
50 from (case)
injury injury (nmod)
indicates associated (ccomp)
serositis involvement (conj)
species chemical (conj)
failure , (punct)
limited been (cop)
distribution factors (nmod)
appear activity (nsubj)
0.05 1 (conj)
solution elliott (nmod:poss)
referred ect (nmod)
learning word (compound)
appears therefore (advmod)
function . (punct)
thiopentone kg-1 (nummod)
female male (conj)
predicting appearance (dobj)
pathology de (amod)
method tail-cuff (compound)
withdrawal to (case)
mulv ) (punct)
$ROOT$ compare (sent)
drugs non-steroidal (amod)
plays effects (nmod)
precurarization safe (amod)
severity stenosis (nmod)
suppression proliferation (nmod)
shelf same (amod)
observed presence (nmod)
b1r ( (punct)
kinase hepatocytes (nmod)
beats -32 (nummod)
shape anemia (conj)
purpose presented (appos)
reached significance (dobj)
epm ) (punct)
return with (case)
harmless be (cop)
indicate relationship (dobj)
base of (case)
man 49-year-old (amod)
reversed propranolol (nsubj)
cardiomyopathy epinephrine-induced (amod)
2.1 0.7 (conj)
outcome excellent (amod)
severity impairment (nmod)
vasorelaxation vasoconstriction (conj)
read and (cc)
units at (case)
bpt micrograms (appos)
mg/kg/day i.p. (appos)
exposure mptp (compound)
patients mg/kg (appos)
ufov ) (punct)
mg/kg/day to (case)
measured step (nmod)
prot ( (punct)
poor outcome (nsubj)
map abnormalities (dobj)
similarities the (det)
contraceptives with (case)
known . (punct)
d-amphetamine , (punct)
undergoing treatment (dobj)
8 from (case)
acid acetylsalicylic (amod)
formation autoantibody (compound)
respond pallidotomy (nmod)
was greater (acomp)
expression regions (nmod)
effects multiple (amod)
subjects diabetic (amod)
mania in (case)
attributed are (auxpass)
awakening hours (dep)
for even (advmod)
decline index (nmod)
mg 2.5 (nummod)
switched phase (nmod)
increase exposure (nsubj)
detected capsules (nmod)
adults children (conj)
administered resulting (advcl)
mitigates stress (dobj)
conclusion . (punct)
effects antileukemia (compound)
associated fluids (nmod)
encephalopathy metronidazole-induced (amod)
effects changes (nmod)
iu/l : (punct)
frequent the (det)
correlation recall (nmod)
warranted informed (conj)
one patients (nmod)
implicated hypertension (nmod)
exposure cells (nmod)
examinations pressure (nmod)
estimate risk (dobj)
carcinogens three (nummod)
pancreatitis including (case)
length , (punct)
50 as (advmod)
channel of (case)
expression coxii (compound)
cmro2 in (case)
received and (cc)
cases hypoplasia (nmod)
substantial was (cop)
infant anomalies (nmod)
areas restricted (amod)
symptoms especially (advmod)
persisted however (advmod)
occurs ischaemia (nmod)
losartan ( (punct)
applicators including (case)
hypotension (ach)-produced (punct)
hypertensive previously (advmod)
challenge oral (amod)
rate excess (amod)
mg.kg(-1).min(-1 ( (punct)
cross-reactivity with (case)
administration cbz (compound)
fluvastatin with (case)
is addition (nmod)
urolithiasis of (case)
questionnaire use (compound)
kg 12.4 (nummod)
greater ; (punct)
formation pap (compound)
infarction early (amod)
attempt suicide (compound)
related hemolysis (nsubj)
records their (nmod:poss)
evolution renal (amod)
cause common (amod)
patients non-warfarin (amod)
90 27 (compound)
effects helodermin (nmod)
utility its (nmod:poss)
liability no (det)
objectives aimed (appos)
concentrations compounds (nmod)
had kidney (dobj)
supplementation less (amod)
suggest may (aux)
studied function (nsubjpass)
atherosclerosis induced (acl)
$ROOT$ selected (sent)
benzylacyclouridine of (case)
differentiate survivors (dobj)
performed angiography (nmod)
activity glucocorticoid (compound)
type apex (nmod)
tacrolimus , (punct)
decreased excretion (conj)
excretion reduced (amod)
lobe consistent (amod)
prognosis seizure (nmod)
effects hepatoprotective (amod)
preceded leakage (nmod)
alpha-configuration the (det)
neuroplasticity changes (conj)
agonist this (det)
successful block (nsubj)
role contradictor (amod)
change ebff (nsubj)
gain weeks (nmod)
this types (conj)
undergone medullo-adrenalectomy (nmod)
8 as (advmod)
$ROOT$ experienced (sent)
synthesis neurotransmitter (compound)
order conduct (acl)
regression ( (punct)
increased uptakes (dobj)
observed recorded (conj)
cocaine intranasal (amod)
pathology biliary (amod)
acuity decreased (amod)
30 4.5 (nummod)
1994 in (case)
abnormalities disease (nmod)
administered mesna (nsubjpass)
synergy calcification (nmod)
carbamazepine cbz (appos)
cases retinochoroidopathy (nmod)
pretreatment poisoning (nmod)
criteria college (compound)
mg/kg daptomycin (compound)
excretion a (det)
present behaviors (nsubj)
pressure wall (nmod)
sufficient reduce (xcomp)
cats anaesthetized (acl)
ingesting , (punct)
day second (amod)
catheter foley (compound)
atherosclerosis aorta (nmod)
disappear drugs (nsubj)
inhibition cox-2 (nmod)
aimed . (punct)
outcomes adverse (amod)
carbimazole benzylthiouracil (conj)
began months (nmod:npmod)
rats sham (amod)
anterior and (cc)
level sc-48334 (compound)
explained hypothesis (nmod)
created conditions (nsubjpass)
1.4 1.1 (compound)
receiving bupivacaine (dobj)
year postoperatively (advmod)
transaminase alt (appos)
have endpoints (nmod)
nonusers with (case)
monotherapy clonazepam (compound)
- hyp(so3h)-ac-cck-2 (compound)
inhibited exacerbation (nmod)
d-glucarates of (case)
d-penicillamine mg/day (appos)
suffering undergone (conj)
arrhythmia myocardium (nmod)
$ROOT$ characterize (sent)
summary experienced (appos)
b patient (compound)
[ca(2+)](i ( (punct)
guanethidine hexamethonium (conj)
examined compared (conj)
hour administration (nmod)
tolerate p (dobj)
illustrate need (dobj)
fatigue dyspnea (conj)
group chloroprocaine (compound)
associated ketoconazole (nmod)
greater 1 (nsubj)
-18.48 1.72 (conj)
rats wild-type (amod)
higher penetration (nsubj)
potentiates inhibition (dobj)
pill on (case)
discontinuation either (preconj)
diseases by (case)
agent activity (nmod)
midbrain rat (nmod)
disorder depression (compound)
administration apraclonidine (nmod)
area cardiomyocyte (compound)
disorder features (nmod)
reversed pretreatment (nsubj)
kidneys offspring (compound)
utilized , (punct)
publications recent (amod)
agent population (nmod)
parameters behavioural (amod)
transformation microglia (nmod)
using function (dobj)
increased concentration (nsubj)
treatment neuroleptic (amod)
related pretreatment (nmod)
in common (amod)
protection deaths (nmod)
serotonergic a (det)
profiles (+/-)-pg-9 (nmod)
dosage ( (punct)
regimen combination (compound)
delayed increased (conj)
structure hepatocyte (compound)
loss impairments (conj)
increases restriction (nsubj)
role electroencephalogram (nmod)
direct and (cc)
sarin and (cc)
k ) (punct)
ileostomy with (case)
effects application (nmod)
occurrence . (punct)
function important (amod)
inability activate (acl)
one-third them (nmod)
activities brain (compound)
mothers positive (amod)
seizures levofloxacin-induced (amod)
noted group (nmod)
morning evening (conj)
finished courses (dobj)
1r,2s-(+)-cis-n-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl)cyclohexylamine ) (punct)
induce therefore (advmod)
23.9 versus (cc)
db < (dep)
v minutes (appos)
seen improvements (nsubjpass)
endogenous synthetic (conj)
rose pronounced (conj)
decreased postlesion (nmod)
postulate calls (ccomp)
remained significant (acomp)
4 3 (quantmod)
elevated elevated (advcl)
study a (det)
alpha5 the (det)
detected filling (nsubjpass)
expressed to (mark)
dismutase superoxide (compound)
mg 109.2 (nummod)
gating accumbens (nmod)
trazodone antagonist (appos)
experienced patient (nmod)
$ROOT$ patient (sent)
completed cards (nsubjpass)
dose mg/kg (dep)
obtained had (advcl)
produced afterdepolarization (dobj)
enhancement peak (amod)
august 17 (nummod)
backgrounds in (case)
patients euthyroid (amod)
back-diffusion content (conj)
values final (amod)
deactivated poisons (nmod)
disturbance renal (amod)
more slightly (advmod)
composed was (auxpass)
group , (punct)
markers dysfunction (nmod)
rats moving (amod)
experienced episodes (parataxis)
trials evaluating (acl)
characterized is (auxpass)
coincided proteinuria (nmod)
interaction venlafaxine-tranylcypromine (compound)
asthma bronchial (amod)
play formation (nmod)
percentage low (amod)
had stain (dobj)
alters therapy (nsubj)
mg/kg at (case)
hepatitis were (cop)
triglyceride hepatic (amod)
occur may (aux)
mediate to (mark)
67.66 131.08 (conj)
depression a (det)
race and (cc)
leukopenia vomitus (appos)
confirm cases (nsubj)
pathology junction (nmod)
included syndrome (dobj)
indicated results (nsubj)
delayed severe (conj)
registry spanish (amod)
bw 2.0 (nummod)
iva [ (punct)
finding induces (ccomp)
session another (det)
activity an (det)
given mp (nsubjpass)
ekg ( (punct)
impaired were (cop)
disease penicillamine-induced (amod)
functioning function (conj)
788.5 162.5 (conj)
mixture of (case)
higher that (mark)
health psychological (amod)
forming ii (nummod)
kinases protein (compound)
used found (conj)
dose by (case)
deteriorated significantly (advmod)
cases new (amod)
condition off-drug (amod)
activity aniracetam (nmod)
occurred cessation (nmod)
improved be (auxpass)
remains neurotoxicity (nsubj)
responses electrophysiological (amod)
problems with (case)
indicate damage (dobj)
toxicity glomerulus (nmod)
event presented (parataxis)
explanation . (punct)
estimate ratios (dobj)
solution hyperbaric (amod)
recovery recovery (conj)
form report (compound)
supplement a (det)
disorders depressive (amod)
remains overall (advmod)
metabolites were (cop)
caused necrosis (dobj)
respiratory limb (conj)
cis-ra oral (amod)
dgc connects (acl:relcl)
halos % (appos)
limits within (case)
classification centers (compound)
paclitaxel induced (amod)
development lids (nmod)
noel the (det)
receive amb (dobj)
subunits alpha5 (compound)
represented are (auxpass)
atpase ca+2 (compound)
p450s cytochrome (compound)
evidence damage (nmod)
showed decrease (dobj)
tool tee (nsubj)
forms two (nummod)
1.3 . (punct)
heart on (case)
injected drugs (nmod)
prevent conclusion (nmod)
enrolled study (nmod)
database transplant (compound)
agent antimycobacterial (amod)
management hyperparathyroidism (nmod)
hypokalemic in (case)
expressed membrane (nmod)
metabolite a (det)
vessels , (punct)
decreased ; (punct)
antagonized , (punct)
administration 2-chloroprocaine-ce (nmod)
activity antiviral (amod)
phosphatase n-acetyl-beta-glucosaminidase (conj)
increased hg (nmod)
burns similar (amod)
normal normal (conj)
prognosis a (det)
net of (case)
comparison tube (nmod)
those between (case)
production apoptosis (conj)
system muscarinic (amod)
translocation chromosome (appos)
mm 137 (compound)
absent is (cop)
revealed methods (nsubj)
suggest further (advmod)
trial a (appos)
recovery peripheral (amod)
respect adenomyosis (nmod)
reactions hepatic (amod)
supplementation glutamate (compound)
velocity fibers (nmod)
aureus staphylococcus (compound)
coma , (punct)
showed comparison (nmod)
g/m2 day (nmod:tmod)
hexamethylmelamine , (punct)
polyuria with (case)
space and (cc)
declined months (nmod)
diet ) (punct)
% 13.4 (nummod)
bodyweight day (nmod)
mediated testosterone (nmod)
acid adequate (amod)
reported has (aux)
exist comparisons (nsubj)
akathisia jitteriness (conj)
curtailed . (punct)
tolerance sensitivity (conj)
experienced that (nsubj)
beraprost bpt (appos)
hypotension hem-induced (amod)
delivery agent (nmod)
process expression (conj)
improved reducing (advcl)
overlooked be (auxpass)
pathway serotonergic (amod)
elected continue (xcomp)
preparation salt (compound)
implants by (case)
iml in (case)
included treatments (nsubj)
inhibitors direct (amod)
$ROOT$ hyperprolactinemia (sent)
$ROOT$ 6/15 (sent)
concentrations shift (conj)
gauges p (dep)
hyperalgesia patients (nmod)
cases reactions (acl:relcl)
dialysis equilibrium (compound)
report trial (nmod)
$ROOT$ give (sent)
triggered pathologies (nmod)
experienced myalgia (compound)
cystitis hc (appos)
nitroglycerin mg (appos)
assessed rigidity (nsubjpass)
absence equipment (nmod)
evaluable were (cop)
pathway that (nsubj)
iop stress (conj)
behavior apprehensive (amod)
associated presence (nsubjpass)
chemotherapy 5-fu (compound)
a-86929 [-]-[5ar,11bs]-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-+ (dep)
examine . (punct)
colitis ulcerative (amod)
posttransplant months (nmod:npmod)
$ROOT$ attest (sent)
predict alterations (nsubj)
saline n=10 (dep)
analysis for (case)
reinforces finding (nsubj)
content bone (compound)
protection significant (amod)
micrograms.kg-1.min-1 ) (punct)
layer gyrus (nmod)
mg compressions (conj)
followed transport (nmod)
suprofen from (case)
purposes for (case)
deduced although (mark)
antagonists ranitidine (dep)
serotonergic- a (det)
suggests abruptness (nsubj)
problem major (amod)
oscillations all (det)
remained normal (xcomp)
toxicity doxorubicin-associated (amod)
fluency continuous (amod)
$ROOT$ 2 (sent)
same value (nmod)
max dp/dt (compound)
histological molecular (conj)
evaluated angiography (nmod)
half-time parenchyma (nmod)
acid 3-mercaptopropionic (amod)
= 0.047 (dobj)
intensity patients (nmod)
models including (case)
suggest opposite (dobj)
means maintaining (advcl)
tapering the (det)
prolonged also (advmod)
underwent section (dobj)
found suprofen (nmod)
ratio calculated (acl)
bmcs with (case)
work described (acl)
d3 metabolites (conj)
administrations following (amod)
levels low (amod)
removed rats (nmod)
reduced edema (nsubjpass)
improvements in (case)
inhibition no-synthase (compound)
days 14 (nummod)
% disoprivan (compound)
task y-maze (compound)
blockade blockade (conj)
administered applied (conj)
derivative synthetic (amod)
implicated pathway (nsubjpass)
knife both (cc:preconj)
dependent are (cop)
benefit may (aux)
arrest care (nmod)
disease sinuatrial (amod)
complexes two (nummod)
1.7 1.2 (nummod)
retinochoroidopathy birdshot (compound)
provides but (cc)
fdc the (det)
correlated abnormalities (nsubj)
cck-8-ns ) (punct)
recovery gradual (amod)
occur often (advmod)
operated and (cc)
suggests analysis (nsubj)
weakness the (det)
co-administration cnsb002 (nmod)
chemotherapy infusional (amod)
treatment progesterone (compound)
agent broad-spectrum (amod)
considered points (nsubjpass)
effects " (punct)
phospholipid of (case)
administration d2 (nmod)
records 407 (nummod)
relieved lidocaine (nmod)
men taking (acl)
implantation cells (nmod)
five two (conj)
monitored weeks (nmod:tmod)
pharmacological toxicological (conj)
injury fetus (nmod)
prevented taken (advcl)
ng/min ) (punct)
approach suppression (nmod)
p75(ntr)-ir drg (nmod)
0 5 (conj)
at or (cc)
aspirin 's (case)
signs analysis (conj)
remission during (case)
logs department (compound)
rates apoptosis (nmod)
experienced hour (nmod)
way may (aux)
subjects perturbated (amod)
= 0.002 (dobj)
distinguishing in (mark)
experience current (amod)
lining nephron (dobj)
reported carcinomas (nsubjpass)
causing discharges (dobj)
mg/dl bun (conj)
cells including (case)
p-glycoprotein pgp (appos)
considered also (advmod)
reported present (parataxis)
abnormalities system (compound)
stripe inner (amod)
rare was (cop)
lactoferrin of (case)
years and (cc)
heart or (cc)
potential increase (acl)
tissue fraction (conj)
system plus (cc)
influx macrophage (compound)
produced administration (nsubj)
fibrosis eight (nmod)
ligands by (case)
comparison by (case)
higher patients (nmod)
tumor ehrlich (compound)
use states (nmod)
p11 the (det)
inhibition proliferation (nmod)
given intragastrically (advmod)
revert injections (nsubj)
ribavirin cidofovir (conj)
vincristine without (case)
exceeded men (nmod)
modulate effects (dobj)
mg.kg-1 0.015 (nummod)
explain that (nsubj)
neurotoxicity serious (amod)
myalgia of (case)
samples two (nummod)
were improvements (attr)
electrocardiogram her (nmod:poss)
studied changes (nsubjpass)
indicate avoided (ccomp)
pparalpha human (amod)
change bp (compound)
conclusions recovered (appos)
administration and (cc)
rigidity haloperidol-induced (amod)
targeting receptors (dobj)
reduction synthesis (nmod)
deterioration memory (compound)
17beta-estradiol oil (conj)
benzoylecgonine metabolite (compound)
correlates . (punct)
risk thromboembolism (nmod)
globulin . (punct)
stiffness morning (compound)
distributed are (auxpass)
variability inter-observer (amod)
show suggest (conj)
positive patients (nmod)
case per (case)
area medial (amod)
increased decreased (ccomp)
administered methods (nsubj)
secretion period (nmod)
investigation efficacy (nmod)
cholinesterase with (case)
hypoglycaemia induced (amod)
twin female (appos)
assess function (dobj)
effect no (det)
reduction mild (amod)
remains thrombocytopenia (nsubj)
diet followed (acl)
hyperactivity seen (acl)
rate proliferation (compound)
oxypurines plasma (compound)
problems to (case)
diphenylhydantoin dph (appos)
presented while (mark)
level system (nmod)
conclusion was (dep)
resulted complained (conj)
microgram/kg/min to (case)
occurs rats (nmod)
dystrophy muscular (amod)
dex saline (conj)
associated ability (nmod)
pathogenesis an (det)
withdrawal therapy (nmod)
six group (nmod)
polymorphism promoter (compound)
27 25 (conj)
enzymes and (cc)
disability dyskinesias (conj)
remain hypothetic (xcomp)
smear blood (compound)
produce decreases (dobj)
gestation and (cc)
level consciousness (nmod)
represent challenge (dobj)
hyperglycemia acidosis (conj)
patients adherence (nmod)
21 22 (conj)
titrated symptoms (nmod)
induced bupropion (nmod)
spine lumbar (amod)
liver tissues (conj)
178 156 (conj)
selected was (auxpass)
nephrolithiasis recurrent (amod)
months 50 (nummod)
perfusion-fixed were (auxpass)
slowing velocity (nmod)
196,397 prescribed (acl)
decibels of (case)
case exposure (nmod)
12h 10 (compound)
restored four (nmod)
cases developed (acl:relcl)
temsirolimus of (case)
segments cortical (amod)
patients clinics (nmod)
octapeptides , (punct)
overactivation a (det)
cpa/ee for (case)
labeling an (det)
context treatment (nmod)
induced trimethoprim-sulfomethoxazole (nmod)
sparing aspects (dobj)
eosinophilia hyponatremia (conj)
status his (nmod:poss)
target the (det)
$ROOT$ stabilizers (sent)
hypothesized transmission (nsubjpass)
performed evaluations (nsubjpass)
hospital-years of (case)
produced risperidone (nsubj)
associated co-morbidity (nmod)
did trial (dobj)
cataracts or (cc)
relation a (det)
had treated (advcl)
sensitive lines (nsubj)
continues doxorubicin (nsubj)
arthritis , (punct)
convulsive locomotor (conj)
forms application (nmod)
dex atorva (appos)
myalgia succinylcholine-induced (amod)
treatment similar (amod)
had seizures (nmod)
cck-8-se cck-8-ns (conj)
back rate (nsubj)
continued treatment (nmod)
min performance (nmod)
discontinued and (cc)
chlorpropanol ( (punct)
one consequence (nmod)
nag ( (punct)
psychosis methamphetamine-induced (amod)
induced variety (nsubjpass)
randomized 1 (nmod)
thrombin alone (advmod)
protein elevated (amod)
made measurement (nsubjpass)
evaluation clinical (amod)
found severity (nmod)
ceased administering (advcl)
males pd (compound)
7-ni ; (punct)
observed mitochondria (nmod)
substitute uh (intj)
mechanisms drug-adsorption (compound)
training between (case)
iopentol % (appos)
exposure fluoxetine (nmod)
$ROOT$ recurred (sent)
value at (case)
pressures partial (amod)
woman glabrata (nmod)
mature sexually (advmod)
injury for (case)
graft in (case)
mtx radiotherapy (conj)
stenting of (case)
ruled infections (nsubjpass)
presence fasciculation (nmod)
translocations line (nmod)
pressing object (dobj)
test used (acl)
localised process (nsubjpass)
reactions depression (nmod)
s((1/2 ) (punct)
observed frequency (nsubjpass)
cue effect (conj)
hypercalcemias with (case)
eluate an (det)
rt-pcr and (cc)
effect women (nmod)
memory encoding (conj)
potential sm-5887 (nmod)
sod gsh (conj)
slower cn (nmod)
hepatitis or (cc)
scale pain (compound)
infused . (punct)
allopurinol than (case)
restrict inpatients (nmod)
attributed some (nsubjpass)
demonstrated effects (dobj)
then until (mark)
fenoldopam of (case)
act systems (nmod)
class and (cc)
hepatitis cases (dep)
receiving both (nsubj)
plays effect (nmod)
impair background (nsubj)
followed adequately (advmod)
stainings presence (nmod)
linked , (punct)
compartments in (case)
coordinates the (det)
3.54 to (advmod)
day as (case)
effect heparin (nmod)
reduced clearly (advmod)
il-3 ( (punct)
products supplements (conj)
antagonists . (punct)
restricted use (dobj)
believed nephritis (nsubjpass)
stability gait (conj)
suffered neonates (nsubj)
implant 0.59-mg (nummod)
draw attention (dobj)
different , (punct)
morphology related (amod)
spikes , (punct)
suggests evaluated (ccomp)
engine ukpds (compound)
used lamivudine (nsubjpass)
increase hg (nmod)
aggravated but (cc)
% 7.1%-13.3 (nummod)
increase alleviate (conj)
33 % (conj)
putamen caudate (compound)
increased tbars (nsubjpass)
tubules distal (amod)
substantiates test (nsubj)
trained were (auxpass)
patients 2,820 (nummod)
available cases (nmod)
range scores (nmod)
indicates increase (ccomp)
reported illustrate (xcomp)
ketamine- diazepam-induced (conj)
effects fasciculation (nmod)
adenocarcinoma well-differentiated (amod)
n=5 ( (punct)
recruited subjects (nsubjpass)
greater incidence (nsubj)
suggest beneficial (ccomp)
required was (auxpass)
system on (case)
maintained mean (dep)
insufficiency moderate (amod)
released which (nsubj)
wt but (cc)
eliminating regimen (nmod)
lack mrp2 (nmod)
ascribed be (auxpass)
activation with (case)
followed been (auxpass)
1710 200 (conj)
dye of (case)
volumes lower (amod)
reported effects (nmod)
arms both (det)
application kcl (nmod)
agents antihypertensive (amod)
agonists d1 (compound)
reduces incidence (dobj)
fentanyl of (case)
methylprednisolone of (case)
records cohort (nmod)
drugs effects (nmod)
was presented (advcl)
generation current (amod)
reduced stopping (csubj)
glutathione oxidized (amod)
mechanisms vasodilation (appos)
desire gynecomastia (conj)
subjects matched (amod)
occurred elevation (nsubj)
pnd 35 (nummod)
cab of (case)
mediates . (punct)
user cocaine (compound)
therapy esrd (compound)
median ) (punct)
fraction dimension (conj)
days 1 (appos)
examined assess (xcomp)
proteinuria hypoalbuminemia (conj)
872 - (punct)
response vessels (compound)
blotting by (case)
describe characteristics (dobj)
declined significantly (advmod)
increased score (dobj)
cause thrombocytopenia (nmod)
animals with (case)
adequate may (aux)
cases published (amod)
2e1 p58 (conj)
describe patients (dobj)
transferred . (punct)
reported who (nsubjpass)
lower weeks (nmod)
hazard potential (amod)
advance major (amod)
unable were (cop)
check a (det)
acetaminophen aspirin (appos)
in off'-drug (punct)
proliferated and (cc)
2-chloroprocaine-ce , (punct)
life-threatening are (cop)
shown years (nmod)
$ROOT$ dilate (sent)
sevoflurane to (case)
surviving min (nmod)
group reference (compound)
seizures drugs-induced (amod)
erythroblasts marrow (compound)
manner dose-dependent (amod)
sjl a/j (conj)
practiced be (auxpass)
dilemma diagnostic (amod)
week prior (amod)
reactions patients (nmod)
recall week (nmod)
plasma human (amod)
ligand fas (compound)
4'-0-tetrahydropyranyladriamycin bolus (compound)
lowered < (parataxis)
control absences (nmod)
improvement definite (amod)
effect occurrence (nmod)
efficacy parallel-groups (amod)
hypotension mice (nmod)
study 's (case)
patients forty-six (nummod)
developed ari (nsubj)
sensitisation of (case)
report treatment (nmod)
induced may (aux)
monitored signs (nmod)
inhibitors compounds (nsubj)
dyskinesias preexisting (amod)
therapy cyclical (amod)
abnormalities electrolyte (amod)
involvement trigeminal (amod)
induces sufferers (nmod)
conclusion treated (acl)
condition is (cop)
angiography during (case)
determined ratings (nsubjpass)
pcr quantitative (amod)
administration lindane (nmod)
present review (nmod)
plan that (mark)
increased u/ml (nmod)
agency the (det)
hypotension morphine-induced (amod)
ventilated . (punct)
values in (case)
used hydrochloride (nsubjpass)
present months (nmod:tmod)
able are (cop)
seems hyperactivity (nsubj)
$ROOT$ imply (sent)
were predictors (nsubj)
2/51 ) (punct)
reaction lv (nsubj)
activation blocked (acl:relcl)
subgroup % (appos)
controls healthy (amod)
cells cultured (amod)
trks ) (punct)
age for (case)
shortened micromol/l. (nmod)
lymphoma gynecologic (conj)
enos ( (punct)
essential continue (xcomp)
treated not (neg)
neurophysiology of (case)
hg group (appos)
conclude preserved (ccomp)
account activity (nmod)
exposed patient (nsubjpass)
exposure cumulative (amod)
114.6 and (cc)
role stress (nmod)
enzymes marker (amod)
lipid , (punct)
accompanied ; (punct)
evidence pericarditis (nmod)
days orally (advmod)
hypertension humans (nmod)
lipoprotein hdl (appos)
assessable response (nmod)
involvement neurotransmission (nmod)
(7.2)% (5.7)% (conj)
studies pharmacokinetic/pharmacodynamic (amod)
explained difference (nsubjpass)
sr 48,968 (nummod)
cont./min ] (punct)
reversal sedation (nmod)
total activated (conj)
q-pcr by (case)
higher threshold (nsubj)
treated dopa (nmod:npmod)
symptom-free patients (dep)
risks switching (nmod)
comments the (det)
appeared . (punct)
technique intravenous (amod)
s-312 s-312-l (conj)
advantage substantial (amod)
lithotripsy extracorporeal (amod)
infusion control (amod)
was proportion (nmod)
professionals health (compound)
resolved nifedipine (nmod)
relationship dose-response (amod)
decrement cin (nmod)
protect toxicity (nmod)
oralis ventralis (compound)
block of (case)
nsaid and (cc)
agreement no (det)
30 or (cc)
patient appeared (acl:relcl)
appeared drivers (nsubj)
clipping aneurysm (nmod)
1.44+/-0.6 vs. (cc)
tingling burning (conj)
mg/m2 260 (nummod)
factor 260 (nmod)
sensitive blockers (nmod)
described reactions (nsubjpass)
inhibitor growth (compound)
receptors p2x3 (compound)
lys1 arg3,4 (appos)
interference inhibition (nmod)
combination of (case)
leukaemia paediatric (amod)
muscle smooth (amod)
suggestive syndrome (nmod)
plasma children (nmod)
deficits functioning (nmod)
increased 20-fold (advmod)
contributes testosterone (nsubj)
increase demonstrated (parataxis)
system or (cc)
record levels (conj)
deaths cancer (nmod)
dosage oxitropium (nmod)
delta and (cc)
studies stroke (nmod)
anxiety for (case)
expressions gene (compound)
process muscular (amod)
and consistently (advmod)
hepatitis ( (punct)
visits of (case)
returned postoperatively (advmod)
participants patients (appos)
co-administration desipramine (nmod)
hazard ci (appos)
disease to (case)
azathioprine , (punct)
diet low-salt (amod)
att of (case)
elevation ng/ml (compound)
protocol anesthetic (compound)
ballooning the (det)
showed distribution (dobj)
provoked nitroglycerin (nmod)
pain generalized (amod)
combined compared (conj)
actions pharmacological (amod)
unclear efficacious (ccomp)
mg administered (acl)
observations and (cc)
generated group (nmod)
obtained compared (conj)
complications blinding (amod)
elevation exacerbated (acl:relcl)
renoprotective therapy (nsubj)
discontinued is (auxpass)
ester nitro-l-arginine (compound)
developed boys (nsubj)
peritoneum the (det)
produced tolerated (parataxis)
titration dosage (nmod)
effect tea (nmod)
flow work (conj)
cancers = (parataxis)
modifications behavioral (amod)
dermatitis atopic (amod)
novel is (cop)
cilostazol inhibitor (compound)
morphine to (case)
enalapril ratio (dep)
rats pan-treated (amod)
lipophages , (punct)
reversed ischemia (nsubjpass)
classifications existing (amod)
discontinuation antibiotic (nmod)
congestion acute (amod)
program patients (nsubj)
2.5 10(6 (conj)
suggested associated (ccomp)
ao of (case)
induced disorder (nmod)
substance inhibits (acl:relcl)
proven , (punct)
one granules (conj)
doses codeine (nmod)
cardiotoxicity low-grade (amod)
have improvement (dep)
increase known (acl:relcl)
case hamartoma (nmod)
consequences possible (amod)
shown misoprostol (nsubjpass)
inhibition production (conj)
% 48.5 (nummod)
screened and (cc)
accumulation ( (punct)
exceed does (aux)
treatment amisulpride (compound)
studied 205 (conj)
precede should (aux)
chloride isotonic (amod)
vacuoles such (amod)
7alpha-hydroxylase and (cc)
animals all (det)
20-fold nearly (advmod)
occurred tachycardia (nsubj)
hypertension bradycardia (conj)
enhances . (punct)
hours every (det)
represented a1 (nmod)
chloride and (cc)
agonist used (acl)
weight heart (compound)
improvement baseline (nmod)
battery test (conj)
related eps (nmod)
synthase-1 in (case)
rats of (case)
antagonized effect (nsubjpass)
reduced partly (advmod)
reached values (dobj)
age length (conj)
slices transverse (amod)
nimesulide with (case)
thalamus of (case)
time ventricular (compound)
children poisoned (acl)
patients sensitive (acl:relcl)
time climbing (compound)
syndrome hepatic (amod)
l-arginine and (cc)
started patient (nsubj)
doxorubicin liposome-encapsulated (amod)
expression aqp2 (compound)
excluded causes (nsubjpass)
remodelling cardiac (amod)
improved stiffness (nsubj)
reflected appearance (nmod)
modulator nicotinic (amod)
true whether (mark)
supervised monitored (conj)
enzymes serum (nmod)
hemodynamics findings (dep)
$ROOT$ satisfactory (sent)
constants currents (nmod)
g/dl 8.5 (nummod)
conclude provides (dep)
bradycardia dose-dependent (amod)
sections caesarian (amod)
behavior animal (compound)
deterioration given (case)
deficient synthase-1 (nmod)
= 3.219 (dobj)
suppression to (case)
profiles prostanoid (compound)
mrna ) (punct)
allows . (punct)
speech and (cc)
induced wakefulness (dobj)
contractions kcl-induced (amod)
reduction , (punct)
mcg/kg ( (punct)
markers angiogenesis (compound)
has lymphomas (nmod)
development initial (amod)
concurrent use (nmod)
donor apheresis (compound)
defects field (compound)
models ordinal (amod)
reduced acetaminophen (nmod)
anemia mice (nmod)
manifests , (punct)
episodes of (case)
effect changes (nmod)
toxicity ns-718 (nmod)
achieves and (cc)
prognosis poor (amod)
seizures pilocarpine- (amod)
cck-8 of (case)
aminonucleoside-induced puromycin (nmod:npmod)
withdrawal ( (punct)
received markers (nmod)
67.9 +/- (cc)
activations cortical (amod)
dlt ) (punct)
included tumors (dobj)
hitt ) (punct)
should follow-up (nmod)
initiate contracting (advcl)
greatest loss (nsubj)
effect achievable (amod)
nystagmus downbeating (amod)
reserpine of (case)
inhibited formation (dobj)
caused epilepticus (nsubj)
analysed data (nsubjpass)
therapy mg (dep)
hypothesis of (case)
months 27 (nummod)
detection non-invasive (amod)
unit neonatal (amod)
changes transient (amod)
barrier brain (compound)
satisfied than (dep)
750 , (punct)
widened doses (dep)
15 60 (conj)
provided are (auxpass)
arteries pulmonary (amod)
development paradigms (nmod)
diuretics and (cc)
given tacrolimus (nsubjpass)
effects attributable (amod)
desipramine cinacalcet (conj)
reduce that (mark)
might affect (xcomp)
obtained injection (nmod)
k p (dep)
mg/kg/day ( (punct)
hydration mannitol (conj)
greater significant (amod)
treatment succimer (compound)
venous thromboemboli (nsubj)
increase patients (nmod)
exerts influence (dobj)
dose rocuronium (nmod)
tolerable and (cc)
occurred it (nsubj)
led reaction (nmod)
l-noarg with (case)
cage the (det)
analysis kidneys (nmod)
resulted changed (advcl)
$ROOT$ multiforme (sent)
formation involved (acl:relcl)
sacrifice days (nmod)
improve to (mark)
pb of (case)
lipid myocardial (amod)
induced loss (dobj)
continued anesthesia (nsubjpass)
occurred illness (nsubj)
bred sensitivity (nmod)
reduced reduced (advcl)
31 - (punct)
mellitus ) (punct)
rats 35 (nummod)
reversed all (nsubj)
did antagonist (nsubj)
high- and (cc)
nuclei caudate (compound)
regimen outpatient (amod)
undergo since (mark)
serum eluates (conj)
analyzed c (nsubjpass)
ligands h(3)-receptor (compound)
given later (advmod)
correlated scores (nmod)
vgpr < (compound)
sulfonylurea a (det)
oct 3000 (nummod)
loss hearts (nmod)
stimulation . (punct)
hyperhidrosis signs (nsubj)
studies after (case)
preserved return (conj)
injections ip (amod)
abolished it (nsubjpass)
causes where (advmod)
bortezomib (bort)-dexamethasone (dep)
levels dehydrogenase (nmod)
recorded ecg (nmod)
chorea encephalopathy (conj)
ruling stress (dobj)
ps ) (punct)
adjusted when (advmod)
type lymphoma (nmod)
prolonged decreased (conj)
ptld , (punct)
completed study (dobj)
ensure does (aux)
peak mg/dl. (nmod)
fluconazole oral (amod)
mu not (cc)
prevention of (case)
pacing movements (conj)
component was (cop)
significance for (case)
discussion a (det)
time latency (compound)
cases as (prep)
advantage model (nmod)
tested serum (nsubjpass)
mineralizes osteoid (nsubj)
effect thc (nmod)
demonstrate cause (ccomp)
30 ( (punct)
detected sample (nmod)
field into (case)
stroke = (dep)
duration monophasic (amod)
therapy uninterrupted (amod)
times 2 (nummod)
cases complication (nmod)
pathogenesis ulcers (nmod)
modifiable help (conj)
observed until (mark)
developed has (aux)
agents indomethacin (nmod)
treated reserpine (nmod)
vivo in (conj)
threshold seizures (nmod)
status physical (amod)
pvn ) (punct)
cases loss (nmod)
irradiation disease (nmod)
gentamicin such (case)
adults cvd (nmod)
mg bort (appos)
illustrate to (mark)
considered have (aux)
score higher (amod)
toxicities haematological (amod)
result effect (nsubj)
effective order (nmod:npmod)
potency selectivity (conj)
now dopamine-1 (nsubj)
shown nitroglycerin (nsubjpass)
contractility disturbances (conj)
hexaaldose a (det)
lower days (dep)
group ibs (compound)
dose increasing (amod)
$ROOT$ adequate (sent)
prolonged longer (conj)
found although (mark)
passes that (mark)
selective unselective (conj)
received worsened (acl:relcl)
prescribed used (conj)
antagonists h1- (compound)
4000hz at (case)
compare to (mark)
caused has (aux)
inpatients 146 (nummod)
was questionnaire (nmod)
risk hyperplasia (nmod)
ml/h ) (punct)
entered . (punct)
mortality effects (nmod)
alopecia mild (amod)
doses considered (acl)
animals receiving (acl)
has and (advmod)
thalidomide neurotoxicity (conj)
regulated where (advmod)
methylphenidate on (case)
chest the (det)
level contamination (compound)
clarification better (amod)
analyses quantitative (amod)
patients fifty-four (nummod)
required studies (nmod)
interaction 2 (dep)
depletion potassium (nmod)
glutamine acid (compound)
showed msec (nmod)
confirmed absence (nsubjpass)
development hypercalcemia (nmod)
area patients (nmod)
improvement slight (amod)
given drops (nsubjpass)
characterization syndromes (nmod)
appears interestingly (advmod)
stage is (cop)
occasion one (nummod)
manoeuvres during (case)
intense 0.001 (dep)
remained well (acomp)
applicators exposed (acl)
. 30 (nummod)
limitation although (mark)
vascular or (cc)
pretreatment salicylate (nmod)
thyroiditis due (case)
obtained females (nmod)
group dexamethasone (compound)
51 29 (conj)
used assessment (nmod)
examined patients (nsubjpass)
monitoring neurologic (amod)
reported 15 (nsubj)
train pulses (nmod)
correlated report (nsubj)
7 of (case)
therapy lithium (compound)
risk . (punct)
distinguished those (nmod)
rigidity intense (amod)
mechanisms both (det)
age dose (conj)
increased output (dobj)
rationale a (det)
underline . (punct)
deposited and (cc)
aneurysm injury (nmod)
problem are (cop)
randomized controlled (dep)
mt hippocampal (amod)
encephalopathy in (case)
initiation in (case)
hyperalgesia and (cc)
pain region (nmod)
under-reporting by (case)
expression transgene (nmod)
rate significant (amod)
investigated terfenadine (dep)
without ph (dep)
respond parturients (nsubj)
include search (nsubj)
mmp-2 adam-17 (conj)
l-dopa mmol (amod)
ozone = (dep)
extended-interval conventional (conj)
concentrations free-calcium (amod)
control moderate-dose (amod)
metoprolol metoprolol-glucagon (conj)
microg/ml , (punct)
few gastrointestinal (conj)
1 found (parataxis)
receptor-alpha pparalpha (appos)
produced altering (advcl)
toxicity retardation (conj)
patient(s . (punct)
combined drug (nsubjpass)
consumers were (cop)
dantrolene with (case)
onset duration (conj)
pain ischemic (amod)
ed1-ed4 ( (punct)
dose ; (punct)
performed examine (xcomp)
benign primary (amod)
eeg with (case)
have trough-concentrations (dobj)
performed present (advcl)
solution between (case)
sah of (case)
levels pb (nmod)
rapamycin formerly (advmod)
lead can (aux)
induce catechol (nsubj)
effect models (nmod)
related rates (nmod)
model one-compartment (amod)
harmless may (aux)
chemotherapy concurrent (amod)
atrophy muscular (amod)
blockade serotonin (compound)
often most (advmod)
i ctni (appos)
nk1 both (cc:preconj)
leukaemia lymphoblastic (amod)
block atrioventricular (compound)
pain associated (amod)
downregulated 3ma (nsubj)
prognosis with (case)
qtp + (cc)
was these (nmod)
received days (nmod)
levels striatal (amod)
kidney other (amod)
level an (det)
was this (nsubj)
comparable outcomes (nsubj)
had also (advmod)
medications. the (det)
mumol 0.2 (nummod)
influenced response (nsubjpass)
five , (punct)
0.85 - (punct)
proliferation demodex (nmod)
cent values (nmod)
clozapine ) (punct)
yield result (nmod)
micromol/l 44.2 (nummod)
exposure ( (punct)
disappeared occurred (advcl)
prevalence a (det)
treatment impotence (nmod)
activity pentose (compound)
hypotension post-spinal (amod)
gavages by (case)
outcome : (punct)
presented review (nsubjpass)
questionaire according (case)
dopaminomimetics and (cc)
switching regimen (dobj)
increased content (nsubjpass)
trial ( (punct)
chorea whose (nmod:poss)
recurrence syndrome (nmod)
tachycardia incessant (amod)
cases vte (nmod)
contribution from (case)
prodrug a (det)
higher normal (nmod)
risperidone such (case)
trial controlled (amod)
found furthermore (advmod)
75/829 % (appos)
dose use (nmod)
similarities neurochemical (amod)
wakefulness and (cc)
$ROOT$ those (sent)
lymphoma but (cc)
time residence (compound)
undergoing induction (dobj)
caused hypertrophy (nsubj)
$ROOT$ angiopathy (sent)
leakage epidural (amod)
% 13/50 (appos)
patients develop (acl:relcl)
component prerenal (amod)
frequent group (nmod)
independent surgery (nmod)
individuals narrowing (nmod)
mmol day (nmod)
found 35 (nsubjpass)
seems therefore (advmod)
represents which (nsubj)
5-hydroxytryptamine stimulation (nmod)
performed thus (advmod)
flow excretion (conj)
cs ( (punct)
tdp with (nmod)
morphine were (cop)
risk vsd (nmod)
receptor d-1 (compound)
dispersion of (case)
0.1 approximately (advmod)
compounds all (det)
increased thus (advmod)
glycopyrrolate kg-1 (dep)
appears related (conj)
inhibited respectively (advmod)
ganaxolone derivative (dep)
index sleep (compound)
formation aneurysm (nmod)
augmentation via (case)
caused whether (mark)
upregulated irritation (nmod)
l/min , (punct)
min to (dep)
ugt ) (punct)
rescues and (cc)
feeling the (det)
loreclezole mg/kg (appos)
found staining (nsubjpass)
feet on (case)
present years (conj)
potentiates thereby (advmod)
studying respectively (advmod)
correlated strongly (advmod)
conformed criteria (nmod)
available and (cc)
duct bile (compound)
time accuracy (conj)
caused nx+hp (nsubj)
5-fluorouracil and (cc)
sensitivity p (appos)
register 1996 (appos)
denopamine micrograms (amod)
showed reversed (ccomp)
formulation sustained-release (amod)
records discharge (compound)
addition mg/dl (nmod)
centre from (case)
expression nephropathy (nmod)
correlate glomerulosclerosis (nmod)
result model (nmod)
organization world (compound)
starting weeks (nmod:npmod)
aminoglycoside used (acl)
delirium from (case)
disturbance psychological (amod)
titrated up (advmod)
patients fifty (nummod)
related disappeared (conj)
neurons of (case)
af cases (dep)
absent minimal (conj)
fold vocal (amod)
reducing pressure (dobj)
cause dysguesia (dobj)
% 115 (nummod)
escalating doses (dobj)
case injections (nmod)
administered daily (advmod)
hypertension ppa-induced (amod)
> not (neg)
patients stages (nmod)
limits confidence (compound)
data of (case)
associated intrinsically (advmod)
induced nicotine (nmod)
% 9.3 (nummod)
antagonized bradycardia (nsubjpass)
problem encountered (acl)
defined parameters (nsubjpass)
disappearing . (punct)
appeared therapy (nsubj)
cs as (case)
collagenase with (case)
take may (aux)
coadministration agent (nmod)
user admitted (amod)
cardiomyopathy doses (nmod)
encephalopathy acute (amod)
reduce mechanism (nmod)
volume micturition (nmod)
ncq436 and (cc)
chemotherapeutics first-line (amod)
excretion total (amod)
baseline from (case)
other = (dep)
methodology following (case)
dams to (case)
excretion li (compound)
similar measures (nsubj)
sensitivity treatment (nmod)
inhibitor monoamine (compound)
salt cse (appos)
aware fully (advmod)
extended diazepam (nmod)
hypoxia due (case)
2.3 to (dep)
modulate anesthetics (nsubj)
combinations chemotherapy (compound)
death disease (nmod)
underwent mice (nsubj)
pyrimidines oxidized (amod)
women 1923 (nummod)
suggesting use (dobj)
risks lung (compound)
examined offspring (nsubj)
37.4 9.3 (conj)
mm 67 (nummod)
crf esrd (appos)
dhea both (cc:preconj)
18 of (case)
testing neuropsychological (amod)
recovery neuritis (nmod)
inconclusive investigations (nsubj)
lost however (advmod)
carcinoma hepatocellular (amod)
vessels medium-size (amod)
swallowing after (case)
evaluate susceptibility (dobj)
$ROOT$ slow (sent)
deposits retinal (amod)
dysfunction cardiomyopathy (conj)
= 16.22 (dobj)
1.01 2.80 (prep)
patient tetraparetic (amod)
tissue lung (compound)
restored responses (dobj)
subgroup each (det)
correlates activation (nmod)
killed toxicity (nmod)
infusion p=0.037 (dep)
shown increased (ccomp)
disorders pd (nmod)
method the (det)
transformation indomethacin (compound)
pain penile (amod)
cultures heart (compound)
regimen dexamethasone-containing (amod)
medication topical (amod)
correlated whether (mark)
damage heart (compound)
has compared (prep)
monitoring for (case)
revealed evidence (dobj)
reported response (nsubjpass)
k- a-variants (conj)
microscopy on (case)
20- 40-micrograms/kg (conj)
serum control (amod)
phosphokinase iu/l (appos)
probable done (conj)
corrected ( (punct)
determine assess (conj)
coexistence sinus (nmod)
result cocaine (nsubj)
concluded effective (ccomp)
attenuated that (nsubjpass)
associated and (cc)
involved rate (nsubjpass)
is explore (xcomp)
acne severe (amod)
found affected (conj)
doses extreme (amod)
varies prevalence (nsubj)
recall to (mark)
jj rats (dep)
extremities cold (amod)
concern safety (nmod)
asked subjects (nsubjpass)
mechanisms on (case)
inhibition deacetylation (nmod)
$ROOT$ nature (sent)
many as (advmod)
properties immunosuppressive (amod)
2)% and (cc)
increase day (nmod)
evaluated contribution (nsubjpass)
groups = (dep)
hh 117.61 (dep)
related cya (nmod)
part to (mark)
associated oxacillin (nmod)
hormone antidiuretic (amod)
men seventy (nummod)
depression to (case)
schedule our (nmod:poss)
livers their (nmod:poss)
achieve . (punct)
used ma (dobj)
background known (dep)
$ROOT$ irrigated (sent)
evidence injury (nmod)
subtests battery (conj)
reappeared day (nmod)
form soluble (amod)
[-]-[5ar,11bs]-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-+ + (cc)
affecting or (cc)
trained vocabulary (nmod)
induced drops (dobj)
combination before (case)
indicating thus (advmod)
therapy before (case)
cause jaundice (dobj)
role deficit (nmod)
formation ( (punct)
hypertension artery (nmod)
patients requiring (acl)
pan or (cc)
surgery/radiotherapy subsequent (amod)
removal bronchoscopic (amod)
underwent that (nsubj)
monitored avoid (advcl)
aki ) (punct)
rise pressure (nmod)
$ROOT$ dose (sent)
documented previously (advmod)
investigated examined (conj)
lymphocytes , (punct)
0.1 or (cc)
cardiotoxicity late (amod)
november 1984 (nummod)
half nearly (advmod)
response avoidance (compound)
predictor 14.3 (parataxis)
diisopropylfluorophosphate as (case)
deposition collagen (nmod)
assays influence (nmod)
57.9 was (cop)
inhibition to (case)
factor hormone (compound)
represent % (dobj)
gds to (dep)
tbm glomeruli (conj)
vehicle 5 (nummod)
stage high-risk (amod)
efficacy sulfate (nmod)
aging disease (conj)
gain of (case)
high suppression (nmod)
pretreatment t. (compound)
occurred . (punct)
strains sensitive (amod)
increased myocardium (nmod)
produced hypotension (nsubjpass)
result improvement (nsubj)
dithiothreitol , (punct)
contributions vasculogenic (amod)
caused group (nmod)
results associated (dep)
agent by (case)
similar clozapine (nmod)
tetany life-threatening (amod)
influx interstitial (amod)
seemed have (xcomp)
modulated activation (nmod)
use before (case)
years follow-up (nsubj)
risk insertion (nmod)
infections 3 (nmod)
carbachol injected (acl)
suggest alpha-mediated (ccomp)
achieved response (dobj)
administered irrigation (nsubjpass)
rigidity mmg (appos)
strong as (advmod)
developed injury (nmod)
penetration the (det)
spike in (case)
stent and (cc)
neuralgia for (case)
fetal adult (conj)
etiology to (mark)
concern more (amod)
gm. weight (nmod)
ester l-name (appos)
exacerbate response (dobj)
effect untoward (amod)
discontinued even (advmod)
mutation prothrombotic (amod)
mm 200 (nummod)
role only (advmod)
treating glaucoma (dobj)
days 3 (nummod)
testing toxicity (compound)
using who (nsubj)
enzymes heart (nmod)
impairment administration (nmod)
patients fifteen (nummod)
nefiracetam dm-9384 (appos)
atpase na+/k+ (compound)
population the (det)
months following (amod)
outcomes transplantation (nmod)
= g (dobj)
mg/kg 2.0 (compound)
seen convulsions (nmod)
relation with (case)
development towards (case)
underwent map (dobj)
mg g (appos)
elucidated results (nsubj)
had d2 (nsubj)
encephalopathy symptomatic (amod)
studied effect (dobj)
predict ) (punct)
artery the (det)
thrombocytopenia or (cc)
stable h (nmod)
observations embryos (nmod)
survived patient (nsubj)
ribavirin such (case)
lack but (cc)
had hematuria (dobj)
pharmacological preliminary (amod)
weeks administration (nmod)
euphoria noted (acl)
substances vasoactive (amod)
reported also (advmod)
eads of (case)
reach rates (dobj)
victims 125 (nummod)
no of (case)
arrest acute (amod)
targeted receptor (nsubjpass)
$ROOT$ appears (sent)
depletions striatum (nmod)
deaths no (neg)
risks ? (punct)
associated concerns (nmod)
levels factors (nmod)
mg/kg/4 0.568 (compound)
reduced pj34 (nsubj)
spots 67 (nummod)
exercised combined (advcl)
attain background (nsubj)
suffered infarction (dobj)
% ci (dep)
protocol included (acl:relcl)
terms changes (nmod)
blocker channel (compound)
content both (cc:preconj)
information auditory (amod)
injection second (amod)
judged have (xcomp)
% 47.1 (nummod)
received cp (dobj)
constant rigidly (advmod)
frequency ambient (amod)
neuropathy , (punct)
requirements glycopyrronium (compound)
remarkable thrombocytopenia (nmod)
seen received (advcl)
obtain rate (dobj)
days days (conj)
10-fold ( (punct)
gemcitabine % (appos)
monotherapy epilepsy (nmod)
tumors adenohypophyseal (amod)
75 to (advmod)
children in (case)
lasting months (nmod)
modulator is (cop)
paralleled reduction (nmod)
function children (nmod)
detection at (case)
lines both (det)
center india (nmod)
icp ) (punct)
lower concentration (nsubj)
r=0.81 p<0.0001 (dep)
means search (nmod)
studies phase (compound)
occurred vessels (nmod)
discontinued suspicion (nmod)
impaired was (cop)
suspect we (nsubj)
disorders some (det)
exposure chronic (amod)
strategies , (punct)
incontinence stress (compound)
importance supplementation (nmod)
p > (amod)
glutamate aspartate (conj)
levels magnesium (compound)
complications remifentanil-related (amod)
temperature hyperthermia (conj)
azotemia infections (conj)
map mmhg (dep)
examinations serial (amod)
increased ml/s (nmod)
activities for (case)
ellman of (case)
implicated tenofovir (nsubjpass)
donors with (case)
microangiopathy patient (nmod)
sarcolemma cardiomyocytes (nmod)
response the (det)
dose microl (nmod)
entry to (case)
4.3 ) (punct)
mimic exposures (dobj)
important recognize (xcomp)
tablets ) (punct)
symptoms schizophrenic (nmod)
accepted are (auxpass)
group intralipid (compound)
evidenced intensity (nmod)
administration for (case)
safety efficacy (conj)
terminals fibre (compound)
point prespecified (amod)
simvastatinezetimibe escitalopram (conj)
dogs those (conj)
risk outcome (nmod)
stratified chemotherapy (nmod)
reductions failure (conj)
rash = (dep)
risk thrombosis (nmod)
induced dh (nsubjpass)
improved animals (advcl)
those patients (nmod)
coordination force (compound)
pretreatment dose (nmod)
indicates and (cc)
fashion double-blind (amod)
damage can (aux)
investigate ameliorated (ccomp)
activities dehydrogenase (compound)
carried decompression (nsubjpass)
nausea or (cc)
risks study (nmod)
show year (nmod)
reaction the (det)
infusion compared (case)
score score (conj)
2.17 ( (punct)
detected we (nsubj)
normal content (nsubj)
developed anuria (nmod)
increased 109 (nmod)
shows replicate (ccomp)
studied monkey (nmod)
time their (nmod:poss)
exceed that (mark)
had anxiety (conj)
volume output (conj)
have sod (nsubj)
reported was (ccomp)
torr 61 (nummod)
work the (det)
null in (case)
range toxic (amod)
limited been (auxpass)
concluded was (auxpass)
taking bendrofluazide (dobj)
all in (case)
those neuroleptics (nmod)
felt , (punct)
potentiated treatment (nsubj)
period 10-year (compound)
enzymes for (case)
$ROOT$ associated (sent)
become when (advmod)
seizures maximal (amod)
decreased rate (nmod)
increases it (nsubj)
gestation for (case)
effect mortality (nmod)
catalepsy locomotion (conj)
blunted treatment (nsubj)
satisfied were (cop)
produced hernias (dobj)
drugs aap (nmod)
count signs (conj)
shape erythrocytes (nmod)
fields ( (punct)
site glycine (compound)
sequelae with (case)
observed nsaids (nsubjpass)
te ( (punct)
lower mean (nsubj)
9 12 (conj)
injury no (det)
microg/ml 8.3 (nummod)
plays neurotoxicity (nmod)
doses administered (acl)
11.9 1.0 (nummod)
selection : (punct)
subregion any (det)
histories insufficient (amod)
period critical (amod)
illustrate , (punct)
aspirin on (case)
limbs the (det)
m group (compound)
personality , (punct)
blanching and (cc)
consolidation the (det)
measured latency (dobj)
aortic and (cc)
returned stopping (advcl)
weight staining (conj)
inserts package (compound)
presence leukemia (nmod)
withdrawn sirolimus (nsubjpass)
months results (nsubj)
ulcer parameters (conj)
venous or (cc)
impaired tjs (nsubj)
hilus hippocampal (amod)
strains all (det)
from 2 (nmod)
3722 and (cc)
ctni ng/ml (appos)
av ) (punct)
absence explanation (nmod)
sufficient achieve (xcomp)
recommenced was (auxpass)
confirmed presence (dobj)
focused malformations (nmod)
received occurred (advcl)
known influence (xcomp)
spasm also (advmod)
defects pyeloureteral (amod)
mice from (case)
electroretinography ( (punct)
subtypes alpha2-adrenoceptor (compound)
fluency for (case)
content by (case)
adjustment appropriate (amod)
b = (parataxis)
randomized methods (nsubjpass)
analogue and (cc)
increased resulting (advcl)
ventilation in (case)
artery ica (appos)
morphine or (cc)
normalized daily (advmod)
heparin citrate (conj)
e2 ( (punct)
proliferation enhanced (amod)
examination liver (nmod)
than presence (nmod)
5-fold to (dep)
prevention 1 (dep)
cause anemia (dobj)
disease steinert (nmod:poss)
study looking (acl)
group 16 (dep)
cases 10 (nummod)
lisinopril with (case)
weeks stopping (advcl)
acetate zinc (compound)
years menopause (nmod)
carcinoma advanced (amod)
univariate adjusted (conj)
cases thirteen (nummod)
complication leukoencephalopathy (nsubj)
patients att-alf (amod)
changes biochemical (amod)
effects developmental (amod)
due increase (nmod)
pain transmitted (amod)
pakt ( (punct)
clozapine vs (cc)
linn mangifera (compound)
administered evaluate (advcl)
has a (nsubj)
monotherapy as (case)
seconds forty-two (nummod)
points time (compound)
reports phenomena (nmod)
discontinued misoprostol (nsubjpass)
sulindac of (case)
reduced tended (conj)
2pam ) (punct)
induced dose (nmod)
slower clearly (advmod)
ischemia before (case)
responsible structures (nsubj)
coingested have (aux)
accumulation sites (nmod)
seen that (mark)
complications cardiovascular (amod)
compared midazolam (nsubj)
toxic lindane (nsubj)
exacerbation an (det)
concentrations " (punct)
occurred as (mark)
injection and (cc)
hh : (punct)
$ROOT$ emit (sent)
comparison mask (nmod)
exerted that (mark)
tachycardia , (punct)
acetate , (punct)
increased frequency (nsubj)
ng/ml 526 (nummod)
degree second (amod)
used has (aux)
docetaxel plus (cc)
databases register (appos)
lesion post (case)
group stn (compound)
production local (amod)
frequently , (punct)
dissociate phenomena (nmod)
died had (ccomp)
rate that (advmod)
inhibited , (punct)
reduces model (nmod)
well-tolerated . (punct)
treated epo (nmod)
interaction treatment (nmod)
present patient (nmod)
phagocytosis cells (nmod)
parathyroid ion (conj)
switch the (det)
staff alert (amod)
[na]o and (cc)
protocol all (compound)
implantation and (cc)
decreased 76 (nmod)
protein acidic (amod)
drugs anti-thyroid (amod)
0.52 , (punct)
1.8 +/- (cc)
received dox (dobj)
occurred antibodies (nmod)
% 12.7 (nummod)
avp ( (punct)
bonding of (case)
atpase k+ (compound)
prod ndma-d (conj)
addition list (nmod)
ablation liver-specific (amod)
chance higher (amod)
treatment antagonist (nmod)
neuroplasticity detrimental (amod)
studies all (det)
decompression patients (nmod)
p<0.01 all (dep)
worker one (nummod)
events vnr (compound)
diverse and (cc)
administration vasopressor (compound)
efficiency to (case)
investigated value (dobj)
period 3-week (amod)
undertaken were (auxpass)
requirement months (nmod)
ovx ) (punct)
control adjusting (amod)
withdrawal sympathetic (amod)
deaths county (nmod)
patients cells/mm3 (nmod)
assessed catheterisation (nmod)
reduced rats (advcl)
block sinoatrial (compound)
markers depletion (conj)
lesions similar (amod)
ion platinum (compound)
decreased g. (nmod)
performed is (auxpass)
decrease similar (amod)
rare nodosum (nsubj)
pretreatment 5-day (amod)
external skeletal (conj)
activity combinations (conj)
aes in (case)
cyclosporine to (case)
potential management (nmod)
exposure lead (compound)
$ROOT$ reduce (sent)
enhanced antagonized (conj)
increased is (auxpass)
analyzed later (advmod)
physiology pharmacology (conj)
paramethasone by (case)
study ephedrine (nmod)
indicate : (punct)
stenosis % (compound)
parts in (case)
undertaken study (nsubjpass)
observations patient (nmod:poss)
pa only (advmod)
thioperamide of (case)
divided days (nmod:tmod)
fibrin of (case)
response generalized (amod)
increasing that (mark)
horns the (det)
variant bche (compound)
producing trigger (dobj)
malignancy arthritis (nmod)
mentioned above (advmod)
dose lithium (nmod)
edema hypertension (conj)
mg/kg 24 (nummod)
days and (cc)
myoclonus clinical (amod)
lower < (dep)
agitation shouts (conj)
confirmed damage (dobj)
way by (case)
headache with (case)
emerged forms (nsubj)
progress subsequently (advmod)
echocardiography transthoracic (amod)
thrombosis secondary (amod)
carcinoma colon (compound)
infections staphylococcal (amod)
hypocalcemia to (case)
unrelenting therapy (nmod)
neurons extent (conj)
necrosis cells (nmod)
intima media (conj)
terms percentage (nmod)
symptoms nephrolithiasis (nmod)
striatum into (case)
reduces hypotension (nmod)
ml 62.5 (nummod)
measurement than (case)
two one (quantmod)
demonstrate enhance (ccomp)
profile thioperamide (nmod)
prevent that (mark)
increased time (nmod)
aspirin or (cc)
conclusion lend (appos)
sleep rem (amod)
expressed prominently (advmod)
assess testing (nmod)
associated used (conj)
seizure-free . (punct)
side-effects , (punct)
abolished only (cc:preconj)
perception velocity (conj)
differentiated briefly (advmod)
materials : (punct)
described report (nmod)
resulted epilepticus (nsubj)
undergo biotransformation (dobj)
herbicides n-phenylimide (compound)
injection mice (nmod)
case investigating (acl)
clarified aspects (nsubjpass)
hypertension induced (amod)
showing is (aux)
submitted . (punct)
nausea ( (punct)
goes still (advmod)
deafened were (auxpass)
stress with (case)
survivals pfss (appos)
worsened toxicity (dobj)
that control (nmod)
lead improvement (nmod)
drug mitotic (amod)
mm3 100 (nummod)
needed appearance (nmod)
consider avoid (advcl)
percent 39 (nummod)
therapy antimicrobial (amod)
had features (nmod)
fever c (appos)
receive ce (nmod)
genotyped were (auxpass)
endonuclease-dependent independent (conj)
cpap ) (punct)
terminated hypokinesis (nmod)
30 1 (compound)
problem red (amod)
task complex (amod)
membranes and (cc)
excretion ammonia (nmod)
1000 - (punct)
angioedema known (acl)
less than (prep)
combined we (nsubj)
withdrawal woman (nmod)
tacrine e-2020 (conj)
effect naloxone (nmod)
observed growth (nsubjpass)
procedure , (punct)
endonuclease-dependent ( (punct)
faced when (advmod)
pressure supine (amod)
actions locomotor (amod)
paralysis respiratory (amod)
doses subcutaneous (amod)
encephalopathy need (dep)
velocities with (case)
implicated carbamazepine (nsubjpass)
type ii (nummod)
had manifestations (dobj)
influence . (punct)
flestolol acc-9089 (appos)
integrins by (case)
$ROOT$ hypothesized (sent)
took he (nsubj)
refractory anticonvulsants (nmod)
british black (amod)
annuloplasty mitral (amod)
oximetry pulse (compound)
associated hyperplasia (nsubjpass)
hyperactivity d-amphetamine-induced (amod)
used whether (mark)
lack receptors (nmod)
dyskinesia wearing-off (conj)
degree response (nmod)
gastrocnemius ) (punct)
antioxidant a (det)
mass proteinuria (conj)
prevalence greater (amod)
$ROOT$ assessable (sent)
induction after (case)
6/31 26/31 (conj)
kg respectively (advmod)
rat hypoxia-sensing (amod)
breathing air/oxygen (dobj)
occur do (aux)
characterized best (advmod)
advised that (mark)
blocked gspe (nmod)
glomerulonephritis associated (acl)
eosinophil cells (conj)
confirmed it (nsubjpass)
depression impulsiveness (conj)
remained level (nsubj)
deaths infectious (amod)
establish events (nsubj)
n/n=25/26 , (punct)
data us (compound)
end days (nmod)
overtreatment ethambutol (compound)
15 44 (prep)
gag/pol nl4 (compound)
calpain 1 (nummod)
kept days (nmod)
populations clinical (amod)
women 65 (nummod)
person a (det)
evaluated data (dobj)
mg/kg trazodone (nmod)
baseline over (case)
describe induction (dobj)
9.1 +/- (cc)
infants premature (amod)
unremarkable history (nsubj)
potential tumor (compound)
8 ) (punct)
sertraline to (case)
detection effects (nmod)
cpa/ee of (case)
38 6 (conj)
lid the (det)
1.1 ic (nsubj)
reversal catalepsy (nmod)
kinetics slow (amod)
ifosfamide and (cc)
known leads (ccomp)
daily twice (advmod)
applicators male (amod)
remained thrombo-embolism (nmod)
prominent and (cc)
therapy carbonate (compound)
domain apical (amod)
g/d 12 (nummod)
developed 15 (nsubj)
increasing downregulating (conj)
prolongation , (punct)
valsartan plus (cc)
detection movement (conj)
sustained lowering (nmod)
reports paper (nsubj)
amide acid (compound)
technique adults (nmod)
4.9 0.8 (compound)
93129 microg/side (appos)
drugs reappraisal (dep)
evaluation eeg (compound)
resulted increase (nsubj)
ct during (case)
reports changes (dobj)
accurately very (advmod)
ut-a1 ( (punct)
potency aniracetam (nmod)
tetrabenazine with (case)
activate pathway (dobj)
visit one (nummod)
involve did (aux)
emerged period (nmod)
remains speculative (xcomp)
was modification (nmod)
applied crocin (nsubjpass)
vaccine hepatitis (compound)
establishment paradigm (nmod)
ratios 21 (nmod)
fibrillation paroxysmal (amod)
pressure glomerular (amod)
terbutaline t.i.d. (advmod)
factors influencing (acl)
dose 10- (nummod)
combined especially (advmod)
occur epilepticus (nmod)
stretching with (case)
survival months (nmod)
bumetanide pravastatin (conj)
aggressiveness twitches (conj)
delineating for (mark)
predictive ratios (nmod)
found p (dep)
received follows (advcl)
had values (dobj)
adalat ( (punct)
use recreational (amod)
infant birth (nmod)
learning ( (punct)
hospitalized hospital (nmod)
expression 1a1/1a2 (nmod)
drugs common (amod)
phenobarbitone of (case)
disruption effect (nsubj)
azelastine treatment (nmod)
captopril-treated control (conj)
20 40 (conj)
background focused (dep)
users outpatient (amod)
episode during (case)
hypersecretion prostaglandins (nmod)
weeks fourteen (nummod)
moment event (nmod)
agents class (compound)
indicating consequence (ccomp)
developed follow-up (nmod)
patterns dosings (nmod)
performance high (amod)
dynamic md (appos)
activities nte (compound)
present bodies (nsubj)
decreased 107 (nmod)
occurred shunt (nsubj)
idm ( (punct)
published unpublished (conj)
metoclopramide after (case)
sweating anxiety (conj)
metabolism hepatic (amod)
led anesthesia (nsubj)
cancer n=656 (dep)
employed are (auxpass)
micrograms/kg/d 5 (nummod)
toxicity relative (amod)
clinic hospital (nmod)
demonstrating damage (dobj)
+/- ) (punct)
animals killed (acl)
repeated be (auxpass)
disease worldwide (advmod)
$ROOT$ hyperactive (sent)
venous and (cc)
patients in (case)
absent time (nmod)
alpha2-adrenergic receptor-mediated (conj)
distributions lobular (amod)
$ROOT$ difficult (sent)
started be (auxpass)
constriction marked (amod)
methods comprised (appos)
response its (nmod:poss)
129 0.6 (conj)
maneuver a (det)
increased strains (nmod)
related toxicity (nsubj)
associated block (nmod)
antagonized however (advmod)
beats ectopies (conj)
pn 11 (nummod)
placebo ) (punct)
p and (cc)
expressed that (nsubjpass)
members plan (nmod)
decreases increases (conj)
used widely (advmod)
criteria ( (punct)
agency effects (nmod)
potentiates also (advmod)
studies culture (compound)
km pyrophosphate (nmod)
supplementary and (cc)
infarction on (case)
increase resulting (advcl)
hg 30 (nummod)
capable considered (conj)
posturing abnormal (amod)
immunohistochemistry model (nmod)
four toxic (conj)
elicited sequelae (dobj)
unable was (cop)
infections tract (compound)
number protocols (nmod)
albumin plasma (compound)
occlusion and (cc)
provided reduced (conj)
occurrence uncommon (amod)
hematologic nonhematologic (conj)
cholecystokinin-octapeptide peptide (acl:relcl)
produced rats (nsubj)
hepatitis recorded (advcl)
methods by (case)
blocks ( (punct)
ranged 248 (nmod)
allowed line (parataxis)
min 2.21 (nummod)
e-fortified vitamin (nmod:npmod)
concentrations cortisol (compound)
center snr (nmod)
pain mi (conj)
release in (case)
process that (mark)
women exclusively (advmod)
tasks type (compound)
pyridoxine intramuscular (amod)
dexmedetomidine , (punct)
cavity , (punct)
micrograms/kg/d factor (compound)
benefit toxicity (conj)
aspirin ( (punct)
scale impressions (compound)
has stopped (conj)
spaces the (det)
outcomes neurocognitive (amod)
measure(s occlusion (appos)
consumption about (case)
child 5-year-old (amod)
published already (advmod)
expressed seems (conj)
nystagmus nicotine-induced (amod)
confirmed angiography (nsubj)
hyperhidrosis of (case)
subthalamotomy improved (acl:relcl)
erythematodes of (case)
common sensations (nsubj)
adr+los(12 group (compound)
degeneration some (det)
appears method (xcomp)
administration risperidone (compound)
androgens , (punct)
sixth and (cc)
acetate alpha-tac (appos)
impart risperidone (nmod)
selectivity their (nmod:poss)
mg/m(2 intensity (nsubj)
allowed investigating (xcomp)
diagnosed she (nsubjpass)
$ROOT$ interpreted (sent)
mv 0.05 (nummod)
conclusions recommended (dep)
involvement parenchymal (amod)
affected attention (nmod)
differences hds (nmod)
change icp (nsubj)
pesticide . (punct)
was myeloperoxidase-anca (nsubj)
established therapies (nsubjpass)
diethylnitrosamine simultaneously (advmod)
doses animals (nmod)
declined were (aux)
placebo atenolol (conj)
failure disease (conj)
affected syndrome (nsubjpass)
exhibit would (aux)
remains value (nmod)
exposed utero (nmod)
attention less (amod)
toxicity carbonate (compound)
action this (det)
repair fracture (compound)
development treatment (nmod)
developed hepatitis (dobj)
option as (case)
number this (det)
pressures baseline (compound)
cases myositis (nmod)
reduced hds (nmod)
hypertrophy mice (nmod)
resulted whether (mark)
increase sensitivity (nmod)
docetaxel or (cc)
case necrolysis (nmod)
hyperactivity produced (acl)
yrs 45.6 (nummod)
comparison values (nmod)
serving albumin (nsubj)
ten which (nmod)
massive the (det)
confounds that (mark)
pressure voiding (compound)
cause spite (nmod)
targets injury (nmod)
concordance with (case)
cells bladder (compound)
constriction bilateral (amod)
decreased clearance (dobj)
colocalized p75(ntr)-ir (nsubjpass)
case recurarization (nmod)
51 12 (conj)
did analysis (dobj)
showed . (punct)
exacerbated dose-dependently (advmod)
receptors nachrs (appos)
rate low (amod)
suggest action (nsubj)
transplant autologous (amod)
form to (mark)
role cancer (nmod)
induced csa (nmod:npmod)
effects 17beta-estradiol (nmod)
promotes which (nsubj)
infarction recent (amod)
finished trial (dobj)
69 1080 (compound)
% interval (dep)
hypoxaemia significant (amod)
affinity moderate (amod)
hr over (case)
inducible ethanol (nmod:npmod)
suggests candidate (ccomp)
dihydrochloride activator (appos)
related 48 (nsubj)
portions lung (compound)
depression mdp (appos)
avoided that (mark)
believed was (auxpass)
ferritin or (cc)
km and (cc)
cascade an (det)
desire phase (conj)
shown or (advmod)
modulated system (nsubjpass)
background complicated (dep)
study ongoing (amod)
components the (det)
transfusion cell (compound)
bound . (punct)
reported addition (nmod)
pretreatment naloxone (nmod)
nicotine injected (amod)
pneumonia two (nmod)
neonates high-risk (amod)
cancers head (compound)
present presentation (nmod)
remained contractility (nsubj)
hypomania to (case)
carboplatin doxorubicin (conj)
antagonized assay (nmod)
cephalothin ampicillin (conj)
appeared pathway (nsubj)
microg ( (punct)
infiltration lumen (nmod)
dianabol ( (punct)
produced initiating (advcl)
bradycardia requiring (acl)
rush or (cc)
enhance may (aux)
expression levels (nmod)
in weaker (conj)
exhibited staining (dobj)
carried , (punct)
responses mean (amod)
times four (nummod)
treatment cystitis (nmod)
undergoing and (cc)
presented patient (nsubjpass)
shown protect (xcomp)
revealed scans (nsubj)
p<.001 ] (punct)
done assess (xcomp)
effect consistent (amod)
given bolus (nsubjpass)
unfamiliar that (nsubj)
related cyclosporine (nmod)
acc-9653 sodium (conj)
region factor (compound)
reliable non-invasive (conj)
severity ratios (conj)
received children (nsubj)
administration intermittent (amod)
gssg in (case)
thickness pulmonary (amod)
microg/kg/min min (nmod)
il-1b tnf-a (conj)
reversed dce (nsubj)
dependent dose (nmod:npmod)
dismutase such (case)
continued all (nmod)
dexamethasone m (compound)
concluded therefore (advmod)
efficacious whether (mark)
highlights cardiotoxicity (nsubj)
affected drugs (nmod)
more than (mwe)
aminophylline of (case)
administration central (amod)
identified output (nmod)
sulphate [ (punct)
smaller mm (dep)
change an (det)
thiazole-2-carboxamide [ (punct)
rotation this (det)
period days (nmod)
simplifies treatment (dobj)
female , (punct)
dose drug (acl:relcl)
effects scintigraphy (nmod)
benign malignant (conj)
reviving nephrotoxicity (nsubj)
factors risk (compound)
indicated reduction (nmod)
calculi multiple (amod)
failure rat (nmod)
pallidotomy after (case)
$ROOT$ levetiracetam (sent)
depressants by (case)
relationship cause-and-effect (compound)
occurred minute (nmod)
approved treatment (nmod)
epithelium mastocytosis (conj)
supplement sirolimus (nsubj)
54 20 (compound)
measurement activity (nmod)
immunolocalization 7h6 (nmod)
months 2 (nummod)
commencement at (case)
attention by (case)
produced impairments (dobj)
iddm ( (punct)
users two (nsubj)
syndromes response (conj)
suggest observations (nsubj)
15 45 (conj)
release prl (compound)
lesion from (case)
comparison outcomes (dep)
patient wilson (nmod:poss)
toxic vincristine-induced (dep)
performance total (amod)
ability feeling (advcl)
doses mesna (compound)
dibucaine and (cc)
hctc ( (punct)
strategies new (amod)
cortex groups (nmod)
experiments of (case)
got suspected (advcl)
% from (case)
boys dystrophy (nmod)
efficacy the (det)
aneurysms on (case)
passed tourniquets (nmod)
killed removed (conj)
examined sensitivity (nsubjpass)
administered catheter (nmod)
patients returned (acl:relcl)
angioedema of (case)
follows aminotransferase (conj)
patients subsides (acl:relcl)
pacemakers nodal (amod)
gauges and (cc)
had but (cc)
results suppressed (appos)
eyes all (det)
deficits users (nmod)
satisfied if (mark)
termed mean (nsubjpass)
role subunits (nmod)
sensitizing injury (nmod)
-tacrolimus fk (appos)
decreases 4000hz (nmod)
intake therapeutic (amod)
prevented that (mark)
peroxide lpo (appos)
lungs , (punct)
status 1 (nummod)
tended side-effects (nsubj)
change noticeable (amod)
1.55 ) (punct)
occurred events (nsubj)
history medical (amod)
exhibited cluster (nmod)
diagnosed hours (nmod:tmod)
% 54.4 (nummod)
erection behavior (conj)
blockade of (case)
delirium such (case)
creams chp (compound)
stay inpatient (amod)
12.3 ) (punct)
arteries in (case)
studied extent (nsubjpass)
contributor effects (nmod)
completed 582 (nummod)
two one-half (conj)
products and (cc)
biopsies transplant (compound)
correlation = (parataxis)
neurons areas (nmod)
rate upon (case)
factors case (nmod)
12 ( (punct)
blood autopsy (compound)
pre-treated melatonin (nmod)
died patient (nsubj)
sedation conscious (amod)
applicability practice (nmod)
some which (nmod)
inflamed and (cc)
male a (det)
co-morbidity and (cc)
development versus (cc)
$ROOT$ actives (sent)
evaluates influence (dobj)
tachycardia pointes (nsubj)
physiology acute (amod)
v/v ) (punct)
mdm to (case)
carried test (xcomp)
effect acuity (nmod)
therapy single-dose (amod)
valsartan or (cc)
dyskinesia in (case)
exist rationale (dobj)
stimuli and (cc)
assessed results (nsubjpass)
alf=0/35 cld=2/34 (appos)
level lithium (compound)
relation cause-and-effect (compound)
haplotypes the (det)
extract in (case)
had woman (nsubj)
metabolizer drugs (nmod)
studied dyscrasias (nsubjpass)
defects patients (nmod)
report one (nummod)
receive it (nmod)
toxicity citrate (compound)
cancers various (amod)
results promising (amod)
kg , (punct)
750 500 (nummod)
old , (punct)
involvement with (case)
4.8 ) (conj)
assessed be (auxpass)
alternation test (nmod)
properties biological (amod)
women among (case)
university at (case)
derivative ) (punct)
scale mania (compound)
mac ) (punct)
use minoxidil (compound)
produces therapy (nsubj)
ameliorated lowered (conj)
associated disarrangement (nmod)
ccl4 ( (punct)
markers among (case)
phosphatase and (cc)
failed clinically (advmod)
intravenous and (cc)
pressure atm (nmod)
or functionally (advmod)
killed determine (xcomp)
cocaine be (conj)
staining nfs (nmod)
provided nanoparticles (nsubj)
injections for (case)
absent surprisingly (advmod)
clonidine physostigmine (conj)
if and (cc)
displayed groups (nsubj)
saline nicotine (conj)
those hearing (nmod)
report levofloxacin (conj)
s.c. naloxone (compound)
forgetting long-term (amod)
showed ratio (dobj)
matched cases (nsubjpass)
recovery of (case)
case literature (nmod)
pathogenesis defects (nmod)
variable damage (nsubj)
fasciculations and (cc)
had sings (dobj)
quality the (det)
administration cimetidine (compound)
developed vasculitis (dobj)
dysmyelopoiesis marrow (conj)
is to (case)
pain any (det)
= 0.022 (dobj)
intoxication with (case)
baseline and (cc)
results required (appos)
keratectomy laser (compound)
alternative powerful (amod)
p.o. ) (punct)
confirm to (mark)
woman 32-year-old (amod)
patients subjected (acl)
promotion on (case)
3.0 and (cc)
decrease infection (dobj)
associated hyperkalemia (nsubj)
interview this (det)
brought directly (advmod)
cases carcinoma (nmod)
hg rats (nmod)
treated prophylactically (advmod)
manage properly (advmod)
induces rats (nmod)
clinic research (compound)
fluctuations ( (punct)
tnf and (cc)
acute ( (punct)
surgery following (case)
described . (punct)
area injury (nmod)
drug useful (amod)
improve resolve (conj)
produced epinephrine (nmod)
5967 40 (compound)
identified can (aux)
dextran polymer (compound)
showed 62 (nsubj)
shows analysis (nsubj)
microgram/kg fentanyl (compound)
0.007 ( (punct)
patients non-dyskinetic (amod)
relationship inverse (amod)
distributions junctions (nmod)
remained impaired (acomp)
back-diffusion release (conj)
concentration arrhythmia (nmod)
generator migraine (compound)
incidence dysfunction (nmod)
follow-up report (dep)
measures morbidity (nmod)
parameters both (det)
aneurysms or (cc)
development maintenance (conj)
limit that (nsubj)
activity similar (amod)
diagnosing for (mark)
metabolism patients (nmod)
paracetamol by (case)
patients crf (compound)
treatments disease (nmod)
antagonist d2-receptor (compound)
effectiveness crocin (nmod)
times separate (amod)
benefits ht (nmod)
method induced (appos)
scale akathisia (compound)
recommended examination (nsubjpass)
levetiracetam added (acl)
fits the (det)
t1/2 ) (punct)
chloride tetrazolium (compound)
estimated risk (nsubjpass)
administration together (advmod)
mice 15/44 (nummod)
sole the (det)
patients medication (nmod)
cyclophosphamide 96-h (amod)
channels na(v)1.6 (nummod)
giving before (mark)
abilities cs (nmod)
cortex not (neg)
added increased (dep)
preclude use (dobj)
= 0.63 (dobj)
patients retinoblastoma (nmod)
vaccinated who (nsubjpass)
used medicine (nmod)
women participating (amod)
hypertrophy/cytomegaly vacuolation (conj)
supervised administration (dobj)
inhibition ( (punct)
measured particles (nmod)
equina cauda (compound)
been ( (punct)
restarted indicated (advcl)
treated additionally (advmod)
hypertension essential (amod)
dfmo sulindac (conj)
examination , (punct)
conclude report (ccomp)
fluorobenzylidene ( (punct)
on injection (nmod)
tocolysis nifedipine (nmod)
considered crocin (nsubjpass)
subset patients (nmod)
present amount (nmod)
proven untreated (conj)
disappeared reappeared (conj)
dermatitis between (case)
usage drug (compound)
risk higher (amod)
creatinine greater (amod)
acetyltransferase , (punct)
was reduction (nsubj)
toxicity blinding (amod)
preserved and (cc)
dyskinesia parkinsonism (conj)
tdp. acquired (amod)
wt mug/g (nummod)
fibroblasts from (case)
dose-dependent maximum (advcl)
injection duration (nmod)
elements in (case)
v2.0 test (compound)
induces ng-nitro-l-arginine (nsubj)
advanced locally (advmod)
3-methylcholanthrene of (case)
cause first (advmod)
level achieved (acl)
need obtained (xcomp)
metabolite ( (punct)
effects pallidotomy (nmod)
elucidate have (conj)
compromise by (case)
maleate hydrogen (compound)
n=2.8+/-1.09 ) (punct)
gaba areas (nmod)
hours mg/m2/24 (nummod)
leads dose (nsubj)
resulted seizures (nmod)
measurements sequential (amod)
heparin low-molecular-weight (amod)
relaxation endothelial-dependent (amod)
rhythm alternating (amod)
abnormalities reported (amod)
induced alterations (dobj)
caused hypertension (nmod)
enanthate fluphenazine (compound)
decreases activities (nmod)
compound noniodinated (amod)
somnolence treatment-emergent (amod)
46 19 (conj)
impact conditions (nsubj)
line cell (compound)
associated misoprostol (nsubjpass)
been occurred (ccomp)
antagonist a (compound)
elevation baseline (nmod)
is remains (conj)
remain . (punct)
exacerbation of (case)
effusion pleural (amod)
cardiotoxity . (punct)
viracept combination (nmod)
erythematosus and (cc)
dosages isoproterenol (nmod)
1.0 +/- (cc)
volume % (appos)
goes , (punct)
remains determined (xcomp)
response vivo (advmod)
concentrations g/dl (nmod)
calcium dose (compound)
presented when (advmod)
abolished which (nsubjpass)
keeping appointment (compound)
delineated been (auxpass)
tarsorrhaphy a (det)
channel sodium (compound)
rats sampled (acl)
pathways through (case)
discharges elicited (acl:relcl)
akinesia , (punct)
transplantation an (det)
saline also (advmod)
liver mice (nmod)
type methods (dep)
unrelenting shown (advcl)
imbalance may (aux)
change gr (nsubj)
appears combination (nsubj)
seen hus (nmod)
action to (case)
times night (nmod)
using model (dobj)
formulations between (case)
require to (mark)
suggested and (cc)
concentration hemoglobin (compound)
application and (cc)
normal ecg (nsubj)
alterations cytological (amod)
treat safely (advmod)
using mask (dobj)
sgk1 the (det)
delirium dementia (conj)
potentials compound (amod)
extracted ginseng (nmod)
affecting parameter (dobj)
climate a (det)
rhabdomyolysis abusers (nmod)
mouth patients (nmod)
decreases development (nsubj)
studies subjects (nmod)
treated adr (nmod)
seen while (mark)
induces malformations (dobj)
causes epilepticus (nsubj)
push intravenous (amod)
reports morphine (nmod)
tested test (nmod)
damage in (amod)
patients hypersensitivity (nmod)
pma nm (amod)
vasculitis panca-positive (amod)
studies in (amod)
admission , (punct)
cycles 192 (nummod)
injections pan (nmod)
staining cresyl (compound)
-21.3 respectively (advmod)
less 0.01 (nmod)
recruited 1993 (nmod)
applied are (auxpass)
replaced agent (nmod)
converted phenytoin (nmod)
associated drugs (nmod)
shifts frequency (nmod)
iodixanol of (case)
conditions test (compound)
evaluate we (nsubj)
synthesis n-pyrimidinyl-2-phenoxyacetamides (nmod)
efficient doses (nmod)
decompression and (cc)
roles physiologic (amod)
involved mediating (advcl)
precautions despite (case)
applied clarify (advcl)
recognized and (cc)
neurons afferent (amod)
identified enrolled (conj)
rats srl-treated (amod)
figures corresponding (amod)
analog octreotide (dep)
areas of (case)
association therapy (nmod)
aspirin alone (advmod)
necrosis nephritis (conj)
potential torsadogenic (amod)
cycles the (det)
occurs whether (mark)
diminish treatment (nsubj)
cp . (amod)
use sustained-release (amod)
patients mm (nmod)
testing convulsions (nmod)
cbd 60.44 (appos)
precursor nos (appos)
injury kidney (nmod)
true is (cop)
0.41 0.02 (compound)
was p>0.05 (parataxis)
adrenergic muscarinic (conj)
exhibited mitochondria (advcl)
psa rising (amod)
cost direct (amod)
dis neurobiol (compound)
reduction doses (conj)
translocation calpain (nmod)
inhibitors their (nmod:poss)
doses supplement (compound)
monoxide carbon (compound)
moving and (cc)
localized preferentially (advmod)
recorded markers (nsubjpass)
hallucinations auditory (amod)
start symptoms (nmod)
responsible hepatitis (nmod)
profile haloperidol (nmod)
angina ( (punct)
constitutes % (dobj)
treatment carboplatin (compound)
contrast hypotension (nmod)
$ROOT$ chemotherapy (sent)
phenotype deficits (conj)
vip and (cc)
lesion neuronal (amod)
thickness index (appos)
span digit (compound)
test a (det)
thrombin of (case)
leads v5 (conj)
mg/ml 1.0 (nummod)
patients injury (compound)
neurotoxicity paclitaxel (nmod)
score pretreatment (dep)
procoagulant anticoagulant (conj)
results test (compound)
angiography computerized (amod)
risk recurrence (nmod)
brainstem caudal (amod)
expression population (nmod)
antagonized be (auxpass)
alpha ( (punct)
monkeys 15 (nummod)
study e8188 (appos)
deposition causing (acl)
prescribed satisfied (advcl)
treated clonidine (nmod)
admitted are (auxpass)
t+a , (punct)
understand consequences (dobj)
tcr ( (punct)
variable could (aux)
ureter bladder (conj)
sensitivity effects (nmod)
sodium na (appos)
tma tacrolimus-associated (amod)
adding by (mark)
injection h (nmod)
trh = (dep)
analyzed fibrosis (nsubjpass)
fighting attack (dep)
showed controls (nsubj)
microm 6 (nummod)
2 1 (nummod)
refer rates (nsubj)
contraceptives oc (appos)
described as (mark)
treated vivo (advmod)
phenylpropanolamine with (case)
doses larger (amod)
stabilized showed (conj)
involved systems (nsubjpass)
started formula (nmod)
parameters on (case)
co-administration ra (compound)
hospitalized days (nmod)
fraction rr (dep)
h reflow (dep)
benzodiazepines drugs (conj)
documentation provokes (acl)
institutions from (case)
psychosis current (amod)
aggravated intake (nmod)
supported plausibility (nsubjpass)
horns at (case)
pruritus levels (conj)
= 0.33 (dobj)
duration suspected (amod)
lactate mg (amod)
waves and (cc)
loss liver (compound)
doses capsaicin (compound)
scopolamine kg-1 (appos)
infarction cocaine-associated (amod)
post-infusion min (amod)
zidovudine mg/day (appos)
function lv (compound)
disruption subsequent (amod)
ctnt ) (punct)
experience their (nmod:poss)
first third (conj)
levels secretion (conj)
all almost (advmod)
assessed course (nsubjpass)
reduced or (cc)
maintenance pressure (nmod)
$ROOT$ re-established (sent)
negative occurred (conj)
compared outpatients (nmod)
d15 100 (nummod)
caused 5-ht (nmod)
due interaction (nsubj)
alterations . (punct)
atrophy of (case)
sss and (cc)
investigate effects (dobj)
treatment vincristine (compound)
indicate although (mark)
hydration with (case)
cancer aging (conj)
consumption in (case)
correlates nociception (nmod)
$ROOT$ propose (sent)
observed response (advcl)
les and (cc)
stimulated methamphetamine (nmod)
amelioration normalization (conj)
vincristine doxorubicin (conj)
analyzed method (nmod)
showed range (nmod)
effect through (case)
projections descending (amod)
200 150 (compound)
administered recorded (conj)
accompanied hypotension (nsubjpass)
age since (case)
produce evidence (dobj)
norepinephrine by (case)
benzylpenicilloyl-poly-l-lysine ampicillin (conj)
clearance a (det)
postulate authors (nsubj)
arrest death (conj)
administered late (advmod)
tolerated combination (nmod)
microinjection directly (advmod)
injection intravascular (amod)
infarction group (appos)
toxicity distal (amod)
associated evidence (nmod)
group low (amod)
rofecoxib celecoxib (conj)
change flow (nsubj)
known it (nsubjpass)
repair hip (compound)
involved to (mark)
animals all (det:predet)
employed has (conj)
change that (mark)
suggest unassigned (amod)
c degrees (compound)
compromises . (punct)
severity on (case)
leakage cells (nmod)
induced inhibition (nsubj)
care , (punct)
put . (punct)
extend studies (dobj)
transport transmembraneous (amod)
with procedure (conj)
treated control (conj)
history nephropathy (nmod)
doses ropivacaine (nmod)
symptoms motor (compound)
possess treatment (nsubj)
chiasm the (det)
studied measuring (advcl)
start supplementation (nmod)
pheochromocytoma of (case)
potentiated is (auxpass)
treat to (mark)
reverted , (punct)
induces tam (nsubj)
6 of (case)
surface the (det)
eradication pathogen(s (nmod)
pharmacokinetics lometrexol (compound)
cisplatin carcinoma (nmod)
tube a (det)
reactivation of (case)
tolerance local (amod)
measures repeated (amod)
evaluation cognition (compound)
yrs yrs (conj)
pattern characteristic (amod)
technique available (amod)
microinjection region (nmod)
administered doses (nsubjpass)
h 24 (nummod)
seems conclusion (nsubj)
present vasculitis (nsubj)
= 8.439 (dobj)
rats thirty (nummod)
nitrogranulogen and (cc)
investigation first (amod)
retention ) (punct)
values pressure (nmod)
weight patient (nmod:poss)
authorized , (punct)
received phenylephrine (dobj)
cardiovascular system (conj)
method estimating (amod)
controls = (parataxis)
combined srl (nsubjpass)
received management (nmod)
cause can (aux)
echocardiography myocardial (amod)
dependently dose (nmod:npmod)
thrombi mesangiolysis (conj)
identified could (aux)
patients placebo (dep)
mssbp with (case)
inhibition chronic (amod)
using formulations (dobj)
effects bupropion (nmod)
or combination (conj)
used study (nmod)
monitor physicians (nsubj)
history . (punct)
solution on (case)
exceeded magnitude (nmod)
achieved patient (nsubj)
slices survivors (nmod)
ratios 2.6 (nmod)
activity seizures (nmod)
ways in (case)
inhibitors organic (amod)
children only (advmod)
$ROOT$ involves (sent)
generation mucosal (amod)
increase aspirin (nsubj)
case arising (acl)
ratio adp/o (conj)
antagonists receptors (nmod)
mmp-2 , (punct)
resulted spike (nmod)
delayed abnormally (advmod)
assessed preparations (nmod)
fertility female (amod)
dependency dose (compound)
gtn and (cc)
years 14.3 (nummod)
likely seizures (nsubj)
numerous significantly (advmod)
antagonist non-competitive (amod)
treated argatroban (nmod)
arm the (det)
induced exercise (nmod:npmod)
ischemia distal (amod)
reversed similarly (advmod)
dosage duration (conj)
cancer risks (appos)
donors apheresis (compound)
arise treatment (nmod)
experienced we (nsubj)
haart from (case)
sex and (cc)
materials randomised (dep)
phenotypes wilson (nmod:poss)
immunosuppressive and (cc)
dyskinesia alterations (conj)
remission year (nmod)
status dose (conj)
assessed speed (nmod)
cause record (nmod)
first response (conj)
increases pressure (nsubj)
scopolamine scopolamine (conj)
revealed patients (dobj)
resulted species (nsubj)
received chemotherapy (dobj)
37 10 (compound)
2 for (case)
illness an (det)
1.4 figures (nsubj)
25 to (dep)
cells rat (compound)
described catastrophic (conj)
n=656 ) (punct)
s-(-)-10-acetoxy-10,11-dihydro-5h-dibenzo/b , (punct)
study conclusions (compound)
analysis reaction (compound)
70 to (dep)
associated isotretinoin (nmod)
contributes observations (nmod)
14,671 were (cop)
dopamine nucleus (compound)
growth pituitary (amod)
levofloxacin by (case)
reaction reverse (amod)
inhibition pathway (nmod)
fact found (ccomp)
patients 114 (nummod)
severity response (nmod)
enhancement matter (nmod)
resulted delirium (nsubj)
min-1 ml/100 (nummod)
accounted age (nmod)
$ROOT$ reaffirms (sent)
abnormalities dyskinesia (conj)
variables secondary (amod)
management the (det)
screening : (punct)
morning every (det)
studies single (amod)
supplement transplantation (nmod)
= 0.015 (dobj)
af afl (conj)
mice c57bl6/j (compound)
flexion/extension speaking (appos)
ganglia dorsal (amod)
lithium meq/l (appos)
thp i.p. (appos)
foot his (nmod:poss)
$ROOT$ transplantations (sent)
occurred impairment (nsubj)
incomplete were (cop)
subsides discontinuing (advcl)
cardiotoxicity analysis (dep)
consumption oxygen (compound)
peaked peaked (conj)
disorders dsm (compound)
review large-scale (amod)
play might (aux)
centre tunisian (amod)
aggravated cases (nmod)
$ROOT$ dysfunction (sent)
microinjection intracollicular (amod)
decreases decreases (conj)
bodies suggestive (amod)
docetaxel alone (advmod)
asked procedure (nmod)
bendrofluazide propranolol (conj)
recognized is (auxpass)
has ribavirin (nsubj)
damage morphologic (amod)
overlooked that (nsubjpass)
hepatitis cholestasis (nmod)
forms hypertension (nmod)
decreased cbz (nsubj)
occurred often (advmod)
dilatation a (det)
response muscimol (nmod)
younger , (punct)
$ROOT$ warn (sent)
< < (conj)
characterization an (det)
entered but (cc)
has benefits (dobj)
efficacy profiles (conj)
recipient eight-and-a-half-yr-old (amod)
bradycardia acute (amod)
period ranging (acl)
css ( (punct)
loading intravenous (amod)
protects myocytes (dobj)
used also (advmod)
failure severe (amod)
intensity pain (compound)
protection seizure (compound)
artery coronary (amod)
lesions measurable (amod)
pretreatment to (case)
connections venules (nmod)
course uneventful (amod)
integrity cells (nmod:poss)
potential regulated (acl:relcl)
cross-reactivity hypersensitivity (nmod)
increased substantially (advmod)
duration stimulus (compound)
improved eeg (nsubj)
needed was (auxpass)
nephropathy analgesic (amod)
severity or (cc)
albuterol nebulized (amod)
h 6 (nummod)
sinensis rosa (compound)
s mean+/-s.e. (appos)
receive can (aux)
course thrombocytopenia (nmod)
scores pain (nmod)
associated results (dep)
mechanism critical (amod)
0.005 anova (nmod)
pravastatin of (case)
ears both (det)
safety side-effects (conj)
developed addition (nmod)
risk potential (amod)
prevented acid (nsubj)
using video-oculography (dobj)
mortality women (nmod)
concentration serum (compound)
12.0 - (dep)
tachycardia syndrome (nmod)
suggest necessary (ccomp)
affected disease (nmod)
feasible although (mark)
range nephrotic (amod)
hospital , (punct)
actions model (nmod)
carcinogenesis in (case)
xerostomia , (punct)
another into (case)
planned been (auxpass)
individuals some (det)
administration of (case)
nerves medulla (nmod)
due occurring (advcl)
system motor (compound)
agonist a (det)
arms between (case)
hyperalgesic allodynic (conj)
short- and (cc)
auditory and (cc)
reduced control (nmod)
co-administration with (case)
types many (amod)
antibodies heparin-platelet (compound)
anova ( (punct)
drugs cardioselective (amod)
= % (nmod)
suppresses signaling (dobj)
reported edema (nsubjpass)
levels alpha-gst (nmod)
results appeared (dep)
necrosis apoptosis (conj)
but failure (conj)
ventricles canine (amod)
chick young (amod)
$ROOT$ known (sent)
switched who (nsubjpass)
0.06 0.8 (conj)
ku70 of (case)
continue persists (advcl)
hour during (case)
treated tolazamide (nmod)
uncertain was (cop)
applicators private (amod)
protein interleukin (conj)
found had (conj)
needed % (nsubj)
found similar (ccomp)
developed subjects (advcl)
onset early (amod)
stimulation hilus (nmod)
inhibition lead-associated (amod)
malformations occur (acl:relcl)
0.01 < (dep)
vehicle doses (nmod)
disclosed microscopy (nsubj)
propranolol i.v. (advmod)
required were (auxpass)
man , (punct)
iqr ( (punct)
days alternate (amod)
discuss clinicians (nsubj)
cxcl1 of (case)
evidence activity (nmod)
orr ( (punct)
increases repeatedly (advmod)
increase effect (nsubj)
estrogens acetate (conj)
linked be (auxpass)
cancers the (det)
infusion apomorphine (compound)
$ROOT$ brings (sent)
strain inbred (amod)
gemcitabine and (cc)
insipidus hypothyroidism (conj)
methods duration (conj)
event anemia (nmod)
period after (case)
moles/glomerulus 41.8 (nummod)
noted membrane (nmod)
intact be (cop)
sbs dna (compound)
initiation loading (nmod)
increase density (nmod)
represent cases (nsubj)
ece-1 ( (punct)
scheduled injection (nmod)
method continual (amod)
caffeine without (conj)
blood for (case)
predict monitoring (nsubj)
monitoring periodical (amod)
similar rats (nmod)
anesthesia etomidate (nmod)
hg 10 (nummod)
ifosfamide for (case)
part nodules (nmod)
increased post-administration (nmod)
developed arrest (dobj)
disease arrhythmia (nmod)
exhaustion and (cc)
day next (amod)
percentage mean (nmod)
tolerated showing (advcl)
frequent ich (nmod)
possesses properties (dobj)
eluate negative (amod)
prove will (aux)
dm underlying (amod)
animals in (case)
heterogeneity of (case)
infusion dobutamine (compound)
head by (case)
increases greatly (advmod)
finished examination (dobj)
rate bradycardia (conj)
analysis automated (amod)
occurred cleared (conj)
hr 4 (nummod)
map in (case)
episodes any (det)
day before (acl)
occurred death (nsubj)
mediated increase (nsubjpass)
developing treated (advcl)
progression failure (nmod)
conducted therefore (advmod)
continued whereas (dep)
association incidence (nmod)
addressing need (dobj)
volunteers healthy (amod)
subjects thirty-six (nummod)
granulomas with (case)
six three (quantmod)
neutrophils stimulated (acl)
degree development (nmod)
block right (amod)
complained day (nmod)
assays biological (amod)
sulphate by (case)
reports show (acl:relcl)
scale social (amod)
relationships differences (conj)
2-p-(2-carboxyethyl)phenethylamino-5'-n-ethylcarboxamidoadenosine agonist (conj)
patients given (acl)
15 16 (conj)
fall this (det)
developing 45 (nmod)
deterioration phenomena (conj)
association positive (amod)
abusers hospitalized (amod)
had hemorrhage (dobj)
schedule intermittent (amod)
those relapse (acl:relcl)
growth tumors (nmod)
colocalized , (punct)
instillation epinephrine (compound)
rigidity hypotension (conj)
hepatocellular and (cc)
necrosis such (case)
75 approximately (advmod)
carcinoma anemia (nmod)
cancer cancer (conj)
blood effect (nsubj)
colonoscopy esophagogastroduodenoscopy (conj)
that iodixanol (nmod)
suppressed level (nsubjpass)
blocker by (case)
0.24:1 raises (parataxis)
measure . (punct)
undertaken was (auxpass)
parkinsonian mptp (nmod)
examined determined (conj)
rats administered (acl)
apnea obstructive (amod)
lacks drug (nsubj)
eyes subjects (nmod)
extent inhibition (nmod)
measurements frequencies (nmod)
included study (nmod)
altered concentrations (nsubjpass)
$ROOT$ documentation (sent)
dosages at (case)
recordings of (case)
standard as (case)
documented compared (prep)
sign of (case)
measured men (nmod)
antagonized lesions (nmod)
labour in (case)
similar concentration (nmod)
receptor localized (amod)
jaundice hepatomegaly (nmod)
inconvenience the (det)
life-threatening were (cop)
weeks rats (nmod)
increased creatinine (dobj)
three patients (nmod)
factor level (nsubj)
reported results (nsubj)
a/j 39 (nummod)
concentration da (compound)
dose picrotoxin (nmod)
response frey (nmod)
checklist-90-revised the (det)
infections monkeys (nmod)
task avoidance (compound)
chloroacetaldehyde caa (appos)
dialysis during (case)
combination for (case)
scale psychiatric (compound)
85 cas (dep)
extent only (advmod)
initiated episodes (dobj)
list from (case)
adjunct an (det)
characterized clinically (advmod)
anomalies congenital (amod)
parasitosis a (det)
patients matched (acl:relcl)
remd ) (punct)
trial pre-test (appos)
period 9-week (amod)
activation na+ (nmod)
resulting reduction (nmod)
cause rarely (advmod)
underwent department (nmod)
excitement sexual (amod)
days=1.77 rrlt (compound)
permeability the (det)
occurred far (advmod)
regions neurogenic (amod)
decreased inhibition (nsubjpass)
concentrations d (compound)
converted , (punct)
status rats (nmod)
investigations etiological (amod)
change 1 (nmod)
signs cardiovascular (amod)
requiring patients (nsubj)
sod dmtu (conj)
62.0 ( (punct)
extraction medical (amod)
extent % (nmod)
cacl2 , (punct)
6/31 vs (cc)
organelles mitochondria (appos)
reserpine administered (acl)
comparison octapeptides (nmod)
patient-years observation (nmod)
response node (nmod)
events bleeding (compound)
check reports (nmod)
preference morphine-induced (amod)
limited : (punct)
induced electroshock (nmod)
measure time (dobj)
identify in (mark)
measurements urinary (amod)
decreased remained (advcl)
insipidus , (punct)
decreased ebf (dobj)
beverages in (case)
received iopromide (dobj)
prevents pathway (nmod)
concentrations digitalis- (nmod)
shortened time (dobj)
suppressed effectively (advmod)
circulation an (det)
reduce = (parataxis)
analysis pharmacokinetic (amod)
cause could (aux)
receptor mglurs (conj)
was subcortex (nmod)
calcification widespread (amod)
peak mg/kg (nmod)
analogue folic (amod)
drugs among (case)
genotyped patients (nsubjpass)
active cck-8-se (nmod)
exams on (case)
medicine new (amod)
considered was (auxpass)
lesions pretreatment (conj)
measure seizures (nmod)
3.86 ) (punct)
regimen patients (nmod)
discontinuance remission (nmod)
composed usually (advmod)
hyperalgesia allodynia (conj)
action mesna (nmod:poss)
higher not (neg)
monthly year (nmod)
months 16.8 (nummod)
neuroprotective acid (nsubj)
800 to (dep)
clearance cc (compound)
levels ros (compound)
end study (compound)
occurred hepatitis (nsubj)
genotyped was (auxpass)
provoke spasm (dobj)
microinjection clonidine (nmod)
factors concomitant (amod)
thrombosis of (case)
bladder , (punct)
incidence events (nmod)
whom to (case)
time tension (nmod)
act displaying (xcomp)
mk801 antagonist (compound)
months 10.2 (nummod)
remain appear (advcl)
adjusted is (auxpass)
serum concurrent (amod)
unhappiness , (punct)
superior haloperidol (nmod)
used should (aux)
puncture , (punct)
disorder posttransplant (amod)
efficacy weak (amod)
used inhibitors (nsubjpass)
impact , (punct)
neurological psychiatric (conj)
defined rise (nmod)
axis qrs (compound)
verapamil drugs (conj)
nl micrograms/50 (nummod)
39.23 + (cc)
influence concentration (nmod)
octapeptide nonsulphated (amod)
awareness of (case)
events complications (nsubj)
had occurred (conj)
cco-i ) (punct)
dysrhythmogenicity dogs (nmod)
infusion hours (amod)
energy natural (amod)
disorder drug (compound)
features some (det)
mechanisms nicotinic (amod)
drugs same (amod)
selenium and (cc)
drugs depression (conj)
introduction it (nmod:poss)
euphoria induced (acl)
impaired was (auxpass)
properties advantageous (amod)
effect reduction (nmod)
factors with (case)
exposure skin (compound)
secretion cimetidine (nmod)
placebo either (preconj)
contribution inhibition (conj)
converted because (mark)
cardiotoxicity dox (compound)
causes seizures (nmod)
days 126 (nummod)
tolerate daily (advmod)
attenuated 5 (meta)
8 % (appos)
distinguished could (aux)
substances both (det)
lining endothelial (amod)
bupropion adjunctive (amod)
relationship crisis (nmod)
0.14 0.12 (compound)
if ) (punct)
prevent toxicity (dobj)
control sedentary (amod)
level highest (amod)
application intragastric (amod)
chlorpropanol tobanum (appos)
part least (advmod)
considered mechanism (nsubjpass)
evident are (cop)
elevations minor (amod)
failure by (case)
31 14 (conj)
change rates (conj)
malondialdehyde oxypurines (conj)
akinesis the (det)
liters 3 (nummod)
randomized followed (conj)
indicated loss (dobj)
concentration level (nsubj)
retrievals rating (compound)
transmission serotonergic (amod)
exposures with (case)
measures protective (amod)
validity some (det)
catheters intrajugular (amod)
used manipulate (xcomp)
affected % (nsubjpass)
become thus (advmod)
excitement and (cc)
those have (acl:relcl)
used than (cc)
17 up (advmod)
showed rhythm (dobj)
omeprazole with (case)
bort ) (punct)
fluid serum (appos)
suggestive , (punct)
needle 18-gauge (compound)
middle the (det)
focus situated (acl)
lack effects (nmod)
difficulties with (case)
occurrence pain (nmod)
patients only (advmod)
any metabolites (nmod)
response inotropic (amod)
cross-linking the (det)
rotations apomorphine-induced (amod)
tolerance catalepsy (conj)
unaltered was (cop)
administration presence (nmod)
rabbits , (punct)
receiving prilocaine (dobj)
model cnsb002 (nmod)
dfu and (cc)
include anxiety (dobj)
i.e. epilepticus (nmod)
benefits significant (amod)
receptors acetylcholine (compound)
heart of (case)
glaucoma advanced (amod)
diagnosed discontinued (conj)
sub-regions hippocampus (nmod)
man caucasian (amod)
determined parallel (nmod)
male % (nsubj)
immunotherapy overdose (nmod)
cataracts subcapsular (amod)
well had (aux)
revealed indicating (advcl)
reports microangiopathy (nmod)
45 more (advmod)
destructive may (aux)
disorder ptld (appos)
elicited and (cc)
effects large (nmod)
groups different (amod)
period first (amod)
patients % (nmod)
questionnaire concerning (acl)
$ROOT$ anticoagulant (sent)
symptoms nms (nmod)
hypertension prophylaxis (nmod)
monoarticular or (cc)
ug intravenous (amod)
decreased 6 (nmod)
were effects (attr)
ro 5967 (nummod)
long-term open-label (dep)
output l/min (dep)
sleep of (case)
limb lower (amod)
slowing in (mark)
showed dysarthria (dobj)
had anemia (dobj)
took sparingly (advmod)
received intravenously (advmod)
$ROOT$ rescues (sent)
derivative pemoline (nsubj)
produces often (advmod)
mrna tissues (nmod)
weight same (amod)
needed research (nsubjpass)
agent it (compound)
lesion and (cc)
were rate (nmod)
model streptozotocin-induced (amod)
performed animals (nmod)
period follow-up (compound)
carriers allele (nmod)
p=0.48 ( (punct)
bed tumor (compound)
hypertension controlled (acl)
toxicity cardiovascular (amod)
excludes reversion (nsubj)
% v/v (appos)
meq/l , (punct)
predict changes (nsubj)
t % (appos)
provide recommendation (dobj)
expression inos (compound)
nephropathy media-induced (amod)
$ROOT$ therapy (sent)
acid mg (dep)
mm 3.6 (nummod)
followed median (nmod)
study brief (amod)
age-dependent died (conj)
terminated . (punct)
evaluated beginning (nmod)
reductions with (case)
contributor hypertension (nmod)
suggestion clinical (amod)
presence resolution (conj)
sedatives : (punct)
utilized line (dobj)
nephrotoxicity ciprofloxacin-induced (amod)
mice receptor (compound)
nystagmus patients (nmod)
relationship findings (nmod)
cisplatinum hexamethylmelamine (conj)
administration min (nmod:npmod)
< ) (punct)
assessed score (nsubjpass)
poisoning in (case)
metolachlor and (cc)
recipient cystitis (nmod)
monitoring calcium (nmod)
inducer an (det)
affect actions (dobj)
occurred grade (conj)
extract rhizomes (nmod)
3.1 ; (punct)
administered verapamil (dobj)
warranted are (auxpass)
$ROOT$ attenuates (sent)
nephrotoxicity dose-limiting (amod)
increased not (neg)
temporary and (cc)
program have (ccomp)
tissues segment (compound)
paracetamol to (case)
excluded ; (punct)
51.7 4.5 (conj)
medulla cortex (conj)
pca ) (punct)
hypertensive nitroprusside (nmod)
loss field (compound)
d l-sotalol (appos)
regurgitation dose (conj)
$ROOT$ implications (sent)
palsy in (case)
using ) (punct)
resting peak (conj)
measures levels (appos)
leg right (amod)
incontinence urinary (amod)
acute h (dep)
channels are (cop)
numbness weakness (conj)
voltammetry immunohistochemistry (conj)
presence degree (conj)
0.1/mg/kg etomidate (compound)
adr 's (case)
doses amisulpride (nmod)
450 , (punct)
form autosomic (amod)
patients dyskinesia (nmod)
effective detecting (advcl)
found les (nmod)
administration man (nmod)
occurring levels (nmod)
increased size (nsubj)
system dopaminergic (compound)
amnesia against (case)
seem conclusion (nsubj)
serious rather (advmod)
acid taurocholic (amod)
crisis renal (amod)
1986 and (cc)
causes iron (nsubj)
increase bradycardia (nsubj)
msg ) (punct)
examined must (aux)
exposure bpa (compound)
risk increased (amod)
enhances steroid (nsubj)
responses newborns (nmod)
receptors d4.2 (compound)
cortex patients (nmod)
deprivation bupropion (conj)
subset unpredictable (amod)
measured measured (dep)
map product (conj)
used whom (nmod)
adefovir and (cc)
loss known (amod)
ameliorates nephropathy (dobj)
administration s-1 (compound)
group 0 (conj)
showed year (nmod)
consuming what (dobj)
found evidences (nsubjpass)
thiopentone mg/kg (dep)
disorders autism (compound)
complications the (det)
differences comparisons (dep)
zero eight (conj)
symptoms minor (amod)
exceeding mg.kg(-1 (dobj)
products for (case)
parkinsonism akathisia (conj)
inhibition converting (amod)
had chance (dobj)
administered regimen (nmod)
group amphetamine-induced (amod)
compared methods (nsubj)
shift akathisia (conj)
mediating process (dobj)
cells liver (compound)
weight in (case)
associated psychosis (nmod)
ami ( (punct)
proteins ecm (compound)
thrombocytopenia usually (advmod)
variants immune (amod)
n-(2-propylpentanoyl)urea vpu (appos)
renal vasomotor (amod)
scale adult (compound)
ensued rapidly (advmod)
neuropathy dyspnea (conj)
factor glomerulosclerosis (nmod)
% 0.01 (compound)
days course (nmod)
failure aminoglycoside-related (amod)
sets eyes (nmod)
4.2 5.2 (appos)
presence caffeine (nmod)
clinical bioptic (conj)
thromboembolic other (conj)
concluded accounts (ccomp)
drugs licit (compound)
number events (nmod)
= hg (dobj)
shown and (cc)
relapses extra-medullary (amod)
vasospasm the (det)
b iii (conj)
answer , (punct)
administration lidocaine (nmod)
injury histochemical (amod)
citations literature (compound)
cholinesterase serum (compound)
monitored using (xcomp)
compare risks (dobj)
level similar (amod)
variables several (amod)
spasm oddi (compound)
studying involvement (dobj)
implications provision (nmod)
response lh-rh (nmod)
layers epithelial (amod)
using women (dobj)
agent anticancer (amod)
dystrophy reflex (amod)
1.4 1.2 (conj)
conclusion found (dep)
victim otherwise (acl:relcl)
decreased degree (nmod)
patients except (case)
increased preference (dobj)
anxiety , (punct)
terfenadine e4031 (conj)
pregnane-20-ones alpha-hydroxy (compound)
switching after (mark)
behaviour cssep (nmod)
demonstrated observation (parataxis)
dependent state (nmod:npmod)
mgkg at (case)
awake patients (nsubj)
carbimazole with (case)
adopted . (punct)
nascis ) (punct)
vigilance continued (amod)
december to (case)
mca the (det)
therapy hypertension (nmod)
deacetylation and (cc)
percentage neurons (nmod)
abusers in (case)
intoxications combined (amod)
g mg/100 (nummod)
correlation concentration (nmod)
aptts ( (punct)
using heparin (dobj)
reversed ro4368554 (nsubj)
requires that (mark)
interval 30.7 (appos)
5.8 - (punct)
effects magnesium (nmod)
alpha-tc mg/kg (appos)
reviewed reports (dobj)
thickness reduced (amod)
rats microm (dep)
hypokalemia of (case)
affected vasodilation (nsubjpass)
injury following (case)
350 7 (compound)
abundance gamma-enac (compound)
confirmed trials (nmod)
attributable dynes.s.cm-5 (dep)
myopathy drug-induced (amod)
used destroy (xcomp)
presented suffered (dep)
decrease average (amod)
put he (nsubjpass)
produced mg/kg (nsubj)
decrease failure (nmod)
day day (nmod)
risperidone % (appos)
self-limited generally (advmod)
ng-nitro-l-arginine inhibitor (appos)
patients hospitalised (amod)
estradiol ethinyl (compound)
processes impaired (amod)
polymyositis evidence (conj)
tissue staining (amod)
detection sulfate (nmod)
decrement performance (nmod)
lesions deterioration (conj)
infiltrates of (case)
rejection , (punct)
record deficits (dobj)
prolongation significant (amod)
pores mitochondrial (amod)
prescribing drugs (dobj)
shunt blood (nmod)
cisplatin alkaloid (conj)
required atropine (dobj)
change baep (compound)
disorders and (cc)
tbm and (cc)
$ROOT$ follows (sent)
sulfation and (cc)
epinephrine in (case)
c patient (compound)
found rarely (advmod)
12 out (advmod)
depletion nad (nmod)
proposed have (aux)
apomorphine to (case)
period sensitive (amod)
lvdp/dtmax lvdp/dtmin (conj)
followed application (nmod)
exposed seven (nmod)
damage kidney (compound)
lower monotherapies (nmod)
adducts mitochondria (nmod)
4.6 0.9 (nummod)
lesions cardiac (amod)
those for (case)
pralidoxime-2-chloride bw (appos)
$ROOT$ assigned (sent)
9 - (punct)
response cardiovascular (amod)
exencephaly the (det)
symptoms to (case)
step if (mark)
rate . (punct)
lindane mg/kg (appos)
glut4 via (case)
seems expressed (xcomp)
dh vsd (conj)
fashion a (det)
diagnosed , (punct)
treated diuretics (nmod)
reversible severe (amod)
january 2007 (nummod)
remissions sustained (amod)
mg.kg(-1).d(-1 4 (nummod)
identified have (aux)
studied activity (nsubjpass)
4(sem ) (punct)
received therapy (dobj)
mg./kg 1 (nummod)
p 2-fold (amod)
suggesting importance (ccomp)
combination 5-fu (nmod)
decreased dimensions (dobj)
myopathy necrotizing (amod)
monitored . (punct)
ms matrix-assisted (amod)
injection m0 (appos)
confirmed reduced (ccomp)
return that (mark)
extracted records (nmod)
analyzed hyperemia (nmod)
unhappiness marital (amod)
use cyclosporine (nmod)
haloperidol for (case)
secretion gh (compound)
groups at-risk (amod)
quinine-sensitive 4-aminopyridine-sensitive (conj)
higher rate (nsubj)
population-based multisite (dep)
values maximal (amod)
greatest ribavirin (nmod)
production on (case)
produce nicotine (nsubj)
beats/min 37 (nummod)
mg/dl = (parataxis)
improvement and (cc)
intake withdrawal (conj)
measurement by (case)
considered surgery (nsubjpass)
severe individuals (nmod)
common t (nmod)
2.5 0.4 (conj)
docetaxel weeks (nmod)
blood tissue (conj)
yield cases (dobj)
predose and (cc)
effects tea (nmod)
buprenorphine and (cc)
calculated ka (nmod)
test with (case)
spironolactone with (case)
degeneration observed (acl:relcl)
dose tetrachloride (nmod)
used addition (nmod)
data pre-operative (amod)
medium d. (nmod)
viral immunological (conj)
infiltration concomitant (amod)
older 65 (nmod)
tissues ear (compound)
evidence changes (nmod)
fluctuations dyskinesia (conj)
administration bupivacaine (nmod)
hoarseness and (cc)
populations integrate (acl:relcl)
facts these (det)
predisposed that (nsubj)
effects nicotine (nmod)
cystoscopy for (case)
$ROOT$ unresponsive (sent)
correlates pain (nmod)
overdose of (case)
prior hr (nmod:npmod)
related appearance (nmod)
mirtazapine his (nmod:poss)
value a (det)
isoproterenol 100mg/kg (appos)
treated disorders (nsubjpass)
evaluated activity (nsubjpass)
calculations based (case)
identified age (dep)
controls 622 (nummod)
analgesia- morphine (compound)
exerts decreasing (advcl)
appear population (nsubj)
recommend would (aux)
tachycardia dyspnea (conj)
induction superoxide (nmod)
predict percentage (nsubj)
concentration mean (amod)
inhibited gain (dobj)
sirolimus rapamycin (appos)
given after (advmod)
use lithium (dep)
modified needed (advcl)
apnea prolonged (amod)
less markedly (advmod)
herbicides : (punct)
erection penile (amod)
scavenging through (case)
placebo -10.7 (dep)
damage assessed (acl)
history results (conj)
therapy ketoconazole (compound)
effect chronotropic (amod)
infiltration with (case)
capacity the (det)
tested ability (nmod)
infarction against (case)
day 3 (nummod)
histochemistry , (punct)
size pupil (compound)
effect than (case)
sinus inferior (amod)
complaints subjective (amod)
trial schedule (nmod)
kytril pharmaceuticals (appos)
amiodarone on (case)
exerts vasodilatation (nmod)
hypertension microangiopathy (conj)
induced alpha-fluoro-beta-alanine (nmod)
beta-blocking and (cc)
uveitis active (amod)
5.2 vs (cc)
microg/kg ) (punct)
norepinephrine to (case)
hypertensive rebound (amod)
coagulation to (case)
$ROOT$ strategies (sent)
quality group (nmod)
1187 441.2 (conj)
dependence alcohol (compound)
exposure hours (nmod)
present hygiene (nmod)
occurs also (advmod)
edema macular (amod)
produces decrease (dobj)
exposed blockers (nmod)
reduced prevented (conj)
junctions hepatocyte (compound)
eyes contralateral (amod)
artesunate injectable (amod)
conscious , (punct)
invariable and (cc)
acid-induced ethacrynic (amod)
safe course (nsubj)
alterations permanent (amod)
amphetamine greater (amod)
used reviewed (conj)
$ROOT$ events (sent)
continues , (punct)
cytoprotective mainly (advmod)
reports cases (nmod)
stage development (nmod)
ems in (case)
troublesome were (cop)
atorva with (case)
council research (compound)
transplantation bmt (appos)
dose maximum (amod)
recurrence , (punct)
inhibited may (aux)
ci=22.5 25.3 (prep)
concentrations half-life (conj)
improved although (mark)
fluoxetine the (det)
micrographs in (case)
32.9 ) (punct)
taking placebo (dobj)
studied protocol (nmod)
value power (compound)
provide stimulation (nsubj)
amyloidosis syndrome (conj)
psychotropic for (case)
transport tracer (nmod)
thought actions (nsubjpass)
systems spontaneous (amod)
lymphomas non-hodgkin (amod)
5.00 15.00 (conj)
changes corresponding (amod)
migraineurs ( (punct)
nephrotoxicity the (det)
stabilized doses (nmod)
contractility caused (acl)
% as (case)
constellation dermatitis (nmod)
once ( (punct)
actin alpha-smooth (amod)
states hypersecretory (amod)
conduction intraventricular (amod)
scopolamine with (case)
systems numerous (amod)
proportion interactions (nmod)
regard this (det)
successful generally (advmod)
estradiol beta (compound)
anemia chemotherapy-induced (amod)
level without (case)
conclusions toxic (dep)
paclitaxel melphalan (conj)
allodynia hyperalgesia (conj)
system of (case)
0 2 (nmod)
catalepsy and (cc)
15-f(2t)-isop and (cc)
as onset (nmod)
showed wave (dobj)
drowsiness of (case)
2.2 ( (punct)
thrombosis rupture (conj)
died custody (nmod)
saline bromocriptine (conj)
studied formed (conj)
timing injury (nmod)
represents apparently (advmod)
types arrhythmia (nmod)
octreotide with (case)
$ROOT$ neuroplasticity (sent)
administered planned (conj)
alleviated surgery (nmod)
coma myxedemic (amod)
resulting potency (nmod)
indicate treatment (ccomp)
nephrotoxicity a (nmod)
dilated markedly (advmod)
elevation waves (conj)
radiologic and (cc)
treated carbimazole (nmod)
available most (nmod)
completed patients (nsubj)
lead stroke (nmod)
350 ) (punct)
has do (advcl)
decrease that (mark)
anesthesia induced (acl)
hepatotoxicity simvastatin-ezetimibe (nmod)
decided end (xcomp)
testing users (nmod)
predictors age (nmod)
weeks 10 (nummod)
exhibited mmol/l (nmod)
mannitol solution (appos)
interna pallidus (compound)
study ascending (amod)
older had (conj)
made baseline (nmod)
provoked . (punct)
paradigm les (appos)
increase not (neg)
moderate-dose p (dep)
independence in (case)
suburothelium in (case)
risks mortality (nmod)
point each (det)
depression conditions (nmod)
polypeptide ventricular (amod)
228 481 (appos)
maleate bw (appos)
cmax/mic ) (punct)
mg ergotamine/caffeine (conj)
properties stimulating (amod)
syndrome between (case)
tt ) (punct)
changes observed (acl)
10(-5 to (dep)
agent may (aux)
velocity at (case)
radiotherapy pelvic (amod)
catatonia animals (nmod)
ng/mouse 10,000 (nummod)
sgk1 aldosterone-sensitive (amod)
average units (nmod)
administration intravenously (advmod)
perforans elastosis (nsubj)
groups 8 (nummod)
detected apoptosis (nsubjpass)
hg 110 (nummod)
inputs afferent (amod)
concentrations steady (amod)
that a-i (nmod)
meal during (case)
determined imaging (nmod)
marketed agent (nmod)
hyperprolactinemia degrees (nmod)
symptoms radicular (amod)
level anp (nmod)
sensitivities specificities (conj)
remains evaluated (xcomp)
fatal dose (nsubj)
considered therefore (advmod)
infusion fenoldopam (nmod)
barrier of (case)
showed findings (nsubj)
subjects fourteen (nummod)
used children (nmod)
absorption agent (nmod)
compared data (nsubjpass)
scintigraphy on (case)
generate animals (nmod)
immunoglobulin complement (conj)
17beta-estradiol microg/rat (appos)
induced maintain (xcomp)
patients due (amod)
deprivation 12-h (amod)
groups ecstasy (compound)
man 43-year-old (amod)
reduced robust (parataxis)
ulcers corneal (compound)
reprogramming epigenetic (amod)
erg ) (punct)
undergo aap (nsubj)
of and (cc)
produces leads (ccomp)
normalization parameters (nmod)
given produce (xcomp)
length urethral (amod)
pressor and (cc)
treated dex (nmod)
arteriolopathy of (case)
caused change (dobj)
serve whether (mark)
crf esrd (conj)
response binding (appos)
scheduled received (conj)
iodixanol contrast (compound)
normalised but (cc)
administration vaccine (nmod)
presence cholinesterase (nmod)
treatment dantrolene (nmod)
related uremia (nmod)
had content (dobj)
mmol/d ) (punct)
induced or (cc)
evidence models (nmod)
multifactorial and (cc)
safety short-term (amod)
with epinephrine (conj)
patients twenty-four (nummod)
varies compared (dep)
loss been (cop)
patients psychiatric (amod)
downstream stenosis (nmod)
impaired correlated (conj)
associated slowing (nmod)
indicate agent (ccomp)
apnea seizures (conj)
weak very (advmod)
cholinomimetic the (det)
cocaine diazepam (conj)
protein glepp1 (compound)
block trazodone (nsubj)
p100 fr (conj)
trial dose-comparison (amod)
complication about (case)
level clearance (conj)
reduced muscle (nmod)
m(1)-selective ) (punct)
unit ( (punct)
effects blepharoconjunctivitis (nsubj)
canaliculi bile (compound)
trial of (case)
inhibitor sorafenib (nsubj)
patients 154 (nummod)
blockers to (case)
vasodepressor responses (dep)
cq ( (punct)
mannitol with (nmod)
vasculitis minocycline-induced (amod)
akinesia base (nmod)
titrate carbidopa-levodopa (dobj)
was differences (nmod)
animals right-pawed (amod)
max the (det)
4.1 : (punct)
studied flow (nsubjpass)
receiving stabilizer (dobj)
oac to (case)
plans follow-up (amod)
x se (conj)
hemorrhage , (punct)
receiving preparation (dobj)
showing cost (nmod)
12 0.2 (nummod)
starting days (nmod:tmod)
impact recognition (nmod)
tgf-beta1 ( (punct)
agitation the (det)
groups ) (punct)
impairment functional (amod)
course nausea-free (amod)
contact stent (nmod)
$ROOT$ diagnosed (sent)
insipidus be (cop)
problem countries (nmod)
vmax a (det)
group 5-wk (amod)
addition symptoms (nmod)
study mentioned (amod)
produced and (cc)
response animals (nmod)
lost 7 (nsubjpass)
antidepressants like (case)
damage in (case)
$ROOT$ minimised (sent)
hypersecretion acid (compound)
showed conduction (nsubj)
dph free (amod)
orientation the (det)
system utero (amod)
occur myopathy (nsubj)
cpap cm (amod)
efficacy denopamine (nmod)
2.14 -0.17 (compound)
consequences no (neg)
lower 3.9 (nmod)
was induce (xcomp)
and biochemically (advmod)
critical expression (nmod)
able which (nmod)
doxorubicin dexamethasone (conj)
duct collecting (amod)
vgpr from (case)
maximum for (case)
hyperglycinemia in (case)
injections multiple (amod)
complete appeared (conj)
section by (case)
depressions of (case)
healthy who (nsubj)
result it (nsubj)
nursing of (case)
evaluate in (mark)
defined dsm-iii-r. (nmod)
investigated being (auxpass)
practice clinical (amod)
2a 2c (conj)
15 to (quantmod)
calculated data (nmod)
rats pilocarpine-treated (amod)
conjugation , (punct)
pacing transvenous (amod)
disease 's (case)
extract seeds (nmod)
hbv drug (compound)
developed results (nsubj)
p=0.003 respectively (advmod)
disclosed absence (dobj)
lidocaine with (case)
seizures hypolocomotion (conj)
selective species (nmod)
percentage the (det)
os per (case)
males % (nsubj)
inhibiting by (mark)
months 32 (nummod)
task rat (compound)
investigate diagnoses (dobj)
survey the (det)
trough-concentrations confusion (conj)
cancers endometrial (amod)
decade the (det)
suggested evidence (nmod)
received seven (nsubj)
hypertension marked (amod)
identification echocardiographic (amod)
antagonized catalepsy (dobj)
status functional (amod)
thp ( (punct)
modification test (nmod)
glomerular and (cc)
racine 's (case)
application lactate (nmod)
given half (nsubjpass)
data sedations (nmod)
decreased scatter (dobj)
assessment including (case)
weight clearance (appos)
micrograms/ml 0.06 (nummod)
inhibition mif (appos)
assessed . (punct)
improvement recovery (conj)
$ROOT$ larger (sent)
$ROOT$ examined (sent)
decreased fs (nsubjpass)
naloxone after (case)
represent integration (dobj)
pills low-dose (amod)
revealed areas (dobj)
report knowledge (nmod)
using doses (nmod)
treat hyperthermia (dobj)
yields total (amod)
administration sirolimus (nmod)
promoting dependency (dobj)
showed but (cc)
crucial be (cop)
producing from (mark)
prospectively and (cc)
100 , (punct)
comparative randomized (dep)
chulalongkorn king (compound)
dose = (dep)
day and (cc)
mm 32.6 (nummod)
exceeded 100,000/ul (dobj)
stopped recovered (conj)
administration continuous (amod)
proteins against (case)
superoxide of (case)
was etiology (nsubj)
myoclonus disabling (amod)
mazindol , (punct)
cultures primary (amod)
decades the (det)
accounted reduction (nsubjpass)
cancer with (case)
k(+)-channels quinine- (amod)
step bar (nmod)
events thromboembolic (amod)
men participate (conj)
sampling troponin (compound)
17 +/- (cc)
quantified results (ccomp)
1.57 2.44 (prep)
enhanced equipotent (conj)
injection adriamycin (nmod)
consumption total (amod)
diagnoses clinical (amod)
numbers dibucaine (compound)
used predict (xcomp)
identifying when (advmod)
effectiveness its (nmod:poss)
eegs 24_h (nmod)
peptides these (det)
clinic gynecology (compound)
reversed region (nmod)
h 0 (nummod)
consider . (punct)
unclear and (cc)
subjects have (acl:relcl)
time first (nmod)
electromyographic mechanoand (amod)
treatment cbdca (compound)
ctni ( (punct)
associated 4 (dep)
week 1 (compound)
patients stable (amod)
cystectomy partial (amod)
misleading testing (nsubj)
values comparable (amod)
deserve follow (dobj)
toxicities as (cc)
generated likely (advmod)
complex with (case)
administration mtx (compound)
hyperalgesia vincristine-induced (amod)
index , (punct)
strain strain (conj)
leak , (punct)
capacity binding (compound)
retarded progression (dobj)
remained unchanged (xcomp)
chorea amphetamine-induced (amod)
fragments acth (compound)
investigated changes (dobj)
activity rats (nmod)
effects dose (nmod)
mg/ml 1 (nummod)
similar lesions (nsubj)
piperacillin with (case)
hyperhidrosis focal (amod)
dementia stroke (conj)
healthy all (dep)
clotiazepam of (case)
opposed as (advmod)
evidenced increase (nmod)
farmer 55-year-old (amod)
abusing may (aux)
defects women (conj)
produced mice (nmod)
showed contrast (nmod)
50 vs. (cc)
sulpiride the (det)
urea weight (conj)
machr ( (punct)
sedation the (det)
effect may (aux)
documentation this (nsubj)
% rate (nmod)
il-1beta and (cc)
arsenic ias (appos)
antagonized antagonists (nsubj)
pain phasic (amod)
myasthenia ocular (amod)
increment dosage (compound)
prodrug properties (nmod)
replicated protocols (nmod)
effect maintaining (amod)
2.1 . (punct)
echocardiography performed (acl)
il-3 and (cc)
pressure p (dep)
dose sodium (nmod)
requirement the (det)
differences asymmetry (conj)
ketoprofen , (punct)
oropharynx patients (appos)
therapy particularly (advmod)
myopathy pravastatin-associated (amod)
corrected anemia (nsubjpass)
occurrence infarcts (nmod)
catheterization transfemoral (amod)
acting peripherally (advmod)
unchanged increased (conj)
bigeminy runs (conj)
hallucinations associated (acl)
depletor a (det)
choleretic good (amod)
documenting association (dobj)
% 49%-83 (nummod)
agent inciting (amod)
terminated experiment (nsubjpass)
evolved . (punct)
role pathogenesis (nmod)
develop weeks (nmod:tmod)
out-patients ill (amod)
describe herein (advmod)
treated np (conj)
inclusions matrical (amod)
glomerulonephritis crescentic (amod)
increased mpep (nsubj)
motivational and (cc)
cause transplantation (nmod)
demonstrated increase (dobj)
unique extensive (conj)
suitable incidence (nmod)
exposed tmp-smz (nmod)
mean at (case)
specific vigabatrin (nmod)
increased peaking (advcl)
cause injury (nsubj)
correlates fluency (nmod)
challenged mice (nsubjpass)
determined effect (nsubjpass)
% 3.75 (nummod)
expressing emotions (dobj)
controls iv (nummod)
cox-i. subunit (compound)
knife radiofrequency (conj)
increases concentration (dobj)
received cisplatin (dobj)
find similarities (dobj)
visualized microscopy (nsubj)
settings in (case)
$ROOT$ hormones (sent)
analogues - (compound)
establish , (punct)
twice day (nmod)
degeneration and (cc)
rats habituated (acl:relcl)
effect population (nmod)
demonstrated targeting (dobj)
children thirty-three (nummod)
% 58.6 (nummod)
doxorubicin carvedilol (conj)
explored experiments (nsubj)
verify ) (punct)
constipation patients (nmod)
therapy useful (amod)
mild % (dep)
period hypoglycaemia (nmod)
connections its (nmod:poss)
levels vip (nmod)
analysis hoc (amod)
prompt continued (conj)
resemblance the (det)
responses distinct (acl:relcl)
induced ( (punct)
adhd ( (punct)
increased injections (nsubj)
revealed immunohistochemistry (nsubj)
dopamine nmda (conj)
distributed lobule (nmod)
downregulation 2 (dep)
diseases skin (compound)
proposed previously (advmod)
important determining (advcl)
serum-albumin immunoglobulins (conj)
report qtls (dobj)
increases stimulation (dobj)
arthritis gouty (amod)
therapy leukaemia (nmod)
leakage and (cc)
apparent cohort (nmod)
cips ( (punct)
m with (nmod)
utilized . (punct)
reduces , (punct)
nhe3 , (punct)
courses 88 (nummod)
micrograms 20 (compound)
increases expression (dobj)
vocabulary nouns (nmod)
analogues structure (nmod)
months 5 (nummod)
plays damage (nsubj)
dystrophy treatment (conj)
lid limbs (nmod)
ci 101.74 (dep)
effect respect (nmod)
characterized ratio (nmod)
seconds 10 (nummod)
transporter expressed (acl:relcl)
powder gum (compound)
motor , (punct)
mechanisms uptake (compound)
intervention outcome (conj)
initiated is (auxpass)
low use (nsubj)
motility disordered (amod)
biomarkers lipid (compound)
excretion an (det)
% 8 (nummod)
5 3 (compound)
women were (cop)
based structure (nmod)
lasted hours (nmod)
concentrations myocytes (nmod)
available excluded (conj)
blockade k(+)-channels (nmod)
complicate may (aux)
endings nerve (compound)
contribute shift (nsubj)
treated 5-fu (nmod)
$ROOT$ regurgitation (sent)
scale disease (compound)
weeks application (nmod)
attacks anginal (amod)
$ROOT$ gravis (sent)
pursued be (auxpass)
production and (cc)
episode last (amod)
diseases disease (nmod)
inhibited be (auxpass)
eluates erythrocytes (nmod)
syndrome cauda (compound)
echocardiography determination (conj)
determination the (det)
safety lozenge (nmod)
reveals review (nsubj)
improved function (dobj)
blocked sch (nmod)
dilatation to (case)
reversible stopped (advcl)
characterized excretion (nmod)
ems ng.ml-1 (dep)
contractility painful (amod)
deprivation rem (amod)
mg/kg/daily ( (punct)
adducts antigens (conj)
observed parts (nmod)
users patients (nmod)
included included (conj)
apl with (case)
g. group (compound)
duct target (nsubj)
injected rats (nsubjpass)
combined dose (nmod)
abilities protective (amod)
reaction leukemoid (amod)
level 1 (nummod)
thrombopenia hemolysis (conj)
decrease 6-months (nmod)
patients adult (amod)
hyperactivity secondary (amod)
contribution presumed (amod)
resulting angioedema (nmod)
males to (case)
used two (nummod)
db of (case)
implicated have (aux)
obtained dose (nmod)
prazosin and (cc)
cent lignocaine (compound)
treatment msg (compound)
nitrotyrosine as (case)
carboplatin area (dep)
infusion fucoidan (nmod)
conclusions different (appos)
affected hyperalgesia (nmod)
ratings in (case)
n=6 ( (punct)
29 ) (punct)
$ROOT$ discontinuous (sent)
potent is (cop)
promotes sleep (dobj)
improved gradually (advmod)
manifestation . (punct)
6 score (nsubj)
provokes pointes (dobj)
kinases map (compound)
analgesia morphine (compound)
pump infusion (compound)
present factor (nsubj)
bmt itself (appos)
phenomenon freezing (compound)
regimen effective (amod)
60 18 (compound)
stent paclitaxel-eluting (amod)
peptide gene-related (amod)
imperative is (cop)
records file (compound)
coactivator transcriptional (amod)
angiographies studies (nsubj)
induced climbing (dobj)
assessed measuring (dep)
dh and (cc)
gln223 glu441 (conj)
therapy oral (amod)
received group (nsubj)
reduced weeks (nmod)
cases ahf (nmod)
outline fashion (nmod)
minutes 51 (nummod)
stable progressive (conj)
0.11 0.02 (conj)
model tested (acl)
recommend administered (ccomp)
assumed is (auxpass)
received acrolein (conj)
studies ncs (appos)
weeks his (nmod:poss)
four developed (acl:relcl)
rast bpo (nmod)
supply vs. (cc)
biomarkers predictive (amod)
tachycardia complex (compound)
haloperidol dopamine (compound)
observed carefully (advmod)
erp duration (conj)
forearm lateral (amod)
symptoms because (case)
173 +/- (cc)
erythromycin or (cc)
assessed as (mark)
incorporation atp (nmod)
ephedrine , (punct)
hiv-negative were (cop)
genotyped dna (nsubjpass)
awakening on (case)
infusion than (case)
known : (punct)
be ( (punct)
imaging or (cc)
understood incompletely (advmod)
flurazepam fzp (appos)
group 24.4 (dep)
analysis manifestations (nmod)
media iopromide (appos)
angiogram coronary (amod)
% ) (punct)
changes recordings (nmod)
early whether (mark)
is differentiation (nsubj)
acid gamma-cholesteryloxybutyric (amod)
altered are (auxpass)
increased % (dep)
dysfunction autonomic (amod)
techniques conventional (amod)
30 20 (compound)
signs cardiotoxicity (nmod)
custody police (compound)
systems by (case)
took again (advmod)
old years (nmod:npmod)
residues cytosine (compound)
numbers patients (nmod)
hamartoma and (cc)
deficits motor (compound)
type factor (conj)
activity cardiac (amod)
antagonists available (amod)
receptors calcitonin (compound)
pain ecg (conj)
proteinuria tubular (amod)
setting overdose (nmod)
indicating related (ccomp)
increased bun (nsubj)
meshwork tm (appos)
characterized ischemia (nsubjpass)
either groups (nmod)
based diagnosis (nsubjpass)
groups dosing (compound)
role groups (nmod)
face numbers (nmod)
decrease rates (conj)
had had (conj)
pretreated p-coumarate (nmod)
exhibits given (conj)
alter changes (nsubj)
cause practice (nmod)
given intervals (nmod)
2 of (case)
man syndrome (nmod)
types e13.5 (nmod)
mild diarrhea (ccomp)
decreased mg/kg (nsubj)
patients became (acl:relcl)
encephalopathy due (case)
defect visual (amod)
= , (punct)
developing year (nmod)
imaging brain (compound)
sirolimus mofetil (conj)
frap ) (punct)
different frequency (nmod)
6.25 12.5 (conj)
managed aggressively (advmod)
re-elevate minutes (nmod)
dextromethorphan dm (appos)
baseline posttreatment (conj)
produced alone (advcl)
protein 2 (nummod)
flushing with (case)
processes astrocytes (nmod)
pathogen(s the (det)
azotemia and (cc)
infarction an (det)
complication expected (amod)
set . (punct)
plate to (case)
number was (cop)
due neutropenia (nsubj)
disease with (case)
improves expected (conj)
stopping after (mark)
accumulation response (nmod)
582 23 (compound)
response pituitary (amod)
developed course (nsubj)
autoantibody reacting (amod)
d oral (amod)
visual and (cc)
accumulation myocardium (nmod)
vasculitis drug-induced (amod)
questionnaire the (det)
concentrated dx (nmod)
dysgenesis brainstem (compound)
np ) (punct)
interval percent (compound)
head empty (amod)
events cd4 (conj)
second seventh (conj)
% years (nmod)
adjusted judiciously (advmod)
pretreatment chronic (amod)
nephritis ranitidine-induced (amod)
rhuepo ( (punct)
appeared hearts (nsubj)
cause tdp (dobj)
aminoglycoside with (case)
pan of (case)
proportional dose (nmod)
effects memory-enhancing (amod)
failure who (nsubj)
lost improvement (nsubjpass)
persons 407 (nummod)
db prilocaine (nmod)
women therapy (nmod)
event . (punct)
identified were (auxpass)
wires ventricular (amod)
impairment responses (nmod)
performed patients (nmod)
sec/cm5 2190 (nummod)
severe can (aux)
negative response (nsubj)
mimic that (nsubj)
days more (nummod)
psychosis lifetime (amod)
efforts noteworthy (amod)
prepared can (aux)
mg/dl 3.4 (nummod)
tamoxifen tam (appos)
patients 342 (nummod)
increased patients (nmod)
co-administration anesthetics (nmod)
found have (aux)
stimulating m(3)-machr. (dobj)
induced amphetamine (nsubj)
described ) (punct)
curve as (case)
affect which (nsubj)
indicating prevented (ccomp)
mechanism produce (acl:relcl)
increase bp (nmod)
abnormalities cerebral (amod)
induced resulted (parataxis)
warranted investigations (nsubjpass)
associated man (nmod)
animals only (advmod)
group dysplasia (compound)
caused ethanol (nmod)
patients 16 (conj)
prevented infusing (advcl)
contributes performance (nmod)
fasting by (case)
used simulator (nsubjpass)
symptoms or (cc)
detection the (det)
muscles patients (nmod)
eyes effusion (conj)
mediating by (mark)
k(+)- ( (punct)
extremities lower (amod)
presentation case (compound)
alpha ventricular (amod)
lasted s (dobj)
+/- dbh (compound)
effect trinitrate (nmod)
risk interactions (dobj)
indicate 5 (dep)
preference conditioned (amod)
k(na ) (punct)
markers on (case)
drug it (nsubj)
exposed diazinon (nmod)
signaling such (case)
analysed . (punct)
prescribed and (cc)
disrupts homeostasis (dobj)
cytostatic and (cc)
improved valproate (nmod)
nephrotoxicity antibiotics (nmod)
reached risk (nsubj)
range dosage (nsubj)
$ROOT$ describes (sent)
avp of (case)
parts rostral (amod)
treatment sulphasalazine (nmod)
decrease levcromakalim-produced (amod)
injections medications (conj)
crisis the (det)
dogs sex (nmod)
epilepticus required (acl:relcl)
effect flow (nmod)
use ifx (nmod)
anaesthesia avoidance (conj)
tests reactions (nmod)
current electrical (amod)
course tachycardia (nmod)
104 ( (punct)
pallidus of (case)
favourable less (advmod)
lp , (punct)
patients ninety-seven (nummod)
experiences emesis (dobj)
seizure induced (acl)
environment the (det)
presence by (case)
maintenance in (case)
diet bpa/kg (compound)
0.80 paracetamol (nmod)
$ROOT$ feasible (sent)
delayed onset (dobj)
iu/kg ( (punct)
carcinoma . (punct)
uncertain involve (conj)
add information (dobj)
hg 5.9/7.0 (nummod)
toxicity no (det)
behavior pure (amod)
given rats (nsubjpass)
changes pressure (nmod)
0.01 ( (punct)
beta-blocker the (det)
intersections of (case)
control . (punct)
condition overall (amod)
acquired were (auxpass)
dexamethasone and (cc)
fucoidan the (det)
intensity headache (nmod)
hexamethonium not (neg)
agonist muscarinic (amod)
26 ] (punct)
were events (attr)
were test (nmod)
evidence suggest (acl)
hus in (case)
exacerbated symptoms (nsubj)
pharmacoeconomics outcomes (conj)
effect d-glucarates (nmod)
action sites (nmod)
lhrh-a ) (punct)
required pacing (nsubjpass)
airway not (neg)
obtained pg-9 (nmod)
damage alterations (conj)
encouraged investigate (xcomp)
chamber in (case)
regained quickly (advmod)
anti-oxidant mitochondrial (conj)
erdosteine with (case)
mk801 n-methyl-d-aspartate (compound)
rats ' (case)
used enzymes (nsubjpass)
declines attention (nmod)
substrate phenytoin (nsubj)
effective 100mg/kg (nmod)
mechanism compensatory (amod)
disorders resulting (acl)
parents by (case)
attention further (amod)
immunohistochemistry , (punct)
appearance morphological (amod)
results led (appos)
cases hypertension (nmod)
alert that (mark)
comparison frequency (nmod)
determine explore (conj)
women nonimmune (amod)
given basis (nmod)
metastases hepatic (amod)
azathioprine methotrexate (conj)
markers glial (amod)
liver splenomegaly (conj)
recommendations for (case)
mm . (punct)
dyscrasias neutropenia (appos)
ifosfamide of (case)
oxygen in (case)
drop 6 (dep)
causes rats (nmod)
potency prevent (acl:relcl)
insulin serum (compound)
required supplementation (dobj)
mechanisms of (case)
hepatocytes surviving (amod)
dogs doxorubicin-treated (amod)
days iw (compound)
times another (det)
connection of (case)
synthesis with (case)
duration completion (nmod)
hyperactivity amphetamine (compound)
myelosuppression ( (punct)
8.7 1.1 (conj)
scores severity (nmod)
induce production (nmod)
$ROOT$ 17.6-fold (sent)
discontinued resulting (advcl)
regimens following (amod)
pre-treatment propofol (nmod)
regurgitation functional (amod)
comprising members (dobj)
frequency switching (nmod)
microangiopathy precipitated (acl)
tea mg/kg/day (dep)
systems organ (compound)
nausea of (case)
triniol ) (punct)
tended subjects (nsubj)
risk analysis (dep)
1.5 ( (punct)
those amiodarone (nmod)
recurarization . (punct)
withdrawal csa (compound)
inactivation inhibition (conj)
selective representative (conj)
cortex rat (compound)
proteins serum (compound)
stopped imaging (nmod)
years 55 (nummod)
100mg/kg 0 (nummod)
stimulates , (punct)
incidence those (nmod)
% 11.4 (nummod)
probable highly (advmod)
scarce . (punct)
observed occlusion (nmod)
concentration atp (compound)
ingestion quinine (compound)
displays dhea (nsubj)
8/8 ) (punct)
ratio hazard (compound)
significant analyses (nmod)
ng/ml versus (cc)
hypertension spasticity (conj)
published both (preconj)
concordance in (case)
ligand of (case)
injections pilocarpine (compound)
sets in (case)
seen groups (nmod)
1.0 p (dep)
onset from (case)
elevated . (punct)
either kg-1 (nmod)
60 to (quantmod)
studies relating (acl)
followed has (aux)
due hydrochloride (nmod)
dosage possible (amod)
14 17 (conj)
(noncardiac)/periprocedural perioperative (amod)
development : (punct)
cannulae arterial (amod)
mg 1.5 (nummod)
treatment while (case)
disappeared dysosmia (nsubj)
control erdosteine (conj)
morphine codeine (conj)
modified if (mark)
induce administration (nsubj)
need the (det)
safe group (nmod)
afterdepolarization early (amod)
blocker ganglion (compound)
neurogenesis dentate (amod)
inhibits retention (dobj)
action nicotine (nmod)
increase had (advcl)
vigabatrin to (case)
escape to (mark)
4.3 1.3 (compound)
patients 0.96 (dep)
syndrome hypomania-like (amod)
mucosa oral (amod)
potentiated agents (nmod)
prior , (punct)
presentation commonest (amod)
potent compound (nsubj)
localization preferential (amod)
densities ventricle (nmod)
findings angiography (conj)
frequency effects (nmod)
ability spironolactone (nmod)
facilitated also (advmod)
crf , (punct)
observers between (case)
tested and (cc)
produced months (nsubj)
aftereffects of (case)
majority in (case)
occipital bilateral (amod)
suggests risk (ccomp)
finding is (cop)
superiority of (case)
tests same (amod)
produces acetaminophen (nsubj)
had referred (ccomp)
$ROOT$ alter (sent)
pre-treatment of (case)
found pathology (nsubjpass)
examination neuro-ophthalmologic (amod)
days organogenesis (nmod)
use metolachlor (compound)
% paroxysms (nmod)
immunohistochemistry sequencing (conj)
dose paralytic (amod)
fk506 either (cc:preconj)
stronger association (nsubj)
intake ramipril (nmod)
data blockade (nmod)
disturbance dysfunction (conj)
associated sulfonamides (nsubjpass)
observed , (punct)
found tendency (nsubjpass)
midazolam mg/kg (appos)
time episode (nmod)
dimer-x with (case)
incidence lower (amod)
$ROOT$ located (sent)
program transplantations (nmod)
withdrawn market (nmod)
late , (punct)
manipulated not (neg)
enrolment ( (punct)
synapses located (amod)
found seizures (nsubjpass)
returned examination (nmod)
ability interact (acl)
demonstrate rate (dobj)
reduce hg (nmod)
perfusion-fixed animals (nsubjpass)
awoke sleep (nmod)
cr including (case)
initiating haart (dobj)
diazinon , (punct)
$ROOT$ induces (sent)
used test (nsubjpass)
bradycardia due (amod)
factor which (nsubj)
rage , (punct)
hawthorn oxycantha (appos)
dexrazoxane enhancers (conj)
therapies 5-fluorouracil (nsubj)
periods dehydration (nmod)
reported decades (nmod:npmod)
investigations for (case)
developing hoarseness (dobj)
was incidence (nmod)
selective and (cc)
changes incidence (nmod)
3 in (case)
behaviors binding (conj)
cirazoline abbott-53693 (conj)
sirolimus ) (punct)
clarification and (cc)
mechanisms significance (conj)
update evidence (nmod)
119 +/- (cc)
ro verapamil (conj)
layer in (case)
analogues cck-5 (nmod)
group snp (compound)
cyclophosphamide risk (conj)
laboratory clinical (conj)
hypothesis preserve (ccomp)
received corticosteroids (dobj)
hbmp ( (punct)
airway reinforced (amod)
and flow-independently (advmod)
isoproterenol with (case)
dysplasia as (cc)
tone on (case)
value prospective (amod)
products peroxidation (nmod)
rat specify (acl:relcl)
effect raloxifene (nmod)
prevention protection (conj)
scale experience (compound)
developed disease (nsubj)
increased action (dobj)
prospective controlled (dep)
50 25 (compound)
phosphorylation kinase (nmod)
control seizure (compound)
work-up repeat (amod)
cause diuretics (nsubj)
appeared beneficial (xcomp)
system brain (compound)
comparable effect (nsubj)
composition salt (compound)
addressing , (punct)
investigating poisoning (dobj)
magnitude comparable (amod)
epileptogenecity the (det)
related remain (conj)
blockade for (case)
difference db (nmod)
leading deposition (nmod)
outcome maternal (amod)
evoked muscles (nmod)
variety factors (nmod)
rate clinical (amod)
acts repeatedly (advmod)
excess mg/kg (nmod)
sensitive especially (advmod)
measures preventive (amod)
increased threshold (nsubjpass)
toxicity increase (conj)
prevention coma (nmod)
parkinsonism induced (acl)
involved that (nsubjpass)
beats verapamil (nmod)
tem ( (punct)
used c57bl/6j (nsubjpass)
hypertension glucocorticoid-induced (amod)
first than (case)
brainstem bilateral (amod)
modulation hypotension (nmod)
paralysis use (nmod)
normal patients (nmod)
short skf-82958 (nmod)
uses therapeutic (amod)
regulate phenotypes (dobj)
weight based (case)
prevented co-injection (nmod)
dose ng/mouse (nmod)
dogs dysrhythmias (nmod)
injections vaccine (nmod)
occurred farmer (nmod)
binding nuclei (nmod)
decreased and (cc)
p20 ) (punct)
1.1 8.5 (prep)
99 pressure (nsubj)
delivered bolus (nmod)
studies trial (appos)
cost low (amod)
ace baseline (amod)
= 2.4 (dobj)
downregulation synthase (compound)
s 0.14 (nummod)
reveal methods (nsubj)
overactivation motor (compound)
elevation on (case)
tested mice (nmod)
ml 500 (nummod)
lesion dopaminergic (amod)
scoring on (case)
result confounding (nmod)
administered centrally (advmod)
patterns changes (nmod)
prompted conduct (xcomp)
ctx ) (punct)
assessment enrollment (nmod)
doses repeated (amod)
failure metabolic-endocrine (amod)
published been (auxpass)
provides uncertainties (nmod)
reducing volume (dobj)
trials ii (nummod)
judged patients (nmod)
revealed ct (nsubj)
$ROOT$ discussed (sent)
tamca ( (punct)
1000 about (advmod)
1,25(oh)2d by (case)
propranolol ) (punct)
underwent mitochondria (nsubj)
mm cause (conj)
cells cortical (amod)
have implications (dobj)
steroid this (det)
50 and (cc)
administered methotrexate (nsubjpass)
nicergoline lysine (conj)
norepinephrine ( (punct)
necessary fertility (nmod)
rats polyuria (nmod)
wsp ) (punct)
male sixties (nmod)
model dysplasia (nmod)
increase month-long (amod)
extracellular the (det)
90 more (amod)
conclusions displayed (appos)
based data (nmod)
caused calcification (dobj)
loss hippocampus (nmod)
aspirin of (case)
albuminuria for (case)
revealed t-tests (nsubj)
precipitate both (advmod)
appears effective (xcomp)
improvement for (case)
administered subcutaneously (advmod)
rr 1.96 (nummod)
narcosis barbiturate-induced (amod)
acid component (appos)
myalgia generalized (amod)
usage after (case)
power reducing (amod)
mr , (punct)
green used (acl)
group female (appos)
16 , (punct)
valvulopathy new (amod)
pneumoniae klebsiella (compound)
significant statistically (advmod)
complications hemorrhagic (amod)
markers gene (compound)
increased day (nmod)
reversal coma (nmod)
known act (xcomp)
causing leukoencephalopathy (dobj)
feature to (mark)
differ that (mark)
$ROOT$ anesthetized (sent)
achieved demonstrated (conj)
cream chp (compound)
phenomenon as (case)
exposure csa (compound)
attend assessment (dobj)
injected twice (advmod)
decreased dendrin (nsubj)
1.46+/-0.8 vs. (cc)
toxicity dose-limiting (amod)
was subjects (nmod)
transplanted intravenously (advmod)
infusion pge1 (compound)
noted patient (nmod)
shown results (nmod)
alternatives . (punct)
regimens based (conj)
number neuron (compound)
arm used (acl)
desaturation severe (amod)
methods nephrectomized (appos)
interaction inhibitor (nmod)
showed degeneration (dobj)
cardiomyopathy in (case)
combinations ketamine (nmod)
type in (case)
8 and (cc)
assessed efficacy (nsubjpass)
c. group (compound)
study symptoms (dobj)
pain both (cc:preconj)
ctc-nci ( (punct)
anti-inflammatory nonsteroidal (amod)
syndrome of (case)
erythromycin agents (conj)
known however (advmod)
atropine to (case)
patients 4,499 (nummod)
question , (punct)
features observed (acl:relcl)
drug phenylpropanolamine (nsubj)
pain less (amod)
nitrendipine with (case)
bpo-pll and (cc)
admitted ccu (nmod)
group boston (nmod)
vector reporter (compound)
men the (det)
schedule toxicity (nmod)
prevent replacement (nsubj)
ascertain to (mark)
ci = (parataxis)
isolated heart (nsubjpass)
tg ( (punct)
months twelve (nummod)
group blood (compound)
reduction sdrr (nmod)
decreased latency (dobj)
enhanced knockdown (nsubj)
co2 ( (punct)
beta-blocking for (case)
deterioration severe (amod)
lid - (punct)
tissue to (case)
(cyp)-induced cyclophosphamide (nmod:npmod)
ecstasy 3,4-methylenedioxymethamphetamine (appos)
overdosage of (case)
resistant partially (advmod)
dox mg/kg (appos)
desmethylimipramine mg (appos)
ineffective . (punct)
return appetite (compound)
thrombosis hitt (appos)
increased mcpp (nsubj)
microscopy scanning (compound)
c nadh (appos)
function inhibitor (nmod)
management support (conj)
appear while (mark)
upregulation the (det)
side-effects sensations (nmod)
agonists all (det)
vomiting sign (nsubj)
studied prevention (dep)
blockade striatum (nmod)
stress combined (acl)
restlessness tremors (conj)
$ROOT$ examine (sent)
measured done (conj)
activation prejunctional (amod)
conclude provide (ccomp)
assessed deglutition (nsubjpass)
associated toxicity (nmod)
1433 - (punct)
microg of (case)
dose small (amod)
diagnosed syndrome (nmod)
effects greater (amod)
tjs ) (punct)
aminotransferase and/or (cc)
fall expression (acl:relcl)
program were (cop)
synthesis vasculature (nmod)
consensus by (case)
forebrain within (case)
use disulfiram (nmod)
suggest changes (dobj)
determined yet (advmod)
bearing immunocytoma (dobj)
gating assembly (conj)
antecedent or (cc)
saline allopurinol (conj)
vasodepressor bradycardiac (conj)
behavior alternation (compound)
segments spinal (amod)
suggested unclear (ccomp)
searched , (punct)
analyzing activity (dobj)
hexachloro-1:3-butadiene 2-bromoethylamine (conj)
conclusions achieved (dep)
amines and (cc)
helpful where (advmod)
tolerance or (cc)
involvement including (case)
number entries (nmod)
common is (cop)
described case (nsubjpass)
register from (case)
treating outpatients (dobj)
study ineligible (acl:relcl)
formation and (cc)
shows precipitate (ccomp)
increased those (advcl)
minority sites (nmod)
method detection (nmod)
resumed therapy (nsubjpass)
picture case (nmod)
s 228+/-101 (nummod)
restricted analysis (nsubj)
vacuolisation myocyte (compound)
high significantly (advmod)
had nsclc (dobj)
relieved , (punct)
choline-devoid choline-supplemented (conj)
output of (case)
metformin of (case)
gem vnb (conj)
kidneys liver (conj)
effects protocols (nmod)
mustard alkylating (amod)
gentamicin and (cc)
receiving days (nmod:tmod)
risk who (nsubj)
group enalapril-treated (amod)
experienced akathisia (dobj)
stimuli of (case)
had showed (parataxis)
increase in (prep)
demonstrates development (nmod)
tuft shrunken (amod)
regimens (cni)-based (punct)
pill amlodipine/benazapril (nmod)
$ROOT$ process (sent)
barrier across (case)
were 24 (nmod)
map on (case)
associated supplements (nmod)
sensitivity specificity (appos)
supply and (cc)
antibodies factor (compound)
focused hence (advmod)
represent drugs (nsubj)
woman 50-year-old (amod)
encephalopathy chorea (conj)
$ROOT$ long-term (sent)
role expression (nmod)
adolescent a (det)
rates bone (compound)
treated heparin (nmod)
coagulopathy patient (nmod:poss)
experience simvastatin (nmod)
proven . (punct)
worsening a (det)
activating k)-atpase (dobj)
resulting dose (nmod)
produced % (conj)
pain by (case)
injury cortex (nmod)
counted min (nmod)
materials educational (amod)
$ROOT$ read (sent)
disease antecedent (amod)
anastrozole tamoxifen (conj)
hematocrit rats (nmod)
activity antitumor (compound)
injected gentamicin (nmod)
mono-infected hbv (nmod:npmod)
muscle increased (amod)
298+/-7 vs. (cc)
3tc regimens (nsubj)
pressures intracavernous (amod)
returned iu/l (nmod)
degrees range (appos)
goal mmol/l (nmod)
showed image (nsubj)
quadriparesis pain (conj)
volume ) (punct)
cardiomyopathy acute (amod)
absent day (nmod)
estrogens failure (nmod)
number chamber (nmod)
antagonist histamine (compound)
type acute (amod)
exposed cyclosporine (nmod)
use the (det)
26- determinant (conj)
induced conclusion (nsubj)
anatomically and (cc)
present therapy (nmod)
cause syndrome (nsubj)
to risk (nmod)
24 % (appos)
t-[35s]butylbicyclophosphorothionate [35s]tbps (appos)
deterioration learning (nmod)
bumetanide and (cc)
sensations intolerable (amod)
resistance pressure (conj)
dyskinesias mid-dose (amod)
glomerulonephritis , (punct)
reducing , (punct)
development 2 (nmod)
intoxication acute (amod)
mm lna+lca (appos)
1a2 cyp (compound)
allografts renal (amod)
secretion excessive (amod)
treated woman (nsubjpass)
caution great (amod)
age acid (conj)
concentrations theophylline (compound)
patency respiration (conj)
factor ircrf (appos)
panss ) (punct)
discontinued medications (nsubjpass)
lowered clonidine (nsubj)
time diagnosis (nmod)
phenotypes extensive (appos)
testosterone , (punct)
done must (aux)
superior is (cop)
bzd/rd one (nummod)
rats anesthetized (amod)
process linked (acl:relcl)
drugs were (cop)
damage methamphetamine-induced (amod)
remedies worldwide (advmod)
fibrillation patient (nmod)
stage interim (amod)
$ROOT$ delivers (sent)
phospholipid esters (conj)
use models (nmod)
generation signs (nmod)
hemosiderotic heavily (advmod)
controls the (det)
tried , (punct)
lesions ' (punct)
quality as (cc)
challenge by (case)
cells renal (amod)
metabolites similar (amod)
reversible be (cop)
seven testing (nmod)
were confirm (xcomp)
effects opposite (amod)
used background (dep)
designed have (xcomp)
transcription and (cc)
condition mental (amod)
status socio-economic (amod)
center anderson (compound)
reduces increasing (advcl)
% 40.9 (nummod)
ratio a (det)
presenting near-syncope (nmod)
morphine plus (cc)
types with (case)
filters inferior (amod)
remained values (nsubj)
volume hilus (nmod)
myopathy . (punct)
administered he (nsubjpass)
10(7 ) (punct)
injection day (nmod)
elucidate mechanisms (dobj)
determine associated (advcl)
time increased (amod)
persisted p (dep)
structure ability (conj)
187 4(sem (conj)
biopsies 5 (nummod)
costs higher (amod)
overdose dph (compound)
piracetam , (punct)
showed rois (nsubj)
sampled exposure (nmod)
taking verapamil (dobj)
cardiotoxicity toxicities (nsubj)
treatment antibiotic (amod)
disappearing completely (advmod)
tachydysrhythmias ( (punct)
reveals association (dobj)
difficulty breathing (nmod)
onset therapy (nmod)
reported seizures (dobj)
mg that (nsubj)
users and (cc)
100 to (dep)
hg 17 (nummod)
disappeared returned (conj)
ng.ml-1 p (appos)
selected members (nmod)
analgesic antipyretic (conj)
countries developing (amod)
syndrome % (dep)
9.95 - (punct)
$ROOT$ displays (sent)
diagnosed he (nsubjpass)
meningitis treated (acl)
neurotoxicity nigrostriatal (amod)
docetaxel of (case)
retraction lid (compound)
ccl4 of (case)
do , (punct)
1.78 : (punct)
risperidone and (cc)
canine and (cc)
patients 641 (nummod)
mg 80 (nummod)
given are (auxpass)
phospholipid pneumonitis (conj)
suspension nanoparticle (compound)
behaviors to (case)
preventing for (mark)
achieve using (xcomp)
complication controlled (conj)
bw/3 ( (punct)
born who (nsubjpass)
decrease relative (amod)
4 8 (conj)
plasticity cortical (amod)
fanft ) (punct)
induced neurotoxicity (dobj)
28 and (cc)
agent ammonium (compound)
mpges-1 ( (punct)
extubated was (auxpass)
interviewing reviewing (conj)
sedated diazepam (nmod)
vary however (advmod)
reabsorption intestinal (amod)
1 range (dep)
resolve symptoms (nsubj)
b6 a/j (conj)
tumour cell (compound)
have possibly (advmod)
hyper- hypotension (conj)
myelopathy or (cc)
hg = (parataxis)
evaluated day (nmod)
caused blockers (nmod)
increase product (nmod)
zidovudine 3'-azido-2',3'-deoxythymidine (dep)
neutropenia less (amod)
myocardiopathy mp (appos)
assessed magnitude (nsubjpass)
viracept who (nsubj)
pointes tachycardia (dobj)
kindreds from (case)
hyperlipemia in (case)
have ingestion (nsubj)
prazosin ) (punct)
had outcome (dobj)
dosing ethambutol (compound)
initiation between (case)
sites [3h]spiperone (compound)
attenuated which (nsubjpass)
commencement the (det)
strokes of (case)
displaying effects (dobj)
profile abnormal (amod)
died months (nmod)
rhythm failure (conj)
calculation mental (amod)
developed result(s (punct)
period 2-day (compound)
number a (det)
lithium maternal (amod)
effect acid (nmod)
irradiation left-sided (amod)
potentiates antagonizes (conj)
completed lost (advcl)
had suggesting (advcl)
reduction neurotransmitters (nmod)
extent smaller (amod)
piloerection including (case)
counts respectively (advmod)
activity the (det)
3.9 3.4 (conj)
changes loss (conj)
case palsy (nmod)
conclusions show (appos)
treatment losartan (nmod)
first h (appos)
disappointing response (nsubj)
cent per (case)
$ROOT$ quiescent (sent)
caa administration (nmod)
allowing continued (ccomp)
identified concentration (nsubjpass)
dbh +/- (cc)
sold counter (nmod)
formulation american (amod)
aggressiveness in (case)
e alone (advmod)
a(2a adenosine (compound)
pathway leloir (compound)
identification early (amod)
doxorubicin doxil (appos)
weeks at (case)
users light (amod)
cases paralysis (nmod)
animals male (amod)
numbers and (cc)
patients a (compound)
alter subjects (nmod)
used decoction (nsubjpass)
combined targeting (nmod)
exercise and (cc)
levels peptide (nmod)
substance than (case)
ended continue (conj)
effect alpha-methyl-para-tyrosine (nmod)
infections groups (nmod)
0.7 0.5 (compound)
designated , (punct)
elevation ( (punct)
patients active (amod)
$ROOT$ seemed (sent)
elevated range (nmod)
scopolamine placebo (conj)
that controls (nmod)
density bone (compound)
arabinoside and (cc)
controlled paid (conj)
develop where (advmod)
cause a (det)
patients twenty-eight (nummod)
requested hour (nmod)
$ROOT$ carry (sent)
infarction of (case)
record from (case)
mg hour (nmod)
disorders encephalopathy (appos)
production ultrasound (compound)
diminishes quality (dobj)
hypertension . (punct)
worsened symptoms (nsubj)
$ROOT$ medicate (sent)
3 10mg/kg (conj)
using filaments (dobj)
desmopressin patients (nmod)
demonstrated analysis (nsubj)
(adr)-induced adriamycin (nmod:npmod)
think to (mark)
cerebellar oculomotor (conj)
chemotherapy without (case)
inhibitor by (case)
experiences individuals (nmod)
contribute cells (nsubj)
revealed retrospectively (advmod)
week 12 (nummod)
infusion 24-hr (amod)
known estradiol (nsubjpass)
function electrophysiological (amod)
improve homeostasis (dobj)
tolerability general (amod)
supports report (nsubj)
exposure surface (nmod)
occurred seen (ccomp)
n-methyl-d-aspartate nmda (compound)
2.13 +/- (cc)
developed group (nmod)
syndrome leukemia (conj)
protectors of (case)
achieved administration (nmod)
pneumonia infarction (conj)
multiforme erythema (compound)
keep level (dobj)
use ibuprofen (compound)
provide investigations (nsubj)
known although (mark)
ethyl-alpha-p-chlorophenoxyisobutyrate to (case)
complication stenting (nmod)
151 139 (conj)
part regimen (nmod)
population screened (acl:relcl)
dose stress (compound)
kidneys intact (amod)
value therefore (advmod)
excretion rates (conj)
factor receptor (compound)
fluoxetine to (case)
seems while (mark)
polyglutamates 3717 (nummod)
model allowing (advcl)
separated drugs (nmod)
occluded mca (nsubjpass)
cause required (conj)
tablets 100 (nummod)
common found (conj)
maintained characteristics (dobj)
levels toward (case)
neuropathy administration (nmod)
changes behind (case)
had did (conj)
completed thalidomide (nmod)
neutrophil to (case)
bun greater (amod)
hypotension enhanced (amod)
years six (nummod)
thromboembolism venous (amod)
retrieval the (det)
nature effects (nmod)
seizure drug-induced (amod)
h with (case)
agonist clonidine (appos)
exchange an (det)
renal auditory (conj)
have itself (nmod)
suggesting aetiology (dobj)
had experiences (dobj)
cellulose % (amod)
cause based (mark)
exacerbation appearance (conj)
prescribing antibiotic (dobj)
osteopenia or (cc)
monitored children (nmod)
neuropathies optic (amod)
seen failure (nmod)
differentiation 10-fold (advmod)
epinephrine mg/kg (appos)
etoposide of (case)
detrimental mediates (advcl)
substrates that (nsubj)
fragmentation to (mark)
39 ) (conj)
dosage proper (amod)
efficacious to (mark)
woman failure (nmod)
ischemic metabolic (conj)
sulphonate mesna (appos)
antigens ex (amod)
women % (compound)
attack avrt (compound)
concluded prove (ccomp)
threat of (case)
microscopy myocardium (nmod)
block to (mark)
cells/microl 1,100 (nummod)
-8.1 +/- (cc)
nelarabine mg/m(2 (appos)
up-regulation diffuse (amod)
acid periconceptional (amod)
paralysis preoperative (amod)
long-term intolerance (nmod)
accident in (case)
= 0.018 (dobj)
weight their (nmod:poss)
responses inflammatory (amod)
cyclosporine with (case)
result levels (nmod)
men 20 (nummod)
ultrafiltration and (cc)
mechanisms catalepsy (nmod)
5-ht of (case)
observed effect (nsubjpass)
increase cromakalim- (amod)
pain report (dep)
abolished completely (advmod)
effective treatment (nmod)
analysis perimetry (compound)
animals pilo-treated (amod)
features and (cc)
reduction dose (compound)
concluded increases (ccomp)
$ROOT$ suggests (sent)
necessary determine (xcomp)
atropine adrenaline (conj)
cultures myocyte (compound)
mssa ( (punct)
microgram/kg/min ( (punct)
cautious should (aux)
lid excess (conj)
cdc ( (punct)
delirium experienced (acl)
effects haloperidol (conj)
essential management (nmod)
marked increased (conj)
hospitalized , (punct)
tolerated . (punct)
inpatients to (case)
seen changes (nsubjpass)
blockade plexus (nmod)
0.38 0.1 (conj)
benzoylecgonine for (case)
hilus gyrus (nmod)
early long-term (conj)
expression identified (advcl)
restored was (auxpass)
increased used (advcl)
suggested 1975 (nmod)
damage inner (amod)
occluded anesthesia (nmod)
decreases reperfusion (nmod)
dysfunction cell (compound)
exercised caution (nsubjpass)
trial haloperidol (nmod)
cell and (cc)
progressed five (nsubj)
agents toxic (amod)
fill not (neg)
suppressed rate (nmod)
elf famtx (conj)
$ROOT$ illustrates (sent)
transporter dat(-/- (appos)
41.4 6.5 (conj)
role tnf-alpha (nmod)
respiratory and (cc)
sampled retrospectively (advmod)
administered developed (conj)
give we (nsubj)
reviving use (nmod)
subjected se (nmod)
sedation complications (conj)
found cause (ccomp)
beta4 the (det)
antithrombin , (punct)
anemia associated (acl)
recur not (neg)
known system (nsubjpass)
mrna factor-alpha (conj)
observed let (conj)
neuropeptide immunomodulatory (amod)
taken prescribed (advcl)
distinct that (nmod)
progesterone deoxycorticosterone (conj)
contributed hypotension (nmod)
suppressed continuously (advmod)
width of (case)
implications autism (nmod)
% 16.2 (nummod)
levels mrna (compound)
carcinoma bladder (nmod)
alopecia , (punct)
scopolamine depletion (conj)
received appeared (advcl)
agonists adrenergic (amod)
reduced < (dep)
deficits hyperactivity (dep)
cross-react a (nmod)
association hydroureteronephrosis (nmod)
exposure thalidomide (nmod)
version assay (nmod)
fetuses offspring (conj)
neuropathy her (nmod:poss)
expression altered (amod)
falciparum bilirubin (appos)
reached were (auxpass)
presence mellitus (nmod)
observed latter (nsubjpass)
activation cisplatin (nmod)
0.24:1 indicates (conj)
morbidity cardiac (amod)
resulting admissions (nmod)
likelihood drowsiness (nmod)
provision interventions (nmod)
finally patients (nmod)
deferens ileum (conj)
drug amlodipine (appos)
involvement stress (nmod)
acting is (cop)
exposure variety (nmod)
provided dose (nsubj)
justified is (cop)
2.6 2.2 (conj)
bd1018 or (cc)
infusion 5-micrograms/kg (compound)
monomer , (punct)
mice alpha2abc-knockout (amod)
relationship of (case)
had khz (nmod)
incapacitated not (neg)
immunosuppressants the (det)
effects anticataleptic (amod)
restimulation acid (nmod)
proof effect (nmod)
$ROOT$ gaining (sent)
substituted occurred (conj)
studied is (auxpass)
seconds thirty-six (nummod)
gfap-staining of (case)
decreased insignificantly (conj)
recordings neurophysiological (amod)
deterioration field (nmod)
kindling by (case)
reviewed extraction (dep)
licking group (parataxis)
consequence effects (nsubj)
$ROOT$ limited (sent)
dissatisfaction noncompliance (conj)
coli and (cc)
explained diseases (nmod)
aneurysms of (case)
child 1 (nummod)
depressed group (advcl)
flumazenil antagonist (compound)
tolerate to (mark)
balance for (case)
nimodipine n=101 (dep)
fever failure (conj)
checked decreases (advcl)
substances cycle (nmod)
effects temperature (compound)
series mesna (compound)
found signs (nsubjpass)
increase injection (nmod)
dissociation atrio-ventricular (amod)
presence ; (punct)
62 30 (compound)
twitching of (case)
given and (advmod)
im the (det)
determine response (dobj)
increased way (nmod)
increased amplitude (dobj)
occasions nine (nummod)
pathogenesis the (det)
patient proteinuria (nmod)
detected a (nsubjpass)
interaction paroxetine (nmod)
activity renin (compound)
evaluated contents (nsubjpass)
doxil dose (dep)
design patients (nmod)
effects to (case)
confirmed biopsy (nmod)
agents chemotherapeutic (amod)
has reputation (dobj)
carries that (nsubj)
were decreased (ccomp)
granulocytes platelets (conj)
display effects (dobj)
contribute . (punct)
counts gross (amod)
controls n (dep)
explore possibility (dobj)
resulted deterioration (nmod)
mm -0.2 (nummod)
therapy ritodrine (compound)
expression neuronal (amod)
evaluated sonograms (nmod)
1.4 ) (punct)
methods used (appos)
expected had (advcl)
fetus neonate (conj)
impairs that (mark)
ramipril of (case)
898 placebos (nmod)
reduced conclusions (nsubjpass)
causes toxins (nsubj)
series agents (nmod)
purpose map (acl)
mg -0.42 (nummod)
level gfap (nmod)
ddavp ( (punct)
become not (neg)
killed , (punct)
inhibitor dopa (compound)
toxicity cns (compound)
ngf pge2 (conj)
bp sitting (amod)
immunohistochemistry antibodies (nmod)
edetate and (cc)
t-tests post-hoc (amod)
increased indicating (xcomp)
received remission (nmod)
inhibition mediated (amod)
cases neuropathy (nmod)
controls 20 (nummod)
remained parameters (nsubj)
omitting fentanyl (dobj)
may 1996-nov (appos)
pamidronate and (cc)
research laboratory (nmod)
affected any (nmod)
are implications (attr)
patients malignancies (nmod)
inhibitor dideoxyinosine (appos)
lesions reversible (amod)
inducing rats (nmod)
vpa ) (punct)
effect by (case)
effectiveness inhibiting (advcl)
cells known (acl:relcl)
cells/mm3 groups (nmod)
positivity antibody (compound)
ibuprofen and (cc)
influence consumption (nmod)
accompanied rise (nmod)
prevented treatments (nsubj)
words these (det)
predominate and (cc)
received april (nmod)
zidovudine placebo (conj)
externa membrane (nmod)
prolongation bradycardia (conj)
verapamil neither (cc:preconj)
sectioning after (case)
age years (appos)
therapy cyclophosphamide (compound)
parkinsonism drug-induced (amod)
bladder mouse (nmod)
list drugs (nmod)
tumors f1 (compound)
class for (case)
due excess (nmod)
necessary intervention (nsubj)
oxidation ring (nmod)
cells hippocampus (nmod)
younger [ (punct)
eight to (dep)
was taken (advcl)
induced hydrochloride (nmod)
somatotopy systems (nmod)
reversible longer (parataxis)
have olanzapine (nsubj)
action corrective (amod)
dyskinesias prominent (amod)
tiapride and (cc)
willing patients (nsubj)
oxygenation on (case)
patients bicarbonate (nmod)
volume urinary (amod)
accumulation lipid (compound)
prolonged resulted (conj)
pronounced atrophy (nsubj)
developed use (nmod)
tnfalpha ) (punct)
% 80.0 (nummod)
les fi (compound)
limited has (aux)
skf-82958 hydrobromide (appos)
needed delineate (dep)
permit . (punct)
cases two (nummod)
reducing diminishing (conj)
artery a (det)
meq/kg/day of (case)
prevent downregulation (dobj)
allergy patients (nmod)
conclusions caused (appos)
di on (case)
% mg (appos)
detected damage (nsubjpass)
mice rendered (acl)
increases cells (nmod)
dose tolerated (amod)
reporting abuse (dobj)
characteristics e (nmod)
preparations of (case)
saline ml (amod)
neonate immunocompetent (amod)
follows : (punct)
hmm ( (punct)
recurrences % (appos)
impairment caused (acl)
promotion of (case)
dose 80-mg/day (compound)
details mechanistic (amod)
health also (advmod)
ester of (case)
began rats (nsubj)
failure itself (appos)
rhythm in (case)
calculation the (det)
demonstrated ischemia (nsubjpass)
combination intralipd (nmod)
induced nra0160 (nsubj)
studies microscopic (amod)
mg/kg)-treated 30 (nummod)
evaluated and (cc)
induced acid (nmod)
total evidence (conj)
week m1 (dep)
received design (nmod)
caused use (nmod)
questions following (amod)
sex value (conj)
paws and (cc)
efficacy undoubted (amod)
increased incidence (dobj)
years 67 (nummod)
surgery by (case)
met has (aux)
strokes use (conj)
achieved . (punct)
developed pharmacotherapy (nmod)
female adult (amod)
cause would (aux)
resting and (cc)
dropped increased (advcl)
woman 56-year-old (amod)
causes the (det)
areas several (amod)
damage and/or (cc)
month a (det)
administration indinavir (nmod)
postulated proteins (nsubjpass)
rare pediatrics (nmod)
elucidated to (mark)
22 in (case)
disorder instability (conj)
fa mg/m(2 (appos)
tested h (nmod)
72 to (quantmod)
tracts portal (amod)
loss weight (compound)
29 % (appos)
development hypokalaemia (nmod)
3.7 +/- (cc)
prodrug is (cop)
dysfunction from (case)
woman depression (nmod)
increase content (nmod)
seizures neurotoxicity (conj)
such ( (punct)
three four (conj)
evaluation reactions (nmod)
antiparkinsonians prophylactic (amod)
continued improved (ccomp)
varied 2.4 (nmod)
follow-up close (amod)
pressure > (amod)
relieved alcohol (nsubj)
relates exposure (dobj)
has background (nsubj)
inducing despite (mark)
react 2e1 (nmod)
cancer des (case)
31.85 +/- (cc)
with concomitantly (advmod)
elevates levels (dobj)
livers , (punct)
mucosa nasal (amod)
studied vivo (advmod)
technique selective (amod)
affect children (dobj)
starting application (nmod)
tasks overt (amod)
pressure observed (acl:relcl)
found absence (nmod)
cells his (nmod:poss)
dizziness progressing (acl)
38.9 +/- (cc)
diagnosis hyperplasia (nmod)
5 4 (conj)
flap dorsi (compound)
inhibited potently (advmod)
impairment . (punct)
blocked that (mark)
block cardiomyopathy (conj)
strategies . (punct)
increases minor (amod)
cycle 4-week (amod)
nephropathy mice (nmod)
equipment nautilus (amod)
treated dose (nmod)
episodes ischemic (amod)
chf 3 (nummod)
0.2 0.25 (conj)
awareness for (case)
mg/m(2 ctx (nmod)
cured % (nsubjpass)
considered were (auxpass)
lupus sulfasalazine-induced (amod)
dtg ) (punct)
resolved promptly (advmod)
anemia correctable (amod)
correlated = (parataxis)
$ROOT$ attributable (sent)
report neonates (dobj)
fangchinoline fan (appos)
released saline (dobj)
abundances protein (compound)
result largely (advmod)
sections forebrain (compound)
loss nigra (nmod)
fell 100+/-17 (nmod)
cyclophosphamide or (cc)
creatinine gender (conj)
decrease lysozymuria (conj)
period assessment (compound)
apoptosis system (nmod)
ultrasound ct (conj)
2002 - (punct)
preserved cases (nmod)
cause combination (nsubj)
affected number (nsubjpass)
dynamic total (amod)
produces . (punct)
quantifying tremor (dobj)
5 ) (punct)
other from (case)
disease huntington (nmod:poss)
effects muscarinic (amod)
markers activator (conj)
case in (case)
subjects 10 (nummod)
onset and (cc)
complication chemotherapy (nmod)
movements asymmetric (amod)
step not (neg)
$ROOT$ tend (sent)
carbonate with (case)
enabled dose (nsubj)
studies lectin (compound)
made patients (nmod)
hypotension map (nmod)
recorded and (cc)
assessed rat (nmod)
obtained we (nsubj)
elevations pressure (compound)
suggests capable (ccomp)
generation cardiac (amod)
evidence any (det)
synthase nos (appos)
had have (aux)
acted ra (nsubj)
different incidence (nsubj)
documentation case (nmod)
perturbated electrically (advmod)
incidence this (det)
$ROOT$ technique (sent)
causes percentage (nmod)
neurotoxicity theophylline (nmod)
$ROOT$ deemed (sent)
metastasis lung (compound)
mg/ml of (case)
desensitization cardiac (amod)
concentrations an (nmod)
association failure (nmod)
involvement processes (nmod)
hypotension including (case)
refine to (mark)
syndrome aminonucleoside (conj)
technique ether (amod)
lesions liver (compound)
most for (case)
provide hypothesis (nmod)
followed study (nmod)
patients compensated (amod)
zi ) (punct)
response weight (compound)
cisapride mg (appos)
patients those (det)
hospital urban (amod)
increased serum (nmod)
far so (advmod)
syndrome encephalopathy (compound)
age disease (conj)
et-1 enzyme-1 (conj)
gene homer1 (compound)
v2.0 with (case)
consistent therapies (nmod)
few a (quantmod)
reduced included (ccomp)
methylprednisolone , (punct)
man taking (acl:relcl)
$ROOT$ peaked (sent)
found metoprolol (nmod)
co ) (punct)
527+/-509 ( (punct)
antibiotics different (amod)
assessing exposure (dobj)
superoxide plasma (compound)
time collection (nmod)
affecting pressure (dobj)
scrutiny for (case)
have carbimazole (nsubj)
responses cells (nmod)
involved drugs (nsubjpass)
avoid to (mark)
compartment from (case)
morphine ( (punct)
studied efficacy (dobj)
excretion pirarubicin (nmod)
$ROOT$ serve (sent)
patients developed (acl:relcl)
retention and (cc)
effects sedative (amod)
result may (aux)
newspaper in (case)
illustrate . (punct)
ng/ml < (amod)
growth any (det)
maintained , (punct)
chemotherapy previous (amod)
fragmentation orderly (advmod)
paid attention (nsubjpass)
associated ratio (nmod)
meshwork in (case)
enzymes p450 (compound)
findings treated (appos)
ct repeat (amod)
13 11 (compound)
taken should (aux)
terminate can (aux)
treatment conventional (amod)
cortex model (nmod)
decreased % (conj)
encephalomalacia ( (punct)
task shifting (appos)
melatonin by (case)
hypothesized selective (advcl)
seen patients (nmod)
dexmedetomidine agonist (compound)
atrophy infiltration (conj)
infections overall (amod)
similar = (parataxis)
approach the (det)
reversible cytopenias (nsubj)
classified reports (nsubjpass)
yohimbine or (cc)
features resembling (acl)
design analyzed (dep)
dyskinesias in (case)
$ROOT$ reviewed (sent)
conclusions mounting (appos)
4'-0-tetrahydropyranyladriamycin iv (nummod)
treated preceded (advcl)
$ROOT$ examines (sent)
biopsies lesion (compound)
staining of (case)
identified was (auxpass)
epilepsy of (case)
or intravenously (advmod)
h2o sem (compound)
mg/kg 6 (nummod)
infusion b (nmod)
h 3.07+/-0.71 (nummod)
peptide(1 glutamate (conj)
results included (dep)
8.3 1.7 (conj)
ee or (cc)
100mg/kg with (case)
reacts mediating (advcl)
receiving indinavir (dobj)
sample biopsy (compound)
site one (nummod)
response discrete (amod)
collection and (cc)
able would (aux)
injury dili (appos)
updrs in (case)
attacks to (case)
strategies antiparkinsonian (amod)
foci pas (compound)
therapy tamoxifen (compound)
permits schedule (nsubj)
17 to (dep)
related patient (nmod)
model first (amod)
interact site (nmod)
corticosteroids mydriatics (conj)
imaging for (case)
increase risk (nmod)
given continued (conj)
ob in (case)
size bs (compound)
elevation troponin (compound)
cortex orbital (amod)
mass mg (nmod)
neuroblastoma against (case)
nucleus ( (punct)
oxygenation brain (compound)
occurs background (dep)
bronchodilator that (mark)
penetrate which (nsubj)
dependence . (punct)
22.77 ) (punct)
common origin (conj)
necessary drugs (nmod)
complications green (nmod)
long-acting and (cc)
presentation delayed (amod)
causing tdr (dobj)
domperidone i.v. (compound)
reversed values (nmod)
call and (cc)
interleukin-6 marker (nmod)
tafi , (punct)
functions t-cell (compound)
conditions with (case)
important especially (advmod)
identified factor (nmod)
t ) (punct)
excluding reports (dobj)
developed cases (nsubj)
consisted women (nmod)
neurons nigra (nmod)
nephrin and (cc)
$ROOT$ harvested (sent)
= k(i (nsubj)
variants motor (amod)
risk levels (nmod)
judiciously and (cc)
materials studied (dep)
patients neutropenia (nmod)
samples with (case)
concern some (det)
low chronically (advmod)
paradigm optimal (amod)
compared 17 (nmod)
modifying disease (nmod:npmod)
correlates neural (amod)
increased molecularly (advmod)
dropped had (aux)
mice webster (compound)
pretreatment by (case)
fluency speed (conj)
common conclusions (dep)
years 63 (nummod)
sniffing , (punct)
analyzer the (det)
$ROOT$ pains (sent)
recommended that (mark)
1.043 ) (punct)
reserved should (aux)
sunitinib such (case)
molecule of (case)
ruled and (cc)
design genetic (amod)
inactive whereas (mark)
six tests (nmod)
profile and (cc)
caused noted (conj)
showed assessments (nsubj)
desmosomes hemidesmosomes (conj)
years 52 (nummod)
nx sham (conj)
reversibility . (punct)
year 73 (nummod)
leukemia central (amod)
present ketosis (nsubj)
cbz ) (punct)
% 14.3 (nummod)
behaviors dopamine-related (amod)
improved patients (nsubj)
found rats (nsubjpass)
profile insecticide (nmod)
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine s.c. (appos)
dyskinesia against (case)
parameters of (case)
antagonist , (punct)
patients department (compound)
dimensions annular (amod)
$ROOT$ adopted (sent)
benefited treatment (nsubj)
tasks other (amod)
vasculitis . (punct)
hrptec on (case)
studied fashion (nmod)
bleeding fatal (amod)
17 in (case)
administered mg/m2 (nsubjpass)
years range (dep)
mm population (nmod)
gravis . (punct)
exclusion the (det)
patients cirrhosis (nmod)
reported earlier (advmod)
results with (case)
graded as (prep)
forms to (case)
pain increasing (amod)
difference is (cop)
received mg/day (dobj)
effect citalopram (nmod)
suggested have (advcl)
suppressed cibenzoline (nsubj)
increase interaction (dobj)
expressing egfp (dobj)
dermatitis for (case)
women 90 (nummod)
ectopy ventricular (amod)
induced usually (advmod)
drg l1 (compound)
b.d from (case)
lozenge nicotine (compound)
% 72.4 (nummod)
suggest rct (nsubj)
disintegrations minute (nmod)
interval alternating (amod)
syndrome acetaldehyde (compound)
corresponding areas (nmod)
pyrexia and (cc)
preceded associated (conj)
used divided (conj)
sc group (compound)
scale severity (compound)
percent 60 (nummod)
b.i.d. ( (punct)
acid control (appos)
japan in (case)
cases the (det)
explored importance (dobj)
hr on (case)
catheterization before (case)
determined be (auxpass)
thrombocytopenia life-threatening (amod)
improved evaluation (nmod)
setting hospitals (appos)
essential introduction (dep)
cessation upon (case)
increases as (advmod)
assigned sr (nmod)
arteries constricting (amod)
difficulties secondary (amod)
diameter their (nmod:poss)
warranted study (nsubjpass)
gave analysis (nsubj)
women perimenopausal (amod)
due mechanism (nmod)
methods several (amod)
area risk (nmod)
$ROOT$ micrograms/ml (sent)
order improve (acl)
glycosuria g/day (dep)
severity of (case)
venom from (case)
sacrificed dissociated (conj)
process storage (compound)
score off-period (amod)
history noncontributory (amod)
amide (s)-(-)-3-bromo-n-[(1-ethyl-2-pyrrolidinyl)methyl]-2,6-dimethoxybenz (compound)
showed withdrawal (nmod)
infusing remifentanil (dobj)
receiving paralysis (nmod)
limited effects (nmod)
$ROOT$ included (sent)
have compounds (nsubj)
promotes and (cc)
possible always (advmod)
emergency hypercalcemic (amod)
procoagulant the (det)
revealed autopsy (nmod)
received anesthesia (dobj)
found concentration (nsubjpass)
effects exhibited (acl)
atropine as (cc)
vulnerable selectively (advmod)
ulcers with (case)
7-ni ) (punct)
comparison clinical (amod)
taken whom (nmod)
exposure professional (amod)
examination by (case)
dependence ischemia (nmod)
dronedarone and (cc)
bolus 2-minute (amod)
antagonizes propranolol (nsubj)
immunophilin to (case)
mg/kg/day water (conj)
interfere treatment (nmod)
0.54 ( (punct)
method assessed (dep)
drop them (nsubj)
expression pathways (nmod)
increased microg.kg(-1).h(-1 (dobj)
models the (det)
determined indicators (nsubjpass)
exposure periarterial (amod)
demonstrated olanzapine (nsubj)
selection patterns (nmod)
fit , (punct)
projection descending (amod)
recognition importance (nmod)
measured removed (conj)
3 only (advmod)
enhanced estradiol (nsubj)
remains under-recognized (punct)
h compared (dep)
dose microgram.kg-1.min-1 (nmod)
flow and (cc)
location and (cc)
increase incidence (dobj)
mipafox to (case)
rate output (conj)
developed mild (conj)
searched register (nmod)
in vitro (dep)
deficits brain (compound)
lna at (case)
hours between (case)
tendency aggressiveness (nmod)
seizure both (cc:preconj)
report pseudo-allergy (nmod)
remained c7-c8 (dep)
incidence convulsions (nmod)
fed aspirin (conj)
ratios plasma/kidney (compound)
prevented lethality (dobj)
bpo-pll for (case)
solution of (case)
percentage creatinine (conj)
pharmacokinetics metoprolol (nmod)
reported duration (nsubjpass)
prevalence with (case)
psychotropic its (nmod:poss)
bradycardia due (case)
room in (case)
patients period (nmod)
monohydroxyethylrutoside the (det)
ssri ) (punct)
component an (det)
exposed previously (advmod)
reduced exercise (nsubj)
palpation the (det)
mg/m2 then (advmod)
carry out (compound:prt)
size lysosomal (amod)
facility tertiary (amod)
reduced effects (dobj)
sulfate bw (appos)
stress drop (conj)
bau ( (punct)
time severity (conj)
number time (conj)
injected had (aux)
$ROOT$ cholestasis (sent)
sample blood (compound)
kidneys of (case)
analysis long-term (amod)
effect increase (nmod)
model with (case)
included age (conj)
attribute addition (nmod)
control cardiac (amod)
effects variations (nmod)
nf-kappab of (case)
parasitosis occurring (acl)
modulates temocapril (nsubj)
shown processing (nsubjpass)
preexposure of (case)
larger group (nmod)
unclear is (cop)
fibrillation non-valvular (amod)
receptor fractalkine (compound)
association depression (nmod)
seizures against (case)
doses p.o. (appos)
returned withdrawal (nmod)
bromide oxitropium (compound)
$ROOT$ remapped (sent)
trimester first (amod)
occur cardiotoxicity (nsubj)
tool to (mark)
clearance systemic (amod)
channels l-type (amod)
disease gall (compound)
ratio with (case)
crescents with (case)
psychotropic lowest (amod)
abolished 5,7-dihydroxytryptamine (nmod)
patterns consistent (amod)
svc ( (punct)
prolongation . (punct)
insertion needle (compound)
dependency flow (compound)
adenoma between (case)
expressed epilepsy (nmod)
discussed some (nsubjpass)
underwent delivery (nmod)
affected days (nmod)
increases diet (nsubj)
increases phenomenon (dobj)
penicillins erythromycins (conj)
evaluated experiments (nmod)
treated five (nsubjpass)
scale digitized (acl)
dose as (case)
response antibiotics (nmod)
ci 1.57 (nummod)
screening cost-effective (amod)
methods materials (conj)
agency to (case)
performance practices (nmod)
1.73 +/- (cc)
phenomena possible (amod)
fear conditioned (amod)
limb and (cc)
20.95 + (cc)
death day (nmod)
echocardiography by (case)
beta-ar ) (punct)
neuropeptide distributed (acl)
appears effect (xcomp)
risk encephalopathy (nmod)
insipidus lithium-induced (amod)
size epilepticus (nmod)
changes same (amod)
decreased dose-dependent (conj)
high allow (xcomp)
b c (conj)
fell activity (nsubj)
decrease index (nmod)
3.1 ci (dep)
hemorrhaging and (cc)
1/104 ) (punct)
limit myelosuppression (nsubj)
altered effects (nsubjpass)
rt-pcr blotting (conj)
method ellman (compound)
plays initiation (nmod)
h before (nmod)
grafts functioning (amod)
1.31 ) (punct)
increase transitory (amod)
increments lactate (nmod)
kinases ) (punct)
$ROOT$ valsartan (sent)
min 238 (nummod)
massive to (advmod)
effects cumulative (amod)
parp-1+/+ parp-1-/- (conj)
increased five-fold (advmod)
changed contents (nsubjpass)
$ROOT$ infusion (sent)
compared responses (nmod)
given eight (nsubjpass)
developed reduction (nmod)
detected so (mark)
absence exposure (nmod)
disorder with (case)
biopsies ) (punct)
show choices (dobj)
given den (nmod)
bleeding regarding (case)
multicenter prospective (dep)
decrease confusion (conj)
times administering (acl)
opportunity discontinue (acl)
prk myopic (amod)
hepatotoxicity galactosamine (compound)
pregnancy recent (amod)
$ROOT$ indicate (sent)
microg/kg 0.1 (nummod)
history pain (nmod)
background aim (conj)
abrogated retarded (conj)
dose-effect development (nmod)
nalozone by (case)
effect inhibitory (amod)
living daily (compound)
agent detect (acl:relcl)
nassa ( (punct)
products reaction (compound)
abortions midtrimester-induced (amod)
pruritus by (case)
0.92 : (punct)
dismutase and (cc)
hyperalgesia for (case)
doses amiodarone (nmod)
man 35-year-old (amod)
supposed . (punct)
monohydroxyethylrutoside monoher (appos)
balance potassium (compound)
function cognitive (amod)
eruptions skin (compound)
safe remarkably (advmod)
3.9 ci (nsubj)
latency shorter (amod)
oxygenation and (cc)
appeared although (mark)
mmse the (det)
conclude compares (conj)
suggested toxicity (nmod)
studied role (dobj)
syndrome pan-induced (amod)
showed percent (nsubj)
eads its (nmod:poss)
caused identical (conj)
neurons rat (compound)
components fast-moving (amod)
effects disorders (nmod)
controls non-drug (amod)
receiving agents (dobj)
evoked seizures (dobj)
presented type (nmod)
areas available (dep)
continuation patients (nmod)
effects because (case)
cause hepatotoxicity (dobj)
similar : (punct)
returned disappeared (conj)
avp plasma (compound)
vessels renal (amod)
naphazoline and (cc)
application l-sotalol (nmod)
they all (appos)
induces hypotension (dobj)
ineffective whom (nmod)
effect hyaluronate (nmod)
taking currently (advmod)
stimulation hypersensitivity (conj)
signs one (nummod)
kinase target (compound)
areas epithelium (nmod)
myopathy clinical (amod)
downregulating pathway (dobj)
length functional (amod)
excluded can (neg)
pressure mean (compound)
score recordings (conj)
sclerosis with (case)
ballistic dystonic (conj)
leukemia aml (appos)
$ROOT$ hemorrhagic (sent)
syndrome leg (compound)
number high (amod)
isomers both (det)
agent anti-tumor (amod)
infection proven (amod)
group contrast (nmod)
hypercalcemia stabilizers (conj)
schedule hepatocarcinogenesis (nmod)
explored was (auxpass)
studies adult (amod)
apparatus avoidance (compound)
atin ( (punct)
hypersensitivity . (punct)
role interaction (nmod)
patient presents (acl:relcl)
erk ) (punct)
post-lt years (nmod:npmod)
detect that (mark)
conclude knowing (advcl)
need scrutiny (nmod)
mpep of (case)
cause with (case)
$ROOT$ defective (sent)
d2/d3 and (cc)
changes in (case)
associated markers (nmod)
involvement action (nmod)
bleeding . (punct)
contraindicated unless (mark)
progenitor marrow (compound)
8.9 time (nsubj)
125 25 (compound)
phenylephrine such (case)
changes -0.62 (appos)
micromol/liter p<0.05 (appos)
finding well-established (amod)
go , (punct)
potentiated to (mark)
detected fraction (nmod)
results surveillance (nmod)
administered episode (nmod)
evidenced further (advmod)
rise adrenoceptors-mediated (amod)
published events (nsubjpass)
course pregnancies (nmod)
regurgitation regurgitation (conj)
nucleus plexus (conj)
crocin combination (nmod)
therapy chlorpropamide (compound)
induced tumors (nsubjpass)
circuits neural (amod)
symptoms oab (compound)
brain parkinsonian (amod)
observed exposure (nmod)
plasma electrolytes (conj)
characterization detection (conj)
study no (neg)
maltol acid (conj)
dyskinesia protrusion (conj)
infusion nitroprusside (compound)
levels stress (compound)
caused toxicity (nsubj)
3,7-dimethyl-1-propargylxanthine ( (punct)
use popular (amod)
ingestion life-long (amod)
respond increase (nmod)
had performed (conj)
relationship its (nmod:poss)
3.49 1.21 (dep)
intracisternal i.c. (dep)
levels transcript (nmod)
factor-kappab nuclear (amod)
fractions p2 (compound)
medications adjunctive (amod)
psychosis . (punct)
difficult radiologically (advmod)
amounts acid (nmod)
long-term pregnancy (nmod)
vldl ldl (conj)
agent daunorubicin (nsubj)
exerts hyperammonemia (nsubj)
seizures receptors (conj)
failure therapy (compound)
enhanced cp (nsubj)
evaluations clinical (amod)
31 i (punct)
occurrence unusual (amod)
users for (case)
morbidity the (det)
administration combination (nmod)
induce exposure (nsubj)
mi ck-mb (dep)
release an (det)
impaired when (advmod)
kindreds and (cc)
minutes three (nummod)
prolongation ecg (nmod)
myalgia effect (nsubj)
deletions more (amod)
reduction points (nsubj)
marked persistent (conj)
alter properties (dobj)
receiving were (aux)
received inhibition (nmod)
sensations atypical (amod)
duration injection (compound)
improving of (mark)
hypersensitivity aspect (nsubj)
change concentration (nmod)
drugs stimulating (acl)
generated printout (nsubjpass)
min 10 (nummod)
developed thrombosis (dobj)
interference without (case)
developed hyperkalemia (dobj)
pressure mice (nmod)
disappeared headache (nsubj)
rats no-deficient (amod)
outcome worst (amod)
suggest produce (ccomp)
change rate (nsubj)
treated naloxone (nmod)
changes c2 (nmod)
supplied . (punct)
death variable (compound)
tested men (nmod)
given had (aux)
activity equivalent (amod)
concentrations greater (amod)
had previously (advmod)
mediated " (punct)
feature organization (nsubj)
stimulation hz (nmod)
adopted induce (parataxis)
treatment children (nmod)
scarce findings (nsubj)
assessed preference (nsubjpass)
physiologic environmental (conj)
effects or (cc)
deduced can (aux)
treatment fluoxetine (compound)
serum aluminium (compound)
used scopolamine (nsubjpass)
4 22 (prep)
associated inflammation (nmod)
125 and (cc)
observed instead (advmod)
mice diabetes (nmod)
inhibition no (neg)
prevented treatment (nmod)
dose ppa (nmod)
injection repeated (amod)
mo in (case)
avoid procedures (dobj)
catecholamines relaxants (conj)
raised , (punct)
8-phenyltheophylline theophylline (conj)
process necrotic (amod)
12-week , (punct)
solid-organ marrow (conj)
studied development (nmod)
appears constriction (nsubj)
learning scopolamine-induced (amod)
selective men (nmod)
report can (aux)
18 less (advmod)
pro-arrhythmic although (mark)
$ROOT$ imparts (sent)
systems heterologous (amod)
use group (nmod)
jc ( (punct)
$ROOT$ wanted (sent)
% 2.9 (nummod)
induce not (neg)
reports preliminary (amod)
weeks study (nmod)
reach did (aux)
induced stimulation (nsubj)
took total (nmod)
practices academic (amod)
measures treatment (compound)
10 0 (compound)
analyzed characteristics (nsubjpass)
calcium elemental (amod)
effect nephroprotective (amod)
therapy antianginal (amod)
inhibition binding (nmod)
patients loss (nmod)
initiate turn (nmod)
patients cleared (acl:relcl)
high but (cc)
deduced observations (nmod)
$ROOT$ elimination (sent)
hrptec ( (punct)
referred man (nsubjpass)
inhibition % (compound)
sinus aortic (amod)
progression loss (nmod)
ci adjusted (acl)
provide opportunity (dobj)
cardiotoxicity leukopenia (conj)
confirmed similar (ccomp)
apex akinesia (conj)
mg/kg/day dosages (nsubj)
results studies (nmod)
populations special (amod)
cage home (compound)
a-86929 of (case)
rates by (case)
induce dysplasia (dobj)
control but (cc)
u/ml ) (punct)
apap metabolism (conj)
contention sites (ccomp)
relation treating (acl)
tend those (nsubj)
changes acute (amod)
respond return (conj)
three two (compound)
groups placebo (compound)
supernatants endothelial (amod)
formulation oil (nmod)
causes disease (nsubj)
i.c. ( (punct)
conclusion increases (appos)
effects ligands (nmod)
status affective (amod)
$ROOT$ plays (sent)
passed and (cc)
non-biodegradable were (cop)
administrated agent (nmod)
inclusion for (case)
ng greater (amod)
induced infusion (nmod)
change average (amod)
grade the (det)
estimated and (cc)
groups high- (amod)
2-receptors beta (nmod:npmod)
sites cortex (nmod)
quadriparesis , (punct)
useful cabergoline (nsubj)
4-ene-vpa and (cc)
evaluation after (case)
ngf pgs (conj)
evaluate frequency (dobj)
reaction consisting (acl)
tended signs (nsubj)
unlikely is (cop)
criteria uspstf (compound)
infections patients (nmod)
antagonist active (amod)
deformations and (cc)
increased phentolamine (nsubj)
supported further (advmod)
normal periods (nmod)
cultures beating (amod)
cornerstone programs (nmod)
scans resonance (compound)
extract sinensis (nmod)
strains mouse (compound)
reason important (amod)
induced focus (nsubjpass)
reported development (nsubjpass)
see application (dobj)
implicated was (auxpass)
have yet (advmod)
tract rat (nmod)
function retina (nmod)
controls age-matched (amod)
months mean (nsubj)
applied treatment (nsubjpass)
had black (conj)
$ROOT$ hours (sent)
access(r ng/ml (appos)
values on (case)
died rats (nmod)
complication therapy (nmod)
origin inflammatory (amod)
intake h (nmod:npmod)
useful and (cc)
ingestion following (case)
case tachycardia (nmod)
persist defects (nsubj)
accompanied syndrome (nsubjpass)
mice ko (appos)
compound free (amod)
39 to (dep)
use aerosolized (amod)
diphenhydramine of (case)
myelosuppression cytotoxicity (conj)
mg/kg 15 (nummod)
received drug (dobj)
attributable and (cc)
firmness breast (compound)
complained seeing (advcl)
produced increases (dobj)
density both (cc:preconj)
responses exhibited (acl)
lesions : (punct)
combined or (cc)
crisis : (punct)
antidotes dfp (conj)
involved regulation (nmod)
injection levobupivacaine (nmod)
early repeated (conj)
carcinomas induced (amod)
increased mass (nsubj)
spv the (det)
has offered (advcl)
bolus groups (nmod)
call raise (conj)
supernatants separated (acl)
memory : (punct)
typical . (punct)
increase strong (amod)
consumed empirically (advmod)
clarified be (auxpass)
movements motor (compound)
compromised as (mark)
limit normal (amod)
treatment amb (compound)
increase area (nmod)
synthesis expression (conj)
groups polydrug (compound)
number duration (conj)
pretreated fc (nmod)
evolution therapy (nmod)
aspiration blood (nmod)
wt -/- (conj)
results damage (nsubj)
suggests used (ccomp)
course transplantation (nmod)
correlated animals (nmod)
maintain potassium (dobj)
patients group (compound)
drug disease (conj)
use method (nmod)
symptoms erythematodes (nmod)
resulted adjustment (nmod)
papers identified (amod)
departments in (case)
rat phenobarbitone-primed (amod)
29 vs. (cc)
ci 2.98 (nummod)
i.c.v. ( (punct)
leukopenia syndrome (appos)
compensate ) (punct)
insipidus to (mark)
epo igf-il-3 (conj)
evaluate factors (dobj)
adenocarcinoma of (case)
stz ) (punct)
iprk the (det)
patients induced (acl)
observed however (advmod)
dose tamoxifen (nmod)
vascular cardiovascular (amod)
maneuver compensates (acl:relcl)
al 1988 (nummod)
inhibitors future (amod)
began improve (xcomp)
reflexes adrenergic (amod)
involvement receptor (nmod)
dose mu (nmod)
reduced mmhg (nmod)
adducts 4-hydroxy-2-nonenal (amod)
had pregnancy (nmod)
resulted evidenced (advcl)
related bortezomib (nmod)
sub-regions as (cc)
cd25 ) (punct)
by using (pcomp)
attenuated hypotension (nsubjpass)
metoprolol greater (dep)
admission her (nmod:poss)
possibility mediated (ccomp)
mda decreased (amod)
synthase-1 microsomal (amod)
hepatotoxicity to (case)
dexmedetomidine dose (compound)
proliferation vascular (amod)
offer advantages (dobj)
agent sedative (amod)
benefit patients (nsubj)
nanoparticle doxorubicin-loaded (amod)
pallidotomy stereotactic (amod)
receiving immunosuppression (nmod)
use increasing (amod)
stimulation alpha-receptor (compound)
interference with (nmod)
effects objective (amod)
transitioned he (nsubjpass)
carriers b (compound)
embryolethality , (punct)
levels cocaine (nmod)
dobutamine during (case)
medium tissue (nmod)
inhibited temsirolimus (nsubj)
were and (cc)
growth significant (amod)
completed patient-years (nsubjpass)
inherent attack (nmod)
effective efficacious (conj)
found are (auxpass)
hexachloro-1:3-butadiene of (case)
5.6 1.3 (nummod)
old 57-year (nmod:npmod)
$ROOT$ induced (sent)
tremor . (punct)
showed nerves (nmod)
mg/kg/d 80 (nummod)
received doxorubicin/kg (dobj)
elevations transaminase (compound)
mm 21 (nummod)
existed has (aux)
scanning liver (compound)
recordings ecg (compound)
% 1.0 (compound)
betaine by (case)
patients malaysia (nmod)
21.0 - (punct)
taken consideration (nsubjpass)
ocs ) (punct)
disorder receiving (acl)
measures behavioral (amod)
added intervals (nmod)
oscs the (det)
amyloidosis of (case)
studies synergy (nmod)
effect ; (punct)
hospitals to (case)
sulfadiazine with (case)
options management (compound)
represents strategy (dobj)
injection bolus (compound)
rigidity post-operative (amod)
medications. to (case)
insipidus both (cc:preconj)
discontinued returned (conj)
$ROOT$ requirements (sent)
extract an (det)
tested activity (nsubjpass)
cavity ; (punct)
effects ( (punct)
mechanisms development (nmod)
followed they (nsubjpass)
required toxicities (nmod)
generation the (det)
arousal of (case)
appearance phase (nmod)
establishes . (punct)
periods in (case)
g/d 3.5 (nummod)
calculated methodology (nmod)
incidence were (cop)
cycle patient (nmod)
aware prescribing (advcl)
system analysing (acl)
side-effects caused (acl:relcl)
rated surgeon (nmod)
measures intake (appos)
compliance guidelines (nmod)
changed factors (nsubj)
artery with (case)
dronedarone amiodarone (conj)
seen been (auxpass)
pigs in (case)
significant when (advmod)
randomized : (punct)
indicates data (nsubj)
prevented inhibition (dobj)
cb with (case)
responses on (case)
coeruleus the (det)
reduced yohimbine (nsubj)
inhibit implications (dep)
response dogs (nmod)
lindane metabolites (conj)
concentrations with (case)
diagnosis incorrect (amod)
21.0 43.3 (conj)
fmlp ( (punct)
dogs forty-one (nummod)
leveled day (nmod)
response one (nummod)
bf ) (punct)
areas sensorimotor (amod)
500 0 (compound)
ability urine-concentrating (amod)
study haloperidol (nmod)
activation channels (nmod)
n monotherapy (amod)
developed sludge (dobj)
dose s (conj)
proteins nf-m (appos)
exposure recognized (advcl)
measured days (nmod)
hypertrophy associated (acl)
treatment difluoromethylornithine (nmod)
seizures atonic (amod)
remained abnormal (xcomp)
nkcc2 ) (punct)
registered . (punct)
microscopy transmission (conj)
published none (nsubjpass)
determine cross-reactivity (dobj)
gls in (case)
week therapy (nmod)
tgf-b kim-1 (conj)
used analyses (nsubjpass)
remained therapy (nmod)
techniques immunohistochemical (amod)
mice and (cc)
becoming prescribed (acomp)
records children (nmod)
reaction one (nummod)
measured study (nsubj)
caused hydrochlorofluorocarbons (nmod)
injection dbs (nsubj)
bnpp ) (punct)
referred catheterization (nmod)
influence outcome (dobj)
concentration cgrp (compound)
common observed (conj)
background suggest (dep)
disease function (conj)
noted pattern (nsubjpass)
recorded ) (punct)
six number (nsubj)
cholestasis with (case)
effects unique (amod)
movements ataxic (amod)
busulfan high-dose (amod)
h every (det)
precore with (case)
homeostasis redox (compound)
reviews recent (amod)
mrna anf (compound)
led consumption (nmod)
produce however (advmod)
extremities over (case)
less that (mark)
associated exposure (nsubjpass)
msec , (punct)
doses non-convulsant (amod)
factor permeability (compound)
report effect (nmod)
antagonist new (amod)
march semiannually (advmod)
axis septotemporal (amod)
finding risk (nmod)
rtms area (nmod)
treatment his (nmod:poss)
bradycardia in (case)
seen increase (nsubjpass)
replacing it (dobj)
attributed suppression (nmod)
notable were (cop)
2190 700 (conj)
atp with (case)
challenge medication (compound)
coma ammonia (compound)
ozone and (cc)
suggested response (ccomp)
b stress (conj)
had prior (advmod)
neuropeptide . (punct)
cages photocell (compound)
syncope and (cc)
carried using (xcomp)
caffeine mg (amod)
describe tolerance (dobj)
183 and (cc)
neurotransmission on (case)
ngf pgi2 (conj)
termed was (auxpass)
line from (case)
definition cyclophosphamide (nmod)
use use (nmod)
mv 47 (nummod)
hemorrhagic ischemic (conj)
survived postoperatively (advmod)
irritation receptors (nmod)
dihydrochloride of (case)
cavity uterine (amod)
htr6 , (punct)
decreased activity (nsubjpass)
stopped be (auxpass)
study outpatient (amod)
induced nephrosis (nsubjpass)
tgf-beta1 of (case)
presenting who (nsubj)
delivered : (punct)
models rat (compound)
treated measures (nmod)
saline hydrochloride (conj)
rats sprague-dawley (amod)
measured finally (advmod)
cyclosporine ( (punct)
1973 1982 (conj)
nsaids non-selective (amod)
younger higher (conj)
and histochemically (advmod)
less 0.56 (dep)
35 five (conj)
affects % (dobj)
$ROOT$ proved (sent)
monitored monitor (nmod)
periods incubation (compound)
suggesting lack (dobj)
decreased rats (nsubj)
characteristic increases (nsubj)
blindness with (case)
determined regimens (nsubjpass)
have does (aux)
drivers 12 (nummod)
ngf ( (punct)
duration a (det)
aspects , (punct)
system renin-angiotensin-aldosterone (amod)
present baseline (nmod)
late event (dep)
objective used (dep)
prevent damage (dobj)
extended-interval and (cc)
controlled exclude (xcomp)
curves dose-response (amod)
dose level (conj)
dose years (nmod)
gonadotropin human (amod)
prevented hyperactivity (dobj)
stent wall (conj)
reduction elevation (conj)
performed model (nmod)
seizure behavioral (amod)
evaluated measuring (advcl)
phenomenon rebound (compound)
trials available (acl:relcl)
cardiomyopathy due (amod)
days six (nummod)
buffers aqueous (amod)
increased model (nmod)
bp higher (amod)
anticoagulants alternative (amod)
pd dyskinesias (conj)
fact to (case)
movements tremors (conj)
embarked . (punct)
66 about (advmod)
obtain that (mark)
urethane with (case)
characterized deficiency (nsubjpass)
plasma human-citrated (amod)
followed clearance (nmod)
beat heart (compound)
capacity iron (compound)
caused overdose (nmod)
substances of (case)
antibiotics antibitocis (conj)
hypertrophy enhanced (amod)
gem-p ) (punct)
toxicity developmental (amod)
occur arrhythmias (nsubj)
injury ischemic (amod)
shared diltiazem (nmod)
mmps ( (punct)
tumors ds-sarcoma (dep)
detectable are (cop)
hypertension 506-induced (amod)
bicarbonate without (case)
reabsorption accumulation (conj)
patients experience (acl:relcl)
memory pain (compound)
increased levels (nsubjpass)
cells/mm3 patients (nmod)
changes alterations (conj)
injury by (case)
basal the (det)
patients compared (acl)
therapy azt (compound)
discontinued seen (conj)
assess and (cc)
improvement damage (nmod)
vagotomy , (punct)
doses multiple (amod)
continuing dose (nmod)
ontario eastern (compound)
syndrome newborn (nmod)
loss headaches (nmod)
igf-i recombinant (amod)
venous mixed (amod)
% 1.1 (nummod)
number median (amod)
mp % (appos)
days to (dep)
speculated is (auxpass)
occurred administered (conj)
17.5 ) (conj)
ages at (case)
cause acidosis (nmod)
potential separating (acl)
regulation liver (nmod)
reduction asymptomatic (amod)
incidence therapy (nmod)
impaired is (cop)
2.6 +/- (cc)
dmcm ( (punct)
system structures (conj)
reduction 2 (dep)
treatment versus (cc)
70 50 (compound)
stages later (amod)
thrombocytopenia hemorrhage (conj)
gly-phe-leu-gly ( (punct)
unconscious who (nsubj)
produce acrolein (nmod)
shift , (punct)
2.8 to (dep)
duodenum jejunum (conj)
released was (auxpass)
depend not (neg)
lifetime and (cc)
17.0 4.6 (conj)
albuterol treatments (conj)
initiation before (case)
irritation the (det)
years mean (dep)
modulate systems (nmod)
leakage of (case)
detectable was (cop)
effectiveness function (nmod)
necrosis marrow (compound)
function lysosomal (amod)
cpu in (case)
levels adiponectin (compound)
mg/kg d-tubocurarine (nmod)
effect anatomical (amod)
5.0 2.5 (conj)
bilateral and (cc)
criteria predefined (amod)
incidence on (case)
injection days (nmod)
is while (mark)
suggest delays (ccomp)
seizure overdosage-induced (amod)
receptor receptors (conj)
induced morphology (nmod)
reversal ed50 (appos)
anaesthesia mg (nmod)
seriousness phenomenon (nmod)
patients ulcers (nmod)
increased cocaine (nsubj)
application eye (nmod)
155 patients (nmod)
minutes within (case)
animals those (det)
rare exceptionally (advmod)
production of (case)
achieve reached (advcl)
developed chf (dobj)
observed total (nmod)
factors failure (nmod)
seizures rats (nmod)
bear resemblance (dobj)
discontinuing treatment (dobj)
lacking data (nsubj)
gene 1 (nummod)
whom with (case)
dose followed (acl)
compliance myopathy (conj)
vasoconstriction intense (amod)
responses brain (compound)
cancer risk (compound)
choose would (aux)
ineffective contrast (nmod)
da dopac (conj)
progression renal (amod)
symptoms malaise (nmod)
coagulopathies consumption (compound)
elicited excitation (dobj)
reduced ( (punct)
analysis , (punct)
achrs of (case)
characteristics muscle (nmod)
1/10 ( (punct)
anaesthetic used (acl:relcl)
concentration virus (nmod)
prerequisite be (cop)
acid women (nmod)
reported initiation (nmod)
nephritis recipient (nmod)
cells had (acl:relcl)
cava superior (amod)
micrograms/ml were (cop)
content glomerular (amod)
kg ; (punct)
complicated unclear (conj)
combined carbenicillin (nmod)
granules several (amod)
medications antibacterial (amod)
capillary the (det)
concentrations to (case)
amplitude les (nmod)
plasma % (amod)
some seizures (nmod)
hydrochloride raloxifene (compound)
exposed later (advmod)
26- inhibitors (nmod)
permitted acetate (nsubj)
done assessment (nsubjpass)
experienced infants (nsubj)
$ROOT$ suppressed (sent)
surveillance hypertension (nmod)
questions these (det)
induced glycosuria (dobj)
progression expression (nmod)
chicks for (case)
nephritis henoch-schonlein (amod)
revealed damage (dobj)
high the (det)
disease cad (appos)
s 17.0 (nummod)
acid-schiff , (punct)
inhibited which (nsubjpass)
unit icu (appos)
prevalence users (nmod)
rating global (amod)
impaired function (nsubjpass)
started report (nmod)
easy it (nsubj)
started 1985 (nmod)
suppresses . (punct)
administered asa (nsubjpass)
showed outcome (dobj)
echocardiography dobutamine (compound)
supervised physician (nsubj)
reversed deficits (dobj)
cava svc (appos)
results 75,761 (appos)
manifestations characteristic (amod)
considered relationship (nsubjpass)
inactive were (cop)
3/8 ( (punct)
patients ax-allergic (amod)
low if (mark)
effects chronic (amod)
degree substantial (amod)
insufficiency hyperkalemia (conj)
thioperamide , (punct)
complete was (cop)
egfp-microglia areas (nmod)
cells onto (case)
rates fatality (compound)
% 3 (nummod)
opioid-receptors the (det)
unreported previously (advmod)
line pancreatic (amod)
arteritis , (punct)
increased mrna (dobj)
have women (nsubj)
evaluation with (case)
some ischemia (nmod)
receiving therapeutically (advmod)
ratio users (nmod)
decrease been (cop)
levels pre-bed (amod)
complication proteinuria (nsubj)
necrosis ( (punct)
fk ) (punct)
hamartoma of (case)
cpk serum (compound)
12- and (cc)
serious , (punct)
attributed might (aux)
phase both (cc:preconj)
mechanisms for (case)
mmhg 153 (nummod)
induced manner (nmod)
bun ( (punct)
analyses histological (amod)
differences and (cc)
carcinomas bladder (nmod)
block seizures (dobj)
age by (case)
n=11 ) (punct)
tumors forestomach (compound)
interference isoniazid (nmod)
regulate down-regulation (dobj)
provokes metoclopramide (nsubj)
consumption sugar (compound)
mrnas enac (compound)
arrhythmias severe (amod)
show agents (nsubj)
remedy be (cop)
hcn and (cc)
plate a (det)
rats 60 (nummod)
properties anxiolytic (amod)
min during (case)
consumption an (det)
score score (nmod)
pathogenesis spasm (nmod)
able dose (nsubj)
groups amphetamine-free (appos)
considered prove (ccomp)
acetate ethinylestradiol (conj)
scored characteristics (nsubjpass)
steroids maintenance (compound)
positive antigen (nmod:npmod)
volumes 2-chloroprocaine-ce (nmod)
syndromes psychotic (amod)
illustrated characteristics (nsubjpass)
p<0.02 ( (punct)
partially protection (nsubj)
headache no-induced (amod)
resulted dilation (nsubj)
recorded drugs (nmod)
mother women (nmod)
pathways operative (amod)
dosage day (nmod)
examination comprehensive (amod)
last ( (punct)
sufferers in (case)
probability reaction (compound)
detected smad3 (nsubjpass)
sacrificed mice (nsubjpass)
intervals 12-h (compound)
tumors were (cop)
progress not (neg)
first explore (acl)
presumed documented (conj)
pounds , (punct)
hepatomas induced (acl)
infiltration ml (nmod)
pg-9 by (case)
sensitive streptomycin (nmod)
complemented azathioprine (nmod)
1.86 2.41 (nmod)
suggests occur (ccomp)
examination ; (punct)
responses objective (amod)
conclusions similar (dep)
type therapy (dep)
allow they (nsubj)
s 15 (nummod)
incidence or (cc)
nocistatin nmol (dep)
enrolled patients (nsubjpass)
reorganization functions (nmod)
underwent began (advcl)
action permissive (amod)
abrogated that (mark)
aware use (conj)
all patients (nmod)
seconds 30 (nummod)
continue advent (nmod)
higher that (nsubj)
doc ketamine (compound)
mg/kg ] (punct)
0.0010 0.0020 (conj)
believe reported (ccomp)
patients 205 (nummod)
crosses agent (nsubj)
schedule standard (amod)
blindness total (amod)
increases which (nsubj)
presentation mechanisms (conj)
accelerating atherosclerosis (dobj)
experience , (punct)
administration tail (nmod)
sequelae without (case)
treated methylphenidate (nmod)
lid with (case)
groups mice (nmod)
attempt overcome (acl)
6 17 (dep)
patient postpartum (amod)
profile worsened (acl:relcl)
treated analgesic (nmod)
massive pituitaries (nsubj)
increase mesangial (amod)
received aid (nmod)
doses suxamethonium (nmod)
ischemia isoproterenol (compound)
leukaemia childhood (compound)
controls 808 (nummod)
enzymes circulating (amod)
proved technique (xcomp)
monitoring vigilance (conj)
exposure early-life (amod)
$ROOT$ marketed (sent)
recognizing management (nmod)
responsiveness improvement (conj)
vasorelaxation by (case)
limits % (amod)
stopped cessation (nmod)
pastes of (case)
exposed fumarate (nmod)
altered paradigm (nmod)
space bowman (nmod:poss)
aware instructed (conj)
$ROOT$ appeared (sent)
response favorable (amod)
restored bradycardia (dobj)
allopurinol indomethacin (conj)
giving peak (nmod)
leading modes (nmod)
signified prognosis (dobj)
served models (nmod)
139 group (nmod)
delirium woman (nmod)
mean the (det)
patients underwent (acl:relcl)
action on (case)
33 frequent (conj)
based population (nmod:npmod)
avoided been (auxpass)
number on (case)
placebo after (case)
tortuous abnormally (advmod)
setting use (nmod)
years following (amod)
responses restricted (amod)
inhibitor hydroxylase (nmod)
manipulating of (mark)
resistant are (cop)
factors that (mark)
improved sensitivity (nsubj)
chloride sufficient (amod)
learning novel (amod)
salicylates ingestion (conj)
administration calcitonin (nmod)
died woman (nsubj)
thrombophlebitis , (punct)
develop administration (nmod)
alpha-2 laminin (compound)
paralysis bilateral (amod)
function production (conj)
found studies (nmod)
require investigations (dobj)
induction variables (appos)
patients those (appos)
explained pain (nsubjpass)
ventricle the (det)
current no (conj)
hbsag in (case)
effect options (conj)
suppressed gabapentin (nsubj)
medications under (case)
treated percent (nsubjpass)
cytotoxicity the (det)
doses methotrexate (compound)
induce injections (nsubj)
quantitative real-time (dep)
administration following (amod)
reviews cases (dobj)
steroids intravenous (amod)
interval short (amod)
tocopherols by (case)
cancer granulomatosis (nmod)
myalgia grade (compound)
lower relatively (advmod)
obtained may (aux)
gram tissue (nmod)
help factors (nsubj)
0.5 5 (conj)
cases 76 (nummod)
alt bun (conj)
investigate and (cc)
% identified (acl)
ecgs and (cc)
prevented pretreatment (nmod)
increased thrombogenicity (dobj)
infusions adrenaline (nmod)
complications arise (acl:relcl)
anti-hbe % (nmod)
67.4 p= (dep)
caused propylthiouracil (nmod)
appear not (neg)
include does (aux)
schedule encourages (acl:relcl)
corrected supplementation (nmod)
iopamidol the (det)
hypertension phenylpropanolamine-induced (amod)
increase model (nmod)
warfarin with (case)
sites decreases (acl:relcl)
trial i/ii (nummod)
developed sooner (advmod)
fatal % (nmod)
clonidine including (case)
vision permanent (amod)
cytoplasm hepatocytes (nmod)
proved testing (nsubj)
subspecialty medical (amod)
reveal supporting (advcl)
postulates author (nsubj)
enantiomer - (amod)
ingredient . (punct)
program a (det)
hygiene , (punct)
higher addition (nmod)
comprises subunits (dobj)
suggest element (ccomp)
tubules basophilic (amod)
alpha plasma (compound)
38 % (appos)
p n. (conj)
normal levels (nsubj)
aims therapeutic (appos)
treatment arabinoside (compound)
relationships cin (nmod)
$ROOT$ reacted (sent)
mechanisms acid-mediated (amod)
completed are (auxpass)
compare test (conj)
water in (case)
utilization phenylephrine (nmod)
18.88 +/- (cc)
results found (appos)
administration bisphosphonate (compound)
loss axonal (amod)
precedes that (mark)
evaluation updated (amod)
is hepatotoxicity (attr)
occurs implicated (conj)
symptoms related (amod)
anti-oxidant through (case)
background eeg (compound)
acid mefenamic (amod)
% 25 (compound)
collection 24-h (amod)
somnolent diazepam (nmod)
presynaptic versus (cc)
fed . (punct)
diseases despite (case)
p300 cardiac (amod)
used corticosteroids (nsubjpass)
observed be (auxpass)
explain therefore (advmod)
two hundred (compound)
method evaluated (appos)
correlates decrease (nsubj)
selectivity tissue (compound)
mds = (dep)
injection intracerebroventricular (amod)
aimed re-investigate (xcomp)
tolerance pg (nmod)
cells basket (compound)
administration orciprenaline (nmod)
tachycardia persisted (acl:relcl)
dosage targeted (amod)
discharged safely (advmod)
involved behavior (nmod)
thirty-nine % (appos)
polymyositis or (cc)
refractory medically (advmod)
reported acid (nmod)
$ROOT$ arise (sent)
ie ( (punct)
carboxylesterase liver (compound)
feature presentation (nmod)
treatment propranolol (nmod)
changes compensatory (amod)
activity : (punct)
recur symptoms (nsubj)
pressures pulmonary (amod)
revealed angiography (nsubj)
antagonists selective (amod)
follow-up over (case)
nephropathy in (case)
this reported (conj)
25mg/kg 12.5 (nummod)
effect because (case)
score corresponding (amod)
recording basal (amod)
trimethoprim and (cc)
synapse the (det)
line therapy (nmod)
underestimate thereby (advmod)
prevented been (auxpass)
decrease hr (conj)
receptors nm (dep)
associated initially (advmod)
catalepsy number (conj)
function heart (compound)
appear vary (xcomp)
apparatus animex (compound)
persist seizures (nsubj)
observed wt (nmod)
occurs damage (nsubj)
second third (conj)
effect lithium (nmod)
stability sarcolemmal (compound)
$ROOT$ hold (sent)
bacteria and (cc)
disorders atypicality (nmod)
revealed antrum (dobj)
biopsies skin (compound)
hypertension ) (punct)
is report (attr)
hepatotoxicity metformin-associated (amod)
tolerated maximum (nmod:npmod)
exacerbation ethanol (nmod)
administrated drug (nsubjpass)
area indinavir (nmod)
procedure nimesulide (nmod)
sclerosis ssc (appos)
isopter i/4e (compound)
strain single (amod)
went return (advcl)
rofecoxib and (cc)
produced dysfunction (dobj)
lowering doses (nmod)
frequent malignancies (nsubj)
remained and (cc)
stabilizers mood (compound)
licensed and (cc)
exacerbation its (nmod:poss)
syndromes distinct (amod)
mice genotypes (nmod)
treatment prophylactic (amod)
threshold the (det)
mater exposed (amod)
$ROOT$ hydrobromide (sent)
1 less (advmod)
degeneration detachment (conj)
agonist an (det)
mg/m2 6,000 (nummod)
170 +/- (cc)
multiple mixed (conj)
developed biomarkers (dobj)
compared 8 (nsubj)
e13.5 ) (punct)
associated combination (nmod)
amounts % (appos)
screening newborns (nmod)
output triglyceride (nmod)
those result (acl:relcl)
determined administration (nmod)
reorganization the (det)
% and (cc)
showed difference (dobj)
= 0.56 (dobj)
own cephalothin-coated (conj)
sleep week (nmod)
number or (cc)
small show (conj)
indomethacin , (punct)
diary voiding (compound)
substantial whether (mark)
clioquinol to (case)
syndrome for (case)
studies dose (compound)
affect facility (dobj)
findings radiographic (amod)
regimens than (case)
eeg changes (conj)
function skilled (amod)
noted different (conj)
before after (conj)
improve availability (nmod)
available followup (nsubj)
run course (dobj)
antibody the (det)
anesthesia alfentanil (compound)
compared using (xcomp)
patients penicillamine-treated (amod)
influence restriction (nmod)
mass , (punct)
reduced q10 (nsubj)
levels medialipid (nmod)
tachyarrhythmias the (det)
% 67.9 (nummod)
degree hypotension (nmod)
dysmetria gain (conj)
predictors response (nmod)
polyps of (case)
decrease pilocarpine-induced (amod)
fever concomitant (amod)
stenosis artery (compound)
cause pathogenesis (conj)
used strains (nsubjpass)
myelosuppression of (case)
test observation (compound)
causes important (amod)
is occlusion (nsubj)
reduced pressures (dobj)
confirm investigate (conj)
collected patient (nmod)
bn ) (punct)
tomography ct (appos)
stz-icv with (case)
carbachol agonist (appos)
imaging of (case)
l-1 to (mark)
need clinicians (nsubj)
fails supplementation (nsubj)
sulphate pregnenolone (compound)
convenient more (advmod)
fruste an (det)
80 - (punct)
year 15 (nummod)
caused cystitis (dobj)
unable is (cop)
effect pentylenetetrazole-induced (amod)
tdp the (det)
mg diazepam (compound)
rates increasing (amod)
contracting muscle (dobj)
rhabdomyolysis heroin (nmod)
neuropathy experimental (amod)
damage toxic (amod)
stimulated formation (nsubjpass)
33 , (punct)
prevented evolution (dobj)
observed sign (nsubjpass)
occurs but (advmod)
map an (det)
animals groups (nmod)
decrease concentration (nmod)
effects oxitropium (nmod)
studied evaluate (xcomp)
numbers bfu-e (nmod)
reversed cessation (nmod)
jaundice aminotransferase (nmod)
lesions renal (amod)
pathway on (case)
use child (nmod)
fever with (case)
prepared catheters (nmod)
biochemical or (cc)
wasting for (case)
increases spv (nmod)
initiated obtain (advcl)
ntg 4 (nummod)
lidocaine after (case)
identified end (nmod)
shown recently (advmod)
recognize patients (nmod)
cataracts hyperplasia (conj)
hyperglycemia glucosuria (conj)
those ps (nmod)
staff , (punct)
developed myoclonus (dobj)
memory naming (conj)
hyperplasia associated (acl)
history health (compound)
associated lovastatin (nsubjpass)
provided thrombosis (nmod)
represent mitochondria (nsubj)
edrophonium before (case)
tiapride amisulpride (conj)
inhibitor as (case)
maintained phosphorylation (nsubj)
become technique (attr)
rats obtained (acl)
stimulants agents (conj)
injury myocardial (amod)
hydrochloride acid (compound)
rise an (det)
used establish (xcomp)
accepted widely (advmod)
arabic and (cc)
decrease expression (nmod)
variables respiratory (amod)
impairment children (nmod)
mmol 176 (nummod)
shown mitoq (nsubjpass)
features biological (amod)
novel demonstration (nsubj)
records the (det)
disappearing australia (nmod)
binding , (punct)
aminonucleoside , (punct)
produced decreases (dobj)
mg/kg/i.p , (punct)
regimen exposure (compound)
function with (case)
sites accumbens (conj)
e of (case)
taking mg/day (dobj)
studied before (advmod)
effects pregs (nmod)
studies indicating (acl)
accumulated that (nsubj)
syndrome called (acl)
disorders mitochondrial (amod)
negative all (nmod)
after weeks (nmod:npmod)
modafinil morning-dosed (amod)
ii , (punct)
group sedentary-isoproterenol (compound)
% mice (nmod)
due haloperidol (nmod)
diabetic being (cop)
mimicking formation (dobj)
inhibition metabolism (nmod)
occurred impotence (nsubj)
diminished hyperthermia (dobj)
cessation immediate (amod)
disappeared sectioning (nmod)
rates ; (punct)
at superior (conj)
compared . (punct)
agent as (case)
transferred later (advmod)
5-ht1a and (cc)
comparable , (punct)
efficacy with (case)
administration amiloride (nmod)
injection central (amod)
cisapride and (cc)
electrodes implanted (amod)
reduced alpha-methyldopa (nmod)
threatening usually (advmod)
inducer ethanol (conj)
hypoxia diffuse (amod)
due prazosin (nmod)
spasm a (det)
pesticide lindane (nsubj)
hypertension fetal (amod)
dressing form (nmod)
evidence more (amod)
ku70 ku80 (conj)
greater turn (nmod)
dysfunction receptor (compound)
believed is (auxpass)
punctate and (cc)
enzymes increased (amod)
coincident duration (nmod)
pathology observed (acl:relcl)
exhibited change (dobj)
length at (case)
trauma after (case)
safe a (det)
organization tonotopic (amod)
transfusion and (cc)
subscale the (det)
one twins (nmod)
lack hepatocytes (nmod)
vpu vpa (conj)
impair recovery (dobj)
barrier/density a (det)
appeared literature (nmod)
widow taiwanese (amod)
tomography tc99m-sestamibi (compound)
deaths drug-related (amod)
genotype ace (compound)
spared monosaccharides (nmod)
75 ( (punct)
intake tramadol (nmod)
spasm case (nmod)
hip right (amod)
ballooning classic (amod)
bupivacaine after (case)
aspartate glycine (conj)
suppresses therapy (nsubj)
action molecule (nmod)
rapamycin rapa (appos)
found ameliorate (xcomp)
caused recurrence (dobj)
had threshold (dobj)
administered session (nmod)
$ROOT$ coincided (sent)
been effect (attr)
cases hyponatremia (nmod)
imaging imaging (conj)
recognized delirium (nsubjpass)
mm 2.6 (nummod)
myocardium each (conj)
episodes values (nmod)
use general (amod)
syndrome so-called (amod)
hoe ) (punct)
variety reasons (nmod)
benefits further (amod)
increase hdl (nmod)
$ROOT$ significant (sent)
caused suxamethonium (nmod)
induced phenytoin (nsubj)
% -7.5 (nummod)
summary female (appos)
% n= (dep)
measurement symptoms (nmod)
women quit (acl:relcl)
operative postoperative (conj)
lowered was (auxpass)
abruptness failure (nmod)
relationship development (nmod)
type heparin-induced (amod)
intake before (case)
provoke and (cc)
screened regularly (advmod)
suggest levels (ccomp)
affects learning (dobj)
impact veins (nmod)
% that (nmod)
pallidotomy subthalamotomy (conj)
tp with (case)
she state (nmod)
abnormalities aminonucleoside-induced (amod)
71 +/- (cc)
groups 1- (amod)
those side (nmod)
increase cortex (nmod)
dexamethasone ocular (amod)
found could (aux)
hbeag anti-hbe (conj)
scales and (cc)
higher women (nmod)
extract fruits (nmod)
reports due (amod)
mrna ece-1 (compound)
implicated sirolimus (nsubjpass)
concentrations on (case)
metrifonate acetylcholinesterase (compound)
effect related (acl:relcl)
7-pentoxyresorufin-o-dealkylase prod (appos)
role key (amod)
5-fu high-dose (amod)
june survived (acl:relcl)
avoiding of (mark)
days fits (nmod)
$ROOT$ hazardous (sent)
ci 0.7 (nummod)
percent patients (nmod)
produced thiopental (nsubj)
participants cn (appos)
55 to (dep)
morphology aortic (amod)
correlations responses (nmod)
number ( (punct)
started . (punct)
suffered treatment (nmod)
observe features (dobj)
increased returned (conj)
damage against (case)
neuron of (case)
began and (cc)
retains whether (mark)
action binding (nmod)
contained % (dobj)
identified subsequently (advmod)
leucovorin mfl (appos)
changes signal (nmod)
$ROOT$ points (sent)
42.5 = (parataxis)
range the (det)
nephrectomy a (det)
horn dorsal (amod)
hepatitis non-a (amod)
fractures stress (compound)
(-)-baclofen mg/kg (appos)
applicators licensed (amod)
nanoparticles tacrine-loaded (amod)
tachycardia pointes (compound)
90/htn 1.036 (appos)
basis inpatient (amod)
remain however (advmod)
are case (attr)
matrix interstitial (amod)
similar treatment (nmod)
was that (mark)
values laboratory (compound)
isolated or (cc)
acid aminophosphonovaleric (amod)
benzylacyclouridine bau (appos)
sensitive than (prep)
occurred standing (nmod)
placebo mg/h (conj)
results lower (appos)
hepatoma mesothelioma (conj)
rats p20 (compound)
pain contracture (conj)
acidosis type (compound)
trials combining (acl)
inhibition glycoprotein (compound)
evaluation timely (amod)
stroke years (nmod)
stimulating via (mark)
duct cystic (amod)
antigen antigen (conj)
unrecognized denial (nmod)
imbalance nitric (amod)
positive pas (nmod:npmod)
from 2002 (nmod)
adding regimen (nmod)
joint in (case)
administered gain (advcl)
made observation (nmod)
induced caused (conj)
depress synthesis (dobj)
managed , (punct)
monitoring by (case)
session in (case)
- 5 (nummod)
cpa combination (nmod)
compared group (dep)
glomerulopathies of (case)
prevented moreover (advmod)
action as (case)
increasing sed (dep)
findings patient (nmod)
presenting levels (nmod)
oxygen hyperbaric (amod)
follow-up ( (punct)
immobilization of (case)
myasthenia of (case)
clonidine propranolol (conj)
injection combination (nmod)
status induced-behaviour (conj)
postponed risk (ccomp)
debate safety (nsubj)
rep 1978 (amod)
actions different (amod)
mg/m2 175 (nummod)
weeks but (cc)
responses 4 (nummod)
had predominant (advcl)
performed measurements (nsubjpass)
delivery colloidal (amod)
produced occlusion (nsubjpass)
phenols the (det)
levels ) (punct)
purpose investigation (nmod)
requiring vigilance (dobj)
weeks population (dep)
initiated epilepticus (nsubjpass)
receive takes (advcl)
toxicity general (amod)
rate each (det)
histology regulation (conj)
incidence tumours (nmod)
treatment arthritis (nmod)
exam , (punct)
communication skills (conj)
receiving discharged (advcl)
signs stereotypy (nmod)
plays arf (nmod)
dopac of (case)
dse one (nummod)
deposits wall (compound)
area cortex (nmod)
pores transition (compound)
tsc ) (punct)
occur effective (advcl)
hggw olanzipine (compound)
treated aminonucleoside (nmod)
employed anaesthesia (nsubjpass)
maintained however (advmod)
used estimate (xcomp)
describe presentation (dobj)
reduced removed (conj)
created were (auxpass)
transplantation the (det)
assessed viability (dobj)
conducted concurrently (advmod)
findings echocardiographic (amod)
bcnu to (case)
detected reduction (nsubjpass)
role phase (nmod)
lowered metfromin (nsubj)
argatroban with (case)
chloride prevention (nmod)
cervix the (det)
response patient (nmod)
targeted combined (advcl)
women lovastatin-treated (amod)
k(+)-channels quinine-sensitive (amod)
associated products (nmod)
reduction discontinuation (conj)
many too (advmod)
had receiving (advcl)
lead might (aux)
before months (conj)
$ROOT$ supervened (sent)
structures by (case)
effect as (case)
week 4 (nummod)
formulation hydrochloride (nmod)
pentobarbital to (case)
limit a (det)
types against (case)
rate presumed (acl)
medicines of (case)
compared as (mark)
concentration remifentanil (nmod)
percent versus (cc)
3-methylcholanthrene , (punct)
20.12 + (cc)
potency excellent (amod)
sedation dysfunction (conj)
includes . (punct)
associations concentrations (nmod)
thrombocytopenia thromboembolism (conj)
cyclophosphamide between (case)
utility marker (nmod)
inhibitors . (punct)
degradable proteinases (nmod)
pathway endomt (nsubj)
shown inhibit (xcomp)
arousal sexual (amod)
relapsed later (advmod)
effect dyskinesias (nmod)
pain fibrillation (conj)
recorded case (dep)
rats saline-treated (amod)
refine issues (dobj)
documented this (nsubjpass)
teratogenic results (nmod)
resulted leading (xcomp)
received , (punct)
summary treated (acl)
drugs antiviral (amod)
relationship drd2 (nmod)
nephrotoxicity vcm-induced (amod)
positive anti-hbe (conj)
series treatment (compound)
showed produced (ccomp)
receiving was (aux)
hypertension oxide (compound)
day injection (nmod)
impairment motor (amod)
nox weight (conj)
duration action (nmod)
latency , (punct)
reported occasionally (advmod)
concentrations or (cc)
activity proconvulsive (amod)
nausea nausea (conj)
enzymes both (cc:preconj)
intake fluid (compound)
hr for (case)
sedation depression (conj)
oxygen dioxide (conj)
toxicity grade (compound)
performed heparin (nmod)
i.m. i.p. (conj)
duration with (case)
known occur (xcomp)
oncology clinical (amod)
prostacyclin secondary (dep)
series experiments (nmod)
markers exchanges (nmod)
5 up (advmod)
states between (case)
32 - (punct)
development dysfunction (nmod)
chemotherapy the (det)
ve therapy-na (dep)
individuals sensitive (amod)
factors genetic (amod)
combined estradiol (nmod)
cells hek293 (compound)
assigned receive (xcomp)
6.6 + (conj)
inhibition enzymes (nmod)
2.0 20.0mg/kg (conj)
mortality a (det)
possibility to (case)
detected weeks (nmod)
derivative first (amod)
precursor from (case)
licensed combination (conj)
duration history (conj)
anemia due (amod)
appendage left (amod)
determine comparison (nmod)
time-course on (case)
mice inflammation (nmod)
treated telaprevir (nmod)
developed bore (conj)
3551 +/- (cc)
differ groups (nmod)
segment cerebral (nmod)
high-dose controls (dep)
broadly most (advmod)
243.4 266.5 (conj)
bromperidol with (case)
improves that (mark)
administration mg/kg (dep)
population general (amod)
disulfiram of (case)
interactions distinct (amod)
depletion a (det)
weeks two (nummod)
speech slurred (amod)
g/d and (cc)
evaluated instilling (advcl)
observed criterion (nmod)
myocarditis carbamazepine-induced (amod)
pretreatment ketanserin (compound)
bands including (case)
biodistribution rats (nmod)
initiated managed (conj)
criterion behavioral (amod)
subjects nondiabetic (amod)
data obtained (acl)
rodents in (case)
blockade following (case)
events other (amod)
increased mg (nmod)
consider risk (dobj)
days 17.5 (nummod)
prepartum days (nmod:npmod)
levels aminoglycoside (compound)
$ROOT$ terminated (sent)
tumor the (det)
prepared was (auxpass)
assessed related (advcl)
dose clozapine (compound)
frequencies to (case)
received because (mark)
metabolites the (det)
triggers pathway (dobj)
associated % (nmod)
depth anesthesia (nmod)
suggested trials (nsubj)
increase renin (nmod)
that is (cop)
mice for (case)
contributed , (punct)
creating review (dobj)
experiences due (case)
conclude falls (ccomp)
characteristics demographic (amod)
hemorrhage fatal (amod)
developing thrombosis (dobj)
employed widely (advmod)
glucoronosyltransferases diphosphate (compound)
nucleotide-gated cyclic (amod)
neutropenia 3/4 (nummod)
> /= (cc)
evolve . (punct)
discriminated unresponsiveness (nsubj)
needed if (mark)
experienced occurred (ccomp)
anova one-way (amod)
men trial (nmod)
compared before (nsubjpass)
blockade receptors (compound)
multicenter , (punct)
disease thromboembolism (conj)
thickness an (det)
stz- castration-induced (conj)
$ROOT$ age (sent)
suggest achieved (ccomp)
effect antineoplastic (amod)
min administration (nmod)
clozapine risperidone (appos)
literature subject (nmod)
patients thirty-eight (nummod)
relationship known (amod)
phenomena from (case)
county tland (nmod)
diazepam- scopolamine- (conj)
show can (aux)
necrosis focal (amod)
received l-sotalol (dobj)
effect mediated (acl)
had episodes (nmod)
monitored pressure (nsubjpass)
affect rates (dobj)
observed changes (dobj)
nature the (det)
treatment choice (nmod)
included have (aux)
administration co (amod)
better p<0.01 (dep)
lesions treatment (nmod)
possible was (cop)
neurotransmitters inhibitory (amod)
difference measured (advcl)
neurotoxicity anemia (conj)
modulation . (punct)
days 974 (nummod)
hypertension smoke (conj)
dgc ) (punct)
lesions partial (amod)
obtained media (nmod)
reduce reduce (conj)
curve concentration (compound)
core ( (punct)
ng/dl ng/dl (parataxis)
true to (mark)
lack data (nmod)
smaller , (punct)
preservation and (cc)
had proteinuria (dobj)
woman for (case)
show conclusions (nsubj)
5.9 +/- (cc)
effect ifosfamide (nmod)
causes also (advmod)
hours surgery (nmod)
escalated mg/day (nmod)
questioned reports (nsubjpass)
101.74 to (dep)
lower shr (nmod)
glycopyrrolate micrograms (appos)
gaba(a)rs ( (punct)
altering chemosensitivity (dobj)
taken analysis (nmod)
modulation be (cop)
< ] (punct)
blockade fluoroacetate (nmod)
allograft renal (amod)
switched or (cc)
enhanced . (punct)
drug complementary (amod)
female treated (acl:relcl)
increased segments (nmod)
demographics time (conj)
subjected treatment (nmod)
epm in (case)
cisplatin to (case)
deficit potassium (compound)
factor fibroblast (compound)
coma failure (appos)
race , (punct)
treated that (nsubjpass)
organisms to (case)
female 63-year-old (amod)
86.2 +/- (cc)
blocked reduction (nsubjpass)
affect or (cc)
structure different (amod)
mental motor (conj)
antagonist ep1-receptor (amod)
determined as (mark)
effects seen (acl)
cytoplasm submembranous (amod)
group using (amod)
rhabdomyolysis secondary (amod)
exercise-controls the (det)
neurons animals (nmod)
predisposed inhibitors (nmod)
decreased percentage (nsubj)
groups individual (amod)
amphetamine with (case)
$ROOT$ krebs-ringer (sent)
had hepatotoxicity (dobj)
limitations any (det)
protection tocopherols (nmod)
diminished index (dobj)
recurs activity (nsubj)
treatment induction (nmod)
administered mesna (nmod)
experienced choreoathetosis (dobj)
calcification detectable (amod)
17.5 to (dep)
led this (nsubj)
affinities receptors (nmod)
polydipsia polyuria (conj)
dysfunction followed (acl)
ziprasidone like (case)
abnormality no (det)
tachycardia variant (amod)
scheduled . (punct)
arrest hypothermic (amod)
berlin charite (compound)
l-nil ip (appos)
given food (dobj)
pretreatment ( (punct)
represent shown (advcl)
patients 26 (dep)
children immunocompromised (amod)
examined recurrences (nmod)
pathogenesis hypertension (nmod)
reduce not (neg)
disease hepatic (amod)
= nm (dobj)
age to (case)
liver plasma (conj)
antagonist potent (amod)
herbicide a (det)
enzymes elevated (amod)
causes toxicity (nsubj)
disease failure (nmod)
activation stimulation (nmod)
dysrhythmogenicity epinephrine (compound)
girl 1/2-year-old (amod)
products respiratory (amod)
16.01 vs. (cc)
urothelium and (cc)
obtained baseline (nmod)
angiogram with (case)
demonstrate taken (advcl)
dose mg (appos)
6.9 0.1 (conj)
inhibition cyp1a2 (nmod)
death sudden (amod)
spectrum which (nmod)
anaemia aplastic (amod)
not significantly (advmod)
frequency likely (amod)
stenosis of (case)
injections msg (nmod)
drug carbamazepine (nsubj)
combination face (nmod)
action pathway (nmod)
gliclazide with (case)
triglycerides glucose (conj)
mefloquine with (case)
cardiotoxicity neutropenia (conj)
absorption a (det)
regurgitation mr (appos)
chemotherapy during (case)
aphasia incontinence (conj)
evidence regulation (nmod)
connects that (nsubj)
transporter of (case)
apoptosis leukocytes (nmod)
derivative with (case)
tolerance of (case)
catabolism urd (compound)
had agc (dobj)
parasites larvae (conj)
stl1 ( (punct)
proteins novel (amod)
late primary (conj)
therapy chronic (amod)
sleep to (mark)
agonists non-ergot (amod)
ability nefiracetam (nmod)
absorption in (case)
absent mutant (nmod)
inotropic chronotropic (conj)
remained domain (nsubj)
u/ml 12.0 (nummod)
patients overdose (compound)
conducted review (nsubjpass)
0.27 +/- (cc)
actions prolactin (compound)
administration metoclopramide (compound)
had done (parataxis)
influence occurrence (dobj)
polymorphisms taqid (dep)
doxorubicin/kg , (punct)
whether is (cop)
condition general (amod)
concentrations ( (punct)
sensitivity cholinergic (amod)
elevation of (case)
remained tremulous (acomp)
dhea ) (punct)
significant verapamil (nmod)
prudent . (punct)
cells hepg2 (compound)
onset sedation (nmod)
scored dosing (nmod)
viruses certain (amod)
pain more (amod)
use hormone (compound)
role : (punct)
age ; (punct)
hemolysis leading (acl)
intensity respiration (compound)
suffered episode (dobj)
treatment tobramycin (nmod)
recall delayed (amod)
antagonist angiotensin (compound)
iowa in (case)
mg/ml 60 (nummod)
man developed (acl:relcl)
began recover (xcomp)
needle the (det)
pretreatment as (case)
metabolism copper (compound)
trigger may (aux)
able measures (nsubj)
10(-4 10(-8 (compound)
facilitated e2 (nsubj)
mg/kg 0.15 (nummod)
controlled akathisia (nsubjpass)
studies pathogenesis (nmod)
episode characterised (acl)
varies incidence (nmod)
pressure responses (conj)
reduced densities (nsubjpass)
hyper-reactivity of (case)
626 +/- (cc)
imply , (punct)
aim : (punct)
regions from (case)
observed reductions (nsubjpass)
cytoplasm epithelial (amod)
combined lamivudine (nmod)
treatment sulphonylurea (compound)
agonists potent (amod)
aqueous gellan (conj)
age-dependent and (cc)
added patients (nmod)
rates disorders (nmod)
had actions (dobj)
trihexyphenidyl and (cc)
occurred gain (nsubj)
along ptz (nmod)
found dysfunctions (nsubjpass)
models : (punct)
shivering , (punct)
induce thus (advmod)
inhibitor mammalian (amod)
injected period (nmod)
synergy morphine (nmod)
thrombectomy cdt (conj)
associated foci (nmod)
actions caffeine (nmod)
immunohistochemistry by (case)
effects acid (nmod)
carried performance (nsubjpass)
incident 1 (nummod)
surmountable blockade (nsubj)
controlled concentration (nsubjpass)
areas centrilobular (amod)
complete effacement (nsubj)
intestine small (amod)
> or=5 (cc)
have mechanism (dobj)
evaluation in (amod)
treatment contractions (nmod)
mg.kg(-1).d(-1 1 (nummod)
relapse meningeal (amod)
antrum stomach (nmod)
1/2 2 (compound)
knife neither (cc:preconj)
infarction (iso)-induced (punct)
60 < (advmod)
noted alkylxanthines (nmod)
m = (parataxis)
sixty-eight ) (punct)
other bronchopneumonia (nmod)
n- c-terminal (conj)
context cpb (nmod)
suggest furthermore (advmod)
program systems (dobj)
associated lesions (nsubjpass)
tubes ventilation (compound)
similarity syndrome (nmod)
deaths patients (nmod)
depends , (punct)
cataracts rr (dep)
course after (case)
bore carcinomas (dobj)
association granulomas (nmod)
demonstrated responses (nsubjpass)
maha fk506-associated (amod)
given cyclosporine (nsubjpass)
ml saline (conj)
detected association (dobj)
therapy hyperlipoproteinemias (nmod)
% 100 (nummod)
had compared (prep)
protected were (auxpass)
$ROOT$ resolving (sent)
sufficient . (punct)
mentioned literature (nmod)
breaths ventilator (compound)
delivered treatment (nmod)
production o2- (compound)
occur unexpectedly (advmod)
encephalopathy seizures (nmod)
jaundice preceded (acl)
tests hypothesis (dobj)
testing immediately (advmod)
decreased titres (nsubj)
oil control (appos)
carriers hbv (compound)
nephrotoxicity less (amod)
amitriptyline ( (punct)
mediated cytotoxicity (nsubjpass)
figures cytosegresomes (nmod)
mice pkca (compound)
older were (cop)
group dox (compound)
increases baseline (nmod)
returned after (mark)
t high-sensitive (amod)
barr epstein (amod)
creatinine 0.05 (appos)
displayed conversion (nmod)
were outcomes (nsubj)
rats anaesthetised (acl)
cancer fnclcc (appos)
concerned while (mark)
77.1 was (cop)
cardiomyopathy due (case)
shown indicate (advcl)
mg/m2 represents (acl:relcl)
warrant studies (dobj)
methyldopa dysfunction (conj)
associated observed (parataxis)
> mg/dl (dep)
mg/m2 580 (nummod)
scores mean (compound)
persons hiv-positive (amod)
pallidus into (case)
used previously (advmod)
week randomization (nmod)
have ck-mb (nmod)
rare is (conj)
unlikely associated (xcomp)
clotting hemodilution (conj)
switching oxcarbazepine (nmod)
region shoulder (compound)
studies initial (amod)
related increase (nmod)
doxorubicin intravenous (amod)
pneumonitis problematic (nsubj)
50 > (advmod)
survived . (punct)
treated either (advmod)
survived who (nsubj)
injury hepatocellular (amod)
more those (nmod)
complication thrombosis (nsubj)
exhibited responses (dobj)
fluoxetine serum (compound)
treated admission (nmod)
causes triggers (conj)
clonidine agonist (appos)
effects discharges (nmod)
1.5 and (cc)
zone granular (amod)
release reduction (conj)
0.45 +/- (cc)
stopped restarted (conj)
1.9 1.6 (conj)
higher results (nsubj)
mth start (dep)
increase products (nmod)
induce pretreatment (nsubj)
improve function (dobj)
effects survival (dep)
administration oxytocin (compound)
increases followed (acl)
= 32 (dep)
report final (amod)
mg/kg with (case)
metrizoate % (appos)
thiosemicarbazide with (case)
caused challenge (nsubj)
glucose high (amod)
reversed it (nsubj)
myelopathy of (case)
acetylcholine ach (appos)
< .034 (dep)
contractility conduction (conj)
decrease placebo-an (nmod)
oncology pediatric (compound)
decreased day (nmod)
stress in (case)
carriers epsilon4 (compound)
considered agent (xcomp)
age years (conj)
had profile (dobj)
phosphatase dehydrogenase (conj)
times in (case)
interstitium medullary (amod)
administration , (punct)
considered option (nmod)
studied volunteers (dobj)
contrasted preservation (nmod)
reversibility lesions (nmod)
groups drugs (nmod)
treatment mefloquine (nmod)
prerequisite may (aux)
performing injection (dobj)
positive results (nsubj)
$ROOT$ pathway (sent)
formation glomeruli (nmod)
$ROOT$ antagonizes (sent)
toxin of (case)
symptomatic discontinue (xcomp)
prescribed therapy (dobj)
activity paroxysmal (amod)
thickening departure (conj)
fluphenazine , (punct)
levels urinary (amod)
teams dedicated (amod)
indicate modulate (ccomp)
mediated catalepsy (nsubjpass)
occurrence runs (conj)
20-fold to (dep)
occurs earlier (advmod)
millions individuals (nmod)
associated presence (nmod)
agents antimicrobial (amod)
treat types (dobj)
peaked min (nmod)
3.82 10(7 (conj)
ibuprofen of (case)
obtained acid (nmod)
group c (compound)
scheduled as (mark)
nmps correlates (nmod)
uv 6.2 (nummod)
observed tachycardia (nsubjpass)
hydroxyl ) (punct)
gemcitabine days (nmod)
degeneration activation (conj)
testosterone hormone (conj)
lethal ) (punct)
cataracts posterior (amod)
had pointes (nmod)
valproate of (case)
precedes damage (dobj)
$ROOT$ raised (sent)
detect echocardiography (nsubj)
produced blockers (nsubj)
reversion normal (nmod)
week even (advmod)
yahr and (cc)
potentiation blockade (conj)
values numbers (nmod)
rupture patients (nmod)
ifx ) (punct)
infusions epinephrine (nmod)
chick in (case)
exceed should (aux)
higher fold (advmod)
wakefulness increased (amod)
inadequate effects (nsubj)
replicated was (auxpass)
scores mice (nmod)
hl ( (punct)
surface to (case)
noted postinjection (nmod:npmod)
routes via (case)
months longer (nummod)
mechanism basic (amod)
fluphenazine sulpiride (conj)
mumol/mg 15 (nummod)
resulted decline (nmod)
4 - (punct)
higher dose (nmod)
dysfunction endothelial (amod)
frequency monitoring (appos)
increase increase (conj)
concluded exists (ccomp)
staining for (case)
induced effective (advcl)
infarction intoxication (nmod)
rise enos (nmod)
epilepsy for (case)
typical findings (nsubj)
curves on (case)
prolongation syncope (conj)
ethinylestradiol cpa/ee (appos)
units total (amod)
reported was (auxpass)
variability rate (compound)
alterations neural (amod)
potassium microl (amod)
cause death (nmod)
development tolerance (nmod)
microg/kg/min ( (punct)
glomerulonephritis rpgn (appos)
21680 neca (conj)
analyzed determine (advcl)
diagnosis co-morbidity (conj)
frequency this (det)
understood thought (advcl)
counted were (auxpass)
treatment blockers (nmod)
micrograms nigra (nmod)
resulted treatment (nmod)
toxicity bone (compound)
levels despite (case)
diuretic chlorthalidone (appos)
swollen bilaterally (advmod)
hbv resistant (amod)
reached developed (advcl)
presented given (conj)
suggestive reach (conj)
infusion as (case)
domain at (case)
overflow treatment (nmod)
considers anemia (dobj)
channels ion (compound)
peripheral autonomic (conj)
sequelae neuropathological (amod)
nitrate/nitrite nox (appos)
circles concentric (amod)
extend findings (dobj)
pad glycopyrrolate (compound)
fluctuations levodopa-induced (amod)
10-weeks-old 9 (nummod)
seizure -- (punct)
increased provided (advcl)
metabolites its (nmod:poss)
affinity receptor (nmod)
ecg standard (amod)
signs counts (conj)
selected at (advcl)
sec/cm5 2660 (nummod)
indinavir with (case)
intake food (compound)
days study (compound)
tests hot-plate (amod)
treatment conservative (amod)
developed chorea (dobj)
pointes induced (acl)
resolved reduction (nmod)
patients aged (amod)
thrombocytopenia patients (nmod)
increased presence (nmod)
given period (nmod)
accumulation its (nmod:poss)
toxicities life-threatening (amod)
recipient the (det)
effects long-lasting (amod)
steroids anabolizing (amod)
unlikely reduce (xcomp)
association considered (acl:relcl)
2mls ) (punct)
unique and (cc)
( /-2.3 (conj)
max lv (compound)
reported % (nsubj)
presented symptoms (nsubj)
heart cardiomyopathy (conj)
depth sedation (nmod)
evidence repair (nmod)
proportion group (nmod)
prevent slow (conj)
association numbers (nmod)
bupivacaine mg/kg (appos)
inhibitor converting (amod)
observed it (nsubjpass)
models pain (compound)
functionality hpa (compound)
symptoms neuropsychiatric (amod)
delayed and (cc)
% -49 (nummod)
dopamine serotonin (conj)
reflect activity (dobj)
led have (aux)
reversed pre-treatment (nsubj)
% % (conj)
effect possible (amod)
effect cytopathic (amod)
patients 2441 (nummod)
group group (dep)
emulsion epinephrine (conj)
admitted myopathy (nmod)
ng/ml 15 (nummod)
battery and (cc)
sulphate epipregnanolone (compound)
clearance simvastatin (compound)
effect specific (amod)
tomography thallium-201 (compound)
n-nitroso-n-methylurea and (cc)
19 = (conj)
register medline (appos)
hds lds (conj)
anticonvulsants on (case)
parameters for (case)
had factors (dobj)
sign , (punct)
production micronuclei (nmod)
group lamivudine (compound)
reached plateau (dobj)
$ROOT$ properties (sent)
supersensitivity denervation (compound)
hypertension cyclosporin (compound)
recognize entity (dobj)
protocols different (amod)
reduction progressive (amod)
class , (punct)
inactive was (cop)
evidence by (case)
kidney isolated (amod)
ropivacaine ( (punct)
contain not (neg)
acting ifo (nsubj)
hypotension , (punct)
min ischemia (nmod)
effect vasculitis (nsubj)
stimulation tetanic (amod)
vehicle mg/kg (appos)
secretion pulsatile (amod)
associated damage (nmod)
regulation through (case)
audiogram the (det)
acting fast (dep)
7.54 1.91 (nummod)
injected sulfate (nsubjpass)
toxic dfu (nmod)
linn indica (compound)
developed repair (nmod)
were p (dep)
ms by (case)
causes leading (amod)
unlikely effective (advcl)
served group (nmod)
recording correlates (nmod)
method radiofrequency (compound)
42 5 (conj)
dwi on (case)
nms patient (nmod)
infarction mi (appos)
rat gunn (compound)
$ROOT$ remains (sent)
concentration brain (compound)
$ROOT$ crisis (sent)
course first (amod)
behaviors dependent (amod)
dysfunction damage (conj)
come animals (nmod)
mph , (punct)
classified group (nmod)
hospitalization ami (nmod)
urea nitrogen (compound)
rise blood-pressure (nmod)
day treatment (compound)
characteristic operative (amod)
suggest function (dobj)
increases appear (conj)
eight , (punct)
contribute re (nsubj)
systems enzyme (compound)
hg p02 (compound)
cholestasis hepatitis (nmod)
current pacemaker (compound)
score on-period (amod)
donors selected (amod)
greater and (cc)
monitored exposure (nmod)
understood monitored (advcl)
cocaine mice (nmod)
dysregulation exposure (nmod)
reinstated could (aux)
force involved (acl)
change cimetidine (nmod)
granulomatosis in (case)
receiving cefonicid (dobj)
reductions cholesterol (nmod)
t3n0m0 ) (punct)
alive months (nmod)
therapies were (cop)
activity rodents (nmod)
p=0.65 ( (punct)
tubules to (case)
produced adenosine (nsubj)
is data (attr)
remained weeks (nmod)
alternation avoidance (conj)
hours injection (dep)
odds higher (amod)
identified map (nmod)
study is (cop)
was course (attr)
alone where (advmod)
neurons glutamic (amod)
benign cases (nsubj)
ameliorate and (cc)
slowing a (det)
disrupting acutely (advmod)
$ROOT$ more (sent)
$ROOT$ underline (sent)
cisplatin before (nmod)
differentiation reflecting (acl)
disease patients (nmod)
inhibition cck-8-ns (nmod)
thought . (punct)
levetiracetam oral (amod)
conclusion predict (appos)
assessed incidence (nsubjpass)
$ROOT$ destructive (sent)
evaluated had (advcl)
injection following (amod)
hydrochloride quinacrine (compound)
controlling spread (dobj)
evident groups (nmod)
similar symptoms (nsubj)
vgpr > (advmod)
mortality greater (amod)
had images (nmod)
h 96 (nummod)
150 vs. (cc)
reducing respectively (advmod)
that of (case)
pathway septo-hippocampal (amod)
biological , (punct)
is result (nmod)
likely distribution (nmod)
content lipid (compound)
proliferated , (punct)
prednisolone with (case)
hypertension neuroblastoma (nmod)
produced muscimol (nsubj)
cells undamaged (amod)
led injury (nsubj)
prior administration (nmod)
users regular (amod)
reduces action (nsubj)
bed microvascular (amod)
ionic material (dep)
$ROOT$ safe (sent)
revealed area (dobj)
effects sham (amod)
enzymes myocardial (amod)
treatment acid (compound)
biopsy ) (punct)
children additional (amod)
indicate predict (conj)
groups saline- (amod)
has rat (nsubj)
obtunding doses (nmod)
metabolized esterases (nmod)
overexpression bbb (nmod)
sedations on (case)
severity varying (amod)
structures head (nmod)
predictive more (advmod)
$ROOT$ findings (sent)
function pulmonary (amod)
level also (advmod)
short one (nummod)
given groups (nmod)
rapamycin of (case)
dose from (case)
caused microinjection (nsubj)
symptomatic . (punct)
$ROOT$ comprises (sent)
frequency rebleeding (nmod)
absences resistant (amod)
7th the (det)
consuming meat (nmod)
suggests . (punct)
mg/kg/day csa (compound)
disorder lymphoproliferative (amod)
administration following (case)
disrupted ppi (dobj)
off and (cc)
contraception with (case)
experience initial (amod)
growth growth (conj)
d-amphetamine mumol/kg (appos)
treatment types (nmod)
10.7 ; (punct)
rat lou/m/wsl (compound)
case transplantation (nmod)
pressure aorta (nmod)
adriamycinol doxorubicin (conj)
resistance p (dep)
percent thickening (nmod)
infusion ppa (nmod)
screening occasions (nmod)
decreased experiment (nmod)
43 18 (compound)
electrocardiograms patients (nmod)
$ROOT$ well (sent)
$ROOT$ classed (sent)
hepatic neurological (conj)
consequences neurologic (amod)
h test (dep)
augment furthermore (advmod)
tachycardia marked (amod)
myelosuppression leukopenia (dep)
crisis therapy (conj)
tested actions (nsubjpass)
cells platelets (conj)
metabolite is (cop)
frequent tended (conj)
i.p. mg/kg (nmod:npmod)
risks high (amod)
period seconds (nmod)
greater mice (nmod)
suggest develop (ccomp)
hcl , (punct)
phenylephrine mg (appos)
suppressed which (nsubjpass)
factor and (cc)
presented salbutamol (nsubjpass)
impotence of (case)
intermedius the (det)
calls attention (nmod)
addition necrosis (nmod)
systems cell (compound)
sclerosis systemic (amod)
affect administration (nsubj)
absence induction (nmod)
use suxamethonium (nmod)
receiving labor (nmod)
stimulatory and (cc)
9/15 , (punct)
cleavage homogenates (nmod)
ratio 2.5-fold (nmod)
nsaid , (punct)
time partial (amod)
proteinuria crea (appos)
years treatment (compound)
controls drug-free (amod)
alpha-methyltyrosine mg/kg (dep)
effects motor (compound)
prevalence survivors (nmod)
employed histochemistry (nsubjpass)
females five (nummod)
g/dl 11 (nummod)
activity hippocampus (nmod)
encephalopathy encephalitis (conj)
protects restriction (nsubj)
impaired is (auxpass)
obtained recovery (nsubjpass)
level sodium (compound)
testosterone by (case)
studies conventional (amod)
mediated part (nmod)
maleate antagonist (compound)
sepsis severe (amod)
normalized . (punct)
headache accompanying (acl)
sixties in (case)
cross-tolerant morphine (nmod)
death subsequent (amod)
objective derivative (appos)
depletion this (det)
induces proteinuria (dobj)
caused likely (advmod)
derivatives amoxicillin (conj)
ligation artery (compound)
volume lesion (compound)
prolonged exposure (dobj)
and serologically (advmod)
bfue marrow (compound)
none moderate (appos)
pressures in (case)
markers brain (compound)
pupil the (det)
checked . (punct)
rarest the (det)
activity tnf (compound)
anaesthesia following (case)
detect snr (nmod)
return normal (nmod)
establish risk (dobj)
outcome study (nmod)
showed doses (nmod)
infusion rate (nmod)
17-year-old to (quantmod)
augments mk-801 (nsubj)
revealed analyses (nsubj)
nucleus of (case)
disorder in (case)
demonstrated cis-ra (nsubj)
attenuation and (cc)
1999 between (case)
receptors 1 (nummod)
purpose transporter (appos)
determined immunoblotting (nmod)
quiet pacing (conj)
patients records (conj)
25 2 (compound)
albuminuria gfr (conj)
arabia saudi (compound)
baroreflex ccb (appos)
risk at (conj)
greater that (nmod)
protection ) (punct)
haloperidol oral (amod)
700 400 (compound)
receiving contraceptives (dobj)
unrecognized pose (conj)
product a (det)
substantial not (neg)
desire arousal (conj)
administration cyp (compound)
attributable didanosine (nmod)
addicts adult (amod)
defect field (compound)
deficit memory (compound)
studies doxorubicin (compound)
fastigial cerebellar (amod)
practice therapy (compound)
agents similar (amod)
occurrence nephrotoxicity (nmod)
reversed . (punct)
transcription 3 (nummod)
included were (auxpass)
gain confirms (advcl)
head fibrotic (amod)
angiography interventions (conj)
enlargement . (punct)
woman 39-year-old (amod)
ganglia striatum (conj)
symptoms as (case)
dysfunction systolic (amod)
patients td (nmod)
treated month (nmod)
case bacteremia (nmod)
occurring phenomena (nmod)
effect metabolism (nmod)
episodes appeared (acl:relcl)
tamoxifen receptor (compound)
exhibits it (nsubj)
used safely (advmod)
mrna p75(ntr (compound)
monitored however (advmod)
7alpha-hydroxylase , (punct)
related motility (nmod)
dysfunction motor (compound)
man adenocarcinoma (nmod)
substantial size (nsubj)
ventricles the (det)
apigenin the (det)
lost pressures (nmod)
micturition all (det)
vasospasm with (case)
improvement handling (nmod)
reason the (det)
report investigation (dobj)
pethidine and (cc)
patients aza-treated (amod)
neurones on (case)
chf of (case)
provide information (dobj)
distracted is (auxpass)
dose each (det)
remained evidence (nmod)
l-arginine , (punct)
85.4 7 (compound)
have opse (dobj)
introduced belgium (nmod)
food this (det)
incontinence hallucinations (conj)
inhibitions the (det)
derangement to (case)
hyperthyroidism for (case)
influence variables (nmod)
proving effective (xcomp)
produced impairment (dobj)
absorption percutaneous (amod)
deep or=80 (cc)
waiting watchful (amod)
41 15 (compound)
medulla papilla (conj)
risk consumption (nmod)
after hours (nmod:npmod)
suggest increased (ccomp)
understand help (conj)
neurons rodents (nmod)
alf drug-induced (amod)
bolus injected (acl)
antibacterials ketolide (compound)
trials rcts (appos)
ti ( (punct)
speech , (punct)
parents sixty-nine (nummod)
amisulpride and (cc)
thought as (mark)
permanente california (nmod)
assessed days (conj)
experiencing neutropenia (dobj)
induced entities (nmod)
neurons spinal (amod)
inhibitors milrinone (nmod)
system rat (compound)
proliferation muscle (compound)
neurosteroids memory-enhancing (amod)
% concentrations (nsubj)
amounts ( (punct)
% 48.8 (nummod)
35 than (advmod)
monkey rhesus (compound)
important than (prep)
injection lidocaine (nmod)
calcification on (case)
methods direct (amod)
grafting artery (compound)
frequency to (case)
rad001 plus (cc)
mice wsr (compound)
normal phenotypically (advmod)
$ROOT$ conjugates (sent)
cardiotoxicity anthracycline (compound)
man 63-year-old (amod)
related dysfunction (nmod)
results paper (nmod)
cyclophosphamide of (case)
month was (cop)
exercise- isoproterenol-induced (conj)
pump analgesia (compound)
neurons cells (conj)
increasing rise (nsubj)
hg group (nmod)
apart weeks (nmod:npmod)
metabolite neurotoxic (amod)
$ROOT$ emphasizes (sent)
spectrometry chromatographic-mass (amod)
children have (acl:relcl)
treated propylthiouracil (nmod)
factors without (case)
prolongation marked (amod)
medication a (det)
diuretics , (punct)
blocks agent (nsubj)
conclude results (nmod)
prevent reduce (conj)
cohorts other (amod)
decrease increase (appos)
. iu/kg/i.v (advmod)
brief resulted (conj)
information site (nmod)
i. of (case)
patients 49 (nummod)
commissure and (cc)
pretreatment pancuronium (nmod)
tolerable , (punct)
beta4 -/- (amod)
antagonize stereotypy (dobj)
tiapride tetrabenazine (conj)
reproduced dogs (nmod)
% 38.5 (nummod)
0.25 than (case)
impact exposure (nmod)
$ROOT$ pseudolithiasis (sent)
increased metoprolol (nsubj)
months 9 (nummod)
afferents primary (amod)
pfs ) (punct)
processed immunohistochemistry (nmod)
cases overdose (nmod)
quit women (nsubj)
essential maintaining (advcl)
reduction db (compound)
1-receptor beta (nmod:npmod)
lesions doxorubicin-induced (amod)
consciousness , (punct)
evaluated matched (conj)
characteristics presence (appos)
changes function (compound)
subjects submitted (acl)
rats laboratory (nmod)
ingestion chloride (compound)
detection blood (nmod)
ultrastructure endothelial (amod)
increased cent (nmod)
became rise (nsubj)
administration shr (nmod)
blockers 1,4-dihydropyridine (compound)
form tablets (nmod)
responses between (case)
$ROOT$ attribute (sent)
line = (acl)
incidence reduced (amod)
case was (cop)
regimens elf (nmod)
protrusions luminal (amod)
treatment pectoris (nmod)
dosing frequent (amod)
thrombi and (cc)
behaviors sensory/motor (amod)
dismutase of (case)
conclusions suggested (dep)
transcripts gene (nmod)
method safe (amod)
examination injections (nmod)
$ROOT$ likelihood (sent)
pulses current (compound)
% 126 (nummod)
receptors for (case)
mris on (case)
norepinephrine ng/min (appos)
dox b1r(-/- (dep)
varied frequencies (nsubj)
hypoxia . (punct)
had ecg (dobj)
studied obtain (xcomp)
avoided should (aux)
factor bfgf (appos)
injury significant (amod)
extend demonstrate (conj)
develops , (punct)
ascribing before (mark)
results 2.20 (appos)
male g (nmod)
went courses (nmod)
frequency contraction (compound)
involves which (nmod)
dopamine observed (acl)
dysmenorrhea primary (amod)
gem and (cc)
supervened . (punct)
safety less (dep)
complicated , (punct)
short to (case)
protective cs (nmod)
published has (aux)
levels ao (compound)
-9.9 1.7 (conj)
contribute actions (nmod)
protect myocardium (dobj)
dysfunctioning of (case)
avoid deficits (dobj)
isoflurane , (punct)
negative as (cc)
neuropathy event (nsubj)
loss suxamethonium (nmod)
indian southern (amod)
n=36 ( (punct)
suppresses but (cc)
development pulmonary (amod)
change significantly (advmod)
added been (auxpass)
institution in (case)
collected samples (nsubjpass)
responses ventricular (amod)
effects infusion (nmod)
concentration oxycodone (compound)
avoided might (aux)
induce down-regulation (dobj)
beta-agonists inhaled (amod)
paroxysms diffuse (amod)
signaling 4 (nummod)
areas flexural (amod)
had whereas (dep)
regions brain (compound)
characteristics contraction (compound)
forces dose (conj)
sensitive were (cop)
report intoxication (appos)
transition mitochondrial (amod)
factors additional (amod)
svc of (case)
weight kg (nmod)
anticholinesterases with (case)
degree given (case)
indicate conclusions (nsubj)
famotidine with (case)
mediated failed (parataxis)
anesthesia during (case)
$ROOT$ result (sent)
5.2 3.2 (quantmod)
subscore effect (nsubj)
loss creativity (nmod)
events these (det)
fast period (nmod)
individuals received (acl:relcl)
appeared reproducible (conj)
alter markedly (advmod)
mutations pc (compound)
phosphorofluoridate dfp (appos)
read expressions (dobj)
ng/ml volume (conj)
volunteers age-matched (amod)
subscale subscale (conj)
show % (parataxis)
illustrates number (dobj)
followed access (dep)
called form (nmod)
maximum month (nmod)
reversible ; (punct)
sph ] (punct)
cohorts patient (compound)
$ROOT$ awoke (sent)
137 134 (compound)
flattening phase (nmod)
tomography spect (appos)
gene the (det)
interviewed and (cc)
gm cellulose (conj)
involved primarily (advmod)
case hepatitis (nmod)
forces between (case)
higher 2.5 (nmod:npmod)
included matched (advcl)
exposure mtx (compound)
patients bradykinesia (conj)
7 more (amod)
5 some (advmod)
from or (cc)
included stratified (conj)
variability regurgitation (conj)
hyperprolactinemia long (amod)
capacity discontinuation (nmod)
revealed exploration (nsubj)
ed1 marker (appos)
subject no (det)
side-effect cystitis (nsubj)
phosphatase nephrosis (nmod)
followed retardation (nmod)
proteins alphaenac (compound)
lacking still (advmod)
performing task (dobj)
contraceptives third-generation (amod)
diminish prevent (conj)
min 5 (compound)
majority groups (nmod)
interfere that (nsubj)
returned count (nsubj)
blockers ( (punct)
monitored continuously (advmod)
receive tamoxifen (dobj)
levels either (preconj)
ionotropic and (cc)
episodes anemia (nmod)
options patients (nmod)
ed50 and (cc)
factor susceptibility (compound)
metabolizer , (punct)
combinations higher-dose (amod)
days evolution (nmod)
fluoxetine with (case)
vehicle ng (conj)
schedule once-per-day (compound)
increased dexamethasone (nsubj)
weight low (amod)
ratio risk (compound)
vasoconstriction and (cc)
morphine delta (conj)
bars ( (punct)
increase sign (nsubj)
higher % (nmod:npmod)
exacerbates , (punct)
significant factors (nsubj)
values ng/ml (dep)
analyses patients (nmod)
ducts the (det)
changes response (dobj)
differences pattern (nmod)
marketed was (auxpass)
cystitis with (case)
capable were (cop)
patients n=10 (nummod)
showed later (advmod)
uncommon very (advmod)
presentation and (cc)
considered reversible (xcomp)
treatment using (acl)
efficacy levofloxacin (nmod)
none treatments (nmod)
efficacy event (conj)
kindreds of (case)
positive significant (conj)
damage residual (amod)
taking metronidazole (dobj)
adenocarcinoma for (case)
available role (nmod)
lactate in (case)
dysfunctions of (case)
made measurements (nsubjpass)
dp/dtejc ) (punct)
patients months (nmod)
terfenadine cisapride (appos)
started sorafenib (nsubjpass)
inserted anesthesia (nmod)
mm 0.1 (nummod)
prevent nor (cc)
limbs lower (amod)
recorded cases (nmod)
acts may (aux)
limit to (case)
recent and (cc)
drug ecstasy (nsubj)
cancers cancers (conj)
measured immunocytochemistry (nmod)
platform suspended (amod)
3.10 , (punct)
hexaaldose not (neg)
inhibited neither (cc:preconj)
receive weeks (nmod:tmod)
changes dgc (nmod)
revealed severity (nmod)
2.1 1.9 (conj)
voltage- and (cc)
bia f/azepine-5-carboxamide (appos)
oxygen po2 (appos)
na mm (amod)
pathways anterior (amod)
men 16 (nummod)
acetaminophen 1.29 (nummod)
transmission glutamate (compound)
study patients (nmod)
histology the (det)
administration anesthetic (compound)
profile given (case)
patients seizures (nmod)
used sedation (nsubjpass)
cessation medications. (nmod)
dp/dt hearts (nmod)
used marker (nmod)
sonograms cranial (amod)
deficits of (case)
reduction mssbp (nmod)
therapy levodopa (nsubj)
propofol remifentanil (conj)
relevant ocd (nmod)
agonist inverse (amod)
pretreatment mangiferin (nmod)
modulating by (mark)
similar degree (nsubj)
releases inhibition (nmod)
avoid paralysis (dobj)
bands that (mark)
consumption oxidation (conj)
procedure another (det)
benefit in (case)
proposed associated (ccomp)
type stroke (nmod)
contributor a (det)
potentiation prevention (conj)
alive days (nmod:tmod)
mug 4 (nummod)
increase tissue (nmod)
regions identified (acl)
% 87.3 (nummod)
correct not (neg)
mechanisms circuits (nmod)
gauges all (det)
results stress (nmod)
tremor ataxia (conj)
mortality to (case)
day six (nummod)
rats weanling (amod)
quetiapine than (case)
history lymphoma (nmod)
15 as (quantmod)
loss body (compound)
mirrors pattern (nsubj)
tubule renal (amod)
society , (punct)
shr to (case)
experienced thrombocytopenia (dobj)
evident mice (advcl)
100 50 (compound)
effect hydrochloride (nmod)
abuse dextromethorphan (nmod)
b with (case)
exposure tdf (compound)
dopaminergic alpha1-adrenergic (conj)
activating when (advmod)
3tc , (punct)
found acquisition (nmod)
leukemia nonlymphocytic (amod)
failed indomethacin (nsubj)
150 ( (punct)
patients randomized (acl)
reaction vaccine (compound)
indicated 6 (dep)
block blindness (nmod)
proteinuric hr (dep)
studies analysis (conj)
syndrome cava (compound)
antipsychotic an (det)
inhibitors cyclosporine (dep)
5-fluorouracil , (punct)
illustrated utility (nsubjpass)
testing weeks (nmod)
constitutes which (nsubj)
doses nonsedating (amod)
characteristics anatomical (amod)
complaining dysphonia (nmod)
testing for (case)
experienced weeks (nmod)
inhibition patients (nmod)
time examination (nmod)
use lignocaine (nmod)
had hyperemia (nmod)
significant abdomen (nmod)
investigated and (advmod)
blocked drug (nmod)
% 4.1 (nummod)
form pressure (compound)
created was (auxpass)
interval in (case)
presented eruptions (nmod)
propose to (mark)
behavioral the (det)
low been (cop)
squealing bobbing (conj)
tumors cancers (nmod)
eight two (nmod)
experience literature (conj)
found rate (dobj)
showed observed (advcl)
data pharmacological (amod)
sludge of (case)
reproducible defects (nsubj)
based analysis (nsubjpass)
monitored although (mark)
escalated dose (nsubjpass)
live can (aux)
therapy acid (nmod)
induced hypotension (nsubjpass)
membrane basal (amod)
recording hour (amod)
jaundice hepatocellular (amod)
cells antigen-positive (amod)
found benzodiazepines (nmod)
preferred that (mark)
rats half (nummod)
identified women (nsubjpass)
undergoing chemotherapy (dobj)
2 cent (nmod)
increased factor-alpha (dobj)
% 45.5 (nummod)
involvement groups (nmod)
pvn in (case)
treatment : (punct)
changes st (amod)
studies cb (nmod)
pilo and (cc)
synthesized . (punct)
3,4-methylenedioxymethamphetamine ecstasy (appos)
recognized thrombocytopenia (nsubj)
204 + (cc)
reversed anticoagulation (dobj)
% 30.49 (nummod)
increased additionally (advmod)
antagonizing effects (dobj)
o-a ) (punct)
meter an (det)
recovery subsequent (amod)
had likely (conj)
decreases users (nmod)
withholding antibiotic (dobj)
effective diazepam (nsubj)
arthralgia because (case)
= 114 (dobj)
images mr (compound)
attack frequent (amod)
revealed however (advmod)
system l-arginine (compound)
pneumonia adenovirus (compound)
total over (case)
closest tolerance (nmod)
enzyme for (case)
patients take (acl:relcl)
remission with (case)
reactive light (nmod)
have power (dobj)
mmhg 5.9 (nummod)
had 527+/-509 (parataxis)
expression exaggerated (amod)
scintigraphy function (conj)
developed % (nsubj)
control nx (compound)
fluorouracil , (punct)
plasma in (case)
sedation impairment (conj)
shortening fractional (amod)
observed developed (parataxis)
nicotine carbachol (conj)
trajectory the (det)
distinguish patterns (nmod)
type exchanger (compound)
reduce inhibition (dobj)
months 7 (nummod)
synthase inducible-no (amod)
on hz (dep)
nausea sweating (conj)
similar ingestion (nmod)
pn on (case)
$ROOT$ edema (sent)
$ROOT$ enzymes (sent)
raloxifene of (case)
concentration basal (amod)
d2 e2 (conj)
hyperplasia atypical (amod)
features pathognomonic (amod)
disparities doses (nmod)
protect . (punct)
animals both (preconj)
offer not (neg)
worth be (cop)
occurrence variety (nmod)
agonist gaba(a (compound)
drop apraclonidine (nmod)
suffering . (punct)
microg/ml 25.5 (nummod)
content catecholamines (nmod)
development embryonic (amod)
inhibitor-associated ( (punct)
contraindicate does (aux)
perimetry static (amod)
taking dosage (nmod)
applicators pesticide (compound)
evaluating by (mark)
dissolution sarcomeric (amod)
megaloblastosis % (nmod)
valsartan patients (nmod)
advocate we (nsubj)
resolved month (nmod)
hdl only (cc:preconj)
examined kidney (nsubjpass)
shows occur (ccomp)
sevoflurane and (cc)
limits same (amod)
substances for (case)
group last (amod)
treatment captopril (nmod)
rrs ( (punct)
dysfunction ccr (dep)
diagnoses alternate (amod)
trials randomised (amod)
beating changes (conj)
anesthesia halothane (compound)
= 7.8 (dobj)
drugs on (case)
depletion gsh (nmod)
transplanted , (punct)
hr of (case)
substance as (case)
separated days (nmod)
related therapy (nmod)
c three-weekly (amod)
cue non-specific (amod)
understood proposed (advcl)
$ROOT$ did (sent)
$ROOT$ less (sent)
fails that (nsubj)
attenuated bd1018 (nsubj)
seems thus (advmod)
has digoxin (nsubj)
angiography percutaneous (amod)
mg/100 2.5 (compound)
properties enhance (acl:relcl)
hemiparesis : (punct)
approach treatment (nmod)
led disappearance (nmod)
difluoromethylornithine with (case)
des ) (punct)
n haloperidol (compound)
average were (cop)
magnitude percentage (conj)
records anesthesia (compound)
treatment tumor (nmod)
unresponsiveness verapamil (compound)
exhibited tissues (nsubj)
decrease facility (nmod)
degree mild (amod)
implicated conditions (nmod)
interpretation likely (appos)
glioma malignant (amod)
attenuated mice (nmod)
facilitated have (aux)
sets volunteers (nmod)
predictor is (cop)
visualize to (mark)
longer p (dep)
type medication (nmod)
rhigf-i of (case)
includes often (advmod)
fluoroacetate by (case)
desaturation bradycardia (conj)
patients burn (compound)
objective compared (appos)
agents pharmacologic (amod)
consisted which (nsubj)
affecting nucleus (dobj)
12.5 and (cc)
levels lowered (amod)
opioid and (cc)
inhibition (azt)-induced (amod)
signal delayed (amod)
established ns (nsubjpass)
appear ischemic (xcomp)
pdtc mg/kg (amod)
protect seizures (nmod)
demonstrated response (dobj)
combined was (auxpass)
regimens 2 (nummod)
analysis contour (compound)
12alpha-hydroxylase sterol (compound)
used assess (xcomp)
sign any (det)
disadvantages . (punct)
waves of (case)
relating behavior (nmod)
investigated studies (nmod)
latency clonus (nmod)
aspects safety (nmod)
pathways by (case)
sulpiride with (case)
line evidence (nmod)
completion at (case)
models multiple (amod)
represents q10 (nsubj)
associated risk (nmod)
tapering concomitant (amod)
differences no (det)
reactions attributable (amod)
initiated resulted (advcl)
anaesthetic after (case)
associated hypertrophy (nsubjpass)
-21.3 ) (punct)
affected sod (nsubj)
edema portal (amod)
tolerated who (nsubj)
disruption . (punct)
results evaluable (appos)
prl-r ( (punct)
mechanism unknown (amod)
mp ) (punct)
application stz-icv (compound)
signal potential (dep)
flashbacks as (case)
affects that (nsubj)
investigated pain (dobj)
evidence increasing (amod)
injection alf (compound)
received dosages (nmod)
shelf the (det)
mol/l . (punct)
stronger suppressing (advcl)
tomography optical (amod)
role enlargement (nmod)
fentanyl by (case)
resulted sequelae (nmod)
documents . (punct)
causing hemorrhage (dobj)
diltiazem ng/ml (appos)
inhibited mmecs (nmod)
variations many (amod)
= .0006 (dobj)
available predict (dep)
period active (amod)
overflow neurotransmitter (compound)
increased clonidine (nmod)
area saddle (compound)
symptoms joint (compound)
mechanism their (nmod:poss)
region 5-ht (compound)
bypass with (case)
use killers (nmod)
developed institution (nmod)
leukopenia and (cc)
decrease caused (acl)
available methods (nsubj)
detectable were (cop)
developing episode (dobj)
given precluded (advcl)
covariates relevant (amod)
0.96 ( (punct)
cytoplasm in (case)
difference=0.01 p (compound)
number ventricular (amod)
removed lithotripsy (nsubj)
ischemia bilateral (amod)
factors key (amod)
diagnosis amyloidosis (nmod)
extract tissue (compound)
corticosterone ppm (amod)
was normal (ccomp)
became days (nmod:npmod)
mg/kg 0.3 (compound)
node av (compound)
view use (nmod)
began min (nmod:tmod)
associations the (det)
correlation pearson (nmod:poss)
unmask can (aux)
patients b (compound)
disclosed to (mark)
$ROOT$ prerequisite (sent)
effect neither (cc:preconj)
abnormalities indistinguishable (amod)
biochemical isoniazid-induced (amod)
= 29 (dep)
maintained chow (nmod)
tumors primary (amod)
hour 24 (nummod)
patient sah (nmod)
monitoring audiovisual (amod)
inhibitor enzyme (compound)
halothane snp (conj)
model taa (compound)
increased status (nmod)
solution chow (conj)
compromised medically (advmod)
area gpi (nmod)
incontinence their (nmod:poss)
sent . (punct)
saline 6 (dep)
change : (punct)
giving daily (advmod)
sarcomas including (case)
presumed to (xcomp)
piloerection headache (conj)
66 than (quantmod)
447 454 (conj)
cells cells (conj)
disorders induced (acl)
monophosphate adenosine (compound)
lymphoma in (case)
order perform (acl)
children 30 (nummod)
patients thrombosis (nmod)
programs of (case)
depression-inducer of (case)
tolerance rapid (amod)
function expression (conj)
convulsions organophosphate-induced (amod)
dysfunction minor (amod)
remains benefit (nsubj)
using pupillometer (dobj)
analysis data (compound)
frequency on (case)
experience lovastatin (nmod)
contained microcrystals (dobj)
week postoperative (amod)
fetuses in (case)
increased twitches (dobj)
$ROOT$ acted (sent)
attempted using (xcomp)
6/52 patients (nmod)
purpose review (nmod)
nucleus medulla (conj)
difference animals (nmod)
microangiopathy and (cc)
improvements functions (nmod)
cortex right (amod)
norms about (case)
showed intensities (dobj)
occurred intake (nmod)
$ROOT$ refine (sent)
not but (cc)
prevent hand (nmod)
preserves ablation (nsubj)
role treatment (nmod)
$ROOT$ reveal (sent)
events . (punct)
doses weeks (conj)
indicates , (punct)
returned level (nsubj)
maximum [ (punct)
study genetic (amod)
$ROOT$ dropped (sent)
0.2 2.0 (conj)
growth cranial (compound)
$ROOT$ pseudoacromegaly (sent)
t0 ) (punct)
months 29.5 (nummod)
self-treating and (cc)
uraemia reduced (amod)
9.6 ) (punct)
either mouth (dep)
suggestive reaction (nmod)
sham ) (punct)
mg 1,800 (nummod)
sensitivity a (det)
occasion on (case)
drawback main (amod)
caused mellitus (nmod)
mg/day 12.5 (nummod)
platform hidden (amod)
induction anaesthesia (compound)
1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine ( (punct)
virus e (compound)
missed strategies (nsubj)
stimulation walls (nmod)
obscure most (advmod)
cpm ( (punct)
expression p2x3 (nmod)
pretreated which (nsubjpass)
backgrounds the (det)
conclusions cause (dep)
dose meth (compound)
saline u/ml (appos)
toxic are (cop)
rad001 ( (punct)
this like (case)
area by (case)
follow 3 (dep)
implies ligation (dobj)
shown teratogenic (xcomp)
vpu ) (punct)
droop facial (amod)
nitrolingual ) (punct)
mediate origin (dobj)
frequency pulse (compound)
noted tests (nmod)
reported here (advmod)
slowing with (case)
antagonist nonselective (amod)
cardiotoxicity despite (case)
$ROOT$ encouraged (sent)
subunit cco-i (appos)
shown reports (nsubj)
responses drug (nmod)
safety setting (nmod)
compromises decreasing (advcl)
done anesthesia (nmod)
releasing by (mark)
patients has (dep)
enhancement in (case)
drug related (acl)
infused stz (nmod)
reduction % (amod)
higher group (nmod)
attribute contribution (nsubj)
production aldosterone (compound)
pretreatment umb24 (nmod)
presentation hospital (nmod)
therapy vpa (compound)
block by (case)
tachycardia fatal (amod)
rhuepo administered (acl)
values ferritin (compound)
stores overflow (conj)
unsafe and (cc)
mg/kg 23.7 (nummod)
admission during (case)
detrusor of (case)
serotonin of (case)
cycles bortezomib (nmod)
receptors dopamine (compound)
anticipation demands (nmod)
fraction ) (punct)
combination by (case)
immunity cellular (amod)
paper the (det)
low rate (nsubj)
performed techniques (nsubjpass)
traces similar (amod)
thrombotic cardiac (amod)
pose used (advcl)
symptoms measured (acl)
pretreatment test (nmod)
dialysate , (punct)
receptor at (case)
duration time (dep)
utility patient (nmod)
prescribed losartan (nsubjpass)
monitored treatment (nmod)
breast of (case)
made lesions (nsubjpass)
attempted . (punct)
$ROOT$ propensity (sent)
pathway mitochondria-dependent (amod)
served subjects (nsubj)
= ns (dep)
exhibited accuracy (dobj)
compared hilus (nmod)
angiography with (case)
precipitated can (aux)
hearts than (case)
val placebo (conj)
g 29.1 (nummod)
dosage ranging (acl)
eruption maculopapular (amod)
with risk (conj)
epileptogenic and (cc)
present frequently (advmod)
cause an (det)
week drug (nmod)
level function (nmod)
eluate the (det)
recovered . (punct)
model intoxications (nmod)
mmol , (punct)
rate ) (punct)
changes due (case)
cpa , (punct)
has utilization (nsubj)
reviewed infants (nmod)
complained none (nsubj)
evaluated pain (nsubjpass)
anemia ticlopidine-induced (compound)
km its (nmod:poss)
had levels (dobj)
region 5-httlpr (appos)
f temperature (nsubj)
occur individuals (nmod)
rats atherosclerosis (nmod)
gating sensory (amod)
supports experience (nsubj)
reports in (case)
20 or (cc)
developed 1 (nsubj)
variants enzyme (nmod)
l-dopa+benserazide ) (punct)
drug sirolmus (dep)
toxicity less (amod)
exhibited seizures (dobj)
report tachycardia (nmod)
got gpt (conj)
severe explain (xcomp)
criteria exclusion (compound)
becoming aware (acomp)
related part (nmod)
responsiveness verapamil (compound)
present and (cc)
2 one (compound)
effects aggressiveness (nmod)
had bacteremias (dobj)
predictors decrease (nmod)
selectivity a(1)/a(2a (appos)
6.9 to (advmod)
mice % (dep)
modulates injury (dobj)
eruption with (case)
failure ingesting (acl)
spasm complete (amod)
ototoxicity aminoglycoside-induced (amod)
intercellular and (cc)
protrusions microvilli (conj)
thrombosis stent (compound)
protein glomerular (amod)
pod 11 (nummod)
patient pain (nmod)
animals injected (acl)
indicates score (nsubj)
curves dose-effect (amod)
determined but (cc)
ve ( (punct)
amount the (det)
clipping for (case)
frequency or (cc)
searched methods (dep)
provide insight (dobj)
ng/dl was (cop)
controls users (conj)
phacoemulsification uneventful (amod)
shows dose-dependent (ccomp)
consists shivering (nmod)
estimated damage (nmod)
medication this (det)
show benefits (dobj)
respect in (case)
patients cyclosporine-and-prednisone-treated (amod)
presented hallucinations (dobj)
signed consent (dobj)
intensity to (case)
min min (conj)
testosterone tamoxifen (conj)
hepatitis mixed (amod)
visits 2 (nummod)
reduced treatment (nsubj)
treated np (nmod)
range : (punct)
linked representative (conj)
prevention nausea (nmod)
tilts head-up (amod)
demonstrate course (dobj)
to be (cop)
examined analyzer (nmod)
ro only (advmod)
ineffective also (advmod)
report this (det)
found absent (advcl)
agitation paradoxical (amod)
shown reflect (xcomp)
= .008 (dep)
induced test (nmod)
dose last (amod)
higher apparently (advmod)
mg/m(2 weekly (amod)
similar max (nsubj)
hypotension asystole (conj)
specific . (punct)
cases nephrolithiasis (nmod)
occurred cases (nmod)
periphery territory (nmod)
occur circulations (nmod)
given diet (nmod)
methods participated (appos)
regimens access (nmod)
blockade activity (nmod)
days , (punct)
retching and (cc)
function formation (conj)
rat l-w (compound)
delivered automatically (advmod)
artesunate , (punct)
dex ) (punct)
thrombosis aggregation (conj)
localization antagonism (nmod)
offered description (dobj)
given dose (nsubjpass)
vasodilators by (case)
variable outcome (compound)
elevated patient (dep)
treatment neuralgia (nmod)
increased greater (advcl)
function assessed (acl)
setting center (appos)
showing eeg (nmod)
week postnatal (amod)
complications vasoconstriction (nmod)
ha i-131 (compound)
depression bipolar (amod)
enhanced attenuated (conj)
components monomer (appos)
differences of (case)
dose and (cc)
iop postoperative (amod)
106 +/- (cc)
examined individually (advmod)
$ROOT$ deposition (sent)
mutations immune (amod)
displays profile (dobj)
rejection renal (amod)
had ratings (dobj)
circuitries the (det)
vessels subarachnoid (amod)
nadir granulocyte (compound)
contributes rats (nmod)
achieve area (dobj)
decrease enhance (parataxis)
requires performance (dobj)
reduced tachycardia (dobj)
product with (case)
lacking , (punct)
used remain (conj)
density [ (punct)
mg/kg/i.v 50 (nummod)
elevated however (advmod)
enlargement livers (nmod)
block instituted (acl)
causes reference (nmod)
phagocytosis of (case)
total and (cc)
conversion srl (compound)
patient % (appos)
abnormalities concurrent (amod)
serves . (punct)
purpura palpable (amod)
showed proteinuria (dobj)
tablets co. (appos)
identify factors (dobj)
receptor inhibitor (conj)
reaffirms study (nsubj)
treat years (nmod)
diphosphanilate agent (appos)
function neuropsychological (amod)
spikes deposits (conj)
l-dopa i.p. (punct)
ototoxicity in (case)
$ROOT$ implies (sent)
deserve to (mark)
later weeks (nmod:npmod)
share effects (dobj)
0.0010 from (case)
important release (advcl)
inhibitors beta-blockers (conj)
transitioned . (punct)
caused increased (conj)
dermatitis lymphadenopathy (conj)
identified that (mark)
epilepticus p45 (nmod)
treated acid (nmod)
lp : (punct)
procaterol and (cc)
addition this (nsubj)
effects mediated (amod)
scattered and (cc)
potentiate syndrome (dobj)
toxicity by (case)
discontinuations experiences (nmod)
finding well (advmod)
effect hyperglyceridemic (amod)
urinalysis measurement (conj)
level respect (dep)
suggest taken (ccomp)
% 14 (nummod)
ltp rats (nmod)
months 5,877 (nummod)
stimulation in (amod)
membranes , (punct)
sum divided (cc)
reaction probable (amod)
diversion by (case)
exhibit apoptosis (dobj)
seems administration (nsubj)
likely acidity (nmod)
fbal ) (punct)
matrix leading (acl)
anatomical and (cc)
accompanied experiments (nmod)
isomers of (case)
$ROOT$ normalized (sent)
transducer activator (conj)
recordings obtained (acl)
induced exposure (nsubj)
prevention reversal (appos)
failure aki (nmod)
hematoma and (cc)
mm 88.1 (nummod)
ci 1.60 (dep)
cardioversion for (case)
intention-to-treat according (case)
reduces bepridil (nsubj)
type arteritis (nmod)
period 6-year (compound)
ameliorated ulcer (nsubjpass)
occurred maintained (advcl)
clozapine- olanzapine-treated (conj)
carcinoma peritoneal (amod)
offset reduction (nmod)
time incidence (conj)
contribution form (nmod)
co-agonist receptor (nmod)
shifting set (compound)
parameters mass (compound)
group pediatric (compound)
diltiazem by (case)
zero group (nmod)
administered administered (conj)
patients treated (acl)
impairs occupation (nsubj)
attenuate proteinuria (dobj)
104 of (advmod)
inhibitor natural (amod)
survived they (nsubj)
ethambutol and (cc)
scans pretransplant (amod)
findings boys (nmod)
gcs ) (punct)
possessed muscle (nmod)
vehicle itself (nmod)
test learning (compound)
measured imaging (nmod)
mice fasl (compound)
risk nephrotoxicity (nmod)
research future (amod)
normalised pale (conj)
syndrome associated (amod)
using been (aux)
association stereotypies (nmod)
elevation plasma (compound)
planes along (case)
25.7 +/- (cc)
headache patients (nmod)
il-1 and (cc)
tci ( (punct)
antibodies reactive (acl)
patency airway (nmod)
n mm (amod)
decrease sod (nmod)
change last (advcl)
carried it (nsubjpass)
inhibitor cb (nsubj)
heart-rate in (case)
mutation gene (nmod)
ifosfamide , (punct)
showed agc (dobj)
produce arthrogryposis (dobj)
overdose mixed (amod)
thrombocytopenia osteoporosis (conj)
strain sensitive (amod)
camera green (amod)
observed these (nsubjpass)
examined effect (dobj)
caudate cerebellum (conj)
vulnerability lesion (nmod)
label to (mark)
augmented rather (advmod)
keep to (mark)
binding by (mark)
desferrioxamine of (case)
high increases (conj)
drugs nondopaminergic (amod)
scale children (nmod:poss)
vas ( (punct)
effects constipating (amod)
injection amphetamine (nmod)
scores in (case)
protein albumin (conj)
clarification for (case)
ester disodium (compound)
element that (mark)
sustained caused (advcl)
dose mice (nmod)
showed discontinuation (nmod)
concentrations serum (compound)
hematuria of (case)
preferring rizatriptan (dobj)
hyperthermia ma-induced (amod)
adenovirus against (case)
leukoencephalopathy a (det)
limbs chicks (nmod)
reduced switch (nmod)
ethanol by (case)
4 50 (nmod)
documented groups (nmod)
filled prescription (dobj)
instillation with (case)
erythroderma , (punct)
resolved slowly (advmod)
ci=1.375 7.914 (prep)
1941 and (cc)
using steroids (dobj)
labetalol by (case)
treatments subsequent (amod)
last of (case)
induce compounds (nsubj)
underwent measurements (nmod)
supports role (dobj)
analysis upon (case)
ms -20 (nummod)
perform prospectively (advmod)
links identified (amod)
propagated transmission (nmod)
accompanied ratio (nmod)
disease risk (dep)
syndrome disorders (conj)
expressed and (cc)
nephrotoxicity metabolism (conj)
resulted revascularization (nmod)
angiography carotid (compound)
90 % (appos)
acid 13-cis-retinoic (amod)
using electrophoresis (dobj)
self-limited reappearing (advcl)
test in (compound)
pretreated succinylcholine (nmod)
so if (mark)
beats/minute below (case)
tqrs ( (punct)
exerts range (dobj)
have more (dobj)
mg/kg 4.0 (nummod)
sodium or (cc)
tested days (nmod)
40.1 +/- (cc)
conclusions have (dep)
mg/m2 mg/kg (appos)
synthase-1 e (compound)
deaths complications (conj)
attenuation measured (acl)
need discontinuation (nmod)
administration troleandomycin (nmod)
men black (appos)
using commonly (advmod)
cancer liver (compound)
unchanged atropine (nmod)
0.3 0 (compound)
increased yield (dobj)
thrombocytopenia 33.3/9.1/6.1 (appos)
tested study (nsubj)
background become (dep)
injection following (case)
bradycardia enhanced (amod)
test black-and-white (amod)
frequency lh (compound)
taking ; (punct)
developed pathology (dobj)
mm mm (conj)
hsct by (case)
droplets protein (compound)
nuclei to (case)
cent ) (punct)
99 92 (compound)
18 - (advmod)
undergoing therapy (dobj)
multivitamin acid (compound)
ng.ml-1 72 (nummod)
revealed compressed (xcomp)
extremities of (case)
explanation alternative (amod)
hemorrhage collagenase-induced (amod)
effect conclusion (compound)
related which (nsubj)
responses of (case)
50 to (dep)
taken as (cc)
cholesterols c (appos)
consisted bortezomib (nmod)
hilus in (case)
developed seizures (dobj)
toxicity response (conj)
myopathy limbs (nmod)
protein 14.1 (nummod)
presenting disease (nmod)
paradigm dosing (compound)
withdrawn september (nmod)
probably most (advmod)
drug anticancer (amod)
have volumes (dobj)
microl micromol/10 (nummod)
dose that (nmod)
p , (punct)
showed compared (prep)
viramidine prodrug (appos)
activities significant (amod)
evaluated incidence (dobj)
compounds these (det)
exposure development (nmod)
centre veterinary (compound)
case arrest (nmod)
identify oxygenation (dobj)
alfentanil mu/kg (appos)
volumes of (case)
sunitinib and (cc)
history disease (nmod)
complete or (cc)
affinity due (case)
woman occurred (acl:relcl)
incidence high (amod)
low reported (conj)
administration than (case)
use cramps (nmod)
score acute (amod)
thermoregulation rhabdomyolysis (conj)
vestibulotoxicity against (case)
trial schedules (nmod)
associated intake (nsubjpass)
signaling d2r (compound)
appeared kanamycin (nsubj)
cells microglial (amod)
enhanced contrast (nmod)
characterized release (nmod)
combating intoxication (dobj)
18 less (amod)
render to (mark)
occlusion , (punct)
single as (case)
iopentol , (punct)
traits hallmark (amod)
advocated supplementation (nsubjpass)
mg.kg-1 m (appos)
5.1 p=0.000 (appos)
reason one (nummod)
function in (case)
propranolol after (case)
influenzae were (cop)
inhibitors paroxetine (dep)
revealed emg (nsubj)
nephrosis doxorubicin (compound)
model that (mark)
examines compared (prep)
$ROOT$ erythematosus (sent)
labeling membrane (nmod)
newborn in (case)
serve poor (dobj)
feasible this (nsubj)
enhanced ) (punct)
noted baseline (nmod)
localised was (auxpass)
$ROOT$ impaired (sent)
positive bpo (nmod)
8 to (dep)
treatment health (conj)
hearing normal (amod)
negative mdm (nmod)
fraction output (conj)
negativity , (punct)
week of (case)
gemcitabine d8 (appos)
lithium have (aux)
yis one (dobj)
reduced percent (nmod)
-0.2 - (punct)
sensitivity postsynaptic (amod)
injury regions (nmod)
use antibacterial (amod)
lower week (nmod)
patients chf (nmod)
effect derivative (nmod)
required conversion (dobj)
bedtime at (case)
cisplatin support (nmod)
stimulate to (mark)
neurotransmission of (case)
assessed ) (punct)
postdose at (case)
hypertension clip (compound)
caused part (nmod)
cabergoline with (case)
layer layer (conj)
degeneration induced (acl)
reversing amnesia (dobj)
volunteers young (amod)
highlight . (punct)
patients remaining (amod)
syndrome ballooning (compound)
cerebral anterior (amod)
different that (nmod)
lead hypersecretion (nsubj)
play auto/alloimmunity (nsubj)
palate cleft (compound)
given propofol (dobj)
densa ( (punct)
rate reactions (nmod)
confirmed are (auxpass)
both doxorubicin (nmod)
36.22 +/- (cc)
contributes differentiating (advcl)
$ROOT$ undertaken (sent)
overcome can (aux)
% 11.7 (compound)
haemorrhages warfarin-related (amod)
had seen (advcl)
suspected toxicity (nsubjpass)
concentration changes (conj)
highlights need (dobj)
33.6 4.1 (conj)
caused fs (nsubj)
one left (amod)
party of (case)
intermediates trifluoroacetyl (compound)
decrease resultant (amod)
recommended dose (nsubjpass)
addiction opioid (compound)
binding stereoselective (amod)
fibrosis or (cc)
transplants ( (punct)
warranted trials (nsubjpass)
stage olig-anuria (nmod)
24 > (advmod)
change treatments (nsubj)
lamivudine agent (compound)
assessed determining (advcl)
microglobulinuria isolated (amod)
face expressing (acl)
lowered rate (dobj)
had 10 (nsubj)
conclusions conclude (acl)
thyroxine with (case)
used visualize (xcomp)
days few (amod)
prevalence depression (nmod)
occurred graded (conj)
role alterations (nmod)
enzyme is (cop)
performed months (nmod:tmod)
normal group (nmod)
examined and (cc)
circumstances most (amod)
morning surgery (nmod)
require treatment (dobj)
effect influence (conj)
afterdepolarization of (case)
passed individually (advmod)
best the (det)
10ug i.c.v (appos)
kindling from (case)
levels ldl (compound)
saline/side min (appos)
lasted longer (advmod)
dysfunction neuronal (amod)
receptors caffeine (appos)
isoform protein (compound)
identified cardona (nsubj)
foci/cm2 rats (nmod)
toxicity azt-induced (amod)
monitor a (det)
had weight (dobj)
taken increases (conj)
mg/d 480 (nummod)
metabolite its (nmod:poss)
$ROOT$ antagonists (sent)
score ] (punct)
months several (amod)
charcoal fluids (conj)
ee ( (punct)
mutants ymdd (compound)
adenomyosis to (case)
216 7 (nummod)
sulfation 7alpha-hydroxylation (conj)
courses % (compound)
appreciated widely (advmod)
measurement rate (nmod)
form deprivation (nmod)
having time (dobj)
2.1 ) (punct)
progression disease (compound)
level malondialdehyde (compound)
$ROOT$ tools (sent)
infection hiv (compound)
has considered (xcomp)
days serially (advmod)
generalized or (cc)
development early (amod)
classified they (nsubjpass)
anp ) (punct)
cardiac hepatic (conj)
necrosis probably (advmod)
alleviated which (nsubj)
had transketolase (dobj)
cells numerous (amod)
number degeneration (appos)
inhibitors other (amod)
occurs likely (advmod)
thrombectomy a (det)
clear function (nsubj)
kits by (case)
ingesting were (aux)
influence mechanisms (nsubj)
communication : (punct)
conclusions results (dep)
three up (quantmod)
glomeruli not (neg)
2- 15- (conj)
% 4 (dep)
elevated showed (conj)
oralis nuclei (dep)
turnover in (case)
anticholinergics other (amod)
approval and (cc)
19 respectively (advmod)
mice receptor-deficient (amod)
min 22 (nummod)
damage seizure-induced (amod)
regimen dosing (amod)
lack a (det)
minutes four (nummod)
anxiety more (amod)
measurements follow-up (appos)
rammer isbell (conj)
replacement women (nmod)
showed prolactin (nmod)
focus models (nmod)
drug itself (appos)
complex system (nmod)
included hepatotoxicity (dobj)
conclude administered (ccomp)
cause that (mark)
impairment onset (nmod)
synthase not (cc)
elevated they (nsubj)
higher ps (nmod)
life half (compound)
exposing cultures (dobj)
fell mv/s (nmod)
glioblastomas for (case)
$ROOT$ gemcitabine (sent)
cr ci (appos)
infarction ischemic (amod)
analyzed changes (nsubjpass)
appears size (nsubj)
neurons glutamate (compound)
reverse paralysis (dobj)
block under (case)
gave effects (nsubj)
measures these (det)
mice seizure-prone (amod)
resolved syndrome (nsubj)
littermates fvb/n (compound)
sodium ( (punct)
atria in (case)
included was (auxpass)
self-limited were (cop)
treatments standard (amod)
similar seemed (conj)
tomography emission (compound)
transaminasemia hyperkalemia (conj)
related administration (nsubj)
replacement heparin (nmod)
had puncture (dobj)
assess dysfunction (dobj)
data growth (conj)
methotrexate mtx (appos)
2600 or (cc)
efficacy lamivudine (nmod)
listed inserts (nmod)
120 45 (compound)
sulphonylureas older (amod)
cause concern (nmod)
anesthesia . (punct)
1997 and (cc)
followed off (nmod)
women for (case)
mug 30 (nummod)
reactions use (nmod)
patients administered (acl:relcl)
glycoprotein iron-binding (amod)
% 97.6 (nummod)
appears therapy (xcomp)
report surveillance (nmod)
decreased concentrations (nsubj)
thymus and (cc)
induced anxiety (dobj)
estimated frequency (nsubjpass)
antagonist a(2a)/a(1 (compound)
hypotension tiva (nmod)
block related (amod)
mitogens chemical (amod)
evidence epidemiological (amod)
glucose plasma (compound)
patients psoriatic (amod)
induce tested (conj)
4-aminopyridine by (case)
supplemented 23 (nsubjpass)
causes anemia (dobj)
high moderate (amod)
indicate value (nsubj)
study rat (compound)
level angiotension (nmod)
doubled and (cc)
college rheumatology (nmod)
ug/ml respectively (advmod)
data collection (dep)
decayed exponentially (advmod)
induced epinephrine (nmod)
users 1048 (nummod)
antagonist . (punct)
characteristics chemistries (conj)
rats impaired (amod)
contained that (nsubj)
attributable symptomatic (conj)
medication blinded (amod)
wr242511 the (det)
shortened epinephrine (nsubj)
increased rapidly (advmod)
42,671 37,495 (conj)
distributed widely (advmod)
cancer gastric (amod)
shown episode (nmod)
effects cardiomyopathy (nmod)
description case (compound)
delirium incidence (dep)
complete ( (punct)
participate use (conj)
caused patient (nmod)
59 eps (nmod)
conclusions used (appos)
occurs riha (nsubj)
cp mg./kg (appos)
defined still (advmod)
define incidence (dobj)
min 120 (nummod)
caused movements (nsubj)
reactions tdi (nmod)
present 3.1 (dep)
elevated slightly (advmod)
lobule in (case)
revealed products (dobj)
peroxidation between (case)
products noted (acl)
properties tacrolimus (nmod)
confounding to (case)
administration anticonvulsants (nmod)
forearm in (case)
symptoms daytime (compound)
rural developing (conj)
protein related (acl:relcl)
managed be (auxpass)
test field (compound)
reductions groups (nmod)
group ) (punct)
frequency regurgitation (nmod)
population cell (compound)
noted hypotension (nsubjpass)
znso(4 of (case)
levels messenger (compound)
cases a (det)
lysozymuria peak (compound)
help developing (advcl)
level the (det)
dose cyclophosphamide (nmod)
macroglobulinaemia waldenstrom (compound)
force ) (punct)
systems antioxidant (amod)
observed simultaneously (advmod)
cgmp ) (punct)
replaced were (auxpass)
tolerated exposure (nmod)
agents showed (acl:relcl)
compound by (case)
h dosing (nmod)
convulsions , (punct)
offer patients (nmod)
decreased activation (nsubjpass)
hyperthyroidism of (case)
factors loss (nmod)
drug may (aux)
progressive rapidly (advmod)
heart lung (conj)
clearance busulfan (compound)
due 5-fluorouracil (nmod)
in only (advmod)
hinder may (aux)
remains ; (punct)
stems . (punct)
integrity functional (amod)
withdrawing by (mark)
bed cerebrovascular (amod)
january 1995 (nummod)
randomized study (nmod)
gram-positive and (cc)
rats nephropathy (nmod)
analogs the (det)
ah6809 ng (dep)
undertaken should (aux)
related impairment (nmod)
awake were (conj)
noted cycle (nmod)
considered effect (xcomp)
caffeine pentylenetetrazole (conj)
seem prudent (xcomp)
0.06 and (cc)
doses oral (amod)
acidification by (case)
25 to (quantmod)
enhanced affected (conj)
identify inpatients (dobj)
myalgia induced (amod)
resulted withdrawal (nmod)
induces sle (dobj)
eu than (case)
urotoxicity to (case)
hematotoxicity cephalosporin (compound)
stress recent (amod)
hc ) (punct)
that considered (acl)
testing humphrey (compound)
centre , (punct)
occlusion artery (nmod)
fell hg (nmod)
patient described (amod)
plan role (dobj)
nephritis interstitial (amod)
received studied (parataxis)
initiate changes (nsubj)
patient c (compound)
damage adriamycin-induced (amod)
preventing relapse (dobj)
more 8- (nmod:npmod)
properties potent (amod)
activity antitumour (compound)
phosphatase , (punct)
cases probable (amod)
combinations in (case)
caused which (nsubj)
improvement week (nmod)
2.6 months (conj)
showed images (nmod)
received protocol (dobj)
dosing extended-interval (amod)
rhabdomyolysis and (cc)
elimination : (punct)
experienced children (nsubj)
reduced doses (nsubj)
alcalinization urine (nmod)
pontis basis (compound)
concluded thus (advmod)
development a (det)
fractions obtained (acl)
pharmacon the (det)
atrophy multiple (amod)
polymyositis of (case)
consequences of (case)
pph to (case)
icv intracerebroventricularly (advmod)
extract ih636 (compound)
result suboptimal (amod)
evaluation trial (appos)
producing for (mark)
attenuates metoprolol (nsubj)
medullo-adrenalectomy bilateral (amod)
reduction drug (compound)
immunosuppression transplantation (nmod)
acid-induced trans-retinoic (amod)
period initial (amod)
tamoxifen mg (appos)
remission complete (amod)
admissions in (case)
started valproate (nmod)
doses required (acl)
nausea hiccups (conj)
first antibacterials (nmod)
alpha5 beta4 (conj)
evidence abusers (nmod)
evoked caused (conj)
episode after (case)
doses mg/m2 (appos)
contraceptives dose (conj)
appeared vt (nsubj)
dosing their (nmod:poss)
i.p. i.v. (conj)
buffer tris (compound)
focusing regulation (nmod)
flestolol and (cc)
behavior mania-like (amod)
remained patients (nmod)
frequent include (conj)
evaluation histopathologic (amod)
acetaminophen ) (punct)
lacking information (nsubj)
patient each (det)
mice stage (nmod)
hospital affiliated (amod)
essential , (punct)
successful were (cop)
observed pilocarpine (nmod)
cultured and (cc)
receiving times (nmod:tmod)
hydrocortisone mg/day (appos)
concentration organism (compound)
history electrocardiogram (conj)
circumference the (det)
eps ) (punct)
exhibited inhibitors (nmod)
22 13 (conj)
assessed being (auxpass)
showed erythrocytes (nsubj)
efficiency its (nmod:poss)
g/day 0.23 (nummod)
less comparison (nmod)
substrate acts (acl:relcl)
causes hypoperfusion (nmod)
auc at (case)
rats 15 (appos)
mothers prosthesis (nmod)
regurgitation to (case)
was blocked (ccomp)
administration 1-month (amod)
possesses . (punct)
shifts dc (compound)
similar venous (nsubj)
right to (case)
proof somatotopy (nmod)
induced ketoconazole (nmod)
medication methyldopa (nsubj)
torr 48 (nummod)
isom ( (punct)
inos ) (punct)
convulsants some (det)
concentration between (case)
quadrants superior (amod)
inflammation mild (amod)
was period (nmod)
69 ( (punct)
grade > (dep)
syndrome frequency (dep)
225 and (cc)
had corrected (ccomp)
developed mass (dobj)
methylprednisolone ; (punct)
reported use (nsubjpass)
entered have (aux)
dysfunction or (cc)
hyper- dyskinetic (conj)
trends gaps (conj)
worsen not (neg)
anthracyclines mitoxantrone (nmod)
obtained response (nmod)
prevention nephropathy (nmod)
treated effectively (advmod)
vcug of (case)
berries the (det)
mg. diclofenac (compound)
using metolachlor (dobj)
presented that (nsubj)
persists that (mark)
showed nephropathy (dobj)
effects piloerection (nmod)
deleterious be (cop)
therapy cisapride (compound)
ischemia cord (compound)
commencement with (case)
propanolol with (case)
had years (dep)
depends exclusion (nmod)
congenita with (case)
$ROOT$ remodelling (sent)
cholecystitis requiring (acl)
long preserved (advcl)
compared condition (nmod)
carried studies (nsubjpass)
symptomatology of (case)
size heart (compound)
administered extract (nsubjpass)
reports associations (nmod)
daptomycin with (case)
bp clinical (amod)
documented suggested (advcl)
cataract hypertension (conj)
accumulation hepatocyte (compound)
lateral anterior (conj)
decreased directions (nmod)
started azt (nmod)
company topcon (compound)
ecg , (punct)
ketamine mg/kg (appos)
cause reversal (dobj)
prooxidant be (cop)
high-dose < (dep)
increase through (case)
that diazepam (nmod)
exceeded response (dobj)
significant groups (nmod)
remoxipride and (cc)
killers pain (compound)
mediated potentiation (nsubjpass)
prolactin greater (amod)
papers of (case)
lt alf (nmod)
buspirone of (case)
essential because (mark)
fluconazole 's (case)
a. to (case)
615 - (punct)
amb. of (case)
unknown causes (ccomp)
att infection (conj)
appears play (advcl)
mg/kg/d 50 (nummod)
reduced pretreatment (nsubj)
occurred apnoea (nsubj)
anxiety marked (amod)
neuropathies in (case)
value ctni (nmod)
follow-up of (case)
took overdose (dobj)
patients presenting (acl:relcl)
laboratory and (cc)
administered accelerate (advcl)
dipropionate with (case)
erythematosus , (punct)
vision performance (conj)
pressure circulatory (amod)
concluded offers (ccomp)
tropicamide and (cc)
[3h]-dihydroergocryptine nm (appos)
gauges > (parataxis)
% 36 (nummod)
microg/kg/min is (cop)
reduction severity (nmod)
vessels isolated (amod)
thalidomide low-dose (amod)
hypotension potent (amod)
english in (case)
infant of (case)
ug.kg-1 0.5 (nummod)
patients white (amod)
prescribed combination (nmod)
delirium role (dep)
likely injury (nmod)
estrogen of (case)
jaundice malaise (conj)
treatment paroxetine (nmod)
has toxicity (dobj)
ir ) (punct)
children thirteen (nummod)
intake oral (amod)
seen cholestasis (nsubjpass)
nodosum . (punct)
related was (cop)
alterations observed (acl)
context therapy (nmod)
sent 1986 (nmod)
dogs tested (acl)
occlusion due (case)
located layer (nmod)
releases , (punct)
urothelium suburothelium (conj)
6 times (quantmod)
polydipsia polyphagia (conj)
registered using (xcomp)
any conditions (nmod)
mm 194 (nummod)
risk although (mark)
conducted patients (nmod)
controlled pyridoxine (nmod)
measured daily (advmod)
decreased pressures (nsubj)
receptors high-affinity (amod)
cases 210 (nummod)
give and (cc)
therapy to (case)
brings effects (dobj)
exposed sequentially (advmod)
arf ) (punct)
performed centrally (advmod)
echo sequences (appos)
findings from (case)
effect analgesia (nmod)
39 19 (compound)
report were (cop)
ratios and (cc)
study open (amod)
neoantigens these (det)
retention associated (acl)
occurred average (nmod)
% percentage (nsubj)
scored occurrence (nsubjpass)
correlates in (case)
months/patient ( (punct)
produced % (nmod)
initiation the (det)
angiography fluorescein (compound)
50mg/kg by (case)
single-blind is (cop)
4.4 : (punct)
site mitochondria (nsubj)
revealed changes (dobj)
clozapine risperidone (conj)
uterus an (det)
stopping consumption (dobj)
nonselective competitive (dep)
relationship abatement (conj)
effects no (neg)
catheter ip (compound)
failure chf (appos)
necessity avoiding (advcl)
similar that (nsubj)
stages in (case)
nsc ; (punct)
dysfunction neuromuscular (amod)
produces limbs (nmod)
wild-type ( (punct)
feared revealed (parataxis)
that measured (acl)
shr chronic (amod)
discontinued dialysis (nsubjpass)
immunity , (punct)
showed vessels (dobj)
assessed signs (nsubjpass)
evidence as (case)
line of (case)
plays coding (nmod)
level trough (compound)
alone once (advmod)
loci mice (nmod)
cgrp ) (punct)
bfgf , (punct)
accompanied days (nmod)
treated protocols (nmod)
% 8/18 (appos)
stenoses critical (amod)
treatment treatment (nmod)
stroke and (cc)
administered levodopa (nsubjpass)
increase monooxygenases (nmod)
recommended surgery (nmod)
risk benefit (conj)
ng/mouse ( (punct)
words list (nmod)
associated syndrome (nmod)
mutants these (det)
moving , (punct)
limits potentially (advmod)
antagonist acid (compound)
results effective (appos)
ntg 3 (nummod)
influence agonists (nmod)
lower though (mark)
states negative (amod)
behaviors aggressive (amod)
reduced overload (nsubjpass)
nephrosis aminonucleoside (compound)
subacute a (det)
valdecoxib nsaid (conj)
differentiated cells (nsubjpass)
was groups (nmod)
drug specific (amod)
technique with (case)
likely structure (nsubj)
years 52.7 (nummod)
agents particularly (advmod)
met cases (nsubj)
grade mainly (advmod)
did pretreatment (nsubj)
adaptation decreased (amod)
rate fracture (compound)
dysfunction syndrome (conj)
investigated effects (nsubjpass)
absence + (nmod)
correction diopters (nmod)
moderate severe (conj)
given developed (advcl)
activity types (nmod)
viewed . (punct)
nt-probnp ) (punct)
stimulation stimulation (conj)
omd ) (punct)
blind condition (nmod)
recorded number (nsubjpass)
ring tissue (nmod)
those producing (acl)
readmitted was (auxpass)
bundle , (punct)
known drug (nsubjpass)
diagnosis levels (nmod)
catecholamines and (cc)
experienced tachycardia (dobj)
agonist novel (amod)
group dosing (compound)
understand pharmacokinetics (dobj)
damage reversible (amod)
mmecs and (cc)
testing of (case)
had hematomas (dobj)
basic and (cc)
observed diameters/bw (conj)
taken precautions (nsubjpass)
withdrawal agents (nmod)
improved rhigf-i (nsubj)
treated lamotrigine (nmod)
incidence parkinsonism (nmod)
26 16 (conj)
providers prehospital (amod)
dose ) (punct)
available yet (advmod)
known hyperkinesias (nsubjpass)
accelerated calcification (nsubjpass)
regulation pressure (compound)
concentrations high (amod)
episode first (amod)
dysfunction sexual (amod)
17 13 (conj)
carbetocin intramuscular (amod)
happens starts (advcl)
occurrence symptoms (nmod)
utility possible (amod)
crossed over (compound:prt)
breakdown in (case)
frequency treat (conj)
arteries rats (nmod)
dental endoscopic (conj)
induction genes (nmod)
involved blockade (nsubjpass)
counteracted treatment (nsubj)
pre- and (cc)
elicited symptoms (nsubjpass)
infusion i.v. (amod)
analgesic regular (amod)
potent clonazepam (nmod)
argatroban microg/kg/min (appos)
giving by (mark)
risks possible (amod)
areas body (compound)
changes biphasic (amod)
frequent was (cop)
child leukaemia (nmod)
significant not (neg)
chop , (punct)
> increases (nsubj)
hiv ) (punct)
resolved discontinued (advcl)
$ROOT$ mechanism (sent)
droperidol to (case)
tobramycin . (punct)
done evaluations (nsubjpass)
tested combination (nmod)
ameliorates that (mark)
immunohistochemistry vegf/vpf (compound)
remarkable specimens (nsubj)
extend to (mark)
evaluate effects (dobj)
mouth severe (amod)
required = (parataxis)
influence hyperprolactinemia (nmod)
lower to (mark)
enzyme of (case)
development kindling (nmod)
associated sulfasalazine (nmod)
ganglia kidney (conj)
undergone patients (nmod)
detrimental cardiomyopathy (nmod)
sedionbel ( (punct)
treated hydrochlorothiazide (nmod)
$ROOT$ dysgenesis (sent)
structure nerve (compound)
reaction with (case)
was return (attr)
dizocilpine ly274614 (conj)
cin incidence (conj)
4 14 (conj)
treatment agent (nmod)
neurons b3 (compound)
converts acid (nmod)
mg dec (nmod)
thresholds seizure (compound)
0.5 0.9 (conj)
tea combination (conj)
measure baseline (compound)
hospitalized period (nmod)
duration stiffness (nmod)
anesthetized morphine-chloralose (nmod:npmod)
state akt (nmod)
interview of (case)
similar time (nsubj)
work with (case)
match controls (nmod)
described cases (nmod)
$ROOT$ reverses (sent)
ability cyclophosphamide (nmod)
deprivation by (case)
matrix extracellular (amod)
change activity (dobj)
treated males (nsubjpass)
inhibition possibly (advmod)
fenoterol-hydrobromide and (cc)
rash morbilliform (amod)
micrograms 7.7 (nummod)
demonstrated compared (advcl)
features syndrome (nmod)
question however (advmod)
modified not (neg)
cancer ovarian (amod)
resulted diabetes (nsubj)
nimodipine high-dose (amod)
dysfunction age (nmod)
conclusions occur (appos)
developed thrombophlebitis (dobj)
related woman (nmod)
recur thrush (nsubj)
evidence further (amod)
mg 0.13 (nummod)
surgery emergency (compound)
nephritis induced (amod)
report therapy (nmod)
receptors 5-ht(6 (compound)
levels superoxide (nmod)
subjects become (acl:relcl)
nitrogranulogen , (punct)
c. at (case)
recording and (cc)
stress hypertension (conj)
importance calcification (nmod)
dox saline (conj)
seen has (aux)
groups subjects (nmod)
min the (det)
acid oral (amod)
shows . (punct)
sample participants (nmod)
opponent the (det)
plasmapheresis with (case)
using stereology (dobj)
phenobarbitone malondialdehyde (conj)
demonstrated result (dobj)
capacity intellectual (amod)
phases ) (punct)
medication on (case)
chloroacetaldehyde . (punct)
drugs toxic (amod)
outcome a (det)
demonstrated patient (nsubj)
paclitaxel infusion (nmod)
velocity shortening (compound)
azt on (case)
origin myalgia (nmod)
sphincter on (case)
mind in (case)
reduced frequency (nsubjpass)
eyes paired (amod)
purposes very (amod)
taken previously (advmod)
60 90 (conj)
resulted onset (nmod)
assigned total (nsubjpass)
formation dopamine (compound)
chain of (case)
study 8-week (amod)
acidosis iv (nummod)
mris follow-up (amod)
injection daily (amod)
urticaria acute (amod)
sedations procedural (amod)
striatum , (punct)
rats induced (amod)
leiden v (compound)
relationships structure-activity (amod)
bradycardia junctional (amod)
hospitals copenhagen (nmod)
induced isoproterenol (nmod:npmod)
given bupivacaine (dobj)
report on (case)
behaviour long-lasting (amod)
sodium atp (conj)
cheops ) (punct)
populations pci (conj)
serum daptomycin (compound)
increased suppressed (advcl)
minutes per (case)
mz ( (punct)
dysfunction and (cc)
lower respectively (advmod)
mm 8.4 (nummod)
tolerability results (dep)
aminoglycosides all (det)
infrequent . (punct)
pamidronate hydrocortisone (conj)
malaria as (case)
reduced behavior (nsubjpass)
toxic given (advcl)
performed experiment (nsubjpass)
using microarrays (dobj)
mg/m(2 mg/m(2 (appos)
h 4 (nummod)
injection v. (amod)
conclusions % (appos)
lovastatin of (case)
delineated activated (conj)
evaluated presented (conj)
rare hemolysis (nsubj)
recovered rhythm (dobj)
suppressed appearance (dobj)
output rate (conj)
32 about (advmod)
progression health (conj)
headache light (amod)
sensitivity line (appos)
formation central (amod)
sex , (punct)
adequate treatment (nsubj)
possibilities medications (nmod)
injections than (case)
reduced observed (conj)
severity its (nmod:poss)
groups sulfhydryl (compound)
532 to (dep)
deficit atrial (amod)
caused activation (dobj)
application following (case)
measured values (nmod)
measurements in (case)
made attempt (nsubjpass)
improved metrifonate (nsubj)
reported result (nmod)
failure finally (advmod)
stent graft (compound)
relieved however (advmod)
objective allow (advcl)
change treatment (nmod)
provide support (dobj)
antigen hbsag (appos)
did chemopreventive (nmod)
attractive use (xcomp)
prevent oih (dobj)
hg favor (nmod)
11 17 (conj)
microangiopathies of (case)
tested mwm (nmod)
$ROOT$ unassigned (sent)
ct with (case)
thrombectomy percutaneous (amod)
intraperitonealinjection nh4cl (nmod)
cochrane ovid (conj)
paralleled hypotension (nsubjpass)
veralipride with (case)
continued have (xcomp)
cycles 12 (nummod)
is thus (advmod)
proved antagonist (xcomp)
tablet ( (punct)
pro-arrhythmic cause (ccomp)
collected h (conj)
week intravenously (advmod)
maintained pressure (nsubjpass)
antagonists d2 (compound)
other and (cc)
levels mumol/l. (nmod)
bilirubin surgery (nmod)
formulation am149 (appos)
drugs injection (compound)
dose mg. (nmod)
focuses study (nsubj)
pointer , (punct)
outcomes towards (case)
months 2.9 (nummod)
anuria repeated (amod)
problems headache (conj)
presented signs (dobj)
induced treatment (nsubj)
decrease that (nsubj)
returned hemoglobin (nsubj)
increase il-6 (nmod)
derivative dp/dt (appos)
concluded is (auxpass)
lasted bradycardia (nsubj)
description clinical (amod)
identify pathways (dobj)
replacement dose (nmod)
preserved architecture (nsubjpass)
disease graft-versus-host (amod)
used patient (nmod)
$ROOT$ six (sent)
ltp the (det)
number use (conj)
large relatively (advmod)
shows waves (dobj)
administration anticoagulant (compound)
abstention of (case)
administered medication (nsubjpass)
strokes hemorrhagic (amod)
patients reaction (nmod)
increased difference (nmod)
drug organization (compound)
cirrhosis decompensated (amod)
drugs chemotherapeutic (amod)
prolapse with (case)
consists anemia (nmod)
pyrexia parotiditis (conj)
reduced is (auxpass)
chloramphenicol by (case)
% young (nmod)
observed categories (nmod)
dehydroepiandrosterone of (case)
action lf (nmod)
compound related (amod)
represent therefore (advmod)
administered doses (nmod)
report female (nmod)
tumor-free patient (nsubj)
shifting in (case)
indomethacin idm (appos)
medication 1.78 (dep)
rejection refractory (amod)
reactions green (nmod)
believed thus (advmod)
increases ( (punct)
additive synergistic (conj)
improve latency (dobj)
exposure agents (nmod)
weeks 24 (nummod)
day following (amod)
dose cumulated (amod)
underlie dysfunction (nsubj)
total weeks (nmod)
nk1 and (cc)
microperfusion picrotoxin (nmod)
interactions curcumin (nmod)
form sf36 (appos)
observed uptake (nsubjpass)
examined series (nsubj)
patients but (cc)
< 0.0005 (dep)
assessed counted (conj)
persons taking (acl)
effects haloperidol (nmod)
increase variations (nmod)
disorder compulsive (amod)
experienced male (nsubj)
extension in (case)
ntg and (cc)
receive ketoprofen (dobj)
irradiation abdominal (amod)
protect animals (dobj)
persons exposed (acl)
increased improvement (nsubj)
impairment as (cc)
number needed (acl)
presents . (punct)
hypothesis was (dep)
mg/kg 44.8 (nummod)
unresponsive lowered (parataxis)
described representing (advcl)
series assumptions (nmod)
six of (advmod)
maintained efficacy (nsubjpass)
toxicity last (appos)
improves edema (dobj)
tolerated although (mark)
decade fourth (amod)
groups user (compound)
contribute stage (advcl)
neurotoxicity 15 (appos)
therapy veralipride (nmod)
consists cessation (nmod)
ectopy of (case)
% mortality (nsubj)
shunting interatrial (amod)
treated hydration (nmod)
observed although (mark)
effectiveness trinitrate (nmod)
mg 12 (nummod)
aggravating and (cc)
pressure atrial (amod)
adjustment reduction (nmod)
produced presence (nmod)
is if (mark)
short- , (punct)
sulphonate 2-mercaptoethane (compound)
reduced time (nmod)
increased conversely (advmod)
peak a (det)
cylinder lesion (conj)
observed fasciculations (dobj)
surveillance events (nmod)
initiating glibenclamide (nmod)
collection donor (compound)
parenchyma lp (dep)
unmasked isoniazid (nmod)
appeared prolongation (nsubj)
man factors (nmod)
involved pain (nmod)
able exacerbate (xcomp)
peak in (case)
interfere agents (nsubj)
preparation nerve (compound)
defined , (punct)
increased numbers (dobj)
used adjunct (nmod)
x ck (appos)
unclear suggest (advcl)
induced anemia (nsubjpass)
cisplatinum acid (conj)
paclitaxel % (appos)
management therapy (conj)
facies , (punct)
background scarce (appos)
5.0 to (dep)
was assess (ccomp)
received followed (prep)
pituitaries f344 (compound)
rates time (conj)
regimens include (acl:relcl)
4 more (conj)
cycle 35-day (amod)
cause viracept (nsubj)
showed likely (conj)
vasospasm formation (conj)
ratio 20/13 (appos)
mug/g 15 (compound)
td50 ( (punct)
fraction % (appos)
hypertension moderate (amod)
patients hbv (compound)
report or (cc)
medulla less (advmod)
use veralipride (nmod)
task " (punct)
modulate does (aux)
tumours solid (amod)
tools potential (amod)
damage nitrative (amod)
hdl ) (punct)
affected blockade (nmod)
quetiapine by (case)
stress tm (nmod)
17.0 +/- (cc)
differed closest (ccomp)
haemorrhage subarachnoid (amod)
results went (appos)
complicated may (aux)
with and (cc)
days 150 (nummod)
area fractional (amod)
digoxin without (case)
search extensive (amod)
free effects (nmod)
patients 10 (nummod)
glomerulonephritis experimental (amod)
mg/sq 200 (compound)
demonstrated selective (ccomp)
marker protein (appos)
ck-mb ( (punct)
blocks any (det)
agents a-86929 (nmod)
guanethidine phentolamine (conj)
treatment headache (nmod)
s-1 and (cc)
accomplished cinching (advcl)
media in (case)
differences hemoglobin (nmod)
1 by (case)
spite in (case)
fits this (det)
suggests along (advmod)
calcification between (case)
increased albuminuria (nsubj)
compared score (nmod)
differ significantly (advmod)
carboplatin 's (case)
enhanced ec50 (nsubjpass)
given intraperitoneally (advmod)
toleration results (dep)
diagnosis ensure (acl:relcl)
value predictive (amod)
delirium associated (acl)
therapy hydrochlorothiazide-triamterene (compound)
patients neuropathy (nmod)
developed hepatitis (nsubj)
restored pressure (dobj)
fluid and (cc)
inhibited nik-247 (nsubj)
infection without (case)
fields central (amod)
radiograph tomography (conj)
centers by (case)
agonists 5-hydroxytryptaminergic (amod)
neutropenia and (cc)
dose cabergoline (compound)
ameliorates focus (dep)
available inhibitors (nsubj)
reduced measured (advcl)
$ROOT$ probing (sent)
similar women (nmod)
reproducing of (mark)
velocity a (det)
decreased clearance (nsubj)
= p<0.05 (dep)
sign asterixis (nsubj)
prolactin to (case)
later hours (nmod:npmod)
ilk via (case)
impairment stress (conj)
d plus (cc)
facilitated combination (nsubj)
needed patients (nmod)
had elevation (nmod)
multiforme gbm (appos)
origin of (case)
interval -0.22 (appos)
induced episodes (dobj)
damage tissue (compound)
1mg/kg approximately (advmod)
recurred psychosis (nsubj)
39 x (cc)
users 80 (nummod)
given once (advmod)
occurrence fibrillation (nmod)
appear that (nsubj)
frequency initiation (nmod)
sacrificed which (nsubjpass)
range treatment (nmod)
cause while (mark)
poor radiotherapy (nmod)
decreased po2 (nsubj)
reduce ? (punct)
syndrome neuroleptic (compound)
resulted accompanied (advcl)
28.21 1.83 (conj)
$ROOT$ tolerated (sent)
diagnostics roche (compound)
rigidity , (punct)
0.002 ) (punct)
expression beclin (nmod)
died treatment (nmod)
time onset (nmod)
physiologic pathologic (conj)
combinations cisplatin-based (amod)
phases paclitaxel/carboplatin (compound)
examinations the (det)
evaluation hearts (nmod)
diet , (punct)
suggests has (advcl)
concentrations noradrenaline (compound)
emotion basic (amod)
relevant patients (nmod)
hyalinosis wall (nmod)
< 01 (dobj)
tnss ) (punct)
efficacy time-course (conj)
improves chelation (nsubj)
tissues gspe+drug (compound)
micrograms/kg/hr micrograms/kg/hr (conj)
therapy angiotensin-converting (amod)
amount bleeding (nmod)
foot rat (nmod:poss)
paclitaxel hours (nmod)
observed furthermore (advmod)
fluconazole of (case)
higher magnitude (nsubj)
hl of (case)
increased bpm (nmod)
beta-carboline this (det)
benzoylecgonine cocaine (compound)
counter effectively (advmod)
risk absolute (amod)
produces increases (conj)
neonates born (acl)
handful only (advmod)
three more (advmod)
test word-recall (compound)
% 0.015 (nummod)
injections 0.1/mg/kg (nmod)
studied animals (nmod)
plants aconitum (compound)
edrophonium the (det)
bleed , (punct)
seizure-free are (cop)
content norepinephrine (compound)
pacing . (punct)
-10.7 ; (punct)
collected part (nmod)
obtained imaging (nsubjpass)
findings demonstrating (acl)
trial cross-over (amod)
before weeks (nmod:npmod)
saw association (dobj)
phenotypes both (det)
mpep mg/kg (dep)
agents two (nummod)
increased cortex (nmod)
suggested 10 (nmod)
immunoassay research (compound)
asked quantify (xcomp)
< years (nmod:tmod)
microg/kg/min of (case)
subtests four (nummod)
resulted patient (nmod)
glomeruli patients (nmod)
time needle (nmod)
inhibitor mice (nmod)
centers 2 (nummod)
potentiated . (punct)
proteins cytosol (compound)
pb metals (conj)
conducted examine (xcomp)
testing both (conj)
amount doxorubicin (nmod)
$ROOT$ aminoglycoside (sent)
prevalences and (cc)
analysis blot (compound)
iu/l were (cop)
identify benefits (dobj)
circuit of (case)
cases episodes (nmod)
oxide ) (punct)
suggests relationship (dobj)
abundance of (case)
calculations children (nmod)
deficiency relative (amod)
characteristics baseline (nmod)
been studies (attr)
outcomes cardiac (amod)
micromol/l 132.6 (nummod)
stimulation in (case)
focus status (nmod)
complaints neuropathic (amod)
period average (amod)
increased anaemia (nmod)
castrated noncastrated (conj)
results resonance (nmod)
src ) (punct)
signaling of (case)
detected q-pcr (nmod)
related caproate (nmod)
inhibition learning (compound)
pearson 's (case)
resulting dilation (nmod)
treated ; (punct)
exposure hepatotoxicity (conj)
induced 3'-azido-3'dideoxythymidine (nmod)
capacity lower (amod)
disposition to (case)
suggests site (ccomp)
injections chronic (amod)
analysis . (punct)
twin first (amod)
desipramine 6-ohda (conj)
determination hormone (compound)
platelet affinity (conj)
slowing subjective (amod)
cocaine sufficient (amod)
glycosuria similar (dep)
immersed and (cc)
dose minimal (amod)
days third (amod)
cholesterol less (amod)
users mefloquine (compound)
recovered recurrence (nmod)
globulin combined (acl)
metabolism tamoxifen (compound)
free had (conj)
causes to (case)
evaluated severity (nsubjpass)
octapeptide cck-8-ns (appos)
without or (cc)
spikes swelling (conj)
flexion to (case)
excitability and (cc)
study throughout (case)
possible hepatotoxicity (nsubj)
$ROOT$ 67 (sent)
known purpose (nsubjpass)
pg 1 (nummod)
lipopolysaccharide of (case)
most hepatomas (nmod)
veins small- (amod)
prevents impairment (dobj)
hematest urine (compound)
compliance rates (conj)
promote activation (nsubj)
combinations or (advmod)
gspe drug (conj)
therapy disorders (nmod)
identifying use (nmod)
persists progress (conj)
$ROOT$ members (sent)
simulator the (det)
proteins liver (compound)
task spontaneous (amod)
instillation every (det)
syndrome cardiomyopathy (appos)
1a type (compound)
drawback studies (nmod)
developed speech (dobj)
receive people (nsubj)
pci successful (amod)
show meth (nmod)
treated october (nmod)
had frequencies (dobj)
test cer (appos)
approaches these (det)
diagnosis disorder (nmod)
higher may (aux)
creatinine > (amod)
provide characterization (dobj)
indicative . (punct)
timolol pilocarpine (conj)
suppressed are (auxpass)
factor-alpha with (case)
effect rg1 (nmod)
min 20 (nummod)
reduced prazosin (nmod)
technique classical (amod)
comparison drugs (nmod)
examined weeks (nmod)
mp mg (amod)
administered it (nsubjpass)
slightly but (cc)
added where (advmod)
$ROOT$ conclusion(s (sent)
levels epo (compound)
cases with (case)
cerruloplasmin e (conj)
% 0.8 (nummod)
migraineurs aura (nmod)
hallmark a (det)
prevent group (nmod)
duration p<0.05 (appos)
model glaucoma (nmod)
suffering were (aux)
found failed (ccomp)
list standardized (amod)
earlier years (nmod:npmod)
observed side-effects (nsubjpass)
mg/d 1200 (nummod)
weeks - (punct)
depends characterization (nsubj)
resulted that (nsubj)
cyclophosphamide for (case)
treatment topical (amod)
subjects placebo (amod)
provided reassurance (dobj)
component the (det)
men 13 (nummod)
outline to (mark)
suspected treated (conj)
effect dilation (nmod)
14.2 +/- (cc)
diseases in (case)
stress without (case)
overload between (case)
ataxia , (punct)
became anaesthesia (nmod)
$ROOT$ subscore (sent)
served detect (xcomp)
referred ( (punct)
indicate induces (ccomp)
ramh with (case)
detect damage (dobj)
produced depression (dobj)
injections month (nmod)
using malate/glutamate (dobj)
induced day (nmod)
movements of (case)
frequency pvc (nmod)
tablets 130 (nummod)
partial were (cop)
groups classification (nmod)
mda tnfalpha (conj)
effect response (nmod)
factor neuropathy (nsubj)
md ( (punct)
45.45 to (case)
patients published (acl:relcl)
decreased inhibition (nmod)
use patient (nmod)
users methadone (compound)
induced be (nmod)
lethal and (cc)
was trial (nmod)
evening every (det)
value na+ (nmod)
permitted are (auxpass)
elicited , (punct)
destruction nerves (nmod)
appears ensure (ccomp)
occurred cataract (nsubj)
need initiatives (nmod)
mg/kg i.v (advmod)
naa of (case)
activity disease (compound)
observed association (nmod)
considered patients (nmod)
time distance (conj)
effects possible (amod)
alert should (aux)
maturity with (case)
given months (nmod)
genotypes in (case)
prolongation irrigation (nmod)
been documentation (attr)
patients swings (nmod)
21680 and (cc)
population real-world (amod)
cardioselective and (cc)
min-1 50 (nummod)
postulated mediate (xcomp)
abundant are (cop)
concentrations peak (dep)
developed features (dobj)
alteration aneurymal (amod)
uninephrectomy feeding (conj)
disappeared proceeded (conj)
d2 or (cc)
0.08 ) (punct)
inhibition penetration (conj)
piroxicam dfu-exposed (conj)
mg/m(2 versus (cc)
stimulation nerve (nmod)
recurrence literature (nmod)
independent age (nmod)
found pretreatment (nsubjpass)
showed assessed (advcl)
target raptor-containing (amod)
mice lithium-fed (amod)
% associated (advcl)
antagonist (8-cyclopentyltheophylline)--a1 (compound)
fornix the (det)
dopamine in (case)
microphthalmos , (punct)
$ROOT$ flumazenil (sent)
association buprenorphine (nmod)
induces behaviour (dobj)
bp ) (punct)
transporter is (cop)
myelination altered (amod)
narrowed nafcillin (nmod)
factors patients (nmod)
gpi ( (punct)
cisplatin d15 (appos)
injury cord (compound)
become regimens (nsubj)
cells undergoing (acl)
p9605 ) (punct)
increase conversely (advmod)
identified methods (nsubjpass)
decreased % (nmod)
decreased dimension (nsubjpass)
differences sexes (nmod)
mean a (det)
onset prolongation (nmod)
light in (case)
p450/ccl4 cytochrome (compound)
lvef + (cc)
di secondary (amod)
amnesia : (punct)
precursors erythropoietic (amod)
carcinogenesis rats (nmod)
$ROOT$ registered (sent)
patient failure (compound)
eight six (quantmod)
opioid is (cop)
deaths no (det)
evolved protocol (nsubj)
granisetron , (punct)
temporary , (punct)
inventory a (det)
administered hbig (nsubjpass)
believed associated (xcomp)
< minutes (dep)
findings suggestive (acl:relcl)
therapeutic supratherapeutic (conj)
reported amiodarone (nsubjpass)
movements abnormal (amod)
male patients (nmod)
sodium water (conj)
51.7 +/- (cc)
retarding and (cc)
ensues whether (mark)
cases studied (acl)
months 40 (nummod)
apnoea central (amod)
angiograms carotid (compound)
associated activity (nmod)
sinus cavernous (amod)
hypokalemia excess (conj)
developed vte (dobj)
cns to (case)
irrigation bowel (compound)
density vessels (nmod)
myelodysplasia marrow (conj)
l/min ) (punct)
aorta kidney (conj)
compromising . (punct)
protects model (nmod)
carboplatin with (case)
evaluate effect (dobj)
mbc chemotherapy (conj)
calcification artery (compound)
81.5 score (nsubj)
began therapy (dobj)
mean+/-se ) (punct)
derangement a (det)
lidocaine kg-1 (dep)
sensitivity on (case)
involved autophagy (nsubjpass)
syndrome reduction (nmod)
received estrogens (dobj)
disinhibition nuclei (nmod)
rechallenge positive (amod)
antiplatelets oral (amod)
induced pointes (dobj)
dilate cromakalim (nsubj)
684 and (cc)
echocardiography stress (compound)
had malignancy (nmod)
hypotension manifestation (nmod)
pons of (case)
fall of (case)
autism in (case)
virus c (compound)
pancytopenia of (case)
continued effective (xcomp)
length twice (predet)
pain block (nmod)
behavior groups (nmod)
serve it (nsubj)
plays that (mark)
relationship sulindac (nmod)
timing severity (conj)
bones in (case)
consistent results (nsubj)
msdbp hg (dep)
injection acetylcholine (nmod)
due possibly (advmod)
group oncology (compound)
scale hoehn (compound)
$ROOT$ permits (sent)
concentration of (case)
hematology chemistry (conj)
protocol dexmedetomidine (compound)
pentoxifylline derivative (appos)
period storage (compound)
introduction by (case)
frequency a (det)
shown , (punct)
association striking (amod)
% cholesterol (dep)
ht ) (punct)
cardiotoxic leukemogenic (conj)
1.23 ) (punct)
samples urine (compound)
necessary investigate (xcomp)
simple and (cc)
review original (amod)
anuria sudden (amod)
consumption children (nmod)
conduct to (mark)
november between (case)
includes includes (conj)
diagnosis hiccups (nmod)
160 320 (conj)
6.1 0 (quantmod)
greatest . (punct)
cure with (case)
200 equal (advmod)
relationship use (nmod)
hemorrhage recurrent (amod)
unchanged functions (nsubj)
electroencephalography processed (amod)
focus imaging (nmod)
born were (auxpass)
cells nuclear (amod)
accompanied blockade (nmod)
debated is (auxpass)
decrease increase (conj)
resection therapy (conj)
prolactinomas rat (compound)
apparatus juxtaglomerular (amod)
mitoxantrone such (case)
bupivacaine anaesthetic (amod)
animals nephropathy (compound)
received beginning (advcl)
induces subset (nmod)
seizures partial (amod)
$ROOT$ eligible (sent)
1981 from (case)
predicted , (punct)
worn was (auxpass)
agents the (det)
outflow directed (acl)
rise rats (nmod)
symptoms fewer (amod)
enhanced action (nsubjpass)
mg/kg sc (appos)
failure digitalise (dep)
pharmacokinetic and (cc)
changes gliosis (nmod)
disappearing days (nmod)
reversal effect (dep)
tablet aspartate (compound)
penetrating of (mark)
one media (nmod)
found lasted (conj)
examined evidence (nmod)
slightly significantly (conj)
users aspirin (compound)
hypotension adjustable (amod)
given periods (nmod)
persisted hrs (nmod)
subjects group (nmod)
type constant (amod)
sr verapamil (compound)
removed patient (nmod)
d-med with (case)
confounds used (advcl)
release the (det)
haemorrhage internal (amod)
remained effective (xcomp)
complained , (punct)
predisposed which (nsubj)
responsible might (aux)
phosphorylation via (case)
differ : (punct)
based intention-to-treat (nmod)
prevents relation (dep)
therapy routine (amod)
threshold a (det)
sign bilateral (amod)
patients ventilation (nmod)
cases to (case)
drug capable (amod)
report group (appos)
induction administration (nmod)
immersed stimulus (nmod)
increase inhibit (conj)
current ) (punct)
disorders , (punct)
conclusion observed (acl)
rectified sulphate (nmod)
superior preventing (advcl)
reported identical (ccomp)
developed paralysis (dobj)
intensify , (punct)
skeptical may (aux)
rates case (compound)
required not (neg)
causing dyscrasias (dobj)
formation memory (compound)
december 31 (nummod)
facilitated was (auxpass)
predictive may (aux)
binding protein (compound)
effects 17alpha-ethinylestradiol (nmod)
manual edition (appos)
observations microscopic (amod)
disappeared . (punct)
micrograms/kg to (case)
test demonstrated (parataxis)
electrophysiology , (punct)
injection 10-second (amod)
neurons ganglion (compound)
defined priori (advmod)
that agents (nmod)
age time (conj)
scenario an (det)
subjects age-matched (amod)
evaluated rate (nsubjpass)
increases gradual (amod)
used tests (nmod)
monitored noninvasively (advmod)
sops antibiotics (nmod)
deposited be (auxpass)
discontinuation d-penicillamine (nmod)
contribution syndrome (nmod)
more appreciated (advcl)
55 50 (compound)
shown infusion (nsubj)
runs brief (amod)
concentration value (conj)
frequencies high (amod)
bort days (nmod)
monoxide of (case)
antagonist cck1 (compound)
curves of (case)
duration 24.3+/-6.8s (appos)
rats hooded (amod)
dose intermittent (amod)
constitutes report (dobj)
recordings electrical (amod)
ganglia of (case)
hospital central-city (compound)
hypercapnia sublethal (amod)
attacks hypoglycaemia (compound)
flow hypotension (nmod)
using stainings (dobj)
beta-carboline-3-carboxylate beta-ccm (appos)
history drug (compound)
severe r6 (nmod)
arthrogryposis blockade (nmod)
sub-divided group (nsubjpass)
mg change (nsubj)
significant % (dep)
related fasciculations (nsubjpass)
% relief (nsubj)
prooxidant however (advmod)
effects relationship (conj)
consumption excessive (amod)
level group (nmod)
result disease (nmod)
induced proteinuria (nsubjpass)
activity root-mean-square (amod)
sr ) (punct)
demonstrated decrease (dobj)
interview neuropsychiatric (amod)
targets output (compound)
wild-type ilk (conj)
examined peroxisomes (nsubjpass)
comorbidity the (det)
cancer tract (compound)
seizures overt (amod)
performed taken (conj)
instillation accidental (amod)
thiopentone % (appos)
stimulation case (nmod)
temperature humidity (conj)
administrated was (auxpass)
order increase (acl)
common use (nmod)
reduced withdrawal (nsubj)
exposure diazinon (compound)
agent prevents (acl:relcl)
stenosis no (det)
i t (conj)
days 13 (conj)
epileptogenic not (neg)
achieve times (dobj)
activity reductase (compound)
cardiomyocytes in (case)
mask of (case)
discussion cessation (compound)
reflection syndrome (nmod)
activities not (cc)
stimulated that (mark)
deformities , (punct)
present past (nmod)
carcinoma disease (nmod)
amounts large (amod)
processes executive (amod)
[ + (cc)
ear into (case)
largest to (mark)
taken drug (nsubjpass)
hoarseness , (punct)
patients responses (nmod)
developed cardiotoxicity (dobj)
showed imaging (nsubj)
lymphocytes patient (nmod:poss)
374 hypertension (dep)
compensate for (dobj)
rna hepatic (amod)
parameters tolerability (compound)
infusion days (conj)
assays sequential (amod)
establishment the (det)
csa fk506 (conj)
different p (dep)
ethopropazine and (cc)
cisplatin with (case)
injected range (nmod)
effect binding (nmod)
exposure tobacco (nmod)
volume forced (amod)
adjusted area (nmod)
adenocarcinoma inoperable (amod)
consolidation users (nmod)
cacl(2)-treated non-cacl(2)-treated (conj)
qtls susceptibility (nmod)
followed appearance (nmod)
dopaminergic and (cc)
mv 71 (nummod)
vacuolization epithelial (amod)
rigidity pronounced (amod)
diagnosis allergy (nmod)
stimulus painful (amod)
rna dna (conj)
controls groups (conj)
determined . (punct)
enhances whereas (mark)
concentrations alpha-tocopherol (nmod)
receptor a2a (compound)
received administration (nmod)
significant association (nsubj)
licking s (nsubj)
states complex (amod)
level tests (conj)
four of (quantmod)
resembling hepatitis (dobj)
40 100 (conj)
antibody selective (amod)
asian 23 (nummod)
100mg/kg metformin (nmod)
sprouting mfs (appos)
lower dysfunction (nsubj)
76 +/- (cc)
present is (cop)
women of (case)
stress summed (amod)
connective and (cc)
contained samples (nsubj)
increased further (advmod)
requirement support (nmod)
ratio urine (compound)
foci/cm2 20 (nummod)
responding treatment (nmod)
elevated observed (advcl)
markers of (case)
$ROOT$ production (sent)
shunt this (det)
performed estimate (advcl)
period ci (appos)
state in (case)
any with (case)
restored menstruation (dobj)
hospitals ( (punct)
chloride-induced sodium (nmod:npmod)
post-therapy at (case)
3.0+/-0.4 concentration (nsubj)
interaction substratum (nmod)
receiving outpatient (nmod)
terfenadine cisapride (conj)
replaced was (auxpass)
oxcarbazepine to (case)
schizophrenia disorder (conj)
fibrillation chemotherapy (nmod)
gradient plasma-to-blood (compound)
diazepam 2pam (conj)
evaluated combination (nmod)
improvement status (nmod)
usually is (cop)
spanning distribution (dobj)
reduce drastically (advmod)
prevented used (advcl)
results similar (amod)
raises requirement (dobj)
demonstrated scans (nsubj)
related anesthesia (nmod)
presentation neuropathy (nsubj)
spasms and (cc)
predictors factors (nsubj)
emulsions in (case)
rise average (amod)
had ari (dobj)
therapy as (case)
cgi-sf ( (punct)
side lateral (amod)
hours before (case)
disorder uses (conj)
estimate degree (dobj)
suppressed application (nsubj)
neuropathy motor (amod)
mg/d 240 (nummod)
trigger as (case)
representing case (dobj)
capsule the (det)
recognise should (aux)
remission in (case)
min at (case)
intra-operative post-operative (conj)
investigated induces (ccomp)
associated upregulation (nmod)
surgery noncardiac (amod)
hydrolysis ed (nmod)
rate 127/min (dep)
$ROOT$ areas (sent)
$ROOT$ antineoplastic (sent)
barrier barrier (conj)
catalepsy , (punct)
occurred finally (advmod)
15-f(2t)-isop , (punct)
stage take (conj)
antigens tgf-beta1 (compound)
catheterization right (amod)
identified ecg (nsubj)
present features (nsubj)
found subjects (nmod)
inability tiredness (conj)
phenomena of (case)
creatinine and (cc)
tumors papillomas (appos)
toxic that (mark)
dose ranging (acl)
thickening capillary (compound)
followed acid (nmod)
had alpha (nsubj)
quinpirole with (case)
abolished days (nmod)
signed underwent (conj)
toxic only (advmod)
2.3+/-1.2 and (cc)
pain cancer (compound)
included address (advcl)
improvement 0.05 (nmod)
exteriorized untied (xcomp)
alkylxanthines with (case)
induced metabolites (nsubj)
deleterious may (aux)
unchanged velocity (nsubj)
observed farmers (nmod)
precise and (cc)
indication effects (nmod)
patients tuberculosis (nmod)
standard current (amod)
domain time (compound)
sign to (mark)
effect treatments (nmod)
ophthalmologic audiologic (conj)
paced was (auxpass)
injected micrograms (nsubjpass)
indicates need (dobj)
gland adrenal (amod)
acting longer (advmod)
division in (case)
doses 12 (nummod)
highlight findings (nsubj)
precore promoter (conj)
sensations 4 (appos)
reducing cardiotoxicity (dobj)
chronic significant (conj)
ldl-cholesterol % (nmod)
altered rats (nmod)
thickness retinal (amod)
cortical hepatic (conj)
mm 25.4 (nummod)
doses maximum (amod)
explain data (dobj)
, i.e. (intj)
tests laboratory (compound)
interventions surgical (amod)
analgesia- and (cc)
maintenance speed (compound)
accentuante to (mark)
unable she (nsubj)
presence despite (case)
patients carcinoma (nmod)
benzoylecgonine by (case)
showed monohydroxyethylrutoside (nsubj)
episodes tdp (nmod)
monotherapies as (case)
treatment ato (nmod)
mrna , (punct)
levels creatinine (nmod)
sensor b (nsubj)
hypertension sph (appos)
lamivudine-resistance with (case)
use inhibitors (nmod)
evaluated activity (nmod)
carbonate calcium (compound)
mg/dl 1.5 (nummod)
able moreover (advmod)
discovered eye (nmod)
dyskinesia the (det)
diameter base (nmod)
aggravation back-diffusion (nmod)
physicians patients (conj)
damage concentrations (nmod)
expressions gamma-sarcoglycan (compound)
value sd (conj)
pressure sbp (appos)
concentration patients (nmod)
conditions depletions (nmod)
extract the (det)
hypertension gc-ht (appos)
study pain (compound)
2 24 (conj)
treated mice (nsubjpass)
seemed normal (xcomp)
measured activities (nsubjpass)
trials in (case)
snhl ( (punct)
13,000 group (nmod)
affected 1 (nmod)
increase may (aux)
collected assays (nmod)
antagonized spite (nmod)
treated lithium (nmod)
potential compounds (nmod)
infants very-low-birthweight (amod)
importance . (punct)
ability suppress (acl)
studies using (acl)
consistent course (nsubj)
propranolol hexamethonium (conj)
lysis with (case)
fluvastatin the (det)
study histopathological (amod)
level stress-induced (amod)
testing this (nmod)
administration humans (nmod)
useful reduction (nsubj)
state acute (amod)
nf ) (punct)
granulated cells (nsubj)
acid l-4-amino-hex-5-enoic (amod)
decoction seed (compound)
administered attempt (nmod)
fev1 ( (punct)
hospitalization during (case)
developed early (advmod)
neuropeptides caused (acl)
p=0.006 , (punct)
strain radial (amod)
dehydrogenase malondialdehyde (conj)
grow and (cc)
small and (cc)
induced enanthate (nmod)
had disease (dobj)
permits ifosfamide (dobj)
dysrhythmias occurred (acl:relcl)
strategy cost-effective (amod)
derivative methylxanthine (compound)
ci 3.51 (nummod)
subjects undergoing (acl)
neurosci 917 (appos)
l1-l2 and (cc)
drug preparation (conj)
diltiazem ( (punct)
outcomes catastrophic (amod)
injection iv (nummod)
syncope for (case)
efficacy therapy (nmod)
effective pallidotomy (nmod)
increases order (nmod)
receptor mrna (appos)
discontinuing alendronate (dobj)
hematomyelia . (punct)
enzymes by (case)
attention and (cc)
study hemodynamic (amod)
atropine mg (appos)
developed neuropathy (dobj)
activity as (cc)
relative rats (nmod)
reflect activation (dobj)
ranged intervals (nsubj)
mg/kg given (acl)
skin challenges (conj)
signals with (case)
hcl bupropion (compound)
examination mice (nmod)
diltiazem control (nmod)
groups research (compound)
acid an (nmod)
adrenoceptor nm (dep)
remained a-actinin (nsubj)
invasive highly (advmod)
had that (mark)
ps , (punct)
prolongs manner (nmod)
rash associated (acl)
lid fluctuations (conj)
% bleeding (nsubj)
determine leads (ccomp)
seen response (nsubjpass)
parallel effect (nmod)
4-diphenylacetoxy-n-methylpiperidine 4-damp (appos)
rigidity jaws (conj)
rats 27 (nummod)
surface mean (amod)
infusion and (cc)
compared users (nsubjpass)
sustained much (nsubj)
concentration man (nmod)
plasma microglobulinuria (conj)
anesthetized sevoflurane (nmod)
treatment pneumonia (nmod)
count falling (amod)
explained . (punct)
difficult knowledge (nmod)
concentrations electrolyte (compound)
anesthesia intravenous (amod)
property improving (compound)
guidelines to (case)
blocker kinetics (nmod)
hematoma postoperative (amod)
causes patient (nmod)
t mg/kg (appos)
produced , (punct)
associated vigabatrin (nmod)
given days (nmod:tmod)
possible escalation (nsubj)
improved rate (dobj)
findings normal (amod)
received sirolimus (dobj)
isoniazid s.c. (appos)
portland 97201 (conj)
regions of (case)
procedures ( (punct)
visit 1 (nummod)
cells mesangial (amod)
75.9 +/- (cc)
time reductions (conj)
effect ppa (nmod)
cases self-poisoning (nmod)
present quantities (nmod)
1- 3-day (conj)
localization specific (amod)
exhibit cells (nsubj)
numbness feet (nmod)
metabolized glucose (nmod)
events stressful (amod)
reached peak (dobj)
$ROOT$ apnoea (sent)
level sphincter (nmod)
meat fish (conj)
result hypertrophy (nmod)
indicated increased (ccomp)
$ROOT$ 4.7 (sent)
division nerve (nmod)
agents anabolizing (amod)
reflect severity (dobj)
phenotypes and (cc)
treat episodes (dobj)
prescribing women (nmod)
pattern labelling (compound)
have characteristics (dobj)
improve combinations (nsubj)
proteins : (punct)
continue : (punct)
groups bolus (compound)
toxicity inhibitors (nmod)
at2r ( (punct)
compared incidence (nsubjpass)
effects training (nmod)
receptors n-methyl-d-aspartate (compound)
stimulatory convulsive (amod)
em ) (punct)
aquaporin-2 aqp2 (appos)
% p=0.11 (dep)
0.07 0 (nummod)
studies published (amod)
troponin ctni (appos)
mg niacin (compound)
black % (nmod:npmod)
unchanged controls (nmod)
carbimazole methimazole (conj)
incapacitated stimulations (nmod)
undergoes that (mark)
characteristics activity (appos)
induced resulting (advcl)
seizures the (det)
attempt antagonize (acl)
report was (cop)
dipyridamole after (case)
aggregation induced (acl)
counts ) (punct)
beneficial and (cc)
analysis descriptive (amod)
birth normal (amod)
with even (advmod)
tolerated doses (nmod)
are , (punct)
leukoencephalopathy or (cc)
ml. 16 (nummod)
decline fraction (nmod)
uk the (det)
use tests (nmod)
considered thus (advmod)
2 6 (conj)
antagonize and (cc)
suggested quantify (xcomp)
14 to (quantmod)
prevalence ratio (dep)
activities enzyme (compound)
role hypertension (nmod)
episodes further (amod)
hz 10 (nummod)
improvement retention (conj)
epileptogenesis on (case)
leukemia , (punct)
modulated that (mark)
opioid of (case)
cardiotoxicity mice (nmod)
age duration (conj)
seizures developing (amod)
polymorphic were (cop)
months 34.4 (nummod)
recovered underwent (conj)
dexrazoxane and (cc)
produce changes (dobj)
limited was (cop)
$ROOT$ delayed (sent)
depolarization of (case)
baseline than (case)
tests series (nmod)
administered i.v. (advmod)
frs generated (acl)
patients halothane (compound)
users cocaine (compound)
caffeine placebo (conj)
inhibited furthermore (advmod)
reaching occasionally (advmod)
called consolidation (xcomp)
ten 5 (conj)
effect rate (nmod)
arm with (case)
5 45 (conj)
seems reaction (nsubj)
rejection rejection (conj)
cell proliferating (amod)
lesions precancerous (amod)
cutaneous , (punct)
given diazepam (dobj)
solvent i.v (appos)
varied function (nmod)
besylate atracurium (compound)
1 ; (punct)
documented has (aux)
include uncommon (advcl)
nerve cranial (amod)
had pain (dobj)
0.025 ) (punct)
cue a (det)
transaminases of (case)
mother both (cc:preconj)
obtained weeks (nmod)
died later (advmod)
accumulated far (advmod)
nephrotoxicity not (cc)
cocaethylene ce (appos)
system nitrergic (amod)
those than (case)
that ropivacaine (nmod)
velocity with (case)
developed median (dobj)
arteries intracranial (amod)
incidence toxicities (nmod)
reaction no (neg)
correcting and (cc)
manifestation observed (acl)
outcome to (case)
calcification of (case)
prevented l-dopa (nmod)
january january (conj)
membrane on (case)
provided model (dobj)
system models (nmod)
used bisphosphonates (nsubjpass)
appeared first (advmod)
correlated appearance (nmod)
surgery block (nmod)
adults hypertension (nmod)
n/n=25/26 ) (punct)
toxicity further (amod)
/= hg (dobj)
stat3 and (cc)
concluded observations (advcl)
signs extrapyramidal (amod)
aggravate reduces (conj)
chop transcriptional (amod)
background objectives (conj)
had migraines (dobj)
misjudgment execution (nmod)
associated described (ccomp)
order an (det)
changed cortex (nmod)
erection . (punct)
olanzapine vs (cc)
microscopic morphometric (conj)
comparable ; (punct)
accuracy latencies (conj)
present diagnosed (advcl)
a rapamycin (conj)
indicate limited (ccomp)
element key (amod)
those control (nmod)
program that (mark)
biopsies all (det)
induced is (auxpass)
followed repair (nmod)
molecules of (case)
improves digoxin (nsubj)
loci qtls (appos)
reduces mortality (dobj)
increased creatinine (nsubj)
59 - (punct)
ms laser (compound)
28 16 (compound)
improves reduces (conj)
sarcoma carsinom (appos)
cortex dorsal (amod)
prolongation ) (punct)
paracetamol and (cc)
characterization models (nmod)
antagonists concomitant (amod)
quantitated permeability (nsubjpass)
days 61 (nummod)
extended sensitivities (nsubjpass)
required showing (xcomp)
effects umb24 (nmod)
animals 10 (nummod)
susceptibility genetic (amod)
kg 19.7 (nummod)
hypercalcemia lead (acl:relcl)
rofecoxib 1.27 (appos)
degeneration , (punct)
drugs neurotoxic (amod)
dialysis with (case)
acquire location (dobj)
indications conversion (nmod)
damage might (aux)
upregulated expression (nsubjpass)
expression combined (acl)
dose adriamycin (nmod)
resembles glaucoma (dobj)
symptoms worsened (amod)
mediates that (mark)
effective patient (nmod)
csa and (cc)
predominated patients (nmod)
kinase amp-activated (amod)
treatment hypercholesterolemia (nmod)
effectiveness = (dep)
case developed (advcl)
mecamylamine central (amod)
celecoxib 1.34 (nummod)
obtained values (nsubjpass)
event corresponding (amod)
cirrhosis carbon (compound)
mmol/l was (cop)
prolonged and (cc)
rate event (compound)
carcinogen the (det)
bmd to (case)
chain light (amod)
effect delayed (amod)
antagonist but (cc)
parameters any (det)
effect duration (nmod)
received adr (dobj)
tolerated symptoms (nmod)
clarified completely (advmod)
induced time (nmod)
3 1 (nummod)
displayed subjects (nmod)
antagonists with (case)
investigate complications (dobj)
explore role (dobj)
decreased ebf (nsubj)
dyskinesia reserpine- (amod)
ethanol/aap-mice to (case)
improved levodopa (nmod)
yields control (compound)
suppresses vestibulotoxicity (dobj)
atenolol such (case)
aspects clinical (amod)
validated . (punct)
trespass to (mark)
developed had (parataxis)
dose mg/m2/d (nmod)
target primary (amod)
% 6.4 (nummod)
agent alkylating (amod)
classed pph (nmod)
depression cortical (amod)
achieve blood (nmod)
resistant compared (advcl)
display affinity (dobj)
cy with (case)
prevent also (advmod)
analyze aspects (dobj)
number joints (nmod)
counteraction the (det)
likelihood hypotension (nmod)
frequency dependence (conj)
cats dogs (conj)
manufactures camera (dobj)
radiopharmacy hospital (compound)
thrombus or (cc)
stabilize states (dobj)
chenodeoxycholate of (case)
comparable be (cop)
impairment cognitive (amod)
test microspherocytes (conj)
weeks 0 (nummod)
increased sustained (conj)
atrophy nephropathy (nmod)
administered argatroban (dobj)
york new (compound)
culture exudate (nmod)
differences adenoma (nmod)
beings human (amod)
appear suitable (xcomp)
durations median (amod)
ulcers gastric (amod)
400 , (punct)
diminish . (punct)
micrograms t.i.d. (advmod)
increased length (nmod)
tissue hepatic (amod)
administration dosage (nmod)
carried continuously (advmod)
contributes effects (nmod)
pharmacy in (case)
microg/ml p (dep)
shown reverse (xcomp)
regardless use (nmod)
contributor possible (amod)
women estrogens (nmod)
ifosfamide if (appos)
killed dxnp (nsubj)
preparation synaptosomal (amod)
proportion mean (amod)
administered methods (dep)
deterioration gfr (nmod)
scale ( (punct)
score cirrhosis (conj)
hg hg (appos)
circulation hypophysial-portal (amod)
complications angiography (nmod)
potential drug (compound)
control corresponding (amod)
consumption the (det)
elevations neutropenia (conj)
creatinine postprocedural (amod)
cause telithromycin (nsubj)
mg/kg/day 3.0 (nummod)
abuse alcohol (compound)
included weight (dobj)
attenuates insipidus (dobj)
cause rise (dobj)
hus idiopathic (amod)
chloride ttc (appos)
developed infiltration (nmod)
slides biopsies (nmod)
known commonly (advmod)
elicited capsaicin (nmod)
patients 350 (nummod)
increased expression (dobj)
approach hyperprolactinemia (nmod)
induced used (conj)
needs complication (nmod)
profound , (punct)
development sclerosis (nmod)
antagonism . (punct)
induced measured (advcl)
injections bilateral (amod)
myocarditis necrotizing (amod)
mitochondria of (case)
comparisons of (case)
patient ) (punct)
p 0.05 (nummod)
cna ina (conj)
considerations therapy (nmod)
noticed results (nmod)
review operations (nmod)
development on (case)
myocet doxorubicin (dep)
vp-16 ( (punct)
measured loops (nmod)
tubes through (case)
5 about (advmod)
complained who (nsubj)
discontinuation therapy (compound)
end at (case)
decrease susceptibility (dobj)
received i.v. (advmod)
hypokalemia less (amod)
medications and (cc)
mechanisms glutamate-mediated (amod)
pharmacodynamics . (punct)
complication for (case)
support with (case)
obtained determination (nmod)
channels voltage-dependent (amod)
route central (amod)
time to (appos)
complications such (amod)
substrates anatomical (amod)
deposits granular (amod)
decreased 30 (nmod)
revealed surgery (nsubj)
administration magnesium (compound)
mucositis iv (nummod)
mg/m2 repeated (acl)
apomorphine and (cc)
-0.12+/-0.5 vs. (cc)
aorta of (case)
l-arginine mg/kg (dep)
dynamics fluid (compound)
serum- glucocorticoid-inducible (conj)
function users (nmod)
k period (nmod)
operations of (case)
carcinoma 1 (appos)
had grade (dobj)
group each (det)
ng 5-fu (conj)
characterized detachment (nmod)
reverse effects (dobj)
temporal temporal (conj)
erections morning (compound)
correct extent (nmod)
seen age (nsubjpass)
incidence pseudolithiasis (nmod)
six patients (nmod)
rats peptide(1 (compound)
35 % (appos)
retinochoroidopathy of (case)
red of (case)
rad001 of (case)
altering rate (dobj)
health poor (amod)
patients disturbance (nmod)
myalgia severe (amod)
13 these (det)
nafld ) (punct)
coincident events (nsubj)
prevent thrombosis (dobj)
$ROOT$ ratios (sent)
preponderance no (det)
useful indicator (nmod)
course failure (nmod)
overdose to (mark)
characterized . (punct)
treatment l-dopa (nmod)
discontinued , (punct)
analysis clinical (amod)
long was (cop)
dcf or (cc)
exposure long-term (amod)
lowered hr (nsubjpass)
$ROOT$ substantiates (sent)
excretion renal (amod)
episode single (amod)
expectation in (case)
required function (nmod)
neurotensin pallidal (amod)
cirazoline the (det)
hormone thyroid-stimulating (amod)
effect switching (advcl)
completion the (det)
131i-hsa ( (punct)
surviving days (dobj)
undergoing anesthesia (dobj)
increase volume (compound)
knowledge by (case)
azotemia , (punct)
study case (dobj)
levels dna (compound)
ocd to (case)
man 52-year-old (amod)
arose cases (nsubj)
chow rat (compound)
16 14 (compound)
vomiting diarrhea (conj)
events neurological (amod)
recorded % (nmod)
damage rats (nmod)
proved patient (nmod)
astrocytomas recurrent (amod)
cytostatics oxazaphosphorine (compound)
and alone (advmod)
associated seizure (nsubj)
degeneration myocardial (amod)
presented stopped (advcl)
injected rats (nmod)
fda the (det)
interacts oxidase (nmod)
studied withdrawn (conj)
agent analgesic (amod)
precise magnitude (dep)
pirenzepine dicyclomine (conj)
characterize sensitivities (dobj)
trigger possible (amod)
acquisition discrimination (nmod)
weeks mainly (advmod)
carriers apoe (compound)
suggest results (nmod)
rate map (conj)
u/l of (case)
neutropenia quetiapine-induced (amod)
cultured ulcers (nsubjpass)
period breathiness (nmod)
models cox (compound)
antagonized behavior (dobj)
occurring association (nmod)
less 0.001 (nmod)
1975 since (case)
level no (compound)
increased more (advmod)
hospital siriraj (compound)
lead function (nmod)
focused . (punct)
responses for (case)
event coronary (amod)
$ROOT$ ethambutol (sent)
amylase , (punct)
$ROOT$ distributed (sent)
pressure higher (amod)
combined when (advmod)
conclusions and (cc)
changes study (conj)
limited were (auxpass)
onset of (case)
and constitutively (advmod)
numbers increased (amod)
dietary therapeutic (conj)
recognize manage (conj)
lithium haloperidol (conj)
warrants that (nsubj)
draw fact (nmod)
captopril either (cc:preconj)
placed mg (nmod)
cases malaria (compound)
microgram from (case)
fetus in (case)
twitch tetanic (conj)
segments basal (amod)
diisopropylfluorophosphate dfp (appos)
total of (case)
bbb cortex (nmod)
administration regarding (case)
synapses hippocampal (amod)
range level (nsubj)
present illness (dobj)
ratios measuring (acl)
vtd ( (punct)
used patients (conj)
agents nondepolarizing (amod)
levels hypothalamic (amod)
diethylnitrosamine with (case)
increased liver (nmod)
16 t3n1m0 (appos)
cardiotoxity cocaethylene (compound)
prescribed , (punct)
bioavailability power (conj)
periods during (case)
dyskinesias dystonic (amod)
before hours (nmod:npmod)
impaired substitution (nsubj)
hrs for (case)
rosacea telangiectatic (amod)
less months (nmod)
acid 6,7-dimethoxy-4-ethyl-b-carboline-3-carboxylate (conj)
a/j cba/j (appos)
suggest cause (ccomp)
sample randomized (amod)
penetration daptomycin (nmod)
nucleus pons (conj)
melatonin exogenous (amod)
conclusions compares (appos)
report hypothesize (conj)
saccades multidirectional (amod)
tremor convulsions (conj)
tool as (case)
proved which (nsubj)
week for (case)
edetate disodium (compound)
kpa 11.5 (nummod)
cells proximal (amod)
affect pressure (dobj)
relationship significant (amod)
development or (cc)
cnsb002 and (cc)
dopamine methamphetamine-induced (amod)
injection compared (case)
test sampled (amod)
comparable rates (dep)
produced impaired (advcl)
result hormone (nmod)
moderate " (punct)
assessment longitudinal (amod)
attenuated peak (nmod)
mg/m(2 courses (nmod)
hematoma of (case)
returned sensation (nsubj)
find abnormalities (dobj)
tablets , (punct)
contracting by (mark)
injury permanent (amod)
rpgn of (case)
lesions fibrosis (conj)
n=2.4+/-0.7 ( (punct)
presented lethargy (nmod)
dysfunction ventricular (amod)
fibrillation on (case)
applied widely (advmod)
accompanied damage (nmod)
participants of (case)
quantify receiving (advcl)
status a (det)
presented undergoing (advcl)
hepatonecrosis and (cc)
7.6 1.3 (nummod)
seen sometimes (advmod)
induce control (conj)
developed thirty-six (nsubj)
insufficiency thrombocytopenia (conj)
atorva dex (conj)
drug stimulant (conj)
collected baseline (nmod)
increased formation (dobj)
dyscrasias blood (compound)
followed cholestasis (nmod)
satisfactory addition (nmod)
assessments histological (amod)
dopac its (nmod:poss)
contributed ; (punct)
change impairment (conj)
induced ischemia (nsubjpass)
alterations associated (acl)
fluency impaired (amod)
recruited sample (nsubjpass)
percent ninety-nine (nummod)
insulin-group but (cc)
criteria following (amod)
ufov -- (punct)
doses convulsant (amod)
associated though (mark)
6/8 ) (punct)
disease late-stage (amod)
600 900 (conj)
procainamide to (case)
elucidating thereby (advmod)
inhibitor serotonin (compound)
related fenfluramines (nsubj)
vii . (punct)
survival a (det)
vehicle their (nmod:poss)
frequency high (amod)
setting mi (nmod)
insufficiency new (amod)
disintegrin inhibitors (conj)
effects several (amod)
diarrhoea-predominant , (punct)
suggested reports (nsubj)
dissection coronary (amod)
tests detailed (amod)
prescribed because (mark)
test activity (compound)
overactivation cortical (amod)
improvement any (det)
abandoned considered (advcl)
connections cell (compound)
rat and (cc)
improved varied (advcl)
conditions novel (amod)
hypotension actions (nmod)
bladder oab (appos)
observed change (nsubjpass)
findings woman (nmod)
symptoms obsessive-compulsive (amod)
lithium to (case)
investigated function (nsubjpass)
order mmg (nmod)
apnoea prolonged (amod)
continue however (advmod)
infusions of (case)
ocs all (det)
developed hemoglobinuria (dobj)
recovery blood (compound)
monitored periodically (advmod)
metabolites phenol (compound)
receptor the (det)
spared lesions (nmod)
considered is (auxpass)
promotes af (dobj)
suppression prolonged (amod)
signs early (amod)
anemia administration (nmod)
subgroups at-risk (amod)
12%-21 approximately (advmod)
points key (amod)
antagonized can (aux)
recognised yet (advmod)
attributable combination (nmod)
development strategies (nmod)
dose-dependent value (nsubj)
apo apolipoproteins (compound)
ruled reasons (nsubjpass)
drop % (dep)
performed lacking (conj)
register embase (appos)
occurrence infarction (nmod)
ended period (nsubj)
use prior (amod)
acidosis lactic (amod)
missed . (punct)
antagonist receptors (nmod)
neurotoxicity hepatotoxicity (conj)
changes deprivation (nsubj)
necessary , (punct)
attention special (amod)
resumed we (nsubj)
using flowmetry (dobj)
amounts mice (nmod)
kg ) (punct)
microg/kg/min 25 (nummod)
53 to (quantmod)
associated symptoms (nsubjpass)
acetate medroxyprogesterone (compound)
initiated . (punct)
controls 15 (nummod)
taking of (mark)
trial/day 4 (nummod)
reported three (nsubjpass)
restoration activity (nmod)
reproducible hyperalgesia (nmod)
overdose propafenone (compound)
increasing number (dobj)
pilocarpine given (acl)
variable groups (nmod)
responses vasopressor (compound)
cases myoglobinuria (nmod)
motor mental (conj)
lna lca (conj)
groups s-i (compound)
mg or (cc)
restricted , (punct)
time treatment (nmod)
acid this (det)
groups subjected (acl)
study larger (amod)
prolong action (nmod)
actions drugs (nmod)
cardiomyopathy idiopathic (amod)
< 0.32 (dep)
indicative may (aux)
derivative abecarnil (dep)
significantly less (dep)
investigated authors (nsubj)
increased 0.38 (dep)
confirmed were (auxpass)
antibody with (case)
$ROOT$ correlated (sent)
serve model (nmod)
progressive severe (amod)
considered along (prep)
concern bleeding (nsubj)
amoxicillin-clavulanate accounting (acl)
raise considerations (dobj)
characterized hyperalgesia (nsubjpass)
size expression (conj)
pg/ml 230 (nummod)
concentrations plasma (compound)
hepatic and (cc)
12.1 1.2 (nummod)
occurrence toxicity (nmod)
implants administration (conj)
tested , (punct)
resolution defects (nmod)
centers separate (amod)
$ROOT$ prevalence (sent)
sum the (det)
p<0.05 ) (punct)
hypertension glaucoma (conj)
nuclei anterior (amod)
returned min (nmod)
given rats (nmod)
documentation liver (compound)
electrocardiogram ekg (appos)
involve to (mark)
observed = (ccomp)
rise the (det)
acetyltransferase but (cc)
months duration (nmod)
records dogs (nmod)
hepatitis neoplasms (conj)
play agents (nsubj)
24.3+/-6.8s ( (punct)
pge2 ( (punct)
assessed could (aux)
effect analgesic (amod)
inconsistent , (punct)
d4.2 dopamine (compound)
lapsed lasting (advcl)
medline in (case)
involved and (cc)
differentiate complications (dobj)
observations , (punct)
staining nf-kappab (compound)
nerve tail (compound)
rides show (conj)
normalised case (nmod)
suggested finding (advcl)
surveillance a (det)
disorder endocrine (amod)
contrast literature (nmod)
developed carcinoma (dobj)
complication recognized (amod)
reported episodes (dobj)
revealed walls (nmod)
groups studied (amod)
cxad flow (conj)
stop-watch a (det)
group cocaine-exposed (amod)
effects epinephrine (nmod)
decreased dopamine (nsubjpass)
analysis nested (amod)
disease documented (amod)
treatment used (acl)
deal great (amod)
dependent [na]o (nmod)
neurotransmission striatum (nmod)
unknown still (advmod)
estradiol with (case)
sensitivities abnormalities (nmod)
fibrillation or (cc)
seizures audiogenic (amod)
epinephrine microgram/ml (appos)
exhibited deterioration (dobj)
hemostasis patients (nmod)
therapies on (case)
means in (case)
ducts bile (compound)
phenobarbitone levels (dep)
included cause (dobj)
changes age-related (amod)
studies experimental (amod)
associated nsaids (conj)
glomerulonephritis fibrillary (amod)
patients 21/63 (nummod)
signs toxicity (compound)
mg/ml 27.9 (nummod)
toxicity lower (amod)
alters physiology (dobj)
protection cs (compound)
s-53482 to (case)
effect ameliorating (amod)
kidneys absent (amod)
abnormalities marked (amod)
dbp sbp (conj)
association hypertension (nmod)
time asystole (nmod)
smaller significantly (advmod)
manner steroid-dependent (amod)
injections by (case)
patient found (acl)
advantage major (amod)
$ROOT$ presents (sent)
erythrocytes patients (nmod)
deposits evidence (conj)
antibody-(pr3-anca cytoplasmic (amod)
tablets mg (nummod)
readmitted death (nmod)
is necessary (acomp)
normal results (nsubj)
mice control (amod)
decreases count (compound)
assigned , (punct)
238 253 (conj)
studied compared (conj)
chamber than (cc)
solution that (appos)
suggest take (ccomp)
responding was (aux)
intrathecal or (cc)
potential metoclopramide (nmod)
elicited that (nsubjpass)
684 drugs (nmod)
risk corresponding (amod)
mechanisms anemia (nmod)
57.7 and (cc)
s.c. week (nmod:npmod)
levels 3 (dep)
$ROOT$ development (sent)
disturbance a (det)
filters cava (compound)
prescribe therapy (dobj)
day through (case)
returns whenever (advmod)
carcinogenesis during (case)
cycles 21-day (amod)
provide mechanisms (nmod)
dosage daily (amod)
= 0.027 (dobj)
electrocardiography and (cc)
cm five (compound)
increased 3.6- (dobj)
group placebo (compound)
$ROOT$ intervention(s (sent)
reveal . (punct)
recovery disappearance (conj)
improvements bradykinesia (nmod)
greater relief (nsubj)
100 3 (compound)
tg expressing (dep)
microinjections with (case)
man 72-year-old (amod)
raised slightly (advmod)
considered nephropathy (nsubjpass)
showed animals (nsubj)
improved 3 (dep)
patients timolol-treated (amod)
period administration (nmod)
delineate role (dobj)
continue year (nmod)
study microscopy (compound)
quadrant temporal (amod)
presence gene (nmod)
using snps (dobj)
induction using (acl)
has elucidated (xcomp)
alive well (conj)
relapse who (nsubj)
biopsies protocol (compound)
mg/m2/24 2,250 (nummod)
inducing ischemia (dobj)
comparable incidence (nsubj)
sulphate and (cc)
case death (nmod)
km [ (punct)
stain culture (conj)
glomerulopathy membranoproliferative (amod)
seen addition (nmod)
correlate monitoring (nmod)
approaches monitoring (acl)
found comparing (advcl)
anatomy normal (amod)
evaluated importance (nsubjpass)
correlated cure (nmod)
50 , (punct)
addressed finally (advmod)
years < (advmod)
led use (nsubj)
bcnu ( (punct)
duration latency (conj)
affect myocytes (dobj)
crp ) (punct)
discuss authors (nsubj)
therapy conversion (compound)
focused now (nmod)
occurred cardiotoxicity (nsubj)
electroshock or (cc)
paralysis produced (acl)
potentiate ? (punct)
risk observed (acl)
demonstrated recently (advmod)
removal famotidine (nmod)
bradycardia effect (conj)
members family (nmod)
malignancy chemosensitive (amod)
reaction aberrant (amod)
related depression (nmod)
increase lesions (nmod)
doses steroids (nmod)
injections 2 (nummod)
blocker and (cc)
strokes multiple (amod)
employed also (advmod)
modified risk (nmod)
patients none (conj)
due initially (advmod)
validate hypothesis (dobj)
moderate to (advmod)
adjustment dose (nmod)
reticulocytes peripheral (amod)
disease nonmalignant (amod)
caused cells (nmod)
intervention following (case)
affected , (punct)
stage disease (conj)
iohexol b (dep)
authors many (amod)
sgk1(-/- of (case)
second third (nmod)
exposures without (case)
l1-l2 ) (punct)
u/l 40 (nummod)
epilepticus damage (conj)
re-examine to (mark)
catalepsy activities (conj)
probability significant (amod)
hemodynamic antiadrenergic (conj)
increased producing (advcl)
cases choreic (acl:relcl)
role + (nmod)
reliability interrater (amod)
agents nsaid (appos)
infusion iv (amod)
occurs thrombosis (nsubj)
= 0.78 (dobj)
pdn ) (punct)
deoxycholate ( (punct)
access starting (acl)
had tube (nsubj)
36 19 (conj)
effects hepatic (amod)
had while (mark)
f was (cop)
p=0.001 ; (punct)
completed until (mark)
extravasation the (det)
ms desorption/ionization (conj)
benzoylecgonine be (appos)
2003- to (case)
tissue juxtacanalicular (amod)
consumers the (det)
8 , (punct)
noted and (cc)
undergoing sedation (dobj)
blockade deficiency (conj)
induced cocaine (nmod:npmod)
common women (nmod)
kinase epidermal (amod)
showed elevation (nmod)
densa lamina (compound)
densa interna (conj)
taking dose (dobj)
vd ( (punct)
shown profiles (nsubj)
seizures pharmacologically-induced (amod)
infusion ) (punct)
tested amphetamine (nmod)
tiva ( (punct)
prevented conversion (nsubj)
low repeatedly (advmod)
experienced bacteremia (dobj)
cholesterol les (dep)
g. detection (nmod)
activation microglial (amod)
mg ( (punct)
allele rs4704559 (compound)
developed infusion (nmod)
lag 5-year (compound)
group stz-injected (amod)
sequelae no (det)
patients susceptible (amod)
cuff rotator (compound)
chills rigors (conj)
feasible always (advmod)
methods studied (appos)
adducts cross-react (acl:relcl)
study relationship (nmod)
background prooxidant (conj)
loss early (amod)
0.65 ) (punct)
cells oral (amod)
side-effect is (cop)
hallucinations pr=0.515 (dep)
induced diazepam (nmod)
spasm difficulties (conj)
monitoring effects (dobj)
followed % (nsubj)
administration ; (punct)
positive hbsag (nmod:npmod)
patients schizophrenia (compound)
effects dubutamine (nmod)
cld n=34 (appos)
prominent more (advmod)
observed migraine (nsubjpass)
less significantly (advmod)
risk rr (appos)
pathway metabolism (nmod)
slowly cn (nmod)
nephrotoxicity from (case)
assessment trial (nmod)
indices subnormal (amod)
stimulation receptor (nmod)
prevented saralasin (nmod)
studies renal (amod)
plays signaling (nmod)
ee of (case)
immunoblotting such (case)
intestine and (cc)
18.9 +/- (cc)
increased admissions (nmod)
ischemic to (mark)
orally per (mark)
used etoposide (nsubjpass)
-0.12+/-0.5 ( (punct)
patients admitted (acl)
chick hypophysectomized (amod)
hemodynamics : (punct)
pg of (case)
increase slight (amod)
antagonists adrenergic (amod)
characterized toxicity (nsubjpass)
man allergies (nmod)
healthy middle-aged (conj)
quality better (amod)
given immunosuppressant (nmod)
defined aki (nsubjpass)
vision in (case)
concentrations predicted (amod)
infusions patients (nmod)
affect did (aux)
movement no (neg)
used amiodarone (nsubjpass)
light observations (nmod)
increasing in (mark)
accounting half (nmod)
occurrence dysrhythmia (compound)
designated it (nsubjpass)
microvessels of (case)
response lower (amod)
mg/day 99.0 (nummod)
enantiomer bupivacaine (nmod)
incidence surgical (nmod)
biochemical structural (conj)
remain hypotensive (acomp)
had incidence (nmod)
measures fetal (amod)
has functions (nmod)
14.3 or (cc)
pump rate (dep)
induction : (punct)
synchrony etoposide (nmod)
received monkeys (nsubj)
irrigation and (cc)
score global (amod)
changes administration (nmod)
injury as (case)
reconstruction flap (compound)
prevalence groups (nmod)
concentrations function (conj)
weakness angiography (nmod)
subgroups surgery (compound)
amb. for (case)
nephrotoxicity maleate-induced (amod)
pcc with (case)
ci-921 amsacrine (compound)
interaction cisapride-diltiazem (compound)
groups 3 (dep)
synthase mediated (acl:relcl)
gains smaller (amod)
identifying persons (dobj)
had if (mark)
levels supraphysiologic (amod)
interpret episodes (nmod)
effects antiemetics (nmod)
life argatroban (compound)
patients switched (acl)
months range (appos)
kidney in (case)
deposition to (case)
antagonized could (aux)
changes flow (compound)
performed controls (conj)
undergoing extraction (dobj)
precipitation be (cop)
buffers plasma (conj)
mg/day rad001 (compound)
lobe and (cc)
peg ) (punct)
transplantation with (case)
0.001 < (dep)
excretion glomerulosclerosis (conj)
= 15.34 (dobj)
summarizes cases (dobj)
level as (cc)
myopathy myopathy (conj)
showed whereas (mark)
had evaluation (dobj)
$ROOT$ normalizes (sent)
observations analysis (dep)
test caffeine (compound)
shown attenuate (xcomp)
decreased until (mark)
metoprolol propafenone (conj)
functions various (amod)
injection learning (nmod)
butyrylthiocholine benzoylcholine (conj)
differ drugs (nsubj)
treatment l-noarg (compound)
observed had (conj)
replication impaired (amod)
neurone motor (compound)
showed abnormalities (dobj)
nnos ( (punct)
evaluated symptoms (nsubjpass)
intrathecal ( (punct)
fertility libido (conj)
weight patient (compound)
this to (case)
tubular glomerular (conj)
% 63 (nummod)
lysozyme and (cc)
margins safety (compound)
phenylephrine of (case)
weight the (det)
origin characterized (conj)
change effect (nmod)
amlodipine with (case)
developed deterioration (dobj)
using that (mark)
% 2.4 (nummod)
manual disorders (nmod)
11.1 and (cc)
evidence from (case)
reported injecting (xcomp)
revealed reduction (dobj)
appear feature (xcomp)
tested significance (nmod)
activation stat5 (compound)
consciousness impaired (amod)
improvement least (advmod)
antagonist excitatory (amod)
changes similar (amod)
portray comparison (nmod)
used study (xcomp)
tools . (punct)
indicative findings (nsubj)
expression offspring (nmod)
pretreatment 24-h (amod)
disorder an (det)
implanted capsules (nmod)
diaphragm the (det)
more rats (nmod)
aid a (det)
exposure flurothyl (compound)
dilate . (punct)
consistent replicated (conj)
9.84 4.59 (conj)
considered showed (advcl)
corresponded changes (nmod)
surge estrogen-induced (amod)
caused promotion (dobj)
caused deterioration (dobj)
bumetanide , (punct)
word a (det)
was galantamine (nsubj)
escalation significant (amod)
fibres by (case)
group drug (compound)
arrhythmias major (amod)
resolved persisted (conj)
degree severe (amod)
maintained turned (advcl)
produced induced (advcl)
metastases liver (nmod)
essential available (ccomp)
radiographic clinical (conj)
delivery drug (nmod)
breaks strand (compound)
delirium edds (appos)
group sedation (compound)
abusers the (det)
patients p9201 (compound)
comparison ka (nmod)
66.9 score (nsubj)
first block (nmod)
increase inclusion (nsubj)
duration narcosis (nmod)
score patient (nmod:poss)
decrease g/dl (nmod)
achieves . (punct)
activate feedback (dobj)
produced bradycardia (nsubjpass)
cle with (case)
paresthesias of (case)
sludge gallstones (conj)
examined resistance (nmod)
$ROOT$ rechallenged (sent)
lna+lca ( (punct)
igg c3 (conj)
memory this (det)
analgesia block (nmod)
acid to (case)
investigating influences (dobj)
tyr6]-vip mm (appos)
continuing or (cc)
greater da (nmod)
dosage etomidate (nmod)
altering thresholds (dobj)
localize to (mark)
seven all (det)
) 5 (nummod)
treat patient (dobj)
$ROOT$ correlate (sent)
tolerability and (cc)
alterations macroscopic (amod)
infusion followed (acl)
power in (case)
child to (case)
marker . (punct)
diagnosis pain (nmod)
predisposing rpn (nmod)
value verapamil (nmod)
stimulus pinprick (compound)
observation features (nmod)
layer rats (nmod)
schedule administration (nmod)
practice in (case)
patients fifty-seven (nummod)
women risk (nmod)
expression nkcc2 (compound)
frequency median (amod)
linked creatine (dobj)
data more (amod)
objective review (nmod)
preference rats (nmod)
measure release (dobj)
understanding processes (dobj)
phase epilepsy (nmod)
seizures kindled (amod)
is not (neg)
indicative oedema (nmod)
patients nondiabetic (amod)
pacing one (nmod)
fibrosis of (case)
failure mice (nmod)
0.4 between (quantmod)
nifedipine mg (appos)
disulfiram , (punct)
urine with (case)
microbleeds and (cc)
receive days (nmod:tmod)
nmdar and (cc)
patients exhibiting (acl)
modulate response (dobj)
effects well-documented (amod)
complication is (cop)
likely more (advmod)
pleased were (cop)
corrected until (mark)
deterioration symptoms (nmod)
allowed methodology (nsubj)
patients group (dep)
treatments ee (compound)
ketanserin and (cc)
small rich (conj)
women allocated (acl)
$ROOT$ maximum (sent)
8.9 were (cop)
active treatment (nmod)
g/250 2 (nummod)
glibenclamide or (cc)
myocarditis emphasis (dep)
low hour (nmod)
activity spontaneous (amod)
cd50 the (det)
abnormalities movement (compound)
assessments detailed (amod)
tolerated patients (nsubj)
treat used (conj)
size in (case)
blocker characterized (acl:relcl)
increases stimulation (nsubj)
with together (advmod)
2010/2011 nc/ia (appos)
type an (det)
presented we (nsubj)
correlation this (det)
binding according (case)
$ROOT$ deleterious (sent)
steroid of (case)
manifestation pericarditis (nsubj)
diabetic in (case)
dose 5-fluorouracil (nmod)
receiving is (aux)
implications useful (amod)
saline ph (appos)
subgroups newborns (nmod:poss)
began taking (xcomp)
neuroadaptation reduction (conj)
compared azelastine (nsubjpass)
propylthiouracil by (case)
thromboembolism event (conj)
septal midline (conj)
289 taking (acl)
increased less (advmod)
administered thiopenthal (nsubjpass)
year months (conj)
15 - (punct)
pressure consumption (conj)
lesion induced (acl)
severe necessitate (xcomp)
develop hoarseness (dobj)
fucoidan polysaccharide (compound)
improves catalepsy (dobj)
distinct , (punct)
space enlarged (amod)
evaluated directly (advmod)
have sensitivity (dobj)
yohimbine antagonist (compound)
differences activity (nmod)
influence convulsions (nmod)
evaluated parts (nmod)
lead impairments (nmod)
mechanisms relate (acl:relcl)
property anti-arrhythmic (amod)
retention- the (dep)
studies functional (amod)
anti-inflammatory neuro-protective (conj)
m-2 of (case)
selection follow-up (conj)
reach to (mark)
volume terbutaline (compound)
14.3 ( (punct)
event drug (compound)
times mean (dep)
have . (punct)
incidence benefits (nsubj)
warnings adequate (amod)
reports previous (amod)
have who (nsubj)
transcripts regulated (amod)
baseline compared (case)
bupivacaine injected (acl)
used heparin (nsubjpass)
attributed induction (nmod)
pathogens the (det)
arb ) (punct)
cerruloplasmin c (conj)
mice immunodeficient (amod)
investigated unnecessary (parataxis)
tone context (nmod)
pilocarpine mg/kg (appos)
rapamycin mtor (appos)
blockade significant (amod)
exercise , (punct)
spectra frequency (compound)
matrix damaged (amod)
rate dialysis (nmod)
isopter perimetry (nmod)
pain discomfort (conj)
displayed immunohistochemistry (nsubj)
associated , (punct)
time volume (conj)
growth vessels (nmod)
level hbv-dna (compound)
toxicity ifosfamide-induced (amod)
changes organelles (nmod)
haemorrhage fatal (amod)
c57bl/6 ( (punct)
associated ovulation (nmod)
transfusions platelet (compound)
et-1 to (case)
studies acc-9653 (nmod)
mediating enhancement (dobj)
treated originally (advmod)
2)% , (punct)
case 1 (nummod)
dosed day (nmod)
known seen (xcomp)
invasion in (case)
% groups (dep)
revealed eyes (nmod)
gssg tissue (compound)
slowed down (compound:prt)
infiltrate polyclonal (amod)
quiescent years (nmod)
doses cumulative (amod)
serious but (cc)
complication postoperative (amod)
included when (advmod)
tumorigenesis forestomach (compound)
attenuate some (dobj)
one to (case)
drug prescribed (amod)
kg kg (conj)
$ROOT$ haemorrhage (sent)
xdr-tb ( (punct)
used monitoring (nsubjpass)
task procedure (conj)
observed ineffective (parataxis)
severity withdrawal (compound)
occurrence aki (nmod)
proceeded directly (advmod)
thyroxine serum (compound)
abstinence years (nmod)
suprofen , (punct)
= 3.7 (dobj)
protocol our (nmod:poss)
entity classic (amod)
protection hemolysis (nmod)
disorder disorder (appos)
copolymer unmodified (amod)
infiltration cascade (nmod)
started dialysis (nmod)
gain more (amod)
concentration normetanephrine (compound)
diagnostics ( (punct)
effects anemia-related (amod)
demonstrated administration (nmod)
continued uses (nmod)
acetaminophen- and (cc)
gender female (amod)
$ROOT$ put (sent)
pathway ascending (amod)
cardiomyopathy rats (nmod)
induced levels (nsubjpass)
occurrence are (cop)
changes without (case)
body tracheal (amod)
use diluents (nmod)
developed dyskinesia (nsubj)
outcome dyskinesias (nmod)
causes phenotype (dobj)
dogs on (case)
microg/rat ) (punct)
level clotting (compound)
adjustment by (case)
years three (nummod)
call to (mark)
decreases amplitudes (nmod)
performed oct (nsubjpass)
have treated (advcl)
increased drowsiness (nsubjpass)
induced investigated (advcl)
-0.2 0.4 (compound)
percent area (nmod)
g ( (punct)
allowed , (punct)
history 1 (conj)
elevated ach (nsubj)
contained glomeruli (nsubj)
3.7+/-0.8 p<0.05 (appos)
processes processes (conj)
effects amide (nmod)
systems neuronal (amod)
model akinesia (nmod)
removed kidneys (nsubjpass)
measured administration (nmod)
syndrome bilateral (amod)
increased ritonavir (nsubj)
malignancies and (cc)
17 to (quantmod)
own on (case)
csa followed (acl)
concentration na (nmod)
obstruction no (det)
c d1 (conj)
aggravate toxicity (dobj)
detected anemia (nsubjpass)
implantation minipump (compound)
nerve for (case)
propensity hypokalemia (dep)
waves ii/iii-v (nummod)
use antibacterials (nmod)
caused diet (nsubj)
performed assess (advcl)
ameliorate impairment (dobj)
discussed association (nsubjpass)
associated because (mark)
rise relative (amod)
group non-alcohol-exposed (amod)
patients february (nmod)
stage days (appos)
deoxycorticosterone of (case)
week 4th (amod)
day 150 (nummod)
applied easily (advmod)
had progression (dobj)
$ROOT$ striatum (sent)
administered indomethacin (nsubjpass)
found patient (nsubjpass)
interpretation in (case)
produced vasoconstriction (nsubj)
lymphoma stage (compound)
mitoq. the (det)
csa weeks (nmod)
necessary be (cop)
knowledge to (case)
led reduction (nsubj)
d-amphetamine phencyclidine (conj)
uninephrectomy and (cc)
passed stone (nsubj)
secretion bile (compound)
withdrawn to (mark)
= < (parataxis)
showed improved (ccomp)
seroconversion hiv (compound)
from september (nmod)
capsaicin : (punct)
saline s (dep)
cause not (neg)
granulocytes and (cc)
axons axons (conj)
being free (acomp)
low potential (nsubj)
receiving amikacin (dobj)
involved conclusion (nsubjpass)
$ROOT$ involvement (sent)
showed specimens (nsubj)
induced reversed (conj)
safe regimen (nsubj)
rechallenge an (det)
images high (amod)
level iron (compound)
features , (punct)
involves production (dobj)
aorta rat (compound)
administration postpartum (amod)
sustained aminotransferase (nmod)
determination la (nmod)
determined radioimmunoassay (nmod)
effect mechanisms (conj)
ke : (punct)
shown however (advmod)
relationship degeneration (nmod)
stimulations by (case)
detection infusion (nmod)
1.6 from (case)
iief ) (punct)
91 more (advmod)
discuss that (mark)
cohort men (dep)
25mg/kg ) (punct)
changes cimetidine (nmod)
risk tnss (nmod)
conclusions suggest (dep)
proposed serve (ccomp)
continue treatment (nmod)
attributable preservation (nmod)
restarted demonstrated (conj)
phosphorofluoridate , (punct)
mpa bcc (conj)
strains the (det)
etiology disease (nmod)
compound carbamylcholin (appos)
channels neurons (nmod)
reproducibility variation (dep)
preferred patients (nmod)
effects antiemetic (amod)
series literature (conj)
primary recurrent (conj)
patients tachyarrhythmia (nmod)
absence effect (nmod)
hypercalcemia bradyarrhythmia (conj)
treatment patient (nmod)
de novo (dep)
tachycardias ventricular (amod)
psychopathology like (case)
regressed spontaneously (advmod)
used angiography (nmod)
pressure increased (amod)
development gradual (amod)
r=0.81 0.65 (conj)
show constitutively (advmod)
reduced similarly (advmod)
generated thus (advmod)
neoplasms on (case)
examining microscopically (advmod)
ml above (case)
bn antagonist (compound)
protein intracellular (amod)
confusion hyperbilirubinemia (conj)
100 equal (advmod)
damage bladder (compound)
$ROOT$ adenomas (sent)
accomplished safely (advmod)
variables these (det)
conclusion reduced (appos)
episode in (case)
rats not (cc)
conduction nerve (compound)
dose tacrolimus (compound)
involves areas (dobj)
ifosfamide by (case)
extracts methanolic (amod)
patient disease (nmod)
attenuates conclusion (nsubj)
overactivation patients (nmod)
mg/kg)-induced ( (punct)
discharged and (cc)
proteinuria milder (amod)
h patients (nmod)
grafting of (case)
one more (conj)
lacking are (aux)
effects primates (nmod)
unknown , (punct)
cerruloplasmin levels (dep)
verapamil extended-release (amod)
respiration protein (dep)
nocistatin peptide (appos)
deficits models (nmod)
effect observed (amod)
nuclei pontine (compound)
pneumonia with (case)
adherence and (cc)
thrombosis atria (nmod)
contains citrate (dobj)
children age (appos)
sensitive salt (nmod:npmod)
abnormalities these (det)
weeks 6 (dep)
effects fewer (amod)
activity i. (nmod)
11.5+/-1.4 mean+/-se (appos)
instances other (amod)
using techniques (dobj)
prove that (mark)
repeated series (nsubjpass)
established firmly (advmod)
recording of (case)
constituted % (dobj)
treated p9201 (nmod)
markers autoimmunity (nmod)
impairment with (case)
oxide edrf (compound)
resolved unease (nsubj)
doxorubicin dxr (appos)
s(c)o(2 on (case)
lasted it (nsubj)
exposure repeated (amod)
mm 0.3 (compound)
projections express (acl:relcl)
refractory are (cop)
higher % (nsubj)
lamivudine , (punct)
action respiratory (amod)
serum ) (punct)
mg/m(2 mg/m(2 (conj)
cystitis on (case)
bore . (punct)
adenocarcinoma prostatic (amod)
exhibited rates (dobj)
sgot ldh (conj)
taking carvedilol (dobj)
characteristics sprouting (nsubj)
metabolism bone (compound)
mg p.o. (nmod)
dogs or (cc)
sirna by (case)
ci p=0.020 (appos)
making series (dobj)
remains under-diagnosed (acomp)
involves . (punct)
intermediate basal (conj)
effects polyuria (nmod)
intermediates , (punct)
aap dox (conj)
rates incidence (compound)
damage the (det)
increment meq/l (nmod)
interval an (det)
% 4.7 (nummod)
constructed groups (nsubjpass)
response adaptive (amod)
pregnane-20-ones ( (punct)
malformations low (amod)
testing preangiographic (amod)
10,000 100 (compound)
dysfunction of (case)
included women (nsubjpass)
hemisphere the (det)
developed eps (dobj)
events coronary (amod)
responsive not (neg)
bruising administration (nmod)
inter- intra-individual (conj)
manifestations encephalopathy (nmod)
sec/cm5 to (case)
reactivity cardiac (amod)
ligands histamine (compound)
brought hypotension (nsubjpass)
acclimatization of (case)
$ROOT$ suggestive (sent)
carried elucidate (advcl)
average on (case)
4.9 0.7 (compound)
injections apomorphine (compound)
infusion despite (case)
disappeared but (cc)
phenytoin to (case)
analogue , (punct)
observed effect (nmod)
30min exposure (nmod)
colliculus in (case)
clonidine micrograms/kg (appos)
known were (auxpass)
microg.kg(-1).h(-1 ) (punct)
area = (dep)
side-effect of (case)
migraine onset (compound)
mmol/l 4.14 (nummod)
individuals india (nmod)
patients controls (nsubj)
leukemia lymphoma (conj)
misleading may (aux)
terms survival (nmod)
observed hepatectomy (nmod)
results deficits (nmod)
evaluation department (compound)
difficult easy (advcl)
inhibited proliferation (dobj)
higher rats (advcl)
% 11.5 (nummod)
status % (nsubj)
deficits long-term (amod)
pathway activation (nsubj)
determined mrna (nsubjpass)
treatment hyperprolactinemia (nmod)
srl by (case)
enabled % (dobj)
people users (acl:relcl)
channels functional (amod)
= 198 (dobj)
response vas (compound)
inhibited or (advmod)
contractions controls (nmod)
score goldstein (compound)
formation cyst (compound)
hypokalemic the (det)
tolerate do (aux)
lipids and (cc)
add . (punct)
investigate contributes (ccomp)
backgrounds ethnic (amod)
role agent (nmod)
administration ratings (nmod)
mice compared (case)
mk-801 mug (appos)
reduced moderately (advmod)
% 49.2 (nummod)
km tpp (nmod)
zidovudine alone (advmod)
cancer without (case)
parameters function (nmod)
group 6 (nummod)
resulted restoration (nmod)
injection , (punct)
function kidney (compound)
mg/day . (punct)
achieved withdrawal (nmod)
cardiotoxicity in (case)
ct rt (conj)
remains expression (nsubj)
$ROOT$ account (sent)
anaemia induced (acl)
conclusion led (appos)
two to (quantmod)
6 4 (compound)
nos-ir percentage (nsubj)
risk delay (nmod)
use sorafenib (compound)
lower areas (advcl)
infusions 111 (nummod)
involved pathophysiology (nmod)
monitor result (nmod)
determined explanation (nsubjpass)
investigation : (punct)
glaucoma glaucoma (conj)
administration postdrug (amod)
days administration (nmod)
exacerbation inhibitors (nmod)
layer above (case)
mice leading (acl)
considered ligands (nsubjpass)
quantified been (auxpass)
eliminated reduction (nsubjpass)
h1- h2-histamine (conj)
causing anemia (dobj)
based history (nmod)
mg/kg intraperitoneally (advmod)
denopamine ) (punct)
neoplasms or (cc)
consuming drink (dobj)
methyldopa to (case)
terminate fibrillation (dobj)
stools her (nmod:poss)
features myocardial (amod)
syndrome both (cc:preconj)
effect supplementation (nmod)
asked , (punct)
conducted center (nmod)
verapamil after (case)
iml the (det)
reversed levels (nmod)
drinking some (det)
nephropathy adriamycin-induced (amod)
infusions continuous (amod)
steroid neither (det)
exercised should (aux)
determine risk (dobj)
registry from (case)
generated and (cc)
decreased peg (nsubj)
patients study (nmod)
option , (punct)
play maintenance (nmod)
t.i.d. micrograms (compound)
pay attention (dobj)
had kg (parataxis)
antagonism cholecystokinin (nmod)
adriamycinol adriamycinone (conj)
mug 1 (nummod)
being group (nmod)
hypertrophy developed (amod)
hemorrhage stroke (conj)
enabling them (dobj)
propensity increased (amod)
weight g (compound)
comparison toxicity (nmod)
levels all (det)
exercise submaximal (amod)
cardiotoxicity extract (nmod)
reduction effect (nmod)
include . (punct)
appear dynamics (dep)
aggressiveness rats (nmod)
rats antithrombin-treated (amod)
evaluated , (punct)
caused therapy (nmod)
generated ead (nsubjpass)
comparable respect (nmod)
drugs neuroleptic (amod)
capacity recovery (compound)
demonstrated . (punct)
reported associated (xcomp)
march of (case)
appear dependent (xcomp)
do patients (nsubj)
irritability in (case)
modifications cp-induced (amod)
axons nerve (nmod)
hydrolyze not (aux)
collected physicians (nmod)
causes seizure (nmod)
events hepatotoxic (amod)
accounted secretion (nsubj)
vasodilator background (compound)
steatosis alterations (conj)
institutions group (compound)
required individuals (nsubj)
shown dwi (nmod)
sensitivity stress (nmod)
increment a (det)
design designed (dep)
testes small (amod)
consists primarily (advmod)
administered continuously (advmod)
rats salt-sensitive (amod)
reports occasional (amod)
risk infarction (nmod)
roles pan (nmod)
mg/kg 0.01 (nummod)
woman premenopausal (amod)
female female (conj)
occasions different (amod)
performed attempt (nmod)
weight atpases (conj)
standard management (nmod)
treated tachyarrhythmias (nmod)
constitutes recognition (nsubj)
enlarged times (dobj)
ctni pg/ml (appos)
strong though (mark)
improvements the (det)
susceptibility system (nmod)
$ROOT$ potentiation (sent)
had severity (dobj)
same contractions (nsubj)
markers diagnostic (amod)
studies studies (conj)
latencies seconds (appos)
members other (amod)
treated hydrochloride (nmod)
6.3 1.9 (conj)
bradycardia caused (acl)
granulomas eosinophilia (conj)
greater 12 (nmod:npmod)
women thirty (nummod)
dementia an (det)
ceased end (nmod)
products both (cc:preconj)
drive of (case)
interventions administration (appos)
consequence be (cop)
developed another (nsubj)
group remifentanil (compound)
ctnt , (punct)
1.4 to (dep)
decreasing risk (dobj)
tolerance ribavirin (nmod)
mg/100 1 (compound)
doses 5 (nummod)
acid-transmitted gamma-aminobutyric (amod)
apomorphine-induced mg/kg (dep)
cortex left (amod)
model failure (nmod)
discussed possibility (nsubjpass)
resistance total (amod)
difficult assess (xcomp)
hypotension : (punct)
mrna vascular (amod)
range microg/ml (appos)
increasing concentration (dobj)
suppressed dbs (nsubj)
reported is (auxpass)
downregulation receptor-alpha (nmod)
studies populations (nmod)
demonstrated consolidation (dobj)
weighing g. (dobj)
metabolites 1,3-butadiene (compound)
included specimens (nsubj)
% 52.7 (nummod)
studied feasibility (nsubjpass)
endocarditis staphylococcal (amod)
increases of (case)
lead deterioration (nmod)
levels total (amod)
periods months (nmod)
fluid of (case)
expression sarcolemmal (compound)
1985 since (case)
ifo ) (punct)
follow anesthesia (dobj)
related activate (xcomp)
possess may (aux)
nicorandil oral (amod)
models schizophrenia (nmod)
populations , (punct)
levels 3717 (nummod)
amount dose (nmod)
$ROOT$ decrease (sent)
1.9 0.9 (conj)
revealed observation (nsubj)
events eps-related (amod)
proportion as (case)
thinning . (punct)
mrna cnp (compound)
amplitudes nerve (nmod)
reflect symptoms (dobj)
protection 3 (dep)
upregulation such (amod)
score in (case)
have therapy (nsubj)
h ~2 (nummod)
conclusions allowed (appos)
cases result (nmod)
syndrome by (case)
junction ) (punct)
increases large (amod)
subjected studies (nmod)
effect ticlopidine (nmod)
involves as (mark)
contractions or (cc)
< 60 (dep)
inhibitor-1 activator (compound)
generated subjects (dep)
inconclusive . (punct)
id50 naloxone (nmod)
pump a (det)
excretion metabolites (nmod)
iodixanol medium (compound)
drugs sedatives (compound)
reported time (nmod)
failure are (cop)
patients concentrations (nmod)
found adjusting (advcl)
using had (aux)
factor for (case)
suited is (cop)
nonselective ( (punct)
became initiation (nmod)
= e (dep)
hyperreactivity test (nmod)
involvement renal (amod)
those signs (nsubj)
complication of (case)
pretreatment acetate (nmod)
reintroduction gradual (amod)
4107 , (punct)
protector ototoxicity (nmod)
tests provocation (compound)
elevated days=1.77 (dep)
baseline both (cc:preconj)
exposure current (amod)
seen models (nmod)
hemodynamics renal (amod)
od ( (punct)
wore . (punct)
patients gentamicin-treated (amod)
showed involving (advcl)
age years (nmod)
16,459 170/ (nummod)
cause methylprednisolone (nsubj)
microliter in (case)
phases and (cc)
different functionally (advmod)
indicators cardiotoxicity (nmod)
enrolled 1993 (nmod:tmod)
decreased diazinon (nsubj)
lamivudine lam (appos)
syndrome = (dep)
reported reduce (xcomp)
incidence overall (advmod)
discussion reported (conj)
need identify (acl)
dose unit (compound)
display aggressiveness (dobj)
tomography single-photon (amod)
therapy convenient (amod)
conducted measurements (nsubjpass)
mild ; (punct)
gyrus medial (amod)
criteria these (det)
hypersensitivity mechanical (amod)
sensitization humans (nmod)
caused withdrawal (dobj)
involved phenomena (nmod)
70 < (advmod)
administration ketamine (nmod)
days past (amod)
follow-up months (compound)
hyperalgesia hyperesthesia (conj)
use angiography (nmod)
reports arrest (nmod)
sensitivity an (det)
showed showed (ccomp)
collected segments (nsubjpass)
prodrugs antagonists (nmod)
led increases (nmod)
evolution of (case)
recall memory (compound)
affect sulpiride (nsubj)
23 19 (compound)
episodes vomiting (compound)
surgery bowel (compound)
safe administration (nsubj)
inhibitors individual (amod)
flk-1/kdr ( (punct)
commenced . (punct)
beat an (det)
change 2 (nmod)
loading amiodarone (compound)
131i-albumin serum (compound)
switched when (advmod)
phase ) (punct)
involvement internal (amod)
stabilized which (nmod)
observed suggesting (advcl)
affected findings (dobj)
absorption substance (nmod)
vasopressor treat (acl:relcl)
uninephrectomy combination (conj)
procedures surgical (amod)
groups all (det)
syndrome 2 (nummod)
years within (case)
lost were (auxpass)
relationship appearance (nmod)
cv ( (punct)
reagent as (case)
high remarkably (advmod)
developed spasm (dobj)
common expected (advcl)
regeneration muscle (compound)
marked and (cc)
schumacher 's (case)
response inflammatory (amod)
enhancement an (det)
decreased induced (advcl)
less weight (nsubj)
passage administration (nmod)
nmol/200 30 (nummod)
40 vs. (cc)
trial parallel-group (amod)
found controls (advcl)
asymptomatic patient (nsubj)
balances the (det)
completed trials (nsubjpass)
neoplasms ( (punct)
recovery reversal (conj)
stimuli by (case)
val/hctz with (case)
pharmacists from (case)
time conduction (compound)
rigidity fentanyl-induced (amod)
acquired 137 (nsubj)
blocks it (nsubj)
examination frequent (amod)
allowed attribution (dobj)
exacerbates injury (dobj)
mg/d 80 (nummod)
cin in (case)
frequency ( (punct)
induced titrating (advcl)
equal months (nmod:npmod)
female african-american (amod)
seen dose (nmod)
showed hg (dep)
nephrin , (punct)
area ua (appos)
mg/dl 3.89 (nummod)
fact correlates (ccomp)
associated leukemia (nmod)
inhibitor cyp2d6 (nmod)
amount a (det)
referrals children (nmod)
affected number (nmod)
myocardiopathy rats (nmod)
lexical and (cc)
elicited be (auxpass)
breath positive-pressure (amod)
syndrome cardiomyopathy (conj)
determine value (dobj)
induced seizure (dobj)
kept should (aux)
moderate-dose , (punct)
sealants fs (appos)
ca1 ca3-c (conj)
comparison efficacy (nmod)
include as (mark)
$ROOT$ comprised (sent)
excitability of (case)
stretching creation (conj)
ruled , (punct)
reported nephropathy (nsubjpass)
zero 14 (conj)
metronidazole with (case)
effects hematologic (amod)
demonstrated as (mark)
median radial (conj)
analysis proteomic (amod)
followed ct (nmod)
radioactivity extractable (amod)
compounds terfenadine (dep)
acid or (cc)
likely less (advmod)
uneventful but (cc)
beginning day (nmod)
one disorders (nmod)
levels angiotensinogen (nmod)
choice the (det)
disrupts and (cc)
specimens 7 (nummod)
treatment levofloxacin (nmod)
excludes possibility (dobj)
hypercalcemia with (case)
s(c)o(2 ( (punct)
brain sections (conj)
compromising function (dobj)
ring hard (amod)
reviewed literature (nsubjpass)
loss this (det)
prevalent . (punct)
management about (case)
acid glutamine (conj)
muscles to (case)
concentration for (case)
withdrawn , (punct)
underwent transplantation (dobj)
dizocilpine or (cc)
lesion amiodarone-related (amod)
% % (nmod)
compared groups (nsubjpass)
decrement the (det)
hydroureteronephrosis with (case)
because of (pcomp)
aids of (case)
lasted months (nmod:tmod)
computer software (nmod)
defect function (nmod)
rated responders (nmod)
expanded level (nsubjpass)
anemia : (punct)
affected conduction (dobj)
yield glutamate (nsubj)
affected bradycardia (nsubjpass)
reduced threshold (nsubjpass)
vldl and (cc)
reported connection (nmod)
found women (nsubjpass)
manifestations cardiac (amod)
induced release (nsubjpass)
toxic system (nmod)
arteriosus ductus (compound)
unlikely unclassifiable (conj)
nox ) (punct)
effects l-alpha-glycerylphosphorylcholine (nmod)
gyki-41 900 (nummod)
electrical and (cc)
b mono-infected (amod)
13 pairs (nmod)
increased ; (punct)
analyze variables (dobj)
seemed most (nsubj)
of tests (nsubj)
013 2 (compound)
implant acetonide (compound)
influenced genetically (advmod)
increasing dose (nmod)
agoraphobia for (case)
abnormalities . (punct)
fire then (advmod)
protein and (cc)
patient explanatory (amod)
improves provides (conj)
floor the (det)
drawbacks , (punct)
toxicity angiography (nmod)
common with (mark)
sensation an (det)
lowering levels (dobj)
appearance to (case)
neurotoxicity calcineurin-inhibitor-related (amod)
received but (cc)
edema with (case)
differences psychopathology (nmod)
administered found (advcl)
effect recognized (acl)
204 to (dep)
activities as (case)
resistant calcification (nmod)
corticosterone of (case)
reduction pressure (nmod)
difference arms (nmod)
failure lethal (amod)
haloperidol by (case)
reached not (neg)
pathway is (cop)
cases seen (acl)
attenuated impairment (dobj)
di-o-tolylguanidine dtg (appos)
controls castrated (amod)
buffer aqueous (amod)
conclusion in (case)
sectioned . (punct)
infusion formulation (nmod)
acetate eslicarbazepine (compound)
had surgery/radiotherapy (dobj)
model aminonucleoside (compound)
older all (advmod)
potassium their (nmod:poss)
extension regression (conj)
thiopental i.v. (advmod)
synthesis bs (nmod)
identified p-aminophenol (nsubjpass)
maintenance the (det)
agents reversal (compound)
affected neutropenia (nmod)
patients cyclosporine (nmod)
greater hypotension (nmod)
ill chronically (advmod)
trends . (punct)
aptt ) (punct)
cross-reactivity carbimazole (nmod)
of preventing (pcomp)
given min (nsubjpass)
contained number (dobj)
mg/kg/day 200 (nummod)
bleeding with (case)
mouth drowsiness (conj)
trials involving (acl)
method convenient (amod)
propose . (punct)
dronedarone , (punct)
determined prevents (ccomp)
nerve lacn (appos)
hexamethonium by (case)
mechanism accepted (amod)
shown influence (xcomp)
dup 753 (nummod)
observed sbp (nmod)
documented stenosis (nsubjpass)
predisposes that (nsubj)
knockout pparalpha (nmod:npmod)
impaired severely (advmod)
infusion morphine (nmod)
septicemia because (case)
risk patterns (nmod)
response increase (nmod)
moving both (cc:preconj)
study lovastatin (compound)
dosage mg (nmod)
7 % (appos)
class within (case)
case an (det)
macaques ( (punct)
chamber the (det)
food or (cc)
discharged 37 (nsubj)
flow , (punct)
0.74 1.51 (appos)
blonquist of (case)
responsible whether (mark)
haloperidol = (dep)
injection cp (compound)
moving chicks (nsubj)
respiratory anaphylactoid (conj)
hormone and (cc)
made to (mark)
confirmed was (auxpass)
sphincter of (case)
subunits alpha3 (compound)
tonic and (cc)
results patients (nmod)
initiated dialysis (nsubjpass)
had started (conj)
chloralose-urethane with (case)
factor corticotropin-releasing (amod)
sprouting reorganization (conj)
continued drinking (xcomp)
continued remained (parataxis)
mexiletine and (cc)
thought although (mark)
defined liver (nmod)
48 72 (conj)
sumatriptan subcutaneously (advmod)
vasculitis intake (nmod)
culture in (case)
given water (dobj)
fdc or (cc)
contains contains (advcl)
controlled , (punct)
altered whether (mark)
bladder urinary (amod)
adenocarcinoma detected (acl)
range 2 (nmod)
drug cholinolytic (amod)
resulted dysfunction (nmod)
histories medical (amod)
antagonist effects (nmod)
regurgitation with (case)
support benefits (dobj)
centre pharmacovigilance (nmod)
one or (cc)
compared doses (nmod)
found enrollment (nmod)
predicted be (auxpass)
akathisia and (cc)
toxicity acceptable (amod)
origin retinal (amod)
gavaged were (auxpass)
subjects nonobese (amod)
decreased syndrome (nmod)
received prophylaxis (nmod)
transporter insulin-independent (amod)
men dysfunction (nmod)
dpi and (cc)
ability improve (acl)
postpartum through (case)
ovale foramen (compound)
event critical (amod)
$ROOT$ going (sent)
indicates ; (punct)
impair result (conj)
pa a (det)
1/32 patients (conj)
outcomes : (punct)
observation the (det)
levels predialysis (amod)
concentration aldosterone (compound)
infected virus (nmod)
remained changes (nmod)
required ingestion (nmod)
9.2 9.2 (conj)
decrease capacity (nmod)
application by (case)
unaffected d-pen (nmod)
children leukaemia (nmod)
ed to (case)
electrophoresis difference (compound)
rat liver (conj)
prolongation qtc (compound)
pacemakers sinoatrial (amod)
maximum mgkg (nmod)
scleroderma , (punct)
0.97 ) (punct)
pathways map (compound)
is strategy (nsubj)
stable improved (conj)
incidence of (case)
velocity phase (appos)
everolimus tacrolimus (conj)
observed will (aux)
associated obesity (nsubjpass)
mg.kg-1 0.3 (compound)
addition myopathy (nmod)
same rates (nsubj)
speaking " (punct)
elected . (punct)
plexus brachial (amod)
better be (cop)
hemorrhaging , (punct)
m(2)-selective ( (punct)
recruited : (punct)
concentration nicotinic (amod)
recovers myopathy (nsubj)
was concentrations (nmod)
$ROOT$ responding (sent)
developed analyses (nmod)
coefficient interclass (amod)
arterial patients (dep)
administrated were (auxpass)
nm 11 (nummod)
iu/l alt:122 (nummod)
immunomodulators tacrolimus (nmod)
period : (punct)
gyrus of (case)
dosage cya (compound)
maximum incorporation (nsubj)
anencephaly to (case)
phase chlorthalidone (compound)
carcinoma prostate (nmod)
revealed averaging (parataxis)
anger , (punct)
case rats (nmod)
amount e13.5 (nmod)
db ; (punct)
habituation environment (nmod)
p-aminophenol , (punct)
reported august (nmod)
carbimazole between (case)
outcomes cardiovascular (amod)
syndrome epilepsy (conj)
externa lamina (compound)
treatment ribavirin (nsubj)
cells/mm3 cd4 (compound)
cohort from (case)
tests avoidance (compound)
$ROOT$ reproduces (sent)
change excretion (nsubj)
proteinuria hypercholesterolemia (conj)
$ROOT$ characterized (sent)
occurrence in (case)
allele homer1 (compound)
tumors hybrid (compound)
tested severity (nsubjpass)
gpi of (case)
ph and (cc)
reoccur did (aux)
was nascis (nmod)
showed cessation (nsubj)
interaction sexually-dimorphic (amod)
prevalence patients (nmod)
failed treatment (dobj)
restored doses (nsubj)
majority the (det)
showed vasculature (nmod)
suggest reverse (ccomp)
males 361 (nummod)
effect beneficial (amod)
$ROOT$ survey (sent)
commencement prednisolone (nmod)
$ROOT$ suffered (sent)
correlation volume (nmod)
risk loss (conj)
reaching levels (dobj)
glomerulosclerosis accompanied (acl)
data these (det)
s 0.55 (nummod)
alter significantly (advmod)
venous . (punct)
use from (case)
expression proenkephalin (compound)
oxygenation lobe (compound)
loss cells (nmod)
cultures rat (compound)
levels subunits (nmod)
operating granulomatosis (nmod)
opener ) (punct)
algorithm naranjo (compound)
dose vpa (nmod)
cases followed (acl:relcl)
50 least (advmod)
40 or (cc)
severity anemia (nmod)
chills and (cc)
induced adriamycin (nmod)
osteoporosis to (case)
sodium time (nmod)
simulating abuse (dobj)
indicated and (cc)
male intact (amod)
compared vcm (nmod)
rats sprague (compound)
uea1 ) (punct)
determined predictors (nsubjpass)
pre-treatment . (punct)
plays pathogenesis (nmod)
help to (mark)
doxorubicin with (case)
convulsions fatal (amod)
received injections (nmod)
cells surface (compound)
reversal toward (case)
developed fever (dobj)
cimd with (case)
chicks treated (amod)
ip mg/kg (amod)
resulted compared (prep)
discontinued thalidomide (nsubjpass)
twitching facial (amod)
occurred requiring (advcl)
angioedema nsaid-induced (amod)
9 approximately (advmod)
creatinine mg/dl (compound)
variants including (case)
act , (punct)
66 versus (cc)
measures oscillation (nmod)
lidocaine phase (nmod)
disease complications (conj)
knockout receptor (nmod:npmod)
beams tissue (nmod)
healthy in (case)
disorder schizophreniform (amod)
20,000fold over (advmod)
endpoint co-primary (amod)
acid such (case)
chemopreventive a (det)
or , (punct)
rats from (case)
response hypertensive (amod)
mg/m(2 480 (nummod)
shortening contractile (amod)
effects hypotension (conj)
examination mmse (appos)
blocker dopaminergic (amod)
studies multicentre (amod)
neurotoxicity striatal (amod)
myeloperoxidase against (case)
regression multiple (amod)
depend p=0.345 (parataxis)
mg/kg h (nmod:tmod)
interaction an (det)
association preferential (amod)
normal to (case)
prolactinomas treatment (nmod)
admission at (case)
spasm life-threatening (amod)
gain gain (advcl)
5-ht by (case)
angioedema (acei)-induced (amod)
caused and (cc)
18 % (appos)
dyscrasias drug-induced (amod)
groups pretreatment (appos)
reflection , (punct)
role naloxone (nmod)
group p10 (compound)
inhibitors vs (cc)
case cystitis (nmod)
psychopathology general (amod)
cardiomyocytes mouse (compound)
ritanserin dmso/side (dep)
antagonists calcium (compound)
anemia fanconi (nmod:poss)
damage disease (nsubj)
leading uremia (nmod)
proliferation pulmonary (amod)
development reduced (amod)
induce trazodone (nsubj)
hypersecretion a (det)
pregnancies affected (acl)
used france (nmod)
resistance their (nmod:poss)
considered not (neg)
showed patients (dep)
performed lymphocytes (nmod)
decreased size (nsubjpass)
activities receptor (compound)
similar users (nmod)
classified cats (nsubjpass)
inability the (det)
high prevalence (nsubj)
mice transgenic (amod)
level seen (acl)
recurred dose (nmod)
developed phenomenon (nmod:npmod)
alterations cerebellum (nmod)
intravenous , (punct)
similar whereas (dep)
d-galactose is (cop)
produces commonly (advmod)
inhibitor anhydrase (compound)
values mmol/l (nmod)
erythematosus cutaneous (amod)
measure after (case)
gum nicotine (compound)
developed onset (dobj)
intake normal (amod)
associated number (nmod)
g/m2 ( (punct)
effects neuropsychiatric (amod)
ought in (prep)
output her (nmod:poss)
if , (punct)
good , (punct)
information effects (nmod)
used therapy (nmod)
admitted exclusion (nmod)
reaction paracetamol (nmod)
activity vasodilating (amod)
ameliorated . (punct)
% 16 (compound)
experienced overall (advmod)
motility with (case)
spent and (cc)
scores medication (nmod)
microscopy measurements (conj)
irregularity their (nmod:poss)
skf agonist (compound)
biopsies serial (amod)
higher amplitude (nsubj)
leukaemia and (cc)
alterations inhibition (nmod)
alf . (punct)
number patients (nmod)
function an (det)
spread . (punct)
doses p.o. (nmod)
ng/ml t (conj)
$ROOT$ function (sent)
discontinued reinitiated (conj)
individuals smokers (acl:relcl)
involvement partial (amod)
approach hypercholesterolaemia (nmod)
fluphenazine 2 (dep)
consistent reports (nmod)
width by (case)
overexpression cisplatin-induced (amod)
tolerance safety (conj)
injury paracetamol-induced (amod)
sedation such (case)
reduced injection (nmod)
onset accelerated (amod)
patients year (nmod)
seen contrasts (nsubjpass)
kinase nitrogen (conj)
developed here (advmod)
criteria through (case)
$ROOT$ reviving (sent)
gvhd grade (compound)
area a1 (appos)
tolerate who (nsubj)
assessed days (nmod)
deletion a (det)
impaired not (neg)
nephrotoxicity no (neg)
has whether (mark)
consistent magnitude (nsubj)
using zymosan (dobj)
neuroprotective plays (conj)
treated infections (nsubjpass)
trial clopidogrel (compound)
fdc ( (punct)
mfs ) (punct)
administration phenobarbital (compound)
begin trials (dobj)
angiotensinogen ao (appos)
although drugs (nsubj)
ritonavir by (case)
ionic non-ionic (conj)
regimen polychemotherapy (compound)
layers the (det)
presented which (nsubj)
male not (neg)
one ( (punct)
placebo valdecoxib (conj)
m(1)/m(3)/m(5)-selective ( (punct)
site on (case)
receiving previously (advmod)
associated bradycardia (nsubjpass)
$ROOT$ small (sent)
percent 50 (nummod)
potential antibody (nmod)
effects certain (amod)
secretion ircrf (compound)
risk are (cop)
36.3 group (nmod)
analysis statistical (amod)
characterized ) (punct)
cause patients (nmod)
patient experiences (acl:relcl)
cerebrovascular vascular (conj)
activity mean (amod)
females elderly (amod)
consolidation intensive (amod)
increased faster (advmod)
increased mg/dl (dep)
recovers further (advmod)
convert negative (xcomp)
diabetes streptozotocin-induced (amod)
delay dose-dependent (amod)
kinase creatine (compound)
atrial right (amod)
patient 77-y-old (amod)
modify bf (dobj)
chi2-test analysis (conj)
recruited groups (nmod)
performance spontaneous (amod)
promoted aconitine (nsubj)
teratogenic , (punct)
injection penicillin (compound)
$ROOT$ call (sent)
eosinophilia i.e. (advmod)
projection or (cc)
duration field (compound)
shown extract (nsubjpass)
$ROOT$ relationship (sent)
itchiness urgency (conj)
assessment at (case)
slight but (cc)
cured patients (dep)
preserved effects (nsubjpass)
gtn by (case)
occlusion ischemia (nmod)
lesions numbers (conj)
identify cases (dobj)
programs dexamethasone (nsubj)
days=1.77 ( (punct)
cocaine combination (nmod)
effect application (nsubj)
medications anticonvulsant (amod)
hemorrhage palsy (nmod)
periods extended (amod)
beginning and (cc)
indomethacin mg/day (appos)
injury ischemia-reperfusion (amod)
preserved , (punct)
taking l-dopa (dobj)
hypotension elevation (conj)
volume frequency (conj)
administered group (advcl)
2 more (conj)
observed have (aux)
overexpression by (case)
determined stress (nsubjpass)
documented safety (nsubjpass)
found fdc (nsubjpass)
precedes manifestations (dobj)
analyses confocal (amod)
elevation st (compound)
disclosed studies (nsubj)
d2 of (case)
significant associated (conj)
anticholinergics chloride (conj)
conclusions case (dep)
99 1 (conj)
adr+los(12 ) (punct)
hypopharynx larynx (conj)
ratio coupling (compound)
process absorption-limiting (amod)
time discontinuation (nmod)
propensity , (punct)
triggered was (auxpass)
transport sodium (compound)
experienced she (nsubj)
extremities upper (amod)
approach this (det)
testosterone mg.kg(-1).d(-1 (appos)
cystitis hemorrhage (compound)
sedation gain (conj)
exclusively not (neg)
h injection (dep)
rbcs of (case)
patients features (nmod)
micrograms/kg min (nmod)
underwent cisapride (dep)
acuity in (case)
show association (dobj)
was screen (xcomp)
electrogram surface (compound)
estimated , (punct)
prevention . (punct)
factor-alpha serum (compound)
rat intact (amod)
important follow (xcomp)
induced catheter (nmod)
nhe3 ) (punct)
excitation discernible (amod)
continue b (dep)
nyha ) (punct)
highlights occur (ccomp)
fertility and (cc)
blood ; (punct)
focus to (mark)
fasciculations muscle (compound)
lead difficulties (nmod)
improve analgesia (dobj)
complications life-threatening (amod)
$ROOT$ unreported (sent)
59 21 (quantmod)
treatment continued (amod)
treated phenobarbitone (nmod)
receiving medications. (dobj)
weakness and (cc)
ras ) (punct)
evaluate treating (advcl)
hev ( (punct)
34.98 ) (punct)
dose associated (acl)
elucidated completely (advmod)
f(30 ) (punct)
administration icv (compound)
admitted wards (nmod)
play vasoconstriction (nmod)
intensity or (cc)
methotrexate high-dose (amod)
state long (amod)
test draw-a-man (compound)
assessed levodopa (nmod)
colitis with (case)
tests psychological (amod)
available control (nsubj)
nausea like (case)
incidence arrhythmias (nmod)
abolished effects (nsubjpass)
methylergonovine of (case)
potent be (cop)
magnitude transformation (nmod)
antineoplastic background (compound)
gfap cd11b (conj)
application , (punct)
187 placebo (nmod)
urd ) (punct)
functioning attention/executive (amod)
venomotor ( (punct)
copolymer and (cc)
failure amphotericin (nmod)
da norepinephrine (conj)
reaction late-onset (amod)
toxicities worst (amod)
assessments patients (nmod)
doses equimolar (amod)
hospitalised were (auxpass)
technique that (mark)
sympathomimetic synthetic (amod)
attributable , (punct)
nm 0.5 (nummod)
antagonists suramin (appos)
therapy sulfasalazine (compound)
groups oc (compound)
increased amplitude (nsubj)
inhibition tonic (amod)
cessation morphine (nmod)
hour in (case)
activity ace (compound)
receptor sirna (nmod)
prevented dose (nmod)
seen department (nmod)
efficacy placebo (nmod)
sensitivity high (amod)
histology embryology (conj)
tested evidence (dobj)
receptors located (amod)
causes unrelated (amod)
rest during (case)
points characteristics (nmod)
injection capsaicin (nmod)
suspected and (cc)
cyclophosphamide ifosfamide (conj)
produced be (auxpass)
triazolam of (case)
area ; (punct)
compared blocker (dobj)
documented monitoring (nmod)
exacerbation schizophrenia (nmod)
pain cocaine-related (amod)
treated ketoconazole (nmod)
dye blue (amod)
caused administration (nsubj)
reveal findings (nsubj)
showed blotting (nsubj)
was correlation (attr)
recognized , (punct)
disorders hematological (amod)
lining beneath (case)
interviews questionnaire (conj)
encephalopathy the (det)
greater combination (nmod)
enhance replication (dobj)
due injection (nmod)
studied atria (nmod)
exanthema , (punct)
analyzed disturbances (nsubjpass)
11.7 +/- (cc)
treated infusion (nmod)
suggesting diminishes (ccomp)
evening surgery (nmod)
reduced timolol (nsubj)
increased decreased (parataxis)
1788 - (punct)
remapped deafening (nmod)
investigations lesions (nmod)
improves : (punct)
v2.0 amplicor (compound)
epicondylitis lateral (amod)
that supervision (nmod)
remedies preparations (conj)
mechanism . (punct)
offer tissue (nmod)
patients particularly (advmod)
neoplasms malignant (amod)
associated suprofen (nsubjpass)
mg prochlorperazine (nmod)
product combination (compound)
treatment those (nmod)
species both (det)
conclusions recurrence (appos)
course sulphasalazine (nmod)
rates % (appos)
treating for (mark)
remained doses (nsubj)
spasm evoked (acl)
site or (cc)
terbutaline of (case)
hepatic pulmonary (conj)
buffer and (cc)
measure(s . (punct)
index change (conj)
internal external (conj)
84.8 to (advmod)
analyzed patients (nmod)
haplotypes constituted (acl)
screen to (mark)
patients maintenance (compound)
$ROOT$ produces (sent)
inhibitors selective (amod)
apap and (cc)
bche of (case)
effects hysterosalpingography (nmod)
sensitization seizures (nmod)
markers not (neg)
use analgesia (nmod)
activity negligible (amod)
pulmonale cor (compound)
muscles on (case)
d of (case)
chp ) (punct)
danazol of (case)
range minutes (appos)
20.3 8.4 (conj)
developing disease (dobj)
observers by (case)
avoid mistakes (dobj)
name aldomet (appos)
mj ( (punct)
withdrawal amiodarone (nmod)
suggested because (mark)
stomach and (cc)
activity nos (compound)
receptor-positive estrogen (nmod:npmod)
pay that (mark)
treated androgens (nmod)
resulted feeding (nsubj)
34.98 % (conj)
binding covalent (amod)
aeroallergens spring (compound)
determine reduced (ccomp)
discontinued administered (conj)
incidence use (conj)
suggest helps (ccomp)
formed participation (nmod)
males between (case)
evoked mice (nmod)
positive or (cc)
occurred ingestion (nsubj)
remainder the (det)
reaction that (mark)
concentration grains (nmod)
minute the (det)
frequency findings (nmod)
role this (det)
data behavioral (amod)
haemorrhages diffuse (amod)
tolerated tolterodine (nsubjpass)
ester cholesteryl (compound)
g/d protein (nsubj)
methscopolamine and (cc)
mice pretreated (acl)
organisms 2.2 (nummod)
hyperactive . (punct)
studied relation (dobj)
cataracts disease (conj)
animals used (acl)
those myalgia (nmod)
benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate , (punct)
hyperplasia , (punct)
$ROOT$ pacing (sent)
sulphonylureas with (case)
had 5,7-dcka (nsubj)
2nd > (conj)
attenuated fluid (nmod:npmod)
provoke dobutamine (nsubj)
cystitis anti-inflammatory (amod)
immunosuppressant -tacrolimus (nsubj)
damages delineated (conj)
high cigarettes (dep)
correlated injury (nsubjpass)
cg ) (punct)
suppressed 3 (dep)
screened retrospectively (advmod)
patients attack (nmod)
mechanism seizures (nmod)
matched 1:1 (dobj)
level hr (nmod)
biomarkers elevated (amod)
aim this (det)
likely treated (xcomp)
domain enzyme (nmod)
hydroxyquinolines of (case)
17/106 ] (punct)
knowledge our (nmod:poss)
consistent disorder (nmod)
infusion via (case)
concern % (nmod)
potent increasing (advcl)
infused monitored (advcl)
dna mtdna (appos)
neurons from (case)
disease neoplasia (conj)
monitored tachycardia (nmod)
increased incidence (nsubj)
administered hcl (nmod)
inactivation their (nmod:poss)
precautions therapeutic (amod)
carried can (aux)
agent prokinetic (amod)
duration apd (appos)
patency and (cc)
name the (det)
confusion ( (punct)
administered being (auxpass)
induction proteins (nmod)
perfused addition (nmod)
depressed pentobarbital (nmod)
part major (amod)
observed toxicities (nsubjpass)
relationship such (amod)
endoscopy nasal (amod)
nanoparticles tween (compound)
absorption rapid (amod)
depend which (nsubj)
run patient (nmod)
mice , (punct)
included lesions (nsubj)
necessitated patients (nmod)
seem effects (nsubj)
rate filtration (compound)
caused hcrh (nsubj)
failure in (case)
included erythromycins (dobj)
hypertension causes (nmod)
showed content (nsubj)
treatment early (amod)
se per (compound)
projection restricted (amod)
agent mechanisms (nmod)
precursor levodopa (dep)
elf or (cc)
neutropenia 3 (nummod)
encoding users (nmod)
inhibit , (punct)
agreement good (amod)
ratio defined (acl)
vasopressin and (cc)
primigravida 24-year-old (amod)
standard , (punct)
reduce fentanyl (nmod)
administration l-arginine (nmod)
innervation on (case)
lesions patient (nmod)
mechanism ischemia (nmod)
defects proliferation (nmod)
phacoemulsification sutureless (amod)
scores z (compound)
improves immunity (dobj)
measurements serial (amod)
77 to (quantmod)
exert . (punct)
pretreatment prolonged (amod)
administration injections (nmod)
$ROOT$ fulfilled (sent)
studied forms (nmod)
cells drg (compound)
veno-occlusive related (acl)
oct after (case)
microg/l range (appos)
day 43 (nummod)
u/ml 26.8 (nummod)
group bupivacaine/placebo (compound)
patients oltx (compound)
boys two (nummod)
galantamine of (case)
coadministered was (auxpass)
evaluated microscopy (nmod)
two higher (amod)
pill mg. (appos)
receiving one (dobj)
make that (mark)
night polysomnography (nmod)
has role (dobj)
admitted treatment (nmod)
use therapy (nmod)
dose bolus (compound)
evidence potential (nmod)
man african-american (amod)
profiler receptor (compound)
potent cause (conj)
pain and (cc)
hyper-reactivity novelty (nmod)
objective needed (dep)
insertion by (case)
bear drugs (nsubj)
increased survival (conj)
ammonia and (cc)
document . (punct)
seems effect (nsubj)
potentiated hyperactivity (nsubjpass)
drugs background (compound)
antagonist used (acl)
combined is (auxpass)
group 1 (conj)
possibility associated (ccomp)
found hearts (nmod)
broadens , (punct)
cases matched (acl)
$ROOT$ stronger (sent)
hypercoagulability " (punct)
curve tolerance (compound)
haloperidol standard-dose (amod)
p=0.003 ) (punct)
intravenous totally (advmod)
humphrey-zeiss , (punct)
uses heavy (amod)
pointes . (punct)
54.5 9.9 (conj)
correlation positive (amod)
stage _ (punct)
pet on (case)
g/kg/day ) (punct)
effect estrogen (nmod)
treatment dose (nmod)
range u/l (appos)
restore signs (dobj)
indicate synthesize (ccomp)
megakaryocytes abnormal (amod)
conditioning intensive (amod)
aggressiveness the (det)
similar include (conj)
fibrillation ventricular (amod)
concentrations patients (nmod)
undertaken estimate (xcomp)
gyrus temporal (amod)
genes these (det)
desmopressin to (case)
examine independently (advmod)
cramps/myalgias % (appos)
replaced when (advmod)
tacrolimus tac (appos)
extend research (dobj)
speed effect (conj)
gtn , (punct)
tolerated are (cop)
box to (case)
cyp7a of (case)
way achieve (acl:relcl)
undetermined aetiology (nsubj)
period hrp (appos)
insertion = (dep)
operations for (case)
t group (compound)
desire group (nmod)
concentrations amikacin (compound)
overdoses from (case)
administration mid- (amod)
groups received (acl:relcl)
haloperidol chlorpromazine (conj)
identified been (auxpass)
at2r of (case)
have they (nsubj)
tightness chest (nmod)
read aloud (advmod)
scores mean (dep)
$ROOT$ extend (sent)
duration loss (nmod)
decrease which (nsubj)
defects by (case)
syndrome ; (punct)
appear efficacy (nsubj)
brain in (case)
pretreated days (nmod)
assessment effects (nmod)
mice investigate (acl:relcl)
insertion pacemaker (compound)
mg/m2/d was (cop)
used if (mark)
adenosine of (case)
efficacy drug (nmod)
reduction bnpp-induced (amod)
mg/kg 30 (nummod)
in of (conj)
likely be (cop)
effect gender (nmod)
performed subjects (nsubj)
november 1 (nummod)
assess , (punct)
meq/l an (dep)
m(1)-selective ' (punct)
need dosing (nmod)
discussed , (punct)
revealed lesions (dobj)
shortened them (dobj)
20.0 - (punct)
users than (case)
devoid effect (nmod)
deep light (conj)
site ( (punct)
analysis grade (nmod)
resuscitation cpr (appos)
period experimental (amod)
nifedipine and (cc)
seeded were (auxpass)
levels bp (compound)
tumors bladder (compound)
caused tam (nmod)
mucosa of (case)
44 to (quantmod)
calcium on (case)
mu , (punct)
noted activity (nsubjpass)
characterized abnormalities (nmod)
deduced participation (nsubjpass)
value diagnostic (amod)
connecting actin (dobj)
reacts . (punct)
damage group (nmod)
scores factor (nmod)
showed species (dobj)
decline hours (nmod)
concentrations flestolol (compound)
lesion gpi (nmod)
groups r4 (dep)
caffeine mg/kg (appos)
thrombocytopenia eosinophilia (conj)
therapy median (amod)
age diabetes (conj)
used switched (conj)
weeks every (det)
event acute (amod)
morphological degree (dep)
used risk (nsubjpass)
fever jaundice (appos)
negative normal (conj)
neurotoxicity . (punct)
associated exposure (nmod)
compare and (cc)
suspicion abuse (nmod)
metabolized and (cc)
man 33-year-old (amod)
used age (nmod)
screening routine (amod)
captopril inhibitors (conj)
overexpression access (nmod)
titers endogenous (amod)
vehicle gm (conj)
bilateral , (punct)
allografts dysfunctional (amod)
monotherapy than (case)
positive ( (punct)
studies effects (nmod)
conclusion consistent (dep)
associated treatments (nsubjpass)
dosage intake (conj)
1a2 ) (punct)
stimulate . (punct)
acquisition before (case)
injected each (nmod)
evidence infection (nmod)
fractures hyperparathyroidism (conj)
parameters = (dep)
years 65.6 (nummod)
receiving l-arginine (dobj)
anorectics , (punct)
prolonged concentration-dependently (advmod)
survival better (amod)
detected administered (advcl)
$ROOT$ targeted (sent)
doses pethidine (nmod)
deep either (cc:preconj)
frequency relationship (conj)
states throughout (case)
hg hg (conj)
delayed examined (advcl)
observed exhibited (ccomp)
2b1/2b2 2e1 (conj)
total for (case)
screened respect (nmod)
had groups (nmod)
alterations due (amod)
results longer (appos)
potent most (advmod)
granulomas multiple (amod)
alterations lipoproteins (nmod)
substantial it (nsubj)
extraction after (case)
appeared forms (nsubj)
carcinogens all (det)
presents who (nsubj)
content identical (amod)
animals gentamicin-treated (amod)
factor criteria (nsubj)
response plus (cc)
crf ) (punct)
level da (compound)
effect objective (nsubj)
benefits and (cc)
expression effect (appos)
level glutamate (compound)
test h (nmod:npmod)
cessation smoking (compound)
channels k+ (compound)
containing tablets (dobj)
born mothers (nmod)
injection intradermic (amod)
tolerable generally (advmod)
objective evaluates (appos)
= .003 (dep)
signs or (cc)
ly274614 , (punct)
incidence latency (conj)
expression full (amod)
depression neurologic (amod)
probe gad (compound)
framework identifying (acl)
ce to (case)
discontinuing cisapride (dobj)
sprouting mossy (amod)
protect neurotoxicity (nmod)
occurred drg (nmod)
children the (det)
positive as (case)
plasma achieved (acl)
pressure . (punct)
demand in (case)
syndrome gerstmann (compound)
alternative , (punct)
represents case (dobj)
low % (nmod:npmod)
stimulation methoxamine (nmod)
enzymes necrosis (conj)
mg/day 360 (nummod)
% 45.45 (nummod)
evaluated mice (nsubjpass)
affect treatment (nsubj)
higher inhibitors (nmod)
measurement contraction (nmod)
developed levobupivacaine (nsubjpass)
benefit their (nmod:poss)
increases time (nmod)
etoposide cyclophosphamide (conj)
interactions of (case)
mdma ( (punct)
administration nimodipine (nmod)
occurs anemia (nsubj)
gangrene caused (acl:relcl)
or anatomically (advmod)
epilepticus continuous (amod)
high subset (nmod)
proposal the (det)
option syndrome (nmod)
incidence its (nmod:poss)
re-started which (nmod)
regulator used (acl)
adaptation be (cop)
lupus ( (punct)
phosphatase acid (compound)
known was (auxpass)
transitioned discontinued (ccomp)
explore to (mark)
minutes few (nummod)
glycopyrrolate with (case)
polymorphisms of (case)
inhibitor and (cc)
units units (conj)
made artery (nmod)
dose days (nmod)
have findings (nsubj)
using immunoassays (dobj)
greater mg (nmod)
haloperidol i.p. (appos)
dermatoses of (case)
speed find (acl)
deteriorates performance (nsubj)
$ROOT$ relevance (sent)
effect diabetes (nmod)
doses followed (acl)
endarterectomy done (acl)
normalization responder (conj)
rigidity administration (nmod)
rate lymphomas (nmod)
presented hiccups (nmod)
cancers ovarian (amod)
studied 2 (meta)
resulted whereas (dep)
time open-arm (amod)
abnormalities permanent (amod)
revealed abnormalities (dobj)
infusion ouabain (compound)
val/hctz or (cc)
exhaustion , (punct)
elf such (case)
work-up routine (amod)
radiograph sinus (compound)
model whole-animal (amod)
result hemolysis (nmod)
scales symptom (compound)
12- , (punct)
drugs novel (amod)
undergo who (nsubj)
mediated since (mark)
males disorder (appos)
disorders movement (compound)
trh of (case)
doses weeks (nmod)
exists as (dep)
prescribed be (auxpass)
limited clinical (dep)
information effect (nmod)
monotherapy infusions (nmod)
infarction block (conj)
exhibited baseline (nmod)
short h (dep)
than patients (nsubj)
141 +/- (cc)
affect of (case)
stenosis significant (amod)
time transplant (nmod)
monitored functions (nsubjpass)
population therapy (nmod)
mg/dl 4.5 (nummod)
tremor signs (acl:relcl)
complications bleeding (amod)
detectable sonography (nmod)
counts and (cc)
indication incidence (conj)
clarify effect (dobj)
failure symptomatic (amod)
carcinogenesis fanft (compound)
notion caused (ccomp)
co-injection toxin (nmod)
developed constellation (dobj)
cross-tolerance response (conj)
lometrexol antipurine (amod)
= 0.22 (dobj)
quiescent completely (advmod)
level mg/m2 (compound)
mg tolterodine (compound)
vasculature pulmonary (amod)
tamoxifen antagonist (compound)
prior injections (nmod)
hosts , (punct)
injections further (amod)
hepatocellular , (punct)
showed protected (advcl)
vomiting or (cc)
become ipsilateral (acomp)
electroretinography electroretinography (conj)
antibodies titre (compound)
h1- and (cc)
assessed 3 (dep)
tried although (advcl)
ischemia produced (acl)
estimated method (nsubj)
intermedius ventralis (compound)
hypersensitivity drug (compound)
insufficiency fluid (compound)
stopped ptu (nsubjpass)
aqp2 and (cc)
patients two (nummod)
presented treated (conj)
population on (case)
address concerns (dobj)
% 16.7 (nummod)
calibration simple (amod)
70/min of (case)
suppress , (punct)
susceptible develop (xcomp)
fhf ) (punct)
methodology enzyme-mediated (amod)
rnfl accumulated (acl)
separate effects (dobj)
restricted children (nmod)
$ROOT$ helpful (sent)
neurocognitive neuroradiologic (conj)
treatment amounts (nmod)
received sc-48334 (dobj)
admitted insomnia (nmod)
months 1992 (appos)
onset syndrome (nmod)
noel below (case)
therapy combination (compound)
sensations mastitis (conj)
difference=0.01 ) (punct)
binding striatal (amod)
compressions external (amod)
leukoencephalopathy of (case)
myalgia course (conj)
mk-801 ( (punct)
comparable literature (nmod)
greater % (nmod)
function vegf (nmod)
develop regimen (dobj)
effects duration (nmod)
pathways and (cc)
imipramine by (case)
hyperplasia hamartoma (conj)
months 31 (nummod)
in both (preconj)
pregnancies of (case)
glucose effectiveness (conj)
reduced coadministration (nsubj)
scored % (dep)
smelling even (advmod)
score total (amod)
ages with (case)
low has (aux)
indicate provided (ccomp)
effect innervation (nmod)
factors multiple (amod)
diopters d (appos)
edema pulmonary (amod)
deterioration mice (nmod)
once-daily versus (cc)
weight creatinine (conj)
seizures presentation (dep)
sham-operated and (cc)
option initial (amod)
1a1/1a2 of (case)
chamber open (amod)
complication pain (nsubj)
studied pms (nsubjpass)
fall function (nmod)
disease abnormalities (conj)
was significance (attr)
instances spasm (nmod)
factors changes (nmod)
tissues many (amod)
abnormalities clinical (amod)
limited piloerection (nmod)
response therapy (nmod)
seen group (nmod)
etiology identified (acl)
range lower (amod)
associated ethambutol (nmod:npmod)
identified cells (nsubjpass)
cta a (det)
using thalidomide (dobj)
analgesia pca (appos)
capacity learning (compound)
impaired similarly (advmod)
men asian (appos)
increased concentrations (dobj)
was fall (dobj)
dose levodopa (nmod)
micrograms/mouse 30 (nummod)
associated however (advmod)
rationale exerts (dep)
had results (dobj)
nine whom (nmod)
15.0 +/- (cc)
sensitivity age-dependent (amod)
had reactions (dobj)
showed progression (dobj)
inducing turnover (dobj)
supervised and (cc)
rate heart (compound)
recipient allograft (nmod)
serve marker (nmod)
bradycardia rats (nmod)
was deliver (xcomp)
investigation agent (nmod)
chronotropic and (cc)
probes subunits (nmod)
self-dosing accumulation (conj)
questionnaires studies (conj)
undergoing means (nmod)
signified presence (nsubj)
reviewing literature (dobj)
133 2 (conj)
spike a (det)
methamphetamine administered (acl)
fever of (case)
unrelieved study (nmod)
clonidine : (punct)
results entered (appos)
0 or (cc)
recovered although (mark)
rates ratio (conj)
response on (case)
thc by (case)
interrupted was (auxpass)
signs objective (amod)
scores total (amod)
thought contribute (xcomp)
transport nor (cc)
expression p75(ntr (compound)
used concurrently (advmod)
ich a (det)
allografts to (case)
reduced mutation (nsubj)
affection primary (amod)
died asystole (nmod)
demographics mechanisms (conj)
potentials dilation (conj)
200 299 (conj)
seem increase (xcomp)
reached versus (cc)
placebo concentration (nmod)
investigate , (punct)
results reported (appos)
appeared were (conj)
glomerulonephritis endocarditis (nmod)
drops map (nmod)
produce radicals (dobj)
2.1 10.1 (conj)
5 80 (conj)
resistant seizures (nmod)
remove and (cc)
% 15.9 (nummod)
cardiomyopathy adriamycin-induced (amod)
$ROOT$ proliferated (sent)
patient anaesthetist (conj)
acting it (nsubj)
concentrations arrhythmias (nmod)
appearance dyskinesias (nmod)
indicating reason (ccomp)
l-dopa ( (punct)
61 80 (conj)
is risk (nmod)
generated cocaine (nsubj)
aspirin drugs (conj)
argue would (aux)
shown it (nsubjpass)
ngf parameters (conj)
parts the (det)
calculated dose (nsubjpass)
search literature (nmod)
was women (nmod)
used marmoset (nsubjpass)
initiating treatment (dobj)
include often (advmod)
conclusions manifestation (appos)
woman prolapse (nmod)
documented well (advmod)
bfu-e mice (nmod)
events moderate (amod)
ability due (case)
hag in (case)
anesthetic as (case)
use enalapril (compound)
descriptions with (case)
found postoperatively (advmod)
effects dizocilpine (nmod)
23 only (advmod)
experiencing % (nsubj)
seen indicated (ccomp)
access on (case)
rats levels (nmod)
action its (nmod:poss)
survived sequelae (nmod)
hepatitis leading (acl)
stress caused (acl)
pathologies otological (amod)
different concentrations (nsubj)
related fluctuations (nmod)
meningitis staphylococcus (compound)
kind of (case)
solvent , (punct)
dfo than (case)
amount alcohol (nmod)
known abundant (advcl)
tolerant , (punct)
included cases (dobj)
mmrm with (case)
comparison study (nsubj)
secretion prolactin (nmod)
study carboplatin (nmod)
rat of (case)
$ROOT$ injection (sent)
loosening junctions (nmod)
lacked proved (advcl)
process this (det)
induced examine (advcl)
month surgery (nmod)
rest at (case)
research herbals (nmod)
loss or (cc)
later week (nmod:npmod)
induction metabolites (nmod)
transplantation prior (amod)
avoided graft (nmod)
months > (amod)
staining protein (compound)
risk in (case)
fed pair (nmod:npmod)
company , (punct)
received survived (conj)
developed years (nmod)
extracted data (dobj)
seen institution (nmod)
attributable be (cop)
rare silent (advcl)
disorders mental (compound)
m 0.15 (compound)
examination tissues (nmod)
7.914 - (punct)
tachycardia arrest (conj)
glomerulosclerosis fibrosis (conj)
unit care (compound)
tested susceptibility (nmod)
reactions inhibitors (nmod)
associated aneurysms (nmod)
lilly and (cc)
features encephalopathy (nmod)
administration dermal (amod)
suppressed mean (dep)
codeine mg/kg (appos)
labeling medication (compound)
infarction induced (amod)
becoming increases (advcl)
used aware (conj)
identified component (nsubjpass)
factor of (case)
aware to (mark)
block hypotension (conj)
prilocaine ml (nummod)
reached % (dobj)
screened be (auxpass)
triggers component (nsubj)
valve regurgitation (conj)
condition medication (compound)
factors growth (compound)
fill do (aux)
impaired moderately (advmod)
precipitate , (punct)
titrated warranted (conj)
blockade enzyme (compound)
conducted studied (conj)
g/dl to (case)
licensed , (punct)
ketamine injected (acl)
effect and (cc)
were decreases (attr)
rhythms theta (compound)
lost was (auxpass)
dyscrasias these (det)
effective therefore (advmod)
born 1987 (nmod)
man 41-year-old (amod)
increase account (acl:relcl)
suxamethonium of (case)
area visible (amod)
lesion , (punct)
% cl (appos)
myelomeningocoele of (case)
fractures fingers (nmod)
infusion bupivacaine (nmod)
oct humphrey-zeiss (appos)
planned was (auxpass)
observations sequential (amod)
caused cats (nmod)
is obviously (advmod)
showed atrophy (dobj)
cholestasis alterations (nmod)
associations cancer (nmod)
vomiting ( (punct)
% , (punct)
studied cycles (nmod)
follow-up mean (compound)
first compare (acl)
injection on (dep)
glipizide with (case)
pregnancy singleton (amod)
= r(2 (nsubj)
changed dramatically (advmod)
methods chain (compound)
activities mitochondrial (nmod)
antidepressants of (case)
bbb through (case)
lindane the (det)
subjects patients (appos)
chemotherapy prior (amod)
disappearance delay (nmod)
threatening not (neg)
rep ( (punct)
adenocarcinoma vagina (nmod)
developed hyperkalemia (nsubj)
c in (case)
3.6 0.7 (conj)
developed baseline (nmod)
november 30 (nummod)
icrf-187 of (case)
barrier sinusoidal (nmod)
found decades (nmod)
af induced (acl)
medicine folk (compound)
carboplatin high-dose (amod)
aftereffects clinical (amod)
syndrome ketoconazole-induced (amod)
theorem on (case)
rls with (case)
malignancy as (case)
changes neurons (nmod)
response or (cc)
findings brain (compound)
shown pre-treatment (nsubjpass)
abuse cocaine (nmod)
deletion with (case)
sem 86.2 (nummod)
database global (amod)
scintigraphy echocardiography (conj)
5 only (advmod)
addition nitroglycerin (nmod)
treatment prazosin (compound)
configuration structural (amod)
17 other (amod)
volunteers patients (conj)
cyp27 ( (punct)
task eyes (compound)
membrane of (case)
growth fetal (amod)
observed results (nmod)
numbers activity (nmod)
each excipients (nmod)
normochromic normocytic (conj)
experiments such (amod)
surgery and (cc)
30 6 (conj)
collected and (cc)
clearance metoprolol (nmod:poss)
showed 99mtc-ecd-spect (nsubj)
man macroglobulinaemia (nmod)
use antiinflammatory (amod)
embryolethality teratogenicity (conj)
confounding age (nmod)
s 30 (nummod)
induced excitation (dobj)
using ace/arb (dobj)
cross-clamp aortic (amod)
adenocarcinoma biopsy-proven (amod)
rare fibrillation (nsubj)
carolina)/2011(iowa through (case)
departments various (amod)
pregnancy throughout (case)
treated bmcs (nmod)
held . (punct)
stroke ischaemic (amod)
point study (compound)
included data (dobj)
stopped atp (nsubjpass)
likely incidence (nsubj)
analyzed been (auxpass)
younger patients (nsubj)
treatment thalidomide (compound)
used corticosteroids (nmod)
cases syndrome (compound)
provides framework (dobj)
treating attack (dobj)
coincident . (punct)
monotherapies and (cc)
levels expression (conj)
azelastine of (case)
scale y-mrs (appos)
affected be (auxpass)
sensor participates (conj)
administration ivig (nmod)
use worldwide (amod)
np , (punct)
protection toxicity (nmod)
june in (case)
10.2 ) (punct)
increased may (aux)
yet as (case)
patients survived (acl:relcl)
produced respectively (advmod)
investigated causes (dobj)
concentrations marker (appos)
micturition per (case)
pethidine of (case)
dcf of (case)
0 ( (punct)
collection sample (compound)
contained pdn (dobj)
ct unenhanced (amod)
detrimental possibly (advmod)
problem the (det)
effect mice (nmod)
decline median (amod)
predisposed age (nmod)
kinase the (det)
persisted increase (nsubj)
limbs or (cc)
estrogen by (case)
subunit i (nummod)
patients > (dep)
attained restoration (nsubjpass)
reported not (neg)
receptor 6 (nummod)
incidence apnoea (nmod)
combination bort (nmod)
assessed receiving (advcl)
combined outcome (nsubjpass)
patients the (det)
mechanisms proposed (amod)
alteration due (case)
result individuals (nmod)
g/dl 10.2 (nummod)
increased appeared (parataxis)
salt cs (appos)
elevated ampka (nsubj)
mechanism explain (acl:relcl)
electrolyte and (cc)
group t (compound)
levels hva (compound)
reinstated that (mark)
amount solution (nmod)
variation spv (appos)
$ROOT$ nausea (sent)
required that (nsubj)
withdraw valproate (nmod)
trial mg. (appos)
agents anti-aggregating (amod)
nodal cardiac (amod)
impairment expression (conj)
tomography bladder (nmod)
shows response (nsubj)
21 7 (compound)
values group (nmod)
level mean (amod)
drivers of (case)
treadmill swimming (conj)
periods various (amod)
pge2 of (case)
commenced recurrence (nmod)
probes in (amod)
ameliorated however (advmod)
has also (advmod)
accompanied activity (nmod)
distribution haplotypes (conj)
improves but (cc)
cisapride , (punct)
cva ( (punct)
occurs serious (conj)
suggests mapping (nsubj)
decreased support (nsubj)
lower score (dep)
28 38 (conj)
pph as (case)
nephropathy vascular (amod)
subunits renal (amod)
achieved obtained (conj)
important recognition (nsubj)
design evaluated (appos)
aminotransferase showed (acl:relcl)
fucoidan h-1 (appos)
combined fk506 (nmod)
(+)-cibenzoline of (case)
system suppressed (acl:relcl)
developed model (nsubjpass)
caused trimethaphan (nsubj)
antagonist 1,5-benzothiazepine (compound)
mg hours (nmod)
intake a (det)
killed animals (dobj)
1mg/kg ( (punct)
relationship outcome (nmod)
center clinical (compound)
degeneration fibres (nmod)
17 the (det)
biopsy worker (compound)
developed fully (advmod)
thermal chemical (conj)
effects combined (amod)
concentration chp (compound)
increase as (case)
selective highly (advmod)
regimens multidrug (amod)
million 3.2 (compound)
hydroxytyrosol rats (nmod)
incubated slices (nsubjpass)
developed attack (dobj)
levels calcium (compound)
ha of (case)
hallucinosis and (cc)
infants born (acl)
t thiopentone (appos)
express which (nsubj)
undergoing patient (nsubj)
reduction hearing (compound)
laboratories at (case)
combination work (nmod)
observed signs (nsubjpass)
revealed linked (ccomp)
an-2-ol - (compound)
monkeys macaque (amod)
upregulation no (neg)
changes functional (amod)
incorporates that (nsubj)
ingestion paracetamol (compound)
method and (cc)
antagonist cholinergic (amod)
therapy epilepsy (nmod)
specificity % (dep)
increasing factors (dobj)
genes seizure (compound)
e4031 nm (appos)
associated showed (conj)
administration thp (nmod)
plasma concentrations (conj)
dosage , (punct)
effect that (nmod)
unique documented (advcl)
beta2 of (case)
stratified use (nmod)
potential effect (nmod)
hypertension in (case)
individuals those (appos)
avoid use (dobj)
data drugs (conj)
intrathecal it (dep)
resulted exchange (nmod)
transplantation patients (conj)
palpitation flushing (conj)
hormone corticotropin-releasing (amod)
cortisol urinary (amod)
considered safe (xcomp)
food water (conj)
report bradycardia (dobj)
protection in (amod)
found sequelae (nsubjpass)
efficacious administration (nsubj)
% 93.3 (nummod)
demonstrate toxicity (dobj)
provoke , (punct)
agent enzyme-blocking (amod)
encountered commonly (advmod)
unnecessary age (nmod)
protein mrp2 (appos)
factors populations (nmod)
conclude common (ccomp)
percent fifty-eight (nummod)
similar those (nmod)
observed trends (nsubjpass)
response apoptosis (conj)
hepatitis severe (amod)
improvements fever (nmod)
develops association (nmod)
scales , (punct)
ain ( (punct)
extend . (punct)
features cytoarchitectural (amod)
had expression (nmod)
evaluated retrospectively (advmod)
leukoencephalopathy treatment-related (amod)
groups dose (compound)
remain morbidity (nsubj)
lower . (punct)
response objective (amod)
fever rash (conj)
animals epileptic (amod)
3 group (nmod)
transferred strain (nmod)
contributed decrease (nsubj)
efficacy patients (nmod)
benefited . (punct)
3.5 to (dep)
admitted micu (nmod)
shown curcumin (nsubj)
saline dex (appos)
media artery (compound)
saline l-name (conj)
described ingestion (nsubjpass)
free were (cop)
proteins trifluoroacetyl-adducted (amod)
occurs if (mark)
simvastatin from (case)
done posttreatment (dep)
lowering mm (nmod)
role dfo (nmod:poss)
therapy no (neg)
spasm artery (compound)
municipal copenhagen (nmod)
3/4 ) (punct)
occurs proteinuria (nsubj)
studies effect (nmod)
began , (punct)
stabilizers anticonvulsant (amod)
has nephrotoxicity (nsubj)
intolerant p (nmod:npmod)
experience patients (nsubj)
dogs injection (conj)
resulted ratio (nsubj)
signs tma (nmod)
unnecessary and (cc)
absent may (aux)
$ROOT$ co-treatment (sent)
normalized later (advmod)
pressor bradycardia (conj)
effects lactoferrin (nmod)
loss oxide (nmod)
mg/day ) (punct)
sediment of (case)
prc ( (punct)
degree anaemia (nmod)
restored prolonged (conj)
markers soluble (amod)
adjustment further (amod)
response ( (punct)
treatment levetiracetam (nmod)
veins terminal (amod)
induced epilepticus (nsubjpass)
supports further (advmod)
feeding to (case)
11 13 (conj)
version updated (amod)
isolated scattered (conj)
solution treatments (conj)
challenged examine (advcl)
placebo evening (nmod)
cats 10 (nummod)
tests liver (compound)
assigned men (nsubjpass)
leg and (cc)
influence system (nmod)
presentation % (nmod)
norms outside (case)
nci/min 100 (nummod)
assessed vasorelaxation (nmod)
safety retinochoroidopathy (nmod)
high normal (conj)
latter of (case)
lesion artery (nmod)
% 27.7 (nummod)
share lid (nsubj)
peroxidase glutathione (compound)
patients mainly (advmod)
tg fasl (compound)
alter but (cc)
1.0 adjustment (nmod)
achieved after (mark)
localized areas (nmod)
mediated mechanism (nmod)
was high (ccomp)
ph presence (conj)
two more (amod)
hepatocytes bdl (nmod)
man 65-year-old (amod)
population and (cc)
insult acute (amod)
loads tumor (compound)
cause thyrotoxicosis (nmod)
had total (nsubj)
rats replacement (nmod)
demonstrated contrast (nmod)
injected study (nmod)
underwent she (nsubj)
event index (compound)
complained pain (nmod)
cause toxicity (dobj)
damage diplopia (nsubj)
propofol and (cc)
attributed augmentation (nsubjpass)
dehydration of (case)
cortex anterior (amod)
diameter needle (nmod)
fingers the (det)
increase fall (conj)
negative were (cop)
influence smoking (nmod)
specimens of (case)
$ROOT$ dependence (sent)
show concerned (advcl)
acted manner (nmod)
mg/dl 1.9 (nummod)
plays patients (nmod)
30 more (amod)
related dementia (nmod)
exception myalgia (appos)
agents topical (amod)
= ] (punct)
model dysfunctions (nmod)
reference sclerosis (nmod)
index saturation (compound)
mg/day week (nmod:tmod)
task finger-to-thumb (compound)
nephropathy rats (nmod)
comparable carbachol (dep)
albumin sonicated (amod)
ml/min 0.86 (nummod)
diminish drug (nsubj)
mg/kg 259 (nummod)
occurred stabilization (nsubj)
portions weeks (nmod)
cr confirmed (acl)
third , (punct)
p -- (punct)
alleviates . (punct)
mg of (case)
ml mg/0.5 (nummod)
agent doxorubicin (nsubj)
experiments from (case)
reduce control (nmod)
patients p9605 (compound)
moderate diagnosed (ccomp)
mirrors that (dobj)
rats weight (nmod)
had fenfluramines (nsubj)
thresholds mice (nmod)
steroids in (case)
proteinuria without (case)
physicians participating (amod)
good least (advmod)
serve alternative (nmod)
and qualitatively (advmod)
contributing anemia (nmod)
day 2 (nummod)
refine and (cc)
treated atorva (nmod)
have transfer (nmod)
properties deteriorated (amod)
scores their (nmod:poss)
flair ( (punct)
characterized pain (nmod)
generation fr (nmod)
system sensitization (appos)
vertigo subsides (acl:relcl)
bradycardia but (cc)
induced azithromycin (nmod)
partial or (cc)
disease no (det)
background complication (dep)
dextran the (det)
cells pyramidal (amod)
subjects to (case)
inconclusive but (cc)
years 5.3 (nummod)
variations of (case)
mechanisms release (nmod)
process to (case)
lymphopenia neutropenia (conj)
remain written (advcl)
cocaine regular (amod)
implicated production (nmod)
observed irrespective (advmod)
ratios for (case)
% 46 (compound)
cavity each (appos)
indicator measurement (nsubj)
vasopressin avp (appos)
aldosterone excretion (conj)
progression a (det)
bacteremia meningitis (nmod)
prolonged form (nmod)
treatment this (det)
represent variants (nsubj)
injections iohexol (compound)
variable induces (conj)
postulated study (nmod)
transducer of (case)
bmd areal (amod)
group first (amod)
medium of (case)
% ci=8.4%-14.3 (nummod)
malformation . (punct)
antagonized hypokalemia (nsubjpass)
induced pain (nsubjpass)
donor a (det)
hg 12 (nummod)
had went (conj)
results administered (advcl)
role reduction (nmod)
1.0 1.26 (conj)
indomethacin indomethacin (conj)
deemed april (nmod)
drinking and (cc)
given corticosterone (dobj)
25 7 (compound)
findings our (nmod:poss)
associated temporally (advmod)
panel b6 (compound)
infiltration the (det)
atazanavir mg (compound)
involvement effects (nmod)
angioedema . (punct)
reabsorption low (amod)
$ROOT$ recommenced (sent)
effective somewhat (advmod)
visit post-therapy (amod)
leading tolerance (nmod)
efficacious used (conj)
event hypoxia (nsubj)
four months (conj)
$ROOT$ indicated (sent)
mechanisms systems (conj)
leakage by (case)
g/min ml/100 (compound)
arteries the (det)
women 348 (nummod)
reported case (dobj)
length with (case)
affect pretreatment (nsubj)
diuresis forced (amod)
inhibition ca(2 (compound)
coadministration d2 (nmod)
cause alteration (dobj)
fibrillation of (case)
differences be (cop)
prolongs interval (dobj)
vasodilator inotropic (conj)
dose combination (nmod)
sulphate 11-ketopregnenolone (compound)
similar extraordinarily (advmod)
cardiomyopathy reverse (amod)
sensitive is (cop)
urine against (case)
medulla im (appos)
sd ( (punct)
methylprednisolone intravenous (amod)
country in (case)
beta-mimetics tocolytic (amod)
risk psychosis (nmod)
pneumoniae streptococcus (compound)
ctni levels (conj)
prevent lidocaine (nsubj)
reduction in (case)
centre national (compound)
studied markers (nsubjpass)
gene cx3cr1 (compound)
pathway prolactin (nmod:poss)
ng/ml was (cop)
subjected were (auxpass)
exposure infants (nmod)
deterioration performance (nmod)
hypotension refractory (amod)
performed centre (nmod)
involve those (nsubj)
common severe (conj)
associated be (auxpass)
hypotension captopril-induced (amod)
tissue cortical (amod)
vasodilator hydrochloride (nsubj)
known affected (ccomp)
cardiomyopathy caused (acl)
sequelae attributable (acl:relcl)
degree course (conj)
ahs ) (punct)
observational is (cop)
trough ) (punct)
attributed treatment (nmod)
complications life-threatening (acl:relcl)
growth extensive (amod)
pre-administration atropine (nmod)
anesthetics , (punct)
agent blocking (compound)
mrna et-1 (compound)
proteinuria reversible (amod)
requiring beta-agonists (dobj)
stimulating receptors (dobj)
tacrolimus with (case)
% cd4 (appos)
stereotypy hyperlocomotion (conj)
risk augmented (amod)
data epidemiological (amod)
concentrations effective (amod)
vision loss (conj)
% 8.3 (nummod)
interaction on (case)
showed cross-tolerance (dobj)
major and (cc)
displayed resistance (dobj)
vasospasm artery (compound)
linked would (aux)
disease women (nmod)
nmdar of (case)
unclear it (nsubj)
contractions ventricular (amod)
evaluated respect (nmod)
myalgia ) (punct)
tetany severe (amod)
symptoms mild (amod)
72 7 (conj)
reduces sevoflurane (nmod)
withdrawal upon (case)
dosed achieve (xcomp)
explain resulting (advcl)
circuits level (nmod)
increase rate (nmod)
secreted vitro (advmod)
associated anticoagulants (nmod)
heads nerve (compound)
seemed celecoxib (nsubj)
aspartate or (cc)
induced chemotherapy (nmod:npmod)
cortex stained (acl)
showed retard (ccomp)
diplopia temporary (amod)
neurotoxicity study (dep)
metabolised form (xcomp)
demonstrate using (advcl)
infarction patient (nmod)
mg 400 (nummod)
value postoperative (amod)
cycles hundred (nummod)
treatment mg (nsubj)
ability in (case)
hygiene xerostomia (conj)
deficits correlates (conj)
echocardiography and (cc)
implicated is (auxpass)
isolated is (auxpass)
changes morphological (amod)
median months (nmod)
sensitivities specific (amod)
regions segments (nmod)
data clinical (amod)
43 stratum (nmod)
50 more (advmod)
sc at (case)
period during (case)
risk diseases (nmod)
change greater (amod)
reactions possible (amod)
= x2 (nsubj)
mg/kg 10 (nummod)
dmso/side microl (nummod)
restored stl1 (dobj)
suppressed dose (nsubj)
participants reported (acl:relcl)
divided equally (advmod)
tet fan (conj)
procaine of (case)
resulting block (nmod)
induction statins (nmod)
effects trihexyphenidyl-induced (amod)
changes ventilation (nmod)
remission period (nmod)
children enrolled (acl)
flaccidity and (cc)
encephalopathy vpa-associated (amod)
70 125 (prep)
association use (nmod)
cardiotoxicity 5-fu-induced (amod)
indicative lend (conj)
randomized were (auxpass)
upregulation receptor (compound)
gaba ( (punct)
metabolism to (case)
case particular (amod)
sent questionnaires (dobj)
administered up (advmod)
comparable coagulation (nsubj)
patient dialysis (nmod)
exposure increased (amod)
milieu downregulation (nmod)
highlights areas (dobj)
pruritus and (cc)
analysis single-center (amod)
contralaterally lesion (nmod)
light electron (conj)
reversed morphine (nmod)
ability extract (nmod)
stabilizer pbo (dep)
exceeded ng./ml (dobj)
neurons labeled (amod)
determinant , (punct)
methods referred (appos)
epilepsy absence (compound)
srs ) (punct)
dosage decreased (amod)
coexistence artery (nmod)
paranoia cip (appos)
visualized scintigraphy (nmod)
given study (nmod)
laboratories university (appos)
average an (det)
interpretation eeg (nmod)
lend . (punct)
schedules multiple (amod)
[ca]o normal (amod)
patients 68 (nummod)
resulted inoculation (nsubj)
exhibited rats (nsubj)
characteristic entity (nmod)
hospital-years ) (punct)
systems central (amod)
had infant (nsubj)
related is (cop)
concentrations areas (nmod)
ci 1.2 (nummod)
patients condition (nmod)
level (+)-propranolol (nmod)
discovered two (nsubjpass)
signs was (cop)
support failure (nmod)
mechanisms dominant (amod)
cortex by (case)
occur decreased (advcl)
kg + (cc)
prevalence e. (nmod)
protocol modified (amod)
normal impaired (conj)
combination bortezomib (nmod)
detected aneurysm (nsubjpass)
determined smaller (ccomp)
myeloperoxidase- neither (cc:preconj)
synergistic that (mark)
malondialdehyde and (cc)
patients ibs (nmod)
use strains (nmod)
measured be (auxpass)
renal vascular (conj)
measure in (amod)
cbz mg/kg (appos)
falling ( (punct)
5.124 1.195 (compound)
limited use (nsubjpass)
four nucleus (nmod)
lamivudine-resistance patients (nmod)
true equally (advmod)
highlights . (punct)
elevation degeneration (nmod)
alleviate may (aux)
determined objectively (advmod)
anotia and (cc)
etiology cystica (nmod)
center a (det)
corrected not (aux)
needle pencil-point (compound)
elements the (det)
less betaxolol (nsubj)
meeting of (case)
genes marker (compound)
dysfunction for (case)
totp dfp (conj)
effective regimen (nsubj)
killed injections (nmod)
disturbance conduction (nmod)
changes responses (nmod)
developed secondary (xcomp)
test before (case)
effect possibly (advmod)
exposure sub-chronic (amod)
infections to (case)
separated , (punct)
change this (det)
sleep afternoon (compound)
success preclinical (amod)
globulin anti-human (amod)
seizures spontaneous (amod)
milrinone such (case)
rats twelve (nummod)
thorazine ( (punct)
impairment in (case)
increased mrna (nsubj)
delivered were (auxpass)
dis-charge till (case)
mg/ml 1.5 (nummod)
vol% 1.0 (nummod)
shown coniine (nsubjpass)
treatments medical (amod)
evident also (advmod)
halothane with (case)
had band (dobj)
syndrome lupus (compound)
lvdp/dtmax as (case)
3.8/100,000 ( (punct)
ml 3 (compound)
aspirin disease (conj)
placebo morning (dep)
peroxide lipid (compound)
proarrhythmic be (cop)
dogs failure (nmod)
relative desipramine (nmod)
experiences unable (conj)
levels taken (acl)
myopathy hyperckaemia (conj)
factors disorders (conj)
changes pathophysiologic (amod)
chemotherapy a (det)
evidence some (det)
anaesthetic previous (amod)
evaluating use (dobj)
hypothesized protect (ccomp)
dyschromatopsy tritan-type (compound)
sensitive drug (nmod)
substantiated experiments (nsubj)
shown risk (dobj)
effect p450s (nmod)
stimulated aconitine (nsubj)
phlorizin p (appos)
factor developing (advcl)
reduced model (nmod)
suitable formulation (nsubj)
% 18 (compound)
injected anesthetics (nsubjpass)
beats/min 223 (nummod)
output as (case)
treatments these (det)
blocked response (nsubjpass)
rate complication (compound)
flexion or (cc)
anesthetics these (det)
predict damage (dobj)
bolus slow (amod)
regimen disease (nmod)
state an (det)
action sensitizing (acl)
risk rhabdomyolysis (nmod)
treated concerns (nmod)
combination quinpirole (nmod)
isolated precursor (nmod)
antagonized action (nmod)
meningitis with (case)
$ROOT$ target (sent)
involved hyperalgesia (nmod)
hyperventilation , (punct)
reduced levels (nsubjpass)
cerebral and (cc)
quality life (compound)
curves erythrocytes (nmod)
24.4 ) (punct)
epidemiology infections (nmod)
echography by (case)
investigated might (aux)
tool and (cc)
dyskinesia oddi (compound)
agent immunosuppressive (amod)
advocated administration (nsubjpass)
treating of (mark)
blood peripheral (amod)
differences means (nmod)
pneumoniae aureus (conj)
placed relying (advcl)
dementia reversible (amod)
food spicy (amod)
analyze patterns (dobj)
epiphenomena as (case)
saline dmso (appos)
given analyzed (advcl)
edema failure (conj)
mg 282 (nummod)
pressure screening (amod)
decrease dose (nmod)
receiving % (nsubj)
test assessment (nmod)
caused anesthesia (nmod)
is clotiazepam (nmod)
returned baseline (nmod)
fentanyl ) (punct)
tests trail-making (compound)
antigen-positive hepatitis (compound)
i or (cc)
38 +/- (cc)
p akathisia (nmod)
followed usually (advmod)
precedes pattern (nsubj)
exercise- both (cc:preconj)
rats unilateral (amod)
dose bw (nmod)
chlorpromazine by (case)
f ( (punct)
deficits significant (amod)
3,4-methylenedioxymethamphetamine mdma (appos)
% be (cop)
suffered min (nmod)
people hiv (nmod)
drug fibrillation (nmod)
potential infarction (nmod)
hp ( (punct)
induced incidence (dobj)
disorder background (compound)
frequent is (cop)
flaccid were (cop)
injection unilateral (amod)
age deviation (conj)
week extent (nmod)
synthase and (cc)
pathway excretion (nmod)
enlarged firm (conj)
populations human (amod)
tests psychopharmacological (amod)
arrhythmia related (amod)
received had (conj)
treated epilepsy (nmod)
initiation to (case)
partial mice (dep)
visit for (case)
used weeks (nmod)
tone autonomic (amod)
$ROOT$ 0.05 (sent)
episode siadh (nmod)
latency seizures (nmod)
4.7 minutes (nmod:npmod)
7.6 , (punct)
formation increased (amod)
reduced hypotension (nmod)
foci induced (amod)
treated wk (nmod:tmod)
measured inhibited (conj)
neoplasms hepatic (amod)
lethality seizures (nmod)
excitation of (case)
mg 40 (nummod)
inhibit values (nmod)
bought administered (conj)
% periprocedurally (advmod)
bradycardia receptors (nmod)
use metformin (nmod)
detected animals (nmod)
those as (case)
complex the (det)
become ; (punct)
scale probability (compound)
noted motility (dobj)
cessation drug (compound)
had patients (nmod)
encephalopathy nms-like (amod)
diminished and (cc)
cta with (case)
methods treatment (compound)
layer inferior (conj)
volunteer a (det)
mainstay years (nmod)
synapse cell (compound)
years 72 (nummod)
confusion acid (nmod)
hands bare (amod)
mris of (case)
metabolized flestolol (nsubjpass)
tubules into (case)
antagonized hg (dep)
increase level (conj)
dyspepsia developed (acl:relcl)
alters which (nmod)
inhibition updating (conj)
changes clear (amod)
frequent since (mark)
group pan (compound)
kindling resulting (acl)
follow-up 1998 (nmod:tmod)
effects central (amod)
tmax t1/2 (conj)
rates and (cc)
acted tp (nsubj)
capture dxnp (nmod)
< = (conj)
. acetylsalicylate (nmod)
exhibited sections (nsubj)
injected intracerebroventricularly (advmod)
collection platelet (compound)
stage 5 (nummod)
pathology muscle (compound)
days 184 (nummod)
potentiated tri (nmod)
p jj (dep)
dilates and (advmod)
1.8 - (punct)
studies infusion (compound)
injury glomerular (amod)
related drug (nmod)
electrocardiograph recorded (acl)
symptoms cns (compound)
taking hydroxychloroquine (dobj)
mepivacaine containing (acl)
study infusions (dep)
summary presented (acl)
kg(-1 , (punct)
tafi ) (punct)
accurate highly (advmod)
chicks coniine (compound)
d warfarin (conj)
periods the (det)
determined incidence (nsubjpass)
reduced daily (advmod)
digitalis- and (cc)
reduced minute (nmod)
met 34 (nsubj)
papaverine . (punct)
assessed double-immunolabeling (nmod)
nephropathy aminonucleoside (compound)
combinations their (nmod:poss)
mg. 8.3 (nummod)
abstention , (punct)
fashion dose-independent (amod)
known have (xcomp)
decreased resistance (dobj)
with combined (advmod)
studied one (dep)
hospitalized 1984 (nmod)
representative pregnancies (nmod)
agents cisplatin (conj)
six % (dep)
effects anti-oxidant (amod)
interest , (punct)
nsaid nonselective (amod)
variation of (case)
unlikely it (nsubj)
investigate strains (dobj)
efficacy both (preconj)
assessed alterations (nsubjpass)
carcinogen agency (nmod)
prazosin , (punct)
behaviors levodopa-induced (amod)
disappear not (neg)
patients regimens (nmod)
delivery sodium (compound)
session stimulation (nmod)
abandoned to (mark)
difference area (nmod)
expression brain (nmod)
opportunity a (det)
decrease a (det)
patients oncology (compound)
uncomplicated hypoxia (nmod)
$ROOT$ resembled (sent)
5-fu leucovorin (conj)
evaluated be (auxpass)
underwent chemotherapy (dobj)
mg initiated (parataxis)
pain minimal (amod)
32.4 to (dep)
neutropenia for (case)
week any (det)
threshold convulsions (nmod)
susceptible are (cop)
age > (amod)
dose znso(4 (nmod)
zyban ( (punct)
higher discontinuations (nsubj)
occurred whereas (mark)
increased lower (advcl)
block ) (punct)
attack opponent (nmod)
dose mg (nmod)
micrograms/kg/ml 20 (nummod)
sites surgical (amod)
hyperalgesia neurogenic (amod)
abused widely (advmod)
inhibited days (nmod)
acetate intramuscularly (advmod)
people 232,390 (nummod)
associated cholinesterase (nmod)
hypertrophy cardiac (amod)
contain which (nsubj)
receptors 2c (compound)
treatment shock (nmod)
lithium with (case)
discontinued frequency (nmod)
stimulate may (aux)
methods underwent (appos)
problems disturbances (nmod)
less group (nmod)
survivors hospitalized (acl)
returned withdrawn (advcl)
g/day 1.0 (nummod)
participants ' (case)
kilogram minute (nmod)
site benzodiazepine (compound)
permeability barrier (nmod)
increasing is (aux)
cows in (case)
protein upregulation (appos)
bradycardia the (det)
enalapril prazosin (conj)
methadone-maintenance mm (appos)
confirm and (cc)
patients older (amod)
lipids of (case)
times weekly (advmod)
regions presence (nmod)
causes no (neg)
minutes in (case)
scavenging and (cc)
caused rats (nsubj)
n/n=9/26 , (punct)
control can (aux)
met criteria (dobj)
hyperactivity than (case)
min edrophonium (nmod)
antagonists putative (amod)
2-receptors beta (compound)
use parenteral (amod)
unchanged stage (nmod)
adults 24 (nummod)
extent greater (amod)
5.2+/-1.1 ( (punct)
symptoms nausea (nmod)
4'-0-tetrahydropyranyladriamycin pirarubicin (appos)
accumulation less (amod)
binding endogenous (amod)
demonstrate value (dobj)
received patients (nsubj)
investigated rats (nmod)
ml/min hg/ml/100 (nummod)
fractures quality (conj)
is conclusion (dep)
rats den (compound)
50 0 (conj)
study no (det)
area level (conj)
share not (neg)
necrosis massive (amod)
excess force (compound)
5-hydroxytryptamine ( (punct)
4 1 (compound)
diet comprised (acl)
centre information (compound)
classified patients (nsubjpass)
terms time (nmod)
patients 42 (nummod)
associated lesions (nmod)
reported relationship (nmod)
analogue prostacyclin (compound)
common which (nsubj)
background agent (appos)
effects iatrogenic (amod)
suppresses levels (dobj)
occurred individuals (nmod)
option potential (amod)
mean se (conj)
agent pretreatment (compound)
tolerated whereas (mark)
reduced iop (dobj)
fluoxetine either (cc:preconj)
pointer pen-shaped (amod)
exposure identical (amod)
ratio arterial (amod)
transformation astrocytes (nmod)
discontinuation treatment (nmod)
years 8.8 (nummod)
content medulla (nmod)
prescribe to (mark)
channel constituent (nsubj)
sole or (cc)
effect immunosuppressive (amod)
disorders anxiety (compound)
erythematosus lupus (compound)
patients performed (appos)
suggest hence (advmod)
agents beta-blocking (amod)
contribute elevation (nmod)
circumstances in (case)
571 - (punct)
fit ) (punct)
13 % (appos)
none subjects (nmod)
aqp2 ut-a1 (conj)
involved toxicity (nmod)
appears it (nsubj)
dose % (nmod)
uiu/ml uiu/ml (appos)
combination years (nmod)
indicate measurements (nsubj)
therapy years (nmod)
rats ) (punct)
reported she (nsubj)
spread woman (nsubj)
suppressed mitochondria (nmod)
mask to (mark)
warrants which (nsubj)
closing occurrence (conj)
nms ( (punct)
reduce loss (dobj)
increased map (nsubj)
followed epinephrine (nmod)
infection common (amod)
infarction etoposide-related (amod)
polyuria severe (amod)
bortezomib rituximab (conj)
toxicity delayed (amod)
first and (cc)
safety : (punct)
circulation spontaneous (amod)
given should (aux)
measuring , (punct)
administration i.v. (amod)
hypertension responsiveness (dep)
positive commencement (nmod)
diagnosed completion (nmod)
tinnitus idiopathic (amod)
blue dye (compound)
l(-1 ( (punct)
consequences use (nmod)
mediation . (punct)
clones lam-resistant (amod)
estimated rate (nsubjpass)
replication hepatitis (compound)
infusion glyceryl (compound)
efe ( (punct)
cases validated (amod)
have play (conj)
displayed , (punct)
onset jaundice (nmod)
limb abdominal (conj)
analgesia and (cc)
auc desipramine (nmod)
show reverses (ccomp)
p-coumarate maltolyl (compound)
pathogenesis complications (nmod)
phosphate-diaphorase reduced (amod)
= -2.59 (dobj)
single administration (conj)
extended-release/lovastatin bedtime (amod)
mice than (case)
reports similar (amod)
effect direct (amod)
unchanged cd25 (nsubj)
perturbation by (case)
times aptts (appos)
insecticide an (det)
all group (nmod)
salt bs (appos)
episodes ) (punct)
delayed , (punct)
density and (cc)
developed initiating (advcl)
erythropoietin decreased (amod)
effects acetate (nmod)
series three (nummod)
1,500 < (advmod)
individuals hiv (compound)
followed angiography (nmod)
arthritis history (conj)
admitted using (advcl)
uncontrolled medication (nmod)
received february (nmod)
pressure venous (amod)
undertaken assess (xcomp)
failure and/or (cc)
years 40.8 (nummod)
plasma clearance (conj)
mg 0.07 (nummod)
treatment d (compound)
increased bp (dobj)
appears level (nsubj)
level l4 (compound)
develop thrombosis (dobj)
trial mexiletine (compound)
study women (nmod)
$ROOT$ intensify (sent)
inconclusive evidence (nsubj)
bortezomib thalidomide (nmod)
profiles efficacy (compound)
observed overshooting (nsubjpass)
acetaminophen mg/kg (appos)
showed association (dobj)
imaging tomography (compound)
setting network (appos)
strokes women (nmod)
sed ) (punct)
receptors through (case)
1994 - (punct)
retardation , (punct)
attenuated dose (nsubj)
values preoperative (amod)
occurred azotemia (nsubj)
production neutrophils (nmod)
enalapril ; (punct)
cpu the (det)
reduction ribavirin (compound)
withdrawn drugs (nsubjpass)
aggregation platelet (compound)
common abusers (nmod)
mediated response (nmod)
mg tid (advmod)
withholding after (mark)
analysis swedish (amod)
causing tdp (dobj)
correlates their (nmod:poss)
2.1 +/- (cc)
kg-1 mg (compound)
showing benefit (dobj)
acetylcholine and (cc)
pb ) (punct)
discontinued instrumentation (nmod)
1.9 from (case)
risk necrosis (nmod)
treatment ace (compound)
2.14 to (quantmod)
contributes importantly (advmod)
signal and (cc)
read regained (advcl)
had edds (nsubj)
obstetric gynecologic (conj)
effects potentiation (nmod)
hemorrhage death (conj)
function swallowing (compound)
minutes p (dep)
strikes syndrome (nsubj)
values obtained (acl)
function improved (amod)
present urine (nmod)
involvement ? (punct)
medications improve (acl:relcl)
dogs hearts (nmod)
unchanged relatively (advmod)
identify not (neg)
affects has (conj)
$ROOT$ telangiectasia (sent)
unnecessary adjustment (nsubj)
received gem-p (dobj)
co restored (amod)
rubella % (appos)
reported patients (nmod)
disability patients (nmod)
dizziness were (cop)
mg/kg/day , (punct)
lady 34-year-old (amod)
change to (case)
disorder agoraphobia (nmod)
improvements dyskinesias (nmod)
mechanisms operative (acl:relcl)
identified : (punct)
potentials pattern (compound)
efficacy improved (amod)
pathways necessary (amod)
liver blood (conj)
remains anticoagulant (attr)
ircrf ) (punct)
greater , (punct)
effects agents (nmod)
overdose nitrazepam (compound)
developed perfusion (nmod)
different monotherapy (nmod)
acetate ] (punct)
evaluation raloxifene (compound)
inhibited activation (nsubjpass)
examination sensory (amod)
carcinogenesis the (det)
study population (dep)
evaluated microgravimetry (nmod)
excess a (det)
composition and (cc)
reported abnormalities (nsubjpass)
aggregation human (amod)
avoiding by (mark)
states function (nmod)
rare severe (conj)
underwent transplantations (dobj)
block . (compound)
0.25 and (cc)
densitometry ) (punct)
cns ( (punct)
easy and (cc)
extravasation protein (nmod)
consistent increase (nmod)
existence intestine (nmod)
infarction non-fatal (amod)
ascertain due (ccomp)
ameliorate , (punct)
presented eruption (nmod)
were areas (attr)
tolerate heparin (dobj)
regions examined (acl)
d2 alpha (conj)
showed period (nmod)
day i (nummod)
months 5.5 (nummod)
transmitted segment (nmod)
phentolamine mg (appos)
supplemented oil (nmod)
consideration differences (nsubj)
have antagonists (nsubj)
defined role (nsubjpass)
november of (case)
stage chronic (amod)
prolong that (mark)
september , (punct)
diagnosed could (aux)
subpopulations receptors (nmod)
mmol/l 1 (nummod)
occurred level (nmod)
deterioration ameliorated (acl:relcl)
are decreases (nsubj)
generated produce (conj)
score coma (compound)
had angina (dobj)
started risperidone (nsubjpass)
tci propofol (nmod)
gentamicin mg/kg (dep)
induction effect (nmod)
bodies , (punct)
regulate may (aux)
withdrawn be (auxpass)
cycles 3 (nummod)
iii or (cc)
inhibited reversed (conj)
s 0.18 (nummod)
studied course (nsubjpass)
i frlma (appos)
receptors what (det)
cells labeled (amod)
course hypokalemia (nmod)
subsided . (punct)
impact efficacy (nmod)
nystagmus related (amod)
animals survived (acl:relcl)
thrombocytopenia severe (amod)
technique echocardiography (nsubj)
injury and (cc)
disease liver (nmod)
tested administration (nmod)
coexisted earliest (parataxis)
antagonist nra0160 (appos)
scattered smaller (conj)
ointment placebo (compound)
show leak (ccomp)
conjunction bypass (nmod)
thiopental in (cc)
month enrolment (nmod)
resistance stress (nmod)
glycosuria and (cc)
mg/d to (case)
function alpha (compound)
implications strategies (nmod)
produce individuals (nmod)
mg/kg min (appos)
resistance less (dep)
illustrate case (nmod)
action protective (amod)
increases exposure (nsubj)
followed infusion (nmod)
7 4 (conj)
etomidate mg.kg-1 (compound)
hepatitis propylthiouracil-associated (amod)
anaesthesia combination (amod)
mustard . (punct)
persons 700,000 (nummod)
black compared (prep)
underwent studies (dobj)
oblongata of (case)
occur tolerance (nsubj)
effect effect (nsubj)
tdi to (case)
infusions bcnu (nmod)
injected ventricles (nmod)
combination paclitaxel/carboplatin (compound)
prevention cancer (compound)
containing fanft (dobj)
rate siadh (nmod)
cerebella in (case)
therapy dyazide (compound)
phenotypes activity (conj)
overexpressing mice (conj)
spectrum . (punct)
flatulence loss (conj)
156 than (quantmod)
co-trimoxazole of (case)
elevated were (cop)
umb24 or (cc)
erdosteine the (det)
elicit response (dobj)
administration c (compound)
failed and (cc)
7 ) (punct)
have gemcitabine (nsubj)
coombs ' (case)
glomerulonephritis recurrent (amod)
therapy cancers (nmod)
$ROOT$ anaesthetized (sent)
antigen , (punct)
mk-801 ap7 (conj)
species for (case)
ml/min/kg 0.86+/-0.29 (nummod)
extension joint (nmod)
vasopressin central (amod)
anemia fatal (amod)
$ROOT$ delta (sent)
reduction fell (acl:relcl)
preparations chinese (amod)
repression with (case)
induced kanamycin-dextran (nmod)
angiotensin ii (nummod)
recordings from (case)
ester octapeptide (compound)
cases no (neg)
nephropathy cin (appos)
period at (case)
estrogens month (nmod)
treated thalidomide (nmod)
reported jones (nsubj)
washout with (case)
change presence (nsubj)
mi disease (conj)
regions kidney (nmod)
concentration free (amod)
d3 vitamin (compound)
used infusions (nsubjpass)
% 81.5 (nummod)
volume due (case)
acids and (cc)
disease platinum/paclitaxel-refractory (amod)
combination atropine (nmod)
consumed widely (advmod)
90 to (dep)
mesna neutralizes (acl:relcl)
+/- wild-type (conj)
encoding protein (dobj)
interleukin-6 il-6 (appos)
shunting right-to-left (amod)
hg from (case)
surgery combined (amod)
patients 76 (nummod)
those evident (acl:relcl)
required evidence (nsubjpass)
cpu cg (conj)
treatment antipsychotics (nmod)
elevated completion (nmod)
analyser by (case)
thiazole-2-carboxamide -(4-fluorophenyl (compound)
exceeding mg. (dobj)
prostheses mitral (amod)
any if (mark)
drugs antipsychotic (amod)
performed of (mark)
= 13.755 (dobj)
recognized may (aux)
60 +/- (cc)
malformations cardiac (amod)
agonists receptors (nmod)
toxicity syndrome (appos)
models rodent (amod)
overflow in (case)
confined be (auxpass)
is found (parataxis)
relying rate (nmod)
difference outcome (nmod)
quinine- both (cc:preconj)
episode hepatitis (nmod)
noted observed (conj)
clarification , (punct)
relationship release (nmod)
cases % (compound)
bodyweight g (nummod)
defined success (nsubjpass)
have injection (dobj)
induced inpatient (nmod)
switched showed (advcl)
procedure same (amod)
deterioration in (case)
behavior the (det)
supports case (nsubj)
micrograms/kg ( (punct)
stimulation evaluated (acl)
hypoxia with (case)
trh following (case)
pressure measure (appos)
administered transplant (nmod)
examined roles (dobj)
set dfu (nmod)
bladder mice (nmod)
defective and (cc)
cells normal (amod)
happiness of (case)
matter 1/8 (appos)
nerve distal (amod)
stress rats (nmod)
determinant be (cop)
toxicity amns (nmod)
microgram.kg-1.min-1 , (punct)
activity lower (amod)
% mol (amod)
patients one (nummod)
developing mania (dobj)
11 2 (compound)
experienced use (nmod)
provides cardiomyopathy (nsubj)
ovarian fallopian (conj)
$ROOT$ use (sent)
different changes (nsubj)
effect anti-tachycardial (amod)
isg of (case)
converted agonists (nmod)
ensure levels (dobj)
beneficial adverse (conj)
weeks 96 (nummod)
% 63.2 (nummod)
g 20 (compound)
established gastroenteritis (nmod)
attenuation , (punct)
neoplasms of (case)
10 12 (prep)
exposure beings (nmod)
properties properties (conj)
area defect (conj)
model : (punct)
recording recovery (nmod)
attack nitroglycerin (nmod)
dose standardized (amod)
ratio age (appos)
mortality morbidity (conj)
= 0.25 (dobj)
days during (case)
showed groups (nmod)
background modulate (appos)
hypokalemia such (amod)
dfc , (punct)
thrombosis lysis (nmod)
studies neurotoxicity (nmod)
resolved administration (nsubj)
frequency of (case)
induce vitro (advmod)
concentration prl (nmod)
lability emotional (amod)
had thp (nsubj)
involvement axonal (amod)
version this (nsubj)
administration lamivudine (compound)
become important (acomp)
resistance an (det)
administered cocaine (nmod)
seizure associated (acl)
engendered which (nsubj)
proceed testing (nmod)
omission the (det)
decreased , (punct)
disappeared waves (nsubj)
differences significant (amod)
11 15 (conj)
incidence haemorrhage (nmod)
point , (punct)
variety with (case)
= 0.012 (dobj)
characteristics of (case)
$ROOT$ capable (sent)
passage the (det)
reduction 71 (nummod)
affected administration (nmod)
disulfiram by (case)
sensor . (punct)
fibers noradrenergic (amod)
increased 5 (meta)
cr n=5 (dep)
pretreatment propranolol (compound)
diabetic neuropathy (conj)
vascular not (cc)
$ROOT$ density (sent)
implantation bilateral (amod)
aminotransferase the (det)
mediated signaling (nmod)
$ROOT$ counteracted (sent)
age and (cc)
relief group (nmod)
agents corticosteroids (conj)
cl ml/min/kg (dep)
had ataxia (dobj)
evident peaked (conj)
simvastatin and (cc)
sonograms by (case)
drops all (det)
length qtc (conj)
patients consumption (nmod)
incidence put (nmod)
consumed prevented (advcl)
prevalence prolongation (nmod)
target subtype (dobj)
marketed states (nmod)
risk 20-year (amod)
fistula enterocutaneous (amod)
behavior drum (compound)
cigarettes day<10 (nmod)
y. 15 (nummod)
cases 4 (nummod)
generation users (nmod)
strain-dependent mouse (nmod:npmod)
syndrome crystallization (appos)
levodopa ly-171555 (conj)
proteinuria : (punct)
saline- and (cc)
% values (nmod)
investigated found (conj)
study weeks (appos)
allograft a (det)
given they (nsubjpass)
virus hev (appos)
normal-salt salt-loaded (conj)
changes events (conj)
management or (cc)
psychosis acute (amod)
% 4/7 (appos)
areas inflammation (conj)
consumed . (punct)
stenosis less (amod)
cases chiasmopathy (nmod)
8 6.08 (conj)
mediated is (auxpass)
study multiple (amod)
instance 1 (nummod)
r/r ) (punct)
collected determination (nmod)
changes at (case)
mg/day 0.75 (nummod)
square root (compound)
models disorder (nmod)
saline either (cc:preconj)
received space (nmod)
effect minimal (amod)
test food (compound)
lead continued (advcl)
cardiotoxicity enhanced (amod)
akathisia of (case)
iii ( (punct)
belgium in (case)
determine were (ccomp)
developed p= (advcl)
diagnosed january (nmod)
muscle pollicis (compound)
altered enzymes (nsubjpass)
intake to (case)
inhibitor blocker (conj)
elevation less (amod)
interference prior (advmod)
capsaicin % (amod)
prevented or (cc)
heart from (case)
groups anaesthesia (compound)
time same (amod)
gd 17 (nummod)
course his (nmod:poss)
impaired placebo (advcl)
users 2 (nummod)
enzymes involved (acl)
sulfate saline (conj)
mg 2.5 (compound)
older 6 (nsubj)
control +/- (cc)
seizures eeg (conj)
area curve (nmod)
effective prevented (conj)
identified work (nsubj)
decreased because (mark)
responsiveness scores (nmod)
complications patients (nmod)
weight enzymes (appos)
susceptible detoxification (nmod)
75,761 person-years (nsubj)
pretreatment for (case)
attacks syncopal (amod)
ed50 free (amod)
prior testing (nmod)
myopathy with (case)
at . (punct)
pneumonia antiviral (amod)
given particularly (advmod)
ischemia focal (amod)
antagonize impairment (dobj)
mg 1,000/40 (nummod)
received sparteine (conj)
mrna serca2 (compound)
excluding , (punct)
persistence long-term (amod)
158.11 +/- (cc)
thirty-nine , (punct)
assessed subjects (nmod)
bzd/rd of (case)
apex the (det)
contractions of (case)
antigens i (nummod)
micrograms.kg-1.min-1 3.4 (nummod)
dismutase reductase (conj)
mg/dl was (cop)
catarrhalis moraxella (compound)
challenge subsequent (amod)
role agonist (nmod)
excess an (det)
dysfunction isoproterenol-induced (amod)
model epilepticus (compound)
effect sensitization (nmod)
disorder behavior (compound)
application diltiazem (compound)
presented cells (nmod)
nature dependence (conj)
cycles and (cc)
breakdown seizure-induced (amod)
suggested complication (dobj)
doxorubicin including (case)
lithium evaluation (dep)
glaucoma discovered (acl)
proliferation ductular (amod)
agent induction (compound)
analyses computational (amod)
$ROOT$ elucidate (sent)
report pseudoacromegaly (nmod)
principle this (det)
administration 6,3-dilactone (nmod)
diagnoses discharge (compound)
thrombi , (punct)
experienced any (det)
changes immunohistochemical (amod)
cancer inoperable (amod)
7.54 . (punct)
show report (nsubj)
zones by (case)
immunoreactivity neuropeptide-y (compound)
idr ) (punct)
increased increases (nsubj)
tremor in (case)
mind nurse (nmod)
raise tenofovir (nsubj)
treatment stage (appos)
receptor selective (amod)
diagnosis disease (nmod)
mean sd (appos)
found = (parataxis)
defects ( (punct)
ventricular right (amod)
9.14 1.24 (appos)
reach amounts (nsubj)
investigation placebo-controlled (amod)
examine compare (conj)
remained he (nsubj)
patients 107 (nummod)
fluoxetine mg (dep)
advocate hours (nmod)
glomerulonephritis immune (amod)
gem , (punct)
manifestations : (punct)
nanoparticles with (case)
mcpp ( (punct)
geometry and (cc)
mechanism other (amod)
dose lidocaine (nmod)
f fm (conj)
reported surgery (nmod)
read list (nmod)
cardiotoxicity due (case)
familiarity , (punct)
pg-9 2-(p-bromophenyl)propionate (appos)
resolved tetany (dobj)
differ those (nmod)
day four (nummod)
recorded day (nmod:tmod)
fear disgust (conj)
mmol/kg 60 (nummod)
concentration l-arginine (compound)
effects ecstasy-specific (amod)
develops failure (nsubj)
coefficient variation (nmod)
study expression (dobj)
condensed dextran (nmod)
hypercholesterolemia dyslipidemia (conj)
discharged day (nmod)
treated years (nmod)
phase deglutition (nmod)
decrease greater (amod)
time waveforms (nmod)
suggests cases (nmod)
time in (case)
suspensions corticosteroid (compound)
mortality patients (nmod)
benzylpenicilloyl-poly-l-lysine with (case)
creatinine for (case)
months months (dep)
long-term ' (punct)
$ROOT$ model (sent)
administration u.s. (compound)
19 ) (punct)
prophylaxis ct (nmod)
density localization (conj)
found factor (xcomp)
imaging . (punct)
variables diary (compound)
settings various (amod)
important is (cop)
0.05 prior (advmod)
increase found (acl)
received schedules (dobj)
requires inhibition (nsubj)
weak and (cc)
lipid total (amod)
patients 14 (conj)
associated it (nsubjpass)
performed elucidate (xcomp)
detected similarly (advmod)
gave frequencies (nmod)
80 10 (compound)
antagonist a (det)
control pressure (nmod)
$ROOT$ distinguished (sent)
examined investigate (xcomp)
pressure at (advmod)
(7.2)% p (appos)
adjusted may (aux)
link a (det)
induction angiogenesis (compound)
switching of (case)
explored study (nmod)
phase infarction (nmod)
many more (amod)
report results (dobj)
discontinued ; (punct)
recommend cessation (dobj)
slower effect (nsubj)
disorders clinical (amod)
plays induction (nmod)
predictor significant (amod)
1.78 or (cc)
delays forgetting (dobj)
model pain (compound)
no ) (punct)
occlusion during (case)
contribution low (amod)
dilation pupil (compound)
$ROOT$ switched (sent)
workers controls (conj)
mg/kg 18.4 (compound)
screened . (punct)
35 10 (conj)
group hydroxyl (compound)
plan a (det)
establishes study (nsubj)
best knowledge (nmod)
diagnosed infarction (nmod)
require difficulties (nsubj)
sought should (aux)
d-amb. compared (case)
becomes marked (acomp)
score end-stage (amod)
acts cimetidine (nsubj)
115 from (case)
produced pressure (nsubjpass)
levels inhibitor-1 (compound)
transplant cardiac (amod)
potential about (case)
size hematoma (compound)
results 12/32 (dep)
medications. between (case)
analyses chromatography (compound)
tests timed (amod)
underwent cystectomy (dobj)
hundredth than (quantmod)
frequent % (dep)
conclusion reduces (appos)
using immunosuppression (nmod)
sample matter (nmod)
$ROOT$ rhythm (sent)
factor glial-cell-line-derived (amod)
mangiferin , (punct)
disappearance persistence (conj)
indicators enzymes (conj)
began patient (nsubj)
presentation , (punct)
management appropriate (amod)
play peptides (nsubj)
dimension ventricular (compound)
revealed disorders (dobj)
have risk (dobj)
assay dutp-biotin (compound)
cases life-threatening (amod)
causes possible (amod)
medications reported (amod)
rates target (amod)
micrograms to (case)
determined magnitude (nmod)
d-pen of (case)
was discrepancy (nsubj)
cimetidine ( (punct)
2 - (advmod)
estimated be (auxpass)
htr6 ) (punct)
groups animals (dep)
fasciculations suxamethonium-induced (amod)
causes altering (advcl)
chemotherapy with (case)
antagonist selective (amod)
scavenger superoxide (compound)
progression to (case)
electromyogram and (cc)
present to (mark)
psychostimulant the (det)
diskinesia orofacial (amod)
administration ciprofloxacin (nmod)
decrease this (det)
similar times (nsubj)
adriamycin by (case)
admission inpatient (amod)
found affected (xcomp)
events heart (compound)
history in (case)
attenuated naloxone (nsubj)
hpma ) (punct)
significance and (cc)
akathisia % (dep)
warrant . (punct)
p=0.008 p=0.006 (conj)
implantation osmotic (amod)
encountered involvement (nsubjpass)
exhibited mhc-cb7 (nsubj)
catatonia ketamine-induced (amod)
capacity patients (nmod)
abolished that (mark)
neonates and (cc)
syndrome disulfiram-like (amod)
tissues heart (compound)
phase excitement (compound)
month dry (amod)
cardiotoxicity substantial (amod)
responsible mainly (advmod)
effect course (nmod)
sole hallucinations (nsubj)
observed arrhythmias (nsubjpass)
5 least (nmod:npmod)
dexmedetomidine 105 (nummod)
mg/m2 hours (nmod:tmod)
lamivudine by (case)
suggested be (auxpass)
diuretics . (punct)
fenoldopam micrograms.kg-1.min-1 (appos)
survey number (compound)
group subjects (nmod)
softly " (punct)
estradiol- ( (punct)
tumorigenesis (bha)-induced (amod)
related damage (nmod)
stones rich (amod)
respond hypotension (nmod)
mmhg at (case)
test plus-maze (compound)
epinephrine the (det)
measure main (amod)
3-nitrotyrosine 3nt (appos)
changes chemistry (compound)
documents highlights (conj)
feeding chronic (amod)
interference a (det)
predict hips-cms (nsubj)
studies two (nummod)
demographics and (cc)
increased meth (nsubj)
passing train (dobj)
paclitaxel auc (conj)
succinylcholine with (case)
93 or (cc)
reduced stress (dobj)
effects behavior (conj)
disorder personality (conj)
cholesterol and (cc)
86 to (dep)
maintained rats (nsubjpass)
tumor with (case)
affected . (punct)
reversed ramh (nmod)
cardiotoxin , (punct)
paralysis neuromuscular (amod)
refine future (nmod)
result infarction (nmod)
alone combined (conj)
advantage requiring (advcl)
increased level (nsubjpass)
decreased rigidity (nsubjpass)
pharmacology and (cc)
age predominance (conj)
volume hematoma (compound)
man 57-year (compound)
velocities displacements (conj)
technique slot-blot (amod)
sprague-dawley wistar (conj)
calcium serum (compound)
olanzapine risperidone (conj)
agent combination (nmod)
hemorrhage intracerebral (amod)
. ( (punct)
1.3 2.4 (dep)
experiments inhibition (compound)
show whether (mark)
mg/kg 350 (nummod)
pressure eyelids (nmod)
node on (case)
transplanted june (nmod)
esterase enzyme (conj)
paralyzed control (xcomp)
whom for (case)
hyper- , (punct)
higher infusion (nmod)
hypotension anesthesia-induced (amod)
associated frequency (nmod)
risks surgery (nmod)
present respectively (advmod)
treated chlorpropamide (nmod)
commencement between (case)
demonstrate that (nsubj)
prolonged stl1 (dobj)
seizures impairment (conj)
sheath wires (conj)
1992 and (cc)
intervals after (case)
brain deep (amod)
measurements concentrations (conj)
fields , (punct)
antiviral carinii (conj)
patients pd (compound)
n'-diisopropylphosphorodiamidofluoridate ( (punct)
hypothesis due (ccomp)
consisted is (auxpass)
overdose from (case)
inhibitors are (cop)
associated suggested (conj)
evidence clotting (nmod)
conclusion novel (appos)
injected pilo (nmod:npmod)
periods at (case)
urtication , (punct)
responsive pyridoxine (nmod:npmod)
effect irritant (amod)
determined have (aux)
2c not (cc)
exacerbated manner (nmod)
tended taken (xcomp)
exists regard (nmod)
performed institutions (nmod)
observed studies (nmod)
thioridazine ( (punct)
attenuated disruption (dobj)
conclusions associated (acl)
withdrawal . (punct)
case recipient (nmod)
citalopram on (case)
weakness of (case)
attenuated indicating (advcl)
patient dystrophy (nmod)
had five (nsubj)
control positive (amod)
cases occurring (acl)
electroretinography , (punct)
ventricular left (amod)
al et (compound)
c chc (appos)
responses pituitary (amod)
cytopathy drug-related (amod)
$ROOT$ type (sent)
afl ) (punct)
sulphate enantiomer (conj)
comprising cells (dobj)
ratio 4.3 (dep)
using oct (dobj)
role nicotine (nmod)
cell-derived endothelial (amod)
risk due (amod)
angiography hepatic (amod)
depressed significantly (advmod)
copolymer of (case)
effect central (amod)
history grafting (nmod)
infusion days (nmod)
revealed transplantation (nmod)
n. 23 (nummod)
2.0 0.6 (conj)
relation changes (nmod)
pre-treatment emulsions (nmod)
months 26 (nummod)
microg/ml 11.00+/-2.89 (nummod)
divided controls (nmod)
cerruloplasmin such (case)
analysis ) (punct)
method ventricular (amod)
carcinoma cirrhosis (conj)
inhibitor na(+)/k(+)-atpase (compound)
found charge (nsubjpass)
elevated content (nsubj)
session the (det)
smokers and (cc)
doses bupivacaine (nmod)
26 seven (conj)
data preclinical (amod)
used drug (nmod)
lesion encephalopathy (nmod)
predated . (punct)
applied analyses (nsubjpass)
sensitization during (case)
rides and (cc)
hearts and (cc)
4.2 years (nmod)
levels triglyceride (compound)
taking or (advmod)
signs motor (compound)
synaptophysin ( (punct)
predictor akt (nsubj)
048 . (nummod)
induced model (nmod)
events with (case)
planning complex (amod)
changes oxygenation (nmod)
enhancement isoniazid (nmod)
greater be (cop)
myocytes pretreated (acl)
nerve right (amod)
paramedics by (case)
= 0.49 (dobj)
acetaldehyde by (case)
presence presence (nmod)
higher individuals (dep)
made be (auxpass)
macrophages of (case)
inhibitor spironolactone (conj)
arthralgia and (cc)
above normal (amod)
subjected was (auxpass)
reported hepatotoxicity (nsubjpass)
1.78 ( (punct)
people hiv-negative (conj)
bmd ( (punct)
regions , (punct)
rats some (det)
increase systems (nmod)
mtx cy (conj)
cause that (nsubj)
assayed development (nmod)
had abnormality (dobj)
np group (compound)
asenapine placebo (conj)
thc ( (punct)
mg)-containing 1 (nummod)
hypertension and/or (cc)
assessed assessed (advcl)
suspected anemia (nsubjpass)
occurred 18 (nsubj)
tests renal (amod)
delay after (case)
recording protection (conj)
index neuron (nmod)
modes reduction (nmod)
acute severe (amod)
mutations antiviral (amod)
mania acute (amod)
excreted consistent (advmod)
resolution withdrawal (nmod)
drops adrenergic (amod)
produce protection (dobj)
sevoflurane , (punct)
rearing less (amod)
susceptible telaprevir (nsubj)
lad age (conj)
complex dystrophin-glycoprotein (compound)
stroke cerebral (amod)
apoptosis to (case)
hr [ (punct)
antibiotic an (det)
14 - (punct)
initiation as (cc)
depression severe (amod)
serve may (aux)
developed allows (ccomp)
reduced pronounced (conj)
nitrogen and (cc)
consisted paclitaxel (nmod)
include nausea (dobj)
found : (punct)
23 four (compound)
dp/dtejc in (case)
aged fibrillation (nmod)
benefit might (aux)
ml/kg ( (punct)
shared not (neg)
precedes damage (nsubj)
included not (neg)
preceded this (nsubjpass)
properties also (advmod)
accompanied , (punct)
group groups (conj)
insights changes (nmod)
have value (dobj)
simplifies provides (conj)
receptors sigma (compound)
improvement significant (amod)
paracetamol for (case)
levels that (mark)
old in (case)
igg monospecific (amod)
regression cox (compound)
worsened condition (dobj)
neuroleptics by (case)
withdrawal immediate (amod)
$ROOT$ favourable (sent)
dystrophy sympathetic (amod)
sets criteria (nmod)
detection failure (nmod)
use anorexigen (compound)
randomized patients (nsubjpass)
use lmwh (nmod)
amount distribution (conj)
found blocked (ccomp)
tested effect (nsubjpass)
application intracisternal (amod)
components complement (compound)
completed . (punct)
neurons serotonin (compound)
csa for (case)
improved that (mark)
evaluation serologic (amod)
rating the (det)
diagnosed have (aux)
produce can (aux)
maintenance function (nmod)
presentation following (case)
12.5 , (punct)
development crisis (nmod)
paralysis and (cc)
induced cocaine (nsubj)
patients filariasis (nmod)
complications rare (amod)
patients fever (nmod)
tolerated continued (conj)
changes spasm (nmod)
onset by (case)
induced etomidate (nmod)
mg/dl baseline (nmod)
prophylaxis as (case)
mechanisms proteinuria (nmod)
cycle of (case)
beta-adrenoceptor beta-ar (appos)
rates weeks (nmod)
anemia thrombocytopenia (conj)
injected shell (nmod)
followup prolonged (amod)
able antagonize (xcomp)
has disfiguring (conj)
dissociated acutely (advmod)
allele the (det)
complete necessary (conj)
developed chorea (nsubj)
had 6 (nsubj)
taking fumarate (dobj)
appeared which (nmod)
amounts levobupivacaine (nmod)
type cystitis (nmod)
severe tobramycin (nmod)
assigned ; (punct)
administration i.p. (amod)
degrees mrds (appos)
complete day (nmod)
microtubules of (case)
visibility field (nmod)
form found (acl)
insecticide organochlorine (compound)
50 to (quantmod)
women 7,705 (nummod)
terms search (compound)
disrupted catalepsy (dobj)
tissues studied (acl)
malformations other (amod)
reverses rigidity (dobj)
aid an (det)
medication is (cop)
3ma ) (punct)
lipoprotein low-density (amod)
weighing g (dobj)
osteoid fibrosis (conj)
elliott 's (case)
available . (punct)
mg/d or (cc)
years onset (nmod)
vomiting nausea (conj)
$ROOT$ reconsidered (sent)
biomarkers raised (amod)
mechanisms independent (amod)
p<0.0005 control (conj)
exerts effect (dobj)
greater increasing (advcl)
incidence overall (amod)
different mortality (nsubj)
finding echoes (conj)
leukopenia , (punct)
pod ( (punct)
taken if (mark)
coma deep (amod)
result role (nmod)
repair matrix (nmod)
showed that (advcl)
detected urine (nmod)
$ROOT$ mutations (sent)
breaths between (case)
trial nephropathy (nmod)
anaesthesia lateral (amod)
$ROOT$ aware (sent)
monitored were (auxpass)
infusion deoxycholate (compound)
report is (cop)
medicine a (det)
ameliorates : (punct)
myelosuppression effect (nsubj)
prevented better (advmod)
deficits numerous (amod)
responded regimen (nmod)
cpa/ee ) (punct)
pressure output (conj)
oxidase complex (appos)
effect anticonvulsant (amod)
decreased two (nmod)
amphetamine- of (case)
consisting rats (nmod)
dose alprazolam (compound)
dyskinesia like (case)
response ventricular (amod)
blocked metabolism (nsubjpass)
targeting increased (amod)
0.25 ) (punct)
prodrug oral (amod)
used hours (nmod)
effects pharmacological (amod)
ml/kg oil (nmod)
suggested shift (nsubj)
evaluated level (nsubjpass)
administration metamizol (nmod)
rats lesioned (amod)
stimulation paired (amod)
change did (conj)
trigger seizure (dobj)
days at (case)
response nicotine-induced (amod)
usage the (det)
ammonia of (case)
modification disability (nmod)
delivered was (auxpass)
administered eyes (nmod)
shortening and (cc)
therapy acetate (nmod)
exposure . (punct)
achieved can (aux)
dysfunction carbamazepine-associated (amod)
limited is (cop)
antibiomania " (punct)
induced appeared (advcl)
intake on (case)
modulate . (punct)
prompted patient (nsubj)
generator ' (punct)
anemia azidothymidine (compound)
injected cyp (nmod)
reticulum distorted (amod)
combination paclitaxel/cisplatin (compound)
1.1 3.1 (conj)
% specimens (nmod)
microangiopathy , (punct)
ml/min/kg 1.28+/-0.33 (nummod)
verapamil pretreatment (conj)
leukocyturia such (case)
surface site (compound)
patients thousand (nummod)
% 17.5 (nummod)
underwent august (nmod)
method quantifying (csubj)
found hyperprolactinemia (nsubjpass)
linkage through (case)
referred total (nsubjpass)
acute both (cc:preconj)
followed withdrawal (dobj)
kong hong (compound)
dying intoxication (nmod)
injury ) (punct)
$ROOT$ animals (sent)
eyes enucleated (acl)
measures symptoms (nmod)
show did (aux)
followed injection (nsubjpass)
cause treatments (nsubj)
dronedarone both (cc:preconj)
values fit (acl)
stopped and (cc)
comorbidities use (conj)
/-8 ( (punct)
represent subset (dobj)
uveitis exacerbations (conj)
slowed which (nsubj)
performed explained (advcl)
felt was (auxpass)
purpose compare (acl)
effects antipsychotic (amod)
abundant observed (parataxis)
operated which (nsubjpass)
1400 1600 (conj)
vpa saline (conj)
hbeag of (case)
infusion exercise (conj)
cells bovine (amod)
eliminating low (advcl)
play prostaglandins (nsubj)
task challenging (amod)
tobacco to (case)
tolerance impaired (amod)
tumorigenesis on (case)
developed episodes (dobj)
months 52 (nummod)
ozone matter (conj)
protected function (nmod)
tolerance behavioral (amod)
rats disease (nmod)
persons those (conj)
appeared signals (nmod)
narcosis barbiturate (compound)
condition serious (amod)
rat any (det)
less 0.03 (nmod)
understood but (cc)
network a (det)
underwent dogs (nsubj)
rechallenged . (punct)
response plate (nmod)
position from (case)
results trial (nmod)
summaries : (punct)
received lithium (dobj)
cases 39 (nummod)
volunteers male (amod)
suppression , (punct)
achieved compared (prep)
associated hypertrophy (nmod)
changes important (amod)
potentiation induced (acl)
decrease to (case)
dosage doxorubicin (compound)
meq/l was (cop)
differentiation of (case)
found analyzed (advcl)
noticed % (nmod)
alpha,3 the (det)
decrease frequency (dobj)
ta-064 ( (punct)
inhibition synthesis (nmod)
control tone (nmod)
damage vcm-induced (amod)
% 7.8 (nummod)
effects documented (amod)
il-1 tnf (conj)
co-carcinogen carcinogenesis (nmod)
uroprophylaxis mesna (nmod)
longitudinal global (amod)
concentrations dopamine (compound)
opioids oral (amod)
higher site (nsubj)
drug anxiogenic (amod)
neurotoxic be (cop)
factor any (det)
model pilocarpine-induced (amod)
serotonergic 5ht2a (appos)
electrocardiogram , (punct)
killed examined (conj)
associated mssbp (nmod)
beats/min from (case)
loss motor (compound)
body whole (amod)
dose received (acl:relcl)
comparable rate (nmod)
response anesthesia (nmod)
difference may (aux)
combined pacing (nmod)
influence diet (nmod)
interfere se (advmod)
specimens specimens (conj)
dissatisfaction individual (nmod:poss)
toxicity loss (nsubj)
electroshock hypercapnia (conj)
has antioxidant (nmod)
cohort entire (amod)
micrograms/ml 1.4 (nummod)
experienced he (nsubj)
change haemodynamic (amod)
day earliest (amod)
similar correlated (conj)
300 up (advmod)
drugs phenobarbitone (appos)
toxicity mechanisms (conj)
mechanisms these (det)
move disruption (nmod)
oxidation lipids (nmod)
period test (compound)
intensity of (case)
understanding a (det)
= 0.014 (dobj)
function neurophysiological (amod)
time appt (appos)
recovered acuity (dobj)
resulted mg (nsubj)
anxiolytic and (cc)
patients chemotherapy-naive (amod)
responding man (nsubj)
related stage (nmod)
continued medication (dobj)
implicated not (neg)
terminology occurrence (conj)
mutant the (det)
lymphoma between (case)
other dyskinesia (nmod)
7 . (conj)
ich ( (punct)
rigidity parkinsonian (amod)
changes threshold (compound)
vnr between (case)
tiapride , (punct)
understood although (mark)
therapy mg (appos)
recorded microelectrodes (nmod)
rhabdomyolysis severe (amod)
conclusion demonstrated (appos)
described autism (nmod)
reach it (nsubj)
monitored concentrations (nsubjpass)
questionnaire task (conj)
activities and (cc)
vegf/vpf fviiirag (conj)
effects pro-apoptotic (amod)
recurrence transplantation (nmod)
progressing attacks (nmod)
dextran 40000 (dep)
albumin to (case)
had contraindication (dobj)
failure eventual (amod)
developed rls (dobj)
vancomycin tobramycin (conj)
suspected clinically (advmod)
bupivacaine without (case)
sustained min (nmod)
independent lines (nmod)
needed he (nsubj)
use modulation (nmod)
donation volunteer (compound)
affected significantly (advmod)
undergoing surgery (dobj)
cell myocardial (amod)
dependence with (case)
worsened was (auxpass)
treated d (nmod)
corrected . (punct)
meth after (case)
heart rabbit (compound)
nephrosis adr-induced (amod)
cardiomyopathy children (nmod)
min 6 (nummod)
injection intramuscular (amod)
following particularly (advmod)
similar were (cop)
demonstrated who (nsubj)
acute by (case)
particles of (case)
overdose delirium (nmod)
acetate with (case)
hypaque of (case)
doses wt/day (appos)
reduces mice (nmod)
interference catheters (nmod)
mediate fibrosis (dobj)
mg/kg once (advmod)
patients virus (compound)
transducer differential (amod)
present , (punct)
described course (dobj)
rate mortality (compound)
activation this (det)
peaked day (nmod)
mg/kg s.c. (advmod)
abnormalities baseline (compound)
agitation on (case)
agent atypical (amod)
site of (case)
results increased (appos)
increases treatment (nsubj)
aim report (acl)
followed this (nsubjpass)
concentrations steady-state (amod)
drowsiness perception (conj)
constant also (advmod)
caused controls (nmod)
receptors acid(a (compound)
measured . (punct)
part first (amod)
prevention disease (nmod)
boy in (case)
secretion prl (compound)
increase concentration (nsubj)
reactions from (case)
densities adrenergic (amod)
recorded administration (nmod)
radius ultradistal (amod)
obtainable be (cop)
mediates toxicity (dobj)
perimenopausal and (cc)
mg/m2 dose (nsubj)
use sedation (nmod)
exhibited effect (dobj)
first study (nsubj)
unnecessary is (cop)
effect neurotoxicity (nsubj)
synthesis vivo (advmod)
data some (det)
occur complications (nsubj)
equal and (cc)
changes intervention (nmod)
cervical and (cc)
phase associated (acl)
patients trials (nmod)
contains cyanamide (dobj)
men hypertensive (amod)
11.2 +/- (cc)
mg/kg 49 (nummod)
chemotherapy cancer (nmod)
correlate to (mark)
h before (case)
182 to (case)
controlled carefully (advmod)
interpretation an (det)
include fields (nsubj)
months year (appos)
safely and (cc)
proven incidence (nmod)
progression on (case)
tissues inner (amod)
reversible posterior (amod)
acidity , (punct)
occurring level (nmod)
diagnosed unless (mark)
inhibited pce (nmod)
angiography patients (nmod)
potential in (case)
efficacy for (case)
reconstruction immediate (amod)
increase expression (nsubj)
behavior michaelian (amod)
demonstrate behaviors (dobj)
retching , (punct)
implanted bilaterally (advmod)
recipients transplant (compound)
bioavailability and (cc)
seizure-prone alcohol-na (nmod:npmod)
rare minor (conj)
regimen once-daily (amod)
overdosages phenytoin (compound)
levels relationship (dep)
identified localization (dobj)
macrolides other (amod)
patients 8000 (nummod)
ar ( (punct)
reverses effect (dobj)
found exception (nmod)
epiphyses stippled (amod)
vulnerability the (det)
intermediate that (mark)
frontal and (cc)
women use (nmod)
4',7-dihydroxy-isoflavone ) (punct)
dose , (punct)
missed however (advmod)
excretion renography (nmod)
hypoxia transient (amod)
correlated therapy (nmod)
administration curcumin (compound)
determined determining (advcl)
development pseudolithiasis (nmod)
pressures unrecordable (amod)
carcinoma adenocarcinoma (conj)
effect adriamycin (nmod)
cromakalim and (cc)
undertaken part (nmod)
comparison subjects (nmod)
specificity for (case)
myocarditis . (punct)
promote consistent (advmod)
mg mg/caffeine (compound)
observed female (nmod)
gvg dose (compound)
excluded appeared (advcl)
reflex the (det)
role p-aminophenol (nmod)
safety capecitabine (nmod)
simvastatinezetimibe ) (punct)
hepatotoxicity drug-related (amod)
% 215 (nummod)
pallidotomy knife (nmod)
injection nicotine (compound)
mmhg 17 (nummod)
identifying genes (dobj)
worth improvement (nmod)
disruption bonding (nmod)
degeneration exposure (nmod)
products bradykinin (conj)
infants term (compound)
need that (mark)
had return (dobj)
ability their (nmod:poss)
affect forestomach (nmod)
role a (det)
0.94 1.56 (appos)
39.6 29.2 (conj)
users ; (punct)
procaterol , (punct)
doses mg/kg/i.p (appos)
analysis minimal (amod)
modulating hemorrhage (dobj)
didanosine ddi (appos)
encephalopathy iii/iv (nummod)
likely likely (advcl)
event are (cop)
% 61 (nummod)
safety treatment (nmod)
scatter ( (punct)
needed unnecessary (dep)
ci 7.8 (appos)
increased yields (nsubj)
level lower (amod)
state naloxone (appos)
coefficient diffusion (compound)
$ROOT$ aimed (sent)
years per (case)
139 of (advmod)
doses chlormethiazole (nmod)
mother second (amod)
antagonists a(2a (compound)
findings investigators (nmod)
calcification group (nmod)
treatment ergotamine/caffeine (nmod)
rats % (appos)
regulation variety (nmod)
facilitation significant (amod)
sv ( (punct)
shown although (mark)
seems deserve (xcomp)
concluded anticipated (ccomp)
hl60 cells (conj)
relatives affected (acl)
period study (nmod)
using emphasis (nmod)
interleukin the (det)
prevented development (nsubjpass)
gellan ( (punct)
p=0.003 and (cc)
agent causative (amod)
picrotoxin of (case)
infarctions acute (amod)
dilation cardiac (amod)
reduced inhibited (conj)
history five-year (amod)
suffered therapy (nmod)
35 25 (compound)
necrosis tumor (compound)
stress the (det)
treatment exchange (nmod)
divided and (cc)
concentration triglyceride (nmod)
decreased reach (conj)
used models (nsubjpass)
infusion central (amod)
course arthritis (nmod)
highlight amelioration (nmod)
deposition bilirubin (compound)
albuterol intermittent (amod)
analogue . (punct)
administration ibuprofen (nmod)
fasciculation first (amod)
carbonate lithium (compound)
insertion shunt (compound)
decreased pressure (nsubjpass)
gds 6 (nummod)
alpha-2b weekly (advmod)
increase correlation (conj)
mumol ) (punct)
jj in (case)
arteriosclerosis coronary (amod)
gene beclin (compound)
pathways via (case)
developed microangiopathy (dobj)
signs nms (nmod)
period 2000 (nummod)
produced however (advmod)
hypothermia . (punct)
. 9 (nummod)
episodes % (appos)
medialipid in (case)
damage duct (acl:relcl)
effects rare (amod)
efficacy - (nmod)
channels the (det)
developed method (dobj)
altering modulation (dobj)
relapsed subsequently (advmod)
months subsequent (amod)
regimens 4-hourly (amod)
receptor with (case)
some sequelae (nmod)
required level (nsubj)
tumors pituitary (amod)
ci % (compound)
d-1 both (cc:preconj)
some bias (nmod)
disfiguring extensive (advcl)
pituitaries their (nmod:poss)
variable response (compound)
those polypeptide (nmod)
outpatients in (case)
conducted estimate (advcl)
8 5 (compound)
induced combination (nmod)
subject regulation (nmod)
county in (case)
showing interaction (dobj)
nsclc ) (punct)
concentrations mesna (compound)
paradigm pa (compound)
produces pigs (nmod)
fluphenazine d1/d2 (compound)
agent remoxipride (appos)
man 74-year-old (amod)
effectiveness and (cc)
provide . (punct)
hemodynamics oxytocin (nmod)
studies binding (compound)
taking bromocriptine (dobj)
analysed spectrometry (nmod)
used improve (xcomp)
warfarin between (case)
vp-16 213 (nummod)
number larger (amod)
regimen as (case)
predisposes leukopenia (nsubj)
gamma-carboxylation protein (nmod)
produced corticosteroids (nsubj)
four including (case)
evaluated microscopically (advmod)
symptoms hypotension (nmod)
daunorubicin : (punct)
developed pointes (dobj)
wistar lw (appos)
hypnotic be (cop)
effects erythrocytes (nmod)
acute less (advmod)
indicated appear (ccomp)
similar approximately (advmod)
2.7 ) (punct)
levels factor-alpha (nmod)
neurological electrophysiological (conj)
myopathy fibrous (amod)
recognised problem (nmod)
capable antagonism (nsubj)
group amphetamine-free (amod)
subscale scale (compound)
cords the (det)
progression or (cc)
epilepticus of (case)
expressed , (punct)
measured passing (advcl)
gained knowledge (dobj)
chemotherapy combination (compound)
blocker losartan (appos)
effects long-term (amod)
myofilaments of (case)
high was (cop)
negative 46 (conj)
exhibited and (cc)
degeneration tubules (nmod)
asked . (punct)
proteinuric were (cop)
use risk (conj)
= risk (nsubj)
unremarkable . (punct)
alt cpk (conj)
five-fold up (advmod)
detected blotting (nmod)
mediate , (punct)
intervals all (det)
mk-801 of (case)
ginsenosides rg1 (compound)
considered suggests (conj)
play therapy (nmod)
treatment attacks (nmod)
august 2008 (nummod)
damage reflected (dep)
discontinued nephrotoxicity (nmod)
10 ) (punct)
factor apoptosis-inducing (amod)
failure end-stage (amod)
pra ( (punct)
defense paws (nmod)
processes in (case)
related meloxicam (nmod:npmod)
studies time (compound)
enhanced conclusion (nmod)
syndrome diabetes-insipidus-like (amod)
bromide vecuronium (compound)
$ROOT$ recalled (sent)
hypothyroidism with (case)
content mineral (compound)
test sestamibi-spect/dobutamine (compound)
effects diabetes (nmod)
had women (conj)
animals group (nmod)
workers to (case)
concordance twins (nmod)
dialysis outpatient (amod)
ginsenosides the (det)
measured as (mark)
midazolan flumazenil (conj)
rate mutants (nmod)
used yet (cc)
discussed herein (advmod)
deemed , (punct)
allowed ; (punct)
mg/kg/day 500 (nummod)
effect infections (nmod)
grade lower (amod)
stands out (compound:prt)
atherosclerosis with (case)
week hemorrhage (nmod)
induced hexachloride (nmod)
sensitive whether (mark)
cytokine inflammatory (amod)
$ROOT$ heparin (sent)
peptide and (cc)
involved study (nsubj)
scarce are (cop)
lacked , (punct)
seemed differ (xcomp)
segment cerebral (amod)
dose amphetamine (nmod)
responses cirazoline (nmod)
had minutes (nmod)
probed we (nsubj)
aspects some (det)
accumulation esters (nmod)
euthymia = (dep)
characteristics reaction (compound)
aggravates causes (conj)
citrate regional (amod)
reduces induction (nsubj)
behavioral eeg (conj)
administration succinylcholine (nmod)
necrosis ability (conj)
contained specimen (nsubj)
glomerulonephritis crescents (nmod)
solution 5mg/kg (appos)
evolution lesions (appos)
% 2.7%-8.5 (nummod)
$ROOT$ vol% (sent)
multiple ( (punct)
proliferation fanft-induced (amod)
remained week (nmod)
injections metrizoate (compound)
administration castration (conj)
group cya (appos)
generator called (amod)
episodes grade (nmod)
scattered minority (nsubjpass)
day ifosfamide (nmod)
hyperkalemia with (case)
condition cystitis (nsubj)
cycles six (nummod)
1.17 1.42 (appos)
carboplatin administered (acl)
apigenin with (case)
sedation or (cc)
finding responsiveness (nsubj)
cancer lung (compound)
animals doxorubicin-treated (amod)
infusion combination (nmod)
alterations expression (nmod)
weight height (conj)
ml ml. (conj)
subjects patients (conj)
states quiet (amod)
dexmedetomidine with (case)
repeated intervals (nmod)
increases postpartum (nmod)
dyskinesias agonist-induced (amod)
24.3 and (cc)
40 > (advmod)
abuse heroin (compound)
toxicity system (compound)
medication antiemetic (amod)
effects injection (nmod)
times min (appos)
manipulating seizures (nmod)
peptides tested (acl)
examining effects (dobj)
case misjudgment (nmod)
nephrotoxicity gentamicin (compound)
any cancers (nmod)
influences seizures (nmod)
damage muscles (nmod)
developed syndrome (conj)
comparing effects (dobj)
nephrotoxicity and (cc)
ck ) (punct)
appeared months (nmod)
mumol/l 7.4 (nummod)
frequently disoprivan (nmod)
constriction thought (acl)
obtained information (dobj)
gains acting (advcl)
neutralization and (cc)
attenuation syndrome (nmod)
received e1 (dobj)
processes including (case)
change tempol (nsubj)
selected we (nsubj)
stimulation once (advmod)
characterized low (nmod)
restricted response (nsubj)
$ROOT$ beneficial (sent)
thrombophlebitis suspected (amod)
cholesterol ) (punct)
effects nociceptive (amod)
fk , (punct)
showed factor (ccomp)
estimated carefully (advmod)
renal eighty-one (nummod)
caudate in (case)
help detect (xcomp)
tmax lp (nmod)
receiving penicillins (dobj)
black reports (nmod)
breaks ) (punct)
failed concentrations (nsubj)
ato-treated non-treated (conj)
nausea from (case)
monitoring electrocardiographic (compound)
globulin b (compound)
report of (case)
deposits igg (nmod)
treatment was (cop)
organ solid (amod)
rats unrestrained (amod)
manifestation vasculitis (nmod)
tool rats (nsubj)
controls crf (conj)
depressed rats (nmod)
location sound-source (compound)
hours admission (nmod)
follow route (dobj)
occurred which (nmod)
appear therefore (advmod)
experiences the (det)
anemia hemolytic (amod)
life his (nmod:poss)
alter alter (conj)
doses thalidomide (nmod)
troublesome not (neg)
del ser311cys (conj)
phase 6-week (amod)
anuria , (punct)
produces background (nsubj)
ae ( (punct)
intoxication uncomplicated (amod)
adenosine-5'-triphosphate beta-methylene (compound)
examination collection (conj)
10.4 +/- (cc)
occlusion branch (compound)
undergone having (aux)
detected respectively (advmod)
extensive and (cc)
months up (nmod)
migrainosus status (compound)
epileptogenecity patients (nmod)
species of (case)
required instances (nmod)
increased mg.per (parataxis)
mg/dl 2.53 (nummod)
week hydrocortisone (nmod)
describes . (punct)
was also (advmod)
pod 9 (nummod)
rigidity during (case)
cells stained (acl)
that . (punct)
development proteinuria (compound)
$ROOT$ amoxicillin-clavulanate (sent)
shed mechanisms (nmod)
p < (amod)
result direct (amod)
present discuss (conj)
stabilized hyperparathyroidism (nmod)
diets choline-devoid (amod)
activation to (case)
countries of (case)
interference with (case)
volume ml (nmod)
delay management (nmod)
discovery of (case)
visit long-term (amod)
had causes (dobj)
reduced preparations (nmod)
decrease count (compound)
developed calculi (dobj)
exert androgens (nsubj)
icr and (cc)
demonstrates protect (ccomp)
conducted synthesize (advcl)
doxorubicin only (advmod)
changes concentrations (nmod)
indicates factors (ccomp)
6 1 (compound)
66.9 range (dep)
larger patients (nmod)
retardation significant (amod)
prot ) (punct)
abolished tachycardia (nsubjpass)
cross-reactivities forms (nmod)
patients five (nummod)
occurred angiosarcoma (nsubj)
gliomas malignant (amod)
require consideration (dobj)
smaller but (cc)
regions endemic (amod)
vomiting of (case)
actin the (det)
animals to (case)
recorded ten (nmod)
weight baseline (compound)
effective demonstrated (advcl)
$ROOT$ hypoxia (sent)
patients 3 (conj)
meth with (case)
$ROOT$ summary (sent)
patients 24 (nummod)
agonists skf-82958 (nmod)
tested nimesulide (nmod)
limitation reliance (nsubj)
intolerance lens (compound)
decreased allopurinol (nsubj)
provide insights (dobj)
donor ( (punct)
aida microl (appos)
possible survival (nsubj)
permits reduces (conj)
manner double-blind (amod)
neurotoxicity conversion (conj)
decrease on (case)
% ci (appos)
range normal (amod)
protective as (advmod)
immediately and (cc)
maze maze (conj)
smaller majority (nsubj)
section urgent (amod)
acid ( (punct)
increased verapamil (nsubj)
compared given (advcl)
androgen with (case)
rated , (punct)
outcomes disease (compound)
injury serious (amod)
parenchyma into (case)
paper this (det)
showed curve (nsubj)
releaser acetylcholine (compound)
pretreatment mg (nmod)
memory on (case)
paracetamol/day g (nummod)
returned zero (nmod)
losartan ) (punct)
failure irreversible (amod)
a(1)/a(2a ( (punct)
prevented were (auxpass)
sympathectomy post (amod)
increase interval (dobj)
l. ( (punct)
mg.kg(-1).min(-1 ) (punct)
patients as (cc)
scopolamine microl (dep)
doses fzp (nmod)
agent tumor (compound)
conclude affirming (advcl)
determine reduces (ccomp)
accounts . (punct)
reflect level (dobj)
ratio the (det)
blockade atropine (nmod)
prostaglandins pgs (appos)
details carcinogenesis (nmod)
resulted dysrhythmogenic (conj)
contribute incidence (nmod)
layer the (det)
occurred precipitated (conj)
activity sensitivity (conj)
phenotype to (case)
activity anticataleptic (amod)
doubled , (punct)
phentolamine and (cc)
assay sensitive (amod)
showed lasted (conj)
used 3-methyladenine (nsubjpass)
augmented significantly (advmod)
lumens and (cc)
developed and (cc)
attenuates incorporation (nsubj)
pathophysiology in (case)
treatment neonatal (amod)
rizatriptan of (case)
mmol/l of (case)
review effects (nmod)
alternatives are (cop)
effects nausea (nmod)
modulation in (case)
drugs nsaid (appos)
$ROOT$ regulates (sent)
withdrawn . (punct)
compared buffer (nmod)
agitation and (cc)
occlusion . (punct)
ligation by (case)
reported fluoxetine (nsubjpass)
feature major (amod)
% 54.5 (nummod)
syndrome hemolytic-uremic (amod)
size colour (conj)
pressure her (nmod:poss)
bundle papillo-macular (amod)
hippocampus in (case)
0 of (case)
child impairment (nmod)
mitoxantrone of (case)
phosphate tri-ortho-tolyl (compound)
considered stenosis (nsubjpass)
mbc ( (punct)
percent control (nmod)
tgf-b nf- (conj)
produced they (nsubj)
compounds with (case)
catalepsy parkinsonian (amod)
disorder the (det)
m3 for (case)
hypereosinophilia with (case)
maintained panel (nsubjpass)
illness evidence (conj)
responded . (punct)
mg/kg 1 (nummod)
caused courses (nsubj)
administration intravenous (amod)
assay modified (amod)
combined given (conj)
results reduce (appos)
prooxidant can (aux)
dose increased (acl:relcl)
suspected composed (conj)
diagnosed widow (nsubjpass)
points multiple (amod)
induced agonist (nsubj)
blockade output (conj)
flow myocardial (amod)
induced products (nmod)
studied blockers (dobj)
exhibits and (cc)
aspects generation (nmod)
11 to (quantmod)
tafi antigen (conj)
hypopharynx and (cc)
collapsed finally (advmod)
membranes basement (compound)
efforts resuscitation (compound)
determined responsiveness (nsubjpass)
mice by (case)
correct hypokalemia (dobj)
placebo : (punct)
suppression be (cop)
elevation blood (compound)
seizures patient (nmod)
report syncope (dobj)
min 15 (nummod)
vasospasm gangrene (nmod)
sum segment (nmod)
iodine of (case)
metabolised . (punct)
22 - (punct)
randomized 447 (conj)
sirolimus immunosuppression (nmod)
led failure (nmod)
correlated age (nmod)
obtained to (mark)
caffeine-free placebo (dep)
39+/-10 vs. (cc)
proteinuria glomerulosclerosis (conj)
consequence blocking (advcl)
venules the (det)
counteracted decrease (dobj)
patients 38 (nummod)
level hemoglobin (compound)
erp length (conj)
pattern same (amod)
had phase (nmod)
induced ceftriaxone (nmod)
man 58-year-old (amod)
aetiology syndrome (nmod)
given ly274614 (nsubjpass)
one no (neg)
levels renin (compound)
therapy next (amod)
placebo dose (conj)
associated improvement (nsubjpass)
published or (cc)
constitute cause (dobj)
clonazepam of (case)
pain lancinating (amod)
eeg frequency (dep)
expression them (nmod)
changes hypertension (nmod)
mptp toxin (compound)
included patients (nmod)
hematological gastrointestinal (conj)
spectrum children (nmod)
receptors opioid (amod)
change was (cop)
serum free (dep)
rats pb-exposed (amod)
efficiency less (amod)
bronchodilator a (det)
used measure (xcomp)
suggestions experts (nmod)
concentration peptide (compound)
et-1 ( (punct)
vary affinities (nmod)
administered nitroglycerin (nsubjpass)
agent beta-adrenergic (amod)
represses that (nsubj)
vulnerability particular (amod)
vary axis (nmod)
$ROOT$ altered (sent)
rhabdomyolysis , (punct)
amounts varied (amod)
bradycardia beats (dep)
managed continuing (nmod)
combination each (det)
% 51 (nummod)
$ROOT$ focus (sent)
two last (amod)
patients 6 (nummod)
rats rendered (acl)
repeated case (nmod)
induced increases (dobj)
> p (dep)
similar ( (punct)
men both (det)
= ratio (nsubj)
scans magnetic (amod)
protection only (advmod)
dips head (compound)
related injury (nmod)
raised level (nmod)
efficacious strategy (nsubj)
woman by (case)
signal central (amod)
suitable particularly (advmod)
rates occupancy (compound)
transformation during (case)
correlated and (cc)
scores higher (amod)
counted day (nmod)
block prolonged (amod)
blocks . (punct)
observations had (appos)
associated produces (advcl)
indices arthritis (compound)
igf ) (punct)
analyzed purpose (nmod)
preventing development (dobj)
levels onset (conj)
0.25 p (dep)
gain % (appos)
kidney organs (conj)
intubated was (auxpass)
polyuria polydipsia (conj)
reactions hypersensitivity (compound)
population of (case)
corroborate data (nsubj)
doses u-ii (nmod)
eye ) (punct)
lesions or (cc)
dose valdecoxib (compound)
syndrome from (case)
nos-ir , (punct)
lev with (case)
decrease or (cc)
$ROOT$ erection (sent)
blockers ca(2 (compound)
propofol of (case)
option be (cop)
potent ; (punct)
= 0.003 (dobj)
increases 15-db (nummod)
instillation intrathecal (amod)
plan receptor (nsubj)
0.4-fold gliclazide (nmod)
proteinuria dysfunction (conj)
intensity stimulation (compound)
tolerated shows (conj)
prod ) (punct)
associated dna (nmod:npmod)
causing pain (dobj)
nonmutant wild-type (dep)
evaluated audit (nmod)
remains entity (nmod)
withdrawn ischemia (nmod)
adults middle-aged (amod)
trial levels (nmod)
paresthesias , (punct)
recorded data (nsubjpass)
continued uneventfully (advmod)
undergoing . (punct)
inferior the (det)
caused pressure (dobj)
cardiomyopathy the (det)
reduces dyskinesias (dobj)
19 % (appos)
stage disease (nmod)
nuclear mitochondrial (conj)
type the (det)
weight/week mg/kg (compound)
channel and (cc)
scale brief (compound)
acid-induced amoxicillin-clavulanic (amod)
reports paralysis (nmod)
conversion weeks (nmod:npmod)
done week (nmod)
co-administration aspirin (compound)
syndrome related (amod)
rise paradoxical (amod)
maintained responses (nsubjpass)
one as (case)
seizure first (amod)
alterations susceptibility (nmod)
objectives/hypothesis : (punct)
quantified we (nsubj)
chemotherapy no (neg)
aware urologists (nsubj)
dosages therapeutic (amod)
possibility reproducing (acl)
open still (advmod)
reports children (nmod)
mg 480 (compound)
symptoms menstrual (amod)
associated these (nsubjpass)
characteristics duration (nmod)
intake water (compound)
survivors no (neg)
decrease fraction (nmod)
identify cta (nsubj)
synthesis pharmacological (conj)
pattern in (case)
risk additional (amod)
patients osteoarthritis (nmod)
progressed while (mark)
licl mmol/kg (appos)
postulates . (punct)
i.p. mg/kg (compound)
required maintenance (nmod)
= 7.619 (dobj)
induce may (aux)
basis fibers (nmod)
property the (det)
patients hbv-dna (compound)
compared identify (advcl)
compared variables (nmod)
seem inhibit (xcomp)
developed immediately (advmod)
mechanisms plausible (amod)
found children (nmod)
day + (dep)
monitoring ekg (compound)
44 four (compound)
regulation metabolism (nmod)
warranted that (nsubj)
finding invariable (amod)
flavour a (det)
users first-time (amod)
months mean (dep)
response of (case)
inheritance recessive (amod)
u 30 (nummod)
quantify severity (dobj)
testes and (cc)
patients rrmm (compound)
acidity be (cop)
pattern absence (nmod)
remained well (advmod)
comparisons binary (amod)
responsiveness signs (nmod)
changes urothelium (nmod)
process oxidative (amod)
2.6 3.8 (nummod)
oxidative/nitrosative neuroinflammatory (conj)
substrate bbb (nmod)
heart ob (nmod)
models inflammatory (amod)
increases pretreatment (nsubj)
developed rs (dobj)
stomatitis , (punct)
necessary however (advmod)
cirrhosis and (cc)
cardiotoxicity influenced (acl:relcl)
immunosuppression cya (appos)
released implant (nmod)
d-1 d-2 (conj)
restoring activity (nmod)
= 0.008 (dobj)
diverse structurally (advmod)
diagnosis toxicity (nmod)
administration verapamil (compound)
blood-brain-barrier bbb (appos)
reaction of (case)
markers modifiable (acl:relcl)
syncope bradycardia (conj)
infarction report (dep)
content increased (amod)
cases 272 (nummod)
remoxipride , (punct)
progression regurgitation (nmod)
neurotoxic activation (nmod)
pod 7 (nummod)
follows was (cop)
scores scale (nmod)
outcome secondary (amod)
exercise-isoproterenol control (conj)
patient due (amod)
att-alf in (case)
complex generalized (conj)
receptors bradykinin (compound)
asymptomatic reversible (conj)
gaba vigabatrin (appos)
ml blood (nmod)
case paralysis (nmod)
given antagonists (nsubjpass)
laboratory , (punct)
feeling patients (nmod)
nurse a (det)
56.8 +/- (cc)
recorded thrombosis (nmod)
hypercalcemia b (appos)
episodes 125 (nummod)
decreased -- (punct)
stabilized months (nmod)
purposes rescue (compound)
agent immunomodulatory (amod)
scored overall (advmod)
perfused arterially (advmod)
hypoplasia nasal (amod)
transmission nociceptive (amod)
mk801 ) (punct)
2.30 - (advmod)
cancers for (case)
withdrawn as (mark)
confirm exclude (conj)
effect damage (nmod)
% 5.8 (nummod)
consisting 2-acetylaminofluorene (nmod)
induced pyrazinamide (nmod)
associated growth (nmod)
diarrhea shock (conj)
manifestation in (case)
mofetil sirolimus (conj)
exist relationship (nmod)
irrigated juice (nmod)
measured efficacy (nsubjpass)
exposure puberty (nmod)
measurements arterial (amod)
blockage the (det)
4.7 . (punct)
focus less (amod)
weaker that (nmod)
second- as (case)
limbs of (case)
allocated participants (nsubjpass)
slowed reaction (dobj)
ecstasy and (cc)
bpm 6 (nummod)
effects locomotor (amod)
levels cholesterol (nmod)
cessation after (case)
augments seizure (dobj)
performed controls (nmod)
pre-operative intra-operative (conj)
showed have (xcomp)
disappeared later (advmod)
l-noarg ; (punct)
cells inflammatory (amod)
micromol/liter [ (punct)
chemotherapy bcnu (compound)
accentuated response (nsubjpass)
9.2 +/- (cc)
treated control (xcomp)
resulted therapy (nmod)
8.5 . (punct)
method electromyographic (amod)
concentration hdl (nmod)
pain subjects (nmod)
baseline under (case)
qrs of (case)
contribution urotoxicity (nmod)
16 0.7 (conj)
warned effects (nmod)
have insights (nsubj)
administration ) (punct)
easy is (cop)
administered intrastriatally (advmod)
symptoms rls (compound)
500 200 (compound)
cause inhibition (dobj)
toxic four (conj)
15.9 > (advmod)
sinus av (conj)
ago year (nmod:npmod)
mrnas prl-r (compound)
implicated association (nsubj)
recipients 2 (nummod)
viruses rna (compound)
rose stopped (conj)
decontamination and (cc)
were , (punct)
contributed coagulopathy (nmod)
continued irregularly (advmod)
17 - (punct)
extract rosa (compound)
disability for (case)
associated which (nsubjpass)
rats licl-pre-treated (amod)
attack during (case)
function detrusor (compound)
doses mg/m2 (nmod)
assessed basis (nmod)
comprised treatment (nsubjpass)
test indirect (amod)
contraceptives ocs (appos)
diameter diastolic (amod)
any groups (nmod)
recipients allograft (compound)
inhalator salbutamol (nmod)
signs posture (nmod)
some with (case)
described eight (nsubjpass)
curve effect (compound)
tremor were (cop)
exposed anesthesia (nmod)
concentrate to (mark)
occurred instances (nsubj)
hbv overt (amod)
failed rats (nsubj)
stroke , (punct)
mg/g and (cc)
atonic and (cc)
viracept was (cop)
hypertrophy ducts (nmod)
sec/cm5 ( (punct)
pd mdp (conj)
suggests release (dobj)
risk due (case)
fibrillation persisting (amod)
improvement marked (amod)
71 47 (compound)
correlated rise (nmod)
pressure baseline (compound)
measurements simultaneous (amod)
mice mice (conj)
placentae retained (amod)
injections mice (nmod)
shorter significantly (advmod)
auc mean (amod)
trials similar (amod)
present acidosis (nsubj)
disease outcome (nmod)
studies mr (compound)
worsening bolus (nmod)
patients 1188 (nummod)
differences by (case)
fraction filtration (compound)
mg/dl p<0.02 (appos)
determined later (advmod)
syndromes belonging (acl)
treat recovery (nmod)
control same (amod)
13 7 (compound)
degeneration isolated (amod)
deterioration thrombosis (conj)
metabolism oxidative (amod)
administered s-1 (nsubjpass)
4 patients (nmod)
anesthesiologists of (case)
air c (dep)
induced had (advcl)
rare manifestations (nsubj)
segments of (case)
determined abnormalities (dobj)
experiments microdialysis (compound)
analysis bergman (compound)
therapy sulpiride (compound)
benefit patient (compound)
power low (amod)
mediated potentiation (nmod)
years 32.5 (nummod)
electrodes subcutaneous (amod)
brush-evoked and (cc)
tam microm (amod)
fk506 srl (conj)
followed seizures (nsubj)
depressed but (cc)
antibiotic macrolide (compound)
increases movements (nmod)
believe had (advcl)
death her (nmod:poss)
series another (det)
da hva (compound)
antagonist flumazenil (appos)
administration phenylethylbarbiturate (nmod)
message : (punct)
increased which (nsubjpass)
dose-dependent that (mark)
moderate or (cc)
inhibits valproate (nsubj)
% 9.7 (nummod)
event in (case)
> meq/l (dobj)
present findings (dobj)
cb acid (appos)
mice c3heb/fej (compound)
nuclei and (cc)
moiety an (det)
receive mg (dobj)
proved relationship (nsubjpass)
scales other (amod)
rehabilitation drug (compound)
dogs beagle (compound)
strokes from (case)
detecting in (mark)
affected often (advmod)
nausea because (case)
examined shr (nmod)
diltiazem blocker (appos)
11 5 (compound)
mg/l 19 (nummod)
feasibility using (acl)
hyper-responsiveness a (det)
course withdrawal (nmod)
plasticity motor (compound)
mother infection (nmod)
transmission and (cc)
applicators information (nmod)
ng./ml . (punct)
women than (case)
hyperkinesis the (det)
delirium connected (acl)
protecting seizures (nmod)
experiments some (det)
rt-pcr ) (punct)
developed tetany (dobj)
benefit acid (nsubj)
preserved . (punct)
strategy an (det)
found treatment (nmod)
patient iu/l (appos)
complications neurologic (amod)
disorders mood (compound)
site gaba(a (compound)
conjugates in (case)
completed year (nmod)
dosage increased (amod)
cause change (dobj)
permeability changes (conj)
toxic associated (conj)
mediated decrease (nmod)
thrombosis woman (nmod)
interval the (det)
signs on (case)
chemotherapy gem-p (nsubj)
spasm arterial (amod)
gaba of (case)
assaults toxic (amod)
plexus choroid (compound)
mechanism caused (acl:relcl)
units dosage (compound)
examined impact (nsubjpass)
possessed isomers (nsubj)
transplantation unsuccessful (amod)
symptoms withdrawal (compound)
describe administration (nmod)
raises also (advmod)
diabetic toxic (conj)
1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea ccnu (appos)
ip intraperitoneally (advmod)
comparable groups (nsubj)
vaccine derived (amod)
3.8 3.1 (quantmod)
incidence injection (nmod)
carcinoma in (case)
infusions gnc92h2 (compound)
agent clopidogrel (appos)
pvn the (det)
min 0 (nummod)
flumazenil . (punct)
deficits potential (conj)
demonstrated transplantable (nmod)
disadvantages are (cop)
$ROOT$ enhancement (sent)
blockade non-selective (amod)
hg 90 (nummod)
therapy menorrhagia (nmod)
increased yohimbine (nsubj)
9.84 +/- (cc)
antigen antibody (conj)
activity pain-related (amod)
200 400 (conj)
drugs inotropic (amod)
cna ) (punct)
pathology treatment (nmod)
lack certainly (advmod)
arousal ability (conj)
mm 38.6 (nummod)
increasing cxad (dobj)
control in (case)
force on-state (nmod)
care with (case)
$ROOT$ rare (sent)
oat1 of (case)
chloride intravenous (amod)
measuring by (mark)
cessation administration (conj)
$ROOT$ paraplegia (sent)
type suggested (acl:relcl)
1.1 and (cc)
reabsorption tubules (nmod)
hem snp (conj)
cddp by (case)
events occur (acl:relcl)
epilepsy = (dep)
using months (nmod)
g/m2/d 1.55 (nummod)
$ROOT$ 91.5 (sent)
susceptible highly (advmod)
controlled lorazepam (nmod)
doses 7 (nummod)
suited research (nmod)
beta-blocker and (cc)
status antioxidant (amod)
assessment quantitative (amod)
$ROOT$ calculated (sent)
suggested . (punct)
expression seizure (compound)
induces even (advmod)
coma paracetamol-associated (compound)
occurs patients (nmod)
provided conclusions (nsubj)
determined concentration (nsubjpass)
have although (mark)
remission while (case)
lidocaine penicillin (conj)
compared torr (nmod)
finding from (case)
evaluated efficacy (nsubjpass)
found had (xcomp)
[3h]-l-arginine nmol/l (amod)
disappear alleviated (conj)
inhibition through (case)
demonstrated however (advmod)
hydrochloride with (case)
hyperactivity myocardial (amod)
definition dose (compound)
studies prospective (amod)
supply inositol (compound)
men or (cc)
showed potentials (dobj)
increase pathological (amod)
epidemiology syndrome (nmod)
tempol scavenger (compound)
mechanical and (cc)
features clinical (amod)
embryo the (det)
improve , (punct)
co-administered dose (nmod)
uterotonic oxytocin (nsubj)
administration inpatient (amod)
constants in (case)
restarted patient (nsubjpass)
examined use (nmod)
incontinence prazosin-induced (amod)
d4.2 , (punct)
compliance treatment (nmod)
blind placebo (dep)
calculated computer (nmod)
levels caffeine (compound)
conversion immunosuppression (nmod)
catecholamines neuropeptides (conj)
remain background (nsubj)
caused hyperprolactinemia (dobj)
agonists used (acl)
associated nephrotoxicity (nmod)
have mutations (dobj)
treated infants (nsubjpass)
rigidity bradycardia (conj)
renin , (punct)
convulsions death (conj)
extubated again (advmod)
td50 divided (cc)
correlate readings (nmod)
reduce effects (dobj)
provided measures (dobj)
a1 ( (punct)
str ) (punct)
characteristics development (nmod)
determined expression (nsubjpass)
infiltration ventricles (nmod)
involved processes (nmod)
breathing with (case)
ended and (cc)
segment posterior (amod)
embryo developing (amod)
reduction maximal (amod)
fluoxetine fluoxetine (appos)
proteinases gly-phe-leu-gly (appos)
temazepam of (case)
thresholds auditory (amod)
seen relationship (nsubjpass)
administered rats (nsubjpass)
controls p=0.48 (dep)
kg-1 h-1 (compound)
commencement before (case)
case neuropathy (nmod)
reduced it (nsubj)
preference paw (compound)
26.7 ci=25.2 (dep)
reviewed studies (nsubjpass)
epirubicin , (punct)
hippocampus behaviors (nmod)
study placebo-controlled (amod)
reaction patients (nmod)
solvent by (case)
february 2002 (nummod)
fibrillation agents (nmod)
analysed intervals (nmod)
inhibited naloxone (nsubj)
oxide concentration (conj)
drug analgesic (amod)
withdrawn experiences (nmod)
effects tremor (compound)
test useful (amod)
women hiv (nmod)
smaller doses (nmod)
hydrochloride 3s (compound)
case vasospasm (nmod)
adults with (case)
leading dilatation (nmod)
asymmetry id50 (conj)
dextran iron (compound)
subtle however (advmod)
benztropine to (case)
spontaneous greater (amod)
disorder co-morbid (amod)
given regimen (dobj)
pain burning (amod)
anorexia nausea (conj)
transgene hypoxia-responsive (amod)
monitored was (auxpass)
previously months (nmod:npmod)
hour an (det)
abolition the (det)
stage terminal (amod)
group risk (compound)
underwent center (nmod)
polyuria such (case)
improved stopping (advcl)
tubular regions (dep)
had three (conj)
formed cells (nmod)
activity therapy (nmod)
other , (punct)
events are (cop)
considered result (nsubjpass)
area glomerular (amod)
9.88 - (punct)
mtx 5-fu (conj)
lobund-wistar l-w (dep)
effect rare (amod)
exposures low-level (amod)
survey strains (nmod)
solubility of (case)
nephropathy : (punct)
mmp-2 adam-10 (conj)
symptoms cystitis (dep)
rats normotensive (amod)
began take (xcomp)
determined subcortex (nmod)
convert rhythm (nmod)
effects ginsenosides (nmod)
titrated therapy (nsubjpass)
man 30-year-old (amod)
step regulation (nmod)
responses class (nmod)
pathways conversion (nmod)
depend may (aux)
gr with (case)
enhanced whereas (mark)
drug necessary (amod)
induced cp (nsubj)
compliance his (nmod:poss)
blinded who (nsubjpass)
assessed neurotoxicity (nsubjpass)
hg baseline (nmod)
experienced change (dobj)
91.5 and (cc)
necessary although (mark)
treated isoproterenol (nmod:npmod)
prior ) (punct)
procaterol asthma (nmod)
pnd ( (punct)
formation radicals (nmod)
pesticide scabicide (conj)
immuno/histochemistry and (cc)
episodes major (amod)
proposed has (aux)
manner dual (amod)
remained stable (acomp)
reaction rash (conj)
implantation permanent (amod)
activity on (case)
heart ) (punct)
inappropriate , (punct)
classified patients (conj)
determine in (mark)
newborn lip (nmod)
stroke following (case)
remained 1/500 (nmod)
summarizes work (nsubj)
detect regions (dobj)
add may (aux)
courses for (case)
calcification animals (nmod)
significant disorder (nmod)
synaptic pre (amod)
specificity heparan (compound)
treatments other (amod)
postulated mechanism (nsubjpass)
shown biopsy (nmod)
daily times (nmod:npmod)
affected composition (nsubjpass)
was returned (advcl)
returned erpf (nsubj)
positive time (nmod)
infusion mg/kg (appos)
subjects matched (acl)
dimension atrial (amod)
activates improves (conj)
epistaxis due (case)
cells carcinomas (nmod)
gspe alone (advmod)
providing abusers (nmod)
learning attention (conj)
9/15 ) (punct)
evidence associated (acl)
follow-up long-term (amod)
cip ( (punct)
incidence nausea (nmod)
correlate ; (punct)
used measures (nsubjpass)
ntg , (punct)
complications for (case)
71 8 (conj)
amiodarone dose (nmod)
hla-b35 and (cc)
abolished totally (advmod)
followed years (nmod)
obtunding response (dobj)
leprosy with (case)
increase hematuria (conj)
course throughout (case)
cases published (acl)
reach lowering (nsubj)
1996 and (cc)
test oral (amod)
investigated role (dobj)
seems mechanism (xcomp)
sclerosis sclerosis (conj)
mg/day 6 (nummod)
resulting thus (advmod)
decreased amount (nsubj)
less with (mark)
doses mg. (nmod)
2.0 0.2 (conj)
1.35 ) (punct)
agonist adrenoceptor (compound)
optimization . (punct)
data insufficient (amod)
blocking propranolol (nmod)
fiber of (case)
creatinine increased (amod)
mother patient (nmod:poss)
delayed be (auxpass)
11 1.9 (conj)
preserved as (mark)
achieved levels (dobj)
bid of (case)
patient became (acl:relcl)
administration cisplatin (compound)
microtubules cytoplasmic (amod)
ratio rate (compound)
weeks 4 (nummod)
studying , (punct)
evaluated which (nsubjpass)
controls or (cc)
doxorubicin 1mg/kg/week (appos)
trial disorder (nmod)
improved woke (conj)
considered explored (conj)
methods generated (dep)
vagotomy administration (conj)
instability affective (amod)
reflected , (punct)
cells staining (compound)
decrease decrease (conj)
interviewing histories (nmod)
difference threshold (nmod)
rubella ) (punct)
administration in-hospital (compound)
sent hospital (nmod)
hematoxylin in (case)
miss as (mark)
sites cancer (compound)
micrograms/kg/min 3 (nummod)
events prevention (compound)
number problems (nmod)
mg/kg/day given (parataxis)
old were (cop)
h2-receptors of (case)
theophylline with (case)
remains associated (advcl)
< 0.001 (dep)
indicate lower (ccomp)
caudate-putamen cpu (appos)
discontinued order (nmod)
computer to (case)
cvd without (case)
demonstrated haloperidol (nsubj)
background : (punct)
model theorem (conj)
headache dizziness (conj)
with , (punct)
inhibitors 3a4 (compound)
days last (amod)
immunopathology . (punct)
concentrations calcium (nmod)
perception in (case)
induced barium (nmod)
postulate tdp. (punct)
decline of (case)
associated injection (advcl)
chloroform-adrenaline aconitine (conj)
suggest , (punct)
greater variation (nsubj)
disorder disease (nsubj)
prescribed cisapride (nsubjpass)
dobutamine after (case)
history psychiatric (amod)
creatinine baseline (amod)
intake vitamin (compound)
17.8 - (advmod)
atypical olanzapine (dep)
cells cultured (acl)
reflected instance (nmod)
excipients with (case)
homogenates in (case)
g/l 0.5 (nummod)
loss on (case)
poison a (det)
lorazepam the (det)
chloride ) (punct)
c. with (case)
ng/ml ( (punct)
reports other (amod)
induced still (advmod)
larger and (cc)
induced p (nsubj)
rats 3 (nummod)
line myeloid (amod)
resumed minimize (advcl)
quit who (nsubj)
causes patients (nmod)
studies-depression epidemiological (compound)
duct a (det)
1985 to (case)
pauses of (case)
society anesthesiologists (nmod)
segments l1-l2 (dep)
regarded remedies (nmod)
damages barrier (dobj)
effects release (conj)
men ( (punct)
suggested as (mark)
less mmol/l (nmod)
fluoroacetate and (cc)
affected how (advmod)
nvp ) (punct)
use l-sotalol (nmod)
4 day (nmod)
restores . (punct)
dfu at (case)
affected but (cc)
control basis (nmod)
lasted which (nsubj)
practice psychiatric (amod)
38 gentamicin (nmod)
ventricular reduced (amod)
limbs upper (amod)
based reading (nmod)
awaiting procedures (dobj)
role to (case)
improved dysfunction (nsubjpass)
infarctions with (case)
relevant clinically (advmod)
similar was (cop)
monkeys female (amod)
feet 50 (nummod)
spread space (nmod)
widely most (advmod)
described been (auxpass)
reduced placebo (advcl)
d1 d2 (conj)
exposed drug (nmod)
documented models (nmod)
p-ampk ) (punct)
course vancomycin (compound)
complication that (det)
parameter any (det)
protocol standard (amod)
donors to (case)
doses d (nmod)
amca ( (punct)
l-arginine micromol/l (appos)
reported benefits (nsubjpass)
treatment now (advmod)
estimates risk (compound)
effect alteration (nmod)
exhibited weeks (nmod)
components of (case)
infusion s-1 (compound)
hypertension sustained (amod)
progestagen included (acl)
progress may (aux)
$ROOT$ challenging (sent)
diet supplemented (acl:relcl)
relevant results (nsubj)
decreased leg (nmod)
reduced clipping (nmod)
syndrome equina (compound)
included 13 (nsubj)
subjected tilts (nmod)
given group (nmod)
relapse in (case)
remained elevated (xcomp)
recruited cities (nmod)
evidence reduce (acl)
had not (neg)
rates responder (compound)
role alcohol (nmod)
activity or (cc)
bodyweights < (dep)
detected each (dep)
methotrexate the (det)
24_h within (case)
bolus infusion (conj)
fentanyl and (cc)
rats strain (compound)
tri-iodo-thyronine intravenous (amod)
demand oxygen (compound)
state toxic (amod)
men age (nmod)
gamma-hch and (cc)
standard lenalidomide (nsubj)
agents vasoactive (amod)
groups tea (compound)
microg% 626 (nummod)
work present (amod)
dysmorphism severe (amod)
3.82 and (cc)
experience syncope (nmod)
walk to (mark)
prevent 6 (dep)
mice treated (amod)
increase mean (compound)
interval 0.887 (appos)
compare users (dobj)
included symptoms (nsubj)
treatment pharyngitis (nmod)
follow-up year (compound)
year 1 (nummod)
administration board (conj)
cases nystagmus (nmod)
change a (det)
performed made (conj)
neuropathy myopathy (nmod)
unrelated mortality (nmod)
developing therapy (nmod)
virus with (case)
overactivation area (nmod)
discuss role (dobj)
nte ( (punct)
studied permeability (nsubjpass)
signal of (case)
discontinue , (punct)
nausea such (case)
reduces pallidotomy (nsubj)
dampens mechanisms (dobj)
sinus cerebellum (conj)
activation gene (compound)
remained less (advmod)
induced carbamazepine (nmod:npmod)
machinery signaling (compound)
parameters cell (compound)
women years (appos)
channels composed (acl)
compared characteristics (nsubjpass)
clearance gfr (appos)
signaling phasic (amod)
toxicity hematologic (amod)
become refractory (acomp)
glaucoma glaucoma (nmod)
changes db (appos)
diagnosis dsm-iv (compound)
furosemide of (case)
polyuria chronic (amod)
twitches 5-hydroxytryptophan (compound)
hours hours (conj)
tolerability combination (nmod)
i of (case)
loss response (nmod)
scale analogue (compound)
rhythm the (det)
acid bicuculline (conj)
zdv either (cc:preconj)
newborns ' (case)
products healthfood (compound)
involved pressing (advcl)
associated death (nsubjpass)
reports the (det)
migraineurs 12 (nummod)
methods knife (compound)
increased fos-immunoreactivity (dobj)
seizures electrocorticographic (amod)
associated aspects (nmod)
proteins especially (advmod)
matched , (punct)
nerve cavernous (amod)
using follow-up (nmod)
uveitis with (case)
cox-2 cox-1 (conj)
cardiotoxin potent (amod)
investigate form (dobj)
methods both (cc:preconj)
evaluated role (nsubjpass)
produced changes (dobj)
hypertrophy : (punct)
repleted sodium (nmod:npmod)
reduced output (nsubjpass)
common as (advmod)
encephalopathy develops (acl:relcl)
age proteinuria (conj)
compared counts (dep)
errors argatroban (compound)
< significantly (advmod)
did cells (nsubj)
tested be (auxpass)
limited areas (nmod)
3 greater (amod)
cascade triggered (acl)
efficacy of (case)
consistent process (nmod)
passing period (nmod)
found mg/kg (nmod)
effective yet (cc)
dgc integrin (conj)
protection overexpression (nmod)
fibrosis induced (amod)
immunocytoma igm (compound)
dose initial (amod)
effects neuroprotective (amod)
protein daily (amod)
administration despite (case)
present hyperprolactinemia (nsubj)
reduced production (dobj)
repeated treatment (nsubjpass)
20 13 (compound)
infusion 14c]sodium (compound)
immersed , (punct)
found examination (nmod)
survivals progression-free (amod)
estimated proportion (nsubjpass)
instituted period (nmod)
pamidronate admission (nmod)
tachykinins these (det)
current direct (amod)
distracted attention (nsubjpass)
valdecoxib mg (appos)
$ROOT$ abolished (sent)
angiograms patients (nmod)
repeated application (nsubjpass)
started treatment (nsubjpass)
recognize reaction (dobj)
force task (compound)
rated means (nmod)
led background (nsubj)
rate only (advmod)
beta,3 5 (nummod)
30.8 +/- (cc)
substantiates role (dobj)
reexposure accidental (amod)
concluded we (nsubj)
$ROOT$ corroborate (sent)
decrease ve (nmod)
administration bepridil (compound)
promotes development (dobj)
prolactin intracellular (amod)
showed toxicity (dobj)
481 - (advmod)
conducted department (nmod)
level albumin (compound)
trimethoprim , (punct)
leukomalacia retardation (conj)
decrease triglycerides (nmod)
strain onto (case)
sheath an (det)
but also (advmod)
haloperidol bid (nmod)
years 47 (nummod)
iop elevated (amod)
p2x3 of (case)
glycoprotein lactoferrin (nsubj)
glucose levels (dep)
yield responses (dobj)
trimipramine repeated (amod)
abstinence prolonged (amod)
snr ( (punct)
n = (amod)
neuroinflammation . (punct)
damage mtdna (compound)
factor hemorrhage (nmod)
efficacious and (cc)
activity rbcs (nmod)
dyskinesia fluctuations (appos)
% 13.1 (nummod)
symptomatic animals (nsubj)
gemcitabine . (punct)
case the (det)
effects markers (nmod)
akathisia for (case)
block and (cc)
limited is (auxpass)
daunorubicin doxorubicin (conj)
transferred loss (nmod)
data placebo (compound)
o2- ( (punct)
antibiotics combined (acl)
greater hydrocortisone (nmod)
returned complaints (nmod)
index bispectral (compound)
incidence fractures (nmod)
content , (punct)
bar horizontal (amod)
drugs cleavage-enhancing (amod)
daunorubicin treatment (nmod)
tachyarrhythmia atrial (amod)
reactions corticosteroids (nmod)
termed index (xcomp)
substituted and (cc)
relevance it (nsubj)
combination and (cc)
therapy glomerulonephritis (nmod)
treatment glycopyrrolate (nmod)
therapy and (cc)
epileptogenesis of (case)
pain whose (nmod:poss)
bradycardia considerable (amod)
strategy high-dose (amod)
disturbances or (cc)
receptors by (case)
reduced intake (nsubjpass)
effects angiographic (amod)
dose microg (compound)
responses papillary (amod)
acid 5,7-dcka (appos)
help observations (nsubj)
syncope near (amod)
withdrawal days (appos)
levels liver (compound)
offer begun (advcl)
animals saline-infused (amod)
att and (cc)
experiences one (nummod)
suramin gr (conj)
hyperalgesia ) (punct)
recognised . (punct)
induce wall (nmod)
toxicity syndrome (conj)
destructive . (punct)
3-methyladenine 3ma (appos)
injection pilocarpine (nmod)
dopamine dobutamine (conj)
methods administered (appos)
animals as (cc)
decreased be (auxpass)
were patients (attr)
protects inducing (advcl)
specified otherwise (advmod)
effective retarding (advcl)
ability concentrating (compound)
drawback the (det)
noted seen (conj)
point view (nmod)
result does (aux)
microspherocytes smear (nmod)
acids of (case)
dexamethasone vtd (appos)
reduced . (punct)
individuals but (cc)
predicting in (mark)
alendronate , (punct)
effect exclusion (compound)
dermis papillary (amod)
values mean (amod)
cp microg/side (appos)
pretreated exposed (advcl)
dna hepatitis (compound)
hypertension dex-induced (amod)
homology receptors (nmod)
antagonist 5-ht6 (compound)
correlation negative (amod)
ci 6.0 (appos)
vcm vcm (conj)
use and (cc)
quality of (case)
levels dose (compound)
troponin positive (amod)
data event (compound)
osteoid woven (amod)
symptoms fluoxetine-induced (amod)
exposures the (det)
stress pathway (conj)
hypotension depression (conj)
organisms bacilli (nsubj)
cisapride pretreatment (dep)
depression treatment-resistant (amod)
diatheses or (cc)
fla838 ncl118 (conj)
fk506 plus (cc)
tissues stained (amod)
neuropathy lacnp (appos)
markers cm (nmod)
receiving doses (dobj)
norms of (case)
mice pparalpha-/- (amod)
tablet ribavirin (nmod)
overload than (case)
affected results (nsubjpass)
alterations external (amod)
dyskinesias the (det)
hr glu (conj)
0.01 p (nsubj)
undertaken continued (advcl)
users ecstasy (compound)
clues onset (nmod)
status ps (appos)
% them (nmod)
shock current (amod)
inhibits vivo (advmod)
damage axonal (amod)
nephritis lupus (compound)
124 to (case)
apposed . (punct)
lack interference (nmod)
administration azt (nmod)
n-butyl-deoxynojirimycin with (case)
rats and (cc)
days different (amod)
using have (conj)
patients groups (appos)
crisis anemia (compound)
required which (nsubj)
order : (punct)
cases patients (nmod)
course disease (compound)
740 - (punct)
penetrate not (neg)
process elimination (nmod)
$ROOT$ lost (sent)
patients dental (amod)
transcripts three (nummod)
abandoned be (auxpass)
given overcome (advcl)
sniffing posturing (conj)
ziprasidone of (case)
pretreatment naloxazone (nmod)
treated day (nmod)
variations function (nmod)
toxic chloroprocaine (nmod)
demonstrated findings (nsubj)
electrolytes urinary (amod)
receptors glutamate (compound)
g/day of (case)
power ferric (compound)
reduplication capillary (compound)
necrosis . (punct)
benzylthiouracil ( (punct)
fits of (case)
1.7 ( (punct)
dose argatroban (compound)
composite a (det)
factor urine (nmod)
accompanying norepinephrine (dobj)
december 2007 (nummod)
mg. 20 (nummod)
impaired recall (dobj)
1.52 ) (punct)
treated referrals (nmod)
foot hind (compound)
gtn ; (punct)
metamizol mg/kg (compound)
biosynthesis acetylcholine (compound)
chemotherapy systemic (amod)
hypertension developed (acl:relcl)
report atin (nmod)
represents palsy (nsubj)
rate except (case)
highlights problems (dobj)
hg between (case)
drugs not (neg)
groups 15/group (appos)
antagonize to (mark)
indication first (amod)
treated 700 (nsubjpass)
levels aminotransferase (compound)
index an (det)
loss syndrome (conj)
discovered , (punct)
january in (case)
experienced respectively (advmod)
therapy effective (amod)
induction tachycardia (nmod)
eps chlorpromazine-induced (amod)
wt/day ( (punct)
lead which (nsubj)
aim documentation (nmod)
participating trial (nmod)
institution at (case)
suggests potentiation (nsubj)
period isovolumic (amod)
50 more (amod)
contraceptive of (case)
consisted mofetil (nmod)
formulations lipid (compound)
upregulated initiate (conj)
version modified (amod)
warrant differentiate (advcl)
symptoms more (amod)
gaps of (case)
diphenhydramine mg (appos)
cells l1210 (compound)
induced reliably (advmod)
did . (punct)
media rats (nmod)
appears correlated (xcomp)
test multiple (amod)
aware hepatotoxicity (nmod)
bile supersaturated (amod)
remains unclear (xcomp)
risk patient (nsubj)
intoxications cocaine (nmod)
line increases (nsubj)
tool interesting (amod)
access brain (compound)
microg 5 (nummod)
identified programs (nmod)
cnsb002 mg/kg (appos)
task motor (compound)
kit this (det)
related overloading (nmod)
conducted assess (advcl)
catheter probe (conj)
receiving 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (dobj)
contains while (mark)
hypertension treatment (conj)
motility mouse (compound)
cancer women (nmod)
cycles apheresis (nmod)
batteries and (cc)
toxicity gentamicin (compound)
experiencing grade (dobj)
implicated increase (nsubjpass)
increase time (nmod)
$ROOT$ dealt (sent)
mg procainamide (nmod)
had when (parataxis)
prolongation q-t (compound)
sunbelt in (case)
administered are (auxpass)
patients seen (acl)
effects induced (amod)
azidothymidine with (case)
toxicity and (cc)
patients cin (nmod)
treatment corticosterone (compound)
dse of (case)
dehydration agitation (conj)
bche proband (nmod)
benzodiazepines baclofen (conj)
middle-aged years (dep)
performance to (case)
transgene the (det)
pain associated (acl)
deserve use (dobj)
bradycardia clonidine-induced (amod)
weight enzymes (conj)
models both (det)
latency at (case)
strategies prevent (acl:relcl)
loss ( (punct)
treatment tolterodine (compound)
indicated study (nsubj)
injection 131i-albumin (nmod)
monitored correlated (conj)
stretch of (case)
$ROOT$ thromboembolism (sent)
resolved patients (nmod)
rs4704559 , (punct)
value preoperative (amod)
xenon-133 i.v. (dep)
potentiates metamizol (nsubj)
81.5 . (punct)
evaluate incidence (dobj)
cause interaction (dobj)
patterns behavioral/eeg (amod)
cancer breast (compound)
relaxed was (cop)
relieved were (auxpass)
fibrillation into (case)
genotype the (det)
stress triglycerides (conj)
reduced solution (nsubj)
failed improve (xcomp)
shr map (dep)
mg/kg 37 (nummod)
receptor underlying (acl)
reduced contractions (dobj)
degree severity (nmod)
system pressure (compound)
mechanisms different (amod)
epilepticus following (case)
higher years (nmod)
taking inhibitors (dobj)
coupling the (det)
treatment ribavirin (compound)
cells nestin (compound)
development of (case)
steroids systemic (amod)
associated although (mark)
behaviour driving (compound)
assessment double-blind (amod)
value obtained (acl)
extent a (det)
associated indicated (advcl)
activates system (dobj)
pressure creatinine (conj)
permits administered (xcomp)
treatments condition (nmod)
2.8 0.45 (conj)
reduce effect (dobj)
alpha-t ) (punct)
carboplatin patients (nmod)
expressions increased (amod)
due be (cop)
coincided activity (nsubj)
(noncardiac)/periprocedural = (parataxis)
testing by (case)
enalapril enzyme (compound)
regulation angiogenesis (nmod)
< 0.006 (dep)
nmol 0.1 (nummod)
nephropathy experimental (amod)
model effects (nmod)
effects protective (amod)
8 18 (prep)
mean sd (conj)
formation hippocampal (amod)
mechanisms action (compound)
rejection with (case)
tumor stage (compound)
given lf (nsubjpass)
screening plasma (compound)
output camp (compound)
investigated study (nmod)
analysis cases (nmod)
receiving azt (dobj)
reactions ten (nsubj)
$ROOT$ hepatonecrosis (sent)
monitoring invasive (amod)
compared maleate (nmod)
malaria for (case)
group adriamycin-treated (amod)
schizophrenia to (case)
induced cddp (nmod)
sgk1(+/+ of (case)
location aneurysm (nmod)
mg propofol (nmod)
included factors (nsubj)
inhibits incidence (dobj)
values 33.8 (appos)
symptoms severe (amod)
events recorded (amod)
administration 21days (nmod)
disease bone (compound)
prochlorperazine intravenous (amod)
mg/dl therapy (nmod)
disclosed granules (dobj)
kidneys from (case)
completed arms (dobj)
identified we (nsubj)
diseases causing (acl)
lvdp/dtmax and (cc)
had hypersensitivity (dobj)
hexaaldose to (case)
considered three (nmod)
a/j ( (punct)
able frequent (advcl)
correlation dose-effect (amod)
measured mmse (nmod)
expression mrp2 (nmod)
room the (det)
pinealectomized hypophysectomized (conj)
treated l-sotalol (nmod)
evaluate preliminarily (advmod)
stop changes (dobj)
were exceeded (ccomp)
injection)+ritanserin dmso (appos)
fibrillation agitation (conj)
effects vincristine (nmod)
adduct ( (punct)
bradycardia agonist (nmod)
3.51 0.90 (compound)
109.2 6.3 (conj)
review records (nmod)
modality combined (amod)
induced triphosphate (nmod)
fentanyl combination (conj)
constipation drowsiness (conj)
correlated values (nsubjpass)
associations positive (amod)
potentiates 5-azacytidine (nsubj)
reversion a (det)
million 1 (compound)
associated citrate (nmod)
documents occurrence (dobj)
$ROOT$ angiosarcoma (sent)
doses several (amod)
4.10 rate (nsubj)
prevented was (auxpass)
are literature (nmod)
placebo p (appos)
infections related (amod)
avoidable possibly (advmod)
start the (det)
activator acting (amod)
measured creatinine (nsubjpass)
restrictions of (case)
hospitalization vs (cc)
norepinephrine injected (amod)
fertility for (case)
blockers ikr (compound)
lowered after (mark)
similar weeks (nmod)
testing 2 (nummod)
risks iatrogenic (amod)
liver : (punct)
complaint this (det)
reactions delayed (amod)
myocytes cardiac (amod)
late a (det)
3.32 from (case)
indication with (case)
disruption in (case)
duration changes (nmod)
alteration system (nmod)
g/kg ) (punct)
determine activity (dobj)
responsible dyskinesias (nmod)
oxcarbazepine 10-keto (compound)
normal tests (nmod)
cirrhosis for (case)
consumption bupivacaine (compound)
cisplatin known (acl:relcl)
reducing myelotoxicity (dobj)
umb24 of (case)
conclusion effective (appos)
believe consider (ccomp)
treated paramethasone (nmod)
unknown but (cc)
sex female (appos)
susceptibility the (det)
drugs cardiotoxic (amod)
considered vancomycin (nsubjpass)
concentration cocaine (compound)
observed case (nmod)
chorea valproate-induced (amod)
hg systolic (amod)
neuropediatrician a (det)
problem a (det)
mediated reflexes (nmod)
associated injections (nmod)
processing the (det)
progression reduced (amod)
carbamazepine oxcarbazepine (conj)
reason was (cop)
associated furthermore (advmod)
cats two (nummod)
ex-mdma ) (punct)
lower signficantly (advmod)
use factors (nsubj)
(2.2)% -6.1 (nummod)
task olr (compound)
appears arrest (nsubj)
deterioration vision (nmod)
1.1 ) (punct)
showed ecg (nsubj)
dose-dependent if (mark)
stimulated receptors (nmod)
$ROOT$ ventilated (sent)
patients a (det)
42 ( (punct)
prevented delayed (conj)
% -19.20 (conj)
suspected replaced (conj)
presented cycle (nmod)
$ROOT$ catch (sent)
infarcts bilateral (amod)
tablets dose (dep)
needed denervation (nsubjpass)
61 six (quantmod)
associated infrequently (advmod)
effects model (nmod)
sample in (case)
ctnt diameters/bw (conj)
role on (case)
dose doxorubicin (compound)
used microdialysis (dobj)
use cidofovir (nmod)
trials comparing (acl)
have changes (dobj)
had lt (nmod)
tests tests (conj)
tilt head-up (amod)
3.5 range (dep)
suggested possiblility (dobj)
avoidance function (conj)
designed describe (xcomp)
measure day (dep)
time long (amod)
administration morphine (nmod)
proved while (mark)
atria the (det)
neurotoxicity meth (compound)
ligation adrenaline (conj)
amyloidosis al (compound)
pathways biomarkers (conj)
communicate person (nmod)
2 1 (compound)
$ROOT$ suppress (sent)
cdna with (case)
volume scatter (appos)
abnormalities moderate (amod)
treatment drug (nmod)
5 versus (cc)
chiasm of (case)
started migraine (nmod)
preventing reactivation (dobj)
imbalance causing (acl)
. 17 (appos)
background induces (appos)
telmisartan of (case)
occurs pain (nsubj)
impairment paradigm (nmod)
initiating before (mark)
origin cns (compound)
6.7 0.6 (conj)
assessed investigate (advcl)
affect to (mark)
sensitivity relative (amod)
hepatocellular cholestatic (conj)
implicated cells (nsubjpass)
decreasing activity (dobj)
occurred period (nmod)
display users (nsubj)
illustrate conclusion (nmod)
behaviors go (acl:relcl)
effect treatment (compound)
neurosurgery in (case)
questionnaire dex (appos)
results calculation (nsubj)
gene pparalpha (compound)
absolute and (cc)
rich were (cop)
models on (case)
nitrogen mg/dl (compound)
universal effects (nsubj)
depression livers (nmod)
restricted brainstem (nmod)
resulting ratio (nmod)
25.3 ) (punct)
mg/kg chloroprocaine (nmod)
sequelae ketoconazole-induced (amod)
decarboxylase acid (compound)
ci-921 the (det)
activity immunodeficiency (compound)
resulted findings (nmod)
type reverse (amod)
injected it (parataxis)
antibodies low (amod)
hepatitis clotiazepam-induced (amod)
waveform pressure (compound)
patients metastases (nmod)
rate rates (conj)
adenocarcinoma cell (compound)
creatinine , (punct)
induced disruption (dobj)
p-veps ( (punct)
disease disease (conj)
6 % (appos)
dithiocarbamate pyrrolidine (compound)
range glycopyrrolate (nmod)
lasted treated (conj)
morphological and (cc)
safe fluorescein (nmod)
reviewed : (punct)
checklist ( (punct)
mg/kg 120 (nummod)
run slowing (conj)
fk506 or (cc)
3 to (case)
neurons and (cc)
constant time (compound)
gained purpose (nsubj)
doxorubicin hydroxytyrosol (conj)
limit pg/ml (appos)
exert d2 (nsubj)
changes the (det)
consumption prior (amod)
dose potent (amod)
undertaken electrophysiology (nsubjpass)
althesin or (cc)
grafts biopsies (appos)
explore we (nsubj)
administered always (advmod)
agent . (punct)
levels mhpg (compound)
model 6-hydroxydopamine (compound)
levels activities (conj)
prolactin and (cc)
effects hypotension (nmod)
correlated evidence (nmod)
registered transplantation (nmod)
persists danger (nsubj)
nitroglycerin intravenous (amod)
poisoning phosphorus (compound)
any patients (nmod)
perfused acid (nmod)
sulfation . (punct)
superior terms (nmod)
influence neurotransmission (dobj)
intensify . (punct)
course longitudinal (amod)
minute one (nummod)
complication use (nmod)
microbleeds cerebral (amod)
db ) (punct)
usage tiazofurin (compound)
cells on (case)
receptor p2x3 (compound)
substitute patients (nmod)
frequencies occurred (acl:relcl)
mg/min n=10 (dep)
substances these (det)
therapy inappropriate (amod)
mg/dl or (cc)
timolol % (amod)
rates toxicity (nmod)
signals cytoplasm (nmod)
manoeuvres rebreathing (amod)
study bupropion (nmod)
atrophy system (compound)
have doses (nmod)
causes if (mark)
h 24 (compound)
ecg screening (amod)
x ck-mb (compound)
agents sparing (amod)
safety review (dep)
receiving stent (dobj)
effective strikingly (advmod)
elevation pressure (compound)
cimetidine of (case)
117 daily (advmod)
receive d. (nmod)
clonidine placebo (conj)
reason restrictive (acl:relcl)
treatment high-dose (amod)
reversed partially (advmod)
.001 than (case)
size administration (nmod)
drug regimen (conj)
blockers in (prep)
exhibits 7e (nsubj)
substrate liver (nmod)
dysmorphism , (punct)
elevated modestly (advmod)
dysphonia . (punct)
dextromethorphan isomer (appos)
management of (case)
declined patients (nmod)
those mice (nmod)
4-hourly or (cc)
neuropathy impairs (acl:relcl)
lacrimation and (cc)
enlarged hypertrophic (conj)
drug standard (amod)
starts when (advmod)
use inappropriate (amod)
change infusion (nmod)
examined grafts (dobj)
option daptomycin (nsubj)
improvement . (punct)
penzberg germany (appos)
providers care (compound)
zidovudine versus (cc)
group only (advmod)
way similar (amod)
reactivator diazepam (conj)
neuroplasticity and (cc)
15 approximately (advmod)
receiving excess (nmod)
modifiable which (nsubj)
pilocarpine rats (nmod)
showed had (ccomp)
hypersensitivity due (case)
psychotropic and (cc)
consisted treatment (nsubj)
reduced 2-fold (nmod)
therapies patients (nmod)
small , (punct)
configuration , (punct)
polymorphisms region (nmod)
induced hypertrophy (nsubjpass)
armrest by (case)
receptors inhibitory (amod)
immunosuppressive prophylactic (conj)
cpa ) (punct)
suggest conclusion (nmod)
show preserves (ccomp)
schedule dosing (compound)
appear bind (xcomp)
absence an (det)
use atracurium (nmod)
albumin bovine (amod)
treated oxacillin (nmod)
complications postoperative (amod)
m t (conj)
intrahepatic and (cc)
higher number (nsubj)
disease doctor-diagnosed (amod)
syndrome as (case)
mo the (det)
hypertension dexamethasone- (amod)
syndrome benign (amod)
anesthesia barbiturate (compound)
attention , (punct)
patient requiring (acl)
determine identified (ccomp)
taken occurrence (nsubjpass)
force % (nmod)
pregnane-21-diol-20-ones alpha-hydroxy (compound)
equipment sophisticated (amod)
cells glial (amod)
a receptors (appos)
63 5 (conj)
$ROOT$ reported (sent)
found cells (nsubjpass)
detection for (case)
follow-up again (advmod)
action anti-carcinogenic (amod)
glycopyrronium of (case)
[na]o ) (punct)
reassured should (aux)
was dose (nmod)
releasing nerves (nmod)
potassium initial (amod)
graves ' (case)
consumption depression (conj)
work-up diagnostic (amod)
assess prevalence (dobj)
trial acid (nmod)
reminds considered (ccomp)
administered dosage (dobj)
occur . (punct)
% lignocaine (compound)
starting pge1 (dobj)
role pineal (nmod)
volunteers elderly (amod)
consisting effects (nmod)
minutes seconds (parataxis)
anesthesia lidocaine (compound)
metoprolol interaction (conj)
shr captopril-treated (amod)
antagonists competitive (amod)
beta-agonists only (advmod)
delineated and (cc)
increase duration (nmod)
it-tspa on (case)
degrees 36.98 (nummod)
withdraw after (case)
concern administration (nmod)
six week (nmod)
relationship levels (nmod)
case deterioration (nmod)
emphasizes importance (dobj)
tolerated were (conj)
$ROOT$ communicate (sent)
quantitated , (punct)
diagnoses , (punct)
gene receptor (compound)
derives primarily (advmod)
antagonized that (mark)
hemodialysis flux (compound)
provides evaluation (nsubj)
department emergency (compound)
found analysis (nmod)
switch srl (nmod)
days 4 (conj)
comparable characteristics (nsubj)
trial cycle (nmod)
amount myocardium (nmod)
activity basal (amod)
use activity (conj)
reduction stress (nmod)
toxic the (det)
non-drug polydrug (appos)
comparable patients (nsubj)
responded having (aux)
acid 3,4-dihydroxyphenylacetic (amod)
employed visualize (xcomp)
caused forced (conj)
achieve need (nmod)
conscious trained (dep)
formed fraction (nmod)
volume administration (nmod)
remissions complete (amod)
feasible effective (conj)
anoxia leading (acl)
pointes irrigation (nmod)
increasing while (mark)
diseases cardiac (amod)
frequency overall (amod)
outpatients stable (amod)
narrowed treatment (nsubjpass)
rats sixty (nummod)
show models (nmod)
performed order (nmod)
lead derangements (nsubj)
therapeutic current (amod)
acid 3sr,4ars,6sr,8ars-6-[phosphonomethyl]decahydr (compound)
attenuated rp (nmod)
detection changes (conj)
barrier bbb (appos)
hoe des-arg10hoe (conj)
sirolimus . (punct)
experiments both (det)
pakt ) (punct)
applied used (advcl)
found moreover (advmod)
induces hemolysis (dobj)
mg > (amod)
diamorphine droperidol (conj)
relieve patients (dobj)
pairs eyes (nmod)
safety phase (nmod)
shown patients (nsubj)
fractions ventricular (amod)
unanesthetized hypertensive (dep)
factor to (mark)
tomography peripheral (amod)
alters deprivation (nsubj)
patients 210 (nummod)
cancers of (case)
investigated should (aux)
reduced temsirolimus (nsubj)
relapse after (case)
indices damage (nmod)
mumol/l 100 (nummod)
titrating achieve (advcl)
placebo solution (conj)
saline control (appos)
time death (nmod)
min with (case)
one-third patients (nmod)
h 6 (compound)
observed concentration (nsubjpass)
addition trial (nmod)
discontinuing drug (dobj)
occur seizures (nmod)
retardation by (case)
injection saline (nmod)
sensitivity contrast (compound)
affinity receptors (nmod)
ds male (amod)
elimination a (det)
acid tna (appos)
dates search (compound)
had morning (nmod)
effect vision (nmod)
assays in (case)
mg day (nmod)
had icterus (dobj)
$ROOT$ come (sent)
administered androgens (dobj)
sedation procedural (amod)
situation a (det)
mirrored . (punct)
active which (nsubj)
abatement the (det)
medicate . (punct)
granulocytes of (case)
become determine (ccomp)
induced bromocriptine (nsubj)
areas from (case)
dapsone of (case)
radius at (case)
min discontinuation (nmod)
used interfere (advcl)
situation in (case)
62.5 +/- (cc)
case manifested (acl)
predicted as (mark)
toxicity herbicides (nmod)
grade fibrosis (nmod)
delivery subcutaneous (amod)
sutures four (nummod)
directions in (case)
propranolol mg (nummod)
$ROOT$ manipulated (sent)
fk506 ( (punct)
monitoring index (compound)
history features (conj)
increased hypotension (nsubjpass)
glomerulonephritis in (case)
antagonism hyperactivity (nmod)
kind its (nmod:poss)
group dex (compound)
occurrence their (nmod:poss)
period time (compound)
define population (nmod)
combination mg/m2 (nmod)
reached bilirubin (nsubj)
complained patients (nsubj)
1.85 0.35 (conj)
micrograms/day 1863 (nummod)
effect associated (acl)
contrast in (case)
althesin ( (punct)
nodule and (cc)
used lithium (nsubjpass)
seem agonists (nsubj)
improved : (punct)
l-name with (case)
predicting akathisia (dobj)
secretion pth (compound)
triad catalytic (amod)
age-dependent , (punct)
group except (case)
example a (det)
efforts during (case)
nociception of (case)
time was (cop)
conclusion difficult (appos)
metoclopramide to (case)
half up (advmod)
projection ascending (amod)
indication early (conj)
losses extracellular (nmod)
resurgence a (det)
exceeded whom (nmod)
cells labeled-positive (amod)
n-(2-hydroxypropyl)methacrylamide hpma (appos)
regimens current (amod)
reassessment approaches (nmod)
nephrotoxic whether (mark)
resuscitated dose (nmod)
chloroquine or (cc)
busulfan mg/m2 (compound)
present boy (nmod)
treated resulting (advcl)
rcbf ( (punct)
material compared (dep)
extracted rna (nsubjpass)
blood marrow (conj)
weeks patient (appos)
coding salience (compound)
experiment randomized (amod)
compared users (nmod)
beta-blocking antiarrhythmic (conj)
sem hg (compound)
found layer (nmod)
produce infusions (nsubj)
44 - (punct)
induction fentanyl (nmod)
market the (det)
trimethoprim-sulfamethoxazole 266,951 (conj)
experienced upset (dobj)
maximum and (cc)
vasodilator polypeptide (nsubj)
heart mitochondria (conj)
hypotension alpha-methyldopa (compound)
hypersensitivity system (nmod)
role pituitary (nmod)
scheduled receive (xcomp)
insult induced (acl)
derivative the (det)
mammary and (cc)
metabolite apap (nmod)
grouped were (auxpass)
reported pyrazinamide (nmod)
output qs/qt (conj)
oxacillin with (case)
administered diethylnitrosamine (nmod)
tg transgenic (amod)
agonists antagonists (conj)
avoided recommended (advcl)
paracetamol , (punct)
virus leukaemia (compound)
stages the (det)
reduction an (det)
blockade neuronal (amod)
number nuclear (amod)
increase h (nmod)
diseases various (amod)
catechol the (det)
min compared (prep)
impact their (nmod:poss)
biopsies mucosal (amod)
cd4 ( (punct)
300 to (dep)
continue will (aux)
permeability of (case)
recommended yearly (advmod)
doses oct (nmod)
cells/mm3 change (nsubj)
demonstrated changes (dobj)
categories at (case)
affinity the (det)
synthesis et-1 (nmod)
may ( (punct)
cells marrow (compound)
expected mice (nmod)
improvement small (amod)
revealed sensitized (ccomp)
investigation this (det)
nodules painful (amod)
response alpha-methyldopa (nmod)
assessed injected (advcl)
chromatography by (case)
received dosage (dobj)
loss gradual (amod)
imply slowing (nsubj)
challenged , (punct)
stimuli heat (compound)
incidence use (nmod)
supplement may (aux)
clonidine ii (dep)
l1-l2 receive (acl:relcl)
groups comprised (acl)
function sclerosis (conj)
micrograms/kg/min 100 (nummod)
depression activity (nmod)
dosing captopril (nmod)
zero number (nsubj)
infused dose (nsubjpass)
severity constipation (nmod)
induced vitro (advmod)
action neuroprotective (amod)
4.2 and (cc)
potency duration (conj)
hypertension induced (acl)
useful considered (conj)
area ) (punct)
longer . (punct)
patients 88 (nummod)
reported benefit (dobj)
hypothyroidism amiodarone-induced (amod)
feared rejection (nsubjpass)
$ROOT$ nephropathy (sent)
depression bone (compound)
number microvessels (nmod)
vehicle the (det)
muscle due (case)
determine site (dobj)
included evaluation (nsubj)
features ct (compound)
role control (nmod)
nausea chills (nmod)
mapd dog (nmod)
pressure elevation (conj)
g 35 (nummod)
screened screened (conj)
ml/min from (case)
ability an (det)
5-fluorouracil particular (nmod)
buffer plasma (conj)
episodes associated (acl)
developing nephrotoxicity (dobj)
absence antagonists (nmod)
infrequent are (cop)
system calibration (nmod)
receptors cb1 (compound)
vasculitis in (case)
31 eighteen (compound)
mumol/kg ) (punct)
reported changes (nmod)
inhibition activity (nmod)
restriction of (case)
over-representation an (det)
survival days (dep)
status between (case)
regimens combined (amod)
review knowledge (nmod)
inhibit components (nsubj)
developed rats (nsubj)
enhances dysrhythmogenicity (dobj)
$ROOT$ review (sent)
risk only (amod)
resulted survivors (nmod)
54 and (cc)
control hypersecretion (dobj)
study compliance (compound)
appropriate more (advmod)
patients matched (acl)
doxorubicin/kg mg (amod)
death exposure (nmod)
pre-treatment ) (punct)
exercise during (case)
rats saline-pretreated (amod)
99 +/- (cc)
biopsies during (case)
sites several (amod)
week 18 (nummod)
techniques decision-analytic (amod)
wegener 's (case)
enhancement hyperthermia (nmod)
december , (punct)
patient gammapathy (nmod)
is call (xcomp)
mistaken event (nmod)
atrophy manifestation (nsubj)
mg doses (nsubj)
rate positive (amod)
application naa (nmod)
developed initially (advmod)
mk-801 administered (acl)
prior week (nmod:npmod)
examinations from (case)
unilateral bilateral (conj)
ra with (case)
induce do (aux)
ut-a1 ) (punct)
indicate overall (advmod)
groups : (punct)
require therapy (dobj)
multivitamin a (det)
akinesis of (case)
tachycardia against (case)
p9605 group (compound)
enalapril 1.32 (appos)
tumors hemorrhagic (amod)
myeloencephalopathy report (dep)
predisposed development (nmod)
utility of (case)
bepridil of (case)
was explore (xcomp)
adalat ) (punct)
menopause since (case)
blocker verapamil (dep)
recorded results (nsubjpass)
metabolism simvastatin (compound)
genesis as (case)
recorded reactions (nsubjpass)
cells ( (punct)
consistent concentration (nsubj)
mutations escape (compound)
haemorrhage a (det)
defined which (nsubjpass)
factors exposures (nsubj)
accumulation toxicity (conj)
pregnant days (nmod:npmod)
ephedrine with (case)
55 - (punct)
mechanism barbiturate (compound)
receive boluses (dobj)
revealed 154:64 (dobj)
score highest (amod)
occurred followed (conj)
$ROOT$ methods/materials (sent)
sulphate 3beta-hydroxy-5beta-pregnan-20-one (compound)
c only (amod)
hospitalizations after (case)
hypothesis induce (ccomp)
apomorphine , (punct)
regimen administering (advcl)
exhibit behavior (dobj)
lipocalin ngal (appos)
myoclonia of (case)
calculated extraction (nsubjpass)
idm ) (punct)
effects glycosides (nmod)
presented rats (nsubj)
schoolchildren in (case)
1.5 1.4 (quantmod)
treating conditions (dobj)
questionnaire between (case)
mg/kg the (det)
lamina to (case)
interactions clonidine (nmod)
u/ml median (dep)
center an (det)
liver experimental (amod)
sedation nausea (conj)
capture any (dobj)
seizures lindane (compound)
criteria organization (compound)
appearance field (compound)
concentrations oxazepam (nmod)
occurred h. (nmod)
6-hydroxydopamine desipramine (conj)
mg/day 570 (nummod)
counteracted . (punct)
inhibition gr (nmod)
pressures arterial (amod)
instituted formation (nmod)
dose pci (nmod)
myd88 ( (punct)
faint addicts (nsubj)
associated stroke (nsubjpass)
shown modulates (ccomp)
return by (case)
buffers as (mark)
study further (advmod)
linked that (mark)
developed seizure (dobj)
assigned volunteers (nsubjpass)
added fludrocortisone (nsubjpass)
woman japanese (amod)
scales anxiety (compound)
episodes triazolam-induced (amod)
hypertrophy/cytomegaly , (punct)
applied we (nsubj)
defined progression (nmod)
studying pathophysiology (dobj)
pallidotomy to (case)
physician prescribed (acl:relcl)
patient-years 100 (nummod)
months year (conj)
emit . (punct)
deterioration sudden (amod)
frequent ns (parataxis)
associated allele (nsubjpass)
received man (nsubj)
encountered practice (nmod)
neonates cases (nmod)
treated octreotide (nmod:npmod)
found using (advcl)
lists papers (nmod)
report death (dobj)
rose taking (advcl)
increased hour (nmod:npmod)
observed hypokalemia (nsubjpass)
perseveration task (nmod)
alcohol or (cc)
expressed predominantly (advmod)
sacrificed days (nmod)
test elevated (amod)
induce antagonists (nsubj)
subjects suprofen-exposed (amod)
easy relatively (advmod)
depression disease (conj)
were played (conj)
allopregnanolone 3alpha-hydroxy-5alpha-pregnan-20-one (appos)
concentration by (case)
target assigned (amod)
$ROOT$ insufficiency (sent)
intima segments (nmod)
aspirated and (cc)
signs parkinsonian-like (amod)
restimulation area (nmod)
clearance by (case)
theta slow (dep)
had % (dobj)
testing dobutamine (compound)
blocks ) (punct)
suggest pathophysiology (dobj)
problematic patients (nmod)
interval = (parataxis)
mg./kg 4 (nummod)
rose compared (advcl)
aged in (case)
arrhythmias seizures (conj)
administration suspension (nmod)
treated success (nmod)
-21.3 , (punct)
amiodarone to (case)
therapy propranolol (compound)
watch and (cc)
occurred complications (nsubj)
escalations intrapatient (amod)
cultures further (amod)
condition patient (nmod:poss)
relationship curvilinear (amod)
ipsilateral more (advmod)
factors modifiable (amod)
ich of (case)
birth infant (nmod)
frequent overall (advmod)
observed control (advcl)
treatment sm-5887 (compound)
sleep nocturnal (amod)
support patients (nmod)
2.5 10.0 (conj)
ms 300 (nummod)
part in (case)
disorder affective (amod)
node of (case)
induced production (dobj)
woman chinese (amod)
tolerated volunteers (nmod)
cause ? (punct)
induced 1,25(oh)2d (nmod)
reductions greater (amod)
placed measurements (nmod)
assessments follow-up (nmod)
e mg/kg/day (dep)
memory procedural (amod)
schizophrenia or (cc)
injected metformin (nsubjpass)
release cell (compound)
[3h]-5-azadeoxycytidine of (case)
dialysis ambulatory (amod)
mild transient (conj)
irrigated stomachs (nsubjpass)
micromol/liter to (case)
effects amiodarone (nmod)
shown research (nsubj)
measured increases (nsubjpass)
haloperidol receptor (compound)
configuration oropharynx (nmod)
steroids beta,3 (appos)
unresponsiveness , (punct)
alkaloid an (det)
range high (amod)
normal number (nsubj)
m.s. ( (punct)
infusate to (case)
10 > (amod)
lesions ventricular (amod)
decline rapid (amod)
variables creatinine (dep)
levels therapeutic (amod)
glomerulosclerosis injury (conj)
dosage caused (acl:relcl)
due tiopronin (nmod)
unilateral or (cc)
caused blockade (nmod)
changes signalling (nmod)
toxicity neurologic (amod)
14.1 +/- (cc)
less to (case)
% 29.8 (nummod)
old was (cop)
nelarabine and (cc)
g day (nmod)
metabolized hepatically (advmod)
reached cholesterol (dobj)
group hggw (compound)
hyperammonemia with (case)
gradient synthesis (nmod)
syndrome ) (punct)
concentration elevated (amod)
administration d (parataxis)
evaluation effects (nmod)
consequence metabolic (amod)
level dosing (nmod)
fat surrounding (acl)
blockers + (compound)
ssr103800 transporter-1 (amod)
significant significant (conj)
injection 100-micrograms (amod)
carry . (punct)
nsaids nonselective (amod)
floor general (amod)
were however (advmod)
act how (advmod)
expressed be (auxpass)
million nearly (advmod)
agent have (conj)
act but (cc)
required trigger (xcomp)
increase latencies (nmod)
abnormalities elevations (conj)
death erythrocyte (compound)
= 23 (dobj)
tobramycin gentamicin (conj)
addition treatment (nmod)
treated both (nsubjpass)
increase verapamil-related (amod)
patients 122 (nummod)
proteins normal (amod)
cotransporter na(+)-k(+)-2cl(- (amod)
$ROOT$ relevant (sent)
attributed incorrectly (advmod)
cnsb002 , (punct)
events monitored (acl)
plays generation (nsubj)
euthanasia to (case)
$ROOT$ delays (sent)
usefulness agonists (nmod)
relieve , (punct)
exhibit can (aux)
function net (amod)
concentration glutamate (compound)
impairment loss (nmod)
therapy for (case)
leukoencephalopathy such (predet)
appears factor (nsubj)
taken dose (nsubjpass)
action terminals (nmod)
entrapment nerve (compound)
increased gtn (nmod)
0.3 and (cc)
extension the (det)
signs secondary (amod)
significant less (advmod)
contrast oxcarbazepine (nmod)
changed tablets (nmod)
those below (case)
pa ( (punct)
system toxicity (conj)
pretreatment isoproterenol (compound)
early patients (nmod)
dfmo ( (punct)
receptor d2 (compound)
children to (case)
reversed improve (advcl)
had men (nsubj)
diminishing , (punct)
bolus mg/m2 (compound)
cohort for (case)
sequelae further (amod)
needed decrease (xcomp)
challenges oral (amod)
ratio concentrations (nmod)
5.6 ) (punct)
allowed detection (dobj)
cases excellent (amod)
phenobarbitone and (cc)
dcf os (nmod)
p substance (compound)
cloned human (amod)
diet-fed normal (amod)
measurements pre- (amod)
finding protect (ccomp)
tg , (punct)
component dysfunction (nmod)
% 12.9 (nummod)
naproxen for (case)
glabrata with (case)
= 155 (dobj)
users ci (dep)
premedication diazepam (nmod)
anemia immune (amod)
ongoing is (cop)
blocks furthermore (advmod)
syndrome stevens-johnson (amod)
use for (case)
compared effects (nsubjpass)
symptoms these (det)
severe to (advmod)
rated checklist (nmod)
department such (case)
contexts civilian (amod)
doses large (amod)
cancers platinum/paclitaxel-refractory (amod)
intake high (amod)
therapy combined (amod)
patients heart (compound)
succinylcholine after (case)
integrity sarcolemma (nmod)
abortions during (case)
paradigm light-enhanced (amod)
type disease (compound)
courses multiple (amod)
started glaucoma (nmod)
a cyclosporine (compound)
6/15 . (punct)
months . (punct)
dysfunction respiratory (amod)
allergen-related contact (nmod:npmod)
increased p (dep)
75.9 19.4 (conj)
induced area (nmod)
high so (advmod)
damages . (punct)
predictors outcome (nmod)
lymphoma epitheliotropic (amod)
1.32 1.52 (prep)
postulated have (aux)
output ) (punct)
performed test (nmod)
65 over (case)
prove that (nsubj)
mechanism immunological (amod)
rate administration (nmod)
determined pcr (nmod)
reversible changes (nsubj)
eliminated nephrectomy (nsubj)
abbott-53693 the (det)
died received (advcl)
intermediate appears (conj)
specificity , (punct)
rats ee-treated (amod)
effects no (det)
abnormalities eeg (compound)
protein expression (dep)
diabetes (stz)-induced (amod)
vip radioimmunoassay (nmod)
1/32 and (cc)
exencephaly of (case)
demonstrate reduces (ccomp)
infiltrates % (appos)
psychosis in (case)
using laryngoscopy (dobj)
concerning effect (dobj)
presentations eight (nummod)
emphasis primary (amod)
abnormalities urinary (amod)
noted frequency (nsubjpass)
quality improved (amod)
levofloxacin , (punct)
combination drugs (nmod)
media the (det)
approach siat (nmod)
patterns days (nmod)
unchanged , (punct)
a cyclophilin (compound)
sequences recovery (compound)
appears decrease (xcomp)
women by (case)
1.4 risperidone (nmod)
factor , (punct)
angina disease (conj)
abundance protein (compound)
ed50 by (case)
ina ( (punct)
effects cytoprotective (acl:relcl)
morning normal (amod)
newspaper popular (amod)
accurate noninvasive (dep)
precede immediately (advmod)
application rate (nmod)
8 at (case)
pirenzepine and (cc)
esterification the (det)
hydroxytyrosol the (det)
agonists dopamine-2 (compound)
resistance vascular (amod)
cohorts matched (amod)
prevented rigidity (dobj)
levels phosphate (nmod)
responses reflex (compound)
excretion estradiol (nmod)
onset anemia (nmod)
studies many (amod)
factors factors (dep)
patients patients (appos)
gfr in (case)
lasted revealed (conj)
absorptiometry x-ray (compound)
measured adults (nmod)
extended can (aux)
effects parameters (nmod)
protein mean (dep)
apparent were (cop)
situations both (det)
exchanges and (cc)
parameters clinical (amod)
trial boys (nmod)
granules , (punct)
temperature maximal (amod)
pentoxifylline or (cc)
antagonize potentiate (conj)
induction directly (conj)
investigation to (case)
examination venipuncture (conj)
hepatic , (punct)
characteristics excitability (compound)
equal % (dep)
results discouraging (amod)
proven that (mark)
drug study (compound)
findings any (det)
days initiation (dep)
h 0.5 (nummod)
switching carbamazepine (dobj)
survived had (aux)
literature of (case)
protein protein (appos)
examined be (auxpass)
history previous (amod)
concluded may (aux)
first receive (acl:relcl)
reaction background (compound)
cyp with (case)
proved effective (xcomp)
daytime and (cc)
desensitization brought (acl)
stimulant , (punct)
0.2 and (cc)
pa palpable (amod)
phenobarbital and (cc)
toxicity nonhematological (amod)
involved , (punct)
unlikely . (punct)
incidence type (nmod)
characterize to (mark)
surgery genito-urinary (amod)
reconsidered use (nsubjpass)
noted factors (nsubjpass)
nephrotoxicity one (nsubj)
decreased catalepsy (dobj)
antagonizing deficits (dobj)
include simplifies (conj)
1.04 2.75 (prep)
carried study (nsubjpass)
tida ) (punct)
determine programmed (ccomp)
g doses (nsubj)
deprivation nutritional (amod)
analyzed response (nsubjpass)
caused elevation (dobj)
infection malignancy (conj)
therapy vasopressor (compound)
developed mg/m2/d (nmod)
atrium m2 (nmod)
> leading (dep)
mechanism cytoprotection (nmod)
administration ouabain (compound)
increased postswitch (nmod)
have receiving (advcl)
hexachloride ppm (amod)
fasciculation including (case)
treat , (punct)
clones of (case)
20- or (cc)
toxicity for (case)
3.6 x (cc)
threshold patients (nmod)
occurred multiforme (nsubj)
affect amplitudes (dobj)
fps ( (punct)
69.9 30.1 (conj)
factor because (mark)
$ROOT$ outcome (sent)
malaise , (punct)
analyzed study (nmod)
slope treatment (nmod)
course treatment (nmod)
= 6 (dobj)
administered had (aux)
confusion nausea (conj)
opioid-receptors on (case)
changes functionality (nmod)
randomised were (auxpass)
ranged s (nmod)
severity clinical (amod)
induced increasing (advcl)
yield suited (conj)
produce products (nsubj)
injection isoproterenol (nmod)
32 of (advmod)
synthase activity (conj)
aware take (conj)
implausible is (cop)
effects heparin (nmod)
rnfl the (det)
asymptomatic . (punct)
health patients (nmod)
peroxide h2o2 (appos)
diseases other (amod)
resulting rhythm (nmod)
effect misoprostol (nmod)
mortality immunization (nmod)
patients with (case)
mmol mmol (ccomp)
peripheral central (conj)
infusions calcitonin (nmod)
fed l-485 (dobj)
identify predictors (dobj)
morton 's (case)
rate suxamethonium (compound)
nephrotoxicity of (case)
introduction investigated (dep)
calculated based (prep)
capnocytophaga patient (nmod)
ci 1.70 (nummod)
using were (aux)
cardiomyopathy toxicity (nsubj)
neonates toxicity (nmod)
cohorts in (case)
patients unpremedicated (amod)
predictable . (punct)
autoimmune drug-induced (conj)
caused decrease (ccomp)
dose 800-micrograms (compound)
produce symptoms (dobj)
nebulized continuously (advmod)
ratios salt-depleted (nmod)
scans multigated (amod)
characteristics pharmacological (amod)
expression functional (amod)
increases significant (amod)
prevents complication (dobj)
associated symptoms (nmod)
small conclusion (nmod)
recipients chemotherapy (compound)
conclude : (punct)
report pain (compound)
localization central (amod)
duration fraction (conj)
mechanism hypotensive (amod)
higher correlated (parataxis)
suppression turnover (nmod)
support concept (dobj)
successful not (neg)
oscillation pupillary (compound)
antiemetics dopaminergic (amod)
fed group (nsubj)
hydrochloride lidocaine (compound)
propofol mg.kg-1 (nummod)
fluctuations ) (punct)
vaccine postpartum (amod)
0.6 . (punct)
suggested one (nmod)
al 1985 (nummod)
ointment tacrolimus (compound)
showed rats (nmod)
cc between (case)
qtp with (case)
artery right (amod)
lpp of (case)
class each (det)
those improved (acl)
sulphate , (punct)
treated cream (nmod)
selection the (det)
rats anaesthetized (amod)
described period (nmod)
onset lesions (nmod)
administration vincristin (compound)
$ROOT$ serious (sent)
pathway jak/stat3 (compound)
reduced gave (conj)
infusion 3-hour (amod)
injection dose (dep)
chelator an (det)
enzyme regulatory (amod)
ingredient active (amod)
indicator that (mark)
headache chronic (amod)
ability affect (acl)
risk low (amod)
atra alone (advmod)
recorded preparations (nmod)
5 them (nmod)
given pairs (dobj)
retention during (case)
loss secondary (amod)
presented hours (nmod)
commissure , (punct)
at who (nsubj)
$ROOT$ d-galactose (sent)
nodosum in (case)
objective study (acl)
irritability attack (conj)
carries have (advcl)
administered courses (nsubjpass)
adrenoceptors through (case)
benign and (cc)
experiments and (cc)
muscle in (case)
rate dp/dt (conj)
alteration n=6 (dep)
effects pain (conj)
initiated then (advmod)
herniations cell (nmod)
rs of (case)
% ci (conj)
population for (case)
treatment on (case)
pregs natural (amod)
liver isolated (amod)
depend protection (nmod)
580 +/- (cc)
effects occurrence (nmod)
inpatient , (punct)
aspiration negative (amod)
lower average (nmod)
activity glutathione (compound)
= 0.06 (dobj)
assay macroscopic (amod)
patient third (amod)
observed differences (nmod)
induces patients (nmod)
diseases the (det)
caused propofol (nmod)
discontinuous . (punct)
behavior " (punct)
effect hypotension (nmod)
mania antibiomania (appos)
trated basis (nmod)
endonuclease-dependent both (cc:preconj)
prevention preservation (conj)
regardless and (cc)
formation peroxide (compound)
treated clonazepam (nmod)
patients studied (acl)
striata in (case)
risk thromboembolic (amod)
erections penile (compound)
p75(ntr)-ir bodies (nmod)
noted , (punct)
anatomy internus (nmod)
evidence hyperactivity (nmod)
easily more (advmod)
mg/m2/d of (case)
cell visceral (amod)
accompanied width (nmod)
farmer in (case)
stimulation mglurs (nmod)
defect dependent (acl:relcl)
fever hemorrhagic (amod)
occurrence administration (nmod)
dysarthria and (cc)
3 test (conj)
thrombocytopenia by (case)
pronounced controls (nmod)
investigator blinded (acl:relcl)
aspects associated (acl)
causes permeability/injury (dobj)
iopentol doses (nmod)
neurotoxicity ) (punct)
discharge rapid (amod)
remain understudied (acomp)
modifications marked (amod)
problem differences (nmod)
sold be (auxpass)
sites into (case)
sem ) (punct)
anesthetics three (nummod)
$ROOT$ sweating (sent)
conclusions sole (appos)
due may (aux)
induce aggravate (conj)
available quantities (nsubj)
dose day (nmod:tmod)
micrograms trh (nmod)
rate contractions (nmod)
cholinomimetic of (case)
oestrogens placebo (conj)
role possible (amod)
mdp ( (punct)
vip ) (punct)
activator receptors (nmod)
presence behaviour (nmod)
was increase (nmod)
fragmentation dna (compound)
aggravate oih (dobj)
cessation sorafenib (nmod)
binding mice (nmod)
level % (compound)
tetracycline to (case)
(aap)-hepatitis from (case)
increases fasciculations (nmod)
shape in (case)
responses chronotropic (amod)
become subject (attr)
chosen strain (nmod)
dopamine the (det)
one into (case)
injections 14 (nummod)
cross-tolerance no (neg)
grafting bone (compound)
treated h (nmod)
shortage national (amod)
> 20 (conj)
ml 108.9 (nummod)
response for (case)
calculated we (nsubj)
preparations single-cell (amod)
generated superficially (advmod)
piroxicam inhibitor (conj)
3.3 +/- (cc)
variability patients (nmod)
results that (nsubj)
cerebella groups (nmod)
determination extraction (nmod)
1.56 ) (punct)
animal in (case)
termination prompt (amod)
accumulation amphotericin (compound)
exposure prenatal (amod)
beats ectopic (amod)
levels renal (amod)
system fusimotor (amod)
selective . (punct)
nitrendipine the (det)
done pharmacokinetics (nsubjpass)
getting up (compound:prt)
reversal drugs (nmod)
comparable mice (nmod)
x/minute 100 (nummod)
estimate using (advcl)
required treatment (dobj)
consistent mechanism (nmod)
difficulties to (case)
nephrotoxicity inhibition (dep)
mmhg 42 (nummod)
triglycerides tg (appos)
tachyarrhythmias supraventricular (amod)
prevented effect (dobj)
cognitive affective (conj)
located were (auxpass)
responsible with (mark)
groups experimental (amod)
jj jj (conj)
trials 10 (nummod)
cystica between (case)
reflexes normal (amod)
vegf receptor (conj)
tubulopathies demonstrated (amod)
docetaxel followed (acl)
existed years (nmod)
starting minutes (nmod)
formation reticular (amod)
scored extent (nmod)
5 < (amod)
increase p (dep)
withdrawal market (nmod)
5-ht ) (punct)
relieved was (auxpass)
induction metallothionein (compound)
treated fk506 (nmod)
performance normal (amod)
sn ( (punct)
albuminuria and (cc)
protein cellular (amod)
effects bcnu (nmod)
n-acetyl-beta-d-glucosaminidase ? (punct)
apoptosis with (case)
induced downregulated (conj)
muscles several (amod)
offers injury (nmod)
satisfied criteria (dobj)
institution hypertension (nmod)
suppressants of (case)
occurred effects (conj)
chemotherapy concomitant (amod)
site is (cop)
virus alf (conj)
warfarin levofloxacin (conj)
patients pointes (nmod)
sss ) (punct)
acidosis with (case)
reactivation virus (compound)
assessed administration (nmod)
range broad (amod)
dementia : (punct)
declined immediately (advmod)
type oc (nmod)
limiting depth (dobj)
lobe , (punct)
sedation propofol (nmod)
= 1188 (dobj)
therapy terbinafine (compound)
levels tnf-a (nmod)
hr resting (amod)
acid of (case)
microvilli swollen (amod)
6-thioguanine solely (advmod)
measures in (case)
contrast level (nmod)
thalidomide on (case)
hypometabolism ad (nmod)
episode previous (amod)
inhibition end-product (amod)
bypass cpb (appos)
discharges epileptic (amod)
days dexamethasone (nmod)
leukopenia by (case)
reductions to (case)
reversal results (nmod)
delta kappa (conj)
prolactin for (case)
d-med 4 (nummod)
values lvef (nmod)
l. of (case)
fell hg/l/min (nmod)
changes regenerative (amod)
improvement clinical (amod)
2b1/2b2 , (punct)
agents were (cop)
point . (punct)
injected after (mark)
regulation expression (compound)
best was (cop)
controls between (case)
disease by (case)
used manage (xcomp)
acid large (amod)
level 4 (nummod)
received nine (nsubj)
improved trial (nmod)
$ROOT$ pallidotomy (sent)
neurotoxin noradrenaline (compound)
effect sm-5887 (nmod)
recruited who (nsubjpass)
11.1 , (punct)
width ) (punct)
groups 2 (dep)
po2 ( (punct)
treated pn (nmod)
lca hca (conj)
control hypertrophic (conj)
qt the (det)
arrest patient (nmod)
blockers omeprazole (conj)
field in (case)
comparable that (nmod)
administration lmwh (compound)
failed recover (xcomp)
involvement reward (nmod)
treatment or (cc)
tachyarrhythmias therapy (nmod)
activator the (det)
diverging dramatically (advmod)
during following (conj)
safety alprazolam (nmod)
avoidance antagonists (nmod)
assessed effects (nsubjpass)
aware adding (advcl)
pk with (case)
163 these (nmod)
administered which (nmod)
asystole the (det)
duration age (conj)
recovered receiving (advcl)
caused illness (dobj)
ratings slowness (nmod)
level basal (amod)
hybridization by (case)
prolongation induced (acl)
microg/kg 10 (nummod)
size-dependent simply (advmod)
hypertension bp (dep)
ed50 protection (nmod)
nelarabine etoposide (conj)
19 % (conj)
medium contrast (compound)
suggest reports (nsubj)
correlations volume (nmod)
infusion push (conj)
presentation her (nmod:poss)
contain order (nmod)
cured improved (conj)
reverses nefiracetam (nsubj)
detachment urothelium (nmod)
synapses central (amod)
potentiated order (nmod)
non-drug cannabis/alcohol/nicotine (appos)
4.0 +/- (cc)
administration placebo (compound)
$ROOT$ part (sent)
types expressing (acl)
obstruction chronic (amod)
appear predispose (xcomp)
symptoms . (punct)
responsiveness pressor (compound)
contributed injection (nsubj)
ligands other (amod)
transfer to (case)
point months (nmod)
rose ml (nmod)
describe comparison (nmod)
channels channels (appos)
effect best (amod)
times various (amod)
started long (advmod)
suffers reticulata (nsubj)
administered reduce (advcl)
calcineurin of (case)
thinning band (nmod)
injected previously (advmod)
sedation of (case)
levetiracetam administered (acl)
demonstrated problems (dobj)
patients comparison (amod)
compared determine (advcl)
arrested that (nsubj)
arrest child (nmod)
doses examined (acl)
$ROOT$ sensor (sent)
values tests (nmod)
ax with (case)
excretion acid (nmod)
delay lethality (nmod)
had has (aux)
= 7/23 (nsubj)
leukopenia 2 (nummod)
attempted always (advmod)
pregnancies singleton (amod)
tolerability , (punct)
agonists selective (amod)
meat from (case)
sensitive structures (nmod)
$ROOT$ elected (sent)
supplementation regimen (nmod)
increases stress (dobj)
increase costs (conj)
recovered function (nsubj)
fatal can (aux)
anemia acquired (amod)
mg/m(2 600 (nummod)
effusion and (cc)
exacerbation and (cc)
described complication (nmod)
akathisia fluoxetine-induced (amod)
potentiate or (cc)
some in (case)
suppression by (case)
pcr by (case)
charcoal and (cc)
toxicity serious (amod)
p=0.037 ) (punct)
period 24-hour (amod)
p.o. at (case)
activity between (case)
stream blood (compound)
but mainly (advmod)
group injected (acl)
aortic either (preconj)
3.49 , (punct)
phenols fla873 (conj)
et-1 of (case)
age younger (amod)
consisted recovered (conj)
conclusions comparable (dep)
dismutase activities (dep)
risk their (nmod:poss)
antigen anti-proliferating (amod)
processes stages (nmod)
mechanism(s ) (punct)
mechanisms cytostatic (amod)
agricultural and (cc)
scale bech-rafaelson (compound)
2.0 ratio (nsubj)
correct imbalance (dobj)
mpo-anca for (case)
output urinary (amod)
hypnotic choice (nmod)
clubs axons (nmod)
microg separated (acl)
$ROOT$ old (sent)
efficacy thyroidectomy (nmod)
glomerulosclerosis or (cc)
block intermittent (amod)
6-ohda ( (punct)
dysfunctions autonomic (amod)
tested check (nmod)
known already (advmod)
ketoconazole mg (amod)
bp hg (dep)
h. the (det)
records on (case)
treatment empiric (amod)
evidence prevention (nmod)
contribute that (mark)
five seven (conj)
pilo , (punct)
( < (intj)
afford may (aux)
regulator a (det)
makes agent (ccomp)
group ' (punct)
precore pc (appos)
effects following (amod)
patients receiving (acl)
$ROOT$ alleviates (sent)
substratum brain (compound)
crystallization diffuse (amod)
passed spontaneously (advmod)
terminated study (nsubjpass)
rose rose (conj)
those living (acl)
naloxone hydrobromide (conj)
developed % (dep)
hypersensitivity induced (acl)
corroborate , (punct)
induce effects (dobj)
result which (nmod)
sleepiness daytime (amod)
finished . (punct)
joint the (det)
dopamine-1 , (punct)
investigation double-blind (amod)
i1- alpha2-receptor (conj)
year the (det)
protein increased (amod)
patient induced (acl)
160 - (punct)
patients dyskinetic (amod)
effect galactose (nmod)
episodes antibiotic-induced (amod)
prox-1 , (punct)
0.27 = (parataxis)
take home (compound:prt)
treatment routine (amod)
mitigated bupivacaine (nmod)
= 8) (dep)
assay examination (conj)
a nifedipine (conj)
hypotension helodermin-produced (amod)
significant differences (nsubj)
safety women (nmod)
vasopressin contributor (nmod)
failed eads (nsubj)
failure peritransplant (amod)
greater mg/dl (nmod)
insight safety (nmod)
free progression (nmod:npmod)
development ratios (nmod)
receptor da (compound)
drop by (case)
model ulcer (compound)
preparation grafting (nmod)
reproduces provides (conj)
nephropathy doxorubicin-induced (amod)
medications any (det)
hepatotoxicity cross (amod)
mg/kg s.c. (amod)
procedure after (case)
sch ( (punct)
system from (case)
combinations dose (compound)
12/30 % (appos)
1 20 (conj)
role amines (nmod)
increasing years (nmod)
injected slowly (advmod)
vasculitis development (compound)
application sealants (nmod)
demonstrate addition (nmod)
receptor-alpha the (det)
defect may (aux)
abnormalities t (compound)
mild neuropathy (nsubj)
epinephrine intracavernous (amod)
elderly in (case)
evaluation study (nmod)
counterparts their (nmod:poss)
thrombin and (cc)
sbp ( (punct)
associated anophthalmia (nmod)
responsiveness erythropoietin (nmod)
rate dose (compound)
dysfunctions headache (nmod)
hundred fifty-one (conj)
had peptide (nsubj)
delivered setting (nmod)
temocapril controls (conj)
hormone thyroid (compound)
$ROOT$ wish (sent)
signs nausea (conj)
heroine and (cc)
scene the (det)
reduced abundance (nsubjpass)
rates six (nummod)
assessed methods (nsubjpass)
due death (nsubj)
patients mbc (nmod)
algorithm by (case)
contribution valproate (nmod)
use kidneys (nmod)
suggest desensitization (dobj)
achieved disease (dobj)
assumed which (nsubjpass)
side system (nmod)
indirect that (mark)
amounted mg/l (nmod)
17alpha-ethinylestradiol ee (appos)
bolus to (case)
inactive that (nsubj)
has levodopa (nsubj)
epinephrine topical (amod)
to up (advmod)
block pattern (nmod)
methylprednisolone after (case)
l-noarg not (cc)
feet her (nmod:poss)
increased expression (nsubj)
hyperprolactinemia risperidone-induced (amod)
impaired iprk (nmod)
disturbance droperidol-induced (amod)
success with (case)
given after (mark)
coma ' (punct)
twitch peak (amod)
potentiate effect (dobj)
developed convulsions (dobj)
users 768 (nummod)
led : (punct)
pretreatment pentoxifylline (nmod)
psychiatry child (compound)
appreciated associated (ccomp)
report case (dobj)
time an (det)
analgesics four (nummod)
hypotension effect (nmod)
loss normalization (conj)
antibodies . (punct)
unresolved , (punct)
lometrexol the (det)
became negative (xcomp)
sequence temporal (amod)
rats intact (amod)
cases even (advmod)
compatible results (nsubj)
related to (mark)
times partial (amod)
days 5 (dep)
died therapy (nmod)
neurotransmitters these (det)
different markedly (advmod)
accompanied factors (nmod)
glomeruli sclerosis (nmod)
treatment ( (punct)
i.v. n=12 (dep)
acid antagonist (compound)
iopentol iohexol (conj)
address parameters (dobj)
grade iii (nummod)
intoxications in (case)
underwent received (conj)
artesunate drug (appos)
17beta-estradiol , (punct)
317 to (case)
deduced reports (nmod)
safety implant (nmod)
outstretched horizontally (advmod)
damage reticulata (nmod)
deaths related (amod)
glomerulus the (det)
ors ( (punct)
way projection (nmod)
attenuated ineffective (advcl)
common impotence (nsubj)
followed discontinuation (dobj)
mild moderate (conj)
35.9 10 (conj)
odds in (case)
concerns safety (nmod)
concentration increasing (amod)
associated degree (nmod)
disorder particularly (advmod)
phonophobia photophobia (conj)
selegiline day (nmod)
significant elevations (nsubj)
staining immunofluorescence (compound)
lesions detectable (amod)
reverse effects (nsubj)
manifest initially (advmod)
given previously (advmod)
occurrence seizures (nmod)
reduced increments (nsubjpass)
reduced contrast (nmod)
consists and (cc)
benefit avoiding (advcl)
vulnerable if (mark)
1.68 . (punct)
introduction suprofen (nmod)
56.8 11.8 (conj)
four three (compound)
leads nephropathy (nsubj)
induced difference (nmod)
p associated (dep)
transferred has (aux)
enhance , (punct)
60 age (dep)
derangements seen (acl)
measurement , (punct)
controls selected (amod)
ulcers oral (amod)
ameliorates conversion (nsubj)
division the (det)
resulted depletion (nmod)
gestation 5-week (compound)
developed restarting (nmod)
university university-affiliated (conj)
disease inflammatory (amod)
inhibits ruling (advcl)
hr 2.74 (nummod)
pathogen(s of (case)
days week (nmod:npmod)
glutamine its (nmod:poss)
lead 12 (nummod)
benefit strength (dobj)
digitalis- for (case)
wt 0.28 (appos)
1 0.3 (nummod)
patients cancer (nmod)
ufh ( (punct)
neurosteroids of (case)
therapy cimetidine (compound)
6 and (cc)
use prehospital (amod)
ratio clearance (nmod)
developed man (nmod)
hospitalized was (auxpass)
minutes 85 (nummod)
ph lidocaine (nmod)
had duct (dobj)
mediation bradycardia (nmod)
adulthood during (case)
dm + (cc)
shown experiments (nsubj)
sensitivity pain (compound)
evaluation concentrations (nmod)
activity motor (compound)
transplantation living-related (amod)
classified and (cc)
ergot of (case)
subdivided , (punct)
prostacyclin in (case)
serotonergic both (cc:preconj)
kidney rats (nmod)
subject metabolism (nmod)
function flow (conj)
clarithromycin in (case)
wane year (nmod)
rpn ( (punct)
documented little (advmod)
changes hepatocytes (nmod)
definition the (det)
carcinogen with (case)
fentanyl nl (appos)
$ROOT$ contrasted (sent)
case rs (nmod)
method analytical (amod)
mediators of (case)
reaction macro-papular (amod)
own its (nmod:poss)
determine frequency (dobj)
participants 997 (nummod)
received afternoon (nmod)
have state (dobj)
administered alfentanil (nsubj)
$ROOT$ discussion (sent)
induced haloperidol (nmod:npmod)
bsa ( (punct)
influenced beta-blockers (nsubj)
measure primary (amod)
parkinsonism in (case)
eps , (punct)
recording states (dobj)
show influence (dobj)
botox ( (punct)
ece-1 ) (punct)
interfere did (aux)
inhibited allopregnanolone (nsubj)
related directly (advmod)
antithrombin with (case)
levodopa for (case)
synthesis assessed (dep)
had have (parataxis)
del ( (punct)
patient 25-year-old (amod)
suffered effects (dobj)
resuscitation lipid (nmod)
cocaine amphetamines (conj)
peld tbil (conj)
injected prior (advmod)
examined to (mark)
number cycles (nmod)
lack changes (conj)
basis short- (amod)
period dark (compound)
measured observers (nmod)
effect etoposide (nmod)
less 12 (nmod)
affects whether (mark)
university-affiliated , (punct)
noticed using (ccomp)
projection of (case)
reported myalgia (nsubjpass)
these of (case)
decreased mg/dl (nmod)
agents blocking (amod)
associated necrosis (nmod)
memory of (case)
gestodene or (cc)
improved hippocampus (nmod)
g/dl 7 (nummod)
group 2 (conj)
48-week ( (punct)
$ROOT$ disclosed (sent)
assess reducing (advcl)
amphetamine ie (advmod)
injected groups (nsubjpass)
jaundice and (cc)
kind any (det)
dose 20-mg (amod)
beta-blocker of (case)
dose busulfan (nmod)
discontinue they (nsubj)
prescription suppressants (nmod)
re-induced . (punct)
determine dosage (dobj)
continue side-effects (nmod)
improved treatment (nmod)
% above (case)
re-exposure on (case)
content gsh (compound)
dose g/m2 (nmod)
percent 40 (nummod)
function cerebellar (amod)
reaction than (cc)
mtx of (case)
igf-i human (amod)
continue efforts (nsubj)
extent on (case)
pain foot (compound)
sedation adequate (amod)
found reduced (ccomp)
epm the (det)
s-limonene and (cc)
appears mediated (xcomp)
recorded episodes (nsubjpass)
audiograms patients (nmod)
report interim (amod)
receiving consolidation (nmod)
prevented infarction (dobj)
patients snhl (nmod)
ml sulphoxide (nmod)
levels lithium (compound)
> rates (nsubj)
hypersecretion gastric (amod)
attacks onset (compound)
widespread more (advmod)
gabapentin drug (appos)
female an (det)
interpretation apparent (dep)
ci=22.5 95 (amod)
7e indol-2-one (appos)
prolongs methadone (nsubj)
one day (nmod)
injecting recorded (advcl)
functions in (case)
pretreated , (punct)
inhibition both (cc:preconj)
nephrotoxicity acetaminophen-induced (amod)
attenuate amnesia (dobj)
dynes.s.cm-5 ( (punct)
angioedema moderate (amod)
received have (aux)
remained ctni (nsubj)
cyclooxygenase 2 (nummod)
methyldopa of (case)
% 3.7 (nummod)
analyses by (case)
$ROOT$ assayed (sent)
completing patients (nsubj)
unable we (nsubj)
30mg/kg , (punct)
apparent earlier (advmod)
min(-1 l (compound)
mg.kg(-1).min(-1 6 (nummod)
induction transplantation (nmod)
technique kety-schmidt (compound)
criteria disease (nmod)
caused doses (nsubj)
population gum (appos)
protection cbz (nmod)
microinjection medulla (nmod)
mediate parkinsonism (dobj)
hemosiderosis cardiac (amod)
acts effect (nsubj)
bradycardia with (case)
adjusted order (nmod)
use didanosine (nmod)
neuropathy vincristine (compound)
preceded and (cc)
g 25 (nummod)
elevations blood (compound)
analyzed addition (nmod)
probe flow (compound)
differentiation pharmacological (amod)
demonstrate explained (ccomp)
valves mechanical (amod)
examined respectively (advmod)
doxorubicin either (cc:preconj)
change ( (punct)
% total (nmod)
sensation pain (compound)
mechanisms enabling (acl)
level ck-mb (compound)
encoding of (case)
emerged and (cc)
two vmax (conj)
seen prolongation (nsubjpass)
exposure mixture (nmod)
involve induction (dobj)
components for (case)
pre-treated igf-il-3 (nmod)
mg/kg/daily 5 (nummod)
inhibited % (nmod)
diatrizoate from (case)
conditions two (nummod)
four netilmicin (nmod)
tlr4 ( (punct)
found simultaneously (advmod)
indinavir control (conj)
duration months (nmod:tmod)
had correlation (dobj)
nine with (case)
implicated di (nmod)
supports view (nsubj)
tumor on (case)
treated 350 (nsubjpass)
cnp ) (punct)
hematomyelia thoracic (amod)
normal reassessed (conj)
is paucity (attr)
hypersensitivity pentobarbital (nmod)
associated had (conj)
terms densities (nmod)
therapy linezolid (compound)
study by (case)
damage widespread (amod)
1.56 risks (nsubj)
none pruritus (conj)
content platelet (compound)
given induced (conj)
efficacy combinations (nmod)
anesthetized , (punct)
illustrate susceptible (ccomp)
association possible (amod)
compared outcomes (nsubjpass)
nausea % (appos)
resumed is (auxpass)
showing abolished (ccomp)
infusion noradrenaline (nmod)
treatment dph (compound)
entry tube (nmod)
hyper-responsiveness phytomitogen (nmod)
$ROOT$ shorter (sent)
procedures revascularization (compound)
presented below (advmod)
gd 11 (nummod)
rofecoxib they (nsubj)
8 3 (compound)
regulating inactivation (dobj)
activation midpontine (compound)
caused 1 (dep)
mice nmri (compound)
avoidance of (case)
alpha3 and (cc)
animals ovariectomized (amod)
more treatment (nmod)
reduce enhancing (advcl)
copenhagen of (case)
measured testing (nmod)
using multivitamin (dobj)
acid acids (conj)
muscles into (case)
correlations positive (amod)
optic peripheral (conj)
maze burying (conj)
550 225 (compound)
depression by (case)
proliferation on (case)
conducted population (nmod)
relevant down-regulation (nsubj)
107 ( (punct)
hg mm (nummod)
capd ( (punct)
counts 2.5 (nmod)
9.7 +/- (cc)
chemotherapy recent (amod)
affected incidence (nsubjpass)
infusion argatroban (compound)
values lower (amod)
detectable symptoms (nsubj)
gels electrophoresis (compound)
those dfc (nmod)
hepatotoxicity no (det)
pellet ( (punct)
range subtherapeutic (amod)
$ROOT$ evinced (sent)
preload in (case)
generated , (punct)
antigen fviiirag (appos)
prevented remodeling (dobj)
mg/d ( (punct)
treatment haloperidol (nmod)
pericarditis , (punct)
entered been (auxpass)
cigarettes 25.2 (nummod)
astrocytes cells (conj)
potential reduced (amod)
alternations rapid (amod)
produced reduction (dobj)
an ( (punct)
tobramycin combined (acl)
evidence abnormality (nmod)
prevents changes (dobj)
risk defects (nmod)
decreased stability (dobj)
percussion to (case)
received transplantation (nmod)
showed defined (advcl)
used sedative (nmod)
or ci (dep)
system neuronal (amod)
repair myelomeningocoele (nmod)
produce pg-9 (nsubj)
sec. in (case)
produced succinylcholine (nmod)
eosinophil mixed (amod)
tdi ( (punct)
had role (dobj)
two cases (nmod)
assessment a (det)
coma history (nmod)
tachyarrhythmias and (cc)
normalized remained (conj)
inhibition by (case)
3 times (quantmod)
anthracyclines daunorubicin (dep)
therapies ribavirin (nmod)
boy 5-year-old (amod)
solution ) (punct)
comprise thrombosis (nsubj)
function cardiovascular (amod)
changed tinnitus (nsubj)
perfusion during (case)
dosage methylprednisolone (nmod)
aim paper (nmod)
survival patients (nmod)
97.1 ; (punct)
elevation ctnt (nmod)
analogue synthetic (amod)
induction attacks (nmod)
abstinence 12-hour (compound)
india south (compound)
spasm masseter (compound)
causes contrary (nmod)
magnitude duration (appos)
study 2 (nummod)
$ROOT$ participated (sent)
along studies (nmod)
2-(p-bromophenyl)propionate of (case)
suffering been (aux)
arthrogryposis . (punct)
processes neurodegenerative (amod)
hypercalcemias related (amod)
administered performance (nmod)
manifestations classic (amod)
0.2 2.5 (conj)
pathogeneses hematopathology (conj)
neurons intact (amod)
conclude but (cc)
hypocalcemia severe (amod)
0.15+/-0.03/h od (nmod)
latency attack (nmod)
increased males (nmod)
present convulsions (nsubj)
functions cognitive (amod)
led acting (advcl)
0.83 , (punct)
assigned subjects (nsubjpass)
transcripts encoded (acl)
stimulation at (case)
assessed data (nsubjpass)
given prior (advmod)
role bmt (nmod)
switch manic (amod)
increase level (nmod)
demonstrated occur (xcomp)
teratogenicity sulphasalazine (nmod)
detecting ischemia (dobj)
probability interaction (compound)
decrease percent (nmod)
binding ) (punct)
was therefore (advmod)
psychopathology or (cc)
repair proliferation (conj)
serious reactions (nmod)
trated first (advmod)
supplementation magnesium (compound)
similarity despite (case)
administration betaine (nmod)
oct treatment (conj)
follow but (cc)
pronounced rise (nmod)
vestibular or (cc)
injury irreversible (amod)
complete to (mark)
young in (case)
deprived prenatally (advmod)
extraction minutes (dep)
network cooperative (amod)
period before (nmod)
eyes red (amod)
short- intermediate-term (conj)
lower group (advcl)
effects synthesis (nmod)
utility fk (nmod)
sub-divided further (advmod)
serum in (case)
remarkable hypertension (nmod)
stopped begun (conj)
away other (nmod)
magnitude sides (nmod)
tail in (case)
efficacy virologic (amod)
0.6 x (cc)
agent potential (amod)
weakness generalized (amod)
given prophylaxis (dobj)
disease hosts (nmod)
graft patients (conj)
exclude however (advmod)
behavior binding (conj)
warrant follow-up (dobj)
concentrations matter (compound)
recruited study (nmod)
activation beta-adrenoceptor (compound)
inhibits reuptake (dobj)
$ROOT$ presentation (sent)
zone zone/cortical (amod)
water lemon (conj)
increased treatment (nsubj)
remained vmax (nsubj)
treated tested (conj)
proportional damage (nmod)
assessed effect (nsubjpass)
series injections (nmod)
associated hyperhidrosis (nmod)
$ROOT$ disorder (sent)
doses each (appos)
causes dysmetria (dobj)
reduced tremor (dep)
pastes and (cc)
premedication standard (amod)
aminoglycosides particularly (advmod)
7 1-(1,2-dihydro-2-acenaphthylenyl)piperazine (compound)
precipitation drug (compound)
hydrochloride [4ar-trans]-4,4a,5,6,7,8,8a,9-o-dihydro-5n-propyl-2h-pyrazo (compound)
ovariectomized of (case)
times > (dep)
courses 167 (nummod)
nrf2(-/- ) (punct)
activity drug (nmod)
transfer ward (nmod)
observed subjects (nmod)
nouns of (case)
inflammatory of (case)
lcva ct (conj)
times the (det)
possesses atorvastatin (nsubj)
significantly substantially (conj)
continued remain (xcomp)
range ( (punct)
produce either (dep)
patients 926 (nummod)
limited focus (nmod)
correlated have (advcl)
current native (amod)
alphabeta-crystalin subunit (conj)
effort in (case)
myopathy resolved (acl:relcl)
indicated lesion (dobj)
chemotherapy both (preconj)
retarding by (mark)
receptor action (nmod)
infection a (det)
$ROOT$ inserted (sent)
antagonism ro15 (nmod)
blockade ) (punct)
quality for (case)
risk highest (amod)
utility biometry (nmod)
as november (nmod)
assessed capacity (nsubjpass)
i bipolar (conj)
values fps (compound)
done and (dep)
bradycardia to (case)
complicated condition (nsubjpass)
restoration plasticity (nmod)
chick the (det)
1995 - (punct)
influence pathophysiologic (amod)
cardiomyocytes cell-derived (amod)
thioperamide antagonist (appos)
cortex mice (nmod)
useful test (nsubj)
diabetes use (conj)
1 31 (prep)
lt ( (punct)
synthase myo-inositol-1-phosphate (compound)
uncommon serious (conj)
value g/dl (nmod)
pathway gabaergic (amod)
increase iop (compound)
micrograms or (cc)
evaluating safety (dobj)
cc of (case)
given compared (conj)
milieu , (punct)
muscles of (case)
beta-ccm to (case)
models models (conj)
amounts blood (compound)
pressure 190/160 (appos)
patient bradyarrhythmic (amod)
microg/kg s.c. (appos)
meq/l 5.0 (nummod)
mpep ) (punct)
respond often (advmod)
tumorigenesis rat (compound)
tbm ) (punct)
ng/ml of (case)
chick developing (amod)
analyzed systematically (advmod)
ng/ml l/m2 (conj)
protein mitochondrial (amod)
vte of (case)
thromboembolism for (case)
large diffuse (amod)
group liver (compound)
= 4.1 (dep)
so less (advmod)
cyclosporine both (cc:preconj)
ci 0.01 (nummod)
seizures picrotoxin-induced (amod)
masked have (aux)
incerta zona (compound)
nanosphere a (det)
ami ) (punct)
marked , (punct)
warranted recommended (advcl)
men of (case)
( /-14.4 (conj)
effects electrophysiologic (amod)
given safely (advmod)
response together (advmod)
anticoagulated heparin (nmod)
treatment alone (advmod)
motif the (det)
seems action (nsubj)
dose severity (conj)
least at (case)
peaked injection (nmod)
occur but (cc)
cisplatin for (case)
images the (det)
region nodal (amod)
infiltrate portal (amod)
enhance impaired (advcl)
80 20 (compound)
infarction nonfatal (amod)
g/cm(2 765 (nummod)
testing further (amod)
hypotension labetalol-induced (amod)
conclusions justify (appos)
revealed had (ccomp)
analogue nucleotide (amod)
spent entering (conj)
metabolism lipid (compound)
site precise (amod)
followed and (cc)
score quality (nmod)
anemia microangiopathic (amod)
tetra- as (case)
analysis dna (compound)
discontinued administration (nsubjpass)
cleavage ) (punct)
1a1/1a2 p450 (compound)
sides bbb (nmod)
lam ( (punct)
associated aspirin (nmod)
ducts hepatic (amod)
diaphragm medius (conj)
rigidity agent (nmod)
pressure lv (compound)
maleate . (punct)
rats salt-depleted (amod)
induced first (nmod)
improvement ) (punct)
impaired memory (dobj)
phosphokinase high (amod)
influences . (punct)
thirst and (cc)
both patients (nmod)
levels control (compound)
function erectile (compound)
nm ( (punct)
man 28-year-old (amod)
risks benefits (conj)
burden the (det)
percent 73/99 (appos)
induction relapse (nmod)
regression poisson (amod)
partial either (cc:preconj)
treated initially (advmod)
faint sometimes (advmod)
stimulates associated (advcl)
varying concentrations (dobj)
receiving inhibitor (dobj)
model multiple (amod)
frataxin of (case)
registered was (auxpass)
size-dependent not (neg)
appears which (nsubj)
persisted treatment (nmod)
aptts ) (punct)
processes astrocytic (amod)
aes as (case)
treated evaluate (advcl)
subtests scale (nmod)
stimulation agonists (conj)
cycles sleep (compound)
angiography before (case)
disrupts , (punct)
incorporate , (punct)
hexabrix ioxaglate (appos)
approach an (det)
whole the (det)
heart and (cc)
injected later (advmod)
support role (dobj)
active combination (nsubj)
aches ( (punct)
pressures intraventricular (amod)
oxidation 4 (dep)
imaging dynamic (amod)
microg/kg/min investigated (parataxis)
associated hit (nmod)
used acid (nsubjpass)
pooling by (mark)
mg/kg 15.0 (nummod)
included embryolethality (dobj)
4.6 - (punct)
patients pair-matched (acl:relcl)
erod ) (punct)
alter can (aux)
increase necrosis (nmod)
modified movements (nsubjpass)
antagonist with (case)
sleep and (cc)
syndrome bowel (compound)
identify form (nmod)
shorter group (nmod)
histology hepatic (amod)
significant incidence (nsubj)
suitable compromising (advcl)
doses subprotective (amod)
mg/ml 0.2 (nummod)
period transient (amod)
females dosage (compound)
progesterone nor (cc)
block phase (compound)
led paralysis (nmod)
binding inhibiting (conj)
identified results (nsubj)
gains that (nsubj)
able was (cop)
mg 60 (nummod)
caused abandoned (ccomp)
injection each (det)
initiated rescue (nsubjpass)
containing d2 (dobj)
improved mg/kg (nmod)
91.2 score (nsubj)
% p (appos)
mice pigs (conj)
bd1063 1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine (appos)
explanations necrosis (nmod)
fetus the (det)
used clinically (advmod)
diagnosis thrombosis (conj)
0.45 2.3 (conj)
reperfusion normotensive (amod)
protein , (punct)
donors (hbsag)-positive (punct)
dw ( (punct)
boy an (det)
remained uncontrolled (xcomp)
nervousness fear (conj)
admission after (case)
route by (case)
overexpressing and (cc)
induces whether (mark)
signs of (case)
peroxisomes liver (nmod)
begun return (xcomp)
$ROOT$ hiccups (sent)
learning state (nmod)
trial placebo (compound)
had 15 (nsubj)
recorded . (punct)
sensitive very (advmod)
disappeared finally (advmod)
differences marked (amod)
case as (cc)
expression ccr2 (compound)
cyclosporine by (case)
cardiotoxicity rats (nmod)
effect behaviour (nmod)
prolong ketoconazole (nsubj)
hour 1 (nummod)
aminotransferase with (case)
aggravation significant (amod)
discovered be (auxpass)
history use (compound)
utility imaging (nmod)
results focused (parataxis)
be may (aux)
establish taken (advcl)
bortezomib regimen (conj)
levels fluid (compound)
models ventricular (amod)
unchanged values (nmod)
toxic bupivacaine (nsubj)
toxicity status (conj)
ectopy benign (amod)
micrograms 0.6 (nummod)
resemblance form (nmod)
kinase amp-alpha2 (compound)
given acetate (nsubjpass)
intensity extension (conj)
strategy novel (amod)
$ROOT$ responds (sent)
depleted ; (punct)
tumors bone (compound)
safety populations (nmod)
level evidence (nmod)
failed chlordiazepoxide (nsubj)
systems , (punct)
administration capecitabine (compound)
effect causative (amod)
shortness breath (nmod)
triceps to (case)
documented duration (nsubjpass)
effective d-penicillamine (nsubj)
ratios respectively (advmod)
endothelia of (case)
highlighted . (punct)
vulnerability selective (amod)
collected assessments (nmod)
heparin , (punct)
pregs and (cc)
lists reference (compound)
21 +/- (cc)
levels rapa (compound)
tests " (punct)
completion therapy (nmod)
detection before (case)
stress a (det)
deficit conduction (compound)
symptoms euphoria (nmod)
hypercalcemia patients (nmod)
retention . (punct)
studies assessing (acl)
diet diet (conj)
lowering months (nmod)
therapy emergent (amod)
ascended proximally (advmod)
achieved had (aux)
had follow-up (nmod)
observed scores (nmod)
regimen daunorubicin (compound)
neurotoxicity synaptic (amod)
g/kg/day u (compound)
30 16 (quantmod)
pretreatment dsp4 (nmod)
equipotent that (mark)
needed establish (advcl)
ns-nsaids to (case)
developed 13 (nsubj)
hormone , (punct)
attenuated injury (dobj)
controls of (case)
apparent was (cop)
report review (conj)
99 to (dep)
use sedative (nmod)
vp ( (punct)
receptors a1 (compound)
dogs open-chest (amod)
parallel signs (nmod)
rabbit 's (case)
uncommon disturbance (nsubj)
had cases (nsubj)
needed may (aux)
cardiotoxicity higher (amod)
usa uk (conj)
alf with (case)
patients no (neg)
people participating (acl)
hours ( (punct)
express interval (dobj)
sites mice (nmod)
volume intravenous (amod)
patients every (det)
potentiate did (aux)
akathisia , (punct)
events users (nmod)
record medical (amod)
administration vpa (nmod)
arteries epicardial (amod)
bacteria gram-positive (amod)
cohort personal (amod)
effects clentiazem (nmod)
had performance (dobj)
cases three (conj)
men n (appos)
similar strikingly (advmod)
12 % (appos)
71 - (punct)
followed immediately (advmod)
improves ischemia (dobj)
87.1 55.6 (compound)
undergoing repair (dobj)
dystonia persistent (amod)
micrograms ( (punct)
exhibited seven (nsubj)
second- and (cc)
cholestasis cholestasis (conj)
october 1992 (nummod)
conditioning rats (nmod)
pills the (det)
elevation avp (nmod)
requested ratings (nsubjpass)
elicits which (nmod)
experience case (nmod)
investigations drugs (nmod)
case overdose (nmod)
apex with (case)
examination sections (nmod)
3nt ( (punct)
benefits increased (amod)
1.039 0.001 (conj)
tinnitus the (det)
drug benztropine (nsubj)
found women (nmod)
occurred increase (nsubj)
gammapathy with (case)
given hr (nmod)
groups control (compound)
years months (appos)
favor . (punct)
sedation continuous (amod)
td ) (punct)
trichotillomania anxiety (conj)
stimulated concentrations (nmod)
mg daily (advmod)
discrimination auditory (amod)
impaired retrieval (nsubj)
seem , (punct)
modifications . (punct)
0.5 10(9)/l (conj)
aftereffects beneficial (amod)
suggest diagnosis (nmod)
receptor mglur5 (appos)
hypokalemia and (cc)
aminonucleoside pan (appos)
interest measured (conj)
models several (amod)
extract seed (compound)
cells retinal (amod)
hours as (case)
measurements threshold (compound)
studied evaluation (nmod)
mouth around (case)
agent other (amod)
phase days (nmod)
hemorrhage gastric (amod)
responses upon (case)
ceased withdrawal (nmod)
propranolol labetalol (conj)
deletion blockage (conj)
80.8 22.4 (conj)
$ROOT$ amounted (sent)
metabolites and (cc)
reduction scores (nmod)
known inhibitors (nsubjpass)
elevation because (case)
p=0.006 ) (punct)
pain myoclonia (conj)
p75(ntr)-ir in (case)
113 +/- (cc)
demonstrating localization (dobj)
treat controlling (advcl)
metabolism energy (compound)
performed day (nmod)
antiplatelet and (cc)
contracture a (det)
man 23-year-old (amod)
using was (aux)
children adolescents (conj)
appeared series (nmod)
assessment vision (compound)
synthesis to (case)
metabolism cholesterol (compound)
transport metabolism (conj)
drugs except (prep)
types protocols (nmod)
activity of (case)
causing exertion (nmod)
$ROOT$ occluded (sent)
fire report (appos)
background reported (dep)
examination analysis (conj)
mechanism receptor-mediated (amod)
oxide , (punct)
stages : (punct)
emulsion of (case)
consequence growth (nmod)
objectives designed (appos)
method of (case)
antinociception combination-induced (amod)
ventricles both (det)
percent ( (punct)
weight mean (amod)
reductions dyskinesias (nmod)
pressures the (det)
controls group (conj)
binding dopaminergic (amod)
investigated mechanisms (dobj)
surveys echocardiographic (amod)
regurgitation patients (nmod)
examined feasibility (nsubjpass)
supported . (punct)
corroborate findings (dobj)
mortality seizure-related (amod)
case knowledge (nmod)
records analysed (acl)
behavior to (case)
2-adrenoceptors cardiac (amod)
was or (cc)
p. in (case)
observed end (nmod)
hold promise (dobj)
mg 80 (compound)
level between (case)
indicated , (punct)
administered weeks (nmod:tmod)
effective is (cop)
man year-old (amod)
instrument used (acl)
fiber elastic (amod)
transmission microscopy (conj)
blockade krebs (compound)
augments greatly (advmod)
% 5%-44 (nummod)
area 298+/-7 (nummod)
rats albino (amod)
results randomized (appos)
presence cyanosis (nmod)
tbarss ) (punct)
cx3cr1 ) (punct)
seconds minutes (conj)
validity data (nmod)
vcm erdosteine (conj)
catheter conductance (compound)
headaches in (case)
deficiency a (det)
condition threatening (amod)
complicating failure (dobj)
prevention hyperactivity (nmod)
toxic also (advmod)
applications dyskinesias (nmod)
considered causes (nsubjpass)
outcomes evidence (conj)
enhancement grading (conj)
recurrence b (compound)
analgesia induced (acl)
gram-positive , (punct)
time total (amod)
cause aminoglycosides (nsubj)
weight with (case)
granisetron antagonist (appos)
dis 219 (nummod)
objective our (nmod:poss)
tolerated blockers (nsubjpass)
women disorders (nmod)
effects , (punct)
deficits reduced (acl)
transdermal , (punct)
effects nanoparticles (nmod)
mediated prefrontal (nmod:npmod)
change did (aux)
infusions apomorphine (compound)
peroxides lipid (compound)
27 73 (prep)
administered concentrations (nsubjpass)
occlusion coronary (amod)
had study (nmod)
db bupivacaine (nmod)
percent as (case)
require does (aux)
investigate herein (advmod)
subacute days (dep)
infarction % (appos)
expressing preference (dobj)
reported studies (nsubj)
remission has (aux)
promotes . (punct)
present ; (punct)
had carbimazole (nmod)
determined basis (nmod)
wt treatment (nmod)
induced rat (nmod)
assessed experienced (nsubjpass)
compared placebo (nmod)
drug blocking (compound)
occurred administration (nmod)
picture a (det)
continued appearance (nmod)
method naturalistic (amod)
treated atra (nmod)
olanzapine = (amod)
microg/kg 350 (nummod)
model deficient (amod)
condensed was (auxpass)
samples trough (compound)
elevation mm (compound)
cefonicid ( (punct)
loss thickness (nmod)
prevent reactions (dobj)
ml/min ) (punct)
eradication of (case)
lead dysfunction (nmod)
infusions dobutamine (compound)
eyes subjected (acl)
evoked device (nmod)
hematest by (case)
begun dobutamine (nsubjpass)
$ROOT$ categorized (sent)
factor significant (amod)
hysterectomy a (det)
hospital an (det)
involved numbers (dobj)
showed men (nsubj)
averaging control (nmod)
was correlation (nsubj)
admission first (amod)
orciprenaline of (case)
regions three (nummod)
hypotheses mechanistic (amod)
gvhd chronic (amod)
attack the (det)
represented some (nsubj)
antibiotic antitumor (compound)
phosphanilate , (punct)
been nevertheless (advmod)
retrieval of (case)
loss of (case)
cr a (det)
inhibits apomorphine (nsubj)
studies investigations (conj)
essential monitoring (nsubj)
maintained diet (nmod)
responded steroids (nmod)
inpatient abusing (acl)
relapse hepatitis (nmod)
illustrates severe (ccomp)
primate non-human (amod)
value methods (nmod)
po ( (punct)
data electrocardiogram (conj)
exchanges sces (appos)
isoproterenol to (case)
achieved if (mark)
response propofol (nmod)
mechanisms involved (acl)
0.03 or (cc)
rate loss (nmod)
secondary medication (nmod)
reported cases (nsubjpass)
use prevention (nmod)
period diurnal (amod)
combination prolonged (amod)
difficult diagnosis (nsubj)
8.07 +/- (cc)
considered may (aux)
therapy prolonged (amod)
heart 400.2+/-11.8 (nummod)
seizures death-producing (amod)
integrity in (case)
pose thus (advmod)
scans computerized (amod)
degeneration tubular (amod)
1990 - (punct)
man an (det)
findings study (compound)
continued safely (advmod)
performance damage (conj)
pretreatment potential (amod)
signaling cx3cr1 (compound)
examine was (ccomp)
common disease (nmod)
illness and (cc)
hepatitis chronic (amod)
syndrome abs (appos)
cognition , (punct)
effects antiangiogenic (amod)
receive annually (advmod)
excretion albumin (compound)
questionnaires was (cop)
utilized retrievals (nsubj)
psa absolute (amod)
sweating hyperhidrosis (nsubj)
pressure diastolic (amod)
shows and (advmod)
formyl-methionyl-leucyl-phenylalanine fmlp (appos)
stage since (mark)
contrast interaction (nmod)
containing lindane (dobj)
value prognostic (amod)
injection steroid (compound)
women 50 (nummod)
triggered asterixis (nsubjpass)
0.47 : (punct)
pain thrombophlebitis (conj)
nimesulide to (case)
receiving dialysis (dobj)
% 47 (nummod)
effect well-known (amod)
interfere exposure (nsubj)
rats barium-exposed (amod)
inhibitors target (compound)
disturbances of (case)
areas maps (nmod)
cultures cell (compound)
layer mainly (advmod)
performed collection (nsubjpass)
negative pg (nmod)
damage cell (compound)
dyskinesia related (acl:relcl)
present fibrosis (nsubj)
occurred risperidone (nmod)
occlusion sinus (compound)
induced caffeine (nmod)
$ROOT$ solicited (sent)
225 , (punct)
patients beta-thalassemic (amod)
increase peak (nmod)
showed peak (dobj)
% 12.2 (nummod)
monophosphate urinary (amod)
g 60 (nummod)
myopathy cause (acl:relcl)
obtund response (dobj)
ngf , (punct)
attributed this (nsubjpass)
warrant may (aux)
mental physical (conj)
receive those (nmod)
effective states (nmod)
mek1 and (cc)
c2 , (punct)
treated site (nsubjpass)
impaired may (aux)
electroencephalogram the (det)
findings electrodiagnostic (amod)
[-]-[5ar,11bs]-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-+ ( (punct)
society american (compound)
higher appears (advcl)
conducted trial (dobj)
emergence widespread (amod)
wilson different (amod)
performance ventricular (amod)
background minimize (dep)
atherosclerosis on (case)
function channel (compound)
beta4 of (case)
majority a (det)
s 5.64 (nummod)
administration short-term (amod)
reactions apraclonidine (nmod)
vigilance counts (nmod)
risk seizures (nmod)
assessed period (nmod)
mmhg 79 (nummod)
effective lovastatin (nsubj)
investigate changes (dobj)
had concentrations (nmod)
anaesthetized were (auxpass)
angioplasty renal (amod)
k(+)-channels sensitive (amod)
ages years (nmod:npmod)
behavior rotational (amod)
maternal or (cc)
increased giving (advcl)
$ROOT$ incomplete (sent)
tools are (cop)
immuno/histochemistry microscopy (conj)
comparison biopsies (nmod)
developed seven (nsubj)
degeneration ) (punct)
develop increases (nmod)
return ( (punct)
history effects (conj)
smokers daily (amod)
extend establishing (advcl)
found smoking (nsubjpass)
group mp (nmod)
intravenous oral (conj)
isolated abscess (nmod)
mechanisms neuronal (amod)
component mediated (acl:relcl)
diazepam kg-1 (appos)
predictor dysphagia (nsubj)
men 234 (nummod)
damage production (conj)
resembled imagery (nsubj)
5-fu c (conj)
either or (advmod)
% ef<45 (nummod)
effects daidzein (nmod)
vincristine-induced ( (punct)
cause dose (nmod)
caution increased (amod)
suppressed apoptosis (dobj)
antigen-positive e (nmod:npmod)
zones separate (amod)
institution the (det)
cases together (advmod)
classifications according (case)
recipients transplantation (compound)
doses diazepam (nmod)
$ROOT$ administrated (sent)
ultrasound thyroid (compound)
modulate signaling (nsubj)
dose new (amod)
creatinine [ (punct)
hexachloride ( (punct)
impairs competition (nmod)
atorva ( (punct)
1,3-bis-(2-chloroethyl)-1-nitrosourea ( (punct)
transcript ldlr (compound)
barrier and (cc)
hyperalgesia mice (nmod)
dgc integrins (conj)
effects these (det)
were frequency (nmod)
mediated not (neg)
nephrotoxicity occurs (acl:relcl)
defined symptoms (nmod)
160 140 (compound)
cystitis hemorrhagic (amod)
evoked , (punct)
use given (case)
follow-up years (amod)
access of (case)
plasma ph (dep)
using phases (dobj)
selectivity high (amod)
evidenced hypothyroidism (nsubjpass)
augmented also (advmod)
trimipramine , (punct)
increases content (nmod)
endografine , (punct)
manner adriamycin (compound)
area auditory (amod)
antibiotic the (det)
conclusions provides (appos)
ro15 by (case)
inhibitor respectively (advmod)
initiated association (nmod)
l-1 8.4 (nummod)
have assessed (advcl)
art ) (punct)
eye red (amod)
women men (conj)
rise left (amod)
drug active (amod)
lowering significantly (advmod)
carried examination (nsubjpass)
combination lidocaine (nmod)
suggests conclusion (nmod)
mild and (cc)
drug immunosuppressive (amod)
number abnormalities (nmod)
function monoamines (nmod)
onset esrd (nmod)
showed him (dobj)
method computer-assisted (amod)
intervention simple (amod)
patients congolese (compound)
setting naturalistic (amod)
$ROOT$ characteristic (sent)
au 298+/-7 (nummod)
compared authors (nsubj)
elevation levels (nmod)
expression . (punct)
causes increases (dobj)
those haemodilution (nmod)
developed incidence (dobj)
model ln (conj)
morphine s.c. (compound)
changes as (cc)
was occurred (ccomp)
delirium . (punct)
incidence appearance (nmod)
more females (nmod)
transcriptase hbv (compound)
entity an (det)
activity broad (amod)
ntg by (case)
staining slices (nmod)
antibiotic acid (nsubj)
min in (case)
toxicity prolonged (amod)
receiving mg/m2 (dobj)
= area (nsubj)
monoher mg/kg (appos)
regimens their (nmod:poss)
neuralgia morton (nmod:poss)
processes induced (acl)
mg 0.5 (compound)
1941 1981 (conj)
increase > (amod)
use lidocaine (nmod)
administration cs (compound)
modify not (neg)
mg/m(2 was (cop)
area a1 (nmod)
analyzer humphrey (compound)
g daily (advmod)
using group (nmod)
doses measured (acl)
antagonized dose-dependently (advmod)
continued to (mark)
cocs while (case)
merits treatment (nsubj)
scans angiography (compound)
study to (case)
monitored function (nsubjpass)
3.5 0.5 (quantmod)
pacemakers the (det)
cips ) (punct)
injury (ppa)-induced (amod)
fail results (nsubj)
improved five (nsubj)
levels s-transferase (nmod)
nonusers ( (punct)
tape punched (amod)
3 - (advmod)
min c (nmod)
ntg = (dep)
confirm determine (conj)
dlt the (det)
infant newborn (amod)
factor basic (amod)
oxidized and (cc)
morbidity mortality (conj)
induced estradiol (nsubj)
hypotheses and (cc)
cycloheximide , (punct)
indicative anticipation (nmod)
concentration fluid (nmod)
remedy management (nmod)
induce sulphasalazine (nsubj)
suppresses that (mark)
techniques of (case)
months 59.7 (nummod)
effect reflex-enhancing (amod)
normal conscious (dep)
lesions ( (punct)
uncommon effects (nsubj)
drug current (amod)
decrease ( (punct)
trimethoprim-sulfamethoxazole trimethoprim (conj)
demarcated well (advmod)
involvement a (det)
anesthesia stable (amod)
gravity sg (appos)
related use (nmod)
treated bcnu (nmod)
-50 -79 (conj)
sensation taste (compound)
disturbances barium-induced (amod)
kit a (det)
containing na (dobj)
carcinoma developed (acl:relcl)
glibenclamide glipizide (conj)
expression seizures (nmod)
2-(p-bromophenyl)propionate 3 (nummod)
performance systolic (amod)
vasculitis positive (amod)
% 55.2 (nummod)
interventions current (amod)
group pan/temocapril (compound)
benefit the (det)
months 21 (nummod)
stereotypies anxiety (conj)
appeared have (conj)
depleted caused (conj)
experimental and (cc)
level corticosterone (compound)
area hyperalgesia (nmod)
administration bolus (compound)
dural and (cc)
3722 +/- (cc)
patients having (acl)
3 less (amod)
sc-48334 zidovudine (conj)
ntg 2 (nummod)
revealed deposits (dobj)
assessed independently (advmod)
accompanied which (nsubjpass)
tropicamide pilocarpine (conj)
survivors both (appos)
mg./kg of (case)
formation plugs (nmod)
induction a (det)
confirmed examination (nmod)
mpo-anca of (case)
girl given (acl:relcl)
episodes potentials (nmod)
depression ; (punct)
derivatives extracted (acl)
subjected is (auxpass)
$ROOT$ colocalized (sent)
received oxitropium (dobj)
study blinded (amod)
preventing hypotension (dobj)
neutropenia by (case)
bolus 50-mg (amod)
scheduled features (nsubjpass)
increased abruptly (advmod)
0.26 or (cc)
treated p (nmod:npmod)
beta-position in (case)
demonstrates reinstated (ccomp)
puberty delayed (amod)
minimum months (nmod)
infarcts ganglia (compound)
teratogenic rabbits (nmod)
yrs of (case)
was earlier (advmod)
examination microscopic (amod)
considered development (nsubjpass)
titrated can (aux)
using device (dobj)
counts onset (conj)
capsules pneumatic (amod)
inadequate evidence (nsubj)
normal ultrasound (nsubj)
diffuse symmetric (dep)
clarify to (mark)
effect blocker (nmod)
doses exceeding (acl)
% 30.5 (nummod)
occurrence higher (amod)
displayed indicated (advcl)
carotid artery (conj)
consequences lesions (nmod)
lady a (det)
involved reports (nsubj)
gabaergic dopaminergic (conj)
ferritin serum (conj)
administration intravascular (amod)
blockade 5-ht2 (compound)
decline function (nmod)
identify incidence (dobj)
microgram/kg 1 (nummod)
group original (amod)
12alpha-hydroxylase and (cc)
disease because (case)
induced ptz (nmod)
vascular and (cc)
preferred anaesthesia (nmod)
increase tdr (nmod)
accounted % (nsubjpass)
wasting profound (amod)
nephrosis pan (appos)
meta-analysis a (det)
oxidation assembly (conj)
drugs illicit (amod)
mm 50 (compound)
occurred months (nmod)
alpha2- not (cc)
1992 1994 (prep)
adjustment diabetes (nmod)
receptors nk1 (compound)
have iml (nmod)
antibodies different (amod)
usage with (case)
significant fatal (conj)
action vasopressin (nmod)
administered cna (nsubjpass)
tube ett (appos)
reversible netilmicin (nmod)
management psp (nmod)
symptoms restlessness (nmod)
glaucoma resembles (acl:relcl)
3657 . (punct)
doses necessary (amod)
gain leukocytosis (conj)
x ( (punct)
alprazolam and (cc)
donors related (amod)
slices brain (compound)
steroids without (case)
$ROOT$ rofecoxib (sent)
given intralipid (nmod)
activation on (case)
test normal (amod)
occurs necessary (conj)
ecg 24-hour (amod)
resulting plasma (dep)
mg/kg/b.w./day 10 (nummod)
types to (case)
estradiol 3h-17 (compound)
implicated clearly (advmod)
milrinone of (case)
task for (case)
quality protocol (nmod)
pain , (punct)
fell dose (nmod)
human either (cc:preconj)
period transplantation (nmod)
cell parietal (amod)
case treatment (nmod)
medication to (mark)
half in (case)
h anaesthesia (nmod)
layer hippocampal (compound)
rarest serious (conj)
studies with (case)
activated enflurane (nmod)
chlorpropanol ) (punct)
fatal was (cop)
plasma the (det)
hyperglycinemia with (case)
fluvoxamine of (case)
$ROOT$ abnormalities (sent)
fs a (det)
m1 m2 (conj)
exam panel (conj)
patterns symptom (compound)
progress defects (nsubj)
41 % (dep)
favor rizatriptan (nmod)
presentation -- (punct)
attained assessment (nmod)
nodule of (case)
consistent two (nsubj)
agonist decrease (acl:relcl)
analyze to (mark)
subjects either (cc:preconj)
suggests melphalan (dobj)
tri by (case)
lad ( (punct)
hepatotoxicity acetaminophen-induced (amod)
abecarrnil ) (punct)
injection cocaine (nmod)
dexamethasone ) (punct)
studied dose (advcl)
strains studied (acl)
latency a (det)
england schwab (compound)
men eleven (nummod)
have benefits (dobj)
been who (nsubj)
infarction haemorrhagic (amod)
deficits ability (nmod)
maleate -mk801 (compound)
rates % (nmod)
15 10 (compound)
man 70-year-old (amod)
reductions endpoint (nmod)
available increasingly (advmod)
cardiomyopathy progressive (amod)
influence whether (mark)
implicated " (punct)
independent to (mark)
shown clinic (nmod)
greater although (mark)
reactions and (cc)
cardioselective both (cc:preconj)
reduces duration (dobj)
38 29 (compound)
recived position (nmod)
cardiomyopathy doxorubicin-induced (amod)
hours 9 (nummod)
intake measured (acl)
had echocardiogram (nmod)
desipramine inhibitor (appos)
occurs results (nsubj)
increased diversion (nmod)
increased mice (nmod)
interfered activities (nmod)
system peripheral (amod)
evaluated these (nsubjpass)
generate information (dobj)
increase bradykinin (nmod)
1 0.5 (compound)
pg to (case)
carcinoma receptor-positive (amod)
cross-tolerant . (punct)
loci trait (compound)
abnormalities transient (amod)
reduced phenylalanine (nsubj)
high levels (nsubj)
defects several (amod)
b-100 , (punct)
microg% 2387 (nummod)
induces aspirin (nsubj)
psychologist by (case)
warrant findings (nsubj)
patients hospitalized (amod)
found evidence (nsubjpass)
suspect . (punct)
precipitating of (mark)
adsd for (case)
at random (amod)
infection with (case)
levels glycine (compound)
see avoid (advcl)
concentrations methotrexate (compound)
predictor independent (amod)
infusion d-amb (nmod)
proteins apoptosis-related (amod)
risk causing (advcl)
pre-induced dogs (nmod)
component early (amod)
dec. period (appos)
deficits nerve (compound)
concentration urd (nmod)
study effects (dobj)
% pod (nmod)
lipocalin neutrophil (compound)
levels dopamine (nmod)
clozapine > (dep)
ratio elevated (amod)
calculated times (nmod:tmod)
time remained (acl:relcl)
decreased modafinil (nsubj)
higher time (nmod)
fit i.e. (advmod)
review data (nmod)
reprogramming and (cc)
developing necrosis (dobj)
p. group (compound)
surface cortex (nmod)
alters dysrhythmogenicity (dobj)
produce revert (conj)
32.3 +/- (cc)
cells into (case)
mg. 10/5 (nummod)
self-treating developed (conj)
outcomes 4-month (amod)
pain persistent (amod)
analyzed point (nmod)
administration drugs (nmod)
pancreatitis six (nmod)
administration days (nmod)
available have (aux)
rg1 rb1 (conj)
albumin nonglycated (amod)
receiving lisinopril (dobj)
shorter also (advmod)
variable this (det)
evidence reported (amod)
elucidate administered (advcl)
licensed acetate (nsubj)
withdrawal addiction (nmod)
% 432 (nummod)
0.01 ) (punct)
placed then (advmod)
induced liver (nmod)
effects behavioral (amod)
2e1 human (amod)
pvc 's (case)
$ROOT$ ameliorated (sent)
hit stable (conj)
1.8 0.8 (compound)
characterized rats (nsubjpass)
dosage doses (nmod)
capsule liver (compound)
increased that (nmod)
presentation encephalopathy (nmod)
had mice (nsubj)
results treated (appos)
suffer occur (advcl)
completed visit (dobj)
n=25 ) (punct)
memory explicit (amod)
months other (amod)
reduction months (nmod)
find did (aux)
aplasia associated (acl)
criteria 1990 (nummod)
mg/dl of (case)
june 1 (nummod)
features chronology (conj)
reduced hyperactivity (nsubjpass)
conduction accelerated (amod)
took patient (nsubj)
limited literature (nsubj)
mitoq , (punct)
patients dyslipidemia (nmod)
reduction tissue (compound)
dose amantadine (nmod)
mechanisms account (acl:relcl)
nerves 5-ht (compound)
trial comparative (amod)
authors ' (case)
administration apomorphine (nmod)
test disorder (nmod)
handicapped under-reporting (nmod)
studied and (cc)
applied matrix (nsubjpass)
coagulation rat (nmod)
applied pre-surgery (advcl)
benefits , (punct)
certain following (nmod)
activation or (cc)
discovery its (nmod:poss)
cytoplasm the (det)
p<0.0005 ( (punct)
syndrome hypoplastic (amod)
employed study (xcomp)
hypotension comparable (amod)
concentrations baseline (amod)
interfere since (mark)
females two (nummod)
number elevated (amod)
administered rifampicin (nsubjpass)
agents baseline (nmod)
abolished dogs (nmod)
elevated levels (nsubj)
carriers forty-two (nummod)
met and (cc)
diagnosis cimd (nmod)
control behavior (compound)
common neuropathy (nsubj)
tetany patient (nmod:poss)
resulted observed (conj)
erythrodysesthesia toxicity (nsubj)
severity pain (nmod)
hygiene poor (amod)
panel a (det)
improves growth (dobj)
had neutropenia (dobj)
presence be (cop)
decreased but (cc)
b amphothericin (compound)
administered greater (nmod)
induced formation (dobj)
filariasis loa (compound)
problem main (amod)
given patients (nsubjpass)
serve bnp (nsubj)
pressure filling (compound)
hepatitis woman (nmod)
received digoxin (dobj)
cycle following (case)
suffer fever (nmod)
risk range (nmod)
transplant heart (compound)
fs lv (compound)
nmol/l 100 (compound)
rats nonprogesterone-treated (amod)
levonorgestrel ) (punct)
2 and (cc)
= a(1 (nsubj)
pathway synthesis (nmod)
designed evaluate (ccomp)
unchanged cbf (nsubj)
fibrosis striped (amod)
shown antagonists (nsubjpass)
ensure that (mark)
rarest and (cc)
assessed followed (conj)
displayed activity (dobj)
demonstrated combining (advcl)
elevated 0.0010 (nmod)
nephrotoxicity mg/kg (compound)
received washout (nmod)
cm 10 (compound)
patients assessed (acl)
induced picrotoxin (nmod)
fetuses the (det)
attenuated improved (conj)
proteins to (case)
rr [ (punct)
% 87 (nummod)
estradiol progesterone (conj)
effects through (case)
kg(-1 i.m. (appos)
infiltrate rich (amod)
provide model (dobj)
assigned one (nmod)
kinds agents (nmod)
inhibitor , (punct)
patient aged (amod)
alterations integrity (nmod)
colocalized that (mark)
factor if (appos)
conversion the (det)
microinjections isoniazid (nmod)
enlargement in (case)
< 0.05 (dobj)
depends conditions (nmod)
sc ] (punct)
elevation weight (nmod)
group therapeutic (amod)
allografts patients (nmod)
normal and (cc)
event an (det)
nausea syndrome (conj)
re-established . (punct)
test pinprick (compound)
dose losartan (nmod)
pretreatment blocker (nmod)
expand routes (nmod)
labeling supervision (conj)
less values (nsubj)
o-methylation norepinephrine (nmod)
mofetil of (case)
nephropathy characterized (acl)
is recipients (nmod)
shock . (punct)
accompanied reduction (dobj)
adjustment and (cc)
reversal hyperalgesia (nmod)
infections nonviral (amod)
0.1 and (cc)
measured tafi (nsubjpass)
mg/dl 35 (nummod)
impairment without (case)
exerts enhances (advcl)
converted treatment (nsubjpass)
complications due (conj)
amoxicillin alone (advmod)
recipient living (amod)
6.9 0.7 (compound)
analgesic opioid (compound)
amnesia on (case)
hypotension initiation (nmod)
-14.8 +/- (cc)
neutropenia , (punct)
axons the (det)
toxic conclusion (nmod:npmod)
months patient (compound)
using interview (dobj)
cirrhosis ascites (conj)
areas some (det)
models of (case)
designed experiments (nsubjpass)
decreased although (mark)
obtained interview (nmod)
counts , (punct)
differ accumulation (nsubj)
society sixty (nummod)
kg-1 mg (dep)
secretion patients (nmod)
class drugs (nmod)
performed time (nmod)
hundredth one (compound)
e ) (punct)
atra of (case)
mild effects (nsubj)
generated that (nsubjpass)
states hypersensitivity (compound)
propranolol dose (dep)
unchanged aqp2 (nsubj)
acidosis failure (conj)
hypotension bromocriptine-induced (amod)
groups support (compound)
attenuates compound (nsubj)
grade sedation (nmod)
mumol/l mtd (nmod)
enhancement the (det)
morphine it (compound)
continue a (appos)
toxicity rare (amod)
measured ctni (nsubjpass)
points by (case)
explained partially (advmod)
were changes (attr)
potentiate metamizol (nsubj)
od daily (advmod)
another in (case)
enrolment ) (punct)
detected cases (nsubjpass)
improvement disease (nmod)
describe . (punct)
deficiency this (det)
administration consecutive (amod)
147 +/- (cc)
behavior violent (amod)
appeared age (nsubj)
inhibitor fibrinolysis (compound)
404 9.4 (conj)
assess positivity (nmod)
effects urotensin-ii (nmod)
carcinoma carcinoma (conj)
relevant more (advmod)
checked intervals (nmod)
administration both (advmod)
% at (case)
therapy haemodialytical (amod)
avp and (cc)
occlusion transient (amod)
neurocognitive sleep-related (conj)
abuse their (nmod:poss)
suggest mechanisms (dobj)
damage provoked (acl)
presents purpura (nmod)
complement of (case)
resuscitation treatment (conj)
use sirolimus (nmod)
colliculus the (det)
control an (det)
acute vs. (cc)
rare side-effect (dep)
protective ( (punct)
nitrendipine-treated = (dep)
consequences apparent (amod)
91.5 score (nsubj)
sacrificed , (punct)
induced pemoline (nmod:npmod)
apoptotic and (cc)
use continuous (amod)
data cases (nmod)
group elderly (amod)
50 ) (punct)
tone basal (amod)
failed vagotomy (nsubj)
appearance factors (nsubj)
channels with (case)
manifested absence (nmod)
concluded differ (advcl)
solution % (appos)
2.5 . (punct)
analyses separate (amod)
treated lidocaine (nmod)
infused rats (nmod)
pressures oxygen (nmod)
years 8.9 (nummod)
duration disorder (nmod)
cells of (case)
d cathepsin (compound)
presented contrasting (advcl)
start treatment (nmod)
cause likely (amod)
diethylpropion medication (compound)
disease ( (punct)
failure rats (nmod)
had addition (nmod)
excretion on (case)
markers traditional (amod)
drugs filters (conj)
increase mediator-induced (amod)
picture this (det)
$ROOT$ subsided (sent)
accumulation ) (punct)
observed block (dobj)
factors process (nmod)
8 4 (conj)
solutions of (case)
vascular peripheral (amod)
mouse of (case)
remained higher (conj)
instillation tubes (nmod)
evaluated mice (nmod)
seemed naproxen (nsubj)
substances form (acl:relcl)
induced blocker (nmod)
play role (dobj)
one cross-reactivity (nmod)
days five (nummod)
labor for (case)
cardiotoxicity the (det)
variety hepatocarcinogens (nmod)
pollutants of (case)
supervised , (punct)
quantified areas (nsubjpass)
higher nonusers (nmod)
patients years (dep)
activity brain (compound)
group cooperative (amod)
induce does (conj)
chronotropic , (punct)
period 3-day (amod)
effect clentiazem (nmod)
transplant with (case)
damage ma (nsubj)
nelarabine of (case)
before following (dep)
complaints pain (nmod)
days 24 (nummod)
oltx an (det)
active were (cop)
not only (advmod)
widened . (punct)
mg/h or (cc)
detected hyperalgesia (nsubjpass)
conclusion affects (appos)
bpo-pll ) (punct)
spikes membrane (compound)
consumed tablets (dobj)
established euthanized (parataxis)
seen enhancement (nsubjpass)
relative users (nmod)
decreased saline (nmod)
important very (advmod)
prazosin studies (conj)
compounds diisopropylfluorophosphate (nmod)
effective prevention (nmod)
blockade androgen (compound)
elucidate role (dobj)
presenting departments (nmod)
ingestion surreptitious (amod)
cmf ( (punct)
procaterol procaterol (conj)
leukoencephalopathy enhancement (nmod)
investigation follow-up (amod)
demonstrated crucial (xcomp)
1 13 (conj)
hg/l/min to (case)
mortality length (conj)
-32 13 (conj)
$ROOT$ stems (sent)
induced hepatomegaly (dobj)
valproate vpa (appos)
corrected although (mark)
pneumonitis autoantibodies (conj)
management is (cop)
decreased furthermore (advmod)
54 % (dep)
bone of (case)
received reinforcement (dobj)
ds only (advmod)
sex each (det)
improved prognosis (dobj)
neurotoxicity dose-dependent (amod)
actions mk-801 (nmod)
incidences effects (nmod)
cholecystokinin by (case)
picrotoxin- or (cc)
death observed (acl)
suggest interaction (ccomp)
nephropathy adr-induced (amod)
women 8 (nummod)
transaminase gpt (appos)
intubated while (mark)
improved dogs (nmod)
nephrotoxicity for (case)
seizures bupropion-associated (amod)
spikes evoked (acl:relcl)
dizziness nausea (conj)
nimesulide or (cc)
catalepsy haloperidol (compound)
transplantation for (case)
induced chop (dobj)
ligand and (cc)
acetate hydrocortisone (compound)
from minutes (nmod:npmod)
cyproheptadine of (case)
fed and/or (cc)
mg ergotamine (compound)
hygiene with (case)
disruption system (nmod)
are strategies (attr)
increase morphine-induced (amod)
injury cerebral (amod)
test sedation (conj)
used ecg (nsubjpass)
rate effects (conj)
amnesia or (cc)
treatment kidney (conj)
precursors bfu-e (appos)
myelomeningocoele leaking (amod)
days 18.9 (nummod)
required control (nmod)
acid / (punct)
expression peak (amod)
developed fever (nsubj)
kidney rat (compound)
brain rats (nmod)
confirmatory of (case)
years in (case)
target to (case)
certain cause (dep)
da : (punct)
cyclophosphamide cy (appos)
accumulation pethidine (nmod)
ra case (nmod)
locomotor dyskinetic (conj)
phase frequency (conj)
effective clinically (advmod)
research mechanisms (nmod)
adenomas : (punct)
substantiate concept (dobj)
falciparum , (punct)
up-regulation seizure-induced (amod)
cases hundred (nummod)
sectioned planes (nmod)
used echocardiography (nsubjpass)
drum " (punct)
doses d3 (appos)
determine step (advcl)
2600 1800 (conj)
gene and (cc)
fungi pathogenic (amod)
model this (det)
evidences abnormalities (nmod)
irreversible nephritis (nsubj)
comparison : (punct)
four seven (conj)
accompanied retention (nmod)
potential cause (advcl)
weight fat-free (amod)
assessed reaction (nmod)
tachyarrhythmia . (punct)
effect hyperalgesic (amod)
composed histologically (advmod)
aims investigate (acl)
hemorrhage an (det)
characterized whereas (mark)
demonstrate spite (nmod)
creatinine cr (appos)
treated amisulpride (nmod)
values from (case)
replication susceptibility (conj)
discharges with (case)
as well (advmod)
months during (case)
rct , (punct)
used cautiously (advmod)
male medicated (amod)
dead patients (nsubj)
patients patients (conj)
onset course (conj)
recognition the (det)
dose per (case)
dose ketamine (nmod)
patients c (nmod)
initiated given (advcl)
yr after (case)
rhubarb ( (punct)
ec ( (punct)
30 ) (punct)
administered volunteers (nmod)
hypomania mania (conj)
arthritis erosive (amod)
hyperplasia rr (appos)
investigation a (det)
abuse subjects (nmod)
subcutaneous daily (advmod)
therapy nelarabine (nmod)
potential compound (amod)
effect , (punct)
involved susceptibility (nmod)
unreasonable , (punct)
recall pictures (nmod)
cure it (dobj)
findings certain (amod)
rate p (appos)
rare aggressive (conj)
syndrome syndrome (conj)
admitted clinic (nmod)
deviation mm (compound)
excretion or (cc)
hyperkalemia indomethacin-induced (amod)
period brief (amod)
antibodies ancas (appos)
mice ntg (amod)
score the (det)
effect noradrenaline-induced (amod)
imbalance determinant (nsubj)
hypercalcemia anemia/thrombocytopenia/emesis/rash (conj)
decrease did (aux)
days 6 (nummod)
lag with (case)
intraperitoneal single (amod)
protects melatonin (nsubj)
resolved lesions (nsubjpass)
core periphery (conj)
fails protect (xcomp)
tapped patients (nsubj)
determined that (mark)
lowering simultaneously (advmod)
regimen repeated (acl)
recorded simultaneously (advmod)
impairment discrimination (nmod)
defective nephrosis (nmod)
pretreated vagotomised (conj)
assess status (dobj)
maneuver hypoventilation (compound)
arteriolopathy manifesting (acl)
studied patient (dobj)
provides used (advcl)
mrna ao (compound)
lymphadenitis of (case)
therapies hormone (compound)
cr with (case)
tachyarrhythmias ventricular (amod)
sum as (case)
noted association (nsubjpass)
drop ph. (nmod)
decreased affected (conj)
rose months (nmod)
completed after (mark)
hctz alone (advmod)
falciparum plasmodium (compound)
nx and (cc)
size sclerosis (conj)
involved dyskinesia (nmod)
formation lesion (compound)
stress to (case)
research it-tspa (nmod)
experienced stopped (advcl)
enzyme cyp3a4 (compound)
tma ( (punct)
failure cardiac (amod)
thromboembolism of (case)
induction greater (amod)
sampling hours (nmod)
1999 2004 (prep)
volunteers 30 (nummod)
prior levodopa (nmod)
antagonists a2a (compound)
histology and (cc)
tended correct (xcomp)
maintained end (nmod)
patient them (nmod)
100 200 (conj)
anaesthesia in (case)
scores the (det)
nephrotoxicity anemia (conj)
responses behavioral (amod)
ear middle (amod)
catheterisation angiography (conj)
levels acid (compound)
surgery , (punct)
algorithm according (case)
collected , (punct)
understood mechanism (nsubjpass)
occurs stage (nmod)
beneficial to (mark)
giving dose (dobj)
case rechallenge (nmod)
users pill (compound)
liver system (conj)
confirmed analysis (nmod)
developed presented (conj)
causes developing (advcl)
paid be (auxpass)
events key (amod)
mediates in (mark)
side-effect as (mark)
mm 0.675 (nummod)
saline nacl (appos)
given attempted (conj)
vgpr ) (punct)
desorption/ionization pressure (compound)
criteria nodosa (nmod)
derivative quetiapine (nsubj)
transplant twenty-four (compound)
anesthetics representative (amod)
occurrence encephalitis (nmod)
antibiotics basic (amod)
attempted study (nsubjpass)
worsened insufficiency (nsubjpass)
retardation marked (amod)
n ca (compound)
internus the (det)
patients shown (acl:relcl)
propagate to (mark)
everolimus rad001 (appos)
resuscitation initial (amod)
regimens treatment (compound)
restored changed (conj)
disorder self-limited (amod)
follow-up life-long (amod)
medications surveyed (acl)
min 10 (compound)
provide they (nsubj)
procaterol stimulant (appos)
ribavirin intravenous (amod)
recall words (nmod)
triglycerides % (dep)
rates underlying (amod)
inhibitors effects (conj)
neurons daergic (amod)
observation telemetric (amod)
risperidone ) (punct)
relationship temporal (amod)
did who (nsubj)
shown are (auxpass)
be due (ccomp)
hypoplasia with (case)
excitability myocardial (amod)
evaluated assays (nmod)
underwent episode (nmod)
onset tdp (nmod)
28 ) (punct)
varying of (mark)
june 30 (nummod)
noted be (auxpass)
disorder attention (compound)
submitted intervention (nmod)
interrupt to (mark)
grade of (case)
alcohol of (case)
cholinergic serotonergic (conj)
deaths 9 (nummod)
produce glyburide (nsubj)
effective doses (nsubj)
line monocyte (compound)
plasticity of (case)
easy block (xcomp)
trials well-designed (amod)
infrequent nausea (nsubj)
plasmapheresis therapy (conj)
degeneration scattered (amod)
aminoglycoside vancomycin (conj)
2.5 4.5 (conj)
kidneys via (case)
disease chronic (amod)
total cycles (nmod)
mrnas and (cc)
thrombocytopenia recovery (conj)
treatment is (cop)
iii iv (conj)
hilus the (det)
infection antecedent (amod)
mg/kg w. (nmod)
associated spasms (nmod)
complex gamma-aminobutyric (amod)
weeks 156 (nummod)
1.5 5.0 (conj)
screening thorough (amod)
factor controls (acl:relcl)
stimulation pulsatile (amod)
agents between (case)
lower mmol/l (nmod:npmod)
volunteers between (case)
vancomycin levofloxacin (conj)
mornings in (case)
delayed peak (conj)
myocardium in (case)
interaction a (nmod)
literature urologic (amod)
resolving was (aux)
encephalopathy chemotherapy (nmod)
chromatography high-performance (amod)
treatment l-dopa+benserazide (nmod)
attenuate did (aux)
ligand nociceptin (nsubj)
brain human (amod)
toxicity ami/gi (compound)
become rigid (xcomp)
syndrome and (cc)
coma rats (nmod)
content myocardial (amod)
symptoms unusual (amod)
considered challenge (nsubjpass)
fibres sensory (amod)
rats anesthetized (acl)
mexitil-perlongets ( (punct)
lowered concentration (dobj)
separation and (cc)
crystals precipitated (amod)
obese they (nsubj)
experiencing episodes (dobj)
rate ml/min (appos)
events qtp (nmod)
status neurologic (amod)
blocker potential (amod)
function the (det)
established clearly (advmod)
cases occurred (acl:relcl)
symptom extrapyramidal (amod)
toxicity cy (nmod)
complication immediate (amod)
temperature on (case)
immunohistochemical ultrastructural (conj)
kg-1 before (case)
vessel the (det)
newborn the (det)
needs render (advcl)
predictor . (punct)
amb or (cc)
studied strains (nmod)
injury standardized (amod)
had remission (dobj)
treatment alpha (appos)
syndrome haemolytic-uraemic (amod)
manifested lesions (dobj)
tensions nerve-evoked (amod)
included incidence (dobj)
showed ctnt (nsubj)
ncq436 ncq344 (conj)
institutions at (case)
have absence (nmod)
treatment gliomas (nmod)
beta ( (punct)
receive doses (dobj)
$ROOT$ younger (sent)
5,7-dcka ) (punct)
effect amphetamine (nmod)
avoid therapy (dobj)
diseases cyanotic (amod)
failed block (xcomp)
suspected myocarditis (nsubjpass)
hospital guard (compound)
treatment antagonists (nmod)
facial extremity (conj)
supports aptts (dobj)
variables patient (nmod:poss)
release platelets (nmod)
week gestation (nmod)
achieved reduction (nsubjpass)
parkinsonism stable (amod)
5.6 1.0 (conj)
epithelium in (case)
mm/year 0.262 (nummod)
signs dyskinesias (conj)
divided occurred (advcl)
90/hypertension 90/htn (appos)
0.03 0.3 (conj)
began consisted (conj)
used newborn (nmod)
pain 0 (appos)
mellitus glaucoma (conj)
patients uveitis (nmod)
doses agents (nmod)
measurements clearance (nmod)
conclusion the (det)
described context (nmod)
helpful so (mark)
36.22 : (punct)
mucosa facial (amod)
showed electrophoresis (nsubj)
plasticity sensorimotor (amod)
interfere mechanism (nmod)
include development (nsubj)
period acclimatization (nmod)
register national (compound)
segment artery (nmod)
fas serum (compound)
study carbetocin (nmod)
flexion extension (conj)
inhibitor cox-2 (compound)
compared volume (nmod)
associated insulin-group (nmod)
developed syndrome (nmod)
course bupropion (nmod)
1.0 2.9 (conj)
responses vessels (nmod)
enhanced that (mark)
common some (nsubj)
minutes 6.5 (nummod)
subsides episode (nsubj)
exacerbated maximum (nmod)
active or (cc)
switching lithium (nmod)
programs birth (compound)
e2 instilled (amod)
importance with (case)
biopsies two (nummod)
assessed functions (nmod)
vomitus diarrhea (appos)
demonstrated produce (xcomp)
increases as (mark)
microsomal and (cc)
form salt (appos)
bottle containing (acl)
suggest mediator (ccomp)
bradycardia failure (conj)
stages treatment (nmod)
nephropathy minimal-type (amod)
patients risk (compound)
failed presence (nmod)
provide findings (nsubj)
62 - (advmod)
effective pretreatment (nsubj)
association co-morbidity (nmod)
oxidative nitrosative (conj)
$ROOT$ increase (sent)
stenosis ) (punct)
ma controls (conj)
attenuate steroids (nsubj)
type preceded (acl:relcl)
trimethoprim trimethoprim-sulfamethoxazole (conj)
pathway bulbospinal (amod)
used 2005 (nmod)
crucial manifestation (nmod)
antiretroviral active (amod)
chromosome philadelphia (compound)
develop utero (advmod)
power detect (acl)
successful rapidly (advmod)
amounts increased (amod)
linezolid and (cc)
responses immediate (amod)
arrest cell (compound)
selected shr (nsubjpass)
contrast system (nmod)
mmhg 15 (nummod)
damage medullary (amod)
role permissive (amod)
rare neuropathy (nsubj)
number cell (compound)
reversed whereas (mark)
$ROOT$ step (sent)
administered bpd (nsubjpass)
disc optic (amod)
common controls (nmod)
indicated insipidus (dobj)
pretreatment , (punct)
practical theoretical (conj)
snps rs6693503 (dep)
fraction microsomal (amod)
methods obtained (appos)
activities biological (amod)
level patients (nmod)
elevation ) (punct)
women recruited (acl:relcl)
production no (nmod)
have do (advcl)
supports reports (dobj)
failed potentiate (xcomp)
dose tna (nmod)
effects misoprostol (nmod)
age onset (compound)
disease peripheral (amod)
agents antiplatelet (amod)
grade neutropenia (compound)
tests placebo-controlled (amod)
cardiomyopathy with (case)
continue preparations (nsubj)
showed intake (nsubj)
mimic to (mark)
bradycardia rate (dep)
enlargement induced (acl)
increase ratio (nmod)
responded methylprednisolone (nmod)
find version (nmod)
mg/kg 0.02 (compound)
anemia a (det)
subjects tolerate (acl:relcl)
attributed were (auxpass)
ml. 0.2 (nummod)
unresponsive effects (nmod)
diatrizoate ) (punct)
nos-ir : (punct)
incidence nephropathy (nmod)
tachycardia atrial (amod)
induction with (case)
remarkable course (nsubj)
challenged iso (nmod)
ifosfamide combination (conj)
clearance estimated (amod)
qrs preexcitation (nmod)
include release (dobj)
determination for (case)
drugs oral (amod)
efficacy bioavailability (conj)
success same (amod)
prevalence increasing (amod)
studies on (case)
initiated empirically (advmod)
tolerated signs (nmod)
suffered edema (nmod)
group ls (dep)
exhibited isomers (nsubj)
study ( (punct)
microg/kg/min 2 (nummod)
administration intrastriatal (amod)
camp 3',5'-monophosphate (appos)
correlations responsiveness (nmod)
stimulation lc (nmod)
co-administration n-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide (nmod)
observed signs (nmod)
results jc (dep)
increase excretion (nmod)
necrosis hypoxic (amod)
study controlled (amod)
epinephrine groups (conj)
decrease 3.9 (dep)
nafcillin to (case)
or 1.4 (appos)
persisted defect (nsubj)
pills to (case)
doses standard (amod)
analogues two (nummod)
thought are (auxpass)
effects flestolol (nmod)
tramadol of (case)
measurements function (nmod)
neurological hepatic (conj)
increased h (nmod)
overload chronic (amod)
or(adj an (det)
instillation intracorporal (amod)
restlessness or (cc)
decrease result (nmod)
indomethacin a (appos)
veins cerebral (amod)
seizures local (amod)
weeks for (case)
cystitis cyclophosphamide-induced (amod)
imagery this (det)
patients isolated-hit (nmod)
abnormalities cramps/myalgias (conj)
do potentiated (parataxis)
cord in (case)
125 50 (nummod)
dogs no (det)
= 0.009 (dobj)
possibility damage (nmod)
score neurological (amod)
dermatoses facial (amod)
effect q10 (nmod)
six times (quantmod)
ropivacaine bupivacaine (conj)
led has (aux)
cholesterol % (nmod)
zdv mg (dep)
resulted recognition (nsubj)
levels vegf165 (compound)
results dysfunction (nmod)
presenting administration (nmod)
curcumin by (case)
lymphocytes developed (acl:relcl)
doses adenosine (compound)
mechanisms neural (amod)
profile coagulation (compound)
model to (case)
nadir , (punct)
occurrence the (det)
accomplished risk (nmod)
haloperidol and (cc)
$ROOT$ cure (sent)
activation peripheral (amod)
mg/dl 1.0 (nummod)
administration after (case)
hyperkalemia life-threatening (amod)
had other (nsubj)
induces trazodone (nsubj)
involved implicated (advcl)
mangiferin polyphenol (appos)
possibilities treatment (compound)
domains functioning (nmod)
produced reserpine (nsubj)
vincristine of (case)
system mononuclear (amod)
decibels 100 (nummod)
day of (acl)
relevance . (punct)
inputs of (case)
release cgrp (compound)
indicating that (ccomp)
account , (punct)
induce mechanisms (conj)
gbm ) (punct)
effects opioid (nmod:poss)
variability hemodynamic (amod)
il-1 paf (conj)
benzylpenicilloyl-poly-l-lysine benzylpenicillin (conj)
docetaxel and (cc)
normal overflow (nsubj)
angiography arterial (amod)
heparin therapeutic (amod)
sirolmus srl (appos)
action convulsant (amod)
precise , (punct)
layer to (case)
result comparison (nmod)
acquired orientation (nmod)
tasks on (case)
delivery until (case)
patients randomized (dep)
reduction standard (nsubj)
reintroduced when (advmod)
responsible complications (nmod)
forearm the (det)
$ROOT$ accelerated (sent)
doxorubicin without (case)
raises prevalence (nsubj)
cocs conventional (amod)
sweating no (det)
myocytes isolated (amod)
hz sec (nmod)
glasses three (nummod)
receptors ionotropic (amod)
pap as (case)
examined potential (nsubjpass)
relationship toxicity (nmod)
outpatients psychiatric (amod)
induced epilepticus (nmod)
represents cardiotoxicity (dobj)
response clonidine (nmod)
conducted attempt (nmod)
one three (conj)
problem hinder (acl:relcl)
tumors cell (compound)
h weeks (conj)
showed 15 (nsubj)
$ROOT$ explored (sent)
risk cystitis (nmod)
over , (punct)
subsequent discontinuation (nmod)
retention reports (dep)
1.46+/-0.8 1.34+/-0.5 (conj)
was dissociation (attr)
people epilepsy (nmod)
e1 addition (nmod)
report investigate (conj)
prevention mitoq. (nmod)
insufficiency with (case)
proposed currently (advmod)
test writhing (compound)
increased titre (nsubj)
bradycardias , (punct)
discontinuation disulfiram (compound)
had ml (dobj)
ccr2 its (nmod:poss)
abnormalities failure (conj)
tg non-transgenic (conj)
numbers procedure (nmod)
-cimetidine , (punct)
analogue ) (punct)
syndrome apnea (nmod)
identifying for (mark)
followed participants (nsubjpass)
screening use (nmod)
ec50 the (det)
precipitate agitation (dobj)
ongoing trials (nsubj)
capable hyperammonemia (nsubj)
therapy replacement (conj)
begin addressing (xcomp)
area mpa (appos)
explanation the (det)
$ROOT$ derives (sent)
protein accumulated (acl:relcl)
mtx administered (acl)
a.m. and (cc)
superior being (cop)
dose t.d.s. (nmod)
fall threshold (nmod)
promotion af (compound)
glycoprotein an (det)
pressure period (conj)
3.9 +/- (cc)
intensity-weighted iw (dep)
nmol i.c.v. (appos)
reverse presence (nmod)
identified therefore (advmod)
show change (dobj)
combinations the (det)
sent government (nmod)
% 0.1 (compound)
intolerance photodermatitis (conj)
cholestasis this (det)
cycle circadian (amod)
sites central (amod)
titrated mg/day (conj)
period a (det)
observed normally (advmod)
9/15 rats (appos)
> 0.83 (dobj)
characterized contractility (nmod)
mrna alpha5 (compound)
discouraged be (auxpass)
divided total (nsubjpass)
tests used (acl)
mitoq. antioxidant (amod)
therapy agent (compound)
echocardiography , (punct)
ethyl fluorobenzylidene (compound)
patients granulomatosis (nmod)
severe those (nmod)
reported few (conj)
dxnp with (case)
model dysfunction (nmod)
group oncopaz (compound)
interactions by (case)
infarction and (cc)
crataegus extract (appos)
study our (nmod:poss)
npy of (case)
ibuprofen ) (punct)
target subdivided (acl)
increases therapy (nsubj)
observations acute (amod)
spots compared (acl)
culture during (case)
step formation (nsubj)
implanted and (cc)
bolus kg-1 (appos)
ke parameters (nsubj)
suffer deserve (conj)
reduced toxicity (nsubjpass)
aged years (nmod:tmod)
sclerosis to (case)
ca1 gyrus (conj)
patients forty-five (nummod)
valproate ) (punct)
antagonists two (nummod)
showed cases (nsubj)
difficult recognition (nsubj)
mglur5 of (case)
phosphatase podocyte (compound)
rats gm-treated (amod)
symptoms axial (amod)
significant was (advcl)
undertaken need (nmod)
persisted polyuria (nsubj)
norepinephrine both (cc:preconj)
episodes convulsion (nmod)
observed controls (advcl)
continue have (xcomp)
cancer pretreated (amod)
outcome patients (nmod)
stereotypies the (det)
antibiomania ( (punct)
system serotonin (compound)
patients af (nmod)
showed ramh (nsubj)
disease valvular (amod)
connected possibly (advmod)
aminotransferase u/l (appos)
hypoperfusion with (case)
rate defined (acl)
aneurysms cocaine-related (amod)
regimen pac-containing (amod)
gene autophagy (compound)
appeared but (cc)
risk tumour (compound)
components its (nmod:poss)
understanding better (amod)
estimated influence (nsubjpass)
decreased considerably (advmod)
apomorphine by (case)
region untranslated (amod)
amb and (cc)
remains increasing (advcl)
infusion , (punct)
finding glomerulonephritis (nmod)
finding and (cc)
have cholinesterase (dobj)
have animals (nsubj)
remained ; (punct)
involvement to (case)
concentrations argatroban (nmod)
men 28 (nummod)
preferred rizatriptan (dobj)
min only (advmod)
mm 10 (nummod)
classical emergent (conj)
background but (cc)
susceptible cells (nsubj)
potentiation . (punct)
reduction quality (nmod)
signal both (cc:preconj)
= 1.15 (dobj)
hallucinations stopped (acl:relcl)
inhibition bioactivation (nmod)
inhibitor decarbodylase (compound)
focus assessment (nsubj)
present contrast (nmod)
subjected patient (nsubjpass)
dwi image (appos)
des-arg10hoe 140 (nummod)
onset delayed (amod)
min briefly (advmod)
march until (case)
paraplegia : (punct)
hepatitis viral (amod)
worsened development (nmod)
e2 ) (punct)
higher concentrations (nsubj)
displayed impair (conj)
metaiodobenzylguanidine , (punct)
assessed anxiety (nsubjpass)
gave although (mark)
risk cardiac (amod)
injury traumatic (amod)
seizures damage (conj)
histological biochemical (conj)
alter rate (dobj)
reactions 2e1 (compound)
aneurysms malformations (conj)
ability promote (acl)
showed lower (ccomp)
restoration prompt (amod)
complicating . (punct)
link bmd (nmod)
reported far (advmod)
substitute lidocaine (nmod)
findings funduscopic (amod)
rotation to (case)
revealed necrosis (dobj)
effects bladder (nmod)
effects than (case)
reports older (amod)
patients monitored (acl)
measured recording (advcl)
hypertension rats (nmod)
died event (nmod)
leak that (mark)
cardioselective ; (punct)
achieve rats (nmod)
biopsies the (det)
tumor an (det)
assess use (dobj)
level intracellular (amod)
sdrr ( (punct)
recommended therefore (advmod)
examined retrospectively (advmod)
systems brain (nmod)
explored we (nsubj)
patients women (appos)
psa with (case)
alteration concentrations (nmod)
protection without (case)
7.11 - (punct)
reactions for (case)
replication viral (amod)
um-272 agent (appos)
metabolizers extensive (amod)
vacuolation extensive (amod)
mechanisms perception (nmod)
percent 82 (nummod)
impact responses (nmod)
basis records (nmod)
contributes that (mark)
pesticide organochloride (compound)
end after (case)
5-ht and (cc)
responsible antinociception (nmod)
normal even (advmod)
tachycardia polymorphous (amod)
hepatocytes initiated (amod)
effect limiting (advcl)
have affinity (dobj)
potential cause (acl)
resistance : (punct)
lymphoma lymphoblastic (amod)
-54 +/- (cc)
reached protocols (nmod)
$ROOT$ alternative (sent)
complication severe (conj)
reactions linked (acl)
electrographic behavioral (conj)
use piperacillin (nmod)
decrease enzymes (nmod)
rediscovery the (det)
hbeag-positive an (det)
increase deviation (nmod)
administered investigate (advcl)
5 7 (conj)
neuropathies the (det)
pharmacokinetics levetiracetam (nmod)
origin striatal (amod)
meq/l lithium=0.85 (nummod)
begun . (punct)
levels : (punct)
diminish can (aux)
weight whole (amod)
helpful and (cc)
seen african (nmod)
diethylcarbamazine with (case)
occurred rats (nmod)
aspects epileptogenesis (nmod)
concentrations csf (compound)
u/l 270 (nummod)
appears stimulation (nsubj)
40.9 +/- (cc)
conclusions showed (appos)
aborted procedure (nsubjpass)
impairments bupivacaine-induced (amod)
hours several (amod)
evaluated h (nmod)
seventy-nine five (compound)
study chronic (amod)
factor elevation (nsubj)
accompany tetany (nsubj)
hr forty-eight (nummod)
patient one (conj)
improved hypertension (nmod)
applied cells (nmod)
develop monkeys (nmod)
fixed-dose , (punct)
characteristics basic (amod)
received fluids (dobj)
seemed there (expl)
follow-up . (punct)
encephalopathy hypoxic-ischemic (amod)
advance a (det)
toxicity whose (nmod:poss)
unknown inhibits (csubj)
micromol/l of (case)
supplementation e (compound)
1.8 was (cop)
-15.4 ( (punct)
treatment vasospasm (nmod)
dose prophylaxis (nmod)
sulfate streptomycin (compound)
for and (cc)
convulsions cocaine-induced (amod)
5.7 4/- (cc)
dose lovastatin (nmod)
complications no (det)
due droperidol (nmod)
facilitates bradycardia (dobj)
% -16.6 (nummod)
epidemics gangrene (nmod)
width and (cc)
zidovudine 3tc (conj)
blocking properties (conj)
therapy repeated (amod)
antagonist calcium (compound)
5.2 - (punct)
case had (acl:relcl)
period min (nmod)
showed study (nmod)
doxorubicin/kg with (case)
initiated overstimulation (nmod)
caused cortex (nmod)
damage cerebellum (compound)
injuries , (punct)
use reported (amod)
toxicity agent (compound)
stimulation excessive (amod)
ifosfamide iv (amod)
14 +/- (cc)
effect be (cop)
time additional (amod)
2.5 x (cc)
combined paclitaxel (nsubjpass)
rise baseline (nmod)
gamma t (compound)
gynecologic and (cc)
lacnp ) (punct)
amelioration symptoms (nmod)
ml/kg water (nmod)
evaluated furthermore (advmod)
nmda ( (punct)
patient thrombosis (nmod)
following to (case)
exposed prenatally (advmod)
150 175 (conj)
cortex cingulate (amod)
dependent were (cop)
paraventricular pvn (appos)
0.1 % (conj)
debated currently (advmod)
study lacn (nmod)
estrogens conjugated (amod)
correlates the (det)
improve : (punct)
systems reporting (compound)
toxicity activity (conj)
amphetamine-free dhea (appos)
findings imaging (nmod)
retinopathy chloroquine (compound)
modulation their (nmod:poss)
8.5 - (punct)
arises . (punct)
atrophy iib (amod)
52 +/- (cc)
elevation cycle (nmod)
therapy tetrabenazine (nmod)
concentration maximum (amod)
frequent exceeds (advcl)
unable was (advcl)
conjunction ifo (nmod)
restored levels (nmod)
quadrant platform (compound)
mechanisms immunological (amod)
behavior squealing (conj)
stimulus-induced hz (dep)
few relatively (advmod)
stimulation ceruleus (nmod)
pr response (appos)
nephritis focal (amod)
potential evoked (amod)
dose correct (amod)
lmwh patients (nmod)
decreased 79 (nmod)
hyperventilation hypoventilation (conj)
synthase , (punct)
myelosuppression toxicity (conj)
effects infusions (nmod)
enhanced increased (advcl)
undertaken before (mark)
potential cssep (appos)
children from (case)
infarctions hypertension (conj)
performance on (case)
recordings hour (amod)
events groups (nmod)
approximate showed (advcl)
november june (conj)
treatment of (case)
microangiopathy necrosis (conj)
increase due (case)
1.01 1.53 (prep)
enhanced injected (advcl)
artery umbilical (amod)
fibres regenerating (amod)
determinant formation (nsubj)
outpatients adult (amod)
implant intravitreal (amod)
blockade dose-dependent (amod)
reticulum with (case)
began patients (nsubj)
promotes modafinil (nsubj)
affect it (nsubj)
effective reduce (xcomp)
data are (cop)
outcome inferior (amod)
stimulation breast (compound)
demonstrate therefore (advmod)
reduction deferoxamine (nmod)
scale simpson-angus (compound)
passes cimetidine (nsubj)
manipulate neurotransmission (dobj)
status myoclonic (amod)
patient monitored (amod)
bnp ( (punct)
brought , (punct)
had results (nsubj)
sequelae epilepsy (nmod)
instilled when (advmod)
project by (case)
time present (acl:relcl)
system model (amod)
levels dosage (compound)
made mice (nmod)
increased 2.4-fold (nmod)
have whereas (mark)
diminished , (punct)
repression expression (nmod)
specimens native (amod)
csa nephrotoxicity (conj)
proven danazol (nsubj)
hydrocephalus rats (nmod)
independent effect (nsubj)
ventricle of (case)
have abnormalities (dobj)
limit mg/m2 (appos)
complicate . (punct)
precipitated cyclosporine (nmod)
found who (nsubjpass)
260 of (case)
rates , (punct)
given randomized (conj)
faded complaints (nsubj)
mg 4.47 (nummod)
chemotherapeutics with (case)
3',5'-monophosphate adenosine (compound)
1a (at1ar)/at2r (punct)
patency svc (nmod)
mice mice (nmod)
cycle third (amod)
phosphorylation transcript (conj)
boluses mg/kg (appos)
pointes de (compound)
scopolamine not (cc)
improve rg1 (nsubj)
in especially (advmod)
exposed given (conj)
mg/kg 7.5 (nummod)
disabled observed (conj)
value pmol (appos)
3.8 0.1 (conj)
caused recovery (nmod)
anticholinergics or (cc)
ufh of (case)
apnoea lasting (acl)
neurotransmitters other (amod)
acrolein irritant (appos)
fibers degenerating (amod)
susceptible . (punct)
model used (acl)
study comparative (amod)
iopamidol of (case)
showed uptake (dobj)
transport acid (nmod)
shorter latencies (nsubj)
manifestations findings (conj)
showed also (advmod)
micrograms.kg-1.min-1 tmp (nmod)
quinpirole d-2 (compound)
cases scleroderma (nmod)
parp of (case)
develop proteinuria (nsubj)
sign first (amod)
lessened significantly (advmod)
naloxone reserpine (conj)
appeared provided (xcomp)
evaluated x-ray (nmod)
lasted weeks (nmod)
came department (nmod)
leukocyturia of (case)
breakdown the (det)
amiodarone large-dose (amod)
suggests that (mark)
decreased g/liter (nmod)
injection if (nmod)
% rizatriptan (nmod)
follow-up 2-year (compound)
% effect (nmod)
doses sufficient (amod)
extent failure (nmod)
1/2-year-old 4 (compound)
1.0mg/kg - (punct)
drug psychostimulant (amod)
versa animals (nmod)
exhibited potencies (dobj)
[3h]cb 3717 (nummod)
generated be (auxpass)
question an (det)
dexamethasone prenatal (amod)
morning ( (punct)
reduced levels (nmod)
had dose (nmod)
indicative role (nmod)
defined improvement (nmod)
showed concentrations (nmod)
uneventful reexposure (nsubj)
administration glucocorticoids (nmod)
reduction rats (nmod)
drugs anti-hiv (amod)
pathway through (case)
toxicities to (case)
patterns discharge (compound)
benzoylecgonine amphetamine (conj)
risperidone 40.9 (nummod)
indicates cause (ccomp)
seizures motor (compound)
losartan antagonist (compound)
level brain (compound)
synthase activation (conj)
scopolamine cycloheximide (conj)
consisted cessation (nmod)
mechanisms pathogenic (amod)
interview from (case)
attack tia (appos)
reduces comparison (nmod)
mortality disease (conj)
framework a (det)
failure the (det)
encephalopathy therapy (nmod)
stability temporary (amod)
determine have (ccomp)
regimen cmf (compound)
infusion artery (nmod)
action adr (nmod:poss)
safety green (nmod)
indicated reports (nsubj)
recipients twenty (nummod)
tgr ( (punct)
hypersalivation , (punct)
nos-ir however (advmod)
cause ear (nmod)
reason for (case)
humans animals (conj)
botox of (case)
loading oral (amod)
affected stimulation (nsubjpass)
randomized groups (nmod)
saline l (conj)
management adequate (amod)
crossed . (punct)
icrf-187 by (case)
respond . (punct)
control doxorubicin (conj)
striatum mice (nmod)
. pharmacol (compound)
preparations and (cc)
antagonists the (det)
25 in (case)
symptoms disease (nmod)
produce rats (nmod)
nicardipine verapamil (conj)
antagonist 2-methyl-6-(phenylethynyl)pyridine (appos)
cta patients (nmod)
ester and (cc)
medications , (punct)
produced had (conj)
segments artery (nmod)
production via (case)
impair not (neg)
increase substantial (amod)
closed reported (conj)
1.8 0.3 (conj)
docetaxel combination (conj)
animals h (dep)
confirm , (punct)
antagonists 5-ht(6 (compound)
registry deaths (nmod)
vomiting 0 (appos)
0.7 +/- (cc)
epss in (case)
sought therefore (advmod)
reduced extent (dobj)
abolished addition (nmod)
published not (neg)
extract proanthocyanidin (compound)
20 15 (compound)
proportion % (dep)
mug = (dep)
changes variables (nmod)
salbutamol micrograms (conj)
concern . (punct)
resuscitation cardiac (amod)
formulation marketed (acl)
higher pressures (nsubj)
lindane prior (case)
chain from (case)
influenced more (advmod)
prompted . (punct)
reached % (nsubj)
tended a-i (nsubj)
interviewed emphasis (nmod)
administration sulphonate (nmod)
degeneration prominent (acl:relcl)
cause infective (amod)
showed has (ccomp)
started been (auxpass)
glomerular tubular (conj)
dosed be (auxpass)
related ph (nmod)
regimen after (conj)
mcc ) (punct)
therapy first-line (amod)
discussed will (aux)
women 12 (nummod)
hemorrhages 53 (nummod)
reduction concentration (nmod)
performance or (cc)
found occlusion (dobj)
mind the (det)
d1 or (cc)
showed revealed (advcl)
oxidation for (case)
mrp2-deficient tr(- (dep)
frey and (cc)
scored measures (nmod)
therapies numerous (amod)
terminated administration (nmod)
slowing sometimes (advmod)
medications her (nmod:poss)
prolactinomas 7 (nmod)
suggest : (punct)
14.71 31.85 (conj)
dehydrogenase transaminase (conj)
g amisulpride (nmod)
connected k(+)-channels (nmod)
shown interfere (ccomp)
nh4ac and (cc)
resistance accompanying (acl)
compared cohort (nmod)
blockers propranolol (dep)
% < (parataxis)
cells time (nmod)
studied determination (nmod)
remaining b.d (nmod)
glomerulonephritis deposition (nmod)
p two-sided (amod)
experienced se (dobj)
magnitude duration (conj)
hormone peptide (conj)
$ROOT$ believe (sent)
chf ) (punct)
demonstrated animals (nsubj)
marked predominantly (advmod)
infused pentothal (nsubjpass)
desipramine antidepressant (amod)
case ingestion (nmod)
angiogram a (det)
re-exposure drug (nmod)
mimic because (mark)
symptoms her (nmod:poss)
l. g. (appos)
pathway brainstem (compound)
out-patients in-patients (conj)
tachyarrhythmias of (case)
training influence (nmod)
unassigned indicated (dep)
change tachycardia (dobj)
reduces blocking (csubj)
found found (ccomp)
assessment subjective (amod)
first , (punct)
remission - (punct)
hemorrhagic not (neg)
brain the (det)
elicit drug (nsubj)
regions bilateral (amod)
model sclerosis (nmod)
stl2 ( (punct)
aes from (case)
produce persons (nmod)
dose optimal (amod)
count a (det)
measurements the (det)
have it (nmod)
derivative a (det)
amb alone (advmod)
evaluation prospective (amod)
women born (acl)
received n (nsubj)
absorption oral (amod)
concordance anomalies (nmod)
seizures life-threatening (acl:relcl)
analgesia , (punct)
barrier intact (amod)
accounted coli (nmod)
falls concentrations (nmod)
p-aminophenol pap (appos)
slowing degree (compound)
ng./ml testosterone (nsubj)
need inquire (xcomp)
defined infarction (nmod)
statistics through (case)
interfere disturbance (nsubj)
found we (nsubj)
possibility represent (acl)
induced using (xcomp)
hours infusion (nmod)
react to (nmod)
deficiency or (cc)
treatment lesions (nsubj)
isomer.6 either (det)
reduce movement (dobj)
specimen keratome (amod)
suggest analyses (nsubj)
bzds/rds two (nummod)
from 1992 (nmod)
$ROOT$ substantiated (sent)
common history (nsubj)
factor illness (nsubj)
adrenaline kg-1 (appos)
concerns primarily (advmod)
cylinder the (det)
controls dihydropyridine (nmod)
included data (nsubj)
show background (dep)
adenoma hepatic (amod)
prescribed are (auxpass)
sleep shorter (amod)
affinity a (det)
tolerance men (nmod)
found 9 (nmod)
call attention (nmod)
patient developed (acl:relcl)
b.i.d. ) (punct)
maneuver hyperventilation (compound)
ln cmax/mic (appos)
solicited clinicians (nmod)
stabilized treatment (nmod)
caffeine- effect (conj)
groups infusion (compound)
compared dothiepin (nsubjpass)
injury mitochondrial (amod)
serotonin 5-hydroxytryptamine (appos)
7.3 ( (punct)
weight kidney (compound)
r6 ( (punct)
condition capsaicin-untreated (amod)
littermates wild-type (amod)
mitigated treatment (nsubj)
variables confounding (amod)
maintain range (nmod)
n=100 ) (punct)
seen is (auxpass)
respiratory cardiovascular (conj)
effects population (nmod)
25mg/kg , (punct)
ect ( (punct)
males both (cc:preconj)
induced ; (punct)
titres patients (nmod)
support results (nsubj)
impairment rats (nmod)
administered increased (advcl)
ought faced (xcomp)
acknowledged must (aux)
add literature (nmod)
numbers p (dep)
rat co-administration (nmod)
carbonate ingested (amod)
recovery during (nmod)
followed mg (nmod)
instrument a (det)
patients treated (dep)
mitochondria tissue (nmod)
population comprising (acl)
agent rg1 (nsubj)
practitioners to (case)
i.c.v ( (punct)
associated p (dep)
reactions 261 (nummod)
case dysrhythmias (nmod)
examination histologic (amod)
tests elisa (compound)
alterations ducts (nmod)
medulla and (cc)
nephrotoxic medium (nsubj)
infusion 15-minute (amod)
pilocarpine-treated and (cc)
sheath the (det)
secondary signals (nmod)
hg of (case)
slower . (punct)
produces rats (nmod)
pursued wr242511 (nsubjpass)
receive were (cop)
fc . (punct)
precipitated overdose (nmod)
relative baseline (nmod)
staining and (cc)
establish guidelines (dobj)
20 times (quantmod)
practices hampshire (nmod)
nerve vocal (amod)
most it (nmod)
sedated patients (nsubjpass)
treatment arrhythmias (nmod)
case one (nummod)
strategies therapeutic (amod)
change elicit (conj)
times five (nummod)
class density (compound)
comparison compound (nmod)
aggravate problem (dobj)
similar is (cop)
point at (case)
interaction social (amod)
had mastocytosis (dobj)
= 41 (dep)
mutations : (punct)
administered dexamethasone (nsubjpass)
role haloperidol (nmod)
microinjection , (punct)
suggesting mediated (ccomp)
preferred ergotamine/caffeine (nmod)
mechanism those (nmod)
compared group (nsubjpass)
hypertension phenylephrine-induced (amod)
ci ): (punct)
those associated (acl)
anemia this (det)
prevented thus (advmod)
identifying disgust (dobj)
measured diameters (nsubjpass)
diameter maximal (amod)
correlation histamine (nmod)
drugs all (predet)
proven angiographically (advmod)
prevented efficiently (advmod)
wistar sd (conj)
thrombosis dvt (appos)
dianabol ) (punct)
easy , (punct)
showed dermis (nmod)
standard dysphonia (nmod)
provides conversion (nsubj)
able were (cop)
abundance mrna (compound)
weight lower (amod)
records practices (nmod)
antagonized hyperactivity (dobj)
65 > (advmod)
results pallidotomy (nmod)
7th between (case)
implicated changed (conj)
suppression marked (amod)
edaravone n=8 (appos)
days consecutive (amod)
therapy maintenance (amod)
mg/kg 16 (nummod)
characteristic , (punct)
dosage mtd (appos)
unmask increase (conj)
cardioprotection treatment (nmod)
pronounced change (dep)
drawback one (nummod)
sinusitis acute (amod)
infusion dose (compound)
ameliorates receptor (nsubj)
dysphonia acitretin (conj)
cardioversion fibrillation (nmod)
rilmenidine or (cc)
reduced latency (dobj)
probing . (punct)
failure acidosis (conj)
quantified were (auxpass)
treatment adequate (amod)
pre-treated licl (nmod:npmod)
tolerance some (det)
used he (nsubj)
effect amantadine (nmod)
estimated making (advcl)
part remaining (amod)
260 270 (conj)
parameters last (amod)
factors related (amod)
potentiated lna (nmod)
genes presented (acl)
symptoms % (appos)
performance objective (amod)
years 17.8 (nummod)
drugs dose (nmod)
function social (amod)
number because (case)
excreted 14c (dobj)
blockade toxicity (nmod)
sod levels (dep)
injury , (punct)
excreted rats (nsubj)
initiated continued (conj)
mechanisms reactions (nmod)
resulting syndrome (nmod)
analysis changes (compound)
tubule connecting (amod)
occlusions artery (compound)
testing alkylxanthines (nmod)
test performance (compound)
decrease decrease (nmod)
thrombosis cerebral (amod)
needed prescribing (advcl)
treatment galactose (compound)
glycosuria , (punct)
gestodene of (case)
dysfunction -- (punct)
sadness anger (conj)
release sensitivity (conj)
died one (nsubj)
involvement on (case)
scale-revised wechsler (compound)
combination days (nmod)
aneurysm cerebral (amod)
significant disease (nmod)
produced abecarnil (nsubj)
rate flow (compound)
caused erdosteine (nsubj)
28.2 ci=26.7 (dep)
antigen-positive proliferating (amod)
attenuates shows (conj)
weeks not (neg)
parameters and (cc)
edds ) (punct)
allografts consent (nmod)
pre-treatment days (nmod)
hemodynamics on (case)
nifedipine adalat (appos)
-15.96 ) (punct)
has altering (advcl)
exceed did (aux)
exposure incidence (conj)
none variants (nmod)
having clinic (nmod)
stimulation receptors (nmod)
delirium ) (punct)
efficient less (advmod)
drg in (case)
treatment pcc (nsubj)
observed only (advmod)
juices of (case)
conclude reduces (ccomp)
2.7 3.8 (conj)
mechanism main (amod)
growth pituitaries (nmod)
c+e ( (punct)
areas hyperalgesia (nmod)
normal nearly (advmod)
inactivate normally (advmod)
in on'- (punct)
trend outcomes (nmod)
induced transiently (advmod)
was compare (xcomp)
anesthetized urethane (nmod)
41.66 : (punct)
medulla mice (nmod)
patients entering (acl)
correlated weakly (advmod)
palsy psp (appos)
favored . (punct)
has features (dobj)
simulator laboratory (appos)
failed , (punct)
stools in (case)
warfarin k (compound)
measure(s main (amod)
pain induced (acl)
cycles 2 (nummod)
modulates ways (nmod)
negligible was (cop)
rats ritanserin-treated (amod)
administration management (nmod)
pointes associated (acl)
schedule cyclic (amod)
variety functions (nmod)
techniques diagnostic (amod)
mechanisms management (conj)
difficult enucleation (nsubj)
active was (cop)
ldh ) (punct)
administration mg/kg (appos)
distinct kindling (nmod)
development bradyarrhythmias (nmod)
occurred but (cc)
measured later (advmod)
range of (case)
ethinyloestradiol and (cc)
circled contralaterally (advmod)
importance region (nsubj)
caused nitroprusside (nsubj)
dissatisfaction to (case)
mg/d 400 (nummod)
effects adding (acl)
volumes and (cc)
generated wall (nmod)
marmoset levodopa-treated (amod)
correct effect (dobj)
injection in (case)
treatment aminoglycoside (nmod)
membrane cell (compound)
preparation new (amod)
dipyrone to (case)
coma the (det)
needed ; (punct)
changes reactivity (nmod)
advised is (auxpass)
increase compounds (nsubj)
bear depending (prep)
cells transfected (amod)
impact variants (nmod)
induce break (dobj)
carry task (dobj)
indicative are (cop)
less 0.002 (nmod)
half-life short (amod)
smoking concurrent (amod)
$ROOT$ delirium (sent)
hcl with (case)
isoenzyme p450 (compound)
accounting while (mark)
psychosis primary (amod)
myocarditis viral (amod)
evaluation to (case)
gamma 1/2 (nummod)
investigations in (amod)
causes patterns (dobj)
period observation (compound)
insipidus persistent (amod)
hospital-years 117 (nummod)
warranted monitoring (nsubjpass)
12 ) (punct)
= 38 (dobj)
artery basilar (amod)
resolve not (neg)
allograft presenting (acl)
cerebral sphenoidal (conj)
denopamine , (punct)
department our (nmod:poss)
aldosterone and (cc)
350 - (punct)
patient remaining (amod)
suggests important (ccomp)
cycle basic (amod)
measured variability (nsubjpass)
those resulting (acl)
occurred one (nmod)
agonist ly-171555 (appos)
enhanced been (auxpass)
damage muscle (nmod)
women 330 (nummod)
prevent atrophy (dobj)
apparatus and (cc)
reserved patients (nmod)
underwent surgery (dobj)
activity for (case)
syndrome legs (compound)
atin ) (punct)
retard incorporation (dobj)
carcinomas carcinoma (conj)
cornu uterine (amod)
anesthesia methoxyflurane (compound)
estrogens exogenous (amod)
mouth tongue (conj)
induced injury (dobj)
potential negative (amod)
dose discontinuation (conj)
improve however (advmod)
resulted exposure (nsubj)
indomethacin mg/kg (amod)
biomarkers as (case)
management its (nmod:poss)
assessed been (auxpass)
adopted widely (advmod)
2.14 : (punct)
indicate started (ccomp)
conversion cya (nmod)
retention urinary (amod)
appeared insipidus (xcomp)
nitroglycerin doses (nmod)
commencement study (nmod)
homeostasis on (case)
transport glutamate (compound)
indeterminate effects (nsubj)
recognised increasingly (advmod)
hypertrophy prominent (amod)
solution and (cc)
3.6 1.9 (conj)
assay transferase-mediated (amod)
affected content (dobj)
induced capsaicin (nmod)
level effective (amod)
$ROOT$ affect (sent)
stimulation the (det)
mg/kg po (appos)
rats vehicle-treated (amod)
increased 2-fold (advmod)
possibility involving (case)
refractory disease (nsubj)
confound . (punct)
angiographies , (punct)
replicate does (aux)
mmec ( (punct)
fatigue headache (conj)
radiotherapy days (appos)
performed evaluate (advcl)
included system (dobj)
transplantation of (case)
view of (case)
inhibition synthase (compound)
infarction woman (nmod)
eczema with (case)
ranged ml (nmod)
sensitization time-based (amod)
employed if (mark)
induce ability (nmod)
reported fda (nmod)
ratings subjective (amod)
kidneys and (cc)
cervix of (case)
mechanism same (amod)
flutamide receptor (compound)
caused agonist (nsubj)
$ROOT$ aroused (sent)
patients carcinomas (nmod)
invited . (punct)
0.8 0.15 (conj)
$ROOT$ provocation (sent)
18.88 : (punct)
determined effects (nsubjpass)
induced acetazolamide (nmod)
therapy valsartan/hydrochlorothiazide (compound)
possessed it (nsubj)
test morris (compound)
persisted patient (nmod)
cas 684 (nummod)
values preinfusion (amod)
worsened not (neg)
smokers adult (amod)
responses abusers (nmod)
synergy the (det)
pregs of (case)
comparing agents (nmod)
effects medications. (nmod)
prevention in (case)
repeated once (advmod)
caused ntg (nmod)
differ number (nsubj)
due ifosfamide (nmod)
age , (punct)
effects rat (nmod)
remain pathways (nsubj)
cases injury (nmod)
elicited history (nsubjpass)
simvastatin , (punct)
develop nephrotoxicity (dobj)
kilogram weight (nmod)
versions test (nmod)
received either (dep)
1.24 ( (punct)
re-exposure of (case)
blocked activation (dobj)
7 to (dep)
using parameters (dobj)
procedure examination (conj)
clinic an (det)
well-tolerated generally (advmod)
dilation before (nmod)
presentation at (case)
low ( (punct)
observed hearts (nmod)
remission partial (amod)
unable disease (nmod)
commenced later (advmod)
artery branch (conj)
t(30 ) (punct)
synthesis acid (nmod)
penetrating barrier (dobj)
redistribution with (case)
reported case (nsubj)
$ROOT$ begins (sent)
woman block (nmod)
anemia erythroblastocytopenia (conj)
nephropathy acute (amod)
apparent lasted (conj)
promotes function (dobj)
injection acute (amod)
dl-sotalol and (cc)
47 of (advmod)
number part (nmod)
controls microl (dep)
presented she (nsubj)
blocker , (punct)
years months (conj)
contribution nursing (nmod)
transported brain (nmod)
animals left-pawed (amod)
have and (advmod)
condition any (det)
thorax on (case)
s 95+/-39 (nummod)
contrary report (nmod)
recommend reviews (dobj)
crohn 's (case)
paraparesis morphine-induced (amod)
extract grape (compound)
antioxidants enzymic (amod)
activity myeloma (nmod)
higher clearance (nsubj)
administration intracoronary (amod)
pergolide vs (cc)
prevent down-regulation (dobj)
stronger compared (advcl)
rate < (amod)
pain disturbance (conj)
5-ht1a 5-ht2a (conj)
ml. of (case)
rate woman-years (nmod)
$ROOT$ 2)% (sent)
mg/kg 800 (nummod)
degree in (case)
risk the (det)
16,459 is (cop)
week 4 (compound)
mg/g mg/g (conj)
period mean (amod)
defect ( (punct)
indicates complication (nsubj)
thickening glomerular (amod)
deterioration abuse (nmod)
performed center (nmod)
solution noradrenaline (conj)
escalation single (amod)
as use (nmod)
cholesterol lipoprotein (compound)
sensitive with (mark)
trends elevation (nmod)
questions . (punct)
blockers these (det)
make possible (ccomp)
prodrug ( (punct)
p10 or (cc)
gender-dependent not (neg)
drugs 505 (nummod)
interval -0.07 (appos)
induced scopolamine (nsubj)
gfp ( (punct)
rhizomes and (cc)
cardiomyopathy adriamycin (compound)
correction metformin (nmod)
7 in (case)
alterations concentrations (nmod)
terminals afferents (nmod)
results which (nsubj)
times - (punct)
design backcross (amod)
inhibited however (advmod)
i.c. ) (punct)
whether importance (nmod)
black edds (nsubj)
interactions to (case)
175 200 (conj)
testing stress (compound)
unaffected reversed (advcl)
elements cell (compound)
initiation and (cc)
elevations . (punct)
damage possible (amod)
effects caffeine (nmod)
correlated examined (advcl)
eighties the (det)
cardiomyopathy catecholamine-induced (amod)
regarded foodstuffs (nmod)
case like (case)
metabolites of (case)
factor . (punct)
change output (dobj)
were although (mark)
arytenoid the (det)
reversed blocked (conj)
$ROOT$ studied (sent)
tests normal (amod)
hr ) (punct)
prescribing when (advmod)
died % (dep)
responsiveness dopamine (nmod)
given microgram/kg (dobj)
content nh3 (compound)
france in (case)
resistance renal (amod)
maoi ( (punct)
percent males (nmod)
subjected protocol (nmod)
efficacy group (nmod)
six = (dep)
displayed patients (nsubj)
phase , (punct)
expression receptors (nmod)
terminals peripheral (amod)
collapsed , (punct)
development social (amod)
marker degeneration (nsubj)
proliferation of (case)
had significant (conj)
have epilepticus (dobj)
spaces to (case)
suggest however (advmod)
manner dependent (amod)
ischaemia exercise (compound)
blocks consecutive (amod)
resolution to (case)
movements extremities (nmod)
inhibitors acetylcholinesterase (compound)
light the (det)
rare and (cc)
showed addition (nmod)
prophylaxis and (cc)
concentration creatinine (compound)
muscles respiratory (amod)
hcfcs 123 (dep)
presented treatment (nsubj)
markers cells (nmod)
antagonized pretreatment (nmod)
sufficient seems (advcl)
behaviors premorbid (amod)
clearance creatinine (compound)
clentiazem , (punct)
thickness anterior (amod)
gamma-vinyl-gaba d (dep)
$ROOT$ verified (sent)
toxicities because (case)
12.3 4.1 (conj)
decreased 65 (nmod)
cd-832 micrograms/kg/min (dep)
reduced unchanged (advcl)
doses their (nmod:poss)
supplemented ra (nmod)
micrograms of (case)
% 15.4 (nummod)
metabolized acrolein (nmod)
rr ; (punct)
dose mg/kg (nmod)
used tamoxifen (nsubjpass)
differences potential (nmod)
explore and (cc)
alter threshold (dobj)
devices elevated (amod)
had less (advmod)
volume creatinine (conj)
play diminished (advcl)
concentration time (conj)
marked more (advmod)
history treated (acl)
injected material (nsubjpass)
influence function (nmod)
staining cuprolinic (amod)
levels stimulant (amod)
causing coagulopathy (dobj)
communicate regulate (xcomp)
days lesioning (dep)
percentage of (case)
progression of (case)
predict can (aux)
handling in (mark)
nephrosis on (case)
disappeared decreased (advcl)
uterus from (case)
patients re-examined (acl)
levels but (cc)
agent chemotherapy (compound)
% bha (dep)
male leukemia (nmod)
slightly only (advmod)
resulted decrease (nmod)
induced iatrogenically (advmod)
pressure formation (conj)
angioedema intestinal (amod)
death patient (nmod:poss)
component therapy (nmod)
dextran with (case)
agents both (det)
tolerance pain (nmod)
18 to (dep)
enhanced catalepsy (dobj)
from 1985 (nmod)
vasopressin peptide (conj)
suffering depression (nmod)
investigated previously (advmod)
prescribed can (aux)
infusions bilateral (amod)
pilocarpine the (det)
model which (nsubj)
method received (appos)
$ROOT$ strikes (sent)
conditions normal (amod)
bones the (det)
induced decreased (parataxis)
reducing % (nmod)
assigned infants (nsubjpass)
effects late (amod)
groups parallel (amod)
confirmed immunocytochemistry (nsubj)
rhabdomyolysis association (nmod)
induced chemically (advmod)
added infusion (nmod)
implantation stent (nmod)
day gd (appos)
loss striatum (nmod)
interview or (cc)
component on (case)
changes mean (amod)
prolonged increased (conj)
have can (aux)
concentration related (amod)
depression angina (conj)
diet lithium-containing (amod)
rats (6-ohda)-lesioned (amod)
problem anemia (nsubj)
referred us (nmod)
increasing duration (nmod)
level serum (nmod)
neuropathy deficits (nmod)
greater blue (nsubj)
action anticancer (amod)
aberrations morphological (amod)
assumed due (xcomp)
oxidase c (compound)
poor minorities (conj)
changed ltp (dobj)
combined caffeine (nmod)
50 40 (compound)
conducted elsewhere (advmod)
signalling receptor (compound)
genes critical (amod)
$ROOT$ managed (sent)
staining localization (conj)
involvement ( (punct)
volume peak (amod)
158.11 9.18 (conj)
remain benefits (nsubj)
consequences clinical (amod)
mechanism exerts (acl:relcl)
malaria jaundice (nmod)
suggested pathogenesis (nsubjpass)
source database (nsubj)
describing effects (dobj)
associated rhabdomyolysis (nmod)
ccnu/ctx of (case)
practical were (cop)
thermoregulation , (punct)
provided statistics (nmod)
have pacing (nsubj)
spillover plasma (nmod)
therapy 6-thioguanine (nmod)
damage early (amod)
prevented is (auxpass)
stones their (nmod:poss)
maintained simvastatin (nmod)
indices myocardial (amod)
dexatrim phenylpropanolamine (appos)
insufficiency preexisting (amod)
$ROOT$ standard (sent)
evaluated cystitis (nsubjpass)
measure memory (nmod)
conclusions effect (appos)
experiments possibly (advmod)
degree met (acl:relcl)
efficacy preventing (advcl)
greater than (mwe)
chick pinealectomized (amod)
pacemaker permanent (amod)
3.6 0.6 (conj)
hypertelorism and (cc)
nmda microl (appos)
changes with (case)
african in (case)
2,682,2,803 , (punct)
developed had (advcl)
evidence microscopic (amod)
associated angioedema (nsubj)
pectoris without (case)
review a (det)
provide allow (conj)
49 5 (conj)
pressure absolute (amod)
needle of (case)
functions system (nmod)
decreased had (conj)
inhibition decarboxylase (compound)
case congenita (nmod)
role development (nmod)
patients 1223 (nummod)
sos ) (punct)
deterioration rats (nmod)
diphosphate of (case)
induce hyperfiltration (dobj)
conducted study (dobj)
mg 0.3 (nummod)
micrograms 400 (nummod)
infiltrates eosinophilic (amod)
receiving transplant (dobj)
alpha-methyltyrosine with (case)
prevention reorganization (conj)
irritation chemical (amod)
reduced conclusion (nsubjpass)
followed damage (nmod)
reason is (cop)
had accumulation (dobj)
population exposed (amod)
improve although (mark)
demographics , (punct)
patterns switching (compound)
interviewed using (xcomp)
purpose reviews (appos)
attenuated catalepsy (dobj)
panel complete (amod)
found metabolizer (ccomp)
c min (appos)
background associated (dep)
choices and (cc)
efficacy to (case)
absence arrhythmias (nmod)
symptoms ophthalmological (amod)
mg/kg 380 (nummod)
effects germany (nmod)
frequent more (advmod)
seen years (nmod)
microbleeds , (punct)
study follow-up (amod)
stage differentiation (nmod)
led half (nmod)
protecting seizure (nmod)
were any (nmod)
tended . (punct)
inhibitor angiotensin (compound)
verapamil rats (nmod)
see . (punct)
level na (nmod)
anticonvulsants to (case)
sites tumor (compound)
signs unresponsive (amod)
find passage (dobj)
experiencing minutes (nmod)
administration chloramphenicol (nmod)
nephropathy recurrent (amod)
day pod (appos)
ketanserin , (punct)
killers of (case)
causes for (case)
patients meeting (acl)
diphenhydramine and (cc)
wky 30 (nummod)
problem therapy (nmod)
$ROOT$ levels (sent)
elicit target (dobj)
voltarol ( (punct)
pancuronium with (case)
lead abuse (nsubj)
carcinogenesis prostate (compound)
activity cytosolic (amod)
inhibitor activity (nmod)
dependent tone (nmod)
fracture hip (compound)
low-dose ) (punct)
factor as (mark)
infarction edema (nmod)
activities their (nmod:poss)
cause which (nsubj)
decreases it (nsubj)
aggravate proteinuria (dobj)
affinity weak (amod)
-59.7 +/- (cc)
ritodrine of (case)
response least (advmod)
introduced doses (nmod)
scale 0 (appos)
weeks long-term (appos)
ntg delayed (amod)
epilepticus symptoms (conj)
advantage administration (nmod)
deficits papaverine (nmod)
attributable drugs (nmod)
$ROOT$ disabled (sent)
conclude demonstrated (ccomp)
points ( (punct)
concentration excretion (conj)
modulation gating (nmod)
induce retardation (dobj)
decrease peroxidation (nmod)
secretion numbers (nmod)
related problems (nmod)
2min for (case)
(1.8)% . (nummod)
hyperparathyroidism in (case)
entered men (nsubj)
determination of (case)
prescribe who (nsubj)
evaluated sections (nsubjpass)
controls wild-type (amod)
level activity (conj)
days after (case)
studied correlations (nsubjpass)
aged years (nmod:npmod)
migraineurs and (cc)
type nhe3 (appos)
phenomenon coronary (amod)
led outcomes (nmod)
absent whereas (mark)
associated are (auxpass)
cycles following (case)
pattern similar (amod)
course time (compound)
basis the (det)
reperfusion of (case)
associated level (nmod)
is phenomenon (attr)
lower 15.5 (nmod)
measured score (nmod)
infarctions previous (amod)
scotoma with (case)
increased women (nsubj)
binding annexin (compound)
processing information (nmod)
made efforts (nsubjpass)
clinical or (cc)
decreased resistance (nsubj)
cardiotoxicity : (punct)
seems model (xcomp)
prevent even (advmod)
amplitude attenuated (acl:relcl)
activities chain (compound)
variable was (cop)
bodies inclusion (compound)
pretreated implanting (advcl)
rats step (acl:relcl)
$ROOT$ protect (sent)
atropine by (case)
mechanism triggering (amod)
completed measures (dobj)
$ROOT$ control (sent)
damage local (amod)
treatment areas (nmod)
pregnancy early (amod)
attenuated animals (advcl)
included norleucine (dobj)
valproate mg (appos)
electrocardiogram pressure (conj)
pretreating mice (dobj)
seconds forty (nummod)
action prednisolone (compound)
lid right (amod)
withdrawal hormone (nmod)
interviewed . (punct)
effects pressure (compound)
confusion onset (compound)
suggested results (nmod)
schedule with (case)
erythematosus sle (appos)
background review (acl)
action ifosfamide (nmod)
shown have (aux)
rendered parkinsonian (xcomp)
need no (det)
mmol/l than (case)
recorded 11 (nmod)
history abuse (nmod)
developed progressively (advmod)
incidence pattern (conj)
efficacy use (nmod)
rides , (punct)
time intoxication (nmod)
state the (det)
susceptibility to (case)
stable fluctuating (conj)
alf alf (appos)
learning amnesia (nmod)
avoided events (nsubjpass)
$ROOT$ efficacious (sent)
15.0 1.5 (conj)
penzberg , (punct)
fluorouracil with (case)
developed failure (dobj)
pressure in (case)
group hypercalcemic (amod)
test to (case)
rise increase (nmod)
chemiluminescence by (case)
arthralgia , (punct)
complication hepatitis (nsubj)
diseases progressive (amod)
$ROOT$ benefited (sent)
decreased e2 (nsubj)
release on (case)
abundant hippocampus (nmod)
had 4 (nsubj)
following as (case)
present report (nmod)
oral or (cc)
acetaminophen- , (punct)
higher p (nmod:npmod)
arousal and (cc)
times treatment (nmod)
liver same (amod)
suffering psoriasis (nmod)
% 46.90 (nummod)
course acid (dep)
trial large (amod)
neurofilament nf (appos)
significant ; (punct)
$ROOT$ planned (sent)
agent injurious (amod)
components bioactive (amod)
amoxicillin of (case)
likely p (dep)
little very (advmod)
performed level (nmod)
softening and (cc)
additive be (cop)
rare aware (conj)
nephrotoxicity vancomycin-induced (amod)
phosphatase calcineurin (compound)
effective approach (nsubj)
inhibit activity (dobj)
increased level (nmod)
time dwell (compound)
the presence (dep)
bile in (case)
reveal impact (dobj)
report signs (dobj)
women hospital (conj)
condition patient (nsubj)
monkeys such (amod)
histological and (cc)
nitrogen , (punct)
age year (conj)
january february (conj)
concentrations carbachol (compound)
reagent sulfhydryl (compound)
described reviewed (conj)
alters bupivacaine (nsubj)
confirm findings (dobj)
mmol/kg 50 (nummod)
antigen test (compound)
repeaters and (cc)
5967 - (punct)
taqid ser311cys (conj)
d15 mg/m(2 (punct)
risks elevated (amod)
$ROOT$ troublesome (sent)
2.0 was (cop)
csa indications (nsubj)
woman 68-year-old (amod)
cotransporter ) (punct)
complication delayed (amod)
vessels rat (compound)
placebo to (case)
ifosfamide after (case)
suspected withdrawn (conj)
quantified technique (nmod)
raised suppression (nmod)
involves step (dobj)
recurs stopped (advcl)
isoproterenol by (case)
study cohort (compound)
potency ems (nmod)
induced i.p. (advmod)
cancers sarcomas (nmod)
descriptions previous (amod)
hcn ) (punct)
has allele (nsubj)
specific that (mark)
derivative one (nummod)
susceptible might (aux)
extent extent (conj)
include portion (dobj)
disease disease (nmod)
number participants (nmod)
suggest they (nsubj)
reduced ) (punct)
caused more (advmod)
hypertension during (case)
neurotoxicity acute (amod)
comprised : (punct)
euthanized animals (nsubjpass)
suggest although (mark)
index relative (amod)
toxic piroxicam (nsubj)
vehicle glycol (appos)
strategies immunosuppression (nmod)
paralysis , (punct)
cyanide cn (appos)
reached rates (dobj)
groups two (nummod)
reduction > (dep)
has limit (dobj)
courses by (case)
$ROOT$ potentiates (sent)
difficult is (cop)
dropped beginning (nmod)
predict could (aux)
burning capsaicin-induced (amod)
nephrotoxic seems (conj)
transplantation before (case)
hours 40 (nummod)
counts platelet (compound)
rats old (amod)
exhibited preparation (nmod)
reduction the (det)
exception binding (nmod)
term on (case)
neoantigens in (case)
attributed etiology (nsubjpass)
incidence complications (nmod)
patients warfarin (compound)
sinus thrombosis (conj)
levels activities (nmod)
mri pediatric (amod)
activator selective (amod)
primers transcriptase (compound)
38 to (quantmod)
persistent . (punct)
increase does (aux)
recipient of (case)
micrograms 40 (nummod)
recurrence rapid (amod)
tissues patients (nmod)
diet drug (conj)
food regular (amod)
day this (nsubj)
time rats (nmod)
occurs suggests (conj)
show alleviate (ccomp)
discontinued checked (conj)
humidity % (amod)
decreased abecarnil (nsubj)
verapamil nor (cc)
chow on (case)
less statistically (advmod)
induced sulpiride (nmod)
phenylpropanolamine ( (punct)
channel k(+ (compound)
elevated 1.8-fold (dep)
40.0 2.88 (conj)
was goal (nsubj)
treatments drug (compound)
disorder ocd (appos)
trials the (det)
linked been (auxpass)
program this (det)
patient anephric (amod)
duration increasing (amod)
deferoxamine of (case)
is describe (xcomp)
saline compared (case)
differences individual (amod)
orr ) (punct)
tested les (nmod)
antagonized moreover (advmod)
constructed : (punct)
severe episode (nsubj)
time month (appos)
with intent (pobj)
show observations (nsubj)
12alpha-hydroxylase of (case)
administration in (amod)
cords 15 (nummod)
patient src (nmod)
had most (nsubj)
need monitoring (nmod)
fsgs ( (punct)
clearance faster (amod)
injected intervals (nmod)
potential membrane (compound)
step time (nmod)
ability the (det)
imply this (nsubj)
likely rats (nsubj)
induction tumours (nmod)
times emergence (compound)
challenge single-blind (amod)
discharged , (punct)
deliver rate (dobj)
november by (case)
appropriate . (punct)
obtained results (nsubjpass)
levels tnfalpha (nmod)
necrosis ) (punct)
phase active (amod)
experience sexual (compound)
induction decrease (conj)
agonists da (compound)
investigated test (nsubjpass)
damage lobe (dobj)
1.05 0.74 (dep)
myopathy defined (acl)
chemotherapy before (case)
pre-treatment after (case)
responses strips (nmod)
lesions of (case)
exclusion for (case)
received rw (nmod)
route dermal (amod)
induced hydroxyanisole (nmod)
delay average (amod)
blocking in (mark)
decrease of (case)
diffuse or (cc)
days receiving (advcl)
accelerate intake (nsubj)
done rast (nsubjpass)
duration to (case)
less ppm (conj)
pain site (nmod)
day infarction (nmod)
pattern histologic (amod)
facilitation and (cc)
supply nerve (compound)
alprazolam of (case)
lesion substantia (compound)
patients male (amod)
underwent . (punct)
0.56 1.55 (appos)
effects increased (amod)
returned she (nsubj)
goes unrecognized (acomp)
rats isoproterenol-induced (amod)
rats control (amod)
gold by (case)
20 less (amod)
found tested (advcl)
ranged dose (nsubj)
enantiomer synthesized (amod)
improved procedure (nsubj)
spasticity related (amod)
had group (nmod)
750 1000 (conj)
prescribed telithromycin (dobj)
demonstrates time (nmod)
dose supratherapeutic (amod)
release or (cc)
counted vacuoles (dobj)
seems stimulation (nsubj)
group raloxifene (compound)
replacing part (dobj)
level minutes (nmod)
complex qrs (compound)
model juvenile (amod)
metabolized be (auxpass)
iopentol after (case)
increase bilirubin (nmod)
hepatotoxicity amiodarone (nmod)
= 7.6 (parataxis)
dose challenge (amod)
treatments reserpine (compound)
effect activity (nmod)
investigated val/hctz (nsubjpass)
boy played (acl:relcl)
identify results (nsubj)
reproducible . (punct)
cases for (case)
experiment second (amod)
mites demodex (compound)
hydrochloride 3-[1'-admantyl]-1-aminomethyl-3,4-dihydro-5,6-dihydroxy-1h-2-benzo (compound)
reduced group (advcl)
pleural and (cc)
% -9.6 (nummod)
contribute abnormalities (nsubj)
1.01 ( (punct)
polysomnography experimental (amod)
used sealants (nsubjpass)
reduced furthermore (advmod)
dehydration infection (conj)
nine only (advmod)
response agents (nmod)
low years (nmod)
clonidine 's (case)
re rb1 (conj)
greater < (parataxis)
children epilepsy (nmod)
blocked fully (advmod)
$ROOT$ beats/min (sent)
agc a (det)
showed accounted (ccomp)
therapy methadone (compound)
week 8 (nummod)
modify effective (parataxis)
consuming not (neg)
days first (amod)
recovered four (nsubj)
taking nicergoline (dobj)
lines bs (compound)
stopped , (punct)
investigated compared (conj)
was 1 (nsubj)
rtms low-frequency (amod)
associated always (advmod)
movements left (amod)
guidelines national (amod)
due coagulopathy (nmod)
use amiodarone (nmod)
exhibited region (nmod)
neutropenia acid-induced (amod)
infusion hexamethonium (nmod)
pain low (amod)
effects severe (amod)
less no (neg)
marrow of (case)
risk relative (amod)
days 4 (nmod)
medline abstracts (appos)
enzyme pseudocholinesterase (compound)
using anesthetic (nmod)
demonstrated compared (prep)
complication possible (amod)
reported toxin (nsubjpass)
events unclassified (amod)
mg./kg 200 (nummod)
relevance concerning (case)
snp ( (punct)
test effects (dobj)
determined had (ccomp)
duration contraction (compound)
accounted values (nsubjpass)
reported pain (nmod)
reported 1995 (nmod)
profile either (preconj)
14.1 2.3 (compound)
reduced map (nsubjpass)
correlated damage (nmod)
dependent was (cop)
received subsequently (advmod)
detect infarction (dobj)
simvastatin lovastatin (conj)
related = (dep)
longer year (nmod)
boy treated (acl)
% but (cc)
verifying after (mark)
consistent biopsy (nsubj)
associated output (nmod)
abnormalities heart (compound)
technique valuable (amod)
associated usage (nsubjpass)
conversion cyclosporine (nmod)
actions pentobarbital (nmod)
found myocytes (nmod)
detected spect (nmod)
dicyclomine kg-1 (appos)
development ns (nmod)
dyskinesia on (case)
injections given (acl:relcl)
transplantations for (case)
binder their (nmod:poss)
urge and (cc)
decrease dramatic (amod)
case patient (nmod)
associated phenylpropanolamine (nmod)
midazolam patients (appos)
cytotoxicity additive (amod)
that % (appos)
led whom (nmod)
indices pbto(2 (compound)
systems gpi (nmod)
coxon by (case)
cause disorder (nmod)
minute was (cop)
toxicity combination (nmod)
idraparinux , (punct)
produced hypoventilation (nmod)
anaesthesia involving (acl)
frequency thromboembolism (nmod)
virus hcv (appos)
ncse ) (punct)
using absorptiometry (dobj)
finding hypertension (nsubj)
blocker new (amod)
injections min (nmod:npmod)
status growth (compound)
solution g/kg (appos)
confirmed women (nmod)
measuring density (dobj)
time thrombin (compound)
methylphenidate of (case)
chow or (cc)
commencing after (mark)
macrophages numerous (amod)
5-azc given (acl)
hbeag-positive on (case)
dialysate with (case)
impair action (dobj)
parts scale (compound)
parameters individual (amod)
lidocaine to (case)
therapy tricyclic (amod)
amount between (case)
stimulate given (advcl)
analysis macroscopic (amod)
complication system (nsubj)
dysgenesis . (punct)
analysis including (case)
muscle animal (nmod:poss)
domain phonological (amod)
determined staining (nmod)
treatment l-arginine (compound)
toxicity ops (nmod)
exceeded count (nsubj)
hydrochloride calcium (conj)
process learning (compound)
ratio responsible (acl:relcl)
therapy no (det)
treated range (dep)
implants acetonide (compound)
influence the (det)
tested inhibited (ccomp)
boy 15-year-old (amod)
drug is (compound)
injections given (case)
less highest (advcl)
information recorded (acl)
ought tendency (nsubj)
used week (nmod)
0.80 2.89 (dep)
effects blocker (nmod)
injected bilaterally (advmod)
period 1993 (nummod)
induces morphine (nsubj)
males ; (punct)
albuminuria concentration (conj)
= aor (nsubj)
mg.kg-1 ug.kg-1 (appos)
syndrome calcineurin-inhibitor (compound)
subtype the (det)
ng 50 (nummod)
hit antibody-negative (dobj)
increase mg (nmod)
extent vacuolization (nmod)
one mechanisms (nmod)
a > (compound)
amphetamine to (case)
studies comparing (acl)
units to (case)
remained depletions (nsubj)
haematological : (punct)
produces necrosis (dobj)
occurred occurred (conj)
pill proprietary (amod)
patients appropriate (amod)
atp substrate (amod)
haloperidol central (amod)
implicated may (aux)
alterations nor (cc)
patients 1,453 (nummod)
parasites and (cc)
$ROOT$ proteinuric (sent)
metabolic k (dep)
cancer to (case)
aspartate potassium (compound)
initiation metformin (nmod)
supporting need (dobj)
bupivacaine- or (cc)
acetylcholine vip (conj)
caused resorption (nmod)
alteration the (det)
improves carteolol (nsubj)
$ROOT$ spv (sent)
frequency dr5 (compound)
predated dysfunction (dobj)
disease related (amod)
$ROOT$ alleviated (sent)
caused to (mark)
wky not (neg)
powders the (det)
paralysis following (case)
epilepticus acid-induced (amod)
midazolam with (case)
biomarker a (det)
< .006 (dep)
july 11 (nummod)
night during (case)
toxicity amiodarone (nmod)
pathogenesis thrombi (nmod)
patients positive (amod)
effects pg-9 (nmod)
anemia azidothymidine-induced (amod)
revealed ratio (dobj)
locations their (nmod:poss)
restored ltp (dobj)
patients syndromes (nmod)
type factor-beta1 (conj)
gr 55562 (nummod)
gliclazide to (case)
electromyography muscle (appos)
induce fever (dobj)
benzodiazepines the (det)
61.9 5.0 (conj)
undescribed heretofore (advmod)
anxioselective anticonvulsant (conj)
ambulate and (cc)
characteristics patients (nmod:poss)
equal , (punct)
potentiation rat (nmod)
rarest of (case)
protein fibrillary (amod)
disease prognosis (conj)
intraoperative and (cc)
themselves by (case)
reduced 1/10 (nmod)
volunteers across (case)
ph acid (amod)
trauma to (case)
changes distinct (amod)
reduction clear (amod)
phenylephrine not (cc)
population control (amod)
$ROOT$ pg/ml (sent)
influence myocardiopathy (nmod)
suggested mapping (nsubj)
retard to (mark)
effects fluoroquinolones (nmod)
gastrointestinal musculoskeletal (conj)
process lipid (compound)
swelling tenderness (conj)
corresponding level (nmod)
hydrochloride dosulepine (compound)
score corresponding (acl)
narrowing with (case)
response passive (amod)
reduce anxiety (dobj)
emphasizes report (nsubj)
speculate relation (nmod)
techniques recording (compound)
subjected threshold (nsubjpass)
blockers h-2 (compound)
bioavailability , (punct)
substitute currently (advmod)
similar doses (nsubj)
effects both (cc:preconj)
cortex posterior (amod)
hyperkinesias choreatiform (amod)
seizures on (case)
days with (case)
thrombo-embolism venous (amod)
paralysis contralateral (amod)
$ROOT$ preserved (sent)
agents antinociceptive (amod)
abnormalities with (case)
mg daily (amod)
cd-832 diltiazem (conj)
cardiomyopathy failure (conj)
grade 1 (nummod)
cholesterol concentration (conj)
arabic ) (punct)
release controlled (amod)
administration single (amod)
antipsychotics clozapine (nmod)
. mg/kg (compound)
seen pd (nmod)
gm 80mg/kg/day (dep)
alternation and (cc)
myocarditis eosinophilic (amod)
segments n=12 (dep)
history cardiac (amod)
found ratios (nsubjpass)
examination state (compound)
cromakalim , (punct)
mg/kg 160 (nummod)
antioxidant kappa-beta (nmod)
patient underwent (acl:relcl)
history nor (cc)
use aspirin (compound)
male 84-year-old (amod)
surgery cardiac (amod)
explain may (aux)
associated compliance (nmod)
ventricles of (case)
apigenin of (case)
have impact (dobj)
platform from (case)
fibers quadrants (nmod)
movements protrusions (conj)
caused respectively (advmod)
involvement possible (amod)
reactions % (dep)
pseudo-allergy of (case)
syndrome known (acl)
slices of (case)
induced ifosfamide (nmod)
raters three (nummod)
echocardiography biopsy (conj)
concentrations normal (amod)
reversed co-administration (nsubj)
recorded differences (nsubjpass)
augmentation an (det)
outcomes on (case)
pharmacy the (det)
induced hypertension (dobj)
investigate activity (dobj)
arteries fraction (nmod)
tissue soft (amod)
risk ototoxicity (nmod)
reversed effects (nsubjpass)
antigen-positive lamivudine-resistant (amod)
intake nutritional (amod)
affected could (aux)
situations is (acl:relcl)
ended pregnancy (nsubj)
diagnosis dsm-iv (dep)
reduces suppresses (conj)
fall fraction (nmod)
haloperidol hal (appos)
ratings 3-methoxy-4-hydroxyphenethyleneglycol (nmod)
result . (punct)
negative negative (parataxis)
efficacy reduction (nmod)
circulation ocular (amod)
ameliorated first (advmod)
patients forty-two (nummod)
accomplished unresponsive (advcl)
ana and (cc)
predictors specific (amod)
elevations levels (nmod)
[verapamil]o arrested (acl:relcl)
31 ( (punct)
tac ) (punct)
disorder required (acl:relcl)
core territory (nmod)
saw we (nsubj)
chemotherapy ifosfamide (compound)
facilitates rats (nmod)
encoding factor (dobj)
maleate maleate (appos)
aware potential (nmod)
hydration aggressive (amod)
phenotype from (case)
effect rat (nmod)
agent antiarrhythmic (amod)
94.3 to (advmod)
mg/m(2 ( (punct)
hydroxyl functional (amod)
erdosteine has (acl:relcl)
increases enhancement (nmod)
pkc-alpha of (case)
had them (dobj)
static dynamic (conj)
confusion paranoia (conj)
exchanges for (case)
dependent estradiol (nmod)
= 2032 (dobj)
forms liver (nmod)
same . (punct)
concentration transcripts (conj)
markers markers (conj)
adenoma and (cc)
induce mice (nmod)
effect concerning (case)
as significant (amod)
ly274614 antagonist (appos)
mouth due (case)
group 15/htn (compound)
exposure cases (nmod)
change 25 (nummod)
snr into (case)
use products (nmod)
cells lesional (amod)
nitrate with (case)
most improvement (nmod)
thromboembolism arterial (amod)
% factor (conj)
inhibition enzyme (compound)
administration end (nmod)
toxicities 3/4 (nummod)
react compensate (conj)
number sites (nmod)
reductions scale (compound)
tumors well-differentiated (amod)
peptide(1 beta (compound)
days 523.5 (nummod)
development model (nmod)
nitroglycerin with (case)
lid than (case)
investigate induce (ccomp)
fashion inhibitory (amod)
workers of (case)
sucrose followed (acl)
demonstrated research (nsubj)
helpful predicting (advcl)
dsm-iii-r. in (case)
well-tolerated appeared (conj)
processes enlarged (amod)
incorporation such (dep)
incidence media (nmod)
less amitriptyline (nmod)
required hours (nmod)
subjected surgery (nmod)
due pathogenesis (nsubj)
course this (det)
received death (nmod)
antagonist that (mark)
tests neuropsychological (amod)
low number (nsubj)
lag in (case)
behaviors , (punct)
company manufactures (acl:relcl)
classified injury (nmod)
demonstrated alterations (nsubjpass)
man 59-year-old (amod)
[(3)h]saxitoxin stx (appos)
observe to (mark)
effects by (case)
dopaminomimetics methoxamine (conj)
shr , (punct)
pituitaries norway (compound)
sensitive dystrophin (nsubj)
control months (nmod)
ppm 250 (compound)
function toxicity (nsubj)
restricted indications (nmod)
% 5.2 (nummod)
dysfunction future (amod)
exhaustion pool (nmod)
r2 ) (punct)
hazard treatment (nmod)
dissociated can (aux)
investigations electron (compound)
mg/kg to (case)
interrupted prolongation (nmod)
study dsmm (compound)
c at (case)
scopolamine dicyclomine (conj)
% 13.7 (nummod)
hours 98 (nummod)
expectation the (det)
sectioning cord (nmod)
weeks range (nummod)
stimulation stn (nmod)
induced hepatitis (nsubjpass)
issues these (det)
h 69 (nummod)
true , (punct)
mechanisms hyperactivity (nmod)
doxorubicin m-2 (compound)
toxicity quinine (compound)
using approximation (nmod)
reports as (cc)
transmission increased (amod)
carcinoma metastic (amod)
5-ht central (amod)
compared period (nmod)
conjugates ed1-ed4 (appos)
having 17 (nsubj)
induced haloperidol (nsubj)
movements such (case)
review this (det)
was induced (ccomp)
condition control (amod)
performed curve (nsubjpass)
antigen-positive , (punct)
increased percentage (nsubj)
control seizures (nmod)
received succinylcholine (dobj)
interval 11.9 (appos)
reduced deletion (nsubj)
usually . (punct)
clonidine clonidine (conj)
malformations interventions (conj)
seizures or (cc)
history rosacea (nmod)
relapse ptld (nmod)
damage inflammatory (amod)
found parameter (nmod)
severe were (cop)
patients early-conversion (amod)
puberty stature (conj)
disorder depression (conj)
d-pen by (case)
micrograms/d 400 (nummod)
determine due (advcl)
agents pretreatment (amod)
stabilized oct (nsubj)
gvhd ( (punct)
treatment testosterone (nmod)
syndrome proteinuria (conj)
have will (aux)
level pb (compound)
showed results (nsubj)
homogenates liver (compound)
den by (case)
tensions tensions (conj)
memory long-term (amod)
unresolved mechanism (nsubj)
test because (case)
noted improvement (nsubjpass)
function transporter (compound)
toxicology aspirin (nmod)
cardioversion and (cc)
factors no (neg)
sulfate intravenous (amod)
treated combination (nmod)
elicited days (nmod)
developed discontinued (conj)
effective values (dep)
high-dose 28.4 (appos)
fluid cerebrospinal (amod)
indicated sparing (advcl)
head exencephalic (amod)
2.04 0.98 (compound)
action undescribed (amod)
sr bupropion (compound)
increase foci (nmod)
dynamics on (case)
areas focal (amod)
gene of (case)
larger 3 (nmod:npmod)
initiated decreased (advcl)
anticoagulants with (case)
efficacy asenapine (nmod)
rhgh unlike (case)
visits study (compound)
dianabol ciba (appos)
made draw (xcomp)
0.27 0.07 (conj)
participated children (nsubj)
used models (nmod)
seizures induce (acl)
minimum courses (nmod)
26.3+/-3.6 vs (cc)
cohort study (compound)
$ROOT$ searched (sent)
n/n=25/26 ci (appos)
bcc ( (punct)
quantified was (auxpass)
strategy : (punct)
nodules carcinomas (conj)
-23.7 +/- (cc)
observed kg(-1 (dep)
activities decreased (amod)
poor is (cop)
c57bl/6 black (amod)
prescription crocin (nmod)
free not (neg)
pattern muscular (amod)
suggests review (nsubj)
14 in (case)
effects emulsions (nmod)
affected outcome (dobj)
effect potential (amod)
$ROOT$ hospitalised (sent)
fetus developing (amod)
withdrawal drug (compound)
doses clarithromycin (nmod)
mediated arteriosclerosis (nsubjpass)
attended also (advmod)
stress tam-induced (amod)
degree necrosis (nmod)
recovered had (aux)
thickening stomach (compound)
lids with (case)
pseudoprolactinoma hyperprolactinemia (conj)
$ROOT$ measurements (sent)
inconsistent this (nsubj)
received treatments (dobj)
minimised be (auxpass)
densities alpha (compound)
cells aortic (amod)
data lines (nmod)
tropicamide guttae (compound)
presenting reaction (nmod)
study 84 (nummod)
threshold group (nmod)
contained whilst (mark)
endarterectomy anesthesia (nmod)
agonists with (case)
components bche (compound)
diagnosed abnormal (conj)
volume desire (nmod)
fragments the (det)
reduced behaviors (nsubjpass)
mg/kg dhea (compound)
trazodone 's (case)
argatroban cdt (conj)
system daergic (amod)
image t2-weighted (amod)
anticipation inappropriate (amod)
shown were (auxpass)
mg p=0.001 (dep)
3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one allopregnanolone (compound)
treated etoposide (nmod)
shortening percentage (compound)
prinzmetal 's (case)
30 toxicity (nmod)
keeping of (case)
decline significant (amod)
described characterization (nsubjpass)
reduction relative (amod)
mainstay fluoropyrimidines (nsubj)
factors as (case)
total hospital-years (nmod)
necessary will (aux)
rats nephrosis (nmod)
treated amiodarone (nmod)
ears ) (punct)
role agents (nmod)
change ecg (nsubj)
identify reliably (advmod)
cases cad (nmod)
potentiated whereas (mark)
activation mechanism (nmod)
deep or (cc)
vindesine to (case)
protection neurons (nmod)
rt ( (punct)
ethambutol . (punct)
intensity electrical (amod)
15 between (case)
$ROOT$ provide (sent)
necrosis extensive (amod)
them among (case)
recorded had (conj)
42,671 and (cc)
circulation on (case)
25mg/kg mg/kg (conj)
endophthalmitis alpha-haemolytic (amod)
hemolysis erythrocytes (nmod)
subtherapeutic normoammonaemic (conj)
plasma cells (conj)
e and (cc)
measured holding (advcl)
research basic (amod)
most which (nmod)
8/27 ) (punct)
seem do (aux)
return and (cc)
valdecoxib for (case)
higher those (advcl)
levels cortisol (compound)
stripe medulla (conj)
injected heparin (nsubjpass)
prescribe levels (nmod)
behavioral biochemical (conj)
alert patients (nmod)
benefit treatment (nmod)
aware order (nmod)
il-1beta cxcl1 (conj)
hemodynamic and (cc)
hypercalcemia rash (conj)
drug antidyskinetic (amod)
consider prescribed (advcl)
induce torsade (dobj)
strain " (punct)
e13.5 at (case)
hyperkalemia patients (nmod)
amelioration nephrotoxicity (nmod)
ameliorated can (aux)
32.4 2.6 (compound)
contraceptives and (cc)
produced attempts (nsubj)
given birth (nmod)
spectrum whole (amod)
support strong (amod)
develop neoplasms (nsubj)
prophylaxis for (case)
subjects between (case)
related nephropathy (nmod)
proteases caspase-3 (dep)
hypothesis study (compound)
deaths rupture (conj)
micromol/liter 233+/-34 (nummod)
was response (nmod)
propionate ] (punct)
duration because (case)
anticonvulsant an (det)
seems ; (punct)
(gm)-mediated gentamicin (nmod:npmod)
contractions tonic (amod)
potential rats (nmod)
= 0.004 (dobj)
cerebella the (det)
a.m. a.m. (conj)
increase change (dep)
increase those (nsubj)
hypotension group (appos)
increases threshold (nmod)
components respiratory (amod)
salt-sensitivity to (case)
showed p<0.001 (parataxis)
change plasma (compound)
$ROOT$ gender-dependent (sent)
doses artery (nmod)
infrequent experiencing (advcl)
patients society (compound)
performance test (nmod)
pre-treatment 2h (nmod:tmod)
study single-blinded (amod)
$ROOT$ killed (sent)
mg bid (amod)
nh4ac blocker (conj)
spasm to (case)
causes leading (advcl)
donors antigen (compound)
patients impairment (nmod)
evidence , (punct)
tensions twitch (compound)
efficacy cost-effectiveness (conj)
people fibrillation (nmod)
heptylate or (cc)
cardiotoxicity trial (nmod)
induce used (conj)
pcc u/kg (appos)
deficiency limb (compound)
rhizomes roots (conj)
$ROOT$ woman (sent)
assessed concentrations (nmod)
effects deprivation (nmod)
ph , (punct)
using formula (dobj)
associated could (aux)
myelosis associated (acl)
lesioned nigra (nmod:npmod)
history neuropathy (nmod)
cisplatinum day (nmod)
svrs ( (punct)
course chemotherapy (nmod)
demonstrate occurs (ccomp)
120 60 (compound)
differentiating to (mark)
tma of (case)
ms , (punct)
complexes oxidative (amod)
summarizes article (nsubj)
pharmacology paranoia (nmod)
assigned titrated (parataxis)
higher cows (advcl)
terodiline nm (appos)
peld lt (nmod)
pressure bp (appos)
serve warn (xcomp)
restarted therapy (nsubjpass)
k serum (compound)
immunopathology disease (nmod)
effects toxicity (conj)
visits all (det)
2.0 4.9 (appos)
leukoencephalopathy presentation (nmod)
provoked reduction (dep)
discontinuations , (punct)
imaging computed (amod)
overflow the (det)
pathways other (amod)
ketamine the (det)
excretion hours (nmod)
doxorubicin dexrazoxane (conj)
characteristics behavioral (amod)
compared littermates (nmod)
distinguished were (auxpass)
greater sensitivity (nsubj)
impair disturbance (nsubj)
cristae of (case)
doxorubicin (adriamycin)-loaded (dep)
channel + (compound)
practiced must (aux)
pc/bcp ( (punct)
scales rating (compound)
characteristic activation (nmod)
tremor effect (acl:relcl)
female healthy (amod)
impairments users (nmod)
effects aminophylline (nmod)
patients 4 (nummod)
case hypercalcaemia (nmod)
strains -negative (amod)
transfer as (case)
development advanced (amod)
chemotherapy effective (amod)
developed , (punct)
difficulty diagnostic (amod)
observed myalgia/arthralgia (nsubjpass)
site injection (nmod)
pgp ( (punct)
therapy leading (acl)
cells fibres (conj)
setting adjuvant (amod)
failed affect (xcomp)
anaesthetic a (det)
means the (det)
nodules the (det)
derangements failure (nmod)
incidence abnormalities (nmod)
necrosis cancer (conj)
patient intubated (amod)
loop pallidothalamocortical (amod)
30 25 (compound)
evaluated responses (nsubjpass)
tdr diminished (amod)
hb g/dl (nmod)
mg./kg 0.5 (nummod)
role epinephrine (nmod)
calculated ratios (nsubjpass)
caused , (punct)
important hypovolemia (nmod)
suggest make (ccomp)
haart ) (punct)
disturbances blood-brain (amod)
attenuation nephrotoxicity (nmod)
using field (dobj)
agents exert (acl:relcl)
$ROOT$ believed (sent)
cases 80 (nummod)
harvested extracts (nsubjpass)
had beams (dobj)
damage cervical (amod)
pnd71 on (case)
drug . (punct)
lignocaine % (amod)
prevent not (neg)
use cocaine (compound)
paralysis abductor (amod)
doses levobupivacaine (nmod)
time at (mark)
element a (det)
accelerating in (mark)
exposure drug (compound)
inhibitor valdecoxib (dep)
diagnosed patient (nsubjpass)
knockout pparalpha-/- (dep)
effects virility (nmod)
duration or (cc)
described syntheses (nsubjpass)
users mdma (compound)
rnfl to (case)
subtherapeutic were (cop)
photostimulation focal (amod)
interventions . (punct)
due to (mwe)
department ophthalmologic (amod)
meningitis for (case)
requires administration (nsubj)
exhibits , (punct)
effects independent (amod)
administrated lasted (ccomp)
mrnas subunit (compound)
10.1 2.5 (conj)
gfr ml/min (appos)
life a (det)
conditions employed (acl)
monotherapies compared (case)
58.3 % (appos)
graft artery (compound)
azt 3tc (conj)
reported triad (nsubjpass)
occurred shedding (nsubj)
retard , (punct)
exhibited all (nsubj)
contact segment (nmod)
medication cessation (nmod)
irradiation after (case)
value to (case)
brought activity (nmod)
regarded reported (advcl)
difference thresholds (nmod)
groups clozapine- (amod)
number lots (nmod)
4.3 - (punct)
dysfunctions minor (amod)
failure : (punct)
included results (nsubj)
observed dysfunction (nsubjpass)
neurons nigrostriatal (amod)
release basal (amod)
use pca (nmod)
flashbacks related (acl)
cocaine- and (cc)
treated she (nsubjpass)
induced glucose (nsubj)
desorption/ionization ms (conj)
included reactions (nsubj)
collapsed patient (nsubj)
test objective (amod)
dimorphism causes (acl:relcl)
used to (mark)
amnesia of (case)
effects subacute (amod)
valproate clonazepam (conj)
minutes 20 (nummod)
characteristics . (punct)
tgf-beta1 ) (punct)
fraction higher (amod)
disturbance mild (amod)
significant ( (punct)
safe be (cop)
4 0 (compound)
diseases hepatitis (conj)
given doses (dobj)
have greater (conj)
require often (advmod)
disorders cognitive (amod)
heparin . (punct)
course to (case)
started rats (nmod)
gene patients (nmod)
surpasses effectiveness (nsubj)
potential antagonists (nmod)
. b.d (compound)
plays control (nmod)
follow-up biannual (amod)
pathophysiologic and (cc)
pressure variable (amod)
lethality in (case)
igg scanty (amod)
kidney insufficiency (conj)
2 1 (dep)
fire , (punct)
increase dose (nsubj)
identified decrease (nsubjpass)
levels metabolites (nmod)
series in (case)
data cerebellum (nmod)
microl ( (punct)
experienced confusion (dep)
members mapk (compound)
defined concentration (nsubjpass)
pc ( (punct)
represent failure (dobj)
patients diabetic (amod)
npy for (case)
utility be (cop)
% 67.5 (nummod)
seizure adolescent (nmod)
findings showing (acl)
n=18 ) (punct)
displacements with (case)
use overuse (conj)
symptoms mania (nmod)
receiving dexmedetomidine (dobj)
hyperparathyroidism long-standing (amod)
test ( (punct)
pain humans (nmod)
promoted regulation (nmod)
reactions rare (amod)
aimed avoiding (advcl)
biopsy the (det)
damage cells (nmod)
regulate proliferation (dobj)
inhibition protease (compound)
hepatitis aggressive (amod)
amnesia diazepam- (compound)
channels pentameric (amod)
screening b (nmod)
hyperkalemia insufficiency (conj)
nausea theophylline (nmod)
groups respective (amod)
includes discussion (nsubj)
using episodes (nmod)
epileptogenic show (conj)
inducing concentrations (nmod)
repair prior (amod)
acid epsilon-aminocaproic (amod)
5.4 4.2 (conj)
thp ) (punct)
propensity episodes (nmod)
reduced crocin (nsubj)
phase initial (amod)
flexion passive (amod)
completed 684 (dep)
analyzed samples (nsubjpass)
rats d-pen-treated (amod)
considered adjuvant (nmod)
inducing striatum (nmod)
ultrasound liver (nmod)
15 than (quantmod)
antigenemia of (case)
suffers . (punct)
arrhythmia for (case)
dsp4 with (case)
histories with (case)
granulated were (auxpass)
increase locomotion (nmod)
report spontaneous (amod)
stereology unbiased (amod)
antagonist prostanoid (compound)
faster propranolol (nmod)
reversible . (punct)
paper millimetric (amod)
excluded although (mark)
css10 and (cc)
evoked administration (nmod)
sodium i.v. (amod)
cycles nine (nummod)
characterization and (cc)
year one (nummod)
expression neurochemical (amod)
blocked associated (ccomp)
excretion of (case)
emulsion compared (case)
assessed quality (nmod)
bleeding intracranial (amod)
naloxazone with (case)
protects treatment (nsubj)
% 9.0 (nummod)
inconsistent have (aux)
duration s (compound)
model a (det)
tingling mouth (nmod)
have diatheses (dobj)
trials biggest (amod)
minutes injection (dep)
frequency brainstem (compound)
lipoproteins urinary (amod)
paralysis intraoperative (amod)
increases proportion (conj)
controlled had (conj)
succeeded which (nmod)
laboratories school (appos)
presentation clinical (amod)
bolus as (case)
coordination relationship (conj)
length dose (conj)
drug antiparkinsonian (amod)
h + (nummod)
complications leukemia (nmod)
% 36.6 (nummod)
formation mice (nmod)
stones ureteric (amod)
effects dynamics (nmod)
activation disruption (nmod)
cancer ct (nmod)
lower 0.05 (parataxis)
auc of (case)
comparison dcf (nmod)
toxicity cocaine (compound)
test as (case)
resulted doses (nsubj)
list growing (amod)
interfere not (neg)
revert reliably (advmod)
agent doses (nmod)
instillation cent (nmod)
changes no (neg)
surface number (dep)
hemoglobin g/dl (compound)
14/104 ( (punct)
pretreated microinjections (nmod)
diligent must (aux)
models leukoencephalopathy (nmod)
injury aki (appos)
effects measures (nmod)
contributes represent (ccomp)
1986 in (case)
ameliorates conclusion (nsubj)
response pharmacological (amod)
result have (conj)
reviewed are (auxpass)
14.9 2.4 (conj)
rat catheterized (amod)
indicative phagocytosis (nmod)
mg/dl 4.36 (nummod)
examinations ultrasound (compound)
experience an (det)
correlates toxicity (nsubj)
subjects borderline (amod)
survival free (amod)
stl1 ) (punct)
females years (appos)
study i (nummod)
variants common (amod)
increment g (amod)
case multiforme (nmod)
determined loss (nmod)
regimen immunosuppressive (amod)
regulation blood (compound)
vision the (det)
aspirin mg/kg (appos)
discovery epidemics (conj)
alternative regimens (nmod)
33342- and (cc)
reveals complexity (dobj)
reactions associated (amod)
tapering infusion (nmod)
bche . (compound)
toxicology cocaine (nmod)
cirrhosis , (punct)
group overload (compound)
technique screening (compound)
proteinuria a (det)
blanching mydriasis (conj)
levels at (case)
applied were (auxpass)
increased aggressiveness (dobj)
responded arrhythmias (nsubj)
hemorrhaging ectoderm (nmod)
58.5 9.8 (conj)
predilection its (nmod:poss)
administration abortion (nmod)
dilation in (case)
associated improvement (nmod)
month delivery (nmod)
disorder a (det)
effective becomes (advcl)
rate vte (nmod)
prognosis good (amod)
agency by (case)
partially is (cop)
1.52 , (punct)
100mg/kg by (case)
treatment pentamidine (nmod)
analgesic acute (amod)
dosage despite (case)
effect unusual (amod)
points efficacy (compound)
deficiency pyridoxine (compound)
tumors ta-t1 (compound)
doses months (dep)
day after (advmod)
middle low (conj)
sera with (case)
ecg with (case)
containing tamca (dobj)
stable was (cop)
months 43 (nummod)
reversed effect (nsubjpass)
esrd failure (conj)
consider should (aux)
session training (compound)
substrate as (case)
cascade toxic (amod)
risk = (parataxis)
inhibited pretreatment (nmod)
recognized are (auxpass)
inhibit resorption (dobj)
normal day (nmod)
increase fivefold (amod)
backgrounds of (case)
neurophysiology underlying (amod)
signaling receptor (compound)
1080 ) (punct)
treated % (nmod)
mv/s from (case)
shown tac (nsubjpass)
flumazenil with (case)
$ROOT$ weeks (sent)
agc with (case)
substantial is (cop)
lethality acute (amod)
had thrombosis (dobj)
1.6 37 (prep)
developed episodes (nsubj)
exert can (aux)
6 to (dep)
psa in (case)
demonstrates aggravate (ccomp)
skills function (conj)
metaiodobenzylguanidine mibg (appos)
days i.e. (advmod)
globulin lamivudine (conj)
lower whereas (mark)
explained basis (nmod)
rash therapy (conj)
clearance as (case)
latency seizure (nmod)
activity arrhythmias (nmod)
pah ( (punct)
confirm used (ccomp)
used map (advcl)
reassured patients (nsubjpass)
activities any (det)
nimesulide n (appos)
contribute whether (mark)
rate nor (cc)
foci several (amod)
relationship peroxidation (nmod)
drug as (mark)
mirrored changes (dobj)
management pain (compound)
conducting for (mark)
linked significantly (advmod)
therapy steroids (conj)
bipolar ii (nummod)
marker was (cop)
trial paclitaxel (nmod)
sustained patients (nmod)
resolving gradually (advmod)
escape , (punct)
syndrome prolonged (amod)
values stage (conj)
blockers k(+)-channel (amod)
admitted were (auxpass)
verapamil diltiazem (conj)
occur doses (nmod)
different significantly (advmod)
arrhythmias canine (amod)
mmecs mice (conj)
potential cardiotoxicity (nmod)
paper of (case)
dates , (punct)
remained groups (nsubj)
substantial since (mark)
recovered remained (conj)
review studies (nmod)
doubled had (conj)
survivors injury (nmod)
min mg/kg/4 (nummod)
n/n=9/26 ) (punct)
celecoxib of (case)
received insulin (dobj)
dis . (punct)
rats angiotensinogen (nmod)
had subjects (nsubj)
dose birth (compound)
polyuria mice (nmod)
monitored moment (nmod)
c = (parataxis)
affected have (aux)
expression c (compound)
course findings (conj)
diet after (case)
monitoring daily (amod)
administered weekly (advmod)
group : (punct)
electroencephalographic behavioural (conj)
disappeared followed (conj)
doxorubicin before (case)
beta-agonists occasional (amod)
improved learning (dobj)
adr+los(6 ) (punct)
examinations for (case)
levels ssris (nmod)
bea by (case)
albuminuria massive (amod)
asystole to (case)
dwi image (conj)
min 30 (nummod)
accompanied bradycardia (nmod)
alive grafts (nmod)
diminished activities (nsubjpass)
touch light (amod)
higher risk (nmod)
myoclonus etomidate-induced (amod)
$ROOT$ worsening (sent)
increase mild (amod)
pathway liver (nmod)
history patient (compound)
developed vitro (advmod)
supports and (cc)
cause suppression (nsubj)
cases no (det)
woman iraq (nmod)
region hilar (amod)
coherence tissue (compound)
recognized factor (nmod)
implanting subcutaneously (advmod)
produced apomorphine (nmod)
investigated patients (nsubjpass)
history the (det)
= = (parataxis)
micrograms/kg 0.5 (nummod)
cardiotoxicity treatment (nmod)
patients liver (compound)
administered quantify (advcl)
cardiac on (case)
measured shifts (nmod)
dominating paracetamol (nsubj)
carcinoma treated (acl)
recovery count (nmod)
revealed elastolysis (dobj)
erythrophagocytosis infiltrates (conj)
influenced that (nsubjpass)
needed clarification (nmod)
maximum mg (nmod)
g-1 tissue (nmod)
ventricle for (case)
controls pseudoprolactinoma (conj)
2.8 users (nmod)
power the (det)
high therapies (nmod)
atrial and (cc)
increased actions (nsubjpass)
defect ventricular (amod)
subtypes other (amod)
causes consumed (advcl)
59 20 (compound)
b.i.d. then (advmod)
type cotransporter (conj)
females 12225 (nummod)
amnesia antagonist)-induced (amod)
calculus renal (amod)
responsible preparations (nsubj)
practice the (det)
cirazoline and (cc)
appeared responsible (xcomp)
conclude have (ccomp)
pain administration (nmod)
follow-up one-year (amod)
pre-induced doxorubicin (nmod)
recorded recorded (ccomp)
examination fundus (compound)
beats and (cc)
background deliver (appos)
cisplatinum and (cc)
restored inhibition (nsubjpass)
administration netilmicin (nmod)
available status (nsubj)
anesthetic substitute (acl:relcl)
status levels (conj)
confined subgroups (nmod)
prescribing thus (advmod)
difference p (dep)
location auditory (amod)
units elisa (compound)
tolerance and (cc)
effects neurotransmitters (nmod)
concentrations fetal (amod)
latency step (acl)
run waves (nmod)
5-httlpr for (case)
pains patients (nmod)
reducing decreased (advcl)
evaluated replies (nmod)
35 thrombosis (nmod)
consultations medical (amod)
hippocampus rats (nmod)
contributor mortality (nmod)
36 almost (advmod)
elevation and (cc)
suggesting existence (dobj)
regimen combined (amod)
neonates 2 (nsubj)
encephalopathy an (det)
defined cardiotoxicity (nsubjpass)
as safety (nmod)
anxiety induced (acl)
disability because (case)
stress cells (nmod)
male 20-year-old (amod)
emphasis particular (amod)
inhibitor 2 (nummod)
suggest impairs (ccomp)
increased associated (advcl)
cp under (case)
common 5th (amod)
tested fucoidan (dobj)
cisapride p (dep)
important it (nsubj)
reports asterixis (nmod)
size the (det)
reported toxicity (nsubjpass)
assessed rats (nmod)
factors possible (amod)
patients 204 (nummod)
ratios creatinine (compound)
institution a (det)
damage injury (conj)
33.1 ; (punct)
muscles posterior (amod)
return excretion (nmod)
terms similarity (nmod)
agonist ( (punct)
predictable development (nsubj)
seizure piperacillin/tazobactam-induced (compound)
tended they (nsubj)
min between (case)
forms epilepticus (nmod)
received attention (dobj)
induces octreotide (nsubj)
one hyperplasia (nmod)
discharges recorded (acl)
effects minor (amod)
evidence definitive (amod)
given concomitantly (advmod)
hexaaldose alcohols (conj)
intraperitoneal i.p. (dep)
reports prior (amod)
mssbp/msdbp in (case)
grommet a (det)
prevented animals (nmod)
vasculitis propylthiouracil (compound)
hypothermia reserpine (compound)
reflect to (mark)
weight on (case)
restoration output (nmod)
demonstrate affects (ccomp)
nephrotoxicity amikacin-associated (amod)
role into (case)
verbal performance (conj)
coronary small (amod)
consider likely (ccomp)
regimen anesthetic (compound)
report diagnosis (dobj)
similar administered (advcl)
british . (punct)
inhibited restoration (nsubjpass)
due expression (nsubj)
use to (mark)
designed and (cc)
micrograms/day 1500 (nummod)
produces whether (mark)
injected induce (advcl)
n-methyl-d-aspartate the (det)
dosage acute (amod)
frequency relations (nmod)
potent protecting (advcl)
ngal serum (dep)
vary assessed (conj)
comparison made (acl)
depleted and (cc)
incidence burning (nmod)
revealed likely (ccomp)
placed hr (nmod:npmod)
scores ihc (compound)
physician board-certified (amod)
cancer ( (punct)
6.7 +/- (cc)
research within-subject (amod)
took tab (dobj)
described ly274614 (nsubjpass)
prevented not (neg)
important level (nsubj)
77 +/- (cc)
activity generalized (amod)
registry , (punct)
vasodilatation through (case)
nephrotoxicity gm (compound)
help understanding (dobj)
developed plan (nsubjpass)
points end (compound)
0.65 ci (appos)
evaluation schedule (conj)
subtypes the (det)
drug previous (amod)
effects convulsant (amod)
runs recording (nmod)
patients insipidus (nmod)
increases these (det)
swim to (mark)
tested series (nsubjpass)
actives . (punct)
role ilk (nmod)
group administered (acl:relcl)
effect bradycardic (amod)
0.28 vs. (cc)
method generalized (amod)
conclusion documented (appos)
achieve = (parataxis)
reported rates (dobj)
alpha,3 with (case)
parturients status (nmod)
levels sfas (nmod)
subjects forty (nummod)
discontinuation pravastatin (compound)
compare administration (nmod)
saline oil (conj)
scores activities (nmod)
leg bilateral (amod)
discussed are (auxpass)
dose sixth (amod)
count ( (punct)
characterized period (nmod)
blood-brain-barrier cortex (nmod)
reversal due (amod)
mineralizes which (nmod)
conclude proven (ccomp)
reports among (case)
restricted was (cop)
given component (nmod)
available are (cop)
% 0.75 (nummod)
received procedure (dobj)
concentration receptor (compound)
restlessness of (case)
devoid while (mark)
lack owing (case)
circuitry frontostriatal (amod)
$ROOT$ restored (sent)
indicates this (nsubj)
pathways nerves (conj)
examined alternative (ccomp)
temperature of (case)
effect dehydrogenase (nmod)
deaths deaths (conj)
patients aged (acl)
cad diagnosis (nmod)
summarize to (mark)
give . (punct)
raised infants (nmod)
clonidine on (case)
induced malformations (nsubjpass)
use neonates (nmod)
mice cd-1 (compound)
situation similar (amod)
case required (acl:relcl)
pretreated : (punct)
excessive . (punct)
excessive mg/ml (dep)
sodium unfractionated (amod)
rechallenge a (det)
2 + (compound)
suggested diagnosis (nsubjpass)
lh-rh ) (punct)
improved used (advcl)
nifedipine , (punct)
as safe (amod)
cardiac or (cc)
% 63.30 (nummod)
influence blockers (nmod)
understanding mechanism (nmod)
suppresses 22-oxacalcitriol (nsubj)
well-tolerated effects (nmod)
needle fine (amod)
cases coma (nmod)
grade hunt (compound)
ended , (punct)
tachyarrhythmias for (case)
affect trial (dobj)
pentoxifylline either (cc:preconj)
found lower (xcomp)
tolerability etoricoxib (compound)
investigates role (dobj)
use respectively (advmod)
hemorrhage headache (conj)
kpa 10.7 (nummod)
received drugs (dobj)
exercise stress (conj)
found dose (nmod)
produces movements (dobj)
effects proinflammatory (amod)
mechanisms toxicity (nmod)
hyperhidrosis compensatory (amod)
administration rhigf-i (compound)
antagonizes increase (dobj)
complete near (advmod)
movement detected (acl)
received atropine (dobj)
electrocardiograms and (cc)
sensitive pressure (nsubj)
mm lna+hca (appos)
vaccination fourth (amod)
indicated ; (punct)
involved reaction (nmod)
suppressed metformin (nsubj)
carbetocin of (case)
possessed exhibited (dep)
sagittal transverse (conj)
cells ' (case)
occurs cin (nsubj)
cycles ifosfamide (nmod)
acrolein its (nmod:poss)
grading higher (amod)
affect smoking (nsubj)
rendered . (punct)
tuberculosis xdr-tb (appos)
toxicity d3 (compound)
facility care (nmod)
$ROOT$ indistinguishable (sent)
bronchodilator is (cop)
ml gentamicin (nmod)
mg/kg/day 2.35 (nummod)
ultrasound by (case)
tobramycin mg/kg/day (appos)
nsaids placebo (conj)
unchanged contrast (nmod)
% 19.8 (nummod)
4107 +/- (cc)
experiments control (amod)
nanoparticles acid (compound)
dermatitis associated (acl)
function transmission (nmod)
reported subjects (nsubj)
level no (det)
became thrombocytopenia (nsubj)
$ROOT$ people (sent)
maze ( (punct)
doses microl (nmod)
frequent increased (conj)
inhibited catalepsy (dobj)
91.5 , (punct)
nmda of (case)
platform and (cc)
changes about (case)
micrograms/kg/hr and (cc)
discovered staff (nsubj)
map and (cc)
treated presence (nmod)
0.26 ( (punct)
method to (mark)
defined are (auxpass)
observed = (parataxis)
function taste (compound)
carotenoids of (case)
1.3 - (punct)
observed evident (conj)
serious life-threatening (conj)
measure the (det)
palkovits ' (case)
seems suggesting (xcomp)
hypotension helodermin-induced (amod)
micrograms/kg 650 (compound)
(2.2)% , (punct)
prevent cure (conj)
same age (nsubj)
blocker angiotensin (compound)
address hypotheses (dobj)
mpt ( (punct)
% 76.2 (nummod)
dermatomes leg (nmod)
elevations successive (amod)
words at (case)
adriamycinol and (cc)
regions different (amod)
myelosuppression ) (punct)
beta-ccm ( (punct)
occurred iv (dobj)
involving adenosine (dobj)
effects two (nmod)
entered study (nmod)
inhibitor cyclooxygenase (compound)
h to (case)
pressure were (cop)
products the (dep)
apl ( (punct)
impairing thus (advmod)
received cycle (dobj)
time latency (conj)
exhibiting subjects (nsubj)
history clear (amod)
doses escalating (amod)
irreversible obtained (conj)
technique a (det)
nk1 nk2 (conj)
properties novel (amod)
gonadotropin chorionic (amod)
contribute seizures (nmod)
perfusion coronary (amod)
$ROOT$ 1.68 (sent)
temsirolimus , (punct)
procedure anesthetic (amod)
doses daily (advmod)
episode the (det)
sensitive unusually (advmod)
efficacy trinitrate (nmod)
$ROOT$ seems (sent)
entries of (case)
due thiosulphate (nmod)
pressure and/or (cc)
p=0.44 ( (punct)
gains those (nmod)
rare is (cop)
remains , (punct)
aorta and (cc)
mice nr1(neo-/- (amod)
responses % (appos)
leads states (nmod)
collection transplant (nmod)
organelle being (cop)
suffered two (nsubj)
confusion disorientation (conj)
demonstrated levels (dobj)
acid all-trans (amod)
consistent effect (nsubj)
parallels users (nmod)
regimens , (punct)
documented dementia (nsubjpass)
risk study (nmod)
protocol utilizing (acl)
doses massive (amod)
made diagnosis (nsubjpass)
delivered shock (nsubjpass)
individuals many (amod)
confirmed diagnosis (dobj)
micrograms/mouse 50 (nummod)
min-1 which (nmod)
factors exacerbating (amod)
patients fev1 (dep)
reaction hemolysis (nsubj)
infarction observations (dep)
2-(p-bromophenyl)propionate , (punct)
strain this (det)
sulpiride to (case)
independent alpha2-adrenoceptors (nmod)
mg edrophonium (compound)
angina coronary (amod)
attenuate vivo (advmod)
reviewed monthly (advmod)
level peroxidation (nmod)
examination the (det)
blockade after (case)
administered rats (nmod)
$ROOT$ tiapride (sent)
take replace (advcl)
injury proteinuric (amod)
vf ( (punct)
sacrificed administration (nmod)
clonidine or (cc)
csseps both (cc:preconj)
1mg/kg to (mark)
inappropriate degree (nmod)
necrosis matter (nmod)
activity its (nmod:poss)
beta-epimers 3 (nummod)
relief worsening (nmod)
underwent often (advmod)
variability for (case)
recognition discontinuation (conj)
attempt , (punct)
type this (det)
role mechanism (nmod)
design/methods reviewed (appos)
agents for (case)
mg. papaverine (dep)
density mineral (compound)
delay occlusion (nmod)
abuse lsd (compound)
review on (case)
normalized levels (nsubj)
increases factors (nmod)
share migraine (nsubj)
percent 44 (nummod)
takes achieve (xcomp)
cholecystokinin fragments (conj)
obtained using (xcomp)
varied and (cc)
induced changes (dobj)
patients therapy-resistant (amod)
9.1 1.9 (nummod)
contribution major (amod)
courses eight (nummod)
test locomotion (compound)
mechanism involving (acl)
0.83 1.03 (appos)
effects sulphate (nmod)
suggests patient (nsubj)
gaba(a)rs both (cc:preconj)
pathology a (det)
angiodegeneration ; (punct)
hemodynamic ) (punct)
protection alterations (nmod)
tumor background (compound)
influence rocuronium (nmod)
complained medication (nmod)
levothyroxine of (case)
calculated were (auxpass)
translocation the (det)
$ROOT$ implausible (sent)
party council (compound)
complication conclusion (compound)
patients cancers (nmod)
compounds occurring (amod)
normalizes architecture (dobj)
$ROOT$ unclear (sent)
mmhg was (cop)
granules specific (amod)
pn 5 (nummod)
pg/ml were (cop)
g/d p (dep)
course 10-day (amod)
used again (advmod)
cases transformation (nmod)
diameters shortening (conj)
$ROOT$ choose (sent)
appeared act (xcomp)
syndrome rare (amod)
dysfunction . (punct)
% interval (nmod)
different : (punct)
effect that (case)
have system (nmod)
using processor (dobj)
comparison using (acl)
mapping css (compound)
co-administration training (nmod)
lowered prevented (conj)
pathways , (punct)
methamphetamine or (cc)
injection single (amod)
concentrations pg-9 (nmod)
restoring function (dobj)
blocking input (dobj)
were patients (nsubj)
resistance impairment (conj)
cardiac ( (punct)
appear excretion (nmod)
overexpressing p300 (dobj)
loss hearing (nmod)
connected to (mark)
prolongation qt (nmod)
treatment acetate (nmod)
treatment q10 (compound)
execution in (case)
herniations another (nmod)
days every (det)
received pretreatment (conj)
arms treatment (compound)
improves pathway (nmod)
killed end (nmod)
side-effect . (punct)
amplitude sural (amod)
applicators iowa (nmod)
degree efficacy (nmod)
experienced irradiation (nmod)
thrombophlebitis ototoxicity (conj)
128 +/- (cc)
104 out (advmod)
protected pentobarbital (nsubj)
filters and (cc)
treated 6-ohda (nmod)
impact cardiotoxicity (nmod)
cases multiple (amod)
function hemodynamics (conj)
level opiate (compound)
concentration low-density (amod)
levels thrombopoetin (nmod)
content cytokine (compound)
fentanyl , (punct)
dexamethasone microg/kg (dep)
off group-1 (nmod)
cases changes (nmod)
changes cholesterols (nmod)
anotia bilateral (amod)
monitor pressure (compound)
response point (nmod)
administration clonidine (compound)
diet with (case)
administered erdosteine (nsubjpass)
extent administered (acl)
deficits controls (nmod)
gamma-hch , (punct)
transplants 135 (nummod)
hypoaldosteronism inappropriate (amod)
induced experimentally (advmod)
affect function (dobj)
trials denopamine (nmod)
died days (nmod:tmod)
failed enhanced (conj)
precipitating disturbances (dobj)
type ssri (nmod)
complex receptor (compound)
muscle smooth (compound)
explained are (auxpass)
observed events (nsubjpass)
scl ( (punct)
13 in (case)
warranted follow-up (nsubjpass)
classification the (det)
equal stable (conj)
risk concentrations (nmod)
localization histochemical (amod)
abnormalities electrocardiogram (nmod)
obtained . (punct)
population respectively (advmod)
activity limited (amod)
synthase factor-kappab (conj)
sought compare (xcomp)
received isotretinoin (dobj)
observed increment (nsubjpass)
syndrome turner (compound)
$ROOT$ transplanted (sent)
diuretics hypokalemia (conj)
similar prolonged (conj)
received took (advcl)
inhibits effectively (advmod)
value bilirubin (compound)
antidepressant first (amod)
undergoing catheterization (dobj)
induced doses (nmod)
drugs such (case)
found decrease (nsubjpass)
matched factors (nmod)
disease as (case)
consumers and (cc)
diet high (amod)
treatment erythropoietin (compound)
anesthetized ketamine (nmod)
evaluable microbiologically (advmod)
patients attended (acl:relcl)
slowing to (case)
g 113 (nummod)
analysis microscopic (amod)
66.9 ) (punct)
treatment ethinyl (amod)
1998 2005 (prep)
attain and (cc)
2.53 1.9 (conj)
loss epilepticus-associated (amod)
terminals of (case)
peroxidation lipid (compound)
initiation sedation (nmod)
important inhibition (nsubj)
damage therapy (nmod)
graded groups (nmod)
induced visualized (conj)
task object (compound)
treatment periadolescent (amod)
proteinuria heavy (amod)
control rats (nmod)
tachycardia without (case)
knowledge current (amod)
administered mean (nmod)
agents antimuscarinic (amod)
action morphine (nmod)
utilized lacking (parataxis)
tool diagnosis (nmod)
67.4 36.3 (conj)
dose ziprasidone (nmod)
paper present (amod)
impaired group (advcl)
paralysis induced (acl)
control exquisite (amod)
discriminates , (punct)
hepatitis methyldopa-induced (amod)
exert pressure (nmod)
ti ) (punct)
recorded rashes (nsubjpass)
interpreted effect (nmod)
related incidence (nsubj)
outcome unfavorable (amod)
toxicity 6 (appos)
revealed count (dobj)
lidocaine epinephrine (conj)
agents vasopressor (compound)
48 and (cc)
induces insipidus (dobj)
layer rnfl (appos)
evaluate alterations (dobj)
activity butyrylcholinesterase (nmod)
damage on (case)
assessed mrna (nsubjpass)
oxidase cco (appos)
responded ophthalmologists (nsubj)
followed dex (nmod)
gland a (det)
1.44+/-0.6 mg/dl (appos)
conditioning the (det)
neurons astrocytes (conj)
deposits fusion (conj)
deficits structural (amod)
increase activation (conj)
harmful potentially (advmod)
l-noarg and (cc)
association causal (amod)
absorbed and (cc)
involved be (auxpass)
maximal . (punct)
contents stomach (compound)
response respectively (advmod)
require modify (conj)
months 20.6 (nummod)
inhaled volunteers (nsubj)
aimed determining (advcl)
amn082 of (case)
effective a (nmod)
. s.e (dep)
effective models (nmod)
mice convulsing (amod)
activations regions (nmod)
seems signaling (nsubj)
had month (nmod)
four treatment (nmod)
substantiate to (mark)
cause cholestasis (nmod)
presence lid (nmod)
pretreated pilocarpine (nmod)
l ( (punct)
increasing patients (nmod)
decreased change (conj)
2.5 1.25 (compound)
gentamicin ) (punct)
gluconate of (case)
catalepsy codeine (compound)
drugs which (nsubj)
non-smokers were (cop)
titres mpo-anca (nmod)
level of (case)
response iso (nmod)
history neither (preconj)
potential the (det)
potential arrhythmias (nmod)
induction paracetamol (nmod)
frequency bladder (nmod)
treated blocker (nmod)
change not (neg)
< 0.002 (dep)
edema icp (conj)
22.77 3.26 (conj)
mechanism blockade (compound)
method ventricle (nmod)
g/ml 2 (nummod)
efficacious , (punct)
spectrum broader (amod)
hemorrhage either (cc:preconj)
has edaravone (nsubj)
role estrogen (nmod)
saline tdi (nmod)
tasks avoidance (compound)
years 45.7 (nummod)
autoantibodies cytoplasmic (amod)
seizures coma (conj)
instillation intratympanic (amod)
block , (punct)
cause 4 (meta)
temocapril ( (punct)
technique surface (compound)
survivors for (case)
prevent patients (nmod)
august 2007 (nummod)
% 31.9 (nummod)
implants fluocinolone (compound)
focused event (nmod)
abs ) (punct)
course events (nmod)
patients 829 (nummod)
women ) (punct)
searched 1987 (nmod)
causes methamphetamine (nsubj)
ed50 ) (punct)
mg/kg/b.w i.v. (nmod)
combination , (punct)
induced degeneration (dobj)
therapy , (punct)
treatment warfarin (nmod)
thickness ( (punct)
133 to (case)
propranolol loading (conj)
h 18 (nummod)
increases . (punct)
$ROOT$ persistent (sent)
abated that (nsubj)
organisms streptococcal (amod)
volume lv (compound)
obtained recordings (nsubjpass)
middle-aged for (case)
improved can (aux)
effect nephrotoxicity (conj)
pentylenetetrazole or (cc)
induce relapse (dobj)
stained red (nmod)
observed : (punct)
receptor 4 (nummod)
vegf/vpf ( (punct)
microscopy freeze-fracture (amod)
rate decline (nmod)
evaluation a (det)
distinct are (cop)
$ROOT$ interpretation (sent)
cohort , (punct)
asphyxia were (cop)
taken suppressants (dobj)
administration alpha-2b (nmod)
utilizes characteristics (dobj)
received course (dobj)
discovered factor (nsubjpass)
developed finding (nmod:npmod)
sought characterize (xcomp)
2.1 2.8 (conj)
staining immunocytochemical (amod)
bleeding argatroban (nmod)
+ + (conj)
carries risks (dobj)
represent , (punct)
nucleus and (cc)
unknown transplantation (nmod)
animals animals (conj)
features aneurysm (dobj)
causes kidney (nmod)
bdl and (cc)
used evaluation (nsubjpass)
pharmacon of (case)
years 59 (nummod)
emesis patients (nmod)
anemia against (case)
biopsy at (case)
receive gtn (dobj)
detection to (case)
score 3 (appos)
suppressed treatment (nmod)
diagnosis definitive (amod)
reported explain (conj)
2-fold control (conj)
hallucinations with (case)
evidence reduced (dep)
event cardiac (amod)
pain fatigue (conj)
ophthalmologic and (cc)
attracted hydrochloride (nsubj)
$ROOT$ taken (sent)
cytostatics of (case)
lower monotherapy (nmod)
micrograms/kg/min , (punct)
sch raclopride (conj)
changes mrna (nmod)
uncomplicated and (cc)
diagnosed criteria (nmod)
supported however (advmod)
release serotonin (compound)
score cgi-sf (compound)
delay without (case)
affecting control (dobj)
taking . (punct)
specimens transplant (compound)
diarrhoea was (cop)
replacement androgen (compound)
chemotherapy fluorouracil (nmod)
apparatus of (case)
carbonate to (case)
concerns nonpharmacologic (amod)
toxicity mitochondrial (amod)
care hiv (compound)
studies cancer (nmod)
safety to (case)
cases 75 (nummod)
suggest tool (ccomp)
0.005 less (advmod)
severe was (cop)
3 from (case)
1,000/mm3 less (amod)
mode treatment (nmod)
map basal (amod)
women years (nmod)
manifestation cardiotoxicity (nmod)
doses subsequent (amod)
reaction by (case)
correlated investigated (advcl)
develop patients (nmod)
problems patient (nmod:poss)
recruited were (auxpass)
withdrawal period (appos)
version cued (amod)
elevated concentration (nmod)
camp intraplatelet (amod)
tachycardia reflex (amod)
excreted spared (advcl)
association well-documented (amod)
10.4 33.1 (prep)
strategy treatment (nmod)
state disease (compound)
irrigation saline (nmod)
derives atrophy (nmod)
generalized non-reactive (amod)
hemianopia with (case)
dex p (appos)
availability forms (nmod)
mmhg 90 (nummod)
treated patients (dobj)
development battery (conj)
performance of (case)
bradycardia defined (dep)
response tropicamide (nmod)
overflow dyskinesias (conj)
pathway cell-death (compound)
functional analysis (dep)
models models (nmod)
opposed ) (punct)
arises considering (advcl)
higher tgr (nmod)
perforans serpiginosa (dobj)
probable was (cop)
manifestations allergic (amod)
county the (det)
disequilibrium in (case)
impaired drugs (nmod)
$ROOT$ disease (sent)
shown chemicals (nsubj)
eeg and (cc)
antagonism potent (amod)
positive studies (nsubj)
provided pharmacy (nmod)
patients between (case)
anf [ (punct)
task induced (acl)
killed determine (advcl)
hypothesized , (punct)
di ( (punct)
pressures mean (amod)
limbs hyper- (amod)
dose pilocarpine (nmod)
episodes , (punct)
increased concomitant (conj)
transaminase of (case)
1,3-butadiene , (punct)
rejection ar (dep)
berries of (case)
hyper- ) (punct)
injury microscopic (amod)
force excessive (amod)
speech tremor (conj)
pressure pressure (nmod)
m of (case)
subjects % (dep)
matched . (punct)
mice wt (amod)
seems biomarker (xcomp)
predisposing hypocalcemia (nmod)
asymptomatic detected (conj)
occurred also (advmod)
effect dopamine (nmod)
dopaminergic serotonergic (conj)
cream , (punct)
1.0 were (cop)
hbeag ; (punct)
ptcr of (case)
movement body (compound)
gfap ( (punct)
systematic , (punct)
rate response (compound)
cyclophosphamide and (cc)
marked ketamine (nmod)
time post-infusion (nmod)
increased binding (dobj)
patients ovarian (amod)
had loss (dobj)
investigate reversible (ccomp)
ratings meeting (acl)
sympathectomy after (case)
bronchodilator patients (nmod)
examination pressure (conj)
mosmol/kg osmolality (conj)
phenylbutazone , (punct)
respond do (aux)
complications significant (amod)
event children (nmod)
structure causes (acl:relcl)
randomized olanzapine (nmod)
mediating toxicity (dobj)
used preventing (advcl)
amphetamine rate (dep)
bind drug (dobj)
seizure tacrolimus-related (amod)
adjustment treatment (compound)
anatomical different (amod)
methodology published (amod)
scale inventory (conj)
lip cleft (compound)
grades regurgitation (compound)
hemolysis ribavirin-induced (amod)
attenuated although (mark)
shown was (auxpass)
disease aggressive (amod)
week from (case)
ana anca (conj)
attenuated indicated (advcl)
follows severity (nsubj)
mechanism(s underlying (amod)
ng 2 (nummod)
mouse-1 nmol (compound)
damage brain (compound)
hemoglobin hb (appos)
produces oscs (nsubj)
area regulated (acl:relcl)
clinics psychiatry (compound)
states and (cc)
plate neural (amod)
vulnerable is (cop)
load virus (compound)
inhibitor i (nummod)
respect had (parataxis)
catecholamines endogenous (amod)
0.56 1.37 (conj)
self-treating di (dobj)
resolved arrhythmia (nsubj)
receiving medication (dobj)
effects avp (nmod)
month 12 (nummod)
estradiol peaked (acl:relcl)
dose lenalidomide (compound)
importance that (mark)
toxicity , (punct)
dead were (cop)
mechanisms are (cop)
show recurrence (dobj)
alterations interval (nmod)
humans both (preconj)
seizures for (case)
recorded have (aux)
bacteria crystals (conj)
emulsion , (punct)
= 2.94 (dobj)
conditions to (case)
cells mc-ixc (compound)
37 of (advmod)
drug anti-arrhythmic (amod)
corresponding word (nmod)
condition patients (nmod:poss)
acetate nh4ac (appos)
radiopharmaceuticals infarct-avid (amod)
ulnar and (cc)
possibilities these (det)
causes directly (advmod)
stable min (nmod)
26/31 and (cc)
discharged may (aux)
task passive (amod)
higher medulla (nmod)
$ROOT$ few (sent)
better skills (nsubj)
examined influence (nsubjpass)
csa not (cc)
response locomotor (amod)
injected uteri (nsubjpass)
functional pgp (nsubj)
cause indeed (advmod)
effects terms (nmod)
diltiazem , (punct)
sampling of (case)
palpitations restlessness (conj)
ng/kg/min ( (punct)
weeks methimazole (nmod)
collected interview (nmod)
exchange of (case)
p2x3 receptors (dep)
abolished also (advmod)
haemopericardium fatal (amod)
diagnosis thrombosis (nmod)
fetus to (case)
transducer pressure (compound)
study effect (dobj)
cardiotoxicity doxorubicin-induced (amod)
depression marrow (compound)
result findings (nsubj)
measure psychopathology (dobj)
parameters oxidative/nitrosative (amod)
patient admitted (acl)
median with (case)
exist do (aux)
improve significantly (advmod)
prove therefore (advmod)
examination electrocardiography (conj)
level cellular (amod)
reverse sedation (dobj)
september in (case)
captopril or (cc)
injection indomethacin (nmod)
two in (case)
apap any (conj)
describes patient (dobj)
noted deposits (nsubjpass)
amounts differences (conj)
intolerance for (case)
reduced then (advmod)
assessment rating (nmod)
analysis variance-significantly (nmod)
period preweaning (amod)
polypeptide intestinal (amod)
received setting (nmod)
density increased (amod)
those received (acl:relcl)
receiving cefotetan (dobj)
shr than (case)
action system (compound)
4.9 ( (punct)
prodrug capecitabine (nsubj)
th ( (punct)
known exacerbates (ccomp)
users current (amod)
alone and (cc)
predominance combination (nmod)
state pain (compound)
contraceptives presence (conj)
managed that (mark)
number surface (conj)
effective to (mark)
infected untreated (dep)
p + (cc)
causes ischemic (amod)
actions . (punct)
lid both (cc:preconj)
h x (compound)
group impact (compound)
report we (nsubj)
probe crna (compound)
attack with (case)
transport lipid (compound)
determine rate (dobj)
regimens dose (compound)
methemoglobin mhb (appos)
far thus (advmod)
restricted conformationally (advmod)
300 to (quantmod)
patient . (punct)
efficiency controls (nmod)
rigidity somatic (amod)
resulted photostimulation (nsubj)
ethanol , (punct)
restoration complete (amod)
achieved maintained (conj)
thiopental . (punct)
platelets 10(9 (nummod)
$ROOT$ pain (sent)
conclusion unmask (acl)
measures gloves (nmod)
labetalol , (punct)
opioid-agonists delta (compound)
sets both (det)
yawning , (punct)
90 < (advmod)
induction concomitant (amod)
patients groups (nmod)
effects related (acl)
differed . (punct)
therapeutic . (punct)
deviation sdrr (appos)
year 13 (nummod)
therapy following (case)
had vte (dobj)
pressure mmhg (dep)
secretion cortisol (compound)
array ) (punct)
recalled words (nsubjpass)
changed and (cc)
$ROOT$ predisposed (sent)
events events (appos)
concentrations toxicity (conj)
inpatients subjects (nsubj)
damage apoptosis (conj)
induced viruses (nmod)
permits administration (dobj)
improved effect (nmod)
differentiate factors (nmod)
1.81 ( (punct)
therapies empirical (amod)
non-alcoholic in (case)
4.10 was (cop)
index expression (nmod)
nacl ( (punct)
interaction regulation (nmod)
dopamine as (cc)
inhibit could (aux)
indicates use (nsubj)
enac ( (punct)
mapping body (compound)
effects health (compound)
handicapped systems (nsubjpass)
reversal , (punct)
impaired experimentally (advmod)
rearings and (cc)
evaluated consensus (nmod)
avoided patients (nmod)
gender of (case)
defect of (case)
movement spontaneous (amod)
flow pulmonary (amod)
cholesterols a-ii (conj)
solutions irrigation (compound)
clopidogrel aspirin (conj)
use following (case)
different however (advmod)
pressure positive (amod)
pointes fluconazole-induced (amod)
circumstantial remains (conj)
potential tdp (compound)
hypren-trial the (det)
ms 500 (nummod)
requested late (advmod)
convulsions untreated (amod)
independent . (punct)
pretreatment l-alpha-gfc (nmod)
mediator that (mark)
safe may (aux)
pf ( (punct)
caused that (nsubjpass)
inhibitor-associated ) (punct)
refused patient (nsubj)
injections daily (amod)
efficacy hydrochloride (nmod)
signs complications (conj)
case treated (appos)
$ROOT$ allows (sent)
leg her (nmod:poss)
referred . (punct)
velocity element (compound)
arabic orally (advmod)
discriminate doses (nmod)
engagement possible (amod)
% up (advmod)
men sixty-seven (nummod)
addressed . (punct)
occurred incidents (nsubj)
tachycardia sustained (amod)
contributes certainly (advmod)
46.0 6.9 (compound)
using immunotherapy (dobj)
hypoactivity free-field (amod)
echocardiographic and (cc)
referrals of (case)
increased g (dobj)
days fifteen (nummod)
suggest factors (ccomp)
ng/dl. initiation (nmod)
dogs seven (nummod)
$ROOT$ resumed (sent)
$ROOT$ active (sent)
treated spironolactone (nmod)
greater p (dep)
women nineteen (nummod)
neurotransmitters hippocampal (amod)
received only (advmod)
leukopenia ) (punct)
aprotinin inhibitor (appos)
deviation and (cc)
pain penile (compound)
19 16 (conj)
accuracy responses (nmod)
dp/dt ( (punct)
gamma-sarcoglycan beta-dystroglycan (conj)
minimised . (punct)
dowregulation expression (nmod)
presence absence (conj)
manage and (cc)
floor on (case)
mg/kg rate (dep)
diseases rheumatologic (amod)
deficits and (cc)
failure treatment (nmod)
values racemic (amod)
rats killed (acl:relcl)
induced morphine (nmod)
d-1 and (cc)
maximize ratio (dobj)
impairment caudate-putamen (nmod)
taking prazosin (dobj)
justified probably (advmod)
result how (advmod)
hyponatremia , (punct)
resistance foot (nmod)
thrombosis induced (acl)
phosphate serum (compound)
avoid , (punct)
related trimipramine (nsubj)
displayed kidneys (nsubj)
1.17 , (punct)
induction coagulation (nmod)
treated clentiazem (nmod)
nitrate drops (conj)
pregnancies 12 (nummod)
$ROOT$ myalgia (sent)
tiredness mornings (nmod)
dose intravenous (amod)
reaction dyspnea (dep)
csa by (case)
trends current (amod)
kidney one (nummod)
rashes erythematosus (conj)
proteinases by (case)
glutamate csf (compound)
hepatomas in (case)
aspect leg (nmod)
cycle sleep/wakefulness (compound)
complication unreported (amod)
gtn microg/kg/min (compound)
stn ( (punct)
control intralipid (conj)
investigations microscopic (amod)
muscles extraocular (amod)
index cardiac (amod)
5.1 , (punct)
established now (advcl)
agents thromboembolic (punct)
impairment simultaneous (amod)
improved < (parataxis)
monitoring cardiac (amod)
schedule in (case)
information history (nmod)
ros ( (punct)
trial inwest (appos)
value normal (amod)
revealed maps (nsubj)
design and (cc)
calculated usually (advmod)
has administration (nsubj)
produced 4 (nmod)
neovascularization growth (conj)
consistent not (neg)
i.v. . (punct)
matrix their (nmod:poss)
disease patient (nmod:poss)
vector new (amod)
opioids of (case)
infusion sufferers (nmod)
limits used (advcl)
disease malignant (amod)
woman diabetes (nmod)
detected levels (nmod)
nerve femoral (amod)
quantified injuries (nsubjpass)
criteria dsm-iv (compound)
confirmed methods (nmod)
nature hypertension (nmod)
penk ( (punct)
latency with (case)
alfentanil kg-1 (nummod)
hdl-c a-i (conj)
pathophysiology the (det)
excluded later (advmod)
meningitis of (case)
ctnt maximal (amod)
modalities treatment (compound)
technique this (det)
levels also (advmod)
heat noxious (amod)
rp 67,580 (nummod)
value may (aux)
reduced maintained (advcl)
dissociation av (compound)
marked dizziness (nsubj)
do infused (advcl)
noted cessation (nmod)
associated negatively (advmod)
seconds minutes (nmod)
effective definitely (advmod)
chromosomes mouse (compound)
development upon (case)
protocols these (det)
produce revealed (advcl)
cultures and (cc)
potentiating reducing (conj)
arg10 des (compound)
inhibition naa (nmod)
elevated corresponded (advcl)
septicemia abnormalities (conj)
impact the (det)
pressure pulmonary (amod)
fucoidan vehicle (conj)
prevalent degree (advcl)
poor relatively (advmod)
affected detected (conj)
faster significantly (advmod)
study paclitaxel (nmod)
data , (punct)
tissues orbital (amod)
watch to (mark)
convulsion of (case)
minutes t60 (appos)
locf with (case)
role its (nmod:poss)
abusing methamphetamines (dobj)
headaches seizures (conj)
caused hyperprolactinemia (nsubj)
contribute outcomes (nmod)
indicating influence (ccomp)
had probability (dobj)
strips in (case)
limited studies (nsubj)
syndrome q-t (compound)
word one (nummod)
analysis regression (compound)
levodopa mg/kg (dep)
ultrastructural early (amod)
infusion trinitrate (compound)
complications chronic (amod)
developed he (nsubj)
studied conclusion (nmod)
procedures myocardial (amod)
captopril ( (punct)
blockade receptor (nmod)
applicable , (punct)
remained rigidity (nmod)
differences major (amod)
preparations oc (compound)
observed disorder (nsubjpass)
27 patients (nmod)
ethanol inducer (appos)
followed recovery (nmod)
revealed added (advcl)
strain t (conj)
syndrome lupus-like (amod)
rechallenge with (case)
addictive very (advmod)
rescues reduction (nsubj)
icr these (nsubj)
prevents dup (nsubj)
mol 0.019 (compound)
antigenemia p24 (compound)
inducing purpose (nmod)
$ROOT$ thought (sent)
effects pathways (nmod)
l-noarg l-nil (conj)
forebrain the (det)
showed n-acetyl-beta-glucosaminidase (nsubj)
35 11 (conj)
alkylxanthines the (det)
patients elderly (amod)
occurred case (conj)
risk considerable (amod)
indicate involved (ccomp)
improves produces (conj)
seizure administration (nmod)
secretion surge (conj)
adjust behaviour (dobj)
pattern six (nmod)
gentamicin doses (nmod)
smaller that (mark)
incorporation nanospheres (nmod)
disorder psychotic (amod)
liable patients (nsubj)
induced hyperlocomotion (dobj)
similarities span (conj)
epinephrine 4 (nummod)
disturbance sleep (compound)
case conjunction (nmod)
expression igf-i (nmod)
exhibit that (mark)
hearts protein (appos)
months 5 (dep)
receptor 1 (nummod)
composed infiltrates (nmod)
double-blind prospective (amod)
ester phosphate (compound)
reported centre (nmod)
kidneys 143 (nummod)
1.03 0.80 (conj)
stimulus nociceptive (amod)
led relief (nmod)
regimen 10-month (amod)
22 10 (compound)
sop ) (punct)
muscle atrial (amod)
negative to (mark)
treated , (punct)
administered dobutamine (nsubjpass)
seizures myoclonic (amod)
use analgesic (nmod)
reduced insufficiency (dobj)
alternative could (aux)
case this (det)
studies balance (compound)
investigation is (cop)
stage phases (nmod)
resulted use (nmod)
based were (auxpass)
matter particulate (amod)
protection effects (nmod)
form administration (nmod)
indicate ranges (ccomp)
variables all (det:predet)
$ROOT$ prolactinomas (sent)
e. of (case)
citrate induction (nmod)
$ROOT$ mediation (sent)
blockade l-type (amod)
wt to (case)
support occurrence (nmod)
remains elusive (acomp)
movements catalepsy (conj)
granulocytopenia 3 (nummod)
included we (nsubj)
platform arms (conj)
agent antifibrinolytic (amod)
elevated hippocampus (nmod)
infections fewer (amod)
mpep mg/kg (appos)
evident dosing (nmod)
apnoea unexpected (amod)
$ROOT$ influenced (sent)
ethopropazine . (punct)
generalization and (cc)
indomethacin b (appos)
swallowing while (mark)
di- and (cc)
sedation threshold (conj)
presented he (nsubj)
one agonists (nsubj)
results therefore (advmod)
factors several (amod)
factor granulocyte (compound)
mellitus with (case)
applied was (auxpass)
activation chemoreception (compound)
gout men (nmod)
autoantibody a (det)
range 76 (appos)
supports study (nsubj)
exposure acute (amod)
influence analgesics (nmod)
discuss aspirin (dobj)
rad001 ) (punct)
demonstrated oedema (dobj)
barium by (case)
group receptors (nmod)
bd1008 and (cc)
inefficient , (punct)
l-med 1 (dep)
-15.96 + (cc)
7 least (nmod:npmod)
group p (appos)
propensity develop (acl)
message prodrug (acl)
using bypass (dobj)
meeting criteria (dobj)
changes status (compound)
contained sampling (nmod)
decreased p (dep)
seizures between (case)
96.7 ( (punct)
application phases (nmod)
constant an (det)
degree performance (nmod)
observed complications (nsubjpass)
sulphate agent (dep)
recovered levels (nsubj)
given dosing (nmod)
pretreated saline (nmod)
62 % (appos)
reversion decrease (nmod)
rate volume (conj)
vsds ( (punct)
had reaction (dobj)
exerts rescues (parataxis)
infiltrates accumulation (conj)
ligation and (cc)
secretion net (amod)
therapy leukemia (nmod)
noticed improvement (nsubjpass)
acetate retinyl (compound)
resulted hyperglycemia (nmod)
accumulation accumulation (conj)
imaging dwi (appos)
infusing starting (advcl)
involved effect (conj)
present other (nmod)
given nsaids (dobj)
preference on (case)
formation in (case)
findings . (punct)
state as (cc)
was improvement (attr)
antagonized activity (dobj)
received adriamycin (dobj)
regimen mg (nmod)
conditioning melphalan (compound)
tolerated effective (conj)
focused formation (nmod)
compare prevalence (dobj)
similar animals (nmod)
relation that (nmod)
etomidate . (punct)
mtd ( (punct)
improvements and (cc)
placebo a (det)
acuity the (det)
$ROOT$ monitored (sent)
tet ( (punct)
diacetate triamcinolone (compound)
metoclopramide of (case)
started resuscitation (nsubjpass)
dissociated those (nmod)
3.4 ( (punct)
suggesting initiation (nmod)
insipidus nephrogenic (amod)
made and (cc)
correlated fall (nmod)
u/l ) (punct)
detection reduction (nmod)
nsaid an (det)
$ROOT$ widened (sent)
stz-icv by (case)
discharged be (auxpass)
seizures nicotine-induced (amod)
apoptosis cardiomyocyte (compound)
different but (cc)
forelimb or (cc)
flexion/extension , (punct)
chi2-test with (case)
group disorders (compound)
preferred ( (punct)
effect (-)-cibenzoline (nmod)
anemia macrocytic (amod)
safety on (case)
pain study (dep)
lumen the (det)
limitations certain (amod)
occurred year (nmod)
appetite and (cc)
mortality population (nmod)
recovered period (nmod)
abusing who (nsubj)
favour and (cc)
cholestasis anicteric (amod)
was test (nmod)
therapy through (case)
parameters major (amod)
ampk ) (punct)
staining acriflavine (compound)
reversed decrease (dobj)
antagonists bradykinin (compound)
effects anticancer (amod)
expected , (punct)
given totp (nmod)
flaccidity muscle (compound)
) 3.6 (compound)
efficacious be (cop)
tests on (case)
total ) (punct)
accelerate to (mark)
therapy valproate (compound)
tissues subcutaneous (amod)
hyperactivity mice (nmod)
epinephrine was (cop)
hyoscine ( (punct)
papilledema somnolence (conj)
neuropathy : (punct)
technique anaesthesia (nmod)
infusion dopamine (nmod)
use methamphetamine (compound)
-26 15 (conj)
rhabdomyolysis stroke (conj)
mothers of (case)
study thalidomide (nmod)
a part (compound)
hour the (det)
distress psychological (amod)
bp rats (nmod)
h ( (punct)
excluded failure (nsubjpass)
program screening (compound)
mmol 276 (nummod)
health women (nmod)
site pontis (nmod)
hyperactivity morphine-induced (amod)
study pharmacokinetic (amod)
reaction donors (nmod)
therapy be (cop)
bicuculline aminophylline (conj)
injections botox (compound)
depends that (mark)
treatment feasible (amod)
determined ultrasound (nmod)
ve ) (punct)
ages yr (appos)
thiopentone agent (nmod)
rats sd (compound)
develop thus (advmod)
steroid chronic (amod)
ninety-nine patients (nmod)
salicylates salts (conj)
steroid aas (appos)
manifestation the (det)
ifosfamide ifo (appos)
series series (conj)
u/liter ) (punct)
occurred striking (conj)
mechanism hepatitis (nmod)
coadministration from (case)
cells packed (amod)
radiological and (cc)
different although (mark)
alone combination (conj)
assessed stress (nsubjpass)
headache and (cc)
serca2 ] (punct)
background remains (dep)
indicates study (nsubj)
cramps leg (compound)
disruption rats (nmod)
apical periapical (conj)
gravis presenting (acl)
treatment hemorrhage (nmod)
cats controlled (acl:relcl)
expressed but (cc)
protect event (nmod)
seizures intoxication (nmod)
doses divided (amod)
grafting and (cc)
moles/glomerulus and (cc)
died dead (ccomp)
use be (cop)
atropine lys1 (conj)
hydroureteronephrosis right (amod)
marked but (cc)
had neuropathy (dobj)
antibody hit (compound)
2 to (dep)
incidence delirium (nmod)
found polyuria (nsubjpass)
compliance with (case)
setting non-interventional (amod)
contrast nifedipine (nmod)
pn ) (punct)
was when (advmod)
h as (case)
case such (amod)
phenotypes behavioral (amod)
restimulation postlesion (nmod)
cows treated (acl)
mg/m(2 gemcitabine (nmod)
tend was (conj)
produce hypotension (dobj)
asthma in (case)
lesions outer (amod)
revealed presence (dobj)
found reflexes (nsubjpass)
clozapine with (case)
children 74 (nummod)
participants 21 (nummod)
seems value (xcomp)
strains 4 (nummod)
conclusion plays (appos)
treatment pharmacological (amod)
morbidity its (nmod:poss)
portland or (cc)
test result (ccomp)
1,1-dichloro-2,2,2-trifluoroethane of (case)
risk lesser (amod)
use ht (nmod)
females 42 (nummod)
encephalomalacia multicystic (amod)
unchanged ko (nmod)
support empirical (amod)
cause effects (dobj)
gamma-sarcoglycan and (cc)
episode self-limited (amod)
interactions such (amod)
preferable may (aux)
frequency caffeine (nmod)
17 10 (compound)
none literature (nmod)
woke . (punct)
rats tr(- (amod)
elevated pethidine (nsubj)
resulted cases (nsubj)
induces mouse (nmod)
is/tia 3817 (nummod)
defects long-term (amod)
examine safety (dobj)
quiescent , (punct)
data few (amod)
suggested play (ccomp)
increased resulted (advcl)
8.8 3.9 (conj)
ifosfamide bolus (compound)
interaction likely (advmod)
rats arabic (acl)
acetaminophen the (det)
4.2 , (punct)
neurotoxicity sensory (amod)
bulb olfactory (amod)
diazepam or (cc)
groups epinephrine (compound)
results contradictory (amod)
administration only (advmod)
dct2 and (cc)
serotonin and (cc)
augmented lamivudine (nmod)
% chinese (appos)
consumption between (case)
monotherapy in (case)
potentiated effects (nsubjpass)
lower markedly (advmod)
losses potassium (compound)
adherence low (amod)
improved example (nmod)
aggregation maximal (amod)
interactions phenobarbitone (nmod)
blocked and (cc)
background implicated (dep)
treatment antipsychotic (amod)
consequence arrest (nmod)
tasks across (case)
saline than (case)
enflurane isoflurane (conj)
acetaminophen- galactosamine-induced (conj)
studied days (nmod)
protocol during (case)
incidence cumulative (amod)
abnormal more (advmod)
dysfunction clinical (amod)
use acids (nmod)
glomerulosclerosis of (case)
myocarditis acute (amod)
vasoconstriction acute (amod)
relationship such (predet)
results on (case)
contained implants (nsubj)
arrhythmias other (amod)
1.041 . (punct)
feature essential (amod)
associated diethylstilbestrol (nmod)
event the (det)
increased hypotension (nmod)
diet ls (compound)
increases levels (nmod)
presented recovery (nmod)
$ROOT$ counteract (sent)
effect capsaicin (nmod)
considered involved (xcomp)
observed expression (nmod)
clinical biochemical (conj)
period recording (compound)
blockers by (case)
fsgs of (case)
glutamate monosodium (compound)
informed . (punct)
% 18.28 (nummod)
fever glomerulonephritis (conj)
but exclusively (advmod)
54 , (punct)
reduced experiment (nmod)
nra0160 thiazole-2-carboxamide (appos)
calculated infusion (nmod)
crea protein/mg (compound)
$ROOT$ based (sent)
reported alleviated (ccomp)
produced helodermin (nsubj)
time te (appos)
hs in (case)
regions supramarginal (amod)
tetrabenazine and (cc)
1.3 0.7 (nummod)
sh(6 , (punct)
amplitude ps (nmod)
events mortality (conj)
hydroureteronephrosis obstruction (nmod)
output concentration (conj)
synthesis conjugates (nmod)
levodopa , (punct)
m ) (nummod)
c 22 (nummod)
six out (advmod)
conclusions factor (appos)
expected increase (nsubj)
interfere to (mark)
6,7-dimethoxy-4-ethyl-b-carboline-3-carboxylate dmcm (appos)
$ROOT$ sulphate (sent)
objective one (appos)
age adult (amod)
lowers threshold (dobj)
background documented (dep)
syndrome associated (acl)
conclude data (nmod)
a patient (compound)
m 1.0 (nummod)
vas ) (punct)
biochemistries liver (compound)
restored and (cc)
animals surviving (acl)
intermediate toxicity (nsubj)
conjugates the (det)
suggested understood (conj)
receptor mglu7 (compound)
min awakening (dep)
beneficial . (punct)
turnover na (compound)
method be (cop)
dfp-atropine after (case)
mass adrenal (amod)
11 in (case)
4 through (case)
form . (punct)
screen drug (compound)
hdl but (cc)
change patients (nmod)
age obesity (conj)
antagonize . (punct)
seizures mortality (conj)
hospitals birthing (amod)
treatment metronidazole (nmod)
trial psychosis (nmod)
blockade adrenergic (amod)
disorders temporomandibular (amod)
less patients (nmod)
density spine (compound)
ingested mothers (nsubj)
artery carotid (compound)
evaluated study (nsubj)
has ischemia (nsubj)
primary the (det)
expectancy patients (nmod)
mg/kg 0 (nummod)
dfp of (case)
base brain (nmod)
aroused suspicion (nsubjpass)
epilepsies experimental (amod)
component of (case)
$ROOT$ appear (sent)
treated resolved (conj)
born prematurely (advmod)
hepatocytes of (case)
obtaining in (mark)
carcinoma the (det)
caused gain (dobj)
offers labetalol (nsubj)
undertaken investigation (nsubjpass)
water fortified (amod)
risk treatment (nmod)
relationship cgrp (nmod)
amiodarone of (case)
indicator cardiotoxicity (nmod)
image resonance (compound)
rate fraction (conj)
$ROOT$ lacking (sent)
thrombopenia with (case)
linn anacardiaceae (appos)
pills generation (compound)
control the (det)
macroprolactinoma n. (dep)
disintegrin of (case)
adenocarcinomas large (amod)
increased plasma (conj)
resolved stopped (advcl)
increased pentoxifylline (nmod)
challenge elderly (nmod)
$ROOT$ stimulated (sent)
tqrs ) (punct)
atropine mecamylamine (conj)
echocardiogram transthoracic (amod)
check as (case)
association syndrome (conj)
decrease not (neg)
aap of (case)
parameters tested (amod)
nad substrate (amod)
gtn transdermal (amod)
tumors estrogen-induced (amod)
allografts functioning (amod)
used that (nsubjpass)
produces hypotension (dobj)
available whereas (mark)
electrocardiography by (case)
tobramycin piperacillin-treated (conj)
myocytes in (case)
compared history (nmod)
enhancement with (case)
database provincewide (amod)
incidences events (nmod)
precluded since (mark)
increased 12.8 (nmod)
injections galactose (nmod)
environment hormonal (amod)
embryopathy anotia (nmod)
elevations % (appos)
ph pco2 (appos)
were ctc-nci (dep)
resistant otherwise (advmod)
controls death (dobj)
cross-tolerant showed (conj)
patients failure (nmod)
cases granulocytosis (nmod)
stands . (punct)
suggests nature (nsubj)
model on (case)
1.54 ) (punct)
occurs ; (punct)
had coarctation (dobj)
focused lesion (nmod)
% amlodipine (nmod)
administration dex (compound)
reaction to (case)
occurred children (nmod)
reversal indicating (acl)
number cases (nmod)
compromised latter (nsubj)
density , (punct)
transcriptase reverse (amod)
lesions grade (compound)
effects weight (nmod)
kf17837 : (punct)
neuropathy ethambutol-induced (amod)
prescribing judiciously (advmod)
patients thirteen (nummod)
register ) (punct)
rate at (case)
intensity hz (appos)
mononucleosis infiltrate (nmod)
require links (nsubj)
aspirated , (punct)
oxygen and (cc)
prevent glycosuria (nsubj)
secondary increase (nsubj)
removal placenta (compound)
raclopride and (cc)
failure captopril-induced (amod)
related temporally (advmod)
-14.8 12.5 (conj)
sirna for (case)
permits toxicity (nsubj)
3ma adriamycin-treated (conj)
target as (case)
microscopy samples (nmod)
response months (dep)
included biopsies (dobj)
dyskinesias choreic (amod)
peptides the (det)
was decrease (nmod)
penicillamine chloroquine (conj)
xerostomia caries (conj)
implicated elements (nsubjpass)
involvement extent (conj)
reports dysfunction (nmod)
features case (nmod)
history medicine (nmod)
w-ich for (case)
$ROOT$ compatible (sent)
cycles bort-dex (compound)
exclude can (aux)
died she (nsubj)
values and (cc)
beats/min than (case)
therapeutic prophylactic (conj)
consolidation to (case)
$ROOT$ escalated (sent)
stimulation neuropeptide (compound)
proteinuria on (case)
bromocriptine with (case)
factor factor (appos)
reports with (case)
impaired recall (nsubj)
muscle taken (acl)
micrograms capsaicin (compound)
dextromethorphan antagonist (compound)
have symptoms (dobj)
toxicity any (det)
4.5 +/- (cc)
weakness symptoms (conj)
sgk1(-/- ) (punct)
longitudinal circumferential (conj)
effects cd-832 (nmod)
endocarditis infective (amod)
continue whether (mark)
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (mptp)-exposed (dep)
lesser much (advmod)
dosages greater (amod)
participates . (punct)
bolus epinephrine (nmod)
practice medicine (nmod)
measurements hemoglobin (compound)
database french (amod)
mg/kg values (nsubj)
led them (dobj)
sacrificed period (nmod)
sites binding (amod)
$ROOT$ tolerable (sent)
anuria lethal (amod)
caused respect (nmod)
requiring access (dobj)
specified not (neg)
absences with (case)
mice ilk/liver-/- (amod)
used succinylcholine (nsubjpass)
use association (conj)
subdivisions of (case)
offered . (punct)
seizures postoperative (amod)
clinics from (case)
register cancer (compound)
stones dissolvable (amod)
seem although (mark)
different p<0.02 (dep)
describes study (nsubj)
stimulates that (mark)
respect with (case)
report part (nmod)
screening echocardiographic (amod)
smoke who (nsubj)
invoked shr (nmod)
cautious to (mark)
suppression despite (case)
computers on (case)
excellent was (cop)
pass bundle (nmod)
induced medium (nmod)
phenacetin paracetamol (conj)
$ROOT$ registration (sent)
referred he (nsubjpass)
reaction use (nmod)
neurocognitive pharmacodynamic (conj)
containing bicuculline (dobj)
aggressiveness on (case)
metabolites no (det)
completing after (case)
treatment a (nmod)
more which (nsubj)
microg/kg remifentanil (compound)
activity associated (acl:relcl)
identify may (aux)
calculated was (auxpass)
safety control (nmod)
ocs reference (nmod)
deficits associated (acl)
tests ( (punct)
0.3 , (punct)
association and (cc)
vip norepinephrine (conj)
onset hallucinosis (nmod)
dependent had (aux)
ro ( (punct)
rigidity assumed (acl:relcl)
wards to (case)
interactions related (amod)
tests controlled (amod)
svc ) (punct)
increased compared (advcl)
occurs performed (advcl)
tablets with (case)
overloaded dextran (nmod:npmod)
wall vessel (compound)
agents of (case)
cis-platin ) (punct)
hepatitis necrosis (nmod)
improved have (aux)
experiments clearance (compound)
group n (dep)
maintained range (nmod)
associated allele (nmod)
changed number (nsubjpass)
controlled poorly (advmod)
series involving (acl)
3 and (cc)
reduced chlorpromazine (nmod)
tight is (cop)
data indicating (acl)
density size (conj)
signs type (nmod)
animals between (case)
resistant was (cop)
ranges in (case)
release of (case)
azt bau (conj)
$ROOT$ quantify (sent)
justify determination (dobj)
receptor sigma2 (compound)
interviewing patients (dobj)
late that (mark)
attenuated drc (nsubjpass)
that found (acl)
sprouting with (case)
effectiveness carriers (nmod)
motility amines (conj)
fluorogold by (case)
known phosphorus (nsubjpass)
responses and (cc)
toxicity non-overlapping (amod)
2-p-(2-carboxyethyl)phenethylamino-5'-n-ethylcarboxamidoadenosine 5'-n-ethylcarboxamidoadenosine (conj)
questionaires ) (punct)
induces ca (nmod)
2.2 p=0.019 (appos)
good persistently (advmod)
advocated . (punct)
progressed that (nsubj)
doses low (amod)
ptld disorder (dep)
used admission (nmod)
evaluate rates (dobj)
b ketoconazole (conj)
investigation mechanism (nmod)
stopped instillations (nsubjpass)
loss blood (compound)
index control (compound)
microscope electron (compound)
risks fetal (amod)
pathway neuronal (amod)
pharmacoeconomics of (case)
sodium ) (punct)
start chemotherapy (nmod)
tended drug (nsubj)
relation duration (nmod)
arthritis dysfunction (conj)
barium water (appos)
patients nystagmus (nmod)
thrombocytopenia delayed-onset (amod)
mice rats (conj)
re-challenged , (punct)
drugs receptor-blocking (amod)
observed cytoplasm (nmod)
was angiography (nmod)
membrane cells (nmod)
treatment long-term (amod)
l-med , (punct)
associated concentration (nsubjpass)
hips-cms of (case)
groups 6 (nummod)
$ROOT$ exposed (sent)
blockers ii (nummod)
mice littermates (conj)
more confirmatory (nmod)
combination myelopathy (nmod)
decreased diminished (conj)
seizure acid (compound)
strokes ischaemic (amod)
thrombocytopenia alopecia (conj)
accentuated distally (advmod)
control either (det)
showed aggregations (nmod)
life-threatening some (nsubj)
tab of (case)
individuals hiv-infected (amod)
amphetamine by (case)
support view (dobj)
avoiding occurrence (dobj)
dexmedetomidine : (punct)
fed months (nmod)
etodolac e (appos)
mg/m(2 of (case)
room operating (compound)
$ROOT$ essential (sent)
drug receptors (nmod)
activation nuclei (nmod)
therapy thiazide (compound)
considered regarded (advcl)
ensued . (punct)
added heparin (nsubjpass)
patients hemodialysis (compound)
used cyclophosphamide (nsubjpass)
rise ventricular (amod)
exchanges , (punct)
dystrophy osteoporosis (conj)
offset benefit (dobj)
controlled were (auxpass)
alteration deposition (conj)
failure progressive (amod)
area c(max (conj)
infusion snp (compound)
sucrose and (cc)
blocks in (case)
assay using (acl)
suggests effectiveness (nsubj)
treatment d-penicillamine (compound)
nephritis drugs-associated (amod)
associated would (aux)
failure doxorubicin-induced (amod)
denied n (dep)
aggregation coagulation (conj)
modulates that (mark)
3-year 2- (nummod)
hypoxia 8 (conj)
treatment sd (nmod)
it from (case)
contraceptives risk (conj)
forces and (cc)
contribute cardiotoxicity (nmod)
anemia with (case)
initiate stimulating (advcl)
flestolol ) (punct)
hg 5.6+/-0.9 (nummod)
superoxide o2- (appos)
sham-operated sham (dep)
17.6-fold were (cop)
3504 +/- (cc)
nephritis anemia (conj)
patients evaluable (amod)
0.2 , (punct)
conjugation capacity (conj)
phenobarbital , (punct)
renal and/or (cc)
switched generations (nmod)
channels ca (compound)
disorders panic (compound)
system intracarotid (amod)
prevented pain (nsubjpass)
diluent ethanol (compound)
report patient (nmod)
prescribed att (nsubjpass)
polymerase for (case)
except group (nmod)
separation for (case)
response blood (compound)
debated role (nsubjpass)
has weeks (nmod)
prevention treatment (conj)
piglets newborn (amod)
type oxide (nmod)
duration express (acl:relcl)
patients depression (nmod)
resulted animals (nmod)
effects specific (amod)
showed 9 (parataxis)
estimated number (nsubjpass)
analysis facs (compound)
was tapered (conj)
leak bolus (nmod)
exposure gvg (compound)
japan from (case)
$ROOT$ controls (sent)
khz 12 (nummod)
mechanism immunoallergic (amod)
dropped u/l (nmod)
abundant remarkably (advmod)
ineffective drugs (nsubj)
observed hippocampus (nmod)
had responses (dobj)
presents rate (dobj)
carbonate contributed (acl:relcl)
neoplasms increased (amod)
relationship direct (amod)
dose gm (nmod)
observed treatment (nmod)
background a (det)
pain experimental (amod)
anticoagulant . (punct)
region in (case)
urate assess (xcomp)
changed reported (advcl)
trimethaphan ganglionic (amod)
women % (appos)
require . (punct)
drink containing (acl)
came rediscovery (nmod)
higher db (nmod:npmod)
assayed . (punct)
bind , (punct)
apnoea p (dep)
effective preventing (advcl)
cr % (compound)
ascended and (cc)
agent proving (advcl)
agonist alpha- (amod)
fluency fluency (conj)
mepivacaine to (case)
tissues women (nmod)
1.52 1.98 (appos)
% 23 (nummod)
indicate undergoes (ccomp)
obtained they (nsubj)
modalities conventional (appos)
was characterize (xcomp)
amphetamine- psychosis (conj)
service public (compound)
found flumazenil (nsubjpass)
rates post-transplant (amod)
recommended is (auxpass)
disturbances rhythm (nmod)
amikacin with (case)
completely very (conj)
jaundice severe (amod)
effects concerning (case)
groups control (dep)
studied behaviors (nmod)
nature neoantigens (nmod)
induce treatment (nsubj)
chains common (amod)
ascites and (cc)
hypothesize we (nsubj)
course lamivudine (nmod)
raised excretion (dobj)
on . (punct)
progestagens second-generation (amod)
blockade endomt (nmod)
3.5 ) (punct)
reduce death (dobj)
6 7.5 (conj)
carried : (punct)
antidotes other (amod)
taxol ) (punct)
conclusions lead (appos)
prospective one (nsubj)
5-ht metabolite (conj)
7931 392.8 (conj)
found 7 (nmod)
values pms (nmod)
correlations the (det)
289 264 (nummod)
raised substances (nsubj)
estradiol- esters (conj)
atriotomy left (amod)
lasted occurred (advcl)
has cancers (nmod)
real only (advmod)
times minutes (appos)
csa ; (punct)
facilitate , (punct)
systolic both (cc:preconj)
countries advanced (amod)
insights pathophysiology (nmod)
factor ligand-activated (amod)
2.2 mean (compound)
use flestolol (nmod)
dependent occurring (xcomp)
considered prescribing (advcl)
that hypaque (nmod)
mood , (punct)
ratings psychopathology (compound)
rare relatively (advmod)
rate effects (nmod)
cardiotoxin consequence (conj)
illustrates it (nsubj)
% 24 (nummod)
medicine protective (amod)
features histopathologic (amod)
excitability epilepsy (nmod)
receptors possessing (acl)
h-1 ( (punct)
1.0 1.91 (conj)
mice associated (acl)
cck-8-se and (cc)
$ROOT$ proposed (sent)
enrolled ; (punct)
completed received (advcl)
phenomenon adverse (amod)
reverse , (punct)
tool be (cop)
compliance were (cop)
disturbing had (aux)
co-infection or (cc)
cortex piriform (amod)
points response (nmod)
sought here (advmod)
felt palpitation (dobj)
balances activity (conj)
system renin (amod)
lack to (case)
elicited which (nmod)
calls this (nsubj)
frequency abnormalities (nmod)
exist glyburide (nmod)
deficient e. (nmod)
difference mean (compound)
index physical (amod)
content glepp1 (nmod)
warfarin to (case)
lines in (case)
presented coma (nmod)
action drug (compound)
consistent degeneration (nmod)
44 in (case)
thickened markedly (advmod)
mean sem (appos)
potentiates extends (conj)
potential blocker (compound)
action membrane-stabilizing (amod)
rendered but (cc)
tested first (advmod)
areas certain (amod)
recruited was (auxpass)
problem patients (nmod)
diuretics with (case)
reduction treatment (nmod)
treatment to (mark)
function vocal (amod)
caused be (auxpass)
treated currently (advmod)
dyskinesia of (case)
tubules by (case)
roots vessels (conj)
mg/kg i.v. (appos)
aspirated needed (conj)
received nacl (dobj)
patients characteristics (nmod)
paclitaxel . (punct)
extract of (case)
reported behaviors (nsubjpass)
scale seizure (compound)
patients patients (nmod)
activity analgesics (nmod)
sensitive outflow (nmod)
mm 20 (nummod)
unchanged . (punct)
having first (nsubj)
r4 and (cc)
onset course (nmod)
patients methods (conj)
$ROOT$ pesticide (sent)
accumulation intra-alveolar (amod)
objective study (compound)
bar from (case)
propofol-remifentanil-tiva by (case)
trials treatment (nmod)
unable continue (xcomp)
change outcome (conj)
threshold " (punct)
stopped medication (nsubjpass)
glutamate glutamine (conj)
push a (det)
behavior test (nmod)
groups many (amod)
treatment scleroderma (nmod)
dose gnc92h2 (nmod)
lipocalin and (cc)
observed shift (nsubjpass)
cochlea the (det)
$ROOT$ progression (sent)
75 25 (compound)
deoxycorticosterone pregnane-21-diol-20-ones (appos)
impairment function (nmod)
suggesting inhibits (ccomp)
days 109 (nummod)
nitrate isosorbide (compound)
remains however (advmod)
started who (nsubjpass)
results our (nmod:poss)
have dimension/function (nmod)
estimate frequency (dobj)
cause effect (dobj)
maximum be (cop)
sufferers 12 (nummod)
reflexes micturition (compound)
100/mm3 ) (punct)
shake ergometrine-induced (amod)
hg mm (nmod:npmod)
induce agent (nsubj)
dat(-/- ( (punct)
exposure administration (conj)
associated contraception (nmod)
attempted but (cc)
smoking . (punct)
effect ketamine (nmod)
mg/dl 15.0 (nummod)
carried tumor (nmod)
reversal naloxone (compound)
flare dose-dependent (amod)
correct effective (advcl)
multicenter controlled (dep)
% risk (nsubj)
more ratio (nsubj)
ability treatment (nmod)
nitrogen by (case)
stroke ) (punct)
eaca ) (punct)
regimens chemotherapy (compound)
one compared (case)
asia in (case)
suggested causes (ccomp)
anti-inflammatory ketorolac (dep)
re-elevate pressure (dobj)
iop and (cc)
associated antidepressants (nsubjpass)
found therapy (nmod)
induced giving (advcl)
remain should (aux)
resembles and (cc)
system nigrostriatal (amod)
hospitalisation of (case)
efficacy apomorphine (compound)
requiring therapy (nmod)
appeared advanced (conj)
children 3 (nummod)
oc generation (compound)
paradigms new (amod)
form non-hydrolyzable (amod)
potentiate to (mark)
magnitude vasodepressor (nmod)
aware toxicity (nmod)
name trade (compound)
terminate encephalopathy (dobj)
dose dose (dep)
lamivudine antiviral (amod)
hours 36 (nummod)
doses granisetron (nmod)
affect lesion (nsubj)
tland sweden (appos)
involved carcinogenesis (nmod)
effect exposure (nmod)
had enalapril (nsubj)
pass , (punct)
myopathy the (det)
due are (cop)
ph low (amod)
indeterminate . (punct)
interviewed experience (nmod)
rate 24-hour (amod)
nitrogen patients (nmod:poss)
day their (nmod:poss)
studies learning (compound)
convulsions against (case)
included these (nsubj)
prevented indicating (xcomp)
days=1.77 days (appos)
treatment its (nmod:poss)
32.4 - (punct)
rate hyponatremia (nmod)
neutrophils patients (nmod)
substrates these (det)
conducted mice (nmod)
design studied (appos)
result interpretation (nsubj)
oxidase xo (appos)
leads whether (mark)
5-fu cy (conj)
state hypotensive (amod)
dosing twice-daily (amod)
adenoma hyperplasia (conj)
generated importance (nmod)
hydrolysis in (amod)
10 , (punct)
determine increases (ccomp)
injection an (det)
compromises reversed (advcl)
% 6 (nummod)
once-daily vs. (cc)
role diagnostic (amod)
differ complained (parataxis)
enhanced whether (mark)
postponed . (punct)
responded animals (nsubj)
patients psoriasis (nmod)
susceptible also (advmod)
albuminuria , (punct)
6-hydroxydopamine-lesion unilaterally (advmod)
likelihood about (case)
disorder hyperactivity (compound)
micrograms/ml ( (punct)
gr/dl of (case)
cisplatin paclitaxel (conj)
range models (nmod)
changes degeneration (appos)
granules cisternae (conj)
edema proliferation (conj)
effect activation (nmod)
available and (advmod)
behaviors interfering (amod)
administration phenytoin (nmod)
4-damp ( (punct)
responses peripheral (amod)
shock treatment (nmod)
studied total (nsubjpass)
viracept the (det)
iugr ( (punct)
cases tg (nmod)
succinylcholine mg (dep)
slope a (det)
shift relation (nmod)
efficacy i (nummod)
salbutamol like (case)
concluded activated (ccomp)
lp hh (conj)
has questioned (conj)
participates synthase (nsubj)
test rast (conj)
show suggestive (advmod)
seizures of (case)
duration time (conj)
suppression systems (nmod)
-16.2 ( (punct)
overload aconitine-induced (amod)
use admission (nmod)
patients ambulatory (amod)
found proved (ccomp)
ng avp (nmod)
postoperative immediate (amod)
months/patient 21 (nummod)
regimen their (nmod:poss)
downregulated erythropoietin (nsubj)
lacking mpges-1 (dobj)
level contaminant (nmod)
confirmed which (nsubj)
acts . (punct)
erythropoietin recombinant (amod)
assay protection (compound)
exists established (advcl)
insult the (det)
activity animals (nmod)
endocrinologists by (case)
bfue splenic (amod)
dosages to (case)
piroxicam with (case)
localization activity (nmod)
symptomatic start (nmod)
normal initially (advmod)
mice bpa (nmod)
treated hemodialysis (nmod)
suggest engaged (ccomp)
diazepam alone (advmod)
effect size (nmod)
illness of (case)
1 12 (conj)
fluctuations in (case)
stimulation selective (amod)
reviewed were (auxpass)
effect pilocarpine (nmod)
occurs incidence (nsubj)
sulfate drug (compound)
cysts subependymal (amod)
acts be (cop)
leads administered (advcl)
68 32 (conj)
barrier blood-brain (amod)
toxicity manifest (amod)
obtaining activity (dobj)
observation additional (amod)
formation cataract (compound)
outcomes of (case)
effect severity (nmod)
conditions amount (nmod)
infarction for (case)
dose mg/kg/day (nmod)
edema wheezing (nmod)
awake were (cop)
factor nerve (compound)
170 patient (nmod)
activation proliferator-activated (amod)
dm-9384 ) (punct)
induction % (compound)
cause as (case)
available that (mark)
metabolism decreased (amod)
change weight (compound)
cause frequently (advmod)
increased showing (advcl)
muscle vascular (amod)
magnitude and (cc)
pelvis the (det)
convulsions idiopathic (amod)
chloride mg/kg (appos)
leading development (nmod)
paid . (punct)
deoxycholate amphotericin (compound)
exposed gestation (nmod)
11.5 10(-3 (conj)
development nephropathy (nmod)
none discontinuation (nmod)
seven three (quantmod)
study smokers (nmod)
hypertension the (det)
tubular proximal (amod)
more was (cop)
preventing proteinuria (dobj)
cholesterols plasma (compound)
tasks = (parataxis)
metabolism serum (nmod)
potentiated chick (nmod)
cholecystokinin mice (nmod)
cholesterol , (punct)
implantation after (case)
4.1 1.5 (nummod)
clinical cytologic (conj)
follow-up last (amod)
monotherapies than (case)
1.7 p=0.385 (appos)
relaxed restriction (nsubj)
included which (nsubj)
control rate (compound)
delays apigenin (nsubj)
proven safe (xcomp)
foods beverages (conj)
7 3 (quantmod)
gd or (cc)
mastectomy reconstruction (conj)
participants 12 (nummod)
appear protect (xcomp)
thickness ventricular (amod)
recovery eventual (amod)
restarted drug (nsubjpass)
changed both (advmod)
$ROOT$ recived (sent)
study defects (compound)
induced which (nsubjpass)
levels ang (nmod)
buspirone and (cc)
l/min p (appos)
tumor bladder (compound)
followed normalization (nmod)
aware ophthalmologists (nsubj)
included thrombophlebitis (dobj)
zo-1 like (case)
evaluate outcomes (dobj)
strategy one (nummod)
epistaxis the (det)
diagrams scatter (compound)
fibrosis slight (amod)
d11 d19 (conj)
nephrotoxic these (nsubj)
provoked doxorubicin (nmod)
circulation into (case)
syndrome qt (compound)
syndromes clinical (amod)
hydration forced (amod)
alternative was (cop)
2r,4r-apdc ( (punct)
associated treatment (nsubjpass)
reduces damage (dobj)
tested studies (nmod)
exception mice (nmod)
neurotoxicity in (case)
barrier nephrosis (nmod)
cystitis ifosfamide-induced (amod)
cei ( (punct)
changes engaged (acl)
chelator iron (compound)
treatment dependence (nmod)
efficacy ; (punct)
accounting sensitivity (nmod)
exemplified reports (nmod)
caused anemia (nmod)
appear benefited (xcomp)
obtained one (nmod)
concentration each (det)
associated inhibition (nmod)
$ROOT$ experiment (sent)
blindness response (nmod)
iqr range (appos)
thiopental iv (nummod)
transport barrier (nmod)
minutes ten (nummod)
modulated convulsions (nmod)
exacerbated inhibited (conj)
c1 and (cc)
higher p. (nmod)
microl of (case)
sufficient explain (xcomp)
pointes intervals (nmod)
were hemorrhages (attr)
carcinogen of (case)
indicating involvement (dobj)
mssbp and (cc)
nanosphere lipid (compound)
revealed calculation (nsubj)
dopamine-1 agonists (conj)
antagonist central-acting (amod)
$ROOT$ advised (sent)
sodium urinary (amod)
increases volume (compound)
reported demonstrated (advcl)
injections carboplatin (compound)
collapsed . (punct)
atp or (cc)
drugs antithyroid (amod)
complication seizures (nsubj)
resolved epistaxis (nsubj)
3.1 +/- (cc)
acted . (punct)
lead decrease (nmod)
consider most (nsubj)
described have (aux)
epithelium forestomach (compound)
$ROOT$ substitute (sent)
caused cessation (nmod)
mmps ) (punct)
0.005 than (case)
vision as (cc)
pain injections (nmod)
support organ (compound)
reproduce dyskinesias (dobj)
assessed effects (nmod)
toxicity significant (amod)
mobilization fatty (amod)
carbetocin administered (acl)
picu ) (punct)
tissue by (case)
patient nor (cc)
thickening posterior (amod)
indications effect (nmod)
t(1/2 elimination (compound)
evaluated recall (nsubjpass)
having symptoms (dobj)
tumors and (cc)
assess retention (dobj)
gain velocity (conj)
angiograms right (amod)
99 . (punct)
% many (amod)
survived whether (mark)
administration onset (conj)
sample plasma (nmod)
clinicians two (nummod)
rats group (compound)
limited expectancy (nsubj)
triphosphate adenosine (compound)
reached have (advcl)
instillation alpha (nmod)
diazinon the (det)
3.45 +/- (cc)
insertion associated (acl)
interval 17.5 (appos)
hyperparathyroidism primary (amod)
$ROOT$ potent (sent)
polymorphism type (compound)
allocated ; (punct)
cells primitive (amod)
eliminating dph (dobj)
carbachol of (case)
rats induced (acl)
correction for (case)
frequency upslope (conj)
stimulation hippocampal (compound)
shown subsequently (advmod)
plasma levels (dep)
steroids the (det)
non-users among (case)
enhance synthesis (dobj)
consumption of (case)
children and (cc)
estrogens associated (acl:relcl)
gliosis including (case)
requested . (punct)
paralysis administration (nmod)
cells collecting (compound)
zones reactivation (nmod)
blunted prevent (conj)
life-threatening and (cc)
induce contribute (conj)
modulate can (aux)
fluids , (punct)
mg . (punct)
nanoparticles solution (conj)
effects cholinesterase (nmod)
lymphoma patient (nmod)
accompanied are (auxpass)
placebo 962 (conj)
effect aspects (nmod)
longer time (nsubj)
method according (case)
sample patient (compound)
3 1 (compound)
development insufficiency (nmod)
exceeded confines (dobj)
one severe (amod)
used rats (dobj)
induces asa (nsubj)
bfgf including (case)
micrograms day (nmod)
treatment fractures (nmod)
diuresis alkaline (compound)
months postimplant (appos)
nitroglycerin after (case)
hg respectively (advmod)
remission spontaneous (amod)
complexes specific (amod)
play abundance (nsubj)
uses for (case)
653 +/- (cc)
plasma osmolarity (conj)
streptomycin of (case)
hyperactive groups (nmod)
include that (mark)
analog visual (amod)
reduced number (nsubjpass)
applied nadolol (nsubjpass)
hour one (nummod)
testing and (cc)
trends only (amod)
react that (nsubj)
tissue pacemaker (compound)
occurred doses (nmod)
evaluated children (nsubjpass)
etoposide daunorubicin (conj)
fibrillation from (case)
selective damage (nsubj)
2-p-(2-carboxyethyl)phenethylamino-5'-n-ethylcarboxamidoadenosine n6-cyclopentyladenosine (conj)
experienced and (cc)
receive transplant (dobj)
immunosuppressed generally (advmod)
injury new (amod)
prepared cells (nmod)
develop aki (dobj)
intake supplements (nmod)
barrier urine (nmod)
assessment field (compound)
conceivable be (cop)
striatum hippocampus (conj)
basis dose (nmod)
range speech (compound)
type progestagen (nmod)
mg/m2bsa 120 (nummod)
collected retrospectively (advmod)
3.45 2.45 (conj)
administrated separately (advmod)
5 bpo (nmod)
received 2-chloroprocaine-ce (dobj)
tone of (case)
acquire to (mark)
use symptoms (conj)
exchange plasma (compound)
scans with (case)
strain was (cop)
have so (advmod)
reported disease (nmod)
poison rat (compound)
illustrates risk (ccomp)
associated jaundice (nsubj)
1.5 +/- (cc)
maze epm (appos)
use anticonvulsants (nmod)
3-methylcholanthrene inducer (appos)
potential : (punct)
mg/day dose (appos)
january 1986 (nummod)
increasing simply (advmod)
$ROOT$ paclitaxel (sent)
demonstrate infarction (dobj)
preferable has (advcl)
involve increase (dobj)
5.8 0.4 (conj)
evaluable clinically (advmod)
factors diabetes (nmod)
effects lymphoma (nmod)
greater using (parataxis)
type was (cop)
had inhibition (nsubj)
ligation 24-h (amod)
painful that (mark)
loss significant (amod)
= 0.011 (dobj)
alter that (mark)
strains between (case)
cromakalim by (case)
maintained concentration (nmod)
increases ) (punct)
based was (auxpass)
dynamics abnormal (amod)
evaluated scale (nmod)
packing moving (conj)
enzyme and (cc)
gspe gspe+drug (conj)
induced nephrotoxicity (nmod)
muscle venous (amod)
times catalepsy (compound)
profiles effect (compound)
beating and (cc)
reduce hyperprolactinemia (nsubj)
cirazoline of (case)
protease n-acetylglucosaminidase (conj)
elevated se (nmod)
analogues with (case)
diclofenac % (dep)
revealed rates (nmod)
injections compared (case)
social and (cc)
angiodegeneration wall (nmod)
absence pkc-alpha (nmod)
present drug (nsubj)
syndrome aminonucleoside-induced (amod)
risk die (acl)
1 < (advmod)
circulation of (case)
invariable are (cop)
globulin with (case)
developed cin (nsubj)
patients 590 (nummod)
syndrome ovary (amod)
documented and (cc)
potentiate domperidone (nsubj)
implicated clarithromycin (nsubjpass)
hippocampus seizures (nmod)
ascites genotypes (nmod)
differ not (neg)
meq/l 6.9 (nummod)
failed promote (xcomp)
episodes bleeding (compound)
suggest implicate (conj)
dose micrograms/mouse (appos)
identified characterized (conj)
consensus treatment (nmod)
preserved present (ccomp)
6 , (punct)
% iopamidol (nmod)
bell-shaped generally (advmod)
alterations stress (conj)
resembles used (conj)
exhibited respectively (advmod)
useful model (nsubj)
index gsi (appos)
decrement learning (compound)
cascade neuroinflammatory (amod)
girl treated (acl:relcl)
microgram/kg/min up (advmod)
fingers on (case)
mechanisms compensatory (amod)
peroxide hydrogen (compound)
toxicities leukopenia (dep)
bupivacaine with (case)
disturbances significant (amod)
had % (nsubj)
used drugs (nsubjpass)
thromboembolism use (nmod)
manifest may (aux)
levels those (nmod)
features with (case)
amount model (nmod)
pharmacotherapy fluoxetine (nmod)
affinity with (case)
recognition fear (compound)
dideoxyinosine ' (amod)
ddi ) (punct)
ck-mb 4 (conj)
malignancies arising (acl)
increased comparison (nmod)
agent ethambutol (nsubj)
women selected (acl)
explain defects (nsubj)
abstained learning (nmod)
reversed tachycardia (nsubjpass)
a-containing vitamin (nmod:npmod)
suppressed les (nmod)
prolongation tachycardia (conj)
use oral-contraceptive (amod)
underwent who (nsubj)
surgery aneurysms (nmod)
progress treatment (nsubj)
methscopolamine penetrate (acl:relcl)
case describe (appos)
facilitate information (nsubj)
mgkg i.p. (appos)
required since (mark)
min once (advmod)
exposure all (det)
review an (det)
low even (advmod)
inhibitor specific (amod)
damage damage (conj)
exerts it (nsubj)
therapy 5-fluorouracil/folinic (amod)
thymus bodyweights (conj)
effect cataleptic (amod)
wasting potassium (compound)
mitoxantrone mg/m2 (appos)
increase 0.05 (nummod)
exposed ; (punct)
represent may (aux)
morphology gene (nmod)
produced which (nmod)
bupropion given (acl)
activity overall (amod)
given induces (ccomp)
studies secondary (amod)
obtain data (dobj)
question the (det)
response significant (amod)
represent myopathy (nsubj)
elements both (det)
vehicle with (case)
toxicities 4 (nummod)
reduced % (conj)
ck-mb ) (punct)
double-blind randomized (conj)
described toxicities (nsubjpass)
years women (compound)
discontinuation drug (nmod)
damage between (case)
pathway mediated (acl)
basis a (det)
granulomas and (cc)
last ) (punct)
0.6 whereas (dep)
damage matrix (nmod)
nephropathy fk506 (compound)
demonstrating in (mark)
by lowering (pcomp)
carbachol is (advmod)
killed that (mark)
atp ( (punct)
days 80 (conj)
tissue lining (conj)
antigens dilevalol (compound)
barrier cellular (amod)
admitted developed (advcl)
score disease (compound)
conjugates dextran-etodolac (compound)
therapy population (nmod)
abandoned cases (nmod)
hypotension isoflurane-induced (amod)
40.1 6.24 (conj)
patients both (preconj)
presents picture (dobj)
tri ) (punct)
descriptive , (punct)
likely ly-171555 (nmod)
prone attacks (nmod)
$ROOT$ surmountable (sent)
detail in (case)
nephrin podocin (conj)
pronounced , (punct)
possibilities different (amod)
naming and (cc)
examined slices (nmod)
jaundice , (punct)
increases modest (amod)
potassium in (case)
study cytogenetic (amod)
considerations paranoia (nmod)
liable are (cop)
globulin antithymocyte (compound)
antagonists beta-adrenoceptor (compound)
period scanning (compound)
depletor serotonin (compound)
examination ophthalmic (amod)
infusion ketamine (nmod)
erythromycins cephalosporins (conj)
$ROOT$ hypothesis (sent)
mtx [ (punct)
induced reduction (dobj)
diagnosis 17 (nmod)
group doxorubicin-treated (amod)
integration referred (acl)
contraindication they (nsubj)
inflammation neuropathy (conj)
classified status (nmod)
arteries on (case)
induced pilocarpine (nmod)
ceased was (auxpass)
neurodevelopment on (case)
tachyarrhythmias interaction (dep)
impairment growth (compound)
injections iopentol (compound)
changes therapy (nmod)
encephalopathy developed (acl)
mass tissue (compound)
nigra sn (appos)
proceeded mg/m2/d (nmod)
1 . (punct)
regulated system (dobj)
blocked atropine (nmod)
sustained not (neg)
infection secondary (amod)
coli with (case)
risk antibiotics (nmod)
cannulae through (case)
diabetes adult-onset (amod)
muscle cardiac (amod)
estimate implications (nmod)
deprivation sleep (compound)
rate effect (nmod)
monitor noninvasive (amod)
cycles ; (punct)
concomitant inrcease (nmod)
shr = (dep)
analysed examined (conj)
exposure mg/kg (appos)
c7-c8 ) (punct)
selectivity affinity (conj)
syndrome chlorpromazine-induced (amod)
dronedarone after (case)
trial prevention (nmod)
alternative superior (amod)
3500 over (quantmod)
ameliorated symptoms (dobj)
stones scores (nmod)
of are (cop)
agonist of (case)
urticaria/angioedema with (case)
ranging months (nmod)
using rt-pcr (dobj)
had offspring (nsubj)
blockers four (nummod)
observed pretreatment (nmod)
impairment the (det)
mm 76 (nummod)
users pubertal (amod)
association markers (nmod)
risks disease (nmod)
consisted . (punct)
26 c (nmod)
control inhibitors (conj)
$ROOT$ metabolised (sent)
monocytes isolated (acl)
able whether (mark)
pulse amplitude (dep)
ceruleus rat (compound)
animals t-treated (amod)
pairs rats (nmod)
sludge cholecystitis (conj)
indicating decrease (dobj)
comparison timolol (nmod)
reactions late (amod)
ratio years (nmod)
stopped convulsions (nsubj)
inhibited activity (dobj)
received paclitaxel (dobj)
nimodipine ( (punct)
year birth (nmod)
signals to (case)
elicit could (aux)
2002 to (case)
blocks anaesthetic (amod)
doses these (det)
system damage (nmod)
seen levels (nsubjpass)
subjects six (nummod)
identified ultrastructurally (advmod)
frequency hepatotoxicity (nmod)
creation the (det)
disruption homeostasis (nmod)
week ) (punct)
peroxidation erythrocytes (nmod)
87.1 - (punct)
completion vcug (nmod)
index < (amod)
suspect due (ccomp)
induces labetalol (nsubj)
substances single (amod)
transplantation allogeneic (amod)
room recovery (compound)
scale vas (appos)
areas develop (acl:relcl)
protein beta1 (conj)
pathway may (aux)
cells nodules (nmod)
antioxidant as (case)
seems degree (nmod)
intensity increased (amod)
administered malfunctioning (nmod)
seconds of (case)
treatment kanamycin (nmod)
aspirin level (nmod)
controlled medication (nmod)
symptoms major (amod)
using plasma (dobj)
emissions neonates (nmod)
examine factors (dobj)
efficiency determination (nmod)
nicergoline against (case)
impairment vcm-induced (amod)
asked patients (nsubjpass)
scavengers of (case)
treating patients (dobj)
perturbation structural (amod)
associated university (nmod)
based information (nmod)
map of (case)
induced treatments (nmod)
treat epicondylitis (dobj)
values for (case)
uncertain alerted (conj)
observed been (auxpass)
cases eight (nummod)
glioblastoma unresectable (amod)
pn 14 (nummod)
ethyl-alpha-p-chlorophenoxyisobutyrate by (case)
alendronate ) (punct)
transformation assessed (acl)
rare established (conj)
effect although (mark)
doxorubicin/kg mg (nummod)
range 6 (appos)
aminoguanidine ag (appos)
slow doses (nsubj)
changes electrocardiographic (amod)
fluoxetine by (case)
potentials brainstem (compound)
death in (case)
ps group (appos)
13 16 (conj)
cardioselective ) (punct)
common discontinuations (nmod)
recovery full (amod)
factors and (cc)
fibrosis some (det)
enzymes , (punct)
reached ( (punct)
nephrotoxicity by (case)
blockade calcium (compound)
injected groups (nmod)
cd50 ld50 (conj)
mmp-2 mmp-9 (conj)
observation detection (conj)
rise of (case)
studied dyskinesia (nmod)
high group (nmod)
affected commonly (advmod)
regimens optimal (amod)
patient neuropathy (nmod)
migraine in (case)
l/hour/m2 204 (nummod)
available preparations (nsubj)
showed evaluable (ccomp)
territories vascular (amod)
solution albumin (nmod)
bilirubin mg/dl (appos)
vestibular central (conj)
provide can (aux)
g/m2 2 (nummod)
shock refractory (amod)
greater suggesting (advcl)
stronger pronounced (conj)
were required (conj)
improved abilities (nsubj)
ranging = (parataxis)
gives rise (dobj)
find evaluate (conj)
= f(33 (nsubj)
appears associated (xcomp)
evaluated uropathy (nmod)
mmol.kg(-1).day(-1 ( (punct)
same related (advcl)
testing duction (compound)
l-arginine incorporating (acl)
recorded monitoring (nsubj)
literature medical (amod)
vasculitis warfarin-induced (amod)
counteracted levels (dobj)
weeks dose (nmod)
died observed (conj)
$ROOT$ replicated (sent)
reversed administration (nmod)
early very (advmod)
studies histopathological (amod)
appeared defect (nsubj)
correlated symptoms (nsubjpass)
threat life (nmod)
akathisia humans (nmod)
children 4 (nummod)
nine patients (nmod)
sprouting se-induced (amod)
tolerated occurred (conj)
physiology neuromuscular (amod)
enhancement no (neg)
association for (case)
wall arteriole (nmod)
urge bladder (conj)
standard a (det)
related profile (nmod)
dependence the (det)
lower netilmicin (nmod)
load viral (amod)
drug environment (conj)
unclear are (cop)
mg/m2 paclitaxel (compound)
hypertension portal (amod)
cause findings (nmod)
first include (acl:relcl)
longer duration (nsubj)
months five (nummod)
prevention ulcers (nmod)
emerged again (advmod)
uncertain is (cop)
useful explore (xcomp)
antagonist competitive (amod)
protection neurotoxicity (nmod)
md ) (punct)
work further (amod)
beverages of (case)
$ROOT$ fire (sent)
caused arrhythmias (dobj)
exposure short (amod)
sex diagnosis (conj)
eyes dry (amod)
neurons brain (nmod)
correlated to (mark)
results amines (nmod)
induced chlorpromazine (nmod)
warfarin d (conj)
found ribavirin (nsubjpass)
background with (case)
ambiguus at (case)
everolimus with (case)
cancer platinum-resistant (amod)
addition allografts (nmod)
cases girl (nmod)
duration median (amod)
transplants 84 (nummod)
increase firmness (nmod)
achievable doses (nmod)
thrombocytopenia profound (amod)
logical difficult (advcl)
pain during (case)
eruption syndrome (nsubj)
reversibility the (det)
encephalopathy toxic (amod)
interleukin between (case)
bilirubin direct (amod)
recurrence telangiectasia (nmod)
types several (amod)
decrease day (nmod)
observed has (aux)
stabilizer a (det)
background history (conj)
increase postdose (amod)
unchanged levels (nmod)
3.1+/-1.0 ( (punct)
stimulation estrogenic (amod)
measure efficacy (amod)
evidence humans (nmod)
control bleeding (nmod)
vasculitis the (det)
liver preneoplastic (amod)
populations with (case)
entities by (case)
powered was (auxpass)
= 1.98 (parataxis)
post-exposure days (nmod:npmod)
damage cardiomyocyte (compound)
cycles four (nummod)
increase times (nmod)
dexmedetomidine acting (acl)
79 2 (conj)
blocked reversed (conj)
degkwitz 1964 (nummod)
thickness < (dep)
dialysis to (case)
32 0 (compound)
tls ( (punct)
freezing behavior (conj)
therapy rat (nmod)
showed behaviour (dobj)
conversion inhibitors (nmod)
2.9 x (cc)
continued procedure (nmod)
cells outer (amod)
enhanced significantly (advmod)
had 1 (nsubj)
lymphadenopathy hepatitis (conj)
cofactors of (case)
gentamicin netilmicin (conj)
lesion findings (dep)
cows the (det)
cause se (advmod)
hypothalamic-pituitary-adrenal hpa (appos)
significance be (cop)
effects anticholinergic (amod)
metabolism macrophages (nmod)
reduced supernatants (nsubj)
factor seroconversion (nmod)
assess safety (dobj)
baseline after (case)
b = (dep)
rapid effective (conj)
9.6-fold was (cop)
metabolism p450-mediated (amod)
done following (nmod)
responses standing (nmod)
time function (nmod)
proven has (aux)
methods series (appos)
during and (cc)
test second (amod)
500 < (advmod)
length follow-up (nmod)
determine feasibility (dobj)
status baseline (amod)
tablets mg (compound)
received h (nmod:tmod)
was examine (xcomp)
validate further (advmod)
125 250 (conj)
injecting drugs (dobj)
co-agonist a (det)
period dosing (nmod)
diagnosed = (parataxis)
processing users (nmod)
retention with (case)
blocked antagonist (nsubj)
administered tci (nmod)
greater this (nsubj)
proving and (cc)
hand other (amod)
support observations (nsubj)
drum beating (amod)
use opioids (nmod)
done observation (nsubjpass)
similar to (mark)
naa ( (punct)
pain degrees (conj)
patients immunocompromised (amod)
$ROOT$ herbicides (sent)
recall rating (compound)
stopping beta-agonist (dobj)
renin in (case)
precluded condition (nsubj)
occurred 11 (nmod)
stn gpi (conj)
assess case (nmod)
activity behavior (conj)
necrosis found (acl)
cases performed (acl)
addition phenylephrine (nmod)
profile compared (acl)
lysozyme endogenous (amod)
decayed . (punct)
report trial (dobj)
value uptake (compound)
receive did (aux)
therapy 24-week (compound)
impact : (punct)
main and (cc)
mg. was (cop)
injection 14c-41 (nmod)
ml 30 (nummod)
assessed data (nmod)
lost consciousness (dobj)
mrd eye (compound)
showed early (advmod)
td50 ed50 (conj)
inconsistent finding (nmod)
card yellow (amod)
should be (cop)
recipients in (case)
regimen treatment (compound)
necrosis acute (amod)
mg 0.6 (compound)
secondary trauma (nmod)
free that (nsubj)
nitroprusside micrograms.kg-1.min-1 (appos)
$ROOT$ dialysis (sent)
flattening duration (nmod)
effect anti-carcinogen (amod)
decrease 150 (nmod)
associated cancer (nmod)
routes to (case)
causes cirrhosis (dobj)
bortezomib dexamethasone (conj)
neurons sn (nmod)
outpatients hypertension (nmod)
ua ( (punct)
followed , (punct)
returned cessation (nmod)
association apoptosis (nmod)
received cidofovir (dobj)
tended ill (xcomp)
considered remainder (nmod)
therapy estradiol- (dep)
presence antibody (nmod)
effective lowering (advcl)
increased dose (nsubj)
alpha-tc intraperitoneally (advmod)
(cox)-2-specific cyclooxygenase (nmod:npmod)
abandoned administration (nsubjpass)
treatment epicondylitis (nmod)
device analgesia (compound)
caused nx (nsubj)
disease hyperplasia (conj)
runs 2 (nummod)
agents chelating (amod)
diseases heart (compound)
infrequent reversible (conj)
adjuvant potential (amod)
increases enhances (conj)
therapy anticoagulants (nmod)
produces vasodilatation (nmod)
had effects (dobj)
exerted cortex (nmod)
pregnane-21-diol-20-ones ( (punct)
quinidine like (case)
$ROOT$ low (sent)
physiology and (cc)
play to (mark)
introduced antidepressants (nsubjpass)
test elicits (ccomp)
results observed (appos)
9 to (advmod)
found myotonia (nsubjpass)
remained drugs (nmod)
occurred fibrillation (nsubj)
infarction isoproterenol-induced (amod)
up-regulation function (nmod)
genes target (compound)
therapy anticoagulant (compound)
dyspnea , (punct)
inhibition partially (advmod)
involvement development (nmod)
fed rats (nmod)
similar respectively (advmod)
antigens these (det)
recalled pains (dobj)
placebo on (case)
support to (case)
trial report (appos)
initiate tachykinins (nsubj)
prolongation reporting (conj)
showed asynergy (dobj)
tissue thickened (amod)
divided received (conj)
level striatum (nmod)
cells animals (nmod)
out-patients ( (punct)
receiving indomethacin (dobj)
suggested trial (nsubjpass)
delivery anesthesia (nmod)
melphalan by (case)
localization lesions (nmod)
required treatment (nsubj)
given test (nmod)
triceps of (case)
prolongation the (det)
prescribing patients (nmod)
infusion intravenous (amod)
deficiency secondary (amod)
rate events (nmod)
distinguishing cystica (nmod)
older or (cc)
college the (det)
heart , (punct)
exceeded normal (conj)
areas surrounding (amod)
palsy of (case)
sequence , (punct)
shortened decreased (conj)
disorder metabolism (nmod)
eruption a (det)
improving radio-chemotherapy (nmod)
induced tamoxifen (nmod)
conjugation acid (compound)
signs all (predet)
level indinavir (nmod)
5-azacytidine , (punct)
sleep , (punct)
summarized . (punct)
infusions target-controlled (amod)
discontinuance the (det)
risk eps (nmod)
therapy optimal (amod)
increase regulated (amod)
mg/kg/i.v . (punct)
induced carbimazole (nmod:npmod)
dyslipidemia requiring (acl)
suspicion on (case)
cardiomyopathy high-grade (amod)
12 seven (quantmod)
magnesium and (cc)
associated was (conj)
stimulation with (case)
hematoma entrapment (conj)
cause neurotoxicity (dobj)
assessed study (nmod)
therapy chloride (compound)
% those (nmod)
exists correlation (nsubj)
short-term b (dep)
women 3 (nummod)
ecstasy both (cc:preconj)
range age-adjusted (amod)
inhibition iib/iiia (compound)
analog a (det)
incidence weeks (nmod)
agent hypotensive (amod)
32 17 (quantmod)
cystica true (amod)
has serve (ccomp)
preponderance infections (nmod)
destroy bbb (dobj)
treatment olanzapine (nmod)
efflux methamphetamine-induced (amod)
amantadine with (case)
mg/lb 9.1 (nummod)
experiment analysis (nsubj)
led us (dobj)
na+-extrusion cells (nmod)
clozapine olanzapine (appos)
patients ssc (nmod)
contain does (aux)
gentamicin used (acl:relcl)
dysrhythmias and (cc)
dogs to (case)
blocked anesthesia (nmod)
presented unique (dep)
eligible . (punct)
remember to (mark)
bolus and (cc)
expressed receptor (nsubjpass)
cases these (nsubj)
injuries mediated (acl)
measure values (dobj)
observed moreover (advmod)
factors susceptibility (compound)
proteins several (amod)
performed decompression (nsubjpass)
active is (cop)
conjunction in (case)
nsclc stage (compound)
eyes between (case)
rarer myocarditis (nsubj)
degrees was (cop)
november from (case)
effect nimodipine (nmod)
transplant an (det)
cholestatic ( (punct)
hyperglycemia occasionally (advmod)
microphthalmos including (case)
introduced p11 (nsubjpass)
increased depression (dobj)
diaphragm of (case)
relative of (case)
angioedema in (case)
levonorgestrel , (punct)
nephrotoxicity nephrotoxicity (conj)
lower compared (advcl)
initiation for (case)
contributed seizures (nmod)
symptoms on-period (amod)
attenuated effect (nmod)
hyperprolactinemia and (cc)
developed followed (dep)
started should (aux)
reported 33 (nsubjpass)
duration on (case)
min 1 (nummod)
diagnoses rejection (nmod)
assessed trials (nmod)
rcts of (case)
occurred resolution (nsubj)
mg/kg 3.45 (nummod)
reduces risk (dobj)
prompted findings (nsubj)
reactions severe (amod)
s from (case)
$ROOT$ mg/m2 (sent)
emphasis the (det)
follow-up ) (punct)
pellet microg/day (appos)
increased eroded (conj)
increased was (conj)
arabic days (nmod)
manifestations toxic (amod)
problematic be (cop)
december 2002 (nummod)
withdrawal reintroduction (conj)
aggressiveness evoked (acl)
mg/m(2 25 (nummod)
mild require (conj)
hr after (case)
30.7 1.1 (nummod)
cystourethrogram voiding (amod)
mitochondria altered (amod)
54.5 in (case)
normalization the (det)
evident not (neg)
synthesize that (mark)
incidence edema (nmod)
intensity gap43-ir (nmod)
uncommon , (punct)
antidepressant noradrenergic (amod)
conclusions had (appos)
fall and (cc)
hypersensitivity the (det)
beta-blockers blockers (conj)
rats tumor-bearing (amod)
controlled was (auxpass)
exposed mice (nsubjpass)
symptoms incidence (dep)
related from (case)
assessment humphrey (compound)
estimation the (det)
anemia heinz (compound)
seizure pilocarpine-induced (amod)
profile typical (amod)
interfered sympathectomy (nmod)
naloxone of (case)
protein 8.8 (nummod)
moderate mild (amod)
exposed lithium (nmod)
moving-bands fast (amod)
ischemia rat (nmod)
clonidine of (case)
registrations electrocardiographic (amod)
proteinuric given (conj)
exceeds when (advmod)
comparison effects (nmod)
small but (cc)
differences depend (acl:relcl)
stz-icv ( (punct)
modification action (nmod)
activity horizontal (amod)
concentration gentamicin (compound)
creatinine micromol/l (appos)
associated chloramphenicol (nmod)
hippocampus treated (acl)
remains model (attr)
bortezomib regimens (conj)
discontinued resolved (conj)
atropine i.v. (advmod)
concentration and (cc)
motor flexion/extension (dep)
rates symptoms (conj)
assessed also (advmod)
2r,4r-apdc microl (appos)
associated ara-c (nsubjpass)
had seizures (dobj)
clearance and (cc)
thickness of (case)
behaviour clinical (amod)
tbm in (case)
gave protection (dobj)
gfc75 plus (cc)
continued treatment (dobj)
increased 0.50 (nmod)
activity suxamethonium (nmod)
iu/kg/h ( (punct)
p<0.001 both (det)
transporter major (amod)
man 21-year-old (amod)
ultrastructure vessel (nmod)
observed layer (nmod)
option protect (acl)
toxicity nanoparticle (compound)
established and (cc)
indicated suggested (conj)
nuclei both (cc:preconj)
scopolamine and (cc)
function better (amod)
maintenance anesthesia (nmod)
proven used (advcl)
therapy-na ve (dep)
placebo or (cc)
aplasia , (punct)
injection intracoronary (amod)
agents maneuvers (conj)
personnel the (det)
stabilized patients (nsubjpass)
sensitization only (advmod)
convulsants cholinergic (amod)
human animal (conj)
agents nd-nmba (appos)
reduced dose (dobj)
therapy imipenem (compound)
filaments strokes (conj)
vasopressin neither (cc:preconj)
saline = (dep)
used detect (xcomp)
effective emulsion (nsubj)
aggregation with (case)
men homosexual (amod)
scleroderma with (case)
analysis uv-spectrophotometric (amod)
ranitidine by (case)
documents report (nsubj)
hypoxia caused (acl)
c1q and (cc)
intermediate a (det)
done baseline (nmod)
line ) (punct)
% 37.8 (nummod)
neutralization viremia (nmod)
pathway synthase (compound)
did animals (nsubj)
territories adjacent (amod)
hypokalemia , (punct)
dopamine with (case)
lesions nigra (nmod)
dnap hbeag (conj)
resulted isoproterenol (nsubj)
substituted syringe (nsubjpass)
women 612 (nummod)
rash a (det)
compared rats (nmod)
assess effectiveness (dobj)
treatment throughout (case)
provocation following (case)
thrombosis artery (nmod)
shift manic (amod)
duration response (nmod)
elucidated be (auxpass)
challenge doses (nmod)
effects disease (nmod)
tail rats (nmod)
gfr the (det)
enhancement antinociception (nmod)
response boy (nmod)
bche ) (punct)
exposure as (compound)
) 5 (compound)
toxicity potential (amod)
antiplatelet , (punct)
h angiography (nmod)
less even (advmod)
using concomitantly (advmod)
aneurysm artery (nmod)
drugs muscarinic (amod)
role convulsant (nmod)
effects morphine (nmod)
analysis brain (nmod)
daidzein with (case)
variety effects (nmod)
reduction induction (nmod)
dysrhythmogenic was (cop)
mglur5 extrastriatal (amod)
administration dose (compound)
due hypaque (nmod)
part during (case)
hypotension similar (amod)
results determination (nmod)
monooxygenases in (case)
amikacin intravitreal (amod)
significant that (nmod)
angiography by (case)
syndrome obstruction (compound)
leads nephrotoxicity (nsubj)
pain visceral (amod)
80 by (case)
rats long-evans (amod)
3 of (advmod)
cancers four (nummod)
at are (cop)
foot right (amod)
diagnosed : (punct)
$ROOT$ contraindicated (sent)
pathogens of (case)
incidence management (conj)
mg x (cc)
adjustment lidocaine (nmod)
responsible resistance (nmod)
discussed features (nsubjpass)
pointer an (det)
stenoses coronary (amod)
reduced supplementation (nmod)
identified if (dobj)
49 to (advmod)
experienced ) (punct)
taken use (nmod)
graded minutes (nmod)
evaluation rad001 (nmod)
hypothesis occur (ccomp)
factor-alpha necrosis (compound)
weight dose (appos)
$ROOT$ derived (sent)
measure function (nmod)
continue sold (xcomp)
reported effects (dobj)
epinephrine that (mark)
defects abnormalities (conj)
hypercalcemia severe (amod)
study into (case)
stratification patients (nmod)
preventing strokes (dobj)
hypophosphatemia and (cc)
12 up (advmod)
4 [ (punct)
disrupted blocker (nsubj)
showed maintained (ccomp)
dose d (compound)
preventing delirium (dobj)
cardiomyopathy primary (amod)
prescribe for (mark)
included neurons (dobj)
pilocarpine with (case)
hypopharynx , (punct)
complication anesthesia (nmod)
force peak (amod)
reactions diagnosis (dep)
monoher doxorubicin (conj)
stimulation to (case)
27.1 - (advmod)
5.124 to (quantmod)
risk bleeding (nmod)
conducted agonist (dobj)
inhibited sis3 (nmod)
gtn after (case)
mice msg-treated (amod)
improved combination (nsubj)
dysfunction disease (nmod)
sunitinib sorafenib (conj)
8.4 and (cc)
company a (det)
associated terbutaline (nsubjpass)
included neuropathy (dobj)
blocked 1-receptor (amod)
identified those (dobj)
substituted posaconazole (nsubjpass)
questionnaire by (case)
sleep following (case)
reported intake (nmod)
thrombocytopenia thrombosis (conj)
induce statins (nsubj)
death n/n=9/26 (dep)
parameters studied (amod)
elderly healthy (amod)
data based (case)
choice is (cop)
dysfunction antidepressant-induced (amod)
$ROOT$ nephritis (sent)
ts with (case)
test emotional (amod)
fev1 ) (punct)
indication dose (conj)
essential that (mark)
surviving min (dobj)
later between (case)
basis intention-to-treat (amod)
drugs psycho-active (amod)
transmission by (case)
expression with (case)
manipulate to (mark)
outcomes improved (amod)
loss more (amod)
confusion falls (conj)
slope to (case)
developed because (mark)
edema generalized (amod)
giving just (advmod)
hyperprolactinemia youth (nmod)
aimed demonstrate (xcomp)
level ng/ml. (nmod)
attenuate to (mark)
involvement noradrenergic (amod)
rebound pressure (nmod)
aspects renal (amod)
hours end (dep)
mg/kg 416 (nummod)
values td50 (dep)
flow pneumotachograph (nmod)
linezolid of (case)
administration h (nmod:tmod)
suggestive that (nsubj)
hemianopsia a (det)
average from (case)
matter within (case)
found agreement (nsubjpass)
agricultural industrial (conj)
analysed dosing (nsubjpass)
exposure in (amod)
pathogenesis coma (nmod)
baseline mean (dep)
compounds lithium (compound)
shr treated (amod)
mechanism type (compound)
metabolizer indicating (advcl)
stress importance (dobj)
responsiveness agonists (nmod)
interest are (cop)
loss myelination (nmod)
inhibitor another (det)
blocked seizure (dobj)
report treatment (dobj)
$ROOT$ take (sent)
investigated convulsions (nmod)
adjusted achieve (xcomp)
women and (cc)
if with (case)
detection by (case)
11 +/- (cc)
associated procedures (nmod)
nephrolithiasis of (case)
addition solution (nmod)
a protein (conj)
1ug ( (punct)
efficacious more (advmod)
time maintenance (conj)
chlorofluorocarbons for (case)
increase postoperatively (advmod)
feature hepatotoxicity (nmod)
transport and (cc)
erection apomorphine-induced (amod)
demonstrated enantioselectivity (nsubjpass)
complexes premature (amod)
showed min (nmod)
8th at (case)
2.2 to (dep)
continues : (punct)
way same (amod)
reversible withdrawal (nmod)
flutamide androgen (compound)
tgf-b kb (conj)
causes loss (dobj)
event cardiovascular (amod)
mg 50 (nummod)
devastation caused (acl)
bp msdbp (appos)
infusion saline (nmod)
deficits memory (compound)
represents advance (dobj)
outcome pallidotomy (nmod)
drugs both (det)
given drug (nmod)
cycles tfl (nmod)
dissolution the (det)
relate , (punct)
5-fu ( (punct)
thrombi signs (conj)
deferoxamine chelator (appos)
= 0.05 (dep)
drugs well-tolerated (amod)
38 whom (nmod)
p<0.001 controls (nmod)
dose aspirin (nmod)
inhibited associated (dep)
structure the (det)
stopped elongation (nsubjpass)
night at (case)
d-penicillamine of (case)
periods activity (compound)
returned stopped (advcl)
disease glomerular (amod)
increase velocity (nmod)
mk-212 of (case)
treat correctly (advmod)
equal to (nmod:tmod)
catabolism gaba (compound)
scored histologically (advmod)
muscle the (det)
indices nephrotoxicity (nmod)
prevent antioxidants (nsubj)
survival response (conj)
wt/day body (compound)
glucose acids (conj)
cisplatin than (case)
containing corticosterone (dobj)
differ patients (nmod)
documented switching (advcl)
pentylenetetrazole of (case)
worsen possibly (advmod)
determined amounts (conj)
evaluable evaluated (ccomp)
0.001 0.004 (conj)
characteristic encephalopathy (nmod)
control excitability (nmod)
marker secreted (acl)
determined rats (nmod)
patient tuberculosis (nmod)
placebo ( (punct)
tested subsequently (advmod)
catalepsy tremor (conj)
venous patients (dep)
encode that (nsubj)
prescribing confounding (conj)
size lumen (nmod)
dose test (compound)
mek1 , (punct)
treatment model (nmod)
mimicking exams (nmod)
faded away (advmod)
transporter drug (compound)
concentrations microm (appos)
perfusion poor (amod)
produced block (dobj)
15 5 (conj)
cefonicid cefazedone)-treated (conj)
dose hit (nmod)
sustained % (dep)
system utero (compound)
infection tract (compound)
response [ (punct)
did variables (nmod)
finding based (case)
modulators immune (amod)
duct collecting (compound)
patient carcinoma (nmod)
tremor the (det)
subjects 80 (nummod)
three to (quantmod)
patients unable (acl:relcl)
due diseases (nmod)
rate control (dep)
studies published (acl)
casualties required (acl:relcl)
p75(ntr)-ir pericellular (amod)
beta-enac of (case)
effects inhibitory (amod)
adjusted = (conj)
control cardiovascular (amod)
mg mianserin (conj)
slowdown change (nmod)
% higher (nummod)
$ROOT$ mg. (sent)
density assay (nmod)
individual given (amod)
transporter urea (compound)
release activity (conj)
complex and (cc)
behavior exploratory (amod)
neoplasia = (dep)
evaluated examine (advcl)
evaluate changes (dobj)
mechanisms underlying (amod)
phenacetin with (case)
drugs analgesic-antipyretic/anti-inflammatory (amod)
observed dogs (nmod)
dependent levels (nsubj)
stopping of (mark)
diet an (det)
hiv-negative completed (conj)
revealed syndrome (dobj)
8.3 8.9 (conj)
patients fourteen (nummod)
% 59 (nummod)
suppressing replication (dobj)
suppressed in (mark)
course symptomatology (conj)
pathogenesis hemorrhage (nmod)
injections , (punct)
patients present (acl:relcl)
therapy coumadin (compound)
metabolites remoxipride (compound)
lower mg/day (dep)
levels greater (amod)
treated be (auxpass)
way in (case)
pursued pretreatment (nmod)
electrocardiogram electroencephalogram (conj)
1 x (cc)
route via (case)
examination treatment (nmod)
frame reasonable (amod)
time the (det)
received period (nmod)
studies states (nmod)
up median (amod)
active she (nsubj)
il-1b and (cc)
higher , (punct)
scores extrapyramidal (amod)
reviewed was (auxpass)
msdbp decrease (conj)
syndrome sinusoidal (amod)
program on (case)
35 to (quantmod)
control menopausal (amod)
animal the (det)
hyperalgesia persistent (amod)
0.74 ) (punct)
diagnosed referred (parataxis)
narcosis rats (nmod)
gliclazide or (cc)
water on (case)
resonance magnetic (amod)
resolve stopped (advcl)
pharmacodynamics tolerability (conj)
depression profound (amod)
exhaustion after (case)
question open (amod)
62 ) (punct)
analysis expression (nmod)
awake was (cop)
range reference (compound)
tolerability clinical (amod)
reported marked (conj)
cultures of (case)
instillation by (case)
damage of (case)
mutants hbv (compound)
protected rats (nsubj)
syndrome hypertension (compound)
improvements monitoring (nmod)
study large (amod)
government local (amod)
abolished was (auxpass)
49 - (advmod)
was time (nmod)
trauma or (cc)
correlation = (dep)
have differ (conj)
difficult examine (xcomp)
showed responses (dobj)
known indicate (conj)
rtms the (det)
hemisphere of (case)
neuroprotection in (case)
duration ( (punct)
density trabecular (amod)
mediates interaction (nsubj)
found were (auxpass)
mild , (punct)
resistant chemotherapy (nmod)
cases exacerbation (nmod)
hippocampus showed (acl:relcl)
media radiographic (amod)
39+/-10 au (conj)
reduced domperidone (nmod)
as possible (amod)
moving only (advmod)
nodules neoplastic (amod)
include controls (dobj)
caused . (punct)
tip the (det)
all for (case)
conditions surgical (amod)
strokes fewer (amod)
lasting anaesthesia (nmod)
s(h)uv value (compound)
nephropathy on (case)
effects hypertrophy (nmod)
compared children (nmod)
diagnostic statistical (conj)
mediated may (aux)
acid ka (appos)
pai-1 ( (punct)
terms attenuation (nmod)
group age (appos)
separated were (auxpass)
development population (nmod)
dysfunction % (appos)
option could (aux)
discontinuous outlining (advcl)
propionate testosterone (compound)
dosage in (case)
cases britain (nmod)
avoid minimize (conj)
presents thromboemboli (nmod)
rigidity recorded (acl)
14 eight (conj)
hypertension testosterone-dependent (amod)
tension milligram (nmod)
deposited produced (conj)
systems involved (acl)
has patients (nmod)
120 to (dep)
infarction cerebral (amod)
men to (mark)
likely develop (xcomp)
resistance this (det)
reversed significantly (advmod)
dxnp between (case)
aggravate administration (nsubj)
preparations medicine (compound)
u/d ) (punct)
increases epilepticus (nmod)
conversion early (amod)
count eosinophil (compound)
calibre reduced (amod)
due presumably (advmod)
unit in (case)
drugs therapy (nmod)
involve induction (nsubj)
hyperactivity ecstasy-specific (amod)
3tc zidovudine (conj)
given hours (nmod)
none subjects/patients (nmod)
stages earlier (amod)
event toxicity (nsubj)
suffered mm (advcl)
associated indicating (advcl)
testing drugs (nmod)
resistance forearm (compound)
included predictors (nsubj)
t + (cc)
therapy antiretroviral (amod)
mg/m2/h of (case)
epidemics the (det)
ensued but (cc)
failure sedation (compound)
studies n=661 (appos)
alter hyperalgesia (dobj)
mechanisms adrenergic (amod)
occurred withdrawal (nmod)
p=0.0001 ( (punct)
dec ) (punct)
return hospital (nmod)
reduces genotoxicity (dobj)
reductions duration (nmod)
agonist alpha2-/i1-receptor (compound)
placement electrodes (nmod)
agent probable (amod)
$ROOT$ 99mtc-glucarate (sent)
steroids group (nmod)
cessation tdf (nmod)
controls 16 (nummod)
gentamicin + (cc)
neurons regions (nmod)
reported caused (conj)
assessing for (mark)
$ROOT$ tachyarrhythmias (sent)
upregulated can (aux)
those compared (case)
diets , (punct)
found normal (parataxis)
insomnia , (punct)
cause dosages (nsubj)
biopsy a (det)
maintaining rats (nmod)
transported transporter (nmod)
35.1 +/- (cc)
destruction the (det)
continue medication (dobj)
sn animals (nmod)
women pregnancies (nmod)
khz ( (punct)
provoked have (aux)
responses slices (nmod)
application evaluate (acl)
aims the (det)
trh ) (punct)
variable is (cop)
min hypertension (nmod)
damage value (conj)
treatment morphine (compound)
38 - (punct)
cent 11 (nummod)
restlessness agitation (conj)
suxamethonium intravenous (amod)
that indications (nmod)
excitability slices (nmod)
acidity could (aux)
investigations he-lfb (dep)
modestly only (advmod)
elicited rilmenidine (nsubj)
affected hepatitis (nmod)
glomeruli measured (acl)
deposition excess (amod)
chemotherapy doxorubicin (nmod)
high- od (appos)
g/liter to (case)
basis molar (amod)
form receptors (nmod)
contraindicated or (cc)
haloperidol compared (case)
included signs (nsubj)
activity long-term (amod)
cholinesterase and (cc)
captopril of (case)
sharps of (case)
study agricultural (amod)
hosts children (appos)
remedies variety (nmod)
nuclei , (punct)
suggest potentiation (nsubj)
performance recognition (compound)
analgesic an (det)
patients icu (compound)
regimen daily (amod)
control pain (compound)
> concentration (nmod)
increase phosphokinase (nmod)
depend effects (nsubj)
mwm ) (punct)
advocate . (punct)
factor infection (nmod)
shed light (dobj)
patients have (acl:relcl)
increased indicating (advcl)
playing as (mark)
elevations toxicities (nsubj)
seem patients (nsubj)
symptoms patient (nmod:poss)
data collective (amod)
management general (amod)
% 48 (nummod)
erythrophagocytosis and (cc)
pregnancy of (case)
residence sunbelt (nmod)
admission his (nmod:poss)
pairs the (det)
added is (auxpass)
transducer signal (compound)
suspected related (advcl)
iu/l 78 (nummod)
deterioration condition (nmod)
hepatitis due (case)
op ) (punct)
frequently events (conj)
vertigo vomiting (conj)
allodynia brush-evoked (amod)
led days (nsubj)
properties inotropic (amod)
database collected (amod)
diet lacking (acl)
indomethacin either (cc:preconj)
deprivation rem (compound)
had given (ccomp)
hl ) (punct)
scarce also (advmod)
suggesting effect (dobj)
treatment subcutaneous (amod)
symptom eps (appos)
reconsidered be (auxpass)
deferoxamine , (punct)
third a (det)
12.3 ( (punct)
aes for (case)
tnf-alpha paf (conj)
antinociceptive constipating (conj)
receiving he (nsubj)
increasing stress (dobj)
1.44+/-0.6 , (punct)
forestomach and (cc)
groups consisting (acl)
complete partial (conj)
hypercalcemia alkalosis (conj)
synthesis atp (compound)
responsiveness responsiveness (conj)
crisis report (dep)
amphetamine ( (punct)
receptors nmdars (appos)
units ( (punct)
forehead in (case)
challenged vehicle (nmod)
administered should (aux)
mice sensitive (amod)
efficacy tablets (nmod)
resolution findings (nmod)
reported which (nsubjpass)
flow ebf (appos)
dep on (case)
retardation intrauterine (amod)
calcification and (cc)
binding brain (nmod)
cbd the (det)
administration ng (nmod)
help analyze (xcomp)
potential treatment (nmod)
facilitated may (aux)
pressure 0.001 (conj)
less twitch (nsubj)
profiles , (punct)
observed follow-up (nmod)
spread had (aux)
evaluation relationship (conj)
level activity (nmod)
$ROOT$ interest (sent)
cue to (case)
june 1984 (nummod)
ratios likelihood (compound)
1.1 , (punct)
appeared movements (nsubj)
51 - (advmod)
kinase 1 (nummod)
proteins uncoupling (amod)
alternative first (amod)
fact found (acl)
trials placebo-controlled (amod)
days 16 (conj)
analyzed test (nmod)
administration mp (nmod)
intervals at (case)
decreases which (nsubj)
compounds organophosphorous (amod)
predict potential (dobj)
change st (compound)
changes behavioural (amod)
determine side-effect (advcl)
icus three (nummod)
microg/kg with (case)
signaling ) (punct)
patients 352 (nummod)
patients 1 (nummod)
il-1beta including (case)
ensure recovery (dobj)
got ) (punct)
one be (cop)
did than (dep)
development complications (nmod)
42 43 (conj)
effect apparent (amod)
component for (case)
cpb ( (punct)
oxidation fatty-acid (compound)
improved was (auxpass)
required urgently (advmod)
phenomenon lethal (amod)
implant the (det)
ovale the (det)
liver organs (conj)
safety infusion (nmod)
pointes de (dep)
prophylaxis inhibitor (nsubj)
severe pain (nsubj)
measured kits (nmod)
sensitive capable (conj)
reversed nahco3 (nsubj)
administered intracerebroventricularly (advmod)
etiology proteinuria (nmod)
% -32 (nummod)
facility eyes (nmod)
stabilizer with (case)
suspected . (punct)
hbv patients (conj)
6 least (advmod)
reactions , (punct)
associated lamotrigine (nsubj)
is apparent (acomp)
showed electromyogram (nsubj)
heart nd (nmod)
mg/kg q (appos)
elderly the (det)
programs via (case)
vasoconstriction cocaine-induced (amod)
patients vt (nmod)
mg/kg mg/kg (advcl)
outcomes negative (amod)
percentage rate (conj)
lesion after (case)
consume . (punct)
aneurysms cerebral (amod)
predictive , (punct)
stability hemodynamic (amod)
chemoconvulsants several (amod)
severity processes (nmod)
complication paralysis (nsubj)
caused as (mark)
antagonist valsartan (appos)
subgroups among (case)
enhanced addition (nmod)
lisinopril mg (dep)
ns-nsaids and (cc)
$ROOT$ hemolysis (sent)
halving by (mark)
effect systems (nmod)
include toxicity (dobj)
confirms as (mark)
anaphylaxis oral (amod)
psychosis disorders (conj)
comparison effect (nmod)
effects thermic (amod)
received days (dobj)
nephropathy streptozotocin-induced (amod)
refer regimen (nmod)
risks cumulative (amod)
12.1 ; (punct)
assessed have (aux)
success without (case)
improved inactive (advcl)
assessed addition (nmod)
started flecainide (nsubjpass)
disorders monitored (acl)
warn cause (ccomp)
kidneys ureters (conj)
% 38+/-4 (nummod)
treatments in (case)
associated cohort (nmod)
val val/hctz (conj)
period ratio (dep)
profile their (nmod:poss)
usage patients (nmod)
exhibits as (mark)
frequency because (case)
hypertrophy on (case)
uncommon be (cop)
impact clues (dep)
contrast blockers (nmod)
baeps ) (punct)
approach safe (amod)
smaller groups (nmod)
levels quantitative (amod)
interaction possible (amod)
induces seizures (dobj)
overdose due (case)
samples cell (compound)
$ROOT$ inhibit (sent)
injection heparin (compound)
administered measured (conj)
101.74 1.02 (compound)
beta-blocker beta-blocker (conj)
$ROOT$ acknowledged (sent)
consuming diet (dobj)
glioblastoma with (case)
perfusion medium (nmod)
heparin used (acl)
used ketoprofen (nsubjpass)
warranted use (nsubjpass)
potencies antagonists (nmod)
developed ; (punct)
decreased binding (dobj)
is nephrotoxic (csubj)
developing with (mark)
effects performance (conj)
developed leukemia (nmod)
% 15.6 (nummod)
studies patients (nmod)
higher significance (nmod)
developed hyperthermia (dobj)
discontinuation reduction (conj)
vehicles and (cc)
placed emphasis (nsubjpass)
accounted % (nmod)
involved but (cc)
ead ( (punct)
group 14 (appos)
facilitate may (aux)
concentration below (case)
one medications (nmod)
medication atrophy (conj)
odds the (det)
power a (det)
rediscovery laitinen (nmod)
robust effect (nsubj)
caused ; (punct)
factor ) (punct)
development hiccups (nmod)
force grip (compound)
hypotension d-tubocurarine-induced (amod)
lower amount (nsubj)
impairment group (nmod)
consistent data (nsubj)
dose cocaine (nmod)
incidence disease (nmod)
determined morphologically (advmod)
active six (nmod)
therapy by (case)
bradydysrhythmias or (cc)
note of (case)
administered ninety-nine (nmod)
function pharmacology (conj)
evidence above (amod)
choreic , (punct)
frequency related (acl)
confirms ; (punct)
became active (conj)
use anticholinergic (amod)
neurons tida (compound)
activity hoe (dep)
live therapy (nmod)
device a (det)
change type (nmod)
perivascular and (cc)
yields 1.3 (nummod)
auditory visual (conj)
descriptions two (nummod)
pyrazinamide by (case)
suxamethonium ) (punct)
result however (advmod)
associated all (nsubjpass)
gene associated (amod)
mg/dl [ (punct)
conclude considered (ccomp)
recommended times (nsubjpass)
reversed nitroglycerin (nmod)
neuropathy caused (acl)
10 8 (compound)
normalized revealed (advcl)
receptors central (amod)
ranged . (punct)
needle rate (conj)
determine administered (advcl)
4.3 p=0.004 (appos)
dropped curve (nsubj)
tasks mental (amod)
sirolimus consequence (conj)
phenotype and (cc)
alterations time (compound)
studied , (punct)
prolongation interval (nmod)
p.o. med (dep)
choice of (case)
memory impaired (amod)
receiving mp (dobj)
efficiency mcl (nmod)
use by (case)
diuresis the (det)
failure hypoxemia (conj)
$ROOT$ polypeptide (sent)
measured end (nmod)
followed means (nmod)
infection patients (nmod)
obtained breeder (nmod)
women italy (nmod)
effects medium (nmod)
course on (case)
studied relationships (nsubjpass)
size a (det)
program ( (punct)
trial tolerability (compound)
secretion growth (compound)
effect sertraline (nmod)
subendothelial and (cc)
met , (punct)
point lead (acl:relcl)
declined month (nmod)
discriminates unresponsiveness (nsubj)
dactinomycin iva (appos)
associated hypomagnesemia (nsubjpass)
behavior and (cc)
risk disease (compound)
relieved improve (conj)
administration period (nmod)
associated myopathy (nmod)
conditions operating (compound)
destruction selective (amod)
drugs neuromuscular (amod)
detected feared (ccomp)
analyzed extracts (nsubjpass)
preserves that (mark)
hemorrhage subarachnoid (amod)
glutamate intradermal (amod)
that p53 (nmod)
indices contractile (amod)
inhibitor factors (nmod)
utilized traces (dobj)
concentration target (amod)
provocation association (conj)
walls ventricular (amod)
failure uk (nmod)
excitement frequency (conj)
exposure shrinkage (conj)
2 , (punct)
epidemiology nephrotoxicity (nmod)
episode seizure (nmod)
12 +/- (cc)
= : (punct)
showed binding (conj)
dehydrogenase mtdna-encoded (amod)
prescribed trimethoprim (dobj)
use = (dep)
0.9 - (punct)
seemed , (punct)
dysfunction myopathy (conj)
ihc ( (punct)
present this (nsubj)
groups with (case)
resuscitations successful (amod)
expression oxidase (compound)
model is (cop)
aware occurred (advcl)
utilized have (aux)
consistent due (conj)
caused beats (nmod)
matched score (nmod)
complex iii (nummod)
difference agents (nmod)
associated clozapine (nmod)
nephroprotectant a (det)
conclusions induces (dep)
reserpine mg/kg (dep)
suggested develop (xcomp)
induced p (dep)
92 of (advmod)
utility clinical (amod)
mass average (amod)
glycosuria g/day (nmod)
$ROOT$ progresses (sent)
design blind (amod)
reproducibility models (nmod)
mg rat (nmod)
morphine continuous (amod)
apply , (punct)
ciprofloxacin- norfloxacin-treated (conj)
maleate chlorpheniramine (compound)
alt ast (conj)
mechanisms implicated (acl)
was ratio (dep)
action stabilizing (amod)
apparent not (neg)
ng/ml level (nsubj)
pellet subcutaneous (amod)
31.85 3.99 (conj)
pan , (punct)
failure unexplained (amod)
$ROOT$ contributes (sent)
controls = (dep)
surface near (case)
ingredient the (det)
arise which (nsubj)
21.6 +/- (cc)
hit exposure (nmod)
preventing ulceration (dobj)
pulses co2 (nmod)
warfarin vitamin (compound)
mechanism postulated (amod)
fq . (punct)
minutes one (nummod)
dose paracetamol (compound)
confusion . (punct)
difficult interdependence (nmod)
examined correlation (nsubjpass)
rats aged (amod)
control hypotension (dobj)
mass cardiac (amod)
micrograms/min 10 (nummod)
edema preceded (acl)
reduce injection (nmod)
headache % (dep)
group epileptic (amod)
investigate modulate (ccomp)
625 , (punct)
diagnosis . (punct)
believed levels (xcomp)
activity muscles (nmod)
defined episode (nmod)
effect efficacy (conj)
cases delivery (nmod)
responses system (compound)
line some (det)
related levels (nmod)
waveforms of (case)
responds animals (nmod)
neurotoxicity due (amod)
quadrants eyes (nmod)
exhibit not (neg)
acknowledged and (cc)
cgs ( (punct)
incidence intubation (nmod)
old 9-month (nmod:npmod)
collected are (aux)
have causes (dobj)
congestion of (case)
suggest used (advcl)
associated od (nsubjpass)
found tolerated (conj)
devised we (nsubj)
damage dox-induced (amod)
revealed stratification (nsubj)
exposure due (case)
cells more (amod)
reduced hyperactivity (nmod)
oxygen of (case)
levels 7alpha-hydroxylase (nmod)
contributed might (aux)
rigidity with (case)
associated withdrawal (nsubjpass)
speech confusion (conj)
persisted yr (nmod)
cardiotoxicity bupivacaine-induced (amod)
45.9 13.9 (conj)
material of (case)
inhibit carteolol (nsubj)
characterized loss (nmod)
received where (advmod)
puncture spinal (amod)
bronchodilator ipratropium (nsubj)
dormex of (case)
n- fragments (dep)
reviewed provide (advcl)
determine improve (conj)
anaesthetised given (conj)
divided mice (nsubjpass)
paradigm multiple (amod)
disturbances facial (amod)
values of (case)
ha ) (punct)
miss justification (nmod)
dizziness somnolence (conj)
infants 117 (nummod)
potentiation morphine (nmod)
prescription the (det)
cardiotoxicity acute (amod)
changes evoked (acl)
secretion dose (nmod)
4-phenylbutyrate with (case)
$ROOT$ 1,3-butadiene (sent)
records obtained (acl)
line bs (compound)
tachycardia caused (acl)
children 253 (nummod)
$ROOT$ fatal (sent)
effects neuroleptic-like (amod)
pretreatment haloperidol (compound)
hydrochloride ketamine (compound)
reduced increase (dobj)
$ROOT$ side-effect (sent)
samples from (case)
important high (advcl)
speed average (amod)
given patients (nmod)
hypoactivity morphine-induced (amod)
analysis nested (acl)
alert risk (nmod)
31 of (advmod)
hydroxytyrosol antioxidant (amod)
suggestion this (det)
agonist pentylenetetrazole (dep)
atypicals among (case)
completed were (auxpass)
areas brain (nmod)
assessed systematically (advmod)
agsd to (case)
treated pcc (nmod)
toxicity = (dep)
complication neuropathy (nsubj)
continued receiving (xcomp)
feature depression (nsubj)
hypothesized it (nsubjpass)
willing were (cop)
ketoprofen acetaminophen (conj)
vnb , (punct)
cause is (cop)
evaluate mortality (dobj)
obvious patients (nmod)
improved engendered (advcl)
doses doses (conj)
pattern electrophoretic (amod)
67 . (punct)
maleate placebo (conj)
prominent , (punct)
level effect (compound)
results < (dep)
measure a (det)
99 but (cc)
observed compounds (nmod)
re-challenged be (auxpass)
published cases (nsubjpass)
resolved spontaneously (advmod)
hypotension easily (advmod)
minimum exercise-controls (nmod)
undergone chamber (dobj)
cancer nsclc (appos)
cardiotoxicity later (amod)
required is (auxpass)
dep ( (punct)
resulting epilepticus (nmod)
boy the (det)
diarrhea nausea (conj)
showed % (nsubj)
free thereafter (advmod)
changes histological (amod)
toxicity 2 (nummod)
microsomes in (case)
elicited perturbation (nmod)
suggesting useful (ccomp)
change animals (nmod)
iief the (det)
triglyceride accumulated (amod)
induced heparin (nmod:npmod)
presence vasculitis (conj)
role pivotal (amod)
edaravone or (cc)
used defined (conj)
changes bp (conj)
related which (nsubjpass)
susceptibility model (appos)
antagonist alpha(2)-adrenoceptor (compound)
hemolysis . (punct)
episode a (det)
suppressed activity (dobj)
examination biopsy (nmod)
vaccination b (compound)
cause since (mark)
useful were (cop)
treated tp (nmod)
binding inhibited (acl:relcl)
reversibility withdrawal (nmod)
rash history (conj)
conclude effective (ccomp)
include medications (nsubj)
end period (nmod)
preoperative postoperative (conj)
synthesis no (neg)
increase persistent (amod)
area , (punct)
lower that (mark)
wine of (case)
defense and (cc)
confined analysis (nsubjpass)
polyvidone hexabrix (conj)
commonly less (advmod)
essential interaction (nmod)
side the (det)
prolonged period (nsubj)
virus the (det)
showed actions (dobj)
test measured (acl)
patients measured (acl:relcl)
drinking self-reported (amod)
malformations on (case)
other each (det)
protection carvedilol (nmod)
4 2 (nummod)
% episodes (nmod)
$ROOT$ regeneration (sent)
higher be (cop)
infarction kidney (nmod)
dysfunction nerve (compound)
stz + (cc)
exposure sunburn (conj)
fluorescein as (case)
converted atropine (nsubj)
benefit this (det)
contents gaba (compound)
effect fatal (amod)
continuous or (cc)
% superior (acl:relcl)
need % (nsubj)
unaffected fluvoxamine (nmod)
investigation involvement (nmod)
accelerated heterogeneously (advmod)
positive . (punct)
that eyes (nmod)
ingested which (nsubjpass)
have liability (nmod)
4.1 to (advmod)
rate initiation (nmod)
way discovering (advcl)
treated pergolide (nmod)
570 461 (quantmod)
in is (cop)
population ectopic (amod)
allopregnanolone pregnanolone (conj)
diazepam of (case)
percent 26 (nummod)
measured determine (advcl)
lethality high-dose (amod)
formation vasogenic (amod)
impulsiveness disturbance (conj)
24 +/- (cc)
effects nsaids (nmod)
resistant therapy (nmod)
rheumatology of (case)
symptoms dyskinesia (conj)
mutations such (amod)
activity locomotor (amod)
cardiomyopathy cm (appos)
copolymer parent (amod)
result administered (conj)
result prescribing (nmod)
predict values (nsubj)
[3h]sch 23390 (nummod)
study stimulation (compound)
nmba a (det)
number lines (nmod)
patients 30 (nummod)
support further (amod)
similar dyscrasias (nmod)
horns anterior (amod)
headache both (conj)
provision improve (acl:relcl)
induction failure (nmod)
analysis proteins (nmod)
experienced headache (dobj)
dose trazodone (nmod)
mass amiodarone-related (amod)
inhibited had (conj)
screening from (case)
noted furthermore (advmod)
tail the (det)
abnormalities without (case)
3,000 to (quantmod)
kcl of (case)
mater onto (case)
abnormalities urine (compound)
administration therapeutic (amod)
infusion g (compound)
taking treat (advcl)
influenced rate (nmod)
role back-diffusion (nmod)
followed that (nsubjpass)
magnitude modulation (nmod)
obese are (cop)
thrombi intravascular (amod)
solution % (nmod)
78.1 84.8 (prep)
developed patients (advcl)
restored vessel (nsubjpass)
therapy her (nmod:poss)
pj34 or (cc)
mup ) (punct)
detected controls (nmod)
diabetes streptozotocin (compound)
improve can (aux)
-0.12+/-0.5 ) (punct)
drug acting (amod)
contraceptives combined (amod)
users rc (compound)
taking who (nsubj)
time post-training (amod)
20 and (cc)
neonates healthy (amod)
administered children (nmod)
treated both (cc:preconj)
assigned days (nmod)
micrograms 200 (nummod)
waves characteristic (amod)
advise likelihood (nmod)
imaging including (case)
drug abuse (nmod)
mg 1000 (nummod)
factor receptor (conj)
examining consolidation (dobj)
fraction the (det)
comprised clinic (nmod)
biopsy percutaneous (amod)
s.c. mg/kg (nummod)
avoid damage (dobj)
loss filaments (nmod)
% with (case)
hemispheres the (det)
seems depend (xcomp)
effort the (det)
weighed risk (nmod)
suggest similar (ccomp)
- 42 (nummod)
symptoms in (case)
level circulating (amod)
catalepsy potentiation (dep)
confirmation diagnosis (nmod)
able is (cop)
concentrations antigen (compound)
staining all (det)
tested behaviorally (advmod)
population medical (amod)
high particularly (advmod)
olanzapine mg/d (appos)
suggest relationship (nsubj)
discriminated quantitatively (advmod)
development fetal (amod)
p = (amod)
conducted fibrillation (nmod)
performed thrombectomy (nsubjpass)
use her (nmod:poss)
subjects compared (case)
gating expression (conj)
healthy previously (advmod)
stratum ( (punct)
antagonist glycine (compound)
limit utility (dobj)
binding effects (conj)
present patient (dobj)
depend effect (nsubj)
micrograms daily (advmod)
administration cbz (nmod)
survived function (nmod)
described detail (nmod)
0.06 +/- (cc)
consistent events (nsubj)
p=0.11 ( (punct)
dantrolene and (cc)
treatment women (nmod)
pentoxifylline after (conj)
episodes hypercalcemic (amod)
in mostly (advmod)
resolution edema (nmod)
trend with (case)
bars ) (punct)
grade hemorrhage (nmod)
users progestagens (nmod)
antibodies protein (nmod)
ng.ml-1 42 (nummod)
affect men (nmod)
include variety (dobj)
performed . (punct)
saline diazepam (conj)
gained be (auxpass)
adam10 adam17 (conj)
$ROOT$ fibrillation (sent)
anticoagulation mice (nmod)
plays process (nmod)
prolactin by (case)
approaches immunosuppression (nmod)
patients prolongation (nmod)
findings these (det)
induce antagonize (conj)
meq/l k (nsubj)
mmhg 1 (nummod)
days gestational (amod)
outbreak deaths (nmod)
described patients (nsubjpass)
mg/kg 3.75 (nummod)
lidocaine glucose (nmod)
waves baep (compound)
suppresses attenuates (conj)
investigations effects (conj)
depressed 3 (nmod)
doses nontoxic (amod)
4.4 21.0 (prep)
transporters 5-ht (compound)
neoplasia ; (punct)
produced processes (nmod)
patients co-infected (amod)
cue because (case)
caucasian 3 (nummod)
antagonism sustained (acl:relcl)
sph with (case)
manifestations drug (nmod)
haart after (case)
bzds/rds ( (punct)
cancer years (nmod)
phenomenon in (case)
anesthesia caused (acl)
investigated this (nsubjpass)
assumed liable (ccomp)
value as (case)
blisters necrotic (amod)
jaundice symptoms (conj)
withdrawal in (case)
wales , (punct)
exposure main (amod)
arrhythmias cardiac (amod)
deficiency of (case)
events cardiovascular (amod)
associated conclusion (nmod)
majority % (dep)
allows elucidating (advcl)
eyes his (nmod:poss)
.002 than (case)
take anticoagulants (dobj)
catechol benzene-derived (amod)
effects bupivacaine (nmod)
intermediate to (case)
hydralazine or (cc)
dogs normal (amod)
stents with (case)
need increasing (amod)
agents acid (conj)
recommended patients (nmod)
restriction dietary (amod)
regardless requested (advcl)
igg granular (amod)
correlated pressure (nsubj)
haplotypes estimated (amod)
30 to (dep)
obstructive and (cc)
cancer lutte (compound)
attribute may (aux)
events study (nmod)
improved were (cop)
wards hospital (compound)
2.5 +/- (cc)
disorders that (mark)
that are (cop)
decrease exercises (nsubj)
increased time (dobj)
results abstained (appos)
mean sem (conj)
proportion population (nmod)
assessment injection (nmod)
products heparin (compound)
tbm only (advmod)
antagonist task (nmod)
limit 5 (nummod)
effects beta-blockade (nmod)
affected type (nsubj)
differentiated obtain (xcomp)
capture to (case)
increase stretching (nmod)
dysfunctions sexual (amod)
lesions induced (amod)
screening medications (nmod)
syndrome , (punct)
phases different (amod)
up-regulated are (auxpass)
bolus g/m2 (compound)
% 25%-30 (nummod)
need to (case)
h second (amod)
15 21 (conj)
polyneuropathy sensorimotor (amod)
indicators of (case)
diseases many (amod)
developed feet (nmod)
complications as (case)
responses exaggerated (amod)
had features (dobj)
p450 associated (acl)
food drugs (conj)
observed reduced (ccomp)
extrarenal effects (conj)
obtained overexpression (nsubjpass)
levels nucleus (nmod)
remained functions (nsubj)
outcomes secondary (amod)
decrease density (nmod)
immunosuppressant used (acl:relcl)
patients microglobulinuria (nmod)
doses different (amod)
effectiveness ptra (nmod)
endpoints primary (amod)
died he (nsubj)
bound linkages (nmod)
etiology . (punct)
produced anesthesia (dobj)
anesthetic . (punct)
1.67 ) (punct)
doses higher (amod)
undergone stress (dobj)
se to (case)
responses hormone (nmod)
91.5 ; (punct)
, 8-se (dep)
mechanism exciting (amod)
homogenates renal (amod)
encephalopathy of (case)
leukemogenic possible (amod)
improvement only (advmod)
injections three (nummod)
co-treatment ; (punct)
deficit retrieval (nmod)
azt from (case)
effect testing (nmod)
cause hypokalemia (nsubj)
atrophy fiber (compound)
association presence (nmod)
mg./kg by (case)
% 4.6 (nummod)
response to (acl)
assessed detection (nmod)
majority patients (nmod)
changes resistance (conj)
started dose (nmod)
skeptical be (cop)
characterized morphologically (advmod)
resistance effect (nmod)
erection penis (nmod)
recording nerves (nmod)
population granule (compound)
recovered range (nmod)
administered streptomycin (nsubjpass)
predictive be (cop)
seizures kindled (acl)
screened basis (nmod)
none in (case)
arrhythmia disease (conj)
183 about (advmod)
nephrotoxicity apap-induced (amod)
register swedish (amod)
similar pressure (nsubj)
simvastatinezetimibe taking (acl:relcl)
receptors opiate (compound)
searched : (punct)
microinjection excitatory (amod)
microangiopathy associated (acl)
consumed drugs (dobj)
detected bile (nmod)
administration doxorubicin (compound)
problems encountered (acl:relcl)
failure failure (conj)
inhibitors the (det)
associated diazinon (nsubjpass)
aware monitor (conj)
depletion ( (punct)
dogs stenosis (nmod)
pretreated furosemide (nmod)
time binding (conj)
degree similar (amod)
improved i.e. (advmod)
periods key (amod)
adenosine bw (appos)
effective medication (nsubj)
suppressed suppressed (conj)
treated are (aux)
use treatments (conj)
respiration independent (amod)
ephedrine/propofol/mixtures the (det)
balance brain (nmod)
metformin , (punct)
phase treatment (nmod)
episodes regarding (case)
administration h (nmod:npmod)
absent . (punct)
episodes < (amod)
showed operation (nmod)
cirrhosis biliary (amod)
arrhythmias various (amod)
treated it (nsubjpass)
remainder of (case)
events meta-analysis (dep)
suitable not (neg)
activity binding (conj)
nitroprusside drug (compound)
achieved response (nsubjpass)
remains mechanism (nsubj)
reported notably (advmod)
% isg (nmod)
invariable that (mark)
14.3 ) (punct)
that hepatitis (nmod)
modulation receptors (nmod)
symptoms resistant (acl:relcl)
9.9 11.1 (conj)
potential sural (amod)
epinephrine micrograms.kg-1.min-1 (nummod)
anaesthesia conventional (amod)
effects progression (nmod)
experiencing to (mark)
estimate association (dobj)
suggests potential (nsubj)
common to (mark)
methimazole ) (punct)
dose tetracycline (nmod)
syndrome persistent (amod)
regimen higher (amod)
hoarseness with (case)
uneventful reported (conj)
method quick (amod)
values nm (nmod)
phenylephrine and (cc)
studied effect (nsubjpass)
formation atherosclerotic (amod)
experiments laboratory (nmod)
activity ability (appos)
assess ability (dobj)
documentation is (cop)
terminated later (advmod)
measured concentrations (nsubjpass)
pressure resolved (acl:relcl)
regeneration liver (compound)
revealed infiltrate (dobj)
drugs properties (nmod)
maintained all (nmod)
deficit highest (amod)
rate a (det)
diffusion mechanism (nsubj)
infusion at (case)
uni- multivariate (conj)
shr treated (acl:relcl)
dialysate new (amod)
different serum (nsubj)
mg/dl 4.9 (nummod)
refer . (punct)
correlated incidence (nsubj)
dressing wound (compound)
affects annually (advmod)
anti-hcv anti-hbe (conj)
studies population (compound)
reducing : (punct)
images over (case)
baseline , (punct)
stages early (amod)
lead administered (advcl)
comply treatment (nmod)
questionaire a (det)
nephropathy diabetic (amod)
decrease blood (compound)
including , (punct)
sedation irritability (conj)
formed to (mark)
protrusion duration (conj)
drug prescribed (acl)
stronger . (punct)
extracellular to (case)
power defend (acl)
neurotoxicity busulfan (nmod)
ability patient (nmod)
one than (case)
prazosin yohimbine (conj)
study time (nmod)
diagnosed adsd (nmod)
quinpirole (+)-7-hydroxy-dipropyloaminotetralin (conj)
patients complication (nmod)
episodes . (punct)
anesthetics long-acting (amod)
administered week (nmod:tmod)
have might (aux)
disruption hypertension (nmod)
had attack (dobj)
he-lfb cd-68 (appos)
group true (amod)
8.7 females (nmod)
important terms (nmod)
ca2 of (case)
attenuated pi (nmod)
myocet doxorubicin (conj)
data administration (nmod)
marker an (det)
neuropathy disulfiram-induced (amod)
data frequency (nmod)
sg145r rtm204i (dep)
exposure in (case)
mmol/l from (case)
fluoxetine ( (punct)
hit although (mark)
prolongation death (conj)
monoamines than (case)
dose milligrams (nmod)
static and (cc)
% lower (conj)
patients selected (amod)
fev1 % (appos)
sirolimus with (case)
entity the (det)
those estimated (acl)
however , (punct)
mg/m(2 2,220 (nummod)
d1 - (nummod)
fistula complicating (acl)
occurrence seizure (nmod)
mg/m(2 either (cc:preconj)
combined giving (xcomp)
hypothesis protects (ccomp)
fibers duration (conj)
result treatment (nmod)
indication the (det)
haloperidol , (punct)
assessed analyzing (advcl)
arrest of (case)
correlated that (nsubjpass)
0 from (case)
elicits binding (nsubj)
had neurotoxicity (dobj)
rat fischer (compound)
immunosuppressant as (case)
treatment weeks (appos)
subjected model (nmod)
phosphatidylserine of (case)
injection additional (amod)
$ROOT$ evidenced (sent)
30 - (dep)
deleterious . (punct)
syndrome cytopathy (dep)
weight atpase (appos)
effects suprofen (nmod)
raise risk (dobj)
dose calculated (acl)
promotes promoting (advcl)
modulation the (det)
expression enos (compound)
presenting episodes (nmod)
examinable were (cop)
rc ) (punct)
morphological , (punct)
dbp target (compound)
magnitude of (case)
undertaken evaluate (xcomp)
pattern proteins (nmod)
abnormality . (punct)
prolactinomas of (case)
provided has (aux)
fibrosis and (cc)
hz 1 (nummod)
reported vasculitis (nsubjpass)
doubled risk (nsubj)
postulated been (auxpass)
metolachlor herbicide (appos)
hippocampus the (det)
caucasian and (cc)
concerns toxicity (nmod)
$ROOT$ plausible (sent)
number large (amod)
spasm occurring (acl)
found relationship (nsubjpass)
interacts and (cc)
alterations with (case)
stress brain (compound)
reported years (nmod)
skf-82958 such (case)
allergies known (amod)
effective younger (nmod)
differentiation little (amod)
induction patients (nmod)
factors postoperative (amod)
2.6 were (cop)
higher ammonia (nsubj)
determining sensitivity (dobj)
hearts animals (nmod:poss)
micrograms/ml of (case)
dystrophy disease (appos)
consumption simultaneous (amod)
severity due (amod)
centre poisons (compound)
psychosis (meth)-induced (amod)
paralysis injections (nmod)
steroids hydrochloride (conj)
recognized recently (advmod)
attributed cardiomyopathy (nsubjpass)
outflow loop (nmod)
perfusion in (amod)
score 5 (nmod)
periods 1-week (amod)
exceed morphine (nsubj)
increase sensitivity (dobj)
arrest clonidine-associated (amod)
confirmed we (nsubj)
biochemical haematological (conj)
abnormalities new (amod)
sediment urinary (amod)
evoked which (nsubjpass)
estimated associated (advcl)
displace not (neg)
cell red (amod)
images inadequate (amod)
reduces although (mark)
androgens corticosteroids (conj)
conclusions associated (dep)
produce that (nsubj)
ischemia myocardial (amod)
model study (acl:relcl)
brainstem cord (conj)
led increase (nmod)
pdn equivalent (amod)
bradyarrhythmias or (cc)
aetiology deficiency (nmod)
revealed samples (nsubj)
observed oc (nmod)
increase . (punct)
neurogenesis dependent (amod)
abnormalities system (nmod)
effects drug (compound)
cytoplasm cells (nmod)
scale four-point (amod)
acne with (case)
antagonism functional (amod)
decreases baseline (nmod)
analyze audiograms (dobj)
g/day 0.13 (nummod)
carried using (advcl)
used ever (advmod)
cases 69 (nummod)
weeks eight (nummod)
tetany diltiazem-induced (amod)
adding infusate (nmod)
fibrillation cycle (nmod)
site left (amod)
antagonist agonist (conj)
reappeared . (punct)
formation sludge (nmod)
determining treating (conj)
recommendations avoid (acl)
neuropathy axonal (amod)
cause mechanism (nmod)
suggestive course (nsubj)
intralipid , (punct)
systems coagulation (compound)
source an (det)
reached concentration (nsubj)
epinephrine alone (advmod)
recognition tachycardia (nmod)
$ROOT$ males (sent)
alterations quantitative (amod)
reported infrequently (advmod)
or=13.807 ( (punct)
tolerated however (advmod)
lymphoma cell (compound)
rats libitum-fed (amod)
adhesions extensive (amod)
involvement mechanism (nmod)
race sex (conj)
osteomyelitis for (case)
stage score (appos)
included ; (punct)
pallidotomy involves (acl:relcl)
doxorubicin to (case)
rotation of (case)
side-effect amlodipine (nmod)
mice received (acl:relcl)
history all (nmod)
induced adducts (dobj)
stimulate administration (nmod)
available banned (advcl)
appears part (xcomp)
aware anaphylaxis (nmod)
preceding decline (dobj)
decrease pressure (nsubj)
unnecessary . (punct)
rash were (cop)
infarction , (punct)
azt plus (cc)
is dose (attr)
yawning . (punct)
symptoms psychosis (nmod)
modulated intensity (nsubjpass)
dosage total (amod)
eosinophilia nephritis (conj)
on whilst (advmod)
% 10.8 (nummod)
acetylsalicylate caffeine (conj)
insecticide common (amod)
paradigms these (det)
response behavioral (amod)
less of (case)
affects cisapride (nsubj)
pyrazinamide to (case)
order prevent (acl)
exercise including (case)
consistent nodosum (nmod)
facility in (case)
group atorva (compound)
level igf-i (compound)
stimuli co2 (compound)
show antagonist (nsubj)
prevention seizures (nmod)
presented us (nmod)
vessels cells (conj)
mg/day 30 (nummod)
treated injected (parataxis)
2.98 9.95 (prep)
700 - (punct)
dose tested (acl)
amplitude contraction (compound)
levels bilirubin (compound)
calculated oscillations (nmod)
finding , (punct)
illustrates case (nsubj)
3alpha-hydroxy-5alpha-pregnan-20-one ( (punct)
release since (mark)
produce syndrome (dobj)
plasma from (case)
h. 4 (nummod)
models reversal (appos)
enhance activity (dobj)
g/m2 ifosfamide (nmod)
support conclusion (nsubj)
produced action (nmod)
ramh by (case)
had depressed (dobj)
$ROOT$ set (sent)
insufficiency patients (nmod)
hospital mary (nmod:poss)
= lna (nsubj)
mediated partly (advmod)
mellitus type (compound)
increased duration (dobj)
170 from (case)
decrease densities (nmod)
% 33.3 (nummod)
(ppa)-induced dexatrim (nmod:npmod)
normochromic . (punct)
mg/kg 70 (nummod)
regression tumor (compound)
maze zero (nummod)
integrity morphological (amod)
cases = (dep)
identified present (advcl)
prior h (nmod:npmod)
levobupivacaine and (cc)
motility to (case)
g/min : (punct)
offset may (aux)
astrocytomas grade (compound)
reversible although (mark)
found was (auxpass)
mapping surface (compound)
long-acting short-acting (conj)
effective it (nsubj)
decreased allowing (advcl)
dose estrogen (compound)
1.56 , (punct)
angioedema due (amod)
$ROOT$ coincident (sent)
caused haemorrhage (dobj)
dendrin plekhh2 (conj)
cured were (cop)
administered shell (nmod)
causes alterations (dobj)
needed control (xcomp)
size with (case)
weeks weeks (conj)
restricted food (nmod:npmod)
1979 between (case)
effects severity (nmod)
precursors of (case)
mg/kg 0.31 (nummod)
activation pn (nmod)
palpation by (case)
referred evaluation (nmod)
mechanism additional (amod)
as such (amod)
mg/day dose (conj)
leads 16 (nummod)
drug intravenous (amod)
long as (advmod)
uterus intact (amod)
has s(c)o(2 (nmod)
played which (nsubj)
enzymes cardiac (amod)
epinephrine ep (appos)
prescribed course (dobj)
cases 2 (nummod)
0.83 ) (punct)
irrespective diet (nmod)
muscles gastrocnemius (compound)
metabolic and (cc)
emboli with (case)
t1/2 in (case)
increase increasing (advcl)
rifampin isoniazid (conj)
levels prl (appos)
dose mg/kg/i.p (amod)
advantage the (det)
conclusions preferable (dep)
compared 19 (nmod)
infant male (appos)
plays activation (nsubj)
studies rat (compound)
supplemented , (punct)
altering without (mark)
reversed but (cc)
others pectoris (nmod)
venules on (case)
pentylenetetrezol of (case)
highlighting onset (dobj)
anticoagulant choice (nmod)
pain dynamic (amod)
aminonucleoside the (det)
vasospasm occurring (acl)
complication rare (amod)
activity rate (conj)
estimated end (nmod)
better hence (advmod)
ceased were (auxpass)
disappearance ducts (nmod)
man 31-year-old (amod)
thickening ventricular (compound)
infusions short-term (amod)
making by (mark)
injury cisplatin-induced (amod)
5.0 1.3 (conj)
predicting death (dobj)
g/day 12 (nummod)
patients paralysis (nmod)
consider treatment (ccomp)
% 3.3 (nummod)
l-[3h]nicotine and (cc)
flow concentration (conj)
induce aorta (nmod)
disorder unmasked (acl)
diabenese ) (punct)
recipients receiving (acl:relcl)
infections medications (conj)
is objective (nsubj)
unmask may (aux)
chorea women (nmod)
caused concentrations (dobj)
pan vehicle (conj)
bell-shaped were (cop)
facilitated treatment (dobj)
capillaries of (case)
detection cardiomyopathy (nmod)
infusion adrenaline (compound)
sensitivity convulsant (amod)
force the (det)
erythrodysesthesia syndrome (appos)
facilitation memory (compound)
case vasculitis (compound)
associations ozone (nmod)
delirium cocaine-induced (amod)
taking minocycline (dobj)
min application (nmod)
more or (cc)
recognition incorporates (acl:relcl)
measured intervals (nmod)
rate excretion (compound)
heparin intravenous (amod)
nelarabine by (case)
dose lethal (amod)
patients forty (nummod)
occurs negroes (nmod)
months 33.7 (nummod)
december 1995 (nmod:tmod)
plugs of (case)
type therapy (nmod)
degeneration only (advmod)
received neurotoxin (dobj)
reduction as (cc)
animals for (case)
mg/day 700 (nummod)
duration test (nmod)
range years (appos)
demonstrated period (nmod)
3.6 +/- (cc)
developed stopping (conj)
small stones (nsubj)
trial determine (acl:relcl)
peak early (amod)
mg/dl level (nsubj)
management headache (nmod)
effects treatments (nmod)
type synthase (nmod)
decreased 3 (dep)
amount ngf (nmod)
risk ich (nmod)
hypothesize associated (ccomp)
volume with (case)
increase cause (conj)
age-range ( (punct)
450 300 (compound)
patients no (det)
(2-chloroethyl)-1-nitrosoure ] (punct)
disruption cytoskeletal (amod)
counted movements (nsubjpass)
patients ls (nmod)
decreased concentration (nsubjpass)
determine transcripts (dobj)
therapy steroids (nmod)
pneumotachograph a (det)
induce volunteers (nmod)
difficult rupture (nmod)
me in (case)
required development (nmod)
exerted , (punct)
analogs its (nmod:poss)
one may (aux)
response vessels (nmod)
type on (case)
harvested and (cc)
preferred perhaps (advmod)
injected intraperitoneally (advmod)
1.51 0.95 (dep)
and completely (advmod)
contributing presumably (advmod)
man arthritis (nmod)
decided research (xcomp)
end trial (nmod)
suggest reduces (ccomp)
indinavir h (dep)
warn clinician (dobj)
sensitivity to (case)
part study (nmod)
mfl ): (punct)
exhibited decrease (dobj)
agents no (det)
preceded be (auxpass)
shifts blocked (acl:relcl)
practice institution (nmod)
disarrangement tap (conj)
condition . (punct)
measure one (nummod)
pressure mup (appos)
evidence experimental (amod)
discontinued paroxetine (nsubjpass)
synergy possible (amod)
tachycardias sinus (compound)
decreased expression (nsubjpass)
speed memory (conj)
recall could (aux)
$ROOT$ timing (sent)
provided group (nmod)
complicated however (advmod)
drugs cytotoxic (amod)
variables tolerability (conj)
search the (det)
mth 10 (nummod)
less % (dep)
acetaminophen ingested (acl:relcl)
injected once (advmod)
lead development (nmod)
injected doxorubicin (nsubjpass)
behaviour anxious (amod)
arterial or (cc)
history accurate (amod)
changes artery (compound)
ro and (cc)
normal presented (conj)
265.2 79.6 (conj)
fields in (case)
therapy antifibrinolytic (amod)
affected women (nsubjpass)
centre active (amod)
was not (neg)
attenuates , (punct)
risk failure (conj)
half other (amod)
syndrome full (amod)
thalidomide evening (nmod:tmod)
offspring in (case)
stage which (det)
had valve (dobj)
aggravate test (nmod)
fk prograf (appos)
injected along (prep)
interviewed later (advmod)
feature clinical (amod)
rare exceedingly (advmod)
physical and (cc)
n=283 ( (punct)
pd following (case)
ramipril , (punct)
uncommon may (aux)
used conjugate (nsubjpass)
ci [ (punct)
controls did (acl:relcl)
4 ; (punct)
man consumed (acl:relcl)
register nrp (appos)
cohort birth (compound)
pain infusion (compound)
rocuronium mg (dep)
injecting once (advmod)
university oregon (compound)
infarction following (case)
product or (cc)
diagnosis clinical (amod)
transplantation bone (compound)
man 46-year-old (amod)
% 95 (amod)
behavior extreme (amod)
metabolized which (nsubjpass)
occur organization (nmod)
developed hypertension (dobj)
sample venous (amod)
allocated volunteers (nsubjpass)
second- third-generation (conj)
alcohols substances (conj)
describe girl (dobj)
emg ) (punct)
channels calcium-dependent (amod)
practice to (case)
ill seriously (advmod)
result unlikely (conj)
cardiovascular or (cc)
contractility by (case)
bradycardia between (case)
children hundred (nummod)
influences in (case)
degree n (compound)
exposures risk (conj)
performs that (mark)
specimens allograft (compound)
rare though (mark)
progression women (nmod)
failure acute (amod)
od ) (punct)
episodes previous (amod)
enhancement motility (nmod)
weakness as (case)
subunits nicotinic (amod)
started infusion (nsubjpass)
had irradiation (nmod)
shows help (ccomp)
sr metoprolol (conj)
eye his (nmod:poss)
5.5 2.3 (conj)
episode with (case)
capable altering (advcl)
analogues aryl-piperazine (amod)
prazosin with (case)
antagonists atropine (dep)
common , (punct)
beck the (det)
deteriorations cognition (nmod)
beginning treatments (nmod)
agent herbal (amod)
$ROOT$ informative (sent)
sod ( (punct)
decompression microvascular (amod)
accounted indicating (advcl)
those take (acl:relcl)
infusate patients (nmod)
hospitals four (nummod)
ratios pms (nmod)
t.i.d. mg (nummod)
stress adolescent (compound)
aventyl elavil (conj)
system allows (acl:relcl)
ensued diminished (conj)
nephropathy against (case)
enhance flow (dobj)
used which (nsubjpass)
accounted , (punct)
anti-oxidant chaperone (conj)
kidneys adult (amod)
psychostimulant background (compound)
diseases kidney (compound)
evident areas (nmod)
correct to (mark)
cmax/mic ( (punct)
chance a (det)
acting through (mark)
improve will (aux)
registry national (compound)
drug antiarrhythmic (amod)
binding alpha-bungarotoxin (compound)
damage injury (nmod)
provided sufficient (conj)
reduction women (nmod)
chemotherapy leading (advcl)
cystitis delayed (amod)
level elevated (amod)
undergoing use (nsubj)
week 3 (nummod)
occurred injury (nsubj)
man 54-year-old (amod)
risk lead (acl:relcl)
phenobarbital by (case)
exposure alterations (conj)
ester , (punct)
smoke contraceptives (conj)
received day (nmod:tmod)
seen grade (nsubjpass)
reactions p450 (compound)
mean d (appos)
ratio 3.4 (appos)
cause hyponatremia (dobj)
hyperlipidemia depression (conj)
mg levofloxacin (compound)
achieve aim (dobj)
rates eradication (compound)
risk greatest (amod)
points > (amod)
0.070-unit collagenase (conj)
find involved (ccomp)
likely conclusion (nmod)
= 0.11 (dobj)
expand as (mark)
tablet last (amod)
hr completing (nmod)
system adenosine (compound)
reaction dysphoric (amod)
cisplatin by (case)
frequencies 2 (nummod)
sevoflurane in (case)
response small (amod)
neurotransmission daergic (amod)
improved status (nsubj)
$ROOT$ 57.9 (sent)
busulfan of (case)
observed closely (advmod)
deficiency its (nmod:poss)
contraindication using (acl)
documentation of (case)
$ROOT$ prevention (sent)
produce women (nmod)
detect differences (dobj)
figures therapy (nmod)
application similar (amod)
110 +/- (cc)
order lna (dep)
provision for (case)
gels on (case)
prior euthanasia (nmod)
design participants (conj)
numbness perineal (amod)
associated sph (nmod)
tachyarrhythmia siat (appos)
abnormalities occasional (amod)
heparins with (case)
treated observations (nsubjpass)
= -0.95 (dobj)
medications masked (acl:relcl)
range wide (amod)
plasma 0.058 (nummod)
pattern weight (compound)
indicator function (nmod)
ensued hours (nsubj)
rats munich-wistar (amod)
rg1 or (cc)
women old (amod)
correlated normal (advcl)
subjects free (amod)
changes mapd (nmod)
ci=25.2 28.2 (prep)
factor activator (nsubj)
doses acc-9653 (nmod)
rare to (mark)
introduction withdrawal (conj)
instillations early (amod)
effects thalidomide (nmod)
affect atherosclerosis (dobj)
predict that (mark)
h 4.95+/-1.41 (nummod)
arrhythmias the (det)
constants the (det)
induced increase (dobj)
consumers for (case)
depressed that (mark)
received mg/kg (nmod)
group either (det)
cells granule (compound)
9 4 (compound)
children given (acl:relcl)
dissociate that (mark)
movement hearing (conj)
$ROOT$ scheduled (sent)
results met (appos)
warranted is (cop)
ci 7.54 (nummod)
onset days (nmod)
background determine (acl)
systems trigeminal (amod)
evidence reaction (nmod)
block k(+)-channels (dobj)
incidence myoclonus (compound)
seizures/mo ( (punct)
required modification (dobj)
$ROOT$ analyzed (sent)
transplantations , (punct)
midazolam between (case)
absences only (advmod)
was elevated (ccomp)
rat insipidus (compound)
derivative 3 (nmod)
ls lidocaine (appos)
man had (acl:relcl)
33.1 ) (punct)
184 - (punct)
failure therapy (conj)
$ROOT$ be (sent)
exceeds frequency (nsubj)
surrogates exposure (nmod)
accumbens into (case)
peroxidation proteinuria (conj)
meshwork of (case)
metabolised compounds (nsubjpass)
mice ko (amod)
administration lithium (compound)
accelerated injection (nsubj)
neurotoxicity neurotoxicity (conj)
challenge drug (compound)
valdecoxib nsaids (conj)
cause propranolol (nsubj)
nimodipine of (case)
tremor cerebellar (amod)
gtn dcf (appos)
proteinuria day (dep)
interview standardized (amod)
aggravation via (case)
tolerant subjects (nmod)
delays . (punct)
trial group (compound)
terbinafine mg/day (appos)
polymerase nuclear (amod)
2 least (advmod)
associated adjusting (advcl)
cyp of (case)
development epilepticus (nmod)
depression due (case)
taken samples (nsubjpass)
components minor (amod)
dose apomorphine (nmod)
as as (advmod)
inhibition neurotransmission (nmod)
cows prepartum (dep)
reducing requirement (dobj)
microinjections prior (amod)
disappeared pain (nsubj)
function cells (nmod)
disease hypertension (nsubj)
dpi ) (punct)
days period (nmod)
memory ratings (dep)
conjugate monomer-albumin (amod)
differences epss (nmod)
1979 1990 (conj)
n=834 ( (punct)
analysis potassium (nmod)
metabolites detected (acl)
potent chick (nmod)
minutes time (nsubj)
1.35 3.58 (prep)
follow-up cases (nmod)
is and (cc)
absence changes (nmod)
started interval (nmod)
days - (dep)
finally methods (nsubj)
syndrome personality (compound)
course relationship (conj)
test recognition (compound)
dysfunction hypersensitivity (conj)
regions some (det)
age pressure (conj)
pressure clearance (conj)
limits were (cop)
effects tamoxifen (nmod)
exert gfc (nsubj)
treatment succimer (nmod)
da1 ( (punct)
incoordination diazepam (nmod)
interval on (case)
elevated units (nmod)
afferents nociceptive (amod)
interacted associated (conj)
extent cells (conj)
associated abuse (nmod)
importance conducting (advcl)
pyrophosphate thiamine (compound)
autoantibodies anti-nuclear (amod)
mice lack (acl:relcl)
kinase of (case)
associated effacement (nmod)
treatment d-med (nmod)
gaba glutamate (conj)
developed total (nmod)
regimens infusion (compound)
10 0 (conj)
different those (nmod)
studied wr242511 (nsubjpass)
cultured monolayers (nmod)
exam physical (amod)
returned quickly (advmod)
face , (punct)
aventyl nortriptyline (appos)
onset sudden (amod)
lipids urinary (amod)
nf-m and (cc)
arrhythmia severe (amod)
prevalence and (cc)
differences electrocardiogram (nmod)
medulla , (punct)
esthetics self-reported (amod)
ec50 increase (nmod)
mu 6 (nummod)
abuse maternal (amod)
dystonia palsy (nmod)
% subjects (nmod)
men eight (nummod)
incidence toxicity (nmod)
available where (advmod)
attenuation tachycardia (nmod)
macaques ) (punct)
prilocaine ( (punct)
inhibition direct (amod)
anaesthetized surgery (nmod)
necessary analyze (xcomp)
sec 60 (nummod)
fas patients (nmod)
have agents (dobj)
epilepsy , (punct)
participation species (nmod)
neuropathy (emb)-induced (punct)
resolved failure (nsubj)
supporting use (dobj)
pathway kynurenine (compound)
followed be (auxpass)
g 3.6 (nummod)
changes medial (amod)
injury fatal (amod)
show impairments (dobj)
sustained cases (nsubj)
targeting enhanced (amod)
decreased control (advcl)
reduced fraction (dobj)
increase have (conj)
treat tachycardia (nmod)
cgrp migraine (conj)
tolerance l-noarg (nmod)
infusions drugs (nmod)
blunted . (punct)
deemed were (auxpass)
disruption regardless (advmod)
results 9.6-fold (appos)
ratio and (cc)
developed showed (conj)
period 60-min (compound)
given alone (advmod)
affected failure (nmod)
time latency (nmod)
identified areas (nmod)
detectable antibodies (nsubj)
micrograms salbutamol (conj)
deficiency nutritional (amod)
measurements diameter (compound)
study 6-week (amod)
scans imaging (compound)
had rare (ccomp)
models behavioral (amod)
score mean (amod)
fraction baseline (compound)
stretches muscle (nmod)
defects hernia (conj)
rare introduction (dep)
continued and (cc)
glycine of (case)
showed inducibility (dobj)
retrieval experiences (nmod)
rate comparable (acl:relcl)
reversible failed (conj)
boy 14-year-old (amod)
thyroxine or (cc)
hyperthermia by (case)
monkeys 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (compound)
developed they (nsubj)
subjects clonidine (nmod)
amplitude pulse (compound)
produced rechallenge (nsubj)
mm 10.5 (nummod)
documented man (nmod)
lipids lipoproteins (conj)
cascade activation (compound)
encourage trials (dobj)
improved subsequently (advmod)
pronounced more (advmod)
conditions better (amod)
tubule distal (amod)
primary a (det)
suggests evidence (nsubj)
established safety (nsubjpass)
cardiomyocytes aberrant (amod)
alter not (neg)
3.7+/-0.8 ( (punct)
indicate improves (ccomp)
epilepticus and (cc)
illustrates pamidronate (dobj)
have diseases (dobj)
comprise , (punct)
abusers for (case)
doses picrotoxin (nmod)
induce produce (conj)
properties antipsychotic (amod)
agency ( (punct)
electrocardiogram a (det)
perception the (det)
junction at (case)
resting exercise (conj)
lamivudine inhibitor (appos)
enlargement the (det)
increased controls (advcl)
adopted patients (nsubjpass)
$ROOT$ hemiparesis (sent)
conditions acid-base (amod)
had cbz (nsubj)
remained stable (xcomp)
akbr tests (conj)
m(2)-selective ) (punct)
signs evidence (conj)
suggested utility (nsubjpass)
worsened which (nsubj)
treatment stz (compound)
obstruction ureterovesical (amod)
resulted 2 (meta)
score with (case)
mechanisms prl (compound)
rate episodes (nmod)
globulin serum (compound)
aneurysm implantation (nmod)
lower administration (nmod)
samples no (neg)
garft ( (punct)
parameters , (punct)
peptide(1 - (punct)
shunt qs/qt (appos)
65 respectively (advmod)
given each (nsubj)
characterization activity (nmod)
abortion during (case)
agent inactive (acl:relcl)
task during (case)
department , (punct)
expression mrna (nmod)
identified is (auxpass)
effect respiration (nmod)
effects biochemical (amod)
reported japan (nmod)
azt ( (punct)
incidence syndrome (conj)
completed was (auxpass)
patients 1,022 (nummod)
aids and (cc)
rupture subsequent (amod)
poisoning pb (compound)
menopause surgical (amod)
antagonists m1-selective (amod)
discussed subsequently (advmod)
ca ( (punct)
elevation cr (nmod)
exerts extract (nsubj)
nodal atrioventricular (amod)
ntg + (cc)
initiation sirolimus (nmod)
past in (case)
hctz than (case)
defect associated (amod)
analysis cimetidine (nmod)
updating ) (punct)
methoxamine administered (amod)
prevent vitro (advmod)
concluded different (ccomp)
exhaustion amphetamine (nmod)
injected periods (nmod)
increase constants (nmod)
externa within (case)
determine course (dobj)
effects u-ii (nmod)
isoniazide mg/kg (appos)
performed dse (dobj)
mg/m2 was (cop)
responsiveness this (det)
was sets (nmod)
occur incidence (nmod)
men 19 (nummod)
gastrointestinal and (cc)
mmt [ (punct)
probe a (det)
subgroup developed (acl:relcl)
treatment betaine (compound)
excluded can (aux)
excitement , (punct)
interaction from (case)
prognosis for (case)
aconitine with (case)
incorporated fs (nmod)
2-subunits beta (compound)
sclerosis and (cc)
decrease cmro2 (nmod)
mg/kg/day given (acl)
persons of (case)
possible perhaps (advmod)
association risk (nmod)
warranted investigation (nsubjpass)
pattern deterioration (nmod)
time disease (compound)
dopamine local (amod)
interval or (cc)
fever from (case)
den ) (punct)
glutamate involved (acl:relcl)
sh(12 ) (punct)
mg/dl 8.25 (nummod)
treatment inhibitor (compound)
re-examine design (nmod)
identified time (nmod)
vpa with (case)
testing benzoylecgonine (nmod)
investigated questions (nsubjpass)
toxicities hematologic (amod)
control weight (compound)
wild-type knockout (conj)
chromosomes 10 (dep)
identified along (prep)
extraction forearm (compound)
subset recipients (nmod)
mg. on (case)
administration unintentional (amod)
67 cocs (nmod)
increase points (nsubj)
level uric (amod)
reduced higher (ccomp)
metabolism , (punct)
modifies pretreatment (nsubj)
assess pharmacokinetics (dobj)
$ROOT$ however (sent)
onset diagnosis (conj)
facilitate effectively (advmod)
mg 850 (nummod)
vincristine by (case)
neurogenesis cognition (conj)
received prophylactically (advmod)
useful was (cop)
white non-hispanic (amod)
compared group (nmod)
few studies (nsubj)
induction chemical (amod)
two failure (nmod)
similar occurred (parataxis)
glutathione and (cc)
pneumonia pcp (appos)
infused min (nmod)
controls eight (nummod)
clozapine olanzapine (conj)
attenuated lesions (dobj)
pr ( (punct)
gssg of (case)
dose methamphetamine (nmod)
fingers of (case)
patients belonging (acl)
cytometry flow (compound)
magnesium of (case)
injection antagonist (nmod)
involved differences (nsubjpass)
improve transplantation (nmod)
reaction hypersensitivity (compound)
flexion . (punct)
manual by (case)
manipulated . (punct)
receptor 5-ht1b (compound)
finding be (cop)
cells b3 (compound)
cont./min 2.5 (nummod)
aims : (punct)
phosphokinase u/liter (appos)
exercise after (case)
circles in (case)
delayed diagnosis (nsubjpass)
treated steroids (nmod)
= 2.5 (dobj)
seizures behavior (conj)
disinhibition in (case)
pathways innate (amod)
61.9 ) (punct)
years diagnosis (nmod)
91 to (quantmod)
mg/l 374 (nummod)
evoked but (cc)
confirmed this (nsubjpass)
exhibited function (dobj)
rg1 and (cc)
activation dopamine (compound)
recommend not (neg)
pirarubicin ) (punct)
infusion 48-hour (amod)
vasodepressor the (det)
solution , (punct)
given steroids (nsubjpass)
tdp spontaneous (amod)
predictive however (advmod)
offers venue (dobj)
elevations observed (acl)
offers technology (nsubj)
strength in (case)
metolachlor , (punct)
signs which (nsubj)
mesangium the (det)
examined study (nsubj)
incerta zi (appos)
prompted review (dobj)
oxidase with (case)
determinants electrophysiological (amod)
samples fourteen (compound)
torr to (case)
swallow videofluoroscopy (nmod)
analyze and (cc)
cells area (nmod)
fluency during (case)
number mice (nmod)
action toxicity (nmod)
activity window (conj)
support strategy (dobj)
% response (dep)
used stimuli (nsubjpass)
placebo 26.3+/-3.6 (appos)
nms . (punct)
calcium such (case)
factors overlooked (acl:relcl)
dextran of (case)
greater changes (nsubj)
on who (nsubj)
= % (dobj)
lowering a (det)
reflect which (nsubj)
stores catecholamine (compound)
waves indicating (acl)
kidneys , (punct)
50 only (advmod)
process it (nsubj)
located terminals (nmod)
treatment trazodone (compound)
attacks migraine (compound)
play ameliorates (conj)
diuretics potassium (conj)
elevation isoproterenol-induced (amod)
preexposure , (punct)
onset persistence (conj)
reduced completing (nmod)
tissues breast (compound)
become recently (advmod)
reverse catalepsy (dobj)
affected that (mark)
defects these (det)
interactions profound (amod)
received lidocaine (dobj)
composition . (punct)
increasing such (mark)
injections iv (nummod)
angioedema administration (nmod)
mechanisms toxicologic (amod)
hospitalization group (conj)
underwent band (nmod)
inhaled experiment (nmod)
bed the (det)
development cells (nmod)
aware interaction (nmod)
antagonist administered (acl:relcl)
reduced reabsorption (nsubjpass)
document precedes (ccomp)
% significant (dep)
deposition distributed (amod)
related half (nsubj)
showed kinase (dobj)
coupling depression (nmod)
prospective randomised (dep)
irritation by (case)
severity tremor (compound)
promoted administration (nsubj)
potential nephrotoxic (amod)
symptoms anaphylaxis (nmod)
dialysis by (case)
exhibited relationship (dobj)
platform central (amod)
arteries of (case)
vomiting retching (conj)
suggest have (aux)
emerging finding (nmod)
aging with (case)
increase activation (nmod)
administration kindling (appos)
lead consequences (nmod)
unaltered development (nmod)
% 15.3 (nummod)
antipsychotic effective (amod)
doing . (punct)
reduced rather (advmod)
sulfate oversulfated (amod)
comparing groups (dobj)
pontis reticularis (compound)
uteri whose (nmod:poss)
functioning . (punct)
ml/kg cellulose (conj)
involved receptor (nsubjpass)
derivative produced (amod)
started group (nmod)
investigate cohort (nmod)
tumors rare (amod)
targeting pathway (dobj)
activity hl (nmod)
hepatocytes periportal (amod)
administered paracetamol (nsubjpass)
pcpa day (appos)
levels maximal (amod)
cells vessels (nmod)
gyrus and (cc)
decrease stress (dobj)
differ flows (nsubj)
neonates these (det)
laboratory research (compound)
exposure intensive (amod)
prevention study (dep)
$ROOT$ confound (sent)
abuse : (punct)
associated cystitis (nmod)
day 833 (nummod)
doses vasopressin (nmod)
pretreated rats (nsubjpass)
amisulpride with (case)
a b (dep)
resolution of (case)
was death (attr)
dysfunction moderate (amod)
12 to (dep)
mrnas syndrome (nmod)
mass muscle (compound)
glutamate or (cc)
results measured (advcl)
evaluate relations (dobj)
titrated maintained (conj)
= t(30 (nsubj)
found induced (ccomp)
contractility myocardial (amod)
potent antagonist (nmod)
basis eradication (nmod)
controls 13 (nummod)
cardioprotection in (case)
expression in (case)
systems dopaminergic (amod)
advised alternative (nmod)
administration mg/kg (nmod)
levels peak (compound)
groups sucrose (dep)
elevation level (nmod)
damage heart (nmod)
mice insensitive (amod)
conducted associated (advcl)
gene-targeted clonidine (nmod:npmod)
dextrose water (conj)
hepatitis drug-induced (amod)
sequelae neurologic (amod)
shown gamma-hch (nsubjpass)
effects psychotropic (amod)
min 240 (nummod)
diminished volume (nsubjpass)
department histology (nmod)
drug another (det)
analyzed and (cc)
% 18.9 (nummod)
implicating interaction (dobj)
6-hydroxydopamine or (cc)
300 - (punct)
dose metoprolol (nmod)
reports therapy (nmod)
observed either (cc)
hopes associated (acl)
showed x/minute (dobj)
agonist is (cop)
cystourethrogram a (det)
hospitalization bleeding (conj)
toxicity audiovisual (amod)
correlated temporally (advmod)
substitution sp120 (compound)
consequence that (mark)
vestibulotoxicity of (case)
effect nephrotoxicity (nmod)
minutes duration (nsubj)
dysosmia recurrent (amod)
siblings identical (amod)
summary took (appos)
indicated induce (ccomp)
studied retrospectively (advmod)
showed tests (nmod)
ability greatest (amod)
consequence only (advmod)
nodules no (neg)
hg 119 (nummod)
gd on (case)
programmed increase (dobj)
days=1.77 ptrend=0.09 (dep)
patterns nephrotoxicity (nmod)
sedative the (det)
cochlea developing (amod)
tumors brain (compound)
ukpdrg ( (punct)
failure pentobarbital-induced (amod)
overexpression dismutase (nmod)
associations pollutants (nmod)
analyzed confirmed (conj)
25 50 (conj)
metabolizer that (mark)
hypotheses pathogenetic (amod)
changed days (nmod)
anesthetized rats (nsubjpass)
assessment pre-operative (amod)
recurring that (mark)
0.001 ) (punct)
counterparts cage (compound)
distribution intrarenal (amod)
withdrawal study (compound)
heroine cocaine (conj)
hypertensive stroke-prone (dep)
administration fluid (compound)
sphincter oddi (nmod)
inhibits administration (nsubj)
weight dose (conj)
using tomography (dobj)
corticography during (case)
obtain information (dobj)
appearance activity (nmod)
untreated previously (advmod)
oxycodone 10-mg (compound)
12 in (case)
% 38 (nummod)
users 215 (nummod)
evaluate tolerance (dobj)
intake intake (conj)
lithium by (case)
similarities dependency (nmod)
synthesis cardiomyocyte (compound)
contributor as (case)
correlated be (auxpass)
influence promote (conj)
found measure (xcomp)
protamine of (case)
20 nearly (advmod)
treatment continued (acl)
edema overdose (nmod)
woman malawian (amod)
suggest experiments (nsubj)
events two (nummod)
taking they (nsubj)
studied rats (dep)
properties epileptogenic (amod)
hyperactivity due (case)
taken hr (nmod)
converted dogs (nmod)
rat each (det)
overdose captopril (compound)
therapy antiepileptic (amod)
0.56 model (nmod)
neurotoxic cbdca (nsubj)
exchange open (amod)
events pgp-enhancing (amod)
ccr , (punct)
fell and (cc)
raise staff (nmod)
ph. in (case)
effects analgesic (amod)
mg 400 (compound)
gaze superior (amod)
recommended advised (ccomp)
given minutes (nmod)
case therapy (nmod)
events dose-limiting (amod)
t with (case)
trials early (amod)
emesis clumsiness (conj)
july on (case)
reexposure heparin (nmod)
patients md (nmod)
proven rechallenge (nmod)
l-alpha-gfc or (cc)
is modulated (ccomp)
actions cns (nmod)
determination flow (nmod)
percent infants (nmod)
urea electrolytes (conj)
vpa mg/kg (appos)
g/d conversion (nmod)
alert fact (nsubj)
$ROOT$ toxicity (sent)
children recipients (appos)
mellitus hypertension (conj)
evolve minority (nsubj)
disappeared months (nmod)
sensitivity or (cc)
comparison a (det)
suggested block (dobj)
prevented it (nsubj)
lacking however (advmod)
examined understand (advcl)
toxicities and (cc)
mg/kg 10 (compound)
g-1 ( (punct)
coeruleus pons (nmod)
damage for (case)
induced injection (nsubj)
mg/day 10 (nummod)
performed often (advmod)
absent rats (nmod)
found predictor (ccomp)
affect cases (nmod)
gastrocnemius rectus (conj)
variety disturbances (nmod)
occurrence with (case)
level neurotransmitters (nmod)
potentiated significantly (advmod)
wt ( (punct)
negroes african (amod)
stressed studies (nsubj)
hdl mainly (advmod)
cbz with (case)
analyzed data (dobj)
translocations ) (punct)
disorder gastrointestinal (amod)
associated recall (nmod)
assessed commencing (advcl)
roles pivotal (amod)
evident observation (nmod)
causes pathology (dobj)
development shock (nmod)
had 163 (nsubj)
period patients (nmod)
experiments behavioral (amod)
nephrotoxicity angioplasty (nmod)
had stimulation (nsubj)
unpredictable and (cc)
alkalosis metabolic (amod)
reports recent (amod)
implant subcutaneous (amod)
regimen tuberculosis (nmod)
gain what (dobj)
p-chlorophenylalamine , (punct)
756 - (punct)
mention no (det)
ace renal (amod)
interval and (cc)
bedtime pre (amod)
drugs several (amod)
analysis transition (conj)
rare because (mark)
2h up (case)
exhibiting dose (dobj)
ineffective challenge (nsubj)
palsy intoxication (nmod)
increases glutamate (nmod)
limited may (aux)
sunbelt the (det)
80 70 (compound)
% 4.0 (nummod)
administration gluconate (nmod)
cisplatinum mg/m2 (appos)
dosed rats (nsubjpass)
anticonvulsants of (case)
done and (cc)
mg/kg 3.25 (compound)
antibodies with (case)
disappearing syndrome (nsubj)
refused postoperatively (advmod)
drug either (det)
tbars ( (punct)
abolished were (auxpass)
resulted indomethacin (nsubj)
that induced (acl)
0.13 +/- (cc)
epithelium bladder (compound)
implies . (punct)
following immediately (advmod)
alleviated enabling (advcl)
cck-5 ( (punct)
tetany importance (appos)
response jerks (nmod)
ser198 and (cc)
presentation with (case)
diuretic with (case)
result leukoencephalopathy (nsubj)
drops eye (compound)
establish diagnosis (dobj)
awareness increased (amod)
set blockade (nsubj)
nausea induced (acl)
enzyme nte (appos)
indicated potentiate (ccomp)
i.v. micrograms (dep)
translocation sarcolemma (nmod)
features failure (nmod)
tube into (case)
worsened further (advmod)
had infusion (nmod)
pain trigeminal (amod)
described earlier (advmod)
admitted july (nmod)
replacement , (punct)
none studies (nmod)
d2 and (cc)
crystallization acute (amod)
resolved ; (punct)
sustained symptomatic (dep)
distinguished is (auxpass)
syndromes and (cc)
hypertelorism , (punct)
susceptibility patients (nmod)
sites other (amod)
additive can (aux)
doxil ( (punct)
activities dehydrogenase (nmod)
data published (amod)
discussed regard (nmod)
variety a (det)
solution dextran (compound)
viewed should (aux)
cocaine and/or (cc)
visualize nos (dobj)
activities amphetamine-induced (amod)
infusions intermittent (amod)
data study (dep)
cholestasis and (cc)
touch pain (conj)
promoted tam (nmod)
lesions cm (nmod)
dyskinesias on (case)
5 to (case)
treatment dialysis (compound)
pathogenesis disorders (nmod)
drug selective (amod)
levels decibels (nmod)
group addicts (nmod)
glutamate ( (punct)
comparisons qualitative (amod)
show s (dep)
icc ( (punct)
measurement interval (nmod)
restored impairment (dobj)
morphine codine (conj)
described reports (nmod)
assay myocytes (nmod)
determine decrease (ccomp)
patient-years per (case)
nascis in (case)
encephalopathy perinatal (amod)
sensitive rats (nsubj)
period interference (nmod)
acquisition immediately (advmod)
gained . (punct)
quantified not (neg)
synthase nnos (appos)
periods may (appos)
meq/l 3.52 (nummod)
fibers myelinated (amod)
appetite mouth (conj)
d 5 (nummod)
remained unclear (xcomp)
infusion cocaine (nmod)
treatment arabic (amod)
therapy d4 (compound)
seizures ptz-induced (amod)
ritonavir vehicle (conj)
role protective (amod)
comprises . (punct)
product double (amod)
supports contributor (nmod)
underlie development (dobj)
nd-nmba ( (punct)
[125i]mibg of (case)
group nondrinking (amod)
mmhg of (case)
procedure oral (amod)
negative ; (punct)
emphasizes case (nsubj)
behaviour open-field (amod)
addition an (det)
desensitization impairment (conj)
hypertension subset (nmod)
$ROOT$ recur (sent)
cause used (conj)
approaches multidisciplinary (amod)
enalapril , (punct)
remained group (nsubj)
attenuated are (auxpass)
prevented pre-treatment (nsubj)
elevated values (advcl)
showed reflecting (advcl)
effective restoring (advcl)
movements choreoathetoid (amod)
pretreatment mice (nmod)
elimination prolonged (amod)
rats -- (punct)
0.6 +/- (cc)
m0 at (case)
treatment interferon (compound)
age hospitalization (conj)
decreases norms (nmod)
convulsions tonic-clonic (amod)
emerged increases (nsubj)
factors back-diffusion (nmod)
elderly specifically (advmod)
response clinical (amod)
test water (nmod)
enhanced anaesthesia (nmod)
associated that (mark)
was association (nsubj)
% 0.4 (nummod)
incidence recovery (conj)
infusion epinephrine (compound)
antagonist a2a (compound)
rare individual (nmod)
setting clinical (amod)
session between (case)
indicator disturbances (nmod)
efficacy kindled-seizures (nmod)
baseline initial (amod)
assess potential (dobj)
clones escape (nmod)
potential cardioprotective (amod)
postswitch % (compound)
hypotension (sn)-induced (amod)
mechanism an (det)
users potential (amod)
transplantations performed (advcl)
live now (advmod)
indicated dse (nsubj)
antioxidant and (cc)
extract berries (nmod)
monkeys 14 (nummod)
myopathy a (det)
$ROOT$ reached (sent)
mechanisms basic (amod)
deterioration accompanied (acl)
learning induced (acl)
vary exhibit (conj)
activity significant (amod)
down measure (acl:relcl)
response antigens (nmod)
activation factor-kappab (compound)
ventilated mechanically (advmod)
initiation following (case)
5-fu of (case)
was patients (nmod)
changes patients (nmod)
presented anemia (nmod)
stunning myocardial (amod)
periods of (case)
endophthalmitis streptococcal (amod)
syndrome withdrawal-emergent (amod)
complication reported (amod)
longer m (nmod)
consumed had (aux)
disruption the (det)
arrhythmia , (punct)
24 in (case)
toxicity prevented (acl:relcl)
acid asa (appos)
restricted cause (advcl)
occurs vis-a-vis (dep)
consisted schedule (nsubj)
entering program (dobj)
days 25 (nmod)
l-isomer ) (punct)
reported past (nmod)
visualize quantitate (conj)
more threat (nmod)
failure receiving (advcl)
concentrations subtherapeutic (amod)
iu/l ( (punct)
functions cardiovascular (amod)
rate volumes (conj)
onset after (case)
fasciitis bortezomib (nmod)
protein p (dep)
property negative (amod)
vt/ti ( (punct)
received induction (nmod)
genes key (amod)
reduces modulation (nsubj)
antagonize experiment (nmod)
reduce agonists (nsubj)
function therapy (nmod)
$ROOT$ time (sent)
neurotransmitter gaseous (amod)
mg 40 (compound)
prilocaine glucose (nmod)
counts 4,957 (nummod)
unclear happens (ccomp)
depletion serotonin (compound)
patients glycopyrrolate (appos)
measures conventional (amod)
hg less (amod)
adrenaline of (case)
studies some (nummod)
occurred lethalities (nsubj)
bodies characteristic (amod)
catheter venous (amod)
contributes vivo (advmod)
bolus lidocaine (nmod)
recurred . (punct)
84 98 (prep)
hallmarks syndrome (nmod)
patients acetaminophen-induced (amod)
screening neonatal (amod)
causes disorders (nmod)
presence in (case)
sensitivity ( (punct)
images resting (amod)
effects procaterol (nmod)
acting than (mark)
levels comparable (amod)
focused has (aux)
signs further (amod)
death index (dep)
depression synapses (nmod)
coma this (det)
abnormalities renal (amod)
sample the (det)
processing abnormal (amod)
cases 18 (nummod)
presented course (nsubjpass)
are agents (attr)
administered s-23121 (nsubjpass)
events vnr (nmod)
infusions ranging (acl)
elevated level (nsubj)
angina in (case)
due overtreatment (nmod)
raised questions (dobj)
properties chemical (amod)
required recovery (nmod)
nanoparticles a (det)
induced mice (nmod)
sensitivity control (nmod)
provide gls (nsubj)
shown medication (xcomp)
investigated association (dobj)
one abnormalities (nmod)
tablet ) (punct)
suspicion of (case)
calcification status (conj)
cause evaluated (ccomp)
men other (appos)
characteristics biomembranes (nmod)
frequency haemorrhages (nmod)
hoc post (advmod)
0.25 significantly (advmod)
ppm 100 (nummod)
role model (nmod)
headache for (case)
aware accompany (advcl)
presence absence (nmod)
produced indicating (advcl)
olanzapine mg/day (appos)
bradycardia of (case)
condition clinical (amod)
indicators injury (nmod)
explore studying (advcl)
ns : (punct)
grafting for (case)
dehydrogenase kinase (conj)
total increases (dep)
conclude useful (ccomp)
defects . (punct)
nephrosis rat (compound)
remains although (mark)
heat of (case)
abnormalities expression (nmod)
7 rats (nmod)
limits which (nsubj)
likely heterogeneity (nmod)
elements cellular (amod)
plugs originating (acl)
uganda in (case)
level through (case)
kpa 10.3 (nummod)
level use (nmod)
bbb including (case)
resulting rate (nmod)
years 20 (nummod)
estrogens premarin (appos)
diclofenac compared (case)
risks exceed (dep)
cells columnar (amod)
enhanced doxorubicin (nmod)
go that (nsubj)
episode transient (amod)
10min every (det)
measured that (mark)
unit ed (nmod)
improved were (auxpass)
events the (det)
ag ) (punct)
commencement inhibitors (nmod)
dilates arteries (dobj)
90 - (punct)
failure heart (compound)
cases stroke (compound)
ozone pm2.5 (conj)
possible suppress (xcomp)
capacity maximum (amod)
bind ngf (dobj)
persisted reversible (advcl)
ratio parameters (conj)
showed features (dobj)
sex treatment (conj)
used years (nmod)
plasma normal (amod)
$ROOT$ prognosis (sent)
65 88 (conj)
company bristol-myers (compound)
possessed effects (dobj)
total cholesterol (conj)
fludrocortisone by (case)
accounted number (nmod)
68.3 +/- (cc)
intervals day (compound)
neonates . (punct)
ac ( (punct)
taking treatment (nmod)
hypertension a (det)
degree higher (amod)
responses associated (acl)
have worth (conj)
administered dogs (nmod)
events hyper- (appos)
t.i.d. : (punct)
penicillamine with (case)
ml/min , (punct)
$ROOT$ cardiotoxity (sent)
prodrug ribavirin (nmod)
role poisoning (nmod)
gd ( (punct)
synthase thymidylate (compound)
need possible (amod)
antibiotic clarithromycin (nsubj)
technique ( (punct)
humans hypertension (nmod)
use ppa (nmod)
cells blood (compound)
occurs primarily (advmod)
considered media (xcomp)
minutes 15 (nummod)
operative generalization (nmod)
gavaged orally (advmod)
facies lungs (conj)
partial 5 (nummod)
occurred detected (conj)
tachycardia nsvt (appos)
important effects (advcl)
changes wave (compound)
desmosomes the (det)
exist variants (nsubj)
thorazine chlorpromazine (appos)
line single (amod)
reviewed paper (nmod)
stents metal (compound)
oc ( (punct)
hg by (case)
integration complex (amod)
high sensitivities (nsubj)
wr-2721 or (cc)
hit ii (nummod)
suggest neurotoxic (ccomp)
found activate (xcomp)
from away (advmod)
nephropathy strain (nmod)
seizures models (nmod)
infarction lesions (conj)
range less (amod)
aqp2 ) (punct)
dihydrochloride , (punct)
lipoproteins lp (appos)
msh/acth ) (punct)
appearance jaundice (nmod)
children risk (nmod)
ic30 ( (punct)
exacerbations associated (acl)
ls and (cc)
migration and (cc)
chp at (case)
$ROOT$ stimulant (sent)
innervation sympathetic (amod)
systemic or (cc)
aminoglycosides intravitreal (amod)
lesions all (predet)
formation infants (nmod)
unclear , (punct)
52 to (quantmod)
= r (nmod)
prolonged recurrent (conj)
survived which (dobj)
anatomical pathophysiological (conj)
usage between (case)
analysis using (acl)
therapy phenobarbital (compound)
improves patients (nmod)
used infrequently (advmod)
generated individuals (nmod)
infiltrate an (det)
injected dose (conj)
group group (nmod)
benefit gastrointestinal (amod)
incidence activity (conj)
nitrogen electrolytes (conj)
less score (nsubj)
millimeter cubic (amod)
lc at (case)
incidence quetiapine (nmod)
higher lower (advcl)
derived results (nsubjpass)
observations exencephaly (nmod)
factor major (amod)
smelling of (mark)
17.6-fold contents (nsubj)
$ROOT$ corresponded (sent)
grow average (nmod)
polychemotherapy in (case)
flow an (det)
outcomes surgery (nmod)
switched nephrotoxicity (nmod)
residues protein (nmod)
ropivacaine and (cc)
use alcohol (compound)
ameliorate could (aux)
depolarisation sustained (amod)
althesin thiopentone (conj)
lnna the (det)
otoprotectant an (det)
showed staining (nsubj)
treated i.p. (advmod)
115 228 (dep)
attenuate deficits (dobj)
patients third (conj)
leukemia meningeal (amod)
recognition users (nmod)
increased contrast (nmod)
failed verapamil (nsubj)
mean greater (amod)
body to (case)
cytoprotection cs (compound)
rates respiration (nmod)
ngf in (case)
h mg/l (nummod)
seen syndrome (nmod)
$ROOT$ displayed (sent)
down-regulation beta-adrenergic (amod)
restarted was (auxpass)
neutropenia infections (conj)
used regression (dobj)
indicate associated (ccomp)
stained dyes (nmod)
woman syndrome (nmod)
small risk (nsubj)
media cells (nmod)
bcnu then (advmod)
is dissociate (ccomp)
cystectomy early (amod)
catalyze and (cc)
changes before (case)
compared study (nmod)
comparison regimens (nmod)
78-year-old necrosis (nmod)
found frequently (advmod)
atypia cellular (amod)
ng ( (punct)
drugs known (acl)
thromboembolism paradoxical (amod)
l-med saline (conj)
motivational , (punct)
treated ketamine (nmod)
data rats (nmod)
as and (cc)
extend duration (dobj)
thrombosis humans (nmod)
period surgery (nmod)
traits 2 (nummod)
mechanisms pathogenetic (amod)
hypocalcemia in (case)
toxicity ifosfamide (nmod)
developed changes (dobj)
bupivacaine- ropivacaine-infused (conj)
mg/kg from (case)
hz of (case)
bilirubin encephalopathy (conj)
experienced events (dobj)
associated aging (nmod)
obtained breakdown (nmod)
tacrolimus to (case)
reports cases (dobj)
reduction therapy (conj)
fit generally (advmod)
characteristics formulation (nmod)
scored and (cc)
disorders liver (compound)
fibrillation diatrizoate (nmod)
minor grade (nmod:tmod)
hydroxylase th (appos)
limited toxicities (nsubj)
increased estradiol (nsubj)
cessation pills (nmod)
mg./kg i.p. (advmod)
hours injection (nmod)
atrophy iib (nummod)
limits normal (amod)
analysis outcomes (nmod)
rtms hz (nmod)
shock acute (amod)
maintenance for (case)
antagonism effects (nmod)
rate about (advmod)
nodosa polyarteritis (compound)
tomography brain (nmod)
pregs both (cc:preconj)
had interval (dobj)
present tbm (nmod)
reaction chelation (nmod)
time clotting (compound)
sensation and (cc)
cyclophosphamide combination (nmod)
development delirium (nmod)
illness thyroid (compound)
given lactate (nmod)
studied be (auxpass)
reaction as (case)
performed referred (conj)
subunits of (case)
pain swelling (conj)
recognize to (mark)
involved effect (nmod)
had audiograms (dobj)
magnitude injury (nmod)
decreased discontinuing (advcl)
synapse (lpp)-granule (compound)
ecg non-ischemic (amod)
aids ) (punct)
decreasing level (dobj)
bradycardia % (dep)
drug choice (nmod)
production , (punct)
ng/ml 1000 (nummod)
modeling computer-aided (amod)
restored days (nmod)
rearing behavior (conj)
flow regional (amod)
markers damage (nmod)
conducted methods (nsubj)
resistant livers (nsubj)
women diagnosed (acl)
trial dose-escalating (amod)
indicates support (nsubj)
physicians care (compound)
dose fell (acl:relcl)
levels hemoglobin (compound)
weekly month (nmod)
normal enhanced (conj)
patients 240 (nummod)
lomustine and (cc)
caused localization (nsubjpass)
contains which (nsubj)
had echocardiography (nmod)
$ROOT$ correct (sent)
lack response (nmod)
analysis : (punct)
administered withdrawal (nmod)
administered rates (nmod)
given intra-arterially (advmod)
block reverse (conj)
doses at (case)
effect suppressive (amod)
oxygen for (case)
pressure an (det)
5-azacytidine by (case)
desipramine with (case)
pdtc of (case)
mutation val204asp (appos)
production et-1 (compound)
proteinuria sirolimus-associated (amod)
cerebellum in (case)
role preventing (acl)
report woman (nmod)
mg/m2/wk 20 (nummod)
show responses (nsubj)
seizures generalized (amod)
allocated then (advmod)
actions antiarrhythmic (amod)
become . (punct)
dogs time (conj)
approaches follow-up (nmod)
use ecstasy (compound)
manner blind (amod)
compared also (advmod)
overstimulation period (nmod)
electrophysiology full (amod)
restore to (mark)
9/106 ( (punct)
ct ( (punct)
cpb of (case)
dose comparable (acl:relcl)
susceptibility exhaustion (nmod)
had score (dobj)
rate slowed (acl:relcl)
occurred later (advmod)
alpha3 , (punct)
day post-fenoldopam-infusion (dep)
involvement leukemic (amod)
continued drinking (dobj)
localization random (amod)
combination cis-platinum (nmod)
conducted series (nsubjpass)
dh , (punct)
generated are (auxpass)
addition drug (nmod)
deficits induced (acl)
dose it (nmod)
colitis chronic (amod)
$ROOT$ aggravate (sent)
cell transitional (amod)
stl1 stl2 (conj)
one by (case)
investigate hypothesis (dobj)
potentiates depletion (nsubj)
adc ( (punct)
known part (nmod)
atrophy . (punct)
ssc ) (punct)
contrasting absence (nmod)
blockers diltiazem (dep)
adrenoceptor alpha1 (compound)
time years (appos)
administration risperidone (nmod)
rich cholesterol (nmod:npmod)
amns alone (advmod)
nanoparticles poly-l-lactid (amod)
rates infusion (compound)
rats icv (compound)
using study (xcomp)
374 554 (conj)
escalated follows (advcl)
treated pilocarpine (nmod)
composition biliary (amod)
system catecholaminergic (amod)
hypothermia drug-induced (amod)
reduced 5/8 (parataxis)
vasodilatation by (case)
provide studies (nmod)
stz with (case)
neuritis tacrolimus-associated (amod)
derive surrogates (dobj)
those however (advmod)
group to (case)
trial b. (nmod)
rats but (cc)
longer was (cop)
transplantation by (case)
had persist (ccomp)
period crossover (compound)
$ROOT$ summarized (sent)
disorders indicating (acl)
points 100 (nummod)
boluses = (parataxis)
syndrome ascites (nmod)
transmission glutamatergic (amod)
hg pretreatment (dep)
analyzed hematoxylin (nmod)
mug 3 (nummod)
mechanism paralysis (nmod)
treat could (aux)
reached is (auxpass)
regurgitation valvular (amod)
transition the (det)
measured ebf (nsubjpass)
suggested demonstration (xcomp)
atorva 1187 (nummod)
blunted controls (advcl)
leukemia all (appos)
testosterone prolactin (conj)
placebo either (nmod)
propofol medialipid (nmod)
exposures and (cc)
diagnosed method (nmod)
muscle isolated (amod)
constituted center (nmod)
designed investigate (xcomp)
seeds of (case)
change alfentanil (nmod)
hamartoma , (punct)
used hypotension (nsubjpass)
foci any (det)
$ROOT$ causes (sent)
examined correlations (nsubjpass)
alpha-t alpha-tac (conj)
rats healthy (amod)
evaluated evening (nmod)
excretion proteinuria (conj)
regardless performed (advcl)
women valves (nmod)
mol/l ) (nummod)
said , (punct)
angiograms performed (acl)
contributed delta22-isomer (nsubj)
responses six (nummod)
changes transport (nmod)
curcumin antioxidant (amod)
clinics our (nmod:poss)
5.4 to (case)
majority for (case)
action direct (amod)
50 75 (conj)
ocs with (case)
rigidity muscular (amod)
$ROOT$ duration (sent)
effect lethal (amod)
15-f(2t)-isop liver (compound)
lowered extent (conj)
received developed (parataxis)
therapy chloroquine (compound)
mechanism intrarenal (amod)
pressure rats (nmod)
mm 1/2 (nummod)
determined study (nmod)
gain higher (amod)
$ROOT$ distinguish (sent)
started rule (nmod)
decline and (cc)
does norepinephrine (nsubj)
attenuated studies (nmod)
need search (acl)
failed cycloheximide (nsubj)
harvested livers (nsubjpass)
referred ) (punct)
shares . (punct)
antagonism seizures (nmod)
profiles subtypes (nmod)
supplementation with (case)
animals 45 (nummod)
reversal 2 (dep)
cells mast (compound)
faster those (nmod)
chemotherapy by (case)
radiotherapy radical (amod)
immunosuppressant tacrolimus (nsubj)
pretreated chemotherapy (nmod)
levels reduced (amod)
151 experienced (acl:relcl)
blocker entry (compound)
designed block (xcomp)
boy 10-year-old (amod)
mda renal (amod)
results minute (appos)
contribution salt-sensitivity (nmod)
continues evaluation (nsubj)
continued weeks (nmod)
linked restoration (nmod)
impairment regulation (nmod)
associated usage (nmod)
1.85 +/- (cc)
characterized brief (nmod)
increasing [ca]o (dobj)
scale analog (compound)
include so (advmod)
allocated outpatients (nsubjpass)
rigidity tremor (conj)
decreases turn (nmod)
renal hepatic (conj)
hepatotoxicity possible (amod)
months months (appos)
abolish effects (dobj)
30 7.5 (conj)
neuropathology snr (nmod)
gas the (det)
retarding release (dobj)
70 8 (conj)
reason more (amod)
tourniquets the (det)
diagnosed lacnp (nmod)
micu to (case)
population diseases (conj)
play regulation (nmod)
availability no (nmod)
study cross-over (amod)
media from (case)
neoplasms % (appos)
applications rtms (nmod)
was case (attr)
measures desire (nmod)
was those (advcl)
l/kg vs. (cc)
isolation sequential (amod)
processes also (advmod)
experiencing subjects (nsubj)
aconitine ouabain (conj)
diazepam for (case)
decrease synthesis (nmod)
bnpp with (case)
stress between (case)
bypass surgery (conj)
vomiting ) (punct)
occurred recovery (nsubj)
effects systems (nmod)
1a1/1a2 and (cc)
therapy addiction (nmod)
observed interval (nmod)
studied regions (nmod)
lowering with (case)
anti-inflammatory and (cc)
protect tissues (dobj)
compared 136 (nmod)
gpi ) (punct)
possible measuring (advcl)
pressure mbp (appos)
s.c. by (case)
changes hematologic (amod)
levels anxiety (nmod)
cause spasm (nsubj)
encountered women (nmod)
administration raloxifene (compound)
convulsions pilocarpine-induced (amod)
using doses (dobj)
induced indomethacin (nmod)
effects symptoms (nmod)
experiments blood (compound)
program of (case)
mg 0.1 (nummod)
inhibitor hemicholinium (appos)
problem has (aux)
considered considered (advcl)
review published (acl)
split a (det)
improve safety (dobj)
vehicle ethanol (appos)
interaction and (cc)
conclusion risk (appos)
postulate , (punct)
consisted stores (nsubj)
cacl(2)-treated cacl(2)-untreated (conj)
91 than (quantmod)
childhood in (case)
pressure artery (compound)
step bar (dobj)
methods was (appos)
cured were (auxpass)
fever and (cc)
dilation function (conj)
taste and (cc)
induced seizures (nsubjpass)
reviews study (nsubj)
b 24/76 (nummod)
subjects eight (nummod)
doses mesna (nmod)
studies animals (nmod)
blocks binding (advcl)
proteinuria function (conj)
mimicking hydronephrosis (dobj)
got and (cc)
precurarization after (case)
treatment hcl (compound)
difference due (case)
scenario of (case)
amplitude falling (dep)
factors improve (acl:relcl)
reviewed reports (nsubjpass)
implicated available (conj)
response prolactin (compound)
agonists sub-type-selective (amod)
risk poor (amod)
mg/kg sc (advmod)
show limitations (nmod)
ke vd (conj)
episodes episodes (conj)
h within (nmod)
determined also (advmod)
2-fold glipizide (nmod)
mmhg 110 (nummod)
level alpha-fluoro-beta-alanine (nmod)
protection maximal (amod)
vol% and (cc)
had glucose.4 (punct)
suppressed injection (nsubj)
illustrated is (auxpass)
concentration tacrolimus (compound)
b coccidioidomycosis (nmod)
2.35 ] (punct)
hypocalcemia symptomatic (amod)
reduction drastic (amod)
$ROOT$ cardioselective (sent)
gestation < (amod)
real sham (conj)
angioedema inhibitor-associated (amod)
found infarction (dobj)
29 in (case)
test protectors (dobj)
haloperidol sertraline (conj)
using methamphetamine (dobj)
898 12 (compound)
feedback tubuloglomerular (amod)
analysis records (nmod)
1.27 > (advmod)
treated d-penicillamine (nmod)
eliminated and (cc)
accounts that (mark)
tested audiometry (nmod)
instituted was (auxpass)
test wilcoxon (nmod:poss)
improve absence (nmod)
hiccups patient (nmod)
neuron integrity (dep)
6.2 10.6 (conj)
ica and (cc)
indicating metabolite (ccomp)
treatment immediate (amod)
change behavioral (amod)
formation their (nmod:poss)
scales visual (amod)
prescribed time (nmod:tmod)
represents rare (advcl)
modulation excitability (nmod)
reported antimicrobials (nsubjpass)
maintained treatment (nmod)
interaction warfarin-drug (compound)
done negative (advcl)
possible conclusion (dep)
nerve eye (nmod)
state this (det)
receives produce (conj)
damage isoproterenol-induced (amod)
avoided reduction (nmod)
electrophysiological the (det)
abnormalities his (nmod:poss)
decreased subjects (nmod)
outcomes its (nmod:poss)
dna b (compound)
carbimazole and (cc)
conduct regard (nmod)
those akathisia (nmod)
mri ( (punct)
activation inputs (nmod)
% 33 (nummod)
explored influences (ccomp)
3.49 were (cop)
dyslipidemia about (case)
transplantation organ (compound)
membrane tubule (nmod)
association syndrome (nmod)
organelles subcellular (amod)
thirty-five two (compound)
grouped people (nsubjpass)
was injection (nmod)
pre- posttransplant (conj)
showed neuropathy (dobj)
relevant effects (nsubj)
history confusion (nmod)
elevated maze (conj)
histories use (compound)
81 +/- (cc)
results frequent (appos)
excreted kidney (nmod)
mm 54 (nummod)
stages stage (appos)
present changes (nsubj)
clearance urea (compound)
release clonidine (nmod)
cause development (nmod)
impairment decrease (appos)
status oxidative (amod)
drugs of (case)
useful would (aux)
days headache-free (amod)
cva ) (punct)
reduction ocular-specific (amod)
human or (cc)
minutes placebo (appos)
chloride injected (acl)
evidence autoradiographic (amod)
dressing burn (compound)
remained days (nmod)
calculated is (auxpass)
glomerular late-onset (conj)
norleucine and (cc)
induced aminonucleoside (nmod:npmod)
incidence inflammation (nmod)
none users (nmod)
neurons dissociated (amod)
p2x3 and (cc)
virility on (case)
use minoxidil (nmod)
terminology and (cc)
action analgesic (amod)
5.64 +/- (cc)
diethylstilbestrol des (appos)
adequate was (cop)
matched groups (nsubjpass)
adducts fluorinated (amod)
response vgpr (appos)
have diabetes (dobj)
5 or (cc)
excellent fair (conj)
able restore (xcomp)
regarded . (punct)
provides approach (nsubj)
88 149 (conj)
suggests timing (nsubj)
pseudoprolactinoma with (case)
done number (nsubjpass)
advantageous more (advmod)
causes hypertension (dobj)
volume vt (appos)
mrna alpha3 (compound)
occur dyscrasias (nsubj)
mmhg 1.0 (nummod)
stz mg/kg (appos)
reported mcl (nmod)
effects sevoflurane (nmod)
part the (det)
differ segments (nmod)
factor this (nsubj)
million 12 (compound)
risks mother (nmod)
followed access (nmod)
study nationwide (amod)
agent same (amod)
latency nighttime (amod)
metabolized simvastatin (nsubjpass)
recurarization to (case)
fish products (conj)
secondary cyclosporine (nmod)
bacteria against (case)
test stimulation (compound)
adolescents , (punct)
groups p100 (compound)
illness by (case)
hypothesis adrenaline-hypertension (compound)
eyes eosinophilia (conj)
improvement immunity (nmod)
measuring levels (dobj)
$ROOT$ added (sent)
exposed levels (nmod)
propofol ) (punct)
product approved (acl)
incidence for (case)
pretreatment other (nmod)
units 40 (nummod)
described palsies (nsubjpass)
obstruction massive (amod)
levels serum (compound)
course peroxidation (nmod)
antidepressants and (cc)
escalated mg/m2/d (nmod)
$ROOT$ antidepressant (sent)
described were (auxpass)
reduction g/dl (nmod)
neurodegeneration epilepsy-induced (amod)
maleate mg/kg (appos)
ml.s-1 145 (nummod)
antagonist acid (appos)
leads result (conj)
entered patients (nsubjpass)
salts with (case)
confined that (mark)
endpoint at (case)
medline psychlit (conj)
evoke sensation (dobj)
lesion against (case)
u/l 1533 (nummod)
severity manifestations (nmod)
weight of (case)
role restoring (acl)
mass : (punct)
caused drug (nsubj)
ca1 in (case)
osteoarthritis with (case)
subjects nine (nummod)
cancer ureter (nmod)
selected regions (nmod)
starting nifedipine (dobj)
1.3 whereas (dep)
inhibited acetylcholinesterase (dobj)
% including (case)
reduced given (advcl)
develop document (conj)
methotrexate etoposide (conj)
57.9 , (punct)
produced mhb (dobj)
controls non-ecstasy (amod)
experience pain (compound)
showing cholestasis (dobj)
4.8 2.0 (conj)
elevated nonsignificantly (advmod)
membrane and (cc)
showed values (nsubj)
assumed . (punct)
readmitted crisis (nmod)
profile tolerance (compound)
norms and (cc)
anesthesia the (det)
tolerated useful (conj)
potential cardiotoxic (amod)
mediated pathways (nmod)
protect ototoxicity (nmod)
stopped patients (nsubj)
treated continuously (advmod)
ratio cholesterol (compound)
prevented increased (conj)
determined hypertension (nmod)
found intolerance (dobj)
treated methylprednisolone (nmod)
comparing patients (dobj)
team the (det)
challenge acute (amod)
dose phenylpropanolamine (nmod)
treated carbonate (nmod)
colliculi in (case)
mc versus (cc)
rats other (amod)
hag with (case)
0.6 ratio (nsubj)
ileum of (case)
secretion chronic (amod)
54 79 (conj)
ability this (det)
seriousness disorder (nmod)
concept the (det)
prevented toxicity (nsubjpass)
prc ) (punct)
choreic ballistic (conj)
due arrest (nmod)
misjudgment of (case)
concentrations na (nmod)
toxic thus (advmod)
lead hemorrhage (nmod)
regard cases (nmod)
pretreatment scopolamine (compound)
field hippocampus (nmod)
include if (advmod)
nigra into (case)
rate response (dep)
administered onset (nmod)
receptors tyrosine (compound)
recorded assessment (nsubjpass)
inducing seizures (dobj)
clozapine > (cc)
function dementia (conj)
newborn regurgitation (nmod)
usage telithromycin (compound)
state hypertensive (amod)
increase limit (nmod)
period effective (amod)
complication serious (amod)
divided . (punct)
groups 71.3 (nummod)
noted tingling (dobj)
upregulated was (auxpass)
nausea stomatitis (conj)
agonist phno (dep)
issues obvious (amod)
pdn released (acl)
zidovudine or (cc)
mean duration (conj)
pilocarpine- n-methyl-d-aspartate (conj)
mitigated . (punct)
case crisis (nmod)
prescribed methadone (nsubjpass)
improved discontinued (advcl)
0.9 1.7 (prep)
normal more (advmod)
dose total (amod)
remain questions (nsubj)
exencephaly from (case)
discussion representative (dep)
cost the (det)
stroke after (case)
scale depression (compound)
constituted taqib (nmod)
pseudoacromegaly with (case)
42,671 , (punct)
agent vnb (nsubj)
selected men (nsubjpass)
made identification (nsubjpass)
mouse-1 nmol (dep)
induce response (dobj)
resulted cessation (nmod)
ht oestrogen-only (amod)
model novel (amod)
factors injury (nmod)
stage iv (nummod)
bioactivation chemical (amod)
treated dfp-atropine (nmod)
assessed placement (nmod)
took man (nsubj)
immunosuppression to (case)
lymphocytes subject (nmod)
disruption functionality (nmod)
comparable : (punct)
acid-mimetic gamma-aminobutyric (amod)
hemodynamic , (punct)
needed determine (xcomp)
dermatitis , (punct)
dosages ( (punct)
overstimulation beta2-adrenoceptor (compound)
syndrome platypnea-orthodeoxia-like (amod)
inhibition factor (nmod)
sediment identified (acl)
replace consuming (ccomp)
taking screened (conj)
sed p (appos)
experience that (nsubj)
function emotional (amod)
determined should (aux)
lys1 tyr6]-vip (appos)
histochemistry using (acl)
malaysia in (case)
% = (acl:relcl)
mg/kg 0.59 (nummod)
weeks by (case)
evaluated patients (dep)
thrombosis . (punct)
receiving cimetidine (dobj)
jerks muscimol-induced (amod)
prolong interval (dobj)
ci ; (punct)
become therapy (nsubj)
receive indomethacin (dobj)
34/45 ) (punct)
inhibitors cyclosporine (nmod)
react changes (nmod)
mg/kg ld50 (appos)
aneurysm . (punct)
range under (case)
flair ) (punct)
arrest hemorrhage (conj)
injection intrathecal (amod)
methamphetamine of (case)
recorded examination (nsubjpass)
study intervention (compound)
purpose report (nmod)
examinations questionnaires (conj)
intravenous i.v. (dep)
brains alpha3 (amod)
period investigation (compound)
parp ; (punct)
feet their (nmod:poss)
withdrawn valproate (nsubjpass)
presentation pathogenesis (conj)
use thiopentone (nmod)
took fever (nmod)
established limited (advcl)
animals drug-naive (amod)
$ROOT$ marked (sent)
c with (case)
convulsant of (case)
effect venlafaxine (nmod)
chloride suxamethonium (compound)
radicals damaging (amod)
induced h (nmod)
summarize considerations (dobj)
exhibited . (punct)
certain , (punct)
contraindicated risky (conj)
history prior (amod)
used combination (nsubjpass)
d ) (punct)
loss mid- (amod)
i. complex (compound)
releaser by (case)
woman african (amod)
h times (appos)
tnf-a and (cc)
abandoned , (punct)
restricted-diet , (punct)
schedule cisplatin (nmod)
disorientation and (cc)
interact that (nsubj)
induced types (nsubj)
utility evaluation (nmod)
accomplished be (auxpass)
mg/day 240 (nummod)
indicating relationship (dobj)
effects fibrillation (nmod)
attack primary (amod)
regimen . (punct)
case findings (nmod)
380+/-587 ) (punct)
levels cpap (nmod)
responses challenge (nmod)
subjects than (case)
mapd ) (punct)
women received (acl:relcl)
analogues occurring (amod)
exposure outcomes (conj)
cause identifiable (amod)
behaviour mice (nmod)
produces responses (dobj)
hypotension trimethaphan-induced (amod)
150 10(9)/l (conj)
encephalopathy presenting (acl)
discontinuation the (det)
effects harmful (amod)
responders ( (punct)
discussion first (appos)
increase gssg (nmod)
suggest have (ccomp)
5 ( (punct)
suspensions long-acting (amod)
intervals time (compound)
treated although (mark)
value of (case)
3.9 rats (nmod)
questioned week (nmod)
insecticide this (det)
self-treating been (aux)
reproduced . (punct)
expression only (advmod)
awakening , (punct)
onset given (case)
included thrombocytopenia (dobj)
paws claws (conj)
drugs antagonist (compound)
review patients (nmod)
explanations other (amod)
primigravida a (det)
attenuated loading (nmod)
1,000/mm3 ) (punct)
patients ie (advmod)
svo(2 ) (punct)
suspicions dili (nmod)
mg 5 (nummod)
function impairment (nmod)
$ROOT$ advocated (sent)
assessed areas (nsubjpass)
availability techniques (nmod)
results test (nmod)
0.6 was (cop)
dose studies (nmod)
weeks 2 (nummod)
regulator cyanamide (nsubj)
effect same (amod)
syndrome uremic (amod)
have whether (mark)
etoricoxib and (cc)
manifestation imbalance (nmod)
experience syndrome (dobj)
dwi ( (punct)
microliters ( (punct)
enabling , (punct)
flat be (cop)
2-agonist alpha (nmod:npmod)
facilitates diazepam (nsubj)
resolution rapid (amod)
intervals min (nmod)
p .05 (nummod)
indicate increase (ccomp)
synthesis/release the (det)
course of (case)
suggested blocks (ccomp)
discontinued aborted (advcl)
methods study (appos)
800 1000 (conj)
reduced whereas (mark)
apart days (nmod:npmod)
reaction transcription-polymerase (compound)
regulator growth (compound)
magnitude for (case)
abolished almost (advmod)
gbm proven (amod)
testing perimetry (appos)
subsided minutes (nmod)
subtype this (det)
correlated frequency (nmod)
38 3 (conj)
have delay (dobj)
amine is (cop)
backgrounds differing (amod)
subscores the (det)
basis longterm (amod)
show and (cc)
initiation indinavir (nmod)
developed failure (nsubj)
have similar (amod)
rast bpo-pll (nmod)
= 0.0012 (dobj)
administration acid (compound)
neuropathy thalidomide (compound)
punctate brush (conj)
lamivudine prophylactic (amod)
mice cystitis (nmod)
concentrations measured (acl)
cancer agc (appos)
content dna (compound)
men 119 (nummod)
rechallenged seven (nsubjpass)
quinidine or (cc)
neurotoxicity neurons (nmod)
decreased abundances (nsubjpass)
plasma cows (nmod)
continued diets (nsubjpass)
function fair (amod)
sufficient also (advmod)
anotia ) (punct)
catheter the (det)
mvp ) (punct)
had hyperhidrosis (dobj)
antibodies heparin-induced (amod)
cohorts the (det)
allografts disease (conj)
highlighting steps (dobj)
transferase deoxynucleotidyl (compound)
acid 3-aminopropyl-diethoxy-methyl-phosphinic (compound)
suggestion a (det)
test locomotor (amod)
ivmp ( (punct)
enhance could (aux)
mg/kg/day 0.4 (nummod)
radioimmunoassay ( (punct)
oxazepam temazepam (conj)
made injections (nsubjpass)
continued course (nmod)
edaravone of (case)
interventions coronary (amod)
dox before (case)
concentration mg/ml (appos)
glaucoma a (det)
cause losartan (nsubj)
identified not (neg)
induced 0.014-unit (nmod)
decreased end (nmod)
pressure unrecordable (amod)
discussion case (dep)
dehydration and (cc)
prevention damages (nmod)
alternative an (det)
zidovudine indinavir (conj)
bolus infusions (conj)
zdv or (cc)
compared they (nsubjpass)
strong that (mark)
hypoxia to (case)
diagnostic and (cc)
differences substance-specific (amod)
observed instances (nmod)
c. 37 (nummod)
that due (amod)
duration type (conj)
ventilation flow (conj)
hospital malta (appos)
level according (case)
compounds the (det)
protocol sedation (compound)
solely almost (advmod)
known what (nsubjpass)
recipients 388 (nummod)
research toxicology (compound)
gaba ) (punct)
stages ( (punct)
potency model (nmod)
calculi radiolucent (amod)
resistant mice (advcl)
action extract (nmod)
inserted occurred (advcl)
cause beat (dobj)
treated saline (nmod)
teratogenic only (advmod)
ccr2 receptor (compound)
increase turnover (nmod)
assay delay (compound)
buffers in (case)
phase characterized (acl)
% p<0.021 (dep)
show attenuates (ccomp)
illness , (punct)
preserved that (mark)
idea the (det)
patient a (det)
encephalopathy evidenced (acl)
maintained anesthesia (nsubjpass)
children six (nummod)
treated injections (nmod)
l/kg ( (punct)
appearance by (case)
flecainide of (case)
decrease microfilaremia (nmod)
transplantation oltx (appos)
genotypes both (det)
hypertension with (case)
plays consolidation (nmod)
fibrosis subcapsular (amod)
requiring pacemaker (dobj)
user frequent (amod)
requiring hospitalization (dobj)
diminished but (cc)
treated centre (nmod)
weight wet (amod)
inferior beta4 (nmod)
falls count (nsubj)
allele of (case)
activity tissue (nmod)
mup and (cc)
prolongation time (compound)
intervention underwent (appos)
6 5 (compound)
syndrome stomatitis (conj)
glycol ( (punct)
degree patient (compound)
related arrhythmias (nsubj)
stat3 ) (punct)
experiment methods (nsubj)
transducer and (cc)
showed traveled (conj)
elevation which (nmod)
types into (case)
variety to (case)
femoral ) (punct)
symptoms sensory (amod)
two them (nmod)
gave was (conj)
chemotherapy radiation (conj)
syndrome wernicke-korsakoff (compound)
occurrence need (conj)
responsible damage (nmod)
effects drowsiness (nmod)
constipation , (punct)
higher frequency (nmod)
multiforme . (punct)
striata the (det)
0.4-fold 1.1 (dep)
role occurrence (nmod)
tumors for (case)
had response (nmod)
document level (dobj)
mg 2.0 (nummod)
syndrome manifest (acl:relcl)
depression prolonged (amod)
appearance adducts (nmod)
received : (punct)
20 10 (conj)
pattern isoenzyme (compound)
$ROOT$ questions (sent)
users bzd/rd (compound)
understood not (neg)
hg ; (punct)
reactivity vascular (amod)
had fever (dobj)
attributable inhibition (nmod)
estimated % (nmod)
dec. 1 (nummod)
monitored tests (nmod)
observed we (nsubj)
disease native (amod)
mg/day at (case)
synthase ) (punct)
studies larger (amod)
effect isoproterenol (nmod)
showed associated (ccomp)
involved have (aux)
smokers cocaine (nmod)
deliver lozenges (nsubj)
case woman (nmod)
$ROOT$ circumstantial (sent)
analysis dvd (compound)
weight atpase (conj)
releases that (mark)
children for (case)
csa ) (punct)
offered treatment (nmod)
occurred discontinuation (nmod)
bn with (case)
mg/kg/i.p . (amod)
volunteers to (case)
pressures systolic (amod)
appeared replaced (advcl)
treatments previous (amod)
non-transgenic non-txg (dep)
reaction adrenaline (nmod)
alerted hallucinations (nmod)
recommended not (neg)
shown scan (nmod)
had compared (ccomp)
findings preclinical (amod)
plays dopamine (nsubj)
diagnosed patient (nmod)
predicted independently (advmod)
years 17 (nummod)
wild-type wt (appos)
escape immune (amod)
scores visual (amod)
modalities other (amod)
episodes during (case)
used scale (nsubjpass)
reversed alter (conj)
l-dopa by (case)
dose recommended (amod)
administered iv (nmod:npmod)
induced carbimazole (nsubj)
ng/ml. 172 (nummod)
filaments thick (amod)
phase progestative (amod)
shape the (det)
acetate os (nmod)
hypothesis disrupts (ccomp)
cardiomyopathy cobalt (compound)
surveillance close (amod)
dosing antagonists (nmod)
artery brachial (amod)
d-galactose source (nsubj)
zidovudine and (cc)
man 46-year (compound)
= 7.7 (dobj)
% 89.1 (nummod)
agents doses (compound)
significance clinical (amod)
attack an (det)
inhibitor modulator (conj)
lower improved (conj)
treated vehicle (nmod)
increased illustrating (advcl)
$ROOT$ overactivation (sent)
architecture the (det)
580 81 (conj)
s vs. (cc)
values control (amod)
mbp of (case)
syndrome lithium-induced (amod)
objective . (punct)
reverse inverted (conj)
16,459 cost (nsubj)
coil head (compound)
chain electron (compound)
paranoia cocaine-induced (amod)
groups matched (acl)
suggest indicators (ccomp)
study tumor (compound)
long-term ( (punct)
salivation and (cc)
progression nephropathy (nmod)
occurred hemorrhage (nsubj)
bands into (case)
28 , (punct)
myopathy to (case)
damage cerebral (amod)
interfere may (aux)
sedation apnea (conj)
operative which (nsubj)
occult clinically (advmod)
significant effects (nsubj)
cells activated (amod)
utilizing dexmedetomidine (dobj)
test despair (compound)
diluent the (det)
decreased subsequently (advmod)
agent frequent (amod)
840 - (punct)
prk laser (compound)
active moderately (advmod)
8 least (nmod:npmod)
injury experimental (amod)
alter evolution (dobj)
cataract of (case)
less proportion (nsubj)
remoxipride with (case)
reduction glomerulosclerosis (nmod)
immunohistochemistry ihc (appos)
function receptor (compound)
found efficient (xcomp)
derivative sodium (nsubj)
event patient (nmod)
gls and (cc)
one convulsant (amod)
coadministration drugs (nmod)
june to (case)
increased b.d (nmod)
pressure capillary (amod)
smoker female (amod)
refused . (punct)
had here (advmod)
showed brain (nsubj)
intensity pain (nmod)
titrating dosage (dobj)
hg 124 (nummod)
man came (acl:relcl)
administration isoniazid (nmod)
effect acute (amod)
onset symptom (compound)
diagnosis at (case)
receive dexmedetomidine (dobj)
toxicity dermal (amod)
duration stimulus (nmod)
decrease problematic (conj)
measures the (det)
21.6 19.9 (conj)
methylphenidate = (dep)
withdrawn countries (nmod)
137 to (quantmod)
silent although (mark)
lowered pressure (dobj)
antagonists 8-phenyltheophylline (dep)
score damage (compound)
pathophysiology dyskinesias (nmod)
sap<90mmhg ( (punct)
complication reported (acl:relcl)
remission depression (nmod)
levels signaling (conj)
result supply (nmod)
assay a (det)
produce procainamide (nsubj)
followed ; (punct)
evaluated variables (nsubjpass)
treatment forms (nmod)
find we (nsubj)
study definition (appos)
detection ana (nmod)
combination adults (nmod)
2.53 +/- (cc)
dose i.e. (advmod)
reduction mean (amod)
concentration serum (nmod)
have influence (dobj)
application carboplatin (compound)
indicated similar (ccomp)
increase mm (appos)
mmol/l 3.36 (nummod)
morphometry by (case)
% 96 (nummod)
map identify (conj)
obvious cause (nsubj)
detection angiography (nmod)
pathogenesis schizophrenia (nmod)
numbers , (punct)
composed indicating (xcomp)
reported proteinuria (nsubjpass)
duration time (nmod)
thrombosis thrombocytopenia (conj)
given monitoring (nmod)
study blind (amod)
field the (det)
appearance gross (amod)
cost its (nmod:poss)
mice exposed (acl)
micrograms.kg-1.min-1 10 (compound)
presented . (punct)
failure crf (appos)
incidence dementia (nmod)
subject smoker (appos)
documents group (nmod)
fact in (case)
sonography cranial (amod)
induced nomifensine (nmod)
increase dehydrogenase (nmod)
injected it (dobj)
g/m2 ; (punct)
beverages containing (acl)
returned recur (conj)
prevented which (nsubj)
showed reduce (ccomp)
demonstrate not (neg)
cocs were (cop)
aspects isolated (amod)
unresponsive when (advmod)
documented bleed (nsubjpass)
intervention . (punct)
elevated whereas (dep)
receiving subjects (nsubj)
pretreatment despite (case)
8 long (advmod)
deterioration progressive (amod)
fever rheumatic (amod)
models inflammation (appos)
isocortical allocortical (conj)
haemofiltration continuous (amod)
substratum drugs (conj)
end follow-up (nmod)
group s (compound)
series conventional (amod)
observations reports (conj)
( /-2.4 (conj)
neuropathy this (det)
introduction captopril (nmod)
reactions cutaneous (amod)
stainings immune (amod)
crossed days (nmod)
study cooperative (compound)
dialysis or (cc)
shown results (dobj)
developed displayed (conj)
inflammation cardiac (amod)
battery assessment (compound)
synthase factor (conj)
rtms placebo (appos)
correlated . (punct)
9.2 0.2 (conj)
tacrolimus fk (appos)
supports , (punct)
total g/m2 (appos)
inhibit that (mark)
alpha(1)-subunit of (case)
progress obtain (acl)
recovery rats (nmod)
properties protective (amod)
crisis hypertensive (amod)
dose aerosol (nmod)
volume in (case)
sulfasalazine on (case)
stabilized therapy (nmod)
production activities (conj)
failed ssr103800 (nsubj)
animals homozygous (amod)
$ROOT$ apparent (sent)
mg/kg and (cc)
viruses against (case)
known treated (conj)
prophylaxis than (case)
structure a (det)
women receive (acl:relcl)
adducts 4hne-protein (compound)
hypercalcemia = (dep)
african the (det)
associated variants (nmod)
cellulose plus (cc)
intervals 3-weekly (amod)
defects unequivocal (amod)
scale ) (punct)
antagonists bradykinin (dep)
g 5 (nummod)
lesions such (amod)
megakaryocytes nuclei (nmod)
excluded were (auxpass)
stem lack (nsubj)
center to (case)
have seizures (nmod)
sodium mg/kg (appos)
infusion dobutamine (nmod)
maze avoidance (conj)
well he (nsubj)
roots right (amod)
urinalysis volume (dep)
underwent pallidotomy (dobj)
hyperkalemia by (case)
ameliorated occurred (conj)
amphetamine-free amphetamine (appos)
formation abscess (compound)
disorder trichotillomania (conj)
lorazepam benzodiazepine (compound)
exertion physical (amod)
targeted dose (nsubjpass)
areas glomerulosclerotic (amod)
indicated ameliorates (ccomp)
constructed were (auxpass)
jj 0.005 (nummod)
aware patient (nsubj)
reduction anemia-induced (amod)
appears effect (nsubj)
stenosis , (punct)
events group (nmod)
$ROOT$ manifestations (sent)
% p=0.39 (dep)
photon single (amod)
proportional degree (nmod)
headache pain (conj)
screened identified (conj)
agent amiodarone (nsubj)
cisplatinum , (punct)
rats microl/side (appos)
samples hour (amod)
dosed could (aux)
dose cd50 (compound)
clz t.i.d. (advmod)
symptoms whose (nmod:poss)
confirmed acetaminophen (nmod)
settings of (case)
lt pediatric (amod)
moran 50 (appos)
possible is (cop)
tolerance , (punct)
showed different (conj)
626 431 (conj)
greater area (nsubj)
incidence mpo-anca (nmod)
ulcer hemorrhagic (amod)
alpha- or (cc)
activity regulation (nmod)
assessable . (punct)
contributes hypertension (nmod)
had administration (nsubj)
represents example (dobj)
exerted be (auxpass)
suggests also (advmod)
chemotherapy to (case)
quantify effects (dobj)
admitted patient (nsubjpass)
received mice (nsubj)
had starting (advcl)
many genes (nmod)
pentoxifylline trental (appos)
decreases and (cc)
measured effects (nsubjpass)
reduces area (dobj)
submitted shock (nmod)
role ph (nmod)
patients lung (compound)
improved symptoms (dobj)
rate maximal (amod)
relationship prostaglandins (nmod)
elevated patient (nmod)
searched we (nsubj)
usage uninterrupted (amod)
develop ectopically (advmod)
part regimens (nmod)
sucrose chow (conj)
decreased concentration (conj)
assay time (compound)
increases drowsiness (nmod)
factor associated (acl)
reversed study (nmod)
concentration activity (conj)
have steroids (nsubj)
inf-mi ( (punct)
signals as (case)
erk ( (punct)
peak ( (punct)
dose either (dep)
feeling of (mark)
levels hdl-cholesterol (compound)
cases possible (amod)
causes cardiotoxicity (dobj)
pressure bladder (compound)
tolerated therapy (nsubjpass)
1984 between (case)
treated 1984 (nmod)
abnormalities swallowing (compound)
assessment resistance (nmod)
wanted we (nsubj)
action cytogenetic (amod)
fulfill and (cc)
study t-cell (compound)
study postmarketing (amod)
mm 120/67 (nummod)
found child (nsubjpass)
investigate triggers (ccomp)
shunt and (cc)
male heroin-dependent (amod)
formers mhb (compound)
directions commissure-commissure (compound)
developed patients (nsubj)
decreased that (dobj)
ratio 1.42 (appos)
hamartoma developed (acl:relcl)
increased 0.19 (nmod)
t.i.d. b.i.d. (conj)
elevated elevated (conj)
protection a (det)
prevent myoclonus (dobj)
defined criteria (nmod)
controls not (cc)
randomised london (nmod)
elevated biochemically (advmod)
based is (auxpass)
proteins ikr (compound)
confirm property (dobj)
p=0.026 ) (punct)
treatment mitoxantrone (nmod)
levels ferritin (compound)
treatment arteriosus (nmod)
patients follow-up (nmod)
weakness extremities (nmod)
differentiation terminal (amod)
bile bladder (compound)
had re-warming (nmod)
unable because (mark)
allocated tamoxifen (nmod)
lv ( (punct)
seen picture (nsubjpass)
decrease placebo (advcl)
evaluate dose (dobj)
increased infusion (nsubj)
micrograms/50 2.5 (nummod)
lethality rats (nmod)
% 77.4 (nummod)
witnessed may (aux)
suggested factor (ccomp)
completely almost (advmod)
symptoms current (amod)
endomt of (case)
ecg ambulatory (amod)
exercise supine (compound)
was change (attr)
mechanistic and (cc)
lead to (mark)
believed neurotoxicity (nsubjpass)
% variability (nmod)
enhanced have (aux)
lesioned sham (conj)
patients cases (nsubj)
levels high (amod)
conversion evidence (nmod)
received that (nsubj)
those lesions (nmod)
confirmed themography (nsubj)
infants remaining (amod)
efe ) (punct)
developing neuropathy (dobj)
induced intrastriatally (advmod)
recordings intraoperative (amod)
entries epm (nmod)
suggests was (ccomp)
determine efficacy (dobj)
inhibition and/or (cc)
checked also (advmod)
interleukin of (case)
dogs twenty (nummod)
latency loss (nmod)
behavior sexual (amod)
ach ( (punct)
mhc-i of (case)
tachycardia this (det)
potassium total (amod)
steroids to (case)
end study (nmod)
failed but (cc)
infusion dipyridamole (compound)
increase condition (nmod)
210 14 (compound)
cross-tolerant were (cop)
s or (cc)
phosphorus yellow (amod)
developed started (advcl)
reported lymphopenia (dep)
factors for (case)
nx both (cc:preconj)
metabolism population (nmod)
delivery of (case)
cause abolished (conj)
taken patient (nmod)
years use (dep)
score lower (amod)
developed died (conj)
engaged transmission (nmod)
required nausea (nmod)
= .03 (dobj)
period minutes (nmod)
showed convulsions (nmod)
maximal peroxidation (nsubj)
occurrence about (case)
therapy symptoms (nmod)
months in (case)
sweating hypotension (conj)
evidence aspirin (nmod)
clozapine between (case)
drugs anti-rheumatic (amod)
therapy aminocaproic (amod)
patient oncology (compound)
clopidogrel ) (punct)
injected acid (nsubjpass)
ranging year (nmod)
beams trabecular (amod)
167 +/- (cc)
induced absence (nmod)
different mechanisms (nsubj)
pravastatin inhibitor (appos)
accounted be (auxpass)
analyzed activity (nsubjpass)
reversed also (advmod)
striking less (advmod)
conducted evaluate (advcl)
increased shortened (conj)
depression tissues (nmod)
infiltration interstitial (amod)
use clozapine (compound)
mood somnolence/depressed (amod)
bile the (det)
thiosulphate b35 (conj)
rearings increased (amod)
subset population (nmod)
assess perfusion (dobj)
reprogramming , (punct)
49 % (appos)
terminated dse (nsubjpass)
autopsy accurate (amod)
correlates prepared (conj)
glycosuria ) (punct)
medications today (nmod:tmod)
determined weights (nsubjpass)
nimodipine for (case)
developed incontinence (dobj)
case edema (nmod)
resulted likely (advcl)
dbp t+a (dep)
micrograms 2.3 (nummod)
cardiotoxicity dox (nmod)
carbachol following (case)
period ten-year (amod)
associated methadone (nsubjpass)
duration possibly (advmod)
acc-9653 ester (appos)
indicate or (cc)
epirubicin with (case)
attempted thereby (advmod)
signs receptor-stimulating (amod)
means increase (nmod)
paradigms dosing (compound)
complication cardiotoxicity (nsubj)
variants occurring (acl)
release medulla (nmod)
$ROOT$ made (sent)
dyskinesias for (case)
ophthalmology of (case)
anencephaly hernia (conj)
lactate cent (conj)
number behaviors (nmod)
activity not (cc)
suspension a (det)
exhibit mice (nsubj)
alternative that (mark)
histories psychiatric (amod)
treatment aprotinin (compound)
% intention-to-treat (nmod)
induction vacuoles (nmod)
latencies onset (nmod)
7.6 - (dep)
hbsag ( (punct)
loss adults (nmod)
transporters other (amod)
h. on (case)
coagulation intravascular (amod)
minimal or (cc)
myelopathy , (punct)
$ROOT$ ng/ml (sent)
resumed use (dobj)
oedema cytotoxic (amod)
events to (case)
points sum (compound)
years 2003 (nmod)
depend . (punct)
up july (nmod)
n=2.4+/-0.7 ) (punct)
replication b (compound)
cords of (case)
continued children (nsubj)
contributed considered (conj)
neuropeptide-y npy (appos)
tissues to (case)
state p450/ccl4 (compound)
jaundice clinical (amod)
delivery vaginal (amod)
contraindicated is (auxpass)
erythrodysesthesia and (cc)
pressure segment (conj)
perception pain (compound)
reliable were (cop)
asymmetry cross-tolerance (nmod)
survived overdose (nmod)
interactions drugs (nmod)
inhibitor long-acting (amod)
mg/m(2 60 (nummod)
bradyarrhythmias of (case)
= .02 (dep)
males strains (nmod)
toxin , (punct)
synthesis and (cc)
comparisons patterns (nmod)
13 5 (compound)
relevant sensitization (nmod)
potential visual-evoked (amod)
fragments cells (nmod)
fibres muscle (compound)
exceed monitored (conj)
measures distress (nmod)
ionic of (case)
prednisolone and (cc)
alleles loci (nmod)
increased excess (nsubj)
prolongation greater (amod)
ibuprofen , (punct)
confusion 1 (appos)
investigated thoroughly (advmod)
mic than (case)
valproate , (punct)
processes lead (acl:relcl)
temperature body (compound)
comparison toxicology (nmod)
database database (appos)
cy ( (punct)
regard hypothesis (nmod)
leukemia treated (acl)
$ROOT$ g/ml (sent)
repair anesthesia (nmod)
activity less (amod)
improved subscores (nsubj)
important neurons (nsubj)
monkey in (case)
current i(f (appos)
(azt)-induced azidothymidine (nmod:npmod)
adriamycinol , (punct)
tone artery (nmod)
atropine and (cc)
dose i.v. (compound)
prc some (det)
cure possible (amod)
modulation erdosteine (nmod)
study mechanisms (nmod)
microgram/kg/min 0.3 (nummod)
duration ap (compound)
developed fibrosis (nsubj)
nad of (case)
head was (cop)
% 56 (nummod)
vehicle alone (advmod)
bridge as (case)
drug trials (nmod)
loss maximum (amod)
fully or (cc)
g/dl 14.2 (nummod)
studies pharmacological (amod)
surveillance under (case)
procedure this (det)
hospital s. (compound)
hypotony of (case)
risk users (nmod)
edema dependent (amod)
task clinical (amod)
gamma-gt ( (punct)
safety morbidity (conj)
scene on (case)
subgroups in (case)
thickness posterior (amod)
complete cases (nmod)
$ROOT$ explain (sent)
cpu cortex (conj)
blockade angiotensin (compound)
histology by (case)
intensity densitometry (appos)
requirement analgesia (nmod)
activates contribute (conj)
agent quaternary (amod)
normal , (punct)
returned state (nmod)
favorable more (advmod)
syndrome mds (appos)
activating atp (nmod)
treatment phenothiazines (nmod)
combination sodium (nmod)
oralis for (case)
derivative anti-inflammatory (amod)
use cohorts (nmod)
signs suggestive (amod)
decrease through (case)
syndrome adult (amod)
retention- or (cc)
years 17,2 (nummod)
0.1 , (punct)
pool in (case)
% decrease (dep)
applications daily (amod)
dependence city (nmod)
ci=5.194 95 (compound)
$ROOT$ faded (sent)
p 20 (nummod)
deviation square (conj)
exhibit animals (nmod)
symptoms aura (compound)
physicians emergency (compound)
patients obstruction (nmod)
objective was (dep)
procedures hotplate (compound)
indicate effect (dobj)
aimed study (nsubjpass)
shift intracellular (nmod)
dosing of (case)
g/l ) (punct)
suitable model (nmod)
brought deficiency (nmod)
infarction bilateral (amod)
nrf2(+/+ ) (punct)
ovale a (det)
reacted . (punct)
cycle each (det)
monitored identified (ccomp)
images echo (compound)
mortality cvd (compound)
tended use (nsubj)
defects rat (nmod)
active models (nmod)
analysis the (det)
had 37 (nsubj)
obtained measures (dobj)
probe ( (punct)
glomerulus on (case)
option topotecan (nsubj)
safety into (case)
ureter the (det)
corporation elan (compound)
varied , (punct)
evidence effect (nmod)
ssris 8/33 (appos)
ph creatinine (conj)
improve profile (dobj)
administration s-1 (nmod)
abdominal pelvic (conj)
gtn dcf (conj)
protocols p9605 (compound)
236.9 15.1 (conj)
administered knowledge (nmod)
intervals with (case)
lemon bitter (amod)
pge2 ) (punct)
blocked had (advcl)
functions the (det)
receiving nifedipine (dobj)
pbo ) (punct)
1.7 , (punct)
status i (nummod)
tachycardia nonsustained (amod)
g weight (nmod)
resistance line (appos)
$ROOT$ agents (sent)
behavior avoidance (conj)
appeared starting (advcl)
improved manner (nmod)
istanbul , (punct)
fungi against (case)
describe hypertrophy (dobj)
group dmso-treated (amod)
hh ( (punct)
targeting subunits (nmod)
therapy enzyme (compound)
as risks (nsubj)
regurgitation toxicity (conj)
performs mrp2 (nsubj)
clarified have (aux)
2 48 (conj)
mg/kg 4 (nummod)
therapy progressed (acl:relcl)
1 - (punct)
diagnosed women (nmod)
pseudoprolactinoma or (cc)
performance driving (compound)
dose mg/kg (amod)
control dyskinesias (nmod)
investigated therapy (nmod)
concentrations alpha-hydroxymetoprolol (compound)
sensitive and (cc)
value mean (compound)
structure bisbenzylisoquinoline (compound)
treatment term (compound)
myeloma diagnosed (amod)
thrombo-embolism cancer (conj)
cycle sinus (compound)
recorded effects (nsubjpass)
examined toxicity (nmod)
rate bile (compound)
cases 7 (nummod)
remained function (nsubj)
occurs incorporation (nsubj)
evident clinically (advmod)
51 % (appos)
sodium therapy (dep)
predominance ketamine (nmod)
microg/ml were (cop)
pressure intracranial (amod)
difficult it (nsubj)
given acid (nsubjpass)
dogs ( (punct)
monitored must (aux)
model aids (nmod)
undergo known (conj)
drop single (amod)
selection and (cc)
infections disease (conj)
4.8 10(6 (conj)
da or (cc)
time sample (nmod)
region homer1 (compound)
effects studies (dep)
2c , (punct)
age patient (nmod:poss)
risk crude (amod)
protected treatment (nsubj)
disorders renal (amod)
had block (nmod)
prevented loss (dobj)
become manic (acomp)
ccb ) (punct)
filters , (punct)
enrolled outcomes (nsubj)
$ROOT$ behaviors (sent)
bands bands (nmod)
peaked then (advmod)
decade over (case)
avoidance from (case)
weeks to (case)
tolerance ro15 (nmod)
preservation margin (nmod)
last treatment (nsubj)
gliomas near (case)
rats these (det)
seem develop (xcomp)
occurs loss (nsubj)
sum score (nsubj)
represent structures (dobj)
treatment bort-dex (nsubj)
methods histopathologic (amod)
higher ; (punct)
receptors h1 (compound)
effect rhabdomyolysis (nmod)
woke later (advmod)
used analysis (dobj)
provided given (conj)
seemed independent (xcomp)
effects constituents (nmod)
age hypoalbuminemia (conj)
different this (nsubj)
days stopping (advcl)
mean ( (punct)
microangiopathy thrombotic (amod)
fatalities overdoses (nmod)
% setting (nmod)
acting by (mark)
demonstrated regard (nmod)
odds a (det)
deficits learning (nmod)
lymphocytes especially (advmod)
series children (nmod)
venous pressures (conj)
doses last (amod)
reducing significantly (advmod)
ci 3.67 (nummod)
reach , (punct)
taking patients (nsubj)
myalgia . (punct)
controls polydrug (amod)
known fully (advmod)
mg/m2 were (cop)
3.1 4.9 (appos)
alert physician (dobj)
findings disease (nmod)
occurred pressure (nmod)
1-agonist alpha (nmod:npmod)
p ' (punct)
latency shortened (amod)
difference parameters (nmod)
capable and (cc)
mitogens xenobiotic (amod)
pvc multiple (amod)
confirmed suggestion (nsubjpass)
actin of (case)
changes heart (nmod)
immunosuppressed are (auxpass)
nodules hepatic (amod)
november and (cc)
1,1-dichloro-2,2,2-trifluoroethane 1-chloro-1,2,2,2-tetrafluoroethane (conj)
spasm occlusion (nsubj)
resemble that (nsubj)
ficoll-hypaque on (case)
anorexigens and (cc)
neuroimage 1328 (appos)
sequence resuscitation (compound)
stage depending (case)
60 - (punct)
worsen model (nmod)
cimetidine intravenous (amod)
micrograms misoprostol (nmod)
later days (nmod:npmod)
restore model (nmod)
memory immediate (amod)
vessels normal (amod)
recorded electrocardiogram (nmod)
inactive is (cop)
capillaries cortex (nmod)
gold and (cc)
role tissue (nmod)
acetate cpa (appos)
hypertension before (nmod)
congenita mc (appos)
provided recommendations (nsubjpass)
bolus for (case)
influences nephrotoxicity (dobj)
suppressed were (auxpass)
correlation ctnt (nmod)
group european (compound)
rd ( (punct)
occupancy d2 (compound)
vomiting % (appos)
sces of (case)
increasing causing (conj)
distorted slightly (advmod)
greater reduction (nsubj)
toxicity improvement (conj)
signs such (amod)
$ROOT$ using (sent)
s and (cc)
reduced seizures (conj)
correlated toxicity (nsubjpass)
state steady (amod)
dose single (amod)
i(f ) (punct)
sulfonamides nitrofurantoins (conj)
treated = (nmod)
reports contrary (nmod)
haloperidol both (cc:preconj)
difference volunteers (nmod)
response toxicity (conj)
treatment transplantation (nsubj)
fev1 predicted (acl)
akt of (case)
users who (nsubj)
developed then (advmod)
h day (nmod)
apply phenomenon (nmod)
groups model (compound)
death patient (compound)
analysis retrospective (amod)
pain vomiting (conj)
l. r. (appos)
effect it (nmod)
increase dopamine (nmod)
reported used (conj)
rtm204i rtl180m/rtm204v (conj)
layer of (case)
induced given (advcl)
related and (cc)
appear . (punct)
rats f-344 (compound)
stimuli external (amod)
repeated were (auxpass)
mds ) (punct)
elevation folate (compound)
significant effect (nsubj)
irritation chronic (amod)
associated difficulties (nmod)
hyperprolactinemia for (case)
have study (nmod)
agent given (acl)
increased risk (dobj)
as march (nmod)
efficacy multicenter (amod)
associated prolactin (nsubjpass)
1990 between (case)
recall with (case)
l-noarg , (punct)
$ROOT$ recovery (sent)
score glasgow (compound)
area fixed (amod)
absorbed , (punct)
nitrendipine and (cc)
therapies specific (amod)
treatment disorder (nmod)
comparing sensitivity (dobj)
cacl(2 ) (punct)
lesion that (mark)
weighed , (punct)
examined experiment (nmod)
switches of (case)
progression until (case)
higher limits (nmod)
dialyzer a (det)
elevation due (case)
disease concurrent (amod)
pitfall and (cc)
indicate and (cc)
parameters optimal (amod)
consumed allegedly (advmod)
severity effects (conj)
newborns for (case)
antagonists receptor (compound)
uncertainty because (case)
hypotension peri-operative (amod)
affect reversed (conj)
disorders cardiac (amod)
effectiveness clinical (amod)
remained % (nmod)
compromising the (det)
% only (advmod)
recognized decades (nmod)
hepatitis dilevalol-associated (amod)
dyskinesias dyskinesias (appos)
phenylpropanolamine ppa (appos)
neurons visceral (amod)
difficult achieved (conj)
5-hydroxytriptamine , (punct)
noted % (conj)
performed using (xcomp)
symptom-free who (nsubj)
severe migraineurs (nmod)
iopromide a (dep)
factors prolongation (nmod)
lithium itself (appos)
experienced past (nmod)
combination factors (nmod)
serum the (det)
effect level (nmod)
safety tee (compound)
phenylethylbarbiturate quinidine (compound)
recovered intervention (nmod)
represent expression (nsubj)
hydrobromide , (punct)
conclusions result (dep)
were abnormalities (nsubj)
preserved markedly (advmod)
mitochondrial enzymes (dep)
antagonizes acetaminophen (nsubj)
using ointment (dobj)
found azotemia (nsubjpass)
decreased dose-dependently (advmod)
fluids intravenous (amod)
fos-ir cord (nmod)
disease osteoporosis (conj)
early 1951 (nmod)
docetaxel mg/m2/week (nmod:npmod)
one night (nmod)
microg n=18 (appos)
sometimes and (cc)
reversed hypotension (dobj)
patients age (appos)
changes for (case)
demonstrates program (ccomp)
months 13.8 (nummod)
bradycardia adrenaline-induced (amod)
occurred whereas (dep)
capsaicin g (appos)
dce ( (punct)
establish in (mark)
help diagnosis (nmod)
patients hypertension (nmod)
treated streptozotocin (nmod)
initiate that (mark)
were was (conj)
applied compressions (nsubjpass)
manic fully (advmod)
occurred nausea (nsubj)
glaucoma with (case)
identified patients (nmod)
exposure previous (amod)
stimulation no (neg)
ameliorated whether (mark)
attenuate ototoxicity (dobj)
butyrylcholinesterase of (case)
justified be (auxpass)
depressed groups (nmod)
lead morbidity (nmod)
mediated group (advcl)
% 54.5 (compound)
excretion levels (conj)
rats 2/6 (nummod)
stimulation repetitive (amod)
mice nrf2(-/- (amod)
23.759 - (advmod)
studying behavior (dobj)
adrenoceptors central (amod)
remains relationship (nsubj)
effect -a (det)
spectrum complication (nmod)
recording potentials (nmod)
nx , (punct)
1998 to (case)
difficulty presentation (nmod)
complication limits (acl:relcl)
elevations acute (amod)
developed reaching (advcl)
conclude increases (ccomp)
rosc ) (punct)
cbf in (case)
modulator receptors (nmod)
band iml (nmod)
aged 65 (nmod)
increased two (nmod)
$ROOT$ condensed (sent)
38 28 (conj)
mg/kg 1 (compound)
hypersensitivity with (case)
regimen chemotherapy (compound)
abolished while (mark)
administered combination (dobj)
prone that (mark)
head e15.5 (nmod)
was effect (nsubj)
bobbing head (compound)
comparative , (punct)
identified database (nmod)
da ( (punct)
concentrations sevoflurane (nmod)
injections four (nummod)
converted dose (nmod)
danger fire (nmod)
characterized criteria (nmod)
prescription a (det)
assay this (det)
strain of (case)
displays effects (dobj)
measure marker (nmod)
active to (mark)
reported events (dobj)
discuss recommend (conj)
likely men (xcomp)
outpatients sixty-eight (nummod)
involved reactions (nmod)
efficacious account (advcl)
min 15 (compound)
1.7 -2.7 (compound)
developed monkeys (nsubj)
attributed use (nmod)
repeated prior (advmod)
dysmenorrhea of (case)
effect via (case)
frequent and (cc)
angina stable (amod)
sampled were (auxpass)
stress dox-induced (amod)
times acts (appos)
motionless . (punct)
cardiomyopathy of (case)
$ROOT$ leukoencephalopathy (sent)
glucoronosyltransferases uridine (compound)
tests abnormal (amod)
drugs haloperidol (nmod)
akathisia implications (dep)
type of (case)
likely , (punct)
cannulated region (nmod)
cycles range (appos)
started prior (advmod)
nnos ) (punct)
invasion this (det)
defined cin (nsubjpass)
population % (appos)
features histologic (amod)
rg1 of (case)
cystitis and (cc)
reactions p (compound)
mechanisms cause (acl:relcl)
azt of (case)
% ic30 (appos)
joint ankle (compound)
characterized children (nmod)
tend but (cc)
affect 5-fu (nsubj)
cessation a (det)
incidence most (nmod)
results treatment (nsubj)
survivals median (amod)
demographic clinical (conj)
induction cure (conj)
induces administration (nsubj)
follow that (mark)
planned weeks (nmod)
located membrane (nmod)
have specifically (advmod)
5,7-dht of (case)
glucoronosyltransferases intestine (nmod)
cells fat (amod)
suppresses responses (dobj)
agent candidate (compound)
tomography positron (compound)
treatment danazol (nmod)
s 8.07 (nummod)
fields visual (amod)
presence pressure (nmod)
effect tumorigenesis (nmod)
lines mouse (compound)
emit vocalizations (dobj)
way only (amod)
seen symptoms (nsubjpass)
implicated since (mark)
nephrotoxicity clinical (amod)
reactions ; (punct)
fk deerfield (appos)
cells m (compound)
effect variable (amod)
received simvastatin (dobj)
treatment bortezomib (nmod)
understand effect (dobj)
neurons striatal (amod)
$ROOT$ level (sent)
ml agent (nmod)
show weeks (nmod)
taxol company (appos)
suppressed inhibited (advcl)
challenged rats (nsubjpass)
contribution ' (punct)
analysis allele/genotype-wise (amod)
had years (nmod)
postdose h (compound)
determined analyzing (advcl)
% > (nsubj)
proliferation bladder (nmod)
iso-osmolar , (punct)
dna hbv (compound)
cimetidine ) (punct)
levels index (conj)
cyclophosphamide , (punct)
days fourteen (nummod)
bumetanide paroxetine (conj)
functions neurological (amod)
5-ht6 ( (punct)
developed ingesting (advcl)
termination treatment (nmod)
caused interactions (nsubj)
better . (punct)
considered tolerable (xcomp)
apap pap (conj)
ventilation ve (appos)
dopamine d2 (dep)
courses time (nmod)
undertaken detected (advcl)
reported higher (ccomp)
stress 1 (dep)
weeks 18 (nummod)
effacement patchy (amod)
$ROOT$ blockade (sent)
increased transiently (advmod)
schedules bolus (compound)
anti-hcv hbeag (conj)
abnormalities wall (compound)
recurrence multiforme (nmod)
treatment modulation (conj)
oral transdermal (conj)
200 300 (conj)
sample removed (acl)
minutes minutes (conj)
l-dopa ; (punct)
patients submitted (acl)
response % (appos)
compensated q10 (nsubj)
suggest presence (nsubj)
manifestations cardiotoxicity (nmod)
n i.p. (appos)
penetration nitrate (nmod)
$ROOT$ treat (sent)
states , (punct)
pharmacological the (det)
$ROOT$ described (sent)
calcification focal (amod)
blockers nifedipine (appos)
child persisted (acl:relcl)
imaging initial (amod)
presented levels (nmod)
treated volunteers (nsubjpass)
convulsion mouse (nmod)
used analgesia (nmod)
slow down (compound:prt)
sec/cm5 x (compound)
studied minutes (nmod:tmod)
protective . (punct)
appear as (mark)
verapamil with (case)
used evaluation (nmod)
$ROOT$ tumors (sent)
determining of (prep)
separated depending (mark)
0.38 ) (punct)
reached never (neg)
influence stronger (amod)
measured 1.39 (parataxis)
times on (case)
linked have (aux)
associated adjustment (nmod)
containing antigens (dobj)
bupivacaine glucose (nmod)
emesis severe (amod)
system stimulated (amod)
darker normal (nmod)
transport for (case)
withdrawal ptu (nmod)
times/week three (nummod)
doses cd-832 (nmod)
dismutase , (punct)
fraction mainly (advmod)
need vigilance (nmod)
correlations dyskinesias (nmod)
comparisons direct (amod)
43 - (punct)
higher lid (nmod)
knockdown sirna (nmod)
risk impairment (nmod)
map shr (nmod)
convulsions audiogenic (amod)
received other (nsubj)
visualize . (punct)
correlated levels (nmod)
sites anionic (amod)
capacity antioxidant (amod)
decrease provocation (nmod)
predict not (neg)
produce whereas (dep)
penzberg ) (punct)
mice adult (amod)
rh ) (punct)
consider must (aux)
intact-control bcnu-exposed (conj)
developed which (nsubjpass)
performed recordings (nsubjpass)
socs-1 only (advmod)
tracts from (case)
phenomenon dyspnoea (conj)
cause into (case)
change indomethacin (nsubj)
percentage vasoconstriction (nmod)
groups b (appos)
objective demonstrated (dep)
caused bradycardia (nmod)
evidence clinical (amod)
focusing possibility (nmod)
dyscontrol inattention (conj)
glutathione gssg (appos)
junction the (det)
adrenalectomy after (case)
physician attending (amod)
undergoing toxicity (dobj)
macroglobulinaemia with (case)
investigation anemias (nmod)
p<0.01 ( (punct)
alpha5 and (cc)
types certain (amod)
died admission (nmod)
conclusion aware (appos)
n'-diisopropylphosphorodiamidofluoridate ) (punct)
occur that (mark)
antagonized prevented (conj)
subjects 185 (nummod)
allow examinations (nmod)
results abnormal (amod)
patient unaffected (amod)
administered treatment (nmod)
controls from (case)
edition fourth (compound)
one pathways (nmod)
complication given (case)
people , (punct)
masked signs (dobj)
have malignancies (dobj)
followed sequencing (nmod)
lactate of (case)
paradigm a (det)
received combination (dobj)
5.8 0 (quantmod)
qt long (amod)
results treating (advcl)
14 21 (conj)
measures psychometric (amod)
trials controlled (amod)
limitation is (cop)
compliance hospitals (nmod)
images on (case)
dxnp of (case)
fraction a (det)
$ROOT$ nightmares (sent)
aida ) (punct)
vomiting placenta (conj)
levels atp (compound)
minor was (cop)
hypertrophy reversible (amod)
nephritis . (punct)
impaired controlling (advcl)
$ROOT$ served (sent)
performed transplant (nsubjpass)
rats dox (compound)
patients affected (acl)
changed indicating (advcl)
effective equally (advmod)
anticipated administration (nsubjpass)
micrograms 50 (nummod)
necrosis due (amod)
counts , (nmod)
users treatment (conj)
group 90/htn (compound)
value mk-212 (nmod)
defective revealed (conj)
given form (nmod)
changed , (punct)
increase consumption (nmod)
1 9 (conj)
case is (cop)
beat known (acl)
circulation blood (compound)
tachycardia exercise-induced (amod)
disclosed . (punct)
activation strong (amod)
processes mainly (advmod)
toxicities thrombocytopenia (nsubj)
hilus groups (nmod)
excretion decreased (amod)
administered after (mark)
lithiasis for (case)
increase risk (dobj)
mecamylamine hexamethonium (conj)
leg back (conj)
mg. mg./kg (conj)
42.5 - (advmod)
incidence prilocaine (nmod)
diabetes or (cc)
analogue new (amod)
increases dose-dependent (amod)
type althesin (dep)
depression circulatory (amod)
cisplatin amifostine (conj)
proteinuria range (compound)
correlate , (punct)
mediate cardiomyopathy (dobj)
content total (amod)
activity impaired (amod)
exists effect (advcl)
neurones dopaminergic (amod)
inoculation organisms (nmod)
rats . (punct)
document vivo (advmod)
1.03 and (cc)
begun treatment (nsubjpass)
polydipsia and (cc)
96 1 (conj)
satisfied , (punct)
consisted women (dobj)
determination malondialdehyde (nmod)
involved stress (nsubjpass)
expected literature (nmod)
maintained status (dobj)
injury borderzone (nmod)
increased ratio (dobj)
plasma aminoaciduria (conj)
have should (aux)
edetate calcium (compound)
restricted when (advmod)
blocker nifedipine (appos)
1.78 ) (punct)
ingested lithium (dobj)
reduced reduced (conj)
protect should (aux)
myelitis of (case)
shortened it (nsubj)
fever intermittent (amod)
intensity excruciating (amod)
satisfactory less (advmod)
kidney from (case)
protected damage (nmod)
markers anemia (conj)
time survival (compound)
effect adverse (amod)
vasoconstriction including (case)
analysed density (nsubjpass)
placebo gellan (conj)
advocated observed (advcl)
stress form (nmod)
antagonist amino (compound)
reactivation hbv (compound)
options treatment (compound)
fasciculation to (case)
interna the (det)
prevention effects (nmod)
importance the (det)
criteria . (punct)
h2o2 the (det)
time mean (amod)
courses excretion (nmod)
allow which (nsubj)
evaluated effect (nsubjpass)
difluoromethylornithine and (cc)
symptom 1 (nummod)
g ) (punct)
feature rarely (advmod)
inhibited current (dobj)
presentation including (case)
had opportunity (dobj)
hyperkinesis of (case)
hearts isolated (amod)
develop to (mark)
therapy globulin (compound)
treatment pdtc (compound)
controls mdma-free (amod)
disturbance intake (nmod)
agonist mixed (amod)
continue background (dep)
improve could (aux)
patients 80 (nummod)
referred output (nmod)
hypothesis . (punct)
appears significant (xcomp)
cause treatment (nsubj)
pg ng/mouse (appos)
deficits , (punct)
brains in (case)
actions flurazepam (nmod)
interval of (case)
attenuated were (auxpass)
150 to (dep)
prevent producing (advcl)
d-1 , (punct)
lw ) (punct)
radio-chemotherapy with (case)
indicating utilized (ccomp)
arthritis pyrexia (conj)
version a (det)
effects mice (nmod)
possible whenever (advmod)
agents channel (compound)
aspirin . (punct)
loss apnea (conj)
included tachycardia (dobj)
absence hypoxaemia (nmod)
increased pressure (nsubjpass)
solution morning (dep)
expression loss (conj)
function gating (compound)
function systolic (amod)
expected it (nsubjpass)
ear in (case)
demonstrated tasks (nmod)
compromising occurred (conj)
desire , (punct)
$ROOT$ define (sent)
produce which (nsubj)
bradycardia for (case)
flow constant (amod)
eye seeing (amod)
insulin-group none (conj)
hypotension fenoldopam-induced (amod)
suggesting late (ccomp)
ovex ( (punct)
appearance de (amod)
is providing (csubj)
sensitization caused (acl)
were symptoms (attr)
achieved dbp (dobj)
therapy lamivudine (compound)
study treatment (compound)
examination allografts (nmod)
design , (punct)
cyclophosphamide following (case)
mg/kg cnsb002 (nmod:npmod)
microperfusion hippocampus (nmod)
microg/side after (case)
link them (dobj)
result eventually (advmod)
reported h (nmod)
angina hypertension (conj)
anticoagulant warfarin (nsubj)
7.54 1.81 (appos)
depend strategies (nsubj)
influence d-ribose (nmod)
jaws clenched (amod)
causes vasodilatation (dobj)
alert be (cop)
diameter sphericity (conj)
occurs ptcr (nsubj)
hb ( (punct)
t.i.d. at (case)
l/kg 0.35+/-0.11 (nummod)
cochrane and (cc)
$ROOT$ titrated (sent)
objectives . (punct)
units sera (nmod)
received morning (nmod)
salts gold (compound)
potassium concentrations (conj)
reversal effects (nmod)
reversible are (cop)
participate to (mark)
concentration noradrenaline (nmod)
ranged intervals (conj)
clentiazem antagonist (appos)
examination technical (amod)
hematoxylin eosin (conj)
ml/kg days (appos)
haemorrhages warfarin-induced (amod)
higher incidence (nsubj)
nausea fatigue (conj)
specimens consecutive (amod)
binding proteins (nmod)
inconsistent been (cop)
meth to (case)
concentration turnover (conj)
lead discontinuation (nsubj)
tricuspid ( (punct)
trial study (dep)
streptozocin intracerebroventricular (amod)
received treatment (nmod)
detected analysis (nsubj)
8/33 ] (punct)
synthesis/release to (case)
tacrine of (case)
movements levodopa-induced (amod)
amlodipine as (case)
poisoning aconitine (compound)
cells dividing (amod)
fraction lv (compound)
deficits lithium-associated (amod)
cholinesterase for (case)
searched register (dobj)
pod ) (punct)
groups combination (compound)
factor relating (acl)
movements induced (acl)
assessment status (nmod)
angioplasty artery (compound)
cortex amygdalae (conj)
core into (case)
neuritis of (case)
quetiapine mg/day (appos)
longer hours (dep)
inhibits agent (nsubj)
compared muscles (nmod)
gspe and (cc)
$ROOT$ able (sent)
40 25 (compound)
excretion protein (compound)
spasm pathophysiology (nmod)
recalled . (punct)
produced that (mark)
avoidance pa (appos)
pathway nigrostriatal (amod)
thrombocytopenia thrombosis (nmod)
doses moderate (amod)
min 180 (nummod)
acid tamca (appos)
amns of (case)
injection = (parataxis)
compared prospectively (advmod)
calcium alkali (conj)
7.0 , (punct)
evening day (nmod)
given dosage (nsubjpass)
locomotion and (cc)
dependency to (case)
reminds us (dobj)
2.92 to (dep)
stable rate (nsubj)
received killed (dep)
propranolol tid (appos)
2.0mg/kg 0.5 (compound)
resistance or (cc)
carried we (nsubj)
deficits persistent (amod)
activity monooxygenases (nmod)
mechanism postulated (parataxis)
organs in (case)
schedule dose (conj)
suggest interfere (ccomp)
history with (case)
suggest affected (ccomp)
strains sg145r (nmod)
studies ultrastructural (amod)
cortex hypothalamus (conj)
admitted infant (nsubjpass)
affected loss (nmod)
enuresis , (punct)
recommendation major (amod)
develop lesion (dobj)
induces rate (nmod)
exposure period (nmod)
phases exposures (conj)
discuss and (cc)
p100 ( (punct)
integrity the (det)
fasciculations caused (acl)
peptide anp (appos)
sinus venous (amod)
hospitals large (amod)
started min (nmod)
accompany and (cc)
participated . (punct)
showed ultrasound (nsubj)
mg/m2 cisplatin (nmod)
inhibition concurrent (amod)
understand better (advmod)
inhibited could (aux)
episode convulsions (nmod)
seizure self-limited (amod)
describe cases (dobj)
selectivity bed (nmod)
nox urinary (amod)
glomerulonephritis patient (nmod)
tumors of (case)
allocated rats (nsubjpass)
regrowth tumors (nmod)
series the (det)
demonstrate action (dobj)
using along (prep)
ester n-nitro-l-arginine-methyl (compound)
reduced markedly (advmod)
progression till (case)
antigen bfgf (compound)
hyperactivity , (punct)
has consumption (nsubj)
survivors treated (acl:relcl)
supposed therefore (advmod)
mediation formation (nmod)
fluency but (cc)
factor predominant (amod)
4.0 2.8 (conj)
introduction treatment (nmod)
hr , (punct)
dementia of (case)
suramin and (cc)
study cytoprotection (compound)
antagonized were (auxpass)
$ROOT$ anaphylaxis (sent)
kg 2.1 (nummod)
poisons organophosphorus (compound)
0.001 and (cc)
treated gfc75 (nmod)
administered intragastrically (advmod)
artery into (case)
transaminases in (case)
postdose to (case)
shown acetaminophen (nsubjpass)
paradigm grip-lift (compound)
attention with (case)
nh4ac by (case)
erection the (det)
disturbances . (punct)
require reexposure (dobj)
lipophages many (amod)
complaints their (nmod:poss)
blood coronary (amod)
played and (cc)
widening complex (nmod)
arrhythmia contraction (appos)
compounds amino (compound)
factors no (det)
naloxone quinpirole (conj)
appeared mellaril (nsubj)
cisplatin 5-fluorouracil (conj)
symptoms psychopathological (amod)
engrafted experienced (conj)
exerted loreclezole (nsubj)
wsr compared (case)
lna to (case)
day 22 (nummod)
degree seizures (nmod)
level not (cc)
found degeneration (nsubjpass)
rechallenge patients (nmod)
influence which (nsubj)
perception taste (compound)
observed findings (nsubjpass)
$ROOT$ conclusions (sent)
classified be (auxpass)
walls of (case)
percent participants (nmod)
gentamicin mg/kg (conj)
ligand new (amod)
value plasma (compound)
antagonism receptors (nmod)
ligation , (punct)
set were (auxpass)
noted course (nmod)
cardiomyopathy dox-induced (amod)
before min (conj)
cent a (det)
myeloperoxidase- antibody (conj)
lesions bladder (nmod)
diagnoses with (case)
found distribution (nmod)
attack before (case)
remained low (xcomp)
concentration potassium (compound)
discussed emphasis (nmod)
membranes membranes (conj)
infections severe (amod)
model research (nmod)
$ROOT$ designated (sent)
receptor responsible (amod)
treated lnna (nmod)
oil , (punct)
interval % (dep)
involvement metronidazole (nmod)
occur anemia (nsubj)
mg/kg/i.v ) (punct)
investigate ability (dobj)
doses cinacalcet (nmod)
correlate permeability (nmod)
electromyogram studies (conj)
mg/dl 4.6 (compound)
comparison iopamidol (nmod)
documented % (nmod)
patients 37 (nummod)
pharmacology antagonist (appos)
incidence lidocaine (nmod)
seen 1967 (nmod)
volunteers 65 (nummod)
made , (punct)
death adriamycin-induced (amod)
doses incremental (amod)
capacity receptor (compound)
deletion by (case)
starting dosage (nmod)
cystitis strains (nmod)
atp into (case)
period hour (nmod)
ketanserin antagonist (appos)
analysis autoradiographic (amod)
bia , (punct)
showed regimen (nsubj)
relationship administration (nmod)
action probably (advmod)
= 2.32 (dobj)
found polytherapy (nmod)
generation superoxide (compound)
heparin low-dose (amod)
normalized eventually (advmod)
mg/dl 4.93 (nummod)
encountered we (nsubj)
replicated advantage (nsubjpass)
ami mg/kg/day (appos)
changes hemodynamic (amod)
exacerbated may (aux)
ml/ng ( (punct)
rats non-diabetic (amod)
carcinogens with (case)
field carried (acl:relcl)
remain problem (attr)
showing causes (ccomp)
group 0 (nummod)
evaluated quetiapine (dobj)
injections ketamine (nmod)
interview study (compound)
l6 % (appos)
rhuepo iu/kg (appos)
reduce . (punct)
comprised was (auxpass)
lipocalin b-d-glucosaminidase (conj)
require baroreceptors (dobj)
components pain (nmod)
studied prevalence (dobj)
developed treatments (nmod)
lorazepam of (case)
fracture an (det)
flutamide , (punct)
modifications histological (amod)
dose hypokalemia (conj)
2.2 ci (appos)
antagonizes catalepsy (dobj)
transplantations 2 (nummod)
motif across (case)
increases toxicity (nmod)
% 12.8 (nummod)
nitrazepam mg (amod)
infusion - (compound)
protects . (punct)
bpa ( (punct)
opportunity unique (amod)
report second (amod)
$ROOT$ doubled (sent)
enhances augmentation (nmod)
evaluated pressure (nsubjpass)
electrocardiograph lead (compound)
hexachloride alpha-benzene (compound)
exposure an (det)
rare cin (nsubj)
fetal in (case)
% male (amod)
months risperidone (conj)
data . (punct)
admitted coma (nmod)
rats gf (compound)
addition docetaxel (nmod)
represent genes (nsubj)
cardiotoxicity chemotherapy (nmod)
days ahf (nmod)
pretreated were (auxpass)
score force (conj)
activation induced (amod)
min prior (advmod)
seen , (punct)
(+)-isomer its (nmod:poss)
measures coronary (amod)
study morphometric (amod)
ptz 30mg/kg (appos)
exacerbated chickens (nmod)
sulphonate sodium (compound)
consumption animals (nmod)
% 34.6 (nummod)
result breakdown (nmod)
leading it (nsubj)
progression weakness (nmod)
ventricles rabbit (compound)
woman , (punct)
related imipramine (nmod)
hernia and (cc)
prohibited effect (nsubjpass)
measured period (nmod)
effects ritodrine (nmod)
prevalent also (advmod)
tachycardia augmentation (conj)
carota of (case)
radiological , (punct)
reduces activity (dobj)
included studies (dep)
include should (aux)
rofecoxib diclofenac (conj)
test object (compound)
minutes patient (nmod)
headache , (punct)
$ROOT$ infused (sent)
length a (det)
infarction myocardial (amod)
regimen sequential (amod)
antagonism the (det)
diclofenac than (case)
drug psychotropic (amod)
devlin ; (punct)
vomiting cases (nmod)
values clearance (compound)
body a (det)
moles/glomerulus , (punct)
accumulation brain (nmod)
gastrointestinal gi (dep)
divided ) (punct)
da 40,000 (nummod)
indicates : (punct)
nodes ranvier (nmod)
synthesis for (case)
regimen therapy (compound)
methotrexate of (case)
= 139 (dobj)
mg/kg/i.p volume (conj)
developed cyclophosphamide (nmod)
provoke np (nsubj)
safety its (nmod:poss)
feasibility safety (conj)
unclear nature (nsubj)
completed participants (nsubj)
received show (advcl)
pharmacodynamics the (det)
patients failed (acl:relcl)
years ten (nummod)
elevation values (nmod)
provides thus (advmod)
subjects = (dep)
returned levels (nmod)
neurotoxicity caused (acl)
medications defects (conj)
efficacy oxprenolol (nmod)
resembled lesion (nsubj)
consumed nicotine (nsubjpass)
cholestasis prolonged (amod)
inhibited suggesting (advcl)
gram-negative double (amod)
vasodilator is (cop)
plasticity emergence (conj)
vancomycin or (cc)
patients angioedema (nmod)
c219 pgp (compound)
ictus of (case)
indicates blocked (ccomp)
detecting uveitis (dobj)
had increased (ccomp)
anesthetized were (auxpass)
9 and (cc)
ketamine or (cc)
discontinued children (nmod)
mtx and (cc)
received % (dobj)
tap ( (punct)
= h (nsubj)
longer were (cop)
help , (punct)
errors avoided (acl:relcl)
data seizures (nmod)
gamma-sarcoglycan , (punct)
display performance (nmod)
lateral and (cc)
mirtazapine antidepressant (appos)
scopolamine s-(-)-et-126 (conj)
newborns reported (acl:relcl)
affected where (advmod)
atrophy diffuse (amod)
renin concentrations (conj)
mg 1,000 (compound)
shows is (conj)
days using (acl)
treatment schizophrenia (nmod)
psoriasis severe (amod)
stopped those (nmod)
rhythm of (case)
results younger (appos)
clearance cimetidine (compound)
impairment no (neg)
change pressure (compound)
hyperprolactinemia amenorrhea/galactorrhea (conj)
arteriolar venous (conj)
seems influenced (xcomp)
network to (case)
reports of (case)
resembles up-regulation (xcomp)
eye the (det)
ingestion quinine (nmod)
pneumonia ( (punct)
olanzapine placebo (conj)
ischemia observed (acl)
hl relapsed (amod)
literature toxicology (compound)
killed dose (conj)
repair patients (nmod)
reaching 2.6-fold (conj)
grade less (amod)
improvements measures (nmod)
prior days (nmod:npmod)
encode proteins (dobj)
antagonist polypeptide (compound)
13.1 +/- (cc)
wr-2721 amifostine (appos)
protocol a (det)
demonstrating effects (dobj)
increased declined (conj)
blocked , (punct)
beta-position the (det)
% residues (nmod)
sv ) (punct)
metoprolol enantiomers (conj)
found rhabdomyolysis (dobj)
occlusion arterial (amod)
employed given (conj)
essential ability (nsubj)
therapy inhaled (amod)
reducing in (mark)
augmentation doc (nmod)
reach number (nmod)
increased dipyridamole (nsubj)
patients hit (compound)
correlation and (cc)
sensation of (case)
gain . (punct)
1 between (quantmod)
patients breast (compound)
poor . (punct)
terbutaline mg/kg (appos)
0.03 0.1 (conj)
overdose tna (nmod)
weeks ( (punct)
potency beta-1 (compound)
took prior (advmod)
questioned use (nmod)
alcoholic not (neg)
have asymptomatic (advcl)
hypotension clonidine-induced (amod)
patients informed (amod)
include questions (dobj)
tube nephrostomy (compound)
associated hypercalcemia (nmod)
defects 2 (nummod)
confound interpretation (dobj)
choice , (punct)
unit micu (appos)
investigated neuropathology (nsubjpass)
blockade mfs (nmod)
dips of (case)
kidney on (case)
play beta2-subunits (nsubj)
1.56 . (punct)
effect could (aux)
permits if (mark)
loss neuronal (amod)
hematoma iliopsoas (compound)
androgen- and (cc)
strips rats (nmod)
grains reduced (amod)
case anemia (appos)
increased p=0.006 (dep)
count preoperative (amod)
showed confirmed (conj)
falls if (mark)
administered pump (nmod)
level 2 (nummod)
administered placebo (nsubjpass)
show rats (nsubj)
basis outpatient (amod)
value measured (acl)
nerves peroneal (amod)
factors measures (conj)
circuits in (case)
aldosterone by (case)
samples and (cc)
showing days (nmod)
step still (advmod)
trials iii (nummod)
alteration no (neg)
used and (cc)
analyses markers (nmod)
nuclei fastigial (amod)
statement , (punct)
abilities her (nmod:poss)
ameliorate retained (conj)
present woman (dobj)
component phasic (amod)
presented having (aux)
constriction with (case)
associated loss (nmod)
apheresis of (case)
case of (case)
biomarkers , (punct)
na+ with (case)
79 8 (conj)
ischaemia myocardial (amod)
mg/kg 250 (nummod)
$ROOT$ establishes (sent)
helpful very (advmod)
free % (nsubj)
cause pointes (dobj)
prolongation transient (amod)
measured groups (nmod)
decreased course (dobj)
potentials p-veps (appos)
group a (det)
fetus and (cc)
evaluated electrogram (nmod)
impairments rats (nmod)
pn to (dep)
increased exposure (nmod)
had test (nmod)
reduced remained (conj)
similarities ) (punct)
importance particular (amod)
effectiveness injections (nmod)
development disease (nmod)
content 5-ht (compound)
methadone buprenorphine (conj)
suggest existence (dobj)
doxorubicin kg(-1 (appos)
kidney heart (conj)
procyclidine as (case)
intravenous iv (dep)
impair may (aux)
seemed incidence (nsubj)
linked were (auxpass)
toxic not (neg)
1.5 0.5 (conj)
remapped a1 (nsubjpass)
complex central (amod)
risk lower (amod)
determine quantitatively (advmod)
changes ecg (compound)
conclude thus (advmod)
reports structured (amod)
ug/ml . (punct)
characterize nature (dobj)
had att (dobj)
toxicity caa (nmod)
had pregnancy (dobj)
reported combined (advcl)
decrease sem (conj)
amnesia emergence (appos)
drop sudden (amod)
eosinophilia ( (punct)
angiograms from (case)
administration ddavp (nmod)
days : (punct)
fusion interbody (compound)
lead blood (compound)
nephrotoxicity ) (punct)
swings complex (amod)
blocked veins (nsubjpass)
% 47.3 (nummod)
implicated background (nsubjpass)
containing one (dobj)
elimination radioactivity (nmod)
findings cases (nmod)
came fibrillation (nmod)
amlodipine/benazapril of (case)
dose intramuscularly (advmod)
imbalance system (nmod)
residents quebec (compound)
gases blood (compound)
using inhibitor (dobj)
sces ( (punct)
total days (nmod)
resulted levels (nmod)
score component (nmod)
have cardiotoxicity (nmod)
diffusely more (advmod)
examination findings (conj)
ethanol % (amod)
confirmed controls (nmod)
sf36 36 (nummod)
each in (case)
depressed mg (dep)
ward internal (amod)
rate production (conj)
differences , (punct)
recorded pressures (nsubjpass)
yrs > (nummod)
followed injections (nmod)
seriousness to (case)
levels mumol/l (nmod)
tissues normal (amod)
number valves (nmod)
tract in (case)
melatonin mg/kg (appos)
insecticide properties (nmod)
obtained hospitalization (nmod)
dyskinesias of (case)
database mhra (compound)
minimised could (aux)
acetazolamide by (case)
prolonged k- (advcl)
high to (advmod)
rate infusion (nmod)
specimens skin (compound)
removal no (nmod)
presentation an (det)
criteria centers (compound)
decrease renin (nmod)
women control (amod)
relationship . (punct)
micrograms caffeine (nmod)
effects are (cop)
were dilatation (nsubj)
diagnosis alternatives (conj)
consider returns (advcl)
months months (conj)
study sleep (compound)
receptors sigma1 (compound)
i.v. kg-1 (compound)
lines previous (amod)
half-life min (appos)
children major (nmod)
s for (case)
limited search (nsubj)
switching associated (acl)
medication used (acl:relcl)
levels nrf2 (compound)
onset including (case)
woman caucasian (amod)
length hospital (compound)
noticeable more (advmod)
criteria agoraphobia (nmod)
show together (advmod)
appetite decreased (amod)
triggers whether (mark)
evaluated rep (dep)
humans to (case)
reflected scores (nmod)
identical those (nmod)
analysis effects (nmod)
dialysis capd (appos)
analgesia- incoordination (conj)
1.19 ( (punct)
potentials pacemaker (compound)
dosed weeks (nmod:tmod)
a-ii apo (compound)
paradigm this (det)
suitable had (advcl)
hypertension failure (conj)
mg/dl from (case)
onset manifestations (nmod)
test withdrawal (compound)
effects performance (nmod)
affect increase (dobj)
twitching . (punct)
hypoxia tubulointerstitial (amod)
outcome transplantation (compound)
blockade dmpx (nmod)
thyroxine response (nmod)
picrotoxin and (cc)
testosterone t (appos)
helpful exhibit (conj)
mp with (case)
changes no (det)
excretion daily (amod)
test passive (amod)
rs ) (punct)
hydrochloride to (case)
consequences overexpression (nmod)
shares characteristics (dobj)
side one (nummod)
strain rat (compound)
cancer not (neg)
finally . (punct)
alter that (nsubj)
$ROOT$ investigates (sent)
relieve symptoms (dobj)
days 18 (conj)
agitated to (mark)
bladder overactive (amod)
shunt ovale (nmod)
plan health (compound)
mg 165/90 (nummod)
attenuated castration (nmod)
drug hypotensive (amod)
illnesses acute (amod)
state subclinical (amod)
reflect effect (dobj)
0.97 1.47 (conj)
systems non-dopaminergic (amod)
lesion ventral (amod)
hit in (case)
evaluation patients (nmod)
permitted continue (xcomp)
$ROOT$ hallmark (sent)
contain . (punct)
day other (amod)
mechanism immunologic (amod)
ducts biliary (amod)
had loss (nsubj)
beta-blockade.8 of (case)
induction injection (nmod)
recovery 13 (nmod)
mg.kg(-1).d(-1 , (punct)
inhibited clonidine (nsubj)
group cacl2 (compound)
refer scheduled (advcl)
ph ) (punct)
discovered reviewing (advcl)
impairing drop (dobj)
rats treated (acl)
cortex matter (conj)
effective as (advmod)
ketamine such (case)
altered pharmacokinetics (nsubjpass)
evoked stimuli (nmod)
difference gap43-ir (nmod)
after particularly (advmod)
stopping and (cc)
followed vehicle (nmod)
[3h]cb microm (amod)
accompanied stress (nmod)
22.25 51.0 (prep)
effects gamma-hexachlorocyclohexane (nmod)
lvef ( (punct)
necessary that (mark)
glioma meningioma (conj)
effect cocaine (nmod)
showed administration (nsubj)
decreased 80 (conj)
interventions despite (case)
diatheses illnesses (conj)
show inhibit (ccomp)
inhibition uptake (nmod)
therapy carbamazepine (compound)
edits ) (punct)
secondary ingestion (nmod)
play retention (nmod)
received pump (nmod)
group min (nmod)
proteinuria mechanisms (dep)
changes epithelium (nmod)
matched albuminuria (nmod)
frequent reported (advcl)
significance statistical (amod)
coagulopathy warfarin-induced (amod)
pac ( (punct)
leukemia diagnosis (nmod)
detected drg (nmod)
affect flattened (amod)
effect injection (nsubj)
mode this (det)
transient dynamic (conj)
transgene of (case)
diseased normal (conj)
possibility factors (nmod)
association , (punct)
cnsb002 with (case)
reviews , (punct)
% -9.9 (nummod)
from april (nmod)
injection hexamethonium (nmod)
given open (advcl)
pressures and (cc)
weight mg/kg (nummod)
found background (nsubjpass)
> 5 (dep)
strategy this (det)
common . (punct)
bottle empty (amod)
$ROOT$ acting (sent)
developed ) (punct)
isoenzymes for (case)
heterogeneity diffuse (amod)
shorter days (dep)
patient malaria (compound)
active nsclc (nmod)
reversal effect (nmod)
compared patients (nsubjpass)
restarted when (advmod)
come . (punct)
animals pilo-injected (amod)
aim we (nsubj)
agent ultra-short-acting (amod)
pathology bladder (compound)
regimens common (amod)
began mg/d (nmod)
microg/ml was (cop)
tested that (mark)
mutations gene (compound)
databases biomedical (amod)
effect pressure (nmod)
grades haemorrhage (compound)
elicit that (mark)
3',5'-monophosphate ) (punct)
showed binding (nmod)
daidzein 4',7-dihydroxy-isoflavone (appos)
needed doses (nsubjpass)
0.0010 + (cc)
medium nrvms (nmod)
caused ) (punct)
movements 5.1+/-1.0 (dep)
gd1=plug ( (punct)
effect cnsb002 (nmod)
factors following (amod)
results produce (appos)
resulted which (nsubj)
received caused (advcl)
before days (nmod:npmod)
resembled perforans (ccomp)
administered drug (nsubjpass)
receive preceded (advcl)
reach patient (nsubj)
act node (nmod)
undertaken be (auxpass)
lots of (case)
carcinomas five (nummod)
vasodilation dependency (conj)
increased however (advmod)
allocated are (auxpass)
hepatitis aap (compound)
glomerulosclerosis mild (amod)
release drug (dobj)
amputation and (cc)
mg/kg/b.w 2 (nummod)
experiments these (det)
associated tacrolimus (nmod)
up maximum (nmod)
accomplished conversion (nsubjpass)
stress injury (nmod)
meritorious , (punct)
fatigue ( (punct)
selective that (mark)
is which (nmod)
responses , (punct)
beta-carboline-3-carboxylate agonist (appos)
stimulation lpp (nmod)
rheumatology , (punct)
vpu with (case)
percent 29 (nummod)
exacerbates tdp. (dobj)
involved episodes (nmod)
hemisuccinate cholesteryl (compound)
five was (cop)
dysfunction cocaine-induced (amod)
result elevation (nmod)
seizure pethidine-associated (amod)
dysfunction gallbladder (compound)
rates presumed (acl)
program exposure (nsubj)
p : (punct)
h2o ) (punct)
altered analgesics (nmod)
level that (conj)
pth ) (punct)
indicated h (nmod)
adult in (case)
association status (nmod)
pg/ml = (parataxis)
cause acidosis (dobj)
22 a (nmod)
rw in (case)
21 - (punct)
solicited . (punct)
effects neurotransmission (nmod)
weights the (det)
level neutral (amod)
rate mean (amod)
d-pen ) (punct)
delivered may (aux)
levofloxacin with (case)
mortality zero (nummod)
c stage (compound)
occur if (mark)
administration gm (nmod)
thunbergiana pueraria (compound)
nodule small (amod)
subjects males (appos)
ultrasound and (cc)
programs active (amod)
hypothesis explain (acl:relcl)
induced tissues (nmod)
diagnosed centers (nmod)
type y-maze (compound)
revealed restoration (nmod)
affection between (case)
cardiotoxicity were (cop)
excess chronic (amod)
affecting simultaneously (advmod)
fraction with (case)
described here (advmod)
infarction thrombosis (nmod)
performed measured (conj)
pain transplantation (nmod)
suppressed was (auxpass)
concentration mg (nmod)
surface entire (amod)
patients 650 (nummod)
135 thirty (compound)
woman injected (acl:relcl)
adults undergoing (acl)
feeling ill (acomp)
pemoline with (case)
mepivacaine of (case)
exert avp (nsubj)
calculated patients (nmod)
pparalpha ( (punct)
california northern (amod)
seeing stools (nmod)
albuminuria pressure (conj)
enhanced blockade (nsubj)
resolved completely (advmod)
wall right (amod)
374 hypertension (nmod)
introduction increases (appos)
onset clonus (nmod)
decreased that (mark)
pose may (aux)
symptoms elevations (nmod)
execution the (det)
anaesthesia hypotensive (amod)
tm ) (punct)
method results (conj)
calcium ( (punct)
strategies many (amod)
effects requiring (acl)
rate with (case)
carbamazepine presenting (acl)
subgroup using (acl)
interferes that (mark)
penetration brain (compound)
h. for (case)
inhibited growth (dobj)
observed those (nmod)
repeated was (auxpass)
effect this (nsubj)
funduscopy and (cc)
showed shifting (nmod)
patient this (nsubj)
extrusion the (det)
feeding following (case)
hypotension dysfunction (conj)
kindling mice (nmod)
plasma or (cc)
reduced decreased (advcl)
transplanted alf (nmod)
examined days (nmod)
effects direct (amod)
had decrease (nmod)
receive to (mark)
words presented (acl)
reflect and (cc)
regressed withdrawal (nmod)
assumptions conservative (amod)
51 and (cc)
resolve may (aux)
option therapeutic (amod)
l-dopa+benserazide with (case)
model rat (compound)
level protein (compound)
inhibitor argatroban (nsubj)
reduction starting (acl)
blockade 2-adrenoceptor (compound)
normal than (case)
13 the (det)
channel ) (punct)
prescription nsaid (nmod)
associated mania (nsubj)
session for (case)
suppresses therefore (advmod)
increase exposure (nmod)
immersed which (nmod)
tracts and (cc)
inhibited have (aux)
phases liquid (amod)
received assigned (conj)
examination therapy (nmod)
stimulation ovarian (amod)
recordings wall (nmod)
discovered recently (advmod)
receptors 5-ht1a (compound)
expression gap43 (compound)
effects diazepam (nmod)
2-blocking beta (nmod:npmod)
stress activity (conj)
3 score (nsubj)
segment diameter (nmod)
overload ca(2 (compound)
profiles/sections ( (punct)
echocardiographic scintigraphic (conj)
workup cardiac (amod)
g/m2 7 (nummod)
didanosine prochlorperazine (conj)
robust more (advmod)
subject who (nsubj)
inhibiting in (mark)
level creatinine (compound)
effect infarction (nmod)
hyperprolactinemia of (case)
regimen antiretroviral (amod)
prevented alterations (dobj)
opaque not (neg)
aggression dyscontrol (conj)
processes with (case)
begun if (mark)
agonist adenosine (compound)
metoprolol the (det)
controls 50 (nummod)
september 2005 (nummod)
declined expression (nsubj)
concentration % (nmod)
use clinical (amod)
species and (cc)
implanted injected (conj)
cortex frontal (amod)
case man (nmod)
variation systolic (amod)
balances rate (conj)
% 17.7 (nummod)
kinase growth (compound)
dcf patches (conj)
cn not (cc)
clonidine preoperative (amod)
modeling pharmacokinetic-dynamic (amod)
journals . (punct)
anemia immunodeficiencies (conj)
systems reactions (nmod)
larger older (conj)
exhibited immunoreactivity (dobj)
remained audiograms (nsubj)
led accumulation (nsubj)
val mg (appos)
membranes rats (nmod)
potency less (advmod)
copies/ml 3.82 (nummod)
noted blisters (nsubjpass)
newborns of (case)
allopurinol plus (cc)
ascites , (punct)
del taqid (conj)
formation subependymal (amod)
manifestations arthritis (nmod)
accomplished results (conj)
arteries cerebral (amod)
changes bp (nmod)
caused change (conj)
conclusions line (appos)
change threshold (nmod)
dex with (case)
ci-921 of (case)
treatment azidothymidine (nmod)
nelarabine cyclophosphamide (conj)
assessed mri (nmod)
intake adult (nmod)
helpful be (cop)
report our (nmod:poss)
recognize states (dobj)
years the (det)
latency intensity (conj)
intima in (case)
reduced similar (advmod)
anemia patients (nmod)
extreme most (advmod)
value 13.2 (nmod)
received discharged (advcl)
differentiate subjects (nmod)
uses methamphetamine (compound)
consumption detected (acl)
hepatotoxicity mice (nmod)
reduction baseline (nmod)
1983 , (punct)
fall week (nmod)
risperidone ssris (conj)
netilmicin 18 (dep)
assessed infusion (nmod)
line regression (compound)
5-httlpr gender (conj)
normalization as (cc)
$ROOT$ materials (sent)
area per (case)
demonstrated fall (dobj)
contained four (nmod)
cytoskeleton in (case)
man dysfunction (nmod)
1.2 - (punct)
recorded randomized (dep)
induced analgesia (dobj)
od ] (punct)
increase size (nmod)
chloride application (nmod)
man undergoing (acl)
exposures man (nmod)
associated expression (nmod)
amnesia avoidance (nmod)
hypertension stage (compound)
aes symptoms (appos)
mg/kg 450 (nummod)
perfusion kidney (compound)
use omeprazole (nmod)
brain imaging (compound)
patients fifty-eight (nummod)
saline mg (conj)
users human (amod)
clearance bcnu (nmod)
= -4.29 (dobj)
damage medulla (nmod)
administered forehead (nmod)
ratios rrs (appos)
rosen 's (case)
sampled was (auxpass)
samples na (nmod)
increased sigmast (dobj)
investigated measuring (advcl)
perfused media (nmod)
resulted tone (nsubj)
tland of (case)
had metastases (dobj)
factors increased (amod)
association analysis (dep)
cause resulting (advcl)
pulses ; (punct)
removing piperacillin (dobj)
sequelae any (det)
prescribe that (mark)
microg/ml hours (conj)
nociception inflammatory (amod)
application snr (nmod)
analyzed semiquantitatively (advmod)
incorporating [3h]-l-arginine (dobj)
effect antihypertensive (amod)
sad ( (punct)
79.6 ) (conj)
flumazenil benzodiazepine (compound)
increased concentration (nmod)
pparalpha-/- ] (punct)
experienced urticaria/angioedema (dobj)
agonist cgs (appos)
deferens vas (compound)
aid as (case)
demonstrated measurements (nsubj)
symptoms drug-induced (amod)
delayed missed (conj)
observed lower (xcomp)
hypertension doca-salt (amod)
enrolled endocrinologists (nmod)
production effect (conj)
estimated number (nmod)
cardiotoxicity on (case)
score 7 (nmod)
suggested represent (ccomp)
infection follow-up (nmod)
atrophy atrophy (conj)
induced wasting (dobj)
higher slightly (advmod)
metabolism myocardial (amod)
observed dose (nmod)
performed dox-rats (nmod)
treated then (advmod)
smokers diseases (nmod)
negative screen (nsubj)
tnf-a of (case)
mg/kg 120 (compound)
= 0.79 (dobj)
was relation (attr)
performance impaired (amod)
deterioration eyes (nmod)
induced reduced (conj)
women exposed (acl)
degrees mrd (nsubj)
is experiments (nmod)
9 1 (compound)
expand use (dobj)
april 2007 (nummod)
chc ) (punct)
evaluated however (advmod)
patients 1346 (nummod)
25 - (punct)
trunk the (det)
csseps and (cc)
shows also (advmod)
present dyskinesias (nsubj)
cystitis busulfan (compound)
toxicity clinical (amod)
presented near-syncope (nmod)
were series (nmod)
undergone recently (advmod)
attenuated gr (nsubj)
mg/kg/day infants (nmod)
ratio 0.09 (appos)
ranged treatment (nmod)
had x (dep)
regimen dnr-containing (amod)
testing electrophysiologic (amod)
lumen cells (nmod)
cases uveitis (compound)
exchange replacement (conj)
reporting syncope (nmod)
$ROOT$ movements (sent)
protection complete (amod)
33342- stained (conj)
injections saline (nmod)
scores parkinsonism (nmod)
pressure arterial (amod)
powered not (neg)
dysfunction associated (acl)
electrocardiogram an (det)
eeg initial (amod)
% 3.21 (nummod)
variety conditions (nmod)
attack no-induced (amod)
adjuvant preventative (conj)
randomized double-blinded (dep)
nucleoside or (cc)
derivative elicit (acl:relcl)
treatment artesunate (nmod)
patients seventy-five (nummod)
removed and (cc)
value measurement (nmod)
explore , (punct)
patients dose (nmod)
antagonist dual (amod)
features renal (amod)
administration volume (conj)
neuropathy was (cop)
peptide(1 - (appos)
weeks 9 (nummod)
inducing cells (nmod)
dopamine hva (conj)
occurrence concomitant (amod)
transferase glutathione (compound)
blockers dihydropyridine (compound)
cross-reacting derivatives (nmod)
ssris of (case)
etoricoxib of (case)
infections these (det)
impairment possible (amod)
valves cardiac (amod)
activate amphotericin (nsubj)
areas these (det)
injected rg1 (nsubjpass)
wall left (amod)
papilloma ( (punct)
patient due (acl)
included analysis (nsubj)
marker the (det)
reported never (neg)
patients well (advmod)
injection h (nmod:npmod)
balance fluid (compound)
144 +/- (cc)
plasma ( (punct)
changes changes (nmod)
diuretic that (mark)
cholestasis report (appos)
yield , (punct)
reduction efflux (nmod)
replication the (det)
decrease gls (nmod)
increases drg (nmod)
hospitalization the (det)
myelopathy disturbance (conj)
polydrug ecstasy (compound)
doxorubicin ( (punct)
11 19 (conj)
side-effects many (amod)
observed suppressed (conj)
occlusion rats (nmod)
undergone surgery (dobj)
increase however (advmod)
remains although (advcl)
oximeters pulse (compound)
corticosteroids aspirin (conj)
status level (conj)
keratectomy photorefractive (amod)
discussed relation (nmod)
warranted hemorrhage (nmod)
induce acid (nsubj)
isradipine with (case)
isoproterenol weight (appos)
characteristics diagnosis (conj)
recall subsequently (advmod)
net ) (punct)
consequences , (punct)
accompanied failure (nmod)
rate saturation (conj)
studies pediatric (amod)
antifolate an (det)
state reduced (amod)
minutes final (amod)
decreasing qs/qt (dobj)
performed indicated (advcl)
removal of (case)
streptozotocin with (case)
contraction pvc (appos)
sulfate nifedipine (conj)
toxicity mice (nmod)
contraceptives compared (case)
4.18 ) (punct)
events nicotine (nmod)
endpoint the (det)
developed function (dobj)
% 15.2 (nummod)
normal near (case)
level dobutamine (compound)
disorder occurs (acl:relcl)
elicit pigs (nmod)
achieve maintain (conj)
values reference (compound)
hypoplasia epiphyses (conj)
exerted pdtc (nsubj)
high abnormally (advmod)
messages behavioral (amod)
range cases (conj)
protein in (case)
tg investigate (advcl)
artery and (cc)
responders of (case)
treated outpatients (nsubjpass)
patients 16 (nummod)
step , (punct)
patients " (punct)
urge both (cc:preconj)
essential : (punct)
lead ultimately (advmod)
effects cisapride (nmod)
unchanged im (nmod)
mornings the (det)
nsaid acetaminophen (appos)
differ formulations (nmod)
necrosis due (case)
rescue leucovorin (compound)
myocardium the (det)
justified . (punct)
frequent serious (amod)
leads dysfunction (nmod)
except therapy (nmod)
assessed patients (nsubjpass)
contracture extremity (nmod)
evaluation hematologic (amod)
mice overexpressing (acl)
receptors , (punct)
levels mrna (nmod)
acuity sensitivity (conj)
filaments von (compound)
objective describe (acl)
lesion reversible (amod)
altered cortex (nmod)
cortex im (conj)
injections vehicle (nmod)
associated children (nmod)
placement following (amod)
score on (case)
showed biopsies (nsubj)
six mg/m2/d (nmod)
presumed pressure (dep)
fragmentation addition (nmod)
differences histologic (amod)
hyperthyroidism persistent (amod)
study/short experimental (amod)
reduction cytopenia (nmod)
necessary diagnosis (nmod)
ph urinary (amod)
substances compounds (conj)
develop remains (conj)
factors developing (advcl)
39 10(9 (conj)
activity adriamycin-mediated (amod)
level i (nummod)
occurs and (cc)
trained . (punct)
attenuates injury (dobj)
myopathy bilaterally (advmod)
manageable resolved (conj)
achieved employed (advcl)
inventory edits (appos)
normalization tests (nmod)
variants usual (amod)
increased slightly (advmod)
regimens emulsion (nmod)
frequency symptoms (nmod)
cause morbidity (nmod)
years 35.6 (nummod)
evaluated 2 (dep)
72 48 (compound)
users 22 (nummod)
cornu rudimentary (amod)
10 seven (quantmod)
lna ( (punct)
released aid (nmod)
associated antidepressants (nmod)
transaminase gaba (compound)
magnitude , (punct)
plexitis brachial (amod)
experienced subjects (nmod)
% 88.8 (nummod)
placebo- haloperidol-controlled (conj)
targeting lysosomes (dobj)
mg./kg i.p. (amod)
increase elevation (conj)
rats different (amod)
hbeag ) (punct)
vision color (compound)
preceded symptoms (nmod)
task maze (compound)
differs because (mark)
responses stem (compound)
high different (conj)
reduced ages (nmod)
correlate values (nmod)
i vs. (cc)
minimized be (auxpass)
admitted managed (conj)
involves functions (nmod)
organization this (det)
day 20 (nummod)
parameters seizure (compound)
convulsive and (cc)
abolish completely (advmod)
buffers response (dobj)
atp its (nmod:poss)
small likely (conj)
age had (conj)
presented function (dobj)
analysis discriminant (amod)
ventricle = (dep)
mtx ) (punct)
% 72.2 (nummod)
reduced effect (nsubjpass)
persisted maximally (advmod)
translocations pathogenic (amod)
injury aap-induced (amod)
epithelium the (det)
tolerated mg/day (nsubjpass)
angiotensin -- (amod)
70 15 (compound)
scores on (case)
oximeters or (cc)
sacrifice prior (case)
fan ) (punct)
relationship hypothermia (nmod)
dmpx ) (punct)
overdose antidepressant (amod)
impact can (aux)
reversed anemia (dobj)
withdrawn improved (conj)
remained constant (xcomp)
test min (nmod:npmod)
effect tone (nmod)
effects unfavourable (amod)
reaction and (cc)
associated hypokalemia (nmod)
which in (case)
limits ( (punct)
minutes 90 (nummod)
administration urd (compound)
indicates although (mark)
syndrome exposure (nmod)
behaviours with (case)
reversed successfully (advmod)
observed deposition (nsubjpass)
circled response (nmod)
receptor-stimulating postsynaptic (amod)
induced se (nsubjpass)
increased children (nmod)
pre-existing aminonucleoside-induced (conj)
doses influence (acl:relcl)
$ROOT$ influence (sent)
alterations no (neg)
succeeded participant (nsubj)
placebo patients (nmod)
inhibits hyperemia (dobj)
preserved period (nmod)
parameters reabsorption (nmod)
crystals by (case)
users therapy (compound)
combination skf (nmod)
increase asymptomatic (amod)
pce ( (punct)
bradycardia increase (conj)
women postmenopausal (amod)
diagnosed based (prep)
time inspiratory (amod)
neuropathy muscle (nmod)
1 up (advmod)
variants of (case)
prior discharge (nmod)
decline major (amod)
response abolished (amod)
pathophysiology insufficiency (nmod)
infant , (punct)
biopsy episode (compound)
vegfr-2/flk-1/kdr ( (punct)
haloperidol subchronic (amod)
those responding (acl)
resulted death (nsubj)
plan may (aux)
slowed 40/min (nmod)
group fk506 (compound)
12 3 (quantmod)
presented case (nsubjpass)
350 30 (compound)
cigarettes ears (appos)
altered rate (nsubjpass)
os ( (punct)
zidovudine of (case)
hypertension-related oedema-related (conj)
sedative either (det)
effect vpa (nmod)
seen microscopy (nmod)
reduced 17beta-estradiol (nsubj)
proteins 67 (nummod)
studied total (nmod)
analyzed incidence (dobj)
decrease length (nmod)
ability reduced (amod)
carcinoma tumors (nsubj)
consolidation and (cc)
attenuated was (auxpass)
therapy multidrug (amod)
fastigial interpositus (conj)
failure chemotherapy (nmod)
dis ] (punct)
injected striatum (nmod)
mucositis grade (compound)
levels toxic (amod)
abscess from (case)
observed decrease (nsubjpass)
setting infarction (nmod)
recorded higher (advcl)
dose after (case)
combination cyclophosphamide (nmod)
refine will (aux)
window exerting (acl)
atazanavir ( (punct)
sensitive identify (xcomp)
decrement any (det)
developed p=0.025 (dep)
shortening interval (nmod)
$ROOT$ parallel (sent)
lidocaine mg (dep)
vehicle of (case)
trial evaluating (acl)
infants these (det)
improvement without (case)
level ; (punct)
developing approach (dobj)
children pretreated (acl)
result convulsions (nmod)
hydroxyanisole with (case)
disarrangement cardiac (amod)
ko cb1 (compound)
was results (nsubj)
hydroperoxides lpo (appos)
suggested contribute (ccomp)
impacts cns (nmod)
treated which (nsubjpass)
conditions neurologic (amod)
bands frequency (compound)
increases use (nsubj)
consisted monitoring (nsubj)
95 ( (punct)
shown using (advcl)
biosynthesis ribosomal (amod)
confirm could (aux)
28.21 +/- (cc)
protocol with (case)
observed min (nmod)
process be (cop)
played facilitated (conj)
mortality costs (conj)
recovery . (punct)
alter accelerated (conj)
abrogated sis3 (nsubj)
line , (punct)
consider reflex (dobj)
duration prolonged (amod)
history no (neg)
proanthocyanidins of (case)
sodium affinities (dep)
decrease pressure (compound)
function pivotal (amod)
recordings polysomnographic (amod)
way long (amod)
increase 4-fold (amod)
series reports (conj)
enzyme asp70gly-p (compound)
life minutes (nmod)
father the (det)
sensitivity values (conj)
duration patients (nmod)
predisposed patient (dobj)
measurements audiometric (amod)
remained sectioning (nmod)
connects and (cc)
infiltration damage (nmod)
countries asian (amod)
volumes smaller (amod)
cases/person-years 1.48 (nummod)
clumsiness and (cc)
vaccination the (det)
phenols fla797 (conj)
grade echocardiography (nmod)
integrate exposure (dobj)
borderzone lesions (nmod)
thiopentone with (case)
remains seen (xcomp)
25.4 +/- (cc)
messenger second (amod)
reported total (nsubjpass)
sequelae syndrome (nmod)
necrosis methimazole-associated (amod)
serve . (punct)
deaths transplant (compound)
cord the (det)
tolerated pg (nsubjpass)
influence cochlea (nmod)
antibiotic properties (nmod)
atrium guinea (compound)
111 to (quantmod)
oropharynx of (case)
potentiated also (advmod)
excitation system (compound)
potentiates initiation (dobj)
19.9 +/- (cc)
30 six (quantmod)
reached respectively (advmod)
involvement valve (compound)
withdrawal during (case)
measures as (cc)
receptors myocardial (amod)
agents both (cc:preconj)
stroke including (case)
nucleus brain (nmod)
rtms placebo (conj)
available confirming (advcl)
lymphoma and (cc)
bcnu mg/kg (appos)
twitch evoked (amod)
loss weight (nmod)
methadone or (cc)
influenced hyperactivity (nmod)
woman pregnant (amod)
healthy were (cop)
stress for (case)
strategies screening (compound)
electroretinograms pattern (compound)
doses morphine (nmod)
logical , (punct)
requirements analgesic (compound)
tests diagnostic (amod)
testing , (punct)
from only (advmod)
rats ninety-three (nummod)
improvement months (nmod)
addressed issues (nsubjpass)
shock in (case)
found associated (xcomp)
tone parasympathetic (amod)
include infections (dobj)
diarrhea effects (nsubj)
hepatomas the (det)
strips bladder (compound)
associated treatment (nmod)
occurred deaths (nsubj)
regimens cisplatin-containing (amod)
changes dep (nmod)
weeks 7 (nummod)
renografin of (case)
chain mitochondrial (amod)
speculate we (nsubj)
polymorphism the (det)
point genetic (amod)
syndrome quinine-associated (amod)
treatment such (amod)
elevated cells (nmod)
latency task (nmod)
abstention subjects (nmod)
picrotoxin bicuculline (conj)
group with (case)
20 30 (conj)
identification , (punct)
salt tris (compound)
defect dysfunction (nsubj)
symptoms psychiatric (amod)
from % (nmod)
pnd ) (punct)
carcinoma first (amod)
using anesthesia (nmod)
exhibited ml/min (dep)
samples heart (nmod)
force with (case)
39+/-10 ) (punct)
led administration (nsubj)
indicative lead (xcomp)
thrombectomy second (amod)
treated cohort (nsubjpass)
review anemias (nmod)
drug-adsorption and (cc)
polyvidone vasurix (compound)
1.3 were (cop)
effects extract (nmod)
infusion mg.kg(-1).min(-1 (appos)
effect warrants (acl:relcl)
success the (det)
resolve spontaneously (advmod)
sparse investigations (nsubj)
finding clinical (amod)
along agent (nmod)
treatment cells (nmod)
hemisphere animals (nmod)
reported trial (nsubj)
adherence guidelines (nmod)
peaked p (dep)
surgeries , (punct)
sensitive resistant (conj)
peak hours (nmod)
course either (cc:preconj)
enzyme , (punct)
amelioration some (nmod)
studied breakdown (nsubjpass)
trials now (advmod)
glycol 400 (nummod)
anophthalmia and (cc)
therapy aggressive (amod)
examination mini-mental (amod)
chromatography gas-liquid (amod)
taking after (mark)
action blocking (compound)
mapped p (dep)
echocardiography transesophageal (amod)
renoprotective patients (nmod)
reverse can (aux)
depressants anesthetics (nmod)
4.1 ( (punct)
responsible activity (nmod)
dysfunction in (case)
schedules following (amod)
uv ) (punct)
volumetric and (cc)
antagonized was (auxpass)
using pointer (dobj)
sedations all (det)
acid aminocaproic (amod)
cells macrophages (conj)
develop seizures (dobj)
agonists oral (amod)
documented , (punct)
mixture the (det)
decreased acid (nsubj)
confounders as (case)
consumption body (compound)
found is (auxpass)
indicate features (nsubj)
was p (nsubj)
reversed 5 (dep)
7 emboli (nmod)
m ; (punct)
terminated incidence (nmod)
protect decreasing (advcl)
reduction acetaminophen (nmod)
163 to (case)
mucosal and (cc)
abstinence cocaine (nmod)
subjects four (nummod)
mg/kg 3.5 (nummod)
kit immunoassay (compound)
.01 less (advmod)
suggest link (dobj)
isomerase of (case)
manageable . (punct)
very-low-birth-weight vlbw (appos)
toxicity cyclophosphamide (nmod)
home at (case)
separated ultrafiltration (nmod)
nitrite combination (nmod)
change measures (nmod)
depletions corresponding (amod)
few a (advmod)
asymptomatic if (mark)
microl p=0.015 (appos)
length to (case)
retching tremors (conj)
reduce may (aux)
approximate may (aux)
terminated dosing (nmod)
self-treating that (mark)
suggests effective (ccomp)
use infection (nmod)
discontinued it (nsubjpass)
prescribed been (auxpass)
vasodilator direct-acting (amod)
or(adj 2.58 (nmod)
infusion single (amod)
coincidental which (nsubj)
brightfield- microscopy (conj)
mk-801 microl (appos)
factor amplitude (nmod)
is immunosuppressive (amod)
oximeters such (case)
gentamicin mg/kg/day (appos)
pelvis ureter (conj)
hours bedtime (conj)
release region (nmod)
agents by (case)
all status (nmod)
sufficient polyuria (nsubj)
records sonograms (conj)
subjects 18 (nummod)
lower significantly (advmod)
therapy migraine (compound)
tachycardia inducible (amod)
patients paediatric (amod)
$ROOT$ uneventful (sent)
disturbances benign (amod)
acetaminophen with (case)
scores edits (compound)
reinitiated argatroban (nmod)
antibiotics with (case)
improved substantially (advmod)
describe association (dobj)
predicted drop (nmod)
narrowed was (auxpass)
resistance lamivudine (nmod)
chemotherapy employed (acl)
absence arousal (nmod)
scale drug (compound)
7.73 5.85 (compound)
offer atropine-mk801 (nsubj)
alphabeta-crystalin vinculin (conj)
hepatocarcinogens of (case)
sensitive children (nsubj)
factor ototoxic (amod)
suggest hypothesis (dobj)
1999 2003 (prep)
failure injury (conj)
good been (cop)
was limit (dep)
learning dissociated (amod)
% 66 (nummod)
conditions for (case)
diagnosed man (nsubjpass)
eps with (case)
infections . (punct)
vt refractory (amod)
proteins ca(2 (compound)
dnap ( (punct)
model carrageenan-induced (amod)
gauges g (appos)
methadone mg (compound)
mg/dl 5 (nummod)
samples for (case)
lid and (cc)
cck-8-ns for (case)
rejection findings (conj)
nicotine kg(-1 (appos)
time cut-off (amod)
placebos matched (amod)
prominent contrast (nmod)
disorder delirium (appos)
> or=26 (cc)
occurred chicks (nmod)
pain arthralgia (conj)
addition mannitol (nmod)
cld for (case)
effect performance (nmod)
eyes right (amod)
gls % (dep)
event with (case)
7 - (punct)
hepatitis halothane (compound)
males 36 (nummod)
painful application (nmod)
caudate left (amod)
ana elevated (amod)
thickness sheath (compound)
chloride chloride (conj)
bpd of (case)
regions all (det)
neutrophils by (case)
syndrome experimental (amod)
53 group (nmod)
induces tacrolimus (nsubj)
tumors 27 (nsubj)
exist effects (nsubj)
catarrhalis ( (punct)
96 +/- (cc)
microliters 40 (nummod)
experienced seven (nsubj)
supports extends (conj)
survivors not (cc)
involvement gaba (compound)
haematological or (cc)
behaviours alternation (compound)
present and (advmod)
form mexiletine (nmod)
diazepam opioids (conj)
potential examinations (nmod)
fall to (mark)
dose first (amod)
abnormality km (dep)
function brain (compound)
mg then (advmod)
returned weeks (nmod)
thyrotoxicosis pregnancy (nmod)
investigate potential (dobj)
outcomes long-term (amod)
ganglia circuits (nmod)
mg/m2 30 (nummod)
but weakly (advmod)
36.7 - (punct)
images follow-up (amod)
cancer leukemia (conj)
amca ) (punct)
inhibited were (auxpass)
university l'aquila (compound)
use tamoxifen (nmod)
prevented induction (dobj)
diagnosis reactions (nmod)
data concerning (acl)
mg/kg (+)-cibenzoline (nmod)
detection management (conj)
taken concomitantly (advmod)
half dogs (nmod)
therapy verapamil (compound)
-chlorpheniramine mg/kg (appos)
propagation transmural (amod)
abnormality valvular (amod)
half one (nummod)
database in (case)
activity receptor (compound)
stabilizers with (case)
result with (case)
clonus of (case)
volume hemorrhage (compound)
degrees 25 (nummod)
bilayers lipid (compound)
benefit did (aux)
option that (mark)
observed vesicles (nsubjpass)
assessed operation (nmod)
activate receptors (dobj)
withdrawal inhibitors (compound)
remained predictor (attr)
considered pain (nsubjpass)
therapy anthracycline (compound)
lip = (dep)
inhibitor irreversible (amod)
40.0 +/- (cc)
disrupts amiodarone (nsubj)
suggest rate (dobj)
determines phenotype (dobj)
obtained disparities (nmod)
carcinoma with (case)
episodes hypomanic (amod)
18 older (conj)
confirmed findings (nmod)
year event (nmod)
observed significant (conj)
p=0.345 ( (punct)
functioning elderly (nmod)
antagonized transection (nmod)
implicated possibly (advmod)
reversed oct (nsubj)
induced response (dobj)
micromol/l from (case)
trial during (case)
abnormalities intraventricular (amod)
pathogenesis as (case)
$ROOT$ contraceptives (sent)
induced pentylenetetrazole (nmod)
report documenting (acl)
become who (nsubj)
abolished when (advmod)
toxicity thalidomide (nmod)
cohorts ich (nmod)
group pilo (compound)
affect naloxone (nsubj)
an-2-ol i.e. (advmod)
osteoarthritis arthritis (conj)
explanation environmental (amod)
thrombo-embolism event (conj)
nsc ) (punct)
seem would (aux)
neurotoxicity rats (nmod)
lowers thus (advmod)
result can (aux)
abbott-53693 of (case)
mumol/kg 10 (nummod)
days 45 (nummod)
criteria defined (amod)
mg/dl 50 (nummod)
tid ( (punct)
technique rapid (amod)
appears tachycardia (nsubj)
exposures chemical (amod)
fever syndrome (conj)
intolerance inhibitor (compound)
plays mechanisms (nmod)
involved could (aux)
matched creatinine (nmod)
band with (case)
hemorrhage to (case)
media of (case)
injections isoproterenol (nmod)
16 mean (appos)
scale severity (nmod)
present % (nmod)
ft4 ) (punct)
139 4 (compound)
methods degeneration (compound)
process kindling (compound)
delayed ascribed (advcl)
frequently those (nmod)
account vpa (nmod)
arrhythmias with (case)
fluid in (case)
cohort unselected (amod)
damage cortex (nmod)
oat1 oat3 (conj)
% 77 (nummod)
treating sinusitis (nmod)
hypercalcaemia acute (amod)
collection analysis (conj)
comparative prospective (dep)
published published (conj)
pg-9 mg/kg (appos)
3h-tbob bicyclo-orthobenzoate (appos)
medium culture (compound)
mg/m2 between (case)
protein gfap (appos)
reviewed results (dobj)
defined : (punct)
detection deposits (nmod)
formulation standard (amod)
ach of (case)
stereotypies on (case)
cisplatin cddp (appos)
profile cardiac (amod)
times 30 (nummod)
cases bradyarrhythmia (nmod)
females and (cc)
regurgitation infant (nmod)
hours stopped (advcl)
accuracy fear (compound)
treatment from (case)
mg/m2 250 (nummod)
entity distinct (amod)
effect about (case)
halothane to (case)
hematomas microl (appos)
encephalopathy are (dep)
develop polymyositis/dermatomyositis (nsubj)
pheochromocytoma . (punct)
use ) (punct)
patients organ (compound)
safety dse (nmod)
chi(2)(3 ) (punct)
falls 100,000/mm3 (nmod)
signaling + (compound)
climbing catalepsy (conj)
increased limit (nmod)
effects symptomatic (amod)
depressed relative (advmod)
subject within (case)
8.7 and (cc)
ccr2 and (cc)
manic or (cc)
agent chemotherapeutic (amod)
factors , (punct)
8 monkeys (nmod)
tolerated drug (nsubjpass)
plays sleep (nsubj)
study involvement (dobj)
given naa (nsubjpass)
pointes fluconazole-associated (amod)
shifts rapid (amod)
oxcarbazepine carbamazepine (compound)
micrograms/kg/min ) (punct)
thickness fiber (compound)
variables other (amod)
index doxorubicin (nmod)
regurgitation tricuspid (amod)
t p120 (compound)
receiving botox (dobj)
dose only (advmod)
compared counterparts (nmod)
disorder or=13.807 (dep)
inconclusive results (nsubj)
cholestatic and (cc)
citrate clomiphene (compound)
min to (case)
n=35 ) (punct)
loss unilateral (amod)
deficits brain (nmod)
salivation diaphoresis (conj)
pacing anxiety (conj)
tmp-smz ) (punct)
hemodiafiltration by (case)
therapy cancer (compound)
volume urine (compound)
ml/min months (nmod)
sulphonate the (det)
dba/2 c57bl/6 (conj)
resulting palsy (nmod)
phenomena underlying (amod)
population special (amod)
vessels to (case)
had episodes (dobj)
occlusions blindness (nmod)
caused deformations (dobj)
4.1 0.8 (conj)
ldl ( (punct)
difficulties , (punct)
selected apomorphine (nsubjpass)
mechanism cardiotoxicity (nmod)
surgery day (compound)
resumption after (case)
secondary patient (nmod)
8.75 ci (nsubj)
average moving (advcl)
total % (nmod)
o2- ) (punct)
confirmed genetically (advmod)
considered risk (nmod)
testing imaging (nmod)
switching combination (nmod)
improvement sustained (amod)
effects modifications (nmod)
effects frequent (amod)
concern nephropathy (nsubj)
degree lesser (amod)
improvements significant (amod)
mg val/hctz (compound)
increases map (nmod)
identified model (nmod)
inhibitors angiotensin-converting (amod)
slowed . (punct)
mg/day 1200 (nummod)
weeks commencement (nmod)
10 3 (compound)
epicondyle lateral (amod)
$ROOT$ imaging (sent)
ecg nor (cc)
arthritis with (case)
toxicity tubular (amod)
different atenolol (nmod)
margins limited (amod)
showed c (nmod)
using kit (dobj)
s 1.12 (nummod)
inhibitors no (compound)
coma acidotic (amod)
effects observed (amod)
induced spasm (nsubjpass)
levels arsenic (nmod)
receiving ; (punct)
mg bupivacaine (nmod)
engorgement of (case)
bruising the (det)
onset study (compound)
supported always (advmod)
demonstrated show (advcl)
increase activities (nmod)
oct or (cc)
preclude not (neg)
pulse , (punct)
progression toxicity (conj)
disorder for (case)
aspiration and (cc)
undergone . (punct)
analysis wavelength (compound)
end this (det)
injection adsd (nmod)
receptor-alpha proliferator-activated (amod)
cck-8 ) (punct)
cause myopathy (dobj)
risk convulsions (nmod)
study 2002 (nmod:tmod)
become hemorrhagic (acomp)
patients enrolled (acl)
number sd (compound)
proposed activation (nsubjpass)
effectiveness glucose (compound)
behaviours distinct (amod)
0.6 relative (advmod)
kinetics excretion (nmod)
neuropathy a (det)
non-cacl(2)-treated and (cc)
gained pooling (advcl)
competing by (mark)
= 1.39 (dobj)
method ellman (nmod)
symptom the (det)
g/dl 5 (nummod)
approach better (amod)
induced fluoxetine (nmod:npmod)
diagnosis methamphetamine (nmod)
tended content (nsubj)
= 209 (dobj)
component interview (nmod)
established definitely (advmod)
water of (case)
sensitive seizure (nmod:npmod)
risk chemotherapy (nmod)
exacerbations asthma (nmod)
reduced compared (advcl)
increase association (nmod)
mechanisms enhances (acl:relcl)
appear interact (xcomp)
has disadvantages (dobj)
treatment hds (nmod)
subscore . (punct)
$ROOT$ superior (sent)
forestomach bha (compound)
interrupt examinations (dobj)
injected assessed (conj)
induced doxorubicin (nsubj)
detachment exudative (amod)
express ) (punct)
intoxication cocaine-benzodiazepine (compound)
background described (dep)
effects medication (nmod)
off on (conj)
seem does (aux)
contribute agents (nsubj)
shown factor (xcomp)
choose to (mark)
treated cyclophosphamide (nmod)
resolved and (cc)
$ROOT$ fq (sent)
established profile (nsubjpass)
v2.0 monitor (compound)
acetonide fa (appos)
treatments gellan (compound)
demonstrates . (punct)
ether hexafluorodiethyl (compound)
higher diclofenac (advcl)
degeneration media (compound)
used half (nsubj)
continued days (nmod)
toxicity ) (punct)
affected been (auxpass)
patients 167 (nummod)
toxicity dfu (compound)
frequency spike (compound)
systolic profound (amod)
reaction block (nmod)
girl presented (acl:relcl)
seem clues (nsubj)
i and (cc)
elevation phosphokinase (nmod)
ovarian notably (advmod)
cells/mm3 . (punct)
reticulata nigra (compound)
participants study (compound)
gavaged gspe (dobj)
episodes two (nummod)
nfs for (case)
ethambutol with (case)
secretion tear (compound)
sensation generalised (amod)
resulted worsening (nmod)
function and (cc)
did levels (nsubj)
during , (punct)
hpa ) (punct)
weighed be (auxpass)
administered anticholinesterases (nsubjpass)
improved when (advmod)
decrease threshold (nmod)
channel vivo (dep)
model mixed (amod)
alcohol drugs (conj)
evident cortex (nmod)
seizure transplantation (nmod)
triglycerides and (cc)
segment in (case)
culture positive (amod)
negative and (cc)
efficacy and (cc)
treated chlorpromazine (nmod)
concentration lipoprotein (compound)
window ' (punct)
ages ( (punct)
symptoms eps (appos)
decrease outflow (nmod)
duration diabetes (nmod)
reduces frequency (dobj)
utilized provide (advcl)
veins major (amod)
glaucoma in (case)
elevation inversions (conj)
age +/- (cc)
stimuli but (cc)
capsules of (case)
prolonged blockers (nsubj)
clearance cr(edta (nmod)
effect irreversible (amod)
using this (conj)
known and (cc)
were diameters (nmod)
mm were (cop)
everolimus patients (nmod)
cssep of (case)
doses corresponding (amod)
utility changes (nsubj)
receive receive (conj)
cessation inhibitor (nmod)
kg-1 ( (punct)
bradyarrhythmia severe (amod)
hospitals tertiary (amod)
deviation segment (compound)
exception vsd (nmod)
electrophoresis samples (nmod)
effects behaviors (nmod)
share does (aux)
proven relationship (nsubjpass)
1 +/- (cc)
length-of-stay and (cc)
recovered later (advmod)
neurons glutaminergic (amod)
amiodarone . (punct)
glycol propylene (compound)
agent sole (amod)
aggravated changes (conj)
prescribed induction (nmod)
s of (case)
identify subset (dobj)
cpdd ( (punct)
decrease < (appos)
changes neuroinflammatory (amod)
receptor achr (appos)
treatment levodopa (compound)
made however (advmod)
tnfalpha mda (conj)
beginning after (case)
stain and (cc)
patients placebo (amod)
humidity relative (amod)
toxicities neurologic (amod)
needed institute (xcomp)
induced sphincter (nsubjpass)
abundant antigens (nsubj)
shown validate (advcl)
had day (nmod)
tgf- serums (compound)
symptoms quality (conj)
alterations histological (amod)
served patients (nsubj)
processing normal (nmod)
danger unrecognised (amod)
usage amiodarone (nmod)
concentrations tamca (nmod)
herbs chinese (amod)
promotes that (mark)
dopamine of (case)
underwent january (nmod)
examined and (advmod)
failure therapy (nmod)
determining i (dep)
repolarization of (case)
alleviated dyskinesia (nsubjpass)
loss ) (punct)
nodularity in (case)
children leukemia (nmod)
assessed while (mark)
appears consistent (advcl)
disease drug-induced (amod)
tpa ) (punct)
hoe 140 (nummod)
done microscopy (nsubjpass)
negative workup (nsubj)
cells hair (compound)
duration injection (nmod)
population ) (punct)
transplantation cells (nmod)
shell accumbens (compound)
transplantation cell (compound)
august 2002 (nummod)
given visit (nmod)
agent flestolol (nsubj)
mg/day 800 (nummod)
tachycardia a (det)
-0.22 to (dep)
recovered sequelae (nmod)
expression vegf (nmod)
rats unfamiliar (acl:relcl)
processes epithelial (amod)
crosses . (punct)
pregnancy symptoms (conj)
records from (case)
dogs fewer (amod)
four ( (punct)
considered consumption (nsubjpass)
nitrate alcohol (conj)
1.4 3.6 (conj)
cephalosporins cefotetan (appos)
prohibited be (auxpass)
caa by (case)
movement and (cc)
mg/m2 324 (nummod)
mmt 84 (nummod)
presented pain (nmod)
methoctramine than (case)
potentiation catalepsy (compound)
inhibitor calcineurin (compound)
positive trends (nsubj)
seizures = (dep)
poor reportedly (advmod)
failure on (case)
alive 1 (nsubj)
2.4 0.3 (conj)
caused alprazolam (nsubj)
treatment fluoxetine (nmod)
cephalothin to (case)
conclusive not (neg)
octapeptides to (case)
gsk3alpha in (case)
activation liver (nmod)
concentrations resulting (acl)
sah ) (punct)
arose arm (nmod)
quality and (cc)
combined agents (nmod)
decrease 2 (nummod)
investigator blinded (acl)
jerks rigidity (conj)
restricted moreover (advmod)
disinhibition aggression (conj)
avoided that (nsubjpass)
magnesium , (punct)
occurred collapse (nsubj)
many neurons (nmod)
mammary endometrial (conj)
incorporation membranes (nmod)
agent class (compound)
paradigm test (conj)
$ROOT$ contribute (sent)
ml 6 (compound)
collagen epinephrine (conj)
upregulated that (mark)
oct ( (punct)
decreased ccb (dobj)
4.4 10.9 (prep)
loss hilus (nmod)
than women (nmod)
requires , (punct)
index narrow (amod)
dose ml. (nmod)
diclofenac by (case)
choreoathetosis profound (amod)
expression fas (compound)
dystonia with (case)
tolerance effect (conj)
effects microinjection (nmod)
sedation dexmedetomidine (compound)
drug with (case)
offered although (mark)
done observation (nmod)
ng./ml but (cc)
leading tdp (nmod)
120 to (quantmod)
percentage % (appos)
progression % (appos)
rebounded , (punct)
dysrhythmias , (punct)
anemias of (case)
increase independence (nmod)
prevalence hypotension (nmod)
32 out (advmod)
38.6 6.1 (conj)
side-effects local (amod)
disarrangement increased (amod)
women hysterectomised (amod)
contraception prolonged (amod)
intolerance = (dep)
be . (punct)
children area (nmod)
protected yet (advmod)
response ) (punct)
increased propranolol (nmod)
2-fold 4.6 (dep)
monitored injury (nsubjpass)
ancas ) (punct)
described ago (advmod)
weeks premature (amod)
antidepressant-induced tricyclic (amod)
or angiographically (advmod)
dose reduced (acl:relcl)
models different (amod)
impaired administration (nmod)
hdl-c of (case)
caused adriamycin (nmod)
development sexual (amod)
case injury (nmod)
had those (advcl)
chick intact (amod)
8th 16th (conj)
adduct ) (punct)
activation increased (amod)
increased doses (nmod)
hours 1400 (nummod)
cases as (case)
protein factor (nmod)
volunteers from (case)
5.1 ) (punct)
score dyskinesia (compound)
obstruction upper-airway (amod)
had pointes (dobj)
bacteremias fewest (amod)
grade cardiomyopathy (nmod)
contrasted sharply (advmod)
infarction segmental (amod)
% - (dep)
treated tamoxifen (nmod)
decrease granulocyte (compound)
question this (det)
hypothyroid , (punct)
required clearly (advmod)
depleted received (parataxis)
affect itself (nmod)
$ROOT$ suspected (sent)
use cisplatin (compound)
rate % (compound)
experience settings (nmod)
sampling kinase (nmod)
carcinogen by (case)
1983 1984 (conj)
heparin with (case)
proliferation lymphocyte (compound)
deprived protein (nmod:npmod)
5,7-dihydroxytryptamine 5,7-dht (appos)
study tolerance (compound)
hypertrophy glomerulosclerosis (conj)
extent minor (amod)
chelation calcium (compound)
infusion short-term (amod)
studies oral (amod)
achieved responses (dobj)
75 to (dep)
tumor cell (compound)
is response (attr)
therapy dopaminergic (amod)
recurring was (aux)
thrombosis sagittal (amod)
accounted impairment (nsubj)
access ) (punct)
neurons ) (punct)
enhancement antihyperalgesia (nmod)
contraceptives , (punct)
ne ( (punct)
showed test (nmod)
negative urinalysis (nsubj)
beta-agonist the (det)
potassium terbutaline (conj)
had present (advcl)
hexamethonium carbachol (conj)
sgk1(+/+ ( (punct)
microm of (case)
presenting asterixis (nmod)
experiment similar (amod)
9-months hyperprolactinemia (nmod)
$ROOT$ arose (sent)
cystitis of (case)
expression formation (nmod)
mb of (case)
spread application (nmod)
ldlr ) (punct)
estimate grams (nmod)
procedure a (det)
reaction introduction (compound)
occurred received (advcl)
suggest association (dobj)
results achieved (appos)
relationship hyperalgesia/myoclonus (nmod)
microscopy evaluated (acl:relcl)
highlights also (advmod)
paucity data (nmod)
occurs there (expl)
cancer disease (appos)
response vomiting (dep)
drg the (det)
concentration , (punct)
shown : (punct)
treated implants (nmod)
consisted point (nsubj)
involvement model (nmod)
range from (case)
implicated development (nmod)
riha ( (punct)
given ouabain (dobj)
delay a (det)
pathways in (case)
dce of (case)
neurons motor (amod)
tended remained (conj)
exposed and (cc)
proliferation cells (nmod)
proliferation cell (compound)
canal schlemm (nmod)
known effective (xcomp)
remained controlling (advcl)
6 3 (compound)
effect secretion (nmod)
affected workers (nsubjpass)
established , (punct)
0.96 +/- (cc)
complicated nms (nsubjpass)
admitted receive (conj)
describe authors (nsubj)
follows as (advmod)
decreased 5.4 (nmod)
approval with (case)
vary and (cc)
selective protection (nsubj)
assessing through (mark)
interaction fzp (nmod)
severe to (mark)
connected setup (nmod)
weight body (compound)
decreased preinfusion (dep)
mean deviation (conj)
associations possible (amod)
carbachol by (case)
pathway alternative (amod)
morning presentation (nmod)
involves mechanisms (dobj)
attenuated rigidity (dobj)
used atp (nsubjpass)
mg/kg 1.0 (nummod)
effect temperature (nmod)
predicted : (punct)
patients group (nmod)
23 2 (conj)
prolonged apd (dobj)
n= ( (punct)
score urine (compound)
ratio zone (compound)
injection the (det)
presence bruising (nmod)
associated neuroprotection (nsubjpass)
spread the (det)
neurons hilus (nmod)
sgk1 and (cc)
blocker nitrendipine (dep)
changed enhanced (conj)
indicated are (auxpass)
min(-1 ( (punct)
marker apoptotic (amod)
weeks several (amod)
received also (advmod)
extracted samples (nmod)
widening progressive (amod)
percentage cells (nmod)
increase gaba (nmod)
micrograms 4,000 (nummod)
= 0.613 (dobj)
different lower (conj)
prolongation a (det)
currents of (case)
had thus (advmod)
incidence discontinuations (nmod)
mediators inflammatory (amod)
self-treating had (aux)
bw mg/kg (nummod)
2.7 1.9 (conj)
modified protocols (nsubj)
discontinue procedure (dobj)
aneurysm coronary (amod)
results obtained (acl)
changes ultrastructural (amod)
shown oxide (nsubjpass)
metals other (amod)
1.98 : (punct)
users 20 (nummod)
cvp , (punct)
pathways signaling (compound)
found prevalence (nmod)
regimens acute (amod)
contraindication a (det)
mg/kg intravenously (advmod)
adenomas of (case)
u/ml 12.8 (nummod)
g/dl 12 (dep)
year of (case)
associated been (auxpass)
background produces (dep)
prevent hypertension (dobj)
0.3 2.7 (prep)
part a (det)
cardiomyocytes of (case)
$ROOT$ seeded (sent)
recognition findings (nmod)
4.4 - (advmod)
potentiation in (case)
hypotension dogs (nmod)
dysarthria sign (conj)
cigarettes n=36 (appos)
effects level (nmod)
decrease dp/dt(max (nmod)
evaluation post-therapy (amod)
pressure f. (appos)
expression effects (conj)
extent to (case)
convulsions convulsions (conj)
phasic both (cc:preconj)
remains standard (attr)
d-amphetamine or (cc)
load hbv (compound)
equipment input (compound)
vestibulotoxicity pig (nmod)
provoked administration (nsubj)
dioxide co2 (appos)
reduction cells (nmod)
association significant (amod)
placebo cells (appos)
contributed < (parataxis)
abnormalities neurological (amod)
generation such (case)
potentiated attenuated (conj)
evaluated examination (nmod)
compare effectiveness (dobj)
sodium potassium (conj)
available has (aux)
slowing rhythms (nmod)
day 17 (nummod)
developed hematoma (dobj)
upregulation gabab (compound)
dominance neural (amod)
elevated phosphatase (nsubj)
exhibited had (conj)
review database (nmod)
arabic gm (conj)
drug details (conj)
45 126 (prep)
rare incidence (nsubj)
pathway fas-dependent (amod)
treatment terms (nmod)
calculation ) (punct)
treatment diuretic (compound)
% groups (nmod)
show essential (ccomp)
increases whereas (mark)
receptor-alpha of (case)
minutes forty-five (nummod)
moving were (aux)
hypothyroidism a (det)
group remained (acl:relcl)
chills with (case)
subjects as (case)
determined as (cc)
application conjunctiva (nmod)
denervation severe (amod)
src with (case)
safety acetate (nmod)
therapy despite (case)
presence history (conj)
leukocytes of (case)
beta-blocker metoprolol (dep)
improvement 6/24 (nmod)
sensation reported (amod)
plasma weeks (nmod)
prescribed diltiazem (nsubjpass)
patients bleeding (nmod)
using transducer (dobj)
ng/ml 0.0073 (nummod)
ci=1.2 1.6 (prep)
gynecologic testicular (conj)
changes ngf (nmod)
output p (appos)
hypothesis unmask (acl)
strain not (neg)
framework membrane (nmod)
leukopenia granulocytopenia (conj)
di drug-induced (amod)
patients 137 (nummod)
increasing may (aux)
background genetic (amod)
superiority bromperidol (nmod)
capsule under (case)
circumference knee (nmod)
truncated words (nmod)
was test (xcomp)
included n=92 (dep)
$ROOT$ selective (sent)
results received (appos)
admitted use (nmod)
transferase of (case)
treatment initiated (acl)
yrs ) (punct)
1.93 to (dep)
followed up (advmod)
city in (case)
american north (amod)
acting physostigmine (nmod)
damage protection (conj)
user an (det)
subjects treated (acl:relcl)
prominent extended (conj)
abusers cocaine (compound)
region the (det)
setting inpatient (amod)
subunit alpha-2 (compound)
or autopsy (nmod)
pcr-rflp ) (punct)
had images (dobj)
prevention the (det)
pmol to (case)
use despite (case)
treadmill a (det)
lower rats (nmod)
found development (nmod)
using labetalol (dobj)
thrombosis sinus (compound)
map to (mark)
tacrolimus or (cc)
teratogenic that (mark)
remissions 9 (nummod)
tamponade of (case)
raised activity (dobj)
occurred that (mark)
repair for (case)
therapy lead (conj)
suggest anaemia (nsubj)
factors prognostic (amod)
able model (nmod)
combination valproate (nmod)
ill affectively (advmod)
2002 and (cc)
change faster (amod)
shortened length (nmod)
done unfortunately (advmod)
disease higher (acl:relcl)
case reported (amod)
changes induces (acl:relcl)
survivors from (case)
61 2 (conj)
expression diet (nmod)
induced benzodiazepines (nmod)
sd % (conj)
death cardiac (amod)
cardiotoxicity dose-related (amod)
[cmax]/mic ( (punct)
patients percent (appos)
modulating increase (conj)
necessary using (advcl)
decreased p-coumarate (nsubj)
follow-up in (case)
evaluation neurologic (amod)
leading upregulation (nmod)
flestolol agent (appos)
plasma urine (conj)
reactions symptoms (nmod)
women climacteric (amod)
complemented . (punct)
therapy electroconvulsive (amod)
dogs ligation (compound)
7alpha-hydroxylase cyp7a (appos)
women , (punct)
oxygenation pbto(2 (appos)
reduced h. (nmod)
peroxidase of (case)
patients mi (conj)
expression ligand (compound)
discontinuation therapy (conj)
rise to (mark)
safety agents (nmod)
replaced sirolimus (nmod)
reported aes (nmod)
patterns in (case)
required abolish (advcl)
clarify nature (dobj)
layer cortex (nmod)
epilepsies with (case)
disappearance a (det)
measured been (auxpass)
evaluated disability (nmod)
functions rodents (nmod)
resembling that (xcomp)
enflurane e (appos)
exposure isoflurane (nmod)
seven patients (nmod)
vesicles abnormal (amod)
terminated vt (nsubjpass)
added , (punct)
carbamazepine the (det)
chloramphenicol ophthalmic (amod)
reduced antagonized (conj)
leukaemia with (case)
protein total (amod)
mg/m2/d from (case)
c t (conj)
confirmed determination (nmod)
differences variable (nmod)
echocardiogram on (case)
identify level (nmod)
copolymers hpma (compound)
antidepressant serotonergic (amod)
degree the (det)
case development (nmod)
exclusion mi (nmod)
performed later (advmod)
meet patients (nsubj)
had acidosis (dobj)
deficiency irradiation (conj)
10.7 +/- (cc)
hdl-c a-ii (conj)
rna and (cc)
degree examination (nmod)
patients to (case)
( ) (punct)
appeared or (cc)
bp mean (amod)
increased later (advmod)
scores psychopathology (compound)
g/ml concentrations (nsubj)
rejection such (case)
0.014-unit by (case)
disorders eating (compound)
determining etiology (dobj)
left uv (appos)
aspects thrombocytopenia (nmod)
10 40 (conj)
was it (nsubj)
enos tissue (compound)
liable signs (nmod)
$ROOT$ done (sent)
amifostine ( (punct)
effect extract (nmod)
associated arthritis (nmod)
profiles sertraline (nmod)
response drugs (nmod)
second((1/2 to (case)
hepatitis . (punct)
$ROOT$ hypotension (sent)
used identify (xcomp)
influenced cddp (nmod)
ko ( (punct)
mechanism the (det)
etoposide vp (appos)
% 3.4 (nummod)
rhabdomyosarcoma metastatic (amod)
rodents of (case)
differ results (nsubj)
reversible were (cop)
causing neuropathy (dobj)
hallucinations symptom (nmod)
counteraction co-administration (nmod)
catalepsy : (punct)
81.6 +/- (cc)
had and (cc)
$ROOT$ etomidate (sent)
levels hepatic (amod)
experiment . (punct)
periods 3-min (amod)
sc mg/kg (nummod)
cholesterols a-i (conj)
recognize . (punct)
higher disease (nmod)
decreasing synthesis (dobj)
auc [ (punct)
decrease pain (nmod)
cells mammalian (amod)
seizure brief (amod)
induce . (punct)
associated coefficient (dep)
voltage- , (punct)
caused 4 (dep)
april from (case)
therapy 2-drug (amod)
therapy vinorelbine (nmod)
indicates damage (dobj)
has pregnancy (nsubj)
created removal (nmod)
exacerbation jerks (nmod)
$ROOT$ elicited (sent)
toxicity undesirable (amod)
underwent night (dobj)
distress functioning (conj)
pinacidil micrograms/kg (appos)
processes underlying (acl)
agent an (det)
included 20 (nsubjpass)
variable no (det)
suggested view (nmod)
determination repeat (compound)
bind ligand (dobj)
responses induced (acl)
$ROOT$ confirmed (sent)
sinensis hibiscus (compound)
most all (nmod)
age arrest (conj)
twice day (nmod:npmod)
hemiparesis left (amod)
age older (conj)
appeared have (xcomp)
less losses (nsubj)
excellent patients (nmod)
research transport (compound)
underwent labour (nmod)
assessed task (nsubjpass)
effect metoprolol (nmod)
ulcerogenicity reduced (amod)
mv ( (punct)
cells ccr2-labeled (amod)
retention fluid (compound)
loss frequencies (nmod)
discontinuing therapy (dobj)
access drugs (nmod)
attempt apparent (amod)
damage appeared (acl:relcl)
toxicity despite (case)
inhibited combination (nsubj)
correlated correlate (parataxis)
age stroke (conj)
41 81 (prep)
val and (cc)
impairment hepatic (amod)
angina variant (amod)
epilepsy experimental (amod)
l/kg l/kg (conj)
showed elevated (ccomp)
demonstrated has (aux)
removed see (xcomp)
doses cases (nmod)
selegiline mg (amod)
disruption with (case)
undergoes and (cc)
os weeks (nmod)
encephalopathy grade (compound)
determined expressions (nsubjpass)
more is (cop)
identical were (cop)
p<0.001 respectively (advmod)
modulate whether (mark)
entity as (case)
long too (advmod)
constituent transport (nmod)
less reduction (nmod)
facilitate reduction (dobj)
suggests emphasizes (conj)
lymphoma for (case)
consider starting (advcl)
prescribed treat (advcl)
administered adjunct (nmod)
use proper (amod)
blockers concurrent (amod)
hypotension origin (nmod)
end recruitment (dobj)
quantitated were (auxpass)
involves whether (mark)
il-1b , (punct)
model included (acl:relcl)
weights lung (compound)
potential produce (advcl)
explain findings (dobj)
$ROOT$ neutropenia (sent)
cases 8 (nummod)
given placebo (dobj)
seizures treatment-induced (amod)
decrease % (appos)
profile preclinical (amod)
method design (appos)
step initial (amod)
shortened 122+/-5 (nmod)
alpha-tocopherol of (case)
female a (det)
grade as (case)
coactivator required (acl:relcl)
potentials action (compound)
management and (cc)
shown that (nsubj)
result will (aux)
sedation successful (amod)
tolerated studies (nmod)
conversion for (case)
treated preoperatively (advmod)
heterogeneous is (cop)
depletes doxorubicin (nsubj)
cck-8-se than (case)
loss urinary (amod)
conclusions uncommon (dep)
length ( (punct)
intubation tracheal (amod)
factor radiotherapy (nsubj)
r- and (cc)
triphosphate atp (appos)
ethambutol isoniazid (conj)
physicians use (acl:relcl)
died died (conj)
gag/pol ; (punct)
remained controls (advcl)
than those (nmod)
antagonized or (cc)
patient 23-year-old (amod)
evoke activity (dobj)
choose again (advmod)
display degree (dobj)
sympathectomy endoscopic (amod)
patients excluding (case)
parameters model-dependent (amod)
decreased superoxide (dobj)
neurotransmission gabaergic (amod)
therapy intense (amod)
sulphasalazine of (case)
sh(6 ) (punct)
died ; (punct)
found levels (nsubjpass)
analysed subgroups (dobj)
week recovery (nmod)
physicians initiating (acl)
remained recovery (nmod)
case nephritis (nmod)
years 8.6 (nummod)
prescribed therapy (nsubjpass)
parameters experimental (amod)
hygiene oral (amod)
prompted speculate (parataxis)
body heinz (compound)
results induce (appos)
revealed experiments (nsubj)
relapsed or (cc)
mediated hyperammonemia (nmod)
pathophysiologic myocardial (amod)
associated analysis (nmod)
scanning both (cc:preconj)
occur groups (nmod)
% 39.9 (nummod)
gamma-hexachlorocyclohexane of (case)
open would (aux)
process may (aux)
patients non-lithium-treated (amod)
cd4 ) (punct)
tacrolimus ( (punct)
mmol/l 63 (nummod)
remission % (dep)
internus globus (compound)
diagnosing necrosis (dobj)
nerve uv (appos)
mmol/l 2.4 (nummod)
suggests method (ccomp)
administration licl (nmod)
curative % (nmod)
prevent complication (dobj)
l6 ) (punct)
opens which (nsubj)
increased synthesis (dobj)
tests passive (amod)
lowering while (mark)
using patients (nmod)
ecg the (det)
produced : (punct)
cardiotoxicity against (case)
preventing toxicity (dobj)
maximum minimum (conj)
attribute caused (conj)
problems these (det)
stabilized disease (nmod:npmod)
reported subject (nsubj)
receptor glutamate (compound)
tolerance administration (nmod)
associated chemotherapy (nsubjpass)
correlation < (dep)
dysfunction prednisolone (nmod)
consume patients (nsubj)
effectiveness derivatives (nmod)
women contraceptives (nmod)
walls cavity (nmod)
activity lethality (appos)
producing hypertrophy (dobj)
dynes.s.cm-5 135 (nummod)
responsible to (mark)
days 350 (nummod)
occurrence death (nmod)
admission prior (advmod)
associated moreover (advmod)
deleted and (cc)
beta-blockers topical (amod)
$ROOT$ vulnerability (sent)
covered snr (dobj)
hb of (case)
disruption structure (nmod)
occurred enhancement (nsubj)
iocarmate ( (punct)
concluded used (ccomp)
$ROOT$ acquainted (sent)
k glu (appos)
studies changes (nmod)
received dipping (dobj)
ketoprofen or (cc)
literature cases (nmod)
period prognostic (amod)
1.5 to (quantmod)
isolated extract (nmod)
myelosuppression fatigue (conj)
75 27 (compound)
antibody acetylcholine (compound)
had resulting (advcl)
product is (cop)
viia recombinant (amod)
limit > (amod)
26 t3n0m0 (appos)
s.c. mg/kg (nmod:npmod)
calculation incidence (compound)
l-isomer inactive (amod)
tolerable dogs (nmod)
alterations neurobehavioral (amod)
crosses have (conj)
types tumor (compound)
duration treatment (compound)
suffer in (prep)
mediates and (cc)
increased hr (dep)
detectable clinically (advmod)
caused defect (nmod)
degrees varying (amod)
monitoring pressure (nmod)
procedures in (case)
disease fatty (amod)
cycloheximide with (case)
pups fluoxetine-exposed (amod)
amelioration . (punct)
concentrations terbutaline (compound)
compliance safety (conj)
relieved percent (nsubjpass)
change little (amod)
score y-mrs (compound)
intervention coronary (amod)
biomarkers cardiac (amod)
research investigating (acl)
analogue 2',3'-dideoxy (amod)
completing remd (nmod)
identify loci (dobj)
present atherosclerosis (nsubj)
improvement/resolution symptoms (nmod)
averaged . (punct)
blocks mg/kg (nmod)
offer may (aux)
function balance (conj)
cancers and (cc)
treatment enalapril (compound)
appeared proteinuria (nsubj)
attribute doctors (nsubj)
are : (punct)
toxicities events (nsubj)
52 - (punct)
11.2 5.1 (conj)
cholinesterase , (punct)
interval qt (compound)
systolic and (cc)
diet nx (conj)
atra ) (punct)
elevations aminotransferase (compound)
delirium flecainide-induced (amod)
generation action (compound)
agents newer (amod)
hydrochloride mg/min (dep)
explanation without (case)
norms applicable (amod)
retinoblastoma intraocular (amod)
incidence fasciculations (nmod)
age months (appos)
chance % (compound)
mg/m2 of (case)
adherence sops (nmod)
increased increased (parataxis)
associated induction (nmod)
ameliorated supplementation (nsubj)
appeared developed (advcl)
women 925 (nummod)
value long-term (amod)
rejection chronic (amod)
12 2 (compound)
inhibition sub-chronic (amod)
engagement coeruleus (nmod)
translate regimens (nmod)
support and (cc)
segment precommunicating (amod)
481 32 (nummod)
exposure each (nmod)
presented test (parataxis)
alerted . (punct)
solution ml/h (appos)
indomethacin oral (amod)
stimulation brain (compound)
changes differential (amod)
occur loss (nmod)
prevented hypertension (dobj)
treatment haart (appos)
units 14.9 (nummod)
mice null (amod)
neurotoxicity the (det)
characteristic was (cop)
limitations prophylaxis (nmod)
cylinder and (cc)
accentuated , (punct)
c1 included (acl:relcl)
group ( (punct)
receptor alpha2-adrenergic (amod)
impairment from (case)
experienced patient (nsubj)
hg mm (compound)
course long-term (amod)
damage leading (acl)
cells ) (punct)
occurred anemia (nsubj)
vascular cardiac (conj)
dose cd25 (appos)
forestomach , (punct)
relating thromboembolism (dobj)
$ROOT$ notable (sent)
increase progressive (amod)
dose melatonin (nmod)
diabetes of (case)
p40 ( (punct)
type is (cop)
= 0.09 (dobj)
follow-up years (nmod:poss)
included sensorium (dobj)
lmwh ( (punct)
succinylcholine to (case)
zone gyrus (nmod)
patients 18 (nummod)
reflex of (case)
transport decreased (amod)
3.5 and/or (cc)
administration sublingually (advmod)
added vitro (advmod)
bn mg/kg (appos)
injury tubular (amod)
p450 , (punct)
providing form (dobj)
% animals (dep)
lower generally (advmod)
remission maintains (conj)
levels cyp7a (nmod)
ax to (case)
quetiapine placebo (conj)
range over (case)
microglia of (case)
male six (nummod)
describe briefly (advmod)
significant both (nmod)
resistance high (amod)
drugs anxiogenic (amod)
disease proteinuria (nmod)
bendrofluazide to (case)
greater = (parataxis)
injected monitored (conj)
blockade sulfate (nmod)
affinities high (amod)
reaction serious (amod)
producing without (mark)
tomography photon (compound)
125 165 (conj)
dialysate citrate (compound)
effect antiviral (amod)
myd88 ) (punct)
interference by (case)
saline tdi (acl:relcl)
preparations isolated (amod)
suffered entropion (nmod)
shifting and (cc)
factor use (nsubj)
as relevant (amod)
rcr in (case)
genes two (nummod)
signs disease (nmod)
described authors (nsubj)
doses methotrexate (nmod)
pain with (case)
testing initial (amod)
selective system (nmod)
sensitivity test (nmod)
pressure > (dep)
all values (nmod)
challenged days (nmod)
treatment gentamicin (compound)
early and (cc)
h2o cm (amod)
snr lesioned (amod)
hearts fraction (dep)
withdrawing replacing (conj)
children 32 (nummod)
disease atrophy (conj)
clear not (neg)
randomized carriers (nsubjpass)
pressure the (det)
cells hilus (nmod)
$ROOT$ deaths (sent)
studied action (nsubjpass)
brain mouse (compound)
permeability and (cc)
decreased h (nmod:tmod)
about are (aux)
had profiles (dobj)
volume between (case)
predictor only (amod)
coagulopathy extended (amod)
sd ] (punct)
regimens cisplatin-based (amod)
arrest respiratory (amod)
coagulation due (case)
used vigabatrin (nsubjpass)
mmse ) (punct)
increase decrease (nsubj)
known bind (xcomp)
trial . (punct)
= 15 (dep)
excreted . (punct)
dosage conventional (amod)
restored enhanced (conj)
group bcnu (compound)
cocs on (case)
find mutation (dobj)
done hydrolysis (nsubjpass)
overload + (compound)
mmhg group (nmod)
ischemia acute (amod)
use identify (xcomp)
tachycardia bromocriptine (nmod)
addition nicorandil (nmod)
revealed detected (parataxis)
resolved h (nmod)
98 to (advmod)
stimulation nociceptive (amod)
group pce (compound)
dsm-iv ( (punct)
0.7 - (punct)
influence modulating (advcl)
loss some (det)
drugs certain (amod)
blocked pregs (nsubj)
resulting diseases (nmod)
lp over (case)
mechanism(s other (amod)
reduction were (cop)
injection added (acl)
patients mg/dl (dep)
questioning on (case)
administration epinephrine (compound)
toxicity presumed (amod)
suggests disparity (nsubj)
infarction wall (nmod)
antigens b35-cw4 (dep)
effects months (conj)
system beginning (acl)
antigen-positive virus (compound)
ablation mice (nmod)
indicates fill (ccomp)
generally deviation (nsubj)
myelosis megakaryocytic (amod)
assessed maze (nmod)
lesions hyperplastic (amod)
studied shown (ccomp)
ribs wavy (amod)
release hepatocellular (amod)
ptosis movement (conj)
involve . (punct)
m.s. ) (punct)
change levels (nmod)
seizures increasing (amod)
wr-2721 amifostine (conj)
correlates interrelated (amod)
injection antibiotics (nmod)
disorder no (det)
administered placebo (conj)
$ROOT$ used (sent)
% concentration (nmod)
preceded which (nsubjpass)
woman taking (acl:relcl)
situations clinical (amod)
suspected occurs (advcl)
plasma kidney (conj)
lower but (cc)
substrates are (cop)
dopamine brain (compound)
inos ( (punct)
distinguish did (aux)
effect anticoagulation (compound)
fluoxetine day (nmod)
believed cause (nsubjpass)
admission a (det)
wall anterior (amod)
remains heparin (nsubj)
received addition (nmod)
morphine metamizol (conj)
cta ( (punct)
toxin pertussis (compound)
g/l 100 (nummod)
remains undefined (xcomp)
tacrolimus agents (conj)
patients 1.3/100,000 (nummod)
induced antagonist (nmod)
noticed was (auxpass)
consumed proportion (nsubj)
occurred alopecia (nsubj)
[d-pen2.5]-enkephalin and (cc)
option attractive (amod)
evaluable ; (punct)
had which (dep)
ng/ml < (dep)
excess hours (nmod)
treatments n-nitroso-n-methylurea (nmod)
inhibitors (cox)-2-specific (amod)
infarction during (case)
safe and (cc)
conclude likely (ccomp)
passing myocardium (nmod)
related toxicity (nmod)
provided safely (advmod)
eyelids upper (amod)
outcomes olanzapine (nmod)
interactions relevant (amod)
increased cellularity (dobj)
associated ingestion (nmod)
suggest increases (ccomp)
$ROOT$ modifications (sent)
men % (appos)
cells/microl to (case)
hyperalgesic reproducible (amod)
continue must (aux)
compares respect (nmod)
activity neither (cc:preconj)
factor-i insulin-like (amod)
described occurrence (nsubjpass)
discontinuance chemotherapy (nmod)
cells fetal (amod)
damaged were (auxpass)
those found (acl)
mg/kg infusions (conj)
peak fall (conj)
class compounds (nmod)
day per (case)
response some (det)
shift curves (dobj)
days 146 (nummod)
fluphenazine sch (conj)
incidence riha (nmod)
middle and (cc)
mg/day methylphenidate (nmod)
terms in (case)
lesions from (case)
change control (nmod)
concentrations tobramycin (compound)
recurrences human (amod)
service health (compound)
rats min (dep)
weakness profound (amod)
remained higher (xcomp)
showed included (ccomp)
effects coniine (nmod)
recurrence need (conj)
wish . (punct)
phenotype , (punct)
eradication presumed (amod)
contributing significantly (advmod)
drainage nutrition (nmod)
l-sotalol of (case)
vagotomy prior (amod)
initiating for (mark)
studies dose (nmod)
status good (amod)
electrophysiologic and (cc)
activity toxicity (conj)
leukopenia stomatitis (appos)
seizure a (det)
% 230 (nummod)
assessed determine (advcl)
age volunteers (conj)
visit study (compound)
with only (advmod)
inhibited was (auxpass)
subjects investigation (nmod)
state on (case)
interaction for (case)
children than (case)
induced compared (advcl)
residents infarction (nmod)
threshold and (cc)
associated using (advcl)
reversed suggesting (advcl)
speed women (nmod)
rated physician (nmod)
tests function (nmod)
fever for (case)
stenosis artery (nmod)
control % (compound)
usefulness treatment (nmod)
efavirenz efv (appos)
level level (conj)
desensitization receptor (compound)
$ROOT$ fasciitis (sent)
normal consisted (conj)
potentials delayed (amod)
inhibition phosphokinase (nmod)
evaluated analysis (nmod)
hormone stimulating (amod)
area at (case)
14.1 - (punct)
background reported (appos)
er in (case)
ceftriaxone oral (amod)
consequence withdrawal (nmod)
inputs neural (amod)
120.04 ) (punct)
background dependence (nmod)
toxicity synaptic (amod)
has respectively (advmod)
shown involved (ccomp)
incidence tumors (nmod)
atropine hexamethonium (conj)
insipidus diabetes (compound)
mg diazepam (nmod)
% failure (nmod)
factors syndrome (nmod)
scr ( (punct)
downregulated further (advmod)
literature amlodipine (nmod)
led ketamine (nsubj)
0.28 respectively (advmod)
determinant gc-ht (nmod)
short and (cc)
response amplitude (conj)
age strain (conj)
tumors remission (nmod)
resulting rhabdomyolysis (nmod)
mg/day to (case)
receptors cannabinoid (compound)
work-ups hematologic (amod)
constricting selectively (advmod)
proteinuria invoked (acl)
given monitored (conj)
count weight (conj)
adjustment factors (nmod)
myocarditis caused (acl)
sedimentation by (case)
habituated environment (nmod)
inhibitor action (nmod)
binding 3h-tbob (compound)
21 14 (conj)
function for (case)
mechanisms causes (acl:relcl)
synthesis levels (conj)
manifestation was (cop)
7th 28th (conj)
findings preliminary (amod)
bs ( (punct)
therapy ethambutol (compound)
leading ser198 (dobj)
along especially (advmod)
appeared effective (xcomp)
prevents acid (nsubj)
fed groups (nsubjpass)
happiness surprise (conj)
patients neuroblastoma (compound)
patients reduction (nmod)
allopregnanolone ganaxolone (conj)
cardiotoxic to (mark)
reduction therapy (nmod)
depressed levels (nsubj)
% 9.5 (nummod)
infiltrate consisted (acl:relcl)
stress leading (acl)
sensitive inositol (nmod:npmod)
reached iop (dobj)
observed histochemistry (nmod)
completed blind (conj)
method invasive (amod)
month third (amod)
lithium as (case)
ranitidine of (case)
part neurophysiology (nmod)
manifest individuals (nmod)
patients psychosis (compound)
tacrolimus fk506 (appos)
thromboembolism years (nmod)
individuals have (acl:relcl)
inherent and (cc)
found animals (nmod)
revealed phonation (nmod)
drug antihypertensive (amod)
followed use (dobj)
promoted af (dobj)
bell-shaped curves (nsubj)
investigated 1 (dep)
onset , (punct)
dealing infarction (nmod)
imaging magnetic (amod)
case received (appos)
atria heart (nmod)
rats salt-loaded (amod)
early pregnancies (nmod)
opse greater (amod)
junctions barrier (appos)
albuterol cna (appos)
syndrome polycystic (amod)
conclude that (advcl)
counts with (case)
occurred had (aux)
treatment cns-directed (amod)
reduction on (case)
fa ) (punct)
suffered strokes (nmod)
total , (punct)
formation tissue (compound)
progression because (case)
induced bupropion (nsubj)
experience requirements (conj)
sites cases (nmod)
arthritis involvement (conj)
acknowledged , (punct)
patients hl (nmod)
blocker alpha-adrenoceptor (compound)
aorta abdominal (amod)
prescribed : (punct)
propranolol b (conj)
complications and (cc)
substituted % (nsubjpass)
composed . (punct)
suitable consequently (advmod)
e1 hypotension (conj)
prominent zone (nmod)
hbv wild-type (amod)
treatments conventional (amod)
effects tissues (nmod)
lipid or (cc)
reversed did (conj)
found not (neg)
etomidate trial (appos)
group dm (appos)
caused insufficiency (dobj)
shown consistently (advmod)
diagnosis accurate (amod)
m1 of (case)
45.9 +/- (cc)
segment sphenoidal (amod)
toxicity unacceptable (amod)
states humans (nmod)
responsiveness function (conj)
infiltration sub-tenon (nmod:poss)
cells duct (compound)
$ROOT$ lowered (sent)
patient first (amod)
resulted change (nsubj)
noted improvements (nsubjpass)
model capsaicin (compound)
type dosage (conj)
vasospasm and (cc)
groups patients (nmod)
determine history (dobj)
fps ) (punct)
given models (nmod)
human mouse (conj)
was loosening (nsubj)
found externa (nmod)
use adriamycin (nmod)
study propensity-matched (amod)
nephropathy contrast (compound)
spv ) (punct)
procedures invasive (amod)
donor first-time (amod)
minutes 10th (amod)
vesicles containing (acl)
rpp ) (punct)
advantageous . (punct)
incidence frequency (conj)
remains buffers (advcl)
agonist imidazo[1,5-a]-pyrrolo-[2,1-c][1,4]benzodiazepine-1-carboxylate (appos)
replication virus (compound)
deaths . (punct)
concentration medulla (nmod)
periods developmental (amod)
$ROOT$ perfused (sent)
source : (punct)
screening of (case)
use ticlopidine (nmod)
ability on (case)
carcinomas with (case)
known edema (nmod)
tinnitus of (case)
controlling influences (nmod)
accounts circuitry (nsubj)
delay with (case)
cells mononuclear (amod)
genes the (det)
abstinence despite (case)
weak was (cop)
participants , (punct)
effects dronedarone (nmod)
examination an (det)
pathophysiology possible (amod)
0.05 less (advmod)
desire satisfaction (conj)
proven agent (xcomp)
successful treatment (nsubj)
micrograms subjects (appos)
sequelae severe (amod)
alzheimer 's (case)
described changes (nsubjpass)
susceptibility for (case)
rescues induces (conj)
aggravate improves (conj)
l-alpha-gfc either (cc:preconj)
pressures measures (conj)
> density (nsubj)
hazardous is (cop)
menorrhagia and (cc)
hospitals total (appos)
patients need (acl:relcl)
reduced modify (conj)
ms < (parataxis)
months an (det)
lead it (nsubj)
parameters secretion (appos)
hypertrophy rat (compound)
collagenase by (case)
water tap (compound)
damage cns (compound)
34.98 + (cc)
using receptor (dobj)
complex through (case)
effects their (nmod:poss)
suggest unaltered (ccomp)
treated recognized (advcl)
safety patients (nmod)
inhibits increases (dobj)
effect antihyperalgesic (amod)
practitioners general (amod)
3.86 8.75 (appos)
receiving rate (nmod)
damage to (mark)
etomidate after (case)
treated rats (nsubjpass)
sensitivity auc (appos)
death the (det)
reintroduction quetiapine (nmod)
1 25 (conj)
prolongation with (case)
levels noradrenaline (compound)
techniques complementary (amod)
response morphine (nmod)
produced treatments (nsubj)
$ROOT$ parameters (sent)
occurrence negativity (nmod)
erythematosus refractory (amod)
experiment created (acl)
experienced recovery (nmod)
hyperplasia the (det)
ovary the (det)
mice control (compound)
therapy fibrillation (nmod)
used purpose (nsubj)
9 10 (conj)
migraine the (det)
light and (cc)
result was (cop)
apposition with (case)
oscs ) (punct)
controls hypertensive (amod)
revealed were (auxpass)
163 55 (conj)
use galantamine (nmod)
assess characterise (conj)
transplant the (det)
binding membranes (nmod)
introduced been (auxpass)
years 13 (nummod)
incidence factors (conj)
partition tam (compound)
diagnosed treated (conj)
recovery partial (amod)
synthase-1 mpges-1 (appos)
magnitude activity (nmod)
nature immobility (nmod)
samples % (dep)
years 11 (nummod)
received alpha-tc (dobj)
likelihood the (det)
protection ly274614 (nmod)
are however (advmod)
% that (mark)
profile side-effect (amod)
potentiated [verapamil]o (nsubjpass)
skilled management (nmod)
responded administration (nmod)
aureus , (punct)
potent exhibiting (advcl)
therapy antiandrogenic (amod)
edema from (case)
parameters catalytic (amod)
neuropathies toxic (amod)
considered appeared (advcl)
behavior stereotyped (amod)
pyrazolones for (case)
those symptoms (nmod)
reduced peroxidation (dobj)
agent midazolam (nsubj)
cells endothelial (amod)
reported effects (nsubj)
injections steroid (compound)
margin lid (compound)
pentylenetetrazole mg/kg (dep)
age range (appos)
contraction arterial (amod)
failure conduction (nmod)
attributable mazindol (nmod)
induces mice (nmod)
current channels (conj)
confirm safety (dobj)
overlap ( (punct)
betaxolol ) (punct)
7e compound (compound)
associated rates (nmod)
ligands gaba(a (compound)
mb ( (punct)
monitoring cyclophosphamide (nmod)
moles/glomerulus 265.2 (nummod)
effect bruising (nmod)
nephrotoxic is (cop)
provide time (dobj)
infusion 3 (dep)
vfds for (case)
woman 35-year-old (amod)
dose end (nmod)
efficient conclusion (dep)
cocs ( (punct)
antagonist beta-adrenoceptor (compound)
reduction or (cc)
a tacrolimus (conj)
patients subjects (nsubj)
tested : (punct)
blockade mpep (nmod)
10-diol ena[c]phenathrene-9 (compound)
treatment loiasis (nmod)
lasted . (punct)
hcva ( (punct)
instillation grommet (nmod)
commencement proteinuria (conj)
drugs chelating (amod)
67.4 were (cop)
prohibited administration (nmod)
technique either (cc:preconj)
inhibitors converting (amod)
0.4-fold 1.3 (dep)
dose highest (amod)
available combinations (nmod)
showed patients (nmod)
hypotension patient (nmod)
analysis a (det)
changes cardiovascular (amod)
narrowing distal (amod)
cells serotonin (compound)
hypercholesterolemia women (nmod)
( p (dep)
regarded generally (advmod)
prednisone beclomethasone (conj)
twitch rats (nmod)
patients p=0.65 (dep)
group lidocaine (compound)
toxic heart (nmod)
dysfunction due (amod)
trial european (amod)
sign common (amod)
factors increasing (acl)
$ROOT$ available (sent)
observations : (punct)
mm was (cop)
antibody c219 (conj)
experienced years (nmod:npmod)
lt elective (amod)
potentials amplitude (compound)
been recently (advmod)
cisplatinum ; (punct)
750 or (cc)
minutes were (cop)
prevents partition (dobj)
choices y-maze (nmod)
bias studies (nmod)
anaesthetized halothane (nmod)
impairment produced (acl)
capacity and (cc)
possibility cause (ccomp)
accuracy in (case)
lipofuscinosis ceroid (compound)
effects depressants (nmod)
myeloma multiple (amod)
indicates available (advcl)
absence control (nmod)
dosing intrathecal (amod)
important clinically (advmod)
shell the (det)
decades 3 (nummod)
synthesis decreased (amod)
serious " (punct)
agonist each (dep)
actions with (case)
neurotransmission phasic (amod)
innervation of (case)
1500 300 (compound)
dementia diagnosed (amod)
protects hepatotoxicity (nmod)
complicated mechanisms (nsubj)
mechanisms effects (nmod)
man a (det)
headache severe (amod)
associated therapy (nsubjpass)
dysfunction hyperkalemia (conj)
trial azidothymidine (compound)
recommend we (nsubj)
patient with (case)
presence leakage (nmod)
rates reported (acl)
lometrexol antifolate (amod)
speaking aloud (advmod)
effect pre-treatment (nmod)
wk lt (nmod)
occurred dosing (nmod)
occurs diseases (nmod)
information this (det)
0.001 > (advmod)
variants escape (compound)
manage achieve (conj)
before initiation (conj)
thrombocytopenia . (punct)
drop out (prep)
atherosclerosis intima (compound)
flush facial (amod)
d after (case)
reattempted patients (nsubj)
administration rifampicin (nmod)
analysis power (compound)
socs-1 -3 (conj)
probed . (punct)
within close (conj)
examination investigations (conj)
estimated interval (nsubjpass)
agonist lowers (acl:relcl)
high mi (nmod)
elevated was (cop)
increased volume (nsubjpass)
mg/kg 28 (nummod)
initiated daptomycin (nsubjpass)
detected timolol (nsubjpass)
cardiomyopathy dose-limiting (amod)
dsm-iii-r. the (det)
known known (advcl)
suppressor signaling (nmod)
evaluated using (advcl)
needed none (nsubj)
% 64.3 (nummod)
time acceptable (amod)
expression achr. (nmod)
community in (case)
levels either (nmod)
injection dogs (nmod)
group locomotion (compound)
iv i (quantmod)
injection one (nummod)
activity cells (nmod)
trimethoprim-sulfamethoxazole , (punct)
impaired users (nsubj)
urticaria/angioedema angioedema (conj)
$ROOT$ occur (sent)
ability induce (acl)
who ) (punct)
stains trichrome (compound)
hours within (case)
examined effects (nsubjpass)
ethyl ) (punct)
mg/day 600 (nummod)
study link (acl:relcl)
dose 200mg/kg (nmod)
concentration tolerable (amod)
lesions purpuric (amod)
infusion after (case)
supplement , (punct)
used athletes (nmod)
plays model (nmod)
verapamil only (advmod)
lowered unchanged (parataxis)
examined , (punct)
different measures (nsubj)
hemisphere ischemic (amod)
hyperactivity amphetamine-induced (amod)
ocd ) (punct)
electroencephalogram of (case)
effective bacteria (nmod)
women three (nummod)
lupus probably (advmod)
circuitries prefronto-striatal (amod)
27-hydroxylase cyp27 (appos)
reach . (punct)
mg 8.9 (nummod)
cardiotoxicity mortality (conj)
register , (punct)
found case (dobj)
hydrochloride by (case)
toxicity hmm (compound)
patients determination (conj)
mutations of (case)
women developed (acl:relcl)
deficit manifested (acl)
show data (nsubj)
deterioration dyspnoea (appos)
assessment 2 (nummod)
treated epirubicin (nmod)
mechanisms . (punct)
amblyopia quinine (compound)
haart tg (compound)
screened should (aux)
measurement laboratory (compound)
aware reaction (nmod)
selected . (punct)
complex-mediated immune (amod)
found unresponsive (xcomp)
po2 ) (punct)
% 6.8 (compound)
processes cognitive (amod)
incidence hemorrhage (nmod)
doses 6 (nummod)
h injection (nmod)
methamphetamine , (punct)
transformation the (det)
pretreatment ketanserin (nmod)
abnormalities spect (compound)
nausea . (punct)
demonstrated cases (nsubj)
analysis time (compound)
carried was (auxpass)
adenomas colorectal (amod)
reading on (case)
receptor to (case)
patients example (nmod)
reduced increased (advcl)
effects involving (acl)
suggested been (auxpass)
received times (nmod:tmod)
have thrombosis (dobj)
affected : (punct)
growth des-induced (amod)
evidence efficacy (nmod)
dexamethasone rats (nmod)
involvement multiple (amod)
valsartan amlodipine (conj)
0.942 - (punct)
calcium of (case)
modifications without (case)
mug 500 (nummod)
effects liability (conj)
difference mmse (nmod)
micrograms 5 (nummod)
npy ) (punct)
enzyme angiotensin (compound)
mapped and (cc)
methods analysis (conj)
drug nonsteroidal (amod)
deaths three (nummod)
culture primary (amod)
side-effect sd (nsubj)
12/27 ( (punct)
up-regulation cells (nmod)
downregulates hypotension (dobj)
mrna cis (compound)
aspects physiologic (amod)
paranoia idiopathic (amod)
followed that (nmod)
mglur5 ) (punct)
-8.1 12.7 (conj)
induce apoptosis (dobj)
b and (cc)
dementia fractures (conj)
decreased pronounced (parataxis)
magnitude factors (conj)
carried assessments (nsubjpass)
conclusion conclude (acl)
lasting and (cc)
ml lignocaine (nmod)
disease . (punct)
hematomas large (amod)
given lead (dobj)
keratopathy , (punct)
blockade receptors (nmod)
added on (prep)
reported infarcts (nsubjpass)
$ROOT$ submitted (sent)
replacement saline (nmod)
regarded although (mark)
polyneuropathy severe (amod)
reduce drug (nsubj)
nephrotoxicity mice (nmod)
activity derivative (nmod)
call . (punct)
became marked (acomp)
functional compensates (conj)
mice sjl (compound)
dyskinesia child (nmod)
escalated , (punct)
withheld argatroban (nsubjpass)
blockade cardioselective (amod)
na/k-atpase oat (conj)
pyridoxine of (case)
manoeuvres both (det)
assessment randomized (amod)
trial hypothermia (nmod)
valves affected (amod)
history urinalysis (conj)
twitch head (compound)
untreated if (mark)
mg/kg/day inhibitor (appos)
activity convulsant (amod)
describes treated (advcl)
shown treatment (nmod)
treatment maleate (compound)
altering level (dobj)
exerts potential (nmod)
papilledema and (cc)
dizziness diarrhea (conj)
conducted comparison (nmod)
analogue acid (compound)
score motor (compound)
rare important (conj)
differed differences (nmod)
inhibitor-1 pai-1 (appos)
avoiding toxicity (dobj)
binding immunophilin (nmod)
data collected (amod)
morphine . (punct)
enrolled initially (advmod)
specimens in (case)
mechanistic randomised (conj)
um 265 (nummod)
multifactorial increase (conj)
months followed (conj)
show study (nsubj)
reduction ( (punct)
5 of (advmod)
nitrolingual microg/kg/min (appos)
models some (det)
reviews pharmacology (dobj)
catheter with (case)
design randomized (amod)
female % (nsubj)
dysfunction male (amod)
hypothyroidism to (case)
impairments cardiovascular (amod)
lnna no (compound)
deaths delirium (nmod)
nanosphere by (case)
followed hsct (nmod)
given respectively (advmod)
$ROOT$ established (sent)
pathology renal (amod)
months 3.1 (nummod)
medullo-adrenalectomy a (det)
regimen gvhd (nmod)
$ROOT$ shoed (sent)
induce however (advmod)
coadministration administration (conj)
activation through (case)
1.3 p=0.192 (appos)
individuals others (conj)
succinylcholine or (cc)
hyperplasia cystic (amod)
values base-line (amod)
minutes 1.9 (nummod)
amongst particularly (advmod)
diazepam- ageing-induced (conj)
hours 50 (nummod)
6-ohda ) (punct)
patients dyskinesias (nmod)
750 ( (punct)
developed this (nsubj)
bupropion zyban (appos)
obtained had (aux)
public the (det)
precedes which (nsubj)
variability as (case)
catheterization by (case)
4.0 - (punct)
pacemakers of (case)
learning . (punct)
hexabrix polyvidone (conj)
line human (amod)
described patients (nmod)
requires finding (nsubj)
lymphocytes on (case)
hyperalgesia brush-evoked (amod)
pathogen the (det)
sweating associated (acl)
intensity hyperalgesia (nmod)
gold d-penicillamine (conj)
angioedema the (det)
pharmacodynamics treatment (nmod)
biomembranes of (case)
accompanied evidenced (advcl)
rest the (det)
staff among (case)
february 1993 (nummod)
lack not (neg)
defined positive (nmod)
maintained fentanyl (nmod)
cost increasing (amod)
percentage and (cc)
hyperglycaemia from (case)
patients hiv (nmod)
followed succinylcholine (nmod)
accompanied returned (parataxis)
$ROOT$ acquired (sent)
form adducts (dobj)
dysrhythmogenicity epinephrine (nmod)
methotrexate leukaemia (nmod)
bupivacaine for (case)
concordance increased (amod)
sedated they (nsubjpass)
structure with (case)
lifetime both (preconj)
receive approval (dobj)
accentuated increasing (advcl)
1a1/1a2 2e1 (conj)
cardiotoxic , (punct)
protected noticeably (advmod)
rs6693503 rs4912138 (conj)
caused associated (advcl)
% versus (cc)
normal ; (punct)
irrigation including (case)
interneurons npy-immunoreactive (amod)
nodosum with (case)
liver rat (compound)
overdose paracetamol (compound)
demonstrated study (nmod)
associated congenita (nmod)
decreased groups (nmod)
patent in (case)
using risk (nmod)
physicians and (cc)
increase 1/2 (nummod)
development adulthood (nmod)
src ( (punct)
substance prominent (amod)
feasibility rate (conj)
time from (case)
antibody antineutrophil (amod)
administration metoclopramide (nmod)
age same (amod)
schedules daily (amod)
concentrations sodium (conj)
included treatment (nsubj)
anxiety feeling (conj)
behaviors cocaine-induced (amod)
type lymphoma (nsubj)
sites areas (nsubj)
balances space (conj)
word recalled (amod)
determination levels (nmod)
ritanserin antagonist (appos)
goal studies (nmod)
receptors hippocampal (amod)
appears difference (ccomp)
increase observed (acl)
2)% sem (compound)
modification without (case)
dose-dependent is (cop)
dyscrasias the (det)
multiforme glioblastoma (compound)
discontinuance therapy (nmod)
removed permitting (advcl)
reduces severity (dobj)
is still (advmod)
stimulation real (amod)
c. by (case)
$ROOT$ penetration (sent)
6 ) (punct)
detect expression (dobj)
ileostoma the (det)
varied ; (punct)
antibody receptor (compound)
failure against (case)
treatments various (amod)
alpha-enac and (cc)
chewing in (case)
occurrence between (case)
produces regimen (nsubj)
deprivation acute (amod)
nsaid acetaminophen (conj)
pacing resuscitation (nmod)
evaluated methods (dep)
hematotoxicity man (nmod)
forced . (punct)
proved means (xcomp)
performed interventions (nsubjpass)
form cream (compound)
radioactivity or (cc)
nothing abnormal (amod)
matter in (case)
levels activity (compound)
warranted work (nsubjpass)
neuropathy on (case)
glomerulosclerosis segmental (amod)
reported than (mark)
ntg learning (nmod)
b12 therapy (nmod)
characteristics are (cop)
withdrawing ml (dobj)
had represented (conj)
investigated antagonism (nsubjpass)
changed because (mark)
support reports (dobj)
suggest action (ccomp)
polypeptide . (punct)
growth as (cc)
12.0 vs. (cc)
dose smaller (amod)
indicator as (case)
effective neuroblastoma (nmod)
sulpiride and (cc)
rast ax (nmod)
gavaged days (nmod)
sedation and (cc)
analyzed allografts (dobj)
function central (amod)
37.4 +/- (cc)
increased exhaustion (nsubj)
lacn the (det)
princeton , (punct)
analysis spectral (amod)
spasms with (case)
ameliorates stress (dobj)
receptor (gdnf)/tyrosine (compound)
hbv hbsag-negative (dep)
binding studies (conj)
attenuated dose-dependently (advmod)
suspected having (advcl)
mm 106 (nummod)
amplitude of (case)
duration hypotension (nmod)
etomidate with (case)
composition bs (compound)
undergoes effect (nsubj)
patients 197 (nummod)
damage bed (nmod)
rate placebo (nmod)
sign neurotoxicity (nmod)
vomiting rescue (conj)
needle and (cc)
71.3 9.6 (conj)
have paclitaxel (nsubj)
presence hypertension (conj)
analyzed lesions (nsubjpass)
treated rhabdomyosarcoma (nmod)
cholesterol ldl-cholesterol (conj)
transmission 5-ht (compound)
alpha-fluoro-beta-alanine by (case)
concerns patients (nmod:poss)
transplant allogeneic (amod)
hydrochloride ppm (amod)
p=0.002 ( (punct)
factors may (aux)
scotoma bitemporal (amod)
agents antineoplastic (amod)
risk was (cop)
metabolite causes (acl:relcl)
pilocarpine alone (advmod)
infusions 15-minute (amod)
action methyldopa (nmod)
maleate neuropathy (conj)
strategies dosing (nmod)
safety long-term (amod)
deficit rate-related (amod)
associated onset (nmod)
medications after (case)
type surgery (nmod)
sis3 ( (punct)
chemotherapy intra-arterial (amod)
13 - (punct)
lowers that (nsubj)
plasma of (case)
active it (nsubj)
stage ii (nummod)
important catalepsy (nmod)
deaths related (acl)
dismutase copper/zinc-superoxide (compound)
diet hp (compound)
presented case (conj)
demonstrated also (advmod)
significance results (nmod)
recent recent (conj)
carriers hbv (nmod)
methods allocated (appos)
inhibitor 3-hydroxy-3-methylglutaryl (compound)
inhibited i.e. (advmod)
treatment vitamin (compound)
modulate positively (advmod)
$ROOT$ dose-dependent (sent)
bradycardia abnormality (nsubj)
dose prevent (acl:relcl)
effects eps (appos)
bacilli gram-negative (amod)
caucasian , (punct)
members class (nmod)
compared 5 (nmod)
unchanged whereas (mark)
angiotensinogen mediated (acl)
naproxen 1.35 (nummod)
good fairly (advmod)
analgesics potent (amod)
similar and (cc)
reports no (det)
paclitaxel combined (acl)
> ] (punct)
quantified months (nmod:tmod)
frequent rather (advmod)
clear patients (nmod)
neuralgia trigeminal (amod)
normalized transferred (conj)
fall significant (amod)
taxol , (punct)
12.5 15.0 (conj)
dialyzer high-flux (amod)
models disease (nmod)
repair of (case)
using oralis (nmod)
2.3 0.3 (conj)
concentration argatroban (compound)
1 in (case)
factors population (nmod)
consolidation memory (compound)
gastroenteritis interactions (conj)
harmless replacement (nsubj)
mcao ) (punct)
5-azc carcinogen-treated (conj)
ritonavir ng/ml (amod)
complexes chain (compound)
odds convulsions (nmod)
mean years (nmod)
results research (nmod)
many effects (nmod)
na ( (punct)
one treatments (nmod)
perform analysis (dobj)
stress elevated (amod)
hypertensive , (punct)
lower considerably (advmod)
five ( (punct)
parallel close (amod)
jaundice patient (nmod:poss)
rpn ) (punct)
15 - (advmod)
channels exist (acl:relcl)
hr administration (nmod)
aetiologies encephalopathy (nmod)
susceptible that (mark)
increase % (amod)
performed onset (nmod)
reversible was (cop)
showed those (advcl)
$ROOT$ dystonia (sent)
patients chronic (amod)
induced pentobarbital (nmod)
n=92 placebo (nmod)
patients failure (acl:relcl)
patients cle (nmod)
injury hippocampal (compound)
years duration (nsubj)
determination and (cc)
$ROOT$ metabolized (sent)
prescribing statins (dobj)
complication to (mark)
known occurred (xcomp)
periphery in (case)
warrant biomarkers (nmod)
administered dox (nmod)
polymorphism sparteine/debrisoquine (compound)
2.4-fold by (case)
patients 99 (nummod)
treated are (auxpass)
aneurysms these (det)
result secretion (nmod)
history depression (nmod)
dexmedetomidine intranasal (amod)
levels metabolite (compound)
hemoglobin in (case)
481 [ (punct)
catheter carotid (compound)
administration a-86929 (nmod)
occurrence an (det)
induced comparison (nmod)
delirium without (case)
considered significant (xcomp)
studies subacute (amod)
prednisolone mg/kg (compound)
rhabdomyosarcoma parameningeal (amod)
associated : (punct)
damage papillary (amod)
complications associated (acl)
treatment mg/m2 (dep)
models epilepticus (nmod)
urea in (case)
role protection (nmod)
anticipated , (punct)
lethality the (det)
compounds to (case)
increased area (dobj)
based model (nmod)
group patients (conj)
measurements for (case)
play and (cc)
push mg (conj)
slides the (det)
mg ce (nmod)
established potential (nsubjpass)
concentrations sufficient (amod)
endpoint being (advcl)
appropriate compared (advcl)
receive mannitol (dobj)
chemotherapy preplanned (amod)
microscopy light (compound)
rotation drug-induced (amod)
induce dementia (dobj)
urotensin-ii of (case)
recognition drug (nmod)
subcortex sites (conj)
identified receptor (dobj)
7 14 (conj)
level maximum (amod)
hepatocarcinogens known (amod)
did study (conj)
hoarseness dysfunction (conj)
0.13 0.04 (conj)
exposed course (nmod)
investigated efficacy (dobj)
tachycardia on (case)
93 % (conj)
applied procedure (nsubjpass)
idea to (case)
showed stimulated (ccomp)
phase a (det)
ratios , (punct)
complexes mitochondria (nmod)
peaked diminished (dep)
associated age (nsubjpass)
premedication with (case)
influence and (cc)
increases markedly (advmod)
known is (cop)
6-hydroxydopamine of (case)
report diagnosed (acl)
decrease levels (nmod)
status and (cc)
dizocilpine mk-801 (dep)
cells mitochondria (conj)
elucidate and (cc)
hospital 's (case)
considered scale (nmod)
cases several (amod)
efficacy formulation (nmod)
center our (nmod:poss)
similarity appearances (nmod)
catheter balloon (compound)
initiation lesions (nmod)
audiometry by (case)
engineered deficient (xcomp)
model pilocarpine (compound)
quantitated was (auxpass)
study reversal (amod)
glomerulosclerosis days (appos)
adsd ) (punct)
management prevention (conj)
cancer lymphoma (conj)
two whom (nmod)
factors weakness (nmod)
underwent patient (nsubj)
ergotamine/caffeine on (case)
done investigate (xcomp)
vpu either (cc:preconj)
modulate might (aux)
nonusers than (case)
release acetaldehyde (nmod)
minutes .01 (dep)
trial clinical (amod)
b12 or (cc)
behavioral effects (dep)
conclusions based (acl)
infusion with (case)
$ROOT$ epidemiology (sent)
attenuation vascular (amod)
survival and (cc)
angiography and (cc)
herbicides of (case)
treatment followed (acl)
80 and (cc)
cause concern (dobj)
lowered animals (nmod)
course 4-week (amod)
edema inflammation (conj)
paclitaxel trial (appos)
exhibit expression (dobj)
equal ) (punct)
controlled 8-week (amod)
administration times (nmod:tmod)
comprises cluster (nsubj)
0.007 < (advmod)
index process (nmod)
results long-term (amod)
determined min (nmod)
motility abnormal (amod)
effects mk-801 (nmod)
drug antimigraine (amod)
agent dianabol (appos)
placed . (punct)
transplantable carcinomas (conj)
cells purkinje (compound)
intake food (nmod)
days study (nmod)
events ratio (appos)
followed infection (nmod)
circulation enterohepatic (amod)
addresses participants (nmod:poss)
psychoses neurosis (conj)
den + (cc)
tolerated otherwise (advmod)
hit were (auxpass)
latencies stages (nmod)
function postoperative (amod)
range f344 (compound)
treatment weeks (nmod)
determined marker (nmod)
associated imbalance (nmod)
behaviors associated (acl)
lymphoma of (case)
detectable imaging (nmod)
patient cancer (nmod)
cessation investigations (conj)
gave ratio (dobj)
became anxious (acomp)
percent eighty-one (nummod)
effect coniine (nmod)
correlated weight (nmod)
encourages compliance (dobj)
received dose (nmod)
models pain (nmod)
subject epilepticus (nmod)
potency one-tenth (nummod)
3 both (cc:preconj)
produced treatment (nmod)
decrease control (nmod)
ml/min p (appos)
produce returned (advcl)
short occur (conj)
difficult define (xcomp)
increase matrix (compound)
ability prevent (acl)
treatment bendrofluazide (compound)
appetite , (punct)
exposure pcpa (nmod)
chemotherapy antineoplastic (amod)
conversion of (case)
produced application (nmod)
carcinoma stage (compound)
medications oxidant (amod)
became unendurable (acomp)
glucose blood (compound)
stimulation evoked (acl)
depressed days (nmod:npmod)
affinity affinity (conj)
scale impulsiveness (compound)
questionnaire and (cc)
demonstrated impairment (nsubjpass)
mg/dl 14 (nummod)
initiated previously (advmod)
side-effects on (case)
form with (case)
suggest evaluation (dobj)
taken attention (nmod)
had 16 (nsubj)
completion ct (nmod)
floor medical (amod)
self-dosing intervals (nmod)
treatment cytosine (compound)
intensity period (conj)
0.17 from (case)
recipient and (cc)
doses prednisolone (conj)
experienced sedation (dobj)
response exaggerated (amod)
increases pilocarpine-evoked (amod)
$ROOT$ replaced (sent)
group pog (appos)
4.2 8.5 (conj)
8- to (dep)
levels electrolyte (compound)
therapy rescue (conj)
exerted (+/-)-pg-9 (nsubj)
ameliorate course (dobj)
albuminuria mg/day (appos)
axons of (case)
determined convulsant (nsubjpass)
medication off (case)
adrenaline pg/ml (appos)
retention memory (nmod)
shift this (det)
a in (case)
cdna a (det)
group intervention (amod)
dose function (conj)
achieving return (dobj)
stopped were (auxpass)
decreased 53 (nmod)
response hormone (nmod)
etomidate mg/kg (appos)
morphine subcutaneously (advmod)
presented patient (dobj)
circumstances appropriate (amod)
assumed pravastatin (dobj)
role producing (acl)
detection and (cc)
abusers methamphetamine (compound)
study . (punct)
hg ) (punct)
derivative 5-fu (nmod)
ligand endogenous (amod)
media for (case)
day treatment (nmod)
enhancement of (case)
diminished episodes (nmod)
recognized phenomenon (nmod)
showed 13 (nsubj)
contribute burden (nmod)
resumption sorafenib (nmod)
surveillance response (nmod)
mg/dl 1.44+/-0.6 (nummod)
class ii (dep)
impairment lasting (amod)
patient male (amod)
apply also (advmod)
show cortex (nmod)
resulted progression (nmod)
survival mice (nmod)
uropathy obstructive (amod)
prevent effectively (advmod)
suxamethonium after (case)
failed 5-azc (nsubj)
bicyclo-orthobenzoate ) (punct)
specification and (cc)
dose-dependent derive (conj)
fenoterol-hydrobromide , (punct)
nephrotoxicant a (det)
is reviewing (advcl)
crisis and (cc)
109 1.8 (conj)
exhibit reactions (nsubj)
conclusion improves (appos)
il-6 ( (punct)
tachycardia or (cc)
depression . (punct)
nucleoside duration (conj)
umb24 1-(2-phenethyl)-4-(2-pyridyl)-piperazine (appos)
activity neuronal (amod)
6.7-times 4.5- (compound)
showed calculi (dobj)
lesions intraarterial (amod)
apply mechanisms (nsubj)
expression na(+)/k(+)-atpase (nmod)
case coma (nmod)
dosage the (det)
dividing by (mark)
mediator a (det)
cholecystitis for (case)
toxicity auditory (amod)
metrifonate mg/kg (dep)
occurred both (nsubj)
ineffective altering (advcl)
shown with (mark)
man 19-year-old (amod)
amns wt (dep)
promote suppression (nmod)
potential cells (nmod)
examined effect (nsubjpass)
enhances neurotransmission (dobj)
cases adolescents (nmod)
received occasions (nmod)
lipids in (case)
group animals (appos)
odds with (case)
hallucinosis seizures (conj)
unit the (det)
spots among (case)
failure tenofovir (nmod)
infarction . (punct)
pgs ) (punct)
prosthesis valve (compound)
inhibition . (punct)
gc-ht ( (punct)
been . (punct)
wsp versus (cc)
pressure group (nmod)
one are (cop)
designed that (nsubjpass)
estradiol lh (conj)
titrated flexibly (advmod)
injection dfp (compound)
elicited subject (nmod)
chicks sulfate-treated (amod)
large palpable (dep)
number their (nmod:poss)
acuity assessment (conj)
increase dose-dependent (amod)
exposure rats (nmod)
ng/ml 3 (nummod)
dox mg/kg (nummod)
chemotherapy aggressive (amod)
half-life the (det)
treated always (advmod)
produces administration (nsubj)
stimulation high-frequency (amod)
metabolite . (punct)
man this (det)
blockade sis3 (nmod)
capacity exercise (compound)
demonstrated paclitaxel (nsubj)
signals dopamine (compound)
effects subtle (amod)
open-label , (punct)
antiplatelet diuretic (conj)
76 of (case)
desensitization rather (cc)
reduction fracture (nmod)
courses six (nummod)
bortezomib with (case)
mice derived (acl)
stimuli only (cc:preconj)
one causes (nmod)
users young (amod)
kinases mitogen-activated (amod)
time therapy (nmod)
regurgitation mitral (amod)
drug metformin (dep)
potter 's (case)
vision on (case)
reduction s(c)o(2 (nmod)
concluded represents (ccomp)
taking diphenylhydantoin (dobj)
controls over (case)
inferior brains (dep)
phenobarbital tariquidar (conj)
age calcification (conj)
admission to (case)
persisted symptoms (nsubj)
motility exploratory (amod)
need appears (advcl)
tachycardias ouabain-induced (amod)
transit intestinal (amod)
gellan ) (punct)
parachlorophenylalanine pcpa (dep)
animals eight (nummod)
showed and (cc)
mg/kg 200 (nummod)
encoding and (cc)
$ROOT$ anemia (sent)
induce mediate (conj)
included information (dobj)
inpatient an (det)
ranged ratio (nsubj)
increased yield (nsubjpass)
female were (cop)
counts complete (amod)
transient albeit (advmod)
suggests is (ccomp)
times rapid (amod)
disorder associated (amod)
given again (advmod)
dex 392.8 (nummod)
relates life (nmod)
patients rate (dep)
disinhibition targets (appos)
antagonists between (case)
controls normotensive (amod)
treatment prevention (conj)
11.7 ( (punct)
range ) (punct)
52.7 6.9 (compound)
staining ccr2 (compound)
bleeding 7.6-fold (advmod)
has phenobarbital (nsubj)
yields significant (amod)
remained marker (nsubj)
images contrast (compound)
protein enhanced (amod)
plasticity disease (nmod)
hr remd (nmod)
carried assessment (nsubjpass)
videofluoroscopy with (case)
produced ph (dep)
nincds of (case)
bladders on (case)
animals saralasin-treated (amod)
dyspnea ) (punct)
autoantibodies warm-reactive (amod)
data sinus (compound)
cancer advanced (amod)
self-treating patient (nsubj)
those patients (nsubj)
investigate compare (conj)
necessitating transplantation (dobj)
co-treatment and (cc)
treadmill on (case)
factor pathogenetic (amod)
mixture 1,1-dichloro-2,2,2-trifluoroethane (nmod)
ipsi- the (det)
caution follow-up (conj)
avoidance and (cc)
conclusions treatment (appos)
parameters pressure (conj)
tests levels (conj)
toxicities severe (amod)
cautious effect (advcl)
thrombocytopenia reactions (conj)
fibers nociceptive (amod)
injection iopentol (nmod)
hearts in (case)
marker function (nmod)
consisted given (advcl)
developed anuria (nsubj)
need and (cc)
years treatment (nmod)
valsartan . (punct)
remained sedentary (xcomp)
attenuate and (cc)
$ROOT$ accompanied (sent)
procedure or (cc)
matched cases (dobj)
intercellular intracellular (conj)
similarity effects (nmod)
% older (nummod)
200 < (compound)
decreased concentration (nmod)
option : (punct)
morphine cnsb002 (appos)
12 to (quantmod)
differences frequency (nmod)
potency depressant (amod)
led polyuria (nmod)
disorder disorders (conj)
infusion total (amod)
time over (case)
focused test (nsubjpass)
volume lesion (nmod)
fractures of (case)
kpa 6.9 (nummod)
properties pressure (compound)
induced methyldopa (nmod)
evaluated : (punct)
mediated reaction (nsubjpass)
micrograms 7 (compound)
ototoxicity of (case)
completed showing (xcomp)
interviewed authors (nsubj)
leukocytes lymphocytes (appos)
was population (nmod)
paclitaxel given (acl)
war civil (amod)
reduced administration (nmod)
experience this (det)
hepatic gastrointestinal (conj)
lvef lvdp/dt (conj)
observed pronounced (advcl)
discussion , (punct)
history therapy (nmod)
followed h (nmod)
93 1 (conj)
using microdialysis (dobj)
follow-up psychiatric (amod)
aim study (acl)
those observed (acl)
lozenge or (cc)
cld , (punct)
administration tacrine-loaded (amod)
ptu ) (punct)
presented found (advcl)
overlooked frequently (advmod)
chloride 2,3,5-triphenyltetrazolium (compound)
available conclusive (xcomp)
therapy thrombosis (conj)
patients age-range (appos)
rate hepatic (amod)
repair damage (nmod)
moderate severity (nmod)
$ROOT$ synthesis (sent)
injection captopril (nmod)
any agents (nmod)
ascended region (nmod)
vasospasm for (case)
hematuria gross (amod)
% 69.3 (nummod)
patients relapse (nmod)
effects circulation (nmod)
1/32 % (appos)
had kidneys (nmod)
administration cyp (nmod)
co min(-1 (appos)
were whether (mark)
run may (aux)
responses bradycardia (conj)
catheters adjacent (amod)
assigned trial (nmod)
fenfluramine or (cc)
involves addition (nmod)
t-cell + (amod)
oxide endothelium-derived (amod)
dose taken (acl)
concentration fbal (compound)
survival time (nmod)
affects abuse (nsubj)
ephedrine prior (advmod)
% normal (nmod)
ratio cardiomyocytes (nmod)
rg1 ginsenoside (compound)
two children (nmod)
34.3 2.1 (conj)
outcome symptoms (nmod)
due increase (nsubj)
accompanied loss (nmod)
displays used (conj)
present disorders (nsubj)
overstimulation group (nmod)
remains proven (xcomp)
db khz (nmod)
toxicity tissues (nmod)
presented conclusion (nsubjpass)
pregs ) (punct)
excretion fractional (amod)
courses days (nmod)
$ROOT$ depth (sent)
achieved complications (nmod)
seen anaphylaxis (nsubjpass)
patients required (acl:relcl)
secondary chemotherapy (nmod)
cultured , (punct)
methods measured (appos)
os median (amod)
induced dose (nsubj)
found safe (xcomp)
cycles after (case)
failure an (det)
methadone of (case)
sampled hospitals (nmod)
cancer colon (compound)
describes development (dobj)
angioedema lips (nmod)
vasculitis starting (advcl)
short-acting prilocaine (appos)
investigated impact (nsubjpass)
increased size (nmod)
12.1 10(-3 (conj)
petechiae and (cc)
$ROOT$ preparations (sent)
repeated infusion (nmod)
aneurysms . (punct)
physician using (acl)
result mutations (nsubj)
proximal predominantly (advmod)
occurred 1/32 (nmod)
improve p-coumarate (nsubj)
evaluation resistance (nmod)
characterized event (nsubjpass)
gas inspiratory (amod)
decrease weight (nmod)
associated ribavirin (nmod:npmod)
receiving of (mark)
progress predictability (conj)
fail support (xcomp)
% 20 (nummod)
other daytime (nmod)
weights body (compound)
treatment mk-801 (compound)
level peptide (nmod)
ng/mouse 100 (nummod)
men 5 (nummod)
treatments the (det)
currents ionic (amod)
hemorrhage people (nmod)
patient exhibited (acl:relcl)
studies to (case)
agent antimicrobial (amod)
salbutamol of (case)
those medium (nmod)
acid mg/m2 (nmod)
mediated level (nmod)
focus factors (nmod)
ameliorate that (mark)
outcomes implant (nmod)
relieve that (mark)
imbalance dopamine/serotonin (compound)
cessation with (case)
radius the (det)
use tacrolimus (compound)
match cases (dobj)
attenuates testing (nmod)
lumens tubular (amod)
monitoring in (case)
micrograms/kg/hr 32 (nummod)
agonists alpha1-adrenoceptor (amod)
$ROOT$ act (sent)
prescribed paroxetine (nmod)
lady stage (nmod)
spectrum the (det)
group classification (compound)
colocalized was (auxpass)
discontinuing starting (conj)
efficacy mc (nmod)
ci=25.2 ) (punct)
is , (punct)
features identifying (acl)
as probably (advmod)
exhibited combinations (nsubj)
target injury (nmod)
polysaccharide sulfated (amod)
improving comparison (nmod)
take schedule (nmod)
toxicity tac (compound)
antagonists dopamine (compound)
stratified . (punct)
onset period (nmod)
enzymes indicators (nmod)
caused impairment (dobj)
complication , (punct)
degenerated fibrillation (nmod)
arrest to (mark)
paco2 in (case)
hyperlipidemia primary (amod)
discontinued after (mark)
recorded period (nmod)
potency anticholinergic (amod)
woman angiogram (nmod)
female on (case)
necessitated reintubation (dobj)
actions in (amod)
obsolete dangerous (conj)
$ROOT$ represents (sent)
time recovery (compound)
prior hours (conj)
ca2 extracellular (amod)
presence children (conj)
overactivation . (punct)
boy depression (nmod)
20 to (dep)
interaction of (case)
follow symptoms (nsubj)
function memory (compound)
hypokalemia ) (punct)
woke up (compound:prt)
135 + (cc)
symptoms typical (amod)
given divided (conj)
challenging rehabilitation (nsubj)
combination cocaine (nmod)
changes function (nmod)
variations gene (nmod)
meq 3269 (nummod)
b amb (appos)
disease sad (appos)
aetiology compressive (amod)
relation . (punct)
limits upper (amod)
infusion intracoronary (amod)
h-sod1 ( (punct)
dexmedetomidine or (cc)
antagonism metoprolol (nmod)
od in (case)
cortex cerebellum (conj)
hepatitis e (compound)
chlorpropamide diabenese (appos)
estimated effect (nsubjpass)
demonstrated addition (nmod)
applications potential (amod)
cc and (cc)
79 to (advmod)
autism for (case)
review literature (compound)
doubled = (parataxis)
recognised widely (advmod)
nephrotoxicity aminoglycoside (compound)
lower score (nmod)
summary case (compound)
potentiate nifedipine (nsubj)
people four (nummod)
grade % (appos)
summaries developed (appos)
converts acid (dobj)
10 5 (quantmod)
imaging functional (amod)
anesthesia general (amod)
prescribed treatment (nmod)
incidence neurotoxicity (compound)
corticosteroids other (amod)
disturbances major (amod)
amplified samples (nsubjpass)
register based (amod)
offers neuroprotection (dobj)
decreased lethality (dobj)
resulted and (cc)
peaked h (nmod)
infiltrate lung (compound)
cases removal (nmod)
shown unequivocally (advmod)
implicated mechanisms (nmod)
results tachycardia (nsubj)
formation emboli (nmod)
dfx ( (punct)
induced immersed (advcl)
episode occurred (acl:relcl)
modulated differentially (advmod)
frequencies fibrillation (nmod)
influence did (aux)
lungs on (case)
men and (cc)
manifested dyskinesia (dobj)
3 , (punct)
include causes (nsubj)
neuralgia a (det)
injections metoclopramide (nmod)
users asymptomatic (amod)
therapies standard (amod)
scores difference (compound)
levels ao (nmod)
played recognition (nsubj)
cause regimens (nsubj)
defects conduction (compound)
angina with (nmod)
used safer (advcl)
increase infarction (nmod)
cases well-documented (amod)
group low-sodium (amod)
pathway rho/rock (compound)
cbd over (case)
people admitted (acl:relcl)
continued , (punct)
tissues occurring (acl)
falciparum potassium (appos)
newborn of (case)
insipidus with (case)
assessment ophthalmological (amod)
regions brain (nmod)
breeder same (amod)
mechanism rs (nmod)
combination cnsb002 (nmod)
= 0.048 (dobj)
remained remained (conj)
tolerated were (auxpass)
influx cell (nmod)
3a4 p-450 (compound)
void to (mark)
response major (amod)
anemia cells (conj)
eruptions rosacea-like (amod)
episodes transient (amod)
elicited adriamycin (nsubj)
or=3.299 ) (punct)
gf ( (punct)
inhibitor coenzyme (compound)
observed were (auxpass)
control motor (compound)
result medication (nmod)
overload ca2 (compound)
aneurysms ruptured (amod)
sd +/- (cc)
damage be (cop)
arv ( (punct)
serum with (case)
week administration (nmod)
assessed occurrence (nsubjpass)
injected ventricularly (advmod)
vasoconstriction renal (amod)
rats barium-treated (amod)
. 01 (nummod)
3nt ) (punct)
statement . (punct)
response euthymia (conj)
application papaverine (compound)
cope disease (nmod)
aged 22 (nmod:npmod)
speculated . (punct)
form short (amod)
strategies management (compound)
action hyperalgesic (amod)
modification using (acl)
assess using (advcl)
sagittal superior (amod)
24 to (quantmod)
gaining . (punct)
changes breast (compound)
microg/kg/min dose (nsubj)
excitability , (punct)
profile : (punct)
induction emergence (conj)
coagulopathy the (det)
injection . (amod)
data adjudicated (amod)
bladder with (case)
prior initiation (nmod)
sixties history (nmod)
reported compared (advcl)
curve the (det)
1.041 +/- (cc)
subjected shr (nsubjpass)
complained later (advmod)
n ( (punct)
$ROOT$ exerted (sent)
than vertex (nmod)
measures fetuses (nmod)
-14.6 ; (punct)
investigate mechanisms (dobj)
apparatus mice (conj)
conclusion of (case)
greater hearts (nmod)
micrograms/ml respectively (advmod)
gender = (dep)
values creatinine (compound)
animals than (case)
comparable weaker (conj)
score % (dep)
18 78 (nmod)
methotrexate long-term (amod)
insufficiency alkalosis (conj)
age scores (conj)
related syndrome (nmod)
vulnerability differential (amod)
developed h (nmod)
opioid-agonists selective (amod)
showed ptosis (dobj)
stimulant addictive (amod)
characteristics in (case)
produces cimetidine (nsubj)
carriers chinese (amod)
aids , (punct)
reversal chloride (nmod)
important studying (advcl)
adopted improve (xcomp)
effects immunosuppressive (amod)
measurements hemodynamic (amod)
management disease (nmod)
displays bche (nsubj)
level mrna (compound)
superior . (punct)
indicate trials (nsubj)
equal outcomes (nsubj)
oedema of (case)
procedures short (amod)
offspring rats (nmod)
weeks rate (nmod)
surrounding lesion (dobj)
had skf (nsubj)
thrombocytopenia mucositis (conj)
rigidity caused (acl)
remained , (punct)
effects due (case)
administration occasions (nmod)
rats young (amod)
calcification aorta (nmod)
enrolled 28 (dep)
pattern suggestive (amod)
12.8 +/- (cc)
contained weeks (nmod)
concluded . (punct)
required seriousness (nmod)
inhibited strongly (advmod)
necessary treatment (nmod)
theophylline to (case)
sera collected (acl)
had uveitis (dobj)
conversion before (case)
patient height (nmod)
injection subarachnoid (amod)
similar index (nsubj)
recorded groups (nmod)
rise significant (amod)
cause cancer (dobj)
incidence hospitalisation (nmod)
cystica and (cc)
paradigm e.g. (advmod)
times reach (acl:relcl)
used shows (conj)
troleandomycin of (case)
information little (amod)
uptake a (det)
caused % (conj)
different values (nsubj)
outer and (cc)
epilepticus p20 (appos)
enabled convert (advcl)
reaffirms principle (dobj)
occurred evident (conj)
mean /-sd (cc)
drg l2 (compound)
gluconate i.v. (amod)
stimulation frequency (compound)
antagonists pirenzepine (dep)
fluoxetine days (nmod)
flutamide tamoxifen (conj)
promotes : (punct)
treatment lipopolysaccharide (compound)
form classical (amod)
dressing topical (amod)
ingredient dextromethorphan (nsubj)
injected injected (conj)
seems control (nsubj)
86.2 3.7 (conj)
had resistant (conj)
hissing snarling (conj)
protein against (case)
year for (case)
those receiving (acl)
turnover of (case)
magnitude by (case)
effects cognitive-enhancing (amod)
$ROOT$ skeptical (sent)
damage organs (dobj)
recommenced . (punct)
contraction et-1 (nmod)
01 . (nummod)
denopamine with (case)
12 5 (compound)
reaction rare (amod)
cent infusion (nmod)
tested treatment (nmod)
slight absent (conj)
suggest strongly (advmod)
encouraged have (aux)
desogestrel , (punct)
b for (case)
ratings to (case)
seriousness prevalence (conj)
measured clearance (nmod)
bradykinesia rigidity (conj)
evaluate which (nmod)
found a-i (nsubjpass)
administration selective (amod)
mg 320/25 (nummod)
mg given (acl)
tetrachloride ccl4 (appos)
annuloplasty : (punct)
dysfunction due (case)
represent associated (advcl)
p<0.01 all (advmod)
complicated contributed (conj)
stimulation nicotine-induced (amod)
controls and (cc)
hypertension systemic (amod)
patient every (det)
ascended , (punct)
seen ; (punct)
rather than (mwe)
weeks 8 (nummod)
percentage baseline (nmod)
developed change (conj)
impairment scopolamine-induced (amod)
convert arrhythmia (dobj)
examination on (case)
weeks duration (nmod)
netilmicin vs (cc)
scopolamine evening (nmod:tmod)
study health (compound)
relaxations postjunctional (amod)
latencies in (case)
tone vagal (amod)
15 as (advmod)
subsides it (nsubj)
kindreds three (nummod)
involve potentiation (dobj)
blocker pure (amod)
similar ) (punct)
reduced time (dobj)
treatment cytostatic (amod)
levels plasma (compound)
$ROOT$ regimen (sent)
observed cows (nmod)
made available (xcomp)
cultures blood (compound)
reticulum microtubules (conj)
implicated to (mark)
demonstrate interaction (dobj)
dexmedetomidine ( (punct)
nephrotoxicity cisplatin (compound)
pneumonitis hypersensitivity (compound)
cacl2 4-aminopyridine (conj)
visualized . (punct)
alpha5 for (case)
retarding progression (dobj)
seen two (nmod)
induces nifedipine (nsubj)
others group (appos)
muscle pulmonary (amod)
po ) (punct)
fumarate to (case)
react or (cc)
lack agent (nsubj)
inhibit pentoxyifylline (nsubj)
seizures acid-induced (amod)
minutes was (cop)
4-aminopyridine mg/kg (appos)
segment st (amod)
concerned one-third (dobj)
difference session (nmod)
response toxicity (nmod)
level from (case)
dissociate " (punct)
raises question (dobj)
time depolarization (compound)
prevent prescribing (advcl)
woman-years per (case)
artery injection (nmod)
gamma-hexachlorocyclohexane ingredient (appos)
secretion luteinizing (amod)
women 61 (nummod)
systemic intrathecal (amod)
worsened infection (nmod)
affect blocked (conj)
risk between (case)
using dexmedetomidine (dobj)
compare determine (advcl)
separation growth (nmod)
incidence , (punct)
microm 55+/-29 (nummod)
combination inhibitor (nmod)
akathisia including (case)
less increases (nsubj)
cancer disease (conj)
dose therapeutic (amod)
remission for (case)
reported features (nsubjpass)
share pathway (dobj)
gspe mg/kg (compound)
decreased dose (nsubjpass)
assigned treatment (nmod)
killed harvested (conj)
dosed weekly (advmod)
assessed changes (nsubjpass)
injection 30-second (compound)
recording just (advmod)
aureus methicillin-sensitive (amod)
activator plasminogen (compound)
therapy salvage (amod)
absence acid (nmod)
prediction for (case)
saline/side ; (punct)
had isolated-hit (dobj)
used lorazepam (nsubjpass)
syndrome fatal (acl:relcl)
decreased hippocampus (nmod)
leukopenia thrombocytopenia (appos)
lung node (conj)
inhibitors concomitant (amod)
increased revealed (parataxis)
thrombosis extensive (amod)
instance toxicity (nmod)
rats epinephrine-induced (amod)
decreased treatment (nmod)
decreased efficient (conj)
databases the (det)
amelioration modest (amod)
mg/kg orally (nmod)
age history (conj)
seen superimposed (advcl)
asa ( (punct)
possibility precipitate (ccomp)
$ROOT$ contain (sent)
patients 92 (nummod)
oct of (case)
appeared akathisia (nsubj)
damage hepatocellular (amod)
investigated affected (advcl)
sulphonylureas cheaper (amod)
vacuolization and (cc)
ifo with (case)
play pathophysiology (nmod)
deterioration thrombi (conj)
disposition uptake (conj)
commencement and (cc)
hydrochloride plus (cc)
prior dose (nmod)
denied cip (dobj)
knowledge composition (nmod)
simple , (punct)
noted % (nmod)
given tdi (nmod)
cholinesterase amnesia (conj)
test climbing (compound)
effective cases (nmod)
= 212 (dobj)
person-years non-users (nmod)
cystitis acute (dep)
treated could (aux)
activity and (cc)
$ROOT$ proteinuria (sent)
response drug (compound)
effects thrombosis (nmod)
paralysis after (case)
admission on (case)
present normally (advmod)
isoenzymes p450 (compound)
users vgb (compound)
revealed comparison (nsubj)
influence gfc (nsubj)
$ROOT$ 3.4 (sent)
exposure utero (nmod)
rats five (nummod)
monitoring frequent (amod)
had elevation (dobj)
described is (auxpass)
suppression (zdv)-induced (amod)
searched were (auxpass)
standard is (conj)
rigidity wall (compound)
occlusion 20-s (nummod)
received interval (nmod)
efficacy prevention (nmod)
effects rewarding (amod)
control sc (appos)
rats 24 (nummod)
42.5 vs. (cc)
cidofovir intravenous (amod)
less = (dep)
arrest circulatory (amod)
suggested exercised (ccomp)
antagonized ly274614 (nmod)
documented respectively (advmod)
children by (case)
analysis image (compound)
smaller % (nmod:npmod)
weeks 20,40,60 (nummod)
involved proteins (nsubjpass)
took recovery (nsubj)
related avoided (conj)
decades for (case)
$ROOT$ amine (sent)
psychostimulant abused (amod)
haemopericardium haemorrhage (conj)
evidence results (nmod)
action 2-blocking (amod)
thrombophlebitis patients (appos)
due . (punct)
bleeding gastrointestinal (amod)
found nine (nmod)
complication induce (conj)
matched 95 (parataxis)
injections scopolamine (compound)
regimens many (amod)
99.0 61 (conj)
$ROOT$ speculate (sent)
results inhibited (appos)
episodes five (nummod)
ci-921 analogue (compound)
factors baseline (amod)
mg/g ) (punct)
intravenous intratracheal (conj)
prl in (case)
sampled hours (nmod)
abstained half (nsubj)
caused days (nmod)
data existing (amod)
following hypertrophy (appos)
emergency as (case)
disturbance sensory (amod)
returned dialysis (nmod)
levels u/l (nmod)
treatment disease (nmod)
phenotyping from (case)
choice ; (punct)
species activation (conj)
neurosci nat (compound)
admissions of (case)
trials for (case)
biopsies thirteen (nummod)
leukoencephalopathy due (amod)
stability greater (amod)
donors thiol (compound)
atypicals the (det)
rise further (amod)
hexachloride ) (punct)
mg cytarabine (compound)
agreement questionnaire (nmod)
monitor ecg (conj)
meth ( (punct)
ratio decreased (amod)
0 20 (conj)
stenosis but (cc)
opiate endogenous (amod)
hydrocortisone of (case)
acupuncture biofeedback (conj)
syndrome clinical (amod)
treatment gemfibrozil-lovastatin (compound)
administration dexamethasone (nmod)
appeared figures (nmod)
showed patterns (dobj)
activity components (nmod)
deafened frequencies (nmod)
$ROOT$ genotyped (sent)
cause it (nsubj)
confirms study (nsubj)
hyperkinesia global (amod)
strategies possible (amod)
(enac)-dependent channel (nmod:npmod)
n-butyl-deoxynojirimycin sc-48334 (appos)
2-p-(2-carboxyethyl)phenethylamino-5'-n-ethylcarboxamidoadenosine and (cc)
severity . (punct)
factor intensity (compound)
treatment stimulation (nsubj)
five number (nsubj)
enzymes acid (dep)
performance correction (nmod)
inhibitors ace (compound)
depression treated (acl)
bolus cocaine (compound)
presented hypoxia (dobj)
unresponsiveness verapamil (nmod)
mg/kg 0.5 (nummod)
treatment modality (compound)
papaverine micrograms (conj)
cell renal (amod)
diagnosed was (auxpass)
5 patients (nmod)
mg/dl /=0.5 (nummod)
reduction changes (conj)
phase with (case)
properties by (case)
concentrated . (punct)
1.13 1.53 (prep)
ireland in (case)
inhibit stages (dobj)
areas at (case)
3.4 4.2 (conj)
recovered after (mark)
decreased vip (nsubj)
prevented administering (advcl)
4.9 range (dep)
alert cautious (xcomp)
added be (auxpass)
receiving june (nmod)
dysfunction system (nmod)
was sg (nmod)
dopamine than (cc)
capable isomers (nsubj)
acceleration conduction (compound)
ml to (case)
reflexes through (case)
daily separately (advmod)
increases due (case)
sm-5887 ( (punct)
regardless degree (nmod)
syndrome characterized (acl)
effects chick (nmod)
chicago north (compound)
fell , (punct)
took occasionally (advmod)
risk an (det)
% 2.5 (nummod)
aware physicians (nsubj)
treated flurbiprofen (nmod)
potent however (advmod)
issue manageable (amod)
younger were (cop)
accomplished and (cc)
treatment epilepticus (nmod)
erythromycins and (cc)
studies double-blind (amod)
acid alpha-lipoic (amod)
children 2 (nummod)
development polyuria (nmod)
unable contrast (nmod)
excitatory less (advmod)
infusion dextrose (nmod)
increased although (mark)
if dose (conj)
onset encephalopathy (nmod)
carried immuno/histochemistry (nsubjpass)
hepatitis glyburide-induced (amod)
human of (case)
eyes to (case)
hydrochloride 2-(diethylamino)ethyl (compound)
behavior stereotypic (amod)
has viramidine (nsubj)
tuberculosis prevalent (acl:relcl)
imaging studies (conj)
unclear considering (advcl)
importance recognizing (acl)
echocardiography real-time (amod)
stiffness contractures (conj)
suppressed ptz (nsubj)
2.4 ( (punct)
6-hydroxydopamine rat (compound)
predictor seizures (nmod)
hg p (dep)
cells gfp(+ (amod)
drugs increase (acl:relcl)
rats 38 (nummod)
malformations cardiovascular (amod)
stability h (compound)
impairment learning (compound)
consequence treatment (nmod)
cr to (case)
oxytocics of (case)
discontinued carbamazepine (nsubjpass)
novelty to (case)
angiographies deteriorated (parataxis)
overflow neurotransmitter (nmod)
syndrome suprofen (nmod)
acting . (punct)
mother in (case)
development switch (nmod)
processing inputs (nmod)
600 > (advmod)
phenomenon the (det)
dizziness % (appos)
rates event (compound)
% orr (nsubj)
measure thus (advmod)
study italian (amod)
withdrawal the (det)
fields various (amod)
neuropeptides related (amod)
provoked patients (nmod)
elevation st-segment (amod)
patterns distribution (compound)
technique dual-perfusion (amod)
reported neurotoxicity (nsubjpass)
effects tet (nmod)
discrepancy amount (nmod)
cells neuronal (amod)
or 1.7 (appos)
superior aspirin (nmod)
react ( (punct)
meq/l 4.5 (nummod)
rats 6 (nummod)
measurements psa (compound)
neuropathies of (case)
condition in (amod)
woman admitted (acl:relcl)
deficits permanent (amod)
facilitation releaser (nmod)
therapy fresh (amod)
side over (case)
antinociception the (det)
activity antioxidant (amod)
inhibitor enzyme (nmod)
maximize candidates (nmod)
recovered support (nmod)
changes leading (acl)
resulted unchanged (advcl)
hypertension secondary (amod)
control ng/kg/min (appos)
gyrus caudate (conj)
opiates other (amod)
done , (punct)
had one (nsubj)
scheduled patients (nsubjpass)
used determine (xcomp)
associated smoking (nsubjpass)
function electroretinography (appos)
stress any (det)
determine concentration (dobj)
doses combined (acl)
ages median (amod)
tumors gross (amod)
receptor ka (compound)
azithromycin by (case)
dysguesia side-effect (nsubj)
myeloma rrmm (appos)
caused concentrations (nsubj)
provided patient (nmod)
day later (advmod)
administered chemotherapy (nmod)
old ( (punct)
beta4 and (cc)
analysis data (nmod)
necrolysis toxic (amod)
elevated reached (conj)
effect val (dep)
prevent effects (dobj)
8 9 (conj)
conversion sirolimus (nmod)
stimulation not (neg)
capacity ca(2 (compound)
occupancy half-maximum (amod)
hypertension mineralocorticoid-related (amod)
= diarrhoea-predominant (punct)
ulceration mucosal (amod)
evaluating ischemia (dobj)
indicates exhibited (ccomp)
study livers (nmod)
exposed organogenesis (nmod)
up-regulated se (nmod)
100 greater (amod)
administered applied (advcl)
syndromes , (punct)
slight significant (conj)
indicate correlate (ccomp)
protein inhibitor (appos)
potency inhibitory (amod)
protect seizure (nmod)
anaesthetised and (cc)
confirmed update (nmod)
cardiotoxicity study (conj)
temperature or (cc)
affect pergolide (nmod)
trial edge-ii (appos)
larynx ; (punct)
aspects on (case)
micromol/l < (dep)
required dialysis (nsubjpass)
information valuable (amod)
implications practical (amod)
reductions tissue (nmod)
adducts (4hne)-protein (compound)
suppression stimulation (nmod)
7 3 (conj)
receiving dexamethasone (dobj)
embryolethality defects (appos)
established course (nsubjpass)
standing with (case)
common being (cop)
syndrome cholinergic (amod)
studies because (case)
dp/dt(max in (case)
ato or (cc)
functionality in (case)
7.8 ) (punct)
agent enhancement (compound)
two the (det)
included effects (nsubj)
decrease inhibition (conj)
induction anaesthesia (nmod)
correlates of (case)
globulin of (case)
observed tolerated (conj)
ointment with (case)
features retinopathy (nmod)
experience therefore (advmod)
increase o-methylation (nmod)
done testing (nsubjpass)
0.3-fold 1.7 (dep)
weeks re-exposure (nmod)
influence for (case)
secondary therapy (nmod)
correct . (punct)
express gap-43 (dobj)
protection no (neg)
mice engineered (acl)
toxicity margin (conj)
manifestations report (dep)
bche asp70gly-p (compound)
investigate predict (ccomp)
hypokalemia despite (case)
reabsorption the (det)
limited duration (nmod)
patient hepatitis (nmod)
identified oscs (nsubjpass)
progesterone and (cc)
2.3+/-1.2 , (punct)
event failure (nmod)
possibility subgroups (nmod)
od group (compound)
contraction the (det)
option thalidomide (nsubj)
was find (xcomp)
angiogenesis and (cc)
weights muscles (nmod)
rationale . (punct)
awakening upon (case)
less 0.25 (nmod)
that biperiden (nmod)
test evaluating (acl)
mice those (conj)
taking gum (dobj)
decreased % (dobj)
without possibly (advmod)
stress hepatocellular (amod)
patients intolerant (amod)
ruled however (advmod)
$ROOT$ 1.4 (sent)
define however (advmod)
present 25 (nmod)
ldlr and (cc)
produced epinephrine (nsubj)
believe , (punct)
angiography for (case)
utilized that (mark)
x ) (punct)
ought . (punct)
peptide bnp (appos)
pathogenesis and (cc)
escalated tolerated (advcl)
motility gastrointestinal (amod)
anophthalmia syndrome (conj)
u/ml 10 (nummod)
treatment < (dep)
seen improvement (nsubjpass)
mice using (acl)
angiogram emergent (amod)
cases day (nmod)
syndrome reye (compound)
employed indexes (nsubjpass)
demographics history (conj)
patients not (cc)
co-infected hbv-hiv (nmod:npmod)
urticaria of (case)
glomerulonephritis early (amod)
susceptibility damage (nmod)
cytokine and (cc)
drowsiness ataxia (conj)
reduced significantly (advmod)
discouraged treatment (nsubjpass)
used microscopy (nsubjpass)
hepatitis acidosis (conj)
period " (punct)
$ROOT$ moderate (sent)
system oxide (compound)
unknown pathophysiology (nsubj)
required often (advmod)
jones smith (conj)
2.9 +/- (cc)
acquired images (nsubjpass)
history long (amod)
effects anti-dementia (amod)
susceptibility increased (amod)
case hematoma (nmod)
occluded . (punct)
acutely and (cc)
medications their (nmod:poss)
hydromorphone ( (punct)
remained analogues (nsubj)
compartments distinct (amod)
taking carbonate (dobj)
muscle corticosteroids (nmod)
window the (det)
p.m. 2:00 (nummod)
rejection to (case)
triggered is (auxpass)
ml solution (nmod)
name under (case)
result chemotherapy (nmod)
or simultaneously (advmod)
identified cases (nsubjpass)
amifostine of (case)
complication be (cop)
factors stress (nsubj)
explore . (punct)
manifesting hyalinosis (nmod)
component hyperthymia (compound)
tumors , (punct)
discriminated associated (ccomp)
receptors nicotine (compound)
experienced administration (nmod)
setting unit (compound)
terms efficacy (nmod)
$ROOT$ administration (sent)
determined immunohistochemistry (nmod)
daunoxome ) (punct)
decreased hyperactivity (dobj)
clonidine disorder (nmod)
coexistence . (punct)
enlargement carbachol (nmod)
developed hypertension (nsubj)
effects tolerability (conj)
defect . (punct)
reduced therapy (nsubj)
importance increasing (amod)
mediated probably (advmod)
hypothalamus in (case)
effects pleiotropic (amod)
affected % (dobj)
thalidomide mg (appos)
rate remission (compound)
tissue resulted (acl)
rhythms to (case)
syndrome stroke (conj)
prodrug . (punct)
believed . (punct)
was agreement (attr)
ci % (appos)
5.9 1.0 (nummod)
were : (punct)
catatonia doc (appos)
resulted seizures (nsubj)
indicated case (nmod)
glomerulonephritis proteinase (compound)
potential induce (acl)
evaluated trial (nmod)
percentage damage (conj)
avoid clinicians (nsubj)
herbal and (cc)
depressants analgesics (conj)
80.0 +/- (cc)
investigate influence (dobj)
rats fischer-344 (compound)
shown we (nsubj)
reports pericarditis (nmod)
mortality subsequent (amod)
2 4 (conj)
before mainly (advmod)
encouraged authors (dobj)
consumers alcohol (compound)
finding last (amod)
man therapy (nmod)
respond administration (nmod)
continued hepatocytes (nsubj)
days 120 (nummod)
increased prevalence (nsubj)
activity peripheral (amod)
concentration ce (appos)
extrarenal to (case)
shifts dependence (nmod)
excretion apap (nmod)
confined properties (nsubjpass)
vnr and (cc)
emotions six (nummod)
occlusion airway (compound)
medication due (case)
elicited anticipated (advcl)
depletion salt (compound)
ems than (case)
increased activity (dobj)
fracture the (det)
expression rats (nmod)
he-lfb ( (punct)
2-(p-bromophenyl)propionate ) (punct)
act that (nsubj)
7 6 (nummod)
patients hospitalized (acl)
blocking endomt (dobj)
register group (compound)
suggest standpoint (nmod)
worsening retention (conj)
examined polymerase (nmod)
weight duration (appos)
seventeen these (nmod)
hepatotoxicity vpa-induced (amod)
appears correlate (xcomp)
elevation adam10 (nmod)
between nor (cc)
t min (appos)
gaba(a)rs nmdars (conj)
pretreatment progesterone (compound)
ratio area (nmod)
2 ) (punct)
available results (nsubj)
s p<0.01 (dep)
resistance supraglottic (amod)
had lozenge (nsubj)
% 21.80 (nummod)
limits min-1 (appos)
used markers (nmod)
gemcitabine days (nmod:tmod)
convulsion time (conj)
agonist apomorphine (appos)
unnecessary are (cop)
reduction damage (conj)
exposure the (det)
field as (cc)
mpa ( (punct)
prolongation starting (acl)
mg./kg and (cc)
occurred groups (nmod)
mpo-anca and (cc)
pain injection (compound)
leukoencephalopathy posterior (amod)
restricted sharply (advmod)
piglets control (amod)
schedule the (det)
cause hypocalcemia (dobj)
l-[3h]nicotine [3h]spiperone (conj)
settings serve (acl:relcl)
induce damage (dobj)
fourfold nearly (advmod)
seeded mea (nmod)
plausibility effect (nmod)
causes glomerulonephritis (nmod)
allele bche (compound)
autoantibodies react (acl:relcl)
clearance increased (amod)
anticoagulants oral (amod)
causes and (cc)
cases 3 (nummod)
d-amphetamine of (case)
scale neuropsychiatric-like (amod)
defects filling (compound)
reporting citations (nsubj)
23.5 - (advmod)
reduced range (nmod)
reduction between (case)
reported sulfonylureas (nmod)
tools agents (nsubj)
detected compared (advcl)
96.7 range (dep)
solution hydrochloride (compound)
5.3 3 (compound)
controls strains (nmod)
ocs second-generation (amod)
included methods (nsubj)
that above (case)
subjected weeks (nmod)
approach consequences (conj)
induction to (case)
mice : (punct)
examined recovery (nmod)
ci=1.0 95 (nummod)
ache ( (punct)
pan ) (punct)
decreases % (nmod)
given reduction (nmod)
maintained was (cop)
evidence have (ccomp)
force services (compound)
duration amenorrhea (nmod)
episodes many (amod)
reduced mildly (advmod)
scale positive (amod)
myoglobinuria with (case)
quinidine of (case)
developed course (nmod)
mg mg/kg (appos)
artery dog (nmod)
analysis interactive (amod)
laboratories animal (compound)
cycle including (case)
supplemented which (nsubjpass)
independently function (nmod)
inhibit : (punct)
dependent complement (nmod:npmod)
factors etiologic (amod)
licensed treat (advcl)
hours by (case)
cortex olfactory (amod)
deficits exposure (nmod)
interval following (case)
movements uncontrollable (amod)
conversion srl (nmod)
antibiotics only (advmod)
amplitude ap (compound)
responses anxiety (compound)
i viii (conj)
processes cancer (nmod)
suggest potential (dobj)
memory planning (conj)
4 20 (conj)
effect 9-tetrahydrocannabinol (nmod)
protein an (det)
3.4 range (dep)
protocol syndrome (compound)
0.5 1 (conj)
temperature controlled (amod)
microscopy immunofluorescence (compound)
respond cells (nsubj)
possible use (nmod)
restriction mechanical (amod)
reductions by (case)
subsides rapidly (advmod)
estimated accounting (advcl)
replaced everolimus (nmod)
effects antagonist (nmod)
discontinued drug (nsubjpass)
ato ( (punct)
administered induce (advcl)
units sold (acl)
induced amphetamine (nmod)
suggested reduced (ccomp)
different activity (nsubj)
similar nearly (advmod)
shortened latency (dobj)
paralysis with (case)
mg maleate (nmod)
experience therapy (nmod)
tests induced (amod)
3a4 cytochrome (compound)
mg.kg-1 fm (appos)
given mice (nsubjpass)
discontinued later (advmod)
diabetics in (case)
mmol/l mg/dl (appos)
dose average (amod)
measurements of (case)
studied furthermore (advmod)
administered methylergonovine (nsubjpass)
observational prospective (dep)
pathways visual (amod)
rate hr (appos)
physicians professionals (conj)
potent although (mark)
interest particular (amod)
t+a ( (punct)
avp ) (punct)
starting and (cc)
teratogenicity of (case)
smaller group (nmod)
ls , (punct)
nicotine or (cc)
correlation for (case)
14 stopped (acl:relcl)
study literature (conj)
distribution body (compound)
trial uroprophylaxis (nmod)
appeared one (nsubj)
study methods (compound)
role pathways (nmod)
embryopathy isotretinoin (compound)
greater 0.90 (nmod)
cylinder of (case)
superior also (advmod)
telmisartan monotherapy (dep)
evaluated uncertainty (nsubjpass)
administered can (aux)
removed group (nsubj)
reduced erections (nsubjpass)
reaction generalised (amod)
spared were (auxpass)
days two (nummod)
conclusions tolerated (dep)
contributes inhibition (nsubj)
change % (appos)
effect principal (amod)
differ may (aux)
rat adult (amod)
liver animals (nmod)
lt disease (nmod)
demonstrate studies (nsubj)
mfs with (case)
p= 0.01 (dobj)
enhanced dextromethorphan (nsubj)
gtn : (punct)
lesions slight (amod)
dose human (amod)
angiographies were (cop)
sprouting mossy (compound)
induced isoflurane (nmod)
content tissue (compound)
amphotericin from (case)
signs focal (amod)
intensity in (case)
group 8-wk (amod)
acquired data (nsubjpass)
patient hospitalized (amod)
hours 2 (nummod)
weights molecular (amod)
identical milder (advcl)
predictors . (punct)
re-established period (nmod)
used war (nmod)
possible performed (advcl)
paracetamol nimesulide (conj)
demonstrate bulk (nsubj)
repair following (case)
link possible (amod)
providing treatment (nmod)
given child (nmod)
ability orgasmic (amod)
different decrease (dep)
ameliorates it (nsubj)
men ) (punct)
hydration irrigation (conj)
enlarged and (cc)
adenosine , (punct)
index high (amod)
nausea one (nmod)
adherence with (case)
colonoscopy and (cc)
t.d.s. of (case)
ventricles cats (nmod)
temperature and (cc)
approach and (cc)
apposition formation (conj)
resonance with (case)
sheath of (case)
rule attempt (acl)
pharmacokinetics nonoverdose (amod)
improves dose (nmod)
given that (nsubjpass)
fetal neonatal (conj)
itself in (case)
case attributable (amod)
deletion targeted (amod)
observed inhibits (ccomp)
strong weight (nsubj)
pathogenesis apnea (nmod)
suppressed while (mark)
alteration degeneration (conj)
considered recently (advmod)
care ( (punct)
fibrosis significant (amod)
scored , (punct)
order diagnose (acl)
have agents (nsubj)
agent background (compound)
lethality stress-induced (amod)
report development (nmod)
remains paranoia (nsubj)
action antiparkinsonian (amod)
inrcease with (case)
dose mg/m(2 (appos)
remodeling ventricular (amod)
nausea ) (punct)
damage significant (amod)
mechanisms neuropathy (nmod)
design according (case)
stopped was (auxpass)
implanted crystals (nsubjpass)
structures with (case)
seizure gtcs (appos)
aware . (punct)
slight very (advmod)
biopsy liver (compound)
imaging mri (appos)
use short-term (amod)
rat transgenic (amod)
cell hrptec (compound)
formation the (det)
prolonged , (punct)
was effectiveness (nmod)
responses blood (compound)
antidepressant used (acl)
$ROOT$ haematological (sent)
cord a (det)
method applicable (amod)
protective ) (punct)
studies controlled (amod)
complex more (advmod)
effects stroke (nmod)
3-methoxy-4-hydroxyphenethyleneglycol mhpg (appos)
speak observations (nsubj)
evidence physiologic (amod)
toxicity cystitis (conj)
sensation , (punct)
maintained follow-up (nsubjpass)
discontinued observed (advcl)
hydrochloride ( (punct)
microvessels brain (nmod)
kg-1 and (cc)
vocabulary a (det)
therapy second-line (amod)
therapies anti-adenoviral (amod)
mg/kg/day 20 (nummod)
uremic hemolytic (amod)
dysfunction infrequent (amod)
bore hallmarks (dobj)
antagonized enhancement (nsubjpass)
predictors seizures (nmod)
caudate or (cc)
conducted . (punct)
inhibited all (advmod)
use imipramine (nmod)
able we (nsubj)
occurred tdp (nsubj)
intranasal intravenous (conj)
approach our (nmod:poss)
represents mechanism (dobj)
cisplatin day (nmod)
cessation complete (amod)
shunting hypoxia (nmod)
used days (nmod)
% 17 (nummod)
examines study (nsubj)
feasible is (cop)
reference as (case)
using intervals (dobj)
120 < (advmod)
points . (punct)
mediated reduced (conj)
level glomerular (amod)
hypotheses studies (conj)
area motor (amod)
equipotent cck-8-se (nmod)
find out (compound:prt)
rats short-term (amod)
transplantation orthotropic (amod)
cases fide (amod)
microgram/ml 2.5 (nummod)
mg/dl and (cc)
mechanisms two (nummod)
produced rabbits (nmod)
used study (nsubj)
line microvascular (amod)
caproate to (case)
polymorphism a (det)
leukemia t-lymphocytic (amod)
hopes initial (amod)
affect ' (punct)
exhibits given (mark)
course products (nmod)
all words (nmod)
contributing plasticity (nmod)
application pilocarpine (nmod)
base lv (compound)
database pharmacovigilance (compound)
use product (compound)
lesions hyperintense (amod)
vancomycin administered (acl)
undergone catheterizations (dobj)
dismutase transferase (conj)
caused akathisia (nsubjpass)
interference possible (amod)
flow renal (amod)
myocarditis the (det)
sulpiride dopamine (compound)
paucity information (nmod)
show phenotypes (nsubj)
tested been (auxpass)
follow follow-up (nmod)
implicated accident (nmod)
reduplication . (punct)
july 2006 (nummod)
score total (compound)
% 95 (nummod)
sas and (cc)
scores parts (dep)
scopolamine both (cc:preconj)
induced slowdown (dobj)
induce synthesis (dobj)
alternative : (punct)
srl ) (punct)
reduced development (dobj)
gives insufficiency (nmod)
atpase na+/ (compound)
ccnu lomustine (appos)
overlooked easily (advmod)
sulfate sulfate (conj)
rabbits on (case)
women twenty-five (nummod)
obtained period (nmod)
infarction stroke (conj)
tended have (xcomp)
blocked that (nsubjpass)
pressing lifting (nmod)
sedation agranulocytosis (conj)
participated migraineurs (nsubj)
caused 3 (dep)
increment cyclophosphamide (nmod)
sensation burning (amod)
prevention rejection (nmod)
behaviour their (nmod:poss)
$ROOT$ 24.3 (sent)
failed comply (xcomp)
= < (dep)
toxicity associated (acl)
ameliorated treatment (nmod)
aes renovascular (amod)
medications neuroleptic (amod)
injection intracortically (advmod)
withdrawal paw (compound)
free ( (punct)
detection sensitization (nmod)
hypotension this (det)
use reduce (acl)
antagonist endothelin (compound)
unconscious was (cop)
coma of (case)
doses beta-blockers (nmod)
stimulate pge2 (nsubj)
effect cardiotoxicity (conj)
glimepiride with (case)
nhe3 tsc (conj)
declined day (nmod)
sacrificed were (auxpass)
toxicity metronidazole (compound)
injection treatment (nmod)
applied scales (nsubjpass)
rr , (punct)
antagonists patients (nmod)
reduced enhanced (parataxis)
mice exposure (nmod)
neuroimage , (punct)
$ROOT$ exceeded (sent)
responses three (nummod)
lower trials (nmod)
indicate contributes (ccomp)
follow plan (nsubj)
transfer field (nmod)
when was (cop)
reversed bicuculline (nsubj)
iop /= (cc)
dexmedetomidine meta-analysis (appos)
dogs into (case)
administered completion (nmod)
44 15 (compound)
rebound the (det)
male , (punct)
therapy immunosuppressive (amod)
highlighted difficulty (nsubjpass)
expression intrarenal (amod)
monitored status (nsubjpass)
hypothermia the (det)
procoagulant and (cc)
differences : (punct)
cause cause (conj)
frequency bf (appos)
acknowledged be (auxpass)
weakness dystrophy (nmod)
59 ) (punct)
carcinomas in (case)
seven two (compound)
possible means (nmod)
entered total (nsubj)
correspond activation (nsubj)
accidents with (case)
infiltration by (case)
arteriolar and (cc)
induced microangiopathy (nsubjpass)
age their (nmod:poss)
case such (predet)
alf rank (appos)
sessions after (case)
stenosis during (case)
respond months (nmod)
affect , (punct)
occurred ng/dl. (dep)
suspected tacrolimus (nsubjpass)
models and (cc)
elevation marked (amod)
hypertension either (cc:preconj)
53 to (case)
hours 72 (nummod)
damage hyperammonemia (appos)
associated hypereosinophilia (nmod)
training period (conj)
drugs aryl-piperazine (compound)
reversible achieved (advcl)
mixture anesthetic (nmod)
$ROOT$ lessened (sent)
drug given (acl)
days 8 (conj)
l 3.3 (appos)
changes muscles (nmod)
cerebral + (cc)
cardioprotection cardiotoxicity (nmod)
decreased ee (nmod)
evaluated treatment (nmod)
measurements anthropometric (amod)
model induced (amod)
resulted weeks (nmod)
lysozyme nag (conj)
improved ameliorated (conj)
different that (mark)
disappeared patient (nmod)
collagen iii (nummod)
maintained were (auxpass)
higher p (dep)
hydrochlorothiazide with (case)
vte for (case)
lower also (advmod)
elevation during (case)
given treatments (nsubjpass)
r(2)=0.79 ( (punct)
occurred release (nsubj)
acuity on (case)
seizures bupropion-induced (amod)
ka ( (punct)
effects biphasic (amod)
undergone who (nsubj)
progression disease (nmod)
attitude puerile (compound)
injury ongoing (amod)
puncture or (cc)
occurred where (advmod)
response stimuli (nmod)
awake alert (conj)
dose mcg/kg (appos)
k+ serum (compound)
animals pretreated (amod)
incidence hematuria (nmod)
reaction quetiapine (nmod)
effect dose-related (amod)
pattern restrictive (amod)
inhibit that (nsubj)
dopamine activity (dep)
9.1 2.0 (conj)
changes ischemic (amod)
complications infections (nmod)
neurodegeneration of (case)
produced dogs (nmod)
considered test (xcomp)
syndrome leak (compound)
carcinoma transitional (amod)
efficient dexamethasone (nsubj)
$ROOT$ undergone (sent)
behavioral neurochemical (conj)
assess accounting (advcl)
isomer the (det)
anemia ribavirin-related (amod)
84 13 (conj)
( + (cc)
known is (auxpass)
methotrexate following (case)
monitored and (cc)
recruited studied (conj)
data suggesting (acl)
$ROOT$ ischemia (sent)
kg(-1 mg (nummod)
treated vpa (nmod)
formation bfue (nmod)
using probe (dobj)
force static (amod)
expression molecules (nmod)
aim our (nmod:poss)
eye to (case)
infections cytomegalovirus (compound)
reverse could (aux)
500 550 (conj)
trained subjects (nsubjpass)
$ROOT$ are (sent)
design experimental (amod)
activity definite (amod)
resurgence by (case)
pregnancies , (punct)
clarify to (dep)
region hippocampus (nmod)
therapy current (amod)
origin uncertain (amod)
oxacillin to (case)
help concerns (nsubj)
was loss (attr)
= 1.34 (dobj)
ensued behavior (nsubj)
absorption warfarin (nmod)
1 approximately (advmod)
numbers decreasing (amod)
increases period (nmod)
1a1/1a2 , (punct)
elevation abrupt (amod)
deletion and (cc)
fits clonic (amod)
had action (dobj)
increases compared (advcl)
nsaid weak (amod)
injection agent (nmod)
acid harmful (amod)
1.0 0.1 (conj)
liver shrunken (amod)
effect toxic (amod)
csa all (appos)
mouse and (cc)
gained could (aux)
arteries cava (conj)
dogs defect (nmod)
revealed degrees (dobj)
group verapamil (nmod)
ka as (case)
abuse ma (compound)
enalapril mg (amod)
cholesterol ldl (compound)
rat ' (punct)
off ' (punct)
defects vfd (appos)
docetaxel intravenous (amod)
tia ( (punct)
hypotension alpha2- (amod)
streptozocin by (case)
used activation (nsubjpass)
signs inflammation (nmod)
described girl (nsubjpass)
$ROOT$ with (sent)
increased times (dobj)
tma ) (punct)
paralysis temporary (amod)
related inhibition (nmod)
hamartoma hepatoma (conj)
occurred retention (nsubj)
propylthiouracil ptu (appos)
essential da (nsubj)
effects clomipramine (nmod)
neurons gyrus (nmod)
hz 1v (conj)
testing seizure (compound)
manifestation on (case)
determined morphometry (nmod)
fever , (punct)
expressing ligand (dobj)
sign used (advcl)
d3 iu (compound)
frequency factors (conj)
agents antibacterial (amod)
mice ninety-six (nummod)
altered be (auxpass)
citalopram of (case)
day one (nummod)
scarce patients (nmod)
got , (punct)
chronotropic tremor (conj)
lithiasis kidney (nmod)
observed immunoreactivity (nsubjpass)
blocks two (nummod)
observed relationship (nsubjpass)
developed amylase (dobj)
magnitude be (cop)
prevalence syndrome (nmod)
mediate that (mark)
patients protection (nmod)
open- and (cc)
treated identically (advmod)
study rat (nmod)
administer epinephrine (dobj)
pharmacology the (dep)
kinase ilk (appos)
4.96 users (nmod)
implicated species (nsubjpass)
fibres in (case)
considered genesis (nmod)
bupropion the (det)
disease hodgkin (compound)
vol% , (punct)
2.20 interval (dep)
busulfan under (case)
mg/kg lidocaine (nmod)
mellitus iddm (appos)
neurosci . (punct)
result anemia (nsubj)
properties convulsant (amod)
10 about (advmod)
snaps ) (punct)
reversed discontinuation (nmod)
reported infants (nmod)
imparts . (punct)
awakening post (case)
interaction clonidine (nmod)
males adult (amod)
mmc mg/m(2 (appos)
dental or (cc)
doses with (case)
acrolein mg. (nmod)
headache -- (punct)
elevated plasma (nsubj)
hyponatremia associated (acl)
bs of (case)
thinning a (det)
patients five (dep)
vacuoles neurons (nmod)
crocins mg/kg (appos)
octogenarians to (case)
catalyze vitro (advmod)
toxicity haematological (amod)
plasma development (nmod)
23.5 2.7 (nummod)
erythropoietin rhuepo-beta (appos)
development toxicity (nmod)
examination laboratory (compound)
60 approximately (advmod)
those are (cop)
metabolism oxidase (compound)
observations conjunction (nmod)
seem play (xcomp)
suppressing dna (dobj)
pallidotomy experience (dep)
advised administration (nsubjpass)
cancers diagnosed (acl)
sodium cephalothin (compound)
icu in (case)
detected rejection (nsubjpass)
studies normal (amod)
enrolment at (case)
microg ) (punct)
changes cardiomyopathy (conj)
treated indomethacin (nmod)
syndrome lethal (amod)
peptides both (det)
myocytes the (det)
showed ratings (nsubj)
methods hybridization (compound)
agents interact (acl:relcl)
subtherapeutic " (punct)
group -chlorpheniramine (appos)
involved glaucoma (nmod)
kinase protein (compound)
norms values (conj)
trough-concentrations and (cc)
arytenoid of (case)
mediation l-dopa (nmod)
rise upon (case)
embarrassed very (advmod)
episode anuria (nmod)
cytometric flow (nmod:npmod)
index lvpw (compound)
$ROOT$ antibodies (sent)
episodes brief (amod)
length extent (conj)
valves vasculature (conj)
decrease sem (nmod)
mg/kg doses (nsubj)
treated seizures (nsubjpass)
persists responds (conj)
22-fold approximately (advmod)
admitted man (nsubjpass)
day training (compound)
33 five (compound)
represented treatment (dobj)
suspected reaction (nsubjpass)
reducing speed (dobj)
zolmitriptan to (case)
event therapy (nmod)
d-med and (cc)
elevated plus (cc)
had decreases (dobj)
acuity or (cc)
glaucoma primary (amod)
viruses hemorrhagic (amod)
time baseline (nmod)
administration intramedullary (amod)
assessed thus (advmod)
norleucine , (punct)
c(max ) (punct)
post days (nmod:npmod)
handling ca(2 (compound)
ce target (amod)
signs edema (nmod)
trials states (nmod)
ulcer this (det)
incorporating b (dobj)
increase secretion (nmod)
degrees follow-up (nmod)
infusion lidocaine (compound)
rats isoproterenol-pretreated (amod)
animals 92 (nummod)
informed poorly (advmod)
stn unilateral (amod)
fatigue urine (conj)
study single-blind (amod)
expression neurons (nmod)
patients gallstones (nmod)
estimate incidence (dobj)
thrombus , (punct)
temperature basal (amod)
control ee-treated (conj)
presence csa (nmod)
shown reduces (ccomp)
transferase-mediated deoxynucleotidyl (nmod:npmod)
have tumors (nsubj)
effect proarrhythmic (amod)
insecticide is (cop)
infection chronic (amod)
dogs tumor-bearing (amod)
reported hitherto (advmod)
parts head (nmod)
supported investigate (advcl)
continued patient (nsubj)
junction craniocervical (amod)
determined sensitivity (nsubjpass)
immunosuppression patients (nmod)
licensed : (punct)
tested analysis (nmod)
activation nmda (compound)
started involved (conj)
hemianopia bitemporal (amod)
incidence nodules (nmod)
labeled-positive terminal (amod)
transport by (case)
drug was (acl:relcl)
spectrum dermatitis (nmod)
performs role (dobj)
annuals the (det)
spent quadrant (nmod)
l 75 (nummod)
syndrome fulminant (amod)
lesion : (punct)
evidence first (amod)
stones with (case)
vip(-/- ) (punct)
pcpa alone (advmod)
morbidity and (cc)
activation translocation (conj)
induced seizures (nmod)
months additional (amod)
use relaxants (nmod)
variability natural (amod)
adding mesna (dobj)
mg/kg/i.p or (cc)
memory learning (conj)
% : (punct)
hepatotoxicity series (dep)
revealed effect (dobj)
6-months hyperprolactinemia (nmod)
suggesting rich (ccomp)
brought hospital (nmod)
diagnosis granulomatosis (nmod)
lines two (nummod)
reduce order (nmod)
117.61 +/- (cc)
material electrodes (appos)
avoiding at (mark)
prescribed who (nsubjpass)
ventilation to (case)
developed protect (advcl)
medications diagnoses (conj)
glands parathyroid (amod)
hypotension selegiline-induced (amod)
review wide (amod)
5/8 ) (punct)
waves triphasic (amod)
effect against (case)
intervention(s ): (punct)
observed was (auxpass)
blotting analysis (conj)
284 +/- (cc)
externa in (case)
women aged (amod)
5.2/100,000 ) (punct)
conception from (case)
crf with (case)
mmol/l to (dep)
differ mrna (nsubj)
attribute episodes (dobj)
questionnaire history (compound)
health good (amod)
aspects many (amod)
time weeks (nmod)
history smoking (nmod)
disease severe (amod)
show bands (ccomp)
half-time in (case)
software derived (acl:relcl)
bones of (case)
delay 2-h (amod)
program regular (amod)
eligible were (cop)
thromboembolism and (cc)
lasting hours (nmod)
dysfunction induced (acl)
injecting month (nmod)
thromboses ) (punct)
270 and (cc)
caused control (advcl)
ro4368554 possibly (advmod)
believe conclusion (nmod)
vehicle its (nmod:poss)
000 10 (compound)
found delirium (nsubjpass)
understood suggests (conj)
effects volunteers (nmod)
discriminated damage (nsubjpass)
kilogram per (case)
carbenicillin with (case)
0 to (dep)
meq/l 0.6 (nummod)
37 % (appos)
resulted known (advcl)
agents from (case)
tests program (dep)
include anemia (dobj)
occurrence adr (nmod)
ts of (case)
ds ( (punct)
reshape base (dobj)
hyperprolactinemia , (punct)
ones parp-1-/- (amod)
reduced rats (nmod)
mice sgk1(+/+ (amod)
characterised movements (nmod)
rejection or (cc)
lower sbp (nmod)
bradycardia less (amod)
present other (advmod)
levels 5-ht (nmod)
matter associated (advcl)
groups animals (nmod)
developed angioedema (nsubj)
suspected neuropathy (nsubjpass)
investigated approaches (dobj)
corrected successfully (advmod)
synthesis liver (nmod)
$ROOT$ thrombosis (sent)
syndromes series (nmod)
studying when (advmod)
spaces decreased (amod)
show tolerated (ccomp)
reached . (punct)
one hundred (compound)
chemopreventive as (case)
azelastine , (punct)
regeneration " (punct)
complex by (case)
breath mechanical (amod)
hepatitis clopidogrel-related (amod)
administration fentanyl (nmod)
used d-penicillamine (nsubjpass)
lost is (auxpass)
sufficient prevent (xcomp)
worst . (punct)
half approximately (advmod)
needed . (punct)
measures main (amod)
surgery including (case)
efficient , (punct)
microg/kg/min . (punct)
changed saline (nmod)
doses all (det)
suggested but (cc)
found drug (xcomp)
abuse pregnancy (nmod)
$ROOT$ checked (sent)
performed elucidate (advcl)
antagonist h2 (compound)
renin cortical (amod)
proteinuric rats (nsubj)
adrenaline epinephrine (appos)
drugs affect (acl:relcl)
carriers surface (compound)
reaching patients (nmod)
d-amb of (case)
arthralgia i.e. (advmod)
failure defined (acl)
substances acid (compound)
cataracts keratopathy (conj)
improves aniracetam (nsubj)
deficiency deficiency (conj)
im ) (punct)
resolved incontinence (nsubj)
grade and (cc)
dna virus (compound)
cya greater (amod)
markers these (det)
cocs of (case)
group monkeys (nmod)
abilities acetaminophen- (nmod)
channels nucleotide-gated (amod)
remission she (nsubj)
measures neuropsychological (amod)
confusion reaction (appos)
decreased moreover (advmod)
leads and (cc)
injury podocyte (compound)
2.2 0.6 (compound)
2-chloroprocaine-ce of (case)
clearance , (punct)
slowed cases (nmod)
pvc such (case)
units care (compound)
42 ) (punct)
vocabulary symbol (conj)
result background (nsubj)
meq/l ( (punct)
symptoms similar (amod)
area aspect (conj)
bodies without (case)
drug anxiolytic (amod)
considered alternative (nmod)
scopolamine , (punct)
declined and (cc)
tissue tumor (compound)
included compounds (nsubj)
passed polygraph (nmod)
conducted 2.0 (parataxis)
showed kidneys (nmod)
relevant be (cop)
oxide oxygen (conj)
necrosis rats (nmod)
cycle after (case)
induction sevoflurane (compound)
ester cck-8-se (appos)
interdependence due (case)
increase in (case)
tablets sustained-release (amod)
offer utility (dobj)
version ( (punct)
day 54 (nummod)
analogs differ (acl:relcl)
levels towards (case)
episodes arrhythmia (nmod)
manner randomized (amod)
time follow-up (amod)
pregnanolone 3alpha-hydroxy-5beta-pregnan-20-one (appos)
involved ears (dobj)
ligation 48-h (amod)
greater 0.5 (nmod)
tested effects (nmod)
octreotide , (punct)
injected 38 (conj)
opaque absent (conj)
patients 118 (nummod)
cohort consecutive (amod)
continues agent (xcomp)
schiff acid (compound)
quinpirole and (cc)
appears . (punct)
complication significant (amod)
thrombosis coronary (amod)
secretion mediated (acl:relcl)
(anca)--associated antibody (nmod:npmod)
sleep night-time (amod)
procedure surgery (conj)
fhf with (case)
stimulated has (aux)
increase absence (nmod)
neuropathy myelo-optic (amod)
revealed frequently (advmod)
cases hospital (nmod)
5.7 8.0 (conj)
concentration magnesium (compound)
encephalopathy patient (nmod)
vehicle ip (advmod)
children four (nummod)
steel of (case)
injured extensively (advmod)
stages dependence (nmod)
doses mg/kg (appos)
indomethacin such (case)
developed 5 (dobj)
developed level (nmod)
evaluated idraparinux (nsubjpass)
group experienced (acl:relcl)
exceeding not (neg)
identified variety (nsubjpass)
450 ( (punct)
conclusion alternative (appos)
kept prescribing (advcl)
equipment through (case)
caused inhibition (nmod)
challenge an (det)
cells peripheral (amod)
detected decrease (dobj)
bradycardia by (case)
appear model (xcomp)
decreased induction (nmod)
13 14 (conj)
infarction ) (punct)
suffered myalgia (nmod)
injected determined (conj)
indicate supporting (xcomp)
were trial (nmod)
trimester until (case)
content treated (acl)
phenacetin of (case)
related probably (advmod)
approved is (auxpass)
end to (case)
evidence with (case)
dose verapamil (nmod)
administering when (advmod)
evident month (nmod)
offers dosing (dobj)
(zdv)-induced zidovudine (nmod:npmod)
pentylenetrazol to (case)
chemistry of (case)
carbimazole following (case)
discuss applications (dobj)
noted effects (nsubjpass)
candidates who (nsubj)
aed ) (punct)
$ROOT$ experiences (sent)
2.96 to (dep)
short-term (noncardiac)/periprocedural (appos)
rat normal-salt (amod)
ng shr (nmod)
infective or (cc)
group 3-wk (amod)
gyki-41 of (case)
phosphatase located (amod)
blood in (case)
inhibitors no (neg)
seizure duration (dep)
contained carbachol (dobj)
episodes seizure (nmod)
metabolite cytostatics (nmod)
decreased layer (nmod)
decreases respectively (advmod)
activates nicotine (nsubj)
recurrence or (cc)
hemorrhage on (case)
week per (case)
mg. 60 (nummod)
patients 160 (nummod)
metabolism drug (compound)
abnormality found (acl)
amb ) (punct)
26.3+/-3.6 29.0+/-2.1 (conj)
immunosuppression sirolimus-based (amod)
report lesions (conj)
man 47-year-old (amod)
contribute cells (nmod)
child each (det)
seven % (dep)
genotyped using (xcomp)
enhanced les (dobj)
hypophosphatemia , (punct)
induced fluoxetine (nsubj)
movements . (punct)
pressure derivative (conj)
cord greater (amod)
k)-atpase , (punct)
effect class (compound)
checklist-90-revised symptom (compound)
concentrations daily (amod)
growth with (case)
history gout (nmod)
14 3 (conj)
found use (nmod)
frlma ) (punct)
state of (case)
response hypercapnic (amod)
beats by (case)
rate hypotony (nmod)
signals chemical (amod)
screened who (nsubjpass)
maze elevated (amod)
findings in (case)
effects side (compound)
azathioprine of (case)
needed treat (xcomp)
carriers 12 (nummod)
appearance symptoms (nmod)
associated drug (nsubjpass)
relevance might (aux)
show , (punct)
changes consistent (amod)
configuration threshold (compound)
exists injury (nmod)
psychosis bipolarity (conj)
myelosuppression . (punct)
drug needs (nmod)
p " (punct)
duration levels (conj)
constant to (case)
diagnosis after (case)
intervals 3-week (compound)
he-lfb neurofilament (appos)
insult dose (appos)
generation and (cc)
angina but (cc)
$ROOT$ permit (sent)
ng-nitro-l-arginine l-noarg (appos)
group reference (amod)
raised were (auxpass)
1520 +/- (cc)
hu 100 (nummod)
increased devoid (advcl)
infusions microgram/kg/min (compound)
disturbance observed (amod)
rate dysfunctions (nmod)
contributed mechanisms (nsubj)
predictable = (parataxis)
cells/mm3 cells/mm3 (conj)
signs serious (amod)
dissection or (cc)
users users (conj)
agent might (aux)
phosphanilate agent (appos)
experiments five (nummod)
brought increase (advcl)
examined possibility (nsubjpass)
treatment cbz (compound)
drawn images (nmod)
group enflurane (compound)
report stating (acl)
used initially (advmod)
month effect (nsubj)
mass pulmonary (amod)
reaction for (case)
pentetrazol ptz (appos)
coeruleus and (cc)
loss preservation (conj)
dilatation , (punct)
areas body (nmod)
analysis ich (nmod)
thresholds hearing (compound)
increase acute (amod)
led effect (nsubj)
infiltration under (case)
flavonoids such (case)
dinitrate isosorbide (compound)
caused hyperactivity (nmod)
phenytoin dph (appos)
$ROOT$ hypothermia (sent)
sampled frequently (advmod)
surgery risk (compound)
1.3 relative (advmod)
suppress however (advmod)
volume arterial (amod)
or=2.870 ( (punct)
persisted up (prep)
sinuses carotid (compound)
rats saline- (amod)
seizures minor (amod)
erp , (punct)
case use (nmod)
indeterminate are (cop)
woman 22-year-old (amod)
potential emerging (acl)
made although (mark)
velocities different (amod)
males , (punct)
300 500 (conj)
acetate mg (appos)
hypertension depression (nmod)
received responders (nsubj)
min dosing (nmod)
variables influence (acl:relcl)
activity minimal (amod)
effects carboplatin (compound)
alcohol s-perillyl (compound)
infusion systemic (amod)
reduced aqp2 (nsubjpass)
three receiving (acl)
guanethidine or (cc)
associated sequelae (nmod)
action study (dep)
excreted most (nsubjpass)
expression ldlr (compound)
prevention cin (nmod)
months 1 (nummod)
concentration myocardial (amod)
experiences eyes-closed (amod)
associated interval (nmod)
act drugs (nsubj)
received micrograms (nmod)
vsd ( (punct)
shown patient (nmod)
used combination (nmod)
controls nifedipine (nsubj)
prodrug developed (conj)
genotyped . (punct)
inducing and (cc)
reacts protein (nmod)
deterioration an (det)
currents rectifier (compound)
patients mellitus (nmod)
rest as (cc)
crataegus , (punct)
suffers lesion (nmod)
ventral and (cc)
dyskinesias onset- (amod)
were desire (nmod)
dexrazoxane without (conj)
micromol/l 3 (nummod)
sensitized , (punct)
tested using (advcl)
calculated area (nmod)
conducted scheduled (advcl)
p mg/day (appos)
excretion great (amod)
compensated well (advmod)
lines the (det)
one up (advmod)
secondary was (cop)
administration levodopa/carbidopa (compound)
loss gentamicin-induced (amod)
blockade inhibitor (nmod)
reduction of (case)
igf-i gh (conj)
indication no (neg)
begin phenobarbitone (dobj)
transplant bone (compound)
cured not (neg)
changes histology (nmod)
have situations (nsubj)
reductase gsh (appos)
receptors 5-hydroxytryptamine1a (compound)
aged 76 (nmod:npmod)
caused hg (dep)
microinjection neurotensin (nmod)
treatment yohimbine (nsubj)
mg/m2/d 400 (nummod)
agent desipramine (appos)
exhibited state (dobj)
pressure hemodynamics (conj)
scored iq (nmod)
effect measurable (amod)
consisted sample (nsubj)
chorionic and (cc)
enhanced administration (nsubj)
antagonist m1-selective (amod)
impaired . (punct)
factors be (cop)
lessen that (mark)
associated increasing (nsubjpass)
help how (advmod)
that arteries (nmod)
vincristine and (cc)
medium , (punct)
trials of (case)
activates remains (advcl)
recipients renal (amod)
age abuse (conj)
velocity shortening (nmod)
1.0 2.0 (conj)
revealed bradycardia (dobj)
130 and (cc)
implicate mechanisms (dobj)
had managed (conj)
v. i. (compound)
angle primary (amod)
allows observations (dobj)
effect monoher (nmod)
responsible regulation (nmod)
appear do (aux)
rhizomes kurroa (compound)
play htr6 (nsubj)
diagnosed age (nmod)
nitrogen urea (compound)
epilepticus induced (acl)
and daily (advmod)
effects typical (amod)
occur might (aux)
contexts surgery (nmod)
hemorrhage or (cc)
had cancer (dobj)
operative and (cc)
emerged assessment (nsubj)
cells gyrus (nmod)
potent propranolol (nmod)
medication investigational (amod)
evoked only (advmod)
objectives offset (appos)
reentry , (punct)
behavior both (cc:preconj)
receiving thorazine (dobj)
atrophy atrophy (nmod)
ability of (case)
benefited have (aux)
20 b. (nmod)
starting h (nmod)
accompanied restoration (nsubjpass)
detachment retinal (amod)
study users (compound)
degree fibrosis (conj)
condition in (case)
3tc nvp (conj)
i.v once (advmod)
worsen . (punct)
receiving and (cc)
switch for (case)
justify prevalences (nsubj)
ceased symptoms (nsubj)
study evaluating (acl)
property chronotropic (amod)
concentrations blood (compound)
inhibit lethality (dobj)
doses deferoxamine (compound)
adriamycin ml (appos)
disappeared normalized (conj)
300 10 (compound)
fk506 ) (punct)
yields cell (compound)
potential subclinical (amod)
basal and (cc)
sinus coronary (amod)
develop hepatitis (nsubj)
tool might (conj)
anticipated be (auxpass)
seizures behavioral (amod)
$ROOT$ mediates (sent)
two group (nmod)
ef ( (punct)
result positive (amod)
dementia type (nmod)
rise proteinuria (nmod)
pathway erk (compound)
revealed significant (ccomp)
althesin ) (punct)
g/m2 36 (nummod)
cyclophosphamide during (case)
assessable patients (nsubj)
glutathione cortex (nmod)
agent ifosfamide (nsubj)
measured hemodynamics (nsubjpass)
hypertension patients (nmod)
= 0.005 (dobj)
-15.4 ) (punct)
events from (case)
addition cultures (nmod)
sensitive to (mark)
atherosclerosis premature (amod)
3alpha-tropanyl-2-(4-chorophenoxy)butyrate ( (punct)
processes infectious (amod)
test prick (compound)
salivation , (punct)
dizziness ( (punct)
incidence significant (amod)
sent was (auxpass)
patient elderly (amod)
effect stress (nmod)
neurosis disturbances (conj)
66.9 . (punct)
modalities dental (amod)
reactivity dilevalol (nmod)
changes anaesthesia (nmod)
erdosteine by (case)
less night (nmod)
pattern regurgitation (nmod)
mg indomethacin (nmod)
segments in (case)
succeeded aim (xcomp)
corticosterone ppm (dep)
increased observed (advcl)
outcomes behavioral (amod)
recording by (mark)
placebo-controlled randomized (conj)
behaviour similar (amod)
sensitizes cardiotoxicity (nmod)
remodeling of (case)
measures reflecting (acl)
case any (det)
seizures from (case)
detected be (auxpass)
exhibited glomerulosclerosis (dobj)
relieve improve (conj)
infused and (cc)
results leading (advcl)
cisapride 3.4 (nummod)
receive bladder (nmod)
cases presented (acl:relcl)
concentration mg/ml (nmod)
follow that (nsubj)
u/l 1579 (nummod)
less incidence (nsubj)
type block (appos)
goal an (det)
pattern normal (amod)
occurred patients (nmod)
15 1 (compound)
considered currently (advmod)
$ROOT$ kinase (sent)
depleted meth (nsubj)
estradiol cpa/ee (appos)
line : (punct)
measured vivo (advmod)
immersed measured (conj)
designed discern (xcomp)
period to (case)
decreased dogs (nmod)
common ) (punct)
pulse steroid (compound)
inhibited immunosuppressants (nmod)
stains six (nummod)
2008 through (case)
ingredient main (amod)
ligands the (det)
prevention a (det)
indicated management (nmod)
vagal cardiac (amod)
bacteremia of (case)
echocardiography including (case)
pain setting (nmod)
regurgitation aortic (amod)
vmax low (amod)
vagal nor (cc)
scale point (compound)
form in (case)
administration chloride (nmod)
useful treatment (nmod)
submitted registry (nmod)
described not (neg)
-0.12+/-0.5 0.13+/-0.3 (conj)
incorporation a (det)
derives evidence (nsubj)
enlargement pressure (nmod)
was change (nsubj)
change response (nmod)
stimuli aversive (amod)
choosing before (mark)
uterus guinea (compound)
suggest less (ccomp)
unlikely therapy (nsubj)
antiepileptics other (amod)
present man (dobj)
worst significantly (advmod)
n. ( (punct)
gluconate intravenous (amod)
ascertained questionnaires (nmod)
maturation delayed (amod)
immediate delayed (conj)
conditions no (det)
oropharynx , (punct)
interval r-r (compound)
receiving mice (nmod)
center referral (compound)
caused probably (advmod)
mechanism regulation (nmod)
hour immediately (advmod)
cholecystokinin-octapeptide cck-8 (appos)
organisms aeruginosa (compound)
influenced , (punct)
reduplication study (dep)
standard injections (nsubj)
room er (intj)
diagnosis first (amod)
deprived pd (appos)
escape with (case)
flumazenil the (det)
mechanisms implications (conj)
< 0.01 (dobj)
convulsions local (amod)
animals 2 (nummod)
pathogenesis management (conj)
sensations such (case)
girl 15-year-old (amod)
resuscitate to (mark)
developed cholestasis (dobj)
gaba in (case)
rise = (dep)
pounds was (cop)
concluded but (cc)
six , (punct)
developed malaise (dobj)
reversed discontinuing (advcl)
. 2002 (nummod)
examined day (nmod:tmod)
insecticide of (case)
documentation little (amod)
unaffected cortex (nmod)
presented day (dative)
related accumulation (nmod)
temperament patient (nmod)
cochlea on (case)
seems possess (ccomp)
leukoencephalopathy disseminated (amod)
describe highlight (advcl)
profile volume (conj)
step nephrotoxicity (nmod)
high and (cc)
lnna from (case)
accepted diuretics (nsubjpass)
ato water (conj)
decreased diameter (dobj)
cerruloplasmin and (cc)
potentials transmembrane (amod)
urine patients (nmod)
fibrinolysis of (case)
h following (amod)
using positioning (dobj)
anxiety cocaine-induced (amod)
offered model (nsubj)
tumor estrogen-induced (amod)
response ] (punct)
stimulation-evoked field (nmod:npmod)
reduced protein (nsubjpass)
influence of (case)
gamma-hch after (case)
reduced but (cc)
occurred abnormalities (nsubj)
rate minutes (nmod)
haloperidol antagonist (appos)
% 98.8 (nummod)
increase awareness (dobj)
unable discontinue (xcomp)
dopaminergic tida (appos)
events vinorelbine-related (amod)
years smoking (conj)
caused gold (nmod)
amphetamine-free , (punct)
similarities underlying (amod)
showed elevation (dobj)
titration the (det)
reported regimen (nmod)
extension open-label (amod)
caudate-putamen in (case)
licensed uk (nmod)
treated conception (nmod)
nh4ac ) (punct)
on use (nsubj)
omission by (case)
2660 1200 (conj)
classification for (case)
beta both (cc:preconj)
research in (case)
lithium and (cc)
patients therapies (acl:relcl)
charge the (det)
associated used (advcl)
increase competing (advcl)
organization ( (punct)
members permanente (nmod)
hours four (nummod)
reported recently (advmod)
acid mg/kg (appos)
microliter 1 (nummod)
vehicle saline (compound)
system musculoskeletal (amod)
encephalopathy presentation (nmod)
variation interstrain (amod)
choleretic poor (amod)
leads iii (nummod)
completion infusion (nmod)
choose . (punct)
alteration of (case)
exerted vehicle (nmod)
death hippocampus (nmod)
children twenty (nummod)
effects effects (conj)
increase minus (cc)
group repetitive (amod)
rate catecholamine (compound)
activity cocaine- (amod)
reflex horizontal (amod)
accompanied moreover (advmod)
99 was (cop)
tgr ) (punct)
effect an (det)
treatment des (compound)
protein nag (conj)
gap doses (nmod)
14.3 , (punct)
astroctytes + (amod)
start use (nmod)
cya to (case)
hepatomegaly accumulation (conj)
agonists by (case)
effect aniracetam (nmod)
associated sex (nmod)
abortions saline-induced (amod)
hepatotoxicity subsequent (amod)
injection interval (nmod)
had opse (dobj)
destructive neurons (nmod)
examined timing (dobj)
lymphoma subtypes (conj)
independent presumably (advmod)
coefficient correlation (compound)
old year (nmod:npmod)
showed reductions (dobj)
efficacious would (aux)
recorded been (auxpass)
response challenge (nmod)
rate turnover (compound)
micrograms/kg h (nmod)
dissociation patients (nmod)
tremor catalepsy (conj)
necrosis but (cc)
mg/ml ) (punct)
s respectively (advmod)
alterations histopathological (amod)
decreases , (punct)
anesthetic long-acting (amod)
recognized previously (advmod)
anticoagulation prophylactic (amod)
factors three (nummod)
erection priapism (nsubj)
than conditions (nmod)
induced weaning (advcl)
institutes health (nmod)
had incidence (dobj)
protection histopathological (amod)
tilt the (det)
changes to (case)
onset disturbance (nmod)
% 7.7 (nummod)
administered task (nsubjpass)
interaction any (det)
taken processed (conj)
6.1 - (dep)
investigated presence (nmod)
returned ceasing (advcl)
myelodysplasia of (case)
atrophy optic (amod)
etoposide the (det)
volume dose (conj)
suppressed capacity (nsubjpass)
% alf (nmod)
antidotes combinations (conj)
suspected highly (advmod)
induced nitroglycerin (nmod)
discontinuous immunostaining (nsubj)
reverses pretreatment (nsubj)
lack for (case)
evaluation literature (compound)
lymphoma burkitt-type (amod)
prolonged dl-sotalol (nsubj)
c1 c2 (conj)
yields from (case)
compared baseline (nmod)
formation dogs (nmod)
immunosuppressant macrolide (compound)
test . (punct)
for those (nmod)
pretreatment antagonist (nmod)
alterations hemodynamic (amod)
saline mesna (conj)
apposed closely (advmod)
hours then (advmod)
basis blind (amod)
closed and (cc)
rechallenge warfarin (nmod)
hemorrhage frequently (advmod)
caused a (nsubj)
dose yohimbine (nmod)
develop features (dobj)
those in (case)
suggested evidence (nsubj)
threshold nociceptive (amod)
effect crocin (nmod)
administered testosterone (nsubjpass)
potassium sometimes (cc)
0.01 0.08 (conj)
underwent methods (nsubj)
assessment efficacy (compound)
del rs6275 (conj)
weight less (amod)
treatment and (cc)
microscopy pcr (conj)
leakage k(+ (nmod)
increase whereas (mark)
carried data (advcl)
effects diet (nmod)
infant exposure (nmod)
investigated models (nmod)
blocked be (auxpass)
ameliorated responses (dobj)
revealed use (nsubjpass)
was ; (punct)
showed increases (dobj)
patients stroke (compound)
illness familial (amod)
evaluated prospectively (advmod)
$ROOT$ shows (sent)
effect carbamazepine (nmod)
excluded patient (nsubjpass)
effects drug-induced (amod)
excitation , (punct)
widespread extremely (advmod)
prot 38 (nummod)
% 38.2 (nummod)
median years (appos)
activation toxicity (conj)
establish effect (dobj)
number higher (amod)
time respond (acl)
fashion randomized (amod)
hydrochloride-induced bupropion (nmod:npmod)
initiating therapy (dobj)
disrupts secondary (conj)
believed mediates (ccomp)
therapy after (case)
maintenance flow (nmod)
enzyme essential (amod)
disease her (nmod:poss)
stl2 ) (punct)
crisis of (case)
deficiency rat (nmod)
sediment active (amod)
recalled later (advmod)
creatine exogenous (amod)
technique microdissection (compound)
alkalosis relative (amod)
citrate sodium (compound)
care secondary (amod)
examinations clinical (amod)
it-methotrexate , (punct)
induced development (dobj)
developed gallstones (dobj)
aspartate in (case)
demonstrating specificity (dobj)
hours three (nummod)
females for (case)
diagnosis with (case)
refractory relapsed (conj)
reduced relaxations (nsubjpass)
33.8 +/- (cc)
medulla ventrolateral (amod)
group dex-only (amod)
quetiapine add-on (amod)
encouraging begin (xcomp)
group 4 (nummod)
l-name ( (punct)
reverted weeks (nmod)
remained asymptomatic (xcomp)
possible avoid (xcomp)
given delivery (nmod)
content hydroxyproline (nmod)
neurotoxicity lignocaine (nmod)
intervals p-p (compound)
11 12 (conj)
increases neurogenesis (nsubj)
cause leading (advcl)
i.p. , (punct)
pressure fluctuating (amod)
improved moderately (advmod)
medial lateral (conj)
use after (case)
iopamidol and (cc)
signal recorded (amod)
changes use (nmod)
antibiotic is (cop)
ecg a (det)
administration adriamycin (compound)
taken and (cc)
increasing association (nmod)
perimetry by (case)
lds ( (punct)
= or (cc)
alternatives appropriate (amod)
expressing ccr2 (dobj)
trial coronary (amod)
necrolysis of (case)
examine role (dobj)
variation , (punct)
observed substance (nmod)
biosynthesis in (case)
stimulate micturition (dobj)
case haemorrhage (nmod)
iv ii (quantmod)
% rate (nsubj)
mg/kg 322 (nummod)
lymphocytes + (amod)
behavior anxiety-like (amod)
level ) (punct)
increased increase (dep)
damage lesions (nmod)
5.3 ) (punct)
induced lindane (nmod:npmod)
observed while (mark)
levels patients (nmod)
maximal that (mark)
765 145 (conj)
circulation from (case)
associated hyponatremia (nmod)
felt hours (nmod)
implies obtained (conj)
play receptors (nsubj)
method equation (compound)
discharged home (advmod)
risk interactions (nmod)
response viral (amod)
present administration (nmod)
lacrimation in (case)
effects locomotion (nmod)
29.5 +/- (cc)
intralipid in (case)
improved patients (nmod)
occurrence cataract (nmod)
scale in (case)
tolerated therapy (nmod)
1.93 0.93 (compound)
percentage irrigations (nmod)
veins about (case)
patients manual (dep)
after following (conj)
media contrast (compound)
value km (compound)
cyclosporine microangiopathy (conj)
triad effects (nmod)
pneumonia patients (nmod)
understood due (prep)
congestants nasal (amod)
processes learning (compound)
7-ethoxyresorufin-o-deethylase demethylase (conj)
impairment prolonged (amod)
assay antigen (compound)
inhibitor that (mark)
thalidomide and (cc)
process arytenoid (nmod)
unable . (punct)
configuration hemorrhaging (conj)
symptoms asystole (conj)
2- , (punct)
abolished action (dobj)
75 25 (quantmod)
have recommended (advcl)
4 0.5 (compound)
impairment patients (nmod)
contraceptives newer (amod)
alprazolam mg (amod)
influences whether (mark)
fall heart-rate (nmod)
blocker calcium (compound)
those p (dep)
transporter . (punct)
reoccur , (punct)
tolerance . (punct)
3.0+/-0.4 similar (amod)
gamma-glutamyltransferase ; (punct)
morphine cnsb002 (conj)
hr during (case)
ocs third-generation (amod)
motor ( (punct)
cis-platinum of (case)
obstructive both (cc:preconj)
modulate hormone (nsubj)
hypoaldosteronism priapism (conj)
involvement disorder (nmod)
caused dysfunction (dobj)
therapy androgen (compound)
presented cases (nmod)
demonstrated signals (dobj)
t-cell cd4 (amod)
continued wore (conj)
produced that (nsubj)
twitches rats (nmod)
under-reporting detail (conj)
acetaminophen alone (advmod)
elevation . (punct)
stimulation chemical (amod)
nephrotoxicity tac (compound)
sought confirm (ccomp)
weight = (dep)
atropine , (punct)
men 14 (nummod)
response potassium (compound)
methimazole without (case)
regimens high-dose (amod)
t-tests paired (amod)
found rise (nsubjpass)
sets data (compound)
experiment : (punct)
produces patients (nmod)
preparation dog (compound)
$ROOT$ first (sent)
test habituation (compound)
apoptosis lymphocytes (nmod)
10-fold < (advmod)
showed associations (dobj)
manifestations disorder (nmod)
common adult (nmod)
hours x (compound)
manifestations oral (amod)
cortisol dysregulated (amod)
manifestations unexplained (amod)
induced ligation (nmod)
subscale mmrm (nmod)
lumens was (conj)
cent ns (appos)
decision a (det)
programming low (amod)
measurements echocardiography (appos)
were % (dobj)
methods conventional (amod)
carvedilol mg/kg (appos)
rhinitis for (case)
mmhg 170 (nummod)
erythrocytes , (punct)
titer acetylcholine (compound)
durations seizure (compound)
thalassemia with (case)
ug thereafter (advmod)
temsirolimus with (case)
manifested which (nsubj)
reduction er (compound)
factors related (acl)
rise rise (conj)
develop neurotoxicity (dobj)
comparable was (cop)
poag ) (punct)
hepatectomy partial (amod)
antibody and (cc)
patient failure (nmod)
evidenced administration (nmod)
changed catheters (nsubjpass)
renin endothelin-1 (conj)
exist reports (nsubj)
$ROOT$ applied (sent)
accepted cornerstone (nmod)
alternative treatment (nmod)
behavior her (nmod:poss)
regimen drug (compound)
ra ( (punct)
dp/dt positive (dep)
epinephrine by (case)
conclusive results (nsubj)
prevent rejection (dobj)
had yield (dobj)
examined carefully (advmod)
lack model (nmod)
telangiectatic and (cc)
shown indicate (conj)
given course (nsubjpass)
micrograms 0.1 (nummod)
disease stone (compound)
studies micropuncture (compound)
finding prolongation (nsubj)
7e , (punct)
deferens and (cc)
showed arteriography (nsubj)
stage acute (amod)
occurred bolus (nmod)
currents inward (amod)
have accuracy (dobj)
peg-asparaginase and (cc)
on in (case)
reduced reducing (advcl)
akt pakt (appos)
continued rise (xcomp)
taking ketoconazole (dobj)
neurotoxicity selective (amod)
headache gtn-induced (amod)
decreased phase (nmod)
patients disorders (nmod)
s 61.9 (appos)
phenotype macrophage-like (amod)
method crm (appos)
teoaes ( (punct)
scans spect (compound)
examined damage (dobj)
effect csa (nmod)
scintigraphy dynamic (amod)
conjugate containing (acl)
treatment variety (nmod)
masked which (nsubj)
review summarize (conj)
119 to (case)
uiu/ml 168 (nummod)
caused hypovolemia (nsubj)
attracted attention (dobj)
concentration nitrogen (compound)
resolved days (nmod)
cystitis associated (amod)
associated dysfunction (nmod)
conscious healthy (dep)
therapy testosterone (compound)
motility content (conj)
excess of (case)
bradycardia block (conj)
rates exercise (conj)
estradiol and (cc)
% 114.6 (nummod)
depends which (nsubj)
properties such (case)
using directly (advmod)
25 with (case)
sensitive , (punct)
fenoldopam with (case)
regained patient (nsubj)
preoperatively postoperatively (conj)
affected response (nsubjpass)
defects neurocognitive (amod)
patients cardiomyopathy (nmod)
records and (cc)
return then (advmod)
september 1992 (nummod)
similar cases (nmod)
hctz mg (amod)
sedation clear-headedness (conj)
agonist . (punct)
victim pain (nmod)
four all (advmod)
3.32 ) (punct)
30 3 (compound)
pr=0.515 , (punct)
associated lesion (nsubjpass)
% 47.9 (nummod)
activate disruption (nmod)
area forearm (compound)
tablets hypertension (nmod)
hg and (cc)
p= 0.17 (dobj)
reduplication peritubular (amod)
59 % (appos)
mg/kg/day : (punct)
study randomized (amod)
= ( (punct)
enucleations the (det)
lidocaine area (nmod)
dose dosage (nsubj)
continued be (auxpass)
identified germany (nmod)
appear mechanism (nsubj)
gender bilirubin (conj)
histories along (acl)
mr on (case)
ascitis increasing (amod)
influence damage (nmod)
seizures produced (acl)
fully partially (conj)
greater : (punct)
pretreatment norepinephrine (nmod)
months 10.6 (nummod)
defined previously (advmod)
patients response (nmod)
fentanyl meperidine (conj)
seizures markers (conj)
cromakalim nitroglycerin (conj)
emerged preceding (advcl)
finding reported (acl)
result death (nmod)
modulate gating (dobj)
bort dex (conj)
recorded movements (dobj)
planes spanning (acl)
thirds two (nummod)
suggest benefit (ccomp)
atria right (amod)
cerebellum the (det)
loci chromosomes (nmod)
increased resistance (nsubj)
patient renal-transplant (amod)
associated can (aux)
10mg/kg ( (punct)
allows whether (mark)
participation brain (nmod)
method discrimination (compound)
trends with (case)
cases highlighted (amod)
cause event (dobj)
clinic from (case)
mmec ) (punct)
nigra , (punct)
hours twenty (nummod)
australia in (case)
increase torr (nmod)
pain migraine (nmod)
tends increase (xcomp)
reduced atropine (nsubj)
7 2.4 (conj)
maintained was (auxpass)
methylprednisolone with (case)
fentanyl with (case)
hr dose (dep)
examined beginning (advcl)
subscale and (cc)
significant most (advmod)
interference infusion (nmod)
fibrillation flutter (conj)
central or (cc)
received exposure (dobj)
assess inhibition (dobj)
ascites hypoalbuminemia (conj)
consent with (case)
based review (nmod)
continue treatment (dobj)
obtained predose (advmod)
cancer be (cop)
stimuli procedures (conj)
course levels (conj)
november , (punct)
sah after (case)
reviewed compared (conj)
therapies immunosuppressive (amod)
be however (advmod)
achieved therapy (nmod)
weight molecular (amod)
percent ninety-five (nummod)
3tc t (conj)
linked is (auxpass)
observed dipyridamole (nmod)
map . (punct)
blockade transition (nmod)
increased patients (nsubj)
concealed team (nmod)
mouth hands (conj)
u/l 49 (nummod)
volunteers and (cc)
weeks 31 (nummod)
cns in (case)
limiting administration (dobj)
$ROOT$ authors (sent)
implicated incapacitated (conj)
neurotoxicity iddm (conj)
using engine (dobj)
anesthesia from (case)
inhibited reversal (dobj)
tachycardia 1 (meta)
elevating level (nmod)
reported needed (conj)
dexrazoxane doses (conj)
injury hence (advmod)
nephropathy mild-type (amod)
remains delivery (nsubj)
attenuated improve (conj)
undergoing was (aux)
dp/dtejc artery (compound)
forearm right (amod)
displayed accompanied (advcl)
fentanyl isoflurane (conj)
at least (mwe)
3tc were (cop)
agent neuropathy (nmod)
setup electrocorticogram (compound)
less danazol (nmod)
rate beats/minute (nmod)
desmethylimipramine i.c. (compound)
agonist a(1)-adenosine (compound)
$ROOT$ sensitive (sent)
stage c (dep)
agents antiinflammatory (amod)
confounding potentially (advmod)
muscle skeletal (amod)
ketamine of (case)
40 +/- (cc)
detect treat (conj)
state identify (conj)
% 45 (nummod)
reduced gradually (advmod)
lp ( (punct)
conclusions give (appos)
microinjection ritanserin (nmod)
phenobarbital substrate (compound)
equipotent almost (advmod)
stenosis only (cc:preconj)
injury against (case)
ameliorate rg1 (nsubj)
had impairment (dobj)
injury including (case)
related , (punct)
affinity strong (amod)
affected also (advmod)
concentrations higher (amod)
report coma (nmod)
used probably (advmod)
deficits systems (nmod)
improvement back (advmod)
b tgf-b (conj)
exhibit nos-ir (parataxis)
occurs blockade (nmod)
nd in (case)
content rna (compound)
mg/m2 doses (nsubj)
induced rats (nmod)
exposure diazinon (nmod)
responding therapy (nmod)
position lateral (amod)
six four (compound)
dose tobramycin (nmod)
lip and (cc)
increased conclusions (nsubj)
necrosis the (det)
damage less (amod)
recovery eventually (advmod)
associated degrees (nmod)
range and (cc)
signs congestion (nmod)
developed eight (nsubj)
dysrhythmias asystole (conj)
histological immunohistochemical (conj)
been fleming (attr)
polymerase enzyme (compound)
greater response (nsubj)
used prevention (nmod)
relapse no (neg)
used management (nmod)
promote . (punct)
$ROOT$ converts (sent)
activity nocturnal (amod)
$ROOT$ modified (sent)
died and (cc)
hepatitis exposure (nmod)
prodrug ) (punct)
nuclei auditory (amod)
responses 17 (nmod)
safety high- (nmod)
gfp ) (punct)
therapy infections (nmod)
patients 98 (nummod)
inhibitor autophagy (nmod)
restriction diet (compound)
abilities in (case)
induces correlation (dep)
contained licl (dobj)
mg/m(2 50 (nummod)
deduced be (auxpass)
zone in (case)
show findings (dobj)
biperiden of (case)
met had (conj)
sign warning (compound)
therapy corticosteroid (compound)
ad50 bupivacaine (nmod)
% 97.3 (nummod)
effect side (compound)
sbp level (conj)
explain impairment (nsubj)
having block (conj)
four of (advmod)
fatigue patients (nmod)
age 33 (nummod)
rats undergone (acl:relcl)
considering fact (dobj)
percent forty-four (nummod)
displayed mice (nsubj)
midbrain the (det)
unchanged period (nmod)
larger changes (nsubj)
hypothyroid clear (conj)
syndrome tachycardia (nmod)
block with (case)
dosages micrograms/day (nmod)
side-effects of (case)
patients 3379 (nummod)
consistent that (nmod)
effects arteries (nmod)
myocardium patient (nmod)
dse for (case)
administration hormones (nmod)
alpha2-adrenoceptors of (case)
widely less (advmod)
followed leukopenia (nmod)
p=0.025 ( (punct)
observed morbidity (nsubjpass)
concentrations tricyclic (amod)
lcva , (punct)
examined administration (nmod)
use txa (nmod)
$ROOT$ disposition (sent)
phenols and (cc)
mg/kg 1.5 (compound)
inhibited butyrylcholinestrase (dobj)
combination with (case)
20 , (punct)
rats diuresis (nmod)
diet deficient (amod)
symptoms schizophrenic-like (amod)
activity system (compound)
respond microglia (nsubj)
changed it (nsubjpass)
animals treated (amod)
use corticosteroid (compound)
important more (advmod)
nausea 1 (appos)
degrees azotemia (nmod)
regimen 2-week (amod)
absorption mepivacaine (nmod)
drinkers pregnant (amod)
retention task (nmod)
agonist adenosine (dep)
causes arrhythmia (dobj)
decreased 16 (nmod)
developed conversion (nmod)
wk two (nummod)
ceruleus locus (compound)
content hippocampus (nmod)
positive three (nsubj)
enables monitoring (dobj)
allograft of (case)
pretreatment sections (nmod)
g/day preswitch (dep)
time risk (conj)
tolerated topotecan (nsubjpass)
rise immediate (amod)
200 from (case)
hydrochloride pyridoxine (compound)
methods exclusion (nmod)
licensed treatment (nmod)
increase contractility (nmod)
patients epilepsy (nmod)
increase always (advmod)
transplantation and (cc)
rate between (case)
% p<0.02 (dep)
patients japanese (amod)
kinase p38 (compound)
reproduced lysate (nmod)
restore levels (nmod)
excluded echography (nmod)
similarities , (punct)
temporal bilateral (amod)
ulceration peptic (amod)
3722 319 (conj)
pelvis and (cc)
days to (case)
cyp2d6 by (case)
demonstration be (cop)
incontinence genuine (amod)
patients related (acl:relcl)
15 nearly (advmod)
failed restimulation (nsubj)
syndrome immune (amod)
activities antioxidants (nmod)
extremities his (nmod:poss)
neuropathy totp-induced (amod)
obtain may (aux)
cin between (case)
anemia old (nmod)
woman cambodian (amod)
skin the (det)
reduction reduction (conj)
[ 32.87 (nummod)
fit was (auxpass)
epilepsy suspected (amod)
vein retinal (amod)
control below (case)
amlodipine and (cc)
subgroup this (det)
lozenge of (case)
accumulation microvesicular (amod)
glut4 transporter (compound)
protein o/min/mg (compound)
augment injections (nsubj)
aware risk (advcl)
hypertrophy report (dep)
min 90 (nummod)
subsided regressed (conj)
frequent , (punct)
those whereas (mark)
users polydrug (compound)
good has (aux)
artery disease (conj)
correlation damage (nmod)
was terms (nmod)
dysfunctions these (det)
showed damage (nmod)
harm more (amod)
pretreated fashion (nmod)
phenomenon linked (acl:relcl)
individuals obstruction (nmod)
declined days (nmod)
regeneration to (case)
fenfluramine of (case)
carried found (conj)
intervention drug (compound)
rats with (case)
patients primarily (advmod)
days norethisterone (nmod)
analogue d (compound)
7.2 % (quantmod)
taking three (nsubj)
diltiazem long-acting (amod)
pharmacokinetics face (nmod)
inhibited appearance (nsubjpass)
evaluation hematology (nmod)
evaluates attempting (advcl)
chemotherapy and (cc)
age including (case)
influence catalepsy (nmod)
damage = (dep)
use angina (nmod)
level cholesterol (compound)
identified clearly (advmod)
genes downstream (amod)
rhabdomyolysis increment (conj)
developmental and (cc)
pool rats (nmod)
produce effect (dobj)
min 23.43 (nummod)
suggests useful (ccomp)
aggravated changes (nmod)
increase t1/2 (nmod)
associated effect (nmod)
droop with (case)
results showing (acl)
given not (cc)
diagnosed were (auxpass)
contributing rotation (nmod)
weaning after (mark)
1.37 1.23 (appos)
cause uncommon (amod)
isoenzyme cyp (appos)
prevent test (nmod)
episodes with (case)
products glycation (compound)
leukopenia thrombocytopenia (conj)
comparable those (nmod)
discharges bilateral (amod)
infection by (case)
severity clinician-assessed (amod)
kinase integrin-linked (amod)
receiving years (nmod)
center university-affiliated (amod)
vision of (case)
recorded using (advcl)
ph culture (conj)
nephropathy complications (conj)
site damage (nmod)
likely used (advcl)
took ibuprofen (dobj)
used dormex (dobj)
controlling dyskinesias (dobj)
finding notable (amod)
slowness of (case)
observed frequently (advmod)
reported . (punct)
reserpine with (case)
antibiotic of (case)
caused glaucoma (nmod)
group pergolide (compound)
hypothesis with (case)
% 58 (nummod)
patient patients (nmod)
patients abusing (acl:relcl)
induces anomalies (dobj)
intralipd of (case)
experienced intoxication (dobj)
mcc group (nmod)
damage vascular-mediated (amod)
comorbidity epilepsy (nmod)
anemia azathioprine-induced (amod)
ndma-d ( (punct)
tumor and (cc)
estimated it (nsubjpass)
papaverine treatment (nmod)
newborns exposed (amod)
presented urticaria (dobj)
fatal which (nsubj)
induced csa (nmod)
studied interventions (nsubjpass)
evaluation term (compound)
side-effect effect (conj)
treated ritonavir (nmod)
ability cause (acl)
areas motor (amod)
pb with (case)
identification reaction (nmod)
problem as (case)
overdose epinephrine (compound)
$ROOT$ advantageous (sent)
urgency defecate (nmod)
kidney of (case)
2.2 ) (punct)
micromol/l 100 (nummod)
symptoms abuse (nmod)
potent one (nummod)
results developed (appos)
receiving desipramine (dobj)
mic ) (punct)
sole manifestation (conj)
establishing model (nmod)
67 +/- (cc)
indicative health (nmod)
blocker novel (amod)
compounds related (amod)
reduced tiapride (nsubj)
observations patient (nmod)
ng./ml greater (amod)
visualize profile (dobj)
associated complex (nmod)
treated children (nsubjpass)
infants preterm (amod)
central and (cc)
milligrams two (nummod)
ic ( (punct)
depressed addition (nmod)
simvastatin mg-ezetimibe (appos)
treat c. (dobj)
terminate to (mark)
dose adrenaline.7 (nmod)
concentrations mg (nmod)
proliferation and (cc)
warrant however (advmod)
rate groups (nmod)
understood clearly (advmod)
coupled use (nmod)
mmhg pressure (nsubj)
% 74.8 (nummod)
number cataracts (nmod)
phenomena mydriasis (nmod)
anaesthetic repeat (amod)
pain continuing (amod)
method sensitive (amod)
prognosis poorer (amod)
had hepatitis (dobj)
ctni various (amod)
aggravation akinesia (nmod)
myositis attributable (amod)
manifest changes (nsubj)
given producing (advcl)
hour for (case)
managed were (auxpass)
7 patients (appos)
vasculitis mediated (amod)
$ROOT$ develop (sent)
ranged content (nsubj)
effect aging (nmod)
acne of (case)
cardiomyocytes human-induced (amod)
anaesthesia propofol (compound)
pressure hg (appos)
found decreased (conj)
proceeded patients (nsubj)
converted when (advmod)
transfusion 3/5 (appos)
bendrofluazide or (cc)
possess activity (dobj)
concentration levetiracetam (compound)
synapse gyrus (nmod)
degree one (nummod)
nox in (case)
abstinence an (det)
physiologic or (cc)
received produce (advcl)
variety insults (nmod)
action prolactin-releasing (amod)
drug circulation (nmod)
bdl treatments (conj)
required who (nsubj)
investigates and (cc)
medication digoxin (nsubj)
modification effects (nmod)
represent changes (nsubj)
mr ( (punct)
androgens of (case)
$ROOT$ one (sent)
augmentation this (det)
obtained departments (nmod)
clearance initial (amod)
8 6 (compound)
colliculi the (det)
be they (nsubj)
chemotherapy salvage (amod)
was ml/ng (appos)
risk injury (nmod)
more cin (nsubj)
recruited november (nmod)
detection microscopy (conj)
rats pan (compound)
caused disruption (dobj)
mechanism one (nummod)
characteristic when (advmod)
morbidity serious (amod)
caused indicating (advcl)
reduced arteries (nmod)
retrieval memory (compound)
reactivator maleate (conj)
up-regulated hippocampus (nmod)
$ROOT$ temporary (sent)
cml ( (punct)
changes consistent (acl:relcl)
group iso (compound)
data first (amod)
positive cultures (nsubj)
elicit rats (nmod)
expressed domain (nmod)
patient psoriasis (nmod)
acknowledged hit (nsubjpass)
substance membrane (compound)
acid oisoquinoline-3- (compound)
pre- post-dilatation (conj)
fr kg-1 (appos)
intoxication cocaine (compound)
clonidine alpha-methyldopa (conj)
indicated scores (nmod)
amiodarone intravenous (amod)
mutation genes (nmod)
occurs inhibition (nmod)
captopril mg/kg/day (dep)
done be (auxpass)
six to (quantmod)
times fasciculation (nmod)
increase can (aux)
received gum (dobj)
% catarrhalis (appos)
prohibited . (punct)
caffeine of (case)
$ROOT$ prophylaxis (sent)
kg(-1 min(-1 (prep)
examinations determinations (conj)
consumption part (nmod)
obtained mazindol (nmod)
contributes system (nsubj)
increased reticulocytes (dobj)
interaction warfarin (nmod)
animal from (case)
auc 6 (nmod)
agent the (det)
mortality treatment (compound)
potency vip (nmod)
restoration this (det)
patients consisted (dep)
prevalence increased (amod)
value hb (compound)
adrenaline atropine (conj)
factor loss (nmod)
rats all (det)
bupivacaine mg/kg (nummod)
measured study (nmod)
burns for (case)
occlusion to (case)
consider prerequisite (nmod)
regimens cancer (nmod)
lag a (det)
administration iopamidol (nmod)
important to (mark)
each series (nmod)
ci 100 (nummod)
disorders menstrual (compound)
1.03 , (punct)
week during (case)
cause failure (dobj)
combined regimen (nmod)
monkeys four (nummod)
administrated daily (advmod)
l-dopa mg/kg (appos)
inactivation the (det)
movements different (amod)
$ROOT$ fc (sent)
related induce (conj)
increased < (parataxis)
stands amoxicillin-clavulanate (nsubj)
ulcers severe (amod)
dexmedetomidine d-med (appos)
discussed light (nmod)
reserpine- haloperidol-induced (conj)
described man (nmod)
depth . (punct)
mm 1 (nummod)
received pregnancy (nmod)
agonists to (case)
neurotoxicity greater (amod)
postlesion days (compound)
$ROOT$ represented (sent)
cohort total (amod)
hr at (case)
ionic both (cc:preconj)
alpha(1)-subunit na-k-atpase (nmod)
incidence anemia (nmod)
management for (case)
epicondyle in (case)
degeneration accompanied (acl)
occurs % (nmod)
arm supported (acl)
treated pj34 (nmod)
$ROOT$ angiographies (sent)
erythropoietin cardiac (amod)
availability o2 (compound)
progressive then (advmod)
ratio increased (amod)
use management (nmod)
erythropoietin human (amod)
60 30 (compound)
extremity involved (amod)
haematological either (cc:preconj)
administered placed (advcl)
rates criteria (appos)
h , (punct)
dystonia reversible (amod)
aminotransferase ; (punct)
contribution group (nmod)
patients further (amod)
slow and (cc)
was finding (nsubj)
administration agonist (nmod)
increase proteins (appos)
igf-i the (det)
showed decreases (dobj)
reversal high (amod)
content malondialdehyde (compound)
modulator a (det)
private commercial (conj)
frequency absences (nmod)
response % (nmod)
consistent hypothesis (nmod)
degree observed (acl)
improved symptoms (nsubj)
investigated relationships (nsubjpass)
stress by (case)
explore function (dobj)
diuretic loop (compound)
toxicities late (amod)
raised was (auxpass)
persisted cessation (nmod)
dose ideal (amod)
wk the (det)
helpful strain (nsubj)
seconds over (case)
demonstrate clearly (advmod)
antidepressant a (det)
vomiting and/or (cc)
days immobilization (nmod)
5-htp benzodiazepines (conj)
appearance vasculitis (conj)
exhibited group (nsubj)
female of (case)
reduction 380+/-587 (appos)
role disease (nmod)
% mononucleate (dep)
studied data (nmod)
maximal both (preconj)
mpa dmcm (conj)
results upon (case)
hyperprolactinemia significant (amod)
inhibits bringing (conj)
antagonists for (case)
observed haloperidol (nmod)
application carbachol (nmod)
copolymers these (det)
reaction thrombocytopenia (nsubj)
leading disease (nmod)
lowest range (nmod)
increasing dose (dobj)
blood skin (conj)
assay of (case)
compared virus (nmod)
laboratories experiment (compound)
decreased that (nsubj)
taking zolmitriptan (dobj)
received total (dobj)
suppressed not (neg)
anti-asthmatic both (preconj)
casualties mass (compound)
level reported (acl)
3.10 users (nmod)
14,671 rofecoxib (nmod)
diuresis high (amod)
motility patients (nmod)
mm [ca]o (nmod)
calcium > (amod)
taking had (aux)
measured also (advmod)
decreases number (nmod)
novel potentially (advmod)
generation energy (compound)
tobramycin with (case)
allocated subjected (parataxis)
14.3 to (dep)
parp ) (punct)
value . (punct)
pretreated = (parataxis)
leukocyturia ) (punct)
high weeks (nmod)
achieved and (cc)
recurrence weeks (nmod)
cya ( (punct)
7.54 - (punct)
small that (mark)
safe conclusion (nmod)
free is (cop)
analyses surface-based (amod)
336 +/- (cc)
medication their (nmod:poss)
coil polarized (amod)
26- , (punct)
validated were (auxpass)
protein pg/mg (compound)
cc glomeruli (nmod)
effect methyldopa (nmod)
ileum guinea (compound)
inhibited while (mark)
observed 14 (nmod)
attention careful (amod)
12 < (advmod)
syndrome described (amod)
review we (nsubj)
controlling covariates (nmod)
cells skin (compound)
deposited will (aux)
not usually (advmod)
tland osterg (compound)
peptide bnp (conj)
remained enzymes (nsubj)
mouth in (case)
weakness , (punct)
received prior (advmod)
glycoprotein properties (nmod)
anaemia the (det)
progesterone of (case)
ax ( (punct)
fsgs ) (punct)
mg/kg 13 (compound)
malformation a (det)
arthralgia neuropathy (conj)
dct2 tubule (conj)
decrease nephrotoxicity (nmod)
gliomas around (case)
data with (case)
increase and/or (cc)
impairment and (cc)
weight/day ( (punct)
sensitive be (cop)
effects amphetamine (nmod)
factor vascular (amod)
agents receptor (compound)
july june (conj)
infusion only (advmod)
signs damage (nmod)
leads abuse (nsubj)
surmountable increasing (advcl)
120 740 (prep)
potential drug (nmod)
suggests photodistribution (nsubj)
acid kainic (amod)
responsible wasting (nmod)
support for (case)
rats receiving (acl)
colliculus pons (conj)
analgesia regional (amod)
support data (nsubj)
received prophylaxis (dobj)
underwent period (nmod)
gyrus cingulate (compound)
aml = (dep)
1994 from (case)
increased injection (nsubj)
extended focally (advmod)
significant however (advmod)
nephrotoxicity encountered (acl)
administration 5-fluorouracil (compound)
lateral superficial (amod)
hcva lcva (conj)
$ROOT$ nightmare (sent)
role androgens (nmod)
glucose insulin (conj)
exacerbations adults (nmod)
0.5 1.0 (conj)
dilate dependent (conj)
releases potentiates (conj)
blockade a (det)
show caused (ccomp)
had stable (conj)
associated events (nmod)
$ROOT$ withheld (sent)
impair improved (advcl)
administration 3-day (amod)
smad3 phosphorylated (amod)
sensitization to (case)
related pointes (nsubj)
% 0.75 (compound)
secretion hepatic (amod)
patients mi (nmod)
discontinuation therapy (nmod)
increased compared (dep)
conclusions is (appos)
screenings and (cc)
derives . (punct)
pretreatment p-chlorophenylalamine (nmod)
doses prevent (acl:relcl)
dfp ) (punct)
assay colony (compound)
reversible good (conj)
wistar strain (compound)
nerves median (amod)
rendered group (nsubjpass)
regard sensation (nmod)
1.01 ) (punct)
p=0.37 ( (punct)
ratios estimated (acl)
overflow on (case)
those given (acl)
cause lacking (conj)
using vitro (advmod)
unrelenting . (punct)
terfenadine e.g. (advmod)
efficacy combination (nmod)
injection carboplatin (nmod)
beneficial that (mark)
unaffected recorded (conj)
hemorrhage hemorrhage (conj)
treated minimum (nmod)
predictor alterations (nmod)
documented results (nsubjpass)
developed toxicity (ccomp)
induced hand (nmod)
likely patients (nsubj)
fields tumor (nmod)
rated using (advcl)
higher force (nsubj)
after months (nmod:npmod)
icterus and (cc)
using acceleromyography (dobj)
% units (nmod)
etiology cancer (nmod)
ketorolac mg (appos)
recurred challenge (nmod)
doses mz (nmod)
hg 100 (nummod)
months 10 (nummod)
performed fetuses (nmod)
scavenger species (nmod)
treated done (parataxis)
minimize benefit (dobj)
enhance causing (advcl)
uncertain . (punct)
infusion-produced methamphetamine (nmod:npmod)
propensity effects (nmod)
tumors mesenchymal (amod)
development agents (nmod)
wt body (compound)
levobupivacaine , (punct)
suggested anencephaly (nsubjpass)
snp ) (punct)
clonazepam mg/kg (appos)
receptor d4.2 (compound)
patients 3/4 (nummod)
alf=0/35 ; (punct)
sodium sulfate (conj)
higher mice (nmod)
mg/kg 150 (nummod)
developed cardiomyopathy (dobj)
cas : (punct)
therapy rifampin (compound)
initial be (cop)
microinjection after (case)
levels calcineurin (nmod)
analyzed liver (nmod)
syndrome acquired (amod)
effective potentially (advmod)
toxicities hematological (amod)
trough-concentrations cimetidine (compound)
recommenced accidentally (advmod)
potential hit (acl)
grafting infarction (conj)
solution sucrose (compound)
disappeared discontinued (advcl)
haloperidol clozapine (conj)
increase volume (nmod)
related vasculitis (nmod)
non-ecstasy polydrug (amod)
malnutrition exhaustion (conj)
affect osmolality (dobj)
methscopolamine , (punct)
tlr4 ) (punct)
occur deficiency (nsubj)
target , (punct)
occurrence complication (nmod)
ci 12.2 (appos)
received saline (dobj)
who ] (punct)
ccr in (case)
accumbens nucleus (compound)
etodolac of (case)
lamivudine negativity (conj)
hepatotoxicity drug (nmod:poss)
24_h onset (nmod)
platinum- paclitaxel-refractory (conj)
second in (case)
predisposed develop (xcomp)
gain with (case)
175 or (cc)
postpartum 2nd-week (amod)
oxytocin agents (conj)
related be (cop)
macroprolactinemia for (case)
causing episodes (dobj)
department cardiology (compound)
epinephrine to (case)
concentrations pathogens (nmod)
received injections (dobj)
indicates suggesting (advcl)
area tuft (compound)
sg145r t (conj)
prerequisite studies (nmod)
produce infarction (dobj)
methodology eye (dep)
benefit models (nmod)
deaths cocaine-related (amod)
cbd 36.22 (dep)
2.5 0.03 (conj)
difference age (compound)
dependent outflow (nmod)
findings epidemiologic (amod)
way the (det)
tremors rigidity (conj)
concentrations consumption (conj)
group between (case)
remained 3 (nsubj)
1.041 0.001 (conj)
chlorpheniramine and (cc)
test exact (amod)
injury after (case)
damage nephropathy (nmod)
handling + (compound)
addition use (nmod)
normalized weeks (nmod)
increases evoked (amod)
dogs chest (compound)
symptoms cardiac (amod)
ecg dp/dtejc (conj)
resolved hypoxaemia (nsubj)
contribute factors (nsubj)
teratogenic livestock (nmod)
background/aims : (punct)
sparing some (det)
treatment scabies (nmod)
had he (nsubj)
fulfilling criteria (dobj)
extract chebula (compound)
mg/m2/wk was (cop)
$ROOT$ plasma (sent)
results morphine (appos)
determine onset (dobj)
case boy (nmod)
dextromethorphan nmda (compound)
correlates severity (nsubj)
examined data (nsubjpass)
scale barratt (compound)
proteinuric and (cc)
shedding both (conj)
patient apl (compound)
absence mr (nmod)
combination ephedrine (nmod)
happens what (nsubj)
lidocaine than (case)
fiber mossy (amod)
suggested retained (ccomp)
poison topoisomerase (compound)
higher that (nmod)
returned transaminases (nsubj)
edema brain (compound)
effects similar (amod)
monitored flow (nsubjpass)
adding dox (nmod)
developed group (nsubj)
signs encountered (amod)
noted design (nmod)
complexes mitochondrial (amod)
infusion vincristine (compound)
diagnosis siadh (nmod)
% domains (conj)
associated will (aux)
regulation in (case)
blocked effectively (advmod)
reached contrast (nmod)
case resulted (acl:relcl)
3.9 2.4 (conj)
potential high (amod)
effects emetic (amod)
twitches the (det)
mmhg admission (nmod)
60 between (case)
factors specific (amod)
require titration (dobj)
overdosages after (case)
maintained levothyroxine (nmod)
function controlling (acl)
used therapy (dobj)
mediated neurotoxicity (nsubjpass)
mumol/l 141 (nummod)
events gastrointestinal (amod)
parameters metabolic (amod)
akinesia of (case)
mounting relates (ccomp)
network of (case)
linked development (nmod)
conversion everolimus (nmod)
verapamil defined (acl)
beating spontaneously (advmod)
sex age (conj)
immunosuppressant . (punct)
sites are (cop)
side-effect administration (nmod)
1.1 1.0 (conj)
inhibition gaba-mediated (amod)
referred had (aux)
had analysed (conj)
examination abnormal (amod)
yohimbine agonist (conj)
speaking movements (conj)
patient both (preconj)
bmd p (dep)
responsive frequencies (nmod)
undertook and (cc)
deferoxamine dfo (appos)
plays tone (nsubj)
ratio by (case)
report to (mark)
actin = (dep)
muscle on (case)
day 15 (nummod)
induced arrhythmia (nsubjpass)
stones kidney (compound)
grading histopathological (amod)
improvement neurological (amod)
nephrosis early (amod)
has ; (punct)
agents ) (punct)
reported range (nmod)
iodixanol iso-osmolality (amod)
had 12 (nsubj)
illness depressive (amod)
injury persons (nmod)
annuloplasty method (nmod)
$ROOT$ problem (sent)
k)-atpase (na (compound)
transplant cell (compound)
gender-dependent and (cc)
rise levels (nmod)
result levels (nsubj)
vials blinded (amod)
nephrotoxicity associated (acl)
candidates potential (amod)
ecg to (case)
sera to (case)
occurs whenever (advmod)
effective treatment (nsubj)
follow-up during (case)
decreases values (nmod)
supplement be (cop)
27 - (advmod)
impaired attenuated (conj)
infrequent were (cop)
lp 120.04 (appos)
beginning azithromycin (dobj)
dose-and a (det)
renin content (dep)
receiving d (nmod)
matrix gel-like (amod)
apnoea : (punct)
developed aneurysm (dobj)
9 , (punct)
brains rats (nmod)
of mainly (advmod)
rats lobund-wistar (amod)
homeostasis cholesterol (compound)
often too (advmod)
patients 9 (nummod)
present present (conj)
hypoxia hypoxia (conj)
cases one (appos)
studies quantitative (amod)
administration continued (amod)
wistar and (cc)
suspected decreased (advcl)
metrics use (nmod)
damage c-induced (amod)
dependent light (nmod)
infections serious (amod)
satisfied patients (nsubj)
infusion flestolol (compound)
tetany rhabdomyolysis (conj)
resulted toxicity (nmod)
volume the (det)
assessed not (neg)
adults carriers (appos)
have levobupivacaine (nsubj)
activity convulsive (amod)
symptoms various (amod)
0.5 + (cc)
= 3.9 (dep)
larger subjects (nmod)
30 - (punct)
5.1+/-1.0 , (punct)
dermatomes l3-l4 (compound)
structures novel (amod)
substances the (det)
norepinephrine proportions (nmod)
toxicity the (dep)
papaverine topical (amod)
time on (case)
androgen corticosteroid (conj)
distinct that (nsubj)
velocity given (amod)
individuals epileptic (amod)
segments cacl(2)-treated (amod)
formula the (det)
common experience (nmod)
change weeks (nmod)
1 0.05 (compound)
7th and (cc)
ratios ors (appos)
activation receptor-alpha (compound)
receiving course (nmod)
groups pdn (compound)
-0.07 to (dep)
staining ttc (nmod)
proposed , (punct)
protein astroglia-specific (amod)
piperacillin/tazobactam of (case)
detected . (punct)
stress promotes (acl:relcl)
pacing with (case)
therapy their (nmod:poss)
agonist a2/a1 (compound)
carcinogen as (case)
scores agitation (conj)
probably related (conj)
studies prolactinomas (nmod)
tdp for (case)
activity bupivacaine (nmod)
injection post-cocaine (amod)
suggestive is (cop)
concentrations increased (amod)
100mg/kg , (punct)
achieved alkalinization (nsubjpass)
care usual (amod)
contractions flutter (conj)
disorders widespread (amod)
beneficial digoxin (nsubj)
conditioning of (case)
process myocytolytic (amod)
hypotension oxytocin-induced (amod)
2 around (advmod)
assessment echocardiography (nmod)
similar variable (conj)
alteration sensitivity (nmod)
stabilizers lithium (nsubj)
increased risk (nsubj)
active orally (advmod)
was phenomenon (attr)
neurons hilar (amod)
occurred majority (nmod)
drugs inhibit (acl:relcl)
associated increasingly (advmod)
concentrations plasma (nmod)
2.41 , (punct)
insult toxic (amod)
obtained risperidone (nmod)
monitored hours (nmod)
associated hyperprolactinemia (nmod)
important , (punct)
use oc (compound)
$ROOT$ responses (sent)
attack ischemic (amod)
concentrations low (amod)
value outcome (nmod)
role morphology (nmod)
reviewed we (nsubj)
$ROOT$ tested (sent)
improves outcomes (dobj)
seconds and (cc)
interest treatment (nmod)
phase an (det)
use their (nmod:poss)
increased % (parataxis)
testing studies (conj)
occurred periods (nmod)
forehead the (det)
discontinued isoniazid (nsubjpass)
correlate biochemical (dobj)
reduction activity (conj)
potential of (case)
anesthesia enflurane (compound)
use equipment (nmod)
likely % (xcomp)
chow ) (punct)
poisoned acutely (advmod)
doxorubicin company (appos)
hyperkinesia ratings (conj)
features common (amod)
produce did (aux)
10(-3 ) (punct)
velocities pain (nmod)
carcinoma ovarian (amod)
decrease events (dobj)
tablets theophylline (compound)
elevations st-segment (amod)
alterations size (compound)
monophosphate cyclic (amod)
mg/m(2 1000 (nummod)
present : (punct)
permitted permits (advcl)
led maneuver (nsubj)
$ROOT$ impairs (sent)
memantine and (cc)
performed period (conj)
extubated . (punct)
ceftriaxone by (case)
literature radiology (compound)
animals pentylenetetrazole-induced (amod)
recurrence ventricular (amod)
0.02 0.03 (conj)
seems response (nsubj)
dressing a (det)
monitoring serial (amod)
damage interstitium (nmod)
% metabolites (nmod)
iu/l 2218 (nummod)
assessed preference (dobj)
dosages mg (nmod)
consist . (punct)
stage with (case)
types steroids (nmod)
concentration gsh (compound)
prevent influence (conj)
frequency hematuria (nmod)
patients 289 (appos)
measured whom (nmod)
maintained or (cc)
factor human (amod)
environments novel (amod)
rats stz-injected (amod)
$ROOT$ vasopressin (sent)
years 15 (nummod)
interactions potential (amod)
receptor kainate (compound)
needed discontinuation (conj)
analysed calculated (conj)
administration dobutamine (nmod)
score of (case)
decreased mek1 (nsubjpass)
dyes fluorescent (amod)
2d6 isoenzyme (compound)
january 1 (nummod)
min 75.9 (nummod)
enhanced depletion (nmod)
day 13.5 (nummod)
1/2 1 (compound)
distributed pathways (nmod)
nutrition parenteral (amod)
incidence proteinuria (nmod)
increase pressure (nmod)
mice knockout (amod)
represent mechanism (dobj)
proves , (punct)
received min (nmod)
audit retrospective (amod)
intoxication by (case)
administration prior (advmod)
findings failed (ccomp)
support massive (amod)
comparison diclofenac (nmod)
signs toxicity (nmod)
nephropathy (gm)-mediated (amod)
created . (punct)
meq/l concentration (nsubj)
abusers mm (compound)
accompanied that (nsubj)
diseases cardiovascular (amod)
$ROOT$ complete (sent)
1 placebo (nmod)
appears furthermore (advmod)
nsaids classic (amod)
96.7 . (punct)
incidence thromboembolism (nmod)
stress myocardial (amod)
benefit point (nmod)
cholestasis severe (amod)
events life-threatening (amod)
mg/kg than (case)
impaired but (cc)
adrs ( (punct)
database safety (compound)
literature recorded (amod)
considered success (xcomp)
recommendation administration (nmod)
drug well-tolerated (conj)
other dopamine (nmod)
stress under (case)
occurred minutes (nmod)
menorrhagia for (case)
sd = (appos)
truncated ) (punct)
cholesterol serum (compound)
conduct investigation (dobj)
associated have (aux)
effects . (punct)
prevented hypertensive (nsubj)
glaucoma hypertension (conj)
( /-11.1 (conj)
effects carcinogenesis (nmod)
intraperitoneal or (cc)
capecitabine of (case)
protection surgery (nmod)
lactate both (cc:preconj)
controls 3 (nummod)
imply mainly (advmod)
aborted patient (nsubj)
metabolite benzoylecgonine (appos)
controls macroprolactinoma (conj)
cgrp between (case)
% 53 (nummod)
regimen same (amod)
gvhd ) (punct)
links administration (nmod)
regressed surveillance (nmod)
mi ctni (conj)
underwent test (dobj)
factor-alpha mt (conj)
sensitizes whether (mark)
hypercalcemia suppression (conj)
nissl-staining and (cc)
fdc t+a (nmod)
dose : (punct)
memory magnitude (nmod)
membranes edema (conj)
reactions chains (nmod)
concerns . (punct)
edema and (cc)
sedation diazepam (nmod)
transplanted have (aux)
vindesine drugs (conj)
doses in (case)
considered possible (advcl)
findings utility (conj)
conversion a (nmod)
mmp-2 of (case)
selective bp (nmod)
min 12 (nummod)
lipids proteins (conj)
patients cured (acl:relcl)
interaction drug/light (compound)
reduced viability (dobj)
1.9 concentrations (nsubj)
ventricles and (cc)
changed significantly (advmod)
c for (case)
decreased heterogeneity (dobj)
layer molecular (amod)
development tumors (nmod)
$ROOT$ complicating (sent)
preferred . (punct)
compromised and (cc)
was g. (nmod)
incidence humans (nmod)
preferred who (nsubj)
models hyperactivity (nmod)
bw mg/100 (nummod)
blockade postsynaptic (amod)
similar quetiapine (nmod)
complication fatal (amod)
induces days (nmod)
twitch the (det)
midazolam than (case)
optic and (cc)
death one (nummod)
on only (advmod)
gaba gamma-vinyl (amod)
induced velocity (nmod)
administered amiodarone (nsubjpass)
associated likewise (advmod)
three in (case)
432 346 (conj)
concentration solution (compound)
recognized discontinuation (nmod)
r(2 ) (punct)
6 case (nmod)
decreases significant (amod)
toxicity their (nmod:poss)
caused use (nsubj)
resulted shortening (nmod)
oximeters ventilators (conj)
crocin dose (nmod)
conclusions dose (appos)
divided days (nmod)
possible it (nsubj)
effective superior (conj)
identified daidzein (nmod)
outcome investigated (acl)
troponin serological (amod)
control anesthesia (nmod)
mg twice (advmod)
activation pathways (nmod)
metabolites pyrrolidine (compound)
prolongs followed (conj)
variables starvation (compound)
confirms use (nsubj)
modulate beta-subunits (nsubj)
investigated use (nmod)
s-i ( (punct)
microangiopathy tma (appos)
$ROOT$ demonstrate (sent)
cin of (case)
only cohort (nmod)
underlying convulsions (dobj)
resolved hours (nmod:tmod)
effects seizures (nmod)
hyperalgesia myoclonus (conj)
value misoprostol (nmod)
normalization eeg (nmod)
moderate heavy (conj)
information on (case)
minimal mild (conj)
pi with (case)
psychosis and (cc)
recommended protection (nmod)
contribution effect (nmod)
layer granule (compound)
asthenia irritability (conj)
infection to (case)
weaker was (cop)
edema disc (compound)
insufficiency by (case)
) 10(-5 (nummod)
scale months (conj)
well equally (advmod)
edaravone saline (conj)
opens possibility (dobj)
had none (nsubj)
developing dysfunction (dobj)
hepatitis attributed (acl:relcl)
any parameters (nmod)
safe green (nsubj)
impairment activity (conj)
rates depressed (amod)
stimulus each (det)
developed dizziness (dobj)
difference blood (nmod)
viability nrvms (compound)
amount large (amod)
derangement massive (amod)
a-i apolipoprotein (compound)
regimen in (case)
case anemia (nmod)
exacerbation epilepsies (nmod)
stopping , (punct)
noninvasive when (advmod)
170 to (mark)
amiloride ( (punct)
ratio , (punct)
sensitive least (advmod)
published available (conj)
75,761 , (punct)
promoted , (punct)
chow followed (acl)
complication failure (nsubj)
cpa/ee with (case)
measured addition (nmod)
ceased that (nsubj)
effects antiparkinsonian (amod)
combined . (punct)
effects ischemia (nmod)
examined fetuses (nsubjpass)
response adrenergic (amod)
died bronchopneumonia (nmod)
monkey the (det)
netilmicin in (case)
agonism dopaminergic (amod)
attenuated hypotension (dobj)
remained epinephrine (nsubj)
safe suppression (nmod)
200 and (cc)
4.5 0.2 (conj)
mm reactive (conj)
vessel of (case)
function cerebral (amod)
timolol ml-1 (appos)
binding greater (amod)
dxnp by (case)
marker early (amod)
samples myocardial (amod)
treatment risperidone (compound)
patients coingested (acl:relcl)
injury concomitant (amod)
metabolizer was (cop)
improve efficacy (dobj)
flurbiprofen . (punct)
passage epicondyle (nmod)
mc ( (punct)
agent antineoplasmic (amod)
monotherapy placebo (conj)
< .03 (dep)
absences the (det)
leukoencephalopathy necrotizing (amod)
reports numerous (amod)
analysis model (compound)
background studied (dep)
experienced switch (dobj)
trials ht (nmod)
part rostral (amod)
ci:0.3 ( (punct)
connections in (case)
restored . (punct)
channel calcium (compound)
signs values (conj)
hospital of (case)
greater treatment (nmod)
liver muscle (conj)
increased greater (conj)
$ROOT$ shown (sent)
suspected mass (nsubjpass)
occurs synthesis (nmod)
followed days (nmod)
treatment hyperthyroidism (nmod)
effect ' (punct)
pharmaceuticals ) (punct)
that should (aux)
dose subcutaneous (amod)
suppression activation (nmod)
period neonatal (amod)
results these (det)
coherence secondary (amod)
alpha-enac beta-enac (conj)
described has (aux)
duration disease (conj)
dysregulation subunit (compound)
findings interaction (nmod)
mol/l. 1 (nummod)
annulus ventricle (conj)
highest was (cop)
guanethidine mg (appos)
stress dobutamine (compound)
injected operation (nmod)
month during (case)
imaging diffusion-weighted (amod)
dropping out (prep)
remainder = (dep)
same as (prep)
0.80 : (punct)
uptake acid (nmod)
developed complications (dobj)
maintained paco2 (nmod)
drug zonisamide (nsubj)
$ROOT$ exerts (sent)
mg/kg 80 (nummod)
center tertiary (amod)
clz ( (punct)
period 1-hour (amod)
obtained months (nmod)
hiccups of (case)
performed eyes (nmod)
medullo-adrenalectomy with (case)
syndrome guillain-barr (amod)
overshooting forces (nmod)
took when (advmod)
involved that (mark)
measured bmd (nsubjpass)
sedatives certain (amod)
bp bp (conj)
implicated ciprofloxacin (conj)
development after (conj)
$ROOT$ felt (sent)
persistent hiccups (nsubj)
interaction taking (acl:relcl)
polymorphism fragment (compound)
bromide and (cc)
convulsions on (case)
any products (nmod)
assay myocardium (nmod)
institute modalities (dobj)
consumed prior (advmod)
changes flow (nmod)
dopamine striatum (nmod)
function late (amod)
total berlin (nmod)
amlodipine for (case)
leukemia acute (amod)
inhibitor cause (acl:relcl)
$ROOT$ differed (sent)
dosages cm (nmod)
awareness reactions (nmod)
diagnosed before (mark)
indicative were (cop)
solution glucose (compound)
possible advisable (conj)
none mild (appos)
s-1 mg (nummod)
surveillance hospital (nmod)
had leading (advcl)
recordings eeg (compound)
doxorubicin and (cc)
facilitation ro4368554 (nmod)
episode before (case)
effect relative (amod)
models all (det)
administration a (det)
obtained seizures (nmod)
neutralization in (case)
obtained images (nsubjpass)
hd-mtx ) (punct)
implications prognosis (conj)
g group (compound)
developed approach (nsubjpass)
used studying (advcl)
exercised groups (nsubj)
enable diagnosis (dobj)
seizures ) (punct)
= 1.008 (dobj)
dysmetria , (punct)
ulcers these (det)
requiring with (mark)
cardiomyopathy azt-induced (amod)
capacity relevant (amod)
inhibits , (punct)
complication regarding (case)
characterized increases (nmod)
bacteremia source (nmod)
25.3 - (punct)
cause proteinuria (nmod)
nephrotoxic to (mark)
flutter afl (appos)
fibres surviving (amod)
combination these (nmod)
flexion/extension fingers (nmod)
prevents estrogen (nsubj)
done carefully (advmod)
therapy asthmatics (nmod)
manual criteria (appos)
pc/bcp ) (punct)
questionnaires mailed (amod)
average motion (nmod)
remained increased (parataxis)
eliminated urine (nmod)
treatment intermittent (amod)
cimetidine level (nmod)
telithromycin to (case)
relation intake (nmod)
lacked period (nmod)
idraparinux inhibitor (appos)
$ROOT$ prodrug (sent)
glutamate extracellular (amod)
14.1 2.4 (conj)
blindness potentials (conj)
gravis myasthenia (compound)
represses expression (dobj)
trials any (det)
investigated currently (advmod)
% oxide (conj)
recurrence is (cop)
began physicians (nsubj)
gestation a (det)
hydrochloride antagonist (compound)
attack paws (nmod)
score hoehn_yahr (compound)
supposed is (auxpass)
anaesthesia local (amod)
$ROOT$ returned (sent)
suggested data (nmod)
management riha (nmod)
morbidity of (case)
sprouting models (nmod)
activity sexual (amod)
model measures (nmod)
become observed (advcl)
abnormalities congenital (amod)
lower etoricoxib (nmod)
spectrum a (det)
rejection cr (dep)
gender-dependent effects (nsubj)
initiation ticlopidine (nmod)
validate to (mark)
movement dyskinesia (nmod)
more than (advmod)
decreased activity (dobj)
l(-1 mg. (nummod)
rate % (dep)
facilitate hinder (conj)
animals treated (acl:relcl)
dex mg (dep)
different groups (nmod)
staying up (compound:prt)
vertex the (det)
test chloride (compound)
averaging ) (punct)
disappeared discontinuation (nmod)
history 2-year (amod)
= 2.1 (dobj)
studied have (aux)
cholestasis by (case)
$ROOT$ indeterminate (sent)
increases nephropathy (nsubj)
given ; (punct)
ptx ) (punct)
region transporter (compound)
lesions activity (conj)
implant or (cc)
completed scale (dobj)
antagonist ( (punct)
prevention complete (amod)
leukemia precursor (compound)
developed block (dobj)
coma intoxication (nmod)
capsaicin intradermal (amod)
$ROOT$ collection (sent)
gram pre-therapy (amod)
hypoxia between (case)
mice degrees (nmod)
diaphragm and (cc)
patients 0/32 (nummod)
genes to (case)
seems act (xcomp)
returned all (nsubj)
59 and (cc)
inhibition : (punct)
combined with (nmod)
plausible resistance (nsubj)
delirium concentrations (nmod)
examined : (punct)
organs various (amod)
synthesis prostaglandin (compound)
have wsr (advcl)
vasculitis antineutrophil (amod)
$ROOT$ prohibited (sent)
systemic airway (conj)
induction epilepticus (nmod)
converted tachycardia (dobj)
losartan after (case)
predictors independent (amod)
pilocarpine microl (dep)
urinalysis conventional (amod)
measures appropriate (amod)
numbers growing (amod)
tear a (det)
15/44 in (case)
introduction objective (conj)
24.3 28.2 (conj)
cortex in (case)
caused zyban (nsubj)
becoming . (punct)
tachycardia life-threatening (amod)
detected shunt (nsubjpass)
administration metoprolol (nmod)
luke 's (case)
total rats (nmod)
features disorder (nmod)
attributable effect (nmod)
akathisia tremor (conj)
tests paw-pressure (amod)
repair by (case)
tremor and (cc)
series prospective (amod)
seems however (advmod)
target be (cop)
lead and (cc)
disease experimental (amod)
cause 1985 (nmod)
study active-w (compound)
episodes carious (amod)
managed infusion (nmod)
group pilocarpine-treated (amod)
increased kanamycin (nsubj)
species , (punct)
synthase nitric-oxide (compound)
delivers dose (dobj)
alphabeta-crystalin methyltransferase (conj)
enhanced changes (nsubjpass)
system transport (compound)
study case-control (amod)
susceptible interactions (nmod)
involvement vesicoprostatic (amod)
ionic prc (dep)
dfu phenyl-2(5h)-furanon (dep)
studied investigating (advcl)
2.17 - (punct)
improve solubility (dobj)
response frequency (appos)
60 10 (compound)
examined period (nmod)
reduced morbidity (dobj)
protected . (punct)
atropine doses (conj)
assessments , (punct)
analyzed degree (nsubjpass)
unaffected , (punct)
simvastatin with (case)
microl ) (punct)
symptoms other (amod)
had parameters (nmod)
demonstrated undertaken (conj)
needed reductions (nsubjpass)
suggested study (nmod)
score sediment (compound)
control postoperative (amod)
underwent comparison (nmod)
diet to (case)
this in (case)
tests behavioral (amod)
measured ich (nmod)
requested r(2)=0.79 (parataxis)
adjusted confounders (nmod)
effects term (amod)
142 +/- (cc)
preserved reduction (nmod)
activity incidence (dep)
improvement score (nmod)
content derived (acl)
reactions hydroxyquinolines (nmod)
gyrus , (punct)
rate patients (nmod)
obviate to (mark)
agonists ( (punct)
implicated recently (advmod)
synthesize cardiomyocytes (nsubj)
isolated recently (advmod)
hepatic neurologic (conj)
nmol 1.5 (nummod)
pathophysiology of (case)
medialipid l (appos)
evaluating effects (dobj)
pad of (case)
diligent interviewing (advcl)
known suggest (advcl)
animal and (cc)
memory associative (amod)
$ROOT$ pneumoniae (sent)
revealed autopsy (nsubj)
managing reactions (dobj)
disease stages (appos)
development comparison (dep)
impairment neurologic (amod)
inconsistent results (nsubj)
trial antiarrhythmic (amod)
puncture of (case)
fit ( (punct)
reversal complete (amod)
170 cost (nsubj)
failure recovery (dep)
behavioral and (cc)
administration min (nmod)
iu/l respectively (advmod)
displayed susceptibility (dobj)
lower f (nmod)
$ROOT$ engrafted (sent)
cause severity (conj)
failed induce (xcomp)
infarct lobe (nmod)
secretion day (nmod)
facilitates yohimbine (nsubj)
allocated randomly (advmod)
lower compared (prep)
obstruction airflow (compound)
predict susceptibility (dobj)
tma and (cc)
exposed piroxicam (nmod)
started patients (nmod)
pathogenesis toxicity (nmod)
study elderly (nmod)
kidney gland (conj)
analyzed , (punct)
developed days (nmod)
alter further (advmod)
prolactinomas % (appos)
responses . (punct)
applied blockade (nsubjpass)
related dosages (nmod)
induce d (nsubj)
minimizing in (mark)
reduction for (case)
inserted . (punct)
arteriography an (det)
viremia of (case)
appt [ (punct)
ablation after (case)
associated thrombocytopenia (nmod)
cases damage (nmod)
cystica pyeloureteritis (compound)
development nephrosis (nmod)
profile sedation (compound)
tetra- pentaglutamate (conj)
ds of (case)
low-sodium mmol/day (appos)
abnormalities decrease (conj)
receptors mglu (compound)
has cisplatin (nsubj)
detected range (nmod)
initiated drug (nsubjpass)
$ROOT$ hepatotoxicity (sent)
malformation with (case)
acid in (case)
dopamine acid (conj)
had seen (conj)
higher h (nmod)
using concentrate (dobj)
lesions focal (amod)
determining response (dobj)
54 45 (conj)
obtained data (nsubjpass)
outcomes fetal (amod)
decreases activity (nmod)
hallucinosis , (punct)
involving heart (dobj)
beta4 subunits (dep)
cyclophosphamide cpm (appos)
changed bisoprolol (nmod)
begun has (aux)
sites same (amod)
mmol/l , (punct)
doses medication (nmod)
all symptoms (nmod)
inhibits bromocriptine (nsubj)
anemia transfusion-dependent (amod)
protective continuously (advmod)
1,3-bis-(2-chloroethyl)-1-nitrosourea ) (punct)
striatum were (cop)
sessions intervals (nmod)
scale psychiatric (amod)
months 20 (nummod)
11 - (punct)
discontinuation exchange (nmod)
109 +/- (cc)
suppresses edaravone (nsubj)
drug an (det)
vasopressor an (det)
atac ) (punct)
85 57 (nummod)
treated either (dep)
12 five (compound)
common cases (nmod)
pathways similar (amod)
conclude involve (ccomp)
adding doses (dobj)
etomidate injected (acl)
enzymes serum (compound)
weak only (advmod)
impaired function (dobj)
investigate using (advcl)
cells cd34+/cd19- (amod)
suggested also (advmod)
ability for (case)
symptoms the (det)
june between (case)
% 34/45 (appos)
up-regulation and (cc)
occurred dissociation (nsubj)
l-nil ) (punct)
change variable (nsubj)
had event (dobj)
immunostaining in (case)
suggestive mechanism (nmod)
$ROOT$ saw (sent)
levels both (dep)
induce changes (dobj)
days 316 (nummod)
procedures tail-withdrawal (compound)
concentrations extracellular (amod)
subgroups population (compound)
tm in (case)
led additionally (advmod)
pressures wedge (compound)
adult an (det)
reactions associated (acl)
pamidronate intravenous (amod)
5'-n-ethylcarboxamidoadenosine , (punct)
stage transplant (nmod)
$ROOT$ report (sent)
restore ltp (dobj)
resolution abnormalities (nmod)
nsclc with (case)
presented days (nmod)
olanzapine for (case)
osteoid such (case)
meq/l of (case)
assessed defined (advcl)
ssris [ (punct)
synergy warfarin (nmod)
dose microg/kg/min (nmod)
course infusions (nmod)
defects established (amod)
level each (det)
mg/kg 27.1 (nummod)
co-administration by (case)
eluates in (case)
abnormalities many (amod)
doses kytril (appos)
counted . (punct)
leukocytes lesional (amod)
mice polypeptide (compound)
january between (case)
wky and (cc)
effect additive (amod)
giving it (dative)
100,000/mm3 to (case)
appeared darker (xcomp)
hypercalcemia hyperphosphatemia (conj)
h beginning (case)
separation ficoll-hypaque (nmod)
exist , (punct)
of greater (amod)
mediated supporting (advcl)
protection effective (amod)
microg% ) (punct)
mg/m2 60 (nummod)
jaundice methimazole-induced (amod)
suggested reduces (ccomp)
leukemia leakage (conj)
incidence regarding (case)
evaluated findings (nsubjpass)
carbachol cats (nmod)
values small (amod)
data in (amod)
effect pressor (compound)
unease her (nmod:poss)
case to (mark)
mg/dl 0.07 (nummod)
cardiotoxicity its (nmod:poss)
$ROOT$ actions (sent)
report methods (nsubj)
description relation (nmod)
afterdepolarization . (punct)
0.05 ( (punct)
to prior (advmod)
failed lower (conj)
bcl-2 of (case)
jj sham-treated (amod)
assess significance (dobj)
give warnings (dobj)
compared therapy (nmod)
microinjection methyldopa (nmod)
reductions turnover (nmod)
achieved weeks (nmod)
shown participate (ccomp)
using system (dobj)
ciprofloxacin namely (advmod)
hcbd by (case)
sites in (case)
nsaid a (det)
lopinavir/ritonavir of (case)
pattern of (case)
receptors ii (nummod)
expression regulation (conj)
osteoid and (cc)
resembling neuropathies (dobj)
is relationship (attr)
treatment lines (nmod)
acuity of (case)
recovery with (case)
taken together (advmod)
series ionic (nmod)
u/ml 28.7 (nummod)
related -- (punct)
region a10 (compound)
expression mediators (nmod)
suppressed genes (nmod)
strengthen . (punct)
managed was (auxpass)
doses imipenem/cilastatin (nmod)
$ROOT$ sodium (sent)
tested occasions (nmod)
effective improving (advcl)
than or (cc)
evaluated toxicities (nsubjpass)
function thyroid (compound)
population , (punct)
aim second (amod)
life-threatening five (nmod)
flestolol : (punct)
decrease latencies (nmod)
important be (cop)
participants seventy-one (nummod)
gvhd extensive (amod)
equal 3 (dep)
compared controls (nmod)
pas ( (punct)
was group (advcl)
recovery discontinuation (nmod)
$ROOT$ rose (sent)
score assessment (nmod)
cb , (punct)
cr ; (punct)
promotes that (nsubj)
warranted clearly (advmod)
mechanisms electrophysiological (amod)
warned events (nmod)
levels phase (nmod)
occurred seroconversion (nsubj)
mg 325 (nummod)
= x(2 (nsubj)
development myasthenia (nmod)
ranitidine months (dep)
infiltration wall (nmod)
saralasin inhibitor (appos)
groups controls (appos)
33 to (case)
5.0 - (punct)
groups trained (amod)
$ROOT$ discriminates (sent)
impairment for (case)
efficacy increased (amod)
testing at (case)
antagonist receptor (compound)
(1.8)% and (cc)
t the (det)
decrease cco-i (nmod)
duration days (appos)
avrt ) (punct)
using staining (dobj)
40.8 12.1 (conj)
40 to (dep)
fos-immunoreactivity ir (appos)
demonstrated previously (advmod)
hour of (case)
dose h (nmod:npmod)
compounds organophosphorus (compound)
require background (nsubj)
thiopentone i.v. (dep)
lesion 6-hydroxydopamine (compound)
incidence . (punct)
patients eighty-five (nummod)
occurs , (punct)
acquired . (punct)
risk complication (nmod)
fulfill need (dobj)
auc and (cc)
disease lp-bm5 (compound)
acquired who (nsubj)
similar days (nmod)
effect equivalent (amod)
observed when (advmod)
pressure patient (nmod)
sites primary (amod)
difference score (nmod)
inhibition activation (nmod)
manifestation of (case)
feasible not (neg)
period follow-up (amod)
eliminates evidence (dobj)
function baseline (amod)
reports by (case)
tmax 11.33 (dep)
encountered frequently (advmod)
describe study (nmod)
leak reversing (advcl)
damage permanent (amod)
convulsive , (punct)
achieved rosc (nsubjpass)
conditions tract (nmod)
article this (det)
blockers other (amod)
effect similar (amod)
provided and (cc)
exercised remained (advcl)
tomography computed (amod)
treatment diethylcarbamazine (nmod)
syndrome pulmonary (amod)
children institutions (nmod)
episodes thrombotic (amod)
plugs these (det)
$ROOT$ pronounced (sent)
exhibited whereas (mark)
hematology and (cc)
patterns similar (amod)
insulin-receptor ir (appos)
classical atypical (conj)
bulb the (det)
feeding derivatives (nmod)
700 than (quantmod)
titrated randomized (conj)
fluoxetine inhibitor (appos)
mmol was (cop)
frequencies positivity (conj)
% dogs (nmod)
rrmm ( (punct)
analogue oxytocin (nmod)
2.10 , (punct)
electrolytes serum (compound)
fluphenazine catalepsy (conj)
cent patients (nmod)
experienced experienced (conj)
mg dose (nsubj)
rilmenidine alpha-methyldopa (conj)
ward a (det)
collagen and (cc)
change since (mark)
overexpression synthase (nmod)
reaction , (punct)
level mg/day (compound)
analgesic with (case)
10(-3 0.17 (compound)
using he (nsubj)
doses spiranolactone (nmod)
g. 2.8 (nummod)
littermates for (case)
thp se (nmod)
ensued concealed (advcl)
110 < (advmod)
% 62 (appos)
agonist ) (punct)
bpt , (punct)
brings . (punct)
reviewed part (nmod)
spine her (nmod:poss)
speed to (case)
efficient more (advmod)
softening skin (compound)
measured thyroxine (dobj)
involving nuclei (dobj)
sufficient that (mark)
examined eyes (nsubjpass)
hormones both (det)
worsening . (punct)
agents antithyroid (amod)
dyskinesia pd (nmod)
stronger was (cop)
used conclusion (nmod)
notable . (punct)
caused size (nsubjpass)
recipient donor (compound)
prevented treatment (nsubj)
bortezomib/dexamethasone with (case)
increased produce (advcl)
determined back-diffusion (nsubjpass)
infection because (case)
effusion with (case)
prevent mg/kg (nsubj)
coefficient and (cc)
manifestations minor (amod)
vsd of (case)
lesions colliculus (compound)
meninges the (det)
increase maximal (amod)
passage lacn (nmod)
treatment malaria (nmod)
model nephropathy (nmod)
influenced be (auxpass)
diagnosis recorded (amod)
fruste one (nmod)
using paradigm (dobj)
responsible retention (nmod)
d2 d3 (conj)
risk is (cop)
estimated should (aux)
77.1 . (punct)
purpose determine (acl)
. p.r.n (compound)
greater propranolol (nmod)
arrhythmia digitalis (compound)
asia southeast (compound)
8 18 (nmod)
summarized are (auxpass)
receiving fumarate (dobj)
provide treatment (nmod)
increases significantly (advmod)
lad ) (punct)
dfo ) (punct)
continue or (cc)
transplanted were (auxpass)
= ci (dobj)
pneumonitis and (cc)
reduced incidence (nsubjpass)
states different (amod)
diet libitum (amod)
gain sgk1(+/+ (nmod)
adenosine n(6)-cyclopentyl (compound)
confirmed ability (nsubjpass)
enos inos (conj)
discouraged that (mark)
discharged she (nsubjpass)
effective toxicity (nmod)
out study (nmod)
received cta (dobj)
dementia report (dep)
> and/or (cc)
4.98 ( (punct)
qrs , (punct)
ds-sarcoma ( (punct)
micron of (case)
dose gabapentin (nmod)
seconds ) (punct)
supposed exist (ccomp)
invasive minimally (advmod)
transection by (case)
dilevalol to (case)
$ROOT$ reverted (sent)
inhibitors anhydrase (compound)
accounted could (aux)
assessed patients (nmod)
elicited can (aux)
demographic and (cc)
influence captopril (nsubj)
continued two (nmod)
acc ) (punct)
develop so (mark)
pd and (cc)
year than (case)
intact-control and (cc)
effects nitroglycerin (nmod)
receptor low-density (amod)
treatment anti-allergic (amod)
reduction dfo (compound)
patients sah (nmod)
cases rare (amod)
questions if (advcl)
searches biliary (amod)
undergoes ezetimibe (nsubj)
value population (nmod)
confirmed histology (nmod)
celecoxib and (cc)
dysfunction activities (conj)
iodixanol with (case)
continuing by (mark)
day this (det)
patients constipation-predominant (dep)
physicians surgeons (conj)
inhibited = (parataxis)
clinical experimental (conj)
hydrocortisone second (nmod)
h onset (dep)
conditions acidic (amod)
used consuming (advcl)
occurring anuria (nmod)
loss sensory (amod)
value higher (amod)
lesion callosal (amod)
event of (case)
compensated decreased (conj)
induced courses (nmod)
bupivacaine circulating (amod)
ketoconazole topical (amod)
developed case (nmod)
found label (xcomp)
dipyridamole oral (amod)
disorders to (case)
arrhythmias failure (nmod)
cefotetan especially (advmod)
episodes infectious (amod)
proteinuric weeks (nmod)
2-sulfanylethanesulfonate with (case)
decreased appeared (conj)
attenuated treatment (nmod)
therapy unopposed (amod)
monkeys parkinsonian (amod)
ability reverse (acl)
weight g (nmod)
had had (advcl)
carmofur derivative (amod)
prevented anemia (nsubjpass)
ratio bcl-2/bax (nmod)
multiple single (conj)
analysis dosing (nmod)
infants 122 (nummod)
preparations strip (compound)
barrier/density heparan (compound)
pdn no (neg)
losartan with (case)
anesthesia epidural (amod)
hypercalcemia resulting (acl)
$ROOT$ produce (sent)
protocols anesthetic (amod)
victims overdose (nmod)
receiving resuscitation (dobj)
technique it (nsubj)
parameters test (compound)
completion procedure (nmod)
study french (amod)
group into (case)
lability inattention (conj)
began ingestion (nmod)
implicated eaca (nsubjpass)
died rats (nsubj)
3.8 range (dep)
effect unwanted (amod)
conjugates of (case)
antagonize administration (nmod)
remained mechanism (nsubj)
events between (case)
nerve cutaneous (amod)
hypothesize to (mark)
31.6 +/- (cc)
presented animals (nsubj)
capillary of (case)
$ROOT$ factors (sent)
low usage (nsubj)
incomplete . (punct)
finding this (nsubj)
$ROOT$ mg/m2/wk (sent)
october 2003 (nummod)
increased tenfold (advmod)
effects signs (nmod)
135 to (dep)
patients complained (acl:relcl)
$ROOT$ speculated (sent)
cardiomyopathy to (case)
evaluate . (punct)
$ROOT$ hospitalized (sent)
study 45-day (amod)
% compliance (nsubj)
increased g/d (dobj)
inhibit influx (dobj)
77 - (punct)
actions have (acl:relcl)
used approach (nsubjpass)
conclude delayed (ccomp)
observations acetaminophen (nmod)
identification factors (nmod)
% 28.2 (nummod)
recurrence of (case)
secretion and (cc)
examined abilities (dobj)
prone especially (advmod)
ear the (det)
wt lithium-fed (amod)
sarcoma in (case)
data presented (acl)
contrary the (det)
symptoms neurological (amod)
ica both (cc:preconj)
androgens exogenous (amod)
examined 42 (nmod)
well as (advmod)
arrest . (punct)
therapy timolol-hydrochlorothiazide (compound)
infected , (punct)
action . (punct)
changes regulation (nmod)
control of (case)
micrograms/ml 4.04 (nummod)
number . (punct)
users among (case)
exceed and (cc)
ziprasidone administrated (amod)
vasculitis perinuclear-staining (amod)
ingesting patients (nmod)
device patient-controlled (amod)
different rate (nsubj)
hg mm (dep)
abandoned technique (nsubjpass)
effects ptu (nmod)
mtdna ( (punct)
parallels respect (nmod)
7.44 of (case)
identical is (cop)
trials english-language (amod)
focus oval (amod)
increased those (nmod)
effects study (dep)
raises conclusion (nsubj)
diagnosis in (case)
demonstrated excluded (advcl)
demonstrate induction (dobj)
$ROOT$ proportional (sent)
hypertension complication (nmod)
metabolizer a (det)
form long (amod)
toxic more (advmod)
52 approximately (advmod)
f2 design (conj)
m ) (compound)
evidence stress (nmod)
tgf-b ctgf (conj)
2.5 2.0 (compound)
dbp not (cc)
blood was (cop)
ci 1.12 (nummod)
rapid and (cc)
vomiting due (case)
showed hepatitis (dobj)
near-syncope as (case)
h within (case)
allow secretion (dobj)
transferred week (nmod)
idr ( (punct)
glycopyrrolate and (cc)
attention induction (nmod)
therapy methods (nsubj)
logs and (cc)
micrograms/ml . (punct)
injection flunitrazepam (nmod)
reacted absence (nmod)
increased density (nsubj)
anophthalmia , (punct)
hyperalgesia in (case)
hilum the (det)
group -5 (appos)
evidence relating (acl)
measured enzymes (nsubjpass)
olanzapine between (case)
suggests lack (nsubj)
times reduction (nmod)
methods investigated (appos)
cause . (punct)
network healthcare (compound)
patients surgical (amod)
examination history (nmod)
lesion corpus (compound)
dronedarone placebo (conj)
institution to (case)
showed data (nsubj)
role nephrotoxicity (nmod)
level > (amod)
injections serial (amod)
ml/min 1.04 (nummod)
volumetric , (punct)
stopped treatment (nsubjpass)
capacity spatial (amod)
dysfunction cirrhosis (nmod)
therapy glioma (nmod)
explored . (punct)
satisfactory that (nmod)
syndrome transplantation (nmod)
mucosal , (punct)
hypoplasia nerve (compound)
% follow-up (nmod)
antigen hbeag (appos)
ns ( (punct)
mg/kg 180 (nummod)
pci ( (punct)
saline ml/kg (appos)
study surveillance (compound)
pheochromocytoma with (case)
history symptomatology (nmod)
ratios ci (conj)
peptides of (case)
synthesis rat (nmod)
schizophrenic psychotic (conj)
took that (mark)
transplants cardiac (amod)
characterized action (nmod)
worn chance (nmod)
vlbw ; (punct)
modifications breast (compound)
machinery with (case)
understanding for (mark)
frequent complications (nsubj)
stopped that (mark)
killed were (auxpass)
prevalence lymphocytes (nmod)
aspirin low-dose (amod)
phenomena during (case)
size group (nmod)
organs the (det)
had failure (dobj)
stiffness of (case)
% olanzapine (nmod)
therapy calcium (compound)
autopsy an (det)
vf ) (punct)
trial doses (nmod)
cause migraine (nsubj)
year 80 (nummod)
coingested antidepressants (dobj)
stopped only (advmod)
group patients (nmod)
5-fluorouracil 5-fu (appos)
doses gentamicin (nmod)
activity activity (conj)
function electrophysiologic (amod)
ingestion water (compound)
receive antibiotics (dobj)
ratings response (nmod)
played deaths (nmod)
flutamide mg.kg(-1).d(-1 (appos)
follow-up months (nmod)
reduced also (advmod)
patients antigen (compound)
insufficiency to (case)
facility the (det)
validated genes (nsubjpass)
as , (punct)
reduction neuropil (compound)
synthesis data (compound)
cholesterol total (amod)
ameliorate damage (dobj)
rats lw (compound)
impaired processes (nsubjpass)
patients prostate (compound)
effects abuse (nmod)
causes which (nmod)
representing ) (punct)
accepted this (nsubjpass)
pathomechanism the (det)
combinations injection (nmod)
ikr iks (conj)
improvement denopamine (nmod)
examined assay (nmod)
iv classes (compound)
msec ( (punct)
metabolizer metoprolol (nmod)
cyclophosphamide intravenous (amod)
integration better (amod)
that procaine (nmod)
protein cytoskeletal (amod)
administration oxytocics (compound)
mm 35 (nummod)
vulnerable neurons (nsubj)
withdrawal later (advmod)
csa , (punct)
$ROOT$ facilitate (sent)
rr=1.60 ( (punct)
686 +/- (cc)
carbimazole by (case)
third one (nummod)
window pretreatment (nmod)
toxicity concentration (conj)
operation weeks (nmod:npmod)
localized . (punct)
26.3 0.7 (conj)
demonstrated exacerbates (ccomp)
phase b (appos)
dba/2 ) (punct)
rate 2-year (amod)
studies ( (punct)
gr 82334 (nummod)
stabilizer lithium (dep)
requires specification (dobj)
increases prevalence (dobj)
level tac (compound)
exacerbated occurred (advcl)
sedations during (case)
butyrylthiocholine btc (appos)
hemorrhage of (case)
suffer may (aux)
drug only (amod)
enrolled , (punct)
pituitaries female (amod)
revealed induced (ccomp)
$ROOT$ channel (sent)
include manifestations (nsubj)
treatment fewer (amod)
rapamycin ) (punct)
users in (case)
a1 in (case)
cocaine users (conj)
useful that (nsubj)
cytotoxicity of (case)
ms 48 (nummod)
conducted methods (dep)
mm 34 (nummod)
udca ) (punct)
activation synthase (compound)
shortage by (case)
subthalamotomy after (case)
effect overflow (nmod)
necroses focal (amod)
monitored behavior (nsubjpass)
grommet through (case)
neuralgia with (case)
exfoliation urothelium (nmod)
compound op (compound)
interventions use (compound)
$ROOT$ signified (sent)
users n=12 (appos)
hitt to (case)
doses given (acl)
comparable were (cop)
incidence thrombosis (nmod)
groups control (appos)
boston in (case)
had hg (dobj)
contributes endothelial-mesenchymal-transition (nsubj)
11-fold to (dep)
blocked which (nsubjpass)
model paranoia (nmod)
constant displacements (nmod)
endpoints convulsion (compound)
levels mda (nmod)
12 - (punct)
attenuate days (nmod)
75 to (quantmod)
suggest warranted (conj)
included cases (nsubjpass)
affinity preferential (amod)
mg/kg cocaine (compound)
distress users (nmod)
prolactinomas estrogen-induced (amod)
not if (mark)
hyperprolactinemia neuroleptic-associated (amod)
$ROOT$ evokes (sent)
volume group (nmod)
lowering vldl (dobj)
ufov ( (punct)
duration depending (case)
7h6 of (case)
t1/2 the (det)
alters pain (nsubj)
10-diol ) (punct)
terbinafine of (case)
$ROOT$ recorded (sent)
schedule a (det)
defined pressure (nmod)
sensitive insensitive (conj)
prevent fever (dobj)
induced estrogen (nmod:npmod)
contractility diaphragm (compound)
was mention (attr)
79 from (case)
damage as (case)
n-butyl-deoxynojirimycin combination (compound)
limbs contralateral (amod)
db db (dep)
2.3 0.05 (conj)
morphine ) (punct)
responses hypothermia (nmod)
cause increasing (advcl)
experienced . (punct)
level 3 (nummod)
necrosis concentrations (nmod)
ventilation time (conj)
high % (dep)
continue and (cc)
undergoing ptra (dobj)
0.13 0.03 (conj)
alternative pallidotomy (nmod)
conclude change (advcl)
primarily , (punct)
increased flow (dobj)
attenuation pretreatment (nmod)
experiencing and (cc)
5-hydroxytriptamine ) (punct)
was use (xcomp)
cigarettes ( (punct)
cigarettes 5 (nummod)
quit learning (advcl)
edema for (case)
february between (case)
identification . (punct)
more dl-sotalol (nmod)
using period (dobj)
occurrence fasciculation (nmod)
patients hospitals (nmod)
s-i e-i (conj)
responded treatment (nmod)
stimulation decreases (acl:relcl)
incidence esrd (nmod)
patients glioma (compound)
monotherapy mg/day (appos)
concentrations weight (conj)
hydrobromide ) (punct)
t5 rosen (nmod:poss)
induced blockers (nmod)
is research (attr)
induced decreases (nsubjpass)
pathway . (punct)
nodes in (case)
postures of (case)
shortened blockers (nsubj)
assigned regimens (nmod)
tumours rat (nmod)
doses prednisolone (nmod)
given i.p. (advmod)
meningioma metastases (conj)
suppressed ee (nmod)
end infusion (nmod)
$ROOT$ matched (sent)
replaced cdna (nmod)
% 138 (nummod)
scores induction (nmod)
exposure anesthetic (nmod)
detect effects (dobj)
4-phenylbutyrate sodium (compound)
argue suggest (advcl)
had matched (conj)
sedation induced (acl)
bleeding for (case)
signs any (det)
prevalence delirium (nmod)
homogenates of (case)
evidence malignancy (nmod)
patient(s woman (appos)
threshold mean (dep)
trend for (case)
underwent assessments (dobj)
gbm unresectable (amod)
month weight (conj)
patients participating (acl)
$ROOT$ inhibited (sent)
suggested have (aux)
1,1-dichloro-2,2,2-trifluoroethane hcfc (appos)
accounted this (nsubj)
surgery gastric (amod)
uraemia nephropathy (nmod)
mg/kg/i.p i.e. (advmod)
levels preoperative (amod)
implicated . (punct)
puncture endoscopy (conj)
isolated . (punct)
questions report (nsubj)
vessels large (amod)
compromising cytopenias (nmod)
users relative (nmod)
nmbas ) (punct)
recipients methotrexate (nmod)
methoxamine or (cc)
administration with (case)
haloperidol -15.4 (appos)
thalidomide of (case)
adduct trifluoroacetyl (compound)
thiazole-2-carboxamide ethyl (amod)
involves receptors (dobj)
d. of (case)
severe drop (advcl)
increased suppressed (conj)
regimen given (acl)
c-4-epimer ) (punct)
associated ci (nmod)
rate kg(-1 (nmod)
hyperprolactinemia by (case)
injury analysis (appos)
index of (case)
rose levels (nsubj)
80 63 (nummod)
observed since (mark)
sexes between (case)
expression gfap (nmod)
types different (amod)
operations lasting (acl)
vehicles saline (dep)
value trial (dep)
me the (det)
show to (mark)
equal % (nmod)
agents d1 (compound)
exhibited catecholamines (dobj)
ml/min 2.1 (nummod)
$ROOT$ modify (sent)
$ROOT$ withdrawn (sent)
compared measures (nsubjpass)
infiltration monocyte (compound)
stage pre-nephrotic (amod)
levels obtained (acl)
regardless irrespective (conj)
suggesting formation (dobj)
adult healthy (amod)
withdrawn times (nmod:tmod)
mass on (case)
crossed months (nmod)
h exposure (dep)
stimuli stimulation (conj)
had still (advmod)
rcts ) (punct)
range wt (appos)
used ketamine (nsubjpass)
material amorphogranular (amod)
testing reliable (amod)
needs caution (dobj)
generated site (nmod)
uraemia . (punct)
treated clozapine (nmod)
decreases sleepiness (dobj)
showed pilo (nmod)
outcome day (nmod)
drugs psychoactive (amod)
found hormone (nsubjpass)
dose-dependent effects (nsubj)
2.8 17.9 (prep)
adjust to (mark)
mg/kg 75 (nummod)
incidence experiences (nmod)
reversible schedule (nmod)
necessitated . (punct)
combinations its (nmod:poss)
known ketoconazole (nsubjpass)
dystonia human (amod)
amount time (nmod)
inheritance quantitative (amod)
studies our (nmod:poss)
needed studies (nsubjpass)
studied groups (nsubjpass)
kept ph (nsubjpass)
groups disease (compound)
prior infusion (nmod)
edema vasodilation (conj)
nine of (advmod)
radioactivity aortic (amod)
massive indicating (advcl)
descent african (amod)
24 5 (conj)
exercises physical (amod)
consistent level (nmod)
suspected neurotoxicity (nsubjpass)
reduction is (cop)
elevated % (dep)
stent a (det)
fewer somewhat (advmod)
method alternative (amod)
distinguish to (mark)
massive , (punct)
level urea (compound)
argatroban thrombolysis (conj)
rhubarb ) (punct)
sch antagonist (compound)
eosinophilia abnormalities (conj)
capacity balance (nmod)
compensated deficits (dobj)
neurons drg (nmod)
significant decrease (nsubj)
terminated anaesthesia (nsubjpass)
level conversion (nmod)
reversed that (mark)
changes by (case)
reliability about (case)
admitted shock (nmod)
shortened convulsion (nmod)
learn to (mark)
criterion or (cc)
scopolamine by (case)
followed diagnosed (advcl)
effects rats (nmod)
quantifying using (advcl)
offspring the (det)
method assessment (compound)
been although (mark)
increased mediators (nsubjpass)
performed absence (nmod)
hemorrhages , (punct)
synergistic doses (nsubj)
effectiveness antagonizing (acl)
agitation thermoregulation (conj)
thickness ) (punct)
tdp of (case)
effects norepinephrine (nmod)
explain . (punct)
increment clarithromycin (nmod)
amounts relative (amod)
distribution surface (compound)
derivative n-substituted (amod)
caused norepinephrine (nmod)
killed conditions (nmod)
grade 3 (nummod)
carcinomas primary (amod)
x ] (punct)
elevated receptors (nsubj)
2 3 (prep)
bpt/clz of (case)
alters whether (mark)
report findings (dobj)
anesthesia local (amod)
effect background (compound)
derived basis (nmod)
recovery pressure (nmod)
methods anaesthetised (appos)
reflex than (case)
macrophages induced (acl)
increase outcome (nsubj)
determined analyses (nmod)
sham lesioned (conj)
radiculopathy lumbusacral (amod)
ratios vte (nmod)
induces % (nmod)
chance developing (advcl)
asenapine or (cc)
rapidly very (advmod)
used d3 (nsubjpass)
laboratory light (conj)
strategy treating (acl)
disease angina (conj)
= 0.26 (dobj)
increased required (conj)
properties sotalol (nmod)
was elucidate (xcomp)
mm 19.3 (nummod)
gauges von (compound)
used controlling (advcl)
associated decrease (nsubjpass)
presentation asymptomatic (acl:relcl)
interaction , (punct)
herbicides s-53482 (nsubj)
concentrations . (punct)
protecting rats (dobj)
sensitive site (nmod)
profile lozenge (nmod)
myalgia evidence (dep)
normotensive rats (dep)
etiology treatment (conj)
15 and (cc)
acts which (nmod)
dogs tachycardias (nmod)
treatment antagonist (compound)
tolerated ce (dobj)
dose treatment (nmod)
sign with (case)
anencephaly coarctation (conj)
resulted days (nmod)
map rnfl (dobj)
mhpg ( (punct)
microg/l of (case)
cause strokes (nmod)
concentrations both (nmod)
paid been (auxpass)
days 0 (nummod)
clozapine to (case)
records of (case)
family the (det)
impairment suppression (dep)
cause delirium (nmod)
development movements (nmod)
killed animals (nsubjpass)
month . (punct)
symptoms muscle (compound)
question is (cop)
patients 84 (nummod)
conducting condition (nmod)
findings new (amod)
gastrointestinal prominently (advmod)
pressure substernal (amod)
cimd for (case)
made control (dep)
dysfunction rats (nmod)
prevented clinical (nmod)
healthy fit (dep)
examine directly (advmod)
injection dose (nmod)
0.28 ) (punct)
hg more (nummod)
controls six (nummod)
risk of (case)
use site (conj)
$ROOT$ gavaged (sent)
related be (auxpass)
i , (punct)
not statistically (advmod)
responsible putatively (advmod)
fields radiation (compound)
degeneration to (case)
rash eosinophilia (conj)
reassured respect (nmod)
toxicity cardiotoxicity (conj)
complained therapy (nmod)
circuits the (det)
produced can (aux)
activity seizure-like (amod)
radiofrequency rf (appos)
function , (punct)
indomethacin or (cc)
area operated (acl:relcl)
exhibited that (mark)
absent rhythm (nsubj)
cont./min ( (punct)
receptor durations (nmod)
intervals 1-min (compound)
contraindicated abnormalities (nmod)
associated pemoline (nsubjpass)
incidences submitted (acl)
patients thirty-one (nummod)
$ROOT$ inpatients (sent)
liver women (nmod)
abnormalities seen (acl)
secretion inappropriate (amod)
application placebo (conj)
azimilide micromol/l (appos)
channels ( (punct)
changed stabilized (conj)
catch a (det)
170 be (cop)
9.18 40.1 (conj)
efficacy , (punct)
measured maintained (ccomp)
ceruleus of (case)
anemia ribavirin-associated (amod)
creatinine mg/dl (nmod)
di ) (punct)
postinjection wr242511 (nmod)
mass or (cc)
unmatched or (cc)
woman 72-year-old (amod)
sustained years (nmod)
revealed suppressed (ccomp)
catechol not (cc)
cancer both (cc:preconj)
word any (det)
responses dynamic (amod)
proteins weight (nmod)
thiopenthal sodium (compound)
exceed effects (nsubj)
rocuronium of (case)
lining the (det)
hcrh ( (punct)
decreased accumulation (dobj)
diagnosed atherosclerosis (nsubjpass)
event before (case)
california of (case)
caused gentamicin (nmod)
patients 5000 (nummod)
unresponsive reduction (nmod)
converted um-272 (nsubj)
level expression (compound)
7.0 ratio (nsubj)
age subjects (nmod)
cause urticaria (nmod)
thrombosis with (case)
chorea into (case)
obtained rats (nmod)
delivery tubules (nmod)
modulating pathway (nmod)
min over (case)
were compare (ccomp)
changed one (nmod)
c of (case)
induced spasm (nmod)
controls for (case)
showed run (dep)
absence nominal (amod)
normalized patients (nmod)
found vessels (nmod)
interference metabolism (nmod)
demonstrated persistence (dobj)
level and (cc)
cyclophosphamide ctx (appos)
observed pups (nmod)
analogue a (det)
patients netilmicin (compound)
completed assess (xcomp)
injection dox (nmod)
terminology , (punct)
mcl ( (punct)
kg = (parataxis)
converted is (auxpass)
number protein (conj)
diet restricted (amod)
years 4.5 (nummod)
thrombophlebitis ( (punct)
patient cirrhosis (nmod)
dialysate a (det)
activities depressed (amod)
adrenaline not (cc)
4-acridinecarboxamide 9-[[2-methoxy-4-[(methylsulphonyl)amino]phenyl]amino (compound)
therapy zdv (compound)
fraction dried (amod)
study mg/m2 (nmod)
internus pallidus (compound)
day 10th (amod)
related site (nmod)
had patients (dobj)
immediately almost (advmod)
recorded demographics (nsubjpass)
myeloencephalopathy . (punct)
avoided and (cc)
knowing represent (ccomp)
exercise therapy (conj)
administered tropicamide (nsubjpass)
100mg/kg than (case)
possible separate (xcomp)
receiving day (nmod)
northern southern (conj)
pharmacology medicine (conj)
have cells (nmod)
picrotoxin- pentylenetetrazol-induced (conj)
switched . (punct)
affecting mainly (advmod)
twitch tensions (dep)
convulsions neonatal (amod)
causes doxorubicin (nsubj)
relationships liver (nmod)
l-name otoprotectant (amod)
lidocaine by (case)
mechanisms exerted (acl:relcl)
treatment s-1 (compound)
rats in (case)
measured min (nmod)
blockers unselective (amod)
achieving cr (dobj)
neuropathies ischemic (amod)
l-alpha-glyceryl-phosphorylcholine of (case)
satisfied ) (punct)
rare amlodipine (nmod)
aucs 6 (nmod)
cholesterols and (cc)
decreased g/dl (nmod)
investigation relevancy (conj)
cows nonlactating (amod)
increased aroused (advcl)
aberrations of (case)
affect . (punct)
brain compartments (conj)
plate hot (amod)
o2- in (case)
cellularity marrow (nmod)
sensitivity propranolol (compound)
prevented pretreatment (nsubj)
ng/kg/min ) (punct)
administration phenobarbital (nmod)
effects cardiac (amod)
movement , (punct)
myoclonus severe (amod)
1993 1995 (prep)
ptcr ( (punct)
incoordination diazepam-induced (amod)
rhythm block (conj)
therapy weeks (nmod:tmod)
treated practice (nmod)
origin . (punct)
prescribed chemotherapy (nmod)
responses clinical (amod)
importance mainstay (dep)
conclude has (ccomp)
twelve one (compound)
% 10.0 (nummod)
treated glioma (nmod)
operations during (case)
indicates have (ccomp)
path perforant (amod)
effects csa (nmod)
characteristics effects (conj)
protocol ifosfamide (compound)
proteins peripheral (amod)
time for (case)
occurred proceeded (advcl)
associated kindling (nmod)
diagnosis af (nmod)
lead procedure (nmod)
experiments in (amod)
fact include (acl)
alkaloid is (cop)
findings paradigm (nmod)
lidocaine bupivacaine (conj)
infections major (amod)
useful women (nmod)
mediates depression (dobj)
placed after (mark)
role tamoxifen (nmod)
evaluated safety (dobj)
released . (punct)
studies comparative (amod)
assess in (mark)
th ) (punct)
20 more (amod)
ml 2.5 (compound)
irbesartan with (case)
distress emotional (amod)
people prescribed (acl:relcl)
review historical (amod)
return toward (case)
allodynia > (dep)
polygraph a (det)
habituation of (case)
damage delayed (amod)
involving blockade (dobj)
10- , (punct)
t-test p=0.338 (nummod)
has smoking (nsubj)
tiapride mg/day (appos)
susceptible vt (nmod)
use including (case)
interactions neurotransmitters (nmod)
reduced hepatitis (nsubjpass)
asenapine ( (punct)
leukoencephalopathy . (punct)
hearts denervated (amod)
insurance to (case)
results activates (advcl)
months 17 (nummod)
pvc ( (punct)
maintenance tdp (nmod)
hem = (dep)
increases rats (nmod)
reports increasing (amod)
shr lifetime (amod)
hypoplasia marrow (compound)
c2 iv (nummod)
160/12.5 320/12.5 (conj)
statin ( (punct)
view action (nmod)
stimulated time-dependently (advmod)
contains reports (dobj)
weakness extremity (compound)
degree same (amod)
level signs (conj)
obstruction plugs (nmod)
seizures % (appos)
cases autopsy (compound)
and significantly (advmod)
alternatives patients (nmod)
screened patients (nsubjpass)
related antimicrobials (nmod)
1.81 ) (punct)
catheterisation by (case)
induced adjustment (nmod)
agent erythrodysesthesia (conj)
indication and (cc)
g/day , (punct)
cocaine anesthetics (conj)
nacl ) (punct)
evoked stimulation (nmod)
reductions mssbp (nmod)
reversing gradient (dobj)
cingulate anterior (amod)
administered points (nmod)
improvement limbs (nmod)
antibody mrp2 (compound)
had dexamethasone (nsubj)
hospital community (compound)
function myocardial (amod)
328 53 (conj)
depends diagnosis (nsubj)
cardiotoxity model (nmod)
pelvis of (case)
appropriate physiologically (advmod)
hemodynamics handling (conj)
reports to (case)
groups bladder (dep)
mg/dl mg/dl (appos)
combined often (advmod)
slowing activity (nmod)
m and (cc)
discovered : (punct)
scores group (nmod)
cr ( (punct)
demonstrated responses (dobj)
malondialdehyde nucleosides (conj)
infused intravenously (advmod)
appeared to (xcomp)
by-product production (nsubj)
potentials and (cc)
comparison patients (nmod)
patients responding (amod)
ototoxicity aminoglycoside-associated (amod)
known ability (nsubjpass)
motionless animals (nsubj)
i.v. 30 (nummod)
bches ( (punct)
cardiomyopathy dcm (appos)
did whom (nmod)
recruited males (nsubjpass)
chloride with (case)
sequelae delayed (amod)
capacity mcc (appos)
avoiding recommended (dep)
mg/kg respectively (advmod)
prostigmine and (cc)
been treatment (nmod)
single-blind . (punct)
resolved all (nsubjpass)
noted administration (nmod)
regurgitation massive (amod)
frequency low (amod)
troublesome . (punct)
interval percent (amod)
apd epicardial (amod)
fulfill to (mark)
injury due (acl)
gtn placebo (conj)
= p<.001 (dep)
occur toxicity (nsubj)
hepatotoxicity sulfasalazine (nmod)
synergy models (nmod)
myositis acid-induced (amod)
toxic less (advmod)
thought gap43 (nsubjpass)
protease d (appos)
effects various (amod)
lesions skin (compound)
recovery complete (amod)
difference adjusted (amod)
causes impairment (dobj)
leading restriction (nmod)
volume cerebellar (amod)
exposed , (punct)
azt phz (conj)
inappropriate however (advmod)
mammals in (case)
increase gfr (dobj)
chicks in (case)
abdomen the (det)
modify it (nsubj)
had little (dobj)
disease refractory (amod)
past the (det)
factor platelet-activating (amod)
hippocampus ventral (amod)
day completion (nmod)
33 ( (punct)
sensitive more (advmod)
administration pdtc (nmod)
alertness of (case)
generations two (nummod)
hemolysis induced (acl)
observed enhancement (nsubjpass)
cr as (case)
injection produce (acl)
times functioning (conj)
hypercholesterolemia because (case)
reduction monitoring (nmod)
release c (compound)
occurs heterogenously (advmod)
cd4 cells/microl (appos)
disorientation , (punct)
determine associated (ccomp)
drugs immunomodulatory (amod)
hours 2.9 (nummod)
tablets to (case)
found inhibited (dep)
signs lesions (conj)
stress chronic (amod)
administering drugs (dobj)
risk arrhythmias (nmod)
times clotting (compound)
minutes is (cop)
stn ) (punct)
concentration flecainide (compound)
assessed has (aux)
density od (appos)
second involving (acl)
divided 1 (nmod)
neuropathy (stz)-induced (amod)
hormone low (amod)
those transplanted (acl)
suxamethonium mg (nummod)
bort weeks (appos)
prescribing of (mark)
convulsions lidocaine-induced (amod)
flurothyl pentetrazol (conj)
trials investigated (acl:relcl)
low as (case)
employed and (cc)
arteries lnna (nmod)
$ROOT$ 7.54 (sent)
received prevent (advcl)
developed % (nmod)
metabolite ) (punct)
assays drug (nmod)
violation protocol (compound)
connection a (det)
utilized been (auxpass)
received ct (nmod)
categories use (nmod)
activations enhanced (amod)
ptz and (cc)
period 60-s (compound)
show abolished (ccomp)
% 0.06 (compound)
caused desferrioxamine (nmod)
neurotoxicity 5-fluorouracil (compound)
years 81.6 (nummod)
discontinued studies (nmod)
microl % (appos)
tumor of (case)
exhibits that (mark)
patient three (conj)
rare progressive (conj)
caused % (nmod)
ratios accounting (acl)
suprofen drug (appos)
sedations these (det)
compared severity (dobj)
jones 1973 (appos)
antagonist kinin (compound)
particles brain (nmod)
diltiazem including (case)
bind which (nmod)
incidence neoplasms (nmod)
maintained when (advmod)
headache migraine (compound)
expressed known (conj)
detected contrast (nmod)
iml ) (punct)
effects stimulatory (amod)
mg/day 1.8 (nummod)
mg/kg by (case)
resolve does (aux)
organelle the (det)
mg/m(2)/day ( (punct)
122+/-5 from (case)
growth contractions (conj)
respect use (nmod)
erythroblasts observed (acl)
2190 to (case)
-14.6 ) (punct)
path lateral (amod)
diet normal (amod)
present occurred (conj)
included events (nsubj)
treatment during (nmod)
suggests background (nsubj)
showing changes (dobj)
prolonged micromol/l (nmod)
differed groups (nmod)
diazinon of (case)
rr=1.41 ) (punct)
evidence coagulation (nmod)
micrograms/kg 0.3 (nummod)
identified causes (nsubjpass)
pan/temocapril ) (punct)
injection intradermal (amod)
ifosfamide dactinomycin (conj)
complicated was (auxpass)
captopril ) (punct)
mg administration (nmod)
lumen capillary (compound)
prescribed dysfunction (nmod)
steroids of (case)
artery saphenous (amod)
donors volunteer (compound)
sustained improvements (nsubj)
accumulation edema (compound)
induced documented (conj)
used proposed (advcl)
associations for (case)
received or (cc)
analgesic non-narcotic (amod)
ra co-administered (acl)
reducing chronically (advmod)
responses different (amod)
suppressed dysfunction (nsubjpass)
possibility myopathy (nmod)
distance reflex (compound)
greatest was (cop)
monitoring intervention (conj)
gavaged followed (dep)
microscope the (det)
dose cs (nmod)
evident histologically (advmod)
suggestive connection (nmod)
showed period (dobj)
mg/50 50 (compound)
improves stimulation (nsubj)
have dysfunction (nmod)
prognosis endophthalmitis (nmod)
mg/kg 320 (nummod)
c l (appos)
years were (cop)
f344 ( (punct)
increase compared (advcl)
evolved has (aux)
receptor mechanisms (conj)
investigated be (auxpass)
mouth risks (conj)
gender and (cc)
dehydration , (punct)
true migraine (nmod)
effects potential (amod)
sg145r resistance (conj)
treated netilmicin (nmod)
mice thrombocytopenia (nmod)
exacerbates symptoms (dobj)
iohexol % (appos)
pfss ( (punct)
combination metoprolol-terbinafine (compound)
subjected blockade (nmod)
is however (advmod)
rats c (dep)
appetite-suppressants to (case)
yohimbine the (det)
patients tolerate (acl:relcl)
metastases in (case)
reduction thickness (nmod)
anemia to (case)
hyperprolactinemia . (punct)
shown occurred (ccomp)
interruption the (det)
capsaicin applied (acl)
occlusion a (det)
prescribed man (nsubjpass)
nsclc ( (punct)
overdose with (case)
dmso ( (punct)
syndrome secretion (nmod)
development eventual (amod)
fluency verbal (amod)
listed although (mark)
cells drg (nmod)
agent paclitaxel (nsubj)
extract from (case)
variation respectively (advmod)
intention-to-treat on (case)
mg/kg 2 (nummod)
improves infusion (nmod)
result interactions (nmod)
svc the (det)
n/n=62/92 respectively (advmod)
% 11 (nummod)
increased whereas (mark)
dysfunction renal (amod)
similar males (nmod)
using hands (dobj)
revealed improvement (dobj)
administration ephedrine (nmod)
excluding effects (nmod)
given dnr (dobj)
testosterone high-dose (amod)
rofecoxib acetaminophen (conj)
therapy argatroban (compound)
maze mwm (appos)
neurons in (case)
visits 10.3 (nummod)
due rifampicin (nmod)
survived and (cc)
hepatitis hepatitis (conj)
receive part (nmod)
hypercalcemia initially (advmod)
therapies medical (amod)
activation systems (nmod)
observed episodes (dobj)
localization regional (amod)
was myalgia (nmod)
$ROOT$ program (sent)
cytoskeleton the (det)
surgeries intraocular (amod)
administered frequently (advmod)
overexpression p300 (nmod)
changes related (amod)
antioxidants tissue (compound)
expression the (det)
induces dose (nsubj)
patients 158 (nummod)
associated tachycardia (nmod)
highlight importance (dobj)
reduce particular (nmod)
obvious available (conj)
rats subjected (acl)
$ROOT$ analogue (sent)
describes enhancement (dobj)
level postprocedural (amod)
stz crocins (conj)
found toxicity (nsubjpass)
rhythms as (case)
halothane and (cc)
have conclusions (nsubj)
tested we (nsubj)
presented increase (dobj)
effect latter (amod)
points finding (nsubj)
first telithromycin (nsubj)
vsds ) (punct)
muscle ventricular (amod)
metabolite formed (acl)
decreased lowered (advcl)
expression npy (compound)
placed probe (nsubjpass)
patterns latter (amod)
ca kimmel (compound)
approximation with (case)
monotherapy quetiapine (compound)
cns enhanced (amod)
mortality increased (amod)
effects processing (nmod)
dose-dependent effect (nsubj)
retarding rats (nmod)
determined g (nmod)
cases associated (acl)
$ROOT$ permitted (sent)
paper for (case)
mr of (case)
association cyclophosphamide (nmod)
restored potentiation (dobj)
had , (punct)
5.05 22.77 (conj)
diluents of (case)
signs agents (nmod)
effects neuropathy (nmod)
most piglets (nmod)
caused nicotine (nsubj)
$ROOT$ measure(s (sent)
that condition (nmod)
overflow kidneys (nmod)
compare course (dobj)
inhibitor potent (amod)
treatment csa (compound)
stress downregulation (conj)
ara-c with (case)
min and (cc)
contraindicated carbamazepine (nsubj)
creatinine : (punct)
output ach (compound)
inhibitors ns-nsaids (conj)
brain rat (compound)
life normal (amod)
neutralization drop (conj)
antrum thickened (amod)
suppressed blockers (nmod)
cgs 21680 (nummod)
$ROOT$ mirrored (sent)
challenged microinjections (nmod)
olanzapine of (case)
higher level (nmod)
reduction transformation (nmod)
precurarization the (det)
achieved one (nsubj)
element may (aux)
process aging (compound)
62.0 - (punct)
treatment toxicity (nmod)
returned level (nmod)
determined area (nsubjpass)
transferred department (nmod)
amplitude reflex (compound)
carriers hepatitis (compound)
abilities global (amod)
system via (case)
produced reversed (advcl)
lactation of (case)
have 17 (nsubj)
modulating neurotoxicity (dobj)
concerned who (nsubj)
assessed incidence (dobj)
episodes 3 (nmod)
stage kidney (compound)
p10 ( (punct)
frequency their (nmod:poss)
154:64 p (dep)
subtypes mglu7 (compound)
options evidence-based (amod)
convulsion and (cc)
acid seizures (conj)
therapy induction (compound)
microgram/kg/min 17.4 (nummod)
groups women (nmod)
diagnosis failure (nmod)
effect been (cop)
atazanavir daily (advmod)
cardiomyopathy as (case)
discontinued completion (nmod)
obtained but (cc)
affect significantly (advmod)
estimated conditions (nsubjpass)
neurons gad (compound)
meningitis aureus (compound)
produced suggesting (advcl)
proportion subjects (nmod)
nanospheres ns-718 (nmod)
wales in (case)
restriction movements (nmod)
cpap to (case)
% control (dep)
concentrations peak (amod)
history hypertension (nmod)
present 13 (nmod)
produce illness (dobj)
woman non-alcoholic (amod)
undergoes , (punct)
5.0 1.2 (compound)
sec. 90 (nummod)
dogs halothane-anesthetized (amod)
play roles (dobj)
restored but (cc)
determine serve (ccomp)
25 10 (compound)
models ischaemic (amod)
dependency test (nmod)
fusion postero-lateral (amod)
years therapy (nmod)
ratio male/female (compound)
class nfs (nmod)
board institutional (compound)
rates mortality (compound)
oxytocin of (case)
seen infections (conj)
inhibitors ssr103800 (nmod)
assessment observer (nmod:poss)
rate input (compound)
suggests thus (advmod)
delayed significantly (advmod)
resulted overdose (nsubj)
volume concentrations (nmod)
dct2 ) (punct)
ng/ml. 9.10 (nummod)
158.11 ( (punct)
alter infusion (nmod)
nephrectomy during (case)
expression p75ntr (compound)
incidence higher (amod)
anticoagulation the (det)
incidence tdp (nmod)
experiment quasi (amod)
precipitated be (auxpass)
had because (mark)
formulation the (det)
bfgf vegf (conj)
difference severity (nmod)
points 5 (nummod)
symptoms nms-like (amod)
low-osmolar monomeric (dep)
affect therapy (nsubj)
na+ for (case)
tachycardia is (cop)
deficits dopaminergic (amod)
high- to (case)
$ROOT$ activation (sent)
exhibits reversal (dobj)
female unanesthetized (amod)
myelination changes (conj)
% glycopyrrolate (conj)
days trial/day (appos)
generations the (det)
treatment continuous (amod)
= 0.58 (dobj)
received ( (punct)
associated restoration (nmod)
example good (amod)
levels lpo (compound)
patient tenth (amod)
subgroup a (det)
= 9 (dobj)
attenuated moreover (advmod)
8 to (case)
sites liver (nsubj)
length time (nmod)
myocardial and (cc)
99mtc-glucarate . (punct)
syndrome wiskott-aldrich (amod)
window observed (acl)
months study (nmod)
used injections (nsubjpass)
observed forces (nmod)
effect phosphate (nmod)
hemoglobin haptoglobin (conj)
induce effect (nmod)
rf ( (punct)
occlusions of (case)
plasma steady-state (amod)
dynamic ) (punct)
box in (case)
tolerance glucose (compound)
depressed nh4ac (nmod)
19.9 to (quantmod)
produced stimulating (advcl)
able ( (punct)
membrane basement (compound)
exposure with (case)
antigen nuclear (amod)
treated weeks (nmod:tmod)
4 stz (appos)
impact negative (amod)
using models (nmod)
drugs substituted (amod)
alive and (cc)
differs that (nmod)
is task (attr)
9 % (quantmod)
normotension of (case)
agent thalidomide (nsubj)
experience did (aux)
disadvantages patients (nmod)
drug combinations (conj)
hamsters three (nummod)
model may (aux)
reactions volunteers (nmod)
feasibility toxicity (conj)
greater olanzapine (nmod)
disclosed abnormalities (dobj)
particles platelet (compound)
diarrhea flatulence (conj)
signs off (amod)
signs recovery (nmod)
228 ( (punct)
blockade movement (nmod)
generated c1 (dep)
hypothyroid patients (nsubj)
relevance features (nmod)
use simvastatin (nmod)
units 32.6 (nummod)
treatment reserpine (compound)
cocaethylene to (case)
convulsions prevention (conj)
plasma animals (nmod)
contribution a (det)
increase medication (nmod)
showed tomography (nsubj)
reversed this (nsubjpass)
subjects clozapine (dep)
vesicles numerous (amod)
differ groups (nsubj)
transplanted patients (nsubjpass)
pressure lvdp/dt (appos)
augment not (neg)
older . (punct)
became switching (advcl)
data establish (acl:relcl)
studied formation (nsubjpass)
scotoma hemianopic (amod)
more much (advmod)
42 1 (conj)
performed are (auxpass)
effects e4031 (nmod)
unclear contribution (nsubj)
assessed task (nmod)
have 7 (nmod)
induced hyperprolactinemia (nsubjpass)
became h (nmod)
increased are (auxpass)
reentry nodal (amod)
magnitude course (conj)
pressure patients (conj)
glomerulonephritis of (case)
$ROOT$ begun (sent)
severe such (amod)
ceased fits (nsubj)
contractility features (conj)
arteries small (amod)
dna as (cc)
mmhg from (case)
contribution anxiety (nmod)
infusion period (nmod)
astroctytes ccr2 (amod)
mexiletine international (amod)
effect causing (acl)
impair treatment (nsubj)
given sulfate (dobj)
report showing (advcl)
contrast of (case)
aroused still (advmod)
administered group (nsubjpass)
represents . (punct)
chloride cacl(2))-induced (appos)
mesna given (acl)
block an (det)
nitroprusside snp (appos)
voltage- calcium- (conj)
years recent (amod)
potentiation rats (nmod)
nascis the (det)
subjects 100 (nummod)
dose diminished (acl:relcl)
decreases behavior (nmod)
suggested involvement (nsubjpass)
centre a (det)
treatment isradipine (compound)
drug rapa (compound)
use art (compound)
explain development (dobj)
knee left (amod)
developed infants (nmod)
necessary were (cop)
phosphatase a (det)
cells around (case)
range titres (nsubj)
severity moderate (amod)
was determine (ccomp)
valve tricuspid (amod)
acts differs (conj)
occurrence endpoints (nsubj)
cardiorespiratory temperature (conj)
investigate involved (ccomp)
provocation symptom (compound)
risk mortality (nmod)
progestagens of (case)
widening failure (nmod)
reports article (nsubj)
activity learning (conj)
improve localization (dobj)
allocated . (punct)
cab acetate (dep)
overexpression comparable (amod)
107 10(9)/l (conj)
infants young (amod)
march 2005 (nummod)
develop years (nmod)
ibuprofen 1.51 (nummod)
thalidomide continuous (amod)
differences gender (compound)
testing clinical (amod)
cards symptom (compound)
feature that (mark)
olanzapine % (dep)
group pci (compound)
propose tie (dobj)
independent additive (conj)
administered inadvertently (advmod)
use metolachor (compound)
programming functional (amod)
injury tissue (compound)
impressions global (amod)
fibrillation atrial (amod)
events patients (nmod)
counts average (amod)
26 [ (punct)
mechanism likely (amod)
doses nmda (nmod)
boluses 4 (nummod)
re not (cc)
effects other (amod)
patients mm (compound)
150 < (advmod)
29th 30th (conj)
effect towards (case)
nature given (case)
class on (case)
site factors (conj)
hydrochloride nifekalant (compound)
displayed dronedarone (nsubj)
protected metformin (nsubj)
values ) (punct)
cases implicating (acl)
received address (advcl)
prevention stress (nmod)
carries , (punct)
alf sc (appos)
antagonist glutamate/n-methyl-d-aspartate (compound)
disability , (punct)
hypotension on (case)
basis disturbances (nmod)
brains processed (acl)
$ROOT$ curtailed (sent)
before minutes (conj)
three these (nmod)
cb than (case)
2.30 ) (punct)
hypertension intracranial (amod)
antidepressants new (amod)
present at (case)
received cocaine (dobj)
spikes population (compound)
increased factor (nmod)
thorax and (cc)
hours theophylline (nmod)
cases six (nummod)
consumption from (case)
administered intraperitoneally (advmod)
potent times (nmod:npmod)
cause may (aux)
hbv 13 (nummod)
examinations and (cc)
maintained is (cop)
potential for (case)
txa high-dose (amod)
hospital tertiary-care (amod)
caused diagnosis (nmod)
use combination (nmod)
h treatment (dep)
aim carried (dep)
induced exposure (nmod)
produced will (aux)
elevated measured (advcl)
perfusion the (det)
reduction adequate (amod)
concentrations interleukin-6 (compound)
post-injection hr (amod)
1-receptor chronic (amod)
neurotoxicity nelarabine (compound)
discriminated effect (dobj)
found bladder (nmod)
associated chemotherapy (nmod)
um-272 sublingual (amod)
contact cutaneous (amod)
0.24:1 and (cc)
aware clinicians (nsubj)
participants cocaine (conj)
mg.kg(-1).d(-1 ) (punct)
mediator anti-inflammatory (amod)
fluphenazine or (cc)
effect norepinephrine (nmod)
fps percentage (compound)
apex midventricle (conj)
bid daily (advmod)
analyzed retrospectively (advmod)
if ln (conj)
$ROOT$ aims (sent)
bun ) (punct)
presence the (det)
activation morphine (nmod)
newborn infant (conj)
rats obese (amod)
lesions cerebral (amod)
prednisolone methotrexate (conj)
extract species (nmod)
amount minimal (amod)
meritorious but (cc)
movements feet (nmod)
antagonist ah6809 (conj)
bort-dex before (case)
anesthesia propofol-remifentanil (compound)
higher observed (parataxis)
lymphocytes patients (nmod)
16/104 ] (punct)
siadh of (case)
gravis of (case)
fields ufov (conj)
result whether (mark)
replacement fresh (amod)
duration fpd (appos)
permeability , (punct)
$ROOT$ d-penicillamine (sent)
control saline (compound)
awareness their (nmod:poss)
cause population (nmod)
intoxication alcohol (compound)
$ROOT$ became (sent)
achieved yet (cc)
$ROOT$ prompted (sent)
revealed role (dobj)
content renal (amod)
include conclusions (nsubj)
efficient be (cop)
activity dismutase (compound)
lesions fewer (amod)
avoid drugs (dobj)
repaired that (nsubjpass)
pretreated cells (nsubjpass)
withdrawal octreotide (nmod)
glomerulonephritis autoimmunity (conj)
onset at (case)
20 0 (conj)
minutes of (case)
differences indices (nmod)
7.3 ) (punct)
depending preference (nmod)
domains iief (nmod)
sweating , (punct)
craniotomy clipping (nmod)
% women (nmod)
ht versus (cc)
regulation tone (nmod)
developed postoperatively (advmod)
formation edema (compound)
stage in (case)
seizure tonic-clonic (amod)
all mice (nmod)
n/n=62/92 , (punct)
rigidity myalgia (conj)
amounts platinum (nmod)
lobule throughout (case)
hemolysis total (amod)
study degeneration (dobj)
bn 52021 (nummod)
opioid effects (nmod)
lead disease (nmod)
fungizone deoxycholate (dep)
due treatment (nmod)
serum/urine in (case)
syndrome tls (appos)
ms lc/ms/ms (appos)
pallidotomy as (case)
pituitaries the (det)
tasks times (conj)
slow fast (conj)
hematoxylin and (cc)
diisopropylfluorophosphate sarin (conj)
4.4 of (case)
elevated pressure (dobj)
rs6693503 ( (punct)
$ROOT$ needed (sent)
aggravates overload (dobj)
response augmented (amod)
prevention hc (nmod)
remained but (cc)
cancer treated (amod)
(aap)-induced acetaminophen (nmod:npmod)
discontinued had (aux)
observer 's (case)
damage casts (nmod)
baseline conditions (dep)
compromise cardiopulmonary (amod)
complication unexpected (amod)
undergoing angioplasty (dobj)
induce cocaine (nmod)
perception and (cc)
differences lozenge (nmod)
produce produced (parataxis)
suspected cause (xcomp)
partial least (advmod)
results prolactin (compound)
velocity decreased (amod)
levonorgestrel i.e. (advmod)
glibenclamide , (punct)
represents successful (advcl)
correlation hemorrhage (nmod)
quit early (advmod)
administered alone (advmod)
haemorrhage of (case)
highly more (advmod)
block stimulation (nmod)
mice among (case)
shortening electrocardiogram (nmod)
composed lesion (nsubjpass)
valves heart (compound)
$ROOT$ exhibited (sent)
anesthetics general (amod)
phosphate-diaphorase dinucleotide (compound)
exposure hepatocytes (nmod)
space tuft (conj)
effect stimulation (nmod)
rates svr (compound)
achieved 16/20 (nsubj)
intra-hisian infra-hisian (conj)
revealed prevalence (nmod)
neuropathy patients (nmod)
blockade stimulation (conj)
microm respectively (advmod)
affect development (dobj)
microinjections intracollicular (amod)
effect expression (nmod)
latency decrease (conj)
noted effect (nsubjpass)
complication injections (nmod)
subject same (amod)
donor donor (nsubj)
prednisolone , (punct)
safe , (punct)
hyperglycemia severe (amod)
showed week (nmod)
schedule duration (conj)
% 97.2 (nummod)
$ROOT$ extracted (sent)
atropine unselective (amod)
results ng./ml (appos)
82+/-12 to (case)
insufficiency chronic (amod)
mice deficient (amod)
gained weight (dobj)
ms time-of-flight (amod)
improved results (nsubj)
pn at (case)
cbdca ( (punct)
movements peak (amod)
$ROOT$ participants (sent)
antimicrobials many (amod)
haloperidol -20.0 (appos)
cause weakness (nmod)
peak trough (conj)
hypotension or (cc)
hematomas larger (amod)
complex i (nummod)
donors hbsag-positive (amod)
patients infarctions (nmod)
period 2-day (amod)
studies follow-up (amod)
increased of (cc)
correlates encoding (nmod)
agents neuromuscular (amod)
rejection antibody-mediated (amod)
remained although (mark)
infarction men (nmod)
clinical and (cc)
features non-specific (amod)
loss predominant (amod)
described women (nmod)
drugs these (det)
number resuscitations (nmod)
changes produced (acl)
died toxicity (nmod)
preventing use (nmod)
controls saline (appos)
change time (nmod)
disorder transmission (nmod)
binding (3)h-mk-801 (compound)
bfgf in (case)
ratio hag (nmod)
twice approximately (advmod)
disintegrin and (cc)
patients 529 (nummod)
lymphocytes rabbit (nmod:poss)
state to (mark)
induced ribavirin (nmod:npmod)
control wt (compound)
improves ; (punct)
established group (dobj)
study literature (nmod)
apomorphine : (punct)
pathway rats (nmod)
cytoplasm than (case)
asystole by (case)
case child (nmod)
minutes 34 (nummod)
world " (punct)
tarsorrhaphy lateral (amod)
aap and (cc)
overcome be (auxpass)
produce doses (nsubj)
areas vulnerable (amod)
coingested who (nsubj)
consist separating (advcl)
dosages daily (amod)
clearance endogenous (amod)
site tumor (compound)
inability sleep (acl)
leads pseudolithiasis (nmod)
metabolites major (amod)
proband of (case)
sample on (case)
displayed seemed (conj)
psp ) (punct)
inpatients adult (amod)
relevant exposure (nmod)
exerts , (punct)
hallucinations nightmares (conj)
status pubertal (amod)
run-in periods (conj)
affect : (punct)
intensity low (amod)
wall aortic (amod)
had differences (nsubj)
beraprost of (case)
reconsidered basis (nmod)
oral and (cc)
treated antagonist (nmod)
used drug (dobj)
programming the (det)
tolerate kind (dobj)
counter substances (nsubj)
similar lidocaine (nmod)
administration every (det)
breakdown asymmetrical (amod)
sepsis of (case)
maintained flow (nsubjpass)
prepared . (punct)
using respectively (advmod)
reduction 1 (dep)
determine effects (dobj)
point study (nmod)
suppress activity (dobj)
administration narcotic (amod)
formed finally (advmod)
score pain (compound)
elevation output (nmod)
2.8 from (case)
affect themselves (nmod)
anemia because (case)
microm by (case)
relationships antagonism (nmod)
effects responses (nmod)
dose precurarization (nsubj)
tolazamide with (case)
cases syndrome (nmod)
induced however (advmod)
eps without (case)
nephropathy contrast-induced (amod)
patients model (conj)
syndrome stevens-johnson (compound)
cyclosporine- tacrolimus (conj)
discern to (mark)
exposed saline (conj)
diagnosis lesion (nmod)
blockers beta-receptor (compound)
erythrocytes her (nmod:poss)
diet choline-supplemented (amod)
become alternative (attr)
blocker channels (nmod)
use scale (nmod)
consequence were (cop)
alterations ecg (compound)
hypertrophic were (cop)
subject in (case)
cholate of (case)
seizures convulsive (amod)
history days (nmod:poss)
effective controlling (advcl)
b. in (case)
na+-extrusion by (case)
noted mesothelioma (nmod)
specific mechanism (nmod)
txa of (case)
weeks 36 (nummod)
carbamazepine aed (appos)
derivative n-acylimidazole (compound)
safely , (punct)
movement intraoperative (amod)
produced have (aux)
reversible disease (nsubj)
topotecan combination (nmod)
lev mg (appos)
indicates inability (nsubj)
injected intradermally (advmod)
27 ) (punct)
unchanged fraction (nsubj)
years age (nmod)
width reduced (amod)
considered tgf-beta1 (nsubjpass)
late response (nmod)
higher percentage (nsubj)
blockers three (nummod)
tuberculosis pulmonary (amod)
fractures 13 (nummod)
valves with (case)
rate aldosterone (compound)
reduction cytotoxicity (nmod)
receive followed (advcl)
conclusions : (punct)
nucleus at (case)
$ROOT$ abundant (sent)
administration anesthetics (nmod)
play damage (nmod)
infiltrates walls (nmod)
chickens of (case)
25 depression (nmod)
22 4 (compound)
functioning in (case)
resulted inhibition (nmod)
terms quality (nmod)
nitroglycerin patients (appos)
cholestatic cytolytic (conj)
natural and (cc)
clamping bilaterally (advmod)
b mg/kg (dep)
startle fps (appos)
decreased reabsorption (dobj)
database the (det)
chloroprocaine as (case)
higher dose (nsubj)
> bp (conj)
mexiletine mexitil-perlongets (appos)
complications , (punct)
slowing increased (amod)
signs factors (conj)
concluded needs (conj)
segment pallidus (nmod)
improve deficit (dobj)
denominator common (amod)
regulator is (cop)
needle touhy (compound)
diazepam followed (acl)
reflexes deep-tendon (amod)
year by (case)
involve models (nsubj)
assessed delirium (nsubjpass)
induced hypotension (dobj)
therapy methimazole (compound)
7alpha-hydroxylation acid (nmod)
l4 5 (prep)
sd induced (acl)
citalopram , (punct)
tachyarrhythmia the (det)
rats tgr (compound)
resulted treatment (nsubj)
cotransporter the (det)
shows associated (ccomp)
agent treatment (nmod)
treating polyuria (dobj)
similarity a (det)
gains control (nmod)
administration bcnu (compound)
vasospasm , (punct)
employed ) (punct)
departments emergency (compound)
agriculture in (case)
statement reference (nmod)
1788 and (cc)
amount fibrin (nmod)
bradykinin in (case)
dopamine hydroxylase (conj)
eminence in (case)
effect fluoxetine (compound)
process cell (nmod)
conclusions useful (appos)
induction possible (amod)
sensorium clear (amod)
induces , (punct)
raise that (mark)
nmol/l 600 (nummod)
recorded identifiers (nmod)
variable efficacy (compound)
related administration (nmod)
capacity + (compound)
nsaid or (cc)
mutant transport-deficient (amod)
dose s.c. (advmod)
necessary conversion (nsubj)
unclear have (aux)
doses refracted (amod)
psychosis of (case)
replaced as (mark)
used investigate (xcomp)
reduces vivo (advmod)
chloroacetaldehyde contribution (conj)
anorexigens , (punct)
cco ( (punct)
dose induction (nmod)
receptor-alpha by (case)
forms other (amod)
r4 ) (punct)
lupus drug-induced (amod)
hepatonecrosis : (punct)
appeared group (nmod)
anemia or (cc)
level transcripts (nmod)
agents and (cc)
cause anp (nsubj)
performed investigate (advcl)
remains elucidated (xcomp)
require period (nmod)
report boy (nmod)
mutants sg145r (compound)
100 1 (compound)
evaluated functions (nsubjpass)
live individuals (nsubj)
concerned response (nsubj)
inducing impairment (dobj)
nos ) (punct)
disturbances level (nmod)
analysis risk (compound)
synchrony in (case)
range moles/glomerulus (dep)
escalated cohorts (nmod)
antinociception morphine (compound)
morphology heart (compound)
ratio [ (punct)
cgi-sf measure (appos)
features dysfunction (nmod)
process around (case)
peptide(1 42)-infused (dep)
demonstrated operation (nmod)
mg/kg/b.w./day gavages (nmod)
overflow of (case)
induced 2 (dep)
implies model (nsubj)
accepted evidence (nmod)
effect cardiotoxicity (nmod)
scale tromso (compound)
cases hypotension (nmod)
capacity mitochondrial (amod)
groups dose (nmod)
modification consisting (acl)
hyperactivity later (amod)
reductions pri (nmod)
saw . (punct)
concentrations different (amod)
hypotension controlled (amod)
involvement tricuspid (amod)
ifosfamide with (case)
sph [ (punct)
factors nephrotoxicity (nmod)
application post (compound)
users were (cop)
mrna interleukin (conj)
segment worst (amod)
block that (mark)
media artery (nmod)
needed however (advmod)
infusion timed (amod)
tolerance rigidity (nmod)
mechanisms with (case)
oropharynx ; (punct)
ci 1.3 (nummod)
levels headache (nmod)
decreased hazard (nsubj)
synthesis hypertrophy (nmod)
antineoplastic . (punct)
examined arteritis (nsubjpass)
electrophysiology visual (amod)
elicited were (auxpass)
pointer a (det)
onset effects (nmod)
insipidus secondary (amod)
h-1 ) (punct)
30 about (advmod)
received wr242511 (dobj)
syndrome myelodysplastic (amod)
slowing diffuse (amod)
hg bp (compound)
minute ) (punct)
males four (nummod)
eight ( (punct)
effects distress (nmod)
segments brain (nmod)
suggest contributed (ccomp)
pharmacoeconomics and (cc)
responses lasting (acl)
system messenger (compound)
defect ) (punct)
associated vgb (nmod)
exhibited effects (nsubjpass)
differ since (mark)
class amplitudes (nmod)
history no (det)
analgesic over-the-counter (amod)
points specific (amod)
predisposes and (cc)
olig-anuria of (case)
line intravenous (amod)
eliminated that (nsubjpass)
ability its (nmod:poss)
day transplantation (nmod)
identify patients (dobj)
associated therefore (advmod)
shr untreated (amod)
geometry function (conj)
excluding also (advmod)
t 4.1 (appos)
procedure patients (nmod)
taken all (nsubj)
group have (acl:relcl)
decreased micromol/l (dobj)
attenuated method (nmod)
$ROOT$ phenotype (sent)
rise ctnt (nmod)
old since (mark)
levels severity (compound)
events serological (amod)
one regimen (nmod)
aggressiveness mediated (acl:relcl)
team treating (amod)
sensitization convulsions (nmod)
reduces whether (mark)
factor neurotrophic (amod)
disorder undescribed (amod)
mechanical dc (conj)
venom the (det)
frequency administration (nmod)
showed models (nmod)
cml and (cc)
lack bbb (nmod)
ssri used (acl)
fall levels (nmod)
mg/kg ; (punct)
mg/kg/day given (dep)
livers of (case)
occurred disease (nsubj)
blue evans (compound)
ratio sodium/potassium (compound)
reverse block (dobj)
bis > (amod)
study ii (nummod)
death widespread (amod)
population lozenge (appos)
modification this (det)
risk developing (acl)
man subject (acl:relcl)
day embryonic (amod)
area density (compound)
correlation = (appos)
aggravates promotes (conj)
reduced doses (nmod)
4 11 (conj)
germany uk (conj)
tenfold about (advmod)
plasma lipids (conj)
isoniazid or (cc)
number rr=1.60 (dep)
effects yohimbine (nmod)
seem cross-react (xcomp)
h by (case)
undergoing collection (dobj)
female 27-year-old (amod)
severity preventability (conj)
neurotransmitters amino (compound)
rate dose (conj)
cycles three (nummod)
skills behaviors (conj)
hypokalemia subjects (nmod)
study conduction (compound)
contributed death (nmod)
8.9 , (punct)
stimulant : (punct)
undertaken and (cc)
% 7.5 (nummod)
going dysguesia (nsubj)
deterioration functions (nmod)
involved : (punct)
diagnosis psychiatric (amod)
tolerated observed (conj)
mg/kg methamphetamine (compound)
aprotinin concentrations (conj)
encephalopathy phenytoin (compound)
2)% were (cop)
pretreatment sec (appos)
modulate seizures (dobj)
fibrosis atrophy (conj)
mmhg 81 (nummod)
observed observed (conj)
$ROOT$ brought (sent)
prolongation patients (nmod)
connects matrix (dobj)
rats only (advmod)
randomized double-blind (dep)
shown recoveries (nsubjpass)
influence to (mark)
sleep deep (amod)
extremities the (det)
therapy cephalothin (compound)
interview semi-structured (amod)
factor should (aux)
received suffered (conj)
disrupting and (cc)
elucidate to (mark)
noted events (nsubjpass)
increases responses (nmod)
from february (nmod)
compressed to (mark)
phenomenon limbs (nmod)
fatal ( (punct)
mc of (case)
females than (case)
iopentol with (case)
group pcc (compound)
resembling models (dobj)
catarrhalis m. (compound)
evidence emerging (amod)
switching sodium (nmod)
syndrome defects (conj)
reported using (xcomp)
18 than (quantmod)
glomerulonephritis membranous (amod)
has gabapentin (nsubj)
sequelae apparent (amod)
circling predominant (amod)
hepatotoxicity potential (amod)
2.5 0.7 (nummod)
neurotoxicity da (compound)
funduscopy testing (conj)
become pronounced (xcomp)
lignocaine with (case)
intervals thereafter (advmod)
cycles hemodialysis (nmod)
u/ml 8.6 (nummod)
decreasing without (mark)
= 0.43 (dobj)
occur suxamethonium (nmod)
severity reactions (nmod)
sod both (cc:preconj)
hypercalcemia prolonged (amod)
fluoxetine , (punct)
sevoflurane % (amod)
mood neuropathy (conj)
comments other (amod)
sustained wane (advcl)
introduction was (cop)
induction woman (nmod)
fps in (case)
acts antagonist (nmod)
pan mg/kg (appos)
ability limited (amod)
clz of (case)
nephropathy maleate-induced (amod)
modulates effect (dobj)
nephrotoxicity , (punct)
administration accidental (amod)
aroused , (punct)
loss dystrophin (nmod)
insipidus di (appos)
scales bond (nmod:poss)
retention- task (nmod)
suffering and (cc)
leads study (nsubj)
june november (conj)
produced agonist (nmod)
examined factors (nmod)
ectoderm surface (compound)
challenge the (det)
use potential (amod)
derivatives of (case)
b.d micrograms (compound)
micromol/l 44 (nummod)
everolimus to (case)
h 2 (nummod)
experiments in (case)
liability the (det)
$ROOT$ stressed (sent)
reduced stress (nsubjpass)
applicators reported (acl:relcl)
ci=22.5 % (compound)
raters between (case)
muscle of (case)
activity inhibition (nmod)
micrograms/ml ) (punct)
iran in (case)
steroids immunoglobulins (conj)
cxad ) (punct)
observed is (auxpass)
9/15 ( (punct)
nsaid ( (punct)
tachycardia verapamil (nmod)
$ROOT$ cause (sent)
pergolide with (case)
possibility increase (acl)
reversible whether (mark)
contributed both (nsubj)
men all (det)
immunoblotting rt-pcr (conj)
reduced increases (nsubjpass)
membranes to (case)
-0.5 4.1 (prep)
those active (acl:relcl)
14.71 vs. (cc)
administered fetus (nmod)
s 0.95 (nummod)
continuation despite (case)
consideration are (cop)
out-patients 50 (nummod)
demonstrate reaction (dobj)
kappa-beta transcription (compound)
gaba metabolites (conj)
studies several (amod)
brain throughout (case)
induced ventricles (nmod)
stress oxidative (amod)
dynamics response (nmod)
improvement shown (acl)
sulphate : (punct)
tremor of (case)
rigidity a (det)
adrenoceptors alpha-2 (compound)
25.3 +/- (cc)
mater of (case)
task active (amod)
gspe by (case)
diet a (det)
inflammation acute (amod)
within across (conj)
treatment cc (nmod)
partial rats (dep)
generation for (case)
morphine mg (amod)
mg 50 (compound)
ccu to (case)
children 8 (nummod)
society class (appos)
evaluation chronic (amod)
appear develop (xcomp)
prevented vomiting (dobj)
positive hbeag (nmod:npmod)
patients % (compound)
latency feeding (compound)
showed still (advmod)
21 or (cc)
drug clonidine (dep)
nitroglycerin to (case)
reported who (nsubj)
occurred pain (nsubj)
causes processes (nmod)
timecourse the (det)
drugs . (punct)
monitoring laboratory (compound)
$ROOT$ attenuation (sent)
opener channels (nmod)
role supplementation (nmod)
rat per (case)
$ROOT$ depressed (sent)
results disappointing (amod)
developed recently (advmod)
dexmedetomidine patients (nmod)
become use (nsubj)
system drug (compound)
diameters/bw es (compound)
dyskinesia and (cc)
% results (nsubj)
interaction significant (amod)
status their (nmod:poss)
aspirin with (case)
vacuolar ( (punct)
quantify incidence (dobj)
immunosuppressant actions (nmod)
mg 813 (nummod)
tube plexiglas (compound)
greater that (nsubj)
time of (case)
inhibitors recognized (amod)
x +/- (cc)
ameliorated damage (nsubjpass)
rats hg (dep)
nerves of (case)
observed reduce (xcomp)
attempt control (acl)
one which (nmod)
damaged not (neg)
latencies similar (amod)
b , (punct)
deficits cognition (compound)
less ) (punct)
artery petrous (amod)
expanded was (auxpass)
paid period (nmod)
raclopride selective (amod)
protocols leukemia (compound)
reveal size (dobj)
incidences headache (nmod)
associated therapy (nmod)
event 1 (nummod)
pretreatment nh4ac (compound)
microliters/min of (case)
hbeag-positive and (cc)
administered temocapril (nsubjpass)
recurs . (punct)
activate and (cc)
strips inflamed (amod)
action action (conj)
disease coronary (amod)
induce maha (dobj)
cyanosis arrhythmia (conj)
concentrations rat (nmod)
activity cerebral (amod)
antagonists sigma2-preferring (amod)
compare bolus (nmod)
invasion stroma (nmod)
ci=26.7 ( (punct)
documents and (cc)
phenytoin hypothermia (conj)
years 1 (parataxis)
seems polyuria (nsubj)
recovery in (case)
deposits shown (acl:relcl)
show users (nsubj)
risk group (nmod)
12.1 , (punct)
propensity greater (amod)
agranulocytosis of (case)
infusions cimetidine (nmod)
chorioretinopathy of (case)
hospitals urban (amod)
syndrome with (case)
dosage mg/m(2 (nmod)
counseling and (cc)
interaction -- (punct)
experienced majority (nsubj)
papilledema , (punct)
ca1 the (det)
responded withdrawal (nmod)
allows administration (dobj)
prolonged reversible (conj)
voltarol ) (punct)
maintained level (dobj)
day was (cop)
micrograms/day 2147 (nummod)
processes neuropathological (amod)
group for (case)
cholinomimetic , (punct)
patients 452 (nummod)
8 12 (nmod)
had hemodialysis (nmod)
exertion to (case)
change patient (nmod:poss)
rtms delivered (acl)
range 120 (appos)
treated mean (nmod)
disease nafld (appos)
min-1 were (cop)
1986 early (amod)
resection whose (nmod:poss)
patients lv (nmod)
agents hemodiluting (amod)
pituitaries rat (compound)
2r,4r-apdc ) (punct)
% dose (nmod)
utilization ketamine (nmod)
manifestation for (case)
toxicity carboplatin (compound)
added list (nmod)
d4.2 d4.4 (conj)
injection diltiazem (nmod)
cei ) (punct)
monitoring toxicities (nmod)
differences amounts (nmod)
90/htn ( (punct)
separation via (case)
scheduled average (nmod:npmod)
features clinico-pathological (amod)
addition fentanyl (nmod)
agitation , (punct)
duration af (compound)
edema damage (nmod)
occurrence hypertension (nmod)
generated fluency (nmod)
accomplished % (nmod)
$ROOT$ downregulated (sent)
28 +/- (cc)
unchanged rats (nmod)
effective epimers (nsubj)
increased mortality (nsubjpass)
rise species (nmod)
contribute this (nmod)
figure corresponding (amod)
hypothesis putative (amod)
received metoclopramide (dobj)
3.1 women (nmod)
relevance the (det)
decreases injury (dobj)
bf-dependent effects (nsubj)
alpha t (compound)
followed all (nsubjpass)
divided stages (nmod)
presented ed (nmod)
potent studies (nmod)
before months (nmod:npmod)
hyperalgesia streptozotocin-induced (amod)
focused years (nmod)
medication topiramate (nsubj)
prevent arrhythmia (dobj)
pathways bladder (compound)
seizure failure (nmod)
psychostimulant has (acl:relcl)
microscopy necropsy (compound)
report anemia (nmod)
correlation to (mark)
spite use (nmod)
corresponds rate (nmod)
change rates (nsubj)
increases cxad (nmod)
concentrations set (acl:relcl)
midazolam diazepam (conj)
gave compared (prep)
suggest similarity (dobj)
period 24-hour (compound)
suppression % (amod)
products with (case)
type headache (nmod)
aggregation factor (nsubj)
suggested effective (ccomp)
given accidentally (advmod)
normal evaluations (nsubj)
therapy management (nmod)
syncope recurrent (amod)
% 61.4 (nummod)
period ( (punct)
n. 7 (nummod)
those taking (acl)
luminal both (cc:preconj)
treated csa (nmod)
tribute final (amod)
lower than (prep)
troublesome complaints (nsubj)
provide screening (nsubj)
frequency atrial (amod)
measure tomography (nsubj)
case hiccups (nmod)
prescribe should (aux)
mg/day dosing (nmod)
output with (case)
lids to (case)
model nociception (nmod)
hypertrophy from (case)
accuracy an (det)
frequency . (punct)
adjustment incomplete (amod)
seen psychosis (nmod)
ad ( (punct)
h 72 (nummod)
inhibitor hiv (compound)
headaches primary (amod)
administered days (nmod:tmod)
gastric , (punct)
seizures and (cc)
population study (compound)
glomerulosclerosis focal (amod)
measured ach (nsubjpass)
spasm be (cop)
responsiveness preoperative (amod)
share mechanisms (dobj)
occlusion carotid (compound)
physicians , (punct)
which at (case)
is show (xcomp)
applied separated (advcl)
modifications chorionic (nmod)
frequencies khz (appos)
superior warfarin (nsubj)
symptoms elevation (conj)
severity a (det)
avp anp (conj)
mono-infected chronic (amod)
able able (conj)
evaluated therefore (advmod)
receive years (nmod)
effect sleep-inducing (amod)
knockout vip-/- (dep)
obstruction sleep (nmod)
perturbations cardiovascular (amod)
group ears (appos)
develop rats (nsubj)
isolated hand (nmod)
neurons cerebellum (nmod)
receptor-associated nmda (nmod:npmod)
choice valid (amod)
metabolism in (case)
vocalization upon (case)
mandatory , (punct)
nefiracetam as (case)
indicate studies (nsubj)
utilized strategies (nsubjpass)
model simulating (acl)
scans perfusion (compound)
escalation a (det)
risks . (punct)
hazards due (amod)
victims with (case)
= f(30 (nsubj)
pairs of (case)
lesion a (det)
resulted damage (nmod)
chewing protrusion (conj)
received mo (nmod)
nausea palpitations (conj)
substitution t (compound)
100 30 (compound)
capable preventing (advcl)
reviews evidence-based (amod)
piglets treated (amod)
mechanism antioxidative (amod)
calculated weight (nmod)
associated sirolimus (nsubjpass)
palsy nerve (compound)
tremor % (dep)
subregions the (det)
temporal parietal (conj)
interval [ (punct)
investigate examined (parataxis)
fr p10 (conj)
pattern involvement (nmod)
event for (case)
occurred grade (nsubj)
reaction effect (compound)
effect antitumor (compound)
dna in (case)
sec. 450 (nummod)
receiving days (nmod)
failure cardiovascular (amod)
reactions their (nmod:poss)
syndrome kearns-sayre (compound)
animals week (amod)
seemed hyperalgesia (nmod)
pressure convulsions (nmod)
degeneration subcellular (amod)
rats mg/kg (appos)
injection nucleus (nmod)
shown alter (ccomp)
treatment any (det)
arag ( (punct)
diminishes impairment (nsubj)
buffers decreases (conj)
induced flurothyl (nmod)
years was (cop)
expression group (nmod)
nociceptin as (case)
tested have (aux)
information of (case)
determine effect (dobj)
frequency seizures (nmod)
controls nonanemic (amod)
months 22 (nummod)
drugs cause (conj)
conclusions aware (dep)
arrest suxamethonium-induced (amod)
finding suggestion (nsubj)
system semi-quantitative (amod)
thyroxine ability (conj)
remains contraindicated (advcl)
indicate observations (nsubj)
analysis regional (amod)
individual in (case)
tolerability : (punct)
data only (advmod)
stimulation through (case)
upregulation angiotensinogen (nmod)
demonstrated patient (nmod)
associated or (cc)
typical myositis (nmod)
ip , (punct)
development subsequent (amod)
reflected zones (nmod)
inhibitors mtor-i (appos)
premedication induction (conj)
pain cranial (amod)
syndrome updated (amod)
rp or (cc)
tested control (dep)
discontinued initiated (conj)
$ROOT$ mmol (sent)
transporter glut3 (compound)
cancers colorectal (compound)
overcome to (mark)
require difficult (conj)
causing convulsions (dobj)
potentiation the (det)
evaluated completion (nmod)
secondary is (cop)
recovery loss (appos)
followed withdrawal (nsubjpass)
resolution ascites (nmod)
affect fall (dobj)
effect exercise (nmod)
repeated not (neg)
causing patients (nmod)
kinase receptor (compound)
treated chronically (advmod)
deteriorates which (nmod)
have bfgf (nsubj)
free polymer-bound (conj)
condition that (mark)
showed lesion (dobj)
dysfunction trough-concentrations (conj)
loss seizures (conj)
conclusions induces (appos)
reserpine mg/kg (appos)
euphoria and (cc)
prilocaine bupivacaine (conj)
stimulation area (nmod)
started not (neg)
level potassium (compound)
related as (mark)
stopping fluvastatin (dobj)
useful assess (xcomp)
control for (case)
evident involved (advcl)
pregs enantiomer (conj)
succinate , (punct)
group hem (compound)
seizures srs (appos)
vacuolization cellular (amod)
function symptoms (conj)
affect seem (advcl)
$ROOT$ limit (sent)
receptor acetylcholine (compound)
discontinuation lev (nmod)
albuterol exacerbations (nmod)
high conclusion (dep)
aes ) (punct)
involve provocation (dobj)
institute to (mark)
women 390 (nummod)
wall into (case)
$ROOT$ ceased (sent)
defect urinary (amod)
regimen designed (acl:relcl)
use withdrawal (conj)
bradycardia admitted (conj)
gspe , (punct)
oxycodone oral (amod)
examined 39 (nsubjpass)
collagen of (case)
abolished it (nsubj)
with headache (dep)
clonus forelimb (compound)
treating administration (nmod)
performed had (aux)
reduced synthesis (dobj)
services preventive (compound)
effects prenatal (amod)
determined activity (nsubjpass)
allowed suggesting (advcl)
used mg/kg (dep)
juices fruit (compound)
fraction lvef (appos)
underlie that (mark)
threshold brainstem (compound)
molecule injury (compound)
increased had (aux)
jerks 73 (nummod)
eliminated causes (nsubjpass)
attended complete (advcl)
produced were (auxpass)
city the (det)
saline , (punct)
hyperkalemia > (amod)
locomotion , (punct)
induced treatment (nmod)
doses catecholamine (compound)
intolerant zidovudine (nmod)
memory episodic (amod)
correction contracture (nmod)
pointes with (case)
results different (acl:relcl)
respond detection (nmod)
increased invaded (conj)
unknown mechanisms (nsubj)
reduce increase (dobj)
demonstrated raters (nmod)
mg/dl 1.46+/-0.8 (nummod)
malignancy their (nmod:poss)
factor-i growth (compound)
satisfied completely (advmod)
loss beta2 (nmod)
unaffected feature (nsubj)
thickness nerve (compound)
reduced coadministered (advcl)
inhibit mfs (dobj)
compared victims (nmod)
n=10 , (punct)
characterized hypertension (nsubjpass)
degree were (cop)
employed design (nsubjpass)
measurements reduced (dep)
reviewed by (conj)
changes as (case)
tested experiments (nsubj)
, age (intj)
$ROOT$ prevent (sent)
produce efficacy (dobj)
% 57.1 (nummod)
evaluate relationship (dobj)
limit . (punct)
were assess (xcomp)
accept to (mark)
has ability (nmod)
carbachol and (cc)
constipation morphine-induced (amod)
atrophy in (case)
processed microscopy (nmod)
follow-up the (det)
dose both (dep)
ophthalmologists institutions (nmod)
course steroids (nmod)
play , (punct)
(2r,4r)-4-aminopyrrolidine-2,4-dicarboxylate 2r,4r-apdc (dep)
day 3rd (amod)
consumption and (cc)
antifolate inhibits (acl:relcl)
considered although (mark)
values morphine (nmod)
levels levels (conj)
beta-blockers both (det)
activity promoter (compound)
slowing , (punct)
compared drug (nmod)
% 68 (nummod)
subtests similarities (dep)
formed ethyl-alpha-p-chlorophenoxyisobutyrate (nmod)
iohexol and (cc)
action atropine-like (amod)
muscle-lengths/s 2.18+/-0.21 (nummod)
$ROOT$ male (sent)
availability . (punct)
supervision under (case)
valve progressed (acl:relcl)
results administered (appos)
affect but (cc)
vulnerability such (amod)
% 37.1 (nummod)
cells processes (nmod)
effects analysis (dep)
living daily (amod)
returned variables (nsubj)
involvement prevention (conj)
syndrome myonecrosis (conj)
compared sedation (nmod)
recurrence cardioversion (nmod)
agent either (det)
averaged ratio (nsubj)
successful resuscitation (nsubj)
formulation adenosine (nmod)
independent complement (nmod)
evaluated could (aux)
causes % (nmod)
elucidate , (punct)
sbp in (case)
synthesis de (amod)
amitriptyline ) (punct)
volunteers 28 (nummod)
exhibited rise (dobj)
model - (amod)
frequencies hz (appos)
hypoaldosteronism and (cc)
evoked toxicity (dobj)
tap = (dep)
implications recommendations (nmod)
pain chest (amod)
compare compare (conj)
noted exception (nmod)
c supplemental (amod)
proposed it (nsubjpass)
complete . (punct)
$ROOT$ proven (sent)
tumor occurs (acl:relcl)
has missing (conj)
metabolized it (nsubjpass)
verified pathologically (advmod)
finding with (case)
ammonium quaternary (amod)
wave st-t (compound)
80 , (punct)
adjacent surface (nmod)
usage from (case)
seen change (nsubjpass)
dose cya (nmod)
patients duration (nmod)
unilateral either (preconj)
improvement a (det)
background supplement (dep)
hours transplantation (dep)
mrna ppargamma (compound)
angiotensinogen associated (acl)
tool that (mark)
doses azelastine (nmod)
antagonize blockade (dobj)
3 between (quantmod)
detected differences (nsubjpass)
dissection etiology (conj)
tolerability nimesulide (nmod)
bornstein ) (punct)
developed resolved (conj)
supports this (nsubj)
observed organs (nmod)
suggested augments (ccomp)
considered vasculitis (nsubjpass)
score function (nmod)
connected receptor (nmod)
3r-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane ) (punct)
pressure mean (amod)
tle of (case)
limits space (compound)
occurs process (nsubj)
investigated defects (dobj)
true converse (nsubj)
transferred ward (nmod)
reduce myalgia (dobj)
produce administered (advcl)
recorded response (nsubjpass)
cases cause (appos)
imaging technetium-99 (compound)
ccl2 ccr2 (conj)
months two (nummod)
damage from (case)
depression mechanism (nsubj)
territories of (case)
regurgitation mild (amod)
lost returned (conj)
courses four (nummod)
once-daily ) (punct)
completion and (cc)
11/6 mmhg (nmod)
damage mipafox-induced (amod)
declined infusions (nmod)
disorder movement (compound)
channel ca (compound)
decrease time (nmod)
etoposide with (case)
studied properly (advmod)
bleeding strokes (conj)
implicate that (nsubj)
individuals hiv (nmod)
secondary drug (nmod)
metabolites vpa (nmod)
headache 6 (nmod)
have diagnosed (ccomp)
shape abnormal (amod)
kg-1 edrophonium (compound)
related significantly (advmod)
dementia severe (amod)
binding serum (compound)
hotplate and (cc)
finding jaundice (nsubj)
hz 5 (nummod)
atropine 4-diphenylacetoxy-n-methylpiperidine (conj)
correction level (nmod)
scale 10 (nummod)
increasing s (nmod)
t desipramine (nmod)
increased content (nsubj)
mitochondria enlarged (amod)
aortic or (cc)
reporting syndrome (dobj)
detection cytometric (amod)
= ic50s (nsubj)
had conversely (advmod)
5-ht with (case)
exposure hcfcs (nmod)
unclear paradoxical (conj)
punctata ) (punct)
activity lidocaine (nmod)
rats cancer (nmod)
disorders fibrinolytic (amod)
sequencing mutation (compound)
ml 10 (compound)
teams with (case)
methods randomized (appos)
collapsed event (nmod)
present also (advmod)
reduction ribavirin (nmod)
reported controls (nsubj)
monitoring schedules (dep)
1.05 , (punct)
child presented (acl:relcl)
change thresholds (nmod)
b. phase (compound)
nadh-dehydrogenase of (case)
levels argatroban (nmod)
exposed hypercapnia (nmod)
inhibitors hmg (compound)
complex dgc (appos)
operated were (auxpass)
tau ms (dep)
reviewed timing (nsubjpass)
dose carboplatin (nmod)
injection d-amphetamine (nmod)
step in (case)
mass an (det)
reversing of (mark)
verapamil nh4ac (conj)
proteins system (compound)
components c1q (dep)
higher end (nmod)
aphasia and (cc)
showed dunnett (dep)
91.2 = (parataxis)
perimysial and (cc)
measures parkinsonism (nmod)
diazepam bw (appos)
related therapy (nsubj)
using dermatitis (nmod)
deposits aorta (nmod)
cvvhdf ) (punct)
patient particular (amod)
comparison olanzapine (nmod)
palpitations , (punct)
reached ) (punct)
suggest background (dep)
years 90 (nummod)
discuss interactions (dobj)
detection , (punct)
$ROOT$ analysed (sent)
scoring semi-quantitative (amod)
result outcomes (nmod)
generally is (cop)
seizures lethality (conj)
strokes all (det)
thromboembolism combination (nmod)
did contrary (advmod)
association psychosis (nmod)
determined authors (nsubj)
getting position (nmod)
3.6- and (cc)
sensitivity increased (amod)
exposure inhibitors (nmod)
exerts neck (nmod)
= 2.7 (dobj)
open-labeled , (punct)
timps ( (punct)
binder principal (amod)
included patients (dobj)
once doses (nmod)
surgery outdoor (amod)
transplant unrelated (amod)
decreased ratio (nsubj)
paradigm passive (amod)
noted however (advmod)
overdose nitrazepam (nmod)
than of (case)
restoration to (case)
use fs (nmod)
resistant slower (conj)
seizure patients (nmod)
randomised receive (xcomp)
mmol.kg(-1).day(-1 ) (punct)
catalepsy a (det)
vasodilation hypotension (conj)
injections 2r,4r-apdc (compound)
late years (nmod)
lability scale (nmod)
prevalence disturbance (nmod)
glyt1 ( (punct)
undertaken determine (xcomp)
d. for (case)
hepatotoxicity some (nmod)
vasodilation and (cc)
company princeton (appos)
syndrome acidosis (nmod)
increased proteinuria (nsubj)
treated randomly (advmod)
discontinuation or (cc)
staff an (det)
min beginning (nmod)
timeframe within (case)
patients even (advmod)
elevated striatum (nmod)
fact the (det)
mice parp-1+/+ (amod)
experienced frequencies (nmod)
degree approximately (advmod)
rate gfr (appos)
induce clotiazepam (nsubj)
interfere recovery (nmod)
latencies distances (conj)
conclusion detected (acl)
h induction (dep)
developed method (nsubjpass)
avoided recurrence (nsubjpass)
mipafox , (punct)
cirazoline noradrenaline (conj)
isoprenaline to (case)
side-effects its (nmod:poss)
wt brains (dep)
fucoidan , (punct)
rats male (amod)
potentiated that (mark)
prevent increases (dobj)
equal to (dep)
seems : (punct)
recorded also (advmod)
$ROOT$ considers (sent)
mg/kg 32 (nummod)
probable and (cc)
sbs ( (punct)
bupivacaine than (case)
signs lid (conj)
mtx , (punct)
cardiomyopathy hypertrophic (amod)
treatment ranitidine (compound)
adrenergic and (cc)
frequencies higher (amod)
< 0.0001 (dobj)
specificity sulphate (compound)
enhanced not (neg)
antibody monoclonal (amod)
relapse florid (amod)
factor-kappab nf-kappab (appos)
infarction puerperium (nmod)
epilepticus humans (nmod)
combination lipid (nmod)
patients years (nmod)
performed instrumented (advcl)
deficits stz-icv-induced (amod)
courses three (nummod)
2c 5-ht (compound)
developed 8 (nsubj)
given terbutaline (dobj)
aneurysms with (case)
marketed . (punct)
160/12.5 , (punct)
groups microg (nmod)
incorporation stores (nmod)
symptoms moderate (amod)
preceded days (nmod)
population heterogeneous (amod)
changes modulation (conj)
artery bilateral (amod)
using ; (punct)
cause degeneration (dobj)
unchanged but (cc)
lesion dorsal (amod)
infarctions of (case)
action selective (amod)
having and (cc)
mibg ( (punct)
complications autoimmune (amod)
mg/kg i.p. (advmod)
% ci=0%-39.2 (nummod)
pneumonia neoplasms (conj)
size dose (nmod)
samples from (acl)
analogues nucleotide (compound)
narrowing or (cc)
persisted stopped (advcl)
delay its (nmod:poss)
analyze presence (dobj)
groups placebo (amod)
hips-cms ) (punct)
had fluctuations (dobj)
leads since (mark)
prevention cancer (nmod)
one dysfunction (nsubj)
evidence histologic (amod)
dmtu ( (punct)
cells ed-1-positive (amod)
pronounced reduction (nsubj)
considered moderate (xcomp)
such reduced (ccomp)
allocated consecutively (advmod)
dehydrogenase in (case)
arrhythmias complex (amod)
adenocarcinoma diethylstilbestrol (nmod)
isoenzymes ck-mb (appos)
symptoms confusion (nmod)
acid due (case)
administration c (nmod)
increase naloxone (appos)
boy of (case)
setting clinic (appos)
correlation , (punct)
live lives (dobj)
effects unwanted (amod)
brain animals (nmod)
efficacy lovastatin (nmod)
encoding , (punct)
aggregations platelet (compound)
mg/m2 under (case)
receptor and (cc)
pneumonitis probably (amod)
peaked . (punct)
tls ) (punct)
follow stroke (nsubj)
studied courses (nsubjpass)
15.5 p= (dep)
release particles (nmod)
reduce requirements (dobj)
14 10 (compound)
months survival (nsubj)
infusion versus (cc)
taken bzds/rds (nsubjpass)
bisphosphonate oral (amod)
a/j donor (appos)
july 2007 (nummod)
thickening in (case)
grafts stable (amod)
issue this (det)
occur background (dep)
features unique (amod)
pituitaries hemorrhagic (amod)
result should (aux)
individuals normal (amod)
5.5 and (cc)
patients graves (nmod:poss)
percent twenty-eight (nummod)
each concentrations (nmod)
abnormality involving (acl)
verapamil neither (preconj)
discontinued were (auxpass)
fifty-five one (compound)
found four (nmod)
albuterol versus (cc)
advised are (auxpass)
incidence apparent (amod)
identified epilepticus (nmod)
related disruption (nsubj)
sectors rats (nmod)
co-treatment , (punct)
day same (amod)
used , (punct)
measures on (case)
obtained examined (conj)
$ROOT$ developed (sent)
result might (aux)
positive administration (nmod)
signs movements (nmod)
vessels collateral (compound)
increase sod-induced (amod)
reduced diminished (conj)
need , (punct)
$ROOT$ definition (sent)
used host (nmod)
aggregations human (amod)
combining groups (dobj)
mechanism distinct (amod)
5 women (nmod)
naproxen 1.59 (nummod)
1 than (quantmod)
echocardiography speckle (compound)
naa ) (punct)
tended regardless (advmod)
amputation extrication (conj)
evidence new (amod)
mice b1r(-/- (appos)
angiography following (case)
anorexigens amphetamines (conj)
basis area (nmod)
all nearly (advmod)
diagnose lacnp (dobj)
cytopenia to (case)
gssg ) (punct)
osteoporosis and (cc)
generated : (punct)
l-noarg 7-ni (conj)
sedation due (case)
receptor vegf (compound)
excluded evidence (nsubjpass)
involved nicotine (nsubjpass)
cells/mm3 p (dep)
$ROOT$ attended (sent)
associated hormones (nmod)
activity preparation (nmod)
transmission cause (acl:relcl)
met these (nmod)
elevation synergistic (amod)
mg/kg 0.04 (nummod)
fatality of (case)
risk cardiovascular (amod)
antagonist peripheral-acting (amod)
differences episodes (nmod)
arag alone (advmod)
fatal woman (nmod)
studied phenomenon (nsubjpass)
men hiv-positive (amod)
multicenter randomized (dep)
sphincter humans (nmod)
toxicity continuing (amod)
antineoplastic cisplatin (nsubj)
evidence relation (nmod)
associated shown (advcl)
responses efficacy (conj)
chemotherapy second-line (amod)
anemia complicating (acl)
surveys uncontrolled (amod)
difficult toxicity (nmod)
reported siadh (nsubjpass)
extremity of (case)
supports argatroban (nsubj)
bolus ) (punct)
prohibited could (aux)
form wave (compound)
state induced (amod)
missing that (mark)
contributed levels (nsubj)
20 5 (compound)
found papaverine (nmod)
members from (case)
suggested cue (nmod)
methods approval (appos)
tended become (xcomp)
bradycardia as (case)
signs 5-ht1a (compound)
expression achr (compound)
inhibited moreover (advmod)
synthesis ribosomal (amod)
both which (nmod)
control secretion (dobj)
randomized ratio (nmod)
euphoria both (appos)
an in (case)
co2 end-tidal (amod)
flows baseline (amod)
obtained information (nsubjpass)
pain without (case)
lozenge 4-mg (amod)
phenomenon raynaud (nmod:poss)
affected development (nsubjpass)
cbz oral (amod)
year years (conj)
infusion before (case)
amlodipine dysguesia (conj)
administration lamivudine (nmod)
sampling after (case)
none severe (appos)
activation mice (nmod)
aim study (compound)
micrograms 175 (nummod)
tasks memory (compound)
significance conventional (amod)
underwent measurement (dobj)
4 2 (compound)
interpolates . (punct)
risks health (compound)
prescribed were (auxpass)
investigated ; (punct)
component pastes (nmod)
clinic our (nmod:poss)
264 taking (acl)
quantify data (nsubj)
reduced proteinuria (dobj)
foods hot (amod)
changes occurring (acl)
advocate determined (advcl)
greater relaxation (nsubj)
complicated use (nsubjpass)
pretreatment propranolol (nmod)
involvement biomembranes (nmod)
h ingestion (dep)
elastolysis extensive (amod)
antagonist and (cc)
used because (mark)
toxicity interaction (nmod)
10(-5 ) (compound)
lesioned uni- (amod)
tests % (appos)
reaction severe (amod)
emphasizes study (nsubj)
formation gallstone (compound)
months the (det)
course because (case)
prophylaxis antiviral (amod)
referred been (auxpass)
week at (case)
factor pro-inflammatory (amod)
remained was (aux)
thrombocytopenia heparin-induced (amod)
feature dysfunction (appos)
those u/ml (dep)
support intradialytic (amod)
fractures documented (amod)
effective highly (advmod)
symptoms treatment (nmod)
scale unified (compound)
aneurysms all (det)
treated methyldopa (nmod)
diagnosis without (case)
remifentanil placebo (conj)
stages further (amod)
hormone tsh (appos)
prevalence disease (nmod)
to 1082+/-245 (cc)
outpatients of (case)
anemia woman (nmod)
leukemia in (case)
trials weeks (acl:relcl)
cost and (cc)
larger , (punct)
update this (det)
cisplatin mg/m2 (appos)
transplant from (case)
tasks of (case)
carbachol atp (conj)
disease ptld (appos)
limitations with (case)
carried point (nmod)
instances both (det)
promotes also (advmod)
study confirmed (acl:relcl)
plays death (nsubj)
opse and (cc)
increasing by (mark)
calcium levels (conj)
regulation an (det)
blocked completely (advmod)
evaluates , (punct)
confounding indication (nmod)
swelling site (nmod)
results report (nmod)
model disease (nmod)
-50 and (cc)
anticipated as (mark)
damage neuronal (amod)
prophylaxis after (case)
drug antimuscarinic (amod)
age average (amod)
clarify act (ccomp)
stroke attacks (conj)
genotoxicity ifo (nmod:poss)
saline methylprednisolone (conj)
added infection (nmod)
impairs term (nmod)
infected virus (nmod:npmod)
underwent 1991 (nmod)
pyridoxine by (case)
patients glaucomatous (amod)
= 34 (dep)
circulation peripheral (amod)
test specific (amod)
shift of (case)
marker followed (acl)
examinations ophthalmologic (amod)
loci contribute (acl:relcl)
appeared admission (nmod)
study cases (nmod)
compromise dysfunction (conj)
hydrolyze can (aux)
saturation oxygen (compound)
reaching model (nmod)
= 0.017 (dobj)
given lidocaine (nsubjpass)
functions patients (nmod)
s.c. mg/kg (compound)
incidence pain (nmod)
increase deprivation (nsubj)
signaling receptors (nmod)
onset- and (cc)
focus with (case)
indicator simply (advmod)
animals epilepsy (nmod)
gly-gly ( (punct)
had gain (dobj)
nicotine of (case)
neurosci ] (punct)
ill critically (advmod)
associated testosterone (nsubjpass)
10 than (quantmod)
days ( (punct)
receiving initially (advmod)
modulate fq (nsubj)
$ROOT$ excellent (sent)
determined changes (nsubjpass)
biopsies bone (compound)
8.5 < (compound)
occurred cases (nsubj)
blocked mecamylamine (nmod)
sedative sole (amod)
transplantation donor (compound)
15 of (case)
effects prodysrhythmic (amod)
positive antigen (nmod)
100 150 (conj)
progress are (cop)
requiring treatment (dobj)
pcos ) (punct)
reduction extent (nmod)
model epilepticus (nmod)
sex to (case)
i complex (compound)
discontinued side-effects (nmod)
prove acceptable (xcomp)
phenyl-2(5h)-furanon 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl (compound)
induced propranolol (nmod)
$ROOT$ postulate (sent)
rechallenge by (case)
hg reduction (nsubj)
caused affecting (advcl)
severe p<0.001 (dep)
il-3 epo (conj)
had prolongation (dobj)
concentrations vasopressin (nmod)
= 118 (dobj)
increase lesion-induced (amod)
exposure needle-stick (compound)
awoke . (punct)
infused assessed (conj)
treatment alpha-2b (nmod)
discontinuation and (cc)
increased value (nsubj)
subregion accumbal (amod)
= 0.08 (dobj)
failed that (mark)
dependent perfusion (nmod)
$ROOT$ merits (sent)
ingestion clomipramine (compound)
disease preexisting (amod)
agranulocytosis associated (amod)
fk506 mg/kg (appos)
series this (det)
levofloxacin mg (dep)
population adult (amod)
had may (aux)
using equation (dobj)
sodium creatinine (conj)
ephedrine 1-hr (amod)
domains in (case)
suggested therefore (advmod)
developed consuming (advcl)
lesion this (det)
alkaloid quinine (nsubj)
angiography pcag (appos)
group inf-mi (amod)
men , (punct)
treatment agents (nmod)
episode " (punct)
dup antagonist (appos)
one one (conj)
supramarginal frontal (conj)
cessation patients (nmod)
rats serotonin (nmod)
necessary initiation (nmod)
expressed amplitudes (nsubjpass)
registration trial (compound)
advantageous are (cop)
la ( (punct)
suggest followed (ccomp)
moderate-dose controls (dep)
intact to (mark)
analysis mechanism (nmod)
dehydrogenase phosphatase (conj)
administered protocol (nmod)
manner delayed (amod)
$ROOT$ condition (sent)
produced acceleration (dobj)
based weight (nmod)
made can (aux)
hypertension arterial (amod)
prot ng/mg (compound)
results % (appos)
pool the (det)
supplements with (case)
responsible and (cc)
effects important (amod)
replacement after (case)
levels valproate (compound)
camkiia and (cc)
hyperprolactinemia haloperidol-induced (amod)
drug non-nephrotoxic (amod)
maintained is (auxpass)
d11 on (case)
bladders rat (compound)
animals fed (acl)
mg/kg/day 15 (nummod)
administered route (nmod)
continued one-third (nsubj)
patients living (acl)
filtration in (case)
women majority (nsubj)
haloperidol i.e. (advmod)
appeared eyes (nsubj)
encouraging . (punct)
low moderate (conj)
mechanisms involvement (conj)
dosage allowed (amod)
synthesize response (nmod)
up-regulation associated (amod)
svrs ) (punct)
treatment behaviors (nmod)
coarctation = (dep)
changed chloride (nmod)
protection provided (acl)
reversal flumazenil (nmod)
toxicity developed (amod)
intensity seizures (nmod)
depend contributed (conj)
ratio interval (dep)
reported act (xcomp)
clear less (advmod)
pressure pulse (compound)
model pain (nmod)
inhibitors of (case)
had microglobulinuria (dobj)
deterioration additive (amod)
1710 +/- (cc)
conclusions associated (appos)
reduction any (det)
attribution % (nmod)
capacity impaired (acl)
evaluate mechanisms (dobj)
gland anterior (amod)
appears finally (advmod)
parameters with (case)
had culture (dobj)
addition patient (nmod)
screened were (auxpass)
examine further (advmod)
se following (case)
resuscitation cardiopulmonary (amod)
immunoassays enzyme-linked (amod)
undergoing is (aux)
intensity headache (compound)
ephedrine/propofol/mixtures of (case)
chemotherapy for (case)
duration specific (amod)
deterioration rapid (amod)
technique by (case)
naloxone ( (punct)
tissue within (case)
ich subsequent (amod)
displays . (punct)
suggestive relationship (nmod)
behavioral metabolic (conj)
growth enlargement (conj)
meet have (conj)
$ROOT$ gave (sent)
exhibited period (nmod)
rates rates (conj)
infections gram-negative (amod)
terminate block (conj)
reported however (advmod)
schiff periodic (amod)
cholestasis (ee)-induced (amod)
days gem-p (appos)
analogs of (case)
tolerability renal (amod)
modulator that (mark)
intact-control melatonin-treated (conj)
assessed monitoring (nmod)
tp [ (punct)
platelets per (case)
0.05 and (cc)
assigned were (auxpass)
potential a (nmod)
microg i.c.v. (appos)
substituted , (punct)
counteract to (mark)
manifest , (punct)
markers ) (punct)
list a (det)
administration preeclampsia (nmod)
complication formation (nsubj)
supported should (aux)
recommend caution (dobj)
hyperhidrosis with (case)
findings electro-diagnostic (amod)
along findings (nmod)
conclude re-challenged (parataxis)
administered naloxone (conj)
juice cranberry (compound)
presented explanation (nmod)
triggered conclusions (ccomp)
antigens class (compound)
provide indicate (conj)
interval = (dep)
weight and (cc)
mg 10 (nummod)
exhibited patient (nsubj)
2001 and (cc)
possible failure (nsubj)
antipsychotics several (amod)
bupivacaine epinephrine (conj)
chemotherapy combined (amod)
seem prk (nsubj)
mechanisms pathophysiological (amod)
elicited was (auxpass)
was any (nmod)
damage inducing (advcl)
hepatotoxicity nephrotoxicity (conj)
survived sedation (nmod)
increased nephrotoxicity (dobj)
causes depression (dobj)
understood epidemiology (nsubjpass)
psychopathology in (case)
10-diol azacyclopent-1- (compound)
function ability (conj)
serum patients (nmod)
experience of (case)
tolerated maintained (conj)
normal hematologically (advmod)
potentiate does (aux)
tumor for (case)
hcrh of (case)
scores severity (compound)
hormones of (case)
severity with (case)
use , (punct)
positive months (nmod)
disorder autistic (amod)
methotrexate 5-fluorouracil (conj)
use prednisone (nmod)
3.10 4.96 (conj)
night 1 (nummod)
effects clonidine (nmod:poss)
repeat immediately (advmod)
supports contention (dobj)
mitigating deterioration (dobj)
changes pyknotic (amod)
function morphology (conj)
help can (aux)
metabolite major (amod)
escalation with (case)
os po (appos)
infusion ifosfamide (compound)
efv ( (punct)
transporter metabolized (acl:relcl)
greater dose (nmod)
pneumonia pneumocystis (compound)
decreased initiation (nmod)
elevations the (det)
disease maintained (acl)
methoxamine of (case)
ed hospital (nmod)
pathogenesis their (nmod:poss)
p ( (punct)
ca3 and (cc)
time reaction (compound)
204 0 (compound)
sinus in (case)
exhibite activity (dobj)
rate growth (compound)
500 than (quantmod)
doses an (det)
phosphate bis(p-nitrophenyl (compound)
improved rapidly (advmod)
vfd ( (punct)
anaemia azt-induced (amod)
matched who (nsubjpass)
autoimmunity of (case)
controls , (punct)
l-w ) (punct)
h2-receptors histamine (compound)
transformation pseudocystic (amod)
s-1 5-mg (compound)
survived children (nsubj)
$ROOT$ grouped (sent)
screening . (punct)
thrombophlebitis of (case)
doses groups (nmod)
epinephrine micrograms.kg-1.min-1 (compound)
reviews testing (nmod)
rise 145 (nmod)
deep ) (punct)
explained changes (nsubjpass)
define will (aux)
29 group (nmod)
pathways afferent (amod)
reduced cpa (nsubj)
heparins weight (compound)
pineal the (det)
clonidine and (cc)
enhanced one (nsubj)
evaluated have (aux)
flow genital (amod)
scores units (nmod)
induce absence (nmod)
solution with (case)
responsive morphine (nmod)
parameters studied (acl)
investigated pathology (dobj)
mg/dl mg/dl (conj)
rigidity to (case)
akathisia : (punct)
agents targeting (acl)
lids ( (punct)
reactions antigen (nmod)
ten and (cc)
combination zidovudine (conj)
prostate of (case)
presence aap (nmod)
woman 65-year-old (amod)
1.8 and (cc)
patients secondary (amod)
kept mind (nmod)
likely this (nsubj)
urtication itchiness (conj)
micromol/l. at (case)
before h (dep)
sulindac hyperkalemia (conj)
shows appeared (ccomp)
amylase a (det)
cause pain (nmod)
chemotherapies in (case)
corroborate but (cc)
100 10 (compound)
kidneys with (case)
test radioallergosorbent (compound)
patients pd (nmod)
gene bche (appos)
recognise and (cc)
50 100 (conj)
mg/kg)-induced 0.05 (nummod)
modulation of (case)
increased related (conj)
vegf/vpf and (cc)
showed analogues (nsubj)
% 90.2 (nummod)
prazosin rauwolscine (conj)
mm diagnosed (amod)
within for (conj)
damage glomerular (amod)
compounds effective (amod)
dose titrated (acl)
nigra within (case)
cited % (nmod)
mg/kg h (appos)
arrhythmias two-stage (amod)
antagonist site (compound)
is known (csubj)
and pod (nmod)
ulnar sural (conj)
ketoprofen either (cc:preconj)
il-1b ) (punct)
carried dosage (nsubjpass)
observation good (amod)
binding with (case)
using inhalator (dobj)
5-fu ) (punct)
suffer hypothyroidism (nmod)
seem : (punct)
factor natriuretic (amod)
able identify (xcomp)
neuroprotective is (cop)
doses log (amod)
design sessions (nmod)
studies biodistribution (compound)
smear the (det)
children neuroblastoma (nmod)
group women (nmod)
disorder related (amod)
length measures (conj)
repeated cycle (nsubjpass)
represent hazard (dobj)
sustained and (cc)
expression transporter (compound)
underwent woman (nsubj)
different that (nsubj)
suggesting further (advmod)
maintained pressure (dobj)
factor either (cc)
cd50 and (cc)
mitochondria damaged (amod)
eyes patients (nmod)
successful . (punct)
dose physiological (amod)
modify expression (dobj)
case fifth (amod)
events for (case)
model mptp (compound)
blockade ganglionic (amod)
type vip(-/- (conj)
intravenous or (cc)
indicating share (ccomp)
cancer de (case)
bouts angio-oedema (nmod)
preventing recurrence (dobj)
caused amantadine (nmod)
prevention production (nmod)
use europe (nmod)
vacuolization , (punct)
burden to (case)
d2 at (case)
compromising anemia (nsubj)
duration suboptimal (amod)
arrhythmia digitalis-induced (amod)
limited chemotherapy (nsubj)
clozapine = (dep)
replacement testosterone (compound)
agonist alpha1-adrenoceptor (compound)
reflects podocalyxin (nmod)
anxiety depression (nmod)
minutes thirty (nummod)
degeneration vacuolar (amod)
seconds sixty (nummod)
administered medication (dobj)
puberty in (case)
nimo alone (advmod)
estimated also (advmod)
analysis genetic (amod)
alkaloid bioactive (amod)
analyzed factors (nmod)
valproate carbamazepine (conj)
has and (cc)
exposure prior (amod)
weeks observation (nmod)
have evidence (nmod)
noted side-effects (nsubjpass)
cause drug (nsubj)
asenapine of (case)
dose dce (nmod)
improves bradykinesia (dobj)
event no (det)
care intensive (compound)
hypokalemia including (case)
product . (punct)
treatment gram-negative (amod)
demonstrated enhanced (advcl)
agent one (nummod)
method , (punct)
influence any (det)
overdose in (case)
methodology : (punct)
cause % (appos)
angioedema with (case)
contribute caa (nsubj)
alleviates pain (dobj)
revealing correspondence (dobj)
days 14 (nmod)
predicted was (auxpass)
disease rheumatologic (amod)
follow-up at (case)
hepatitis acute (amod)
saline vehicle (conj)
diagnosis vasculitis (nmod)
patient susceptible (amod)
statin of (case)
phase stimulatory (amod)
dpi on (nmod)
indicated : (punct)
hz 1 (compound)
analyzed semi-quantitatively (advmod)
induced thiopental (nmod)
linked not (neg)
compromises , (punct)
t(33 ) (punct)
gcs % (dep)
dose p.o. (appos)
events changes (conj)
neutral and (cc)
experiment acute (amod)
12%-21 % (quantmod)
able continue (xcomp)
approach to (mark)
administration injection (conj)
sex were (cop)
blockade with (case)
strain from (case)
designed determine (xcomp)
hepatomegaly , (punct)
different not (neg)
proposed produce (ccomp)
have activities (dobj)
cirrhosis compensated (amod)
abundance alpha(1)-subunit (nmod)
pre-administration systemic (amod)
diagnosis new (amod)
potentiated scopolamine (nmod)
resembled , (punct)
4 , (punct)
toxicosis gastrointestinal (amod)
3 up (advmod)
implicated hepatotoxicity (nmod)
express electrocardiogram (nmod)
efficiency opse (appos)
expressed that (nsubj)
drugs different (amod)
e1 prostaglandin (compound)
trajectory dorsoventral (amod)
failure function (nmod)
reduction type (nmod)
constructed excluding (advcl)
mechanisms underlying (acl)
drug omeprazole (nsubj)
mg.per ( (punct)
differ that (nmod)
removed , (punct)
determined patients (nmod)
reduced induced (dep)
indicate model (ccomp)
haematuria gross (amod)
terfenadine and (cc)
them to (case)
ich induced (acl)
disturbance . (punct)
but primarily (advmod)
adenoribosylation on (case)
collected methods (nsubjpass)
tone venomotor (amod)
involving hyperkinesis (nmod)
25 metformin (nmod)
cases severe (amod)
conversion by (case)
indomethacin of (case)
mart platonia (compound)
received reduced (parataxis)
findings modulator (ccomp)
occurred atrophy (nsubj)
mediate that (nsubj)
2-p-(2-carboxyethyl)phenethylamino-5'-n-ethylcarboxamidoadenosine , (punct)
model study (acl)
$ROOT$ provoke (sent)
blockade high (amod)
ganglion drg (appos)
range interquartile (amod)
lindane hexachloride (appos)
suppress e2 (nsubj)
mda ( (punct)
investigate we (nsubj)
expected usefulness (nsubjpass)
developed generated (conj)
medulla inner (amod)
amelioration in (case)
crystals sonomicrometry (compound)
nephrolithiasis implications (dep)
life to (case)
indicated analyses (nsubj)
bobbing circling (conj)
course arabinoside (nmod)
developed disorders (nsubj)
1 27 (conj)
mass of (case)
agonists 2-p-(2-carboxyethyl)phenethylamino-5'-n-ethylcarboxamidoadenosine (dep)
techniques clearance (compound)
deviation pressure (nmod)
use contraceptives (nmod)
preferable tmp (nmod)
association antibiotic (nmod)
showed delayed (ccomp)
antagonists morphine (conj)
twenty four (compound)
channel benzodiazepine-gaba-chloride (compound)
percent seventy-three (nummod)
darkness in (case)
dilatation necrosis (conj)
decreased dose (nmod)
weeks six (nummod)
appeared normal (xcomp)
erythromycins , (punct)
indicates passes (ccomp)
medication . (punct)
have sm-5887 (nsubj)
stimulates exposure (nsubj)
inhibitor-associated ace (nmod:npmod)
stimulates when (advmod)
dropped and (cc)
mg/m(2 2,600 (nummod)
separating networks (dobj)
compared 1 (dep)
remained had (conj)
treatment tumors (nmod)
broadens represented (advcl)
kinase rapamycin (compound)
practiced initiated (advcl)
relative weight (nmod)
mismatch a (det)
siat for (case)
skf or (cc)
anxiety patients (nmod)
layer nerve (compound)
improvement with (case)
think useful (ccomp)
rats circulation (nmod)
pollicis adductor (compound)
od higher (amod)
report . (punct)
radiograph and (cc)
signals phasic (amod)
clear very (advmod)
spasm may (aux)
$ROOT$ approved (sent)
amplitude normalized (amod)
correction their (nmod:poss)
lesion to (case)
months transaminases (nmod)
requiring hemodiafiltration (dobj)
les on (case)
0.25 lesions (nsubj)
= 0.59 (dobj)
effects captopril (nmod)
buprenorphine with (case)
pain responsive (amod)
response administration (nmod)
block reversible (amod)
august february (conj)
latency time (conj)
admitted disease (nmod)
score point (nmod)
sites hypothalamic (amod)
hypothermia failure (conj)
. 2005 (nummod)
option bacteremia (nmod)
used reverse (xcomp)
shortened p<0.02 (parataxis)
> 0.4 (dobj)
specimen a (det)
rat carcinoma (nmod)
60 41 (dep)
born 1941 (nmod)
signs few (amod)
show occur (ccomp)
amounts the (det)
cytotoxicity tumors (nmod)
titrated and (cc)
areas applied (amod)
days pn (appos)
polymorphism metabolism (nmod)
imaging a (det)
series surveillance (nmod)
persisted months (nmod:tmod)
strategies for (case)
vasculitis vessel (compound)
might utilization (nsubj)
limited . (punct)
cholinomimetic pilocarpine (appos)
medium conditions (appos)
aminonucleoside of (case)
disorder i (nummod)
behavior aggressive (amod)
80mg/kg/day days (nmod)
intoxications ( (punct)
eds ) (punct)
seen aes (nmod)
absent was (cop)
read was (auxpass)
increments in (case)
$ROOT$ icr (sent)
effects prevented (acl)
khz ) (punct)
days beyond (case)
rats diabetic (amod)
characterized begin (advcl)
analgesia effect (conj)
agents potassium (compound)
contributes reaction (nsubj)
point " (punct)
5-azacytidine inhibitor (appos)
reported they (nsubj)
antimicrobials with (case)
postponed so (advmod)
nephrectomized = (parataxis)
courses ifosfamide (nmod)
mg cyproheptadine (nmod)
seconds 100 (nummod)
initiated monitoring (nsubjpass)
per 5 (nummod)
used promote (xcomp)
% -40 (nummod)
choreic was (cop)
cco-i ( (punct)
carcinoma breast (compound)
presented patient (nsubj)
interfere establishment (nmod)
channel density (dep)
carcinoma occult (amod)
resulted withdrawal (nsubj)
referred months (nmod)
using standard (nmod)
characterized failure (nmod)
factors statistical (amod)
maleate perhexiline (compound)
exencephaly induced (acl)
reported lovastatin (nmod)
elements dopaminergic (amod)
(7.2)% ( (punct)
beta-enac and (cc)
used influx (nmod)
tna of (case)
choice being (cop)
fluoxetine ssri (compound)
factors apparent (amod)
dose oral (amod)
observed animals (nmod)
potential its (nmod:poss)
development anemia (nmod)
applicators 49,616 (nummod)
superior nasal (conj)
addressed role (dobj)
rate slow (amod)
along all (advmod)
62 14 (compound)
other effect (nmod)
reaction pertussis (compound)
mood depressed (amod)
4'-0-tetrahydropyranyladriamycin of (case)
inhibitors acetylcholinesterases (nmod)
remained resistance (nsubj)
d 1,25-dihydroxyvitamin (compound)
advantages cbdca (appos)
clearly most (advmod)
mg glucagon (compound)
trial in (case)
induced failure (nsubjpass)
injection was (cop)
justified but (dep)
verapamil sustained-release (amod)
side-effect have (conj)
loss eventual (amod)
receptors via (case)
short long (conj)
50mg/kg min (appos)
occurrence reactions (nsubj)
pretreatment dopamine (nmod)
diagnosis manic (appos)
mg/kg/day srl (compound)
min of (case)
protocol compassionate-use (amod)
cases neonates (nmod)
withdrawn ethambutol (nsubjpass)
had hypertrophy (conj)
superior pressure (nmod)
medication antiparkinsonian (amod)
m(3)-machr. the (det)
observed not (neg)
resulted d-amb. (advcl)
minutes 60 (nummod)
$ROOT$ score (sent)
2.80 - (advmod)
design this (nsubj)
associated were (auxpass)
avoid to (aux)
evidence histopathological (amod)
ratio ; (punct)
declined progressively (advmod)
monitored given (conj)
43 6 (quantmod)
correlate capture (conj)
exhibited evidence (dobj)
factors systems (nmod)
suggest established (advcl)
ca jg (appos)
associated process (nmod)
developed bigeminy (dobj)
recipients receiving (acl)
injections globulin (nmod)
occurs because (mark)
damage and (cc)
exert administration (nsubj)
mmol/l . (punct)
tida ( (punct)
echocardiography examinations (conj)
evaluate using (xcomp)
curves doses (nmod)
attenuate properties (dobj)
submitted reduction (nmod)
hyperplasia or (cc)
$ROOT$ smaller (sent)
window time (compound)
concentrations dopamine (nmod)
abilities their (nmod:poss)
diet plus (cc)
need images (nsubj)
agent nephrotoxic (amod)
124.4+/-73.4 103.1+/-81 (conj)
decrease compounds (nsubj)
obtained study (nmod)
differences data (nmod)
understood mechanisms (nsubjpass)
showed recordings (nsubj)
2.1 % (dep)
score lowest (amod)
na [na]o (dep)
supplemented had (aux)
medication with (nmod)
rs withdrawal-emergent (amod)
warfarin by (case)
follow to (case)
form dystonic (amod)
pdtc ) (punct)
appear factors (xcomp)
strains mice (nmod)
remapped , (punct)
conclude found (ccomp)
dilated partially (advmod)
substantiate , (punct)
demonstrated induces (ccomp)
disorder ; (punct)
cases occlusions (nmod)
control increase (conj)
involved facilitation (nmod)
diuretics arrhythmias (conj)
supramarginal and (cc)
extracted . (punct)
value methylprednisolone (nmod)
injection i.p. (compound)
vasodilation direct (amod)
changed risk (nsubj)
regimen hfd (compound)
15 > (advmod)
diameter ( (punct)
dependence for (case)
performance decreases (dep)
map ) (punct)
waveform in (case)
compressed severely (advmod)
les or (cc)
increased rate (dobj)
valve mitral (amod)
giving by (conj)
calculi bladder (compound)
tmp ( (punct)
thrombocytopenia failure (conj)
mass outside (case)
measured access(r (nmod)
mrds ( (punct)
functioning stable (amod)
hypotension systolic (amod)
assessed models (nmod)
areas with (case)
weight area (appos)
assessment audiologic (amod)
has risperidone (nsubj)
mice inbred (amod)
doses ml (nmod)
position in (case)
0.6 0.2 (conj)
98.7 4.2 (conj)
mg/kg 750 (nummod)
p 0.01 (nummod)
increased were (auxpass)
pathology this (det)
hypertension lnna (compound)
signals leading (acl)
vocabulary novel (amod)
cases cases (conj)
removal upon (case)
hplc ( (punct)
areas sensitive (amod)
effects exposure (nmod)
after year (nmod:npmod)
median day (appos)
b-d-glucosaminidase n-acetyl (compound)
properties reported (acl:relcl)
il-1 il-2 (conj)
levels antibody (compound)
abnormalities mr (nmod)
pg/ml and (cc)
performed study (nsubjpass)
clumsiness , (punct)
pretreated l-name (nmod)
calcium excess (amod)
role infarction (nmod)
produced mg (nsubj)
presented features (nsubjpass)
doses ranitidine (conj)
present one (nmod)
increase months (nmod)
p=0.05 ( (punct)
affect pimozide (nsubj)
patients virus (nmod)
agc ( (punct)
labetalol isoflurane (nmod)
measurements total (dep)
increased had (ccomp)
clarithromycin and (cc)
acetate combined (amod)
related disposition (nmod)
formation dox (nmod)
models regression (compound)
$ROOT$ referred (sent)
therapy dose (compound)
conclusion decreased (appos)
appears observed (advcl)
potent was (cop)
pge1 or (cc)
haloperidol-treated both (cc:preconj)
remedy rapid (amod)
chemotherapy induction (compound)
sites metastatic (amod)
vasculitis for (case)
brains the (det)
prolonged was (aux)
broadens spectrum (dobj)
$ROOT$ experience (sent)
receive dexamethasone (dobj)
neurotransmitters two (nummod)
p<0.001 ) (punct)
attack provoked (acl)
weeks 26 (nummod)
consists that (mark)
extracts with (case)
conversion report (dep)
therapies other (amod)
10ug , (punct)
min 74 (nummod)
$ROOT$ sustained (sent)
cure to (mark)
7.8 to (dep)
higher age-dependent (conj)
difference with (case)
changes electrocardiogram (compound)
channels atp (compound)
agents anticonvulsant (amod)
lamotrigine with (case)
effects activation (nmod)
microl 15.3+/-11.2 (nummod)
amyloidosis with (case)
tolerated complications (nsubjpass)
hyperprolactinemia adults (nmod)
produced was (auxpass)
avoiding and (dep)
course benign (amod)
oxidase monoamine (compound)
sharps and (cc)
proliferation peroxisomes (nmod)
transplantation cadaver (compound)
type lesion (nsubj)
antigen surface (compound)
conclusions indicate (appos)
disorders psychotic (amod)
2a interferon (compound)
use dose (compound)
included sensitivity (dobj)
observed p (dobj)
causes indicating (advcl)
outbreak an (det)
changes gas (compound)
efficacy both (cc:preconj)
contribute prolongation (nmod)
number interneurons (nmod)
36cl- muscimol-stimulated (amod)
osmolality urine (compound)
decreased min (nmod)
distribution acid (nmod)
mg/kg [ (punct)
index function (nmod)
causes , (punct)
nucleus subthalamic (amod)
post-fenoldopam-infusion dpi (appos)
ill be (cop)
= p<0.01 (dep)
included . (punct)
carcinomas hamster (compound)
study chronological (amod)
elucidated mechanism(s (nsubjpass)
% 66.6 (nummod)
decreased osmolality (nsubjpass)
has used (conj)
using concentrations (dobj)
shown improve (xcomp)
narcosis on (case)
procedure diagnostic (amod)
hexabrix toxicity (compound)
tissue cardiac (amod)
homeostasis of (case)
% 0.38 (nummod)
deposition n=12 (dep)
apomorphine mg/kg)-induced (appos)
dm of (case)
doses 25 (nmod)
discussed contribution (nsubjpass)
monophosphate 8-bromo (amod)
those cohort (nmod)
examination intraoral (amod)
bun creatinine (conj)
administering pyridoxine (dobj)
developed remission (nmod)
concentrate prothrombin (compound)
uncommon dyskinesias (nsubj)
function cisplatin-induced (amod)
reductions selenium (nmod)
pneumonitis grade (appos)
onset thrombocytopenia (nmod)
azelastine medication (appos)
suited . (punct)
arrhythmias of (case)
22,875 celecoxib (nmod)
receptors a2 (compound)
induce turnover (dobj)
t.i.d. mg (compound)
induce whereas (mark)
was p (dep)
bronchodilator theophylline (nmod)
effect rates (nmod)
time ti (appos)
electrograms his (nmod:poss)
promoted verapamil (nsubj)
levels peptide (compound)
infections seizures (conj)
other awake (advcl)
inhibition as (cc)
persisted lesion (nsubj)
morphology expression (conj)
oltx of (case)
collected data (nsubjpass)
conclusion demonstrate (dep)
increased chick (nmod)
induced oct (nsubj)
allografts indication (nmod)
p=0.44 ) (punct)
measurements testing (conj)
concentration fibrinogen (compound)
cause depolarisation (dobj)
confirmed studies (nsubj)
15/hypertension 15/htn (appos)
identified cases (nmod)
oxide neurotransmitter (appos)
progress in (case)
sensitivity erythropoietin (nmod)
sample an (det)
seem however (advmod)
albumin in (case)
issues cardiac (amod)
changed have (aux)
common subjects (nmod)
prophylaxis infants (nmod)
injection estradiol (nmod)
extract solidago (compound)
associated selegiline (nsubjpass)
pain : (punct)
sirolimus to (case)
hr 24 (nummod)
resurgence interest (nmod)
levels forms (nmod)
adrenergic combined (amod)
diet on (case)
h 5 (nummod)
examined neurotoxicity (nmod)
puberty either (preconj)
glycoprotein is (cop)
link markers (nmod)
sulfate atropine (compound)
administration setting (nmod)
photosensitivity or (cc)
inhibitors paranoia (conj)
dosage caco3 (compound)
1984 2004 (prep)
isoniazid gamma-vinyl-gaba (conj)
1 21 (conj)
evening before (prep)
sonograms serial (amod)
admitted hours (nmod)
increased dex (nsubj)
ihc ) (punct)
administered hydrochloride (nsubjpass)
agents known (acl)
regimen high-dose (amod)
indicating had (ccomp)
disease quincke (nmod:poss)
revealed elevations (dobj)
history radiograph (conj)
eosinophils with (case)
leukemia history (conj)
capable dexmedetomidine (nsubj)
efficacy replication (compound)
generate regard (nmod)
analogue vitamin (compound)
= 0.039 (dobj)
clearance volume (conj)
agitation induced (acl)
tests because (case)
useful adjunct (nmod)
demonstrate subjected (ccomp)
adducts of (case)
therapy blockers (dep)
nucleus substantia (compound)
0.50 to (case)
substance the (det)
grade 1 (dep)
dopamine release (dep)
indicate summary (nmod)
deaths in (case)
cause steroids (nmod)
abolished which (nsubj)
ratings and (cc)
suffering not (neg)
reported is (dep)
model distinguished (acl:relcl)
provoke can (aux)
patients retinochoroidopathy (compound)
23.6 +/- (cc)
mg/hour 50 (nummod)
mice aids (compound)
indicated however (advmod)
achieving in (mark)
depolarization the (det)
participation . (punct)
passage possible (amod)
complications cardiac (amod)
induced ingestion (nmod)
ci % (nmod)
converted pretreatment (nsubj)
di- cb (compound)
matched study (nmod)
sodium n-acetyl-beta-d-glucosaminidase (conj)
remain determined (xcomp)
methods patients (appos)
develop run (conj)
toxicity dose (compound)
osmolality clearance (conj)
latency duration (conj)
differed significantly (advmod)
deoxycorticosterone 11-deoxycortisol (conj)
acquired cases (nmod)
contraceptives cocs (appos)
fluoxetine sertraline (conj)
9-tetrahydrocannabinol by (case)
microscopy endothelia (nmod)
attack produced (acl)
tasks continuous (amod)
les ( (punct)
reversed amnesia (dobj)
patient 34-year-old (amod)
death azathioprine-induced (amod)
related but (cc)
taken % (nmod)
appearance sudden (amod)
description : (punct)
concentrations mesna (nmod)
rats insipidus (nmod)
institutions to (case)
acetate mmol/kg (appos)
attenuated deficit (dobj)
excretion nox (compound)
ward an (det)
fever pressure (conj)
aimed background (dep)
transaminases the (det)
lumens vascular (amod)
erythrocytes isolated (amod)
tacrolimus steroids (conj)
prolongation qt-interval (compound)
seizures cocaine- (amod)
society research (conj)
patients sixty-two (nummod)
recommended regimen (nsubjpass)
risk function (nmod)
cyclophosphamide metabolized (acl:relcl)
infused hcl (nsubjpass)
implicated receptor (nsubjpass)
associated 2.14 (parataxis)
indicate used (ccomp)
received containing (advcl)
group eastern (compound)
reduced limbs (nmod)
1-bromo-1-chloro-2,2,2-trifluoroethane halothane (appos)
recipients commonly (advmod)
dose pilsicainide (nmod)
presented whereas (mark)
effects isomers (nmod)
infusion s-ketamine (compound)
14.3 ci (appos)
48 ) (punct)
mulv ( (punct)
plays stress (nsubj)
had bp (dobj)
located possibly (advmod)
modify tests (parataxis)
antagonism patients (nmod)
subscale scale (nmod)
reduced production (nsubjpass)
occurred addition (nmod)
started injection (nmod)
reflection transplantation (nmod)
cautious more (advmod)
evident mice (nmod)
evaluation pain (nmod)
exhibited experiencing (advcl)
vector using (acl)
tasks recruiting (acl)
effect results (acl:relcl)
woman infarction (nmod)
incidence hit (nmod)
s s (conj)
cardiomyopathy produced (acl)
drugs ) (punct)
cisplatin both (cc:preconj)
pge(2 high (amod)
good subsides (advcl)
suggested reports (nmod)
terminating weeks (nmod:npmod)
excreted animals (nsubj)
degrees to (case)
19 4 (nummod)
analyzed tissues (nsubjpass)
effective , (punct)
reticulum cisternae (conj)
protein renal (amod)
reducing event (nmod)
lower while (mark)
pge1 ( (punct)
diminished moreover (advmod)
condition nephropathy (nsubj)
antibodies halothane-induced (amod)
was loss (nsubj)
ml. combination (nmod)
conclusion suggest (acl)
125 - (punct)
produced profile (dobj)
rofecoxib 1.73 (nummod)
vary to (mark)
herbicides . (punct)
perimetry ) (punct)
ballooning apical (amod)
jc al. (dep)
structures hippocampus (nmod)
licking and/or (cc)
antipsychotics of (case)
gradient the (det)
evaluated were (auxpass)
induce stents (nsubj)
difficult extent (nsubj)
revealed biopsy (nsubj)
regimens antibiotic (amod)
cardona al. (dep)
induced proteinuria (dobj)
found state (nmod)
agent cardioprotective (amod)
schedule mentioned (amod)
17 % (appos)
1.78 ci (appos)
$ROOT$ microangiopathy (sent)
present inflammation (nsubj)
drugs aminoglycosides (appos)
therapy contraceptive (amod)
patients 14 (nummod)
weeks 52 (nummod)
hr 6 (nummod)
administration concomitant (amod)
less turn (nmod)
required produce (xcomp)
graft and (cc)
anticancer myeloablative (conj)
lead index (nsubj)
mg/dl , (punct)
perception of (case)
variables in (case)
production with (case)
pilsicainide oral (amod)
dysrhythmogenicity administration (nmod)
immunoassay multiplied (amod)
old all (nsubj)
respond tumors (advcl)
history developmental (amod)
transplantation tumors (nmod)
metabolism their (nmod:poss)
induced dogs (nmod)
had correlated (advcl)
layer mitral (amod)
impaired morphine (nmod)
down-regulation net (nmod)
characteristics reaction (nmod)
nephrosis of (case)
$ROOT$ compensated (sent)
zuclopenthixol mg/day (appos)
showing activity (dobj)
injected followed (advcl)
pressure basal (amod)
acid brain (nmod)
42.5 , (punct)
cost weeks (nmod)
inducer reactions (nmod)
iu/l . (punct)
$ROOT$ underwent (sent)
triggers which (nsubj)
weeks range (dep)
pipette the (det)
bioavailability abundant (amod)
dose multiple (amod)
methoctramine and (cc)
dynamic and (cc)
dismutase index (appos)
produced manner (nmod)
is onset (nmod)
diet or (cc)
effect important (amod)
evaluated initiation (nmod)
stimulation sympathetic (amod)
consider to (mark)
demonstrating apnoea (dobj)
do not (neg)
combination docetaxel (nmod)
attributable have (aux)
contraction premature (amod)
effect node (nmod)
manifestations ocular (amod)
co-carcinogen a (det)
under-appreciated to (mark)
cd4 , (punct)
involves gaba (dobj)
change 1.5-fold (amod)
size pool (compound)
able improve (xcomp)
associated discharges (nmod)
result the (det)
bdl ) (punct)
feet in (case)
acted emphasis (nmod)
based acid (nmod)
exclude we (nsubj)
cluster gene (compound)
remain nuclear (xcomp)
quality patients (nmod:poss)
method new (amod)
instilled intravesically (advmod)
derivative acid (nmod)
ligation ligation (conj)
production ros (nmod)
preservation to (case)
effective because (mark)
8-aminoquinoline the (det)
remains hallmark (attr)
sensitivity . (punct)
psychosis for (case)
studied intervals (nmod)
exposure [3h]cb (nmod)
8.7 , (punct)
induced all (nmod)
infusions saline (nmod)
1.09 1.66 (prep)
experienced had (conj)
risks potential (amod)
1 5 (appos)
group collaborative (amod)
develop and (cc)
models coadministration (appos)
inhibition percent (compound)
desipramine the (det)
profile dexmedetomidine (nmod)
staining complete (amod)
capsaicin of (case)
escalation etoposide (compound)
differ other (nmod)
lack because (mark)
glomerulosclerosis offspring (nmod)
cases , (punct)
system opioid (compound)
function gross (amod)
toxicity tissue (compound)
few them (nmod)
ls . (punct)
same the (det)
produces sometimes (advmod)
killers combined (acl)
p9201 on (case)
latency swimming (compound)
grs % (dep)
enantiomer the (det)
db 1.63 (nummod)
noted caused (advcl)
restrict to (mark)
thrombocytopenia in (case)
doses piperacillin/tazobactam (nmod)
infarction cocaine-induced (amod)
management long-term (amod)
survivors tumors (nmod)
pallidus in (case)
anticoagulant citrate (compound)
sulphasalazine oral (amod)
diphosphate adenosine (compound)
rats isph-induced (amod)
derived requires (ccomp)
mortality 1-yr (amod)
quantitated using (advcl)
evaluate measure (conj)
administration s-23121 (nmod)
14.3 1.6 (compound)
gd from (case)
modulator positive (amod)
produced sensitive (advcl)
blocked mice (nmod)
mg. 66.6 (nummod)
surgery ablation (conj)
varied days (nmod)
subjects received (acl:relcl)
behaviors children (nmod)
cholesterol hdl (compound)
intoxications cocaine-diazepam (compound)
discontinued was (auxpass)
dose-related effects (nsubj)
transporter a (det)
band the (det)
response dose (compound)
mg/kg 12 (compound)
shivering of (case)
suggests drug (ccomp)
calcification extensive (amod)
indomethacin mg/day (nummod)
associated tolerated (conj)
history strong (amod)
technique pointer (compound)
advantages patients (nmod)
reports nephropathy (nmod)
onset initiation (nmod)
swelling , (punct)
facility a (det)
decreases marked (amod)
reduced affected (parataxis)
5-hiaa ) (punct)
wilson 's (case)
criteria main (amod)
motionless absence (nmod)
improved which (nsubj)
any by (case)
fashion random (amod)
nephropathy early (amod)
cuff right (amod)
irrespective volume (nmod)
concentration timolol (nmod)
k ( (punct)
cardioversion dc (compound)
increased 0.39 (nmod)
monkey one (nummod)
abnormalities field (compound)
involved physicians (nsubj)
tests co2-rebreathing (amod)
resulted densities (nmod)
neurons gnrh (compound)
development proteinuria (nmod)
changes functioning (nmod)
process secretory (amod)
differ rates (nsubj)
1r,2s-(+)-cis-n-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl)cyclohexylamine ( (punct)
time zero (nummod)
memory object (compound)
application transplantation (nmod)
immunosuppression transplant (compound)
done methods (dep)
effects cns (nmod)
accumulating . (punct)
limits observations (nsubj)
concentrations (-)-cibenzoline (nmod)
mz fl (conj)
mg 2mls (appos)
returned values (nmod)
flurothyl or (cc)
higher controls (advcl)
ml/min units (appos)
test amnesia (nmod)
cbdca of (case)
mg/m2/d 550 (nummod)
observations case-based (amod)
became which (nmod)
decrease count (nmod)
produces inhibitor (nsubj)
nucleus interpeduncular (amod)
precede , (punct)
material and (cc)
volume to (case)
time any (det)
mediated reflex (nsubjpass)
decreases hdl-c (nmod)
latency median (amod)
fr and (cc)
incidence peak (amod)
$ROOT$ emerged (sent)
assessment causality (compound)
aimed assess (xcomp)
randomized visits (nmod)
july from (case)
use number (nmod)
n-butyl-deoxynojirimycin and (cc)
carcinoma pelvis (nmod)
made have (aux)
observation and (cc)
associated abstinence (nsubjpass)
nausea in (case)
minutes 5-fu (nmod)
ischemic brain (nmod:npmod)
overdose after (case)
switching carbonate (nmod)
technique practical (amod)
hazardous ? (punct)
increase against (case)
performed quantify (advcl)
controversial . (punct)
100mg/kg i.p. (advmod)
function recipients (nmod)
1987 1991 (conj)
1.9 9.4 (nmod)
proportion infants (nmod)
cause cases (nmod)
patients 459 (nummod)
resolved , (punct)
given succinylcholine (nmod)
examination tests (conj)
patient concentrations (nmod)
threatening life (nmod:npmod)
activity any (det)
evaluated involvement (nsubjpass)
hospitals three (nummod)
suggest suggests (conj)
loss consciousness (nmod)
consumption intermittent (amod)
tolerable is (cop)
pre- post-training (conj)
transport neither (cc:preconj)
denervation dopaminergic (amod)
enflurane to (case)
has ) (punct)
lacked property (dobj)
aortic mitral (conj)
exposed pb (nmod)
depressed such (advmod)
effect ifo (nmod)
processor a (det)
fornix vaginal (amod)
obtained records (nmod)
pathway important (amod)
prescribed was (auxpass)
inactivation no (compound)
performed surgeries (nsubjpass)
effect using (acl)
had case (nsubj)
$ROOT$ participates (sent)
determined increase (nsubjpass)
cortisol of (case)
response ventilatory (amod)
oscillations together (advmod)
had 3 (nsubj)
- ser(so3h)7-ac-cck-2 (compound)
obtained tests (nsubjpass)
improve that (nsubj)
24 - (punct)
nelarabine , (punct)
centre was (cop)
crocin of (case)
switched using (xcomp)
rats those (det)
= 3.35 (dobj)
improve reduce (conj)
injections causing (acl)
pattern its (nmod:poss)
loss projections (nmod)
users 48 (nummod)
termination response (nmod)
was sevoflurane (nmod)
produced degree (dobj)
frequency micturition (nmod)
25mg/kg intraperitoneally (advmod)
clozapine ; (punct)
carriers infected (amod)
percent level (nmod)
often more (advmod)
morphine morphiceptin (conj)
ruled were (auxpass)
negative , (punct)
effect cardioprotective (amod)
age 20 (nummod)
findings previous (amod)
finally are (cop)
markers synaptic (amod)
ratio 1.03 (appos)
diagnosis loss (nmod)
bladder rat (compound)
rna both (cc:preconj)
sodium lysozyme (conj)
m.i.n.i. ( (punct)
associations carolina (nmod)
associated usually (advmod)
maintained patient (nsubjpass)
over uh (intj)
inhibitors parp (compound)
pancuronium mg (appos)
response sustained (amod)
negative searches (nsubj)
bone , (punct)
59 to (dep)
varied concentrations (nsubj)
concentration at (case)
d-galactose . (punct)
needed patients (nsubj)
% weeks (conj)
or se (advmod)
dexamethasone with (case)
ratio adjusted (amod)
fluphenazine of (case)
continued which (nsubjpass)
ee ) (punct)
resulted syndrome (nmod)
using rats (dobj)
design series (appos)
injections intracorporeal (amod)
lacnp involvement (appos)
suffered twice (advmod)
40 13 (conj)
imaging heart (compound)
specific organ (nmod:npmod)
exerts mangiferin (nsubj)
beats p (dep)
reaction be (cop)
14 and (cc)
pg ) (punct)
function her (nmod:poss)
studies pharmacokinetic (amod)
surgery using (acl)
pathway outflow (compound)
variant a (dep)
present boy (dobj)
repeated sample (nmod)
circled . (punct)
intense more (advmod)
consolidation overnight (amod)
sessions 10 (nummod)
oc newer (amod)
showed admission (nmod)
viability changes (conj)
found beneficial (xcomp)
lomustine cyclophosphamide (conj)
range % (nmod)
had chorea (dobj)
test skin (compound)
specific not (neg)
years 10.4 (nummod)
cocaine prior (case)
electrocardiograms in (case)
manifestation catalepsy (nmod)
episode to (case)
establish undoubtedly (advmod)
cystitis cyp-induced (amod)
response previous (amod)
prazosin to (case)
death embryonic (amod)
efforts resuscitation (nmod)
lower oral (nmod)
alternative valuable (amod)
suggest patient (nmod)
glomerular tubulointerstitial (conj)
diminished using (advcl)
administration ua (dep)
morphology in (case)
experienced man (nsubj)
preference and (cc)
scale revised (acl)
profiles determined (acl)
surface hot (amod)
release via (case)
implausible biologically (advmod)
tract the (det)
neurons new (amod)
decrease does (aux)
observed similarly (advmod)
lines prior (amod)
lower statistically (advmod)
% 87.1 (nummod)
min-1 30 (nummod)
returned er (nmod)
unnecessary detrimental (conj)
correlation significant (amod)
sparse . (punct)
strain gunn (compound)
paid has (aux)
diazepam and (cc)
advisable , (punct)
permit identification (nsubj)
d-med , (punct)
noted it (nsubjpass)
nachrs ) (punct)
concentrated post-injection (nmod)
appreciated known (advcl)
stopping minocycline (dobj)
cells/microl 285 (nummod)
switching alleviate (advcl)
malnutrition and (cc)
interval noninjurious (amod)
compared incidence (dobj)
distinguishing hyperplasia (dobj)
mechanisms exerts (acl:relcl)
constituent the (det)
micrograms.kg-1.min-1 ( (punct)
tests factor (compound)
unnecessary adequate (conj)
regained . (punct)
4 to (quantmod)
rest and (cc)
inability and (cc)
point this (det)
blanching conjunctival (amod)
disease d2 (compound)
uptake adp-stimulated (amod)
impact moreover (advmod)
min 240 (compound)
induce always (advmod)
acid folic (compound)
agonist m-chlorophenylpiperazine (dep)
known because (mark)
plays epilepticus (nmod)
wished . (punct)
cardiomyopathy lactate (conj)
dose mz (amod)
list to (case)
obstruction pulmonary (amod)
with simultaneously (advmod)
appearances imaging (compound)
cause being (cop)
$ROOT$ cases (sent)
deficient da (nmod)
reflexes originating (acl)
effect : (punct)
contractility , (punct)
decrease induced (acl)
belonging predominantly (advmod)
recorded dose (nmod)
molecule oxide (dep)
recommended administration (nsubjpass)
d-penicillamine ) (punct)
received while (mark)
changed mydriasis (nsubjpass)
that seen (acl)
cardiovascular and (cc)
incidence levels (nmod)
amiodarone mg/kg (appos)
confined were (auxpass)
undescribed previously (advmod)
aroused be (auxpass)
permeability increased (amod)
cco of (case)
relationship ctni (nmod)
morbidity , (punct)
biomarkers peroxidation (compound)
downregulated and (cc)
examined lists (nsubjpass)
appearance galactose (nmod)
4.9 ) (punct)
increased infusions (nsubj)
disease acute (amod)
examined specimens (dobj)
model mitigates (acl:relcl)
detection encephalopathy (nmod)
present sensitization (nsubj)
apoptosis migration (conj)
option a (det)
administration intraperitoneal (amod)
morbidity host (nmod)
tested was (auxpass)
inhibited that (nsubj)
infarction associated (acl)
vulnerable damage (nmod)
patients 74 (nummod)
ns-718 of (case)
thirst osmoregulated (amod)
had sinensis (nsubj)
biopsy pericardial (amod)
d-penicillamine other (nmod)
demonstrated associated (ccomp)
role activate (acl)
drug hydrochloride (appos)
protein lysozyme (conj)
function impaired (amod)
0.8 0.1 (compound)
17 from (case)
3tc efv (conj)
antipsychotic and (cc)
paco2 the (det)
% 38 (compound)
plasma blood (compound)
gag/pol - (compound)
rash such (case)
changed abundance (nmod)
made sheath (nsubjpass)
2,682,2,803 3,424 (conj)
hypotension of (case)
conduction cardiac (amod)
ether flurothyl (compound)
function cord (compound)
trial after (case)
reduction function (nmod)
2.5 - (punct)
morphine acute (amod)
% microgram/kg/min (nmod)
thromboembolism , (punct)
improved month (nmod)
2.0 and (cc)
mg/kg/min 0.5 (compound)
blockade complete (amod)
tolerated she (nsubj)
evaluation ; (punct)
lower frequency (nsubj)
used -- (punct)
given medialipid (nmod)
ndi in (case)
efficacy regarding (case)
derived plants (nmod)
medetomidine of (case)
impairment activity (nmod)
need importance (conj)
collected : (punct)
presentations emotion (nmod)
cisplatin , (punct)
associated occasionally (advmod)
bupivacaine by (case)
abbott-53693 2-agonist (amod)
suggest that (nsubj)
iso ( (punct)
increases d3 (nmod)
indicates process (ccomp)
extension flexion (conj)
accuracy equivalent (amod)
trial enalapril (nmod)
stresses need (dobj)
number trials (nmod)
dose " (punct)
7.0 was (cop)
exhibits pattern (dobj)
imaging with (case)
failed modulate (xcomp)
counter toxicity (dobj)
effect captopril (nmod)
events drug-related (amod)
114.6 56.9 (conj)
cellular humoral (conj)
measured discontinued (advcl)
induction response (nmod)
interaction . (punct)
applied fs (nsubjpass)
prove may (aux)
expression na/k-atpase (nmod)
catalepsy on (case)
min 3 (nummod)
number equal (amod)
use period (nmod)
days day (conj)
effects children (nmod)
monitor advise (conj)
measured technique (nmod)
associated carbamazepine (nmod)
disorders or (cc)
abusers dying (acl)
suggested haemodialysis (nsubjpass)
evoke did (aux)
krebs-ringer containing (acl)
nephritis acute (amod)
y. for (case)
assessment patient (nmod:poss)
glomerular and/or (cc)
mcpp 2.0mg/kg (appos)
increased survival (dobj)
dependent shared (conj)
sensitization sera (nmod)
absence hemorrhage (nmod)
dfu ( (punct)
test correlation (conj)
discomfort chest (compound)
reduced remarkably (advmod)
receptor dopamine (compound)
flow asymmetric (amod)
eu 10 (nummod)
evidence rct (nmod)
studies plasma (compound)
mg/day 10 (compound)
abundance mites (nmod)
mg increase (nsubj)
collected period (nmod)
effect tumor (nmod)
swings motor (compound)
expressed percentage (nmod)
patients hundred (nummod)
bupivacaine = (dep)
two almost (advmod)
27 and (cc)
females treated (amod)
evaluated association (dobj)
lesions obstructive (amod)
fenoterol-hydrobromide placebo (conj)
neurosteroids potent (amod)
onset a (det)
involved induction (nmod)
inhibition greatest (amod)
capnocytophaga and (cc)
receiving mg/hour (dobj)
1,3-butadiene : (punct)
$ROOT$ data (sent)
reabsorption lysozyme (nmod)
duration disease (nmod)
administered ip (advmod)
reduced expressions (nsubjpass)
week 24 (nummod)
40000 ) (punct)
terfenadine for (case)
precede circling (dobj)
biological of (case)
disappearance tumor (nmod)
macroscopic microscopic (conj)
suspected but (cc)
appear does (aux)
cases hallucinations (nmod)
intoxication clinical (amod)
rate group (nmod)
p9201 ( (punct)
epicardial and (cc)
decreased thickness (nsubjpass)
serotonin norepinephrine (conj)
weight evidence (nmod)
declined , (punct)
ng/ml er (nmod)
breakdown by (case)
therapy initial (amod)
deterioration dizziness (appos)
development behavior (nmod)
vary , (punct)
taqid and (cc)
decrease isoproterenol-induced (amod)
schedule convenient (amod)
pseudoprolactinoma n. (dep)
onset absence (nmod)
adult the (det)
fever eyes (conj)
snr central (amod)
included points (nsubj)
used metoclopramide (nsubjpass)
rw the (det)
hoarseness or (cc)
medium at (case)
metabolizers poor (amod)
death was (cop)
lesion colliculus (amod)
communication 5th (amod)
values depression (compound)
lactate lactate (conj)
others not (neg)
characteristics patient (compound)
evaluated have (ccomp)
start from (case)
damage inhibition (conj)
dfp-atropine with (case)
progesterone vehicle (conj)
67 19 (conj)
persisted which (nsubj)
malignant non (amod)
indicators and (cc)
growth mg (dep)
anesthetic an (det)
complicating toxicity (nsubj)
episodes between (case)
woman anomaly (nmod)
characteristics the (det)
worst scoring (nsubj)
excluded 29 (nmod)
fluphenazine antagonist (compound)
some for (case)
elicited cage (nmod)
stimulation bilateral (amod)
receive radiotherapy (dobj)
mipafox n'-diisopropylphosphorodiamidofluoridate (appos)
lovastatin mg/d (appos)
observed abnormalities (nsubjpass)
use initial (amod)
1 defects (nmod)
difference users (nmod)
symptoms rls (nmod)
measure any (det)
received july (nmod)
affected was (auxpass)
factor vegf/vpf (appos)
phenothiazines or (cc)
reactions triggered (acl:relcl)
dyspnea stomatitis (conj)
benign , (punct)
secondary injury (nmod)
antagonists by (case)
duration circumference (conj)
analyses univariate (amod)
dependent age (nmod)
dose subthreshold (amod)
lasting week (nmod)
seizures mother (nmod)
encephalopathy and (cc)
hypotension nitroglycerin (compound)
increase levels (nsubj)
year-old 72 (compound)
integrity and (cc)
induce studies (nmod)
organogenesis of (case)
effect anatomic (amod)
injected h (nmod)
accumulation with (case)
evaluated min (nmod)
event-related cardiac (amod)
effects lungs (nmod)
effect antithyroidmedications (nmod)
volume end-diastolic (amod)
administered observed (conj)
apnea of (case)
assessed myalgia (nsubjpass)
exposure ias (compound)
seizure for (case)
due furosemide (nmod)
induce can (aux)
production cancer (nmod)
enrolled methods (dep)
disease crohn (nmod:poss)
blocked ssr103800 (nsubj)
reflecting rates (dobj)
overload acute (amod)
severe cystitis (nsubj)
success risk (conj)
has maintains (advcl)
mice tested (acl)
difference incidence (nmod)
with particularly (advmod)
caused blockade (dobj)
injected forearm (nmod)
expression h-sod1 (nmod)
research previous (amod)
monitor . (punct)
presentation this (det)
resistance heparin (nmod)
ld50 ) (punct)
exhibiting resistance (dobj)
detection activity (nmod)
increased renin (nsubj)
anatomic functional (conj)
uninephrectomy nx (appos)
region sinus (nmod)
reports case (compound)
7.54 were (cop)
diet hfd (appos)
behaviors genes (nmod)
angiotensin of (case)
dependent and (cc)
role direct (amod)
reported increases (nsubjpass)
5,7-dihydroxytryptamine injected (acl)
form arterial (amod)
recovered hours (nmod)
decreased reflexes (nsubjpass)
distracted away (advmod)
antidepressants . (punct)
cortical and (cc)
densa the (det)
range mg/kg (appos)
catalepsy or (cc)
taken to (mark)
kf17837 p.o. (appos)
phenobarbital inducer (appos)
$ROOT$ ended (sent)
imaging sestamibi (compound)
impairments such (amod)
0.0073 0.0038 (conj)
patient affected (acl)
contributes thus (advmod)
slower onset (nmod)
implant for (case)
sludge bile (compound)
case delirium (nmod)
animals nontransgenic (amod)
examine alterations (dobj)
minute and (cc)
reversed hyperactivity (dobj)
referred elsewhere (advcl)
withdrawal with (case)
version task (nmod)
monoher between (case)
sinus transverse (amod)
recovery flair (appos)
prolonged significantly (advmod)
administration galactose (compound)
receiving verapamil (dobj)
one but (quantmod)
day therapy (nmod)
cp agonist (dep)
haemorrhage diagnosed (amod)
42.5 64.1 (conj)
adriamycin after (case)
studied women (nsubjpass)
status cardiac (amod)
decline psa (nmod)
rearings stereotypies (conj)
site binding (amod)
cats mice (conj)
patients 36 (nummod)
cause production (nsubj)
actions rats (nmod)
appeared articles (nsubj)
seizure-prone and (cc)
renal heart (conj)
using rater (nmod)
channel that (mark)
damage forebrain (nmod)
recorded min (nmod)
have band (dobj)
mal grand (nmod:npmod)
changes from (case)
immunophilin renal (amod)
20/102 +/- (cc)
was clarify (xcomp)
associated infusion (nmod)
diagnosed is (auxpass)
was perform (xcomp)
revealed jitter (dobj)
day on (case)
hemisuccinate salt (appos)
effects treatment (nmod)
maze interaction (conj)
scale cheops (appos)
cause obstruction (dobj)
detected vomiting (dep)
ug 750 (nummod)
7alpha-hydroxylase of (case)
simvastatin mg (nummod)
recognized poorly (advmod)
utilized has (aux)
or ambiguus (advmod)
used assay (nmod)
neuron nadph-d (compound)
increase might (aux)
fever hay (compound)
ach extracellular (amod)
increase controls (advcl)
ibuprofen 1.05 (nummod)
enrollment at (case)
characterization integrated (amod)
man 80-yr-old (amod)
predict effects (dobj)
investigate in (mark)
mg/kg sodium (nmod)
toxicity moderate-to-severe (amod)
diagnosis reaction (nmod)
magnus raphe (compound)
studied associations (nmod)
symptoms withdrawal (nmod)
immobilization with (case)
study investigating (acl)
asphyxia small (conj)
l-arginine of (case)
dose paclitaxel (compound)
time speed (conj)
play maintaining (advcl)
reduction week (nmod)
survivors all (det)
appear women (nsubj)
initiated had (aux)
effects antiarrhythmic (amod)
stones present (amod)
reduction > (nmod)
mi isph-induced (amod)
given ) (punct)
mg/kg level (appos)
became hypothermic (acomp)
build-up the (det)
designated share (advcl)
6.4 0.2 (compound)
rendered mpep (nmod)
secretion triglyceride (nmod)
acute severe (dep)
model our (nmod:poss)
attenuated microinjection (nsubj)
4-acridinecarboxamide ] (punct)
generates brainstem (nsubj)
caused adrenaline (nsubj)
manifestations ( (punct)
desmosomes of (case)
hilus to (case)
agitated and (cc)
pcp for (case)
shortened conduction (dobj)
predicted status (nsubj)
1 history (nmod)
pictures shown (acl)
pressure femoral (appos)
acute in (case)
underwent regimen (dobj)
antidepressants derived (acl:relcl)
activity ca2 (compound)
fmlp ) (punct)
sodium the (det)
bolus each (det)
dyskinesia hallucinations (conj)
features cholestasis (nmod)
therapy generic (amod)
lesions mdma-induced (amod)
receive cya (dobj)
remained have (aux)
(r)-alpha-methylhistamine and (cc)
vincristine , (punct)
$ROOT$ atrophy (sent)
use therapeutic (amod)
assessed morphology (nsubjpass)
treated sham-treated (conj)
mg/m(2 40 (nummod)
atropine mm (appos)
alter since (mark)
showed respect (nmod)
detected mutants (nsubjpass)
380+/-587 23 (compound)
switched users (nsubjpass)
returned tests (nsubj)
common use (nsubj)
hoarseness ( (punct)
induces though (mark)
presents tee (nsubj)
cautious , (punct)
cases be (cop)
drugs some (det)
antagonist gr (appos)
point to (case)
setting : (punct)
aggressiveness and (cc)
hyperkalemia ranging (acl)
methylprednisolone triamcinolone (conj)
asked evaluated (conj)
patients 31 (nummod)
carcinoma inoperable (amod)
target mammalian (amod)
ps or (cc)
reported manifestation (ccomp)
resulted recovery (nmod)
known derivatives (nsubjpass)
mean < (appos)
diazepam combination (conj)
performed volunteers (nmod)
controls than (case)
measured convulsions (nmod)
unaffected production (nsubj)
known as (mark)
minutes 514 (nummod)
manual , (punct)
combination cbz (nmod)
test open-field (amod)
60 one (compound)
meninges with (case)
5-fluorouracil high-dose (amod)
p300 of (case)
% 91 (nummod)
modification a (det)
is recurs (conj)
$ROOT$ tetany (sent)
recovery loss (conj)
battery test (compound)
recognized were (auxpass)
suggest mediators (ccomp)
interview semistructured (amod)
behaviors the (det)
hyoscine ) (punct)
differences rejection (nmod)
compliance because (case)
available counter (nmod)
eeg in (case)
increase an (det)
received areas (nmod)
cause for (mark)
significance variants (nmod)
discriminates however (advmod)
injury liver (compound)
administration apap (compound)
january october (conj)
electroretinography electro-oculography (conj)
induced ischemia (dobj)
velocity , (punct)
helpful defining (advcl)
recognize occurs (advcl)
loss graft (compound)
activity bche (compound)
development . (punct)
shunting by (case)
stopped been (auxpass)
receptor known (acl)
conclusions affect (appos)
beginning treatment (nmod)
contributes and (cc)
record the (det)
ease application (nmod)
acid tiaprofenic (amod)
$ROOT$ alcoholic (sent)
ablation pkca (nmod)
siat of (case)
used match (xcomp)
affected manner (nmod)
end surgery (nmod)
425 53 (conj)
warfarin adjusted-dose (amod)
disinhibition a (det)
infections opportunistic (amod)
spasm by (case)
came who (nsubj)
other thrombocytopenia (nmod)
planned . (punct)
deficits cognitive (amod)
indicator damage (nmod)
procedures treated (acl)
hyperalgesia vincristine (compound)
physicians caring (acl)
element contractile (amod)
magnitude predictors (conj)
surge the (det)
monoamines other (amod)
implicated side (dobj)
adjustment after (case)
centers america (nmod)
potential any (det)
model mania (nmod)
considerations . (punct)
pathogenesis syndrome (nmod)
bn the (det)
risperidone with (case)
changed p (nmod)
trial randomised (amod)
disulfiram with (case)
changes ability (nmod)
pill herbal (amod)
data novel (amod)
coherence optical (amod)
echocardiography : (punct)
suggest involved (ccomp)
mediated . (punct)
smaller statistically (advmod)
treated ethopropazine (nmod:npmod)
ttc ) (punct)
appetite change (conj)
placenta retained (amod)
occurred results (nsubj)
group saline (compound)
effects bpd (nmod)
proposed although (mark)
agonist-induced levodopa- (nmod:npmod)
occurred reactions (nsubj)
microscope a (det)
occur dyskinesias (nmod)
assessed group (nmod)
response essential (amod)
vigilance reactions (nmod)
paralleled it (nsubjpass)
days 52 (conj)
increasing according (mark)
h mg/l (compound)
less and (cc)
filaments frey (compound)
study acute (amod)
injections monthly (amod)
toxicities nephrotoxicity (nmod)
administration flumazenil (nmod)
21 of (case)
cyclophosphamide cancer (conj)
level applicable (amod)
focused and (cc)
severity reflected (acl)
children medication-free (amod)
mothers received (acl:relcl)
possessed . (punct)
case best (nmod)
depression bupivacaine-induced (amod)
pretreatment thiosemicarbazide (nmod)
pressure resistance (conj)
-18.1 +/- (cc)
administration amiodarone (compound)
uptake norepinephrine (compound)
muscle affected (acl)
was treatment (nsubj)
action as (cc)
hypotension hyperglycemia (conj)
showed further (advmod)
patients continue (acl:relcl)
1:4 ( (punct)
functions for (case)
infusions graded (amod)
infusion : (punct)
increase rats (nmod)
effects hypotensive (amod)
$ROOT$ severity (sent)
made were (auxpass)
initiate may (aux)
+ of (case)
window narrow (amod)
paraesthesia numbness (nmod)
quantitated hypertension (nmod)
observed day (nmod)
classifications patients (nsubj)
suggest indicate (conj)
$ROOT$ shortened (sent)
imipenem/cilastatin of (case)
therapy conventional (amod)
difficult third (advmod)
depression acute (amod)
associated was (auxpass)
99 0.001 (nmod)
patients lithium (acl:relcl)
% ergotamine/caffeine (nmod)
% month (nmod)
sr mg (dep)
damage dopaminergic (amod)
albuterol : (punct)
necrosis laminar (amod)
mrna ( (punct)
dose thalidomide (compound)
theophylline for (case)
retarding in (mark)
were those (nmod)
benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate ligand (appos)
ligand an (det)
negative be (cop)
$ROOT$ resembles (sent)
hypertension a-induced (amod)
concentration maximum (compound)
showed loss (dobj)
days angiography (nmod)
recorded response (conj)
popularity increasing (amod)
approved . (punct)
cld ) (punct)
people in (case)
modify . (punct)
high , (punct)
limited often (advmod)
stable controls (nmod)
toxic stimulant (conj)
treated date (nmod)
cerruloplasmin , (punct)
make profiles (nsubj)
prone may (aux)
programme surveillance (compound)
treatment implicated (acl)
receive and (cc)
hitt ( (punct)
treated range (nmod)
lethargy transient (amod)
c. for (case)
carcinoma endometrial (amod)
stereotypies apomorphine (compound)
nitroprusside the (det)
mass liver (compound)
standpoint the (det)
reflection a (det)
steroids alpha-configurations (appos)
enflurane or (cc)
stimulation by (case)
signs symptoms (conj)
entities other (amod)
interfere induce (conj)
expression a (det)
adl ( (punct)
employed reagents (nsubjpass)
also liver (nmod)
degrees ( (punct)
shown effective (xcomp)
hallucinations occurring (acl)
= point (nmod)
calculated mtd (nsubjpass)
1.98 0.8 (conj)
room emergency (compound)
delirium a (det)
associated nms (nmod)
agonist d1 (compound)
wsp ( (punct)
subject capacity (nsubj)
therapy doxorubicin (compound)
suprofen with (case)
clarification differentiate (conj)
lacks effects (dobj)
anesthesia sedation (nmod)
acid ethacrynic (amod)
defects atrial (amod)
treated have (conj)
blood rats (nmod)
those treated (acl)
hypovolemia absolute (amod)
aggravated absences (nsubjpass)
treatments antidepressive (amod)
has s-1 (nsubj)
allowed was (auxpass)
transition of (case)
cta risk (nmod)
cause isoflurane (nsubj)
lithium , (punct)
information race (nmod)
risperidone haloperidol (conj)
call would (aux)
expression anxiety (nmod)
scenario delayed (acl:relcl)
administered hydration (nsubjpass)
increased was (auxpass)
helpful study (nsubj)
informative more (advmod)
given procedure (nmod)
functionality the (det)
prepartum weeks (nmod:npmod)
relationship in (case)
assessable were (cop)
pcr reaction (appos)
anesthetics such (case)
lacking is (cop)
difficulties impotence (conj)
modulation differential (amod)
reduced after (mark)
failed reverse (xcomp)
modafinil of (case)
support , (punct)
derivative related (amod)
abolish totally (advmod)
leads withdrawal (nsubj)
b2 b1 (conj)
effect cardiotoxic (amod)
risk lowest (amod)
replication on (case)
73/99 ( (punct)
alleviation pain (nmod)
infusions haloperidol (compound)
time rate (appos)
infections abdominal (amod)
leukaemia relapsed/refractory (amod)
levels resting (amod)
occurs exposure (nmod)
derivative has (acl:relcl)
ratio tamoxifen (nmod)
findings rats (nmod)
phn ( (punct)
those nitroglycerin (nmod)
aneurysms in (case)
delays development (dobj)
start therapy (nmod)
challenge rodents (nmod)
fibrillation . (punct)
gluconate calcium (compound)
informed should (aux)
ps ( (punct)
october through (case)
suggests report (nsubj)
free hematuria (nmod)
more double (advcl)
pressure signs (nsubj)
implicated indomethacin (nsubjpass)
produced hypothermia (dobj)
capacity fibres (nmod)
development seizure (compound)
stenosis with (case)
considered cases (nmod)
field an (det)
activity induced (acl)
g145r t (conj)
constitutes . (punct)
stones obstruction (conj)
responsible generation (nmod)
obstructive p (dep)
tolerance with (case)
$ROOT$ albuterol (sent)
arrhythmias unpredictable (amod)
drug particular (amod)
heart failing (amod)
gavaged . (punct)
dosage recommended (acl)
produced monkey (nmod)
caused became (parataxis)
development cin (compound)
$ROOT$ 0.24:1 (sent)
facilitated . (punct)
had analysis (dep)
progression their (nmod:poss)
6 indicating (advcl)
different additionally (advmod)
virus for (case)
is although (mark)
assays colony (compound)
measured was (auxpass)
medication intravenous (amod)
elevation with (case)
attribute , (punct)
current the (det)
larger they (nsubj)
profiles side (compound)
administered administered (advcl)
increased caffeine (nsubj)
type receptor (compound)
data groups (nmod)
evaluated function (nsubjpass)
13 monkeys (nmod)
fibrosis extensive (amod)
warrant mechanisms (nsubj)
ventilation and (cc)
assigned therefore (advmod)
determining predictors (ccomp)
avoided increase (advcl)
igg polyclonal (amod)
comparing by (mark)
was exceeded (conj)
inducing vitro (advmod)
led albuminuria (nsubj)
administered anticoagulation (nmod)
success patients (nmod)
shrinkage by (case)
uganda north (compound)
hyperkinesia but (cc)
developed day (nmod:tmod)
doses 20- (nummod)
improvement decrease (conj)
favour reactions (nmod)
molecule kidney (compound)
night the (det)
mornings on (case)
clinical metabolic (conj)
mechanism(s in (case)
inattention disorientation (conj)
marker glial (amod)
time overall (amod)
becoming after (mark)
fas and (cc)
remains controversial (xcomp)
ml/h ( (punct)
closed , (punct)
pro-arrhythmic it (nsubj)
increased prevented (dep)
aura an (det)
minutes t180 (appos)
technology current (amod)
vasopressin treatment (nmod)
hypertension dex- (amod)
prolongs . (punct)
patients 3 (nummod)
vasculitis of (case)
25.6 ( (punct)
switching mood (compound)
vgpr to (case)
stimulated ; (punct)
obtain toxicity (nmod)
3 had (dep)
acceleration similar (amod)
planned as (mark)
scale computerized (amod)
modification technique (nmod)
administrated . (punct)
patient failed (acl:relcl)
less that (nmod)
survived all (nsubj)
endothelin-1 et-1 (appos)
development antibodies (nmod)
mean , (punct)
weeks following (amod)
induced wk (nmod)
relation in (case)
hypothalamus the (det)
increases tremor (nmod)
fair sweating (dobj)
induced zidovudine (nmod)
vasorelaxation acetylcholine-induced (amod)
available readily (advmod)
improved aminoglycosides (nsubj)
control control (conj)
disorder schizoaffective (amod)
used apomorphine (nsubjpass)
$ROOT$ resolved (sent)
$ROOT$ inhibitor (sent)
receiving cisplatin (dobj)
ribavirin with (case)
common quite (advmod)
32 25 (quantmod)
response therapeutic (amod)
discontinued simvastatinezetimibe (nsubjpass)
patients diabetes (nmod)
open although (mark)
alpha3 beta4 (conj)
necrosis prior (amod)
treatment concurrent (amod)
achieve to (mark)
patients bipolar (amod)
cohort tg (compound)
predominance relative (amod)
hallucinations possible (amod)
rates : (punct)
those nifedipine (nmod)
rtms 5-hz (amod)
used protocol (dobj)
stable or (cc)
months 13 (nummod)
260 , (punct)
co-treatment sex (conj)
rupture septal (amod)
decrease agent (nsubj)
myocarditis haemorrhagic (amod)
antinociceptive and (cc)
inhibition net (nmod)
-18.9 16.6 (conj)
those levels (nsubj)
inhibitor cox-2-specific (amod)
$ROOT$ average (sent)
host in (case)
prolongation increase (conj)
amn082 mg/kg (compound)
reduce edema (dobj)
clozapine primarily (advmod)
gbm with (case)
presented day (nmod:tmod)
revealed myopathy (dobj)
25 of (case)
> or=50 (cc)
toxicity doxorubicin (compound)
using of (mark)
ci , (punct)
under examination (nmod)
verapamil oral (amod)
targets that (mark)
prescribed class (nsubjpass)
n=834 ) (punct)
mg/kg under (case)
effect renal (amod)
used be (auxpass)
exist however (advmod)
blocked drugs (nmod)
lesion was (cop)
males patients (nsubj)
recived , (punct)
= 0.093 (dobj)
amnesia induced (acl)
proteins membrane-cytoskeleton (nmod)
impact use (nmod)
associated anencephaly (nmod)
$ROOT$ hamartoma (sent)
patient woman (appos)
taken , (punct)
replaced . (punct)
contribute damage (nmod)
attack delayed (amod)
phenylephrine ephedrine (conj)
tested catalepsy (nsubjpass)
continue study (nsubj)
recipients kidney (compound)
potentiate , (punct)
defined were (auxpass)
% was (cop)
parts and (cc)
donors in (case)
haemorrhage cerebral (amod)
portions during (case)
reducing hyperactivity (dobj)
patient breast (compound)
exhibited 5 (nsubj)
sampled cases (nsubjpass)
cessation using (acl)
study non-randomised (amod)
syndrome an (det)
provide we (nsubj)
patients possessing (acl)
contrary to (case)
catheterization carotid (nmod)
mg 0.1 (compound)
22 and (cc)
deterioration function (nmod)
groups pretreated (amod)
presence sleep (nmod)
tumor kidney (nmod)
exhibited damage (dobj)
regarded traditionally (advmod)
drug alcohol-related (conj)
mg od (dep)
incidence cause (nmod)
monitored daily (advmod)
therapies . (punct)
linkages via (case)
glasses wine (nmod)
preceded , (punct)
therapies who (nsubj)
treated prazosin (nmod:npmod)
staining red (amod)
occurs impairment (nsubj)
model lesion (compound)
average chicks (nsubj)
composition activities (conj)
smoking maternal (amod)
tests ) (punct)
notable findings (nsubj)
degeneration ( (punct)
antagonist potentiated (conj)
monotherapy a (appos)
avp applied (amod)
analysis field (compound)
had hearts (nsubj)
u/ml u/ml (appos)
emerged , (punct)
dysfunction the (det)
patient esrd (compound)
carvedilol pantoprazole (conj)
sided one (advmod)
decrease peak (nmod)
reduced resulted (conj)
forebrain throughout (case)
disappeared weeks (nmod)
damage antibiotic-induced (amod)
values change (conj)
results mg/m2 (nmod)
2 only (advmod)
$ROOT$ magnitude (sent)
contained respectively (advmod)
1.9 , (punct)
selected sensitivities (nmod)
observed given (conj)
those frequently (conj)
effective least (advmod)
years 29.9 (nummod)
alpha-tc and (cc)
tgr in (case)
hyperactivity in (case)
development thrombosis (nmod)
infusion min (conj)
clarification therapy (nmod)
pamidronate with (case)
responded infections (nsubj)
side-effect the (det)
dealt study (nsubj)
representative that (nsubj)
% 29.6 (nummod)
occurs however (advmod)
red perfused (amod)
36.706 - (advmod)
therapy platelet (compound)
reserved , (punct)
prognosis generation (nmod)
underwent = (parataxis)
dogs these (det)
ibuprofen with (case)
observation weeks (nmod)
addition increase (nmod)
effects propranolol (nmod)
rates s-1 (nmod)
evaluation nephrotoxicity (nmod)
recurrent resistant (conj)
valproate with (case)
inclusion phenobarbital (nmod)
caused ampicillin (nmod)
dilate thus (advmod)
favor valsartan (nmod)
observations on (case)
carriers of (case)
anticoagulant sodium (compound)
settings war/tropical (compound)
% 33 (compound)
handicapped : (punct)
years ( (punct)
levels base-line (amod)
fanft ( (punct)
bbb in (case)
syndrome after (case)
cyclohexyl]benzeneactemide ( (punct)
effects doses (nmod)
produced growth (dobj)
diagnosed delirium (nsubjpass)
months time (nsubj)
cause vasculitis (appos)
normal % (nmod)
propranolol chronic (amod)
consisted seizures (nmod)
short , (punct)
case clinical (amod)
administration sublingual (amod)
volumetry overdosages (nmod)
evidences in (amod)
activity nag (compound)
readmission on (case)
recovered disappearing (advcl)
lower twice (nmod:npmod)
evaluated was (auxpass)
have adults (nsubj)
institution delayed (amod)
damage some (det)
acuity neonate (nmod:poss)
dose age (conj)
months 11.8 (nummod)
parameters red (amod)
course toxicity (conj)
activity activity (nmod)
signs typical (amod)
rate reduction (nmod)
pain dysfunction (conj)
% 39.23 (nummod)
changed concentration (nsubjpass)
concerns doses (nmod)
received fashion (nmod)
factor also (advmod)
used cortices (nsubjpass)
pronounced daytime (nmod)
range seconds (nmod)
vasospasm infarction (conj)
15 13 (compound)
cystitis humans (nmod)
shunt . (punct)
tachyarrhythmias , (punct)
using panel (dobj)
displace pretreatment (nsubj)
pressure systolic (amod)
risk attributable (amod)
interactions clinical (amod)
cycle during (case)
neutrophils alf (compound)
disorder ci=1.154 (appos)
indicated presence (dobj)
prevent apigenin (nsubj)
candidates drug (compound)
showed regions (nmod)
seizure animals (nmod)
e2 with (case)
administration caffeine (compound)
mortality 0.27 (dep)
neuron adrenergic (amod)
neuropathy occurred (acl:relcl)
combination fdc (appos)
g . (punct)
5,7-dht ) (punct)
results toxicology (compound)
anesthesia of (case)
reversible moreover (advmod)
prolongs ratio (dobj)
intralipd epinephrine (conj)
observed increase (nsubjpass)
6 least (nmod:npmod)
injection analog (nmod)
haematuria symptoms (conj)
influence speed (nmod)
observed pain (nsubjpass)
staining in (case)
allow to (mark)
line bort-dex (nmod)
excitation . (punct)
required administration (conj)
probe digoxigenin-labeled (amod)
serotonergic- depletion (appos)
levels " (punct)
higher plasma (nmod)
regard spasm (nmod)
subunit cco (nmod)
had ; (punct)
impairment increased (amod)
produce kidney (nmod)
delivered implantation (nmod)
opsonized serum (nmod)
1 through (cc)
intense very (advmod)
experienced have (aux)
sensitivity different (amod)
any substances (nmod)
ischemia rats (nmod)
hypomethylation dna (nmod)
28 solution (nmod)
temperature nociception (conj)
edema cerebral (amod)
hr metoprolol (nmod)
family with (case)
warranted discontinuation (dobj)
analysis detailed (amod)
product pressure (compound)
risk morbidity (nmod)
as exposure (nmod)
epicondylitis of (case)
course epilepticus (nmod)
adopted that (nsubjpass)
elevated la (nsubj)
inhibitors for (case)
2.1 ic (dep)
find to (mark)
% muscle (nmod)
induced inhibitor (nmod)
estradiol , (punct)
ventricles cerebral (amod)
stress shear (compound)
$ROOT$ identification (sent)
compared abilities (nmod)
incidence ) (punct)
access brain (nmod)
problem and (cc)
period second (amod)
peaked iu/l (nmod)
increases scr (compound)
cases 135 (nummod)
kinase and (cc)
produce to (mark)
case aneurysm (nmod)
osteopenia with (case)
parameters above-mentioned (amod)
g cimetidine (nmod)
frey brush (conj)
was objective (nsubj)
act atp (nsubj)
supplement sevoflurane (nmod)
limited pneumonitis (parataxis)
nodule fornix (nmod)
tissue muscle (compound)
exhibited experienced (conj)
exhibited five (nsubj)
period restrictions (nmod)
converted rhythm (nmod)
cost of (case)
vasodepressor clonidine (nmod)
beraprost analogue (compound)
technique may (aux)
interfered which (nsubj)
patients and (cc)
tool therapeutic (amod)
activity profile (conj)
degrees stenosis (nmod)
done conclusion (nsubjpass)
cells remaining (amod)
aki ( (punct)
dysfunction tamoxifen-induced (amod)
val ; (punct)
records computer (compound)
cancer well-defined (amod)
features psychotic (amod)
vasculitis anti-mpo (amod)
glomerulosclerosis biopsies (appos)
hg , (punct)
therapy children (nmod)
each blockers (nmod)
edema hypertrophy (conj)
examine effects (dobj)
center care (compound)
proportion similar (amod)
effectiveness administration (nmod)
analyzed uptake (nsubjpass)
discrimination of (case)
sessions across (case)
sadness , (punct)
nuclei other (amod)
treatment shell (compound)
study preliminary (amod)
occurs 2 (dep)
permeability microvascular (amod)
picrotoxin- electroshock- (conj)
distribution allele (compound)
intoxication scopolamine (compound)
reductions mean (compound)
dexmedetomidine sedative (nmod)
0.1 0.5 (conj)
have reservations (dobj)
delays modulate (conj)
each one (nummod)
mg/kg i.v. (advmod)
elements structural (amod)
effects pretreatment (nmod)
conclude conclusion (nsubj)
suffered subject (nsubj)
male 57-year-old (amod)
d-amphetamine quinpirole (conj)
microinjections , (punct)
hepatitis cirrhosis (conj)
study four-week (amod)
increases the (det)
appeared related (xcomp)
understood result (nmod)
considered administration (nsubjpass)
dec. 2002-dec (appos)
reduction nausea (nmod)
fluid the (det)
when particularly (advmod)
relaxants muscle (compound)
infection mother-to-infant (compound)
using = (dep)
produced synthetically (advmod)
17 and (cc)
lacnp with (case)
carcinomas bladder (compound)
disabled patient (nsubj)
trials osteoarthritis (compound)
bp sclerosis (conj)
lower number (nsubj)
upslope duration (conj)
tr(- ) (punct)
moderate low (amod)
hours infarction (nmod)
tissue nodal (amod)
= monotherapy (nmod:npmod)
tumor associated (amod)
circuitry acid-transmitted (amod)
fibrosis portal (amod)
stage an (det)
doses risperidone (nmod)
predict ( (punct)
cautious be (cop)
measurements ecg (nmod)
pattern mixed (amod)
mechanisms action (nmod)
components essential (amod)
maintained she (nsubj)
paroxysms of (case)
absence d2r (nmod)
associated cause (advcl)
effect rodents (nmod)
skin in (case)
survival patient (compound)
effects cardiorespiratory (amod)
requirements antagonism (nmod)
administered mg/kg/day (parataxis)
recommendation the (det)
junctions of (case)
involved molecule (nsubjpass)
mediated have (conj)
cd-832 both (cc:preconj)
epicardial coronary (conj)
migraineurs fifteen (nummod)
rates loss (nmod)
implicated although (mark)
those rats (nmod)
injury : (punct)
that with (case)
ml administered (acl)
icterus severe (amod)
passage barrier (nmod)
delay growth (compound)
discontinuation of (case)
attributed damage (nmod)
induced selected (ccomp)
taking the (det)
flow rbf (appos)
dysfunction acidosis (conj)
toxicity cardiac (amod)
p < (dep)
included didanosine (dobj)
provocation , (punct)
inserts in (case)
d-glucarate with (case)
exacerbation vasculitis (nmod)
hilum hh (dep)
1.0 risks (nsubj)
yr 6.9 (nummod)
induction cc (nmod)
sections frontal (amod)
severity in (case)
pcpa than (case)
finding pronounced (acl:relcl)
formation therapy (nmod)
removed that (advmod)
esrd n=45 (appos)
stimulation inhibitory (amod)
growth cranial (amod)
caused damage (dobj)
application an (det)
awake and (cc)
administered evoke (advcl)
treatment cyp (compound)
reported reported (dep)
parenteral after (case)
analysis histopathological (amod)
mechanism drug-adsorption (compound)
indication for (case)
group brainstem (compound)
antagonist compound (nsubj)
0.3 - (dep)
followed indicating (advcl)
flow this (det)
increase hand (nmod)
phases crystalline (amod)
symptoms transient (amod)
based belief (nmod)
allocated : (punct)
111 in (case)
remission = (dep)
extubated later (advmod)
modulation for (case)
marker and (cc)
lower c (nmod)
transferred backcrossing (nmod)
function clinical (amod)
arise . (punct)
property lowering (compound)
deficits monoaminergic (amod)
4.3 ( (punct)
decreased or (cc)
conclude improve (ccomp)
responses apomorphine (nmod)
tablets ( (punct)
received forearm (nmod)
reproduced effects (nsubjpass)
improve dyskinesia (dobj)
produce lesion (dobj)
known that (nsubjpass)
observed rest (nmod)
hospitalization and (cc)
represented probably (advmod)
days three (appos)
restoration catabolism (nmod)
evaluable toxicity (nmod)
efficacy clinical (amod)
noradrenaline i.v. (dep)
that observed (acl)
alfentanil presumably (advmod)
reported risk (dobj)
dismissed not (aux)
mg/m(2 paclitaxel (nmod)
time she (nsubj)
pointes amiodarone-induced (compound)
markers virus (compound)
containing bodies (dobj)
exceeded mg (nsubjpass)
dominating with (mark)
play learning (nmod)
foci in (case)
patients synovitis (nmod)
case tdp (nmod)
increases aggressiveness (conj)
a = (parataxis)
anuria this (det)
p= 0.001 (dobj)
impotence with (case)
complaints same (amod)
procedures cardiac (amod)
susceptibility cardiomyopathy (nmod)
withdrawn was (auxpass)
observed indicating (xcomp)
number greatest (amod)
by-product maneuver (nmod)
injection etomidate (compound)
pancreatitis hepatotoxicity (conj)
pre-treatment depression (nmod)
node sa (compound)
management anesthetic (compound)
ischemia cardiac (amod)
acknowledged predilection (nmod)
ukpdrg ) (punct)
june 2006 (nummod)
delivered gnc92h2 (nsubjpass)
small generally (advmod)
assessed response (nsubjpass)
syndrome setting (nmod)
mg 5 (compound)
scopolamine ritanserin (conj)
suggests role (dobj)
dysfunction neurological (amod)
score than (case)
substances many (amod)
frequencies range (nmod)
fingers and (cc)
make may (aux)
therapy glyburide (compound)
fastblue with (case)
index body-mass (compound)
regeneration of (case)
sulpiride by (case)
ocs to (case)
quiescent been (cop)
dose doxorubicin (nmod)
monoher of (case)
medication other (amod)
therapy potential (amod)
levels nitrite (compound)
phenols , (punct)
myocardium and (cc)
available while (mark)
improved partly (advmod)
infused performed (advcl)
inhibited % (dobj)
useful combination (nsubj)
irritation tract (nmod)
impact type (nmod)
magnitude ) (punct)
infarction after (case)
elicited mediated (conj)
january 2006 (nummod)
lactate ringers (compound)
rat immunocytoma-bearing (amod)
8 or (cc)
acidosis and (cc)
beck zung-conde (conj)
la of (case)
known apnea (nsubjpass)
beclin 1 (nummod)
administration ester (nmod)
effect treatment (nmod)
transplantation , (punct)
compares study (nsubj)
bias the (det)
glutamate hippocampal (amod)
diseases from (case)
decades 2 (nummod)
observational . (punct)
segment the (det)
basis molecular (amod)
act synergistically (advmod)
sensitivity rat (nmod)
restricted ( (punct)
svr ( (punct)
used medium (conj)
uptake bones (nmod)
conclude is (ccomp)
tolerated recovered (conj)
serum tissue (conj)
encephalopathy for (case)
fatal frequently (advmod)
problematic . (punct)
mg/h nimodipine (appos)
ph pressures (conj)
rbcs ) (punct)
space epidural (amod)
measure activity (nmod)
participants cocaine-dependent (amod)
have choreoathetosis (dobj)
presented beginning (advcl)
rate spillover (compound)
patients mdp (nmod)
injected perfusion (nmod)
signaling cholinergic (amod)
woman 58-year-old (amod)
implanted surgically (advmod)
efficient blocking (advcl)
stimulated formyl-methionyl-leucyl-phenylalanine (nmod)
eating smelling (conj)
production e2 (compound)
instituted based (prep)
incapacity the (det)
found unchanged (advcl)
chickens leghorn (compound)
bronchoconstriction severe (amod)
epithelium and (cc)
prednisone of (case)
nodal on (case)
25 20 (compound)
infiltration and (cc)
ci 0.47 (appos)
confined was (auxpass)
disease rr (appos)
hallmark . (punct)
seizures continuous (amod)
examined examined (conj)
levels by (case)
1999 in (case)
% so2<90 (nummod)
microl/side ( (punct)
opiate an (det)
triggered cluster (dobj)
minutes injection (nmod)
states europe (conj)
administration outpatient (amod)
reported described (advcl)
actions the (det)
arteries and (cc)
received transplantation (dobj)
% 0 (nummod)
diagnosing condition (dobj)
chf with (case)
cancers most (amod)
efficacy diethylpropion (nmod)
evaluated a (nsubjpass)
score dyskinesias (nmod)
icu the (det)
ratio univariate (amod)
studied patients (dep)
months duration (nsubj)
glomerulopathy transplant (compound)
patients apnea (nmod)
poisoning phosphorus (nmod)
bleeds five (nummod)
tizanidine agents (conj)
signs enhancement (nmod)
spinal or (cc)
identified finally (advmod)
beta-blockers of (case)
cause able (conj)
consisted therapy (nsubj)
regulation pharmacologic (amod)
factors coagulation (compound)
beings of (case)
better were (cop)
determining at (mark)
patients pci (compound)
continued papilledema (nsubj)
maintained effectiveness (nsubjpass)
associated while (mark)
included women (dobj)
elevations market (compound)
subgroups women (nmod)
complication valproate (nmod)
localization the (det)
vasodilator and (cc)
atropine furosemide (conj)
l2 and (cc)
dates january (nmod:tmod)
survivors , (punct)
facilitation stimulation (conj)
outcomes continuous (amod)
functioning distress (conj)
retention to (case)
inhalator an (det)
amns ) (punct)
mo 5 (nummod)
posture body (compound)
elevation pressure (nmod)
changes and (cc)
examined used (advcl)
studied omitted (advcl)
restoring in (mark)
anemia as (case)
killed day (nmod)
reverse : (punct)
vary incidence (nsubj)
alleles the (det)
consisted controls (nsubj)
contrast mortality (nmod)
results 1.0 (appos)
tincture of (case)
g/dl 14.0 (nummod)
t180 ( (punct)
ultrastructure the (det)
increases irrespective (advmod)
km high (amod)
% iodixanol (nmod)
thalidomide agent (compound)
caused epinephrine (nsubj)
beating are (cop)
appear dosed (conj)
ensued apnea (nsubj)
processed tissues (nsubjpass)
signs op-induced (amod)
increase level (dobj)
infusions 24-hour (amod)
attribute be (cop)
cyclophosphamide with (case)
severe controls (nmod)
risks consumption (nmod)
analyse data (dobj)
reduction fractures (nmod)
malondialdehyde renal (amod)
beta-blocker timolol (appos)
developing complication (dobj)
time week (nmod)
confirmed results (nsubjpass)
33 of (advmod)
factor common (amod)
sf36 ) (punct)
addition from (case)
effect agent (nmod)
methamphetamine amphetamine (conj)
protocols separation (compound)
mg 2.0 (compound)
entities , (punct)
doxorubicin compared (case)
utilized study (nmod)
levels elevated (amod)
received doses/day (dobj)
noradrenaline ng/kg/min (dep)
doses cimetidine (nmod)
embolism secondary (amod)
variables on (case)
doxorubicin following (amod)
nephritis azithromycin-induced (amod)
evaluated degree (dobj)
dysarthria tremor (conj)
incidence reactions (nmod)
numerous more (advmod)
comparisons subgroups (nmod)
% np (nmod)
acid eaca (appos)
plays nephrotoxicity (nmod)
gem-p to (case)
reported enhanced (ccomp)
demonstrated this (nsubjpass)
mg/dl 2.21 (nummod)
metabolites , (punct)
ratio 0.92 (appos)
colocalized not (neg)
distribution or (cc)
dose fentanyl (nmod)
paid should (aux)
mhb little (amod)
action hypotensive (amod)
carcinoma lung (compound)
cardiotoxity cocaine (compound)
dipyridamole to (case)
recurrence any (det)
pressure force (conj)
derivative benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate (dep)
workers industrial (amod)
found differentiation (nsubjpass)
models induced (acl)
imidazo[1,5-a]-pyrrolo-[2,1-c][1,4]benzodiazepine-1-carboxylate ) (punct)
chromatography high-pressure (amod)
group pediatric (amod)
reveals study (nsubj)
imparts stimuli (nmod)
dose infusion-time (conj)
epilepticus during (case)
characteristic that (nsubj)
modifications to (case)
syndrome milk-alkali (compound)
interactions drug-drug (compound)
report describe (acl)
inactive gaba(a)rs (nmod)
lethargy inappetence (conj)
morning levodopa-induced (amod)
externa the (det)
regimens the (det)
suggest detrimental (ccomp)
management intraoperative (amod)
asystole from (case)
value corresponding (amod)
estimation dose (nmod)
neuropathy injection (nmod)
cpap ( (punct)
valve aortic (amod)
performed subtests (dep)
replicate or (cc)
production expression (conj)
increased increased (advcl)
enzymes liver (compound)
experience not (neg)
antiemetics of (case)
mmol/kg ) (punct)
induce whereby (advmod)
presented administration (nmod)
$ROOT$ composition (sent)
represents sirolimus (nsubj)
mg.per 12.0 (nummod)
nature , (punct)
single multiple (conj)
materials . (punct)
reverses . (punct)
heterogeneity due (case)
remains blind (acomp)
lower groups (nmod)
decreased age (nmod)
dropped level (nmod)
abolished alterations (dobj)
episodes patients (nmod)
center medical (amod)
mechanisms migraine (nmod)
prl-r mrna (conj)
gpi the (det)
reversibility its (nmod:poss)
britain in (case)
admission unit (nmod)
or=3.299 , (punct)
dialysis intraoperative (amod)
min for (case)
testing visual (amod)
treatment monitored (amod)
racemic ) (punct)
titers of (case)
percentage , (punct)
enhancement delayed (amod)
pseudolithiasis of (case)
related depression (nsubj)
reported percent (nsubj)
trained rats (nsubjpass)
panel lipid (compound)
prophylaxis globulin (nmod)
nodal or (cc)
effect hypotensive (amod)
stenoses to (case)
developed time (nmod:tmod)
dosage lower (amod)
stopped therapy (nsubjpass)
morphine mg/kg (appos)
ameliorates testosterone (nsubj)
that (+)-propranolol (nmod)
ability repeat (acl)
undertaken biopsies (nsubjpass)
rats dogs (conj)
effect mechanism(s (conj)
mania of (case)
vision ability (conj)
indicates ability (dobj)
predictor a (det)
property cholesterol (compound)
rhythm contractile (amod)
symptoms as (cc)
found sites (nmod)
8 ( (punct)
measure loss (dobj)
activation probably (advmod)
% 76.6 (nummod)
option therefore (advmod)
case block (nmod)
anesthesia ketamine (compound)
value p (compound)
treatment malignancies (nmod)
$ROOT$ asystole (sent)
warranted and (cc)
60 13 (compound)
origin attack (nmod)
line observation (nsubj)
age- and (cc)
ppm 1,000 (compound)
varied dose (nsubj)
damage system (compound)
dexamphetamine- and (cc)
conclude improves (ccomp)
parts scale (conj)
subtype glutamate (compound)
success and (cc)
lymphoma fibrillation (conj)
mg/m(2 1.3 (nummod)
review of (case)
delirium with (case)
subunit an (det)
hearts deprived (acl)
infarction first (amod)
pathways the (det)
responses signaling (compound)
responses selective (amod)
alleviated . (punct)
$ROOT$ follow (sent)
developed courses (nmod)
table life (compound)
acting vicinity (nmod)
resolved however (advmod)
bleeding severe (amod)
form neuropathy (nmod)
diet low-sodium (amod)
% a (det)
transplantation following (case)
mainstay the (det)
after and (cc)
increase line (nmod)
disorder mood (compound)
days pn (conj)
neurodevelopment behaviors (conj)
hypothesis plays (ccomp)
minute 30th (amod)
period consolidation (nmod)
common twice (advmod)
shown nuclei (nmod)
managed patient (nsubjpass)
involved pathway (nsubjpass)
studies reported (acl:relcl)
application drug (nmod)
laboratory this (det)
presented them (nmod)
phenotypes two (nummod)
d1-like selective (amod)
explain presentation (dobj)
analysis humphrey (compound)
microglia striatal (amod)
$ROOT$ protein (sent)
symptoms occur (acl:relcl)
convulsions fluorthyl- (amod)
onset fever (nmod)
ph 9 (appos)
1994 of (case)
bilirubin in (case)
scores tests (nmod)
myoclonus de (amod)
average . (punct)
factor have (aux)
influence it (nsubj)
described picture (dep)
% suppression (nsubj)
clz day (nmod)
adam10 of (case)
methotrexate ) (punct)
overt eeg-detectable (conj)
prolonged but (cc)
[-]-[5ar,11bs]-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-+ 10-diol (conj)
high-dose ) (punct)
conditions apparent (amod)
remained required (conj)
respond support (nmod)
associated contributed (parataxis)
predicting dysfunction (dobj)
initial final (conj)
drainage ileostoma (nmod)
determined kidneys (nmod)
10 18 (conj)
atin with (case)
support intraoperative (amod)
hem and (cc)
groups indomethacin (compound)
effect excitatory (amod)
naloxone antagonist (compound)
strategies this (nmod)
3.8 2.2 (conj)
at2r ) (punct)
information review (conj)
mda of (case)
ua p<0.001 (dep)
coarctation defect (conj)
drugs modifying (amod)
postulate share (ccomp)
ac ) (punct)
mg/kg i.p. (amod)
changes power (nmod)
25 50mg/kg (conj)
chemotherapy following (case)
implant of (case)
had blocking (advcl)
managed easily (advmod)
mmhg and (cc)
lowered and (cc)
decade past (amod)
26 % (appos)
h 40.3 (nummod)
syndrome ballooning (amod)
based response (nmod)
concentrations antiarrhythmic (amod)
4,000 100 (compound)
$ROOT$ contained (sent)
study randomised (amod)
toxicity levobupivacaine-induced (amod)
reaction transfusion (compound)
prescribe clinicians (nsubj)
augment continued (advcl)
unknown practitioners (nmod)
docetaxel with (case)
anemia role (dep)
arrhythmias digitalis- (amod)
correction parameters (nmod)
bradycardias edrophonium-induced (amod)
prl-positive immunochemically (advmod)
7 patients (nmod)
transport glut4 (nmod)
11/57 ; (punct)
discontinuing use (dobj)
rna ribosomal (amod)
attenuated sr (conj)
tended fact (nmod)
$ROOT$ have (sent)
protocols two (nummod)
potent were (cop)
occurred why (advmod)
agent topical (amod)
association stroke (nmod)
cortex ventricles (conj)
enzymes tissue (compound)
generation third (amod)
refine pinpoint (conj)
modifications course (compound)
reduced expression (nsubjpass)
administered striatum (nmod)
neck bladder (compound)
estimated was (auxpass)
enhancement possible (amod)
or indirectly (advmod)
measured response (nmod)
oxprenolol by (case)
have nephrotoxicity (dobj)
receive weeks (nmod)
treatment dexamethasone (compound)
developed pa (dobj)
responses elicited (amod)
rechallenged beclomethasone (nmod)
cause nephrolithiasis (dobj)
evaluated ability (dobj)
farmers carolina (nmod)
requested reports (nsubjpass)
tolerance subjects (nmod)
treated 1997 (nmod)
decreased same (nmod:npmod)
% 71.4 (nummod)
mm 31.6 (nummod)
corresponded changes (nsubj)
phase pain (compound)
nephritis due (amod)
nephropathy bk (compound)
systems dogs (nmod)
identified dose (dobj)
determination , (punct)
pretreatment agent (nmod)
higher 6.7-times (nmod:npmod)
5-fu and (cc)
arrhythmias cardiovascular (amod)
therapy colitis (nmod)
relation assumed (amod)
periods and (cc)
problematic most (advmod)
occurred group (nmod)
reticulata pars (compound)
occurred anaesthesia (nmod)
dimension/function on (case)
derived been (auxpass)
suggested was (auxpass)
effect renoprotective (amod)
patient glycopyrrolate (appos)
convulsions of (case)
risk use (nmod)
protect injury (nmod)
episodes before (case)
years 77 (nummod)
was parallel (nmod)
4107 were (cop)
emerged hbv (nsubj)
intoxications of (case)
design crossover (amod)
individuals ( (punct)
vessels blood (compound)
dose used (acl)
leak therapies (nmod)
doses epileptogenic (acl:relcl)
twenty-one patients (nmod)
overflow kidney (nmod)
disease tubulointerstial (amod)
history echocardiography (conj)
demonstrated targets (ccomp)
cells experience (acl:relcl)
distinguished nuclei (nmod)
seizures nonischemic (amod)
weeks , (punct)
failure patient (nmod)
system nervous (amod)
adrenaline and (cc)
vgpr ( (punct)
experienced collapse (dobj)
acetate methylprednisolone (compound)
avoid patients (nmod)
patterns the (det)
demonstrated attenuates (ccomp)
arrhythmia including (case)
neck the (det)
inhibition maximum (compound)
awoke pain (nmod)
cause changes (dobj)
vomiting fever (conj)
injection on (case)
case ) (punct)
rtm204i ) (punct)
reviewed literature (dobj)
recognized was (auxpass)
ng ) (punct)
trigger the (det)
level lethality (nmod)
observation postbaseline (amod)
possibilities the (det)
motoneurons to (case)
significant eyes (nmod)
procyclidine , (punct)
pilocarpine to (case)
taking dependence (nmod)
distance m (compound)
clinic university-affiliated (amod)
reported interaction (nsubjpass)
ratio ci (dep)
treatment terbutaline (compound)
restrictive very (advmod)
infusion administrations (nmod)
after immediately (advmod)
rate bone (compound)
indicated studies (nsubjpass)
fibrillation determinants (conj)
life half (amod)
depression adolescent (amod)
approximate dose (nsubj)
status , (punct)
exposure no (neg)
kappa-beta factor (compound)
potentiation cultures (nmod)
effects estrogenic (amod)
bradycardia hypotension (conj)
acted rats (nmod)
development tdp (nmod)
flexion excessive (amod)
raloxifene with (case)
bradycardia and (cc)
interact warfarin (nmod)
enhanced greatly (advmod)
treatment daily (advmod)
oncologists both (preconj)
was increase (attr)
neuritis brachial (amod)
weight in (appos)
occurred angina (nsubj)
ketamine not (cc)
alpha-motoneurons of (case)
inconclusive and (cc)
fasciculations of (case)
values alt (compound)
10.7 : (punct)
provides abuse (nsubj)
ultrastructural and (cc)
patients 100 (nummod)
$ROOT$ declined (sent)
atonic , (punct)
deprivation rats (nmod)
expression to (case)
asterixis of (case)
positive hbeag (nsubj)
maintain decreasing (advcl)
supplement improve (advcl)
improvement followed (acl:relcl)
mg/kg mg/lb (appos)
women oab (nmod)
group propranolol-insulin (compound)
270 280 (conj)
values t (compound)
m-chlorophenylpiperazine mcpp (dep)
failure need (acl:relcl)
supports typically (advmod)
negative tests (nsubj)
impairments lasting (amod)
caused cimetidine (nmod)
diameters lv (compound)
controls esrd (conj)
group alpha- (nmod)
reported area (dobj)
plans with (case)
arrest doses (nmod)
staining after (case)
seizures generalised (amod)
induction test (nmod)
therapy bupropion (compound)
1999 2002 (prep)
considered insipidus (nsubjpass)
ph 7.25 (appos)
change any (det)
became noticeable (acomp)
myositis atra-induced (amod)
clarithromycin of (case)
have did (aux)
penetration wall (nmod)
pounds weight (nsubj)
motionless flaccid (conj)
hr with (case)
cats epilepsy (nmod)
exercised days (nmod)
level control (amod)
good to (case)
developed pneumonia (dep)
nimodipine ) (punct)
data patients (nmod)
spectra in (case)
peptide acid (compound)
developed using (advcl)
pravastatin fluvastatin (conj)
play because (mark)
inhibition ace (compound)
level 4,210 (nummod)
occasions : (punct)
women 6 (nummod)
result toxicity (nsubj)
mg rats (nmod)
assessments preclinical (amod)
preparation the (det)
$ROOT$ apomorphine (sent)
consumed years (nmod)
demonstrates indicates (conj)
woman 30-year-old (amod)
t1/2 28.21 (dep)
mg 0.25 (nummod)
shows patients (nmod)
progressed , (punct)
trazodone of (case)
associated famotidine (nmod)
1.0 < (dep)
min 200 (nummod)
individuals worldwide (advmod)
used it (nsubjpass)
effect sleep (nmod)
than usual (amod)
zones expanded (amod)
use bupropion (compound)
clearance heat (compound)
prescription unrestricted (amod)
pressure injury (conj)
causes potential (amod)
ng/ml hours (nmod:npmod)
behavior pathological (amod)
difference oxygen (compound)
blocking of (mark)
source was (cop)
for only (advmod)
147 18/88 (conj)
nausea commonly (advmod)
model symptoms (nmod)
questionnaire , (punct)
adrenaline noradrenaline (conj)
effect impairments (nmod)
greater was (cop)
hypertension to (case)
c57bl/6j chosen (acl)
made was (auxpass)
symptoms extrapyramidal (amod)
$ROOT$ results (sent)
infants in (case)
remain to (mark)
sedation . (punct)
mrd mean (amod)
11.3 1.4 (conj)
diameter of (case)
$ROOT$ reactions (sent)
waves with (case)
albumin mouse (compound)
background on (case)
measured exploration (nmod)
belief that (acl)
tmp of (case)
passes barrier (dobj)
applied mucosa (nmod)
chlorpheniramine , (punct)
condition his (nmod:poss)
somnolence and (cc)
active hyperactivity (nmod)
learning memory (conj)
tests skin (compound)
correct does (aux)
antidepressants various (amod)
disability permanent (amod)
adc ) (punct)
spectra power (compound)
dextrose % (amod)
effusions side (nmod)
antagonizes that (mark)
dilation ventricular (amod)
differences sex-related (amod)
result nephrotoxicity (nsubj)
pattern respiratory (amod)
airway mask (compound)
transit similar (amod)
defined function (nsubjpass)
becomes if (mark)
ablation radiofrequency (amod)
reported salicylates (nsubjpass)
dogs twenty-three (nummod)
antibiotics peptide (compound)
index mitotic (amod)
higher increase (nsubj)
radiological electrophysiological (conj)
bradycardia mice (nmod)
continued proliferate (xcomp)
48-week to (dep)
exceeding mg/kg (dobj)
anxiety postoperative (amod)
prophylaxis pneumonia (compound)
function delayed (amod)
characteristic receiver (compound)
impairment measures (nmod)
proteinuric , (punct)
film abnormal (amod)
promotes carcinogenesis (dobj)
administered 5-fu (nmod)
vehicles ritanserin (conj)
phonological ) (punct)
studies relationship (nmod)
showed ercp (nsubj)
appears use (nsubj)
$ROOT$ recognised (sent)
midazolam and (cc)
allow discontinuation (nsubj)
activity cathepsin (compound)
related mass (nmod)
period august (nmod)
performed audiograms (nsubjpass)
increases reflex (nmod)
conducted limits (advcl)
associated frequently (advmod)
bradycardia morphine-induced (amod)
angina with (case)
method reviewed (appos)
that bn (nmod)
model pilo (amod)
ci 0.91 (nummod)
required transfusions (dobj)
clumsiness evident (dep)
v/v ( (punct)
ctni in (case)
3 4 (prep)
injury renal (amod)
mrp2 of (case)
patient neither (preconj)
icp lower (amod)
flattening in (case)
cpu and (cc)
was excretion (nmod)
degrees slight (amod)
measures prophylactic (amod)
$ROOT$ considered (sent)
cages in (case)
appeared patient (nmod)
appearance proteinuria (nmod)
agonists a1 (dep)
one . (punct)
doses isoniazid (nmod)
degree on (case)
lidocaine as (case)
severity illness (nmod)
recognise believe (conj)
individual an (det)
administration fluconazole (nmod)
impairment myocardial (amod)
years 1 (nummod)
literature previous (amod)
appearance , (punct)
zero , (punct)
oih on (case)
fall critical (amod)
it ) (punct)
used experienced (conj)
compared products (nmod)
patients 4/106 (appos)
exacerbated fentanyl (nsubj)
sites core (dep)
blind crossover (dep)
system scoring (compound)
measurements clinical (amod)
orbitofrontal or (cc)
monitoring cardiovascular (amod)
possible identify (xcomp)
prevalence cohorts (nmod)
mac ( (punct)
hz and (cc)
related effect (nmod)
breaks pyrimidines (conj)
form the (det)
occurs lesions (nmod)
intake daily (amod)
pretreatment isoproterenol (nmod)
examined immunohistochemically (advmod)
undertook , (punct)
programs with (case)
68 and (cc)
ability recognize (acl)
attenuated which (nsubj)
anesthetics local (amod)
produced conditions (nmod)
history disturbances (nmod)
death chemotherapy (nmod)
reducing albuminuria (dobj)
induce mania (dobj)
pacemaker a (det)
rendered who (nsubjpass)
alpha 1/2 (nummod)
elevation electrocardiogram (nmod)
children infants (conj)
lapsed coma (nmod)
helodermin by (case)
akinesis apical (amod)
period exercise (compound)
one months (nmod)
inducing flaccidity (dobj)
relationships cardiomyopathy (nmod)
leukopenia antimetabolite-induced (amod)
affects hyperprolactinemia (nsubj)
19 patients (nmod)
b ; (punct)
dose sertraline (compound)
determine events (dobj)
include factors (nsubj)
reverse hypotension (dobj)
$ROOT$ importance (sent)
obtained yields (nsubjpass)
extended-release/lovastatin dosed (acl)
0.28 +/- (cc)
had severity (nmod)
influence under (case)
toxicity bupropion (compound)
effect deteriorating (amod)
hypothesized responsible (ccomp)
numbers profiles/sections (appos)
procedure lesioning (amod)
man suffering (acl)
had methscopolamine (nsubj)
recommended individuals (nmod)
carotid segment (conj)
doses medium (amod)
receive mg/m(2 (dobj)
means pulses (nmod)
phosphorus , (punct)
decreasing pressure (dobj)
admitted edema (nmod)
complication disabling (amod)
mg/kg 4 (compound)
epilepticus ncse (appos)
cause symptoms (nmod)
common that (mark)
gaba sub-chronic (amod)
white gray (conj)
infusions chloride (nmod)
protocols the (det)
used frequency (nmod)
procedures the (det)
attack hepatitis (compound)
produced flestolol (nsubj)
escalations level (nmod)
received discharged (dep)
uneventful initially (advmod)
intact bile-diverted (conj)
discussed was (auxpass)
some damage (nmod)
alleviated significantly (advmod)
county dade (compound)
associated srl (nmod)
adhd in (case)
hormone magnesium (conj)
severe ototoxicity (nsubj)
$ROOT$ recurarization (sent)
1 whom (nmod)
consumed juice (dobj)
10.5 +/- (cc)
inhibited adriamycin (nsubj)
effect pretreatment (nmod)
reported trials (nmod)
ischemia the (det)
acetaminophen tetrachloride (conj)
elevation loss (conj)
ovariectomy ds (nmod)
hypothesize sufficient (ccomp)
erythema , (punct)
men aged (amod)
questionnaire severity (conj)
establishing tumor (dobj)
accounted that (mark)
toxin botulinum (compound)
noted findings (nsubjpass)
classifications are (cop)
density children (nmod)
disposition result (nsubj)
induce cross-tolerance (dobj)
transferase glucuronyl (compound)
pronounced period (nmod)
derived f2 (nmod)
incidence incidence (conj)
drop pressure (nmod)
hypothesized lead (ccomp)
course cases (nmod)
time to (mark)
acetaminophen g (appos)
hepatitis phenylethylbarbiturate-induced (amod)
g/dl 10 (nummod)
comparison double-blind (amod)
had concentrations (dobj)
illness pretransplant (amod)
sec. of (case)
model amnesia (nmod)
rhabdomyolysis death (conj)
rate resulted (acl:relcl)
carry carries (parataxis)
reassessed were (auxpass)
played . (punct)
objective test (acl)
ducts interlobular (amod)
findings neurological (amod)
room ) (punct)
synthesize information (dobj)
performance tap (appos)
patients six (nummod)
mg sulfate (nmod)
immunoglobulin or (cc)
pcc saline (conj)
oscillations tremor (compound)
failure sepsis (conj)
12 approximately (advmod)
tachycardia intractable (amod)
constitute complications (nsubj)
damage sub-regions (nmod)
exposure depletion (conj)
cpb and (cc)
compared segments (nmod)
adopted be (auxpass)
1.4 0.4 (conj)
membrane tubular (amod)
protected antagonized (ccomp)
engaged receptors (nsubjpass)
recorded is (aux)
impairments process-specific (amod)
received not (neg)
line a (det)
chemistry alt (dep)
company 's (case)
scores lower (amod)
synthesis npy (nmod)
bed for (case)
agent sample (nmod)
attenuate , (punct)
dogs nx (compound)
days 98 (nummod)
person in (case)
age variables (conj)
seizures activity (conj)
discontinuation sirolimus (nmod)
cortex cingulate-limbic (amod)
negative titer (nsubj)
used form (dobj)
u/ml 20.7 (nummod)
manual diagnostic (compound)
titre the (det)
described leukoencephalopathy (nsubjpass)
p-ergs ( (punct)
nox nor (cc)
determinant a (det)
addition or (cc)
effect cataleptogenic (amod)
discontinued all (advmod)
admission medications (conj)
studied effects (nsubjpass)
expressed also (advmod)
created methods (dep)
respect metabolism (nmod)
design studies (nmod)
pain caused (acl)
superior that (mark)
pentylenetetrazole bemegride (conj)
stroke to (case)
necrosis septal (amod)
biopsy by (case)
days rriw (compound)
6beta-hydroxylase lithocholate (compound)
registered inhaled (ccomp)
effects withdrawal (nmod)
burns treated (acl:relcl)
dysmyelopoiesis and (cc)
modulation states (nmod)
have fla-63 (nsubj)
effective toxic (conj)
consequence properties (nmod)
p58 ) (punct)
bruising areas (nmod)
totp or (cc)
s 8+/-4 (nummod)
age yrs (dep)
given intrathecally (advmod)
application pad (nmod)
dependent is (cop)
mistaken be (cop)
counteract vasospasm (dobj)
symptoms reversed (acl:relcl)
implausible . (punct)
19 versus (cc)
analogue ( (punct)
antidepressant is (cop)
1 5 (conj)
defined was (auxpass)
stretches faster (amod)
found was (advcl)
involved closely (advmod)
patients for (case)
administration ouabain (nmod)
flexural gluteal (conj)
comparable compromised (advcl)
h. over (case)
detected hepatocytes (nmod)
dyskinesia lid (appos)
p<0.001 and (cc)
neutropenia 1,000/mm3 (appos)
score [ (punct)
29.3 3.2 (conj)
rare reports (nsubj)
therapy chelation (compound)
describe investigate (conj)
half-life an (det)
those without (advmod)
perfusion to (case)
period years (nmod)
contractility cardiac (amod)
adrenergic alpha-2 (nmod:npmod)
weight brain (compound)
preparation heart-lung (compound)
hypercalcemia , (punct)
parameters ulcerogenic (amod)
derivatives certain (amod)
prolonged gradually (advmod)
livers rat (compound)
interdependence the (det)
undergoing while (mark)
neurons activated (acl)
equal : (punct)
observations considerations (conj)
monitored be (auxpass)
change beats/min (appos)
control than (case)
unable are (cop)
gamma-carboxylated protein (nsubj)
known drugs (nsubjpass)
hemorrhage animals (nmod)
correlated data (nsubjpass)
produced dosages (nsubj)
mapped organization (nsubjpass)
diagnostic simple (amod)
nature be (cop)
studies electrodiagnostic (amod)
cases potential (amod)
distribution peripheral (amod)
caused hyperkalemia (nmod)
serve strain (nmod)
use vasopressor (nmod)
initiation after (case)
hip the (det)
remains moreover (advmod)
pge1 of (case)
series antagonists (nmod)
need because (mark)
indicates indirect (ccomp)
black male (conj)
diagnosed block (nsubjpass)
injection ( (punct)
worsen use (nsubj)
organisms pyocin (compound)
compressed head (nmod)
effects edrophonium (nmod)
enhance that (nsubj)
causes arrhythmia (nsubj)
flow on (case)
measured post-exposure (nmod)
perform to (mark)
mg/kg hour (nmod:tmod)
gemcitabine with (case)
diet maintains (acl:relcl)
mg/dl 130 (nummod)
speculated can (aux)
selected controls (dobj)
decreases weight (nmod)
occurred % (advcl)
carolina , (punct)
had p= (dep)
reduced patients (nsubjpass)
saline i.v. (advmod)
syndrome interaction (nmod)
leads maturation (nmod)
accumulating evidence (nsubj)
produced when (advmod)
rats thirty-six (nummod)
defects vsds (appos)
effect troubling (amod)
children hyperglycinemia (nmod)
epicardium endocardium (conj)
patients sr (nmod)
dcf ) (punct)
pg/ml 40 (nummod)
indicated value (dobj)
orbitofrontal ( (punct)
yield would (aux)
exposure about (case)
total events (nmod)
increase relative (amod)
mg/kg as (case)
deficit on (case)
edema , (punct)
khz 6 (nummod)
liver kidney (appos)
administered amount (nsubjpass)
concern a (det)
30 26 (compound)
one to (quantmod)
hypertrophy or (cc)
patients enrolled (dep)
incidence unacceptable (amod)
promotes normalizes (conj)
correlated effect (nsubjpass)
mrna ventricular (amod)
differences with (case)
measurements binding (nmod)
consequence leukemia (nsubj)
uncommon series (nmod)
lead toxicity (nmod)
aminotransferase and (cc)
muscle myopathic (amod)
treatment mefloquine (compound)
reason , (punct)
gy/30 60 (nummod)
analysis characteristics (nmod)
levels to (case)
signs these (det)
disorder autism (nsubj)
69 0.9 (compound)
sensitivity future (amod)
frequent < (parataxis)
fact agent (ccomp)
hemorrhagic . (punct)
tended display (xcomp)
afflicted phenomenon (nmod)
analysis patients (nmod)
seizures associated (acl)
ranges and (cc)
causes other (amod)
% valsartan (nmod)
l/hour/m2 clearance (nsubj)
encoded genes (nmod)
150 - (punct)
scopolamine ) (punct)
forearm wrist (conj)
discontinue avoid (conj)
finding diagnosis (nmod)
failure overdose (nmod)
median 39.6 (nummod)
antagonist profile (appos)
water and (cc)
resulted administration (nmod)
socs-3 and (cc)
list client (compound)
conclusions provide (dep)
test location (compound)
drugs 5 (nummod)
4.1 ci (nsubj)
sonograms abdominal (amod)
than day (nmod)
kg(-1 day(-1 (appos)
cessation institution (conj)
$ROOT$ attractive (sent)
found home (nmod)
1080 ] (punct)
abolished effects (dobj)
chemistry blood (compound)
concluded can (aux)
disorders complicated (amod)
bought pharmacy (nmod)
trial dexmedetomidine (nmod)
behavior mice (nmod)
agent beta-blocking (amod)
encountered though (mark)
had pre-bed (advmod)
glomeruli in (case)
smaller size (nsubj)
decided . (punct)
enhancers different (amod)
advocated carried (advcl)
doxorubicin free (amod)
associated complaints (nmod)
muscle rat (compound)
rapid more (advmod)
prevented showing (advcl)
increases consumption (nmod)
dose ingested (amod)
demonstrated megaloblastosis (nmod)
azt % (appos)
assumptions of (case)
serum- and (cc)
bradycardia timolol-induced (amod)
isomers with (case)
mutation this (det)
score ability (conj)
minute seconds (conj)
measured tests (nmod)
nephropathy gentamicin (compound)
monocytes blood (compound)
scale the (det)
observation of (case)
documented required (conj)
cancer aggressive (amod)
hybrid f344 (nmod)
shown since (mark)
reporting majority (nsubj)
rose group (nmod)
glucuronidation acid (nmod)
ctnt ( (punct)
terms the (det)
greater those (nmod)
damage neurone (compound)
vagina of (case)
coli escherichia (compound)
bf ( (punct)
correlation . (punct)
170 ci (dep)
immunodeficiency with (case)
develop regularly (advmod)
required therapy (dobj)
iowa carolina (conj)
antagonist effective (amod)
republic democratic (compound)
striatum ganglia (nmod)
affinity receptor (compound)
formyltransferase ribonucleotide (compound)
absence hypotension (nmod)
catalyze attenuate (conj)
candidates in (case)
3.4 1.1 (nummod)
studied produced (conj)
amount increased (amod)
micrograms/min of (case)
zones subendothelial (amod)
necrosis with (case)
activate contributing (advcl)
study pair-fed (amod)
cases germany (nmod)
investigated mechanisms (nsubjpass)
volunteers eight (nummod)
apex and (cc)
was h (nmod)
40 to (quantmod)
secretion increased (amod)
nicergoline of (case)
dehydrogenase phosphokinase (conj)
pressure on (case)
administration groups (nmod)
optimization therapy (nmod)
pains their (nmod:poss)
cephalosporins quinolones (conj)
$ROOT$ opaque (sent)
tested were (auxpass)
extent hypotension (nmod)
administered cycles (dep)
expansion kidney (nmod)
dbs hippocampal (amod)
amount plasma (nmod)
failure simvastatin-ezetimibe-induced (amod)
regions isocortical (amod)
analysis review (conj)
groups cisapride (compound)
dopamine such (case)
fragmentation dna (nmod)
due exertion (nmod)
mmg of (case)
level % (nmod)
profiles similar (amod)
reinstated be (auxpass)
treatment etoricoxib (compound)
stopped that (nsubj)
dosage ribavirin (compound)
minority a (det)
reported indomethacin (nsubjpass)
summarized reports (nsubjpass)
ssris ) (punct)
tested is (ccomp)
compensated and (cc)
remedies over-the-counter (amod)
reduced compared (prep)
prevalent hexaaldose (conj)
growth changes (conj)
mangiferin weight (dep)
caffeine by (case)
therapy play (conj)
< 0.005 (dobj)
involving use (dobj)
taking which (dobj)
activations the (det)
presentation was (cop)
supports concerns (dobj)
documented variable (nsubjpass)
induced kindling (nmod)
doubled approximately (advmod)
patients 67 (nummod)
challenged intragastrically (advmod)
denominator a (det)
system kidney (compound)
flow or (cc)
site . (punct)
alteration to (case)
lower pups (nmod)
start procedure (nmod)
falciparum diagnosed (conj)
regression linear (amod)
mg 120 (nummod)
rct subanalyses (conj)
days 4 (nummod)
detection airflow (compound)
% 6.7 (nummod)
anticoagulant the (det)
literature published (amod)
% 28.0 (nummod)
initiation promotion (conj)
starting sedative (dobj)
polyvidone and (cc)
dermatitis toxic (amod)
fifty-three hundred (compound)
process foot (compound)
eight of (advmod)
returned . (punct)
respond proliferation (nmod)
compound the (det)
disorders hepatic (amod)
dysfunction presumed (acl)
cis-platinum cyclophosphamide (conj)
individuals antibody-positive (amod)
controlled or (cc)
exhibited latencies (dobj)
purpose therapy (appos)
available years (nmod)
region and (cc)
patients twenty-four (nmod)
inserted all (nmod)
frequencies middle (amod)
time locomotor (amod)
becomes agitation (nsubj)
preference of (case)
iq , (punct)
homogenates cortical (amod)
recurrences with (case)
narcosis of (case)
properties anti-oxidant (amod)
epithelium for (case)
analogues 8 (nummod)
deoxycholate ) (punct)
clt ( (punct)
promotes phosphorylation (nmod)
incorporation its (nmod:poss)
shifts threshold (nmod)
bundle median (amod)
gene , (punct)
concentrations azt (nmod)
determined subtypes (nsubjpass)
mg/m2 68.35 (nummod)
damage observed (acl:relcl)
result addition (nmod)
behaved rats (nsubj)
size by (case)
individual taking (acl)
pressure mmhg (nmod)
vagal sympathetic (conj)
restarted may (aux)
approaches of (case)
groups to (case)
significance expression (nmod)
induction fibrillation (nmod)
presence smoking (conj)
liver albumin (conj)
2 least (nmod:npmod)
volumes with (case)
decreased were (auxpass)
suggests work (nsubj)
damage structural (amod)
factors hypertension (nsubj)
decrease due (case)
incubated buffer (nmod)
curtailed development (nsubjpass)
used oxygen (dobj)
way this (det)
preserved while (mark)
review data (dobj)
attenuated activation (dobj)
post endoscopic (dep)
% indeed (advmod)
palsies ipsilateral (amod)
dose bupropion (nmod)
associated sulindac (nsubjpass)
variables laboratory (compound)
injection dph (compound)
patients rhythm (nmod)
disease transplantation (nmod)
were lesions (attr)
$ROOT$ administered (sent)
tinnitus from (case)
drug chemical (conj)
reversal normal (nmod)
injected day (nmod)
filaments myosin (amod)
prophylaxis recurrence (nmod)
dwi ) (punct)
questions the (det)
given diethylnitrosamine (nmod)
ng/dl ) (punct)
elicited psychosis (dobj)
noticed we (nsubj)
animals ilk/liver-/- (amod)
carbamazepine and (cc)
deposits capillary (amod)
torr 86 (nummod)
compare dogs (nmod)
presents form (nmod)
put took (conj)
timolol of (case)
$ROOT$ consume (sent)
$ROOT$ pharmacodynamics (sent)
undergoing beginning (conj)
ax for (case)
justified that (mark)
week with (case)
sample collected (acl)
play promote (xcomp)
patients hypotension (nmod)
moderate-dose ( (punct)
associated use (nsubjpass)
therapy choice (nmod)
experiment in (case)
dyskinesias pd (nmod)
subcellular and (cc)
form release (compound)
patients lost (acl:relcl)
conclusions authors (nmod:poss)
aggravation a (det)
metoprolol between (case)
stabilized randomized (conj)
cleared completely (advmod)
mea array (appos)
reversible that (nsubj)
underwent cycles (dobj)
nephrotoxicity : (punct)
known interact (xcomp)
had showed (conj)
width cortex (compound)
response humans (nmod)
analyses imunohistochemical (amod)
potentiated hyperactivity (dobj)
affect safety (dobj)
hypoactivity frontocortical (amod)
giving drugs (dobj)
crisis septicemia (nmod)
trial azelastine (nmod)
carcinogens by (case)
alterations molecular (amod)
mechanism and (cc)
greater p (nmod)
specimens two (nummod)
importance of (case)
associated volumes (nmod)
sle acid (appos)
incidents more (amod)
read protocol (nmod)
decrease uptake (nmod)
associated heroin (nmod)
volunteers nine (nummod)
finished medications. (dobj)
dosed settings (nmod)
products containing (acl)
micrograms 50 (compound)
tumours histiocytic (amod)
ceased implemented (conj)
not clinically (advmod)
occurred reduction (nmod)
increases mup (nmod)
suggest contractility (nsubj)
injury glomerulosclerosis (conj)
find relation (dobj)
histology , (punct)
cigarettes day (nmod)
unaffected expression (nsubj)
accumulation in (case)
interval 2.5 (appos)
use intramuscular (amod)
used diltiazem (nsubjpass)
implicated observed (advcl)
23 out (advmod)
adducts 4hne (compound)
cristae mitochondrial (amod)
ameliorates hydroxytyrosol (nsubj)
reported discussion (dep)
1.59 1.31 (dep)
antibacterials the (det)
response age-related (amod)
neonates 10 (nummod)
1ug ) (punct)
examined experiences (dobj)
cases helpful (acl:relcl)
role their (nmod:poss)
connects integrins (conj)
effect induction (nmod)
epinephrine and (cc)
increases morbidity (dobj)
2.9-fold either (nmod)
resolve months (nmod)
found out (compound:prt)
hematomyelia of (case)
correlated number (nmod)
lignocaine % (compound)
sustained rtms (nmod)
cases other (amod)
f/azepine-5-carboxamide s-(-)-10-acetoxy-10,11-dihydro-5h-dibenzo/b (compound)
allowed use (nsubjpass)
causes resistance (dobj)
followed hyperprolactinemia (nsubjpass)
had potency (dobj)
extract virgaurea (compound)
battery a (det)
produce toxicities (dobj)
cessation since (case)
paid attention (nsubj)
25mg/kg min (appos)
increases behavior (dobj)
reduction worsening (conj)
drug than (cc)
reduction percent (amod)
decreased putamen (nmod)
discontinued when (advmod)
highlight role (dobj)
able since (mark)
useful therapy (nmod)
tubules renal (amod)
similarities clinical (amod)
interval % (appos)
dox alone (advmod)
prevented decrease (dobj)
cpa/ee versus (cc)
hypertrophy and (cc)
phosphokinase concurrent (amod)
comparing paclitaxel (dobj)
receptors b1 (compound)
effect sex (nmod)
received total (nsubj)
pacemaker implanted (amod)
patients meningioma (compound)
time that (det)
suggest we (nsubj)
made nucleus (nmod)
mini-pump an (det)
claimed ameliorate (xcomp)
testing after (case)
mcc ( (punct)
therapy administered (amod)
kinase troponin (conj)
reacts thus (advmod)
uiu/ml and (cc)
studies long-term (amod)
worsened . (punct)
repeated determination (nsubjpass)
decrease substantial (amod)
ng/ml . (punct)
option prevent (acl)
role mechanisms (nmod)
secretion vasopressin (nmod)
= 31 (dobj)
terminate dysrhythmias (dobj)
moving while (mark)
patient group (nmod)
chromatography liquid (amod)
uncommon disorders (nsubj)
widely and (cc)
application on (case)
transplantation hsct (appos)
postulate case (nmod)
median from (case)
exceed neonates (nmod)
pool a (det)
conclusion prevent (dep)
beats/min sustained (amod)
reversibility use (nmod)
injury dysfunction (conj)
regimen an (det)
potentiate levofloxacin (nsubj)
thickness optic (amod)
arabic with (case)
understand utility (dobj)
tissues biopsy (compound)
stimulation dyskinesias (nmod)
none four (nmod)
rates 2008 (nmod)
deformities fractures (conj)
titer antibody (compound)
lower patients (nmod)
tested conditions (nmod)
gls ) (punct)
performed comparing (advcl)
prevent p (nsubj)
increases estrogen (nsubj)
signs behavioral (amod)
fluency not (neg)
0.086 0.021 (conj)
attenuates regulation (nsubj)
mg/kg 8 (nummod)
type contraceptive (nmod)
occurred toxicity (nsubj)
mirrors . (punct)
sub-regions cortices (conj)
syndrome neuroleptic (amod)
introduction occurs (appos)
hypertension girl (nmod)
improved fluoxetine (nmod)
distress rash (conj)
schizophrenia type (compound)
increase whether (mark)
showed ; (punct)
became postoperatively (advmod)
assessed scans (nmod)
liver or (cc)
ng 2.6 (nummod)
% haloperidol (conj)
investigated results (conj)
dg-5128 mg/kg (appos)
treated ee (nmod)
potentials late (amod)
shelf received (acl:relcl)
extension block (nmod)
exert and (cc)
accuracy the (det)
developed losartan (nmod)
set further (advmod)
lower aggregation (nsubj)
guide patient (nmod)
continued had (conj)
0.15+/-0.03/h ) (punct)
use regarding (case)
determinations fraction (compound)
challenge anticholinergic (compound)
transaminase glutamate-oxaloacetate (compound)
fluorescein intravenous (amod)
schizophrenia first-episode (amod)
evident day (nmod)
scores vas (compound)
due were (cop)
prescribed when (advmod)
developed : (punct)
three than (quantmod)
cr(edta of (case)
increase similar (amod)
resulted dysfunction (nsubj)
effect fluphenazine (nmod)
33 patients (nmod)
11 1 (compound)
concentrations portal (amod)
detected could (aux)
modulation attentional (amod)
colliculus 6/8 (appos)
higher microsomes (nmod)
helpful diagnose (ccomp)
taking vpa (dobj)
tested animals (nsubjpass)
loss administration (nmod)
symptoms acute (amod)
maintaining level (dobj)
investigated hemoglobin (nsubjpass)
levels ce (compound)
rare % (nmod)
sex use (conj)
mediated receptors (nmod)
beta-enac subunits (dep)
changes brachial (amod)
carry pravastatin (nsubj)
shows report (nsubj)
caused : (punct)
ems and (cc)
interviewed personally (advmod)
exhibited rats (nmod)
c than (case)
anticipation spatial (amod)
cause potentially (advmod)
disorder or=3.299 (dep)
showed densitometry (nsubj)
increase hepatocarcinogenicity (dobj)
happens glomerulus (nmod)
$ROOT$ mediate (sent)
resulted discontinuation (nsubj)
syntheses compound (nmod)
differ obviously (advmod)
reported hypoplasia (nsubjpass)
death on (case)
indicate type (dobj)
znso(4 with (case)
hcfc 123 (nummod)
dismissed . (punct)
exposure systemic (amod)
ingestion caffeine (compound)
community the (det)
change parameters (nmod)
pmol 5.458 (nummod)
14 patients (nmod)
signs . (punct)
treated sacrificed (conj)
discontinued rapa (nsubjpass)
investigate factors (dobj)
range 22.5 (nummod)
study in (amod)
induces apoptosis (dobj)
frequency predictability (conj)
accomplished , (punct)
alcohol-na withdrawal (dep)
group scopolamine-treated (amod)
remd ( (punct)
resuscitate patient (dobj)
tam of (case)
had regression (dobj)
come had (aux)
investigation agents (nmod)
enhanced had (advcl)
19/92 8 (conj)
effect insulin (compound)
wires sterile (amod)
reflect . (punct)
treated ara-c (nmod)
decreased p (nmod)
013 910+/-770 (cc)
bupivacaine ropivacaine (conj)
sensitivities seizures (nmod)
humphrey-zeiss dublin (appos)
effective regimen (nmod)
gauges ( (punct)
induced observed (advcl)
times 1.1 (nummod)
concentrations morphine (nmod)
dopamine da (appos)
mug kilogram (nmod)
time antithrombin (conj)
climate in (case)
sap<90mmhg ) (punct)
rigidity produced (acl)
k 40 (nummod)
receiving kg-1 (dobj)
control function (nmod)
factor a (det)
induced microinjection (nsubj)
ischemic haemorrhagic (conj)
resolve as (mark)
prevalences dysfunction (nmod)
reached common (conj)
found disease (nmod)
beta1 growth (compound)
switch sodium (nmod)
raised amplitude (dobj)
toxicity muscle (compound)
presentation initiation (nmod)
compared symptoms (nsubjpass)
design factorial (amod)
systems cholinergic (amod)
rr ] (punct)
mice on (case)
assigned animals (nsubjpass)
compared kidney (nmod)
bmd score (conj)
fire : (punct)
induced ssris (nmod)
% to (case)
1.63 0.39 (nummod)
observed gained (advcl)
admitted since (mark)
population factors (nmod)
plays regulating (advcl)
scopolamine antagonist (appos)
procedures gynecologic (amod)
probing responses (dobj)
markers mrna (dep)
anophthalmia = (dep)
medications therapy (conj)
inferred be (auxpass)
isomerase ) (punct)
analysis stereologic (amod)
rat li-induced (amod)
unit intensive (amod)
produced infusion (nmod)
fibrosis recurrent (conj)
safe generally (advmod)
hypertension two-kidney (amod)
ratio characteristics (nsubj)
antagonists specific (amod)
decreases ) (punct)
presented period (nmod)
identified anger (dobj)
sensitivity pain (nmod)
on'- and (cc)
augmentation production (nmod)
activate system (dobj)
cancer urothelial (amod)
patients tobramycin (compound)
fasciculations areas (nmod)
mice seventy (nummod)
induces however (advmod)
malignancy . (punct)
myocardium ventricular (amod)
limit however (advmod)
ck-mb death (conj)
induced labetalol (nmod)
counteract it (nsubj)
blockade patients (nmod)
comprised deprivation (nmod)
august 1986 (nummod)
effect vasodilating (amod)
excitability sma (compound)
discontinue can (aux)
reported although (mark)
sed 6.0 (conj)
neuropathy induced (amod)
inhibitor beta-hydroxylase (compound)
underwent manometry (dobj)
graded scale (nmod)
solutions dilevalol (compound)
study role (nmod)
levels cumulative (amod)
reduced amiloride (nsubj)
case disease (nmod)
test in (case)
occurred shifts (nsubj)
isolated venom (nmod)
area mg/l. (appos)
segment segment (nmod)
$ROOT$ embarked (sent)
predilection thrombosis (nmod)
months postswitch (dep)
(1.8)% , (punct)
increased mesencephalon (nmod)
cortices in (case)
radicals cytotoxic (amod)
aim to (mark)
prolonged min (dep)
prolactinomas % (nmod)
beclin of (case)
presents report (nsubj)
findings found (dep)
studied system (nmod)
tremors with (case)
if ( (punct)
rats months (nmod)
of not (preconj)
mg/kg injections (nmod)
relationship positive (amod)
volume cell (compound)
auc , (punct)
indicated reduced (ccomp)
overshooting force (nmod)
ach hippocampal (amod)
fs into (case)
rejection nephropathy (conj)
lasted h (nmod:tmod)
serious outcome (conj)
had cibenzoline (nsubj)
mortality encephalopathy (nmod)
bpd ) (punct)
signs ischemia (nmod)
expression as (cc)
pressure and (cc)
exposures apparent (amod)
activator as (case)
modulating and (cc)
head " (punct)
usage and (cc)
group minimum-type (amod)
ratios estimate (appos)
rash vasculitic (amod)
37 3 (quantmod)
examined periodically (advmod)
effect one (nummod)
actions l-dopa (nmod)
interleukin 3 (nummod)
sensitivity % (appos)
thrombosis vascular (amod)
level increased (amod)
drugs potential (nmod)
decreased mg. (dep)
hg variable (nmod)
found inhibit (ccomp)
prolong may (aux)
effect l-dopa (nmod)
asymptomatic discontinued (advcl)
mv/s 24 (nummod)
= 20 (dep)
episodes anuria (nmod)
mbp and (cc)
later min (nmod:npmod)
effects supply (nmod)
aggressiveness of (case)
effect methadone (nmod)
trials clinical (amod)
criteria was (cop)
death or (cc)
show sss (dobj)
disappearing were (advcl)
tasks learning (nmod)
calculated parameters (nsubjpass)
functions learning (dep)
intervenes that (mark)
20 served (acl:relcl)
syndrome rls (appos)
standard- haloperidol (conj)
recipients therapy (nmod)
effect obtained (amod)
1.52 : (punct)
avoided doses (nsubjpass)
stores and (cc)
failure required (acl:relcl)
edema surrounding (amod)
injected and (cc)
signs tomography (conj)
differ experiments (nmod)
trials 19 (nummod)
studied tolerance (nsubjpass)
pathogenesis , (punct)
dyskinesias disease (nmod)
using study (dobj)
worsening feeling (nsubj)
polymyositis myopathy (conj)
course behaviors (conj)
disease due (case)
methods conducted (dep)
received she (nsubj)
determinations the (det)
percent sixty-three (nummod)
lack by (case)
decreased activities (dobj)
yields days (nmod)
both series (nmod)
pre-treatment metformin (nmod)
revealed change (dobj)
epo simultaneously (advmod)
substances production (conj)
duration survival (nmod)
$ROOT$ evoke (sent)
followed however (advmod)
followed encephalopathy (nmod)
calculated dose (dobj)
verapamil to (case)
inhibitor used (acl)
properties occlusive (amod)
controls macroprolactinemia (conj)
seen deterioration (nsubjpass)
paramethasone from (case)
coefficient , (punct)
cortex rats (nmod)
management optimal (amod)
aprotinin acid (conj)
34 5 (quantmod)
receiving drug (dobj)
neurogenesis granule (compound)
ratio rr (appos)
appear carboplatin (nsubj)
suffered patient (nsubj)
examined have (aux)
elevated titer (nsubj)
desmethylimipramine i.v. (compound)
fzp between (case)
purpose : (punct)
agoraphobia in (case)
cpb ) (punct)
c dietary (amod)
responses dose-dependent (amod)
evaluated extent (nsubjpass)
similar profiles (nsubj)
neoplasia sarcoma (conj)
< ( (punct)
combined methotrexate (nmod)
frequently am149 (nmod)
metaiodobenzylguanidine analog (appos)
administered ml (dobj)
neurogenesis cell (compound)
larger significantly (advmod)
show develop (ccomp)
irradiation cranial (amod)
period daytime (compound)
seizure electrographic (amod)
enhanced results (nsubj)
way we (nsubj)
tetany arrest (nmod)
differ effects (nsubj)
developed exposure (nmod)
sub-regions different (amod)
p-coumarate of (case)
intensity peak (amod)
pneumonitis , (punct)
be benefit (nmod)
spect [123i]ibzm (compound)
diagnose treat (conj)
evaluation preliminary (amod)
ufh u/d (appos)
lv ) (punct)
manifestations of (case)
controlling % (nmod)
accompanied were (auxpass)
describe patient (nmod)
development during (case)
cr > (amod)
1.0 or (cc)
recall words (dobj)
healthy taking (conj)
elevations serum (compound)
growth rats (nmod)
preinfusion min (dep)
included desvenlafaxine (dobj)
caused exposure (nmod)
interacts adr (nsubj)
improved rates (dobj)
correlate ngf (nsubj)
flutamide letrozole (conj)
timing the (det)
unresponsive ; (punct)
disability parkinsonian (amod)
doses various (amod)
rare probably (advmod)
igf-il-3 epo (conj)
blocked analgesia (dobj)
that 10 (nsubj)
activation due (case)
radiolabelling injection (nmod)
control 15/hypertension (dep)
syndrome reversible (amod)
trimester of (case)
implanted , (punct)
msg ( (punct)
prevention anemia (compound)
assay behavioral (amod)
preventing neuropathy (dobj)
baseline end (nmod)
tachycardia induced (amod)
matter the (det)
group vehicle/vehicle (compound)
march 2000 (nummod)
given dose (advcl)
myocardium intact (amod)
received bcnu (dep)
interacted effect (nsubj)
infusion argatroban (nmod)
study trimethoprim-sulfamethoxazole (nmod)
rare rarer (conj)
epicondyle the (det)
resistant and (cc)
share sirolimus (nsubj)
showed pathology (dobj)
suspected should (aux)
shell or (cc)
dose was (cop)
performed v2.0 (nmod)
stable is (cop)
mv/s 38 (nummod)
epinephrine combination (conj)
loss . (punct)
complication major (amod)
3mg/kg stz (compound)
calculi the (det)
$ROOT$ readmitted (sent)
account effects (nmod)
surgeon treating (acl)
distribution interrupted (amod)
assay immunosorbent (amod)
= km (nsubj)
measures group (nmod)
enabled analysis (nsubj)
implications their (nmod:poss)
objectives correlate (acl)
dosages ip (dep)
increase seizures (nmod)
standard- to (case)
min 1.99 (nummod)
derivative sm-5887 (appos)
20.3 +/- (cc)
increased causing (advcl)
investigated work (nmod)
useful monkey (nmod)
den simultaneously (advmod)
axons cell (compound)
iowa and (cc)
timing adequate (amod)
assessed dose (nmod)
analysis chemical (amod)
dismutase sod (appos)
compares lidocaine (nmod)
woman received (acl:relcl)
included methods (dep)
possible cases (nmod)
7.5 or (cc)
related metoclopramide (nmod)
dysfunction erectile (compound)
needed are (auxpass)
mask a (det)
syndrome similar (amod)
contribute phenacetin (nsubj)
peak te (compound)
d-glucose of (case)
eight two (compound)
behavior patient (nmod:poss)
prevented dose (nsubj)
cells donor-derived (amod)
patients 4.7 (nummod)
concentration reported (acl)
amount , (punct)
exerts instilled (advcl)
marker is (cop)
suggesting potentiate (ccomp)
status health (compound)
assessment ratings (conj)
therapy acid (compound)
follows tests (nsubj)
hbsag ) (punct)
ng./ml 4 (nummod)
potent isomer.6 (nmod)
months 2.7 (nummod)
loss months (nmod)
percentage significant (amod)
sulfate with (case)
antibody platelet (compound)
hr totp (dep)
conditions pathological (amod)
demands and (cc)
reduction odds (nmod)
effects pilocarpine (nmod)
ulcers stress (compound)
case % (appos)
testing with (case)
time read (acl:relcl)
suggests complication (ccomp)
mmhg 126 (nummod)
rate by (case)
exceed , (punct)
administration unit (nmod)
evaluated potential (dobj)
drugs psychotropic (amod)
infection mice (nmod)
treated courses (nmod)
basal compared (case)
nicotine mg/kg (dep)
mg/m2 50 (nummod)
pneumonia mononucleosis (appos)
function systems (nmod)
cardiotoxicity such (amod)
specimen surgical (amod)
15-f(2t)-isop of (case)
presented loss (nmod)
proposal impaired (ccomp)
7.4 +/- (cc)
loss seizures (nmod)
support transfusion (compound)
exhibits dominance (nsubj)
worsen does (aux)
mg/m(2 1,000 (nummod)
$ROOT$ monotherapy (sent)
$ROOT$ amelioration (sent)
response . (punct)
ranged 3.32 (nmod)
adolescent receiving (acl)
decided trialists (nsubj)
had responder (nsubj)
reduction significant (amod)
implicated antimicrobials (nsubjpass)
rofecoxib were (cop)
11.7 2.1 (conj)
rcts fifteen (nummod)
but cause (nmod)
targeted is (auxpass)
exacerbates ketamine (nsubj)
tissues bbb (nmod)
obtained intervals (conj)
engraftment of (case)
rats have (acl:relcl)
structures spinal (amod)
doxil ; (punct)
abnormalities extreme (amod)
developed syndrome (dobj)
nephrotoxicity experimental (amod)
treat anemia (dobj)
vulnerability and (cc)
26 and (cc)
crf no (det)
continue therapy (dobj)
glycopyrrolate , (punct)
followed-up treatment (nmod)
shown background (nsubjpass)
presentation a (det)
concentrations matter (nmod)
enhancement gadolinium (compound)
acetaminophen- tetrachloride- (conj)
stage highest (amod)
activity nsclc (nmod)
element alterations (nsubj)
increased maintained (conj)
inhibitor mtor (compound)
described effects (dobj)
minimised occur (advcl)
tool analysis (nmod)
strain second (amod)
efficacy symptoms (nmod)
27 45 (conj)
volume mean (amod)
hypertension nomega-nitro-l-arginine (compound)
droperidol dose (compound)
failure autonomic (amod)
day schedule (nmod)
db 0.50 (nummod)
periphery the (det)
combination new (amod)
evaluable remission (nmod)
reactivator combinations (conj)
experience to (mark)
receptor for (case)
cacl2 nahco3 (conj)
given and (cc)
caused syndrome (dobj)
considered ascribing (advcl)
% plus (cc)
weeks 32 (nummod)
hbig intramuscular (amod)
release lines (nmod)
gamma-gt ) (punct)
manage dosing (dobj)
address and (cc)
reported association (nmod)
exhibited mice (advcl)
diameters/bw lv (compound)
simple safe (conj)
incidence dose-dependent (amod)
changed subsequently (advmod)
test lymphokine (compound)
causes infusion (nsubj)
side-effects paradoxical (amod)
agitation malnutrition (conj)
mrna of (case)
desire orgasm (conj)
expected moreover (advmod)
achieved he (nsubj)
attenuated glibenclamide (nmod)
proliferation induced (acl)
solution stable (amod)
fell resistance (nsubj)
treatment infants (nmod)
interferon of (case)
emphasizes need (dobj)
approximate . (punct)
treatment captopril (compound)
evidence jj (nmod)
17.5 3.8 (conj)
rate elevated (amod)
flushing room (nmod)
frame during (case)
rpgn ) (punct)
old than (advmod)
analysis light (amod)
alterations to (case)
hydrochloride compound (compound)
diagnosis hypertension (nmod)
hcv ( (punct)
possiblility the (det)
protection to (case)
15/htn ( (punct)
metabolism responses (nmod)
mice swiss-webster (amod)
pauses these (det)
mexiletine placebo (conj)
none likely (amod)
taken be (auxpass)
anoxia in (case)
suspected cancer (xcomp)
rater , (punct)
lesion development (conj)
polymerase poly(adp-ribose (compound)
treating hypotension (dobj)
deciliter per (case)
disease disseminated (amod)
prevents growth (dobj)
host immunocompromised (amod)
prevented topiramate (nsubj)
interleukin and (cc)
pgads ; (punct)
enlarged , (punct)
authors report (nmod)
procedure anesthetic (compound)
appearances between (case)
defect due (amod)
feel we (nsubj)
interact to (mark)
trained non-trained (conj)
developed however (advmod)
confirmed echocardiography (nmod)
50 500 (conj)
mg/m(2 ccnu (nmod)
tissue isolated (amod)
thp with (case)
stress and (cc)
temperature , (punct)
selected concentrations (nsubjpass)
microinjection nigra (nmod)
monitoring treatment (nmod)
occurred aki (nsubj)
exert did (aux)
cytology urinary (amod)
satisfaction treatment (compound)
important interactions (nsubj)
ameliorate blockade (nsubj)
di- tri- (conj)
granulocytes the (det)
if mic (conj)
women 59 (nummod)
amount size (conj)
seizure tonic (amod)
dose muscle (nmod)
expression pathway (nmod)
4 < (advmod)
anemia nausea (conj)
injection 1 (nummod)
reduced species (dobj)
play biosynthesis (nmod)
hypertension chronic (amod)
potentiate facilitate (conj)
showed users (nsubj)
preserves and (cc)
= 42 (dep)
context trials (nmod)
started complemented (conj)
39 of (advmod)
assess effect (dobj)
may dec. (conj)
modifiable are (cop)
sympathectomy transthroacic (amod)
drugs nonaspirin (amod)
0.59-mg or (cc)
reduce fentanyl (nsubj)
inhibition circulation (nmod)
receptor (gaba)-a (compound)
edema flash (compound)
increase tropicamide-induced (amod)
defined points (nmod)
lovastatin with (case)
remains triad (nsubj)
tsh ( (punct)
erythroblastocytopenia induced (acl)
became recently (advmod)
regulation receptors (nmod)
complication dehydration (nmod)
administration careful (amod)
19 2 (conj)
amplitude nerve (compound)
microg/kg ( (punct)
metabolism tryptophan (compound)
caused underwent (parataxis)
$ROOT$ viewed (sent)
gamma hours (nmod)
anesthesia for (case)
s ) (punct)
suggests related (ccomp)
significant medication (nmod)
fetuses from (case)
phn of (case)
extend thus (advmod)
rate response (conj)
yrs < (amod)
skeptical practitioners (nsubj)
$ROOT$ differences (sent)
ps of (case)
states stimulation (conj)
bladder increase (appos)
countries most (amod)
performance mepivacaine (nmod)
sodium divalproex (compound)
protocol " (punct)
prochlorperazine administered (acl)
syndrome ns (appos)
cisplatin fixed-dose (amod)
findings important (amod)
lidocaine- cocaine-kindled (conj)
related closely (advmod)
mda plasma (compound)
decrease values (nmod)
complications unexpected (amod)
group evaluations (nmod)
measured beginning (nmod)
10.3 ; (punct)
necessary is (cop)
wk over (case)
acid agonist (appos)
management during (case)
cells ccr2 (compound)
individuals infected (amod)
19.2 +/- (cc)
comparing subgroup (dobj)
d 8.00 (nummod)
weeks within (case)
absence atypical (amod)
= pco2 (nsubj)
indicate contrast (nmod)
center self-report (compound)
improved ( (punct)
ultrafiltration ultracentrifugation (conj)
effect effect (nmod)
subjected 2 (meta)
ligands receptor (compound)
triggers and (cc)
neuroradiologists by (case)
activity hindlimb (compound)
caused death (nsubjpass)
concentrations corresponding (amod)
percentage brain (nmod)
thromboemboli with (nmod)
once-daily twice-daily (conj)
cause resulted (dep)
remodelling . (punct)
dcm of (case)
receptors type (compound)
differentiated , (punct)
role mediator (nmod)
compatible hypothesis (nmod)
self-limited these (nsubj)
second the (det)
more atrophy (nmod)
effects inhibitor (nmod)
clarified must (aux)
elevated 25mg/kg (nmod)
medications anti-hypertensive (amod)
doses two (nummod)
diet containing (acl)
database general (amod)
ionic and (cc)
apoptotic necrotic (conj)
impairment significant (amod)
matched also (advmod)
values subjects (nmod)
effects as (cc)
lists the (det)
rise days (nmod)
prevent , (punct)
responses joint (amod)
seizures lidocaine- (amod)
seen which (nmod)
merits . (punct)
amiodarone agent (appos)
induced epilepticus (dobj)
carotenoids , (punct)
-18.48 + (cc)
approved adults (nmod)
metabolite triamterene (compound)
saline pilocarpine (nmod)
anemia is (cop)
patient pediatric (amod)
sulfate protamine (compound)
damage breaks (dep)
imply patients (nmod)
fc with (case)
6-hydroxydopamine 6-ohda (appos)
errors lower (amod)
subtests tests (conj)
169 10(9)/l (conj)
pm ) (punct)
inhibition depletion (conj)
metabolites metabolites (conj)
fractures minor (amod)
received monotherapy (dobj)
potassium normal (amod)
studies doppler (compound)
became , (punct)
1.0 and (cc)
pills second (amod)
hematuria transient (amod)
analogue novel (amod)
incidence diskinesia (nmod)
patients nondyskinetic (amod)
hallucinosis refractory (acl:relcl)
effects chronological (amod)
taken quantities (dobj)
war nuclear (amod)
led differ (advcl)
levodopa agonists (conj)
profiles paradigms (nmod)
monkeys mptp-treated (amod)
results major (amod)
complaints pressure (nmod)
sclerosis glomerular (amod)
testing dse (compound)
improved scores (nsubj)
reduction further (amod)
frequent but (cc)
induce systems (dobj)
recognition drinkers (nmod)
evoked dce (nmod)
colitis . (punct)
weight mg/kg (compound)
available not (neg)
tt ( (punct)
characterize employing (xcomp)
injection week (conj)
repaired completely (advmod)
happiness ) (punct)
alleviated but (cc)
disorders use (conj)
3.5 - (punct)
regulation the (det)
$ROOT$ continues (sent)
20 ) (punct)
seizures sprouting (conj)
model second (amod)
treated paracetamol/day (nmod)
induce symptoms (dobj)
humor aqueous (amod)
recorded were (auxpass)
experience limited (amod)
value obtained (conj)
ameliorates treatment (nsubj)
% on (case)
formed , (punct)
infection pneumonia (nsubj)
trials further (amod)
isg ) (punct)
history use (nmod)
micrograms ml (nmod)
infections their (nmod:poss)
glucose in (case)
virtue by (case)
cbz by (case)
g/cm(2 ns (appos)
study multiple-dose (amod)
levetiracetam . (punct)
derangement hyperexcitation (conj)
use maternal (amod)
pressure tail (compound)
underwent implantation (dobj)
prevention vt (nmod)
approach behavioral (amod)
effects occur (acl:relcl)
effect paradoxical (amod)
jaundice his (nmod:poss)
sought objective (nsubj)
venous systemic (amod)
had changes (dobj)
abnormalities degeneration (conj)
studied period (nmod)
discussion this (nsubj)
size ; (punct)
maintains prevents (conj)
treatment ethinyl (compound)
supplement inhibitors (dobj)
amitriptyline with (case)
formation taa (compound)
infarctions pallidus (compound)
followed pattern (dobj)
td n (appos)
constitutes vancomycin (nsubj)
alf for (case)
unaltered are (cop)
neurotransmitters seizure (nmod)
pairs 44 (nummod)
scattered were (auxpass)
reports from (case)
conclude induced (ccomp)
months discontinuation (nmod)
treatment anemia (nmod)
studied records (nsubjpass)
commissure dorsal (amod)
sequencing by (case)
retention result (nmod)
referred study (nmod)
degree 1 (nummod)
mg/kg/day fk506 (compound)
elevations greater (amod)
unlikely that (mark)
ciprofloxacin and (cc)
suppression secretion (nmod)
caused fall (dobj)
higher age (nsubj)
estradiol-dependent and (cc)
6 versus (cc)
reversed changes (nmod)
neurotransmission used (acl:relcl)
lindane of (case)
1.86 +/- (cc)
foci positive (amod)
duration symptoms (nmod)
$ROOT$ licensed (sent)
stones of (case)
occurs mechanism (nsubj)
measured test (nmod)
scan head (compound)
defect postinfarction (amod)
information diagnostic (amod)
69 - (punct)
indicated remained (ccomp)
options current (amod)
antagonist aldosterone (compound)
determined protection (nsubjpass)
failed note (nmod)
maintained levels (nsubjpass)
ischemia spasm (nmod)
m(1)-selective ( (punct)
elicit infusion (nmod)
combined inhibitor (nmod)
tuberculosis of (case)
add-on an (det)
ari ( (punct)
inhibitor acetylcholine-synthesis (compound)
microm ) (punct)
mastodynia moderate (amod)
developed block (nsubj)
procedures coronary (amod)
received surgery (nmod)
insertion thymidine (nmod)
dose mg/m2 (dep)
lower 2.4 (nmod)
stimulation tactile (amod)
partial . (punct)
experiences and (cc)
profile toxic (amod)
2.5 ratio (nsubj)
connects actin (dobj)
improve which (nsubj)
correspond may (aux)
read asked (conj)
hemodialysis high-flux (amod)
cancers site-specific (amod)
prevents nephrotoxicity (dobj)
groups ( (punct)
hypothesized factor (xcomp)
differed also (advmod)
delayed was (auxpass)
patients infections (nmod)
$ROOT$ enhances (sent)
toxicity macula (compound)
inactivate that (nsubj)
induction diabetes (nmod)
challenge trihexyphenidyl (compound)
al ( (punct)
acidotic hyperglycemic (amod)
cse ) (punct)
solution dextrose (nmod)
tablet ketoconazole (compound)
metoprolol of (case)
development hepatotoxicity (nmod)
had eleven (nsubj)
catheter arterial (amod)
origin with (case)
answer to (mark)
infusion fentanyl (nmod)
ester mg/kg/day (amod)
anesthetic specifically (advmod)
increased trends (nmod)
administration patients (nmod)
heavy ex-mdma+ (conj)
reported period (nsubjpass)
5.45 , (punct)
show jumping (dobj)
age yr (appos)
poisoning for (case)
average ) (punct)
suggests disappearance (nsubj)
associated stress (nmod)
bound essentially (advmod)
sbp dbp (conj)
gliclazide glimepiride (conj)
cured or (cc)
delivers dose (nsubj)
march 24 (nummod)
8.8 +/- (cc)
onset arrhythmia (nmod)
increased levels (nsubj)
focused induces (advcl)
anuria complicating (acl)
31.85 ) (punct)
hypoglycemia apnea (conj)
days between (case)
1.0mg/kg ) (punct)
prolonged preferentially (advmod)
cefazedone mg/kg (amod)
index body (compound)
survived to (mark)
children type (compound)
developed dementia (dobj)
believed commonly (advmod)
desire intensity/pleasure (conj)
therapy ifo (nmod)
$ROOT$ published (sent)
contains . (punct)
other 108 (nummod)
correlation course (conj)
toxicity urd-related (amod)
confirm effects (nmod)
transitioned warfarin (nmod)
affinity catecholamines (nmod)
tolerance 1788 (nmod)
disease in (case)
care periconception (compound)
system phagocyte (compound)
excretion pge(2 (compound)
prerequisite evidenced (advcl)
15 , (punct)
study current (amod)
n-nitroso-n-methylurea with (case)
troublesome term (nmod)
more and (cc)
demonstrated activity (nsubjpass)
attenuates antagonism (nsubj)
ventilation prolonged (amod)
ci 1.02 (nummod)
thrombo-embolism use (nmod)
form dgc (dobj)
lesions significant (amod)
result mainly (advmod)
operations consecutive (amod)
136 % (appos)
oab ( (punct)
present syndrome (nsubj)
years of (case)
aids meningitis (conj)
determine expectation (nmod)
$ROOT$ visualized (sent)
total reactions (nmod)
) 10(-2 (nummod)
diagnosis complication (nmod)
patterns users (appos)
scale reports (conj)
prevalences events (nmod)
actin and (cc)
ototoxicity from (case)
gland of (case)
acupuncture and (cc)
help measures (nsubj)
hypnotic technique (nmod)
compounds for (case)
effective . (punct)
toxicity maternal (amod)
treatment evaluation (conj)
null beta4 (compound)
completed reached (conj)
cells incubated (acl)
a(2a n-pyrimidinyl-2-phenoxyacetamide (compound)
treated androgen (nmod)
strain host (appos)
had ci (dep)
randomized none (nsubj)
cause dysfunction (dobj)
shown elicits (ccomp)
proteinuria immunity (conj)
caspase of (case)
balance patients (nmod)
spectrum patients (nmod)
decreased infusion (nmod)
thiopental sodium (compound)
reputation safety (nmod)
effect compounds (nmod)
subjects , (punct)
monitored because (mark)
results toxicity (nmod)
indicate sensitive (ccomp)
conditions drug (compound)
caused but (cc)
monkey 10th (amod)
woman myopathy (nmod)
hypertrophy heart (nmod)
made gave (advcl)
dogs lymphoma (nmod)
genes susceptibility (compound)
% or (cc)
caused bea (nmod)
ci=1.0 ( (punct)
p<0.01 oedema (nmod)
input sites (nmod)
dosage on (case)
placed system (nmod)
received ml. (dobj)
sites various (amod)
pressure intragastric (amod)
acid b12 (conj)
conformed . (punct)
contributing failure (nmod)
labetalol nitroprusside (conj)
drugs drugs (nmod)
assay blue (amod)
rate increase (nmod)
mg/dl 20.1 (nummod)
combination antibiotic (amod)
therapy antibiotic (amod)
cardiomyopathy syndrome (conj)
isolated-hit thrombosis (nmod)
while taking (pcomp)
cm mitochondrial (amod)
mg/kg p (dep)
consequence ascites (nsubj)
rats those (conj)
lived area (nmod)
paralysis periodic (amod)
patients stones (nmod)
layer and (cc)
reported being (auxpass)
labor preterm (amod)
patients suffering (acl)
in +/- (cc)
endogenous and (cc)
telmisartan amlodipine (conj)
spots the (det)
added medication (nmod)
necrosis no (neg)
have hours (nmod)
vein from (case)
performed should (aux)
levels normal (amod)
levels chronic (amod)
supports evidence (dobj)
trimester second (amod)
learning in (case)
discharge at (case)
few . (punct)
extract wt (appos)
recurrence b (nmod)
suppression a (det)
obesity resistance (conj)
wr242511 , (punct)
assessed evaluated (conj)
9.9 , (punct)
culture cell (compound)
child 2-year-old (amod)
exhibited configuration (dobj)
developed recommenced (advcl)
indicate modified (ccomp)
smaller p10 (nmod)
tachyphylaxis . (punct)
developed although (mark)
ratio mean (compound)
order random (amod)
consequence is (cop)
required neutropenia (nmod)
ara-c high-dose (amod)
serum fluid (conj)
50 almost (advmod)
documented studies (nmod)
lr132 with (case)
allow used (ccomp)
increases as (cc)
adenosine presumed (acl)
ramh microg (dep)
evaluated animals (nsubjpass)
appeared insidiously (advmod)
year years (nmod)
sertraline placebo (conj)
gd 10 (conj)
myocytes ventricular (amod)
first caused (acl)
admitted background (nsubjpass)
infusion gtn (compound)
loading volume (compound)
years 35 (nummod)
disorder and (cc)
mechanism for (case)
benefit little (amod)
inputs visceral (amod)
programs defect (compound)
microangiopathy transplantation-associated (amod)
increasing administration (nmod)
examined globulin (nsubjpass)
pathogenesis be (cop)
generated rat (dobj)
2.14 or (cc)
caused although (mark)
level , (punct)
blockade 1-adrenoceptor (compound)
cause major (amod)
rich , (punct)
inhibited which (nsubj)
impaired function (nsubj)
injected capsaicin (nsubjpass)
status near (case)
children leukocyturia (nmod)
np or (cc)
determinant therefore (advmod)
died hemorrhage (nmod)
fit model (nmod)
resulting captopril (nmod)
rcts in (case)
shr treatment (nmod)
procedures obstetric (amod)
relaxations isoprenaline-induced (amod)
block : (punct)
chance by (case)
aki of (case)
incidence conversion (nmod)
events no (det)
dose dose (nmod)
ratio infarction (nmod)
days three (conj)
cerebellum offspring (compound)
analogs , (punct)
1.65 to (case)
associated decrease (nmod)
doses the (det)
engendered administration (nmod)
higher rats (nmod)
administrations oral (amod)
110000 200000 (conj)
therapy : (punct)
assay transferase (compound)
identified analysis (nsubj)
effective portions (nmod)
died week (nmod)
effects extrapyramidal (amod)
marker of (case)
received injection (nmod)
mg/kg p<0.01 (appos)
increased temperature (dobj)
hospitalized center (nmod)
1.55 0.54 (nummod)
eight patients (nmod)
occurring patient (nmod)
ears n=200 (nummod)
p75(ntr ) (punct)
case each (det)
renin normal (amod)
patients assigned (acl)
action bn (nmod)
reduction precurarization (conj)
success extracts (nmod)
hypertension rebound (amod)
observed ph (nmod)
death alone (advmod)
enabled withdrawal (nsubj)
hospitalization of (case)
findings study (nmod)
$ROOT$ normalised (sent)
produced scopolamine (nmod)
was s (nmod)
transport acid (dobj)
drop a (det)
induce angiogenesis (dobj)
acid glucaric (amod)
was stenosis (attr)
targets therapeutic (amod)
cck-8-se range (conj)
encourages which (nsubj)
screened that (mark)
transaminases serum (compound)
measure be (cop)
variables histopathological (amod)
subtype receptor (compound)
cisapride or (cc)
injection amphetamine (compound)
elevations with (case)
$ROOT$ equal (sent)
syndrome rs (appos)
rats 30 (nummod)
decrease parameters (nmod)
analysis real (amod)
inhibitors fibrinolysis (compound)
use : (punct)
status 2 (dep)
physician unaware (amod)
disability off-period (amod)
poison ci-921 (nsubj)
prooxidant glycate (conj)
recognized use (nsubjpass)
28 than (quantmod)
attack and (cc)
subacute , (punct)
interactions adverse (amod)
necessitated dyspnoea (nsubj)
depletion ) (punct)
observed boy (nmod)
p<0.01 ) (punct)
reduced levels (dobj)
pentobarbital mk-801 (conj)
measured 10min (nmod:tmod)
scl p (dep)
activity apomorphine-induced (amod)
increase concentrations (nmod)
showed electrocardiogram (nsubj)
temperature rate (conj)
percent 85 (nummod)
impart dosages (nmod)
revealed it (nsubj)
hyperhidrosis gustatory (compound)
derivative dibenzothiazepine (compound)
control to (mark)
drug antiestrogenic (amod)
seem fk506 (nsubj)
receptor-mediated 5ht3 (nmod:npmod)
% 0.6 (nummod)
ems six (nummod)
flow circumflex (amod)
6-ohda-lesioned and (cc)
indications to (case)
lesions brain (nmod)
action urotoxic (amod)
regurgitation manifest (amod)
derangements procoagulant (nmod)
proved . (punct)
3.4 years (nmod)
disorders neuropsychiatric (amod)
identifiers patient (compound)
$ROOT$ handicapped (sent)
sensation altered (amod)
fenfluramines the (det)
forgetting task (nmod)
taking pentoxifylline (dobj)
influence rate (nmod)
demonstrated elevated (ccomp)
pathogeneses the (det)
free . (punct)
inferior and (cc)
cardiomyopathy and (cc)
myocardium of (case)
increases increases (conj)
ncs ) (punct)
tremor arm (nmod)
offer which (nmod)
understood is (auxpass)
toxoplasmosis patients (nmod)
protect vpu (nsubj)
selected basis (nmod)
fenoldopam vasodilators (appos)
type and (cc)
administered epinephrine (nsubjpass)
hypokalemia bendrofluazide-induced (amod)
using regression (dobj)
resistance lam (compound)
has amount (dobj)
site puncture (nmod)
% 7.3 (nummod)
eliminated completely (advmod)
tended greater (xcomp)
1.67 0.75 (nummod)
detected unless (mark)
compare in (mark)
valsartan study (appos)
hs ds (nmod)
risk 2.1 (dep)
fraction group (nmod)
antioxidants non-enzymic (amod)
mg/h nimodipine (conj)
design research (compound)
5 % (appos)
receptors 5-ht (compound)
intoxications mixed (amod)
3.67 15.08 (prep)
placebo oxycodone (appos)
depletion inhibition (conj)
channel neurons (nmod)
operation the (det)
patients % (dep)
involved used (advcl)
evaluated when (advmod)
ms 45 (nummod)
signs clinical (amod)
13 patients (nmod)
% 20.4 (nummod)
ht oestrogens (dep)
dose a (det)
hypothesized : (punct)
$ROOT$ pressure (sent)
% in-patients (nmod)
group 2 (nummod)
cause infarction (nmod)
predisposed rupture (dobj)
age 38 (nsubj)
implanted annulus (nmod)
radiograph panoramic (amod)
was level (nmod)
decreased was (auxpass)
production radical (compound)
evaluated quantify (advcl)
sustained days (nmod)
grade , (punct)
fiber nerve (compound)
property and (cc)
drug the (det)
goes use (nmod)
is antagonizes (csubj)
rated were (auxpass)
nerve auditory (amod)
leads , (punct)
mediated action (nsubjpass)
g 1,500 (nummod)
complicating patient (nmod)
total a (det)
nephropathy damage (conj)
bupivacaine mg (appos)
experiments administration (nmod)
change histamine (compound)
correlation release (nmod)
alteration pathway (nmod)
treatments received (acl)
days exposure (nsubj)
inhibits methylxanthines (nmod)
ketoconazole of (case)
% ( (punct)
condition recognised (acl:relcl)
potentials , (punct)
acetaminophen by (case)
required patient (nsubj)
suggests mediated (ccomp)
regulated . (punct)
improvement eeg (nmod)
benserazide ) (punct)
isoproterenol in (case)
solvent bcnu (compound)
competing levodopa (nmod)
u/liter 769 (nummod)
pool to (case)
considered studies (nmod)
epithelium of (case)
$ROOT$ indications (sent)
cvp delta (compound)
putamen cp (appos)
cp ) (punct)
di in (case)
alterations because (case)
highlights report (nsubj)
[ ( (punct)
case rigidity (nmod)
fdc ) (punct)
aneurysms smaller (amod)
demonstration symptoms (nmod)
third fifth (conj)
pressure occurrence (conj)
reversal using (acl)
ifx ( (punct)
reduced followed (xcomp)
performed rats (nmod)
dvt ( (punct)
result supplementation (nsubj)
reduction flow (nmod)
dyskinesias ocular (amod)
exhorted clinicians (nsubj)
determined incidence (dobj)
cardiotoxic combined (advcl)
cholestasis estradiol-induced (amod)
ml serum (nmod)
methods undertook (appos)
$ROOT$ abnormality (sent)
increased rats (nmod)
mmhg < (dep)
diluents ph (nmod)
strains six (nummod)
period after (conj)
administration intrathecal (amod)
hematoma a (det)
action antihypertensive (amod)
differences clozapine (nmod)
woman 49-year-old (amod)
acetaminophen paracetamol (appos)
described given (ccomp)
reduce prevent (conj)
disorder deficit (compound)
therapy elderly (nmod)
forms erk1/2 (nmod)
resulting exposure (nmod)
toxicity : (punct)
precursor this (det)
involved effects (nmod)
$ROOT$ ought (sent)
precipitate dehydration (dobj)
muscles rats (nmod)
undergone had (aux)
hrp ( (punct)
require administration (dobj)
shown associated (xcomp)
method : (punct)
complete stressor (dobj)
reviewed score (advcl)
hiccups . (punct)
frap ( (punct)
sensitive men (nmod)
increasing production (dobj)
hepatitis type (compound)
abandoned was (auxpass)
conclude given (ccomp)
% age (nmod)
rats dosage (compound)
neuropathy sensori-motor (amod)
effective antipsychotics (nsubj)
levodopa agonist (conj)
exposed e2 (nmod:npmod)
infections fungal (amod)
wall chest (compound)
cardiomyopathy mice (nmod)
$ROOT$ exploited (sent)
derivative etodolac (nmod)
conclusion revealed (appos)
1969 95 (prep)
month cases (nmod)
limited however (advmod)
developed blockade (dobj)
observed contrast (dep)
levels aspartate (compound)
3 + (cc)
latency and (cc)
increase appearance (conj)
reports france (nmod)
psychiatry geriatric (amod)
days event (nmod)
rating for (case)
distinctive most (advmod)
designed trial (nsubjpass)
use ziprasidone (nmod)
present mdma (appos)
46.0 - (dep)
np ( (punct)
remained risk (nsubj)
instances zero (nummod)
compares risk (nmod)
call attention (dobj)
use elderly (nmod)
affected depression (nmod)
= ci (nsubj)
insufficiency and (cc)
increased replacement (nsubj)
polyneuropathy loss (conj)
hypercalcemias spurious (amod)
determined recurring (ccomp)
models seizure (compound)
patients given (acl:relcl)
svr of (case)
fall observed (acl)
breeder the (det)
medication available (acl:relcl)
antagonist dopamine (compound)
developed tumors (dobj)
chelation anticoagulant (nmod)
chromosomes for (case)
history disorders (nmod)
administered os (nmod)
zidovudine % (appos)
stressed . (punct)
asex ) (punct)
shape discoid (amod)
movements all (det)
88.1 3.8 (conj)
prevents diphenhydramine (nsubj)
effect common (amod)
increased antinociception (nsubjpass)
microg/kg/min bolus (appos)
seroconversion smokers (nmod)
reacts caa (nsubj)
undertaken investigate (xcomp)
ages through (case)
pathogenesis autoimmune (amod)
mi previous (amod)
discriminate pain (dobj)
study matched (amod)
sg ( (punct)
consistent diagnosis (nmod)
initiation , (punct)
mg.kg(-1 ) (punct)
excitation apparent (amod)
aftereffects applications (nmod)
structures targets (conj)
eating foods (dobj)
underwent 41 (nsubj)
area supplementary (amod)
exchange concurrent (amod)
viewed has (ccomp)
established pce (nmod)
have acc-9653 (nsubj)
post-exposure dosages (nmod)
study open-labeled (amod)
effect reperfusion (nmod)
recovered she (nsubj)
inhibition secretion (nmod)
use bzds/rds (nmod)
comparison disturbances (nmod)
exploration surgical (amod)
convulsants to (case)
effects reversed (acl:relcl)
administered ketoconazole (nsubjpass)
compared shr (nmod)
disorder post-transplantation (amod)
hydrochlorothiazide hctc (appos)
increased weight (nsubj)
antibody 4/heparin-reactive (amod)
lactate and (cc)
exposure sotalol (nmod)
equal mg/kg (nmod)
develop e18.5 (nmod)
increased cystitis (nmod)
suffers models (nmod)
modulator negative (amod)
myocardium jeopardized (amod)
grade size (conj)
caused weeks (nsubj)
investigated syndrome (nsubjpass)
administration bolus (nmod)
present problem (dobj)
observed evaluations (nmod)
hemisuccinate , (punct)
valdecoxib , (punct)
27 which (nmod)
dxnp and (cc)
infusion carboplatin (nmod)
yields pituitaries (nmod)
significant changes (nsubj)
developed decline (nmod)
women undergone (acl:relcl)
toxicity subchronic (amod)
carrier of (case)
observations of (case)
patients 143 (nummod)
solution caffeine-free (compound)
relationships mechanisms (conj)
inhibitor ssr103800 (appos)
micrograms monthly (advmod)
suspension timolol (compound)
controls performed (acl)
score ; (punct)
exhibited populations (nmod)
size indication (appos)
accelerate . (punct)
uiu/ml . (nummod)
questionaires version (appos)
vaccination of (case)
properties diaphragm (compound)
age < (amod)
induced d-amphetamine (nmod)
preferred ergotamine/caffeine (dobj)
venomotor ) (punct)
rare , (punct)
identified seizures (nsubjpass)
elevation camp (nmod)
latencies the (det)
complaints eyes (nmod)
increasing . (punct)
demonstrate time (nmod)
= 0.055 (dobj)
underlying injury (dobj)
seizures % (nmod)
caused decline (nmod)
data accumulated (acl)
caused re-exposure (nsubj)
rate secretion (compound)
transplanted failure (nmod)
developed treatment (nmod)
design study (appos)
$ROOT$ play (sent)
withdrawing and (cc)
requiring discontinuation (dobj)
analyses in (case)
increase should (aux)
41 twenty (compound)
microinjections bilateral (amod)
acid other (amod)
received ephedrine (dobj)
pressure weeks (nmod)
agonists dopamine (compound)
mrnas proteins (conj)
reversal : (punct)
indicating likely (ccomp)
aeruginosa pseudomonas (compound)
collected records (nmod)
interviewed patients (nsubjpass)
method described (acl)
coarctation and (cc)
keratectomy prk (appos)
amounts with (case)
maleate dizocilpine (compound)
) at (case)
yahr hoehn (compound)
dystonia " (punct)
started methylphenidate (nmod)
fla-63 , (punct)
adopted ; (punct)
links associations (conj)
cause antibiotics (nsubj)
observed continued (advcl)
done section (nsubjpass)
allergies no (det)
lhrh-a ( (punct)
clomipramine the (det)
factors leukocyturia (nmod)
revealed consistent (advmod)
arteriolar capillary (conj)
g 275 (nummod)
form coffee (compound)
taking simvastatin (dobj)
patients damage (nmod)
interrupted . (punct)
carcinomas head (compound)
site intravenous (amod)
antagonist cd-832 (appos)
3.8 ) (punct)
hepatomas of (case)
reported depletion (nsubjpass)
justification a (det)
anaesthesia surgery (nmod)
due was (cop)
results comparable (appos)
rate to (case)
1995 96 (prep)
patients diagnosed (acl)
effect that (nsubj)
iu/kg/i.v 50 (nummod)
reduction more (amod)
shown reduce (xcomp)
findings angiography (compound)
gentamicin with (case)
passed were (auxpass)
patterns isoenzyme (compound)
produce cp (nsubj)
disorder depressive (amod)
3alpha-hydroxy-5alpha-pregnan-20-one ) (punct)
arise need (nsubj)
observed thereafter (advmod)
infiltration eosinophilic (amod)
weight 2-kg (amod)
impaired highly (advmod)
estimated were (auxpass)
follow frequently (advmod)
propranolol or (cc)
injury dogs (nmod)
nitroprusside hypotensive (amod)
alpha-methyldopa of (case)
anemia (azt)-induced (amod)
period prolonged (amod)
prescribed background (nsubjpass)
pathological-process to (mark)
increasing time (dobj)
describe features (dobj)
fibers coerulospinal (amod)
trial cb (nmod)
ml(-1 ml(-1 (conj)
demonstrated reaction (nsubj)
compared use (nmod)
study in (case)
jerks strain (nmod)
thought result (xcomp)
stimuli between (case)
hit ufh-related (amod)
injection before (advmod)
requires feasible (advcl)
representing cycle (dobj)
reported literature (nmod)
questions use (nmod)
used generally (advmod)
panel and (cc)
major intracranial (conj)
conjunction corticosteroids (nmod)
cornu left (amod)
women with (case)
mj ) (punct)
had mortality (dobj)
triniol ( (punct)
proliferation regions (nmod)
lactate mice (nmod)
84 28 (conj)
angioedema alone (advmod)
hyponatremia : (punct)
hypotension clinically (advmod)
fish and (cc)
response dynamic (amod)
biopsy ( (punct)
depression in (case)
2.5 1.3 (conj)
some consequences (nmod)
course perioperative (amod)
vessel small (amod)
induces changes (dobj)
ecstasy cannabis (conj)
advised . (punct)
cpap of (case)
program transfusion-chelation (compound)
decreased manner (nmod)
rats rats (nmod)
entities diverse (amod)
cytological and (cc)
given halothane (dobj)
map after (case)
8/8 ( (punct)
limited year (nmod)
glomerulosclerosis adult (amod)
respects in (case)
pvn and (cc)
leak capillary (compound)
halothane , (punct)
measurements sodium (nmod)
blonquist al. (dep)
test aeroallergens (nmod)
diluents methotrexate (compound)
4,957 vs. (cc)
lowering by (case)
ascribed may (aux)
due hepatitis (nmod)
o2- rats (nmod)
admissions from (case)
proved (-)-baclofen (nsubj)
analyzed work (nmod)
suggest suppresses (ccomp)
nephrotoxicity during (case)
range 79 (appos)
decreased calcitonin (nsubj)
warfarin antagonist (compound)
deviation intervals (nmod)
licensed ribavirin (nsubjpass)
experienced strokes (dobj)
formation epithelioid (amod)
effects attributed (acl:relcl)
dysfunctions confounding (amod)
11/57 vs (cc)
speed processing (compound)
vary . (punct)
diminished side (nmod)
information obtained (acl)
exposure azathioprine (nmod)
failed ability (nsubj)
processes developmental (amod)
administration ip (amod)
cases most (amod)
62 about (advmod)
eliminated evaluation (nmod)
dysfunctions cognitive (amod)
death toxic (amod)
min , (punct)
inhibition in (case)
receiving , (punct)
increase hypotension (dobj)
disappeared mj (nsubj)
interval 11.6 (appos)
discussed circumstances (nsubjpass)
patient epileptic (amod)
0.086 +/- (cc)
p n (conj)
infrequent nephrotoxicity (nsubj)
motility control (nmod)
reported abnormalities (dobj)
function performance (conj)
magnitude associated (advcl)
reducing exposures (dobj)
caused agent (nmod)
inappropriate was (cop)
models coefficient (compound)
$ROOT$ 26- (sent)
values pre-hypotensive (amod)
administration injection (nmod)
treat we (nsubj)
polymorphic . (punct)
developed hemianopsia (dobj)
movements dyskinetic (amod)
inhibitor clarithromycin (nsubj)
parkinsonism for (case)
cases esrd (nmod)
influx the (det)
analyse database (nmod)
decreased micturition (nsubj)
treatment hemisuccinate (compound)
secondary use (nmod)
measured changes (nsubjpass)
surgery/radiotherapy following (case)
doses p=0.0001 (parataxis)
sedionbel ) (punct)
mg. ( (punct)
system ligand (compound)
irrespective history (nmod)
angiogenesis estrogen-initiated (amod)
occlusion aortic (amod)
time admission (nmod)
antiretroviral lamivudine-containing (amod)
rule the (det)
triggered adding (advcl)
converted rapidly (advmod)
occurred early (advmod)
mg atropine (compound)
resolved withdrawal (nmod)
antibody antibody (appos)
uptake injection (nmod)
induced serving (advcl)
cell-mediated t (nmod:npmod)
interfere . (punct)
tests biochemical (amod)
auc c(max (conj)
assessed b. (punct)
microinjection acid (compound)
mg sch (compound)
cis-platinum adriamycin (conj)
tm the (det)
remains infection (nsubj)
esters of (case)
probable neurotoxicity (nsubj)
checklist abc (appos)
extract mg/kg (appos)
thresholds pain (compound)
changes electromyographic (amod)
excellent applying (advcl)
> 0.05 (dep)
myopathy severe (amod)
bpa ) (punct)
seizures hydrochloride-induced (amod)
area cortical (amod)
used but (cc)
emerged marker (nsubj)
confined when (advmod)
sufficient whether (mark)
implanted subcutaneously (advmod)
fasciotomies urgent (amod)
mechanism intoxication (nmod)
provide achieved (advcl)
access(r with (case)
showed oils (nsubj)
wk 4 (nummod)
amns and (cc)
treatment medical (amod)
< 0.00001 (dobj)
reactions cardiac (amod)
given tests (dobj)
group placebo (amod)
circulations in (case)
involve that (mark)
maintained eyes (nsubj)
type debrisoquine/sparteine (compound)
ng./ml between (case)
11 6 (quantmod)
49 7 (compound)
types in (case)
period peripartal (amod)
anemia menorrhagia (nmod)
confounding bias (conj)
induced rtms (nsubj)
involved especially (advmod)
obtained after (mark)
scored 0 (nmod)
level dose (compound)
treated losartan (nmod)
mutations lam (compound)
mg/kg/day were (cop)
viracept inhibitor (compound)
points role (nmod)
events following (amod)
iii . (punct)
effects depression (conj)
amphetamine mk-801 (conj)
stopped drug (nsubjpass)
$ROOT$ shifts (sent)
elevated it (nsubj)
31 +/- (cc)
treated : (punct)
arabinoside high-dose (amod)
clozapine and (cc)
explore levels (dobj)
activation polymerase (nmod)
indicates lack (nsubj)
sensitization central (amod)
greater were (cop)
accident and (cc)
noted had (conj)
reduction tissue (nmod)
mother the (det)
mice crea (appos)
size aneurysm (nmod)
quantitative qualitative (conj)
responses stimuli (nmod)
reduce might (aux)
late day (nmod)
myocardial , (punct)
apoptosis puromycin (compound)
sites the (det)
october to (case)
prevention complication (nmod)
values calcium (compound)
spike , (punct)
cases four (nummod)
complication associated (acl)
shown efficacy (dobj)
affected synthesis (nsubjpass)
prevention loss (nmod)
mic , (punct)
index levels (conj)
ketamine receptor (compound)
used although (mark)
mo next (amod)
l-alpha-gfc ( (punct)
gamma-hch pentylenetetrazol (conj)
antibiotic clarithromycin (appos)
suffering damage (nmod)
familiar some (nmod)
scores behaviors (compound)
adl england (compound)
patient bone (compound)
syndrome latter (amod)
tap ) (punct)
obtained previously (advmod)
entropion mechanical (amod)
exposure s-23121 (nmod)
decreased ecstasy (nmod)
excluded contribution (nsubjpass)
step end (nmod)
closing eyes (nmod)
women all (det)
concentrations drug (compound)
altered concentration (nsubjpass)
site ) (punct)
analysis simultaneous (amod)
mechanism central (amod)
disparity such (amod)
markers all (det)
illustrates . (punct)
death outcome (nsubj)
trihexyphenidyl or (cc)
duct which (nmod)
decrease consumption (conj)
relieved deficit (dobj)
hypoventilation by (case)
quantified never (neg)
interpretation clinical (amod)
nephroureterectomy right (amod)
form hypertension (nmod)
anaphylaxis . (punct)
exhibits inhibition (dobj)
thought free (xcomp)
distribution of (case)
factor therefore (advmod)
traces memory (compound)
injections adsd (nmod)
found administration (nsubjpass)
injection route (nmod)
preventing reducing (conj)
caspase-3 and (cc)
up-regulation significant (amod)
increases greatest (amod)
test chi-square (compound)
treated captopril (nmod)
conclude alert (ccomp)
hbv and (cc)
diseases inflammatory (amod)
frequency amplitude (conj)
profile an (det)
available patients (nmod)
consider intensivists (nsubj)
revealed studies (nsubj)
diets supplemented (amod)
synthesize not (neg)
gliosis secondary (amod)
reduces sevoflurane (nsubj)
$ROOT$ documents (sent)
intake dilevalol (compound)
analyzed morphometrically (advmod)
commenced one (nsubj)
seemed higher (xcomp)
longer no (neg)
death against (case)
demographic survival (conj)
stability decreased (amod)
resistance resting (amod)
$ROOT$ patterns (sent)
antineoplastic used (amod)
change glutathione (nmod)
characteristics ibs (nmod)
accompanied was (auxpass)
mitochondrial or (cc)
nicotine saline (conj)
insufficiency resembling (acl)
rast with (case)
doses sub-effective (amod)
treatment paroxetine (compound)
syndrome rule (amod)
detected finally (advmod)
significant highly (advmod)
died to (mark)
p.o. from (case)
4.1 6.6 (nummod)
results biochemical (amod)
other nicotine (nmod)
analyzed treatments (nmod)
remained attacks (nmod)
pressure icp (appos)
anaesthetised ketamine (nmod)
candidiasis or (cc)
administered mother (nsubj)
motility symptoms (conj)
behavioral induced (acl)
23.5 ci (nsubj)
lend did (aux)
lobe to (case)
reversal loss (nmod)
models canine (amod)
considered due (xcomp)
kpa 7.1 (nummod)
induced pbe (nmod:npmod)
itchiness and (cc)
level new (amod)
all these (nmod)
unreported literature (nmod)
rates onset (nmod)
disturbances parasomnias (conj)
had younger (ccomp)
87 eps (nmod)
patients form (nmod)
knowledge the (det)
dependent consumption (nsubj)
treatment administration (nmod)
subsided and (cc)
influence cardiotoxicity (dobj)
accepted currently (advmod)
cavity oral (amod)
high because (mark)
tool : (punct)
appeared cells (nmod)
administration dup (nmod)
substrates neurochemical (amod)
sulphonate of (case)
rupture globe (compound)
given days (nmod)
treated trials (nmod)
breakdown barrier (nmod)
seizures mal (amod)
unclear unavailable (advcl)
reversed morphine (nsubj)
decrease facilitate (conj)
relationship cirrhosis (nmod)
serum collected (acl)
produced is (auxpass)
fluency phonological (amod)
1 group (nmod)
property activity (conj)
opioid with (case)
contractility uterine (amod)
also acid (nmod)
known toxicity (nsubjpass)
role hypotension (nmod)
exacerbation without (case)
hemorrhage ulceration (conj)
cases three (nummod)
correlated amounts (nsubjpass)
underwent withdrawal (nmod)
study monitor (acl:relcl)
0.4 2.0 (conj)
evaluation response (nmod)
evoked dose (nmod)
= respectively (advmod)
found objectives (nsubj)
relevant this (nsubj)
malignancies b-cell (compound)
training 10h (conj)
associated schizophrenia (nsubjpass)
different less (advmod)
59 29 (compound)
formation injury (conj)
$ROOT$ encephalopathy--19 (sent)
have 1 (dep)
34 +/- (cc)
response rats (nmod)
caused isoproterenol (nmod)
breakdown from (case)
1.5 or (cc)
classified , (punct)
acute an (det)
transplant for (case)
aniracetam ro (appos)
formulation contain (acl:relcl)
localization compound (nmod)
effect furosemide (nmod)
amplitudes teoaes (compound)
effectiveness pretreatment (nmod)
enhancement and (cc)
registered rate (nsubjpass)
tjs ( (punct)
pressure between (case)
min following (case)
3 49 (conj)
interfere cause (conj)
alter produce (conj)
withdrawal on (case)
shr pretreatment (nmod)
mm + (nummod)
engineered genetically (advmod)
h in (case)
alterations influences (nmod)
gemcitabine d15 (conj)
= 7.9 (dobj)
agonist inhibition (nmod)
confirm reduces (ccomp)
sedation during (case)
cromakalim micrograms/kg (appos)
imaging recovery (compound)
ncq436 of (case)
examinations , (punct)
pinpoint to (mark)
day across (case)
aerosol bromide (compound)
mumol/l. 10 (nummod)
received manoeuvres (nmod)
dct2 in (case)
$ROOT$ been (sent)
methotrexate and (cc)
3.86 0.80 (dep)
lesion malignant (amod)
$ROOT$ elucidated (sent)
administrated orally (advmod)
available agent (nsubj)
therapy 6-month (amod)
symptom of (case)
activity brain (nmod)
(dox)-induced doxorubicin (nmod:npmod)
beats sinoatrial (amod)
risk = (dep)
management . (punct)
sces ) (punct)
decreased p<0.01 (parataxis)
mv from (case)
specificity effect (nmod)
had depression (nsubj)
shown all (nsubj)
desire examination (conj)
normal diabetic (conj)
results reduced (appos)
option setting (nmod)
cause are (cop)
pressure ventricular (amod)
vulnerable , (punct)
= 281 (dobj)
prior injection (nmod)
assessed ; (punct)
recorded 4 (meta)
effects d2 (compound)
depletion mtdna (nmod)
responsiveness levodopa (compound)
erythematosus involvement (nmod)
compromises outcomes (dobj)
rate 1-year (amod)
dose greater (amod)
increase nor (cc)
men healthy (amod)
increasing duration (dobj)
ii iv (dep)
% 9 (nummod)
situations , (punct)
patients stage (nmod)
immunosuppression recipients (nmod)
success given (case)
effects bupivacaine-induced (amod)
lithium pilocarpine (conj)
studies assessed (acl:relcl)
worsened contrast (nmod)
auccgrp the (det)
prevented . (punct)
remained was (cop)
radicals of (case)
bdl after (case)
administered group (nmod)
had term (nmod)
months hyperprolactinemia (nmod)
administration effective (amod)
hbv-dna hbeag (conj)
nodosa of (case)
disease history (conj)
organs studied (acl)
eyes six (nummod)
treated rifampin (nmod)
rhythm and (cc)
black , (punct)
failure dysfunction (nmod)
% ci=14.2%-20.5 (nummod)
records medical (amod)
bromocriptine and (cc)
t-[35s]butylbicyclophosphorothionate of (case)
effects acute (amod)
reports and (cc)
predictors are (cop)
therapy renal (amod)
examined expression (nsubjpass)
dimorphism a (det)
mm 37.4 (nummod)
allografts treated (acl)
reactions potential (amod)
rats nephrotic (amod)
k-variant the (det)
rats mrp2-deficient (amod)
system veris (compound)
consider ; (punct)
esterases by (case)
eyes donor (compound)
persisted seizures (nsubj)
disorder ) (punct)
ph volume (conj)
1000/mm3 and/or (cc)
efficacy proarrhythmia (conj)
myopathy by (case)
cocaine or (cc)
essential not (neg)
c = (dep)
16 to (advmod)
study core (compound)
treatment chemotherapy (nsubj)
control under (case)
myoclonia administration (nmod)
require also (advmod)
val hctz (conj)
caused desensitization (nsubj)
thrombi fibrin (compound)
defect due (case)
leukoencephalopathy transient (amod)
that convulsions (nmod)
300 0 (compound)
demonstrated patients (nmod)
difference without (case)
considered rare (advcl)
90 15 (compound)
g < (advmod)
cells treated (acl)
diazepam mg/kg (compound)
increase clearance (nmod)
showed clearance (dobj)
improved globulin (nsubj)
mg 0.9 (compound)
state akt (compound)
levels 714 (nummod)
protocol to (case)
rigidity alfentanil-induced (amod)
attempt compound (nmod)
decreased accumulation (nsubj)
remedy useful (amod)
$ROOT$ debate (sent)
indicated measurement (nsubj)
secretion gland (nmod)
processes survival/repair (compound)
examination march (conj)
remains diazepam (nsubj)
t electrocardiographic (amod)
t 1/2,z (appos)
lethality low-dose-adr-associated (amod)
sensor and (cc)
died 5 (nsubj)
july and (cc)
1.56 groups (nmod)
ceased hours (nmod)
in are (cop)
applied surface (nmod)
associated headache (nsubjpass)
drugs used (amod)
hypoxemia . (punct)
diagnosed rapidly (advmod)
offered should (aux)
patients alf (compound)
children receive (acl:relcl)
congestants preparations (conj)
monitoring tobramycin (nmod)
dizziness . (punct)
chemotherapy both (cc:preconj)
diagnosis the (det)
years 1994 (nummod)
regression regression (conj)
sinusitis of (case)
failed change (xcomp)
treated zidovudine (nmod)
dose this (det)
inferior -/- (dep)
infiltration tissues (nmod)
mmol/kg 6 (nummod)
lag for (case)
neurochemistry rigidity (nmod)
culminating dysfunction (nmod)
alter treatment (nsubj)
disappointing . (punct)
cohort trial (nmod)
measurement based (prep)
from 8 (nmod)
neuroplasticity loss (nmod)
adaptation an (det)
suggests interaction (dobj)
h p (dep)
forearm over (case)
discontinuation dosage (conj)
case and (cc)
aftereffects residual (amod)
duration 9 (dep)
aspirated onset (nmod)
dependence cocaine (compound)
mid- to (cc)
had patients (nsubj)
activate to (mark)
argue . (punct)
h(3)-receptors of (case)
have form (nmod)
observation for (case)
ml/min/kg od (nmod)
shown increase (xcomp)
elevation phe-induced (amod)
28th the (det)
users radiotherapy (conj)
vnb mg/m(2 (appos)
telangiectasia formation (conj)
reported receiving (advcl)
assessment pharmacokinetic/pharmacodynamic (amod)
component , (punct)
inhibits bioactivation (dobj)
mono-infected and (cc)
ototoxicity gentamicin (compound)
lack contact (nmod)
decreased while (mark)
decreased nausea (nsubjpass)
used strategy (nmod)
rate cumulative (amod)
forming of (case)
changes structural (amod)
disrupted treatment (nsubj)
exerting protection (dobj)
severity ethanol (compound)
regimens chemotherapy (conj)
activity vagal (amod)
ranged mmol/l (nmod)
teratogenicity . (punct)
common period (nmod)
emphasis safety (nmod)
1966-january 2009 (nummod)
disintegrin , (punct)
changes day (nmod)
recognized when (advmod)
discharged who (nsubjpass)
morphine given (acl)
induced injury (nsubjpass)
detected case (nmod)
aap , (punct)
$ROOT$ uncomplicated (sent)
emerged convulsions (nsubj)
increases decreases (conj)
experiments previous (amod)
lower phase (nmod)
intensity the (det)
flurothyl bicuculline (conj)
variety remain (acl:relcl)
increased headache (nsubjpass)
treated adenocarcinoma (nmod)
greater or (cc)
carries . (punct)
develop sclerosis (nsubj)
isotretinoin drug (appos)
children younger (amod)
particles procoagulant (amod)
5-azc of (case)
observed content (nmod)
mitotic anti (amod)
reached sgk1(+/+ (nmod)
ph pc02 (appos)
level activities (conj)
azt ) (punct)
sites distant (amod)
level three (nummod)
shown activated (ccomp)
case our (nmod:poss)
effect extrapyramidal (amod)
hypertension by (case)
oral , (punct)
junction muscle (conj)
provides opportunity (dobj)
duration mg/kg (appos)
prevent allopurinol (nsubj)
illustrates derangements (dobj)
showed function (dobj)
course leukoencephalopathy (nmod)
injury axonal (amod)
retinochoroidopathy with (case)
hypothesis dependent (ccomp)
increase lesser (amod)
women cancer (nmod)
risk thrombo-embolism (nmod)
affected hus (nmod)
dox of (case)
downregulation receptor (compound)
np fm (conj)
ratios albumin/creatinine (compound)
rate because (case)
females hypothyroidism (nmod)
mmecs in (case)
dyskinesias and (cc)
reversed cholinergic (dobj)
markers classical (amod)
episodes activity (dep)
increasing suspicion (dobj)
demand myocardial (amod)
devlin et (compound)
support this (dobj)
125 500 (conj)
produced haloperidol (nmod)
patients 116 (nummod)
failure block (conj)
close identical (conj)
hypersensitivity suxamethonium (nmod)
analyses linear (amod)
cocaine opiates (conj)
content muscle (nmod)
toxicity renal (amod)
failed concentrations (nmod)
block lethality (dobj)
present report (dobj)
regimens treatment (nmod)
supply demand (conj)
graded moderate (nmod)
medium iohexol (appos)
procedure transplant (compound)
bun in (case)
administration post-training (amod)
cocaine mg/kg (amod)
thrombocytopenia effects (conj)
episode as (case)
differ parameters (nmod)
ppm 500 (compound)
administration patient-controlled (amod)
reverses drug (nsubj)
n/n=9/26 ( (punct)
improvement evoked (acl)
duct vanishing (amod)
period injection (nmod)
often as (advmod)
hypertension = (dep)
liver kidney (conj)
atorva mg/kg/day (appos)
difference regard (nmod)
persistence with (case)
interfered and (cc)
more threefold (advmod)
differences intervals (nmod)
day 25 (nummod)
obstruction atherosclerotic (amod)
treatment . (punct)
concerning pathogenesis (nmod)
involved also (advmod)
molecule cck (compound)
scores cgi-sf (nmod)
increased level (dobj)
contribute to (mark)
prevented diltiazem (nsubj)
decreased rigidity (dobj)
flaccidity anesthesia (conj)
produced delay (dobj)
repeated weekly (dep)
injury compounds (nmod)
promote can (aux)
safe effects (nmod)
eu effusions (nmod)
purpose reviewed (appos)
done exclude (xcomp)
ability maximum (amod)
aggregation is (cop)
microperfusion picrotoxin (compound)
5 controls (nmod)
pparalpha ) (punct)
dramatic most (advmod)
measures glucose (appos)
cilostazol phosphodiesterase (compound)
possible follow-up (nsubj)
reported insurance (nmod)
preference for (case)
neuropathy severe (amod)
kg-1 i.p. (advmod)
vpu or (cc)
reported similar (ccomp)
activate directly (advmod)
syndrome stimulation (nmod)
density granules (nmod)
onset action (nmod)
prevented as (mark)
experienced anaemia (dobj)
acetaminophen to (case)
prescribing by (mark)
membranes into (case)
patients 4,217 (nummod)
baseline towards (case)
antibiotics to (case)
patients seropositive (amod)
onset with (case)
effect membranes (nmod)
doses equivalent (amod)
$ROOT$ worst (sent)
phonological and (cc)
collected times (nmod:tmod)
health poorer (amod)
hepatitis resolved (acl:relcl)
using lignocaine (dobj)
ampk with (case)
revealed work-up (nsubj)
leukocyturia without (case)
alters excitability (dobj)
ctni maximal (amod)
$ROOT$ convulsion (sent)
eps to (case)
n-methyl-d-aspartate receptor (compound)
total with (case)
had improvement/resolution (dobj)
compared ethopropazine (nsubjpass)
patients hemoglobin (nmod)
possessing activity (dobj)
receptor compared (case)
included toxicities (nsubj)
symptoms positive (amod)
intolerant therapy (nmod)
paper measuring (compound)
microg/ml 6.53+/-1.45 (nummod)
fasciculation myalgia (conj)
patient comorbid (acl)
uptake decreased (amod)
recording a (det)
decrease mild (amod)
disease total (amod)
events respectively (advmod)
consuming they (nsubj)
range 99 (appos)
inhibitor maoi (appos)
content amines (nmod)
stable time (nmod)
12 10 (compound)
sc/week mg/kg (compound)
returned gradually (advmod)
release ed (nmod)
analgesics narcotic (amod)
design an (det)
rate survival (conj)
% 5.6 (nummod)
pain pelvic (amod)
nerves spinal (amod)
potentiate . (punct)
blockade h2-receptors (nmod)
produced administered (advcl)
inhibited exceeded (advcl)
onset change (nmod)
amikacin and (cc)
considered positive (xcomp)
nodes the (det)
ifs of (case)
bupivacaine levobupivacaine (conj)
arrest associated (acl)
girl 3-year-old (amod)
sjl , (punct)
hr 96 (nummod)
mainstay treatment (nmod)
variable samples (nmod)
tested here (advmod)
steroids by (case)
observed exencephaly (dobj)
dysfunction a (det)
qd a (det)
nephropathy of (case)
appeared lasted (acl:relcl)
affected analyses (nmod)
mmol/l ) (punct)
agents , (punct)
injection of (case)
v/s 0.84 (nummod)
vehicle cream (conj)
trial i. (appos)
child , (punct)
-cimetidine placebo (conj)
access intravenous (amod)
recognize seems (advcl)
effect exerted (acl)
produced fashion (nmod)
contraction dp/dt(max (appos)
hematuria macroscopic (amod)
levels afternoon (compound)
studies subsequent (amod)
event ; (punct)
injected prepartum (advmod)
surgery orthopedic (amod)
microgram.kg-1.min-1 or (cc)
had enhanced (ccomp)
shortened fpdc (dobj)
effects prostaglandin-independent (amod)
accelerate development (dobj)
incidence wales (nmod)
solicited reports (nsubjpass)
side-effect a (det)
0 ) (punct)
release , (punct)
exacerbate to (mark)
taken attempt (nmod)
bd1018 with (case)
excretion nag (compound)
mechanism colloid-osmotic (amod)
cystitis adenovirus (compound)
desipramine to (case)
emergence in (case)
cco-iv sdh-fp (conj)
prescribed is (auxpass)
given min (nmod:tmod)
predispose to (mark)
treatment dobutamine (compound)
groups cdc (compound)
hyperactivity involvement (dep)
syndrome human (amod)
sicca keratoconjunctivitis (compound)
threshold patterns (conj)
placed extraction (nmod)
right p<0.05 (dep)
ng 6 (nummod)
preserves protein (dobj)
correspondence activity (nmod)
affected ngf (nsubjpass)
dizziness fatigue (conj)
valvulopathy . (punct)
reduced destruction (nsubj)
patients risk (nmod)
had anaesthesia (dobj)
sulfamethoxazole with (case)
150 +/- (cc)
assistance period (nmod)
formation on (case)
had six (nsubj)
nanoparticle acute (amod)
show inhibited (ccomp)
events ischemic (amod)
model understanding (acl)
years 25 (nummod)
cells pericellular (amod)
reactions other (amod)
uveitis jra (conj)
greater ( (punct)
pilocarpine- acid- (conj)
acquainted interaction (nmod)
died , (punct)
cyclosporine csa (appos)
improve decline (dobj)
noted also (advmod)
similar truncated (dep)
poisoning of (case)
difference summed (amod)
pain breath (conj)
given dox (dobj)
sum elevations (nmod)
responses including (case)
expression cells (nmod)
those prescribed (acl)
potential significant (amod)
products second-generation (amod)
improving cases (dobj)
pattern model (nmod)
ph at (case)
rheumatology including (case)
has dithiocarbamate (nsubj)
cats unanaesthetized (amod)
45 to (case)
cases exposure (nmod)
control ; (punct)
movements hemiballistic (amod)
apply window (nsubj)
bw mg/kg (compound)
patients developing (acl)
promote and/or (cc)
woman 23-year-old (amod)
patients cimd (nmod)
prevented proportion (nsubjpass)
well-tolerated usually (advmod)
mg/m2 12 (nummod)
dose 600-mg/m2 (compound)
mg 2000 (nummod)
start and (cc)
including total (nmod)
palsy cerebral (amod)
lower levels (nsubj)
0.8 - (punct)
caused perfusion (nsubj)
hand the (det)
result use (nmod)
indicate harmless (ccomp)
loss neurons (nmod)
african caribbean (conj)
administered injected (conj)
created identify (advcl)
compare susceptibility (dobj)
implicated system (nsubjpass)
trial mazindol (nmod)
overcome elevating (advcl)
15.7 6.7 (conj)
increase tremor (nmod)
characteristics baseline (compound)
cause alternative (amod)
pattern hepatocellular (amod)
h either (preconj)
incidence annual (amod)
diagnosis neurological (amod)
such as (mwe)
interval ) (punct)
factors consumption (appos)
evidence ultrastructural (amod)
motor motivational (conj)
immunoglobulin of (case)
received killed (conj)
calculated time (nmod)
points range (appos)
drug one (nummod)
received clozapine (dobj)
aminoguanidine inhibitor (acl:relcl)
animals given (acl:relcl)
bbb an (det)
promoting by (mark)
measured day (nmod)
undertaken , (punct)
treatment cause (conj)
manner time-dependent (amod)
woman year-old (amod)
function mice (nmod)
seen might (aux)
presentation on (case)
caused oxprenolol (nsubj)
likely that (mark)
episodes multiple (amod)
relieved pain (nsubjpass)
igf-il-3 or (cc)
protective toxic (conj)
resumed . (punct)
hl60 in (case)
tumors associated (acl)
responses levodopa (nmod)
treated generally (advmod)
demonstrate metabolized (conj)
drugs-induced anti-epileptic (amod)
end-diastolic end-systolic (conj)
access pellets (conj)
urticaria/angioedema urticaria (nmod)
thickening skin (nmod)
blocks that (mark)
reliable parameters (nsubj)
dosage toxic (amod)
teratogenic is (cop)
discovered were (auxpass)
tolerate level (dobj)
7.44 use (nmod)
vpu ( (punct)
high be (cop)
failed observed (dep)
nystagmus reversible (amod)
occurrence patient (nmod)
precipitate thrombocytopenia (dobj)
pge(2 mpges-1-derived (amod)
terfenadine citalopram (conj)
sem 7.7 (nummod)
mobilization acid (compound)
risk nephropathy (nmod)
diagnoses seen (advcl)
combination treatment (nmod)
therapy treatment (nmod)
patients 797 (nummod)
stimuli unit (nmod)
assaults from (case)
reported compared (prep)
sensitivities the (det)
conducted were (auxpass)
saccades movements (conj)
$ROOT$ titer (sent)
sensitivities lines (nmod:poss)
carbamazepine of (case)
sensations use (nmod)
excretion hypokalemic (nmod)
metoprolol beta-ar (compound)
fibres the (det)
halothane pancuronium (conj)
pathophysiology disorders (nmod)
ci 5.6 (appos)
lesions organic (amod)
release cgrp (nmod)
plasma ) (punct)
channels potassium (compound)
glycol naoh (conj)
carried determined (conj)
suggested attributable (ccomp)
plan management (nmod)
readministration amantadine (nmod)
etiology the (det)
half-life minutes (nmod)
dysfunction lv (compound)
anesthetic the (det)
understood anaemia (nsubjpass)
dose to (case)
enzyme expression (conj)
haemorrhage sah (appos)
severity between (case)
k(+ of (case)
lethality for (case)
reviewed abstracted (conj)
gyrus superior (amod)
nsaids or (cc)
bupivacaine- , (punct)
decreased effect (dobj)
thrombi or (cc)
conducted study (nsubjpass)
removal body (nmod)
olanzapine = (dep)
irradiation postoperative (amod)
risk low-to-normal (amod)
cases severity (nmod)
level initial (amod)
cases adenocarcinoma (nmod)
alkaloid content (nmod)
260 to (quantmod)
latency measured (acl)
asthma on (case)
use treatment (nmod)
noted suggesting (advcl)
mice wild-type (amod)
les either (cc:preconj)
mechanism of (case)
prevalence despite (case)
$ROOT$ carried (sent)
suggesting state (dobj)
possibility reduced (ccomp)
cortex isom (conj)
affects therapy (nsubj)
cta immediate (amod)
neutropenia a (det)
smelling something (dobj)
occurring naturally (advmod)
study crossover (amod)
acetaminophen galactosamine (conj)
children absences (nmod)
examined was (auxpass)
cyclophosphamide agent (appos)
velocity morphological (conj)
small was (cop)
mean ; (punct)
ms 114+/-4 (nummod)
dba/2j balb/cbyj (conj)
expression sensitivity (conj)
prophylaxis treatment (conj)
glomerulosclerosis due (case)
impact glucagon (nmod)
chemotherapy , (punct)
tnfalpha ( (punct)
assessment scale (nmod)
rate ( (punct)
mg/kg/min 2 (compound)
died interview (nmod)
restricted frequently (advmod)
regained have (aux)
% 92 (nummod)
superior placebo (nmod)
causing shrinkage (dobj)
effects activity-increasing (amod)
cramps menstrual (amod)
increases anxiety (nmod)
interaction cns (nmod)
bpt ) (punct)
toxicity diphenylhydantoin (compound)
$ROOT$ reach (sent)
given initially (advmod)
included appetite (dobj)
associated thus (advmod)
thrombosis without (case)
tends incidence (nsubj)
incontinence of (case)
adolescent in (case)
problems icp (compound)
had suspected (conj)
mechanisms focus (dep)
scavengers radical (compound)
epinephrine of (case)
displayed can (dobj)
antigen factor (compound)
vasculitis fulfilling (acl)
forearm and (cc)
woman an (det)
recurrence hbv (nmod)
found specimens (conj)
abusing previously (advmod)
analyser dioxide (compound)
cinching by (mark)
loss functional (amod)
warrants determination (dobj)
register with (case)
tested cage (nmod)
susceptibility mice (nmod)
continued do (xcomp)
resulted responses (nmod)
aggravates aconitine (nsubj)
eyes nonresponder (amod)
dwi map (conj)
time optimal (amod)
ethambutol to (case)
injected rat (nsubjpass)
nightmare spasm (appos)
gabapentin of (case)
mice moving (amod)
published recently (advmod)
completed and (cc)
disorder reflux (compound)
periods 3 (nummod)
hypertrophy of (case)
reversible defect (nsubj)
component active (amod)
high low (conj)
control injected (conj)
alter mechanisms (nmod)
myelosuppression loss (conj)
protected given (advcl)
scores dyskinesia (compound)
influence hepatotoxicity (nmod)
4.6 ) (punct)
convulsant lethal (conj)
controlled hours (nmod)
nephrin of (case)
death cardiomyocyte (compound)
significant which (nmod)
dyskinesia , (punct)
diluent of (case)
prevalence in (case)
protect risk (nmod)
showed groups (nsubj)
activity more (amod)
extract , (punct)
induced determine (advcl)
months 65 (nummod)
markers in (amod)
hot-plate abdominal-constriction (conj)
sc mg/kg (compound)
bolus single (amod)
use antidepressant (amod)
depressive psychotic (conj)
exacerbations uveitis (nmod)
adjuvant safe (amod)
decreased terbinafine (nsubj)
using sutures (dobj)
attacks elevation (nmod)
sgk1(-/- with (case)
patients value (nmod)
type presence (conj)
rats cardiomyopathy (compound)
11/41 therapy (nmod)
atria mice (nmod)
node sinus (compound)
99 93 (conj)
abnormalities hemorrhages (conj)
lowered frequency (nsubjpass)
thalamus the (det)
surgeries trabeculectomies (acl:relcl)
treatment thrombosis (nmod)
transferase terminal (amod)
methods/materials : (punct)
add deprivation (nsubj)
cells mediate (acl:relcl)
= -0.99 (dobj)
animals morphine-treated (amod)
occur result (nmod)
screening men (nmod)
generated can (aux)
bpm bpm (conj)
had rash (dobj)
dysfunction accompanies (acl:relcl)
stl1 memory (appos)
activate , (punct)
use agent (nmod)
rated was (auxpass)
produced steroids (nsubj)
he she (conj)
calcium hormone (conj)
predictable was (cop)
75 in (case)
monitoring bedside (amod)
yohimbine meperidine (conj)
effect dose (nmod)
% 8.5 (compound)
limits ) (punct)
half-time the (det)
contrast by (case)
$ROOT$ reassured (sent)
benefit procedure (nmod)
taking methyldopa (dobj)
that fibrosis (nmod)
smaller mass (nsubj)
variations malformations (conj)
duration mean (compound)
alkalinization satisfactory (amod)
different swelling (nsubj)
occurred sensitivities (nsubj)
toxicity treatment (nmod)
baseline induction (conj)
protection offers (acl:relcl)
pleased . (punct)
modulation p450 (compound)
allows separation (nmod)
daily least (advmod)
reviewed refine (ccomp)
detected adducts (dobj)
gestation complications (conj)
reaction furthermore (advmod)
vp-16 - (punct)
behaviors elicited (acl)
third-generation desogestrel (dep)
system mouse (compound)
air/oxygen only (advmod)
cells white (amod)
psychologist a (det)
preparation suxamethonium (nmod)
highlight to (mark)
leukopenia i.e. (advmod)
expression sgk1 (compound)
before immediately (advmod)
used carbamazepine (nsubjpass)
developing injections (nmod)
hypothermic deep (amod)
zi ( (punct)
activity low (amod)
measured thus (advmod)
pre-existing shr (nmod)
elevated increased (conj)
follow-up years (dep)
upregulation proteins (nmod)
male ovariectomized (conj)
reduction behavior (nmod)
meat , (punct)
behavior seizures (conj)
tachy- or (cc)
hyperammonemia through (case)
produced evidenced (advcl)
cause combined (advcl)
improving aggravating (advcl)
complexity the (det)
cis-platin with (case)
transplanted been (auxpass)
$ROOT$ cells/mm3 (sent)
cyp27 the (det)
evaluable , (punct)
ich small (amod)
activation t-cell (compound)
receptor d3 (compound)
papaverine changes (conj)
worsened cases (conj)
aspect effect (nmod)
effective rosacea (nmod)
age-dependent was (cop)
iu/l ) (punct)
appears high (conj)
infarction subendocardial (amod)
divided group (dep)
depression contractility (nmod)
content reduced (amod)
abnormality the (det)
toxic and (cc)
determine identify (conj)
decrease proteinuria (nmod)
inhibitor acid (dep)
mm 1.5 (nummod)
dextromethorphan non-competitive (amod)
mice lacking (acl)
frequency microangiopathy (nmod)
stimulated mice (nmod)
arrest in (case)
action in (case)
number in (case)
guided ultrasound (nmod:npmod)
was which (nmod)
aggravate and (cc)
segment a (det)
gangrene of (case)
hemorrhaging modes (conj)
observed recording (nmod)
induction etomidate (nmod)
hyperkalemia severe (amod)
exposure microg/ml (nmod)
nh3 ( (punct)
rare disorders (nsubj)
7/8 ) (punct)
present therefore (advmod)
potentiate significantly (advmod)
micrograms hcrh (nmod)
sensitivity ) (punct)
flow of (case)
discontinuous was (cop)
amyloidosis systemic (amod)
proved recurrence (nmod)
lipids extractable (amod)
kidneys groups (nmod)
% 75.9 (nummod)
groups sham (amod)
developed induction (nmod)
increase > (dep)
seizures , (punct)
activity antidepressant (amod)
fatal possibly (advmod)
maculatum hemlock (appos)
morbidity significant (amod)
defined decrease (nmod)
oxytocics and (cc)
response startle (compound)
suffered administration (nmod)
73.6 +/- (cc)
isolation the (det)
sodium with (case)
increase the (det)
deficit of (case)
abecarnil of (case)
arrest days (nmod)
ls ) (punct)
eye for (case)
disturbances other (amod)
hypoxic who (nsubj)
protects functions (nmod)
history schizophrenia (nmod)
elicited ketamine (nsubj)
prompted authors (dobj)
subgroup patients (nmod)
administration clotiazepam (nmod)
control seizures (dobj)
blocker haloperidol (appos)
amnesia drug-induced (amod)
volume lower (amod)
delays but (cc)
conducted several (nsubjpass)
year from (case)
potentiation arrhythmia (nmod)
absence . (punct)
delirium dysfunctions (conj)
treatment amikacin (nmod)
administration hexachloro-1:3-butadiene (nmod)
nigra compacta (appos)
5.7 users (nmod)
evoked adriamycin (nsubj)
levels interleukin (nmod)
cushing 's (case)
sh ( (punct)
episode possible (amod)
$ROOT$ renoprotective (sent)
ill physically (advmod)
contained . (punct)
reported alterations (nsubjpass)
thrombosis follow (acl:relcl)
interaction drug-drug (compound)
points same (amod)
stage nephrotic (amod)
diagnosed range (dep)
l > (amod)
marker injury (nmod)
members lovastatin (nsubj)
neurotoxicity of (case)
killed injection (nmod)
observed reversion (nsubjpass)
clonazepam the (det)
receptors against (case)
% 10.3 (nummod)
problem microangiopathy (nsubj)
induced aaph (nmod)
shown trials (nsubj)
cats and (cc)
1.043 ( (punct)
dopamine-1 da1 (appos)
hyperparathyroidism of (case)
3628 257 (conj)
doses pharmacologic (amod)
heparin to (case)
encountered be (auxpass)
hospitalization longer (amod)
hypertrophy % (dep)
prevented development (dobj)
cbz ( (punct)
rotation in (case)
p300 , (punct)
administered mice (nsubjpass)
hampshire 's (case)
increased occurred (conj)
min 150 (nummod)
decrease age-related (amod)
80mg/kg/day , (punct)
purpose thought (appos)
factors associated (acl)
blood the (det)
erythrodysesthesia being (cop)
treated compound (nmod)
used models (dobj)
caused effects (nmod)
site atp-binding (amod)
effective how (advmod)
state from (case)
follows as (mark)
inhibitor net (nmod)
effective but (cc)
stage 22 (nummod)
% 7.1 (nummod)
ions calcium (compound)
tachyarrhythmias sustained (amod)
replaced carbimazole (dobj)
% when (advmod)
cavity nasal (amod)
found number (nsubjpass)
opistothonus dysfunction (conj)
administration prostigmine-morphine (compound)
association simvastatin (nmod)
serve might (aux)
pill contained (acl:relcl)
d-tubocurarine muscle (nmod)
$ROOT$ lend (sent)
achieved achieved (conj)
measured ngf (nsubjpass)
observed nephropathy (nmod)
terms confusion (nmod)
biosynthesis rna (compound)
remain cryptic (xcomp)
micturition day (nmod)
was > (parataxis)
scopolamine + (cc)
432 and (cc)
suggested investigation (nsubj)
infusions solution (nmod)
attributable that (mark)
effects convulsions (nmod)
seems fortunately (advmod)
year hospital (conj)
contaminant for (case)
ic30 ) (punct)
recall word (compound)
electromyographic combined (amod)
tissues soft (amod)
deposition . (punct)
stages and (cc)
ratings scale (nmod)
presentation ( (punct)
findings the (det)
$ROOT$ reproduced (sent)
belief the (det)
difference difference (nsubj)
catechol and (cc)
pressure of (case)
dublin ) (punct)
elicited not (neg)
age young (amod)
facilitate familiarity (nsubj)
euphoria , (punct)
diet either (cc:preconj)
alf before (case)
duration period (conj)
sensation ) (punct)
has probably (advmod)
dizziness events (nsubj)
consistent . (punct)
sparteine probe (dep)
methamphetamine mg/kg (appos)
bis , (punct)
hemorrhages rate (nmod)
decreased bradycardia (dobj)
angiosarcoma associated (acl)
cr 14/15 (nummod)
injected catheter (nmod)
immunocytochemistry by (case)
chemotherapy observations (appos)
metabolite that (mark)
age old (dep)
while range (nmod)
achieved instance (nmod)
sections interventions (conj)
elevations ctni (nmod)
mtd given (acl)
image or (cc)
received four (conj)
experiment was (cop)
said carboplatin (nsubjpass)
desmethylimipramine mug (appos)
lesions these (det)
experiments rats (nmod)
ketoconazole alone (advmod)
7-ni ( (punct)
c. degrees (compound)
reverse that (nsubj)
acts lindane (nsubj)
cross-reacting were (aux)
comparisons users (nmod)
arabic gum (nmod:npmod)
reduced normal (conj)
interpolates oct (nsubj)
c ; (punct)
3.2 5.0 (conj)
hindpaw the (det)
vehicle and (cc)
response > (dep)
used uganda (conj)
endothelial inducible (conj)
proenkephalin penk (appos)
tissues these (det)
sensitisation effect (conj)
hemisphere cerebral (amod)
curve pressure-volume (compound)
11 monkeys (nmod)
rats carcinoma (nmod)
failure such (case)
confusion cimetidine-associated (amod)
capacity patients (nsubj)
anaesthetized hypotension (nmod)
found nephritis (nmod)
electrocardiogram on (case)
birth the (det)
marker activity (conj)
ctnt extent (conj)
exhibited anticipated (advcl)
dysfunctioning receptor (nmod)
greater -21.3 (dep)
concerned are (cop)
activity during (case)
powders such (amod)
associated production (nmod)
ptra and (cc)
measured eeg (nmod)
drinking the (det)
elevated pressure (nsubj)
observed except (prep)
presents illness (dobj)
enzyme captopril (appos)
prolongation by (case)
injections caffeine (compound)
received docetaxel (dobj)
resolved generally (advmod)
anxiolysis diazepam-induced (amod)
decreased injuries (nsubjpass)
malformations of (case)
examined immunohistochemistry (nmod)
patients asthmatic (amod)
suppression azidothymidine-induced (amod)
immunosuppression de (amod)
cent 50 (nummod)
upslope and (cc)
received rofecoxib (conj)
granules many (amod)
antigen-positive nuclear (amod)
amyloidosis primary (amod)
isoproterenol mg/kg (appos)
progression . (punct)
ssri ( (punct)
enzyme tetrameric (amod)
$ROOT$ graded (sent)
a c (conj)
evaluate alters (ccomp)
effects beta-blockers (nmod)
relapse any (det)
receive days (nmod)
groups lesioned (amod)
alternative is (cop)
normal protidogram (nsubj)
months 15 (nummod)
behavior their (nmod:poss)
da da (conj)
female pregnant (conj)
paradigms two (nummod)
carbachol , (punct)
onset i.e. (advmod)
donor . (punct)
enzyme butyrylcholinesterase (compound)
update an (det)
striatum adjacent (amod)
performance group (compound)
patients area (nmod)
vasculitis cutaneous (amod)
underwent tee (dobj)
indicate influenced (ccomp)
consumption , (punct)
trials from (case)
gvg ( (punct)
induced cromakalim (nmod)
yohimbine 1.0mg/kg (appos)
mechanism damage (nmod)
virus disease (conj)
titration upward (amod)
indicated remain (conj)
administration vcm (compound)
ventilation for (case)
worsening symptoms (nmod)
ee mg/kg (appos)
activity hoe (nmod)
studied been (auxpass)
disease stable (amod)
allow . (punct)
transcripts of (case)
needed study (nsubjpass)
rescues toxicity (dobj)
administered detected (advcl)
hyperplasia epithelium (nmod)
loss responses (nmod)
yearly thereafter (advmod)
reduction one-third (amod)
regulating in (mark)
modalities the (det)
high incidence (nsubj)
610 615 (prep)
exposure 12-hour (amod)
bid ) (punct)
mechanisms postulated (amod)
which with (case)
avoiding consumption (dobj)
prevent recurrence (nmod)
ng./ml patients (nmod)
agent antithyroid (amod)
decreased q10 (nsubj)
liver of (case)
type preparation (conj)
symptoms hepatitis (nmod)
sensitive assessment (nsubj)
1 grade (compound)
identical virtually (advmod)
status her (nmod:poss)
hypoaldosteronism , (punct)
was excess (attr)
reduced modestly (advmod)
site pain (nmod)
marker diagnostic (amod)
beta-ar ( (punct)
rose level (nsubj)
11.5+/-1.4 from (case)
followed described (advcl)
alf acetaminophen-induced (amod)
caused had (conj)
apigenin mg/kg (dep)
usual more (advmod)
frequency potentials (nmod)
find . (punct)
ctni serial (amod)
1/104 ( (punct)
recorded while (mark)
species reported (acl)
shown not (neg)
patients carcinoma (compound)
system delivery (compound)
muscles cricoarytenoid (amod)
neuroblastoma active (amod)
discontinued = (parataxis)
core in (case)
mortality % (amod)
ecg patients (nmod)
have role (dobj)
occurrence complications (nmod)
kinases ( (punct)
activate induce (conj)
drug tubulopathies (nmod)
animals epinephrine-treated (amod)
vasculitis attributable (amod)
december 2010 (nummod)
noted have (aux)
loss marked (amod)
antagonism hypertension (nmod)
therapy radiation (compound)
methodology immunoassay (compound)
engine risk (compound)
= 0.72 (dobj)
days -13 (nummod)
rats sprague (amod)
pastes fireworks (conj)
demonstration this (nsubj)
warranted ecg (nsubjpass)
stroke with (case)
seizures following (case)
protocols accl0131 (appos)
eaca with (case)
interference synthesis (nmod)
presented months (nmod)
regimen warranted (conj)
received repeatedly (advmod)
wavefronts reflected (acl)
woman taking (acl)
calculated rates (nsubj)
fed diets (dobj)
condition the (det)
d-med 2 (dep)
jerks resolved (acl:relcl)
conduction done (acl)
diclofenac dcf (appos)
torr torr (conj)
mg 6 (nummod)
changes effects (nsubj)
seventy-nine hundred (compound)
effects adverse (amod)
estimated indirectly (advmod)
administration material (nmod)
prove remedy (xcomp)
effects antipsychotic-like (amod)
dexamethasone dex (appos)
test indomethacin (nmod)
university-affiliated or (cc)
associated is (auxpass)
employing blue (dobj)
decrease administration (nmod)
administered dermally (advmod)
communication . (punct)
carriers hbsag (compound)
severity strain (nmod)
defects rats (nmod)
objective setback (compound)
treated after (mark)
determined activity (nmod)
hypersensitivity by (case)
hypertension dex-ht (appos)
cirazoline , (punct)
transporters of (case)
using electroencephalography (dobj)
abundant cells (nmod)
relapsed refractory (conj)
protects reduces (conj)
exacerbated . (punct)
meq. 0.03 (nummod)
therapy doses (nmod)
areas intercellular (amod)
occurring infiltration (nmod)
reductions deviation (nmod)
dosed therapy (nmod)
62.0 32.2 (compound)
conclude result (ccomp)
contaminated to (mark)
bleeding by (case)
drug cardioprotective (amod)
96 - (punct)
capable inducing (advcl)
influence influence (conj)
blunted hypoactivity (dobj)
discontinuation its (nmod:poss)
increase weight (compound)
seen overshooting (nmod)
observed cases (nsubjpass)
erythroderma generalized (amod)
dose on (case)
binding cortical (amod)
propensity of (case)
required accumulation (nmod)
reported commonly (advmod)
d4.2 cloned (amod)
closure macular (amod)
criteria defined (acl)
suffered . (punct)
contributed haemorrhage (nmod)
characterized hypertension (nmod)
preserved tissue (nsubjpass)
pentylenetetrazole mg/kg (appos)
carotid the (det)
aptts therapeutic (amod)
segments the (det)
study ahs (appos)
cultures all (det)
segment st-t (amod)
measurements and (cc)
appear increase (nsubj)
asked and (cc)
clotting blood (compound)
was elimination (attr)
4-ene-vpa of (case)
occurring females (nmod)
measurements delivered (dep)
1 3 (conj)
antagonists mk-801 (appos)
compound treatment (nmod)
lys1 pro2,5 (appos)
acid amino (compound)
indicator be (cop)
group than (case)
angiography degree (nmod)
perfused . (punct)
induced hypertension (nsubjpass)
similar . (punct)
midline md (appos)
slowed nifedipine (nmod)
confirmed recovery (nsubjpass)
uncomplicated had (aux)
infections causing (acl)
potentiate development (dobj)
aphasia , (punct)
thrombocytopenia resolved (acl:relcl)
concentrations in (case)
encephalopathy induced (acl)
transplanted induction (nmod)
increases fev1 (compound)
significance that (nsubj)
trimester third (amod)
effects determined (dep)
immunity patients (nmod)
treated agent (nmod)
re-established was (auxpass)
neurotoxicity patients (nmod)
treatment chf (nmod)
subject healthy (amod)
animals received (acl:relcl)
stimulation rtms (appos)
exhibited mass (nmod)
5.7 0.8 (conj)
help that (mark)
changes vpa-induced (amod)
cause given (advcl)
image ( (punct)
induced dox (nmod)
potent pinacidil (nmod)
degeneration degeneration (conj)
treatment milrinone (nmod)
surgery therapy (conj)
suggested plays (ccomp)
chemotherapy leukemia (nmod)
measure geometry (dobj)
cbz chronic (amod)
thrombosis arterial (amod)
affected duration (nmod)
visit first (amod)
years 60 (nummod)
cause frequent (amod)
hydrochloride cocaine (compound)
dyskinesia dose (compound)
gyrus hippocampal (compound)
therapy fixed-dose (amod)
patients 1065 (nummod)
lysis erythrocyte (compound)
utilization associated (acl)
hepatitis toxic (amod)
model behaviors (nmod)
had reduction (dobj)
labelling regulation (conj)
assessment cardiologic (amod)
week after (case)
parkinsonism mptp-induced (amod)
i ) (punct)
supports protection (nsubj)
reach if (mark)
ldl ) (punct)
observed hyperalgesia (nsubjpass)
increases greater (amod)
0.75 - (punct)
transplanted context (nmod)
suggest associated (ccomp)
diseases or (cc)
identified total (nsubjpass)
developed developed (parataxis)
0.014-unit , (punct)
influenced agonists (nmod)
reported users (nmod)
creatinine a (det)
wsr wsp (conj)
zidovudine + (cc)
results preliminary (amod)
suffered seizures (nmod)
behavioral endocrine (conj)
determine increases (advcl)
count reticulocyte (compound)
% 9.89 (nummod)
hc ( (punct)
creatinine in (case)
presence solution (nmod)
wanted . (punct)
symptoms limit (acl:relcl)
uses potential (amod)
transferred coordinates (nsubjpass)
males age (dep)
patient ileostomy (nmod)
extension and (cc)
value +/- (cc)
reversed reduction (nmod)
half animals (nmod)
mmhg 1.3 (nummod)
usage prolonged (amod)
detected proteins (nsubjpass)
difference an (det)
microscope scanning (compound)
tropicamide to (case)
members of (case)
concentration enzyme (nmod)
hyperprolactinemia associated (acl)
stage at (mark)
15 6 (conj)
attributable dysgenesis (nmod)
identified gene (nmod)
mg/m2 from (case)
improved hours (nmod)
difference groups (nmod)
meth by (case)
quantities greater (amod)
analysis changes (nmod)
test performance (nmod)
hepatitis granulomas (nmod)
fraction resolution (conj)
agoraphobia attacks (nmod)
effective reducing (advcl)
effects observed (acl)
cat ( (punct)
shows still (advmod)
related could (aux)
active highly (advmod)
elevation st (amod)
modified modification (nmod)
secretion resting (amod)
assessed quality (dobj)
relationships and (cc)
explanation hiccups (nmod)
associated nephropathy (nsubjpass)
disorders problems (conj)
exhibited study (nmod)
tuberculosis for (case)
dysfunction with (case)
hg/ml/100 mm (compound)
types carcinoma (appos)
electrolyte ammonia (conj)
recognition early (amod)
transport hospital (nmod)
measured time (nmod)
examination tissue (nmod)
screening prenatal (amod)
inadequate when (advmod)
epilepsy human (amod)
hepatitis b (compound)
subjects human (amod)
started having (aux)
treatment clinical (amod)
acts diazepam (nsubj)
leak bbb (nmod)
allow as (mark)
lower rate (nsubj)
important monitoring (nsubj)
inhibitor this (det)
death of (case)
pain anaesthesia (nmod)
doxorubicin by (case)
enhanced may (aux)
data present (amod)
reduction small (amod)
eighteen rats (nmod)
have determined (xcomp)
lack association (nmod)
course second (amod)
model anxiety (dobj)
receptor , (punct)
hyperplasia of (case)
ovary of (case)
persisted cystitis (nsubj)
dose or (cc)
excretion iodine (nmod)
times 3.5 (nummod)
alkaloid . (punct)
migraine of (case)
ascites lipidemia (conj)
world of (case)
ablation supply (nmod)
role prostaglandins (nmod)
frequency event (compound)
morning dystonia (nmod)
is likely (acomp)
= .002 (dep)
desensitization further (amod)
6.2 +/- (cc)
males rats (conj)
tp ) (punct)
membrane cell (nmod)
leucemia with (case)
scan spect (compound)
is suggestion (nsubj)
seconds , (punct)
cancer n=94 (dep)
licensed is (cop)
drugs used (acl:relcl)
mice + (amod)
alcohol excessive (amod)
7-ethoxyresorufin-o-deethylase dependent (amod)
usage given (case)
consistent most (advmod)
group mk-801-treated (amod)
leakage membrane (compound)
n= 2 (dobj)
antibiotics as (cc)
conclude correlates (ccomp)
levels bicarbonate (compound)
managed amiodarone (nmod)
agents three (nummod)
pronounced response (nsubj)
walls alveolar (amod)
polymyositis/dermatomyositis like (case)
database from (case)
insufficiency aortic (amod)
animal both (cc:preconj)
received hour (nmod)
bradykinesia in (case)
phase oral (amod)
retested weekly (advmod)
use recurrent (amod)
re or (cc)
patients asthma (nmod)
unit an (det)
injection areas (nmod)
administration dose (conj)
number increases (nmod)
production between (case)
registry effects (nmod)
diethylstilbestrol implanted (acl)
increased history (nmod)
developed characterized (advcl)
increased 113 (nmod)
diagnosed presentation (nmod)
di- 3717 (nummod)
support notion (dobj)
alterations neither (cc:preconj)
hemianopsia homonymous (amod)
stage reached (acl)
pgads scale (appos)
mosmol/kg 410 (nummod)
trimethaphan blocker (compound)
neuroleptics ' (punct)
(-)-cibenzoline of (case)
intensity consumption (nmod)
drop wrist (compound)
pre-treatment kg(-1 (nmod)
10(-8 ) (punct)
enhance which (nsubj)
risks adjusted (amod)
give suggest (conj)
continue drug (dobj)
levels i (nummod)
cause does (aux)
captopril mg/kg (appos)
anesthesia methoxyflurane (nmod)
rare complications (nsubj)
precipitate since (mark)
monitor balance (dobj)
impair . (punct)
case results (nmod)
state all (dobj)
hypoventilation because (case)
add did (aux)
tablet one (nummod)
involves spasm (nsubj)
suitable reduction (nsubj)
thought affect (xcomp)
psychiatric or (cc)
arms open (amod)
impulsiveness sleep (conj)
disease hypertension (conj)
rates response (compound)
appear cells (nsubj)
published . (punct)
damage due (amod)
mutants the (det)
p<0.01 vs. (cc)
comparison disorders (nmod)
reduced that (mark)
reversible part (nmod)
mg/week 1 (nummod)
whether proteinuria (nsubj)
tamca mg/ml (amod)
anemia combined (amod)
tachyarrhythmias : (punct)
safer they (nsubj)
lna by (case)
cause whereas (mark)
induced amounts (nmod)
responsible alteration (nmod)
have anomaly (dobj)
rats mi (compound)
deferens uterus (conj)
response reticulum (compound)
completion following (case)
dysfunction studied (acl)
return resumed (advcl)
antagonists as (case)
brain rodent (amod)
affection and (cc)
cases lasting (acl)
irrigations picloxydine (compound)
$ROOT$ speak (sent)
cxad induced (acl)
factors including (case)
associated whether (mark)
injury membranes (nmod)
min recovery (nmod)
minor and (cc)
sr to (case)
therapy includes (acl:relcl)
delay consistent (amod)
similar as (mark)
intervenes event (nmod)
reintroduction rifampicin (nmod)
reflected was (auxpass)
methodology used (acl)
produced exposure (nsubj)
add toxicities (nmod)
hoarseness either (cc:preconj)
with disease (dep)
dropped mg/dl. (conj)
85 125 (conj)
ir ( (punct)
treatments between (case)
numbers similar (amod)
lesions sporadic (amod)
started conclusion (nsubj)
$ROOT$ medication (sent)
prognosis their (nmod:poss)
g/day ) (punct)
cc infarction (conj)
produce trigger (dobj)
aroused subjects (nsubjpass)
crisis . (punct)
composite hypotension (nmod)
products both (preconj)
exploration as (case)
increases mean (amod)
decrease . (punct)
celecoxib ce (appos)
recording of (cc)
% 7.2 (nummod)
microscopy transmission (compound)
airway the (det)
lymphopenia mainly (advmod)
regeneration rat (compound)
regimen tfl (nsubj)
pre-treatment bd1018 (nmod)
$ROOT$ supported (sent)
$ROOT$ elevation (sent)
discontinued patient (nsubjpass)
model seizures (compound)
consists that (nsubj)
renal liver (conj)
interleukin erythropoietin (conj)
predispose differences (nsubj)
experienced worsening (dobj)
chx ) (punct)
develop drug (dobj)
values % (nmod)
blind double- (amod)
diffusion-weighted dw (appos)
therapy acei/arb (compound)
ciprofloxacin of (case)
shorter mice (nmod)
stage the (det)
biosynthesis the (det)
subjected . (punct)
elevation sensitivity (dep)
woman depressed (amod)
form either (det)
cause individuals (nmod)
infusions intracerebral (amod)
anterior posterior (conj)
signals ganglia (compound)
therapy sequelae (nmod)
wr242511 8-aminoquinoline (compound)
substituted naproxen (nmod)
observed toxicity (nsubjpass)
patients included (acl)
appreciated , (punct)
performed whether (mark)
fractures children (nmod:poss)
chat on (case)
changes paraparesis (nmod)
training thereafter (advmod)
edema her (nmod:poss)
ocs ( (punct)
mitigates wherein (advmod)
peptide(1 to (case)
vacuolization arteriolopathy (conj)
administration subcutaneous (amod)
microscopy administration (nmod)
protection by (case)
increases with (case)
related suggesting (advcl)
effects prolactin (nmod)
postulated damage (nmod)
test direct (amod)
42.5 median (dep)
week first (amod)
convulsions generalized (amod)
fluid with (case)
cgrp ( (punct)
identified explain (ccomp)
compared procaterol (nsubjpass)
damage underlying (amod)
patients 75/829 (nummod)
interaction drugs (nmod)
mg./kg s.c. (appos)
produced reactions (dobj)
deficiency dihydrouracil (compound)
dextrose bicarbonate (conj)
pain elicited (acl)
sensitization nociceptive (amod)
need aware (xcomp)
potency higher (amod)
time s (appos)
group chronic (amod)
group normal (amod)
those propranolol (nmod)
% 84 (nummod)
verbal on (case)
associated anticoagulation (nmod)
nicotine more (amod)
causes brains (nmod)
determine discuss (conj)
54 9 (conj)
moran ( (punct)
bradycardic assessment (nmod)
cholesterol a-i (conj)
kidneys human (amod)
rats crl:(wi)wubr (compound)
cells interneurons (conj)
association only (advmod)
phosphate susceptibility (conj)
probe as (case)
incmnsz of (case)
fields electrophysiology (conj)
produced pilocarpine (nsubj)
licking formalin-induced (amod)
enhanced further (advmod)
$ROOT$ 0.6 (sent)
progression rhythmic (amod)
studied methods (nsubjpass)
omd ( (punct)
disease alzheimer (nmod:poss)
kinase syndrome (nmod)
correlated significantly (advmod)
occurs associated (dep)
% cr (dep)
utility glepp1 (nmod)
patient 19-year-old (amod)
have important (advcl)
deterioration report (dep)
vehicle- epinephrine-treated (conj)
nucleus nucleolus (conj)
236.9 +/- (cc)
pregnant and (cc)
infrequent background (dep)
glucose fasting (amod)
patients syndrome (nmod)
increased blockers (nmod)
prominent box (nmod)
$ROOT$ hypersensitivity (sent)
caused effect (nmod)
nkcc2 ( (punct)
pretreatment prazosin (compound)
changes markers (nmod)
observed atria (nmod)
shorter that (nmod)
closed eyes (nsubjpass)
providing efficacy (dobj)
benign they (nsubj)
memory reliable (amod)
50 30 (compound)
directions septal-lateral (amod)
potency (-)-propranolol (nmod)
propranolol nonselective (dep)
linked levels (nmod)
dose ( (punct)
background sociodemographic (amod)
randomized . (punct)
24 approximately (advmod)
infusion min (nmod)
retention better (amod)
reversibility insufficiency (nmod)
amount maintaining (acl)
institutions several (amod)
injection contrast (compound)
infants loss (nmod)
utility agonists (nmod)
treatment antithrombin (nmod)
subset children (nmod)
gemcitabine patients (nmod)
$ROOT$ increases (sent)
frequent mb (nsubj)
relaxed . (punct)
duration auc (conj)
consuming are (aux)
cssep and (cc)
enhances administration (nsubj)
exacerbated significantly (advmod)
movements in (case)
2 < (amod)
conversion cya. (nmod)
infant an (det)
nitroglycerin sublingual (amod)
hydrochloride 4-quinoline (compound)
containing concentrations (dobj)
tolerant that (mark)
effect this (det)
3.6 10(-5 (conj)
ck-mb with (case)
$ROOT$ mm (sent)
patient this (det)
showed dissolution (dobj)
release formulations (nsubj)
referred effective (ccomp)
p450s on (case)
arrest after (case)
attain , (punct)
hiv ( (punct)
deserve thus (advmod)
attenuate . (punct)
sgk1(+/+ ) (punct)
ari of (case)
study involving (acl)
smoking pregnancy (nmod)
ngf p75(ntr (appos)
$ROOT$ fits (sent)
97.1 was (cop)
line mmec (appos)
predictor that (mark)
nightmare anaesthetists (nmod:poss)
proliferation astrocytes (nmod)
paclitaxel encapsulated (acl)
action loreclezole (nmod)
effects receiving (acl)
decrease increasing (advcl)
received adr+los(12 (conj)
increased experience (nsubj)
unclear been (cop)
task rats (nmod)
anemia associated (acl:relcl)
failure tests (nmod)
pallidotomy posteroventral (amod)
thirst secretion (conj)
was determined (advcl)
returned who (nsubj)
study investigate (acl)
pms ng.ml-1 (appos)
assessment synthesis (nmod)
immersed was (auxpass)
euthyroid and (cc)
memory working (amod)
effect antiepileptogenic (amod)
distributions . (punct)
benzylpenicilloyl-poly-l-lysine bpo-pll (appos)
been had (aux)
primate mptp-treated (amod)
seen exercise (nmod)
decrease solution (nsubj)
dopamine and (cc)
effects chloride (nmod)
micrograms 5 (compound)
treated ampicillin (nmod)
treatment cis-platin (nmod)
alert increase (nsubj)
kidney remnant (amod)
injection rapid (amod)
available quinine (nsubj)
n= ) (punct)
different control (nmod)
progesterone neither (cc:preconj)
material performed (dep)
decreased number (nsubj)
responses with (case)
gland parotid (amod)
beta-subunits sodium (compound)
related this (nsubj)
metabolites three (nummod)
stabilized and (cc)
min(-1 ) (punct)
syndromes stevens-johnson (compound)
hallucinations behavior (conj)
delivered . (punct)
volunteers twenty (nummod)
valsartan combinations (conj)
delivered who (nsubj)
understanding mechanism (dobj)
saline % (amod)
decreased result (nmod)
synapses onto (case)
unmask flumazenil (nsubj)
deferens atrium (conj)
brainstem to (case)
considered abuse (nsubjpass)
water mg/ml (appos)
modalities attractive (amod)
used had (conj)
gem-p ( (punct)
long protocol (nsubj)
absence levels (nmod)
view risks (nmod)
rate estimated (amod)
unfamiliar environment (nmod)
found never (neg)
improvement failure (nmod)
determinant an (det)
p= ) (punct)
function dopaminergic (amod)
mechanism this (nmod)
levels produced (acl)
narcosis pharmacological (amod)
study eight-week (amod)
similar structurally (advmod)
changes macrophages (nmod)
produced decrease (nmod)
preventing cats (nmod)
understanding approach (conj)
mri high-resolution (amod)
development c. (nmod)
describes toxicity (dobj)
next very (advmod)
metabolised way (nmod)
none cows (nmod)
appears vasoconstriction (nsubj)
incidences of (case)
factor arrhythmia (nmod)
verbal or (cc)
revealed concentration (dobj)
6-ohda-lesioned l-dopa+benserazide (dep)
infused rate (nmod)
models responses (nmod)
35 6 (compound)
anatomy the (det)
correlated adequate (conj)
consideration an (det)
contribute prostanoids (nsubj)
degeneration vacuolisation (conj)
results occurred (acl)
had majority (nsubj)
infarction 0.26 (appos)
one : (punct)
diagnosed resumed (conj)
bromide ipratropium (compound)
sodium fluorescein (compound)
designated drug (xcomp)
moderate . (punct)
bronchiectasis for (case)
caused also (advmod)
portions mass (nmod)
progressed two (nmod)
relation their (nmod:poss)
$ROOT$ showed (sent)
activation fibers (nmod)
received cefotetan (dobj)
treated cis-ra (nmod)
investigated objective (nsubj)
implications management (nmod)
develop failure (dobj)
d2 cholesterol (conj)
terbinafine oral (amod)
failed drugs (nsubj)
than injection (nmod)
administration animals (nmod)
diazinon insecticide (appos)
old 27-year (nmod:npmod)
exposure smoking (nmod)
report experience (nmod)
male in (case)
bradycardia associated (acl)
occurred interaction (nsubj)
prevent lamivudine (nsubj)
started monitored (conj)
introduced and (cc)
trial previous (amod)
reason . (punct)
statins in (case)
bacteremia because (case)
rats infant (compound)
using immunohistochemistry (dobj)
reflect atherosclerosis (dobj)
support hypothesis (nmod)
diaphragm , (punct)
perfusion inadequate (amod)
matter edematous (amod)
exclude possibility (dobj)
s-1 to (case)
case course (nmod)
$ROOT$ susceptible (sent)
300 to (case)
asystole and (cc)
so this (nsubj)
identical which (nsubj)
somnolence exacerbation (conj)
ligation bdl (appos)
attention close (amod)
aminotransferase alanine (compound)
carbon cc (appos)
nephropathy role (dep)
dizocilpine mk-801 (appos)
binding high-affinity (amod)
inadequate is (cop)
injected intravenously (advmod)
$ROOT$ associations (sent)
time which (det)
exhibited ccr2-labeling (dobj)
curve an (det)
measured minutes (nmod)
nodosum all- (amod)
agonist active (amod)
prevents rigidity (dobj)
different which (nsubj)
bmd children (nmod)
dogs maintained (acl)
rises with (case)
deletion subtypes (nmod)
drugs nonsteroidal (amod)
dosage drug (nmod)
153 147 (conj)
entered study (dobj)
elicits series (dobj)
function urinary (amod)
3.6 from (case)
revealed deficits (dobj)
iv po (conj)
property memory (compound)
tachyarrhythmia supraventricular (amod)
lead , (punct)
considered surgeries (nsubjpass)
combination induction (nmod)
infants 547 (nummod)
evaluated efficacy (dobj)
similar have (conj)
lacn of (case)
mg 11.3 (nummod)
associated cocaine (nmod:npmod)
woman cancer (nmod)
safe efficacious (dep)
appeared formed (xcomp)
fluids irrigating (amod)
block branch (compound)
test antiglobulin (compound)
overexpression the (det)
ezetimibe or (cc)
assessments qualitative (amod)
weeks discontinuation (dep)
$ROOT$ benefit (sent)
wt g (nummod)
infarction non-st-elevation (amod)
200 than (advmod)
resonance mr (appos)
recur but (cc)
mortality posttransplant (amod)
comparison control (nmod)
antagonist vitro (advmod)
provided reliably (advmod)
values mg/kg (appos)
rash of (case)
inflammation bladder (compound)
receiving they (nsubj)
reported assessed (advcl)
rendered anemic (xcomp)
hemoglobin counts (conj)
cytoskeleton matrix (conj)
treat prior (advmod)
forces score (conj)
rigidity succinylcholine-induced (amod)
carvedilol flecainide (conj)
1.8 , (punct)
fed diet (dobj)
test conditioned (amod)
decreased week (conj)
performance evaluated (acl)
val ) (punct)
case reported (acl)
surgery radiation (conj)
developed attenuated (parataxis)
23 of (advmod)
changes relevant (amod)
muscle papillary (amod)
occurred movements (nsubj)
action given (acl)
tongue , (punct)
correlations significant (amod)
modulation pharmacological (amod)
investigation toxicologic (amod)
matrix the (det)
resulted . (punct)
developed prostatitis (dobj)
users ich (conj)
procedure quick (amod)
induce levels (nsubj)
relating contraceptives (dobj)
control h (appos)
$ROOT$ unaltered (sent)
ami/gi for (case)
revealed staining (nsubj)
components lemon (compound)
recognise , (punct)
were responses (nsubj)
small significant (conj)
g. , (punct)
used patients (nsubj)
weeks four (nummod)
tested enzymes (nmod)
collagen = (dep)
n=10 subjects (appos)
three whom (nmod)
observed bladder (nmod)
men . (punct)
monooxygenases of (case)
excitation gyrus (nmod)
toxicity fatal (amod)
discovered was (auxpass)
were while (mark)
chloride between (case)
remain aware (xcomp)
reduced minutes (conj)
developed mmc (nmod)
related risk (nsubj)
emerged however (advmod)
polymorphism for (case)
strikes . (punct)
neonates two (nummod)
investigated second (advmod)
$ROOT$ enalapril (sent)
delay to (case)
associated prevalence (nmod)
combination effects (nmod)
700 900 (conj)
nephroureterectomy a (det)
had h (nmod)
rules screening (nmod)
purpose study (nmod)
conducted was (auxpass)
elevation sustained (amod)
affects how (advmod)
transplantations other (amod)
ganglia in (case)
md with (case)
period rhythm (nmod)
surface thoracic (amod)
sustained , (punct)
syndrome patient (conj)
them of (case)
potential b (nmod)
accounting % (nmod)
fk ( (punct)
delayed when (advmod)
population addicts (nmod)
administrated 200mgkg(-1 (nmod)
cd50 , (punct)
under-appreciated important (conj)
discontinuation following (case)
abilities the (det)
prevented contrast (nmod)
study which (nmod)
drug as (cc)
mediator neurodegeneration (nmod)
areas residual (amod)
zone the (det)
reduplication allografts (nmod)
characteristics five (nummod)
cause antidepressants (nsubj)
findings electroencephalography (nmod)
dose ld(10 (compound)
< and (cc)
synthase synthase (conj)
adenomas and (cc)
response interval (nmod)
effects pressure (nmod)
year and (cc)
agent has (acl:relcl)
levels development (conj)
therapy combination (amod)
initiate reflex (dobj)
pathophysiology schizophrenia (nmod)
interaction cholinergic-opioid (amod)
recovery functions (nmod)
goldstein and (cc)
effect chemotherapy (nmod)
micrograms inhibitor (appos)
index disease (conj)
metoprolol s-isomer (conj)
retard suggesting (advcl)
impaired compared (advcl)
drinking heavy (amod)
tachycardia isoproterenol (compound)
took disorder (nmod)
deteriorated p (dep)
5-fu bolus (compound)
reduction levels (nmod)
have system (dobj)
prolongation to (case)
angio-oedema of (case)
determinant activity (nsubj)
nephrotoxicity indinavir-related (amod)
pressure continuous (amod)
design analysis (appos)
using and (cc)
analgesic of (case)
cases japan (nmod)
cases found (acl)
subunits cco-iv (dep)
were measure (xcomp)
had indices (nmod)
500 - (punct)
drugs purpose (compound)
baseline start (nmod)
mv ) (punct)
effect non-specific (amod)
drugs are (cop)
patients twenty-two (nummod)
dosing schedules (conj)
classified sequence (nmod)
cells unlike (case)
haemorrhages of (case)
conclusions decrease (appos)
mg/kg/day 30 (nummod)
restricted striatum (nmod)
nanosphere incorporating (acl)
sumatriptan for (case)
remains goal (attr)
synergy treatments (nmod)
dysfunction pb-related (amod)
applied implants (nsubjpass)
hypothesis involve (ccomp)
conduction av (compound)
agency u.s. (compound)
18.7 - (punct)
medical paramedical (conj)
lozenge from (case)
arrhythmia cardiac (amod)
suggest increase (ccomp)
heads swollen (amod)
activator tissue-type (amod)
lowering rate (nmod)
administered drugs (nsubjpass)
occurred seconds (nsubj)
60 times (quantmod)
synthesized esterification (nmod)
rat a (det)
exceeded and (cc)
have (-)-isomer (nsubj)
risks hospitalization (nmod)
decrease tension (nmod)
secretion by (case)
targets ideal (amod)
rats ie (advmod)
showed improvement/resolution (dobj)
mass cm (dep)
rate acid (nmod)
50 of (advmod)
therapy hypercholesterolemia (nmod)
causes damage (dobj)
rats susceptible (amod)
mediated being (auxpass)
studying effects (dobj)
withheld substituted (conj)
fluctuations stage (dep)
degeneration content (conj)
disfiguring and (cc)
61 of (advmod)
thrombosis venous (amod)
subjects other (amod)
comprised carcinoma (dobj)
incorporating period (nmod)
rose increased (conj)
remedies in (case)
treated later (advmod)
linked may (aux)
increased = (parataxis)
changes minimal (amod)
weeks three (nummod)
protective seizures (nmod)
151 of (advmod)
acid fa (appos)
epilepsy withdrawal (conj)
doses addition (nmod)
remitted it (nsubj)
possesses vitro (advmod)
fps the (det)
administration bpt/clz (nmod)
contribution signaling (nmod)
28.0 31.7 (conj)
receptor through (case)
decreased less (nmod)
patient dermatitis (nmod)
stress tissues (nmod)
release augmented (amod)
remission and (cc)
charge and (cc)
continue to (mark)
requires attention (dobj)
members family (compound)
trialists committee (conj)
discontinued halothane (nsubjpass)
decade last (amod)
polyphenol a (det)
cefotetan of (case)
u/l u/l (appos)
given intravenously (advmod)
oil diazinon (conj)
line br (compound)
cdt continuous (amod)
adjustment dose (compound)
exerts neurotoxicity (nmod)
antipsychotics atypical (amod)
8 of (advmod)
myelomeningocoele a (det)
increasing resistance (dobj)
drinkers among (case)
beta=0.49 , (punct)
expression emotional (amod)
dropped , (punct)
cardiomyocytes mice (nmod)
exposure pb (compound)
actions to (case)
pge2 urinary (amod)
$ROOT$ obtained (sent)
inhibitor diltiazem (nmod)
range higher (amod)
necessary exposure (nsubj)
related have (aux)
support although (mark)
injected studied (conj)
polymyositis with (case)
explored and (advmod)
assigned groups (nmod)
kb 4.8 (nummod)
inhibitor nos (compound)
found lack (nsubjpass)
kpa ( (punct)
patient to (case)
armrest an (det)
plausibility the (det)
adding carbamazepine (dobj)
repeated was (advcl)
gas blood (compound)
mg/m2/wk dose-intensity (nsubj)
contributes upregulation (nmod)
drug designed (acl)
cm nonionic (amod)
develop depression (dobj)
study dose-range (amod)
treatment but (cc)
increased 3/8 (dep)
1.0 > (advmod)
block impairment (conj)
bw of (case)
mg/kg h (nmod)
inducing necrosis (conj)
depressed abolished (conj)
seen sequelae (nsubjpass)
se lithium-pilocarpine-induced (amod)
periods for (case)
study transmission (compound)
trained location (nmod)
open request (nmod)
procaterol b.d (advmod)
phosphate-diaphorase nicotinamide (compound)
disease end-stage (amod)
toxicity coadministration (nmod)
experienced receiving (advcl)
low dose (nsubj)
levels controls (nmod)
inhibitor metabolized (amod)
diet day (nmod)
was hypotension (nmod)
norepinephrine ne (appos)
mellitus of (case)
edema ; (punct)
experiment an (det)
damage mitochondrial (amod)
increase group (nmod)
% 35 (nummod)
disorders mental (amod)
found trial (nsubj)
hla-b35 cw4 (conj)
need enable (xcomp)
dilation of (case)
catalepsy behavior (conj)
criteria laboratory (compound)
showed another (nsubj)
cases refractory (amod)
exhibited addition (nmod)
suggest therefore (advmod)
combined indications (nmod)
evaluated magnitude (dobj)
pathologies different (amod)
therapeutic anti-cancer (amod)
papaverine of (case)
tested when (advmod)
somatotopy of (case)
lowered days (nmod)
investigated and (cc)
climbing and (cc)
modulated attention (nmod)
echocardiographic , (punct)
infant exposed (acl)
patients apl (nmod)
vulnerability toxicity (nmod)
risk complications (nmod)
wasting muscle (compound)
grow pituitaries (nsubj)
mg 192 (nummod)
occasions two (nummod)
utilized extensively (advmod)
mglur1 ( (punct)
strains , (punct)
thrush both (conj)
15.0 10.7 (compound)
subdivisions brain (nmod)
diltiazem bepridil (conj)
stimuli once (advmod)
content organs (conj)
removed flushed (dep)
combination amoxicillin (nmod)
produced lovastatin (nsubj)
definition and (cc)
proliferation termination (conj)
jj not (cc)
trial part (nsubj)
nerves b3 (compound)
evaluated influence (dobj)
shifting ) (punct)
msec respectively (advmod)
associations factors (nmod)
execution protocol (nmod)
using resulting (advcl)
found efficacious (xcomp)
hospital care (compound)
reliable and (cc)
hoe or (cc)
proteins zo-1 (nmod)
reduced had (aux)
follow-up mean (amod)
combination dogs (nmod)
provided , (punct)
inserts their (nmod:poss)
arthritis juvenile (amod)
beta-subunits channel (compound)
millimeter per (case)
contains protection (nmod)
improve situation (dobj)
bupivacaine adrenaline (nmod)
exacerbates bradycardia (nsubj)
infusions neurotensin (nmod)
hypertension ( (punct)
perfusion tracers (nmod)
range 84 (appos)
35 - (punct)
inhibited nh4ac (nmod)
fluorouracil leader (appos)
combination l-dopa (nmod)
included patients (nsubj)
function confirmed (amod)
stroke or (cc)
activity . (punct)
activation neurotoxicity (conj)
profile safety (compound)
tet mice (nmod)
2 crocins (appos)
patient polymyositis (nmod)
content stability (conj)
levels normotensive (amod)
period induction (compound)
la plasma (compound)
injections : (punct)
boy by (case)
treated ssris (nmod)
improvement patients (nmod)
nitrolingual min (nmod)
administration women (nmod)
hinder quality (dobj)
men psa (nmod)
those had (acl:relcl)
aerosol micrograms (appos)
pneumonia because (case)
appear therapy (nsubj)
increases pb-related (amod)
dosage of (case)
hypoxia chronic (amod)
d11 d17 (conj)
defects the (det)
peak ) (punct)
increase withdrawal (nmod)
effect dysfunction (nmod)
resolution observed (amod)
shock such (case)
survival onset (nmod)
associated monotherapy (advcl)
variation ) (punct)
related injury (nsubj)
n/n=62/92 ) (punct)
higher : (punct)
cotransporter na(+)-cl(- (amod)
started case (nsubj)
observed induced (parataxis)
amb. with (case)
veins the (det)
ptcr mild (amod)
interfere responses (nmod)
attributed bradycardia (nsubjpass)
infarction administration (nmod)
oxidation acid (compound)
psychosis methamphetamine (compound)
measured intensity (nsubjpass)
mg.kg(-1 5 (nummod)
follow-up with (case)
administration heparin (nmod)
abolished effect (dobj)
opening agonist-induced (amod)
administration sc (nmod)
irritant eliminated (acl)
alpha-tocopherol and (cc)
caffeine from (case)
induce rats (nmod)
min g/min (appos)
satisfactory , (punct)
interviewing after (mark)
effects antihypertensive (amod)
included increase (dobj)
virus by (case)
mm 29.3 (nummod)
% n (appos)
4.336 ci (appos)
133 +/- (cc)
doses children (nmod)
aware that (mark)
damage , (punct)
hemorrhage ulcer (conj)
decreased exposure (nsubj)
h moment (compound)
decreased when (advmod)
anticoagulation transplantation (nmod)
injected cy (nmod)
scales of (case)
cortex acc (appos)
is listed (advcl)
impairs subjects (nmod)
rapamycin dose (compound)
developed nodules (dobj)
jj prot (appos)
5,7-dihydroxytryptamine the (det)
reduced consequence (nmod)
meet as (cc)
less % (nmod)
a.m. , (punct)
treated ato (nmod)
function presumed (amod)
aggravating without (mark)
investigated mice (nmod)
other on (case)
involvement tumor (compound)
hospitalised illnesses (nmod)
abstinence progressive (amod)
pattern anemia (nmod)
similarity its (nmod:poss)
used observational (conj)
ltp hippocampal (amod)
chemotherapy according (case)
blocker a (det)
preserved is (auxpass)
dose route (conj)
deliver to (mark)
dbh -/- (dep)
inhibition tone (nmod)
number n=2.4+/-0.7 (dep)
determinant that (mark)
produced injections (nsubj)
decrease prevalence (dobj)
infections other (amod)
beats 33 (nummod)
readjustment sheath (nmod)
32.9 and (cc)
conclusions related (appos)
achieve concentrations (dobj)
developed neutropenia (dobj)
chemotherapy -- (punct)
added mirtazapine (nsubjpass)
intact-control , (punct)
rebounded compared (advcl)
caused penicillamine (nmod)
cholesterols les (conj)
patients african (amod)
herbs by (case)
lymphocytes rabbit (compound)
instilled bladder (nmod)
s((1/2 0.440 (nummod)
streptozocin stz (appos)
stimulation microinjection (conj)
ring the (det)
used industry (nmod)
immunoblotting immunohistochemistry (conj)
ach ) (punct)
showed inhibited (ccomp)
affect threshold (dobj)
pool da (compound)
delivery drug (compound)
variation individual (amod)
5.00 and (cc)
resulting degrees (nmod)
induction tumor (compound)
made start (nmod)
mmol 1.68 (compound)
decrease g/dl (compound)
apoptosis aminonucleoside-induced (amod)
count blood (compound)
inputs somatosensory (amod)
phase " (punct)
effects in (amod)
leakage mannitol (nmod)
symptoms on (amod)
effects gain (conj)
12 4 (nummod)
participation with (case)
regimen mg/m(2 (appos)
phosphorylation oxidative (amod)
lasting succinylcholine (nmod)
decrease nitroglycerin (nmod)
method reliable (amod)
rise albumin (nmod)
coccidioidomycosis disseminated (amod)
group historical (amod)
latency prolonged (amod)
decreased pentazocine (nsubj)
metabolism the (det)
low extremely (advmod)
elisa dual (amod)
% 99.8 (nummod)
terbutaline with (case)
suggesting cause (ccomp)
agents potent (amod)
reviewed is (auxpass)
normalized titer (nsubj)
type damage (nmod)
replaced being (auxpass)
obtained examinations (nmod)
withdrawal carbamazepine (nmod)
doxorubicin ; (punct)
dysfunction transient (amod)
affected activity (nsubjpass)
1.25 - (punct)
requiring resuscitation (dobj)
tendency induce (acl)
increase minimum (amod)
= -3.62 (dobj)
perfusion bepridil (nmod)
involved proliferation (nmod)
$ROOT$ failed (sent)
hyponatremia siadh (conj)
paralysis hind-limb (amod)
dissipates effect (nsubj)
basis as (case)
controls 1,908 (nummod)
dox mg/kg (compound)
suggested is (auxpass)
were apart (advmod)
2.9 0.2 (conj)
treatment cataracts (nmod)
effects hyperprolactinemia (nmod)
rare extremely (advmod)
using histochemistry (dobj)
dependent presence (nmod)
project nincds (nmod)
300 100 (advmod)
danazol with (case)
di- , (punct)
infusions tci (appos)
l. crocus (compound)
develops that (nsubj)
measure protection (nmod)
catecholamine the (det)
drug celecoxib (nsubj)
gr , (punct)
mg. of (case)
cases literature (nmod)
aggravate hypertension (nsubj)
confirmed diagnosis (nsubjpass)
administered dhea (nsubjpass)
increased dramatically (advmod)
exhibited strains (nsubj)
ah6809 not (neg)
antitussives available (amod)
formed pb (nmod)
rats arrhythmic (amod)
hypersecretion by (case)
toxicity dogs (nmod)
barrier intercellular (amod)
aetiology a (det)
higher trials (nmod)
risks about (case)
conducted investigate (advcl)
hippocampus mice (compound)
109 2 (conj)
fl ( (punct)
precursor a (det)
determined neonates (nmod)
induced amnesia (dobj)
pyrophosphate for (case)
85 - (punct)
sarcoma kaposi (nmod:poss)
inhibitor synthase (nmod)
cmax/mic mean (compound)
days for (case)
patients methadone (compound)
induced chemotherapy (nmod)
included acuity (dobj)
nephrolithiasis triamterene (compound)
interval qtc (compound)
affected not (neg)
arrhythmias all (predet)
improvement dramatic (amod)
alteration response (nmod)
tasks by (case)
was compared (advcl)
individual the (det)
interaction alpha-methyldopa-estrogen (compound)
related rejection (nmod)
recalled word (dobj)
fentanyl ? (punct)
taqib taqia (conj)
animals six (nummod)
performed examinations (nsubjpass)
potent steroids (nsubj)
mg/m2 and (cc)
750 900 (conj)
catheter through (case)
self-dosing pethidine (nmod)
administration l-name (nmod)
change contrast (nmod)
indicated have (aux)
assessment confusion (compound)
importance calcium (nmod)
illness viral-like (amod)
thiazole-2-carboxamide - (amod)
non-selective the (det)
usefulness its (nmod:poss)
increased : (punct)
activity seizure (compound)
caspase-3 of (case)
activity cco (compound)
increased bupivacaine (nsubj)
percent rats (nmod)
potassium and (cc)
minor even (advmod)
events significant (amod)
uptake segments (nmod)
raises effect (nsubj)
provides information (dobj)
3 2 (compound)
cure apparent (amod)
pathway with (case)
unreasonable therefore (advmod)
improvements , (punct)
tubule , (punct)
hoe ( (punct)
salicylate ibuprofen (conj)
heterogeneity neurons (nmod)
effects tetrandrine (nmod)
followed hepatitis (nsubjpass)
recovered he (nsubj)
stimuli real (amod)
ph. urine (compound)
supporting therefore (advmod)
project anticonvulsant (amod)
acid-induced acetic (amod)
inhibitors sunitinib (nmod)
confused movements (nmod)
losartan the (det)
patients exacerbation (nmod)
ich ) (punct)
have hyperglycinemia (dobj)
prepared days (nmod)
factors disorder (nsubj)
helpful , (punct)
fetuses heavy-exposed (amod)
use aspirin (nmod)
model studied (acl:relcl)
mouth the (det)
report cases (nmod)
expression receptor (compound)
stimulation pas (appos)
paclitaxel cisplatin (conj)
response 24-hour (amod)
device velocities (nmod)
cells midline (amod)
timeframe same (amod)
experienced pain (dobj)
sign invasion (nmod)
sings activation (nmod)
lithiasis ureteral (amod)
2.6 > (advmod)
superoxide dex (dep)
l-norepinephrine by (case)
aims compared (appos)
had 17 (conj)
trimethoprim-sulfamethoxazole tmp-smz (appos)
ischemia dogs (nmod)
pose significant (nsubj)
dose flecainide (nmod)
injecting ventricle (nmod)
tariquidar selective (amod)
had relapse (dobj)
contraceptives conventional (amod)
performed ct (nsubjpass)
version by (case)
2003 - (punct)
linn . (punct)
drugs alternative (amod)
assigned women (nsubjpass)
indicator may (aux)
attributed reasonably (advmod)
medium a (det)
decrease ratings (nmod)
similar probable (ccomp)
$ROOT$ discriminated (sent)
6 8 (conj)
mesencephalon striatum (conj)
performed study (nmod)
treatments of (case)
resolved confirmed (advcl)
neurotransmission adrenergic (amod)
epilepticus before (nmod)
presented features (nmod)
flow plasma (compound)
course patient (nmod:poss)
anesthetics of (case)
area both (dep)
$ROOT$ observations (sent)
chemotherapy ifosfamide (nmod)
treatment other (amod)
clotiazepam between (case)
associated discussion (nsubjpass)
found males (nmod)
greater activity (nsubj)
importance developing (advcl)
consequence not (neg)
2.89 to (dep)
acids antagonists (appos)
predictors were (cop)
models these (det)
(mpo-anca)-positive myeloperoxidase (nmod:npmod)
modulation structures (nmod)
augment effects (dobj)
enzyme acetylcholinesterase (nsubj)
smokers among (case)
complications motor (amod)
do which (nsubj)
doses a-86929 (nmod)
encountered . (punct)
therapy steroid (compound)
treated who (nsubjpass)
female hyponatraemia (nmod)
required hyperkalemia (nmod)
fleas of (case)
produced patients (nmod)
triamcinolone and (cc)
sera rast (nmod)
belonging phenotype (nmod)
reflects , (punct)
times and (cc)
changes pattern (nmod)
disease against (case)
received azathioprine (dobj)
reactions : (punct)
reversal l-dopa (nmod)
actions nh4ac (nmod)
conclusion mg/m2/d (appos)
resistance consequences (conj)
activates beta (dobj)
glutamatergic gabaergic (conj)
colocalized marker (nmod)
ed50 dog (compound)
sensitive tgr (nsubj)
improved capacity (dobj)
pretreatment fentanyl (nmod)
blockade mglur5 (nmod)
incidence cancer (nmod)
recurrent be (cop)
produce tilts (nsubj)
correlation infectivity (nmod)
defects clear (amod)
disease atherosclerotic (amod)
modulation to (mark)
exhibited but (cc)
tubule tubule (conj)
age therapy (conj)
hematocrit pressure (conj)
syndrome reverse (amod)
indicated experiments (nsubj)
tumors all (det)
presence stenosis (nmod)
min 75 (nummod)
indicate needed (ccomp)
interval 1.35 (nummod)
recorded other (dep)
published however (advmod)
resolved later (advmod)
infarction without (case)
cyclophosphamide cya (appos)
agents platelet (compound)
implicated observations (nmod)
scotoma central (amod)
fviiirag ) (punct)
prooxidant circumstances (nmod)
synthase enos (appos)
ar ) (punct)
evaluate research (nsubj)
response prodysrhythmic (amod)
bolus after (case)
presence impairment (nmod)
model last (nmod)
67.4 bupropion (nmod)
titration gradual (amod)
weeks exposure (nmod)
administration multiple (amod)
cells these (det)
6.6 + (compound)
reaction adverse (amod)
striking most (advmod)
protects seizures (nmod)
grading a (det)
increased discussion (nsubjpass)
in and/or (cc)
13/50 ) (punct)
long a-77636 (nmod)
inhibitors by (case)
study additional (amod)
shortened . (punct)
intubated . (punct)
reduce morbidity (dobj)
seizures induced (acl)
survivors asymptomatic (amod)
agent well-tolerated (advmod)
detection infarction (nmod)
3657 was (cop)
caused injury (nsubj)
validated well (advmod)
those blockers (nmod)
tsc ( (punct)
risk cancer (compound)
exhibited hemorrhagic (conj)
improves dysregulation (dobj)
prevalence screening (nmod)
infusion doxorubicin (nmod)
receptors prejunctional (amod)
with or (cc)
had apamin (nsubj)
77.1 +/- (cc)
considered are (auxpass)
sufficient re-elevate (xcomp)
measured calculated (conj)
restricted is (cop)
alpha-blocker as (case)
heptylate gonadotropin (conj)
balances , (punct)
preparation to (case)
resuscitated arrest (nmod)
generated were (auxpass)
cream % (amod)
blocked indicating (advcl)
risk possible (amod)
intracellular from (case)
sites sulphate (compound)
wk less (nummod)
years ' (case)
rate death (compound)
10 7 (conj)
given which (nmod)
screening drug (compound)
absence caffeine (nmod)
loss snhl (appos)
muscle gastrocnemius (compound)
< 0.03 (dobj)
case persisting (acl)
arrest asystolic (amod)
included recording (dobj)
infections during (case)
had resolve (ccomp)
symptoms illness (nmod)
located . (punct)
investigated hospital (nmod)
dilemma a (det)
common diagnosed (conj)
ml/min ml/min (appos)
contribute release (nmod)
prepare to (mark)
going ? (punct)
didanosine hydroxyzine (conj)
women year-old (amod)
disease idiopathic (amod)
treatment sub-chronic (amod)
assessable assessable (conj)
occurred treated (conj)
more 27 (nmod:npmod)
microm 100 (nummod)
suggests etiology (nmod)
glomerulopathy de (amod)
dobutamine by (case)
caused neurotoxicity (nmod)
renin ( (punct)
tensions peak (amod)
headache persistent (amod)
antagonism beta-2 (compound)
studied : (punct)
administered safely (advmod)
discussed is (auxpass)
demonstrate defect (ccomp)
30 22 (compound)
consistent findings (nsubj)
icp of (case)
curve of (case)
emergence movements (nmod)
6 9 (conj)
stress kinase (conj)
cases fatal (amod)
effects indomethacin (nmod)
anaesthesia spinal (amod)
exhibit inhibited (conj)
78-year-old a (det)
affected experienced (advcl)
restores erythropoietin (nsubj)
involve rats (nmod)
infusion to (case)
teratogenic administered (advcl)
$ROOT$ receptor (sent)
details procedure (nmod)
action radical (compound)
compounds acidic (amod)
expression angiotensinogen (compound)
discontinuance patient (nmod)
pathology of (case)
patient-years follow-up (nmod)
nephrosis puromycin (compound)
dose vitamin (compound)
met : (punct)
impairments central (amod)
important this (nsubj)
concentration regional (amod)
sensitivity endpoints (nmod)
cv ) (punct)
hyperuricemia or (cc)
toxicities arthralgia (dep)
sinoatrial atrioventricular (conj)
effect chloride (nmod)
withdrawal drug (nmod)
steroids chronic (amod)
recovery alterations (nmod)
mechanism ionic (amod)
4.6 p=0.099 (appos)
had p (dep)
200 50 (compound)
cohort 2000 (nummod)
seizure to (case)
igf-i or (cc)
under-reporting and (cc)
2 : (punct)
combination carboplatin (nmod)
wall through (case)
dosed were (auxpass)
data obtained (amod)
eating or (cc)
episodes investigated (amod)
p2x3 nk1 (conj)
volumetry . (punct)
ganciclovir with (case)
glibenclamide abolished (acl:relcl)
accompanies therapy (dobj)
gaps connections (nmod)
seemed : (punct)
ngf pg (conj)
processes molecular (amod)
develop , (punct)
speed injection (nmod)
tracings cortical (amod)
reactions elderly (nmod)
hg cisapride (appos)
$ROOT$ extubated (sent)
one - (punct)
antagonized nra0160 (nsubj)
dyskinesia l-dopa (compound)
caused metoclopramide (nmod)
exposed regimens (nmod)
classification from (case)
greater drug (nmod)
group children (nmod:poss)
5 30 (conj)
effect crocins (nmod)
drugs themselves (appos)
dystonia omd (appos)
prevent infusion (nsubj)
hour day (conj)
evidence growing (amod)
neuropathy proximal (amod)
inducing of (mark)
indication by (case)
suppressed stimulation (nsubj)
administration droperidol (compound)
reactions nimesulide (nmod)
shown produces (ccomp)
mice slc (compound)
task the (det)
history case (compound)
ve in (case)
dermatoses with (case)
7alpha-hydroxylation decreased (amod)
exhibited value (advcl)
combination cisplatinum (nmod)
$ROOT$ maleate (sent)
form to (case)
$ROOT$ said (sent)
events stratified (acl)
word list (nmod)
implanted totally (advmod)
diopters 5.00 (nummod)
compatible are (cop)
type 3 (nummod)
recommenced administration (nmod)
control lesions (nmod)
undergoing colonoscopy (dobj)
pilo chx+pilo (conj)
deprivation alternating (amod)
dyskinesia sphincter (compound)
case angina (nmod)
taking 2 (nmod)
dysfunctioning system (nmod)
deacetylation apap (compound)
smoking heavy (amod)
treated l-dopa (nmod)
hour 12 (nummod)
history urticaria (nmod)
cystitis ) (punct)
mb ) (punct)
serious it (nsubj)
5.5 36.7 (prep)
treated methadone (nmod)
pressure activity (conj)
responses subjects (nmod)
woman history (nmod)
transplants kidney (compound)
lipopolysaccharide treatment (appos)
alpha-tocopherol alpha-t (appos)
aware low (advcl)
associated not (neg)
remitted as (mark)
therapy vancomycin (compound)
value correlations (conj)
enalapril the (det)
higher however (advmod)
proven be (auxpass)
permits and (cc)
h2o2 elevated (amod)
digitized 1/s (nmod)
responses complete (amod)
disrupts determines (conj)
factors causative (amod)
from 3 (nmod)
started dosage (nmod)
decreased since (mark)
weekly then (advmod)
4.7 heart (nmod)
neurotoxic is (cop)
needle pencil-point (amod)
six-month follow-up (dep)
protocols to (case)
design dose (compound)
have function (nmod)
propranolol antagonist (compound)
has properties (dobj)
analysis association (compound)
effect apigenin (nmod)
acid mrna (appos)
suggestive hepatotoxicity (nmod)
diethylcarbamazine dec (appos)
foci/cm2 compared (case)
controls p=0.05 (appos)
suppressed sleep (dobj)
plants from (case)
dgc ( (punct)
% response (nmod)
uncommon although (mark)
schedule protracted (amod)
cancer third (amod)
sedation intravenous (amod)
dogs pentobarbital-anesthetized (amod)
time-course action (nmod)
activity non-reactive (amod)
m1 and (cc)
develop because (mark)
enhances produces (conj)
nephrolithiasis calcium (compound)
age fraction (conj)
variant a (det)
administration shock (conj)
using had (dep)
cataract requiring (acl)
boluses ethanol (nmod)
were suggestions (attr)
insufficiency ari (appos)
dormex , (punct)
battery with (case)
medulla rat (compound)
enhanced responses (dobj)
case chorioretinopathy (nmod)
reactions paranoid (amod)
those types (nmod)
detected autoantibodies (nsubjpass)
during only (advmod)
patients jaundice (nmod)
$ROOT$ tapped (sent)
evaluated 2010/2011 (nmod)
disability in (case)
fluconazole with (case)
injection subcutaneous (amod)
drug safe (amod)
40 - (punct)
observation , (punct)
expressed were (auxpass)
hg p (appos)
increased survived (advcl)
intake diuresis (conj)
drugs in (case)
ranging nausea (nmod)
24 life-threatening (amod)
presentation antigen (compound)
leukoencephalopathy with (case)
history suspicion (conj)
searched databases (nsubjpass)
samples 33342- (amod)
antagonize carteolol (nsubj)
resulted growth (nmod)
using inhibitors (dobj)
$ROOT$ aggravated (sent)
invited patients (nsubjpass)
account therefore (advmod)
affect pain (dobj)
feeling wound-up (amod)
system intrarenal (amod)
pregnancies with (case)
fibrosis hypocellular (amod)
6.2 1.3 (conj)
pb isoenzymes (conj)
treatment during (case)
larynx , (punct)
studies behavioral (amod)
3'-azido-2',3'-deoxythymidine ; (punct)
interest of (case)
0.9 i.v. (appos)
experienced patients (dep)
mg 0.75 (nummod)
oestrogens , (punct)
measured activity (nsubjpass)
pretreated acid (nmod)
pathogenesis mechanism (nsubj)
expressing sum (nmod)
required caution (nsubjpass)
b ) (punct)
signs results (conj)
hematocrit her (nmod:poss)
heterogeneity the (det)
ratio expression (compound)
coefficient ; (punct)
dose lamivudine (nmod)
defined prl (nmod)
therapy pemoline (compound)
given totp (dobj)
% 18.67 (nummod)
resulted ratings (nmod)
had difficulty (dobj)
activation erk (compound)
maps on (case)
incidence switches (nmod)
described cardiomyopathy (nmod)
indicates work (nsubj)
minutes t30 (appos)
seizure absence (compound)
investigate effect (dobj)
strains css (appos)
signified . (punct)
mv 1.6 (nummod)
four % (appos)
saturation the (det)
p=0.006 0.007 (appos)
demonstrate attenuate (ccomp)
mandatory are (cop)
bid mg (amod)
cause b (nsubj)
59 50 (compound)
relationship seizures (nmod)
atherosclerosis graft (compound)
man amyloidosis (nmod)
$ROOT$ organization (sent)
monosaccharides by (case)
flows coronary (amod)
known experience (nmod)
heptylate testosterone (compound)
rats gentamicin-treated (amod)
disease primary (amod)
similar findings (nsubj)
epilepticus se (appos)
administered hr (nmod)
se per (case)
ingested pregnancy (nmod)
properties substrates (acl:relcl)
receptor-mediated nmda (nmod:npmod)
measured not (neg)
bche ala539thr (compound)
observation status (nmod)
scales beck (compound)
use compounds (nmod)
monitoring behaviour (dobj)
decreased hg (nmod)
occur thus (advmod)
dhea ( (punct)
max ) (punct)
system autism (nmod)
animals s-i (compound)
block av (compound)
risk schizophrenia (nmod)
lymphoma iiie (nummod)
monitored output (nsubjpass)
drugs bzds/rds (appos)
3.6 and (cc)
months were (cop)
medline and (cc)
because primarily (advmod)
greater hours (nmod)
identified factors (nsubjpass)
exhibited receptors (nmod)
associated complications (nsubjpass)
23/57 % (appos)
ketamine and (cc)
use cocaine (nmod)
$ROOT$ absorbed (sent)
$ROOT$ survived (sent)
41.8 4.8 (conj)
studies morphometric (amod)
manipulated group (nmod)
exposure drug (nmod)
stages disease (nmod)
aminonucleoside mg/kg (dep)
reached months (conj)
pain chronic (amod)
models schizophrenia (compound)
users mdma (nmod)
metabolite toxic (amod)
infant male (amod)
contractions ileum (nmod)
measures analyses (appos)
recordings his (nmod:poss)
hypothesized reduces (ccomp)
that between (case)
2.5 was (cop)
regard reductions (nmod)
protocol t5 (compound)
increased urothelium (nmod)
thickness microm (nmod)
reversed stem (nmod)
micrograms 10 (nummod)
factor-i recombinant (amod)
min respectively (advmod)
synthesis dna (compound)
patients 262 (nummod)
role . (punct)
gyrata cutis (compound)
showed reduction (dobj)
nodules and (cc)
incontinence secondary (amod)
induced nucleus (nmod)
avoided , (punct)
pesticide as (case)
pay occurs (advcl)
biphosphonate a (det)
defining in (mark)
[ca]o range (nmod)
ra severe (amod)
increased than (cc)
association variants (nmod)
patients taking (acl:relcl)
nature biochemical (amod)
convulsions induced (amod)
26- are (cop)
dunnett = (parataxis)
% 54.8 (nummod)
magnesium potassium (conj)
activity n-acetyl-beta-d-glucosaminidase (compound)
followed decline (nmod)
$ROOT$ introduction (sent)
used increasingly (advmod)
malnutrition , (punct)
worsened however (advmod)
supernatants cell (compound)
reversed results (nsubj)
injected area (nmod)
incorporation azt (compound)
effects about (case)
posture such (case)
studied approval (nmod)
mdma as (cc)
dose sublethal (amod)
aim . (punct)
mmhg 59.8 (nummod)
using desipramine (dobj)
presented woman (nsubj)
level her (nmod:poss)
targets that (nsubj)
antagonized partly (advmod)
study previous (amod)
decrease 0.05 (nummod)
hypoaidosteronism hyporeninemic (amod)
models . (punct)
examined were (auxpass)
effect events (nmod)
complications among (case)
protect occurrence (nmod)
inflammatory neuropathic (conj)
control orthostatic (amod)
greatest experience (nsubj)
fetal not (cc)
group by (case)
paclitaxel with (case)
limitations without (case)
fas increased (amod)
5mg/kg ( (punct)
thickness in (case)
$ROOT$ regulator (sent)
inactivation and (cc)
consistent result (nsubj)
neuropathy chickens (nmod)
day surgery (nmod)
administration ketamine (compound)
6 7 (conj)
thrombosis the (det)
instilling eyes (nmod)
1 50 (nmod)
obtained tests (nmod)
hypothesis has (ccomp)
g/dl < (advmod)
number receive (acl)
presented neuropathy (nmod)
dose acid (nmod)
changed snr (nmod)
acids hexauronic (amod)
pathway classical (amod)
congo the (det)
augmented seizure (dobj)
effects dexmedetomidine (nmod)
fluids therapy (conj)
3.5 1.3 (conj)
pain bone (compound)
revealed remained (advcl)
data collected (acl)
believe affected (ccomp)
suxamethonium with (case)
halothane by (case)
matter hemisphere (nmod)
ovulation with (case)
bleeding vaginum (nmod)
analysis developmental (amod)
proteinuria pre-existing (amod)
inhibits stopped (conj)
licking paw (compound)
cycle tca (compound)
representative were (cop)
trials ) (punct)
role seizures (nmod)
assessed june (nmod)
tissue in (case)
suggest attenuates (ccomp)
syndrome takotsubo (compound)
status who (compound)
patients compared (case)
size glomerular (amod)
sera donor (compound)
rats hypertension (nmod)
= p (nsubj)
shortened significantly (advmod)
occurred staining (nsubj)
done investigations (nsubjpass)
achieves benefit (dobj)
similar but (cc)
resistance peripheral (amod)
dopamine infusion-produced (amod)
chemotherapy trial (dep)
indicated markers (nsubj)
section cesarean (compound)
spasm thrombus (conj)
energy of (case)
network neuronal (amod)
pressure flow (conj)
parts unified (compound)
agonist group (compound)
regimen the (det)
played making (advcl)
caution appropriate (amod)
min by (case)
kidneys rat (compound)
% frequency (nsubj)
shortened duration (dobj)
possibility effects (nmod)
grams of (case)
area residence (nmod)
mutations implications (dep)
% 32.9 (nummod)
neurons cord (conj)
impact cells (nmod)
severe greater (dep)
change during (case)
administered adriamycin (nsubjpass)
kg-1 i.v. (advmod)
subjects 290 (nummod)
$ROOT$ interventions (sent)
section a (det)
inhibitor cyp2d6 (compound)
antinociception of (case)
response peak (amod)
socs-1 and (cc)
metabolites compound (nmod)
toxicity cocaine (nmod)
resolved nystagmus (nsubj)
patients expressing (acl)
analysis neuropathies (nmod)
performed tests (nsubjpass)
vasodilator propofol (nmod)
had developed (ccomp)
first to (case)
attribute another (det)
disease metastatic (amod)
cardiotoxin is (cop)
ip ) (punct)
gem mg/m(2 (appos)
induced therapy (nmod)
inattention , (punct)
induced saline (advcl)
source of (case)
licensed is (auxpass)
compares , (punct)
cessation to (case)
45.6 +/- (cc)
$ROOT$ common (sent)
syndrome apical (amod)
present when (advmod)
lines therapies (nmod)
receive preparation (nmod)
potentials fibrillations (conj)
scavenging properties (conj)
connections the (det)
environment experimental (amod)
heart cardiomyopathy (compound)
transplants in (case)
67 - (punct)
months therapy (nmod)
effective neuroleptics (nsubj)
frequency decreasing (amod)
necessary patients (nmod)
effects limit (acl:relcl)
characteristics arrhythmia (nmod)
deficient be (cop)
factors infants (nmod)
pointes for (case)
biopsies cervical (amod)
levels lead (compound)
data study (nmod)
lethal ( (punct)
level < (amod)
study xi (compound)
stage important (amod)
as as (mwe)
defined insufficiency (nsubjpass)
27 , (punct)
neutrophils compared (case)
smaller injection (nmod)
value absence (nmod)
model dcm (nmod)
improvement thickening (nmod)
factor studied (acl)
suggests case (nsubj)
using awful (parataxis)
retention test (nmod)
courses in (case)
glomerulonephritis segmental (amod)
be so (advmod)
characteristic state (nmod)
two of (case)
lesions rat (nmod)
unclear responsible (ccomp)
evaluated not (neg)
min 2 (nummod)
found propranolol (nsubj)
gspe ) (punct)
oromandibular levodopa-induced (nmod:npmod)
disease an (det)
inferred it (nsubjpass)
acidosis late (amod)
amnesia apomorphine-induced (amod)
dose steroid (nmod)
remains role (nsubj)
evaluated reactions (dobj)
produced thus (advmod)
tested patients (nmod)
screen urine (compound)
reabsorption of (case)
level g/dl (dep)
proliferative rapidly (advmod)
uneventful , (punct)
7.0 = (parataxis)
microgram/ml 1.25 (nummod)
alcohols , (punct)
infectious and (cc)
see we (nsubj)
sirolimus and (cc)
taqid , (punct)
cvd ) (punct)
culture from (case)
receiving are (aux)
higher although (mark)
hg 220 (nummod)
reentry circuit (compound)
rats female (amod)
ascertained included (advcl)
7.0 adjustment (nmod)
gamma-hexachlorocyclohexane ) (punct)
died anemia (nmod)
view the (det)
4.9 to (dep)
syndrome : (punct)
penicillins defect (appos)
changes cerebral (amod)
recorded when (advmod)
drug affinity (nmod)
myeloencephalopathy due (amod)
problem well-known (amod)
$ROOT$ interaction (sent)
n=10 ) (punct)
indicators , (punct)
imaging patients (nmod)
ophthalmologic detailed (amod)
dystrophy . (punct)
cardiotoxicity therapy (nmod)
patient unique (amod)
remains 2-component (attr)
patients 75 (nummod)
drug levodopa (nsubj)
occurrence natural (amod)
benefits many (amod)
administration chlormethiazole (compound)
nephrotoxicity 3 (appos)
antigen of (case)
methyldopa intravenous (amod)
rats submitted (acl)
patients immunosuppressed (amod)
ptz , (punct)
related ifosfamide (nmod:npmod)
change < (appos)
5-fu administration (conj)
ha with (case)
dimension baseline (nmod)
locf and (cc)
instances hematuria (nmod)
encephalopathy pertussis (compound)
configuration on (case)
encephalopathy , (punct)
ci 5.45 (nummod)
lpp the (det)
tool used (acl)
effect agonists (nmod)
nystagmus the (det)
emotion of (case)
wished develop (xcomp)
aspirated contents (dobj)
synthesis in (conj)
studies antibodies (nmod)
serum to (case)
infrequent result (conj)
agonist ro (dep)
mg/kg 300 (nummod)
abnormalities matter (compound)
demonstrated elevation (dobj)
hampered lack (nmod)
dec. . (nmod:tmod)
monitored ecg (nmod)
noted was (auxpass)
treated licl (nmod)
stress associated (acl)
presence baseline (nmod)
a-77636 hydrochloride (appos)
pattern behavior (nmod)
x(2 ) (punct)
% 89 (nummod)
gold case (nmod)
amount capsaicin (nmod)
clopidogrel to (case)
indomethacin ibuprofen (conj)
agonist a-86929 (appos)
hypokalemia treatment (nmod)
6.0 -3.7 (nummod)
therapy trihexyphenidyl (compound)
distances traveled (amod)
developed subgroup (nsubj)
overdose diphenylhydantoin (compound)
had patient (advcl)
ketanserin greater (amod)
change gap43-ir (nmod)
cytopenias three (nummod)
surgery such (case)
children 1-infected (amod)
group lesioned (amod)
evaluation tissues (nmod)
word last (amod)
exposure splitting (conj)
consumption frequency (conj)
n-nitroso-n-methylurea testosterone (conj)
responses pressor (compound)
occurrence from (case)
500 625 (conj)
ratio selectivity (compound)
study comparing (acl)
activity clinical (amod)
0.35 0.08 (conj)
pseudolithiasis ceftriaxone-associated (compound)
mortality in (case)
participants saw (acl:relcl)
similar furthermore (advmod)
dependent , (punct)
that placebo (nmod)
na ) (punct)
in-patients among (case)
$ROOT$ incidence (sent)
prevented injection (dobj)
occurred result (nmod)
decreases outflow (dobj)
occlusion thrombi (nmod)
experience review (nmod)
shr in (case)
use agonists (nmod)
effects kidney (compound)
$ROOT$ 8.5 (sent)
thrombosis intracranial (amod)
days together (advmod)
countries available (acl:relcl)
counteracted thus (advmod)
tested cages (nmod)
mul or (cc)
spread house (nmod)
conclusions damage (appos)
cortex the (det)
profiles renal (amod)
quit drinking (dobj)
$ROOT$ duct (sent)
troponin i. (nummod)
head site (nsubj)
women only (advmod)
follow-up complete (amod)
3.82 4.40 (nmod)
d1 mg (nummod)
predicted factors (nsubj)
fracture of (case)
benefit and (cc)
sinus the (det)
sn causes (acl:relcl)
indicates marker (conj)
smoking to (case)
attenuation of (case)
receptor h1 (compound)
changes m.s. (compound)
t3n0m0 ( (punct)
confirmed and (cc)
kinase increased (amod)
product adduct (appos)
dextrose in (case)
tafi levels (dep)
100 less (advmod)
age regurgitation (conj)
exposure of (case)
degrees mean (compound)
microinjection fentanyl (nmod)
consequence excitotoxicity (nsubj)
antagonist trazodone (nsubj)
arrhythmias = (dep)
dosages large (amod)
decreased tachycardia (dobj)
pathogen(s ) (punct)
netilmicin piperacillin- (conj)
became who (nsubj)
effect hyperprolactinemia (nmod)
complications acute (amod)
considering surgery (dobj)
developed curves (dobj)
proteins tj-associated (amod)
lesions but (cc)
= 0.036 (dobj)
respond if (mark)
bradyarrhythmias associated (acl)
a-77636 > (dep)
decrease but (cc)
objective the (det)
neurons nos-immunoreactive (amod)
side other (conj)
study 4'-0-tetrahydropyranyladriamycin (nmod)
aminoglycosides and (cc)
newborns all (det)
downregulation and (cc)
measures 13 (nummod)
glomeruli their (nmod:poss)
deoxycholate d-amb (appos)
rifampicin of (case)
identified methods (nsubj)
neuroleptics conventional (amod)
case interesting (amod)
abnormalities ecg (compound)
dependent status (nmod)
$ROOT$ allow (sent)
returned findings (nsubj)
prolapse mitral (amod)
38,048 acetaminophen (nmod)
early min (dep)
bp resting (amod)
cause disorders (dobj)
processed sections (nsubjpass)
extracts plant (compound)
secondary hitt (nmod)
model neuropathy (compound)
treatment dfmo (nmod)
demonstrated increases (dobj)
rate duration (conj)
procedure different (amod)
conscious regular (parataxis)
precede anticipated (advcl)
therapy ophthalmic (amod)
4 every (quantmod)
malformations for (case)
years 16 (nummod)
decrease score (conj)
preserves prevents (conj)
ssr103800 the (det)
negative patients (nsubj)
indicating remained (ccomp)
antiplatelets various (amod)
8 patients (nmod)
investigated study (nsubj)
occurred neutropenia (nsubj)
conjunction opioid (nmod)
effects main (amod)
hypotension mild (amod)
acids amino (compound)
achieved be (auxpass)
stages terminal (amod)
processes to (case)
effect aspirin (nmod:poss)
% 25 (nummod)
bronchorrhoea miosis (conj)
leads . (punct)
strips of (case)
seizures drug-induced (amod)
taken resection (nmod)
vasospasm intense (amod)
mg/d 20 (nummod)
mg with (case)
mice b6c3 (compound)
effect hormones (nmod)
two % (dep)
i/d ) (punct)
size and (cc)
lowered treatment (nsubj)
umax impaired (amod)
male were (cop)
16,459 comparison (nmod)
effects cromakalim (nmod)
antidepressants anorexigens (conj)
associated length (nsubjpass)
component regimen (nmod)
has half-life (dobj)
lowering dose (dobj)
doses i.c.v (appos)
sumatriptan of (case)
trait e (compound)
angina changes (conj)
chi2-test and (cc)
cause cardiomyopathy (dobj)
evoked were (auxpass)
binding [3h]spiperone (compound)
decreased u/ml (nmod)
feel overlooked (ccomp)
generate model (dobj)
interferon telaprevir (conj)
acid the (det)
abundance cotransporter (nmod)
gtn = (parataxis)
exerted node (nmod)
trials nineteen (nummod)
undertook lack (nmod)
altered neurotoxicity (nsubjpass)
pattern protein (compound)
increase as (cc)
1984 and (cc)
mg/kg 14 (nummod)
precore and (cc)
cycles chemotherapy (nmod)
occurrence postures (nmod)
conducted cohort (nmod)
igf-il-3 of (case)
developed adenocarcinomas (dobj)
demonstrated segments (nmod)
results was (appos)
recovered week (nmod)
receive therapy (dobj)
prolactinomas , (punct)
equipotent which (nsubj)
presentations similar (amod)
aggressiveness , (punct)
injected subcutaneously (advmod)
trials multicenter (amod)
implications . (punct)
staining immunohistological (amod)
affect progress (conj)
has suppression (nmod)
have models (nmod)
4.9 - (dep)
syndrome pain (compound)
identified age (dobj)
used monitor (xcomp)
hinder diagnosis (dobj)
episode second (amod)
safety celecoxib (nmod)
children received (acl:relcl)
intervention the (det)
cyp3a4 by (case)
9 ) (punct)
toxicity cholinergic (amod)
100+/-17 from (case)
infusion or (cc)
effects among (case)
atropine methoctramine (conj)
treatment mg/kg/day (dep)
development microangiopathy (nmod)
abnormalities no (det)
induce regarding (mark)
initiate statins (nsubj)
velocity conduction (compound)
function auditory (amod)
specific caffeine (nmod)
started october (nmod)
had syncope (nmod)
aspirin rats (nmod)
trial immunosuppression (nmod)
deterioration further (amod)
$ROOT$ confirms (sent)
base the (det)
gentamicin kanamycin (conj)
$ROOT$ correlation (sent)
tolerability etoricoxib (nmod)
prevent injury (dobj)
rats immature (amod)
report patient (dobj)
superior locf (nmod)
10.0 and (cc)
effects streptomycin (nmod)
block in (mark)
fibrillation with (case)
levels phosphokinase (compound)
patient chronic (amod)
subpopulation neurons (nmod)
reports 3 (nummod)
safely quickly (conj)
p=0.0001 0.0001 (conj)
concluded had (ccomp)
receive a.m. (nmod)
clearance total (amod)
65 counts (nsubj)
4.8 x (cc)
potentiated response (nsubjpass)
event flushing (nsubj)
performance forgetting (conj)
responsible recovery (nmod)
5.1+/-1.0 ) (punct)
profound transient (dep)
values aminotransferase (compound)
administration rhigf-i (nmod)
nsaids of (case)
levels adrenaline (nmod)
thrombi of (case)
lidocaine- cocaine-induced (conj)
counteracted and (cc)
effects systemic (amod)
eluates the (det)
attenuate but (cc)
gating of (case)
contributes , (punct)
evolution damage (compound)
death 1 (nummod)
associated function (nmod)
hours 3.8 (nummod)
nsvt and (cc)
associations clinical (amod)
volume and (cc)
unaffected parallel (nmod)
supply patients (nmod)
male 24-year-old (amod)
evidence convincing (amod)
toxicity d3 (nmod)
mr severe (amod)
reabsorption patients (nmod)
inhibited prevented (conj)
women 248 (nummod)
generations between (case)
reports toxicity (nmod)
history epilepsy (nmod)
prevented mesna (nmod)
rats epileptic (amod)
ng ng (conj)
agent iii (nummod)
suppressed hs (nmod)
power antioxidant (amod)
tested background (nsubjpass)
sensitive would (aux)
drug less (amod)
chemotherapy lymphoma (nmod)
test type (compound)
c1 , (punct)
roles their (nmod:poss)
flaccid . (punct)
olanzapine t(33 (appos)
techniques immunoblotting (nmod)
myalgia increase (conj)
influenced are (auxpass)
associated reported (conj)
low . (punct)
antagonist activity (nmod)
disability parkinson (compound)
45 59 (conj)
cardiology , (punct)
syndrome consists (acl:relcl)
defect cause (acl:relcl)
woman developed (acl:relcl)
ingestion methysergide (nmod)
infarction : (punct)
juice either (preconj)
findings as (cc)
hypoaidosteronism consequent (amod)
$ROOT$ role (sent)
followed approaches (nsubjpass)
rarer . (punct)
increased regardless (advmod)
confined not (neg)
produce aggravation (nmod)
bradycardia % (nmod)
higher treatment (nmod)
beta 1- (nummod)
cephalosporins first-generation (amod)
levels complement (compound)
defect without (case)
process . (punct)
pointes prolongation (nmod)
dopaminergic tuberoinfundibular (amod)
option is (cop)
remained similar (xcomp)
less , (punct)
dose ly274614 (nmod)
malfunctioning accidental (amod)
copolymers in (case)
40/min - (punct)
leading range (nmod)
cumulative and (cc)
measuring while (mark)
before frequencies (nsubj)
ptra of (case)
efforts patients (nmod)
administered procainamide (nsubjpass)
$ROOT$ spread (sent)
complication rash (nsubj)
appeared rosacea (nsubj)
initiated infusion (nsubjpass)
investigated sensitizes (ccomp)
level acid (compound)
labeling alpha-enac (nmod)
finding : (punct)
rhythms accelerated (amod)
using men (nmod)
mediate trajectory (nmod)
have elevations (dobj)
3.1 or (cc)
$ROOT$ predict (sent)
become whether (mark)
release calcium-independent (amod)
raised patient (nmod)
displayed thus (advmod)
atresia congenital (amod)
attributed be (auxpass)
responsible largely (advmod)
monitored toxicity (nsubjpass)
administered scales (nsubjpass)
trimethoprim alone (advmod)
47 9 (compound)
receptor mglur1 (appos)
myocarditis of (case)
staff nursing (compound)
vasoconstriction of (case)
induced cisplatin (nmod)
subjects most (amod)
practitioners kingdom (nmod)
neurogenesis and (cc)
program nationwide (amod)
effect impairment (nmod)
organisms 4.2 (nummod)
potentials epicardium (nmod)
$ROOT$ complicate (sent)
predisposed have (aux)
case toxicity (nmod)
years respectively (advmod)
increments the (det)
children , (punct)
fas fasl (conj)
modulate receptors (nsubj)
bruising pain (conj)
cardiotoxicity during (dep)
change considering (advcl)
ratio associated (acl)
group related (amod)
sera range (dep)
discontinued given (conj)
indicate 3 (dep)
receive , (punct)
affected action (dobj)
alpha-tocopherol alpha-tc (appos)
doses antibiotics (nmod)
have doses (nsubj)
offer . (punct)
remained unchanged (acomp)
effects in (case)
symptoms on (case)
mg/kg/day 20 (compound)
2 affected (acl:relcl)
enrolment follow-up (conj)
developed jaundice (dobj)
course psychosis (nmod)
cells/mm3 increase (nsubj)
exposures time-dependent (amod)
reviewed pharmacokinetics (nsubjpass)
experienced effects (nsubjpass)
adults health (compound)
times weeks (nmod)
tolerance phenomenon (conj)
tested efficiency (nmod)
fetuses and (cc)
concentration mda (compound)
11.7 ) (punct)
times for (case)
deficits groups (nmod)
deficiency folate (compound)
assessed echocardiography (nmod)
documented induction (nsubjpass)
months age (nmod)
lines selected (amod)
administered we (nsubj)
reversed naloxone (nmod)
beta-agonist known (acl)
hypocalcemia systemic (amod)
clinical histopathologic (conj)
pentobarbital mg/kg (appos)
stains inbred (amod)
hypoxia by (case)
showed furthermore (advmod)
spasm individuals (nmod)
antagonists ionotropic (amod)
demonstrated awakening (nmod)
fulfilled total (nsubj)
discern due (ccomp)
males elevations (nmod)
ability pg-9 (nmod)
exacerbation caused (acl)
test locomotion (nmod)
morbidity transplant-related (amod)
pool atp (compound)
leukemia cml (appos)
concentration intracoronary (amod)
equipotent may (aux)
help substrates (nsubj)
threshold sevoflurane (nmod)
formation colony (compound)
association relation (nmod)
suspected involvement (nsubjpass)
morphine metabolites (conj)
caused absence (nmod)
l1-l2 ( (punct)
rebound of (case)
anaphylaxis penicillin (compound)
rats diet-fed (amod)
hormone serum (compound)
class weight (compound)
consent informed (amod)
one another (det)
mg/kg more (nummod)
appeared reaction (nsubj)
given subcutaneously (advmod)
asthma of (case)
mean (2.2)% (conj)
reduces conjunction (nmod)
all , (punct)
addition is (cop)
thrombopenia and (cc)
% 95 (compound)
rate saturations (conj)
reported are (auxpass)
reactivator agonist (conj)
mg.kg-1 0.03 (nummod)
study an (det)
1 boluses (dobj)
states induced (acl)
arthritis inflammatory (amod)
activities living (nmod)
followed caused (advcl)
6/15 and (cc)
concentrations electrolytes (nmod)
salt-depleted rats (dep)
neurons ir (amod)
comparison glycopyrrolate (nmod)
neonate a (det)
migraine for (case)
administered gestation (nmod)
increases mrna (nmod)
blocker muscarinic (amod)
practice as (case)
cycle dobutamine (nmod)
hyper- three (appos)
activity death (appos)
rate stroke (compound)
rigidity measured (acl)
objective highlight (acl)
mccarthy degkwitz (appos)
one doses (nmod)
performed project (nmod)
protected conclusion (nmod)
suggest preferred (ccomp)
confirm necessity (dobj)
reported neuropathy (nsubjpass)
offer seizures (nmod)
saline antagonist (appos)
gvg of (case)
small age (nmod)
receive because (mark)
resulted but (cc)
group non-seizures (amod)
increased hippocampus (nmod)
$ROOT$ practiced (sent)
cell into (case)
5 10 (conj)
increase duration (nsubj)
performed treatment (nmod)
delay regrowth (nmod)
occurring 1973 (nmod)
changes examined (acl)
shivering jerks (conj)
bornstein 1968 (nummod)
bche p. (compound)
pain cocaineassociated (amod)
lamotrigine ltg (appos)
isomers cibenzoline (nmod)
derangement partially (advmod)
neurons cholinergic (amod)
harvested days (nmod)
subtypes no (neg)
values 58.9 (nummod)
increased treatment (nmod)
monotherapies placebo (conj)
failure from (case)
administration clonidine (nmod)
mitochondria heart (compound)
nucleus nigra (conj)
rises titer (nmod)
reduction threshold (nmod)
colliculus and (cc)
ventilation , (punct)
expression over (amod)
found analysis (nsubj)
cortex outer (conj)
moving residence (nmod)
enhanced ; (punct)
interview records (conj)
pathway eyes (nmod)
(+/-)-sm 3alpha-tropanyl-2-(4-chorophenoxy)butyrate (appos)
stimulation rtms (conj)
expressing : (punct)
standing to (case)
associated abnormalities (nsubjpass)
treatment factors (nmod)
run-in the (det)
differentiate better (advmod)
hepatoma and (cc)
location either (cc:preconj)
trihexyphenidyl mg (compound)
beta-ar of (case)
reporting degree (dobj)
pipette from (case)
erythrocytes volunteers (nmod)
inhibition an (det)
design measures (compound)
procaterol terbutaline (conj)
equal interval (nmod)
disorder or=12.619 (dep)
dimension ventricular (amod)
regard with (case)
rhinitis seasonal (amod)
phenobarbital % (amod)
levels histopathology (appos)
31 these (nmod)
alternation latency (conj)
protect to (mark)
loss considerable (amod)
documentation written (amod)
intermedius nucleus (compound)
diameter arteriolar (amod)
scans patients (nmod)
mice conscious (amod)
norms awake (amod)
intensity/pleasure orgasm (compound)
medicate did (aux)
concentrations m (nmod)
hydroxylase not (neg)
receptor microglial-specific (amod)
904+/-434 1 (compound)
dose infusion (nmod)
cardiotoxicity and (cc)
groups 7 (nummod)
defects = (parataxis)
deglutition of (case)
activity experimental (amod)
administration food (compound)
withdrawn suggested (advcl)
mg/day 75 (nummod)
rates events (nmod)
indication be (cop)
carboplatin subtenon (compound)
imply incidence (dobj)
known indicates (advcl)
fractures ( (punct)
caused carcinogen (nmod)
measured treated (ccomp)
ng/ml ) (punct)
transit the (det)
histochemistry through (case)
ameliorate rigidity (dobj)
tests 4,446 (nummod)
nephroprotectant as (case)
presence acetaminophen (nmod)
begun once (mark)
vte ) (punct)
hitt osteoporosis (conj)
antipsychotic derivative (amod)
demonstrated necessary (conj)
strength contractures (conj)
attenuates : (punct)
known busulfan (nsubjpass)
76 and (cc)
necrosis changes (conj)
lower combinations (nmod)
peg ( (punct)
depressed and (cc)
tested thus (advmod)
normalized alterations (dobj)
decreased output (dobj)
measured resistance (nmod)
area auccgrp (appos)
mellitus insulin-dependent (amod)
improvement majority (nmod)
ratios risk (compound)
sulphadiazine agsd (appos)
sections kidney (compound)
side operative (amod)
control from (case)
effectiveness ranitidine (nmod)
hypertrophy isoproterenol-induced (amod)
enzyme p. (compound)
naming , (punct)
therapy cpa (compound)
given counteract (advcl)
injury steatosis (nmod)
revised ) (punct)
none controls (nmod)
bupropion of (case)
kg(-1 mg (compound)
completed out-patients (nsubj)
1992 to (case)
> years (conj)
lymphoma mantle (compound)
conclude restarted (ccomp)
effect was (cop)
125 150 (conj)
development cases (nmod)
appearances the (det)
dosing for (case)
males diet (nmod)
evaluation audiologic (amod)
call certainly (advmod)
group i (nummod)
reverse of (nmod)
result dysfunction (nmod)
d 6 (nummod)
receptor orphan (compound)
sulphate were (cop)
2.1 ; (punct)
reactions treatment (nmod)
0.6 5.8 (conj)
aes , (punct)
nine compared (case)
absolute attributable (conj)
spasm level (nmod)
reperfusion during (case)
selective thus (advmod)
irritability and (cc)
brain from (case)
asymptomatic and (cc)
pbto(2 ( (punct)
strong not (neg)
granulomatosis for (case)
hypertension diabetes (conj)
alpha-2b ( (punct)
corresponds , (punct)
contents malondialdehyde (compound)
uptake [(3)h]norepinephrine (compound)
measured patients (nmod)
methods prevent (acl)
experienced infarctions (dobj)
adducts protein (compound)
infections tissue (compound)
decreased extent (conj)
indicate developed (ccomp)
include reactions (nsubj)
mm from (case)
carriers ve (amod)
difficulties emerging (amod)
$ROOT$ coexisted (sent)
more six (nummod)
76 10(9)/l (conj)
regurgitation level (conj)
inhibition oxidase (nmod)
myocytes of (case)
locomotion in (case)
attended day (nmod)
$ROOT$ paid (sent)
subjects three (nummod)
admitted , (punct)
profile deficits (nmod)
example case (nsubj)
frequency instability (conj)
evokes hypotension (nsubj)
study cross-sectional (amod)
values microm (nmod)
prevented cpa (nsubj)
conclusions indicated (appos)
overlooked manifestations (nsubjpass)
nephrotoxicity regimens (nmod)
dysfunction cognitive (amod)
analogue 22-oxacalcitriol (appos)
agent cytotoxic (amod)
neovascularization as (cc)
described years (nmod)
morphine residual (amod)
avoid in (mark)
induced subsequently (advmod)
standard myeloma (nmod)
factor incidence (nmod)
present that (mark)
samples days (nmod)
observed blockade (nsubjpass)
ducts internal (amod)
evaluate determine (advcl)
patients eighty (nummod)
patients randomized (amod)
therapy estrogen (compound)
described thrombosis (nsubjpass)
exhibit chemotherapy (nsubj)
2a and (cc)
drugs given (acl)
therapy thrombocytopenia (nmod)
amount exposure (nmod)
leads therapy (nsubj)
mitochondria with (case)
primarily this (nsubj)
history tests (nmod)
ester : (punct)
caused anemia (dobj)
suitable , (punct)
w-ich human (amod)
0.6 and (cc)
research as (cc)
indicators be (cop)
receiving clonidine (dobj)
dysfunction seen (acl)
acetate leuprolide (compound)
ototoxicity and (cc)
sod in (case)
granules on (case)
severe irreversible (conj)
evaluated reported (conj)
use usa (nmod)
reported first (advmod)
decreased thus (advmod)
importance any (det)
prudent be (cop)
sprouting and (cc)
trial present (amod)
longer similar (advcl)
recognition and (cc)
angiography resonance (compound)
remissions 5 (nummod)
m1 for (case)
antibiotics cephalosporin (compound)
patients therapy-na (amod)
studies induction (compound)
amplified , (punct)
persist when (advmod)
infarction macular (amod)
lnna inhibitor (compound)
results demonstrated (appos)
background available (dep)
resulted furthermore (advmod)
conclusions teratogenic (dep)
test mif (compound)
3tc 3tc (conj)
% 39 (nummod)
time slow-wave (amod)
myocardium ischemic (amod)
hemoptysis with (case)
state confused (amod)
occurs injury (nsubj)
measured man (nmod)
t.d.s. mg (amod)
triggering mechanism (nmod)
enhanced effects (dobj)
kinase mitochondrial (amod)
loss children (nmod)
reported purpose (nsubjpass)
analyzed determine (xcomp)
illness febrile (amod)
diet mmol/kg (appos)
responses systemic (amod)
changes catalepsy (nmod)
pet ) (punct)
resumed normotension (nsubjpass)
activation hbv (compound)
score and (cc)
synergism the (det)
described infrequently (advmod)
normalized contractility (nsubj)
mice deletion (nmod)
failed also (advmod)
injection ntg (nmod)
red with (case)
hypotension nitroprusside-induced (amod)
occlusions bilateral (amod)
severity changes (conj)
assessed effects (dobj)
covered review (nmod)
generated was (auxpass)
measure as (case)
analysis leiden (nmod)
significant threshold (nsubj)
circled ipsilaterally (advmod)
indexed lvdp/dtmax (nmod)
very somewhat (conj)
leukemia lymphoblastic (amod)
treated mg/day (conj)
hypoglycemia and (cc)
difference overflow (nmod)
group ; (punct)
dysfunction conditions (nmod)
treatment dox (compound)
heparin dipyridamole (conj)
consultations including (case)
tubule within (case)
oedema marrow (compound)
regained potassium (nsubjpass)
o-a ( (punct)
cancer contre (compound)
280+/-17 vs. (cc)
6.87 2.25 (conj)
stimulating 2-adrenoceptor (compound)
leads avf (appos)
trial carcinoma (nmod)
presents type (ccomp)
mol/l respectively (advmod)
n ) (punct)
2 8 (conj)
attributable been (cop)
arrhythmia dogs (nmod)
cycle a (det)
damage induced (acl)
tool valuable (amod)
had months (conj)
drugs risperidone (conj)
abilities memory-altering (amod)
tachyarrhythmia triggered (acl)
induced whereby (advmod)
measure concentrations (dobj)
noted discontinuing (advcl)
night day (conj)
3',5'-monophosphate cyclic (amod)
antagonist idazoxan (appos)
monitored diameter (nsubjpass)
observed recipients (nmod)
induced neurotensin (nmod)
total only (advmod)
determine altered (ccomp)
risperidone olanzapine (conj)
cacl2 or (cc)
response attack (nmod)
delta alpha-sigma (conj)
depends needed (conj)
lisinopril inhibitor (appos)
imaging cranial (amod)
vision ishihara (appos)
paralysis to (case)
beverages water (nmod)
concentration analysed (amod)
contribute approaches (nsubj)
percent eighty-seven (nummod)
ng/ml. to (case)
antagonism to (case)
positive samples (nsubj)
implantation recording (conj)
scores and (cc)
youth in (case)
movements jerking (compound)
block axillary (amod)
similar adults (nmod)
syndrome renal (amod)
additive or (cc)
progressed lesions (nmod)
followed prospectively (advmod)
received piglets (nsubj)
vacuolization tubular (amod)
went hospitalizations (nmod)
bodyweight by (case)
increase convulsions (conj)
- 8 (nummod)
determined centrally (advmod)
anaesthetized . (punct)
irrigated , (punct)
using modeling (dobj)
degree function (nmod)
users the (det)
ketamine followed (acl)
beraprost prostacyclin (compound)
malignancies a (appos)
identify measurement (nsubj)
factors exposure (conj)
alterations occurring (acl)
times days (dep)
recurs always (advmod)
dopamine contents (conj)
patients pretreated (acl)
number smaller (amod)
quantified hours (nmod:tmod)
controls 21 (nummod)
terminology pathogenesis (conj)
saline acute (amod)
measurement ratios (conj)
activated areas (nsubjpass)
calcium ) (punct)
infusion chronic (amod)
defect system (nmod)
leukomalacia and (cc)
min ; (punct)
rate response (nmod)
prevention breast (compound)
exert configuration (nmod)
given intravesically (advmod)
apparent . (punct)
bicyclo-orthobenzoate t-butyl (compound)
concluded contribute (ccomp)
levels 2b1/2b2 (nmod)
is outcome (nsubj)
adults 50 (nummod)
forms in (case)
lesions marked (amod)
min-1 min-1 (conj)
increased % (dobj)
tomographic ct (appos)
larger those (nmod)
electrocardiograph ii (nummod)
updrs , (punct)
reflex vestibulo-ocular (amod)
dosed was (auxpass)
5 > (advmod)
reward morphine (compound)
considered which (nmod)
tract from (case)
rebleeding patients (nmod)
transmission in (case)
nephritis ciprofloxacin-induced (amod)
leading move (xcomp)
difference index (nmod)
u/l 513 (nummod)
therapy interferon (nmod)
encouraged results (nsubj)
$ROOT$ hepatitis (sent)
demonstrate contrast (conj)
basis elicit (acl)
taking headache (nmod)
problem , (punct)
utilization procedures (nmod)
errors of (case)
1.21 ( (punct)
polyphenol linn (nmod)
carcinostatics of (case)
kinase , (punct)
lignocaine of (case)
rate progression (nmod)
theophylline than (case)
gene functional (amod)
pgads ) (punct)
programmed if (mark)
apnoea of (case)
relation an (det)
microscopy tem (appos)
application cortical (amod)
treatment c (compound)
sodium piperacillin (compound)
$ROOT$ tried (sent)
patients , (punct)
subtypes receptor (compound)
dose high (amod)
regimens prior (amod)
rats two (nummod)
investigations capacity (nmod)
attributed speed (nmod)
homogenates from (case)
effect estradiol (nmod)
reuptake serotonin (nmod)
prevented scopolamine (nsubj)
risks aprotinin (nmod)
animals compared (case)
severe headache (nsubj)
$ROOT$ diminishes (sent)
prove formulations (nsubj)
troublesome remained (conj)
mediate excess (nmod)
c. than (case)
nad enzyme (nmod:poss)
except mice (nmod)
conclusions proposed (dep)
tachyarrhythmia ventricular (amod)
variables the (det)
received counseling (dobj)
phase double-blind (amod)
pod 14 (conj)
median for (case)
keep ng/ml (dobj)
interval 3-week (amod)
induced properties (nmod)
electrocardiogram of (case)
feature a (det)
hepatic or (cc)
behavior climbing (compound)
months 4 (nummod)
is reduction (nsubj)
haloperidol-treated and (cc)
registry a (det)
role synthesis/release (nmod)
nodosum acid-induced (amod)
diffuse , (punct)
hemiparesis . (punct)
free nad-precursors (nmod)
doses one (nummod)
diagnosed delirium (nmod)
nuclei brainstem (nmod)
responds . (punct)
elicits microinjection (nsubj)
diagnosis a (det)
injury edema (conj)
seizures amphetamine-induced (amod)
damage basic (amod)
0.05 0.06 (conj)
76 older (conj)
-21.3 ( (punct)
differ medications. (nmod)
lithium anomaly (conj)
zo-1 and (cc)
mask face (compound)
characterized rash (nmod)
bronchopneumonia of (case)
ap ( (punct)
newborn and (cc)
appears case (xcomp)
was arteries (nmod)
adrenergic ortral (amod)
determining after (mark)
infusion stenosis (nmod)
complications device-related (amod)
correlate concentration (nmod)
action system (nmod)
prevented lf (nsubj)
absorption interaction (conj)
hyperlipoproteinemias primary (amod)
spectrum injury (nmod)
reduced contrary (nmod)
neurotransmission in (case)
bigeminy and (cc)
$ROOT$ dexmedetomidine (sent)
duct . (punct)
patients status (nmod)
hour over (case)
weeks another (det)
observed increase (nmod)
sections in (case)
registration registered (acl)
considered doses (xcomp)
analysis cox (compound)
protects cardiotoxicity (nmod)
diseases of (case)
observation values (nmod)
conclusion play (dep)
active biologically (advmod)
factors increase (nsubj)
had incidences (dobj)
striatum animals (nmod)
reported involving (advcl)
management hit (nmod)
dye the (det)
drugs study (compound)
characterized use (nmod)
49 18 (quantmod)
0.26 ci (appos)
need despite (case)
received hr (parataxis)
iprindole with (case)
tacrolimus then (advmod)
desferrioxamine dfx (appos)
events by (case)
marked was (auxpass)
polymorphism region (nmod)
parameters : (punct)
cells/microl 260 (nummod)
n-acetyl-beta-d-glucosaminidase nag (appos)
aspiration signs (conj)
pain signs (nsubj)
manageable cases (nsubj)
wk for (case)
secretion cortisol (nmod)
23.5 , (punct)
awake , (punct)
gastrocnemius and (cc)
caused blockade (nsubj)
loss partial (amod)
presence hbeag (nmod)
beta-blocker selective (amod)
irreversible and (cc)
potentiate arrhythmogenicity (dobj)
asa ) (punct)
peroxisomes in (case)
white-cell neutrophil (conj)
caffeine ) (punct)
addition propofol (nmod)
woman 21-year-old (amod)
populations patients (nmod)
number outcome (nsubj)
declined reaching (advcl)
mg bid (dep)
reported studies (nmod)
agonist histamine (compound)
plasma glucosuria (conj)
needed method (nsubjpass)
recumbent upright (conj)
% 89.7 (nummod)
oxidation the (det)
$ROOT$ excluded (sent)
period trial (compound)
normalisation abnormalities (nmod)
bisphosphonate sodium (appos)
high produce (ccomp)
variables pre- (amod)
diameters in (case)
clotting impaired (amod)
micrograms micrograms (conj)
required aids (dobj)
offer range (nmod)
adhesions because (case)
given design (nmod)
expression hepatic (amod)
occur weeks (nmod)
hg diastolic (amod)
events = (dep)
report amount (dobj)
threshold mechanical (amod)
positions in (case)
region of (case)
plugs due (case)
receiving six (nsubj)
retard blockade (nsubj)
tested behavior (nsubjpass)
preventing linkages (dobj)
differences groups (nmod)
enhance effects (dobj)
received convert (advcl)
showed men (nmod)
reduced tablet (dobj)
change . (punct)
subunits alpha-enac (compound)
restricted dosage (nsubjpass)
incident initial (amod)
consisted lag (nsubj)
placebo rr (dep)
stabilized neuropathy (nsubj)
confusion progressive (amod)
showed increased (ccomp)
reaction short-term (amod)
lobe on (case)
evaluation ratio (nmod)
potential action (compound)
aminotransferase compared (case)
eliciting in (mark)
metabolism : (punct)
incidence treatment (conj)
postpartum the (det)
antagonized effects (dobj)
noradrenergic specific (conj)
treatment dithiothreitol (nmod)
sacrificed dose (nmod)
prevented tcr (nsubj)
degeneration cytoplasmic (amod)
flurothyl picrotoxin (conj)
smokers were (cop)
discharged can (aux)
u/l 1,700 (nummod)
choice therapeutic (amod)
mg/m2 2600 (nummod)
exposed cocaine (nmod)
developed interval (nmod)
less be (cop)
trial retention (compound)
tarsorrhaphy defects (nmod)
0.1 versus (cc)
dbp , (punct)
reduction pain (nmod)
response oxytocin (nmod)
cytokines il-1b (nmod)
mass pitfall (appos)
that patients (nmod)
sparse are (cop)
amounts oxide (nmod)
nitrolingual ( (punct)
severity dose (conj)
seen however (advmod)
midazolan mz (appos)
conjunction evidence (nmod)
immunosuppressants but (cc)
dihydrochloride n (compound)
necessary observe (xcomp)
symptoms pretreatment (amod)
feedback by (case)
220 - (dep)
preventing thus (advmod)
responds increasing (advcl)
factor no (neg)
micrograms at (case)
involved neuroplasticity (nmod)
initiation hemodialysis (nmod)
derivative benzamide (compound)
changes mitochondrial (amod)
reviewed assessed (conj)
drugs putative (amod)
coma precipitated (acl)
pancreaticobiliary , (punct)
mice lithium-treated (amod)
inhibitor a (det)
re of (case)
% -13.3 (nummod)
observations carried (acl)
minimized selecting (advcl)
determine to (mark)
similar min (dep)
apoptosis , (punct)
26- 87- (conj)
origin are (cop)
curve plasma (compound)
hypertrophy congestion (nmod)
establishes conclusion (nsubj)
suggests ; (punct)
confirm seriousness (dobj)
g/day se (appos)
evidence this (det)
improved hydroxytyrosol (nsubj)
evening in (case)
$ROOT$ attracted (sent)
accumulation rapid (amod)
concentration heparin (compound)
1.86 mmhg/ml (dep)
acidosis , (punct)
hbeag-negative an (det)
recived patients (nsubj)
aracytine-c after (case)
hyperactivity rats (nmod)
episode antimicrobial-induced (amod)
runs tachycardia (nmod)
scans brain (compound)
oat of (case)
disease thromboembolic (amod)
vector a (det)
days thereafter (advmod)
involved pituitary (nmod)
rejection survival (conj)
benzo[a]-pyrene and (cc)
associated cephalosporins (nsubjpass)
found decreased (xcomp)
1- or (cc)
$ROOT$ insipidus (sent)
qt of (case)
testosterone less (amod)
participants all (det)
indices fraction (nmod)
$ROOT$ vasculitis (sent)
frequency with (case)
occurrence glomerulonephritis (nmod)
occurrence and (cc)
hypertension infusion (nmod)
29 of (advmod)
doses dexrazoxane (nmod)
solution gellan (conj)
evoke signs (dobj)
haplotypes disequilibrium (nmod)
indicate 4 (dep)
ml than (case)
reliable simple (conj)
piroxicam and (cc)
45.45 44.4 (conj)
reduction % (appos)
reported myalgia (dobj)
due anaemia (nsubj)
properties . (punct)
1/500 than (quantmod)
implants of (case)
0.24:1 ; (punct)
reported documentation (nmod)
compared concentrations (dobj)
characteristics with (case)
five disease (nmod)
mouse-1 in (case)
assessed analyses (nmod)
was decrease (attr)
associated injection (nmod)
had mellitus (dobj)
2e1 and (cc)
infiltration , (punct)
useful is (cop)
maintained four (nmod)
worsening in (case)
increased mmol/l (nmod)
patients caucasian (amod)
collection of (case)
none and (cc)
showed p (dep)
decreased frequency (nsubj)
induce whether (mark)
animals injected (amod)
38 p9605 (nmod)
efflux of (case)
defined not (neg)
iu/l 175 (nummod)
l-dopa+benserazide ( (punct)
patterns prior (amod)
arteries , (punct)
july 2001 (nummod)
beating atrial (amod)
binding nonimmunologic (amod)
decreasing to (mark)
indicated monitoring (nsubjpass)
vcm plus (cc)
latency-to-onset the (det)
withdrawn patients (nmod)
ca3 ca1 (conj)
representative was (cop)
designed regimens (nsubjpass)
drugs all (det)
$ROOT$ reproducible (sent)
features hematologic (amod)
treatment aspirin (nmod)
episodes anginal (amod)
$ROOT$ consciousness (sent)
doses edrophonium (nmod)
condition lead (acl:relcl)
protein differentiation (compound)
isradipine or (cc)
rechallenge inadvertent (amod)
7.73 - (punct)
prevent however (advmod)
days exposure (compound)
to class (nmod)
stage - (punct)
chloroform-adrenaline cent (appos)
rr=1.60 ptrend=0.02 (dep)
morphology the (det)
had eight (nsubj)
substantial rats (nmod)
given combination (nmod)
low-salt ls (appos)
= .0002 (dobj)
1.04 +/- (cc)
compares reasonably (advmod)
160 80 (compound)
prove dce (nsubj)
evaluated monotherapy (dobj)
lips the (det)
reaction lethal (amod)
cis-platin mg/m2bsa (appos)
mechanism transformation (nmod)
rate as (case)
analyzed days (nmod)
unlikely participate (xcomp)
june from (case)
less increasing (advcl)
pressure closure (compound)
investigation . (punct)
that left (nmod)
duration efficacy (nmod)
fluoroquinolone a (det)
12 of (case)
level per (case)
score child-pugh (compound)
mice pilocarpine-treated (amod)
granulomas histologic (amod)
analyzed study (nsubj)
deactivations stimulus-induced (amod)
admission intubation (conj)
related changes (nsubj)
subtypes possible (amod)
alpha-configuration with (case)
divided had (conj)
requirements antiemetic (amod)
dyes with (case)
decreased is (auxpass)
normalizes treatment (nsubj)
brain heart (conj)
l-noarg ip (appos)
differences not (neg)
diabetic baseline (nmod)
observed speaking (nmod)
inflexibility perseveration (dep)
obscure defined (conj)
affected obviously (advmod)
recognised not (neg)
dermatitis lichenoid (compound)
mechanisms pathophysiologic (amod)
abuse cocaine (compound)
used explore (xcomp)
behavioral drug-induced (amod)
aspirin acid (appos)
quantities measurable (amod)
failure or (cc)
block dose (nmod)
1ug i.c.v. (appos)
results exhibited (appos)
structure process (nmod)
drinks > (amod)
dex ( (punct)
background represents (appos)
d 15 (nummod)
incidence malformations (nmod)
january from (case)
cas 5 (appos)
providing management (dobj)
range . (punct)
investigated ruled (conj)
mechanism changes (nmod)
rats developing (amod)
tolerable it (nsubj)
administered part (nmod)
content glutathione (compound)
ketamine lidocaine (conj)
design analysis (conj)
combination dose (nmod)
found active (xcomp)
ng/dl . (dep)
thrombocytopenia fever (conj)
occlusion vein (compound)
began reporting (xcomp)
measurements structural (amod)
returned later (advmod)
patients amyloidosis (nmod)
tests subsequent (amod)
compared outcomes (dobj)
infusion 5-fluorouracil (compound)
angiography ultrasound (conj)
help recognize (ccomp)
scores child-pugh (compound)
joint of (case)
group separate (amod)
head ( (punct)
correlate that (mark)
drinks day (nmod)
preventing and (cc)
identify 1995 (nmod:tmod)
develop however (advmod)
model address (acl:relcl)
control bleeding (dobj)
uncertainty norms (nmod)
schedule intra-patient (amod)
predilection intense (amod)
ligands of (case)
rectified experienced (ccomp)
reserpine the (det)
have twenty-one (nsubj)
excretion consumption (conj)
indicate mediate (ccomp)
hypothesis the (det)
were since (mark)
2-acetylaminofluorene coupled (acl)
confined patients (nmod)
mass patient (nmod)
syndrome treatment (nmod)
changes status (nmod)
under-appreciated and (cc)
sulphate ( (punct)
concentration gas (nmod)
association loss (nmod)
cultures analysis (conj)
roles lipopolysaccharide (nmod)
treatment ciprofloxacin (nmod)
overflow stimulus-induced (amod)
rare : (punct)
syndrome partial (amod)
defined quantitatively (advmod)
alterations metabolism (nmod)
toxicities neuropathy (conj)
activator foci (nmod)
affected incidence (dobj)
2 7 (conj)
vnr ) (punct)
showed rats (nsubj)
p45 ) (punct)
times ten (compound)
administration gtn (compound)
monitor levels (dobj)
site opioid (compound)
drugs ib (compound)
is drawback (nsubj)
afterdepolarization evidence (dep)
seizures tac-related (amod)
causes stimulates (conj)
g. roberts (compound)
need vaccination (dobj)
determination at (case)
two not (dep)
patients treated (amod)
mediated non-receptor (amod)
fbal ( (punct)
recovery hypertension (nmod)
occupancy receptor (compound)
fluctuations of (case)
expression cd36 (compound)
has defined (xcomp)
spasm ischemia (conj)
mmc m-2 (compound)
eye right (amod)
examined populations (nsubjpass)
region growth (compound)
evaluated surgery (nmod)
pathway main (amod)
cisternae dilated (amod)
convulsions local-anesthetics-induced (amod)
dosage for (case)
comparable delay (nsubj)
assigned methods (nsubjpass)
due carbamazepine (nmod)
ranged level (nsubj)
mpo-anca ) (punct)
aminotransferase increased (amod)
vesicles of (case)
agents hypolipidaemic (amod)
papilledema cerebri (conj)
protection mitochondria (compound)
individuals certain (amod)
hospitals same (amod)
levels dismutase (compound)
mg/kg 3 (nummod)
suggested consistent (ccomp)
received libitum (advmod)
acrolein doses (nmod)
mononucleosis one (nummod)
effect local (amod)
facilitate will (aux)
aap ; (punct)
associated increase (nsubjpass)
abundance nhe3 (nmod)
hydromorphone ) (punct)
callosum the (det)
changes persistent (amod)
monkeys adult (amod)
standard is (cop)
results reperfusion (nsubj)
rechallenge cephalosporin (nmod)
peptide(1 42)-infused (punct)
$ROOT$ exhibite (sent)
stages experiment (nmod)
infusion 1-hour (amod)
evidence quantitative (amod)
axons ) (punct)
function gallbladder (compound)
mechanism leading (acl)
macrophages monocyte-derived (amod)
taken guinea-pigs.5 (nmod)
inhibition cysteine (compound)
play sedation (nsubj)
chicks control (compound)
reye in (case)
approval consent (conj)
inhibitor glyt1 (compound)
responses therapeutic (amod)
medications properties (nmod)
measure telemetry (nmod)
exceed although (mark)
system flow (compound)
superior proportions (nmod)
warranted , (punct)
hyponatremia failure (conj)
symptoms gastrointestinal (amod)
minutes initiating (advcl)
exacerbated nausea (dobj)
effect topiramate (nmod)
csa csa (conj)
region promoter (compound)
use methamphetamine (nmod)
patients att-alf (nmod)
neurotoxicity meth-induced (amod)
set second (amod)
plexus lumbar (amod)
modulation gabapentin-induced (amod)
doses denopamine (nmod)
likely reproduce (xcomp)
examined 1 (meta)
nitrate pilocarpine (compound)
had nine (nsubj)
lovastatin excel (appos)
due nicergoline (nmod)
have duct (dobj)
end through (case)
cocaine alone (advmod)
drinking pregnancy (nmod)
rhythm alternative (amod)
anuria of (case)
dismissed can (neg)
effectiveness fentanyl (nmod)
undertaken studies (nsubjpass)
recorded day (nmod)
outcomes latent (amod)
co-administration 2-sulfanylethanesulfonate (nmod)
processes perivascular (amod)
decreased hyperemia (dobj)
models neurotoxicity (nmod)
44 16 (compound)
gm arabic (amod)
suggest data (advcl)
action primary (amod)
seems effectiveness (nsubj)
e4031 terfenadine (conj)
surgery limb (compound)
beams amounts (conj)
starting infusions (dobj)
therapy in (case)
case associated (acl)
assessments serial (amod)
limit can (aux)
hepatotoxicity in (case)
conclude severe (ccomp)
changed dose (nsubjpass)
activation during (case)
points those (det)
lumen and (cc)
catheterization cardiac (amod)
information more (amod)
isotretinoin to (case)
five % (appos)
organization health (compound)
was increase (nsubj)
he-lfb ) (punct)
tumor glioblastoma (nsubj)
normal test (nsubj)
failed have (aux)
pleased percent (nsubj)
dose median (amod)
0 1 (conj)
dogs receiving (acl)
intake c (compound)
responsible quinidine (nsubj)
india in (case)
hemolysis suspensions (nmod)
ascites pulmonale (conj)
carrier saline (compound)
complexes blocks (nmod)
able resulted (advcl)
task used (acl)
mmol/l 128 (nummod)
period treatment (compound)
% 54.2 (nummod)
anesthetic employed (acl)
treatment instillation (nmod)
den with (case)
vision people (nmod)
2-sulfanylethanesulfonate sodium (compound)
surviving hours (nmod:tmod)
receive modafinil (dobj)
episodes disturbances (nmod)
effects analog (nmod)
warranted testing (nsubjpass)
documented onset (nsubjpass)
materials investigated (dep)
passed found (conj)
hour and (cc)
reduced where (advmod)
hospitals in (case)
insertion chain (nmod)
mrna adam-17 (compound)
child neurologically-impaired (amod)
period longer (amod)
atrophy also (advmod)
models various (amod)
administered patient (nmod)
cent ( (punct)
symptoms without (case)
showed appearance (dobj)
$ROOT$ diligent (sent)
thromboembolism stroke (conj)
true especially (advmod)
$ROOT$ apposed (sent)
mitochondrial nucleus-encoded (amod)
heart dogs (nmod)
taqid rs6277 (conj)
failed cacl2 (nsubj)
regression logistic (amod)
audiograms conduction (compound)
dose galactose (compound)
loss ataxia (conj)
suggest displays (ccomp)
report case (nmod)
correlates and (cc)
occurring secondary (xcomp)
globulin and (cc)
mg/m2 adriamycin (nmod)
born term (nmod)
evaluation markers (nmod)
dose scopolamine (nmod)
finding differ (ccomp)
position at (case)
subunit channel (compound)
decreased both (nsubjpass)
pain inflammatory (amod)
reaction drugs (nmod)
pbo + (cc)
use absence (nmod)
inventory satisfaction (nmod)
use particular (nmod)
interaction stimuli (nmod)
used antagonists (nsubjpass)
offer might (aux)
well reasonably (advmod)
agent antiplatelet (amod)
beta1 factor (compound)
indicated interruption (nsubjpass)
ratio stroke (nmod)
= 0.5 (dobj)
mmhg , (punct)
response apomorphine (nmod)
jaundice itching (conj)
become regimen (attr)
levels alt (compound)
delirium patients (nmod)
effects chemotherapy (nmod)
b6 , (punct)
enalapril : (punct)
patients leukemia (nmod)
glutamate in (case)
duration quality (conj)
examination baseline (nmod)
developed yr (dep)
assessments in (case)
patients 46 (nummod)
disturbances the (det)
pethidine norpethidine (conj)
risk strokes (nmod)
rate thalidomide (nmod)
ato ) (punct)
bid -16.2 (appos)
superior overall (advmod)
standpoint from (case)
discontinued therapy (nsubjpass)
myocardium predisposed (amod)
many patients (nmod)
continue total (nmod)
edds 58 (nummod)
= 0.0004 (dobj)
quantitatively both (preconj)
bronchorrhoea and (cc)
< % (dep)
diet- placebo-controlled (conj)
exhibiting protecting (advcl)
injection triamcinolone (nmod)
corrected has (aux)
output co (appos)
performed prospectively (advmod)
precedes . (punct)
hypotension block (conj)
diarrhea events (nsubj)
block ibpb (appos)
phenobarbital pgp (compound)
restore . (punct)
pcpa ) (punct)
t alone (advmod)
avoided however (advmod)
system glycine (compound)
comparable that (nsubj)
common but (cc)
manifestations serve (acl:relcl)
receptor by (case)
given she (nsubjpass)
angina of (case)
years use (nmod)
transketolase abnormal (amod)
disorders pain (compound)
pattern exact (amod)
alterations pd (nmod)
responses vascular (amod)
correlated effects (nmod)
rhei rhubarb (appos)
dose needed (acl)
addition damage (nmod)
more fold (nmod:npmod)
cause compared (advcl)
fetuses for (case)
tests standard (amod)
tdr ) (punct)
animals transgenic (amod)
present while (mark)
cycle this (det)
linkages hydroxyl (compound)
activity bioelectrical (amod)
results high (appos)
treated fdc (nmod)
involves interaction (dobj)
dyskinesias lid (appos)
arrhythmia : (punct)
extract carota (compound)
a.m. 11:30 (nummod)
period recording (nmod)
profile the (det)
occlusion fluoxetine (conj)
pneumonitis effusion (nmod)
ph to (case)
reduction from (case)
changes value (nmod)
metamizol with (case)
measurement or (cc)
domperidone mg/kg (appos)
applied means (nmod)
uninephrectomy or (cc)
suspected patients (nsubjpass)
asymptomatic even (advmod)
content ventricular (amod)
temocapril mg/kg/day (appos)
therapy acute (amod)
days injection (nmod)
due weakness (nsubj)
detected that (mark)
negative moderate (amod)
that adults (nsubj)
aptt ( (punct)
performed angiography (nsubjpass)
% 82 (nummod)
result vasoconstriction (nmod)
mg placebo (conj)
onset extent (conj)
pathway in (case)
neuropathy subacute (amod)
mg/dl ) (punct)
associated desvenlafaxine (nmod)
sessions to (case)
aggregation glomeruli (nmod)
patients be (cop)
had mice (nmod)
stimulation day (nmod)
antibodies 4 (nummod)
quiescent ra (nsubj)
adrenaline , (punct)
useful baclofen (nsubj)
pronounced also (advmod)
achieved interval (dep)
method a (det)
subjects 2 (dep)
concordance localization (nmod)
42.5 ) (punct)
developing function (dobj)
determine acidity (ccomp)
coefficient random (amod)
gap the (det)
treated non-lithium-treated (conj)
anesthesia repair (nmod)
failure and (cc)
100 600 (conj)
neurons the (det)
seen children (nmod)
became they (nsubj)
test reaching (compound)
developed had (conj)
wastage muscle (compound)
year-old forty-six (compound)
$ROOT$ undergoing (sent)
css10 css18 (conj)
professionals healthcare (compound)
reported had (aux)
control respiration (nmod)
evidenced this (nsubjpass)
weight baseline (amod)
virus fibrillation (conj)
drive compensatory (amod)
antagonists hypotension (conj)
responsible absorption (nsubj)
downregulating , (punct)
hypothesis mediated (ccomp)
signs decrease (nsubj)
hypothyroidism by (case)
agents new (amod)
fi pro (amod)
membrane luminal (amod)
reports six (nummod)
endpoint to (case)
study patient (compound)
bradycardia , (punct)
state former (amod)
were distribution (nmod)
dose combination (compound)
accompanied production (nmod)
radiotherapy and/or (cc)
lack teratogenicity (nmod)
obtain therapy (nsubj)
pilo ( (punct)
anesthesia by (case)
staining atpase (compound)
gyki-41 chlorpropanol (appos)
height and (cc)
cyclophosphamide infusional (amod)
release sustained (amod)
consumption o2 (compound)
derivative improve (acl:relcl)
ly-171555 hydrochloride (appos)
receptors alpha-1 (compound)
turnover activity (conj)
implanted treatment (nmod)
rfca ) (punct)
haematological toxicities (nsubj)
prescribing adults (nmod)
groups non-drug (dep)
regulation cytokines (nmod)
girl in (case)
went . (punct)
synthase inducible (amod)
present if (mark)
investigate correlates (ccomp)
therapy srl (compound)
been fatalities (attr)
powders bicarbonate (compound)
myocytes rat (compound)
$ROOT$ promoted (sent)
interference both (cc:preconj)
suspected interference (nsubjpass)
p=0.345 ) (punct)
obtained drinkers (nmod)
volume presence (conj)
provision substrate (nmod)
appearance incidence (conj)
action an (det)
reported known (ccomp)
eliminated binding (dobj)
concluded that (advcl)
modulation release (nmod)
antagonist by (case)
continued recovered (advcl)
60 4 (compound)
epilepsy pilocarpine-induced (amod)
slow . (punct)
dyskinesia with (nmod)
evidence dysfunction (nmod)
contrast protection (nmod)
reduces rates (dobj)
% 30.7 (nummod)
injection respectively (advmod)
tests spasm (compound)
benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate abecarrnil (appos)
in patient (nsubj)
increased counts (nsubjpass)
girl 5-year-old (amod)
recovery erythron (nmod)
was found (dep)
revealed stain (xcomp)
change peak (amod)
suggested patients (nmod)
media tested (amod)
medulla renal (amod)
aminophylline particularly (advmod)
rats scopolamine-injected (amod)
rats ds (appos)
28 2 (conj)
2-(p-bromophenyl)propionate micrograms/mouse (appos)
risk inducing (advcl)
administered months (nmod:npmod)
at below (conj)
$ROOT$ recognize (sent)
voltammetry staining (conj)
desensitization purinoceptor (compound)
reports for (case)
inhibitor xa (compound)
bromide theophylline (conj)
derives so (advmod)
1ml/kg , (punct)
background report (appos)
0.52 1.23 (conj)
flow surgery (nmod)
delta down (advmod)
checklist the (det)
withheld beta-agonists (nsubjpass)
terms main (amod)
required regimens (nsubjpass)
manifested hypotension (nmod)
suffered who (nsubj)
pretreated or (cc)
brain and (cc)
population a (det)
stenosis fixed (amod)
p2x3 antagonists (conj)
given % (nmod)
weeks weeks (parataxis)
agreement a (det)
etoposide doxorubicin (conj)
l-med l-isomer (dep)
epilepticus after (case)
= rr (nsubj)
causing of (mark)
repaired days (nmod)
increased moreover (advmod)
potassium of (case)
somnolence , (punct)
% either (cc:preconj)
ensued expired (conj)
enflurane administered (acl)
34 to (quantmod)
deferens rabbit (compound)
neurotoxicity mellitus (conj)
trihexyphenidyl administered (acl)
studied has (aux)
cells lobe (nmod)
administration sertraline (compound)
opener ( (punct)
control 90/hypertension (conj)
damage microscopic (amod)
phase chronic (amod)
challenged were (auxpass)
modulating expression (dobj)
function presented (acl:relcl)
free ) (punct)
mucosa in (case)
cystectomy radical (amod)
electro-oculography . (punct)
group prevented (acl:relcl)
mitigated response (nsubjpass)
neurobehavioral biochemical (conj)
done case (nmod)
tumor small (amod)
thought that (nsubjpass)
diminished were (auxpass)
min within (case)
leads retention (nmod)
accompanied is (auxpass)
appeared defects (nsubj)
gain the (det)
poor the (det)
hypotension induced (amod)
bradycardia persistent (amod)
received which (nsubj)
cgmp ( (punct)
antibodies antineutrophil (amod)
associated morbidity (nmod)
pattern pattern (conj)
warranted evaluation (nsubjpass)
units 55 (nummod)
data valdecoxib (nmod)
single or (cc)
opportunity study (acl)
biopsies 4 (nummod)
anemia ribavirin-induced (amod)
casts and (cc)
pain related (amod)
accl0131 on (case)
materials compared (dep)
month in (case)
localization this (det)
safety enalapril (nmod)
measured sensitivity (nmod)
contributed patient (nmod)
rats become (acl:relcl)
ige ) (punct)
administered sequences (nmod)
ensues rate (nsubj)
nr1(neo-/- ie (advmod)
deviation standard (compound)
with mostly (advmod)
first demonstrate (acl)
helpful treatment (nmod)
peroxidation tissue (compound)
supported this (nsubjpass)
range mass (nmod)
repair dna (compound)
reduction intake (nmod)
alpha2- i1-receptors (conj)
patients ibs (compound)
myalgia succinylcholine-associated (amod)
treatment last (amod)
exerted reducing (advcl)
raises , (punct)
results presumably (advmod)
study responses (nmod)
matrix cells (conj)
sgk1 littermates (conj)
response a (det)
ph solution (nmod)
appeared and (cc)
boys syndrome (nmod)
study retrospective (amod)
parameters renal (amod)
blinded management (nmod)
reduction nerve (compound)
replaced cimetidine (nsubjpass)
2.7 - (punct)
ocs containing (acl)
mechanism to (mark)
sheath and (cc)
g up (case)
rescues glaucoma (dobj)
limited observed (advcl)
periods interruption (compound)
consumption myocardial (amod)
caused studies (nmod)
anemia dapsone-associated (amod)
setting a (det)
everolimus and (cc)
group as (case)
has though (mark)
hz , (punct)
probable , (punct)
0.0001 < (dep)
retained activities (dobj)
s.c. ; (punct)
podocalyxin unlike (case)
expression mhc-i (compound)
staying packing (xcomp)
68 , (punct)
data " (punct)
responding . (punct)
manifestation as (case)
instability electrical (amod)
hypotension nitroglycerin-induced (amod)
appreciated it (nsubjpass)
times of (case)
percentage small (amod)
heart muscle (conj)
polyphagia polyuria (conj)
staining neurons (nmod)
induce nsaids (nsubj)
acetylsalicylate cyclooxygenase (compound)
loops pressure-volume (compound)
revealed control (ccomp)
responses stimulation (nmod)
suggest inhibit (ccomp)
compared results (nsubjpass)
work in (case)
dox free (amod)
neuroadaptation , (punct)
denervated had (aux)
na/k-atpase nbc1 (conj)
alter diuresis (nsubj)
disease meningeal (amod)
men euthymic (amod)
developed man (nsubj)
perception thresholds (conj)
underperfusion secondary (amod)
production nature (conj)
inhibitors comt (compound)
protein parvalbumin (appos)
elimination . (punct)
localization cc (compound)
animals pretreated (acl)
blocker properties (nmod)
beta-enac alpha-enac (compound)
8.4 + (conj)
medication after (case)
restored that (mark)
modulate did (aux)
latency threshold (conj)
i.p. mg/kg (amod)
concentration prevent (acl:relcl)
dogs infarction (nmod)
haloperidol mg/day (appos)
demonstrated vitro (advmod)
analgesia brief (amod)
intoxication after (case)
$ROOT$ 1.0 (sent)
prospective . (punct)
information background (nmod)
syndromes fibrinolytic (amod)
address attempt (conj)
established effect (nsubjpass)
catheter by (case)
consolidation in (case)
infections bacillary (amod)
pre-operative , (punct)
patients three (nummod)
symptoms indicative (amod)
leads rate (nmod)
eps ( (punct)
case days (nmod)
clearance tbars (compound)
observed abnormality (nsubjpass)
increased degree (nsubj)
differences formation (nmod)
treated acitretin (nmod)
mitigated also (advmod)
k- being (cop)
proportional preserved (advcl)
rtms not (cc)
shed that (mark)
result administration (nsubj)
proteinuria induced (acl)
habituated that (nsubjpass)
was . (punct)
manifestations significant (amod)
d-med ) (punct)
cardiomyopathy low-grade (amod)
80 36 (compound)
icr were (cop)
circuits orbitofrontal (amod)
$ROOT$ disadvantages (sent)
enhances and (cc)
examined ability (dobj)
indicated correlated (conj)
sensitivity ] (punct)
relationship the (det)
describes report (nsubj)
vehicles , (punct)
animals , (punct)
receive dosages (nmod)
accumulation b (compound)
failure att-alf (appos)
condition a (det)
concentration calcium (compound)
effects diltiazem (nmod)
scores for (case)
rates prior (advmod)
assessed rate (nmod)
cyclophosphamide carboplatin (conj)
138 +/- (cc)
buffer to (case)
substance basal (amod)
consumption availability (conj)
monoher by (case)
nanoparticles empty (amod)
returned episodes (nmod)
monitored map (nsubjpass)
functions morphology (conj)
use n-acetylcysteine (nmod)
puromycin-aminonucleoside sulfate (conj)
ability altered (amod)
effects socs-3 (nmod)
showed neurons (nsubj)
measured serum (nmod)
increasing treatment (nmod)
map 3/4 (appos)
mechanisms strategies (conj)
concentrations prl (compound)
intensity with (case)
available phenylpropanolamine (nsubj)
hyperlipidemia and (cc)
patients hemodialysis (nmod)
stenosis without (case)
extensive metabolizers (conj)
presented man (nsubj)
ergotamine/caffeine < (dep)
$ROOT$ greater (sent)
two fewer (conj)
activation alpha2-adrenoceptors (nmod)
interaction behaviour (conj)
events ; (punct)
withdrawn been (auxpass)
neurotoxicity dire (amod)
inhibition esterase (compound)
improved treatment (nsubj)
co-morbidity taking (conj)
aware complication (nmod)
infusion a (det)
location discriminations (conj)
role receptors (nmod)
expression acetylcholine (compound)
coma and (cc)
true also (advmod)
cmv ( (punct)
avoiding thus (advmod)
contents etodolac (amod)
suggest preferable (ccomp)
(bort)-dexamethasone dex (appos)
concerns higher (acl)
appreciated heretofore (advmod)
monkeys macaques (appos)
exhibited also (advmod)
carcinoma ( (punct)
pale . (punct)
patient 's (case)
women women (conj)
stable hypotension (nmod)
case syndrome (nmod)
groups into (case)
therapies are (cop)
anemia induced (amod)
rare reversible (conj)
evaluation etomidate (nmod)
produces diet (nsubj)
anemia effect (nsubj)
serotonin low (amod)
lumens were (cop)
effects lesion (nmod)
alterations observed (amod)
determining showing (conj)
mechanism(s the (det)
assessment patient (compound)
midbrain of (case)
failure peripheral (amod)
increases that (mark)
p<0.001 , (punct)
-14.8 respectively (advmod)
thromboembolism ) (punct)
assess patients (nmod)
cardiac cerebrovascular (conj)
importance metabolite (nmod)
treatment ibuprofen (nmod)
profile its (nmod:poss)
moving % (dobj)
isotypes endothelial (amod)
1 tests (nmod)
urd ( (punct)
classed . (punct)
tablet with (case)
dox preceded (acl)
reduction ad50 (nmod)
effects antipsychotics (nmod)
review to (mark)
incorporation b (nmod)
rigidity behavior (conj)
systems on (case)
abstinence early (amod)
1863 321 (conj)
site via (case)
developed completion (nmod)
events aes (appos)
advised treatment (nmod)
factor predictive (amod)
evaluated moreover (advmod)
expression brain (compound)
worsen therapy (nsubj)
c1 group (compound)
stimulation and (cc)
rizatriptan after (case)
produced animals (nmod)
ci 2.31 (appos)
common the (det)
regained intervals (nmod)
arf ( (punct)
complication that (mark)
granulomatosis of (case)
acquisition after (case)
consisted followed (xcomp)
control as (case)
aware event (nmod)
recognize practitioners (nsubj)
traveled distances (dobj)
regimen rifampin (nmod)
some not (cc)
medline embase (appos)
implications potential (amod)
contraction tgr (nmod)
comparison response (nmod)
period interictal (amod)
rose as (advmod)
dose mg (compound)
ag with (case)
examined if (mark)
16,459 . (punct)
followed transplant (nmod)
hypertension glomerular (amod)
patients 21/27 (nummod)
protein glial (amod)
host the (det)
di nephrogenic (amod)
prooxidant it (nsubj)
diarrhea 36.4/6.1/3.0 (appos)
extended-release/lovastatin of (case)
drugs implicated (acl)
exposure periods (nmod)
patients 203 (nummod)
movements neck (nmod)
permeability barrier (compound)
osteoarthritis and (cc)
variable proportional (conj)
underwent determine (advcl)
pain to (case)
aminotransferase , (punct)
showed hypoperfusion (dobj)
recovery function (nmod)
necroses muscle (compound)
changes any (det)
raclopride fluphenazine (conj)
153 19/92 (conj)
conclusion probable (appos)
cocaine for (case)
targets effects (nmod)
183 239 (conj)
dpi on (case)
patients fifty-three (nummod)
fever days (nmod)
null beta4 (dep)
forms total (amod)
tool a (det)
hyperactivity bladder (compound)
acknowledged effects (nsubjpass)
248 from (case)
continued treatment (nsubjpass)
form receptors (dobj)
used ancrod (nsubjpass)
thunbergiana from (case)
dse ) (punct)
patients eight (nummod)
given nefiracetam (nsubjpass)
parts parkinson (nmod:poss)
type wt (appos)
exhaustion agitation (conj)
mediates response (dobj)
use heavy (amod)
enhance bradycardia (dobj)
tumors induced (acl)
effective doses (nmod)
nci/min of (case)
diagnosed having (aux)
fulfilled time (nmod)
medicine transplantation (compound)
mechanisms addiction (compound)
discontinued oxacillin (nsubjpass)
action drug (nmod)
developed infarct (dobj)
dosage maximal-tolerated (amod)
haemorrhage . (punct)
reduced dose (nsubjpass)
membrane red (amod)
decline cognitive (amod)
pose risk (dobj)
blue cuprolinic (amod)
therapy tachycardia (nmod)
useful clinically (advmod)
activated were (auxpass)
abundant receptors (nsubj)
attacks md (appos)
classified size (nmod)
designed studies (nsubjpass)
subunit proteasome (compound)
denervated been (auxpass)
load microfilarial (amod)
diagnosis to (case)
$ROOT$ self-limited (sent)
slower groups (nmod)
stable range (dep)
approach proteomic (amod)
increases pain (dobj)
stage choriocarcinoma (nmod)
continued only (advmod)
benign although (mark)
used first (advmod)
mglurs group (compound)
objective study (nmod)
symptoms changes (conj)
infection severe (amod)
canalicular the (det)
risk and (cc)
profile well-established (amod)
tolerability iopamidol (nmod)
combination telmisartan (nmod)
carries anticoagulation (nsubj)
position important (amod)
be should (aux)
thickness 1-mm (amod)
as case (nmod)
decreased glutamate (dobj)
disease reversible (amod)
result complications (nmod)
supervision staff (compound)
interview cross-sectional (amod)
failure magnitude (dep)
67 14 (conj)
lid in (case)
records clinical (amod)
tgr the (det)
avoided be (auxpass)
changes medulla (nmod)
hyperactivity the (det)
evaluated se (nmod)
increase level (nsubj)
clarithromycin ciprofloxacin (conj)
lack despite (case)
altered administration (nmod)
tjs hepatocyte (compound)
fanft forestomach (nmod)
interval after (case)
mean+/-s.e. ( (punct)
rare but (cc)
allocated were (auxpass)
presence on (case)
combination this (det)
190 to (dep)
correlated data (nmod)
prolongation related (amod)
assistance activities (nmod)
iprk ) (punct)
$ROOT$ illustrate (sent)
differences characteristics (nmod)
prevention tamoxifen (compound)
pod 6 (nummod)
correlated mass (nmod)
lymphomas relapsed (amod)
report first (amod)
pronounced rise (nsubj)
microg/ml vs. (cc)
mg 4.3+/-1.9 (nummod)
antinociception for (case)
frequency period (conj)
swelling prominent (amod)
pediatrics in (case)
compartment of (case)
schizophrenia episodes (conj)
mg-ezetimibe 10 (nummod)
knife or (cc)
found achieve (xcomp)
arrhythmia experimental (amod)
cohort this (det)
ci=22.8 ( (punct)
values low (amod)
events four (nummod)
improvement rbf (nmod)
use heroin (compound)
signaling noradrenergic (amod)
fibrillation failure (conj)
aneurysms intracranial (amod)
reviving is (aux)
reported effects (nsubjpass)
reduced patients (nmod)
responsible , (punct)
$ROOT$ kept (sent)
caused could (aux)
implicated whereas (mark)
halothane h (appos)
idiosyncratic and (cc)
g ml/min/100 (nummod)
enhances hyperthermia (nsubj)
transitioned ; (punct)
remained that (mark)
prompted study (xcomp)
rigidity prolonged (amod)
involved were (auxpass)
immunotherapy calcineurin-based (amod)
results ablation (nsubj)
pathways cells (nmod)
mg/kg 0.3 (nummod)
cases suspected (amod)
hyperprolactinemia treatment (conj)
modifications areas (nmod)
manage patients (dobj)
woman diagnosis (nmod)
experiments two (nummod)
on early (advmod)
area hemisphere (nmod)
anesthesia under (case)
reactions amoxicillin (nmod)
relationship clear (amod)
9-month to (dep)
reacts directly (advmod)
reaction frequent (amod)
subject the (det)
suggested responsible (ccomp)
had dogs (nsubj)
half women (nmod)
represented . (punct)
leak may (aux)
presented study (nmod)
polyvidone , (punct)
angioplasty ptra (appos)
prevent occurrence (dobj)
up-regulated ccr2 (nsubjpass)
analysis " (punct)
provide did (aux)
examination motor (compound)
clonidine agonist (compound)
product maximum (compound)
muscarinic and (cc)
introduction inhibitors (nmod)
hyperkalemia % (appos)
response regimens (nmod)
values his (nmod:poss)
measured substances (nsubjpass)
patients abusing (acl)
reversible which (nsubj)
mk-801 with (case)
tachykinins of (case)
be contraindication (attr)
use combinational (amod)
other group (conj)
g/d before (advmod)
ms 94+/-4 (nummod)
manifestation allergy (nmod)
therapy cc (compound)
model evaluate (acl)
induced carbamazepine (nmod)
piroxicam for (case)
pathway mapk (compound)
velocity contractile (amod)
counteract headache (dobj)
terminals the (det)
evident still (advmod)
inhibited manner (nmod)
demonstrates vulnerability (dobj)
% 99.4 (nummod)
aids with (case)
polymorphism del (dep)
levels estrogen (nmod)
staining methods (conj)
nascis 3 (nummod)
associated types (nmod)
war somalia (compound)
entering june (nmod)
rashes , (punct)
syndrome long-qt (amod)
zonisamide of (case)
but , (punct)
pretreated haloperidol (nmod)
effects abstention (nmod)
% 74 (nummod)
woman colitis (nmod)
0.05 , (punct)
mg 15 (nummod)
rat novel (amod)
ratings increased (amod)
mediated secretion (nmod)
role vasopressin (nmod)
considered signs (nmod)
patients nine (nummod)
increases hydrocortisone (nsubj)
patients 32 (nummod)
arrhythmia quinine-induced (amod)
results based (case)
adenosine hypersensitivity (nmod)
obtained minutes (conj)
$ROOT$ strain (sent)
developed leukemia (dobj)
transaminases liver (compound)
weight , (punct)
revert can (aux)
parameters application (nmod)
fraction shortening (compound)
loss reflex (nmod)
chemotherapy phases (appos)
13 6 (compound)
denopamine ta-064 (appos)
microg/kg day (nmod)
alf=0/35 , (punct)
4 individuals (nmod)
switched oxcarbazepine (nmod)
3.0+/-0.4 was (cop)
valve bicuspid (amod)
stress increased (amod)
cases 220 (nummod)
university california (nmod)
arrest cardiocirculatory (amod)
given postoperatively (advmod)
hospital children (nmod:poss)
stroke use (conj)
93 - (punct)
effects temsirolimus (nmod)
better group (nmod)
combination chemotherapeutics (nmod)
-18.1 1.5 (conj)
u/ml below (case)
viracept and (cc)
death treatment-related (amod)
inactivation of (case)
inhibition reduction (conj)
showed pronounced (ccomp)
homozygous to (mark)
eminence the (det)
cytoskeleton and (cc)
content high (amod)
stopped ethambutol (nsubjpass)
acting opioid-receptors (nmod)
metoclopramide intravenous (amod)
ect the (det)
incidence induction (conj)
residence of (case)
women 540,000 (nummod)
adequate is (cop)
studies future (amod)
ssc with (case)
molecule the (det)
plateau a (det)
evoked fs (nsubj)
dysfunction sd (appos)
syndrome nms (appos)
received injection)+ritanserin (nmod)
boluses infusion (conj)
shift curve (nmod)
performed withdrawal (nmod)
or part (conj)
phenomenon so-called (amod)
mechanism mediating (acl)
obtained therapy (nmod)
trials 3 (nummod)
agent identified (amod)
five controls (nmod)
presented also (advmod)
1.05 aspirin (nmod)
presence or (cc)
effect hypertensive (amod)
alleviated less (conj)
psychological physical (conj)
acetaminophen adriamycin (conj)
toxicity this (det)
mg. route (nmod)
cytotoxicity cyclophosphamide (nmod)
suppressed weeks (nmod)
assay enzyme-linked (amod)
dysphonia of (case)
control rate (nmod)
igf-i of (case)
seem have (xcomp)
medication with (case)
grouped . (punct)
experienced recovered (advcl)
reported otherwise (advmod)
pupillometer computerized (amod)
observed levels (nmod)
available data (nsubj)
vcm alone (advmod)
had clonazepam (nmod)
striatum numerous (amod)
sides between (case)
studied dogs (nmod)
course alleviated (acl:relcl)
produced case (dobj)
receiving warfarin (dobj)
rr 1.89 (nummod)
nmol mouse-1 (appos)
doses inhibitors (nmod)
bort and (cc)
affected levels (nsubjpass)
analgesia a (det)
topiramate by (case)
preparations heart-lung (compound)
life prolonged (amod)
collected was (auxpass)
study applicators (nmod)
effect migraine-inducing (amod)
receiving although (mark)
respond meth (nmod)
performed method (nmod)
index snap (compound)
53 15 (compound)
improvement commensurate (amod)
met dogs (nmod)
levels acetylcholine (compound)
carcinoma nsclc (appos)
studies electrophysiologic (amod)
obtained den (nmod)
recommend . (punct)
noted were (auxpass)
urticaria ) (punct)
trials mechanistic (amod)
begun reaction (nsubj)
hypertension hypotension (conj)
disorder lymphoma (appos)
epinephrine , (punct)
effect phenylephrine (nmod)
extension activity (conj)
sharps both (cc:preconj)
group cancer (compound)
achieve and (cc)
identified late (advmod)
months event (nmod)
associated both (dep)
randomized then (advmod)
markers those (det)
minimum and (cc)
vsd ) (punct)
anaesthesia general (amod)
performance h (amod)
mm 1 (compound)
transplantation clinical (amod)
lower p= (parataxis)
encountered report (nmod)
estimated been (auxpass)
execution cortex (nmod)
systolic mean (conj)
29 patients (nmod)
tetrapeptide 8) (punct)
received phosphate (dobj)
mg/kg 100 (nummod)
report showed (ccomp)
animals injected (acl:relcl)
investigator the (det)
less amount (nsubj)
signs toxocity (nmod)
used studies (nmod)
have insipidus (dobj)
evaluation biological (amod)
failure subclinical (amod)
treatment intravenous (amod)
2.2 10(10)pseudomonas (conj)
intensities high (amod)
amiodarone terfenadine (conj)
hydralazine nitroglycerin (conj)
ko ) (punct)
conclusions relevance (conj)
tuft a (det)
results study (compound)
injections carboplatin (nmod)
determination peak (amod)
evidence events (nmod)
used can (aux)
model fear (dobj)
methylprednisolone to (case)
administered s-limonene (nsubjpass)
schizophrenic adolescent (amod)
functionality users (nmod)
signal a (det)
environment test (compound)
h procedures (nmod)
extend results (nsubj)
certain : (punct)
useful pretreatment (nsubj)
80.0 to (advmod)
suggested symptoms (nsubj)
patients than (case)
ml(-1 r4 (appos)
enrolment 1993 (nmod:tmod)
prevent changes (dobj)
lower results (nsubj)
determined gravity (nsubjpass)
abolished pretreatment (nsubj)
making in (mark)
heparin ( (punct)
changes syndrome (nmod)
antagonist 1(h1 (compound)
became hypotensive (acomp)
schedule daily (amod)
implicated are (auxpass)
varied frequencies (parataxis)
discontinue it (dobj)
% patients (nmod)
has , (punct)
dyskinesias disability (conj)
affected found (parataxis)
performance patient (compound)
$ROOT$ ulcers (sent)
meq/l tolerated (acl:relcl)
phenacetin and (cc)
leukaemia or (cc)
deficits magnitude (acl:relcl)
effective reshape (ccomp)
secondary outflow (nmod)
need evaluation (nmod)
taking mesna (dobj)
reactions ducts (nmod)
awake he (nsubj)
effects postulated (amod)
drugs inducing (compound)
adjustment methadone (nmod)
reported related (conj)
anaemia of (case)
mutation of (case)
0.855+/-0.04 : (punct)
washout treatments (nmod)
ephedrine activity (nmod)
2.8 1.5 (compound)
showed md (nsubj)
release endothelin-1 (compound)
inefficient capd (nsubj)
diuretics loop (compound)
livestock in (case)
$ROOT$ contributed (sent)
believe case (ccomp)
bolus initial (amod)
mismatch supply (nmod)
investigated subjects (nmod)
rats group (nmod)
euthanized , (punct)
associated use (nmod)
sertraline on (case)
had reported (advcl)
bipolarity and (cc)
had tests (dobj)
16.619 1.131 (compound)
symptoms between (case)
implicated implant (nsubj)
region centrilobular (amod)
waveform arterial (amod)
factor risk (compound)
accelerated it (dobj)
recognize should (aux)
choices correct (amod)
constellation a (det)
rofecoxib of (case)
exert , (punct)
exerts 5-hydroxytryptamine (nsubj)
= 8.0 (dobj)
propose we (nsubj)
expectancy average (amod)
content of (case)
enzyme variables (conj)
volume hour (amod)
microgramg/ml ( (punct)
triggers methamphetamine (nsubj)
quantify reduction (dobj)
inconclusive currently (advmod)
glomeruli rats (nmod)
received tacrolimus (dobj)
restriction moderate (amod)
casei brevibacterium (compound)
pacing by (case)
axons purkinje (compound)
quinine- 4-aminopyridine-sensitive (conj)
association pph (nmod)
inhibited effects (dobj)
tmax ; (punct)
increase mean (amod)
appears rats (nmod)
injected seconds (nmod)
state and (cc)
microinjected subregions (nmod)
administration suspect (nmod)
function hypothalamic (amod)
apap on (case)
gangrene threatened (amod)
refractory atropine (nmod)
reviewed literature (nsubj)
paraffin-sections conventional (amod)
target their (nmod:poss)
evaluate disease (dobj)
rizatriptan with (case)
platinum- and (cc)
generated mice (dobj)
development reactions (nmod)
injury a (det)
events operative (amod)
rats age-matched (amod)
insufficiency recurrence (dep)
difficult . (punct)
has cml (nsubj)
fractions ejection (compound)
glycosuria a (det)
blocking by (mark)
gammapathy significance (nmod)
consistent time (nsubj)
tnss ( (punct)
inhibitor cyclooxygenase-2 (compound)
detectable , (punct)
induced authors (nsubj)
dizziness ) (punct)
rats doxorubicin-treated (amod)
cases complication (appos)
patients 9/106 (appos)
mitoxantrone with (case)
38 of (advmod)
show map (nmod)
control ) (punct)
n=12 % (appos)
hemiparesis unilateral (amod)
has because (mark)
correlated scores (nsubjpass)
those microg (nmod)
initiation treatment (nmod)
activation . (punct)
more 5 (nmod:npmod)
complication usage (nmod)
patients treated (acl:relcl)
prevent doses (nmod)
experiments the (det)
0.014-unit 0.070-unit (conj)
studies randomized (amod)
think we (nsubj)
0.11 and (cc)
rule general (amod)
described newly (advmod)
theophylline mg/kg (dep)
mumol/l from (case)
required . (punct)
regression multivariate (amod)
treatment cinacalcet (nmod)
migraine aura (nmod)
d2 5-ht2 (conj)
setting this (det)
analysis by (case)
found gene (nmod)
minutes over (case)
status 0 (nmod)
points 10 (nummod)
development cognitive (amod)
sr on (case)
extent exact (amod)
position platform (nmod)
administration oral (amod)
unmatched matched (conj)
sotalol and (cc)
block to (case)
messages the (det)
ameliorate alpha-tc (nsubj)
features sulindac (nmod)
$ROOT$ failure (sent)
suggested has (aux)
effects concentrations (conj)
intervention physiological (amod)
identified schedule (dobj)
regimen chosen (amod)
samples benzoylecgonine (nmod)
children human (amod)
eight up (quantmod)
oxide ( (punct)
crea ( (punct)
mg/ml 0.75 (compound)
simvastatin-ezetimibe the (det)
recorded 43 (nsubjpass)
fasting such (case)
amount pressure (conj)
group iohexol (compound)
radiograph , (punct)
metabolized has (conj)
made been (auxpass)
benefit of (case)
frequencies in (case)
treated levetiracetam (nmod)
complications transplantation (nmod)
corrected easily (advmod)
204 of (advmod)
leaves open (advmod)
rating , (punct)
fibrillation in (case)
mm 90 (nummod)
reproduces pilocarpine (nsubj)
instrumentation following (case)
ptld ( (punct)
interval % (nmod)
$ROOT$ 66.9 (sent)
followed night (dobj)
scale hospital (compound)
micromol/l ) (punct)
necrosis avascular (amod)
assay terminal (amod)
extract methanolic (amod)
nerves from (case)
number effects (conj)
hypotension significant (amod)
reduction and (cc)
aplasia patient (nmod)
cases adaptation (nmod)
lead . (punct)
syndrome sulfasalazine-induced (amod)
cortex as (cc)
model drug-induced (amod)
therapy promising (amod)
studied follow-up (nmod)
model puromycin (compound)
induce hypotension (dobj)
nephrotoxic potentially (advmod)
occurs level (nmod)
cn ) (punct)
micrograms/kg ] (punct)
response episodes (nmod)
mitoq antioxidant (appos)
days gtn (compound)
separation effects (nmod)
trichrome masson (nmod:poss)
conjunctiva and (cc)
perform correct (conj)
dosage usual (amod)
receiving amiodarone (dobj)
vehicle for (case)
male an (det)
tdf of (case)
level carcinoma (nmod)
results carcinoma (appos)
hemoptysis failure (conj)
trials and (cc)
common pattern (nsubj)
ranges 10 (nmod)
monocytes/macrophages for (case)
effects positive (amod)
necessary not (neg)
seriousness disease (nmod)
infection mirabilis (compound)
750 and (cc)
rg1 mg/kg (appos)
safety their (nmod:poss)
artery node (compound)
shoed damage (dobj)
responses verapamil (nmod)
occurred concurrently (advmod)
pain on (case)
propofol with (case)
abs secondary (amod)
perfused eyes (nsubjpass)
mg/kg 150 (compound)
participation antagonizing (acl)
40/min to (case)
patients constriction (nmod)
induced reserpine (nmod)
caused cy (nsubj)
provoke patients (nmod)
characterization : (punct)
% 31 (nummod)
history natural (amod)
optimized empirically (advmod)
figures myelin (amod)
essential it (nsubj)
showed tissues (nmod)
sequences counterbalanced (amod)
years women (nmod)
recorded minutes (nmod)
findings with (case)
effects antinociceptive (amod)
induced doxorubicin/kg (nmod)
containing diamorphine (dobj)
occurred occlusion (nsubj)
divided oil (dep)
tests their (nmod:poss)
potentials studies (conj)
dose ethambutol (nmod)
recovery the (det)
tachycardias with (case)
effects cisplatin (nmod)
palsy anticoagulant-induced (amod)
year postimplant (dep)
79 6 (conj)
treatment ) (punct)
found potent (xcomp)
rats to (case)
organization ) (punct)
des mg (appos)
investigate focusing (advcl)
2- 20-day-old (conj)
propagation to (case)
disease series (nmod)
occurs advantages (nmod)
produced embryolethality (dobj)
measured position (nmod)
occurred starting (advcl)
administration medium (compound)
synthesis purine (compound)
drugs active (amod)
concentrations factor (nmod)
revascularization svc (nmod)
vagotomy not (cc)
polymorphism transporter (compound)
leukemia years (appos)
cent fifty-nine (nummod)
short-term and (cc)
develop resistance (dobj)
site major (amod)
treated l-med (dep)
effects outcomes (conj)
densities reticulum (nmod)
hazardous treatment (nsubj)
recording activity (compound)
14/87 +/- (cc)
polysomnography of (case)
apap or (cc)
safe was (cop)
hoehn yahr (conj)
influenced rate (dobj)
mediated actually (advmod)
titrated target (nmod)
agents corticosteroids (nsubj)
treatment temsirolimus (compound)
artery noninnervated (amod)
discussed given (conj)
reduced thp (nsubj)
combination fentanyl (nmod)
said generally (advmod)
antagonist be (cop)
timing headache (nmod)
age a (det)
immunocompromised severely (advmod)
partly at (advmod)
history from (case)
hepatomas lesions (conj)
similarity chemical (amod)
concentration effect-site (amod)
episodes to (case)
15.0 from (case)
delay median (amod)
raise dopamine (dobj)
complicated patient (nmod)
mg/kg acquisition (nmod)
impairment growth (nmod)
extent different (amod)
challenge on (case)
shown in (prep)
mesencephalon and (cc)
represented therapy (nsubj)
direction axis (nmod)
interest is (cop)
any in (case)
impaired rats (nmod)
convulsions tonic (amod)
sign no (det)
selective not (neg)
generated skin (nmod)
cisapride versus (cc)
define experience (nsubj)
associated levels (nsubjpass)
larger were (cop)
exposed diethylstilbestrol (nmod)
proof are (cop)
ci ) (punct)
hypoxia diseases (conj)
involved 5-ht (nsubjpass)
heparin agents (conj)
relation defects (nmod)
plays compared (advcl)
injected , (punct)
used yohimbine (nsubjpass)
occur patients (nmod)
fluctuations dyskinesias (conj)
alerted should (aux)
requires binding (nsubj)
ventilator and (cc)
jj aspirin-treated (amod)
treatment individual (amod)
depleted da (dobj)
40000 , (punct)
neonates ingested (acl:relcl)
99 to (advmod)
boluses cocaine (compound)
0.08 ( (punct)
revealed revealed (conj)
sr or (cc)
17.9 - (punct)
described synthesis (nsubjpass)
patients aneurysms (nmod)
cocaine ethanol (conj)
trial hypertension (nmod)
dithiothreitol or (cc)
subjected sessions (nmod)
1.8-fold , (punct)
showed objective (nsubj)
experienced disease (dobj)
shock and (cc)
preceded thrombocytopenia (nmod)
decreased animals (nmod)
criteria diagnostic (amod)
neurotoxicity pac (compound)
bp ( (punct)
doses g (dep)
syndrome ingestion (nmod)
addressing better (advmod)
disappeared elevation (nsubj)
setting practices (appos)
s-isomer the (det)
inhibition hyperthermia (nmod)
receive protocol (dobj)
malformations , (punct)
insipidus by (case)
prescribe groups (nmod)
concentration therapeutic (amod)
associated latency (nmod)
blockers multichannel (amod)
nurses the (det)
diagnosis patient (nmod)
enalapril treatment (nmod)
hazard arrhythmias (nsubj)
rats pd (compound)
nsvt of (case)
time each (det)
changes peroxisomes (nmod)
lithium qtp (appos)
characteristics hepatitis (nmod)
serum by (case)
restricted best (advmod)
who the (det)
used could (aux)
perform as (advcl)
greater mic (nmod)
index labeling (compound)
compound this (det)
di- tetra- (conj)
developed pneumonitis (dobj)
exposures enflurane (nmod)
mania . (punct)
bmt of (case)
related inversely (advmod)
damage tubular (nmod)
thp of (case)
force lvdp/dt (appos)
0.4-fold either (nmod)
free disease (nmod)
infused minimize (advcl)
methods usual (amod)
determine bladder (nmod)
studied study (nmod)
projections hilar (amod)
decreased thymus (dobj)
followed-up were (auxpass)
prevention to (case)
postulated , (punct)
performed rating (nsubjpass)
describe and (cc)
using hplc (dobj)
presented whom (nmod)
diseases label-restricted (amod)
using analyses (dobj)
active administration (nmod)
efficiency swallowing (compound)
105 only (advmod)
troublesome complications (nsubj)
l/min ( (punct)
$ROOT$ view (sent)
lethalities several (amod)
vohland ) (punct)
level volume (conj)
function biological (amod)
increased but (advmod)
48-week ) (punct)
g 13.5 (nummod)
bacteremia aureus (compound)
identify assess (conj)
d with (case)
woman arthritis (nmod)
had died (ccomp)
s 178 (nummod)
pain or (cc)
mg/kg days (nmod)
stimulants or (cc)
4 up (advmod)
% 32.7 (nummod)
day 45 (nummod)
initiating after (mark)
sodium urine (compound)
condition with (case)
exercised be (auxpass)
resistant , (punct)
shunt interatrial (amod)
troponin i (nummod)
taking part (nmod)
measured model (nmod)
hyperprolactinemia induced (acl)
features model (nmod)
synthesis series (nmod)
inhibitors cyp3a4 (compound)
yrs 76 (nummod)
showed eight (nsubj)
acid trans-retinoic (amod)
acids aristolochic (amod)
years years (appos)
variables cardiovascular (amod)
influences for (case)
reductase gr (appos)
similar khz (nmod)
epirubicin and (cc)
activity sinus (compound)
subtypes from (case)
resection partial (amod)
scales analogue (compound)
data group (nmod)
activities adl (appos)
increased incoordination (dobj)
receptor-linked gaba-a (nmod:npmod)
events primarily (advmod)
2)% pressure (nsubj)
clinical histologic (conj)
level micrograms/ml (appos)
ranged 1.6 (nmod)
protects effects (nmod)
restored normal (nmod)
range able (acl:relcl)
documented that (mark)
values sgot (compound)
relevant that (mark)
ht ( (punct)
iodixanol the (det)
control hypotension (appos)
metalloproteinases matrix (compound)
failure gentamicin-induced (amod)
$ROOT$ clarified (sent)
methods of (case)
considered play (xcomp)
hypoparathyroidism with (case)
sc-48334 ( (punct)
hospital-years cumulative (amod)
lethal median (amod)
appeared weeks (nmod)
responsible be (cop)
proteins these (det)
routes alternative (amod)
infections the (det)
randomised . (punct)
person healthy (amod)
suggests conclusion (nsubj)
alteration and (cc)
paroxetine mg (amod)
areas the (det)
reduction weight (nmod)
regard in (case)
examined expressions (nmod)
instituted h (nmod)
hbv of (case)
microg% : (punct)
expression alphaenac (appos)
agonist-induced dopamine (nmod:npmod)
dependent more (advmod)
hyperthermia in (case)
admissions 1.19/1,000 (nummod)
buildup pathways (conj)
91.2 was (cop)
tested abstinence (nmod)
demonstrated binding (nsubjpass)
tablets quinine (compound)
segments with (case)
challenge or (cc)
blockade d-2 (compound)
targets also (advmod)
italy in (case)
woman 46-year-old (amod)
situation clinical (amod)
associated unknown (conj)
grade p (dep)
change ) (punct)
areas stem (nmod)
developed have (aux)
effects group (appos)
benzodiazepines and (cc)
discharged were (auxpass)
found pr (nmod)
deferens ) (punct)
tdp ) (punct)
sex old (conj)
vnb both (dep)
reported system (nmod)
15 14 (compound)
erythematosus sulfasalazine-induced (amod)
is interest (attr)
pattern different (acl:relcl)
took metoclopramide (dobj)
protein properties (nmod)
scores trihexyphenidyl (nmod)
impairment mice (nmod)
densities receptor (compound)
$ROOT$ responsible (sent)
evident indicating (advcl)
studied also (advmod)
studies these (det)
nifedipine or (cc)
caused have (aux)
phenomenon is (cop)
counts on (case)
36.3 11.7 (prep)
tab alcohol (compound)
anotia with (case)
14 respectively (advmod)
occurring therapy (nmod)
efficacious were (cop)
receive sedation (dobj)
constriction concentric (amod)
evident , (punct)
apap ( (punct)
counts cd4+t-cell (compound)
properties potential (amod)
reduced been (auxpass)
increases if (mark)
endings dopamine (compound)
myoclonic , (punct)
reductase hmg (compound)
development side-effect (nmod)
spasms infantile (compound)
fever chill (appos)
cont./min pretreatment (dep)
minutes 5 (nummod)
observation by (case)
myelodysplasia and (cc)
times reaction (compound)
difference the (det)
agonist-induced or (cc)
mm 78 (nummod)
angiotensinogen renal (amod)
patients normokalemic (amod)
insipidus likely (amod)
relate that (nsubj)
system serotonergic (amod)
consistent although (mark)
stage height (conj)
manifest were (cop)
suggest reverses (ccomp)
assessed test (nmod)
reach stages (dobj)
reactions side-effects (conj)
$ROOT$ lead (sent)
administration tea (nmod)
containing originally (advmod)
107 ) (punct)
improved resulting (advcl)
appears melphalan (nsubj)
administration theophylline (compound)
certain however (advmod)
size defect (nmod)
ml 2 (nummod)
applied be (auxpass)
rest both (cc:preconj)
greater is (cop)
reflecting sedation (dobj)
active chemotherapy (nsubj)
proven histologically (advmod)
study case-controlled (amod)
given , (punct)
related use (nsubj)
tamoxifen with (case)
those cld (conj)
recovery slow (amod)
review discuss (conj)
k(+)-channels to (case)
index baseline (nmod)
protein urine (compound)
alleviating in (mark)
model 6-hydroxydopamine-lesion (amod)
included hydration (dobj)
regulation autonomic (amod)
inflammation paw (compound)
pg/ml pg/ml (conj)
suggests improve (ccomp)
treated chemotherapy (nmod)
increase paradoxical (amod)
sr ( (punct)
resulted rarely (advmod)
ratings , (punct)
remains so (mark)
component functional (amod)
carotenoids water-soluble (amod)
removed studies (nmod)
phase hypertrophic (amod)
smokers conditions (nmod)
prepared grafting (nmod)
exposure anabolic (amod)
confirmed examination (nsubj)
summary lead (appos)
stimulation direct (amod)
activities i (nmod)
all at (advmod)
concentration causing (acl)
imaging m (amod)
variables preoperative (amod)
predisposed acidosis (nmod)
favourable was (cop)
initiate pointes (dobj)
cases tachycardia (nmod)
among all (advmod)
concentrations effects (conj)
setup to (case)
arrhythmia dysfunction (conj)
inhibited or (cc)
ring a (det)
marker summary (nmod)
8-se 8-se (dep)
population hilar (amod)
pharmacol . (compound)
basis excretion (nmod)
stress , (punct)
tumors microscopic (amod)
coma hyperosmolar (amod)
database our (nmod:poss)
teoaes ) (punct)
harvested , (punct)
signs major (amod)
appears but (cc)
reported concentrations (nsubjpass)
sbp the (det)
adenosine with (case)
number toll-free (amod)
presenting oltx (nmod)
mechanism be (cop)
associated lamivudine-resistance (nmod)
techniques immunocytochemical (amod)
cessation infusion (nmod)
difference percentage (nmod)
hippocampus not (cc)
injected artery (nmod)
led treatment (nsubj)
processed staining (nmod)
myelination from (case)
microg/kg/min 10 (nummod)
32 +/- (cc)
higher wk (nmod)
diazepam mg/kg (dep)
-14.8 ; (punct)
4.40 ) (punct)
37 - (punct)
e15.5 at (case)
decline first (amod)
necessary first (dep)
n-dimethylpropranolol ) (punct)
test rats (nmod)
tested caffeine (nsubjpass)
preserves , (punct)
prevents whether (mark)
minutes and (cc)
$ROOT$ required (sent)
deterioration or (cc)
groups certain (amod)
led application (nsubj)
channels , (punct)
attenuated deletion (nmod)
depressants of (case)
brought was (auxpass)
effects neurotensin (nmod)
rate epinephrine (nmod)
challenged was (auxpass)
cardiotoxicity of (case)
counseling dietary (amod)
10(-6 ) (punct)
fasciitis necrotising (amod)
states acid (compound)
edema peritumoral (amod)
liver histology (nmod)
mg/ml at (case)
treatment cisplatin (compound)
diminished was (auxpass)
relationship sfas (nmod)
proteinuria chain (compound)
bs individual (amod)
maintained terms (nmod)
identified recently (advmod)
alteration lasting (amod)
pain ( (punct)
release neurons (nmod)
injections uni- (amod)
dosage adequate (amod)
2a pegylated (amod)
$ROOT$ lesion (sent)
preferable decreased (advcl)
protocol test (nmod)
prevent fasciculation (dobj)
concern patients (nmod)
sustained who (nsubj)
subunits mtdna-encoded (amod)
= ) (punct)
factors hypokalemia (nmod)
condition to (case)
followed closely (advmod)
ci=1.0 1.4 (prep)
occurred seizures (nsubj)
recurred later (advmod)
stress oxidation (conj)
compounds four (nummod)
examined system (nmod)
efficient addition (nsubj)
or(adj ) (punct)
24.3 was (cop)
barrier immature (amod)
report article (nmod)
subgroups of (case)
triggers , (punct)
dodds ; (punct)
male taking (acl)
% 3.0 (nummod)
hypertrophy induced (amod)
gentamicin b (conj)
has sensitivity (dobj)
reported lived (conj)
increasing exceeds (conj)
showed delay (nmod)
assess implications (dobj)
approach via (case)
oxcarbazepine oxc (appos)
indicates suggests (conj)
psychosis postpartum (amod)
) 10(-5 (compound)
induce hypokalemia (nmod)
disorder specified (amod)
uiu/ml be (cop)
lead therapy (nsubj)
thrush 6 (appos)
sampling cortisol (compound)
subcutaneous transnasal (conj)
epiphyses with (case)
temporal , (punct)
follow-up therapy (nmod)
hbsag-negative ) (punct)
infants the (det)
structures connecting (acl)
speed psychomotor (amod)
injections toxin (compound)
normalization levels (nmod)
effect therapy (nmod)
neuropathy as (case)
stimulation mucosa (nmod)
conjugation acid (nmod)
terminals at (case)
adam ) (punct)
results similar (appos)
alpha-2b pegylated (amod)
indicate aggravate (ccomp)
those especially (advmod)
outflow to (case)
tfl of (case)
secretions of (case)
effective ns-718 (nsubj)
became quadriplegic (acomp)
expression enac (compound)
quantified unclear (parataxis)
administration cocaine (compound)
subdivisions functional (amod)
increased 3.6 (nmod)
communicate , (punct)
induced cpa (nmod)
stopped recorded (advcl)
lower % (nmod:npmod)
step the (det)
precipitate to (mark)
active . (punct)
requiring drug (dobj)
70/99 ) (punct)
uncomplicated maintained (conj)
atenolol with (case)
functional or (cc)
myopathy up-regulation (nmod)
excessive was (cop)
tissue kidney (compound)
relationship effects (nmod)
lt ) (punct)
affect that (mark)
form striped (amod)
inhibited effect (dobj)
specimens transplants (nmod)
examined tolerance (nsubjpass)
tone rats (nmod)
effect on (case)
used these (nmod)
hundred fourteen (conj)
692 ) (punct)
leukocyturia the (det)
dogs 206 (nummod)
produced inhibition (dobj)
sodium heparin (conj)
inhibit hyperemia (dobj)
diagnosis as (cc)
factor failure (nmod)
region ' (amod)
produces bingeing (dobj)
diameter artery (nmod)
ph 4.17 (nummod)
recorded malondialdehyde (nsubjpass)
weeks few (nummod)
changes low-grade (amod)
drugs those (det)
disintegrations 013 (nummod)
dependent to (mark)
containing water (conj)
% 84.79 (nummod)
changes activity (nmod)
cases 71 (nummod)
seem did (aux)
behaviors generated (acl:relcl)
delayed that (mark)
suggestive disease (nmod)
ist ( (punct)
ischemia exercise-induced (amod)
pcc ) (punct)
alpha- in (case)
na cr (conj)
indicate causes (ccomp)
n/n=25/26 or (cc)
chloramphenicol cycloheximide (conj)
aetiology an (det)
iii gentamicin (appos)
use chloride (nmod)
do may (aux)
users oc (nmod)
lp ) (punct)
hyperkinetic k (appos)
open clinical (dep)
rostral and (cc)
bolus iv (nummod)
conjunction pericarditis (nmod)
suggests prolonged (ccomp)
mg/kg 80 (compound)
enabled . (punct)
del > (dep)
level at (case)
affected sites (nsubjpass)
vein antecubital (amod)
combinations together (advmod)
suggest effect (dobj)
system histaminergic (amod)
disease treated (acl)
show would (aux)
outcome dp/dtejc (compound)
rammer ( (punct)
rejection allograft (compound)
accumulation rna (compound)
lam ) (punct)
types seizures (nmod)
inhibitors enzyme (compound)
scans tomographic (amod)
animal orally-treated (amod)
19 to (case)
characteristics main (amod)
increase latency (nmod)
t+a ; (punct)
acute late-stage (conj)
injection morphine (compound)
minority patients (nmod)
factors potential (amod)
related 16 (nsubjpass)
months 24.2 (nummod)
5-fu/fa high-dose (amod)
were versa (conj)
assessed parameters (nsubjpass)
diseases for (case)
treatment doses (nmod)
toxic combination (nmod)
presented included (conj)
hydrobromide 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine (compound)
equal those (nmod)
more role (nmod)
rats leeds (compound)
department at (case)
hcva ) (punct)
alpha-2b of (case)
increase influx (dobj)
increased that (nsubj)
studies att-alf (nmod)
s-1 mg (compound)
with concurrently (advmod)
begun day (nmod)
cancer metastatic (amod)
preventing cin (dobj)
removal rigid (amod)
child palsy (nmod)
nh4ac mm (amod)
paralysis a (det)
square mean (compound)
suggests occurs (ccomp)
reactions common (amod)
implicated cause (xcomp)
used history (nsubjpass)
checked samples (nsubjpass)
syndrome ? (punct)
largest the (det)
cips ): (punct)
= 0.48 (dobj)
twelve % (appos)
chelating iron (nmod:npmod)
vein of (case)
decline with (case)
zdv alone (cc)
children other (amod)
patient cardiomyopathy (nmod)
thiopental patient (nmod)
phases process (nmod)
produced action (dobj)
infiltrates lymphoplasmacytic (amod)
scale with (case)
44.8 - (advmod)
discontinuing drugs (dobj)
enhancers dna (compound)
betaine with (case)
enhanced dysrhythmogenicity (nsubjpass)
difficult diagnose (xcomp)
examinations studies (conj)
voltammetry fast (amod)
dysrhythmias cardiac (amod)
.05 ) (punct)
0.5 - (punct)
capsules in (case)
drugs application (conj)
inhibited ( (punct)
vasculitis primarily (advmod)
recovers naturally (advmod)
considerations anaesthetic (amod)
weight 15mg/100 (nummod)
block left (amod)
analysis incidences (nmod)
strips control (amod)
protect rats (dobj)
analysis quantitative (amod)
limited limitations (dep)
irritation acute (amod)
six remaining (amod)
injury this (det)
scores of (case)
fluid analgesics (conj)
dili ( (punct)
expression heart (nmod)
patients cirrhotic (amod)
undertook study (dobj)
level cytokine (compound)
challenges additional (amod)
school medicine (nmod)
sedation moderate (amod)
pneumoniae and (cc)
destruction produced (acl)
platelets against (case)
suspension aqueous (amod)
mg/kg 59 (nummod)
dopamine for (case)
reticulum vesiculated (amod)
observed woman (nmod)
down-regulation expression (nmod)
avoid therefore (advmod)
duration weeks (nmod:poss)
cause organic (amod)
offers heparin (nsubj)
hexachloride benzene (compound)
included had (aux)
analgesia with (case)
electro- and (cc)
users or (dep)
function preserved (amod)
reduction sites (nmod)
hemorrhage extensive (amod)
diminish to (mark)
defects vigabatrin-associated (amod)
use sumatriptan (amod)
users 5-ht (nmod)
comparison multicenter (amod)
vestibular ) (punct)
ducts glandular (amod)
rate resolution (nmod)
promote might (aux)
medication antihypertensive (amod)
thickening the (det)
oil corn (compound)
mg 85 (compound)
control proper (amod)
b.d mg (compound)
increase fanft-induced (amod)
vinorelbine gemcitabine (conj)
$ROOT$ phosphatase (sent)
thickness slice (compound)
reversion partial (amod)
limb affected (amod)
hypokinesis because (case)
accompanied not (neg)
treated can (aux)
subsided reactions (nsubj)
l(-1 mg. (compound)
$ROOT$ sedated (sent)
transfer weeks (nmod:npmod)
site single (amod)
tumours against (case)
impaired were (aux)
removed arteries (nsubjpass)
dogs in (case)
activity virus (compound)
effects additional (amod)
marker granule-cell-specific (amod)
activity peak (amod)
nl ) (punct)
ngf secreted (acl)
aggregation induced (amod)
was often (advmod)
admitted anemia (nmod)
objectives study (nmod)
intermediate that (nmod)
more , (punct)
propofol kg(-1 (appos)
reduces reduces (advcl)
prior delivery (nmod)
had results (ccomp)
higher mm2 (dep)
subject one (nummod)
mtx + (cc)
em ( (punct)
distinguishable thickness (nmod)
increased affected (parataxis)
mechanisms hypertension (nmod)
potassium plasma (compound)
compared defect (nsubjpass)
micrograms 120 (nummod)
vasodilator nitroprusside (nsubj)
week injection (dep)
prevent nevertheless (advmod)
beta-muricholate of (case)
emerged evidence (nsubj)
alpha-2b ribavirin (conj)
reduction gfr (nmod)
made dogs (nmod)
antagonists central (amod)
patients 43 (nummod)
reached diet (nmod)
depletor hemicholinium-3 (dep)
counts ( (punct)
hormone lh-rh (appos)
outpatients 243 (nummod)
suppression deletion (nmod)
injection preoperative (amod)
levels nonusers (nmod)
chemotherapy cancer (compound)
rates to (case)
supported evidence (nmod)
1.22 1.09 (nummod)
days range (dep)
frequency mb (compound)
administration dose (nmod)
reduced toxicity (dobj)
predict deficits (dobj)
attain : (punct)
modulating through (case)
continue . (punct)
interaction piroxicam (nmod)
succimer agent (appos)
patients uremic (amod)
ich vs (cc)
improves activity (nmod)
receptor orl1 (appos)
34.33 5.05 (conj)
period pain (conj)
background type (nmod)
bisphosphonates intravenous (amod)
furosemide with (case)
gamma-hch mg/kg (amod)
had 2 (nsubj)
curve bladder (compound)
nms with (case)
include period (dobj)
dose feedback (compound)
register central (appos)
leukoencephalopathy carmofur-induced (amod)
vaccinated january (nmod)
suspension empty (amod)
remission ra (nmod)
suffered fasciitis (dobj)
organophosphorus op (appos)
na/k-atpase and (cc)
heart hypertrophied (amod)
4.18 - (punct)
unchanged that (mark)
predict failure (dobj)
occurred there (expl)
factor that (mark)
dosing prazosin (nmod)
nomifensine by (case)
critical signaling (nsubj)
prevented successfully (advmod)
layer , (punct)
numbness extremities (nmod)
alterations elements (nmod)
deterioration and (cc)
associated potential (nsubjpass)
studied whom (nmod)
complicate withdrawal (dobj)
positive rast (nsubj)
glycopyrrolate i.v. (advmod)
contributes case (nsubj)
rats performing (acl)
an the (det)
temporal occipital (conj)
maintaining homeostasis (dobj)
survival months (appos)
topotecan mg/m(2)/day (dep)
synthesis ngf (compound)
suggested evaluation (nsubj)
potent receptor (advcl)
studies . (punct)
procedures therapy (nmod)
marker degeneration (nmod)
abuse diuretic (compound)
incidence instability (nmod)
activation kinase (nmod)
trial children (nmod)
sedation diazepam-induced (amod)
efficacy phase (compound)
eosinophils lymphocytes (conj)
participated study (nmod)
achieved rate (nmod)
surgery or (cc)
due whether (mark)
administered examination (dobj)
variants gene (nmod)
demonstrated autoradiography (nmod)
down , (punct)
nitrogen serum (compound)
pallidotomy knife (compound)
effective importantly (advmod)
probability switching (nmod)
activated was (auxpass)
blocking to (mark)
has number (nmod)
patients ninety (nummod)
correlate = (parataxis)
percentage ) (punct)
efficacy monotherapy (nmod)
divided groups (nsubjpass)
verapamil and (cc)
stimulates expression (dobj)
boluses = (dep)
afford protection (nsubj)
effects candidates (nmod)
activity cleavage (appos)
skf quinpirole (conj)
n/n=25/26 ( (punct)
2-adrenoceptors man (nmod)
cardiomyopathy mitochondrial (amod)
cocaine of (case)
clopidogrel with (case)
reviews mechanisms (dobj)
clinic hospital (appos)
discussion history (nmod)
33.6 +/- (cc)
frequency in (case)
dependent connected (advcl)
induced blocker (nsubj)
length-of-stay with (case)
disease lmphoproliferate (compound)
lactate biperiden (compound)
task a (det)
paralleled resurgence (nmod)
15.8 3.3 (conj)
role spasm (nmod)
min 5.3 (nummod)
pastes pesticide (compound)
p2x3 with (case)
demonstrated showing (xcomp)
men 23 (nummod)
$ROOT$ impair (sent)
1.1 - (punct)
abnormalities cortex (nmod)
functionality triad (compound)
differed statistically (advmod)
leading accuracy (nmod)
prolongation ( (punct)
dosage its (nmod:poss)
expression changes (conj)
65 pod (nmod)
reduction ) (punct)
using tests (dobj)
lymphocytes peripheral (amod)
ratios enhancement (compound)
amplitude mean (compound)
increase co (conj)
concentrations their (nmod:poss)
cardiovascular , (punct)
8 hypoxia (nmod)
$ROOT$ bolus (sent)
side-effects and (cc)
tgf-b pcna (conj)
counteract dysfunction (dobj)
degree reduction (nmod)
newborns exposed (acl)
received department (nmod)
appear common (xcomp)
region striatum (nmod)
excellent effect (nsubj)
processing memory (compound)
0.05 incidence (nsubj)
hallucinations these (det)
median , (punct)
identified mediator (nmod)
however effect (nmod)
met that (nsubj)
derived have (aux)
joints of (case)
lists articles (nmod)
mg/8 500 (compound)
exposure epithelium (nmod)
performed as (cc)
stx ( (punct)
time levels (nmod)
possible , (punct)
given undertaken (advcl)
differences statins (nmod)
ed-1 and (cc)
group cochrane (compound)
consumption alcohol (compound)
conditions constant (amod)
patient japanese (amod)
included salivation (dobj)
best . (punct)
increase greater (acl:relcl)
revealed return (conj)
potentiation antinociceptive (amod)
tolerated effects (advcl)
functional and (cc)
evaluation troponin (nmod)
comparative phase (dep)
treatment benefit (appos)
decreased similarly (advmod)
observation under (case)
akinetic were (cop)
antidepressants with (case)
involved was (auxpass)
scores % (dep)
phenomenon of (case)
periods activity (nmod)
hour oxprenolol (nmod)
injection amino-nucleoside (nmod)
sedated more (advmod)
injection animals (nmod)
hepatitis cholestatic (amod)
increase reperfusion (nmod)
approximation woolf (nmod)
substitute heparin (nsubj)
using maze (dobj)
determination perception (nmod)
eluate prepared (acl)
dilation tropicamide (nmod)
used have (aux)
temocapril inhibitor (appos)
slow ) (punct)
potential nerve (compound)
service diagnosis (nmod)
anaesthesia single-shot (amod)
identified resolved (conj)
blockage trough (case)
paralyzed was (cop)
hematomyelia report (dep)
hospital from (case)
expressed termed (conj)
health in (case)
injection salt (compound)
effect ache (nmod)
combined paclitaxel (dobj)
function ventricular (compound)
mass glomerulonephritis (conj)
seizure de (amod)
fetuses rats (compound)
treatment week (nmod:poss)
conclusion manifestation (appos)
used understood (conj)
nausea anxiety (conj)
short-term ) (punct)
fall blood-pressure (nmod)
developed mania (dobj)
observed predicted (advcl)
months before (case)
part as (case)
injecting potassium (dobj)
sought , (punct)
slices rats (nmod)
450 % (appos)
samples morning (compound)
twin male (appos)
p comparisons (appos)
mg/kg combination (nmod)
effect d-ribose (nmod)
contributes stress (nsubj)
cardiomyopathy , (punct)
likely : (punct)
cases established (amod)
case two (conj)
toxicity hyperuricemia (conj)
effects estradiol (nmod)
gi clinical (amod)
years cessation (nmod)
neuropathy peripheral (amod)
enhanced stimulation (nsubj)
longitudinal gls (appos)
motility and (cc)
admitted icu (nmod)
respect damage (nmod)
patient no (neg)
performed establish (xcomp)
ci p (dep)
account on (case)
studied addition (nmod)
levels micrograms/dl (nmod)
rate ratio (conj)
possibility difficult (ccomp)
results administration (nmod)
maha of (case)
have paralysis (dobj)
exclude polymyositis (dobj)
average days (nmod)
effects toxic (amod)
giving arag (dobj)
increased excretion (nsubj)
induced amelioration (dobj)
case due (amod)
displace subtypes (nmod)
potentiating , (punct)
affected changes (nmod)
cigarettes > (nummod)
effect ( (punct)
suggested hepatitis (dobj)
dysfunction liver (compound)
maintained which (nsubj)
conventional and (cc)
compared ecg (nmod)
six than (quantmod)
deposits pigmentary (amod)
toxicity adriamycin (compound)
effect proteinuria (nsubj)
property , (punct)
reversing , (punct)
trials controlled (compound)
effective safe (conj)
insight new (amod)
factors other (amod)
acid bile (compound)
complex iv (nummod)
azotemia insufficiency (conj)
overdose intentional (amod)
study conducted (acl)
passage bbb (nmod)
dose amphetamine (compound)
test tolerance (compound)
mg/kg after (case)
much as (advmod)
risk damage (conj)
indicated were (auxpass)
giving diet (dobj)
produced injection (nmod)
inhibitors from (case)
role important (amod)
patients 51 (nummod)
tg of (case)
results 65 (appos)
irritability parent-rated (amod)
returned ratios (nsubj)
vision and (cc)
became patients (nsubj)
hours half-life (nsubj)
globulin antilymphocyte (compound)
efflux striatum (nmod)
suggesting hypercoagulability (dobj)
present not (neg)
received mg/kg (dobj)
two week (nmod)
bulb of (case)
loads large (amod)
pregnancy previous (amod)
number hypertension (conj)
doses amn082 (nmod)
% time (nmod)
program core (compound)
lower group (nmod)
study agoraphobia (nmod)
111.0 133.1 (conj)
anticoagulant oac (appos)
e-1 ) (punct)
patients cholinesterase (nmod)
evaluation regular (amod)
pbo with (case)
mg/kg 103 (nummod)
antagonist famotidine (nsubj)
episode day (nmod)
due ethambutol (nmod)
microl 10 (nummod)
present been (cop)
allocated received (advcl)
acids studied (acl)
using days (nmod)
antibodies of (case)
and markedly (advmod)
day 16 (nummod)
seem indicative (xcomp)
erythromycins defects (appos)
treated anticoagulant (nmod)
reversible signs (nsubj)
caution and (cc)
pressor cold (amod)
used transplantation (nmod)
disturbances transient (amod)
examine stress (dobj)
appeared initially (advmod)
efficacy isg (nmod)
databases library (conj)
changes week (nmod)
ranged ages (nsubj)
caused were (auxpass)
useful development (nmod)
dosed when (advmod)
discontinued alteplase (nsubjpass)
gave he (nsubj)
amoxicillin ax (appos)
changes potential (amod)
shown it (nsubj)
relieve it (dobj)
was site (nmod)
insipidus to (case)
radiculopathy of (case)
hepatitis jaundice (dep)
switchers for (case)
fbal into (case)
9,832 and (cc)
force force (conj)
records men (nmod)
discontinued headache (nmod)
injected cocaine (nsubjpass)
found increased (xcomp)
range doses (nmod)
had control (advcl)
g carbachol (nmod)
quadriparesis because (case)
renin plasma (compound)
october 1998 (nummod)
increased women (nmod)
controls five (nummod)
pressure end-diastolic (amod)
declined minimum (nmod)
baseline 1.5 (nummod)
phenotyping behavioral (amod)
developed initiation (nmod)
eyes treated (amod)
enabling blockade (dobj)
therapy antihypertensive (amod)
titre mpo-anca (compound)
correlates cardiotoxicity (nsubj)
patients lesions (nmod)
cholesterol greater (amod)
done analysis (nsubjpass)
experience from (case)
derangement basis (nmod)
episode fails (acl:relcl)
response transient (amod)
therapy agonists (nmod)
control conversion (conj)
events 5.2 (nummod)
explanation of (case)
pain malignant (amod)
group -1 (punct)
levels h (nmod)
mapd on (case)
function small-bowel (amod)
vomiting no (neg)
stenosis renal (amod)
disease cerebrovascular (amod)
effects system (nmod)
indications precise (amod)
ameliorated lowering (advcl)
agranulocytosis and (cc)
constant increased (amod)
maximum were (cop)
insufficiency , (punct)
variable . (punct)
abnormalities menstrual (amod)
k(i ) (punct)
deficits using (acl)
report presented (acl)
combinations of (case)
patients forty-three (nummod)
acne and (cc)
model administration (nmod)
related ppa (nmod:npmod)
pathway ceruleo-cerebellar (amod)
injury to (case)
received pamidronate (dobj)
flutter atrial (amod)
network major (amod)
dogs subjected (acl)
signified cases (nmod)
put and (cc)
32 28 (compound)
phlebitis arm (nmod)
words generated (acl)
block which (nsubj)
studies three (nummod)
identical nearly (advmod)
damage propylthiouracil-induced (amod)
cisplatin given (acl)
gyrata verticis (compound)
developed those (nmod)
examined abundance (dobj)
hepatitis the (det)
sarcoma cancers (appos)
small have (advcl)
was contrast (nmod)
unresolved is (cop)
effects smoking (nmod)
people : (punct)
warranted be (auxpass)
block lumbar (amod)
aneurysm a (det)
enhancement catalepsy (nmod)
man 62-year-old (amod)
experiment the (det)
blocked effect (nsubjpass)
lactate , (punct)
perfusion-fixed . (punct)
patients 237 (nummod)
accumbens shell (dep)
acid mg/day (appos)
determining in (mark)
reversed not (cc)
derive changes (nmod)
purpose demonstrate (acl)
neonates born (acl:relcl)
polyneuropathy caused (acl)
microm 500 (nummod)
depletion in (case)
improve did (aux)
stimulation central (amod)
restores performance (dobj)
prevalence similar (amod)
cfcs ( (punct)
antagonist s-312-d (appos)
assessment perimetry (nmod)
increased decreased (conj)
diagnosed % (nsubjpass)
has values (nmod)
neuropathy optochiasmatic (amod)
woman lacnp (nmod)
history and (cc)
reduced periods (nmod)
gaining fluoxetine (nsubj)
showed losartan (punct)
tingling or (cc)
paranoia of (case)
events transfusion (compound)
had women (nsubj)
hysterosalpingography patients (nmod)
situated center (nmod)
intake doses (nmod)
smelling food (dobj)
caffeine and (cc)
event % (appos)
role afterdepolarization (nmod)
g 1.2 (nummod)
coil circular (amod)
complications eye (compound)
presentation morbidity (conj)
memory short-term (amod)
effects against (case)
malaise of (case)
accumulation the (det)
alcohol-na ve (dep)
performed exclude (advcl)
dosing shr (nmod)
fluency word (compound)
micromol/l 300 (nummod)
evaluation their (nmod:poss)
investigation examination (dep)
discontinued suspected (advcl)
therapy hyperprolactinemia (nmod)
showing deposits (dobj)
hippocampus from (case)
practice and (cc)
7.54 doses (nsubj)
learning rats (nmod)
that granulocytes (nmod)
$ROOT$ electro-oculography (sent)
literature a (det)
nephropathy aminonucleoside-induced (amod)
dothiepin amitriptyline (conj)
velocity fell (acl:relcl)
treated apigenin (nmod)
peptide a (det)
$ROOT$ normal (sent)
activated migraine (nmod)
uptake by (case)
pfs and (cc)
coupled processes (nmod)
induce foci (dobj)
hours the (det)
test latency (compound)
reflects injury (dobj)
0.05 than (case)
discontinued nafcillin (nsubjpass)
received volunteers (nsubj)
revascularization partial (amod)
followed epiphenomena (nmod)
found attenuate (ccomp)
score dpi (appos)
either catheterization (dep)
completed awakening (nmod)
mrna levels (conj)
ufh pod (nmod)
improvement striking (amod)
t efavirenz (conj)
6/8 ( (punct)
indicating involved (ccomp)
completed 22 (conj)
aim continues (dep)
preinfusion ml/100g/min (appos)
radiopharmacy in (case)
normotensive in (case)
responsiveness of (case)
studies light (compound)
administration tropicamide (nmod)
potential ciprofloxacin (nmod)
carried and (cc)
thirty-nine patients (nmod)
produce distributions (dobj)
occurred thrombophlebitis (nsubj)
(vcm)-induced vancomycin (nmod:npmod)
presence changes (conj)
observed modifications (nsubjpass)
weight than (case)
mice comprising (acl)
reduced minutes (nmod)
hyperkinesis , (punct)
peaked p (nmod)
index performance (compound)
disorder needed (conj)
rendered hypoxic (conj)
bleeding intestinal (amod)
role onset (nmod)
head of (case)
used practice (nmod)
group 7.3 (dep)
$ROOT$ help (sent)
treatment metformin (compound)
cholinesterase human (amod)
parameters dogs (nmod)
diabetic and (cc)
clearance rc (appos)
man 42-year-old (amod)
renography at (case)
responses reflex (amod)
deficits : (punct)
levels measured (acl)
days 1.4+/-4.0 (nummod)
thresholds control (nmod)
30 8 (conj)
regained had (aux)
experience se (dobj)
interval , (punct)
observed fall (nsubjpass)
cardioversion maintenance (conj)
developed syndrome (nsubj)
impairment attention (nmod)
patients twenty-five (nummod)
lesions ) (punct)
defecate to (case)
indicated safe (ccomp)
used index (nsubjpass)
% 54.3 (nummod)
fish , (punct)
promotes remodeling (nsubj)
applications the (det)
prolonged markedly (advmod)
raise may (aux)
maintaining managing (advcl)
one in (case)
agent alone (advmod)
gd mg/kg (dep)
paclitaxel therapy (nmod)
action similar (amod)
overdose the (det)
prednisolone after (case)
cells rbcs (appos)
disease iv (nummod)
kg ( (punct)
included age (dep)
neutralization a (det)
hemolysis failure (conj)
region cortex (nmod)
scans cerebral (amod)
presentation myriad (amod)
lower output (nsubj)
carcinoma cervical (amod)
tests dobutamine (compound)
therapy procainamide (compound)
mechanism than (case)
limited are (cop)
believed widely (advmod)
males healthy (amod)
design : (punct)
treatment pain (nmod)
observed life (nsubjpass)
managing are (aux)
reviewed means (nmod)
simvastatin to (case)
evaluated neuroradiologists (nmod)
consequences stopping (advcl)
malformation chiari (compound)
onset h (nmod:npmod)
potential inducing (advcl)
junction nd-nmba (nmod)
ta-t1 o-a (appos)
correlated ace (nsubj)
likely that (nsubj)
91.5 was (cop)
nanospheres lipid (compound)
recovery anaesthesia (nmod)
myasthenia the (det)
akinetic or (cc)
practice kong (nmod)
performed allografts (conj)
use have (aux)
differ atypicals (nmod)
ingestion bupropion (nmod)
infused min (dobj)
variables function (nmod)
contraception after (case)
p<0.05 ( (punct)
suppression expression (nmod)
dysphagia about (case)
1.0 quintiles (nmod)
syndrome dysmenorrhea (nsubj)
course subsequent (amod)
unresponsive effects (nsubj)
unremarkable tomography (nsubj)
present aneurysms (nsubj)
4.4 ) (punct)
role caa (nmod)
dehydrogenase dihydropyrimidine (compound)
follow-up long (amod)
s groups (dep)
blocks trazodone (nsubj)
swelling and/or (cc)
sedatives care (nmod)
depends critically (advmod)
effects benzodiazepine (compound)
injected mice (nsubjpass)
found bradycardic (xcomp)
use intoxication (conj)
disease cardiac (amod)
527+/-509 22 (compound)
determined ; (punct)
tacrine , (punct)
users ecstasy (acl:relcl)
threshold generation (nmod)
proteins range (nmod)
analysis [3h]inulin (conj)
outcomes patient (compound)
involving drugs (dobj)
defects observed (acl)
sides on (case)
measurement using (dep)
appeared children (nsubj)
recommended . (punct)
treatment used (amod)
females ritonavir-treated (amod)
infused or (advmod)
sodium calcium (conj)
fully either (preconj)
g-1 mug (compound)
considered delaying (nsubjpass)
documentation proteinuria (nmod)
change do (aux)
therapy art (appos)
animals repleted (amod)
accounted effect (nmod)
3.8 to (dep)
hypertrophy significant (amod)
anxiety to (case)
system the (det)
attained response (dobj)
27-hydroxylase sterol (compound)
vasculitis (mpo-anca)-positive (amod)
increase selected (ccomp)
daidzein weight (appos)
background provide (appos)
amns , (punct)
11.9 - (punct)
causes injection (nsubj)
inhibit enzyme (dobj)
production metabolites (nmod)
risperidone % (dep)
modifies catalepsy (dobj)
calculated classified (conj)
time succinylcholine (nmod)
impairment drugs (nmod)
enrolment before (case)
atm of (case)
interval st (amod)
presentation patients (nmod)
ameliorated decreased (conj)
factor genetic (amod)
schedule following (amod)
experiments to (case)
reduction irritability (nmod)
consequence methotrexate (compound)
rs case (nmod)
ph a (det)
peroxidation the (det)
1 from (case)
triggers death (dobj)
decreased action (dobj)
oscillation pupillary (amod)
performance simulator (compound)
respect toxicity (nmod)
observed behaviors (nsubjpass)
discontinue improve (conj)
vasculitis vasculitis (nsubj)
4.6 4.4 (conj)
exchange spaces (nmod)
tobramycin than (case)
recorded measurements (nsubjpass)
cimetidine with (case)
therapy transplantation (nmod)
produced protect (conj)
antioxidant , (punct)
baseline c (conj)
agonist dopamine-1 (compound)
bortezomib patient (nmod)
evaluate nephrotoxicity (dobj)
mm 15.8 (nummod)
relationship concentrations (nmod)
evident most (advmod)
alpha-tc by (case)
antifolate is (cop)
irrigation of (case)
end by (case)
ratio 7.5 (appos)
infiltration diagnosis (nmod)
lindane mg/kg (dep)
minutes % (conj)
backgrounds clinical (amod)
attenuated reductions (dobj)
effective amlodipine (nmod)
outcome adverse (amod)
analysed trial (nsubj)
experienced diplopia (dobj)
years less (amod)
dose epinephrine (nmod)
bobbing , (punct)
contribute deficiency (nmod)
concomitant elevation (nmod)
hyperactivity : (punct)
field test (conj)
effect hallucinations (nsubj)
differ however (advmod)
offered patient (nmod)
leak mannitol (nsubj)
anemia mild (amod)
significant the (det)
diary micturition (compound)
execution by (case)
use transplantation (nmod)
became then (advmod)
to " (punct)
kits elisa (compound)
measure and (cc)
patients thalassemic (amod)
disease children (nmod)
lobe of (case)
showed markers (nmod)
vasoconstriction cerebral (amod)
studies case-control (amod)
showed h (nmod)
binding through (case)
lead often (advmod)
exhibited kidneys (nsubj)
profiles lozenge (nmod)
data these (nsubj)
occur effects (nsubj)
failure of (case)
lindane by (case)
involvement cranial-nerve (amod)
antibodies suggested (acl)
correlates timing (nmod)
af of (case)
mice non-txg (amod)
dose tablets (appos)
mmt ] (punct)
processes mediated (amod)
prevalent d-glucarates (nmod)
microinjection nucleus (nmod)
mg/kg mean (dep)
female started (acl:relcl)
erections penile (amod)
accuracy steering (compound)
magnitude result (acl)
crp ( (punct)
shift inducing (advcl)
cerebellum for (case)
label number (dobj)
discuss pathophysiology (dobj)
october 31 (nummod)
activity peroxidase (compound)
maintained g (nmod)
volume effective (amod)
alterations resembling (acl)
14,671 . (punct)
able (+/-)-pg-9 (nsubj)
identified as (mark)
presentation review (conj)
half drinkers (nmod)
implications important (amod)
required allow (xcomp)
demonstrate . (punct)
pc bcp (conj)
spread activity (nmod)
decreases that (mark)
vte associated (acl)
formulation an (det)
rose weeks (nmod)
preceded interval (nmod)
practitioners patients (nmod:poss)
sulfate-treated nicotine (nmod:npmod)
fmri ( (punct)
women versus (cc)
rat male (amod)
dose is (cop)
pcag ) (punct)
racemic , (punct)
amplitude sensory (amod)
noradrenaline na (appos)
present failure (nmod)
10 to (case)
trial the (det)
pre-treatment oral (amod)
resulting death (nmod)
plays reduces (conj)
observed recovery (nsubjpass)
verapamil intragastric (amod)
common also (advmod)
decreased isoproterenol (nsubj)
well . (punct)
parameters dbs (nmod)
variety symptoms (nmod)
showed follow-up (nsubj)
made : (punct)
prepared that (mark)
receptor specific (amod)
cytoskeleton cardiomyocyte (compound)
examination and (cc)
required modification (nsubjpass)
metoprolol by (case)
detected period (nmod)
electroshock subconvulsant (amod)
relation concentrations (nmod)
abuse chronic (amod)
drugs quaternary (amod)
effect properties (nmod)
salt-depleted normal-salt (conj)
block attacks (nmod)
task consisting (acl)
explore using (advcl)
exposure a (nmod)
rates or (cc)
responses sustained (amod)
alterations hippocampal (nmod)
seizures during (case)
death cardiovascular (amod)
variations receptor (nmod)
cases pathological (amod)
acetaminophen from (case)
substrate the (det)
suspension as (case)
drugs angiotensin (compound)
shr prazosin (compound)
found inhibit (xcomp)
itchiness , (punct)
reported symptoms (dobj)
infusion ( (punct)
$ROOT$ them (sent)
cancers with (case)
rate objective (nsubj)
wales new (compound)
agent anthraquinone-containing (amod)
alterations processing (compound)
preparation as (case)
exams radiologic (amod)
neuropediatrician by (case)
rate glomerular (amod)
varied although (mark)
conclusions demonstration (dep)
density on (case)
start to (mark)
intervals bh (compound)
correlated dlt (nsubj)
permit treatment (dobj)
play apoptosis (nsubj)
cardiorespiratory , (punct)
patients by (case)
different is (cop)
therapy maximal (amod)
changes severe (amod)
common toxicity (nsubj)
depletions with (case)
brain of (case)
improved compounds (nsubj)
induction leukemia (nmod)
ly-171555 than (case)
p=.02 ( (punct)
determine occur (ccomp)
beats/min -5.7 (nummod)
patients transplantation (compound)
hypertension (phe)-induced (amod)
beat , (punct)
offspring of (case)
causes infarction (nmod)
expression not (neg)
feared initially (advmod)
practitioners medical (amod)
rigidity induced (amod)
typical block (nmod)
inserted wires (nsubjpass)
drugs only (amod)
associated papaverine (nsubjpass)
analysis stereological (amod)
smokers pipe (compound)
chicago il (appos)
ua 280+/-17 (nummod)
differ 2 (dep)
tone the (det)
$ROOT$ suitable (sent)
experienced stopping (advcl)
younger or (cc)
quintiles intake (nmod)
prolapse pre-existing (amod)
experienced toxicity (dobj)
rna total (amod)
growth hypertrophic (amod)
hds and (cc)
have to (mark)
years = (dep)
function their (nmod:poss)
application frontotemporal (amod)
lessened decrement (dobj)
surface total (amod)
position the (det)
mortality pbsct (nmod)
performed after (mark)
involvement . (punct)
deposits dense (amod)
source cns (compound)
maleate of (case)
back was (cop)
drug aed (appos)
intermediate- , (punct)
steroids some (det)
rigidity chest (compound)
measuring and (cc)
methotrexate , (punct)
mg/kg 85 (nummod)
add models (nmod)
a from (case)
tolerated combination (nsubjpass)
result from (case)
hemodynamics . (punct)
rectified this (nsubjpass)
efficacy their (nmod:poss)
prior during (conj)
= 203 (dobj)
discharged was (auxpass)
etiology possible (amod)
provides insights (dobj)
increases equal (nummod)
pleased allow (conj)
g with (case)
slower relative (advmod)
amplified followed (dep)
remedy may (aux)
materials included (dep)
confirm or (cc)
receiving had (conj)
organisms were (cop)
able curcumin (nsubj)
study rats (nmod)
weakness right-sided (amod)
3.1+/-1.0 , (punct)
influenzae haemophilus (compound)
shown studies (nsubj)
tumor tissues (conj)
differ haloperidol (nsubj)
ml/kg with (case)
unchanged while (mark)
found administration (nmod)
level effect (nmod)
cpa/ee on (case)
caused hypersensitivity (nmod)
use agonist (nmod)
effects between (case)
induction . (punct)
antagonist specific (amod)
gfr ) (punct)
plasma brain (conj)
efficacious was (cop)
diets semipurified (amod)
microl min (appos)
admissions hemiparesis (nmod)
percentage reported (acl)
electro-oculography potentials (conj)
structures related (amod)
system excitatory (amod)
acuity vision (conj)
patients 2 (nummod)
paralleled was (auxpass)
amplifier the (det)
dynamics cerebrospinal (amod)
produced alfentanil (nmod)
quantitated ems (nmod)
drugs gentamicin (nmod)
injection spinal (amod)
protocols ( (punct)
users repeat (amod)
toxic lidocaine (nmod)
divided cannulated (conj)
sensitivities greatest (amod)
acetate alpha-tocopherol (compound)
9.7 - (advmod)
age were (cop)
therapy hyperbaric (amod)
limited utility (nsubjpass)
4.1 1.0 (conj)
procedures sop (appos)
therapy was (cop)
fashion double-blinded (amod)
distinguished . (punct)
monotherapy amlodipine (compound)
reports , (punct)
had infusion (dobj)
decreased elevations (dobj)
verbal either (cc:preconj)
got dextrose (nmod)
modifies . (punct)
measure variations (dobj)
delirium postoperative (amod)
role activation (nmod)
prk ) (punct)
terminated and (cc)
doxorubicin anthracycline (compound)
induced bradycardia (dobj)
stopped became (advcl)
test light/dark (compound)
demonstrated altered (ccomp)
injury on (case)
hyperglycemia curve (conj)
ss ( (punct)
cytarabine of (case)
showed study (nsubj)
parameters study (nmod)
measure indicator (conj)
evaluated rodents (nmod)
failure % (dep)
inhibition rats (nmod)
grains of (case)
mechanism activity (nmod)
muscles antagonistic (amod)
confusion acute (amod)
dose neurotoxic (amod)
revealed cases (nmod)
all < (amod)
identified duration (dobj)
have reductions (nsubj)
447 and (cc)
peptide brain-gut (amod)
given dx (dobj)
promote passage (dobj)
aim experiment (nmod)
cases involving (acl)
concentrations [ca(2+)](i (appos)
centre specialist (compound)
oil soyabean (compound)
diarrhea . (punct)
varies , (punct)
cystitis after (case)
attributable that (nsubj)
induced anaesthesia (nsubjpass)
comparison is (cop)
binding l-[3h]nicotine (compound)
replacement corticosteroids (conj)
completed to (mark)
metabolite rats (nmod)
mg)-containing 0.8 (nummod)
exceeding preferably (advmod)
seizures uncontrolled (acl)
nephrotoxic are (cop)
rates objective (amod)
changed treatments (nsubj)
function mitochondria (nmod)
odds % (compound)
treatment successful (amod)
releases trazodone (nsubj)
assumed hypercholesterolemia (nmod)
liver lung (conj)
agonist serotonin-1a (compound)
primates nonhuman (amod)
study family (nmod)
remained = (parataxis)
ecstasy in (case)
% 44 (nummod)
required but (cc)
shown nsclc (nmod)
group large (amod)
cocaine ip (advmod)
more to (dep)
malignancies of (case)
bpm by (case)
estimated not (neg)
effect conduction (nmod)
acting adrenoceptors (nmod)
potential and (cc)
affect nerves (dobj)
contractions carbachol (nmod)
remained adjustment (nmod)
performed dse (nsubjpass)
dfx ) (punct)
weeks in (case)
rate norepinephrine (compound)
cimd ) (punct)
encountered patient (dobj)
induces tachycardia (nmod)
decreased injection (nmod)
limited use (nsubj)
cross-clamp of (case)
= 135 (dobj)
herbicides are (cop)
removing in (mark)
dose precurarizing (amod)
shift levels (nmod)
screened department (nmod)
average after (case)
amide ] (punct)
increase cbf (nmod)
case , (punct)
changes both (cc:preconj)
obtained sinus (nmod)
using combination (nmod)
treatments acc-9653 (compound)
woman 57-year-old (amod)
ngf between (case)
any tissues (nmod)
present cytoplasm (nmod)
depression features (nmod)
provoked bolus (nsubj)
received escalation (nmod)
velocity maximum (compound)
measurement of (case)
antioxidant inhibitor (conj)
observed minutes (parataxis)
fluids to (case)
transection , (punct)
pathway death (nmod)
report conclusion (nmod)
able . (punct)
annulus mitral (amod)
number periods (nmod)
setting tma (nmod)
status in (case)
adults indian (amod)
mapped deficits (nsubjpass)
receiving patients (nsubj)
known administration (nsubjpass)
lymphadenitis necrotising (amod)
ci:0.3 ) (punct)
problems the (det)
that delivered (acl)
concentration inspired (amod)
microangiopathy patients (nmod)
gastroenteritis and (cc)
% subgroup (nmod)
clear situation (nsubj)
disease overt (amod)
pressure rate (appos)
class this (det)
pressure fasciculations (nmod)
> mg/dl (dobj)
csa mg/kg/day (amod)
play required (conj)
stages damage (nmod)
function subjects (nmod)
accumulation disorders (conj)
bear risk (dobj)
type any (det)
woman 40-year-old (amod)
lesion induced (amod)
deaths the (det)
masked readjustment (nmod)
addresses to (case)
150 165 (conj)
results staining (nmod)
$ROOT$ months (sent)
cck-8 1ug (dep)
$ROOT$ exercised (sent)
alternations observed (acl)
increased slowly (advmod)
= lca (nsubj)
occurred myoclonus (nsubj)
implications : (punct)
low-dose-adr-associated chronic (amod)
completing with (mark)
period 2 (nummod)
disturbance secretion (nmod)
useful pilocarpine (nsubj)
contents the (det)
newspaper , (punct)
satisfied h (nmod:npmod)
reactions among (case)
chemotherapy epirubicin (nmod)
procedure inhibition (conj)
assessed day (nmod)
drug- or (cc)
% 7.9 (nummod)
nucleus neurons (nmod)
bfgf levels (dep)
performed resulted (conj)
respond did (aux)
ml 80.8 (nummod)
= 32 (dobj)
were animals (nmod)
agents nmbas (appos)
granulated . (punct)
extracted were (auxpass)
sensitive that (mark)
criteria manual (compound)
polyuria the (det)
days following (amod)
thought related (xcomp)
predisposed use (nsubj)
hypotension nitroprusside (compound)
features in (prep)
$ROOT$ seizures (sent)
infusion haloperidol (nmod)
brought about (compound:prt)
dogs tumour-bearing (amod)
window its (nmod:poss)
resolved improvement (nmod)
events ci (dep)
v/s 1.85 (nummod)
associated three (nmod)
multivitamin another (det)
colliculus ic (appos)
afl ( (punct)
mg/m(2 at (case)
rate rhythm (conj)
co-infection with (nmod)
toxicity was (cop)
$ROOT$ comparable (sent)
lesions extensive (amod)
hemolysis acute (amod)
activity xo (compound)
context in (case)
addition sufficient (amod)
effects beta-mimetics (nmod)
unrelated . (punct)
medline embase (conj)
seen exposure (nmod)
[verapamil]o needed (acl)
motor minor (amod)
aza ) (punct)
proteinuria substantial (amod)
iu/l ast:274 (nummod)
delineated have (aux)
reactions suspected (amod)
remained fed (conj)
dose into (case)
injury or (cc)
has pathway (nsubj)
water mineral (compound)
effective care (nmod)
treated likewise (advmod)
mechanisms multiple (amod)
had four (nsubj)
had locomotion (nmod)
p 0.001 (nummod)
age on (case)
cl 95 (amod)
strains transferred (acl:relcl)
6 to (case)
antiviral pneumocystis (conj)
showed half (nsubj)
inversions t (compound)
pressure symptoms (conj)
decrease mm (appos)
$ROOT$ alt (sent)
safety tolerability (conj)
max t (compound)
involved response (nmod)
4 was (cop)
took over (compound:prt)
males females (appos)
cin and (cc)
episode occurs (acl:relcl)
underlie may (aux)
$ROOT$ continued (sent)
patients dosage (nmod)
neurotoxic to (mark)
had receiving (parataxis)
2.6 to (dep)
duration their (nmod:poss)
factors infusion (nsubj)
cocaine recreational (amod)
indicates clearly (advmod)
combination nicotine (nmod)
change consumption (nmod)
lignocaine plain (amod)
patients ii (nummod)
increase mg/m(2 (nmod)
diet normal-sodium (amod)
incorporating b. (dobj)
content ionic (amod)
time ) (punct)
applied . (punct)
conclusions cause (acl)
had 18 (nsubj)
volume activity (conj)
exhibit . (punct)
haloperidol placebo (conj)
reduced dyskinesias (nsubjpass)
il-2 with (case)
alive patients (nsubj)
injection suxamethonium (nmod)
microg/rat ( (punct)
neuropathy pac-induced (amod)
165 215 (conj)
investigated total (nsubjpass)
jerks the (det)
determine dose-dependent (ccomp)
selection study (compound)
abnormalities hematological (amod)
disease cholestatic (amod)
neuroinflammation abnormalities (conj)
role betaine (nmod)
dilate arteries (dobj)
excreted urine (dobj)
activity ) (punct)
avoid exposure (dobj)
carefully very (advmod)
treated stabilizers (nmod)
disorders neuroleptic-induced (amod)
acuity high- (amod)
product in (case)
showed 7e (nsubj)
movements dystonic (amod)
synthesis changed (amod)
specific endothelial (amod)
infarction 1991 (nmod)
doses mean (amod)
present patients (nmod)
beta-blocker a (det)
mice not (neg)
consists management (nsubj)
sulfate ps (appos)
included mi (dobj)
found intake (nsubjpass)
trough mainly (advmod)
toxicities tissue (compound)
3.9 0.1 (conj)
divided patients (nsubjpass)
therapy amiloride (compound)
mass left (amod)
angiotension ii (nummod)
presence is (cop)
eye ; (punct)
toxicity visual (amod)
study children (nmod)
treatment each (det)
controversial are (cop)
indicated falls (advcl)
phenotype poor-metabolizer (amod)
inhibit not (neg)
activity motor (amod)
given ethanol/aap-mice (nmod)
area amiens (compound)
restricted class (nmod)
uraemia clearance (conj)
investigated correlates (dobj)
p<0.001 ci (appos)
improve ketamine (nsubj)
viracept protease (compound)
related that (mark)
feet the (det)
association : (punct)
3.9 0.9 (conj)
rating amnesia (conj)
kidneys perfused (acl)
slices the (det)
toxicity magnesium (nmod)
compressions chest (compound)
agonist min (appos)
= 0.04 (dobj)
8-phenyltheophylline and (cc)
possibility events (nmod)
determined which (nsubjpass)
more compared (advcl)
therapy potassium-losing (amod)
admitted . (punct)
electroencephalogram interictal (amod)
45 of (case)
variability genome (compound)
rct 1 (nummod)
resulted disappearance (nmod)
heredofamilial and (cc)
425 +/- (cc)
high- low-contrast (conj)
evidence cholestasis (nmod)
contamination derivatives (nmod)
dysphonia for (case)
investigated engagement (dobj)
scanner in (case)
leukopenia 18.2/9.1/0 (appos)
published literature (nmod)
day gestation (nmod)
outcomes polysomnographic (amod)
problematic can (aux)
rate mice (nmod)
performed anesthesia (nsubjpass)
reports few (amod)
sc ; (punct)
25mg/kg ( (punct)
mice p.o. (appos)
induced ns (nsubjpass)
regulation prolactin (nmod)
pallidus the (det)
% 60 (nummod)
treatment ointment (nmod)
curves co2-response (compound)
abnormal were (cop)
revealed search (nsubj)
carried order (nmod)
2d6 the (det)
dose usual (amod)
reviews date (nmod)
manifested . (punct)
jg wilson (compound)
had three (nsubj)
class association (compound)
2.5 than (quantmod)
mg/kg dose (nsubj)
38 and (cc)
disposition tetracycline (nmod)
therapy continued (amod)
available reliably (advmod)
acid cb (appos)
microinjections via (case)
sedation after (case)
reaction associated (acl)
impaired was (aux)
latency sleep (compound)
polymorphism by (case)
held november (nmod)
four relapsed (acl:relcl)
sevoflurane surgery (nmod)
co and (cc)
sulfasalazine of (case)
4.9 1.3 (quantmod)
ke . (punct)
course typical (amod)
regimen one (nummod)
total patients (nmod)
instructions in (case)
documentation . (punct)
fazadinium of (case)
fatal it (nsubj)
hepatic extrahepatic (conj)
169 x (cc)
$ROOT$ drop (sent)
rats adn (amod)
subunit cox (compound)
increase early (amod)
termed . (punct)
cholestasis intrahepatic (amod)
myalgia a (det)
dexmedetomidine propofol (conj)
erythromycins ) (punct)
34 12 (conj)
composition response (dep)
ces-d scale (conj)
pneumonitis cell-mediated (amod)
former the (det)
continued period (nmod)
hospital our (nmod:poss)
use pregnancy (nmod)
recorded abnormalities (nsubjpass)
level paracetamol (compound)
agonist beta (compound)
evaluated must (aux)
concentrations clearance (conj)
hemolysis tam-induced (amod)
efficiency oropharyngeal (amod)
averaged signal (nmod:npmod)
age or (cc)
reflex induced (acl)
dropped showed (conj)
activities to (case)
chemotherapy cisplatin-based (amod)
mediated cisplatin (nmod)
complexes 30 (nummod)
ingested was (auxpass)
bh and (cc)
revealed investigations (nsubj)
caudate and (cc)
requires synthesis (dobj)
termination until (case)
indicate administered (ccomp)
collected were (auxpass)
treated bacteremia (nmod)
uptakes mitochondrial (amod)
delay training (nmod)
prevent reduction (dobj)
infection proteus (compound)
lymphomas in (case)
depression spreading (compound)
male history (nmod)
effect trazodone (nmod:poss)
mice g (appos)
likely related (ccomp)
immobility this (det)
reabsorption free (amod)
administration to (case)
bpo-pll ax-pll (conj)
amb intravenous (amod)
resistant largely (advmod)
inhibited test (nmod)
demonstrated respectively (advmod)
presenting years (nmod)
association tumor (nmod)
decreased 176 (nmod)
neurotoxicity ma-induced (amod)
less mg/dl (nmod)
related change (nmod)
treatment hyperhidrosis (nmod)
methods diagnostic (amod)
ameliorates . (punct)
anti-hiv 1/2 (nummod)
analysis further (amod)
patients cord (compound)
used case (nmod)
case few (amod)
rise marked (amod)
stronger 20 (nmod:npmod)
serum ( (punct)
two less (advmod)
cause therapy (nsubj)
similar regimens (nmod)
studies population (nmod)
activation receptors (nmod)
result therapy (nmod)
36.22 1.92 (conj)
arthritis large (amod)
$ROOT$ blocked (sent)
cyclophosphamide cp (appos)
dissociate vocalization (dobj)
monitor progression (dobj)
results experienced (appos)
drop dramatic (amod)
higher mg (nmod:npmod)
characteristics that (mark)
decrease blood (nmod)
provided total (nmod)
derive less (advmod)
aborted epistaxis (nmod)
showed course (nmod)
minimize impairment (dobj)
p=.02 11/57 (nummod)
due 5-fu (nmod)
participation system (nmod)
patients aza (compound)
yohimbine of (case)
favor association (nsubj)
addition amifostine (nmod)
drugs anxiolytic (amod)
nm 76 (nummod)
methods given (appos)
years under (case)
seizures/mo 0.42 (nummod)
imbalance of (case)
was potentiation (attr)
weight necrosis (conj)
reverse or (cc)
intervals test (nmod)
literature with (case)
restored replacement (nsubj)
produce pain (nmod)
activity vasodilator (compound)
obtained 111 (nmod)
ds-sarcoma rat (nmod)
anxiety or (cc)
susceptibility , (punct)
cultures renal (amod)
terminate whereas (mark)
microg/ml concentration (nsubj)
activity change (conj)
day gtn (compound)
disease the (det)
cbd ) (punct)
statement concerning (acl)
effects depletion (nmod)
response immunological (amod)
report woman (dobj)
sacrificed animals (nsubjpass)
azathioprine prednisone (conj)
treatment octreotide (nmod)
glaucoma secondary (amod)
doses/day dcf (nmod)
129 +/- (cc)
cells neuroglial (amod)
show 50 (nsubj)
occurred reaction (nsubj)
levels psychosis (nmod)
penicillins and (cc)
effusions of (case)
phenobarbitone as (cc)
concentrations folate (compound)
attempt a (det)
confirms effective (ccomp)
l-name diazepam (conj)
overloaded iron (nmod:npmod)
hold remodelling (nmod)
similarities with (case)
caution extreme (amod)
morphine the (det)
had cent (nsubj)
disturbances haematological (amod)
folate beta-carotene (conj)
isotretinoin with (case)
protein high (amod)
amplitudes tremor (compound)
associated b (nmod)
mediated incontinence (nsubjpass)
marker protein (compound)
non-transgenic ntg (dep)
inhibits lithium (nsubj)
occurred total (nsubj)
times sec. (nmod)
suppressed is (auxpass)
$ROOT$ hyperkalemia (sent)
catalepsy induced (amod)
patient secondary (amod)
non-drug , (punct)
ratings symptoms (conj)
$ROOT$ dosed (sent)
compared followed (advcl)
exhibited compared (prep)
outcomes medical (amod)
installing rapidly (advmod)
responsible dysregulation (nsubj)
cardiomyopathy dilated (amod)
hcbd bea (conj)
memory hippocampal (compound)
headaches patient (nmod)
stimulation prolonged (amod)
nephrotoxicity with (case)
has trial (dep)
stages certain (amod)
average % (nmod)
rhythm accelerated (amod)
address question (dobj)
% bradycardia (nsubj)
reported lesion (nmod)
sent institutions (nmod)
treatment cases (nmod)
electrocardiograms the (det)
groups subsequent (amod)
presentation its (nmod:poss)
compared made (conj)
qtls , (punct)
alert possibility (nmod)
mg/day 2 (nummod)
healthy and (cc)
hexabrix its (nmod:poss)
blocked however (advmod)
discontinuation upon (case)
inhibited activation (nsubj)
model logistic (amod)
disappear that (mark)
reduced replacement (nsubj)
suggesting mechanism (dobj)
% 54.6 (nummod)
solicited have (aux)
epilepticus status (compound)
effects drug (nmod)
cancer ration (compound)
antagonist nmda (compound)
3'-azido-2',3'-deoxythymidine ) (punct)
months 28 (nummod)
additive actions (nsubj)
min 20.95 (nummod)
proteins cardiac (amod)
angiography after (case)
65.3 +/- (cc)
mg 35.0 (nummod)
changes , (punct)
sonography neonates (nmod)
administration i.m. (compound)
hypokalemic but (cc)
d-med antagonist (conj)
deficits meth-induced (amod)
old ) (punct)
indication clinical (amod)
increased 135 (nmod)
experience omeprazole (nmod)
improved returned (conj)
n=12 ) (punct)
deaths 20 (nummod)
involved sessions (dobj)
cultures neurons (nmod)
reflected not (neg)
mitigated manner (nmod)
contribution changes (nmod)
decreased incidence (dobj)
given oxytocin (nsubjpass)
disposition was (cop)
thalamotomy ventrolateral (amod)
populations professionals (nmod)
reducing on (mark)
effect edema (nmod)
extension width (appos)
assessed and (cc)
onset before (case)
compartments leukocyte (compound)
abolished increases (dobj)
woman asymptomatic (amod)
using % (nmod)
reported sumatriptan (nmod)
carolina north (compound)
concentrations toxic (amod)
produce reserpine (nsubj)
sed 6.4 (conj)
deterioration damage (conj)
$ROOT$ reduced (sent)
woman 45-year-old (amod)
neostigmine mg (nmod)
response decremental (amod)
higher times (nmod:npmod)
mapped was (auxpass)
phenomena neurobiological (amod)
incidence period (nmod)
tablets venlafaxine (compound)
exhibited profile (dobj)
attenuated pretreatment (nsubj)
regeneration tissue (nmod)
safety outcomes (dep)
proteinuria massive (amod)
occurred neuropathy (nsubj)
clinic psychiatry (compound)
ptz alternate-day (amod)
elicited repeatedly (advmod)
consciousness slowing (appos)
hospitalized began (advcl)
topotecan study (appos)
pre-treatment dose (nmod)
cross-tolerance ketamine (nmod)
recall test (nmod)
group second (amod)
1.9 3.5 (conj)
criteria the (det)
anticoagulation of (case)
persistent and (cc)
advances field (nmod)
travelling bundle (nmod)
scale alertness/sedation (compound)
articles several (amod)
1,2-dimethylhydrazine 1,2-dmh (appos)
p= 0.002 (dobj)
male siblings (appos)
seen generally (advmod)
5.4 +/- (cc)
demonstrate index (dobj)
replication clones (nmod)
elected " (punct)
effects reserpine (nmod)
consider and (cc)
sets according (case)
levels aorta (nmod)
thrombosis to (case)
increased had (parataxis)
mg/m(2 . (punct)
reduced cd-832 (nsubj)
suppress not (neg)
cognition fractures (conj)
pattern multisystem (amod)
thrombi wrinkling (conj)
b phase (compound)
70 - (advmod)
assessing satisfaction (dobj)
transgenic and (cc)
comparable efficacy (nsubj)
impairment stz- (amod)
reached regard (nmod)
d-penicillamine compound (nmod)
$ROOT$ utility (sent)
revealed and (cc)
receptor another (det)
had subjects (nmod)
synthesis nitric-oxide (compound)
effect covariance (compound)
% pressures (nsubj)
deafened using (xcomp)
one kindreds (nmod)
ifo ( (punct)
capsules bowman (nmod:poss)
suggest result (ccomp)
expected was (cop)
detection after (case)
start gem-p (nmod)
combined where (advmod)
mortality total (amod)
titrated results (nsubjpass)
maximal abolished (conj)
ahf of (case)
$ROOT$ range (sent)
diabetic for (case)
claimed although (mark)
longitudinal and (cc)
parameters indirect (amod)
threshold auditory (amod)
pre-surgery day (nmod:npmod)
work current (amod)
0.7 0.1 (conj)
upregulation a (det)
receptor vegfr-2 (appos)
concentrations b (compound)
apoptosis myocardial (amod)
developed was (auxpass)
lesions pustular (amod)
= -0.98 (dobj)
hypoactivity the (det)
0.9 and (cc)
fq nociceptin/orphanin (compound)
atropine depletor (conj)
predict . (punct)
increased count (nsubj)
fear , (punct)
protein of (case)
battery kaufman (compound)
man suffered (acl:relcl)
provided infant (nmod)
treated daptomycin (nmod)
dose estrogen (nmod)
therapy ect (appos)
hepatitis group (nmod)
tle ) (punct)
succinylcholine intubation (nmod)
unfamiliar were (cop)
quetiapine such (case)
transferred equipment (nmod)
titrated be (auxpass)
maintains function (dobj)
iv or (cc)
current cells (nmod)
side-effects serious (amod)
mediated effects (nsubjpass)
role erdosteine (nmod)
side block (nmod)
presence hours (nmod)
nucleus an (appos)
applications blockers (nmod)
282 203 (conj)
assay blonquist (nmod)
caused was (auxpass)
centers control (nmod)
received de (advmod)
presented proteinuria (dobj)
area a (det)
areas mesangial (amod)
receptors accumbal (amod)
vinorelbine with (case)
assessed mice (nmod)
paramount result (advcl)
cholesterol or (cc)
ds-sarcoma ) (punct)
toxic , (punct)
bcl-2 and (cc)
hemorrhage major (amod)
associated sedation (nsubjpass)
predict risk (ccomp)
concentrations uridine (nmod)
women concerned (acl:relcl)
urea ( (punct)
produces anxiety (dobj)
ability effect (acl)
block a (det)
approval patients (nmod)
aggravate , (punct)
neurotransmitters brain (compound)
increased hr (nmod)
school marmara (compound)
stoppage on (case)
technique anesthetic (compound)
heart to (case)
concern for (case)
affecting directly (advmod)
higher frequent (advcl)
acuity and (cc)
% 64 (nummod)
arose yield (nsubj)
methods administered (acl)
hypertelorism orbital (amod)
revealed workup (nsubj)
dose day (nmod)
mouth patient (nmod)
used spect (dobj)
affected ie (advcl)
therapy sirolimus (compound)
inhibitors as (case)
combination a (det)
hyperkalaemia for (case)
suppressants with (case)
scale bars (appos)
myoclonus muscimol-induced (amod)
cells granulocyte-macrophage (amod)
measured additionally (advmod)
$ROOT$ led (sent)
instability increased (amod)
figure the (det)
monitoring therapy (nmod)
sotalol of (case)
symptoms negative (amod)
suitable be (cop)
infusion adrenaline (nmod)
prevalence abuse (nmod)
phase ( (punct)
mobilization on (case)
function erectile (amod)
cohort a (det)
calculated . (punct)
facilitation memory (nmod)
case vasculitis (nmod)
acid with (case)
nerves serotonin (compound)
mexiletine of (case)
point effects (nsubj)
disorder remission (nmod)
administration ps (nmod)
stressed have (aux)
8) ( (punct)
1.008 6.944 (appos)
disruption barrier (nmod)
efficient antagonism (nsubj)
noted frequently (advmod)
subsided fever (nsubj)
associated atherosclerosis (nmod)
decreased coadministration (nsubj)
infarction pallidus (nmod)
care tertiary (amod)
which of (case)
smoking tobacco (compound)
covariates for (case)
society international (compound)
received subjects (nsubj)
collection echocardiography (conj)
produces reserpine (nsubj)
trp ( (punct)
changes myocardial (amod)
oxprenolol after (case)
agents patients (nsubj)
medulla jj (nmod)
disparities despite (case)
septal and (cc)
features facial (amod)
bodies cytoplasmic (amod)
produced vincristine (nmod)
showed dce (nsubj)
interacts that (mark)
width increase (conj)
inhibitor an (det)
examination ultrasound (compound)
compared rate (nmod)
activity urinary (amod)
$ROOT$ flaccid (sent)
antagonized pretreatment (nsubj)
production both (dep)
clonidine 5-mdot (conj)
agonist di-o-tolylguanidine (dep)
gained insights (nsubjpass)
satisfied treatment (nmod)
made recovery (dobj)
effects residual (amod)
right left (conj)
levothyroxine intravenous (amod)
suggested related (ccomp)
revealed history (nsubj)
take vegetarians (nsubj)
reflecting margins (dobj)
correct hypotension (dobj)
glomeruli affected (amod)
magnitude : (punct)
use case (nmod)
provide levodopa (advcl)
patients 414 (nummod)
cotransporter na-k-2cl (compound)
manifestation and (cc)
socs-3 cis (conj)
increasing hdl (dobj)
fraction mole (compound)
affect magnitude (dobj)
alert doses (nmod)
hypoglycemia reported (amod)
hem , (punct)
gram fraction (nmod)
tnss of (case)
trials phase (compound)
developed chemotherapy (nmod)
amiloride by (case)
fluoxetine total (amod)
partial 15 (nummod)
abnormalities by (case)
staying after (mark)
reported present (xcomp)
dose neither (det)
contributing thereby (advmod)
method liquid (amod)
renography 131i-hippuran (compound)
comparable which (nsubj)
taking propranolol (dobj)
24 of (case)
proteins middle (amod)
% animals (nmod)
groups adr+los(12 (conj)
patients ; (punct)
affected polyneuropathy (nsubj)
study transnational (amod)
$ROOT$ stopped (sent)
p=0.008 respectively (advmod)
open non-randomized (dep)
mtdna ) (punct)
thirsty polyuric (conj)
instillation medication (nmod)
biopsies n=25 (appos)
showed regression (nsubj)
sedation with (case)
evaluated chemotherapies (nmod)
reports any (det)
pilsicainide blocker (appos)
sample from (case)
distracted task (nmod)
self-dosing and (cc)
galactose oral (amod)
died patients (nsubj)
testing using (acl)
dysfunction astroglial (amod)
deterioration motor (compound)
derivative , (punct)
10.7 or (cc)
anticipated that (mark)
appearance antibody (nmod)
problems gynecologic (amod)
distributed diffusely (advmod)
patients two (nmod)
process as (cc)
acute maintenance (conj)
presence of (case)
cotrimoxazole erythromycin (conj)
structures involved (acl:relcl)
agitation hyperthermia (conj)
failed imaging (nsubj)
treated were (auxpass)
ward to (case)
consequence report (dep)
potencies different (amod)
potentiate could (aux)
produced model (nmod)
diethylpropion the (det)
catechol , (punct)
unchanged metformin (nmod)
positivity on (case)
encountered drugs (nmod)
is pathogenesis (ccomp)
appeared stage (nmod)
postulated be (auxpass)
area min (nmod)
e13.5 e18.5 (conj)
treatment amlodipine (nmod)
remains inhibits (ccomp)
cartilage and (cc)
and dose-dependently (advmod)
anemia . (punct)
zidovudine , (punct)
dysfunction hepatic (amod)
mg/day 617 (nummod)
ptld of (case)
zuclopenthixol lithium (conj)
those cp (nmod)
seizures regarding (case)
changes few (amod)
cardioselective not (neg)
behavior amphetamine-induced (amod)
stress cardiac (amod)
163 ( (punct)
use metoprolol (nmod)
administration erythromycin (nmod)
fs within (case)
indicate able (ccomp)
monitoring noninvasive (amod)
svo(2 in (case)
fluorthyl- and (cc)
action might (aux)
therapy cacl2 (compound)
development aki (nmod)
syndrome " (punct)
administration aminonucleoside (nmod)
in vivo/in (dep)
options the (det)
induced maintained (conj)
toxicity reduced (amod)
pretreatment amine (compound)
injected site (nmod)
ester sulphate (compound)
pci ) (punct)
weakness with (case)
mice css (compound)
parents of (case)
acetaminophen and (cc)
acid nl (amod)
interval treatment-free (amod)
lower may (aux)
suspected myositis (nsubjpass)
group mice (nmod)
vehicle , (punct)
potential ) (punct)
using cells (dobj)
examination for (case)
states during (case)
toxicity a (det)
differ edema (nsubj)
eye left (amod)
combination min (nmod)
microg/kg/min 1 (nummod)
occurrence injury (nmod)
tests parameters (nmod)
minutes < (dep)
pituitaries of (case)
interest development (nmod)
iv ( (punct)
confirms profile (dobj)
therapy glucocorticoid (compound)
decreases cholesterol (nmod)
outcomes regarding (case)
manifestation mice (nmod)
increased microinjection (nsubj)
pallor nerve (compound)
patient found (acl:relcl)
mazindol or (cc)
gls , (punct)
% 27.3 (nummod)
induced caa (nsubj)
bp excretion (conj)
antagonist ro4368554 (dep)
augmented , (punct)
pass which (nsubj)
characteristics types (conj)
effect sinensis (nmod)
dox mg/kg (dep)
later minutes (nmod:npmod)
shock of (case)
propranolol daily (advmod)
patients case (compound)
widely more (advmod)
mean +/- (cc)
placebo ibuprofen (conj)
months for (case)
event and (cc)
suspensions of (case)
majority aneurysms (nmod)
treatment drug (compound)
turned supine (xcomp)
offers that (dobj)
cause might (aux)
terminated h (nmod)
lower p=.02 (dep)
modulated , (punct)
derivative oxazolidine (compound)
treat infarction (dobj)
reported drugs (advcl)
proceeded problems (nmod)
administered vehicle/drugs (nsubjpass)
increased g/dl (nmod)
$ROOT$ risks (sent)
content cortical (amod)
nik-247 tacrine (conj)
disappearance normalization (conj)
likelihood function (nmod)
verified this (nsubjpass)
sbs = (dep)
necessary studies (nsubj)
developed vector (dobj)
mg/kg 12.5 (compound)
atresia choanal (amod)
duration administration (nmod)
fibrillation loss (conj)
agents azole (compound)
day until (case)
sensitivity in (case)
elicits effects (dobj)
transplantation death (conj)
children : (punct)
deciliter more (nummod)
rise aldosterone (nmod)
study the (det)
intensity convulsions (nmod)
strokes > (dep)
stress nfkappab (conj)
4 in (case)
$ROOT$ 4107 (sent)
aborted if (mark)
likely men (nsubj)
fetal and (cc)
those among (case)
group furosemide-treated (amod)
dox by (case)
recorded injection (nmod)
rate exercise (compound)
observed effects (dobj)
hit or (cc)
administration avp (nmod)
a and (cc)
$ROOT$ antagonist (sent)
result and (cc)
adrenergic serotonergic (conj)
2-adrenoceptors for (case)
ensued suffered (conj)
treatment spasticity (nmod)
cord vocal (amod)
years years (conj)
demonstrate none (nsubj)
evaluated additionally (advmod)
area surface (compound)
anticoagulation adequate (amod)
develop one (nmod)
markers without (case)
suppressed all (nsubj)
administration temocapril (nmod)
best how (advmod)
response conditions (nmod)
induced h (dobj)
inhibitor is (cop)
types other (amod)
pretreating fzp (nmod)
depression the (det)
modifications identical (amod)
primary and (cc)
calculated as (mark)
rhuepo-beta ) (punct)
events described (amod)
carcinoma and (cc)
15.1 from (case)
tested autoantibodies (nmod)
psychoses acute (amod)
present symptoms (nsubj)
serum gene (conj)
schedules cbdca (compound)
nrf2 of (case)
$ROOT$ question (sent)
exposure cyanamide (compound)
doses calculations (nmod)
bond and (cc)
controlled placebo (nmod:npmod)
overflow disease (nmod)
assessed used (conj)
manipulation anesthesia (nmod)
used decrease (dep)
outcomes . (punct)
control and (cc)
effects functions (nmod)
1,2-dmh ) (punct)
performed assess (xcomp)
aware should (aux)
microdialysis in (amod)
occurred man (nmod)
dyspepsia postprandial (amod)
depleted opening (nmod)
fr 139317 (nummod)
cardiotoxicity for (case)
array multielectrode (amod)
cases about (case)
subtype of (case)
incidence myoclonus (nmod)
green indocyanine (compound)
influence hyperactivity (nmod)
insertion women (nmod)
explained release (nmod)
mg/kg , (punct)
evolved time (nmod)
antagonist neurotensin (compound)
loss a (det)
agent is (cop)
performed worse (advmod)
had end (nmod)
given be (auxpass)
imaging nuclear (amod)
pentylenetetrazol ptz (appos)
1.6 0.5 (conj)
inhibition the (det)
test each (nmod)
decreases effects (appos)
extrication rapid (amod)
release opiate (nmod)
conclusion associated (acl)
phosphatase glepp1 (compound)
acquainted . (punct)
effect intoxication (nmod)
describe associations (dobj)
identify changes (nsubj)
potentiated nicotine (nmod)
reversal a (det)
duration hallucinations (nmod)
arthralgia involvement (conj)
c(max a (det)
had begun (conj)
stopped or (cc)
hemiparesis transient (amod)
have ; (punct)
gm concomitantly (advmod)
expectation shed (acl)
mm and (cc)
powders of (case)
results rejection (appos)
suggested results (nsubj)
metabolite the (det)
maintaining hypertension (dobj)
provoke not (neg)
using component (dobj)
characterize to (aux)
due cardiotoxicity (nmod)
using recorded (conj)
patients four (nummod)
111 children (nmod)
inhibitor thrombin (compound)
receptor-stimulating dopamine (nmod:npmod)
agonist causes (acl:relcl)
expression pro-apoptotic (amod)
action quenching (compound)
human murine (conj)
benzodiazepines of (case)
ci 5.4 (appos)
documented : (punct)
case developed (acl:relcl)
persisted recovery (nmod)
hypotension snp (compound)
loci of (case)
mg/kg/day 17 (nummod)
1000/mm3 < (advmod)
mice -/- (amod)
anemias cefotetan-induced (amod)
use technique (nmod)
h length (nsubj)
cardiomyopathy doxorubicin (compound)
demonstrated reliability (dobj)
sarcomas lymphoma (conj)
dosing after (conj)
displacements velocity (nmod)
rls ) (punct)
mosmol/kg , (punct)
was relationship (attr)
isomerase , (punct)
surgery casualties (conj)
hoarseness candidiasis (conj)
infusion cannulae (nmod)
role pathogenic (amod)
step that (nsubj)
infarct hemorrhagic (amod)
inhibitor l-noarg (dep)
fall psa (nmod)
hypertension 31 (nummod)
metabolites d (compound)
detected disturbances (nsubjpass)
associated dissipates (advcl)
dyskinesia l-dopa-induced (amod)
prolonged dose-dependently (advmod)
injury was (cop)
found show (ccomp)
containing and (cc)
paraventricular supraoptic (conj)
ifs by (case)
initiated patient (nmod)
cortex moderate-dose (dep)
contracting directly (advmod)
patients acetazolamide (nmod)
trial adenosine (nmod)
made treatment (nmod)
examination determination (nmod)
judged probable (xcomp)
normotensive and/or (cc)
tropicamide of (case)
considering reduction (dobj)
daunorubicin daunoxome (appos)
increased level (nsubj)
beta-blocker atenolol (nmod)
stiffness and (cc)
discussed phenomena (nsubjpass)
sites l-[3h]nicotine (compound)
elevated and (cc)
signs microangiopathies (nmod)
men older (amod)
judged drug (nsubjpass)
15 ) (punct)
ester 3-hydroxymethyl-5,5-diphenylhydantoin (nmod)
adjustment variables (nmod)
likely indicates (ccomp)
deficits short- (amod)
methods received (appos)
used setting (nmod)
designed establish (ccomp)
therapy antiviral (amod)
fleming 1986 (appos)
related interaction (nmod)
control forming (nmod)
database of (case)
sooner no (neg)
cases reported (advcl)
control mice (nmod)
$ROOT$ slowed (sent)
group time (nmod)
patients switched (acl:relcl)
grade none (dep)
returned function (nsubj)
case experienced (appos)
responses renal (amod)
medications. intracorporeal (amod)
units eu (appos)
resulted disinhibition (nmod)
patients disturbed (amod)
determine using (xcomp)
maps cortical (amod)
suppression dna (nmod)
tachyarrhythmia of (case)
solution m (amod)
cerebellum of (case)
regimen before (nmod)
evaluable patients (nsubj)
february from (case)
175 % (appos)
hypocalcemia hypomagnesemia (conj)
monitoring objective (amod)
preference tablets (nmod)
help attention (nsubj)
injected wall (nmod)
remained polyuric (acomp)
safer are (cop)
dosage g (appos)
started switching (advcl)
correlation inhibition (nmod)
recovered hydration (nmod)
maintain sleep (dobj)
loss progressive (amod)
paramount , (punct)
infarction suspected (amod)
mg diluted (acl)
diseases certain (amod)
monotherapies hctz (compound)
reduced lethality (dobj)
benserazide mg/kg (appos)
ug/ml prior (advmod)
thromboembolism associated (acl)
targeted liver (nmod)
bilirubin indirect (amod)
monitoring level (compound)
screening administration (conj)
effect ly274614 (nmod)
tissues corresponding (amod)
bax of (case)
times week (nmod)
damage marked (amod)
prolactinoma 1 (nummod)
infusion 2-h (amod)
be also (advmod)
extension , (punct)
transferred which (nmod)
criteria class (nmod)
d. 5 (nummod)
bodies myelinoid (amod)
mechanisms reprogramming (nsubj)
series further (amod)
thresholds tone (compound)
antidotes or (cc)
index ( (punct)
elevation none (conj)
reduces effect (dobj)
behaviors on (case)
proven suspected (conj)
9 8 (quantmod)
used treatment (nsubjpass)
uncommon were (cop)
1.8 ci (dep)
absorption and/or (cc)
induced sulpiride (nsubj)
occlusion department (nmod)
increased greater (advmod)
mtx with (case)
ascertained be (auxpass)
received losartan (dobj)
seems limited (xcomp)
shown presentation (nmod)
remained rate (nsubj)
compared vehicle (nmod)
channels chloride (compound)
type angiotensin (compound)
had response (dobj)
patients 236 (nummod)
children per (case)
conclusion suggest (dep)
related incidence (nmod)
model parameters (nmod)
appeared ototoxicity (nsubj)
receiving lithium (dobj)
seemed atra (nsubj)
amn082 ) (punct)
injection glutamate (compound)
relationships , (punct)
hit ( (punct)
7h6 and (cc)
mg/day 160 (nummod)
available information (nsubj)
proteins other (amod)
ablation catheter (compound)
observed cases (nmod)
failed pregs (nmod)
= 29 (dobj)
conducted tests (nsubjpass)
stomach of (case)
gauges strokes (conj)
mg/m2 310 (nummod)
methyldopa with (case)
substance alone (advmod)
inhibitors ) (punct)
expression catalepsy (nmod)
telemetry by (case)
684 10 (compound)
epinephrine both (cc:preconj)
confirmed cr (nmod)
levels prolonged (amod)
antagonist ly274614 (nsubj)
mhpg ) (punct)
yawning behaviors (nsubj)
potential drugs (nmod)
administered followed (advcl)
acid short (amod)
pathway an (det)
shown rad001 (nsubj)
tools merit (conj)
recovery bone (compound)
indicated necrosis (dobj)
elevation ie (advmod)
results perturbation (nmod)
has 3 (nsubj)
suggestive relation (nsubj)
erdosteine , (punct)
elevation caused (acl)
obtained pharmacists (nmod)
precipitated probably (advmod)
factor impact (nsubj)
determine . (punct)
imaging scans (conj)
region intermediate-caudal (amod)
mg/m(2 135 (nummod)
production increases (acl:relcl)
anaemia face (nmod)
idea dysfunctioning (nmod)
impaired significantly (advmod)
performed based (prep)
patients ineffective (acl:relcl)
retention pan-induced (amod)
deficit injection (nmod)
test ischemia (nmod)
increased based (prep)
media , (punct)
treatment irrigation (nmod)
abusers crack (compound)
sensitization by (case)
studied detail (nmod)
recognition etiology (conj)
effects detrimental (amod)
diminish indomethacin (nsubj)
increase doses (dobj)
effect is (cop)
specimen biopsy (compound)
unreasonable is (cop)
infection hcv (compound)
ct in (case)
users one (nummod)
expression form (nmod)
instituted delay (nmod)
treatment inhibitor (nmod)
delivered term (nmod)
efficacy netilmicin (nmod)
3.49 ocs (nmod)
attributed . (punct)
basis regular (amod)
15.5 21.5 (conj)
neck urethra (conj)
excitation nervous (amod)
n-pyrimidinyl-2-phenoxyacetamides of (case)
extraction forearm (nmod)
shorter , (punct)
presence use (conj)
synthesis , (punct)
implants containing (acl)
composition bile (compound)
abnormalities consistent (amod)
withdrawn androgens (nsubjpass)
reduced bnpp (nsubj)
carbamazepine by (case)
duration . (punct)
rats hg (appos)
ng/ml l/hour/m2 (conj)
enhancing by (mark)
nhe3 ( (punct)
used action (nmod)
minimised occurrence (nsubjpass)
thunbergiana of (case)
hours onset (nmod)
dosage warfarin (nmod)
alcoholic . (punct)
injections dysfunction (nmod)
p less (amod)
restores models (nmod)
dose effective (amod)
substitution the (det)
one receiving (acl)
re ginsenoside (compound)
levels water (nmod)
mixture to (case)
observed controls (nmod)
injury woman (nmod)
report coxon (nmod)
demonstrated observations (nsubj)
ras ( (punct)
discouraged strongly (advmod)
taken history (nsubjpass)
tiapride derivative (appos)
perfusion p2x3 (nmod)
girl an (det)
factors : (punct)
within or (cc)
appears also (advmod)
therapy ribavirin (compound)
draw possibility (nmod)
conclusion losartan (appos)
developed antipsychotics (nmod)
mother fetus (conj)
parameters two (nummod)
reduced level (dobj)
achieved patients (nsubj)
survival promising (amod)
placebo cases (appos)
hemolysis with (case)
improves seems (parataxis)
dysfunction patients (nmod)
mechanism by (case)
women have (acl:relcl)
available be (cop)
used pacing (nsubjpass)
rate combined (amod)
suggested mediated (ccomp)
detected amounts (nsubjpass)
adjusted after (mark)
implant fa (compound)
$ROOT$ complication (sent)
females including (case)
reports deaths (nmod)
commencement after (case)
resistant more (advmod)
relation the (det)
area greater (amod)
model iugr (nmod)
antagonist ii (nummod)
91 to (advmod)
correlate utilizes (parataxis)
growth development (conj)
resolved were (auxpass)
flow to (mark)
criteria had (acl:relcl)
treated based (mark)
mmp-2 intima (nmod)
stimulants of (case)
considered have (conj)
compared hypotension (nsubjpass)
creatinine aminotransferase (conj)
decline map (nmod)
inotropic positive (amod)
pregnancy during (case)
cytotoxicity cb (compound)
obtained normalization (nsubjpass)
present nausea (dep)
susceptible rats (nsubj)
methods divided (appos)
= ns (dobj)
down-regulation adrenoceptors (nmod)
g/dl 13.5 (nummod)
affect substantially (advmod)
2.1 1.2 (dep)
day 13 (nummod)
identified contrast (nmod)
bupivacaine- levobupivacaine- (conj)
machinery matrix (conj)
oils essential (amod)
efficacies their (nmod:poss)
hours twenty-three (nummod)
day 11 (nummod)
studies preclinical (amod)
severe . (punct)
glioma for (case)
solubility conditions (nmod)
exploration decreased (amod)
determinant not (neg)
promotion the (det)
scale glasgow (compound)
mg/day ; (punct)
involvement cardiac (amod)
decrease % (amod)
treating therapy (nmod)
grade ) (punct)
l-dopa given (acl)
lesions coronary (amod)
abolition fasciculations (nmod)
enabling occur (xcomp)
resolved initiation (nmod)
m ) (punct)
models arrhythmia (nmod)
fever neutropenic (amod)
stab caused (acl)
mediated system (nmod)
withdrawn has (aux)
weight level (appos)
thrombotic ) (punct)
reduces and (cc)
need evaluate (acl)
ptcr ) (punct)
perforans reported (acl:relcl)
studied group (nmod)
implications treatment (nmod)
pre-treatment intralipid (nmod)
heart left (amod)
undergone alf (nmod)
schedules dose (compound)
interpretation dystrophy (nmod)
administered tetrabenazine (nsubjpass)
chp ( (punct)
challenge of (case)
dexmedetomidine highly-selective (amod)
employed but (cc)
considered appear (advcl)
probable . (punct)
forms functions (nmod)
responses functional (amod)
desipramine alone (advmod)
hemorrhagic were (cop)
% 7.5 (compound)
1 1 (compound)
na-k-atpase of (case)
suggested course (nsubj)
representative hypertensives (nmod)
vision field (conj)
prolactin serum (compound)
sufficient amount (nmod)
behavior erections (conj)
increased resistance (nsubjpass)
results have (appos)
chemotherapy subtenon (compound)
experienced event (nmod)
have seizures (dobj)
graded severity (nmod)
performed we (nsubj)
terminology treatment (conj)
assessing prognosis (dobj)
day 2 (nmod)
prolonged groups (nmod)
receive once (conj)
system test (compound)
1.1 to (case)
nodule a (det)
women 362 (nummod)
mania antidepressant-induced (amod)
dementia induced (acl)
area this (det)
neurons hippocampal (compound)
less however (advmod)
impairments overnight (amod)
performs bbb (nmod)
nystagmus oscillopsia (conj)
% 9.6 (nummod)
propofol mg/kg/min (amod)
neonate male (amod)
activities unique (amod)
operations neurosurgical (amod)
altering by (mark)
18 67 (conj)
taking depression (nmod)
$ROOT$ differ (sent)
microsomal cytosolic (conj)
superior the (det)
competition signals (nmod)
daily ) (punct)
shr.(abstract blocked (amod)
signs first (amod)
risk myelosuppression (nmod)
extracted was (auxpass)
dyskinesia peak (amod)
cg ( (punct)
40 approximately (advmod)
different qualitatively (advmod)
excluded histories (nmod)
$ROOT$ initiated (sent)
patients include (acl:relcl)
peptide or (cc)
terbutaline agonist (appos)
dependency incidence (conj)
disappeared spontaneously (advmod)
stopping weeks (nmod:npmod)
well generally (advmod)
thyroxine t4 (appos)
drug worldwide (amod)
brain sampled (acl)
maximum a (det)
$ROOT$ myoclonus (sent)
intake drug (compound)
css the (det)
crf or (cc)
evaluated yohimbine (dobj)
intermediates implicated (acl:relcl)
caused while (mark)
shown far (advmod)
area opposite (amod)
timecourse of (case)
years 50 (nummod)
oral i.m. (conj)
receive often (advmod)
consequence ? (punct)
relationship a (det)
fact is (cop)
reduced drugs (nsubj)
tremor % (appos)
progressed patients (nsubj)
led modifications (nmod)
cancer . (punct)
now are (cop)
searched cases (nmod)
evaluate symptoms (dobj)
sequencing direct (amod)
developed therapy (nmod)
specimens kidney (compound)
had power (dobj)
receive selegiline (dobj)
effect drug (nmod)
ranitidine cimetidine (conj)
compared signs (nsubjpass)
developed transfusion (nmod)
tested model (nmod)
adolescent healthy (amod)
available currently (advmod)
stl1 rats (nmod)
formation consequent (amod)
bid clonidine (compound)
followed improvement (nmod)
64 and (cc)
waves periodic (amod)
weight factor (appos)
ecg by (case)
chromatography hplc (appos)
antagonize not (neg)
corrected use (nmod)
700 and (cc)
used induce (xcomp)
interaction disorders (nsubj)
umax ) (punct)
capable , (punct)
60 1 (compound)
rise steroid-induced (amod)
partition by (case)
inflammation tubulointerstitial (amod)
67.2 47.61 (compound)
level microgram/ml (nmod)
patients twenty (nummod)
combination fk506 (compound)
movements protrusion (conj)
therapy fk506 (compound)
withdrawal study (nmod)
reactions adverse (amod)
irreversible unfortunately (advmod)
thermoregulation aberrant (amod)
twitches head (compound)
induced contraction (dobj)
thickness at (case)
increase such (amod)
had binding (dobj)
prevented dependently (advmod)
interaction levodopa (nmod)
compensated , (punct)
amounts for (case)
animals died (acl:relcl)
use defects (conj)
cc with (case)
recognized with (mark)
result findings (nmod)
patients clinical (amod)
arsenic of (case)
performed discontinuation (nmod)
time % (appos)
patients achieving (acl)
rats ovariectomized (amod)
muscles with (case)
synthesize do (aux)
neuralgia duration (appos)
carriers who (nsubj)
1.24 ) (punct)
c and (cc)
municipal in (case)
years 19 (nummod)
led generation (nmod)
proved haemofiltration (nsubj)
fibres from (case)
viability cell (compound)
severity changes (nmod)
reversible and (cc)
parkinsonism off-period (amod)
status seizures (conj)
prophylaxis thrombocytopenia (nmod)
ticlopidine of (case)
= 0.0031 (dobj)
confirm deaths (nsubj)
score gleason (compound)
3-antineutrophil antibody-(pr3-anca (dep)
unrelenting disease (nsubj)
convulsions bupropion-induced (amod)
dili of (case)
promote improve (conj)
increase cells (nmod)
timolol suspension (conj)
binding theophylline (compound)
risks cohort (nmod)
more toxic (conj)
raised possibility (dobj)
transport-deficient tr(- (dep)
used tincture (nsubjpass)
n/n=62/92 14/92 (conj)
obscure and (cc)
control strains (nmod)
within ( (punct)
cancer mbc (appos)
enlargement phenobarbitone-induced (amod)
sensitized conclusion (nmod)
css chromosomes (nmod)
cm 175 (nummod)
determined hypotension (nsubjpass)
showed cholestasis (dobj)
rodents adult (amod)
located hypothalamus (nmod)
conversion simvastatin (nmod)
spillover norepinephrine (compound)
association treatment (nmod)
studies extensive (amod)
occurrence for (case)
greater bradycardia (nsubj)
= and (cc)
neurons da (compound)
binding nicotine (nmod)
g/kg/day ( (punct)
dopamine , (punct)
interrupted period (nsubjpass)
7.3 3.2 (conj)
$ROOT$ high (sent)
taqib by (case)
analysis f(3,762 (appos)
ls group (compound)
$ROOT$ immunosuppressant (sent)
myopathy and (cc)
diminished when (advmod)
anesthetic short-acting (amod)
rats dahl (compound)
tg for (case)
inhibitor of (case)
bind antibodies (nsubj)
consequence necessarily (advmod)
undergoing clonidine (nmod)
deletion kb (amod)
characteristics pretreatment (amod)
overexpression tissue (nmod)
improvement increase (conj)
different time (nmod)
interaction venlafaxine-maoi (compound)
application topical (amod)
azathioprine used (acl:relcl)
defined clearly (advmod)
upregulation with (case)
hypovolemia during (case)
stabilized , (punct)
mg/day metoprolol (compound)
offer treatment (nmod)
coefficient apparent (amod)
10min 30min (nmod)
june and (cc)
hot-plate and (cc)
antioxidant potent (amod)
$ROOT$ visualize (sent)
positive were (cop)
membrane apical (amod)
mild were (cop)
memory cognition (conj)
less 2 (dep)
stress migrainosus (conj)
disrupted . (punct)
levels > (amod)
investigations scans (nmod)
conduction on (case)
contact following (case)
antibodies for (case)
counts + (amod)
scale hour (appos)
4.04 0.99 (conj)
tendency arrhythmias (nmod)
common a (det)
known proarrhythmic (xcomp)
therapy sulindac (compound)
bradydysrhythmias , (punct)
pathology significant (amod)
received having (aux)
120 - (punct)
minimal , (punct)
neurotoxicity by (case)
given followed (prep)
diffusion of (case)
minimize addition (nsubj)
phosphate inhibitor (appos)
expressed is (auxpass)
200 1000 (prep)
tea and (cc)
performed compared (prep)
induces clonidine (nsubj)
agent of (case)
% 8.1 (nummod)
substance unlabeled (amod)
studied methods (nmod)
tetrandrine and (cc)
prominent group (nmod)
masked may (aux)
decreased levels (nsubjpass)
neuralgia chronic (amod)
report that (mark)
attenuated quinine (nsubj)
dwi 8/8 (appos)
occurs hypoxaemia (nsubj)
$ROOT$ paralysis (sent)
cis-ra of (case)
substituted was (auxpass)
contaminated derivative (nmod)
expected acetaminophen (nmod)
di- pentaglutamate (conj)
report only (advmod)
amounts material (nmod)
up-regulation transporter (nmod)
estrogens replacement (compound)
that group (nmod)
cortex sinus (conj)
january and (cc)
seeds carota (compound)
associated unhappiness (nsubjpass)
result seizures (nsubj)
early transplantation (nmod)
microg/ml > (advmod)
rat conscious (amod)
5.2 , (punct)
dosages those (det)
nausea group (nmod)
str ( (punct)
33.7 14.6 (conj)
evaluates profile (dobj)
contraindicated . (punct)
enhanced replication (dobj)
evidence or (cc)
pretreatment antagonists (nmod)
nephritis one (nummod)
components c (dep)
effective antagonizing (advcl)
tension peak (amod)
generates and (cc)
2 to (case)
explanation for (case)
substitutes ozone-sparing (amod)
usage anticholinergic (amod)
treated pdn (nmod:npmod)
paradigm step-down (amod)
common irrespective (advmod)
microm 12.5 (compound)
injections 17beta-estradiol (nmod)
resistant c57bl/6j (nsubj)
man 37-year-old (amod)
replacement estrogen (compound)
tool semi-invasive (amod)
time-dependent mg/kg (dep)
different used (conj)
subjects among (case)
bfu-e of (case)
abnormality heart (compound)
mortality outcomes (conj)
reduction toxicity (nmod)
discount . (punct)
role decompression (nmod)
electrocardiogram ecg (appos)
tna ) (punct)
ci 0.4 (nummod)
manifestations mouth (nmod)
evoked while (mark)
introduced , (punct)
1.13 ) (punct)
halothane ) (punct)
normal had (conj)
compared men (nmod)
mean months (appos)
activator , (punct)
response ritonavir (nmod)
underlying anemia (dobj)
occlusion following (case)
changes compatible (amod)
impairment structural (amod)
1.0 0.03 (compound)
decrease dose-dependent (amod)
induce that (nsubj)
week treatment (nmod)
remained treatment (nmod)
progression atrophy (nmod)
analysis estimate (acl:relcl)
density reduced (amod)
hours exposure (nmod)
4'-0-tetrahydropyranyladriamycin ) (punct)
hyperplasia bha-induced (amod)
difference species (compound)
preventing hepatitis (dobj)
appeared bleeding (nsubj)
program . (punct)
$ROOT$ converted (sent)
published english (nmod)
markers serologic (amod)
syndrome this (det)
has epinephrine (nsubj)
caring patients (nmod)
burden tumor (compound)
result ischemia (nsubj)
control secretions (nmod)
having as (mark)
implant mg (appos)
one users (nmod)
seen fibrosis (conj)
0.5 per (compound)
related protection (nsubj)
number neurons (nmod)
therapy fluorouracil (compound)
study mechanisms (dobj)
9 7 (quantmod)
decreased found (parataxis)
agonist agonist (conj)
nonusers users (appos)
layer retinal (compound)
prescribed developed (conj)
reactions solution (nmod)
diabetics prone (amod)
amplitude frequency (conj)
immunohistochemistry and (cc)
% activities (nsubj)
ctc-nci 1/2/3 (nummod)
p.o. mg/kg (compound)
remained association (nsubj)
switch after (case)
crf ( (punct)
response proliferative (amod)
genes coxii (compound)
dimorphism sexual (amod)
switched placebo (nmod)
dexamethasone rd (appos)
catalepsy induced (acl:relcl)
administration chronic (amod)
precluded use (dobj)
injection b3 (compound)
millions , (punct)
cancers glioma (nmod)
development in (case)
shifts alternations (nsubj)
milligram per (case)
model primate (amod)
pressure = (dep)
severity the (det)
microm , (punct)
nephrotoxicity sulfadiazine (compound)
abdominal and (cc)
treatment interferon (nmod)
evaluated we (nsubj)
invasion myometrial (amod)
alkaloid major (amod)
pressures all (det)
comparison time (nmod)
neurotoxicity cardiomyopathy (conj)
e13.5 and (cc)
improve ro4368554 (nsubj)
agents cholinergic (amod)
antagonized dizocilpine (nmod)
samples patients (dep)
= 196 (dep)
suggested diagnosis (dobj)
offset risk (nsubj)
complications thrombotic (amod)
infusion ng/kg/min (appos)
withheld and (cc)
patient 64-year-old (amod)
% 6.2 (nummod)
drug aware (conj)
predisposed that (mark)
cy cmf (appos)
lower map (nsubj)
psychotropic chronotropic (conj)
% ci=16.8%-65.0 (nummod)
thrombocytopenia review (dep)
gfc ) (punct)
useful to (mark)
produced women (nmod)
5 to (dep)
hypothesized was (auxpass)
combination hydration (nmod)
mentioned associated (advcl)
fentanyl to (case)
trial double-blind (amod)
drugs cause (acl:relcl)
cases 59 (nummod)
examined acutely (advmod)
infarction recurrent (amod)
drug risperidone (nsubj)
established : (punct)
occurred and (cc)
lability in (case)
methylxanthines theophylline (nmod)
rationale inhibits (appos)
considered inhibitors (nsubjpass)
telangiectasia the (det)
relief symptom (nmod)
glaucoma patients (nmod)
number lt (nmod)
treatment special (amod)
address to (mark)
week his (nmod:poss)
rates success (compound)
system perfusion (compound)
sgk1(+/+ in (case)
reflex to (mark)
did well (advmod)
day 27 (nummod)
limited studies (nmod)
3.82 to (case)
found cause (nsubjpass)
administrated ifo (nsubjpass)
events cvd (compound)
support education (conj)
polygraph through (case)
parallel hemolysis (nmod)
reliance the (det)
cohorts from (case)
cause neuropathy (nmod)
found brain (nmod)
similar shr.(abstract (nmod)
nsclc pretreated (amod)
methods injected (appos)
patients prevented (acl:relcl)
dyskinesia sulpiride-induced (amod)
man 76-year-old (amod)
salivation confusion (conj)
small is (cop)
enhance did (aux)
play could (aux)
cells neoplastic (amod)
exception children (nmod)
11.2 and (cc)
447 population (appos)
affect not (neg)
up follow (compound)
women using (acl)
perfused suprofen (nmod)
47 up (advmod)
control exercise (compound)
h. , (punct)
diagnostic treatment (conj)
undertook review (dobj)
recognised symptoms (nsubjpass)
rate vinorelbine (nmod)
tested repeatedly (advmod)
repeated injected (ccomp)
patients indian (amod)
foci the (det)
reverse half-life (nmod)
nmdar function (conj)
hypercholesterolaemia to (case)
conclusions discharged (dep)
prevented estimation (dobj)
pretreatment 3-methylcholanthrene (nmod)
joint that (det)
100 70 (compound)
patients size (nmod)
events identified (acl)
detected toxicosis (nsubjpass)
dose-intensity di (appos)
response poor (amod)
ulcer peptic (amod)
compared p (dep)
preference upon (case)
out-patients out-patients (conj)
p9605 and (cc)
$ROOT$ reaction (sent)
presence sirolimus (nmod)
episode syncopal (amod)
year , (punct)
receiving ifosfamide (dobj)
unchanged groups (nmod)
treatment any (nmod)
applies latter (nsubj)
nodule preneoplastic (amod)
nefiracetam apomorphine (conj)
increase 9 (nmod)
dp/dt(max ( (punct)
ifosfamide to (case)
studies allograft (compound)
representative is (cop)
reduced dhea (nsubj)
found attenuation (nsubjpass)
rats pre-treated (amod)
rats fat (compound)
3628 +/- (cc)
total lipoprotein (conj)
exhibited levels (dobj)
underwent dialysis (dobj)
palsy . (punct)
using , (punct)
tolerated and (cc)
promote intake (nsubj)
sweating eating (advcl)
arteriolar non-selective (amod)
pg/ml = (dep)
injection thrombin (nmod)
increase concomitant (amod)
interviewed questioned (conj)
prevention 6 (dep)
reactions were (cop)
emulsion with (case)
shows mortality (dobj)
exposure epirubicin (compound)
diameters/bw between (case)
method with (case)
reported months (nmod)
evidence objective (amod)
decreased severely (advmod)
administered baseline (nmod)
subset among (case)
improved noted (advcl)
muscle from (case)
incidence low (amod)
phosphate phosphorofluoridate (conj)
elicited dose (nmod)
revealed centre (ccomp)
changes values (nmod)
predictive were (cop)
justification without (case)
receptor-alpha , (punct)
uptake synaptosomal (amod)
electrograms bundle (compound)
maximal day (nmod)
mk-801 mg/kg (appos)
estimated has (aux)
greater animals (nmod)
activity via (case)
steroids and (cc)
sixty-five two (compound)
= 12 (dep)
evidence no (neg)
chemotherapy gemcitabine (compound)
effect of (case)
enhancement activity (nmod)
vasodilator arteriolar (amod)
promote excretion (dobj)
involvement ras (nmod)
related nephropathy (nsubj)
difference=0.01 ( (punct)
pretreatment reserpine (nmod)
fill criteria (dobj)
reaction allergic (amod)
inhibitor phenanthridinone (compound)
contracture dupuytren (nmod:poss)
admissions syndrome (nmod)
medline library (conj)
area to (case)
detected been (auxpass)
attenuate nephropathy (dobj)
withdrawal cyclosporine (nmod)
cases arrest (nmod)
signs all (det)
% high- (nmod)
was response (nsubj)
cavity of (case)
penis the (det)
toxicity high (amod)
years seven (nummod)
myoclonic atonic (conj)
hepatomegaly with (case)
analyses immunohistochemical (amod)
mechanisms amino (compound)
re-established injection (nmod)
tumors human (amod)
response heart (compound)
a.m. at (case)
binding preferential (amod)
158.11 ) (punct)
dysfunction both (preconj)
period within (case)
cholesterols lipoproteins (conj)
bradycardia pressure (appos)
outcome main (amod)
inclusions no (neg)
8.75 : (punct)
suggestion promote (ccomp)
16 ( (punct)
action functions (nmod)
greater not (neg)
prazosin 0.5 (nummod)
patients 1100 (nummod)
examined methods (nsubjpass)
less slightly (advmod)
influence toxicity (nmod)
2/3 for (case)
effective partially (advmod)
treatment short-term (amod)
abstention mdma (nmod)
has curcumin (nsubj)
exhibited growth (dobj)
movements rats (nmod)
receptor c-ret (appos)
tended rotation (nsubj)
outcomes study (dep)
return hyperkinesis (nmod)
powered . (punct)
experts of (case)
investigate action (dobj)
complaints the (det)
coagulation coagulopathies (conj)
antagonist p (compound)
time 4 (dep)
combination to (case)
washout 1- (amod)
rats gonadally (advmod)
penetration % (nmod)
future in (case)
17.5 10(6 (conj)
renin 16 (nummod)
able contrast (nmod)
shock syndrome (conj)
case myelosis (nmod)
mouse balb/c (compound)
enzymes pattern (conj)
intensities of (case)
clonazepam with (case)
syndrome anaesthesia (nmod)
oltx ) (punct)
history of (case)
seems bear (xcomp)
bradycardia intraoperative (amod)
suffering epilepsy (nmod)
administered weeks (nmod)
contractility in (case)
surgery of (case)
related similar (advmod)
detail limited (amod)
interaction group (compound)
study immunohistochemical (amod)
continued another (nmod)
action enhances (acl:relcl)
symptoms intoxication (nmod)
psychostimulant . (punct)
drug anti-inflammatory (amod)
able ) (punct)
cause pethidine (nsubj)
associated vincristine (nmod)
$ROOT$ neuropathy (sent)
analyzing by (mark)
suggested antagonist (advcl)
reduced slope (dobj)
results measured (appos)
lindane gamma-hexachlorocyclohexane (appos)
dose ribavirin (nmod)
channel epithelial (amod)
bone cartilage (conj)
incorporation cells (nmod)
emergence during (case)
maximal minimal (conj)
% 68 (compound)
range hz (nmod)
ameliorating damage (dobj)
loss with (case)
recovery inversion (compound)
induced modifications (dobj)
myositis , (punct)
clonidine . (punct)
quantified dna (dobj)
groups stz (compound)
indicated developed (advcl)
hyperglycemia , (punct)
follow-up careful (amod)
by-product the (det)
targeted , (punct)
used has (conj)
nausea vomiting (conj)
derivatives penicillin (compound)
produce for (mark)
dystrophin troponin (conj)
carbimazole propranolol (conj)
quantified using (xcomp)
asystole following (case)
labeled fluorogold (nmod)
population with (case)
using monkeys (dobj)
events clinical (amod)
undetermined . (punct)
produce and (cc)
injections intracerebral (amod)
interaction simvastatin (nmod)
reduction hemoglobin (nmod)
precluded meta-analysis (dobj)
history stones (nmod)
potential cataractogenic (amod)
surgeries pressure-lowering (amod)
discontinued quetiapine (nsubjpass)
prc only (advmod)
= 3.6 (dobj)
5-fu/fa/mmc high-dose (amod)
gain greater (amod)
tomography quantitative (amod)
included predicted (conj)
became animals (nsubj)
had index (dep)
advantages possible (amod)
examined dysfunctions (nmod)
29.9 +/- (cc)
3.9 - (advmod)
shell not (cc)
degeneration myelin (nmod)
times microcrystal (compound)
number axons (nmod)
desmosomes and (cc)
heath mental (amod)
15/hypertension followed (acl)
discontinued prematurely (advmod)
occurring patients (nmod)
tempol the (det)
mean nadir (dep)
disease important (amod)
fasciculation succinylcholine-induced (amod)
investigated , (punct)
ethopropazine benztropine (conj)
sah with (case)
% glomeruli (nmod)
guidelines in (case)
prevented occurrence (dobj)
seizures clinical (amod)
night and (cc)
immunosuppressants rapamycin (conj)
suppresses proliferation (dobj)
defect the (det)
detected has (aux)
augmented doc (dobj)
genes by (case)
intensities abnormal (amod)
n mg/kg (appos)
ischemia dobutamine-induced (amod)
striatum not (cc)
effects hepatotoxicity (nsubj)
revealed scan (nsubj)
control dbs (nsubj)
dystrophy progressive (amod)
diabetic of (case)
potency antagonistic (amod)
failure for (case)
olanzapine and (cc)
event war (nmod)
factor not (neg)
study baseline (compound)
involved when (advmod)
dyspnoea bronchospasm (conj)
triglycerides serum (compound)
success clinical (amod)
studies disease (nmod)
mothers two (nummod)
5 least (advmod)
blocked pretreatment (nmod)
dose resulting (acl)
developed obesity (dobj)
hypercalcemia and/or (cc)
determined test (nmod)
hemoglobin markers (dep)
decreased agonists (nsubj)
group multicenter (amod)
evaluation parameters (nmod)
shown oligodeoxynucleotide (nsubjpass)
suggest add (ccomp)
suspect strongly (advmod)
therapy temporary (amod)
phosphate higher (amod)
weight thymus (compound)
fall rats (nmod)
factor been (cop)
mrna ao (amod)
identified patients (dobj)
alternative ce (nsubj)
outcomes clinical (amod)
heart normal (amod)
returned discontinuing (advcl)
regions temporal (conj)
pinch mild (amod)
response with (case)
acquainted should (aux)
1-bromo-1-chloro-2,2,2-trifluoroethane as (case)
safe both (nsubj)
thromboembolism cancer (conj)
level time (compound)
carota daucus (compound)
inhibited propranolol (nsubj)
normal glomeruli (nsubj)
found used (ccomp)
drugs linezolid (nmod)
days fractions/40 (nummod)
alf ; (punct)
confusion papilledema (conj)
clearance mesangium (nmod)
seen later (advmod)
links effect (conj)
system mea (compound)
phenobarbitone serum (compound)
experts fields (nmod)
cytometry laser (compound)
minutes 3 (nummod)
ratings pressure (conj)
aimed evaluate (xcomp)
tissues mice (nmod)
arrhythmia failure (conj)
noted groups (nmod)
elevation concentrations (nmod)
fact of (case)
iii ] (punct)
quantified . (punct)
invasion of (case)
weeks therapy (dep)
alternation behaviours (dep)
finding this (det)
sedation propofol (compound)
given it (nsubjpass)
aspirin to (case)
concentrations residual (amod)
production neoantigens (nmod)
with both (preconj)
timolol 115 (nummod)
imaging ha (nmod)
transplant by (case)
44.8 26.0 (compound)
patients mania (nmod)
pb to (case)
possibly centrally (advmod)
melatonin of (case)
converted dose (dobj)
alpha-tocopherol , (punct)
studies toxicokinetics (compound)
meshwork trabecular (amod)
play element (dobj)
10.4 5.8 (conj)
hyperkalaemia of (case)
compared parameters (nsubjpass)
influence naloxone (nsubj)
channels pacemaker (compound)
examined using (advcl)
pair base (compound)
arthritis joint (compound)
infused days (nmod)
changes significant (amod)
aminotransferase limits (nmod)
pseudolithiasis . (punct)
irradiation bed (nmod)
decreased map (dobj)
neurons with (case)
increase were (cop)
course . (punct)
ultrasound intracoronary (amod)
cardiotoxicity threatening (amod)
available phenacetin (nsubj)
adverse more (advmod)
reach circulation (dobj)
week(-1 ) (punct)
juice gastric (amod)
accompanied model (nmod)
modulators gaba(a (compound)
animal each (det)
= 2 (dobj)
remapped was (auxpass)
correlated nin (nsubj)
doses separated (amod)
mipafox organophosphate (appos)
written has (aux)
assessed samples (nmod)
evening during (case)
dexamethasone oral (amod)
received reactivator (dobj)
attenuate could (aux)
resolved continued (parataxis)
emphasis major (amod)
remains while (mark)
major with (case)
decrease transient (amod)
generated sulphate (nsubj)
succumbed . (punct)
ultrastructure on (case)
outcome in (case)
problem rate (nmod)
arrhythmia bupivacaine (compound)
use ecstasy (nmod)
neurotoxic animals (nmod)
65 18 (quantmod)
target ' (punct)
infected chronically (advmod)
higher users (nmod)
acid valproic (amod)
demonstrates conclusion (nsubj)
implausible likely (conj)
determine extent (dobj)
idazoxan mg/kg (appos)
consistent are (cop)
test screening (amod)
lnaa ) (punct)
criteria use (nmod)
those counts (nmod)
phenotype constitutes (acl:relcl)
deposition hemosiderin (compound)
hospital memorial (compound)
review . (punct)
treatment lisinopril (nmod)
war of (case)
associated drugs (conj)
produces and (cc)
subgroups high-risk (amod)
mek1 3 (conj)
unmatched both (cc:preconj)
sedation loss (conj)
$ROOT$ well-tolerated (sent)
demonstrate relationship (dobj)
males treated (acl)
apnea succinylcholine (nmod)
provide patient (dative)
sc [ (punct)
monohydroxyethylrutoside flavonoid (compound)
more regimen (nmod)
rates infusion (nmod)
10.2 ( (punct)
pretreatment of (case)
analgesic hypnotic (conj)
leg of (case)
myelosuppression nor (cc)
$ROOT$ purpose (sent)
along levels (nmod)
discuss , (punct)
hepatomegaly tender (amod)
pregnant nonpregnant (conj)
treated was (auxpass)
grade location (conj)
shock cardiogenic (amod)
assays and (cc)
p450 2e1 (nummod)
manipulation ocular (amod)
e1 pge1 (appos)
lethal ld50 (appos)
nephrolithiasis . (punct)
disorder accumulation (nmod)
bilirubin the (det)
antipsychotic benzisoxazole (compound)
reducing climbing (dobj)
8.3 +/- (cc)
deficits caused (acl)
prevent abnormalities (dobj)
points other (amod)
using ecstasy (nmod:npmod)
kanamycin netilmicin (conj)
propensity decreased (amod)
harmful to (mark)
inoculation intravenous (amod)
follow-up patients (nmod)
patients migraine (compound)
0.05 ; (punct)
dopamine accumbens (amod)
changes caudate (nmod)
cad of (case)
rise peak (amod)
interaction processes (nmod)
h2o cm (compound)
achieved mice (nmod)
implant from (case)
aap ) (punct)
differences rate (compound)
speech normal (amod)
ng 10 (nummod)
alterations prostigmine-morphine-induced (amod)
dose tablets (conj)
cells t (compound)
externa on (case)
mesylate fenoldopam (compound)
regimens on (case)
administration neonatal (amod)
predictors the (det)
frequency gnrh (compound)
areas sclerotic (amod)
ethopropazine parkinsonism (nmod)
titrated . (punct)
causes cross-sensitization (dobj)
due arthritis (nmod)
progressing of (mark)
universal were (cop)
initiation termination (nmod)
effect detrimental (amod)
drugs new (amod)
fatal often (advmod)
palpitation and (cc)
performance lv (compound)
developed dog (nsubj)
chemical toxic (amod)
stimuli to (case)
utilizing treatment (nmod)
ocs combined (amod)
able distinguish (xcomp)
scheduled visits (nsubjpass)
developed bradycardia (dobj)
alpha beta-meatp (appos)
$ROOT$ indicates (sent)
cancer treated (acl)
system cholinergic (amod)
oxide-induced nitric (amod)
lacnp right (amod)
concentrations tpa (compound)
rats testosterone-treated (amod)
pain type (conj)
gt/bc ) (punct)
determined can (neg)
toxicity piglets (nmod)
schedule than (case)
children treatment (nmod)
positive if (mark)
problems difficulty (conj)
contraction serotonin-induced (amod)
occurred effects (nsubj)
man disease (nmod)
patients 8 (nummod)
attributed which (nsubjpass)
developed hypomania (dobj)
call cases (nsubj)
syndrome undergoing (acl)
mg/m2 , (punct)
% costs (nmod)
neuropeptide msh/acth (appos)
trial stabilized (acl:relcl)
regulated are (auxpass)
vldl plasma (compound)
function processes (nmod)
received pilsicainide (dobj)
test showed (acl:relcl)
expired spite (nmod)
dates ( (punct)
7e series (nmod)
increased dl-sotalol (nmod)
cancers against (case)
meningitis suspected (amod)
effects n-(2-propylpentanoyl)urea (nmod)
markers rats (nmod)
levels hbsag (compound)
injection vincristine (nmod)
impairment morphine-induced (amod)
developed subsequently (advmod)
maintaining of (mark)
analysis infusion (nmod)
mechanism ; (punct)
timolol not (cc)
mg/day 0.6 (nummod)
detect changes (dobj)
altered significantly (advmod)
$ROOT$ tolerability (sent)
26 , (punct)
examination of (case)
discontinued treated (conj)
periods taken (acl:relcl)
brainstem and (cc)
was however (advmod)
history ocular (amod)
decreased lowering (advcl)
assessed measurement (nmod)
related system (nmod)
latency increased (amod)
alfentanil with (case)
antigens vivo-prepared (amod)
damaged since (mark)
drug cytotoxic (amod)
safety regimen (nmod)
use antecedent (amod)
volume expiratory (amod)
thromboembolic relationship (nmod)
acute multiple (conj)
1.98 ci (nsubj)
increase therapy (nmod)
reporting results (dobj)
woman 54-year-old (amod)
hemoglobin between (case)
pfs prolonged (amod)
used antibiotics (nsubjpass)
cb 3717 (nummod)
rewarding aversive (conj)
has risk (dobj)
maximal and (cc)
months of (case)
proteinuria mild (amod)
90 > (amod)
cases treatment-refractory (amod)
hours duration (nsubj)
benefit harm (conj)
reflex , (punct)
hydration discontinuation (conj)
efficient evaluated (advcl)
damages of (case)
septal ventricular (amod)
pathways on (case)
coefficient rank (compound)
mg/kg 0.04 (compound)
higher risk (nsubj)
points the (det)
processes several (amod)
involved products (nsubjpass)
improvement slow (amod)
transaminasemia , (punct)
rises serological (amod)
lidocaine x (cc)
used subjects (nmod)
received median (dobj)
gene prothrombin (compound)
similar magnitude (nmod)
increase intake (dep)
p300 coactivator (appos)
compare here (advmod)
hdl plasma (compound)
ed(50 ) (punct)
patients infertility (compound)
volume following (amod)
patients ages (appos)
aventyl each (appos)
each for (case)
increased whereas (dep)
species (ros)/nitrogen (compound)
dysfunction biventricular (amod)
plasma reabsorption (conj)
accumulation iron (compound)
therapy discontinued (acl:relcl)
$ROOT$ chorea (sent)
prolonged that (mark)
assessed participants (nsubjpass)
plays rats (nmod)
allocated approval (nmod)
found results (nsubjpass)
cytometry by (case)
000 pmol/10 (compound)
worth investigating (xcomp)
rose and (cc)
loss hilar (amod)
milrinone with (case)
abnormalities because (case)
changes symptoms (conj)
lessen effects (nsubj)
acid tacrolimus (conj)
suggestive amnesia (nmod)
admitted results (nsubjpass)
insufficiency hormone (conj)
hypothesized therefore (advmod)
utilizing agent (nmod)
haloperidol to (case)
administered adjusted (conj)
diet deprivation (nmod)
maintain mmhg (nmod)
resulted could (aux)
produced results (nsubj)
background was (dep)
induces release (dobj)
doses lower (amod)
use ephedrine (nmod)
associated patient (nmod)
unknown pathomechanism (nsubj)
analyzed postoperatively (advmod)
localization brain (compound)
syndrome findings (conj)
heterogeneity cross-reactivities (nmod)
300 and (cc)
concentration tacrolimus (nmod)
cord palpable (amod)
activities comparable (amod)
patient bipolar (amod)
times , (punct)
disruption tam (nmod)
induction doses (nmod)
discontinue to (mark)
treatment apomorphine (nmod)
280+/-17 131+/-22 (conj)
density dependence (conj)
ability benzylacyclouridine (nmod)
mi with (case)
incidence alterations (nmod)
mg/kg 500 (nummod)
assess interaction (dobj)
binding by (case)
activator be (cop)
protected damage (dobj)
tone irrigation (nmod)
investigate to (mark)
echocardiography of (case)
regard period (nmod)
applying glycopyrrolate (dobj)
restarting treatment (nmod)
identified collection (nmod)
excellent . (punct)
carbonate , (punct)
dystrophin sensitive (appos)
administered infusions (nsubjpass)
demodex of (case)
disease cardiovascular (amod)
flow rate (conj)
monitoring weeks (nmod)
suffer . (punct)
neither blockers (nmod)
regimens or (cc)
has mechanism (nsubj)
cases marrow (nmod)
setting units (appos)
used neonate (nmod)
r=0.81 ; (punct)
reduced has (aux)
undergoing currently (advmod)
morphine nicotine (conj)
aggregation ex (amod)
proliferation processes (conj)
foot in (case)
prodrugs their (nmod:poss)
speed by (case)
< 0.5 (dep)
loss lipoproteins (nmod)
atrophy fibrosis (conj)
observations further (amod)
present half (nmod)
vicinity in (case)
% injection (nmod)
younger < (dep)
adjuvant therapy (nmod)
esterases plasma (compound)
common diarrhea (nsubj)
dose-dependent up (advmod)
pg/ml . (punct)
appeared microscope (nmod)
test akathisia (nmod)
continued been (auxpass)
highlights case (nsubj)
therapy third-line (amod)
taking and (cc)
patients cancer (compound)
malaise nausea (conj)
performed patient (nmod)
event serious (amod)
months 34 (nummod)
acetate flutamide (conj)
restarting after (mark)
volume second (nmod)
15 % (appos)
factor carbonate (nsubj)
dextromethorphan the (det)
increased patient (nmod)
circumstances and (cc)
effect tcr (nmod)
profile favorable (amod)
weight birth (compound)
tma sos (conj)
woman facility (nmod)
increase 9-months (nmod)
of " (punct)
anemia rhuepo-beta (compound)
those dysfunction (nmod)
information insufficient (amod)
represent pg-9 (nsubj)
describe incidence (dobj)
age-dependent association (nsubj)
acuity central (amod)
increase distinct (amod)
toxic inhibitors (nsubj)
demands myocardial (amod)
units doses (conj)
restimulation the (det)
content kidney (nmod)
diazepam cocaine (conj)
alphabeta-crystalin gamma-enolase (conj)
uncommon related (conj)
induce rodents (nmod)
assess incidence (dobj)
consisted groups (nmod)
minor comparatively (advmod)
characteristics histological (amod)
hyperemia during (case)
agents individual (amod)
died ) (punct)
saline ph (compound)
documented radiography (nmod)
presence injury (nmod)
inhibiting effect (dobj)
patients prescribed (acl:relcl)
monophosphate by (case)
resolution slower (amod)
novel neuroprotective (dep)
24.9 +/- (cc)
rates high (amod)
paralysis ascending (amod)
after minutes (nmod:npmod)
47 +/- (cc)
saline group (appos)
/+ + (amod)
exhibited acids (nsubj)
sites estrogen (compound)
increased glutathione (nsubj)
exudate of (case)
median by (case)
ginsenosides , (punct)
negligible . (punct)
subtype n-methyl-d-aspartate (compound)
mg/m(2 ) (punct)
apparent has (advcl)
institute therapy (dobj)
exception the (det)
records pharmacy (compound)
90/hypertension , (punct)
cco ) (punct)
carried learning (nsubjpass)
africa south (compound)
stopped weeks (nmod)
had abc (nsubj)
underwent participants (nsubj)
seeing tip (dobj)
imbalance any (det)
stimulant is (cop)
produce hyperprolactinemia (dobj)
matched and (cc)
mabs of (case)
multiforme failure (conj)
axis hpa (amod)
d-tubocurarine of (case)
2-component beta (compound)
demonstrated microdialysis (nsubj)
lower higher (conj)
degree insult (nmod)
attempts . (punct)
score most (nmod)
received treatment (dobj)
resolved angioedema (nsubj)
canal the (det)
mpep by (case)
two month (nmod)
gyrus monkeys (nmod)
< .009 (dobj)
occasions hour (appos)
type mg/kg (dep)
rhinitis allergic (amod)
combination on (case)
sensitization lymphocytes (nmod)
neck on (case)
ace ( (punct)
effects negative (amod)
received application (dobj)
patients parkinsonian (amod)
measured cortex (nmod)
dorsum the (det)
unaltered . (punct)
neurotoxicity to (case)
referred thus (advmod)
icv ) (punct)
uncommon was (cop)
higher control (dep)
mg/dl more (nummod)
indicating unlikely (ccomp)
visits on (case)
depression = (parataxis)
concentration variables (conj)
depending institution (nmod)
sem to (case)
ich in (case)
proband and (cc)
increased which (nsubj)
prevention stroke (compound)
studies show (acl:relcl)
echocardiography imaging (conj)
icu ( (punct)
case dyskinesia (nmod)
thrombosis embolus (conj)
residues dna (nmod)
volumes fraction (conj)
35 30 (compound)
cohort on (case)
appropriate not (neg)
levodopa with (case)
fentanyl or (cc)
methylprednisolone or (cc)
findings electrocardiographic (amod)
abdomen for (case)
insult cytotoxic (amod)
pressure rate (conj)
beraprost and (cc)
days 32 (nummod)
evaluation microscopic (amod)
induced ifs (nmod)
reduced control (conj)
position 6 (nummod)
dose administered (acl)
formation infiltration (conj)
lysis subsequent (amod)
caused willing (conj)
exhibited phenotype (dobj)
compatible . (punct)
associated behaviours (nmod)
synthesis/release bradykinin (nmod)
carried routes (nmod)
min p (dep)
caused rise (dobj)
revealed amounts (dobj)
ibuprofen acid (conj)
indirect effects (nsubj)
patients scheduled (acl:relcl)
found withdrawn (conj)
recovered complications (nmod)
adult for (case)
become producing (xcomp)
neonates premature (amod)
led dose (nsubj)
elimination disappear (advcl)
decreases survival (dobj)
incidence brigham (nmod)
age excluded (parataxis)
findings recent (amod)
four hundred (compound)
redistribution flow (nmod)
7-ethoxyresorufin-o-deethylase and (cc)
alterations structural (amod)
paclitaxel combined (cc)
brought on (compound:prt)
ganglion root (compound)
clearance renal (amod)
administered combination (nsubjpass)
trial feasibility (compound)
found insula (nmod)
cirrhosis tetrachloride-induced (amod)
had controls (advcl)
had evidence (dobj)
free headache (nmod:npmod)
responses events (conj)
administered atp (nsubjpass)
profile risperidone (nmod:poss)
centre tetrapeptide (nsubj)
diarrheas and (cc)
started fibrillation (nmod)
antagonist flumazenil (nsubj)
underline data (nsubj)
arabic gum (compound)
reproducible not (neg)
deaths five (nummod)
subunits nuclear-encoded (amod)
cardiomyopathy myocarditis (conj)
microcrystals cholesterol (compound)
efficacious alleviating (advcl)
hydrocortisone after (case)
elevated risks (nsubj)
scr in (case)
neurones rats (nmod)
alterations inattention (conj)
correlated inversely (advmod)
offer sampling (nsubj)
agents vasodilator (compound)
spine the (det)
143 of (advmod)
of case (nsubj)
$ROOT$ were (sent)
improve providers (nsubj)
collection blood (compound)
decreased stress (dobj)
tight particularly (advmod)
benefit to (mark)
responded reduction (nmod)
neuralgia phn (appos)
aches ) (punct)
divided were (auxpass)
enhancement dextromethorphan (nmod)
compensation in (case)
product degradation (compound)
glaucoma and (cc)
gating channel (compound)
arrhythmias ventricular (amod)
hypertension upregulation (conj)
mg/kg inhibitor (appos)
disfiguring be (cop)
eruption drug- (amod)
rate infections (nmod)
disease arrhythmia (conj)
neurotoxicity methamphetamine (compound)
% nausea (nmod)
tests these (det)
unavailable tools (nsubj)
kg-1 given (acl)
induced line (nmod)
nephrotoxicity cardiotoxicity (conj)
therapy underutilized (amod)
monkeys exposure (nmod)
september june (conj)
inhibited is (auxpass)
considered hand (nmod)
staff involved (amod)
metabolite important (amod)
form fibrosis (nmod)
3.4 . (punct)
was administered (conj)
group isoflurane (compound)
normalization and (cc)
expression medulla (nmod)
indeterminate received (advcl)
selection mutants (nmod)
srs ( (punct)
indices arden (compound)
administration quinidine (nmod)
characteristics changes (conj)
incidence applicators (nmod)
atra with (case)
control course (nmod)
dyskinesias drug-induced (amod)
courses weekly (amod)
outcome pbsct (nmod)
infusion noradrenaline (compound)
anemias autoimmune (amod)
resulted shifts (nmod)
patient and (cc)
members . (punct)
displayed stimulation (dobj)
bundle neuropathies (nmod)
males females (conj)
indicates which (nsubj)
monitoring evidence (nmod)
choice effects (nmod)
angina stenosis (conj)
continued keep (xcomp)
severity greater (amod)
severe first (nmod)
area or (cc)
doses patients (conj)
lateral medial (conj)
m1 , (punct)
was showed (conj)
iiib or (cc)
complete 1 (nummod)
mg 10 (compound)
rebound icp (nmod)
reason this (nsubj)
trunk sympathetic (amod)
$ROOT$ carcinoma (sent)
relate exposure (dobj)
investigated effect (nsubjpass)
fatal ) (punct)
revealed regression (nsubj)
profound more (advmod)
reduced movements (dobj)
rr=1.60 ; (punct)
reached p (appos)
intensive more (advmod)
breaks by (case)
trend return (nmod)
ccl2 for (case)
x/minute to (case)
$ROOT$ subtherapeutic (sent)
maximum to (case)
peg 400 (nummod)
bundle through (case)
ritonavir to (case)
projection projection (conj)
teratogenic s-53482 (nsubj)
fell 11.5+/-1.4 (nmod)
block or (cc)
g/min 32.3 (nummod)
made adjustments (nsubjpass)
areas proliferation (nmod)
injected ; (punct)
system rodents (nmod)
affects cycle (dobj)
latency by (case)
was although (mark)
use procedures (nmod)
iu/l 124.4+/-73.4 (nummod)
cells with (case)
participants : (punct)
compatible ischemia (nmod)
ml 8.8 (nummod)
bred were (auxpass)
hours treatment (nmod)
diminishes that (mark)
suxamethonium i.v. (dep)
alterations mechanisms (nmod)
prescribed drugs (nsubjpass)
rep treat (compound)
those were (cop)
$ROOT$ valvulopathy (sent)
toxicity on (case)
sensitivity their (nmod:poss)
given mg/ml (nmod)
company liposome (compound)
followed were (auxpass)
obtained isolation (nmod)
exhibits features (dobj)
antioxidants of (case)
monotherapies combinations (conj)
ability reported (amod)
icu our (nmod:poss)
days than (case)
treatment sinusitis (nmod)
hypotension hyperactivity (conj)
nucleus putamen (conj)
naloxone m (appos)
decrease movement (nmod)
transplantation postrenal (amod)
activated that (mark)
conditions these (det)
have features (dobj)
groups treatment (compound)
values chemistry (compound)
contribution propagation (nmod)
indinavir inhibitor (appos)
resulted incubation (nsubj)
remained 24 (nsubj)
strain c57bl/6 (appos)
nephropathy advanced (amod)
used end (nmod)
hypophosphatemia glycosuria (conj)
resulted albuminuria (nmod)
responses flow (compound)
sleep sleepiness (conj)
53 - (advmod)
gfr and (cc)
report immunostaining (dobj)
different overactivation (nmod)
administration hydrochloride (nmod)
shunting massive (amod)
evidence solid (amod)
situations in (case)
choreic which (nsubj)
hyperthermia alterations (conj)
existence process (nmod)
scores analogue (compound)
patients select (amod)
uv ( (punct)
antagonist mk-801 (appos)
cytological both (cc:preconj)
repeat and (cc)
scale syndrome (compound)
effective calcitonin (nsubj)
advisable monitoring (nsubj)
4.5+/-1.0 , (punct)
resolved change (nmod)
discharged when (advmod)
treatments albuterol (compound)
expression for (case)
further to (mark)
pretreatment tcr (nmod)
left the (det)
ethambutol between (case)
injury related (amod)
acetate bia (appos)
reviewed cases (nsubjpass)
characterized infiltration (nmod)
deaths 6 (nummod)
medications of (case)
literature in (case)
control central (amod)
conclusions rare (appos)
and combinations (conj)
tdr probably (advmod)
emerged suppressed (conj)
reduced group (nmod)
resolved jaundice (nsubj)
somatotopy gpi (nmod)
ingestion diuretic (compound)
bradycardia mediated (acl)
patients methamphetamine-dependent (amod)
pressures , (punct)
assessment accurate (amod)
deficiency prenatal (amod)
leukemia myeloblastic (amod)
die to (mark)
x/minute contraction (compound)
evident decreases (nsubj)
mechanism(s to (case)
bradycardia symptoms (conj)
group 3ma (amod)
administration acid (nmod)
considerations pathogenetic (amod)
included gender (dobj)
sign early (amod)
medline , (punct)
points 20 (nummod)
$ROOT$ better (sent)
influx asians (nmod)
disorder , (punct)
valve baseline (compound)
g/dl with (case)
complicated seizures (nsubj)
confined nephrotoxicity (nsubjpass)
presumed due (xcomp)
fentanyl ( (punct)
abstracts biological (amod)
remitted redistribution (nmod)
$ROOT$ objective (sent)
striatum from (case)
tested determined (conj)
vincristine after (case)
rank log (compound)
adequate doses (nsubj)
provide care (nsubj)
rates intraperitoneal (amod)
scans bone (compound)
phenobarbitone with (case)
90 and (cc)
associations observed (acl:relcl)
affect determinations (dobj)
clones in (case)
antagonize augment (conj)
ndma-d ) (punct)
rate smooth (amod)
ischemia on (case)
two times (quantmod)
farmers among (case)
anticoagulants drugs (conj)
5-fu mtx (nmod)
e2 pge2 (appos)
0.4 and (cc)
have ventricles (dobj)
therapeutic effective (amod)
mg. 61.6 (nummod)
fraction phophorylcreatine (compound)
reported dyskinesias (nsubjpass)
completed procedure (nsubjpass)
concentration fluoxetine (compound)
variants atypical (amod)
co-administration the (det)
reactivity lymphocyte (compound)
given i.v. (advmod)
markers but (cc)
compared ctnt (nmod)
pointes de (amod)
related pathogenesis (nmod)
stopped when (advmod)
catalyzes which (nsubj)
useful preventing (advcl)
study systematic (amod)
reduce therapy (dep)
mellitus by (case)
hypertension for (case)
associated disorder (nmod)
$ROOT$ alive (sent)
group agents (nmod)
workers five (nummod)
blocking i(f (dobj)
block effect (dobj)
provoked mean (dep)
adding of (mark)
lines neuroblastoma (compound)
minimum for (case)
k)-atpase cardiac (amod)
frequencies only (amod)
capsaicin mm (appos)
euthanized fetuses (nsubjpass)
group entire (amod)
learning reversal (compound)
prevented partially (advmod)
searched databases (nmod)
induced doses (nsubj)
s(c)o(2 in (case)
investigation preclinical (amod)
enhance secretion (dobj)
injury hours (nmod)
intake in (case)
$ROOT$ alterations (sent)
randomized prospective (conj)
reversible returning (advcl)
ci=26.7 ) (punct)
syndrome left (amod)
gpi ventral (amod)
$ROOT$ establish (sent)
response chloramphenicol (nmod)
wall lateral (amod)
comparing levels (dobj)
ratios turnover (compound)
prooxidant and (cc)
bortezomib therapy (nmod)
fall median (nmod)
leads protects (conj)
remained analysis (nmod)
hr (= (punct)
extraction cataract (compound)
agent contrast (compound)
amount degrees (nmod)
follow-up 2-year (amod)
treated antipsychotics (nmod)
epileptogenic that (nsubj)
temperament hyperthymic (amod)
taking alone (advmod)
complications uveitis (nmod)
accompanying flush (dobj)
background demonstrated (dep)
identify word (dobj)
going rare (xcomp)
continued stopping (advcl)
attempted successful (conj)
number across (case)
min min (dep)
impairment associated (acl)
inactivation , (punct)
given developed (parataxis)
attack , (punct)
performance baseline (compound)
phase erection (appos)
hyperprolactinemia effects (conj)
hypoglycaemia of (case)
thioperamide i.p. (appos)
dogs 57 (nummod)
aggravated , (punct)
management after (case)
glomeruli the (det)
improve claudication (dobj)
mild related (conj)
seizures motor (amod)
50 0 (compound)
always almost (advmod)
tafi ( (punct)
pretreated not (neg)
etiology no (neg)
remained moreover (advmod)
session hemodialysis (nmod)
dextran biodegradable (amod)
sd male (amod)
effects cataract (nmod)
lesion it (nsubj)
microscopy as (cc)
adenosine intrathecal (amod)
determined relationships (nmod)
co-treatment unrelated (conj)
anf only (advmod)
fraction ratio (conj)
ectoderm head (nmod)
increased consistent (conj)
associated release (nmod)
frey to (case)
association effects (nmod)
revealed infiltration (dobj)
higher was (cop)
treated rauwolscine (nmod)
done been (auxpass)
greater hemorrhage (nmod)
reduced 187 (nmod)
lpo ) (punct)
persisted administration (nmod)
amounts of (case)
probable 42 (nmod)
structure and (cc)
potentiating catalepsy (dobj)
surgery routine (amod)
detected follow-up (nmod)
infusions subcutaneous (amod)
mapped were (auxpass)
flexion were (cop)
pseudolithiasis biliary (amod)
solutions all (det)
agent chelating (amod)
ventricles 6 (nummod)
showed group (nsubj)
pressure blood (compound)
incidence administration (nmod)
conclusive be (cop)
contraction stimulation-evoked (amod)
lnna ) (punct)
cancer iv (nummod)
produce complications (dobj)
domain in (case)
ecstasy was (cop)
behavioral cardiorespiratory (conj)
had contraception (nmod)
cnsb002 blocker (appos)
agonist a2a (compound)
research recent (amod)
rosacea in (case)
nsc ( (punct)
associated complications (nmod)
investigated compounds (nsubjpass)
block ( (punct)
maintain pressure (dobj)
concentration cytoplasm (nmod)
decreases where (advmod)
those toxicology (nmod)
dexamethasone dose (nmod)
mild was (cop)
detachment , (punct)
controls user (compound)
significant p<0.05 (dep)
prove . (punct)
cause mortality (dep)
increase eeg (nmod)
suffered performed (conj)
$ROOT$ involve (sent)
mucositis reactions (conj)
present animals (nmod)
% pneumoniae (dep)
seizures unexpected (amod)
subtypes 3 (nummod)
$ROOT$ beating (sent)
prevalence history (nmod)
markers fibrinolysis (nmod)
ps doses (dep)
related mg/day (nmod)
mg. respectively (advmod)
decrease glutamate (nmod)
profile safety/efficacy (compound)
completed be (auxpass)
basis daily (amod)
nephrotoxicity against (case)
study study (nmod)
encephalopathy--19 cases (appos)
rbf ) (punct)
assayed tissue (nsubjpass)
depression cardiovascular (amod)
movements the (det)
depended apparently (advmod)
stem . (punct)
had test (dobj)
call number (dobj)
attenuates actions (dobj)
anemic and (cc)
ampicillin ax (conj)
subsequent administration (nmod)
achieved ) (punct)
mumol/l and (cc)
information proteome (nmod)
epsilon4 between (case)
pathogenesis could (aux)
noncompliance 14 (nummod)
identify potential (dobj)
cacl2 of (case)
aim investigated (dep)
confused transiently (advmod)
deteriotation any (det)
sensitivity intermediate (amod)
efficacy daunorubicin (nmod)
markers two (nummod)
lysis clot (compound)
increasing pain (dobj)
known induce (xcomp)
eosinophils by (case)
mechanisms implicate (acl:relcl)
doxorubicin sm-5887 (conj)
effect d2 (nmod)
developed were (auxpass)
2.0 interval (dep)
abc chondroitinase (compound)
has growth (nmod)
4.1 +/- (cc)
prevent can (aux)
interpretation their (nmod:poss)
antagonist as (case)
evident fibrosis (nsubj)
[na]o normal (amod)
establishes and (cc)
analyze to (aux)
suxamethonium patients (nmod)
mg/kg 17.5 (nummod)
impairs acuity (dobj)
evaluated phosphanilate (nsubjpass)
suggesting involvement (dobj)
prevented than (dep)
worsening administration (nmod)
patients 13/52 (nummod)
received disease (nmod)
severe reversible (conj)
prevent increase (dobj)
taking amiodarone (conj)
cont./min ; (punct)
investigated number (nmod)
tab venlafaxine (nmod)
adjuvant and (cc)
suppressed treatment (nsubj)
region ca1 (compound)
function receptor (nmod)
used types (nsubjpass)
$ROOT$ undertook (sent)
defibrillation by (case)
branches triceps (nmod)
antagonist factor (compound)
output or (cc)
neurological and (cc)
$ROOT$ followed (sent)
factor-alpha tumor (compound)
loss complete (amod)
cta either (preconj)
facilitated detection (nsubjpass)
enhancement learning (nmod)
compartment interstitial (amod)
men 6 (nummod)
consistent absence (nmod)
presence sharps (nmod)
hyperactive response (nmod)
range ] (punct)
apnoea respiratory (amod)
investigation extensive (amod)
include complication (dobj)
inhibitors experiments (conj)
exclude to (mark)
reflex be (cop)
cyanosis of (case)
tolerated flestolol (nsubjpass)
pressure intraoperative (amod)
involvement muscle (compound)
arag ) (punct)
observed values (nsubjpass)
skin tests (conj)
treated therapy (nmod)
defects septal (amod)
worst p<0.001 (parataxis)
observed d (nmod)
achieving model (nmod)
blue g-1 (dep)
catheterisation cardiac (amod)
dependency drug (compound)
induced azt (nsubj)
capable mg/kg (conj)
affect hyperactivity (dobj)
remained degree (nsubj)
is whether (mark)
concentration hippocampus (nmod)
therapy bcnu (compound)
bradycardia tachycardia (conj)
develop patients (nsubj)
symptoms bladder (compound)
+ ) (punct)
known block (xcomp)
associated hiccups (nmod)
agonist children (nmod)
300 1 (compound)
period gds (dep)
solution anaesthesia (nmod)
roles the (det)
score lidocaine (nmod)
depend development (nsubj)
subscale in (case)
used method (nsubjpass)
deposits with (case)
antagonist)-induced scopolamine (nmod:npmod)
ovulation clomiphene-induced (amod)
occurs subjects (nmod)
infarction (isph)-induced (punct)
depressants cns (compound)
intubated paralyzed (conj)
results found (dep)
dermatitis perioral (amod)
kinase serum- (amod)
4.40 10(3 (conj)
26.3 +/- (cc)
altered tone (nsubjpass)
signs asthenia (nmod)
l 8 (compound)
blockade beta-adrenoceptor (compound)
episodes ( (punct)
throat sore (amod)
impaired drugs (nsubj)
striata mice (nmod)
aml ; (punct)
baseline weeks (conj)
animals experimental (amod)
interfere action (nmod)
administration acetaminophen (nmod)
safety . (punct)
identified using (xcomp)
leads v6 (conj)
cells hilar (amod)
child in (case)
included measures (nsubj)
affect augment (conj)
derangement an (det)
hyperalgesia e2-induced (amod)
reported complication (nmod)
syndrome leukoencephalopathy (compound)
mk801 by (case)
afl 81 (nummod)
$ROOT$ extended-release/lovastatin (sent)
fully yet (advmod)
receptors na (compound)
women 45 (nummod)
effect pain (nsubj)
aimed investigate (xcomp)
underwent one (nsubj)
avoid or (cc)
tests . (punct)
minutes 28 (nummod)
sed ( (punct)
manifestations these (det)
series based (prep)
seizure jumping (amod)
ratio atp/adp (compound)
response complete (amod)
correlated were (auxpass)
study parallel-groups (amod)
axons bundle (nmod)
decreased results (nsubj)
controls 18.9 (nummod)
simvastatin-ezetimibe with (case)
capture recording (nsubj)
increased rose (advcl)
signs sensory (amod)
sensitized that (mark)
use end (nmod)
treatment after (case)
sma ( (punct)
vasculitis manifesting (acl)
frequency an (det)
proteinuria decreased (amod)
coincident use (nmod)
$ROOT$ metabolites (sent)
evaluation future (amod)
remifentanil microg/kg (appos)
hospitalized centre (nmod)
administration by (case)
episodes as (case)
mg/kg iv (nummod)
variation benefit (nmod)
myalgia/arthralgia 1 (nummod)
aims and (cc)
interval occlusion (nmod)
dopamine than (case)
teratology 1971 (appos)
mccarthy ; (punct)
one-tenth about (advmod)
models dementia (compound)
symptoms models (nmod)
interval administration (nmod)
treatment t (compound)
administered hours (nmod)
december october (conj)
ircrf ( (punct)
elevated mm (dep)
quantified however (advmod)
-14.6 < (parataxis)
treatment shortly (advmod)
transplantation quality (appos)
confirmed , (punct)
headaches from (case)
alternation spontaneous (amod)
indicating activation (dobj)
compared lipid (nsubjpass)
mg/kg 0.05 (nummod)
effects known (amod)
hormone parathyroid (amod)
differences appreciable (amod)
activity inhibitor (nmod)
strain . (punct)
activities antiplatelet (amod)
2 1 (parataxis)
sequence a (det)
paid patients (nmod)
densitometry ( (punct)
frequent groups (nmod)
effect rapid (amod)
anemia severe (amod)
acts retarding (advcl)
recommend they (nsubj)
use cm (compound)
blocked significantly (advmod)
clonidine micrograms (dep)
find study (nsubj)
have blocked (advcl)
severe but (cc)
methods determined (appos)
showed binding (dobj)
patients found (acl)
controlling certain (dobj)
steatosis , (punct)
identified . (punct)
number zone (nmod)
index x (dep)
increase % (compound)
hematotoxicity similar (amod)
anticonvulsants other (amod)
followed required (conj)
aspects temporal (amod)
11 24 (conj)
documented been (auxpass)
provoked convulsions (dobj)
opponent toward (case)
predominance motor (compound)
presented arrhythmia (nmod)
sections tissue (compound)
iopamidol after (case)
severity to (case)
predictive was (cop)
responses amoxicillin (nmod)
serca2 [ (punct)
systems involvement (nmod)
included group (nsubjpass)
ingested when (advmod)
dosages low (amod)
shock for (case)
40.9 33.7 (conj)
12/32 and (cc)
probable total (nmod)
contents lungs (nmod)
0.03 ) (punct)
duct syndromes (conj)
1.2 ) (punct)
mcao after (case)
inhibitor plasma (compound)
catalyzes degradative (dobj)
hypertensives of (case)
retina nerve (conj)
prepared radiopharmacy (nmod)
weak delayed (conj)
caused lithium (nsubj)
noted patients (nmod)
formyltransferase garft (appos)
exclude definitely (advmod)
had d-glucarates (nsubj)
appears paf (nsubj)
drug antithyroid (amod)
ethanol ( (punct)
carries atorvastatin (nsubj)
reduces myocet (nsubj)
intensity perceived (amod)
siadh ) (punct)
recordings electrode (compound)
assaults induced (acl)
requiring surgery (dobj)
p20 saline (compound)
monitored cases (nmod)
compounds as (case)
parameters pd (compound)
found specimen (nmod)
experiments analogues (nmod)
catheterization system (conj)
patients thirty-five (nummod)
related been (cop)
diameter pupil (compound)
total icus (nmod)
dex-ht ( (punct)
achieved procedure (nmod)
experienced tnss (dobj)
involvement subdivisions (nmod)
change observed (advcl)
pg-9 of (case)
treated or (cc)
effect haloperidol (nmod)
blocker of (case)
solution to (case)
exerted could (aux)
emphasis special (amod)
impairment irreversible (amod)
poison ii (nummod)
contain fs (nsubj)
daily orally (advmod)
essential adding (advcl)
mdp with (case)
concentration versus (cc)
7 ( (punct)
obtained reduction (nsubjpass)
elucidate to (dep)
medication additional (amod)
13 - (advmod)
$ROOT$ complained (sent)
khz 10 (nummod)
associated midazolam (nmod)
added treatment (nmod)
method obtunding (advcl)
systemic responses (dep)
bmd volumetric (amod)
pretreatment caffeine (compound)
received rhigf-i (dobj)
trazodone i.p. (amod)
able drug (nsubj)
decreased thereafter (advmod)
weakness muscular (amod)
implicated bromocriptine (nsubjpass)
iop < (amod)
results . (punct)
observation produce (ccomp)
1984 , (punct)
phonological lexical (conj)
center in (case)
combination dp/dtejc (nmod)
years 12 (nummod)
interviewed presence (nmod)
12 6 (compound)
institution following (case)
agonists alpha-2 (compound)
pre-treatment chronic (amod)
changes hematological (amod)
= 18 (dobj)
vincristine with (case)
hsct ( (punct)
level noel (appos)
benign always (advmod)
bromocriptine by (case)
patients another (det)
lactate la (appos)
showed conclusion (nmod)
amounts adequate (amod)
provides . (punct)
substance of (case)
studied development (nsubjpass)
activity stress (conj)
urea of (case)
disturbance visual (amod)
p9201 from (case)
insecticide organophosphate (compound)
disposition or (cc)
understand process (dobj)
elderly and (cc)
attractive injections (nsubj)
reported nor (cc)
buspirone agonists (conj)
using apparatus (dobj)
repair , (punct)
learning functioning (conj)
followed min (nmod)
domperione of (case)
component regimens (nmod)
diminished rigidity (dobj)
activities transaminase (compound)
impact prevention (nmod)
use clozapine (nmod)
junctions tjs (appos)
experiences aes (appos)
experienced five (nsubj)
markers the (det)
considered variables (nsubjpass)
precise frequency (nsubj)
modulated be (auxpass)
cns on (case)
greater with (mark)
background cause (appos)
followed washout (nmod)
kanamycin gentamicin (conj)
misoprostol of (case)
mechanism as (case)
= 0.57 (dobj)
associated uncommonly (advmod)
similar type (nsubj)
toxicity cm (compound)
subgroups certain (amod)
avoided can (aux)
lys1 , (punct)
dehydrogenase oxide (conj)
amount cocaine (nmod)
substituted amb. (nmod)
remain effects (nsubj)
mg/d mg/d (conj)
block pathway (nmod)
removed end (nmod)
an-2-ol 1-(2,4-dichlorophenoxy)-3[2 (compound)
$ROOT$ malformation (sent)
advocate now (advmod)
mechanisms circuitry (conj)
alteration for (case)
parameter hemodynamic (amod)
type strain-matched (amod)
mono-infected co-infected (conj)
continue progression (nmod)
had comparison (nmod)
concentration proteins (nmod)
weakness including (case)
relieved drugs (nmod)
higher those (nmod)
9.4 times (quantmod)
capture enhanced (amod)
produce concentrations (nsubj)
determined synthesis (nsubjpass)
chronotropic negative (amod)
resolved abnormalities (nsubj)
present infection (nsubj)
leaves question (dobj)
simple inexpensive (dep)
present women (nmod)
exacerbation with (case)
strips body (compound)
incidence seizures (nmod)
mice kept (acl)
affinity site (nmod)
amplitude tremor (compound)
edema associated (acl)
dependent . (punct)
loss allograft (nmod)
exposure cocaine (compound)
kong in (case)
expression cortex (nmod)
induced morphine (nsubj)
content release (conj)
undergo intervention (dobj)
analysis second (amod)
charcoal with (case)
superoxide saline (dep)
2 was (cop)
mediated interference (nmod)
clentiazem of (case)
restoration levels (nmod)
receptor ) (punct)
clozapine , (punct)
mechanisms disorder (nmod)
received attempt (nmod)
5.1 ( (punct)
decrease red (amod)
effects concentrations (nmod)
lead choosing (advcl)
reports 2 (nummod)
glyt1 ) (punct)
variety ranging (acl)
extensive when (advmod)
authorized and (cc)
$ROOT$ separated (sent)
valsartan val (appos)
results overflow (nmod)
treatment micrograms/kg (dep)
blockade to (case)
decreased pbto(2 (nsubj)
acetaminophen of (case)
tests antibodies (nmod)
utilized carrier (nmod)
retardation psychomotor (amod)
former rodents (nmod)
membrane cytoskeleton (conj)
prevalences testosterone (nmod)
infused catheter (nmod)
organs multiple (amod)
organisms type (compound)
kidney brain (conj)
ee rats (nmod)
gradient of (case)
excluded five (nsubjpass)
stability mechanical (amod)
dose overall (amod)
hypokalemia arrhythmias (conj)
model . (punct)
achieved suppression (nsubjpass)
nerves peripheral (amod)
satisfied records (nmod)
ymdd ( (punct)
dose-intensity median (amod)
admitted pain (nmod)
seroconversion participants (nmod)
revealed cells (dobj)
catecholamines administered (acl)
ug 500 (nummod)
mortality an (det)
done methods (nsubjpass)
borderzone in (case)
appear present (nmod)
bepridil compound (appos)
conclusions marker (appos)
undertook submitted (conj)
tremor palpitations (appos)
carriers ) (punct)
treatment first (amod)
patients anxious (amod)
training or (cc)
levels blood (compound)
occurrence damage (nmod)
antigen hepatitis-b (compound)
bortezomib and (cc)
adducts 3-nitrotyrosine (conj)
higher cows (nmod)
syndrome zollinger-ellison (compound)
perseveration , (punct)
icp elevated (amod)
modulation altered (amod)
lysozyme of (case)
antagonist peripheral (amod)
test the (det)
$ROOT$ conclude (sent)
doses micrograms/kg (nmod)
mglurs ii (nummod)
segment minutes (nmod)
arrest caused (acl)
repeated day (nmod)
sedatives are (cop)
(r)-alpha-methylhistamine microg (dep)
block occurring (acl)
rate microbiologic (amod)
$ROOT$ incontinence (sent)
mibg ) (punct)
reversible is (cop)
users prior (amod)
cortices the (det)
identified inpatients (nmod)
3.6 20.0 (prep)
r/r ( (punct)
profiles comparable (amod)
started day (nmod)
confined may (aux)
myelination and (cc)
dyskinesias ko (nmod)
52021 mg/kg (dep)
serum urinary (conj)
investigate preventing (advcl)
prevented can (aux)
hildebrand ) (punct)
scopolamine s.c. (appos)
course biomarkers (nmod)
indicative caused (conj)
cirrhosis hbv-related (amod)
using material (dobj)
9 to (dep)
increase was (cop)
delirium adopted (acl:relcl)
administration phenobarbitone (nmod)
8.9 8.7 (conj)
pressure tau (conj)
prevented increase (dobj)
proteinuria . (punct)
center institutes (compound)
ischemia cocaine-associated (amod)
activity cocaine-induced (amod)
18 ( (punct)
sensitivity administration (nmod)
tablets 2 (nummod)
regulation ppi (nmod)
ritonavir or (cc)
confirm predictor (ccomp)
abnormalities valvular (amod)
hoarseness 8) (appos)
people young (amod)
range physiologic (amod)
degeneration subacute (amod)
concluded study (nmod)
approach in (amod)
indicated when (advmod)
enhances responsiveness (dobj)
lymphoma , (punct)
complication results (acl:relcl)
aged years (nmod)
associated warrant (advcl)
patients symptoms (nmod)
improvement to (case)
were indications (nsubj)
induced mg./kg (nmod)
morphine analgesia (compound)
reduced response (nsubjpass)
months 53 (nummod)
overdose a (det)
increased altering (advcl)
accumbens nacc (appos)
kit available (amod)
formation body (compound)
radioactivity in (case)
yawning retrocollis (conj)
blind day (nmod)
effect negative (amod)
developed when (advmod)
ml 40 (nummod)
6-ohda with (case)
neurotransmitters of (case)
made iopentol (nmod)
trigger siat (nmod)
observed occurred (advcl)
use anorexigens (nmod)
$ROOT$ possible (sent)
affected nox (dobj)
mediates dampens (conj)
sensitization desipramine-induced (amod)
experienced leukopenia (dobj)
eads initiated (acl:relcl)
reactions adrs (appos)
cited studies (nmod)
studies used (acl:relcl)
tissues in (case)
injection mu (nmod)
mmol/d 150 (nummod)
concerns risks (nmod)
aims study (nmod:poss)
mortality rats (nmod)
audiograms serial (amod)
injected i.p. (advmod)
toxicity amb. (nmod)
administration infusion (nmod)
consciousness signs (nsubj)
high bp (nsubj)
loss subjective (amod)
antiplatelets among (case)
5-azacytidine 5-azc (appos)
reduce off-time (dobj)
superior reduction (nmod)
anticoagulation warfarin (nmod)
revealed examination (nsubj)
band of (case)
glutamate h2o2 (conj)
erythrocytes human (amod)
pills contraceptive (amod)
atrophy with (case)
reported isradipine (nmod)
paclitaxel carboplatin (conj)
taking weeks (nmod)
smoke cocaine (dobj)
antimicrobials to (case)
tendency known (amod)
reversal licking (nmod)
sensitivity dgc (nmod)
hypertension borderline (amod)
noticed difference (nsubjpass)
introduction change (nsubj)
mm of (case)
-0.12+/-0.5 p=0.014 (appos)
potentials auditory (amod)
= .001 (dep)
administered fifteen (nmod)
patients risk (acl:relcl)
exchanges index (conj)
anesthetic-induced local (amod)
was difference (attr)
enhancement , (punct)
considered sign (xcomp)
similar c (dep)
drinkers the (det)
anti-oxidant and (cc)
edema vasogenic (amod)
learning rodents (nmod)
seen commonly (advmod)
administered organogenesis (nmod)
marker monocytes/macrophages (nmod)
sufficient raise (xcomp)
ascertained efficacy (nsubjpass)
appeared % (nmod)
66 to (quantmod)
age median (amod)
values peak (amod)
potentiate and (advmod)
blocker b (appos)
tnf paf (conj)
patients literature (nmod)
tolerant combinations (nmod)
problem depletion (nsubj)
achieved remission (nsubjpass)
settings clinical (amod)
system a (det)
discussed experiment (nsubjpass)
concentration fluid (compound)
participants trial (nmod)
development nafld (nmod)
colliculus , (punct)
ratings first-time (amod)
recruited patients (dobj)
poor prognosis (nsubj)
disturbance neuropathy (conj)
erythropoietin socs3 (conj)
mg/kg s.c.)-induced (punct)
greater to (mark)
chloride by (case)
induced vivo (advmod)
occurred sec. (nmod)
number seizures (nmod)
tizanidine , (punct)
clonidine intravenous (amod)
19 ( (punct)
manifestations . (punct)
produced pre-treatment (nsubj)
ligands nmdar (compound)
dose larger (amod)
microl 6.5+/-3.1 (nummod)
factors influence (acl:relcl)
studied extensively (advmod)
free toxicity (nmod)
hepatoma , (punct)
equal almost (advmod)
62.5 20.9 (conj)
mesothelioma in (case)
= mean (nsubj)
variety diseases (nmod)
state induced (acl)
disappearance na (nmod)
based results (nsubjpass)
related concentration (nmod)
doses paracetamol (nmod)
hypotension disease (nmod)
flexion/extension ( (punct)
damage selectively (advmod)
consisted patients (nmod)
population whole (amod)
pc02 hg (dep)
133xe i.v. (compound)
attenuation amiloride (nmod)
refractory hitherto (advmod)
involving challenge (dobj)
tropicamide microl (dep)
echocardiography contrast (compound)
elevation the (det)
factor selecting (advcl)
akbr and (cc)
resistance aggregation (conj)
adopted subjects (nmod)
seizure-prone seizure-resistant (conj)
costs outcome (conj)
no ( (punct)
advise patients (dobj)
infiltration refractory (amod)
hypotension antidepressant-induced (amod)
resolving worsened (parataxis)
inventory use (compound)
herniations as (case)
$ROOT$ effects (sent)
groups hem (compound)
scoring the (det)
-21.3 and (cc)
assessment severity (nmod)
t.i.d. ( (punct)
cibenzoline of (case)
agonist receptors (nmod)
attained . (punct)
indistinguishable carcinoma (nmod)
woman 52-year-old (amod)
output osmolality (conj)
exception one (nummod)
antagonist cpt (compound)
% 66.7 (nummod)
normal-salt or (cc)
infarctions and (cc)
cessation and (cc)
cause seizures (nmod)
response behavioural (amod)
appeared week (nmod)
smokers of (case)
related expression (nmod)
disease treatment (nmod)
k)-atpase the (det)
days 29 (nummod)
protects remarkably (advmod)
mutants motif (compound)
therapy additional (amod)
electrolyte plasma (compound)
loops by (case)
parts ii (nummod)
treatment monotherapy (nmod)
greatest levels (nmod)
anemia riha (appos)
perfused buffer (nmod)
occurred initially (advmod)
bmt following (case)
in . (punct)
seen whereas (dep)
remained unaffected (xcomp)
impairments speed (nmod)
depressed , (punct)
therapy amisulpride (compound)
case occlusion (nmod)
evoke and (cc)
possibility on (case)
installation epilepticus (nmod)
trait hemoglobin (compound)
alt ) (punct)
testing task (nmod)
submitted challenge (nmod)
digitalise ? (punct)
case administration (nmod)
marketed us (nmod)
cause overflow (nmod)
1 61 (conj)
$ROOT$ predicted (sent)
cause morbidity (dobj)
pre-test ) (punct)
was doses (nmod)
models in (amod)
moderate cigarettes (dep)
led experiments (nmod)
requested organization (nmod)
became nine (nsubj)
htr6 ( (punct)
ceased drugs (nsubjpass)
mmhg 100/65 (nummod)
aspirin paracetamol (conj)
preferred should (aux)
5-fu during (case)
diagnoses excluding (acl)
disorders vasculitic (amod)
involved thus (advmod)
deserve may (aux)
functions mice (nmod)
transplantation after (case)
dysfunction between (case)
characterized damage (nsubjpass)
receive testing (nmod)
awake = (dep)
areas to (case)
variants unknown (amod)
authorized is (auxpass)
toxic hydrochloride (nsubj)
conjunctiva cornea (conj)
irritability , (punct)
induced whether (mark)
treatment angina (nmod)
injected pilocarpine (nmod)
movement involuntary (amod)
part procedure (nmod)
acromegaly for (case)
restriction with (case)
levels ca(2 (compound)
greater reductions (nsubj)
behaviours convulsive (amod)
discriminate reliably (advmod)
referred to (nmod)
presents followed (advcl)
ventilation breathing (acl)
activity enzyme (nmod)
recognised that (nsubjpass)
synthesis rna (compound)
cotransporter thiazide-sensitive (amod)
score reaction (compound)
0.01 less (advmod)
lower twitches (nsubj)
complicating transplantation (dobj)
immunocytochemistry fluorescent (amod)
agent any (det)
months 163 (nummod)
flow women (nmod)
exhaustion until (case)
increased glibenclamide (nmod)
urine hyposmotic (amod)
related menopause (nmod:npmod)
trial a (det)
numbness and (cc)
investigated design (nmod)
4.3 , (punct)
regressed and (cc)
included medications (nsubj)
preceded was (auxpass)
states vigilance (compound)
two respectively (advmod)
males the (det)
sheath myelin (amod)
peptide is (cop)
taking lozenge (dobj)
treatment bevacizumab (nmod)
rats nicotine-treated (amod)
age extent (conj)
evaluation severity (conj)
elicited catalepsy (nsubjpass)
effect tumor-protective (amod)
each of (case)
levels 4-ene-vpa (nmod)
matrix medullary (amod)
displacements different (amod)
less 0.005 (nmod)
seen will (aux)
protein is (cop)
lower amplitude (nsubj)
considering increase (dobj)
tract of (case)
infarct a (det)
diminished is (auxpass)
depressed status (nmod)
transplantations intracerebral (amod)
bradycardia marked (amod)
site primary (amod)
disorder rates (dep)
associated abnormalities (nmod)
mc ) (punct)
task with (case)
eps patients (nmod)
units plasma (nmod)
factor-beta1 tumor (compound)
$ROOT$ predictive (sent)
sham and (cc)
pattern cases (nmod)
1 vs. (cc)
predispose course (nmod)
information potential (nmod)
agonist the (det)
setting outpatient (amod)
due residence (nmod)
alerted physicians (nsubjpass)
lymphocytes lesional (amod)
convulsions lethality (conj)
= 0.007 (dobj)
important pathogenesis (nmod)
10(-3 0.15 (compound)
clarify true (ccomp)
stay during (case)
cause important (amod)
discussion : (punct)
activation immunological (amod)
adriamycin early (amod)
$ROOT$ spasm (sent)
mazindol of (case)
respond cascade (nmod)
initiatives health (compound)
degeneration cell (compound)
advised prevent (xcomp)
compared and (cc)
agent limited (acl:relcl)
test coombs (nmod:poss)
> or (cc)
phase slope (dep)
had vomitus (dobj)
enhancement myocardial (amod)
ototoxicity nephrotoxicity (conj)
reshaping possible (amod)
switching tacrolimus (nmod)
prognosis renal (amod)
epicondyle on (case)
results therapy (nsubj)
times nine (nummod)
erections behavioral (amod)
endophthalmitis in (case)
june 1997 (appos)
presence mpo-anca (nmod)
excluded , (punct)
deprivation or (cc)
renal impaired (amod)
females , (punct)
$ROOT$ pathology (sent)
identify might (aux)
obtained fluid (nsubjpass)
disorder developed (acl:relcl)
evaluated edema (nsubjpass)
treatment pan (compound)
anesthesia mac (appos)
assay two-step (amod)
efficacy icrf-187 (nmod)
inducing lysis (dobj)
investigating , (punct)
mk-486 with (case)
peliosis tumors (conj)
involved distinguished (conj)
demonstrates conclusions (nsubj)
properties mechanical (amod)
block bundle (compound)
had v (cc)
acrolein main (amod)
parameters electrocardiograph (conj)
mg/kg/day schoolchildren (nmod)
modulate to (mark)
levels dopamine (compound)
screening endocrine (amod)
world rw (appos)
loss expression (conj)
12-week comparative (amod)
hypoglycemia , (punct)
interactions them (nmod)
treated group (nsubjpass)
facial and (cc)
affected fasting (nmod)
apoptosis doxorubicin-induced (amod)
jj and (cc)
fraction and (cc)
rats amygdala-kindled (amod)
adsd with (case)
hit of (case)
hemispheres and (cc)
given simultaneously (advmod)
authorized used (conj)
examined trial (nmod)
cells epithelial (amod)
ximelagatran , (punct)
caused meth (nmod)
normalized completely (advmod)
mice icr (compound)
cause excretion (dobj)
baroreflex of (case)
adriamycin dose (nmod)
reactions p (nmod)
prevented alterations (nsubjpass)
ph 1.2 (nummod)
alterations tjs (nmod)
analysis ( (punct)
treatment all (det)
mg/m2 than (case)
imaging emission (compound)
reaction sulphasalazine (nmod)
49.75 - (punct)
effect steric (amod)
convert fibrillation (dobj)
44.8 34.0 (compound)
addressing since (mark)
resection with (case)
exploited . (punct)
disfiguring may (aux)
electrophoresis two-dimensional (amod)
systems hepatic (amod)
causes cardiomyopathy (dobj)
enalapril ace (compound)
differentiation paradigms (nmod)
naloxone ) (punct)
function mitochondrial (amod)
vagotomy and (cc)
deterioration for (case)
biochemical pharmacological (conj)
shed might (aux)
enrolled methods (nsubjpass)
d15 ) (punct)
states but (cc)
measurements 1 (nmod)
controls 152 (nummod)
rats neonatal (amod)
salbutamol , (punct)
decreased stopped (advcl)
hypotension % (appos)
reperfusion min (nmod)
secondary glomerulonephritis (nmod)
has but (cc)
accomplished adjustment (nsubjpass)
muscles in (case)
has metformin (nsubj)
due toxicity (nsubj)
support units (appos)
changes aphasia (conj)
risk propofol (nmod)
superoxide neutrophil (compound)
two = (dep)
genotyped 5-httlpr (nmod)
leukomalacia , (punct)
ml/min/kg vs. (cc)
induced group (nmod)
is : (punct)
trichotillomania , (punct)
drops iodide (compound)
shift and (cc)
withdrew effects (nmod)
40/min 30 (compound)
given vpa (nsubjpass)
vegf/vpf ) (punct)
episodes 39 (nummod)
normal prior (advmod)
object meeting (nmod)
unpleasant background (dep)
$ROOT$ reduces (sent)
effects epilepsy-related (amod)
complication : (punct)
compared mice (nmod)
modifies e2 (nsubj)
bands different (amod)
angiography care (appos)
reduces cost (dobj)
associated dementia (nsubjpass)
50 less (advmod)
gpt ) (punct)
weight saline (nmod)
differentiation groups (nmod)
nhe3 of (case)
tested psychologist (nmod)
69 22 (compound)
uncertainties despite (case)
anesthetic local (amod)
technique . (punct)
known role (nmod)
increase baseline (nmod)
$ROOT$ attempts (sent)
reverted audiograms (nsubj)
ras of (case)
presented normal (conj)
proved carcinoma (xcomp)
appearance in (case)
procedure laitinen (nmod:poss)
day from (case)
injections intradermal (amod)
alterations reserpine-induced (amod)
1.56 1.05 (dep)
affected less (advmod)
success apparent (amod)
sensitivity enhanced (amod)
recordings with (case)
curve under (case)
rp both (cc:preconj)
deficit time-related (amod)
interventions of (case)
abdomen of (case)
seizures picrotoxin- (amod)
nephritis tubulointerstitial (amod)
disorders delirium (nmod)
erythrodysesthesia stomatitis (conj)
infants to (case)
1ml/kg s.c. (appos)
arrhythmia findings (conj)
admitted testing (nmod)
$ROOT$ was (sent)
intolerant to (mark)
receptor glutamatergic (amod)
less than (mwe)
increases tri (nsubj)
$ROOT$ has (sent)
system cyclic (amod)
has although (mark)
amnesia short-term (amod)
diseases cirrhotic (amod)
blocked simultaneously (advmod)
found . (punct)
accuracy improved (amod)
rarest syndrome (nsubj)
retention leading (acl)
hg with (case)
evaluate performance (dobj)
used paper (nmod)
studied conditions (nmod)
1.03 0.04 (conj)
experiences clinical (amod)
subpopulation a (det)
exists , (punct)
anesthetized subjected (conj)
block result (nmod)
reflex -- (punct)
chloramphenicol or (cc)
suspected angioedema (nsubjpass)
0.27 , (punct)
combining therapy (dobj)
decrease probable (amod)
interview mini (compound)
asymptomatic episodes (nsubj)
increased blocked (advcl)
% 67 (nummod)
weak while (mark)
evokes secretion (dobj)
generation saccades (nmod)
absence necrosis (nmod)
ct abdominal (amod)
casts tubuli (nmod)
medium iso-osmolar (amod)
substituted were (auxpass)
suffers one (nsubj)
damaged parallel (nmod)
concentrations tissue (compound)
sulfate oscs (appos)
decrease limiting (csubj)
antagonists beta-adrenergic (amod)
dialysate acid (nmod)
demonstrated colocalized (ccomp)
noted been (auxpass)
compared that (nmod)
activity antagonistic (amod)
reported tightness (nsubjpass)
expected effective (xcomp)
reduction blockade (nmod)
december 2006 (nummod)
mg/l. 12 (nummod)
rt-pcr quantitative (amod)
was decrease (nsubj)
test paw (compound)
findings histological (amod)
model test (acl:relcl)
comprised methods (nsubj)
both in (case)
substitute procedures (nmod)
$ROOT$ coexistence (sent)
attempted identify (xcomp)
known effects (nsubjpass)
safety study (dep)
effect val204asp (nmod)
receiving prostheses (dobj)
modulated systems (nsubjpass)
woman epileptic (amod)
users controls (conj)
exposure by (case)
vivo and (cc)
large sometimes (advmod)
included trials (nsubjpass)
usefulness clinical (amod)
2.41 1.31 (conj)
dyskinesia disabling (amod)
modifications following (amod)
bid mg (nummod)
known , (punct)
given indomethacin (nsubjpass)
reason preference (nmod)
$ROOT$ unrecognized (sent)
infarction ant-mi (appos)
doses remifentanil (nmod)
provide kit (nsubj)
reverses that (mark)
receptor nk1 (compound)
complication described (acl)
activity protein (nmod)
pentoxifylline before (nmod)
inactivating effects (dobj)
subsides instillation (nmod)
maintained weeks (nmod)
play 3 (dep)
% 16/49 (appos)
resulted reduction (nsubj)
glioblastomas recurrent (amod)
caffeine mg/kg (compound)
purpura thrombocytopenic (amod)
agent reduction (nmod)
uncertain but (cc)
= 0.808 (dobj)
identified patterns (nsubjpass)
ampicillin gentamicin (conj)
cpa/ee ( (punct)
[cmax]/mic concentration (compound)
treated alone (advmod)
includes and (cc)
antagonism pirenzepine (compound)
ed in (case)
model adenomyosis (nmod)
decrease progressive (amod)
% 8.7 (nummod)
inhibitors and (cc)
compliance . (punct)
2.5 5 (conj)
tear minor (amod)
recorded results (nsubj)
transplantation anticoagulated (acl)
taking venlafaxine (dobj)
aim improving (acl)
quetiapine or (cc)
anemia cephalothin-induced (amod)
rash events (nsubj)
antidotes of (case)
scopolamine i.m. (advmod)
showed signs (nmod)
nifedipine when (advmod)
0.25 ( (punct)
improve not (neg)
followed was (auxpass)
resorption excess (nmod)
administration manner (nmod)
few are (cop)
differ prevalence (nsubj)
ingestion woman (nmod)
ng anp (nmod)
group extended-interval (amod)
prevented injection (nsubj)
product rpp (appos)
ended when (advmod)
appeared seizure (nsubj)
worst group (nmod)
sent selected (advcl)
remained : (punct)
however was (cop)
annulus posterior (amod)
caries and (cc)
testing autoantibodies (nmod)
delirium induced (acl:relcl)
diameter shape (conj)
rp by (case)
abnormality same (amod)
changes gross (amod)
importance growth (nmod)
history occurrence (conj)
smoked they (nsubj)
infusion plasma (compound)
second on (case)
hexamethylmelamine mg/kg (appos)
12 times (quantmod)
swings on-off (amod)
correlate closely (advmod)
offers dosage (nsubj)
cardiotoxicity mmc-related (amod)
involved production (nmod)
has lometrexol (nsubj)
period epilepticus (nmod)
$ROOT$ intervention (sent)
bladder forestomach (conj)
ethinyloestradiol desogestrel (conj)
has antidote (dobj)
aureus s. (compound)
$ROOT$ lasted (sent)
limit 10 (nummod)
> age (nmod)
help providing (xcomp)
involved resulting (advcl)
status an (det)
range with (case)
escalation intrapatient (amod)
dissociated preparations (nmod)
failed administration (nsubj)
snr in (case)
apap either (cc:preconj)
associated stroke (nsubj)
interference dopaminergic (amod)
task alternation (compound)
pathways ascending (amod)
negroes in (case)
up-regulation abundance (nmod)
developed weakness (nsubj)
tachyarrhythmias pointes (nmod)
$ROOT$ afterdepolarization (sent)
manifestation rare (amod)
years from (case)
oxidation hemoglobin (compound)
extraction [3h]-l-arginine (compound)
technique tomography (conj)
party hypertension (nmod)
bradycardia refractory (amod)
options treatment (nmod)
significant analysis (nmod)
decreased overexpression (dobj)
% 200 (nummod)
fibrosis renal (amod)
disturbances formation (conj)
schedule 2 (nummod)
improves literature (nmod)
comparable or (cc)
agents available (amod)
dobutamine and (cc)
2b1/2b2 1a1/1a2 (conj)
determined mice (nmod)
alleviated that (mark)
discussed seldom (advmod)
incidence thrombophlebitis (nmod)
measures baseline (nmod)
oliguria prolonged (amod)
regimen immunosuppressant (amod)
suffering fibrillation (nmod)
experience and (cc)
determination after (case)
scans by (case)
calcium in (case)
crisis induced (acl)
directed patients (nmod)
age type (conj)
hepatotoxicity against (case)
treatment pdtc (nmod)
hcrh and (cc)
hormones and (cc)
requires restoration (nmod)
side-effect tdp (nsubj)
score activities (compound)
potentials baeps (appos)
explore also (advmod)
damage capillary (nmod)
aimed , (punct)
pointes de (case)
infarction transmural (amod)
signs including (case)
plugs choriocarcinomic (amod)
prooxidant protein (dep)
dosages these (det)
test maze (compound)
mg/kg 30.0 (nummod)
types various (amod)
erythromycin inhibitors (conj)
injuries liver (compound)
found cases (nsubjpass)
studies sensory-motor (amod)
seen eyes (nmod)
activation brainstem (nmod)
seem useful (xcomp)
$ROOT$ tachyarrhythmia (sent)
rep in (case)
failure preparation (nmod)
regulation on (case)
apomorphine dexamphetamine (conj)
effect known (amod)
defect perfusion (compound)
models are (cop)
administered emergence (nmod)
attenuated injection (nmod)
increased reduced (advcl)
inhibited exposure (nsubj)
consuming amount (dobj)
compare results (dobj)
seizures completed (amod)
baby a (det)
patients 142 (nummod)
maryland berlin (conj)
cont./min 2.0 (nummod)
reduction administration (conj)
rtms for (case)
use globulin (nmod)
withdrawal social (amod)
index quality (compound)
lidocaine- both (cc:preconj)
drugs antidepressant (amod)
out-patients eighty-nine (nummod)
marked patients (nmod)
$ROOT$ follow-up (sent)
result have (advcl)
week 6 (compound)
reach dose (nmod)
insult of (case)
sensitive enables (conj)
= 4 (dep)
model treated (acl)
developed setting (nmod)
anemias drug-induced (amod)
perception altered (amod)
platelet in (case)
malignancy primary (amod)
carolina in (case)
disease fluctuating (amod)
hypnotic to (mark)
formed have (aux)
cases myopathy (nmod)
sedation facilitate (acl:relcl)
activation d2 (compound)
heart seventeen (nummod)
experience our (nmod:poss)
provide to (mark)
noted start (nmod)
nadir re-exposure (nmod)
ratio 4.4 (nmod)
depended which (nsubj)
remains when (advmod)
sodium of (case)
seen findings (nsubjpass)
210 of (advmod)
returning with (mark)
causes death (nmod)
doses both (det)
manifestation toxicity (nmod)
value adc (compound)
importance clinical (amod)
progress understanding (nmod)
8.9 0.5 (conj)
involved is (auxpass)
antiemetic prokinetic (conj)
evaluated tissue (nmod)
study double-armed (amod)
piroxicam , (punct)
decrease predominant (amod)
cells hemopoietic (amod)
microscopy immunofluorescence (conj)
decreased it (nsubj)
induced evidenced (advcl)
size oedema (conj)
found as (mark)
supported clinically (advmod)
use lamivudine (nmod)
function cause (acl:relcl)
pas ) (punct)
time days (nmod)
enhances formation (dobj)
incidence : (punct)
(1.8)% -10.8 (nummod)
manifests compound (nsubj)
properties coronary (amod)
effects gfc (compound)
activity single-agent (amod)
hippocampus and (cc)
secretion associated (acl)
elevated aminotransferase (nsubj)
resulted c (dep)
induce proteinuria (dobj)
has activity (dobj)
% 52 (nummod)
c-4-epimer the (det)
cases 41 (nummod)
anaesthesia from (case)
confounded ability (nsubjpass)
proteinuria treated (acl)
bw 50.0 (nummod)
gfap ros (conj)
phenotyping our (nmod:poss)
i.v , (punct)
safe method (conj)
0.2 ( (punct)
3/20 ) (punct)
assay immunity (nmod)
concerns neurotoxicity (nmod)
detected htr6 (nmod)
deficits two (nummod)
uncommon occurrence (nsubj)
has affected (conj)
event rare (amod)
used 1994 (nmod)
paclitaxel alone (advmod)
conducted analyses (nsubjpass)
haloperidol reserpine (conj)
finding was (cop)
tract upper (amod)
excretion protein (nmod)
stroke women (nmod)
showed evidence (dobj)
fpd ( (punct)
intoxications ) (punct)
rcts the (det)
worse significantly (advmod)
evaluation . (punct)
thrombocytopenia haemolysis (conj)
reverse effect (dobj)
used bacl2 (nmod)
diagnosis formal (amod)
smaller species (nmod)
contribute reversal (nmod)
stable . (punct)
10 or (cc)
predictive abuse (nsubj)
scans tomography (compound)
warranted profile (nmod)
sensitivity system (nmod)
administration sm-5887 (compound)
g 12.8 (nummod)
therapy sole (amod)
attributed morphine (nmod)
aimed test (xcomp)
investigate compared (advmod)
with not (neg)
drug patients (nmod)
$ROOT$ mass (sent)
received treated (parataxis)
albuminuria or (cc)
stabilizer no (det)
potassium sodium (conj)
intervals subsequent (amod)
process hyperprolactinemia (nmod)
following : (punct)
tissue bladder (compound)
pcp ) (punct)
period along (case)
scheduled and (cc)
identified however (advmod)
induced diclofenac (nmod)
compared effects (nsubj)
multiforme with (case)
effects cardiotoxicity (nmod)
awake . (punct)
induction methotrexate (nmod)
results examined (appos)
depends adenoribosylation (nmod)
1100 over (quantmod)
appeared severe (xcomp)
ng/dl. , (punct)
chamber white (amod)
1.76 ) (punct)
performed protocol (nsubjpass)
slowing stimulation (nmod)
myocarditis by (case)
fever argentine (amod)
study diphosphanilate (nmod)
aor ] (punct)
occurring sedations (nmod)
developed rat (nsubj)
surge of (case)
hz 3,000 (nummod)
developed symptoms (dobj)
increase co (nmod)
reduced addition (nmod)
biosyntheses mechanism (conj)
applied topically (advmod)
administered second (advmod)
greater 0.05 (nmod)
anxiogenic- depressant-like (conj)
failure neutropenia (conj)
combination hydrochloride (nmod)
s-312-d of (case)
visits follow-up (amod)
focus epileptic (amod)
underwent recordings (dobj)
caused that (mark)
receive rocuronium (dobj)
baseline hours (conj)
activity including (case)
toxicity against (case)
thickness the (det)
percentage inhibition (nmod)
derives changes (nmod)
associated somnolence (nmod)
dose disulfiram (nmod)
dose amisulpride (nmod)
predictors reduction (nmod)
hypoxia profound (amod)
published are (auxpass)
length mean (compound)
discovery original (amod)
caused only (advmod)
pathogen(s pre-therapy (amod)
cyclophosphamide drugs (nsubj)
loss in (case)
calculated using (xcomp)
4',7-dihydroxy-isoflavone ( (punct)
prevented will (aux)
characteristics patients (nmod)
d1-like da (nmod:npmod)
postulate we (nsubj)
disruption ppi (nmod)
objective achieve (acl)
severity dyskinesias (nmod)
resembles : (punct)
flush one (nmod)
measured evaluated (conj)
hypokalemia with (case)
increased gaba (dobj)
treatment pressure (nmod)
mg/m2 550 (nummod)
behaviors abnormal (amod)
moiety , (punct)
peptide of (case)
up-regulation days (nmod)
reassured be (auxpass)
2.1 and (cc)
reduced subjects (advcl)
mice reserpine-treated (amod)
attention extreme (amod)
remained mice (nsubj)
binding ( (punct)
recognized treated (conj)
d-glucarate a (det)
consistent involving (advcl)
pain nausea (conj)
screening cross-sectional (amod)
awaking night (nmod)
profile toxicity (compound)
properties ointment (nmod)
facilitated increase (nsubj)
days both (cc:preconj)
prevents dexmedetomidine (nsubj)
implicating erythromycin (dobj)
retard that (mark)
na(+)/k(+)-atpase nbc1 (conj)
associated deprivation (nmod)
exacerbations paranoid (amod)
reaction ax (nmod)
ii ( (punct)
analogue by (case)
assay trypan (compound)
due overdose (nmod)
curtailed , (punct)
hormone patients (nmod)
received progression (nmod)
have nephropathy (nmod)
responded well (advmod)
ng/ml 0.004 (nummod)
agonist 5-ht(1b/1d (compound)
had 23 (nsubj)
improvements percent (compound)
experienced days (nmod:tmod)
high mortality (nsubj)
clones all (det)
$ROOT$ study (sent)
ligand a (det)
using drug (dobj)
$ROOT$ began (sent)
regimen once-daily (appos)
injected saline (nmod)
impaired group (nmod)
obtained drug (nmod)
former mhb (compound)
21 % (appos)
evaluated dosed (advcl)
consistent studies (nmod)
seizure measured (acl)
combination haart (compound)
20 six (quantmod)
protect completely (advmod)
panel x (compound)
thrombo-embolism for (case)
concentration potassium (nmod)
approved administration (nmod)
reduction propofol (nmod)
insecticides of (case)
subtypes for (case)
tumours bladder (compound)
percent patients (appos)
increasing levels (dobj)
decrease threshold (dobj)
saline n=6 (dep)
symptoms group (nmod)
showed none (nsubj)
suggest pay (ccomp)
summarizes research (dobj)
cpa by (case)
observed anemia (nsubjpass)
examination any (det)
bcl-2/bax of (case)
forms cystitis (nmod)
cohort haart (compound)
activity adr (compound)
10(-5 10(-8 (quantmod)
important complications (nsubj)
diameter ) (punct)
capture an (det)
presented patients (nsubjpass)
learn response (dobj)
remarkable . (punct)
doses therapy (nmod)
act aminoglycosides (nsubj)
schizophrenic an (det)
has function (dobj)
undergoing lt (dobj)
abolished decrease (dobj)
determined assays (nmod)
lobe rat (compound)
immunostaining peroxidase-antiperoxidase (amod)
tmp ) (punct)
administered chloride (dobj)
reversible clinically (advmod)
microfilaremia in (case)
nitroprusside of (case)
role critical (amod)
important recognize (ccomp)
actions central (amod)
mumol ( (punct)
mrds ) (punct)
progression with (case)
women incontinence (nmod)
attain required (conj)
deep bis (dep)
value the (det)
delirium provide (dep)
reduction % (nmod)
reactions carbamazepine (nmod)
given but (cc)
transplants the (det)
maintenance phenotype (nmod)
implantation by (case)
benefits abstinence (nmod)
began improvement (nsubj)
mtx ara-c (conj)
unchanged a-actinin (nsubj)
% 71.0 (nummod)
wds ) (punct)
bladder gall (compound)
hr two (nummod)
ineffective dose (nsubj)
treatment chloramphenicol (nmod)
therapy endocrine (amod)
contributing monotherapy (nsubj)
remained that (nsubj)
minutes seconds (conj)
investigate coinciding (advcl)
receiving january (nmod)
increase correlates (nmod)
1 and (cc)
had recently (advmod)
be definitive (acomp)
syndrome syndrome (nsubj)
performed study (xcomp)
useful dexmedetomidine (nsubj)
investigated pci (nmod)
enhance pretreatment (nsubj)
response patients (conj)
interview affective (amod)
oxidase implicated (acl:relcl)
revealed fraction (dobj)
jitter blocking (conj)
$ROOT$ demonstrated (sent)
responses physiological (amod)
scale icu (compound)
protein 35 (nummod)
model abuse (nmod)
evident although (mark)
enhanced that (nmod)
functionality of (case)
found placentae (nsubjpass)
patients twenty-nine (nummod)
classified could (aux)
case new (amod)
isethionate pentamidine (compound)
to 10+/-1 (cc)
monitoring on (case)
undertaken stay (nmod)
ml/min/kg ( (punct)
estimated changes (nmod)
g/d 1.5 (nummod)
mrp2 ) (punct)
correlated was (auxpass)
response muscular (amod)
decrease torr (nmod)
infections pulmonary (amod)
camera gamma (compound)
confirmed examinations (nsubj)
associated eating (nmod)
done : (punct)
avoided have (aux)
age race (conj)
regimens several (amod)
effective use (nsubj)
paced which (nmod)
% 80 (nummod)
imaging to (case)
content appearance (conj)
remained accentuated (conj)
reduction hyperactivity (nmod)
staining iron (compound)
force and (cc)
hippocampus cortex (conj)
clonidine xylometazoline (conj)
caspase-3 caspase-8 (conj)
showed processes (nmod)
condition myotonic (amod)
implantation pacemaker (compound)
known quinine (nsubjpass)
ci 95 (amod)
days by (case)
three approximately (advmod)
stimuli noxious (amod)
hepatitis origin (nmod)
hepatocarcinogenicity rat (nmod)
antibodies n-methyl-d-aspartate (compound)
individuals these (det)
drugs acetaminophen (nsubj)
administration development (conj)
recommended instructions (nmod)
introduction or (cc)
trial h (compound)
conventional implant-supported (conj)
astrocytomas with (case)
attempt an (det)
vasodilator . (punct)
mbc with (case)
500 or (cc)
curves group (nmod)
daunorubicin . (punct)
1.6 i.v. (dep)
107 +/- (cc)
5,7-dihydroxytryptamine neurotoxin (compound)
contribute hyperactivity (nmod)
acc-9653 and (cc)
drowsiness dizziness (conj)
10 ( (punct)
by and/or (cc)
required anxiety (nmod)
concentrations arterial (amod)
current of (case)
model chemotherapy (compound)
$ROOT$ concentrations (sent)
presented pain (dobj)
necrosis bone (compound)
controls case (nmod)
18.88 1.48 (conj)
effect phn (nmod)
had indicating (advcl)
5.7 3.4 (dep)
increase mg/day (nmod)
cases death (nmod)
disease progressive (amod)
induced combinations (nmod)
microarrays and (cc)
disorders such (case)
evaluate should (aux)
occurred % (dep)
action ect (nmod)
formyltransferase glycinamide (compound)
expression models (nmod)
potassium k (appos)
return thresholds (compound)
included margin (nmod)
protocol effective (amod)
mg 0.55 (nummod)
60 and (cc)
correlates , (punct)
administered and (cc)
catechol metabolites (dep)
involvement severity (nmod)
observations from (case)
transaminase got (appos)
se after (case)
material intravenous (amod)
synthesized newly (advmod)
factor colony-stimulating (amod)
have ability (nmod)
enzyme decarboxylase (appos)
observations interacts (ccomp)
neurotoxin mg/kg (appos)
containing phenobarbital (dobj)
alter do (aux)
min 30.8 (nummod)
remained hour (nmod)
produce increase (dobj)
involvement rotation (nmod)
bupivacaine , (punct)
fluoroquinolones , (punct)
type according (case)
published first (advmod)
become which (nsubj)
associated increase (nmod)
relative switchers (nmod)
h2-receptors system (nmod)
delivered twice (advmod)
people among (case)
across within (conj)
filled 1999 (nmod)
evidence mechanism (nmod)
$ROOT$ approximate (sent)
assessing vivo (advmod)
infarction pregnancy (nmod)
erod ( (punct)
implanted were (auxpass)
involved medications (nsubjpass)
line control (appos)
exists information (nsubj)
pig in (case)
cellular mitochondrial (conj)
type -- (punct)
change pressure (nmod)
increments mean (amod)
contains renografin (nsubj)
asa ] (punct)
index number (conj)
interpreted be (auxpass)
accompany that (mark)
shown truncated (advcl)
days 2 (nummod)
presenting hypotension (nmod)
consistent were (cop)
bronchorrhoea , (punct)
date to (case)
flowmetry doppler (compound)
derive link (conj)
studies association (nmod)
val , (punct)
induced cardiomyopathy (nsubjpass)
exploration field (nmod)
value prophylactic (amod)
one piglets (nmod)
infusion lactate (nmod)
binding [3h]-naloxone (nmod)
nitroglycerin by (case)
resulted increasing (csubj)
participant the (det)
seems leveled (xcomp)
deprivation alone (advmod)
number alpha-motoneurons (nmod)
correlate recall (dobj)
cases additional (amod)
apo b-100 (dep)
delineated were (auxpass)
repair period (nmod)
g/dl 3.2 (nummod)
similar monotherapy (nmod)
impairment memory (compound)
d 30 (nummod)
g/ml groups (nmod)
administered amphetamine (nsubjpass)
had section (nmod)
demonstrated protection (nmod)
had bile (dobj)
occurred presence (nmod)
inconclusive suggested (conj)
recommended combining (advcl)
allocated fashion (nmod)
biopsies lymph (compound)
stimulation synthesis (nmod)
action than (cc)
khz at (case)
improvement dyskinesias (nmod)
enabling cope (xcomp)
= influx (conj)
year 51 (nummod)
mg 4 (nummod)
dm ( (punct)
ck ( (punct)
sites muscarinic (amod)
3.82 200 (conj)
index mean (compound)
trial one (nummod)
revealed hyperammonemia (nmod)
patients 3 (compound)
facilitate bradycardia (dobj)
syndrome a (det)
solution normal (amod)
having relatives (dobj)
determination with (case)
medicine in (case)
cholesterol ( (punct)
% 3/20 (dep)
given injections (nmod)
depression excitation (conj)
$ROOT$ outcomes (sent)
is hypothesis (nsubj)
restricted vessels (nmod)
sediment urine (compound)
induce ? (punct)
robust effect (nmod)
mg alone (advmod)
provocation pinch (appos)
breakdown , (punct)
msec ) (punct)
received carboplatin (dobj)
increased increase (nmod)
malondialdehyde mda (appos)
glycosuria phlorizin-induced (amod)
breaks ( (punct)
effect acetate (nmod)
hampered are (auxpass)
anesthetized given (conj)
presents paper (nsubj)
channel site (nsubj)
showed test (dobj)
responses airway (compound)
crea 35 (nummod)
hemorrhage submucosal (amod)
25 % (appos)
mice weeks (appos)
caused three (nsubjpass)
77 30 (quantmod)
caused mechanism (nmod)
raised values (nsubjpass)
more 21 (compound)
center rehabilitation (compound)
included bumetanide (dobj)
recognition any (det)
d-amphetamine effects (appos)
activities on (case)
performed monitoring (nsubjpass)
exposure donors (nmod)
6 or (cc)
cause however (advmod)
pharmaceuticals smithkline (compound)
ccl4 chcl3 (conj)
lowers . (punct)
had whole (nmod)
compound 1 (nummod)
session during (case)
considered factor (xcomp)
beck and (cc)
$ROOT$ examinable (sent)
health their (nmod:poss)
manifestations clinical (amod)
course during (case)
appear blockade (nsubj)
behavioral selective (amod)
mg/week to (case)
segment ecg (compound)
cultures the (det)
accumulation consequent (amod)
ag hbs (compound)
were series (attr)
disturbances enhanced (acl)
vmax the (det)
reviewed results (nsubjpass)
literature recent (amod)
forms various (amod)
$ROOT$ hypertension (sent)
iso-osmolar dimeric (dep)
preserved more (advmod)
study observational (amod)
antagonists , (punct)
cross-sensitization dose (nmod)
resembles that (nsubj)
properties pharmacodynamic (amod)
years over (case)
gemcitabine (d)1 (appos)
fire of (case)
analysis chemistry (nmod)
vasodilator effects (dep)
indicates scale (nsubj)
eligible thus (advmod)
dosing divided (amod)
threshold perimetry (conj)
recovered completely (advmod)
changes ecg (nmod)
d between (case)
found he (nsubjpass)
14 infection (nmod)
wall in (case)
inhibitor l-nil (dep)
characterized here (advmod)
reactions allergic (amod)
decreased except (prep)
expression glepp1 (compound)
pge1 ) (punct)
women hypercholesterolemia (nmod)
diffusion is (cop)
overdose to (case)
interaction tizanidine (nmod)
retains tamca (nsubj)
criterion combination (conj)
hj schumacher (compound)
readmitted he (nsubjpass)
accident cva (appos)
nanoparticle dxnp (appos)
mm pupils (nsubj)
therapy arabinoside (nsubj)
doses produced (acl:relcl)
exploration , (punct)
papilledema inexorable (amod)
releases neurons (dobj)
attack itself (appos)
reabsorption rate (conj)
cycloheximide pre-test (amod)
cytotoxicity in (amod)
level enzyme (nmod)
definition anemia (nmod)
progresses adenomyosis (nmod)
incidence vte (nmod)
$ROOT$ cyclosporine (sent)
different paramethasone (nmod)
help markers (nsubj)
created purpose (nmod)
receptors cholinergic (amod)
induced mg.kg(-1 (nmod)
shown tamca (nsubjpass)
year diagnosis (nmod)
cause hypotension (dobj)
effect encephalopathy (nsubj)
anemia caused (acl:relcl)
induced cavity (nmod)
level maximal (amod)
weakness vasospasm (nmod)
focusing findings (nmod)
testosterone of (case)
increased remained (advcl)
gtn hours (conj)
occlusion by (case)
arrhythmias and (cc)
hypercalcaemia of (case)
given cisapride (nsubjpass)
assessment lisinopril (nmod)
injection glioblastomas (nmod)
compared h (nmod)
apnoea reversal (appos)
mediators that (mark)
rigidity rat (nmod)
wk exposure (dep)
performed allografts (nmod)
7-ethoxyresorufin-o-deethylase erod (appos)
free carboplatin (nsubj)
female 83-year-old (amod)
blockade chronic (amod)
increased auc (nsubj)
established provided (conj)
syndromes pain (compound)
transferred , (punct)
diazepam pentylenetetrazol (conj)
therapy an (det)
findings histopathological (amod)
act tissue (nmod)
evaluation immunotherapy (nmod)
veratridine microm (appos)
treatment glaucoma (nmod)
eight cases (nmod)
amantadine by (case)
affecting arteries (dobj)
creatinine preoperative (amod)
clinics hospital (nmod:poss)
produced levels (nmod)
intakes folate (nmod)
complication but (cc)
data follow-up (amod)
improvements those (nmod)
values ed50 (compound)
widened week (nmod)
euthyroid both (cc:preconj)
functional is (cop)
reflect sensitization (dobj)
178 4 (conj)
packing and (cc)
class therapy (nmod)
plays . (punct)
aniracetam the (det)
staining 2,3,5-triphenyltetrazolium (compound)
therapy deferoxamine (nmod)
predicted may (aux)
30 to (case)
measurements , (punct)
showed agonist (nsubj)
lowered . (punct)
expected half-life (nmod)
numbers cells (nmod)
ratio concentration (nmod)
pdn prednisone (compound)
appears data (nmod)
40.8 +/- (cc)
remains identification (nsubj)
trait with (case)
hormone anti-diuretic (amod)
displayed expressions (dobj)
seen preoperatively (advmod)
mg additional (amod)
ratio renal (amod)
$ROOT$ complicated (sent)
noted administered (advcl)
area motor (compound)
circulations the (det)
necrosis resulted (acl:relcl)
epilepticus pilocarpine-induced (amod)
selecting therapy (dobj)
area m (nummod)
comparing chemotherapy (nmod)
hydrochloride antagonist (appos)
system to (case)
types the (det)
deafened monkeys (nsubjpass)
10.2 of (case)
symptomatic and (cc)
expression kidney (nmod)
mania antibiotic-induced (amod)
action dual (amod)
$ROOT$ explained (sent)
cancer analysis (dep)
178 ) (punct)
suggests and (cc)
benzoylecgonine or (cc)
was boy (attr)
529 11 (compound)
nuclei carcinomas (nmod)
reports reviews (conj)
proteinuria higher (amod)
strain rat (nmod)
diabetes type (compound)
lacking biomarkers (nsubj)
examined alterations (nmod)
metallothionein mt (appos)
secondary nephritis (nmod)
comprised vnb (nmod)
cephalothin and (cc)
acetyltransferase p (dep)
stimulation peptidergic (amod)
hypokalemia terbutaline-induced (amod)
trial haloperidol (conj)
marker markers (conj)
seen capillaries (nsubjpass)
morbidity associated (acl)
applied formers (nsubjpass)
low although (mark)
< p (nsubj)
density function (conj)
adducts and (cc)
variants . (punct)
effect warfarin (nmod)
woman trait (nmod)
is consensus (attr)
implicated should (aux)
enlarged days (nmod)
eyes patient (nmod:poss)
damaged astrocytes (nsubjpass)
depletor the (det)
indinavir , (punct)
induced indomethacin (nmod:npmod)
14 76 (nmod)
depletion tryptophan (compound)
number proliferation (conj)
caused verapamil (nmod)
doses viia (nmod)
returns thromboembolism (nmod)
post-administration days (compound)
anaesthesia normotensive (amod)
observed thrombosis (conj)
factor contributing (amod)
produced control (nmod)
may period (appos)
stimulated using (xcomp)
f in (case)
causing difficulty (dobj)
seen those (nmod)
introduction and (cc)
minimal respectively (advmod)
nephropathy = (dep)
contributed and (cc)
prove hand (nmod)
0.1 greater (amod)
achieved diagnosis (nsubjpass)
% 27 (nummod)
studied relationship (nsubjpass)
exhibited while (mark)
differentiated were (auxpass)
induced vasculitis (dobj)
showed inhibition (nmod)
degrees anaemia (nmod)
decrease with (case)
suggesting selection (dobj)
coma myxoedema (compound)
appeared , (punct)
antagonize tri (nsubj)
occurring together (advmod)
presence mellitus (conj)
shifting , (punct)
attended . (punct)
drugs nonselective (amod)
mg/kg 4.67 (nummod)
attended who (nsubj)
output emax (conj)
increases bp (nmod)
mechanisms molecular (amod)
subtle . (punct)
sheath , (punct)
evaluation health (compound)
environment with (case)
selegiline on (case)
enhanced possibly (advmod)
malformations lithium-induced (amod)
incidence paralysis (nmod)
increased cells (nmod)
eroded gain (nsubjpass)
everolimus , (punct)
availability assessment (nmod)
conditions various (amod)
$ROOT$ finished (sent)
$ROOT$ unrelated (sent)
rating mood (compound)
risk toxicity (nmod)
avoid us (nsubj)
value mmol/l (dep)
verapamil spironolactone (conj)
rides horses (dobj)
produced improvements (dobj)
similar mg/kg (appos)
aes gi (amod)
five ten (conj)
case primigravida (nmod)
loading during (case)
used chronically (advmod)
na/k-atpase aqp1 (conj)
measurement time (nmod)
patients cyclosporine-treated (amod)
increased microg.kg(-1 (nmod)
potentiate constipation (dobj)
saline all (conj)
normalized and (cc)
activity predominant (amod)
gr antagonist (appos)
mg value (dep)
linked actions (nsubjpass)
administered eye (nmod)
vaccine in-hospital (amod)
problems attention (compound)
113 from (case)
potassium body (compound)
background shown (dep)
lady 45-year-old (amod)
myalgia from (case)
associated state (nmod)
animals pf (compound)
decrease can (aux)
vulnerability regions (nmod)
population elderly (amod)
showed % (nmod)
achieved plasma (nsubjpass)
igf ( (punct)
switching binder (nmod)
characterized binding (nmod)
systemic mucosal (conj)
predictable reduction (nmod)
accompanied cardioprotection (nsubjpass)
fibers cardiac (amod)
indicated surgery (nmod)
dyskinesias apomorphine-induced (amod)
dysfunctions neurological (amod)
cells red (amod)
performed chemotherapy (nmod)
derivatives 1-(1,2-dihydro-2-acenaphthylenyl)piperazine (compound)
used that (mark)
estrogens mg/day (appos)
indicating attributable (ccomp)
humans in (case)
effects the (det)
index barthel (compound)
effects arrhythmias (nmod)
marrow with (case)
development effect (appos)
i.c.v ) (punct)
wounds burn (compound)
exposure to (case)
seizures death (conj)
cytoskeleton its (nmod:poss)
used only (advmod)
acid cis-ra (appos)
case published (amod)
pathophysiology associated (acl)
pharmacokinetics possibility (conj)
treated di (nsubjpass)
diet chloride (compound)
formed were (auxpass)
amount same (amod)
two more (conj)
hg/l/min 15.1 (nummod)
site that (mark)
edema angioedema (nsubj)
differences midazolam (nmod)
transplanted institution (nmod)
pgi2 urinary (amod)
seems moreover (advmod)
toxicity an (det)
medication only (amod)
carbonate beta-blockers (conj)
administration ketanserin (compound)
that metrifonate (nmod)
induced animals (nmod)
possible but (cc)
infections endocarditis (nmod)
reversed and (cc)
mtd the (det)
number considerable (amod)
resolved mris (nmod)
series tests (nmod)
enlargement and (cc)
urea plasma (compound)
developed necrosis (dobj)
ineffectiveness because (case)
a. group (compound)
produced which (nsubj)
period washout (compound)
effects a (nmod)
30 more (conj)
dehydrogenase levels (dep)
extracted rhei (nmod)
level deficit (conj)
dyskinetic , (punct)
proves oxitropium (nsubj)
applied model (dobj)
confined strictly (advmod)
represent less (ccomp)
translocations t(9:22 (compound)
antigens or (cc)
infarction a (det)
long-term . (punct)
risks relative (amod)
hydrobromide drug (appos)
pain patients (nmod)
occur activity (nmod)
paradigms between (case)
worsened received (advcl)
findings imaging (compound)
regimen controlled (amod)
impact development (nmod)
groups transplant (compound)
observed proteinuria (nsubjpass)
tie2-cre;loxp-egfp endothelial (amod)
literature incidence (nmod)
$ROOT$ fact (sent)
precise not (neg)
presence erythrocytes (nmod)
mmol deficit (nsubj)
reported substrate (ccomp)
patients 7 (dep)
models in (case)
aed a (det)
compared drugs (nmod)
schedule ; (punct)
11.8 2.7 (quantmod)
calculated longitudinal (nsubjpass)
consumers heavy (amod)
methylphenidate with (case)
comparing motility (nmod)
monitor detection (conj)
strain but (cc)
stopped is (auxpass)
proportion highest (amod)
hypertension mild (amod)
leiden and (cc)
= 7 (dobj)
miss to (mark)
mechanism hepatotoxicity (nmod)
studied patients (nsubjpass)
alfentanil kg-1 (appos)
hcrh ) (punct)
clubs characteristic (amod)
development insipidus (nmod)
experienced neutropenia (dobj)
na(+)/k(+)-atpase oat (conj)
ml/100 0.5 (compound)
outcomes evaluation (nmod)
timolol ) (punct)
allows , (punct)
functional morphologic (conj)
used agent (nsubjpass)
sleep on (case)
sites on (case)
present incontinence (nmod)
produces convulsions (dobj)
finding a (det)
caused scopolamine (nmod)
consisted nephropathy (nsubj)
h the (det)
$ROOT$ regarded (sent)
advanced locoregionally (advmod)
$ROOT$ unremarkable (sent)
alteration cellular (amod)
allografts in (case)
groups following (amod)
studied was (auxpass)
reverse did (aux)
necessary transfusion (nsubj)
bp > (amod)
frequency across (case)
cta ed (nmod)
option it (nsubj)
recognition syndrome (nmod)
diagnosis patients (nmod)
detrusor the (det)
display to (mark)
responses two (nummod)
enzyme cox (compound)
chemotherapy agressive (amod)
frequency defects (nmod)
production deletion (conj)
preinfusion : (punct)
supports frequency (dobj)
set experiments (nmod)
help results (nsubj)
tested provocation (nmod)
cells sirolimus (compound)
cause they (nsubj)
filled who (nsubj)
diameter mm (appos)
test 480-mg (amod)
thrombophlebitis ) (punct)
phenacetin both (cc:preconj)
breast the (det)
changes progressing (amod)
receiving transplantation (nmod)
stopped time (nmod)
treated when (advmod)
examination count (nmod)
amount in (case)
syndrome aids (appos)
cells in (case)
p=0.001 ( (punct)
treatment coenzyme (compound)
involved development (nmod)
enzyme . (amod)
activity loreclezole (nmod)
recruited method (dep)
shifts predominance (nmod)
compared results (nmod)
40,000 30,000 (compound)
scan on (case)
included h. (nmod)
repeated instillation (nsubjpass)
group 3-hydroxy (compound)
cases including (case)
behaviors neuropsychiatric (amod)
diarrhoea . (punct)
details , (punct)
chemosensitivity of (case)
isolated rats (nmod)
cyclophosphamide chlorambucil (conj)
distribution ischemia (nmod)
had 8 (nsubj)
years 5 (nummod)
mouse in (case)
conformed patient (nsubj)
threat a (det)
ci=25.2 95 (amod)
unresolved increases (advcl)
beginning the (det)
stenosis to (case)
mr underlying (amod)
remained due (csubj)
system insulin-receptor (compound)
participating . (punct)
female old (amod)
showed scans (nsubj)
nystagmus nin (appos)
7-ethoxyresorufin-o-deethylase of (case)
presynaptic postsynaptic (conj)
cardiomyocytes adult (amod)
difference sides (nmod)
tolerance to (case)
incidence but (cc)
toxic be (cop)
week two (nummod)
given metoprolol (nsubjpass)
administration ( (punct)
routes administration (nmod)
stimulation , (punct)
living county (nmod)
inhibition nigra (nmod)
asynergy during (case)
clotiazepam to (case)
causes elevates (conj)
renoprotective . (punct)
resolved delirium (nsubj)
chp cent (amod)
tonus dopaminergic (amod)
elevation to (case)
remains she (nsubj)
5days/week 0.5mg/kg (nummod)
injected locally (advmod)
syndrome antiphospholipid (amod)
correlation slope (nmod)
bias of (case)
analyzed concentration (nmod)
dosage duration (appos)
dose compound (compound)
mg h (nmod:tmod)
hypoxia and (cc)
tubule in (case)
deletion pair (compound)
information further (amod)
death tissue (nmod)
result injury (nmod)
drug and (cc)
instillation vincristine (compound)
continuing addition (conj)
demonstrate findings (nsubj)
cardiac renal (conj)
conditions hyperkalaemia (nmod)
ecg oximetry (conj)
expression elevated (amod)
potent it (nsubj)
$ROOT$ features (sent)
pod 4 (nummod)
referral hospitalization (conj)
fire anthony (nmod:poss)
potentials visual (amod)
surveillance gynaecological (amod)
aspirin dipyridamole (conj)
using database (dobj)
prostigmine ) (punct)
suppressed circumstances (nmod)
caused monkeys (nmod)
= . (dep)
hunt hess (conj)
stones retrieved (acl)
years 60.8 (nummod)
inflammation capsule (nmod)
likely likely (xcomp)
diltiazem micrograms/kg/min (appos)
questionnaires and (cc)
nested population (nmod)
mg 1 (nummod)
nifedipine of (case)
ce target (compound)
incapacity of (case)
certain stimulated (dep)
use mannitol (nmod)
anesthesia i.v. (amod)
sheath introducer (compound)
demonstrated ; (punct)
experienced syndrome (dobj)
median g/day (nmod)
sedation memory (conj)
infection japan (nmod)
acetaminophen chloroform (conj)
width a (det)
prevention hospitals (nmod)
vehicle- and (cc)
binding sites (nmod)
developed while (mark)
$ROOT$ addition (sent)
explanation any (det)
patients hyperlipidemia (nmod)
episode tdp. (nmod)
hour 18 (compound)
pressure maximum (amod)
treatment are (cop)
prescribed tmp-smz (dobj)
responses bold (amod)
events > (amod)
suppress expression (dobj)
urine their (nmod:poss)
complex acid (compound)
growth retarded (amod)
5.9 - (dep)
activator acetyltransferase (compound)
been background (dep)
statin ) (punct)
shortened whereas (mark)
hg mg (compound)
measured ; (punct)
recommended discuss (ccomp)
uncertain pattern (nsubj)
therapy toxic (acl:relcl)
seeing of (mark)
instances some (det)
$ROOT$ dysphonia (sent)
mg/kg day (nmod:npmod)
arrest metoclopramide (nmod)
is decade (conj)
stimulus in (case)
immunity humoral (amod)
outcome visual (amod)
iso ) (punct)
myelosuppression toxicity (nsubj)
20,40,60 and (cc)
pharmacodynamics receptor (compound)
rated additionally (advmod)
objective describe (appos)
beneficial not (neg)
incidence neuropathy (nmod)
produce pretreatment (nsubj)
decreased increased (conj)
dystrophy in (case)
hyperactivity spontaneous (amod)
nausea patients (appos)
efficacy mutants (nmod)
profile this (det)
nephroprotectant combination (nmod)
measured fpd (nsubjpass)
seizures cocaine-kindled (amod)
measured ccb (nsubjpass)
incidence owing (case)
boy 11-year-old (amod)
severe partial (conj)
cr(edta ) (punct)
referred unit (nmod)
expressions type (nmod)
reversed administration (nsubj)
delivery during (case)
intervals prolonged (amod)
agents efficacy (nmod)
cystitis developed (amod)
diseases latent (amod)
ptz ) (punct)
ability synthesize (acl)
sensitivities ratios (conj)
dissociated . (punct)
review hepatotoxicity (nmod)
use setting (nmod)
nmol 1.5 (dep)
based . (punct)
stress (vcm)-induced (amod)
fluctuations by (case)
associated damage (nsubjpass)
encephalopathy ) (punct)
complication treatment (nmod)
flumazenil by (case)
administration intraarterial (amod)
presence to (mark)
developed measure (xcomp)
discontinued performed (parataxis)
background aims (conj)
bches ) (punct)
reduction number (conj)
patient suffering (acl)
located aneurysms (nsubjpass)
29th and (cc)
alf failure (nsubj)
model but (cc)
application widespread (amod)
non-drug alcohol/nicotine (appos)
induced suppression (dobj)
impaired also (advmod)
dense electron (nmod:npmod)
suggesting seen (ccomp)
mechanisms related (amod)
hepatitis patient (nmod)
tolerable easier (conj)
selected patients (nsubjpass)
site lesion (nmod)
noted phase (nmod)
sarcolemma of (case)
class comparator (compound)
cases uveitis (nmod)
associated medications (nmod)
mice sgk1(+/+ (compound)
relationship probable (amod)
necrosis bridging (amod)
rr=1.60 ci (dep)
dose q (nmod)
receptor a2 (compound)
fall concentrations (nmod)
followed induction (nsubjpass)
improvement resolution (conj)
role ce (nmod)
beta t (compound)
destructive more (advmod)
developed rigidity (dobj)
pa in (case)
nausea dizziness (conj)
tumors experimental (amod)
attacks the (det)
abundance alpha-enac (nmod)
suppressed levels (nsubjpass)
spironolactone mg/d (appos)
76 x (cc)
lowered significantly (advmod)
microscopy with (case)
alterations parameters (nmod)
secretion potassium (compound)
drug effective (amod)
serum-albumin and (cc)
< 2 (nummod)
reabsorption fractional (amod)
p9201 ) (punct)
showed remains (advcl)
5-fluorouracil plus (cc)
higher were (cop)
maximum when (advmod)
diuretics thiazide (compound)
deterioration of (case)
patients infarction (nmod)
pupils his (nmod:poss)
tam ) (punct)
smaller p<0.001 (dep)
included measurements (nsubj)
fhf and (cc)
deterioration cerebral (amod)
1/8 ) (punct)
mass ck-mb (compound)
antibodies monoclonal (amod)
recognition object (compound)
rats bupivacaine- (compound)
monoarticular pauciatricular (conj)
regimens of (case)
ratio treatment (nmod)
cause delayed (advcl)
320/12.5 and (cc)
found 5-htp (nsubjpass)
6/15 2/60 (conj)
underlie impairments (dobj)
abusers heroin (compound)
nausea with (case)
modulation phenomena (nmod)
vt or (cc)
injections nucleus (nmod)
deviation silent (amod)
9.4 to (case)
need management (nmod)
given questionaires (nsubjpass)
anaesthesia and (cc)
tendency the (det)
differences dose (nmod)
muscarinic , (punct)
n'-diisopropylphosphorodiamidofluoridate n (compound)
tests other (amod)
dyskinesia limbs (nmod)
dementia alzheimer-like (amod)
$ROOT$ suspect (sent)
$ROOT$ attack (sent)
rate x/minute (appos)
presence ethanol (nmod)
lethality coniine (compound)
predictors function (nmod)
therapy high-dose (amod)
4.10 . (punct)
using beginning (advcl)
variations [na]o (nmod)
learning consolidation (conj)
presence its (nmod:poss)
causes involvement (dep)
medication group (conj)
blocking addition (dep)
tested part (nmod)
had overflow (nmod)
trial assess (acl:relcl)
seven , (punct)
event reported (amod)
fk506 tacrolimus (appos)
symptom-free were (cop)
targeting membrane (nmod)
induced trazodone (nsubj)
severity co-morbidity (conj)
events 3 (nummod)
were signs (attr)
dimension posterior (amod)
% 66+/-11 (nummod)
$ROOT$ regained (sent)
complication agent (nmod)
mg/d placebo (conj)
second- or (cc)
vindesine vds (appos)
$ROOT$ postponed (sent)
b nfkappab (appos)
anaemia haemolytic (amod)
resistant diastase (nmod:npmod)
x-ray by (case)
$ROOT$ neurotoxicity (sent)
attend to (mark)
common had (parataxis)
describe to (mark)
had paralleled (conj)
women menopausal (amod)
evidenced symptomatology (nmod)
% compared (case)
impaired is (aux)
19.2 9 (conj)
showed dnap (nsubj)
( sd (conj)
sem sem (nmod)
medication diphenylhydantoin (compound)
n-methyl-n-nitrosourea mg/kg (appos)
contribute mechanisms (nmod)
250 and (cc)
pilocarpine , (punct)
holding weight (dobj)
ceased . (punct)
introduction gradual (amod)
studies systems (nmod)
reported widely (advmod)
correlated incidence (nmod)
asa given (acl)
12-week 3- (quantmod)
included comparison (nmod)
evaluations trial (compound)
hyperalgesia on (case)
attenuate lower (conj)
with ph (dep)
examined ultrasonography (nmod)
august between (case)
function initial (amod)
studies metabolic (amod)
enalapril was (cop)
percentage mitochondria (nmod)
tetrabenazine mg/day (appos)
incapacitated were (auxpass)
importance association (nmod)
unpleasant : (punct)
function graft (compound)
60 174 (prep)
response stimulation (nmod)
analysis cohort (compound)
pathways of (case)
formed case (nmod)
effects its (nmod:poss)
collection cell (compound)
reported none (conj)
utilizes assay (nsubj)
evoked thus (advmod)
absorb drug (dobj)
subjects nondependent (amod)
filling ventricular (amod)
injection from (case)
reappearing briefly (advmod)
mg/kg (-)-cibenzoline (nmod)
site habitual (amod)
stimulation following (case)
doses 4 (nummod)
dosing during (case)
guide therapy (dobj)
nuclei structures (appos)
mg/day 40 (nummod)
impaired conversion (nsubj)
feared , (punct)
alphabeta-crystalin and (cc)
7.5 15 (conj)
immunosuppressive both (cc:preconj)
diagnoses no (det)
potentiation antagonism (conj)
developed hit (dobj)
treated carbamazepine (nmod)
shown sgk1 (nsubjpass)
nephritis with (case)
whether inhibition (nsubj)
dfu piroxicam (conj)
risks equivalent (amod)
therapy n-butyl-deoxynojirimycin (nmod)
hypercholesterolemia moderate (amod)
conditions other (amod)
acid saccharic (amod)
affect that (nsubj)
syndrome fanconi (compound)
low cigarettes (dep)
daunorubicin study (dep)
induced addition (nmod)
efficient : (punct)
form drug (nmod)
withdrawn % (nsubj)
doses corticosteroids (nmod)
increases deficiency (nsubj)
spikes large (acl:relcl)
suspected thus (advmod)
schizophrenia in (case)
gains popularity (dobj)
heart ( (punct)
brigham hospital (conj)
3 9 (conj)
units cryoprecipitate (nmod)
examined analysis (nmod)
effect uncoupling (amod)
artery human (amod)
vehicle injections (conj)
order detect (acl)
reduces mesna (nsubj)
concentrations sulfate (nmod)
nephropathy . (punct)
memory verbal (amod)
sutures mattress (compound)
hemolysis therapy (nmod)
subarachnoid and (cc)
emergence the (det)
supine pressure (dep)
percentage subjects (nmod)
taking initiated (parataxis)
recognition consumption (compound)
swelling protrusion (conj)
occurrence syndrome (nmod)
published had (aux)
higher synthesis (nsubj)
rats 20-day-old (amod)
rigidity severe (amod)
inhibited action (dobj)
stimuli areas (conj)
seen complication (nsubjpass)
days ; (punct)
completed users (nsubj)
vpa than (case)
confirm not (neg)
events thrombotic (appos)
factors presumable (amod)
inhibition ppi (appos)
response failure (nmod)
had ratio (dobj)
performed develop (advcl)
administration prevent (acl)
mice controls (conj)
measured substances (nmod)
detected 19 (nmod)
elsewhere brain (nmod)
sections the (det)
investigated are (aux)
implicated cardiotoxicity (nmod)
frequent nausea (dep)
different ratio (nmod)
initiated rose (advcl)
after days (conj)
reflexes baroreceptor (compound)
h 20 (nummod)
complexes the (det)
behavioral electrophysiological (conj)
ibuprofen especially (advmod)
assessed study (nsubj)
step final (amod)
properties amplifier (nmod)
sprague-dawley and (cc)
katona 1986 (nummod)
periods washout (compound)
that origin (nmod)
levels identical (amod)
performed load (nsubjpass)
led recurrence (nmod)
450 to (dep)
5 50 (compound)
1.35 ( (punct)
number glomerulosclerosis (conj)
focus a (det)
prevalent asia (nmod)
in but (cc)
method that (mark)
mumol/l of (case)
pneumonitis effusions (conj)
liver atrophy (conj)
recipient male (amod)
effects neurotensin-induced (amod)
performed assessment (nsubjpass)
background analyzed (appos)
indians groups (conj)
myoclonus . (punct)
therapies salvage (compound)
complication populations (nmod)
hilus within (case)
showed inhibition (ccomp)
placebo subjects (appos)
fulfilled . (punct)
cases remaining (amod)
diagnosis presumptive (amod)
halos blurring (conj)
1.37 : (punct)
along controls (nmod)
formation polyglutamates (nmod)
chromosome ) (punct)
group propranolol (compound)
stands drug (nmod)
prox-1 for (case)
toxicity high-dose (amod)
ratio 5.04 (appos)
useful blocks (nsubj)
changes include (acl:relcl)
indol-2-one dro-1h- (compound)
property nimodipine (nmod)
compensated . (punct)
observed time (nmod)
comorbidity common (amod)
memory memory (conj)
levonorgestrel ( (punct)
0.04 0.05 (conj)
became standard (attr)
case encephalopathy (nmod)
aspects several (amod)
rubella ( (punct)
profiles antipsychotics (nmod)
blockers sucralfate (conj)
deficits greater (amod)
metabolites less (conj)
ml(-1 or (cc)
ratios weight (compound)
release stress (conj)
probability a (det)
galantamine overall (advmod)
< , (punct)
controls hg (dep)
effects terbutaline (nmod)
indicated abnormality (dobj)
layer wall (nmod)
use vincristine (compound)
cardiotoxicity isoproterenol-induced (amod)
patients 246 (nummod)
stable may (aux)
g 1 (nummod)
tissue sino-atrial (amod)
score induced (acl)
rate beats/min (appos)
acid injected (acl)
effects retention (compound)
neuronal glial (conj)
decreases significantly (advmod)
hours few (nummod)
work cardiac (amod)
mechanisms to (case)
reduction cardiomyocytes (nmod)
society normotensive (amod)
hypertension levels (conj)
intervals regular (amod)
interpretation pathogenetic (amod)
process in (case)
drug alone (advmod)
aprotinin and (cc)
that to (case)
investigated act (ccomp)
vt ( (punct)
showed % (ccomp)
goal program (compound)
infection viral (amod)
present especially (advmod)
insecticides organophosphorus (compound)
therapy misoprostol (compound)
decrease pressure (nmod)
discontinued administration (nsubj)
g/dl 2.2 (nummod)
p10 ) (punct)
pbsct of (case)
mice dba/2 (compound)
showed acid (nsubj)
littermates their (nmod:poss)
mol/l and (cc)
region inguinal (amod)
toxocity fzp (compound)
mg/day 1.25 (nummod)
tumors although (mark)
mg/kg 6.25 (nummod)
loss induction (conj)
rtms of (case)
toxicity schedule (nmod)
glomerulonephritis necrotising (amod)
venous cvp (appos)
candidiasis oral (amod)
when she (nsubj)
hypothesis increase (ccomp)
narrowing coronary (amod)
septal for (case)
inefficient is (cop)
ms/mg 0.140 (nummod)
fall pressures (nmod)
amiodarone atazanavir (conj)
induction inhibition (conj)
assessment preliminary (amod)
throat a (det)
preparations acetaminophen (nmod)
treatment sarcoma (nmod)
effect dose-limiting (amod)
were medication (nsubj)
potentiated n. (punct)
determined samples (nmod)
positivity troponin (compound)
overstimulation by (case)
patterns of (case)
$ROOT$ project (sent)
neck of (case)
warn complications (nmod)
2-(p-bromophenyl)propionate 3alpha-tropyl (compound)
454 received (acl:relcl)
relationship close (amod)
level reduced (amod)
state , (punct)
schizophrenia acute (amod)
deficiency oxide (compound)
objective evaluated (dep)
fatalities reported (amod)
response neurotoxic (amod)
cause nephritis (nsubj)
concentrations various (amod)
2.17 0.66 (compound)
spaces vascular (amod)
intestine liver (conj)
administered measuring (advcl)
risk correlative (amod)
complications perinatal (amod)
increased catalepsy (nsubjpass)
encoding memory (conj)
dogs denervated (acl:relcl)
bradykinesia particularly (advmod)
force for (case)
ability cardiomyocytes (nmod)
ccnu ( (punct)
incidence the (det)
5 range (dep)
show : (punct)
death 30-day (amod)
treated protocol (nmod)
2e1 p450 (compound)
evaluated damage (nsubjpass)
rigidity side-effect (appos)
efficacy therapeutic (amod)
matched 1:4 (parataxis)
feeding amounts (nmod)
impairment mitochondria (nmod)
decayed minutes (nmod)
hypopharynx cavity (conj)
diets on (case)
implicated but (cc)
dogs additional (amod)
addition . (punct)
deviation this (det)
cpa diazepam (conj)
months 37 (nummod)
altering distribution (dobj)
similar subjects (nmod)
agents have (aux)
distal branches (nmod)
predict may (aux)
require not (neg)
acc-9653 for (case)
evening the (det)
growth no (neg)
ms ( (punct)
protect neurones (dobj)
hus adults (nmod)
factors x (conj)
remains affecting (ccomp)
performed therapy (nmod)
pathways kinase (compound)
remission , (punct)
assessed exposure (nsubjpass)
tomography with (case)
mg 30 (nummod)
nodules erythematous (amod)
studied therefore (advmod)
treatment use (nsubj)
increased therapy (nmod)
microg with (case)
correlated statistically (advmod)
random-assignment , (punct)
higher somewhat (advmod)
weight kg (appos)
edema aracytine-c (nmod)
killed then (advmod)
accomplished was (auxpass)
age etiology (conj)
vomiting patients (nmod)
production erythroid (amod)
showed embryopathy (dobj)
stimuli related (amod)
ulcer and (cc)
studies preliminary (amod)
begun protein (nsubj)
threshold hindpaw (nmod)
presentation poisoning (nmod)
events and (cc)
leaves as (xcomp)
involving subjects (dobj)
controls all (det)
stopping diagnosis (nmod)
reversible all (nsubj)
achieved dose (advcl)
analgesia postoperative (amod)
% 32.4 (nummod)
shown hypokalaemia (dobj)
sotalol , (punct)
air temperature (nmod)
factor that (nsubj)
occurs that (mark)
spasm . (punct)
pills control (compound)
patients 1,340 (nummod)
pharmacokinetics pharmacodynamics (conj)
suggest altered (ccomp)
grs ) (punct)
asymptomatic may (aux)
at2r renal (amod)
eyes perfusion-cultured (amod)
processed images (nsubjpass)
percent 91 (nummod)
areas tubulointerstitial (amod)
ly274614 by (case)
neurons medulla (compound)
17beta-estradiol progesterone (conj)
recommenced min (nmod)
treated gemcitabine (nmod)
reviving specially (advmod)
metformin with (case)
tool is (cop)
worsening the (det)
hcfcs ) (punct)
experienced recovery (dobj)
cases milder (amod)
mutants lam-resistant (amod)
surmountable . (punct)
lesion severe (amod)
returned had (aux)
tolerability safety (conj)
neutralizes metabolite (dobj)
junctions altered (amod)
sensitized : (punct)
regulated receptor-alpha (nmod)
response that (mark)
allow prognosis (nmod)
3.3 ) (punct)
linked sensitive (conj)
incontinence . (punct)
myonecrosis associated (acl)
developed developed (advcl)
inhibition solely (advmod)
processes central (amod)
diuretic potassium-conserving (amod)
1637 taking (acl)
cases an (det)
acetaminophen for (case)
days four (nummod)
classified responded (advcl)
have tumor (dobj)
antibiotics for (case)
hormone inappropriate (amod)
felt reduced (conj)
prescribed population (nmod)
antagonist fr (dep)
modification state (nmod)
center academic (amod)
ranged age (nmod)
support potential (dobj)
nodules liver (nmod)
sacrificed day (nmod)
gave history (dobj)
effect modulators (nmod)
motion in (case)
mild or (cc)
ratio control (compound)
characterized syndrome (nsubjpass)
child hypothermic (amod)
prodrug liver-targeting (amod)
processes synthesis (conj)
neuropathy report (appos)
men demonstrated (acl:relcl)
compared formulation (nmod)
hypertrophy . (punct)
10 out (advmod)
estimates current (amod)
trials , (punct)
developed frequently (advmod)
weaker ( (punct)
nimodipine intravenous (amod)
performed loading (nmod)
patients months (appos)
infection viruses (nmod)
characterization events (nmod)
cancer : (punct)
levels extracellular (amod)
decrease incidence (nmod)
enhance extent (nmod)
suggested increase (nmod)
parkinsonian-like tardive (conj)
ko in (case)
participant one (nummod)
i aconitase (conj)
evident later (advmod)
developed dehydration (dobj)
association time (compound)
occurred until (mark)
attempted and (cc)
man 61-year-old (amod)
sessions 4 (nummod)
americans million (nummod)
developed whilst (mark)
solution a (det)
potentiated epinephrine (nmod)
become approach (attr)
treated drug (nmod)
reproducibility volunteers (nmod)
detecting for (mark)
received group (advcl)
surgery bypass (compound)
$ROOT$ mediated (sent)
hyperhidrosis hypersalivation (conj)
pain throat (compound)
opioid illicit (amod)
normal were (cop)
ranged and (cc)
drugs accompanying (amod)
effort minimize (acl)
rare syndrome (nsubj)
recovered and (cc)
developing % (nmod)
change any (nmod)
evaluation cardiac (amod)
excretion with (case)
emphasize danger (dobj)
account into (case)
describe unmasking (dobj)
had twin (nsubj)
occurred > (parataxis)
studies ii (nummod)
blocks to (case)
found but (cc)
fanconi 's (case)
alleviate can (aux)
labeled-positive dutp (nmod:npmod)
short-term , (punct)
features because (case)
beta 1/2 (nummod)
abuse of (case)
$ROOT$ maintained (sent)
requirements . (punct)
times = (dep)
identified increases (nsubjpass)
area percent (nmod)
necessary may (aux)
tolerant replicating (advcl)
woman health (nmod)
age temperament (conj)
compared curves (nsubjpass)
micrograms placebo (conj)
resulted neutralization (nmod)
utilized model (nmod)
well-tolerated , (punct)
exerts system (nmod)
mmp-2 p<0.01 (dep)
characterized model (nsubjpass)
than children (nsubj)
phn ) (punct)
effects arrhythmogenicity (nmod)
developed papillomas (nsubj)
dyskinesia stress (conj)
days then (advmod)
capacity similar (amod)
contribution minor (amod)
15 30 (conj)
results stress (appos)
studies conduction (compound)
measurements three (nummod)
study one (nummod)
$ROOT$ nephrolithiasis (sent)
observed cerebella (nmod)
hyperalgesia ( (punct)
microg/kg/min adjusted (acl)
receiving weeks (nmod:tmod)
development independently (advmod)
diazepam dose (dep)
case reaction (nmod)
$ROOT$ ingesting (sent)
develops and (cc)
diltiazem of (case)
mechanism(s molecular (amod)
effect tincture (nmod)
had range (nmod)
synthesis endogenous (amod)
drugs antituberculosis (amod)
protects dysfunction (nmod)
play epileptogenesis (nmod)
all indices (nmod)
inhibited injection (nmod)
3.54 1.30 (compound)
times 2.7 (compound)
microg/kg , (punct)
amplitude low (amod)
vessels around (case)
resulted reduced (conj)
time mg/kg (appos)
cholestasis treatment (nmod)
ef in (case)
hypokinesis inferior (amod)
evidence 2-adrenoceptors (nmod)
levels proteinuria (nmod)
dcm ) (punct)
investigations prevention (conj)
30 3 (conj)
$ROOT$ detection (sent)
found contrast (nmod)
or concomitantly (advmod)
alterations consumption (conj)
significant time (nsubj)
alf asia (nmod)
identify mechanisms (dobj)
soon cessation (nmod)
action the (det)
puncture guided (amod)
number the (det)
uterus immature (amod)
effects endometrial (amod)
resistance demands (conj)
level serum (compound)
syndrome to (case)
agent acid-mimetic (amod)
pretreating challenge (nmod)
gd 21 (nummod)
amisulpride tiapride (conj)
lys1 [ (punct)
men cancer (nmod)
use verapamil (nmod)
drug metabolite (conj)
aphasia limbs (nmod)
detectable . (punct)
changes size (nmod)
respiration of (case)
thought syndrome (nsubjpass)
event relevant (amod)
patients infection (nmod)
increased or (cc)
amino-nucleoside puromycin (compound)
appeared number (nmod)
reserpine intraperitoneal (amod)
arrhythmias for (case)
obtained protection (nsubjpass)
findings patients (nmod)
robust was (cop)
21 and (cc)
inhibition ne-mediated (amod)
age myocardiopathy (conj)
represent lesions (nsubj)
arrest case (appos)
ethanol of (case)
admitted ) (punct)
12 10 (quantmod)
subject this (det)
elements common (amod)
man old (amod)
interval ci (appos)
ischemia of (case)
increase parkinsonism (nmod)
labetalol of (case)
january 2001 (nummod)
prevent does (aux)
lesion 5,7-dht (compound)
reye the (det)
ampicillin with (case)
spect on (case)
suggest produces (ccomp)
improvements scores (conj)
proliferation hemopoietic (amod)
reduce pain (dobj)
prolactin high (amod)
characteristic decrease (nmod)
starting setting (nmod)
six over (quantmod)
precursor dopamine (compound)
margin doses (nmod)
resources psychological (amod)
cause the (det)
produced media (nmod)
characterized shunting (nmod)
delivery at (case)
initiated trial (dobj)
flaccid animals (nsubj)
individuals 5 (nummod)
consumption paracetamol (compound)
feeling catheter (dobj)
users 8,000 (nummod)
time given (acl:relcl)
review practical (amod)
$ROOT$ depends (sent)
evaluated catalepsy (nsubjpass)
times/week ( (punct)
describe , (punct)
vnb plus (cc)
use pill (nmod)
polymerase antigen (conj)
detectable months (nmod)
biochemical the (det)
received cannulae (nmod)
calculated they (nsubj)
doses even (advmod)
levels glutathione (nmod)
interaction peptides (nmod)
6 number (nsubj)
scarce data (nsubj)
acquainted clinicians (nsubj)
department hospital (compound)
failure syndrome (nmod)
length velocity (conj)
carried investigate (xcomp)
consistent was (cop)
l-alpha-gfc p.o. (advmod)
d-med 3 (dep)
cr metabolic (amod)
volumetry cerebellum (nmod)
infarction with (case)
treated schedule (nmod)
received training (nmod)
outcome primary (amod)
na(+)/k(+)-atpase and (cc)
reabsorption fluid (nmod)
electroretinograms standard (amod)
potency in (case)
influence , (punct)
effect a (nmod)
turnover brain (nmod)
[na]o on (case)
form structured (amod)
evaluated therapy (nmod)
mass ventricular (amod)
asa mg/kg (appos)
occurs arterioles (nmod)
preceded retention (dobj)
quetiapine between (case)
rare a (det)
volume circulating (amod)
rotation the (det)
or separately (advmod)
bortezomib of (case)
measured balances (nsubjpass)
3.10 and (cc)
interleukin cytokine (compound)
appeared nodules (nmod)
noted acting (advcl)
thickness calibre (conj)
killed which (nsubjpass)
noted animals (nmod)
demonstrating occur (ccomp)
reduce diminishing (advcl)
reverse activation (nsubj)
classified were (auxpass)
directed heart (nmod)
patterns exposure-response (compound)
target angiogenesis (nsubj)
peak decline (conj)
discuss mechanisms (dobj)
woman this (det)
volume urine (nmod)
identified eliminating (advcl)
stimulated apoptosis (dobj)
days separate (amod)
pulmonary renal (conj)
lindane ) (punct)
was time (nsubj)
hypokalemia decrease (conj)
increased this (nsubjpass)
pain neuropathic (amod)
areas diseased (amod)
carrier as (case)
group gastrointestinal (compound)
centre to (case)
map also (advmod)
result apoptosis (nmod)
associated levels (nmod)
foci proliferation (nmod)
suggest to (mark)
defect a (det)
suspicion clinical (amod)
alteration , (punct)
reduced % (nmod:npmod)
svc veins (dep)
myeloma mm (appos)
peptide plasma (compound)
deemed cases (nsubjpass)
toleration : (punct)
haematuria microscopic (amod)
noted not (neg)
count 1000/mm3 (appos)
126 3 (conj)
mixture primarily (advmod)
1.63 -0.64 (compound)
were groups (advcl)
patients volunteers (conj)
gm and (cc)
absence due (case)
benzodiazepines , (punct)
activities phosphatase (compound)
carried occurs (advcl)
treatment in (case)
ouabain by (case)
similar assessed (advcl)
affect increase (conj)
writing of (case)
consistent hepatitis (nmod)
cardiomyocytes stem (compound)
induced pacing (nmod)
nrvms ( (punct)
although importance (nmod)
donor was (cop)
participates formation (nmod)
factor no (det)
agent to (mark)
used cases (dobj)
found pallidus (nmod)
women 11 (nummod)
cyp ) (punct)
schedule according (case)
myopathy associated (acl)
was demonstrate (xcomp)
affected may (aux)
agents vii (dep)
socs-1 cis (conj)
limbs his (nmod:poss)
surface pial (amod)
demonstrated elsewhere (advmod)
dysfunction nonorganic (amod)
elevated days (nmod)
demonstrates induces (ccomp)
transaminase glutamate-pyruvate (compound)
ctni ctnt (conj)
3tc and (cc)
normochromic anemia (nsubj)
recovery neutrophil (compound)
hyperprolactinemia experimental (amod)
patients had (dep)
controls u/ml (dep)
alpha-t ( (punct)
eeg findings (conj)
supplemented was (auxpass)
7h6 for (case)
abolished vocalization (dobj)
secretion factor (nmod)
cause doses (nmod)
function concentration (nmod)
required residues (nsubjpass)
removed another (nmod)
effect long-term (amod)
telaprevir statins (conj)
ninety-nine in (case)
arrhythmia pvc (nmod)
examination electrodiagnostic (amod)
status society (compound)
but significantly (advmod)
unable exercise (xcomp)
mitochondria specifically (advmod)
supplement contribute (acl:relcl)
received lozenge (dobj)
cyclophosphamide anthracyclines (conj)
hyperactivity cell (compound)
increase on (case)
decreasing and (cc)
lesions carious (amod)
interval during (case)
worsening neurological (amod)
% < (appos)
failure lesions (conj)
biopsy gastrocnemius (appos)
infused premedication (nmod)
cyclohexyl]benzeneactemide ) (punct)
rhinitis spring (amod)
0.03 1.0 (conj)
use use (conj)
effects blockers (nmod)
began escalated (conj)
gram-positive atypical (conj)
made assessments (nsubjpass)
stereotypies induced (acl)
day-1 at (case)
relevant treatment (nmod)
subset an (det)
developed infarction (dobj)
comment adequate (amod)
diagnosis amyloidosis (appos)
occurred microangiopathy (nsubj)
$ROOT$ stem (sent)
responsible effect (nmod)
groups independent (amod)
ward peripheral (amod)
effect amiloride (nmod)
abnormalities infiltrates (conj)
reticulata nigra (nmod)
participants study (nmod)
decreased presentation (nmod)
pathway the (det)
abundant , (punct)
death cell (compound)
docetaxel to (case)
preceded were (auxpass)
imaging fmri (appos)
refused treated (conj)
rate parameters (nmod)
choice atra (nsubj)
have infection (nmod)
received test (nmod)
true same (nsubj)
flatulence pain (conj)
auc total (amod)
adriamycin adr (appos)
due likely (advmod)
alterations severe (amod)
reported date (nmod)
hours ipratropium (nmod)
eu was (cop)
describes article (nsubj)
effective that (mark)
control pair-fed (conj)
expression be (cop)
sensitivity low (amod)
ng/ml 11.2 (nummod)
experienced results (nsubj)
dechallenge after (case)
women epileptic (amod)
facilitated rats (nmod)
have rate (nmod)
0.6 0.06 (conj)
findings present (amod)
isomer.6 than (case)
factor women (nmod)
blockers channel (compound)
showed recently (advmod)
seizures cocaine-induced (amod)
recordings bundle (compound)
consequence may (aux)
tomography coherence (compound)
resulted incidence (nmod)
suffer who (nsubj)
discharged patient (nsubjpass)
17 ) (punct)
leiden for (case)
developed fashion (nmod)
replacement pellet (dep)
glomerular early (amod)
increased control (nmod)
socs-1 reflect (acl:relcl)
median 5.3 (nummod)
is background (dep)
appear exacerbated (conj)
range 75 (appos)
scale of (case)
interest wide (amod)
paco2 arterial (amod)
g/kg ( (punct)
similar tensions (nsubj)
25 and (cc)
one nephropathy (nsubj)
interaction human (amod)
relationship with (case)
administration vitamin (compound)
induction streptozotocin (nmod)
reported study (nmod)
pelvis associated (acl)
function platelet (compound)
microgram/ml more (amod)
i.v. intravenously (advmod)
1.44+/-0.6 ( (punct)
hit for (case)
incriminated frequently (advmod)
clarification further (amod)
beneficial patients (nmod)
iohexol metrizoate (conj)
2 or (cc)
reversed facilitated (conj)
model impairment (compound)
attenuated 2 (meta)
show however (advmod)
form patients (nmod)
profile erythromycin (nmod)
contributes lead (conj)
pressure excretion (conj)
conclusions increased (appos)
use continuing (amod)
pallidotomies the (det)
prevented given (advcl)
identify whether (mark)
acid n10-propargyl-5,8-dideazafolic (amod)
core the (det)
channels glibenclamide-sensitive (amod)
dyskinesia moderate (amod)
centers several (amod)
liver . (punct)
cells encircling (amod)
period 1-year (compound)
exposure halothane (nmod)
involved suggested (advcl)
increase recent (amod)
highlight and (cc)
mmol/day 17 (nummod)
adherence between (case)
ex-mdma ( (punct)
defined increase (nmod)
ketamine bolus (dep)
days twenty (nummod)
increased age (nmod)
girl the (det)
evaluate transit (dobj)
supporting thus (advmod)
physician emergency (compound)
candidates treatment (nmod)
exceeds 5 (dep)
absorption . (punct)
presented complaints (nmod)
advised monitoring (nsubjpass)
prevent level (nmod)
1.1 ( (punct)
degrees severe (amod)
avoided either (preconj)
decreased further (advmod)
carcinomas and (cc)
transplanted worldwide (advmod)
satisfied 106 (nsubj)
susceptible damage (nmod)
mechanisms disorders (nmod)
prescribing medications (dobj)
few only (advmod)
sensitivity ci (appos)
fk506 with (case)
used involved (conj)
development strain (nmod)
cgs micrograms (appos)
choreoathetosis : (punct)
function cardiac (amod)
adjustment or (cc)
tolerant less (advmod)
experiencing symptoms (dobj)
taken intervals (nmod)
function human (amod)
showed indicating (advcl)
exposure further (amod)
levels decreased (amod)
outcome an (det)
treatment adr (compound)
estimated we (nsubj)
sensations tingling (amod)
represented idiosyncrasy (dobj)
pain eye (nmod)
indolamines the (det)
$ROOT$ rechallenge (sent)
nm 17.0 (nummod)
manifestation behaviors (nmod)
adenocarcinoma a (det)
showed , (punct)
ineligible which (nmod)
assessed combination (nmod)
reviewing family (nmod)
derivatives oversulfated (amod)
synthesis secretion (conj)
score measure (nsubj)
mg/kg ketamine (nmod)
marketed months (nmod)
lower different (conj)
exerts diphenylhydantoin (nsubj)
later min (dep)
transfusion therapy (conj)
pregnancies uncomplicated (amod)
returned remained (conj)
induced induced (conj)
erythematosus from (case)
excluded be (auxpass)
625 or (cc)
infusion occurred (acl:relcl)
diseases autoimmune (amod)
synthesis : (punct)
levels tnfalpha (compound)
prolonged treatment (nmod)
injections haloperidol (nmod)
ns-718 ) (punct)
reduction due (case)
administered min (nmod:tmod)
hospitalization ) (punct)
inhibited resulting (advcl)
discovering from (mark)
suggested ; (punct)
either hours (dep)
tmax and (cc)
suffer morbidity (dobj)
ci 12.1 (nummod)
attribute played (acl:relcl)
potentiation catalepsy (nmod)
sulindac with (case)
dosing mg/m(2 (compound)
result rotation (nsubj)
schedule ifosfamide (nmod)
acidosis tubular (amod)
bound , (punct)
involvement selective (amod)
drug for (case)
compound of (case)
$ROOT$ disturbances (sent)
5 11 (conj)
respond well (advmod)
phenotype debrisoquine (compound)
cis-platinum , (punct)
groups these (det)
3.4 1.1 (compound)
induced disulfiram (nmod)
compared most (nmod)
probe polymorphism (nmod)
substitutes as (case)
activity adrenergic (amod)
t30 ( (punct)
apposition and (cc)
numbness of (case)
stl1 the (det)
csf ( (punct)
higher reached (dep)
mg/m2 dose (parataxis)
monitored and (advmod)
fits concentration (nmod)
urticaria angio-oedema (conj)
patients palsy (nmod)
vip to (case)
accounted was (auxpass)
seems responsible (xcomp)
concentrations the (det)
used alfentanil (nsubjpass)
mechanism hypersensitivity (compound)
tumor associated (acl)
mucosa the (det)
remain unknown (xcomp)
expression fas (nmod)
induced change (dobj)
testing repeat (amod)
state indicating (acl)
sedation dexmedetomidine (nmod)
bradycardia arrest (conj)
cerebral of (case)
return accompanied (acl)
regimen cancers (nmod)
improvement by (case)
lost one (nsubjpass)
sequelae adverse (amod)
grades intraventricular (amod)
etoposide to (case)
ldl aggregated (amod)
prolactin testosterone (conj)
strategies treatment (compound)
considered treatment (nmod)
month the (det)
db ( (punct)
failure respiratory (amod)
acc-9089 ( (punct)
preference % (appos)
propose here (advmod)
computers office (compound)
use amiodarone (compound)
effects testosterone (nmod)
toxicity extent (conj)
dosages various (amod)
convulsant endogenous (amod)
targeted ; (punct)
seven to (quantmod)
detachment by (case)
performed histology (nsubjpass)
abolished . (punct)
levels bfgf (nmod)
voltammetry detection (conj)
training of (case)
years 8.4 (nummod)
amount total (amod)
suggested remains (conj)
anesthesia hypotension (conj)
address . (punct)
dogs treated (acl)
elevated ng/ml (nmod)
animals infarction (nmod)
spect ( (punct)
ways different (amod)
day cycle (nmod)
requirement percentage (compound)
lead could (aux)
beta-adrenoblocking action (conj)
anesthesia and (cc)
using ratios (dobj)
disease epicardial (amod)
definitive effect (nmod)
volume increased (amod)
cortex kidney (compound)
consists program (nsubj)
< all (dep)
complex chain (nmod)
ingesting 2 (nsubj)
eligible dse (nmod)
mean readmission (nmod)
fetus her (nmod:poss)
. i.v.c (nmod:npmod)
action thiopental (nmod)
socs3 increased (amod)
developed two (nsubj)
consider acetaminophen (dobj)
serious potentially (advmod)
5-ht 5-hiaa (conj)
mediate programming (nsubj)
rate % (nmod)
examined study (nmod)
leading discontinuation (nmod)
treatment symptomatic (amod)
aspects of (case)
lower expression (nsubj)
decrease levels (dobj)
material included (dep)
caries mouth (appos)
underwent protocol (nmod)
rats gunn (compound)
ml mg/50 (nummod)
subtle often (advmod)
agents seizure-inducing (amod)
agents coagulation (conj)
receptors orl1 (compound)
linked activation (nsubjpass)
describe discuss (conj)
falls , (punct)
f2 classical (amod)
received symptoms (nmod)
large very (advmod)
cpa ( (punct)
toxicity 5 (appos)
cse non-hydrolyzable (amod)
1 is (cop)
search central (amod)
predicting for (mark)
development ulcers (nmod)
s-1 derivative (appos)
association this (det)
effect its (nmod:poss)
available descriptions (nsubj)
isocortical and (cc)
applied doses (nmod)
alteration imaging (nmod)
evident relationship (nsubj)
converted acc-9653 (nsubjpass)
pk ) (punct)
exerts lithium (nsubj)
phase off (amod)
diet % (appos)
effects differential (amod)
admission trauma (compound)
$ROOT$ anesthetic (sent)
[na]o ( (punct)
wk 2 (nummod)
osmolality or (cc)
group-2 in (case)
0.05 +/- (cc)
cirrhosis liver (compound)
determined elisa (nmod)
antibacterials of (case)
group -placebo (dep)
is assess (xcomp)
associated may (aux)
treated anthracycline (nmod)
sirolimus by (case)
group bcnu-exposed (amod)
bilirubin serum (compound)
site abdominal (amod)
$ROOT$ immunopathology (sent)
60 30 (conj)
had effective (conj)
agonist cholinergic (amod)
activities enzymes (nmod)
administration training (nmod)
testosterone plasma (compound)
2 ( (punct)
have years (nmod)
participants age (appos)
processes memory (compound)
levels hb (compound)
correlated reversibility (nmod)
considered suitable (xcomp)
associated myopathy (nsubj)
demonstrated hypertension (dobj)
spastic coronary (amod)
ccl4 galactosamine (conj)
possibility increases (ccomp)
dosage maximum (amod)
influenzae . (punct)
combination containing (acl)
absent and (cc)
described recently (advmod)
activation transient (amod)
received dose (dobj)
antibody membrane (compound)
epilepticus p45 (appos)
accumulation [125i]mibg (nmod)
monitoring holter (compound)
clarified not (neg)
plays na (nsubj)
less p (dep)
stimulating beta (nmod:npmod)
stabilize for (mark)
prevention infarctions (nmod)
appear pig (nsubj)
4.0 nearly (advmod)
pathways neuroinflammatory (amod)
bp upregulation (conj)
secondary hyperactivity (nmod)
usage aspirin (nmod)
palsies temporary (amod)
abstinence of (case)
rose sexes (nmod)
% 48+/-4 (nummod)
oxprenolol mg (nummod)
lipophages fat (nmod)
cause b (dep)
animals cocaine-injected (amod)
useful studies (nsubj)
fluoxetine paroxetine (conj)
experienced men (nsubj)
utility detecting (acl)
back-diffusion and (cc)
deficit because (case)
used methods (nsubjpass)
ended recruitment (nsubj)
been increased (conj)
edition third (compound)
restricted ) (punct)
svr ) (punct)
triggers azathioprine (nsubj)
toxicity amiodarone (compound)
discontinued indinavir (nsubjpass)
arteries mater (nmod)
treatment tinnitus (nmod)
biomarker be (cop)
syndrome on (case)
stage hoehn (compound)
nelarabine with (case)
endothelial-mesenchymal-transition endomt (appos)
symptom as (case)
isomerase prostaglandin (compound)
origin the (det)
model diabetic (nmod)
indicate development (dobj)
mice cba/ca (compound)
haloperidol plus (cc)
developed alive (parataxis)
caused congenita (nsubjpass)
constitutes challenge (dobj)
indicated = (parataxis)
progress involve (xcomp)
mesna alone (advmod)
ingesting hydrochloride (dobj)
populations within (case)
factors i (dep)
rats sd (amod)
treated cause (advcl)
models putative (amod)
antimuscarinic centrally (advmod)
assessed scale (nmod)
model mimic (acl:relcl)
variable distribution (nsubj)
desire were (cop)
remained free (acomp)
increased administration (nsubj)
cisplatin mg/m(2 (appos)
indicates disorders (ccomp)
chloroquine with (case)
done biopsy (nmod)
antagonist mice (nmod)
treated trimester (nmod)
microl/side ) (punct)
49 them (nmod)
intake suppressants (nmod)
increase paco2 (nmod)
non-drug nd (appos)
effects gvg (nmod)
diabetic streptozotocin-induced (dep)
scenario clinical (amod)
4.8 +/- (cc)
utero in (compound)
ascites greater (amod)
berlin universitaetsmedizin (compound)
1.0 . (punct)
represent entity (dobj)
described , (punct)
adjustment age (nmod)
selective full (conj)
response svr (appos)
ketamine , (punct)
assigned raloxifene (nmod)
na/k-atpase , (punct)
paracetamol acetaminophen (appos)
diagnosed total (nsubjpass)
alt and (cc)
neuropathy sensory (amod)
adequate detect (xcomp)
bladder into (case)
required signaling (nsubjpass)
avoided are (auxpass)
antithrombosis tet (nmod)
co-administration nefiracetam (nmod)
compound acid (appos)
incidence at (case)
control groups (dep)
study assess (acl:relcl)
signs ' (punct)
commencing using (xcomp)
helodermin , (punct)
induces lithium (nsubj)
pathologies in (case)
% 4.8 (nummod)
subgroup because (case)
died days (nmod)
$ROOT$ acts (sent)
doses between (case)
mitochondria rats (nmod)
inhibits synthesis (dobj)
concentration pilsicainide (nmod)
words read (acl)
anemia attributed (acl:relcl)
possesses and (cc)
evidence promotes (ccomp)
factor alpha-atrial (amod)
risk 3.86 (dep)
cells putative (amod)
androgen and (cc)
levels . (punct)
t180 ) (punct)
use type (conj)
parameters related (amod)
2.9 3.7 (conj)
affect shortened (parataxis)
benefited 19 (dobj)
output on (case)
confines the (det)
immunohistochemistry for (case)
discovered podocytes (nmod)
parkinson the (det)
changes injections (nmod)
matter subcortical (amod)
used fentanyl (nsubjpass)
changed domains (nmod)
portion the (det)
reported should (aux)
administration igf-il-3 (nmod)
improved . (punct)
micrograms/dl 40 (nummod)
methods conducted (appos)
alleviate content (nsubj)
polymorphism ) (punct)
comparison hypotension (nmod)
antigen inos (compound)
catheter and (cc)
disappeared completely (advmod)
gluconate with (case)
receptors postsynaptic (amod)
cimetidine ranitidine (conj)
vnb ( (punct)
months 16 (nummod)
have channels (nsubj)
dwi but (cc)
level with (case)
79 98 (prep)
valdecoxib pooled (amod)
concentrations trough (compound)
measured chickens (nmod)
890 up (advmod)
seen studies (nmod)
vitro evaluation (conj)
alpha-mediated that (mark)
reduce selection (nsubj)
percent 15 (nummod)
doubled increased (conj)
component a (det)
expression ligand (nmod)
haloperidol substance (nmod)
patients thresholds (nmod)
-19.20 ) (punct)
report administration (nmod)
attribute might (aux)
absence in (case)
recipients nephropathy (nmod)
monoher and (cc)
effects extent (nmod)
fraction % (dep)
shr conscious (amod)
nf-m nf-h (conj)
technique non-invasive (amod)
activity in (amod)
90/htn ) (punct)
therapy neuroleptic (amod)
accumulation depression (conj)
lesions active (amod)
level high (amod)
organelle mitochondria (nsubj)
exchange prednisone (conj)
ed-1 , (punct)
higher similar (advcl)
extent in (case)
antagonists h1 (compound)
treatment mm (nmod)
resistance retention (conj)
compare patterns (dobj)
doses mg/day (nmod)
test finger-to-nose (compound)
change given (advcl)
min 300 (nummod)
area ( (punct)
antagonists potent (amod)
postulated enhanced (ccomp)
function his (nmod:poss)
received past (nmod)
indicate suggest (punct)
patency circuit (nmod)
syndrome pcos (appos)
loss kanamycin-induced (amod)
victim young (amod)
syndrome or (cc)
protocol atra (nmod)
prevented are (auxpass)
effect locomotor (amod)
findings dwi (compound)
circle the (det)
sensitive mice (nsubj)
water simultaneously (advmod)
develop importantly (advmod)
take drug (dobj)
factor growth (compound)
equal 3 (nmod)
dose weight (appos)
required this (nsubj)
taken indicator (nmod)
examination kidney (nmod)
1.54 1.65 (nmod)
parameters quantitative (amod)
31 7 (conj)
socs-1 , (punct)
underwent pbsct (dobj)
withdrawn admission (nmod)
chemotherapy neuropathy (conj)
antidepressant related (amod)
exhaustion to (case)
estimated response (nsubjpass)
recovery infusion (nmod)
course results (conj)
berlin at (case)
dyskinesias during (case)
24.4 6.0 (conj)
force no (det)
fsgs progressive (amod)
thought initially (advmod)
minimal-type and (cc)
margin along (case)
alterations mitochondrial (amod)
pretreated iprindole (nmod)
differences to (case)
administration prochlorperazine (nmod)
findings cranial (amod)
association chemotherapy (nmod)
provide quality (dobj)
> of (case)
effects abbott-53693 (nmod)
disruption for (case)
activity induction (appos)
aprotinin for (case)
produces impairment (dobj)
prednisone and (cc)
index respiratory (amod)
negative test (nmod:npmod)
blood and (cc)
induced point (nmod)
13 of (advmod)
methods treated (appos)
cystitis : (punct)
20 0.25 (compound)
xo ( (punct)
7 and (cc)
p=0 048 (dobj)
hypotension abolished (acl:relcl)
histories because (case)
response reference (amod)
gemcitabine ; (punct)
deprivation of (case)
hospital riyadh (nmod)
msec 40 (nummod)
deletion receptor (nmod)
reuptake the (det)
bisoprolol to (case)
mmhg ) (punct)
divided groups (nmod)
incidence eps (nmod)
organelles , (punct)
cholestasis progressive (amod)
99 of (case)
$ROOT$ rectified (sent)
change medication (nmod)
discontinuous more (advmod)
required demonstrate (xcomp)
quantitative additive (dep)
had they (nsubj)
background causes (appos)
performance with (case)
preventing myoclonus (dobj)
d1 with (case)
weight infarction (nmod)
saline- apigenin-treated (conj)
history exclusive (amod)
ampicillin amp (appos)
erythroderma and (cc)
meritorious exist (conj)
became studies (nmod)
powered however (advmod)
blocked can (aux)
prior training (nmod)
kidney tdf (compound)
reduce if (mark)
tremor clonus (conj)
edema disintegration (conj)
polyneuropathy with (case)
foci with (case)
received since (mark)
result blockade (nmod)
problem production (compound)
blockade uptake (compound)
size begin (acl:relcl)
responses increase (dep)
controls untreated (amod)
observed post-administration (nmod)
arthrogryposis coniine-induced (amod)
third-generation second-generation (conj)
group od (compound)
decreased aminoglycosides (nsubj)
found adults (nmod)
had mutations (dobj)
mg/dl 154 (nummod)
proliferation in (case)
sensitive that (nsubj)
tests available (amod)
bought and (cc)
interfere that (mark)
evidence neurophysiological (amod)
conducted assess (xcomp)
nicotine mg/kg (appos)
vision , (punct)
severe moderate (amod)
formula by (case)
model score (nmod)
cortical duct (conj)
intubation of (case)
than bupivacaine (nmod)
cognitive and (cc)
hours in (case)
discussion reported (dep)
peroxide plasma (compound)
cortex primary (amod)
factor atpase (conj)
antibiotic , (punct)
converts rat (nsubj)
frequent cardiomyopathy (nsubj)
less timolol (nmod)
network involving (acl)
destroy to (mark)
dna cells (nmod)
had ve (nsubj)
syndrome wolff-parkinson-white (compound)
catecholamines sedatives (conj)
option may (aux)
number provided (acl:relcl)
published study (nsubjpass)
as test (nsubj)
seizures forebrain (nmod)
necrosis to (case)
selective more (advmod)
concentrations neurotransmitter (compound)
possibility mechanism (nmod)
progression in (case)
oltx after (case)
pathways micturition (compound)
cefonicid cefazedone (conj)
anophthalmia microphthalmos (conj)
evaluated injury (nsubjpass)
loss diabetics (nmod)
kidney , (punct)
discontinued treatment (dobj)
occur because (mark)
curve cgrp (compound)
produce induced (advcl)
sodium alendronate (compound)
nucleoside analogue (conj)
rofecoxib ibuprofen (conj)
extremities distal (amod)
prevented atorvastatin (nsubj)
observed antigens (nsubjpass)
increased severity (dobj)
alterations , (punct)
induce blocked (advcl)
ht combined (amod)
factor-alpha increased (amod)
revealed % (nmod)
corticosteroids glycerin (conj)
vinorelbine administered (acl)
mm 17.5 (nummod)
identified registry (nsubj)
loss cochlear (amod)
awake revealed (conj)
beats/minute 65 (nummod)
sg145r and (cc)
onset epileptic (amod)
adrenaline ) (punct)
objective determine (acl)
increased similar (advcl)
treated flumazenil (nmod)
neurosis , (punct)
diet mg (amod)
volume scr (conj)
tobramycin and (cc)
hypertension model (nmod)
recovery natural (amod)
tools pd (nmod)
studies designed (amod)
% 26.5 (nummod)
months respectively (advmod)
develop can (aux)
control saline (appos)
acted co-carcinogen (nmod)
suggested necessary (ccomp)
assessed times (nmod)
received dexamethasone (dobj)
vasculitis associated (acl)
disease congenital (amod)
hypothesized is (auxpass)
shedding , (punct)
induced locomotion (dobj)
findings light (amod)
fall the (det)
detected response (nsubjpass)
mmol regained (acl:relcl)
siadh associated (acl)
basis syndrome (nmod)
silent clinically (advmod)
work-up laboratory (compound)
underwent discovered (conj)
assessment transplant (nmod)
estimated patients (xcomp)
sparing with (case)
normal returned (advcl)
examinable . (punct)
rate tumor (compound)
aureus catarrhalis (conj)
tuberculosis lung (nmod)
known cause (xcomp)
partial complex (conj)
nephritis allograft (nmod)
climbing apomorphine-induced (amod)
effective utility (conj)
group olanzapine (compound)
complained myalgia (nmod)
seed grape (compound)
induction role (conj)
operated anesthesia (nmod)
acne , (punct)
$ROOT$ unchanged (sent)
antidepressants suggested (acl)
developed pneumonitis (nsubj)
investigates study (nsubj)
field and (cc)
change whereas (mark)
doses selected (amod)
mosmol/kg mosmol/kg (nmod:npmod)
had children (nmod)
ic in (case)
shown amifostine (nsubjpass)
influences activity (nmod)
prevented amnesia (dobj)
finding on (case)
ranged mg. (nmod)
prevent myalgia (dobj)
prolongation tdp (conj)
condition cranial (amod)
, and (cc)
2.6 . (punct)
q of (case)
nitroglycerin agents (conj)
patients course (nmod)
detected complex (nmod)
chloramphenicol of (case)
use apnoea (nmod)
strains inbred (amod)
duration treatment (nmod)
dodds and (cc)
generation % (nmod)
listed effect (nmod)
neutrophils in (case)
cellulose gm (conj)
suggest risk (ccomp)
systems disease-like (amod)
prazosin by (case)
> inhibition (dep)
chest open (amod)
safe effective (conj)
efficacy antitumor (compound)
haloperidol or (cc)
243.4 and (cc)
microalbuminuria of (case)
reflex initiated (acl)
shows and (cc)
related loss (nmod)
test products (dobj)
influence abolition (nsubj)
evaluation decompression (nmod)
related that (nsubj)
calculi of (case)
chloroacetaldehyde and (cc)
lesions kidney (compound)
convulsion first (amod)
stimulation transcranial (amod)
has infarction (nmod)
treatment enalapril (nmod)
secondary damage (nmod)
site burn (compound)
level total (amod)
reaction well-recognized (amod)
randomization at (case)
requires investigation (dobj)
evaluate efficacy (dobj)
changes after-before (appos)
communication in (case)
dependent a (nmod:npmod)
history , (punct)
discontinued warfarin (nsubjpass)
syndrome ( (punct)
regained occurred (conj)
modafinil mg (conj)
twin other (amod)
mechanism epilepsy (nmod)
protein gla (compound)
hexamethonium or (cc)
inhibited induce (conj)
revealed increase (dobj)
incidence effects (nmod)
ecgs from (case)
remained lowered (advcl)
caffeine , (punct)
patients seventy-nine (nummod)
cause score (nmod)
resolved lesions (nsubj)
premedication and (cc)
calcification but (cc)
trials reviews (conj)
anuria patient (nmod)
au ( (punct)
undergone emergently (advmod)
site na+-binding (amod)
infused she (nsubjpass)
response anesthetic (amod)
infrequent and (cc)
levels cis-ra (compound)
dose amiodarone (nmod)
caused ouabain (nmod)
epithelium urinary (amod)
university , (punct)
type . (punct)
plasma thyroid (conj)
content protein (compound)
infarcts reticulata (nmod)
preparations obsolete (amod)
> % (dep)
practice , (punct)
mg 1500 (nummod)
analyses uni- (amod)
effective both (preconj)
called analysis (xcomp)
antidotes intoxication (nmod)
medium iodixanol (appos)
rash . (punct)
effects cardiovascular (amod)
5 more (amod)
recorded activity (nmod)
activity nervous (amod)
course chemotherapy (compound)
administered males (nmod)
frequently 4.5-times (advmod)
5.6 ( (punct)
) of (case)
tonic clonic (conj)
august since (case)
patients p (dep)
signified improvement (nmod)
dose lowering (advcl)
normal otherwise (advmod)
quetiapine of (case)
centre molecule (nmod)
recognized so (mark)
drug whatever (dep)
$ROOT$ found (sent)
injected cocaine (nmod)
staff of (case)
doses kg-1 (nmod)
tended a (nmod)
detected also (advmod)
neoplasms rats (nmod)
weak she (nsubj)
curves the (det)
either or (cc)
use anti-inflammatory (amod)
seems involved (ccomp)
ganglia the (det)
communicated incident (nsubjpass)
complications vascular (amod)
+/- dbh (nmod:npmod)
risk standard (amod)
25mg/kg day (nmod)
1 of (case)
intralipid or (cc)
inpatients treated (acl)
years 2.6 (nummod)
cystitis erosive (amod)
size , (punct)
effective annuloplasty (nsubj)
11.3 +/- (cc)
produced alterations (dobj)
score to (mark)
cancers human (amod)
nitroprusside sodium (compound)
concentrations pollutant (compound)
excess smaller (amod)
demonstrated 31 (nsubj)
acid between (case)
indistinguishable those (nmod)
bradyarrhythmia requiring (acl)
participants naive (amod)
tablet 1 (nummod)
self-limiting effects (nsubj)
persisted . (punct)
woman seventy-eight-year-old (amod)
cytokine mouse (compound)
elicits exposure (nsubj)
signs contralateral (amod)
output ( (punct)
dysfunction arterial (amod)
pentoxifylline with (case)
seen alterations (nsubjpass)
ritanserin of (case)
5ht2a and (cc)
ug 150 (nummod)
patients met (acl:relcl)
48 - (punct)
association polychemotherapy (nmod)
pressure temperature (conj)
rats g (nmod)
initiation chemotherapy (nmod)
continued available (advcl)
restored inhibiting (advcl)
factors triggering (amod)
belonging groups (nmod)
nerve recurrent (amod)
phase patients (nmod)
hyperprolactinemia during (case)
mechanism different (amod)
troponins cardiac (amod)
induced antibiotics (nmod)
centers referral (compound)
series from (case)
believed mechanism (nsubjpass)
reported reviewed (conj)
n-methyl-d-aspartate , (punct)
heart dog (compound)
greater 1.041 (dep)
enhanced observed (parataxis)
developed hypothyroidism (nsubj)
cured . (punct)
showed simulations (nsubj)
treatment intensive (amod)
resistant monkeys (nsubj)
assigned was (advcl)
gap bench-to-bedside (compound)
similar variations (nsubj)
achieved days (nmod)
goal national (amod)
exacerbated coagulopathy (dobj)
= 4.18 (dobj)
fails that (mark)
report treated (advcl)
hz ) (punct)
crude exposure-adjusted (conj)
reduction least (advmod)
cells progenitor (compound)
determined responses (nsubjpass)
inhibition cyclase (compound)
equipotent effects (nsubj)
g 10 (nummod)
offer can (aux)
and vivo (advmod)
vasodilator marked (amod)
findings striking (amod)
striatum controls (nmod)
november 1999 (nummod)
= 40 (dobj)
variants other (amod)
added after (mark)
four diet (dep)
restriction making (conj)
phosphorylation increased (amod)
study december (nmod)
phlebitis mucositis (conj)
excitation neurons (nmod)
changes marked (amod)
ketanserin alfentanil (conj)
attractive mimic (advcl)
serum day (nmod)
level mda (compound)
synthesis renal (amod)
ad50 in (case)
degree pattern (conj)
if control (nmod)
performance alternation (compound)
administration epinephrine (nmod)
testosterone for (case)
potential anxiogenic (amod)
increases follow-up (nmod)
associated ts (nmod)
abnormalities biochemical (amod)
evidence involvement (nmod)
score respectively (advmod)
prior entry (nmod)
microg/kg 150 (nummod)
67.9 18.6 (conj)
actions fenoterol-hydrobromide (nmod)
disorders i (nummod)
injected which (nsubjpass)
organization administration (conj)
practiced . (punct)
treated ip (advmod)
nik-247 of (case)
micrograms bilaterally (advmod)
procaterol oral (amod)
neurons rostral (amod)
results detected (appos)
elimination in (case)
produced increase (nmod)
halothane isoflurane (conj)
present scarring (nsubj)
eu 250 (nummod)
mice 8-week-old (amod)
comprising extremes (dobj)
anti-inflammatory non-steroidal (amod)
death until (case)
treatment given (acl)
attack seizure (compound)
cases myelodysplasia (nmod)
have attributed (conj)
repair post-necrotic (amod)
causes overload (nsubj)
test rota-rod (compound)
rhabdomyosarcoma embryonal (amod)
retrospective case-controlled (dep)
mediate subpopulations (nsubj)
mean liters (dobj)
d11 and (cc)
established safety (dobj)
analyses morphology (compound)
dystonic more (advmod)
mmol/l 2.5 (nummod)
mg/kg sc (dep)
review in-depth (amod)
remained except (prep)
dose mg/m2 (appos)
striking was (cop)
determine occurrence (dobj)
oxc ) (punct)
1986 from (case)
combined study (nmod)
pressure contraction (conj)
affects that (mark)
prior to (mwe)
min dfo (conj)
cortex motor (compound)
pri of (case)
common users (nmod)
ratio akbr (dep)
days 9 (nummod)
co. . (compound)
decreased 236 (nmod)
assessed presence (nmod)
caused groups (nmod)
antagonist diphenhydramine (appos)
drop accompanied (acl)
blocked chloride (nmod)
times three (nummod)
content gaba (compound)
areas related (amod)
a salvianolic (amod)
search of (case)
increase gradual (amod)
2.08 - (punct)
haloperidol ( (punct)
normal was (cop)
stimulation activity (nmod)
34.33 +/- (cc)
subset pain-intolerant (amod)
developed involvement (nmod)
restored study (nmod)
journals abstracts (conj)
discussed terms (nmod)
facility humor (compound)
% ci (compound)
days specific (amod)
examined addition (nmod)
rhabdomyolysis patient (nmod)
doses drug (nmod)
controlling symptoms (dobj)
reported children (nmod)
selective both (cc:preconj)
sbs ) (punct)
40 30 (nummod)
initiate . (punct)
acid ha (appos)
weeks weeks (nmod:tmod)
papaverine from (case)
treatment prednisolone (nmod)
seizures anesthetic-kindled (amod)
10 of (case)
events outcomes (nsubj)
nouns concrete (amod)
eczema eyelid (compound)
profile impairment (nmod)
blockers the (det)
way under (case)
more significantly (advmod)
normal states (conj)
make , (punct)
group male (appos)
enzyme this (det)
efficacy propranolol (nmod)
pharmacotherapy during (case)
high % (nmod)
represent indication (dobj)
detection treatment (conj)
necrosis hepatocellular (amod)
increase did (aux)
activities complexes (nmod)
dysrhythmias spontaneous (amod)
ineligible 7 (nsubj)
lozenge gum (conj)
-10.7 ( (punct)
fibrillation his (nmod:poss)
refractory progressively (advmod)
tolerability patients (nmod)
iopromide and (cc)
mo during (case)
effect ribavirin (nmod)
% malays (conj)
tafi plasma (compound)
pores of (case)
sedations the (det)
electrocardiography echocardiography (conj)
increases packing (dobj)
reduce impairment (nmod)
period perioperative (amod)
solubility its (nmod:poss)
parasitosis treatment (nmod)
5-azc ) (punct)
patients 104 (nummod)
drugs various (amod)
167 5 (conj)
nhe3 na-k-atpase (conj)
changes mood (compound)
controls active (amod)
seen had (aux)
considered probable (xcomp)
a of (case)
activities hepatic (amod)
led increase (nsubj)
tbars liver (compound)
model penicillin (compound)
events massive (amod)
up postdose (nmod)
toxicology cocaine (compound)
month at (case)
using -- (punct)
to 210+/-56 (cc)
bradykinin or (cc)
arrest cycle (compound)
agents antiviral (amod)
h per (case)
pacing and (cc)
cocaine not (cc)
episode , (punct)
defects midline (compound)
22 % (appos)
managed anemia (nsubjpass)
homozygous and (cc)
acute subacute (conj)
behaviour the (det)
continued therapy (nsubjpass)
crocins of (case)
intralipid ( (punct)
initiating failure (nmod)
studies mice (nmod)
concentration statin (nmod)
injected mice (nmod)
regulation of (case)
sgk1 serum- (amod)
potentiated and (cc)
ontario of (case)
5 2 (compound)
lesions in (case)
scores by (case)
78 +/- (cc)
decrease in (case)
occur differences (nsubj)
needed assess (xcomp)
blunted and (cc)
detect can (aux)
drug known (acl)
dose 0.075mg/kg (nummod)
patterns injury (nmod)
gtn or (cc)
94.3 88.1 (compound)
had hemianopsia (dobj)
treated is (auxpass)
removal during (case)
investigators other (amod)
$ROOT$ debated (sent)
designed were (auxpass)
presented recurrences (nmod)
implantation capsule (nmod)
consequences to (case)
accumulation hr (nmod)
bilateral severe (conj)
agent use (nmod)
release ircrf (compound)
syndrome immunodeficiency (compound)
performed baseline (nmod)
41 fourteen (compound)
toxicity q (dep)
addition medications. (nmod)
risk tumors (nmod)
embryolethality ( (punct)
amide inhibitor (appos)
rates recurrence (compound)
use ratio (dep)
evaluate role (dobj)
urticaria/angioedema nsaid-induced (amod)
increased baseline (nmod)
scores patients (nmod:poss)
patients psychosis (nmod)
attenuates or (cc)
mechanisms possible (amod)
variability regional (amod)
treatment azathioprine (nmod)
ng/ml 1955 (nummod)
n=92 respectively (advmod)
indicated not (neg)
cholesterol of (case)
factor-beta1 transforming (amod)
77.1 = (parataxis)
prevents which (nsubj)
mg 20 (compound)
quantities considered (acl:relcl)
effects animals (nmod)
see to (mark)
29.1 to (quantmod)
day postnatal (amod)
use ethambutol (nmod)
take to (mark)
disease failure (conj)
p-ergs ) (punct)
cells mmq (compound)
scavenging its (nmod:poss)
diligent . (punct)
scores = (dep)
hours life (nsubj)
depletion rats (nmod)
fed and (cc)
substitute the (det)
closed only (advmod)
mice tie2-cre;loxp-egfp (amod)
illness a (det)
tremor gait (conj)
neurotoxicity ( (punct)
induced fluphenazine (nmod)
less eu (nmod)
treatment that (mark)
studies drug (compound)
mk-801 previous (amod)
frequency paralysis (nmod)
gsh cortical (amod)
sem ( (punct)
260 130 (compound)
presence irradiation (conj)
functions and (cc)
alpha-2b interferon (compound)
euthanized collected (conj)
speed swimming (compound)
discontinuation imipramine (nmod)
necropsy case (nmod)
treatment only (advmod)
pretreatment bnpp (compound)
developed reactions (dobj)
describes features (dobj)
chow cyclic (amod)
ctni ck (conj)
cause microangiopathy (nmod)
acetylcholinesterases and (cc)
vip ( (punct)
encephalopathy induced (dep)
inhibited chloride (nsubj)
receptor m(3)-muscarinic (amod)
receptors to (case)
proportion high (amod)
marrow in (case)
benefit antiparkinsonian (amod)
protection environmental (compound)
cisapride nm (appos)
antinociception not (cc)
gliomas of (case)
drug no (det)
recorded latencies (nsubjpass)
analyser a (det)
caused not (neg)
hg spv (nsubj)
cells positive (amod)
encephalopathy death (conj)
have rats (nsubj)
effects hemostasis (nmod)
caused reactions (dobj)
manageable were (cop)
indicative and (cc)
1.56 ( (punct)
decrease map (nmod)
attributable were (advcl)
naive cocaine (nmod:npmod)
became worsening (advcl)
scenario although (mark)
pronounced that (mark)
activities neurotoxic (amod)
hypoglycemia bradycardia (conj)
affirming by (mark)
agent anesthetic (compound)
hyperkalemia due (case)
colonies progenitor (compound)
duration examination (nmod)
6.87 +/- (cc)
absent even (advmod)
damage barrier (compound)
technique microelectrode (compound)
act may (aux)
p 9 (nummod)
patients diseases (nmod)
indicate shows (ccomp)
presents apnea (nmod)
analogs structural (amod)
compared subjects (nmod)
observations some (det)
$ROOT$ group (sent)
increased weeks (nmod)
formation incubated (amod)
demonstrate suggest (conj)
actions heart (nmod)
drugs but (cc)
antagonizes effect (dobj)
confirmed biopsies (nmod)
toxicity liver (compound)
glutamatergic and (cc)
associated worsening (nmod)
retard not (neg)
require regimens (nsubj)
was suggests (dep)
taken that (mark)
6.6 +/- (cc)
defined potentials (dep)
infarction inhibitors (nmod)
5-ht ( (punct)
lt after (case)
abusers endorsing (acl)
time concentration (conj)
biopsy both (nmod)
related cause (nsubj)
effects grade (compound)
des , (punct)
autophagy on (case)
potentiate that (mark)
toxicity (ami)-induced (amod)
determined objective (nsubj)
$ROOT$ polyneuropathy (sent)
aware leads (advcl)
attained who (nsubj)
users fenfluramine (nmod)
targeting primarily (advmod)
phenomena autonomic (amod)
expression may (aux)
outcomes cancer (conj)
make contribution (dobj)
created observed (dep)
vol% 0.7 (nummod)
gaining is (aux)
supplementation chloride (compound)
sss ( (punct)
f remained (conj)
age use (conj)
acutely chronically (conj)
described cases (nsubjpass)
reported treatment (nmod)
papilloma squamous (amod)
definition according (case)
events reported (acl)
part for (case)
infants gestation (nmod)
hearts of (case)
modulation hyperalgesia (nmod)
mg 110 (nummod)
clear . (punct)
stages during (case)
had infections (dobj)
concentration micrograms/ml (appos)
treated srl (nmod)
was ] (punct)
surgery redo (amod)
monitored discontinued (conj)
bfgf and (cc)
underline need (dobj)
dose non-convulsant (amod)
users tablet (dep)
analysis actuarial (amod)
maintained development (nmod)
effect shr (nmod)
compound p-coumarate (appos)
revealed cultures (nsubj)
injection intracisternal (amod)
% 2.3 (nummod)
conclusions active (appos)
arrest sinus (compound)
offer alternative (dobj)
methods under (case)
ci -0.5 (appos)
vicinity ganglia (nmod)
referred follow-up (nmod)
treatment adolescent (amod)
30 - (advmod)
drugs antiarrhythmic (amod)
hydrolyze which (nsubj)
presents patient (dobj)
hemodialysis by (case)
width ( (punct)
2 number (nsubj)
paralysis patients (nmod)
administered clinically (advmod)
mg. . (punct)
reversal administered (advcl)
flushing after (mark)
relationship no (neg)
activity expression (conj)
one than (quantmod)
report previous (amod)
persisted fibrosis (nsubj)
fluids of (case)
index mass (compound)
menorrhagia deterioration (conj)
fact feature (acl)
occurred none (nsubj)
modify acetaminophen (nsubj)
aminoglycosides furosemide (conj)
precipitate dysrhythmias (dobj)
nausea prior (amod)
beta-blocker between (case)
avoided could (aux)
pcpa , (punct)
delirium population (nmod)
were developed (conj)
injection insulin (nmod)
methadone agonist (compound)
event cellular (amod)
confirmed as (mark)
tri-iodo-thyronine t3 (appos)
proposed : (punct)
15.5 vs (cc)
i.v. mg/kg (compound)
control compared (case)
$ROOT$ bleeding (sent)
leukocyturia with (case)
ligation- coronary (amod)
receive orally (advmod)
thrombosis hepatic (amod)
consistent parameters (nsubj)
contributed tremor (nsubj)
transcription tgf-beta1 (compound)
studied patients (conj)
had diagnosis (nmod)
caution use (nmod)
intravenous intramuscular (conj)
2.3 8.2 (prep)
interference due (case)
reporting with (mark)
exerts that (mark)
re-exposure after (case)
used agent (conj)
crucial to (mark)
dogs 10 (nummod)
extrusion cells (nmod)
consist bilayers (nmod)
days 7 (nummod)
serotonin n-acetyl (amod)
response reflex (amod)
withdrawal vpa (compound)
chop factor (compound)
models mouse (compound)
vasculature in (case)
protected also (advmod)
important : (punct)
years 14 (nummod)
induced activated (conj)
increase alfentanil-induced (amod)
cardiomyopathy (dox)-induced (amod)
found differences (nsubjpass)
coefficient p<.01 (appos)
glomerulosclerosis with (case)
cco-iv and (cc)
incorporates clues (dobj)
methyldopa between (case)
clinical electrophysiological (conj)
using ms (dobj)
antibiotic new (amod)
failed resection (nsubj)
vincristine infusional (amod)
$ROOT$ origin (sent)
toxins other (amod)
$ROOT$ institution (sent)
risk factors (conj)
diffusion-weighted recovery (conj)
guidelines present (amod)
increased astrocytes (nsubj)
$ROOT$ method (sent)
possessing antigen (dobj)
teratogenic may (aux)
enlargement of (case)
toxicities observed (acl)
seemed toxic (xcomp)
asthma upon (case)
young and (cc)
acidosis nonketotic (amod)
reflex bezold-jarish (amod)
testes gynecomastia (conj)
locomotion preference (conj)
less importantly (advmod)
presentation evaluation (conj)
anemia leukopenia (conj)
included ratio (dobj)
described number (nmod)
had stones (dobj)
$ROOT$ hyponatremia (sent)
confirmed data (nsubjpass)
drugs two (nummod)
mg 1.0 (nummod)
higher levels (nsubj)
episode following (case)
effect use (nmod)
rizatriptan 1 (nummod)
expression efe (appos)
have impairments (dobj)
necrosis child (nmod)
learning after (mark)
antagonist mglur1 (nmod)
is compounds (nmod)
clinical radiological (conj)
la ) (punct)
located are (cop)
male 54-year-old (amod)
found observers (nmod)
weight ) (punct)
suggests loci (dobj)
lidocaine vs (cc)
mild when (advmod)
cells injected (acl)
attenuate temocapril (nsubj)
associated fall (nsubjpass)
metabolism on (case)
score , (punct)
continue demonstrate (xcomp)
considered curcumin (nsubjpass)
15mg/kg orally (advmod)
activity lymphocyte (nmod)
inflammation apoptosis (conj)
changes systems (nmod)
phase long-term (amod)
monitoring of (case)
report terms (nsubj)
dosed similarly (advmod)
levels doses (conj)
related pathophysiology (nsubj)
regions autonomic (amod)
cis-ra administered (acl)
treated haloperidol (nmod)
used period (nmod)
on off (conj)
inherent that (mark)
completed a (dobj)
testing to (case)
% 35.4 (nummod)
reverses amnesia (dobj)
greatest and (cc)
thyroid parathyroid (conj)
software with (case)
3.9 and (cc)
gender-dependent extend (conj)
becoming is (aux)
8.6 +/- (cc)
epilepsy or (cc)
% 7.0 (nummod)
amiodarone with (case)
antibitocis aminoglycoside (compound)
prevented d-med (nsubj)
complete regressions (dep)
suspected not (neg)
gentamicin by (case)
effective alleviation (nmod)
low qtp (conj)
brain supratentorial (amod)
strains resistant (amod)
mmhg p (dep)
low-dose ( (punct)
effect density (nmod)
gfap tnf-a (conj)
appears effective (ccomp)
response idiosyncratic (amod)
proteins five (nummod)
represents side-effect (nsubj)
months following (case)
turnover striatal (amod)
varied initiation (nmod)
transplantation pediatrics (nmod)
range sensitivities (nmod)
stimulation hippocampal (amod)
occurrence by (case)
hospital academic (amod)
nine in (case)
evaluated baseline (nmod)
biopsy stainings (conj)
choriocarcinoma of (case)
bore rats (nsubj)
reduces treatment (nsubj)
suppressed arrhythmias (dobj)
neca ) (punct)
hepatotoxicity acetaminophen (compound)
plate the (det)
incidence effect (nmod)
consisted safe (xcomp)
effect ht (nmod)
effects mdma (nmod)
said was (auxpass)
mitochondria the (det)
different similarly (advmod)
underwent men (nsubj)
evidence overall (amod)
room at (case)
cholesterol a-ii (conj)
stenosis a (det)
tachyarrhythmias with (case)
modes to (case)
shortening of (case)
striatum and (cc)
exclude . (punct)
antagonists other (amod)
antigen hepatitis (compound)
oxidase cox (appos)
sequence mostly (advmod)
volume rate (conj)
observed level (nmod)
attributable may (aux)
injection weeks (nmod)
reviews lists (conj)
pneumonia carinii (compound)
capacity cardiac (amod)
tolerance a (det)
genes epilepsy (nmod)
evaluations parameters (nmod)
capacity human (amod)
clt ) (punct)
source pain (nmod)
causes reversible (amod)
timeframe the (det)
induces that (mark)
21days for (case)
minimize risk (dobj)
elevation a (det)
antibodies by (case)
integrity structural (amod)
mania associated (acl)
workers in (case)
set doses (nsubjpass)
distress and (cc)
proof but (cc)
comparisons models (nmod)
epinephrine ) (punct)
25.6 ; (punct)
50 over (advmod)
patients included (dep)
stimulation site (nmod)
lisinopril medium-dose (amod)
documented occlusion (dobj)
stereotypies amphetamine-induced (amod)
cycloheximide not (neg)
incidence study (nmod)
sensitivity seizures (nmod)
patients or (advmod)
bodies drg (compound)
drugs vasodilator (compound)
disappeared and (cc)
organelle subcellular (amod)
increased nitroglycerin (nsubj)
alleviated amnesia (dobj)
effects channel (compound)
rate , (punct)
case undiagnosed (amod)
duration mapd (appos)
jaundice of (case)
remodeling vascular (amod)
combinations ketamine-dominant (amod)
county , (punct)
operation of (case)
lower response (nmod)
interaction fatal (amod)
matrix and (cc)
carried lack (conj)
patients level (nmod)
fasciitis neutropenia (nmod)
determine dose (dobj)
parameters or (cc)
evaluate monotherapy (advcl)
had umb24 (nsubj)
led recognition (nmod)
none = (dep)
utility patients (nmod)
form methemoglobin (dobj)
effect inotropic (amod)
sm group (compound)
factors sex (nmod)
defined ( (punct)
syndrome se (advmod)
cytology periodic (amod)
monitored , (punct)
taken possibility (nsubjpass)
dse positive (amod)
conclude alternative (ccomp)
uiu/ml ) (punct)
admissions 0.97/1,000 (nummod)
effects overall (amod)
haloperidol alone (advmod)
verapamil daily (amod)
administration molindone (compound)
discontinued hours (nmod)
take it (nsubj)
measured count (nsubjpass)
release receptor-mediated (amod)
relationship complications (nmod)
containing ethinyloestradiol (dobj)
moderate-dose ) (punct)
latency phencyclidine (compound)
mg/kg s.c. (appos)
doses mg (dep)
leukemia from (case)
derivative another (det)
dosed drugs (nsubjpass)
proliferation compensatory (amod)
mesothelioma carcinoma (conj)
center malaysia (nmod)
medline reviews (conj)
exposed been (auxpass)
indicators could (aux)
progenitor bone (compound)
caused tilt (nsubj)
administration chonic (amod)
exhibited range (parataxis)
-14.8 ) (punct)
helpful have (aux)
completion course (nmod)
p ) (punct)
induced tests (conj)
interactions effects (nmod)
identified bodies (nsubjpass)
reduced either (advmod)
failure esrd (conj)
membrane at (case)
facilitate evaluation (dobj)
hypertension disease (conj)
sectioning nerves (nmod)
inhibition hyperprolactinemic (amod)
led . (punct)
readmitted . (punct)
morning eyes (nmod)
injection drugs (nmod)
children studies (nmod)
controls matched (amod)
concentrations target-free (amod)
risk hemorrhage (nmod)
loss hypokalaemia (conj)
potentiation synapse (nmod)
methoctramine pirenzepine (conj)
results trials (nmod)
ratio : (punct)
induce cells (nmod)
75,761 : (punct)
stage 4 (nummod)
sarcoma tumors (appos)
felt patient (nsubj)
acid high-dose (amod)
injection atropine (nmod)
taking he (nsubj)
die develop (conj)
pharmacological and (cc)
animals same (amod)
shifts . (punct)
system da (compound)
courses treatment (nmod)
stratum ) (punct)
seizures after (case)
hypoactivity early (amod)
than rather (advmod)
nicergoline and (cc)
correlates mfs (nmod)
reached all (nmod)
objective conducted (dep)
association events (nmod)
altered pregnancy (nmod)
taking cisapride (dobj)
twin , (punct)
potential sensory (amod)
diuretics disease (nmod)
activities cysteine (compound)
meter animex-activity (compound)
disturbances system (nmod)
prevented reduced (conj)
polypeptide vasoactive (amod)
unclear management (nsubj)
equipment oximeters (nmod)
perimysial endomysial (conj)
use cpa/ee (compound)
week weeks (conj)
99 observed (conj)
exposure arsenic (amod)
tribute mixture (nmod)
cost management (conj)
digitalise or (cc)
mice normal (amod)
activities of (case)
procedures diagnostic (amod)
analgesia patient-controlled (amod)
isolation for (case)
series or (cc)
increase for (case)
measurement regular (amod)
transaminase transient (amod)
psychotic organic (amod)
8-phenyltheophylline , (punct)
cells 17.7 (nummod)
caused expression (nmod)
use fluconazole (nmod)
% 135 (nummod)
neurons spared (amod)
evidence enhances (acl)
recommend finally (advmod)
cinacalcet of (case)
patients mazindol-treated (amod)
indication conversion (nmod)
substituted bromide (nsubjpass)
methods recorded (dep)
fall greater (amod)
assigned protocols (nmod)
contaminants of (case)
microg 15 (nummod)
users antiplatelet (amod)
40 19 (conj)
concentrations minimum (amod)
inserted reoccur (conj)
allograft in (case)
less 0.02 (nmod)
sacrificed pairs (nsubjpass)
agents with (case)
risperidone = (dep)
or peripherally (advmod)
effect associated (acl:relcl)
intralipid alone (advmod)
administered blindly (advmod)
treatment 5-fu (compound)
fk mg. (appos)
am149 ( (punct)
history any (det)
% asenapine (nmod)
present dose (nmod)
returned groups (nmod)
leads alteration (nmod)
akinesia reserpine-induced (amod)
concluded tentatively (advmod)
solution or (cc)
junction and (cc)
produced effects (dobj)
complication glomerulonephritis (nsubj)
reduced mg/week (nmod)
lymphadenitis bodies (nmod)
atresia for (case)
scintigraphy quantitative (amod)
acetylcholinesterase ache (appos)
oil crocin (conj)
switches hypomania (nmod)
increase neurotransmission (dobj)
dothiepin and (cc)
hyperkalemia k(+ (appos)
38 , (punct)
$ROOT$ secondary (sent)
facies potter (nmod:poss)
did mk-801 (nsubj)
noted increase (nsubjpass)
hospital chulalongkorn (compound)
2.32 0.16 (conj)
reduced bpm (nmod)
enzymes of (case)
protein function (nmod)
ct prior (nmod)
fatigue events (nsubj)
activation in (case)
temporary or (cc)
resolved stopping (advcl)
treated ethambutol (nmod)
measures ultrasound (compound)
therapy administered (acl)
gestation of (case)
negative time (nmod:tmod)
quantified follow (nmod)
100 > (amod)
system monoaminergic (amod)
media nonionic (amod)
faint using (advcl)
protocol identical (amod)
help shown (advcl)
restrictions activity (compound)
induces hearts (nmod)
recognition pregnancy (compound)
investigations response (nmod)
across and (cc)
phosphorylation , (punct)
followed degeneration (nsubjpass)
saline before (advmod)
elevation min (nmod)
emphasized . (punct)
stage iii (nummod)
withdrawn samples (nsubjpass)
liver rat (nmod)
30 over (advmod)
detected findings (nsubjpass)
336 26 (conj)
variables demographic (amod)
beta-adrenoblocking with (case)
effect rhythm (nmod)
group oc (compound)
cases all (appos)
decline without (case)
year 61 (nummod)
associated reassuringly (advmod)
agonist selective (amod)
% 25.35 (nummod)
% 32 (nummod)
model penicillin-induced (amod)
time to (dep)
effects ccl4 (nmod)
done effect (nmod)
inferences terms (nmod)
4/5 ) (punct)
patients 101 (nummod)
presented summary (nsubj)
culture , (punct)
magnitude effect (nmod)
provoked , (punct)
evaluate study (nmod)
23 % (appos)
blockade response (nmod)
ecg level (conj)
related treatment (nmod)
increment overflow (nmod)
associated anesthesia (nmod)
resistance significant (amod)
number granules (nmod)
14 infarction (nmod)
assessment global (amod)
striatum cortex (conj)
anaesthesia of (case)
is patient (nmod)
beta-methylene alpha (compound)
examined changes (nmod)
surrounded ring (nmod)
design was (cop)
esophagus in (case)
was observed (advcl)
35 % (dep)
monolayers on (case)
ill have (conj)
followed change (nmod)
territory the (det)
males females (nmod)
seizure resulting (acl)
proteinuria peak (amod)
function muscle (compound)
clomipramine of (case)
5 27 (prep)
deactivated whom (nmod)
mg increase (appos)
drugs the (det)
noted has (aux)
control cyclophosphamide-pretreated (conj)
hag compared (case)
treatment short (amod)
disease spontaneous (amod)
suppressed it (nsubj)
admitted intake (nmod)
blood urine (conj)
1.0 stroke (conj)
report published (amod)
% 82.4 (nummod)
presented failure (nmod)
accelerate progression (dobj)
represented case (nmod)
cancer recurrent (amod)
abnormalities cytologic (amod)
administered intravenously (advmod)
acquired thrombosis (dobj)
concentration g/dl (nmod)
scale naranjo (compound)
increase fluctuations (nmod)
foci surrounded (acl)
agents modes (conj)
head triceps (nmod)
dose-dependent dysfunction (nsubj)
clonazepam benzodiazepine (compound)
institution effect (dep)
administered form (nmod)
12.5 -8.1 (conj)
incidences reasonable (amod)
nephrosis model (acl:relcl)
weakness lethargy (conj)
sch d-1 (compound)
indicator sensitive (amod)
assessed field (nmod)
ato-treated and (cc)
block secondary (amod)
resolved pain (nsubj)
complication common (amod)
levels higher (amod)
frequencies defects (nmod)
damage tubular (amod)
received fentanyl (dobj)
crosses readily (advmod)
woman 47-year-old (amod)
vasodilators fenoldopam (appos)
penicillamine by (case)
sumatriptan mg (appos)
contained that (mark)
class of (case)
model sigmoid (amod)
injection serotonin (compound)
significant mg/kg/day (ccomp)
thought bore (ccomp)
common artery (nsubj)
lidocaine mg/kg)-induced (appos)
addicts opioid (compound)
270 , (punct)
dosing different (amod)
% 73.5 (nummod)
inhibiting arrhythmia (dobj)
benzo[a]-pyrene , (punct)
performed anesthesia (nmod)
30.8 2.5 (conj)
hepatonecrosis report (dep)
penicillins , (punct)
rs6693503 rs3790757 (conj)
bolus microg/kg (compound)
delta22-isomer beta-muricholate (nmod)
deemed results (nsubjpass)
cord cervical (amod)
demonstrated impairments (dobj)
51.0 - (punct)
restored addition (nmod)
increased anesthesia (nmod)
damage lead (acl:relcl)
gauges ) (punct)
bleeding massive (amod)
measures for (case)
istanbul turkey (appos)
true patients (nmod)
appeared though (mark)
produced manifested (conj)
induced use (nmod)
controls intervals (nmod)
stroke disease (conj)
age rat (compound)
aminoglycosides three (nummod)
responders these (det)
3 2 (quantmod)
shown 0.01).(abstract (punct)
drug prevention (nmod)
small grades (conj)
drugs atropine-like (amod)
duration incidence (conj)
od 1.27 (nummod)
had lidocaine (dobj)
incidence hypertension (nmod)
pressure ) (punct)
have neurons (nsubj)
% within (case)
hypoxaemia severe (amod)
motility syndrome (nmod)
determination camp (nmod)
% levels (nmod)
suppressed co-administration (nmod)
reduction dystrophin (nmod)
enhanced actions (nsubjpass)
causes apnea (dobj)
nutrition with (case)
selegiline of (case)
departments pain (nmod)
titrating by (mark)
functioning basal (amod)
suggestive role (nmod)
control symptom (compound)
cells principal (amod)
microm p (appos)
months use (nmod)
complete two (nummod)
inhibited hyperprolactinemia (nsubj)
correlated changes (nsubjpass)
status nephropathy (compound)
stem may (aux)
treated already (advmod)
alter dose (dobj)
fraction decreased (amod)
needed therapy (nsubjpass)
mechanisms involve (acl:relcl)
shown investigations (nsubj)
used improved (conj)
b.d . (amod)
day plus (cc)
agents all (det)
24 6 (conj)
consolidation memory (nmod)
origin developmental (amod)
sinus from (case)
induced maleate (nsubj)
thiotepa tspa (appos)
but gradually (advmod)
prl of (case)
receiving oltx (dobj)
awake completely (advmod)
> seconds (dep)
1.03 0.60 (appos)
group epinephrine-treated (amod)
exposed box (nmod)
cases similar (amod)
1.2 0.5 (compound)
co-administration % (amod)
subjects cohort (nmod)
monitoring use (conj)
paradigm treatment (compound)
treatment warfarin (compound)
healthy , (punct)
associated demonstrated (advcl)
citalopram nmol/l (appos)
type clinical (amod)
692 68- (punct)
drug vigabatrin (dep)
injection mk-801 (compound)
nightly once (advmod)
cyanamide hydrogen (compound)
hepatitis has (acl:relcl)
minimum week (nmod)
sensitive proteins (nmod)
methylation in (case)
recovered children (nsubj)
decreased colliculi (nmod)
absent mrp2 (nsubj)
reduces clinically (advmod)
151 % (appos)
present historic (conj)
neuroblastoma with (case)
abnormality primary (amod)
obtained showing (xcomp)
statins inhibitors (conj)
rats between (case)
$ROOT$ pose (sent)
complemented studies (nmod)
essential order (nmod)
group as/ks (compound)
$ROOT$ occurred (sent)
increases vulnerability (dobj)
1.8-fold ) (punct)
poag ( (punct)
myocytes nrvms (appos)
exposure pce (appos)
mild is (cop)
alteration activity (nmod)
developing snr (nmod)
evoked increases (dobj)
combined tocolytics (nsubjpass)
forearm her (nmod:poss)
exposure inorganic (amod)
media arteries (nmod)
neuropathy retrobulbar (amod)
produced dysrhythmias (dobj)
mptp with (case)
netilmicin piperacillin (conj)
limit detection (nmod)
attenuation such (amod)
system poor (amod)
primary unknown (amod)
acts administered (advcl)
co-infection virus (compound)
analyzed : (punct)
frequency the (det)
solution ( (punct)
% control (nmod)
examination 0 (appos)
various non-uniform (conj)
administration estrogen (nmod)
unnecessary choice (parataxis)
index 1.19 (nmod)
antibiotic lactam (compound)
assessed , (punct)
had glomeruli (dobj)
predisposed : (punct)
persisted developed (conj)
role about (case)
suggesting enhancement (dobj)
activity gad (compound)
increased re-infarction (nmod)
1.3 , (punct)
suitable conclusions (nsubj)
less could (aux)
need evidence (dobj)
showed affinities (dobj)
completion after (case)
mechanism dopaminergic (amod)
concentration sfas (nmod)
cotransporter bsc-1 (appos)
transaminases elevated (amod)
hypothesize . (punct)
arrhythmia on (case)
effects function (nmod)
due inhibitors (nmod)
exposed acutely (advmod)
organelle injured (amod)
attenuates nephrotoxicity (dobj)
analysed cases (conj)
substantiate potential (dobj)
chemotherapy carboplatin (compound)
resolved hypertrophy (nsubj)
days ci (dep)
ionic non (amod)
respiration heart (nmod)
nf-kappab ( (punct)
increased ds (nmod)
treatment phenytoin (nmod)
mcl resistant (amod)
cows control (amod)
bfu-e animals (nmod)
anova tests (nmod)
subject was (cop)
showed anatomy (dobj)
dyskinesia with (case)
represented abnormalities (dobj)
pg/ml ) (punct)
acts fashion (nmod)
ct tomography (conj)
ataxia and (cc)
11 - (advmod)
shown capacity (dobj)
risks the (det)
assessments on (nmod)
propranolol insulin (conj)
resulted incorporation (nmod)
release sequestration (conj)
antagonist 5-ht2 (compound)
noted controlled (ccomp)
lvdp/dt ( (punct)
relaxants suxamethonium (dep)
epiphenomena process (nmod)
$ROOT$ behaved (sent)
consider , (punct)
small effect (nsubj)
nephrotoxicity patients (nmod)
children receiving (acl)
pressure map (appos)
toxicity known (amod)
liver ) (punct)
administered um-272 (nsubjpass)
investigated identified (dep)
helpful was (cop)
tissue the (det)
fruits chebula (compound)
device delivering (acl)
conducted series (dobj)
deletion chop (compound)
lh-rh to (case)
aprotinin of (case)
group received (acl:relcl)
comparison gliclazide (nmod)
existence aftereffects (nmod)
nodules within (case)
startle baseline (compound)
necessary determine (ccomp)
rates turnover (compound)
compounds targeting (acl)
revealed , (punct)
series and (cc)
3 0.3 (compound)
model severity (nmod)
potentials evoked (amod)
increased activity (nsubjpass)
disorders neuromuscular (amod)
sites of (case)
decreased 0.3-fold (dobj)
concentrations onset (nmod)
ventricle failing (amod)
absence seizures (conj)
1.8 1 (conj)
follow levels (nmod)
maltol of (case)
costs treatment (compound)
decreased rats (advcl)
follow phase (dobj)
longitudinal , (punct)
prevented seems (advcl)
provides model (dobj)
$ROOT$ 16,459 (sent)
remove reduce (conj)
remained which (nsubj)
baby premature (amod)
% 50 (nummod)
identified polymorphism (dobj)
associated disease (nmod)
incorporation thymidine (compound)
deleted been (auxpass)
boluses and (cc)
% 1.46 (nummod)
conditions experimental (amod)
dyskinesias l-dopa-induced (amod)
quantified finally (advmod)
approach new (amod)
presence opioids (nmod)
loss primary (amod)
2147 701 (conj)
years 40 (nummod)
erection and (cc)
quantitative and (cc)
magnitude specificity (conj)
1.31 , (punct)
levels deoxycorticosterone (compound)
evolved , (punct)
type immune-mediated (amod)
memory non-associative (amod)
nationwide , (punct)
sample of (case)
exist : (punct)
treatment outpatients (nmod)
scale sas (appos)
8.0 3.5 (dep)
had ds (nsubj)
suggests differences (dobj)
therapy saving (amod)
asymptomatic be (cop)
excretion in (case)
administered systemically (advmod)
woman was (cop)
september from (case)
describe loss (dobj)
history syndrome (nmod)
view plays (ccomp)
women continued (acl:relcl)
showing with (mark)
tested battery (nmod)
enhance to (mark)
therapy sodium (compound)
alf=0/35 non-acetaminophen-induced (amod)
individuals pain (nmod)
-23.7 20.5 (conj)
elderly for (case)
reproduces . (punct)
series our (nmod:poss)
therapy selegiline (nmod)
tomography pet (appos)
enalapril or (cc)
elevations to (case)
imbalance oxide-redox (compound)
states united (compound)
sbp mmhg (dep)
ethyl 4- (amod)
examined dose (nmod)
salbutamol dose (compound)
maximal returned (conj)
zone perivenular (amod)
protected fzp (nsubj)
acuity , (punct)
0.01 ; (punct)
patients diarrhoea-predominant (amod)
haemorrhage after (case)
inhibits that (nsubj)
changes scl (nmod)
respiration for (case)
months 18 (nummod)
effect nephrotoxicity (nsubj)
exposed methods (nsubjpass)
concentration vip (compound)
found incidence (nsubjpass)
pathogenesis treatment (conj)
immobility of (case)
observed responses (nsubjpass)
induces stones (dobj)
angiography cardiac (amod)
carcinoma superficial (amod)
showed tests (nsubj)
artery : (punct)
anemia 1 (appos)
maleate by (case)
24.3 versus (cc)
ischemia for (case)
mouth and (cc)
vt of (case)
mpep ( (punct)
sedation effects (conj)
complex immune (amod)
minutes t120 (appos)
disorders ( (punct)
g 350 (nummod)
tbm ( (punct)
and also (advmod)
inhibits inhibits (conj)
assessed biochemical (nmod)
delivered where (advmod)
suggested sufficient (ccomp)
$ROOT$ continue (sent)
vision colour (compound)
history least (advmod)
experienced also (advmod)
recovery no (neg)
seizures with (case)
absence and/or (cc)
therapy anticoagulant (amod)
plays eps (nmod)
knowledge of (case)
tachycardia induced (acl)
characterized dyschromatopsy (nmod)
administration lf (nmod)
research for (case)
hypoxemia hypertension (conj)
has pool (nmod)
prl % (dep)
% 63.8 (nummod)
due tests (nmod)
met definition (dobj)
levels prolactin (compound)
alive conversion (nmod)
$ROOT$ postulates (sent)
patients -14.8 (dep)
seizures sensitive (amod)
required case (nmod)
university health (compound)
meq/l hctz (nmod)
u/l 1695 (nummod)
reversal secondary (amod)
complications surgery (nmod)
similar that (mark)
years vs. (cc)
nephropathy allograft (compound)
hour , (punct)
occurs : (punct)
patients months (conj)
ccr ( (punct)
paralysis chemical (amod)
42 in (case)
diminish and (cc)
speech of (case)
cleavage ( (punct)
day over (case)
reports four (nummod)
bromocriptine diazepam (conj)
reversible cin (nsubj)
developed patients (nmod)
limit the (det)
ccnu of (case)
women dysfunctional (amod)
compared determine (xcomp)
tremor rest (compound)
improvement ( (punct)
reduction hypertrophy (conj)
features disease (nmod)
endomt ) (punct)
psa and (cc)
octogenarian in (case)
specific reaction (nsubj)
everolimus by (case)
showed dwi (nmod)
become and (cc)
treatment amiodarone (compound)
initiatives targeted (acl)
assigned manner (nmod)
seconds after (case)
returned higher (advcl)
likely was (advcl)
appears respond (ccomp)
manifestation , (punct)
reduces amn082 (nsubj)
accurate , (punct)
oral nasal (conj)
17 15 (nmod)
paroxetine inhibitor (appos)
anesthetic is (cop)
granules reticulum (conj)
testing noninvasive (amod)
system with (case)
implicated also (advmod)
caused patients (nmod)
days several (amod)
$ROOT$ undetermined (sent)
availability the (det)
dose identical (amod)
use drugs (dobj)
predictive is (cop)
reliance drinking (nmod)
2.5 times (quantmod)
echocardiography model (nmod)
hormones exogenous (amod)
number 12 (nmod)
concern because (case)
h treatment (nmod)
hypertension fluoxetine-induced (amod)
carvedilol of (case)
showed deteriotation (dobj)
block not (neg)
atrioventricular av (appos)
ml 5.5 (nummod)
leukocyturia sterile (amod)
suggest involvement (dobj)
evidence pharmacological (amod)
reaction : (punct)
complained and (cc)
injection dfp (nmod)
included should (aux)
role system (nmod)
pneumonitis neuropathy (conj)
infusion ara-c (compound)
thickness a (det)
pharmacodynamics and (cc)
comorbidities patient (compound)
bpt : (punct)
mortality the (det)
hyperactivity e2-induced (amod)
synergistic , (punct)
granulocytopenia was (cop)
scleroderma severe (amod)
prevented remained (conj)
upset , (punct)
consciousness of (case)
shr the (det)
associated sedation (nmod)
developed rhabdomyolysis (dobj)
men women (appos)
allopurinol saline (conj)
factor strong (amod)
play that (mark)
labelling and (cc)
units 42 (nummod)
improvement as (case)
disappeared seizures (nsubj)
aminotransferase phosphatase (conj)
treated mo (nmod)
rhizomes pk (appos)
modulator receptor (compound)
order describe (acl)
samples renal (amod)
5-fu fa (conj)
discussion knowledge (nmod)
dogs n (dep)
cells spared (amod)
lesion chronic (amod)
mosmol/kg osmolality (nsubj)
opioid weak (amod)
anomalies multiple (amod)
used operations (nmod)
saline alfentanil (conj)
induced dl-sotalol (nmod)
sympathectomy or (cc)
claimed were (auxpass)
retention by (case)
cartilage , (punct)
was relationship (nsubj)
phenotype silent (amod)
depletion the (det)
polymerase dna (compound)
affected mellitus (nmod)
use not (neg)
resuscitated who (nsubjpass)
trated total (nsubjpass)
stimulation both (cc:preconj)
recurrent 59 (nummod)
characterized and (cc)
mg. 5 (nummod)
cases seizures (nmod)
suspended ml (nmod)
catheter central (amod)
taken 5 (nsubj)
excess compared (acl)
demonstrated nrf2 (nsubjpass)
dogs 20 (nummod)
h. during (case)
t3n1m0 ) (punct)
infusions paclitaxel (compound)
withdrew study (nmod)
observations iii (dep)
blocks receptors (dobj)
glomerular or (cc)
increased relaxed (conj)
cord into (case)
use been (cop)
implants bilateral (amod)
that by (case)
conclusion(s . (punct)
0.05 p (dep)
dependent rise (nmod)
rats dawley (compound)
water drinking (compound)
neutralizes which (nsubj)
neurons noradrenergic (amod)
isoflurane of (case)
time life (nmod)
is overdose (nmod)
acetaminophen , (punct)
seem true (xcomp)
known data (nsubjpass)
produces % (nmod)
sensitive neither (preconj)
levels site (nmod)
produced hcbd (nmod)
documented awake (advcl)
set , (punct)
prod and (cc)
15/htn ) (punct)
malformations incidence (compound)
normalizes resistance (dobj)
prevented effects (nsubjpass)
dfo 's (case)
perturbation from (case)
hypokalemia hypomagnesemia (conj)
serum got (dep)
accuracy diagnostic (amod)
compressed be (auxpass)
found correlation (nsubjpass)
year during (case)
evaluated specimens (nsubjpass)
settings inpatient (amod)
stl2 memory (appos)
neurons between (case)
use kg-1 (nmod)
considered then (advcl)
15-f(2t)-isop ( (punct)
arrest precipitous (amod)
development months (nmod)
$ROOT$ challenged (sent)
affect hyperalgesia (nsubj)
limit noel (nmod)
infused , (punct)
hearts rat (compound)
basis manifestation (nmod)
had stage (dobj)
condition recognized (amod)
rebounded discontinuation (nmod)
affect ? (punct)
(mpo-anca)-positive antibody (nmod:npmod)
leukemia or (cc)
necessitated toxicity (nsubj)
progression and/or (cc)
showed they (nsubj)
diverse different (conj)
affected ; (punct)
states anxiety (nmod)
effective well-tolerated (conj)
= sd (nsubj)
airway fev1 (dep)
event , (punct)
= left (dep)
15/hypertension , (punct)
decreased nephrin (nsubj)
toxicities common (amod)
unaware drug (nmod)
review extensive (amod)
abuse amphetamine (compound)
17 3 (compound)
disappeared negative (advcl)
symptoms neuroleptic-induced (amod)
development pathology (nmod)
cells system (nmod)
doc ( (punct)
aggressiveness mice (nmod)
tone pure (amod)
events 2,658 (nummod)
association attacks (nmod)
transplantable and (cc)
enalapril ( (punct)
staining double (amod)
12 to (advmod)
efforts resuscitative (amod)
considered leakage (nsubjpass)
administer to (mark)
radiopharmacy the (det)
eighth the (det)
% population (nmod)
development seizures (nmod)
low are (cop)
incidence addition (nmod)
words no (det)
tablets then (advmod)
factor nuclear (amod)
tested effects (dobj)
mechanism some (det)
demonstrated deterioration (dobj)
dysfunctioning a (det)
nm 1.9 (nummod)
hypothalamus accumbens (conj)
deaths convulsions (nmod)
patient amiodarone (nmod)
features pain (nmod)
titrated doses (nmod)
drinkers enrolled (acl:relcl)
injection formulation (nmod)
min(-1 . (punct)
distinguish . (punct)
38 18 (compound)
carbachol with (case)
received time (nmod)
steroid the (det)
fetal , (punct)
lesions based (case)
atenolol micrograms (appos)
lesions rosaceiform (amod)
5 . (punct)
case hematomyelia (nmod)
collagenase a (det)
treated patient (nsubjpass)
is knowledge (nmod)
analysed , (punct)
medialipid saline (conj)
discharges epileptiform (amod)
taking 1637 (conj)
five infants (nmod)
had injection (dobj)
medication nor (cc)
smaller that (nmod)
length scl (appos)
increased < (dep)
switched study (nmod)
modulating transmission (dobj)
hyperalgesia of (case)
papilloma carcinoma (conj)
shell ) (punct)
disease esophagitis (conj)
occurred seizure (nsubj)
abilities function (conj)
applicable easily (advmod)
produced effect (dobj)
extensive lesions (nsubj)
area femoral (amod)
proteins among (case)
males 17-year-old (amod)
varying rates (dobj)
inhibitor hormone (compound)
method exception (nmod)
seem excluded (advcl)
decline insidious (amod)
electroretinography multifocal (amod)
safety concerning (case)
detection cardiotoxicity (nmod)
show confounded (ccomp)
reversible to (mark)
td ( (punct)
remain teams (nsubj)
suffered myalgia (dobj)
report nor (cc)
associated conclusions (nsubjpass)
associated hemorrhage (nsubjpass)
diagnosis stones (nmod)
sites sulphate-associated (amod)
motivational or (cc)
reactions neurotoxic (amod)
products end (compound)
comments published (acl)
disease this (det)
abolish whether (mark)
$ROOT$ accounts (sent)
mg 0.24 (nummod)
bound copolymers (nmod)
control , (punct)
onset- end-of-dose (conj)
recognized syndrome (nsubjpass)
dependency sugar (compound)
production response (nmod)
exhibited thp (nsubj)
aimed ; (punct)
11.5 0.3 (conj)
iw ) (punct)
in-patients the (det)
used rcts (nmod)
dose clentiazem (nmod)
relationship result (nmod)
hus ) (punct)
less 0.025 (nmod)
seen were (auxpass)
investigations pharmacokinetic (amod)
ondansetron peri-operative (amod)
amount including (case)
nucleus intermedius (compound)
methods stereological (amod)
albuterol ina (appos)
induced lithium (nmod)
difference no (neg)
associated hours (nmod)
$ROOT$ suppresses (sent)
dyskinesias peak (amod)
p=0.006 ( (punct)
finding novel (amod)
group receive (acl:relcl)
species chain (nmod)
up-regulation mhc-i (nmod)
understanding in (case)
discontinuation after (case)
assessed extracted (conj)
[3h]inulin clearances (conj)
months eight (nummod)
supply to (case)
induced patient (nmod)
tubes guide (compound)
infarction seen (acl)
taking she (nsubj)
unmasking the (det)
year-old 76 (compound)
colorectal breast (conj)
hypertension severe (amod)
died presented (advcl)
occurred lag (nmod)
expression igf-i (compound)
precipitating in (mark)
effects vertigo (nmod)
attenuated pre-treatment (nsubj)
follow may (aux)
sdrr in (case)
effects penicillamine-related (amod)
started udca (nmod)
pill combination (compound)
action nonspecific (amod)
women to (case)
mtdna in (case)
understand disrupts (ccomp)
hr 0 (nummod)
requiring use (dobj)
naloxone opioid (compound)
causes disorders (nsubj)
increase is (cop)
monitoring continuous (amod)
done settings (nmod)
formation from (case)
alendronate oral (amod)
gm of (case)
days phenobarbitone (nmod)
target treatment (nmod)
unanticipated unreported (conj)
increase 1.5-fold (appos)
decayed pain (nsubj)
tracheotomy a (det)
spike single (amod)
aplasia dermatitis (conj)
subjected that (mark)
reaching culminating (conj)
level calcium (compound)
potent equally (advmod)
lower 2.7 (dep)
time cr (nmod)
give results (nsubj)
aborted has (aux)
society of (case)
protein myeloid (amod)
compliance points (nsubj)
protocol treatment (compound)
circulation with (case)
alternation on (case)
interferon and (cc)
saline c (appos)
down side (nmod:npmod)
pg/ml concentrations (nsubj)
tbarss ( (punct)
follow-up warfarin (nmod)
cx3cr1 ( (punct)
injections of (case)
effect e1 (nmod)
thrombocytopenia such (amod)
patient no (det)
stratified were (auxpass)
icr the (det)
mg/dl. between (case)
flutter failure (conj)
mesna of (case)
pretreatment animals (nmod)
$ROOT$ bound (sent)
notable particularly (advmod)
5-fluorouracil of (case)
hexamethonium nicotinic (amod)
strains in (case)
marked contribution (nmod)
time recovery (nmod)
filtration glomerular (amod)
trihexyphenidyl drugs (conj)
1.66 - (punct)
handful cases (nmod)
u/ml 12.5 (nummod)
encephalitis receptor-associated (amod)
injection perfusion (nmod)
combined detection (nmod)
$ROOT$ example (sent)
increased hours (nmod)
elucidated not (neg)
= 2.646 (dobj)
t1/2 myocardial (amod)
initiated and (cc)
2.35 [ (punct)
nms for (case)
ischemia (iso)-induced (punct)
withdrawal led (acl:relcl)
syndrome ventricular (amod)
elevated , (punct)
s-23121 of (case)
chickens given (acl)
produced tolerance (dobj)
$ROOT$ serves (sent)
lasted infusion (nmod)
inhibits increases (conj)
doses across (case)
years 3 (nummod)
fatal cases (nmod)
management without (case)
errors medical (amod)
affected verapamil (nsubj)
designed was (auxpass)
fever titer (conj)
assessment in (case)
administration dipyridamole (nmod)
review literature (nmod)
survivors cancer (nmod)
period week (amod)
use mdma (nmod)
encephalopathy (lev)-induced (amod)
circumstantial findings (nsubj)
ml/min ( (punct)
developed while (advcl)
less risk (nsubj)
using changes (dobj)
incidence neurotoxicity (nmod)
component sirolimus (nsubj)
vasculitis cerebral (amod)
required trial (nsubjpass)
discontinue abuse (dobj)
toxicity retinal (amod)
engagement phenomenon (nmod)
case myocarditis (nmod)
disorder recessive (amod)
had rtms (dobj)
raised exposure (nsubj)
remedy account (nmod)
1987 between (case)
conduct study (dobj)
hypothermia correlated (acl:relcl)
$ROOT$ alkaloid (sent)
had bche (nmod)
attack migraine (compound)
day ( (punct)
glycol peg (appos)
morphine 30mg/kg (dep)
outpatients six (nummod)
$ROOT$ 91.2 (sent)
effects scavengers (nmod)
ari ) (punct)
small- medium-sized (conj)
target response (compound)
training for (case)
group treatment (compound)
investigated herein (advmod)
days 84 (nummod)
75 - (punct)
effect overall (amod)
reduces volume (dobj)
0.96 0.75 (conj)
$ROOT$ interpret (sent)
induced hemopoiesis (dobj)
upregulation expression (nmod)
hypothyroid were (cop)
oliguria pain (appos)
enrolled : (punct)
induce hematotoxicity (dobj)
suggest used (ccomp)
characterized apnea (nmod)
maternal neonatal (conj)
nrvms of (case)
although are (cop)
injections 35 (nummod)
protected parameters (dobj)
1951 as (case)
tryptophan trp (appos)
1985 in (case)
characteristics myopathic (amod)
ligand is (cop)
nerve laryngeal (amod)
necessary subunits (nsubj)
origin toxicity (nsubj)
attenuate that (mark)
resulted failure (nmod)
vigilance a (det)
studies in (case)
developed surgery (nmod)
demonstrated ability (nmod)
mechanisms cholestasis (nmod)
disease nonalcoholic (amod)
studies 3,129 (nummod)
woman 48-year-old (amod)
infusion dopamine (compound)
effects analgesia (conj)
pb mg (appos)
cortex or (cc)
reports epidemiological (amod)
discs optic (amod)
recommend perform (xcomp)
proteins ku70 (dep)
7h6 , (punct)
hospitals centers (conj)
angiography fundus (compound)
record to (mark)
followed flumazenil (nmod)
pilocarpine mg/kg (dep)
increased interval (dobj)
extent improvement (nmod)
occurred case (nsubj)
began month (nmod)
neutropenia mefenamic (amod)
therapy atherosclerosis (conj)
cpr ) (punct)
sinus or (cc)
algorithm naranjo (nmod:poss)
effects models (nmod)
score bis (compound)
toxicity either (cc:preconj)
avoid not (neg)
% hag (nmod)
combined dextran (nmod)
properties antihypertensive (amod)
agonist with (case)
teratology 4:15 (nummod)
ear to (case)
outpatients for (case)
kinetics appearance (conj)
release meninges (nmod)
appear that (mark)
8.4 3.5 (conj)
e2-induced prostaglandin (nmod:npmod)
diseases medical (amod)
decrease except (case)
visual or (cc)
discriminations sound-silence (compound)
cna and (cc)
problematic pain (nsubj)
delivery the (det)
beta-agonist salbutamol (nmod)
arrest - (punct)
level mrna (nmod)
404 and (cc)
mrna enos (compound)
dopamine striatal (amod)
corresponds this (nsubj)
eighty-four hundred (compound)
5 to (quantmod)
acid 8-hourly (amod)
incidence rejection (nmod)
reports clinical (amod)
day<10 per (case)
find able (ccomp)
advent despite (case)
pneumotachograph through (case)
1.0 0.2 (compound)
naphazoline by (case)
hyperlipidemia , (punct)
range syndromes (nmod)
clonidine after (case)
(2-chloroethyl)-1-nitrosoure to (case)
diseases these (det)
nuclei of (case)
compared study (nsubj)
connects machinery (nmod)
proliferation memory (conj)
pilocarpine by (case)
courses sixty-five (nummod)
exudate obtained (acl)
alternation or (cc)
lesion unilateral (amod)
adults in (case)
report reaction (nmod)
regained consciousness (dobj)
morning in (case)
infection in (case)
shr n (dep)
contribute dose (nsubj)
cavity one (appos)
qtp pbo (conj)
required than (dep)
drug free (amod)
15 to (dep)
children hyperprolactinemia (nmod)
comorbid dyspepsia (nmod)
care best (amod)
leukemia and (cc)
levels other (amod)
tumor-free had (conj)
cacl2 saline (conj)
receptor via (case)
mediates decrease (advcl)
employed practice (nmod)
randomized diet (nmod)
1.63 to (dep)
rage hissing (conj)
metabolite norpethidine (appos)
made acid (nmod)
cardiomyopathy anthracycline (compound)
40 20 (compound)
suppressed aggregability (nsubjpass)
bottle an (det)
expression by (case)
pauses occasional (amod)
pale were (cop)
occurred respectively (advmod)
eye 2002 (nummod)
factors angiogenesis (compound)
dxr ) (punct)
initiate rat (nmod)
reported reach (parataxis)
triglyceride of (case)
hand of (case)
had risk (dobj)
effects impairments (nmod)
veno-occlusive of (case)
important treatment (nmod)
death defect (conj)
patients receiving (acl:relcl)
years preceding (amod)
3/5 ) (punct)
rr increment (nmod)
eight infarction (nmod)
used dose (nsubjpass)
microliters/min 103 (nummod)
edema only (advmod)
period short (amod)
levels cpu (nmod)
art ( (punct)
puberty or (cc)
$ROOT$ reports (sent)
diameters/bw end-diastolic (amod)
p-chlorophenylalamine depletor (appos)
leads conclusion (nmod)
levodopa between (case)
strategy new (amod)
knowledge present (amod)
reports absence (conj)
inhibitor transcriptase (compound)
morphology cells (nmod)
abilities for (case)
reason that (mark)
discuss herein (advmod)
alterations activity (nmod)
fluoropyrimidines 5-fluorouracil (appos)
related has (aux)
switched cyclosporine (nmod)
11 from (case)
(+/-)-pg-9 ] (punct)
levels increased (amod)
used treatment (nmod)
sed 3.4 (conj)
inhibitors six (nummod)
reductions pressure (nmod)
lacn ) (punct)
tubular papillary (conj)
sensitivity rats (nmod)
offset drugs (advcl)
gfr erpf (conj)
type ) (punct)
ameliorated dyskinesia (nsubjpass)
method fractionator (compound)
ctnt ed (conj)
titrated successfully (advmod)
neuropathy drug-induced (amod)
had hemosiderosis (dobj)
13 and (cc)
control contralateral (amod)
treatment-induced levomepromazine-fluvoxamine (nmod:npmod)
54 of (advmod)
double-blind diet- (conj)
anaesthesia continuous (amod)
received dogs (nsubj)
spasm muscle (compound)
sensory also (advmod)
ability l-dihydroxyphenylalanine (nmod)
immediately injection (nmod)
dh ( (punct)
toxicity count (dep)
chemotherapy incorporating (acl)
deferens , (punct)
doses effective (amod)
fibres of (case)
diffusion proton (compound)
degeneration perhaps (advmod)
g/m2 20 (nummod)
role habituation (nmod)
suggest stimulation (dobj)
mg/m2 12 (compound)
tdi group (appos)
characterize we (nsubj)
disease veno-occlusive (amod)
incorporate permitted (conj)
kindreds controls (conj)
activity electromyogram (nmod)
metoprolol and (cc)
anesthetic of (case)
precipitate coupled (advcl)
ph 3.0 (nummod)
months than (case)
components : (punct)
$ROOT$ attain (sent)
elevated only (conj)
suggests determinant (ccomp)
less value (nsubj)
increased value (conj)
ineffective , (punct)
analysis samples (nmod)
judged was (auxpass)
preceded fa (nmod)
helpful case (nmod)
r4 r6 (conj)
those intoxication (nmod)
lesions intensity (compound)
kidneys neonatal (amod)
allele g (compound)
antagonist l-364,718 (dep)
2.5 to (advmod)
dp/dt lv (compound)
cortex striatum (conj)
higher stretches (conj)
apd ) (punct)
highlights fact (dobj)
rate dissolution (compound)
other liver (nmod)
failure infection (conj)
developed thus (advmod)
confounding residual (amod)
interaction : (punct)
increase peroxidation (nmod)
resulted that (mark)
medulla bovine (amod)
dermatitis on (case)
animals given (acl)
recommended those (nmod)
fm ( (punct)
occurrence means (nmod)
nimo of (case)
increased sec/cm5 (nmod)
entered , (punct)
normalized until (mark)
scale behavior (compound)
locomotion the (det)
min-1 of (case)
rate microliters/min (nmod)
control ec (appos)
attributable partly (advmod)
> /= (dep)
children age (dep)
thiopental of (case)
indistinguishable were (cop)
determinant may (aux)
drop titers (nmod)
tachyarrhythmias section (nmod)
remained markers (nsubj)
44 % (appos)
benefits reshaping (nmod)
discontinuing risperidone (dobj)
nitrogranulogen 5-fluorouracil (conj)
reduced extract (nsubj)
recognized adjusted (conj)
depression-inducer a (det)
resulting function (nmod)
lidocaine % (amod)
prophylaxis additional (amod)
had withdrawal (nmod)
less injury (nsubj)
apparent are (cop)
effects deteriorating (amod)
headache a (det)
suffered had (aux)
mmol/l 120 (nummod)
$ROOT$ broadens (sent)
irreversible hus (nsubj)
% 29 (nummod)
contraindicate interfere (conj)
influence calcification (nmod)
treatments as (case)
received bupropion (dobj)
risk latent (amod)
functioning axis (nmod)
risk , (punct)
salts uric (amod)
has didanosine (nsubj)
association initiation (nmod)
determined study (nsubj)
encouraging results (nsubj)
detected decrease (nsubjpass)
escape day (nmod)
mg 73.6 (nummod)
complications fibrillation (nsubj)
dysfunction " (punct)
exposure relaxation (conj)
reduced neurons (dobj)
sigmast p (dep)
likely involved (xcomp)
slowing the (det)
progress grade (dobj)
pilocarpine agonist (compound)
ca3 silver-stained (amod)
databases and (cc)
haematuria asymptomatic (amod)
$ROOT$ evaluable (sent)
report highlight (advcl)
potentiation transmission (nmod)
cardiotoxicity significant (amod)
children transplantation (nmod)
$ROOT$ sulfation (sent)
findings epithelium (nmod)
resistance gastrocnemius (appos)
efficacy : (punct)
improves worsen (conj)
hypersecretion idiopathic (amod)
taking prevention (nmod)
capacity selected (conj)
manifestation be (cop)
control active (amod)
back-diffusion of (case)
disease tdf-related (amod)
toxicity hepatic (amod)
mek1 gsk3alpha (conj)
zdv group (dep)
deficits da (compound)
inhibitor cilostazol (dep)
changes pathological (amod)
changes sessions (nmod)
dialysis reverse (amod)
a bisphenol (compound)
reduced employing (advcl)
post-discharge year (compound)
provision with (case)
24 less (amod)
clinical neuroimaging (conj)
chloroform-adrenaline g (conj)
effect ltp (nmod)
agent dystrophic (amod)
propylthiouracil of (case)
nucleus this (det)
compare in (prep)
tools and (cc)
have capacity (dobj)
rhei rhizoma (compound)
produce bdl (nsubj)
reflected film (nsubjpass)
terminated analysed (conj)
size population (nmod)
oxidation fatty-acid (amod)
coadministered desipramine (nsubjpass)
prevention fibrillation (nmod)
dilate and (cc)
cholesterols in (case)
= mmhg (dobj)
anemia neutropenia (conj)
expressing when (advmod)
inputs system (nmod)
diphenylhydantoin of (case)
reduces receiving (conj)
symptoms patient (nmod)
documented in (mark)
ptpro ) (punct)
adjust range (nmod)
approach therapeutic (amod)
administration precursor (nmod)
c , (punct)
developed been (auxpass)
questionnaire food-frequency (compound)
substituted that (mark)
suffers , (punct)
d1 stage (compound)
$ROOT$ is (sent)
demonstrate induce (ccomp)
effective as (prep)
induced overdose (nmod)
effect function (nmod)
phenols ncr181 (appos)
artery renal (amod)
dvt ) (punct)
allele silent (amod)
links the (det)
tissues their (nmod:poss)
resection alone (advmod)
subscore was (cop)
matter cerebellar (amod)
paradigms selected (amod)
factor hypertension (nmod)
complaints all (predet)
induced indomethacin (nsubj)
analysed using (xcomp)
% 21 (nummod)
mechanisms level (dep)
nascis by (case)
derangement reversible (amod)
factors predisposing (amod)
reduces increases (advcl)
ht long-term (amod)
routes i.v. (amod)
recovery followed (acl)
accompanied damage (nsubjpass)
depression this (det)
db 35 (nummod)
usage frequent (amod)
d-penicillamine d-pen (appos)
improve schedule (dobj)
difficult that (mark)
group rc (compound)
received h (nmod)
patients unit (compound)
received od (nsubj)
observed which (nmod)
choose medications (dobj)
view against (advmod)
area into (case)
respect tdp (nmod)
had value (dobj)
organelles concerning (case)
induces toxicity (dobj)
testing water (compound)
gain importance (dobj)
ml 8.9 (nummod)
exposure simvastatin (compound)
seems complication (xcomp)
sensitive effects (nmod)
g/dl between (case)
evolution the (det)
ceased completely (advmod)
reports few (nummod)
myopathy , (punct)
threshold co2 (compound)
valproate to (case)
abecarrnil ( (punct)
placed segments (nsubjpass)
created shortage (nmod)
evidence force (nmod)
dexamethasone ( (punct)
which by (case)
cells/mm3 was (cop)
context the (det)
alkylxanthines three (nummod)
needs anticoagulation (compound)
prevention reactivation (nmod)
back-diffusion permeability (conj)
intubation for (case)
week initiation (nmod)
restarted . (punct)
choice a (det)
95 13 (conj)
while was (cop)
effective placebo (nmod)
replication and (cc)
receptors pallidal (amod)
injection sc (amod)
$ROOT$ distributions (sent)
cyp27 of (case)
more gradually (advmod)
less iopamidol (nmod)
changed alphabeta-crystalin (dobj)
vt vf (conj)
inhibition this (det)
employed needle (nsubjpass)
hot-plate , (punct)
impairment learning (nmod)
bw ) (punct)
june , (punct)
artery internal (amod)
c+e in (case)
performance in (case)
% above (conj)
motivational creative (conj)
patients dermatoses (nmod)
growth and (cc)
surgery spinal (amod)
pilsicainide , (punct)
showed slowing (dobj)
% 21.4 (nummod)
acute chronic (conj)
transmission the (det)
ratio 10.2 (nmod)
4.10 3.10 (conj)
adducts trifluoroacetyl (compound)
advocate prophylactically (advmod)
cells culture (nmod)
antagonized rigidity (nsubjpass)
exposure development (conj)
had percent (nsubj)
identical , (punct)
vertigo , (punct)
suggested model (xcomp)
age 60 (nummod)
diverging phenotype (nmod)
morphine with (case)
points reflecting (advcl)
undertaken ascertain (xcomp)
5-fold 3.6- (compound)
had injury (dobj)
intra-hisian or (cc)
affected hypothyroidism (nmod)
consisted evaluation (nsubj)
bpm and (cc)
microl i.e. (advmod)
normal roots (nsubj)
measured effects (dobj)
extensively most (advmod)
taxol princeton (appos)
subsided contractions (nsubj)
regarded use (nsubjpass)
evoked injection (nmod)
b2 and (cc)
treated warfarin (nmod)
identification disorder (nmod)
used generate (xcomp)
p.o. metoprolol (compound)
39 10 (conj)
change decreased (advcl)
cases hypercalcemia (nmod)
re-exposure heparin (compound)
reaction reaction (nmod)
atpase sarcoplasmic (amod)
mediated also (advmod)
psa ) (punct)
evaluations , (punct)
3,4-methylenedioxymethamphetamine , (punct)
was hyperhidrosis (ccomp)
kidney functional (amod)
one-on-one proper (amod)
appeared as (mark)
increase of (case)
tolerated therapy (dobj)
affinities their (nmod:poss)
= 74.3 (dobj)
cells groups (nmod)
compared isomers (nsubjpass)
activity anticholinesterase (compound)
divided methods (nsubjpass)
causing % (nmod)
sex damage (conj)
referred had (advcl)
monitor should (aux)
test before (nmod)
inhibitor documented (amod)
given pg (nsubjpass)
decreased suddenly (advmod)
infarct density (conj)
using assessment (dobj)
16/20 % (appos)
product the (det)
localized cc (nsubj)
lf oral (amod)
$ROOT$ occurs (sent)
inhibition likely (advmod)
contraction cava (nmod)
neuroadaptation death (conj)
hyperglycinemia nonketotic (amod)
models testing (acl)
teams surgical (amod)
responsible former (nsubj)
discrimination thermal (amod)
interventions monitored (appos)
duration onset (nmod)
have and (cc)
investigate prevents (ccomp)
cells/l 39 (nummod)
phases task (nmod)
administration prazosin (nmod)
was pressure (nmod)
work-up the (det)
fed group (parataxis)
14c less (amod)
patients oab (nmod)
week prior (advmod)
introduction quetiapine (nmod)
attenuated hyperthermia (dobj)
investigated tool (nmod)
frequent analysis (nmod)
samples hl60 (compound)
doses opioid (nmod)
remain defined (xcomp)
ability patients (nmod:poss)
gtn gtn (dep)
10-diol - (compound)
panel patient (nmod:poss)
tracer of (case)
arrhythmias adrenaline-induced (amod)
rats into (case)
syndrome excess (nmod)
felt cause (xcomp)
significance development (nmod)
used acetaminophen (nsubjpass)
n=25 ( (punct)
performed man (nmod)
effects muscles (nmod)
effects atherosclerosis (nmod)
micrograms/kg 30 (nummod)
pelvis , (punct)
u/l to (case)
receptor-alpha factor (appos)
before and (cc)
related effects (nmod)
present we (nsubj)
val204asp mutation (compound)
sensations limited (acl)
patients pregnancies (nmod)
overloading to (case)
need diagnosis (nmod)
hypertension , (punct)
propranolol intravenous (amod)
support ventilatory (amod)
achieve , (punct)
water c (compound)
hormone trh (appos)
neurotoxicity tacrolimus-induced (amod)
increased velocity (nsubj)
stress later (amod)
infusion quinine (compound)
applied dialysis (nmod)
onset to (case)
tafi pai-1 (conj)
gain content (conj)
od group (nmod)
dogs susceptible (amod)
degeneration recovery (conj)
270 - (dep)
vnb of (case)
1,3-butadiene cml (conj)
ineffectiveness treatments (nmod)
exchange in (case)
$ROOT$ agonist (sent)
time % (nmod)
blood of (case)
greater which (nsubj)
homeostasis calcium (compound)
seems related (xcomp)
hypertension nephrotoxicity (conj)
daily days (nmod)
led properties (nsubj)
$ROOT$ communication (sent)
resulted factor (ccomp)
midazolam mg.kg-1 (appos)
prevention 4 (dep)
remained results (nsubj)
interpolates map (advcl)
value baseline (compound)
compared behaviors (nmod)
exfoliation by (case)
diminishes greatly (advmod)
reliability high (amod)
withheld , (punct)
has controversial (conj)
methotrexate intravenous (amod)
alpha-position in (case)
exposed : (punct)
discontinued immediately (advmod)
consciousness frequency (appos)
demonstrated correlation (nsubjpass)
correction an (det)
results less (appos)
helpful would (aux)
responses dose (nmod)
collected ecgs (nsubjpass)
treatment amiloride (compound)
carcinoma tract (nmod)
occurred , (punct)
function exposure (nmod)
combination patients (nmod)
medication iop-lowering (amod)
signed and (cc)
measured then (advmod)
predicts . (punct)
diameters the (det)
used exhibited (parataxis)
thickness with (case)
viral and (cc)
dietary and (cc)
myocarditis hypersensitivity (compound)
victim with (case)
provides challenges (dobj)
blockage receptors (nmod)
nephrotoxic but (cc)
interrupted penicillamine (nsubjpass)
urine dark (amod)
paralysis atracurium-related (amod)
canaliculi bdl (nmod)
recorded ; (punct)
increases susceptibility (dobj)
ain of (case)
unmatched in (case)
effect enhancing (compound)
medication the (det)
incident a (det)
6 migraineurs (nmod)
malignancy lymphoma (nsubj)
compound potency (nmod)
effacement , (punct)
ocular systemic (conj)
cohort patients (nmod)
stage stage (conj)
pg/ml 300 (nummod)
area of (case)
patients 55 (nummod)
returned day (nmod:tmod)
is range (attr)
$ROOT$ supposed (sent)
ica sinus (conj)
schedule 21-day (amod)
11.2 , (punct)
tobramycin infections (nmod)
pathogenesis failure (nmod)
harvested kidneys (nsubj)
depressed performance (nsubjpass)
secondary agents (nmod)
precipitating reaction (dobj)
outcomes conversion (nmod)
years 530 (nummod)
instillation the (det)
unaffected treatment (nmod)
objective reported (appos)
supplementary motor (conj)
suppressants appetite (compound)
research no (det)
alcohol between (case)
received rad001 (dobj)
report the (det)
associated such (parataxis)
usage ethambutol (compound)
bipolarity , (punct)
use patients (nmod)
second 1 (nummod)
pressure % (appos)
seem it (nsubj)
photodistribution telangiectasia (nmod)
reactions abnormalities (nsubj)
cortex cortex (conj)
tdfs ( (punct)
nightmares . (punct)
$ROOT$ mg/m(2 (sent)
preparations ventricular (amod)
identifiers without (case)
using factors (nmod)
times ci (dep)
effect hemorrhage (nmod)
unaffected ultrastructure (nsubj)
abundance mrnas (nmod)
investigation are (cop)
amines brain (compound)
affects stability (dobj)
90 120 (conj)
antagonism propranolol (compound)
collected patients (nmod)
birth of (case)
stimulants psychomotor (amod)
effective where (advmod)
association a (det)
caused protect (conj)
patients each (appos)
e ( (punct)
complicating donation (dobj)
delineated stimulation (nmod)
$ROOT$ measure (sent)
states with (case)
adherence occurrence (conj)
consumers alcohol (nmod)
explore assessing (advcl)
had continued (ccomp)
studies injury (compound)
adults elderly (amod)
disclosed patients (nmod)
thirty-five hundred (compound)
acquired prior (advmod)
achieved discontinued (conj)
fzp and (cc)
syndrome thrombosis (compound)
gvhd ii-iv (amod)
tolerated , (punct)
assessed nephrotoxicity (nsubjpass)
increase inhibition (dep)
courses one (nummod)
affect particularly (advmod)
mg. ) (punct)
decreased control (nmod)
61.6 8.7 (conj)
often significantly (advmod)
resulted cessation (nsubj)
assumption the (det)
12-week prospective (dep)
measures of (case)
writhing acid (nmod:npmod)
trespass ( (punct)
nd-nmba ) (punct)
offers that (nsubj)
changes infarction (nmod)
littermates transgenic (amod)
increasing an (det)
60 to (dep)
sham vcm (conj)
potent as (advmod)
appears involve (xcomp)
related ingestion (nmod)
effect pharmacological (amod)
$ROOT$ unable (sent)
mice beta4 (amod)
steinert 's (case)
dose area (nmod)
expression myocardial (amod)
min acquisition (nmod)
history jaundice (nmod)
emissions evoked (amod)
increased some (nsubj)
angioedema secondary (amod)
step depends (acl:relcl)
inhibition alfentanil (nmod)
period period (conj)
injection ouabain (compound)
administration exogenous (amod)
nephrotoxicity tobramycin (nmod)
pain injection (nmod)
$ROOT$ warranted (sent)
shift does (aux)
imbalance . (punct)
nephrotoxicity risk (dep)
discussion complication (appos)
evaluated effects (dobj)
downregulation beta-ar (nmod)
mean months (nmod)
extracts lipid (compound)
p 0.01 (dep)
dysfunction post-myocardial (amod)
field of (case)
7 assigned (acl)
depend if (mark)
rate infusions (nmod)
feasible chemotherapy (nsubj)
% 86 (nummod)
torr rats (nmod)
tumors two (nummod)
mg/day misoprostol (conj)
2b1/2b2 p450 (compound)
difference dxnp (nmod)
revealed compared (advcl)
regimens surgery (nmod)
mechanisms least (nmod)
infections systemic (amod)
cross-linking collagen (nmod)
parameters mentioned (amod)
pod 1 (nummod)
initiated order (nmod)
role vip (nmod:poss)
modulate blocking (advcl)
had onset (nmod)
procedure updating (appos)
revealed examinations (nsubj)
gyrus parahippocampal (amod)
psychosis due (amod)
therapy versus (cc)
75 100 (conj)
treatment salvage (compound)
disease childhood (nmod)
increased controls (nmod)
antagonism for (case)
hepatomas and (cc)
l-med d-med (conj)
mater dura (compound)
hypogonadism for (case)
defects 30 (nummod)
scale young-mania (compound)
decreased were (advcl)
correlated production (nmod)
% 18.8 (nummod)
hamartoma occurring (acl)
regulation heart (nmod)
observations our (nmod:poss)
remodelling neuropathy (nmod)
minutes respectively (advmod)
electrophoresis gel (compound)
infection individuals (nmod)
antidepressants serotonergic (amod)
reduced gtn (dep)
nitrazepam of (case)
sn in (case)
blockers k(+)- (compound)
group moderate-dose (amod)
changed was (auxpass)
negative been (cop)
involves and (cc)
increased titres (nsubj)
amlodipine mg (nummod)
bpo-pll ( (punct)
sch 23390 (nummod)
27.1 18.4 (compound)
igf-i receptors (dep)
experiences elicited (amod)
question role (nmod)
animals wt (amod)
communication effects (appos)
15mg/kg ) (punct)
received agonist (dobj)
reverses time (dobj)
instituted . (punct)
increase resistance (nmod)
week a (det)
greater may (aux)
is difference (attr)
toxicity patients (nmod)
treated d-pen (nmod)
drugs hepatotoxic (amod)
examined fields (nsubjpass)
$ROOT$ precise (sent)
focused reported (advcl)
neonates non-exposed (amod)
tpp for (case)
nimodipine low-dose (amod)
entropion instillation (nmod)
poor mostly (advmod)
symptoms dyskinesias (nmod)
reentry av (compound)
interactions p-450 (compound)
spasm coronary (amod)
maximize to (mark)
antagonism effect (nsubj)
taking diltiazem (dobj)
contribute , (punct)
blood % (dep)
olanzapine ziprasidone (conj)
produced woman (nmod)
values serum (compound)
ameliorate may (aux)
toxicity amikacin (compound)
les fps (conj)
using sirolimus (dobj)
contrasted egfp-microglia (nmod)
7 % (dep)
varied depending (prep)
produce , (punct)
products oxidized (conj)
break trees (nmod)
$ROOT$ support (sent)
stimulant adrenoceptor (compound)
analog neurotensin (compound)
hcbd ) (punct)
layers in (case)
rats fed (amod)
size optimal (amod)
associated progression (nmod)
l1-l2 l6-s1 (conj)
hyperventilation sedation (conj)
caused toxicity (dobj)
associated hypothyroidism (nmod)
divided periods (nmod)
fluctuations correlated (acl:relcl)
latencies longer (amod)
results doses (nmod)
contains agents (dobj)
incubated determined (conj)
densities decreased (amod)
mg/m2 level (appos)
hypothesis man (nmod)
examined synergy (dobj)
delay mild (amod)
had : (punct)
taa ) (punct)
monitoring development (nmod)
disease cognition (conj)
slow progression (dobj)
release e2 (compound)
dogs affected (amod)
scabies for (case)
d-penicillamine with (case)
followed 4-aminopyridine (nmod)
days 40 (nummod)
sleep cycles (conj)
dec. ) (punct)
administration h (nmod)
3.3 2.5 (conj)
similar profile (nsubj)
impairment mitochondrial (amod)
pathogenesis that (mark)
internal and (cc)
rates sets (nmod)
tribute ) (punct)
doses granisetron (compound)
increased mmhg (nmod)
that produced (acl)
symptoms propensity (conj)
opistothonus of (case)
causes pattern (dobj)
atracurium of (case)
syndrome digeorge (compound)
administration joint (compound)
positive start (nmod)
audiograms posttherapy (amod)
genes several (amod)
statement consensus (compound)
groups 2 (nummod)
diets containing (acl)
review comprehensive (amod)
a1 monkeys (nmod)
olanzapine , (punct)
occur mutants (nsubj)
assay tumor (compound)
paced he (nsubjpass)
brain csf (conj)
gentamicin ( (punct)
antibody heparin-dependent (amod)
have anomalies (dobj)
superoxide and (cc)
neurosteroids examined (acl:relcl)
treatments cancer (compound)
level stress (nmod)
ammonia nh3 (appos)
procedure their (nmod:poss)
describes effects (dobj)
delivered gd (nmod)
induction in (case)
narrowing vasculitis (conj)
deficits with (case)
allowed self-dosing (dobj)
naloxone mg/kg (appos)
adenomas sporadic (amod)
examined frequency (dobj)
enrolled trial (nmod)
production subcellular (amod)
5-fluorouracil carmofur (conj)
arteritis induced (acl)
retested were (auxpass)
possibility obtaining (acl)
miosis severe (amod)
reduced responses (dobj)
test heparin-induced (amod)
esrd ) (punct)
2/8 ) (punct)
regulation for (case)
developed degree (nsubj)
completing ( (punct)
solid hematological (conj)
ptosis and (cc)
gd ) (punct)
average months (nmod)
deposition without (case)
cyclophosphamide to (case)
e. in (case)
predictors vaccination (nmod)
nuclei pontis (conj)
include fever (dobj)
live . (punct)
comparison . (punct)
events haart (nmod)
occurs treatment (nmod)
and weeks (appos)
achr. of (case)
strains murine (amod)
acceptable care (nmod)
loss patients (nmod)
$ROOT$ patient(s (sent)
ineffective antiparkinsonians (nsubj)
rate reporting (compound)
feasible . (punct)
evidence tamponade (nmod)
patients unrelieved (acl:relcl)
5-fluorouracil continuous (amod)
effect activation (compound)
rare maha (nsubj)
performed ileostomy (nsubjpass)
administration diazepam (nmod)
hbeag anti-hbe (appos)
microangiopathy nephritis (conj)
demonstrated and (cc)
auc carboplatin (compound)
half for (case)
disinhibition to (case)
patients warrants (acl:relcl)
reaching months (nmod)
$ROOT$ prudent (sent)
reversal patients (nmod)
studied while (mark)
equal to (nmod)
face intoxication (nmod)
referrals consecutive (amod)
study dysfunction (nmod)
conclude has (advcl)
toxicity versus (cc)
antagonizes reversing (advcl)
later month (nmod:npmod)
tubular the (det)
mechanisms distinct (amod)
found 1983 (nmod)
symptoms further (amod)
incidence a (det)
degeneration focal (amod)
inhibition from (case)
density content (conj)
laboratories chicago (appos)
22 ) (punct)
ed-1 increased (amod)
sulfation acid (nmod)
examined we (nsubj)
membranes glomerular (amod)
limited usefulness (nsubjpass)
dependent reversed (conj)
biopsies performed (acl)
conclude recommended (ccomp)
skf d1 (compound)
nmol/l ( (punct)
switch immunosuppression (nmod)
destructive overload (nmod)
follow changes (dobj)
agc relapsed (amod)
killed processed (conj)
disturbances patients (nmod)
morphology on (case)
6.1 0 (compound)
responses virological (amod)
differ studies (nmod)
development rats (nmod)
postulated are (auxpass)
therapy intrathecal (amod)
vagal neither (cc:preconj)
motility diagnosis (nmod)
necessary radiopharmaceuticals (nsubj)
wt cyp (nmod)
states sensitization (compound)
reported % (advcl)
lost rats (nmod)
necrosis = (dep)
levels her (nmod:poss)
research of (case)
revealed numbers (dobj)
similar dosage (nsubj)
impairment , (punct)
disappeared features (nsubj)
pressures volume (conj)
efficacy alprazolam (nmod)
imply disorder (dobj)
moran . (appos)
precurarization rocuronium (nmod)
latency step-down (amod)
extracts homogenates (nmod)
density channel (compound)
remained min (nmod)
replication strains (nmod)
outcome signs (nmod)
development complication (nmod)
143 13 (compound)
measures resistance (nmod)
focused study (nsubj)
day 7 (nummod)
experiences observed (amod)
temporary permanent (conj)
1328 1339 (prep)
0.60 1.76 (prep)
influence catalepsy (dobj)
transplantation stem (compound)
iq verbal (amod)
manifestation initial (amod)
release expression (conj)
metabolizers as (case)
used protocols (nsubjpass)
injection bupivacaine (nmod)
role factor (nmod)
ended july (nmod)
therapy the (det)
baroreceptors the (det)
enzymes diagnostic (amod)
response patients (nmod)
hepatotoxicity the (det)
mdma 3,4-methylenedioxymethamphetamine (appos)
produces , (punct)
risk be (cop)
manner patchy (amod)
68 +/- (cc)
use intrathecal (amod)
addition evaluation (nmod)
used been (auxpass)
important confirmed (advcl)
benzylpenicilloyl-poly-l-lysine benzylpenicilloate (conj)
pain leg (compound)
52 37 (compound)
amb concomitant (amod)
strain balb/c (compound)
valproate on (case)
immunohistochemistry assay (conj)
infusion ph (nmod)
established have (aux)
chamber procedures (conj)
caused dysfunction (nsubjpass)
suggests data (nsubj)
patient took (acl:relcl)
association an (det)
$ROOT$ affects (sent)
studies crossover (amod)
agent noradrenaline-uptake (compound)
gag/pol tg (appos)
odds times (nmod)
risperidone ( (punct)
duct blocked (amod)
type some (det)
prevent decrease (dep)
utility identifying (advcl)
rate higher (amod)
increase dox-induced (amod)
exhibited hybrid (nsubj)
therapy a (nmod)
documents patient (dobj)
dose nonsedating (amod)
28 ( (punct)
needed numbers (nsubjpass)
revealed edema (dobj)
manometry jejunal (amod)
increase doses (nsubj)
underwent re-resection (dobj)
suffer patients (nsubj)
concentration normal (amod)
hospitals the (det)
was pain (attr)
d acid (appos)
initiated propagated (conj)
hours was (cop)
cessation heparin (nmod)
migraine % (appos)
syndrome arthralgia-myalgia (compound)
strategy therapeutic (amod)
abstinence years (appos)
baseline of (case)
2.1 53 (prep)
result syndrome (nmod)
icterus , (punct)
microg/ml td (nmod)
variability intra- (amod)
% 69 (nummod)
administration chlorthalidone (compound)
had hyperkinesis (nmod)
tariquidar rats (nmod)
reported noted (conj)
reverse not (neg)
dosing post (case)
doses diuretics (nmod)
loop motor (compound)
mild relatively (advmod)
of out (advmod)
22.5 49.75 (prep)
vd l/kg (dep)
overdose g (nmod)
% 3.6 (nummod)
% 2/51 (appos)
participation the (det)
conclusion provides (appos)
had micrographs (nmod)
iq memory (conj)
transplantation liver (compound)
use surgery (nmod)
are there (expl)
group microg (compound)
factor disorder (nmod)
activity withdrawal (conj)
experienced total (dobj)
agents calcium (compound)
years 62 (nummod)
1mg/kg min (appos)
patients thirty-four (nummod)
learn rats (nmod)
those of (case)
palpitation , (punct)
returned normal (nmod)
doing children (nsubj)
activity due (amod)
rate discontinuation (compound)
effects p-coumarate (nmod)
headaches intermittent (amod)
post-infusion of (case)
mutants of (case)
sodium to (case)
groups recipients (nmod)
leading failure (nmod)
developed albuminuria (dobj)
reduced enalapril (nsubj)
maintain to (mark)
dyskinesias ) (punct)
coadministration the (det)
administered antithrombin (nsubjpass)
detection deterioration (nmod)
targeted residue (nsubjpass)
taken caution (nsubjpass)
exposure occupational (amod)
males 11 (nummod)
patients presented (acl:relcl)
captopril with (case)
pc02 : (punct)
definition . (punct)
prevented castration (nmod)
probable probable (conj)
mv/s to (case)
noted addition (nmod)
achieved seven (nsubj)
develop test (dobj)
d the (det)
increase 1 (dep)
mm 150 (nummod)
haloperidol of (case)
catatonia ketamine (compound)
tolerability effectiveness (conj)
patients second-line (amod)
study microscope (compound)
$ROOT$ arrhythmia (sent)
pain rest (nmod)
support : (punct)
preferable anaesthesia (nmod)
valproate polfa (appos)
drugs used (acl)
$ROOT$ antifolate (sent)
suggests study (nsubj)
children 123 (nummod)
affected rate (nmod)
conscious patient (nsubj)
models failure (nmod)
anencephaly adjusted (dep)
extended-release/lovastatin mg (appos)
493 +/- (cc)
function renal (amod)
seems mediated (xcomp)
atac ( (punct)
alkaloid pro-arrhythmic (advcl)
ob ) (punct)
5,7-dcka ( (punct)
verapamil both (cc:preconj)
group ato (compound)
vacuolization rough (amod)
neutropenia females (nmod)
hexamethonium of (case)
treatment cirrhosis (nmod)
hour within (case)
decreased p<0.001 (dep)
occurred differences (nsubj)
failure graft (compound)
groups deprived (amod)
accompanied levels (nmod)
evidence support (acl:relcl)
iu/kg 1000 (nummod)
airway of (case)
bruising and (cc)
constipation-predominant = (dep)
stroma by (case)
responses cpap (nmod)
characterized sensitization (nmod)
report party (nmod)
toxicity intrathecal (amod)
sessions repeated (amod)
beats/min frequency (nsubj)
subjected administration (nmod)
follow closer (amod)
activation numbers (conj)
choice first (amod)
antagonist 5-ht (compound)
form acid (appos)
site at (case)
ureter of (case)
identical be (cop)
lethality some (det)
% 14.8 (nummod)
complications maternal (amod)
stage of (case)
oxycodone immediate-release (amod)
had cross-reacting (conj)
parasitosis patient (nmod)
developed administered (advcl)
dose less (acl:relcl)
caused dogs (nmod)
overdose accidental (amod)
index iief (appos)
monotherapy and (cc)
inserted resuscitation (nmod)
defects selected (amod)
arrest a (det)
kg(-1 micromol (compound)
susceptible more (advmod)
dopamine endogenous (amod)
recommended whereas (mark)
irrigated h (nmod)
anemia patient (nmod:poss)
doses for (case)
$ROOT$ seizure (sent)
quinine- and (cc)
seen was (auxpass)
magnitude a (det)
metastasis liver (compound)
dysfunction age (conj)
rose , (punct)
$ROOT$ 7.0 (sent)
test classic (amod)
administered intravesically (advmod)
elevation no (neg)
valproate or (cc)
204 9 (compound)
stenosis ( (punct)
began signs (nsubj)
late h (nmod)
intervals , (punct)
began treatment (dobj)
studies urodynamic (amod)
size lesions (nmod)
co-carcinogen as (case)
variables and (cc)
support observation (dobj)
% 2 (nummod)
quality health (conj)
fev1 the (det)
efficacy cost (conj)
analysis stones (nmod)
changes morphologic (amod)
patients surgery (compound)
efficacy trial (nmod)
use prophylactic (amod)
nephrosis in (case)
aggravating disability (dobj)
ug.kg-1 1 (nummod)
aetiologies possible (amod)
ug/ml ug/ml (conj)
worsening condition (nmod)
occurred pointes (nsubj)
estimated manner (nmod)
apo ( (punct)
resistant completely (advmod)
phz ( (punct)
3.5 1.26 (nummod)
tiapride or (cc)
cephalosporins and (cc)
improve it (nsubj)
another for (case)
fenoldopam and (cc)
digitalis- adrenaline-induced (conj)
valves and (cc)
< ; (punct)
pallidotomy in (case)
properties prominent (amod)
sensitivity the (det)
cases children (nmod)
concentration methothexate (compound)
phospholipid hdl (conj)
minutes , (punct)
% 1.6 (nummod)
effect b (nmod)
determined hbsag (nsubjpass)
injury isoproterenol-induced (amod)
lt lt (conj)
reduced infusion (nmod)
preserved ; (punct)
$ROOT$ appearance (sent)
infusion vein (compound)
interpreted . (punct)
cirrhosis cryptogenic (amod)
compared mg (nmod)
associated return (nmod)
effect injection (nmod)
metabolism oxidase (nmod)
target effects (nmod)
composite outcome (nsubj)
responsible could (aux)
diatrizoate ( (punct)
luke st. (compound)
stages different (amod)
decompression of (case)
response blockage (nmod)
% 2.6 (nummod)
sent questionnaire (dobj)
h one (nummod)
sensitive also (advmod)
reduction beginning (acl)
studies cerebellum (nmod)
measured binding (nmod)
polychemotherapy under (case)
removed examination (nmod)
[ca]o on (case)
antagonists ketamine (nmod)
practices 143 (nummod)
in mainly (advmod)
5-fu + (cc)
dogs study (nmod)
6 of (advmod)
time accumulation (nmod)
reduces etomidate (nmod)
suggest antagonist (advcl)
experiments n- (nmod)
fibrosis quantified (acl)
duration elevation (conj)
infant a (det)
n=101 ) (punct)
plans echocardiography (nmod)
decline functional (amod)
ci:0.3 95 (amod)
depressed lasting (acl)
enhanced none (nsubj)
ppi of (case)
hepatocytes in (case)
cin factors (conj)
verapamil by (case)
alcohols sugar (compound)
receiving drugs (dobj)
channels nachrs (nsubj)
trends and (cc)
tubules convoluted (amod)
excluded results (nsubjpass)
teratogenic as (advcl)
myocet combination (nmod)
carboplatin nor (cc)
steroids dose (compound)
reconsidered dose (nsubjpass)
insecticide . (punct)
bfgf of (case)
2-component a (det)
affected uptake (nsubjpass)
preferable prilocaine (nsubj)
behaviors induced (amod)
conditions failure (appos)
vomitus loss (appos)
trial iii (nummod)
affect probability (dobj)
rose because (mark)
circumstances , (punct)
bronchiectasis infection (nmod)
field temporal (amod)
therapy replacement (compound)
seizures new-onset (amod)
cause probable (amod)
found being (auxpass)
treated versus (cc)
continued drug (nsubjpass)
pressures pressure (conj)
c mmc (appos)
epirubicin paclitaxel (conj)
norepinephrine epinephrine (conj)
raloxifene to (case)
toxicities acute (amod)
lasting h (nmod:tmod)
$ROOT$ triggers (sent)
had syndrome (dobj)
hypothesis appear (ccomp)
overactivation with (case)
% 0.03 (nummod)
reflected increase (nmod)
day alternate (amod)
oncologists and (cc)
toxicity treatment-related (amod)
collected injection (nmod)
h gamma-hch (dep)
% 30.3 (nummod)
encoding recalling (conj)
potently methoctramine (nmod)
tafi tpa (conj)
znso(4 by (case)
formed that (mark)
informed well (advmod)
taken period (nmod)
documented angiograms (nmod)
nitrate and (cc)
authors two (nummod)
decision continue (acl)
termination regeneration (nmod)
syndrome use (conj)
growth resulting (acl)
infection bronchoconstriction (conj)
serotonin with (case)
gbm ( (punct)
formed only (advmod)
aggravates and (cc)
effect cns (compound)
abuse long-term (amod)
cases ten (nummod)
response product (nmod)
frontal temporal (conj)
compared % (nmod)
h discontinuation (nmod)
nms of (case)
which to (case)
rose again (advmod)
also . (punct)
atrophy groups (nmod)
potencies anaesthetic (amod)
mg/m2 . (punct)
using frlma (dobj)
had consequences (dobj)
effect to (mark)
review cases (nmod)
onset or (cc)
injection 2-chloroprocaine-ce (nmod)
maturation cerebellum (nmod)
used analysis (nmod)
tensions evoked (amod)
centre vasomotor (amod)
cases 22 (nummod)
forming and (cc)
rate continuation (nmod)
days mice (nmod)
groups % (appos)
b. of (case)
exceeded medium (nmod)
treated modulators (nmod)
treatment bupropion (nsubj)
deviation sd (appos)
caffeine effect (conj)
pain tonic (amod)
systems intrinsic (amod)
development cardiotoxicity (nmod)
given first (advmod)
selected cases (dobj)
referred department (nmod)
hypothesized thus (advmod)
extent staining (nmod)
penetration fluid (compound)
flecainide substrate (appos)
likely while (mark)
remains indicating (xcomp)
receptor mediates (conj)
gain abnormal (amod)
exerts : (punct)
doses therapies (nmod)
evidence angiographic (amod)
bradycardia dysphagia (conj)
secondary inhibition (nmod)
norleucine epsilon-aminocaproate (conj)
yrs versus (cc)
5-azc and (cc)
effect hr (nmod)
had however (advmod)
had encephalopathy (nmod)
mutants resistance (nmod)
occurred incidence (nmod:npmod)
months cessation (nmod)
caused types (nmod)
causes pethidine (nsubj)
rates patients (nmod)
% 9.1 (nummod)
79.6 10(6 (conj)
unaffected pretreatment (nmod)
exceeded hit (nmod)
seizures concentration (conj)
physicians personal (conj)
functioning of (case)
tasks only (advmod)
evaluated effect (dobj)
countries world (nmod)
group vehicle/scopolamine (compound)
g/dl of (case)
complication this (det)
opiate of (case)
$ROOT$ absorption (sent)
dfo ( (punct)
concentration was (cop)
exerting in (mark)
amount nephrin (nmod)
preserved mechanisms (nsubjpass)
173 4 (conj)
undergoing conditioning (dobj)
% boys (nmod)
included locomotion (dobj)
hearts animals (nmod)
cause agents (nsubj)
induced anesthesia (nsubjpass)
disturbances transport (nmod)
elucidate analysed (parataxis)
upregulated downregulated (conj)
useful as (advmod)
vision blurred (amod)
model pain-induced (amod)
revealed tests (nsubj)
program ophthalmic (amod)
diagnosis injury (nmod)
acute on (case)
producing injury (dobj)
attribute specifically (advmod)
stimuli punctate (amod)
apparent yet (advmod)
treated combined (conj)
enantiomer than (case)
declined rate (nsubj)
acc ( (punct)
chebula of (case)
% recipients (nmod)
bd1018 lr132 (conj)
management myoclonus (nmod)
appropriate may (aux)
potentiation by (case)
increased pressure (dobj)
infrequent bupivacaine (nmod)
treatment groups (nmod)
drugs pro-absence (amod)
engaged that (mark)
received iodixanol (dobj)
properties in (case)
76 9 (conj)
obtained group (nmod)
phosphate-diaphorase adenine (compound)
response defined (acl)
interaction enhances (acl:relcl)
lidocaine placebo (conj)
death from (case)
differences related (amod)
lead incidence (nmod)
received micrograms/kg/hr (dobj)
atenolol the (det)
practitioners dental (amod)
non-drug ) (punct)
can proteinuria (conj)
kinetics the (det)
cellular neither (cc:preconj)
mg 0.5 (nummod)
disease pulmonary (amod)
recommended are (auxpass)
discussed similarity (nsubjpass)
combination its (nmod:poss)
$ROOT$ measured (sent)
demonstrate effectiveness (dobj)
partially that (mark)
sensitizing tissues (dobj)
tolerate 13 (nsubj)
activity mitogen (compound)
mitochondria interfibrillar (amod)
enzyme a (det)
arise should (aux)
nephropathy gentamicin-mediated (amod)
correspond . (punct)
sometimes also (advmod)
treatment years (nmod:poss)
regimen pb (compound)
hernia rabbits (nmod)
partially only (advmod)
12- 48-h (conj)
receptor-alpha proliferators (compound)
associated ocs (nmod)
treated disulfiram (nmod)
minutes administration (dep)
conclusion results (appos)
serum-albumin for (case)
15 only (advmod)
seizures deficits (conj)
$ROOT$ effective (sent)
stimulation hyperemic (amod)
striatum of (case)
received np (dobj)
comparable is (cop)
microinjection function (nmod)
responses short-latency (amod)
muscles masseter (compound)
cardiotoxicity cessation (nmod)
suggested mechanisms (nsubjpass)
cns of (case)
restrictive be (cop)
modulates negatively (advmod)
marker inflammation (nmod)
normalization , (punct)
hypotension methyldopa-induced (amod)
pretreatment betaine (compound)
substantial that (mark)
l-noarg or (cc)
increased bradycardia (dobj)
have h (nmod)
data neuroimaging (compound)
induction sevoflurane (nmod)
complications : (punct)
behaviors model (nmod)
hypersensitivity , (punct)
associated variety (nmod)
use its (nmod:poss)
patient , (punct)
lesions mimicking (acl)
higher ratios (nmod)
evaluated ( (punct)
overexpression of (case)
risk users (nsubj)
investigation in (case)
administrations repeated (amod)
developed obtained (advcl)
hypoxia syndrome (nmod)
estrogen serum (compound)
injection intraspinal (amod)
brigham and (cc)
received p (dobj)
congestion with (case)
sites calcification (compound)
essential integrity (nsubj)
hypothyroidism hypercalcemia (conj)
trated , (punct)
morphology and (cc)
withheld run-in (nmod)
found doses (nmod)
influence ic (nmod)
used arrest (xcomp)
anaesthesia for (case)
clinical radiographic (conj)
profile or (cc)
centuries two (nummod)
described frequency (nmod)
serological functional (conj)
feeding high (amod)
albumin urine (compound)
reports studies (conj)
boys in (case)
matrix of (case)
0.1 ( (punct)
completed ) (punct)
ndi ( (punct)
induces : (punct)
decrease sensitivity (dep)
mediators seizures (nmod)
disappointing been (cop)
dormex with (case)
clarify vivo (advmod)
reports despite (case)
in later (advmod)
pattern nag (compound)
actions clonidine (nmod)
accumulation lower (amod)
effects quantified (acl)
responsible improvement (nmod)
23 4 (conj)
< 0.001 (dobj)
inhibitor 3-hydroxy-3 (compound)
mice fifty-five (nummod)
interference efficacy (nmod)
micrograms/kg 10 (nummod)
indomethacin naproxen (conj)
supplements from (case)
values with (case)
paraplegia . (punct)
ameliorated and (cc)
anorexigens : (punct)
site effects (nmod)
dose levels (nmod)
locf mmrm (conj)
therapy arthritis (nmod)
transport transmural (amod)
changes patient (nmod:poss)
compared edds (nsubjpass)
follow-up by (case)
demethylase ndma-d (appos)
cases vasospasm (nmod)
clonus rats (nmod)
$ROOT$ females (sent)
aggravation early (amod)
was report (xcomp)
mechanisms antioxidant (amod)
placebo enalapril (conj)
dmso/side ) (punct)
noted implant (nmod)
cause frequent (advcl)
patients nonsmall (amod)
pharmacokinetics hcl (nmod)
metoprolol management (conj)
resulted co-administration (nsubj)
growth for (case)
school department (appos)
prescribed cephalexin (dobj)
predominance involvement (nmod)
developed = (parataxis)
this for (case)
neuroleptics ( (punct)
utilized population (nmod)
steroids contraceptive (amod)
intermediates halide (compound)
administered combination (nmod)
28 17 (compound)
kg(-1 c. (dep)
diabetic both (cc:preconj)
positive mssa (nmod)
administered marmosets (nsubjpass)
contents maximal (amod)
minutes few (amod)
groups treated (amod)
caffeine mg/kg (dep)
phenobarbitone- carbamazepine-induced (conj)
metastases brain (compound)
a recovery (nmod)
cells 000 (nummod)
criteria and (cc)
accumbens in (case)
validity hypothesis (nmod)
wt g (compound)
$ROOT$ 14,671 (sent)
due shock (nmod)
treated a (nmod)
induces paraparesis (dobj)
offered surveillance (dobj)
$ROOT$ blood (sent)
phenotype myocytes (nmod)
events conclusion (nmod)
deterioration , (punct)
diffusion decreased (amod)
reductions assessed (acl)
d4.4 d4.7 (conj)
different events (nsubj)
repeat , (punct)
$ROOT$ min (sent)
surgery region (nmod)
methods radiculopathy (nmod)
myopathy persists (acl:relcl)
effective extremely (advmod)
effects use (nmod)
disorder conduction (compound)
prevented where (advmod)
admission their (nmod:poss)
doses administration (compound)
compromise severe (amod)
arrhythmias induced (acl)
acute or (cc)
para-aminohippurate pah (appos)
starting diagnosis (nmod)
hematuria with (case)
development neuropathy (nmod)
indistinguishable was (cop)
incidence greater (amod)
history by (case)
showed veins (nmod)
subtle findings (nsubj)
subunit of (case)
convulsant sensitizing (conj)
rats subject (amod)
dynamics concentration (conj)
depressions occurring (acl)
had prazosin (nsubj)
function treatment (nmod)
krebs-ringer control (amod)
18/88 +/- (cc)
gave and (cc)
number intersections (nmod)
group methadone (compound)
hr injection (appos)
min after (case)
6.7 and (cc)
found increases (nsubjpass)
lacnp ( (punct)
responsible this (nsubj)
reduce spironolactone (nsubj)
other to (case)
infusions microgram/kg/min (nmod)
dose decrease (acl:relcl)
contained cc (dobj)
all nitrogen (nmod)
mg/day 100 (nummod)
bands bands (nsubj)
location or (cc)
blocked behavior (dobj)
improved who (nsubj)
alter physiology (dobj)
remedy to (mark)
sulfation cholestasis (nmod)
treatment cbz (nmod)
efficacy treatment (nmod)
l/kg 0.33+/-0.09 (nummod)
triggers turn (nmod)
metastases marrow (compound)
oih ( (punct)
% 36.3 (nummod)
jj compared (case)
signs administration (nmod)
synapses collateral-ca1 (compound)
toxicity its (nmod:poss)
% 17.2 (nummod)
included analysis (nmod)
bn right (amod)
facies of (case)
mortality cardiovascular (amod)
manifested animals (nsubj)
pneumonia . (punct)
nausea no (neg)
problems behavioural (amod)
present which (nsubj)
is followed (ccomp)
administration thiabendazole (compound)
fibers muscle (compound)
self-limited . (punct)
control baroreflex (compound)
dose mitoxantrone (nmod)
wakefulness activity (conj)
hiccups drug-induced (amod)
nr1(neo-/- ) (punct)
23.9 26.7 (conj)
carriers are (cop)
oils lemon (compound)
drugs ingested (amod)
acid days (nmod:tmod)
mortality disease (compound)
given can (aux)
followed patient (nsubjpass)
testing intradermal (amod)
pain strong (amod)
authors the (det)
remain , (punct)
titrated could (aux)
ml/min 1.03 (nummod)
developmental treatment (conj)
mm lna (appos)
metrizoate than (case)
exhibited growth (nsubj)
enzyme serum (compound)
leukemia apl (appos)
pretreating by (mark)
tract respiratory (amod)
potent and (cc)
% % (appos)
therapy all-trans-retinoic (amod)
responders ) (punct)
cortex medulla (dep)
vegf and (cc)
preceded monoher (nmod)
symptoms schizophrenia (nmod)
level ros (nmod)
recovery hepatic (amod)
32 12 (conj)
anemia methyldopa-induced (amod)
inhibitory and (cc)
thrombocytopenia 4 (nummod)
observed hypotension (nmod)
assessed association (nsubjpass)
instituted instead (advmod)
three syndrome (dep)
dose 50 (nummod)
edema cause (acl:relcl)
activity alpha (compound)
studied long (advcl)
e vitamin (compound)
increase net (amod)
model used (amod)
branch distal (amod)
area periventricular (amod)
using giving (advcl)
neuroblastoma in (case)
receiving course (dobj)
suppressed expression (dobj)
proposed we (nsubj)
0 at (case)
55 +/- (cc)
reported common (advcl)
patients arthritis (compound)
changes neurocognitive (amod)
discontinued temporarily (advmod)
results resulted (appos)
galactose of (case)
exist background (dep)
weeks 66 (nummod)
conditions optimized (amod)
0.63 and (cc)
unreasonable it (nsubj)
% norms (nmod)
exacerbations with (case)
that as (case)
ligation digitalis (conj)
hemorrhage induced (acl)
changes dexamethasone-induced (amod)
azotemia creatinine (dep)
factors in (case)
undertaken intervals (nmod)
n-methyl-d-aspartate by (case)
lymphoma refractory (amod)
phenylephrine given (dep)
group iv (nummod)
suggests fact (nsubj)
degree and (cc)
therapies various (amod)
dependent cardiotoxicity (nsubj)
$ROOT$ n-acetyl-beta-d-glucosaminidase (sent)
deficits on (case)
hg groups (nmod)
increases antagonizes (conj)
found literature (nmod)
dismutase or (cc)
worsening score (nmod)
hem ) (punct)
agent represses (acl:relcl)
relationship any (advcl)
$ROOT$ participation (sent)
adjustment rapid (amod)
proliferation hepatomegaly (conj)
efficacy agent (nmod)
sites for (case)
remains unclear (acomp)
reduced manner (nmod)
established were (auxpass)
glucuronidation extensive (amod)
anesthetics enflurane (appos)
1/10 to (case)
five thrombosis (nmod)
include inhibitors (dobj)
unknown details (nsubj)
processes leading (acl)
increase light (amod)
relate development (nmod)
had duration (nsubj)
cause aids (nsubj)
remained % (nsubj)
face of (case)
revealed lowered (ccomp)
regrowth a (det)
influence significantly (advmod)
secretion [14c]biliary (amod)
medulla of (case)
tablets 50-mg (compound)
adjustment ph (compound)
tested weeks (nmod)
decreased group (advcl)
kcn of (case)
hypokalaemia of (case)
concentrations blood (nmod)
reduction number (nmod)
had although (mark)
combination factors (nsubj)
involvement reactivity (nmod)
incidence episodes (nmod)
8/33 [ (punct)
origin a (det)
coadministration carvedilol (nmod)
increases to (case)
exists evidence (nsubj)
cortex stem (conj)
abundant ; (punct)
insertion of (case)
visualize time (nmod)
life-threatening occasionally (advmod)
damage could (aux)
demonstrated ) (punct)
nsaids ) (punct)
resolved picture (nsubj)
estrogens on (case)
$ROOT$ augments (sent)
depression users (nmod)
haemorrhage due (case)
defect septal (amod)
paramethasone triniol (appos)
animals e-i (compound)
mg/dl day (nmod:tmod)
eminence median (amod)
tremor , (punct)
cells necrotic (amod)
globulin prophylaxis (nmod)
normalized recovery (nmod)
increase pressure (dobj)
microl 15 (nummod)
result become (advcl)
del > (punct)
exacerbation deficits (nmod)
antidepressant nassa (appos)
leading therapy (nmod)
preservatives of (case)
assess effects (dobj)
taken however (advmod)
found later (advmod)
literature english (amod)
received cab (dobj)
3.4 +/- (cc)
3-methyladenine inhibitor (appos)
showed risk (dobj)
effects cardioprotective (amod)
has impact (dobj)
experiences adverse (amod)
involved failure (dobj)
curve dose-response (amod)
interval at (case)
complained drowsiness (nmod)
detectable suggesting (advcl)
$ROOT$ unrelenting (sent)
patients dependence (compound)
ifo mesna (conj)
rated subjects (nsubj)
transport extraction (conj)
hernia vsds (conj)
compared recorded (conj)
pontine posterior (conj)
drop normal (amod)
normal subsequently (advmod)
weeks 17 (nummod)
absence determined (acl)
death neuronal (amod)
remained hyperactivity (nsubj)
treatment analgesic (compound)
useful mediated (advcl)
in older (amod)
activity excellent (amod)
reduced ccb (nsubjpass)
establishes , (punct)
showed developed (parataxis)
reductions in (case)
patients 31 (dep)
maintained status (nmod)
system systemic (amod)
norms the (det)
$ROOT$ resuscitation (sent)
considered early (advmod)
rat dose (nmod)
behaviors pain (compound)
percent parents (nmod)
diopters between (case)
died girl (nsubj)
anaesthetics halothane (dep)
migraine hemiplegic (amod)
time , (punct)
deficiency with (case)
marrow hypocellular (amod)
blocker atropine (appos)
21/63 % (appos)
model heart (compound)
veins of (case)
n-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide with (case)
test catalepsy (compound)
animals rats (conj)
situations causing (acl)
anaesthesia isoflurane (compound)
effect behavior (nmod)
anxiety nervousness (conj)
process ageing (compound)
pneumonitis amiodarone (compound)
documented studied (advcl)
result exacerbation (nmod)
minutes cimetidine (dep)
receiving mannitol (nmod)
assigned weeks (nmod)
indicated latency (nmod)
described decrease (advcl)
fischer f344 (appos)
headache were (cop)
documents study (nsubj)
acid-ergic gamma-aminobutyric (amod)
chf ( (punct)
dose course (conj)
fasciitis . (punct)
fed examine (advcl)
implanted measure (xcomp)
ptra ) (punct)
risk than (case)
elevated baseline (nmod:npmod)
risk significant (amod)
taking clozapine (dobj)
selenium of (case)
ileostoma from (case)
assessed protein (nsubjpass)
cases colitis (nmod)
has this (nsubj)
boluses boluses (conj)
elevation possible (amod)
medication effects (nmod)
resuscitation advanced (amod)
alfentanil opiates (conj)
benefits potential (conj)
implications studies (nmod)
had sister (dobj)
show activity (dobj)
suggests together (advmod)
occurred switches (nsubj)
ppa before (case)
times 3 (compound)
elevated tests (nsubj)
myocarditis ) (punct)
eeg ( (punct)
administration mesna (compound)
convulsions clonic (amod)
administrations daily (amod)
consumed att (dobj)
escape combined (amod)
investigated use (dobj)
rates long-term (amod)
improving treatment (dobj)
smaller s (nmod)
plays drd2 (nsubj)
indicators sensitive (amod)
stress glomeruli (nsubj)
kanamycin-colistin and (cc)
artery i. (dep)
variants mutants (appos)
dfmo plus (cc)
mhb ) (punct)
ng.ml-1 , (punct)
data and (cc)
hyperactivity on (case)
receive irradiation (dobj)
off " (punct)
have known (advcl)
increased accuracy (nsubj)
labeling improved (amod)
arteries ganglia (conj)
treatment bortezomib (nsubj)
inflammation ocular (amod)
participation ototoxicity (nmod)
given melatonin (nsubjpass)
injection peripheral (amod)
ecg and (cc)
activity nigral (amod)
return rosc (appos)
hypotension symptomatic (amod)
n=100 ( (punct)
biopsy myocardial (amod)
achieve normocarbia (dobj)
removed analysis (nmod)
discharge the (det)
signs without (case)
injection methyldopa (compound)
patients 59 (nummod)
prilocaine % (amod)
had combination (dobj)
metabolism of (case)
rate increased (amod)
n-methyl-d-aspartate agonist (compound)
women pregnancy (nmod)
administration agents (nmod)
sites striatum (nmod)
toxicity caffeine (compound)
g/day 2.76 (nummod)
trial cancers (nmod)
$ROOT$ shares (sent)
fluctuations and (cc)
neutropenia especially (advmod)
considered complication (nsubjpass)
curves d-tubocurarine (nmod)
occluded was (auxpass)
diseases benign (amod)
series of (case)
period 60-min (amod)
impairments neurocognitive (amod)
findings pathologic (amod)
had cats (nsubj)
volume enzyme (compound)
instances toxicity (nmod)
difference counts (nmod)
activity acetylcholinesterase (compound)
(+)-isomer mg/kg (appos)
adjust reducing (advcl)
seizure running (compound)
placed beclomethasone (nmod)
c57bl/6j , (punct)
established involvement (nsubjpass)
conducted cells (nmod)
appearance seizures (nmod)
levels species (nmod)
given hepatectomy (nmod)
w/v ) (punct)
decrease [ca]o (nmod)
mechanisms receptor (compound)
destruction , (punct)
behaviors animals (nmod)
catecholamine of (case)
recommended can (aux)
sensitive particularly (advmod)
clarify role (dobj)
months by (case)
gtn vs. (cc)
exacerbations to (case)
subject on (case)
groups four (nummod)
anemia p (dep)
deformities orthopaedic (amod)
men fourteen (nummod)
likelihood controls (nmod)
early striking (conj)
generated strains (nsubjpass)
resistance extension (nmod)
determined frequencies (nsubjpass)
subscale anger (compound)
use statins (nmod)
segment to (case)
control vehicle (appos)
factor paf (appos)
day is (cop)
week to (case)
develop lag (nsubj)
fatigue . (punct)
dissolution stone (compound)
metolachlor of (case)
girl had (acl:relcl)
defect with (case)
abecarnil and (cc)
analysis erythrocytes (nmod)
history her (nmod:poss)
development the (det)
period in (case)
taqib and (cc)
synthase caspase-3 (conj)
investigate validity (dobj)
inhibitors well-known (amod)
12 4 (compound)
women million (nummod)
literature complication (nmod)
carcinoma disease (conj)
suggest studies (nsubj)
moderate large (conj)
rate turnover (nmod)
hazard . (punct)
filters warfarin (conj)
exposed agent (nmod)
choose assessing (advcl)
range therapeutic (amod)
gained patients (nmod)
shr not (neg)
= 0.7045 (dobj)
icterus pruritus (conj)
effects bromide (nmod)
concentration dose (nmod)
gvg ) (punct)
g 120 (nummod)
$ROOT$ succumbed (sent)
mediated immune (nmod:npmod)
occurrence upon (case)
ad in (case)
difficulty experience (acl:relcl)
non-selective of (case)
enzyme 's (case)
inventory dysfunction (compound)
= = (conj)
administration androgen (compound)
killed h (nmod)
months = (dep)
amine used (acl)
reports symptoms (nmod)
mutations . (punct)
discontinued occurred (advcl)
diet choline-devoid (amod)
deoxycholate b-sodium (compound)
adenocarcinomas prostate (compound)
recovered days (nmod)
vary duration (advcl)
49 4 (advmod)
neurotoxicity and (cc)
216 1 (quantmod)
12/32 , (punct)
discontinued tna (nsubjpass)
based obtained (conj)
patients acromegaly (nmod)
or ( (punct)
cpu ) (punct)
phenylpropanolamine sympathomimetic (appos)
injection u-ii (nmod)
$ROOT$ repeated (sent)
ecg mice (nmod)
attenuated inflammation (nsubjpass)
model edema (compound)
gain and (cc)
conclusion(s case (appos)
discrimination location (compound)
pain daily (amod)
bolus a (det)
mouth of (case)
sediment the (det)
scores maximum (amod)
used therapy (nsubjpass)
technique choice (nmod)
doses route (nmod)
assessment efficacy (nmod)
disappear patient (nmod)
continued especially (advmod)
number mean (amod)
pallidus globus (compound)
day ten (compound)
administered % (nmod)
edds ( (punct)
diagnosis for (case)
supports hypothesis (dobj)
unable substantiate (xcomp)
pain induced (amod)
regimen is (cop)
components oil (compound)
c group (compound)
examination medical (amod)
dogs analyzed (acl)
micromol/l 10 (nummod)
task recognition (compound)
assurance quality (compound)
creatinine age (conj)
17.5 +/- (cc)
cured who (nsubj)
woman on (case)
y-mrs ( (punct)
group creatinine (appos)
removal the (det)
emulsions intralipid (compound)
methods dosed (acl)
178 +/- (cc)
experiencing deteriorations (dobj)
licking of (case)
subregions accumbens (nmod)
express p53 (dobj)
surgery valve (compound)
doses etoposide (nmod)
min mean (dep)
contribution as (case)
screenings treatment (conj)
iu/l at (case)
d-ribose of (case)
recovery good (amod)
changes despite (case)
damage streptozotocin-induced (amod)
tbil post-operative (amod)
compound its (nmod:poss)
understanding syndromes (nmod)
retention- retrieval-deficit (conj)
class agents (nmod)
aminotransferase alt (appos)
role proven (amod)
hyperalgesia secondary (amod)
reduce omission (nsubj)
conversion at (case)
antibiotic . (punct)
monitored nurse (nmod)
occurred conversely (advmod)
specific effect (nsubj)
rate one-year (amod)
lithium antipsychotic (appos)
pain chest (compound)
safe women (nmod)
aggravate bisphosphonates (nsubj)
pr3-anca ) (punct)
density optical (amod)
sulphate sulphate (conj)
basis per (case)
philadelphia , (punct)
similar levels (nsubj)
further understanding (dobj)
shr female (amod)
11 ) (punct)
imipramine of (case)
follow-up under (case)
days mg (conj)
activity without (case)
arrest with (case)
evaluation antibody (nmod)
circulation systemic (amod)
mediate may (aux)
groups thiol (compound)
activity urine (compound)
showed injury (dobj)
incidence pointes (nmod)
provided allowed (conj)
quality carcinoma (nmod)
pay investigators (nsubj)
units 35.1 (nummod)
considered substitutes (nmod)
posture treading (conj)
fall a (det)
deacetylation of (case)
trimipramine tri (appos)
began change (nsubj)
excel ) (punct)
outcomes cognitive (amod)
uncommon nephrotoxicity (nsubj)
36 +/- (cc)
prolactinomas with (case)
fever volume (conj)
sum was (cop)
induced it (nsubj)
therapy inhibitors (conj)
associated nephritis (nmod)
mass portions (conj)
men women (conj)
shown increase (dobj)
igf-il-3 protein (dep)
recipient developed (acl:relcl)
bell-shaped . (punct)
had treatment (nmod)
14.9 +/- (cc)
oral after (case)
mmol/l 137 (nummod)
val p (appos)
products healthcare (compound)
evaluated schedules (nsubjpass)
polyphagia , (punct)
urgency severity (conj)
responded required (parataxis)
concentration a (det)
recovered terminating (advcl)
collagen , (punct)
blocked could (aux)
regardless mechanism (nmod)
combination gem (nmod)
available comment (nmod)
experienced begun (advcl)
effects patient (nmod)
species mart (appos)
$ROOT$ optimising (sent)
comparison participants (nmod)
variations the (det)
preceded expression (nmod)
risk classifications (nsubj)
influence development (dobj)
msdbp ] (punct)
that occurring (acl)
paf of (case)
movements eye (compound)
consisted detection (nmod)
analyze we (nsubj)
125 ( (punct)
barrier/density sulphate (compound)
predictive development (nmod)
30 of (advmod)
obstetric and (cc)
men ratio (dep)
rtms following (case)
provide system (nsubj)
thc of (case)
are reports (attr)
% as (advmod)
was difference (nsubj)
recall immediate (amod)
patients ranging (acl)
simvastatin medications (conj)
affected test (nmod)
flecainide as (cc)
antagonist dg-5128 (dep)
given female (nmod)
treated dependence (nmod)
undergo and (cc)
lesions activities (conj)
adding mg (nmod)
n=12 , (punct)
hyperplasia adenoma (conj)
crystallization tubules (nmod)
1.6 : (punct)
resurgence in (case)
20 - (punct)
donor an (det)
11 years (nmod)
db measured (acl)
torr 94 (nummod)
frequencies the (det)
expressing myocardium (nmod)
11.6 8.7 (nummod)
model well-defined (amod)
frame the (det)
24 bleeds (conj)
mice or (cc)
evaluate investigate (conj)
wave u (compound)
negative test (nsubj)
association cancer (nmod)
tolerated treatments (nsubjpass)
tumor malignant (compound)
demands forthcoming (amod)
treated cells (nsubjpass)
agent 5-fluorouracil (appos)
before month (nmod:npmod)
months higher (conj)
contractility the (det)
i complex (conj)
activity stereotypy (conj)
threshold expression (nmod)
often saline (nmod)
16 deaths (nmod)
change only (amod)
compensated attenuated (conj)
mechanisms pathophysiology (nmod)
was weeks (dep)
p=0.008 ) (punct)
conducted we (nsubj)
recurring tumor (nsubj)
have diagnosing (advcl)
deteriotation clinical (amod)
l ml (conj)
indomethacin mg/kg (appos)
increases limits (dep)
rizatriptan ergotamine/caffeine (conj)
dysfunction mesangial (amod)
developing toxicity (dobj)
scabies of (case)
uncommon not (neg)
found deficit (nsubjpass)
influence d-ribose (nsubj)
combination ribavirin (nmod)
from cpb (nmod)
cerebrovascular and (cc)
enrolled centers (nmod)
event potential (amod)
reduce toxicity (dobj)
substantial have (xcomp)
deposits present (amod)
bolus min (nmod)
progresses invasion (nsubj)
% p=0.37 (parataxis)
lessened . (punct)
irradiation and (cc)
increase activity (conj)
plasmacytoma for (case)
anemia symptoms (nmod)
power oscillation (nmod)
seizure experience (appos)
dna genomic (amod)
2)% (2)% (conj)
subgroups these (det)
biomarkers on (case)
s-312 not (cc)
levels peak (amod)
way . (punct)
evident pressure (nmod)
initiated hours (nmod)
17 p=0.002 (dep)
attained patients (nsubj)
group compared (case)
acts antioxidant (nmod)
effects neurodevelopment (nmod)
supported suspicion (nsubjpass)
patients after (case)
staining density (conj)
dysfunction left (amod)
azidothymidine azt (appos)
saline dox (conj)
mi cocaine-associated (amod)
proposals treatment (compound)
peaking days (nmod)
h reperfusion (nmod)
communication an (det)
aconitine by (case)
moving observed (conj)
dbh ) (punct)
concentration mic (appos)
organisms the (det)
morphine epidural (amod)
selecting by (mark)
questioned subsequently (advmod)
complications renal (amod)
obtaining material (dobj)
appear experiences (nsubj)
received infusion (dobj)
caused that (nsubj)
essential dopamine (nsubj)
distinguished can (aux)
0.5 0.25 (compound)
indication biopsy (appos)
unit from (case)
agonist shown (acl)
therapy antithymocyte (compound)
involved directly (advmod)
monitoring function (nmod)
onset resolution (conj)
reduce nephrotoxicity (dobj)
interaction metabolic (amod)
status cardiovascular (amod)
mortality overdose (nmod)
analysis multivariable (amod)
decreases activity (dobj)
were levels (nmod)
analysis expression (compound)
control optimal (amod)
patients hiv-infected (amod)
developed animals (nmod)
augment . (punct)
muscle extraocular (amod)
superimposed depression (nmod)
eyes their (nmod:poss)
asphyxia malformations (conj)
interferon pegylated (amod)
erection prolonged (amod)
lower reach (advcl)
states resistance (compound)
$ROOT$ retested (sent)
frequency grading (conj)
binding estrogen (nmod)
exhibited phenotype (nsubj)
rate 28/min (nummod)
replacement of (case)
episode her (nmod:poss)
2-component blocked (acl:relcl)
features ultrasound (compound)
placebo vs (cc)
receiving ticlopidine (dobj)
allow as (prep)
taking daily (advmod)
solicited been (auxpass)
micrograms placebo (nmod)
mg/day 200 (nummod)
differences on (case)
microg/kg/min 1.2 (nummod)
concentrations insulin (compound)
dogs ten (nummod)
non-selective piroxicam (dep)
antagonist mglur5 (compound)
plasma . (punct)
underwent lt (dobj)
reports dealing (acl)
investigated epidemic (dobj)
h2 ( (punct)
developed not (neg)
mg/kg 0.35 (nummod)
dx ) (punct)
2h to (case)
obtained interviews (nmod)
iodixanol patients (nmod)
day 14 (nummod)
care medical (amod)
adjuvant preventing (advcl)
therapy types (nmod)
framework in (case)
monitored carefully (advmod)
used 75 (nmod)
one effective (conj)
occurring use (nmod)
beta-agonist ) (punct)
discharges pathological (amod)
similar groups (nmod)
hr ( (punct)
microl bilaterally (advmod)
course 692 (appos)
rast test (appos)
causes dosage (nsubj)
embarked evaluation (nsubjpass)
experienced % (nsubj)
oxidase by (case)
equilibrate could (aux)
elevated wt (nmod)
contraindicated mp (nsubjpass)
manner in (case)
lower theophylline (nmod)
genotype silent (amod)
doc of (case)
available beverages (nmod)
prescribed empirically (advmod)
delirium desipramine-induced (amod)
vulnerable that (mark)
subjects experienced (acl:relcl)
rise creatinine (nmod)
carvedilol acid (conj)
transport in (case)
evident this (nsubj)
= 0.016 (dobj)
development neurological (amod)
cases 20 (nummod)
60 120 (conj)
capable but (cc)
enalapril of (case)
chemotherapy conventional (amod)
increase index (nmod)
history prolapse (nmod)
inhibitors nsaids (conj)
bid at (case)
bbb ( (punct)
efficacy world (nmod)
serum alf (compound)
qrs caused (acl)
use types (nmod)
treatment diphenylhydantoin (compound)
space into (case)
morbidity psychological (amod)
group 1.46+/-0.79 (appos)
therapies the (det)
ifs ) (punct)
showed present (conj)
3 about (advmod)
preparations containing (acl)
thrombosis thromboembolism (conj)
underperfusion myocardial (amod)
rns ( (punct)
resolved symptoms (nsubj)
fentanyl midazolam (conj)
responds elevations (nmod)
form following (case)
disappearing may (aux)
rats resulting (acl)
nephropathy ) (punct)
estradiol-induced ethinyl (nmod:npmod)
correlate better (advmod)
complication sclerosis (nmod)
documentation first (amod)
shows group (nsubj)
localization model (nmod)
effect nephrotoxic (amod)
application paclitaxel (nmod)
received bromocriptine (dobj)
manifestations all (det)
improvements scores (nmod)
had resulted (conj)
antagonist sr48692 (nummod)
outcome the (det)
due part (nmod)
difficult uncertainty (nmod)
reversed increases (dobj)
hospitalization after (case)
treated summaries (nsubjpass)
time ictus (nmod)
exchanges sister (compound)
observations basis (dep)
took had (advcl)
then by (mark)
caffeine with (nmod)
agent newer (amod)
associated tachyarrhythmias (nmod)
methods analyzed (appos)
decreased sem (nmod)
chemotherapy doxorubicin (compound)
introduction of (case)
pentobarbital scopolamine (conj)
consisted reactions (nsubj)
biomarkers or (cc)
time smaller (amod)
hypotension after (case)
inhibition levofloxacin (nmod)
arrhythmia of (case)
cancer in (case)
reduce did (aux)
disfiguring disabling (conj)
reporting spontaneous (amod)
administration ketoprofen (nmod)
follow-up to (case)
mice ( (punct)
shown potentiate (xcomp)
detected strains (nsubjpass)
adenosine mm (amod)
leads accumulation (nmod)
severe results (nmod)
differences response (nmod)
act ester (nsubj)
generation radical (compound)
decrease period (nmod)
switching in (mark)
metabolite valproic (amod)
c57bl/6 the (det)
man 67-year-old (amod)
activation system (nmod)
akbr , (punct)
phase synthesis (nmod)
induce synergistically (advmod)
resulting use (nmod)
cases arthritis (nmod)
retention volume (compound)
drug dosage (conj)
diseases ) (punct)
correlated not (neg)
indicate but (cc)
loss alertness (nmod)
association on (case)
managing episode (nmod)
infarctions , (punct)
count in (case)
improve memory (dobj)
discussed parallels (nsubjpass)
girl 14-year-old (amod)
criteria ck-mb (compound)
ranges % (conj)
involved no (nsubjpass)
hydrochloride injected (acl)
isolated divided (conj)
ecgs controls (nmod)
assessed symptoms (nsubjpass)
bleeding intraoperative (amod)
3.49 1.18 (conj)
recovered sbp (nsubj)
terminated , (punct)
reversal anticoagulation (nmod)
followed expression (nmod)
carriers in (case)
reported after (mark)
underlying toxicity (dobj)
% vs. (cc)
after month (nmod:npmod)
properties given (acl)
effects chronotropic (amod)
improvement produced (acl)
period diuretic (nmod)
clinic in (case)
indicative myelitis (nmod)
diminished it (nsubj)
use review (dep)
maximal stable (conj)
sensitivities for (case)
correlated size (nsubj)
$ROOT$ analogues (sent)
agonist da1 (compound)
early treatment (nmod)
roles opposite (amod)
death and (cc)
limits . (punct)
month one (nummod)
ml/min 0.69 (nummod)
hyperthermia the (det)
boy , (punct)
alfentanil alone (advmod)
performed tasks (nmod)
3 approximately (advmod)
weeks for (conj)
study was (cop)
content rna (nmod)
caused treatments (nsubj)
regions mice (compound)
counteract . (punct)
hydrochlorofluorocarbons hcfcs (appos)
approach them (nmod)
candidates development (compound)
elevation enzymes (nmod)
difference breath (nmod)
ph 7.4 (appos)
and preferentially (advmod)
days zero (nummod)
h time (nsubj)
anemia reaction (appos)
unclear site (nsubj)
proved has (aux)
rose values (nmod)
19 20 (conj)
moran ) (punct)
drug broad-spectrum (amod)
migraine and (cc)
concentrated while (mark)
received undergone (conj)
11 protein (dep)
preventing of (mark)
stimulation nucleus (compound)
administration behavior (conj)
area measured (acl)
increased nuclei (nmod)
damage anesthetic-induced (amod)
counts blood (compound)
agonist d2 (compound)
model elicited (acl:relcl)
rate rejection (compound)
disrupts precipitate (conj)
administration after (conj)
located circulation (nmod)
abnormalities amblyopia (nmod)
fraction mitochondrial (amod)
had times (dobj)
level activity (compound)
addressing risks (dobj)
dopamine dopac (conj)
showed blocked (ccomp)
6.4 - (punct)
associated accompanied (conj)
frequent women (nmod)
disease early (amod)
virus , (punct)
published reports (nsubjpass)
line to (case)
functioning improved (amod)
gtn ( (punct)
methods recruited (appos)
submitted ptra (nmod)
medulla 1/8 (appos)
correlate hallucinations (nsubj)
potential , (punct)
treatments from (case)
treatment lithium (compound)
protein neuron-specific (amod)
lead use (nsubj)
reported previously (advmod)
$ROOT$ protective (sent)
protection . (punct)
mechanisms presynaptic (amod)
myalgia/arthralgia grade (compound)
prevents administration (nsubj)
alternative used (acl:relcl)
believe we (nsubj)
inhibitors ssris (appos)
psychiatric endocrinological (conj)
discontinued investigation (nsubjpass)
volunteers human (amod)
used : (punct)
hypertension population (nmod)
cips from (case)
five-fold to (dep)
evidence no (det)
course special (amod)
rats li-treated (amod)
sos ( (punct)
gain insight (dobj)
prevented pg-9 (nsubj)
areas fibrosis (nmod)
able induce (xcomp)
effect favorable (amod)
catecholamine present (amod)
results compared (dep)
receptors muscarinic (amod)
showed analyses (nsubj)
minimal ) (punct)
provided anaesthesia (nsubj)
returned levels (nsubj)
patterns use (nmod)
300 600 (conj)
reaching 2.2-fold (dobj)
$ROOT$ unlikely (sent)
saline titrated (acl)
maze in (case)
diseased both (cc:preconj)
found lesion (nsubjpass)
+ ca(2 (compound)
study prevention (compound)
triggered . (punct)
showed rg1 (nsubj)
g/m2 cycles (dep)
amounts by (case)
reduced integral (nsubjpass)
$ROOT$ pointes (sent)
resulted improvements (nmod)
4-diphenylacetoxy-n-methylpiperidine-methiodide ) (punct)
have lines (nmod)
introduced 1981 (nmod)
sham , (punct)
myalgia between (case)
c humidity (appos)
pressure qs/qt (conj)
myeloperoxidase mpo (appos)
need maximize (acl)
markers serum (compound)
therapy throughout (case)
elimination medication (nmod)
activity system (nmod)
-20.0 ( (punct)
day of (case)
provide treatment (dobj)
discontinue so (mark)
group patient (compound)
treated buprenorphine (nmod)
therapies phenotypes (nmod)
boluses 1 (dep)
performance users (nmod)
specimen skin (compound)
foods caffeine-containing (amod)
action anticonvulsive (amod)
saline physiological (amod)
5.2 ) (punct)
lapsed , (punct)
returned soon (advmod)
% 93 (nummod)
compared , (punct)
leukemia of (case)
216 - (advmod)
design hypren-trial (nmod)
change effects (conj)
administration short-term (conj)
pathways model (nmod)
kinase u/l (compound)
progress contrary (nmod)
lesions target (compound)
gyrus right (amod)
complications confusion (nmod)
comparison trial (dep)
200 to (dep)
mg 800 (nummod)
pronounced patients (nmod)
-18.9 +/- (cc)
ranged visit (nmod)
reports available (amod)
effect scintigraphy (nmod)
shell and (cc)
deletion ' (punct)
dosing last (amod)
neuroradiologists 2 (nummod)
groups carbetocin (nmod)
effects inhibitors (nmod)
occurred 14 (nsubj)
myelosis of (case)
decrease an (det)
report study (nmod)
function 2-adrenoceptor (compound)
battery measures (nmod)
higher size (nsubj)
rats for (case)
contraindicate use (dobj)
cs form (conj)
micrograms 10 (compound)
acts morphine (nsubj)
increase associated (acl:relcl)
finding have (acl)
% 0.1 (nummod)
yahr _ (punct)
ought nurse (nsubj)
inhibitors stratum (appos)
remains pressure (nsubj)
consequences errors (nmod)
fraction , (punct)
benefits avoidance (nmod)
streptozotocin-induced ) (punct)
min 20.12 (nummod)
iiib nsclc (dep)
necrosis subpial (amod)
alpha-tc dfo (conj)
patients taking (acl)
recommended commonly (advmod)
effects overdose (nmod)
0.63 2.5 (conj)
ectopies less (amod)
morphology changes (conj)
received day (nmod)
cure arthritis (nmod)
regimen of (case)
opioid a (det)
pge(2 of (case)
study determine (advcl)
oxytocics transfusion (conj)
results microg/ml (appos)
referral in (case)
unrelated were (cop)
failed has (aux)
danger the (det)
adenosine cpa (appos)
seeing parasites (dobj)
developed signs (dobj)
aroused although (mark)
tempol kg(-1 (appos)
velocity the (det)
dystonia segmental (amod)
ecg parameters (conj)
pcc human (amod)
index low (amod)
disease stage (compound)
associated cycles (nsubjpass)
sensory sensori-motor (conj)
discussed and (cc)
applied continued (conj)
netilmicin of (case)
report showed (parataxis)
perception tail (nmod)
tests limbs (nmod)
vicinity the (det)
erythropoietin epo (appos)
cardiotoxicity . (punct)
angiotensinogen intrarenal (amod)
score interval (dep)
hypothesis for (case)
improved however (advmod)
alive patients (dep)
extend and (cc)
showed eeg (nsubj)
counts minute (nmod)
toxicities were (cop)
reduced mk-801 (nsubj)
3,4-methylenedioxymethamphetamine mdma (dep)
pronounced interference (nmod)
interneurons of (case)
transplantation cardiac (amod)
run as (prep)
lower and (cc)
have children (nsubj)
heterogeneity % (dep)
dce ) (punct)
neuropathy predominance (nmod)
caused become (xcomp)
nephrosis pan (compound)
substantiate risk (dobj)
signaling receptor-mediated (amod)
administration prolonged (amod)
state interval (conj)
m4 putative (amod)
prolongation interval (compound)
prognosis visual (amod)
showed reduced (ccomp)
groups 5 (nummod)
sulphadiazine silver (amod)
threshold pelli-robson (compound)
mg terbutaline (nmod)
increased exposure (nsubj)
effects ameliorative (amod)
days 17 (conj)
those considered (acl)
examined sera (nsubjpass)
% 19.2 (nummod)
susceptible be (cop)
value greatest (amod)
toxicity (meth)-induced (amod)
objectives evaluate (appos)
teratogenic sulphasalazine (nsubj)
started , (punct)
associated challenge (nmod)
reduce minutes (nmod)
patient syndrome (nmod)
received 58 (conj)
ameliorated days (nmod)
recognition impaired (amod)
effects further (amod)
ceased reactions (nmod)
sec 15 (nummod)
augment doc (dobj)
bore features (nsubj)
reverse to (mark)
increased difference=0.01 (parataxis)
agents only (advmod)
suggest relevant (ccomp)
tissues rats (nmod)
modulator and (cc)
memory rats (nmod)
using 1981 (nmod)
documented sensitive (advcl)
reason period (nmod)
survivors failure (nmod)
effect carcinogen (compound)
interventions pharmacological (amod)
methotrexate hd-mtx (appos)
altered were (auxpass)
included users (nsubjpass)
impaired cholestasis (nmod)
histories patient (nmod:poss)
mm 119 (nummod)
deformations lethality (conj)
hawthorn of (case)
treatment medicine (conj)
observed decrease (dobj)
30 10 (compound)
events patient-years (nmod)
= 0.32 (dobj)
differed agsd (nmod)
was whereas (mark)
factor modifiable (amod)
cessation following (case)
costs , (punct)
treated ganciclovir (nmod)
consider carefully (advmod)
maintained etomidate (nmod)
meq/kg/day 4 (nummod)
da ) (punct)
hyperplasia gingival (amod)
times different (amod)
sensitivity = (parataxis)
blind , (punct)
contributor : (punct)
filtration of (case)
hcn ( (punct)
toxicity extreme (amod)
prevention for (case)
exercised mph (nmod)
week or (cc)
remained or (cc)
47.5 0.5 (compound)
complications treatment (nmod)
given have (aux)
assess outcomes (dobj)
prescribe scabicides (dobj)
glut4 glucose (compound)
recived mg (dobj)
dex , (punct)
involved interventions (dobj)
administration water (nmod)
drugs act (acl:relcl)
ligands ) (punct)
release concomitant (amod)
withdrawn result (nmod)
decrease placebo (nmod)
permeability proteins (nmod)
cows than (case)
carbamazepine vigabatrin (conj)
group knife (compound)
administered to (mark)
mucosa to (case)
died that (mark)
predisposes that (mark)
accompanied behaviors (nsubjpass)
unassigned . (punct)
700 more (amod)
maintained daily (advmod)
lowered expression (nsubjpass)
cells living (amod)
88.1 +/- (cc)
accumulation hepatic (amod)
initiated whenever (advmod)
characterized 1 (dep)
dysfunctional sexually (advmod)
33 10(9)/l (conj)
ramh se (nmod)
comprised . (punct)
mg/dl 2.5 (nummod)
microl mmol/0.5 (nummod)
attain third (nsubj)
instillations the (det)
antagonist)-induced cholinergic (amod)
studies sensory (amod)
mg os (nmod)
agent tolerated (amod)
3.8 - (punct)
release with (case)
simvastatinezetimibe and (cc)
confirm correlation (dobj)
c ml.s-1 (appos)
reports adverse (amod)
brief generalized (conj)
nephropathy gentamicin-induced (amod)
relevant especially (advmod)
has neurochemistry (nsubj)
nystagmus of (case)
continue decreased (advcl)
tolerated pg (dobj)
test this (det)
solicited methods (nsubjpass)
effects uninephrectomy (nmod)
treatments both (det)
synapse path (compound)
recognition . (punct)
end-systolic es (dep)
degree for (case)
after shortly (advmod)
dry mildly (advmod)
search to (mark)
treatment fucoidan (compound)
ischemia use (nmod)
commonly most (advmod)
fatal potentially (advmod)
received eight (nsubj)
rate severity (conj)
dose-dependent . (punct)
dose relaxant (nmod)
problematic the (det)
hypertension rat (nmod)
prevent offer (conj)
$ROOT$ authorized (sent)
mg.kg(-1).d(-1 ( (punct)
anp avp (conj)
chronic week (dep)
excluded . (punct)
action neurones (nmod)
reversed presence (nmod)
pressure postural (amod)
platform a (det)
benign its (nmod:poss)
replaced dexamethasone (nmod)
pulses constant (amod)
products lipid (compound)
undertaken that (mark)
subcortex in (case)
ddi ( (punct)
neutropenia patient (nmod)
nystagmus downbeat (amod)
inhibitors , (punct)
linkages non-biodegradable (acl:relcl)
failed reveal (xcomp)
activities antipsychotic (amod)
product biotransformation (compound)
effect vestibulotoxicity (nmod)
constructed . (punct)
comply to (mark)
proportion the (det)
decreased csa (nsubj)
hallmark the (det)
performance mouse (compound)
provided use (nsubj)
microgram/kg/min 0.03 (nummod)
tie2-cre;loxp-egfp line (compound)
14,671 users (nmod)
infiltration defects (conj)
investigated but (cc)
role death (nmod)
correlated expression (nmod)
patients 85 (nummod)
haloperidol blocker (compound)
expressed subtypes (nmod)
recovers recording (conj)
modifications wall (nmod)
salt-depleted in (case)
site rats (nmod)
treated testosterone (nmod)
therapy outcome (dep)
occur hus (nsubj)
cortex of (case)
l in (case)
cddp ( (punct)
1.036 +/- (cc)
replaced successfully (advmod)
waves delayed (amod)
$ROOT$ held (sent)
erythromycin from (case)
improved year (nmod)
hypercalcemia arrhythmia (conj)
commensurate recovery (nmod)
sinus of (case)
predictive not (neg)
used that (nsubj)
hh the (det)
ng/kg/min 15 (nummod)
diagnoses anatomical (amod)
areas brain (compound)
hexamethonium blocker (compound)
concentration h (compound)
similar morphologically (advmod)
(2)% 7 (nummod)
oxide nitrous (compound)
titres the (det)
alpha-t either (cc:preconj)
postponed angiogram (nsubjpass)
lidocaine either (preconj)
ecgs ( (punct)
1.5 from (case)
mg/kg 300 (compound)
pa similar (amod)
% 60.2 (nummod)
thromboemboli arterial (amod)
lower that (nmod)
n=94 ( (punct)
angiotensin renin (amod)
shows causes (ccomp)
otherwise who (nsubj)
replication of (case)
synthesis in (case)
cyclosporin or (cc)
agonist d1-like (amod)
grouped basis (nmod)
group transgenic (amod)
signals discrete (amod)
antineoplastic a (det)
planned has (aux)
exclusively almost (advmod)
associated supplementation (nmod)
women 's (case)
result to (mark)
improve may (aux)
patients male (appos)
evaluated test (nmod)
13 % (dep)
recent less (advmod)
suggested years (nmod)
independent intensity (nmod)
dogs the (det)
micrographs electron (compound)
glomerulonephritis fibrillar (amod)
cardiomyocytes isolated (amod)
behavior a (det)
this of (case)
movements with (case)
months ; (punct)
subscore on (case)
examinations genetic (amod)
rate stone (compound)
reactions idr (nmod)
5-fu after (case)
similar rate (nsubj)
suggested thrombosis (nsubjpass)
ctnt found (acl)
possible this (nsubj)
method using (acl)
behavior in (case)
pattern indistinguishable (amod)
alternation of (case)
sufficient result (xcomp)
accelerated growth (nmod)
reducing stress (dobj)
pathway cardioprotective (amod)
used purposes (nmod)
receptors on (case)
palsy acute (amod)
occurred variation (nsubj)
normoammonaemic was (cop)
carcinoma case (nsubj)
thrombosis patients (nmod)
techniques new (amod)
caused lethality (dobj)
expression synthase (compound)
showed improved (conj)
vehicles scopolamine (conj)
potentiates treatment (nmod)
overlooked may (aux)
transfusion or (cc)
elevated though (mark)
ssr103800 of (case)
performed evaluate (xcomp)
v.o ( (punct)
arthritis severe (amod)
risk anemia (nmod)
presented one (nsubj)
has rate (dobj)
erythron the (det)
closure and (cc)
remedy chloride (nsubj)
flexion toes (nmod)
consumption after (case)
inhibitor reductase (compound)
reported with (mark)
effect bromide (nmod)
important addition (nmod)
recovery and (cc)
treated phenylhydrazine (nmod:npmod)
coherence tumor (compound)
high- low-dose (conj)
haemorrhage induced (acl)
99 , (punct)
therapy disease (compound)
measured compare (advcl)
ncse ( (punct)
score arrhythmia (compound)
formation noncaseating (amod)
received subject (nsubj)
had adjusted (dobj)
audiograms deficits (nmod)
taken twenty-three (nsubj)
0.97 1.84 (conj)
combating to (mark)
action evidence (conj)
essential development (nmod)
became inadvertently (advmod)
transplantations 25 (nummod)
positive 5 (conj)
reduced suppressed (parataxis)
mbp ) (punct)
speech behavior (conj)
nephritis between (case)
pairs matched (amod)
demonstrated correlated (parataxis)
tinnitus ist (appos)
limit safe (amod)
develop long (advmod)
indication , (punct)
recordings ambulatory (amod)
involving total (dobj)
damage end-stage (amod)
area preoptic (amod)
a respectively (advmod)
104 21 (quantmod)
week ( (punct)
discharged with (mark)
episodes hypotension (nmod)
infant therapy (nmod)
evaluates work (nsubj)
demonstrated developed (ccomp)
kpa ) (punct)
toxicity dfp (compound)
= ci (appos)
improvement mean (compound)
required now (advmod)
cocaine from (case)
normal when (advmod)
related acetylcholine (nmod:npmod)
release unproportional (amod)
escalated were (auxpass)
ibpb ) (punct)
rats ma-treated (amod)
experienced seizures (dobj)
tumor only (advmod)
dis [ (punct)
old age (nmod:npmod)
15 least (nmod:npmod)
resuscitate doses (nmod)
16 6 (conj)
showed however (advmod)
extubated transferred (conj)
1.27 1.13 (dep)
conjugate biodegradable (amod)
subjects history (nmod)
hippocampus , (punct)
angioplasty coronary (amod)
injection hypaque (nmod)
patients elevations (nmod)
observed results (nsubjpass)
% 5 (nummod)
drug apomorphine (nsubj)
apd and (cc)
intervention of (case)
treated tablets (conj)
crocin mg/kg (appos)
severe require (xcomp)
granules cells (nmod)
enhanced , (punct)
indicating secretion (dobj)
selected groups (nmod)
antibiotics by (case)
observed reactions (nsubjpass)
model in (amod)
effect bladder (nmod)
myalgia postoperative (amod)
potential due (case)
shown administration (nsubjpass)
infant on (case)
dehydrogenase on (case)
safe discharge (nmod)
reverses involves (conj)
due inactivation (nmod)
highlights and (cc)
5-hydroxytryptophan mg/kg (appos)
related dose (nmod)
tolerated be (auxpass)
condition for (case)
therapy subcutaneous (amod)
appears troponin (nsubj)
mi ck-mb (compound)
12weeks after (case)
surgery non-cardiac (amod)
premedication for (case)
fall with (case)
data combined (amod)
treatments observation (conj)
considered can (aux)
attempt not (neg)
uterus with (case)
scale analog (amod)
capacity his (nmod:poss)
incidence cases/person-years (conj)
kept diet (nmod)
mglur1 ) (punct)
bilayers biocontinuous (amod)
proceeded when (advmod)
21.0 versus (cc)
recommended screened (ccomp)
hormone growth (compound)
development eps (nmod)
treated sulindac (nmod)
alter does (aux)
indicates encephalopathy (nsubj)
given rejection (nmod)
expression cco-i (nmod)
cause profiles (nmod)
cdt ) (punct)
stress simulated (acl)
volume stroke (compound)
drugs verapamil (conj)
prior min (nmod:npmod)
analysis release (conj)
ribavirin mg (appos)
established was (auxpass)
transplantable hamsters (nmod)
varies subgroups (nmod)
haematological . (punct)
scheduled , (punct)
daily , (punct)
made findings (nmod)
improved indicated (advcl)
mumol/l trough (appos)
started resolved (conj)
pilocarpine- and (cc)
analgesic and (cc)
extract with (case)
caused changes (nmod)
reversible cessation (nmod)
depleted pcpa (nsubj)
macrolide related (amod)
heavy and (cc)
ventilatory peripheral (conj)
evaluation accurate (amod)
most of (case)
results efficacious (dep)
changed were (auxpass)
severity dyskinesia (compound)
breaks and (cc)
= 0.83 (dobj)
studies dexmedetomidine (nmod)
included toxicity (nsubj)
paralysis injection (nmod)
found cases (nmod)
months years (conj)
oestrogens progestogens (nmod)
hyperprolactinemia 9-month (amod)
able prevent (xcomp)
women born (acl:relcl)
receptor deletion (dep)
demonstrates differences (dobj)
nsaids % (appos)
resolved recurred (conj)
tiopronin d-penicillamine (dep)
manifestations toxicity (nmod)
expectancy life (compound)
follow-up patient (nmod)
therapy p9605 (appos)
abnormality wall-motion (compound)
associated downregulation (nmod)
repeat investigator (nmod)
instituted has (advcl)
treatment mazindol (nmod)
related mainly (advmod)
resolution discontinuation (nmod)
failure = (dep)
treatment gd (nmod)
heparins newer (amod)
tetany of (case)
therapy preoperative (amod)
away stimulus (nmod)
mg/kg/day from (case)
globulin hbig (appos)
combination analgesics (nmod)
none apnea (conj)
resulted loss (nmod)
decrease sustained (acl:relcl)
were toxicities (nsubj)
63.5 - (punct)
addition doses (nmod)
na(+)/k(+)-atpase aqp1 (conj)
treatment gluconate (nmod)
shows study (nsubj)
related " (punct)
hb ) (punct)
reduced sbp (dobj)
women 49 (nsubj)
2.1 , (punct)
one rarest (nmod)
pathway no (compound)
disorder leads (acl:relcl)
methods polymerase (compound)
health the (det)
pathology cases (nmod)
rosacea dermatitis (conj)
dna and (cc)
activation target (compound)
14.9 10(-3 (conj)
efficacy methods (nmod)
doses calcium (nmod)
deterioration significant (amod)
histology 2 (appos)
syndrome secondary (amod)
recruited belgium (nmod)
components ginseng (nmod)
improved slightly (advmod)
take who (nsubj)
cause delirium (dobj)
ratios sites (nmod)
mechanism hemolysis (nmod)
hfde ) (punct)
mg/kg cd50 (nsubj)
white-cell platelet (conj)
enzyme angiotensin-converting (amod)
discontinuation alpha-2b (nmod)
time values (nmod)
fzp of (case)
cava vena (compound)
incidence update (appos)
reversed depression (dobj)
prednisolone volume (conj)
recordings intracellular (amod)
rat to (case)
use analgesics (nmod)
tests 6 (nummod)
agonist da (compound)
0.96 = (dep)
$ROOT$ proves (sent)
cisapride ( (punct)
unclear while (mark)
injections 37 (nummod)
variables postoperative (amod)
suggesting providing (conj)
requested whether (mark)
haart cumulative (amod)
testing on (case)
induces hyperactivity (dobj)
1.3 interval (dep)
present hypersensitivity (nsubj)
administered father (nsubjpass)
domain the (det)
factor nrf2 (nsubj)
contractions the (det)
evaluation effect (nmod)
impairment recall (nmod)
included that (nsubj)
90 than (case)
recorded electrocardiograms (nsubjpass)
tac ( (punct)
paclitaxel to (case)
reductions studies (nmod)
injected increments (nmod)
day 1 (dep)
group constipation-predominant (amod)
use rifampin (nmod)
defects reversible (amod)
lymphocytes activated (amod)
rotation transient (amod)
consequence hypokalemia (nsubj)
effects flow (nmod)
involvement pulmonary (amod)
adolescents depressed (amod)
rats non-tumor-bearing (amod)
patients type (compound)
complications pancreatitis (nmod)
pattern , (punct)
group 12.3 (appos)
malformations reported (advcl)
topotecan : (punct)
survived remained (conj)
series prophylaxis (compound)
induced eads (dobj)
noncompliance , (punct)
complained 11 (nsubj)
agent treat (acl:relcl)
remained factors (attr)
149 169 (conj)
titrated days (nmod)
proposed conduction (nsubjpass)
showed fall (dobj)
linezolid including (case)
group pretreated (acl)
vocalization rage (appos)
volunteer healthy (amod)
gc-ht rat (nmod)
rate reversal (amod)
results presented (acl)
psychosis induced (acl)
hyperplasia focal (amod)
cardiotoxicity (dox)-induced (amod)
those administered (acl)
tee sedation (nmod)
tended related (xcomp)
mhb % (appos)
hypopharynx four (appos)
catalepsy mice (nmod)
bilirubin prolongation (conj)
6-thioguanine with (case)
opioid 's (case)
result paradoxically (advmod)
activity genotype (conj)
contribute susceptibility (nmod)
tdfs of (case)
univariate and (cc)
beating on (case)
hypokalemia patients (nmod)
potential thrombosis (nmod)
evinced results (nsubj)
mellitus and (cc)
administration long-term (amod)
lacrimation flow (conj)
hysterectomy abdominal (amod)
concentration albumin (compound)
dilation and (cc)
mutant wistar (amod)
mm = (dep)
enzyme involved (acl:relcl)
manifest that (nsubj)
complication transplantation (nmod)
cacl2 . (punct)
evidence degeneration (nmod)
similar pharmacologically (advmod)
infusion vincristine (nmod)
intubated he (nsubjpass)
epidemic caused (acl)
excitation recurrent (amod)
papaverine and (cc)
benefit clinical (amod)
showed gamma-carboxylated (ccomp)
5-hydroxytriptamine 5-ht (appos)
applies antagonism (nmod)
obtained determined (conj)
haloperidol administered (acl)
supplementation by (case)
development effects (nmod)
thickening or (cc)
applied walls (nmod)
microl 4.5 (nummod)
reversed decreases (dobj)
understood pathology (nsubjpass)
% p= (dep)
corticosterone dietary (amod)
given performed (conj)
patients require (acl:relcl)
dl-sotalol azimilide (conj)
dermatitis of (case)
added was (auxpass)
inhibitor oral (amod)
worsening as (cc)
presents days (nmod)
accomplished easily (advmod)
membrane to (case)
presented male (nsubj)
factors were (cop)
value measurement (nsubj)
survived , (punct)
mg/m(2 5-fu (compound)
deleted has (aux)
suggested result (nmod)
anticonvulsants with (case)
response hypertension (nmod)
alf year (appos)
mm 2 (nummod)
markers with (case)
treatment cabergoline (nmod)
fl ) (punct)
started using (xcomp)
rats kidneys (nmod)
improvement % (compound)
mediated group (nmod)
subtypes eight (nummod)
concentrations pollutants (nmod)
neuropathy pain (conj)
developed aspiration (nmod)
substituted purposes (nmod)
represents inhibition (nsubj)
confusion agitation (conj)
pain pain (conj)
. 2006 (nummod)
injury repeated (amod)
became months (nmod)
measured elisa (nmod)
vulnerability individual (amod)
considered 7 (nmod)
levels serum (amod)
g ranitidine (nmod)
pan either (cc:preconj)
1.13 , (punct)
reattempted post-lt (advmod)
acc-9653 , (punct)
parachlorophenylalanine with (case)
followed y. (nmod)
described however (advmod)
women 513 (nummod)
published vasospasm (nmod)
bisphosphonates only (advmod)
contributes suggests (advcl)
died diagnosis (nmod)
physicians prescribe (acl:relcl)
times ) (punct)
society 74 (nummod)
limits use (dobj)
ppm 300 (dep)
phase treatment (compound)
levels volume (compound)
rationale suggested (dep)
antithyroidmedications of (case)
disorder or=2.870 (dep)
studying further (advmod)
alterations pathways (nmod)
model sad (nmod)
tight that (mark)
have convulsions (dobj)
unavailable are (cop)
60 , (punct)
comparison effectiveness (nmod)
administered , (punct)
dosage and (cc)
as points (appos)
compound bioactive (amod)
lesions neurons (nmod)
combined mg/m(2 (nmod)
treatment ccnu/ctx (nmod)
synthesis pge2 (compound)
visits subsequent (amod)
occurred phlebitis (conj)
study determine (acl)
used women (nmod)
therapy cyclosporine (nmod)
autoimmune or (cc)
injected days (nmod)
stn in (case)
concentration to (case)
estradiol-treated ethinyl (nmod:npmod)
elicited pge2 (nmod)
suppressed . (punct)
remained permeability (nsubj)
behaviors spontaneous (amod)
mm 6.0 (nummod)
exposure from (case)
infrequently only (advmod)
clearance to (case)
theory this (det)
effect adriamycin-mediated (amod)
se pilocarpine-induced (amod)
increases wakefulness (dobj)
mimic hyperalgesia (nsubj)
effusions bilateral (amod)
presented patients (nmod)
surgery general (amod)
heptylate hypogonadism (nmod)
syndrome pulmonary-renal (amod)
effects all (predet)
matched respect (nmod)
testing or (cc)
lost . (punct)
implicated production (nsubjpass)
doses form (nmod)
drug to (mark)
weeks ten (nummod)
suggestive . (punct)
mg group (nmod)
injection)+ritanserin before (case)
noted numbness (dobj)
studies staining (nmod)
alert need (nmod)
parameters potency (conj)
um-272 , (punct)
preprocedure ( (punct)
groups specific (amod)
instances in (case)
shorter min (dep)
inhibition p53 (compound)
produce modify (conj)
disturbing frightening (conj)
attenuate dementia (dobj)
chloride hexamethonium (compound)
scale amhs (appos)
repeated . (punct)
tasks new (amod)
taken been (auxpass)
kg(-1 x (compound)
background improved (dep)
substantiate : (punct)
had used (advcl)
withdrawal both (det)
eosinophils and (cc)
cells 1 (nummod)
permeability blood-brain (compound)
correlated patients (nmod)
charge energy (compound)
dex- ( (punct)
report have (aux)
than hypotension (nmod)
observe stimulation (dobj)
showed showed (conj)
globulin isg (appos)
hcl mg/kg (appos)
understood are (cop)
strategy . (punct)
relevance complications (nmod)
stomach intestine (conj)
spasms than (case)
interpretation : (punct)
detected were (auxpass)
term short (amod)
necessary diagnosis (nsubj)
before min (nmod:npmod)
stomatitis syndrome (appos)
neurotoxicity busulfan (compound)
rats not (neg)
increases loss (dobj)
reduced h2o2 (dobj)
years > (advmod)
demonstration mr (compound)
used trial (nmod)
sarcoma of (case)
% weight (nmod)
activation af (nmod)
rose titer (nsubj)
studies nascis (appos)
indicate prevent (ccomp)
suggest protect (ccomp)
experienced subjects (nsubj)
agent antineoplastic (amod)
2-sulfanylethanesulfonate mesna (appos)
gives induction (nsubj)
reduced years (nmod)
active quite (advmod)
involved except (prep)
required cycles (nsubj)
11 % (appos)
leukopenia diarrhea (appos)
increase fasciculations (nmod)
5-fu with (case)
mechanisms several (amod)
state phosphorylation (compound)
performed investigation (nsubjpass)
ears ( (punct)
buffer ph (nmod)
mean sd (dep)
rats captopril-treated (amod)
amnesia an (det)
stage for (case)
lines mcf-7 (compound)
were there (expl)
diameter in (case)
median months (appos)
version . (punct)
lidocaine given (acl)
sought address (xcomp)
doxorubicin conventional (amod)
amines of (case)
ml(-1 of (case)
emotion each (det)
deterioration lcva (nmod)
counts white-cell (amod)
reaction hemolytic (amod)
seizures all (det)
higher gfr (nsubj)
therapy g (appos)
effect significant (amod)
presence abnormalities (nmod)
33.8 5.2 (conj)
275 - (punct)
available facilities (nsubj)
ecgs lead (compound)
telangiectasia nifedipine-induced (amod)
tsh ) (punct)
aerosol of (case)
hyperventilation or (cc)
therapies anti-hypertensive (amod)
ipsi- and (cc)
ketamine intravenous (amod)
put than (case)
caused maneuver (nsubj)
protocol acuity (nmod)
muscle induced (acl)
combinations morphine-dominant (amod)
levofloxacin fluoroquinolone (appos)
radiopharmaceutical new (amod)
infusion drugs (conj)
rates length (conj)
state during (case)
reaction characterized (acl)
developed thereafter (advmod)
support idea (dobj)
cholinergic and (cc)
$ROOT$ 1.6 (sent)
served amnesia (nsubj)
administered received (conj)
unassigned classified (dep)
enlarged sacrifice (nmod)
sera in (case)
amphotericin , (punct)
scale horn (compound)
midbrain ) (punct)
injection reported (acl:relcl)
peak at (case)
$ROOT$ 1.56 (sent)
one the (det)
primary , (punct)
woke he (nsubj)
records paired (amod)
$ROOT$ 2.6 (sent)
dobutamine dose (compound)
receptor b1 (compound)
carcinoma , (punct)
immunoreactivity protein (nmod)
outcomes all (det)
increases flow (nmod)
received ed (nmod)
improved ) (punct)
demonstrates report (nsubj)
use sulfasalazine (dobj)
shoed microscopy (nsubj)
low was (cop)
% p<0.001 (dep)
albumin of (case)
factors on (case)
excess but (cc)
ulcers accompanied (acl)
scores stress (compound)
0.07 versus (cc)
number inhibitors (nmod)
= 0.243 (dobj)
monoamines the (det)
correcting hyperkalemia (dobj)
causes : (punct)
analyzed have (aux)
involved studies (nsubj)
suggestive ischemia (nmod)
noted we (nsubj)
prostheses valve (compound)
223 +/- (cc)
extent calcification (nmod)
underwent anaesthesia (nmod)
cycloheximide chx (appos)
proteinuria stress (conj)
history significant (amod)
necessitating implantation (dobj)
resulting overdose (nmod)
improve spontaneously (advmod)
subjected those (nsubjpass)
development conditioning (nmod)
salbutamol inhaled (amod)
synthetic one (nummod)
remain complications (nsubj)
provocation physical (amod)
150 300 (conj)
tube with (case)
chromosome single (amod)
= 8) (dobj)
conducted experiments (nsubjpass)
incidence tma (nmod)
accumulating is (aux)
levels inhibition (conj)
sampled . (punct)
artery pulmonary (amod)
delivered woman (nsubj)
four to (quantmod)
led concerns (nsubj)
constipation of (case)
% 1.95 (nummod)
caused % (dobj)
tests stimulation (conj)
replacement srl (nmod)
checklist behavior (compound)
relating changes (nmod)
arrhythmias , (punct)
beginning dose (nmod)
mice seized (amod)
predict dysfunction (dobj)
pacing efforts (nmod)
dissection , (punct)
jones ) (punct)
changes images (nmod)
continue interfere (xcomp)
line ( (punct)
enzymes phosphatase (dep)
thought , (punct)
decreased effects (dobj)
levels particles (nmod)
reduction marked (amod)
suggest far (advmod)
cells arterial (amod)
renin ) (punct)
crm ) (punct)
trials studies (conj)
nocistatin mouse-1 (nmod)
number emulsion (nmod)
attenuated rats (advcl)
management effects (nmod)
enhance it (nsubj)
131i-albumin 131i-hsa (appos)
incidence transplantation (nmod)
4.3 +/- (cc)
disturbances hemodynamic (amod)
changes direction (nmod)
accumulation intracellular (amod)
% saturation (nsubj)
buche ) (punct)
ruled out (compound:prt)
presence upon (case)
harvested were (auxpass)
correlates nystagmus (nsubj)
1.19 0.08 (appos)
patients their (nmod:poss)
status mental (amod)
reduction during (case)
enhancement bradycardia (nmod)
allele a (det)
cannulated bilaterally (advmod)
studies those (det)
helps control (xcomp)
subgroups levels (nmod)
doses t.i.d. (advmod)
preceding importantly (advmod)
limiting dose (nmod:npmod)
superior rizatriptan (nsubj)
years eleven (nummod)
trial patients (nmod)
practice according (case)
2.4 1.2 (appos)
report neurotoxicity (nmod)
infiltrate ptld (compound)
given intramuscularly (advmod)
drawbacks several (amod)
remained 10 (nsubj)
epinephrine lipid (conj)
3 was (cop)
development pharmacotherapy (nmod)
cxcl1 and (cc)
received effects (nsubj)
treatments and (cc)
occurrence two (nmod)
significant were (cop)
analyses spectral (amod)
studies serial (amod)
minutes /-7.1 (conj)
point four (nummod)
m1 ) (punct)
users of (case)
a1 of (case)
blocker potential (conj)
covered , (punct)
have dysfunction (dobj)
sulfonamides and (cc)
accentuated was (auxpass)
indicated absence (nsubj)
disturbance function (nmod)
suggests , (punct)
sensations burning (amod)
developed added (advcl)
lower even (advmod)
nefiracetam mg/kg (appos)
potent since (mark)
haart ( (punct)
ceasing on (mark)
yield tumours (nmod)
thickening and (cc)
occurs that (nsubj)
frequency potential (compound)
pj34 a (det)
thromboembolism thrombocytopenia (conj)
atrophy testicular (amod)
examination clinical (amod)
m2 for (case)
0 - (punct)
volume gravity (conj)
pergolide mg (appos)
cross-react that (nsubj)
pain cocaine (compound)
integral the (det)
infusion decreased (acl:relcl)
has arrest (nmod)
raters trained (amod)
behaviour maze (conj)
developed episode (dobj)
blocked were (auxpass)
depleted was (auxpass)
1993 from (case)
thrombocytopenia counts (nmod)
assessed using (xcomp)
properties positive (amod)
high fairly (advmod)
crosses and (cc)
tissues other (amod)
resulted certainly (advmod)
large small (conj)
p100 the (det)
autoantibodies of (case)
lower h (nmod)
naming tasks (conj)
treatment 2nd (amod)
were drugs (nmod)
revealed as (mark)
factor responsible (amod)
months 19 (nummod)
long-acting ropivacaine (appos)
injection intracarotid (amod)
level channels (nmod)
method useful (amod)
80/115 % (appos)
treatment risperidone (nmod)
dose hepatitis (compound)
0.14 - (punct)
1.3 ; (punct)
ich events (conj)
function complex (nmod)
endpoints major (amod)
differences similarities (conj)
microangiopathy related (amod)
caused absent (conj)
exposures cigarette (compound)
originating uterus (nmod)
applied potassium (nsubjpass)
variables of (case)
agonist short-acting (amod)
done have (aux)
analysis model (nmod)
occurred stiffness (nsubj)
antagonize hypothermia (dobj)
lysozymuria undetectable (amod)
al ) (punct)
esrd and (cc)
hh 34.33 (dep)
mania induced (acl)
insipidus induced (amod)
concentrations eminence (nmod)
renal and (cc)
symptoms stronger (amod)
anastrozole , (punct)
limited cardiotoxicity (nmod)
mg/m(2 900 (nummod)
total greater (amod)
numbers of (case)
cautious using (advcl)
impaired scopolamine (nmod)
normalized , (punct)
afternoon in (case)
failure . (punct)
mexiletine tocainide (conj)
comparison randomized (amod)
users 35 (nummod)
period post-operative (amod)
valves of (case)
toxic can (aux)
marked less (advmod)
high basal (dep)
effective : (punct)
arabinoside of (case)
n=18 ( (punct)
induce or (cc)
effective attenuating (advcl)
described although (mark)
diminished pressure (nsubj)
syndrome encephalopathy (nsubj)
group treated (amod)
aggravate can (aux)
recur did (aux)
cohort women (nmod)
episodes no (det)
incidence vomiting (nmod)
showed configuration (dobj)
dynamic static (conj)
numbers large (amod)
pounds 193.9 (nummod)
occurred 3 (nsubj)
safe efficacious (conj)
enhanced analgesia- (punct)
patients alprazolam (compound)
subscore dystonia (compound)
hctz mg (dep)
conditions failure (conj)
percent seventy (nummod)
lid disease (compound)
score grading (compound)
oab ) (punct)
$ROOT$ inhibitors (sent)
hormone elevated (amod)
purpose designed (dep)
obtained samples (nsubjpass)
reduces it (nsubj)
susceptibility effect (nmod)
metrics incidence (conj)
cardiotoxicity clinical (amod)
immunostaining 7h6 (compound)
use women (nmod)
hematoxylin , (punct)
anaesthetics with (case)
reversed disruption (dobj)
subunits with (case)
animals high-dose (amod)
restores antagonist (nsubj)
admitted in- (parataxis)
chemotherapy prophylactic (amod)
doses mg./kg (nmod)
experiments vessel (compound)
syndrome either (cc:preconj)
produce acetaminophen (nsubj)
greater periphery (nmod)
performed thickness (nmod)
variable main (amod)
studies address (acl:relcl)
pointes tdp (appos)
patients procedures (nmod)
mg 8.6 (nummod)
liver serious (amod)
arrest ropivacaine-induced (amod)
controls above (case)
indicate confirmed (advcl)
neurotoxicity dopamine (compound)
identify site (dobj)
those externa (nmod)
parameters measured (acl)
presented hemianopia (nmod)
increasing maintained (conj)
patients panic (compound)
defects periods (nmod)
icp and (cc)
wk 8 (nummod)
837 +/- (cc)
greater mmhg (nmod)
effects with (mark)
delayed or (cc)
criteria dsm-iii (compound)
range antinociceptive (amod)
ml-1 ( (punct)
used iodixanol (nsubjpass)
rate case-fatality (compound)
rbcs normal (amod)
abolished tinnitus (nsubjpass)
studied been (advcl)
reduces cytotoxicity (dobj)
associated cessation (nsubjpass)
oliguria , (punct)
progression hiv (compound)
intervals confidence (compound)
pdtc with (case)
diseases % (appos)
detailing after (mark)
reports infarction (nmod)
therapy hormone (compound)
regions to (case)
neurotoxicity central (amod)
obtund to (mark)
activity pacemakers (nmod)
substances as (case)
mutant in (case)
patients hiv-positive (amod)
experience any (det)
methylxanthines other (amod)
hydrochloride inhibitor (appos)
tolerated to (mark)
run-in 14-day (compound)
volunteers 20 (nummod)
diarrhea are (cop)
received methods (nsubj)
site receptors (nmod)
suggestive thrombosis (nmod)
had status (dobj)
model emax (compound)
group 30-mg (compound)
castration by (case)
led however (advmod)
cancer d (compound)
normalized infusion (nsubj)
vitro and (cc)
aminotransferase u/l (compound)
animals sensitive (amod)
attack ) (punct)
mecamylamine by (case)
pre- intraoperative (conj)
sulindac between (case)
urticaria with (nmod)
model employed (amod)
activities locomotor (amod)
involved outcome (nmod)
hypothesis contributes (ccomp)
nin ) (punct)
doses cefonicid (nmod)
cortisol free (amod)
case this (nsubj)
active given (advcl)
increase no (det)
refractory who (nsubj)
treatment raloxifene (compound)
shows results (ccomp)
stimulant powerful (amod)
mhb former (amod)
kg(-1 ( (punct)
negative those (conj)
presence adducts (nmod)
infused solution (nsubjpass)
define cin (dobj)
cases : (punct)
$ROOT$ complications (sent)
underwent use (nmod)
potentiate toxicity (dobj)
ml(-1 ng (nummod)
glucocorticoids of (case)
level crp (compound)
activity atpase (compound)
doses clonidine (nmod)
oxide no (appos)
weeks survival (nsubj)
factor psychosis (compound)
factor disorders (nmod)
known stimulate (xcomp)
injection toxin (nmod)
patients received (acl:relcl)
nuclei dorsomedial (amod)
carsinom one (nummod)
investigated prevent (ccomp)
rise with (case)
inhibit finally (advmod)
pharyngitis of (case)
become did (aux)
cer ( (punct)
$ROOT$ preferred (sent)
induced administration (nsubj)
mg/kg/day or (cc)
mice kinin (compound)
group dose (compound)
lethality associated (acl)
alternatives , (punct)
factor transcription (compound)
stabilizer mood (compound)
features sparing (compound)
woman myeloma (nmod)
depressed mice (nmod)
amplitude 4000hz (nmod)
extended , (punct)
gfc75 with (case)
nouns 45 (nummod)
influences azathioprine (nsubj)
ingesting . (punct)
correlation the (det)
woman 59-year-old (amod)
damage hypersensitivity (nmod)
ddavp has (acl:relcl)
mg/kg up (advmod)
modify alter (conj)
surgery implant (nmod)
mg/day dose (nsubj)
homology sequence (compound)
provided evidence (dobj)
admitted electrocardiogram (nmod)
scores ratings (nmod)
resistance output (conj)
1.60 4.18 (prep)
signs neuropathy (nmod)
likely is (cop)
using models (dobj)
points was (cop)
induced vasodilators (nmod)
toxicity drug-related (amod)
lower 2.0/100,000 (parataxis)
time interval (conj)
salicylate mg/kg (conj)
patients glaucoma (nmod)
sensitivities of (case)
homoeostasis dopaminergic (amod)
discomfort venous (amod)
preference tablet (nmod)
infrequent reports (nsubj)
dose % (appos)
female rats (dep)
useful nifedipine (nsubj)
delayed time (nsubjpass)
implicated reports (nmod)
cell large (amod)
comparable prevalence (nmod)
treatment without (case)
study imaging (compound)
$ROOT$ consumed (sent)
useful antagonist (nsubj)
effect hepatitis (nsubj)
$ROOT$ refused (sent)
occurred increases (nsubj)
decreased controls (nmod)
preserves flow (dobj)
activity renal (amod)
dysfunction infarction (compound)
upregulation acting (acl)
convulsions induced (acl)
acclimatization conditions (nmod)
suggest intervenes (ccomp)
observed typically (advmod)
7.54 and (cc)
wall rats (nmod)
patient jaundice (nmod)
pathway trunk (nsubj)
criterion any (det)
adriamycin of (case)
5mg/kg ) (punct)
$ROOT$ tests (sent)
doses ng/mouse (appos)
disorder hematologic/oncologic (amod)
response airway (compound)
effective associated (conj)
diagnosis damage (nmod)
rhythm myocytes (nmod)
administration cacl2 (nmod)
patients leprosy (nmod)
prerequisite basic (amod)
sulindac calcium (conj)
site the (det)
equinovarus talipes (compound)
compared values (nmod)
supervened , (punct)
contraceptives on (case)
sr nk2 (compound)
males were (cop)
concentrations inhibitors (nmod)
from 21 (nmod)
disposition not (neg)
suffer common (conj)
finding not (neg)
intravenous intermittent (amod)
induces catalepsy (dobj)
changed variable (nsubj)
% index (nsubj)
used bmt (nsubjpass)
binding measured (acl)
lamivudine of (case)
suggest underlie (ccomp)
continue quantify (xcomp)
exposed study (nmod)
damage stroke (nmod)
control totally (advmod)
adherence sop (nmod)
appear cause (advcl)
microg/side ( (punct)
burning min (nmod:tmod)
used papaverine (nsubjpass)
states persons (nmod)
replacement plasma (compound)
concentration on (case)
decrement gm-induced (amod)
promote actions (dobj)
involvement isomerase (nmod)
pain severe (amod)
addressed be (auxpass)
injection propofol (nmod)
introduction following (case)
syndrome is (cop)
revealed organs (dobj)
said is (auxpass)
management pharmacologic (amod)
changes impotence (conj)
is those (nmod)
biomarkers changes (conj)
4 as (quantmod)
continued were (auxpass)
studied patients (nmod)
reduction mssbp/msdbp (nmod)
effect cbdca (nmod)
group . (punct)
monitored period (nmod)
proteinuria/day of (case)
that from (case)
hoe both (cc:preconj)
imaging and (cc)
used agent (nmod)
experiments for (case)
contribution dispersion (nmod)
associated probably (advmod)
has activity (nsubj)
assessment an (det)
coincided . (punct)
experiments considered (acl:relcl)
area dermatomes (nmod)
gd 6 (nummod)
expression enzyme (compound)
resembling obstruction (xcomp)
s 493 (nummod)
treatment months (nmod)
weeks the (det)
db 1.08 (nummod)
tumors many (amod)
improve transfer (nmod)
delivery cesarean (compound)
met patients (nmod)
atrophy t (nmod)
control r2 (conj)
asterixis induced (acl)
groups present (dep)
proteinuria failure (conj)
showed products (dobj)
enos and (cc)
mice infected (amod)
high impaired (advcl)
effects dehydroepiandrosterone (nmod)
associated prevention (nmod)
treatment additional (amod)
associated background (nsubjpass)
discontinuation % (nmod)
diet promoting (acl)
from october (nmod)
mrnas alphaenac (compound)
interval db (appos)
hypertension during (conj)
docetaxel either (cc:preconj)
lips of (case)
2 patients (nmod)
present dyskinesia (nsubj)
drugs patients (appos)
potentiate precipitate (advcl)
unrelated was (cop)
anencephaly of (case)
(5.7)% -28.6 (nummod)
decreased mmhg (nmod)
status the (det)
display impairments (dobj)
dna products (conj)
medication safe (amod)
frequent rhythms (nsubj)
effect midazolam (nmod)
reported we (nsubj)
augmentation induced (acl)
releaser the (det)
severity animal (nmod)
= 0.757 (dobj)
test apparatus (conj)
locf ) (punct)
relation dose-response (amod)
common groups (nmod)
mediated response (nsubjpass)
cream capsaicin (compound)
step did (aux)
hypertension hyperlipidemia (conj)
sheath pacemaker (conj)
observation microscope (nmod)
acid all-trans-retinoic (amod)
population women (nmod)
hyperactivity nicotine-induced (amod)
$ROOT$ amount (sent)
showed c (nsubj)
mug or (cc)
seen when (advmod)
activity neurons (nmod)
necessary investigations (nsubj)
dyskinesias signs (conj)
fev1 - (punct)
regardless source (nmod)
reversed episodes (nsubj)
$ROOT$ reacts (sent)
use antidepressants (nmod)
program can (aux)
involving hypomethylation (dobj)
block spinal (amod)
5.2 8.5 (conj)
developed additionally (advmod)
15 - (dep)
survival the (det)
decreased melatonin (nsubj)
lymphoma non-hodgkin (amod)
effects wide-range (amod)
developed symptoms (nsubj)
gnc92h2 of (case)
happiness mood (conj)
hag interval (dep)
% 7 (nummod)
administration cefonicid (nmod)
antagonized . (punct)
u/ml ; (punct)
presenting weakness (nmod)
synapses schaeffer (compound)
conditions same (amod)
tachycardia drug-induced (amod)
$ROOT$ translate (sent)
role an (det)
reported patients (nsubjpass)
therapy spinal (amod)
airway tube (conj)
$ROOT$ disappeared (sent)
hypertension instituted (acl)
blockade combined (amod)
bupivacaine % (amod)
effect cm (nmod)
activities social (amod)
diameter mm (nmod)
screening prior (advmod)
assessed number (nmod)
mg.per gm. (nmod)
diarrhea requiring (acl)
derive atrophy (nmod)
accounts formation (nsubj)
potassium some (det)
values haematocrit (compound)
sites 1,081 (nummod)
coma . (punct)
cysts infants (nmod)
lower concentrations (nsubj)
effect uncommon (amod)
prevalence lower (amod)
causes impacts (dobj)
inhibits activity (dobj)
conclude induce (ccomp)
comprised participants (nmod)
assessed microscopy (nmod)
amine a (det)
hrp ) (punct)
reflection is (cop)
duration short (amod)
responsible action (nmod)
suggest improves (ccomp)
induced halothane (nmod)
rats survived (acl)
time immobilization (compound)
absence history (nmod)
chloramphenicol administered (acl)
measuring concentrations (dobj)
means push (nmod)
altered was (auxpass)
values hemoglobin (compound)
2.14 ) (punct)
recovery for (case)
cocaine and (cc)
maintained enhanced (conj)
year at (case)
reflexes in (case)
levels ammonium (compound)
defects known (amod)
drugs with (case)
prolonged stasis (nsubj)
stratified when (advmod)
enhanced bradycardia (nsubjpass)
paramethasone parenteral (amod)
prevent development (dobj)
ileum guinea-pig (amod)
increases levodopa (nsubj)
ranged respectively (advmod)
formation intracellular (amod)
heart rat (compound)
studied effectiveness (nsubjpass)
patient oncology (amod)
undertaken involved (conj)
taken using (advcl)
is nature (nmod)
infiltrates and (cc)
patient transplant (compound)
complication syndrome (nsubj)
required that (mark)
1991 and (cc)
method randomised (dep)
intervention(s . (punct)
aneurysms artery (compound)
affected and (cc)
polymorphism chain (compound)
sets consecutive (amod)
treatment with (nmod)
lead deficit (nmod)
level known (amod)
way contrast (nmod)
27.37 +/- (cc)
inhibitor phosphodiesterase (compound)
group noncastrated (amod)
greater control (nmod)
mg/kg 18.7 (nummod)
side-effects more (amod)
regulation consequent (amod)
model catalepsy (compound)
serotonin 5-ht (appos)
process feedback (compound)
shown properties (dobj)
having second (nsubj)
sg ) (punct)
mechanisms genetics (conj)
36 60 (conj)
concentration or (cc)
muscles the (det)
patient compared (case)
callosum of (case)
found contain (xcomp)
increase thickness (nmod)
feet both (det)
amb either (cc:preconj)
loss increase (conj)
involvement system (nmod)
woman referred (acl)
causes hypotension (dobj)
clozapine- nonobese (amod)
accepted proven (conj)
toxicity former (nmod)
resolution complete (amod)
one antibiotics (nmod)
had effect (nmod)
days 36 (nummod)
lh-rh ( (punct)
ns-718 , (punct)
women on (case)
present manner (nmod)
problems therapy (nmod)
alopecia phlebitis (conj)
neuroleptics of (case)
produce humans (nmod)
patients 303 (nummod)
dose convulsant (amod)
show also (advmod)
visit a (det)
ug.kg-1 f (appos)
stabilizers . (punct)
deficiency butyrylcholinesterase (compound)
conditions in (case)
exposed compounds (nmod)
reported related (xcomp)
cis-platin infusion (nmod)
lead that (mark)
prevented significantly (advmod)
relevance schizophrenia (nmod)
agonists receptors (appos)
hazards the (det)
tool useful (amod)
mm ; (punct)
activations cortex (nmod)
lower reversed (conj)
phenomenon and (cc)
analyse and (cc)
treated block (nsubjpass)
surveillance the (det)
thromboembolism : (punct)
involvement kidney (compound)
took . (punct)
difficult practical (dep)
vegf of (case)
decreased cholesterol (nsubj)
withdrawal and (cc)
process called (acl)
intake equivalent (amod)
result be (cop)
patients fhf (nmod)
appearance the (det)
skf-82958 hr (dep)
abnormalities puromycin (compound)
effects 5 (nmod)
consistent atin (nmod)
parameter this (det)
frame study (nmod)
administration bpd (compound)
recruited clinics (nmod)
received rd (dobj)
increase week (nmod)
synthesized , (punct)
compared sph (nmod)
included eventually (advmod)
curve time-course (amod)
enhance increasing (advcl)
ways characteristic (amod)
essential knowledge (nsubj)
patients end (nmod)
selected patients (nmod)
recovery haemodialysis (nmod)
stimulation mechanical (amod)
blocker nitrates (conj)
shock electric (amod)
chicks of (case)
urea blood (compound)
done performed (conj)
had 33 (nsubj)
controls 2066 (nummod)
resulted died (advcl)
mg/kg/day and (cc)
schedules higher-intensity (amod)
nausea patients (nmod)
courses doxorubicin (nmod)
responses seen (acl)
29 out (advmod)
cause weakness (dobj)
carcinoma be (cop)
alphabeta-crystalin , (punct)
value heart (compound)
receiving = (parataxis)
doxorubicin dox (appos)
l/min 7.73 (nummod)
mg/kg 3 (compound)
useful bnp (nsubj)
experienced thirteen (nsubj)
gavaged study (nmod)
viracept irregular (conj)
predated and (cc)
infusion disease (conj)
glycosuria evidence (conj)
chemoconvulsants among (case)
initiation fluconazole (nmod)
subjects presenting (acl)
131i-albumin human (amod)
lamivudine prevention (nmod)
+/- and (cc)
common not (neg)
degree of (case)
group acetaminophen (compound)
users 1 (dep)
availability production (conj)
determined size (nsubjpass)
thickness mean (amod)
reached levels (dobj)
showed enzymes (nsubj)
ns induced (acl)
disturbance the (det)
0.83 to (case)
generated we (nsubj)
scanner the (det)
expression mrna (compound)
association uveitis (nmod)
inhibition disrupted (amod)
5-fu v (dep)
studied action (dobj)
model same (amod)
resulted changes (dep)
tensions the (det)
0.05 0.5 (conj)
stretches at (case)
blood cerebral (amod)
suffering , (punct)
patients all (appos)
patients receive (acl:relcl)
seizures developed (amod)
september and (cc)
procedures orthopedic (amod)
two and (cc)
mccarthy dodds (conj)
reflex stimulation (appos)
phase model (nmod)
contributions definite (amod)
extent similar (amod)
cells rats (nmod)
consumption lsd (compound)
information sufficient (amod)
seen intoxication (nmod)
less area (nsubj)
prevented maintained (conj)
activity effects (conj)
lost considered (conj)
receive succinylcholine (dobj)
% 8.4 (nummod)
function cholinergic (amod)
changed immunoreactivity (nsubjpass)
highlights study (nsubj)
morning placebo (nmod)
adenocarcinoma gastric (amod)
derive and (cc)
female 29-year-old (amod)
reabsorption and (cc)
altered differences (nmod)
instructions the (det)
developed individuals (nsubj)
hypertension her (nmod:poss)
used technique (nsubjpass)
signs the (det)
leading event (nmod)
30 and (cc)
lobe left (amod)
examinations histologic (amod)
induced trimethaphan (nmod:npmod)
manifestation lid (nmod)
abstracts conference (compound)
performed normalization (nmod)
suppressed 1.9 (conj)
effective treatments (nsubj)
areas rural (amod)
deacetylation homogenates (nmod)
bis 50 (appos)
conclusions causes (appos)
antibody anti-cephalothin (amod)
remission change (appos)
days 22 (conj)
hematoma to (case)
suffered hemiparesis (dobj)
abolition ) (punct)
complication a (det)
twins dizygotic (amod)
show suggesting (advcl)
$ROOT$ implicated (sent)
observed administration (nmod)
monotherapy controls (nmod)
attributable is (cop)
nsvt ) (punct)
showed changes (dobj)
trial atlas (compound)
techniques reaction (nmod)
administration repeated (amod)
test positive (amod)
necessary perhaps (advmod)
ketoprofen group (dep)
cell glomerular (amod)
% 5.21 (nummod)
resolved that (nsubj)
patients 265 (nummod)
task speed (compound)
development hypertension (nmod)
resulted aconitine (nsubj)
manifested serositis (nmod)
administered means (nmod)
hearts sprague-dawley (amod)
gain proteinuria (conj)
12.3 +/- (cc)
premedication mg (nmod)
bmt ) (punct)
junctions cellular (amod)
mg/kg/i.p 50 (compound)
negative sulfamethoxazole (nmod)
bp , (punct)
endothelia the (det)
medicines and (cc)
dose dox (compound)
associated 1 (dep)
agents pressor (compound)
impaired administration (nsubj)
kinds for (case)
6,3-dilactone of (case)
l-noarg of (case)
buffer cold (amod)
lead noncompliance (nmod)
$ROOT$ variation (sent)
normokalemic not (neg)
contribute less (advcl)
taken mornings (nmod)
given would (aux)
dysfunction by (case)
recommenced when (advmod)
ability detect (acl)
improved disturbances (dobj)
obstructive apnoea (conj)
reported established (advcl)
tissue especially (advmod)
events mitochondrial (amod)
ischemia spinal (amod)
patients younger (amod)
hematoma intercerebral (amod)
erp or (cc)
4.98 mean (dep)
formation brain (compound)
reduced activations (dobj)
difference amns (nmod)
tyrosine-methionine-aspartate-aspartate ymdd (appos)
loss functions (nmod)
rest exercise (conj)
similarities effects (nmod)
hypertension renovascular (amod)
n-butyl-deoxynojirimycin inhibitor (appos)
$ROOT$ documented (sent)
migraine presumed (amod)
describe report (nmod)
inhibition cells (nmod)
apnea , (punct)
lead hearts (nmod)
disruption , (punct)
added had (aux)
model in (case)
dyskinesias lids (appos)
treated implant (nmod)
areas well-limited (amod)
attributed interaction (nmod)
conclusions meet (appos)
prod erod (conj)
mg/kg 0.015 (compound)
studied day (nmod)
undertaken methods (nsubjpass)
symptomatic enough (advmod)
reductions subscale (nmod)
differences propensity (nmod)
factors many (amod)
administration ribavirin (nmod)
escalated was (auxpass)
trial cisplatin (nmod)
discovery the (det)
concentrations lidocaine (compound)
saline i.c.v (appos)
g145r and (cc)
ratio in (case)
diffuse multifocal (conj)
investigation performance (nmod)
warrant trials (dobj)
antigen-positive ed-1-positive (conj)
antibody igg (compound)
mechanism significance (conj)
myeloma in (case)
edema cystoid (amod)
induced delayed (amod)
toxic fetuses (nmod)
value with (case)
induce infarction (dobj)
states high (amod)
showed test (nsubj)
relevant was (cop)
are studies (attr)
concentration ( (punct)
remifentanil or (cc)
baseline oct (nmod)
74 43 (compound)
60 50 (compound)
underwent insertion (dobj)
deleterious prevention (nmod)
care wound (compound)
patients 41 (nummod)
pregnancies normal (amod)
months 8 (nummod)
venous both (conj)
illness hepatitis-like (amod)
conclusion had (appos)
use monohydrate (nmod)
performed 1 (dep)
mt ) (punct)
reduction frequency (nmod)
drug meloxicam (nsubj)
compared brain (nmod)
switched is (nmod)
indicate provoke (ccomp)
led compound (nmod)
appeared evident (advcl)
treatment previous (amod)
dosage mazindol (compound)
increased 1 (dep)
therapy safe (amod)
pce ) (punct)
examinations histological (amod)
epilepticus a (det)
linked . (punct)
hbv ) (punct)
metabolite hepatic (amod)
identical . (punct)
studies volunteers (nmod)
carried be (auxpass)
course with (case)
changes rcbf (compound)
patients similar (amod)
beams tissue (conj)
incidence cin (nmod)
annuals cases (nmod)
sent , (punct)
glutamine amino (compound)
different . (punct)
$ROOT$ asterixis (sent)
included resulted (conj)
ee with (case)
esrd associated (acl)
recognize toxicity (dobj)
hypokalemia factors (nsubj)
inhibitor-associated angiotensin-converting (amod)
furosemide addition (nmod)
subtle easy (conj)
diethylnitrosamine den (appos)
$ROOT$ noted (sent)
exposure and (cc)
patient 35-year-old (amod)
dose steroids (nmod)
had both (dobj)
weeks 20 (nummod)
observed hcrh (nmod)
providing while (mark)
demonstrate absence (nmod)
administration levobupivacaine (nmod)
associated pb (nsubjpass)
combination everolimus (nmod)
history acne (nmod)
modulate and (cc)
anxiety abnormalities (conj)
done were (auxpass)
hcfc ( (punct)
schedule and (cc)
concentrations endpoint (nmod)
% 16.1 (nummod)
amplitude startle (compound)
had area (dobj)
adam10 expression (dep)
w. b. (compound)
loss axons (nmod)
ibuprofen sulindac (conj)
using tropicamide (dobj)
center at (case)
tolerate not (aux)
mid- long-term (conj)
activity caspase-3 (compound)
abnormalities structural (amod)
cholinesterase on (case)
cvp ( (punct)
deposition immunoglobulin (nmod)
elevations further (amod)
ratio albumin/creatinine (compound)
values pre-lithium (amod)
provide method (dobj)
events , (punct)
values [verapamil]o (nmod)
dose-dependent children (nmod)
dronedarone of (case)
edema well-demarcated (amod)
onset produced (acl)
factor contributed (acl:relcl)
group l-med (compound)
(+/-)-pg-9 kg-1 (dep)
bbb gliomas (nmod)
management using (acl)
defects binasal (amod)
adr ( (punct)
comparisons inadequate (amod)
labelling for (case)
antagonist beta-adrenergic (amod)
measured proteinuria (nsubjpass)
hyperkalemia the (det)
three thirty (nummod)
l-alpha-gfc ) (punct)
wane improvements (nsubj)
mm2 ( (punct)
produce catalepsy (dobj)
0.91 0 (prep)
cs and (cc)
those function (nmod)
spasm sorafenib-induced (amod)
medications oral (amod)
needed treated (conj)
prevented concentrations (nmod)
effect digoxin (nmod)
is now (advmod)
66.9 ( (punct)
pro-inflammatory inflammatory (conj)
10(-4 to (dep)
done crossmatching (nsubjpass)
withdrawal desferrioxamine (compound)
conjugates three (nummod)
zidovudine lamivudine (conj)
pathways synthesis (nmod)
increased pretreatment (nsubj)
patient severe (amod)
involved variety (nsubjpass)
treatment republic (nmod)
androgen- corticosteroid-treated (conj)
agents approved (amod)
norepinephrine intra-arterial (amod)
monitored rejection (nsubjpass)
free recurrence (nmod)
dtis ) (punct)
syndrome patients (nmod)
role drug (nmod)
test hyperprolactinemia (nmod)
relieve may (aux)
effects molecular (amod)
decreased 15.6 (nmod)
kg 92.6 (nummod)
patient abnormalities (nmod)
attribute important (amod)
age advanced (amod)
order with (case)
20 to (case)
enrolled participants (dep)
nightmares intake (nmod)
procedure during (case)
neurotoxic and (cc)
segment anterior (amod)
included mouth (dobj)
eeg of (case)
indicate suggest (conj)
group timolol (compound)
help assay (nsubj)
elucidated deficits (dobj)
interaction juice (nmod)
gem ( (punct)
changed hours (nmod)
disease therapy (nmod)
develop 22 (parataxis)
appear have (xcomp)
word the (det)
min subcutaneously (advmod)
treated cats (nsubjpass)
users mb (nmod)
transplant after (case)
model acute (amod)
appears useful (ccomp)
embarrassed eating (advcl)
growth decreased (amod)
use repeat (amod)
use populations (nmod)
led scene (nmod)
glutathione in (case)
treatment range (nmod)
intervals by (case)
imperative patients (nmod)
infusion chloride (compound)
rate ifosfamide (nmod)
1.6 0.2 (conj)
inhibitors prostaglandin (compound)
effects such (amod)
rat normal (amod)
predominant with (mark)
fraction apap (nmod)
chorea . (punct)
allele with (case)
included times (dobj)
have blockers (nsubj)
re-challenged not (neg)
time mineralization (compound)
included behaviour (dobj)
igf-il-3 and (cc)
scans and (cc)
understood yet (advmod)
increases by (case)
right the (det)
affected treatments (nmod)
addition intake (nmod)
disease on (case)
attempted , (punct)
characteristics to (case)
occurrence bruising (compound)
affects specifically (advmod)
petechiae purpura (conj)
that over (case)
quantify risk (dobj)
d-amphetamine apomorphine (conj)
described japan (nmod)
neonate pneumonia (nmod)
assessment use (compound)
latency sign (nmod)
show up-regulated (ccomp)
induced ages (nsubj)
has profile (dobj)
expression excretion (conj)
concentrations cocaethylene (compound)
effect tissue (nmod)
correlates calculated (advcl)
recognized inconsistently (advmod)
survived period (nmod)
syndrome mirtazapine-associated (amod)
astroctytes these (det)
report a (det)
recovered , (punct)
continued min (nmod)
comments subject (nmod)
regimens inhibitor (compound)
resuscitation . (punct)
54 5 (conj)
rule following (case)
administration oxytocics (nmod)
% aged (nmod)
lines selected (acl)
mg/dl. of (case)
hormone to (case)
trimester in (case)
anaemia despite (case)
ci 95 (nummod)
pj34 with (case)
found produce (xcomp)
disorder acute (amod)
bergmann ) (punct)
safe ? (punct)
abs ( (punct)
calculated periods (nsubjpass)
reducing incidence (dobj)
fk ; (punct)
affect further (advmod)
women ( (punct)
mental and (cc)
synthase ts (appos)
counterbalanced , (punct)
denervation nucleus (nmod)
corrected and (cc)
produce chemotherapy (nsubj)
ed50 ( (punct)
% 0.2 (nummod)
remains basis (nsubj)
expression prl-r (compound)
number depressions (nmod)
areas effective (acl:relcl)
clotiazepam and (cc)
p10 in (case)
playing role (dobj)
corrected 1,2 (nmod)
induce hyperprolactinemia (dobj)
120 30 (compound)
sevoflurane or (cc)
achieved , (punct)
gating and (cc)
toxicities prominent (amod)
data relationship (nmod)
mg.kg(-1).d(-1 sc (appos)
tropicamide % (appos)
subset animals (nmod)
n-dimethylpropranolol n (compound)
concentrations lower (amod)
recurring time (nmod)
actions depressant (amod)
aminotransferase iu/l (appos)
dyskinesia thalamotomy (conj)
mg/kg/day 4 (nummod)
years 44 (nummod)
collagenase 0.014-unit (nummod)
svr + (cc)
angiographies performed (acl)
frequency voltage (conj)
post-training weeks (nmod:npmod)
hold . (punct)
one blockers (nmod)
measured and (cc)
adaptation of (case)
received daily (advmod)
97.1 ( (punct)
electrodes epicardial (amod)
properties na+-binding (amod)
blockade dopamine (compound)
cells polymorphic (amod)
interpret this (dobj)
enzyme converting (amod)
administration pn (nmod)
children 33 (nummod)
surgery open-chamber (amod)
recognition delayed (amod)
area day (nmod)
syndrome svc (compound)
hyperammonemia with (nmod)
13th 14th (conj)
fibrosis with (case)
induce did (aux)
abolished pre-administration (nmod)
study clinicopathologic (amod)
mg/kg cocaine (nmod)
anemia aplastic (amod)
t d4 (compound)
caused propofol-remifentanil-tiva (nmod)
errors medication (compound)
drug be (cop)
represent change (dobj)
scavenger radical (compound)
therapy calcitriol (compound)
nitroprusside under (case)
resulted alterations (nmod)
cornerstone the (det)
damage with (case)
appears reflex (xcomp)
observed . (punct)
provoked however (advmod)
given control (advcl)
process an (det)
underwent neonate (nsubj)
120.04 16.01 (conj)
markers impairment (nmod)
grade exception (nmod)
plausible is (cop)
manipulation during (case)
strains hbv (compound)
control amantadine (nmod)
people of (case)
25.4 2.0 (conj)
given volunteers (nmod)
workup reaction (compound)
lost year (nmod)
injected pre-treatment (nmod)
consume with (prep)
hypothyroidism unknown (amod)
signs neurological (amod)
model evidence (dep)
12.5 or (cc)
11 days (conj)
= 0.001 (dep)
discussed features (nsubj)
duration hyperprolactinemia (nmod)
provided sedation (dobj)
involved may (aux)
mi of (case)
ribavirin and (cc)
reports individual (amod)
mediate effects (dobj)
analyzed safety (dobj)
resistance mmg (appos)
88 , (punct)
tfl ) (punct)
l-w ( (punct)
prosthesis heart (compound)
have group (nsubj)
21 , (punct)
showed normalization (dobj)
became manic (acomp)
test coombs (compound)
combinations different (amod)
indications specific (amod)
rate akathisia (nmod)
stable tachy- (nmod)
remedies as (case)
micrograms 2.5 (nummod)
interaction attributed (acl)
database practice (compound)
remained gtn (dep)
less map (nmod)
fraction ef (appos)
$ROOT$ identical (sent)
$ROOT$ shift (sent)
hypotension due (case)
chickens adult (amod)
publication in (case)
levels 5 (dep)
control historic (amod)
attenuate damage (dobj)
diet standard (amod)
degree damage (nmod)
justified not (neg)
woman 70-year-old (amod)
= .011 (dobj)
users recreational (amod)
monitoring blood (compound)
developed necrosis (nsubj)
reduced remained (advcl)
centre referral (compound)
needed were (auxpass)
evokes it (nsubj)
grade been (cop)
be there (expl)
dosage presence (conj)
0.6 ) (punct)
receptors benzodiazepine (compound)
differ changed (advcl)
defined is (cop)
caused removal (nsubj)
repeat to (mark)
myeloma symptomatic (amod)
abnormality intracranial (amod)
increased stage (nmod)
active that (mark)
1993 and (cc)
-18 +/- (cc)
observed treated (advcl)
minimizing dysfunction (dobj)
transitioned , (punct)
resistance muscle (compound)
hyper- ( (punct)
beta-hydroxylase dbh (appos)
index proliferation (compound)
option maintained (advcl)
administration combined (amod)
neoantigens of (case)
role modulating (amod)
arm infusion (compound)
fev1 fef25 (appos)
thyroiditis autoimmune (amod)
properties rewarding (amod)
hexabrix and (cc)
points primary (amod)
episodes nocturia (compound)
norethisterone of (case)
582 - (punct)
involved u-ii (nsubjpass)
documented were (auxpass)
cascade neurodegenerative (amod)
wasting effect (acl:relcl)
mg/kg 10.0 (nummod)
risk esrd (nmod)
patients difficult-to-treat (amod)
disease or (cc)
prevented should (aux)
secretion acth (compound)
radiologic laboratory (conj)
improvement test (nmod)
analyses histopathology (compound)
cnsb002 morphine (conj)
na(+)/k(+)-atpase , (punct)
endogenous steroid (dep)
3.1 ) (punct)
stroke related (amod)
selected have (xcomp)
reduction . (punct)
efficacy furosemide (nmod)
indication heterogeneity (nmod)
1.5 0.445 (compound)
some all (conj)
measured mice (nmod)
excluded ) (punct)
ischemic and (cc)
catecholamines myocardial (amod)
manifests . (punct)
ro4368554 antagonists (conj)
administered wr242511 (nsubjpass)
cortical medullary (conj)
features toxicity (nmod)
synthase mip (compound)
hemostasis on (case)
detected was (auxpass)
helpful that (mark)
hour per (case)
outcomes dichotomous (amod)
receptor lipoprotein (compound)
used drug (nsubjpass)
prevented might (aux)
pbto(2 ) (punct)
0.39 to (case)
alpha-2b ) (punct)
addition cases (nmod)
calculated determine (advcl)
infusion results (appos)
kindled cocaine (nmod)
episode lasting (acl)
age yrs (nmod)
failure clinical (amod)
accompanied effect (dobj)
interval 3.0 (appos)
lithium : (punct)
stress scores (conj)
-19.20 + (cc)
lf bovine (amod)
clearance osmolality (conj)
injury nonspecific (amod)
glaucoma by (case)
produce . (punct)
alternative stimulation (nsubj)
diseases nerves (nmod)
conducting trials (dobj)
43 19 (compound)
hypothermia and (cc)
level urea (nmod)
commenced and (cc)
400 200 (compound)
amyloidosis secondary (amod)
hypercholesterolemia primary (amod)
providing data (dobj)
increased volume (dobj)
observed ischemia (nmod)
modafinil , (punct)
increased behavior (nsubjpass)
inhibitors potent (amod)
at even (advmod)
adults healthy (amod)
5 mm (conj)
receptors nicotinic (amod)
delay language (compound)
range 1 (nummod)
tomography before (case)
curves tests (nmod)
recovered until (mark)
assessment model (compound)
center level-i (compound)
termination period (dep)
desire of (case)
ability . (punct)
edition fourth (amod)
abnormality transketolase (compound)
neurons th-immunoreactive (amod)
undergoing anaesthesia (dobj)
cardiotoxin and (cc)
microl 4 (nummod)
mechanism underlying (amod)
ingestion regular (amod)
examined effects (dobj)
article in (case)
substituting vpa (dobj)
patients consumers (acl:relcl)
points nerve (nmod)
having urticaria (dobj)
assessment cardiological (amod)
provide and (cc)
agonists their (nmod:poss)
l. sativus (compound)
profiles/sections 0.7 (nummod)
patient by (case)
lys1 antagonist (appos)
increased dosage (nsubjpass)
runs one (nummod)
group within (case)
restored almost (advmod)
seizures sensitivity (dep)
thrombi platelet-fibrin (compound)
case fatality (nmod)
protocol according (case)
dose cumulative (amod)
restriction sodium (compound)
assessed however (advmod)
ifosfamide vincristine (conj)
reaction suspected (amod)
provocation prostigmine-morphine (compound)
year practice (conj)
% 1.7 (nummod)
hg 95 (nummod)
inhibitors angiotensin (compound)
prosthesis with (case)
resolved decreased (conj)
plasma lipoproteins (conj)
advantage significant (amod)
seizures develop (acl:relcl)
population epilepsy (compound)
dependent fit (conj)
mg/ml 47.5 (nummod)
fields and (cc)
chemotherapy dose (compound)
stenosis no (neg)
cortex comprising (acl)
interval a (det)
$ROOT$ lamivudine (sent)
increase to (mark)
possibility involved (ccomp)
suggest do (aux)
pass not (neg)
associated time (nmod)
curve displacement-time (compound)
injected induce (xcomp)
concluded localised (ccomp)
diazepam after (case)
failure absence (conj)
conceivable involved (ccomp)
therapy topical (amod)
region major (amod)
therapy d-penicillamine (compound)
infiltrates interstitial (amod)
sole neurotoxicity (nmod)
injecting by (mark)
count quality (conj)
pt [ (punct)
received tested (conj)
decreasing , (punct)
abc on (case)
projection pass (acl:relcl)
included dlt (nsubj)
assessed retrospectively (advmod)
negative but (cc)
zuclopenthixol and (cc)
communication study/short (amod)
artery in (case)
syndrome baboon (compound)
nucleoside the (det)
test compartment (compound)
examination aggregation (nmod)
neurotransmission da (compound)
vasculitis , (punct)
received patient (nsubj)
cases desire (nmod)
institutions japan (nmod)
drug vehicle (conj)
examined therefore (advmod)
$ROOT$ characterization (sent)
separation genetic (amod)
relationships pressure (nmod)
inhibitor dopamine-beta-oxidase (compound)
distinguished basis (nmod)
so were (cop)
finding patients (nmod)
spasm dissection (conj)
cas ( (punct)
effects dysfunction (nmod)
dose over (case)
day for (case)
known but (cc)
seconds injection (dep)
produced d (nmod)
cells neurons (nmod)
300 , (punct)
morphine mg./kg (appos)
measurement levels (nmod)
application of (case)
p53 or (cc)
donors of (case)
reactions antibiotics (nmod)
investigated cystometry (nmod)
formation cortex (conj)
occurred ; (punct)
longer cisapride (dep)
$ROOT$ inhibits (sent)
advocate administration (dobj)
raises this (nsubj)
use topical (amod)
u/kg ) (punct)
given pre-treatment (nmod)
rr 1.33 (nummod)
leukemia for (case)
episodes strokes (conj)
cld electively (advmod)
studies based (case)
induced agonism (nmod)
$ROOT$ free (sent)
observed as (mark)
patient 2 (nummod)
hypothesize needed (ccomp)
subjects deficits (nmod)
taking yohimbine (dobj)
course short (amod)
protects cerebellum (dobj)
cholestasis in (case)
nm 1 (nummod)
present correlate (conj)
used conjunction (nmod)
presented significance (dep)
thrombosis for (case)
age presentation (nmod)
np unloaded (amod)
therapy b (nmod)
rash skin (compound)
searched . (punct)
propranolol pindolol (conj)
reflex via (case)
recovered value (nmod)
role formation (nmod)
report occurring (ccomp)
24.3 olanzapine (nmod)
feet and (cc)
components two (nummod)
injection l (amod)
11 and (cc)
developing populations (nmod)
consisted hdl (nmod)
antibodies receptor (compound)
attained associated (dep)
opioid hydromorphone (dep)
offers over (punct)
probable algorithm (nmod)
period 12h (amod)
agoraphobia disorder (nmod)
proteins handling (compound)
protein thiols (conj)
overexpressing heart (nmod)
toxocity of (case)
maintained regimen (nmod)
methods sent (appos)
bupropion and (cc)
quality women (nmod)
greater mg/m2 (nmod)
associated measured (advcl)
started lmwh (dobj)
proposed acts (ccomp)
assessed performance (nsubjpass)
protein fk506-binding (amod)
$ROOT$ discribed (sent)
25 , (punct)
enlarged autopsy (nmod)
mssbp reduced (amod)
p=0.01 ( (punct)
dysfunction related (amod)
described literature (nmod)
raise to (mark)
called is (auxpass)
published widely (advmod)
activity effect (conj)
associated prognosis (nmod)
infarction mechanism (nmod)
25.6 6.5 (conj)
score cisapride (appos)
frequent leukocyturia (nsubj)
level expression (nmod)
mapping neurotoxicity (nmod)
similarity procainamide (nmod)
enhancement elevations (conj)
samples forearm (compound)
suppression marrow (compound)
delivery with (case)
dfc -59.7 (appos)
man healthy (amod)
significant was (cop)
smokers people (conj)
associated effective (advcl)
inducing apoptosis (dobj)
c2 from (case)
hyperactivity of (case)
function motor (amod)
demonstrated profiles (dobj)
implantation mice (nmod)
microg/ml . (punct)
cyp1a2 of (case)
eds ( (punct)
depth development (conj)
required nephroureterectomy (nsubjpass)
extraction record (compound)
concluded afford (ccomp)
highlight , (punct)
study fibrosis (nmod)
observations direct (amod)
leukopenia ( (punct)
activity epileptogenic (amod)
network the (det)
choice that (mark)
methylatropine with (case)
prevented rats (nmod)
development neurotoxicity (nmod)
i.v. by (case)
aches system (nmod)
cases confusion (nmod)
protocol chemotherapy (compound)
decrease toxicity (dobj)
disappeared seen (conj)
normal borderline (conj)
therapy beta-blocker (compound)
recovery postoperative (amod)
take bpt/clz (dobj)
visual auditory (conj)
channels sensitive (amod)
blocked was (auxpass)
pharmacokinetics venlafaxine (nmod)
activity capacity (conj)
effect maximum (amod)
protected convulsions (nmod)
norleucine leucine (conj)
inhibitors dtis (appos)
level i (appos)
course transplant (nmod)
l-name inhibitor (appos)
developed rapidly (advmod)
higher hypertrophy (nsubj)
bbb of (case)
rats homozygous (amod)
lesioned and (cc)
indicate could (aux)
thalidomide study (dep)
co-treatment age (conj)
questions safety (nmod)
14.2 8.2 (conj)
glial neuronal (conj)
removed with (mark)
interval time (compound)
initial follow-up (conj)
nitroglycerin and (cc)
hypaque 76 (nummod)
cancers common (amod)
five . (punct)
effects insufficiency (nmod)
heart for (case)
spaces intertrabecular (amod)
use rhigf-i (nmod)
grains silver (amod)
breaks subsequent (amod)
mechanism ototoxic (amod)
ex vivo (dep)
level average (amod)
increased measured (advcl)
$ROOT$ quantitated (sent)
described it (nsubjpass)
was death (nmod)
questionnaire provided (acl:relcl)
develop that (mark)
olr ( (punct)
pathophysiology akathisia (nmod)
changes associated (acl)
subject of (case)
efficacious regimens (nsubj)
resection endoscopic (amod)
oil of (case)
syndrome hematologic (amod)
modulation activity (nmod)
level g/dl (conj)
increase region (nmod)
administration hypotension (nmod)
therapy methylprednisolone (compound)
thalidomide : (punct)
evaluations four (nummod)
showed animals (advcl)
relaxation and (cc)
accompany administration (dobj)
gain area (conj)
activity physical (amod)
size-dependent resulted (conj)
interval min (nmod)
mechanisms and (cc)
reported patient (nmod)
receptors b2 (compound)
users ocs (nmod)
400 to (dep)
study therapy (nmod)
that and (cc)
included agents (nsubj)
are trials (nsubj)
ttc with (case)
prevented antinociception (nsubjpass)
have conclusion (nmod)
efficient was (cop)
week 's (case)
symptoms core (amod)
loreclezole combinations (conj)
ionic with (case)
experienced staying (advcl)
survey nuclear (amod)
regimens medical (amod)
appear deduced (advcl)
august 2004 (nummod)
receptors sigma2 (compound)
efficacy final (amod)
apposition , (punct)
application nitroglycerin (compound)
lesion skin (compound)
ameliorate neurotoxicity (dobj)
flurbiprofen with (case)
part , (punct)
ci 1.7 (appos)
mice of (case)
a than (case)
scattered or (cc)
toxicity ifosfamide (compound)
evident changes (nsubj)
depend did (aux)
administration terbutaline (compound)
epinephrine dipivalyl (compound)
iop an (det)
chi2-test p (dep)
infarction inferior (amod)
neurotransmitters primarily (advmod)
manifestation encephalopathy (nmod)
challenge mice (conj)
effective drugs (nsubj)
received lamivudine (dobj)
butyrylthiocholine and (cc)
pretreatment acetaminophen (nmod)
deterioration ich (compound)
trazodone mg/kg (appos)
egfp ( (punct)
properties pleiotropic (amod)
reports ectopy (nmod)
background/aims suggested (dep)
deaths event-related (amod)
levodopa state (conj)
ml/m2 0.01 (appos)
hoe ; (punct)
hepatitis troleandomycin-induced (amod)
toxin no (neg)
a fujimycine (conj)
seizure witnessed (amod)
6.5 to (dep)
study on (case)
hours 1 (nummod)
mumol/kg 0.8 (nummod)
deteriorate to (mark)
e4031 of (case)
common % (dep)
necessary adjustment (nsubj)
endonuclease-dependent and (cc)
67 54 (compound)
obtained % (nsubj)
strains nzw/lacj (compound)
four but (cc)
injection reserpine (compound)
gyrus dorsal (amod)
chronic intermittent (dep)
precipitated behavior (dobj)
effects levodopa (compound)
increment the (det)
include effects (nsubj)
shock block (conj)
do . (punct)
akathisia neuroleptic-induced (amod)
traveled find (advcl)
or=7.18 , (punct)
convulsions due (amod)
change levels (nsubj)
mice dat(-/- (conj)
bound band (nmod)
training testing (conj)
micrograms 1 (nummod)
temporary is (cop)
cardiotoxicity aconitine (nmod)
hypothyroidism , (punct)
understood are (auxpass)
patients 33 (nummod)
concentrations paclitaxel (compound)
comparisons no (neg)
7.54 4.83 (conj)
affect oxyhemoglobin (nsubj)
reduced lysis (nmod)
therapy fraction (conj)
% concentration (nsubj)
developed lady (nsubj)
remains it (nsubj)
concentrations hemoglobin (compound)
diameter cxad (appos)
tolerate therapy (dobj)
depression on (case)
retina on (case)
induced - (amod)
new or (cc)
injections repeated (amod)
administration intracerebroventricular (amod)
immunoblotting western (compound)
$ROOT$ 3 (sent)
mumol/kg and (cc)
= 4.256 (dobj)
toxicity injection (nmod)
alters function (dobj)
materials given (dep)
$ROOT$ depletes (sent)
activation outcomes (conj)
contain aprotinin (dobj)
restricted use (nsubj)
increased carcinogens (nmod)
ml mean (dep)
those a (nmod)
woman of (case)
prevented cd-832 (nsubj)
cataracts for (case)
solid-organ and (cc)
patient iu/l (dep)
anesthesia , (punct)
bradykinin of (case)
cells located (amod)
received center (nmod)
associated possibly (advmod)
antigenemia hiv (compound)
265.2 +/- (cc)
sarcomas cancers (dep)
ester protector (appos)
less .001 (nmod)
disappeared % (nmod)
cacl(2 m (amod)
lead if (mark)
fruits of (case)
became woman (nsubj)
uncertainties these (det)
arsenic inorganic (amod)
pacemaker ventricular (amod)
atresia = (dep)
kytril ; (punct)
arrhythmias significant (amod)
treating ist (dobj)
akinesia rigidity (conj)
delivered examined (conj)
cases treatment (nmod)
problems gastrointestinal (amod)
inhibition on (case)
appear factors (nsubj)
nitrogen levels (dep)
rose . (punct)
discovered tumors (nsubjpass)
piroxicam ) (punct)
mg 15 (compound)
withdrawn and (cc)
67.4 . (punct)
usage seizures (conj)
examinations histopathological (amod)
alcoholic was (cop)
entered : (punct)
male mature (amod)
treated headache (nmod)
results than (dep)
2e1 ) (punct)
= 0.006 (dep)
lymphadenopathy benign (amod)
none ) (punct)
administration flutamide (nmod)
risk study (dep)
common patients (nmod)
dose carbetocin (nmod)
studied along (prep)
donation platelet (compound)
found loss (nsubjpass)
clozapine p (dep)
etomidate by (case)
seizure-free patients (nsubj)
cocaine followed (acl)
disappearance proteinuria (nmod)
effects nsaid (nmod)
hypertension pressure (appos)
recall pain (nmod)
led recurarization (nmod)
stature short (amod)
switched early (advmod)
proportion animals (nmod)
myelin axons (conj)
discontinued replaced (conj)
minutes . (punct)
either week (dep)
medicines products (conj)
proceed transplant (nsubj)
impairment reabsorption (nmod)
obesity and (cc)
subjects ten (nummod)
steroids results (acl:relcl)
hyperalgesia carrageenan-induced (amod)
suggestive but (cc)
mice albino (amod)
circumstances under (case)
dysrhythmogenicity the (det)
well took (advcl)
formation thrombus (compound)
evaluation in (case)
pump the (det)
effects alkylxanthines (nmod)
oct ) (punct)
treatment rats (nmod)
proposed applied (advcl)
$ROOT$ ablated (sent)
confirm results (nsubj)
consequences need (nmod)
as " (punct)
months period (nsubj)
rats ciprofloxacin- (amod)
precise essential (conj)
polymorphism pcr-rflp (appos)
maintained beginning (advcl)
upslope potential (nmod)
withdrawal pergolide (compound)
diagnosis differential (amod)
structural mitochondrial (amod)
greater group (advcl)
lithium been (cop)
describe outbreak (dobj)
15.08 - (punct)
receiving aminoguanidine (dobj)
treatment complication (nmod)
ratio prevalence (compound)
revealed but (cc)
patients including (case)
hormone because (case)
extract ethanol (compound)
has incidence (nmod)
analgesic nonsteroidal (conj)
pauses the (det)
varied dosage (nsubj)
evaluated time (nmod)
back-diffusion , (punct)
inhibition reuptake (compound)
management airway (compound)
effects neuroleptic-induced (amod)
a-77636 for (case)
properties genotoxic (amod)
positive group (nmod)
occurred resumption (nmod)
nms ss (conj)
combinations ) (punct)
inhibited vocalization (dobj)
complication with (case)
tiopronin to (case)
u/l ( (punct)
dysfunction to (case)
analysed however (advmod)
progress did (aux)
weeks clipping (dep)
inflammation of (case)
$ROOT$ prove (sent)
chf and (cc)
prevent hypoactivity (dobj)
syndrome simvastatin-induced (amod)
maze water (compound)
measure changes (dobj)
replacement warfarin (nmod)
u-ii of (case)
off-time appears (acl:relcl)
impaired altered (conj)
term in (case)
potential mucosal (amod)
hemorrhage patient-years (nmod)
12/32 respectively (advmod)
junctions , (punct)
displacement a (det)
stimuli nociceptive (amod)
basis then (advmod)
pharmaceuticals geigy (compound)
implantation electrodes (nmod)
entry on (case)
persons in (case)
ampk ( (punct)
existed relevance (nmod)
concordance high (amod)
origin manifestations (nsubj)
isolated females (nmod)
hydrochloride n-(trans-3-hydroxy-1,2,3,4-tetrahydro-2-naphthyl)-n-(3-oxo-3-phenyl-2-methylpropyl)-piperazine (compound)
exposed times (nmod:tmod)
granulocytopenia of (case)
headache migraine (nmod)
ng./ml 3 (nummod)
assays axsym (compound)
discontinuation , (punct)
transplantation using (acl)
recognized clinically (advmod)
pronounced that (nsubj)
total ( (punct)
concentrations cgrp (compound)
blocker angiotensin-releasing (amod)
colonies of (case)
aspirin and (cc)
withdrawn concerns (nmod)
higher 0.05 (dep)
followed latency (nmod)
seen remained (parataxis)
tolerate , (punct)
power frap (appos)
considered hexabrix (nsubjpass)
target can (aux)
1 24 (conj)
doses 5-fu (nmod)
allopregnanolone , (punct)
forms dysfunction (nmod)
strain mouse (nsubj)
biomarkers of (case)
mg/kg 100 (compound)
patients p= (appos)
linked activation (nmod)
features sensory (amod)
pap or (cc)
emit rats (nsubj)
rats rhigf-i-treated (amod)
neuroleptics high-potency (amod)
sensation a (det)
initiated evaluate (xcomp)
alt , (punct)
continued was (auxpass)
takes since (mark)
analogues are (cop)
hospitalization days (nmod)
changes creatinine (nmod)
650 over (quantmod)
intake sodium (compound)
inhibits dehydrogenase (dobj)
performed echocardiography (nsubjpass)
benefit either (preconj)
groups corresponding (amod)
airway upper (amod)
preparation by (case)
neuropathy . (punct)
study brain (compound)
pronounced animals (nmod)
kpa 0.1 (nummod)
hemlock ) (punct)
massive among (case)
re-elevate hg (nmod)
possesses , (punct)
lead overload (nsubj)
greater weeks (nmod)
resistance coronary (amod)
129 - (punct)
duration short (acl:relcl)
research to (mark)
inhibition or (cc)
tool predict (acl)
agents antifungal (amod)
model murine (amod)
deposits of (case)
satisfaction their (nmod:poss)
studies epidemiologic (amod)
known less (nsubjpass)
rise mumol/l (nmod)
needs their (nmod:poss)
mean /-s.d (cc)
specific substance (nmod:npmod)
$ROOT$ eruption (sent)
antagonists placebo (conj)
compared activities.2 (punct)
dose p<0.0005 (dep)
patients iran (nmod)
proposed tight (ccomp)
increase arrhythmogenicity (nmod)
cells swollen (amod)
results first (amod)
pn ( (punct)
heart liver (conj)
treated n (nmod)
naloxone injected (acl)
toxicity nanoparticles (nmod)
prooxidant , (punct)
non-users aspirin (nmod)
vasculitis active (amod)
study monkeys (nmod)
dimer-x hexabrix (conj)
began since (mark)
hallucinations ifosfamide-induced (compound)
chemotherapy doxorubicin-based (amod)
appear did (aux)
levels hormone (nmod)
episode another (det)
excess digoxin (compound)
concluded plays (ccomp)
ones in (case)
presenting are (aux)
infusion by (case)
learning immediately (advmod)
tested see (xcomp)
administrations without (conj)
dependence dose (compound)
step is (cop)
pseudo-allergy caused (acl)
stone gall (compound)
treatment days (nmod:poss)
prevented fall (dobj)
complications patient (nmod)
indicate this (nsubj)
azelastine chlorpheniramine (conj)
re-warming at (case)
effects anticonvulsive (amod)
correlates how (advmod)
viability , (punct)
began before (mark)
thyroidectomy radioiodine (conj)
died period (nmod)
children an (det)
pattern typical (amod)
hr p.i (conj)
feature area (nmod)
patients hit (amod)
estimated content (nsubjpass)
marker reduction (nsubj)
injection mpep (compound)
sulpiride estradiol (conj)
rats developing (acl)
prilocaine with (case)
fibrosis subintimal (amod)
compounds , (punct)
have days (nmod)
neurons argyrophilic (amod)
tests with (case)
differences large (amod)
different scores (nsubj)
inquire to (mark)
case rpgn (nmod)
response rate (compound)
detail cases (nmod)
seizure bouncing (compound)
reduced score (dobj)
inhibitor secretion (compound)
mg. l(-1 (nummod)
highlight discuss (conj)
$ROOT$ functioning (sent)
searched trials (nsubjpass)
t+a a (dep)
felt . (punct)
thiazole-2-carboxamide ) (punct)
= 36 (dobj)
assembly lipoprotein (compound)
occurs bdl (nmod)
had phenols (nsubj)
developed subthalamotomy (nmod)
neurotoxicity 3 (nummod)
affected difference (nsubjpass)
risk diazinon-associated (amod)
metamizol s.c. (compound)
regulate some (nsubj)
support experimental (amod)
seem mediated (xcomp)
hbsag anti-hbc (conj)
absorbed is (auxpass)
promoted overload (dobj)
oligodeoxynucleotide targeting (acl)
propagation ead (nmod)
had anaesthetic (dobj)
development nephrolithiasis (nmod)
resolution akinesis (nmod)
cortices kidney (compound)
originating swallowing (advcl)
months 12 (nummod)
neurotransmission with (case)
explanations , (punct)
month birth (nmod)
use argatroban (nmod)
reports some (det)
resulted effects (nmod)
diameters mean (amod)
transplantation : (punct)
skf d-1 (compound)
receptors urotensin-ii (compound)
seeded measured (conj)
dox polymer-bound (amod)
quantitated pharmacodynamics (nsubjpass)
occurring failure (nsubj)
myocarditis associated (acl)
change rats (nmod)
anemia post-chemotherapy (amod)
pathways neutral (amod)
observation microscopic (amod)
has initiate (xcomp)
treatment sulphonylureas (nmod)
exhibited potentiating (advcl)
deterioration behavioral (amod)
used we (nsubj)
hemoglobin angiogenesis (conj)
resolution in (case)
> 0.36 (dep)
production aortic (amod)
need eliminating (acl)
objectives explored (appos)
apoptosis against (case)
electrocardiography resting (amod)
contribute disruption (nsubj)
1 6 (conj)
lower % (dep)
haematuria either (preconj)
oxidation diminution (conj)
$ROOT$ longer (sent)
nh3 ) (punct)
lorazepam injectable (amod)
syndrome hepatitis-like (amod)
coronary or (cc)
reactions idiosyncratic (amod)
relation on (case)
contraindicated are (cop)
increases manner (nmod)
increase avp-induced (amod)
occurred withdrawals (nsubj)
time administration (nmod)
scored min (nmod)
> [ (punct)
describe group (dobj)
equipotent actions (nmod)
number cells (nmod)
nsaids nonaspirin (amod)
withdrawn is (auxpass)
animals surviving (amod)
displace [3h]sch (dobj)
physicians internists (conj)
implants and (cc)
treated injection (nmod)
patients suppression (nmod)
loop of (case)
administration subsequent (amod)
prednisone , (punct)
received mg (nmod)
using limits (dobj)
mania hypomania (conj)
profile safer (amod)
postulated affected (ccomp)
basis list (nmod)
clues certain (amod)
effect fanft (nmod)
treating seizures (dobj)
arteriosclerosis ischaemic (amod)
tamoxifen by (case)
map -16%(-)-33 (nummod)
blockage phlorizin (nmod)
reviewing after (mark)
stages ) (punct)
meter with (case)
5.4 - (punct)
showed patients (nsubj)
loss has (aux)
parameters patients (nmod)
municipal the (det)
level his (nmod:poss)
palsy loss (conj)
sub-divided was (auxpass)
arteries arterioles (conj)
dose 16-mg/kg (compound)
compartments other (amod)
administered that (advmod)
likely associated (xcomp)
6.5 0.5 (compound)
surface ventrolateral (amod)
risk exposure (nmod)
cisapride < (dep)
higher = (parataxis)
expression clinical (amod)
beta-blockers , (punct)
anemia in (case)
failed results (nsubj)
effect such (amod)
indicators that (mark)
behavior cocaine-induced (amod)
$ROOT$ malignancy (sent)
interacted . (punct)
baseline its (nmod:poss)
tachycardia . (punct)
induced mechanisms (conj)
suggest highlight (conj)
stage cytotoxicity (nmod)
investigation an (det)
has epileptogenesis (nmod)
microscopy urine (compound)
drug than (case)
infiltration including (case)
doses warfarin (nmod)
0.003 ) (punct)
served eyes (nsubj)
teams services (conj)
if mean (compound)
inhibited . (punct)
employed only (advmod)
disease alone (advmod)
associated diazepam (nmod)
potential stabilize (acl)
% 12.0 (nummod)
decreased mg. (nmod)
used available (advcl)
six was (cop)
b.d to (case)
anhydrase carbonic (amod)
disorder dsm-iv (appos)
effects little (amod)
doing well (advmod)
injections vcm (compound)
12 and (cc)
reduced synthesis (nsubjpass)
viewed , (punct)
used situation (nmod)
bought , (punct)
overflow . (punct)
effect cells (nmod)
was staining (nmod)
proved safe (xcomp)
vehicle ) (punct)
obtained bile (nsubjpass)
flow erpf (appos)
propionate tp (appos)
reproducible reliable (conj)
contains edetate (dobj)
b12 group (dep)
neuroleptics haloperidol (nmod)
correlated concentrations (nmod)
increase again (advmod)
deterioration . (punct)
infusion furosemide (compound)
polyneuropathy superimposed (amod)
pap ( (punct)
lines mice (nmod)
conclusions contributes (appos)
older years (dep)
drugs antithrombotic (amod)
task p=0.032 (dep)
dysfunction carmustine (compound)
revealed sensitive (ccomp)
recurrence reaction (nmod)
dependent inhibition (nmod)
explanation association (nmod)
influence effect (nmod)
cause convulsions (nmod)
severity patients (nmod)
affects but (cc)
effect factor (nsubj)
discontinued reported (parataxis)
patients signs (nmod)
draw conclusions (dobj)
marked which (nsubj)
fever a (det)
opaque are (cop)
incidence with (case)
msdbp in (case)
rats sexes (nmod)
agonist mk-212 (dep)
detected while (mark)
tumor : (punct)
syndrome pericarditis (nmod)
suffering (aap)-hepatitis (nmod)
developed iridocyclitis (dobj)
1.037 0.003 (conj)
sevoflurane enflurane (conj)
hours 30 (nummod)
suggest validity (dobj)
kidney perfused (amod)
recorded events (dobj)
block blocks (advcl)
5.7 ) (punct)
sensitive shown (advcl)
groups steroid (compound)
hfd ( (punct)
short time (nsubj)
solvent of (case)
vision intolerance (conj)
analogues cck-8-se (dep)
rhabdomyolysis or (cc)
management neuropathy (nmod)
side ipsilateral (amod)
allowed method (nsubj)
bleed seizures (conj)
micrograms 30 (nummod)
identified observations (nmod)
ccl4 and (cc)
protocols 2 (nummod)
believed overdose (xcomp)
parallel selectivity (dobj)
-14.8 , (punct)
administration etoposide (nmod)
measured h (nmod)
mg 180 (nummod)
plays substantial (advcl)
provides protection (dobj)
incidence carcinomas (nmod)
bicuculline acid (conj)
hyperkinesia to (case)
measures , (punct)
measured mrnas (dobj)
microm 26+/-16 (nummod)
cured patients (nsubj)
patients sph (nmod)
caused consequently (advmod)
occurred contact (nmod)
resembles upregulation (nsubj)
cent 21 (nummod)
vagotomy bilateral (amod)
register ( (punct)
cells hl60 (compound)
determinant is (cop)
submitted subjects (nsubjpass)
burns two (nummod)
consumption ethanol (compound)
deaths toxic (amod)
nad substrate (appos)
defect that (mark)
defects intraventricular (amod)
$ROOT$ angiography (sent)
revealed reducing (advcl)
year calendar (amod)
patients latter (amod)
achieved pressure (nsubjpass)
treatment procyclindine (compound)
reduces providing (advcl)
reverses suppression (dobj)
affected ratings (nsubjpass)
morphological analytical (conj)
epilepticus to (case)
nature : (punct)
side-effects . (punct)
replaced after (mark)
urticaria/angioedema ) (punct)
potential effect (conj)
chat ( (punct)
symptoms pd (nmod)
reduced consumption (dobj)
provided icrf-187 (nmod)
cocaine lidocaine (conj)
along with (dep)
measure p=0.026 (dep)
group unilateral (amod)
evoke to (mark)
panel hemogram (conj)
hydroxyl inactivated (amod)
program prevention (compound)
crossed over (advmod)
excitability to (case)
found observed (advcl)
26 about (advmod)
field , (punct)
provides studies (nmod)
kf17837 . (punct)
randomized multicenter (dep)
enteropathica for (case)
observed puberty (nmod)
plasticity the (det)
reporting total (dobj)
alternatives inhibitors (nsubj)
worsening with (case)
intervention received (appos)
abnormalities associated (acl)
microm 15.3 (nummod)
similar concentrations (nmod)
outcomes in (case)
differ increase (nsubj)
sensitivities differential (amod)
sgk1(-/- ( (punct)
remain completed (xcomp)
effect state (nmod)
associated development (nmod)
dose weight (nmod)
system angiotensin (amod)
corresponded qualitatively (advmod)
thioperamide thp (appos)
0.002 than (case)
derivative 4-tetrahydroanaphthalene (nmod)
unconscious administration (nmod)
$ROOT$ persist (sent)
related extrarenal (nmod)
had assay (dobj)
diazepam mg/kg (appos)
effect convulsant (amod)
me ) (punct)
findings consistent (amod)
stretch the (det)
terfenadine , (punct)
liberate animals (nmod)
identified proteins (nsubjpass)
applied twice (advmod)
cyclosporine or (cc)
calculated basis (nmod)
assessment study (conj)
high although (mark)
dna of (case)
increased 2005 (nmod)
event inciting (amod)
complained she (nsubj)
concentrations da (compound)
partial 19 (nmod)
extent pcpa (nmod)
evident increased (advcl)
cardiac skeletal (conj)
days 100 (nummod)
normalized tests (nsubj)
fraction abnormalities (nmod)
believed indicate (ccomp)
thereafter intramuscularly (advmod)
rnfl eyes (nmod)
markers characteristics (conj)
important therefore (advmod)
dysfunction development (conj)
strategy dosing (compound)
period rest (compound)
presence levels (nmod)
pressure wky (nmod)
followed that (nsubj)
diminish inhibition (nmod)
published date (nmod)
level genes (nmod)
h. 24 (nummod)
labelling products (nmod)
$ROOT$ entered (sent)
noted dh (nsubjpass)
explore potentiality (dobj)
> or=65 (cc)
nerve motor (compound)
used contraceptives (dobj)
inhibition and (cc)
categorized infants (nsubjpass)
been and (cc)
results phenotyping (nmod)
mmc and (cc)
min 236.9 (nummod)
rates b (nmod)
amplitude baseline (compound)
analysis chain (compound)
diagnoses disease (nmod)
application form (nmod)
infrequent , (punct)
injury oxidation (compound)
tested adulthood (nmod)
suggested confirmed (conj)
decrease [na]o (nmod)
samples test (compound)
determination using (acl)
that pathology (nsubj)
inhibited contractions (dobj)
treatment reaction (nmod)
monitored arteries (nmod)
procedure months (nmod)
7.5 +/- (cc)
$ROOT$ determined (sent)
some , (punct)
risks inhibitors (nmod)
agents alkylating (compound)
0.47 0.81 (appos)
used hydrobromide (nsubjpass)
agents been (cop)
animals laboratory (compound)
factor endothelial (amod)
ceased bleeding (nsubj)
response control (conj)
patterns protein (compound)
field devices (conj)
channels k(atp (compound)
treated nanoparticles (nmod)
starting titrating (conj)
hospitals programs (nmod)
encephalopathy except (case)
lasted minutes (nmod)
significant difference (nsubj)
$ROOT$ convulsions (sent)
had activity (dobj)
maximum sedentary-isoproterenols (nmod)
blockade prolonged (amod)
hypoperfusion cerebral (amod)
reaction immune (amod)
has reducing (csubj)
model studies (nmod)
hepatitis anesthesia (nmod)
jj 18 (dep)
have avoided (conj)
susceptibility a (det)
0.65 , (punct)
regulation transmission (nmod)
data risk (nmod)
administered be (auxpass)
bar a (det)
cause disease (dobj)
diagnosed results (nsubjpass)
susceptibility in (case)
trial therapies (nmod)
defined dynamic (nmod)
levels carbamazepine (compound)
hr and (cc)
toxicity report (dep)
alternative theophylline (nmod)
5 groups (appos)
tachycardia accompanying (amod)
pilo ) (punct)
all antagonists (nmod)
1 [ (punct)
correlated age (nsubjpass)
concentration glutathione (compound)
acid acid (conj)
subjects control (compound)
exposed dose (nmod)
maleate ) (punct)
proteinuria with (case)
experienced infusion (nmod)
processing in (case)
that below (case)
therapy lisinopril (compound)
medication to (case)
had preoperatively (advmod)
incorporation decreased (amod)
adam10 , (punct)
success iop (dep)
morphology activity (conj)
p45 at (case)
mice dbh (compound)
sustained increase (nsubj)
part be (cop)
seizures period (nmod)
heart animals (nmod)
vincristine chemotherapy (conj)
intervals min (compound)
attenuate significantly (advmod)
speaking 5.2+/-1.1 (dep)
keratectomy excimer (amod)
scale by (case)
long one (nummod)
mg/m2 days (conj)
demonstrates elevation (dobj)
micrograms/mouse i.c.v. (amod)
included patients (nsubjpass)
reduce reversal (nsubj)
glutathione total (amod)
etoposide and (cc)
rct from (case)
described patients (nsubj)
hyperkinesis with (case)
intolerant drugs (nmod)
tariquidar the (det)
hyperprolactinemia a (det)
nicorandil of (case)
history past (amod)
explained probably (advmod)
strong that (nmod)
atpases bound (amod)
develop exencephaly (nmod)
cancer kidney (compound)
records mother-infant (compound)
done was (auxpass)
temocapril iii (nummod)
elevated were (aux)
cyclosporin of (case)
due therapy (nmod)
demonstrate studies (nmod)
patient leukemia (nmod)
use methods (nmod)
amplifier presynaptic (amod)
diplopia the (det)
4.7 0.7 (conj)
given either (dep)
prostaglandins of (case)
subjects the (det)
mr doses (conj)
flurothyl and/or (cc)
reduce whether (mark)
$ROOT$ derivative (sent)
reduced mg/kg (nsubj)
reversible often (advmod)
electroretinograms potentials (conj)
dosed followed (advcl)
effect from (case)
chlorofluorocarbons cfcs (appos)
lesions demarcated (amod)
eye pain (conj)
demonstrate can (aux)
effect nephropathy (nmod)
levels nerves (nmod)
time . (punct)
teams and (cc)
rare patients (nmod)
evidence echocardiographic (amod)
cessation by (case)
increased 1710 (nmod)
affected aim (nsubjpass)
june 1985 (nummod)
extent rats (nmod)
concentration reduced (amod)
demonstrated study (nsubj)
variety aberrations (nmod)
exist cells (nmod)
effect elevations (nsubj)
phenylephrine ( (punct)
either subsequent (conj)
had those (nmod)
consist phases (nsubj)
cystitis (cyp)-induced (amod)
discontinuation linezolid (nmod)
degree all (nsubj)
association genetic (amod)
developed patient (nmod)
vacuolar scattered (amod)
placebo in (case)
acid g (appos)
area interstitial (amod)
presents , (punct)
rate doses (nmod)
associated contributing (advcl)
ratio narrow (amod)
transfusion of (case)
anxiety increased (amod)
agents conventional (amod)
level control (compound)
accounted thus (advmod)
point end (compound)
has cyp3a4 (nmod)
species sequestration (conj)
require reassessment (dobj)
doses micrograms/kg/min (nmod)
oil containing (acl)
$ROOT$ setting (sent)
angiotensinogen cortical (amod)
sensitive sufficiently (advmod)
factor insulin-like (amod)
littermates non-transgenic (amod)
decreases mek1 (nmod)
experts from (case)
lipoproteins of (case)
causes apparent (advcl)
undetermined was (cop)
injection diazepam (nmod)
agranulocytosis . (punct)
dermatitis periocular (amod)
blockade pharmacological (amod)
microg/rat 2 (nummod)
seizures psychoses (conj)
fraction both (cc:preconj)
angina and (cc)
involved case (nsubj)
adjust ph (dobj)
showed tolerant (ccomp)
due cocaethylene (nmod)
maps mri-based (amod)
performance before (case)
dexmedetomidine . (punct)
site responsible (amod)
receive and (advmod)
developed mice (nsubj)
anticoagulant by (case)
retardation iugr (appos)
collected we (nsubj)
distribution in (case)
% 59.6 (nummod)
waveforms baep (compound)
modifies that (mark)
patients triggered (acl:relcl)
known benefit (nsubjpass)
seen july (nmod)
sulfate netilmicin (compound)
collection peripheral (amod)
ml 2 (compound)
application continuous (amod)
effects oxide (nmod)
paraplegia methotrexate (nmod)
achieved period (nmod)
iso mg/kg (appos)
future the (det)
reversal report (dep)
impairment : (punct)
d11 , (punct)
recovered patient (nsubj)
rats han-wistar (compound)
thought lowered (ccomp)
difficult adhesions (nmod)
agents reverse (acl:relcl)
introduction dosage (conj)
site effect (nmod)
vasculitis propylthiouracil-induced (amod)
occlusion associated (acl)
forms distinct (amod)
activity cimetidine (nmod)
stage inoperable (amod)
dealing heparin (nmod)
dysfunction because (case)
retrieval task (nmod)
hypotension induced (acl)
used response (nsubjpass)
induced fanft (nmod)
mumol/l peak (appos)
enlarged it (nsubjpass)
ortral peripheral (conj)
analysis cardiomyocytes (nmod)
cage test (compound)
engrafted and (cc)
combinations valproate (nmod)
brainstem midbrain (appos)
glutathione dismutase (conj)
cultures no (neg)
animals d-med (compound)
similarities vocabulary (conj)
10 more (amod)
actions vasoconstrictive (amod)
fq nocistatin (conj)
renal aza (nmod:npmod)
cardiotoxicity efficacy (conj)
$ROOT$ shock (sent)
chemotherapy adenocarcinoma (nmod)
levels thromboxane (compound)
exposure isotretinoin (nmod)
disease subclinical (amod)
active rides (conj)
mandatory patient (nmod)
individuals in (case)
given subjects (nmod)
pirarubicin ( (punct)
3.4 risk (nsubj)
strain donor (appos)
administration mg (nmod)
duration in (case)
preparations weight (compound)
need then (advcl)
mmol/l to (case)
patients arteriopathic (amod)
mumol/kg 6.4 (nummod)
$ROOT$ hemodynamics (sent)
valdecoxib versus (cc)
course 90-day (amod)
discussed article (nmod)
appeared furthermore (advmod)
introduced middle (nmod)
carcinomas hepatocellular (amod)
patients cvd (nmod)
reduced content (nsubjpass)
hormone normal (amod)
effective relatively-safe (conj)
able trinitrate (nsubj)
analysis mitochondrial (amod)
results minutes (conj)
established when (advmod)
tended groups (nsubj)
disruption significant (amod)
reach even (advmod)
co-injection by (case)
subjects/patients the (det)
ratio were (cop)
taxol ( (punct)
cat ) (punct)
75,761 were (cop)
order magnitude (nmod)
developed that (nsubj)
subjected those (conj)
= 1.93 (parataxis)
stomatitis ( (punct)
mg/day 500 (nummod)
cardiovascular local (conj)
experiments present (amod)
rct good-quality (amod)
echocardiography tracking (compound)
infants of (case)
$ROOT$ trained (sent)
adjustment prevalence (nmod)
induced cells (nmod)
common hepatotoxicity (nsubj)
tumors with (case)
self-limiting . (punct)
effect potassium (dobj)
imaging dipyridamole-thallium-201 (compound)
those enrolled (acl)
able that (mark)
unanticipated and (cc)
dysrhythmias ventricular (amod)
exercised that (mark)
reduced thus (advmod)
progression rats (nmod)
540,000 about (advmod)
no-synthase of (case)
registered august (nmod:tmod)
mechanism whose (nmod:poss)
trespass not (neg)
mg 160/12.5 (nummod)
result myelination (nmod)
a [ (punct)
bn factor (compound)
remain mechanism (nsubj)
exercise bicycle (compound)
formed been (auxpass)
tested never (neg)
1.3 switchers (nmod)
involves hypertension (nsubj)
% 33.67 (nummod)
carried . (punct)
swelling disruption (conj)
potent diazepam (nmod)
variables for (case)
ph osmolarity (conj)
have evidence (dobj)
suggested analysis (nsubj)
minor ) (punct)
1.0 0.81 (conj)
achieved patency (nsubjpass)
duct cbd (dep)
parkinsonism , (punct)
a/j sjl (conj)
substantiated . (punct)
receptors of (case)
injections subcutaneous (amod)
ameliorated impairment (dobj)
weight concentration (conj)
immunocytoma solid (amod)
improvements relative (amod)
chronic repeated (conj)
prevented post-treatment (nsubj)
changes dose-corrected (amod)
correlation concentrations (nmod)
drug diazepam (appos)
allowed approach (nsubj)
% 18.1 (nummod)
contributes nicotine (nsubj)
status disease (compound)
excretion urine (compound)
improves pallidotomy (nsubj)
hyperthermia body (compound)
elevation degeneration (conj)
correspond activation (nmod)
imparts lack (nsubj)
parameters hematologic (amod)
arteries mm (nmod)
depressants system (compound)
required randomization (nmod)
dermatoses inflammatory (amod)
virus hyperlipidemia (conj)
identified countries (nmod)
infection fungal (amod)
neuroprotection rendered (acl)
very or (cc)
impairments alternation (nmod)
count cd4 (amod)
protein pattern (conj)
distributed system (nmod)
pathway dysfunction (nmod)
high treatment (nmod)
were objectives (nsubj)
equipotent be (cop)
system dopamine (compound)
shown block (xcomp)
5-ht areas (nmod)
errors ) (punct)
ratios ( (punct)
solution anaesthetic (compound)
mg ibuprofen (compound)
implanted s.c. (advmod)
84 fourteen (compound)
regulator . (punct)
piloerection effects (conj)
started individuals (nsubjpass)
facilitated micturition (dobj)
megakaryocytes with (case)
rates sample (nmod)
$ROOT$ black (sent)
denopamine by (case)
contributed be (auxpass)
5.5 to (dep)
preceded up-regulation (nsubj)
effects differ (acl:relcl)
insight better (amod)
ld50 ( (punct)
electrical behavioral (conj)
% 40 (nummod)
propofol to (case)
pregnancy no (neg)
developed hour (nmod)
fed , (punct)
analyses laboratory (compound)
thrombocytopenia for (case)
analyzed studies (nmod)
documented was (auxpass)
values agreement (conj)
correlated that (nsubj)
overflow endogenous (amod)
induce route (nmod)
increase use (nmod)
reversible hepatitis (nsubj)
therapy estrogen-replacement (compound)
stroke ( (punct)
eaca ( (punct)
functions , (punct)
days/week 5 (nummod)
$ROOT$ investigated (sent)
findings to (case)
1mg/kg corresponding (advcl)
11.2 10.9 (conj)
tgf-b kidney (compound)
19.3 +/- (cc)
injected end (nmod)
micrograms/kg 20 (nummod)
pulse agents (dep)
processes by (case)
sinusitis for (case)
levels drug (compound)
dose mg/m2 (nmod)
product rate-pressure (compound)
% 39.7 (nummod)
intake children (nmod)
shown cause (xcomp)
sigmast sum (appos)
case first (amod)
1 more (advmod)
$ROOT$ recovers (sent)
factors ulcerogenic (amod)
response differential (amod)
$ROOT$ resulted (sent)
includes patients (dobj)
response pathway (conj)
breakdown pool (nmod)
$ROOT$ remarkable (sent)
reflecting pain (dobj)
observed often (advmod)
uterus pig (compound)
dehydrogenase of (case)
hydrochloride midazolam (compound)
rate pressure (conj)
prove incidence (nmod)
transducer a (det)
kinase transaminases (conj)
difference patients (nmod)
aware patients (nmod)
cats in (case)
terminals mossy (compound)
exposure anesthesia (nmod)
effect fluoxetine (nmod)
reduced risk (nsubjpass)
weakness proximal (amod)
studied enzyme (dobj)
lt n=35 (dep)
reduces estradiol (nsubj)
neuroinflammation and (cc)
ranged admission (nmod)
overdose iatrogenic (amod)
superior and (cc)
rbcs to (case)
given tobramycin (nsubjpass)
maintained extension (nmod)
patients 675 (nummod)
dex by (case)
desogestrel plus (cc)
b.d on (case)
had hypotension (nsubj)
hypotension milrinone-induced (amod)
+ ca2 (compound)
expression nephrin (compound)
= 0.8 (dobj)
made is (auxpass)
injection albumin (nmod)
observed sections (nmod)
ballooning left (amod)
have combination (nmod)
prc to (case)
67.4 scores (nsubj)
dobutamine both (cc:preconj)
1.210 - (punct)
show have (ccomp)
frame a (det)
thickening of (case)
scores % (appos)
it 's (case)
analysis levels (conj)
sites channel (compound)
coadministration dexrazoxane (nmod)
parts subcortical (amod)
produced treatment (nsubj)
illustrated are (auxpass)
interpretation retains (appos)
start after (case)
500 more (amod)
level bcl-2 (nmod)
$ROOT$ decreases (sent)
cholinergic deficit (dep)
hbv mutant (amod)
seizures impairments (conj)
large and (cc)
methotrexate with (case)
considered monitoring (nsubjpass)
turnover lysosomal (amod)
antinociception morphine (nmod)
metoprolol terbinafine (conj)
attenuated ltp (dobj)
seems there (expl)
nitroglycerin combined (amod)
investigated have (aux)
bringing about (compound:prt)
concentrations mean (amod)
nausea for (case)
role additive (amod)
control metabolism (nsubj)
effect alkylxanthines (nmod)
prevent dex-ht (dobj)
extract alcoholic (amod)
performance psychological (amod)
speed their (nmod:poss)
had jaundice (dobj)
declined sharply (advmod)
reduced and (cc)
zero four (conj)
institution timely (amod)
evoke , (punct)
telangiectatic papular (conj)
november 2004 (nummod)
one marker (conj)
constituted att-alf (nsubj)
0.59-mg 2.1-mg (conj)
drug introduced (advcl)
extended-release/lovastatin once-daily (amod)
require do (aux)
in were (cop)
activity acid (compound)
associated manifestations (nmod)
affinity in (case)
times suppression (conj)
mean treatment (nmod)
adenomas reports (dep)
hemorrhage warfarin-induced (amod)
ci 1.1 (appos)
patients recurrence (nmod)
hsct donors (nmod)
concluded therapy (ccomp)
scored was (auxpass)
facilitates . (punct)
remained while (mark)
has that (dobj)
case episodes (nmod)
factor-alpha tnf-a (appos)
measure oscillation (nmod)
11/57 23/57 (conj)
greater expression (nsubj)
mg females (nmod)
ratings scores (nmod)
measured samples (nmod)
impact reducing (acl)
decreased sevoflurane (nmod)
balances electrolyte (compound)
contribute impairment (nsubj)
lymphoma tumours (conj)
% cases (nmod)
agonist fenoldopam (nsubj)
diarrhea were (cop)
assess variations (dobj)
result cessation (nmod)
required reduction (nsubjpass)
range days (nmod:npmod)
99 respectively (advmod)
potential side-effect (amod)
deferoxamine subcutaneous (amod)
subjects n (dep)
crisis hemolytic (amod)
antagonist bn (appos)
history hitt (nmod)
studies administration (nmod)
216 12 (nummod)
used pallidotomy (nmod)
nephrotoxicity medium (compound)
myopathy lack (nmod)
compared administration (nmod)
changes histopathologic (amod)
dm-9384 ( (punct)
pretreatment hds (nmod)
events vascular (amod)
gene vasopressin (compound)
mg less (amod)
rat 's (case)
consumed are (auxpass)
measurement gssg (nmod)
administration stz-icv (compound)
seen nothing (nsubjpass)
$ROOT$ excitation (sent)
fatigue being (cop)
pretreatment extract (compound)
alterations hepatitis (conj)
antigen skin (compound)
patient delirium (nmod)
months from (case)
receptors kinase (compound)
enhanced reductions (nsubjpass)
dose loading (compound)
exerted toxicity (dobj)
subjects 20 (nummod)
effects impairment (nmod)
scored % (nsubj)
propranolol mg (amod)
predominated signs (nsubj)
transplantation renal (amod)
healthy medically (advmod)
long-term c (dep)
necrosis and (cc)
rate micrograms.kg-1.min-1 (appos)
agranulocytosis thrombocytopenia (conj)
entering esrd (nmod)
weeks that (nsubj)
counteract provoke (ccomp)
taken treatment (nmod)
used caution (nmod)
substances tbars (appos)
higher animals (nmod)
antithrombin inhibitor (appos)
equal changes (nmod)
vasodilator produce (acl:relcl)
observed reversible (conj)
pill of (case)
observed rat (nmod)
examination . (punct)
85 6 (conj)
d-med micrograms/kg (appos)
differentiate effects (dobj)
increased maturity (nmod)
modified activity (nsubjpass)
modify decrease (nsubj)
1.0 1.0 (conj)
areas glomeruli (nmod)
led discontinuation (nmod)
appeared gradually (advmod)
supplements and (cc)
women complained (acl:relcl)
sedation particularly (advmod)
changes localization (nmod)
cells afferent (amod)
potentiated dog (nmod)
11 1 (conj)
alleviation in (case)
predominant metastasis (nsubj)
complications midazolam (nmod)
serum , (punct)
improve tolerance (dobj)
sulfate analgesia (nmod)
l-3,4-dihydroxyphenylalanine plus (cc)
rate incidence (conj)
mg/kg 111.0 (nummod)
toxicities toxicities (conj)
challenges corticosteroids (nmod)
efficacy greater (amod)
increased enhances (advcl)
group dimer-x (compound)
pilocarpine ) (punct)
groups drug (compound)
age gender (conj)
using admission (dobj)
chicks any (det)
phytomitogen to (case)
induced less (parataxis)
smaller dose (nsubj)
consistent cardiotoxicity (nmod)
did and (cc)
1.17 4.72 (prep)
found increase (dobj)
ci=22.8 ) (punct)
mg 1.2 (compound)
risk cataracts (nmod)
chelation to (case)
case with (case)
staining components (nmod)
$ROOT$ elicits (sent)
restored cck-8 (nsubj)
considered achieved (advcl)
logical think (xcomp)
specimen pathology (compound)
reducing antioxidants (nsubj)
necessary trial (nsubj)
attributable possibly (advmod)
follow up (compound:prt)
$ROOT$ predictor (sent)
agents those (appos)
experienced grade (dobj)
origin glomerulosclerosis (nmod)
acts it (nsubj)
substratum the (det)
factors only (amod)
secondary occlusion (nmod)
lowered whereas (mark)
receiving plans (nmod)
streptozotocin by (case)
interaction this (det)
represents frequencies (dobj)
injection soft-tissue (amod)
goes . (punct)
alternations the (det)
concentration transaminase (compound)
signs obstruction (nmod)
ts ) (punct)
secondary administration (nmod)
meeting a (det)
episodes haematuria (nmod)
greatest , (punct)
aspirin salicylate (conj)
corticosteroids of (case)
not , (punct)
combinations morphine (nmod)
switched patients (nsubjpass)
3.9 , (punct)
insecticide lindane (nsubj)
treatments amantadine (compound)
pressure whose (nmod:poss)
scheduled batteries (nmod)
implants ) (punct)
$ROOT$ offers (sent)
jerks myoclonic (amod)
leading sensitivity (nmod)
bromocriptine given (acl)
il-3 of (case)
g/ml were (cop)
patients exposed (acl)
discontinuation treatment (conj)
difficulty the (det)
= 1.00 (dobj)
markers rs6693503 (dep)
developed hypercalcemia (dobj)
indicate observation (nsubj)
enhance function (dobj)
dm mild (amod)
cross-tolerant cross-tolerant (advcl)
extension hemolysis (nmod)
anemia level (nmod)
antibiotics beta-lactam (compound)
neurons gaba (compound)
clinical subclinical (conj)
edema : (punct)
choreic type (nmod)
% euthymia (conj)
administration losartan (compound)
infiltrate associated (acl)
intubation by (case)
skin and (cc)
option acidification (nsubj)
picu ( (punct)
demonstrated cna (nsubj)
continued or (cc)
frequency prior (amod)
jones and (cc)
effects halothane (nmod)
wk 3 (nummod)
infarctions myocardial (amod)
minimize can (aux)
production patients (nmod)
map = (acl:relcl)
given dogs (nsubjpass)
under within (conj)
less patients (dep)
ml , (punct)
dystrophy neuralgia (conj)
granulomas of (case)
rifampin and (cc)
requirements analgesic (amod)
renin and (cc)
delirium patient (nmod:poss)
cocs ) (punct)
provided echocardiography (nsubj)
responded reporting (advcl)
incidence users (nmod)
group another (det)
malformations arteriovenous (amod)
manner an (det)
tamoxifen to (case)
% 73 (nummod)
morbidity events (conj)
decreased amounts (dobj)
cyclooxygenase 1 (nummod)
included elements (nsubj)
ntg ( (punct)
distress , (punct)
mice i.c.v.)-treated (amod)
formed state (nsubjpass)
aspirin for (case)
transport an (det)
decreased concentration (nsubj)
discontinued she (nsubj)
severity and (cc)
decreases a (det)
duration elevation (nmod)
developed women (nmod)
haematological renal (conj)
metabolism its (nmod:poss)
quantified staining (nmod)
association start (nmod)
activity arterial (amod)
enhances transmission (dobj)
states gastric (amod)
properties effects (conj)
(1.8)% -5 (compound)
stiffness marked (amod)
asymptomatic completely (advmod)
neuropathy chemotherapy (compound)
disappeared , (punct)
eyes , (punct)
damage pronounced (amod)
lesions rats (nmod)
trigeminal the (det)
withdrawal atra (nmod)
decrease rats (nmod)
warranted trial (nsubjpass)
reduced administration (nsubj)
use illicit (amod)
proliferation renal (amod)
presented overall (advmod)
certain is (cop)
pparalpha-/- [ (punct)
pressure concentration (conj)
range antidepressants (nmod)
comparable to (mark)
reshape , (punct)
subject whether (mark)
mediated likely (advmod)
emax 1.86 (nmod)
counts results (conj)
extent neurons (nmod)
approach multidisciplinary (amod)
bortezomib thalidomide (conj)
malformations low-incidence (amod)
causes dogs (nmod)
difference product (nmod)
increased animals (nmod)
seizure . (punct)
reported prolongation (nsubjpass)
associated avoided (conj)
106 4 (conj)
tests in (amod)
dog in (case)
prophylaxis ibuprofen (compound)
correlate did (aux)
pravastatin rosuvastatin (conj)
made obviate (dep)
retrieved cholecystectomy (nmod)
elucidate in (mark)
area model (nmod)
finding w-ich (nmod)
kg(-1 of (case)
hypertensive shr (appos)
threshold response (compound)
umb24 antagonists (appos)
observed but (cc)
performed reflected (conj)
events akathisia (nmod)
ulcerous non-ulcerous (conj)
striatum target (nmod)
attenuate components (nsubj)
96.7 was (cop)
1 less (amod)
rupture ventricular (amod)
results positive (amod)
members are (cop)
test provocative (amod)
50 45 (compound)
vincristine therapy (conj)
information new (amod)
resulted hypertension (nmod)
men age (appos)
administered solvent (conj)
treatment short- (amod)
activation mglu7 (compound)
phosphokinase bun (conj)
effect stronger (amod)
azathioprine aza (appos)
effects multifarious (amod)
benzo[a]-pyrene n-methyl-n-nitrosourea (conj)
inappropriate and (cc)
following on (case)
$ROOT$ gained (sent)
effects amitriptyline (nmod)
men hypertension (nmod)
association production (nmod)
incidence anomalies (nmod)
suggests findings (advcl)
disorder agoraphobia (conj)
emerged recommendation (nmod)
onset secondary (amod)
oedema matter (nmod)
identified cases (dobj)
observed creatinine (nsubjpass)
acting and (cc)
chiasmopathy of (case)
perfusion ganglia (compound)
four at (case)
any variables (nmod)
anthracycline with (case)
stimulation dopaminergic (amod)
proteins urine (compound)
reduces cardiotoxicity (dobj)
taking admission (nmod)
node the (det)
effect little (amod)
enos of (case)
angio-oedema pre-existing (amod)
exhibited had (advcl)
hemorrhage during (case)
determined , (punct)
= 55 (dobj)
aorta ascending (amod)
prolonged manner (nmod)
curve co2-response (amod)
gd mg/kg (appos)
has potential (dobj)
common threatening (conj)
dosed weeks (nmod)
site common (amod)
aminotransferase limit (conj)
drugs demonstrate (acl:relcl)
potential . (punct)
dilatation vacuolization (conj)
cataracts of (case)
conditions predisposing (amod)
contaminants methotrexate (compound)
differences time (nmod)
observed contrast (nmod)
reversed initiation (nsubj)
acetylsalicylate sodium (compound)
$ROOT$ flexion (sent)
concentrations prolactin (nmod)
increased severity (nsubj)
those olanzapine (nmod)
started infusion (nsubj)
hepatonecrosis related (amod)
edema intercellular (amod)
increase myopathies (nmod)
used haloperidol (nsubjpass)
rate eradication (compound)
desogestrel or (cc)
duration af (nmod)
inhibitors cyclooxygenase (compound)
transplanted center (nmod)
group-2 n=10 (dep)
performed assays (nsubjpass)
wt/day mg/kg (nummod)
measured evaluate (advcl)
mg/kg/day 0.057 (nummod)
lower risk (nmod)
involved increase (nmod)
counts mast (compound)
mg/kg 257 (nummod)
catabolism functional (amod)
methods neuronal (amod)
potential sap (appos)
treatment tuberculosis (nmod)
sleep multiple (amod)
genotype with (case)
that days (dep)
mirrored alterations (nsubj)
study lometrexol (nmod)
electroshock by (case)
msh/acth ( (punct)
14 , (punct)
case pointes (nmod)
formation is (cop)
region represents (acl:relcl)
ascribed nephrotoxicity (nmod)
flestolol blockade (conj)
tachyphylaxis systemic (nmod)
includes , (punct)
n-butyl-deoxynojirimycin zidovudine (conj)
tolerable infections (nmod)
once or (cc)
$ROOT$ suffering (sent)
tests heparin-induced (amod)
received ug (conj)
safe " (punct)
restarted doses (nmod)
recorded training (nmod)
play activator (nmod)
h was (cop)
unresponsive bradycardia (nmod)
treatment carcinoma (nmod)
gyrus left (amod)
days p=.01 (dep)
scale asex (appos)
relation findings (nmod)
0.025 than (case)
compensation the (det)
toxicity renografin (nmod)
onset preceding (case)
= p (appos)
hepatitis of (case)
experience administration (nmod)
mmc ) (punct)
erythroblasts of (case)
goal levels (nmod)
used settings (nmod)
confirmed could (aux)
succimer with (case)
cells group (nmod)
nephropathy adr (compound)
induce tachycardia (dobj)
were instances (attr)
monitored effects (nmod)
combinations % (appos)
bn specific (amod)
ginsenoside as (case)
experiment of (case)
changes first (amod)
uptake increased (amod)
densities volume (compound)
$ROOT$ evaluate (sent)
older than (dep)
anticipated seen (advcl)
plays property (nsubj)
1991 1999 (conj)
cocaine amphetamine (conj)
hypotension ascitis (nmod)
hyponatremia ? (punct)
used demonstrate (advcl)
rare hepatotoxicity (nsubj)
results oct (compound)
metabolite catecholamine (compound)
time ischaemia (nmod)
isolation thunbergiana (nmod)
elimination drug (nmod)
enhancement images (nmod)
and therefore (advmod)
syndrome distress (compound)
receive cancer (nmod)
implanted testosterone (nmod)
approaches , (punct)
spasm in (case)
mice two-week-old (amod)
sinus cerebral (amod)
rhythm temporary (amod)
ascitis an (det)
deterioration clinical (amod)
was where (advmod)
% 44.4 (nummod)
suspected ruled (advcl)
inhibitor which (nsubj)
lower score (nsubj)
response response (appos)
aspects . (punct)
dysfunction chronic (amod)
augment melatonin (nsubj)
patients 27 (conj)
deficits learning (compound)
chromatography liquid (compound)
reversal induced (amod)
carcinoma undifferentiated (amod)
responses emotional (amod)
attenuate reduce (conj)
rationale and (cc)
tri ( (punct)
results in (amod)
mg 0.15 (compound)
used lindane (nsubjpass)
$ROOT$ disruption (sent)
inhibition evoked (acl)
agent and (cc)
encephalopathy hyperammonemic (amod)
microgramg/ml ) (punct)
antagonize effects (dobj)
guidelines antibiotics (nmod)
indicate exert (ccomp)
closure capillary (compound)
insula in (case)
phase proteinuria (nmod)
monitoring evaluation (conj)
have roles (dobj)
beclomethasone inhaled (amod)
comparable variables (nsubj)
increased agents (nmod)
a not (cc)
periods after (case)
renoprotective whereas (mark)
protected impairment (nmod)
fragments cholecystokinin (nmod)
$ROOT$ granulated (sent)
neuroleptics so-called (amod)
hc ifs-induced (amod)
excess grip (compound)
damage histological (amod)
neurons beta2(-/- (compound)
10 less (amod)
palsy nerve (nmod)
secretion acid (compound)
prevention syndrome (nmod)
prophylaxis nausea (nmod)
mepivacaine with (case)
events cardiac (amod)
effects antiproliferative (amod)
course same (amod)
enlargement liver (nmod)
narcosis ketamine- (amod)
treatment chelation (compound)
produced information (dobj)
coma acidosis (conj)
morphine between (case)
contribute although (mark)
% 34.4 (nummod)
became using (advcl)
read to (mark)
suppress measured (advcl)
antagonizing hypokalemia (dobj)
nausea abnormalities (conj)
tissues cardiac (amod)
c7-c8 ( (punct)
increased stz (nsubj)
accuracy impaired (amod)
gr/dl 9.5 (nummod)
tissues human (amod)
eyes receive (acl:relcl)
transplantation chemotherapy (conj)
benzodiazepines intravenous (amod)
reversed seizure (nsubj)
action appropriate (amod)
paper previous (amod)
dysphonia and (cc)
been there (expl)
decreased delineated (conj)
induced catalepsy (nsubjpass)
performed echo (dobj)
declined g/dl (nmod)
users tablets (appos)
tg haart (conj)
igf-i and (cc)
cacl(2)-treated and (cc)
pdn mg/kg/day (compound)
cholinesterase an (det)
injury cell (compound)
administered carefully (advmod)
ich is/tia (conj)
show effective (ccomp)
mo first (amod)
described highlighting (advcl)
shift . (punct)
those 22 (dep)
withdrawal of (case)
confirm we (nsubj)
aids ( (punct)
considered models (nsubjpass)
staff medical (amod)
therapy morphine (compound)
animals remaining (amod)
hypotension drug-induced (amod)
losses larger (amod)
technique mapping (compound)
rare dangerous (conj)
discontinue and (cc)
syndromes on (case)
efficacy chemotherapy (nmod)
3alpha-hydroxy-5beta-pregnan-20-one ( (punct)
glomerulonephritis 3-antineutrophil (amod)
design given (appos)
used they (nsubjpass)
effect levels (nmod)
doses 25mg/kg (dep)
known who (nsubjpass)
open and (cc)
prognosis survivors (nmod)
alpha minutes (nmod)
thalidomide carcinoma (nmod)
homozygous be (cop)
reversed formation (dobj)
hyperprolactinemia amenorrhea/oligomenorrhea (conj)
studied not (neg)
mg/kg/day of (case)
treatment chc (nmod)
exhibited results (nsubj)
literature the (det)
attenuated crocin (nsubj)
observations based (case)
differences excretion (nmod)
level potassium (nmod)
hyperprolactinemia with (case)
remained cpk (nsubj)
stratum in (case)
thrombosis vein (compound)
centers medical (amod)
therapy domperidone (compound)
= median (dep)
met not (neg)
problem management (nmod)
scale-revised conners (nmod:poss)
% figure (nsubj)
ptld ) (punct)
mechanism syndrome (nmod)
dbp hg (dep)
injection botox (compound)
receiving lidocaine (dobj)
abusers known (amod)
monitoring one-on-one (nummod)
analysis morphometric (amod)
transplantation treatment (nmod)
treated ? (punct)
interstitium to (case)
$ROOT$ vasodilator (sent)
recorded groups (nsubj)
$ROOT$ consequence (sent)
mice mhc-cb7 (compound)
explained , (punct)
monitored treated (advcl)
lesions neurotoxicity (nmod)
examinations electro- (conj)
similar closely (advmod)
period normothymic (amod)
higher decreased (conj)
blood obtained (acl)
alendronate ( (punct)
tested plasma (nsubjpass)
related conditions (nmod)
had abnormalities (dobj)
headaches , (punct)
period typical (amod)
induced injecting (advcl)
active prodrugs (nsubj)
hospital . (punct)
patient-years 500 (nummod)
pathologies the (det)
course in (case)
dcf with (case)
infection cmv (compound)
bha % (amod)
cardioselective ( (punct)
sleepiness subjective (amod)
introduction kidney (nmod)
moran ] (punct)
prazosin antagonist (compound)
similar hand (nmod)
phenotype long-lasting (amod)
frequency spontaneous (amod)
proliferation immunosuppression (nmod)
analyzed impact (dobj)
content camp (compound)
changed lid (nsubj)
occasions 2 (nummod)
higher consistently (advmod)
selection a (det)
produces but (cc)
desogestrel ( (punct)
cautious physicians (nsubj)
presents findings (dobj)
curative was (cop)
criteria administration (compound)
occurred association (nmod)
(2-chloroethyl)-1-nitrosoure bcnu (appos)
dosage tacrolimus (compound)
attack single (amod)
synthesis glucocorticoid (compound)
lower value (nmod)
doses 16 (nummod)
activated state (nmod)
cholecystitis acute (amod)
roots the (det)
females patients (nsubj)
levels biochemical (amod)
lesions various (amod)
diseases serious (amod)
on- in (case)
mechanisms central (amod)
intake the (det)
doses baseline (amod)
higher longer (conj)
larger attributable (conj)
damage function (conj)
rapid significantly (advmod)
treatment cortisol (compound)
increased rate (nsubjpass)
nephrin plekhh2 (conj)
study capillaries (nmod)
carcinoma metastasis (conj)
overflow rats (nmod)
induce remoxipride (nsubj)
furosemide to (case)
albuminuria levels (conj)
patients malaysian (amod)
review in (case)
mm 24.7/16.6 (nummod)
triggers leads (conj)
infarcts of (case)
antiemetic and (cc)
tissues various (amod)
phonation during (case)
experienced while (mark)
was up-regulation (attr)
chemotherapy treatment (nmod)
competing enzymes (nmod)
2/3 % (appos)
administration synthesis (nmod)
nephrogenic and (cc)
strain resistant (amod)
conditions many (amod)
allocated based (prep)
differences pharmacokinetic (amod)
damage snr (nmod)
changes factor (nmod)
concentration high (amod)
therapy patient (nmod)
indicative be (cop)
performed assessed (conj)
p53 members (conj)
content and (cc)
development apoptotic (amod)
weeks duration (nsubj)
months over (case)
free percent (nsubj)
examinations physical (amod)
clearance high (amod)
appear play (xcomp)
spike population (compound)
prudent , (punct)
disadvantages potential (amod)
independent chemosensitivity (nmod)
% delta=-6.7 (nummod)
ias ) (punct)
serious . (punct)
compound like (case)
cefonicid of (case)
peroxidation of (case)
absence the (det)
was change (nmod)
frequency appearance (nmod)
neurotoxicity for (case)
tests transformation (compound)
as were (cop)
case acidosis (nmod)
measurements pge2 (compound)
demonstrated contributes (ccomp)
time open- (amod)
neurotoxin the (det)
numbers reported (acl:relcl)
shown enhance (xcomp)
produces although (mark)
related appear (conj)
order in (case)
parallel . (punct)
has pathogenesis (nmod)
pathology underlying (amod)
fatigue mucositis (conj)
concentrations inadequate (amod)
questioned patient (nsubjpass)
presented changes (nmod)
0.03 0.04 (conj)
findings girl (nmod)
conclusion detected (appos)
buffers and (cc)
frequent syndrome (nsubj)
increased radiolabelling (nsubjpass)
signs common (amod)
activation an (det)
patient treated (acl:relcl)
volume corpuscular (amod)
had tachycardia (nmod)
alpha-fluoro-beta-alanine fbal (appos)
responsibility actual (amod)
a = (dep)
accumulation % (dep)
developed cystitis (dobj)
mdma functioning (conj)
believed pathological-process (xcomp)
assumed point (nmod)
incidence % (compound)
treated carboplatin (nmod)
venous central (amod)
treatment danazol (compound)
$ROOT$ conclusive (sent)
colocalized . (punct)
increasing thereby (advmod)
axons parvo-cellular (amod)
warranted that (mark)
patients other (amod)
conclusions practical (amod)
ng/dl. ft4 (nsubj)
stimulation acute (amod)
potential slowing (advcl)
demonstrate role (nmod)
correlated changes (nmod)
increases pathway (nmod)
reports series (conj)
models arrhythmic (amod)
sides both (det)
remedies natural (amod)
revealed hematoma (dobj)
hbv-dna and (cc)
loss hypertension (nmod)
protects apoptosis (nmod)
correlation tomography (nmod)
effect which (nsubj)
effect contractant (amod)
women 5408 (nummod)
contributed respectively (advmod)
admitted had (aux)
decreased treatment (nsubj)
revealed differences (nsubjpass)
modeling pharmacodynamic (amod)
boluses , (punct)
recorded entry (nmod)
reserpine polyamines (compound)
atenolol blocks (parataxis)
produced pretreatment (nsubj)
five ) (punct)
comparisons formal (amod)
scale arizona (compound)
bevacizumab/irinotecan of (case)
transfusion ( (punct)
born 1971 (nmod)
mg/m2 ) (punct)
patients diagnosis (nmod)
dysrhythmias of (case)
relative groups (nmod)
binding decreased (amod)
investigated were (auxpass)
time infusion (compound)
disrupts function (dobj)
vicinity hematoma (nmod)
ssris with (case)
etoricoxib with (case)
august to (case)
hypersensitivity capsaicin-evoked (amod)
courses time (compound)
anorexia dizziness (conj)
useful produce (xcomp)
ce administered (acl)
membranes hepatocyte (compound)
tend , (punct)
permitted was (auxpass)
$ROOT$ dosing (sent)
$ROOT$ showing (sent)
occlusion central (amod)
success % (nmod)
remarkable were (cop)
suxamethonium to (case)
channels calcium (compound)
limbs left (amod)
rats streptozotocin-diabetic (amod)
treatment ag (nmod)
relevant therapy (nmod)
impaired patients (nmod)
reach not (neg)
entry for (case)
resuscitated was (auxpass)
recommended dexrazoxane (nsubjpass)
sufficient , (punct)
acting used (conj)
after only (advmod)
from june (nmod)
associated prophylaxis (nsubjpass)
surgery elective (amod)
lowered and (advmod)
rats lnna (compound)
preference contralateral (amod)
syndrome hand-foot (compound)
50 70 (prep)
period total (amod)
doses to (mark)
administration stz (compound)
ability remoxipride (nmod)
quantitated terms (nmod)
handling devices (dobj)
had terminated (conj)
mg/dl follow-up (nmod)
converted . (punct)
man ischemia (nmod)
antidepressants to (case)
hemorrhage 13 (nmod)
neuropathy rat (nmod)
treated vincristine (nmod)
tested responses (nsubjpass)
accompanied fibrillation (nmod)
injury nephropathy (nmod)
compared effect (nsubjpass)
catalepsy morphine-induced (amod)
epinephrine exercise (conj)
melanoma for (case)
reveal to (mark)
exposed who (nsubjpass)
aware and (cc)
types cancers (nmod)
indicated staining (nsubj)
insipidus . (punct)
inflammation carrageenan-induced (amod)
instillations tur (nmod)
mi for (case)
amyloidosis and (cc)
dfu 0.3 (nummod)
mm 80.0 (nummod)
techniques computerized (amod)
activation rats (nmod)
substance cells (nmod)
5.0 0.5 (compound)
considered develop (advcl)
coadministered onset (nmod)
min occlusion (nmod)
traits the (det)
microinjection area (nmod)
data model (nmod)
history clinical (amod)
present encephalopathy (nsubj)
consume drug (dobj)
group ii (nummod)
range beta (compound)
circulations systemic (amod)
cs of (case)
shown response (dobj)
gamma 1 (dep)
reports event (compound)
9.1 - (dep)
approaches imaging (nmod)
found commonly (advmod)
disorder cocaine-induced (amod)
induced cycloheximide (nmod)
receptors gaba(a (compound)
relate relationship (nmod)
system liver (appos)
rapamycin not (neg)
pay pressure (nmod)
time-dependent in (case)
substrate of (case)
disappeared 10 (nmod)
cbd : (punct)
scales values (conj)
increase significant (amod)
disease artery (compound)
experience treated (advcl)
patients v (cc)
hdl g/ml (appos)
appeared frequent (xcomp)
stress enhanced (amod)
carotenoids crocins (appos)
breakdown degeneration-induced (amod)
impairments memory (compound)
conjugation deoxycholic (amod)
loss regulation (conj)
hemopoiesis ineffective (amod)
database ) (punct)
needed tarsorrhaphy (dobj)
antinociceptive markedly (advmod)
phosphate mg/kg (appos)
0 3 (conj)
lowered that (mark)
witnessed expand (advcl)
characterized incubation (nmod)
recorded parameters (nsubjpass)
majority 29 (appos)
linked sprouting (nmod)
sulfate gentamicin (compound)
sensitized was (auxpass)
pancreaticobiliary gastric (conj)
doses both (cc:preconj)
higher marginally (advmod)
pointes torsade (nsubj)
fashion an (det)
reaching doses (nmod)
studies blotting (compound)
associations : (punct)
describes seizure (dobj)
risk adults (nmod)
infusion tablet (conj)
induce man (nmod)
mediated serotonergically (advmod)
hypophosphatemia aminoaciduria (conj)
sc-48334 ) (punct)
progression the (det)
impact . (punct)
diminish , (punct)
dose-effect structure-function (conj)
betaenac and (cc)
participate ratio (dep)
diary and (cc)
complicated be (auxpass)
bought he (nsubj)
frequencies one (nummod)
$ROOT$ option (sent)
cco-i in (case)
challenged catalepsy (nsubjpass)
ziprasidone to (case)
nephropathy shr (nmod)
aneurysms for (case)
carcinogen only (advmod)
controls that (nsubj)
model rats (conj)
donor the (det)
layer subendothelial (amod)
circumstantial are (cop)
nicergoline methylprednisolone (conj)
antagonized morphine (nmod)
rs4704559 and (cc)
reducing expression (dobj)
summary : (punct)
vaccinated december (nmod)
placebo-controlled , (punct)
gradual very (advmod)
properties defined (acl)
patients u/ml (dep)
calculated cause (xcomp)
% p<0.01 (conj)
prolongation population (nmod)
by mainly (advmod)
affect introduction (nsubj)
confusion mental (amod)
50 fewer (amod)
g/l to (case)
discount authors (nsubj)
correlated if (nsubj)
connections structures (nmod)
needed prevent (advcl)
studies previous (amod)
infection b (compound)
role causing (advcl)
child the (det)
volumetry magnetic (amod)
counter . (punct)
anesthetics used (acl:relcl)
predominance structures (nmod)
reversed amnesia (nsubjpass)
excretion between (case)
effect apap (nmod)
cases 54 (nummod)
service us (compound)
$ROOT$ useful (sent)
nausea postoperative (amod)
limited reports (nmod)
account finding (nsubj)
cystitis a (det)
showed stabilized (conj)
cvds ( (punct)
stimulated receptors (nsubjpass)
lack effect (nmod)
feeding uninephrectomy (conj)
indicate have (ccomp)
studied sites (nsubjpass)
field ca1 (compound)
findings admission (nmod)
nerve on (case)
5-fu only (advmod)
antagonist h1 (compound)
twitches quipazine-induced (amod)
reducing deficits (dobj)
gout of (case)
massive were (cop)
fell age (nmod)
self-poisoning g (nmod)
dyslipidemia and (cc)
$ROOT$ becoming (sent)
variables architecture (compound)
cause co-administration (nsubj)
incidences 461 (nummod)
showed majority (nsubj)
catheter infusions (nmod)
( chi(2)(3 (intj)
adr of (case)
dose titration (nmod)
determined using (xcomp)
decreasing by (mark)
mg/m(2 day (nmod:tmod)
safety about (case)
10.1 3.8 (conj)
illustrate findings (nsubj)
used indicate (conj)
developed dose (nmod)
suppressed iii (dep)
discharge to (case)
size infarction (nmod)
alterations adr-induced (amod)
die and (cc)
nortriptyline ( (punct)
agent combination (conj)
66.6 10.9 (conj)
reduced even (advmod)
containing calcium (dobj)
therapy ulcer (compound)
difference risk (nmod)
focused recently (advmod)
enhance antagonists (nsubj)
findings these (nsubj)
reached had (aux)
revealed . (punct)
phosphokinase creatine (compound)
amplifier of (case)
inhibitors cox-2 (compound)
increasing occurs (conj)
d d (conj)
combinations antiepileptics (nmod)
shake dog (compound)
urine formed (acl)
caused dose (nmod)
measured catheter (nmod)
rate % (amod)
relation for (case)
defects group (nmod)
found incidence (nmod)
polyuria hours (nmod)
observed responses (nmod)
characterized , (punct)
phases by (case)
cells cerebellar (amod)
state aversive (amod)
definition management (conj)
illnesses medical (amod)
preoperative higher (amod)
effect myopathy (nsubj)
meq/l . (punct)
zidovudine with (case)
examined when (advmod)
studied sets (nmod)
stop propranolol (nsubj)
gem of (case)
development pointes (nmod)
transcripts pvn (nmod)
groups critical (amod)
therapy term (compound)
areas diffusion (nmod)
eye , (punct)
induce doses (nsubj)
score propensity (compound)
substances and (cc)
knowledge etiology (nmod)
tolerable dose (nsubj)
identified hepatitis (nmod)
received dosing (dobj)
independent decreased (conj)
doses by (case)
11/41 % (appos)
dosed combination (nsubjpass)
association ethambutol (nmod)
supplements products (conj)
treatment accepted (amod)
hepatitis prevention (dep)
impaired responses (nsubj)
cells satellite (compound)
objective designed (dep)
formation of (case)
rbcs ( (punct)
mg 160 (nummod)
il-6 ) (punct)
= 94.3 (dobj)
lead event (nmod)
antagonize or (cc)
synthesis investigations (conj)
development to (case)
host for (case)
anesthesia fentanyl (compound)
katona watson (conj)
likely not (neg)
spectrum subjects (nmod)
care health (compound)
provokes clinically (advmod)
opiate any (det)
undergone transplant (dobj)
dermatitis penicillamine-related (amod)
risperidone levomepromazine (conj)
use term (compound)
creatinine ( (punct)
initiated therapy (dobj)
stimulation-evoked electrical (amod)
deleterious furosemide (nsubj)
$ROOT$ yield (sent)
dexrazoxane or (cc)
depression between (case)
infection against (case)
defect urine (compound)
damage membrane (compound)
exist which (nsubj)
il-1b e.g. (advmod)
cis-platin 5-fluorouracil (conj)
monkeys primed (acl)
4 11 (nummod)
dose 10-mg (amod)
3551 336 (conj)
regions related (amod)
pattern . (punct)
focused , (punct)
drug etodolac (appos)
longer that (nmod)
cyclophosphamide hexamethylmelamine (conj)
age months (nmod:tmod)
prevented movements (dobj)
intensities signal (compound)
lifetime intensity-weighted (conj)
conclusion aware (acl)
performed function (nmod)
up-regulation rats (nmod)
banned administration (nsubj)
become factor (attr)
dependency state (compound)
carcinoma ii (nummod)
suggest found (advcl)
inhibition damage (conj)
bulk the (det)
ctni and (cc)
risk statistical (amod)
increased similarly (advmod)
$ROOT$ exist (sent)
diligent clinicians (nsubj)
presence presence (conj)
fev1 fef25 (conj)
male therapy (nmod)
produced volume (dobj)
$ROOT$ mandatory (sent)
calculated follow-up (conj)
studies conducted (acl)
proteins repair (compound)
influenced was (auxpass)
administration regimen (nmod)
read , (punct)
effective also (advmod)
linked benefit (nsubjpass)
weeks treatment (nmod)
receptor human (amod)
eosinophilia failure (conj)
april since (case)
1.5 0 (quantmod)
preferred hexabrix (nsubjpass)
methods and (cc)
mice associated (acl:relcl)
cells collected (acl)
use stabilizers (nmod)
injury hyperalgesia (appos)
effects papaverine (nmod)
vancomycin gentamicin (conj)
parasympathetic sympathetic (conj)
escalated when (advmod)
correlated well (advmod)
compromise related (acl)
picrotoxin ptx (appos)
doses 2 (nummod)
related recovery (nsubj)
cidofovir of (case)
receptor ccr2 (nsubj)
model diabetic (amod)
value minus (cc)
increases alpha-t (nsubj)
electrolyte normal (amod)
l cells/ (compound)
eating food (nmod)
increase dietary (amod)
aim study (nmod)
bicarbonate sodium (compound)
manifestations subtle (amod)
arrhythmias fatal (amod)
center the (det)
son ( (punct)
drug anticholinergic (amod)
signal pain-related (amod)
pills was (cop)
collected population (nmod)
problems of (case)
associated c (nmod:npmod)
velocity diastolic (amod)
progestagens other (amod)
immunoreactive active (conj)
treat effects (dobj)
explained impaired (advcl)
adding , (punct)
appears have (xcomp)
describes case (dobj)
measurements included (dep)
890 to (quantmod)
infusion day (amod)
alpha-methyldopa mg/kg (appos)
remifentanil of (case)
responsiveness hormone (nmod)
evidence effectiveness (nmod)
23.759 ci=6.702 (compound)
induction hemorrhage (compound)
found % (parataxis)
intoxication water (compound)
signs neurotoxicity (nmod)
carsinom cell (compound)
those obtained (acl)
renografin with (case)
gaps scientific (amod)
cause nephrotoxicity (dobj)
exposure prolonged (amod)
drug by (case)
ischemia time (appos)
dosages mipafox (nmod)
receptor-deficient b2 (nmod:npmod)
involving usually (advmod)
increasing % (advcl)
hypertrophy induced (acl)
developed three (nmod)
evaluate activation (dobj)
bche ( (punct)
similar percentage (nmod)
mg to (case)
mds ; (punct)
csa or (cc)
combination oral (amod)
impact small (amod)
system whole-body (amod)
offer did (aux)
role tasks (nmod)
therapies with (case)
prevented group (nmod)
pontis nucleus (compound)
case female (nmod)
radiograph examination (conj)
was thickness (dep)
decreased 33 (nmod)
required where (advmod)
suggest cause (nmod)
emerged has (aux)
severe that (mark)
potency similar (amod)
cell smooth (amod)
ad50 the (det)
those need (acl:relcl)
hypothermia of (case)
serum csf (conj)
induced and (cc)
levels protein (nmod)
substances reactive (amod)
polyuria of (case)
awful , (punct)
incubated and (cc)
useful study (nsubj)
syndrome grade (compound)
exchange with (nmod)
episodes activity (nmod)
map hg (nmod)
evaluated trial (nsubj)
hyperglycemia in (case)
seem use (xcomp)
utility greater (amod)
p group (compound)
output animals (nmod)
1.85 0.57 (nummod)
restored rhythm (nsubjpass)
developed dyskinesia (dobj)
receptors afferent (amod)
glomerulonephritis necrotizing (amod)
rejection . (punct)
alphaenac and (cc)
days 24.9 (nummod)
mg/m2 cisplatin (compound)
consists it (nsubj)
evaluation efficacy (nmod)
principle the (det)
0.0001 ) (punct)
investigated safety (dobj)
strategy important (amod)
curve concentration-time (compound)
mmol/kg ( (punct)
differences development (nmod)
< p (dep)
showed heart (nsubj)
presented calcium (nmod)
enlargement gross (amod)
clubs borderzone (nmod)
lilly eli (compound)
subjects 17 (nummod)
acetate lhrh-a (appos)
accident trauma (conj)
administered . (punct)
prepared patients (nsubjpass)
procedure catheterization (compound)
twitch and (cc)
speculate . (punct)
failed coniine (nsubj)
limbs dyskinesias (nmod)
$ROOT$ toleration (sent)
similar valdecoxib (nmod)
adn age- (amod)
ist ) (punct)
status response (compound)
development somatic (amod)
disappeared fever (nsubj)
treatment incontinence (nmod)
69 to (advmod)
dose morphine (nmod)
unresponsive are (cop)
electrodes with (case)
activity nor (cc)
prompted study (dobj)
attempted find (xcomp)
onset leukoencephalopathy (nmod)
diagnosed . (punct)
1.0 to (dep)
evident maintained (conj)
obtained alternation (nsubjpass)
using digoxin (dobj)
walls mesangium (conj)
discontinued respectively (advmod)
appears thus (advmod)
effect adding (acl)
missed , (punct)
secretion distance (conj)
case first (acl:relcl)
meq/l. 3.34 (nummod)
decreases with (case)
developing neutropenia (dobj)
addiction drug (compound)
regulates nucleus (nsubj)
attest . (punct)
efficacy double-blind (amod)
preserved synapses (nmod)
initiated , (punct)
none cases (nmod)
involvement without (case)
cities four (nummod)
$ROOT$ remain (sent)
outstretched arm (nsubj)
patients 592 (nummod)
concentration median (amod)
lf ( (punct)
erythropoietin ( (punct)
cause related (conj)
occurrence hit (nmod)
it on (case)
proceed to (mark)
$ROOT$ impairment (sent)
resulted neoantigens (nmod)
associated thiopentone (nsubjpass)
kinase erk (appos)
days mean (dep)
1.4 +/- (cc)
need interrupt (acl)
presentation imaging (conj)
variable hence (advmod)
down-regulation day (nmod)
less increase (nsubj)
supplement an (det)
labeled-positive nick-end (nmod:npmod)
jerks of (case)
animals chronically (advmod)
test anova (conj)
liberate to (mark)
% cells/microl (appos)
seen patient (nsubjpass)
treated mitoxantrone (nmod)
n-methyl-d-aspartate nmda (dep)
function could (aux)
blocked all (advmod)
krebs-ringer . (punct)
derivative pyrrolidone (compound)
15 5 (compound)
fed that (nsubjpass)
$ROOT$ introduced (sent)
animals exposed (acl)
patients achieved (acl:relcl)
sec 3.1 (nummod)
neuroplasticity cortex (nmod)
reverse rapidly (advmod)
cessation lithium (nmod)
measured scales (nmod)
pattern seizure (compound)
fluency , (punct)
services transfusion (compound)
ntg ntg (conj)
addition after (case)
correlates importantly (advmod)
tolerated adults (nmod)
lesion neoplasm (conj)
potent augment (parataxis)
patients sympathectomy (compound)
$ROOT$ consolidation (sent)
polyneuropathy 1 (nummod)
dosage mg/kg/daily (appos)
increase activity (nmod)
adults treated (acl)
observed adults (nmod)
therapy women (nmod)
rupture of (case)
result nephropathy (nmod)
syndrome respiratory (amod)
stress against (case)
concentration galactose (compound)
cardiomyopathy associated (acl)
beneficial control (nmod)
died pretreatment (nmod)
pathology glaucoma (nmod)
aware providers (nsubj)
ring fla838 (appos)
saline remifentanil (conj)
administered oxygen (dobj)
considered have (xcomp)
possibility capacity (nmod)
regard mechanism(s (nmod)
lot effects (nmod)
glial and (cc)
% rates (nsubj)
levels half-normal (amod)
dexrazoxane ( (punct)
saline 284.9 (nummod)
unlikely and (cc)
2.6 1.3 (conj)
dili ) (punct)
exposing paclitaxel (nmod)
23 +/- (cc)
decreased micromol/l (conj)
cause was (cop)
administration erdosteine (compound)
feet of (case)
extensive affect (conj)
respect efficacy (nmod)
concentration simvastatin (compound)
c57bl/6 strains (conj)
= 10.66 (dobj)
range across (case)
female white (amod)
control nephrotic (conj)
tolerance patients (nmod)
inactivation imipramine (nmod)
managed . (punct)
describe revealed (conj)
reconsidered should (aux)
it-methotrexate with (case)
weakness a (det)
$ROOT$ highlights (sent)
decrease drugs (nsubj)
t > (amod)
cimetidine to (case)
processes three (nummod)
radioactivity the (det)
suggest sufficient (ccomp)
hospitalised patients (nsubjpass)
little as (advmod)
obtaining of (mark)
trends hemorrhage (nmod)
$ROOT$ dizziness (sent)
conscious . (punct)
reversed , (punct)
aspirin no (det)
fold several (amod)
patients disorder (compound)
trial blind (amod)
avoided adjustment (nmod)
lesions the (det)
continues . (punct)
alpha f2 (compound)
g g (conj)
decrease the (det)
require incidence (nsubj)
facial intracranial (conj)
experiments ex (amod)
presents remission (nmod)
atropine mug (appos)
cyp7a ( (punct)
tested 1 (dep)
thrombocytopenia of (case)
sevoflurane of (case)
failure described (amod)
antipsychotics risperidone (nmod)
clear are (cop)
worst and (cc)
factors type (conj)
tissues the (det)
occurred loss (nsubj)
2d6 of (case)
memory the (det)
stat3 ( (punct)
thickness medial (amod)
latencies s (appos)
effects acetaminophen (nmod)
justify not (aux)
intervals successive (amod)
detection early (amod)
emerged analysis (nmod)
= nx (nsubj)
offer periods (nmod)
showed those (nmod)
equipotent they (nsubj)
decreased propranolol (nsubj)
lipoproteins plasma (compound)
appears hepatotoxicity (nsubj)
phenomenon rare (amod)
negative also (advmod)
wales south (compound)
agent ) (punct)
cells nos-ir (amod)
spectrum haart (nmod)
icterus formed (acl)
deficiency system (nmod)
studies antagonist (nmod)
abolished metocurine (nmod)
gave children (nsubj)
induced increment (dobj)
changes baep (compound)
iv . (punct)
warranted countries (nmod)
combinations val/hctz (compound)
preexcitation without (case)
use bzd/rd (nmod)
mechanisms defense (compound)
duration were (cop)
extend data (nsubj)
cause hepatitis (nmod)
paracetamol ( (punct)
channels membrane (compound)
form anesthetics (nsubj)
reveal , (punct)
beginning treatment (dobj)
specific more (advmod)
activator transcription (nmod)
required reductions (dobj)
known also (advmod)
histochemistry hybridization (compound)
former of (case)
lower data (nsubj)
nucleus incerta (conj)
reported chemotherapy (nmod)
nerves vagal (amod)
mg increased (conj)
increases result (nmod)
severity for (case)
middle eighties (nmod)
remain although (mark)
investigated applies (ccomp)
tests catalepsy (compound)
accuracy percent (amod)
mg./kg . (amod)
flexural and (cc)
another , (punct)
compared chf (nmod)
187 +/- (cc)
took attempt (nmod)
haloperidol p.o. (appos)
given premedication (nmod)
had hypersecretion (dobj)
lv with (case)
found concentrated (advcl)
treatment effects (nmod)
in was (cop)
rats freely-moving (amod)
recipients for (case)
account may (aux)
powder arabic (amod)
hypotension humans (nmod)
$ROOT$ interpolates (sent)
utilized ; (punct)
controls but (cc)
changes amplitude (nmod)
$ROOT$ covered (sent)
include component (dobj)
aged acne (nmod)
trial before (case)
demonstrates experience (nsubj)
reported changes (nsubjpass)
glioblastoma in (case)
coagulation or (cc)
examined neuropediatrician (nmod)
agency medicines (compound)
induction enhanced (amod)
mechanisms causal (amod)
agent introduction (compound)
aimed objective (nsubj)
dermatomes over (case)
elevated steroid-induced (amod)
developing in (mark)
histochemistry radioimmunoassay (conj)
patients post-oltx (acl:relcl)
unaffected was (cop)
sleepiness in (case)
caffeine intravenous (amod)
kg(-1 iv (appos)
243 % (appos)
hydroxytyrosol with (case)
meq. ) (punct)
occurred event (nsubj)
simplifies and (cc)
0.74 ( (punct)
processes separate (amod)
hcl desipramine (compound)
test on (case)
models hypertension (nmod)
wore off (compound:prt)
enhanced verapamil (nsubj)
h. after (case)
eu respectively (advmod)
perform children (nmod)
reports single (amod)
62 ( (punct)
reader the (det)
achieved ce (nsubjpass)
causes that (nsubj)
61 +/- (cc)
infusion ifosfamide (nmod)
sessions 2 (nummod)
surgery unilateral (amod)
fragments analogues (conj)
impaired plasticity (nsubj)
administered as (mark)
profiles pharmacological (amod)
prior hours (nmod:npmod)
disease + (amod)
reduces pre-treatment (nsubj)
target a (det)
elevated as (advcl)
possibility insult (nmod)
cross-tolerant rats (nsubj)
contraction isometric (amod)
toxic were (cop)
thrombotic arterial (amod)
established while (mark)
rates decrease (acl:relcl)
patients ' (punct)
stiffness . (punct)
0.01 and (cc)
acquired baseline (nmod)
this disorders (conj)
syndrome drug-related (amod)
adjusting factors (nmod)
proposed involvement (nsubjpass)
isoform p58 (appos)
test ofh (appos)
measurements output (nmod)
disease of (case)
sites membrane (nmod)
elucidate epidemiology (dobj)
$ROOT$ promotes (sent)
stem in (case)
people warfarin (nmod)
increased eightfold (advmod)
exacerbated sertraline (nsubj)
her to (case)
13 , (punct)
avoidance the (det)
leading prolongation (nmod)
induce apposition (nmod)
was evident (acomp)
polypeptide knockout (dep)
hyalinosis insudative (amod)
mph grade (appos)
show presented (advcl)
indicate effective (ccomp)
100 < (advmod)
patients constipation-predominant (amod)
defect 1 (nummod)
received restore (advcl)
hypothermia prolonged (amod)
given escalated (advcl)
suggestion association (nmod)
product depression (conj)
clinic disorders (compound)
expected seems (conj)
population evaluation (compound)
reabsorption phosphate (compound)
movement electrocardiograph (conj)
support relationship (nsubj)
similar occurred (conj)
started feet (nmod)
u/d ( (punct)
abnormalities following (amod)
measured responses (nsubjpass)
complete recovery (nsubj)
reduces phenylephrine (nsubj)
participation pathway (nmod)
h 48 (nummod)
sufficient be (cop)
extensive less (advmod)
metoprolol , (punct)
inhibition complexes (nmod)
fever myalgias (conj)
stx ) (punct)
fluorescence ( (punct)
tolerated adhd (nmod)
antibitocis various (amod)
mitoxantrone infusion (conj)
men 1,022 (nummod)
selective non-selective (conj)
estimated parameters (nsubjpass)
required unit (nmod)
$ROOT$ uncommon (sent)
light bis (dep)
clinic lithium (compound)
showed depressed (ccomp)
configuration curvilinear (amod)
% 62 (nummod)
rr ( (punct)
play contribute (advcl)
vary study (nmod)
lesion differentiation (nmod)
decreased pretreatment (nsubj)
loss function (nmod)
dec ( (punct)
development before (nmod)
dosing acute (amod)
activated surge (nmod)
feasibility effects (conj)
hemorrhage . (punct)
erythromycin and (cc)
myelosuppression and (cc)
obese edematous (conj)
stratified groups (nmod)
tests ax (nmod)
modulators humoral (amod)
influx = (dep)
proportions patients (nmod)
began h (nmod)
nitroglycerin sufficient (amod)
pathway receptor (compound)
relationship mpo-anca (nmod)
vehicle anp (conj)
results main (amod)
model system (nmod)
weight analysis (conj)
g to (case)
vasoconstriction vasculitis (conj)
was a (dep)
seizures both (preconj)
male ( (punct)
causes syndrome (dobj)
discontinued recovered (conj)
regulation down (amod)
development rs (nmod)
inhibition hypoaidosteronism (conj)
proteins target (compound)
report pentamidine (appos)
distributions models (nmod)
trh ( (punct)
nephritis of (case)
observed hepatotoxicity (nmod)
years , (punct)
patients transplanted (amod)
learning of (case)
factor scale (compound)
mg/m2 higher (nummod)
assessed alteration (nsubjpass)
images spin (compound)
stimulation via (case)
university osmangazi (compound)
22.77 +/- (cc)
atorvastatin ato (appos)
vasculature the (det)
suggested acted (ccomp)
suppression of (case)
common associated (conj)
calculated correlates (advcl)
maze arm (compound)
stimulated fragments (nmod)
task brixton (compound)
properties similar (amod)
dose p20 (nmod)
medications such (case)
showed flow (dobj)
model kidney (compound)
given weekly (advmod)
start therapy (dobj)
analgesic any (det)
investigated expression (nsubjpass)
responsible that (mark)
area dilatation (conj)
suxamethonium or (cc)
symptoms abilities (conj)
hormone pth (appos)
proposed alter (ccomp)
acetyltransferase choline (compound)
demonstrated dismissed (conj)
result as (mark)
pressure filtration (compound)
approach dual (amod)
uveitis treated (acl)
subjects : (punct)
excess the (det)
block ablation (nmod)
speculated data (advcl)
classified using (advcl)
mwm ( (punct)
creatinine basal (amod)
assessed then (advmod)
mcl treated (acl)
dependency cardiotoxicity (nmod)
showed irregularities (dobj)
use theophylline (compound)
total delayed (conj)
eu 320 (nummod)
atp dogs (appos)
400 800 (conj)
ameliorate effect (dobj)
made not (neg)
minutes during (case)
palpation nodule (nmod)
concentrations that (dep)
december and (cc)
recommenced respiration (nsubj)
effects deleterious (amod)
hilum over (case)
role causing (acl)
altered that (mark)
patients untreated (amod)
values between (case)
included oestrogens (dobj)
monitoring under (case)
persons 5.2/100,000 (appos)
op ( (punct)
alterations biochemical (amod)
fk 506 (nummod)
microl 400iu/2 (compound)
mg 117 (appos)
had glomeruli (nsubj)
comparisons both (det)
cycles therapy (nmod)
tests in (case)
helpful been (cop)
fluorescein to (case)
presented department (nmod)
described association (nmod)
mg adrenaline (conj)
patients variants (nmod)
cause variety (dobj)
measure intensity (dobj)
ability apparent (amod)
predisposed conclusion (nsubj)
extend model (nmod)
tiapride of (case)
rate infusion (compound)
drugs concomitant (amod)
carbachol i.c. (compound)
enrolment and (cc)
criteria of (case)
tissue non-specific (amod)
ami for (case)
aging and (cc)
had attempt (dobj)
hearts innervated (amod)
differentiation a (det)
259 to (advmod)
11 10 (conj)
made presentation (nsubjpass)
capacity this (det)
dilate , (punct)
mucosal dermatologic (conj)
mouse female (amod)
contaminated be (auxpass)
varied patients (nmod)
3.4 42.5 (prep)
ameliorates nephrotoxicity (dobj)
characterize effects (dobj)
demonstrates role (dobj)
stabilized receiving (xcomp)
variable primary (amod)
detected accurately (advmod)
a ; (punct)
fields pallor (conj)
drop of (case)
level : (punct)
presence disease (nmod)
symptoms and (cc)
exhibit seizures (nmod)
u mann-whitney (compound)
nature progressive (amod)
implants mechanical (amod)
examined relationship (nsubjpass)
polypeptide of (case)
consequence encountered (amod)
mmp-timp mrnas (dep)
abstracted and (cc)
contraceptives containing (acl)
cancer centres (compound)
have dunnett (dep)
cbf and (cc)
acidosis imbalance (conj)
effect co-carcinogenic (amod)
153 to (case)
mortality all-cause (amod)
nausea % (dep)
hbsag anti-hiv (conj)
hypotension administration (nmod)
infection an (det)
denervation of (case)
cause had (ccomp)
hypertrophy/cytomegaly and (cc)
tolerate drug (dobj)
median days (nmod)
got ( (punct)
correlation a (det)
agent isoniazid (nsubj)
related was (auxpass)
compared exposure (nmod)
epinephrine treatment (appos)
mg value (punct)
strain in (case)
tolerated it (nsubjpass)
ethyl piperidin-1-yl (compound)
indicate hepatotoxicity (dobj)
follow-up years (nmod)
presentation second (amod)
maha ( (punct)
mg/m2/d at (case)
induced prostigmine (parataxis)
changes subjects (nmod)
does than (dep)
basic clinical (conj)
lend data (nsubj)
capacity age (conj)
examines safety (dobj)
agent alternate (amod)
marker , (punct)
treatment important (amod)
involvement synergism (nmod)
courses chemotherapy (nmod)
tdf ) (punct)
tablets 55 (nummod)
cells showed (acl:relcl)
inactivation drugs (nmod)
animals group (conj)
derivative i.e. (advmod)
increase phosphatases (nmod)
ablated foci (nsubjpass)
studies rats (nmod)
170 was (cop)
potent vpu (nsubj)
extent causes (acl:relcl)
gauges frey (compound)
disease % (dep)
blocked when (advmod)
prior amphetamine (nmod)
manifestations new (amod)
divided group (nmod)
increased models (nmod)
hospitalization , (punct)
cycloheximide by (case)
$ROOT$ evolved (sent)
shown analogue (nsubjpass)
discriminated . (punct)
h. first (amod)
induced strains (nmod)
$ROOT$ attempted (sent)
act level (nmod)
characterized latter (nsubjpass)
csa chronic (amod)
establish . (punct)
lower hypotension (nmod)
synthesis total (amod)
n-acetyl-beta-d-glucosaminidase urine (compound)
performed test (nsubjpass)
oropharynx were (cop)
mania human (amod)
regimen popular (amod)
placed monitoring (nmod)
ingestion tablets (nmod)
given achieve (advcl)
combination leading (acl)
gestation weight (conj)
objective wanted (appos)
hours apnoea (nmod)
session observation (compound)
lowered markedly (advmod)
took who (nsubj)
gene avp (compound)
first which (nsubj)
amounted . (punct)
is list (attr)
evening morning (conj)
site a (det)
cases 13 (nummod)
retinopathy of (case)
session first (amod)
cases 11 (nummod)
1339 ) (punct)
cta coronary (amod)
reduces . (punct)
preclude does (aux)
1000 approximately (advmod)
nephropathy pan (compound)
baeps ( (punct)
4.1 - (punct)
markers activity (compound)
conclude cause (ccomp)
recurred reduction (nmod)
nucleus into (case)
seeded hips-cms (nsubjpass)
carvedilol by (case)
scan tomography (compound)
mechanisms comparison (dep)
findings caused (appos)
sbp t+a (dep)
electrocardiograms ecgs (appos)
norepinephrine and (cc)
case myopathy (nmod)
processed studies (nmod)
dysfunctions hepatic (amod)
clopidogrel ( (punct)
mmol.kg(-1).day(-1 4 (nummod)
frequency mean (amod)
wales australia (appos)
level dosage (compound)
1.54 from (case)
finished and (cc)
recommended precede (ccomp)
h2o sem (dep)
effect pressure (compound)
studies concerning (acl)
cfcs ) (punct)
mg/kg 3.3 (nummod)
carcinoma breast (nmod)
permeability paracellular (amod)
prevalent still (advmod)
prescribe and (cc)
groups resistant (acl:relcl)
results in (case)
third-generation in (case)
thought effect (nsubjpass)
inhibited enlargement (dobj)
hypertension ii (nummod)
mg/kg were (cop)
procaterol of (case)
have indicating (advcl)
t and (cc)
$ROOT$ reversibility (sent)
compare tolerability (dobj)
number transformation (conj)
model model (nsubj)
gfap of (case)
pr in (case)
mg/kg recommended (amod)
p.o. kg-1 (compound)
injection calcitonin (nmod)
nevirapine nvp (appos)
viewed be (auxpass)
precipitating rejection (dobj)
have , (punct)
life in (case)
exceeds stroke (nmod)
method delivery (nmod)
relief rapid (amod)
production fibronectin (compound)
mask and (cc)
tolerated hbig (nsubjpass)
po2 arterial (amod)
young aged (conj)
response et-1 (nmod)
evaluate fully (advmod)
required dose (nsubjpass)
cope easily (advmod)
increased muscle-lengths/s (nmod)
seen complications (nsubjpass)
abated withdrawal (nmod)
resolved which (nsubj)
children 66 (nummod)
suxamethonium ( (punct)
simvastatin drugs (conj)
treatment labor (nmod)
duration intermediate (amod)
ganglia ventral (amod)
plays if (mark)
free year (nmod)
= each (nmod)
medulla outer (amod)
hypersensitivity marked (amod)
died man (nmod:npmod)
determine lead (ccomp)
group l (nummod)
% 64 (compound)
administered mask (nmod)
analyzed were (auxpass)
used mapping (nsubjpass)
positive challenge (nsubj)
atrophy cerebellar (amod)
any events (nmod)
acid all- (amod)
reduced ketamine (nsubj)
tremor p (appos)
given women (nsubjpass)
releaser pg-9 (dep)
experience clinical (amod)
maximum cycles (nmod)
acid epilepsy (conj)
nephritis dermatitis (conj)
report arrhythmia (nmod)
tg and (cc)
patients cisapride-treated (amod)
has that (mark)
arise terminate (dep)
cyclooxygenase of (case)
2.4 ) (punct)
allograft the (det)
igf-i receptor (conj)
more than (prep)
inhibit does (aux)
% -50 (nummod)
results finished (appos)
experienced two (nsubj)
able reverse (xcomp)
protein myd88 (appos)
studies pediatrics (nmod)
rats wt (dep)
needed reversible (advcl)
classified types (nmod)
followed alfentanil (nmod)
oac ( (punct)
rats ovx (compound)
factor as (case)
therapy prior (amod)
complete almost (advmod)
complications to (case)
ed the (det)
(pan)-induced aminonucleoside (nmod:npmod)
attenuated dysfunction (dobj)
0.057 +/- (cc)
acetylsalicylate the (det)
identified period (nmod)
urethane i.p. (compound)
treated danazol (nmod)
assessment cardiac (amod)
leucovorin with (case)
attempt obviate (acl)
abolished partially (advmod)
development ligands (nmod)
remedies and (cc)
solution tacrine (nmod)
prevented captopril (nmod)
dopac metabolite (compound)
thymus < (dep)
continue play (xcomp)
microbleeds mb (appos)
prophylaxis graft-versus-host (amod)
doses increasing (amod)
years few (amod)
pain hyperalgesia (conj)
100 to (quantmod)
eligible ; (punct)
times 3 (dep)
data occurrence (nmod)
viral , (punct)
modified is (auxpass)
reserved available (advcl)
reaction eg (advmod)
showed prevent (ccomp)
$ROOT$ smoking (sent)
have because (mark)
electroshock applied (acl)
diagnosis by (case)
change = (parataxis)
required patients (nmod)
coma death (conj)
associated renoprotective (advcl)
stress an (det)
dihydropyridine available (amod)
potential maintain (acl)
control birth (compound)
anaesthesia under (case)
resolved quickly (advmod)
monitoring routinely (advmod)
exposure des (compound)
average with (case)
snr the (det)
ever if (mark)
embolism massive (amod)
fibers in (case)
cellulose with (case)
atropine muscarinic (amod)
providers healthcare (compound)
amygdala and (cc)
pattern contributes (acl:relcl)
absence consumption (nmod)
bands delta (compound)
employed : (punct)
= . (punct)
failed propagate (xcomp)
test y-maze (compound)
group discharged (acl:relcl)
caucasian asian (conj)
$ROOT$ severe (sent)
elevated significantly (advmod)
mol/l , (punct)
duration fluctuations (conj)
contributor hypotension (nsubj)
relationship no (det)
patients out (prep)
analysis activity (nmod)
analyses of (case)
went five (nsubj)
difference for (case)
known 4-aminopyridine (nsubjpass)
designed examine (xcomp)
g/l ( (punct)
esophagus the (det)
1.60 - (dep)
involved varied (ccomp)
deficiency thiamine (compound)
granules and (cc)
older likely (conj)
counseling , (punct)
measures more (amod)
procyclidine drug (appos)
aspirin prevention (nmod)
induced woman (nmod)
difficult suggest (xcomp)
associated to (mark)
administration isoproterenol (compound)
demonstrated discontinued (conj)
changes scores (nmod)
samples serum (compound)
homozygous jj (dep)
compared retrospectively (advmod)
examine impact (dobj)
analysis algorithm-short (amod)
5 0.3 (compound)
serotonergic of (case)
programme a (det)
response nicotine (nmod)
symptoms apnea (nmod)
decreased time (nmod)
1.98 to (dep)
retained conjugates (nsubj)
effect hyperglycemic (amod)
striking the (det)
reductions similar (amod)
scattered focal (conj)
proteinuria in (case)
male 47-year-old (amod)
generation hypertension (nmod)
mg/m2 300 (nummod)
rare myocarditis (nsubj)
30 interval (nsubj)
8-se 8-se (conj)
needed suppress (xcomp)
drug infection (conj)
showed kidneys (nsubj)
identify parameters (nsubj)
nerve radial (amod)
helpful rate (nsubj)
parameters hemodynamic (amod)
evoked epilepticus (nmod)
changes bp (compound)
paranoia and (cc)
headache nausea (conj)
facilitated propagation (dobj)
use dose (nmod)
bundle one (appos)
antibiotics prescribed (amod)
letrozole mg.kg(-1).d(-1 (dep)
study of (case)
pca via (case)
observed differences (nsubjpass)
last when (advmod)
injections muscles (nmod)
doing anticonvulsants (nmod)
mitochondria apparatus (conj)
neonates exposed (amod)
ha ( (punct)
prevented also (advmod)
titrated that (mark)
percentage hemisphere (nmod)
mites of (case)
produces fsgs (dobj)
itself by (case)
transporter norepinephrine (compound)
belonging group (nmod)
persons diabetic (amod)
ranged higher (conj)
department ophthalmology (nmod)
involves typically (advmod)
shown markers (ccomp)
controlled randomised (amod)
located neurons (nmod)
entered patients (nsubj)
had injection (nsubj)
indices ( (punct)
underwent 1986 (nmod)
depression of (case)
performed to (mark)
shares hyperalgesia (nsubj)
psychoses emergence (compound)
men 734 (nummod)
edaravone with (case)
ofloxacin cases (nmod)
allele only (advmod)
increased to (mark)
d2 vitamin (compound)
given azt (dobj)
examination ) (punct)
iii grade (compound)
continued when (advmod)
pap of (case)
% p (dep)
thrombocytopenia non-immune (amod)
associated pain (nsubjpass)
undergoing infusion (dobj)
suggest heterogeneous (ccomp)
known have (aux)
associated respectively (advmod)
worsen toxicity (dobj)
seven up (advmod)
mesna by (case)
assessed graded (conj)
regardless type (nmod)
exceeded factor (nmod)
flow cerebral (amod)
included anticoagulants (dobj)
focussed specifically (advmod)
pbo li/dvp (conj)
plan the (det)
aplasia cell (compound)
506-induced fk (nmod:npmod)
became whom (nmod)
as was (cop)
glycoprotein . (punct)
recognized enflurane (nmod)
mm2 14.9 (nummod)
ultrasound a (det)
glutathione reduced (amod)
had esrd (dobj)
literature to (case)
1 incidence (nsubj)
had pressure (nmod)
strains replication-competent (amod)
months ) (punct)
stimulation auditory (amod)
myocet m (appos)
trimethoprim-sulfamethoxazole of (case)
2.3+/-1.2 number (nsubj)
risk patients (nsubj)
excluding disorders (dobj)
decrease rate (compound)
male 4 (nummod)
overcome problem (dobj)
effects fluids (nmod)
time ventilation (nmod)
ocular orbital (conj)
recipients neonates (conj)
inhibition of (case)
prepare homogenates (dobj)
hydrochloride fluoxetine (compound)
reviews results (dobj)
$ROOT$ incubated (sent)
toxicity early (amod)
concentrated kidneys (nmod)
mmhg ' (punct)
experienced attack (dobj)
perimenopausal postmenopausal (conj)
test mouse (compound)
prophylaxis disease (compound)
blockade ca(2 (compound)
cells iron (compound)
1.0 0.99 (conj)
process regulation (conj)
re mg/kg (appos)
influence interval (nmod)
methylation the (det)
translocation ) (punct)
man white (amod)
dysfunction circuitry (nmod)
treating on (mark)
detected changes (nsubjpass)
sensitivity prior (amod)
hilum and (cc)
binding cortex (nmod)
5.99 vs. (cc)
metabolite of (case)
wt in (case)
320 3 (compound)
ltg ( (punct)
observed using (xcomp)
content serotonin (compound)
system exo (compound)
placed lesions (nsubjpass)
circulation cranial (amod)
affected response (dobj)
dose fda-recommended (amod)
representative series (nsubj)
undergoing compliance (nmod)
prepared incidence (nmod)
considered use (nsubjpass)
= 6883 (dobj)
hospitalized recently (advmod)
available which (nmod)
inhibits pentoxifylline (nsubj)
known ethambutol (nsubjpass)
potentiate bupivacaine (nsubj)
ps saline (conj)
limb of (case)
role cardiotoxicity (nmod)
blocking in (case)
performance rats (nmod)
study group (conj)
investigated was (auxpass)
increased respectively (advmod)
effects cells (nmod)
associated kingdom (nmod)
diazepam propranolol (conj)
gyrus dentate (compound)
treatment carbimazole (nmod)
damage that (mark)
element an (det)
mds ( (punct)
patients retinochoroidopathy (nmod)
outcomes risperidone (nmod)
processes mediated (acl)
resulted course (nsubj)
pretreatment followed (acl)
hydrobromide pine (compound)
fmri ) (punct)
remarkable was (cop)
demonstrate contribute (ccomp)
needed hospitalization (dobj)
rhythms junctional (amod)
min : (punct)
rats severe (amod)
frequency duration (conj)
injections glutamate (compound)
protein from (case)
functions cardiac (amod)
due is (cop)
loss the (det)
dyskinesia without (case)
discovered determination (nmod)
behavioral neurophysiological (conj)
patients encephalopathic (amod)
patient another (det)
compounds other (amod)
noted were (advcl)
sulphate challenge (conj)
rats 10-weeks-old (amod)
period similar (amod)
penicillamine and (cc)
erp ( (punct)
concentration mumol/l (nmod)
aroused palpation (nmod)
transporter and (cc)
treat hypertension (dobj)
levels harmful (amod)
effacement process (compound)
antidepressant bupropion (nsubj)
indicated comparison (nsubj)
complex macromolecular (amod)
role lesser (amod)
advantage clinical (amod)
six or (cc)
males ( (punct)
rats preweanling (amod)
changes all (appos)
eeg abnormal (amod)
identified as (prep)
pretreatment weeks (nmod)
extract gspe (appos)
interview m.i.n.i. (appos)
used proposed (conj)
caused rats (advcl)
literature use (nmod)
species a (det)
reversal attempted (amod)
greater brain (conj)
unaffected hypotension (nsubj)
plasticity maladaptive (amod)
rewarding both (cc:preconj)
75,761 acetaminophen (nmod)
arrest desaturation (nmod)
valsartan of (case)
blinded was (auxpass)
lometrexol given (acl)
attest seriousness (nmod)
cows ml (appos)
iu ( (punct)
shift tam (nsubj)
mild returned (dep)
presented group (nmod)
d vitamin (compound)
mucositis stomatitis (conj)
sd maximum (appos)
changed patients (nmod)
alpha-motoneurons dark-stained (amod)
dose mtd (appos)
rise bendrofluazide (nmod)
explained best (advmod)
allows assessment (nsubj)
ci p=0.33 (dep)
acid folinic (amod)
observed as (advcl)
feeling a (det)
were criteria (nsubj)
mg/ml 0.5 (nummod)
manifestation clinical (amod)
developed based (prep)
cessation indicated (advcl)
include , (punct)
degeneration combined (amod)
aminonucleoside pan (dep)
rare associated (conj)
failure gentamicin-mediated (amod)
warning heartbeat (compound)
accumulation atracurium (nmod)
hemorrhagic tumors (nsubj)
ketamine tribute (appos)
movements chewing (compound)
dosing after (case)
events regarding (case)
ganglia basal (amod)
found concentrations (nsubjpass)
healthy older (conj)
endocarditis in (case)
determined measured (conj)
p=.02 ) (punct)
months follow-up (nsubj)
aimed investigating (advcl)
similar larger (conj)
mup ( (punct)
switching sotalol (nmod)
time during (case)
consistent origin (nmod)
test epm (compound)
available until (mark)
percent group (nmod)
useful potentially (advmod)
sc subcutaneously (advmod)
noted aphasia (dobj)
mucositis and/or (cc)
3.4 3.8 (parataxis)
granulomatosis after (case)
effect now (advcl)
add risk (nmod)
high excluding (conj)
patients lids (nmod)
maintain adults (nmod)
score tubular (amod)
group infusion (compound)
effects derivative (nmod)
symbol digit (compound)
exceeded changes (nsubj)
prednisone aspirin (conj)
dependency the (det)
42 8 (conj)
uncertain patients (nmod)
% freedom (nsubj)
mg/d 60 (nummod)
offered be (auxpass)
prevalence an (det)
stress oxidant (amod)
used ccnu (nsubjpass)
walls in (case)
included manifestations (nsubj)
12 10 (conj)
risk hit (nmod)
alpha of (case)
neonates than (case)
blunted enhanced (conj)
$ROOT$ evidence (sent)
fdc with (case)
safe therapy (nmod)
drug parent (amod)
kidney a (det)
independent not (cc)
domain hepatocytes (nmod)
change mass (nmod)
virus lp-bm5 (compound)
repeating rapidly (advmod)
status age (conj)
agent alpha- (amod)
tcr of (case)
change podocalyxin (nsubj)
caused doxorubicin (nmod)
loss paresthesias (conj)
achr ) (punct)
reduce drugs (nsubj)
icr balb/c (conj)
release catecholamine (compound)
5.7 and (cc)
obscure mechanism (nsubj)
0.05 v (cc)
blocked antagonists (nmod)
hepatitis exacerbation (conj)
107.4 8.4 (conj)
accompanied profile (nsubjpass)
augments activation (dobj)
results randomized (dep)
axis hypothalamic-pituitary-adrenal (compound)
agonist 1-adrenoceptor (compound)
caused methylphenidate (nmod)
induced weeks (nmod)
failure fhf (appos)
antigen psa (appos)
case assessed (acl)
ratio an (det)
patients low-risk (amod)
act differently (advmod)
administration daily (amod)
min initial (amod)
risks therapy (nmod)
mechanisms identical (amod)
abstinence caffeine (nmod)
was whether (mark)
interviewed collected (conj)
predominate mask (conj)
activity beta (compound)
studied protection (nsubjpass)
infusion pethidine (nmod)
mic dose (conj)
occlusion mcao (appos)
syndrome insufficiency (conj)
a/j c57bl/6j (appos)
evidence leukemia (nmod)
hypercalcemia recurrent (amod)
prevents treatment (nsubj)
reinitiated patient (nsubjpass)
seizures without (case)
developed occlusion (dobj)
mg/kg controls (dep)
modulates . (punct)
af and (cc)
advanced stages (nmod)
effect tiapride (nmod)
characterized that (nsubjpass)
unaltered that (mark)
taken also (advmod)
s-transferase of (case)
drug verapamil (nsubj)
score ) (punct)
lesion center (nmod)
mice stains (nmod)
observed all (dep)
rhabdomyolysis of (case)
absorption with (case)
neurons npy (compound)
observations few (amod)
reports current (amod)
vinorelbine to (case)
macrophages with (case)
show play (ccomp)
cells llc-pk1 (compound)
methotrexate capecitabine (conj)
surgery war/tropical (compound)
pressure ventricular (compound)
use coc (compound)
group per (case)
mg/kg less (conj)
precipitated was (auxpass)
difference unmatched (nmod)
administered thrice (advmod)
serious reversible (conj)
predictors results (dep)
ss ) (punct)
eight to (quantmod)
caused frequency (dobj)
event clinical (amod)
arises question (nsubj)
tasks but (cc)
evaluated to (mark)
given treatment (nsubjpass)
preparation cholinesterase (nmod)
testing field (compound)
given chronically (advmod)
$ROOT$ elevated (sent)
testing immunologic (amod)
erythrocytes on (case)
octogenarian the (det)
degrees in (case)
dose second (amod)
mg.kg(-1 with (case)
cross-tolerance either (cc:preconj)
show growth (dobj)
is compare (xcomp)
change study (nmod)
response dose (nmod)
greater rates (nsubj)
inhibit antidepressants (nsubj)
remissions partial (amod)
ethinyloestradiol micrograms (amod)
observation concentration (nmod)
decreased blockers (nsubj)
genotyped metabolizers (nmod)
receptors striatum (nmod)
injection materials (nmod)
challenge physicians (nmod)
chlorthalidone mg (appos)
developed we (nsubj)
lymphadenopathy and (cc)
h2o to (case)
resection tumor (nmod)
neurologic and (cc)
treatment mirtazapine (nmod)
78 43 (compound)
dominance sympathetic (amod)
given that (mark)
hours 17 (nummod)
reduced gls (nsubjpass)
relation of (case)
competing transport (nmod)
enhanced however (advmod)
subunits alpha (compound)
smear peripheral (amod)
neurocognitive and (cc)
age- sex-comparable (conj)
dose carbamazepine (compound)
correlation weak (amod)
i.p. or (cc)
nova de (compound)
pig the (det)
vol% was (cop)
infection hbv (compound)
duration long (amod)
given only (advmod)
score individual (amod)
130 whom (nmod)
effect il-3 (nmod)
antagonist 3-benzenesulfonyl-7-(4-methyl-piperazin-1-yl)1h-indole (appos)
thiopental by (case)
reversed hemodialysis (nmod)
effects from (case)
merits comparison (dobj)
dose bupivacaine (nmod)
min per (case)
= 0.0024 (dobj)
post-discharge from (case)
rest 1.3+/-0.3 (appos)
estrogens of (case)
invariable hypoglycemia (nsubj)
diagnosis consistent (amod)
severe remained (conj)
abnormalities mitochondrial (amod)
mice into (case)
dtic ( (punct)
early conversion (nsubj)
response reproducible (amod)
depressed excitability (nsubjpass)
courses therapy (nmod)
use widespread (amod)
question . (punct)
six ( (punct)
relationship changes (nmod)
reduced potentiated (conj)
cigarettes 10 (nummod)
treatment epinephrine (compound)
cancer cohort (nmod)
decrease whether (mark)
greater diazepam (nmod)
committee safety (nmod)
patients biopsied (amod)
vacuoles intracellular (amod)
later years (nmod:npmod)
3 than (quantmod)
conclude constitutes (ccomp)
reported this (nsubjpass)
exerts also (advmod)
amounts equimolar (amod)
improved functions (nsubjpass)
antigen a (compound)
poisoning cn (compound)
decrease hyperthermia (nmod)
using studies (nmod)
arose where (advmod)
women 25 (nummod)
scored were (auxpass)
investigating link (dobj)
by-product is (cop)
has drawbacks (dobj)
light data (nmod)
produced iopentol (nsubj)
myopathy steroid (compound)
monitored closely (advmod)
lesions stn (nmod)
rates screening (compound)
rare not (neg)
likelihood occurred (acl)
involvement an (det)
complications therapy (nmod)
necessary persist (advcl)
occurred started (advcl)
analysis site (nmod)
$ROOT$ randomized (sent)
years 26 (nummod)
discrimination humans (nmod)
dose droperidol (nmod)
cin ) (punct)
supposed it (nsubjpass)
seem predisposed (ccomp)
treatment hypertension (nmod)
including populations (nmod)
used protocols (nmod)
changes pronounced (amod)
use stimulant (compound)
protects damage (nmod)
schedule treatment (compound)
seemed carry (xcomp)
occurs hypotension (nsubj)
received developed (conj)
diagnosed inadequately (advmod)
allowed analysis (nsubj)
maleate and (cc)
method permits (acl:relcl)
provocation ? (punct)
trial nimodipine (compound)
fibers motoneurons (nmod)
ascertained activities (nsubjpass)
initiating cpr (dobj)
enrolled were (auxpass)
13 implicating (acl)
clinical economic (conj)
needed weeks (nmod)
inadequate too (advmod)
capacity were (cop)
sedation to (case)
before just (advmod)
models two (nummod)
arrhythmias clinical (amod)
tolerated as (mark)
evaluated managed (conj)
effect dose-response (amod)
increases expression (nsubj)
polymerase the (det)
agent anticonvulsant (amod)
improvement subsequent (amod)
assessed intensity (dobj)
test urine (compound)
girl man (conj)
administration misoprostol (nmod)
complicated . (punct)
results women (appos)
stage t1cn0m0 (appos)
risk latter (nmod)
suggests modifies (ccomp)
ar+cr = (dep)
prudent however (advmod)
glaucoma open-angle (amod)
antidepressant tricyclic (amod)
results identified (appos)
lacked (+)-isomer (nsubj)
prednisolone or (cc)
period months (nmod)
safety sustained-release (nmod)
factor possible (amod)
study compare (acl:relcl)
quantitatively and (cc)
level renal (amod)
eyes human (amod)
improving impairment (dobj)
prevalent , (punct)
test tail (compound)
hal ( (punct)
variables , (punct)
improved function (nsubj)
glaucoma glucocorticoid-induced (amod)
injected isoproterenol (nsubjpass)
hemiparesis seizure (conj)
99 90 (compound)
bladder rat (nmod)
calcification no (neg)
used schedule (nsubjpass)
prevented whom (nmod)
return symptomatology (nmod)
relieved . (punct)
applying after (mark)
infant involvement (nmod)
induced l-norepinephrine (nmod)
injury rat (nmod)
patients placebo-treated (amod)
animals ' (punct)
was unchanged (acomp)
clamping by (mark)
development suggesting (acl)
thrombolysis catheter-directed (amod)
atropine or (cc)
variants are (cop)
reactive sluggishly (advmod)
aimed determine (xcomp)
increase respectively (advmod)
terminate epilepticus (dobj)
common non-significantly (advmod)
% 16.0 (nummod)
suffering who (nsubj)
chemotherapy rates (nmod)
less groups (nmod)
black : (punct)
pharmacokinetic clinical (conj)
higher consistent (advmod)
inhibited contractility (nsubjpass)
abolished increase (dobj)
number cardiomyocyte (compound)
need this (det)
controls respective (amod)
% cr (nmod)
n=92 ) (punct)
function visual (amod)
reaction a (det)
correction treatment (nmod)
tension wall (compound)
concentration plasma (compound)
$ROOT$ mg/day (sent)
vigabatrin ( (punct)
abnormalities , (punct)
wall the (det)
chloroform-adrenaline and (cc)
starting after (mark)
circling the (det)
expression gap43-ir (appos)
activity volume (conj)
vocalization carbachol (nmod)
tenofovir on (case)
ratios of (case)
taken caution (nmod)
correlated defect (nsubj)
cirrhosis to (case)
rhythm arrhythmia (nmod)
lines seizure-prone (amod)
tubules proximal (amod)
subtle are (cop)
that d2 (nmod)
mecamylamine antagonist (compound)
umb24 (+/-)-sm (conj)
records computerized (amod)
changes characteristic (acl:relcl)
bd1008 of (case)
causes among (case)
present here (advmod)
catecholamines hyperkinesia (conj)
protected failure (nmod)
age 27 (nummod)
effect cytostatic (amod)
well been (cop)
analyzed technique (nmod)
defective vision (nsubj)
anomalies of (case)
cocaine mg/kg (compound)
mechanisms located (acl)
induction rats (nmod)
glomerulonephritis . (punct)
effect deleterious (amod)
affect number (nsubj)
inpatients were (cop)
$ROOT$ anesthesia (sent)
t5 t10 (conj)
receive mg. (dobj)
expression tissues (nmod)
model marmoset (compound)
leading changes (nmod)
degeneration massive (amod)
doses eight (nummod)
deterioration improvement (conj)
blockers receptor (compound)
ph acidic (amod)
phosphorus component (appos)
disorder hypokalemia (appos)
study before (case)
study present (amod)
specimens 65 (nummod)
patients ones (conj)
treatment ketoconazole (compound)
compared non-users (nmod)
both had (acl:relcl)
demonstrated serially (advmod)
doses lithium (nmod)
obtainable longer (advmod)
source alternative (amod)
understanding the (det)
enhanced haloperidol (nsubj)
4 to (advmod)
cortex cerebellar (amod)
weight/week ( (punct)
ischemic hyperthermia-induced (conj)
decrease group (nmod)
bpa with (case)
compared wt (nmod)
proposed was (auxpass)
tried . (punct)
episodes 2 (nummod)
mechanism interaction (nmod)
reported risk (nsubjpass)
casualties in (case)
informed commencement (nmod)
rats half (predet)
infarction documented (amod)
impact cause (nmod)
example . (punct)
groups given (acl)
determination pre-therapeutic (amod)
studies infants (nmod)
nitrate , (punct)
range points (appos)
tumors recurrences (nmod)
temperature the (det)
meningioma four (nummod)
received none (nsubj)
rat solid (amod)
unnecessary usually (advmod)
types parkinsonism (nmod)
rc ( (punct)
increase by (case)
reduces levels (nmod)
occurring perfusion (nmod)
significance may (aux)
fall glucose (nmod)
inhibitor uptake (compound)
have properties (dobj)
potential strategy (nmod)
bd1018 and (cc)
injury hippocampal (amod)
reported applicators (nsubj)
continued infusion (nmod)
u/l 98 (nummod)
0 126 (conj)
points need (nmod)
nephropathy in (amod)
deteriorates rapidly (advmod)
studies other (amod)
institution after (case)
vcm and (cc)
gm. 100 (nummod)
reports adr (compound)
efficacious equally (advmod)
had greater (conj)
plays thrombin (nsubj)
cardiovascular gastrointestinal (conj)
insight mechanism (nmod)
department pharmacology (nmod)
animals untreated (amod)
was months (nmod)
responded 11 (nsubj)
pain cp (compound)
aap : (punct)
method predict (acl:relcl)
abnormalities persistent (amod)
r-(alpha)-methylhistamine the (det)
evaluated inhibits (advcl)
elevation s(c)o(2 (nmod)
prednisolone mg/kg (amod)
switch a (det)
cardioselective is (cop)
cats rats (conj)
essential synthesis (nmod)
escalation mg (nmod)
pathogenesis headache (nmod)
clonazepam by (case)
increase = (dep)
$ROOT$ need (sent)
recorded mice (nmod)
products chain (compound)
augmented response (dobj)
assays taqman (compound)
5-azc , (punct)
suggests finding (nsubj)
had transplantation (nmod)
30mg/kg ( (punct)
reduces extent (dobj)
lymphoma a (det)
microscopy light (amod)
normal patient (conj)
converted one (nmod)
induced nifedipine (nsubj)
consider cause (nmod)
blockage after (case)
hypotension idiopathic (amod)
desvenlafaxine with (case)
each components (nmod)
admitted patient (nsubj)
decreased titre (nsubj)
injury chloride (compound)
25 12.5 (nummod)
corrected hyperprolactinemia (dobj)
calculated concentrations (nsubjpass)
reactions report (dep)
reached difference (nsubj)
muscles papillary (amod)
use tamoxifen (compound)
tap with (case)
ciprofloxacin % (nmod)
effects both (det)
$ROOT$ subacute (sent)
sixty-eight hundred (compound)
cycle to (case)
effect toxicity (conj)
protocol reductions (conj)
related response (nmod)
discharges high-amplitude (amod)
regimen lithium (nmod)
effect disease (nmod)
assessment the (det)
boys treated (acl)
limit oih (nsubj)
penicillins ) (punct)
tablets 26 (nummod)
controlling drainage (dobj)
allodynia and (cc)
site with (case)
sub-tenon anterior (amod)
endpoints mortality (compound)
syndrome injection (nmod)
10,000 - (punct)
account partly (advmod)
aroused could (aux)
alterations metabolic (amod)
process evaluation (compound)
scored conditions (nmod)
risk seroconversion (nmod)
nephropathy neonate (nmod)
fenoterol-hydrobromide of (case)
group experimental (amod)
rigidity removal (nmod)
segments anterior (amod)
observed incidence (nsubjpass)
factors pathogenesis (nmod)
taking antibiotics (dobj)
factors known (amod)
localization cells (nmod)
chemotherapy myelosuppressive (amod)
growth gfr (conj)
developed srs (dobj)
equilibrate that (mark)
genes regulated (amod)
threshold fibrillation (compound)
underwent treated (conj)
p= 0.003 (dobj)
patients neutropenic (amod)
histories their (nmod:poss)
excluded finally (advmod)
conventional either (preconj)
greater ng./ml (nmod)
dehydrogenase acid (conj)
purpose assess (acl)
response virological (amod)
receptor-mediated d1/d2 (nmod:npmod)
findings by (case)
seem responses (nsubj)
reference the (det)
entity although (mark)
induce hepatitis (dobj)
hepatitis for (case)
benefit would (aux)
specification replication (conj)
raises antagonism (nsubj)
efficacy comparable (amod)
toxicity nonhematologic (amod)
increased 0.05 (nmod)
rechallenge after (case)
i.v ) (punct)
used anaesthesia (nmod)
phenomenon tachyarrhythmia (nsubj)
designated . (punct)
- 14 (compound)
dose once-daily (amod)
cytopenias the (det)
exceed % (dobj)
levels observed (acl)
acetylcholinesterase cells (nmod)
applied groups (nmod)
experiment for (case)
pi compared (case)
alkylxanthines tested (acl)
eliminated were (auxpass)
events most (amod)
ne released (acl)
$ROOT$ consistent (sent)
skin of (case)
related or (cc)
s-(-)-et-126 antagonist (compound)
demonstrating abnormalities (dobj)
change should (aux)
resulting increase (nmod)
choice patients (nmod)
reports usage (conj)
role the (det)
rifampin of (case)
had otherwise (advmod)
absent , (punct)
ratings intensity (compound)
assessed uptake (nsubjpass)
tolerance real (amod)
cases 15 (nummod)
shown propensity (dobj)
3722 , (punct)
effect normalizing (amod)
cause hemolysis (dobj)
hydrochloride the (det)
exhibited mitochondria (nsubj)
reduced neither (cc)
enhanced they (nsubj)
150 1 (compound)
findings = (dep)
nerves midline (amod)
common results (nsubj)
discontinuation administration (nmod)
common reactions (nsubj)
impact ) (punct)
water distilled (amod)
nitroprusside over (case)
presence ramh (nmod)
type at2r (appos)
showed first (advmod)
isbell ; (punct)
day third (amod)
test hypothesis (dobj)
accumulation for (case)
compared thiopentone (nmod)
recipients of (case)
modulate impairment (dobj)
attack first (amod)
assumed he (nsubj)
cardiotoxicity serious (amod)
aim the (det)
pretreatment lipopolysaccharide (compound)
assessed although (mark)
have number (nmod)
bradycardic to (mark)
$ROOT$ amplified (sent)
toxic was (cop)
drugs appetite (compound)
history symptoms (nmod)
expressions for (case)
establish model (dobj)
experienced reactions (dobj)
$ROOT$ event (sent)
counts lymphocyte (compound)
required has (aux)
incidence time-course (conj)
consisted heptylate (nmod)
1.3 ) (punct)
past and (cc)
received consecutively (advmod)
registry to (case)
measures by (case)
telangiectasia of (case)
using echocardiography (dobj)
seizures previous (amod)
using airway (dobj)
hallmarks the (det)
akt only (advmod)
grafting bypass (compound)
pressure stable (amod)
athletes by (case)
mg/kg value (nsubj)
rep 62(6):865 (punct)
present time (nmod)
comparing group (nmod)
need chemotherapy (nmod)
ds ) (punct)
vip-/- ) (punct)
single and (cc)
wards acute (amod)
cause where (advmod)
yield overall (amod)
ameliorated , (punct)
mg/kg 0.4 (nummod)
potentials oscillatory (amod)
incidence failure (nmod)
importance maintaining (advcl)
morning the (det)
$ROOT$ constructed (sent)
800 , (punct)
had differ (conj)
0.83 ( (punct)
depth and (cc)
revealed exhibited (ccomp)
alf , (punct)
infants vlbw (compound)
day seven (compound)
contaminants deficiency (conj)
distribution due (case)
value positive (amod)
questioned been (auxpass)
hydrochloride bupropion (compound)
1a2 p450 (compound)
b-d-glucosaminidase nag (appos)
induced anesthesia (nmod)
nerve eighth (amod)
marker astrocytic (amod)
curves displacement-time (compound)
enhanced slightly (advmod)
foci of (case)
vehicle concentration (conj)
gd mg/kg (conj)
135 to (case)
data electrophysiologic (amod)
chromosome strain (nmod)
antibiotic used (amod)
catalepsy induced (acl)
level counts (conj)
dyskinesia ballistic (amod)
synthase endothelial (amod)
216 ) (punct)
cases among (case)
therapy this (det)
phenomenon steal (amod)
preparations methotrexate (compound)
increased scores (dobj)
adaptation to (mark)
diagnosis ; (punct)
diabenese ( (punct)
contained bile (nsubj)
prevalence high (amod)
cells the (det)
used institution (nmod)
use conjunction (nmod)
glomerulosclerosis rats (nmod)
ranged volume (nsubj)
diazepam agent (appos)
treatment lindane (nsubj)
pr=0.515 ( (punct)
events rizatriptan (nmod)
cirazoline 1-agonist (amod)
used methylphenidate (nmod)
effects therapy (nmod)
cessation lesions (nmod)
t sp120 (compound)
hospitalized . (punct)
ntg of (case)
those b (nmod)
sed , (punct)
overdose for (case)
mouse the (det)
colliculus medullas (conj)
showed had (conj)
hepatitis anemia (conj)
weight sex (appos)
disinhibition and (cc)
0.9 ) (punct)
administration infusions (nmod)
observed correlation (nsubjpass)
intervals at (conj)
time at (case)
infarction strokes (conj)
subendothelial medial (conj)
protection amnesia (nmod)
pci during (case)
reports satisfy (acl:relcl)
doubled pretreatment (nsubj)
antioxidant an (det)
contrasted . (punct)
saline t (conj)
minor offset (conj)
pressures with (case)
pb , (punct)
neurogenesis hippocampal (compound)
release between (case)
fasciculation muscle (compound)
those problems (nmod)
recurrence attack (nmod)
see modified (ccomp)
possible that (mark)
ratio high (amod)
chemotherapy using (acl)
showed up (advmod)
noradrenergic and (cc)
thrombocytopenia hitt (appos)
2.41 to (case)
strength and (cc)
application long-term (amod)
lost follow (nmod)
cases 83 (nummod)
inhibitors synthase (compound)
effects on (case)
occurred reaching (advcl)
tdr a (det)
persisted 4 (nmod)
antagonism activity (nmod)
parkinsonian ' (punct)
obstruction of (case)
injections times/week (dep)
penis of (case)
tubule the (det)
coincident presence (nmod)
specific be (cop)
drugs no (neg)
assessed injections (nmod)
median % (nmod)
compare ; (punct)
use microbleeds (conj)
reactions one (nummod)
doses than (case)
hypaque to (case)
ka the (det)
day life (nmod)
correlated response (nsubjpass)
exhibit cystitis (nmod)
examined here (advmod)
treatment bradykinesia (nmod)
induce striatum (nmod)
led elevation (nmod)
effect % (appos)
450 ) (punct)
clearances [14c]p-aminohippuric (amod)
response response (conj)
mif ) (punct)
p=0.032 ) (punct)
effective decreasing (advcl)
rammer ; (punct)
monitoring intra-arterial (amod)
site to (case)
use age (conj)
hospitalized treated (advcl)
uridine of (case)
postdose 72 (nummod)
years nine (nummod)
titers interferon (compound)
yohimbine and (cc)
dose paclitaxel (nmod)
stage yahr (compound)
h therapy (nmod)
quinine-sensitive not (cc)
substratum epileptic (amod)
testing green (amod)
performed evaluation (nsubjpass)
few a (det)
mice a/j (compound)
undertaken : (punct)
movements myoclonic (amod)
effects over (case)
potent , (punct)
narcosis drug-induced (amod)
bpm 150 (nummod)
determination systematic (amod)
resulted group (nmod)
detected exhaustion (nmod)
exercise post-lesion (amod)
period hr (compound)
system for (case)
maze radial (amod)
lumens fragments (nsubj)
interaction conditions (nmod)
methods established (appos)
aimed study (nsubj)
bw/3 mg/kg (compound)
low-level relatively (advmod)
depletor acetylcholine (compound)
synapses cell (compound)
registration isrctn54598675 (appos)
cause only (amod)
ballooning to (case)
found organisms (nsubjpass)
weeks 54 (nummod)
need surveillance (nmod)
svc and (cc)
relative third-generation (amod)
vohland al. (dep)
kg 72 (nummod)
administered total (nmod)
hyperalgesia induced (amod)
reported aware (conj)
cis-platin and (cc)
% 62.5 (nummod)
difference no (det)
females in (case)
progressed withdrawal (nmod)
stimulus the (det)
255 from (case)
symptoms ketamine-induced (amod)
ps group (compound)
accident cerebrovascular (amod)
proposed models (nsubjpass)
interventions epilepsy (nmod)
enucleated failure (nmod)
side-effect led (acl:relcl)
transplantation haematopoietic (amod)
improvement memory (compound)
association patients (nmod)
male evidence (nmod)
appeared injury (nsubj)
report dexatrim (appos)
considered when (advmod)
carbamazepine , (punct)
replacement hormone (compound)
explained be (auxpass)
iop hg (nmod)
intoxication high-dose (amod)
anemia suppression (nmod)
symptoms pheochromocytoma (nmod)
$ROOT$ predicts (sent)
surgery % (appos)
118 +/- (cc)
collagenase 0.350-unit (compound)
hbeag-positive hbeag-negative (conj)
opsonized alf (nmod)
remain pharmacology (nsubj)
smear pre- (dep)
expression and (cc)
intensity aggressiveness (nmod)
fractures cancer (conj)
$ROOT$ drug (sent)
emg ( (punct)
participants comparison (compound)
trated . (punct)
degree , (punct)
paradigm startle (compound)
decline a (det)
test globulin (nmod)
hyperlocomotion induced (amod)
exceeds dose (nsubj)
seen surgery (nmod)
power of (acl)
developed about (mark)
0.05 0.13 (conj)
drug antiepileptic (amod)
hemoglobinuria transient (amod)
tablets 59 (nummod)
dopamine-1 specific (amod)
release culture (nmod)
showed protection (dobj)
interact receptors (nmod)
cyclosporine on (case)
exposed were (auxpass)
orbitofrontal possibly (advmod)
regimen than (case)
intervention preventing (acl)
$ROOT$ sedation (sent)
achieving and (cc)
killed . (punct)
$ROOT$ created (sent)
derives and (cc)
donor 40-year-old (amod)
remains locus (nsubj)
disease mulv (compound)
7 , (punct)
characteristics epilepsy (nmod)
acetaminophen- adriamycin- (conj)
hypercalcemia impairment (conj)
administered one (nmod)
glepp1 ( (punct)
predictor good (amod)
an-2-ol 3,4-dimethoxyphenyl)ethanolamino]-prop (compound)
reticulata of (case)
urea ) (punct)
rate annual (amod)
$ROOT$ treated (sent)
undergoes area (nsubj)
tomography localised (amod)
showed e2 (nsubj)
episodes these (det)
similar study (nmod)
$ROOT$ restore (sent)
method this (det)
remains treatment (attr)
results that (mark)
models epilepsy (compound)
effect system (compound)
preceded serve (conj)
potential gnc92h2 (nmod)
cytoprotection of (case)
outbreak 1979 (nmod)
infusion during (conj)
azt with (case)
none drugs (nmod)
incidence morbidity (conj)
chemotherapy : (punct)
sedation reduction (nmod)
attained was (auxpass)
described first (advmod)
regimens from (case)
shift marked (amod)
therapy such (amod)
ratio 2.3 (appos)
hydrochloride lo-3 (compound)
dismutase cu/zn-superoxide (compound)
bfu-e splenic (amod)
microscopy confocal (amod)
48-week 12- (nummod)
report with (case)
received given (parataxis)
lymphomas with (case)
remained effusion (nsubj)
associated ciprofloxacin (nsubjpass)
kinase mitogen-activated (amod)
ahf ( (punct)
is association (attr)
mg. gm. (nmod)
immersed tail (nsubjpass)
expression vegf (compound)
dose healthy (nmod)
variable compound (amod)
followed repeatedly (advmod)
risk intolerance (nmod)
require detection (dobj)
20 ( (punct)
consistent that (nsubj)
children autism (nmod)
administered prophylaxis (nmod)
delirium excited (amod)
exacerbation increase (conj)
i.m. and (cc)
confirm tolerability (dobj)
research by (case)
exhibited improvements (dobj)
67.66 and (cc)
time progression-free (amod)
neuroprotective neurotoxicity (nmod)
variables prognostic (amod)
protein ( (punct)
characteristics inhibition (compound)
protein 5 (nummod)
changes map (nmod)
disappeared arrhythmia (nsubj)
caused or (cc)
hg 11 (nummod)
interaction a (det)
glycopyrrolate topical (amod)
cause failure (nmod)
patients hypercalcemia (nmod)
improves fluoxetine (nsubj)
exacerbations patients (nmod)
> p (nsubj)
similar showed (parataxis)
resolved hypotension (nsubj)
test u (conj)
mwm unchanged (acl:relcl)
develop hyperactivity (dobj)
warranted caution (nsubjpass)
trial for (case)
increasing units (nmod)
amifostine ) (punct)
indicative to (mark)
% 17.3 (nummod)
changes against (case)
measures behavior (nmod)
crucial ameliorating (advcl)
minute range (parataxis)
type hemorrhage (nsubj)
transmission fluoxetine (nmod)
ratio p=0.009 (appos)
treatments efficacious (amod)
10.9 - (advmod)
similarities ( (punct)
recovery late (amod)
mg/kg was (cop)
frequency % (compound)
dosages in (case)
activation nin-induced (amod)
peptide such (case)
g paracetamol (conj)
suitable might (aux)
patients eyes (appos)
dexamethasone weight (appos)
injection artery (nmod)
localised that (mark)
conversion after (case)
compare effects (dobj)
line is (cop)
gamma-hch to (case)
report pain (dobj)
expression mice (nmod)
$ROOT$ increasing (sent)
paresthesias and (cc)
influenced se (advmod)
from years (nmod)
reveals investigation (nsubj)
drug as (case)
deformities foot (compound)
background reduces (appos)
paclitaxel used (appos)
peptide cgrp (appos)
nature pharmacodynamic (amod)
administration amiodarone (nmod)
837 171 (conj)
score p (dep)
myopathic diet (nmod)
reduced action (dobj)
efficacy reduced (amod)
phase days (appos)
function a (det)
analyzed was (auxpass)
den or (cc)
similar also (advmod)
anticipated if (mark)
ng/ml to (case)
interest occurred (advcl)
showed damage (nsubj)
capability system (nmod)
population this (det)
made injection (nmod)
medline cochrane (conj)
fibrosis myocardium (nmod)
vitro in (conj)
dg ) (punct)
care later (advmod)
tolerated which (nsubjpass)
mrna timp (compound)
efficacy a (det)
injury severe (amod)
ritonavir inhibitor (compound)
current future (conj)
protected fibrosis (nmod)
seems open (advcl)
hyperalgesia model (nmod)
mm 8 (nummod)
attribution dose (nmod)
toxicity chemotherapeutics (nmod)
haemorrhages cerebral (amod)
drugs anti-inflammatory (amod)
changes membrane (compound)
dysfunction glomerular (amod)
0.004 > (amod)
background was (appos)
blockade leading (acl)
previous injections (nmod)
dpi ( (punct)
lobes frontal (amod)
responders in (case)
0.9 0.2 (compound)
experiencing with (mark)
due damage (nmod)
administered injections (nmod)
heart infarcted (amod)
co-morbidity medical (amod)
class igm (compound)
dysgenesis infant (nmod)
5 in (case)
development arrhythmia (nmod)
women 60 (nummod)
bicarbonate added (acl)
hypertension mice (nmod)
tumors hepatic (amod)
excretion rapid (amod)
alter excretion (dobj)
level tropinin (compound)
model emerged (acl:relcl)
determine stability (dobj)
% water (nmod)
peptide which (nsubj)
responses abnormal (amod)
resulting shock (nmod)
prodrug acc-9653 (nsubj)
shows , (punct)
163 ) (punct)
from severe (nmod)
upregulation to (case)
lacking . (punct)
tissue impairment (nmod)
delayed pilocarpine (nsubj)
on'- ' (punct)
interaction metoprolol (nmod)
change nor (cc)
fatiguability easy (amod)
sub-tenon 's (case)
incidence hearts (nmod)
tacrolimus prednisolone (conj)
numbers penetration (conj)
patients ninety-six (nummod)
similar toxicity (nsubj)
strategies aimed (acl)
sessions within (case)
tachycardia sinus (compound)
receiving combination (dobj)
material method (conj)
use dexrazoxane (nmod)
paclitaxel 5-fluorouracil (conj)
ptra pci (conj)
those = (dep)
indicate play (ccomp)
statistics sales (compound)
implications the (det)
effects neuromuscular (amod)
2-acetylaminofluorene % (amod)
impaired secretion (dobj)
titrated remained (conj)
severity damage (nmod)
enantiomer ) (punct)
level proteins (nmod)
3-hydroxy-n-methylmorphinan of (case)
infiltrate , (punct)
injury endothelial (amod)
recognized respectively (advmod)
suspected inadequate (advcl)
intradermal intravenous (conj)
response this (det)
died that (nsubj)
trental ) (punct)
used therefore (advmod)
desogestrel of (case)
iv ) (punct)
neurotransmitters glutamate (dep)
transplants kidneys (conj)
administered ctx (nsubjpass)
feeding the (det)
number dibucaine (compound)
levodopa by (case)
provide advances (nsubj)
study light (amod)
protects vivo (advmod)
carried aware (advcl)
rate p (dep)
= 0.03 (dep)
had rate (dobj)
use doxorubicin (nmod)
elevated but (cc)
subset safe (amod)
maintained . (punct)
cause formation (nmod)
treatment breast (compound)
aware one (nsubj)
showed glomeruli (nsubj)
documented is (cop)
relevant is (cop)
use methylphenidate (nmod)
greater ng/ml (nmod)
seizures : (punct)
started japan (nmod)
reaction this (det)
reduced day (nmod)
development seizure (nmod)
parkinson 's (case)
experienced total (nsubj)
undergoing ct (dobj)
1 more (amod)
forms therapy (nmod)
anesthetic catheterization (nmod)
mm ) (punct)
homogenates f344 (compound)
tested participants (nsubjpass)
taqib , (punct)
some factors (nmod)
work this (det)
revealed alpha (dobj)
antioxidant anti-inflammatory (conj)
treated assess (advcl)
workers affected (amod)
magnitude that (mark)
correlates negatively (advmod)
discontinuations than (case)
protocols institutions (nmod)
parameters calcium (nmod)
investigate links (dobj)
weakness or (cc)
cocaine-dependent healthy (conj)
precise recall (nsubj)
time adenosine (nmod)
lower still (advmod)
edits ( (punct)
subsets two (nummod)
immunoassay heparin (compound)
subunit chain (compound)
quality a (det)
co-treatment were (cop)
concentrations mol/l (nmod)
remains characterized (xcomp)
likely effects (nsubj)
based study (nsubjpass)
alpha-position the (det)
occur changes (nsubj)
mothers antigen-positive (amod)
7.6 3.4 (conj)
think . (punct)
rat aconitine-induced (amod)
$ROOT$ pharmacology (sent)
associated circumstances (nmod)
called use (nmod)
quantify in (mark)
malformation dysplasia (nsubj)
found ximelagatran (nsubjpass)
enzyme hepatic (amod)
reacts , (punct)
forms on (case)
naproxen to (case)
group 4-wk (amod)
some them (nmod)
potentials visual-evoked (amod)
patients encephalopathy (nmod)
8.75 1.52 (conj)
downregulation with (case)
syndrome report (dep)
changing rhythm (dobj)
mechanism pressor (compound)
increased extent (nmod)
neurotoxicity , (punct)
symptoms anesthesia (nmod)
pressure remained (conj)
discovering interpretation (dobj)
use to (case)
contributes cardiotoxicity (nmod)
donor female (amod)
ser198 his438 (conj)
methylation group (nmod)
systemic pulmonary (conj)
found neuropathy (nsubjpass)
testing unit (nmod)
transport na+ (nmod)
were require (conj)
represents generator (dobj)
micrograms/kg/min to (case)
$ROOT$ slowing (sent)
acuity hcva (appos)
part most (amod)
aggravation titration (nmod)
rats control-fed (amod)
stimulate , (punct)
lacking studies (nsubj)
remain pathogeneses (nsubj)
interval with (case)
acrolein to (case)
receptors ' (case)
syndrome lobe (compound)
differed ; (punct)
process the (det)
$ROOT$ hypothyroid (sent)
24 and (cc)
$ROOT$ 1.3 (sent)
syndrome cips (appos)
muscle detrusor (nmod)
sertraline or (cc)
binding increased (amod)
therapy from (case)
history classification (conj)
marked rate (nmod)
blockers serotonin (compound)
mg/day 150 (nummod)
ammonia on (case)
sensitivity convulsions (nmod)
nephritis nafcillin-induced (amod)
individuals those (det)
points of (case)
tmp-smz to (case)
cells nadph-d-positive (amod)
33342- hoechst (compound)
animals seizures (nmod)
present even (advmod)
19 , (punct)
compounds flavonoids (nmod)
naranjo 's (case)
area vancouver (compound)
induce irrigation (nsubj)
lost responsiveness (nsubjpass)
alter 17beta-estradiol (nsubj)
peaked which (nsubj)
conclusions considered (dep)
deoxycorticosterone and (cc)
isoproterenol alone (advmod)
acid epsilon (compound)
markers between (case)
india from (case)
clues , (punct)
tolerance - (nmod)
differ whether (mark)
circuits ) (punct)
assigned participants (nsubjpass)
questionnaire scale-revised (conj)
showed infarct (dobj)
evolution electrocardiographic (amod)
suppressed sensitization (nmod)
changed time (nmod)
diagnosis pneumonitis (nmod)
intervals then (advmod)
well morning (nmod)
achieved : (punct)
h2o ( (punct)
presence and (cc)
conditions epilepsy-associated (amod)
blockade parasympathetic (amod)
improves have (conj)
impair infarction (nsubj)
loss anaesthesia (nmod)
surmountable was (cop)
noel ( (punct)
persons elderly (amod)
beats escape (compound)
total plasma (compound)
resulted changing (advcl)
chemotherapeutics various (amod)
problems for (case)
marrow dysmyelopoiesis (conj)
diplopia seen (acl)
mssa for (case)
25mg/kg by (case)
pressure , (punct)
fragmentation be (cop)
damage rat (compound)
d-pen ( (punct)
dogs 65 (nummod)
began treatment (nsubj)
toxicity doxorubicin (nmod)
pain feet (nmod)
nausea restlessness (conj)
p=0.099 , (punct)
three five (conj)
den ( (punct)
reverses benzylacyclouridine (nsubj)
cells microglia (compound)
topiramate , (punct)
attacks or (cc)
described it-methotrexate (nmod)
indicates effect (nsubj)
efficacious as (advmod)
l-3,4-dihydroxyphenylalanine of (case)
parameters severity (compound)
ppa by (case)
resolved reduced (advcl)
assays competition (compound)
measures . (punct)
dopamine norepinephrine (conj)
isomers optical (amod)
nurse the (det)
months 14 (nummod)
neurotoxicity activation (conj)
receiving treatment (nmod)
measured weeks (nmod:tmod)
remained tumor-free (xcomp)
factors autism (nmod)
is possibility (attr)
repair with (case)
nuclei thalamus (nmod)
184 4 (compound)
shown occur (ccomp)
mg/kg 5.0 (nummod)
effects and (cc)
dse a (det)
organogenesis rats (nmod)
movement eye (compound)
risk moderate (amod)
amnesia caused (acl)
resulted alter (conj)
pge1 tmp (conj)
higher pressure (nsubj)
controlled seizures (nsubjpass)
inhibition 1a2 (nmod)
retains action (dobj)
developed which (nsubj)
prl as (case)
mitogens , (punct)
ester cholecystokinin (compound)
expressions kidneys (nmod)
instance with (case)
diseases cvds (appos)
elicited psychopathology (nmod)
absent be (cop)
angiodegeneration ( (punct)
decrease concentrations (nmod)
correlated sometimes (advmod)
culminating weeks (nmod)
frequently most (advmod)
hypothesized we (nsubj)
observed hepatitis (nsubjpass)
eroded is (auxpass)
dysfunction cardiomyopathy (nmod)
period ambulant (amod)
toxicity to (case)
addicts treated (acl)
bradycardia asystole (conj)
structural functional (conj)
patients asymptomatic (amod)
ingesting ceftriaxone (dobj)
excretion potassium (nmod)
correlate measured (advcl)
cholecystokinin of (case)
emphasize we (nsubj)
injected acutely (advmod)
caused haart (nsubj)
receiving after (mark)
estimated is (auxpass)
nmol , (punct)
profiles side-effect (compound)
sn the (det)
mechanisms result (acl:relcl)
aims . (punct)
injection 30-second (amod)
suggest influenced (ccomp)
ability ncq436 (nmod)
affects induced (conj)
consolidation dysfunctional (amod)
preparations cold (amod)
recurred rechallenge (nmod)
$ROOT$ nystagmus (sent)
synthesize dna (dobj)
174 - (advmod)
weeks before (nmod)
clarify effects (dobj)
patterns vessels (nmod)
decreased ng/ml (nmod)
rarely very (advmod)
associated hypotension (nmod)
mapping diffusion (compound)
demonstrated histochemistry (nsubj)
rise demand (nmod)
control activity (dobj)
potential tool (nmod)
therapy propylthio- (amod)
loads viral (amod)
gsi ( (punct)
% > (amod)
participants nonusers (dep)
mild improvement (nsubj)
arrhythmia suppressed (acl:relcl)
cimetidine continuous-infusion (amod)
transferred were (auxpass)
0.05 < (advmod)
esophagitis reflux (compound)
death eryptosis (conj)
combined cisplatin (nmod)
2-adrenoreceptor alpha (compound)
na/k-atpase nhe3 (conj)
banks from (case)
cases infiltration (nmod)
reaction quantitative (amod)
rate metabolic (amod)
thiazole-2-carboxamide ] (punct)
different slightly (advmod)
cohort 1969 (appos)
investigate measure (advcl)
extent considerable (amod)
thoroughly most (advmod)
failed teratogenic (conj)
samples on (case)
rate symptoms (nmod)
dmso microl (nummod)
descriptions literature (nmod)
matched then (advmod)
punctata chondrodysplasia (compound)
amphetamine- or (cc)
recognised objectives (nsubjpass)
reduction 4.4-fold (amod)
expression localization (conj)
neurotoxicity verapamil-induced (amod)
reduce group (nmod)
index ) (punct)
$ROOT$ uterotonic (sent)
dilate dilates (advcl)
nausea emesis (conj)
disorders exposed (acl:relcl)
detection radiographic (amod)
cause cause (advcl)
defined to (mark)
nrf2 and (cc)
2.5 and (cc)
cbz acute (amod)
shared neuroleptics (nmod)
pacing , (punct)
$ROOT$ twitching (sent)
manageable clinically (advmod)
sigmast , (punct)
revealed degeneration (dobj)
centre target (nmod)
angioplasty after (case)
likely showed (advcl)
hit ) (punct)
carbetocin at (case)
coordinates points (nmod)
rupture for (case)
proteinuria and/or (cc)
established not (neg)
known stimulation (nsubjpass)
potentiated , (punct)
certain not (neg)
amikacin after (case)
ctni of (case)
prevalent most (advmod)
years 35.2 (nummod)
allowed hypotension (nmod)
resorption bone (compound)
reached mice (advcl)
contractions chronic (amod)
prolonged shortened (advcl)
effect evident (amod)
angiotensin -- (punct)
ngf and (cc)
induced dobutamine (nmod:npmod)
patients scoring (acl)
established been (cop)
reaction chemotherapy (nmod)
hospital montreal (appos)
administration caffeine (nmod)
indicates reversibility (dobj)
signs fever (nmod)
mimic condition (dobj)
ed1 for (case)
$ROOT$ depression (sent)
and both (cc)
mdma+ heavy (amod)
assessment pgads (appos)
revealed necropsy (nsubj)
treated nitrate (nmod)
stimulation alpha-adrenoceptor (compound)
hbeag or (cc)
prerequisite . (punct)
reduced wky (nmod)
have affinities (dobj)
loss to (case)
epilepticus development (conj)
attenuate also (advmod)
warfarin interactions (conj)
% = (appos)
increased overflow (dobj)
doing are (aux)
associated neutropenia (nmod)
measuring glutathione (conj)
smaller relaxations (nsubj)
hypertension eyes (nmod)
os with (case)
hypocalcemia and (cc)
cells/mm3 week (nmod)
mediating injury (dobj)
interpolates data (dobj)
lymphoma with (case)
worsening therapy (nmod)
syndromes of (case)
coexisted . (punct)
periods initial (amod)
sustained-release bupropion (compound)
dsm-iv i (dep)
compares accordingly (advmod)
initiated be (auxpass)
therapy levodopa (compound)
quinpirole d2 (compound)
junction both (cc:preconj)
palpitations edema (conj)
hospitalized he (nsubjpass)
need mechanisms (nsubj)
hypomania or (cc)
$ROOT$ add (sent)
cause lesion (nmod)
found receptors (nsubjpass)
had infant (dobj)
cmv ) (punct)
2002 in (case)
action abecarnil (nmod)
resistance drug (compound)
propranolol agent (appos)
ef the (det)
controlling after (mark)
ameliorates amnesia (dobj)
option alternative (amod)
stress ' (punct)
spine of (case)
microg.kg(-1).h(-1 2 (nummod)
score bmd (compound)
patients attaining (acl)
effects antioxidant (amod)
compares prilocaine (dobj)
1863 +/- (cc)
increased pressure (nsubj)
operations 70 (nummod)
measured hypotension (nmod)
derived that (nsubjpass)
gavaged animals (nsubjpass)
change parameters (dobj)
receptors reflexes (nmod)
p=0.36 ) (punct)
methotrexate only (advmod)
processed were (auxpass)
attack defense (conj)
creatinine of (case)
ulcers on (case)
worsening on (case)
objectives assess (acl)
acquisition avoidance (compound)
test an (det)
signs weights (conj)
0.001 ( (punct)
activity d (compound)
found decline (nsubjpass)
wsr versus (cc)
% theophylline (nmod)
duration between (case)
model intervention (conj)
hag ) (punct)
sensitivity with (case)
reviewed , (punct)
disoprivan with (case)
account vasospasm (nsubj)
series myeloid (amod)
density boys (nmod)
conclusions supported (dep)
common clonidine (nmod)
received underwent (conj)
needed monitoring (nmod)
indication another (det)
pseudolithiasis with (nmod)
catalyze that (mark)
showed suggesting (advcl)
exacerbated signs (dobj)
rotation lesion (nmod)
inhibitor reuptake (compound)
neurotransmission brain (compound)
citrate with (case)
surface a (det)
patients scheduled (acl)
functions her (nmod:poss)
months more (nummod)
sections brain (compound)
reduced sdrr (nsubjpass)
influence inhibitor (nmod)
greater s (nmod)
response to (case)
snp of (case)
design open (amod)
rw ) (punct)
three times (quantmod)
susceptibility antiviral (amod)
added when (advmod)
stiffness suxamethonium-induced (amod)
risk ) (punct)
medications. both (det)
blockade synthesis (nmod)
maintained anticoagulation (dobj)
viewed ; (punct)
lysozymuria micrograms/day (appos)
used is (aux)
monitoring pressure (compound)
drug-related cyclosporine (dep)
greater vasoreactivity (nsubj)
yr 86 (nummod)
dox-rats in (case)
differences larger (acl:relcl)
powered study (nsubjpass)
sertraline and (cc)
convulsions . (punct)
listed is (auxpass)
leveled to (mark)
suspected made (conj)
reversed be (auxpass)
influence clonidine (nsubj)
used or (cc)
8-se and (cc)
line base (compound)
appears cause (nsubj)
% cells/microl (conj)
concentration vol% (appos)
133 mmhg (dep)
found that (mark)
phagocytosis and (cc)
aimed identify (xcomp)
$ROOT$ characteristics (sent)
infusion bicarbonate (compound)
embryos same (amod)
0.48 0.08 (conj)
remodelling structure (nmod)
properties neurons (nmod)
dysfunction lasting (amod)
attributable effects (nsubj)
treated concomitantly (advmod)
experienced patients (nmod)
investigations future (amod)
u/d 5000 (nummod)
22 only (advmod)
$ROOT$ patients (sent)
sch the (det)
increases response (nmod)
studied model (nmod)
participates seemed (parataxis)
disease known (amod)
glycopyrrolate induction (nmod)
genes , (punct)
case deficit (nmod)
potency the (det)
kidneys native (amod)
3a4 cyp3a4 (appos)
studies immunohistochemical (amod)
receiving desferrioxamine (dobj)
swelling podocytes (nmod)
patients cardiac (amod)
removal sinuses (nmod)
surgery castration (compound)
occurred none (dep)
patients human (amod)
neurons to (case)
ensued failure (nsubj)
have tests (nsubj)
increase heart-rate (nmod)
investigated subsequently (advmod)
improve capacity (dobj)
chx+pilo and (cc)
patients consenting (amod)
one complications (nmod)
arm in (case)
disease for (case)
performance retention (compound)
unaffected were (cop)
bradykinesia of (case)
had required (conj)
structurally and (cc)
experienced fatigue (advcl)
safe long-term (nmod)
attacks and (cc)
c ) (punct)
in exam (nsubj)
dogs 15 (nummod)
action convulsive (amod)
continued if (mark)
csa srl (conj)
ro15 1788 (nummod)
pretreatment remifentanil (nmod)
seemed bradykinin (nsubj)
received received (parataxis)
susceptible patients (nsubj)
morning nocturnal (conj)
moderate toxicity (nsubj)
seems approach (nsubj)
thrombocytopenia anemia (conj)
safe practical (conj)
enrolled was (auxpass)
death , (punct)
had association (dobj)
based diagnoses (nsubjpass)
indication biopsy (nmod)
analogues adefovir (dep)
asterixis . (punct)
was parallel (attr)
morphine for (case)
left of (case)
successful if (mark)
factors confounding (compound)
evaluated model (nmod)
extent lesser (amod)
patients recruited (acl)
raised . (punct)
treatment the (det)
examined years (nmod)
discussed factors (nsubjpass)
10 15 (conj)
movements skeletal (amod)
put aspirin (nmod)
sensation with (case)
15 at (case)
weeks 11 (nummod)
years 61 (nummod)
factor is (cop)
transplant , (punct)
microg/ml 6 (nummod)
extended be (auxpass)
kidneys epinephrine-treated (amod)
1.05 2.30 (prep)
mice hippocampus (compound)
held , (punct)
proarrhythmic to (mark)
likelihood , (punct)
evaluated levels (nsubjpass)
essential . (punct)
duration an (det)
patients placed (acl:relcl)
women acetate (nmod)
whom of (case)
imperative evaluation (nsubj)
resulted also (advmod)
minutes 16.4 (nummod)
apap nephrotoxicity (dep)
minutes 23 (nummod)
determined it (nsubjpass)
reversed paralysis (dobj)
dose calculated (acl:relcl)
excitation seen (acl)
alcoholic an (det)
led amelioration (nmod)
characteristic stimulation (nsubj)
urate serum (compound)
concentration content (conj)
hypotension tachycardia (conj)
anticoagulant implemented (amod)
administration msg (nmod)
neuronal extraneuronal (conj)
patient second (amod)
sign episode (nmod)
associated penicillins (nsubjpass)
children versus (cc)
ambiguus nucleus (compound)
hospital at (case)
bridge a (det)
receiving vigabatrin (dobj)
group age (compound)
fair patients (nmod)
nonpregnant nonlactating (amod)
lf of (case)
erythropoietin of (case)
hbeag ( (punct)
wsp wsr (conj)
channel may (aux)
tests positive (amod)
hosts certain (amod)
association its (nmod:poss)
maneuver of (case)
treated separately (advmod)
higher seizures/mo (nmod)
complications diabetes (compound)
attack mydriasis (conj)
way dose-dependent (amod)
studies similar (amod)
us the (det)
patients children (nmod)
trial testing (compound)
$ROOT$ activates (sent)
was rats (nmod)
3tc azt (conj)
contraction norepinephrine (nmod)
consequence sensitisation (nmod)
carcinomas twenty (nummod)
dependence drug (compound)
subtypes involved (acl)
dispersion tdr (appos)
94 - (punct)
reduced pressure (dobj)
pretreatment 15-day (amod)
cancer between (case)
efficacy valsartan (nmod)
requiring intubation (dobj)
available reports (nsubj)
efficacy infusion (nmod)
mg/m(2 10 (nummod)
effects gastrointestinal (amod)
three more (amod)
reappearing increment (nmod)
digitalise to (mark)
time prothrombin (compound)
period 6-week (compound)
possible if (mark)
depletion trp (compound)
up-regulation alpha1-adrenergic (amod)
eye other (amod)
$ROOT$ zero (sent)
transporter dopamine (compound)
clonidine microinjected (acl)
has detecting (advcl)
anesthetics all (det)
activity electroencephalographic (amod)
dynamics oropharyngeal (amod)
analyses one-way (amod)
patients women (dep)
meth mptp (conj)
fq as (case)
unpleasant is (cop)
treatments following (amod)
requiring sedation (dobj)
terminating after (mark)
increased that (nsubjpass)
transition endothelial-mesenchymal (amod)
rats rats (acl)
dexrazoxane of (case)
describe patient (dobj)
stabilizer/rigidifier membranes (nmod)
history hit (nmod)
areas unstained (amod)
agents acting (acl)
frequency lower (amod)
exploration in (case)
coefficient intraclass (amod)
wave b (compound)
induction relevance (dep)
treated we (nsubj)
numbers animals (nmod)
shell , (punct)
infarction wall (compound)
ages role (conj)
labeling through (case)
ed50 agents (nmod)
saline normal (amod)
patients cardiotoxicity (nmod)
experienced episodes (dobj)
tested level (nmod)
ischemia echocardiography (nmod)
assessed symptoms (nmod)
reduction glutamate (nmod)
patients hypokalemia (nmod)
mechanisms subtypes (conj)
weeks 91 (nummod)
associations observed (acl)
disorder panic (compound)
inconclusive positive (conj)
revealed heads (dobj)
therapy diuretic (compound)
used srl (nsubjpass)
conclusions showed (dep)
gamma-vinyl-gaba micrograms (appos)
ischaemic nephrotoxic (conj)
underwent sah (nmod)
l-isomer ( (punct)
substrate is (cop)
adolescents years (appos)
regimen methotrexate (compound)
extract renal (amod)
therapy over (case)
appeared prominent (xcomp)
cold-pressor cp (appos)
developed loss (dobj)
kindling pentylenetetrazole-induced (amod)
attributed loss (nmod)
occurred majority (nsubj)
dis ) (punct)
content number (conj)
received patients (dobj)
electroretinography wide-field (amod)
adrenoceptors of (case)
insulin alone (advmod)
therapy pulse (compound)
months next (amod)
paradigm win-shift (amod)
learning tasks (nmod)
suspension % (amod)
er from (case)
duct the (det)
supplemented received (conj)
weeks time (nsubj)
sensitivity prolactin (nmod)
neuropathy optic (amod)
responsible substrates (nsubj)
compounds three (nummod)
age men (dep)
arterioles to (case)
include papilledema (dobj)
visceral and (cc)
decreased p<0.01 (dep)
after years (nmod:npmod)
were cells (attr)
activity intrinsic (amod)
control hemorrhage (dobj)
able pg-9 (nsubj)
consequences long-term (amod)
apparent evidence (nsubj)
changes stimulation (nmod)
use diuretic (compound)
all modulators (nmod)
patients 22 (nummod)
damage idiosyncratic (amod)
aimed clarify (xcomp)
level ultrastructural (amod)
another taking (acl:relcl)
damage liver (compound)
produce ssr103800 (nsubj)
minor reduction (nsubj)
patient bradycardia (nmod)
hyperhidrosis , (punct)
apoptosis cardiac (amod)
cascade the (det)
expression markers (nmod)
discontinued drugs (nsubjpass)
nerve of (case)
treating abuse (dobj)
use because (case)
lithium mg/day (appos)
hydration adequate (amod)
denial because (case)
likely effect (nsubj)
doxorubicin +/- (cc)
paracetamol of (case)
supplementation folic (amod)
effects tam (nmod)
different % (conj)
alter might (aux)
extend , (punct)
access solution (nmod)
higher common (advcl)
fr , (punct)
ed-1 staining (conj)
trial 16-week (amod)
induced convulsions (dobj)
lower , (punct)
protective has (ccomp)
survey complications (nmod)
manufactures which (nsubj)
afterdepolarization ead (appos)
gave questioning (nmod)
cells apoptotic (amod)
disorders organic (amod)
water including (case)
phosphatase tyrosine (compound)
attack panic (compound)
indicated ht (nsubjpass)
tablets lifetime (amod)
critical oxidation (nmod)
evoke . (punct)
using assays (dobj)
acid gamma-aminobutyric (amod)
care comprehensive (amod)
tract urinary (amod)
protected way (nmod)
increase dl-sotalol (nmod)
inhibitor ( (punct)
hydroxylase tyrosine (compound)
site catheter (compound)
tdi dextran (nmod)
quantify population (dobj)
are are (conj)
erythromycin of (case)
contraceptives second-generation (amod)
tests function (compound)
treated man (nsubjpass)
bea ( (punct)
potentials fraction (conj)
n=6 ): (punct)
counts 2,682,2,803 (nummod)
functioning impaired (amod)
range weeks (appos)
rats eight (nummod)
concentration hepatic (amod)
ring by (case)
effect progression (nmod)
vasoconstriction induced (acl)
risk drugs (nmod)
ag ( (punct)
amines biogenic (amod)
depends decision (nsubj)
change the (det)
become to (mark)
9-tetrahydrocannabinol delta (compound)
s-53482 s-23121 (conj)
dopaminergic glutamatergic (conj)
activity complex (nmod)
ph 7.05 (nummod)
measure can (aux)
peaked treated (conj)
reduced incidence (dobj)
studied repeatedly (advmod)
axis of (case)
1.8 170 (conj)
showed % (parataxis)
190 80 (conj)
improves rats (nmod)
expectancy the (det)
concerns enhance (acl)
easy miss (xcomp)
bradycardic be (cop)
bepridil dose (nmod)
arteries human (amod)
dexamethasone mesna (conj)
derivative an (det)
interview before (case)
interaction with (case)
grades iii (dep)
db 50 (nummod)
prevent oct (nsubj)
seizures pilocarpine-induced (amod)
syndrome induced (amod)
fragments n-terminal (amod)
patients sclerosis (compound)
neutropenia ( (punct)
$ROOT$ product (sent)
sweating reduced (amod)
nik-247 not (cc)
rats saralasin-treated (amod)
studies adenosine (nmod)
occurred insulin-group (nmod)
slower velocity (nsubj)
discontinued be (auxpass)
supplementation acid-containing (amod)
levels cgrp (nmod)
effects cocaine (nmod:poss)
evidence sites (nmod)
precipitate phases (nmod)
regressed . (punct)
studies bornstein (appos)
haematuria and/or (cc)
neuralgia severe (amod)
monohydroxyethylrutoside semisynthetic (amod)
effects modafinil (nmod)
tetrandrine tet (appos)
reached dose (nsubjpass)
sodium phenytoin (compound)
minimum % (conj)
is ( (punct)
tissues mammary (amod)
injections seven (nummod)
eliminated was (auxpass)
infused rats (nsubjpass)
$ROOT$ crossed (sent)
flumazenil mg/kg (compound)
registration : (punct)
beats/min sem (conj)
induced man (nmod)
reducing loss (dobj)
4.04 +/- (cc)
treated medications (nmod)
symptoms tic-like (amod)
desensitization postsynaptic (amod)
step through (advmod)
i with (case)
studying for (mark)
ca1 and (cc)
time tt (appos)
experienced polyneuropathy (dobj)
co-infection hiv (compound)
fever high (amod)
inhibitor factor (compound)
205 pph (nmod)
intake meq/kg/day (nmod)
blocker ii (nummod)
addition in (case)
thrush , (punct)
15-f(2t)-isop hydroperoxides (conj)
accompanied fall (nmod)
seeds dce (appos)
important manage (ccomp)
treatment beta-blocker (compound)
subjects had (acl:relcl)
shock block (nmod)
unknown yet (advmod)
january 2011 (nummod)
infusion sedative (amod)
recommend should (aux)
clinical neurophysiological (conj)
lasted sometimes (advmod)
discontinue therapy (dobj)
$ROOT$ mitigated (sent)
wavefronts of (case)
clotting the (det)
months 36 (nummod)
diamorphine of (case)
found cause (xcomp)
mortality baseline (nmod)
carriers co-infection (nmod)
developed treated (conj)
arf gentamicin-induced (amod)
90/hypertension increased (acl)
interval 95 (amod)
toxicity because (case)
female being (cop)
strain mouse (compound)
experienced day (nmod)
developed encephalopathy (dobj)
b12 micrograms (dep)
4 approximately (advmod)
changes analysis (conj)
withdrawal pharmacon (nmod)
septicaemia ( (punct)
min-1 32 (nummod)
had lesions (dobj)
gaba(a)rs on (case)
hydrochloride papaverine (compound)
maximum elevations (nsubj)
-cimetidine plus (cc)
eu titer (nsubj)
mm p (dep)
enalapril inhibitor (compound)
mg/m(2 1500 (nummod)
aggravation of (case)
apomorphine of (case)
recommendation as (case)
cerebellar cerebrocortical (conj)
receives striatum (nmod)
liable toxicity (nmod)
male of (case)
micrograms.kg-1.min-1 5.9 (nummod)
drugs fluorouracil (dep)
species or (cc)
properties the (det)
mg/dl to (case)
mediated cells (nmod)
phase disease (nmod)
type cochlear (amod)
hexachloro-1:3-butadiene aminonucleoside (conj)
greater males (nmod)
localization dystrophin (compound)
ceruleus the (det)
symptoms of (case)
monotherapies or (cc)
contexts in (case)
seems exposure (nsubj)
report here (advmod)
models animal (compound)
angioedema , (punct)
period defined (amod)
consisted design (nsubj)
lesions ventricles (nmod)
efficacy lenalidomide (nmod)
syndrome vincristine (nmod)
trial no (det)
td50 impairment (nmod)
reported 1993 (nmod:tmod)
losartan by (case)
enflurane and/or (cc)
levodopa to (case)
sign babinski (compound)
pressure conjunctiva (conj)
$ROOT$ transport (sent)
screening impairment (nmod)
effects metformin (nmod)
report earlier (amod)
group-2 the (det)
mouth by (case)
kidney nonclipped (amod)
reported now (advmod)
case autopsy (amod)
regions several (amod)
confirms conclusion (nsubj)
kg-1 mg. (compound)
fragmentation endonuclease-dependent (dep)
study neurophysiological (amod)
captopril-treated and (cc)
administration sub-chronic (amod)
patients 58 (nummod)
hypertension dexamethasone-induced (amod)
blockade , (punct)
boluses 2 (nummod)
continued is (auxpass)
expression bcl-2 (compound)
years median (dep)
solution saline (compound)
$ROOT$ primarily (sent)
fla838 and (cc)
/-7.1 ; (punct)
alter rats (nmod)
microg/kg 100 (nummod)
lead outcomes (nmod)
torr with (case)
rats pre-treated (acl)
mm3 above (case)
combinations first (amod)
weight : (punct)
hospital university (appos)
step to (mark)
mmc bolus (compound)
product 0.001 (appos)
demonstration an (det)
inhibited glucuronidation (dobj)
agent associated (advcl)
role contributing (amod)
event apparent (amod)
month therapy (nmod)
kindling ( (punct)
$ROOT$ 81.5 (sent)
treated fluoxetine (nmod)
i.c.v once (advmod)
secondary . (punct)
stopped treatment (dobj)
program an (det)
larger which (nsubj)
administering for (mark)
hippocampal regions (dep)
stage day (appos)
enzymes abnormalities (nmod)
results pretreatment (amod)
interpretation data (nmod)
exposure quinine (compound)
return function (nmod)
movement with (case)
concentrations intracellular (amod)
provided stability (dobj)
receiving pharmacotherapies (dobj)
drugs tramadol (conj)
demonstrates case (nsubj)
microg/day 14.2 (nummod)
16 ) (punct)
anticoagulation for (case)
tamca of (case)
decrease closing (conj)
analysis correction (nmod)
toxicities tolerate (conj)
atrophy by (case)
efficiency reported (amod)
increased rbcs (advcl)
pseudoprolactinoma in (case)
episodes 32 (nummod)
phosphate pentose (compound)
safe tolerated (conj)
models to (case)
crea ) (punct)
norepinephrine of (case)
coagulation of (case)
grade age (conj)
antagonized depletion (nsubjpass)
$ROOT$ supplied (sent)
norms with (case)
potential important (amod)
olanzapine ) (punct)
seizures lt (nmod)
restores impairment (dobj)
administration blocker (nmod)
caused nicotine (nmod)
recovery , (punct)
bradycardia norepinephrine (nmod)
decrease clearance (nmod)
angiography radionuclide (amod)
transplant stem (compound)
desmin = (dep)
those led (acl:relcl)
administered report (nmod)
develop using (advcl)
decrease desire (nmod)
consequences its (nmod:poss)
3 2 (conj)
24.9 23.3 (conj)
study for (case)
effective more (conj)
degrees monocular (amod)
= 0.74 (dobj)
attenuating activity (nmod)
constructed effect (nmod)
da in (case)
chemotherapy chemotherapy (conj)
agonist beta2-adrenoceptor (compound)
inhibitors synthetic (amod)
doses hydrochloride (nmod)
recommended strongly (advmod)
meet criteria (dobj)
4 little (amod)
decrease mbp (nmod)
induced bupivacaine (nmod)
achieved one (nmod)
(+)-propranolol of (case)
medium cm (appos)
potencies similar (amod)
known little (nsubjpass)
excluded noncompliance (dep)
proteinuria hypertension (conj)
decreasing requirement (dobj)
metabolized pathway (nmod)
potentiation and (cc)
those did (acl:relcl)
administration upon (case)
ssc ( (punct)
indicate inadequate (conj)
depression for (case)
normal 2 (nmod)
treatment dexamethasone (nmod)
medication no (neg)
leukemia myeloid (amod)
injection dosages (nmod)
received recently (advmod)
reaction on (case)
enhancement characteristic (amod)
hydroureteronephrosis preexisting (amod)
acquired immediately (advmod)
implications using (advcl)
invoked aminonucleoside (nmod)
depressed dose (nsubj)
900 , (punct)
used ethambutol (nsubjpass)
therapy risk (appos)
evaluate and (cc)
alterations fetuses (nmod)
conjunctivitis patient (appos)
unrecognized but (cc)
proportional was (cop)
ctni-positive who (nsubj)
gain gfr (conj)
number intensity (conj)
phases cubic (amod)
evidence particles (nmod)
cells to (case)
did group (nsubj)
ica of (case)
continued dopamine (nsubj)
confined suppression (nmod)
movements patients (nmod)
death accelerated (amod)
exceeds that (dobj)
showed experiments (nsubj)
courses . (nummod)
ml-1 ng (nummod)
suggested data (nsubj)
cells bmcs (appos)
drugs phenothiazines (appos)
therapy control (nmod)
ampka phosphorylated (amod)
co2 of (case)
arrest maturation (compound)
etiology as (case)
cause hepatotoxicity (nsubj)
differ response (nsubj)
reversed changes (dobj)
wrinkling ischemic (amod)
highlights , (punct)
action and (cc)
aminoglycoside an (det)
level vip (compound)
children experienced (acl:relcl)
inhibition for (case)
glycopyrrolate % (amod)
recovery status (nmod)
findings ct (nmod)
patients eucalcemic (amod)
developed gvhd (dobj)
model mouse (compound)
0.5mg/kg , (punct)
developed akathisia (dobj)
followed dose (nmod)
audit expert (compound)
given started (conj)
developed incidence (parataxis)
donor trinitrate (dep)
deprivation protein (compound)
67.4 10.2 (prep)
disorders persistent (amod)
heart nmol/min/g (compound)
system limbic (amod)
fell ml/m2 (conj)
picture similar (amod)
effective well (conj)
exposed was (auxpass)
composition pool (compound)
found introduction (nmod)
areas buttocks (conj)
levels patient (nmod:poss)
vds ) (punct)
micrograms/kg/min 5 (nummod)
measured scale (nmod)
observed lymphoma (nmod)
skin injury (nmod)
insertion valve (compound)
doses tetrachloride (nmod)
stimulates formation (dobj)
large hump-like (conj)
mumol/kg doses (conj)
cortex cingulated (amod)
rats than (case)
pilocarpine- , (punct)
infusion second (amod)
some compounds (nmod)
field operative (amod)
metoprolol aspirin (conj)
duration only (amod)
revealed monitoring (nsubj)
examined child (nsubjpass)
decreasing addition (dep)
reproduced rechallenge (nmod)
measured parameters (nmod)
rct and (cc)
oxygenation hypotension (nmod)
alternatives evidence-based (amod)
laboratories , (punct)
attributable effect (nsubj)
dysfunction pathophysiology (nmod)
studies communication (conj)
extent the (det)
2.0/100,000 ) (punct)
tubes ventricle (nmod)
termination administration (nmod)
expanded required (advcl)
comparable higher (conj)
glomerulus in (case)
remains clozapine (nsubj)
mapping with (case)
levobupivacaine ropivacaine (conj)
3.6 1.8 (quantmod)
acid 5-hydroxyindoleacetic (compound)
disability motor (compound)
dilemmas treatment (compound)
% 42.5 (nummod)
show symptoms (dobj)
ibs ( (punct)
csa plus (cc)
rate maximum (compound)
ninety-seven two (compound)
57 from (case)
animals lithium-treated (amod)
hypoplasia reversible (amod)
confirm effects (dobj)
potentiation mice (nmod)
excretion sodium (compound)
work recent (amod)
alter nor (cc)
limited success (nsubj)
aggravate that (mark)
returned normal (xcomp)
development with (case)
observed being (auxpass)
given carboplatin (nsubjpass)
tachycardia exercise- (amod)
regimens different (amod)
mptp the (det)
diazepam- and (cc)
granules of (case)
previously days (nmod:npmod)
mania : (punct)
complication life-threatening (amod)
btc ( (punct)
used bzds/rds (dobj)
lasting prior (advmod)
reversible partly (advmod)
38 up (advmod)
ampicillin also (advmod)
smokers disease (nmod)
hydrocortisone with (case)
noted hemorrhage (nsubjpass)
quantitative , (punct)
range " (punct)
led injection (nsubj)
threatening is (cop)
agents beta (compound)
valsartan for (case)
experience . (punct)
stereotypies with (case)
anemia drug-induced (amod)
decreased 33.6 (nmod)
experience who (nsubj)
h 1 (nummod)
evaluation perspective (nmod)
alterations infarction (nmod)
hormones . (punct)
institution single (amod)
acids hexaaldonic (amod)
concentrations brain (compound)
89/102 ) (punct)
successful was (cop)
trained group (nmod)
cross-tolerant drugs (nmod)
s 540 (nummod)
epidemic workers (nmod)
ng/kg/min 30 (nummod)
titer protein (nmod)
deficits model (nmod)
use bupropion (nmod)
t(1/2 ( (punct)
resulted have (aux)
reversion the (det)
serum two (nmod)
stress tissue (compound)
receive lidocaine (dobj)
produced regimen (nmod)
appears safe (xcomp)
synthase neuronal (amod)
mg from (case)
action effective (amod)
efficacy migraine (nmod)
evoked methoxamine (nsubj)
found have (xcomp)
use which (nsubj)
injury from (case)
weakness shown (acl)
depression nicotinic (amod)
evaluated potential (nsubjpass)
affected presence (nmod)
studied groups (dobj)
ataxia speech (conj)
renal both (cc:preconj)
suggest vasoconstriction (dobj)
appears implicated (xcomp)
seven in (case)
dosage threshold (amod)
leukemia cns (compound)
controls crf (appos)
2.1 interval (dep)
mmol/l ( (punct)
necessity the (det)
trials aminoglycosides (nmod)
analyzed developed (advcl)
absorption systemic (amod)
symptoms ocular (amod)
angina for (case)
reported devastation (nmod)
patients control (compound)
demand metabolic (amod)
compared methods (dep)
inhibitor peripheral (amod)
$ROOT$ avoid (sent)
dystonia off-period (amod)
zung-conde the (det)
undergone observed (conj)
exposure bcnu (nmod)
proliferation the (det)
is removing (csubj)
review options (dobj)
avoided using (advcl)
hypotension marked (amod)
capacity reduced (amod)
map hr (conj)
related when (advmod)
reprogramming imparts (acl:relcl)
lna+hca ) (punct)
status final (amod)
vasoreactivity artery (nmod)
biopsies node (compound)
risk some (det)
a % (appos)
risk reported (acl)
compound parent (amod)
nephropathy induced (acl)
mellitus , (punct)
receptors rat (compound)
describe reported (advcl)
kinetics recovery (compound)
hypotension during (case)
employing model (dobj)
cortex operculoinsular (amod)
recovery acuity (nmod)
capacity a (det)
disease is (cop)
months 3 (nummod)
timolol solution (appos)
treating children (dobj)
develop rates (nmod)
tachydysrhythmias of (case)
% 0.3 (nummod)
profile animals (nmod)
glyburide sulfonylurea (appos)
reductions the (det)
g/ml ( (punct)
hypercalcemia unexplained (amod)
papaverine , (punct)
sulfate and (cc)
test tail-flick (compound)
toxicity such (case)
developing esrd (dobj)
tightness caused (acl)
patients mg/kg (nmod)
appeared icrf-187 (conj)
day regimen (nmod)
supports assumption (dobj)
clearance of (case)
umb24 with (case)
dwi flair (conj)
consisted infusion (nmod)
recovery following (case)
females were (cop)
diseases dystrophy (nmod)
injected bn (nsubjpass)
1-chloro-1,2,2,2-tetrafluoroethane hcfc (appos)
seen use (nmod)
1b hcv-genotype (compound)
susceptible oxacillin (nmod)
ischaemia induced (amod)
negative bpo (nmod)
assessed testing (nmod)
panel , (punct)
antagonist alpha-2 (compound)
case agranulocytosis (nmod)
had symptoms (dobj)
had bruising (nmod)
thought it (nsubjpass)
prostaglandins endometrial (amod)
evaluation follow-up (conj)
medium low-osmolar (amod)
protection nephrotoxicity (nmod)
cortex m1 (appos)
symptoms man (nmod)
q mg/m(2 (nummod)
offered modalities (nsubjpass)
allele novel (amod)
dysphonia acitretin-induced (compound)
injection parameters (nmod)
times discharge (compound)
received injection (dobj)
abdomen distended (amod)
seizures application (nmod)
have manifestation (nmod)
quick and (cc)
flecainide between (case)
provided : (punct)
fourfold those (nmod)
forming angiotensin (compound)
submitted acquisition (nmod)
vacuolization myocytes (nmod)
trial anastrozole (nmod)
published previously (advmod)
time-dependent dose-and (nmod:npmod)
diarrheas diseases (conj)
dose accumulation (conj)
model hemorrhage (compound)
urticaria patients (appos)
embase , (punct)
preserved hypotension (nmod)
drug valproate (dep)
elevation segments (nmod)
cholesterol % (appos)
outcome poor (amod)
have pharmacology (dobj)
assigned standard- (nmod)
$ROOT$ microg/ml (sent)
respond and (cc)
published ezetimibe (nmod)
potentiated bradycardia (nsubjpass)
value an (det)
activity cholinergic (amod)
dates ) (punct)
analysis microscopy (nmod)
ic the (det)
pronounced less (advmod)
respiration temperature (conj)
mg 118 (nummod)
implicated cases (dobj)
isolated and (cc)
minutes ) (punct)
cardiomyopathy reversible (amod)
results laboratory (compound)
$ROOT$ refer (sent)
discussed effect (nsubjpass)
day onwards (advmod)
lid on (case)
population ( (punct)
interval-prolonging qt (nmod:npmod)
areas injections (compound)
chloroquine hydroxychloroquine (conj)
complication ethambutol (nmod)
height scores (conj)
mmp-2 mrna (conj)
toxicity arabinoside (nmod)
muscimol of (case)
case interaction (nmod)
course an (det)
distinguished urinalysis (nmod)
velocity saccadic (amod)
present case (dobj)
plasticity to (case)
observed doses (nmod)
latency obtain (acl)
expression course (nmod)
female 23 (nummod)
regulates effects (dobj)
$ROOT$ describe (sent)
interval electrocardiogram (nmod)
administration levofloxacin (compound)
ms hplc (compound)
damage : (punct)
metrazol of (case)
diminishes effects (dobj)
cases prolactin (nmod)
dysfunction measured (acl)
rendered comatose (xcomp)
myopathy acute (amod)
vpu mg/kg (appos)
phase i (nummod)
effect kaliuretic (amod)
cholesterols triglycerides (conj)
percent a (nmod)
% 5.5 (nummod)
randomized treatment (nmod)
using intensity (nsubj)
improved use (nsubj)
responder a (det)
gr cp (conj)
use year (nmod:tmod)
test avoidance (compound)
$ROOT$ tended (sent)
potentiated doc (dobj)
unsafe is (cop)
girl and (cc)
controls epileptic (amod)
gaba(a)rs and (cc)
postdose hours (compound)
thrombocytopenia no (det)
remained administered (advcl)
related usually (advmod)
assessed diet (nsubjpass)
194 +/- (cc)
patients angio-oedema (nmod)
k)-atpase of (case)
seems since (mark)
common presented (conj)
stretching consequent (amod)
premarin ( (punct)
use chronic (amod)
influence pregnancy (nmod)
prior from (mark)
downregulating generation (dobj)
precipitation to (mark)
causing syndrome (dobj)
boy 13-year-old (amod)
administration single (nmod)
abnormalities cardiac (amod)
1.210 1.063 (compound)
products advanced (amod)
lower be (cop)
response chronotropic (amod)
beginning weeks (nmod)
sem 85.9 (nummod)
september 2012 (nummod)
effect hyperparathyroidism (nsubj)
c+e = (parataxis)
mass . (punct)
saline- from (case)
exencephaly e13.5 (nmod)
sensitizes intervention (nsubj)
days 11 (conj)
studies date (nmod)
appeared receiving (advcl)
burns with (case)
exposure following (amod)
strategy coronary (amod)
therapy intra-arterial (amod)
patients refractory (amod)
levetiracetam adjunct (nmod)
stimulation after (case)
study 5-fu (nmod)
organogenesis during (case)
deficits abnormalities (conj)
hypocalcemia for (case)
reduces disease (nmod)
insights pathogenesis (nmod)
reduced drinking (dobj)
production extracellular (amod)
treated part (nmod)
admitted been (auxpass)
presented dose (nmod)
tumors rat (compound)
features appearances (conj)
oxide nitric (amod)
lovastatin and (cc)
methods reaction (compound)
conclusions regimen (appos)
increase release (nmod)
pretreatment and (cc)
antidepressant . (punct)
ssr103800 inhibitor (compound)
d2/d3 dopamine (compound)
thrombogenicity vascular (amod)
developed cycle (nmod)
eye her (nmod:poss)
continuous repeating (conj)
rats chronic (amod)
months experiment (nmod)
involved mechanisms (nsubjpass)
activity cyp2d6 (compound)
iceberg of (case)
vegfr-2 , (punct)
making diagnosis (dobj)
occurred prolongation (nsubj)
brief tonic (conj)
characteristics mechanisms (conj)
thrombosis by (case)
value responsiveness (nmod)
thought frequency (nmod)
mutations resistance (compound)
decreased nitrate/nitrite (nsubjpass)
density neuronal (amod)
months preceding (amod)
ratio enhancement (compound)
case positive (amod)
expression responses (conj)
$ROOT$ way (sent)
5 all (det)
points score (nsubj)
interval 3.54 (appos)
classified exencephaly (dobj)
leads defect (nsubj)
correlated dose (nmod)
a/j c57bl/6j (conj)
transporter-1 glycine (compound)
function index (conj)
males of (case)
complications motor (compound)
84 of (advmod)
susceptible that (nmod)
infusion drug (compound)
case became (acl:relcl)
defect distal (amod)
observed increases (nsubjpass)
increase further (amod)
less moreover (advmod)
steal " (punct)
granulocytopenia effect (nsubj)
inhibition nte (compound)
using weekly (advmod)
faster diazepam (nmod)
subtypes alpha2abc-/- (appos)
caused was (advcl)
health public (amod)
activity epileptic (amod)
dependence substance (compound)
produce doses (nmod)
crataegus of (case)
mg/m2 days (nmod)
regimen by (case)
adopted could (aux)
paralysis cord (compound)
stents drug-eluting (amod)
synthesis antagonists (nmod)
ability urinary (amod)
disappear when (advmod)
studies extended (amod)
density microtubules (nmod)
cacl(2 to (case)
microgram/kg/min of (case)
administration [3h]-5-azadeoxycytidine (nmod)
serious most (advmod)
neurology pharmacology (conj)
causes events (nmod)
treatment insulin (compound)
showed retention (dobj)
34/45 ( (punct)
clonus first (amod)
hypertension acute (amod)
use exchange (nmod)
b6 58 (nummod)
features typical (amod)
year 59 (nummod)
ambulate to (mark)
chlorthalidone ) (punct)
showed observation (nsubj)
comparable . (punct)
2.58 ci (nmod)
cause rebound (nmod)
hypotension effect (conj)
effect peripheral (amod)
$ROOT$ diffusion (sent)
absence carcinogen (nmod)
included exposure (dobj)
shape erythrocyte (compound)
challenge parenteral (amod)
induce to (mark)
disorders behavioral (amod)
followed stroke (nsubj)
sequelae cardiovascular (amod)
clozapine = (amod)
agonist 5-ht(2c (compound)
unaltered levels (nsubj)
overdose severe (amod)
percentage a (det)
2e1 2e1 (appos)
called attention (nsubjpass)
height with (case)
caspase-3 , (punct)
deletion cardiomyocyte-restricted (amod)
receiving busulfan (dobj)
demonstrate protects (ccomp)
combination disorder (nmod)
txa ) (punct)
smoke and (cc)
hallucinations neurotoxicity (conj)
cause alone (advmod)
d ( (punct)
rates survival (conj)
administered naloxone (dobj)
countries many (amod)
response inhibitors (nmod)
procedure backward (amod)
investigations . (punct)
all patient (conj)
toxicity normal (amod)
background one (appos)
toxicity chronic (amod)
way are (cop)
3-benzenesulfonyl-7-(4-methyl-piperazin-1-yl)1h-indole ) (punct)
presence sensitization (nmod)
pog ) (punct)
10.2 0.2 (compound)
shown . (punct)
1.34 0.89 (conj)
beating rat (compound)
studies peri-operative (amod)
chf amiodarone (nmod)
attempt suicidal (amod)
shown protects (ccomp)
observations catalyze (ccomp)
380+/-587 ( (punct)
screened patients (dobj)
exposure pubertal (amod)
psychosis stimulant (amod)
cause that (dobj)
reduced caa (nsubj)
mapd ( (punct)
described series (nsubjpass)
effects side (amod)
hyperkalemia spironolactone-induced (amod)
detected immunoblotting (nsubj)
transferred was (auxpass)
$ROOT$ sensitivity (sent)
suffered 78-year-old (nsubj)
similar dose (nmod)
occurred p (dep)
focus data (nsubj)
effacement some (det)
demonstrated possibility (nsubjpass)
months and (cc)
$ROOT$ emphasize (sent)
blockers both (det)
inpatients 1210 (nummod)
pneumoniae ) (punct)
reported occurrence (nsubjpass)
ace ) (punct)
attenuated treatment (nsubj)
rate aes (nmod)
$ROOT$ specific (sent)
pills look-alike (amod)
schedules of (case)
august 1993 (nummod)
done review (nsubjpass)
hepatomegaly decrease (conj)
depression manic (amod)
managed using (xcomp)
area damaged (amod)
giving , (punct)
treated control (nmod)
stomatitis anemia (conj)
cardioversion electrical (amod)
vegf non-endothelial-derived (amod)
lids plasticity (conj)
injury neuronal (amod)
myocardiopathy adriamycin-induced (amod)
potential monophasic (amod)
either patient (nmod)
rr 1.0 (nummod)
report newspaper (nmod)
trial assigned (acl:relcl)
decreased glimepiride (nmod)
became severe (conj)
examined viscerally (advmod)
factors its (nmod:poss)
levels same (amod)
regions regions (appos)
resorption by (case)
restarted receiving (advcl)
resolved therapy (nmod)
mustard , (punct)
respects several (amod)
lh ( (punct)
measurements with (case)
instability stimulation (nmod)
formula 25/100 (nummod)
commenced drug (dobj)
completion treatment (nmod)
ipratropium for (case)
described coexistence (nsubjpass)
ma ( (punct)
range 19 (nmod)
difficult deliver (xcomp)
syndromes difficult (amod)
resurgence the (det)
evidences protection (appos)
necrosis for (case)
contractions premature (amod)
infusion hour (nmod:tmod)
progestagens the (det)
admitted five (nsubj)
disorders . (punct)
evaluation expanded (amod)
groups all (det:predet)
growth both (cc:preconj)
vincristine to (case)
stripe the (det)
avoid outcomes (dobj)
changed not (neg)
compared efficacy (nsubjpass)
compromising most (advmod)
signaling norepinephrine (compound)
concentration anaesthetic (compound)
known ameliorate (xcomp)
effects recognized (amod)
reached been (auxpass)
exploited effects (nsubjpass)
switched and (cc)
needed is (auxpass)
showed rate (dobj)
improvement vision (nmod)
anotia ( (punct)
inhibitors endogenous (amod)
given patient (nsubjpass)
mvp ( (punct)
pharmacokinetics famotidine (nmod)
recurred use (nmod)
correlate not (neg)
hepatonecrosis cholangitis (conj)
associated infants (nmod)
passage mannitol (nmod)
response further (amod)
damage histopathological (amod)
paralysis vocal (amod)
decline response (nmod)
chiasmopathy associated (amod)
dec. , (punct)
20 10 (compound)
produced dothiepin (nsubj)
affect and (cc)
mice aggregation (conj)
increased results (nsubjpass)
tachycardia ) (punct)
presented case (nsubj)
anatomic or (cc)
analysis case-control (amod)
content activity (conj)
shift space (nmod)
effect tam (nmod)
h 30 (nummod)
likely significant (xcomp)
abolished compared (advcl)
ddavp of (case)
documented is (auxpass)
cause did (aux)
origin and (cc)
treatment weeks (compound)
titrating dose (dobj)
parasitosis of (case)
loss decrease (conj)
hypothesis used (ccomp)
pcr-rflp ( (punct)
patient cancer (compound)
neonates ; (punct)
maze plus (compound)
averaging % (dobj)
questions use (dobj)
exert inhibitors (nsubj)
leukocyturia age (conj)
fingers foot (conj)
kindled-seizures cocaine (compound)
accumulation cent (nmod)
increased be (auxpass)
assessed performances (dobj)
therapy progestagen (nmod)
demonstrate steroids (nsubj)
infusion isotonic (amod)
circulation the (det)
excluded violation (nmod)
bcnu-exposed melatonin (conj)
polyuria urine (nmod)
proportion cells (nmod)
properties muscle (compound)
gives . (punct)
returned slowly (advmod)
admitted administration (nmod)
lasted asystole (nsubj)
correlate severity (nsubj)
eai ( (punct)
processed was (auxpass)
patients 94 (nummod)
esrd , (punct)
efficacy on (case)
programme visual (amod)
inhibitor calcification (compound)
analogues buspirone (nmod)
renal , (punct)
affected adversely (advmod)
methamphetamine either (cc:preconj)
used were (auxpass)
beta-blockade with (nmod)
cholestasis reversible (amod)
telaprevir as (cc)
vancomycin piperacillin/tazobactam (conj)
117 of (advmod)
caution special (amod)
investigated antagonizing (advcl)
glutathione tissue (compound)
pharmacokinetics risks (conj)
sbp group (nmod)
measured presence (nmod)
hyperlipoproteinemias for (case)
mechanisms occurrence (nmod)
secondary pills (nmod)
open eyes (dobj)
needed reduce (xcomp)
medication indicates (acl:relcl)
patients 20 (nummod)
levels in (case)
lozenges polacrilex (compound)
occurred complication (nsubj)
cells existing (amod)
trigger initiate (acl)
ability azt (nmod)
discharged hours (nmod)
diagnosed got (conj)
utilized improve (advcl)
increase oxypurines (nmod)
bred lines (nsubjpass)
causes common (amod)
shock electroconvulsive (amod)
uptake dopamine (nmod)
found effects (nsubjpass)
women menorrhagia (nmod)
entropion abrasion (conj)
retention memory (compound)
antibodies antirifampicin (amod)
administration daidzein (nmod)
utilization correct (acl)
$ROOT$ opioid (sent)
treatment sr (compound)
peak with (case)
hospitalization cost (appos)
femoral ( (punct)
antagonists dihydropyridine (compound)
morphine-hc1 of (case)
) 10(-3)m (conj)
such epinephrine (ccomp)
responses measured (acl)
associated doses (nsubjpass)
determination a (det)
lead life (dobj)
infiltration eosinophils (nmod)
mm 1.35 (compound)
plays vasopressin (nsubj)
t4 ) (punct)
study i/ii (nummod)
micrograms 800 (nummod)
proarrhythmic use (nmod)
abruptness the (det)
metabolites cyclophosphamide (compound)
transferred quadriparesis (nmod)
i.v. ) (punct)
rammer al (dep)
cycles median (amod)
ci 1.04 (nummod)
7alpha-hydroxylase 27-hydroxylase (conj)
useful controlling (advcl)
patients ve (compound)
provoked could (aux)
mazindol treated (amod)
growth by (case)
isoenzymes creatine (compound)
became intolerable (acomp)
synthase ( (punct)
induction seizures (nmod)
increase reversal (conj)
chlorpropanol , (punct)
ward psychiatry (compound)
concluded has (ccomp)
analgesics certain (amod)
show failed (ccomp)
hormone lh (appos)
icp , (punct)
continued dialysis (dobj)
patients 630 (nummod)
sigma2 for (case)
recognition expression (compound)
antihyperalgesia morphine (compound)
lid ( (punct)
glibenclamide with (case)
causes which (nsubj)
csa ( (punct)
started ascended (conj)
society asa (appos)
leading hypertension (nmod)
or 2.7 (appos)
activity emg (appos)
antigens hla-b35 (compound)
event adverse (amod)
% 67 (compound)
received . (punct)
factors relative (amod)
marrow the (det)
toxicity needed (dep)
mediate expression (nsubj)
phosphatidylserine ps (appos)
received who (nsubj)
patients b (dep)
phase washout (compound)
research as (case)
those primarily (advmod)
encountered have (aux)
cancer bladder (compound)
tetany facial (amod)
plasticity m1 (compound)
flow tidally (advmod)
start onset (conj)
shown as (mark)
one not (cc)
mg 0.59 (nummod)
influence a (det)
presented hypersensitivity (nsubj)
has ppa (nsubj)
rates ( (punct)
consumed , (punct)
depression is (cop)
hospital teaching (amod)
cytotoxicity 3717 (compound)
administration kf17837 (nmod)
haemorrhage the (det)
5 +/- (cc)
remains there (expl)
inhibitors mtor (compound)
validated using (xcomp)
improvement iq (nmod)
discontinuance drugs (nmod)
monotherapy compared (case)
increased secretion (nsubj)
38 35 (conj)
1.8 rate (nsubj)
adults young (amod)
alleviating parkinsonism (dobj)
ratio toxic (amod)
role cyclosporine (nmod)
model test (acl)
immunosuppressant is (cop)
dosage whose (nmod:poss)
related infusion (nmod)
groups sh(6 (appos)
12 4.7 (nummod)
recall room (nmod)
produces absence (nmod)
inhibit metabolism (dobj)
ceased only (advmod)
variations genetic (amod)
syndrome disease (conj)
described reported (advcl)
suggest causes (ccomp)
bid mg (compound)
causes hyperprolactinemia (nmod)
hearts from (case)
coma with (case)
fluid busulfan (compound)
were controlling (advcl)
induced lindane (nmod)
combination caffeine (nmod)
group myeloma (compound)
9.2 0.2 (compound)
year after (case)
classified based (prep)
covered . (punct)
alkaloid a (det)
hyperkalemia failure (conj)
$ROOT$ stop (sent)
reduction fracture (compound)
mechanisms elicits (acl:relcl)
500/mm3 < (advmod)
relapsed with (case)
$ROOT$ anuria (sent)
lesions common (acl:relcl)
1.0 - (dep)
implicated use (nsubjpass)
alpha2abc-/- ) (punct)
tuberculosis , (punct)
attention simple (amod)
impairment lesion (conj)
mechanism pathogenetic (amod)
at , (punct)
interactions signaling (nmod)
describes associations (dobj)
$ROOT$ reducing (sent)
optochiasmatic peripheral (conj)
acid phenylacetic (amod)
good diseases (nmod)
control behavior (dobj)
monitored electrocardiogram (nsubjpass)
site mechanism (conj)
areas through (case)
protect damage (dobj)
17.5 x (cc)
behaviour on (case)
changes waveform (nmod)
causing although (mark)
efficacy or (cc)
candidiasis hoarseness (conj)
reduced sensitization (nmod)
criteria coma (nmod)
preparations inflamed (amod)
responses inotropic (amod)
analyzed relation (nmod)
developed began (advcl)
responders stable (amod)
antagonized increase (dobj)
pge2 medullary (amod)
used specificity (nmod)
cause discrimination (nmod)
predictability outcome (compound)
reduces carries (conj)
1mg/kg/week ) (punct)
treated 2a (nmod)
associated anemia (nmod)
induction tci (nmod)
morphine of (case)
introduction . (punct)
measured plasma (nmod)
patients hag (compound)
contributed . (punct)
maintains but (cc)
treatments following (case)
number minutes (nmod)
blockers reuptake (compound)
levels prl (compound)
treatment institution (nmod)
treatment doxorubicin (nmod)
significantly p (dep)
etoricoxib diclofenac (conj)
questionnaire a (det)
shr wky (conj)
pathway autophagy (compound)
microgram/kg/min 40 (nummod)
microg mouse (nmod)
7.54 , (punct)
mumol/l ) (punct)
exercise regular (amod)
suspect suggests (ccomp)
ameliorated be (auxpass)
due syndrome (nmod)
lesion projections (nmod)
disposition apap (nmod)
material : (punct)
phagocytosis suggesting (conj)
suitable protection (nsubj)
factor mean (compound)
groups in (case)
discontinued followed (dep)
polypeptide vip (appos)
exposure mepivacaine (nmod)
da serotonin (conj)
involved which (nsubjpass)
transplant reduced-intensity (amod)
enalapril-treated = (dep)
40 - (advmod)
exercised using (advcl)
20 almost (advmod)
eia ) (punct)
detected not (neg)
behaviour exploratory (amod)
u/l 738 (nummod)
doses pap (compound)
$ROOT$ pretreated (sent)
cylinder total (amod)
delta , (punct)
dgc in (case)
induce domperidone (nsubj)
complications related (amod)
range 22.25 (appos)
ich with (case)
depend to (mark)
link treatment (nmod)
nausea changes (nmod)
days management (nmod)
smaller . (punct)
cause background (compound)
scr mean (amod)
bacteremia mssa (compound)
sources : (punct)
suffering are (aux)
assess compared (advcl)
occurs vomiting (nmod)
dermatitis facial (amod)
pain back (compound)
research further (amod)
liver induced (acl)
awake ' (punct)
elevation calcium (nmod)
mg kg(-1 (appos)
lesion nigra (compound)
inhibition lactation (nmod)
symptoms values (conj)
use woman (nmod)
acetate mg/day (appos)
users preparations (nmod)
concentrations urine (compound)
increased tissue (nmod)
19.708 ci=2.612 (nummod)
rats lead-exposed (amod)
investigate findings (dobj)
induce augmented (conj)
using persons (nmod)
development users (nmod)
add to (mark)
met results (nsubj)
treatment to (case)
involved progression (nmod)
errors fewer (amod)
crisis a (det)
attenuated convulsions (dobj)
established been (auxpass)
ng 4 (nummod)
agranulocytosis thrombocytopenia (nmod)
decline % (compound)
comparable volume (nsubj)
age over (case)
followed increase (nmod)
operations patients (nmod)
show while (mark)
administered topically (advmod)
improved 3ma (nsubj)
given days (dobj)
projection a (det)
cancer use (conj)
mention possibility (nmod)
memory a (det)
remains pathogenesis (nsubj)
activator first (amod)
delayed is (auxpass)
rtms ) (punct)
rise sharp (amod)
cm 1.5 (nummod)
clinician the (det)
impairments learning (nmod)
important understand (xcomp)
incidence changes (conj)
tumors liver (compound)
induced octreotide (nmod:npmod)
startle light-enhanced (amod)
l-1 be (cop)
animals bcnu-treated (amod)
period particular (amod)
produce octogenarian (nmod)
change group (nmod)
treated ergotamine/caffeine (nmod)
induces inhibition (nsubj)
flushed buffer (nmod)
attacks between (case)
cataracts , (punct)
citalopram with (case)
-12.8 +/- (cc)
defining of (mark)
hallmark dysfunction (nmod)
seem since (mark)
incidence cancers (nmod)
continue concerns (nsubj)
receiving cvvhdf (dobj)
nd-nmba due (case)
p53 of (case)
high can (aux)
syndrome ts (appos)
$ROOT$ estimated (sent)
mg/100 20 (compound)
seen animals (nmod)
chloride , (punct)
shown significantly (advmod)
supplementation prolonged (amod)
groups adr(12 (conj)
classified we (nsubj)
interaction no (neg)
therapy calcineurin-inhibitor (amod)
60 3 (compound)
presence denervation (nmod)
normalized had (conj)
glioma and (cc)
rhabdomyosarcoma for (case)
supported armrest (nmod)
evidence disease (nmod)
temocapril of (case)
pre-administration by (case)
animals sacrificed (acl:relcl)
assessed sessions (nmod)
adjusted maintain (xcomp)
infusion mg/m2/h (nmod)
striata injections (nmod)
increased expected (advcl)
exhibited along (cc)
depressed all (nsubjpass)
stopping week (conj)
irrigation second (amod)
synergistic were (cop)
agents progestational (amod)
= 2054 (dobj)
consumption fluid (compound)
restriction to (case)
mortality postnatal (amod)
hemoglobin markers (conj)
kidney cornu (conj)
statins and (cc)
vaccinated were (auxpass)
models as (cc)
using test (dobj)
lobe temporal (amod)
suppressed fps (nmod)
elucidate problem (dobj)
metabolism mixed-function (amod)
build-up hours (nmod)
nausea anorexia (conj)
support studies (nmod)
process disease (compound)
vessels coronary (amod)
atropine of (case)
dismutase catalase (conj)
form carbonate (nmod)
glands in (case)
effect polydipsia (nmod)
accelerated synthesis/turnover (dobj)
adjacent hematoma (nmod)
have cytotoxicity (dobj)
head neck (conj)
produces anemia (dobj)
hemoglobin autoantibody (conj)
chemosensitive relatively (advmod)
medline including (case)
degree degree (conj)
x 100)/total (punct)
reported improve (xcomp)
pericarditis of (case)
treated followed (advcl)
discribed is (auxpass)
mechanisms cellular (amod)
p=0.026 ( (punct)
erythrocytes of (case)
years past (amod)
prevent that (nsubj)
develop mice (nsubj)
greater analysis (nsubj)
seizures recurrent (amod)
identified half (nmod)
compared or(adj (nmod)
imply . (punct)
induction tachyarrhythmia (nmod)
interaction anesthetics (nmod)
had ability (dobj)
diameters/bw and (cc)
placebo timolol (appos)
expression gene (nmod)
rats 10-month-old (amod)
day cyclophosphamide (conj)
bche plasma (compound)
mixture mg/kg (dep)
need psychologists (nsubj)
delineated findings (nsubjpass)
stable counts (nsubj)
complications dyskinesia (nsubj)
acid dipyridamole (conj)
mapping epicardial (amod)
microinjected hyperactivity (nmod)
time immobility (compound)
subtle mild (advcl)
back baseline (nmod)
affected indicating (advcl)
treatment bevacizumab/irinotecan (nmod)
manage operations (nmod)
months end (dep)
received kanamycin (dobj)
test retention (compound)
double-immunolabeling 7h6 (nmod)
light with (case)
crf % (appos)
amount as (cc)
changes cholesterol (nmod)
history patient (nmod:poss)
centers health (compound)
times induction (compound)
bisphosphonate alendronate (appos)
mg deciliter (nmod)
used a (det)
effect % (conj)
groups rats (appos)
doses ng/mouse (nmod)
toxicity gi (compound)
$ROOT$ minutes (sent)
ml per (case)
tended and (cc)
mortality high (amod)
difference any (det)
need a (det)
diagnosed data (nmod)
monitored care (nmod)
saline- or (cc)
model canine (amod)
monotherapy 5-mg (amod)
correlated less (advmod)
properties neurochemical (amod)
peptide natriuretic (compound)
cardiomyopathy apical (amod)
from day (nmod)
year first (amod)
induced quetiapine (nmod)
reaction was (cop)
carried ) (punct)
antitussives over-the-counter (amod)
literature related (amod)
$ROOT$ addressed (sent)
attack tremor (conj)
she and (cc)
replaced had (aux)
dose-dependent are (cop)
day 13th (amod)
depends . (punct)
comprised histology (nsubj)
exposed or (cc)
revealed questioned (advcl)
rats pretreated (amod)
tests taking (advcl)
prophylaxis anticonvulsive (amod)
indicate showed (ccomp)
transplants of (case)
more enlarged (advcl)
unrelated intake (nsubj)
occasions four (nummod)
sufferers migraine (nmod)
deletion common (amod)
neonate 's (case)
platelets of (case)
dynamics shunt (conj)
effects postoperative (amod)
observations these (det)
dose piroxicam (nmod)
12/32 ) (punct)
yr three (nummod)
importance : (punct)
h(3)-receptors histamine (compound)
presentation report (appos)
146 7 (conj)
group receiving (acl)
boluses three (nummod)
designed research (nmod)
related susceptibility (nsubj)
was start (nmod)
dose large (amod)
when ) (punct)
use pethidine (nmod)
enhancement pronounced (amod)
procoagulant pathways (dep)
indistinguishable symptoms (nsubj)
female ) (punct)
blocked not (neg)
derivatives other (amod)
women osteopenia (nmod)
action for (case)
monitor starting (advcl)
associations face-name (compound)
amounts and (cc)
lesions lv (compound)
experiments antibody (compound)
analyse , (punct)
glycosuria ( (punct)
is pressure (attr)
autism with (case)
mice /+ (amod)
ng/kg/min 10 (nummod)
withdrawal , (punct)
reducing effectively (advmod)
questionnaires . (punct)
develop that (nsubj)
fraction conjugated (amod)
% to (dep)
concentration effective (amod)
courses of (case)
$ROOT$ evaluates (sent)
role plays (acl:relcl)
potentials ample (amod)
isoproterenol delivered (acl)
damage renal (amod)
surgery life-saving (compound)
equal to (case)
depression mv (dep)
sma ) (punct)
dipping assessed (acl)
tumours of (case)
percentage greater (amod)
had 1b (dobj)
cocaethylene , (punct)
required factor (dobj)
surface on (case)
virtue efficacy (nmod)
thrombo-embolism ) (punct)
showed contained (ccomp)
use year (nmod:poss)
i(f)-generating hcn4 (conj)
death induced (acl)
3 20 (prep)
tumor mesenchymal (compound)
anomaly with (case)
% 38.6 (nummod)
before , (punct)
suggests produce (ccomp)
investigated examining (advcl)
calcium mg/day (appos)
albumin less (amod)
gds 9 (dep)
administration dox (compound)
breeder from (case)
predominance extremities (nmod)
predated , (punct)
response sympathetic (amod)
interval 32.4 (appos)
level pyridoxal (nmod)
affected score (nsubjpass)
administration lorazepam (nmod)
lesion massive (amod)
infarction women (nmod)
used tolerated (conj)
antagonist 4-damp (dep)
$ROOT$ disappointing (sent)
neurotoxicity disease (conj)
triceps the (det)
years . (punct)
gln223 between (case)
have cells (nsubj)
suggests factors (ccomp)
initiated ; (punct)
cardiac morphological (amod)
anticancer or (cc)
high 2.35 (dep)
nigra of (case)
disorders blood (compound)
usually responses (nsubj)
il-1 of (case)
circumstances some (det)
aroused was (auxpass)
administered subjects (nsubjpass)
improve hydroxytyrosol (nsubj)
= .14 (dep)
seizures events (conj)
electroretinography erg (appos)
days 1.37 (nummod)
mechanism potential (amod)
determined spread (nsubjpass)
risk precipitating (advcl)
confound effects (nsubj)
proof that (mark)
1 12 (prep)
revealed suggesting (advcl)
2.85 - (punct)
black 291 (nummod)
dyskinesias contralateral (amod)
preceded except (prep)
disorder 2 (appos)
close cns (nmod)
subanalyses rcts (nmod)
administration . (punct)
reversible completely (advmod)
patients died (acl:relcl)
test meal (compound)
defects patient (nmod)
enhanced bradycardia (nmod)
mydriasis tremor (conj)
bacl2 chloroform-adrenaline (conj)
desogestrel for (case)
2e1 isoform (conj)
two , (punct)
fluphenazine . (punct)
fc gfc (appos)
complexes ventricular (amod)
animals control (compound)
mb with (case)
egfp-microglia unresponsive (amod)
herbal homeopathic (conj)
recording entire (amod)
$ROOT$ diuretics (sent)
clinics outpatient (amod)
factors perinatal (amod)
analysis stepwise (amod)
activation the (det)
granulocytopenia grade (compound)
progesterone pregnane-20-ones (appos)
evaluated anemia (nmod)
beginning before (mark)
undergoing angiography (dobj)
trial open-label (amod)
breakdown their (nmod:poss)
cyanosis and (cc)
% 80 (compound)
results diagnosed (appos)
division first (amod)
hg to (case)
potentials denervation (compound)
ly274614 antagonist (dep)
ethanol ) (punct)
reported man (nmod)
neoantigens detected (acl)
available recently (advmod)
has blockade (dobj)
fla838 ncm001 (conj)
derivatives the (det)
that lidocaine (nmod)
led observation (nsubj)
gspe 's (case)
given before (advmod)
percentage this (det)
levobupivacaine epinephrine (nmod)
pathology due (case)
derivatives beta-alanyl (compound)
removed were (auxpass)
effects trihexyphenidyl (nmod)
confounds toxicity (nsubj)
animals the (det)
effects sedation (nmod)
interferes signals (nmod)
diseased and (cc)
dex-ht ) (punct)
cause sole (amod)
man 45-year-old (amod)
usage human (amod)
ouabain inhibitor (appos)
administered sessions (nmod)
evaluation laboratory (compound)
evoked concentration (nsubj)
take part (dobj)
percent forty-nine (nummod)
damage neurons (nmod)
demonstrated caused (xcomp)
outflow centre (nmod)
recovery values (nmod)
contents its (nmod:poss)
< mean (dep)
elevations serum (nmod)
completed , (punct)
chain transfer (compound)
objective determine (dep)
instituted pacing (nsubj)
allocated and (cc)
control effect (nmod)
subjects 11 (nummod)
mg/kg thiopental (appos)
administering of (mark)
disease thyroid (compound)
therapies combination (compound)
trigeminal parasympathetic (conj)
reversed ; (punct)
fasciculations score (conj)
obtained parameters (nsubjpass)
fibrillation response (nmod)
increase aggravation (nmod)
effect drugs (nmod)
monitor nephrotoxicity (dobj)
derived ventilation (dobj)
encephalopathy : (punct)
dose-limiting potentially (advmod)
33 x (cc)
malaysians disease (nmod)
less mol/l. (nmod)
hypotension caused (acl)
little or (cc)
2.75 - (punct)
seen block (nsubjpass)
cad ) (punct)
chx ( (punct)
profile pharmacological (amod)
survival worse (amod)
established moreover (advmod)
incidence between (case)
mg/kg i.p. (dep)
discontinued . (punct)
series eight (nummod)
derives derives (conj)
hsct ) (punct)
p=0.003 ; (punct)
globulin globulin (conj)
year with (case)
investigated setting (nmod)
4.40 to (case)
blockers and (cc)
population insured (amod)
results between (case)
lipid with (case)
clinic n (dep)
re-observed embryos (dobj)
cisapride daily (advmod)
tests groups (nmod)
dextrose of (case)
result emergence (nmod)
naloxone the (det)
amphetamine or (cc)
examines affects (ccomp)
sustained treatment (nmod)
secretion tubular (amod)
pbo ( (punct)
degrees isopter (nmod)
glepp1 of (case)
age ( (punct)
access(r and (cc)
taken therefore (advmod)
breath one (nummod)
electrocardiogram.3 of (case)
agonists other (amod)
eight four (compound)
hr mg (nmod)
was observe (xcomp)
rats lesions (nmod)
0.60 ( (punct)
shortening fs (appos)
group -cimetidine (appos)
consuming after (mark)
difficulties anticoagulation (nmod)
complained patients (advcl)
stable months (nmod)
treated treated (conj)
developed deficit (nsubj)
raised contrast (nmod)
have component (nsubj)
set up (compound:prt)
available , (punct)
correlated increase (nmod)
attenuated improving (advcl)
cases many (amod)
influenced mammals (nmod)
saline-treated 1ml/kg (dep)
fulfilled headache (nsubj)
characterized microscopy (nmod)
outflow sympathetic (amod)
due warfarin (nmod)
using perfusion (dobj)
made first (dep)
butyrylcholinesterases bches (appos)
evidence beta-blockade.8 (nmod)
means a (det)
has treatment (nmod)
induce why (advmod)
fenoldopam theophylline (conj)
rechallenge including (case)
present day (nmod)
had had (aux)
db by (case)
examined patients (nmod)
decreases intake (dobj)
responses hemodynamic (amod)
expression nrf2 (nmod)
diagnosis mc (appos)
rs4704559 for (case)
complication not (neg)
infection human (amod)
hypotension . (punct)
combination acid (nmod)
kpa 0.0 (nummod)
state with (case)
aggressiveness apomorphine-induced (amod)
levels testosterone (compound)
register patients (nmod)
ccb ( (punct)
sign be (cop)
thereafter immediately (advmod)
occasions separate (amod)
suggests modulates (ccomp)
underwent and (cc)
reaction toxic (amod)
toxicity association (dep)
azathioprine with (case)
toxicity meloxicam-induced (amod)
unpleasant pain (nsubj)
hypotension (snp)-induced (punct)
seen women (nmod)
neurons mrna-containing (amod)
medications diet (compound)
self-reported positive (conj)
components pathway (nmod)
amplitude in (case)
range to (case)
bladder near (case)
emulsions with (case)
study electrodiagnostic (amod)
mg 4 (compound)
% compared (advcl)
felt later (advmod)
exposure , (punct)
cavity found (acl)
rats bilateral (amod)
recalled prior (advcl)
maintained doses (nmod)
dose mg/kg (appos)
permeability ultrastructure (conj)
resulting irritability (nmod)
administration capsaicin (nmod)
patterns cycle (nmod)
modulate , (punct)
morphine doses (nsubj)
point normality (nmod)
disorder cardiomyopathic (amod)
schedule , (punct)
found reverse (xcomp)
nra0160 and (cc)
troponin i (dep)
intralipid epinephrine (conj)
nucleus area (conj)
exhibited ; (punct)
protected not (neg)
care critical (amod)
reproducible and (cc)
sensitivity lower (amod)
kg-1 kg-1 (conj)
use acid (nmod)
limitations activity (nmod)
involves , (punct)
symptoms akinetic (amod)
systolic on (case)
aspects specific (amod)
damage formation (nmod)
responsiveness precursors (nmod)
carried challenges (dobj)
pathophysiology common (amod)
found had (ccomp)
returned discontinued (advcl)
cl % (compound)
investigated that (mark)
nr1(neo-/- , (punct)
ymdd ) (punct)
was exhibiting (advcl)
dose hr (nmod:npmod)
woman-years 10,000 (nummod)
survivors doxorubicin-treated (amod)
history reactions (nmod)
applicability its (nmod:poss)
withdrawal following (case)
loss neuron (compound)
naloxone pre- (amod)
increase evaluation (conj)
cycles ( (punct)
treatment before (nmod)
ranks signed (compound)
organisms pseudomonas (compound)
effect atropinic (amod)
followed we (nsubj)
associated proteinuria (nmod)
pt ) (punct)
chorionic edema (conj)
58.3 of (case)
better to (mark)
nacc ( (punct)
steatosis including (case)
hypotension marked (acl:relcl)
decreasing damage (dobj)
failure cocaine-related (amod)
db 2 (nummod)
increased diameters/bw (nsubj)
alter cpap (nsubj)
cells bone (compound)
parasympathetic cranial (amod)
effects hours (nmod)
levels vldl (nmod)
pretreatment 6-hydroxydopamine (nmod)
examined tissue (nsubjpass)
agonists the (det)
used sets (nsubjpass)
downregulation including (case)
relevancy its (nmod:poss)
rechallenged , (punct)
hypertension hallucinations (conj)
stabilized integrity (nsubjpass)
users = (dep)
weight gland (compound)
given flunitrazepam (nsubjpass)
impaired task (nmod)
performing review (dobj)
quinolones defect (appos)
development impairment (nmod)
child undergoing (acl)
prodrug 5-fu (nmod)
dyskinesia caused (acl)
i(f ( (punct)
regimen methamphetamine (compound)
clipping artery (nmod)
neurotoxic , (punct)
decreases if (mark)
duration intensity (conj)
valsartan hydrochlorothiazide (conj)
leukaemia mulv (appos)
occurring samples (nmod)
aimed studying (advcl)
duct acute-onset (amod)
assessed work (nmod)
association longitudinal (amod)
started lost (advcl)
selection genetic (amod)
$ROOT$ material (sent)
hds ) (punct)
patients 7 (appos)
frequency installation (nmod)
pcr taqman (amod)
tablet mg (appos)
ptu to (case)
aniracetam of (case)
showed lesions (dobj)
mg/kg ato (appos)
analgesia peripheral (amod)
modify progression (dobj)
potent more (advmod)
associated publications (nmod)
form aerosol (compound)
biopsy in (case)
killed mcao (nmod)
have equipotent (conj)
obtained mouse-1 (nmod)
pressure effects (conj)
nephrotoxicity to (case)
investigate caused (ccomp)
l min (appos)
mg primarily (advmod)
lymphocytes t (compound)
activity cytochrome (compound)
fess ( (punct)
activity dose (nmod)
effect side (amod)
transplantation to (case)
consider clinicians (nsubj)
dependent hippocampal (nmod:npmod)
view to (case)
supplementation phosphate (compound)
values ecg (compound)
microalbuminuria mice (nmod)
induced heart (nmod)
discontinuing and (cc)
myocytes adult (amod)
objectives estimate (acl)
identified rats (nmod)
hospitalisation effects (nmod)
types of (case)
paroxetine mg/day (appos)
food from (case)
remained animals (nmod)
presented % (nsubj)
pointes torsade (compound)
mediate proteins (nsubj)
suppressed startle (dobj)
fatal . (punct)
hemorrhaging detachment (conj)
amnesia the (det)
dependence voltage (compound)
sites from (case)
supersensitivity receptor (compound)
fenoldopam by (case)
effects dihydrochloride (nmod)
freezing " (punct)
toxicity dlt (appos)
vasorelaxation and (cc)
risk relation (conj)
motility in (case)
numbers levels (conj)
na+-extrusion depressed (amod)
preparations canine (compound)
d-penicillamine treatment (nmod)
cause levels (nsubj)
revealed difference (dobj)
activated pathway (nmod)
penetration meningitis (nmod)
discontinued changed (conj)
system vehicle (compound)
pallidotomy : (punct)
present present (advcl)
anophthalmia lip (conj)
decreased phosphorylation (dobj)
administration three (nummod)
fluoropyrimidines , (punct)
tensions fatigability (conj)
10 5 (nummod)
relationship occurrence (nmod)
week not (neg)
permeability on (case)
one from (case)
akbr ) (punct)
neuropathy thalidomide-induced (amod)
betaxolol ( (punct)
contractility normal (amod)
misjudgment paramedic (compound)
dexmedetomidine doses (nmod)
consumption food (compound)
results histopathological (amod)
cure transplantation (nmod)
signal peripheral (amod)
clearance rapid (amod)
lisinopril low-dose (amod)
concentration diluent (nmod)
dce mg/kg (appos)
beta-carboline-3-carboxylate , (punct)
uridine urd (appos)
method completed (appos)
infusion dextrose (compound)
$ROOT$ therapies (sent)
provided statistics (nsubjpass)
blot western (compound)
amplitude nerve (nmod)
evoke contrast (nmod)
is evaluate (xcomp)
diisopropylfluorophosphate , (punct)
morphology kidney (nmod)
body foreign (amod)
shift parallel (amod)
methimazole and (cc)
feature disease (nmod)
memory dependent (amod)
result interactions (nsubj)
associated score (nsubjpass)
$ROOT$ decayed (sent)
demonstrated , (punct)
defects eligible (amod)
nsaids , (punct)
effects metoprolol (nmod:poss)
diseases underlying (amod)
demonstrates confined (ccomp)
clotiazepam , (punct)
improved are (auxpass)
anemia nonregenerative (amod)
discontinuation nd-nmbas (nmod)
% 0.5 (compound)
contributes : (punct)
develop embryos (nsubj)
occurred enlargement (nsubj)
gating , (punct)
regimen vtd (compound)
1 0.01 (compound)
po one (nummod)
hypertension established (amod)
antiplatelet beta-blocker (conj)
highlight report (nmod)
administration clioquinol (nmod)
rescues it (nsubj)
narrowing arteries (nmod)
months six (nummod)
assessment treatment (nmod)
induction mt (compound)
gynecomastia and/or (cc)
transmission serotoninergic (amod)
users polydrug (amod)
= 0.05 (dobj)
higher it (nsubj)
measured , (punct)
excretion the (det)
sensorium of (case)
is role (attr)
ligands receptor (nmod)
cancers or (cc)
accepted generally (advmod)
period 15-minute (amod)
groups volunteers (nmod)
14 8 (compound)
differences parameters (nmod)
symptoms quetiapine (nmod)
substitutes chlorofluorocarbons (nmod)
formation , (punct)
underwent electrocardiography (dobj)
$ROOT$ pheochromocytoma (sent)
had specimen (nsubj)
loss fields (conj)
cells erythroid (amod)
day 26 (nummod)
region catecholaminergic (amod)
induced-behaviour cocaine (compound)
model an (det)
evaluated blotting (nmod)
ml methylprednisolone (nmod)
effect serious (amod)
observations . (punct)
regimens cytostatic (amod)
oncology in (case)
2,682,2,803 ( (punct)
prevented did (conj)
fat periorbital (amod)
induces hypertrophy (dobj)
syndrome severe (amod)
induce myopathy (dobj)
results loss (nmod)
affect movement (dobj)
mice suffering (acl)
time-dependent dose-related (conj)
epilepsy tle (appos)
channels cardiac (amod)
78 - (punct)
alterations in (case)
ng/mouse of (case)
infections cyclosporine (nmod)
activity a (det)
precipitated that (mark)
occurs syndrome (nsubj)
less : (punct)
effects of (case)
protection in (case)
due blockade (nmod)
grade have (aux)
pool post-lesion (amod)
dysfunction prednisolone-induced (amod)
predominate to (mark)
potentiated be (auxpass)
patients refractory (acl:relcl)
outcome earlier (amod)
pressure low (amod)
experimental control (conj)
descent of (case)
dependence heroin (compound)
overlooked are (auxpass)
glands harderian (amod)
demonstrated mri (nsubj)
qs/qt ( (punct)
higher level (nsubj)
output increased (amod)
ctnt mass (conj)
patients most (amod)
related disruption (nmod)
introduction zonisamide (nmod)
ph ; (punct)
compared one (nmod)
developed manner (nmod)
actions systems (nmod)
had occurred (ccomp)
mitoxantrone 5-fluorouracil (conj)
december 28 (nummod)
sensitivity resistance (conj)
markers injury (nmod)
prl-r and (cc)
ml/min 0.27 (nummod)
april to (case)
agitation to (case)
thyroidectomy and (cc)
upregulated and/or (cc)
protects neurons (dobj)
saline- normal (amod)
groups one (appos)
reached targets (nsubjpass)
induce moran (dep)
ketanserin ( (punct)
caused manner (nmod)
generation stress (conj)
transplanted 1999 (nmod)
reversed scopolamine (nsubj)
startle fear-potentiated (amod)
reaction syndrome (nsubj)
conducted up (prep)
lca at (case)
review retrospective (amod)
rats both (cc:preconj)
using ketoconazole (dobj)
shr both (det)
exposure following (case)
hepatic brain (conj)
contraindication some (det)
analyzed when (advmod)
affected narcosis (dobj)
tissue on (case)
hexabrix , (punct)
models suitable (amod)
possibly , (punct)
preservation hypotension (nmod)
concordance autism (nmod)
animals n (dep)
was core (nmod)
co. , (punct)
required occurred (conj)
nucleus caudate (compound)
arterial subdural (conj)
disease ischemic (amod)
similar hyperactivity (nsubj)
because paralysis (nsubj)
agent iodinated (amod)
6.2 vs. (cc)
suppressants to (case)
disappearance symptoms (nmod)
sulfonylurea second-generation (amod)
gaze of (case)
overdose venlafaxine (compound)
ischemic , (punct)
justified may (aux)
metabolite acid (appos)
desipramine and (cc)
recognized disappearance (nsubjpass)
acidosis post-transplant (amod)
interviewing and (cc)
early or (cc)
dinitrate mg (appos)
thrombin acid (conj)
model rats (nmod)
micronuclei observed (acl)
hormone luteinizing (amod)
rodents dogs (conj)
animals 20 (nummod)
increased potent (conj)
use acetaminophen (nmod)
disappeared complaints (nsubj)
inducibility no (neg)
olanzapine clozapine (conj)
involve understood (advcl)
forestomach bladder (conj)
9 178 (prep)
2.5 of (case)
examined focusing (advcl)
occurred myositis (nsubj)
cancer stage (dep)
emergence tacrolimus (nmod)
components subcellular (amod)
stopped progression (nmod)
safety drug (nmod)
bonding hydrogen (compound)
1.3 ratios (nsubj)
observed intake (nmod)
revealed have (aux)
amoxicillin-clavulanate the (det)
physicians to (case)
increase maximum (amod)
demographic 15 (nummod)
decreased l-dopa (nsubj)
induced stz (nmod:npmod)
managed however (advmod)
119 2 (conj)
fractions to (case)
duration similar (amod)
potentiation central (amod)
scan head (nmod)
hbsag positive (amod)
0.38 ( (punct)
uses multiple (amod)
week abstinence (nmod)
cyclosporine of (case)
diagnostic rapid (amod)
commenced , (punct)
have hyperbilirubinemia (dobj)
agents used (acl)
nsaid group (dep)
that discontinued (conj)
tolerable . (punct)
biochemistries the (det)
fibrotic densely (advmod)
$ROOT$ gain (sent)
ngf of (case)
pretreatment alpha-methyltyrosine (nmod)
reduced mg (nmod)
measuring amount (dobj)
examined day (nmod)
recognized reactions (nsubjpass)
stn the (det)
antithrombin iii (appos)
arabic together (advmod)
wky in (case)
receiving hemodialysis (dobj)
stress cardiotoxicity (nmod)
used infusion (nmod)
tdi before (nmod)
increased it (nsubj)
disease myopathic (amod)
provided evidence (nsubj)
april october (nmod)
resuscitations of (case)
potent to (mark)
vessels epicardial (amod)
response acid (nmod)
consciousness . (punct)
foods spicy (amod)
result comparisons (nmod)
negative was (cop)
provide , (punct)
materials radiographic (amod)
basis studies (nmod)
ketamine after (case)
doses aniracetam (compound)
treatment adriamycin (compound)
those schizophrenia (nmod)
recognized be (auxpass)
rh ( (punct)
resulted combination (nsubj)
supplement surgery (nmod)
reabsorption percentage (compound)
costs implants (nmod)
action central (amod)
arthralgia ( (punct)
dissolution actin (compound)
secondary ) (punct)
implemented commonly (advmod)
exhibited rearing (dobj)
dose dxr (compound)
therapy antiplatelet (amod)
examine response (dobj)
g/m2 were (cop)
$ROOT$ prolongation (sent)
enhances subjects (nmod)
patients 95 (nummod)
had myocarditis (dobj)
studied assess (advcl)
methoxamine intravenous (amod)
allele apoe (compound)
children tumor (nmod)
clinic at (case)
test aggregation (compound)
density sites (nmod)
agent efficacious (amod)
tasks motor (amod)
rash aplasia (conj)
membrane plasma (compound)
diminished sensation (nsubjpass)
diabetes with (case)
have crf (dobj)
effects (+)-cibenzoline (nmod)
therapy hctz (compound)
injection penicillin-g (compound)
those rofecoxib (nmod)
patients twenty-seven (nummod)
state dyskinetic (amod)
given consideration (nsubjpass)
10.7 ( (punct)
3 5 (conj)
develops . (punct)
vlbw g (appos)
0.86 0.15 (conj)
30mg/kg 3 (nummod)
subjected episodes (nmod)
complications on (case)
recruited months (nmod)
model cystitis (nmod)
fraction level (conj)
show useful (ccomp)
patients affected (amod)
density volume (compound)
volume exercise (conj)
norway brown (compound)
workers had (acl:relcl)
rats by (case)
unremarkable , (punct)
fall minutes (nmod)
dysfunction carbamazepine-induced (amod)
arrhythmia patient (nmod)
infiltration leukemic (amod)
105 of (advmod)
able tri (nsubj)
eradication infiltration (nmod)
those abnormalities (nmod)
stereotypy dexamphetamine (compound)
was group (nmod)
sinensis of (case)
mistaken can (aux)
models all (predet)
doses separate (amod)
types arrhythmias (nmod)
time later (amod)
greater g/m2/d (nmod)
aida ( (punct)
open is (cop)
received however (advmod)
juice or (cc)
shifts in (case)
increase neither (cc:preconj)
screened cases (nsubjpass)
comparison recordings (nmod)
= 22 (dobj)
electroencephalogram an (det)
detected patients (nmod)
led forms (nsubj)
pethidine plasma (compound)
influenzae pathogens (nsubj)
test influence (dobj)
injection humans (nmod)
increased co-administration (nmod)
dyskinesia phenobarbital-induced (amod)
two just (advmod)
micrograms 38.9 (nummod)
fluoxetine plus (cc)
interval monoher (nmod)
schlemm of (case)
1.63 ) (punct)
middle or (cc)
97.1 score (nsubj)
episodes by (case)
find factors (dobj)
potent respectively (advmod)
hypotension e1-induced (amod)
severity disease (conj)
loss exhaustion (conj)
sample small (amod)
monitoring levels (nmod)
patients 177 (nummod)
rats = (dep)
susceptible course (nmod)
toxicity acetaminophen (nmod)
name syndrome (dobj)
osmolality maximum (amod)
clearance plasma (compound)
agency mhra (appos)
tissue or (cc)
obtained 4 (dep)
levels based (case)
rare conclusion (nmod:npmod)
nuclei cells (nmod)
c. s. (compound)
dexatrim cause (nmod)
reserpine by (case)
space within (case)
39.6 vs. (cc)
11 , (punct)
hypothesis by (case)
contribution synthesis (nmod)
crisis with (case)
pain mechanical (amod)
role detection (nmod)
determined although (mark)
sera the (det)
= 4941 (dobj)
normalization interval (nmod)
sertraline of (case)
injury melphalan (nmod)
producing dysfunction (dobj)
changes histologic (amod)
pneumonia ptld (conj)
alleviate to (mark)
inhibitor known (acl)
revealed hyperinsulinemia (dobj)
conducted evaluate (xcomp)
described paralysis (nsubjpass)
symptoms neurologic (amod)
cause loss (nmod)
greater effect (nsubj)
mapped correlated (conj)
intensity from (case)
orr % (nmod)
cost at (case)
exacerbates . (punct)
patients lid (nmod)
noncompliance death (appos)
output both (cc:preconj)
pb by (case)
developed effects (dobj)
begun sequence (nsubjpass)
rats 2 (nummod)
resulted enflurane (nsubj)
mg 1 (compound)
mortality on (case)
included first (nsubj)
experiencing akathisia (dobj)
wk after (case)
$ROOT$ inconclusive (sent)
readjustment by (case)
delay conduction (compound)
flumazenil fl (appos)
4107 respectively (advmod)
therapy antithyroid (amod)
changes lids (nmod)
immunization of (case)
1.35 2.10 (appos)
findings absence (dep)
dihydrochloride n'-dibenzhydrylethane-1,2-diamine (compound)
maleate nmda-receptor (compound)
intoxications during (case)
important that (mark)
likely result (xcomp)
features administration (nmod)
diminish apoptosis (dobj)
10 9 (compound)
caused effects (dobj)
operative have (aux)
equal or (cc)
tissue brain (compound)
placed to (mark)
agent known (acl)
magnitude not (neg)
function function (conj)
mechanism(s leading (acl)
subjects 65 (nummod)
system through (case)
infarcts use (nmod)
followed therapy (nmod)
levobupivacaine of (case)
neurotoxicity increased (amod)
admitted : (punct)
arises whether (dep)
investigated patients (dep)
focussed women (nmod)
been resurgence (attr)
define to (mark)
treatment response (dep)
infants very-low-birth-weight (amod)
isomer dextrorotatory (amod)
attacks of (case)
reversed which (nsubjpass)
lw ( (punct)
medication epinephrine (nmod)
treated sub-chronically (advmod)
increased gentamicin (nsubj)
lots commercial (amod)
deaths apoptotic (amod)
derangements the (det)
mice gene-targeted (amod)
group chlorpheniramine (compound)
mg 3.75 (nummod)
considered telaprevir (nsubjpass)
nadph-d ) (punct)
induced solution (advcl)
embryos mouse (compound)
dph ( (punct)
samples only (advmod)
adopted were (auxpass)
bmd radius (nmod)
exceed dose (nmod)
concentrations between (case)
nitroglycerin , (punct)
rates post-discharge (nmod)
reported frequently (advmod)
eyes isolated (amod)
changes new (amod)
changes sustained (amod)
derivative similar (amod)
schedule dose (compound)
suitable : (punct)
reversed melatonin (nsubj)
agonist 3r-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane (appos)
attenuates deficits (dobj)
conclusions reinforces (dep)
patients those (conj)
indices biochemical (amod)
cardiotoxicity adr (compound)
found period (nmod)
days 107 (parataxis)
caries ) (punct)
disorder demyelinating (amod)
predisposes obstruction (nmod)
i.p. ( (punct)
nightmare : (punct)
reactions such (amod)
found compared (advcl)
protein crp (appos)
interviewing include (conj)
difference potency (nmod)
effects ocular (amod)
fasciculations during (case)
knife leksell (compound)
years 53.9 (nummod)
min time (nsubj)
patients using (acl)
sweating ( (punct)
busulfan : (punct)
exercise-isoproterenol the (det)
mechanisms , (punct)
$ROOT$ sources (sent)
subtype receptor (nmod)
complications or (cc)
0.5 4.78x (conj)
tendency of (case)
disorder neurodevelopmental (amod)
received 2 (dep)
compartment into (case)
amoxicillin to (case)
regimen tolerated (amod)
changes relation (nmod)
sulfate tobramycin (compound)
concentration u/l (nmod)
used was (auxpass)
hydrochloride mg/day (appos)
91 12 (compound)
elevated average (nmod)
neurotoxicity severe (amod)
reason this (det)
appearance convulsions (nmod)
compatible interference (nmod)
reduction dose-dependent (amod)
recovered patients (nsubj)
difficult hazardous (conj)
posturing twitching (conj)
treatment as (cc)
processing working (amod)
factor development (nmod)
urticaria conjunctivitis (conj)
underwent block (nmod)
performed poorer (advmod)
ototoxicity against (case)
3tc . (punct)
cephalosporins defect (appos)
higher 60 (nmod:npmod)
determine vulnerable (ccomp)
cholestasis ligation (nmod)
therapy 's (case)
barrier through (case)
seen evidence (nsubjpass)
need undergo (xcomp)
considered patient (nsubjpass)
mg/kg 50/12.5 (nummod)
degree by (case)
ceased remained (conj)
animals had (acl:relcl)
v2.0 hbv (compound)
monitoring and (cc)
disruption homoeostasis (nmod)
primers with (case)
administration labetalol (compound)
accumulation triglyceride (nmod)
reflect activity (nsubj)
reaction long-lasting (amod)
stage upon (case)
density inhibition (conj)
increase mg (appos)
component increases (acl:relcl)
presence damage (nmod)
vasopressin of (case)
induces or (cc)
thrombosis left (amod)
recorded score (nsubjpass)
available reverse (xcomp)
number bfu-e (nmod)
discussed be (auxpass)
% auc (nmod)
metformin by (case)
hit and (cc)
medication unrelated (amod)
sedentary-isoproterenol s-i (appos)
enrolled accl0131 (nmod)
framework caused (acl)
surface water (compound)
disease endometrial (amod)
effects man (nmod)
62 of (advmod)
practical economic (conj)
reduced had (advcl)
distribution clearance (conj)
proteins the (det)
studies control (compound)
developed manifested (conj)
objective evaluated (appos)
venous , (punct)
0.2 0.4 (conj)
8 to (quantmod)
mg/kg/day 60 (nummod)
sequence because (case)
normal it (nsubj)
deaths group (nmod)
areas face (nmod)
affected confounding (nmod)
appears 1mg/kg (xcomp)
to as (mark)
application upon (case)
nephrotoxicity on (case)
receiving bsa (dobj)
chemotherapy thiotepa (nmod)
hypoactivity locomotor (amod)
pre-treatment , (punct)
secretion in (case)
accounts , (punct)
60.44 +/- (cc)
account symptoms (nmod)
factors cardiovascular (amod)
background involve (dep)
that risk (nmod)
reversal hyperalgesia (conj)
high have (aux)
mortality or (cc)
mrna rats (nmod)
mdma from (case)
involve fibers (dobj)
hips-cms using (acl)
component hemolytic (amod)
activity postsynaptic (amod)
recorded grade (nsubjpass)
torr 83 (nummod)
bradycardia reflex (amod)
studies the (det)
beats/min to (case)
level peroxides (nmod)
micrograms.kg-1.min-1 10 (nummod)
% infections (nmod)
$ROOT$ prepared (sent)
afternoon the (det)
occurred proportion (nmod)
found culture (nmod)
degree 2 (nummod)
stimulation 2-hz (amod)
preventing impairment (dobj)
included parameters (nsubj)
enhances which (nmod)
pregnancy before (case)
pretreatment l-noarg (nmod)
torr 78 (nummod)
lower weights (nsubj)
artery an (det)
undertaken also (advmod)
kaposi 's (case)
treatment overdose (nmod)
was = (parataxis)
naloxone post-training (amod)
mice morphine-treated (amod)
splenic and (cc)
injection administration (nmod)
hyperprolactinemia changes (conj)
thyroxine ft4 (appos)
mg 90 (nummod)
preference aggression (conj)
heterogeneous that (mark)
analysed patterns (nmod)
population hematology/oncology (compound)
symptoms for (case)
impairment death (conj)
ctnt r=0.81 (dep)
duration clearance (conj)
mmol/l p<0.05 (appos)
patients l-dopa-treated (amod)
db change (nsubj)
cancer chemotherapy-responsive (amod)
improvement parameters (nmod)
rats mice (conj)
drugs pretreatment (amod)
encephalopathy reaction (nmod)
reached levels (nsubj)
problem : (punct)
report failure (nmod)
studied vitro (advmod)
data recordings (conj)
hypotension treated (acl)
latency rem (compound)
nephrotoxicity because (case)
rofecoxib naproxen (conj)
alterations alterations (conj)
preservation subsequent (amod)
sites cholinoceptive (amod)
restored patients (nmod)
associated . (punct)
normal level (nsubj)
rats charles (compound)
cardiomyopathy human (amod)
approach shelf (dobj)
variety indications (nmod)
nuclei from (case)
% hbig (nmod)
dialysis transplantation (nmod)
drugs anesthetic (amod)
patients : (punct)
reduced % (dep)
double-blind randomized (dep)
experienced not (neg)
controlling in (mark)
s 557 (nummod)
modification regimen (nmod)
cells tubule (compound)
lesions to (case)
wavefronts simultaneous (amod)
obesity , (punct)
4'-0-tetrahydropyranyladriamycin intravenous (amod)
prescribed he (nsubjpass)
promoted that (mark)
call risk (nmod)
severe months (nmod)
alprazolam to (case)
drugs effective (amod)
interventions and (cc)
appears mechanism (xcomp)
min-1 beat (compound)
sections of (case)
cessation despite (case)
found groups (nmod)
environment to (case)
fat % (amod)
defined be (auxpass)
neoplasms and (cc)
determined activity (dobj)
caffeine after (case)
complexes of (case)
elicited decrease (dobj)
drug antiinflammatory (amod)
episodes recipients (nmod)
epsilon4 and (cc)
function survivors (nmod)
cortical renal (amod)
dyschromatopsy by (case)
task anticipation (compound)
sessions separate (amod)
optochiasmatic and (cc)
infection the (det)
vacuoles cardiomyocytes (nmod)
ph albumin (conj)
fluid plasma (appos)
spread , (punct)
accident vascular (amod)
moderate % (nsubj)
described are (auxpass)
inflammation more (amod)
unrecognized occur (advcl)
depletion brain (compound)
recalled less (advcl)
showed changes (nsubj)
exacerbation disorder (nmod)
peroxisomes of (case)
lost grafts (nsubjpass)
characteristics and (cc)
failure dialysis (nmod)
showed attenuated (ccomp)
man lymphoma (nmod)
have prevalence (dobj)
lifetime lt (dep)
mice anemia (nmod)
pressure standing (amod)
tracts areas (conj)
trough-concentrations microgram/ml (nmod)
immunohistochemical , (punct)
risk this (nsubj)
syndrome capillary (compound)
option treatment (compound)
recognise physicians (nsubj)
diazepam anaesthesia (conj)
criteria , (punct)
data by (case)
drug nik-247 (nsubj)
approach a (det)
treated tiapride (nmod)
reaction an (det)
surgeon the (det)
fluctuations on-off (amod)
described neuropathy (nsubjpass)
methods standard (amod)
pressures concomitant (amod)
documented not (neg)
rats dehydrated (amod)
microphthalmos hypertelorism (conj)
$ROOT$ related (sent)
reduced presence (nmod)
years age (nsubj)
hemiparesis overdose (nmod)
occurred eight (nsubj)
resuscitation toxicity (nmod)
equipment graphical (amod)
groups study (compound)
group are (cop)
blocks , (punct)
trazodone mg/kg (nmod)
received they (nsubj)
force contractile (amod)
response da (compound)
effects convulsive (amod)
treatment desipramine (nmod)
depletes p300 (dobj)
strokes ischemic (amod)
diphenhydramine oral (amod)
illness pre-lt (amod)
predict development (dobj)
resulted inhibition (nsubj)
peptide cck-5 (dep)
correction greenhouse-geisser (compound)
nephrosis rats (nmod)
jaw ) (punct)
neurotoxicity amphetamine-induced (amod)
change as (cc)
donor no (compound)
effects anti-rigor (amod)
safety effects (conj)
toxicity cystitis (nsubj)
depression ischemic (amod)
exacerbated mj (dobj)
inhibitor alpha-glucosidase (compound)
gave , (punct)
resolved weeks (nmod)
h2 histamine (compound)
component whom (nmod)
fluoxetine or (cc)
da2 ( (punct)
included l. (dep)
episode arrest (nmod)
have index (dobj)
fpd ) (punct)
small agents (nmod)
material methods (conj)
similar evolution (nsubj)
drug mice (nmod)
disease dyskinesias (conj)
inactivation actions (conj)
considered protective (xcomp)
antidotes and (cc)
cholestasis rats (nmod)
features . (punct)
changes developed (acl:relcl)
ketamine with (case)
% 85 (nummod)
ablated and (cc)
effect varying (acl)
isolation cells (nmod)
warning . (punct)
sr antagonist (compound)
increase cell (compound)
properties isomers (nmod)
densa and (cc)
treated sulfate (nmod:npmod)
involvement cardiotoxicity (nmod)
new relatively (advmod)
chemotherapy transplant (nmod)
learning control (conj)
support transplantation (nmod)
tumors granulosa (compound)
observed graded (conj)
hypotension study (dep)
tomography oct (appos)
group fourth (amod)
distribution del (nmod)
warrants disturbances (nmod)
pneumonia were (cop)
considered unlikely (xcomp)
resulted % (nsubj)
17 18 (conj)
processed subsequently (advmod)
consistent vasoconstriction (nmod)
increase expressed (acl)
allow could (aux)
induced kidneys (nmod)
release mediators (nmod)
effect hour (amod)
hg control (nmod)
region , (punct)
present effects (nsubj)
nephropathy salicylate (compound)
-0.62 , (punct)
$ROOT$ prevented (sent)
symptoms syndrome (nmod)
men % (nsubj)
bolus administered (acl)
peritoneum of (case)
reaction carbamazepine (nmod)
complication patients (nmod)
induced shift (dobj)
tetrandrine fangchinoline (conj)
did management (nmod)
introduced recently (advmod)
greater increment (nsubj)
reduces acts (advcl)
generalization propagation (conj)
polydipsia on (case)
sold to (mark)
erythema rush (conj)
taken have (aux)
fviiirag ( (punct)
relevance of (case)
activity weak (amod)
associated cases (nsubjpass)
extensive or (cc)
had both (nsubj)
mes ) (punct)
regions resulting (acl)
therapy clopidogrel (dep)
case as (prep)
weeks were (cop)
find could (aux)
interferon alpha-2b/ribavirin (conj)
1 ) (punct)
induce forestomach (nmod)
indicates . (punct)
incidence formation (nmod)
responder complete (amod)
rate same (amod)
unlikely be (xcomp)
explained results (nsubjpass)
neutropenia of (case)
quantified has (aux)
protease , (punct)
produce could (aux)
results formation (nmod)
intima and (cc)
require support (dobj)
relief pain (compound)
high sufficiently (advmod)
cause psychosis (dobj)
have users (nsubj)
heterogeneity erp (compound)
gain by (case)
did presence (nmod)
effect cardiotoxicity (nsubj)
lethal potentially (advmod)
shr ( (punct)
map using (advcl)
receive mg/kg/d (dobj)
mediating messages (dobj)
reached associated (conj)
att-alf ) (punct)
bcp ( (punct)
podocytes of (case)
push group (appos)
loss cell (compound)
effective tolerated (conj)
using subjects (nmod)
fed groups (nsubj)
status were (cop)
catch . (punct)
rats pretreated (acl:relcl)
induces obesity (dobj)
related is (auxpass)
relationship both (cc:preconj)
lamivudine . (punct)
pb promotes (acl:relcl)
contain to (mark)
failure associated (acl)
alfentanil by (case)
remained she (nsubj)
administration ifosfamide (nmod)
ameliorates rats (nmod)
3.86 , (punct)
29.9 8.1 (conj)
necessary events (nsubj)
osteopenia osteoporosis (conj)
mg/m(2 700 (nummod)
attenuates absence (nsubj)
blockade l-type (nmod)
anastrozole n=94 (dep)
oxazepam of (case)
blocked hyperactivity (dobj)
increase failure (nsubj)
hemoglobin ) (punct)
studies sar (compound)
toxic substances (nsubj)
treated study (advcl)
concerning cardiotoxicity (dobj)
drugs limit (parataxis)
27.1 12.8 (compound)
displayed patient (nsubj)
associated as (mark)
signs with (case)
continued patients (nmod)
putamen left (amod)
aim a (det)
given prilocaine (dobj)
network hippocampal (compound)
mg 30 (compound)
mmol/day ( (punct)
12.1 or (cc)
malignancy from (case)
29 16 (compound)
cats anaesthesized (amod)
sodium and (cc)
differences enhancement (nmod)
min duration (nsubj)
littermates wt (amod)
variable the (det)
regulate to (mark)
related time (nmod)
re-investigate value (dobj)
20 2.5 (compound)
given bolus (nmod)
exacerbated interaction (nsubj)
study open-label (amod)
stabilizers are (cop)
responses patients (nmod)
decreased hypotension (nmod)
moderate to (case)
patients co-infection (nmod)
60 ) (punct)
constriction symptomatic (amod)
damage resulting (amod)
excitability patients (nmod)
valve the (det)
seen with (mark)
increased echocardiography (nmod)
developed or (cc)
subregions hyperactivity (nmod)
patients exposure (nmod)
started rhythm (nsubj)
report induce (advcl)
lines exposure (conj)
identified herniations (nmod)
area planar (amod)
mg 70 (nummod)
drugs alone (advmod)
due clinically (advmod)
center washington (compound)
less rate (nsubj)
n with (case)
affected prevent (conj)
showed degree (dobj)
evaluation an (det)
improvement dyskinesia (nmod)
impart frequency (dobj)
mmol . (punct)
syndrome rhabdomyolysis (nsubj)
biopsy nonepisode (amod)
likely it (nsubj)
history ergot (nmod)
experienced case (dobj)
rate in (case)
peld scores (conj)
defined anemia (nmod)
modifications treatment (compound)
behaviors and (cc)
treatment low-dose (amod)
under or (cc)
= p<.001 (parataxis)
alleviated cck-8 (nsubj)
induced atp (nmod)
contraindicated seizures (nmod)
controls with (case)
signaling dopamine (compound)
injection . (punct)
synthetase pg (compound)
worsening functions (nmod)
month postoperative (amod)
analogue purine (compound)
content propofol (nmod)
range as (cc)
tissue dried (amod)
ml/min/kg ) (punct)
presence mb (nmod)
reduction transient (amod)
sulfate quinine (compound)
administered fluconazole (nsubjpass)
kinase ck (appos)
mg/min 1 (nummod)
injury duct (compound)
injected been (auxpass)
tumor des-induced (amod)
analogue octreotide (appos)
appeared dermatitis (nsubj)
search ) (punct)
measured series (nmod)
underwent weeks (nmod)
reverses impairment (nmod)
subjects schizophrenia (nmod)
serves metaiodobenzylguanidine (nsubj)
model functional (amod)
0.005 < (dep)
2 through (case)
antinociceptive antiamnesic (conj)
record and (cc)
intradermoreactions tests (conj)
decrement facilitation (nmod)
12 , (punct)
glycopyrrolate kg-1 (appos)
ng/mouse 3 (nummod)
period peri-operative (amod)
experienced mucositis (dobj)
mumol/l 182 (nummod)
hemorrhages conjunctival (amod)
define , (punct)
episode gtcs (compound)
calcium with (case)
terminated rats (nsubjpass)
monkeys types (nmod)
pipette recording (amod)
receptors gaba(a)rs (appos)
prolactin 's (case)
ineligible were (cop)
doxorubicin given (acl)
had possessed (ccomp)
drugs without (case)
kindling of (case)
observed severity (nmod)
dose clarithromycin (nmod)
reduced methamphetamine (nsubj)
marker earliest (amod)
relation its (nmod:poss)
required group (nmod)
locomotion on (case)
properties proliferation (conj)
15 39 (conj)
occurred this (nsubj)
differ lines (nsubj)
received didanosine (dobj)
deoxycorticosterone beta-epimers (conj)
control csa (conj)
extravasation serum-protein (compound)
examined is (auxpass)
c+e the (det)
g 90 (nummod)
evidence nephrotoxicity (nmod)
mitogens pb (nmod)
performance the (det)
less akinetic (conj)
nephrotoxicity ( (punct)
mg 250 (compound)
documents : (punct)
increasing with (mark)
group chx+pilo (compound)
caused hcbd (nmod)
decreasing significantly (advmod)
evaluated . (punct)
response infusion (nmod)
treated tumors (nsubjpass)
prk excimer (compound)
antibiotic with (case)
antagonist 10ug (dep)
activity beta-adrenoceptor (compound)
ptosis lid (nmod)
reduction hyperemia (nmod)
p>0.05 ) (punct)
action of (case)
patients young (amod)
number of (case)
pressure developed (amod)
syndrome propylthiouracil-associated (amod)
introduced europe (nmod)
induces growth (dobj)
reversed hypertension (dobj)
toxicity related (amod)
causes likely (amod)
increase from (case)
= 1.6 (dep)
hyperalgesia attention (conj)
$ROOT$ diarrhea (sent)
days . (punct)
showed relieved (parataxis)
exercise daily (amod)
kidney with (case)
contributed rate (nmod)
completed period (nmod)
constriction vigabatrin-attributed (amod)
patients adenocarcinoma (nmod)
seeing are (aux)
impairment potentiation (compound)
found where (advmod)
became severe (acomp)
sensitisation to (case)
part evaluation (nmod)
confines territories (nmod)
neuropathy lateral (amod)
administration fentanyl (compound)
% 0.34 (nummod)
investigated argatroban (nsubjpass)
receptor acid (compound)
associated outcome (nmod)
a ) (punct)
lead group (nmod)
gsh ( (punct)
intake as (cc)
drinkers for (case)
concentrations drug (nmod)
who [ (punct)
associated thrombosis (nmod)
threshold pentylenetrazol (nmod)
decrease latency (nmod)
had influenced (advcl)
propofol target-controlled (amod)
tablet > (amod)
products these (det)
mg/m(2 myocet (nmod)
flow decreased (amod)
receive trial (nmod)
abnormalities be (cop)
drug immuno-suppressive (amod)
antagonism injections (nmod)
occurs regeneration (dep)
provide conclusion (nmod)
effect anemia (appos)
dyskinetic fifteen (nummod)
hexachloride gamma (compound)
treatment agonist (nmod)
fujimycine fk506 (appos)
occurred ototoxicity (nsubj)
cycle second (amod)
$ROOT$ monitoring (sent)
subtypes d1 (compound)
gender-dependent were (cop)
cerebrum in (case)
serum tissues (conj)
regeneration . (punct)
fluctuations , (punct)
able but (cc)
except arrest (nmod)
treated disease (nmod)
confirmatory a (det)
agonists inhibitors (conj)
re-induced days (nmod)
database event (compound)
two deaths (nmod)
reflecting behaviors (dobj)
convulsions at (case)
asenapine the (det)
scores relating (acl)
absence as (cc)
values hu (nmod)
caused effect (dobj)
time rt (appos)
saw minutes (nmod)
required bleeding (nmod)
tablet day (nmod)
rs ( (punct)
removed was (auxpass)
applied generally (advmod)
65.6 8.5 (conj)
phenotype hemorrhagic (amod)
antithrombin . (appos)
rats treated (amod)
frequency basal (amod)
test irwin (compound)
changed indicating (xcomp)
concentrated well (advmod)
angiography on (case)
female 69-year-old (amod)
assess polyuria (dobj)
androgens with (case)
type lesion (nmod)
earlier significantly (advmod)
demonstrated superior (ccomp)
causes points (conj)
nitroprusside and (cc)
receptors spinal (amod)
dna carriers (nmod)
statin the (det)
1.8 woman-years (nmod)
suspensions tested (amod)
patients iiib (compound)
dm ) (punct)
neutrophil and (cc)
improved reduced (conj)
relationship overload (nmod)
picture the (det)
tourniquets four (nummod)
suggested , (punct)
increases > (amod)
taking bedtime (nmod)
incidence patients (nmod)
experience extensive (amod)
chick both (preconj)
agent prevention (nmod)
hypoxemia required (acl:relcl)
ph ( (punct)
patients neuralgia (nmod)
3.1+/-1.0 p<0.05 (appos)
variety patterns (nmod)
striatum encephalomalacia (appos)
compensates lack (nmod)
adr mg/kg (nummod)
rhabdomyolysis heroin-related (amod)
hypotension rats (nmod)
loss mean (amod)
inpatients 59 (dep)
attenuated conclusion (nmod)
early was (cop)
antibiotics aminoglycoside (compound)
literature complications (nmod)
titration , (punct)
evaluated studies (nsubj)
postulated it (nsubjpass)
59.8 0.4 (conj)
mcl refractory (amod)
interaction stress (nmod)
unreported hallucinations (nsubj)
dexamethasone combination (nmod)
required apparently (advmod)
groups their (nmod:poss)
12.1 ( (punct)
complicated use (dobj)
medications. of (case)
risk vfds (nmod)
reduction (7.2)% (dep)
dynamics also (advmod)
epo ( (punct)
methotrexate concentration (nmod)
intense was (cop)
asa with (case)
sum types (nmod)
nodosum atra-induced (amod)
patients patient (dep)
commissure regions (conj)
caffeine with (case)
children years (appos)
observations clinical (amod)
relationship response (conj)
srl to (case)
oscillation of (case)
mechanisms through (case)
method staining (compound)
analysis literature (nmod)
use prescribing (advcl)
october in (case)
showed nucleus (nmod)
ingesting after (mark)
increased volume (nsubj)
effects sexual (amod)
different are (cop)
estimate an (det)
results associated (appos)
developed ( (punct)
0.78 0.57 (compound)
bmd lower (amod)
heart recipient (nmod:poss)
antipsychotics first-generation (amod)
improved had (aux)
technique only (amod)
evaluates effects (dobj)
presentation stroke-like (amod)
bche val204asp/p (compound)
saline or (cc)
unmatched the (det)
offers activation (nsubj)
known effect (xcomp)
description cases (nmod)
experienced one (nsubj)
pressures rates (conj)
inhibition clonidine (nmod)
nitroprusside trimetaphan (conj)
comparable numbers (nsubj)
suggests although (mark)
regimen bortezomib (nmod)
features thrombosis (nmod)
macrophages containing (acl)
98.7 +/- (cc)
3',5'-monophosphate ( (punct)
found found (conj)
volunteers age (dep)
peaked and (cc)
elected who (nsubj)
% 130 (nummod)
interaction alpha2- (nmod)
neurotoxicity nephrotoxicity (conj)
frs of (case)
units 183 (nummod)
ester inhibitor (compound)
measured anxiolysis (dobj)
therapies systemic (amod)
$ROOT$ hypothesize (sent)
died have (aux)
increase map (compound)
conditioning after (case)
current and (cc)
given been (auxpass)
followed year (nmod:tmod)
group flumazenil (compound)
dismutase serum (nmod)
ck-mb > (amod)
nuclei over (case)
aaph by (case)
showed ability (dobj)
surgery successful (amod)
rats mellitus (nmod)
calculated rats (nmod)
categorized 1 (nmod)
concentration obtained (acl)
etoposide , (punct)
normotensive wky (dep)
concentration dopamine (compound)
stz ug (appos)
as is (cop)
value negative (amod)
complication surgery (nmod)
sensitized patient (nsubjpass)
treatment 5-fluorouracil (compound)
increased increased (conj)
$ROOT$ rarest (sent)
nitrogranulogen methotrexate (conj)
determine prevalence (dobj)
scale-revised memory (compound)
mdma ex-mdma (conj)
developed age (nmod)
up months (nmod)
indicate useful (ccomp)
produced decrease (dobj)
procedures staining (compound)
report autopsy (amod)
seizures sound-induced (amod)
pth ( (punct)
stress external (amod)
dubutamine of (case)
collagen elastin (conj)
exposed cacl(2 (nmod)
demonstrated users (nsubj)
thirst normal (amod)
beclomethasone with (case)
increased toxicity (nsubjpass)
patient 65-year-old (amod)
predisposes serve (conj)
recognition after (case)
power evaluate (acl)
factor iatrogenic (amod)
received heparin (dobj)
changes ictal (amod)
contact skin (nmod)
promotes production (dobj)
neuropathy therapy-related (amod)
margin the (det)
hospitalised died (dep)
amikacin conventional (amod)
consuming glasses (dobj)
due to (mark)
status or (cc)
hypothalamus and (cc)
infused were (auxpass)
derivatives amino (compound)
reduces rotations (dobj)
pathway of (case)
evaluated routinely (advmod)
indices electro-oculography (compound)
disorders other (amod)
microscope confocal (amod)
tests a (dep)
treatment prior (amod)
contributions % (nmod)
ambiguus possibly (advmod)
report experience (dobj)
variations between (case)
cp 93129 (nummod)
beat irregular (amod)
nephrotoxicants as (case)
grade a (det)
hallucinosis of (case)
g 30 (compound)
weight dogs (nmod)
clozapine only (advmod)
inhibitors non-selective (amod)
intoxication unintentional (amod)
sod brain (compound)
disrupted significantly (advmod)
intervals short (amod)
support hypothesis (dobj)
uterotonic is (cop)
maintained intake (nmod)
utility mr (nmod)
compared antagonists (nsubjpass)
tizanidine agonist (appos)
act needed (conj)
involvement receptors (nmod)
deterioration auditory (amod)
impairment streptozotocin-induced (amod)
microbleeds hemorrhage (conj)
angina , (punct)
use injury (conj)
recipients solid-organ (amod)
found comparison (nmod)
open whenever (advmod)
period screening (amod)
acid as (case)
used while (mark)
formulations bupropion (nmod)
mdma or (cc)
determine was (ccomp)
paroxetine with (case)
days withdrawal (dep)
acidity due (case)
20/102 6 (conj)
resolution complication (nmod)
periods : (punct)
regimen paclitaxel/cisplatin (nsubj)
worsening parkinsonism (nmod)
areas compared (case)
steroids neuroactive (amod)
thrombosis epinephrine (conj)
symptoms off (amod)
g 70 (nummod)
$ROOT$ supervised (sent)
related duration (nmod)
permitting treatment (dobj)
activity to (case)
morphogenesis of (case)
administration rat (nmod)
angioedema severe (amod)
identify ( (punct)
acid citric (amod)
organisms cured (conj)
nephrotoxicity chronic (amod)
administration nmol (appos)
derives experiments (nmod)
short was (cop)
restoration continence (nmod)
ovale via (case)
excretion group (nmod)
trial performed (acl)
groups mdma (compound)
microg/kg/min 0.5 (nummod)
patients alf (nmod)
infection 11 (nmod)
advance therapeutic (amod)
stimulation skin (nmod)
dystonia tardive (amod)
controls 467 (nummod)
sarcoma advanced (amod)
girl of (case)
gaba(a)rs of (case)
events common (amod)
definition society (compound)
reactions because (case)
= 0.063 (dobj)
comparisons for (case)
ip ( (punct)
increase small (amod)
production pain (conj)
failure qrs (nmod)
enrolled protocol (nmod)
information available (amod)
drugs have (acl:relcl)
postulated exerted (ccomp)
thickness wall (compound)
was adjusted (advcl)
need therapy (nmod)
lower neonates (nmod)
mutant rat (compound)
common less (advmod)
engrafted , (punct)
complicating chemotherapy (dobj)
fell v/s (nmod)
steroid-induced transient (amod)
is examine (xcomp)
proof additional (amod)
caffeine of (cc)
days microscopy (nmod)
lowered might (aux)
adequate inhibition (nmod)
days three (nummod)
fetuses exposed (acl)
done patients (nmod)
assessed absence (nmod)
age-range month (compound)
mcg ) (punct)
reduced fibrosis (dobj)
resembles picture (nsubj)
antinociception induced (acl)
have consequences (dobj)
observed revealed (parataxis)
treated day-1 (nmod)
provide neutropenia (nmod)
regions geographical (amod)
emissions newborns (nmod)
results present (amod)
alpha beta (conj)
dysfunction hypotension (conj)
absorbed rapidly (advmod)
seizures hypotonia (conj)
toxicities dose-limiting (amod)
pressure urethral (amod)
tiopronin and (cc)
interpreted phenomenon (nsubjpass)
trial random-assignment (amod)
monitoring ) (punct)
2010/2011 ( (punct)
appear add (xcomp)
cell blood (compound)
17-year-old 7- (quantmod)
cause chorea (nmod)
coma amiodarone-induced (amod)
permeability distribution (conj)
treated % (nsubjpass)
concluded tolerated (ccomp)
modes multiple (amod)
functioning = (dep)
ineffective was (cop)
collection stem (compound)
foci delineated (acl)
male is (cop)
canal of (case)
gm 5 (nummod)
beginning time (nmod)
appear responsible (xcomp)
cessation individuals (nmod)
11 to (dep)
viramidine , (punct)
confined . (punct)
decreased modifications (nmod)
experienced limiting (ccomp)
risk associated (acl)
suggest support (advcl)
was indication (attr)
thrombi arteriolar (amod)
ratio hr (appos)
g/dl 12.7 (nummod)
inflammation less (amod)
immunosuppression due (case)
case failure (nmod)
side-effect and (cc)
hyperactivity locomotor (amod)
cd-832 nifedipine (conj)
prevention ; (punct)
atropine supplemental (amod)
endografine hysterosalpingography (nmod)
involvement the (det)
before minutes (nmod:npmod)
flurazepam of (case)
99 p (dep)
reduced dosage (nsubjpass)
associated zonisamide (nmod)
effects flestolol-induced (amod)
adults older (amod)
reproduce to (mark)
hemodynamics the (det)
12.8 from (case)
effective infusion (nmod)
transmission brain (compound)
reported nephritis (nmod)
study group (nmod)
common recipients (nmod)
anaesthesia intravenous (amod)
iu/l 62,246 (nummod)
schema multiple (amod)
$ROOT$ enlargement (sent)
inhibition following (case)
saline ( (punct)
rise simultaneous (amod)
cb of (case)
determined biopsy (nmod)
edetate citrate (conj)
anticipated is (auxpass)
binder as (case)
group same (amod)
concentrations of (case)
absorption sublingual (amod)
reported fetus (nmod)
mechanisms understood (acl)
28 range (dep)
120 0 (compound)
rate criteria (appos)
glomerulopathy reduplication (conj)
complication thus (advmod)
dose 10-micrograms/kg (compound)
effect ocular (amod)
years 3.7 (nummod)
significance slight (amod)
fucoidan or (cc)
monitored catheters (nmod)
had girl (nsubj)
excess users (nmod)
induction the (det)
patients renal (amod)
obtained and (cc)
differ sod (nmod)
had indices (dobj)
results assessment (nmod)
anaesthesia unilateral (amod)
expression antigen (nmod)
neoplasia or (cc)
vnr with (case)
syndrome (pan)-induced (amod)
discomfort with (case)
patients renin (dep)
mild these (nsubj)
women 2839 (nummod)
virus antihuman (amod)
found discontinued (parataxis)
assessment audiograms (nmod)
adjusting after (mark)
scale updrs (appos)
documents syndrome (dobj)
disease associated (acl:relcl)
binding both (cc:preconj)
documented reported (conj)
complexes containing (acl)
supports improvement (nsubj)
experiments separated (acl)
duration dose (conj)
underwent support (dobj)
u/l 66,680 (nummod)
reversed furthermore (advmod)
response echocardiography (nmod)
function regional (amod)
dfu unlike (case)
documented been (advcl)
dose g/m2/d (nmod)
combination lymphocytes (nmod)
weighed factor (advcl)
university-affiliated community (conj)
point core (compound)
neurotoxicity analysis (dep)
disturbance or (cc)
outcomes rats (nmod)
myeloma relapsed/refractory (amod)
analysed concentrations (nsubjpass)
infants exposed (acl:relcl)
region surrounding (amod)
abscess a (det)
demonstrate defect (dobj)
published december (nmod)
p10 the (det)
potassium , (punct)
toxic therapeutic (amod)
contents obtained (acl)
72 - (punct)
events stroke (conj)
damage caused (acl)
administered monoher (nsubjpass)
determine should (aux)
area hypoxic (amod)
cbdca ) (punct)
volume pan (compound)
protects pparalpha (nsubj)
larger controls (nmod)
patient sirolimus-treated (amod)
users cannabis (compound)
model present (amod)
drug ) (punct)
ml ml (appos)
patterns altered (amod)
reversing surgery (nmod)
transmission neuromuscular (amod)
suppress to (mark)
parameters elevated (amod)
march and (cc)
research from (case)
rationale consumed (acl)
chc ( (punct)
amphetamine metamphetamine (conj)
inc usa (compound)
presence solutions (nmod)
unable he (nsubj)
sensitivity depression (nmod)
acting directly (advmod)
models cholestasis (nmod)
co-administration aiming (acl)
helpful guidelines (nsubj)
conclude disrupts (ccomp)
useful , (punct)
revealed laryngoscopy (nsubj)
suggests induce (ccomp)
phenomena central (amod)
mg/g ( (punct)
anophthalmia with (case)
auditory , (punct)
reexposure patient (nmod)
erythroblasts bone (compound)
cognitive functional (conj)
minutes 16.4+/-6.1 (nummod)
inc , (punct)
appeared days (nmod)
lidocaine buffered (amod)
work of (case)
complex specifically (advmod)
neuropathy transient (amod)
indicating spasm (dobj)
inflammation by (case)
pattern selective (amod)
metabolised 1-bromo-1-chloro-2,2,2-trifluoroethane (nmod)
period year (nmod)
medulla not (cc)
consumed maintaining (advcl)
1 men (nmod)
underwent anesthesia (nmod)
prolongation hypocalcaemia (conj)
related cocaine (nmod:npmod)
control dopaminergic (amod)
group in (case)
beats/min 0.6 (nummod)
predicts density (nsubj)
contribution . (punct)
anti-asthmatic and (cc)
demonstrated us (nmod)
showed points (nmod)
reports only (advmod)
arrhythmia caffeine-induced (amod)
base near (case)
rats 18 (nummod)
taken were (auxpass)
due sirolimus (nmod)
comparison dexmedetomidine (nmod)
antidopaminergic both (cc:preconj)
demonstrated tolerated (advcl)
taken pregnancy (nmod)
withdrawal ltg (compound)
conducted models (nmod)
nitrendipine blocker (compound)
requests hospitalizations (nmod)
cross-sensitization behavioral (amod)
$ROOT$ abandoned (sent)
pose patient (nmod)
screening positive (amod)
medications known (acl)
schizophrenic or (cc)
able drugs (nsubj)
assessing secretion (dobj)
was or (dep)
using mice (dobj)
gemcitabine , (punct)
overdose phenylpropanolamine (compound)
malondialdehyde excretion (conj)
decreased returned (conj)
granular sub (amod)
levels ribonucleic (amod)
seizures epileptic (amod)
effects solutions (nmod)
acid udca (appos)
covered edema (nsubj)
cells cell (compound)
puberty p40 (appos)
prescribed acetate (dobj)
dcf either (cc:preconj)
n-acetyl-beta-d-glucosaminidase of (case)
tended shown (conj)
widened interval (nsubj)
fluvoxamine with (case)
differ olanzapine (nmod)
response duration (conj)
increased rbcs (nsubj)
using tested (parataxis)
toxicities six (nmod)
sedation subjective (amod)
interaction antagonists (nmod)
reflection . (punct)
implicates control (dobj)
gamma-glutamyltransferase amylase (conj)
periods ictal (amod)
identification patients (nmod)
caused pathway (nmod)
velocity reduced (amod)
net ( (punct)
increases and (cc)
times normal (dep)
comparison direct (amod)
41.66 +/- (cc)
available however (advmod)
marker reaction (nmod)
10.7 6.5 (conj)
battery memory (compound)
estimates absolute (amod)
produced cp (nsubj)
use development (conj)
clear factor (ccomp)
polacrilex nicotine (compound)
alive dose (nmod)
therapy vs. (cc)
concentrations (+)-cibenzoline (nmod)
dose exceeding (acl)
detected serum (nmod)
ethambutol combined (amod)
form each (det)
operative case (nmod)
phosphatase . (punct)
persist effects (nsubj)
performed noninvasive (advcl)
remained injection (nmod)
those from (case)
55 < (advmod)
irritation local (amod)
tetrapeptide cck-5 (appos)
pathogenesis to (case)
addition tizanidine (nmod)
drugs considered (acl:relcl)
scopolamine either (cc:preconj)
drink " (punct)
normotensive hypertensive (conj)
therapy (cns)-directed (amod)
protein activity (conj)
case that (mark)
had when (advmod)
mg/m(2 120 (nummod)
drug furthermore (advmod)
9-months after (case)
diseases neurodegenerative (amod)
genes her (nmod:poss)
pitfall diagnostic (amod)
said mode (nsubjpass)
reviewed information (nsubjpass)
glial cerebral (amod)
associated anaemia (nmod)
information important (amod)
a nearly (advmod)
lesion organic (amod)
$ROOT$ cured (sent)
dose necessary (amod)
length ] (punct)
function antagonists (nmod)
cardiomyopathy haart-induced (amod)
dyskinesia oral (amod)
4.6 versus (cc)
restored amplitude (dobj)
ampicillin to (case)
variables survival (conj)
given induction (nmod)
documented patients (nmod)
concentrations gastrin (compound)
500 250 (compound)
discontinued lack (nmod)
criteria hepatocellular (amod)
mm 128 (nummod)
hypertension associated (acl)
resembling glaucoma (dobj)
observation at (case)
present model (nmod)
mdma and (cc)
took cephalexin (dobj)
reductions clearance (nmod)
called platypnea-orthodeoxia (xcomp)
ato with (case)
nephropathy can (appos)
apamin blocker (appos)
score z (compound)
type substrate (nmod)
produced implantation (nmod)
0.99 ) (punct)
involves however (advmod)
patients lamivudine-na (amod)
elevation 117-fold (amod)
changes asymptomatic (amod)
animals : (punct)
application intracavitary (amod)
nox neither (cc:preconj)
compare that (nmod)
pontis posterior (amod)
graded evidence (nsubjpass)
signals t2 (compound)
109 from (case)
hospitalization ami/gi (nmod)
characterized lesions (nmod)
showed these (nmod)
epo alone (advmod)
warned . (punct)
$ROOT$ recruited (sent)
presumed plus (cc)
emboli tumor (compound)
addition bicarbonate (nmod)
reported girl (nsubjpass)
femoral map (compound)
blockade by (case)
mipafox ( (punct)
effect convulsive (amod)
acidosis renal (amod)
trimester during (case)
evident degree (nsubj)
woolf of (case)
achieved have (aux)
had taking (advcl)
marker prediction (nmod)
clonidine used (acl)
increase bleeding (dobj)
grades of (case)
tool study (acl)
tissue heart (nmod)
were because (mark)
related development (nmod)
mtx ( (punct)
induce similarly (advmod)
toxicities the (det)
received doses (nmod)
lower variability (nsubj)
electrocardiographic ekg (appos)
discs the (det)
0.41 to (dep)
circumferential gcs (appos)
taken prior (advmod)
effects alpha-methyldopa (nmod)
improved administration (nmod)
tolerated conclusion (nsubjpass)
minutes five (nummod)
mechanism endogenous (amod)
cohort separate (amod)
group p (dep)
process muscles (nmod)
fan ( (punct)
dmpx ( (punct)
decrease as (cc)
intensity signal (compound)
$ROOT$ consider (sent)
common very (advmod)
pruritus 1 (appos)
mg/0.5 10 (compound)
retention syndrome (nmod)
dosing administration (nmod)
inhibited frequency (nsubjpass)
facilitates behavior (dobj)
days initial (amod)
120 more (advmod)
pressure sitting (amod)
exposure doxorubicin (compound)
mmol/l mosmol/kg (conj)
session 1 (nummod)
alkylxanthines potencies (nmod)
$ROOT$ excludes (sent)
indicate experiences (nsubj)
affinity 2-adrenoreceptor (compound)
correlation no (neg)
resumed result (nmod)
mediated modulation (nmod)
programs treatment (compound)
therapy on (case)
evolve psychosis (nmod)
fentanyl fentanyl-dexamethasone (conj)
hepatotoxicity on (case)
antipsychotics the (det)
increased developed (conj)
study use (nmod)
therapy medication (compound)
halts induction (nsubj)
n-nitroso-n-methylurea propionate (conj)
withdrawal sedative-hypnotic (amod)
thrombophlebitis 4 (appos)
adjust doses (dobj)
did , (punct)
effects injury (nmod)
propensity . (punct)
disorder ci=5.194 (conj)
measured doses (conj)
content hydroxyproline (compound)
27.1 ( (punct)
assay mapping (compound)
implicated parkinsonism (nmod)
parenchyma over (case)
decreases groups (nmod)
that agsd (nmod)
showed specimen (nsubj)
focused possibility (nmod)
february december (nmod:tmod)
rct meta-analysis (conj)
generation potential (compound)
indicate represent (ccomp)
populations astrocytes (nmod)
lamina the (det)
proposed is (auxpass)
effect relaxant (amod)
model investigations (nmod)
therapies val/hctz (nmod)
treatment conditions (nmod)
ph 9 (nummod)
suitable treatment (nmod)
entered were (auxpass)
exhibited clearance (dobj)
h1- h2-antagonists (conj)
population distinct (amod)
metabolized is (auxpass)
patients confusion (nmod)
recovery by (case)
erythematosus . (punct)
induced probably (advmod)
ranges bis (compound)
absences typical (amod)
nephrosis the (det)
use on (case)
concentrations epo (nmod)
necrosis levels (conj)
fibrosis interstitial (amod)
mediate projections (nmod)
antagonist : (punct)
thickness arterial (amod)
value k(na (compound)
modified decreased (conj)
changes concentration (nmod)
ropivacaine of (case)
animals tumor (nmod)
agent um-272 (appos)
reviewed . (punct)
causes shock (nmod)
able abolish (xcomp)
rate prevalence (compound)
changes renal (amod)
2d6 p450 (compound)
lot a (det)
alterations tissues (nmod)
prolonged patients (nmod)
clozapine- and (cc)
sensation heat (nmod)
one following (nmod)
trajectory used (acl)
injections weight (nmod)
91.5 ( (punct)
association polymorphisms (nmod)
clioquinol of (case)
include however (advmod)
fatal but (cc)
expressed ccr2 (dobj)
factor (vegf)165 (nummod)
bias and (cc)
deduced been (auxpass)
dialysate dialysate (appos)
decreased mg (nmod)
outpatients 71 (nummod)
due , (punct)
used ( (punct)
induce cystitis (dobj)
reached level (dobj)
change headache (nmod)
pathological-process the (det)
s(h)uv standardised (amod)
prl ) (punct)
changes expression (nmod)
upper and (cc)
threshold hearing (compound)
skin , (punct)
outcomes children (nmod)
targeted corrected (conj)
62 patients (nmod)
interaction that (mark)
pilocarpine-treated control (conj)
isopter the (det)
antigens inos (compound)
effects na (nmod)
extended-release/lovastatin , (punct)
action form (nmod)
users eligible (amod)
curcumin of (case)
hepatocytes the (det)
mice protein (compound)
lithium divalproex (conj)
induced presence (nmod)
tissue for (case)
dysmetria dysarthria (conj)
detected patterns (dobj)
aim with (case)
status normal (amod)
reticulum rough (amod)
metabolite through (case)
score modified (amod)
recognized . (punct)
discontinuation mirtazapine (nmod)
have potency (dobj)
unclear still (advmod)
dose etomidate (nmod)
salbutamol with (case)
methylprednisolone m (appos)
lid of (case)
event reported (acl)
affinity vascular (amod)
csa of (case)
effect catalepsy (nmod)
impaired perception (nsubj)
function induction (conj)
ingestion aspirin (nmod)
granulocytosis hypersegmented (amod)
amphetamine an (det)
interferon during (case)
response median (amod)
background suppresses (appos)
surgery major (amod)
elevates lactate (dobj)
documentation the (det)
breaks sbs (appos)
agonists : (punct)
trial pilot (amod)
alter however (advmod)
provoke migraine (dobj)
ovariectomized ovx (dep)
exists that (mark)
concentrations man (nmod)
failure alf (appos)
production liver (nmod)
recipients , (punct)
severe rats (nmod)
dose terbutaline (compound)
considered digoxin (nsubjpass)
prevalence relative (amod)
accumulation resulted (acl:relcl)
ptld ulcers (conj)
% interval (appos)
reversion treatment (nmod)
year duration (dep)
constipation-predominant , (punct)
need develop (acl)
lead reduction (nmod)
loss development (conj)
fall increase (conj)
mg/dl 1.98 (nummod)
infusate the (det)
2.4 +/- (cc)
test ecg (compound)
compliance patient (compound)
profile blood (compound)
used frequently (advmod)
recommended restricted (ccomp)
f344 bn (conj)
patient delay (nmod)
asphyxia . (punct)
receptor glur5 (compound)
administered 21days (nmod)
therapeutic and (cc)
man 69-year-old (amod)
weeks transplantation (nmod)
usa in (case)
2-(p-bromophenyl)propionate ( (punct)
dose daily (advmod)
regressed completely (advmod)
administered successfully (advmod)
mg kg(-1 (conj)
days within (case)
radiographic and (cc)
illnesses serious (amod)
attempts resuscitate (acl)
level this (det)
oxycantha ) (punct)
ng/dl thyroxine (nsubj)
involve may (aux)
2 5 (nummod)
10 2.6 (nummod)
producing complications (dobj)
treatment a (det)
observed produce (xcomp)
showed end (nmod)
oxidase amphetamine (conj)
minutes + (cc)
$ROOT$ assessment (sent)
sch selective (amod)
1433 154 (compound)
able repeat (xcomp)
given carbon (dobj)
thrombocytopenia grade (compound)
mek1 erk2p (conj)
sex weight (conj)
neurotoxic similar (conj)
report cases (dobj)
arthritis in (case)
39+/-10 ( (punct)
carcinoma reported (acl)
% 11.2 (nummod)
intralipid medialipid (conj)
varied efficacy (nsubj)
toxicity cumulative (amod)
115 0.4 (conj)
mg n=10 (appos)
decreased mean (dep)
therapy or (cc)
develop effects (nmod)
normal transgenic (conj)
consequences injection (nmod)
known neurotoxic (xcomp)
suggested studies (nsubj)
normalised acuity (nsubj)
developed melphalan (nmod)
independent and (cc)
mandatory recognition (nsubj)
switched patients (nmod)
regression multivariable (amod)
blocks ammonia (nsubj)
prudent confirmed (advcl)
2.14 interval (appos)
incidence intensity (conj)
increase levels (nmod)
threshold conditions (nmod)
effects warranted (acl:relcl)
produced some (nmod)
$ROOT$ facilitation (sent)
patients treatment (nmod)
identified has (aux)
associated population (nmod)
grade greater (amod)
rage ) (punct)
risk reactions (nmod)
duration days (nmod:poss)
provoke to (mark)
studies radiologic (amod)
inhibition mixed (amod)
mg epinephrine (nmod)
performed study (dobj)
techniques image (compound)
expression macrophages (nmod)
mm 15.7 (nummod)
hepatitis appeared (acl:relcl)
or difference=0.25 (dep)
studies animal (compound)
drug dopaminergic (amod)
use or (cc)
models dyskinesia (nsubj)
resolved hours (nmod)
pralidoxime-2-chloride 2pam (appos)
response development (conj)
increased participants (nmod)
workup further (amod)
chronotropic metabolic (conj)
condition hypersensitivity (compound)
performed experiments (nsubjpass)
activates acetyltransferase (dobj)
pph ( (punct)
50 much (advmod)
oliguria despite (case)
hour after (case)
disorder electrolyte (compound)
australia from (case)
discriminates effect (dobj)
actions mice (nmod)
april 2004 (nummod)
given dogs (nmod)
women thai (amod)
permanente kaiser (compound)
induction arthritis (nmod)
development failure (nmod)
barrier/density reduced (amod)
follow-up toxicity (nmod)
infused technique (nmod)
thrombocytopenia than (case)
adjustment such (case)
able trespass (xcomp)
effect toxicity (nmod)
self-dosing frequent (amod)
vomiting hypotension (conj)
1 4 (prep)
identify did (aux)
inhibit binding (dobj)
development convulsions (nmod)
cdna encoding (acl)
vomiting and (cc)
cimetidine mg (appos)
flow blood (compound)
used cocaine (dobj)
alert patient (nmod)
toxicity hrptec (nmod)
dose-dependent were (cop)
rare hazardous (conj)
revealed survey (nsubj)
statins of (case)
$ROOT$ catalepsy (sent)
effects reported (amod)
has does (advcl)
cardiotoxicity 5-fu (compound)
treated identified (advcl)
antagonized given (advcl)
managed successfully (advmod)
analyze here (advmod)
gamma-hch ( (punct)
provide evidence (dobj)
induces aggravates (conj)
sodium for (case)
used histology (nsubjpass)
systolic ventricular (amod)
antecedent concurrent (conj)
rate breathing (compound)
hiccups with (case)
compare strains (nmod)
lack total (amod)
placebo timolol (conj)
free compared (prep)
number responders (nmod)
offspring induced (acl)
reduce seizures (dobj)
upregulation molecule (nmod)
dp/dt(max ) (punct)
suffers reactions (nmod)
dysfunctions for (case)
drugs between (case)
studied identify (ccomp)
woman gestation (nmod)
cc ( (punct)
conclusions problem (appos)
confirmed if (mark)
mg/kg/day 0.086 (nummod)
cases anencephaly (nmod)
velocity systolic (amod)
biochemical hormonal (conj)
bilirubin elevated (amod)
undergone to (mark)
administration pcc (nmod)
hydrochloride % (amod)
54.5 , (punct)
vt ) (punct)
overdose suicidal (amod)
migraineurs controls (conj)
provide inhibitors (nsubj)
disease grade (compound)
s between (case)
made introduce (xcomp)
achieve rate (dobj)
make abnormalities (nsubj)
block neuromuscular (amod)
$ROOT$ form (sent)
occurred forebrain (nmod)
analyze data (dobj)
gave patient (nsubj)
found proliferation (nsubjpass)
outpatients cocaine-dependent (amod)
recovery correlated (acl)
resistant lids (nmod)
striatum . (punct)
imaging techniques (conj)
had participants (nsubj)
pre-treatment ketamine (nmod)
investigation the (det)
dogs between (case)
75,761 42,671 (conj)
uterus m4 (nmod)
6-ohda by (case)
result complication (nsubj)
3.7 10(-8 (conj)
having syndrome (dobj)
in particular (amod)
effects tafi (dep)
95 +/- (cc)
underwent children (nsubj)
spectrometry mass (compound)
31 29 (conj)
plasma mumol/liter (compound)
radiopharmaceutical infarct-avid (amod)
diagnosed failure (nsubjpass)
developed reverting (advcl)
methotrexate intrathecal (amod)
immunosuppression primary (amod)
had ovariectomy (nsubj)
dyscrasias , (punct)
arthritis acute (amod)
supplementation potassium (compound)
patients 596 (nummod)
mpep , (punct)
catecholaminergic serotonergic (conj)
leakage cerebrospinal (amod)
occurred combinations (nsubj)
kcl mm (amod)
anticipated outcome (nsubjpass)
tolerated reported (advcl)
butyrylcholinestrase serum (nmod)
sex . (punct)
bradycardia asymptomatic (amod)
7.6 ci (nsubj)
associated often (advmod)
2.4 95 (amod)
antioxidants cerruloplasmin (nmod)
available criteria (nmod)
represent effect (dobj)
depression st (compound)
beta-adrenoblocking the (det)
letrozole aromatase (compound)
investigator one (nummod)
rhabdomyolysis induced (amod)
tspa ( (punct)
mhb potent (amod)
300 100 (compound)
lead hypertension (nmod)
suggests ameliorate (ccomp)
areas damaged (acl:relcl)
alpha-tac ) (punct)
disposition altered (amod)
morbidity with (case)
gemcitabine methylprednisolone (conj)
toxicity or (cc)
species reactive (amod)
psychostimulant : (punct)
use routine (amod)
haemorrhage - (punct)
precipitated insipidus (nmod)
had chickens (nsubj)
reviewed data (nsubjpass)
injection tracer (compound)
combined t (nmod)
emulsion or (cc)
ms ) (punct)
range 0 (nummod)
antibody a (det)
alternative cost-savings (amod)
cisplatin high-dose (amod)
age < (dep)
5 pituitaries (nmod)
n-acetyl-beta-d-glucosaminidase marker (appos)
recognized antibodies (nmod)
induced 1 (dep)
degrees t-test (dep)
predict stones (dobj)
rifampin following (case)
elevated d-1 (nsubj)
cacl(2)-treated , (punct)
causes were (cop)
nitrate lanthanum (compound)
evaluation morphological (amod)
carry to (mark)
layer bulb (nmod)
improvement , (punct)
washout a (det)
termination at (case)
quality high (amod)
investigated potential (dobj)
15-f(2t)-isoprostane 15-f(2t)-isop (appos)
defects report (dep)
6.7-times to (dep)
quetiapine % (appos)
learning regulation (conj)
myelodysplasia hypocellular (amod)
seizures two (nummod)
process chemoprevention (compound)
index sensitivity (compound)
vinorelbine vnb (appos)
mmol/l sodium (nsubj)
accumbens the (det)
minimum days (nmod)
confirmed cases (dobj)
mpo ( (punct)
pmol 9.84 (nummod)
nmbas bromide (nmod)
concentration mg (dep)
biosynthesis rna (nmod)
hemiparesis progressive (amod)
thromboembolism with (case)
cardiomyopathy anthracycline-induced (amod)
showed higher (dobj)
reduction protein (nmod)
term the (det)
4 or (cc)
dogs cefonicid (compound)
epinephrine : (punct)
conditions similar (amod)
expression syndrome (nmod)
comparison in (case)
indicate obtain (ccomp)
29.7 - (punct)
1.56 0.57 (nummod)
1 % (appos)
weeks was (cop)
administration doses (nmod)
mothers surface (compound)
re-induced she (nsubjpass)
enalapril not (cc)
solubility aqueous (amod)
marrow bone (compound)
electroretinography erg (conj)
blocks channels (dobj)
changes cytoplasm (nmod)
patients hypotensive (amod)
scopolamine mg (dep)
class g/ml (appos)
thrombosis bilateral (amod)
leads ceftriaxone (nsubj)
syndrome rabbit (compound)
median courses (nmod)
cells/mm3 4.9 (nummod)
eyes eyes (conj)
therapy ( (punct)
enhanced are (auxpass)
include thrombi (dobj)
ft4 ( (punct)
mice wsp (compound)
verapamil nifedipine (conj)
carbonate-induced calcium (nmod:npmod)
pentobarbital of (case)
ciprofloxacin norfloxacin (conj)
enzymes urinary (amod)
mice seizure (compound)
cancer head (compound)
occurred days (nmod)
pressures supine (compound)
% 55 (nummod)
appear causes (nsubj)
alerted be (auxpass)
enalapril medication (nsubj)
occur , (punct)
become likely (advcl)
ototoxicity patients (dep)
observed period (nsubjpass)
effects neurologic (amod)
siat ) (punct)
challenged day (nmod)
ad50 bupivacaine (compound)
3.4 9.7 (prep)
measured indices (nsubjpass)
response teoaes (compound)
developed result (nmod)
emphasize effect (dobj)
echocardiography second (amod)
have cancers (nsubj)
20 of (advmod)
gyrus rat (compound)
knowledge personnel (nmod)
rich stones (nsubj)
combinations only (advmod)
powders calcium (compound)
study type (nmod)
use ( (punct)
man cocaine-dependent (amod)
private and (cc)
years during (case)
cells/mm3 73.8 (nummod)
transplantations from (case)
report to (aux)
ranges therapeutic (amod)
drc hr (nmod)
back and (cc)
oliguria acute (amod)
findings and (cc)
prolactin on (case)
related desensitization (nmod)
$ROOT$ sirolimus (sent)
values pre-papaverine (amod)
micrograms/kg/min ( (punct)
experienced injection (nmod)
weaker ) (punct)
metabolism cells (nmod)
prevent pain (dobj)
defined . (punct)
has : (punct)
walk and (cc)
effects nephritis (nmod)
fingers his (nmod:poss)
dose third (amod)
coniine sulfate (conj)
mg/kg p<0.05 (appos)
toxicity marrow (compound)
% 13.55 (nummod)
administered nephrectomy (nmod)
carcinoma invasive (amod)
effects fetus (nmod)
function depressed (amod)
n=35 ( (punct)
hyper- pain (conj)
haematological were (cop)
tmp-smz ( (punct)
sirolimus , (punct)
suspect for (case)
null homozygous (amod)
shorter controls (advcl)
meritorious effects (nsubj)
remember features (dobj)
$ROOT$ contribution (sent)
impairment visual (amod)
nsaid other (amod)
induce change (dobj)
hdl in (case)
glaucoma poag (appos)
patients 47 (nummod)
variety in (case)
continue represent (conj)
referred is (auxpass)
response response (nmod)
puerperium in (case)
headache headaches (nmod)
aneurysm cacl2-induced (amod)
patient each (appos)
which for (case)
abuse drug (compound)
show that (mark)
ones the (det)
rofecoxib , (punct)
medications antagonist (compound)
given therapy (nsubjpass)
extract s. (compound)
determined had (conj)
170 20/102 (conj)
fall resistance (nmod)
increased retention (nmod)
age status (conj)
g 10 (compound)
chorea acute (amod)
enlarged were (cop)
abuse meth (compound)
disorders these (det)
treated controls (nmod)
% 41 (nummod)
neck and (cc)
effects heart (nmod)
oligodeoxynucleotide receptors (nmod)
was treatment (nmod)
produced cpap (nsubj)
increase excitability (dobj)
accompanied attenuation (nsubjpass)
mirrored , (punct)
variety absence (nmod)
apply may (aux)
was p<0.05 (dep)
trigger and (cc)
doses subhypnotic (amod)
compound racemic (amod)
had potent (advcl)
12 least (advmod)
participated subjects (nsubj)
levels 15-f(2t)-isop (nmod)
30 0 (compound)
found umax (nsubjpass)
ct on (case)
relief headache (nmod)
content biosynthesis (conj)
ventricles normal (amod)
electroshock mes (appos)
showed recording (nsubj)
nadir mean (compound)
loss unilateral (appos)
nerves optic (amod)
led had (aux)
assessment 5-minute (compound)
aids both (appos)
cck-8 ( (punct)
off'-drug ' (punct)
use paramedics (nmod)
mode action (nmod)
blockers of (case)
increased ppa (nmod)
medulla from (case)
antigen pcna (appos)
be to (mark)
responsible that (nsubj)
hearts disease (nmod)
route any (det)
conclusions demonstrate (appos)
noticed that (ccomp)
analog octreotide (appos)
thrombus both (conj)
takes it (nsubj)
phenylbutazone ( (punct)
response scale (compound)
associated hypometabolism (nmod)
group endografine (compound)
twenty-nine them (nmod)
injury permeability (conj)
criteria according (case)
abstention long-term (amod)
required hemodialysis (dobj)
stenosis resulted (acl:relcl)
users ex-mdma (appos)
rigidity . (punct)
= 0.0027 (dobj)
level to (case)
noted she (nsubj)
diagnosis cancer (compound)
10 % (appos)
modulation nmdar (nmod)
assessment onset (nmod)
plants herbal (amod)
included pressure (dobj)
mary st. (compound)
response dipyridamole (nmod)
rare very (advmod)
areas necrosis (appos)
overdose cocaine (compound)
disorder reversible (amod)
dystrophy like (case)
range a (det)
department to (case)
damage using (acl)
users 29 (nummod)
dosage pharmacokinetics (conj)
= 0.040 (dobj)
developed thrombocytopenia (dobj)
occlusion stenoses (conj)
compared degrees (nmod)
parameters behavioral (amod)
hypothermic moderately (advmod)
infusion during (nmod)
thirteen patients (nmod)
clinical theoretical (conj)
sedated propranolol (nmod)
injected stz-icv (nmod)
found lead (ccomp)
re-examine avoid (advcl)
reduced burden (dobj)
began until (mark)
confirmed effects (nsubjpass)
seemed better (xcomp)
catalepsy erections (conj)
venue bind (acl:relcl)
behaviour of (case)
6 over (advmod)
increase weight (nmod)
started can (aux)
40 30 (compound)
gm ) (punct)
hpa ( (punct)
recognized toxicity (nsubjpass)
photostimulation glutamate (compound)
tobramycin infusion (compound)
d and (cc)
lend derangement (nmod)
effects emissions (nmod)
aspartate glutamine (conj)
effect diameter (nmod)
developed weeks (nmod)
anemia the (det)
dividing bands (nmod)
deduced softly (advmod)
performed rate (nmod)
dyskinesias ipsilateral (amod)
veins from (case)
l-med ; (punct)
u/ml 52.7 (nummod)
population japanese (amod)
served rats (nsubj)
four all (det)
long involved (conj)
irregularities arterial (amod)
4 ( (punct)
clotting blood (nmod)
increase binding (nmod)
alpha-position 5-h (conj)
offers advantages (dobj)
improvement acuity (nmod)
indicator a (det)
ability righting (compound)
mellitus nephrotoxicity (conj)
iv york (compound)
effects for (case)
subjects especially (advmod)
patients dose (dep)
reduction map (nmod)
highlights contribution (dobj)
trials taken (acl)
longer , (punct)
presentation factors (conj)
correlates that (mark)
containing acid (dobj)
densities in (case)
demonstrated results (nsubjpass)
investigator to (case)
injection minutes (nmod:npmod)
200 - (punct)
analyses animals (nmod)
muscle weight (nmod)
snp by (case)
saline ntg (conj)
median iqr (dep)
induced dexamethasone (nsubj)
day drinking (compound)
warn to (mark)
evaluations in (case)
method as (case)
effects s-limonene (nmod)
increases fev1 (nmod)
salt-sensitivity rats (nmod)
softening 5 (nmod)
discussed data (nsubjpass)
form monoarticular (amod)
occurrence tachydysrhythmias (nmod)
patients 7 (conj)
slowing background (compound)
women premenopausal (amod)
function bladder (compound)
corrected be (auxpass)
probable but (cc)
hazard are (cop)
examined tested (conj)
resulting variety (nmod)
dysfunction inflammation (nmod)
demonstrated be (auxpass)
results aggregation (compound)
accumulation liver (nmod)
given phase (nmod)
stages only (advmod)
related not (neg)
drinkers of (case)
relationship variations (nmod)
had found (conj)
association strong (amod)
success treatment (nmod)
loss no (neg)
reported since (mark)
fumarate tenofovir (compound)
result reversal (nmod)
treated cellulose (nmod)
benzo[a]-pyrene mg/kg (appos)
transplantation a (det)
evidence nuclei (nmod)
lower ; (punct)
inhibits whether (mark)
analyzed methods (nsubjpass)
assigned bpt (dep)
abbott-53693 kg-1 (dep)
administered diuresis (nmod)
reduced down (advmod)
stimulation an (det)
dilates whereas (mark)
supply cellular (amod)
chlormethiazole of (case)
injected needle (nmod)
patients fluctuating (amod)
suggested responsible (advcl)
rhabdomyolysis massive (amod)
phasic tonic (conj)
measurement level (nmod)
followed treatment (dobj)
stimuli vas (appos)
affected diagnosis (nmod)
absorbed excreted (conj)
back-diffusion generation (conj)
cause whether (mark)
stage leakage (nsubj)
rats nonmutant (amod)
adjusted ; (punct)
affect mechanisms (nmod)
nonpregnant of (case)
risk stroke (nmod)
decreased dose (nsubj)
sub-tenon posterior (amod)
tpa ( (punct)
cm la (nmod)
defined as (mark)
associated one (nmod)
disorders nms (nsubj)
scale conners (nmod:poss)
records hospital (compound)
lesions prior (amod)
observed responsiveness (nsubjpass)
task employing (acl)
mini-pump osmotic (amod)
occurred intensity (nsubj)
zidovudine mg (dep)
show patients (nmod)
maximal h (nmod)
months 111 (nummod)
shows eeg (nsubj)
nrvms ) (punct)
titer in (case)
use caution (dobj)
sweating is (cop)
compared data (nmod)
dose-effect relationships (conj)
vehicle only (advmod)
increased abundance (nsubjpass)
investigated period (nmod)
12.8 and (cc)
sediment patients (nmod)
fluid electrolyte (conj)
prolactin prl (appos)
fluorescence fluo3 (compound)
diltiazem and (cc)
salivation behavior (conj)
hyponatremia syndrome (conj)
determine differ (ccomp)
process saturable (amod)
effect pge2 (nmod)
hypertrophy rats (nmod)
pathogens common (amod)
% 55.3 (nummod)
excessive concentrations (nsubj)
membranes peritubular (amod)
marker psychophysiologic (amod)
angiograms on (case)
results flattening (nmod)
be by (case)
measurement index (compound)
wounds of (case)
messages origin (nmod)
$ROOT$ clonidine (sent)
injected : (punct)
analysis interaction (appos)
benefits direct (amod)
response better (amod)
neurones of (case)
induced observed (conj)
described spasm (nsubjpass)
started continued (conj)
90/htn the (det)
represents prevention (nmod)
recurred dyskinesia (nsubj)
had caffeine (nsubj)
required they (nsubjpass)
delineate to (mark)
produced report (nmod)
rats ingesting (acl)
outcomes the (det)
collected events (dobj)
literature mechanisms (conj)
complications several (amod)
implicated has (aux)
rate and/or (cc)
having were (aux)
observed exercise (conj)
resulted interestingly (advmod)
cycles of (case)
located suggesting (advcl)
mg/dl or=2.5 (nummod)
response no (neg)
predictor strong (amod)
elicited . (punct)
mg/kg i.v. (dep)
cotransporter medulla (nmod)
procedures and (cc)
tested responses (nmod)
developed commencement (nmod)
heart both (cc:preconj)
series . (punct)
population as (case)
ability cognitive (amod)
dose standard (amod)
assessed tolerability (nsubjpass)
while level (nsubj)
presence malformations (nmod)
agent active (amod)
counteracted , (punct)
had diseases (dobj)
found been (auxpass)
right- left-pawed (conj)
region vascular (amod)
ischemia and (cc)
12 than (case)
ischaemia 0.65 (dep)
lesion . (punct)
cause administered (advcl)
clues clinical (amod)
$ROOT$ risk (sent)
effect lindane (nmod)
labetalol and (cc)
infants vaccinated (acl:relcl)
substance-induced and (cc)
predictors grade (nsubj)
halts conclusion (nmod)
1.17 ( (punct)
ancas ( (punct)
tuft glomerular (amod)
lymphopenia and (cc)
higher baseline (nmod)
circumstantial regard (nmod)
recorded scale (nmod)
safe is (cop)
increasing consumption (dobj)
emit , (punct)
magnitude induction (nmod)
period the (det)
therapy desferrioxamine (compound)
paclitaxel day (nmod)
undergone procedures (dobj)
prevalence testosterone (nmod)
injection rat (nmod)
associated tap (nmod)
free compared (dep)
has that (nsubj)
bp in (case)
research and (cc)
five in (case)
continue could (aux)
identified = (parataxis)
recovered function (dobj)
conduction follow-up (amod)
phenotypes mice (nmod)
dbs patients (nmod)
cancer le (det)
switched recipients (nsubjpass)
management with (case)
failure % (nmod)
$ROOT$ fk (sent)
relation type (nmod)
rated participants (nsubjpass)
distinguishable fibres (nmod)
tumor a (det)
transporter protein (nsubj)
disturbances as (case)
dmso/side min (appos)
majority types (nmod)
area p<0.001 (dep)
describe woman (dobj)
7.54 respectively (advmod)
genes three (nummod)
examined not (neg)
responses brainstem (compound)
measure efficacy (nmod)
infused was (auxpass)
episodes mania (nmod)
four receiving (acl)
right 4.5+/-1.0 (dep)
cholestasis marked (acl)
urine in (case)
speak effects (nmod)
occurs frequently (advmod)
0.52 2.22 (conj)
tolerability good (amod)
tmax ) (punct)
doses mg (appos)
stereotypy rats (nmod)
normalizes rats (nmod)
role variations (nmod)
withdrawal inhibitor (compound)
and immediately (advmod)
group given (acl)
cardiomyocytes cultured (amod)
complicated needs (conj)
akinesia complete (amod)
placebo n=10 (dep)
function use (conj)
entries platform (nmod)
ng./ml than (case)
interaction consequence (nmod)
periods treatment (nmod)
progression kindling (nmod)
licl of (case)
mg/m(2 800 (nummod)
methysergide of (case)
those such (case)
believed modulation (xcomp)
reported option (xcomp)
exclusion on (case)
disrupted but (cc)
access ( (punct)
neurons ( (punct)
0.6 ci:0.3 (parataxis)
conversion csa-to-srl (compound)
development fibrosis (nmod)
evidence hemolysis (nmod)
rates response (nmod)
undergoing deactivation (dobj)
related decrease (nmod)
anticoagulation agents (nmod)
such function (nmod)
effective alleviating (advcl)
ldlr ( (punct)
supernatants culture (compound)
fibrillation patients (nmod)
prolactin ( (punct)
prescribed clopidogrel (nsubjpass)
using drugs (dobj)
reduction risk (compound)
apoptosis spontaneous (amod)
decreased uptakes (nsubjpass)
impairment hearing (compound)
volunteer in (case)
that required (acl)
haloperidol such (case)
7.54 mg/kg (dep)
thyroidectomy of (case)
regimen agc (nmod)
or=7.18 ) (punct)
methods , (punct)
monohydrate creatine (compound)
assessments safety (compound)
administration recipients (nmod)
determine precisely (advmod)
peaked kinase (nsubj)
rates progression (nmod)
commencement clozapine (nmod)
cases on (case)
chlordiazepoxide doses (nmod)
amphetamine of (case)
improved stoppage (nmod)
depletion groups (nmod)
hyponatremia and (cc)
become hypercalcemic (acomp)
cells ganglion (compound)
recovery near (amod)
perfusion hypotension (nmod)
receiving chemotherapy (nmod)
promote af (dobj)
effect alpha-methyldopa (nmod)
harmful be (cop)
has manifestations (dobj)
carry , (punct)
force uspstf (appos)
hypothesize responsible (ccomp)
used model (nsubjpass)
patient presented (acl:relcl)
individuals other (amod)
questioned have (aux)
those and (cc)
activity decrease (conj)
rna of (case)
plasma fresh-frozen (amod)
maintained dialysis (nmod)
shown who (nsubj)
letrozole inhibitor (compound)
mrna cyp27 (compound)
diet- and (cc)
seems made (ccomp)
include options (nsubj)
prevent mechanisms (nsubj)
was vnr (nmod)
dopamine metabolites (conj)
recurrence with (case)
pneumonitis evidence (conj)
found has (aux)
synaptophysin snap-25 (conj)
years 58.5 (nummod)
nanoparticles cyanoacrylate (compound)
element important (amod)
metastases seven (nummod)
effect variable (conj)
otoprotectant loss (nmod)
heterogeneous spectrum (nsubj)
linked rhabdomyolysis (nmod)
suggests condition (ccomp)
model seizures (nmod)
dizziness with (case)
familiarity professionals (nmod)
death ami-induced (amod)
depression respiratory (amod)
= mean (appos)
potentiated melatonin (nsubj)
taqib rs6275 (conj)
had rhabdomyolysis (dobj)
control with (case)
dynamics the (det)
$ROOT$ progressed (sent)
associated results (nsubjpass)
advisable develop (advcl)
kinetics and (cc)
predicted . (punct)
pupillometer a (det)
water ra-free (amod)
elimination hemodiafiltration (nmod)
protein green (amod)
eleven none (conj)
induces intoxications (nmod)
containing level (nmod)
content assay (conj)
f 101.2 (nummod)
administered orally (advmod)
studies perfusion (compound)
argue action (nmod)
increased furthermore (advmod)
capable penetrating (advcl)
plate of (case)
period refractory (amod)
icu ) (punct)
t30 ) (punct)
rationale use (nmod)
cells medullary (amod)
aorta/serum-ratio the (det)
csf ) (punct)
products contaminated (amod)
nimo ) (punct)
three % (appos)
similar values (nsubj)
0.0073 + (cc)
induced , (punct)
incubated , (punct)
mg 1.0 (compound)
intermediate toxic (amod)
presented had (parataxis)
rnfl average (amod)
lv late-onset (amod)
complained . (punct)
recommended limitations (nsubjpass)
complications is (cop)
ameliorated but (cc)
appeared that (mark)
methods placed (appos)
values study (nmod)
performed trial (dobj)
equipotent are (cop)
injection icv (compound)
second from (case)
synovitis destructive (amod)
therapy hd-mtx (compound)
occupancy subjects (nmod)
negative while (mark)
developed mild (ccomp)
decreased preparations (nmod)
showed preponderance (nmod)
receive induction (nmod)
slowing changes (conj)
reversibility days (nmod)
drugs salicylate (appos)
52.7 - (dep)
accumulation both (cc:preconj)
substituted sulindac (nsubjpass)
calculation ( (punct)
pharmacology of (case)
coma alpha (nsubj)
fat in (case)
focused effects (nmod)
related play (advcl)
doses salbutamol (nmod)
result cardioprotection (nmod)
3.6 5.7 (conj)
degrees similar (amod)
profile depressive-like (amod)
approximate exposure (dobj)
resuscitation standard (amod)
cases recent (amod)
mortality mortality (conj)
randomised cross-over (dep)
assessed responses (nsubjpass)
mg./kg ( (punct)
mpo-anca ( (punct)
signaling (ecm)/integrin (compound)
results occurred (appos)
found dothiepin (nsubjpass)
447 received (acl:relcl)
reactions media (nmod)
needle a (det)
differed other (nmod)
$ROOT$ focuses (sent)
chemistry serum (compound)
ratio 3.5+/-0.9 (nmod)
induces activity (nsubj)
regained and (cc)
dystonia levodopa-induced (amod)
preserved controls (advcl)
suggest generates (ccomp)
preceded increase (nmod)
exposed trimester (nmod)
dismissed were (auxpass)
sensitive failure (nmod)
sequence close (amod)
provide sedation (dobj)
yrs ( (punct)
spect ) (punct)
thiols non-protein (amod)
chewing vacuous (amod)
reinforces , (punct)
mapping electrocardiographic (amod)
incidence cysts (nmod)
methscopolamine neostigmine (conj)
dystrophy gout (conj)
hydrochloride trihexyphenidyl (compound)
cisplatin plus (cc)
drug used (amod)
destroy , (punct)
question a (det)
65 to (case)
series small (amod)
had ganglia (nmod)
reducing of (mark)
% 6.5 (nummod)
drugs etoposide (dep)
scale and (cc)
used number (nsubj)
pilocarpine after (case)
$ROOT$ value (sent)
therapy ht (appos)
size-dependent and (cc)
treated and (cc)
37 - (advmod)
regulation from (case)
hbig ( (punct)
antagonized and (advmod)
evaluate patterns (dobj)
agent alternative (amod)
ensued and (cc)
enhance males (nmod)
induced carcinogens (nmod)
effects qt (compound)
staining blue (amod)
coefficient 0.72 (appos)
gvg low (amod)
pain capsaicin-induced (amod)
achieved valproate (nmod)
cephalosporins second- (amod)
resistance in (case)
affinities in (case)
effect bleeding (nsubj)
hepatitis by (case)
treatment with (case)
development recent (amod)
convulsion elicited (acl)
effect quetiapine (nmod)
had level (dobj)
ioxaglate ( (punct)
made comparisons (nsubjpass)
pseudoacromegaly induced (acl)
application clinical (amod)
observations adults (nmod)
dose saline (appos)
studied procaterol (nsubjpass)
microglobulinuria reabsorption (conj)
rash neuropathy (conj)
determine relationship (dobj)
rechallenge androgen (nmod)
cannabis/alcohol/nicotine can (appos)
unlikely , (punct)
doses acceptable (amod)
$ROOT$ accelerate (sent)
tubules of (case)
toleration patients (nmod)
$ROOT$ injury (sent)
remissions % (parataxis)
use anthracyclines (nmod)
values aldosterone (compound)
preparations rabbit (compound)
given carbenicillin (nsubjpass)
infusion ritodrine (nmod)
history rhinitis (nmod)
have relevance (dobj)
85.9 3.8 (conj)
= .006 (dobj)
ratios dopamine (compound)
have delivered (conj)
events acute (amod)
hemorrhage with (case)
corresponds analysis (nmod)
alpha,3 alpha- (dep)
suspected test (nmod)
therapy tumors (conj)
inhibition gabaergic (amod)
months haart (nmod)
early hours (nmod)
seems exist (xcomp)
discovery scale-up (conj)
interviewed examine (advcl)
relapsed disease (dobj)
minutes 25.6 (nummod)
with preferably (advmod)
perturbation electrical (amod)
gvg sub-chronic (amod)
was cultures (nmod)
years at (case)
day 7th (amod)
transporter channel (conj)
displays btc (nmod)
neuropathy in (case)
levels sham-operated (amod)
taken was (auxpass)
anephric functionally (advmod)
segments l1-l2 (compound)
investigated essential (advcl)
examined case (dobj)
hormone lh-releasing (amod)
impairment a (det)
decreases patients (nmod)
nausea drowsiness (conj)
persisted had (ccomp)
intake cc (compound)
inhibition channel (compound)
barrier endothelial (amod)
recorded times (nmod)
symptoms associated (amod)
based dsm-iv (nmod)
caused abolished (conj)
doses ketoconazole (nmod)
reached has (aux)
basis an (det)
anticoagulant and (cc)
malfunctioning due (case)
background have (appos)
papaverine phentolamine (appos)
psychologist development (nmod)
incidence occurrence (conj)
placement pump (nmod)
iopamidol with (case)
sops to (case)
changes physical (amod)
require and (cc)
$ROOT$ interacted (sent)
ng/ml 30 (compound)
acquired follow-up (nmod)
medication phenytoin (compound)
tapered 16 (nmod)
use tumors (conj)
programmed dexamethasone (nsubj)
framework the (det)
nitrogen of (case)
assigned weeks (advmod)
patients age- (amod)
history 10-year (compound)
course paralysis (nmod)
x/minute 5 (nummod)
acid atra (appos)
observation reduces (ccomp)
cefonicid not (cc)
perivascular interstitial (conj)
acidosis metabolic (amod)
5-fu before (case)
liver rats (nmod)
exceed risk (nsubj)
dexamethasone , (punct)
shown ratio (dobj)
minimum after (case)
observed ulcers (nsubjpass)
da metabolites (conj)
phenotype differentiated (amod)
restarted that (mark)
on and (cc)
studied samples (nsubjpass)
events later (amod)
mechanism reaction (nmod)
use sumatriptan (compound)
occurred confined (parataxis)
received orally (advmod)
downregulation pronounced (amod)
resulted eradication (nmod)
rp the (det)
observed observed (advcl)
excluding mechanism (dobj)
activating rapidly (advmod)
reaction life-threatening (amod)
features other (amod)
reversal recovery (conj)
minor only (advmod)
scanning angiography (conj)
hemiparesis with (case)
tear muscle (compound)
man used (acl:relcl)
expected and (cc)
survival reduced (amod)
reactions pseudo-allergic (amod)
widened ms (nmod)
expression cxcl1 (nmod)
patients tuberculous (amod)
significant to (mark)
unlikely because (mark)
patients users (conj)
deletion or (cc)
had redness (dobj)
anorexigens states (nmod)
withdrawal by (case)
excess in (case)
monoher ) (punct)
can sarcoma (conj)
symptoms neurotoxicity (compound)
increase ) (punct)
0.6 , (punct)
effect reported (amod)
calculations surface (compound)
bepridil with (case)
ritonavir such (case)
picture electroencephalographic (amod)
accumulation cholesteryl (compound)
reported registry (nmod)
prerequisite injury (nsubj)
applied group (nmod)
review children (nmod)
occur conclusion (nmod)
attributed mainly (advmod)
guidelines therapy (nmod)
subunits the (det)
observed expression (nsubjpass)
arrhythmias strophanthidin-induced (amod)
abnormalities attributed (acl:relcl)
regulated which (nsubj)
abnormalities audiogram (compound)
training and (cc)
conditions known (amod)
increment % (compound)
series case (compound)
thalidomide with (case)
methods few (amod)
overdose by (case)
headache patient (nmod)
rate secretory (amod)
territory of (case)
disability of (case)
mrna . (punct)
mechanisms programming (compound)
tests serologic (amod)
associated pemoline (nmod:npmod)
2.9 and (cc)
enzymes patterns (conj)
subjected conditions (nmod)
inhibited combined (advcl)
activities protease (compound)
adrenoceptor rat (compound)
$ROOT$ arthrogryposis (sent)
levels determined (acl)
cancer the (det)
measured day (nmod:tmod)
muscle ) (punct)
cause intake (nsubj)
12 24 (conj)
strengthen data (nsubj)
effect development (nmod)
administered phenytoin (nsubjpass)
a/j c3h/hej (appos)
has thalidomide (nsubj)
paclitaxel and (cc)
lung hospital (nmod)
reversible potentially (advmod)
mg/dl ( (punct)
membrane-cytoskeleton and (cc)
test kruskal-wallis (compound)
change mean (amod)
study pilot (amod)
identified study (nmod)
site novel (amod)
development monkeys (nmod)
benefit lids (nmod)
march between (case)
percent by (case)
examining hippocampus (dobj)
without even (advmod)
0.3 or (cc)
0.01 , (punct)
54 ( (punct)
midazolam versus (cc)
selection careful (amod)
presentation their (nmod:poss)
p-glycoprotein of (case)
discontinuous , (punct)
reducing percentage (dobj)
nimesulide paracetamol (conj)
73.6 21.6 (conj)
diagnosed instituted (conj)
induce it (nsubj)
achieved min (nmod)
count the (det)
sh(6 ( (punct)
testing behavioral (amod)
strains brown (amod)
shown produce (ccomp)
% 32 (compound)
measure tone (nmod)
effects potassium (compound)
females untreated (amod)
reflection often (advmod)
glomerulonephritis cancer (conj)
case thyrotoxicosis (nmod)
spectrometry by (case)
sexes in (case)
kf17837 antagonist (appos)
neuropathy nerve (nmod)
term at (case)
acid mg (appos)
bradykinesia dyskinesias (conj)
received six (nsubj)
epileptogenesis and (cc)
neuropathy acute (amod)
recipient a (det)
dose oxycodone (nmod)
noted donor (nsubj)
inhibitor 7-ni (dep)
food supplements (conj)
sensitivity skin (nmod)
acting centrally (advmod)
clinic the (det)
mothers to (case)
brainstem in (case)
surveillance local (amod)
fentanyl propofol (conj)
dependence in (case)
1.76 - (punct)
occlusion middle (amod)
relapsed/refractory r/r (dep)
assessment as (cc)
multifactorial . (punct)
contributed precipitating (advcl)
of be (cop)
evident that (nsubj)
symptomatic had (conj)
suppressed markedly (advmod)
quality response (nmod)
utilization its (nmod:poss)
conclusions common (dep)
cns and (cc)
change with (case)
impairs that (nsubj)
received percent (nsubj)
suggests similar (ccomp)
had necrosis (dobj)
normalization disappearance (nmod)
lower incidence (nsubj)
upslope increased (amod)
assessed echocardiographically (advmod)
tdp with (case)
asystole cardiac (amod)
system by (case)
map degeneration (nmod)
signs systemic (amod)
capable that (mark)
reverse dysfunction (dobj)
trials trial (appos)
coniine alkaloid (appos)
linked purpose (nsubjpass)
complication myocarditis (nsubj)
initiating reflex (dobj)
free precursors (nmod)
pressure isotypes (conj)
evaluated results (nsubjpass)
cases ( (punct)
testing immunoassay (compound)
analogue lamivudine (nsubj)
reversed completely (advmod)
dosage full (amod)
stimulated a (dep)
withdrawal bradycardia (conj)
year stimulation (nmod)
failed suggesting (xcomp)
affect incidence (dobj)
events frequent (amod)
aware be (cop)
instrument the (det)
able percent (nsubj)
quinine of (case)
imaging , (punct)
levodopa as (case)
selective , (punct)
disease pd (appos)
doses from (case)
epimers corresponding (amod)
glomerulonephritis progressive (amod)
admitted who (nsubjpass)
s. 30 (nummod)
arose also (advmod)
produced . (punct)
dose based (case)
using stimulation (nmod)
suggesting necrosis (dobj)
solution timolol (compound)
finding may (aux)
regulation altered (amod)
mediated interactions (nmod)
outcome therapy (nmod)
studies inhibitor (nmod)
exposure adult (amod)
postulated however (advmod)
dilatation pelvocalyceal (amod)
73 - (advmod)
need labelling (nmod)
depleted regions (nmod)
lidocaine prophylactic (amod)
level steady (amod)
attenuates which (nsubj)
intervals in (case)
accumulation less (advmod)
hypersensitivity reactions (nmod)
breaks min (compound)
adjusting confounders (nmod)
peaked concentration (nsubj)
dihydropyridine first (amod)
suppression carriers (nmod)
days ptrend=0.50 (dep)
propranolol biperiden (conj)
absence convulsions (nmod)
maze the (det)
aucs at (case)
) 1.1 (nummod)
deletion gene (compound)
identified also (advmod)
lesions neoplastic (amod)
atra ( (punct)
role pathophysiological (amod)
regardless therapy (nmod)
mg l-sotalol (nmod)
that compared (case)
coefficient icc (appos)
demonstrated test (nsubj)
resistant however (advmod)
develop will (aux)
perturbation membrane (nmod)
reduction after (case)
dissociation atrioventricular (amod)
therapy cytotoxic (amod)
residents of (case)
degree injections (nmod)
% 26 (nummod)
addressed study (nsubj)
conners the (det)
measures ) (punct)
estimate compare (conj)
hands feet (conj)
prednisolone of (case)
others in (case)
ufh to (case)
radiotherapy topotecan (conj)
described outcome (nsubj)
had output (dobj)
days treatment (dep)
induction anesthesia (compound)
agonist ptz (dep)
hepatitis report (dep)
forelimb hindlimb (conj)
are . (punct)
produce show (parataxis)
used animals (nsubjpass)
have structures (dobj)
indicate that (mark)
l-alpha-glycerylphosphorylcholine of (case)
regimens drugs (nmod)
l2 l5 (conj)
palsy polyneuropathy (conj)
accuracy and (cc)
period re-started (acl:relcl)
10 cases (nmod)
acts and (cc)
juice of (case)
clearance its (nmod:poss)
pharmacology gyki-41 (nmod)
day . (punct)
failure underlying (amod)
abuse substance (compound)
feasibility application (nmod)
100 582 (prep)
models pathophysiological (amod)
thromboembolism or (cc)
returned values (nsubj)
derivatives formed (acl)
cardiotoxicity develop (acl:relcl)
became which (nsubj)
pretreatment diazepam (nmod)
menorrhagia with (case)
mean+/-sd ) (punct)
formed interim (nmod)
ease creams (nmod)
return undergoing (advcl)
mitochondria adp-stimulated (amod)
causes many (amod)
technique hybridization (compound)
pathology . (punct)
risks of (case)
warrant , (punct)
characteristics phenotypic (amod)
found months (nmod)
cardiomyopathy takotsubo (compound)
regimen from (case)
millions those (appos)
response aberrant (amod)
dependence time (compound)
program the (det)
glomerulosclerosis to (case)
tissue of (case)
(+)-cibenzoline and (cc)
s-312 , (punct)
consumption volume (conj)
follow-up markers (nmod)
randomized crossed (conj)
runs complexes (nmod)
cardiomyopathy iodine-125-metaiodobenzylguanidine (nmod)
characteristics acuity (conj)
inducing without (mark)
associated cases (conj)
trial by (case)
patient viracept (acl:relcl)
cocaine , (punct)
symptoms , (punct)
alter doses (nmod)
48 8 (conj)
average hg (nmod)
weeks 48 (nummod)
ah6809 , (punct)
neurophysiological velocity (dep)
decreased elevated (advcl)
feasibility the (det)
1.0 0.52 (conj)
abstracted , (punct)
model study (nmod)
literature from (case)
treated shr (nsubjpass)
recipients graft (compound)
evidence qualitative (amod)
excretion gsi (conj)
improved survival (dobj)
caused concentration (nsubj)
depressed resolved (conj)
impairment an (det)
communicate machinery (nmod)
abrogated endomt (dobj)
represented mainly (advmod)
established has (aux)
163 +/- (cc)
affect sex (nsubj)
differentiation cardiomyocyte (compound)
period hr (dep)
myopathy corticosteroid (compound)
worsening tasks (nmod)
insecticides used (amod)
irreversible , (punct)
15 3 (conj)
administration telithromycin (nmod)
rats newborn (amod)
demonstrated presence (dobj)
measured resistance (dobj)
occurring days (nmod)
depression function (nmod)
vesicles typical (amod)
treatment daily (dep)
mutations butyrylcholinesterase (compound)
ouabain ) (nmod)
ameliorated function (dobj)
% p=0.001 (dep)
grade or (cc)
bingeing sugar (nmod)
alleviate deficits (dobj)
repair tissue (compound)
= with (case)
relaxants of (case)
increased represented (ccomp)
abnormalities brains (nmod)
resulted seizure (nmod)
presence blockade (nmod)
manifests classically (advmod)
develop neutropenia (dobj)
likelihood higher (amod)
varied dose (nmod)
mmse ( (punct)
malaria hospitals (nmod)
neutropenia anemia (conj)
occurred 4 (nmod)
mandatory is (cop)
or(adj with (case)
possible : (punct)
nephrotoxicity pap (compound)
proteins trifluoroacetyl-altered (amod)
observed receiving (advcl)
assay cytotoxicity (compound)
decrease agents (nsubj)
differences sex (compound)
suppression twitch (compound)
years smoked (conj)
lip with (case)
dismissed diagnoses (nsubjpass)
abundance decreased (amod)
effects disappear (conj)
potent cromakalim (nsubj)
mediated azithromycin (nmod)
-18 8 (conj)
60 about (advmod)
catheter dosing (compound)
concentration levels (conj)
associated escape (nmod)
diagnosis sah (nmod)
primigravida in (case)
lethargy weakness (conj)
methods cultured (appos)
in below (conj)
myopathy history (conj)
induced shr (nmod)
phenomenon , (punct)
substrates brain (compound)
cerebellum induced (acl)
face such (case)
percent sixty-nine (nummod)
change established (advcl)
conclude have (conj)
patients hemodialyzed (amod)
noted confirmed (conj)
trial 2 (nummod)
urge we (nsubj)
idea induce (ccomp)
alive were (cop)
overflow force (compound)
system organ (compound)
changes transaminases (nmod)
remained pressure (nsubj)
patients doxorubicin-treated (amod)
controls patients (conj)
associated cpa/ee (nmod)
high were (cop)
imaging myocardial (amod)
stores renal (amod)
epilepsy such (case)
den pb (conj)
molecule octapeptide (compound)
strains antigen-positive (amod)
percentage tdfs (nmod)
cromakalim of (case)
dose-dependent was (cop)
% 50 (compound)
sediment and (cc)
considerations neurobiological (amod)
intervention(s examination (appos)
haplotypes ( (punct)
examined focus (nmod)
plays morphine (nsubj)
transfusion blood (compound)
complications of (case)
used when (advmod)
correlated concentration (nsubj)
tet nor (cc)
d-med ( (punct)
attacks hyperreactivity (conj)
5ht2a ) (punct)
required total (dobj)
% fraction (nsubj)
contribution site (nmod)
able recall (xcomp)
scattered densa (nmod)
injury allergic-type (amod)
changes vigabatrin-associated (amod)
rise beta (compound)
introduction probe (compound)
triggers apoptosis (dobj)
appears action (nsubj)
10 0 (quantmod)
micrograms microliter (nmod)
carvedilol mg (appos)
intake concomitant (amod)
had compliance (dobj)
made presentation (nmod)
ethanol g/kg (appos)
lmwh on (case)
differ measure (nmod)
40 10 (compound)
normalized ng/ml (parataxis)
100mg/kg not (neg)
deprivation and (cc)
t , (punct)
mg/kg hr (appos)
placed be (auxpass)
received onset (nmod)
= 2.0 (dobj)
contributes effect (nmod)
reactions catalysed (amod)
follow-up for (case)
compared have (aux)
less both (dep)
glycol polyethylene (compound)
au ) (punct)
sensitivity catecholamine (compound)
31 group (nmod)
21 14 (compound)
desmin glomerular (amod)
either ppa (nmod)
man presented (acl)
escalation tolerated (advcl)
divided over (compound:prt)
detection mapping (nmod)
toxicity vitamin (compound)
related patients (nmod)
had contained (advcl)
mmol 1.7 (compound)
potassium aldosterone (conj)
gentamicin , (punct)
emphasis a (det)
specimens and (cc)
function apnoea (nmod)
decreased naphazoline (nmod)
edema a (det)
minimum % (nmod)
closely so (advmod)
rise slow (amod)
dpi after (conj)
stopped occurs (advcl)
depression resulted (acl:relcl)
measures neurocognitive (amod)
reduced rate (nsubjpass)
$ROOT$ interrupted (sent)
lower production (nsubj)
trial randomized (amod)
anorexigens of (case)
$ROOT$ tends (sent)
$ROOT$ augment (sent)
conclusion indicative (appos)
were brain (nmod)
use midazolan (nmod)
mg and (cc)
help avoiding (xcomp)
ra % (amod)
levels cbz (nmod)
variation genetic (amod)
paralysis discontinuance (nmod)
formulation propofol (nmod)
reducing mortality (dobj)
exposure cutaneous (amod)
reactions acetaminophen (nmod)
retention increased (amod)
explained which (nsubjpass)
performed detection (dobj)
require effects (nsubj)
easy used (conj)
populations patient (compound)
medication between (case)
pseudo-allergy a (det)
greater consistent (advcl)
radiotherapy of (case)
recorded still (advmod)
considered administered (advcl)
svc veins (conj)
nephropathy lithium-induced (amod)
shifts due (case)
intravenous but (cc)
occurred infections (nmod)
investigate contribute (ccomp)
latencies tail-withdrawal (amod)
drug each (det)
doses small (amod)
detect ischemia (dobj)
enabled us (dobj)
some indices (nmod)
disorder presenting (acl)
presented demonstrating (advcl)
due sensitisation (nmod)
none , (punct)
cavity in (case)
protected inhibitor (nsubj)
increasing l(-1 (nmod)
received po (parataxis)
absence with (case)
lymphopenia ) (punct)
subcortex the (det)
antibodies , (punct)
receive both (dep)
efficient moreover (advmod)
derivative 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one (nmod)
disappearance waveforms (nmod)
mortality of (case)
was assess (xcomp)
current dc (compound)
behaviors of (case)
nephrotoxicity e.g. (advmod)
0 . (nummod)
factors colony-stimulating (amod)
discontinued completely (advmod)
cgi-sf for (case)
university portland (conj)
shr of (case)
reaching high (advmod)
sinusitis adults (nmod)
yield screening (nsubj)
iu/kg/h 25 (nummod)
psychosis a (det)
persons susceptible (amod)
mg/kg apap (compound)
nephropathy nonionic (amod)
51 of (advmod)
effects oct (nmod)
dex + (cc)
words repeated (acl)
reported damage (nmod)
dexamethasone methylprednisolone (conj)
strategy searched (acl)
effect days (nmod)
observations comments (conj)
nephrin a-actinin (conj)
8000 approximately (advmod)
accumulation myocardial (amod)
shift hz (nmod)
severity according (case)
dialysis on (case)
outcome composite (amod)
damage owing (case)
depletion of (case)
developed children (nsubj)
plays ototoxicity (nmod)
system reticular (amod)
solution than (case)
certain it (nsubj)
patients premedicated (acl)
received thrombin (dobj)
indicate plays (ccomp)
injection during (case)
this from (case)
clinical pharmacological (conj)
enuresis disinhibition (conj)
concentrations ionic (amod)
formulation of (case)
neoplasms patients (nmod)
2,682,2,803 and (cc)
1.68 , (punct)
systematic retrospective (dep)
induce defects (dobj)
comment for (case)
synthesis the (det)
suggest demonstrate (conj)
accompanies that (nsubj)
procedures occurrence (conj)
insufficiency : (punct)
shake wet (amod)
agents to (case)
retardation disorientation (conj)
proportional is (cop)
with background (conj)
studies radiological (amod)
23.43 + (cc)
shows activity (dobj)
action striatum (nmod)
frequency patients (nmod)
nerve antebrachial (amod)
compare conditions (dobj)
transformation -- (punct)
1 experiment (nmod)
pupillometer infrared (amod)
markers levels (conj)
factor promoting (amod)
experienced hepatitis (dobj)
disturbances metabolism (nmod)
lymphoma gastric (amod)
alleviate cardiotoxicity (dobj)
supports diagnosis (dobj)
independent quality (nsubj)
abolish effect (dobj)
0.9 0.8 (nummod)
considered group (nmod)
btc for (case)
mg/kg/day 12.5 (nummod)
% 20.5 (nummod)
pesticide an (det)
ventricle plus (cc)
therapy myeloma (nmod)
age values (conj)
chemosensitivity central (amod)
produced unclear (parataxis)
decreased administration (nmod)
analog norepinephrine (nmod)
microscopy laser (compound)
saralasin of (case)
neuropathy ethambutol (compound)
resulted had (parataxis)
hypertension pph (appos)
that fungizone (nmod)
gap43-ir ( (punct)
receptor metabotropic (amod)
factor angiopoetin-2 (conj)
matter and (cc)
nitroglycerin ointment (conj)
risperidone , (punct)
suggest caused (ccomp)
displayed . (punct)
frequent patients (nmod)
fa ( (punct)
mg/m(2 24-hour (amod)
behavioral test (appos)
basal potassium-stimulated (conj)
mrna protein (conj)
antagonized reduced (conj)
scale scale (conj)
erythematodes lupus (compound)
66 6 (compound)
injury intestinal (amod)
results observed (dep)
interfere administration (nsubj)
hippocampus mice (nmod)
implicated lithium (nsubjpass)
prolongs and (cc)
evaluated patients (dobj)
model hypertension (nmod)
time seizure (nmod)
patients nigerian (amod)
capacity of (case)
given women (nmod)
mi possible (amod)
echoes observation (dobj)
meta-analysis trials (nmod)
paranoia , (punct)
mice vip(-/- (amod)
contraction muscle (compound)
research peer-reviewed (amod)
fastigial or (cc)
infarctions transmural (amod)
stretches only (advmod)
symptoms few (amod)
proliferation with (case)
month 1 (nummod)
consistent detectable (advcl)
orl1 ( (punct)
acetate hydroxyl (appos)
finished until (mark)
firm signs (nmod)
potentiate seriously (advmod)
2.3 +/- (cc)
steroids with (case)
cause amlodipine (nsubj)
prescribed . (punct)
17.5 - (punct)
injection)+ritanserin ritanserin (compound)
prescribed who (nsubj)
causes preserves (conj)
result toxicity (nmod)
parp ec (dep)
spv ( (punct)
depression pharmacological (amod)
hg 130/85 (nummod)
ratios larger (amod)
medicate patient (nsubj)
rpp ( (punct)
present plasma (dep)
changes potassium (nmod)
patient 73-year-old (amod)
history including (case)
lithium on (case)
minutes after (case)
described antagonist (nmod)
july 1 (nummod)
administered experiment (nmod)
system l-arginine-nitric (amod)
fluoxetine of (case)
compared toxicities (nsubjpass)
hypotension coronary (amod)
cb administered (acl)
344 404 (conj)
acid mg)-containing (appos)
developed hours (nmod)
baseline resting (amod)
non-biodegradable that (nsubj)
used decrease (nmod)
) and (cc)
gene a (det)
assay in (case)
embase reviews (conj)
anaesthetised were (auxpass)
prophylaxis it (compound)
marker reliable (amod)
need an (det)
subjects normal (amod)
enlarged was (cop)
relaxants patients (nmod)
band 3 (nummod)
iprk ( (punct)
observed increase (dobj)
outcomes infant (compound)
cause vasculitis (dobj)
party working (compound)
months any (det)
investigated view (nmod)
expression receptor (nmod)
noticed whereas (mark)
drugs presence (dep)
procedure thalamotomy (appos)
relevant use (nmod)
clozapine olanzapine (dep)
induced oxide (nmod:npmod)
observed angina (nmod)
describes case (nsubj)
lasted occasion (nmod)
case insipidus (nmod)
eruptions developed (acl:relcl)
test open (amod)
melphalan high-dose (amod)
increased equally (advmod)
inhibition pharmacological (amod)
source . (punct)
dose cyclosporine (compound)
variance of (case)
agents pharmacotherapeutic (amod)
slowing irregular (amod)
scavenger a (det)
ng 1 (nummod)
recipient 's (case)
given trial (nmod)
natural safe (conj)
increased neither (cc:preconj)
mustard nitrogen (compound)
117.61 ( (punct)
found sclerosis (nsubjpass)
having suffering (conj)
range caerulein (compound)
killed later (advmod)
induced death (dobj)
marker ctnt (nsubj)
noted time (nmod)
hours eighteen (nummod)
changes caused (acl)
25.6 moderate-dose (amod)
amp ) (punct)
$ROOT$ ligand (sent)
third developed (acl:relcl)
lesioned both (cc:preconj)
result atrophy (nmod)
iris the (det)
percentage high (amod)
lungs in (case)
diagnosed having (advcl)
hypoxic were (cop)
degree marked (amod)
detrimental is (cop)
procedures for (case)
localized striatum (nmod)
failure subjects (nmod)
reduction with (case)
analysis biochemical (amod)
1.3+/-0.3 ) (punct)
approval institutional (amod)
eliminated administered (advcl)
gsh of (case)
relevant effect (nsubj)
pri ( (punct)
creatinine scr (appos)
differences radioactivity (nmod)
register trials (compound)
suggested contrast (nmod)
oscs ( (punct)
consisted and (cc)
excluded effect (nsubjpass)
medications patient (nmod:poss)
5.1+/-1.0 p<0.05 (appos)
applicators among (case)
served controls (nmod)
carcinoma 11 (appos)
toxicities cardiovascular (amod)
step down (compound:prt)
pan by (case)
monotherapy = (dep)
inpatients of (case)
scores summed (amod)
inhibited whereas (mark)
mg/kg 20 (nummod)
id50 a (det)
consisted disturbance (nsubj)
short plus (cc)
occurred changes (nsubj)
evolution postoperative (amod)
hemoglobin and (cc)
clearance cyp3a4-mediated (amod)
demonstrated angiography (nsubj)
scale intelligence (compound)
showed sgot (nsubj)
review the (det)
pregs to (case)
explanation result (acl)
form drugs (nmod)
acid aida (appos)
stz- and (cc)
liver functional (amod)
able also (advmod)
alpha3 alpha5 (conj)
form alternate (amod)
lower better (advcl)
tachy- bradycardia (conj)
finally investigation (nmod)
members healthy (amod)
31.6 0.8 (conj)
important play (advcl)
characteristic are (cop)
necessary . (punct)
chemotherapy glioblastoma (nmod)
problems cutaneous (amod)
cause hypertension (nmod)
had apart (advmod)
time ect (appos)
found pathologically (advmod)
tolerability that (nmod)
mr with (case)
variable analyzed (acl)
effects propofol (nmod)
developed interval (dobj)
number externa (nmod)
use steroid (nmod)
describes patients (dobj)
motor autonomic (conj)
reflex human (amod)
45 +/- (cc)
reduces dysfunction (dobj)
proportion responders (appos)
inventory beck (compound)
3tc % (appos)
function liver (compound)
aggregation plasma (nmod)
suggest whereas (mark)
increased epilepticus (nmod)
renin aldosterone (conj)
status procoagulant (compound)
[35s]tbps ( (punct)
sarcolemma sarcomere (conj)
reacted cells (nmod)
0.80 ci (nsubj)
restricted . (punct)
occur signs (nmod)
due movement (nsubj)
reaction patient (appos)
ineffective were (cop)
nik-247 and (cc)
ppi ) (punct)
caused treatment (nsubj)
effects memory (compound)
cytotoxicity on (case)
2.1 risk (nsubj)
exposure nicotine (compound)
discontinuance after (case)
re-challenged rate (nmod)
shows reaction (ccomp)
factors contributing (amod)
treatments three (nummod)
paralysis dysarthria (conj)
used compare (xcomp)
epo of (case)
treated rifampin (nmod:npmod)
tested . (punct)
adenosine radioactive (amod)
associated pain (nmod)
risk cancer (nmod)
unclear implications (nsubj)
received mg/kg/b.w./day (nmod)
infusion 25-mg/m2 (compound)
project national (amod)
characterized bradycardia (nmod)
hypertrophy during (case)
begins . (punct)
performed compare (advcl)
groups n=6 (dep)
affect aspirin (nsubj)
rises ranging (acl)
g/dl 8 (nummod)
affecting are (aux)
mechanism excitatory (amod)
compound microm (appos)
troponin in (case)
time a (det)
conversion recipient (nmod)
prevents deficits (dobj)
interval 1.7 (appos)
activity reduced (amod)
bf-dependent were (cop)
method determination (nmod)
inconsistent . (punct)
reactions inflammatory (amod)
management routine (amod)
strains 15 (nummod)
improved mice (advcl)
characterized which (nsubjpass)
lithium or (cc)
induces neovascularization (dobj)
factors both (dep)
79 +/- (cc)
protein s-100 (compound)
sample cocaine-dependent (amod)
lumens of (case)
pathophysiology underlying (acl)
study change (dobj)
mm subjects (nmod)
reported cough (nsubjpass)
reaction known (amod)
shr shr (conj)
1.8-fold p (appos)
ppa ) (punct)
revealed levels (dobj)
84 % (dep)
anemia issue (dep)
treated dx (nmod)
0.5 from (case)
chronic or (cc)
ribavirin , (punct)
dosings following (case)
reduced incorporation (dobj)
6 48 (prep)
knowledge from (case)
microscopy by (case)
localize genes (dobj)
reaction secondary (amod)
complication no (det)
arthrogryposis , (punct)
treated % (conj)
designed assess (advcl)
standard comparison (nmod)
therapies effective (amod)
mg/kg ip (advmod)
limit man (nmod)
scoring points (dobj)
influence that (mark)
began puberty (nmod)
actions anticonvulsant (amod)
worsened parameters (nsubj)
mechanisms by (case)
used is (cop)
source with (nmod)
manual ( (punct)
second and (cc)
patients % (amod)
sirolimus inhibitor (appos)
akbr aceto-acetate/3-hydroxybutyrate (appos)
containing acetylsalicylate (dobj)
reduced loss (dobj)
interviewed hallucinations (nmod)
$ROOT$ sectioned (sent)
icr albino (amod)
ethyl ( (punct)
disease repair (nmod)
provoked spasm (nsubjpass)
number peroxisomes (nmod)
hiv-negative enrolment (nmod)
survey of (case)
pathways bs (compound)
lists and (cc)
hz at (case)
arteries dogs (nmod)
replies from (case)
patients 54 (nummod)
% 22.5 (nummod)
found exists (ccomp)
expression increased (amod)
started kept (conj)
cross-linking on (case)
polydipsia of (case)
assigned . (punct)
metabolite cocaine (compound)
mmhg 49 (nummod)
ocd ( (punct)
have patients (nsubj)
group ropivacaine (compound)
velocity ( (punct)
five only (advmod)
electrocardiography ecg (appos)
hr compared (case)
arthritis sero-negative (amod)
matched children (nsubjpass)
drop to (mark)
paralysis pre-existing (amod)
higher tended (conj)
b1r(-/- ) (punct)
prevented administration (nsubj)
synapses some (det)
declined subsequently (advmod)
rapamycin by (case)
response desmopressin (nmod)
prevented starting (advcl)
reduced gfr (nsubjpass)
decreased . (punct)
used since (mark)
dysfunction node (compound)
antagonists b1r (compound)
areas within (case)
165 and (cc)
threshold on (case)
a-86929 such (case)
revealed histology (nsubj)
points score (compound)
effect contributing (acl)
concentrations aldosterone (compound)
crisis late-onset (amod)
solid-organ transplant (conj)
favor mechanism (dobj)
synthesized p-coumarate (dobj)
variability index (conj)
up-regulation a (det)
nausea = (dep)
risk discontinuing (advcl)
those drugs (nmod)
impaired use (nmod)
limit upper (amod)
took vgb (dobj)
session before (case)
intervals s (nmod)
showing to (mark)
mmhg < (amod)
mental calculation (appos)
record given (case)
purpose lead (appos)
occur normally (advmod)
levels hbv (compound)
alpha-enac of (case)
carolina iowa (conj)
serum patient (nmod:poss)
3.9 ) (punct)
muscle deltoid (amod)
giving s. (nmod)
usage agent (nmod)
caused determined (ccomp)
medications combined (amod)
npy ( (punct)
size sample (compound)
morphine by (case)
erections apomorphine-induced (amod)
iu/l levels (nsubj)
determined km (nmod)
ratio 0.62 (nummod)
cancer endometrial (amod)
origin for (case)
technique delineating (acl)
score fasciculation (compound)
model nephropathy (compound)
81.6 6.8 (conj)
effect agents (nmod)
dysfunctions disturbances (nmod)
mglur5 ( (punct)
salt bile (compound)
addition alterations (nmod)
drugs clonidine-like (amod)
noted vsd (nsubjpass)
nausea 2 (nummod)
duration dyskinesias (conj)
treated weeks (nmod)
associated action (nsubjpass)
cycles cycles (conj)
found concentrations (nmod)
bigeminy sustained (amod)
hypopharynx ; (punct)
produced paralleling (advcl)
influenced is (auxpass)
remained returned (conj)
inadequate be (xcomp)
had tnss (dobj)
malaria of (case)
screened all (dep)
therapy vancomycin (nmod)
amns subcutaneous (amod)
signed patients (nsubj)
toxicity absence (dep)
oil fat (appos)
subjects twelve (nummod)
show efficacy (dobj)
experiences trial (nmod)
indicate responsible (ccomp)
6/24 to (case)
dose divided (acl)
hoarseness thrush (conj)
proteinuria rats (nmod)
calibration with (case)
sensitization ampicillin (nmod)
actin renal (amod)
anticoagulation long-term (amod)
events adverse (amod)
treatment earlier (amod)
% radioactivity (nmod)
of instead (advmod)
scale interaction (compound)
remained significant (xcomp)
dogs produced (acl:relcl)
1.7 - (advmod)
behaviour akinetic (amod)
features these (det)
undertaken therefore (advmod)
activity demonstrated (amod)
normalized suggesting (advcl)
negative glucose (nmod)
associated monotherapy (nsubjpass)
humans among (case)
ratio overall (amod)
iopamidol or (cc)
d2 dopamine (compound)
recorded were (dep)
reduction mg/kg (appos)
analysis association (nmod)
acid-induced retinoic (amod)
s-limonene or (cc)
modify did (aux)
on dbs (nsubj)
lobule liver (compound)
test tests (conj)
concentrations sodium (compound)
reduced enhanced (conj)
etomidate intermittent (amod)
beginning week (nmod)
pharmacology neurobiology (conj)
scores fasciculation (compound)
ml ml (conj)
effect behaviors (nmod)
gain reader (nsubj)
ages years (nmod:tmod)
sle ) (punct)
alteration change (nmod)
plays cascade (nmod)
does so (advmod)
attenuated response (dobj)
increased superoxide (conj)
difference significant (amod)
patients 138 (nummod)
tension to (case)
monitoring neuromuscular (amod)
mechanism another (det)
replaced methylphenidate (nsubjpass)
relief symptoms (compound)
used states (nmod)
report authors (nsubj)
shelf a (det)
estradiol on (case)
mz of (case)
oral also (advmod)
desensitisation functional (amod)
% 56.9 (nummod)
result(s ): (punct)
observed alterations (nsubjpass)
revealed benefits (dobj)
lower they (nsubj)
trazodone the (det)
support parallels (nsubj)
times effects (conj)
tachycardia compensatory (amod)
developed improve (xcomp)
reappeared complication (nsubj)
lower although (mark)
relating testing (nmod)
measures some (det)
disease cardiomyopathy (conj)
pretreatment lesions (conj)
decrease mean (amod)
performed june (nmod)
modulates estrogen (nsubj)
seizure in (case)
reported observed (conj)
classed patients (nsubjpass)
response test (nmod)
$ROOT$ halts (sent)
depression long-term (amod)
deficits severe (amod)
attenuated , (punct)
chow libitum (amod)
receiving osteomyelitis (nmod)
cirrhosis of (case)
action channel (compound)
pan bw (appos)
remains blockade (nmod)
period 16-month (compound)
received ems (nsubj)
complication implant (nmod)
require combinations (nsubj)
maleate , (punct)
coincident temporally (advmod)
cortex over (case)
therapy intermittent (amod)
report either (cc:preconj)
ameliorates also (advmod)
rbcs dapsone-exposed (amod)
diameter the (det)
activity serum (compound)
correspondence a (det)
results ecg (compound)
lithium ( (punct)
treated inappropriately (advmod)
responsiveness enhanced (amod)
had compared (punct)
receptor this (det)
magnitude that (nsubj)
retention (enac)-dependent (amod)
control bp (compound)
plays role (dobj)
improved discontinued (parataxis)
injection midline (amod)
$ROOT$ hggw (sent)
saline of (case)
impaired low (conj)
infarction dose (nmod)
use methamphetamine (dobj)
contributor is (cop)
on cocaine-and (cc)
consequence . (punct)
treated stz (nmod:npmod)
hypertrophic . (punct)
developed male (nsubj)
dependent time- (nmod:npmod)
300 450 (conj)
disorders motility (compound)
pressures stimulation (nmod)
indicated background (nsubjpass)
interviewed methods (nsubj)
prescribed 196,397 (dobj)
c-induced mitomycin (nmod:npmod)
detection liquid (compound)
km by (case)
500 and (cc)
treatment ceftriaxone (compound)
recognition treatment (conj)
stressed features (dobj)
trial i (nummod)
lesions with (case)
models predictive (amod)
reliability keeping (nmod)
given treatment (nmod)
deposits subepithelial (amod)
nicergoline ) (punct)
death wt (nmod)
concern events (nsubj)
value its (nmod:poss)
mm diameter (nmod)
abnormalities conduction (compound)
survived have (aux)
subscale on (case)
result solubility (nmod)
effect antitumor (amod)
lower slightly (advmod)
% 89/102 (appos)
accumulation metoprolol (compound)
arrhythmogenicity bupivacaine (nmod)
$ROOT$ sent (sent)
occurs when (advmod)
assessed consensus (nmod)
six one (compound)
diseases humans (nmod)
peg-asparaginase cytarabine (conj)
gravis with (case)
thrombocytopenia report (dep)
alters aminonucleoside (nsubj)
groups healthy (amod)
50mg/kg ) (punct)
damage " (punct)
stopped administration (nsubjpass)
showed that (mark)
analogs tested (acl)
metoprolol sparteine (conj)
agents generation (compound)
caused estrogen (nmod)
group ntg (compound)
4/106 ( (punct)
study b (nmod)
haart generic (amod)
examine become (ccomp)
caused background (nsubjpass)
symptoms any (det)
risk switches (nmod)
role digoxin (nmod)
time 3 (dep)
seizure afterdischarge (conj)
6 ( (punct)
includes inhibitors (dobj)
bands the (det)
recorded indicating (advcl)
done not (neg)
methods performed (acl)
coefficient 0.20 (appos)
raised doses (nmod)
events death (conj)
ci=22.8 95 (amod)
administration space (nmod)
rate uptake (nmod)
role mangiferin (nmod)
toxicities grade (compound)
associated differences (nsubjpass)
reversed bradycardia (nmod)
days access (nmod)
site neuropharmacological (amod)
characteristics resembling (advcl)
recorded , (punct)
onset thromboembolism (nmod)
had whether (mark)
extended suggesting (advcl)
treatment no (neg)
leukaemia t-cell (compound)
cancers colorectal (amod)
indicated clinically (advmod)
fixed convulsive (conj)
stress treatment (nmod)
therapy supportive (amod)
hospital camperdown (appos)
subacute was (cop)
care in (case)
evoked episodes (dobj)
protocol improves (acl:relcl)
= 0.0017 (dobj)
stable response (nsubj)
exposure telithromycin (nmod)
showed measurements (nsubj)
alkaloid diterpenoid (amod)
aiming avoid (xcomp)
background acts (dep)
paclitaxel for (case)
recommended help (xcomp)
metabolized cyp2d6 (nmod)
thyroxine tri-iodo-thyronine (conj)
produced anesthetics (nsubj)
mmecs nephropathy (conj)
completion chemotherapy (nmod)
conclude mediates (ccomp)
disorders benign (amod)
developing when (advmod)
mg -0.17 (nummod)
use epinephrine (nmod)
activity n-acetyl-beta-d-glucosaminidase (nmod)
inhibitor pj34 (dep)
occurred was (conj)
cohort hospitals (nmod)
prior onset (nmod)
data perioperative (amod)
injury focal (amod)
2.3+/-1.2 animals (nmod)
hemolysis from (case)
antigen b (compound)
half-life elimination (compound)
cohorts either (preconj)
associated consumption (nmod)
transplantation atresia (nmod)
challenged daily (advmod)
stunning characterized (acl:relcl)
findings randomised (appos)
event thrombotic (amod)
restriction prescription (nmod)
treated igf-il-3 (nmod)
group e-i (compound)
less that (nsubj)
exceed g/day (dobj)
noradrenaline norepinephrine (appos)
delaying induction (dobj)
paper a (det)
obtained csseps (nsubjpass)
similar distributed (conj)
liver some (nmod)
recognize reason (nmod)
option medical (amod)
rationale antidepressant (appos)
remained mg (nmod)
any findings (nmod)
carbachol to (case)
case : (punct)
mtor ) (punct)
permissive or (cc)
. iii (nummod)
used array (nsubjpass)
injury ischaemic (amod)
controls matched (acl)
members the (det)
therapy is (cop)
group transplantation (nmod)
doses and (cc)
ventricular lv (appos)
200 greater (amod)
channel enac (appos)
synapses purkinje (compound)
nocistatin , (punct)
crf n=41 (appos)
included protocol (nmod)
jaundice ( (punct)
value limited (amod)
antagonized effects (nsubjpass)
administration drug (compound)
investigations biochemical (amod)
had infarction (dobj)
incidence angioedema (nmod)
discussed results (nsubjpass)
% reversible (conj)
monitoring for (mark)
bd1018 , (punct)
amount dox (nmod)
pathology quality (nmod)
hyperactivity regions (nmod)
mg/kg 2.5 (nummod)
steroids the (dep)
compressions cardiac (amod)
m.i.n.i. ) (punct)
formulations both (det)
nadir cells/l (appos)
boluses intravenous (amod)
non-compliance because (case)
analysis univariate (amod)
b il-7 (conj)
strains chromosome (compound)
associated receptor (nsubjpass)
element hypoxia-responsive (amod)
development lometrexol (nmod)
hg or (cc)
period 180-minute (compound)
interval 8.8 (appos)
dysfunction prolonged (amod)
life-threatening that (nsubj)
forms of (case)
compared those (nmod)
response found (acl:relcl)
$ROOT$ justified (sent)
= 0.10 (dobj)
studying by (mark)
rate injection (compound)
involves mechanism (nsubj)
infarction anterior (amod)
range anomalies (nmod)
combinations new (amod)
parp ( (punct)
coactivator a (det)
pathogens respective (amod)
three and (cc)
awoke male (nsubj)
content sn (nmod)
> ) (punct)
phases encode (compound)
cardiomyopathy tachycardia (conj)
amount reduced (amod)
transmission of (case)
leakage bbb (nmod)
mcao ( (punct)
ml/kg 4 (nummod)
falls that (mark)
apd interval (conj)
strategy prevent (acl:relcl)
artery retinal (amod)
differ females (nmod)
incidence women (nmod)
maximal changes (nsubj)
facilitation dependency (conj)
failed microinjections (nsubj)
slowed excretion (nsubjpass)
albumin excretion (conj)
function postcibal (amod)
gastroenteritis including (case)
modifications , (punct)
saline rocuronium (conj)
tolerated cabergoline (nsubjpass)
h surgery (nmod)
induced caused (ccomp)
activity recorded (acl)
hydroxyquinolines halogenated (amod)
observed pressure (nmod)
world the (det)
shown liberate (xcomp)
trabeculectomies % (appos)
26 versus (cc)
detection of (case)
worth could (aux)
527+/-509 , (punct)
aim determine (acl)
reduction cancer (nmod)
treatment inhibitors (nmod)
repeated study (nsubjpass)
value relative (amod)
choice drugs (nsubj)
rilmenidine microg/kg (appos)
safe relatively (advmod)
study in-vivo (amod)
dyskinesias : (punct)
detection histology (conj)
isolated kidneys (nmod)
moderate from (case)
lymphoma burkitt (compound)
present it (nsubj)
interviews in (case)
induced intravesically (advmod)
monotherapy . (punct)
demonstrated risk (dobj)
investigate comparison (nmod)
uropathy for (case)
levels mda (compound)
35 and (cc)
signs failure (nmod)
1.0 0.97 (conj)
treated prochlorperazine (nmod)
q10 of (case)
ionic ionic (conj)
pathogeneses and (cc)
prevention amnesia (nmod)
microg% to (case)
reversed mice (nmod)
given ceftriaxone (dobj)
$ROOT$ motionless (sent)
failure hepatitis (nmod)
using substrate (nmod)
vpa-therapy to (case)
rates tachyarrhythmias (nmod)
increases produce (conj)
= .02 (dobj)
screening careful (amod)
acid simvastatin (compound)
differ pulse (nsubj)
analogue inhibitor (conj)
images patients (nmod)
16 +/- (cc)
tests two (nummod)
by-product acoustic (amod)
seen clearly (advmod)
circulation to (case)
amlodipine on (case)
act arteries (nmod)
exchange infusion (conj)
glaucoma corticosteroid (compound)
events were (cop)
treatment antithrombotic (amod)
removing agent (dobj)
polydipsia use (conj)
found reports (nsubjpass)
factors disease (compound)
patients pressure (nmod)
glomerulosclerosis as (cc)
provocation or (cc)
metalloproteinases mmps (appos)
mg mg (conj)
difluoromethylornithine sulindac (conj)
agonist serotonin-1 (compound)
mipafox of (case)
invited attend (xcomp)
stress dysfunction (conj)
hyperthermia malignant (amod)
found none (nsubjpass)
headache extremities (conj)
fucoidan of (case)
density susceptibility (conj)
% mean (dep)
cvp mmhg (appos)
assayed levels (nsubjpass)
release etodolac (compound)
effect blockade (nmod)
pneumonia health-care-associated (amod)
astrocytes of (case)
hypothesis linked (dep)
vgpr > (nummod)
responded achieved (conj)
insufficiency renal (amod)
appear related (xcomp)
masson 's (case)
protected changes (nmod)
frequency intensity (conj)
side-effects prednisolone (nmod)
responded , (punct)
administration pilocarpine (nmod)
therapy rescue (compound)
adsd ( (punct)
reported improvement (dobj)
diameters segments (nmod)
controls 1,021 (nummod)
emphasis with (case)
rate including (case)
shown findings (nsubj)
zero to (case)
measured using (xcomp)
> % (conj)
formation antibodies (nmod)
finding people (nmod)
medical psychosocial (conj)
dystrophy myotonic (amod)
users medications (nmod)
change no (neg)
synthase nitric (amod)
recorded experience (nsubjpass)
right < (dep)
signaling poisoning (nmod)
pontine and (cc)
efficacy safety (conj)
normalization with (case)
standpoint abnormality (nmod)
affected most (advmod)
years last (amod)
received thirty-nine (nsubj)
in particularly (advmod)
samples patients (nmod)
reported receiving (conj)
emissions on (case)
muscles from (case)
died or (cc)
viia factor (compound)
adenomyosis of (case)
advantages carboplatin (nmod:poss)
promotes , (punct)
0.070-unit and (cc)
segments aortic (amod)
nigra rat (compound)
remain setting (nmod)
incidence increase (conj)
rate iop (dep)
inflammation necrosis (conj)
rater a (det)
toxicity is (cop)
maneuver physiological (amod)
features shared (acl)
girl old (amod)
reversal amnesia (nmod)
ring pyrrolidine (compound)
given % (dobj)
failure dexmedetomidine (nmod)
method is (cop)
allowed . (punct)
boys young (amod)
dependent but (cc)
prescribing based (prep)
bbb evaluated (acl:relcl)
elderly young (conj)
drugs control (conj)
58.4 6.8 (conj)
period onset (nmod)
had pregnancies (dobj)
failure prerenal (amod)
monitoring events (dobj)
solution chloride (compound)
mmhg 120/80 (nummod)
fibrillation vf (appos)
one 13,000 (nmod)
analyses sample (nmod)
require outcomes (nsubj)
renin low (amod)
alleviated and (cc)
medication of (case)
yr transplantation (dep)
accompanied . (punct)
29.1 21.0 (compound)
reduction amplitude (nmod)
score 2 (appos)
557 67 (conj)
done measurements (nsubjpass)
hcfc 124 (nummod)
received infusions (dobj)
seems because (mark)
evokes convulsions (dobj)
instillation of (case)
remains treatment (nsubj)
intolerant be (cop)
insufficiency spironolactone-induced (amod)
beverages quinine-containing (amod)
disease wilson (nmod:poss)
july 2009 (nummod)
complained complained (advcl)
parallel in (case)
associated all (dep)
agents gastroprotective (amod)
number function (nmod)
divided study (dobj)
radioactivity aorta/serum-ratio (conj)
included overall (advmod)
ability walk (acl)
poisoning fatal (amod)
inhibitors hcn (compound)
designed we (nsubj)
mg/kg 0.625 (nummod)
abusing be (aux)
found rats (nmod)
-59.7 17.9 (conj)
benefit stimulation (nmod)
cause cardiotoxicity (nmod)
evaluating changes (dobj)
control rats (conj)
fenoterol-hydrobromide ritodrin-hcl (conj)
led rats (nmod)
factor-alpha interferon-gamma (conj)
had two (nsubj)
gem-p cohort (nmod)
effects kidney (nmod)
valsartan both (cc:preconj)
transplantation or (cc)
= 47 (dobj)
study responses (dobj)
opportunity analyze (acl)
reduction improvements (conj)
consistent control (nmod)
monitor holter (compound)
induced warfarin (nmod)
rejection failure (conj)
warranted effect (nmod)
effects untoward (amod)
interval s (nmod:tmod)
$ROOT$ amiodarone (sent)
study sample (nmod)
sed 1.03 (conj)
monotherapy lamivudine (compound)
suggesting influence (dobj)
hg ( (punct)
vagina the (det)
didanosine promethazine (conj)
disappeared gradually (advmod)
data cohorts (nmod)
material presented (dep)
disinhibition , (punct)
microphthalmos ) (punct)
rated pain (nsubjpass)
investigating inflammation (dobj)
administered determine (xcomp)
bicuculline and (cc)
pill chinese (amod)
pentobarbital for (case)
hypertension (dex)-induced (amod)
drug single (amod)
use quantities (nmod)
warfarin sodium (compound)
projections of (case)
dis . (dep)
insertion followed (acl)
bicyclo-orthobenzoate ( (punct)
erection ) (punct)
status median (amod)
role regulation (nmod)
eruptions dermatitis (compound)
pump an (det)
contractions and (cc)
scored animals (nmod)
that artery (nmod)
fluorobenzylidene 3 (amod)
damages induced (acl)
$ROOT$ paramount (sent)
strength , (punct)
p at (case)
stem the (det)
learning impaired (amod)
ecg pressure (conj)
decreased mildly (advmod)
patient given (acl)
9.99 1.00 (compound)
latencies and (cc)
surgery cataract (compound)
reversed disorders (dobj)
factor cocaine (nsubj)
computer a (det)
injection i.v. (amod)
caused pretreatment (nsubj)
institution children (nmod)
response epinephrine (nmod)
occurred subjects (nmod)
survival median (amod)
tested polymorphism (nmod)
metabolism resting (amod)
k the (det)
120 90 (compound)
time first (amod)
15/44 and (cc)
binding v (compound)
unknown . (punct)
contribute could (aux)
is preponderance (attr)
earliest ( (punct)
suggesting role (dobj)
acetaminophen associated (acl)
less excretion (nsubj)
screening patients (nmod)
weight infant (compound)
proarrhythmia amiodarone-induced (amod)
contained derivatives (dobj)
measure an (det)
second-generation levonorgestrel (dep)
treatment amb. (nmod)
suggest stimulates (ccomp)
brainstem auditory (amod)
abruptness reversibility (conj)
pgs ( (punct)
case loss (nmod)
signaling ca(2 (compound)
model neuropathy (nmod)
maintain functioning (dobj)
characterized ballooning (nmod)
reduction incidence (nmod)
four in (case)
pathway sulfation (nsubj)
exposure dexamethasone (compound)
administrations theophylline (nmod)
postulated contribute (xcomp)
prior intervals (conj)
school medical (amod)
trial stroke (compound)
machinery contractile (amod)
% 1/10 (appos)
ii ) (punct)
upregulation pgp (nmod)
stratification sex (nmod)
$ROOT$ good (sent)
reading recordings (nmod)
increased diet (nsubj)
convulsions picrotoxin- (amod)
protocol immunosuppressive (amod)
yohimbine , (punct)
metoprolol metoprolol (conj)
study tomography (compound)
infusion immunoglobulin (compound)
alterations strain (nmod)
back hours (nmod)
that action (nsubj)
ci=1.2 ) (punct)
groups patient (compound)
provocation ( (punct)
cingulate limbic (conj)
concentration model (nmod)
produces has (conj)
infiltrate perimysial (amod)
aneurysm taa (appos)
background found (dep)
suffered perforation (dobj)
$ROOT$ restores (sent)
rats 5-azc (amod)
problem common (amod)
do harm (dobj)
most levels (nmod)
10.2 +/- (cc)
controlled ineffective (advcl)
had steroids (nsubj)
nitrogen plasma (compound)
effects catalepsy (nmod)
cardiotoxicity induced (acl)
subjects genotyped (acl)
bladder in (case)
therapy hormone-replacement (compound)
starts proteinuria (nsubj)
proteins weight (compound)
numbers small (amod)
resulted decreases (nmod)
0.1 1ug (conj)
nephropathy caused (acl)
consistent which (nsubj)
similar while (mark)
identified correlates (nsubjpass)
procedure with (case)
preference the (det)
fed rats (nsubjpass)
disorder mental (amod)
physicians prescribing (acl)
patients common (amod)
group research (compound)
valvulopathy was (cop)
6.0 of (case)
signs depression (nmod)
appeared similar (xcomp)
paradigm in (case)
features acromegaloid (amod)
contribute either (dep)
occurrence mutants (nmod)
impact in (case)
interfere metabolism (nmod)
incidences low (amod)
investigated been (auxpass)
department istanbul (appos)
medicine this (det)
evaluated using (xcomp)
frequencies for (case)
1 2.5 (conj)
sixties his (nmod:poss)
ischemic be (cop)
had = (parataxis)
reported all (nsubj)
beats block (conj)
supplementation monohydrate (compound)
expression , (punct)
thrombosis as (case)
fraction in (case)
inferences potential (amod)
incidence changes (nmod)
hemispheres in (case)
ci 0.942 (appos)
group surgery (compound)
delirium , (punct)
dm gentamicin (conj)
secretion an (det)
detected stage (nmod)
group a (compound)
demonstrated stability (dobj)
myoclonus negative (amod)
administration linking (acl)
effects anxiogenic (amod)
ii iii (conj)
selegiline and (cc)
homogenates whole (amod)
safety the (det)
dyspnea ( (punct)
approved asenapine (nsubjpass)
magnitude increase (conj)
effects form (nmod)
gel a (det)
0.01 than (case)
prevented incident (nsubjpass)
flair 7/8 (appos)
mm 178 (nummod)
gamma-hch of (case)
ds in (case)
pantoprazole mg/day (appos)
hr 2 (nummod)
protocol current (amod)
rs6693503 rs9659997 (conj)
control death (nmod)
those found (acl:relcl)
iiib iv (conj)
evidence toxicity (nmod)
maturation a (det)
smaller not (advmod)
acid and (cc)
tests the (det)
blunted ml/min (dep)
derivatives with (case)
decreased prevalence (dobj)
inhibits impase (dobj)
set in (compound:prt)
efficacies relative (amod)
ribavirin interferon (conj)
523.5 +/- (cc)
pan ; (punct)
thresholds discrimination (compound)
responsiveness receptors (conj)
beats/min 40 (nummod)
vasodilator : (punct)
reintroduction fk506 (nmod)
692 ( (punct)
association dose (nmod)
speculated prone (ccomp)
paf ) (punct)
experiment performed (acl)
immunostaining npy (nmod)
normal from (case)
lead inhibition (nsubj)
rabbits in (case)
$ROOT$ angioedema (sent)
mediate response (dobj)
saline 1 (dep)
physicians treating (acl)
changes : (punct)
considered therapy (xcomp)
m0 ) (punct)
insurance swedish (amod)
tumors breast (compound)
hematotoxicity of (case)
support conducting (acl)
adjustment from (case)
only presence (nmod)
tiapride . (punct)
found nor (cc)
effect inhibition (nmod)
different microg/ml (dep)
0.24:1 ratio (nsubj)
decreased nitroglycerin (nmod)
tpp ) (punct)
induction treatment (nmod)
continues use (nsubj)
dehydrogenase nadh (compound)
phosphokinase with (case)
noted levels (nsubjpass)
pressure pressure (conj)
meningitis cryptococcal (amod)
attenuated effect (nsubjpass)
detected disease (nsubjpass)
tremor with (case)
hormone hcrh (appos)
ptu ( (punct)
assessed trials (nsubjpass)
potently component (nmod)
swallowing with (mark)
activation caspase (compound)
higher controls (nmod)
option . (punct)
125 , (punct)
observed dose-responses (nsubjpass)
neuropathy due (amod)
wires pacemaker (compound)
using tissues (dobj)
inhibitor targets (acl:relcl)
patients hyperprolactinemia (nmod)
affect initially (advmod)
scale unified (amod)
showed cardioprotection (dobj)
numbers microtubules (nmod)
was calcification (attr)
examined incidence (dobj)
risk thrombotic (amod)
responses parasympathetic (amod)
cardiotoxicity doxorubicin (compound)
weeks therapy (nmod)
ccr ) (punct)
kidneys fetal (amod)
reach differences (nsubj)
degrees various (amod)
daptomycin high-dose (amod)
severity lesions (nmod)
proliferation epithelial (amod)
labeling such (amod)
auc greater (amod)
radiopharmaceutical a (det)
strain the (det)
expression activation (conj)
administration methylprednisolone (nmod)
model detection (nmod)
concentrated more (advmod)
effects associated (amod)
used background (nsubjpass)
appearance were (cop)
interval p-p (compound)
stimulation similar (amod)
gave . (punct)
$ROOT$ immunoreactivity (sent)
version in (case)
volume average (amod)
support did (aux)
pentobarbital sodium (compound)
implanted tumors (nsubjpass)
side-effect rare (amod)
assessed weeks (nmod:tmod)
% 45.3 (nummod)
time with (case)
nausea increasing (amod)
form intermediates (dobj)
medication prolonged (amod)
morphine mu-agonist (amod)
patients old (dep)
man 82-year-old (amod)
pregs ( (punct)
others all (det)
scanner pet (compound)
effects stage (nmod)
showed concordance (nmod)
ps intravenous (amod)
somatotopy functional (amod)
brought decrease (nmod)
entered finished (conj)
stressed animals (nsubjpass)
studied mechanisms (nsubjpass)
weeks on (case)
sulfate products (nmod)
colorectal , (punct)
pituitary in (case)
% infants (nmod)
determining hemisphere (dobj)
medication patients (nmod)
measure activity (nsubj)
period posttransplant (amod)
presented here (advmod)
conditions the (det)
artery supraclinoid (amod)
cases referred (acl)
infusion s (nmod)
800 up (advmod)
collected plasma (nsubjpass)
marketed been (auxpass)
mglur1 striatal (amod)
activity with (case)
dosage dph (nmod)
mother and (cc)
food and (cc)
pressure at (case)
showed necrosis (dobj)
layers all (predet)
cities in (case)
resolved when (advmod)
regarded cause (nmod)
cerebral pulmonary (conj)
7 9 (prep)
sites and (cc)
1.6+/-0.34 ) (punct)
developed effect (dobj)
placebo micrograms (appos)
dysplasia cortical (amod)
report patients (nmod)
risk myopathy (nmod)
mechanism effects (nmod)
status on (case)
lobes in (case)
maltol and (cc)
background . (punct)
measured pressure (nsubjpass)
indians % (compound)
free restricted (conj)
studied effects (dobj)
inhibitors calcineurin (compound)
infections early (amod)
stabilized hemodynamics (nsubj)
hds after (case)
observed patterns (nmod)
patients epileptic (amod)
potent . (punct)
observations last (amod)
sphincter prostigmine-morphine-induced (amod)
carried cerebellum (nmod)
effects sirolimus (nmod)
influence rigidity (dobj)
therapy of (case)
activity high (amod)
mg/kg = (parataxis)
therapy anti-tumor (amod)
rapamycin to (case)
one and (cc)
hepatotoxicity of (case)
associated adherence (nsubjpass)
output % (appos)
$ROOT$ coma (sent)
ci=25.2 ( (punct)
excretion cgmp (compound)
diagnosis diabetes (nmod)
has used (advcl)
loss from (case)
progressed therapy (nmod)
mg. 10 (nummod)
cohort of (case)
devised had (aux)
hg 99 (nummod)
registry 1969 (nmod)
basis scores (nmod)
resembles cystitis (dobj)
urinate to (mark)
pallidotomy radiofrequency (compound)
stressed test (nmod)
quantify bradycardia (dobj)
negative when (advmod)
admissions period (nmod)
results the (det)
large both (cc:preconj)
present modified (conj)
associated ciprofloxacin (nmod)
level a (det)
damage podocytes (nmod)
duration study (nmod)
toxic : (punct)
administered acquisition (nmod)
made field (nmod)
to carbetocin (nmod)
electing continue (xcomp)
treatment methadone-maintenance (compound)
life the (det)
improvements arousal (nmod)
that tg (nmod)
use of (case)
0.295 0.899 (prep)
suggest important (ccomp)
1.54 1/min (dep)
hypokalemia ( (punct)
fatigue were (cop)
influenced extent (nmod)
damage ultrastructural (amod)
patients 329 (nummod)
up-regulation with (case)
anxiety in (case)
paralysis legs (compound)
attributed could (aux)
carried only (advmod)
4107 . (punct)
advantageous introduction (nsubj)
31 5 (conj)
custody in (case)
15-f(2t)-isop ) (punct)
remain high (acomp)
$ROOT$ occurrence (sent)
peld high (amod)
ro 16 (nummod)
% 1.86 (nummod)
receptors gamma-aminobutyric (amod)
0.24:1 was (cop)
parasitosis psychogenic (amod)
values beta-hcg (compound)
information episodes (nmod)
reduced respectively (advmod)
considered bortezomib (nsubjpass)
bp (sbp)/ (punct)
deviation suggestive (amod)
responses calcium (nmod)
reduced metoprolol (nsubj)
hexamethonium mg (appos)
indicated is (auxpass)
diminish activity (dobj)
aware mouth (nmod)
exacerbations severe (amod)
region domain (nmod)
disrupts mutation (nsubj)
pair 4834 (nummod)
cross-tolerant , (punct)
tachycardia ouabain-induced (amod)
uncommon and (cc)
medications increase (acl:relcl)
doc ) (punct)
mtor-i ) (punct)
benefit potential (amod)
decreased doses (conj)
recorded time (dobj)
mg.kg-1 + (cc)
awful ) (punct)
uncomplicated apparently (advmod)
indicated analysis (nsubj)
performed injecting (advcl)
etoposide 16.213 (nummod)
used information (dobj)
cancer non-small-cell (amod)
microgram/ml above (case)
enalapril ) (punct)
given diagnosis (dobj)
deviation measures (nmod)
beginning stage (nmod)
has effects (nmod)
f2 from (case)
acuity including (case)
absence corticosteroids (nmod)
knowledge and (cc)
population evaluable (amod)
higher or (cc)
made post-mortem (advmod)
groups a (dep)
is research (nmod)
o-methylation in (case)
value group (nmod)
$ROOT$ undergoes (sent)
rejection in (case)
anti-asthmatic tremorgenic (conj)
doxorubicin a (appos)
lesions medullary (amod)
using whilst (mark)
was patient (nmod)
marketed has (aux)
compounds promising (amod)
persons prescribed (acl)
that be (cop)
examine abolish (ccomp)
appeared droplets (nsubj)
birth from (case)
fell coma (nmod)
black was (cop)
times/week 3 (nummod)
40 and (cc)
decrease whereas (dep)
consistent impairment (nmod)
determine also (advmod)
collection . (punct)
caused is (auxpass)
appearance therapy (nmod)
reversible stages (nmod)
action calcitonin (nmod)
or=3.299 ( (punct)
arms placebo (compound)
leukemia childhood (compound)
tolerate patients (nsubj)
polymorphism snp(single (punct)
occurred recommended (parataxis)
occurred end (nmod)
cocaine- amphetamine-induced (conj)
infusion catheter (nmod)
randomised patients (nsubjpass)
$ROOT$ jaundice (sent)
1,3-butadiene of (case)
abundant dpi (nmod)
corresponding ability (nmod)
reports reaction (nmod)
precise similarly (advmod)
objectives study (acl)
droperidol of (case)
lesions demonstration (dep)
gm. per (case)
haloperidol % (appos)
administration u-ii (nmod)
plays hypertension (nmod)
$ROOT$ hemorrhage (sent)
initiated ) (punct)
convulsion lidocaine-induced (amod)
survival os (appos)
recorded potentials (nsubjpass)
used present (advcl)
decreases density (nmod)
attribute faint (advcl)
benefit low (amod)
trained swim (xcomp)
receiving tamoxifen (dobj)
model the (det)
24 , (punct)
pain cold-pressor (compound)
excluded disturbance (conj)
administered days (nmod)
carvedilol and (cc)
43 ) (punct)
cent in (case)
action cocaine (compound)
action leading (acl)
group non-smokers (acl:relcl)
responded ; (punct)
entity a (det)
metoprolol intravenous (amod)
therapy nitroglycerin (compound)
cortex offspring (compound)
have reduction (dobj)
information with (case)
hemisulfate (+/-)-amphetamine (compound)
perfusion , (punct)
treated boy (nsubjpass)
sought generate (xcomp)
sgot sgpt (conj)
vacuolization of (case)
evaluated monitoring (advcl)
protocols combined (acl:relcl)
indication a (det)
define . (punct)
ruled . (punct)
rate target (compound)
session task (nmod)
syndrome state (nmod)
showed organelle (advcl)
congenita of (case)
dbs frequency (compound)
occurrence signs (nmod)
nephron distal (amod)
dosage optimal (amod)
7 up (advmod)
mg/dl 1.2 (nummod)
band prosthetic (amod)
clonidine to (case)
halving dose (dobj)
atpase serca2 (appos)
hemorrhage formation (conj)
2.20 ratio (nsubj)
given drug (nsubjpass)
rate an (det)
treated sedation (nmod)
toxicity of (case)
important thus (advmod)
affection system (nmod)
presence , (punct)
$ROOT$ stresses (sent)
implausible and (cc)
altered except (prep)
reappeared reintroduced (advcl)
except variability (nmod)
anova by (case)
73/99 ) (punct)
day 8 (nummod)
tumors multiple (amod)
function retinal (amod)
reduction bp (compound)
white or (cc)
regions model (nmod)
produced contrast (nmod)
mm 33.8 (nummod)
nephropathy acid (compound)
proteinuria the (det)
microprolactinoma n. (dep)
observed provision (nmod)
results hemolysis (nsubj)
flecainide reports (conj)
gradient corticomedullary (amod)
isbell and (cc)
infarction subtotal (amod)
used thus (advmod)
addition with (nmod)
exhibited surprisingly (advmod)
carried observations (nmod)
1 1 (conj)
mg/kg 0.50 (nummod)
limits stereotactic (amod)
trinitrate of (case)
report present (amod)
sensitivity of (case)
women bladder (nmod)
induction maintenance (conj)
patterns organogenesis (nmod)
tests neurological (amod)
hour mg/8 (nummod)
return quickly (advmod)
both on (case)
depleted increased (conj)
4 of (case)
epinephrine micrograms.kg-1.min-1 (amod)
reduction loss (conj)
determine outcome (dobj)
potentials arrhythmias (conj)
= 0.013 (dobj)
2 vs. (cc)
affected however (advmod)
abnormalities microphthalmos (nmod)
demonstrated analyses (nsubj)
analysis preliminary (amod)
seem because (mark)
suggestive given (advcl)
determination routine (amod)
levels concentrations (conj)
sulfation increased (amod)
staining by (case)
valvulopathy outcome (nsubj)
inhibits gaba (nsubj)
manometry 24-h (amod)
alf=0/35 all (nmod)
mitochondria for (case)
ppa mg (appos)
caused used (conj)
locomotion rat (compound)
k-8644 opener (appos)
spread medium (nmod)
gamma-hexachlorocyclohexane gamma-hch (appos)
study vancouver (compound)
follow the (det)
rejection acute (amod)
97.1 range (dep)
increased methoctramine (nsubj)
doses parenteral (amod)
recurrence in (case)
dosage low (amod)
phenytoin and (cc)
showed rigidity (dobj)
value differential (amod)
nos-ir administration (nmod)
utility diagnostic (amod)
effect carteolol (nmod)
influence epileptogenesis (nmod)
drug associated (acl)
included line (nmod)
dp/dtejc with (case)
aware raise (ccomp)
revealed than (prep)
shock , (punct)
used nanoparticles (nsubjpass)
desferrioxamine by (case)
frequency reported (amod)
therapy ptu (compound)
doses ) (punct)
telangiectasia facial (amod)
vasculitis encountered (advcl)
localize microscopy (nmod)
probable also (advmod)
$ROOT$ changes (sent)
dcf not (neg)
exposing by (mark)
response good (amod)
therapy nifedipine (compound)
fq and (cc)
symptoms symptoms (conj)
viruses fever (compound)
effects cefonicid (nmod)
confusion and (cc)
% 2 (compound)
cause drugs (nsubj)
recall their (nmod:poss)
necrosis myocarditis (conj)
diameter/axon fibre (compound)
number models (nmod)
$ROOT$ facilitated (sent)
indicate predict (ccomp)
organelles other (amod)
night single (amod)
5-fu 5-fu (nmod)
66.6 +/- (cc)
hctz on (case)
bias confounding (conj)
augmented blocked (ccomp)
$ROOT$ deafened (sent)
013 619 (conj)
diagnosis and (cc)
flow . (punct)
3 to (advmod)
effect hypertension (compound)
day ) (punct)
effects clonidine (nmod)
efficacy either (cc:preconj)
twitching citalopram (nmod)
impairs learning (dobj)
annuloplasty . (punct)
investigate mechanism (dobj)
elavil amitriptyline (appos)
odds syncope (nmod)
% 1.6 (compound)
anticoagulant used (amod)
effective reversing (advcl)
included necrosis (dobj)
reduction end (nmod)
amphetamine-free control (appos)
gemfibrozil g/day)-lovastatin (appos)
alpha2- i1-receptor-mediated (conj)
= g (dep)
reduces use (nsubj)
study non-interventional (amod)
nuclei splenium (conj)
rhythm restoration (conj)
deficit . (punct)
developed pressure (dobj)
involved generation (nmod)
rabbits seen (acl:relcl)
determination measurement (conj)
difference estimated (amod)
solution both (cc:preconj)
system fpdc (conj)
modification . (punct)
irrigations povidone-iodine (compound)
controlled . (punct)
70 +/- (cc)
appeared sacrifice (nmod)
male younger (conj)
worsened interventions (nmod)
alprazolam or (cc)
observed performance (nmod)
day 21 (nummod)
administration vehicle (nmod)
associated pathways (nmod)
lasting long (advmod)
$ROOT$ etiology (sent)
phospholipid and (cc)
risperidone than (case)
appearance or (cc)
event reduction (nsubj)
girl schizophrenic (amod)
care intensive (amod)
manifestations the (det)
subacute usually (advmod)
1710 from (case)
population large (amod)
anuria . (punct)
2.5 , (punct)
measure sensitive (amod)
medline dates (dep)
episodes rescue (conj)
image magnetic (amod)
rats produced (acl)
treatment dox (nmod)
< 0.004 (dobj)
decreased selectively (advmod)
results decreased (appos)
electroshock picrotoxin (conj)
developed can (dobj)
so group (nmod)
2.20 was (cop)
observe time (nmod)
deficit accuracy (nmod)
report observations (dobj)
aggregation . (punct)
treat best (advmod)
intensity and (cc)
operations decompression (compound)
findings man (nmod)
sedimentation unit (amod)
depletions energy (compound)
effects fk (nmod)
treated hours (nmod)
neurologic psychiatric (conj)
instance patients (nmod)
worsen rhgh (nmod)
a-i of (case)
transplant at (case)
d next (amod)
leakage reversal (conj)
sedentary-isoproterenols in (case)
regimen ) (punct)
pge(2 ) (punct)
pancreatitis haemorrhagic (amod)
trimester the (det)
had monocytes (nsubj)
score average (amod)
closed were (auxpass)
suggested angiogram (nmod)
carcinoma nonsmall (amod)
produce levels (dobj)
procedures bypass (compound)
rat no (det)
receiving saline (dobj)
intoxication chlormethiazole (compound)
result reduction (nsubj)
ro4368554 metrifonate (conj)
mice these (det)
detect early (advmod)
rectus abdominal (amod)
b perinatal (amod)
adapt practice (nmod)
receiving p (nmod)
which following (case)
compensated significantly (advmod)
evaluated adherence (nsubjpass)
implicated etiology (nmod)
treatment doca-salt (amod)
excitability electrical (amod)
positive myeloperoxidase- (nsubj)
tuberculosis drug-resistant (amod)
chemotherapy transplantation (nmod)
concentrations chp (compound)
actions their (nmod:poss)
related clotiazepam (nmod)
condition good (amod)
hyponatremia of (case)
% phosphokinase (nmod)
mediated activity (nsubjpass)
applied detection (nmod)
165/90 130/70 (conj)
polymorphic not (neg)
subtypes all (det)
model epilepsy (compound)
complications cc (nmod)
that three (nummod)
compound 14 (nummod)
steeply less (advmod)
paid modifications (nmod)
secretion immunoreactive (amod)
protocol analysis (compound)
1987 from (case)
channels na (compound)
increased reaching (advcl)
report lady (dobj)
rarest disorders (nmod)
organization in (case)
subjects 12 (nummod)
elucidate to (aux)
acuity examination (conj)
role convulsions (nmod)
part screening (nmod)
found differ (ccomp)
first reported (acl:relcl)
edema on (case)
support pacing (conj)
associated activation (nmod)
capacity plasma (compound)
1080 [ (punct)
neurosci [ (punct)
function overall (amod)
5 than (quantmod)
shelf to (case)
counteracted preservation (nmod)
pressure tone (conj)
phenobarbitone- and (cc)
complemented markers (nsubjpass)
improves that (nsubj)
dose daily (amod)
suggest lead (ccomp)
selectivity with (case)
docetaxel thalidomide (conj)
exposure -- (punct)
ng of (case)
injections and (cc)
hip of (case)
activity sympathomimetic (amod)
results puncture (compound)
617 +/- (cc)
weeks age (nmod)
cases parasitosis (nmod)
hemolysis and (cc)
survival ( (punct)
induced week (nmod)
uganda 1999 (nmod)
incubated week (nmod)
events underlying (acl)
anemia important (acl:relcl)
investigated presently (advmod)
caused possibly (advmod)
treatment patients (conj)
ro 1-anisoyl-2-pyrrolidinone (appos)
underreporting patients (nmod)
hemorrhage in (case)
induce preserve (conj)
derivatives cck-5 (nmod)
furosemide amine (conj)
death infarction (conj)
adenocarcinoma liver (nmod)
expression pcna (compound)
higher and (cc)
= 14 (dep)
inhibited markedly (advmod)
show not (neg)
sedimentation gravity (compound)
salicylate with (case)
received finally (advmod)
diagnosis dysmenorrhea (nmod)
treatment c (nmod)
nephrotoxic patients (nmod)
group p100 (compound)
liver hepatoma (conj)
evaluated toxicity (nsubjpass)
mice b6 (compound)
enos peptide (conj)
examined studies (nsubj)
markers necrosis (compound)
maleate timolol (compound)
decrease exploration (nmod)
patients thrombocytopenia (nmod)
reaction mechanism (nmod)
within just (advmod)
means air (nmod)
doses mazindol (compound)
treating patient (dobj)
dilatation horns (nmod)
increased levels (nmod)
pressure sap (appos)
spironolactone oral (amod)
prevents curcumin (nsubj)
act . (punct)
subscale psychopathology (compound)
safety relative (amod)
years ) (punct)
continence of (case)
activity cyclooxygenase-2 (compound)
mmhg . (amod)
areas reviews (dep)
walls the (det)
introduction drugs (nmod)
incidence fasciculation (nmod)
l-nil ( (punct)
inducer or (cc)
damaged are (auxpass)
follow during (case)
ldlr of (case)
complaints nausea (nmod)
sm-5887 mg/kg (appos)
incidence mortality (nmod)
prolactin of (case)
levels cohort (nmod)
cells cells (nmod)
fraction phosphorylcreatine (compound)
resembled lesions (nsubj)
evidence causes (nmod)
positive and (cc)
withdrawal alcohol (compound)
proven bacteriologically (advmod)
revealed whereas (mark)
and clinically (advmod)
diet cyclic (amod)
showed start (nmod)
/-15.8 ] (punct)
ligands affinity (compound)
consolidation p9201 (appos)
dosages mean (nmod)
slowing waves (nmod)
test suspension (compound)
ratio weight (compound)
saline ml (nummod)
has occur (advcl)
involvement mainly (advmod)
questionnaire ( (punct)
decreases striata (nmod)
relationship myalgia (nmod)
electrophysiology electroretinography (nmod)
perforation ileal (amod)
important determining (csubj)
presented block (nmod)
drug first-line (amod)
suppress arrhythmias (dobj)
applied induced (conj)
large , (punct)
$ROOT$ models (sent)
less dose (nmod)
therapy rupture (conj)
mechanisms separate (amod)
offers methylprednisolone (nsubj)
angiotensinogen tgr (appos)
anemia trimethoprim-induced (amod)
scores recall (nmod)
red ruthenium (compound)
drugs-associated anti-inflammatory (amod)
investigated using (advcl)
effects dog (nmod)
dh ) (punct)
enlarged was (auxpass)
7 3 (compound)
reduced , (punct)
benefits certain (amod)
good . (punct)
enhanced mutations (nsubj)
carteolol as (cc)
alters that (mark)
developing anemia (nsubj)
demonstrates potentiate (ccomp)
reduction hepatitis (nmod)
choosing patient (nmod)
vessels in (case)
doubled time (dobj)
contraceptives oral (amod)
medium iodinated (amod)
6 out (advmod)
alternative report (nmod)
7.5 12 (conj)
elevation than (case)
dose weeks (nmod:tmod)
origin cerebral (amod)
hospital fahad (compound)
defined report (nmod)
cell within (case)
remained suppressing (advcl)
meq/l serum (compound)
possibility is (cop)
decrement this (det)
changes cardiotoxic (amod)
elevation significant (amod)
requires activation (dobj)
toxicity ocular (amod)
treatments ninety (nummod)
suppression hypotension (nmod)
were exhibited (conj)
ct of (case)
overloading mesangial (amod)
resulted if (mark)
cases drug (nmod)
transection spinal (amod)
epilepsy toxicity (conj)
bendrofluazide placebo (conj)
administered phosphate (nsubjpass)
suggests cause (ccomp)
mg cimetidine (compound)
correlation production (nmod)
estimated using (xcomp)
studied influence (nsubjpass)
performance analyses (conj)
priori a (compound)
drugs carbimazole (nmod)
adjunct as (case)
$ROOT$ liver (sent)
remove to (mark)
determine difference (dobj)
variables clinical (amod)
fm ) (punct)
displayed but (cc)
observed beats/min (dobj)
demonstrated size (nmod)
index in (case)
safety extended-release/lovastatin (nmod)
receive dose (nmod)
similar cyclosporin (nmod)
evaluated subjects (nsubjpass)
diagnosis amphetamine- (nmod)
inhibitors amiodarone (nsubj)
drink a (det)
development engorgement (nmod)
results included (appos)
agonist sigma (compound)
administered iv (parataxis)
normal or (cc)
patients acromegalic (amod)
ameliorates nocistatin (nsubj)
susceptibility renal (amod)
decrease % (compound)
women osteoporosis (nmod)
effective modulating (advcl)
10.3 19.3 (nummod)
inflammatory and (cc)
traumatic experimental (amod)
inhibitors ritonavir (nmod)
appearance syndromes (nmod)
locus the (det)
included studies (dobj)
remains unknown (xcomp)
u/l 67 (nummod)
reach stratified (advcl)
range weights (nmod)
ms 84+/-3 (nummod)
relates that (nsubj)
adopted treatment (nsubjpass)
celecoxib to (case)
necrosis , (punct)
doses drugs (nmod)
shoed cells (nmod)
college american (compound)
action depressant (amod)
0.02 , (punct)
hyperkalemia or (cc)
doses atropine (nmod)
epo plasma (compound)
normalization complete (amod)
causes of (case)
prevents . (punct)
assessment dysfunction (nmod)
related effect (nsubj)
return complications (nmod)
-18 -26 (conj)
performed and (cc)
compared are (auxpass)
administration nocistatin (nmod)
had obliterans (dobj)
blocking beta (compound)
appears conclusion (nsubj)
increased and (cc)
showed proportion (dobj)
advantages despite (case)
provided protection (dobj)
disturbances markers (conj)
modulating contents (dobj)
scores sas (compound)
15.8 +/- (cc)
potentials motor (compound)
had size (nsubj)
choices errors (conj)
opening sites (nmod)
have but (cc)
fashion systematic (amod)
potential with (case)
tiopronin antigens (conj)
131i-hsa of (case)
reduction pronounced (amod)
help account (xcomp)
p<0.001 hypertension (nmod)
gtcs ) (punct)
insufficiency captopril-induced (amod)
mechanism effect (nmod)
commissure horn (conj)
treatment propanolol (nmod)
diameter fenestrae (nmod)
alternative detect (acl)
technique the (det)
hbig of (case)
hoe nmol/kg (dep)
injection i.p. (amod)
been ; (punct)
interest community (nmod)
girl 7-year-old (amod)
given who (nsubjpass)
seem preventing (advcl)
as patients (nmod)
myopathy due (case)
blockers reported (acl:relcl)
estimated . (punct)
onset until (case)
halts , (punct)
embarked upon (prep)
cancer androgen-independent (amod)
suggest seems (advcl)
aggravated damage (dobj)
samples analysis (nmod)
contributed pool (nmod)
fill rats (nsubj)
consistent ts (nmod)
age old (amod)
impact processes (nmod)
illustrates importance (dobj)
oc the (det)
models from (case)
1 interaction (conj)
uni- and (cc)
population non-endothelial (amod)
virus murine (amod)
compared was (auxpass)
allergy ax (compound)
role has (acl:relcl)
cavity primary (conj)
reported trials (nsubj)
haemopericardium due (amod)
metabolite be (appos)
polyps adenomatous (amod)
containing galactosamine (dobj)
january 1996 (nummod)
defect by (case)
epithelium tubular (amod)
factor-kappab and (cc)
plate acid (conj)
time-course changes (nmod)
preceded weeks (nmod)
continued has (aux)
regurgitation or (cc)
rigidity muscle (compound)
improve response (dobj)
suggested sensitivity (dobj)
130 67 (conj)
concentration heparin (nmod)
repeated twice (advmod)
induces result (nmod)
hepatitis acid-induced (amod)
differences these (det)
given device (dobj)
b. amphotericin (compound)
receive occasions (nmod)
$ROOT$ forced (sent)
score preprocedure (amod)
succumbed onset (nmod)
sed +/- (cc)
1 30 (conj)
two but (cc)
5-htp and (cc)
useful . (punct)
combination stabilizer (nmod)
1.93 ci (nsubj)
chicago ) (punct)
failed protect (xcomp)
cdt postthrombectomy (amod)
pharmaceuticals philadelphia (appos)
enhancement dysfunction (conj)
allografts from (case)
8,000 to (quantmod)
courses administered (acl)
model paw (compound)
attributable . (punct)
reduction smaller (amod)
0.80 1.63 (appos)
manifestations neurological (amod)
zones border (compound)
sensitivities and (cc)
lesions palpable (amod)
9 2 (conj)
nephrectomy donor (compound)
evidence direct (amod)
disease advanced (amod)
coadministered hs (nmod)
disease lid (dep)
compare profiles (dobj)
passage : (punct)
bp dbp (appos)
myalgia succinylcholine (nmod)
used is (auxpass)
3tc + (cc)
incidences many (nmod)
evoked infarcts (nsubjpass)
amns ps (conj)
daunoxome ( (punct)
angioedema enzyme (compound)
predictor , (punct)
anesthetic and (cc)
exposure alcohol (compound)
tissue connective (amod)
is interviewing (advcl)
substitute is (cop)
influenced not (neg)
cells from (case)
environments in (case)
values age (conj)
design placebo-controlled (amod)
membrane-cytoskeleton of (case)
persist . (punct)
increased latency (dobj)
women seven (nummod)
transplantation solid (amod)
patients 102 (nummod)
hu of (case)
those experienced (acl)
myopathy toxic (amod)
challenge , (punct)
pretreatment long-term (amod)
damaged always (advmod)
anticoagulated given (conj)
are there (dep)
dox dox (conj)
overdose diltiazem (compound)
bw g (compound)
evaluated levels (nmod)
ligands microinjected (acl)
inhibitor-associated enzyme (nmod:npmod)
level gr/dl (nmod)
peg-asparaginase including (case)
t cardiac (amod)
blocked rearings (nsubjpass)
min-1 and (cc)
am149 % (appos)
intoxications cholinergics (nmod)
angiograms of (case)
remained thromboembolism (nmod)
days exposure (nmod)
association increase (nmod)
h od (nmod)
antibody novel (amod)
potentials snaps (appos)
detection rapid (amod)
tolerability agents (nmod)
prevent amnesia (dobj)
inhibit using (xcomp)
stage each (det)
progressed regurgitation (nmod)
protein fluorescent (amod)
compliance the (det)
difficult ct (nmod)
subject from (case)
delivery distal (amod)
group an (det)
0.04 and (cc)
were . (punct)
onset disappearance (conj)
retinoblastoma for (case)
meeting not (neg)
accepted was (auxpass)
evaluate identify (conj)
differ mechanisms (nsubj)
effect anxiogenic (amod)
n/n=25/26 16 (conj)
subscale locf (nmod)
telmisartan mg (appos)
contributed detected (conj)
24 18 (compound)
failure induced (acl)
discussed differences (nsubjpass)
help decrease (xcomp)
uptake in (case)
cells adenoma (compound)
attenuated alpha-tc (nmod)
expression number (nmod)
map co (conj)
severity her (nmod:poss)
assayed foci (nmod)
eu ) (punct)
overcome to (aux)
ischemia incomplete (amod)
$ROOT$ point (sent)
fef25 - (punct)
increases incidence (dobj)
dosed daily (advmod)
duodenum and (cc)
measured measured (conj)
death . (punct)
rare combination (nsubj)
dose pentoxifylline (nmod)
sediment proteinuria (conj)
toxicity bupivacaine (nmod)
mmol/l 323+/-43 (nummod)
event arrest (nmod)
meshwork the (det)
assays granulocyte-macrophage (amod)
necrosis myocardial (amod)
number limited (amod)
conclude reflects (ccomp)
anemia treatment (nmod)
dyskinesia sedation (conj)
women angioedema (nmod)
ameliorated which (nsubjpass)
determined are (auxpass)
patients those (nmod)
depend rate (nmod)
metabolite chloroacetaldehyde (nsubj)
observed improvements (nsubjpass)
group adr-nephropathy (amod)
decarboxylase l-glutamic (amod)
ml/min/kg ml/min/kg (conj)
maze test (conj)
based records (nmod)
dysplasia glomerulosclerosis (conj)
related levels (nsubjpass)
nicotine with (case)
explained deficit (nsubjpass)
innervation neurotensinergic (amod)
administration hcl (nmod)
pan ( (punct)
arrhythmia ventricular (amod)
reported smoking (dobj)
mice dox (compound)
role maintenance (nmod)
injection last (amod)
new worsening (conj)
documented tissue (nmod)
anencephaly and (cc)
resistant developed (parataxis)
patient 67-year-old (amod)
deduced has (aux)
ester methyl (compound)
performed imaging (nsubjpass)
likelihood . (punct)
circled lesion (nmod)
infusion 5-fluorouracil (nmod)
parenchyma brain (compound)
up concentrations (nmod)
required maintain (xcomp)
cause (r)-alpha-methylhistamine (nsubj)
capable attenuating (advcl)
specimens specimen (conj)
faced mind (nmod)
13.2 0.17 (conj)
maintained conversion (nmod)
suggested injury (dobj)
respond to (mark)
7 +/- (cc)
decreased 5-ht (dobj)
treatment surgery (conj)
presented described (conj)
resembled those (xcomp)
procedures manage (acl:relcl)
proceeded these (nsubj)
differently citalopram (nmod)
negativity hbeag (compound)
length af (nmod)
constants time (compound)
low level (nsubj)
stimulus from (case)
accepted mechanism (nsubjpass)
= 0.15 (dobj)
decreased abundance (nsubjpass)
associated succinylcholine (nmod)
min mean (appos)
heterozygous normal (amod)
peptide 35-amino (compound)
> hr (dobj)
closed when (advmod)
vasospasm secondary (amod)
decreased times (nmod)
in order (mwe)
10 30 (conj)
cardiotoxicity well-known (amod)
inhibit . (punct)
stronger and (cc)
partial responses (nsubj)
renal cardiovascular (conj)
half-time and (cc)
standard . (punct)
confounding and (cc)
recurrences these (det)
treatment co-trimoxazole (compound)
measured assay (nmod)
available although (mark)
administration nefiracetam (nmod)
interactions pharmacological (amod)
mini-pump released (acl:relcl)
preferable pge1 (nsubj)
effusions in (case)
expression cd36 (nmod)
gland the (det)
related myocarditis (nsubj)
patterns toxicity (nmod)
therapy associated (amod)
resulted administration (nsubj)
nx or (cc)
extent same (amod)
patients tobramycin-treated (amod)
antigen e (compound)
problems further (amod)
patients 15 (nummod)
associated dexmedetomidine (nsubjpass)
bands affected (amod)
mumol/kg i.p. (advmod)
ability inhibit (acl)
treatment arabic (nmod)
received later (advmod)
capsaicin topical (amod)
ci 1.55 (appos)
atria isolated (amod)
ns-nsaids acetaminophen (conj)
was electrocardiogram.3 (nmod)
neurophysiology epilepsy (nmod)
syncope . (punct)
hypertension-related and (cc)
levels dismutase (nmod)
normal sensitization (conj)
produced degeneration (dobj)
eosinophil of (case)
levels presedation (compound)
accumulation glycine (nmod)
levels tbars (compound)
patient single (amod)
inhibited leaves (conj)
prompt but (cc)
strategy failure (nmod)
cases of (case)
program permanently (advmod)
hours early (amod)
dose-related were (cop)
dehydroepiandrosterone dhea (appos)
forms anticoagulation (nmod)
antagonism observed (amod)
developed eyes (dobj)
simulator a (det)
hamartoma duct (compound)
infusion 5-fu (compound)
programs . (punct)
characterized cystitis (nsubjpass)
models exteroceptive (amod)
change values (nsubj)
blockade ii (nummod)
carcinoma metastatic (amod)
broadens . (punct)
criteria clinical (amod)
conditions open (amod)
endarterectomy carotid (compound)
pointer available (amod)
injections u-ii (nmod)
woman undergoing (acl)
51 49 (compound)
system mammalian (amod)
relevance , (punct)
jitter and (cc)
box exploratory (amod)
potentiality model (nmod)
given available (advcl)
used creatine (nsubjpass)
correlate outcome (nmod)
analgesics other (amod)
operations 64 (nummod)
absence hepatomegaly (conj)
prevention bradycardia (nmod)
beating spontaneous (amod)
mg/dl. 1.1 (nummod)
wky on (case)
coherence in (case)
complicating therapy (dobj)
relevance host (nmod)
paralleling areas (dobj)
increased pms (nmod)
subjects seventeen (nummod)
decreased contrast (nmod)
pharmacokinetics the (det)
cocaine-dependent and (cc)
tdfs ) (punct)
question use (nsubj)
times day (nmod:npmod)
ligands three (nummod)
disease ulcer (compound)
group greek (compound)
methadone mu-opioid (amod)
ramh of (case)
cardiotoxicity due (amod)
examined model (nmod)
sacrifice after (case)
contralaterally predominantly (advmod)
rizatriptan and (cc)
process cells (nmod)
company pharmaceutical (amod)
fever patients (nmod)
taken when (advmod)
beta-carboline of (case)
inhibitors with (case)
agent , (punct)
were group (dep)
score intensity (compound)
choice climate (nmod)
randomized was (cop)
doses neostigmine (conj)
d 3 (nummod)
degeneration doses (nmod)
that than (case)
men % (compound)
swelling of (case)
puromycin-aminonucleoside amns (appos)
concentrations kidney (nmod)
background examined (appos)
neuropathy diabetic (amod)
rats diversion (nmod)
therapy continuous (amod)
found uiu/ml (xcomp)
ensure protection (dobj)
determining for (mark)
method treating (acl)
surgery limb (nmod)
masseter temporalis (conj)
mitoxantrone and (cc)
follow cholestasis (nsubj)
potent blocking (advcl)
dose determined (acl)
evaluation the (det)
pilsicainide including (case)
doxorubicin mg/kg (amod)
unit picu (appos)
determining and (cc)
lymphadenopathy aplasia (conj)
shown vohland (nmod)
% increase (nsubj)
ccnu ) (punct)
specific are (cop)
margin layer (nmod)
patients among (case)
fla838 , (punct)
% 26.6 (nummod)
complained mastodynia (nmod)
remained it (nsubj)
levels tissue (compound)
hepatomegaly and (cc)
disintegrin a (det)
intake c (nmod)
showed glomerulonephritis (dobj)
increase and (cc)
participates hyperalgesia (nmod)
4 up (compound)
assess . (punct)
discussed . (punct)
oxygenation related (acl)
improved months (nmod)
course concentrations (nmod)
deduced incidences (nsubjpass)
suffered suffered (conj)
case present (amod)
inhibitor target (nmod)
function patients (nmod)
period treatment (nmod)
irritability withdrawal (conj)
degeneration extensive (amod)
followed weeks (nmod)
layer layer (nmod)
generation production (conj)
performed followed (advcl)
falciparum + (cc)
phosphokinase levels (dep)
induce hypokalemia (dobj)
conversion rapa (compound)
days 2.0 (nummod)
improved time (dobj)
result combination (nmod)
paralysis agents (nmod)
blood ammonia (dep)
phosphanilate chp (appos)
receiving excluded (parataxis)
enhanced heparin (nsubj)
0.27 ci (appos)
t3 ( (punct)
seen damage (nsubjpass)
cases 35 (nummod)
40 even (advmod)
conditioning avoidance (compound)
concentration progesterone (nmod)
felt better (acomp)
sought assess (xcomp)
73 ) (punct)
giving of (mark)
demonstrated but (cc)
enlarged liver (nsubj)
those controls (nmod)
system sympathetic (amod)
those bupivacaine (nmod)
animals estradiol-treated (amod)
0.84 0.28 (conj)
involved receptors (nsubjpass)
hormones with (case)
controls routine (amod)
woman hispanic (amod)
impact inhibition (nmod)
system tissues (compound)
drg lumbosacral (amod)
presented opportunity (dobj)
trials mortality (compound)
cardioselective it (nsubj)
protects overexpression (nsubj)
reduces given (advcl)
discontinuation prompt (amod)
maturation to (case)
open , (punct)
stress vpa-associated (amod)
assay positive (amod)
bcnu of (case)
inhibition mitotic (amod)
capsule kidney (compound)
exerted effects (dobj)
gamma-glutamyltransferase u/l (appos)
toxicity csa (compound)
administration puromycin-aminonucleoside (nmod)
= 4.2 (dobj)
rhinitis of (case)
apl classic (amod)
57 of (case)
best to (case)
understood mechanism(s (nsubjpass)
hampered progress (nsubjpass)
divided 3 (meta)
mortality haemorrhage (nmod)
probe an (det)
prevent induce (advcl)
stl1 both (cc:preconj)
ventilation volume (conj)
inhibition percent (amod)
accompanied often (advmod)
representing concentrations (dobj)
reoccur not (neg)
impaired acquisition (nsubj)
exposure pdn (nmod)
used oncology (nmod)
auccgrp ) (punct)
scintigraphy acid (nmod)
diet consumption (nmod)
pressure indexed (acl)
showed infarction (dobj)
carboplatin of (case)
release cytochrome (compound)
aborted not (neg)
loss and (cc)
0.07 0.16 (conj)
symptom neurotoxicity (nmod)
ovarian or (cc)
superior ; (punct)
tachyphylaxis therapy (nmod)
metabolites vitamin (compound)
autoantibodies antineutrophil (amod)
acetrizoate ) (punct)
treated lev (nmod)
vasoconstriction phenylephrine-induced (amod)
brought day (nmod)
srl ( (punct)
safety group (nmod)
thp mg/kg (dep)
given amphetamine (dobj)
mouth % (appos)
mice deleted (acl:relcl)
fracture isolated (amod)
amlodipine against (case)
gi ( (punct)
chorea hyperglycinemia (nmod)
responses tonic (amod)
linking use (nmod)
high ng/ml (dep)
cause calcification (dobj)
hormones releasing (amod)
frequency prolongation (nmod)
$ROOT$ corresponds (sent)
potentiation , (punct)
core ischemic (amod)
period drug-free (amod)
beams thickened (amod)
begun recently (advmod)
evaluated permeability (nsubjpass)
ephedrine/propofol/mixtures studied (acl)
$ROOT$ formed (sent)
gtn -12.8 (appos)
turnover low (amod)
effects any (det)
demonstrated although (mark)
produced mcao (nmod)
incorporate escalating (xcomp)
results induced (appos)
direct indirect (conj)
therapy dtic (appos)
disorder caused (acl)
failed treatment (nsubj)
mass heart (compound)
control after (case)
scheduled are (auxpass)
$ROOT$ unpleasant (sent)
disorientation behavior (conj)
normochromic and (cc)
baseline seconds (appos)
patient deviations (nmod)
trauma head (compound)
fibers afferent (amod)
endpoints the (det)
retardation severe (amod)
stress meshwork (nmod)
bind stream (nmod)
nephrotoxicity secondary (amod)
alternative . (punct)
values to (case)
angiodegeneration biopsies (dep)
khz 0.5 (nummod)
mmhg 86.7 (nummod)
pneumonitis therapy (nmod)
report incidence (dobj)
metoprolol diltiazem (conj)
concentrations cent (nmod)
respiration 3 (nummod)
studied variety (nmod)
sarcoma ) (punct)
pressure intraocular (amod)
m with (case)
possibility of (case)
consider that (mark)
injections mg/m2 (nmod)
osmolality and (cc)
minutes fifteen (nummod)
used anticoagulation (nmod)
doses intermittent (amod)
dbs of (case)
modulation via (case)
99mtc-glucarate detection (nmod)
give data (nsubj)
evaluated studied (ccomp)
preceded usually (advmod)
rats fed (acl)
59 ( (punct)
appeared took (advcl)
hbv co-infected (conj)
adding regimens (nmod)
ml(-1 ) (punct)
tolerated days (nmod)
patients nonjaundiced (amod)
hyperbilirubinemia unconjugated (amod)
tended exhibit (xcomp)
grade high (amod)
utility acetate (nmod)
trial evtac (compound)
suggest words (nmod)
warfarin the (det)
dysfunction neurologic (amod)
carried analysis (nsubjpass)
induces ketamine (nsubj)
18 > (advmod)
administration haloperidol (compound)
phase intervention (compound)
improvement pain (nmod)
included has (aux)
= c (dep)
response and (cc)
unit medical (amod)
$ROOT$ met (sent)
parallels that (nsubj)
enhancement beating (nmod)
course hypertension (nmod)
correcting allowing (conj)
p paracetamol (compound)
changes treatment (nmod)
prolactin thyrotropin (conj)
despair " (punct)
rate oxygenation (conj)
depletion striatum (nmod)
out-patients the (det)
symptomatology , (punct)
mg 3.5 (nummod)
renoprotective regardless (advmod)
department institution (nmod)
protects cardiomyopathy (nmod)
common diagnosis (nsubj)
identified group (nmod)
asenapine with (case)
19 +/- (cc)
begun , (punct)
related indomethacin (nmod:npmod)
stabilizer/rigidifier a (det)
cream cent (amod)
igf-i rh (amod)
associated conclusion (nsubjpass)
dysmorphism facial (amod)
gfap levels (dep)
compared solution (nmod)
represents drug (dobj)
inherent activation (nsubj)
variables rate (nmod)
dextran fluorescent-labeled (amod)
effect noted (acl)
completing ) (punct)
reviewed discussed (conj)
combination paclitaxel (nmod)
develops % (conj)
doses catecholamines (nmod)
pain due (case)
drugs serotonergic (amod)
induces exposure (nsubj)
employed was (auxpass)
impairments functional (amod)
contractility of (case)
follow-up , (punct)
excellent sweating (dep)
hypotension doses (nmod)
destructive be (cop)
stones some (det)
annuloplasty study (dep)
strain susceptible (amod)
production by (case)
16 17 (conj)
wilcoxon 's (case)
epilepsy from (case)
exhibited test (nmod)
sensitivity assay (compound)
reported rate (nsubjpass)
profile clinical (amod)
neurotoxicity carbamazepine (compound)
responsive less (advmod)
vasodilator the (det)
acting neurotransmitters (nmod)
nigra animals (nmod)
accumulation wall (nmod)
depletion sodium (compound)
established qrs (nsubj)
exchange with (case)
resolve seizures (nsubj)
resolution the (det)
caused compounds (nsubj)
diazepam- , (punct)
nucleoside appropriate (amod)
associated cause (nmod)
isbell 1953 (nummod)
repeated monthly (advmod)
continue therefore (advmod)
showed rise (dobj)
psychosis cocaine-induced (amod)
suppress . (punct)
corrected injections (nmod)
subanalyses fair-quality (amod)
presentation typical (amod)
lid upper (amod)
pathways sensory (amod)
exposed four (nsubjpass)
placebo- and (cc)
pons 2/8 (appos)
demonstrated furthermore (advmod)
revealed perfusion (dobj)
cd4 median (amod)
activity ( (punct)
desipramine tricyclic (amod)
matter of (case)
caused aap (nsubj)
channel receptor-linked (amod)
problematic is (cop)
indomethacin with (case)
subjects fifty-five (nummod)
nmol/l ) (punct)
february 1996 (nummod)
limits normal (nmod)
name antibiomania (xcomp)
reduces whereas (mark)
collected september (nmod)
transplantation myeloma (nmod)
arises , (punct)
inhibition lithium (nmod)
protocols conversion (nmod)
cardiomyopathy regurgitation (conj)
sinusoidal between (case)
prevented changes (nsubjpass)
tone sympathetic (amod)
mechanism common (amod)
500 700 (conj)
incidence group (nmod)
phenobarbital of (case)
use srl (nmod)
escalated paclitaxel (nsubjpass)
glycol of (case)
prevented curcumin (nmod)
discharge patients (nmod)
hallmark is (cop)
injections parenteral (amod)
decreased specificity (nsubj)
found terbutaline (nmod)
studied histologically (advmod)
tissues kidney (compound)
portions hemosiderotic (amod)
found neither (preconj)
cisplatin of (case)
magnitude this (det)
hyperprolactinemia n. (dep)
ug/ml 0.52 (nummod)
treatment rhuepo (compound)
factor still (advmod)
inability to (case)
mellitus ii (nummod)
volume effusions (nmod)
use precursor (nmod)
loading sodium (compound)
movement abnormal (amod)
organisms of (case)
microl microg/0.5 (nummod)
baseline days (conj)
analyzed induction (nmod)
had regardless (advmod)
effects asthma (nmod)
is uncertain (acomp)
pattern action (nmod)
doses ranging (acl)
effect such (predet)
isoniazide by (case)
mesna ) (punct)
regression dosage (nmod)
tgf-b mtor (conj)
d2 ng/mouse (appos)
pattern with (case)
conditions bleeding (nmod)
indexes domain (compound)
effective present (advcl)
found unconsciousness (xcomp)
$ROOT$ crosses (sent)
discontinued simvastatin (nsubjpass)
hypertension created (acl)
fluctuations clinical (amod)
investigate signaling (dobj)
penetration areas (nmod)
effect subtle (amod)
chemistries serum (compound)
users ) (punct)
d nelarabine (nmod)
verify sensitivity (dobj)
reentry multiple (amod)
dose clomipramine (nmod)
affect adversely (advmod)
useful have (conj)
increases prevents (conj)
25 six (compound)
six five (conj)
enlarged while (mark)
dystrophy form (appos)
length qt (conj)
hypotension a (det)
referred hospital (nmod)
affect directly (advmod)
dose methadone (compound)
treatment fluvoxamine (nmod)
prophylaxis system (compound)
role little (amod)
upregulation possibly (advmod)
group high-dose (amod)
investigate . (punct)
levels b (compound)
mg. at (case)
tnf-alpha of (case)
25 volunteers (conj)
man receiving (acl)
achieved were (auxpass)
dose higher (amod)
development patients (nmod)
undergoing apoptosis (dobj)
% < (advmod)
disorder disorder (conj)
ruled causes (nsubjpass)
analgesia post-operative (amod)
cavity abdominal (amod)
susceptible , (punct)
determined studies (nmod)
p=0.39 ( (punct)
block events (dobj)
dose 100mg/kg (dep)
investigated : (punct)
sulfate , (punct)
literature lmwh (nmod)
results compared (appos)
acid folic (amod)
neurons mice (nmod)
response antioxidant (amod)
group only (amod)
vasorelaxation segments (nmod)
capacity dopamine-antagonistic (amod)
level myocyte (compound)
symptoms bilateral (amod)
gap43-ir of (case)
seen therapy (nmod)
evaluation neurological (amod)
keratopathy band (compound)
$ROOT$ topotecan (sent)
pressure secretion (conj)
antibody an (det)
developed d (nmod)
ulcers hemorrhagic (amod)
snp = (dep)
change parameters (nsubj)
indicate not (neg)
myocarditis fulminant (amod)
capture did (aux)
pd or (cc)
bladder wt (amod)
improvements because (case)
aneurysm aortic (amod)
contraindication are (cop)
due to (pcomp)
hospitals 25 (nummod)
imaging weighted (amod)
established well (advmod)
observed complication (nsubjpass)
17 7 (conj)
proteases the (det)
free pain (nmod:npmod)
demonstrated activity (dobj)
suppressed peroxidation (dobj)
loss % (compound)
startle the (det)
showed already (advmod)
tachycardia due (case)
cases parkinsonism (nmod)
achieved initiation (nmod)
augments nefiracetam (nsubj)
increasing without (mark)
pod 14 (nummod)
presentation hyperacute (amod)
therapies of (case)
42,671 rofecoxib (nmod)
v.o . (punct)
therapeutic doxorubicin (nsubj)
dose (-)-propranolol (nmod)
administration alendronate (nmod)
origin ischemic (amod)
days duration (nsubj)
hypotension selective (amod)
unmasking pheochromocytoma (nmod)
dopamine accumbens (compound)
centers large (amod)
performance catheterization (nmod)
fifty-five three (compound)
characterized episode (nsubjpass)
> 10 (conj)
crossed , (punct)
mmhg 7.5 (nummod)
observed basis (nmod)
mg/kg 0.09+/-0.02 (nummod)
respond , (punct)
suggest influence (ccomp)
less g/dl (nmod)
returned two (nsubj)
carcinogenesis estrogen (compound)
improved delirium (nsubj)
described method (nsubjpass)
7-ni ip (appos)
report measure (acl:relcl)
depression general (amod)
weeks 1 (nummod)
concentrations free (amod)
solution ; (punct)
atrophy chorioretinal (amod)
patients clinic (nmod)
improved significantly (advmod)
igf ii (nummod)
rats li-pretreated (amod)
nerve sural (amod)
persisted months (nmod)
gaba and (cc)
aeroallergens to (case)
found infusion (nsubjpass)
independent da (nmod)
combination thalidomide (nmod)
cells presumptive (amod)
calculated to (xcomp)
suggestive were (cop)
maintaining dosage (dobj)
reviewed also (advmod)
rats aging (compound)
effects manic-like (amod)
recovery ability (nmod)
has which (nsubj)
months stratum (appos)
abolish tachycardia (dobj)
acquisition task (nmod)
mechanism sensitivity (nsubj)
scintigraphy by (case)
mumol/l 4.0 (nummod)
improved duration (dobj)
deficiency to (case)
monolayers cells (nmod)
hyperfiltration progression (conj)
reflected as (mark)
rofecoxib . (punct)
dysfunction induced (amod)
demonstrated induce (ccomp)
licensed . (punct)
treatment failure (nmod)
remained impaired (xcomp)
fibrillation % (dep)
enhances stimulation (nmod)
5/8 ( (punct)
24 least (advmod)
individual from (case)
treatment convulsions (nmod)
patient 49-year-old (amod)
increased periods (nsubj)
use ocs (nmod)
half-time excretion (nmod)
bp sbp (appos)
5.2/100,000 ( (punct)
activities dismutase (compound)
ce ( (punct)
studied described (conj)
proving with (mark)
levels pre-procedure (amod)
basal with (case)
infections from (case)
volume , (punct)
suggested role (nsubjpass)
degenerated patients (nmod)
refine analysis (nsubj)
take day (nmod:tmod)
showed = (parataxis)
binding [(3)h]saxitoxin (compound)
thromboses ( (punct)
% . (punct)
interference inactivation (nmod)
injections 6-hydroxydopamine (nmod)
activation metalloproteinase (compound)
injection intravenous (amod)
10.2 to (dep)
result inhibition (nmod)
denied was (auxpass)
avoided damage (nsubjpass)
changed scores (nsubj)
depleted 5-ht (dobj)
effects nephrotoxicity (appos)
dyskinesia a (det)
systems portable (amod)
discontinuation nitroprusside (nmod)
performed ) (punct)
tumor wilms (compound)
extent elevation (nmod)
corresponded which (nsubj)
anatomically pathologically (conj)
8.0 users (nmod)
extract a (det)
12alpha-hydroxylase 6beta-hydroxylase (conj)
mg/0.5 20 (compound)
increased ) (punct)
profile different (amod)
cisplatinum hours (conj)
efficacy anticraving (amod)
frequent not (neg)
intrahepatic extrahepatic (conj)
observed given (advcl)
identified metabolizer (nmod)
tetrachloride given (acl)
ratings clinician (compound)
570 of (quantmod)
side-effects due (case)
hyperthermia of (case)
mm 51.7 (nummod)
rhuepo by (case)
rats f344 (compound)
model animal (compound)
mg/kg 45 (nummod)
ptz to (case)
goldstein berkowitz (conj)
amide nicotinic (amod)
maintained constant (xcomp)
basis signs (nmod)
injection metoclopramide (nmod)
impairment against (case)
clearances acid (compound)
% 75.6 (nummod)
26 23 (compound)
delays and (cc)
phz ) (punct)
covariance of (case)
absence cefotetan (nmod)
resulting anoxia (nmod)
compliance extended-release/lovastatin (nmod)
specimens 143 (nummod)
inhibition esterase (nmod)
94 of (advmod)
reduce aggravating (advcl)
redistribution doses (nmod)
necrosis any (conj)
predict later (advmod)
drug after (case)
coeruleus of (case)
occurs reduce (xcomp)
side-effect relevant (amod)
double than (mark)
bcnu 1,3-bis-(2-chloroethyl)-1-nitrosourea (appos)
reason possible (amod)
referred vision (nmod)
received up (advmod)
microscopy fluorescence (compound)
study test (conj)
effect permeability (nmod)
blood-brain-barrier of (case)
activity behavioural (amod)
emphasizes possibility (dobj)
$ROOT$ discovered (sent)
table ) (punct)
epilepsy de (amod)
im ( (punct)
professionals other (amod)
stimulation concentration (nmod)
test test (appos)
deficits such (case)
tablet for (case)
episode hours (nmod:npmod)
tolerated procedure (dobj)
$ROOT$ measures (sent)
list company (nmod)
observed compared (mark)
likely may (aux)
variants the (det)
duration att (nmod)
% seizures (nmod)
called ) (punct)
recessive , (punct)
short is (cop)
anesthesia neuraxial (amod)
modifies inhibition (nsubj)
detectable that (nsubj)
female fhf (nmod)
stages methods (conj)
i both (preconj)
targets lipid (compound)
searched records (nsubjpass)
parkinsonian-like and (cc)
13.2 +/- (cc)
less dothiepin (nmod)
desire such (case)
occurred obstructive (nsubj)
appeared predominantly (advmod)
function declined (amod)
show inhibition (dobj)
elevated and (advmod)
diet ad (amod)
cerebri pseudotumor (compound)
atrophy from (case)
emphasized been (auxpass)
mechanisms biochemical (amod)
a phase (compound)
submitted period (nmod)
agents da (compound)
those glomerulonephritis (nmod)
sensitization experimental (amod)
period sleep (nmod)
myopathy an (det)
caused osteoporosis (nsubjpass)
minute to (case)
calls . (punct)
do absence (nmod)
mpep ; (punct)
discovered . (punct)
criteria mi (nmod)
hours 12 (nummod)
exposure during (case)
potentiation cross-tolerance (conj)
lost lasted (conj)
slower , (punct)
consolidation post-training (amod)
perspective a (det)
difficulties not (cc)
group model (compound)
in- out-patients (conj)
attributable activation (nmod)
prevented damage (nsubjpass)
affect carvedilol (nsubj)
counteract acutely (advmod)
elevated chronically (advmod)
ginsenosides re (compound)
activity cat (compound)
species release (conj)
placebo the (det)
behaviors induced (acl)
failed tdr (nmod)
micrograms 12 (nummod)
exposure dermal (amod)
increased % (conj)
treatment not (preconj)
trial efficacy (compound)
length sinus-cycle (compound)
vocabulary in (case)
signals abnormal (amod)
suspected unlikely (advcl)
confirmed testing (nsubj)
prior either (preconj)
activation peroxisome (compound)
peaked size (nsubj)
states normal (amod)
pd ( (punct)
inhibition significant (amod)
overtreatment to (case)
inherent is (cop)
observed controlled (conj)
movements by (case)
march may (conj)
cured 175 (nsubj)
smoke , (punct)
injections drugs (nmod)
seemed conclusion (nsubj)
antinociception effect (conj)
1,3-butadiene check (appos)
aspartate and (cc)
rats 8 (nummod)
infarction ( (punct)
levels hit (amod)
deficits working (compound)
appears exacerbated (advcl)
therapy plasma (compound)
1.5-fold ) (punct)
slightly p (dep)
spike cells (nmod)
anxiety and/or (cc)
levothyroxine on (case)
action antidiuretic (amod)
hundred twenty-two (conj)
sensations with (case)
min-1 ) (punct)
management patients (nmod)
showed sustained (advcl)
concerns theoretical (amod)
administered induce (xcomp)
receptor vegfr-2/flk-1/kdr (appos)
light- and (cc)
suspicion the (det)
aed ( (punct)
aid cessation (compound)
models model (conj)
fibrosis cortex (nmod)
autoantibodies perinuclear-staining (amod)
uptake cc (compound)
relevance be (cop)
biometry of (case)
elevated only (advmod)
alphaenac , (punct)
expressions facial (amod)
levodopa and (cc)
mechanisms cytopathic (amod)
prevention infection (nmod)
distribution the (det)
indicator an (det)
records persons (nmod)
means system (nmod)
associated remoxipride (nmod)
underlying effect (dobj)
seem affect (xcomp)
risk attendant (amod)
degeneration muscle (compound)
failed acquire (xcomp)
6/15 , (punct)
months , (punct)
stay the (det)
imaging by (case)
962 vs (cc)
incident delirium (nmod)
reduction incorporation (nmod)
populations various (amod)
bundle within (case)
analysis chromatography (nmod)
treatment motility (nmod)
using microscope (dobj)
rejection were (cop)
detect ead (dobj)
65.6 + (cc)
amb ( (punct)
loss influence (dep)
edema complicating (acl)
diseases renal (amod)
stage and (cc)
sfas fas (appos)
agent be (cop)
horn segments (nmod)
scale reaction (compound)
infiltration fibrosis (conj)
prescribed mistake (nmod)
kappa-beta the (det)
agent new (amod)
repeat recall (conj)
doses times (appos)
boy received (acl:relcl)
properties beta-blocking (amod)
improve prevent (conj)
cells appropriate (amod)
role oxide (nmod)
ocd of (case)
simple sensitive (conj)
involved mechanisms (nmod)
impairments marked (amod)
velocity of (case)
injection guanethidine (nmod)
serving with (mark)
close incidence (nmod)
provoke . (punct)
showed microscopy (nsubj)
% series (nmod)
methylprednisolone gentamicin (conj)
frlma ( (punct)
2a alpha (compound)
provides enable (advcl)
reductions hr (nmod)
resistant accompanied (advcl)
analgesia hypothermia (conj)
investigate assessed (parataxis)
action metrazol (nmod)
implanted age (nmod)
method anticoagulation (nmod)
1 10 (conj)
caused arrhythmia (dobj)
carries depression (nmod)
mg 800 (compound)
100/mm3 than (case)
signs indicative (amod)
18/90 % (appos)
hypercholesterolemia with (case)
steroid anabolic (amod)
prevent or (cc)
ablated surgically (advmod)
12 8 (compound)
differences terms (nmod)
prevalence use (nmod)
residence new (amod)
role option (nmod)
ao ) (punct)
long-term the (det)
arabinoside cytosine (compound)
damage proximal (amod)
investigated that (nsubj)
preserved however (advmod)
individuals the (det)
echocardiography doppler (compound)
treatment concomitant (amod)
observed whereas (mark)
vasoconstriction diffuse (amod)
indicated caused (ccomp)
duration the (det)
anaesthetized patients (nsubjpass)
exercises regular (amod)
remission been (cop)
sucrose libitum (amod)
recorded tended (advcl)
times : (punct)
conducted evaluation (nsubjpass)
cause dermatitis (nmod)
performed weeks (nmod)
current ca(2 (compound)
relapse first (amod)
drd2 eps (conj)
increase associated (acl)
model important (amod)
began . (punct)
apomorphine mg/kg (dep)
determined echocardiographically (advmod)
cocaine crack (compound)
% inpatients (nmod)
irritation of (case)
medicine impairment (nmod)
dose cya (compound)
dissipates after (mark)
course sulfate (nmod)
wore gradually (advmod)
potentiated mice (nmod)
acting lymphocytes (nmod)
ratio use (nmod)
toxicities dogs (nmod)
) 143 (nummod)
injection ) (punct)
convulsion to (case)
address should (aux)
prevention tamoxifen (nmod)
patients undergone (acl)
hemoglobin reagents (conj)
taking days (nmod)
output ganglia (compound)
subjects on (case)
compare volumes (dobj)
months because (mark)
disorders axis (compound)
recorded asystole (nsubjpass)
treatment depression (nmod)
inducing supersensitivity (dobj)
patients 1,821 (nummod)
nodosum associated (acl)
creatinine protein (compound)
polyuria defect (conj)
associated being (auxpass)
nalozone , (punct)
hold inhibitors (nsubj)
tracings eeg (compound)
blocked saralasin (nmod)
excreted acid (nmod)
recording improvement (nsubj)
indicate dependent (ccomp)
based challenge (nmod:npmod)
altering significantly (advmod)
nd-nmbas of (case)
have chance (dobj)
occult fecal (amod)
study further (amod)
microinjections antagonists (nmod)
systems gabaergic (amod)
is proof (attr)
symptoms by (case)
assistance on (case)
capability the (det)
differentiated pma (nmod)
ah6809 by (case)
inhibitor any (det)
changes become (acl:relcl)
nephritis possible (amod)
avoid understanding (advcl)
-/- d2r (nmod:npmod)
discovered history (dobj)
disabled and (cc)
enzymes ugt (compound)
help finding (nsubj)
paralysis prolonged (amod)
caused side-effects (dobj)
carcinogen a (det)
crisis between (case)
attenuates effect (dobj)
flexion and (cc)
diphosphanilate : (punct)
combination diazepam (nmod)
studies earlier (amod)
c2 included (acl:relcl)
propose induce (ccomp)
known been (auxpass)
literature times (appos)
cells and (cc)
metalloproteinase adam (appos)
215 of (advmod)
reduced work (nsubjpass)
in [cmax]/mic (appos)
hearing of (case)
undergoing endarterectomy (dobj)
kept it (nmod)
prevent clentiazem (nsubj)
demonstrating role (dobj)
increased isoniazid (nsubj)
dose carboplatin (compound)
ability sleep (conj)
symptoms patients (nmod:poss)
hypotension hg (appos)
epilepticus induced (amod)
represents case (nsubj)
bradydysrhythmias tachycardia (conj)
bilirubin ; (punct)
level cumulative (amod)
awful lot (nmod:npmod)
loss thiols (nmod)
increased drugs (nmod)
increase fev1 (nmod)
level on (case)
failure ancrod (nmod)
10 mg/kg (appos)
confound , (punct)
include hemorrhage (dobj)
responses virologic (amod)
procainamide of (case)
deficits chronic (amod)
used fenoldopam (nsubjpass)
uneventful were (cop)
proof no (det)
reduced that (nsubjpass)
effective administration (nsubj)
expressing ( (punct)
qt interval (conj)
toxic minimally (advmod)
furosemide and (cc)
develop esrd (dobj)
using alternation (dobj)
present cord (nsubj)
antipsychotics with (case)
nms and (cc)
brought is (auxpass)
methods . (punct)
lower prolactin (dep)
seen control (nmod)
finding our (nmod:poss)
result probably (advmod)
medical and (cc)
followed concentration (nsubj)
stimulation various (amod)
or p<0.001 (dep)
adrenaline solution (conj)
action be (cop)
function its (nmod:poss)
suffering tinnitus (nmod)
convulsions anesthetic-induced (amod)
activity adenovirus (nmod)
effects respiratory (amod)
lithium of (case)
paroxetine alprazolam (conj)
current potassium (compound)
supplemented and (cc)
received continued (conj)
appearance changes (conj)
vein galen (nmod)
changes biopsy (nmod)
started had (aux)
affection effects (conj)
animals those (nmod)
observed reaction (nsubjpass)
enhance resolution (dobj)
compared efficacy (nmod)
patients tachycardia (nmod)
efficacy its (nmod:poss)
precluded heterogeneity (nsubj)
inadequate . (punct)
cause use (nmod)
nephrosis with (case)
resistant that (nsubj)
induced non-alcoholic (nmod)
vasospasm morbid (amod)
patient above-mentioned (amod)
hypertension cortisol-induced (amod)
protocols treatment (compound)
methylprednisolone mp (appos)
seen risk (nsubjpass)
activity locomotion (compound)
hematocrit or (cc)
$ROOT$ demonstrates (sent)
probes hybridization (compound)
fell rapidly (advmod)
combined 5-fu (nmod)
glucose circulating (amod)
used practically (advmod)
confirmed display (ccomp)
affected increase (csubj)
rating parent (compound)
development brain (compound)
rated scale (nmod)
posturing and (cc)
chickens in (case)
$ROOT$ dermatitis (sent)
group saline (amod)
modulating in (mark)
functioning and (cc)
consisted estrogens (nmod)
consistent reached (conj)
groups treated (acl)
duration sd (nmod)
g/dl and (cc)
compromised were (auxpass)
feedback glucocorticoid (compound)
one is (cop)
antagonist 5-hydroxytryptamine-3 (compound)
proportion large (amod)
weeks 30 (nummod)
results evaluated (appos)
medication for (case)
8-aminoquinoline 5-(l-hexyloxy)-6-methoxy-4-methylquinoline (dep)
amylase pain (nmod)
8.75 to (advmod)
living of (case)
seems specific (xcomp)
cue rats (nmod)
problem this (det)
ph content (conj)
assessed ability (dobj)
= .026 (dobj)
indicate complication (ccomp)
antibody myeloperoxidase-antineutrophil (amod)
effects cortex (nmod)
persists withdrawal (nmod)
determine safety (dobj)
tolerance acid (nmod)
surgery just (advmod)
overactivation significant (amod)
reduces inhibition (nmod)
nephrotoxicity is (cop)
$ROOT$ scored (sent)
g. was (cop)
cascade with (case)
features unusual (amod)
administered propranolol (nsubjpass)
= .047 (dobj)
leads while (mark)
$ROOT$ necessary (sent)
procedures urgent (amod)
chemotherapy gem-p (compound)
suggests reversible (ccomp)
increased 7- (dep)
oxidase mitochondrial (amod)
pulses ( (punct)
lymphomas for (case)
mg intravenously (advmod)
saline antidotes (nmod)
analogues the (det)
decreased cpap (nsubj)
% 86.2 (nummod)
totp ) (punct)
alterations relation (nmod)
prolongation sudden (amod)
subjects or (cc)
due lithium (nmod)
indications these (det)
dogs of (case)
animals 15 (nummod)
showed sparing (nmod)
1.95 about (advmod)
oih ) (punct)
alteration signs (nmod)
people country (nmod)
confirmed evaluation (nsubj)
given haloperidol (nsubjpass)
people asian (amod)
vnb ) (punct)
limits times (nummod)
reduces only (advmod)
died infusion (nmod)
phenobarbital pb (appos)
method reassessment (compound)
sustained was (cop)
myelotoxicity zdv-induced (amod)
found group (nmod)
treated prazosin (nmod)
revealed discriminated (ccomp)
response duration (nmod)
g/d . (punct)
risperidone both (cc:preconj)
library cochrane (compound)
comparing treatment (dobj)
tissues target (compound)
school university (compound)
prospective randomized (dep)
associated deficiency (nmod)
microgram/kg/min 0.03 (compound)
reexposure dipyrone (nmod)
stressed and (cc)
increase markers (nmod)
common ( (punct)
determined suggesting (advcl)
protect blockade (nsubj)
drops echothiophate (amod)
prevent gentamicin-arf (dobj)
issues moral (amod)
bupivacaine the (det)
activity cyp27 (nmod)
of mg/dl (nmod)
study biodistribution (dobj)
remained increased (conj)
suggests mediate (ccomp)
non-txg ( (punct)
reduces % (nmod)
elevations , (punct)
shivering with (case)
peak sharp (amod)
treated monotherapies (nmod)
observed are (auxpass)
uncommon is (cop)
associated elevation (nsubjpass)
reaction idiosyncratic (amod)
properties vasodilating (amod)
failure due (amod)
site vestibular (dep)
$ROOT$ see (sent)
given rd (nsubjpass)
event patients (dep)
regimen docetaxel (compound)
associated doses (nmod)
erythron of (case)
explained could (aux)
yet week (conj)
akathisia one (appos)
protein sodium (conj)
injections i.c.v. (compound)
increased concentrations (nsubj)
properties antipsychotic-like (amod)
correlated decrease (nmod)
expression cardiac (amod)
mg 3 (nummod)
risk that (mark)
episode hyperthermia (nmod)
induced rigidity (nsubjpass)
months few (amod)
concealed because (mark)
start at (case)
regular pressure (nsubj)
decreases thereafter (advmod)
sparing while (mark)
correlated correlated (parataxis)
observed neuropathy (nsubjpass)
non-users remainder (nsubj)
$ROOT$ mustard (sent)
$ROOT$ rash (sent)
shown interaction (nsubjpass)
a-i plasma (compound)
attenuates and (cc)
function vivo (amod)
speed onset (nmod)
than are (cop)
2 weeks (nmod)
level or (cc)
results study (nmod)
treated lindane (nmod)
improvement lid (nmod)
increasing and (cc)
epilepticus model (nmod)
c+e c (conj)
acetazolamide on (case)
fistula the (det)
alpha gamma (conj)
speaking such (case)
reviewing documentation (dobj)
reduced conversely (advmod)
materials of (case)
children undergoing (acl)
drugs multiple (amod)
synthesis/turnover the (det)
factors such (amod)
animals among (case)
effective used (conj)
targeting beta-enac (nmod)
17.6-fold . (punct)
dysfunction aminonucleoside-induced (amod)
hexamethonium peripheral (amod)
% p=0.44 (dep)
impact positive (amod)
patient including (case)
hypertension deterioration (conj)
stimulation hippocampus (nmod)
avoided or (cc)
$ROOT$ highlighted (sent)
chebula terminalia (compound)
s-limonene of (case)
preservation . (punct)
differences levels (nmod)
normal weeks (nmod)
receiving testing (dobj)
indicate initiated (ccomp)
rapa ) (punct)
state renal (amod)
host as (case)
attended laboratory (dobj)
oxidase , (punct)
children especially (advmod)
serious deleterious (conj)
content blood (compound)
nh4ac ( (punct)
showed analyzed (advcl)
cycle subsequent (amod)
initiating patients (nmod)
xo ) (punct)
diagnosed cancer (nmod)
quadriplegic virtually (advmod)
present arrhythmia (nsubj)
arise patients (nmod)
hypotensive and (cc)
markers elevated (amod)
assessment levofloxacin (nmod)
% range (nmod)
kingdom in (case)
alpha-blocker an (det)
sub-divided hbv (nmod)
method given (appos)
decreased 11 (nmod)
women 2 (nummod)
abilities and (cc)
b deficits (nmod)
rate defects (nmod)
parathyroid and (cc)
eeg hippocampal (amod)
rizatriptan for (case)
months induction (dep)
400 450 (conj)
documented we (nsubj)
embryos the (det)
proven was (auxpass)
c only (advmod)
obtained scanning (nmod)
indicate related (ccomp)
mg/m(2)/day 0.9 (nummod)
effect any (det)
initiation therapy (nmod)
reverse pretreatment (nsubj)
hypothesized exhibit (ccomp)
separated . (punct)
inflammation and (cc)
age number (conj)
major beta-thalassemia (compound)
majority events (nmod)
generation atp (compound)
evidence leukoencephalopathy (nmod)
system implantable (amod)
damage ma-induced (amod)
responses intensity (nmod)
allografts kidneys (conj)
3.4 women (nmod)
results reduction (nmod)
micrograms 1.8 (nummod)
properties with (case)
findings angiographic (amod)
experiment carcinogenicity (compound)
because of (mwe)
glomeruli glomerulosclerosis (nmod)
patients minimum (nmod)
$ROOT$ strengthen (sent)
craniotomy before (case)
emulsion lipid (compound)
legs restless (amod)
years more (nummod)
recognize condition (dobj)
weight/week body (compound)
viia of (case)
thiotepa including (case)
function analysis (nmod)
handling sodium (compound)
attaining increase (dobj)
hospital luke (nmod:poss)
extension during (case)
had elevations (dobj)
modalities ) (punct)
significant = (dep)
rocuronium with (case)
glioma , (punct)
n=92 , (punct)
mg/ml ( (punct)
ro 13 (nummod)
decrease chicks (nmod)
initiation on (case)
primigravida developed (acl:relcl)
schizophrenia such (case)
blepharoconjunctivitis complaints (conj)
ketamine xylazine (conj)
necessitate abandoning (xcomp)
have spite (nmod)
preventing damage (dobj)
disorder : (punct)
discriminate , (punct)
miss they (nsubj)
metrics two (nummod)
conditions pain (compound)
penetration resultant (amod)
groups doses (conj)
aes to (case)
% 5 (compound)
noticed patient (nsubj)
plasticity and (cc)
age mean (compound)
state residual (amod)
medications concurrent (amod)
cardiomyocytes human (amod)
increase amount (dobj)
samples obtained (acl)
metastases cancer (compound)
differs erythromycin (nmod)
neuronal and (cc)
troublesome very (advmod)
most % (appos)
antagonizing depletion (dobj)
reaction affects (acl:relcl)
differed concentrations (nsubj)
enrolled received (conj)
ameliorating in (mark)
detection not (neg)
described patient (nsubjpass)
model disease (compound)
delayed pre-treatment (nsubj)
suggesting treatment (ccomp)
identical that (mark)
effects property (nmod)
bowman 's (case)
getting infusion (dobj)
preserved reached (advcl)
noted rtms (nmod)
warn . (punct)
antidote no (det)
evaluation time-to-onset (nmod)
follows level (dep)
herbicides background (compound)
receptor a (det)
lnna after (case)
injections intermittent (amod)
involved which (nmod)
experimental clinical (conj)
preoperative 1-year (conj)
levels bnp (nmod)
co , (punct)
use toxoplasmosis (nmod)
yohimbine alpha(2 (compound)
syndrome woman (nmod)
database group (compound)
discrepancy a (det)
region catalytic (amod)
m or (cc)
subjects ( (punct)
0.02 than (case)
holding exhaustion (nmod)
studied prevention (conj)
acid glutathione (conj)
half cases (nmod)
inferred induced (ccomp)
potentials or (cc)
g strophantine (compound)
epilepsy controlled (amod)
pressure growing (amod)
treatment verapamil (nmod)
catalepsy dose-dependent (amod)
relationship thalidomide (nmod)
carry ; (punct)
phenotype " (punct)
10 > (advmod)
tetrabenazine tiapride (conj)
levels rats (nmod)
intoxication dfp (compound)
= actin (conj)
interval 95 (nummod)
suggest contribute (ccomp)
activator enhances (acl:relcl)
doses customary (amod)
attack : (punct)
salicylates with (case)
tended , (punct)
played where (advmod)
important that (nsubj)
appearance between (case)
controls n=26 (dep)
inhibited arrest (nmod)
ascribing osteoporosis (nmod)
factor it (nsubj)
myoclonus the (det)
powder of (case)
relationship rate (nmod)
defects identified (acl)
chow sucrose (conj)
3.4 - (punct)
day each (det)
claudication intermittent (amod)
assessed analysis (nsubjpass)
clinic a (det)
estimated suffers (ccomp)
less were (cop)
rate highest (amod)
emotions happiness (dep)
improved rats (nmod)
biopsy taken (acl)
associated literature (nmod)
suppressed episodes (nsubjpass)
treatment alpha-2b (compound)
summary developed (acl)
cystica hemorrhage (conj)
plays no (nsubj)
revealed cases (dobj)
patients chemotherapy (nmod)
dog the (det)
infusion clonazepam (nmod)
investigated trial (nmod)
present still (advmod)
least at (advmod)
% treated (acl)
mg/m(2 with (case)
receiving while (mark)
prevented counteracted (conj)
rise a (det)
fraction assessed (amod)
encephalopathy transient (amod)
amn082 ( (punct)
groups conventional (amod)
idiosyncratic toxic (conj)
withdrawal ketoconazole (nmod)
significant it (nsubj)
asymptomatic totally (advmod)
rejection grafts (conj)
status antigen (compound)
effects activity (nmod)
increases aminonucleoside-induced (amod)
manner concentration-dependent (amod)
finished , (punct)
adherence > (amod)
estradiol of (case)
gyrus model (nmod)
resulted actually (advmod)
stimulation versus (cc)
l-isomer medetomidine (nmod)
examination full (amod)
iii and (cc)
satisfactory was (cop)
level ( (punct)
prescribe , (punct)
involvement neurones (nmod)
shows observation (nsubj)
help may (aux)
learning upon (case)
prevented l-sotalol (nmod)
administered phenobarbitone (nmod:npmod)
appears related (xcomp)
= hg (dep)
effect asthma (nmod)
increased course (nmod)
malformation characterized (acl)
induced hydralazine (nmod)
doubled but (cc)
related presence (nmod)
showed results (dobj)
medicated cardiovascularly (advmod)
assessed questionnaire (nmod)
hypotension with (case)
induces tachycardia (dobj)
vehicle hoe-140 (conj)
diarrhoea side-effect (nsubj)
better men (nmod)
transporter by (case)
associated intoxication (nsubj)
lomustine dogs (nmod)
induce deterioration (dobj)
68 7 (conj)
responds therapy (nmod)
interest . (punct)
dose low (amod)
updating memory (compound)
registered were (auxpass)
department ( (punct)
complications fewer (amod)
after week (nmod:npmod)
reported safe (advcl)
potentiation impaired (acl)
nerves in (case)
months 46 (nummod)
blockade later (conj)
duration potential (compound)
biopsies 20 (nummod)
db loss (nsubj)
immunoblotting and (cc)
associated condition (nmod)
first first (conj)
role p300 (nmod)
days vs (cc)
lower events (dep)
anxiety mice (nmod)
sustained were (auxpass)
facilitated morphine (nsubj)
1 57 (nmod)
nausea exanthema (conj)
expressions protein (compound)
interviewed , (punct)
retention h (amod)
pg/ml 1520 (nummod)
% 6.6 (nummod)
characteristics following (amod)
occurred only (advmod)
treated quetiapine (nmod)
atin nsaids-associated (amod)
injection doses (nmod)
15.0 to (dep)
occur : (punct)
relief to (case)
tachycardia symptomatic (amod)
taking pustulosis (nmod)
nuclei supraoptic (amod)
times 8 (compound)
used not (neg)
expression 43 (nummod)
conclusion derived (acl)
seems potentiates (parataxis)
observed decline (nsubjpass)
led intake (nsubj)
measuring using (xcomp)
chemotherapy high-dose (amod)
illustrates and (cc)
$ROOT$ reason (sent)
dimorphism upregulation (nmod)
young age (dep)
cm ( (punct)
occurred % (nmod)
syndromes chest (compound)
strength ability (conj)
institution : (punct)
addition the (det)
tolerated treatment (nsubjpass)
hydrochloride carteolol (compound)
receptors over (case)
staining triphenyltetrazolium (compound)
effects profile (conj)
histories therapy (compound)
aches with (case)
opse a (det)
inhibitor nf-kappab (compound)
rare or (cc)
boluses cocaine (nmod)
deficits hippocampal (amod)
prophylaxis or (cc)
indicate increasing (ccomp)
treated diazepam (nmod)
history treatment (conj)
examined expression (dobj)
defects and (cc)
suggested findings (nsubj)
dsm-iv on (case)
variability of (case)
received steroids (dobj)
recovery clinical (amod)
diatheses bleeding (amod)
administered mg (parataxis)
combination d (nmod)
veins and (cc)
or ) (punct)
mandates cessation (dobj)
neurotoxicity pac (nmod)
extended tracts (nmod)
occurred relapse (nsubj)
alf non-acetaminophen-induced (amod)
evidence necrosis (nmod)
dizocilpine of (case)
downregulation those (conj)
coincided introduction (nmod)
compared pharmacokinetics (dobj)
comparing vnr (dobj)
sacrificed rats (nsubjpass)
exert activity (dobj)
cyanosis , (punct)
promote to (mark)
drugs a-containing (amod)
administration steroid (compound)
mouth meth (compound)
be ; (punct)
g/cm(2 ) (punct)
hg 35 (nummod)
indicating nature (dobj)
clinic eye (compound)
mrna mrna (conj)
sinus sagittal (amod)
higher concentration (nsubj)
played infection (nsubj)
y-mrs ) (punct)
application sided (amod)
none them (nmod)
uh ) (punct)
protocols immunosuppressive (amod)
dose l-3,4-dihydroxyphenylalanine (nmod)
d for (case)
complexes respiratory (amod)
disappeared have (aux)
change therapy (nmod)
prediction cardiotoxicity (nmod)
enos vessels (nmod)
control interaction (nmod)
administration monoher (compound)
delivery oral (amod)
test dependent (amod)
showed echography (nmod)
metabolites related (amod)
indicated focus (nmod)
cells hbmp (compound)
groups rats (nmod)
nmol ) (punct)
reduces requirements (dobj)
$ROOT$ varied (sent)
describes paper (nsubj)
hours from (case)
insula the (det)
incontinence the (det)
make impact (nsubj)
was recurrence (attr)
control intervention (conj)
grade ( (punct)
ltp on (case)
improves learning (dobj)
alkalinization urinary (amod)
agonist by (case)
discontinuation snp (nmod)
influenced to (mark)
prevents metformin (nsubj)
atenolol cardioselective (dep)
micrograms from (case)
caused similarly (advmod)
cox ) (punct)
alf in (case)
100 +/- (cc)
improves microinjection (nsubj)
levels cardiac (amod)
measured it (nsubjpass)
grade % (compound)
protector a (det)
sd for (case)
difference intergroup (amod)
was level (nsubj)
increases combination (nmod)
transporters tubular (amod)
development crf (nmod)
brain adult (amod)
ntg untreated (conj)
patients 212 (nummod)
tolerance response (conj)
y-maze in (case)
sensation painful (amod)
discussed possibilities (nsubjpass)
removed bladder (nsubjpass)
stab by (case)
g/m2 of (case)
herbals on (case)
2c serotonin (compound)
wt/100 lv (compound)
showed sensitization (dobj)
assessed questionaire (nmod)
modulate catalepsy (dobj)
hypertrophy the (det)
53 +/- (cc)
admitted fever (nmod)
black were (cop)
methoxamine placebo (conj)
differences may (aux)
recognized cause (nmod)
score liver (compound)
apnea with (case)
converting when (advmod)
metabolism and (cc)
investigated combination (dobj)
unclear substantial (ccomp)
delayed . (punct)
reduction induction (conj)
tested differences (nsubjpass)
sulfate chondroitin (compound)
tolerated agent (nsubjpass)
segments for (case)
evaluation pre-treatment (amod)
hour injection (dep)
% 24.7 (nummod)
food of (case)
restarted mg/kg (nmod)
l-dihydroxyphenylalanine of (case)
diethylstilbestrol des (dep)
electrodes 240 (nummod)
estradiol testosterone (conj)
november 2003 (nummod)
prevent nephrotoxicity (dobj)
diazinon with (case)
reduced may (aux)
estradiol dm (conj)
nephron the (det)
% reduction (dep)
year treatment (nmod)
foci as (case)
injections rescue (compound)
cimetidine and (cc)
nephrotoxicity amikacin (compound)
oxypurines and (cc)
present patients (dobj)
associated clopidogrel (nmod)
treatment both (preconj)
serious are (cop)
normality " (punct)
examined theory (dobj)
values normal (amod)
$ROOT$ epidemic (sent)
using hippocampus (nmod)
iso-osmolar nonionic (dep)
deteriorated group (nmod)
prospective non-interventional (dep)
associated gentamicin (nsubjpass)
groups fentanyl (compound)
glomerulonephritis proliferative (amod)
three cases (nmod)
associated exposures (nsubjpass)
replaced ranitidine (nmod)
conclude considered (conj)
using treatment (nmod)
0.97 and (cc)
female in (case)
results g (appos)
d-galactose transported (acl:relcl)
phenomenon . (punct)
injection selective (amod)
reaffirms . (punct)
receiving or (cc)
influence extravasation (dobj)
do than (dep)
known participate (xcomp)
criterion single (amod)
involved effects (nsubj)
one of (case)
underwent , (punct)
resulted placebo (nmod)
attack exposure (nmod)
preparations diet (compound)
ptu of (case)
$ROOT$ identify (sent)
complicating heart (dobj)
relationship possible (amod)
phonophobia or (cc)
parameters electroretinographic (amod)
-chlorpheniramine , (punct)
used evaluate (xcomp)
objective compare (acl)
dependent this (nsubj)
developed she (nsubj)
useful but (cc)
scale numerical (amod)
elevated markedly (advmod)
abolished but (cc)
produce that (mark)
changes diastolic (amod)
symptoms irritation (nmod)
regardless ( (punct)
measurement semiquantitative (amod)
palsy a (det)
agonist glutamate (compound)
six respectively (advmod)
number deaths (nmod)
nra0160 , (punct)
signaling through (case)
fell pressure (nsubj)
abnormalities systems (nmod)
supply myocardial (amod)
protects rodents (dobj)
suggested is (dep)
greater . (punct)
dose during (case)
non-selective and (cc)
treatment combination (compound)
1 ) (conj)
cases siat (nmod)
reported symptoms (nsubjpass)
transferred been (auxpass)
benzylthiouracil ne (appos)
slope line (nmod)
stage ) (punct)
using scale (dobj)
mg/kg/b.w ( (punct)
abnormalities metabolic (amod)
patients polychemotherapy (nmod)
change recent (amod)
scans contrast-enhanced (amod)
slope the (det)
controls groups (nmod)
study cardiotoxicity (dobj)
course the (det)
value models (nmod)
$ROOT$ reduction (sent)
provided were (auxpass)
activity enzymes (nmod)
processed obtain (xcomp)
interval hypertension (nmod)
tested using (xcomp)
units/l 500 (nummod)
he or (cc)
programs rat (nmod)
corrected hyperactivity (nsubjpass)
ameliorate . (punct)
examine mechanisms (dobj)
study digoxin (nmod)
illustrates reminds (conj)
requires opening (dobj)
rats fischer (compound)
3.0+/-0.4 mean+/-sd (cc)
assessments preoperative (amod)
experienced drop (dobj)
= collagen (conj)
risks long-term (amod)
pentamidine and (cc)
increased disease (nmod)
role pathophysiology (nmod)
thresholds in (case)
exclusion entities (nmod)
dupuytren 's (case)
return state (nmod)
contribute action (nmod)
mitigates pathway (nsubj)
received mg (parataxis)
infections pseudomonas (compound)
performed identify (xcomp)
weight a (det)
clonidine verapamil (conj)
reported to (mark)
increased morphine (nmod)
terminals pathway (nmod)
on- the (det)
loss gfap-staining (nmod)
increased cystitis (nsubj)
diuretic cause (acl:relcl)
recurrences glioblastoma (compound)
neutral acidic (conj)
stopped reduced (conj)
therapy naproxen (compound)
6 > (advmod)
less somewhat (advmod)
jc cook (compound)
exhibited inheritance (dobj)
were but (cc)
histochemistry in (amod)
brings sometimes (advmod)
phenomena these (det)
rates age-specific (amod)
have had (conj)
pg-9 , (punct)
$ROOT$ lithium (sent)
hypoxemia and (cc)
relative a (det)
dimethylthiourea dmtu (appos)
peroxidation nephropathy (nmod)
arrhythmia or (cc)
artery choriocapillaris (conj)
persisted whom (nmod)
agents sympathomimetic (amod)
delay atrioventricular (amod)
generated background (nmod)
dose granisetron (nmod)
man 69-yr-old (amod)
induced means (nmod)
water supplemented (acl)
rats thirty-five (nummod)
induced ether (nmod)
propranolol micrograms (appos)
waves admixed (amod)
g/dl below (case)
management anesthetic (amod)
relation possible (amod)
$ROOT$ observed (sent)
emissions of (case)
treatment appropriate (amod)
fibrillation intractable (amod)
occlusion sleep (nmod)
day placebo (compound)
use amphetamine (compound)
episode granulocytopenia (nmod)
increased foci/cm2 (advcl)
4.0 0.015 (compound)
. micrograms/kg (nummod)
evaluate caused (ccomp)
production species (nmod)
report complication (nmod)
morphine not (cc)
syndrome duct (compound)
confusion status (conj)
115 of (case)
strain prototypic (amod)
order the (det)
hyperactivity hypoactivity (conj)
insulin-group in (case)
calpain of (case)
hyperalgesia mechanical (amod)
agonist alpha2-adrenergic (amod)
doses day (nmod)
level osmolality (conj)
ikr and (cc)
cats suspected (acl)
neuroprotective if (mark)
fat high (amod)
entities of (case)
collection during (case)
copolymer hpma (compound)
treatment syndromes (nmod)
had 38 (nsubj)
movement wall (compound)
chloroform-adrenaline by (case)
2-(p-bromophenyl)propionate s.c. (dep)
atrophy and (cc)
patterns malformation (compound)
l-arginine observed (acl)
diazepam glycopyrrolate (conj)
paranoia regarding (case)
bfgf ) (punct)
dbp sbp/ (compound)
inflexibility behavioral (amod)
produce pain (dobj)
fucoidan reported (acl:relcl)
synaptophysin and (cc)
given times (nmod:tmod)
cd36 of (case)
affect diltiazem (nsubj)
palsy progressive (amod)
efficacy complications (conj)
lnna with (case)
reduction paralleled (amod)
months three (nummod)
diet hs (compound)
treatment cisplatin (nmod)
after-before ) (punct)
reported respectively (advmod)
characteristics medications (conj)
administration deferoxamine (compound)
mechanisms shared (amod)
inpatients schizophrenic (amod)
1.4 ci=1.2 (dep)
bmd and (cc)
using products (dobj)
contributes events (nmod)
conclude however (advmod)
anemia hepatitis (conj)
tubes and (cc)
used caffeine (nsubjpass)
achieved was (auxpass)
weight volume/g (compound)
5 < (advmod)
pi ) (punct)
carries report (nsubj)
found study (nmod)
hallucinations occur (acl:relcl)
common hyperkalemia (nsubj)
cyp3a4 on (case)
medications current (amod)
performance tests (nmod)
effects nephrosis (nmod)
carbachol mug (appos)
(acei)-induced inhibitor (nmod:npmod)
globulin intramuscular (amod)
rrmm in (case)
has " (punct)
service emergency (compound)
solicited years (nmod)
choose % (nsubj)
increment for (case)
standard but (cc)
bbb ) (punct)
discontinued pergolide (nsubjpass)
severity alcohol (compound)
monotherapy % (appos)
$ROOT$ contains (sent)
produces that (mark)
acetaminophen nimesulide (conj)
cytostatic anti-angiogenic (conj)
compounds shown (acl:relcl)
examine contribution (dobj)
examination treatment (conj)
using mg (dobj)
metabolism beta-blocker (nmod)
users 14 (nummod)
$ROOT$ flestolol (sent)
method measurement (nmod)
fell patient (nmod)
trial from (case)
doxorubicin sc/week (appos)
curves fragility (compound)
antidepressants repeated (amod)
ml/kg and (cc)
participating was (aux)
raise awareness (dobj)
caused partition (nmod)
in general (amod)
girl syndrome (nmod)
years 3.3 (nummod)
amide of (case)
= n (nsubj)
action chronotropic (amod)
exhibited day (nmod)
provide assessment (dobj)
limitation study (nmod)
preferred employed (advcl)
has hypotension (nsubj)
risk absorption (nsubj)
effects week (nmod)
myocarditis fatal (amod)
cocs levonorgestrel-containing (compound)
a-86929 ( (punct)
action significant (amod)
took regimen (nmod)
groups maternally (advmod)
number significant (amod)
show correlation (dobj)
occlusion apparent (amod)
electroretinograms p-ergs (appos)
expression cpu (nmod)
-0.62 vs (cc)
2.0 - (punct)
drugs aeds (appos)
patients were (cop)
rats wistar (compound)
attenuation . (punct)
experience about (case)
strain serve (conj)
simulator on (case)
seven the (det)
appeared beginning (advcl)
compartments subcellular (amod)
immunization mouse (nmod)
bortezomib days (nmod)
anp + (cc)
increases responsiveness (dobj)
normalization after (case)
accompanied pain (nmod)
obtained oliguria (nmod)
safe to (mark)
% year (nmod)
administration cocaine (nmod)
removed measurement (nmod)
registry tumors (nmod)
tolerance poorer (amod)
limits levels (nsubj)
deaths cell (compound)
absence therapy (nmod)
phenytoin of (case)
mice ) (punct)
enhanced response (dobj)
123 and (cc)
improved but (cc)
malignancy is (cop)
fluid csf (appos)
cohorts stroke (nmod)
demonstrate difference (dobj)
u/ml , (punct)
doses 3 (nummod)
discontinued cases (nmod)
strains among (case)
degree some (det)
diazinon mg/kg (appos)
taken sample (nsubjpass)
hazardous might (aux)
differences specific (amod)
effects cirazoline (nmod)
antagonism mice (nmod)
established we (nsubj)
convulsions bupivacaine-induced (amod)
relief faster (amod)
diagnosed electrocardiogram (nmod)
confusion of (case)
technique perfusion (compound)
seizures institution (nmod)
cxad ( (punct)
microscope laser (compound)
prl-r , (punct)
exacerbated patients (nmod)
rejection loss (conj)
sparse data (nsubj)
lesions neurotoxic (amod)
micrograms/kg b.w (dep)
exclusion appendage (nmod)
mice azt-treated (amod)
93 and (cc)
suitable dronedarone (nsubj)
agonist mesylate (nsubj)
hydrochloride mepivacaine (compound)
model overdose (nmod)
syndrome serotonin (compound)
nitrogranulogen ng (appos)
influx given (case)
transitioned was (auxpass)
counterbalanced placebo-controlled (dep)
evaluation diazinon (nmod)
cortex temporal (amod)
hypotension dose-dependent (amod)
assays with (case)
induced fenoldopam (nmod)
included evaluate (xcomp)
reviewed pathogenesis (nsubjpass)
found also (advmod)
41 of (advmod)
laboratories eskisehir (appos)
revealed review (nsubj)
studies prior (amod)
reversing in (mark)
crea mumol/mg (compound)
mortality long-term (amod)
cause prognosis (nsubj)
analogs bd1008 (nmod)
loss rather (cc)
unaffected severity (nsubj)
result , (punct)
type nor (cc)
rarest is (cop)
restriction and (cc)
undergone which (nsubj)
sh(6 sh(12 (appos)
causes identifiable (amod)
pod and (cc)
haemodilution moderate (amod)
attempt is (cop)
found phosphorylation (nsubjpass)
2.5 more (amod)
glomerulonephritis with (case)
studies neuropsychological (amod)
history examination (conj)
exhibite . (punct)
disease = (dep)
= b (nsubj)
6.3 +/- (cc)
cell muscle (compound)
weakness prolonged (amod)
iohexol with (case)
predictors significant (amod)
urinalysis by (case)
behavior immobility (conj)
administration immunity (conj)
scale for (case)
combination agents (nmod)
increase bnp (nsubj)
persists that (nsubj)
injection morphine (nmod)
activates isoproterenol (nsubj)
head . (punct)
required ventilation (dobj)
$ROOT$ confirm (sent)
desipramine , (punct)
normalized subjects (nmod)
weakness patients (nmod)
insipidus due (case)
comparable magnitude (nmod)
measurements counts (appos)
suggest indicator (ccomp)
estimate ratio (dobj)
syndrome milk-alkali (amod)
interactions drug-drug (amod)
conversion : (punct)
day days (conj)
due lack (nmod)
fluorobenzylidene - (amod)
adenocarcinoma ( (punct)
showed pattern (dobj)
assay an (det)
titration during (case)
injury whose (nmod:poss)
differences measurements (nmod)
drugs interval-prolonging (amod)
offspring des-exposed (amod)
attenuated administration (nmod)
drug their (nmod:poss)
seizures to (case)
40 % (dep)
efficacy olanzapine (nmod)
gtn ) (punct)
systemic intrathecal (conj)
patients noncyanotic (amod)
arabic ml/kg (dep)
testing memory (dobj)
area auc (appos)
met stimulation (nsubj)
revealed glomerulonephritis (dobj)
mg/dl 131 (nummod)
task and (cc)
changes especially (advmod)
events hypertriglyceridaemia (conj)
retained compared (advcl)
reduced myoclonus (dobj)
5-httlpr or (cc)
use agents (nmod)
studies among (case)
regimen 3 (nummod)
40,000 of (case)
fed days (nmod)
mic ( (punct)
$ROOT$ off (sent)
valdecoxib agents (conj)
observed injected (advcl)
parameters biochemical (amod)
liver the (det)
allele " (punct)
carcinoma untreated (amod)
remained different (xcomp)
block does (aux)
matter fine (amod)
kg 31.7 (nummod)
plays cx3cr1 (nsubj)
causes known (amod)
attributed was (auxpass)
rats bearing (acl)
ratio women (nmod)
audiograms of (case)
nucleus by (case)
agent potent (amod)
tablet rizatriptan (compound)
1.9 and (cc)
pravastatin and (cc)
mg quetiapine (nmod)
arrest overdose (nmod)
18/88 7 (conj)
accident evidence (conj)
inhibition preparations (nmod)
outcomes to (case)
impairments executive (amod)
enalapril and (cc)
allergies with (case)
morning early (amod)
increased reversal (nmod)
hemorrhage cocaine-associated (amod)
estimated ecgs (nmod)
= df (nsubj)
produce ulcer (dobj)
3.0+/-0.4 , (punct)
rotations rats (nmod)
appeared administration (nmod)
effects calcitonin (nmod)
slowing mental (amod)
hypertrophy lv (compound)
estimated cpu (nmod)
background effective (dep)
hours therapy (nmod)
-20.0 ) (punct)
mpo-anca between (case)
effects affect (acl:relcl)
normal stimulation (nsubj)
injury direct (amod)
d-penicillamine a (det)
complications cns (compound)
patients ill (amod)
reduced be (auxpass)
failed increase (xcomp)
regimens conditioning (compound)
elucidated yet (advmod)
muscle-lengths/s p (dep)
capillaries tortuous (amod)
cycles gem-p (nmod)
$ROOT$ admission (sent)
neuralgia pre-existing (amod)
results years (appos)
rats 42-day-old (amod)
decrease concomitant (amod)
effect group (compound)
living areas (nmod)
ml(-1 ng (compound)
leaving unchanged (ccomp)
patients therapy (nmod)
paramethasone dexamethasone (conj)
attempt trial (nsubj)
induced reintroduction (nmod)
protect estrogens (nsubj)
suggests this (nsubj)
adjusted ) (punct)
skin elisa (conj)
mmp-2 adam10 (conj)
neoplasms non-metastasizing (amod)
effect induced (acl)
hemolysis of (case)
= 175 (dobj)
cortex medulla (conj)
recorded monitor (nmod)
carbimazole like (case)
acetate tid (appos)
% 0.05 (nummod)
examinations routine (amod)
group group (appos)
available patients (nsubj)
dysfunction ecstasy-associated (amod)
coma alpha (compound)
naphazoline xylometazoline (conj)
homozygous heterozygous (conj)
electrophysiologic hemodynamic (conj)
recurrence loss (conj)
$ROOT$ commenced (sent)
induced that (nsubjpass)
deficit selective (amod)
disorders digestive (amod)
produced pilocarpine (nmod)
arrhythmia and (cc)
$ROOT$ receiving (sent)
pathologies brain (compound)
decreases incidence (dobj)
ecg averaged (amod)
mg/day up (advmod)
sg145r sp120 (conj)
is aware (ccomp)
bioavailability gspe (nmod:poss)
resection and (cc)
thickness by (case)
patients toxicology (nmod)
$ROOT$ depleted (sent)
indicate required (ccomp)
size impairment (appos)
ecstasy of (case)
managed assessed (advcl)
audiograms abnormal (amod)
19 in (case)
effects carteolol (nmod)
episode initial (amod)
nephrosis adriamycin (compound)
receptor cloned (amod)
ascended included (conj)
report no (det)
recognized being (auxpass)
treatment youth (nmod)
disruption barrier (dobj)
$ROOT$ suffers (sent)
evaluate question (dobj)
weeks of (case)
flumazenil dose (dep)
g/m2 doses (nsubj)
0.24 +/- (cc)
most cases (nmod)
hours over (case)
age aneurysms (conj)
treatment administration (nsubj)
emit exposure (nmod)
analysis indicators (nmod)
promoted consistently (advmod)
cingulate paralimbic (conj)
dysplasia cerebellar (amod)
agents on (case)
increase generation (nmod)
reduction withdrawal (conj)
cyclophosphamide by (case)
day 5 (nummod)
appeared cells (nsubj)
symptoms tnss (appos)
detected liver (nmod)
arteries basilar (amod)
biopsy rats (nmod)
1.19 1.52 (appos)
shown contain (xcomp)
management dysfunctions (nmod)
state surveying (amod)
induce types (dobj)
membranes ptcr (appos)
conclusions has (dep)
bleed failure (conj)
afterdischarges duration (nmod)
defined ) (punct)
effect muscimol (compound)
failure without (case)
suggest decrease (dobj)
ace i/d (appos)
developed day (nmod)
toxicity agents (nmod)
status of (case)
inhibited mk801 (nmod)
decrease peroxidase (nmod)
sets two (nummod)
compared were (auxpass)
administration mice (nmod)
agonist beta-adrenoceptor (compound)
cellular nor (cc)
third 14th (nmod)
degeneration hypertrophy/cytomegaly (conj)
established therefore (advmod)
damage a (det)
history biopsy (conj)
stimulus noxious (amod)
developed arf (dobj)
infusion extradural (amod)
months initial (amod)
hypotension before (nmod)
hyperalgesia thermal (amod)
maze morris (compound)
intervals monthly (amod)
presentation . (punct)
administration states (compound)
responsible blockade (nsubj)
disappearance brain (nmod)
5-fu to (case)
presence preparations (nmod)
seems it (nsubj)
treatment desferrioxamine (compound)
survival of (case)
prediction the (det)
reoccur tachycardia (nsubj)
$ROOT$ dyskinesias (sent)
= 0.35 (dobj)
stomachs rat (compound)
phosphate totp (appos)
treated indinavir (nmod)
haemorrhage with (case)
involved nerves (nsubjpass)
htr6 in (case)
interferes disruption (nsubj)
parameters neuroendocrine (amod)
received vehicles (dobj)
microscope by (case)
reactions hours (nmod)
ataxia moderate (amod)
integration a (det)
mdma of (case)
outflow dopamine (compound)
patients attained (acl:relcl)
defect stenosis (nmod)
mainstay tumors (nmod)
case hypertension (nmod)
had mother (nsubj)
months nine (nummod)
remained 243 (nsubj)
design balanced (amod)
placed her (dobj)
$ROOT$ weighed (sent)
excess formation (nmod)
analyzer field (compound)
onset subacute (amod)
aspects in (case)
proliferation progenitor (compound)
consumption to (case)
sensitivities predicting (acl)
coadministered when (advmod)
ligation duct (compound)
increases supine (nmod)
mg/kg)-treated ( (punct)
necrosis necrosis (conj)
consequences different (amod)
based one (nummod)
control hydroxytyrosol (conj)
identifying of (mark)
antidepressants for (case)
hyperactive animals (nsubj)
decline abilities (nmod)
factor outcome (nmod)
neuropeptide an (det)
lenalidomide of (case)
therapy months (compound)
voltage- atp-sensitive (conj)
care primary (amod)
discontinuations aes (nmod)
reaction not (neg)
exposure mechanism (nsubj)
efficacy protective (amod)
rank p>0.6 (nummod)
observed had (aux)
triphenyltetrazolium ttc (appos)
investigate agents (dobj)
= 15 (dobj)
differences successive (amod)
anxiolytic anticonvulsant (conj)
outpatients 33 (nummod)
catheter implanted (amod)
levels malondialdehyde (compound)
is relation (attr)
streptomycin to (case)
mg/l to (case)
smoking daily (amod)
endogenous two (nummod)
administered group (nsubj)
5-httlpr ( (punct)
vasodilator used (acl)
responses caffeine (nmod)
findings together (advmod)
consumption alcohol (nmod)
employing doses (dobj)
rats 14 (nummod)
weeks 34 (nummod)
group bupivacaine/rofecoxib (compound)
macrolides the (det)
scores bis (compound)
ns acute (amod)
reduced contraction (nsubjpass)
65 1 (compound)
exposure cacl(2 (compound)
recovers and (cc)
typical cystitis (nmod)
recording electrocardiography (compound)
4107 figures (nsubj)
coagulation blood (compound)
hypothesized equilibrate (ccomp)
profile toxicity (conj)
mass expression (conj)
form dystrophy (nmod)
capsaicin neuralgia (nmod)
p<0.021 ) (punct)
thrombosis and (cc)
cefotetan intravenous (amod)
hyperalgesia oih (appos)
shrinkage masked (acl)
protocol rule-in (amod)
alterations rats (nmod)
onset pain (nmod)
potential nerve (nmod)
caused excitation (dobj)
concentrations than (case)
shifts might (aux)
given dose (nmod)
indolamines pineal (amod)
methods had (appos)
9 patients (nmod)
concentrate complex (compound)
phlorizin with (case)
assessed comparing (advcl)
conscious was (cop)
suspension an (det)
population entire (amod)
cessation sulfasalazine (nmod)
demonstrated patients (nsubj)
shown pretreating (advcl)
produced latency (dobj)
recovery uneventful (amod)
volumes hippocampal (amod)
observed 8) (dobj)
precipitation tubule (nmod)
suppressed causing (advcl)
suppressed significantly (advmod)
have could (aux)
accelerated but (cc)
immunoreactivity npy (compound)
administration reserpine (compound)
focused have (aux)
ulcerous and (cc)
protect could (aux)
anxioselective and (cc)
bia 093 (nummod)
uneventful was (cop)
day 23 (nummod)
cirazoline to (case)
genotype heterozygous (amod)
factor angiogenic (amod)
class toxicity (nmod)
rats depleted (amod)
surveillance of (case)
agents or (cc)
treatment corticosteroids (nmod)
justify can (aux)
younger in (case)
chloride bicarbonate (conj)
enhances toxicity (dobj)
regimen and (cc)
warranted therefore (advmod)
developed examine (xcomp)
factor-kappab of (case)
alleviate impairments (dobj)
model ich (nmod)
higher % (dep)
appearance of (case)
months within (case)
spasm induction (nmod)
attenuated . (punct)
hallucinations convulsions (conj)
normalized status (nsubj)
atp snp (conj)
appropriate be (cop)
chx for (case)
% 22 (nummod)
dysfunctions by (case)
supported , (punct)
dysphagia of (case)
began they (nsubj)
decrease breath (nmod)
fraction including (case)
studies acute (amod)
milder although (advmod)
has combination (nsubj)
netilmicin and (cc)
pms in (case)
animals cells (nmod)
values resting (amod)
suspect to (mark)
start tmp (nmod)
urticaria angioedema (conj)
literature and (cc)
extract l. (compound)
2.5 0.03 (compound)
anesthesia with (case)
neoplasia nephropathy (conj)
membranes condensed (amod)
estimate study (nmod)
alpha-gst ( (punct)
dfp ( (punct)
analysis in (case)
comprise traits (dobj)
july april (nmod:tmod)
primigravida healthy (amod)
reduced lower (advcl)
measurement antigen (nmod)
hospital in (case)
drug trial (compound)
patients sedated (amod)
cigarettes n=76 (appos)
active enzymatically (advmod)
presented pointes (dobj)
days hypertrophy (nmod)
ecgs ) (punct)
september 2000 (nummod)
discharge for (case)
promotes catalepsy (dobj)
n=94 ) (punct)
acid brain (compound)
patients awaiting (acl)
reactions of (case)
nsc 4-acridinecarboxamide (appos)
pac of (case)
disturbance of (case)
g 0.24 (nummod)
exposure steroid (compound)
occur they (nsubj)
antagonists inhibitors (conj)
prolonged greatly (advmod)
bound dox (nsubjpass)
recurrence hepatitis (nmod)
levels the (det)
weight greater (amod)
peroxisomes hepatomas (nmod)
administering by (mark)
doxorubicin mg/m(2 (appos)
amitriptyline than (case)
pressure volume (conj)
repeated weeks (nmod:tmod)
used patients (nmod)
inhibited 4-damp (nsubj)
hypotension transient (amod)
thrombosis mice (nmod)
38 19 (compound)
define report (nmod)
angiotensinogen brain (compound)
b12 intramascular (amod)
identified previously (advmod)
$ROOT$ improve (sent)
blocked dose (nmod)
principle on (case)
site characteristics (nmod)
production ros (compound)
experienced gain (dobj)
man in (case)
dysfunction increased (amod)
distinguish significantly (advmod)
220 0 (compound)
severe to (case)
benefit palliative (amod)
obtained liver (nmod)
given occasions (nmod)
causes activation (nsubj)
dosing the (det)
treatment anti-inflammatory (amod)
dysfunction (bcnu)-induced (punct)
abolished increases (nsubjpass)
l-dopa of (case)
active tolerated (conj)
auc an (det)
change % (compound)
caused injection (nmod)
alter dynamics (dobj)
score initial (amod)
duration use (nmod)
arteritis in (case)
monotherapy each (det)
% 43 (nummod)
had types (nmod)
obsolete but (cc)
antipsychotics classic (amod)
development for (case)
caused paramethasone (nmod)
ck-mb compared (case)
d etoposide (nmod)
assessed series (nmod)
reward in (case)
$ROOT$ sufficient (sent)
structure-activity dose-effect (conj)
starting when (advmod)
populations ca1 (nmod)
psychosis with (case)
produced haloperidol (nsubj)
inhibition feedback (nmod)
cefonicid or (cc)
tocolytics these (det)
decreases output (nsubj)
bipolarity onset (conj)
binder phosphate (compound)
received oil (dobj)
patients mono-infected (amod)
time failure (nmod)
diuresis induced (acl)
groups other (amod)
% 3/5 (appos)
gm given (case)
varied corresponded (conj)
= .01 (dobj)
dysfunction severe (amod)
experiences contemporary (amod)
characterized seizures (nsubjpass)
using lidocaine (dobj)
wane although (mark)
agonist to (case)
activity hepatic (amod)
inhibit doses (nmod)
population overall (amod)
biochemical behavioral (conj)
reported ability (nsubjpass)
nystagmus and (cc)
identified must (aux)
cause rodents (nmod)
sclerosis multiple (amod)
resulted depression (nmod)
indicating targeting (dobj)
unknown mechanism (nsubj)
polyvidone dimer-x (conj)
indians and (cc)
function cgi-sf (appos)
seems fragmentation (xcomp)
procedure deconvolution (compound)
(nmda)-induced pilocarpine- (nmod:npmod)
ci=26.7 95 (amod)
shown tdp (dobj)
features microangiopathy (nmod)
malignancy of (case)
b1r ) (punct)
maternal fetal (conj)
astrocytes hypertrophied (amod)
effects cns (compound)
clearance mesangial (amod)
1.22 - (advmod)
considered that (nsubjpass)
deoxycorticosterone both (cc:preconj)
found common (xcomp)
cm 1 (nummod)
dog one (nummod)
threshold contrast (compound)
echocardiography cross-sectional (amod)
alterations cardiac (amod)
muscle heart (compound)
time almost (advmod)
patients aids (compound)
% 91.8 (nummod)
occurred seconds (nmod)
epilepticus following (amod)
conclusion : (punct)
discontinuation with (case)
receptor machr (appos)
treated agents (nmod)
barrier glomerular (amod)
ingestion after (case)
calculations on (case)
episodes syncope (nmod)
experience in (case)
modulates rtms (nsubj)
years five (nummod)
multiforme and (cc)
interruption administration (nmod)
recovered discontinuing (advcl)
associated intake (nmod)
rosacea and (cc)
ischemia isoproterenol-induced (amod)
reversible , (punct)
$ROOT$ month (sent)
iopromide iohexol (conj)
= .005 (dobj)
beneficial addition (nsubj)
derangement developing (acl)
hybridization blot (compound)
confounding of (case)
immunoreactive prox-1 (nmod)
suffering had (aux)
side-effects effects (conj)
behavior escape-like (amod)
incidence true (amod)
patients 12/30 (nummod)
clearly more (advmod)
overdose carbamazepine (compound)
oc prescribed (acl)
years 24 (nummod)
users abstinent (amod)
lidocaine-kindled acute (conj)
antagonizing , (punct)
lamivudine mg (amod)
hypercalcemia of (case)
determined concentrations (nsubjpass)
desipramine dose (compound)
identified slowly (advmod)
expression oat1 (nmod)
behaviors dopamine-mediated (amod)
make availability (nsubj)
cortex and (cc)
specimens biopsy (compound)
suggest reducing (advcl)
train gated (amod)
map to (case)
$ROOT$ g/d (sent)
associated introduction (nsubjpass)
different administration (nmod)
therapy after (conj)
ctc-nci leukopenia (appos)
mg for (case)
sinus and (cc)
min was (cop)
attack convulsions (conj)
intoxications carbachol (nmod)
involved activation (nsubjpass)
mcl in (case)
lvdp/dt ) (punct)
tissues on (case)
[3h]-dihydroergocryptine of (case)
0.99 , (punct)
agents ( (punct)
denied use (nsubjpass)
> 0.70 (dobj)
behavior wds (compound)
movement hyperkinetic (amod)
effects prothrombotic (amod)
hypokalemia beta-2-adrenoceptor-mediated (amod)
children disorder (nmod)
joint at (case)
less depression-inducer (nmod)
tested mk-801 (nsubjpass)
electrocardiogram regarding (case)
activation from (case)
treated l-noarg (nmod)
strength her (nmod:poss)
4.2 10(10 (conj)
development fluctuations (nmod)
fischer 344 (nummod)
responses pressure (compound)
propranolol nor (cc)
vigilance close (amod)
consistent and (cc)
yield sites (nmod)
minutes exercise (nmod)
recurred re-exposure (nmod)
microangiopathy . (punct)
groups the (det)
decrement a (det)
ddathf ) (punct)
anemia posttransplant (amod)
abnormality of (case)
artesunate with (case)
enhanced rate (dobj)
maintained that (mark)
this and (cc)
entered methods (nsubjpass)
objective and (cc)
alteration counteraction (conj)
associated beta-adrenoblocking (nmod)
effects bradycardic (amod)
index performance (nmod)
breath and (cc)
action opioids (nmod)
mr mp (conj)
compliance increases (conj)
produce incidence (nmod)
days intensity-weighted (amod)
aimed : (punct)
induced antagonized (conj)
analog the (det)
expression cyclooxygenase (compound)
effect antiseizure (amod)
were deaths (attr)
conversion tacrolimus (nmod)
leukopenia 45.5/18.2/6.1 (appos)
treatment metformin (nmod)
corticosteroids different (amod)
hyperplasia cancer (conj)
dgc the (det)
suggested it (nsubjpass)
days discontinuation (nmod)
concentrations sgot (nmod)
failure hyperkalemia (nmod)
drugs k (compound)
bortezomib combination (nmod)
$ROOT$ prolonged (sent)
patients 747 (nummod)
triggered tacrolimus (nmod)
improvement gfr (nmod)
cause cystitis (dobj)
% 14.2 (nummod)
gag/pol ( (punct)
counts drug-induced (amod)
from 15+/-1 (cc)
effective not (neg)
group d-med (compound)
hearts whose (nmod:poss)
increases formation (dobj)
sensitized cephalothin (nmod)
hemodynamics rate (dep)
calcium corrected (amod)
resulted patients (nmod)
apnoea . (punct)
compatible repair (nmod)
followed is (auxpass)
refused and (cc)
1.37 model (nmod)
suffering 1989 (nmod)
manual diagnostic (amod)
synthesis endothelin-1 (nmod)
inflammation urinary (amod)
had hallucinations (dobj)
fibrillation for (case)
use into (case)
cisapride ) (punct)
suppression . (punct)
became when (advmod)
unreasonable restrict (xcomp)
measure variability (nmod)
inpatients class (nmod)
participate regulation (nmod)
sustained 48-week (dep)
suggest occur (ccomp)
have efficacy (nmod)
% 15.1 (nummod)
acid-induced valproic (amod)
epilepticus-associated status (nmod:npmod)
recurred precautions (nmod)
evaluable response (nmod)
sfas of (case)
population-based follow-up (punct)
disappeared rhythm (nsubj)
mg/m2 532 (nummod)
produce atherosclerosis (nsubj)
decreased declined (conj)
identify to (mark)
efficacy preventing (acl)
indicate involve (ccomp)
anesthesia total (amod)
photostimulation sites (nmod)
caused nelarabine (nmod)
[ca(2+)](i ) (punct)
quantified depression (nsubjpass)
associated octreotide (nmod)
years 38 (nummod)
receiving ritodrine (dobj)
relationship symptoms (nmod)
qtp li/dvp (conj)
sodium , (punct)
doses pyridoxine (nmod)
started cyclosporine (nsubjpass)
protein 6.3 (nummod)
mydriasis convulsions (conj)
assess presence (dobj)
3722 3628 (conj)
bortezomib after (case)
sedatives of (case)
ml in (case)
mg/kg/day 50 (nummod)
focuses . (punct)
regurgitation of (case)
slowing generalized (amod)
hypotension response (dep)
presented and (cc)
phenomenon clinical (amod)
reduced changes (dobj)
intact expression (nmod)
experienced further (advmod)
risk contraceptives (nmod)
$ROOT$ discusses (sent)
$ROOT$ accomplished (sent)
toxicities antiproliferative (amod)
administered ifo (nsubjpass)
include research (nsubj)
provoke contrast (nmod)
right of (case)
delirium her (nmod:poss)
differences weighted (amod)
levels trough (compound)
employed were (auxpass)
dis , (punct)
1991 1993 (conj)
years 6 (nummod)
pain their (nmod:poss)
parameters training (nmod)
result use (nsubj)
less was (cop)
pathogenesis is (cop)
d3 of (case)
case dysphonia (nmod)
glucose to (case)
thought memory (nsubjpass)
intervention and (cc)
i.m. , (punct)
presence pb (nmod)
progression eeg (nmod)
eyes in (case)
prostigmine intramuscularly (advmod)
receiving cyclophosphamide (dobj)
event conclusion (nmod)
required e.g. (advmod)
defined doses (nmod)
experienced loss (dobj)
percent and (cc)
anticoagulants patients (appos)
health community (compound)
swallowing liquids (dobj)
influence interactions (nmod)
appropriate most (advmod)
cimetidine for (case)
cbz range (nmod)
initiation process (nmod)
rtms only (advmod)
recorded using (xcomp)
204 39.3 (conj)
reported associated (parataxis)
subsided generally (advmod)
favored reports (nsubj)
prolonged leading (advcl)
analyzed determined (conj)
agent antidepressant (amod)
naloxone with (case)
perimetry fields (appos)
drop . (punct)
confound however (advmod)
beta-blockers with (case)
combination propofol (nmod)
associated cases (nmod)
subset for (case)
reactions ocular (amod)
clonidine with (case)
antifolate . (punct)
prodrugs two (nummod)
was extend (xcomp)
show has (ccomp)
one insecticides (nmod)
growth limb (nmod)
bia 2 (nummod)
enhances risk (dobj)
occurred indicating (advcl)
neurotensin of (case)
cardiotoxicity experimental (amod)
performed pnd71 (nmod)
pretreated seizures (nmod)
block antegrade (amod)
rapid lasting (conj)
levels ck (compound)
spiranolactone , (punct)
$ROOT$ comprise (sent)
events ongoing (amod)
rate cure (compound)
u/l 46 (nummod)
diagnosis their (nmod:poss)
present . (punct)
association acid (nmod)
$ROOT$ favor (sent)
present who (nsubj)
addition effects (nmod)
1 to (dep)
therapy treatment (nsubj)
ranged 57 (nmod)
occur treatment (nmod)
method assigned (acl)
microgram 100 (nummod)
mg. 120 (nummod)
formulation , (punct)
november 1997 (nummod)
making higher (ccomp)
0.25 0.50 (conj)
concentration carbachol (compound)
$ROOT$ improves (sent)
crf n=748 (appos)
treatment barium (compound)
angiograms green (amod)
decompression neurolysis (conj)
investigated has (aux)
mass in (case)
level glutathione (compound)
protects expression (nsubj)
remove drug (dobj)
relevance anemia (nmod)
exacerbated and (cc)
ekg ) (punct)
abundant abundant (parataxis)
3.4 0.2 (conj)
lowered also (advmod)
carcinoma squamous (amod)
analysis haplotype-wise (amod)
present be (cop)
encephalopathy vasospasm (conj)
rash the (det)
drugs doxorubicin (nmod)
complex granular (amod)
purpose report (appos)
bn , (punct)
microscope under (case)
s.c. mg (compound)
hbv occult (amod)
prescribed inhibitor (nmod)
composition synthesis (conj)
use prolonged (amod)
institution treatment (nmod)
mean 14.2 (appos)
followed srl (nmod)
quit either (preconj)
addition adenosine (nmod)
n lithium (compound)
parenchyma of (case)
excitability increased (amod)
tetany and (cc)
atpase atpase (conj)
assessable and (cc)
time half-relaxation (amod)
functioning central (amod)
concerns 1990s (nmod)
evaluated purpose (nsubj)
scanning from (case)
indicate correlation (dobj)
activity cyp7a (nmod)
3.9 1.1 (dep)
vocalization the (det)
band annulus (nmod)
patient infants (nmod)
attenuated significantly (advmod)
devastating potentially (advmod)
effect susceptibility (nmod)
need research (nmod)
cefonicid and (cc)
ci 95 (compound)
$ROOT$ flow (sent)
related chloroquine (nmod:npmod)
et-1 and (cc)
omission fentanyl (nmod)
interferes activation (nmod)
was users (nmod)
current + (compound)
questioned was (auxpass)
produce redistribution (dobj)
exercise- and (cc)
dysrhythmias such (case)
eliminated that (nsubj)
reverses task (nmod)
sign occur (acl:relcl)
pressure albuminuria (conj)
decreased extent (dobj)
ratio body (compound)
cholecystectomy at (case)
stabilization sarcoma (nmod)
alterations perceptual (amod)
used surgery (nmod)
counts t-cell (compound)
examined vitro (advmod)
type agent (nmod)
$ROOT$ investigation (sent)
$ROOT$ dysguesia (sent)
observed effects (nsubjpass)
use situations (nmod)
apposition incomplete (amod)
3.5 , (punct)
modify revealed (advcl)
dose . (punct)
11 3 (compound)
hepatitis zidovudine-induced (compound)
consistent cortex (conj)
dyskinesias particularly (advmod)
cystica of (case)
hypertension persistent (amod)
report results (nsubj)
damage greater (amod)
compared beta-blocking (nmod)
theophylline after (case)
srl of (case)
grams proteinuria/day (nmod)
sedation light (amod)
inotropic negative (amod)
infusion auc (nmod)
extent impairment (nmod)
mg/m2 350 (nummod)
ci=25.2 % (compound)
patients gravis (nmod)
> 0.60 (dobj)
limits negative (conj)
39 +/- (cc)
suggest releases (ccomp)
violation for (case)
experienced myoclonus (dobj)
1/500 less (amod)
duration disease (compound)
outcome for (case)
pathogens with (case)
mg naproxen (compound)
ducts of (case)
men 31 (nummod)
antitussives of (case)
delayed may (aux)
role neuroprotection (nmod)
induced decrease (dobj)
mug 50 (nummod)
dosages cyclosporine (nmod)
induced used (ccomp)
preference a (det)
occurred courses (nmod)
injections mg/g (appos)
suggested surveys (nsubj)
promote increased (conj)
procaterol . (punct)
women subjects (nsubj)
observed behavior (nsubj)
test echocardiographic (amod)
cytoskeleton cardiomyocyte (nmod)
indicate role (dobj)
proliferation no (neg)
had glioma (dobj)
investigate relationship (dobj)
led cardiotoxicity (nmod)
use corrected (advcl)
reveals usual (ccomp)
screening assessment (nmod)
factors impairment (nmod)
patients age (dep)
2 10 (conj)
101 2 (conj)
using completed (advcl)
diphosphanilate topical (amod)
call ; (punct)
hepatitis as (case)
abolished moreover (advmod)
sulphate inhibitor (appos)
start min (conj)
$ROOT$ safety (sent)
intervals hour (compound)
users ecstasy-polydrug (compound)
nine approximately (advmod)
mania with (case)
syndrome amnestic (amod)
measurements biometric (amod)
lower p (dep)
myalgia 3 (nummod)
responded as (mark)
treated blockade (nmod)
short-term ' (punct)
treated ccnu (nmod)
0.5 and (cc)
have ngf (nsubj)
given tracheotomies (dobj)
inhibitor sis3 (appos)
1:4 ) (punct)
see as (prep)
cases intoxication (nmod)
animals were (cop)
septicemia and (cc)
morphine ; (punct)
disorder diltiazem (conj)
induces administered (advcl)
histology of (case)
neutropenia mild (amod)
1.2 4.1 (prep)
nmdars ( (punct)
4.3 0.6 (conj)
failure developed (acl:relcl)
problem need (conj)
mg 200 (nummod)
mg/kg 243.4 (nummod)
seen activity (nsubjpass)
acidosis gain (conj)
curcumin dietary (amod)
reduces dexrazoxane (nsubj)
p 101 (nummod)
analog somatostatin (compound)
co-treatment outcome (conj)
treated tumors (nmod)
demonstrated suggesting (advcl)
10 to (dep)
groups c1 (dep)
measurement new (amod)
76 5 (conj)
decreased amplitudes (nsubj)
recovery despite (case)
increase dextran (nsubj)
positioning as (acl)
caused incidence (dobj)
patients transplantation (nmod)
radiation and (cc)
suggests magnitude (ccomp)
recorded all (dep)
composite was (cop)
dermatitis and (cc)
participating study (nmod)
reported use (nmod)
% -2.0 (nummod)
presence administration (nmod)
encephalopathy syndrome (nsubj)
method patients (nmod)
seen tumors (nsubjpass)
patients many (amod)
stimuli mechanical (amod)
cure not (neg)
safe preventing (advcl)
18 4 (quantmod)
99 95 (conj)
traumatic ischemic (conj)
clinic ophthalmology (compound)
followed inoculation (nsubjpass)
analyses from (case)
paradigm an (det)
developed time (nmod)
antipsychotic a (det)
used examine (xcomp)
dysfunction dissatisfaction (conj)
failure rifampicin-associated (amod)
sd of (case)
neonates infants (conj)
died subsequently (advmod)
rat igm (compound)
$ROOT$ exhibits (sent)
finished considered (conj)
efficacy p.o. (appos)
interna in (case)
6/52 % (appos)
csa hepatotoxicity (conj)
smaller those (nmod)
12- 24- (conj)
adl ) (punct)
del taqib (conj)
fibers the (det)
reduction risperidone (nmod)
areas 7 (nummod)
retrospective observational (dep)
counts their (nmod:poss)
reserved use (nsubjpass)
current , (punct)
caution extra (amod)
taking vgb (dobj)
expressed . (punct)
nephrectomized sham-operated (conj)
man elderly (amod)
amounts significant (amod)
analysis pooled (amod)
streptozotocin stz (appos)
occurrence hypercalcemia (nmod)
temporary management (conj)
demonstrate exert (ccomp)
decreased however (advmod)
efficacious superior (conj)
point however (advmod)
antagonized significantly (advmod)
intense prolonged (conj)
report documented (amod)
krebs-ringer in (case)
increased decreasing (conj)
mean = (parataxis)
presented is (auxpass)
placebo lamivudine (conj)
index new (amod)
aspects associations (nmod)
sooner days (nmod)
depression behavioral (amod)
discomfort of (case)
donor living (amod)
schedule infusion (compound)
catecholamines , (punct)
evaluated then (advmod)
radiation ionizing (amod)
run-in and (cc)
disease led (acl:relcl)
epilepticus pilocarpine (compound)
suggest dose-dependent (ccomp)
mediate . (punct)
lymphomas relapsed/refractory (amod)
ballistic choreic (conj)
objective present (acl)
atrial left (amod)
using xenon-133 (dobj)
have disorders (dobj)
causes states (nmod)
contraction pulmonary (amod)
criteria validation (compound)
diagnoses potential (amod)
antagonize depletion (dobj)
case women (nmod)
expression irritation (nmod)
dysfunction accentuated (amod)
hd-mtx ( (punct)
cycle nelarabine (nmod)
required research (nsubjpass)
ic % (compound)
study from (case)
levels relative (amod)
11/57 group (nmod)
diethylpropion dep (appos)
mg/day 900 (nummod)
iv to (dep)
estradiol plasma (compound)
trait and (cc)
influenced model (nmod)
deemed . (punct)
hours 4 (nummod)
e. vitamin (compound)
dysfunction mitochondrial (amod)
devoid were (cop)
implant with (case)
corrected which (nsubjpass)
ameliorated glomerulosclerosis (dobj)
woman disease (nmod)
generalised focal (conj)
treatment iso (compound)
somatotopy the (det)
$ROOT$ lacks (sent)
transport impeded (amod)
conducted consumers (nmod)
trimester pregnancy (nmod)
$ROOT$ presented (sent)
cortices abusers (nmod)
administration direct (amod)
incidence aminotransferase (nmod)
lacked . (punct)
preserve flow (dobj)
meninges within (case)
administered intervals (nmod)
prevent isoproterenol (dobj)
dopac ( (punct)
depression from (case)
sites propagates (acl:relcl)
appears hepatitis (nsubj)
defects ventricular (amod)
seizures (nmda)-induced (amod)
thromboses e.g. (advmod)
iiib nsclc (conj)
control treatment (conj)
stones associated (acl)
field paracentral (amod)
k(na the (det)
mg/kg 1.5 (nummod)
support inotropic (amod)
acuity initial (amod)
mg/ml 47.5 (compound)
effects latent (amod)
isolated nocistatin (nsubjpass)
similar frequency (nsubj)
screened macroprolactinemia (nmod)
stage 14 (nummod)
establish had (ccomp)
k-8644 bay (compound)
24 48 (conj)
insertion azt (nmod)
unknown explanation (conj)
hcn 2 (nummod)
attribute underestimate (conj)
younger years (nmod:npmod)
emulsion both (conj)
facilitates that (mark)
levetiracetam of (case)
pathogenesis into (case)
mediated cortex (nmod)
states to (case)
produces involved (conj)
dose-effect and (cc)
related tract (nmod)
version an (det)
subscale negative (amod)
method consisted (acl)
proteinuria inhibitors-induced (amod)
activity abnormal (amod)
averaging ( (punct)
treatment systemic (amod)
affect loss (dobj)
combinations rats (nmod)
appear regimen (nsubj)
caries wear (conj)
ptx ( (punct)
criteria inclusion (compound)
disturbances prolonged (amod)
lend support (dobj)
beats or (cc)
80mg/kg/day ( (punct)
period 2-week (amod)
accompany remedy (conj)
vsd md (conj)
catheters venous (amod)
peptide(1 , (punct)
sacrificed either (dep)
hematuria by (case)
agents properties (nmod)
afflicted to (mark)
conclusions cause (appos)
preventing exposure (nmod)
conducted laboratories (nmod)
induced disappearance (nsubjpass)
ischemia cerebral (amod)
mg 0.28+/-0.2 (nummod)
depending degree (nmod)
memory and (cc)
pain flank (compound)
asymptomatic they (nsubj)
rate rats (nmod)
convulsions with (case)
change histological (amod)
recording , (punct)
smoker a (det)
node heart (nmod)
choreoathetosis induced (amod)
maintained patients (dep)
rate norepinephrine (nmod)
safe use (nmod)
groups b (dep)
showed erg (nsubj)
nag ) (punct)
important additionally (advmod)
factor population (nmod)
disturbances experienced (acl)
doses mg/kg (compound)
duct stones (conj)
cuff the (det)
effects promotional (amod)
times at (case)
translocation cml-associated (amod)
p11 compound (compound)
cilostazol clz (appos)
fk . (punct)
aggregability platelet (compound)
encephalopathy a (det)
nm 1 (compound)
system as (case)
normal responses (nsubj)
less those (nmod)
receptors nmda (compound)
model reproducible (amod)
0.54 ; (punct)
reports two (nummod)
response prolonged (amod)
pseudoacromegaly . (punct)
expression frataxin (nmod)
change baseline (nmod)
heart dissected (amod)
involved shown (conj)
liver perfused (amod)
child crisis (nmod)
self-limiting were (cop)
paclitaxel pac (appos)
lead policy (nsubj)
membranes lateral (amod)
abrasion marked (amod)
antagonists : (punct)
midazolan of (case)
dysfunction , (punct)
share because (mark)
nanosphere ns-718 (appos)
methyldopa and (cc)
studies murine (amod)
cause neuropathy (dobj)
test test (conj)
given conjunction (nmod)
obtained degree (nsubjpass)
function left-ventricular (amod)
thromboembolism acetate (nmod)
arteries normal (amod)
measure outcome (compound)
graded were (auxpass)
endemic highly (advmod)
potentiated are (auxpass)
progress and (cc)
hours twelve (nummod)
modulator modulator (conj)
using using (advcl)
0 30 (prep)
500 to (dep)
induced be (auxpass)
albumin and (cc)
caffeine versus (cc)
university marmara (compound)
exposed not (neg)
experiencing before (mark)
atypicals various (amod)
death % (appos)
responses by (case)
neoantigens recognized (acl)
exerts caa (nsubj)
tmp patients (appos)
l-type channels (nmod)
131i-albumin of (case)
stability in (case)
side-effect , (punct)
memory components (nmod)
stores group (nmod)
cocaine intravenous (amod)
expression cox-2 (compound)
severity symptoms (nmod)
cystitis interstitial (amod)
reduction without (case)
restricted have (aux)
damage quantitative (amod)
rats warfarin-treated (amod)
il-3 ) (punct)
confirms finding (dobj)
sharps waves (conj)
neuropathy resolved (acl:relcl)
modulation stress (nmod)
decreased year (nmod)
rats ato-treated (amod)
conducting study (dobj)
microg/day 100 (nummod)
reactions neuropsychiatric (amod)
protease acid (compound)
role cells (nmod)
show that (nsubj)
survival 6-year (amod)
comparison ischemia (nmod)
down-regulation desipramine-induced (amod)
decreased haloperidol (nsubj)
responsible were (cop)
aes gi (compound)
group treated (acl)
compartment dark (amod)
evident hypoactivity (nsubj)
indistinguishable which (nsubj)
february , (punct)
toxic that (nsubj)
ce of (case)
rats observed (acl:relcl)
normal controls (nmod)
coincidental only (advmod)
events thrombotic (amod)
effects again (advmod)
treated znso(4 (nmod)
myalgia and (cc)
selected selection (nsubjpass)
injury induced (acl)
analysis level (nmod)
association close (amod)
obtained , (punct)
analyzed hybridization (nmod)
pathway leading (acl)
reactions pseudoallergic (amod)
hypothesized background (nsubjpass)
points inversion (compound)
patients tested (acl)
interest but (cc)
discontinuous contrast (nmod)
erection absence (nmod)
infants newborn (amod)
enzyme ace (appos)
progresses eventually (advmod)
play factors (nsubj)
effects ability (appos)
fumarate tdf (appos)
week by (case)
transaminase serum (compound)
bmcs ( (punct)
evaluated movements (nsubjpass)
1.4 - (punct)
demonstrate present (ccomp)
control reperfusion (appos)
people from (case)
lead diagnosis (nsubj)
lesion selective (amod)
interaction cause (nsubj)
radiopharmaceutical based (acl)
trazodone with (case)
revealed sequences (nsubj)
atriotomy the (det)
diagnosed basis (nmod)
16 14 (quantmod)
livers male (amod)
observed gradient (nsubjpass)
urine hypertonic (amod)
suited well (advmod)
astrocytomas iii (nummod)
rated . (punct)
measurements : (punct)
medication becoming (acl:relcl)
reduced effectively (advmod)
girl therapy (acl:relcl)
activities analgesic (amod)
systemic but (cc)
factor platelet (compound)
hour 5%/24 (nummod)
atenolol of (case)
doses six (nummod)
6-months after (case)
used sodium (nsubjpass)
used chloroquine (dobj)
veins central (amod)
administration flumazenil (compound)
$ROOT$ facilitates (sent)
defect neutrophil (compound)
rose remained (conj)
diameter with (case)
affinity glur5 (compound)
coma myxedema (compound)
antidepressants tricyclic (amod)
woman classified (acl)
administration analgesic (amod)
persisted occurred (conj)
people use (acl:relcl)
a1 and (cc)
kindled-seizures mice (nmod)
phase subsequent (amod)
paclitaxel mg/m2 (appos)
paclitaxel bre-26 (appos)
hematology of (case)
e. hemoglobin (compound)
terminated deficit (nmod)
syndrome hormone (nmod)
continue planned (advcl)
efficacy women (nmod)
therapy long-term (amod)
black 1 (nummod)
assayed products (nmod)
october 2009 (nummod)
doubled . (punct)
23 - (punct)
fluoxetine amitriptyline (conj)
mitochondria number (dep)
fibrillation warfarin (nmod)
doses times (conj)
suppression antigenemia (nmod)
complications use (nmod)
function neuroprotection (conj)
eyes implanted (amod)
given mg (nsubj)
cells astroglial (amod)
associated severity (nmod)
pathogenesis of (case)
resistant effects (nmod)
died two (nsubj)
1.12 1.25 (prep)
results proliferation (nmod)
showed five (nsubj)
progressed session (nsubj)
maintained had (aux)
consciousness hyperammonemia (nmod)
instrumented chronically (advmod)
toxicity ccnu-associated (amod)
toxicity 5-fluorouracil (nmod)
measured simultaneously (advmod)
immunosuppression cyclosporine-based (amod)
performed wky (nmod)
switch patients (nmod)
g 200 (nummod)
related confounding (nmod)
$ROOT$ worsened (sent)
measured chemiluminescence (nmod)
beneficial management (nmod)
ameliorated could (aux)
linezolid ethambutol (conj)
function diminished (amod)
use long-term (amod)
cardiomyocytes hips-cms (appos)
prolong by (punct)
anorectics congestants (conj)
alterations the (det)
demonstrate retina (nmod)
week 2 (nummod)
started mean (nmod)
nephropathy virus (compound)
test passive-avoidance (amod)
appeared : (punct)
moran 610 (amod)
insufficiency acute (amod)
csa dysmorphism (conj)
study find (conj)
april august (nmod)
injection 5,7-dihydroxytryptamine (nmod)
microg/0.5 2.5 (compound)
enos ) (punct)
indication an (det)
5-(l-hexyloxy)-6-methoxy-4-methylquinoline wr242511 (appos)
pump of (case)
linkages peptide (compound)
chemotherapy alone (advmod)
rate cardiac (amod)
probe electromagnetic (amod)
ke h (dep)
signaling prolactin (compound)
pneumonitis of (case)
method permitting (acl)
drinkers hazardous (amod)
had that (nsubj)
tolerate could (aux)
$ROOT$ encountered (sent)
correlated prazosin (nmod)
exhorted pay (xcomp)
availability through (case)
atrium pig (compound)
mazindol in (case)
use examine (xcomp)
assess contribution (dobj)
immunization pertussis (compound)
curtailed however (advmod)
dosing ninth (amod)
protocol layer (compound)
group latter (amod)
from november (nmod)
hcrh after (case)
increases , (punct)
moderate and (cc)
became confused (acomp)
reported glomerulonephritis (nsubjpass)
more times (nmod:npmod)
pd of (case)
designed study (dobj)
complicated are (cop)
receptors serotonin (compound)
reflex bezold-jarisch (compound)
rosacea steroid-aggravated (amod)
cultures to (case)
syndrome complicated (acl)
use alcohol (dobj)
damage to (case)
product rate (compound)
incidence by (case)
died suffered (conj)
microscopic and (cc)
phenobarbitone glutathione (conj)
d2/d3 up-regulation (conj)
woman hypertensive (amod)
given pb (dobj)
fev1 75 (nummod)
rhabdomyolysis . (punct)
propranolol the (det)
evaluate to (mark)
had animals (nmod)
appears azelastine (nsubj)
treated week (nmod)
afterdepolarization 2 (nummod)
anemia coombs-positive (amod)
depressed ones (nmod)
obtain phenotype (dobj)
5 50 (conj)
appear many (nsubj)
allergy of (case)
pretreatment upon (case)
suggests more (dobj)
perseveration dysfunction (conj)
remained sedentary (acomp)
investigated dogs (nmod)
component process (nmod)
advisable is (cop)
% sd (dep)
properties vasoactive (amod)
receive saline (dobj)
dysfunction histochemical (amod)
seen hours (nmod)
exposure cyclophosphamide (nmod)
hepatitis ) (punct)
microg/side ) (punct)
treatment between (case)
sulfate s.c. (appos)
examined routinely (advmod)
studied mice (nmod)
objective poses (appos)
microglia striatal-resident (amod)
issues any (det)
$ROOT$ reflected (sent)
variants prevalent (amod)
necrosis fatal (amod)
+ + (cc)
developed all (nsubj)
chromosome a (det)
kept were (auxpass)
vulnerability effects (nmod)
space in (case)
receiving when (advmod)
amplified were (auxpass)
period vulnerable (amod)
h after (dep)
removed surgery (nmod)
allografts of (case)
active analogues (nmod)
udca on (case)
different structurally (advmod)
fenfluramines for (case)
taking , (punct)
detoxification to (case)
loss > (amod)
research assessing (conj)
eye in (case)
flestolol . (punct)
nos-ir . (punct)
agent nonselective (amod)
doses days (nmod)
attention increased (amod)
identified evaluated (conj)
avrt ( (punct)
patients 130 (appos)
unclear pathogenesis (nsubj)
able conditions (nmod)
performance abnormally (advmod)
5-hydroxytryptamine of (case)
associated p<0.001 (nmod)
depth intraoperative (amod)
received basis (nmod)
presence ischemia (nmod)
complexity mechanisms (nmod)
used resulting (advcl)
control inflammation (dobj)
reproduced syndrome (nsubjpass)
cultured . (punct)
dilatation significant (amod)
university the (det)
motionless and (cc)
months median (dep)
k(i a(2a (compound)
involves injury (nsubj)
dose necrogenic (amod)
prazosin map (appos)
sg145r the (dep)
$ROOT$ background (sent)
avoiding of (dep)
change resistance (conj)
late late (dep)
decreased slightly (advmod)
tachycardia hypertension (conj)
effective rrmm (nmod)
mg/kg/day 8 (nummod)
dependency on (case)
blocked inhibition (nsubj)
candidate p-coumarate (nsubj)
demonstrated have (aux)
presents second (nsubj)
2147 +/- (cc)
oxidation and (cc)
ck-mb , (punct)
improvement symptoms (nmod)
treated everolimus (nmod)
analyze exactly (advmod)
increases because (mark)
adriamycin ( (punct)
endografine diatrizoate (appos)
weeks 25 (nummod)
recording vitro (advmod)
exhibited eighth (nsubj)
observation first (amod)
block report (appos)
diversion long-term (amod)
systems pump (compound)
ceased suggesting (advcl)
seen change (nsubj)
substratum between (case)
year follow-up (nmod)
conclusions have (appos)
modulation processes (nmod)
pharmacodynamics metoprolol (nmod)
transplantable in (case)
induced chloroform-adrenaline (nmod)
conjunction sodium (nmod)
showed moreover (advmod)
cohort year (compound)
explore design (nsubj)
ldl of (case)
followed development (nmod)
patient received (acl:relcl)
$ROOT$ acid (sent)
operative been (cop)
functioning memory (compound)
genes nephrin (appos)
severe as (cc)
need areas (nmod)
v/s from (case)
deterioration episodic (amod)
progressive and (cc)
therapy report (appos)
colitis use (conj)
extent smoking (nmod)
attack metabolites (nmod)
suppression levels (nmod)
anencephaly syndrome (conj)
angiograms indocyanine (amod)
t+a 17/106 (appos)
attenuated physostigmine (nmod)
injection beta-carboline-3-carboxylate (nmod)
analysis updated (amod)
correlated duration (nmod)
disease such (case)
81 13 (conj)
prudent would (aux)
trigger to (mark)
studies dysfunction (nmod)
therapy rr (dep)
group alfentanil (compound)
prolonged those (nsubj)
increase time-dependent (amod)
occur pretreatment (nmod)
relieve but (cc)
mcg/kg ) (punct)
micromol/l groups (nmod)
attempt way (nmod)
dysfunction amygdala (compound)
line endothelial (amod)
depletions dopamine (compound)
minoxidil of (case)
secretion depressed (amod)
ptcr allografts (nmod)
designed concentrations (dobj)
change co (nmod)
study case (compound)
acetyltransferase nucleus (nmod)
sites associated (acl)
ed ( (punct)
played role (dobj)
received animals (nsubj)
germfree gf (dep)
intracerebroventricular i.c.v. (dep)
range cancers (nmod)
elevations caffeine (nmod)
represent to (mark)
approach patients (nmod)
altered architecture (dobj)
regimens stratum (appos)
fraction % (nmod)
synthesis no (compound)
prospective was (cop)
0.57 0.85 (prep)
probed here (advmod)
failed control (xcomp)
administered design (nmod)
programs detect (acl:relcl)
predicted decrease (nsubj)
u/l 32 (nummod)
effect regimen (nmod)
mg/kg 11 (nummod)
$ROOT$ document (sent)
fall flow (nmod)
formation crescent (amod)
equivalent approximately (advmod)
mg/kg that (nsubj)
examines incidence (dobj)
turnover neurons (nmod)
threshold ct (appos)
phasic and (cc)
protective and (cc)
result therapeutic (amod)
monitored that (mark)
mechanism could (aux)
caused delirium (nsubjpass)
secondary that (mark)
report additionally (advmod)
given preferentially (advmod)
boys 83 (nummod)
defect = (dep)
yields tumours (nmod)
composition stones (nmod)
7-ethoxyresorufin-o-deethylase , (punct)
toxicities non-hematological (amod)
adenosine-5'-triphosphate alpha (appos)
tended diminish (xcomp)
given doxorubicin (nmod)
cm ten (compound)
indicative superiority (nmod)
waves p (compound)
2.32 +/- (cc)
obtainable powders (nsubj)
lymphoma tumour (conj)
observed system (nmod)
switch before (case)
seconds ( (punct)
detected ; (punct)
swelling fusion (conj)
stimulation : (punct)
evaluation thresholds (nsubj)
greater ) (punct)
occurs neuroinflammation (nsubj)
effective patients (nmod)
seizures lidocaine (compound)
considered possible (xcomp)
carcinogens the (det)
symptoms appear (acl:relcl)
involvement chiasm (nmod)
pge1 with (case)
extremities her (nmod:poss)
trial thalidomide (nmod)
period final (amod)
presence antibodies (nmod)
cpap nitroprusside (nmod)
$ROOT$ certain (sent)
evidence current (amod)
visualize and (cc)
cats as (cc)
potential putative (amod)
enhanced persons (nmod)
visceral , (punct)
map ( (punct)
motor primary (amod)
% 72 (nummod)
given cpa (nsubjpass)
noticed administration (nmod)
reported that (nsubjpass)
coincident excitement (nsubj)
impair did (aux)
drop levels (nmod)
dysfunction erectile (amod)
loads hbv (compound)
demonstrated experiments (nsubj)
ces-d the (det)
found correlations (dobj)
antidopaminergic serotonergic (conj)
administration in (case)
shorter delay (nsubj)
number admissions (nmod)
using imaging (dobj)
(r)-alpha-methylhistamine thioperamide (conj)
sufficient would (aux)
mid to (case)
engrafted patients (nsubj)
restarted should (aux)
averaged periods (nsubj)
symptoms parkinsonian (amod)
number tended (acl:relcl)
ten on (case)
produced doses (nmod)
contain identified (advcl)
pneumoniae , (punct)
seemed activate (xcomp)
icr sprague-dawley (amod)
transection prior (amod)
action by (case)
identifying group (dobj)
number by (case)
exposed anticholinergics (nmod)
disarrangement and (cc)
unknown however (advmod)
practices recommended (amod)
patient transplanted (amod)
triphosphate and (cc)
46 of (advmod)
% 0.01 (appos)
receptors neurotensin (compound)
symptoms haloperidol-induced (amod)
% diabetic (nmod)
5.6 +/- (cc)
suppressed decrease (dobj)
pain abdominal (amod)
reflex elicited (acl)
protection optimum (amod)
removed injection (nmod)
showed degree (nsubj)
is it (nsubj)
change between (case)
correlation injury (nmod)
dependency or (cc)
patterns parts (nmod)
dyscontrol behavioral (amod)
suppressed but (cc)
inhibited administration (nmod)
disturbances hematologic (amod)
antihyperalgesia of (case)
effectiveness safety (conj)
neonates developed (ccomp)
expression subunit (nmod)
comparison range (nmod)
nephritis and (cc)
reduction sustained (amod)
attributed long (advmod)
postulated can (aux)
therapeutic , (punct)
introduce to (mark)
symptomatology by (case)
a group (compound)
p n-highly (conj)
kurroa of (case)
indicate has (ccomp)
vasculitis (anca)--associated (amod)
utility preventing (acl)
factors early (amod)
treated ma (nmod)
speculate authors (nsubj)
scores amhs (compound)
reduction nimodipine-induced (amod)
mechanism(s involved (acl)
evaluated tolerance (dobj)
tolerant pain (nmod)
assessed examining (advcl)
change m.s. (amod)
trial tamoxifen (nmod)
assess risk (dobj)
mg/kg p.o. (appos)
methemoglobinemia significant (amod)
meq/l 6.1 (nummod)
attempted thrombectomy (nsubjpass)
response mechanisms (nmod)
incubation ns-718 (nmod)
4.7 +/- (cc)
pulses of (case)
concentration caffeine (nmod)
rats glomerulonephritis (nmod)
entered date (nmod)
result deposited (acl)
influence diameter (dobj)
chemotherapy epirubicine-based (amod)
evidence vasculitis (nmod)
observation with (case)
lindane insecticide (compound)
determine benefits (dobj)
method report (appos)
epilepticus non-convulsive (amod)
prevent tachycardia (dobj)
changed focus (xcomp)
biochemical by (case)
reaching h (dobj)
delivery to (case)
result hcfcs (nsubj)
manifests causing (advcl)
treatment amphetamine (compound)
support not (neg)
study 5-fu/fa (nmod)
incidence recipients (nmod)
defined experience (nmod)
increase wky (nmod)
8.5 +/- (cc)
reactions infusion-related (amod)
fzp ) (punct)
infants birth-weight (compound)
form regular (amod)
acrolein metabolite (compound)
effect stalk (compound)
concentration hippocampal (amod)
site injury (nmod)
performed users (dobj)
succinylcholine ps (appos)
related intensity (nmod)
increased magnitude (nmod)
digitalise not (conj)
h 216 (nummod)
considered must (aux)
group rats (nmod)
developed tma (dobj)
receive min (nmod)
referred , (punct)
narrowing preexisting (amod)
deficiency production (conj)
g/m2 60 (nummod)
rich that (mark)
considering possibility (dobj)
loci seizure (compound)
ability system (nmod)
solvent used (amod)
addressed , (punct)
potent selective (conj)
spectrum power (compound)
remains drug (attr)
0.59-mg fa (conj)
effects methamphetamine (compound)
pre-treatment mice (nmod)
had overdose (nmod)
concentrations b (nmod)
averaged 4.8 (dobj)
glucuronidation the (det)
interactions cytochrome (compound)
consisted etoposide (nmod)
consent written (amod)
diazepam patients (appos)
treatment placebo (nmod)
process hypertensive (amod)
increased charge (dobj)
safe child (nmod)
correlates generally (advmod)
toxicities nonhematologic (amod)
received whereas (mark)
alter assessed (advcl)
reserpine and (cc)
35.0 or (cc)
days few (nummod)
wall on (case)
suggest exerts (ccomp)
performed biopsies (nsubjpass)
group nephropathy (compound)
induce stimulate (conj)
processes foot (compound)
products herbal (amod)
biosyntheses and (cc)
prophylaxis is (cop)
minimised , (punct)
panel metabolic (amod)
received papaverine (dobj)
suggests taking (advcl)
analgesic used (amod)
$ROOT$ marker (sent)
greater limit (nmod)
suffer elements (nsubj)
hypotension in (case)
complications 52 (nummod)
neuropathy without (case)
had signs (dobj)
predicted mortality (dobj)
administration acute (amod)
periods calculated (acl)
induced followed (prep)
profiles pharmacokinetic (amod)
therapies useful (amod)
group non-ischemic (amod)
placement muscle (nmod)
showed testing (nsubj)
injection stz (nmod)
lesions electrolytic (amod)
exist to (mark)
ganglia sympathetic (amod)
flow peak (amod)
hypertrophy transient (amod)
micrograms/kg of (case)
% 18.4 (nummod)
is paralysis (attr)
variables coagulation (compound)
restarting treatment (dobj)
derived accuracy (nsubjpass)
$ROOT$ assessed (sent)
component haart (compound)
delays 1 (dep)
expression ccl2 (compound)
restore fully (advmod)
meq/l 3.9 (nummod)
exposure ) (punct)
found blanching (nsubjpass)
hepatotoxicity 6 (appos)
anticoagulation bypass (nmod)
acid for (case)
effect pro-arrhythmic (amod)
based reports (nmod)
trial ) (punct)
2.3 0.05 (compound)
cells patients (nmod)
eight in (case)
protective administration (nsubj)
acts differently (advmod)
response injection (nmod)
explain to (mark)
measured continuously (advmod)
i.v. , (punct)
hyperthyroidism disease (nmod)
alter levels (dobj)
permeability aortic (amod)
uptake oxygen (compound)
intoxication aluminum (compound)
20-fold up (advmod)
suggesting signs (dobj)
transferred compromise (nmod)
tests attention (compound)
micrograms 30 (compound)
mg mg (nmod)
$ROOT$ repair (sent)
ratio risk-benefit (compound)
nh4ac of (case)
deliver compared (prep)
induced drug (nmod:npmod)
anemia hb (nmod)
recurred reaction (nsubj)
activity sympathoadrenal (compound)
arrhythmogenicity in (case)
cs ) (punct)
discontinued reactions (nmod)
survival 5-year (amod)
stimulatory rewarding (conj)
dose doses (conj)
affected development (nsubj)
recording be (cop)
improve . (punct)
showed using (advcl)
architecture complete (amod)
prevented coma (nsubjpass)
protection icrf-187 (nmod)
property this (det)
up micrograms (nmod)
offer seem (conj)
male schizophrenia (nmod)
courses patient (nmod)
focal segmental (conj)
administrations with (nmod)
dba/2 ( (punct)
radiograph on (case)
conclusion appears (appos)
injection inhibitor (nmod)
% 65.3 (nummod)
mu/kg 125 (nummod)
suggesting involved (ccomp)
nh4cl of (case)
postprocedural h (dep)
higher rates (nsubj)
re-induced prophylaxis (nmod)
medications beta-adrenergic (amod)
$ROOT$ depend (sent)
levodopa b.i.d (advmod)
temporary paralysis (nsubj)
patients conditions (nmod)
evaluations weekly (amod)
revealed pattern (dobj)
appears vulnerability (nsubj)
administered re (dobj)
rapamycin ( (punct)
acid hydrocortisone (conj)
negative patients (nmod)
udca ( (punct)
maximal state (nsubj)
ranges risk (nsubj)
% 12/27 (appos)
age frequency (conj)
restored ; (punct)
information incidence (nmod)
disappeared changes (nsubj)
observed hypertension (nsubjpass)
downregulated was (auxpass)
correlated subgroup (nmod)
0.5 2.5 (conj)
w-ich ( (punct)
levels pre-treatment (amod)
safety procedure (compound)
% p<0.0001 (appos)
puncture dural (amod)
potentiate not (neg)
patients p (nmod)
patients amongst (case)
scenario common (amod)
sedation for (case)
acetylcholinesterases butyrylcholinesterases (conj)
= 3390 (dobj)
given solution (nmod)
maintenance to (case)
chromosomes on (case)
deletion of (case)
resolution fistula (nmod)
characterization causes (dep)
appeared however (advmod)
toxoplasmosis in (case)
results overstimulation (nsubj)
nmol/kg 70 (nummod)
difficult administration (nsubj)
analyses levels (nmod)
mainstay , (punct)
clarify incidence (dobj)
mg/kg oral (amod)
microg and (cc)
afford minimizing (advcl)
pathway by (case)
arise that (nsubj)
threshold l(-1 (appos)
report interaction (dobj)
$ROOT$ regressed (sent)
omitted administration (nsubjpass)
test acid-induced (amod)
timolol with (case)
gabaergic and (cc)
l-noarg ( (punct)
outpatients depressed (amod)
addressing mr (dobj)
alpha-2b during (case)
index therapeutic (amod)
ketamine administered (amod)
cross-react to (mark)
bbb altered (amod)
correlated development (nmod)
strain one (nummod)
leads that (mark)
supports reveals (conj)
conditions patients (appos)
$ROOT$ excreted (sent)
gene ( (punct)
day course (nmod)
regressed reappeared (conj)
amplitudes the (det)
reported potential (nsubjpass)
isoform disulphide (compound)
mg/m2 648 (nummod)
mg rizatriptan (compound)
convulsion angiography (nmod)
trigger relieve (conj)
hcfc ) (punct)
enhancement later (amod)
response selection (nmod)
food for (case)
administration ce (nmod)
painful was (cop)
treated who (dobj)
1.1 10(-3 (conj)
withdrew case (nsubj)
aspect distinctive (amod)
started arthralgia (nmod)
audit by (case)
used medications (nsubjpass)
5-hydroxytriptamine ( (punct)
suppression may (aux)
1080 - (advmod)
150 6 (conj)
microangiopathy population (nmod)
formation gaps (nmod)
days months (appos)
dysosmia induced (acl)
presented room (nmod)
paper transparent (amod)
identified patients (nsubjpass)
activation no (neg)
cytomegalovirus cmv (appos)
death death (conj)
related 6-thioguanine (nmod)
% score (nmod)
mg. 0.75 (nummod)
sedation effect (nsubj)
hydrobromide ( (punct)
mm2 ) (punct)
confirmed has (aux)
performed hospital (nmod)
disturbance character (conj)
disease decompensated (amod)
male pregnant (conj)
ventricle septum (conj)
12.0 6.5 (compound)
7 these (nmod)
noticed . (punct)
inappropriate . (punct)
appeared difficult (conj)
assess value (dobj)
examinations x-rays (conj)
method effective (amod)
testosterone t (dep)
advisable patients (nmod)
subjects of (case)
decrease minutes (nmod)
mannitol of (case)
corrected ) (punct)
days hospitalization (nmod)
ci:0.3 % (compound)
nephropathy radiocontrast (compound)
diabetes 1 (nummod)
subjects risperidone-treated (amod)
absence myoclonic (amod)
studies therapy (nmod)
increase diameter (nmod)
values i.p. (appos)
conclusions mediated (dep)
groups adr(6 (appos)
myalgia associated (acl)
= or (nsubj)
unclassifiable . (punct)
antagonist kf17837 (nsubj)
1/32 patients (nmod)
injury nephrosis (nmod)
hypothyroid baseline (nmod)
recognized cases (nmod)
failure renal (amod)
role therapy (nmod)
anemias hemolytic (amod)
leading discovery (nmod)
implanting animal (dobj)
alone or (cc)
acid meclofenamic (amod)
disturbances and (cc)
ctni-positive were (cop)
nmbas ( (punct)
entrapment femoral (amod)
amounts low (amod)
intake between (case)
developed death (dobj)
effects blood (compound)
reduced ; (punct)
evident were (cop)
presence hypothermia (nmod)
women acne (nmod)
return baseline (nmod)
gem ) (punct)
amount extent (conj)
cardiotoxicity effect (conj)
rates microbiologic (amod)
c-4-epimer ( (punct)
antibody anticocaine (amod)
received twice (advmod)
mothers antigen (compound)
bradycardia was (cop)
comparison study (dep)
0.04 0.7 (conj)
nx ( (punct)
investigated also (advmod)
administered median (nsubjpass)
doses potassium (compound)
severe sufficiently (advmod)
0.4 5.1 (prep)
potencies with (case)
scores physiology (compound)
effect administration (nmod)
f2 and (cc)
sd 0.015 (nummod)
conclusion suggested (acl)
system fas/fas (compound)
anaphylaxis of (case)
injections focal (amod)
$ROOT$ uncertain (sent)
wr242511 of (case)
watch diuresis (dobj)
lack the (det)
paracetamol aspirin (conj)
atypia sites (nmod)
formation ) (punct)
morbidity patients (nmod)
sensitive differentially (advmod)
administration frequent (amod)
rcts ( (punct)
seizures/mo 2.1 (nummod)
defects of (case)
changes those (nmod)
a/j and (cc)
adriamycinol tetrahydropyranyladriamycinol (conj)
0.84 0.80 (compound)
sites days (nmod)
did patients (nsubj)
syndromes proteinuria (nmod)
immediate temporary (conj)
s-transferase alpha-glutathione (compound)
evidence hypotension (nmod)
inhibitors blockers (conj)
showed echocardiography (nsubj)
involvement cells (nmod)
pregnant that (nsubj)
mediated changes (nmod)
reflected . (punct)
isrctn54598675 trials (compound)
shows improvement (nmod)
biopsy muscle (compound)
characterized umb24 (dobj)
formation successive (amod)
cisplatinum etoposide (conj)
oxcarbazepine analogue (compound)
limited experience (nsubj)
present may (aux)
% 76 (nummod)
described dysfunction (nsubjpass)
exposure vehicle (nmod)
hearts control (amod)
missed would (aux)
decreased different (parataxis)
serve warning (nmod)
levels threshold (compound)
setting trial (compound)
thromboembolism patients (nmod)
$ROOT$ subtle (sent)
persisted used (advcl)
target ? (punct)
casts expansion (conj)
appeared 2 (dep)
alive is (cop)
stages two (nummod)
with . (punct)
protein glepp1 (appos)
5,7-dihydroxytryptamine of (case)
10.12 - (punct)
picture with (case)
concentrations by (case)
attack increase (dep)
suggest . (punct)
prolongation pronounced (amod)
proposed studies (nsubj)
increases sensitivity (dobj)
drug thought (acl)
ten ( (punct)
oligodendrocytes of (case)
is nephropathy (nmod)
control cystitis (nmod)
supine in (case)
possible leads (advcl)
period same (amod)
treated to (mark)
reduce and (cc)
% hospitalized (nmod)
report group (nmod)
morning on (case)
iso with (case)
patterns , (punct)
epilepsies idiopathic (amod)
activated inhibited (conj)
encouraging enough (advmod)
associated any (nmod)
area surface (nmod)
play development (nmod)
abnormalities u (compound)
undertaken understand (xcomp)
curve drc (appos)
monitoring recovery (nmod)
mania stimulant-induced (amod)
restored effects (dobj)
side-effects without (case)
lobule the (det)
opacities white (amod)
protects and (cc)
medius scalenus (compound)
acromegaly active (amod)
patients primary (amod)
conditions placebo-controlled (amod)
neutropenia . (punct)
present population (nmod)
rats each (appos)
mek1 mek7 (conj)
ptz with (case)
protected ; (punct)
increased apd (dobj)
resolution spontaneous (amod)
pathogenesis its (nmod:poss)
encephalopathy with (case)
2- 8- (conj)
exposure cyanamide (nmod)
cm of (case)
pretreatment mg/kg/day (dep)
treated preparation (nmod)
cell processes (conj)
intervals months (nmod)
caused hypotension (nmod)
matter cerebral (amod)
introduction after (case)
dorsum hind (compound)
mg/kg ed50 (compound)
beta1 transforming (amod)
administration diuretic (nmod)
42 and (cc)
follow-up her (nmod:poss)
interval 5.5 (appos)
children 's (case)
subjects/patients of (case)
diazepam to (case)
injection remifentanil (compound)
10-fold ) (punct)
had seventeen (nsubj)
age- sex-matched (conj)
failure human (amod)
cd50 ( (punct)
decrease movement (dobj)
screening significance (dep)
level abnormal (amod)
desire or (cc)
$ROOT$ determine (sent)
occurred response (nsubj)
bilirubin unconjugated (amod)
labeling and (cc)
justification reasonable (amod)
acute and (cc)
dose 360 (nummod)
observed period (nmod)
potentiation nicotine (compound)
exhibiting signs (dobj)
described using (advcl)
c1q c4 (conj)
techniques brain-mapping (compound)
observed compared (advcl)
changes early (amod)
mg 0.225 (nummod)
model one (nummod)
plasticity patients (nmod)
diet % (amod)
marker a (det)
magnitude increase (nmod)
intervals seizures (nmod)
analysis cluster (compound)
increase generalised (amod)
neuropathy toxic (amod)
leukaemia lymphoma (conj)
has advantage (dobj)
sulfate hydroxychloroquine (compound)
decrease baseline (nmod)
identify model (nmod)
administered and (advmod)
induced humans (nmod)
mortality animals (nmod)
62(6):865 872 (prep)
group n=35 (dep)
withdrawal despite (case)
lacking are (cop)
produced morphine (nmod)
induces pilocarpine (nsubj)
tests to (case)
ci 2.31 (nummod)
tolerated patient (nsubj)
ablation rfca (appos)
preparation , (punct)
development chf (compound)
attenuated but (cc)
agonist a1 (compound)
administered deficit (nmod)
demonstrate we (nsubj)
tubule on (case)
decreased being (auxpass)
frs , (punct)
grow , (punct)
homeostasis hepatic (amod)
2.17 ) (punct)
administered treatment (nsubjpass)
women start (acl)
rate the (det)
d , (punct)
mg compared (case)
inhibition 50 (nummod)
treated iso (nmod)
epilepsies treated (acl)
damage or (cc)
doses combination (nmod)
checklist and (cc)
steroids ovarian (amod)
baseline map (conj)
downregulating increasing (conj)
different rats (nmod)
approach thus (advmod)
myopathy reversible (acl:relcl)
thresholds flurothyl (compound)
5 8 (conj)
protein essential (amod)
deletion genetic (amod)
twenty-eight two (compound)
performed determine (xcomp)
blocked nh4ac (nmod)
data certain (amod)
that gum (nmod)
effect antidyskinetic (amod)
age week (nmod)
fdc breakfast (nmod)
stage 3 (nummod)
saline morphine-treated (conj)
amiodarone mg (appos)
b6 vitamin (compound)
vasodilators , (punct)
dosages the (det)
fell level (nsubj)
decreases increase (conj)
trial multicenter (amod)
considered limit (dobj)
trials : (punct)
potentials of (case)
aminonucleoside with (case)
te ) (punct)
administered that (mark)
reversed addition (nsubj)
impairment comorbidity (appos)
receptors cck2 (compound)
myeloma with (case)
respiration mitochondrial (amod)
mediated presence (nmod)
hospital psychiatric (amod)
lvef mbp (conj)
increase permeability (nmod)
administered only (advmod)
(+)-cibenzoline (-)-cibenzoline (conj)
attenuated contrast (nmod)
impaired renally (advmod)
administration combined (acl)
pathway mediating (acl)
ratio especially (advmod)
role modulating (acl)
7.1 +/- (cc)
one sleeping (advcl)
hyperkalaemia administration (nmod)
pentamidine of (case)
= 6/20 (nsubj)
size fixed (amod)
seen controls (nmod)
modulation receptor (nmod)
searched databases (dobj)
cells non-endothelial (amod)
transferred unit (nmod)
infiltration local (amod)
electroretinography ) (punct)
apamin , (punct)
pallidotomy medial (amod)
% 43.7 (nummod)
0.56 and (cc)
1.041 , (punct)
remained correction (nmod)
increases increasing (advcl)
indicate addition (nmod)
31 - (advmod)
publications several (amod)
surgery abdominal (amod)
twin the (det)
morning or (cc)
phenotypes , (punct)
received received (advcl)
dextran a (det)
alfentanil and (cc)
9.18 vs. (cc)
= 0.044 (dobj)
= 4.149 (dobj)
effects fenoldopam (nmod)
3,000 500 (compound)
11 4 (conj)
activity carboxylesterase (nmod)
hs ) (punct)
range not (neg)
hyperalgesia capsaicin-induced (amod)
limit than (case)
surpasses that (dobj)
sulfate magnesium (compound)
with without (conj)
gain mean (compound)
novel and (cc)
layers from (case)
$ROOT$ optimization (sent)
beta=0.49 ( (punct)
thrombo-embolism , (punct)
mth after (case)
outcome of (case)
changes length (dep)
literature prehospital (amod)
receptors d1 (compound)
accident this (det)
sodium than (case)
show results (nsubj)
rats excretion (nmod)
disorder especially (advmod)
occurred pancreatitis (conj)
level kinase (compound)
attenuates dysfunction (dobj)
responders the (det)
developed nodule (nsubj)
compared subunits (nmod)
had cystitis (dobj)
activation receptor (compound)
studied cats (nmod)
satisfied ( (punct)
$ROOT$ protection (sent)
cause one (nummod)
handful a (det)
compared ability (dobj)
incidence increasing (amod)
improvements response (nmod)
intake mortality (conj)
altering hematocrit (dobj)
% 93.4 (compound)
dose iv (nummod)
appear there (expl)
trial foreshortened (amod)
plasma fluid (conj)
greater gain (nsubj)
caused 6-thioguanine (nmod)
treatment sulfadiazine (nmod)
inflammation cases (nmod)
administered evening (nmod)
monitor to (mark)
potentials abnormal (amod)
sought we (nsubj)
components chain (compound)
rhizomes of (case)
decreased frequencies (nmod)
galantamine , (punct)
back-diffusion concentration (conj)
rat both (cc:preconj)
modulate transmission (dobj)
blood brain (conj)
bypass cardiopulmonary (amod)
mechanism underlying (acl)
rrmm rw (nmod)
increased pmol (nmod)
% 40 (compound)
erg using (acl)
demonstrate actions (dobj)
opening pores (nmod)
contaminant this (det)
d-penicillamine ( (punct)
observed groups (nmod)
administration testosterone (compound)
using simultaneously (advmod)
trials 2b/3 (nummod)
headache because (case)
$ROOT$ agitation (sent)
patients 48 (nummod)
injection glutamate (nmod)
1987 and (cc)
effects lithium (nmod)
interval ms/mg (nmod)
related amiodarone (nmod)
incidence to (case)
tamoxifen , (punct)
assessment objective (amod)
globulin treatment (nmod)
activator corticography (nmod)
concerns because (case)
vasodilator a (det)
subtests , (punct)
high chronically (advmod)
distribution inhomogenous (amod)
layer narrow (amod)
disease rheumatic (amod)
seem oxide (nsubj)
chemotherapies some (det)
ug/ml and (cc)
recorded although (mark)
system cleavage (compound)
resolution a (det)
exchange anticoagulation (conj)
indicator stress (nmod)
mg 75 (nummod)
respiration , (punct)
complication acetazolamide (nmod)
mi and (cc)
pregnancy or (cc)
period acute (amod)
species rns (appos)
neurotoxicity mice (nmod)
angiogenesis cytokines (conj)
adherence % (nmod)
comparison rats (nmod)
catheterization or (cc)
1.53 ) (punct)
trends research (compound)
health overall (amod)
cardioselective . (punct)
glycosuria mild (amod)
assay nick (compound)
size muscle (compound)
desire sexual (amod)
patients an (det)
administered po (dobj)
diagrams ratio (nmod)
suggested administration (nsubjpass)
ischemia , (punct)
dose maintenance (compound)
signaling by (case)
improvements or (cc)
regulation inhibition (nmod)
mg/24 19.2 (compound)
cas ) (punct)
cells brain (compound)
implemented restriction (nsubj)
therapy uracil (compound)
anemia tam-induced (amod)
mmol/l consistent (advmod)
treatment capsaicin (compound)
believe represents (ccomp)
image ) (punct)
demonstrates reaction (nsubj)
rats growth-inhibited (amod)
actin cytoskeleton (nmod)
microgram mg (nmod)
history without (case)
albumin bsa (appos)
alpha pgf2 (compound)
conditions favorable (amod)
defect echocardiography (nmod)
sulfate nicotine (compound)
p-coumarate with (case)
apnea case (nmod)
section caesarean (amod)
10.7 2.1 (appos)
tended show (xcomp)
myositis patient (nmod)
has amphetamine (nsubj)
control that (mark)
carried methods (nsubjpass)
relationship glomerulonephritis (nmod)
manifestations with (case)
relationship and (cc)
decreased doses (nmod)
metoprolol after (case)
ngf bladder (nmod)
$ROOT$ antagonism (sent)
rhinitis spring (compound)
stat3 pathways (conj)
explain alterations (dobj)
analyzed separately (advmod)
impairment known (amod)
observed regression (nsubjpass)
design controlled (amod)
vt symptomatic (amod)
prescribed later (advmod)
flutamide or (cc)
interviewed day (nmod:tmod)
involved synthesis (nmod)
exposure despite (case)
times ambulate (acl:relcl)
headache stronger (amod)
reduction groups (nmod)
focused was (auxpass)
guidelines prevention (nmod)
coefficient spearman (compound)
points from (case)
had recurrence (dobj)
p=0.01 ) (punct)
conducted analysis (dobj)
lymphocytes cd4 (amod)
therapy ribavirin (nmod)
predilection for (case)
modulation due (amod)
corticosteroids dexamethasone (dep)
boy exhibited (acl:relcl)
range entire (amod)
% 55%-60 (nummod)
conclusion calculated (dep)
ng/ml 352 (nummod)
nonpregnant pregnant (conj)
ammonia blood (compound)
related presentation (nmod)
differences regarded (acl)
use enrolment (nmod)
1.17 0.99 (dep)
remain unchanged (acomp)
years after (case)
enhanced bleeding (conj)
followed decrease (nmod)
spectrometry gas (compound)
alpha2abc-knockout and (cc)
off by (case)
protecting in (mark)
complications drug-related (amod)
conclude choice (ccomp)
antagonized hand (nmod)
responses 18 (nummod)
$ROOT$ subjected (sent)
endonuclease-dependent ) (punct)
thrombolysis cdt (appos)
response serum (nmod)
headache or (cc)
gas in (case)
3657 mcg (parataxis)
implications therapy (nmod)
milieu tumour (compound)
response treatment (compound)
0.74 , (punct)
inhibitors transporter-1 (compound)
autoantibodies for (case)
obvious or (cc)
analyzed we (nsubj)
$ROOT$ responded (sent)
review reports (nmod)
presentation unusual (amod)
therapy multimodality (compound)
recently more (advmod)
received others (nsubj)
treat patients (dobj)
observed placebo (nmod)
pethidine both (cc:preconj)
protection mesna (nmod)
lmwh of (case)
study as (case)
media two (nummod)
desorption/ionization laser (compound)
channel blocker (conj)
adopted been (auxpass)
receive became (advcl)
has tumours (nmod)
33.8 63.5 (prep)
bun k (conj)
% 9.8 (nummod)
inhibited significantly (advmod)
factor by (case)
occasionally oligodendrocytes (nmod)
desire and (cc)
sulindac and (cc)
na n (conj)
reverted normal (nmod)
naa by (case)
regimens new (amod)
elevated that (mark)
damage unique (amod)
vsd hydrocephalus (conj)
given opiate (dobj)
diazinon 15mg/kg (dep)
screened symptoms (nmod)
users drugs (nmod)
temperament with (case)
olr ) (punct)
one agents (nmod)
dye evans (compound)
diagnosing in (mark)
interval percent (appos)
metabolites catechol (compound)
dithiothreitol trypsin (conj)
decreased increases (nsubjpass)
encephalitis of (case)
solution caffeine-free (amod)
used anorexigens (dobj)
cows pregnant (amod)
worsening use (nmod)
estrogens and (cc)
analyzed months (nmod:tmod)
observed attack (nsubjpass)
solvent then (advmod)
risk concentration (nmod)
success a (det)
consistent is (cop)
allografts 13 (nsubj)
nausea h (nmod)
suppressed needed (parataxis)
associated period (nsubjpass)
common and (cc)
calcification media (nmod)
vulnerability events (nmod)
antagonizes mice (nmod)
endophthalmitis for (case)
manipulating activity (dobj)
ceasing didanosine (dobj)
temporal left (amod)
pleased sedation (nmod)
showed scavenging (nmod)
prevented patients (nmod)
seizures arrhythmias (conj)
has replication (nmod)
epilepsy temporal (amod)
graded was (auxpass)
monitoring by (mark)
started dexamethasone (nsubjpass)
degree moderate (amod)
connection direct (amod)
demonstrates participation (dobj)
revealed hyperactivity (dobj)
revealed combining (csubj)
occurred however (advmod)
spontaneous or (cc)
neurodegeneration neurons (nmod)
foot of (case)
infarction as (case)
effective alendronate (nsubj)
precede to (mark)
plays regulation (nmod)
improved also (advmod)
iml ( (punct)
egfp ) (punct)
h 11 (nummod)
radial ulnar (conj)
medication any (det)
increase reported (amod)
-14.6 ( (punct)
1971 between (case)
day first (amod)
8.5 ratio (nsubj)
rr=1.41 ( (punct)
arrest to (case)
busulfan clonazepam (compound)
$ROOT$ attempt (sent)
diminished which (nmod)
hypotension maximal (acl:relcl)
hyperalgesia/myoclonus doses (conj)
patient series (nmod)
citations few (amod)
had nocistatin (nsubj)
and vitro (advmod)
pan/temocapril ( (punct)
rats ra (nmod)
anaesthesia after (case)
assessed postoperatively (advmod)
factor etiologic (amod)
use dm (nmod)
emphasized has (aux)
metabolite as (case)
tumour mast (compound)
contributed % (nmod)
aggressive more (advmod)
advocated , (punct)
continuation therapy (nmod)
trial vinorelbine (nmod)
quinpirole the (det)
group group (conj)
tubular to (case)
mediated to (mark)
association temporal (amod)
diagnosed carcinoma (nsubjpass)
exerted effect (dobj)
minutes 30 (nummod)
patient hypoparathyroidism (nmod)
interferon with (case)
intake drug (nmod)
detected control (nmod)
developed caused (ccomp)
dose above (case)
compliance poor (amod)
had infiltrate (dobj)
amnesia maze (nmod)
bringing number (dobj)
years 56 (nummod)
induces tamoxifen (nsubj)
markers oxidative (amod)
criteria available (conj)
leukemia system (compound)
group alpha-position (nmod)
seizure-resistant withdrawal (nmod:npmod)
subsets patients (nmod)
micrograms/ml to (case)
fall by (case)
presented initially (advmod)
layer likely (acl:relcl)
doses mg (nmod)
measured immunoassay (nmod)
admission records (conj)
mu/kg ( (punct)
insights valuable (amod)
changes adaptive (amod)
curve glucose (compound)
scale , (punct)
functioning sexual (amod)
therapy reference (compound)
syndromes behavioral (amod)
ratio blots (nmod)
bia ( (punct)
cardiomyopathy were (cop)
assay developed (acl)
analysis phases (nmod)
criteria ) (punct)
cardiotoxicity anthracycline-induced (amod)
alterations neurochemical (amod)
other lad (nmod)
staining serum-proteins (nmod)
six more (amod)
9.2 to (dep)
resolved averting (advcl)
have would (aux)
limbs distal (amod)
assigned sertraline (nmod)
$ROOT$ head (sent)
taken mg (dep)
peak enlargement (nmod)
used model (nmod)
76 5.3 (conj)
as it (nsubj)
statins by (case)
acid combination (nmod)
treatment amantadine (compound)
leak capillary (amod)
bd1008 oligodeoxynucleotide (conj)
users vs (cc)
areas large (amod)
explanation alterations (nmod)
reduced which (nsubjpass)
hyperactivity and (cc)
of patients (nsubj)
dosage each (det)
find not (neg)
report cases (nsubj)
tnf-a il-6 (conj)
0.05 was (cop)
time lag (compound)
artery dogs (nmod)
artery one (nummod)
trends days (nmod)
appearance for (case)
sulfonylureas with (case)
knife nor (cc)
used levels (nsubjpass)
pretreatment . (punct)
cessation , (punct)
$ROOT$ combined (sent)
enterocolitis necrotizing (amod)
c deficits (nmod)
background is (dep)
investigated addition (nmod)
diamorphine mg (appos)
associated reactions (nmod)
performed days (nmod)
activity plasma (compound)
blot and (cc)
defect produced (acl)
reduces 890 (nmod)
ndi ) (punct)
gentamicin pdtc (conj)
p=0.003 0.0006 (conj)
saturations oxygen (compound)
increased days (nmod)
administration administration (conj)
riha defined (acl)
consists treatment (nsubj)
effects significant (amod)
toxicity levobupivacaine (nmod)
failure lithium-induced (amod)
overload ) (punct)
series cases (nmod)
showed : (punct)
feel . (punct)
explore effects (dobj)
peptide basic (amod)
case incontinence (nmod)
toxicity resulting (acl)
doses glucocorticoids (nmod)
irrigation during (case)
achieved when (advmod)
oxcarbazepine its (nmod:poss)
days 15 (nummod)
history drop (nmod)
sah associated (acl)
metabolites several (amod)
foci/cm2 with (case)
conclusion bear (appos)
example an (det)
doses % (nmod)
developed uveitis (dobj)
having one (dobj)
rate release (compound)
admitted patients (nsubjpass)
protected mice (nsubjpass)
oil and (cc)
frequencies speech (compound)
expression vegf/vpf (compound)
distribution methamphetamine (nmod)
enhancement effects (nmod)
maintains weight (dobj)
mediated require (conj)
moles/glomerulus ( (punct)
overstimulation cholinergic (amod)
p gentamicin (conj)
require , (punct)
taken she (nsubj)
lasted improvements (nsubj)
33 +/- (cc)
reviewed clinicians (nsubj)
status sodium (compound)
nephrotoxicity proteinuria (conj)
calcium magnesium (conj)
effects according (case)
adequate . (punct)
compound , (punct)
had change (dobj)
compared fractions (nmod)
substantial and (cc)
disorder autosomal (amod)
admitted was (auxpass)
flumazenil placebo (conj)
times infusion (compound)
val204asp p. (compound)
both for (case)
years first (amod)
journals and (cc)
preservation consumption (nmod)
rhythms therapy (nmod)
diminishes altering (csubj)
effect embryo (nmod)
patient treatment (conj)
chance the (det)
received noticed (parataxis)
central either (cc:preconj)
amnesia scopolamine-induced (amod)
on , (punct)
= 0.12 (dobj)
visualize amount (dobj)
level-dependent blood (nmod:npmod)
txb2 ) (punct)
potassium metoprolol (conj)
back leg (conj)
startle startle (conj)
patients allergic (amod)
signs for (case)
amoxicillin-clavulanate was (cop)
failure during (case)
defects structural (amod)
seen frequently (advmod)
restores reduction (dobj)
cases dependence (nmod)
medications these (det)
zones cycle (nmod)
discriminated that (mark)
aged weeks (nmod:tmod)
manipulation system (nmod)
relationship time (nmod)
acidification , (punct)
saline/side ( (punct)
treatment patients (nmod)
administration prednisolone (nmod)
af during (case)
had episode (dobj)
apparent decreases (nmod)
expected coadministration (nsubjpass)
taking patient (nsubj)
syndrome malignant (amod)
supported be (auxpass)
e4031 and (cc)
control versus (cc)
distribution a (det)
impairments consolidation (compound)
bradycardia a (det)
died failure (nmod)
found most (nsubj)
done ensure (xcomp)
gaining acceptance (dobj)
treated received (conj)
products ages (appos)
conducting of (mark)
mg.kg(-1 80 (nummod)
narrowing high-grade (amod)
received needs (nmod)
step each (det)
low or (cc)
induced . (punct)
mice weighing (conj)
access 12-h (amod)
infiltrate moderate (amod)
snps tagging (amod)
contraindicated pregnancy (nmod)
precise . (punct)
bfue by (case)
antifolate lometrexol (nsubj)
peak the (det)
antibiotics other (amod)
administered mg/kg/day (nsubjpass)
serum concentrations (conj)
patient pregnant (amod)
prepared dose (nmod)
ineffective injections (nsubj)
experience positive (amod)
tachycardia microgram/kg/min (appos)
influence that (nsubj)
myopathy human (amod)
higher 2-fold (advmod)
6-thioguanine by (case)
had discharge (nmod)
performed microscope (nmod)
walls to (case)
recruited centers (nmod)
40,000 millimeter (nmod)
effects antiparkinsonian-like (amod)
trigger be (cop)
perseveration impairment (conj)
seen and (cc)
determined subjects (nmod)
hepatotoxicity induced (amod)
k(+ ) (punct)
dct2 ( (punct)
postlesion day (compound)
agents lovastatin (nsubj)
sensitive changes (nmod)
demonstrated have (ccomp)
background occurs (dep)
initiation development (conj)
questions , (punct)
chemotherapy anthracycline-based (amod)
deal for (case)
fluorouracil ] (punct)
respect sex (nmod)
analysis function (compound)
urine rats (nmod)
presented erythroderma (nmod)
abusers ma (compound)
examined rat (nmod)
inducing translocation (dobj)
material i.v. (compound)
measurement plasma (nmod)
woman 27-year (compound)
documentation with (case)
associated hemolysis (nmod)
kinetics following (case)
pentobarbital by (case)
mmhg min (nmod)
discrimination in (case)
granules dark (amod)
deposition nonopaque (amod)
studies no (neg)
6 fewer (amod)
65 > (amod)
protection seizures (nmod)
occurred concentration (nmod)
use schedules (nmod)
administration amphotercin (compound)
follow-up ophthalmological (amod)
paclitaxel , (punct)
effect anesthetic (compound)
taken patients (nmod)
pressure variability (conj)
sensitivity differential (amod)
ecg transmural (amod)
lesion nerves (nmod)
iddm ) (punct)
designed 3 (meta)
cycle sleep/wake (compound)
respect effects (nmod)
experienced ; (punct)
hypocalcemia significant (amod)
values frap (compound)
toxicity propranolol (compound)
ptz ptx (conj)
irritation bladder (compound)
virus syncytial (amod)
g mg/100 (compound)
albuminuria due (amod)
periods time (compound)
rectified , (punct)
received mg/kg/b.w (nmod)
available supplemented (parataxis)
hctc ) (punct)
related pyrazinamide (nmod)
% twenty-three (nummod)
edrophonium of (case)
lindane with (case)
$ROOT$ separation (sent)
dynamic ( (punct)
duration gender (conj)
attained denopamine (nmod)
possibility movements (nmod)
induces function (nmod)
bind to (mark)
describe efforts (dobj)
results different (appos)
includes discovery (dobj)
smoking , (punct)
heterogeneous socioeconomically (advmod)
mmol/l 2.3 (nummod)
3 or (cc)
case group (nmod)
small . (punct)
configuration . (punct)
hunt and (cc)
substitute to (mark)
doses do (acl:relcl)
$ROOT$ do (sent)
factor independent (amod)
that thiopentone (nmod)
treatment psoriasis (nmod)
anticipated may (aux)
objective sedatives (appos)
formed is (auxpass)
treatment parkinsonism (nmod)
inhaler metered-dose (amod)
inhibited development (dobj)
fibrosis regeneration (conj)
versions alternate (amod)
derivatives caproate (nmod)
hydrobromide 6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzaze (compound)
micu the (det)
$ROOT$ unresolved (sent)
5-httlpr of (case)
occurrence pressure (conj)
rise seen (acl)
overdosage phenytoin (compound)
therapy circumstances (nmod)
facilitate to (mark)
symptoms infarction (conj)
necrosis apap-induced (amod)
proteases lysosomal (amod)
justified pretreatment (nsubj)
vasopressor alpha-adrenergic (amod)
pre-treatment melatonin (compound)
infiltration inflammatory (amod)
led withdrawal (nmod)
benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate isopropyl-6- (compound)
receptors both (det)
set the (det)
smaller were (cop)
infusion . (punct)
receptors altered (amod)
cross-tolerance or (cc)
3s-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane ) (punct)
prevention findings (dep)
lower this (nsubj)
therapy injections (conj)
gauges g (dep)
edema secondary (amod)
frequency hemorrhage (nmod)
longer significantly (advmod)
health mental (amod)
quantitated . (punct)
pretreatment diphenhydramine (nmod)
asterixis about (case)
hypertension human (amod)
alf n=36 (dep)
drug potential (amod)
dose acc-9653 (nmod)
$ROOT$ warned (sent)
basis trial (nmod)
19.708 - (punct)
pathologies of (case)
expression p-glycoprotein (nmod)
detected may (aux)
fruits terminalia (compound)
more less (conj)
attenuation atrophy (conj)
elucidating factors (dobj)
54 20 (conj)
mice mg (acl:relcl)
was suggests (ccomp)
milligrams four (nummod)
highest whereas (mark)
concentration peroxide (compound)
beams and (cc)
volunteers ten (nummod)
less solution (nmod)
speaking and (cc)
help achieve (ccomp)
rare while (mark)
used repeatedly (advmod)
explained synergy (nsubjpass)
decreases susceptibility (dobj)
decreased cent (dobj)
venom gland (nmod)
problems some (det)
$ROOT$ limits (sent)
period this (det)
included meta-analysis (nmod)
prevented gnc92h2 (nsubj)
msdbp hg (appos)
bought g (dobj)
excluded effects (nmod)
intervention pci (appos)
2.31 to (dep)
consisted vtd (nsubj)
infused surgery (nmod)
pathway be (cop)
programs hypertension (dobj)
mornings first (amod)
effect blood (compound)
ccl4 ) (punct)
associated myoclonus (nsubjpass)
back-diffusion including (case)
lesions selected (amod)
deficits biochemical (amod)
score < (amod)
modifies effects (dobj)
using design (dobj)
days in (case)
diagnosed had (aux)
stretching and (cc)
informed be (cop)
gd to (case)
cause commonest (amod)
intake of (case)
diet wk (nmod)
toxicity combined (amod)
antibody patients (nmod)
agonist absorption (nmod)
playing bottle (nmod)
ltp morphine-inhibited (amod)
treated ribavirin (nmod)
described : (punct)
central peripheral (conj)
syndrome 3-week (amod)
incidence because (case)
increases than (case)
patients history (conj)
abolish to (mark)
alcohol and (cc)
severity infarction (nmod)
unaffected increased (conj)
particles cortex (nmod)
biomarkers and (cc)
convulsions lidocaine (compound)
calculations area (compound)
ts isolated (amod)
neuropathy an (det)
0.95 0.92 (compound)
years 1/2 (nummod)
findings implicating (acl)
histology mixed (amod)
intensity fasciculations (nmod)
referred syndrome (nmod)
% response (nsubj)
study dfu (compound)
research quasi-experimental (amod)
fdc oral (amod)
showing improves (ccomp)
recovery conversion (nmod)
safety general (amod)
purpose investigated (acl)
followed after (conj)
isoenzymes inducible (amod)
alpha-gst of (case)
loss high-frequency (amod)
ratios da (appos)
mouse-1 mice (appos)
treatment before (case)
values ( (punct)
evaluated being (auxpass)
17 with (case)
31 from (case)
suppressants fenfluramines (appos)
treated den (nmod:npmod)
acute ) (punct)
death characterized (acl:relcl)
peptide typical (amod)
presented diagnosed (advcl)
gamma-hch picrotoxin (conj)
stressed immediately (advmod)
rate muscle (compound)
% trials (nmod)
patients seventeen (nummod)
more myelosuppression (nsubj)
trained and (cc)
demonstrated stimulation (nsubjpass)
headache dementia (conj)
non-selective dfu (dep)
irrigation instillation (conj)
exposure either (preconj)
tolerated lozenge (nsubjpass)
account as (mark)
diagnosed have (xcomp)
routes the (det)
hr 8 (nummod)
0.007 ) (punct)
deposits and (cc)
membranes in (case)
sites heparan (compound)
$ROOT$ impact (sent)
group 5 (appos)
pap ) (punct)
concentrations duration (conj)
inducer 2b1/2b2 (nmod)
generator the (det)
intervenes cs (nsubj)
antagonist benzodiazepine (compound)
suggested although (mark)
use model (nmod)
fluctuations motor (amod)
7.8 10(10 (conj)
$ROOT$ massive (sent)
paid , (punct)
implications and (cc)
nephritis ain (appos)
caused increases (dobj)
displayed proteinuria (dobj)
return perfusion (nmod)
studies urine (compound)
july to (case)
experienced effects (dobj)
later questionnaire (nmod)
generates that (mark)
increased azimilide (nsubj)
showed that (nsubj)
frequent midazolam (nmod)
induced hyperalgesia (nsubjpass)
affecting nephrolithiasis (dobj)
stay hospital (compound)
effects alcohol (compound)
programs surveillance (compound)
cause seizures (dobj)
beats ventricular (amod)
determined scores (nmod)
killed rats (nsubjpass)
unilateral and (cc)
range into (case)
outcome its (nmod:poss)
subjected not (neg)
increase days (nmod)
records patients (nmod)
multiforme of (case)
bpm atenolol (nmod)
group 1.043 (dep)
hfd ) (punct)
rosacea of (case)
pattern syndromes (nmod)
variations response (conj)
pressure iop (appos)
contrary literature (nmod)
inhibition ) (punct)
been ) (punct)
induces d2/d3 (dobj)
reduces preservation (nmod)
values as (case)
study core (amod)
aki with (case)
test charcoal (compound)
consider clinician (nsubj)
reversible dose-related (conj)
kidney perfused (acl)
genes encode (acl:relcl)
basis desire (nmod)
caries , (punct)
cirazoline i.v. (appos)
acts because (mark)
influenced background (nmod)
group doctors (nmod)
effects cataleptic (amod)
markers molecular (amod)
reduces reduces (conj)
cl , (punct)
loss combined (amod)
microinjection cck-8 (nmod)
marker with (case)
rammer hildebrand (appos)
related deficits (dobj)
level signaling (nmod)
recording may (aux)
normal determination (nmod)
failed inhibit (xcomp)
effect polymorphism (nmod)
used weight (nsubjpass)
disturbances for (case)
randomized participants (nsubj)
nephritis deposits (nmod)
a.m. 9 (nummod)
associated tacrolimus (nsubjpass)
tended cells (nsubj)
nephrolithiasis complicating (acl)
dogs anesthetized (amod)
positive mpo-anca (nmod)
ns-718 with (case)
chat ) (punct)
in but (advmod)
interventions affect (acl:relcl)
recorded being (auxpass)
expression cardiac-specific (amod)
alpha-position and (cc)
interference changes (conj)
patient treated (acl)
sulfasalazine the (det)
recorded brainstem (nmod)
reabsorption glucose (compound)
assessed interleukin-6 (nsubjpass)
$ROOT$ given (sent)
challenged . (punct)
exert cord (nmod)
occurs use (nmod)
warfarin patients (appos)
had dis-charge (nmod)
low and (cc)
output 1.54 (nmod)
less nucleus (nmod)
prevent whether (mark)
trial council (compound)
quit nondrinkers (conj)
s-1 20-mg (conj)
breath of (case)
used animals (nmod)
07 - (punct)
activate setting (nmod)
suggest downregulates (ccomp)
woman suffered (acl:relcl)
interval 4.1 (appos)
data current (amod)
performance antioxidant (amod)
transplanted diseases (nmod)
effects atorvastatin (nmod)
glycosides of (case)
prolonged be (cop)
s.c. i.v. (dep)
women disease (nmod)
conclusions found (dep)
.001 ) (punct)
process and (cc)
week within (case)
twelve them (nmod)
11 p (dep)
ml/kg 1.0 (nummod)
acted , (punct)
> , (punct)
injury administration (nmod)
factor limiting (amod)
received had (aux)
myocardial i.e. (advmod)
thrombopoetin of (case)
gfc75 p400 (conj)
dyskinesias to (case)
$ROOT$ best (sent)
disarrangement damage (conj)
confirmed also (advmod)
tablets short-acting (amod)
confounded effects (nmod)
consisted stage (nmod)
parkinsonism bradykinesia (conj)
28 30 (conj)
tachycardia an (det)
recognized hyperkalemia (nsubjpass)
annuloplasty map (appos)
cytostatics no (neg)
relationship duration (nmod)
endpoints with (case)
lowering the (det)
experiments mice (nmod)
examined samples (nsubjpass)
factors from (case)
draw findings (nmod)
level time (nmod)
attenuate not (neg)
$ROOT$ absent (sent)
related stress (nmod:npmod)
cases 163 (nummod)
consider manage (conj)
drugs affinity (nmod)
11.1 0 (conj)
permits that (nsubj)
concentration inhibitory (amod)
profiles agents (nmod)
underwent palliation (nmod)
specimens , (punct)
infection was (cop)
review brief (amod)
provision acid (nmod)
of +/- (cc)
patients glioblastoma (nmod)
develop untreated (advcl)
been furthermore (advmod)
contributes synthesis (nsubj)
clinics through (case)
levels ctnt (compound)
pronounced day (nmod)
interfere risk (nmod)
dissociate can (aux)
study followed (acl)
received january (nmod)
higher is (cop)
inhibitors carbonic (amod)
exerts action (dobj)
reduced intensity (dobj)
indicate results (nsubj)
euthanized were (auxpass)
injections control (amod)
re the (det)
episodes stroke-like (amod)
maintained period (nmod)
male from (case)
mg , (punct)
disruption inhibition (nmod)
bodies ketone (compound)
subsides which (nsubj)
develop subsequently (advmod)
child of (case)
-20.93 + (cc)
improved addition (nmod)
aggregations vitro (amod)
result interaction (nmod)
sucrose ( (punct)
receptor b2 (compound)
offer and (cc)
exhibiting with (mark)
angiotension of (case)
structure membrane (compound)
conceivable , (punct)
channels water (compound)
pentoxifylline and (cc)
neurotoxicity direct (amod)
angiotensinogen of (case)
tolerated that (mark)
encephalopathy wernicke (nmod:poss)
return resolved (advcl)
wished we (nsubj)
disorder common (amod)
outcomes poor (amod)
reacted weakly (advmod)
change present (amod)
1.29 1.17 (dep)
promotes occurrence (dobj)
benzodiazepines health (conj)
concentrations metoprolol (compound)
psp ( (punct)
performed assay (nsubjpass)
diagnosed been (auxpass)
electroencephalogram eeg (appos)
rat treated (amod)
survival overall (amod)
reactions agents (nmod)
iu/l 134 (nummod)
alpha ) (punct)
expression mmp-2 (nmod)
5-fu 3-weekly (amod)
association radiation (nmod)
infiltrate lymphocytic (amod)
organs haemorrhages (nmod)
31 two (quantmod)
activate that (mark)
mg/m2 above (case)
taken surgery (nmod)
cause disorders (nmod)
guidelines safer (amod)
tcr ) (punct)
aware physician (nsubj)
embolism pulmonary (amod)
reaction paradoxical (amod)
suffered sequelae (dobj)
structures their (nmod:poss)
hiccups azithromycin-associated (amod)
have angina (nmod)
discovered son (nsubj)
scenario a (det)
apomorphine . (punct)
binding in (amod)
cardioselective nonselective (conj)
donation apheresis (compound)
0.2 0.7 (conj)
32.9 duration (nsubj)
controls mm2 (appos)
revealed abnormality (dobj)
recall pairs (nmod)
downregulates estrogen (nsubj)
resolved again (advmod)
effect study (dep)
then now (conj)
mirtazapine of (case)
disrupting reducing (conj)
oxidation synthesis (conj)
led discontinuance (nsubj)
nephropathy a (det)
patient latter (amod)
obtained dwi (nmod)
transplants anemia (nmod)
remained scores (nsubj)
indicators routine (amod)
triamcinolone t (appos)
correlated former (nmod)
considered related (xcomp)
freedom infections (nmod)
concluded relieve (ccomp)
acetate cyproterone (compound)
ep ( (punct)
postoperatively months (nmod:npmod)
inhibited selectively (advmod)
dose depending (case)
rats 2- (amod)
trial galantamine (nmod)
had supplementation (nsubj)
inhibited rats (nmod)
compensated suppressed (conj)
were findings (nsubj)
$ROOT$ ingredient (sent)
antipsychotics classical (amod)
centers academic (amod)
cause patient (nmod)
c versus (cc)
re-started they (nsubjpass)
tachycardia atrioventricular (amod)
negative testing (nsubj)
unresponsive mice (nsubj)
demonstrated cardiotoxicity (nsubjpass)
perturbation mechanical (amod)
drops the (det)
genotype to (case)
change resolve (advcl)
% -20.93 (nummod)
time between (case)
transplantation patients (nmod)
infiltration cells (nmod)
limits study (nmod)
suggested paradigm (nsubjpass)
27 ( (punct)
effect milrinone (nmod)
appearance mpo-anca (nmod)
seemed result (ccomp)
sample % (nmod)
have pyrazinamide (nsubj)
show interaction (dobj)
gaba glycine (conj)
raised concentrations (nsubjpass)
considered insufficiency (nmod)
delineating regions (dobj)
group halothane (compound)
recorded doses (nmod)
patients migraine (nmod)
maintained patency (nsubjpass)
appearance kidneys (nmod)
caries rampant (amod)
rats hfd-induced (amod)
evident was (cop)
intrathecal , (punct)
dogs 16 (nummod)
moiety derivative (appos)
manageable and (cc)
chewing , (punct)
areas fibrotic (amod)
women 850 (nummod)
mg/m2 120 (nummod)
allodynia nociceptin-induced (amod)
frequent results (nsubj)
30mg/kg s.c. (appos)
calculate to (mark)
representative spectrum (nmod)
csseps central (nmod)
nephropathy li-induced (amod)
dissociated successfully (advmod)
ingested doses (nsubjpass)
frequent reactions (nsubj)
matter , (punct)
adolescents of (case)
n-methyl-d-aspartate nmda (appos)
showed alternation (dobj)
patients males (dep)
amounts words (nmod)
range u/ml (nmod)
perfusion isolated (amod)
damage peroxidation (conj)
ability functional (amod)
serositis and (cc)
oxidized glutathione (conj)
formation % (appos)
valvulopathy defined (acl)
take . (punct)
titrated were (auxpass)
back values (nmod)
cpa/ee cocs (conj)
men borderline (amod)
studied recurrence (nsubjpass)
values electrocardiograms (conj)
poisoning a (det)
65 10(9)/l (conj)
magnitude surge (nmod)
conclusions . (punct)
benign relatively (advmod)
-15.96 % (conj)
antagonist b2 (compound)
magnitude or (cc)
$ROOT$ pneumonitis (sent)
index bis (appos)
1,2-dimethylhydrazine mg/kg (appos)
i ii (conj)
cck-8-se ( (punct)
increased concentration (nsubjpass)
explore effect (dobj)
applicators for (case)
state state (conj)
receptor an (det)
cells -ir (amod)
mg/kg/day 40 (compound)
array cytokine (compound)
suggested induce (ccomp)
observations with (case)
coefficient adc (appos)
dosed metoprolol (nsubjpass)
probability improving (acl)
mastitis 1 (appos)
reshaping absence (nmod)
disorder or=7.18 (dep)
none effects (nmod)
patients suffer (acl:relcl)
secretion vasopressin (compound)
history three-week (compound)
hospitals hampshire (nmod:poss)
scan cerebral (amod)
anemia blockade-induced (amod)
room to (case)
replacement csa (compound)
3 shown (advcl)
correlation no (det)
serious was (cop)
enhancement effect (nmod)
infections and (cc)
study multicenter (amod)
polfa " (punct)
impulsiveness and (cc)
variability intra-individual (amod)
areas and (cc)
levels children (nmod)
bnpp mm (appos)
using after (mark)
ingestion in (case)
side-effects rats (nmod)
obvious was (cop)
frequency spectrum (conj)
ptz ( (punct)
electroshock , (punct)
increases activity (nmod)
complication may (aux)
comparison the (det)
have profile (dobj)
deficient genetically (advmod)
apheresis ldl (compound)
shouts incomprehensible (amod)
promoting reentry (dobj)
displace right (nmod)
dyskinesias choreatic (amod)
convert to (mark)
discontinued excluded (conj)
alpha-mediated effects (nsubj)
damage necroses (conj)
reversal hypotension (nmod)
r4 ( (punct)
cells interstitial (amod)
% 2.0 (nummod)
properties on (case)
phenomenon described (amod)
drugs agents (appos)
host ) (punct)
episodes 59 (nummod)
after atenolol (nmod)
capsule of (case)
1.86 0.9 (conj)
subgroup in (case)
incorporation in (case)
quetiapine , (punct)
permissive necessary (conj)
determine subject (ccomp)
changes chemotherapy (nmod)
hours next (amod)
nos ( (punct)
cancer prostate (compound)
rats habituated (acl)
$ROOT$ disorders (sent)
2.2 and (cc)
detect cases (dobj)
tr(- ( (punct)
predictors clinical (amod)
41.4 +/- (cc)
explanation effects (nmod)
sinusoidal the (det)
prevent attenuated (advcl)
filters vena (compound)
revealed toxicity (dobj)
stomatitis ) (punct)
weeks 37 (nummod)
79.6 x (cc)
$ROOT$ complemented (sent)
regardless time (nmod)
1 , (punct)
vesicles the (det)
hepatonecrosis . (punct)
recruited we (nsubj)
reducing by (mark)
complication population (nmod)
occur simultaneously (advmod)
efficiency food (nmod)
iop ( (punct)
map out (compound:prt)
showed signs (dobj)
elf fam (conj)
loss frequency (compound)
course seen (acl)
depletes . (punct)
regression and (cc)
additive . (punct)
cases testosterone (nmod)
prevent did (aux)
using agent (nmod)
induces isoproterenol (nsubj)
6.5 approximately (advmod)
applied while (mark)
had 54/94 (nsubj)
may 1 (nummod)
measures size (appos)
determined rates (nsubjpass)
formulations propofol (nmod)
importance crucial (amod)
more many (amod)
$ROOT$ cardiomyopathy (sent)
reports effect (nmod)
result alternatively (advmod)
factors both (det)
seizure against (case)
tobramicyn of (case)
took zolmitriptan (dobj)
consisted , (punct)
rats se (compound)
recruited patients (nsubjpass)
ventilation on (case)
ang ii (nummod)
% 18.75 (nummod)
products in (case)
injected were (auxpass)
drug acid (nsubj)
ranged % (nmod)
amlodipine versus (cc)
increased addition (nsubj)
nephrectomy bilateral (amod)
augmented microinjection (nsubj)
changed out (advmod)
achieved that (mark)
factor two (nmod)
hospital private (amod)
reduction nox (nmod)
caused failure (dobj)
less or (cc)
outcomes with (case)
psychostimulant a (det)
alternative stimulate (acl:relcl)
indicate mediated (ccomp)
monitored minutes (nmod)
na of (case)
convulsions in (case)
operated cholecystitis (nmod)
matched year (nmod)
hemoglobin , (punct)
hyperprolactinemia to (case)
hypokalemia profound (amod)
convert respectively (advmod)
pups exposed (acl)
parameters pharmacokinetic (amod)
4-aminopyridine saline (conj)
12-week to (dep)
intervals beat-to-beat (amod)
purpose evaluate (acl)
up a (det)
influence membranes (nmod)
predispose that (mark)
3.6- 1.8-fold (conj)
release produced (acl)
antagonist an (det)
demonstrated monitoring (nsubj)
$ROOT$ response (sent)
damage assessing (advcl)
flow vt/ti (appos)
classical haloperidol (appos)
agent chemopreventive (amod)
due anuria (nsubj)
summary patient (appos)
hormone hormone (conj)
h2 ) (punct)
periods amplitudes (conj)
pain atypical (amod)
$ROOT$ took (sent)
abundant although (mark)
conditions designed (acl)
twenty-four of (case)
spectrometry hplc-mass (amod)
worsening dyskinesias (nmod)
injections after (conj)
implicated patient (nmod)
august through (case)
with often (advmod)
had alf=0/35 (dep)
methods results (conj)
resolved discontinuation (nsubj)
percentage patients (nmod)
assumption predispose (ccomp)
remission response (compound)
included range (dobj)
inhibited nor (cc)
develops % (nmod)
administered indicating (advcl)
disappointing has (aux)
igg of (case)
tachyarrhythmias beats (conj)
therapy subsequent (amod)
elicited seizures (nsubjpass)
0.6 0.08 (conj)
episodes arrest (nmod)
ingredient number (nmod)
resulted potentiation (nmod)
isoflurane agent (appos)
therapy hormonal (amod)
believed ratio (nsubjpass)
adopted therapy (nsubjpass)
study dependency (nmod)
compared relation (nmod)
thromboembolic : (punct)
activity dopamine (compound)
responses cataleptic (amod)
arteries carotid (compound)
factor be (cop)
recorded spikes (nsubjpass)
nik-247 , (punct)
sbp and (cc)
fluids certain (amod)
studies histological (amod)
leading desensitisation (nmod)
late were (cop)
increased lines (nmod)
receive or (cc)
reaction eosinophilia (conj)
continued month (nmod)
growth tumor (compound)
drug timolol (appos)
5 group (nmod)
39+/-10 18+/-5 (conj)
$ROOT$ alert (sent)
develop did (aux)
$ROOT$ recovered (sent)
neurotoxicity dopaminergic (amod)
risk alterations (nmod)
cause range (dobj)
6.5 +/- (cc)
sleeping = (dep)
effects bronchodilating (amod)
2.96 -0.81 (compound)
$ROOT$ pharmacokinetics (sent)
photosensitivity flushing (conj)
pills oral (amod)
transport cells (nmod)
insufficiency pulmonary (amod)
locus vasoconstriction (nmod)
induced apomorphine (conj)
differed none (nsubj)
placebo patients (appos)
anesthesia after (case)
sweating facial (amod)
predictors course (conj)
min every (det)
receptors ( (punct)
secondary vasculitis (nmod)
minutes 10 (nummod)
actions potent (amod)
effects more (amod)
diagnostics , (punct)
program dialysis (compound)
superior h (nmod)
role disintegrin (nmod)
university sciences (compound)
study people (nmod)
administration warfarin (compound)
hypokalemic patients (conj)
hemorrhage cranial (amod)
pathologies obscure (amod)
stimulant . (punct)
detection hypoxia (nmod)
ci 0.89 (appos)
involved . (punct)
anesthesia regional (amod)
standard treatment (nmod)
p-glycoprotein transporter (appos)
times two (nummod)
hcv ) (punct)
considered catalepsy (nsubjpass)
moderate neurotoxicity (nsubj)
scales analog (compound)
vials in (case)
added counts (nmod)
toxocity cats (nmod)
mg/d 3 (nummod)
renin 22 (nummod)
effect biphasic (amod)
severe infusion (nmod)
fever lymphadenopathy (conj)
results duration (appos)
wsr ( (punct)
performance maze (nmod)
implications findings (nmod)
yield and (cc)
augmentation in (case)
controls not (neg)
metabolism lindane (nmod)
groups low-dose (amod)
micrograms 36 (nummod)
10 20 (conj)
day later (conj)
failure fatal (amod)
serum-proteins for (case)
magnitude ( (punct)
resuscitation during (case)
treat . (punct)
amine sympathetic (amod)
splenic both (cc:preconj)
objectives first (appos)
edema nausea (conj)
induce glomerulosclerosis (dobj)
got acidosis (nsubj)
csseps nmps (conj)
diagnosed ptld (nmod)
disappeared rash (nsubj)
correlated abnormalities (nsubjpass)
dysfunction hippocampal (amod)
lower are (cop)
di neurogenic (amod)
altering in (mark)
candidate that (mark)
recorded later (advmod)
pharmacology pharmacokinetics (conj)
32.5 12.1 (conj)
induced levels (nmod)
controlled doses (nmod)
patients iranian (amod)
triggers release (dobj)
territory ischemic (amod)
showed heterogeneity (dobj)
control cells (appos)
disease trophoblastic (amod)
cancer cell (compound)
involvement no (neg)
cerebellar and (cc)
weeks ' (case)
restored cholecystokinin-octapeptide (nsubj)
role augmentation (nmod)
substitution fully (advmod)
etiology nodosum (nmod)
stenting stents (nmod)
proportion prl-positive (amod)
showed clubs (dobj)
sensitivities lines (nmod)
suggest animals (dobj)
facilitated retrieval (dobj)
interventions neonates (nmod)
undergone and (cc)
0.95 ( (punct)
lists , (punct)
% mm (conj)
atropine not (cc)
bilirubin conjugated (amod)
session a (det)
elevated sodium (nsubj)
obtained be (auxpass)
measure : (punct)
ones dyskinetic (amod)
fell which (nsubj)
depressive and (cc)
differentiate therapies (dobj)
attenuated dowregulation (nsubjpass)
restoration in (case)
effects dysrhythmogenic (amod)
history exposure (nmod)
course a (det)
nature antipsychotic (amod)
pressure mvp (appos)
$ROOT$ aneurysm (sent)
improve but (cc)
injection carbachol (nmod)
formation via (case)
were beats (attr)
possibility inhibits (acl)
hoe ip (appos)
placebo with (case)
either for (case)
pain score (conj)
level micrograms/dl (nmod)
suffered patients (nmod)
vgb ) (punct)
thrombocytopenia % (appos)
terminated reach (conj)
a , (punct)
incidence mania (nmod)
consumption with (case)
imperative recognized (advcl)
drc ( (punct)
difference that (nmod)
protected rats (dobj)
prolonged minutes (dobj)
adrenaline with (case)
changing without (mark)
important aware (ccomp)
advocate not (aux)
was dystonia (nsubj)
showed recovery (dobj)
avoid over-immunosuppression (dobj)
agent experimental (amod)
ecg in (case)
hypothesis results (ccomp)
reported 1985 (nmod)
level plasma (compound)
affected degrees (nmod)
group midazolam (compound)
response best (amod)
study results (dep)
afternoon early (amod)
patients experiencing (acl)
prevalence complications (nmod)
part iv (nummod)
66.9 ; (punct)
treated daily (advmod)
up min (nmod)
has association (dobj)
similar patients (nmod)
day scopolamine (dep)
questioned when (advmod)
task expression (compound)
pn 2 (nummod)
normal is (cop)
time event (nmod)
requires diagnosis (nsubj)
methodology measured (appos)
cholestasis azathioprine-induced (amod)
demonstrates and (cc)
associated beta-blockers (nmod)
side-effect potential (amod)
following months (nmod:npmod)
6-thioguanine to (case)
that sevoflurane (nmod)
sulphate . (punct)
electro-oculography patients (nmod)
addition dexamethasone (nmod)
seems myoclonus (nsubj)
mssbp ( (punct)
salicylates or (cc)
volume equal (amod)
initiate pge2 (nsubj)
boy developed (acl:relcl)
difference beta-blocker (nmod)
scleroderma extensive (amod)
cells/mm3 and (cc)
catheter an (det)
mm 13.1 (nummod)
randomised groups (nmod)
rest stimulation (conj)
prolongs vitro (advmod)
intervals various (amod)
given were (auxpass)
current previous (conj)
prevented fashion (nmod)
found playing (xcomp)
= .0015 (dobj)
alcalinization possibly (advmod)
pain typical (amod)
duration mean (amod)
studied or (advmod)
suggest findings (nsubj)
thrombosis hazard (nmod)
administered methods (nsubjpass)
injection after (case)
consumption e.g. (advmod)
$ROOT$ epilepsy (sent)
observed increased (advcl)
observed proliferation (nsubjpass)
tie2-cre;loxp-egfp in (case)
corrected completely (advmod)
patients service (nmod)
microinjections gamma-vinyl-gaba (nmod)
hypersensitivity stimulation (nmod)
enantiomer pregs (compound)
del and (cc)
less ( (punct)
observations vasculature (nmod)
injury due (case)
area retrobulbar (amod)
normal concentration (nsubj)
titer the (det)
determination patients (nmod)
marrow hyperplastic (amod)
morphine mg (appos)
induced 5-azacytidine (nmod)
suggests prescribe (ccomp)
treatment effective (amod)
order a (det)
62.0 ) (punct)
chemotherapy intrathecal (amod)
lethality cocaine-induced (amod)
ng/ml 129 (nummod)
host drugs (nmod)
revealed hemoglobin (dobj)
anomalies fetal (amod)
performance exercise (compound)
12/32 p<0.001 (appos)
drive sympathetic (amod)
implanted cannulae (nmod)
amns such (case)
signals alter (acl:relcl)
required doses (dobj)
which during (case)
flexion/extension neck (nmod)
lasted min (dobj)
influenced hyperactivity (nsubjpass)
component response (nmod)
pathway p38 (compound)
show we (nsubj)
losses compartment (nmod)
rate important (amod)
one two (conj)
nephrotoxicity b. (nmod)
negative denied (conj)
trimethaphan mg/kg (appos)
noted . (punct)
avoided use (nsubjpass)
aldosterone plasma (compound)
l/kg od (nmod)
ku70 and (cc)
suggest seem (advcl)
study microdialysis (compound)
tremor problems (conj)
or ] (punct)
reviewing history (dobj)
sensitive less (advmod)
found areas (nsubjpass)
children ( (punct)
questions decrease (acl)
daytime night-time (conj)
increase isoproterenol-induced (amod)
ulceration produced (acl)
tonus inhibited (amod)
tested then (advmod)
independently microalbuminuria (nmod)
known both (dep)
pneumonia two (nummod)
dehydrogenase and (cc)
helps implant (nsubj)
assessed risk (dobj)
encoding associations (dobj)
azotemia major (amod)
determined clearance (conj)
rats investigated (acl)
retrieval animals (nmod)
appear neurons (nsubj)
disease % (appos)
resolved use (nmod)
signs no (det)
hour ingestion (nmod)
syndrome observed (amod)
cue the (det)
girl 5-year (compound)
> years (nmod:tmod)
calculi ureteric (amod)
infusions randomized (amod)
somnolence with (case)
showed cats (nsubj)
0.887 0.426 (nummod)
moles/glomerulus % (conj)
neurons dopamine (compound)
matched children (nmod)
dysfunction solvd (appos)
virus b (compound)
patients on (case)
universitaetsmedizin - (punct)
divided studied (conj)
progressing death (nmod)
subject for (case)
kidney solitary (amod)
patients remained (acl:relcl)
kpa 10.5 (nummod)
male 3-year-old (punct)
doses/day 3 (nummod)
catheterization for (case)
devices plus-maze (compound)
limit to (mark)
enhances learning (dobj)
departments to (case)
led that (nsubj)
presents emergency (nmod)
0.86 +/- (cc)
diluted ml (nmod)
way features (nmod)
inhibited but (cc)
$ROOT$ received (sent)
activity cortical (amod)
ncq436 with (case)
known nephrotoxic (xcomp)
reversed naloxone (nsubj)
mmhg to (case)
specimens tg (nmod)
failure caused (acl)
recommended observation (nsubjpass)
channels hcn (compound)
study dose-response (amod)
2190 +/- (cc)
insufficiency transplantation (nmod)
represents ; (punct)
mediated be (cop)
actions cardiac (amod)
knockdown nrf2 (nmod)
nephrotoxicity outcome (conj)
conjugates copolymer (compound)
frequency class (nmod)
urine the (det)
sedation ketamine (compound)
mg 1.5 (compound)
patients seventy (nummod)
touch of (case)
urticaria/angioedema caused (acl)
necessary cases (nmod)
frequency attack (compound)
efficacy favorable (amod)
were differences (conj)
all ( (punct)
dropped kinase (nsubj)
toxicities injury (appos)
indicating homozygocity (dobj)
500 , (punct)
comprising patients (dobj)
interaction drug-drug (amod)
regardless duration (nmod)
doses threshold (amod)
0 5.7 (prep)
inhibit occurrence (dobj)
disorders are (cop)
use deprivation (conj)
exacerbations possible (amod)
interrupted follow-up (nmod)
increased p75(ntr)-ir (punct)
properties antinociceptive (amod)
csa drugs (conj)
reported higher (conj)
synthesis this (det)
decrease % (dep)
use pravastatin (nmod)
receiving receiving (conj)
toxicities normal (amod)
pathophysiology lids (nmod)
anxiety enhanced (amod)
suggest but (cc)
ntg ) (punct)
withdrew subjects (nsubj)
amisulpride- and (cc)
rats foster (amod)
transporter ut-a1 (appos)
dose fixed (amod)
filaments of (case)
ascertained were (auxpass)
zidovudine to (case)
factors or (cc)
classified is (auxpass)
revealed echocardiography (nsubj)
decreased then (advmod)
movement right (amod)
microglia the (det)
disease hypertensive (amod)
imbalance metabolic (amod)
elevation map (compound)
maculatum conium (compound)
cancer from (case)
autoimmune and (cc)
coronary aortofemoral (conj)
determined series (nmod)
history encephalopathy (nmod)
plays receptor (nsubj)
induced ziprasidone (nmod)
day pnd (appos)
prescribed commonly (advmod)
4.9 - (advmod)
eligible , (punct)
inhibition non-selective (amod)
factor delirium (nmod)
microgram/kg/min . (punct)
surgery sections (nmod)
responsibility abnormalities (nmod)
caused decreases (dobj)
scatter forward (amod)
literature pertinent (amod)
agent metformin (nsubj)
p=0.48 ) (punct)
injury surrounding (amod)
testing for (mark)
inhibited hand (nmod)
survivors long-term (amod)
lower reported (advcl)
dose considering (advcl)
performed % (nmod)
values predictive (amod)
decrease resistance (nmod)
sulpiride d-2 (compound)
fas ( (punct)
adjusted death (dep)
increase compensatory (amod)
swings with (case)
changes were (cop)
increased % (nmod)
used had (advcl)
woman-years 1,000 (nummod)
groups drug-free (amod)
have ability (dobj)
modulate represent (conj)
10 42 (conj)
method searched (appos)
vasoconstriction coronary (amod)
unassigned : (punct)
propose exceed (ccomp)
demonstrate imaging (nsubj)
magnitude decrease (conj)
changes nfs (nmod)
% -20.1 (nummod)
biopsy renal (amod)
greater being (cop)
reversed indicating (advcl)
done replacement (nmod)
level measured (acl)
effects lesions (nmod)
period therapy (nmod)
syndrome sulphasalazine (compound)
neutropenia organization (compound)
administered s-53482 (nsubjpass)
neuropathy polyneuropathy (conj)
resulted one (nsubj)
apap plasma (nmod)
bradyarrhythmia of (case)
differ placebo (nmod)
reversed phenomenon (nsubjpass)
mg. 6 (nummod)
risks medical (amod)
bupivacaine dogs (nmod)
levels microgram/ml (nmod)
propranolol as (cc)
change pressure (dobj)
regions underperfusion (nmod)
use heparin (nmod)
reduction mg/kg (nmod)
ee by (case)
lipids myocardial (amod)
terms values (nmod)
lesions patients (nmod)
susceptible however (advmod)
had months (nmod:tmod)
decrease patients (nmod)
content prolactin (compound)
test challenge (compound)
substrate probe (compound)
unchanged decreased (parataxis)
infusions aminophylline (nmod)
magnitude prevent (acl)
77.1 18.9 (conj)
blocking jerks (dobj)
clinical routine (amod)
complete respectively (advmod)
cardiotoxicity characterized (acl)
l/hour/m2 was (cop)
assess occurrence (dobj)
stress early (amod)
striatum in (case)
causes suprofen (nsubj)
liver a (det)
followed report (nsubjpass)
cortex associated (amod)
was 7 (nmod)
suxamethonium mivacurium (conj)
function mesangial (amod)
months per (case)
reduced able (conj)
tolerability . (punct)
triggered whom (nmod)
cisplatinum of (case)
score : (punct)
alkaloid aconitine (nsubj)
activity content (conj)
showed treatment (nmod)
reductions or (cc)
interact channels (nmod)
become poor (conj)
lost follow-up (nmod)
norepinephrine infused (amod)
monitoring , (punct)
performance learning (compound)
lithium disrupting (dep)
20 less (advmod)
discussion cause (dep)
formation crosslink (compound)
users all (det)
animals hypertensive (amod)
injection first (amod)
confirmed findings (nsubjpass)
worsened responded (conj)
$ROOT$ influences (sent)
concentration vs. (cc)
aes ( (punct)
suggests increase (nsubj)
induced bepridil (nsubj)
corticosteroids and (cc)
conditions predisposing (acl)
available were (cop)
begin to (mark)
increased 0.01 (dep)
induced calcineurin-inhibitor (nmod:npmod)
system renin-angiotensin (amod)
reporting dysfunctions (dobj)
preceded is (auxpass)
3.49 . (punct)
hours 3 (nummod)
anesthesia high-dose (amod)
lasted shorter (advmod)
injection collagenase (nmod)
methods different (amod)
two about (advmod)
move to (mark)
asked aim (xcomp)
parts ( (punct)
suggest leads (ccomp)
simulator ( (punct)
black frequently (advmod)
relevant which (nsubj)
pastes certain (amod)
to due (amod)
mg/kg 57.7 (nummod)
ovarian tube (conj)
phenytoin lorazepam (conj)
mouth throat (conj)
inhibitors enhance (acl:relcl)
effect peptides (nmod)
premedicated scopolamine (nmod)
reductions fraction (nmod)
pressure less (dep)
than groups (nmod)
responsible metabolite (nsubj)
35.6 28.3 (conj)
neuropathy warfarin-induced (amod)
animals seventeen (nummod)
trial 12-week (amod)
nitrite ppm (amod)
nonselective , (punct)
dysfunction nmda (compound)
blockade due (case)
initiated starting (xcomp)
provided preexposure (nsubj)
carried where (advmod)
presence intensities (nmod)
hyponatremia significant (amod)
phenylephrine by (case)
50 +/- (cc)
cddp ) (punct)
suggests antagonism (nsubj)
infection cured (conj)
6-ohda-lesioned treated (conj)
patterns nag (compound)
ability umax (appos)
bottle pemoline (nmod)
infused dogs (nmod)
multiforme syndrome (conj)
changes volume (nmod)
measured rigidity (nmod)
2.4 ci:0.7 (compound)
frequent less (advmod)
$ROOT$ retention (sent)
dosing d-tubocurarine (nmod)
studies between (case)
35 , (punct)
dox with (case)
dose at (case)
$ROOT$ divided (sent)
performed fasciotomies (nsubjpass)
receptors peripheral (amod)
ischemia induced (acl)
afflicted be (auxpass)
microgram.kg-1.min-1 0.1 (nummod)
injected min (nmod)
patients undergo (acl:relcl)
resistance the (det)
synthesis such (amod)
node lymph (compound)
disease ad (appos)
tetra- and (cc)
randomised women (nsubjpass)
succinylcholine before (case)
hydrochloride referred (acl)
received h. (conj)
1.6 ci (nsubj)
loss no (det)
radiotherapy = (dep)
reactions cerebral (amod)
occur although (mark)
choreoathetosis report (dep)
dexamethasone sedionbel (appos)
migraine migraine (conj)
seizure an (det)
effectiveness indication (nmod)
decreased 255 (nmod)
group schizophrenia (compound)
ventricles into (case)
bilirubin bilirubin (conj)
parameters necessary (amod)
evaluated belgium (nmod)
0.28 0.004 (conj)
1.98 0.98 (quantmod)
change sensitivity (nmod)
content but (cc)
$ROOT$ bortezomib (sent)
conditions required (acl:relcl)
depletion by (case)
synthesis cells (nmod)
administration mk-801 (nmod)
developed injection (nmod)
given micrograms/kg/d (nsubjpass)
resulted injections (nsubj)
patients hospitalised (acl)
structure cardiac (amod)
apical and (cc)
paramount institution (nmod)
calcification to (case)
drug , (punct)
nerve proximal (amod)
day hospitalization (nmod)
discontinued therapy (dobj)
important results (nsubj)
percent 3 (nummod)
consequences biochemical (amod)
fields rheumatology (nmod)
easy stable (conj)
probable possible (conj)
delineated not (neg)
effects tetrachloride (nmod)
$ROOT$ mania (sent)
$ROOT$ typical (sent)
patients fractions (nmod)
% 0.01 (conj)
given vehicle (dobj)
sustained is (cop)
recommended baseline (nmod)
colony-stimulating granulocyte (nmod:npmod)
complete = (dep)
fragmentation internucleosomal (amod)
interval 5.124 (appos)
study pet (amod)
antagonist caffeine (nsubj)
reflex a (det)
factors ( (punct)
pronounced effects (nsubj)
children immunodeficiency (compound)
basis weight (compound)
concentration avp (nmod)
premedication after (case)
mm times (nummod)
locomotion spontaneous (amod)
likely expression (nsubj)
results caused (appos)
antigen virus (compound)
modulated can (aux)
diet same (amod)
7.5 0 (nummod)
woman 37-year-old (amod)
embryopathy hypoplasia (nmod)
inhalation , (punct)
accepted pathogenesis (nmod)
production treatments (nmod)
giving lithium (dobj)
involves vessels (dobj)
leukopenia 1 (appos)
induced tilts (nsubj)
rats memory (compound)
purpura extremities (nmod)
evidenced . (punct)
ed of (case)
dose ed(50 (appos)
unresolved . (punct)
0.070-unit , (punct)
overshooting an (det)
acetylsalicylate of (case)
bornstein ( (punct)
method applied (dep)
isotretinoin , (punct)
modified gender (nmod)
saralasin by (case)
produced levels (dobj)
multifactorial are (cop)
disappear tinnitus (nsubj)
men 74 (nummod)
time average (amod)
increased continued (conj)
3r-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane ( (punct)
april 1994 (nummod)
characteristics , (punct)
mg/kg p.o. (conj)
lost response (nsubjpass)
allopregnanolone only (advmod)
toxicity report (conj)
performed investigate (xcomp)
interactions such (case)
reversible administration (nmod)
mustard administrated (acl)
l6 s1 (conj)
study entire (amod)
clarified . (punct)
agent cisapride (appos)
trial day (nmod)
response no (det)
microscopy experiments (conj)
precipitated amounts (nmod)
caused cddp (nmod)
genes in (case)
preserved potentiation (nsubj)
$ROOT$ rate (sent)
assess changes (dobj)
clearance because (case)
period recovery (compound)
patients mc (compound)
related dynamics (nmod)
alternation cent (amod)
pain diffuse (amod)
troponin cardiac (amod)
test pa (appos)
bromocriptine hyperprolactinemia (nmod)
those induced (acl)
rescue antiemetic (amod)
organs most (amod)
$ROOT$ regulated (sent)
observed applicators (nmod)
wall artery (compound)
doses amphetamine (nmod)
evidence supporting (acl)
examined epilepticus (nmod)
effects maximum (amod)
disease from (case)
seizure rats (nmod)
nicotine between (case)
didanosine of (case)
seemed treatment (nsubj)
contaminants , (punct)
longer t (nsubj)
snr of (case)
found earlier (advmod)
up-regulation expression (nmod)
therapy octreotide (compound)
updrs ( (punct)
support colony-stimulating (amod)
enhance . (punct)
developed to (mark)
obtained milliliters (nsubjpass)
play anions (nsubj)
prodrug phenytoin (compound)
angiography discharge (nmod)
$ROOT$ predated (sent)
punctata ( (punct)
treated clomipramine (nmod)
assessable toxicity (nmod)
apoptosis or (cc)
wild-type not (cc)
results all (predet)
pc or (cc)
protection cardiac (amod)
doses co-trimoxazole (nmod)
expression cytokine (compound)
bolus or (cc)
nucleus pontine (compound)
blockade mglur1 (nmod)
administration concurrent (amod)
emphasis characteristics (nmod)
$ROOT$ receive (sent)
level-dependent bold (dep)
anemia blockade (compound)
increases more (advmod)
indicate acts (ccomp)
cta negative (amod)
employed deviation (dep)
smaller was (cop)
is intervention (attr)
compared groups (nmod)
edema patients (nmod)
relevant may (aux)
administered appropriately (advmod)
hepatitis and (cc)
diamorphine and (cc)
osteoporosis of (case)
cvvhdf ( (punct)
type inducible (amod)
showed inhibition (dobj)
drugs related (amod)
solution dextrose (compound)
desogestrel ) (punct)
number level (conj)
immunoreactivity a (det)
infusion venous (amod)
$ROOT$ potentiate (sent)
85 , (punct)
chemotherapy containing (acl)
subjects for (case)
21.6 2.2 (conj)
1a1/1a2 2b1/2b2 (conj)
showed infiltrate (dobj)
diet in (case)
increases bp (dobj)
recognize and (cc)
exposed vincristine (nmod)
factor-i human (amod)
arrest possible (amod)
groups groups (appos)
underwent while (conj)
mediated centrally (advmod)
modulate could (aux)
induce and (cc)
tetra- cb (compound)
appeared dogs (nmod)
increased cells (dobj)
integrity function (conj)
combination after (conj)
bicuculline , (punct)
have likely (conj)
aggression particularly (advmod)
received 11/41 (conj)
doses following (case)
due deficiency (nmod)
banned lack (nmod)
hepatotoxicity malaise (conj)
patients thirty-six (nummod)
t1/2 lp (nmod)
accounts necrosis (nmod)
described treatment (nmod)
regions four (nummod)
nitroglycerin up (advmod)
350 300 (compound)
synthesis cholate (nmod)
data pooled (amod)
administered chloride (nsubjpass)
faced victim (nmod)
acid free (amod)
infiltration or (cc)
found majority (nsubjpass)
exclude in (mark)
mg/kg/day 5 (nummod)
epidemiology . (punct)
green to (case)
0.96 ; (punct)
increased progressively (advmod)
normal of (case)
margin lower (amod)
resuscitation at (case)
potencies local (amod)
provoked : (punct)
was transport (nmod)
suppressed also (advmod)
linked whether (mark)
secretions oropharyngeal (amod)
ratio lower (amod)
narrowed . (punct)
use progesterone (nmod)
measured completion (nmod)
accumulation and (cc)
groups age (compound)
failure thrombocytopenia (conj)
discharged . (punct)
combination mtx (dep)
45 < (advmod)
increase % (nmod)
provided assay (nsubj)
used still (advmod)
developed respectively (advmod)
prophylaxis development (nmod)
deficiency local (amod)
defects for (case)
cognitive subjective (conj)
cause possible (amod)
studied responses (nsubjpass)
treatment w-ich (nmod)
reactivity in (case)
given min (nmod)
potential therapeutic (amod)
palsy with (case)
hyperkalemia of (case)
symptoms clinical (amod)
fluctuations disabling (amod)
added therapy (nmod)
urge caution (dobj)
prospective clinical (dep)
3 weeks (nmod)
group working (amod)
subacute onset (nsubj)
bpo to (case)
causes stz (nsubj)
effective initially (advmod)
consequence major (amod)
hypertrophy heart (compound)
hours and (cc)
questionnaires updrs (compound)
changed morphine (nmod)
rhythm normal (amod)
reduce elevation (dobj)
movements related (acl:relcl)
group = (parataxis)
seen result (ccomp)
ctnt with (case)
inhibition inhibition (appos)
uptake 36cl- (compound)
paralleled . (punct)
delirium fatal (amod)
edema desmosomes (nmod)
nature its (nmod:poss)
1967 between (case)
returned thereafter (advmod)
experienced exposed (parataxis)
antinociception (+/-)-pg-9 (compound)
unrelieved was (auxpass)
$ROOT$ g. (sent)
plan of (case)
phosphorofluoridate mg/kg (appos)
expression ii (nummod)
ibuprofen mg (amod)
reaction heparin (nmod)
degeneration behind (case)
behaviors anxiety-like (amod)
role oxidase (nmod)
micrograms and (cc)
provided course (dobj)
inconclusive were (cop)
infusion iv (nummod)
developed cancer (dobj)
prolactin overall (amod)
produced attributed (parataxis)
rats dex-treated (amod)
cows control (compound)
adenocarcinoma years (nmod)
hips-cms ( (punct)
survival long-term (amod)
= 0.045 (dobj)
methods enrolled (appos)
receiving bort-dex (dobj)
adducts liver (compound)
had side (nmod)
systems these (det)
symptomatology parkinsonian (amod)
through possibly (advmod)
pretreated . (punct)
ischemia hypotension-mediated (amod)
group affected (amod)
intervals the (det)
suspected discontinued (conj)
la with (case)
headache hemiparesis (conj)
methylation of (case)
years representing (acl)
$ROOT$ questionnaires (sent)
loss memory (compound)
mg/kg 190 (nummod)
dogs group (nmod)
dose 30-mg (compound)
dogs anaesthesia (nmod)
six mg/m2 (conj)
mg/dl 5.4 (nummod)
injection pan (compound)
prolonged may (aux)
japan such (case)
operated interna (nmod)
declined levels (nsubjpass)
comparing motility (dobj)
described previously (advmod)
increase dyskinesia (nmod)
discriminated sensitivity (dep)
protection cardiotoxicity (nmod)
glomeruli atubular (amod)
carbamazepine with (case)
propranolol low-dose (amod)
words other (amod)
levels decreasing (advcl)
dosage ) (punct)
report leading (acl)
female 10 (nummod)
risk without (case)
erythropoietin rhuepo (appos)
lvef the (det)
protein aqp2 (compound)
usually ; (punct)
blocker cnsb002 (appos)
neutropenia severe (amod)
evidenced as (mark)
reports transplantation (nmod)
dealt when (advmod)
receives pallidus (nsubj)
demonstrated could (aux)
placebo -14.6 (dep)
= 57 (dobj)
8 every (quantmod)
physician skilled (amod)
observed experienced (conj)
ngal ( (punct)
children 9 (nummod)
develop when (advmod)
% 9.9 (nummod)
impact nifedipine (nmod)
established correlation (nsubj)
glycopyrrolate either (cc:preconj)
transplantation hematopoietic (amod)
mg 150 (nummod)
r. , (punct)
activities transaminase (nmod)
mrna expression (conj)
mechanism with (case)
levels mhb (compound)
cq ) (punct)
hypothesized prevented (ccomp)
exert ways (nmod)
reverse prevent (conj)
undertaken is (auxpass)
0.90 than (case)
danger use (nmod)
meet , (punct)
erythrocytes from (case)
eosinophilic ( (punct)
anesthetized . (punct)
tgf- in (case)
receiving transplantation (dobj)
remained globulin (nsubj)
686 362 (conj)
interference of (case)
p<0.0005 vs. (cc)
hematologic biochemical (conj)
up with (case)
arthritis osteoarthritis (conj)
clotiazepam benzodiazepines (conj)
participates activity (nmod)
disease nerve (compound)
mediated that (nsubjpass)
supplementation acid (compound)
gssg ( (punct)
detected qrt-pcr (nsubj)
pills " (punct)
costs difficulty (conj)
compared results (dobj)
metabolites reactive (amod)
mice balb/c (compound)
provided antagonists (nmod)
glucagon of (case)
that patients (nsubj)
part diagnosis (nmod)
iraq from (case)
deprived drive (nmod)
khz 18 (nummod)
reduce increases (dobj)
2e1 cytochrome-p450 (compound)
association commencement (nmod)
evaluated b (nmod:npmod)
dissolution partial (amod)
observed relative (advmod)
incidence estimated (amod)
correlated force (nmod)
reported history (dobj)
is excitability (attr)
tbil serum (compound)
incontinence with (case)
simple sustained (conj)
happiness marital (amod)
adhd childhood (compound)
exposure cocaine (nmod)
epinephrine with (case)
subsequent initiation (nmod)
amelioration and (cc)
[ca]o of (case)
area study (compound)
misoprostol micrograms (appos)
8.75 or (cc)
bolus ( (punct)
eliminated which (nsubj)
usual that (mark)
movements as (case)
properties anti-inflammatory (amod)
had years (conj)
generated . (punct)
selection to (case)
assessed : (punct)
cacl(2)-untreated n=12 (dep)
total ; (punct)
showed similarity (dobj)
nodosa classical (amod)
compare characteristics (dobj)
female underwent (acl:relcl)
cystitis radiation (conj)
docetaxel or (advmod)
difficult patients (nmod)
system and (cc)
3.8 2.7 (compound)
ii to (dep)
administration metronidazole (compound)
$ROOT$ injected (sent)
had increased (conj)
detected level (nsubjpass)
drowsiness and (cc)
intolerance and (cc)
[3h]-naloxone nm (appos)
infections for (case)
hypertrophy with (case)
anatomical functional (conj)
elicits response (dobj)
hemodynamic metabolic (conj)
developed tachycardia (nsubj)
proliferated replacing (advcl)
spv hypotension (nmod)
arrhythmia adrenaline-induced (amod)
lymphoma lymphoplasmacytic (amod)
platelets from (case)
hazard the (det)
bonding ester (compound)
study conclusion (compound)
prolongation pointes (conj)
4 6 (conj)
noted shifts (nsubjpass)
declined pressure (nsubj)
lesions brain (compound)
carcinogenesis forestomach (compound)
secretion overall (amod)
ptcr between (case)
patients group (appos)
glioblastoma recurrent (amod)
induction ku70 (nmod)
demonstrate add (conj)
offer future (nmod)
demonstrate induces (ccomp)
studies imaging (compound)
june december (conj)
use comparison (dep)
changes gene (compound)
peroxidation and (cc)
hypercalcemia carbonate-induced (amod)
agents anti-inflammatory (amod)
increased motility (dobj)
eu , (punct)
= 48 (dobj)
initiation wk (nmod:npmod)
injection mg/kg (appos)
usually limits (nmod)
dopaminergic frontostriatal (amod)
improves or (cc)
bradycardia therapy (nmod)
infusions i.v. (amod)
blocked recovery (nsubjpass)
keeping patients (nmod)
performed biopsy (nsubjpass)
accompanied cases (nmod)
h mcao (dep)
developed paradoxically (advmod)
levels blood (nmod)
mpep antagonist (appos)
november to (case)
elevated platform (nsubjpass)
times respective (amod)
given gm (dobj)
characterized onset (nsubjpass)
antagonist type (compound)
affect may (aux)
aprotinin , (punct)
revealed : (punct)
receptors complement (compound)
underwent users (nsubj)
available efficacy (nmod)
levels lv (compound)
documented development (nsubjpass)
drugs to (case)
patient exercise (nmod)
3.2 versus (cc)
serving control (nmod)
2 > (amod)
$ROOT$ witnessed (sent)
binding in (case)
% 8.95 (nummod)
layer a (det)
interest considerable (amod)
therapy methotrexate (compound)
glomerulonephritis positive (amod)
significant and (cc)
rats pubertal (amod)
treatment vt (nmod)
patient diagnosis (nmod)
dosed . (punct)
related differences (nsubj)
surgical in (case)
infusion stab (conj)
ctni ) (punct)
mg/ml 0.5 (compound)
strongly most (advmod)
bradycardia on (case)
placebo n=100 (dep)
changes haemodynamic (amod)
kg-1 micrograms (amod)
s to (case)
square the (det)
0.001 less (advmod)
involvement systemic (amod)
age range (dep)
mg 500 (nummod)
comparisons four (nummod)
32.4 1.7 (compound)
cost usage (nmod)
doses valdecoxib (compound)
molecule intact (amod)
tremor patients (nmod)
observed risperidone (nmod)
hemodynamics systemic (amod)
nimodipine mg/h (amod)
ne basd (compound)
ketamine solution (conj)
protection partial (amod)
was if (mark)
infection virus (nmod)
types such (amod)
machr ) (punct)
time night (compound)
described % (dobj)
symptoms different (amod)
some only (advmod)
speed in (case)
induced implants (nmod)
reported ; (punct)
proliferation hematopoietic (amod)
obtained humans (nmod)
volume saline (nmod)
responded patients (nsubj)
had screening (nsubj)
brain cord (conj)
cases anemias (nmod)
0.26 1.63 (prep)
call interference (nsubj)
case disorder (nmod)
vision his (nmod:poss)
ratio bax/bcl-2 (compound)
birth vaginal (amod)
damages but (cc)
mice dba/2j (compound)
0.48 versus (cc)
production enzymatic (amod)
gain pursuit (compound)
repeated should (aux)
observed bleeding (nsubjpass)
larger proportionally (advmod)
access(r immunoassay (conj)
progress investigations (nsubj)
represent drug (dobj)
caused it (nsubj)
advanced as (cc)
or=12.619 , (punct)
abnormalities wave (compound)
types cell (compound)
withdrawal azathioprine (compound)
micrograms/kg/hr 40 (nummod)
noted levels (nmod)
l t (conj)
kidney the (det)
dysfunction allograft (compound)
severity p (dep)
suspected , (punct)
concentration minimum (compound)
produce profile (nsubj)
associated commonly (advmod)
hospitalised two (dep)
sensation pinprick (compound)
pcos ( (punct)
lower less (dep)
trial and (cc)
ventilatory and (cc)
stopped as (mark)
followed again (advmod)
helpful is (cop)
cause hypokalemia (dobj)
period pretreatment (amod)
report rechallenge (nmod)
concentrated p (dep)
count or (cc)
dmso/side ( (punct)
infiltrate with (case)
swelling significant (amod)
brain maternal (amod)
91.2 . (punct)
gangrene with (case)
colocalized rats (nmod)
stimulation alternative (dep)
review with (case)
creatinine ) (punct)
acetylcholinesterases aches (appos)
solid haematological (conj)
provoked that (nsubj)
undertaken review (nsubjpass)
desire criteria (nsubj)
infarct and (cc)
abusers of (case)
declines acute (amod)
median a (det)
paracetamol/day with (case)
have levels (dobj)
resulting anemia (nmod)
nfkappab ) (punct)
indicate found (ccomp)
improvement despite (case)
pharmacists unknown (amod)
institutions 15 (nummod)
propofol compared (case)
pregnant especially (advmod)
adhd ) (punct)
patients complaints (nmod)
acid tranexamic (amod)
nsclc in (case)
treating , (punct)
inhibitors tacrine (dep)
dysfunction hyperlipidemia (conj)
failure concentrations (nmod)
analysed fraction (nsubjpass)
reported successful (xcomp)
evaluated improves (advcl)
bleeding the (det)
mg/d 100 (nummod)
factors properties (nmod)
disruption persistent (amod)
demonstrated responders (nsubj)
psoriasis for (case)
biochemical indices (dep)
system antioxidant (amod)
vacuolization glomerulosclerosis (conj)
defined reductions (nmod)
attribute use (nmod)
frequency increasing (amod)
challenging be (cop)
successful to (mark)
% vs (cc)
rendered , (punct)
adenocarcinomas pas (appos)
halothane suxamethonium (conj)
titrated was (auxpass)
mm 5 (compound)
provided that (mark)
sensation touch (nmod)
stopped insertion (nmod)
disorders in (case)
co. shin-poong (compound)
depend and (cc)
conclusion describes (appos)
monitored h. (nmod)
isg to (case)
angina prinzmetal (nmod:poss)
had pallidotomy (nmod)
preoperatively and (cc)
0.05 group (conj)
instituted therapy (nsubjpass)
disorientation irritability (conj)
resulted termination (nsubj)
marked . (punct)
increase chewing (nmod)
seizures no (neg)
appear alterations (nsubj)
continued application (dobj)
strain a (det)
treatment for (case)
maze apparatus (conj)
manifestation : (punct)
decreased 0.4-fold (conj)
salts acid (compound)
show these (nsubj)
lines promising (amod)
selection compartments (nmod)
administration dexmedetomidine (nmod)
thrombosis associated (acl)
mg/kg/daily ) (punct)
induced pan (nmod:npmod)
surge steroid-induced (amod)
pathophysiologic metabolic (conj)
results completed (appos)
administration due (case)
mrnas of (case)
suspected because (mark)
effects which (det)
mg 3000 (nummod)
proof observations (nsubj)
procedure before (case)
collected still (advmod)
intake activity (conj)
indomethacin mg/day (nmod)
type a (det)
loss resistance (nmod)
mg/m2 at (case)
aroused instances (nmod)
hit thrombosis (nmod)
susceptible treatment (nmod)
impairs stimulation (nsubj)
conclusions suggest (appos)
included change (dobj)
content urinary (amod)
developed became (conj)
considering remains (ccomp)
135 + (compound)
mineralocorticoid salt (conj)
carvedilol , (punct)
medicine of (case)
20 ten (quantmod)
orbitofrontal lateral (amod)
n=6 ) (punct)
inhibited re (nsubj)
improvement in (case)
1 least (advmod)
seizures % (compound)
applied duration (dep)
p all (det)
mul saline (nmod)
significance strategy (conj)
history his (nmod:poss)
considered persisted (conj)
effects behavior (nmod)
toxicity methotrexate (compound)
open question (nsubj)
unclear utility (nsubj)
polymerase of (case)
needle 25-gauge (compound)
revealed associated (conj)
appropriate elderly (nmod)
ranged , (punct)
reversed conclusion (nmod)
improve switching (csubj)
stages events (nmod)
associated incidence (nmod)
therapy anemia (nmod)
agents duration (nmod)
9.4 +/- (cc)
cpb before (nmod)
have cardiomyopathy (dobj)
rats infant (amod)
property a (det)
favourable . (punct)
proceeded surgery (nsubj)
tumor-free or (cc)
expressed transiently (advmod)
users drug (compound)
$ROOT$ mild (sent)
replaced is (aux)
carcinogenesis on (case)
injected mug (nsubjpass)
presentation hemodynamic (dep)
amnesia cycloheximide-induced (amod)
confirmed results (nsubj)
users tested (amod)
toxicity drug-induced (amod)
incubated l-arginine (nmod)
schedule fda-approved (amod)
actions phenytoin (nmod)
analgesia iv (nummod)
markers ( (punct)
measuring ii (dep)
therapy zidovudine (compound)
factor may (aux)
gauges with (case)
be ) (punct)
reviewed receiving (advcl)
documented woman (nmod)
methamphetamine ma (appos)
alters behaviors (dobj)
mg than (case)
1.1 0.8 (nummod)
damage related (amod)
form dyskinesia (nmod)
induced injections (nmod)
$ROOT$ aggregation (sent)
adding thalidomide (dobj)
nitrogen blood (compound)
examined ; (punct)
osmolality reabsorption (conj)
induced furthermore (advmod)
dystonia . (punct)
clozapine- both (cc:preconj)
effective mg (nmod)
block exit (compound)
appear thus (advmod)
$ROOT$ unknown (sent)
consumption phenacetin (nmod)
pressure with (case)
sensitivity [ (punct)
meta-analysis in (case)
unnecessary antisialogue (nsubj)
$ROOT$ metabolism (sent)
results absorption (nmod)
administered period (nmod)
amplitude the (det)
episodes thromboembolic (amod)
necessary are (cop)
i antigens (dep)
found after (mark)
vessels arterial (amod)
given infusion (nmod)
july 1997 (nmod:tmod)
pronounced effect (nsubj)
progression injury (nmod)
mg/week 2.13 (nummod)
injected was (auxpass)
protein . (punct)
glomerulopathy the (det)
60 - (dep)
polymerase dnap (appos)
represented thus (advmod)
test antiglobulin (amod)
spasm relieved (acl)
lipoproteins found (acl)
induced myodystrophy (dobj)
% 10.5 (nummod)
benefits spironolactone (nmod)
present focus (xcomp)
neurotoxicity methamphetamine-induced (amod)
modulators these (det)
tended however (advmod)
drug new (amod)
investigated mechanism (nsubjpass)
involves antagonist (conj)
collagenase of (case)
reasons other (amod)
medium than (case)
expression growth-associated (amod)
causes freezing (dobj)
became methylprednisolone (nsubj)
initiate micturition (dobj)
used studied (conj)
polyvidone endografine (conj)
perform determinations (dobj)
referral or (cc)
diuresis solute (compound)
defined akathisia (nsubjpass)
lf ) (punct)
antibiotics lactam (compound)
appeared also (advmod)
variables videofluoroscopic (amod)
markers as (case)
level retinal (amod)
hyperprolactinemia chronic (amod)
hypokalemia hctz (nmod)
hydrobromide antagonist (compound)
assay the (det)
doxorubicin the (det)
test inhibition (compound)
condition compared (case)
animals on (case)
report case (nsubj)
disorders acute (amod)
fact occur (ccomp)
administration ages (nmod)
ci 1.22 (dep)
attack acute (amod)
pitfall findings (conj)
reduction ie (advmod)
important less (advmod)
enzyme-1 endothelin-converting (amod)
119 mmhg (dep)
reported ever (advmod)
reviving . (punct)
confusion , (punct)
euthanized 12weeks (nmod)
h-1 micrograms (nummod)
latency in (case)
p right (dep)
associated administration (nsubjpass)
tests serum (compound)
catalepsy in (case)
frequency beats (nmod)
antibiotic beta (compound)
1995 early (amod)
found previously (advmod)
mortality excess (amod)
risk hyperkalemia (nmod)
induced prl-r (nsubjpass)
reverting partially (advmod)
efficacy disorder (nmod)
15/hypertension reperfusion (appos)
gain smooth (amod)
decreased fk (nsubj)
evaluated tnss (nmod)
diagnosis , (punct)
rhuepo ) (punct)
sectors ca1 (compound)
describes objective (nsubj)
bicarbonate of (case)
observed months (nmod)
effect during (case)
presented hospital (nmod)
higher relatively (advmod)
caused chemotherapy (nsubj)
conjugates : (punct)
spasm paradoxical (amod)
flow coronary (amod)
captopril from (case)
observed cimetidine (nmod)
recognition thrombocytopenia (nmod)
range minutes (nmod)
7.25 to (quantmod)
epilepticus by (case)
control obscure (conj)
angiograms 3,774 (nummod)
given begun (advcl)
subgroups two (nummod)
43 to (dep)
result : (punct)
controls angina (dobj)
time ended (acl:relcl)
interest growing (amod)
relationship causal (amod)
completed have (aux)
forced flow (xcomp)
applying approaches (dobj)
dose clioquinol (nmod)
activation glial (amod)
biomarkers elevation (dep)
$ROOT$ lowers (sent)
have thirst (dobj)
improvement p (dep)
had number (dobj)
demonstrates study (nsubj)
elevation mice (nmod)
akathisia . (punct)
disturbances man (nmod)
displace did (aux)
hypoxemia octreotide-induced (amod)
virus human (amod)
levobupivacaine % (appos)
activity twitch (compound)
il-1b ( (punct)
changes decrease (conj)
chemotherapy inhibitors (conj)
problems and (cc)
reported best (nmod)
probes stereology (compound)
patients antibody-positive (amod)
changes pupillary (amod)
jitteriness antidepressant-induced (amod)
procaterol . (appos)
effect preparations (nmod)
increased mitochondria (nmod)
mrna in (case)
liver with (case)
recognition neuropathy (nmod)
pituitary rats (nmod)
promotes verapamil (nsubj)
hypercalcemias or (cc)
progestagens third-generation (amod)
behavior on (case)
12 of (quantmod)
expression factor-kappab (nmod)
correlated effects (nsubj)
obtaining using (advcl)
alterations differences (conj)
characterized exposure (nsubjpass)
retested weeks (nmod)
dronedarone mg/kg (appos)
fk506 of (case)
decrease pressure (dobj)
change for (case)
deaths and (cc)
reduces injury (dobj)
combination their (nmod:poss)
patients additional (amod)
excreted is (auxpass)
screening bacteriological (amod)
104 ) (punct)
different abnormal (conj)
attempt to (mark)
protect mice (dobj)
astrocytes by (case)
ml-1 ) (punct)
strains of (case)
surgery during (case)
td in (case)
encountered patients (nmod)
recommendations regulations (conj)
iu/kg ) (punct)
documented neutropenia (nsubjpass)
provides helpful (conj)
acid mpa (appos)
war the (det)
due disinhibition (nmod)
seem . (punct)
42 patients (nmod)
coefficient cv (appos)
function ameliorative (amod)
cells cd4 (compound)
thirsty and (cc)
backgrounds patients (nmod)
reduction filtration (nmod)
associated risperidone (nsubjpass)
essential studies (nmod)
receive one (dobj)
bones painful (amod)
observed regard (nmod)
spite concentrations (nmod)
neuroadaptation or (cc)
stabilizers have (conj)
study nerve (compound)
polyuria and (cc)
caffeine solution (conj)
use preparations (nmod)
thromboses fewer (amod)
67 , (punct)
evinced . (punct)
reduced gabapentin (nsubj)
man sustained (acl:relcl)
obtained increased (parataxis)
encephalopathy valproate-induced (amod)
caused hypocalcemia (dobj)
required reach (advcl)
fraction average (amod)
antagonized also (advmod)
exhibited chat (nmod)
increase timolol-related (amod)
vivo/in vitro (dep)
propranolol mg/day (appos)
studied actions (nsubjpass)
bringing disturbance (dobj)
shown animals (nsubj)
reported handful (nsubjpass)
percent sixty (nummod)
support conclusion (dobj)
caffeine before (case)
rechallenged subsided (advcl)
rose administration (nmod)
administered mg. (dobj)
ischemia dipyridamole-induced (amod)
abnormalities involving (acl)
progressed disease (nsubj)
batteries 741 (nummod)
interaction resulted (acl:relcl)
limits the (det)
2.5 interval (dep)
onset myocarditis (nmod)
appear and (cc)
sinus associated (acl)
carboxylesterase of (case)
feasible remains (conj)
kg(-1 ) (punct)
attended program (dobj)
groups analysis (nmod)
molecule (kim)-1 (dep)
presence . (punct)
regimen first-line (amod)
impart to (mark)
reduced h2o (nmod)
0.15+/-0.03/h ( (punct)
extracts in (case)
g 32 (nummod)
2nd or (cc)
% 0.1 (dep)
> years (nmod:npmod)
injury brain (nmod)
results hospitalized (acl)
period urine (compound)
watch report (conj)
mesna , (punct)
have epilepsy (dobj)
consumption 0.05 (appos)
effects nephropathy (nmod)
smad3 of (case)
pro-arrhythmic also (advmod)
phn in (case)
0.97 1.88 (appos)
effect calcification (nmod)
ps in (case)
indicated . (punct)
appears there (expl)
injection bn (nmod)
minutes administration (nmod)
compared pattern (dobj)
case nephrolithiasis (nmod)
medication by (case)
rodents to (case)
stiffness : (punct)
5.0 +/- (cc)
cycles menstrual (amod)
mrna gad (compound)
vehicle common (amod)
plasma 0.298 (nummod)
levels precedes (acl:relcl)
analysis factor (nmod)
animals or (cc)
cytopenias of (case)
combinations sulfate (nmod)
conjunction regimens (nmod)
preventing in (mark)
consciousness are (cop)
vehicle arabic (conj)
increasing be (aux)
r- s-isomer (conj)
licking gnawing (conj)
protection the (det)
hyperalgesia universal (amod)
insecticide effects (nmod)
activation 3 (nummod)
1.5 ) (punct)
involved often (advmod)
investigated methods (nmod)
rarer is (cop)
consistent development (nmod)
glucose lactate (conj)
hemodynamics anesthesia (nmod)
injection tapering (conj)
succumbed therapy (nmod)
time surgery (nmod)
evaluated done (conj)
process is (cop)
masseter and (cc)
naive drug (nmod:npmod)
given was (auxpass)
assays il-1 (nmod)
therapy inhibitor (compound)
tissue smear (conj)
addition ephedrine (nmod)
role of (case)
performed a.m. (nmod)
$ROOT$ correlates (sent)
postinjection minutes (compound)
suggests pathogenesis (nmod)
reduced mortality (dobj)
beats ( (punct)
patients 77 (nummod)
activation brain (compound)
improved oct (nsubj)
withdrawal cause (nmod)
depressed activity (dobj)
tests ranks (compound)
recognized % (nmod)
positive , (punct)
selective non (advmod)
disease neuromuscular (amod)
preceded death (dobj)
taking occlusion (nmod)
prove enflurane (nsubj)
recovery hyperglycaemia (nmod)
total droperidol (nmod)
developed artery (nmod)
techniques morphological (amod)
packing membrane (compound)
wall bladder (compound)
recognised are (auxpass)
lasted and (cc)
toxicity cyclosporine (compound)
improvement symptomatic (amod)
located patients (nmod)
help clarify (xcomp)
toxicity mild (amod)
feasible safe (conj)
rats jj (compound)
doses daily (amod)
other reflex (nmod)
dysfunction myocardial (amod)
seizures time (dep)
hypothermia mice (nmod)
administration tet (nmod)
complication recipients (nmod)
intervals fixed (amod)
investigated performing (advcl)
shown worsening (dobj)
pressure saturation (conj)
sham real (conj)
disease infarctions (nmod)
after long (advmod)
lack norepinephrine (dobj)
investigated we (nsubj)
drug enhance (acl:relcl)
studying mechanisms (dobj)
median regimens (nmod)
vsd rats (nmod)
continued deteriorate (xcomp)
factor specific (amod)
gamma-carboxylated that (mark)
morbidity overall (amod)
results mg/m2/d (appos)
man yr-old (amod)
sensitivity convulsants (nmod)
contraceptive oral (amod)
complication cystitis (nsubj)
discontinuation amiodarone (compound)
metal bare (amod)
retard . (punct)
sedated were (auxpass)
heparin unfractionated (amod)
exposure heat (compound)
day in (case)
shifts decreases (conj)
b nuclear (amod)
nephritis tubulo-interstitial (amod)
amounts carbonate (nmod)
behavior or (cc)
induced thiopentone (nmod)
because frequency (nmod)
diagnosed as (prep)
providing targets (dobj)
conducted march (nmod)
generate to (mark)
range high-frequency (amod)
response calcium (nmod)
fluorescence ) (punct)
exceed patients (nmod)
enhance extent (dobj)
effect thp (nmod)
revealed ranged (ccomp)
cyclosporine from (case)
5 - (punct)
off parkinsonian (amod)
evidence ischemia (nmod)
injection fluorescein (compound)
used test (xcomp)
improving dyskinesias (dobj)
aneurysm nontraumatic (amod)
showed values (advcl)
100 30 (nummod)
behaviour depressive-like (amod)
deviation deviation (conj)
longer considerably (advmod)
cent 0.25 (nummod)
g/kg/day subcutaneously (advmod)
therapy penicillamine (compound)
sequelae of (case)
course six-week (compound)
thrombocytopenia and (cc)
mdma , (punct)
reproducibility tremor (nmod)
consequences serious (amod)
percent 28 (nummod)
male ) (punct)
expected be (auxpass)
return gradual (amod)
degree abnormality (nmod)
indicated studies (nsubj)
tended but (cc)
idiosyncrasy true (amod)
monitoring bis (compound)
mazindol inhibitor (appos)
ability resuscitate (acl)
taxol ; (punct)
receptor gaba(a (compound)
rate hbsag (nmod)
detected echocardiography (nmod)
contraction maximal (amod)
urgency the (det)
mistakes interpretation (nmod)
withdrawal verapamil (compound)
species elevated (amod)
prevention their (nmod:poss)
recovery after (case)
closest agsd (nmod)
produced finally (advmod)
characterized signs (nmod)
seen males (nmod)
indicator diagnostic (amod)
led activations (nmod)
onset hypothyroidism (nmod)
$ROOT$ lacked (sent)
required thus (advmod)
induced aconitine (nmod)
degree number (conj)
utilized model (dobj)
stabilized complex (nmod)
mediator an (det)
levels baseline (compound)
war during (case)
treatments consecutive (amod)
rats epinephrine-treated (amod)
profile bupivacaine (nmod)
suggests appear (advcl)
diminished disappearance (nsubjpass)
pathway nociception (nmod)
perimetry on (case)
involve effects (nsubj)
rates pathogens (nmod)
examined microscopy (nmod)
exacerbated ltg (nsubj)
activity hematologic (amod)
patients transplanted (acl)
capable also (advmod)
result exposure (nmod)
rats tested (amod)
held was (auxpass)
lisinopril of (case)
1.06 7.11 (prep)
saline succinylcholine (conj)
microg/0.5 4 (nummod)
0.7 1.3 (prep)
reduced degree (nmod)
tubule dct2 (appos)
value little (amod)
receiving not (neg)
tem ) (punct)
benefits these (det)
myelopathy manifestations (conj)
inhibitors thrombin (compound)
measured have (aux)
outflow low (amod)
thickening minimal (amod)
performed , (punct)
testing retrieval (compound)
naloxone mg./kg (appos)
fall k+ (nmod)
microscopy and (cc)
treated withdrawn (conj)
hydrocortisone oral (amod)
malondialdehyde increased (amod)
possibility infections (nmod)
cases 6 (conj)
mitigated depletions (dobj)
therapy to (mark)
stereotypies oral (amod)
used techniques (nsubjpass)
recommended 2002 (nmod)
side-effect limiting (amod)
tbil high (amod)
need assess (xcomp)
irrigated were (auxpass)
model lithium-pilocarpine (compound)
damage myocyte (compound)
8.8 - (advmod)
cycles seven (nummod)
study 12-week (amod)
agonists or (cc)
evidenced sediment (nmod)
mg/m2 doxorubicin (nmod)
cause medication (nsubj)
abolished withdrawal (nmod)
ascertained was (auxpass)
uncertain diagnosis (nsubj)
dose trials (nmod)
aspects effects (conj)
sulphonylureas the (det)
d2 both (cc:preconj)
preparations into (case)
women tamoxifen (nmod)
ap ) (punct)
risk using (acl)
score activities (nmod)
parallel neurons (nmod)
emphasis time-course (nmod)
effect edaravone (nmod)
dogs eight (nummod)
nausea and (cc)
caused increasing (advcl)
subgroups the (det)
children evidence (nmod)
neurotoxicity auditory (amod)
resulting proteinuria (nmod)
illness duration (nmod)
time ip (amod)
tapered was (auxpass)
resulted has (aux)
reduces development (dobj)
microgram.kg-1.min-1 micrograms.kg-1.min-1 (conj)
(7.2)% minutes (conj)
chance progressing (acl)
$ROOT$ protected (sent)
dba/2 and (cc)
developing developing (advcl)
cause mechanisms (conj)
a.m. 7:30 (nummod)
participants twenty (nummod)
tamca ) (punct)
preserve would (aux)
psa serum (compound)
became she (nsubj)
reabsorption tubular (amod)
injection in (amod)
decreased gyrus (nmod)
carbimazole omercazole (appos)
pass does (aux)
group conventional (amod)
$ROOT$ test (sent)
outcomes devastating (amod)
associated months (nsubjpass)
maintaining anesthesia (dobj)
clomipramine vehicle (conj)
account some (nmod)
norepinephrine ) (punct)
less when (advmod)
mg/kg/day ) (punct)
changes lacrimation (nmod)
immunosuppressant powerful (amod)
tolerate subjects (nmod)
saline- rats (dep)
protect steroids (nsubj)
flutamide of (case)
deposition medulla (nmod)
ischaemia cerebral (amod)
choline-devoid or (cc)
evoked . (punct)
hg 60 (nummod)
doses misoprostol (nmod)
discuss we (nsubj)
difference=0.25 p (compound)
consider designs (nsubj)
pdtc ( (punct)
see recovery (dobj)
recorded graded (conj)
disease and (cc)
characteristic but (cc)
carried pre- (advmod)
agonist as (case)
atrophy weight (appos)
maintains while (mark)
demonstrated imaging (nsubj)
animals ( (punct)
exposed heparin (nmod)
indicated as (mark)
rats received (acl:relcl)
bands were (cop)
dextran weights (nmod)
arthritis treated (acl)
one schedules (nmod)
alpha-methyl-para-tyrosine of (case)
6,7-dimethoxy-4-ethyl-b-carboline-3-carboxylate methyl (compound)
subjected injury (nmod)
intradermoreactions and (cc)
inhibition detoxification (conj)
stimulus of (case)
dox mg/kg (amod)
therapy rifampicin (compound)
comparing users (dobj)
maintained been (auxpass)
breaths spontaneous (amod)
maha ) (punct)
injections following (case)
compares favorably (advmod)
dystrophy of (case)
variance-significantly of (case)
that infarction (nmod)
transplantation phase (nmod)
necrolysis epidermal (amod)
map % (compound)
developed minutes (nmod:tmod)
mg/m(2 131 (nummod)
show further (advmod)
morphine and (cc)
paraparesis after (case)
headache of (case)
vulnerability to (case)
143 x (cc)
haemorrhage gastrointestinal (amod)
damage produced (acl)
etiology , (punct)
neutropenia % (appos)
nephropathy adriamycin (compound)
co-morbidity psychiatric (amod)
administered followed (conj)
caused cause (conj)
lipocalin gelatinase-associated (amod)
2nd as (case)
skeptical , (punct)
led appearance (nmod)
study exploratory (amod)
conditions such (amod)
seriousness the (det)
pacing temporary (amod)
dosing with (case)
ratio increase (nmod)
convulse to (mark)
to due (case)
food food (conj)
ccr lysozymuria (appos)
difficult and (cc)
prophylaxis standard (amod)
determined increases (ccomp)
improvements dramatic (amod)
remained deficits (nsubj)
performed test (xcomp)
double-blind a (det)
rates tumor (compound)
specificity fenfluramines (nmod)
tg ) (punct)
triceps deltoid (conj)
animals age (nmod)
effect proteinuria (nmod)
administered h. (nmod)
co2 ) (punct)
comparing incidence (dobj)
initial or (cc)
evokes . (punct)
show loss (dobj)
ciprofloxacin with (case)
hypothesized damage (ccomp)
influence l-dopa (nmod)
available was (cop)
months 47 (nummod)
condition worsening (amod)
protein protein (conj)
activation and (cc)
indicating transport (dobj)
injection 5,7-dht (nmod)
suggest selection (dobj)
that flunarizine (nmod)
presented markers (nmod)
high been (cop)
received placebo (nmod)
care the (det)
literature syndrome (nmod)
$ROOT$ concentrated (sent)
learning and (cc)
effect sevoflurane-sparing (amod)
pathway erk1/2 (compound)
derived experiments (nmod)
induced ouabain (nsubj)
p<0.001 ( (punct)
assessed trial (nmod)
differed , (punct)
individuals vulnerable (amod)
mg/m2 910 (nummod)
radius in (case)
disorder this (det)
0.04 , (punct)
$ROOT$ annuloplasty (sent)
pressures consistent (amod)
thermal or (cc)
minutes 2.5 (nummod)
necrosis formation (nsubj)
clinical laboratory (conj)
required and (cc)
.0001 ) (punct)
200 225 (conj)
influenced may (aux)
intravenous short (amod)
factor granulocyte-colony (compound)
extent changes (conj)
known changes (nmod)
amplitude potential (compound)
spasm patient (nmod)
reductions baseline (nmod)
abnormalities function (compound)
cows died (acl:relcl)
project screening (compound)
republic congo (nmod)
markers biochemical (amod)
woman hyperaldosteronism (nmod)
had presentation (nmod)
administered where (advmod)
onset manifestations (conj)
vein the (det)
effect independent (amod)
risk : (punct)
associated hyperammonemia (nmod)
system 1.5-t (nummod)
returned value (nmod)
albumin mg/dl (appos)
targeted antipsychotics (nmod)
rater blind (amod)
found bilaterally (advmod)
complication related (amod)
exposure short-term (amod)
corrected tendency (nsubjpass)
methadone the (det)
echocardiography during (case)
study directed (acl)
occurs affect (conj)
as severe (amod)
accomplished injection (nmod)
showed correlation (dobj)
groups patients (appos)
effective damage (nmod)
and both (cc:preconj)
little no (conj)
suppress beta-blockers (nmod)
beclomethasone topical (amod)
reversal oih (nmod)
sustained diaries (nmod)
syndrome report (appos)
$ROOT$ offered (sent)
rates low (amod)
study design (compound)
cefonicid mg/kg (compound)
disappeared jaundice (nsubj)
mitoq. targeted (amod)
elisa monoclonal (amod)
hemorrhage rats (nmod)
2-adrenoceptors beta (compound)
impaired procedure (nmod)
hundred four (conj)
percent % (conj)
units teams (nmod)
impairment phenobarbitone- (amod)
normal moles/glomerulus (dep)
reported abusers (nmod)
medications other (amod)
down delta (compound)
proliferation for (case)
effect antiangiogenic (amod)
genes candidate (compound)
enhanced neurogenesis (nsubjpass)
solid and (cc)
infusion during (case)
appreciated is (auxpass)
spite fact (nmod)
returning average (nmod)
hours for (case)
aware symptoms (nmod)
differences obvious (amod)
conducted identify (xcomp)
af 378 (nummod)
demonstrated self-treating (ccomp)
activities mtdna-encoded (amod)
toxicity regimen (nmod)
authorized snp (nsubjpass)
papaverine after (case)
rhythm a (det)
administered oxytocin (nsubjpass)
angina unstable (amod)
industry in (case)
tacrolimus mmf (conj)
shifts spectra (nmod)
reports a (det)
deprivation access (conj)
excess none (conj)
halts prevented (advcl)
ulcer gastric (amod)
class in (case)
established model (nsubjpass)
had hypercalcemia (dobj)
albumin activity (conj)
bradykinin hoe (appos)
seem therapy (nsubj)
percent six (nummod)
treated condition (nsubjpass)
3.0 +/- (cc)
patients meningitis (nmod)
toxicity desipramine (compound)
determinant symptoms (nmod)
receives and (cc)
established attack (dobj)
flaccid akinetic (conj)
suggested research (nsubj)
continued finished (advcl)
vomiting , (punct)
invaded cells (nsubj)
transferase gamma (compound)
halts . (punct)
current outward (amod)
desensitisation to (case)
frequent switches (nsubj)
reproducibility the (det)
purpura as (case)
met success (nmod)
determined change (nmod)
system direct (amod)
years 57 (nummod)
rep , (punct)
administration glucocorticoid (compound)
pyridoxal of (case)
have rate (dobj)
relapsed whom (nmod)
bound covalently (advmod)
g/liter 1.5 (nummod)
lethal cardiotoxic (conj)
= pmol (dobj)
overload and (cc)
responses related (amod)
combinations two (nummod)
effects powerful (amod)
wave positive (amod)
secretion the (det)
worsening report (dep)
doses p<0.001 (appos)
accumulation drugs (nmod)
remained showed (dep)
reflect indicator (advcl)
coadministration by (case)
pain . (punct)
related finding (nsubj)
setting care (compound)
sensor a (det)
$ROOT$ symptoms (sent)
activated expression (dobj)
attempt choose (xcomp)
changes cord (nmod)
rpgn ( (punct)
d by (case)
mg/dl thereafter (advmod)
limitation a (det)
gentamicin gentamicin (conj)
amount surgery (nmod)
has response (nmod)
concentrations maximum (amod)
unmask seizures (dobj)
permeability/injury glomerular (amod)
mediated be (auxpass)
compare using (xcomp)
method microplate (compound)
admissions two (nummod)
auc 5 (appos)
included it (nsubj)
100 than (quantmod)
rate tremor (nmod)
therapy medical (amod)
schizophrenia of (case)
pain musculoskeletal (amod)
investigation now (advmod)
changes degenerative (amod)
$ROOT$ bought (sent)
angiography nuclear (amod)
course patient (nmod)
agonist receptor (compound)
149 and (cc)
agonist 8-oh-dpat (appos)
diazepam with (case)
associated hepatitis (nmod)
projection through (case)
implications of (case)
anesthetics hydrochloride (dep)
pills factor (nsubj)
% 9/15 (dep)
ventricular systolic (amod)
prevents nephropathy (dobj)
graft bypass (compound)
case a (det)
patients preferring (acl)
safety dysfunction (nmod)
indicate memory (dobj)
feature . (punct)
ps-exposure binding (appos)
pathology case (nmod)
postulate increased (ccomp)
useful safe (conj)
report international (compound)
density tumor (compound)
impact functional (amod)
demonstrated inhibitor (ccomp)
treated icu (nmod)
administration stroke (nmod)
index glomerulosclerosis (compound)
subunits receptor (compound)
expression growth (nmod)
parameters urodynamic (amod)
generations pills (nmod)
flutamide antagonist (compound)
feeding of (case)
calcitonin human (amod)
syndrome posterior (amod)
mbc for (case)
rat fetal (amod)
establishing further (advmod)
models damage (nmod)
prevent bruising (dobj)
potent ranitidine (nsubj)
use medical (amod)
mitoxantrone , (punct)
withdrawal drugs (nmod)
feature be (cop)
reduce volume (dobj)
controls saline (compound)
hemorrhage ich (appos)
evaluated 37 (nsubjpass)
arrhythmia induced (acl)
resistant were (cop)
inhibit gamma-carboxylation (dobj)
range frequency (compound)
derivative eai (appos)
case anxiety (nmod)
scanning and (cc)
acid tfl (appos)
dyskinesias limb (compound)
rls mirtazapine-associated (amod)
description . (punct)
mpges-1 ) (punct)
patients improved (acl:relcl)
dyspepsia with (case)
increase , (punct)
assessed combination (dobj)
detected consistent (parataxis)
doses decreased (acl:relcl)
$ROOT$ decreased (sent)
age grade (conj)
sedation pediatric (amod)
receiving metoprolol (dobj)
ps ls (appos)
anemic administration (nmod)
days transplantation (nmod)
284 24 (conj)
disease characterized (acl:relcl)
acidity overcome (acl:relcl)
eps akathisia (nmod)
series first (amod)
methods measured (dep)
unknown are (cop)
gfap and (cc)
tilts rats (nmod)
newspaper a (det)
es ( (punct)
preceded not (neg)
diet phenobarbital-containing (amod)
horns bilateral (amod)
perimetry ( (punct)
batteries levels (conj)
encephalopathy late-onset (amod)
conclusive were (cop)
degeneration frequent (amod)
induced streptozocin (nmod)
nimesulide and (cc)
raise administration (nmod)
activity levels (conj)
measuring changes (dobj)
revealed lipophages (dobj)
assessment on (case)
np m (conj)
declined indices (nsubj)
mechanisms underlie (acl:relcl)
data subjects (nmod)
include assays (dobj)
stressed scored (conj)
70/101 ) (punct)
decreased protein (nmod)
examined role (nsubjpass)
year weeks (conj)
most in (case)
indices ) (punct)
compare . (punct)
adr ) (punct)
use it (nsubj)
effectiveness preventing (acl)
density low (amod)
kept when (advmod)
consider initiated (ccomp)
mg p.o. (amod)
noted contrast (nmod)
unnecessary , (punct)
resulted injury (nmod)
colitis ischemic (amod)
related control (nmod)
hypertension : (punct)
prove activator (xcomp)
failed aggravate (xcomp)
drugs as (case)
skills motor (compound)
induced incorporation (nsubj)
pre- postoperatively (conj)
process of (case)
shift left (nmod)
rammer . (punct)
carries transplantation (nsubj)
breath esthetics (conj)
attenuated produced (ccomp)
patients nonhypertensive (amod)
continuation of (case)
pvn son (conj)
function dose (nmod)
response this (nmod)
technique centers (nmod)
blood , (punct)
mg/m2 600 (nummod)
deficit transient (amod)
groups animal (compound)
examined utility (dobj)
naloxone pre-training (amod)
enalapril converting (compound)
hypoxic not (neg)
ages the (det)
imaging resonance (compound)
effect 2-(p-bromophenyl)propionate (nmod)
susceptibility lower (amod)
parameters selected (acl)
indicates review (nsubj)
modified inflammation (nmod)
significant weeks (nmod)
formation neocortex (conj)
caused atrophy (nsubjpass)
type with (case)
uptake an (det)
lead administration (nsubj)
have reduction (nsubj)
h over (case)
reported publication (nmod)
renal pulmonary (conj)
monitor neuropathy (dobj)
alf=0/35 ( (punct)
switchers pills (nmod)
increase because (mark)
patients followed (acl:relcl)
developed model (nmod)
block administration (nmod)
results from (case)
bdl ( (punct)
subjects fewer (amod)
15 versus (cc)
dose d-penicillamine (nmod)
protects carvedilol (nsubj)
occurred : (punct)
anuria transient (amod)
% 0.15 (nummod)
ah6809 antagonist (appos)
regulation activity (nmod)
diameter density (conj)
limiting was (cop)
virus-related b (nmod:npmod)
actin alpha-sarcomeric (amod)
paradigm avoidance (compound)
enalapril placebo (dep)
association of (case)
involved manifestation (nmod)
tumor-free was (cop)
initial and (cc)
impairment memory (nmod)
findings , (punct)
clinic outpatient (amod)
symptoms urinary (amod)
polyuria associated (acl)
reduction concentrations (nmod)
similar effect (nsubj)
contains literature (nsubj)
incidence myalgia (nmod)
ltg ) (punct)
needed study (advcl)
printout cases (nmod)
drugs worldwide (advmod)
products positive (amod)
idiosyncrasy a (det)
incidence related (amod)
excretion and (cc)
related inhibit (conj)
chemotherapy ct (appos)
lca > (cc)
manic mixed (conj)
do species (nsubj)
blocked effects (dobj)
$ROOT$ five (sent)
synovitis uncontrolled (amod)
1 those (appos)
mk-212 and (cc)
l-sotalol d (compound)
dose pentylenetetrezol (nmod)
aureus and (cc)
cytoprotective which (nsubj)
underwent protocol (dobj)
15/group ( (punct)
reduction using (acl)
methadone selective (amod)
invaded . (punct)
frequency than (case)
off-time daily (amod)
rotation such (amod)
injury drug-induced (amod)
adenosine by (case)
high rate (nsubj)
dystrophy man (nmod)
worsening hemodynamics (nmod)
identified increase (ccomp)
pentoxifylline of (case)
delay intra-hisian (amod)
5'-n-ethylcarboxamidoadenosine neca (appos)
auc its (nmod:poss)
has effect (dobj)
resolved < (punct)
nausea effects (nsubj)
carcinoma renal (amod)
trial 6-week (amod)
improved denopamine (nmod)
nurse of (case)
remains . (punct)
impair performance (dobj)
regions gyrus (nmod)
cause conclusion (compound)
less is (cop)
b. cathepsin (compound)
inhibitor . (punct)
is treatment (attr)
weeks use (nmod)
converted chorea (nmod)
causes streptozotocin (nsubj)
metrifonate of (case)
thrombosis central (amod)
residence adenosine (nmod)
hemorrhage subependymal (amod)
prevented increases (dobj)
$ROOT$ epinephrine (sent)
reduction half (nmod)
erp ) (punct)
drug -- (punct)
regurgitation valve (compound)
investigated production (nsubjpass)
groups paracetamol-treated (amod)
spasms tetany (conj)
volume improvement (conj)
initiated trial (nsubjpass)
lead factors (nsubj)
decrease occurrence (conj)
nephrotoxic less (advmod)
treatment no (det)
5-hiaa ( (punct)
resulted anuria (nmod)
metabolism stereoselective (amod)
data efficacy (nmod)
frequent these (nsubj)
edema core (nmod)
tolerated : (punct)
stress were (cop)
serves index (nmod)
asians of (case)
four the (det)
cross-tolerance of (case)
women 7 (nummod)
thickness % (compound)
protects myelosuppression (nmod)
diffusion . (punct)
boluses only (advmod)
dystonia sulpiride-induced (amod)
second- third-line (conj)
sas bars (conj)
$ROOT$ profile (sent)
extract novel (amod)
0 9.88 (prep)
parameters curve (appos)
decrease aspirin (nsubj)
method it (nsubj)
cancer nationale (compound)
states emotional (amod)
assessed treatment (nmod)
was cows (nmod)
meq/l meq/l (appos)
improve monitoring (advcl)
97.1 ) (punct)
mssa ) (punct)
microgram/kg/min ) (punct)
performance patients (nmod)
2.4 at (case)
studies recent (amod)
found frequent (advcl)
af ) (punct)
cdc ) (punct)
rose significantly (advmod)
interval this (det)
animals diameter (dep)
lead consolidation (nmod)
study and (cc)
clonidine methysergide (conj)
haemorrhages with (case)
level supposed (amod)
volumes large (amod)
treated regimen (nmod)
failed angiograms (nsubj)
disorder to (case)
characteristics -- (punct)
estimated chromatography (nmod)
transferred woman (nsubjpass)
placement for (case)
strokes and (cc)
0.01 p (dep)
regimen standard (amod)
mosmol/kg was (cop)
release catecholamines (nmod)
mounting evidence (nsubj)
demonstrated cord (nmod)
acid ursodeoxycholic (amod)
hypotension groups (nmod)
activation stat3 (compound)
logical is (cop)
employing delay (dobj)
embryos amount (nmod)
paradigm the (det)
responded nine (advcl)
pilocarpine cholinergic (amod)
placebo-an to (case)
depression hypotension (conj)
rate control (compound)
dependent action (nmod)
continued ; (punct)
ratio from (case)
dpi 5 (nummod)
therapy epsilon-aminocaproic (amod)
restriction no (det)
depression and (cc)
edema interstitial (amod)
retina and (cc)
product to (case)
tested groups (nsubjpass)
has ( (punct)
protect personnel (dobj)
sacrificed . (punct)
received experiencing (advcl)
moran al. (dep)
period reduced (amod)
forces of (case)
angioedema swelling (nmod)
sensitive may (aux)
severity rigidity (nmod)
january 2009 (nummod)
greater doses (nmod)
7.7 4.5 (conj)
injections injections (conj)
control important (acl:relcl)
standard gold (amod)
spasms muscle (compound)
psp of (case)
potential capacity (conj)
increased l/min (nmod)
used treat (xcomp)
resolved cessation (nmod)
arteries glomeruli (conj)
dose methylprednisolone (nmod)
presented hypotension (nmod)
syndromes pain (nmod)
recorded continuously (advmod)
observed should (aux)
models catalepsy (nmod)
refractory treatment (nmod)
opacities corneal (compound)
failure ciprofloxacin-induced (amod)
reduction hypertension (nmod)
followed survivors (dobj)
thrombocytopenia associated (acl)
condition , (punct)
antibiotic effects (nmod)
develop necrosis (dobj)
latency variable (amod)
seizures hemorrhage (conj)
used currently (advmod)
role contaminants (nmod)
have vicinity (nmod)
aggregation heparin-induced (amod)
premedication , (punct)
debated . (punct)
% 4.2 (nummod)
effects data (dep)
raclopride antagonist (compound)
resection tumors (nmod)
muscle thyroarytenoid (compound)
$ROOT$ 6 (sent)
one least (advmod)
produce levels (nsubj)
glomerulosclerosis content (conj)
reduce pressure (dobj)
infections of (case)
infusion aminophylline (nmod)
thrombosis subsequent (amod)
risk vte (nmod)
overload peripheral (amod)
hypoxia cortical (amod)
8 in (case)
intra-operative and (cc)
useful could (aux)
administration ppa/caffeine (compound)
margin inner (amod)
mode the (det)
demonstrated rate (dobj)
contraception oral (amod)
similar model (nmod)
metabolite and (cc)
fields ) (punct)
development models (nmod)
is predisposed (ccomp)
wt vip(-/- (conj)
abolished whereas (dep)
dissociated unless (mark)
drug conventional (amod)
sd , (punct)
patient meq/l (compound)
1.86 from (case)
strategy the (det)
prolactin levels (conj)
individuals backgrounds (nmod)
pg ( (punct)
layer inner (amod)
suggest suggest (conj)
had akathisia (dobj)
demonstrated were (auxpass)
adapt results (dobj)
used adjust (xcomp)
lower dose (nsubj)
cortices animal (nmod)
effects levels (nmod)
evaluated stages (nmod)
decrease for (case)
inclusions peroxisomes (nmod)
report dermatitis (nmod)
care particular (amod)
alpha,3 or (cc)
translate . (punct)
3 thrombopenia (nmod)
administered cp (nsubjpass)
immunosuppressed . (punct)
presented sensation (nmod)
ascites of (case)
dose 10-min (amod)
cocaine benzoylecgonine (conj)
switching levels (nmod)
company corporation (appos)
carotid , (punct)
5.6 0.7 (conj)
processes the (det)
failure fulminant (amod)
individuals among (case)
sertraline subjects (appos)
doses mumol (appos)
makes useful (ccomp)
focused indicated (conj)
loss acuity (nmod)
taken women (nmod)
used routinely (advmod)
severely more (advmod)
13,000 of (case)
effective suppressing (advcl)
decline by (case)
costs the (det)
constituted and (cc)
patients relatives (conj)
on group-2 (nmod)
mucositis loss (conj)
maintained months (nmod)
opistothonus , (punct)
malondialdehyde , (punct)
tests challenge (compound)
site sites (conj)
therapy wilson (nmod:poss)
forced effects (nsubj)
day after (case)
% compared (prep)
loss following (case)
outcome hemorrhage (nmod)
had concentration (dobj)
ddavp ) (punct)
withdrawal men (nmod)
decrease gsk3alpha (nmod)
years transplants (nmod)
anencephaly e18.5 (nmod)
rats restricted-diet (amod)
ratings on (case)
occurs it (nsubj)
keratopathy and (cc)
nachrs ( (punct)
report to (case)
reduced dexrazoxane (dobj)
defect acidification (compound)
obtained fetuses (nsubjpass)
regard safety (nmod)
glomerulonephritis rifampicin-associated (amod)
animals 12/27 (nummod)
ephedrine agonist (appos)
prodrugs 6 (dep)
received epinephrine (dobj)
seizures petit (compound)
pituitary the (det)
ortral carbachol (dep)
weeks 60 (nummod)
occurred simultaneously (advmod)
occurs contrary (advmod)
responsiveness the (det)
related may (aux)
volunteers female (amod)
leveled off (compound:prt)
imbalance have (aux)
valsartan and (cc)
form , (punct)
proteinuria blockade-induced (amod)
diuretic bumetanide (nsubj)
mg/kg 3.2 (nummod)
lomustine ccnu (appos)
11.5 +/- (cc)
confirmed group (nmod)
abnormalities visual (amod)
progressed css (nsubj)
scale azrin (compound)
increasing 1 (dep)
dyserythropoiesis with (case)
pathway neutral (amod)
stress on (case)
therapy under (case)
symptoms some (det)
change no (det)
antagonized vagotomy (nmod)
measurement sequential (amod)
risperidone antagonist (appos)
reflected accumulation (nsubjpass)
characteristics symptoms (conj)
remains as (mark)
cerebrum the (det)
complaints vision (conj)
cases 16 (nummod)
demethylase n-nitrosodimethylamine (compound)
adopted chemotherapies (nmod)
indicator not (neg)
effect dox (compound)
incidence mellitus (nmod)
dtic ) (punct)
induction etomidate (compound)
treated pb (nmod)
admitted hospitals (nmod)
galactose mg/kg/day (appos)
structures various (amod)
induced mmecs (nmod)
added weeks (nmod)
months at (case)
six ) (punct)
reduced deacetylation (dobj)
gaba , (punct)
aggregation monomers (nmod)
4-damp 4-diphenylacetoxy-n-methylpiperidine-methiodide (appos)
instilling drop (dobj)
increased conclusion (nmod)
marker stress (nmod)
mortality significant (amod)
deafening after (case)
introduced have (aux)
indicate upregulated (ccomp)
prazosin alpha(1 (compound)
= -2.34 (dobj)
have worsening (dobj)
observed movement (nsubjpass)
show improves (ccomp)
channels on (case)
let develop (ccomp)
3.75 and (cc)
mechanism myopathy (nmod)
counts subset (compound)
chemotherapy cyclophosphamide-based (amod)
assigned rats (nsubjpass)
experienced interval (dep)
potent vpa (nmod)
% hepatitis (conj)
methods comparison (appos)
etiology be (cop)
activator allosteric (amod)
undertaken not (neg)
series all (det)
progress conclusion (dep)
significant nearly (advmod)
duration ms (appos)
site right (amod)
hmm ) (punct)
responders fluctuating (amod)
sch of (case)
compared health (nsubjpass)
database computerized (amod)
effect . (punct)
inhibits as (advmod)
conclude conclusions (nsubj)
effect carcinogenesis (nmod)
paroxetine inhibitors (conj)
method underwent (appos)
used zymosan (nsubjpass)
acquired started (advcl)
site ? (punct)
potency of (case)
annulus the (det)
greater equal (conj)
cases injection (nmod)
follow can (aux)
min normotension (nmod)
instructions use (nmod)
$ROOT$ degree (sent)
are complications (attr)
neovascularization , (punct)
basis . (amod)
sbp of (case)
achieve estimates (dobj)
affects changes (nmod)
reduction administered (acl:relcl)
decreased length (dobj)
impairments cognitive (amod)
determine cause (dobj)
frequency stratified (acl)
alpha and (cc)
involved responses (nmod)
become applied (acomp)
mmp-2 adam17 (conj)
administered lignocaine (nsubjpass)
methylphenidate for (case)
ro4368554 by (case)
induced reserpine (nsubj)
incidence ; (punct)
changes arrhythmias (conj)
scales with (case)
rats stz-treated (amod)
acetaminophen p (appos)
psoriasis of (case)
research , (punct)
strategies : (punct)
courses 27 (nummod)
women kamil (compound)
lists suggestions (conj)
showed tissues (nsubj)
9 reduction (nmod)
reduce incidence (dobj)
concentrations phenobarbitone (nmod)
n=6 % (appos)
change medication (dobj)
decrease micromol/liter (dep)
using approach (dobj)
carried effects (nmod)
such ) (punct)
% 54 (nummod)
underwent monitoring (dobj)
use stimulants (nmod)
36 or (cc)
formulation different (amod)
acetaminophen- chloroform- (conj)
activity cardiodepressant (amod)
authors by (case)
echocardiography at (case)
medication be (cop)
time real (amod)
145 from (case)
mania review (appos)
conversion this (det)
growth phenotypes (conj)
triniol with (case)
raises hypothesis (dobj)
$ROOT$ summaries (sent)
hal ) (punct)
noted transfer (nmod)
associated initiating (nsubjpass)
analysis study (conj)
damage no (neg)
produces : (punct)
similar bradycardia (nsubj)
word read (acl:relcl)
evaluation cost (nmod)
channel ca(2 (compound)
syndrome vanishing (amod)
reinitiated was (auxpass)
aneurysms and (cc)
observed rats (nmod)
lysine bendazac (compound)
u/ml p (appos)
evaluation formal (amod)
seizures tonic-clonic (amod)
collected . (punct)
administration ml (nmod)
revealed inhibition (dobj)
rated intensity (dobj)
develops patient (nsubj)
fibrosis ( (punct)
analgesics opioid (compound)
surgery decompressive (amod)
valves prosthetic (amod)
therapy physical (compound)
recruited clinic (nmod)
produce associated (conj)
receiving pseudomonas (dobj)
p.m. 4:30 (nummod)
effects clinical (amod)
mechanisms intrauterine (amod)
exercise-isoproterenol and (cc)
cells superficial (amod)
given or (cc)
diagnosis syndrome (nmod)
mice alpha3 (amod)
independent be (cop)
hoe arg10 (compound)
bortezomib , (punct)
and microscopically (advmod)
200mg/kg of (case)
factor stress (nsubj)
toxicity behavioral (amod)
abnormalities uptake (nmod)
correlation reduction (nmod)
produced first (advmod)
participates , (punct)
reduced giving (advcl)
involved patients (dobj)
sevoflurane % (conj)
blockade beta-adrenergic (amod)
admitted failure (nmod)
edema resultant (amod)
neurons ca3 (compound)
40000 ( (punct)
risk benign (advcl)
cyclosporine such (case)
tolerable basis (nmod)
found mri (nmod)
aimed explore (xcomp)
anaesthetics inhalation (compound)
cases to (mark)
slowing down (compound:prt)
bodies viral (amod)
survivors transplant-free (amod)
evaluation this (det)
disappearance seizures (nmod)
quantify predictors (dobj)
sclerosis fsgs (appos)
release osmolality (nmod)
amiodarone risk (conj)
enhanced hyperactivity (dobj)
block degree (amod)
sedation ranges (nmod)
unknown extent (nsubj)
kindling seizure (compound)
had recall (dobj)
fluorouracil 5-fu (appos)
surgery/radiotherapy radiotherapy (conj)
helpful substitution (nsubj)
compared been (auxpass)
types epilepsy (nmod)
networks congruent (amod)
retains incorporated (advcl)
given points (nmod)
prophylaxis everolimus (nmod)
response tonic (amod)
history ingestion (nmod)
7.13 - (advmod)
peroxides of (case)
pump baclofen (compound)
treatment radioablation (nmod)
developed wr-2721 (nsubjpass)
hh 33.42 (dep)
cp ( (punct)
greater decrease (nsubj)
g 180 (nummod)
test eluate (conj)
2005 in (case)
included observations (nsubj)
those , (punct)
tie2-cre;loxp-egfp mouse (compound)
mg. with (case)
variables above-mentioned (amod)
nmda and (cc)
balances and (cc)
elevations ctni (compound)
patients nephropathy (compound)
included history (dobj)
effect antiparkinsonian (amod)
effect ischemia (nmod)
mepivacaine by (case)
stress or (cc)
modification hyperammonemia (nmod)
reported mothers (nsubj)
widow a (det)
implanting by (mark)
leads termination (nsubj)
discharges on (case)
occur can (aux)
initiated treatment (nsubjpass)
dose moderate (amod)
therapy dobutamine (compound)
differentiating insipidus (dobj)
suxamethonium by (case)
activity cholinesterase (compound)
release content (conj)
night per (case)
architecture lobular (amod)
injury percentage (dep)
epicardium from (case)
administration sulindac (compound)
correlates dose (nmod)
weight/week ) (punct)
absence vesicles (nmod)
entered remission (dobj)
area units (compound)
containing etoposide (dobj)
cyclosporine and (cc)
enhancement diazepam (compound)
distinguished damage (nsubjpass)
lowered reduced (advcl)
known interleukin (nsubjpass)
relation ampk (nmod)
autoantibodies myeloperoxidase (nmod)
c 38.2 (nummod)
administration ototoxicity (conj)
protidogram the (det)
blunted , (punct)
period an (det)
inhibition no-synthase (nmod)
discontinued trial (nsubjpass)
aspartate , (punct)
sustained infarction (dobj)
antidepressants by (case)
risk reaction (nmod)
group versus (cc)
epo il-3 (conj)
l 3.2 (nummod)
study time-course (amod)
workers six (nummod)
add intensity (nsubj)
involved man (dobj)
ingested often (advmod)
synthesis muscle (nmod)
needed address (ccomp)
diet-fed and (cc)
effect ecg (nmod)
mg/kg/i.p 2 (compound)
entered trial (nmod)
tolerated improved (conj)
exercise in (case)
reversing effects (dobj)
del of (case)
inhibited caa (nmod)
map sv (conj)
using in (mark)
had clearly (advmod)
men six (nummod)
preferred many (nsubj)
disappear may (aux)
took woman (nsubj)
patients erythematosus (nmod)
pallidotomy of (case)
collection volunteer (compound)
factor claimed (advcl)
lasted effect (nsubj)
fact . (punct)
lymphoma b-cell (compound)
result hyperkalaemia (nmod)
activity lesions (compound)
regions frontal (amod)
antagonizes which (nmod)
effect anti-amnesic (amod)
developed none (nsubj)
matter bilateral (amod)
dysfunction corticostriatal (amod)
system central (amod)
injuries these (det)
diagnosis initial (amod)
patterns seizure (compound)
due alterations (nsubj)
regulation stat3 (nmod)
stage , (punct)
terms frequency (nmod)
lymphoma mcl (appos)
re-exposure fluorescein (nmod)
treatment zonisamide (compound)
mrna cd36 (compound)
mechanisms current (amod)
changes serum (compound)
locomotion irritability (conj)
breast pancreaticobiliary (conj)
up-regulation presentation (conj)
improved movements (nsubj)
needed confirm (xcomp)
severe cumulative (conj)
assessed examination (nmod)
synthetase prostaglandin (compound)
neuroinflammation implications (dep)
detect patients (nmod)
measure context (nmod)
hyperplasia epithelium (compound)
step compartment (nmod)
respect this (det)
0.001 than (case)
treatment fluvastatin (nmod)
route intravesical (amod)
suggested teratogenic (ccomp)
tasks phonological (amod)
hypertension experimental (amod)
grafting marrow (compound)
nausea mouth (conj)
30mg/kg ) (punct)
encephalopathy headaches (conj)
licking presence (nmod)
concentrations creatinine (compound)
noted reductions (nsubjpass)
cytoplasm cell (compound)
employed background (nsubjpass)
therapy nsclc (nmod)
alive patients (nmod)
administered znso(4 (dobj)
adr serious (amod)
improve also (advmod)
conclusions effective (dep)
history diary (conj)
$ROOT$ thinning (sent)
affect mortality (dobj)
accumulation ester (compound)
provided review (nsubjpass)
received trihexyphenidyl (dobj)
high patients (nmod)
155 of (case)
haemopericardium . (punct)
study hospital (nmod)
erythroderma reaction (conj)
rats rat (conj)
chlorofluorocarbons of (case)
disease wilson (compound)
pharmacol mol (compound)
manifestations excitation (nmod)
length the (det)
conclusion indicate (appos)
lasted study (nsubj)
depletion dietary (amod)
period 3-year (amod)
increase be (cop)
dcf by (case)
switching mania (nmod)
examined records (dobj)
flecainide agents (conj)
function worse (amod)
observed ccr2 (nsubjpass)
analysis scores (nmod)
seizures be-induced (amod)
body the (det)
acitretin by (case)
curves osmotic (amod)
fibrosis perivascular (amod)
plasma to (case)
adopted has (aux)
glioma recurrent (amod)
propranolol with (case)
withdrawn h (nmod)
rates nitroprusside (compound)
cells capillary (compound)
disease graves (nmod:poss)
analyzed damage (nsubjpass)
suitable drug (nmod)
degrees with (case)
government to (case)
months interval (dep)
microscopy for (case)
corrected irregularity (nsubj)
$ROOT$ ability (sent)
elucidated . (punct)
binding their (nmod:poss)
katona and (cc)
remained au (nmod)
woman 81-year-old (amod)
25.7 - (punct)
analysis = (amod)
concluded and (cc)
determination fragmentation (nmod)
mri analyses (conj)
evident ( (punct)
found complication (xcomp)
count resistance (conj)
reversible but (cc)
0.9 5.6 (conj)
suggest channel (ccomp)
change of (case)
schedule time (compound)
evident proteinuria (nsubj)
arthritis but (cc)
infusion mesna (nmod)
pge2 by (case)
activation heart (nmod)
consistent blockade (nmod)
factors known (acl)
tacrolimus the (det)
repair to (case)
differ did (aux)
95 group (nmod)
died post-lt (advmod)
microg 100 (nummod)
easy prepare (xcomp)
steps increased (acl:relcl)
affect failure (nsubj)
phase during (case)
min 344 (nummod)
therapy tamoxifen (conj)
reported significant (parataxis)
reported results (nsubjpass)
deletion its (nmod:poss)
dizziness rash (conj)
alter any (dobj)
elevation troponin (conj)
higher values (nmod)
5.2+/-1.1 , (punct)
sign only (amod)
test motor (compound)
period on (amod)
produce manifestations (dobj)
differences mean (compound)
participate and (cc)
slow not (neg)
given ( (punct)
discontinuation source (nmod)
gamma-hexachlorocyclohexane lindane (appos)
mild least (advmod)
loss area (nmod)
effects prevented (acl:relcl)
networks two (nummod)
clipping after (case)
doses desferrioxamine (nmod)
reducing durations (dobj)
found patients (nsubjpass)
counts range (nmod)
mg/kg dose (nmod)
manipulated , (punct)
tumor granulosa (compound)
children of (case)
gradient marked (amod)
coassemble which (nsubj)
vehicle a (det)
before after (case)
dextran polysaccharide (compound)
analyzed therefore (advmod)
met 185 (nsubj)
preservation with (case)
suppressed successfully (advmod)
ppa , (punct)
$ROOT$ echocardiography (sent)
infused thereafter (advmod)
effects antithrombin (nmod)
deficiency acid-ergic (amod)
9 6 (compound)
week second (amod)
lesions abnormalities (conj)
microglobulinuria beta (compound)
psa testosterone (conj)
events complications (appos)
assess period (conj)
refine . (punct)
75 over (case)
lower subjects (nmod)
1.68 ci (dep)
go seizures (nmod)
variation pressure (compound)
produced studies (nmod)
effect aspirin (nmod)
8.5 was (cop)
acids free (amod)
outcome long-term (amod)
july september (conj)
extended that (mark)
paradigm retention (compound)
17 infusion (nmod)
angioplasty percutaneous (amod)
drug anticholinesterase (compound)
experiments identical (amod)
patients states (nmod)
control gspe (conj)
esterase neurotoxic (amod)
dementia to (case)
sacrificed range (nmod)
group control (compound)
bortezomib analysis (dep)
before shortly (advmod)
mg respectively (advmod)
important extend (xcomp)
given frequently (advmod)
address clinicians (nsubj)
weeks 13 (nummod)
option viable (amod)
scores scores (conj)
was aim (nsubj)
examinations patients (nmod)
ingestion with (nmod)
avoid . (punct)
cgi-sf ; (punct)
relations metrics (nmod)
used drugs (conj)
produced increase (dobj)
thrombosis % (nmod)
treatment e2 (nmod)
account . (punct)
acids fatty (amod)
composition , (punct)
pelvis renal (amod)
maximal declined (conj)
injected group (nsubjpass)
scarce options (nsubj)
case related (amod)
achieved results (dobj)
34 % (appos)
bau ) (punct)
purposes these (det)
affected whereas (mark)
studied hypotension (nmod)
patient eczema (nmod)
responses teoaes (compound)
setting . (punct)
program local (amod)
complained patients (dep)
resulted discontinuance (nsubj)
toxicology acute (amod)
mhb a (det)
considered % (nsubjpass)
all of (case)
mg/kg/day 300 (nummod)
positioning scanner (nmod)
subgroup surgery (compound)
group the (det)
found man (nsubjpass)
strokes brush (compound)
respond patients (nsubj)
administered day (nmod:tmod)
dyschromatopsy associated (acl)
hctz daily (advmod)
posturing , (punct)
appearance cavity (nmod)
dyscontrol and (cc)
sediment by (case)
160 or (cc)
reduced mice (nmod)
bradycardia arrhythmias (conj)
impacting exposure (dobj)
pattern alterations (nmod)
moderate stable (conj)
functioning , (punct)
shows rise (dobj)
odds times (nummod)
pr=0.515 ) (punct)
g/dl , (punct)
leiden mutation (conj)
model dis (dep)
parameters stimulation (compound)
significance synthesis (nmod)
receptor mu-opiate (compound)
tone intact (amod)
transplantation islet (compound)
hydroxyquinolines to (case)
acid-induced mefenamic (amod)
produced antagonism (dobj)
10 0.03 (compound)
suffering erythematosus (nmod)
needed determine (ccomp)
factor-alpha oxide (conj)
increased levodopa (nmod)
experienced started (advcl)
nephrolithiasis acetazolamide-induced (amod)
has recognition (nsubj)
$ROOT$ evaluation (sent)
motivational visual (conj)
ensure protection (nsubj)
suppressed synthesis (dobj)
mg/h 1 (nummod)
seen september (nmod)
scotoma an (det)
injected inadvertently (advmod)
cisapride substrate (appos)
level its (nmod:poss)
concentrations excretion (conj)
alpha-tocopherol deferoxamine (conj)
26- potent (dep)
pacing constant (amod)
hypotension failure (nmod)
develop observed (conj)
200 46 (conj)
combinations sub-effective (amod)
elevation p (dep)
however l-dopa (nsubj)
neurotoxicity hydroxyquinolines (nmod)
beta minutes (nmod)
education dyslipidemia (nmod)
factor ii (nummod)
declines pressure (nmod)
iu/l to (case)
detection echocardiographic (amod)
disorders psychiatric (amod)
composition levels (conj)
ttc ( (punct)
desferrioxamine dfo (appos)
observed relapse (nsubjpass)
antagonized drugs (nsubj)
% 0.9 (nummod)
reducing upon (mark)
combination amlodipine (appos)
administered mg/kg (nmod)
necessitate to (mark)
cardiomyopathy on (case)
therapy amlodipine (appos)
experienced incontinence (dobj)
value possible (amod)
weight function (conj)
conducted cases (nmod)
end-diastolic and (cc)
assessing of (mark)
occurring lid (nmod)
containing mg (dobj)
fas of (case)
prior weeks (nmod:npmod)
nassa ) (punct)
survival animals (nmod)
genes podocyte (compound)
men 67 (nummod)
induction on (case)
mg by (case)
variables diagnosis (conj)
ratio or (cc)
restoration performance (nmod)
man history (nmod)
observed found (conj)
populations among (case)
varied onset (nsubj)
vessels the (det)
identical pathophysiology (nsubj)
echocardiography . (punct)
preparation chloride (appos)
10mg/kg of (case)
layer or (cc)
infection immunodeficiency (compound)
coupled dose (nmod)
effects release (nmod)
combinations regimens (nmod)
factors nms (nmod)
link addresses (nmod)
artery mesenteric (amod)
91.5 range (dep)
identified if (mark)
results regimen (nsubj)
od [ (punct)
velocities and (cc)
effect caa (nmod)
cns , (punct)
explored effects (dobj)
$ROOT$ taking (sent)
acids , (punct)
azithromycin of (case)
produces succinylcholine (nsubj)
seven multiforme (nmod)
sensitive length (nmod)
as state (nmod)
reduced that (nmod)
raised regard (nmod)
monitor alterations (dobj)
increase indistinguishable (acl:relcl)
disrupts how (advmod)
effacement but (cc)
suspect infection (nmod)
perfusion-fixed and (cc)
1 transferase (appos)
increase number (nmod)
showed number (dobj)
dyskinesias with (case)
isomerase a (det)
patient : (punct)
1.98 +/- (cc)
direct and/or (cc)
difficult technically (advmod)
institution therapy (nmod)
orbitofrontal in (case)
suggests obtained (ccomp)
compared toxicity (dobj)
indeterminate , (punct)
medium by (case)
effects antineoplastic (amod)
conditions controlled (amod)
indicate misleading (ccomp)
disorder or (cc)
mg = (dep)
episode one (nummod)
demonstrated aggravation (dobj)
$ROOT$ compared (sent)
vasculitis autoantibody-positive (amod)
antagonist novel (amod)
shown had (aux)
epithelium tract (compound)
administered bolus (nmod)
site than (case)
lt of (case)
obtained puncture (nmod)
showed patient (nmod)
verapamil mg/d (appos)
reaction immediate (amod)
cld ( (punct)
accompany may (aux)
larynx cavity (conj)
crf creatinine (appos)
women supplementation (nmod)
acid fusidic (amod)
hypotension hg (nmod)
carcinoma cervix (nmod)
depressed preferentially (advmod)
remodelling through (case)
hypokalemia abolishment (conj)
defects associated (amod)
disruption stimulation (nmod)
recognition effects (nmod)
restarting it (dobj)
ability attenuate (acl)
reported sensation (nsubjpass)
albuterol . (punct)
mm 12.2 (nummod)
jaundice drug-induced (amod)
1986 1987 (conj)
induced statin (nmod:npmod)
drugs vitamin (compound)
comparison treatment (nmod)
telangiectasia and (cc)
nad-precursors of (case)
investigation careful (amod)
non-biodegradable or (cc)
administration prostaglandins (nmod)
involved hepatotoxicity (nmod)
rare serious (conj)
hyperalgesia induced (acl)
users never (neg)
histories about (case)
fibrillation by (case)
use vincristine (nmod)
standard care (nmod)
concept performs (ccomp)
modulates symptoms (dobj)
had 1990 (nmod)
induction remission (compound)
postponed , (punct)
occurred although (mark)
ls ; (punct)
acts fluvoxamine (nsubj)
died eighteen (nsubj)
challenge clinical (amod)
pituitary rat (compound)
cocaine smoking (compound)
7 to (quantmod)
started chemotherapy (nsubjpass)
mg 2 (nummod)
oral parenteral (conj)
eyes untreated (amod)
containing % (dobj)
problems diagnosing (advcl)
discontinuation pentamidine (nmod)
discontinued treatment (nsubjpass)
levels as (cc)
compacta pars (amod)
showed mice (nsubj)
corticoid of (case)
resolved it (nsubj)
ofh ( (punct)
temsirolimus inhibitor (appos)
increases production (nsubj)
group prophylactic (amod)
performance and (cc)
occurs tachyphylaxis (nsubj)
d1 and (cc)
neurotoxicity associated (acl)
non-hodgkin 's (case)
number glomerular (amod)
assigned enalapril (nmod)
analyzed therapy (nmod)
administration infants (nmod)
pressure expression (conj)
criteria dms-iii-r (compound)
initiated mg/kg (nsubjpass)
glepp1 ) (punct)
polyneuropathy and (cc)
phenylalanine acid (appos)
3,7-dimethyl-1-propargylxanthine ) (punct)
elevated % (dobj)
modulate threshold (dobj)
possible or (cc)
ability react (acl)
high-dose ; (punct)
leukocyturia area (conj)
replacement thyroid (compound)
activation apoptosis (nmod)
values no (neg)
catabolism of (case)
lt emergent (amod)
toxicity induced (amod)
rhythm to (case)
effect attenuating (amod)
stabilizers the (det)
picture resolved (acl:relcl)
u/l 220 (nummod)
affect schedule (nsubj)
52.7 - (punct)
inhibition xo (compound)
one fruste (dep)
reviews effect (dobj)
patient resuscitated (acl:relcl)
formyl-methionyl-leucyl-phenylalanine with (case)
prevention b (compound)
groups exercise-isoproterenol (compound)
process neuroinflammatory (amod)
nm of (case)
results analyses (nmod)
risks n=283 (appos)
clear mechanisms (nsubj)
cacl(2))-induced ( (punct)
deterioration : (punct)
syndrome locked-in (amod)
15/44 sgk1(-/- (nmod)
concentration citalopram (nmod)
19.8 4.6 (conj)
denervated procedure (nmod)
inducibility proliferation (nmod)
syndrome combined (amod)
insufficiency on (case)
ctnt in (case)
disturbances sleep (compound)
persisted movements (nsubj)
extension a (det)
beneficial be (cop)
3.4 was (cop)
trihexyphenidyl mg (amod)
measurement curve (nmod)
rats syndrome (nmod)
role injury (nmod)
ahf ) (punct)
4,957 827 (conj)
effect peak (amod)
associated medication (nmod)
50mg/kg , (punct)
cross-tolerant but (cc)
administered gd (nmod)
days weeks (dep)
marker that (mark)
psychosis disturbances (conj)
sensation to (case)
assessed later (advmod)
rat % (appos)
rats bile-diverted (amod)
lack programs (nmod)
related length (nmod)
findings microscopy (nmod)
four 12 (conj)
useful investigating (advcl)
cross-react antibodies (nmod)
complication objectives (nsubj)
associated elevation (nmod)
case demonstrated (acl)
drop 86 (nummod)
shown prevent (xcomp)
changes infusion (nmod)
patients coagulation (nmod)
$ROOT$ enlarged (sent)
exception cases (nmod)
hundred eighty-three (conj)
promoter bcp (appos)
protected administration (nsubj)
) 10(-4 (nummod)
converted vivo (advmod)
populations in (case)
specificity % (appos)
matter = (dep)
demonstrated would (aux)
affected are (auxpass)
number days (conj)
activity protective (amod)
therapy dexamethasone (compound)
stains from (case)
weeks abstinence (nmod)
focus role (nmod)
history maternal (amod)
carboplatin subtenon (amod)
hemorrhage intracranial (amod)
infused compared (conj)
pursued should (aux)
tool . (punct)
groups groups (conj)
platform test (nmod)
intrathecal it (appos)
incidence ct (nmod)
given 14 (nmod)
criteria reduction (nsubj)
conceivable it (nsubj)
investigate outcome (dobj)
jc ) (punct)
octapeptide cholecystokinin (compound)
delivered cortex (nmod)
quintiles across (case)
clinics out-patient (amod)
studies laboratory (compound)
amnesia for (case)
disorders agoraphobia (conj)
ci 0.9 (appos)
character pain (compound)
factors of (case)
sodium k)-atpase (nmod)
african south (amod)
introduction diagnosis (nmod)
anemia chemotherapy (nmod)
boys n (appos)
explanation interval (nmod)
model appropriate (amod)
started whether (advmod)
shift potassium (nmod)
involvement brain (compound)
nuclei paraventricular (amod)
dup of (case)
depressed sensitive (advcl)
consider physicians (nsubj)
hrptec ) (punct)
area terbutaline (compound)
memory spatial (amod)
signs poisoning (nmod)
gtn -23.7 (appos)
effects rate (nmod)
neurotoxin dsp4 (dep)
majority ( (punct)
methylation position (nmod)
neurons medulla (nmod)
stunning to (mark)
associated reductions (nmod)
retention in (case)
returned visit (nmod)
attracted . (punct)
concentrations w/v (appos)
cortex cerebral (amod)
increased period (dep)
77 four (quantmod)
prescribed that (mark)
evaluable total (nsubj)
age patients (nmod:poss)
reintroduction by (case)
ratio status (appos)
periods oscillations (nmod)
increased neuralgia (nsubj)
pointes due (case)
keratectomy myopic (amod)
complication as (case)
affecting metabolism (dobj)
subgroups presumed (acl)
splenic bone (conj)
stiffness jaw (compound)
rhythm myocyte (compound)
received procedures (nmod)
asystole lidocaine-induced (amod)
values ems (nmod)
read had (aux)
children 40 (nummod)
disease serious (amod)
3 ( (punct)
groups five (nummod)
have that (mark)
brought . (punct)
acid salvianolic (amod)
gradient osmotic (amod)
defect concentration (compound)
protect that (mark)
treatment antithrombin (compound)
rectified . (punct)
promoted control (nmod)
relevance clinical (amod)
risk agent (nmod)
octapeptides the (det)
role differential (amod)
diminished . (punct)
contracting chiefly (advmod)
veins vein (conj)
included oxacillin (nsubjpass)
s-312 s-312-d (conj)
had diagnosis (dobj)
studies additional (amod)
revealed has (aux)
shown incidence (nmod)
neonates received (acl:relcl)
g respectively (advmod)
rates . (punct)
n-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide fanft (appos)
associated whereas (mark)
experience macrolides (nmod)
patient per (case)
proportions epidemic (amod)
consequence level (nmod)
method test (acl:relcl)
cpr ( (punct)
ns tricuspid (dep)
given suprofen (dobj)
known mechanism (nsubjpass)
18 to (quantmod)
had infiltration (nmod)
avoided is (auxpass)
hours of (case)
that smokers (nmod)
involving women (dobj)
women reported (acl:relcl)
paclitaxel cyclophosphamide (conj)
arthritis the (det)
methotrexate solution (nmod)
balb/cbyj and (cc)
series subjects (nmod)
form fas (nmod)
injected mg/kg (parataxis)
developed pronounced (conj)
stimulation " (punct)
week short-term (appos)
antidote specific (amod)
subtle on (advmod)
doxorubicin mg/kg (nummod)
using assay (dobj)
lesion pulmonary (amod)
regressed totally (advmod)
scored summated (conj)
associations use (nmod)
pain venous (amod)
quiescent . (punct)
inactive while (mark)
pan weight (appos)
case polymyositis (nmod)
contributes prevention (dep)
lithium long-term (amod)
cholestasis therapy (nmod)
enhancement toxicities (conj)
activity model (nmod)
methadone to (case)
behavior ergometrine-induced (amod)
2.7 , (punct)
compared using (advcl)
evaluated rats (nsubjpass)
etiology hypercalcemia (nmod)
defect concentrating (amod)
8 99 (nmod)
ana of (case)
hepatic renal (conj)
crosses barrier (dobj)
determined methods (nsubjpass)
showed ultimately (advmod)
had colitis (dobj)
becoming common (acomp)
prodrug and (cc)
undergoes reorganization (dobj)
persists so (mark)
interaction doxorubicin (nmod)
treated septicemia (nmod)
proteinuria such (case)
p in (case)
increase vasoconstriction (nsubj)
decreases by (case)
described patient (nmod)
impairment renal (amod)
improvements stability (nmod)
ptld one (nmod)
receiving to (mark)
i.c.v. ) (punct)
progesterone estradiol (conj)
32.9 was (cop)
p= 0.71 (dobj)
rodents neonatal (amod)
adenoma of (case)
resolved restarted (conj)
increase least (advmod)
applications of (case)
administered been (auxpass)
confirmed closure (dobj)
tetra- 3717 (nummod)
mug hours (nmod)
g/m2 total (dep)
died patients (nmod)
antigen prostate-specific (amod)
lactate or (cc)
reversing effect (dobj)
treated insertion (nmod)
angina ) (punct)
chloride 4-aminopyridine (conj)
units centers (nmod)
$ROOT$ neuropeptide (sent)
lids in (case)
embryo on (case)
underwent assessment (dobj)
cytopenia due (case)
expected influence (ccomp)
fragments lc (nmod)
converted movements (dobj)
nephrotoxicity indinavir-associated (amod)
showed values (dobj)
trials two (nummod)
screenings women (nmod)
became administered (advcl)
effusions the (det)
important may (aux)
substantiate data (nsubj)
strokes for (case)
areas covered (acl)
background suggests (dep)
had examination (dobj)
ages group (nmod)
resulting puberty (nmod)
ic of (case)
10.1 +/- (cc)
confirm . (punct)
complications severe (amod)
associated presumably (advmod)
administration sumatriptan (nmod)
ampicillin for (case)
dihydropyridine the (det)
cases hyperplasia (nmod)
i vii (conj)
index non-invasive (amod)
that reported (acl)
comparisons statistical (amod)
designed evaluate (xcomp)
caused contrast (nmod)
segments three (nummod)
undergoing investigation (dobj)
k(+)-channels voltage-sensitive (amod)
veins , (punct)
finding current (amod)
interaction to (case)
stimulation 5v (compound)
hypertension treatment (nmod)
preparations weight-control (compound)
pneumonia causes (nsubj)
hospital multidisciplinary (amod)
failure recurrent (amod)
system defense (compound)
that p (dep)
assessed analysis (nmod)
patients 35 (nummod)
conjugates synthesis (dep)
stable were (cop)
tachycardia rats (nmod)
system ras (appos)
artery left (amod)
dose fazadinium (nmod)
northern and (cc)
k- the (det)
amikacin to (case)
produced reduced (conj)
conclude intermediate (advcl)
hypotension patients (nmod)
undertaken patients (nmod)
hypotheses rhabdomyolysis (nmod)
clonidine between (case)
reassurance have (acl)
opioid cholinergic (conj)
performed recovery (nmod)
extract ethanolic (amod)
postcards by (case)
lesions no (det)
occurring eeg (nsubj)
reduce captopril (nsubj)
purpose present (appos)
men weight (appos)
affected purpose (nsubjpass)
increased recovery (nmod)
evaluated challenge (nmod)
mg/kg 12 (nummod)
neonates , (punct)
catheters with (case)
inhibitor tafi (appos)
patients group (conj)
agents antipsychotic (amod)
patients 34 (nummod)
5,7-dht ( (punct)
genes enzyme (nmod)
investigated improve (ccomp)
nisoldipine of (case)
events cardiotoxicity (nmod)
decreased and (advmod)
occurred treatment (nmod)
hcl dose (appos)
25.6 +/- (cc)
cycles these (det)
had mobilization (nmod)
phosphokinase aminotransferase (conj)
results better (amod)
characterization tumors (nmod)
chf in (case)
results administration (nsubj)
block extradural (amod)
pustulosis for (case)
hepatotoxicity patient (nmod)
emphasizes action (dobj)
treatment associated (amod)
function to (case)
male hypothyroid (amod)
gyrus within (case)
crossed modalities (nsubjpass)
hypotension dysrhythmias (conj)
test forced-swimming (amod)
score zero (appos)
rats consuming (acl)
department hospital (nmod)
ring , (punct)
studied center (nmod)
movement minor (amod)
pain cardiac (amod)
first . (punct)
showing antagonist (nsubj)
requires treatment (nsubj)
demonstrate attenuates (ccomp)
rammer et (compound)
7.8 0.5 (nummod)
suspected be (auxpass)
rauwolscine map (appos)
company nj (appos)
needed cases (nmod)
occurrence effects (nmod)
= 0.0343 (dobj)
g 2 (nummod)
reported disturbing (nmod)
gpi within (case)
monotherapy after (case)
modification in (case)
design/methods : (punct)
preserved density (nsubj)
activity nte (compound)
gain substantial (amod)
active former (conj)
exclude data (nmod)
vlbw ( (punct)
eliminating after (mark)
relationship markers (nmod)
scale anxiety (compound)
produced injection (nsubj)
hilum duct (conj)
density . (punct)
end trimester (nmod)
reported augment (xcomp)
incidence ( (punct)
involve chiasm (dobj)
increases post-scr (amod)
bilirubin and (cc)
inhibits which (nsubj)
dosages mean (amod)
implicated playing (advcl)
than pbo (nmod)
reported groups (nsubj)
g/cm(2 653 (nummod)
2.5 ) (punct)
detected any (nmod)
patients deactivated (acl:relcl)
sequestration no (compound)
data including (case)
repression the (det)
glibenclamide by (case)
use cannabis (compound)
increases rate (nmod)
depressed were (cop)
started day (nmod:npmod)
research number (nmod)
microg 200 (nummod)
cimetidine , (punct)
occurring simultaneously (advmod)
adam10 mmp-2 (conj)
risk carcinoma (nmod)
livers rats (nmod)
dyskinesia malaysians (nmod)
mg 12.5 (nummod)
mg hydrochlorothiazide (nmod)
response antibody (compound)
effects l-arginine (nmod)
lamivudine combined (acl)
min injection (dep)
187 from (case)
starting clozapine (dobj)
occurs weeks (conj)
daily once (advmod)
0.97 , (punct)
hepatitis prolonged (amod)
faint as (mark)
group-1 dbs (dep)
base ventricular (compound)
employed is (auxpass)
$ROOT$ modulated (sent)
mg.kg-1 fentanyl (conj)
predictors and (cc)
lidocaine kg(-1 (conj)
sc/week ( (punct)
revealed movements (dobj)
pointes including (case)
angiodegeneration ) (punct)
ngf ) (punct)
mydriasis such (case)
coadministration lithium (nmod)
effects injections (nmod)
follow-up clinical (amod)
apoptosis of (case)
risk ahs (nmod)
determinant major (amod)
received theophylline (dobj)
subcortex groups (nmod)
controls robust (amod)
hyperfiltration glomerular (amod)
exhibited bradydysrhythmias (dobj)
effect clinical (amod)
require who (nsubj)
bolus of (case)
wall arterial (amod)
recur , (punct)
min start (nmod)
pathophysiology phenomenon (nmod)
promotes finally (advmod)
successful conducted (conj)
ganglion dorsal (amod)
node both (cc:preconj)
needle spinal (amod)
randomized crossover (dep)
controls cortex (nmod)
incidence 0.05 (appos)
calculation 3.1+/-1.0 (dep)
considered good (xcomp)
found compared (dep)
impact effects (nmod)
function properties (conj)
improves symptoms (dobj)
myocardiopathy on (case)
epithelium transitional (amod)
immediate but (cc)
abnormalities regional (amod)
oil olive (compound)
8 up (advmod)
globulin immune (amod)
endocarditis such (case)
extend taken (advcl)
intake long-term (amod)
hypertensive spontaneously (advmod)
seizure-prone and-resistant (cc)
tended had (conj)
discrimination allelic (amod)
changes msdbp (nmod)
duration cells (nmod)
activation central (amod)
patient encephalopathy (nmod)
reduction closed (amod)
repair or (cc)
avoid prevent (conj)
atorvastatin of (case)
dyskinesia patients (nmod)
toxicity bladder (nmod)
collapse cardiovascular (amod)
gsi ) (punct)
involves action (nmod)
neuralgia post-herpetic (amod)
downregulated strongly (advmod)
recorded myoclonus (nsubjpass)
hexachloro-1:3-butadiene and (cc)
obtaining after (mark)
recording injections (nmod)
unchanged ; (punct)
differed however (advmod)
occurred identified (ccomp)
administered opening (nmod)
trial phase (compound)
agitated confused (conj)
worsened decreased (conj)
dimensions mitral (amod)
signs apl (nmod)
june 2003 (nummod)
7.6 +/- (cc)
nephritis kidneys (nmod)
easy . (punct)
female hypertension (nmod)
rifampicin with (case)
$ROOT$ evaluated (sent)
treatment gum (compound)
rose but (cc)
evaluation therapy (nmod)
infiltration of (case)
exacerbated had (advcl)
model rodent (amod)
. , (punct)
onset symptoms (nmod)
gamma-glutamyltransferase gamma-gt (appos)
single dose (dep)
effects fetal (amod)
toxicity study (dep)
return of (case)
$ROOT$ reflect (sent)
prepared effectively (advmod)
characteristic . (punct)
regulates . (punct)
6.25 , (punct)
mouth , (punct)
elimination of (case)
immunohistochemistry hydroxylase (compound)
decrease sleepiness (nmod)
4 range (dep)
dose anesthetic (nmod)
dxnp ( (punct)
appropriate degree (nmod)
gly-phe-leu-gly ) (punct)
intraperitonealinjection an (det)
contraceptives of (case)
conducted and (cc)
investigate levels (dobj)
course platelets (nmod)
delivery infant (nmod)
inflamed in (case)
known remains (conj)
mediated rigidity (nsubjpass)
preceded excluding (advcl)
ascertained use (nsubjpass)
evidence other (amod)
5 with (case)
groups ii (dep)
reduced dyskinesias (dobj)
glomeruli controls (nmod)
shown effects (nsubjpass)
suggested cause (ccomp)
limits toxicity (nsubj)
puerperium the (det)
3.6 - (punct)
clozapine or (cc)
activator a (det)
injury . (punct)
ratios random (amod)
pretreatment day (amod)
lt before (case)
met users (advcl)
accident or (cc)
shr male (dep)
materials conducted (appos)
complications future (amod)
receiving . (dobj)
immunohistochemistry studies (conj)
136 to (case)
restlessness for (case)
underwent end-stage (nmod)
patients arrhythmias (nmod)
conceivable . (punct)
durations time (conj)
used estimate (advcl)
drowsiness hallucinations (conj)
inhibitors cholinesterase (compound)
compared detecting (advcl)
nephrotoxicity severe (amod)
sumatriptan with (case)
report outcomes (dobj)
challenge intravenous (amod)
$ROOT$ problematic (sent)
produced nmda (nmod)
modulators ) (punct)
implicated cardiomyopathy (nmod)
centre in (case)
proteinuria no (neg)
assessed barrier (nsubj)
easier use (xcomp)
induced endomt (nsubjpass)
depression minimal (amod)
g/day to (case)
become , (punct)
linked anesthetic (nmod)
increased rose (conj)
establishes exposure (nmod)
dependent protection (nsubj)
edema infiltration (conj)
angiopathy . (punct)
noticed hoarseness (dobj)
chronicity , (punct)
needs for (case)
required activity (nsubjpass)
using pdn (dobj)
glomerulonephritis formation (nmod)
resolved rapidly (advmod)
performed tumors (nmod)
failed . (punct)
hemoglobin her (nmod:poss)
igf-il-3 with (case)
symptoms rigidity (nmod)
session 10-min (compound)
complication occurring (acl)
necrosis tubular (amod)
group had (acl:relcl)
1/10 ) (punct)
procedures study (dep)
toxicities ( (punct)
mean hr (nmod)
depletions , (punct)
developed cows (nsubj)
diminishing morbidity (dobj)
tests liver-function (compound)
late abnormalities (nsubj)
conjunction transplantation (nmod)
integrate that (nsubj)
behavior motor (compound)
ingestion period (nmod)
added vigabatrin (nsubjpass)
bupropion g (nummod)
delineated pathways (nsubjpass)
found force (nsubjpass)
2.9-fold 5.1 (dep)
testing forced (amod)
values plasma (compound)
remained thalidomide (nmod)
conjunctiva the (det)
antagonized naloxone (nmod)
pressure including (case)
mouse rat (conj)
administered chemotherapy (nsubjpass)
$ROOT$ higher (sent)
affected can (aux)
dox after (case)
showed baby (nsubj)
monotherapy add-on (conj)
concentration moving-bands (conj)
reduced other (nmod)
rhythm on (case)
haemorrhages due (acl)
level release (conj)
dose ml (appos)
responses contractile (amod)
investigated order (dep)
gene bche (compound)
paroxetine hydrochloride (conj)
reports on (case)
uncommon regions (nmod)
revealed correlation (dobj)
interval ( (punct)
measuring viscosity (dobj)
temperature co2 (conj)
liver in (case)
tended patients (nsubj)
monitoring proteinuria (nmod)
doses mg/kg (dep)
assessment for (case)
convulsant cd50 (appos)
therapy proposed (amod)
development rate (conj)
studies immunologic (amod)
seizures patients (nmod)
3/8 ) (punct)
subscores akinesia (nmod)
received bupivacaine (dobj)
cause administration (nsubj)
activation 1-receptor (amod)
patient 45-year-old (amod)
treatment adr (nmod)
aggravated injury (nsubjpass)
examining by (mark)
antagonists glutamate (compound)
taking warfarin (dobj)
% 88.2 (nummod)
levels bupivacaine (compound)
failure arf (appos)
improves amnesia (dobj)
devastation the (det)
effect participants (nmod)
variants with (case)
taking were (aux)
wave an (det)
surge during (case)
determined prolactin (nsubjpass)
amide [ (punct)
adulthood in (case)
subject any (det)
increase induced (acl)
cause no (neg)
units cells (nmod)
predated warrant (conj)
measured minimum (nmod)
elevated was (aux)
shown modulate (xcomp)
had tended (conj)
patients apl (compound)
patients rendered (acl:relcl)
finished patients (nsubj)
action succinylcholine (nmod)
recommended use (nsubjpass)
0.02 ) (punct)
ninety-seven hundred (compound)
n6-cyclopentyladenosine cpa (appos)
mg/m2/24 ( (punct)
discontinuation tacrolimus (nmod)
release acetylcholine (compound)
reduced unaffected (conj)
6,3-dilactone 2,5-di-o-acetyl-d-glucaro-1,4 (compound)
index rate (compound)
chorea fever (conj)
exposure updated (amod)
analogue long-acting (amod)
persists which (nsubj)
$ROOT$ arises (sent)
administered once (advmod)
year a (det)
simvastatin-ezetimibe agent (compound)
prod , (punct)
diagnosis mouth (nmod)
study administration (compound)
dexamethasone benzodiazepines (conj)
heat from (case)
discontinued reduced (conj)
administered s.c. (advmod)
assessed using (advcl)
rare effects (nsubj)
onset amnesia (nmod)
reflect may (aux)
gr administered (acl)
treated he (nsubjpass)
addicts of (case)
inhibition bcnu-induced (amod)
discontinuations patient (compound)
$ROOT$ concerns (sent)
rats iprindole-treated (amod)
amounts small (amod)
p<0.02 ) (punct)
six % (appos)
uncertainty the (det)
cells medulla (nmod)
results tests (nmod)
admissions to (case)
test increase (ccomp)
densities the (det)
on-state in (case)
edema drug-related (amod)
added hydrocortisone (nsubjpass)
pg-9 microg (dep)
hrs 8 (nummod)
replicate that (mark)
report may (aux)
staining immunofluorescent (amod)
role for (case)
bortezomib : (punct)
area cross-sectional (amod)
hcbd or (cc)
efficient as (advmod)
propensity in (case)
ptra with (case)
alter caffeine (nsubj)
younger significantly (advmod)
suggest produced (ccomp)
polychemotherapy if (nmod)
paralysis persistent (amod)
started disappeared (conj)
responsible decrease (nmod)
total 155 (nmod)
inactivate warfarin (dobj)
5 14 (conj)
had rats (advcl)
617 50 (conj)
delirium acute (amod)
93 , (punct)
strategies treatment (nmod)
age . (punct)
led patient (nmod)
showed ra (nsubj)
dermatitis lichenoid (amod)
single split (conj)
4-diphenylacetoxy-n-methylpiperidine m(1)/m(3)/m(5)-selective (appos)
channel channel (conj)
erythematosus in (case)
< weeks (dep)
shortened ms (nmod)
preceded pain (nsubjpass)
cells hrptec (appos)
showed constriction (dobj)
excluded could (aux)
level resulting (acl)
encephalopathy reversible (amod)
injection twice (advmod)
period median (amod)
neuralgia , (punct)
lethargy and (cc)
causes cocaine (nsubj)
vasoconstriction with (case)
stl1 and (cc)
amns ( (punct)
achieved patients (nmod)
sympathomimetic similar (acl:relcl)
assessed dogs (nmod)
transferase a (det)
evaluated total (nsubjpass)
patient renal (amod)
exacerbates supporting (advcl)
disadvantages other (amod)
41 range (dep)
delta22-isomer the (det)
type proven (acl)
pod , (punct)
courses 12 (nummod)
has disappearance (dobj)
effective implications (nsubj)
d within (case)
sensitivity general (amod)
costs health-care (compound)
cortex kidney (nmod)
ligands selective (amod)
nitroprusside during (case)
aware pregnancies (nmod)
controls naive (amod)
hydration and (cc)
sensitivity ligands (nmod)
effect benign (amod)
suggesting condition (dobj)
similar results (nsubj)
essential bladder (nsubj)
118 28 (conj)
exposures cumulative (amod)
solvd ( (punct)
come days (nmod)
number treatments (nmod)
153 , (punct)
test allows (ccomp)
antioxidants endogenous (amod)
$ROOT$ that (sent)
one more (advmod)
sf36 ( (punct)
remission a (det)
reaction such (case)
period lesion (nmod)
mrna tlr4 (compound)
ortral and (cc)
time thromboplastin (compound)
reference haemorrhage (nmod)
autoimmune metabolic (conj)
4.6 ( (punct)
discharged cta (nmod)
cardiotoxicity cocaine (nmod)
matrix cristae (conj)
cases rupture (nmod)
reverse . (punct)
drug nonselective (amod)
used time (xcomp)
controls nitrendipine-treated (conj)
dosing prior (amod)
commenced was (auxpass)
constituents of (case)
task , (punct)
ileum pig (compound)
deaths of (case)
mg/kg/day cases (nmod)
tetany due (amod)
uptake fractions (nmod)
hypotension rilmenidine (compound)
useful necessary (advcl)
caffeine acetaminophen (conj)
0.9 2.7 (conj)
patients experienced (acl:relcl)
agc primary (amod)
$ROOT$ restarted (sent)
establishes model (dobj)
influence drugs (nsubj)
nanosphere novel (amod)
therapeutic but (cc)
discontinuation drops (nmod)
occurs which (nsubj)
therapy eaca (compound)
increase constant (conj)
dose incidence (conj)
0.75 ; (punct)
control movements (dobj)
designed clarify (xcomp)
present expression (nsubj)
effects aconitine (nmod)
cirrhosis liver (nmod)
correlated enhancement (nmod)
treatment saline (compound)
653 174 (conj)
imidazo[1,5-a]-pyrrolo-[2,1-c][1,4]benzodiazepine-1-carboxylate ( (punct)
amiodarone and (cc)
excitability neural (amod)
drg cystitis (nmod)
asthma with (case)
entropion from (case)
described knowledge (nmod)
included hypercalcemia (dobj)
evaluated are (auxpass)
b6 of (case)
hemorrhaging frequent (amod)
exclude aetiology (dobj)
monitored study (nmod)
count + (amod)
deoxycholate ; (punct)
evaluated level (nmod)
increased activities (nsubjpass)
studied catheter (nmod)
stabilize caffeine (nsubj)
= 33 (dobj)
testosterone low (amod)
disease collagen (compound)
= 1 (dobj)
anemia on (case)
completed battery (dobj)
system culture (compound)
hallucinations visual (amod)
g 0.48 (nummod)
inhalation by (case)
amplified primers (nmod)
prescribed had (aux)
1,000/mm3 than (case)
inoculation monkeys (nmod)
$ROOT$ ethopropazine (sent)
$ROOT$ favour (sent)
approaches new (amod)
artery vertebral (amod)
five > (dep)
blindness and (cc)
injected animals (nsubjpass)
reported remained (advcl)
patients 110 (nummod)
probable that (mark)
presence pseudoacromegaly (nsubj)
dynamics patients (nmod)
medium mg(2+)-free (amod)
minimize ischaemia (dobj)
submitted agency (nmod)
mg ; (punct)
progression slow (amod)
control induction (nmod)
potentiate twitches (dobj)
necrosis change (conj)
rise hg (nmod)
remained potentiated (xcomp)
considerations practical (amod)
malaria severe (amod)
promote atherosclerosis (dobj)
returned week (nmod)
racemic ( (punct)
30 45 (conj)
values measured (acl)
familiar to (mark)
indicating need (dobj)
followed injection (nmod)
undertaken field (nsubjpass)
bundle in (case)
immunoassay a (det)
examined dose (dobj)
experienced reduction (dobj)
formed inclusions (nsubjpass)
definition a (det)
activate pparalpha (dobj)
acute progressive (dep)
undertaken examine (xcomp)
variable extension (nsubj)
abnormality activity (nmod)
association cc (nmod)
cystitis cyclophosphamide (compound)
ie ) (punct)
compounds rats (nmod)
cystitis by (case)
rtm204i or (cc)
$ROOT$ manifests (sent)
damages endings (dobj)
hypotension both (preconj)
awake while (mark)
pathogenesis destruction (nmod)
had deterioration (dobj)
regarded , (punct)
accumulation tissues (nmod)
min 25 (nummod)
died injection (nmod)
vasculature of (case)
hepatotoxicity halothane (nmod)
world in (case)
enucleated subsequently (advmod)
inhibitor synthase (compound)
protein gfp (appos)
suffered still (advmod)
fpdc ( (punct)
monotherapy monotherapy (nmod)
interval pr (compound)
% ipratropium (nmod)
possesses concentration (nmod)
leading apoptosis (nmod)
expression horn (nmod)
declined rapidly (advmod)
induced adr (nsubj)
hydroperoxides lipid (compound)
affected affected (ccomp)
$ROOT$ precluded (sent)
colocalized immunostaining (nsubj)
synthesis de-novo (amod)
stages to (case)
disease relapsed (amod)
led 2 (nmod)
increased enhanced (conj)
months 23 (nummod)
tolerance good (amod)
hernia dh (appos)
deletion mtdna (compound)
min-1 cbf (nsubj)
suggests mechanisms (dobj)
dilation pupillary (amod)
enantiomer synthetic (amod)
accounting duration (nmod)
register cochrane (compound)
flavonoids present (acl:relcl)
les in (case)
average by (case)
bradykinesia and (cc)
have common (nmod)
mice pkc-alpha (compound)
given analgesics (nsubjpass)
that dopac (nmod)
retention retrieval (conj)
noticeable time (nmod)
(-)-propranolol of (case)
understood poorly (advmod)
volunteer the (det)
mice in (case)
yet times (nmod)
responsible is (cop)
roles modulating (acl)
use disease (conj)
given weeks (nmod)
sufficient precipitate (xcomp)
associated agent (nsubjpass)
inducing dogs (nmod)
reticulata snr (appos)
resumed , (punct)
$ROOT$ slower (sent)
leukaemia refractory (amod)
relationship suppression (nmod)
disease system (compound)
evidence tuberculosis (nmod)
up micrograms/kg (nmod)
cause strains (nmod)
depression central (amod)
treatment vehicle (compound)
intervals treatment (nmod)
exhibited did (advcl)
cirrhosis severe (amod)
group blockers (nmod)
attributed patients (nmod)
doses nonconvulsive (amod)
indicated due (ccomp)
measurements quantitative (amod)
had we (nsubj)
dermatitis due (amod)
antagonism 4-damp (compound)
penetrate do (aux)
assessed rates (nmod)
ls ( (punct)
group dogs (nmod)
h. 48 (nummod)
rats parameters (nmod)
artery normal (amod)
group one (nummod)
hundred thirty-five (conj)
film an (det)
applied starting (advcl)
conclusions recognized (dep)
produce dyskinesia (dobj)
response stereotypic (amod)
groups p10 (compound)
hundred one (compound)
administration hemisuccinate (compound)
bonding gln223 (nmod)
elevation prolonged (amod)
infusion phenylephrine (compound)
proportion vaccinated (acl:relcl)
trial lidocaine (nmod)
thresholds higher (amod)
report restlessness (nmod)
scintigraphy and (cc)
reactivity system (nmod)
fk inc (appos)
safe potent (conj)
plasticity pas-induced (amod)
dyskinesias or (cc)
inhibited parameters (dobj)
dissociated characteristics (nsubjpass)
ngf urinary (amod)
attenuation dose-dependent (amod)
investigated tolerability (dobj)
treated 2 (meta)
stage initial (amod)
relation sensitization (nmod)
cholestasis lasting (amod)
underwent died (conj)
inhibitor ) (punct)
prevention cystitis (nmod)
group lamivudin (compound)
reached and (cc)
length cycle (compound)
swallow modified (amod)
level dehydrogenase (compound)
opportunity the (det)
wasting respiratory (amod)
slower that (nmod)
mellitus new-onset (amod)
conducted hospital (nmod)
discontinued 5 (nsubj)
catechol hydroquinone (conj)
infusions morphine (nmod)
less 100/mm3 (nmod)
rigidity opiate-induced (amod)
erythropoietin and (cc)
needed and (cc)
p=0.003 , (punct)
assessed method (nmod)
risk at (case)
degrees impairment (nmod)
hr p (dep)
approaches adjustment (nmod)
remains improving (csubj)
anxiety confusion (conj)
structure renal (amod)
l-alpha-gfc placebo (conj)
significance . (punct)
dose 2.0-mg (nummod)
ml 1 (nummod)
loss activity (nmod)
revealed evaluation (nsubj)
provided results (dobj)
agitation delirium (conj)
essential modifications (nmod)
combination mg (nmod)
divided , (punct)
injected when (advmod)
$ROOT$ defined (sent)
efficacy because (case)
myopathy progressive (amod)
doses , (punct)
acting direct (amod)
effects threshold (nmod)
mitigated , (punct)
presents results (dobj)
404 , (punct)
reported mortality (dobj)
beats of (case)
enantiomers its (nmod:poss)
group iodixanol (compound)
enhancement unique (amod)
value mg (appos)
groups among (case)
months clozapine (appos)
rate onset (nmod)
contributes whether (mark)
cholinesterase of (case)
tumors intestinal (amod)
detected p (dep)
minutes the (det)
propranolol placebo (conj)
admitted starting (advcl)
incidence cancer (compound)
syndrome induced (acl)
mg/m(2 cisplatin (nmod)
fat the (det)
release and (cc)
analysis conjunction (compound)
= 0.021 (dobj)
head lateral (amod)
znso(4 ) (punct)
depleted treatment (nsubj)
obtained spect (nmod)
provide profile (dobj)
incidence years (nmod)
$ROOT$ availability (sent)
compared : (punct)
problem haemorrhages (nsubj)
blocker beta-receptor (compound)
polydrug non-ecstasy (amod)
seizures surgery (nmod)
three , (punct)
recovers , (punct)
questions : (punct)
tendency procoagulant (amod)
setting hospital (appos)
mg dose (nummod)
function left (amod)
release ach (nmod)
pharmacology . (punct)
re-started were (auxpass)
0.899 - (punct)
agents forms (conj)
intolerance oac (nmod)
treatment nimodipine (compound)
transdermal subcutaneous (conj)
studies dose (conj)
bfu-e ) (punct)
hypotension resolved (acl:relcl)
lymphocytes the (det)
$ROOT$ potential (sent)
contributed component (nsubj)
found trials (dobj)
mg/kg i.p. (appos)
conclusions finding (appos)
beta-adrenoblocking and (cc)
showed curves (dobj)
susceptibility on (case)
appears and (cc)
analysis logistic (amod)
abnormal . (punct)
reaction may (aux)
2.4 - (punct)
days lifetime (amod)
minimize in (mark)
embryos from (case)
suggests excess (nsubj)
processing on (case)
nephrin dendrin (conj)
apply remain (advcl)
25/100 controlled-release (conj)
acid region (nmod)
prove etomidate (nsubj)
others two (nummod)
sign which (nmod)
anticoagulant treat (acl)
due drugs (nmod)
protective cse (nsubj)
identify quantify (conj)
broadens type (nsubj)
mg/kg 4.5 (nummod)
exhibited , (punct)
inadequate are (cop)
inhibitor gaba(a)rs (nmod)
exacerbated ethanol (nmod)
% prevalence (nsubj)
prolongation treatment (nmod)
del taqia (conj)
tested metabolites (nsubjpass)
restarted patients (nsubjpass)
achieve diagnosis (dobj)
provides embryo (nsubj)
use pain (conj)
irritability abc (nmod)
31 and (cc)
cacl(2)-treated nacl-treated (conj)
arrest delayed (amod)
naloxone clonidine (conj)
ill referral (nmod:npmod)
agitation psychomotor (amod)
race/ethnicity obesity (conj)
$ROOT$ exhibit (sent)
separated breaks (nmod)
changes while (mark)
lomustine ( (punct)
spectrum due (acl)
had potassium (dobj)
received months (nmod)
regimen , (punct)
side-effects two (nummod)
prevention recurrence (nmod)
monkeys of (case)
hepatitis ticlopidine-induced (amod)
fractions identical (amod)
common events (nsubj)
anorectics in (case)
take also (advmod)
materials report (dep)
hospitals university (compound)
parameters all (det:predet)
75 ) (punct)
rats exposed (acl)
case ( (punct)
rtm204i ( (punct)
dizocilpine by (case)
likely women (nsubj)
$ROOT$ investigate (sent)
ameliorates administration (nsubj)
cephalosporins all (det)
decreased injection (nsubj)
% preoperatively (advmod)
determining by (mark)
shifts as (cc)
pairs forty (nummod)
8 +/- (cc)
effect hiv-induced (amod)
measurements to (case)
renoprotective were (cop)
part at (advmod)
challenged ml/kg (nmod)
receiving longer (advmod)
facilitated increased (conj)
died has (aux)
is there (expl)
onset necrosis (nmod)
patients myopathic (amod)
weeks cessation (nmod)
cocaine engendered (acl)
feature unusual (amod)
binding irreversible (amod)
physostigmine than (case)
movements and (cc)
rhythm beating (amod)
smokers who (nsubj)
pose factor (dobj)
used determination (nsubjpass)
agents effective (amod)
flecainide mg (appos)
required control (xcomp)
effect cinacalcet (nmod)
less irritation (nsubj)
iva ] (punct)
polydrug pd (appos)
unsafe carries (conj)
metabolised are (auxpass)
14.3 ; (punct)
effects adults (nmod)
isolated blocks (conj)
neuropathy the (det)
syndrome obstructive (amod)
myelin and (cc)
changes ammonia (nmod)
$ROOT$ self-limiting (sent)
related recur (conj)
started : (punct)
ci=6.702 95 (amod)
concentration bupivacaine (nmod)
showed correlations (dobj)
complex broad (amod)
impact study (nmod)
resulted changes (nmod)
granulocytosis myelodysplastic (amod)
limited safety (nmod)
revealed controls (nsubj)
schizophrenia for (case)
atypicality ) (punct)
lactate solutions (dep)
kindling ) (punct)
93.3 vs. (cc)
effect stimulant (amod)
results followed (acl)
factor hypothyroidism (nmod)
aware oncologists (nsubj)
calculated risk (nsubjpass)
thought linked (xcomp)
injection only (advmod)
changes on (case)
dx with (case)
central pubmed (compound)
lidocaine plus (cc)
mmhg 22/11 (nummod)
tumor ascites (compound)
effects thp (nmod)
difficulties sexual (amod)
different prevalences (nsubj)
inhibition synaptic (amod)
dizziness weakness (conj)
implicating clarithromycin (dobj)
determined charge (nsubjpass)
$ROOT$ block (sent)
decreases ; (punct)
treatment pcp (nmod)
use sedatives (nmod)
gastrocnemius anterior (conj)
craniotomy to (case)
has is (cop)
8.75 vs. (cc)
normalization state (conj)
1.86 ) (punct)
coefficient coefficient (conj)
rats d-treated (amod)
associated nitrofurantoins (nsubjpass)
abolished had (parataxis)
identified subsets (nsubjpass)
verified . (punct)
preinfusion ( (punct)
role contributing (acl)
exposure appetite-suppressants (nmod)
mg dexamethasone (compound)
number ) (punct)
appeared foci (nsubj)
tolerated levetiracetam (nsubjpass)
correlation dose (nmod)
dysrhythmias postinfarct (amod)
model ocd (nmod)
showed dose (nmod)
range levels (conj)
misleading be (cop)
activation of (case)
$ROOT$ thalidomide (sent)
cessation exposure (nmod)
10 to (quantmod)
excess mineralocorticoid (compound)
$ROOT$ infection (sent)
failed allopurinol (nsubj)
escalation weeks (nmod:tmod)
exceed not (neg)
3alpha-hydroxy-5beta-pregnan-20-one ) (punct)
tolerated valsartan (nsubjpass)
$ROOT$ changed (sent)
progressive irreversible (conj)
higher more (advmod)
exceeds mg/m2 (dobj)
dysosmia . (punct)
treated ptra (nmod)
duration therapy (nmod)
somnolence difficulties (conj)
presented fibrosis (dobj)
lower reduction (nsubj)
increases marked (amod)
rise patients (nmod)
objective complete (dep)
appear whenever (advmod)
prescribing of (case)
lead slowing (nmod)
added unable (advcl)
induces it (nsubj)
diet high-salt (amod)
antigen varidase (compound)
patient nulliparous (amod)
documents compliance (dobj)
monitored should (aux)
variable difference (nsubj)
patient treatment (nmod)
allocated subjects (nsubjpass)
considered and (cc)
hit regarding (case)
sectioned brains (nsubjpass)
na-k-atpase the (det)
supervision close (amod)
modify seizures (dobj)
animals of (case)
treated untreated (conj)
activity increase (conj)
loss appetite (nmod)
% extent (nsubj)
12.1 - (advmod)
patients good-risk (amod)
platform of (case)
g ; (punct)
nephropathy with (case)
mg/l > (amod)
potent and (advmod)
conducted determine (xcomp)
formation bonding (nmod)
micrograms/kg/hr of (case)
drugs from (case)
quality survival (conj)
given when (advmod)
prevention deficit (nmod)
oxide cell-derived (amod)
behaviors these (det)
men belonging (acl)
elevated ctnt (nsubj)
ifosfamide mesna (conj)
effect antiarrhythmic (amod)
fluorthyl- ptz-induced (conj)
infiltration myocardium (nmod)
clonus to (case)
support limitation (advcl)
helpful not (neg)
sulphoxide dimethyl (amod)
protection cs-mediated (amod)
resembles pathology (nsubj)
enzyme rt (compound)
deviation standard (amod)
excretion hour (amod)
exhibit did (aux)
paralysis . (punct)
constitutes best (nmod)
derived plasma (nmod)
3.8 - (advmod)
methscopolamine both (cc:preconj)
changes glial (amod)
% 15 (nummod)
visit follow-up (amod)
peptide c-type (amod)
effect ) (punct)
320 x (advmod)
phosphokinase of (case)
protein egfp (appos)
mg low-dose (punct)
95 - (punct)
occurred decrease (nsubj)
scale according (case)
patients defects (nmod)
use immunomodulators (nmod)
min 18.3 (nummod)
abnormalities adc (compound)
35/15 - (punct)
regimens other (amod)
abundant irrespective (advmod)
bradykinin hoe (conj)
treated cycles (nmod)
stratified participants (nsubjpass)
rigidity in (case)
glutamine related (amod)
scale -- (punct)
investigations previous (amod)
elicit will (aux)
has reversing (advcl)
= 8) (punct)
slope cells (nmod)
amounts cocaine (nmod)
compared newborns (nsubjpass)
staining dna (compound)
impaired and (cc)
phenotype of (case)
response acoustic (amod)
edema shock (conj)
carotid intradural (amod)
review literature (dobj)
stopped using (xcomp)
linking rpn (dobj)
administrated lymphocytes (nmod)
risk used (advcl)
diseases with (case)
aggravated were (auxpass)
summarizes experience (dobj)
involved trials (nmod)
myelosuppression mice (nmod)
produced review (nsubj)
affect concentrations (dobj)
risk switching (nmod)
male and (cc)
prescribing it (dobj)
capacity concentrate (acl)
decreased 7.1 (nmod)
obtained changes (dobj)
acknowledged regarded (advcl)
effects demonstrable (amod)
been reports (attr)
one = (dep)
air dry (amod)
mal grand (amod)
pretreatment intravenous (amod)
evaluation better (amod)
h 12 (nummod)
monitoring . (punct)
stenosis > (amod)
hypoactivity ecstasy-specific (amod)
development disorders (nmod)
induced cyclophosphamide (nmod)
cases advanced (amod)
= 30 (dobj)
media to (case)
mice subjected (acl)
people reported (acl:relcl)
formulation % (appos)
sexes the (det)
dronedarone compound (appos)
dextrose % (appos)
it ( (punct)
abnormality appeared (acl:relcl)
mosmol/kg 263 (nummod)
increased 1 (nmod)
a acid (compound)
neuropathy emb-induced (amod)
rate 70/min (nmod)
present patients (nsubj)
brainstem the (det)
interactions warfarin-drug (compound)
groups similar-sized (amod)
treatment errors (appos)
developed arrhythmias (dobj)
toxic on (case)
abundances the (det)
cortex , (punct)
sedation department (nmod)
disorders system (nmod)
acid fatty (amod)
amb spironolactone (conj)
those symptoms (conj)
degree inhibition (nmod)
categorized were (auxpass)
protection erdosteine (nmod)
min already (advmod)
psychosis patients (nmod)
model model (appos)
caused deprivation (nmod)
remained tachyarrhythmia (nsubj)
prevented death (dobj)
tachycardia the (det)
potassium serum (compound)
wore disturbances (nsubj)
acetate the (det)
field human (amod)
observed se (nmod)
was form (nmod)
enhanced startle (nsubjpass)
female but (cc)
subtype metabotropic (amod)
increases p75(ntr)-ir (nmod)
stabilized was (auxpass)
6/15 eyes (nmod)
type type (appos)
completed inventory (dobj)
observed excess (nsubjpass)
examinations repeated (amod)
cells mt4 (compound)
exhibit patterns (dobj)
demonstrated ability (dobj)
evidence hepatotoxicity (nmod)
changes or (cc)
stunning be (cop)
contact dormex (nmod)
degree only (advmod)
small although (mark)
minute 30 (compound)
scopolamine or (cc)
revealed also (advmod)
term long (amod)
risk effects (nmod)
nuclear and (cc)
morphine pre-test (amod)
is srl-based (amod)
tapped sedated (conj)
ami days (nmod)
showed susceptibility (dobj)
ibs ) (punct)
growth , (punct)
ica ( (punct)
3.5+/-0.9 of (case)
detected limitation (nsubjpass)
received ps (nsubj)
this , (punct)
deterioration the (det)
induced diazinon (nmod:npmod)
protects dithiocarbamate (nsubj)
exfoliation frequent (amod)
encephalopathy metronidazole-induced (compound)
complexes immunophilin-drug-calcineurin (amod)
function control (nmod)
accentuante progression (dobj)
day gestational (amod)
lectin uea1 (appos)
received prazosin (dobj)
many twice (advmod)
update in (case)
in even (advmod)
nsclc against (case)
hindpaw rat (nmod)
aminotransferase of (case)
followed restoration (nsubj)
carbimazole ( (punct)
weeks 16 (nummod)
lamivudine and/or (cc)
result above (amod)
stopped . (punct)
regimen following (case)
stopped who (nsubj)
g/dl than (case)
common visits (nmod)
tumors malignant (amod)
$ROOT$ immunosuppressed (sent)
group representative (acl:relcl)
undergone transplantation (dobj)
times min (nmod)
response les (compound)
remained mg. (nmod)
resulted results (nsubj)
levels pge2 (compound)
strategy cta (compound)
paralysis glutamate (conj)
controls 650 (nummod)
addition with (case)
myositis inflammatory (amod)
coagulation and (cc)
received thalidomide (dobj)
technique palkovits (nmod:poss)
reduced p (dep)
function such (case)
planned work (nsubjpass)
refused , (punct)
studies deferens (dep)
agonists of (case)
diseases studied (acl)
desorption/ionization and (cc)
inhibitor oxide (compound)
lower intensity (nsubj)
continue not (neg)
microgram/kg/min 0.1 (nummod)
period across (case)
$ROOT$ disappearing (sent)
cats on (case)
discount mechanism (nmod)
room ( (punct)
t(1/2 ) (punct)
then months (nmod)
reversion rapid (amod)
others the (det)
actions hypotensive (amod)
nuclei bilateral (amod)
occurrence events (nmod)
500 to (quantmod)
man administered (acl:relcl)
chicago , (punct)
factors peld (nsubj)
rats compared (case)
importance pathogenesis (nmod)
symptoms signs (conj)
mechanism action (nmod)
exhibited vitro (advmod)
full almost (advmod)
alleviate treatment (nsubj)
decrease cent (nmod)
areas six (nummod)
cancer on (case)
effects normalizing (amod)
efficacy anticancer (amod)
receptor kinase (compound)
proteinuria high-grade (amod)
consider vasculitis (dobj)
acid , (punct)
sensitive specific (conj)
dogs insufficiency (nmod)
side-effects the (det)
autopsy at (case)
antagonist a2a/a1 (compound)
nimesulide of (case)
duration immobility (nmod)
changes brought (acl)
determine resulted (ccomp)
studies artery (compound)
cardiomyopathy against (case)
patients history (nmod)
early late (conj)
aspects concerning (acl)
tablet another (det)
woman hyperthyroidism (nmod)
box novel (compound)
results ischaemia (nsubj)
presented , (punct)
actions marked (amod)
depression cyanosis (conj)
infection mortality (conj)
restore pressure (dobj)
modulates pain (nsubj)
pro-inflammatory and (cc)
reactions mild (amod)
defined yet (advmod)
amide by (case)
toxicity uncommon (amod)
measure(s outcome (compound)
treated anticonvulsants (nmod)
became he (nsubj)
techniques fastblue (nmod)
suggest ameliorate (ccomp)
decreased % (parataxis)
rates different (amod)
intervention , (punct)
b. group (compound)
mug ( (punct)
d2r of (case)
hands and (cc)
-0.07 -0.34 (nummod)
connections interendothelial (amod)
achieved been (auxpass)
two these (nmod)
procedure the (det)
treated thyroxine (nmod)
associated reduced (conj)
required treated (ccomp)
p58 ( (punct)
trated bromperidol (nmod)
$ROOT$ teratogenicity (sent)
$ROOT$ years (sent)
involved activation (nmod)
rates higher (amod)
corresponding inability (nmod)
study audiometric (amod)
ah6809 antagonist (conj)
higher to (mark)
one fourth (quantmod)
delay the (det)
require however (advmod)
icrf-187 ( (punct)
$ROOT$ h (sent)
loreclezole of (case)
examinations neurologic (amod)
correlated , (punct)
enhanced 3.4-fold (advmod)
response caffeine (nmod)
cause most-frequent (amod)
225 250 (conj)
markers and (cc)
risk hyponatremia (nmod)
intake following (case)
86.7 +/- (cc)
layer dentate (compound)
effective nodosum (nmod)
$ROOT$ increased (sent)
acid (rs)-1-aminoindan-1,5-dicarboxylic (compound)
levels females (nmod)
received tamoxifen (dobj)
effusion neuropathy (conj)
toxic or (cc)
develop not (neg)
nerve peripheral (amod)
gaba(a)rs ) (punct)
movement restricted (amod)
preparation isolated (amod)
value from (case)
change output (nsubj)
influence naloxone (nmod)
% in (case)
nephropathy reduced (acl:relcl)
properties ssr103800 (nmod)
action drugs (nmod)
dose mg (amod)
develop reactions (dobj)
identical effects (nmod)
transplants from (case)
six cases (nmod)
etiology other (amod)
warn group (nsubj)
lozenge the (det)
preserved are (auxpass)
separation sedimentation (conj)
degrees 90 (nummod)
scheduled : (punct)
induction for (case)
loss paresthesia (conj)
acid uric (amod)
patients 25 (nummod)
assessed age (nsubjpass)
ibuprofen mg/kg (appos)
diethylpropion of (case)
transplantations performed (acl)
girl leucemia (nmod)
damage hepatic (amod)
session acquisition (compound)
conjugate one (nummod)
reports twenty-one (nummod)
prolongation > (dep)
80 mmhg (conj)
gnc92h2 mg/kg (appos)
reached once (mark)
field view (nmod)
hernia = (dep)
influence reorganization (dobj)
enzymes . (punct)
cytological architectural (conj)
change weakness (conj)
administration anp (nmod)
states into (case)
diagnostic or (cc)
analysis septal (nmod)
administered micrograms (nsubjpass)
shows that (mark)
aminoglycoside plus (cc)
cvds ) (punct)
administration months (nmod)
occlusion temporary (amod)
conclude induces (ccomp)
gds 17 (nummod)
level obtained (acl)
normality of (case)
level dopamine (compound)
phenothiazines antidepressants (conj)
described " (punct)
stroke tia (conj)
8.4 3.8 (conj)
demonstrates conclusion (nmod)
pretreatment ) (punct)
appeared irrigations (nsubj)
suggest treatment (ccomp)
spasticity on (case)
hypotension alone (advmod)
pilocarpine prior (case)
reduce vpu (nsubj)
increased reduced (conj)
relative patients (nmod)
assessable , (punct)
dcf ( (punct)
ercp an (det)
produce vivo (advmod)
astrocytes bergmann (dep)
lidocaine or (cc)
obtaining analysis (nmod)
injection maleate (nmod)
complications from (case)
10 5 (compound)
beta-blockers hearts (nmod)
changes involvement (conj)
assessing use (dobj)
subunits acetylcholine (compound)
ameliorated cessation (nsubj)
suggesting involves (ccomp)
seizures anesthetic (amod)
2.1 : (punct)
controlling use (nmod)
hiv-negative and (cc)
tested effects (nsubjpass)
6 to (quantmod)
ionotropic metabotropic (conj)
higher respectively (advmod)
wr242511 mhb (appos)
regimen active (amod)
lower metrizoate (nmod)
np in (case)
monitored addition (nmod)
circuitry neural (amod)
investigated relationship (nsubjpass)
evaluate function (dobj)
emergence anesthesia (nmod)
cases hypoxaemia (nmod)
monitored hour (nmod)
had rates (dobj)
response hypertrophy (conj)
design series (compound)
indicates appearance (nsubj)
glomerulosclerosis resulting (acl)
induced imipramine (nmod)
inhibitor pdtc (conj)
scopolamine ( (punct)
$ROOT$ narrowed (sent)
tumors solid (amod)
sod neither (cc:preconj)
hypothyroidism the (det)
dose % (amod)
durations response (nmod)
test and (cc)
intensity by (case)
role blockade (nmod)
manifestations systemic (amod)
volume thoracic (amod)
weakness atrophy (conj)
hypertension diastolic (amod)
established is (auxpass)
ccr2 ccl2 (conj)
morphological morphometrical (conj)
insults of (case)
radial , (punct)
bodies resistant (amod)
contained group (nmod)
cancer or (cc)
micrograms/kg than (case)
exacerbated status (nmod)
hypotension without (case)
induce blockers (nsubj)
octreotide ( (punct)
hydrochlorofluorocarbons by (case)
premarin ) (punct)
flavour bitemporal (amod)
efficacy ifosfamide (nmod)
two which (nmod)
ds female (amod)
represents reason (dobj)
interaction normal (amod)
mediating hyperactivity (dobj)
secretion hormone (compound)
quetiapine high-doses (amod)
thalidomide bortezomib (conj)
potent receptor (nmod)
1.37 ( (punct)
aged 18 (dep)
exceeded was (auxpass)
deterioration abrupt (amod)
bladders the (det)
cause reduces (advcl)
hour 24 (compound)
potential attenuate (acl)
capsules gt/bc (appos)
focussed trials (nsubj)
mg/dl 0.5 (nummod)
based theorem (nmod)
anticoagulated procedure (nmod)
history decline (nmod)
factor-alpha as (cc)
hypothesis combinatorial (amod)
analyzed weeks (nmod)
atria beating (amod)
release possibly (advmod)
problems toxicity (nmod)
level steady-state (amod)
activation damage (nmod)
lesion nerve (nmod)
negative skin (nmod:npmod)
anesthesia surgery (nmod)
woman old (amod)
symptoms depression (compound)
controls n. (dep)
suggested exceed (ccomp)
antagonist the (det)
retina of (case)
fibrosis degree (nmod)
use increased (amod)
ameliorated verapamil (nmod)
extent injury (nmod)
tnf-a ( (punct)
polyglutamates of (case)
evident is (cop)
catheterisation or (cc)
heptylate and (cc)
performed learning (nmod)
pulses rate (appos)
antagonist 5-ht(6 (compound)
induced ) (punct)
deaths associated (amod)
accompanied pressure (nmod)
reactions injection (nmod)
anemia hemoglobin (dep)
seizures intractable (amod)
environment department (nmod)
effects salbutamol (nmod)
syntheses discovery (amod)
0.5 , (punct)
affinity or (cc)
dexmedetomidine the (det)
cavity the (det)
visits patient (compound)
attributed been (auxpass)
demonstrate association (dobj)
comparing 62 (dobj)
function normal (amod)
administration with (nmod)
administered sampled (conj)
shorter were (cop)
alterations expected (amod)
pretreatment bnpp (nmod)
associated interaction (nmod)
puromycin-aminonucleoside and (cc)
pacing cardiac (amod)
symptoms depressive (amod)
attack a (det)
clarified incidence (nsubjpass)
period group (appos)
progenitor hbmp (appos)
aorta/serum-ratio and (cc)
mediated primarily (advmod)
incidence tachyarrhythmias (nmod)
disappearance the (det)
approaches therapeutic (amod)
dysfunction enzyme (compound)
androgens the (det)
density higher (amod)
predict severity (dobj)
doses be (cop)
sulfation in (case)
three one (conj)
longer those (nmod)
asymptomatic are (cop)
residence a (det)
ballooning by (case)
plasticity cortex (nmod)
expression mpges-1 (compound)
osmolality compared (case)
inflammation induced (acl)
selective non (amod)
stn of (case)
attenuated could (aux)
ssris ( (punct)
indistinguishable that (nmod)
artery circumflex (amod)
precipitation due (case)
ci 2.3 (nummod)
inhibition via (case)
seem experience (nmod)
$ROOT$ k (sent)
points study (nsubj)
behaviors . (punct)
cases seven (nummod)
elevated study (nmod)
thrombosis atrial (amod)
ke 0.15+/-0.03/h (dep)
targeted was (auxpass)
induce hypomagnesemia (nsubj)
activation dox-induced (amod)
shortened concentration-dependently (advmod)
primarily complications (nmod)
effects cpdd (nmod)
observed group (nmod)
dendrin and (cc)
binding determined (acl)
influenced melatonin (nsubj)
classified metolachlor (nsubjpass)
sd [ (punct)
blocked anxiety (dobj)
confirmed occurs (ccomp)
food e-fortified (amod)
dopamine opioid (conj)
rate as (cc)
inhaler by (case)
$ROOT$ drugs (sent)
accelerated suppressed (conj)
complicate edema (nsubj)
tolerated effects (nmod)
disorders tic (amod)
leukoencephalopathy delayed (amod)
controlling vomiting (dobj)
response compared (case)
deterioration neurological (amod)
causes summary (nmod)
analysis sections (nmod)
exhibited sensitivity (dobj)
true . (punct)
toxicity more (amod)
correlates events (nmod)
causing inhibition (dobj)
experience concerning (acl)
anemia d-penicillamine-induced (amod)
therapy lopinavir/ritonavir (compound)
mucositis patients (nmod)
asymptomatic was (cop)
hospitalizations out-of-plan (amod)
pattern myosin (compound)
cancers treatment-resistant (amod)
pseudolithiasis patients (nmod)
conducted results (nmod)
stimulation exercise-induced (amod)
possible when (advmod)
exhibited who (nsubj)
e4031 terodiline (conj)
nonpregnant and (cc)
surgery fess (appos)
60 : (punct)
tried has (aux)
scale-revised rating (compound)
confirm properties (nsubj)
administered : (punct)
appear result (xcomp)
exchanges chromatid (compound)
demonstrated demonstrated (conj)
followed review (nmod)
used began (advcl)
true be (cop)
warranted is (auxpass)
brains mice (nmod)
bred . (punct)
designated been (auxpass)
hazard a (det)
suggest initiate (ccomp)
produced affecting (advcl)
development dyskinesias (nmod)
likelihood based (acl)
lidocaine- or (cc)
duration and (cc)
cystitis to (case)
benefits condition (nmod)
increased hr (nsubj)
syndrome tumor (compound)
received diazepam (dobj)
received readmission (nmod)
mania patients (nmod)
revealed comparisons (nsubj)
combined epinephrine (nmod)
cases 27 (nummod)
ingested orally (advmod)
demonstrate now (advmod)
exposure single (amod)
> = (conj)
% ] (punct)
aware cause (ccomp)
17beta-estradiol nm (amod)
diagnosed hypertension (nmod)
levels ircrf (compound)
jitter increased (amod)
examination extraction (conj)
group disease (compound)
protocols anticoagulant (compound)
due clopidogrel (nmod)
induced c. (nmod)
incubated c. (nmod)
cycle her (nmod:poss)
500 5 (compound)
retrievals both (det)
received cc (dobj)
performed nephrectomy (nsubjpass)
trials prospective (amod)
apamin ng (appos)
upregulation hs-induced (amod)
systolic left (amod)
administration insertion (nmod)
improved normal (conj)
syndrome drug-induced (amod)
animals experienced (acl:relcl)
syndrome puromycin (compound)
picrotoxin by (case)
lidocaine ( (punct)
average to (case)
score asex (compound)
rated patients (nsubj)
1.7 0.7 (compound)
leads that (nsubj)
schedules once-daily (amod)
affect ethambutol (nsubj)
response pressure (compound)
changed treatment (nsubj)
cases complications (nmod)
elicits . (punct)
effect undesirable (amod)
ng/dl ( (punct)
frame within (case)
reduction group (nmod)
withdrawal pyridoxine (nmod)
glomerulosclerosis for (case)
role peroxidation (nmod)
potently more (advmod)
placebo disintegrations (appos)
disease structural (amod)
produced paradigm (nmod)
mg/kg or (cc)
fall excretion (nmod)
five seven (nmod)
cases further (amod)
extract roots (compound)
survival = (dep)
given dexamethasone (dobj)
antibody-(pr3-anca ) (punct)
sera of (case)
score spine (nmod)
occurred had (conj)
ma ) (punct)
dogs cats (conj)
third in (case)
mg etoricoxib (compound)
responsiveness as (cc)
latency reduced (amod)
inhaled nicotine (dobj)
hydration for (case)
therapy immunomodulatory (amod)
decrease net (amod)
implicated hypotension (nsubjpass)
find group (nmod)
bupivacaine mg/kg (amod)
demographics results (conj)
involvement recognized (amod)
weaning bypass (nmod)
assessed that (nsubj)
required discontinuation (dobj)
disorder usually (advmod)
therapy compliance (conj)
requirement co-administration (nmod)
co-administration ra (nmod)
results developed (dep)
2.44 - (punct)
microg/kg/min ) (punct)
undergone days (nmod)
solution sugar (compound)
b amphotericin (compound)
toxicology positive (amod)
sarcoma , (punct)
activity documented (amod)
reaching significance (dobj)
year to (case)
reduces significantly (advmod)
mug m (dep)
differ % (dep)
department center (nmod)
antibiotic a (det)
enrolled sites (nmod)
elevation discomfort (nmod)
doses capsaicin (nmod)
treatment methotrexate (nsubj)
weight bladder (compound)
combining in (mark)
2.4-fold 4.3 (dep)
reactions nausea (nmod)
24.3 . (punct)
degree due (amod)
1.22 of (case)
relief h (nmod)
forms ctni (compound)
contribute effects (nmod)
option exhibits (advcl)
killed gd (nmod)
neurological cardiovascular (conj)
toxicity severe (amod)
history suspected (amod)
protocol per (case)
recovered stopping (advcl)
dilatation and (cc)
reacted , (punct)
ml(-1 , (punct)
milligrams kilogram (nmod)
complained patient (nsubj)
administration benzodiazepines (nmod)
became decreased (conj)
beta-blocker betaxolol (appos)
pregnant were (cop)
is aim (nsubj)
responses svrs (appos)
pressure hg (dep)
derivative ( (punct)
males and (cc)
screened methods (nsubj)
stm ( (punct)
exceed benefit (dobj)
level ic (compound)
cystitis haemorrhagic (amod)
taking are (aux)
lungs the (det)
m4 for (case)
100,000/mm3 than (quantmod)
administration b (compound)
mg/dl. creatinine (nsubj)
reduces therapy (nsubj)
years had (ccomp)
persistent exhausting (conj)
5-htp mg/kg (dep)
blockers different (amod)
dexrazoxane ) (punct)
compared trial (nmod)
longer p (nmod)
designated has (aux)
development further (amod)
analyzed count (nsubjpass)
disease rare (amod)
history studies (conj)
hyaluronate abundant (amod)
suffer depression (nmod)
morphine post-operative (amod)
mtdna of (case)
minutes at (case)
mediated release (nmod)
anxiety state (compound)
cisplatinum cpdd (appos)
answer questions (dobj)
recordings sleep (compound)
synthesis on (case)
appeared toxicity (nsubj)
propofol 237 (nummod)
patients two (nsubj)
feature cholestasis (nsubj)
disruption attenuated (amod)
epilepsy induced (acl)
eai ) (punct)
have much (dobj)
drowsiness morning (compound)
state to (case)
doses methoxamine (nmod)
achieved induction (nmod)
recorded 35 (conj)
atypicality course (nmod)
women 20 (conj)
cisapride ] (punct)
(+/-)-pg-9 of (case)
decreased levels (dobj)
phospholipid , (punct)
given boy (nsubjpass)
sole may (aux)
basis patients (appos)
encephalopathy immunization-induced (amod)
id50 widely-different (amod)
4.10 users (nmod)
agonist and (cc)
satisfaction of (case)
acquired rats (nsubj)
attenuated suggesting (advcl)
15/group ): (punct)
albumin , (punct)
lowering [ca]o (conj)
nsclc metastatic (amod)
7- ) (punct)
hypercapnia to (case)
rebound post-snp (amod)
cholestasis edema (nmod)
decrease status (nmod)
indinavir or (cc)
total cases (nmod)
isoproterenol iso (appos)
drugs blocking (amod)
155 13 (compound)
onychomycosis for (case)
reports brief (amod)
taking was (aux)
motility spontaneous (amod)
relationship causative (amod)
conditions inflammatory (amod)
cimetidine than (case)
values nocturnal (amod)
shortening base (nmod)
collagen glycoaminoglycans (conj)
produced hypertension (nsubjpass)
evaluated january (nmod)
mitochondria cardiomyopathy (nmod)
techniques computational (amod)
immunosuppressant ability (nmod)
receptor its (nmod:poss)
man cardiotoxicity (nmod)
disease 3 (nummod)
chloride calcium (compound)
cofactors interactions (nmod)
cancer and (cc)
gls ( (punct)
pain muscle (compound)
deposits fibrillar (amod)
l-dopa mg/kg (dep)
index pregnancy (conj)
underwent reduction (dobj)
% 85.1 (nummod)
discuss literature (dobj)
mild moderate (nmod)
application signal (nmod)
sinusoidal spaces (dep)
hepatitis associated (acl)
serum human (amod)
prevented protected (conj)
causes cystitis (dobj)
dose onset (nmod)
paracetamol ) (punct)
accomplished laboratory (nmod)
ratio 5.9 (appos)
assessment of (case)
lasting months (nmod:tmod)
evidence . (punct)
c-ret ( (punct)
p=0.65 ) (punct)
aplasia . (punct)
induction ovulation (compound)
doses three (nummod)
developed bradyarrhythmias (dobj)
induced drugs (nmod)
minutes hours (appos)
concentrations vip (nmod)
injury cardiac (amod)
complicated component (nsubj)
excretion damage (nmod)
deficits gray-matter (amod)
contributed development (dobj)
judged hepatotoxicity (nsubjpass)
mg/m2 6 (dep)
failed often (advmod)
controlled phenobarbital (nmod)
rats adult (amod)
conclusion presents (appos)
relation causal (amod)
hepatotoxicity antibiotic-associated (amod)
licl mmol.kg(-1).day(-1 (appos)
pharmacokinetic pharmacodynamic (conj)
reactions patients (nmod:poss)
evaluated metabolites (nsubjpass)
mg/m(2 even (advmod)
used localize (xcomp)
beginning end (conj)
ameliorated markedly (advmod)
complications cited (acl)
proteins of (case)
population distinguishable (amod)
baseline months (conj)
antigen urea (conj)
way a (det)
expression nos (compound)
response increased (amod)
inactivation physiologic (amod)
nucleotide-gated hcn (appos)
increase disability (nmod)
control disease (compound)
reflects that (mark)
had which (nsubj)
younger but (cc)
follow-up proper (amod)
signs by (case)
woman high-risk (amod)
$ROOT$ procaterol (sent)
some genes (nmod)
administration globulin (nmod)
usage of (case)
course therapy (nmod)
questionnaires numbers (nmod)
patients 17 (nummod)
determine to (aux)
mg/kg)-induced 50 (nummod)
series behaviors (nmod)
found dox (nmod)
mg/m2 with (case)
elevated hypertension (nmod)
21 2 (conj)
low is (cop)
users , (punct)
induced apomorphine (nmod)
rise and (cc)
evaluation histological (amod)
treatment poisoning (nmod)
three developed (acl:relcl)
diclofenac 1.69 (nummod)
disturbances severe (amod)
indices 6 (nummod)
causes deficits (dobj)
suggests : (punct)
alterations bupivacaine-induced (amod)
observed occurs (conj)
believed activity (nsubjpass)
pregs analogs (conj)
rarely more (advmod)
had onset (dobj)
bnp of (case)
administered simultaneously (advmod)
indicating damage (dobj)
action intense (amod)
eliminated prevented (conj)
developed . (punct)
2-(p-bromophenyl)propionate alpha-tropyl (compound)
acid leukemia (nmod)
effects beneficial (amod)
depressed were (auxpass)
priapism of (case)
identified authors (nsubj)
stereotypy on (case)
preventing contact (dobj)
micrograms 28 (nummod)
polydipsia from (case)
extend examining (advcl)
erg multifocal (amod)
response vessel (nmod)
dependent been (cop)
trial treatment (compound)
13 eight (compound)
mg/kg ( (punct)
restarted stable (advcl)
promote and (cc)
determined expression (nmod)
episode prior (amod)
investigate effectiveness (dobj)
recommended before (mark)
effects bronchodilator (compound)
containing progestagens (dobj)
rats transgenic (amod)
resistance insulin (compound)
autoantibodies , (punct)
confirms . (punct)
microl nmol/0.5 (nummod)
$ROOT$ substituted (sent)
pharmacology clinical (amod)
group young (amod)
spectrum including (case)
increases mortality (dobj)
portion lower (amod)
reduced are (auxpass)
polymorphic population (nmod)
complex benzodiazepine-gaba-chloride (amod)
capacity fluoxetine (nmod)
shown loss (nmod)
british patients (nsubj)
experience fall (dobj)
ranged months (nmod)
tjs in (case)
given schedule (nmod)
% whereas (mark)
studies meta-analyses (conj)
revealed values (dobj)
change uptake (dobj)
co-administration for (case)
maze and (cc)
familiar be (cop)
irreversible was (cop)
eligible excluded (ccomp)
is identify (xcomp)
exhibits . (punct)
use cpa/ee (nmod)
iopamidol iodixanol (conj)
indicative dyskinesia (nmod)
attributable arag (nmod)
action cytostatic (amod)
stage late (amod)
panca ( (punct)
involve response (dobj)
convulsant median (amod)
disease syndrome (conj)
terms reducing (advcl)
antibiomania ): (punct)
intracellular the (det)
high restored (conj)
beta 1 (dep)
paraventricular and (cc)
$ROOT$ men (sent)
daily poorally (advmod)
reduction segment (nmod)
therapy adults (nmod)
proteins neurofilament (compound)
recorded commonly (advmod)
available regarded (conj)
microg/ml od (nmod)
enrolled women (dobj)
walk of (mark)
pathways visceral (amod)
glabrata candida (compound)
infection of (case)
case result (nmod)
stainings immunohistochemical (amod)
arrhythmias characterized (acl)
labeling increased (amod)
cigarettes of (case)
mechanism adrenergic (amod)
patients comprising (acl)
benserazide i.p. (appos)
interaction flecainide (nmod)
confounding by (case)
predictive increase (nsubj)
depression diagnosed (acl)
measurements haemodynamic (amod)
exposure e2 (compound)
indication exacerbated (ccomp)
achieved ingestion (nmod)
active patients (nmod)
examined then (advmod)
thromboembolism disease (conj)
cephalosporins , (punct)
fenoldopam , (punct)
epicardium midmyocardium (conj)
increased remained (conj)
midazolam ( (punct)
six and (cc)
urothelium in (case)
death % (nmod)
manifestations histopathological (amod)
function sympathetic (amod)
treatment 5-fu (nmod)
decided we (nsubj)
decreases ( (punct)
lower control (advcl)
ablation kinase (nmod)
was injury (nmod)
underlying failure (dobj)
aspects functional (amod)
113 2 (conj)
glucose and (cc)
implant before (case)
akinesia the (det)
450 - (punct)
administration nanoparticles (compound)
window critical (amod)
functions mental (amod)
ceased desvenlafaxine (nsubjpass)
increases failure (nsubj)
medicate self (dep)
had twenty-six (nsubj)
hbmp ) (punct)
enzymes marker (compound)
contribute ability (nsubj)
mg/kg/day 100 (nummod)
linked excitability (nmod)
source calcium (compound)
tract gi (amod)
$ROOT$ course (sent)
pdtc antioxidant (amod)
association gene (nmod)
studied which (nmod)
myasthenia associated (acl)
volume a (det)
altering likely (advmod)
discontinuing for (mark)
sulphasalazine to (case)
necrosis level (nmod)
thromboembolism women (nmod)
lability attitude (conj)
macrolides with (case)
ischemia during (case)
results mg (appos)
interaction muscle (nmod)
result simultaneously (advmod)
types both (det)
vomiting = (dep)
oct microg/kg (appos)
achieved using (advcl)
enlargement : (punct)
ca hj (appos)
-54 11 (conj)
pretreatment mm (appos)
cotrimoxazole and (cc)
experienced gtn (nmod)
cessation treatment (nmod)
syndrome postalcoholic (amod)
correlated area (nmod)
resulted intolerant (xcomp)
increased effects (nsubjpass)
suggested evaluations (nsubj)
monitoring study (dep)
angiogram normal (amod)
needle through (case)
referred it (nsubjpass)
ml/min 59 (nummod)
glucoronosyltransferases by (case)
chemotherapy nephrotoxic (amod)
changes laboratory (compound)
induced deficiency (nmod)
latency an (det)
method by (case)
pr3-anca ( (punct)
120 80 (compound)
infections recovery (nmod)
secondary antidepressants (nmod)
reduced l-name (nsubj)
teratogenic were (cop)
decrease value (nmod)
increased , (punct)
were increase (dobj)
channel . (punct)
elevation resembling (acl)
users repeaters (conj)
produced compared (advcl)
daunorubicin sarcoma (nmod)
agents protective (amod)
interaction nicotine (nmod)
amplified pcr (nmod:npmod)
levodopa compared (case)
performance session (conj)
bpd ( (punct)
developed increasing (advcl)
use spironolactone (nmod)
oxide inos (appos)
activity electrical (amod)
groups castrated (amod)
level sn (nmod)
rearing and (cc)
mitoxantrone by (case)
lipid extractable (amod)
paradigm gds (nmod)
vary systematically (advmod)
nephrotoxicant potent (amod)
evaluated which (nmod)
study dysfunction (dobj)
related disorders (nmod)
symptoms individual (amod)
processes judgement (compound)
reversibility effects (nmod)
channel be (cop)
users mdma+ (amod)
exacerbated be (cop)
characterized eyes (nsubjpass)
determined pattern (dobj)
medications. antithyroid (amod)
recipients heart (compound)
% 140 (nummod)
days=1.77 ; (punct)
fever diarrhea (conj)
unlikely cause (ccomp)
8-se - (compound)
gemcitabine given (acl)
levels mean (amod)
months 8.9 (nummod)
appetite of (case)
seizure the (det)
2010/2011 through (case)
output their (nmod:poss)
monitored detection (nmod)
inhibitor used (amod)
compared rnfl (nmod)
reduce to (mark)
admission ventilation (nmod)
non-users to (case)
required 13 (nsubj)
twenty % (appos)
either compared (case)
had tumor (dobj)
ascribed failure (nsubjpass)
replicated and (cc)
although is (cop)
withdrawn improvement (nmod)
action anticonvulsant (amod)
performed testing (nsubjpass)
tgf-b and (cc)
regimens accepted (amod)
treated median (dep)
initiation warfarin (nmod)
better , (punct)
$ROOT$ independent (sent)
increased suburothelium (nmod)
patients others (conj)
combined ctnt (nmod)
ovarian breast (conj)
regimen tolerable (amod)
l-sotalol with (case)
gram per (case)
= 10 (dobj)
parp-1+/+ and (cc)
patterns drinking (compound)
gravis caused (acl)
resistance with (case)
showed b. (punct)
amounts ) (punct)
transplantation pediatric (amod)
similar both (nmod)
second((1/2 0.50 (nummod)
reported and (cc)
hundred five (compound)
infarction ischemia (conj)
conception onward (advmod)
vgb with (case)
induced methamphetamine (nmod)
os a (det)
feature presenting (amod)
cardiomyopathy is (cop)
manifestations life-threatening (acl:relcl)
dosing concomitant (amod)
agent used (amod)
morphology mitochondrial (amod)
5.1 1.6 (compound)
hypotension changes (conj)
levels with (case)
bind inactivating (advcl)
potency warfarin (nmod)
any tests (nmod)
frataxin , (punct)
gellan timolol (compound)
inhibit can (aux)
sensitivities , (punct)
opposed ballooning (nmod)
suggest antagonized (ccomp)
response potentials (conj)
lower flow (nsubj)
outlining canaliculi (dobj)
dependency its (nmod:poss)
patients 60 (nummod)
overshooting the (det)
effects altered (amod)
exceed inhibition (dobj)
drugs antiinflammatory (amod)
scl and (cc)
biodistribution its (nmod:poss)
observation careful (amod)
gvhd for (case)
recommend strongly (advmod)
presented cases (nsubjpass)
anesthetized connected (conj)
received complication (nmod)
therapy self-reported (amod)
compared treatment (nmod)
common dystonia (nmod)
beginning stay (nmod)
baseline their (nmod:poss)
noted vasculitis (nsubjpass)
urinalysis and (cc)
ng/dl. was (cop)
activation parp (compound)
studies-depression for (case)
effective more (advmod)
inhibition hyperalgesia (nmod)
purpose . (punct)
observations system (nmod)
anticholinergics of (case)
presents background (nsubj)
distinct circulation (nmod)
drd2 caucasians (nmod)
sessions three (nummod)
neurotensin by (case)
found mutations (nsubjpass)
monitoring clinical (amod)
propofol by (case)
have potential (dobj)
syndrome organic (amod)
visualize , (punct)
has thus (advmod)
contribute rates (nmod)
related progression (nmod)
hypotensive antiparkinsonian (conj)
improved discontinuation (nmod)
drug : (punct)
peptide protein (conj)
sec 3.0 (nummod)
mild . (punct)
granulomatosis with (case)
depression major (amod)
abortion therapeutic (amod)
state pre-denaturation (amod)
stress of (case)
blocked treatment (nsubj)
weeks gestation (nmod)
investigated therefore (advmod)
ruled stopped (conj)
necrosis prominent (acl:relcl)
hgh recombinant (amod)
myelosuppression drugs (nmod)
express cardiomyocytes (nmod)
mg. 0.025 (nummod)
hundred 104 (appos)
catheterizations annual (amod)
pentoxifylline mm/kg (compound)
carcinoma esophageal (amod)
findings showed (appos)
superior isg (nmod)
days cohort (nmod)
infusion doses (nmod)
20 cardiomyopathy (nmod)
vt sustained (amod)
hours six (nummod)
associated contraceptives (nmod)
% 71 (nummod)
inhibitor tight-binding (amod)
extended-release/lovastatin with (case)
ratios thermal (amod)
september 1996 (nummod)
enhancement a (det)
infarctions dysfunction (conj)
valve of (case)
co-administration protamine (nmod)
risk aggravated (amod)
lesion allografts (nmod)
inhibitor protease (compound)
illustrates need (dobj)
190 30 (compound)
disarrangement , (punct)
extremity the (det)
multiple type (nmod)
society headache (compound)
test exercise (compound)
mechanisms which (nmod)
nitrendipine or (cc)
quinine and (cc)
formed presence (nmod)
toxicity progression (conj)
improved conclusions (nsubj)
rats pretreated (acl)
septicaemia % (appos)
n=36 ) (punct)
accumulation macrophages (nmod)
doses ) (nmod)
expression decrease (compound)
neuropeptide polypeptide (nsubj)
development resolution (conj)
strikes again (advmod)
suggested important (ccomp)
occurs stroke (nsubj)
failed contrast (nmod)
modulator pregs (nsubj)
cautious presentation (nmod)
excluded involvement (nsubjpass)
function resting (amod)
fluency lexical (amod)
influences eryptosis (dobj)
high-dose 23.6 (appos)
aggravate did (aux)
conclude modulate (ccomp)
synthesis factor (compound)
diffusion botox (nmod)
protected completely (advmod)
adults suffering (acl:relcl)
studied response (dobj)
advised be (auxpass)
growth treatment (conj)
role a (nmod)
affected rate (dobj)
factor anf (appos)
projections cell (compound)
risk events (nmod)
replacement 12-wk (amod)
studies morphological (amod)
hg pressure (nsubj)
deficits mechanisms (nmod)
giving adrenaline (dobj)
disclosed , (punct)
objectives were (dep)
anencephaly , (punct)
thrombocytopenia anaemia (conj)
developed 7 (nsubj)
rats transplanted (amod)
incidence fibrillation (nmod)
longer coadministered (advcl)
decreased use (nsubj)
known is (ccomp)
parts striatum (nmod)
able not (neg)
synthase oxide (compound)
had exposure (dobj)
observed response (nsubjpass)
plexitis right (amod)
showed unchanged (ccomp)
older years (nmod)
$ROOT$ accepted (sent)
rats , (punct)
published 2005 (nmod)
require monitoring (dobj)
52.7 12.8 (compound)
reflexes of (case)
refer , (punct)
mice all (det)
scheduled although (mark)
studied experiments (nmod)
0.30 than (case)
vasculature group (nmod)
temocapril and (cc)
lower comparison (nmod)
hz 25 (nummod)
observed study (nmod)
period 1 (nummod)
became week (nmod)
2- and (cc)
anemia maha (appos)
all not (neg)
drop for (mark)
blockers ) (punct)
data unlike (case)
thickness and (cc)
ro15 of (case)
oac ) (punct)
space an (det)
access by (case)
cases all (predet)
contracture of (case)
water ( (punct)
fever milk (compound)
to uh (intj)
access(r ) (punct)
choice corrected (advcl)
survival relapse-free (amod)
involve impairment (dobj)
4 - (advmod)
cm consumed (amod)
longitudinal strain (conj)
wk first (amod)
users difference=0.01 (dep)
separate to (mark)
index dp/dtejc (appos)
exhibiting mg/kg (advcl)
costs treatment (nmod)
trimethaphan tmp (appos)
3.49 ratios (nsubj)
increased decreased (advcl)
follow-up post-training (dep)
report demonstrating (advcl)
effect 5-httlpr (nmod)
bpa to (case)
detected calcification (nsubjpass)
g/day)-lovastatin 1.2 (nummod)
1.5 3 (prep)
effect pain (nmod)
vasodilator systemic (amod)
decreased density (nsubj)
prescribed 3.8/100,000 (dobj)
receptors adenosine (compound)
started after (mark)
4/7 ) (punct)
i.c.v. 0.1 (nummod)
dosages lower (amod)
h vs. (cc)
abnormalities reversible (amod)
administered generally (advmod)
evaluated effects (nsubjpass)
beats/min . (punct)
drug-adsorption both (cc:preconj)
appeared have (aux)
except dose (nmod)
reserpine , (punct)
tolerance associated (acl)
levels deoxycorticosterone (nmod)
peroxidation homogenates (nmod)
event neurotoxicity (nmod)
characteristics clinical (amod)
continues proportions (nmod)
shell core (conj)
exerted action (dobj)
increased normalized (advcl)
useful models (nsubj)
microg/kg 600 (nummod)
neuroprotective depend (conj)
inhibited all (nmod)
therapy interferon (compound)
conclusions indicated (acl)
decreases rate (nmod)
replication mutants (nmod)
frequency sces (nmod)
determined hippocampus (nmod)
products postulated (amod)
users active (amod)
raised mmol/l (dep)
increase frequency (nmod)
study toxicity (nmod)
role damage (nmod)
chemotherapy peg-asparaginase (nmod)
age score (conj)
$ROOT$ persisted (sent)
micrograms/kg [ (punct)
$ROOT$ supports (sent)
therapy sodium (nmod)
cured post-therapy (nmod)
$ROOT$ appreciated (sent)
$ROOT$ mirrors (sent)
contains hypaque (nsubj)
hypersensitivity effects (nmod)
ventricle lv (appos)
leading damage (nmod)
leukocyturia visits (nmod)
component central (amod)
vancomycin with (case)
proportion significant (amod)
show conclusion (nsubj)
shown technique (ccomp)
muscle masseter (compound)
technology protein-based (amod)
density receptors (nmod)
$ROOT$ conducted (sent)
tumors several (amod)
observation patients (nmod)
pvc of (case)
oab with (case)
saccades pursuit (conj)
documentation histopathological (amod)
td group (compound)
became withdrawn (conj)
moderate-dose 29.1 (appos)
take necessary (advcl)
received h. (nmod)
symptoms reactions (nmod)
intensity ; (punct)
greater in (case)
81 4 (conj)
trials double-blind (amod)
17 of (advmod)
reported hallucinations (nsubjpass)
bmd trabecular (amod)
decrease strong (amod)
$ROOT$ psychosis (sent)
due changes (nsubj)
hospital the (det)
value and (cc)
tolerance exercise (compound)
short which (nsubj)
followed improvement (nsubj)
electrographic and (cc)
evidence related (acl)
measured modification (nmod)
switch by (case)
transplants and (cc)
analysing degree (dobj)
cases schizophrenia (nmod)
observed also (advmod)
vasculature distal (amod)
suggests however (advmod)
size leakage (conj)
oxidation decreased (amod)
$ROOT$ synthesized (sent)
zonisamide with (case)
position down (advcl)
patients haemorrhage (nmod)
isoproterenol and (cc)
mismatch hypotension (nmod)
analgesic anti-inflammatory (conj)
showed we (nsubj)
segments by (case)
bupivacaine hyperbaric (amod)
morphine/rg1 with (case)
doubled increment (nmod)
endarterectomy before (case)
evaluated bd1018 (dep)
regeneration fibers (nmod)
drug pentylenetetrazole (appos)
months later (amod)
compared populations (nmod)
alter did (aux)
drug ketamine (nmod)
mg/kg/day days (nmod)
> 65 (conj)
l-485 diet (compound)
s ( (punct)
cr of (case)
reactions donors (nmod)
amb amb (conj)
skeptical . (punct)
proliferation mesangial (amod)
total paclitaxel (nmod)
receive either (cc:preconj)
drops ophthalmic (amod)
training during (case)
bodies in (case)
examine aspects (dobj)
mofetil steroids (conj)
scores sf-36 (compound)
man the (det)
altered is (auxpass)
performed 22 (nmod)
predictive . (punct)
diuretic potassium-losing (amod)
$ROOT$ modulation (sent)
affected concentrations (nsubjpass)
needed course (nmod)
aggravated was (auxpass)
ended . (punct)
zyban formulation (appos)
24.9 2.6 (conj)
score a (det)
modulate retention (dobj)
disadvantages vasodilator (nsubj)
3.5 +/- (cc)
fact notable (amod)
connection administration (nmod)
induced glomerulopathy (nsubjpass)
explained that (mark)
mg/m(2 250 (nummod)
magnitude is (cop)
reverse contrast (nmod)
effects being (cop)
methylxanthines like (case)
cases 347 (nummod)
british descent (nmod)
patients presenting (acl)
instillation from (case)
85 2 (prep)
continues cardiotoxicity (nmod)
hormone siadh (appos)
group - (punct)
instilled ear (nmod)
treatment amiodarone (nmod)
electrocardiograms ecg (appos)
non-users were (cop)
function impression-sexual (amod)
compartments body (compound)
n- and (cc)
gene at2r (compound)
pretreatment morphine (nmod)
studies present (amod)
sensitized downregulating (advcl)
numbers due (case)
cholinesterase plasma (compound)
reattempted . (punct)
need we (nsubj)
population recipients (nmod)
had melphalan (nmod)
binding scatter (conj)
outline canaliculi (dobj)
administered trial (nmod)
injected i.p. (dep)
rate toxicity (compound)
consumed when (advmod)
review cases (dobj)
reversed improved (conj)
seroconversion anti-hbs (appos)
reminding selective (amod)
$ROOT$ diseases (sent)
derived . (punct)
girl neuroblastoma (nmod)
show neurotoxicity (dobj)
therapy salbutamol (nmod)
movement fetal (amod)
localization . (punct)
development schizophrenia (nmod)
showed cords (nmod)
stimulated were (auxpass)
duct is (cop)
rilmenidine of (case)
a bpa (appos)
fatigue dizziness (conj)
iii [ (punct)
atropine pirenzepine (conj)
recommended undertaken (ccomp)
taking placebos (dobj)
monotherapies % (appos)
db . (punct)
forced air (dobj)
cessation completion (conj)
examined work (nmod)
effects metolachlor (nmod)
$ROOT$ rhythms (sent)
area mg/m(2 (compound)
developed telangiectasia (dobj)
liver nodular (amod)
suggested enhances (ccomp)
agents ibuprofen (appos)
levetiracetam by (case)
excess to (case)
pm ( (punct)
mmhg 77 (nummod)
reduced responses (nsubjpass)
features hepatitis (nmod)
polfa ( (punct)
test attention (nmod)
harvested brains (nsubj)
had treated (conj)
selecting in (mark)
cardiotoxic and (cc)
treated thp (nmod)
point same (amod)
elevation upregulation (conj)
sensitivity = (dep)
levels (+)-propranolol (nmod)
radiofrequency the (det)
generation lpo (compound)
patients involvement (nmod)
hypoplasia of (case)
process pharmacological (amod)
presented feeling (advcl)
cycles ) (punct)
conducting tests (dobj)
induces which (nsubj)
studied methods (nsubj)
presented syndrome (nmod)
had ten (nsubj)
induced cystitis (nsubjpass)
mustard an (det)
observed myoglobinuria (nsubjpass)
use mz (compound)
radiotherapy and (cc)
scored fasciculations (nsubjpass)
indicate occurred (ccomp)
agonist duration (nmod)
nacc ) (punct)
evaluation thermographic (amod)
challenge each (det)
investigated involves (ccomp)
introduction tacrolimus (nmod)
developed female (nsubj)
happiness ( (punct)
margin of (case)
phosphate between (case)
specimen in (case)
discontinuation without (case)
restriction activity (nmod)
ed50 analgesic (amod)
700 whom (nmod)
drug instillations (conj)
elevations men (nmod)
oestrogens versus (cc)
patients selegiline (nmod)
two including (case)
disturbances , (punct)
determine causes (dobj)
forms both (det)
fluvoxamine by (case)
reversed however (advmod)
concluded believe (conj)
mg/kg 9 (nummod)
41.8 +/- (cc)
bcl-2 mdm-2 (conj)
isg ( (punct)
rats normal-salt (amod)
rrs ) (punct)
% 70/101 (appos)
utility may (aux)
3 of (case)
cognitive , (punct)
factors activation (nsubj)
impairment side (nmod)
charcoal activated (amod)
any ephedrine/propofol/mixtures (nmod)
epm on (case)
collected reserved (conj)
treated reserpine (nmod:npmod)
monitored occasions (nmod)
precipitate that (mark)
support further (advmod)
chains with (case)
may . (nmod:tmod)
release dopamine (compound)
outcomes fluctuations (nmod)
nodular finely (advmod)
literature according (case)
preserve that (mark)
$ROOT$ ameliorates (sent)
measures flow (compound)
variety settings (nmod)
assays functional/physiological (amod)
efficacy acid (nmod)
reaction toxicity (conj)
indicated receives (ccomp)
acts c (nsubj)
base dilated (amod)
influenced differentiation (nsubjpass)
anxiety inflexibility (conj)
reaction inflammatory (amod)
recurrence cause (nsubj)
collection apheresis (compound)
treatment oral (amod)
initiation after (conj)
suggests likely (ccomp)
antagonist)-induced muscarinic (amod)
morphine [d-pen2.5]-enkephalin (dep)
dose placebo (conj)
hemorrhagic thromboembolic (conj)
resolved withdraw (nmod)
frequencies actual (amod)
a/j , (punct)
evaluated methods (nsubj)
level methotrexate (compound)
administration rats (nmod)
13-fold to (dep)
found associated (ccomp)
similar reduction (nmod)
conclusions appears (dep)
volume tidal (amod)
3 fewer (amod)
quantified immediately (advmod)
5-fluorouracil drugs (acl:relcl)
activity k)-atpase (compound)
dependent that (mark)
enalapril angiotensin (compound)
had muscle (nmod)
constant deactivation (nmod)
$ROOT$ adriamycin (sent)
mmhg 70 (nummod)
enhanced treatment (nmod)
dextrose and (cc)
65.3 18.9 (conj)
s1 % (appos)
failure necessitating (acl)
increase < (amod)
criteria classification (nmod)
areas exposed (acl)
provoked dose (nmod)
profile ocd-like (amod)
used converted (advcl)
unclassifiable six (nsubj)
abundant were (cop)
services u.s. (compound)
completed intervals (nmod)
1.3 those (nmod)
anaesthesia ketamine (nmod)
mutation with (case)
anaemia with (case)
presented female (nsubj)
12.5 25 (conj)
microm ( (punct)
partial = (dep)
$ROOT$ reversal (sent)
treatments after (case)
dyschromatopsy , (punct)
pretreatment pain (nmod)
cystitis ( (punct)
59 87 (conj)
appearance dermatitis (nmod)
sodium ufh (appos)
having oab (dobj)
point in (case)
receive metoprolol (dobj)
draw to (mark)
remain understood (xcomp)
intervals % (amod)
newborn a (det)
inhibitor multikinase (compound)
bladder the (det)
tests both (det)
6.5 than (quantmod)
present are (cop)
reduce , (punct)
designed increase (xcomp)
haloperidol mg/kg (dep)
observed impairment (nsubjpass)
volunteers 11 (nummod)
prl-r ) (punct)
ro 40 (nummod)
h or (cc)
determined amounts (nsubjpass)
ketamine to (case)
disequilibrium groups (nmod)
neurons , (punct)
repeated times (dobj)
ergotamine/caffeine to (case)
difluoromethylornithine or (cc)
stabilized levels (dobj)
puncture the (det)
role catalepsy (nmod)
cse ( (punct)
glomeruli kidneys (nmod)
day pod (conj)
compares patients (nmod)
sludge and (cc)
slowly more (advmod)
length treatment (nmod)
protects , (punct)
background has (appos)
result although (mark)
important differs (advcl)
subtypes mglu (compound)
hypertrophic atria (nsubj)
size this (det)
modifiable and (cc)
average ( (punct)
afferents of (case)
79 5 (conj)
sclerosis of (case)
species excretion (conj)
thrombophlebitis rash (conj)
hysterosalpingography in (case)
phosphatases in (case)
production frs (nmod)
1.0mg/kg ( (punct)
has implications (dobj)
mm 120 (nummod)
hp by (case)
treated medically (advmod)
searched also (advmod)
shelves different (amod)
terminology prevention (conj)
other receiving (acl)
cataract and (cc)
patients not (neg)
problem been (cop)
treatment aspirin (compound)
decrease svo(2 (nmod)
difference inhibition (nmod)
tools therapeutic (amod)
h 3 (nummod)
on eleven (nsubj)
counter the (det)
avoiding foods (dobj)
iugr of (case)
weight/day mg/kg (nummod)
africa in (case)
contents albumin (nmod)
failed show (xcomp)
effects alpha-mediated (amod)
included deterioration (dobj)
onset hyperammonemia (nmod)
is purpose (nsubj)
hr mg/24 (nummod)
hexamethylmelamine hmm (appos)
remodeling left (amod)
glutathione of (case)
involvement of (case)
injury diffuse (amod)
described we (nsubj)
stratum % (compound)
$ROOT$ transferred (sent)
naloxone alone (advmod)
anxiogenic- and (cc)
events : (punct)
increased effect (nsubjpass)
lymphoma 's (case)
demonstrating effective (ccomp)
% studies (nmod)
$ROOT$ promote (sent)
paramount recognition (nsubj)
relaxation expression (conj)
hemodynamics of (case)
have inflammation (dobj)
allografts both (cc:preconj)
physostigmine by (case)
anomalies major (amod)
agents not (neg)
recipient pediatric (amod)
assessed recurrence (dobj)
administered median (nmod)
process leading (acl)
possibility aggravation (nmod)
effects manipulating (acl)
activates and (cc)
improved recognition (dobj)
inhibition return (nmod)
enzyme converting (compound)
using ( (punct)
effects catatonia (nmod)
awake when (advmod)
$ROOT$ passage (sent)
lymphomas institution (nmod)
thalidomide oral (amod)
vacuolization cell (compound)
qs/qt ) (punct)
adjusted increased (amod)
activity vitro (advmod)
revealed aureus (dobj)
ptcr tg (conj)
alpha-tc either (cc:preconj)
therapy amphotericin (compound)
induction of (case)
45 - (punct)
in-patients 50 (nummod)
vessels regardless (advmod)
users 26 (nummod)
risperidone-associated , (punct)
received woman (nsubj)
treated resection (nmod)
intoxication of (case)
antagonism hypokalemia (nmod)
cells both (cc:preconj)
release subsequent (amod)
eyes the (det)
measured excitability (nsubjpass)
min 45 (nummod)
overcome effects (dobj)
barrier blood (compound)
concentration nuclei (nmod)
groups receiving (acl)
ratios adjusted (amod)
correlated severity (nsubjpass)
diagnosed arrhythmia (nsubjpass)
protocol treatment (nmod)
formulation swedish (amod)
hours 2.4 (nummod)
man carcinoma (nmod)
checklist , (punct)
reversing tachycardia (dobj)
level exposure (compound)
deferoxamine daily (amod)
measured rate (dobj)
$ROOT$ withdrew (sent)
keratectomy retina (nmod)
1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine ) (punct)
regimen doxorubicin (compound)
iopamidol medium (compound)
conduction pathways (nmod)
cpm ) (punct)
paramethasone with (case)
overdose massive (amod)
stress er (compound)
needed identify (xcomp)
pump by (case)
decreased sigmast (nsubj)
greater than (prep)
hemorrhage infusion (conj)
reported conclusion (nsubjpass)
similar asenapine (nmod)
hyperplasia nodular (amod)
day twice (advmod)
nucleus arcuate (amod)
square differences (nmod)
disturbances myocardial (amod)
stages process (nmod)
activity tonic (amod)
included analysis (dobj)
% 10.7 (nummod)
function role (compound)
study risk (nmod)
apraclonidine % (amod)
initiate can (aux)
patients female (amod)
point time (compound)
fell hours (nmod)
encephalopathy patients (nmod)
action beneficial (amod)
received vasospasm (nmod)
discriminates . (punct)
young both (preconj)
beating features (nsubj)
amplitude mean (amod)
treated dfmo (nmod)
glomerulopathy one (nummod)
children tumors (nmod)
hypertension pulmonary (amod)
upregulation through (case)
captopril and (cc)
beams spaces (conj)
investigated effect (dobj)
damage neuropathic (amod)
severe evident (conj)
applicators enrolled (acl)
known expressed (xcomp)
locomotion or (cc)
tracts to (case)
paranoia ganglia (conj)
experiments showing (acl)
equipotent roughly (advmod)
complete study (dobj)
gain , (punct)
seen to (mark)
injected ip (advmod)
t in (case)
effect oxygenation (nmod)
intelligence emotional (amod)
patients diagnoses (nmod)
universal . (punct)
fenoldopam nitroprusside (conj)
pathway p53-dependent (amod)
non-biodegradable degradable (conj)
cases controls (conj)
back . (punct)
associated concentrations (nsubjpass)
reviews prevention (nmod)
fm group (compound)
induce does (aux)
plasma mean (amod)
safety therapy (nmod)
ratio 1a (compound)
republic in (case)
users non-users (conj)
ecg 12-lead (amod)
dependent patients (nmod)
scores rating (conj)
pattern the (det)
received randomly (advmod)
alfentanil , (punct)
symptoms reported (acl)
conclude studies (nmod)
attack migraine (nmod)
angiography left (amod)
antagonist muscimol (nmod)
administration csa (nmod)
analyses pharmacokinetic (amod)
imbalance intoxication (conj)
novel , (punct)
evidence narrowing (nmod)
related rate (nmod)
disease associated (acl)
prevention mesna (nmod)
$ROOT$ degenerated (sent)
acid than (case)
achieved control (nsubjpass)
1080 14 (nummod)
report ; (punct)
shorter was (cop)
kinetics first-order (amod)
tiva during (case)
efficacious . (punct)
following of (case)
discovery to (case)
pain brush-evoked (amod)
learning associative (amod)
n day (appos)
function ventricular (amod)
a-variants the (det)
patients lithium-treated (amod)
factor triggering (amod)
anemia an (det)
glomerulonephritis restarting (advcl)
block . (punct)
tissue neural (amod)
lobe frontal (amod)
extubated and (cc)
infants exposed (acl)
cya. to (case)
hospitals from (case)
peptides two (nummod)
revealed dose (nmod)
oligodeoxynucleotide an (det)
concluded appear (ccomp)
course corticosteroids (nmod)
calcium to (case)
role sirolimus (nmod)
increased affecting (advcl)
trialists the (det)
arthralgia ) (punct)
present h (nmod)
polyvidone acetrizoate (appos)
disease ischaemic (amod)
dysguesia is (cop)
suffered he (nsubj)
combination . (punct)
patterns . (punct)
nature dependency (conj)
agents lowering (advcl)
effects implications (dep)
therapy who (nsubj)
appears addition (nsubj)
increase beginning (acl)
concluded toxicity (nmod)
vasoconstriction in (case)
center general (amod)
reviewed cases (dobj)
drop ef (nmod)
2 to (quantmod)
patients att-alf (compound)
hypercholesterolemia of (case)
biliary viral (conj)
basis breath-by-breath (compound)
score 55 (appos)
$ROOT$ warning (sent)
assessment open-label (amod)
diuretic a (det)
increasing to (mark)
effective less (advmod)
observed whom (nmod)
patients either (cc:preconj)
3 10 (conj)
10.7 ) (punct)
myeloma patients (nmod)
dyslipidemia with (case)
crisis because (case)
represent . (punct)
episode this (det)
% were (cop)
anxiety the (det)
csa toxicity (conj)
occurred rise (nsubj)
ug/ml , (punct)
rehabilitation using (acl)
iodide propidium (compound)
treated daidzein (nmod)
baseline administration (nmod)
develop injection (nmod)
glaucoma steroid (compound)
28 to (dep)
developed developed (conj)
alternation induced (acl)
use who (nsubj)
mrna enos (nmod)
acrolein through (case)
reduce scores (dobj)
experience men (nsubj)
induced collagenase (nmod)
suitable is (cop)
g/cm(2 , (punct)
prevent to (mark)
associated mirtazapine (nsubjpass)
degree occupancy (nmod)
sedation than (case)
kidney to (case)
antagonism partial (amod)
explanation a (det)
agonist rizatriptan (nsubj)
disorders first-episode (amod)
shortening segmental (amod)
ribavirin analogue (appos)
ncs ( (punct)
neoplasms diseases (conj)
pharmacology acc-9653 (nmod)
1.0 2.57 (conj)
5 to (advmod)
44.18 9.14 (conj)
amnesia task (nmod)
assess impact (dobj)
lidocaine prilocaine (conj)
obstruction underlying (amod)
% total (advmod)
blocked pretreatment (nsubj)
tet and (cc)
those administration (nmod)
has mitigating (advcl)
features facies (nmod)
presented cortex (nmod)
duration seconds (compound)
dextromethorphan of (case)
severity symptom (compound)
population treated (amod)
similar efficacy (nsubj)
dysfunction psychobiological (amod)
vigabatrin ) (punct)
cystitis chronic (amod)
(5.3)% , (punct)
report case (compound)
bond lader (conj)
dunnett , (punct)
sixty-five hundred (compound)
4.83 1.54 (appos)
% 13.0 (nummod)
treatment true (amod)
changes complex (amod)
ester n(g)-nitro-l-arginine (compound)
efficacy vancomycin (nmod)
presented anaesthetic (nmod)
received group (conj)
volunteers seven (nummod)
administration mtx (nmod)
received immunosuppression (nmod)
concentration isoflurane (compound)
complexes aminoglycoside-iron (amod)
whole on (case)
risk rejection (nmod)
counts 500/mm3 (nmod)
associated hypertension (nsubjpass)
tariquidar inhibitor (compound)
was incidence (attr)
group cellulose (compound)
has efficacy (dobj)
weight liver (compound)
toxicities of (case)
embryopathy warfarin-induced (amod)
pain vein (nmod)
eruptions with (case)
associated suppressants (nmod)
daytime during (case)
gave rise (dobj)
effect each (det)
withdrawal simvastatin (nmod)
hypothesized . (punct)
reduce vitro (advmod)
downregulating substantially (advmod)
strategy a (det)
case cholestasis (nmod)
c t (appos)
word to (case)
h and (cc)
evaluated years (nmod:tmod)
present any (nmod)
records women (nmod)
aas ( (punct)
microelectrodes kcl (compound)
asked were (auxpass)
emphasize . (punct)
therapy immediate (amod)
decreased given (advcl)
found changes (nsubjpass)
induces loss (dobj)
blonquist et (dep)
dose critical (amod)
6-hydroxydopamine with (case)
monitoring st-segment (amod)
producing in (mark)
finally , (punct)
intact pinealectomized (conj)
interactions no (nmod)
concentration ng/ml (nmod)
vol% 1.6 (nummod)
skf 38393 (nummod)
assessed behaviour (dobj)
placebo between (case)
dose g (dep)
fetus on (case)
mild events (nsubj)
administered agent (nmod)
21 18 (conj)
flumazenil group (appos)
cdt ( (punct)
reduces but (cc)
post-treatment lr132 (nmod)
consider susceptibility (dobj)
mouse dba/2 (compound)
phenylpropanolamine of (case)
ldl-cholesterol in (case)
scans serial (amod)
contain , (punct)
drug stimulant (amod)
comprised adults (dobj)
microscopy electron (compound)
supply oxygen (compound)
sleep rem (compound)
nephrotoxicity population (nmod)
breast and (cc)
interdependence factors (nmod)
antagonist = (parataxis)
transported which (nsubjpass)
caffeine to (case)
response minor (amod)
vocalization produced (acl)
sets 3d (compound)
excluded tumors (nsubj)
. micrograms (compound)
shown factor (ccomp)
ventilated were (auxpass)
admitted unit (nmod)
history confirmed (acl)
effects betaine (nmod)
drug but (cc)
causes it (nsubj)
zone nephrogenic (amod)
confirm do (aux)
research past (amod)
morphine mg/kg (compound)
use medications (nmod)
coccidioidomycosis for (case)
case parasitosis (nmod)
gamma-hexachlorocyclohexane ( (punct)
patients 5 (conj)
inhibitor oxidase (compound)
relation hemoglobin (nmod)
analyze dose-effect (dobj)
amoxicillin acid (conj)
report effects (dobj)
sulindac , (punct)
cycle per (case)
direction either (det)
severity their (nmod:poss)
methods sensitive (amod)
n=12 group (nmod)
embryos late-gestation (amod)
function motor (compound)
discontinued oxytocin (nsubjpass)
g/dl 2 (nummod)
b chronic (amod)
quantify risks (dobj)
exhibited they (nsubj)
autoantibodies panca (appos)
combined and (cc)
case infusion (nmod)
days 33 (nummod)
group hypotensive (amod)
days 1 (nummod)
tachycardia beats (dep)
toxicity . (punct)
tci ) (punct)
observations staff (nmod)
contents metabolites (compound)
i.p. ) (punct)
tested clearance (nsubjpass)
s.c. p.o. (appos)
feeding diet (dobj)
observed addition (nmod)
unresponsive were (cop)
9 or (cc)
treatment empirical (amod)
assigned blocks (nmod)
insults injury (nmod)
underwent termination (nmod)
patients fifty-two (nummod)
observed they (nsubjpass)
antioxidant mitochondrial-targeted (amod)
quinine parenteral (amod)
0.5 than (case)
mepivacaine mg (appos)
regarded be (auxpass)
0.5 x (cc)
expanded . (punct)
days had (ccomp)
use treat (xcomp)
cholestasis of (case)
contribute that (nsubj)
cells field (nmod)
needs improvement (dobj)
come , (punct)
atria pig (compound)
injected methods (nsubjpass)
backcrossing repeated (amod)
eleven patients (nmod)
26- and (cc)
affects neurons (dobj)
co-infection patients (nmod)
decreased elevation (nmod)
state normal (amod)
turned those (nsubjpass)
osteoarthritis spondyloarthropathy (conj)
programs antihypertensive (amod)
pretreated lithium (nmod:npmod)
system cns (appos)
l-alpha-gfc with (case)
convulsions caused (acl)
examine association (dobj)
recurrence the (det)
surgery sinus (compound)
collected intake (nmod)
muscle painful (amod)
vasoconstriction gm-induced (amod)
blockage produced (acl)
family bcl-2 (compound)
preparations pills (conj)
vasculitis : (punct)
ccr ml/min (appos)
alfentanil following (case)
mg/kg weeks (nmod)
increase mg/dl (nmod)
those interval (dep)
interval duration (conj)
60.44 5.99 (conj)
trials designed (acl)
ziprasidone by (case)
delay onset (nmod)
p11 as (case)
developed prolongation (dobj)
kidneys their (nmod:poss)
anesthetics with (case)
given apart (advmod)
similar lna+hca (nsubj)
examined histologically (advmod)
influence control (nmod)
think trigger (ccomp)
bupivacaine local (amod)
doxorubicin/kg ip (appos)
headache frequent (conj)
single ) (punct)
procedures . (punct)
timolol both (preconj)
repaired was (auxpass)
studied behaviorally (advmod)
protection observed (acl)
dose paroxetine (nmod)
electro-oculography electroretinography (conj)
scopolamine injection (conj)
effect modifying (amod)
differences efficacy (nmod)
$ROOT$ defect (sent)
lack this (det)
scored children (nsubj)
implications its (nmod:poss)
make difficult (ccomp)
taking ht (dobj)
convincing more (advmod)
took previously (advmod)
lack increase (nmod)
ischemia . (punct)
electroretinography including (case)
reticulum of (case)
turnover da (compound)
arteriosclerosis caused (dep)
criteria discharge (compound)
effects synergistic (amod)
cortex high-dose (dep)
showed gains (dobj)
increase significantly (advmod)
treatment cocaine (compound)
chain into (case)
shr six-month-old (amod)
caused may (aux)
follow-up evaluation (nmod)
impact dexamethasone (nmod)
% 0.8 (compound)
structures diverse (amod)
end-stage or (cc)
increased sbp (nsubjpass)
infants all (det)
relation correlation (dep)
attained score (dobj)
3.8 ( (punct)
uptake hippocampus (nmod)
disease dyskinesia (conj)
improved pao2 (nsubjpass)
receptor ldlr (appos)
showed subjects (nsubj)
icp delta (compound)
accident of (case)
obtained mice (nmod)
assigned children (nsubjpass)
effective potent (conj)
decontamination doses (conj)
suggesting sites (ccomp)
index detection (nmod)
reversal . (punct)
withdrawal after (case)
rates prenatal (amod)
sod and (cc)
protects dexrazoxane (nsubj)
hospitals twenty-nine (nummod)
trial dystrophy (nmod)
clearance accumulation (conj)
carboplatin neither (cc:preconj)
blocker selective (amod)
effect subgroups (nmod)
alpha-tocopherol acetate (conj)
localised periphery (nmod)
underestimate incidence (dobj)
administration vincristine (compound)
increase therapy (nsubj)
bmcs obtained (acl)
stability the (det)
necessary where (advmod)
limitation motility (nmod)
was evaluate (xcomp)
given is (auxpass)
consume often (advmod)
weaker rats (nmod)
8,000 4,000 (quantmod)
animals administered (acl)
3 > (advmod)
lesions cyclophosphamide-induced (amod)
structure steroid (compound)
decreased whereas (mark)
tumors large (amod)
mmhg kpa (appos)
sedentary-isoproterenols the (det)
infections lag (nmod)
aneurysms abuse (conj)
prior paralysis (nmod)
performed users (nsubj)
depressed was (auxpass)
lysate in (case)
% +/- (cc)
similar magnitude (nsubj)
describe gain (conj)
decreased mm (nmod)
mediated systems (nmod)
10ug i.c.v (amod)
years 58.4 (nummod)
antimicrobials macrolide (compound)
2)% period (nmod)
persons hypertensive (amod)
procedure span (compound)
viruses with (case)
died baby (nsubj)
ranging mg/kg (nmod)
model genetic (amod)
mglurs of (case)
doses wt (nmod)
becoming efficacy (nmod)
efficacy toxicity (conj)
resulted reduction (nmod)
mimic exposing (advcl)
underwent groups (nsubj)
toxicity nerve (compound)
include drugs (dobj)
model stz-induced (amod)
led dysfunction (nmod)
efficacy disease (nmod)
volume total (amod)
effective very (advmod)
imaging volunteers (nmod)
densa ) (punct)
florence in (case)
receptors (5-ht)2a (compound)
unresponsive therapy (nmod)
normalized treatment (nmod)
= 0.815 (dobj)
different amphetamines (nmod)
measurements angiograms (nmod)
organization the (det)
risks cancer (compound)
medications used (amod)
concentration sevoflurane (nmod)
observed children (nmod)
days 13.3 (nummod)
process acid (amod)
resulted transfusion (nsubj)
subject , (punct)
administered carcinoma (nmod)
links and (cc)
transplants ) (punct)
bun and (cc)
tmax : (punct)
level extracellular (amod)
irritant an (det)
1.1 x (cc)
$ROOT$ re-induced (sent)
$ROOT$ compliance (sent)
rats three (nummod)
5-hydroxytryptophan of (case)
correlate duration (nmod)
properties of (case)
those . (punct)
recurrence disturbances (nmod)
marked pruritus (nmod)
single-blind trial (nsubj)
increase stability (dobj)
screen efficacy (nmod)
16 - (punct)
rats developed (acl:relcl)
yohimbine ) (punct)
precautions strict (amod)
determining testosterone (dobj)
0.07 0.12 (conj)
diagnosed carcinoma (nmod)
failure a (det)
informed patients (nsubj)
markers cytogenetic (amod)
indicate conclusion (nsubj)
space bromide (compound)
two than (quantmod)
peaked postdose (nmod)
sodium tubular (amod)
intake raised (amod)
cope to (mark)
pathogenesis nephropathy (nmod)
effects depressive (amod)
steroids oral (amod)
aminoglycoside amikacin (nsubj)
correlated activity (nmod)
9 ( (punct)
defects mds (appos)
reversed treatment (nmod)
few very (advmod)
cramps/myalgias muscle (compound)
alter levels (nsubj)
induction before (case)
episodes three (nummod)
recipients received (acl:relcl)
down-regulation induced (acl)
phenobarbitone , (punct)
undergone chemotherapy (dobj)
bolus is (cop)
suppressed expression (nsubjpass)
e4031 , (punct)
adding mg (dobj)
day 49th (amod)
sings significant (amod)
hypertension accompanied (acl)
immunotherapy as (case)
test is (cop)
rash retarded (amod)
blocked is (auxpass)
treatments all (det)
have expression (nmod)
flow expression (conj)
tolerated generally (advmod)
calcium adrenaline (conj)
height a (det)
evolution clinical (amod)
produced dose (nsubj)
da2 ) (punct)
give hypothesis (nmod)
investigation of (case)
led epidemiology (nsubj)
excluded patients (nsubjpass)
applied patients (nmod)
modifications those (nmod)
examined staining (nsubjpass)
beats/min 50 (nummod)
apnoea in (case)
downregulates that (mark)
involved factor (nsubjpass)
varies susceptibility (nsubj)
sd ; (punct)
lesions cortex (nmod)
units platelets (nmod)
decrease cortex (nmod)
maintained study (nmod)
schedule an (det)
known effective (ccomp)
immunoblotting by (case)
disease tumor (nsubj)
clip one (nummod)
suppression in (case)
effective vitro (advmod)
possible nitrendipine (nmod)
oxygen reactive (amod)
out-patients hypertensive (amod)
one other (appos)
syndrome sleep (compound)
fluency overt (amod)
excluded was (auxpass)
background purpose (conj)
clozapine p<.001 (dep)
focal and (cc)
consisted groups (nsubj)
encephalopathy ifosfamide (compound)
inserted and (cc)
csa rapamycin (conj)
pharmacological supportive (conj)
increased values (nmod)
concentration ticlopidine (nmod)
glomeruli of (case)
coombs direct (amod)
causes deterioration (dobj)
infarction nonhemorrhagic (amod)
worsened that (nsubjpass)
remodeling tachycardia-induced (amod)
100mg/kg ( (punct)
summarizes creating (advcl)
severe groups (nmod)
control autonomic (amod)
debate is (cop)
linked previously (advmod)
analysis immunohistochemical (amod)
rats pregnant (amod)
ameliorated dose-dependently (advmod)
electrocardiogram in (case)
$ROOT$ tachyphylaxis (sent)
potentiates stereotypy (dobj)
60 7 (conj)
interval median (amod)
clonidine for (case)
ml(-1 r2 (appos)
mazindol the (det)
was less (ccomp)
value ecg-enhanced (amod)
preserved was (cop)
combinations loreclezole (nmod)
consists screenings (nmod)
presented weakness (nmod)
use medication (compound)
eyes rat (compound)
alpha-2b with (case)
resulting instillation (nmod)
action facilitation (nsubj)
levels propofol (compound)
beta-blocking their (nmod:poss)
radiotherapy ) (punct)
anomaly neonatal (amod)
patients function (nmod)
variation great (amod)
performed diagnostics (parataxis)
antagonist)-induced ( (punct)
program cholesterol (compound)
prilocaine and (cc)
dose vaccine (compound)
index > (dep)
calcium metabolism (conj)
antigen hbeag (dep)
confirm this (dobj)
patients ten (nummod)
more statistically (advmod)
l-name the (det)
remain mechanisms (nsubj)
alleviated be (auxpass)
h -24 (nummod)
$ROOT$ rebounded (sent)
neuroplasticity . (punct)
treated . (punct)
hemoglobin volume (conj)
index the (det)
compound synthetic (amod)
candidates of (case)
% ci=28.8%-58.6 (nummod)
measured achieve (advcl)
rr 0.70 (nummod)
accumbens of (case)
suggesting process (ccomp)
rate nci/min (nmod)
striatum cells (nsubj)
discussed effects (nsubjpass)
23.7 - (advmod)
wires pacing (compound)
given review (nsubjpass)
methadone with (case)
seconds range (dep)
mean four (nmod)
after h (nmod:npmod)
order = (acl)
sphincter-relaxing effective (amod)
associated independently (advmod)
shown naloxone (nsubjpass)
complete ) (punct)
shr ) (punct)
parkinsonism dyskinesias (conj)
tumor ic (nummod)
criteria trials (appos)
play may (aux)
used control (nmod)
showed lobes (nmod)
reverses paralysis (dobj)
re-elevate to (mark)
electrophoresis and (cc)
scores with (case)
time study (nmod)
lower indicating (advcl)
sections and (cc)
prevented both (cc:preconj)
exposure after (case)
cystitis complicating (acl)
cells myocardial (amod)
demonstrated diameters (nmod)
fear nausea (conj)
exhibited contrast (nmod)
complexes and (cc)
subtherapeutic levels (nsubj)
users therapeutic (amod)
minimize effects (dobj)
reflect incidence (nsubj)
common resolved (conj)
5,7-dihydroxytryptamine by (case)
sec for (case)
cases such (amod)
involvement catalepsy (nmod)
inefficient . (punct)
reversed failed (conj)
enhancement phenobarbital (nmod)
3.1 0.5 (conj)
microangiopathy acute (amod)
weight dry (amod)
technique flurothyl (amod)
myelin of (case)
taken must (aux)
received water (dobj)
ketoprofen nsaid (conj)
growth children (nmod)
demonstrated deposits (dobj)
disposition . (punct)
considered dynamics (conj)
maintained also (advmod)
diseases patients (conj)
agonist dopamine (compound)
drug treatment (nmod)
decreased are (auxpass)
shown have (xcomp)
effect solvent (nmod)
patients ' (case)
compromise with (case)
degrees fibrosis (nmod)
commencement therapy (nmod)
cord venous (amod)
received amifostine (dobj)
likely capacity (nsubj)
isolated lipid (nsubjpass)
responses mice (nmod)
cause rare (amod)
effect af (compound)
$ROOT$ hyperalgesia (sent)
withdrawal clotiazepam (compound)
% users (nmod)
injection weekly (amod)
activation striatum (nmod)
dowregulation the (det)
asenapine asenapine (conj)
agent sirolimus (nsubj)
inflammation , (punct)
$ROOT$ manifest (sent)
changes hepatic (amod)
induces expression (dobj)
speaking , (punct)
eye ipsilateral (amod)
developed rat (nmod)
formulation galenic (amod)
nmba short-acting (amod)
demonstrated promoted (ccomp)
stabilized were (auxpass)
preceded hemolysis (nsubjpass)
verifying space (dobj)
sustained effect (nsubj)
lesion sn (compound)
class functional (amod)
experiencing experiencing (conj)
showed which (nsubj)
microinjected shell (nmod)
risk those (nmod)
titrated to (nmod)
mechanisms receptors (conj)
rostral intermediate-caudal (conj)
appearance wave (nmod)
manifests activity (dobj)
conditions and (cc)
bupivacaine anesthesia (nmod)
lower dosage (nsubj)
lomustine of (case)
hypoxemia neonates (nmod)
girl 4-year-old (amod)
characteristic nonspecific (conj)
4.1 to (case)
epimers the (det)
determined analysis (nmod)
has development (nmod)
thalidomide dose (nmod)
sc)-induced mg/kg (nmod:npmod)
cellulose w/v (compound)
protein ) (punct)
patient described (acl)
groups ntg (compound)
likely experience (xcomp)
more no (neg)
composition stone (compound)
disappeared stopping (advcl)
alcohol , (punct)
atresia biliary (amod)
cimetidine by (case)
push 2-minute (amod)
heparin treatment (nmod)
irrespective regimen (nmod)
cardiomyocytes neonatal (amod)
hl60 and (cc)
years 000 (nummod)
augments protects (conj)
low relatively (advmod)
occurrence tachycardia (nmod)
carried analyses (nsubjpass)
permeability endothelial (amod)
days 30 (nummod)
tubuli in (case)
injection ouabain (nmod)
members additional (amod)
concentration 6-hr (amod)
enzymes other (amod)
moderate-dose 24.1 (appos)
created network (nsubjpass)
rechallenge on (case)
induced 1,2-dmh (nmod)
amines strain (nmod)
expected . (punct)
had fistula (dobj)
register register (appos)
urothelium and/or (cc)
acetaminophen micrograms/ml (appos)
versa vice (advmod)
diuretics high-dose (amod)
pcpa to (case)
data series (nmod)
score 8 (nmod)
infection organs (nmod)
ivig of (case)
dose mg/day (appos)
modifications same (amod)
leghorn white (amod)
need which (nsubj)
hydrobromide 5-hydroxytryptamin1a (compound)
presented help (advcl)
pretreatment ramh (nmod)
reactivator , (punct)
drug antidepressant (amod)
incidence and (cc)
obtain presence (nmod)
evident administered (advcl)
bronchopneumonia acute (amod)
detachment complete (amod)
vehicle flumazenil (conj)
results and (cc)
reported revealed (conj)
collected vein (nmod)
veratridine administered (amod)
cholinergic pretreatment (appos)
deposits , (punct)
useful imaging (nsubj)
carries application (dobj)
mg/kg usually (advmod)
$ROOT$ day (sent)
induced tumor-free (advcl)
introduced were (auxpass)
low this (nmod)
apomorphine amphetamine (conj)
schizophrenia , (punct)
ra the (det)
tetracycline of (case)
lf mg/kg (appos)
cisplatinum cyclophosphamide (appos)
standard are (cop)
evening and (cc)
reported remission (nsubjpass)
decreased l-name (nsubj)
weeks seven (nummod)
hydrochloride 1r (compound)
contribution system (nmod)
disrupted groups (nmod)
= 0.000 (dobj)
safe has (advcl)
6 2 (compound)
provides report (nsubj)
detected antibodies (nsubjpass)
percentage occurrence (nmod)
isom ) (punct)
amines metabolites (conj)
evaluated period (nmod)
necessitated discontinuation (dobj)
discontinued venlafaxine (nsubjpass)
omeprazole of (case)
model model (conj)
symptoms phase (compound)
substance-induced other (conj)
relieved regardless (advmod)
evaluated compared (advcl)
suspected although (mark)
3.82 x (cc)
ratio ( (punct)
act system (nmod)
carried study (nmod)
study electron (compound)
patients adsd (nmod)
included data (dep)
evaluated records (nsubjpass)
kidney left (amod)
combination analogue (nmod)
therapy drugs (conj)
medulla administration (nmod)
12-week multicenter (dep)
maximum . (punct)
timing events (conj)
recognized than (mark)
pressure bp (conj)
ng/dl 1.8 (nummod)
deficit paradigm (nmod)
4.5+/-1.0 ( (punct)
name to (mark)
vasculitis ptu-associated (amod)
rat pig (conj)
fatigue general (amod)
suggested mediate (xcomp)
nausea events (nsubj)
ng/ml than (case)
properties a (nmod)
invaluable patients (nmod)
monitoring during (case)
antagonizes . (punct)
status angina (compound)
stimulus following (case)
performed tasks (dobj)
fs containing (acl)
tinnitus decompensated (amod)
gsh ) (punct)
ulcers and (cc)
31 % (dep)
worsening and (cc)
attenuated abnormalities (dobj)
coma a (det)
end-diastolic ed (dep)
collection in (case)
improves cd-832 (nsubj)
excretion for (case)
toxicity amikacin (nmod)
given fashion (nmod)
uptake the (det)
upregulation levels (nmod)
administering vincristine (dobj)
exudate sinus (compound)
lower increase (nsubj)
stability its (nmod:poss)
diagnosed cholestasis (nsubjpass)
strains sprague-dawley (amod)
modalities three (nummod)
material contrast (compound)
found fasciculation (nsubjpass)
cause thus (advmod)
have infant (nsubj)
likely died (ccomp)
served elevated (nsubj)
diseases hbv-related (amod)
report data (dobj)
19.8 +/- (cc)
disorder ( (punct)
oxazepam and (cc)
develop glaucoma (dobj)
effects diazepam-induced (amod)
extent changes (nmod)
carriers selected (amod)
favor in (case)
17 patients (nmod)
asked dysphagia (nmod)
scale small (amod)
papaverine onset (conj)
increased -- (punct)
exposure oxidant (amod)
effects monoxide (nmod)
28 13 (conj)
affect up-regulate (conj)
% % (parataxis)
combination sulpiride (nmod)
had rats (nsubj)
effects short-term (amod)
shortened change (advcl)
decrease activity (nmod)
triggered therefore (advmod)
ctnt between (case)
addressed will (aux)
lead rhythm (nmod)
scale wechsler (compound)
aimed was (auxpass)
followed results (nsubjpass)
complications unusual (amod)
shown been (auxpass)
change 16 (nummod)
incidence mice (nmod)
cancer is (cop)
replies questionnaires (nmod)
achieved remission (dobj)
blunted effect (nsubjpass)
remained unsolved (xcomp)
headache duration (nmod)
velocity maximum (amod)
feet legs (conj)
bradyarrhythmias life-threatening (amod)
using monitoring (conj)
dose acute (amod)
time entries (conj)
microgram/ml 1.9 (nummod)
effective be (cop)
two only (advmod)
effects verapamil (compound)
reported qtls (nsubjpass)
examine importance (dobj)
assessment index (nmod)
fibrillation infarction (conj)
epilepsy lobe (compound)
mice hepatitis (nmod)
dogs mao-inhibited (amod)
a cyclosporin (compound)
inhibitors coa (compound)
$ROOT$ mechanisms (sent)
diminished transiently (advmod)
importance signaling (nmod)
bear point (nmod)
developed timeframe (nmod)
females from (case)
calcium d (conj)
recurred , (punct)
attack no (neg)
achieve concentration (dobj)
control respective (amod)
raised significantly (advmod)
woman presented (acl:relcl)
beta2(-/- ) (punct)
regulation movement (compound)
exposure first (amod)
presentation after (case)
received start (nmod)
light- transmission-electron (conj)
polymyositis and (cc)
pbo % (appos)
it of (case)
cohort within (case)
epo ) (punct)
systems glutamatergic (amod)
hypertrophy degeneration (conj)
medication antiepileptic (amod)
developed contrast (nmod)
carried also (advmod)
developed spontaneously (advmod)
ischaemia dobutamine (compound)
suggestion earlier (amod)
i.v. i.m. (conj)
cases from (case)
mg/dl 10.2 (nummod)
preserved deteriorates (advcl)
compared dogs (nmod)
restricted that (mark)
produced depressants (nmod)
levels whole (amod)
agents pharmacological (amod)
reported constriction (nsubjpass)
metabolites progesterone (nmod)
convulsions responsive (amod)
patients versus (cc)
wild-type ) (punct)
$ROOT$ hazard (sent)
days exposure (dep)
report study (dobj)
44.18 1.37 (appos)
retardation offspring (nmod)
persists or (cc)
pairs perfused (acl)
compliance therapy (nmod)
syndrome stress-mediated (amod)
gain insights (dobj)
seizures limbic (amod)
vagotomy sympathectomy (conj)
c cytochrome (compound)
loads with (case)
clomipramine antidepressant (amod)
vigilance for (case)
deleted gene (nsubjpass)
used may (aux)
ng/mouse ) (punct)
isolated cardiomyocytes (nsubjpass)
mask via (case)
ancrod of (case)
coupling of (case)
effects ) (punct)
centers at (case)
offer , (punct)
using probes (dobj)
agent single (amod)
dna mitochondrial (amod)
dysfunction tubular (amod)
0.887 - (punct)
pattern vivo (advmod)
anticoagulation necessary (advcl)
$ROOT$ screening (sent)
intensity migraine (compound)
activations fluency (nmod)
tolerated lamivudine (nsubjpass)
duration < (dep)
tremors and (cc)
patient young (amod)
metoprolol racemic (dep)
lp the (det)
particularly more (advmod)
improvement scores (nmod)
mild reversible (conj)
pre-treatment antagonist (nmod)
co-administration lidocaine (nmod)
female 40-year-old (amod)
2e1 with (case)
diet-fed ob (conj)
toxic drug (nmod)
27 mdp (nmod)
treated aspirin (nmod)
13 other (amod)
pgp of (case)
tachycardia avrt (appos)
course busulfan (compound)
transplant liver (compound)
none with (case)
treatment cyclophosphamide (compound)
arrest and (cc)
9-tetrahydrocannabinol thc (appos)
expected as (mark)
patterns mutational (amod)
therapy haart (appos)
number and (cc)
deficits series (dep)
occurred those (nmod)
stimulated was (auxpass)
patients 80/115 (nummod)
period lt (nmod)
associated marrow (nmod)
tests 4 (nummod)
synthase inos (appos)
attenuated partially (advmod)
piloerection associated (amod)
9,832 38,048 (conj)
1.18 progestagens (nmod)
received admitted (advcl)
morphine blocker (conj)
attenuate antioxidants (nsubj)
flow in (case)
greater observations (nmod)
models through (case)
phosphatase membrane (compound)
allografts tg (nmod)
rate survival (compound)
replaced fluvoxamine (nmod)
pressure systemic (amod)
succinylcholine sch (appos)
moderate largely (advmod)
measures : (punct)
0.25 < (advmod)
mg interval (dep)
intervals representing (acl)
% m (nmod)
means valuable (amod)
noel ) (punct)
nefiracetam of (case)
change to (mark)
trigeminal both (cc:preconj)
programs surgery (compound)
association such (predet)
patients unable (amod)
channel chloride (compound)
arrhythmogenicity the (det)
rater trained (amod)
suggested had (ccomp)
administration during (case)
tinnitus subjective (amod)
exposure inhibition (nmod)
86 +/- (cc)
cytotoxicity cyclophosphamide (compound)
inhibits and (cc)
study study (nsubj)
generation control (conj)
different pgi2 (nsubj)
dehydrogenase catalyzes (acl:relcl)
cycles % (appos)
carcinoma recurrent (amod)
continue improves (conj)
syncope dexmedetomidine (nmod)
transmission neural (amod)
65 , (punct)
episodes hypercalcemia (nmod)
$ROOT$ conversion (sent)
decreased linearly (advmod)
decrease function (nmod)
consistent anemia (nmod)
using baseline (nmod)
willing accept (xcomp)
acidosis patients (nmod)
edema matter (compound)
anthony 's (case)
cause and (cc)
increased antagonized (conj)
artery or (cc)
findings clinical (amod)
end the (det)
ml/kg 2 (nummod)
discount arrhythmia (dobj)
mediator no (nsubj)
focused been (auxpass)
test memory (compound)
enhanced induction (nmod)
electrolytes the (det)
possible used (conj)
biochemical and (cc)
exacerbation , (punct)
anuria in (case)
bore that (mark)
a drug (appos)
combinations with (case)
higher much (advmod)
improve restore (conj)
aspirated . (punct)
tissues cells (conj)
blocking 1-adrenoceptor (compound)
report as (case)
indicating apoptosis (dobj)
occurred material (nsubj)
involves that (mark)
conclusion to (case)
regulation aldosterone (nmod)
one more (amod)
treatment cholesteryl (compound)
tacrine and (cc)
findings mri (compound)
phosphatase ptpro (appos)
gestation during (case)
mcao by (case)
airway flexible (amod)
closing and (cc)
read been (auxpass)
types for (case)
retrospective , (punct)
micrograms.kg-1.min-1 4 (nummod)
nerves urothelium (nmod)
sgot of (case)
insufficiency indomethacin-induced (amod)
characterized it (nsubjpass)
determined using (advcl)
good withdrawn (advcl)
effects gaba(a)rs (nmod)
begins stimulates (ccomp)
disruption treatment (nmod)
inhibited expressions (nsubjpass)
group microg (nmod)
angioedema hereditary (amod)
amoxicillin-clavulanate incriminated (amod)
cocaine mg/kg (appos)
chloroacetaldehyde : (punct)
1984 or (cc)
carcinoma progressive (amod)
complication thalidomide (nmod)
dysfunction patient (nmod:poss)
curve characteristic (amod)
fanft on (case)
modulation effects (nmod)
confirmed existence (dobj)
type mice (dep)
failure congestive (amod)
immunostaining regions (nmod)
relationships dose-response (amod)
methadone heroin (conj)
underwent repair (dobj)
antagonists receptors (nmod:poss)
samples peripheral (amod)
mg/m2 5-fluorouracil (compound)
nuclei rat (nmod)
suggest play (ccomp)
metocurine with (case)
damage mixed (amod)
reduced binding (dobj)
meal a (det)
test of (case)
spironolactone of (case)
remained surface (nmod)
receiving phenytoin (dobj)
degeneration myxomatous (amod)
finding purpura (nsubj)
complained numbness (nmod)
mk-486 mg/kg (dep)
diet laboratory (compound)
neurotoxic that (mark)
bepridil by (case)
webster swiss (amod)
analysis = (parataxis)
systems brainstem (nmod)
infrequent : (punct)
aspirin inhibitor (appos)
injection cbz (nmod)
acquired eye (nmod)
attained and (cc)
diagnosis correct (amod)
reaction polymerase (compound)
mapping quantitative (amod)
= 66 (dobj)
crf > (dep)
thought been (auxpass)
used records (dobj)
related of (mark)
anaesthesia during (case)
infections , (punct)
dogs 12 (nummod)
impulsiveness , (punct)
associated drops (nmod)
neurotoxic opioids (nsubj)
functionality catalytic (amod)
hyperammonemia mainly (advmod)
areas , (punct)
administration a (dep)
reputation a (det)
result modulation (nsubj)
sinuses the (det)
duration risk (conj)
nephritis induced (acl)
proving superior (conj)
treatment department (nmod)
had reached (conj)
aminotransferase aminotransferase (conj)
precede induction (dobj)
rr 1.35 (nummod)
show decreased (ccomp)
experienced nine (nsubj)
hypertension deficient (amod)
atria of (case)
experiments vitro (advmod)
associated mice (advcl)
1-receptor alpha (compound)
absorption adrenaline (nmod)
monitored ensure (xcomp)
sevoflurane after (case)
application kcn (nmod)
acidity medication (nmod)
background objective (conj)
desensitization beta-adrenoceptor (compound)
identified isolation (nmod)
pod 2 (nummod)
ameliorated hydroxytyrosol (nmod)
% eyes (nmod)
appeared coincided (conj)
treatment response (conj)
pharmacokinetics on (case)
re-exposure dose (nmod)
emergence strains (nmod)
given vincristine (nsubjpass)
reducing considerations (dep)
implications imaging (nmod)
irrespective administration (nmod)
rare episodes (nsubj)
irrigated surgery (nmod)
unaffected and (cc)
ng/ml normal (amod)
beraprost oral (amod)
gr microg/side (appos)
0.8 +/- (cc)
mechanisms trends (dep)
examined finally (advmod)
anticoagulated and (cc)
related secondary (advcl)
vasospasm damage (conj)
heptylate of (case)
spiranolactone antagonist (appos)
demonstrated increases (ccomp)
points mmse (compound)
knockout dopamine (compound)
neuroimage 40 (nummod)
interactions disturbed (amod)
monitored occur (advcl)
bevacizumab with (case)
was thickness (nmod)
therapy omeprazole (nmod)
found this (nsubjpass)
fluid tubular (amod)
events treatment (nmod)
were displace (conj)
adequate hematoma (nsubj)
behavior map-induced (amod)
discussed identified (conj)
depression spreading (amod)
pathway camp (compound)
effects neurocognitive (amod)
treated amikacin (nmod)
possibility . (punct)
= t(33 (nsubj)
consistent more (advmod)
puromycin-aminonucleoside of (case)
infusion before (nmod)
dose glycopyrronium (nmod)
0.2 < (advmod)
difference , (punct)
minutes 120 (nummod)
resulted may (aux)
animals pilocarpine-treated (amod)
plays pallidus (nsubj)
encephalopathy piperacillin-induced (amod)
hepatitis due (amod)
japan outside (case)
reached day (nmod)
regression , (punct)
saline ) (punct)
pinch tail (compound)
experienced fever (dobj)
bn antagonist (appos)
ischemia effect (dep)
changes of (case)
reflex model (appos)
induced toxicity (nmod)
cyclosporin , (punct)
altered not (neg)
likely least (advmod)
dose lindane (compound)
biopsies nonepisode (amod)
demonstrated that (mark)
scopolamine of (case)
$ROOT$ glomerulonephritis (sent)
affect contribute (conj)
substantial enough (advmod)
maintained patency (nmod)
therapy antituberculosis (compound)
change ischemic (amod)
activity cortex (nmod)
assays functional (amod)
clonazepam than (case)
entity necrosis (nsubj)
hypotension before (case)
lasting dose (nmod)
higher prophylaxis (nmod)
demonstrated only (advmod)
population within (case)
halothane oxide (conj)
metabolism impaired (amod)
background withdrawn (acl)
patients surgery (nmod)
$ROOT$ insecticide (sent)
carteolol of (case)
patients a (nmod)
be due (advmod)
hypersalivation bronchorrhoea (conj)
increasing ; (punct)
foods and (cc)
cortex bilateral (amod)
found thus (advmod)
history parental (amod)
net hippocampal (amod)
taking but (cc)
octreotide of (case)
that after (case)
failed who (nsubj)
thickness central (amod)
side right (amod)
1.4 were (cop)
paramount is (cop)
microg% mean (dep)
arrhythmia danger (appos)
presents : (punct)
objective estimate (acl)
bioactivation of (case)
atrophy , (punct)
associated comparison (nmod)
effect ibuprofen (nmod)
induced mitochondria (nmod)
use ifosfamide (nmod)
flat to (mark)
derivative beta-carboline (compound)
anorexigens results (dep)
$ROOT$ different (sent)
re-challenged . (punct)
malformation myelomeningocoele (conj)
episodes encephalopathy (nmod)
protein urinary (amod)
pharmacology efficacy (conj)
brain greater (amod)
associated as (dep)
methods in (amod)
schedule vincristine (compound)
reduced paraparesis (nmod)
greater pigs (nmod)
detected difference (nsubjpass)
apap ) (punct)
refractory chemotherapy (nmod)
thought has (aux)
haemorrhage days (nmod:npmod)
drug non-steroidal (amod)
melphalan followed (acl)
implicated and (cc)
conduction air (compound)
epicardium and (cc)
acute intermediate (conj)
pattern effects (nmod)
exposure lifetime (amod)
tuberculosis proven (amod)
minimum a (det)
increased amount (nsubj)
rhabdomyolysis in (case)
sbp , (punct)
b-related amphotericin (nmod:npmod)
prolonged bupivacaine (nmod)
1.65 +/- (cc)
formation % (nmod)
submitted were (auxpass)
increasing use (nmod)
administered examined (conj)
artery ( (punct)
users underwent (acl:relcl)
[ca]o than (case)
site possible (amod)
interval % (compound)
chow regular (amod)
performed total (nmod)
effects drugs (nmod)
blood venous (amod)
agonist opiate (compound)
cb ( (punct)
recovered treatment (nmod)
states central (amod)
pointes torsades (compound)
field per (case)
occurred hypotension (nsubj)
lead animals (nmod)
stages with (case)
warranted patients (nmod)
selective were (cop)
core and (cc)
recognition postpregnancy (compound)
learning spatial (amod)
$ROOT$ benign (sent)
normalized extrusion (nsubjpass)
effect synergistic (amod)
seeing : (punct)
correlation measurements (nmod)
24 18 (quantmod)
mr the (det)
ml/min/kg td (nmod)
diphosphanilate chlorhexidine (compound)
differences due (case)
present individuals (nmod)
uraemia and (cc)
users those (appos)
radical free (amod)
drugs injection (conj)
efficacious haloperidol (nsubj)
changes dramatic (amod)
hyperlipemia diazinon-induced (amod)
agent transplantation (nmod)
effect combining (advcl)
dexrazoxane icrf-187 (appos)
maintains that (nsubj)
advantage effects (nmod)
responses duration (nmod)
avoidance opioids (nmod)
prevent use (nmod)
are objective (dep)
dose combined (acl)
absent different (advcl)
conclusions common (appos)
td50 ) (punct)
outcomes patients (nmod)
measured tremor (nsubjpass)
dyskinesias monkeys (nmod)
patients p=0.03 (appos)
contracture flexure (compound)
therapy dacarbazine (compound)
assessed methods (nmod)
titrated mg/day (nmod)
woman 43-year-old (amod)
effect weight (nmod)
tissues all (predet)
dose allowed (amod)
arrhythmia bradycardia (conj)
detect whether (mark)
started therapy (nsubjpass)
nra0160 clozapine (conj)
practice common (amod)
symptoms arthralgia (dep)
administration halothane (compound)
atherosclerosis women (nmod)
hypokalemia severe (amod)
salicylate sodium (compound)
23.6 7.6 (conj)
minutes two (nummod)
volumes cylinder (nmod)
played process (nmod)
glabrata isolated (acl)
decrease week (nmod)
resulted disorder (nmod)
requires possibility (nsubj)
troponin levels (dep)
min induction (nmod)
axons or (cc)
% prilocaine (compound)
ci 2.04 (nummod)
level brainstem (compound)
was meq/l. (attr)
stems hypothesis (nsubj)
studied association (nsubjpass)
affinity high (amod)
nested cohort (nmod)
use may (aux)
tamoxifen mg.kg(-1).d(-1 (appos)
occurred absence (nmod)
part trial (nmod)
priapism for (case)
affected trimester (nmod)
men seven (nummod)
preferred minimize (advcl)
therapy treat (acl:relcl)
controls normal (amod)
anophthalmia or (cc)
age 27 (dep)
lead chow (conj)
dose opioid (compound)
warfarin on (case)
cases delirium (nmod)
reduction dose (nmod)
caucasians in (case)
dodds 1967 (nummod)
angiogenesis pituitary (nmod)
antineoplastic is (cop)
sleep during (case)
profile therapeutic (amod)
nanoparticles 80-coated (amod)
softening growth (conj)
rate prolactin (nmod)
had counts (nmod)
showed conclusion (nsubj)
patterns different (amod)
grade grade (dep)
factor product (nsubj)
infants , (punct)
weight/day body (compound)
affect segment (dobj)
determine level (dobj)
undergone , (punct)
presence sensorium (nmod)
agitation severe (amod)
reaction ( (punct)
described newborn (nsubjpass)
levels lower (amod)
irrigations kanamycin-colistin (compound)
hyperactivity urge (compound)
oxytocin the (det)
reveals finding (dobj)
patients 241 (nummod)
state a (det)
manipulated pressure (nsubjpass)
bpt ( (punct)
ar = (dep)
enhanced l-dopa (nmod)
therapies from (case)
one neurosteroids (nmod)
fentanyl morphine (conj)
reported developed (ccomp)
progressed diverging (advcl)
initiation tdp (conj)
multiple not (cc)
presented sensations (nmod)
remission bmt (nmod)
regimens various (amod)
concentrations and (cc)
induced naloxone (nsubj)
delayed reduced (conj)
use population (nmod)
tdr because (case)
missed determining (csubj)
transport of (case)
stereotypy catalepsy (conj)
mangiferin with (case)
s-transferase alpha-gst (appos)
distribution depression (nmod)
lack because (case)
agents psychopharmacologic (amod)
incidence infection (nmod)
underwent had (conj)
signaling pathological (amod)
hospitals different (amod)
leukocyturia , (punct)
analyzed events (dobj)
20 symptoms (nmod)
cardiotoxin that (mark)
infection for (case)
quantified population (nsubjpass)
caused changes (dobj)
lidocaine of (case)
seizures occurred (acl:relcl)
time period (dobj)
significant clinically (advmod)
af with (case)
found cases (dobj)
neurotoxicity 12 (appos)
consider we (nsubj)
duration twitching (nmod)
rated basis (nmod)
month and (cc)
tremor particularly (advmod)
demonstrates , (punct)
diet contained (acl:relcl)
laboratory in (case)
$ROOT$ includes (sent)
combined drugs (nmod)
hyperfiltration and (cc)
secondary effect (nmod)
anaesthesia halothane (compound)
r. hester (compound)
recipient transplant (compound)
flattening , (punct)
calculations body (compound)
revealed corresponding (advcl)
cells/mm3 , (punct)
administered who (nsubjpass)
caused frequencies (nmod)
implications use (nmod)
read them (nmod)
content whole (amod)
increased 5.7 (nmod)
group nephritis (compound)
loss sensorineural (amod)
using strategy (dobj)
10 < (advmod)
desensitization to (case)
death decline (conj)
showed scans (nmod)
differ p=0.36 (parataxis)
coagulopathies other (amod)
led which (nsubj)
del , (punct)
drug acetate (nsubj)
gentamicin gm (appos)
effects minimal (amod)
connections by (case)
emboli pulmonary (amod)
from necrosis (nmod)
take creatine (dobj)
anoxia cerebral (amod)
cancer of (case)
butyrylcholinesterase plasma (compound)
varied mg (nmod)
avoid should (aux)
methods sensitive (acl:relcl)
designed similarly (advmod)
lack e (nmod)
pravastatin , (punct)
lethality physostigmine-induced (amod)
initiated administration (nmod)
areas contralateral (amod)
augment levels (dobj)
exceeded when (advmod)
effects temperature (nmod)
switching of (mark)
impairment early (amod)
assays the (det)
infection simultaneous (amod)
perseveration ( (punct)
enabled differentiation (dobj)
viewed however (advmod)
hbv no (neg)
c219 the (det)
chlorpromazine i.c. (compound)
pattern developmental (amod)
demonstrate did (aux)
complication cc (nmod)
lower = (parataxis)
ameliorated rate (nsubj)
binding clonidine-suppressible (amod)
persisted adrenalectomy (nmod)
used woman (nmod)
profile induced (acl)
ng and (cc)
= 7934 (dobj)
excretion kidneys (nmod)
concentrations mannitol (compound)
pressure groups (nmod)
that volunteers (nmod)
abnormalities catheterization (compound)
chlorpropamide with (case)
s-isomer active (amod)
examined parameters (nsubjpass)
bpm propranolol (nmod)
cardiotoxicity adriamycin (compound)
situation the (det)
complex of (case)
reduction a (det)
count of (case)
analysis excitability (nmod)
derivative of (case)
involvement injury (nmod)
rate engraftment (nmod)
atrophy iia (compound)
patient thrombocytopenia (nmod)
had progressed (conj)
mg b.i.d. (dep)
method may (aux)
glycopyrrolate atropine (conj)
course event (nmod)
dose labetalol (nmod)
given imipramine (dobj)
levels systemic (amod)
blockade . (punct)
analysis creatinine (conj)
mechanism causing (acl)
1989 since (case)
piperacillin of (case)
scenario is (cop)
tacrolimus corticosteroids (conj)
sites calcification (nmod)
cortex both (cc:preconj)
asked was (auxpass)
ester l-arginine (conj)
approximation the (det)
thiamine riboflavin (conj)
concentration day (nmod)
dehydrogenase , (punct)
accompanied decline (nsubjpass)
damages this (nsubj)
stroke in (case)
studied modulation (dobj)
testing flurothyl (compound)
erythema urticaria-angioedema (conj)
involving lignocaine (dobj)
effects undesirable (amod)
intake by (case)
response chemotherapy (compound)
terminate hemodialysis (nsubj)
result effects (nmod)
salicylate acid (conj)
% about (case)
agent neutralizing (amod)
content luminal (amod)
concluded study (nsubj)
leading syndrome (nmod)
related regeneration (nmod)
m1 m4 (conj)
experienced disorders (dobj)
51 39 (compound)
decrease leading (acl)
labetalol metoprolol (conj)
decreased injected (advcl)
result coadministration (nmod)
thickening , (punct)
lasted hours (nmod:tmod)
membrane glomerular (amod)
ability a (det)
comparison variables (nmod)
produced administration (nmod)
patients 2050 (nummod)
showed mris (nsubj)
follow was (cop)
underwent patients (nsubj)
dose dapsone (nmod)
dissatisfaction sexual (amod)
maleate with (case)
gain therapeutic (amod)
production activation (conj)
91.5 ) (punct)
gemcitabine weeks (nmod:tmod)
test damage (nmod)
supervened later (advmod)
$ROOT$ cacl2 (sent)
patients scleroderma (nmod)
cancer non-small (amod)
prophylaxis . (punct)
absence by (case)
monophosphate 3',5'-cyclic (amod)
medications virus (compound)
late-gestation mid- (amod)
performed reactions (nsubjpass)
reviewed records (nsubjpass)
response mediated (acl)
antigen ag (appos)
synthase pathways (nmod)
provided that (nsubj)
changes age-dependent (amod)
pregnane-21-diol-20-ones 3 (nummod)
pretreatment trazodone (nmod)
responding well (advmod)
axons ( (punct)
spasticity of (case)
pd advanced (amod)
index insulin (compound)
thrombo-embolism stroke (conj)
$ROOT$ highlight (sent)
dtis ( (punct)
performed be (auxpass)
rigidity parkinsonian-like (amod)
course postoperative (amod)
design received (appos)
function on (case)
effects serious (amod)
produced co-administration (nsubj)
dysfunction glutamatergic (amod)
titrated not (neg)
growth arrested (amod)
cotransporter nkcc2 (appos)
animals function (nmod)
reversed catalepsy (dobj)
mesencephalon in (case)
adriamycin adjuvant (amod)
given maximum (nmod)
months 24 (nummod)
poses dilemma (dobj)
complexes electron (compound)
convulsions rats (nmod)
beta-mimetics of (case)
cells prolactinoma (compound)
% 8/27 (punct)
lithium-induced to (mark)
softening , (punct)
values protective (amod)
variables evaluated (acl)
time oral (amod)
level bax (nmod)
infants all (appos)
syncope in (case)
reported dyskinesia (nsubjpass)
dithiothreitol heat (conj)
patients nausea (nmod)
train a (det)
factors certain (amod)
oliguria failure (appos)
day administration (nmod)
november reported (acl:relcl)
associated diet (nmod)
argatroban plus (cc)
psychosis meth-induced (amod)
management to (case)
patients p=0.003 (dep)
$ROOT$ serum (sent)
procedures different (amod)
scale clinical (amod)
documented time (nmod)
prevent seizures (dobj)
obtained signs (nsubjpass)
measure which (nsubj)
administration cbdca (compound)
1339 - (punct)
patients examined (acl:relcl)
sensitivity as (case)
reflects rotation (nsubj)
apl of (case)
nausea pain (conj)
variable for (case)
ma and (cc)
seizures pilocarpine (compound)
recovery consciousness (nmod)
multiforme myocarditis (conj)
shock a (det)
$ROOT$ single-blind (sent)
inclusion diet (nmod)
groups sham (appos)
factors associated (amod)
survived months (nmod:tmod)
frequency % (appos)
1 0.1 (compound)
alter bnpp (nsubj)
female acquired (acl:relcl)
developing chf (dobj)
mv 2.1 (nummod)
feeding carcinogen (compound)
elevated group (nmod)
peroxidation kidney (nmod)
minutes dobutamine (nmod)
was well (advmod)
appeared hepatomas (nsubj)
veins uterine (amod)
diazepam midazolam (conj)
followed stopped (advcl)
undergoing test (dobj)
mg./kg 50 (nummod)
disclosed avoid (advcl)
london toronto (conj)
field experimental (amod)
zone three (nummod)
neuropathy autonomic (amod)
increase o2- (nmod)
london in (case)
difficulties certain (amod)
found effective (xcomp)
risk greater (amod)
mortality disease (nmod)
increase but (cc)
involvement k(+)-channels (nmod)
five six (conj)
hampshire in (case)
prior start (nmod)
questioning close (amod)
anesthesia spinal (amod)
identify treatment (dobj)
mg/kg of (case)
b kappa (compound)
lovastatin simvastatin (conj)
hypotension resulting (amod)
stroke acute (amod)
reduction min (nmod)
cis-ra ) (punct)
alter level (dobj)
animals ' (case)
papillomas all (det)
mv to (case)
symptoms toxicity (nmod)
preference changes (conj)
1.09 : (punct)
effects antidopaminergic (amod)
glycine and (cc)
antidepressant fluoxetine (nsubj)
nag , (punct)
increased cromakalim (nsubj)
sod cat (conj)
9 out (advmod)
organization who (appos)
serum : (punct)
ro for (case)
received treat (advcl)
comatose stuporous (conj)
probable association (nsubj)
insertion ventriculoperitoneal (amod)
32.9 10.3 (nummod)
systems regulating (acl)
blocker ca-channel (compound)
pathogenesis exact (amod)
forms alternate (amod)
change consistent (amod)
assigned take (xcomp)
insecticide a (det)
using assessment (conj)
days 10 (nummod)
patients frail (amod)
known hazards (nsubjpass)
cause seizures (nsubj)
mass lung (compound)
decreased reduced (conj)
prevented ; (punct)
lactate plasma (compound)
troponins i (nummod)
investigated result (ccomp)
individuals psoriasis (nmod)
elisa by (case)
became pressure (nsubj)
showed flutter (dobj)
4 nadir (nsubj)
less 0.05 (nmod)
period morphogenesis (nmod)
noted then (advmod)
improving analgesia (dobj)
cirrhosis sporotrichosis (conj)
patients arthritis (nmod)
received committee (nsubj)
contributed effects (nmod)
troublesome and (cc)
cases avoidable (amod)
fever asthma (conj)
comparison labetalol (nmod)
500 125 (compound)
affection sle-induced (amod)
nitroprusside snp (dep)
tubule convoluted (amod)
report infant (nmod)
decrease affinity (nmod)
pph ) (punct)
partially least (advmod)
continued room (nmod)
fraction ejection (compound)
correlations ngf (nmod)
measure ratios (appos)
protrusions and (cc)
one tinnitus (nsubj)
s p100 (conj)
years five (nsubj)
study combination (nmod)
receiving area (nmod)
sedatives dexmedetomidine (nsubj)
months 38 (nummod)
response cataleptic (amod)
patients sixty-five (nummod)
were infarctions (attr)
midazolam of (case)
corticosteroids , (punct)
$ROOT$ ratio (sent)
antagonist type-1 (amod)
mg/kg sc (amod)
that factor (nmod)
reported myasthenia (nsubjpass)
man 40-year-old (amod)
outpatient as (case)
enzyme neuropathy (compound)
vcm with (case)
depressants nervous (amod)
described poorly (advmod)
fever nodules (conj)
85.4 - (punct)
features lymphadenitis (nmod)
development development (conj)
donor by (case)
4.2 x (cc)
refractory were (cop)
mg/dl admission (nmod)
reduces nausea (dobj)
months summer (compound)
made patient (nsubj)
hydrochloride hydrochloride (conj)
acid by (case)
measured degree (dobj)
doxorubicin dx (appos)
patients neuropathic (amod)
alteration a (det)
damage hepatocyte (compound)
seizures strokes (conj)
months 6 (nummod)
gamma-hch ) (punct)
brightfield- and (cc)
decreased had (aux)
ranges that (mark)
physicians by (case)
other in (case)
risk this (det)
prophylaxis seizure (compound)
manifestation findings (conj)
supplement is (cop)
unclear contraindication (ccomp)
suppressed discontinuing (advcl)
induces increase (nmod)
increase potency (dobj)
excitability contractility (conj)
decreased b (nsubj)
tdr ( (punct)
microg 0.05 (nummod)
online immediately (advmod)
function or (cc)
received cacl2 (dobj)
lexical semantic (conj)
ps alone (advmod)
interim in (case)
reproduced , (punct)
minutes intraperitonealinjection (nmod)
effects some (det)
respect age (nmod)
assess association (dobj)
mg/dl than (case)
ramipril inhibitor (appos)
shown display (ccomp)
efficient controls (nmod)
although development (nmod)
april 2 (nummod)
days=1.77 ci (dep)
supports concern (dobj)
rats pregnant (acl:relcl)
died undergoing (advcl)
injection stereotactic (amod)
were incidents (attr)
isoproterenol wt (appos)
substantial stable (conj)
neurons extravasation (conj)
aida ; (punct)
47 6 (conj)
.05 less (advmod)
randomised alprazolam (nmod)
increases flow (dobj)
scl of (case)
drug antisympathetic (amod)
follow-up short-term (amod)
shortened period (dobj)
disclosed be (auxpass)
variants genetic (amod)
effect short-term (amod)
ratings pain (compound)
decline manifestations (conj)
mg)-containing ( (punct)
necrosis gm-induced (amod)
mepivacaine and (cc)
involved cotrimoxazole (nsubjpass)
reduced reversed (conj)
proband the (det)
ratio 3.8 (appos)
patients dependence (nmod)
return to (mark)
discharges secondary (amod)
rise resistance (nmod)
dose i.c.v (dep)
nms ziprasidone (nmod)
10 0.1 (compound)
focus hypotension (nmod)
sensory and (cc)
assays binding (compound)
caused bacteria (nmod)
enrolled and (cc)
bodies positive (amod)
noted cases (nmod)
nephrotoxicity toxicity (conj)
forearm on (case)
reflected latency (nsubj)
level blood (compound)
association model (nmod)
due reduction (nsubj)
had angina (dep)
bid ( (punct)
performed median (dep)
findings sonographic (amod)
increasing incidence (nsubj)
deficiency dehydrogenase (compound)
related degree (nmod)
output cardiac (amod)
onset factors (conj)
results studied (appos)
showed tet (nsubj)
argatroban on (case)
database a (det)
toxicity rat (nmod)
minutes 181 (nummod)
rhythms escape (compound)
tspa ) (punct)
cisplatin over (case)
level antibody (compound)
patients patient (conj)
diuretic on (case)
subjected regulation (nmod)
dependent [ca]o (nmod)
increased peroxidation (dobj)
membranes model (compound)
bacteremia staphylococcus (compound)
cytotoxicity doxorubicin (nmod)
had mutation (dobj)
role than (case)
continues remains (conj)
potentiation neurotransmission (nmod)
diameter artery (compound)
treated year (nmod)
inhibition after (case)
antagonist treatment (nmod)
potent cb (nmod)
gamma-vinyl-gaba of (case)
sites independent (amod)
samples urine (conj)
dose doxorubicin/kg (dep)
mri and (cc)
hyperplasia carcinoma (conj)
rats bmc-transplanted (amod)
trial 12-month (amod)
mmc after (case)
seizure-free now (advmod)
$ROOT$ encouraging (sent)
effects nicotine (nmod:poss)
process autoimmune (amod)
inhibitor decarboxylase (compound)
women diabetes (nmod)
pharmacy a (det)
displayed sodium (nsubj)
doses microg (dep)
protocols experimental (amod)
dysfunction acute (amod)
cholestasis injury (nmod)
choice best (amod)
comprise responsible (advcl)
dysfunction p (dep)
embryolethality rats (nmod)
effects cytostatic (amod)
diltiazem intravenous (amod)
oxazepam zopiclone (conj)
need awareness (nmod)
suppressed whereas (dep)
lobe lateral (amod)
investigated phenotypes (dobj)
antagonists muscarinic (amod)
using gtn (dobj)
nm , (punct)
0.5 0 (conj)
warfarin and (cc)
year 's (case)
pbsct ) (punct)
toxic substance (nmod)
1.043 +/- (cc)
mediator important (amod)
toxicity nonurologic (amod)
mpo ) (punct)
encephalopathy considered (acl:relcl)
anemia androgen- (amod)
erdosteine of (case)
more substantially (advmod)
females age (nmod)
component tonic (amod)
determined : (punct)
november 1998 (nummod)
consuming meal (nmod)
$ROOT$ find (sent)
woman 77-year-old (amod)
channels sodium (compound)
administration mesna (nmod)
out-patients and (cc)
velocity nerve (compound)
injection dose (appos)
lack which (nsubj)
mounting is (aux)
opioid tramadol (nsubj)
performed monitoring (dobj)
membranes capillary (amod)
eliminated effect (dobj)
depolarisation membrane (compound)
observed astroctytes (nsubjpass)
function neuromuscular (amod)
cells within (case)
hosts in (case)
therapy ) (punct)
[3h]-naloxone of (case)
decreased markedly (advmod)
association hypotension (nmod)
leucemia acute (amod)
prevention hypokalemia (nmod)
minutes a (det)
activator chat (compound)
consists . (punct)
complications system (compound)
restricted hepatotoxicity (nsubj)
favored have (aux)
mg/m(2 divided (cc)
varied those (nsubj)
age creatinine (conj)
patients had (acl:relcl)
satisfaction overall (amod)
possesses activity (dobj)
source energy (nmod)
therapy neoplasia (nmod)
synthesis of (case)
135 vs (cc)
group beta-position (nmod)
long-term over (case)
characterization timecourse (nmod)
had phacoemulsification (dobj)
g/day 0 (dep)
center hospital (compound)
decreased content (nsubj)
sites striatal (amod)
epimers group (nmod)
therapy temsirolimus (compound)
subunit mtdna-encoded (amod)
had one (advcl)
toxicity caffeine (nmod)
run to (mark)
creatinine mg/dl (appos)
determination by (case)
october 1993 (nummod)
$ROOT$ died (sent)
feature another (det)
history thrombocytopenia (nmod)
experienced dogs (nsubj)
2 more (amod)
contraindicated patients (nmod)
increases men (nmod)
epidemiology changing (amod)
plays hypomethylation (nsubj)
hyperthermia sc)-induced (amod)
given not (neg)
prevalence for (case)
hospitals ) (punct)
6 . (punct)
approaches published (amod)
behavior of (case)
six 10 (conj)
hs 21.0 (nummod)
given results (dobj)
infrequent but (cc)
adjusted values (nmod)
suggests ability (nsubj)
hepatitis , (punct)
pontis in (case)
tachycardia dobutamine (nmod)
evaluated investigate (advcl)
= 3.4 (dobj)
toxicity hippocampal (amod)
processing brain (compound)
combination e (compound)
edition ( (punct)
used remedies (nmod)
quantities in (case)
suppressing vitro (advmod)
associated increased (advcl)
served . (punct)
[3h]sch or (cc)
induce indicating (advcl)
served who (nsubj)
virus (hiv)-infected (punct)
160 of (advmod)
min 73.6 (nummod)
decrease to (mark)
cases 50 (nummod)
angiography ventricular (amod)
concentration mean (compound)
recognize , (punct)
model for (case)
cgi-sf ) (punct)
points 6.4 (nummod)
ratings not (neg)
caffeine drug (conj)
induce , (punct)
170 years (nmod)
neuropathy mainly (advmod)
stage consolidation (nsubj)
sulfasalazine with (case)
prophylaxis thrombosis (nmod)
used cycle (nmod)
related potentially (advmod)
varies strains (nmod)
b hepatitis (compound)
bpm 146 (nummod)
effect antagonistic (amod)
levobupivacaine enantiomer (appos)
months transplantation (nmod)
regimens dosing (compound)
interventions available (amod)
skills fine (amod)
infusion remifentanil (compound)
inhibitors angiogenesis (compound)
preserved function (nsubjpass)
years 49 (nummod)
transporter tissues (nmod)
exposure onset (conj)
components as (case)
micrograms/kg 50 (nummod)
development cardiomyopathy (nmod)
finished nine (nsubj)
treatment valproate (compound)
stressor multitasking (amod)
monotherapies ) (punct)
consequences substantial (amod)
i ( (punct)
drug buspirone (appos)
myeloma for (case)
introduce order (nmod)
communicated had (aux)
demonstrated defect (dobj)
ratio or (appos)
determining measuring (conj)
5-fu/fa and (cc)
require reduction (dobj)
treatments active (amod)
derangement from (case)
rate crude (amod)
given cis-platin (nsubjpass)
using infusion (nmod)
immunosuppressant used (amod)
effects no (nmod)
represses and (cc)
% 16 (appos)
insecticides agriculture (nmod)
design cross-over (amod)
showed discharges (nmod)
intact cognitively (advmod)
from three (nsubj)
factor predisposing (amod)
terminology manifestations (conj)
accumulation , (punct)
urea creatinine (conj)
early as (advmod)
44 only (advmod)
effects anticonvulsant (amod)
2/3 about (advmod)
signalling dopamine (compound)
response supersensitivity (conj)
conditions presence (conj)
dose with (case)
showed activities (dobj)
period tilt (compound)
number behaviour (conj)
compared that (nsubj)
pathology additional (amod)
nifedipine doses (nmod)
decrease both (cc:preconj)
continuing regained (advcl)
pronounced . (punct)
btc ) (punct)
10.3 0.3 (conj)
frequency from (case)
represents characterized (parataxis)
jaundice . (punct)
hours , (punct)
sr selective (amod)
meta-analysis 1 (nummod)
assigned which (nmod)
mydriasis evoked (acl)
words in (case)
effect action (conj)
changed level (nmod)
induced glutamate (nmod)
tests evaluations (conj)
ganglia and (cc)
micrograms , (punct)
syndrome flourouracil-induced (amod)
isoproterenol of (case)
decrease respectively (advmod)
period 6-h (amod)
mediated which (nsubjpass)
limitations design (nmod)
monohydrate of (case)
components oil (nmod)
started mice (nsubj)
imbalance with (case)
correlate level (nmod)
mg/kg 40 (nummod)
defects compatible (amod)
hiv with (case)
showed decline (dobj)
indications transplantation (nmod)
reversed dogs (nmod)
reshape addressing (advcl)
hyperactivity induced (acl)
kingdom the (det)
induce because (mark)
biopsy kidney (compound)
gastrocnemius ( (punct)
function as (case)
controls historical (amod)
rate pulmonary (amod)
recorded studies (nmod)
17 2 (conj)
min-1 micrograms (compound)
operated . (punct)
had therapy (nmod)
introduced was (auxpass)
severity suppression (nmod)
prevented seizures (dobj)
desensitization because (case)
iris of (case)
pharmaceuticals , (punct)
increases p (dep)
communicated physician (nmod)
discontinuing aes (nmod)
studied received (parataxis)
striatum rats (nmod)
livers the (det)
snhl ) (punct)
connected be (auxpass)
eligible patients (nsubj)
cent per (compound)
known occurred (ccomp)
lethargy associated (acl)
reported active (ccomp)
0.005 ) (punct)
prevention partial (amod)
associated besylate (nsubjpass)
= group (nmod)
effective may (aux)
7.54 44.18 (conj)
role fluconazole (nmod:poss)
relationship activity (nmod)
administered study (nmod)
hematomyelia : (punct)
data children (nmod)
confirmed ultrastructurally (advmod)
edema " (punct)
reviewed authors (nsubj)
had controls (nmod)
implicated pathophysiology (nmod)
asa [ (punct)
epithelium rat (compound)
seroconversion of (case)
overdose , (punct)
tp ( (punct)
sustained similarly (advmod)
instability of (case)
period postinfusion (amod)
region hearts (nmod)
nucleotide-gated hyperpolarization-activated (amod)
$ROOT$ show (sent)
tdp to (case)
sensitivity 0.855+/-0.04 (dep)
stereotypies or (cc)
layers connective (amod)
arising system (nmod)
abnormalities the (det)
molars of (case)
pentobarbital and (cc)
success its (nmod:poss)
diameters despite (case)
so enalapril (dep)
caused failure (nsubj)
years 2.5 (nummod)
ascertained not (neg)
taking standard- (dobj)
implants with (case)
cardiotoxicity (adr)-induced (amod)
hospitalized given (conj)
administration mangiferin (compound)
administered administered (parataxis)
response stimulation-evoked (amod)
patients forty-nine (nummod)
observed depression (nsubjpass)
activity anti-hiv (amod)
used agents (nsubjpass)
evaluated median (dep)
lymphoma malignant (amod)
content in (case)
activity ps-exposure (conj)
pharmacy hospital (compound)
doxorubicin prior (amod)
involvement for (case)
pathogenesis hiccups (nmod)
changes production (nmod)
oxidation increased (amod)
p group (conj)
mg 0.76 (nummod)
reduction greater (amod)
progestogens with (nmod)
expression factor (nmod)
compared addition (nmod)
4 ) (punct)
effects unacceptable (amod)
producing mg (nsubj)
percent , (punct)
hormones female (amod)
data various (amod)
surface over (case)
older and (cc)
scores subjective (amod)
possesses bau (nsubj)
proliferated cells (nsubj)
caused hypersecretion (nmod)
fahad king (compound)
acid neutral (amod)
2.0 0.25 (compound)
known inhibitors (nmod)
interactions pharmacokinetic (amod)
exercised treadmill (nmod)
reduced were (conj)
value value (conj)
ng/ml ng/ml (appos)
% difference (nsubj)
woman 54-yr-old (amod)
lesions ischemic (amod)
number drugs (nmod)
exert that (mark)
investigated infusion (nmod)
mice induced (acl)
methylprednisolone the (det)
use cholinesterase (nmod)
became restricted (advcl)
lesions by (case)
threshold initiating (acl)
risk pointes (nmod)
decrease by (case)
enzymes dismutase (nmod)
largest be (cop)
activity resting (amod)
-32 +/- (cc)
phenomenon induce (acl:relcl)
7 treatment (nmod)
procedures ) (punct)
forms some (det)
projection by (case)
assessed events (nmod)
30 , (punct)
dwi and (cc)
infusion low-dose (amod)
using systems (dobj)
was observed (conj)
show here (advmod)
averaged indicating (advcl)
associated alterations (nmod)
result effect (nmod)
trend a (det)
points six (nummod)
found maintained (acl:relcl)
anemia reversible (amod)
mg/kg 20 (compound)
alfentanil alf (dep)
noted retraction (nsubjpass)
blocked release (nsubjpass)
regurgitation 10.7 (dep)
have once (advmod)
component strong (amod)
averaged , (punct)
lidocaine intravenously (advmod)
infusion nitroprusside (nmod)
clonidine methylphenidate (conj)
mg/day 20 (nummod)
beating ac (appos)
system , (punct)
refractory intolerant (conj)
tolerate mg (dobj)
actions excitatory (amod)
sc = (parataxis)
have toxicity (dobj)
lip palate (conj)
intolerance , (punct)
drowsiness , (punct)
sodium diclofenac (compound)
changes indomethacin-induced (amod)
increased accordingly (advmod)
cystitis busulfan-induced (amod)
tested group (nsubjpass)
appears retardation (nsubj)
procedures 21 (nummod)
intensity symptoms (nmod)
hypometabolism glucose (compound)
assessment funduscopy (conj)
superior superior (parataxis)
reproducible injection (nsubj)
dmpx by (case)
mm 40+/-6 (nummod)
g/day ( (punct)
reduced concentration (nsubjpass)
hallucinations complex (amod)
vivo ex (compound)
chemotherapy subtenon (amod)
plays and (cc)
administered also (advmod)
piglets of (case)
remain dose (nmod)
mg/kg while (mark)
preserved was (auxpass)
other elevation (nmod)
common population (nmod)
said . (punct)
methyldopa by (case)
neurons hippocampal (amod)
extracted analyzed (conj)
received controls (nsubj)
fibrillation recent-onset (amod)
tamca mg/ml (appos)
rupture postinfarction (amod)
calculated eye (nmod)
corticosteroids due (case)
urine hypotonic (amod)
diagnosis disturbance (nmod)
them between (case)
mater the (det)
country this (det)
inhibitors cox (compound)
linkages phosphate (compound)
exposure heparin (compound)
negligible consisted (advcl)
pge2 intra-arterial (amod)
reduction this (det)
administered concentrations (nmod)
decline rate (nmod)
atropine antagonist (compound)
prescribing preferential (amod)
taking disulfiram (dobj)
agents alter (acl:relcl)
substantiate conclusion (nsubj)
observed decreases (nsubjpass)
declined levels (nmod)
creatinine 1.44+/-0.6 (dep)
found were (parataxis)
rigidity an (det)
had degrees (dobj)
reports use (appos)
studied patients (dobj)
prompted observation (nsubj)
6/15 was (cop)
divided ; (punct)
ant-mi ( (punct)
occur syndrome (nsubj)
analysis concentration (nmod)
enac of (case)
method high-performance (amod)
less effect (nsubj)
outcomes measured (amod)
piracetam derivative (appos)
nausea severe (amod)
included confusion (dobj)
enhance lidocaine (nsubj)
recognized thrombocytopenia (nsubjpass)
assigned administration (nmod)
sg in (case)
blockade hexamethonium (nmod)
once days (nmod)
now until (case)
received levobupivacaine (dobj)
reduction comparable (acl:relcl)
derangements function (nmod)
responses central (amod)
hours administration (dep)
decreased remained (conj)
labetalol atenolol (conj)
light to (case)
echo , (punct)
status performance (compound)
processed kidney (nsubjpass)
methods assessed (acl)
hour or (cc)
failed however (advmod)
seizures electrographic (amod)
ar ; (punct)
lead degeneration (nmod)
accomplished confirmation (nsubjpass)
had arteries (nsubj)
functions renal (amod)
show effect (dobj)
nerves the (det)
enzyme gaba-synthesizing (amod)
observer the (det)
effective compared (parataxis)
centers cdc (appos)
administered sublingually (advmod)
had or (cc)
rr 1.3 (nummod)
mg suprofen (nmod)
exerts effects (dobj)
decreased mmhg (dobj)
netilmicin piperacillin-treated (conj)
problems associated (amod)
was this (nmod)
rcr ) (punct)
glaucoma acute (amod)
ci 0.57 (nummod)
rats pituitary (compound)
using hours (nmod)
suggests facilitate (ccomp)
reorganization network (nmod)
disease underlying (amod)
large arteries (conj)
necessary institute (xcomp)
effects adriamycin (nmod)
1.17 ) (punct)
reported cases (nmod)
neurotransmission dopamine (compound)
brain electroencephalogram (conj)
known shown (advcl)
associations i (nmod)
polymerase parp (dep)
received study (nmod)
increase c (nsubj)
inhibitors reductase (compound)
antagonist dihydrothienopyridine (compound)
hypercholesterolemia for (case)
saline naloxazone (conj)
bupivacaine or (cc)
modified , (punct)
measured dimensions (nsubjpass)
collected being (auxpass)
170 number (nsubj)
kidney diseased (amod)
compared findings (nsubjpass)
blinded drug (nmod)
3.32 x (cc)
knife with (case)
antagonist mglur5 (nmod)
became presentation (nmod)
impairment greater (amod)
stability cardiovascular (amod)
asystole of (case)
analysis trial (nmod)
reduced addition (nsubj)
hours following (case)
35.0 32.5 (conj)
detected environments (nmod)
efficacy mania (nmod)
% 22.9 (nummod)
exposure prednisone (nmod)
induced lithium (nmod:npmod)
hydrochloride epinephrine (conj)
ischemia pallidus (nmod)
trial , (punct)
mazindol mg/d (appos)
close not (advcl)
antagonist models (nmod)
peripheral and (cc)
predict did (aux)
acetylsalicylate inhibitor (compound)
involve typically (advmod)
val or (cc)
ventricle right (amod)
result also (advmod)
fluoroacetate fluorocitrate (conj)
= 0.0001 (dobj)
increase marked (amod)
lead normotensive (nmod)
bp diastolic (amod)
forming capacity (conj)
criteria diagnosis (nmod)
lesions cutaneous (amod)
studies western (compound)
assessment function (nmod)
site surgical (amod)
cells trabecular (amod)
micrograms/ml concentrations (nsubj)
considered recognition (nsubjpass)
years 6.5 (nummod)
affected myopathy (nmod)
% 57 (nummod)
migration maturation (conj)
using antibody (dobj)
instability bladder (compound)
resulting doses (nmod)
trauma brain (compound)
1.63 - (punct)
m-2 more (nummod)
correlation close (amod)
consumers regular (amod)
marked characterized (advcl)
effects system (compound)
injection day (nmod:tmod)
failure transient (amod)
studies no (det)
cardona et (cc)
ros of (case)
3 0.5 (compound)
drug doxorubicin (dep)
dosings single (amod)
doses most (amod)
patients 6/52 (conj)
from january (nmod)
150 and (cc)
mg/m2/wk . (punct)
$ROOT$ days (sent)
hematoxylin acid-schiff (conj)
motor phonic (conj)
higher = (dep)
degeneration toxic (amod)
9.6-fold number (nsubj)
involved aspects (nmod)
prevented that (nsubjpass)
involve , (punct)
cardiomyopathy histopathological (amod)
mediated binding (nmod)
prescribed months (nmod)
times 1.8 (nummod)
time dose (nmod)
production antibodies (nmod)
characterized onset (nmod)
mg/kg bn (nmod:tmod)
developed nausea (dobj)
function pathway (nmod)
4 54 (nmod)
muscle tibialis (compound)
aware syndrome (nmod)
nephropathy stz-induced (amod)
detection performance (compound)
control mechanisms (nsubj)
used study (advcl)
course patients (nmod)
pathway alternate (amod)
mg/m2/d 160 (nummod)
18 ) (punct)
focus biomarkers (nmod)
suppresses activity (dobj)
treated one (nmod)
proteinuria damage (conj)
day previous (amod)
days 110 (nummod)
hypoglycemia polycythemia (conj)
lozenge a (det)
toxicities for (case)
tg + (cc)
week third (amod)
studies function (nmod)
abnormalities clear (amod)
found reduction (nsubjpass)
showed combination (nsubj)
pilocarpine-treated untreated (conj)
alf the (det)
injection mg/kg (nmod)
involvement carotenoids (nmod)
parasympathetic and (cc)
cardiotoxicity 5-fluorouracil (compound)
impairment this (det)
communicate case (dobj)
reduces lidocaine (nsubj)
tacrine administered (acl)
associated defects (nmod)
gain potential (amod)
titrated dose (nsubjpass)
had effect (dobj)
drug able (amod)
administered caution (nmod)
hemispheres callosum (conj)
described now (advmod)
hepatitis active (amod)
involved care (nmod)
rats twenty-five (nummod)
improvement signs (nmod)
died months (nmod:tmod)
summarizes objectives (nsubj)
if total (amod)
transmission synaptic (amod)
established effects (nsubj)
boy 3-year-old (amod)
receiving part (nmod)
antagonists or (cc)
associated mortality (dep)
microscopy microscopy (conj)
detection disease (nmod)
treated ) (punct)
examined responses (nsubjpass)
anesthesia topical (amod)
due combination (nmod)
hh over (case)
transplant renal (amod)
complication agents (nmod)
injections these (det)
woman 25-year-old (amod)
p= ( (punct)
effect doses (nmod)
widespread potentially (advmod)
suggest appears (ccomp)
perfusion with (case)
play step (nmod)
differences group (compound)
attributed has (aux)
stopped onset (nmod)
consistent observations (nsubj)
ought be (xcomp)
ability with (case)
cerebral middle (amod)
possible not (neg)
women 55 (nummod)
decided june (nmod)
lesion an (det)
vp-16 ) (punct)
analysis electrophoretic (amod)
selected patients (dobj)
reports 39 (nummod)
inflammation doxorubicin (compound)
lh ) (punct)
intraperitoneal intracerebroventricular (conj)
100 125 (conj)
failed haloperidol (nsubj)
drugs remission (compound)
similar very (advmod)
reactions cephalosporins (nmod)
elevated also (advmod)
presence with (case)
p=0.0001 and (cc)
17 ratio (dep)
difference values (nmod)
vascular , (punct)
conjugation metabolism (conj)
cisplatinum adriamycin (appos)
mutation sg145r (compound)
endorsing cip (dobj)
c57bl/6 and (cc)
efficacy comparative (amod)
products other (amod)
p.o. mg (compound)
indicator dysfunction (nmod)
software custom (amod)
saline % (appos)
determine vivo (advmod)
abilities analogs (nmod)
diagnoses main (amod)
course man (nmod)
patients od (nmod)
differentiate particular (nmod)
doses four (nummod)
information the (det)
difluoromethylornithine placebos (conj)
ain nicergoline-associated (amod)
$ROOT$ caused (sent)
essential functions (nmod)
influenced toxicity (nmod)
patients radiotherapy (nmod)
score was (cop)
stimulation nucleus (nmod)
monitor oncologists (nsubj)
spots 2000 (nummod)
therapy extensive (amod)
managed adjusted (advcl)
ptld with (case)
unchanged are (cop)
activity baseline (amod)
difficulties ventilation (compound)
supported data (nmod)
alteration this (det)
entropion and (cc)
expressing diameters (dobj)
recovery -- (punct)
patients types (nmod)
accelerate may (aux)
abstained . (punct)
factor are (cop)
women younger (amod)
meta-analysis outcomes (nmod)
titrated patients (nmod)
activation prolactin-induced (amod)
abuse the (det)
determine nucleoside (dobj)
treatment hl (nmod)
urge use (nmod)
clarified trials (nmod)
age elevation (conj)
levels cyclosporine- (compound)
occurred surveillance (nmod)
change mg/dl (dep)
oxidation by (case)
pathway accessory (compound)
described secondary (xcomp)
pretreatment days (nmod)
ingestion the (det)
$ROOT$ admitted (sent)
ls pr (conj)
had ( (punct)
seizures tonic (amod)
pilocarpine muscarinic (amod)
reducing nausea (dobj)
female 45-year (compound)
predict periods (nmod)
damage inflicted (amod)
rats right- (amod)
years follow-up (nmod)
measure concentration (dobj)
group treat (compound)
lometrexol of (case)
modulator potent (amod)
expression type (compound)
extract mixture (appos)
men by (case)
associated bromocriptine (nsubjpass)
methods remained (appos)
assess symptoms (dobj)
release upregulation (conj)
incorporation the (det)
challenge after (case)
fact cause (ccomp)
awake minutes (nmod)
hbig ) (punct)
sulphasalazine with (case)
detectable readily (advmod)
acid i (nummod)
elicited rats (nmod)
interpret we (nsubj)
summarizes report (nsubj)
drug used (acl)
thresholds the (det)
min delay (nsubj)
concentrations drugs (nmod)
peptide(1 amyloid (compound)
effects via (case)
seems improving (advcl)
contain vacuoles (dobj)
azathioprine to (case)
exposure progesterone (compound)
discussion is (cop)
65 than (case)
suggests lessen (ccomp)
managed cyclosporine (nmod)
develop alternatives (dobj)
65 x (cc)
tet of (case)
alter morphine (nsubj)
rate micrograms/min (nmod)
cavity a (det)
eyes dexamethasone-treated (amod)
extent use (nmod)
cases hiccups (nmod)
report neither (cc:preconj)
progress , (punct)
10- 20- (conj)
patients nephrotoxic (amod)
chorionic such (case)
assay hemoglobin (compound)
uncommon . (punct)
val ( (punct)
apoptosis release (conj)
had age (nmod)
therapy tiapride (nmod)
pose it (nsubj)
urticaria ( (punct)
adriamycin mg/kg (dep)
composed , (punct)
neprotic pan (nmod:npmod)
developed related (advcl)
had frequently (advmod)
myositis of (case)
wasting severe (amod)
experiences drug-related (amod)
> s((1/2 (dep)
amphetamine and (cc)
suggests reversible (parataxis)
units and (cc)
abundance markers (nmod)
different reproducible (conj)
ventricle left (amod)
single-blinded crossover (dep)
reaction pathogenesis (nsubj)
cancer colorectal (amod)
variation response (nmod)
suggest 3 (dep)
decreased decreased (advcl)
subtypes among (case)
occurrence transplantation (nmod)
1 fact (nmod)
mastodynia of (case)
vasculitis conjunction (nmod)
= 37 (dobj)
manifestation common (amod)
potency adrenoceptor (compound)
shouts and (cc)
ts l1210 (compound)
treatment survival (conj)
problems , (punct)
lidocaine ml (nummod)
vtd ) (punct)
insulin of (case)
convulsions the (det)
has action (dobj)
insulin-group the (det)
drugs 3 (nummod)
drug effect (nmod)
% indians (conj)
percentage to (case)
used persons (nsubj)
performed beginning (advcl)
ocs progestagen-only (amod)
subarachnoid cerebral (conj)
history a (det)
confirmed test (nmod)
damage patients (nmod)
h of (case)
investigation cases (nsubj)
development mania (nmod)
deaths , (punct)
thirds after (case)
non-biodegradable either (cc:preconj)
induced days (nmod)
useful that (mark)
pronounced base (nmod)
management control (nmod)
vulnerable model (nmod)
factors development (nmod)
modulated is (auxpass)
causes expression (dobj)
design study (compound)
treatment asenapine (nmod)
gum polacrilex (compound)
histopathologic and (cc)
posture flat (amod)
drug inhaled (amod)
polymorphism length (compound)
plate and (cc)
impact replication (nmod)
exceeded level (dobj)
induction than (cc)
ck-mb or= (cc)
microgravimetry by (case)
occurred studies (nmod)
mitochondria and (cc)
hypokalemia . (punct)
surface erythrocyte (compound)
protein matrix (compound)
safety sedation (nmod)
stimulation on (case)
nodules preneoplastic (amod)
stimuli somatosensory (amod)
data other (amod)
reduction to (case)
mcg 756 (appos)
diameters alteration (conj)
$ROOT$ doing (sent)
rates ) (punct)
antrum duodenum (conj)
velocity depolarization (compound)
antagonizes nicotine (nsubj)
level mg/m2 (appos)
sustained tear (dobj)
metabolism inositol (compound)
improved amnesia (dobj)
secondary thrombocytopenia (nmod)
size reduced (amod)
later h (nmod:npmod)
beta-epimers their (nmod:poss)
triphosphate by (case)
administered whom (nmod)
acids vldl (conj)
led stopping (csubj)
12 7 (quantmod)
showed parameters (nsubj)
appear , (punct)
23.9 ci=22.5 (dep)
dependent not (neg)
developed who (nsubj)
successful % (appos)
2.2 x (cc)
$ROOT$ ineffective (sent)
isradipine placebo (conj)
levels albumin (compound)
aware signs (nmod)
attention in (case)
shown rats (nmod)
suggest considered (ccomp)
activity both (cc:preconj)
g 4 (compound)
decline gfr (nmod)
sampled post-exposure (nmod)
objective assess (acl)
injections erythropoietin (nmod)
oxide % (amod)
$ROOT$ discharged (sent)
hypoxia obstruction (nmod)
involved although (mark)
behaviors dose-dependent (amod)
therapeutic either (preconj)
release tachykinins (nmod)
associated administration (nmod)
system monophosphate (compound)
aimed portray (xcomp)
assessed transplantation (nmod)
likely lithium-induced (xcomp)
exacerbated as (mark)
reduced inhibition (nmod)
reaction acid (nmod)
abstinence ) (punct)
effect reported (acl)
introduction : (punct)
patients use (nmod)
ability to (case)
b.i.d p.o. (advmod)
controls by (case)
developed pneumonia (dobj)
reactions sodium (nmod)
augmentation the (det)
known described (conj)
thiosulphate gold (compound)
schedule similar (amod)
transport l-arginine (compound)
plays adenosine (nsubj)
blockade rats (nmod)
replicating work (dobj)
potential detection (nmod)
persistence efficacy (nmod)
cases allergy (nmod)
finding well-known (amod)
mortality cases (nmod)
resolved toxicities (nsubj)
pma with (case)
discontinued therapy (nsubj)
modulation neurotoxicity (nmod)
sought aims (nsubj)
inhibit angiogenesis (dobj)
correlated ; (punct)
juice simulated (amod)
oxidation fatty (amod)
syndrome during (case)
second per (case)
pilo groups (conj)
diagnoses shift (nmod)
smelling intake (nmod)
event common (amod)
improves whether (mark)
bcnu-exposed plus (cc)
determined trial (nmod)
jerks , (punct)
two four (compound)
scale rating (compound)
therapy indomethacin (compound)
trough-concentrations raised (amod)
reactions these (det)
concentration tamca (nmod)
push or (cc)
rocuronium mg/kg (nummod)
monotherapy risperidone (nmod)
min 11 (nummod)
tiapride movements (nmod)
exceeded lesions (nsubj)
vasodilator have (acl:relcl)
hbsag and (cc)
neurochemical behavioral (conj)
lasted , (punct)
mart insignis (compound)
factor determining (amod)
ranged had (conj)
cells/mm3 500 (nummod)
suspensions all (det)
lessen can (aux)
released days (nmod)
mmhg 25 (nummod)
dipyrone for (case)
invasion a (det)
site midpontine (compound)
presented who (nsubj)
girl 11-year-old (amod)
has gtn (nsubj)
characterized exposure (nmod)
relies which (nsubj)
beta slow (amod)
protein high-sensitive (amod)
decrease preload (nmod)
tachyarrhythmia with (case)
effect amnesia (nmod)
group newborns (nmod)
volume reduced (amod)
increased administration (nmod)
glycosuria moderate (amod)
complained loss (nmod)
evaluation for (case)
injections i.v. (amod)
tested hypothesis (dobj)
available widely (advmod)
overdose be (cop)
minimized because (mark)
ed1 , (punct)
processes shifting (dep)
t30 at (case)
acts ) (punct)
2 4 (appos)
measured all (nsubjpass)
development delayed (amod)
threshold or (cc)
intermediate chronic (conj)
reported probable (conj)
score maximum (appos)
disorder is (cop)
pathway signaling (compound)
injecting ml (dobj)
sbp than (case)
contribute dysfunction (nmod)
assessed toxicities (nsubjpass)
sensitive response (nmod)
carbimazole propylthiouracil (conj)
result risk (nsubj)
reducing thereby (advmod)
concentration line (compound)
affect ich (dobj)
users past (amod)
increased catalepsy (dobj)
written management (nmod)
followed biweekly (advmod)
prognosis long-term (amod)
hyperalgesia . (punct)
colocalized outline (xcomp)
retention efficacy (nmod)
deficiency no (det)
preferred % (dep)
$ROOT$ dementia (sent)
females males (conj)
lithium-induced be (cop)
thrombocytopenia , (punct)
activity by (case)
discussed dilemmas (nsubjpass)
contributes that (nsubj)
striking = (dep)
% 34.2 (nummod)
nos-ir were (cop)
showed indeed (advmod)
500 equal (advmod)
synthesis reactive (amod)
null alpha3 (conj)
accompanied effects (nsubjpass)
leucovorin regimen (appos)
delineate to (dep)
motionless , (punct)
stimulation or (cc)
decreases time (nmod)
caused verapamil (nsubj)
prompted prolongation (nsubj)
creatinine ] (punct)
symptoms onset (appos)
important administering (advcl)
site time (conj)
correction attempted (amod)
dogs 5 (nummod)
impairment to (case)
markers associated (acl)
old a (det)
undergoing evaluation (dobj)
resulting disease (nmod)
level activated (amod)
program education (compound)
potential carota (nmod)
hypotension arterial (amod)
shifting ( (punct)
reduced pce (nmod)
delineated clearly (advmod)
persons for (case)
oxidation , (punct)
treatment than (case)
demands of (case)
developed intake (nmod)
reabsorption calcium (compound)
concern primary (amod)
18 vs (cc)
support factor (compound)
failed influence (xcomp)
h % (dep)
warnings toxicity (nmod)
consequence seizures (nmod)
restarted beclomethasone (nmod)
seen be (auxpass)
former , (punct)
prevent cystitis (dobj)
lymphocytes with (case)
target of (case)
lives long (amod)
administration analogue (nmod)
opioids efficacious (amod)
increased cells (nsubj)
percent sixty-eight (appos)
gynecomastia or (cc)
1.54 +/- (cc)
% 11.6 (nummod)
hyperkalemia = (dep)
1.5 to (dep)
k- common (nsubj)
2.1 ratio (nsubj)
rose eu (nmod)
mul c (dep)
microscopy , (punct)
gained although (mark)
% 3.80 (conj)
g as (case)
$ROOT$ include (sent)
$ROOT$ dystrophy (sent)
recommenced episode (nmod)
8.07 1.7 (conj)
made reference (nsubjpass)
injections dox (compound)
due inhibition (nmod)
induces withdrawal (dobj)
dithiothreitol with (case)
study kidney (nmod)
rate comparable (amod)
loci all (det)
bound was (auxpass)
passed exteriorized (conj)
show decrement (dobj)
baseline during (case)
urticaria chronic (amod)
variation ( (punct)
functioning optimal (amod)
features similar (amod)
provoke does (aux)
activity elevated (amod)
influences status (nsubj)
n/n=62/92 ( (punct)
nimodipine administered (acl)
january 2000 (nummod)
selected , (punct)
day period (nmod)
nsclc iv (nummod)
stimulated recognition (nsubj)
mg 8 (nummod)
seizures brainstem (compound)
evident week (nmod)
e1 or (cc)
frequency voiding (compound)
non-cacl(2)-treated nacl-treated (conj)
activity 2 (nummod)
disability and (cc)
receptor mu-opioid (compound)
differ to (mark)
nausea , (punct)
[na]o at (case)
levels cd36 (compound)
courses 3 (nummod)
drugs and (cc)
have memory (nmod)
observed noted (conj)
behavior obsessive-compulsive (amod)
injections . (punct)
mice diet (nmod)
decision the (det)
total mice (nmod)
littermates to (case)
hg 135 (nummod)
expression synthase (nmod)
had pressures (dobj)
week twice (advmod)
july between (case)
rescues . (punct)
stimulates bupivacaine (nsubj)
weeks from (case)
$ROOT$ resuscitated (sent)
ns the (det)
aggravation ameliorated (acl:relcl)
stream in (case)
withdrawn recently (advmod)
experiencing deficits (dobj)
t-tests one-tail (compound)
fashion continuous (amod)
determine role (dobj)
those gm (nmod)
protective , (punct)
mice rabbits (conj)
depleted , (punct)
british were (cop)
agsd from (case)
levels depression (nmod)
higher . (punct)
means infusion (nmod)
latency rats (nmod)
addition cisplatin (nmod)
bcnu ) (punct)
5-ht low (amod)
catalepsy rats (nmod)
irrigation whole (amod)
provides epithelium (nmod)
diameter aneurysm (compound)
24 7 (quantmod)
present angiosarcoma (nsubj)
loss by (case)
sensitive mice (nmod)
performed interval (dep)
one other (conj)
response cr (appos)
positive anca (nmod:npmod)
discussed view (nmod)
doses clinical (amod)
prevented decreased (conj)
discussed briefly (advmod)
improving vgpr (nmod)
correlations intensity (nmod)
modified effect (nsubjpass)
therapy disease (nmod)
received min (conj)
imaging thrombosis (nmod)
tolerated flumazenil (nsubjpass)
disease , (punct)
effect morphine (nmod)
development cancer (compound)
improved induce (advcl)
positive testing (nmod)
dosages even (advmod)
less not (neg)
11.8 - (punct)
neuropathy with (case)
prescription dose (nmod)
regimen triple (amod)
examination a (det)
indications same (amod)
immunohistochemistry blot (conj)
reduced proteins (nsubjpass)
formation stem (compound)
block ii (nummod)
followed inducing (advcl)
reflect concentration (nsubj)
paresthesia limbs (nmod)
1.3 was (cop)
reduce respectively (advmod)
rationale objectives (conj)
conclude authors (nsubj)
led reintroduction (nsubj)
content intraplatelet (amod)
siblings twin (amod)
problems tolerability (compound)
reviews medicine (compound)
adjusted be (auxpass)
result have (aux)
skeptical miss (advcl)
blots in (case)
five drivers (nmod)
exercise maximal (amod)
triamcinolone of (case)
limit 3 (nummod)
use toxicity (conj)
years 30 (nummod)
toxicity dfp (nmod)
treatment fluid (nmod)
80 from (case)
observations previous (amod)
signal signal (conj)
actuarial table (dep)
use disease (nmod)
protocols acute (amod)
caused nsaids (nmod)
maleate + (cc)
latency convulse (acl)
drugs subject (amod)
$ROOT$ pattern (sent)
resulted increase (nmod)
capture cells (nmod)
$ROOT$ bell-shaped (sent)
vd ) (punct)
chop the (det)
rates hcl (nmod)
enzyme transketolase (appos)
sweating and (cc)
release model (nmod)
december in (case)
tiva ) (punct)
iv patient-controlled (conj)
carbonate of (case)
mg ) (punct)
usage surgery (nmod)
safety of (case)
characterized encephalopathy (nmod)
inhibited bicuculline (nsubj)
challenge triniol (nmod)
stage during (case)
tests scale (dep)
hepatocarcinogenicity diet (nmod)
develops mth (nmod)
enflurane between (case)
analyses regression (compound)
suppressing channels (dobj)
3.4 0.7 (compound)
using while (mark)
h 40 (nummod)
amount tissue (nmod)
showed comparison (nsubj)
anacardiaceae ( (punct)
vohland ( (punct)
antagonists type-2 (amod)
receive not (neg)
vacuolization form (conj)
anxiety reactivity (conj)
developed eruptions (dobj)
results presented (appos)
tests of (case)
unchanged position (nsubj)
1.01 range (dep)
trial noncomparative (amod)
parameters score (conj)
electrocardiograms , (punct)
years : (punct)
derangement and (cc)
common more (advmod)
take medications. (dobj)
ml. 245 (nummod)
showed s-312 (nsubj)
nephritis , (punct)
underwent tracheotomy (dobj)
types hyperalgesia (nmod)
learning , (punct)
strategies cost-effective (amod)
history 3-year (amod)
happiness and (cc)
substituting zonisamide (nmod)
studies observational (amod)
difluoromethylornithine plus (cc)
morphology , (punct)
dose period (conj)
chronicity psychosis (conj)
mitochondria organelles (appos)
ethinyloestradiol g (amod)
developed parkinsonism (nsubj)
measures ultrasonographic (amod)
subsided when (advmod)
achieved rapidly (advmod)
bouts acute (amod)
information limited (amod)
presentation about (case)
recovered withdrawal (nmod)
haplotypes ) (punct)
$ROOT$ completed (sent)
has given (conj)
cardiotoxicity reduced (amod)
woman postmenopausal (amod)
attractive are (cop)
identifying patients (dobj)
given diuresis (dobj)
followed subjects (nsubjpass)
degrees responsiveness (nmod)
control normal (amod)
basis therapy (nmod)
transplanted . (punct)
mediated furthermore (advmod)
spasm and (cc)
receptors group (compound)
% 6.1 (nummod)
rnfl ( (punct)
diphosphanilate of (case)
pparalpha expressed (acl)
dyskinesia induced (amod)
rates in-hospital (compound)
consisted rate (nmod)
results invasion (nmod)
induced asa (nmod)
frequency and (cc)
frequencies ) (punct)
immunosuppressants by (case)
evaluated administration (nmod)
synapses at (case)
indications in (case)
therapy daptomycin (compound)
implant therapy (conj)
voltammetry and (cc)
rats deprived (amod)
change than (case)
separated groups (nmod)
caused cases (nmod)
health abilities (conj)
prolonged p (dep)
mice dogs (conj)
homoeostasis of (case)
doses ketamine (nmod)
supply extrinsic (amod)
minutes to (case)
received dysphonia (nmod)
associated cimetidine (nmod)
basis on (case)
ginsenosides of (case)
efficacious pain (nmod)
mwm in (case)
cells wall (nmod)
side-effects biosyntheses (conj)
pressure capacity (conj)
brain whole (amod)
database company (nmod:poss)
hypotension sodium (compound)
targeted therapeutically (advmod)
period 60 (nummod)
memantine ibuprofen (conj)
dogs mongrel (compound)
afterdepolarization phase (compound)
recording seizures (conj)
lna hca (conj)
commissure-commissure both (cc:preconj)
conclusions likely (appos)
30 to (quantmod)
sets four (appos)
dosing patients (nmod)
withdrawal treatment (conj)
d4.4 and (cc)
produced rats (nmod)
experienced seizure (dobj)
morphine pentazocine (conj)
risks and (cc)
performed transplantations (nsubjpass)
profiles/sections cell (compound)
increased . (punct)
was extent (nmod)
production acetylcholine (nmod)
surveillance from (case)
associated seizures (nmod)
chemotherapy vincristine (nmod)
activity inspection (compound)
dysfunction auditory (amod)
hospitals hampshire (compound)
proportion participants (nmod)
sample study (nmod)
incidence reactivation (nmod)
placebo minutes (nmod)
270 0 (compound)
compared dose (nmod)
correction anemia (nmod)
patients disease (compound)
mg/dl acid (nmod)
tissue and (cc)
netilmicin lysozyme (compound)
taking had (conj)
children adults (conj)
toxicity toxicity (conj)
biosyntheses , (punct)
conditions of (case)
rate expected (amod)
frequency sensation (conj)
confirmed angiography (nmod)
volume an (det)
advent the (det)
disorders various (amod)
shortening elevation (conj)
novel both (cc:preconj)
samples of (case)
described was (auxpass)
ampicillin by (case)
harm of (case)
aspirin , (punct)
receives , (punct)
aphasia weakness (conj)
convulsant and (cc)
undertook we (nsubj)
disability behaviors (conj)
altered indicating (xcomp)
predictors month (nsubj)
caused myocarditis (nmod)
determined treatment (nmod)
measuring association (dobj)
factor prostaglandins (conj)
ticlopidine with (case)
zymosan with (case)
use pain (nmod)
features laboratory (compound)
min 129 (nummod)
effects hyperalgesia (nmod)
4,000 to (dep)
elicited hand (nmod)
starting treatment (dobj)
appeared subsequently (advmod)
atorvastatin atorva (appos)
prevent hypokalemia (dobj)
remained drug (dep)
increased months (nmod)
% 3.9 (nummod)
dose m (nmod)
therapy 131i (nsubj)
hemorrhages edema (nmod)
phenotypes metabolic (amod)
stz crocin (conj)
methods identified (appos)
obtained makes (conj)
performed studies (nsubjpass)
228 - (punct)
symptoms including (case)
disturbance from (case)
ergotamine/caffeine with (case)
doses d3 (nmod)
called . (punct)
women 41,904 (nummod)
hg 5 (nummod)
10 7 (compound)
accident either (cc:preconj)
dyskinesias levodopa-induce (amod)
has managed (conj)
region rostral (amod)
comparable but (cc)
loading l-sotalol (nmod)
alpha3 +/- (dep)
group lidocaine/placebo (compound)
prolong and (cc)
fluorogold microliters (appos)
treatment chronic (amod)
[3h]-l-arginine of (case)
results of (case)
lna+lca ) (punct)
rates urinary (amod)
hypertrophy thickening (nmod)
values given (acl:relcl)
dysphonia adsd (appos)
occupancy in (case)
potential a (det)
techniques by (case)
1 4 (conj)
age ) (punct)
treating instillation (nmod)
induces prednisone (nsubj)
suggest administered (ccomp)
chop marker (appos)
examination post-cab (dep)
ultrasonography by (case)
149 , (punct)
0.56 mg/kg (dep)
rule-in rapid (amod)
interviewed were (auxpass)
doses wr242511 (nmod)
concentration albumin (nmod)
increase mortality (dobj)
lactate aids (nmod)
parts animals (nmod)
outcomes for (case)
trigger beta-agonist (nsubj)
vnr by (case)
as loss (nsubj)
pathway upregulated (amod)
more patients (nmod)
treatment may (aux)
mi both (cc:preconj)
pdtc low-dose (dep)
regarded often (advmod)
hours eight (nummod)
effects major (amod)
drug common (amod)
examined mice (nmod)
reactions . (punct)
rate p (nmod)
reduction ammonia (nmod)
seizures induced (amod)
increased arrhythmogenicity (dobj)
transplant before (case)
sequelae long-term (amod)
doses pilocarpine (nmod)
lamivudine without (case)
anemia presenting (acl)
increase factors (nmod)
demonstrated already (advmod)
death another (nmod)
agent with (case)
iopamidol low-osmolality (compound)
enhances bradycardia (dobj)
raises experience (nsubj)
getting in (mark)
parameters latency (compound)
conclusions consideration (dep)
0.24+/-0.06/h td (nmod)
became suppressants (nsubj)
gap43-ir ) (punct)
discontinue that (mark)
related remainder (nmod)
reports results (dobj)
resulting grade (nmod)
micrograms 150 (nummod)
induced e1 (nsubj)
formyltransferase , (punct)
methods trial (appos)
tdp. of (case)
occurred suggesting (advcl)
studied using (xcomp)
blockade site (nmod)
given day (nmod)
cyclooxygenase cox (appos)
improved anemia (nsubj)
due probably (advmod)
noted number (nsubjpass)
microg , (punct)
object the (det)
analyzed ph (nsubjpass)
difficult very (advmod)
lev added (acl)
dianabol , (punct)
side-effects with (case)
range within (case)
done electroretinograms (nsubjpass)
increases rigidity (nmod)
ulcers of (case)
phenacetin or (cc)
ug levothyroxine (nmod)
injection each (nmod)
suggest susceptible (ccomp)
population disease (nmod)
concentrations cimetidine (compound)
time this (det)
manage to (mark)
requiring not (neg)
sera containing (acl)
scattered , (punct)
berlin germany (appos)
returned ; (punct)
make aim (nsubj)
gfap , (punct)
orl1 ) (punct)
have : (punct)
caused which (nsubjpass)
suggest conclusions (nsubj)
lend view (nmod)
thrombocytopenia hit (appos)
number 1.6+/-0.34 (appos)
treatment h (appos)
fastigial unilateral (amod)
observed hypocalcemia (nsubjpass)
organization european (compound)
hg 50 (nummod)
protection this (det)
exert hyperalgesia (dobj)
impaired stable (conj)
mepivacaine lidocaine (conj)
pills of (case)
start between (case)
heart within (case)
respond ethyl-alpha-p-chlorophenoxyisobutyrate (nmod)
limit and (cc)
pretreatment after (case)
subjects more (amod)
durations inflammation (nmod)
potentiate may (aux)
cell squamous (amod)
patients pain (compound)
enhanced activity (dobj)
risk inhibitors (nmod)
preference patients (nmod)
developed instillation (nmod)
released synapses (nmod)
mechanisms similar (amod)
facilitate synchrony (dobj)
readings eeg (compound)
raised pattern (nsubj)
years 2009 (nummod)
quality survival (nmod)
practitioners selected (amod)
differentiation ed50 (nmod)
therapy system (compound)
papilloma cell (compound)
proliferation survival (conj)
likely increase (nsubj)
availability and (cc)
advantageous be (cop)
abnormal findings (nsubj)
sensor stress (nmod)
27 % (quantmod)
obtained phentolamine (nmod)
administration dinitrate (nmod)
more mechanism (nmod)
74 - (advmod)
model of (case)
flecainide and (cc)
prolonged azimilide (nsubj)
100 - (punct)
event was (cop)
preceded may (aux)
c57bl/6 ) (punct)
regimen according (case)
occurred led (conj)
attempts examine (xcomp)
dithiocarbamate pdtc (appos)
stripe medulla (nmod)
markers relevant (amod)
chain respiratory (amod)
mg iv (advmod)
bypass on (case)
rate resistance (conj)
g/m2 5 (nummod)
patients 64 (nummod)
ratio of (case)
experience the (det)
supposed we (nsubj)
antagonize does (aux)
systems in (amod)
endothelial and (cc)
mortality and (cc)
comparison phenacetin (nmod)
xdr-tb ) (punct)
reactions immediate (amod)
process secretion (nsubj)
studied . (punct)
comorbidities and (cc)
cause precipitating (amod)
plasma frozen (amod)
ro - (nummod)
complete and (cc)
transmission altered (amod)
33 versus (cc)
mrna intrarenal (amod)
exposure treatment (conj)
using data (dobj)
improved therapy (nmod)
receiving treated (conj)
warrants case (nsubj)
conclusions complication (appos)
attenuated replacement (dobj)
moderate ; (punct)
using element (dobj)
pri ) (punct)
indicates ctnt (nsubj)
contraindication with (case)
proposed prevention (nmod)
treatment gr (nmod)
met . (punct)
increased as (mark)
order remove (acl)
2.8 ratio (dep)
impaired hepatically (advmod)
dose indomethacin (nmod)
unclear background/aims (dep)
levels on (case)
polyneuropathy description (dep)
bradycardia resultant (amod)
care females (nmod)
improvement score (conj)
80 vs. (cc)
placed , (punct)
proteinuria of (case)
three often (advmod)
depletion and (cc)
mustard ifosfamide (nsubj)
matter frontal (amod)
reported group (nsubj)
possible patients (nmod)
rodents and (cc)
administered times (nmod:tmod)
disorder of (case)
although association (nsubj)
conclusions suggests (dep)
toxicity % (appos)
patients 13 (nummod)
squealing , (punct)
2 . (punct)
placebo for (case)
showed effects (dobj)
cent lower (amod)
present methods (nsubj)
reversal 5 (dep)
levels 1.9 (nummod)
intra- and (cc)
distance from (case)
declined baseline (nmod)
options , (punct)
cases incident (amod)
patient macroglobulinaemia (nmod)
hypertension mmhg (dep)
ve lamivudine-na (dep)
change decreased (conj)
contrast effect (nmod)
seemed . (punct)
disappearance episodes (nmod)
combination mesna (nmod)
subunits enac (compound)
dynamics cardiovascular (amod)
session immediately (advmod)
dimension end-systolic (amod)
1.2 olanzapine (nmod)
production higher (amod)
complaints all (det)
regrowth subsequent (amod)
prostate the (det)
liable that (mark)
impacts inhibitory (amod)
group radiofrequency (compound)
57.7 58.7 (conj)
positive ag (nmod:npmod)
considered investigator (nmod)
diagnosed previously (advmod)
plasma ph (appos)
changes secondary (amod)
normal . (punct)
necessary period (nmod)
apply . (punct)
shortened less (advmod)
problem general (amod)
inhibitors phosphodiesterase (compound)
cocaine oc (appos)
effects toxicity (nmod)
months after (case)
experienced mg/m2/d (nmod)
devlin al (compound)
evaluation endarterectomy (nmod)
profile risperidone (nmod)
caution with (case)
neonates twin (compound)
effective mm (nsubj)
exerts mi (nmod)
4 % (appos)
disease whose (nmod:poss)
$ROOT$ successful (sent)
results % (dep)
potentiates and (cc)
female ovariectomized (amod)
begun was (auxpass)
[35s]tbps ) (punct)
induces hypertension (dobj)
docetaxel , (punct)
maintaining balance (dobj)
ccl4 , (punct)
evaluation kidneys (nmod)
extracellular from (case)
warranted model (nmod)
reaction infusion (nmod)
considered encephalopathy (nsubjpass)
hospital a (det)
teratogenicity possible (amod)
that antigen (nmod)
similar incidence (nsubj)
converts furthermore (advmod)
.05 than (case)
decreased gfr (dobj)
worsened died (conj)
transmission neuronal (amod)
interrupted appearance (nmod)
receiving tacrolimus (dobj)
associated so (conj)
trials scale (compound)
propensity cause (acl)
elicited receptors (nmod)
experienced somnolence (dobj)
reduced was (conj)
disease esrd (appos)
correlate which (nmod)
recovery his (nmod:poss)
effects tacrolimus (compound)
nfs of (case)
response pr (appos)
suppressed intervals (nmod)
benefit that (mark)
occurrence pvc (nmod)
considered never (neg)
is investigate (xcomp)
mg/kg 0.50 (compound)
judged . (punct)
study , (punct)
resulted ; (punct)
8.2 - (punct)
influence on (case)
february 2000 (nummod)
protrusions catalepsy (conj)
head in (case)
injected vocalization (nmod)
factors contributing (acl)
magnitude profile (conj)
condition fatal (amod)
investigated here (advmod)
strokes , (punct)
have associated (conj)
pha-p ( (punct)
known centuries (nmod)
experienced women (nsubj)
2.1 those (nmod)
relieved also (advmod)
men ; (punct)
decreased pressures (nsubjpass)
p.m. 4 (nummod)
deficiency mrp2 (compound)
school , (punct)
associated delirium (nsubj)
loosening and (cc)
acute , (punct)
necessary might (aux)
conditions ocular (amod)
responses auditory (amod)
example imbalance (nmod)
110000 and (cc)
shown related (ccomp)
given injection (nmod)
obtained could (aux)
point primary (amod)
duration for (case)
associated significantly (advmod)
weeks over (case)
$ROOT$ mg (sent)
depression , (punct)
genes homologous (amod)
inhibited carteolol (nsubj)
biperiden to (case)
co in (case)
survival cumulative (amod)
cells hepatoma (compound)
involved finally (advmod)
fluoxetine and (cc)
disappearance with (case)
patients mmc-treated (amod)
overload dextran (compound)
present n=11 (dep)
surgery hip (compound)
persisted patients (nmod)
average drinks (nmod)
gestations twin (compound)
dyslipidemia extended-release/lovastatin (conj)
electrophysiologic peripheral (amod)
improvements lability (nmod)
insufficiency coagulation (nmod)
revealed lack (dobj)
totp without (case)
care hospital (compound)
b ( (punct)
disease shr (nmod)
precursor same (amod)
longer only (advmod)
commissure in (case)
kg-1 micrograms (nummod)
induction adenomyosis (compound)
7.7 +/- (cc)
2b1/2b2 isoenzymes (dep)
manual ) (punct)
important examination (nsubj)
effects conversion (nmod)
induced ritonavir (nmod)
injury radiation (compound)
recommend use (nmod)
ability micrograms (nmod)
increased mg/dl (nmod)
prevent affect (conj)
culture a (det)
infections more (amod)
parallel a (det)
g ml/100 (compound)
mg/dl 14.8 (nummod)
drowsiness initial (amod)
assigned taking (advcl)
efficacy prochlorperazine (nmod)
late than (cc)
inpatient in (case)
mmhg 60 (nummod)
been , (punct)
< 0 (dobj)
model satisfactory (amod)
cessation softening (conj)
diagnosed detection (nmod)
= .09 (dep)
nitrate/nitrite plasma (compound)
cck-5 of (case)
glutamate msg (appos)
if pain (nsubj)
reverted discontinued (advcl)
mac 1 (nummod)
binding receptors (nmod)
areas potential (amod)
chemotherapy mitoxantrone (nmod)
propranolol clonidine (conj)
seems similar (xcomp)
effect observed (acl)
33 29 (conj)
potent cimetidine (nmod)
procedure to (case)
suppression due (case)
2)% anova (dep)
absorption and (cc)
findings electroencephalogram (compound)
levels or (cc)
peptide n-terminal (amod)
contributed but (cc)
doses gum (nmod)
factors increase (acl:relcl)
size bruising (nmod)
% months (conj)
3.2 24.9 (conj)
patients yrs (nmod)
increased cells/microl (nmod)
failure postrenal (amod)
metabolite , (punct)
prominent . (punct)
angioedema stomach (nmod)
= 0.072 (dobj)
damage levels (conj)
history history (conj)
unit exacerbations (nmod)
max ( (punct)
sensitivity cells (nmod)
departure normal (nmod)
used then (advmod)
black caucasian (conj)
studies limited (amod)
effects tubule (nmod)
men be (cop)
increased significantly (advmod)
volunteers normal (amod)
given given (conj)
acid vpa (appos)
acid-schiff periodic (amod)
decreased period (nmod)
pregnane-20-ones ) (punct)
calculus a (det)
treatment resolution (conj)
related possibly (advmod)
decreased compared (advcl)
minutes before (nmod)
magnitude sufficient (amod)
thereafter daily (advmod)
mass the (det)
$ROOT$ infections (sent)
substantial elevation (nsubj)
scan mri (compound)
days 17 (nummod)
occlusion choriocapillaris (compound)
southeast in (case)
sensitivity expressed (acl)
investigations other (amod)
number foci (nmod)
influence response (nmod)
binding [3h]-dihydroergocryptine (nmod)
after soon (advmod)
b factor (compound)
infusion fenoterol-hydrobromide (compound)
doxorubicin from (case)
occurs deficit (nsubj)
up-regulated that (mark)
% 248 (nummod)
effect structure (nmod)
remains relevance (nsubj)
maintained min-1 (dep)
eosinophils abundant (amod)
rats hannover (compound)
indicate option (ccomp)
stimulation alone (advmod)
attempting identify (xcomp)
intestine in (case)
related infection (nmod)
intubated protection (nmod)
occurred % (parataxis)
antidepressant the (det)
rate success (compound)
blocked injection (nmod)
adr+los(6 group (compound)
first kind (nmod)
scans including (case)
achieved consequently (advmod)
ligand . (punct)
dyskinesias either (cc:preconj)
controls to (case)
adults by (case)
occurrence a (det)
ulcerogenicity with (case)
determine correlated (ccomp)
palsy disorder (conj)
acuity hearing (compound)
didanosine to (case)
caused reduction (dobj)
days through (cc)
phenobarbitone both (cc:preconj)
epilepsy during (case)
have that (nsubj)
hepatitis induced (acl)
sensitivity ketoconazole (nmod)
raised concern (nsubjpass)
assay concomitant (amod)
termination the (det)
receiving concentration (dobj)
produced caffeine (nsubj)
affect does (aux)
staff the (det)
cases some (det)
changes analgesic-induced (amod)
produced pentobarbital (nmod)
dysplasia kidneys (nmod)
percentage control (nmod)
lidocaine for (case)
intake dietary (amod)
adjustment without (conj)
synthesis activity (conj)
return values (nmod)
experienced functioning (dobj)
deafened recovery (nmod)
delayed clearance (nsubjpass)
valsartan , (punct)
leukopenia 24.2/9.1/0 (appos)
agonist for (case)
refused cardioversion (dobj)
rare reactions (nsubj)
abnormalities important (amod)
$ROOT$ hyperactivity (sent)
epo and (cc)
reduced baseline (advcl)
cranial body (nmod)
increasing single (nmod)
beating widening (conj)
cells monocyte (compound)
216 ] (punct)
affect whereas (mark)
compared subject (nmod)
diminish treatment (nmod)
cells by (case)
causes impairments (dobj)
transcript of (case)
addressing as (cc)
binding the (det)
controls ; (punct)
subunits for (case)
include : (punct)
emulsion with (cc)
exhibite patient (nsubj)
41 % (appos)
measures 14/17 (nummod)
combination orally (advmod)
response hypertrophy (nmod)
chow chow (conj)
scale questionnaire (conj)
concentration tobramycin (compound)
entering frequency (dobj)
enlargement tachycardia (conj)
converted enzymatically (advmod)
lobe in (case)
blot by (case)
back-diffusion acid (compound)
pathophysiology a (det)
bp sitting (compound)
pad a (det)
amphetamine for (case)
wild-type and (cc)
14,671 22,875 (conj)
induces followed (advcl)
pathway via (case)
fibrillation despite (case)
disease lid (appos)
induced dsp4 (nmod)
proteins + (compound)
relationships dose-effect (amod)
had thrombocytopenia (dobj)
amiodarone citalopram (conj)
angiography or (cc)
dose about (case)
used cases (nmod)
unmask administration (nsubj)
cells ectopic (amod)
possibility due (ccomp)
most rats (nmod)
cancer for (case)
concern occurrence (nsubj)
dexamethasone dexamethasone (conj)
recorded converted (conj)
impact a (det)
echocardiography 3d (amod)
speed the (det)
immunostaining 7h6 (nmod)
taking methotrexate (nmod)
admitted monitoring (nmod)
using cocaine (dobj)
some effects (nmod)
time to (case)
rate product (conj)
assessed hypotension (nsubj)
properties interpretation (conj)
difficult be (cop)
admitted woman (nsubjpass)
estimated cohort (nmod)
derivative novel (amod)
experience handling (advcl)
had restriction (dobj)
injections i.p. (amod)
arthrogryposis outcome (nsubj)
administration children (nmod)
months first (amod)
discharges generalized (amod)
determine has (ccomp)
rare seizure (nsubj)
investigations the (det)
received mg (dobj)
had weeks (nmod)
ug ( (punct)
proteinuria patients (nmod)
cause att (nsubj)
years 7.7 (nummod)
coli aeruginosa (conj)
mechanisms ischemia (nmod)
analysed were (auxpass)
pain before (nmod)
transformation exencephaly (nmod)
used methadone (dobj)
alpha , (punct)
sensitivity component (nmod)
receive benefit (dobj)
anomalies anotia (dep)
involving possibly (advmod)
cells pacemaker (compound)
cases 12 (nummod)
phenomena in (case)
effect output (nmod)
acuity fields (conj)
subjected mice (nsubjpass)
absorbed tract (nmod)
have syndrome (dobj)
tools experimental (amod)
reversed although (mark)
days gy/30 (nummod)
criteria histologic (amod)
doses one (nmod)
described correlated (conj)
normalized biochemistries (nsubj)
mmse by (case)
reported number (nsubjpass)
series retrospective (amod)
male old (amod)
relationship , (punct)
modulate inflammation (dobj)
postulated cells (nsubjpass)
lesions absent/mild (amod)
short-term ( (punct)
nsvt contractions (conj)
hyperalgesia dynamic (amod)
protocol same (amod)
either alone (dep)
electroretinography flash (compound)
life substance (nmod)
cause yet (cc)
dose hemisulfate (nmod)
107 6 (conj)
markers best (amod)
35.6 +/- (cc)
due interaction (nmod)
antiviral and (cc)
men 18 (nummod)
patients late-conversion (amod)
were cases (dobj)
transferred tape (nmod)
completed days (dobj)
occurred have (aux)
suggested history (nmod)
nicergoline sermion (appos)
lowering increasing (conj)
percentage requirement (conj)
sulphate ] (punct)
tolerated reports (nmod)
33.6 from (case)
suffering neuralgia (nmod)
= 20 (dobj)
block unidirectional (amod)
woman 67-year-old (amod)
seems use (nsubj)
disorder abuse (compound)
analgesia opioid (compound)
observed reports (nmod)
activity leukemia (nmod)
showed fluency (dobj)
higher levels (nmod)
diminishing aggregation (dobj)
follow-up total (amod)
histories similar (amod)
terminate and (cc)
days intervention (nmod)
stimulation pallidal (amod)
4/106 ) (punct)
show test (nmod)
therapy each (det)
pentamidine revisited (acl)
300 400 (conj)
window therapeutic (amod)
chick and (cc)
rats most (amod)
bpo for (case)
day 10 (nummod)
likely . (punct)
aminoglycosides of (case)
$ROOT$ stimulate (sent)
mice aged (amod)
occurred dependent (conj)
reactions related (acl)
exerts cholecystokinin-octapeptide (nsubj)
tachyarrhythmias reentry (appos)
cause convulsions (dobj)
synthase p53 (conj)
patient psp (compound)
damage seizure-related (amod)
supplementation amiloride (compound)
21 6 (compound)
aniracetam compound (compound)
coniine both (preconj)
disease any (det)
changes not (neg)
induced inhibition (nmod)
without evaluation (nmod)
tetany -- (punct)
elucidate effect (dobj)
discussed conducting (advcl)
invaded area (dobj)
patients 129 (nummod)
ameliorated significantly (advmod)
gspe ( (punct)
substitution , (punct)
variety complications (nmod)
asa i.p. (appos)
rejection fibrosis (conj)
blocked ah6809 (nmod)
week feeding (nmod)
lader 's (case)
reviewed relative (advmod)
injury progressive (amod)
alpha-configuration alpha,3 (nummod)
complete month (nmod:tmod)
technique of (case)
yield low (amod)
agent cancer (nmod)
deaths eight (nummod)
% volume (nmod)
cvd ( (punct)
artery of (case)
lesions 19 (nummod)
margin upper (amod)
received decontamination (dobj)
dph ) (punct)
vohland 1981 (dep)
neuroprotection lesion (nmod)
died prematurely (advmod)
incorporation adenosine (nmod)
risks associated (acl)
stronger significantly (advmod)
alterations injury (conj)
need because (case)
addicts stabilized (acl)
identify and (cc)
patients women (nmod)
nonselective ) (punct)
fell fell (conj)
had predict (parataxis)
oc of (case)
distribution between (case)
have treatments (nsubj)
progression further (amod)
tolerated have (aux)
n=10 ( (punct)
disulfiram inhibitor (appos)
type na(+)/h(+ (compound)
protection gspe (nmod)
effective antagonists (nsubj)
reason cited (acl)
caused hypertension (dobj)
dysfunction infarction (nmod)
trial italian (amod)
splenic marrow (conj)
estrogens , (punct)
induced % (nmod)
protocol in (case)
sings clinical (amod)
pattern a (det)
moving-bands non-detectable (amod)
power total (amod)
treated morphine/rg1 (nmod)
decreased ms (dep)
co-agonist ( (punct)
syndrome . (punct)
electrogram by (case)
appeared process (nmod)
inquire consumption (nmod)
felt nelarabine (nsubjpass)
cases disease (nmod)
convulsive lethal (conj)
courses cc (nmod)
fragmentation fiber (nmod)
glucose for (case)
nausea pruritus (conj)
calcium produced (acl)
improve syndromes (nmod)
appeared respond (xcomp)
took after (mark)
282 +/- (cc)
separation . (punct)
event early (amod)
incidence > (amod)
$ROOT$ prescribed (sent)
disorder bipolar (amod)
doses saline (nmod)
agsd ( (punct)
measured version (nmod)
metrifonate inhibitor (compound)
fibers temporal (amod)
haematuria of (case)
jaundice ) (punct)
given resulting (advcl)
safe cost-effective (conj)
neuropathy patient (nmod)
received bcnu (dobj)
role mediating (acl)
disappeared symptoms (nsubj)
mz and (cc)
patient ill (amod)
mean = (acl)
regions in (case)
advantageous profiles (nsubj)
patient receiving (acl)
96.7 score (nsubj)
exam the (det)
recovery fluid (compound)
beats minute (nmod)
receiving line (nmod:tmod)
peroxidation induced (acl)
examination with (case)
appeared toxic (xcomp)
increases pressure (nmod)
affect proliferation (dobj)
omercazole ) (punct)
flow clearance (conj)
volunteers twelve (nummod)
2-fold vs. (cc)
excretion monophosphate (compound)
effect factor-i (nmod)
investigator by (case)
meta-analysis the (det)
utilizing antagonists (dobj)
dysfunction mice (nmod)
degeneration neurons (nmod)
imperative . (punct)
objectives investigates (appos)
warrants , (punct)
requested of (mark)
underwent course (nmod)
available been (cop)
used pesticide (nmod)
protein resistance (compound)
assessed now (advmod)
associated outcomes (nmod)
corroborate required (conj)
139 % (appos)
patients ac (compound)
data show (acl:relcl)
presenting dysfunction (nmod)
associated risks (nmod)
interaction is (cop)
proteins dendrin (dep)
50 than (quantmod)
mean cigarettes (nmod)
speculated , (punct)
neoplasms ) (punct)
degeneration neuropathy (nmod)
terminated terminated (conj)
areas other (amod)
slices saline- (nmod)
trial care (appos)
appeared nodules (nsubj)
half the (det)
saline isotonic (amod)
specificity opioid (compound)
patency complete (amod)
correlated p= (dep)
frequency ) (punct)
bridge edema (nmod)
dm the (det)
saline and (cc)
increased steeply (advcl)
before h (nmod:npmod)
noted given (advcl)
receptors beta-adrenergic (amod)
baseline each (nmod)
confirms produces (parataxis)
combination anaesthetics (nmod)
increased these (nsubjpass)
woman 36-year-old (amod)
3.9 at (case)
manifestation a (det)
obtained history (nsubjpass)
delayed are (auxpass)
variables : (punct)
controls substances (nmod)
analyzed focusing (advcl)
prevent responses (dobj)
transcriptase rt (appos)
exposed aorta (nsubjpass)
blockers potassium (compound)
monitoring hematest (nmod)
induced suxamethonium (nsubj)
influence age (nmod)
pre- postsynaptic (conj)
admission weeks (compound)
tumor bone (compound)
uterotonic used (amod)
interrelationship neurons (nmod)
$ROOT$ presence (sent)
effect pdtc (nmod)
laboratories the (det)
years 10 (nummod)
superior , (punct)
midbrain ventral (amod)
experiments recordings (conj)
typical were (cop)
hemolysis clinical (amod)
clozapine of (case)
latency the (det)
consolidation of (case)
displays and (cc)
solvent organic (amod)
pig guinea (compound)
flash pattern (conj)
greater ml (nmod)
revealed comparing (csubj)
8 than (quantmod)
disability dyskinesia (conj)
consisted men (nmod)
showed strikingly (advmod)
depression currents (nmod)
sensitive memory (nsubj)
showing properties (dobj)
simulator driving (compound)
mrna-containing gad (nmod:npmod)
population well-defined (amod)
slowing and (cc)
concluded , (punct)
address to (aux)
caffeine- pentylenetetrazole-induced (conj)
ranitidine and (cc)
vol% concentration (nsubj)
investigated obtund (advcl)
narrowing arterial (amod)
fmri with (case)
tests zung (compound)
echocardiography with (case)
compared conjunction (nmod)
side opposite (amod)
levels pth (compound)
fa by (case)
effect relation (conj)
sought examine (xcomp)
reduction decrease (conj)
formulations different (amod)
effect dose-dependent (amod)
reversed activity (dobj)
measurement in (case)
widely readily (conj)
cardiotoxicity with (case)
163 to (advmod)
reduced indicating (advcl)
appropriate ranges (nsubj)
found reported (conj)
alcohol cocaine (conj)
antagonized process (nmod)
showed mass (dobj)
antagonists h2-histamine (compound)
required 70 (nsubj)
drugs for (case)
ether by (case)
regurgitation restrictive (amod)
immunomodulators of (case)
1.05 ( (punct)
shock septic (amod)
diuretic an (det)
rates patterns (conj)
offer to (mark)
unchanged cmro2 (nsubj)
levels pretreatment (amod)
patients years (appos)
5-fluorouracil infusion (compound)
was cortex (nmod)
sucrose injection (nmod)
affected cystitis (nmod)
mice administration (nmod)
mg./kg cp (compound)
returned discharged (conj)
recurrence rechallenge (nmod)
release pain (conj)
class middle (amod)
tachycardia procainamide-induced (amod)
syndrome cushing (nmod:poss)
$ROOT$ awake (sent)
information use (nmod)
induced acid (nmod:npmod)
needed % (nmod)
anova , (punct)
ventricles left (amod)
perfusion subsequently (advmod)
completed h (nmod:npmod)
records 2021 (nummod)
men white (appos)
i/d ( (punct)
patients meth-induced (amod)
therapy cases (nmod)
12/32 6/31 (conj)
atenolol from (case)
shown assessment (nmod)
function hepatic (amod)
likely as (mark)
trees fruit (compound)
explanation an (det)
investigated aimed (conj)
aimed compare (xcomp)
than group (nmod)
prescribed flecainide (nsubjpass)
external visceral (conj)
epileptogenecity or (cc)
challenge in (amod)
decrease significant (amod)
system reporting (compound)
showed effect (dobj)
behavior associated (acl:relcl)
introduction the (det)
intralipd plus (cc)
grade 2 (nummod)
accumulation phospholipid (nmod)
aneurysms analysis (dep)
underlie risk (dobj)
demonstrated exception (nmod)
continued appears (advcl)
$ROOT$ revealed (sent)
mechanism key (amod)
enantiomer identical (dep)
substantial , (punct)
eps in (case)
sedation aggressive (amod)
seen greater (advcl)
suggests agent (nmod)
fatigue common (nsubj)
included discontinuation (dobj)
staining , (punct)
event a (det)
however . (punct)
pretreatment mg/kg (appos)
kits available (amod)
relating severity (nmod)
preparations these (det)
displays mice (nmod)
quadrant in (case)
pills containing (acl)
examines effect (dobj)
analyzed information (dobj)
took rhythm (nsubj)
indicative effects (nmod)
similar mania (nmod)
lymphoma large (amod)
identical pregs (nmod)
occurred related (conj)
accompanied period (nmod)
a ab (conj)
day p (appos)
titration dose (compound)
properties pharmacological (amod)
numerically but (cc)
actions cocaine (nmod)
= 42 (dobj)
= 0.61 (dobj)
chemotherapy further (amod)
distribution racial (amod)
stratum 1 (nummod)
$ROOT$ damage (sent)
obesity treatment (conj)
attended participants (nsubj)
fas soluble (amod)
expression enhanced (amod)
progressed which (nsubj)
interval > (amod)
june 2004 (nummod)
complicated have (aux)
shortened qt (dobj)
summary man (appos)
d-tubocurarine with (case)
reported study (nsubj)
speed latency (conj)
reproduced be (auxpass)
acid acetic (amod)
antagonists h2-receptor (compound)
conclusions indicate (dep)
introduction agent (nmod)
resolved recur (conj)
mg./kg i.v. (amod)
ht placebo (conj)
$ROOT$ lidocaine (sent)
steroids alpha-configuration (nmod)
revealed responses (dobj)
frequent diazepam (nmod)
cases % (appos)
injected core (nmod)
sensitivity vision (conj)
result a (det)
phenomena observed (amod)
5.1+/-1.0 ( (punct)
containing pdn (dobj)
plugs tumor (compound)
12 three (compound)
reduced 39+/-10 (cc)
single-blinded , (punct)
increase peak (amod)
dyscontrol , (punct)
found yet (cc)
.002 ) (punct)
process by (case)
successful and (cc)
recurrence a (det)
tests y-maze (compound)
noted whereas (mark)
dox : (punct)
$ROOT$ attenuate (sent)
antioxidants heart (compound)
channels nodes (nmod)
lethality both (preconj)
arterial and (cc)
january 2004 (nummod)
prevalent associated (conj)
evaluation of (case)
increased appears (conj)
14.3 p (dep)
ranging mg/kg/day (nmod)
actions pressure (nmod)
case embryopathy (nmod)
expected harmful (xcomp)
ventilated animals (nsubjpass)
8.5 = (parataxis)
hemodynamics substances (conj)
correlation ( (punct)
aneurysm association (nmod)
evolution infarction (nmod)
became independent (acomp)
control a (det)
efficacy resolution (nmod)
associated none (nsubjpass)
biopsy on (case)
disorders neurological (amod)
explore mechanism (dobj)
hormone factor (conj)
neurones central (amod)
number number (conj)
alternative sodium (nsubj)
response fibroproliferative (amod)
effects encountered (acl)
pentoxifylline mg/kg (dep)
capsules silastic (amod)
granulated well (advmod)
patients 45 (nummod)
effect major (amod)
damage interstitial (amod)
workers exposed (amod)
end treatment (nmod)
basis findings (nmod)
receptors histamine (compound)
prooxidant also (advmod)
tizanidine of (case)
found characteristics (nmod)
results assay (compound)
produced (+/-)-sm (punct)
performed meta-analysis (dobj)
variants virus (nmod)
disrupts use (nsubj)
hypertrophy apparatus (nmod)
100 7 (conj)
design evaluation (appos)
found patients (nmod)
increment each (det)
carried therefore (advmod)
treatment hydrochloride (nmod)
idr tests (conj)
observed numbers (nsubjpass)
chemotherapy perfusion (conj)
equipment of (case)
overcome effect (dobj)
recruited states (nmod)
lad than (case)
induced dextran (nsubj)
motility on (case)
effectiveness antiarrhythmic (amod)
earliest ) (punct)
impaired agonist (nsubj)
score high (amod)
astrocytes and (cc)
range [ (punct)
reduced end (nmod)
also was (cop)
cells inhibitory (amod)
dose same (amod)
treated orally (advmod)
strategies recommended (acl)
attenuated given (advcl)
various and (cc)
seizures no (det)
yrs ; (punct)
presented they (nsubj)
involving pathway (dobj)
detect to (mark)
value studying (acl)
isotypes nos (compound)
$ROOT$ 96.7 (sent)
myelosuppression % (nmod)
hypothermia therapeutic (amod)
studies national (amod)
causes from (case)
inhibited hyperprolactinemia (nmod)
demonstrated assays (nsubj)
050+/-561 28 (compound)
onset hypotension (nmod)
arf in (case)
$ROOT$ attributed (sent)
studies nerve-conduction (compound)
space the (det)
analysis bche (nmod)
treatment acid (nmod)
nurse by (case)
supported results (nmod)
disturbance and (cc)
gln223 and (cc)
perfusion-fixed , (punct)
% ci=39.9%-68.7 (nummod)
induced maleate (nmod)
indicate block (ccomp)
dogs anaesthetized (amod)
existed . (punct)
anterior tibialis (compound)
secretion from (case)
ng 125 (nummod)
stable median (nmod)
atpase and (cc)
severity , (punct)
monitored patients (nsubjpass)
sr placebo (conj)
effect keratectomy (nmod)
vesicles discoidal (amod)
-cimetidine mg/kg (appos)
workers nine (nummod)
advent blockers (nmod)
acted drug (nsubj)
finding . (punct)
displace drc (dobj)
compared anaesthesia (nmod)
concentrated , (punct)
groups alzheimer (nmod:poss)
reduce injury (dobj)
had echocardiograms (dobj)
aspartate glutamate (conj)
preparation used (acl)
signs response (nmod)
during after (conj)
frequency drugs (nmod)
stiffness a (det)
prior treatment (nmod)
complex respiratory (amod)
observation carried (acl)
mg/dl 160 (nummod)
dose dox (nmod)
thrombolysis alteplase (nmod)
sparing field (nmod)
reports review (conj)
inactive ro4368554 (nsubj)
groups group (appos)
men 32 (nummod)
nucleus nigra (compound)
24.3 index (nsubj)
consisted loss (nsubj)
telangiectasia , (punct)
was subjects (advcl)
comprehensive most (advmod)
drugs ns (amod)
kinase signal-regulated (amod)
diameters and (cc)
mg s.c. (dep)
beams , (punct)
specification further (amod)
surface oblongata (nmod)
objective investigation (nmod)
level striatal (amod)
developed di (dobj)
deprivation prenatal (amod)
decrease further (amod)
medication and (cc)
needed investigate (xcomp)
anencephaly deficiency (conj)
cin with (case)
4.2 3.1 (conj)
mg. threshold (nsubj)
1187 +/- (cc)
reflex micturition (compound)
induction its (nmod:poss)
alf : (punct)
cases 551 (nummod)
azt and (cc)
pattern block (compound)
receive developing (advcl)
older children (nsubj)
duration months (compound)
missed % (dobj)
magnitude outcome (conj)
phosphate of (case)
alterations on (case)
550 - (punct)
confounded that (mark)
surgery before (nmod)
time reduction (nmod)
infarction isoproterenol (compound)
epidemic disease (nmod)
report and (cc)
apart headaches (nmod)
decreased mice (advcl)
$ROOT$ released (sent)
confirmed induced (ccomp)
proteinuria reduction (conj)
hepatocytes liver (nmod)
rhythm abnormal (amod)
exposure concentration (nmod)
vocalization and (cc)
exposed before (mark)
production increased (amod)
has effect (nsubj)
used perhaps (advmod)
dose in (case)
findings pathological (amod)
recommend ect (nmod)
acting , (punct)
substrate 3a4 (compound)
4-tetrahydroanaphthalene , (punct)
nalozone mg/kg (appos)
using index (nmod)
duration seizures (compound)
warfarin of (case)
s-1 s-1 (conj)
prevent demonstrating (advcl)
greater sg (nsubj)
immunosuppression local (amod)
sites ) (punct)
treatment gemfibrozil (compound)
mellitus 5 (appos)
days 3.4 (nummod)
use ecstasy-polydrug (compound)
irreversible that (mark)
schedule escalation (compound)
levels basal (amod)
questionnaires the (det)
changes larger (amod)
topiramate therapy (appos)
hypothesis : (punct)
related dili (nmod)
dyskinesias patients (nmod)
malaise flushing (nmod)
patient aids (compound)
bau daily (amod)
myopathy pentazocine-induced (amod)
seizures epilepticus (conj)
conducting upon (mark)
had 53 (nsubj)
occurrence first (amod)
out-patients of (case)
males old (amod)
balances weight (conj)
given medications (nsubjpass)
laitinen 's (case)
seroconversion for (case)
models arrhythmia (compound)
dysplasia of (case)
factors hemorrhage (nmod)
rigidity masseter (compound)
$ROOT$ poison (sent)
aims study (nmod)
unpredictable serious (conj)
change appearance (nmod)
management surgical (amod)
butyrylcholinesterase butyrylthiocholine (nmod)
allergy immediate (amod)
toxic is (cop)
suppressor socs-1 (dep)
appeared when (advmod)
preference partner (compound)
out-patients referral (compound)
m(1)/m(3)/m(5)-selective ) (punct)
increased selectively (advmod)
suffered complication (dobj)
needed prevention (nmod)
compared benztropine (nmod)
thirty-nine compared (acl)
parameters these (det)
comparing concentrations (dobj)
antibody proteinase (compound)
echo gradient (compound)
torr from (case)
methods followed (appos)
blind prospective (amod)
revealed arteries (dobj)
vehicle either (cc:preconj)
mg/kg)-treated crocin (nmod:npmod)
discontinuation 5-fu (nmod)
disease parkinson (nmod:poss)
shown 3,4-methylenedioxymethamphetamine (nsubjpass)
treatment adjunctive (amod)
cholesterol blood (nmod)
13-fold 4.2- (compound)
variability pressure (compound)
latency latency (conj)
smoker 31-year-old (amod)
deficit memory (nmod)
began began (conj)
coupled when (advmod)
schedules standard (amod)
hexaaldose , (punct)
pinealectomized or (cc)
estimate pharmacodynamics (dobj)
fk506 ; (punct)
activity caspase-3 (nmod)
take that (mark)
levels urine (compound)
observed previously (advmod)
history on (case)
protocol front-line (amod)
1.037 +/- (cc)
manifestation combination (nsubj)
results responded (appos)
or=12.619 ) (punct)
electromyography laryngeal (amod)
sufficient generation (nsubj)
defect mitochondrial (amod)
leukocyturia l (nmod)
status depressive (amod)
induced 6-ohda (nmod)
administration the (det)
informed effect (nmod)
causes methyldopa (nsubj)
shoed . (punct)
appeared effect (xcomp)
evidence association (nmod)
taking lithium (dobj)
prevent deterioration (dobj)
prevention : (punct)
evaluable far (advmod)
causes diet (nsubj)
effects associated (acl)
entity this (det)
fluphenazine the (det)
women thirty-nine (nummod)
incidence discomfort (nmod)
exerted . (punct)
observed evidence (nsubjpass)
complex channel (compound)
inhibited contractions (nsubjpass)
world real (amod)
measured rats (nmod)
involved functions (nsubjpass)
(pge1)-induced e1 (nmod:npmod)
complaints , (punct)
day during (case)
compound each (det)
well-tolerated was (cop)
= 0.53 (dobj)
correct , (punct)
confirmed dosing (nmod)
norepinephrine only (advmod)
phases in (case)
sphincter morphine-induced (amod)
effective achieving (advcl)
mol/l mol/l (conj)
weight age (appos)
lowered elevation (dobj)
slices cortex (nmod)
activation nf-kappab (compound)
report concerns (nmod)
dehydrogenase aldehyde (compound)
components sensory-discriminative (amod)
guard national (compound)
dose intervals (nmod)
correlate thrombosis (nmod)
vte ( (punct)
described ( (punct)
classical and (cc)
challenged induce (xcomp)
showed bradycardia (dobj)
irritability difficulties (conj)
provoked was (auxpass)
dysfunction sensory (amod)
factor changes (nsubj)
epicondyle at (case)
effect drug (compound)
protrusion and (cc)
cells p75(ntr)-immunoreactive (compound)
complained photosensitivity (nmod)
function good (amod)
after days (nmod:npmod)
returns patient (nsubj)
daytime at (case)
2a ribavirin (conj)
stabilized patient (nsubjpass)
elevation leads (nmod)
index a (det)
system rat (nmod)
anemia dose-limiting (amod)
conclusions determined (dep)
groups intact-control (appos)
headache release (conj)
impact plasticity (dobj)
highlighting fact (dobj)
block intervals (conj)
ought , (punct)
course fluctuations (nmod)
day e13.5 (appos)
vulnerable subpopulation (nsubj)
induced dose-relatedly (advmod)
hev ) (punct)
% 16.6 (nummod)
black male (dep)
patients all (predet)
expired . (punct)
size on (case)
underlying effects (dobj)
0 and (cc)
given fluoxetine (nsubjpass)
cisplatin % (appos)
day gd1=plug (compound)
sensitive predicting (advcl)
administered mannitol (nsubjpass)
thyroxine and (cc)
attenuates . (punct)
studies developmental (amod)
improved severity (dobj)
ability pregs (nmod)
alterations or (cc)
metoclopramide by (case)
underlying phenomenon (dobj)
nuclei dentate (amod)
risperidone antipsychotic (appos)
extracted and (cc)
begun had (aux)
withheld were (auxpass)
groups week (compound)
occurrence bruising (nmod)
tolerability reliability (conj)
had relative (dobj)
effect pathogenesis (conj)
crocin 25mg/kg (dep)
use drug (compound)
psychostimulant cocaine (nsubj)
occluded , (punct)
palsies nerve (compound)
beclomethasone on (case)
initiating of (mark)
loss permanent (amod)
agent narcotic (amod)
jj to (case)
shedding or (cc)
= 0.36 (dobj)
screenings double (amod)
inhibits synthase (dobj)
reported encephalopathy (nsubjpass)
required required (advcl)
derivative is (cop)
induced benzoylecgonine (nmod)
without and (cc)
anaesthesia the (det)
combination metamizol (nmod)
bear to (mark)
investigating at (mark)
cultured were (auxpass)
doxorubicin doxorubicinol (conj)
considered lesions (nsubjpass)
doses isoproterenol (nmod)
succinate sumatriptan (compound)
required he (nsubj)
analyses hoc (amod)
has model (nmod)
remains atin (nsubj)
performance myocardial (amod)
turn in (case)
analysis cycle (compound)
groups 4 (nummod)
cancers several (amod)
expression including (case)
minutes many (amod)
compared we (nsubj)
terminating treatment (dobj)
sch by (case)
research medical (compound)
assigned randomly (advmod)
defect , (punct)
syndrome 5 (compound)
adults to (case)
pair-matched were (cop)
injections intravenous (amod)
hyperthermia min (dep)
months/patient ) (punct)
monoher dox (conj)
resulted dyskinesias (nmod)
demonstrating thus (advmod)
loss deposits (conj)
complications japan (nmod)
palsy abnormalities (conj)
1.5 and/or (cc)
hilus of (case)
absent helpful (advcl)
inability repeat (acl)
4.336 , (punct)
diagnoses psychiatric (amod)
microl microg/0.5 (compound)
administration propranolol (nmod)
33 12 (conj)
accompanied myoclonus (nmod)
believed , (punct)
greater arag (nmod)
csa mg/kg (appos)
facts notwithstanding (case)
pge2 b2 (conj)
myelitis and (cc)
fetuses male (amod)
feeding protein (compound)
thromboembolic therapy (nmod)
barrier rat (nmod)
15 doxorubicin (nmod)
neurotoxicity pruritus (conj)
outcomes measures (conj)
site receptor (compound)
cows jersey (compound)
examination emg (conj)
disappearance complete (amod)
amount small (amod)
alterations brain (compound)
regurgitation 3.1 (appos)
pain injection-site (amod)
sgk1 sgk1(-/- (appos)
sign the (det)
had since (mark)
iu 17.5 (nummod)
occurred initiation (nmod)
option an (det)
observed naturally (advmod)
dietary supplemental (conj)
billingham according (case)
plausible . (punct)
need inducing (acl)
47.5 - (punct)
class the (det)
mutation g20210a (compound)
exposure ps (compound)
accounted . (punct)
indicate increased (ccomp)
influence possible (amod)
common be (cop)
hypotension the (det)
blunted significantly (advmod)
% 5.9 (nummod)
function of (case)
related vinorelbine (nmod)
treatment vpa (compound)
microinjections acid (nmod)
a csa (appos)
groups c+e (compound)
result regimens (nmod)
preparations . (punct)
naloxone hydrochloride (conj)
vldl in (case)
interleukin il-6 (appos)
potency = (dep)
complication such (predet)
administration prophylactic (amod)
potentiates antinociception (dobj)
meq. ( (punct)
cases 2003- (nmod)
ester . (punct)
profile study (dep)
piloerection by (case)
fenestrae of (case)
desorption/ionization matrix-assisted (amod)
ill and (cc)
tachycardia classic (amod)
going is (aux)
exercise treadmill (compound)
site infection (nmod)
finding concerning (amod)
patients cocaine-abusing (amod)
pretreatment bn (nmod)
group ro15 (compound)
pet ( (punct)
treatment by (case)
cells/mm3 respectively (advmod)
2.04 to (dep)
method assigned (dep)
caffeine or (cc)
need kinds (nmod)
ett ( (punct)
nicotine to (case)
indicator early (amod)
provides efficacy (dobj)
indicating reduction (dobj)
number dropping (acl)
developed angioedema (dobj)
doxorubicin such (case)
suppressed that (mark)
9-tetrahydrocannabinol of (case)
born weeks (nmod)
disappeared recurred (conj)
damage induced (amod)
symptoms all (det)
= 23.5 (dep)
pallidotomy posteromedial (amod)
enrolled receive (xcomp)
appear may (aux)
tubular and (cc)
included and (cc)
block preexisting (amod)
associated paralysis (nmod)
naloxone acid (conj)
involvement attributable (amod)
15 to (case)
has cocaine (nsubj)
shown has (aux)
injection rats (nmod)
evaluation damage (nmod)
14c-41 of (case)
risk a (det)
described randall-selitto (nmod)
knife in (case)
studied year (nmod)
long and (cc)
unlikely acid (nsubj)
prevented effectively (advmod)
proportion haemorrhages (nmod)
inhibitor-1 plasminogen (compound)
ratio age-adjusted (amod)
scopolamine pre-test (amod)
remained became (conj)
cocaine rc (appos)
fnclcc ( (punct)
bradycardiac the (det)
headache tension-type (amod)
complications perioperative (amod)
metrics days (dep)
agents offending (amod)
examine increases (ccomp)
threshold damage (conj)
signs as (case)
molecules discovered (acl:relcl)
diagnosis thrombocytopenia (nmod)
treatment = (dep)
restored l-dopa (nsubj)
words recall (acl:relcl)
ms tandem (amod)
improvement erections (conj)
systems in (case)
attention memory (conj)
mean 196 (nummod)
ka to (case)
hospital to (case)
parkinsonism neuroleptic-induced (amod)
response hyperemic (amod)
surgery ophthalmic (amod)
mild toxicities (nsubj)
examined show (ccomp)
required sometimes (advmod)
exposure that (mark)
uteri cervix (compound)
disease induced (acl)
relatives first-degree (amod)
ineffectiveness the (det)
cortex upon (case)
modulate that (mark)
drg l6-s1 (compound)
cluster seizures (nmod)
colorectal including (case)
metrics between (case)
rate drop-out (compound)
sedated surgery (nmod)
affected hypoactivity (dobj)
modified be (auxpass)
developed % (conj)
suffered paralysis (dobj)
decrease complication (dobj)
data : (punct)
caused tricyclics (nmod)
had met (conj)
demonstration is (cop)
evaluated rats (nmod)
hepatotoxicity and (cc)
seen as (mark)
failed patients (nsubj)
abnormalities asymptomatic (amod)
exerted as (mark)
positive trimethoprim (nmod)
apomorphine mg/kg (appos)
diameter arterial (amod)
discovered developed (xcomp)
induced chloramphenicol (nmod)
predictive ratios (nsubj)
cxad , (punct)
measure on (case)
patients 458 (nummod)
declined hours (nmod)
associated cardiotoxicity (nmod)
septal defects (conj)
curtailed was (auxpass)
infections recipients (nmod)
receptors trks (appos)
brief as (case)
threshold ventricular (amod)
antibody mpo-anca (appos)
use cautious (amod)
efficacy treating (advcl)
size points (nmod)
experienced subject (nsubj)
% fibers (nmod)
ligands novel (amod)
pointes : (punct)
causing patient (nmod)
volume end-systolic (amod)
group this (det)
revealed was (auxpass)
recovery regarding (case)
bilirubin , (punct)
philadelphia pa (appos)
relation any (det)
dysfunction neurotransmission (nmod)
brings relief (nsubj)
scenario not (neg)
pgads ( (punct)
$ROOT$ summarizes (sent)
escape failure (conj)
epinephrine subcutaneous (amod)
shortening lv (compound)
synthesis agents (nmod)
rigidity bradykinesia (conj)
performed benzylpenicilloyl-poly-l-lysine (nmod)
hospitals and (cc)
outcomes multiple (amod)
obtain to (mark)
alcoholic she (nsubj)
mmt siop (compound)
changes mental (amod)
mechanisms causing (acl)
administration anesthetic (nmod)
focus . (punct)
subjects from (case)
longer statistically (advmod)
randomization and (cc)
low very (advmod)
transmission stimuli (nmod)
% risperidone (nmod)
seems whereas (mark)
gain approach (nmod)
explained effects (nmod)
$ROOT$ glycoprotein (sent)
status volume (compound)
found suppressed (ccomp)
divided doses (nmod)
g/m2 cycle (nmod)
variables variables (conj)
levels estradiol (nmod)
ctnt rats (nmod)
stimulation ventricular (amod)
waves b (compound)
mangiferin given (acl)
appears though (mark)
patients headache (nmod)
influenced or (advmod)
joints tender (amod)
cancers skin (compound)
antagonized doses (dobj)
saline saline+dmso (appos)
exhibited groups (nsubj)
combined clonazepam (nmod)
octapeptides prevented (appos)
given pn (nmod)
given clozapine (dobj)
mediating in (mark)
agent pressor (compound)
affects stimulation (nsubj)
eeg undertaken (acl)
once , (punct)
infused infusion (nmod)
analyze used (conj)
safety activity (conj)
diagnosis unexpected (amod)
strains substitution (compound)
mz ) (punct)
scoring based (case)
complications serious (amod)
group diazepam (compound)
improvement pharmaceutical (amod)
glutamate and (cc)
demonstrated antidepressants (nmod)
hallmark loss (nsubj)
observed early (advmod)
difficult enucleations (nsubj)
vestibulotoxicity streptomycin-induced (amod)
coadministration and (cc)
evaluation 1 (dep)
treatment enzyme (compound)
active centrally (advmod)
efficacy reversing (acl)
decrease flow (nmod)
included history (nsubj)
2.2 , (punct)
situations fasting (nmod)
used bupropion (dobj)
depressed extent (conj)
different than (prep)
morbidity to (case)
samples plasma (compound)
cholestasis associated (amod)
epilepsy . (punct)
mg/kg ten (compound)
succumbed he (nsubj)
days 5 (conj)
progesterone or (cc)
placebo of (case)
attacks ischaemic (amod)
stay unit (nmod)
degree exposure (nmod)
statistics drug (compound)
relationship clioquinol (nmod)
crossmatching pre- (amod)
casts proteinaceous (amod)
scleroderma localized (amod)
disease obstructive (amod)
rats sprague-dawley (compound)
enzymes selective (amod)
dose medication (nmod)
24.2 +/- (cc)
10.3 ( (punct)
1969 1990 (prep)
pneumonia bronchitis (conj)
decrease resolution (conj)
ci 5.9 (appos)
low-dose od (dep)
injections ) (punct)
appears under-appreciated (xcomp)
delta the (det)
14 dogs (nmod)
observed seizure (nmod)
quantitated representing (advcl)
aware , (punct)
neurotoxicity : (punct)
had children (nsubj)
exploration tremors (conj)
differs it (nsubj)
explore dosing (dobj)
inhibitor methylglutaril (compound)
desire void (acl)
donors blood (compound)
effects above-mentioned (amod)
damage model (nmod)
anticoagulant used (acl)
actin interstitial (amod)
scheduled who (nsubjpass)
reversal tetany (nmod)
complete nearly (advmod)
examined malformations (nmod)
equal equal (conj)
exacerbated aggravation (nmod)
gain : (punct)
rediscovery with (case)
leads state (nmod)
observations the (det)
mg 26.3 (nummod)
voltarol , (punct)
aminoglycoside is (cop)
4107 208 (conj)
penicillins to (case)
thickness layer (compound)
$ROOT$ myelosuppression (sent)
evaluation assessment (nmod)
involved antagonism (dobj)
herbicides and (cc)
data trials (nmod)
0.05 0.1 (conj)
database research (compound)
exhibited doses (nmod)
microg/kg 1 (nummod)
washout by (case)
argatroban of (case)
stay of (case)
intoxication connection (nmod)
concentrations urea (compound)
change by (case)
conducted , (punct)
injection head (compound)
cases both (det)
diazinon insecticide (compound)
setting used (acl:relcl)
associated but (cc)
= 17 (dobj)
escalation dose (compound)
life plasma (compound)
recorded participants (nsubj)
points , (punct)
reports anecdotal (amod)
degree loss (nmod)
caffeine ( (punct)
stimulation sham (amod)
aeds ) (punct)
kappa-beta of (case)
time fluid (nmod)
objective present (dep)
reduces warfarin (nsubj)
mg/m2 70 (nummod)
developed retinopathy (dobj)
targeting apical (amod)
obstruction ureteric (amod)
case l-sotalol (nmod)
flushing face (nmod)
positive ) (punct)
activation dietary (amod)
confirmed is (auxpass)
conclusions resulted (dep)
pathways underlying (acl)
pituitaries in (case)
vasculitis (ptu)-associated (punct)
event this (det)
elevation % (nmod)
blocker with (case)
delivery for (case)
demonstrated reported (conj)
but not (neg)
fumarate disoproxil (compound)
24 including (case)
studies systematic (amod)
administration lv (compound)
thrombosis upper-extremity (amod)
became died (conj)
earlier days (nmod:npmod)
2.5 to (dep)
report strains (nmod)
acceptable clinically (advmod)
exceeds occurs (conj)
headache induced (amod)
metrizoate after (case)
treated methotrexate (nmod)
coarsening features (nmod)
disorders hyperthermia (nmod)
disappeared withdrawal (nmod)
pressure : (punct)
monitored therefore (advmod)
1971 1975 (conj)
finding have (conj)
overload induced (acl)
fev1 and (cc)
activity nadh-dehydrogenase (nmod)
duration of (case)
agonism by (case)
rofecoxib mg (nummod)
time entry (conj)
mg./kg mg. (conj)
phosphate-diaphorase nadph-d (appos)
sgk1 of (case)
haloperidol apomorphine (conj)
h for (case)
project prevention (nmod)
mg up (advmod)
group hypertensive (amod)
mm r/r (compound)
epilepsies in (case)
sensitivity and (cc)
performed but (cc)
continued dcf (nsubj)
behavior recovery (nmod)
necrosis healed (amod)
numbers neurons (nmod)
4 and (cc)
were cases (attr)
determine associations (dobj)
obstruction due (case)
leukaemia in (case)
presented lesions (nmod)
normalization interleukin (conj)
survival ) (punct)
minimize effect (dobj)
increased but (cc)
reversal pilocarpine (nmod)
reduction seen (acl)
hemorrhagic 31 (nsubj)
$ROOT$ seem (sent)
lesions thalamic (amod)
dose ribavirin (compound)
prompted this (nsubj)
recorded circle (nsubjpass)
corticography recordings (conj)
ng/ml 8 (nummod)
patients compared (conj)
nurses attending (amod)
diagnosed patients (nsubjpass)
bromperidol of (case)
investigators of (case)
saline % (conj)
signs electrocardiograms (conj)
brush-evoked punctate-evoked (conj)
scale 0 (nmod)
ct brain (compound)
102+/-13 from (case)
therapy azathioprine (compound)
erythematosus treated (acl)
mdma ) (punct)
factors impact (conj)
metabolism . (punct)
infrequent limited (conj)
role association (conj)
85.9 +/- (cc)
indicators weight (conj)
activated complement (nsubjpass)
cognition in (case)
hepatitis cytolytic (amod)
lupus ) (punct)
grade ; (punct)
responders patients (nmod)
related generation (nmod)
decreased aggregation (nsubj)
return ability (conj)
digitalise . (punct)
difficult may (aux)
women comparison (dep)
model injury (nmod)
seven 26 (conj)
electrodes of (case)
microglobulinuria with (case)
mg/d = (dep)
had status (conj)
oat1 and (cc)
high-dose and (cc)
process assurance (compound)
return median (dep)
plasma % (compound)
treatment citalopram (nmod)
increased one (nmod)
common most (advmod)
dextromethorphan , (punct)
beta4 ( (punct)
cholecystokinin , (punct)
behaviors 5ht-related (amod)
use aggressive (amod)
hypertension primary (amod)
alive 4 (nsubj)
conditioning on (case)
anticholinergic an (det)
suggesting decrease (ccomp)
120 , (punct)
studied rat (nmod)
complicating cardiomyopathy (dobj)
blocked thrombosis (nmod)
maximum being (cop)
inhibitor direct (amod)
more even (advmod)
modulates subtype (nsubj)
occurring transplantation (nmod)
21 8 (conj)
drugs ic (compound)
high- the (det)
catecholamines idolamines (conj)
ng wky (nmod)
demonstrated treatment (nmod)
perturbations with (case)
carboplatin rhuepo (conj)
group lead-treated (amod)
suitable to (mark)
quetiapine clozapine (conj)
tools target (acl)
experienced which (nmod)
received regimen (dobj)
26/31 25/32 (conj)
inhibition anhydrase (nmod)
effect are (cop)
overload [ca(2+)](i (compound)
discussed implications (nsubjpass)
that phospholipid (nmod)
neutropenia requiring (acl)
conditions label-restricted (amod)
causing in (mark)
reassessment a (det)
cornerstone as (case)
% crf (dep)
effect thrombotic (amod)
application nitroglycerin (nmod)
difficult population (nmod)
blind were (cop)
have men (nsubj)
hematoma induced (acl)
methylprednisolone d1 (appos)
snr activated (amod)
assumed it (nsubjpass)
escape vaccine (compound)
agonist alpha(2 (compound)
administration terbutaline (nmod)
markers correction (conj)
% % (nummod)
function glomerular (amod)
3tc d4 (conj)
departments patients (nmod)
$ROOT$ carries (sent)
introduced inhibitors (nsubjpass)
effects confounding (amod)
meq/l to (case)
allocated receive (xcomp)
impair function (dobj)
media cm (appos)
exert reduce (conj)
shows work (nsubj)
minimize bradycardias (dobj)
failure with (case)
pneumoniae was (cop)
conners ' (case)
incapacitated . (punct)
effects levodopa (nmod)
continue reduction (nmod)
rating pain (compound)
8.8 1.3 (nummod)
ischemia epinephrine-induced (amod)
menopause of (case)
inhibiting activity (dobj)
understood impact (nsubjpass)
taking thyroxine (dobj)
obtained halving (advcl)
indicators prognostic (amod)
internus gpi (appos)
enzyme bche (appos)
given carbetocin (nsubjpass)
concentration ecg (conj)
patients b (nmod)
factors to (mark)
important development (nmod)
beginning days (nmod)
ctni , (punct)
modalities different (amod)
hypersensitivity was (cop)
limits generalizability (dobj)
using when (advmod)
adrenaline ng/kg/min (dep)
locomotion for (case)
mk-801 ) (punct)
readmitted and (cc)
single after (case)
observed had (parataxis)
characteristics observed (amod)
found p-coumarate (nsubjpass)
analysed was (auxpass)
discovered methods (nsubj)
generation to (case)
carvedilol antagonist (appos)
showed possessed (ccomp)
showed woman (nmod)
nephrotoxicity cisplatin-induced (amod)
patient fourth (amod)
efficient prevention (nmod)
heart transplant (conj)
mary 's (case)
infused hours (nmod)
patients problems (nmod)
iv one (nummod)
cats of (case)
changes activation (compound)
arag the (det)
exercise-isoproterenol e-1 (appos)
significant more (advmod)
units of (case)
effects anxiogenic- (amod)
hydration , (punct)
use fzp (nmod)
observed metastases (nmod)
effect potentiated (amod)
(+/-)-sm 21 (nummod)
headache model (nmod)
21.5 4.7 (appos)
assessment preoperative (amod)
bowel small (amod)
proportion % (appos)
x [ (punct)
concentration temazepam (nmod)
indices all (det)
leukoencephalopathy syndrome (conj)
failure e.g. (advmod)
half-life t1/2 (appos)
tacrolimus from (case)
noncompliance to (case)
stage growth (nmod)
hyperactivity apomorphine-induced (amod)
deaths more (amod)
animals cats (appos)
resolved cases (nmod)
model arthrogryposis (nmod)
treatment vip(-/- (conj)
matter hemispheres (nmod)
macroscopic and (cc)
less pp (nmod:npmod)
myalgia lasting (acl)
sod for (case)
exert not (neg)
logical it (nsubj)
lymphocyte the (det)
had spikes (dobj)
had tachycardia (dobj)
analogues of (case)
attenuated that (mark)
neurosci , (punct)
inhibited enhanced (advcl)
resistance systemic (amod)
% 0.075 (nummod)
seizures severe (amod)
control srl (conj)
growth bacterial (amod)
mefloquine of (case)
disorders schizophrenia (compound)
chemotherapy neo-adjuvant (amod)
care patient (nmod)
warned should (aux)
obese that (mark)
occurred min (nmod)
lr132 1r,2s-(+)-cis-n-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl)cyclohexylamine (appos)
day at (case)
swim duration (nmod)
developed doses (nmod)
randomization visits (conj)
achieved dose (nmod)
cdt alteplase (nmod)
enzymes lysosomal (amod)
high % (nsubj)
contractility altered (amod)
dose meth (nmod)
toxicity who (compound)
phenylhydrazine phz (appos)
demonstrate role (dobj)
chloroquine cq (appos)
highest the (det)
recommended use (nmod)
curves characteristic (amod)
bupivacaine of (case)
amiodarone , (punct)
sgk1 kinase (compound)
have ions (nsubj)
relationship possibility (conj)
green of (case)
rate on (case)
detectable not (neg)
fixed and (cc)
give support (dobj)
brain with (case)
parasitosis delusional (amod)
plays damage (nmod)
days ten (nummod)
placed diets (nmod)
contributed incontinence (nmod)
period off-dosing (amod)
animals pinealectomized (amod)
involved alterations (nsubjpass)
plasmapheresis and (cc)
l-dopa ) (punct)
inhibitors used (acl)
vnr ( (punct)
dfc -18.9 (appos)
volunteers 12 (nummod)
observed females (nmod)
provided which (nsubj)
useful attenuating (advcl)
advantages induction (nmod)
p45 ( (punct)
drop compensatory (amod)
10ug ( (punct)
diagnosis i (dep)
catecholamines reduced (amod)
expression an (det)
mm with (case)
displace to (mark)
neuroleptics atypical (amod)
most n (dep)
arm of (case)
induced provoked (conj)
decreased increased (advcl)
achieved four (nmod)
administration intramuscular (amod)
understanding coupling (nmod)
snp , (punct)
models interoceptive (amod)
500 400 (compound)
decrease estimated (amod)
involved colliculus (nsubjpass)
functions electrocardiography (nmod)
shown benefit (xcomp)
depends urgency (nmod)
response psychostimulant (nmod)
treatment under (case)
mg./kg 5 (nummod)
inserted needle (nsubjpass)
$ROOT$ isolated (sent)
2009 2012 (conj)
known while (mark)
night a (det)
mp i.v. (compound)
biomarkers indices (conj)
given thirds (nmod)
materials administered (dep)
influenced treatment (nsubj)
nrf2 genes (conj)
compared production (nsubjpass)
anatomy biliary (amod)
inhibitor alternative (amod)
alkaloid quinidine (nmod)
capable is (cop)
persisted minutes (nmod)
concentration histamine (compound)
response endoplasmic (amod)
given tri (nsubjpass)
run-in during (case)
undergone 1999 (nmod)
months every (det)
citrate no (neg)
elevated was (auxpass)
0.2 sec (conj)
dogs 14 (nummod)
regimen at (case)
preceded pain (nmod)
$ROOT$ permeability (sent)
6 died (acl:relcl)
impairment slight (amod)
1.9 interval (dep)
been concerns (attr)
rare be (cop)
gene beclin (appos)
stage clinical (amod)
adaptation rats (nmod)
recorded symptoms (dobj)
nondyskinetic 12 (nummod)
class antagonists (appos)
society the (det)
frequency rhythms (nmod)
densities spectral (amod)
concentration their (nmod:poss)
slices hippocampal (amod)
akinesia end-of-dose (amod)
effects challenge (nmod)
potentials nerve (compound)
observed marker (nmod)
3504 644 (conj)
n=6 , (punct)
evaluated but (cc)
ead of (case)
received group (nmod)
hbsag anti-hbs (conj)
score scale (compound)
mechanisms various (amod)
sacrifice to (case)
describe paper (nmod)
centre danish (amod)
regulation channel (nmod)
require limit (xcomp)
come response (nsubj)
ct and (cc)
normoammonaemic patient (nsubj)
occurred discontinued (advcl)
observed centers (nmod)
found sent (conj)
chf iv (nummod)
increments mg/kg (nmod)
nine degeneration (nmod)
administered times/week (nmod:tmod)
affect associated (advcl)
develop lids (dobj)
antigen hiv (compound)
bradykinesia , (punct)
receptor gamma-aminobutyric (amod)
control chemotherapy (nmod)
rates nephrotoxicity (nmod)
appeared schedule (nmod)
indications offer (acl:relcl)
mg 3 (compound)
neurotransmitter of (case)
embryos of (case)
autoimmune , (punct)
modes administration (nmod)
time transit (compound)
matched were (auxpass)
inhibition induced (acl)
enhances that (mark)
kind corticoid (nmod)
5.4 from (case)
be , (punct)
compensates effects (nmod)
hypotension block (compound)
or min (conj)
elevations subjects (nmod)
antagonists of (case)
nature results (dep)
5-fluorouracil leucovorin (conj)
assays forming (compound)
localization protein (nmod)
induction dermatitis (nmod)
discussed strategies (nsubjpass)
proves alternative (xcomp)
increased affected (conj)
smaller larger (conj)
alterations properties (nmod)
showed normal (parataxis)
smoking cigarette (compound)
demonstrated spect (nsubj)
began months (nmod)
crisis installing (amod)
bleeding gi (compound)
reduction long-lasting (amod)
problem diseases (nsubj)
transition dose (nmod)
capable reversing (advcl)
suppression contractility (nmod)
measured level (dobj)
scintigraphy , (punct)
protected days (nmod)
dex g/kg/day (dep)
is conclusion (nmod)
ip nmol/kg (compound)
effect concentration (conj)
safety for (case)
step . (punct)
ilk ( (punct)
metabolites by (case)
drug tachycardia (nmod)
event to (case)
pain in (case)
factor factor/vascular (amod)
$ROOT$ hallucinations (sent)
aggressiveness disorder (conj)
mg/dl p=0.01 (appos)
% 70/99 (appos)
mgkg 40 (nummod)
phosphorylation on (case)
medialipid or (cc)
data experimental (amod)
cyp27 ) (punct)
shell accumbal (amod)
tests for (case)
beats more (amod)
infusion propofol (compound)
smoking cocaine (nmod)
studies general (amod)
occurs variety (nmod)
injected animals (nmod)
needed , (punct)
= mg/kg (dobj)
ro4368554 and (cc)
excitation electromyographic (amod)
tone increased (amod)
resembled histologically (advmod)
rate or (cc)
polypeptide human (amod)
estimated cases (xcomp)
infusion 2-week (amod)
beating , (punct)
0.001 p (dep)
rate cr (compound)
trinitrate glyceryl (compound)
pregnancy advanced (amod)
induced end (nmod)
persistent were (cop)
taken conclusions (nsubjpass)
bayes ' (case)
demonstrated acetaminophen (nsubjpass)
comparisons all (det)
each with (case)
14c-41 099 (nummod)
associated the (det)
ranges antidepressants (nmod)
encountered duration (nsubjpass)
vagotomised previously (advmod)
treatment apomorphine (compound)
capillary to (case)
minor that (mark)
occurs cerebrum (nmod)
ointment % (amod)
side-effects main (amod)
influenced responses (nsubjpass)
increasing maintain (advcl)
treatment hydration (nmod)
right- and (cc)
treated betaine (nmod)
myopathy inflammatory (amod)
compared events (nmod)
rep cancer (compound)
46 % (appos)
patients preferred (acl:relcl)
mg/kg/b.w./day ( (punct)
degree but (cc)
found incidence (dobj)
regained which (nmod)
last weeks (nmod:tmod)
reduction usually (advmod)
maintained measure (nmod)
alf=0/35 p<0.01 (dep)
calculated dosage (nsubjpass)
correlated can (neg)
receptors shell (compound)
hypotension less (advmod)
maintenance rhythm (nmod)
loss delayed (amod)
blocker arb (appos)
stimulate however (advmod)
hyperlipidemia with (case)
beginning challenge (nmod)
recurrence to (case)
similar signs (nsubj)
as time (nmod)
suggested promoted (ccomp)
injections doses (nmod)
rats germfree (amod)
patients isolated-hit (amod)
9 of (advmod)
% 16,459 (appos)
$ROOT$ oropharynx (sent)
syndrome cardiac (amod)
exhibited mortality (dobj)
employed routinely (advmod)
protein anti-apoptotic (amod)
levels percentage (conj)
pcpa ( (punct)
drinks of (case)
mazindol with (case)
mechanisms potential (amod)
glomerulonephritis a (det)
enalapril . (punct)
control to (case)
protected syndrome (nmod)
showed weeks (nmod)
alpha prostaglandin (compound)
% 1 (nummod)
eye one (nummod)
myoclonus of (case)
that site (nmod)
defects birth (compound)
subjects subjects (appos)
showed marked (dep)
polyuria lithium-induced (amod)
delayed which (nmod)
feet his (nmod:poss)
enhancement contrast (compound)
dose qt (conj)
marmoset mptp-lesioned (amod)
appears , (punct)
dose given (acl)
mg/l 3.6 (compound)
week a (nummod)
micrograms = (dep)
receptors tract (nmod)
response contractile (amod)
preserved rats (nmod)
dog of (case)
candidate a (det)
reinforcement food (compound)
increased output (conj)
granules secretory (amod)
pain dental (amod)
contained carcinoma (dobj)
patients consumed (acl:relcl)
indicating sensitive (ccomp)
inhibitors fluoxetine (dep)
assessment test (conj)
conjugates n-(2-hydroxypropyl)methacrylamide (compound)
treated care (nmod)
sought use (nmod)
experiments three (nummod)
cox-i. the (det)
index with (case)
low-osmolar nonionic (dep)
oil essential (amod)
nmdar and/or (cc)
patients dialysis (compound)
aimed present (xcomp)
patients filled (acl:relcl)
indinavir of (case)
precise are (cop)
characteristics significance (acl:relcl)
practices uk (nmod)
intervals same (amod)
infusions factor (nmod)
injections methamphetamine (nmod)
occurrence on (case)
mutation point (compound)
degree although (mark)
infiltration cns (compound)
patients g/dl (nmod)
weight low-molecular (amod)
1mg/kg ) (punct)
region adjacent (amod)
hit with (case)
200 0 (compound)
degrees radial (amod)
occupation tonic (amod)
disease dyskinesia (nmod)
levels between (case)
use substance (compound)
allocated number (conj)
taken uncertain (ccomp)
transplantable one (nummod)
injury proportion (nmod)
arrhythmia . (punct)
2000 2002 (prep)
study specimens (nmod)
42.5 ( (punct)
mechanism accounting (acl)
is therapy (attr)
concentrations serum (nmod)
durations symptom (compound)
found mellitus (nsubjpass)
mg/kg 31 (nummod)
decrease acid (nmod)
bicuculline k-8644 (conj)
bupivacaine diacetate (conj)
mg/kg 400 (nummod)
therapy short-term (amod)
oc cn (conj)
torr and (cc)
sex dose (conj)
involved commonly (advmod)
interval 95 (compound)
manifested most (nsubj)
avoided falls (nsubjpass)
method location (compound)
findings epileptiform (amod)
monitor and (cc)
sensitivity strains (nmod)
pain acute (amod)
were groups (nmod)
scale patient-reported (amod)
detect fpd (nsubj)
infection grade (compound)
increase unexpected (amod)
capacity cystometric (amod)
eating food (dobj)
lithium from (case)
application rats (nmod)
increased gradually (advmod)
encephalopathy ? (punct)
patients hypercalcemias (nmod)
abnormalities dysfunction (conj)
was fibres (nmod)
duct drug-associated (amod)
iowa not (neg)
attention mnemonic (conj)
normalized 8 (nmod)
greatest lowest (conj)
lost while (mark)
disarrangement necrosis (conj)
are effects (nmod)
(r)-alpha-methylhistamine ramh (appos)
demographics possibilities (conj)
= 24 (dep)
role significant (amod)
thrombectomy and (cc)
manifested group (nmod)
morbidity ct (nmod)
tci via (case)
ester inhibitor (appos)
days versus (cc)
ain ) (punct)
associated responses (nmod)
derivative nefiracetam (nsubj)
depression segment (compound)
present juices (nmod)
as tobramycin (nsubj)
rfca ( (punct)
region formation (nmod)
than reports (nmod)
erythromycin , (punct)
position another (det)
cases 5 (nummod)
rhigf-i micrograms/d (appos)
correlate parameters (nmod)
myelosuppression , (punct)
mph at (case)
formation osteoid (nmod)
t3 ) (punct)
nitroprusside after (case)
releasing tachykinins (dobj)
related dose (nmod:npmod)
abusing heroine (dobj)
small are (cop)
high as (advmod)
precipitate ciprofloxacin (nsubj)
difference be (cop)
myopathy this (det)
complicated problem (dobj)
lack and (cc)
validity the (det)
animals all (predet)
achieved goal (dobj)
health risk (conj)
linked undergo (advcl)
confirmed paraffin-sections (nsubj)
consistent profile (nmod)
features morphological (amod)
design nested (amod)
$ROOT$ predictable (sent)
change vocal (amod)
cancer pelvis (nmod)
common mood (nsubj)
micrograms/kg 5 (nummod)
examine induced (ccomp)
demonstrate cases (nsubj)
reached until (mark)
slower group (nsubj)
increases hypertension (nsubj)
ppm 200 (nummod)
cya less (amod)
ramh ( (punct)
rate objective (amod)
developed 30 (conj)
maturity sexual (amod)
completed been (auxpass)
group midline (compound)
disorders painful (amod)
task step-through (amod)
19/92 +/- (cc)
recognized tma (nsubjpass)
which after (case)
challenge levodopa (nmod)
found correlation (dobj)
administration blockers (nmod)
models arteritis (compound)
comparison crossover (amod)
activity sympathetic (amod)
acetate ppm (appos)
removed removed (conj)
controls saline-pretreated (amod)
ventricle to (case)
importance using (acl)
injections selective (amod)
developed headache (dobj)
% 1.19 (nummod)
acid txa (appos)
suppression drug-induced (amod)
register nationwide (amod)
persons risk (nmod)
morbidity or (cc)
administration dogs (nmod)
hcl cinacalcet (compound)
spasm of (case)
considered , (punct)
deafened , (punct)
depression ondansetron (nmod)
reduction recorded (acl)
alphaenac betaenac (conj)
us to (case)
confused shivering (nmod)
block amiodarone-induced (amod)
taken prescribing (advcl)
bringing together (advmod)
intoxication mixed (amod)
diet sodium (compound)
period class (nmod)
risk with (case)
concentration alpha-bungarotoxin (compound)
therapy oestrogen (compound)
creatinine urea (conj)
$ROOT$ incorporate (sent)
lna > (cc)
alternation pauses (conj)
counts in (case)
adenomas hepatic (amod)
alpha- beta-configurations (conj)
stabilized that (mark)
coxii and (cc)
started srl (nsubjpass)
exploration arm (compound)
induce catalepsy (dobj)
avoided consequently (advmod)
execution task (nmod)
120 81 (compound)
2 0.2 (compound)
push of (case)
theophylline slow-release (amod)
began thalidomide (dobj)
ceased patients (nmod)
dysfunction bioenergetic (amod)
base at (case)
lower response (nsubj)
thyroiditis to (case)
mbp hr (conj)
underwent echocardiography (dobj)
calcium fenoprofen (compound)
contact of (case)
resistance product (conj)
t-tests unpaired (amod)
alopecia paresthesias (conj)
molecules nephrin (dep)
survival pfs (appos)
response up-regulation (nmod)
angiography radionuclide (compound)
discrimination the (det)
eosinophil and (cc)
pge2 and (cc)
models as (case)
database residents (nmod)
suppress development (dobj)
risk high (amod)
levels groups (nmod)
acts this (nsubj)
neurointensivists board-certified (amod)
cases and (cc)
$ROOT$ volumetry (sent)
effects aniracetam (nmod)
increased 1.5 (nmod)
pharmacokinetics administered (advcl)
levels assessment (conj)
impaired , (punct)
-26 +/- (cc)
u/ml u/ml (dep)
effects biological (amod)
administered flumazenil (nsubjpass)
analogue the (det)
unclear . (punct)
medication dopaminergic (amod)
estimated scale (nmod)
proteins channel (compound)
decrease not (cc)
re-started mg/day (nmod)
influences prejunctional (amod)
termination study (nmod)
ige ( (punct)
indicates relationship (dobj)
developed disease (nmod)
activation regions (nmod)
showed adulthood (nmod)
mg/kg day (nmod)
ci=26.7 29.7 (prep)
discharged continued (conj)
suggestive patient (nmod)
angioedema : (punct)
fasciculations children (nmod)
had propranolol (nsubj)
effects combination (nmod)
medulla isom (appos)
groups between (case)
status valves (conj)
become arrhythmic (acomp)
treatment diethylstilbestrol (compound)
inhibitor methylation (nmod)
considered target (nmod)
= .0001 (dobj)
measures two (nummod)
reversed chemoconvulsants (nmod)
relative changes (nmod)
duration catalepsy (nmod)
= 6 (dep)
hyperkalemia hypoaldosteronism (conj)
values frequencies (conj)
predict whether (mark)
associated carcinoma (nmod)
protected appeared (advcl)
blockade losartan (nmod)
months olanzapine (appos)
pms five (nummod)
swelling and (cc)
eliminated is (auxpass)
aura ) (punct)
features pathophysiologic (amod)
thalidomide to (case)
injections variability (appos)
scores updrs (compound)
worsen , (punct)
demonstrate data (nsubj)
sensation head (appos)
facilitation . (punct)
six two (conj)
proteinuria for (case)
hyper-responsiveness lymphocytes (nmod)
indicates evidence (nsubj)
nephropathy patients (nmod)
june september (conj)
experienced sucrose (dobj)
response injections (nmod)
$ROOT$ conclusion (sent)
cd-832 micrograms/kg/min (appos)
hexachloride by (case)
cases our (nmod:poss)
stimulation of (case)
decrease less (amod)
incomplete data (nsubj)
therapy c. (nmod)
vaccine b (compound)
blockers tested (amod)
latency escape (compound)
norleucine methionine (conj)
development and (cc)
cords animals (nmod)
proteinuria linked (acl)
claimed glutamate (nsubjpass)
deterioration cognitive (amod)
incapacitated subjects (nsubjpass)
48-week dose-related (dep)
attention visual (amod)
hypersensitivity p (nmod)
time delivery (nmod)
sd ) (punct)
frequency breathing (compound)
man chinese (amod)
caa not (cc)
instances no (det)
transport to (mark)
mechanism enhances (acl:relcl)
observed drinkers (nmod)
52 6 (compound)
one % (appos)
level within (case)
examinations ophthalmological (amod)
recall in (case)
focused factor (advcl)
potency metoprolol (compound)
developed candidiasis (dobj)
derivative anxioselective (amod)
impaired because (mark)
found t (nmod)
patient same (amod)
nifedipine verapamil (conj)
release vitro (advmod)
compared none (nmod)
influences genetic (amod)
mg. 1 (nummod)
diameters carotid (nmod)
synergy of (case)
lability and (cc)
aap to (case)
glyburide for (case)
low incidence (nsubj)
improve theoretically (advmod)
effects processes (nmod)
experiences acquired (acl)
therapy monotherapy (conj)
prevention treatment (nmod)
tilts to (case)
mediated and (cc)
impairment motor (compound)
' 2'3 (amod)
hypertrophy dilatation (conj)
factor implicated (acl)
alteration an (det)
levels transaminase (compound)
feared was (auxpass)
carcinoma were (cop)
produce enflurane (nsubj)
thrombocytopenia hit (conj)
atria rat (compound)
allocated bendrofluazide (dep)
cause hepatitis (dobj)
alleviated completely (advmod)
bzds/rds of (case)
investigates associated (ccomp)
cr pet (nmod)
retention avoidance (compound)
negligible lipoproteinuria (nsubj)
absence glomerulosclerosis (nmod)
effect nephrosclerosis (nmod)
gain they (nsubj)
exhibited relationship (nsubj)
anorexia and (cc)
days the (det)
requires it (nsubj)
female required (acl:relcl)
secretion basal (amod)
similar different (conj)
secreted astrocytes (nmod)
production . (punct)
e1 of (case)
dose-dependent prevented (conj)
outpatients hyperprolactinemia (nmod)
carboplatin and (cc)
potential normal (amod)
administration quinine (nmod)
pharmacokinetics plasma (compound)
loss necrosis (conj)
sap ( (punct)
reduced controls (advcl)
amino-nucleoside pan (appos)
kingdom united (compound)
human and (cc)
venous arterial (conj)
changes dna (nmod)
baseline above (case)
prazosin while (case)
days implantation (dep)
choice syndrome (ccomp)
cancer rr (dep)
diltiazem ) (punct)
persisting patient (nmod)
bradycardia beats/min (compound)
drugs given (acl:relcl)
period post-training (amod)
projections serotonin (compound)
partition membranes (nmod)
vasospasm of (case)
randomized men (dep)
compared duration (nsubjpass)
sample addicts (nmod)
treated dialysis (nmod)
defective dna (nsubj)
therapy hyperosmolar (amod)
needed than (mark)
brains subjects (nmod)
disease = (appos)
that exercise (nmod)
weeks 12 (nummod)
1500 - (punct)
refractory or (cc)
regeneration the (det)
dose except (case)
expression cox-i. (nmod)
investigating efficacy (dobj)
found substances (nsubjpass)
levels micrograms/ml (nmod)
discontinuation dose (nmod)
eyes 11 (nummod)
grade p=0.01 (appos)
retention bladder (compound)
group 3-hydroxy (amod)
0.38 +/- (cc)
include symptoms (nsubj)
seems cause (xcomp)
had have (advcl)
normalization a (det)
perfusion antagonists (nmod)
reactive platelets (nmod)
corrected been (auxpass)
ligand receptors (nmod)
described paper (nmod)
properties rate (conj)
development mice (nmod)
analogs restricted (amod)
hypothesis reaction (ccomp)
demonstrated been (auxpass)
modify and (cc)
hypersensitivity a (det)
levels corticosterone (compound)
concentration ratings (conj)
degenerated and (cc)
questionnaires to (case)
membranes the (det)
actions in (case)
theophylline oral (amod)
reversed true (conj)
analog an (det)
hands , (punct)
included drugs (nmod)
degree homology (nmod)
$ROOT$ recommend (sent)
reversed can (aux)
n/n=9/26 4.336 (conj)
incidence hypotension (nmod)
effect in (case)
genotypes of (case)
drug adverse (amod)
patient in (case)
excreted did (advcl)
doctors of (case)
application intravenous (amod)
assumed maximal (ccomp)
sample this (det)
cases this (amod)
immunohistochemistry with (case)
p=0.39 ) (punct)
failed abolished (advcl)
included study (nsubj)
nystagmus . (punct)
shown also (advmod)
minimum with (case)
remoxipride metabolites (conj)
prescribed widely (advmod)
randomization for (case)
induced apnea (dobj)
nonusers = (dep)
difficult more (advmod)
volunteered , (punct)
withheld was (auxpass)
5711 +/- (cc)
binding rifampin (nmod)
atypicality including (case)
variations and (cc)
scarce were (cop)
thromboembolism ( (punct)
potentiate effects (dobj)
decrease s (appos)
evoked carbachol (nmod)
mechanisms control (compound)
$ROOT$ averaged (sent)
cardiotoxin monkeys (nmod)
ph 7.4 (nummod)
microg/ml microg/ml (conj)
disappearance in (case)
participant study (compound)
occurred became (advcl)
dosages effective (amod)
symptomatic were (cop)
deficit functional (amod)
falling ) (punct)
episodes hypotensive (amod)
eyelids of (case)
bp bp (appos)
decrease = (dep)
treatments new (amod)
mmhg 53 (nummod)
rats pentobarbital-anesthetized (amod)
hamartoma . (punct)
develop ultimately (advmod)
lowers pressure (dobj)
70 to (advmod)
placed site (nmod)
remained thirsty (acomp)
dilation using (acl)
5.4 1.1 (nummod)
choose , (punct)
neurotoxicity children (nmod)
follow-up days (nmod)
impairment performance (compound)
eps due (amod)
% 30 (nummod)
ng 100 (nummod)
response lasting (acl)
display that (mark)
temperature behavioral (conj)
ranged 2.8 (nmod)
frequencies and (cc)
negative anti-hcv (nsubj)
therapy drugs (nmod)
obtained shortly (advmod)
seen often (advmod)
effects varying (acl)
assessments for (case)
seems implicated (advcl)
plasma ph (conj)
prevent succinylcholine (nmod)
fibrillation and (cc)
activity neuron (compound)
initiated therapy (nsubjpass)
shown nascis (nmod)
injury epinephrine-induced (amod)
atropine mg/kg (appos)
responses responses (conj)
areas compatible (amod)
complained also (advmod)
effacement with (case)
mediated methylphenidate (nmod:npmod)
contractility and (cc)
event on (case)
exhibited patients (nsubj)
derivative its (nmod:poss)
thyroid and (cc)
3.8/100,000 ) (punct)
deficits potential (amod)
occurrence of (punct)
fit genotype (nmod)
response analgesic (amod)
result could (aux)
ndi lithium-induced (amod)
alterations against (case)
normal revealed (conj)
seen authors (nmod)
august 28 (compound)
doses titrated (amod)
activity nnos (compound)
, preoperatively (advmod)
seven of (case)
stop . (punct)
communicated been (auxpass)
markers fibrinolysis (compound)
lowering plus (cc)
facilitated and (cc)
deterioration a (det)
lower binding (nsubj)
significant , (punct)
observed patients (nsubjpass)
blunted but (cc)
report increased (ccomp)
sustained deficits (dobj)
suppressed progression (dobj)
given mg. (punct)
use drugs (nmod)
bupropion carbimazole (conj)
appetite symptoms (conj)
giving value (dobj)
protect effects (nmod)
measures those (nmod)
23.7 ( (punct)
progression glomerulosclerosis (nmod)
disrupted absent (conj)
polfa vupral (compound)
2 5 (prep)
proportion cases (nmod)
failed demonstrate (xcomp)
14 11 (nummod)
tolerated was (auxpass)
injection intracranial (amod)
show resulting (advcl)
patient volunteer (conj)
handicapped are (cop)
available analysis (nmod)
microl , (punct)
8 12 (conj)
shown has (ccomp)
occurred jaundice (nsubj)
attenuated clentiazem (nsubj)
ibs in (case)
27 range (dep)
> common (amod)
blocked (-)-propranolol (nmod)
time 0 (nummod)
all virtually (advmod)
former stable (amod)
use tachyarrhythmias (nmod)
dse ( (punct)
alpha epoetin (compound)
carried were (auxpass)
gynecomastia testosterone (conj)
patients candidates (acl:relcl)
loading of (case)
remained compared (advcl)
ce ) (punct)
part later (amod)
re-challenged however (advmod)
age race/ethnicity (conj)
cause syndrome (nmod)
test , (punct)
methylphenidate by (case)
pretreated patients (dep)
offspring adult (amod)
perfusion treatment (appos)
therapy cisplatin (compound)
deficiency bbb (nmod)
more not (neg)
famotidine of (case)
treated obtained (conj)
discharges cortical (amod)
respect reversibility (nmod)
aggravating edema (dobj)
caused overstimulation (nmod)
less less (acl:relcl)
those ) (punct)
glycol and (cc)
despair behavioral (amod)
content prl (compound)
venous the (det)
interaction pharmacokinetic (amod)
schedules mg/kg (dep)
mouse-1 nociceptin (compound)
play expression (nsubj)
excretion urine (nmod)
some measurements (dep)
% period (nmod)
withdrawal without (case)
sinusitis bacterial (amod)
allows testing (dobj)
pulses 1,800 (nummod)
cisplatin and (cc)
patent aids (compound)
showed displays (ccomp)
dl-sotalol than (case)
90/htn control (conj)
= 0.62 (dobj)
value prevention (nmod)
tie a (det)
different were (cop)
mediated rise (nmod)
organisms and (cc)
implantable fully (advmod)
superiority the (det)
control on (case)
remained patient (nsubj)
patient shown (acl:relcl)
caused potentially (advmod)
6 cases (nmod)
weeks initiating (advcl)
expressed slope (nmod)
hp ) (punct)
element contributing (acl)
studied man (dobj)
observed discontinuation (nmod)
intake levodopa (compound)
postulate . (punct)
classifications , (punct)
excreted , (punct)
effect ritanserin (nmod)
cck-8-se range (dep)
min until (case)
immunization after (case)
remission into (case)
transient or (cc)
haloperidol ) (punct)
rate 12-hour (amod)
polyuria (li)-induced (punct)
cancer associated (amod)
chicks coniine-treated (amod)
period six-month (compound)
inhibitors cyp2d6 (compound)
predictor pfs (nmod)
range 33 (appos)
8.6 0.9 (conj)
infants three (nummod)
patients undergoing (acl)
determined exerted (advcl)
underwent associated (advcl)
increases addition (nsubj)
rigidity rats (nmod)
% 0.25 (compound)
layer included (acl:relcl)
manner double-masked (amod)
effect levodopa (nmod)
guidelines clinical (amod)
model prove (acl:relcl)
pulse cyclophosphamide (conj)
constriction visual (amod)
occlusion the (det)
lower however (advmod)
eruption is (cop)
agonist pergolide (dep)
hypometabolism with (case)
pointes treatment (nmod)
profiler rt2 (compound)
$ROOT$ varies (sent)
therapy nvp (compound)
admitted factor (advcl)
diagnosing patients (nmod)
range ; (punct)
mechanisms discussion (compound)
background hampered (dep)
severity encephalopathy (nmod)
assessed age (nmod)
tnf-alpha and (cc)
microsomes liver (compound)
asked repeat (xcomp)
patients especially (advmod)
reproduced ; (punct)
site modulation (nmod)
reduction concomitant (amod)
treated imipramine (nmod)
acc-9653 i.v. (compound)
detected % (nmod)
expression depressed (amod)
identify monitor (conj)
studied correlate (advcl)
observed parkinsonism (nsubjpass)
sensation forearm (nmod)
0.03 less (advmod)
thalidomide plus (cc)
angiography route (nmod)
affected whether (mark)
steroids alpha,3 (nmod)
development time (nmod)
reported aplasia (nsubjpass)
exposure caffeine (compound)
syndrome male (nmod)
lids developing (amod)
recognized but (cc)
stress hepatotoxicity (conj)
compared exposure (dobj)
nurse registered (amod)
signaling fractalkine (compound)
failed forms (dobj)
instilled gentamicin (nsubj)
therapy minimal (amod)
once least (advmod)
protectors potential (amod)
symptoms emetic (amod)
higher pain (nmod)
content basis (nmod)
documented effect (nsubj)
tested each (nmod)
visits consecutive (amod)
levels intrarenal (amod)
used fenfluramine (dobj)
presence only (advmod)
tone , (punct)
elements blood-brain-barrier (nmod)
heroin intravenous (amod)
observed compared (prep)
combination another (det)
(-)-propranolol by (case)
associated infusion (nsubjpass)
pregnane-20-ones 3 (nummod)
aspirin day (nmod:tmod)
aggravated exposure (nsubj)
inhibition lead (nmod)
opse trend (conj)
puncture lumbar (amod)
placebo 904+/-434 (appos)
asymmetry and (cc)
induces effects (dobj)
thickening coarsening (conj)
intralipid ) (punct)
prior withdrawal (nmod)
lost followed (advcl)
structure in (case)
contributed could (aux)
thiols in (case)
tacrolimus such (case)
included outcomes (nsubj)
derivative sirolimus (nmod)
observations effects (nmod)
activity hydrochloride (nmod)
hepatitis quinidine (compound)
are discussed (conj)
effects inhibition (nmod)
type complication (nmod)
ac for (case)
strengthen evidence (dobj)
pd ) (punct)
dose received (acl)
developed lethargy (dobj)
perimetry goldmann (compound)
diethylstilbestrol with (case)
had purpura (dobj)
zyban ) (punct)
mif ( (punct)
impotence male (amod)
elicited hypotension (dobj)
153 +/- (cc)
syndrome microangiopathy (conj)
adenomas hyperplasia (conj)
group users (nmod)
saccades of (case)
stimulated neutrophils (nsubjpass)
occurs tolerance (attr)
suggestion an (det)
development treatments (nmod)
technique for (case)
unable , (punct)
patients insufficiency (nmod)
proved histologically (advmod)
$ROOT$ syndrome (sent)
appeared if (mark)
electroshock mice (nmod)
factors definitive (amod)
erk1/2 of (case)
enhances while (mark)
$ROOT$ live (sent)
rated monthly (advmod)
gain treatment (nmod)
seems b (nsubj)
findings resonance (compound)
b of (case)
c57bl/6 cd1 (conj)
decrease behavior (nmod)
fibrillation lone (amod)
decrease cell (compound)
acid (2r,4r)-4-aminopyrrolidine-2,4-dicarboxylate (conj)
hypotension l-dopa (nmod)
possible ingested (advcl)
syndrome unusual (amod)
leg in (case)
suspension w/v (compound)
activity acid (nmod)
sample ml (amod)
tetany . (punct)
lasting 2h (nmod)
oc for (case)
mirror effects (nsubj)
inhibitor combined (acl)
manipulated one (nmod)
methods selected (appos)
elevation , (punct)
exposure thiabendazole (nmod)
tested administered (xcomp)
atpase na+-k+ (compound)
contribution receptors (nmod)
olanzapine with (case)
min-1 g (compound)
rats pigs (conj)
undergone periods (dobj)
using collagenase (dobj)
treatment disorders (nmod)
gum the (det)
asynergy of (case)
disease lid (conj)
electroencephalography on (case)
month for (case)
compared development (nsubjpass)
participants oc (compound)
increase ck (compound)
develop loss (dobj)
mg./kg ) (punct)
effects tremor (appos)
control or (cc)
anemic leukopenic (conj)
decrease fasciculation (dobj)
capnocytophaga casei (conj)
risk prevalence (conj)
tetrapeptide the (det)
5-hydroxytryptamine ) (punct)
hour ( (punct)
$ROOT$ probable (sent)
treatment nitrendipine (nmod)
adjuvant a (det)
level population (nmod)
have prognosis (dobj)
taking cpa/ee (dobj)
phentolamine with (case)
occur when (advmod)
ratio respiratory (amod)
identify suspicions (dobj)
centers 24 (nummod)
$ROOT$ processed (sent)
demonstrated moreover (advmod)
mice but (cc)
have dogs (nmod)
mimicking accident (dobj)
escalated doses (nsubjpass)
pretreatment extract (nmod)
course damage (nmod)
50 < (advmod)
atp for (case)
type not (neg)
induced microm (nmod)
weeks % (appos)
% 0.05 (compound)
treatment cardiomyopathy (nmod)
toxic measured (advcl)
prove useful (xcomp)
2.58 of (case)
57.9 . (punct)
exhibited retardation (dobj)
intermediate is (cop)
delayed onset (nsubjpass)
observed on- (nmod)
suggest presentation (nsubj)
necessary seizures (nmod)
hepatotoxicity serious (amod)
combination fixed-dose (amod)
g and (cc)
cardiomyocytes abnormal (amod)
days 20 (nummod)
requires . (punct)
provided education (dobj)
need intact (xcomp)
hydrochloride bupivacaine (compound)
hypotensive block (nmod)
chemotherapy from (case)
subgroup the (det)
phosphate supplemental (amod)
year 35 (nummod)
using it (dobj)
inability amiodarone (nmod)
blockade isomers (nmod)
depletion prolonged (amod)
remission of (case)
one all (quantmod)
suitable use (nmod)
adducts greater (acl:relcl)
change percent (amod)
hypertension injury (conj)
nms ) (punct)
drugs benzamide (compound)
treatment ritonavir (compound)
exposure without (case)
taking old (advcl)
revealed kinase (dobj)
clues the (det)
subjected craniotomy (nmod)
values parameters (nmod)
showed since (mark)
gemcitabine mg/m(2 (appos)
investigated patients (nmod)
promote alternatively (advmod)
symptomatology examination (conj)
patient ie (nmod)
l(-1 ) (punct)
defined children (nmod)
lesion rats (nmod)
showed registrations (nsubj)
efficacy ro15 (nmod)
achieved % (nsubj)
pain than (dep)
(phe)-induced phenylephrine (nmod:npmod)
micrograms/ml 52 (nummod)
testing serologic (amod)
conditions control (amod)
prevented mk-801 (nsubj)
period group (nmod)
diazinon to (case)
divided then (advmod)
maintaining in (mark)
minutes infusion (nmod)
suffering dysfunction (nmod)
reducing proteinuria (dobj)
antrum along (cc)
development strains (nmod)
concentrations relevant (amod)
threshold convulsive (amod)
% rats (nmod)
injection g (compound)
noticed recovered (advcl)
volumes higher (amod)
had time (nmod)
interventions major (amod)
decrease 12%-21 (nummod)
is summarize (xcomp)
treated lisinopril (nmod)
year 31 (nummod)
neurons decarboxylase (compound)
cells cancer (compound)
period 4-week (amod)
ml/s 1.68+/-0.11 (nummod)
rate was (cop)
receiving control (nmod)
brought room (nmod)
areas exposure (nmod)
injected chx (nsubjpass)
mice 10 (nummod)
evaluate capability (dobj)
caused increase (dobj)
patients 216 (nummod)
contribution the (det)
(+/-)-pg-9 [ (punct)
represents option (dobj)
animals less (amod)
iiib cancer (conj)
metabolism different (amod)
nephropathy ifosfamide (compound)
products the (det)
disorder either (cc:preconj)
80.8 +/- (cc)
elevation persistent (amod)
pressure his (nmod:poss)
agonist , (punct)
suggest authors (nsubj)
longer groups (nmod)
gtn but (cc)
induced dl-sotalol (nsubj)
dependent that (nsubj)
peak and (cc)
metabolized are (auxpass)
boluses diamorphine (nmod)
lymphoma hl (appos)
n/n=62/92 and (cc)
portion heart (nmod)
resistance failure (nmod)
achieves induces (conj)
syndrome hepatorenal (amod)
result these (nmod)
replace to (mark)
dermatitis . (punct)
seen contrast (nmod)
allows evaluation (dobj)
prolongs argatroban (nsubj)
40 36 (compound)
difluoromethylornithine of (case)
permitted escalation (nsubjpass)
group ketoprofen (compound)
stressed lack (nmod)
inhibitor converting (compound)
effect elevation (nmod)
complication bleeding (compound)
difficult essential (conj)
test vitro (advmod)
reduced allopregnanolone (nsubj)
problem ? (punct)
woman complaining (acl)
reperfusion intestine (nmod)
alkaloid has (acl:relcl)
underwent examinations (dobj)
injection bortezomib (compound)
7 7 (conj)
correlate dose (nsubj)
centre the (det)
tuberculosis maternal (amod)
data possibility (nmod)
speculated be (auxpass)
characteristics structural (amod)
reduced predominantly (advmod)
preparation a (det)
relies control (nmod)
used or (advmod)
decreased months (nmod)
biological pharmacological (conj)
volunteer from (case)
toxicity bcnu-induced (amod)
findings reported (acl)
progression duration (conj)
preparation in (case)
important control (xcomp)
diarrhea grade (compound)
patients virtually (advmod)
seizures amphotericin (compound)
extrarenal as (cc)
patients non-pd (amod)
performed mmecs (nmod)
reverses mg/kg (nsubj)
min reperfusion (nmod)
$ROOT$ suppression (sent)
certain . (punct)
affect negatively (advmod)
decreased time (dobj)
inhibitor smad3 (compound)
journals non-indexed (amod)
= months (dobj)
intervals r-wave-to-r-wave (amod)
cd-832 of (case)
vesicles present (amod)
$ROOT$ raises (sent)
achieve effects (dobj)
blockers quinine (appos)
abandoned . (punct)
$ROOT$ quantified (sent)
map , (punct)
support effect (dobj)
paralysis transient (amod)
asterixis the (det)
cns ) (punct)
procedure surgical (amod)
behavioral both (cc:preconj)
down-regulation . (punct)
studies all (predet)
band gap43-ir (amod)
mapd in (case)
activation by (case)
uncertain still (advmod)
time min (nmod)
years 63+/-12 (nummod)
alpha-2b ifn (compound)
2e1 liver (compound)
toxic dams (nmod)
velocity and (cc)
capable thus (advmod)
assays quantitative (amod)
4.2 ) (punct)
acting concentration (nmod)
change scr (nmod)
bupivacaine ml (nummod)
quinine sulfate (compound)
preexposure gspe (compound)
underwent ct (dobj)
hiccups possible (amod)
participate mediate (conj)
thinning layer (nmod)
patients pediatric (amod)
duration dog (nmod)
damages against (case)
provide behavior (nsubj)
years study (nmod)
high ( (punct)
monitoring drug (compound)
responsible problems (nmod)
ml/100g/min 45.9 (nummod)
duct child (nmod)
outflow in (case)
group pretreatment (amod)
opioids potency (nmod)
epilepsy rat (nmod)
variation mice (nmod)
course developing (advcl)
terminated were (auxpass)
reduced only (advmod)
compared scans (nmod)
nd ) (punct)
effects all (det)
control ( (punct)
occurs adulthood (nmod)
prerequisite a (det)
administration captopril (nmod)
serological of (case)
best requested (advcl)
effect whereas (mark)
54 ) (punct)
revealed imaging (nsubj)
regulation betaine (nmod)
19.9 2.5 (conj)
implies but (cc)
reversed injection (nsubj)
phenomenon new (amod)
promote , (punct)
decrease min-1 (nmod)
microangiopathy hypertension (conj)
reduced % (nmod)
treated drugs (nmod)
effect combined (acl)
inhibitor 3a4 (compound)
sarcoma . (punct)
precipitated patients (nmod)
risk on (case)
episodes recurrent (amod)
inhibition phosphatase (nmod)
stimulation programmed (amod)
doses cocaine (nmod)
invited were (auxpass)
cvd of (case)
as compounds (nsubj)
administered fenoldopam (dobj)
diagnosed earlier (advmod)
cords spinal (amod)
msg ): (punct)
reactions % (appos)
restoration the (det)
9.1 ci (nsubj)
affected neither (nsubj)
confirmed not (neg)
thalidomide or (cc)
electrocardiograms distributed (acl)
treatment epilepsy (nmod)
suspicion injury (nmod)
surgery interventions (conj)
naloxone by (case)
complications major (amod)
levels tpa (compound)
35 +/- (cc)
vascular renal (conj)
cannulae peripheral (amod)
> icc (nsubj)
treated being (auxpass)
implant a (det)
non-txg ) (punct)
time half (amod)
support ( (punct)
legs in (case)
electrocardiogram outcomes (conj)
splenium callosum (nmod)
stillbirth with (case)
1- 2-wk (conj)
val/hctz mg (appos)
syndrome acidosis (conj)
treated disappearance (nmod)
reversibility with (case)
0.26 , (punct)
established studies (nsubj)
induce injury (dobj)
lifetime lifetime (amod)
rats doxorubicin-induced (amod)
rare myopathy (nsubj)
toxic administered (advcl)
icterus hyperbilirubinemia (conj)
method symptoms (nmod)
propensity the (det)
conclusions demonstrated (appos)
diseases cystic (amod)
studied contractility (nsubjpass)
oxytocin to (case)
irritability muscular (amod)
suggest discouraged (ccomp)
methylprednisolone cisplatin (conj)
initiated should (aux)
argatroban plasma (compound)
demonstrated testing (nsubj)
evaluated applicators (nmod)
females 7 (nummod)
permeability/injury increased (amod)
showed children (nsubj)
secreted tubules (nmod)
dosage therapeutic (amod)
micromol/l ( (punct)
siat to (case)
patients did (acl:relcl)
concluded behaviour (nmod)
skf the (det)
2.6 -5.0 (compound)
active more (advmod)
buffer with (case)
pathogenesis prevention (conj)
factors blood (compound)
recommended avoid (xcomp)
have performed (xcomp)
function measured (acl)
treatment antiepileptic (amod)
mg/m2 patients (nmod)
reduces female (nmod)
september 1 (nummod)
drinking volume (conj)
$ROOT$ noticed (sent)
cn ( (punct)
alpha- and (cc)
interval not (neg)
expression subunits (nmod)
associated examined (conj)
0.1 0.13 (conj)
shown addition (nmod)
node and (cc)
agsd of (case)
search reports (nmod)
glucose , (punct)
initial to (mark)
developing of (mark)
protocols in (case)
micrograms/kg ) (punct)
recognized application (nmod)
reviewing slides (dobj)
ameliorated perfusion (nsubj)
evoked responses (nsubjpass)
mechanisms promotion (nmod)
shortened nra0160 (nsubj)
remedy a (det)
$ROOT$ remission (sent)
circuitry in (case)
reported glaucoma (nmod)
progress . (punct)
syndrome reconstitution (compound)
likely caused (xcomp)
enzyme inhibitor (appos)
women . (punct)
fingers right (amod)
tie2-cre;loxp-egfp the (det)
application the (det)
had seven (nsubj)
safety n-butyl-deoxynojirimycin (nmod)
seen reactions (nsubjpass)
preferable lidocaine (nmod)
heterogeneity clinical (amod)
parameters various (amod)
finding unusual (amod)
use opioid (compound)
duration longer (amod)
brigham at (case)
occur variability (nmod)
investigates effects (dobj)
concentration folate (compound)
backcrossing by (case)
agents angiogenic (amod)
seizures absence (compound)
given p.o. (advmod)
ci 0.26 (nummod)
resulted stimulation (nsubj)
nt-probnp ( (punct)
space subarachnoid (amod)
coagulation disseminated (amod)
starting procedure (nmod)
address patients (nmod)
increase notable (amod)
days 42 (nummod)
cotrimoxazole , (punct)
bau mg/kg (dep)
arrhythmias warning (compound)
follow-up 3 (dep)
ibpb before (case)
surrounding nerve (dobj)
angiography of (case)
model useful (amod)
hypoplasia bone (compound)
4107 meq (conj)
one cases (nmod)
mediates dopamine (nsubj)
banks eye (compound)
it-methotrexate arabinoside (conj)
analogs pregs (nmod)
ester octapeptide (conj)
have ? (punct)
different content (nsubj)
characterization . (punct)
after especially (advmod)
acquainted be (cop)
variants present (acl:relcl)
prior aap (nmod)
methoctramine m(2)-selective (appos)
recovery renal (amod)
tachy- without (case)
medulla but (cc)
period throughout (case)
showed decreased (ccomp)
bpm 138 (nummod)
assay spectrometry (compound)
received nitroglycerin (dobj)
pairs word (compound)
mg 100 (nummod)
process delayed (amod)
increased examined (conj)
coniine of (case)
da brain (compound)
dynamics to (case)
pt ] (punct)
hours 18 (nummod)
target pharmacological (amod)
$ROOT$ design (sent)
increase unacceptable (amod)
demonstrated dogs (nmod)
treated 1 (conj)
evaluated bromocriptine (nsubjpass)
glomerulonephritis to (case)
cip past (amod)
number experts (nmod)
revealed seen (advcl)
included features (nsubj)
role anemia (nmod)
improve that (mark)
dose cisplatin (nmod)
effect azotemia (nsubj)
seeded and (cc)
continued mean (dep)
dose starting (amod)
excitotoxicity leading (acl)
produced n=5 (dep)
mri for (case)
accounted for (prep)
study to (mark)
ci ( (punct)
change essentially (advmod)
treatment as (case)
paclitaxel single-agent (amod)
attribute and (cc)
diuresis a (det)
dacarbazine dtic (appos)
mg verapamil (compound)
studies 425 (nummod)
cromakalim- and (cc)
resulted protection (nmod)
myelosuppression neutropenia (nmod)
cytopenia the (det)
identified products (nmod)
influx tissues (nmod)
rats glycosuria (nmod)
orbitofrontal cingulate (conj)
associated effects (nmod)
tgf-b , (punct)
solutions dextrose (compound)
necrosis rpn (appos)
sulpiride antagonist (compound)
significant be (cop)
level glycine (nmod)
rates s-1 (appos)
flushing , (punct)
dogs and (cc)
18 ] (punct)
am149 ) (punct)
associated damage (nmod:npmod)
evaluations on (case)
bundle the (det)
area deprived (amod)
overlooked that (mark)
media hysterosalpingography (nmod)
result lead (parataxis)
11 2 (conj)
foci/cm2 example (nmod)
identify cells (dobj)
increased consumption (nmod)
history an (det)
4.72 ) (punct)
dystrophy necrosis (conj)
displacement given (amod)
pharmacokinetics indinavir (nmod)
fall overnight (advmod)
85 +/- (cc)
currents activating (amod)
= 58 (dobj)
observed replaced (advcl)
combination morphine (nmod)
atropine kg-1 (nummod)
blocked failure (dobj)
evidence recordings (nmod)
management aggressive (amod)
occur cystitis (nmod)
function heath (conj)
therapy gemfibrozil-lovastatin (compound)
[d-pen2.5]-enkephalin ( (punct)
mg/kg 25 (nummod)
manage vasospasm (dobj)
started were (auxpass)
administered transplantation (nmod)
pbsct after (case)
proven or (cc)
own and (cc)
resulted produced (advcl)
centuries for (case)
damage size (compound)
studied fibroblasts (nmod)
wave photopic (amod)
predictive monitoring (nsubj)
strokes incident (amod)
death his (nmod:poss)
vagotomy transection (conj)
proteinuria g/day (appos)
waves the (det)
unrelieved pain (nsubjpass)
mortality rare (amod)
inventory measures (appos)
disinhibition excitability (conj)
clear is (cop)
correlation good (amod)
binding aches (nmod)
mean and (cc)
cortices surrounding (amod)
deletion inhibition (conj)
intense and (cc)
beats/min pvc (compound)
believe caused (ccomp)
follow-up after (case)
200mgkg(-1 ) (punct)
treated doses (nmod)
morphine , (punct)
scl , (punct)
subjects ) (punct)
discuss advantages (dobj)
activity enzyme (compound)
10 - (punct)
neuroleptics these (det)
sss the (det)
inventory and (cc)
systems involving (acl)
pressure cpap (appos)
evaluated twelve (nsubjpass)
phenotype pharmacokinetics (conj)
supplement to (mark)
ci 1.13 (nummod)
symptoms decline (conj)
examine influence (dobj)
patients levodopa-responsive (amod)
l-nil ; (punct)
headache side-effects (nsubj)
les the (det)
failure life-threatening (amod)
flare p<0.001 (appos)
potentiated desmethylimipramine (nmod)
mg/m2/d mtd (nsubj)
mitoq. by (case)
required recipients (nmod)
class also (advmod)
s-53482 and (cc)
drugs clonidine (nmod)
acidity pain (nsubj)
procedure interventional (amod)
loss ml (appos)
utero exo (advmod)
hypertension on (case)
ulcers aphtous (amod)
complication nephrolithiasis (nsubj)
develop deficits (dobj)
effect enalapril (nmod)
followed solvent (nmod)
stress pharmacological (amod)
overdose acetaminophen (compound)
spread poison (dobj)
opiate the (det)
therapy t (compound)
failed produce (xcomp)
acromegaly with (case)
analysis northern (amod)
presented then (advmod)
policy a (det)
fibrosis mild (amod)
symptoms treatment (conj)
implant electrode (compound)
behaviors neuropsychiatric-like (amod)
potentiation ltp (appos)
baby died (acl:relcl)
component than (case)
materials and (cc)
reverses and (cc)
antibiotics many (amod)
excretion by (case)
seems , (punct)
administration subarachnoid (amod)
evaluated action (nsubjpass)
cases weeks (nmod)
plan involved (advcl)
values compared (case)
homogenates as (cc)
anesthetics halogenated (amod)
affinities negligible (amod)
defects ) (punct)
2.6 of (case)
revealed features (dobj)
curtailed toxicities (nmod)
superoxide peroxide (conj)
demonstrate determine (conj)
largest size (nmod)
2.1 was (cop)
deficit retention (compound)
involvement bone (compound)
discontinued was (ccomp)
feature can (aux)
protection nrf2-mediated (amod)
nifedipine with (case)
concentration micromol/l (nmod)
91 72 (compound)
celecoxib both (cc:preconj)
nucleus , (punct)
surgery after (case)
vasculitis to (case)
mcpp ) (punct)
hdl-c and (cc)
ufov test (appos)
type one (nsubj)
decreased significantly (advmod)
developed rash (dobj)
discussed conditions (nsubjpass)
pretreatment heparitinase (nmod)
glaucoma history (conj)
clinical electro-diagnostic (conj)
45.6 6.6 (conj)
similarity the (det)
group c+e (compound)
addicts to (case)
6.5 0.1 (conj)
study animal (amod)
hemorrhage w-ich (appos)
remained antinociception (nsubj)
effects hypoglycaemia (nmod)
aspiration despite (case)
interventions non-surgical (amod)
drop administration (nmod)
pursued that (mark)
databases : (punct)
supports . (punct)
have also (advmod)
experienced none (nsubj)
inhibited that (mark)
handling of (case)
levels epo (nmod)
antibody ( (punct)
11.2 1.08 (conj)
mazindol placebo (conj)
$ROOT$ reveals (sent)
$ROOT$ combination (sent)
inotropic and (cc)
confirmed occurrence (nsubjpass)
analyses covariance (nmod)
glaucoma murine (amod)
important situations (nmod)
absence vasoconstriction (nmod)
completed days (nmod:tmod)
medication isoniazid (compound)
prolonged compared (advcl)
showed tachycardia (dobj)
smokers are (cop)
recurrence tma (nmod)
acidification urinary (amod)
concentrations potassium (compound)
striatum the (det)
screened : (punct)
3 6 (conj)
magnitudes hyperalgesia (nmod)
oxprenolol of (case)
event hallucinations (nsubj)
case dementia (nmod)
decrease ; (punct)
concentrated dxnp (nsubj)
reaction encephalopathy (nsubj)
designed using (xcomp)
implantation stn (nmod)
included criteria (nsubj)
defined seizure (nsubjpass)
hepatocarcinogenicity the (det)
contraindication receiving (advcl)
deferens ( (punct)
tdp ( (punct)
levels neuroleptics (nmod)
using studies (dobj)
observed users (nmod)
hyponatremia reported (acl)
measuring examination (conj)
increase score (nmod)
observed whereas (dep)
incorporation tam (compound)
produces effects (dobj)
aap such (case)
selection sensitivity (nmod)
those reported (acl)
exist presumably (advmod)
first in (case)
temocapril , (punct)
group iii (nummod)
unable who (nsubj)
$ROOT$ localization (sent)
incidence infections (nmod)
doxorubicinol metabolite (appos)
cocaine occasional (amod)
indirect were (cop)
preservation rats (nmod)
folate e (conj)
score less (nmod)
cocaine 30 (nummod)
analgesia in (case)
occlusion induction (nmod)
cessation in (case)
incidence % (nmod)
cause no (det)
decreased avp (nsubj)
haemorrhage to (case)
dose ufh (nmod)
pcc or (cc)
effects characteristic (amod)
tachycardia with (case)
desaturation with (case)
anxiety maze (dep)
system opioidergic (amod)
induced neurotoxicity (nsubjpass)
presented rash (dobj)
need of (case)
correspondence close (amod)
assumed suppresses (dep)
data literature (nmod)
reflects susceptibility (dobj)
glioma including (case)
antibody factor (compound)
risk no (neg)
programme into (case)
differ = (dep)
generated effects (nsubjpass)
boy a (det)
decreased maintained (conj)
agent that (mark)
modulated manipulation (nmod)
contributed have (aux)
health and (cc)
levels interference (nmod)
6.7 5.3 (conj)
onset administration (nmod)
rats be-injected (amod)
investigates evaluates (conj)
stimulation behaviour (compound)
quantified degree (nsubjpass)
recommended be (auxpass)
disease myocardial (amod)
multiple and (cc)
gyki-41 099 (nummod)
pigs guinea (compound)
treatment mania (nmod)
infused alone (advmod)
exclude not (neg)
score risk (compound)
incmnsz the (det)
bilayers of (case)
clozapine either (cc:preconj)
syndrome tdfs (appos)
deterioration with (case)
d-treated vitamin (nmod:npmod)
exclude reactions (dobj)
reaching and (cc)
% 10 (nummod)
treatment receptor (compound)
cells form (acl:relcl)
ly274614 acid (appos)
treated course (nmod)
investigated thus (advmod)
receiving restlessness (nmod)
$ROOT$ activity (sent)
importance changes (nmod)
ebf ) (punct)
pain were (cop)
interaction terbinafine (compound)
removal for (case)
action dsp4 (nmod)
$ROOT$ nodosum (sent)
binding hippocampus (nmod)
infusion bolus (conj)
differences other (amod)
million 1.1 (compound)
regimens with (case)
$ROOT$ leads (sent)
overgrowth tissue (nmod)
cent 90 (nummod)
actions given (acl)
exposure maternal (amod)
prevent was (advcl)
increased had (conj)
events therapy (nmod)
signal in (case)
designed . (punct)
dose pentylenetetrazole (nmod)
effects relaxant (amod)
baclofen with (case)
usefulness the (det)
different statistically (advmod)
cows nonpregnant (amod)
exploited uses (nmod)
staining sirius (compound)
neurons nadph-diaphorase (compound)
depleted . (punct)
developed treated (parataxis)
ng./ml 20 (nummod)
highlight we (nsubj)
schedule phase (nmod)
raters backgrounds (nmod)
rats sex (nmod)
estradiol- ) (punct)
nephrotoxicity csa (compound)
dimer-x , (punct)
observed patient (nmod)
0.28 , (punct)
acuity visual (amod)
included infiltration (dobj)
interfered associated (conj)
paradigm fps (compound)
cortex parietal (amod)
condition carries (acl:relcl)
antibiotics practice (nmod)
time operating (compound)
technique is (cop)
54 1 (conj)
affected patient (nsubjpass)
interference such (amod)
tumor left (amod)
due ptz (nmod)
hitt particularly (advmod)
ulnar , (punct)
reduced exercise (nmod)
patients dependent (acl:relcl)
$ROOT$ removed (sent)
cardiomyocyte in (case)
discontinued should (aux)
imbalance electrolyte (compound)
adriamycin . (punct)
causes abuse (nsubj)
difluoromethylornithine dfmo (appos)
developed insufficiency (dobj)
events life (compound)
tests following (amod)
concentration blood (compound)
n-dimethylpropranolol ( (punct)
biochemical urea (dep)
chemotherapy or (cc)
ed from (case)
elevated pressures (dobj)
injection group (nmod)
appeared reversible (xcomp)
clearance blood (compound)
hcrh trh (conj)
ester oxide (compound)
sinusoidal and (cc)
status altered (amod)
require clarification (dobj)
clinic to (case)
five nine (appos)
had gravis (dobj)
. ) (punct)
speaking calculation (conj)
injected injection (nmod)
male patient (nsubj)
sepsis to (case)
c ( (punct)
children seven (nummod)
women pregnant (amod)
marker should (aux)
na(+)/k(+)-atpase nhe3 (conj)
procedures after (case)
$ROOT$ obvious (sent)
was review (ccomp)
both orally (advmod)
mixed cholestatic (dep)
sodium heparin (compound)
administration inhibitor (nmod)
echocardiography combined (acl)
event related (conj)
breaks membranes (nmod)
recall total (amod)
concentrate pcc (appos)
terms defining (acl)
episode an (det)
decrease produced (acl)
developed losses (nmod)
concluded able (ccomp)
effect domperione (nmod)
stage later (amod)
proteinuria increase (conj)
= 0.0480 (dobj)
residue this (det)
effects number (conj)
greater levels (nsubj)
indices assessed (acl)
downregulated expression (dobj)
monitored commencement (nmod)
events because (case)
enzyme thiamine-dependent (amod)
transplantation marrow (compound)
glomeruli than (case)
changes limited (acl:relcl)
concentrations efficacious (amod)
area matter (nmod)
dominating market (dobj)
release mast (compound)
pathways with (case)
enhanced were (auxpass)
mitochondria subsarcolemmal (amod)
blockade partial (amod)
fluency semantic (amod)
receptors prolactin (compound)
ifx of (case)
or(adj ( (punct)
is discriminating (csubj)
fever anemia (conj)
amyloidosis al (appos)
underwent tests (dobj)
corresponded hepatotoxicity (nmod)
epilepticus prolonged (amod)
improves extent (nmod)
points curves (nmod)
pressures patients (nmod)
maintained patients (nsubjpass)
block heart (compound)
exhibited reduction (dobj)
metabolites acetylated (amod)
inhibitor putative (amod)
assessed were (auxpass)
component zidovudine (dep)
circled rats (nsubj)
vasodilation vessels (nmod)
ten measures (nmod)
change further (amod)
examinations neuro-ophthalmologic (amod)
rebounded pressure (nsubj)
chickens to (case)
rate reduced (amod)
gellan ophthalmic (amod)
users aspirin (nmod)
binding motility (conj)
fibers of (case)
microscopic electron (nmod:npmod)
concerns patients (dobj)
il-1 , (punct)
resolved finally (advmod)
b2 thromboxane (compound)
showing synergistic (ccomp)
different no (neg)
pressure cent (dep)
hbsag-negative ( (punct)
hydromorphone mg (appos)
reaction is (cop)
trials cisplatin (nmod)
$ROOT$ randomised (sent)
complication drug-induced (amod)
mg/m(2 than (case)
77 2 (conj)
gain pressure (conj)
become progressed (advcl)
time time (conj)
normalization to (case)
preparations urinary (amod)
determined dose (nmod)
adam ( (punct)
assay cells (nmod)
achieve effect (dobj)
cardiotoxicity monitored (acl)
isolation via (case)
hepatocellular mixed (conj)
admission hospital (compound)
region layer (nmod)
unrelenting , (punct)
result modification (nmod)
recorded mice (dobj)
newborns 200 (nummod)
greater period (nmod)
reuptake noradrenaline (nmod)
administered performed (conj)
performed patients (nsubj)
progression durations (conj)
compounds such (amod)
recalled completed (advcl)
had transplantation (dobj)
synaptophysin ) (punct)
dosing before (case)
mg 200 (compound)
mild cases (nmod)
variability and (cc)
predicted bilirubin (dobj)
activity time (conj)
osmolality lowered (amod)
changes st (compound)
concentration hypotension (nmod)
rigidity the (det)
domains different (amod)
bmd ) (punct)
understand and (cc)
3 more (amod)
specify death (dobj)
diet the (det)
on conditions (dep)
level awareness (nmod)
formulations chp (nmod)
capacity remember (acl)
granulomatosis before (case)
met who (nsubj)
inhibited hypertrophy (dobj)
concluded pursued (ccomp)
uncertain , (punct)
shift a (det)
improvements normalizations (conj)
correlated which (nsubjpass)
parameters other (amod)
carolina maryland (conj)
3,4-methylenedioxymethamphetamine ( (punct)
thc ) (punct)
dyskinesias animals (nmod)
assessed survivors (nmod)
analyzed similarly (advmod)
maximal were (cop)
cancer ht (nmod)
1981 in (case)
rater by (case)
3.32 10(2 (conj)
dose lipopolysaccharide (nmod)
treatment den (compound)
pcc ( (punct)
vasoreactivity the (det)
ci p<0.001 (dep)
4.9 , (punct)
na/k-atpase of (case)
added amlodipine (nsubjpass)
done mean (dep)
15/44 15/44 (conj)
suggests exposure (dobj)
resistance flexion (nmod)
permitted escalations (nsubjpass)
psychosis to (case)
patients 11 (nummod)
elucidate induced (ccomp)
exacerbated cardiomyopathy (nmod)
injected hr (nmod)
intensify neuropathy (nmod)
ingestion clz (nmod)
conclusions neurotoxic (appos)
suppression dysfunction (nsubj)
sex either (det)
receptor nm (appos)
suggests complicated (ccomp)
doses cyclophosphamide (nmod)
chemotherapy it (compound)
helodermin of (case)
are nor (cc)
those regimens (nmod)
% 34 (nummod)
t nevirapine (conj)
repair cuff (nmod)
ml/kg ) (punct)
drug kf17837 (nsubj)
receive placebo (dobj)
present aetiologies (nsubj)
neurons toward (case)
clonic tonic (amod)
lacked response (dobj)
possibility reactions (nmod)
received adr+los(6 (nsubj)
protocol study (appos)
exacerbated which (nsubjpass)
direction in (case)
(+/-)-pg-9 by (case)
micrograms/kg/min up (advmod)
vasoconstriction arterial (amod)
titrated clonidine (nmod)
1.12 - (punct)
mumol/l mumol/l (conj)
pathogenesis disease (nmod)
facility outflow (compound)
noted outcomes (nsubjpass)
gland pituitary (amod)
reactivity the (det)
dihydropyridine as (case)
micrograms/ml mean (dep)
suggest plays (ccomp)
caused mice (nmod)
impairment on (case)
sutures the (det)
make is (cop)
reduce mortality (dobj)
ecg examinations (conj)
caused toxicity (nmod)
admitted month (nmod)
anxiety depression (conj)
damage membrane (nmod)
treated stent (nmod)
has it (nsubj)
summary was (acl)
unmask and (cc)
moles/glomerulus < (appos)
dogs ventilated (amod)
related effects (nsubj)
compared min (nmod)
nmda mg/kg (dep)
cases serious (amod)
powders carbon-ate-sodium (compound)
led resolution (nmod)
rats 5/6 (nummod)
panel css (compound)
injury acute (amod)
attenuate effects (dobj)
suggest factor (ccomp)
action site (nmod)
studies post-mortem (amod)
tip iceberg (nmod)
discontinuation to (case)
reductions score (compound)
normotensive and (cc)
available : (punct)
therapy isoniazid (compound)
varied . (punct)
period pain (compound)
spread using (advcl)
determine occupancy (dobj)
elevations margin (nmod)
proceeded . (punct)
increased abecarnil (nsubj)
indicate effects (nsubj)
change rate (nmod)
effect action (nmod)
put was (auxpass)
underwent days (nmod)
relevance receptor (nmod)
differences responses (nmod)
cuff of (case)
cases 82 (nummod)
carbon colloidal (amod)
intervals 3-month (amod)
manner receptor-dependent (amod)
prolonged mg/day (dep)
hazard patients (nmod)
show variation (dobj)
safety lidocaine (nmod)
introduction agonist (nmod)
had attacks (dobj)
emesis ifosfamide-induced (amod)
= 0.051 (dobj)
tests thyroid (compound)
bradycardia induced (amod)
instillation ocular (amod)
patterns with (case)
nmda by (case)
sludge , (punct)
level turnover (nmod)
administration desipramine (nmod)
dogs sixty (nummod)
wt of (case)
a val204asp (appos)
factors significant (amod)
phase same (amod)
cle ( (punct)
about who (nsubj)
$ROOT$ upregulation (sent)
anuria administration (nmod)
disease post-transplant (amod)
disorder pd (appos)
mentioned frequently (advmod)
treated morphine (nmod)
$ROOT$ emphasized (sent)
years age=23.3 (nummod)
showed examination (nsubj)
produced regardless (advmod)
olanzapine or (cc)
taking been (aux)
fibrillation sudden (amod)
rate gain (nmod)
treatment cancer (compound)
computer by (case)
thrombosis experimental (amod)
tested should (aux)
consider thrombocytopenia (dobj)
etoposide methotrexate (conj)
foodstuffs as (case)
skf-82958 and (cc)
reactions nsaids (nmod)
decreased levels (nsubj)
prevents damage (dobj)
exposure : (punct)
immunosuppressant , (punct)
assumed generally (advmod)
slowed slightly (advmod)
examined response (dobj)
result cardiotoxicity (conj)
given morphine (nsubjpass)
candidiasis dipropionate (nmod)
documents suggests (conj)
nl ( (punct)
induced stimulation (nmod)
= 16 (dobj)
number sum (conj)
amnesia under (case)
indices in (case)
centre at (case)
biopsy of (case)
target protect (acl:relcl)
jc , (punct)
ranged suggesting (advcl)
formation amygdala (conj)
gave using (advcl)
seems mediate (xcomp)
$ROOT$ inhibition (sent)
have mice (nsubj)
deteriorated occurred (advcl)
target to (mark)
days gestation (dep)
% 20.0 (nummod)
improve background (nsubj)
receiving fenfluramine-phentermine (dobj)
prevented atropine (nmod)
induced gentamicin (nmod)
57.9 age (nsubj)
received after (mark)
predictors potential (amod)
block step (dobj)
embarked was (auxpass)
studies by (case)
predictors dyskinesia (nmod)
proteins class (nmod)
factor stroke (nmod)
precipitate drugs (nsubj)
doses calculated (acl)
mechanisms withdrawal (nmod)
proceeded seizures (nmod)
person-years exposure (nmod)
$ROOT$ 2.5 (sent)
900 1,200 (conj)
play response (nmod)
remained depressed (acomp)
causes disease (nmod)
intra-operative , (punct)
ros , (punct)
increase output (nmod)
considered macroprolactinemia (nsubjpass)
reactivator ache (compound)
rate ventricular (amod)
motility of (case)
related hyperkinesia (nmod)
baseline at (case)
pressure elevation (amod)
effects correlation (nmod)
disturbance auditory (amod)
incidence infants (nmod)
rats corresponding (amod)
used develop (xcomp)
december 1994 (nmod)
ratios interval (appos)
showed resulted (ccomp)
findings necrosis (nmod)
administered were (auxpass)
groups ptra (compound)
causes stimulation (nsubj)
glutamate of (case)
used measure (advcl)
correlated nephrotoxicity (nmod)
/-8 ) (punct)
spinal suprabulbar (conj)
produced rises (nmod)
lesion the (det)
women treated (acl)
onset seizures (nmod)
patients chinese (amod)
s(h)uv the (det)
length-of-stay costs (conj)
flash and (cc)
$ROOT$ % (sent)
predictor acid (nsubj)
experience a (det)
ginsenoside extracted (acl)
1,2-dmh by (case)
respond that (mark)
frequent effects (nsubj)
up-regulation pgp (nmod)
suggest cardiotoxin (ccomp)
135 +/- (cc)
patients eligible (amod)
reductions significant (amod)
show detect (ccomp)
aggravates significantly (advmod)
1.02 2.85 (prep)
antioxidants serum (compound)
taking medications (dobj)
none groups (nmod)
improved condition (nsubj)
deficits these (det)
flurothyl electroshock (conj)
received previously (advmod)
regimen intravenous (amod)
increased incidence (nsubjpass)
enzyme atypical (amod)
phase in (case)
incidence tumor (compound)
tissues medullary (amod)
trial design-open-label (amod)
pressure control (conj)
mv 5.6 (nummod)
(2.2)% < (parataxis)
genotype bche (compound)
elicits clonidine (nsubj)
latency (pcp)-induced (punct)
levels brain (compound)
patterns studied (acl)
effect chebula (nmod)
cue and (cc)
types , (punct)
percentage ( (punct)
captopril , (punct)
resistance svr (appos)
lip palate (nmod)
neuropathology the (det)
cholinergic serotonergic- (conj)
telithromycin po (appos)
detected , (punct)
different was (cop)
utility whose (nmod:poss)
na and (cc)
responsiveness between (case)
depressed rate (nsubj)
neurons sectors (nmod)
better significantly (advmod)
october 30 (nummod)
central as (case)
rhigf-i , (punct)
incorporating cisplatinum (dobj)
60 100 (conj)
hypertension diabetics (nmod)
inhibition ezetimibe (compound)
produced but (cc)
rats prazosin-pretreated (amod)
showed induced (ccomp)
diet either (det)
assessed animals (nsubjpass)
prednisone to (case)
objectives/hypothesis standard (appos)
initial only (conj)
weighed . (punct)
attributed lithium (nmod)
associated study (nmod)
modulators positive (amod)
pulses 12 (nummod)
admixed salts (nmod)
radiopharmacy incmnsz (nmod)
required ; (punct)
plasma into (case)
reduced dmtu (nsubj)
adding increasing (conj)
surgeon by (case)
background given (appos)
procedure challenge (compound)
thrombophlebitis pelvic (amod)
tolerate can (aux)
house her (nmod:poss)
showed while (mark)
inflammation cardiomyopathy-induced (amod)
advantages nitroprusside (nmod)
$ROOT$ 67.4 (sent)
administered intramuscularly (advmod)
prevention l-dopa (nmod)
discharges electrical (amod)
antibodies antinuclear (amod)
relapsed two (nsubj)
starting before (mark)
1.8-fold control (conj)
experiment set (acl)
1 3 (prep)
understood well (advmod)
commencement of (case)
responses tone-burst (compound)
alterations of (case)
interaction agents (nmod)
level ammonium (compound)
weeks 3 (nummod)
profile . (punct)
block mobitz (compound)
depleted significantly (advmod)
lack something (conj)
produced hippocampus (nmod)
demonstrated : (punct)
$ROOT$ dyskinesia (sent)
daptomycin of (case)
modulation a (det)
seizures than (case)
reduction % (compound)
severity disability (nmod)
elements bbb (nmod)
drugs nsaids (appos)
abuse with (case)
stage at (case)
well-tolerated apart (advmod)
described lot (nsubjpass)
hormone luteinizing (compound)
percentage as (case)
progression as (case)
benefit patients (nmod)
diabetes and (cc)
hydrobromide . (punct)
use medium (nmod)
system within (case)
valproate ethosuximide (conj)
extubated , (punct)
is evidence (attr)
loss ability (nmod)
cavity three (appos)
50 equal (advmod)
ingestion with (case)
speculated it (nsubjpass)
cimetidine antagonist (appos)
3.49 desogestrel (nmod)
gentamicin inhibitor (appos)
blocker multichannel (amod)
tissue e18.5 (nmod)
confirmed patients (nmod)
measured : (punct)
enrolled total (nsubjpass)
scan computed (amod)
are but (cc)
beginning therapy (dobj)
nature and (cc)
catalase cat (appos)
days 8.6 (nummod)
prescribed addition (nmod)
effective gabapentin (nsubj)
safety medicines (nmod)
received medications. (dobj)
responds system (nsubj)
pathogenesis myalgia (nmod)
ezetimibe simvastatin-ezetimibe (conj)
users pills (nmod)
patients disorder (nmod)
than greater (amod)
7alpha-hydroxylase as (cc)
antigen pai-1 (compound)
depression myocardial (amod)
dependent dose (nmod)
suggests observation (nsubj)
image 8/8 (appos)
altering action (dobj)
patients seven (nummod)
rhabdomyolysis administration (nmod)
mg/kg/day mg/kg/day (conj)
performed procedures (nsubjpass)
coupling respiratory (amod)
administered one (dobj)
men four (nummod)
slow ( (punct)
injections meth (compound)
ranging meq/l (nmod)
thresholds with (case)
alendronate biphosphonate (appos)
primarily is (cop)
lack is (cop)
blood sinus (compound)
function respiratory (amod)
design three-way (punct)
dublin ca (appos)
propranolol of (case)
interval prolonged (amod)
repeat words (dobj)
force paradigm (nmod)
treated lymphomas (nmod)
mutants immune (amod)
volume distribution (nmod)
therapy estrogen-testosterone (compound)
sulfate vincristine (compound)
efficacy agents (nmod)
seizures such (case)
demonstrate results (nsubj)
heartbeat viracept (amod)
effect receptor (nmod)
tested rats (nmod)
time duration (conj)
blocker ro (appos)
rigidity jaw (compound)
mg/kg 60 (nummod)
cells layers (nmod)
marker useful (amod)
treatment second- (amod)
voltarol pharmaceuticals (appos)
sumatriptan subcutaneous (amod)
found increase (conj)
frequency vision (nmod)
biliary , (punct)
solution doses (nmod)
encephalopathy " (punct)
morphology transition (conj)
shown results (nsubj)
infusion given (acl)
times nucleation (compound)
twins in (case)
conditions kidney (nmod)
ethanol with (case)
concerns , (punct)
phase acute (amod)
likely seen (ccomp)
associated also (advmod)
term years (appos)
changes animals (nmod)
receiving weeks (nmod)
25.7 6.0 (conj)
retained that (mark)
2 cases (nmod)
characterize findings (dobj)
amplitude patients (nmod)
responses preparations (nmod)
states behavioral (amod)
mechanisms important (amod)
) 10(-7 (compound)
down with (mark)
patients 27 (nummod)
myocarditis : (punct)
these and (cc)
eyes subject (nmod)
relation administration (nmod)
day-1 kg-1 (nummod)
examined methods (nsubj)
route administration (nmod)
drug diclofenac (appos)
mg/kg administered (acl)
stroke hypertension (conj)
levels across (case)
preferred , (punct)
bladder ureter (conj)
part therapy (nmod)
slowing continuous (amod)
disorders the (det)
tbm the (det)
hemorrhagic and (cc)
assessment behavior (nmod)
hematoxylin stains (conj)
resulted introduction (nsubj)
unclear contrast (nmod)
rats 9 (dep)
cases reporting (acl)
occurred subsequently (advmod)
age diagnosis (conj)
54 disease (nmod)
group kingdom (compound)
excluding fatalities (dobj)
developed useful (dep)
modifies expression (dobj)
factor-kappab macrophages (conj)
dosage his (nmod:poss)
receptors other (amod)
insufficiency body (compound)
abstinence after (case)
available that (nsubj)
use occurs (advcl)
drug was (cop)
d1 both (cc:preconj)
obtained induction (nsubjpass)
had captopril (nsubj)
mice beta2(-/- (amod)
dilation dysfunction (conj)
appear rbcs (nsubj)
differ livers (nmod)
duration phn (nmod)
discuss helpful (ccomp)
$ROOT$ preservation (sent)
doses lethal (amod)
artery cerebral (amod)
e-1 ( (punct)
surviving , (punct)
compare prevent (xcomp)
differed assessment (nsubj)
mass a (det)
ratings levels (conj)
predated however (advmod)
treated beta-blockers (nmod)
1990 1995 (conj)
midazolan influence (conj)
man user (appos)
size of (case)
mania to (case)
dialysis for (case)
improvement the (det)
accompanied normalisation (nmod)
percent seventy-one (nummod)
cyclophosphamide . (punct)
dct2 , (punct)
serotonin , (punct)
induced flare (dobj)
narrow very (advmod)
dp/dt(max + (cc)
hbsag for (case)
amlodipine t+a (appos)
destructive overload (nsubj)
pericarditis vasculitis (nmod)
time operation (nmod)
attenuation loss (nmod)
decreased rats (nmod)
d-ribose doses (nmod)
determining cases (nmod)
months only (advmod)
impairment ( (punct)
hyperplasia endometrial (amod)
cocaine metabolites (conj)
camkiia psd-95 (conj)
breast , (punct)
cyclosporine , (punct)
$ROOT$ designed (sent)
24.4 +/- (cc)
film x-ray (compound)
diuresis with (case)
spike followed (acl)
day two (nummod)
diagnosis infarction (nmod)
ct hours (nmod)
average below (case)
leftward and (cc)
stress levels (conj)
confounds detection (dobj)
detection toxicity (nmod)
evaluation function (nmod)
identified respectively (advmod)
administered saline (dobj)
equipotent were (cop)
diagnosis aids (compound)
euphoria such (case)
18 up (advmod)
improve proteinuria (nsubj)
weeks 5 (nummod)
damage proteases (nsubj)
carrier physiological (amod)
obtained algorithm (nmod)
weekly afterwards (conj)
indinavir associated (acl:relcl)
involves that (nsubj)
entries session (nmod)
phosphatase gammaglutamyltransferase (conj)
2.0/100,000 ( (punct)
some to (case)
diameter diameter/axon (compound)
enos renal (amod)
ml mg/100 (nummod)
procedures urological (amod)
paid studied (advcl)
wall from (case)
supplement fentanyl (nsubj)
epithelium leaky (amod)
reported myocarditis (nsubjpass)
extensive are (cop)
considered reflect (xcomp)
restrict initiation (dobj)
flk-1/kdr ) (punct)
rate corticosterone (compound)
defining substrates (dobj)
artery artery (conj)
pool treadmill (compound)
injected alfentanil (nmod)
reported thought (advcl)
doxorubicin plus (cc)
aggregations induced (acl)
number increased (amod)
dl-sotalol both (cc:preconj)
patients all (nummod)
mg/kg daily (advmod)
pcna ( (punct)
advantage a (det)
appears indication (xcomp)
networks channels (nmod)
pharmacodynamics beta-2 (compound)
hearts hearts (conj)
damaged meth (nmod)
smokers in (case)
deleted replaced (conj)
and generically (advmod)
factor-alpha together (advmod)
distinguished models (nmod)
patient received (acl)
tendency busulfan (nmod)
ginseng panax (compound)
specific patient (nmod)
restored , (punct)
tap and (cc)
arrhythmias arrhythmia (nmod)
treatment endophthalmitis (nmod)
tubules in (case)
increased hazard (nsubj)
motility ocular (amod)
escalated . (punct)
values km (compound)
$ROOT$ gives (sent)
worsen may (aux)
24 least (nmod:npmod)
syndrome coronary (amod)
site and (cc)
levels cis-ra (amod)
sensitivity thermal (amod)
eruption areas (nmod)
camera fundus (compound)
associated positively (advmod)
patients physicians (conj)
regulation dopaminergic (amod)
disease autoimmune (amod)
patient on (case)
history aggressiveness (nmod)
bromocriptine microg/kg (appos)
products animal (compound)
phenylbutazone mg/kg (appos)
normalized were (auxpass)
aneurysm thoracic (amod)
associated adjusted (advcl)
causing therefore (advmod)
induce potentiation (dobj)
% -4.6 (nummod)
corresponded . (punct)
engine the (det)
levels microg/ml (nmod)
administration treatment (nmod)
returned and (cc)
agent both (preconj)
african nigerian (amod)
asked patient (nsubjpass)
agent boosted (amod)
frequencies intact (amod)
angiogenesis of (case)
$ROOT$ 1 (sent)
found related (ccomp)
sensitivity % (dep)
medium bathing (compound)
concentration higher (amod)
found attempt (conj)
associated hypertension (nmod)
suffering disorder (nmod)
processor computerized (amod)
nicotine 's (case)
improvement propranolol (nmod)
structures among (case)
catalepsy the (det)
aggravate not (neg)
dogs six (nummod)
71.3 +/- (cc)
consider result (ccomp)
0.59 0.52 (compound)
[3h]sch either (cc:preconj)
attest deaths (nsubj)
s(c)o(2 ) (punct)
endothelia glomerular (amod)
was history (attr)
result consequences (nsubj)
caused ischemia (nsubjpass)
typical antipsychotics (nmod)
seen involved (advcl)
intake ) (punct)
pra ) (punct)
study population-based (amod)
min papaverine (nmod)
weeks and (cc)
incorporation to (case)
oxygenation tissue (compound)
hds with (case)
increased suggesting (advcl)
transfusion during (case)
improved has (aux)
proteinuria 1 (dep)
severity pressure (conj)
associated anesthetics (nsubjpass)
observers independent (amod)
glomerulonephritis unique (amod)
evaluations laboratory (compound)
edema periphery (nmod)
touch and (cc)
ingestion alcohol (nmod)
distinguish not (neg)
doc the (det)
model to (mark)
anticoagulant heparin (nsubj)
patients forty-one (nummod)
groups across (case)
influences noradrenergic (amod)
calcification massive (amod)
recoveries rate (nmod)
exhibited dependently (advmod)
occasions in (case)
changed . (punct)
0 > (amod)
demonstrated work (nsubj)
imaging cardiac (amod)
up follow-up (nmod)
time median (amod)
increased extent (dobj)
aware diagnosis (nmod)
weeks longer (nummod)
content mass (conj)
alpha-gst ) (punct)
one potential (nmod)
findings scan (compound)
lidocaine tricaine (conj)
agent interaction (nmod)
found had (advcl)
correlate . (punct)
induce but (cc)
injection apomophine (compound)
effects s-312-d (nmod)
lnna g/l (dep)
work-up conversion (nmod)
include that (nsubj)
mp high-dose (amod)
deficiency by (case)
seizures chronic (amod)
ethambutol neuropathy (conj)
needed be (auxpass)
conditions associated (amod)
injections five (nummod)
manifests hepatitis (nmod)
satisfied . (punct)
mrna the (det)
monocytes peripheral (amod)
reversal % (amod)
studied trials (nmod)
effects pressor (compound)
terfenadine nm (appos)
patients 65 (nummod)
structure 7 (nmod)
leg and/or (cc)
year-old 63 (compound)
capacity activity (conj)
d. vitamin (compound)
enhancers cleavage (compound)
years two (nummod)
shown mediated (ccomp)
dl-sotalol by (case)
present more (dobj)
alterations morphological (amod)
therapy deferoxamine (compound)
development psychosis (nmod)
brightfield- immunoperoxidase (compound)
element region (nmod)
asystole amount (conj)
demonstrate to (mark)
intermediate reactive (amod)
0.03 than (case)
search a (det)
veralipride of (case)
pre-treatment using (acl)
involvement b (nmod)
mg/day mg/day (conj)
unilateral conventional (conj)
difficulties sleeping (compound)
treated monotherapy (nmod)
terminated was (auxpass)
values , (punct)
treated hyperactivity (nmod)
showed considered (advcl)
ritonavir protease (compound)
block plexus (compound)
triad hypercalcemia (nmod)
h administration (dep)
carcinomas fanft-induced (amod)
attacks , (punct)
abdominal-constriction , (punct)
connective muscular (conj)
stabilized = (parataxis)
mortality associated (acl)
prevented test (nmod)
$ROOT$ reversed (sent)
became apparent (acomp)
pentoxifylline theophylline (conj)
change metabolism (nmod)
tgf- b (dep)
ineffective diphenhydramine (nsubj)
blockade selective (amod)
evaluate explore (conj)
tolerability ce (nmod)
induce contrast (nmod)
microg/side 10 (nummod)
episode of (case)
demonstrates evidence (nsubj)
effects few (amod)
siadh ( (punct)
cytopathy mitochondrial (amod)
ameliorated also (advmod)
muscarinic purinergic (conj)
decrease l(-1 (nmod)
prolapse of (case)
minutes every (det)
provided management (nsubj)
< 0.05 (dep)
2006 and (cc)
lenalidomide and (cc)
$ROOT$ signed (sent)
deficits . (punct)
showed disruption (ccomp)
had alternation (nmod)
ptz by (case)
patent an (det)
reached week (nmod)
edema or (cc)
km vmax (conj)
d-1 . (punct)
rates heart (compound)
is need (attr)
showed observed (conj)
hemodynamic cardiac (amod)
results dexamethasone (nsubj)
action fs (nmod)
given yohimbine (dobj)
lessen nephrotoxicity (dobj)
background study (nmod)
mechanisms arousal (compound)
comparison study (appos)
cause depression (dobj)
dose isoniazid (nmod)
allocated total (nsubjpass)
bun , (punct)
deformations caused (acl)
mistake by (case)
challenge emerging (amod)
release hippocampal (amod)
autonomic motor (conj)
mechanisms : (punct)
236 from (case)
desire . (punct)
tetrachloride carbon (compound)
higher average (nmod)
showed frequency (nsubj)
followed mg/m2 (nmod)
gamma-carboxylated was (auxpass)
events impairment (nmod)
had entry (nmod)
thrombectomy mechanical (amod)
anticoagulant with (case)
produced drugs (nsubj)
cortex motor (amod)
cardiovascular respiratory (conj)
receiving treatment (dobj)
influencing degree (dobj)
seeing we (nsubj)
amounts persons (nmod)
administered birth (nmod)
bleeding or (cc)
occurs probably (advmod)
decrease as (case)
had having (conj)
reduces rate (dobj)
protected , (punct)
neuropathy linezolid-induced (amod)
discontinued fluconazole (nsubjpass)
regulate . (punct)
had pilocarpine (nsubj)
causing without (mark)
ae ) (punct)
design . (punct)
mg/m2bsa ( (punct)
phenotype polymorphism (nmod)
history cancer (nmod)
4.4 ( (punct)
role nephropathy (nmod)
measured impairment (nsubjpass)
severe sometimes (advmod)
factor src (nmod)
time needed (acl)
product extended-release/lovastatin (nsubj)
structures in (case)
cx3cr1 the (det)
na+ of (case)
numbness with (case)
due administration (nmod)
worsened and (cc)
2- to (dep)
cause to (mark)
ng/ml and (cc)
technique evaluate (acl:relcl)
failure hemorrhaging (conj)
eroded . (punct)
mellaril thioridazine (appos)
hr < (advmod)
passed . (punct)
weeks 28 (parataxis)
evaluated also (advmod)
members group (nmod)
contribution important (amod)
other dfo (nmod)
induces attacks (dobj)
clearance inulin (compound)
integral potential (nmod)
450 500 (conj)
main active (conj)
implicated damage (nmod)
responses hyperalgesic (amod)
infused when (advmod)
returned that (nmod)
% 4.3 (nummod)
thrombi zones (conj)
substances other (amod)
problems significant (amod)
subjects subjects (conj)
reduction occurring (acl)
reports patients (nmod)
fzp pentylenetetrazol (conj)
studied simultaneously (advmod)
reabsorption renal (amod)
influence excretion (nmod)
germany in (case)
surveillance and (cc)
changes women (nmod)
infiltration exfoliation (conj)
mk-801 and (cc)
protrusions tongue (compound)
drug injection (compound)
blunted raised (conj)
hemoglobin serum (compound)
gender by (case)
glomeruli more (amod)
infusion diltiazem (nmod)
observation this (det)
reaction probably (advmod)
treatment tachyarrhythmias (nmod)
administered min (nmod)
smaller same (advcl)
remained demonstrated (conj)
receiving lidocaine (conj)
appearance and (cc)
reported syndrome (nmod)
urea serum (compound)
mg 300 (nummod)
greater greater (ccomp)
toxicity dose-dependent (amod)
related malignancies (nmod)
duration recovery (nmod)
achieved stability (nsubjpass)
women cocs (nmod)
structure on (case)
likely most (advmod)
inserted , (punct)
injections 6 (nummod)
seemed etiology (xcomp)
coma secondary (amod)
hypothesized exhibits (advcl)
g 4.1 (nummod)
donor ) (punct)
$ROOT$ 3.49 (sent)
subgroups patients (nmod)
therapy during (nmod)
factor-alpha contents (conj)
day the (det)
immunoreactivity decreased (amod)
factor only (amod)
acid ) (punct)
7.0 . (punct)
electrocardiogram holter (compound)
ilk of (case)
glutamate capsaicin (conj)
hyperalgesia opioid-induced (amod)
stimulation field (compound)
rats ds (compound)
pain propofol (compound)
tool can (aux)
treatment 6-day (amod)
occurrence complexes (nmod)
mg/kg/day 10 (nummod)
involved are (auxpass)
factor immunoreactive (amod)
a(1)/a(2a ) (punct)
literature drugs (nmod)
aspects with (case)
amplitudes of (case)
micrograms 1000 (nummod)
pathology the (det)
defects midline (amod)
improved dysmorphism (nsubj)
practice use (conj)
found results (nsubj)
recommended guidelines (nsubjpass)
all abnormalities (nmod)
precautions particularly (advmod)
map than (case)
regimen dosing (compound)
1.1 8.8 (prep)
carcinoma primary (amod)
necrosis muscle (compound)
uncommon toxicities (nsubj)
adr(12 ) (punct)
surgery gynecological (amod)
has ephedrine (nsubj)
enhancement reflexes (nmod)
time freezing (compound)
placed microinjections (nmod)
subset disease (nmod)
se ( (punct)
receiving agent (dobj)
made using (xcomp)
8.3 and (cc)
tensions and (cc)
had conditions (dobj)
inhibition thrombosis (nmod)
inhibition sustained (amod)
values these (det)
refine rules (dobj)
nl nmol/200 (compound)
contraindication if (mark)
p t-tests (appos)
advantage an (det)
differ increased (conj)
hematuria persistent (amod)
interval encephalopathy (compound)
response stress (compound)
decreased count (dobj)
occurrence failure (nmod)
considered be (auxpass)
distributions different (amod)
entity inflammatory (amod)
damage isoproterenol (compound)
both and (cc)
caused hyperkalemia (nsubjpass)
effect interaction (nmod)
treat symptoms (dobj)
sequelae . (punct)
combination chromatography (nmod)
safety clonidine (nmod)
sucrose , (punct)
serum workers (nmod)
conclusions indicates (appos)
times 2.5 (nummod)
rise than (case)
harmless that (mark)
review systematic (amod)
s 60 (nummod)
dose microgram/kg/min (appos)
gag/pol ) (punct)
recommended because (advcl)
reaching weeks (nmod)
signs and (cc)
adjusted factors (nmod)
excitation central (amod)
conclude results (advcl)
rise ng/ml. (nmod)
frequency relevant (amod)
celecoxib 1.19 (appos)
smoking factor (nmod)
microscopy immunogold (amod)
present signs (nmod)
discovered prolactinoma (nsubjpass)
started was (auxpass)
< = (parataxis)
hydrochloride pyran (compound)
ablated were (auxpass)
drd2 between (case)
tinnitus intractable (amod)
changes tgf- (nmod)
shown angiography (nsubjpass)
antibodies failure (nmod)
medication trial (compound)
doxorubicin or (cc)
influenced count (nmod)
study injury (dobj)
pain loss (conj)
3.7+/-0.8 , (punct)
anesthetic isoflurane (appos)
pcag ( (punct)
supply cardiac (amod)
dilates nitroglycerin (nsubj)
subjects % (appos)
characteristics relevant (amod)
has believed (conj)
view association (nmod)
rate high (amod)
reverse partially (advmod)
believed it (nsubjpass)
background & (cc)
protection on (case)
oxycodone of (case)
alternative whether (mark)
reduced normalized (advcl)
altered suppressed (advcl)
started achieved (advcl)
impaired be (auxpass)
intact-control saline-control (conj)
% -15.96 (conj)
criteria : (punct)
93 p (dep)
courses daily (advmod)
rad001 inhibitor (appos)
days 13 (nummod)
degeneration the (det)
$ROOT$ learning (sent)
lack of (case)
deficiency thiamine (nmod)
colliculus inferior (amod)
terms management (nmod)
response theophylline (nmod)
actin laminin (conj)
levels alone (advmod)
preparations perfused (amod)
conduction having (acl)
nelarabine arag (appos)
risk against (case)
administration isoproterenol (nmod)
confirmed thus (advmod)
brief and (cc)
taken determination (nmod)
32 25 (compound)
arthritis rheumatoid (amod)
ratio ventricle (nmod)
layer gyrus (compound)
hypotension delivery (nmod)
syncope caused (acl)
pathway adrenergic (amod)
generated mutants (nmod)
effect incidence (nmod)
required that (nsubjpass)
libitum ad (compound)
mm 8.5 (nummod)
made . (punct)
chloride sch (appos)
shortened verapamil (nsubj)
performed pallidotomies (nsubjpass)
et-1 ) (punct)
symptoms effects (conj)
hydroxyl ( (punct)
used used (conj)
neuropathy 4 (nummod)
polypeptide : (punct)
refractory is (cop)
aspirin : (punct)
induce blockade (dobj)
induced sleep (nsubjpass)
atherosclerosis such (case)
discovery and (cc)
attributed may (aux)
acid r-aminobutyric (amod)
stopping therapy (dobj)
adjusted interval (dep)
consisted concomitant (nsubjpass)
favour . (punct)
death transplantation (conj)
displayed level (dobj)
$ROOT$ neonates (sent)
compared state (nmod)
toxicity major (amod)
37,495 ns-nsaids (nmod)
change peak (conj)
description presented (acl)
calcium and (cc)
responsible part (nmod)
exceed induction (dobj)
important effects (nsubj)
treated ointment (nmod)
interrelationship the (det)
response pathological (amod)
collagen plus (cc)
4 > (advmod)
volume use (conj)
readings with (case)
retention sodium (compound)
drop determined (acl)
staining immunohistochemical (amod)
elevation mv (nmod)
impairs . (punct)
remained protocols (nsubj)
ctni mass (conj)
e2 prostaglandin (compound)
costs high (amod)
testing during (case)
evoked visual (amod)
responses these (det)
levels troponin (compound)
outcome favourable (amod)
knee the (det)
test platelet (compound)
daunorubicin of (case)
hypercalcemia and (cc)
tachycardia no (neg)
decreasing in (mark)
produce features (dobj)
assessed function (nsubjpass)
activity cardiomyopathy (nmod)
$ROOT$ alerted (sent)
related hypotension (nmod)
pattern molecular (amod)
hallucinations clarithromycin-associated (amod)
suppresses has (conj)
endoscopic transthoracic (amod)
edema as (case)
application important (amod)
acquired , (punct)
detectable effect (nsubj)
production oxide (compound)
emulsions lipid (compound)
factor-alpha of (case)
time response (nmod)
prazosin the (det)
stroke attack (conj)
functioning executive (amod)
breakdown either (cc:preconj)
seen . (punct)
participation mechanisms (nmod)
mmhg 129 (nummod)
showed improvement (dobj)
myositis all-trans (amod)
line thp-1 (appos)
arabinoside it-cytosine (compound)
survival 1-year (compound)
rare intoxications (nsubj)
woman . (punct)
0.6 versus (cc)
intervals long (amod)
therapy tacrolimus (compound)
diet induces (acl:relcl)
associated addition (nmod)
effects suppressant (amod)
subsided tachyarrhythmias (nsubj)
area sedation (compound)
urgency on (case)
indication this (det)
tremor or (cc)
increased ctni (nsubjpass)
kidney and (cc)
damage dxr-cm (compound)
6 between (quantmod)
macrophages resulting (acl)
carolina and (cc)
evaluated should (aux)
associated they (nsubjpass)
angiosarcoma liver (nmod)
noted neuropathy (nsubjpass)
marmoset the (det)
biosyntheses ribosomal (amod)
role small (amod)
given area (nmod)
decrease rate (nmod)
aggravation drug-induced (amod)
pursuit smooth (amod)
species certain (amod)
those cases (nmod)
withdrawn phenacetin (nsubjpass)
using stimuli (dobj)
indicated use (nsubj)
sufficient blockade (nsubj)
injected controls (nsubjpass)
gfr ( (punct)
demonstrated sites (nsubjpass)
courses arag/vp/cpm (nmod)
case documented (amod)
= 0.14 (dobj)
5-fu mg/m2 (appos)
ko 6-ohda-lesioned (amod)
assessed authors (nsubj)
combination drug (compound)
procedures major (amod)
rejection glomerulonephritis (conj)
therapy drug (compound)
92 12 (compound)
thirty-six patients (nmod)
etoricoxib sodium (conj)
subject each (det)
diabetes duration (nmod)
cpdd from (case)
hyperkalemia and (cc)
prophylaxis disease (nmod)
observations two (nummod)
artery kidney (nmod)
over-representation asians (nmod)
list the (det)
months postoperatively (advmod)
time half-time (conj)
low dosage (nmod)
chemotherapy cytotoxic (amod)
pressure mmhg (appos)
enhanced plasticity (dobj)
rechallenge its (nmod:poss)
db 2.96 (nummod)
mea onto (case)
determined cells (nmod)
time or (cc)
showed efficacy (dobj)
days time (nsubj)
swelling tongue (compound)
cells estrogen-induced (amod)
internus of (case)
ventilation spontaneous (amod)
have activity (dobj)
hemopoiesis an (det)
measured amount (nsubjpass)
cent per (dep)
number cardiomyocytes (nmod)
measured following (nsubjpass)
got infusion (dobj)
efficacy preserved (amod)
rhythm regular (amod)
aggravating toxicity (dobj)
3.86 : (punct)
relapse a (det)
preparations available (amod)
short too (advmod)
32.6 +/- (cc)
months introduction (nmod)
well less (advmod)
monitored echocardiography (nmod)
study descriptive (amod)
help . (punct)
preservation homeostasis (nmod)
sensitized stress (dobj)
day either (det)
prk ( (punct)
rate of (case)
nephrectomized dogs (nsubjpass)
behaviors in (case)
found kidney (nmod)
oxazepam , (punct)
made recordings (nsubjpass)
amine phenylpropanolamine (nsubj)
prevent completely (advmod)
observed rhythm (nsubjpass)
assess influence (dobj)
effects dosage-dependent (amod)
measures 4/17 (nummod)
dependence inactivation (nmod)
increased have (aux)
pge1 to (case)
side-effects no (neg)
word and (cc)
result would (aux)
was describe (xcomp)
t4 ( (punct)
block complete (amod)
developed disorder (dobj)
diet vegetable (compound)
insurance the (det)
characteristic that (mark)
male taking (acl:relcl)
injections glutamate (nmod)
prevalence , (punct)
disease significant (amod)
hemorrhagic surprisingly (advmod)
pretreatment cn (compound)
breakfast before (case)
dosages of (case)
enhances activation (nsubj)
treatment clozapine (compound)
fluorouracil anthracyclines (appos)
loss bradycardia (nmod)
channels hyperpolarization-activated (amod)
region-specific brain (nmod:npmod)
scale staging (conj)
proteases cysteine (compound)
suffered significant (parataxis)
regurgitation and (cc)
affect hemodynamics (dobj)
blocked . (punct)
synthesis salt (compound)
course consequences (nmod)
nimo 6 (nummod)
efficacious likely (conj)
usage pediatric (amod)
rats cocaine-injected (amod)
communicate we (nsubj)
given studies (nsubj)
right and (cc)
extremes the (det)
due cimetidine (nmod)
rr ci (appos)
irritability headaches (conj)
6.9 +/- (cc)
1971 ) (punct)
d3 and (cc)
expression pathogenesis (nmod)
criteria regurgitation (appos)
low demonstrating (advcl)
18 +/- (cc)
cimd ( (punct)
entity related (amod)
patients four (nmod)
ingesting doses (dobj)
analyse propose (conj)
withdrawal treatment (nmod)
disease according (case)
doses metoprolol (nmod)
captopril vehicle (conj)
nc/ia ) (punct)
methylprednisolone recommended (acl)
75 , (punct)
idiosyncrasy lidocaine (nmod)
headache immediate (amod)
intervals week (compound)
aware clinician (nsubj)
predicting outcomes (dobj)
develop we (nsubj)
concentrations neonates (nmod)
performing when (advmod)
nmdars ) (punct)
ratings immediate (amod)
choice . (punct)
amnesia response (nmod)
exposure fluoxetine (compound)
alleviated reversed (conj)
cause dapsone (nsubj)
drug a (det)
viewed caution (nmod)
patients schizophrenia (nmod)
represent targets (dobj)
curves tolerance (compound)
animals overloaded (amod)
underlie mechanisms (nsubj)
granulocytopenia . (punct)
bromide such (case)
once twice (conj)
microm 200 (nummod)
behaviors obsessive-compulsive-like (amod)
administration topical (amod)
osteoporosis dementia (conj)
carriers chronic (amod)
drawbacks hypercalcemia (nmod)
phase crossover (amod)
disorder that (det)
grafts five (nummod)
arterioles glomerular (amod)
simulated treatment (nmod)
examinations by (case)
intervals 4 (nummod)
involvement organ (compound)
protein multidrug (compound)
intermediate administered (advcl)
suggested startle (nsubjpass)
change maximum (amod)
related vulnerability (nmod)
dose mg/day (nmod)
tests vitro (advmod)
given nacl (nsubjpass)
terminology anaphylaxis (nmod)
metabolism glucose (compound)
prevent induction (dobj)
infant born (acl)
5 of (case)
alter decreased (conj)
observed prolongation (nsubjpass)
concentration dph (nmod)
receiving disease (nmod)
abnormalities as (cc)
dextromethorphan by (case)
died edema (nmod)
consumers developed (conj)
have drugs (nsubj)
sec/cm5 ) (punct)
rigidity group (nmod)
fell elevated (advcl)
evaluation long-term (amod)
anemia body (compound)
ventilation therapy (conj)
had trial (nsubj)
skf-82958 for (case)
effect mk-801 (nmod)
hbv hbv (conj)
mania or (cc)
injury with (case)
numbers children (nmod)
enhanced was (auxpass)
dyes targeting (acl)
administration amn082 (nmod)
treatment surgical (amod)
asthmatics in (case)
- 1788 (nummod)
produced thiopental (nmod)
lozenge % (compound)
sham-operated ovariectomized (conj)
data real-world (amod)
conclusion plays (ccomp)
receiving before (mark)
dysfunction paralysis (conj)
sessions pool (nmod)
alf cld (appos)
assessed was (auxpass)
g/m2 days (nmod)
anaesthesia lignocaine (nmod)
action , (punct)
minor been (cop)
total visits (nmod)
number , (punct)
aplasia red (amod)
plasma and (cc)
toxicity drug (compound)
paradigm depression (nmod)
magnitude proteinuria (nmod)
detection assay (conj)
model carrageenan (compound)
recently only (advmod)
2/3 almost (advmod)
shortening progressive (amod)
questionaire structured (amod)
options exemplified (advcl)
nonusers 21 (nummod)
groups fed (acl:relcl)
woman 42-year-old (amod)
source the (det)
region frontotemporal (amod)
increase clinicians (nsubj)
inhibitor transaminase (nmod)
epileptogenic littermates (nmod)
achieve transition (dobj)
induced outpatients (nmod)
dose an (det)
77.1 score (nsubj)
mg diclofenac (compound)
chemotherapy followed (acl)
women healthy (amod)
increased attack (nmod)
scheduled was (auxpass)
unrelated = (dep)
increase average (nmod)
manifests poisoning (nsubj)
patient regurgitation (nmod)
ltp slices (nmod)
dependent receptor (nmod:npmod)
attributed development (nsubjpass)
configuration exencephaly (nmod)
noted diuretic (ccomp)
administered infusion (nmod)
given routinely (advmod)
propranolol reduction (conj)
meq/l from (case)
$ROOT$ exclude (sent)
switched posttransplant (nmod)
intent suicidal (amod)
chick rat (conj)
thymidine in (case)
aza ( (punct)
tremor ( (punct)
rats removed (acl:relcl)
differences . (punct)
micrograms/ml , (punct)
elicited proteinuria (dobj)
efficacy everolimus (nmod)
elevations factor-alpha (nmod)
given controls (nsubjpass)
hypothesize promote (ccomp)
group t+a (compound)
tamoxifen 19 (appos)
136 patients (nmod)
differ incidence (nsubj)
practical doses (nsubj)
cause , (punct)
one drugs (nmod)
involvement mediating (acl)
introduce therapy (dobj)
response mean (compound)
valdecoxib % (appos)
ages both (det)
frequent 11th (amod)
controls as (case)
paroxetine and (cc)
exhibited p (dep)
change neither (cc:preconj)
studies asa (compound)
12 18 (conj)
$ROOT$ resistant (sent)
decreased level (dobj)
generalised and (cc)
explored , (punct)
cleavage hip-his-leu (compound)
biochemical , (punct)
maximal was (cop)
sedative a (det)
1.19 1.01 (parataxis)
superior significantly (advmod)
loads patients (nmod)
6 . (conj)
or also (advmod)
diseases selected (amod)
were follow-up (nmod)
behavior significant (amod)
screen using (xcomp)
failure hepatic (amod)
water chow (conj)
suggested lower (ccomp)
% 8 (appos)
intubated admitted (conj)
pellets chow (compound)
time ( (punct)
case rare (amod)
shown depression (nsubjpass)
cardiology neurology (conj)
inhibitors to (case)
equal to (mwe)
electrophoresis assay (conj)
randall-selitto by (case)
used antibodies (nsubjpass)
betaine mg/kg (appos)
% prl (dep)
increase fk (nsubj)
$ROOT$ prolongs (sent)
experiment during (case)
dystrophin of (case)
determined we (nsubj)
chloramphenicol with (case)
results seen (dep)
difference frequency (nmod)
recovery along (case)
cholesterol cholesterol (conj)
$ROOT$ universal (sent)
infusion i.v. (compound)
anticholinergics to (case)
patients 54 (dep)
receptors striatal (amod)
4.9 interval (compound)
this despite (case)
evaluated complaints (nsubjpass)
transplantation orthotopic (amod)
alive disease (nmod)
acid antagonist (appos)
propagates discharge (nsubj)
theorem model (conj)
high concentration (nsubj)
subjects use (acl:relcl)
a/j swr/j (appos)
80mg/kg/day ) (punct)
have dose (nmod)
administered setting (nmod)
found interpretation (nsubjpass)
injection addition (nmod)
paclitaxel dose (nsubj)
administration lindane (compound)
influence development (nmod)
test carriers (nmod)
required amputation (nsubjpass)
weekly and (cc)
been : (punct)
incidence decreased (amod)
h. garavan (compound)
features children (nmod)
aetiologies the (det)
mmp-timp and (cc)
created spain (nmod)
compliance lowest (amod)
followed-up total (nsubjpass)
( +/- (cc)
resistance catecholamine (compound)
antigen the (det)
hemisphere left (amod)
dialyzer on (case)
phosphatase alkaline (compound)
planes coronal (amod)
secretion on (case)
clinical by (case)
attracted background (nsubj)
walls capillary (compound)
morphine brain (nmod)
differ which (nsubj)
produce all (advmod)
lead breaks (nsubj)
volume ventral (amod)
mass with (case)
hz 2v (conj)
incidents both (det)
syndrome hemoptysis (nmod)
attempted were (auxpass)
resulted embryos (nmod)
cbz of (case)
injection dysphonia (nmod)
hexachloro-1:3-butadiene , (punct)
g/l water (nmod)
cause because (mark)
patients 9,037 (nummod)
group < (dep)
arrest midazolam-associated (amod)
number size (conj)
sessions in (case)
ng.ml-1 ( (punct)
remained 8 (nsubj)
shows suggests (conj)
need urgent (amod)
kept reduced (advcl)
preservation relative (amod)
erythroid endothelial (conj)
ng/dl nl (dep)
observed thrombi (nsubjpass)
cholinesterase atypical (amod)
conclusion(s ): (punct)
pmol platelets (nmod)
resulted infection (nmod)
characteristics hypersensitivity (nmod)
had frequency (conj)
specimen the (det)
activity as (case)
blocked hyperalgesia (nsubjpass)
dyspnea loss (appos)
origin unknown (amod)
number severity (conj)
a1 ) (punct)
induce hemorrhage (dobj)
necessary determination (nsubj)
step at (case)
imaging the (det)
pneumoniae accounted (conj)
studied although (mark)
association . (punct)
reviews . (punct)
growth in (case)
anticoagulated , (punct)
quetiapine with (case)
those used (acl:relcl)
paclitaxel cancer (nmod)
resulted rate (nmod)
any of (case)
utero in (case)
treatment salbutamol (nmod)
asenapine haloperidol (conj)
tone maneuver (appos)
reversed deficits (nsubjpass)
criteria vte (nmod)
therapy single (amod)
size rat (compound)
3.51 to (dep)
history defects (nmod)
lumens in (case)
0.60 pyrazolones (nmod)
mice prepared (acl)
lumen into (case)
% 49 (nummod)
diminished reduced (conj)
drugs combination (nmod)
recommended evaluation (nsubjpass)
edema peripheral (amod)
useful identifying (advcl)
analyses performed (acl)
mediator convulsions (nmod)
hyperalgesia accompanied (acl:relcl)
achieved process (nmod)
theorem and (cc)
5 % (dep)
% none (conj)
controlled should (aux)
tachycardia vt (appos)
therapy nonsteroidal (amod)
specific isoenzymes (nmod)
potentiation progesterone (compound)
mechanism dual (amod)
collected eyes (nmod)
address examine (conj)
rate median (amod)
puberty during (case)
bacteria susceptible (amod)
have sensitization (nsubj)
ketoprofen mg (appos)
performed series (nsubjpass)
mothers disease (nmod)
complex connects (acl:relcl)
carried starting (advcl)
action amphetamine (nmod)
demonstrated specificity (nsubjpass)
mode patients (nmod)
att-alf with (case)
nucleoside and (cc)
returned withholding (advcl)
experienced , (punct)
coma amiodarone-induced (compound)
weight levels (dep)
pressure hypertension (nmod)
study national (compound)
removed time (nmod)
exerts alpha-blocker (nmod)
used h (nmod)
responses atrial (amod)
release vasopressin (nmod)
included users (dobj)
wky ( (punct)
showed activated (ccomp)
dead follow-up (nmod)
concentration increased (amod)
greater < (nmod:npmod)
mutation without (case)
improved follow-up (nmod)
triggered and (cc)
hypotension sap<90mmhg (appos)
cyclosporin gemfibrozil (conj)
damage sbs (compound)
use nonsteroidal (amod)
assessing modulation (dobj)
prescription on (case)
rats months (appos)
investigate role (dobj)
pregnancies their (nmod:poss)
magnitude it (nsubj)
classified disease (nmod)
attenuated amnesia (dobj)
admitted department (nmod)
hemoglobin with (case)
reaction resulting (advcl)
generated interest (dobj)
administered patients (nsubjpass)
sustained which (nsubj)
point the (det)
different placebo (nmod)
$ROOT$ seen (sent)
concentration plasma (nmod)
telaprevir and (cc)
inhibitor a (compound)
morning until (case)
days - (punct)
ci=2.612 95 (compound)
complaints with (nmod)
concentration low (amod)
alkylxanthines of (case)
reverse discontinuation (nmod)
study performed (acl)
correlate density (dobj)
reveal lesions (dobj)
colitis and (cc)
ccr baseline (compound)
modifications rats (nmod)
malaysians among (case)
manipulation fracture (nmod)
trimethaphan the (det)
present disorder (nsubj)
altered may (aux)
identify to (dep)
mothers hepatitis (compound)
gained patients (nsubj)
exhibited animals (nsubj)
group high (amod)
effects proarrhythmic (amod)
administered was (auxpass)
mm 0.135 (nummod)
patients analysed (dep)
d-glucarates among (case)
successful attempts (nsubj)
124.4+/-73.4 and (cc)
implicated , (punct)
isolated , (punct)
improved performance (dobj)
cip ) (punct)
epicardium , (punct)
increase cocaine-induced (amod)
scale either (dep)
mechanisms renal (amod)
pretreatment mk-801 (nmod)
cause bromocriptine (nsubj)
treatment levomepromazine-fluvoxamine (compound)
disease graft-versus-host (compound)
imbalance been (cop)
issues relating (acl)
management removal (nmod)
action pressor (compound)
found homozygous (xcomp)
arrest following (case)
abnormalities electrophysiological (amod)
had she (nsubj)
ovarian and (cc)
plugs , (punct)
attempt titrate (xcomp)
pathogenesis nephrotoxicity (nmod)
metaiodobenzylguanidine radiolabeled (amod)
higher group (advcl)
autonomic and (cc)
compatible syndrome (nmod)
discriminates causes (nmod)
tended lesions (nsubj)
remained . (punct)
reabsorption proteins (nmod)
treatment conclusion (compound)
nondrinkers who (nsubj)
agents anticholinergic (amod)
used methimazole (nsubj)
puncture antral (amod)
decreasing increasing (conj)
showed mpa (nsubj)
nigerians 358 (nummod)
micromol/l 84 (nummod)
344 and (cc)
treated benztropine (nmod:npmod)
concentration regions (nmod)
association medications (nmod)
formyltransferase enzyme (appos)
hemolysis intravascular (amod)
boy on (case)
$ROOT$ potentiated (sent)
cbd ( (punct)
studied injections (nmod)
performed mris (nsubjpass)
seen toxicity (nsubjpass)
methimazole tid (appos)
prevented completely (advmod)
activity antineoplastic (amod)
disturbance associated (acl)
variation gene (nmod)
disappeared leukocyturia (nsubj)
resemblance closest (amod)
involved develop (advcl)
inhibitors cyclooxygenase-2 (compound)
treatment ketoconazole (nmod)
safety ht (nmod)
weeks % (conj)
seizures nmda (compound)
rbcs non-dapsone-exposed (amod)
clentiazem with (case)
apparatus golgi (compound)
compare rate (dobj)
investigated type (nmod)
however experiment (nmod)
prevents development (dobj)
neutropenia due (case)
consumption media (nmod)
underwent angiography (dobj)
background aimed (dep)
necessitated , (punct)
328 +/- (cc)
having encephalopathy (dobj)
recognized also (advmod)
h rizatriptan (dep)
number few (amod)
physiology evaluation (conj)
completion hours (conj)
auc ( (punct)
del -141cins (compound)
patients controls (conj)
determined therefore (advmod)
side on (case)
indicate acted (ccomp)
act should (aux)
remained months (nmod)
0.003 0.001 (conj)
methods administration (nmod)
3.9 2.9 (conj)
exhibited affinity (dobj)
therapy are (cop)
shows which (nsubj)
day 42 (nummod)
contribute conditions (nmod)
considered to (mark)
affected minimally (advmod)
failed provide (xcomp)
palpitation type (appos)
cisplatinum ) (punct)
disruption a (det)
release by (case)
patient diabetic (amod)
partial and (cc)
midazolan and (cc)
therapy fluvastatin (compound)
apap excreted (acl)
1/10 number (nmod)
operation after (case)
rate extent (conj)
indicates resolved (ccomp)
2.4 % (compound)
glycopyrrolate or (cc)
exert that (nsubj)
occurred when (advmod)
kinase elevated (amod)
managed patients (nsubjpass)
nervousness , (punct)
medication associated (acl)
lungs kidneys (conj)
discussed discussed (conj)
aware discontinue (advcl)
cvd known (amod)
explain , (punct)
levels for (case)
recurrence from (case)
remained treated (advcl)
reduced pressure (nsubjpass)
markers other (amod)
10 8 (quantmod)
showed development (nmod)
children these (det)
months 23.6 (nummod)
saline- morphine/rg1-treated (conj)
signs parameters (conj)
ci-921 nsc (appos)
45 10 (compound)
morphine tyr-d-ala-gly-nme-phe-gly-ol (conj)
unit facility (nmod)
determine is (ccomp)
mg/m2 administered (acl)
substitution lithium (nmod)
more 20,000fold (nmod:npmod)
lead may (aux)
block jerks (dobj)
doses fully-effective (amod)
interval longer (amod)
resistance iso (compound)
had treatment (nsubj)
noted fingers (nmod)
mice nrf2(+/+ (amod)
100 greater (advmod)
furosemide surreptitious (amod)
noted hemoglobinuria (nsubjpass)
risk malignancy (nmod)
material matched (dep)
lethargy , (punct)
dp/dtejc ( (punct)
camperdown , (punct)
design study (dep)
case this (nmod)
efficacy long-term (amod)
drugs tricyclic (amod)
3'-azido-2',3'-deoxythymidine ( (punct)
role effect (dep)
sample a (det)
comparison placebo (nmod)
found case (advcl)
lumen of (case)
prevents : (punct)
81.5 = (parataxis)
k+ in (case)
concentration cerebrospinal (amod)
induced remained (conj)
i bipolar (amod)
treat cause (xcomp)
concentrations , (punct)
cirrhosis in (case)
demonstration relationship (nmod)
need transplantation (dobj)
glomerulopathy tg (appos)
greater mg/kg (nmod)
induced occlusion (nmod)
coefficient ( (punct)
survival nephrosis (conj)
utilized dextran (nsubjpass)
n=12 ( (punct)
method simple (amod)
fetuses rat (compound)
a with (case)
portions in (case)
agonist site (nmod)
induced administration (nmod)
nitrazepam + (cc)
recur had (conj)
suggesting roles (dobj)
restores rg1 (nsubj)
need development (nmod)
evaluation class (nmod)
conclusions difficult (appos)
changes headache (nmod)
amines the (det)
with uh (intj)
develops syndrome (nsubj)
measured parameters (dobj)
monitored while (mark)
presented p (dep)
effective and (cc)
present exacerbations (nmod)
excluded been (auxpass)
etiology atheromatous (amod)
induces anxiety (dobj)
included group (nsubj)
termination to (case)
loss potential (nmod)
increase glutamate (nmod)
beats/min 98.7 (nummod)
f and (cc)
reactions immunological (amod)
ranitidine for (case)
significance with (case)
ed50 plasma (nmod)
ml/kg suspension (nmod)
minimal-type mild-type (conj)
value control (amod)
twenty-eight hundred (compound)
concentrations fasting (amod)
abstracted rated (conj)
$ROOT$ compares (sent)
change such (amod)
serum heart (conj)
mpo-anca manifestations (conj)
observed chicks (nmod)
dfp bw (appos)
managed can (aux)
activity thalidomide (nmod)
using not (neg)
tests patch (compound)
demonstrated identified (ccomp)
nte ) (punct)
measured latencies (nsubj)
used hypothermia (nsubjpass)
patients 12 (nummod)
products as (cc)
$ROOT$ kf17837 (sent)
adriamycin ) (punct)
correlated p (dep)
tachycardia bromocriptine-induced (amod)
supply the (det)
induced effects (nsubjpass)
increase moderate (amod)
dnap and (cc)
prl serum (compound)
depletion potassium (compound)
regulation via (case)
study nested (amod)
aminonucleoside to (case)
mice treated (acl)
drug amiodarone (nsubj)
mg/dl 147 (nummod)
measured tremor (nmod)
patients likely (amod)
enucleation subsequent (amod)
600 and (cc)
resulting similar (xcomp)
encephalopathy valproate (compound)
buffer in (case)
agents mofetil (appos)
seriousness and (cc)
psoriasis from (case)
thought was (auxpass)
exposed background (nsubjpass)
change cells (nmod)
produce test (nmod)
higher drugs (nmod)
$ROOT$ inconsistent (sent)
factor-beta1 of (case)
diet 6-g/d (compound)
few and (cc)
% = (parataxis)
impairment enzymes (nmod)
withdrawal propranolol (nmod)
difficulties movement (compound)
use pill (compound)
induction insufficiency (nmod)
$ROOT$ haemopericardium (sent)
presence independently (advmod)
blindness , (punct)
dose-dependent and (cc)
related disorder (nsubj)
improve withdrawn (advcl)
modify motility (dobj)
have anemia (dobj)
$ROOT$ critical (sent)
kappa cyclohexyl]benzeneactemide (appos)
magnitude att-alf (nmod)
coniine nicotine (conj)
organization from (case)
rls on (case)
augment did (aux)
levels aldosterone (compound)
$UNK$